PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Sasi, SP; Rahimi, L; Yan, XH; Silver, M; Qin, GJ; Losordo, DW; Kishore, R; Goukassian, DA				Sasi, Sharath P.; Rahimi, Layla; Yan, Xinhua; Silver, Marcy; Qin, Gangjian; Losordo, Douglas W.; Kishore, Raj; Goukassian, David A.			Genetic deletion of TNFR2 augments inflammatory response and blunts satellite-cell-mediated recovery response in a hind limb ischemia model	FASEB JOURNAL			English	Article						apoptosis; muscle regeneration; proliferation; TNF-TNFR2/p75 signaling	NECROSIS-FACTOR-ALPHA; ENDOTHELIAL PROGENITOR CELLS; FIBROBLAST-GROWTH-FACTOR; SKELETAL-MUSCLE; STEM-CELL; RECEPTOR EXPRESSION; MYOGENIC DIFFERENTIATION; SIGNAL-TRANSDUCTION; ANGIOGENIC ACTIVITY; IFN-GAMMA	We have previously shown that TNF-tumor necrosis factor receptor-2/p75 (TNFR2/p75) signaling plays a critical role in ischemia-induced neovascularization in skeletal muscle and heart tissues. To determine the role of TNF-TNFR2/p75 signaling in ischemia-induced inflammation and muscle regeneration, we subjected wildtype (WT) and TNFR2/p75 knockout (p75KO) mice to hind limb ischemia (HLI) surgery. Ischemia induced significant and long-lasting inflammation associated with considerable decrease in satellite-cell activation in p75KO muscle tissue up to 10 d after HLI surgery. To determine the possible additive negative roles of tissue aging and the absence of TNFR2/p75, either in the tissue or in the bone marrow(BM), we generated 2 chimeric BM transplantation (BMT) models where both young green fluorescent protein (GFP)-positive p75KO and WT BM-derived cells were transplanted into adult p75KO mice. HLI surgery was performed 1 mo after BMT, after confirming complete engraftment of the recipient BM with GFP donor cells. In adult p75KO with the WT-BMT, proliferative (Ki67(+)) cells were detected only by d 28 and were exclusively GFP(+), suggesting significantly delayed contribution of young WT-BM cell to adult p75KO ischemic tissue recovery. No GFP(+) young p75KO BM cells survived in adult p75KO tissue, signifying the additive negative roles of tissue aging combined with decreased/absent TNFR2/p75 signaling in postischemic recovery.	[Sasi, Sharath P.; Rahimi, Layla; Yan, Xinhua; Silver, Marcy; Goukassian, David A.] GeneSys Res Inst, Cardiovasc Res Ctr, Boston, MA USA; [Yan, Xinhua; Goukassian, David A.] Tufts Univ, Sch Med, Boston, MA 02135 USA; [Qin, Gangjian; Losordo, Douglas W.] Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc Inst, Chicago, IL 60611 USA; [Kishore, Raj] Temple Univ, Ctr Translat Med, Sch Med, Philadelphia, PA 19122 USA	Tufts University; Northwestern University; Feinberg School of Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Goukassian, DA (corresponding author), Tufts Univ, Sch Med, Cardiovasc Res Ctr, GeneSys Res Inst, 736 Cambridge St,CBR-340, Boston, MA 02135 USA.	david.goukassian@tufts.edu		Goukassian, David/0000-0001-5270-5270; Losordo, Douglas/0000-0002-6857-7506	U.S. National Institutes of Health (NIH) [R21-AG02677]; U.S. American Heart Association [0630113N, 14GRNT18860032]; NASA [NNJ10ZSA001N]; NIH National Heart, Lung, and Blood Institute [HL106098, HL091983]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL106098, R01HL091983] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. American Heart Association; NASA(National Aeronautics & Space Administration (NASA)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank A. Perepletchikov, clinical pathologist and our collaborator from Steward St. Elizabeth's Medical Center. Dr. Perepletchikov submitted full histopathologic reports of all H&E-stained samples, analyzed the data, and contributed to the writing of the sections pertaining to these data. The authors would also like to thank A. Kiladjian and J. Schawb, graduate interns in our laboratory, for all their help with frozen tissue sectioning, immunofluorescence staining, confocal microscopy. and data quantification. Supported by U.S. National Institutes of Health (NIH) Grant R21-AG02677, U.S. American Heart Association Grants 0630113N and 14GRNT18860032, and NASA Grant NNJ10ZSA001N to D.A.G.; and by grants from NIH National Heart, Lung, and Blood Institute HL106098 to X.Y. and HL091983 to R.K.	Aggarwal S, 1999, J IMMUNOL, V162, P2154; Akbarshahi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042654; Arras M, 1998, J CLIN INVEST, V101, P40, DOI 10.1172/JCI119877; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; AUGUSTINVOSS HG, 1993, J CELL PHYSIOL, V157, P279, DOI 10.1002/jcp.1041570210; BECK LS, 1993, J CLIN INVEST, V92, P2841, DOI 10.1172/JCI116904; BENEZRA D, 1990, ARCH OPHTHALMOL-CHIC, V108, P573, DOI 10.1001/archopht.1990.01070060121061; Biressi S, 2013, DEV BIOL, V379, P195, DOI 10.1016/j.ydbio.2013.04.021; BISCHOFF R, 1989, MED SCI SPORT EXER, V21, pS164; Botchkina GI, 1997, MOL MED, V3, P765, DOI 10.1007/BF03401714; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; Cabral A. J. V., 2008, EXP PATHOL HLTH SCI, V2, P9; Capkovic KL, 2008, EXP CELL RES, V314, P1553, DOI 10.1016/j.yexcr.2008.01.021; Chandrasekharan UM, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003743; Charles KA, 2009, J CLIN INVEST, V119, P3011, DOI 10.1172/JCI39065; Chen SE, 2005, AM J PHYSIOL-CELL PH, V289, pC1179, DOI 10.1152/ajpcell.00062.2005; Chen SE, 2007, AM J PHYSIOL-CELL PH, V292, pC1660, DOI 10.1152/ajpcell.00486.2006; Couffinhal T, 1998, AM J PATHOL, V152, P1667; Crameri RM, 2004, J PHYSIOL-LONDON, V558, P333, DOI 10.1113/jphysiol.2004.061846; Cunningham O, 2009, GLIA, V57, P1802, DOI 10.1002/glia.20892; Duran WN, 2008, AM J PHYSIOL-HEART C, V295, pH2221, DOI 10.1152/ajpheart.01050.2008; Edelberg JM, 2003, FRONT BIOSCI-LANDMRK, V8, pS1199, DOI 10.2741/1166; ERNST DN, 1993, J IMMUNOL, V151, P575; Faustman DL, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00478; Frasca D, 2000, BONE MARROW TRANSPL, V25, P427, DOI 10.1038/sj.bmt.1702169; FRATERSCHRODER M, 1987, P NATL ACAD SCI USA, V84, P5277, DOI 10.1073/pnas.84.15.5277; GORDON HM, 1992, J IMMUNOL, V148, P4021; Goukassian DA, 2007, CIRCULATION, V115, P752, DOI 10.1161/CIRCULATIONAHA.106.647255; Grounds MD, 2002, J HISTOCHEM CYTOCHEM, V50, P589, DOI 10.1177/002215540205000501; Gu Q, 2006, J CARDIOVASC PHARM, V48, P320, DOI 10.1097/01.fjc.0000250079.46526.38; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Haldar M, 2008, DEV CELL, V14, P437, DOI 10.1016/j.devcel.2008.01.002; Harrison ML, 2007, J CLIN ONCOL, V25, P4542, DOI 10.1200/JCO.2007.11.2136; Hill M, 2003, J ANAT, V203, P89, DOI 10.1046/j.1469-7580.2003.00195.x; Hoefer IE, 2002, CIRCULATION, V105, P1639, DOI 10.1161/01.CIR.0000014987.32865.8E; Hoffmann J, 2001, CIRC RES, V89, P709, DOI 10.1161/hh2001.097796; Hohenberger P, 2003, ANN SURG ONCOL, V10, P562, DOI 10.1245/ASO.2003.10.005; JACOBSEN SEW, 1994, STEM CELLS, V12, P111; Jasielska M, 2010, INVEST OPHTH VIS SCI, V51, P3874, DOI 10.1167/iovs.09-5003; Kadi F, 2004, MUSCLE NERVE, V29, P120, DOI 10.1002/mus.10510; Kaiser GC, 1997, GASTROENTEROLOGY, V112, P1231, DOI 10.1016/S0016-5085(97)70135-5; Kaiser GC, 1999, EXP CELL RES, V249, P349, DOI 10.1006/excr.1999.4488; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kamihata H, 2001, CIRCULATION, V104, P1046, DOI 10.1161/hc3501.093817; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Kishore R, 2011, ADV EXP MED BIOL, V691, P433, DOI 10.1007/978-1-4419-6612-4_45; Kondo S, 1997, EUR J IMMUNOL, V27, P1713, DOI 10.1002/eji.1830270718; Kronke M, 1992, Immunol Ser, V56, P189; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Kulbe H, 2007, CANCER RES, V67, P585, DOI 10.1158/0008-5472.CAN-06-2941; Kuru S, 2003, ACTA NEUROPATHOL, V105, P217, DOI 10.1007/s00401-002-0632-4; Langen RCJ, 2002, AM J PHYSIOL-CELL PH, V283, pC714, DOI 10.1152/ajpcell.00418.2001; Langen RCJ, 2001, FASEB J, V15, P1169, DOI 10.1096/fj.00-0463; LEEUWENBERG JFM, 1995, CYTOKINE, V7, P457, DOI 10.1006/cyto.1995.0062; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; Li YP, 2001, FASEB J, V15, P1413, DOI 10.1096/fj.00-0632fje; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Maddahi A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-107; Marinho A, 1997, PATHOL RES PRACT, V193, P267; Mizoguchi E, 2002, GASTROENTEROLOGY, V122, P134, DOI 10.1053/gast.2002.30347; Mogford JE, 2002, J CELL PHYSIOL, V190, P259, DOI 10.1002/JCP.10060; Monden Y, 2007, AM J PHYSIOL-HEART C, V293, pH743, DOI 10.1152/ajpheart.00166.2007; Nissen NN, 1998, AM J PATHOL, V152, P1445; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Oshima H, 2014, ONCOGENE, V33, P3820, DOI 10.1038/onc.2013.356; Pownall ME, 2002, ANNU REV CELL DEV BI, V18, P747, DOI 10.1146/annurev.cellbio.18.012502.105758; Reed MJ, 2000, J CELL BIOCHEM, V77, P116, DOI 10.1002/(SICI)1097-4644(20000401)77:1<116::AID-JCB12>3.3.CO;2-Z; Renault V, 2003, AGING CELL, V2, P71; Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111; Ruspi G, 2014, CELL SIGNAL, V26, P683, DOI 10.1016/j.cellsig.2013.12.009; Sack MN, 2002, PHARMACOL THERAPEUT, V94, P123, DOI 10.1016/S0163-7258(02)00176-6; Sadoun E, 2003, J HISTOCHEM CYTOCHEM, V51, P1119, DOI 10.1177/002215540305100902; SAINI A, 1993, LIFE SCI, V52, P1759, DOI 10.1016/0024-3205(93)90464-E; SARZANI R, 1991, HYPERTENSION, V17, P888, DOI 10.1161/01.HYP.17.6.888; Sasi SP, 2012, ONCOGENE, V31, P4117, DOI 10.1038/onc.2011.567; SATO N, 1987, J NATL CANCER I, V79, P1383; SCHULTZ E, 1994, REV PHYSIOL BIOCH P, V123, P213, DOI 10.1007/BFb0030904; Shi XZ, 2006, GENE DEV, V20, P1692, DOI 10.1101/gad.1419406; SMITH CA, 1994, CELL, V76, P959, DOI 10.1016/0092-8674(94)90372-7; Speeckaert MM, 2012, AM J NEPHROL, V36, P261, DOI 10.1159/000342333; Spencer MJ, 2000, NEUROMUSCULAR DISORD, V10, P612, DOI 10.1016/S0960-8966(00)00160-7; SQUADRITO F, 1993, EUR J PHARMACOL, V237, P223, DOI 10.1016/0014-2999(93)90272-J; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Tan JN, 2010, SHOCK, V34, P236, DOI 10.1097/SHK.0b013e3181d75ae3; TARTAGLIA LA, 1991, P NATL ACAD SCI USA, V88, P9292, DOI 10.1073/pnas.88.20.9292; Taubitz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068167; Trendelenburg AU, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-3; Valdez MR, 2000, DEV BIOL, V219, P287, DOI 10.1006/dbio.2000.9621; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Wajant H, 2009, RESULTS PROBL CELL D, V49, P1, DOI 10.1007/400_2008_26; WONG GHW, 1994, J IMMUNOL, V152, P1751; YAMAURA H, 1980, EXP GERONTOL, V15, P145, DOI 10.1016/0531-5565(80)90086-8; Yoshida S, 1997, MOL CELL BIOL, V17, P4015, DOI 10.1128/MCB.17.7.4015; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zhang Y., 2013, MATH PROB ENG, V2013, DOI DOI 10.4018/JIIT.2013010101	96	3	3	2	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1208	1219		10.1096/fj.14-249813	http://dx.doi.org/10.1096/fj.14-249813			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25466901	Green Published			2022-12-26	WOS:000354115000010
J	Mazagova, M; Wang, LR; Anfora, AT; Wissmueller, M; Lesley, SA; Miyamoto, Y; Eckmann, L; Dhungana, S; Pathmasiri, W; Sumner, S; Westwater, C; Brenner, DA; Schnabl, B				Mazagova, Magdalena; Wang, Lirui; Anfora, Andrew T.; Wissmueller, Max; Lesley, Scott A.; Miyamoto, Yukiko; Eckmann, Lars; Dhungana, Suraj; Pathmasiri, Wimal; Sumner, Susan; Westwater, Caroline; Brenner, David A.; Schnabl, Bernd			Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice	FASEB JOURNAL			English	Article						bacterial translocation; innate immune system; microbiome	INTESTINAL MICROBIOME; INNATE IMMUNITY; INDUCED COLITIS; GUT MICROBIOTA; BACTERIAL TRANSLOCATION; INDOLE-3-PROPIONIC ACID; HEPATIC-FIBROSIS; STELLATE CELLS; PROTECTS MICE; DISEASE	Translocation of bacteria and their products across the intestinal barrier is common in patients with liver disease, and there is evidence that experimental liver fibrosis depends on bacterial translocation. The purpose of our study was to investigate liver fibrosis in conventional and germ-free (GF) C57BL/6 mice. Chronic liver injury was induced by administration of thioacetamide (TAA) in the drinking water for 21 wk or by repeated intraperitoneal injections of carbon tetrachloride (CCl4). Increased liver fibrosis was observed in GF mice compared with conventional mice. Hepatocytes showed more toxin-induced oxidative stress and cell death. This was accompanied by increased activation of hepatic stellate cells, but hepatic mediators of inflammation were not significantly different. Similarly, a genetic model using Myd88/Trif-deficient mice, which lack downstream innate immunity signaling, had more severe fibrosis than wild-type mice. Isolated Myd88/Trif-deficient hepatocytes were more susceptible to toxin-induced cell death in culture. In conclusion, the commensal microbiota prevents fibrosis upon chronic liver injury in mice. This is the first study describing a beneficial role of the commensal microbiota in maintaining liver homeostasis and preventing liver fibrosis.	[Mazagova, Magdalena; Wang, Lirui; Wissmueller, Max; Miyamoto, Yukiko; Eckmann, Lars; Brenner, David A.; Schnabl, Bernd] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Wang, Lirui; Schnabl, Bernd] VA San Diego Healthcare Syst, Dept Med, San Diego, CA USA; [Anfora, Andrew T.; Lesley, Scott A.] Novartis Res Fdn, Genom Inst, San Diego, CA USA; [Dhungana, Suraj; Pathmasiri, Wimal; Sumner, Susan] RTI Int, Syst & Translat Sci, Res Triangle Pk, NC USA; [Westwater, Caroline] Med Univ S Carolina, Dept Oral Hlth Sci, Charleston, SC 29425 USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; Novartis; Research Triangle Institute; Medical University of South Carolina	Schnabl, B (corresponding author), Univ Calif San Diego, Dept Med, MC0063,9500 Gilman Dr, La Jolla, CA 92093 USA.	beschnabl@ucsd.edu	Westwater, Caroline/AAZ-9217-2020	Westwater, Caroline/0000-0001-9329-2513; Sumner, Susan/0000-0003-3381-6084; Miyamoto, Yukiko/0000-0001-5650-699X; Brenner, David/0000-0003-2573-525X; Anfora, Andrew/0000-0003-3849-1784; Pathmasiri, Wimal/0000-0002-5199-5744	U.S. National Institutes of Health (NIH) [K08-DK081830, R01-AA020703, U01-AA021856, 2P42-ES010337]; Biomedical Laboratory Research & Development Service of the VA Office of Research and Development [1I01BX002213]; National Gnotobiotic Rodent Resource Center at the University of North Carolina in Chapel Hill [P40RR018603, P30-DK34987]; NIH Grant [P30 GM103331]; NIH Eastern Regional Comprehensive Metabolomics Resource Core [1U24DK097193]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR018603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK097193, K08DK081830, P30DK034987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020703, U01AA021856] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010995] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002213] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Laboratory Research & Development Service of the VA Office of Research and Development; National Gnotobiotic Rodent Resource Center at the University of North Carolina in Chapel Hill; NIH Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Eastern Regional Comprehensive Metabolomics Resource Core; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Drs. Richard Glynne, Alan Hofmann, Reiner Wiest, Balfour Sartor, Dimitrios Moskophidis, and Eric Johnson for helpful discussion. The study was supported in part by the U.S. National Institutes of Health (NIH) Grants K08-DK081830, R01-AA020703 (to B.S.), U01-AA021856 (to B.S. and D.A.B.), and 2P42-ES010337 (to D.A.B.). The project described was supported by Award Number 1I01BX002213 from the Biomedical Laboratory Research & Development Service of the VA Office of Research and Development (to B.S.). The authors acknowledge The National Gnotobiotic Rodent Resource Center Grants P40RR018603 and P30-DK34987 at the University of North Carolina in Chapel Hill for providing GF mice. The MUSC Gnotobiotic Animal Core is supported by the NIH Grant P30 GM103331. The IPA analysis was conducted under RTI Internal Research and Development Funds and in part by the NIH Eastern Regional Comprehensive Metabolomics Resource Core (Grant 1U24DK097193). None of the authors has a financial, personal or professional conflict of interest to disclose.	Abu-Shanab A, 2010, NAT REV GASTRO HEPAT, V7, P691, DOI 10.1038/nrgastro.2010.172; ADACHI Y, 1995, GASTROENTEROLOGY, V108, P218, DOI 10.1016/0016-5085(95)90027-6; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Bjorkholm B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006958; Brandl K, 2010, P NATL ACAD SCI USA, V107, P19967, DOI 10.1073/pnas.1014669107; Brandl K, 2009, P NATL ACAD SCI USA, V106, P3300, DOI 10.1073/pnas.0813036106; Cesaro C, 2011, DIGEST LIVER DIS, V43, P431, DOI 10.1016/j.dld.2010.10.015; Chen P, 2015, HEPATOLOGY, V61, P883, DOI 10.1002/hep.27489; Chen P, 2015, GASTROENTEROLOGY, V148, P203, DOI 10.1053/j.gastro.2014.09.014; Chyan YJ, 1999, J BIOL CHEM, V274, P21937, DOI 10.1074/jbc.274.31.21937; DeMinicis S, 2014, HEPATOLOGY, V59, P1738, DOI 10.1002/hep.26695; Enomoto N, 1998, GASTROENTEROLOGY, V115, P443, DOI 10.1016/S0016-5085(98)70211-2; Fouts DE, 2012, J HEPATOL, V56, P1283, DOI 10.1016/j.jhep.2012.01.019; Frances R, 2008, HEPATOLOGY, V47, P978, DOI 10.1002/hep.22083; Gabele E, 2008, BIOCHEM BIOPH RES CO, V376, P271, DOI 10.1016/j.bbrc.2008.08.096; Gotoh T, 2004, CELL DEATH DIFFER, V11, P390, DOI 10.1038/sj.cdd.4401369; Guo X, 2008, LETT APPL MICROBIOL, V47, P367, DOI 10.1111/j.1472-765X.2008.02408.x; Hartmann P, 2013, HEPATOLOGY, V58, P108, DOI 10.1002/hep.26321; Hartmann P, 2012, GASTROENTEROLOGY, V143, P1330, DOI 10.1053/j.gastro.2012.07.099; Henao-Mejia J, 2013, J AUTOIMMUN, V46, P66, DOI 10.1016/j.jaut.2013.07.001; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Hritz I, 2008, HEPATOLOGY, V48, P1224, DOI 10.1002/hep.22470; Huang HJ, 2007, HEPATOLOGY, V46, P297, DOI 10.1002/hep.21695; Isayama F, 2006, AM J PHYSIOL-GASTR L, V290, pG1318, DOI 10.1152/ajpgi.00405.2005; Iwaisako K, 2012, P NATL ACAD SCI USA, V109, pE1369, DOI 10.1073/pnas.1202464109; Jeong WI, 2006, HEPATOLOGY, V44, P1441, DOI 10.1002/hep.21419; Kang JS, 2008, TOXICOL APPL PHARM, V228, P295, DOI 10.1016/j.taap.2007.11.010; Karbownik M, 2001, J CELL BIOCHEM, V81, P507, DOI 10.1002/1097-4644(20010601)81:3<507::AID-JCB1064>3.0.CO;2-M; Kim DG, 2002, J BIOL CHEM, V277, P38930, DOI 10.1074/jbc.M205941200; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; Kitajima S, 2001, EXP ANIM TOKYO, V50, P387, DOI 10.1538/expanim.50.387; Lai WL, 2005, FREE RADICAL BIO MED, V38, P1585, DOI 10.1016/j.freeradbiomed.2005.02.024; LIN RS, 1995, J HEPATOL, V22, P165, DOI 10.1016/0168-8278(95)80424-2; Maeda H, 2003, FEMS IMMUNOL MED MIC, V39, P81, DOI 10.1016/S0928-8244(03)00224-4; Manna Z, 1996, GASTROENTEROLOGY, V110, P1150, DOI 10.1053/gast.1996.v110.pm8613004; Nakanishi Y, 2006, APPL ENVIRON MICROB, V72, P6271, DOI 10.1128/AEM.00477-06; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Ostman S, 2006, EUR J IMMUNOL, V36, P2336, DOI 10.1002/eji.200535244; Paik YH, 2011, HEPATOLOGY, V53, P1730, DOI 10.1002/hep.24281; Pascual S, 2003, HEPATO-GASTROENTEROL, V50, P1482; Pils MC, 2011, INFLAMM BOWEL DIS, V17, P2038, DOI 10.1002/ibd.21587; Rabot S, 2010, FASEB J, V24, P4948, DOI 10.1096/fj.10-164921; Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055; Rath HC, 2001, INFECT IMMUN, V69, P2277, DOI 10.1128/IAI.69.4.2277-2285.2001; Rivera CA, 2001, AM J PHYSIOL-GASTR L, V281, pG200, DOI 10.1152/ajpgi.2001.281.1.G200; Roh YS, 2014, HEPATOLOGY, V60, P237, DOI 10.1002/hep.26981; Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253; Schnabl B, 2001, HEPATOLOGY, V34, P89, DOI 10.1053/jhep.2001.25349; Schnabl B, 2008, NAT CLIN PRACT GASTR, V5, P496, DOI 10.1038/ncpgasthep1200; Schnabl B, 2014, GASTROENTEROLOGY, V146, P1513, DOI 10.1053/j.gastro.2014.01.020; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Seki E, 2012, J PHYSIOL-LONDON, V590, P447, DOI 10.1113/jphysiol.2011.219691; Strauch UG, 2005, GUT, V54, P1546, DOI 10.1136/gut.2004.059451; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; Ueki T, 1999, NAT MED, V5, P226, DOI 10.1038/5593; Wang LR, 2014, J HEPATOL, V60, P1259, DOI 10.1016/j.jhep.2014.02.012; Westwater C, 2007, FEMS IMMUNOL MED MIC, V51, P134, DOI 10.1111/j.1574-695X.2007.00287.x; Wigg AJ, 2001, GUT, V48, P206, DOI 10.1136/gut.48.2.206; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Wise MG, 2007, J APPL MICROBIOL, V102, P1138, DOI 10.1111/j.1365-2672.2006.03153.x; Yan AW, 2011, HEPATOLOGY, V53, P96, DOI 10.1002/hep.24018; Yin S, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/750904; Zhang W, 2010, EUR J GASTROEN HEPAT, V22, P1481, DOI 10.1097/MEG.0b013e32833eb8b0	64	114	119	1	38	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					1043	1055		10.1096/fj.14-259515	http://dx.doi.org/10.1096/fj.14-259515			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25466902	Green Published			2022-12-26	WOS:000350633000028
J	Kular, J; Tickner, JC; Pavlos, NJ; Viola, HM; Abel, T; Lim, BS; Yang, XH; Chen, HH; Cook, R; Hool, LC; Zheng, MH; Xu, JK				Kular, Jasreen; Tickner, Jennifer C.; Pavlos, Nathan J.; Viola, Helena M.; Abel, Tamara; Lim, Bay Sie; Yang, Xiaohong; Chen, Honghui; Cook, Robert; Hool, Livia C.; Zheng, Ming Hao; Xu, Jiake			Choline Kinase beta Mutant Mice Exhibit Reduced Phosphocholine, Elevated Osteoclast Activity, and Low Bone Mass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; PHOSPHATIDYLCHOLINE METABOLISM; CHOLINE/ETHANOLAMINE KINASE; SIGNALING PATHWAY; MINERAL DENSITY; RANKL; LIGAND; DIFFERENTIATION; INVOLVEMENT; DISRUPTION	The maintenance of bone homeostasis requires tight coupling between bone-forming osteoblasts and bone-resorbing osteoclasts. However, the precise molecular mechanism(s) underlying the differentiation and activities of these specialized cells are still largely unknown. Here, we identify choline kinase beta (CHKB), a kinase involved in the biosynthesis of phosphatidylcholine, as a novel regulator of bone homeostasis. Choline kinase beta mutant mice (flp/flp) exhibit a systemic low bone mass phenotype. Consistently, osteoclast numbers and activity are elevated in flp/flp mice. Interestingly, osteoclasts derived from flp/flp mice exhibit reduced sensitivity to excessive levels of extracellular calcium, which could account for the increased bone resorption. Conversely, supplementation of cytidine 5'-diphosphocholine in vivo and in vitro, a regimen that bypasses CHKB deficiency, restores osteoclast numbers to physiological levels. Finally, we demonstrate that, in addition to modulating osteoclast formation and function, loss of CHKB corresponds with a reduction in bone formation by osteoblasts. Taken together, these data posit CHKB as a new modulator of bone homeostasis.	[Kular, Jasreen; Tickner, Jennifer C.; Lim, Bay Sie; Cook, Robert; Xu, Jiake] Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia; [Pavlos, Nathan J.; Zheng, Ming Hao] Univ Western Australia, Ctr Orthopaed Res, Sch Surg, Nedlands, WA 6009, Australia; [Viola, Helena M.; Hool, Livia C.] Univ Western Australia, Sch Anat Physiol & Human Biol, Nedlands, WA 6009, Australia; [Abel, Tamara] Univ Western Australia, Ctr Microscopy Characterizat & Anal, Nedlands, WA 6009, Australia; [Yang, Xiaohong; Chen, Honghui] Jinan Univ, Guangzhou Inst Traumat Surg, Affiliated Hosp 4, Coll Med, Guangzhou 510182, Guangdong, Peoples R China	University of Western Australia; University of Western Australia; University of Western Australia; University of Western Australia; Jinan University	Xu, JK (corresponding author), Univ Western Australia, Sch Pathol & Lab Med, Nedlands, WA 6009, Australia.	jiake.xu@uwa.edu.au	Hool, Livia C/H-5059-2014; Tickner, Jennifer/H-5965-2014	Hool, Livia C/0000-0001-7758-5252; Tickner, Jennifer/0000-0002-5020-0671; Pavlos, Nathan/0000-0001-7003-188X; Zheng, Minghao/0000-0003-1185-4768; Xu, Jiake/0000-0003-2021-8309	National Health and Medical Research Council; National Natural Science Foundation of China [81228013]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the National Health and Medical Research Council and by Grant 81228013 from the National Natural Science Foundation of China.	Adibhatla R, 2005, NEUROCHEM RES, V30, P15, DOI 10.1007/s11064-004-9681-8; Amblard D, 2003, J BONE MINER RES, V18, P561, DOI 10.1359/jbmr.2003.18.3.561; Aoyama C, 2004, PROG LIPID RES, V43, P266, DOI 10.1016/j.plipres.2003.12.001; Aoyama C, 1998, BBA-LIPID LIPID MET, V1390, P1, DOI 10.1016/S0005-2760(97)00177-X; Aoyama C, 2002, BIOCHEM J, V363, P777, DOI 10.1042/0264-6021:3630777; Bakker AD, 2012, METHODS MOL BIOL, V816, P19, DOI 10.1007/978-1-61779-415-5_2; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Chaves Neto Antonio Hernandes, 2011, J Cell Biochem, V112, P71, DOI 10.1002/jcb.22763; Chim SM, 2011, J BIOL CHEM, V286, P22035, DOI 10.1074/jbc.M110.187633; Concepcion D, 2004, GENETICS, V168, P953, DOI 10.1534/genetics.104.029843; Devaux PF, 2004, TRAFFIC, V5, P241, DOI 10.1111/j.1600-0854.2004.0170.x; Fagone P, 2009, J BIOL CHEM, V284, P6847, DOI 10.1074/jbc.M807338200; Feng HT, 2009, J BIOL CHEM, V284, P14667, DOI 10.1074/jbc.M901670200; Hill P A, 1998, Br J Orthod, V25, P101; Ishidate K, 1997, BBA-LIPID LIPID MET, V1348, P70, DOI 10.1016/S0005-2760(97)00118-5; Jacquin C, 2006, J BONE MINER RES, V21, P67, DOI 10.1359/JBMR.051007; Judex S, 2004, J BONE MINER RES, V19, P607, DOI 10.1359/JBMR.040110; Khor EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070815; Kular J, 2012, CLIN BIOCHEM, V45, P863, DOI 10.1016/j.clinbiochem.2012.03.021; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Larson CM, 2000, J PEDIATR ORTHOPED, V20, P71, DOI 10.1097/00004694-200001000-00016; Lee SE, 2002, BONE, V30, P71, DOI 10.1016/S8756-3282(01)00657-3; Li Z, 2014, BBA-GEN SUBJECTS, V1840, P2112, DOI 10.1016/j.bbagen.2014.03.008; Li Z, 2014, BBA-MOL CELL BIOL L, V1841, P859, DOI 10.1016/j.bbalip.2014.02.004; Matsumoto M, 2000, J BIOL CHEM, V275, P31155, DOI 10.1074/jbc.M001229200; MCLEOD MJ, 1980, TERATOLOGY, V22, P299, DOI 10.1002/tera.1420220306; Mitsuhashi S, 2013, CURR OPIN NEUROL, V26, P536, DOI 10.1097/WCO.0b013e328364c82d; Mitsuhashi S, 2011, AM J HUM GENET, V88, P845, DOI 10.1016/j.ajhg.2011.05.010; Miyazaki T, 2000, J CELL BIOL, V148, P333, DOI 10.1083/jcb.148.2.333; Morgan EF, 2008, OSTEOPOROSIS, VOLS I AND II, 3RD EDITION, P3; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Nelms KA, 2001, IMMUNITY, V15, P409, DOI 10.1016/S1074-7613(01)00199-6; Ng PY, 2013, J BONE MINER RES, V28, P119, DOI 10.1002/jbmr.1725; Pearce JM, 2013, MAGN RESON MATER PHY, V26, P337, DOI 10.1007/s10334-012-0349-0; Quinlivan R, 2013, NEUROMUSCULAR DISORD, V23, P549, DOI 10.1016/j.nmd.2013.04.002; Ramirez de Molina A, 2005, CANCER RES, V65, P5647, DOI 10.1158/0008-5472.CAN-04-4416; Ramirez de Molina A, 2008, INT J BIOCHEM CELL B, V40, P1753, DOI 10.1016/j.biocel.2008.01.013; Rios PG, 2012, ARCH NEUROL-CHICAGO, V69, P657, DOI 10.1001/archneurol.2011.2333; Roberts S, 2007, J BONE MINER RES, V22, P617, DOI 10.1359/JBMR.070108; Roberts SJ, 2004, BIOCHEM J, V382, P59, DOI 10.1042/BJ20040511; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SHAW NJ, 1994, ARCH DIS CHILD, V71, P235, DOI 10.1136/adc.71.3.235; Sher RB, 2006, J BIOL CHEM, V281, P4938, DOI 10.1074/jbc.M512578200; Shuaib A, 2000, EXP NEUROL, V161, P733, DOI 10.1006/exnr.1999.7314; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Tasdemir HA, 2001, PEDIATR INT, V43, P157, DOI 10.1046/j.1442-200x.2001.01352.x; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; UCHIDA T, 1994, J BIOCHEM-TOKYO, V116, P1241, DOI 10.1093/oxfordjournals.jbchem.a124670; UCHIDA T, 1992, J BIOL CHEM, V267, P10156; VANCE DE, 1990, BIOCHEM CELL BIOL, V68, P1151, DOI 10.1139/o90-172; Viola HM, 2007, CIRC RES, V100, P1036, DOI 10.1161/01.RES.0000263010.19273.48; WITTENBERG J, 1953, J BIOL CHEM, V202, P431; Wu GS, 2008, J BIOL CHEM, V283, P1456, DOI 10.1074/jbc.M708766200; Wu GS, 2009, BBA-MOL CELL BIOL L, V1791, P347, DOI 10.1016/j.bbalip.2009.02.006; Xu JK, 2005, J CELL PHYSIOL, V202, P554, DOI 10.1002/jcp.20159; Yadav MC, 2011, J BONE MINER RES, V26, P286, DOI 10.1002/jbmr.195; Yamashita T, 2008, BIOCHEM BIOPH RES CO, V365, P252, DOI 10.1016/j.bbrc.2007.10.169; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zaidi M, 2004, BIOL REV, V79, P79, DOI 10.1017/S1464793103006262	59	22	22	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1729	1742		10.1074/jbc.M114.567966	http://dx.doi.org/10.1074/jbc.M114.567966			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25451916	hybrid, Green Published			2022-12-26	WOS:000348056400038
J	Lee, A; Wang, SY; Williams, B; Hagen, J; Scheetz, TE; Haeseleer, F				Lee, Amy; Wang, Shiyi; Williams, Brittany; Hagen, Jussara; Scheetz, Todd E.; Haeseleer, Francoise			Characterization of Ca(v)1.4 Complexes (alpha(1) 1.4, beta(2), and alpha(2)delta(4)) in HEK293T Cells and in the Retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED CALCIUM-CHANNELS; STATIONARY NIGHT BLINDNESS; DEPENDENT INACTIVATION; CONE PHOTORECEPTORS; CACNA1F MUTATIONS; CA2+ CHANNELS; SUBUNIT; EXPRESSION; MOUSE; GENE	In photoreceptor synaptic terminals, voltage-gated Ca(v)1.4 channels mediate Ca2+ signals required for transmission of visual stimuli. Like other high voltage-activated Ca-v channels, Ca(v)1.4 channels are composed of a main pore-forming Ca(v)1.4 alpha(1) subunit and auxiliary beta and alpha(2)delta subunits. Of the four distinct classes of beta and alpha(2)delta, beta(2) and alpha(2)delta(4) are thought to co-assemble with Ca(v)1.4 alpha(1) subunits in photoreceptors. However, an understanding of the functional properties of this combination of Ca-v subunits is lacking. Here, we provide evidence that Ca(v)1.4 alpha(1), beta(2), and alpha(2)delta(4) contribute to Ca(v)1.4 channel complexes in the retina and describe their properties in electrophysiological recordings. In addition, we identified a variant of beta(2), named here beta(2X13), which, along with beta(2a), is present in photoreceptor terminals. Ca(v)1.4 alpha(1), beta(2), and alpha(2)delta(4) were coimmunoprecipitated from lysates of transfected HEK293 cells and mouse retina and were found to interact in the outer plexiform layer of the retina containing the photoreceptor synaptic terminals, by proximity ligation assays. In whole-cell patch clamp recordings of transfected HEK293T cells, channels (Ca(v)1.4 alpha(1) + beta(2X13)) containing alpha(2)delta(4) exhibited weaker voltage-dependent activation than those with alpha(2)delta(1). Moreover, compared with channels (Ca(v)1.4 alpha(1) + alpha(2)delta(4)) with beta(2a), beta(2X13)-containing channels exhibited greater voltage-dependent inactivation. The latter effect was specific to Ca(v)1.4 because it was not seen for Ca(v)1.2 channels. Our results provide the first detailed functional analysis of the Ca(v)1.4 subunits that form native photoreceptor Ca(v)1.4 channels and indicate potential heterogeneity in these channels conferred by beta(2a) and beta(2X13) variants.	[Lee, Amy; Wang, Shiyi; Williams, Brittany; Hagen, Jussara] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Lee, Amy; Wang, Shiyi; Williams, Brittany; Hagen, Jussara] Univ Iowa, Dept Otolaryngol Head Neck Surg, Iowa City, IA 52242 USA; [Lee, Amy; Wang, Shiyi; Williams, Brittany; Hagen, Jussara] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Scheetz, Todd E.] Univ Iowa, Dept Ophthalmol & Visual Sci, Iowa City, IA 52242 USA; [Scheetz, Todd E.] Univ Iowa, Dept Biomed Engn, Iowa City, IA 52242 USA; [Haeseleer, Francoise] Univ Washington, Dept Physiol & Biophys, Seattle, WA 98195 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Washington; University of Washington Seattle	Haeseleer, F (corresponding author), Univ Washington, Dept Physiol & Biophys, 1705 NE Pacific St,Box 357290, Seattle, WA 98195 USA.	fanfan@u.washington.edu	Wang, Shiyi/AAC-9354-2019	Lee, Amy/0000-0001-8021-0443; williams, brittany/0000-0002-6597-619X; Wang, Shiyi/0000-0003-3433-3025; Scheetz, Todd/0000-0002-1965-5811	National Institutes of Health (NIH), NEI [R01-EY020850]; NIH [DC009433, NS084190, T32 NS007421]; NIH, NCRR [S10 RR025429]; Carver Research Program of Excellence Award; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025429] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY020850, P30EY001730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084190, T32NS007421] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R55DC009433, R01DC009433] Funding Source: NIH RePORTER	National Institutes of Health (NIH), NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Carver Research Program of Excellence Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health (NIH), NEI, Grant R01-EY020850 (to F. H.); NIH Grants DC009433 and NS084190 (to A. L.); NIH Grant T32 NS007421 (to B. W.); and NIH, NCRR, Grant S10 RR025429 (to Sharona Gordon). This work was also supported by a Carver Research Program of Excellence Award (to A. L.).	Ball SL, 2011, BRAIN RES, V1412, P1, DOI 10.1016/j.brainres.2011.07.033; Ball SL, 2002, INVEST OPHTH VIS SCI, V43, P1595; Barnes S, 2002, ADV EXP MED BIOL, V514, P465; Baumann L, 2004, INVEST OPHTH VIS SCI, V45, P708, DOI 10.1167/iovs.03-0937; Bech-Hansen NT, 1998, NAT GENET, V19, P264, DOI 10.1038/947; Bernstein GM, 2007, CELL CALCIUM, V41, P27, DOI 10.1016/j.ceca.2006.04.010; Berntson A, 2003, J NEUROSCI RES, V71, P146, DOI 10.1002/jnr.10459; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Boycott KM, 2001, HUM GENET, V108, P91, DOI 10.1007/s004390100461; Buraei Z, 2013, BBA-BIOMEMBRANES, V1828, P1530, DOI 10.1016/j.bbamem.2012.08.028; Buraei Z, 2010, PHYSIOL REV, V90, P1461, DOI 10.1152/physrev.00057.2009; Busquet P, 2010, INT J NEUROPSYCHOPH, V13, P499, DOI 10.1017/S1461145709990368; Canti C, 2005, P NATL ACAD SCI USA, V102, P11230, DOI 10.1073/pnas.0504183102; Catterall WA, 2000, ANNU REV CELL DEV BI, V16, P521, DOI 10.1146/annurev.cellbio.16.1.521; Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5; Chaudhuri D, 2007, J GEN PHYSIOL, V129, P385, DOI 10.1085/jgp.200709749; Chien AJ, 1996, J BIOL CHEM, V271, P26465, DOI 10.1074/jbc.271.43.26465; Chu PJ, 2004, J MOL CELL CARDIOL, V36, P423, DOI 10.1016/j.yjmcc.2003.12.012; Cui GY, 2007, J PHYSIOL-LONDON, V585, P791, DOI 10.1113/jphysiol.2007.142307; Davies A, 2010, P NATL ACAD SCI USA, V107, P1654, DOI 10.1073/pnas.0908735107; Doering CJ, 2005, BIOPHYS J, V89, P3042, DOI 10.1529/biophysj.105.067124; Dolphin AC, 2013, BBA-BIOMEMBRANES, V1828, P1541, DOI 10.1016/j.bbamem.2012.11.019; Dolphin AC, 2012, NAT REV NEUROSCI, V13, P542, DOI 10.1038/nrn3311; Ebert AM, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-38; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Felix R, 1997, J NEUROSCI, V17, P6884; Ferreira G, 1997, J GEN PHYSIOL, V109, P449, DOI 10.1085/jgp.109.4.449; Gurnett CA, 1996, NEURON, V16, P431, DOI 10.1016/S0896-6273(00)80061-6; Haeseleer F, 2004, NAT NEUROSCI, V7, P1079, DOI 10.1038/nn1320; He LL, 2007, BIOPHYS J, V93, P834, DOI 10.1529/biophysj.106.101691; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; Knoflach D, 2013, CHANNELS, V7, P503, DOI 10.4161/chan.26368; Ko ML, 2007, J NEUROCHEM, V103, P784, DOI 10.1111/j.1471-4159.2007.04816.x; Koschak A, 2003, J NEUROSCI, V23, P6041, DOI 10.1523/JNEUROSCI.23-14-06041.2003; Krizaj D, 2002, FRONT BIOSCI-LANDMRK, V7, pD2023, DOI 10.2741/krizaj; Kurshan PT, 2009, NAT NEUROSCI, V12, P1415, DOI 10.1038/nn.2417; Lipscombe D, 2013, BBA-BIOMEMBRANES, V1828, P1522, DOI 10.1016/j.bbamem.2012.09.018; Liu XN, 2013, CHANNELS, V7, P514, DOI 10.4161/chan.26376; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyford GL, 2002, AM J PHYSIOL-CELL PH, V283, pC1001, DOI 10.1152/ajpcell.00140.2002; Mansergh F, 2005, HUM MOL GENET, V14, P3035, DOI 10.1093/hmg/ddi336; Matthews G, 2010, NAT REV NEUROSCI, V11, P812, DOI 10.1038/nrn2924; McRory JE, 2004, J NEUROSCI, V24, P1707, DOI 10.1523/JNEUROSCI.4846-03.2004; Mercer AJ, 2011, J NEUROSCI, V31, P4397, DOI 10.1523/JNEUROSCI.5921-10.2011; Morgans CW, 1999, EUR J NEUROSCI, V11, P2989, DOI 10.1046/j.1460-9568.1999.00719.x; Morgans CW, 2001, INVEST OPHTH VIS SCI, V42, P2414; Muller LPD, 2013, J COMP NEUROL, V521, P2486, DOI 10.1002/cne.23294; Peloquin JB, 2008, NEUROSCIENCE, V151, P1066, DOI 10.1016/j.neuroscience.2007.11.053; PEREZREYES E, 1992, J BIOL CHEM, V267, P1792; Qin N, 2002, MOL PHARMACOL, V62, P485, DOI 10.1124/mol.62.3.485; Richards MW, 2007, CHANNELS, V1, P92, DOI 10.4161/chan.4145; Roberts-Crowley ML, 2009, J GEN PHYSIOL, V133, P387, DOI 10.1085/jgp.200810047; Sandoval A, 2004, FEBS LETT, V576, P21, DOI 10.1016/j.febslet.2004.08.054; Schlick B, 2010, NEUROSCIENCE, V167, P786, DOI 10.1016/j.neuroscience.2010.02.037; Shaltiel L, 2012, J BIOL CHEM, V287, P36312, DOI 10.1074/jbc.M112.392811; Simms BA, 2014, NEURON, V82, P24, DOI 10.1016/j.neuron.2014.03.016; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Specht D, 2009, INVEST OPHTH VIS SCI, V50, P505, DOI 10.1167/iovs.08-2758; STEA A, 1994, P NATL ACAD SCI USA, V91, P10576, DOI 10.1073/pnas.91.22.10576; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Taylor WR, 1998, VISUAL NEUROSCI, V15, P541; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Vellani V, 2000, J PHYSIOL-LONDON, V529, P333, DOI 10.1111/j.1469-7793.2000.00333.x; Wahl-Schott C, 2006, P NATL ACAD SCI USA, V103, P15657, DOI 10.1073/pnas.0604621103; Whitmore SS, 2014, EXP EYE RES, V129, P93, DOI 10.1016/j.exer.2014.11.001; Wutz K, 2002, EUR J HUM GENET, V10, P449, DOI 10.1038/sj.ejhg.5200828; Wycisk KA, 2006, INVEST OPHTH VIS SCI, V47, P3523, DOI 10.1167/iovs.06-0271; Wycisk KA, 2006, AM J HUM GENET, V79, P973, DOI 10.1086/508944; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x; Zabouri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063853	71	39	39	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1505	1521		10.1074/jbc.M114.607465	http://dx.doi.org/10.1074/jbc.M114.607465			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25468907	Green Published, hybrid			2022-12-26	WOS:000348056400021
J	Yap, TL; Jiang, ZP; Heinrich, F; Gruschus, JM; Pfefferkorn, CM; Barros, M; Curtis, JE; Sidransky, E; Lee, JC				Yap, Thai Leong; Jiang, Zhiping; Heinrich, Frank; Gruschus, James M.; Pfefferkorn, Candace M.; Barros, Marilia; Curtis, Joseph E.; Sidransky, Ellen; Lee, Jennifer C.			Structural Features of Membrane-bound Glucocerebrosidase and alpha-Synuclein Probed by Neutron Reflectometry and Fluorescence Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILAYER-LIPID MEMBRANES; ACID-BETA-GLUCOSIDASE; SAPOSIN-C; PARKINSONS-DISEASE; GAUCHER-DISEASE; LYSOSOMAL DEGRADATION; DEFECTIVE ENZYME; PROTEIN; MUTATIONS; BINDING	Mutations in glucocerebrosidase (GCase), the enzyme deficient in Gaucher disease, are a common genetic risk factor for the development of Parkinson disease and related disorders, implicating the role of this lysosomal hydrolase in the disease etiology. A specific physical interaction exists between the Parkinson disease-related protein alpha-synuclein (alpha-syn) and GCase both in solution and on the lipid membrane, resulting in efficient enzyme inhibition. Here, neutron reflectometry was employed as a first direct structural characterization of GCase and alpha-syn.GCase complex on a sparsely-tethered lipid bilayer, revealing the orientation of the membrane-bound GCase. GCase binds to and partially inserts into the bilayer with its active site most likely lying just above the membrane-water interface. The interaction was further characterized by intrinsic Trp fluorescence, circular dichroism, and surface plasmon resonance spectroscopy. Both Trp fluorescence and neutron reflectometry results suggest a rearrangement of loops surrounding the catalytic site, where they extend into the hydrocarbon chain region of the outer leaflet. Taking advantage of contrasting neutron scattering length densities, the use of deuterated alpha-syn versus protiated GCase showed a large change in the membrane-bound structure of alpha-syn in the complex. We propose a model of alpha-syn.GCase on the membrane, providing structural insights into inhibition of GCase by alpha-syn. The interaction displaces GCase away from the membrane, possibly impeding substrate access and perturbing the active site. GCase greatly alters membrane-bound alpha-syn, moving helical residues away from the bilayer, which could impact the degradation of alpha-syn in the lysosome where these two proteins interact.	[Yap, Thai Leong; Jiang, Zhiping; Gruschus, James M.; Pfefferkorn, Candace M.; Lee, Jennifer C.] NHLBI, Lab Mol Biophys, NIH, Bethesda, MD 20892 USA; [Sidransky, Ellen] NHGRI, Med Genet Branch, NIH, Bethesda, MD 20892 USA; [Heinrich, Frank; Barros, Marilia] Carnegie Mellon Univ, Dept Phys, Pittsburgh, PA 15213 USA; [Heinrich, Frank; Curtis, Joseph E.] NIST, Ctr Neutron Res, Gaithersburg, MD 20899 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Carnegie Mellon University; National Institute of Standards & Technology (NIST) - USA	Lee, JC (corresponding author), NHLBI, Lab Mol Biophys, NIH, 50 South Dr,Bldg 50 Rm 3513, Bethesda, MD 20892 USA.	leej4@mail.nih.gov	Lee, Jennifer/E-9658-2015; Barros, Marilia/I-7772-2019; Heinrich, Frank/A-5339-2010	Lee, Jennifer/0000-0003-0506-8349; Heinrich, Frank/0000-0002-8579-553X; Barros, Marilia/0000-0002-4628-3048	Intramural Research Program at the National Institutes of Health; NHLBI; NHGRI; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006144] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200336] Funding Source: NIH RePORTER	Intramural Research Program at the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the Intramural Research Program at the National Institutes of Health, NHLBI, and NHGRI. Research was performed in part at the NIST Center for Nanoscale Science and Technology and by the NIST IMS program "Precision Measurements for Integral Membrane Proteins."	Alattia JR, 2007, P NATL ACAD SCI USA, V104, P17394, DOI 10.1073/pnas.0704998104; ANKNER JF, 1992, P SOC PHOTO-OPT INS, V1738, P260, DOI 10.1117/12.130637; Atrian S, 2008, PROTEINS, V70, P882, DOI 10.1002/prot.21554; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; Bodner CR, 2009, J MOL BIOL, V390, P775, DOI 10.1016/j.jmb.2009.05.066; Brumshtein B, 2006, ACTA CRYSTALLOGR D, V62, P1458, DOI 10.1107/S0907444906038303; Budvytyte R, 2013, LANGMUIR, V29, P8645, DOI 10.1021/la401132c; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi JH, 2011, MOL GENET METAB, V104, P185, DOI 10.1016/j.ymgme.2011.06.008; Clifton Luke A, 2013, Methods Mol Biol, V974, P119, DOI 10.1007/978-1-62703-275-9_7; Clifton LA, 2012, J BIOL CHEM, V287, P337, DOI 10.1074/jbc.M111.302901; Dura JA, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2219744; Dvir H, 2003, EMBO REP, V4, P704, DOI 10.1038/sj.embor.embor873; Fiaux J, 2004, J BIOMOL NMR, V29, P289, DOI 10.1023/B:JNMR.0000032523.00554.38; Fusco G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4827; Goker-Alpan O, 2010, ACTA NEUROPATHOL, V120, P641, DOI 10.1007/s00401-010-0741-7; Guvench O, 2011, J CHEM THEORY COMPUT, V7, P3162, DOI 10.1021/ct200328p; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Hatty CR, 2014, BBA-BIOMEMBRANES, V1838, P1019, DOI 10.1016/j.bbamem.2013.12.013; Heinrich F, 2014, BBA-BIOMEMBRANES, V1838, P2341, DOI 10.1016/j.bbamem.2014.03.007; Heinrich F, 2014, J BIOL CHEM, V289, P9683, DOI 10.1074/jbc.M113.543561; Heinrich F, 2009, LANGMUIR, V25, P4219, DOI 10.1021/la8033275; HO MW, 1971, P NATL ACAD SCI USA, V68, P2810, DOI 10.1073/pnas.68.11.2810; Jiang ZP, 2013, J AM CHEM SOC, V135, P15970, DOI 10.1021/ja405993r; Kirby BJ, 2012, CURR OPIN COLLOID IN, V17, P44, DOI 10.1016/j.cocis.2011.11.001; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Ladokhin AS, 1999, BIOPHYS J, V76, P946, DOI 10.1016/S0006-3495(99)77258-9; Lashuel HA, 2013, NAT REV NEUROSCI, V14, P38, DOI 10.1038/nrn3406; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Lieberman Raquel L, 2011, Enzyme Res, V2011, P973231, DOI 10.4061/2011/973231; Mak SK, 2010, J BIOL CHEM, V285, P13621, DOI 10.1074/jbc.M109.074617; McGillivray DJ, 2007, BIOINTERPHASES, V2, P21, DOI 10.1116/1.2709308; McGillivray DJ, 2009, BIOPHYS J, V96, P1547, DOI 10.1016/j.bpj.2008.11.020; McGlinchey RP, 2013, BIOCHEM SOC T, V41, P1509, DOI 10.1042/BST20130158; MCINTOSH TJ, 1987, BIOCHEMISTRY-US, V26, P1783, DOI 10.1021/bi00380a042; MORIMOTO S, 1990, J BIOL CHEM, V265, P1933; Murphy KE, 2014, BRAIN, V137, P834, DOI 10.1093/brain/awt367; Nalls MA, 2013, JAMA NEUROL, V70, P727, DOI 10.1001/jamaneurol.2013.1925; Nanda H, 2010, BIOPHYS J, V99, P2516, DOI 10.1016/j.bpj.2010.07.062; Pfefferkorn CM, 2012, BIOPHYS J, V102, P613, DOI 10.1016/j.bpj.2011.12.051; Pfefferkorn CM, 2012, BBA-BIOMEMBRANES, V1818, P162, DOI 10.1016/j.bbamem.2011.07.032; Pfefferkorn CM, 2010, J PHYS CHEM B, V114, P4615, DOI 10.1021/jp908092e; Proukakis C, 2013, NEUROLOGY, V80, P1062, DOI 10.1212/WNL.0b013e31828727ba; Qi XY, 1998, BIOCHEMISTRY-US, V37, P11544, DOI 10.1021/bi980785+; Sardi SP, 2013, P NATL ACAD SCI USA, V110, P3537, DOI 10.1073/pnas.1220464110; Sardi SP, 2011, P NATL ACAD SCI USA, V108, P12101, DOI 10.1073/pnas.1108197108; Shaaltiel Y, 2007, PLANT BIOTECHNOL J, V5, P579, DOI 10.1111/j.1467-7652.2007.00263.x; Shekhar P, 2011, J APPL PHYS, V110, DOI 10.1063/1.3661986; Shenoy S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032591; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Sidransky E, 2012, LANCET NEUROL, V11, P986, DOI 10.1016/S1474-4422(12)70190-4; Tanner DE, 2011, J CHEM THEORY COMPUT, V7, P3635, DOI 10.1021/ct200563j; Ulmer TS, 2005, J BIOL CHEM, V280, P9595, DOI 10.1074/jbc.M411805200; VACCARO AM, 1993, FEBS LETT, V336, P159, DOI 10.1016/0014-5793(93)81631-9; Wilkening G, 1998, J BIOL CHEM, V273, P30271, DOI 10.1074/jbc.273.46.30271; Xilouri M, 2013, MOL NEUROBIOL, V47, P537, DOI 10.1007/s12035-012-8341-2; Yap TL, 2013, BIOCHEMISTRY-US, V52, P7161, DOI 10.1021/bi401191v; Yap TL, 2013, MOL GENET METAB, V108, P56, DOI 10.1016/j.ymgme.2012.11.010; Yap TL, 2011, J BIOL CHEM, V286, P28080, DOI 10.1074/jbc.M111.237859	59	33	33	1	32	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					744	754		10.1074/jbc.M114.610584	http://dx.doi.org/10.1074/jbc.M114.610584			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25429104	Green Published, hybrid			2022-12-26	WOS:000347778200005
J	Chen, CY; Hsu, JS; Jaw, TS; Wu, DC; Shih, MCP; Lee, CH; Kuo, CH; Chen, YT; Lai, ML; Liu, GC				Chen, Chiao-Yun; Hsu, Jui-Sheng; Jaw, Twei-Shiun; Wu, Deng-Chyang; Shih, Ming-Chen Paul; Lee, Chien-Hung; Kuo, Chao-Hung; Chen, Yi-Ting; Lai, Ming-Lai; Liu, Gin-Chung			Utility of the Iodine Overlay Technique and Virtual Nonenhanced Images for the Preoperative T Staging of Colorectal Cancer by Dual-Energy CT with Tin Filter Technology	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY; RENAL MASSES; PHASE; COLONOGRAPHY; ACCURACY; QUALITY; STONES	Objectives: To evaluate the diagnostic accuracy and the potential radiation dose reduction of dual-energy CT (DECT) for tumor (T) staging of colorectal cancer (CRC) using iodine overlay (IO) and virtual nonenhanced (VNE) images. Materials and Methods: This retrospective study included 103 consecutive patients who underwent nonenhanced CT and enhanced DECT for preoperative CRC staging. Enhanced weighted-average (WA), IO and VNE images were reconstructed from enhanced 80 kVp and Sn140 kVp scans. Two radiologists assessed image qualities of the true nonenhanced (TNE) and VNE images. For T-staging, another two radiologists independently interpreted all scans in two separate reading sessions: in the first session, only images derived from the single phase DECT acquisition (IO and VNE images) were read. In the second reading session after 30 to 50 (average: 42) days, the same assessment was again performed with the TNE and enhanced WA images thereby simulating conventional dual-phase single-energy CT. The tumor node metastasis (TNM) system was used for staging with histopathologic reports as gold standard. Analysis of variance was used for statistical analysis. Results: The signal-to-noise ratios (SNRs) of the tumors and normal reference tissues showed significant correlation between the TNE and VNE images (P<0.01). The mean iodine overlay value (48.4 HU +/- 12.2) and enhancement (49.4 HU +/- 11.8) value of CRCs had no significant difference (P=0.52). The mean image noise on TNE (5.0 +/- 1.1) and VNE (5.3 +/- 1.1) images were similar (P=0.07). The quantitative qualities of the VNE images were mildly inferior to the TNE images. Overall accuracy of T-stage CRC when using single-phase acquisition was slightly better than the dual-phase acquisition (90.3% vs 87.4%) (P=0.51). The mean dose of the single-phase DECT acquisition was 6.2mSv comparing with 14.3mSv of dual-phase. Conclusion: Single-phase DECT using IO and VNE images yields a high accuracy in T-staging of CRCs. Thereby, the radiation exposure of the patients can be reduced.	[Chen, Chiao-Yun; Hsu, Jui-Sheng; Liu, Gin-Chung] Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan; [Chen, Chiao-Yun; Jaw, Twei-Shiun; Shih, Ming-Chen Paul; Liu, Gin-Chung] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Radiol, Kaohsiung, Taiwan; [Chen, Chiao-Yun; Hsu, Jui-Sheng; Jaw, Twei-Shiun; Lai, Ming-Lai; Liu, Gin-Chung] Kaohsiung Med Univ Hosp, Dept Med Imaging, Kaohsiung, Taiwan; [Wu, Deng-Chyang; Shih, Ming-Chen Paul] Kaohsiung Municipal Hsiaokang Hosp, Kaohsiung, Taiwan; [Wu, Deng-Chyang; Kuo, Chao-Hung] Kaohsiung Med Univ, Coll Med, Fac Med, Dept Med, Kaohsiung, Taiwan; [Lee, Chien-Hung] Kaohsiung Med Univ, Dept Publ Hlth, Kaohsiung, Taiwan; [Kuo, Chao-Hung] Kaohsiung Med Univ Hosp, Div Gastroenterol, Dept Internal Med, Kaohsiung, Taiwan; [Chen, Yi-Ting] Kaohsiung Med Univ Hosp, Dept Pathol, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Municipal Siao-Gang Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University Hospital	Liu, GC (corresponding author), Kaohsiung Med Univ, Coll Med, Grad Inst Med, Kaohsiung, Taiwan.	gcliu@kmu.edu.tw	Lee, Chien-Hung/D-4437-2009	Lee, Chien-Hung/0000-0002-0988-264X; Chen, yiting/0000-0002-0817-1539				[Anonymous], 2010, AJCC CANC STAGING MA; Ascenti G, 2011, AM J ROENTGENOL, V196, P1408, DOI 10.2214/AJR.10.4505; Boellaard TN, 2013, CLIN RADIOL, V68, P799, DOI 10.1016/j.crad.2013.03.005; Chae EJ, 2010, J THORAC IMAG, V25, P301, DOI 10.1097/RTI.0b013e3181e16232; Dighe S, 2010, CLIN RADIOL, V65, P708, DOI 10.1016/j.crad.2010.01.024; Dighe S, 2010, BRIT J SURG, V97, P1407, DOI 10.1002/bjs.7096; Filippone A, 2004, RADIOLOGY, V231, P83, DOI 10.1148/radiol.2311021152; Gnannt R, 2012, AM J ROENTGENOL, V198, P138, DOI 10.2214/AJR.11.6957; Goshima S, 2011, RADIOLOGY, V260, P139, DOI 10.1148/radiol.11101459; Graser A, 2010, INVEST RADIOL, V45, P399, DOI 10.1097/RLI.0b013e3181e33189; Graser A, 2009, RADIOLOGY, V252, P433, DOI 10.1148/radiol.2522080557; Graser A, 2009, EUR RADIOL, V19, P13, DOI 10.1007/s00330-008-1122-7; Gray PR, 2007, FOXTROT FLUOROPYRMID; Johnson TRC, 2007, EUR RADIOL, V17, P1510, DOI 10.1007/s00330-006-0517-6; Kim JE, 2012, AM J ROENTGENOL, V198, P817, DOI 10.2214/AJR.11.6972; Mangold S, 2012, RADIOLOGY, V264, P119, DOI 10.1148/radiol.12110851; Marin D, 2009, RADIOLOGY, V251, P771, DOI 10.1148/radiol.2513081330; McCollough CH, 2006, RADIOGRAPHICS, V26, P503, DOI 10.1148/rg.262055138; Morrin MM, 2000, DIS COLON RECTUM, V43, P303, DOI 10.1007/BF02258293; Morton UKD, 2012, LANCET ONCOL, V13, P1152, DOI 10.1016/S1470-2045(12)70348-0; Petersilka M, 2008, EUR J RADIOL, V68, P362, DOI 10.1016/j.ejrad.2008.08.013; Primak AN, 2010, AM J ROENTGENOL, V195, P1164, DOI 10.2214/AJR.09.3956; Shrimpton PC, 2004, NRPBPE12004; Smith NJ, 2007, BRIT J CANCER, V96, P1030, DOI 10.1038/sj.bjc.6603646; Sommer CM, 2010, CARDIOVASC INTER RAD, V33, P498, DOI 10.1007/s00270-009-9787-0; Song KD, 2011, AM J ROENTGENOL, V197, pW1076, DOI 10.2214/AJR.11.6922; Takahashi N, 2010, RADIOLOGY, V256, P184, DOI 10.1148/radiol.10091411; Zhang LJ, 2010, EUR RADIOL, V20, P2257, DOI 10.1007/s00330-010-1778-7	28	13	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113589	10.1371/journal.pone.0113589	http://dx.doi.org/10.1371/journal.pone.0113589			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469775	gold, Green Submitted, Green Published			2022-12-26	WOS:000349128700035
J	Heinzel, S; Gold, M; Deuschle, C; Bernhard, F; Maetzler, W; Berg, D; Dodel, R				Heinzel, Sebastian; Gold, Maike; Deuschle, Christian; Bernhard, Felix; Maetzler, Walter; Berg, Daniela; Dodel, Richard			Naturally Occurring Alpha-Synuclein Autoantibodies in Parkinson's Disease: Sources of (Error) Variance in Biomarker Assays	PLOS ONE			English	Article							DRUG-NAIVE PATIENTS; CEREBROSPINAL-FLUID; ELEVATED LEVELS; PLASMA; PROTEIN; ANTIBODIES; NEURODEGENERATION; IMMUNIZATION; IMMUNITY; DJ-1	Alpha-synuclein (alpha-Syn) plays a pivotal role in the pathophysiology of Parkinson's disease (PD), which can partly be modulated by innate and adaptive immune functions, and vice versa. Here, naturally occurring alpha-Syn autoantibodies (alpha-Syn-nAbs) may be effective against alpha-Syn pathoetiology and may serve as a PD biomarker. However, serum and cerebrospinal fluid alpha-Syn-nAbs levels still lack consistent evidence as required for a reliable PD biomarker. Serum and cerebrospinal fluid alpha-Syn-nAbs levels of 66 PD patients and 69 healthy controls were assessed using a validated ELISA assay. Moreover, potential sources of error variance including unspecific ELISA background signals, free serum hemoglobin concentrations, alpha-Syn plate coating procedures, and differences in alpha-Syn-nAbs standards, were investigated. PD patients and controls did not differ in serum (p=.49) nor cerebrospinal fluid (p=.29) alpha-Syn-nAbs levels. Interestingly, free serum hemoglobin concentrations were negatively correlated with alpha-Syn-nAbs levels in controls (Spearman rho=-.41, p<.001), but not in PD patients (rho=.16, p=.21). ELISA alpha-Syn plate coating procedures impacted inter-assay variability (same day coating: 8-16%; coating on different days: 16-58%). alpha-Syn-nAbs standards from different purification batches differed regarding optical density measured in ELISAs suggesting differences in alpha-Syn affinity. While alpha-Syn-nAbs levels may represent a potential PD biomarker, several methodological issues have to be considered to increase reproducibility of alpha-Syn-nAbs findings. Further studies using standardized protocols minimizing sources of error variance may be necessary to establish a reliable PD alpha-Syn-nAbs biomarker.	[Heinzel, Sebastian; Deuschle, Christian; Bernhard, Felix; Maetzler, Walter; Berg, Daniela] Univ Tubingen, Hertie Inst Clin Brain Res HIH, Dept Neurodegenerat, Tubingen, Germany; [Gold, Maike; Dodel, Richard] Univ Marburg, Dept Neurol, Marburg, Germany; [Deuschle, Christian; Maetzler, Walter; Berg, Daniela] German Ctr Neurodegenerat Dis DZNE, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Philipps University Marburg; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Heinzel, S (corresponding author), Univ Tubingen, Hertie Inst Clin Brain Res HIH, Dept Neurodegenerat, Tubingen, Germany.	Sebastian.Heinzel@med.uni-tuebingen.de	Berg, Daniela/A-8728-2019; Maetzler, Walter/A-6796-2011; Maetzler, Walter/AAE-5831-2020; Heinzel, Sebastian/AFK-4188-2022	Berg, Daniela/0000-0001-5796-5442; Maetzler, Walter/0000-0002-5945-4694; Maetzler, Walter/0000-0002-5945-4694; Heinzel, Sebastian/0000-0003-4516-0529	research exchange program of the Competence Network Degenerative Dementias (KNDD) [01GI1005B]; German Federal Ministry of Education and Research [01GI1008C]	research exchange program of the Competence Network Degenerative Dementias (KNDD); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	Funding: This study was supported by the research exchange program of the Competence Network Degenerative Dementias (KNDD; grant number: 01GI1005B). The LANDSCAPE study is part of the KNDD, which was funded by the German Federal Ministry of Education and Research (project number 01GI1008C). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbo DB, 2009, J NEURAL TRANSM-SUPP, P311, DOI 10.1007/978-3-211-92660-4_26; Bach JP, 2012, ADV EXP MED BIOL, V750, P91, DOI 10.1007/978-1-4614-3461-0_7; Bae EJ, 2012, J NEUROSCI, V32, P13454, DOI 10.1523/JNEUROSCI.1292-12.2012; Barbour R, 2008, NEURODEGENER DIS, V5, P55, DOI 10.1159/000112832; Berg D, 2014, MOVEMENT DISORD, V29, P454, DOI 10.1002/mds.25844; Besong-Agbo D, 2013, NEUROLOGY, V80, P169, DOI 10.1212/WNL.0b013e31827b90d1; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Deleersnijder A, 2013, TRENDS MOL MED, V19, P368, DOI 10.1016/j.molmed.2013.04.002; Dodel R, 2011, J NEUROSCI, V31, P5847, DOI 10.1523/JNEUROSCI.4401-10.2011; Duran R, 2010, MOVEMENT DISORD, V25, P489, DOI 10.1002/mds.22928; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Fauvet B, 2012, J BIOL CHEM, V287, P15345, DOI 10.1074/jbc.M111.318949; Foulds PG, 2011, FASEB J, V25, P4127, DOI 10.1096/fj.10-179192; Games D, 2014, J NEUROSCI, V34, P9441, DOI 10.1523/JNEUROSCI.5314-13.2014; Gardai SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071634; GIBB WRG, 1988, POSTGRAD MED J, V64, P345, DOI 10.1136/pgmj.64.751.345; Gold M, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-5; Gruden MA, 2012, NEUROIMMUNOMODULAT, V19, P334, DOI 10.1159/000341400; Gruden MA, 2011, J NEUROIMMUNOL, V233, P221, DOI 10.1016/j.jneuroim.2010.12.001; Guo JL, 2013, CELL, V154, P103, DOI 10.1016/j.cell.2013.05.057; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; Hong Z, 2010, BRAIN, V133, P713, DOI 10.1093/brain/awq008; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Kang JH, 2013, JAMA NEUROL, V70, P1277, DOI 10.1001/jamaneurol.2013.3861; Kannarkat GT, 2013, J PARKINSON DIS, V3, P493, DOI 10.3233/JPD-130250; Koehler NKU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064649; Korff A, 2013, J ALZHEIMERS DIS, V36, P679, DOI 10.3233/JAD-130458; Lee PH, 2006, J NEURAL TRANSM, V113, P1435, DOI 10.1007/s00702-005-0427-9; Li JY, 2008, NAT MED, V14, P501, DOI 10.1038/nm1746; Li QX, 2007, EXP NEUROL, V204, P583, DOI 10.1016/j.expneurol.2006.12.006; Maetzler W, 2014, PLOS ONE, V9; Masliah E, 2005, NEURON, V46, P857, DOI 10.1016/j.neuron.2005.05.010; Mollenhauer B, 2008, EXP NEUROL, V213, P315, DOI 10.1016/j.expneurol.2008.06.004; Mollenhauer B, 2011, LANCET NEUROL, V10, P230, DOI 10.1016/S1474-4422(11)70014-X; Nakai M, 2007, BIOCHEM BIOPH RES CO, V358, P104, DOI 10.1016/j.bbrc.2007.04.108; Papachroni KK, 2007, J NEUROCHEM, V101, P749, DOI 10.1111/j.1471-4159.2006.04365.x; Park MJ, 2011, J CLIN NEUROL, V7, P215, DOI 10.3988/jcn.2011.7.4.215; Roettger Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067743; Shi M, 2010, NEUROSCI LETT, V480, P78, DOI 10.1016/j.neulet.2010.06.009; Smith LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052285; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Thenganatt MA, 2014, JAMA NEUROL, V71, P499, DOI 10.1001/jamaneurol.2013.6233; Tokuda T, 2010, NEUROLOGY, V75, P1766, DOI 10.1212/WNL.0b013e3181fd613b; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Wei X, 2012, J BIOL CHEM, V287, P12858, DOI 10.1074/jbc.M111.255836; Woulfe JM, 2002, NEUROLOGY, V58, P1435, DOI 10.1212/WNL.58.9.1435; Yanamandra K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018513	47	12	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114566	10.1371/journal.pone.0114566	http://dx.doi.org/10.1371/journal.pone.0114566			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470145	Green Submitted, Green Published, gold			2022-12-26	WOS:000349128700122
J	Ragauskas, S; Leinonen, H; Puranen, J; Ronkko, S; Nymark, S; Gurevicius, K; Lipponen, A; Kontkanen, O; Puolivali, J; Tanila, H; Kalesnykas, G				Ragauskas, Symantas; Leinonen, Henri; Puranen, Jooseppi; Ronkko, Seppo; Nymark, Soile; Gurevicius, Kestutis; Lipponen, Arto; Kontkanen, Outi; Puolivali, Jukka; Tanila, Heikki; Kalesnykas, Giedrius			Early Retinal Function Deficit without Prominent Morphological Changes in the R6/2 Mouse Model of Huntington's Disease	PLOS ONE			English	Article							NEURONAL INTRANUCLEAR INCLUSIONS; GANGLION-CELL DYSFUNCTION; PATTERN ELECTRORETINOGRAM; MUTANT HUNTINGTIN; SCHEMATIC EYE; MICE; NEURODEGENERATION; EXPRESSION; GENE; TRANSMISSION	Huntington's disease (HD) is an inherited neurodegenerative disorder that primarily affects the medium-size GABAergic neurons of striatum. The R6/2 mouse line is one of the most widely used animal models of HD. Previously the hallmarks of HD-related pathology have been detected in photoreceptors and interneurons of R6/2 mouse retina. Here we aimed to explore the survival of retinal ganglion cells (RGCs) and functional integrity of distinct retinal cell populations in R6/2 mice. The pattern electroretinography (PERG) signal was lost at the age of 8 weeks in R6/2 mice in contrast to the situation in wild-type (WT) littermates. This defect may be attributable to a major reduction in photopic ERG responses in R6/2 mice which was more evident in b- than a-wave amplitudes. At the age of 4 weeks R6/2 mice had predominantly the soluble form of mutant huntingtin protein (mHtt) in the RGC layer cells, whereas the aggregated form of mHtt was found in the majority of those cells from the 12-week-old R6/2 mice and onwards. Retinal astrocytes did not contain mHtt deposits. The total numbers of RGC layer cells, retinal astrocytes as well as optic nerve axons did not differ between 18-week-old R6/2 mice and their WT controls. Our data indicate that mHtt deposition does not cause RGC degeneration or retinal astrocyte loss in R6/2 mice even at a late stage of HD-related pathology. However, due to functional deficits in the rod-and conepathways, the R6/2 mice suffer progressive deficits in visual capabilities starting as early as 4 weeks; at 8 weeks there is severe impairment. This should be taken into account in any behavioral testing conducted in R6/2 mice.	[Ragauskas, Symantas; Puranen, Jooseppi; Ronkko, Seppo; Kalesnykas, Giedrius] Univ Eastern Finland, Sch Med, Inst Clin Med, Dept Ophthalmol, Kuopio, Finland; [Ragauskas, Symantas] Vilnius Gediminas Tech Univ, Dept Biochem, Vilnius, Lithuania; [Ragauskas, Symantas] State Res Inst Innovat Med, Vilnius, Lithuania; [Ragauskas, Symantas; Puranen, Jooseppi; Kalesnykas, Giedrius] Experimentica Ltd, Kuopio, Finland; [Leinonen, Henri; Lipponen, Arto; Tanila, Heikki] Univ Eastern Finland, AI Virtanen Inst, Dept Neurobiol, Kuopio, Finland; [Nymark, Soile] Tampere Univ Technol, BioMediTech, Dept Elect & Commun Engn, FIN-33101 Tampere, Finland; [Kontkanen, Outi; Puolivali, Jukka] Charles River DRS Finland, Kuopio, Finland	University of Eastern Finland; Vilnius Gediminas Technical University; State Research Institute Centre for Innovative Medicine; University of Eastern Finland; Tampere University	Kalesnykas, G (corresponding author), Univ Eastern Finland, Sch Med, Inst Clin Med, Dept Ophthalmol, Kuopio, Finland.	giedrius.kalesnykas@gmail.com	Kalesnykas, Giedrius/AAG-4084-2021; Nymark, Soile/M-9453-2016; Leinonen, Henri/V-2684-2019	Nymark, Soile/0000-0002-9274-0123; Leinonen, Henri/0000-0002-0388-832X; Lipponen, Arto/0000-0001-6201-6647	Charles River DRS Finland; Experimentica Ltd.	Charles River DRS Finland; Experimentica Ltd.	Funding: The research described was funded by Charles River DRS Finland (www.crl.com) and Experimentica Ltd. (www.experimentica.com). The funders participated in study design, data collection and analysis, the decision to publish, and preparation of the manuscript.	Bach M, 2013, DOC OPHTHALMOL, V126, P1, DOI 10.1007/s10633-012-9353-y; Batcha AH, 2012, NEUROBIOL DIS, V45, P887, DOI 10.1016/j.nbd.2011.12.004; Bradford J, 2009, P NATL ACAD SCI USA, V106, P22480, DOI 10.1073/pnas.0911503106; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bui BV, 2003, EXP EYE RES, V77, P555, DOI 10.1016/S0014-4835(03)00195-7; Chrysostomou V, 2013, INVEST OPHTH VIS SCI, V54, P4691, DOI 10.1167/iovs.13-12415; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Gil JM, 2008, EUR J NEUROSCI, V27, P2803, DOI 10.1111/j.1460-9568.2008.06310.x; GUNDERSEN HJG, 1986, J MICROSC-OXFORD, V143, P3, DOI 10.1111/j.1365-2818.1986.tb02764.x; Heckenlively JR, 2006, ORIGINS ELECTRORETIN, P139; Helmlinger D, 2002, HUM MOL GENET, V11, P3351, DOI 10.1093/hmg/11.26.3351; Holder GE, 2001, PROG RETIN EYE RES, V20, P531, DOI 10.1016/S1350-9462(00)00030-6; Li M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056026; Lione LA, 1999, J NEUROSCI, V19, P10428; Liu Y, 2014, INVEST OPHTH VIS SCI, V55, P3766, DOI 10.1167/iovs.14-13895; London A, 2013, NAT REV NEUROL, V9, P44, DOI 10.1038/nrneurol.2012.227; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; MAFFEI L, 1981, SCIENCE, V211, P953, DOI 10.1126/science.7466368; Mangiarini L, 1996, CELL, V87, P493, DOI 10.1016/S0092-8674(00)81369-0; MASU M, 1995, CELL, V80, P757, DOI 10.1016/0092-8674(95)90354-2; Miller J, 2011, NAT CHEM BIOL, V7, P925, DOI [10.1038/nchembio.694, 10.1038/NCHEMBIO.694]; Miura G, 2009, EXP EYE RES, V89, P49, DOI 10.1016/j.exer.2009.02.009; Nagaraju M, 2007, INVEST OPHTH VIS SCI, V48, P4573, DOI 10.1167/iovs.07-0582; Nguyen CTO, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/796362; PAULUS W, 1993, ANN NEUROL, V34, P574, DOI 10.1002/ana.410340411; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; PENN RD, 1969, NATURE, V223, P201, DOI 10.1038/223201a0; Petrasch-Parwez E, 2005, ACTA NEUROPATHOL, V110, P523, DOI 10.1007/s00401-005-1092-7; Petrasch-Parwez E, 2004, J COMP NEUROL, V479, P181, DOI 10.1002/cne.20327; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; Porciatti V, 2007, DOC OPHTHALMOL, V115, P145, DOI 10.1007/s10633-007-9059-8; Porciatti V, 2007, INVEST OPHTH VIS SCI, V48, P745, DOI 10.1167/iovs.06-0733; REMTULLA S, 1985, VISION RES, V25, P21, DOI 10.1016/0042-6989(85)90076-8; Ridder WH, 2002, EXP EYE RES, V75, P365, DOI 10.1006/exer.2002.2007; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Saszik SM, 2002, J PHYSIOL-LONDON, V543, P899, DOI 10.1113/jphysiol.2002.019703; Schmucker C, 2004, VISION RES, V44, P1857, DOI 10.1016/j.visres.2004.03.011; Sharma S, 2005, VISUAL NEUROSCI, V22, P631, DOI 10.1017/S0952523805225129; Shin JY, 2005, J CELL BIOL, V171, P1001, DOI 10.1083/jcb.200508072; Smith BJ, 2014, DOC OPHTHALMOL, V128, P155, DOI 10.1007/s10633-014-9433-2; Tydlacka S, 2008, J NEUROSCI, V28, P13285, DOI 10.1523/JNEUROSCI.4393-08.2008; Walker FO, 2007, LANCET, V369, P218, DOI 10.1016/S0140-6736(07)60111-1; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Weymouth AE, 2008, PROG RETIN EYE RES, V27, P1, DOI 10.1016/j.preteyeres.2007.09.003; Williams AJ, 2008, TRENDS NEUROSCI, V31, P521, DOI 10.1016/j.tins.2008.07.004; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	48	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113317	10.1371/journal.pone.0113317	http://dx.doi.org/10.1371/journal.pone.0113317			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469887	Green Published, gold, Green Submitted			2022-12-26	WOS:000349128700022
J	Busk, PK; Lange, M; Pilgaard, B; Lange, L				Busk, Peter K.; Lange, Mette; Pilgaard, Bo; Lange, Lene			Several Genes Encoding Enzymes with the Same Activity Are Necessary for Aerobic Fungal Degradation of Cellulose in Nature	PLOS ONE			English	Article							WOOD DECAY; CELLOBIOSE DEHYDROGENASE; ENZYMATIC-HYDROLYSIS; GLYCOSIDE HYDROLASES; TRICHODERMA-REESEI; SERPULA-LACRYMANS; PLANT; CONVERSION; POLYSACCHARIDES; CLASSIFICATION	The cellulose-degrading fungal enzymes are glycoside hydrolases of the GH families and lytic polysaccharide monooxygenases. The entanglement of glycoside hydrolase families and functions makes it difficult to predict the enzymatic activity of glycoside hydrolases based on their sequence. In the present study we further developed the method Peptide Pattern Recognition to an automatic approach not only to find all genes encoding glycoside hydrolases and lytic polysaccharide monooxygenases in fungal genomes but also to predict the function of the genes. The functional annotation is an important feature as it provides a direct route to predict function from primary sequence. Furthermore, we used Peptide Pattern Recognition to compare the cellulose-degrading enzyme activities encoded by 39 fungal genomes. The results indicated that cellobiohydrolases and AA9 lytic polysaccharide monooxygenases are hallmarks of cellulose-degrading fungi except brown rot fungi. Furthermore, a high number of AA9, endocellulase and beta-glucosidase genes were identified, not in what are known to be the strongest, specialized lignocellulose degraders but in saprophytic fungi that can use a wide variety of substrates whereas only few of these genes were found in fungi that have a limited number of natural, lignocellulotic substrates. This correlation suggests that enzymes with different properties are necessary for degradation of cellulose in different complex substrates. Interestingly, clustering of the fungi based on their predicted enzymes indicated that Ascomycota and Basidiomycota use the same enzymatic activities to degrade plant cell walls.	[Busk, Peter K.; Lange, Mette; Pilgaard, Bo; Lange, Lene] Aalborg Univ, Dept Biotechnol Chem & Environm Engn, DK-2450 Copenhagen SV, Denmark	Aalborg University	Busk, PK (corresponding author), Aalborg Univ, Dept Biotechnol Chem & Environm Engn, AC Meyers Vaenge 15, DK-2450 Copenhagen SV, Denmark.	pkb@bio.aau.dk	Busk, Peter/Q-8145-2016; Lange, Lene/Q-8051-2016	Busk, Peter/0000-0003-1920-636X; Lange, Lene/0000-0002-5336-1155; Pilgaard, Bo/0000-0002-8697-6041	Danish Strategic Research Council [2101-08-0041, 09-065251]; Novozymes A/S	Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Novozymes A/S	This work was supported by The Danish Strategic Research Council projects 2101-08-0041 (BioRef), 09-065251 (Bio4Bio) and by Novozymes A/S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; Ainsworth GC, 1995, AINSWORTH BISBYS DIC; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Aspeborg H, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-186; Battaglia E, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-38; Benko Z, 2008, ENZYME MICROB TECH, V43, P109, DOI 10.1016/j.enzmictec.2008.03.005; Brown CT, 2012, ARXIV12034802QBIO; Busk PK, 2013, AMB EXPRESS, V3, DOI 10.1186/2191-0855-3-47; Busk PK, 2013, APPL ENVIRON MICROB, V79, P3380, DOI 10.1128/AEM.03803-12; Busk PK, 2002, PLANT MOL BIOL REP, V20, P287, DOI 10.1007/BF02782464; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Couturier M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-57; Davies G.J., 2008, BIOCHEM J, DOI [10.1042/BJ20080382, DOI 10.1042/BJ20080382]; Eastwood DC, 2011, SCIENCE, V333, P762, DOI 10.1126/science.1205411; Floudas D, 2012, SCIENCE, V336, P1715, DOI 10.1126/science.1221748; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Gao DH, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-5; Glass NL, 2013, ANNU REV MICROBIOL, V67, P477, DOI 10.1146/annurev-micro-092611-150044; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hemsworth GR, 2014, NAT CHEM BIOL, V10, P122, DOI 10.1038/nchembio.1417; Heng L, 2012, SEQTK TOOLKIT PROCES; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Henrissat B, 2000, PLANT PHYSIOL, V124, P1515, DOI 10.1104/pp.124.4.1515; HEREDIA A, 1995, Z LEBENSM UNTERS FOR, V200, P24, DOI 10.1007/BF01192903; Hori C, 2013, MYCOLOGIA, V105, P1412, DOI 10.3852/13-072; Horn SJ, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-45; Hu JG, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-112; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Kaida R, 2009, MOL PLANT, V2, P904, DOI 10.1093/mp/ssp060; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; Korripally P, 2013, APPL ENVIRON MICROB, V79, P2377, DOI 10.1128/AEM.03880-12; Kuhad R. C, 2007, LIGNOCELLULOSE BIOTE, P3; Langston JA, 2011, APPL ENVIRON MICROB, V77, P7007, DOI 10.1128/AEM.05815-11; Le Costaouec T, 2013, BIORESOURCE TECHNOL, V143, P196, DOI 10.1016/j.biortech.2013.05.079; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Lima MA, 2013, J BIOL CHEM, V288, P32991, DOI 10.1074/jbc.M113.479279; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; Martinez D, 2009, P NATL ACAD SCI USA, V106, P1954, DOI 10.1073/pnas.0809575106; Moore-Landecker E, 1972, FUNDAMENTALS FUNGI, P291; NIDETZKY B, 1994, BIOCHEM J, V298, P705, DOI 10.1042/bj2980705; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Rajala T, 2012, FEMS MICROBIOL ECOL, V81, P494, DOI 10.1111/j.1574-6941.2012.01376.x; Richardson M, 2009, CLIN MICROBIOL INFEC, V15, P2, DOI 10.1111/j.1469-0691.2009.02972.x; Riley R, 2014, P NATL ACAD SCI USA, V111, P9923, DOI 10.1073/pnas.1400592111; Rineau F, 2012, ENVIRON MICROBIOL, V14, P1477, DOI 10.1111/j.1462-2920.2012.02736.x; Sanchez C, 2009, BIOTECHNOL ADV, V27, P185, DOI 10.1016/j.biotechadv.2008.11.001; Taylor JW, 2006, MYCOLOGIA, V98, P838, DOI 10.3852/mycologia.98.6.838; Teugjas H, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-105; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; van den Brink J, 2011, APPL MICROBIOL BIOT, V91, P1477, DOI 10.1007/s00253-011-3473-2; Van Dyk JS, 2012, BIOTECHNOL ADV, V30, P1458, DOI 10.1016/j.biotechadv.2012.03.002; Voriskova J, 2013, ISME J, V7, P477, DOI 10.1038/ismej.2012.116; Watkinson SC, 2012, ADV APPL MICROBIOL, V78, P121, DOI 10.1016/B978-0-12-394805-2.00005-1; Westereng B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027807; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang JH, 2011, BIORESOURCE TECHNOL, V102, P9090, DOI 10.1016/j.biortech.2011.06.085	59	33	36	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114138	10.1371/journal.pone.0114138	http://dx.doi.org/10.1371/journal.pone.0114138			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461894	Green Published, Green Submitted, gold			2022-12-26	WOS:000345869700104
J	Dangisso, MH; Datiko, DG; Lindtjorn, B				Dangisso, Mesay Hailu; Datiko, Daniel Gemechu; Lindtjorn, Bernt			Trends of Tuberculosis Case Notification and Treatment Outcomes in the Sidama Zone, Southern Ethiopia: Ten-Year Retrospective Trend Analysis in Urban-Rural Settings	PLOS ONE			English	Article							COMMUNITY RANDOMIZED-TRIAL; HEALTH EXTENSION WORKERS; HIV-INFECTION; GENDER; TB; PREVALENCE; DIAGNOSIS; REGION; INDIA; COINFECTION	Background: Ethiopia is one of the high tuberculosis (TB) burden countries. An analysis of trends and differentials in case notifications and treatment outcomes of TB may help improve our understanding of the performance of TB control services. Methods: A retrospective trend analysis of TB cases was conducted in the Sidama Zone in southern Ethiopia. We registered all TB cases diagnosed and treated during 2003-2012 from all health facilities in the Sidama Zone, and analysed trends of TB case notification rates and treatment outcomes. Results: The smear positive (PTB+) case notification rate (CNR) increased from 55 (95% CI 52.5-58.4) to 111 (95% CI 107.4-114.4) per 10(5) people. The CNRs of PTB+ in people older than 45 years increased by fourfold, while the mortality of cases during treatment declined from 11% to 3% for smear negative (PTB-) (chi(2)(trend), P<0.001) and from 5% to 2% for PTB+ (chi(2)(trend), P<0.001). The treatment success was higher in rural areas (AOR 1.11; CI 95%: 1.03-1.2), less for PTB-(AOR 0.86; CI 95%: 0.80-0.92) and higher for extra-pulmonary TB (AOR 1.10; CI 95%: 1.02-1.19) compared to PTB+. A higher lost-to-follow up was observed in men (AOR 1.15; CI 95%: 1.06-1.24) and among PTB-cases (AOR 1.14; CI 95%: 1.03-1.25). More deaths occurred in PTB-cases (AOR 1.65; 95% CI: 1.44-1.90) and among cases older than 65 years (AOR 3.86; CI 95%: 2.94-5.10). Lastly, retreatment cases had a higher mortality than new cases (6% vs 3%). Conclusion: Over the past decade TB CNRs and treatment outcomes improved, whereas the disparities of disease burden by gender and place of residence reduced and mortality declined. Strategies should be devised to address higher risk groups for poor treatment outcomes.	[Dangisso, Mesay Hailu; Lindtjorn, Bernt] Univ Bergen, Ctr Int Hlth, Fac Med & Dent, Bergen, Norway; [Dangisso, Mesay Hailu] Sidama Zone Hlth Dept, Hawassa, Ethiopia; [Datiko, Daniel Gemechu] Hawassa Univ, Hawassa, Ethiopia; [Datiko, Daniel Gemechu] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	University of Bergen; Hawassa University; Liverpool School of Tropical Medicine; University of Liverpool	Dangisso, MH (corresponding author), Univ Bergen, Ctr Int Hlth, Fac Med & Dent, Bergen, Norway.	mesayhailudangiso@yahoo.com	Dangisso, Mesay Hailu/AAU-7743-2020; Lindtjorn, Bernt/K-9465-2018; Datiko, Daniel/AAE-7019-2020; Datiko, Daniel G./AAE-6856-2020	Lindtjorn, Bernt/0000-0002-6267-6984; Datiko, Daniel/0000-0002-8556-3069; 	University of Bergen, Centre for International Health	University of Bergen, Centre for International Health	University of Bergen, Centre for International Health funded the study. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Abebe Y, 2003, AIDS, V17, P1835, DOI 10.1097/00002030-200308150-00013; Abubakar I, 2008, EPIDEMIOL INFECT, V136, P122, DOI 10.1017/S0950268807008333; Ahsan Giasuddin, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P126; Balasubramanian R, 2004, INT J TUBERC LUNG D, V8, P323; Boccia D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020824; Borgdorff MW, 2000, INT J TUBERC LUNG D, V4, P123; Central Statistical Agency [Ethiopia] ICF International, 2012, ETH DEM HLTH SURV 20; Central Statistical Agency of Ethiopia, 2012, POPULATION; Connolly Maire, 1996, World Health Statistics Quarterly, V49, P115; Daniel O J, 2006, Niger J Med, V15, P63; Datiko DG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009158; Datiko DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-266; Datiko DG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005443; Diwan VK, 1999, LANCET, V353, P1000, DOI 10.1016/S0140-6736(99)01318-5; Dogar OF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-244; dos Santos APG, 2013, INT J TUBERC LUNG D, V17, P192, DOI 10.5588/ijtld.11.0831; Federal Ministry of Health, 2011, TUB PREV CONTR PROGR; Federal Ministry of Health, 2008, TUB LEPR TB HIV PREV, V4th; Federal Ministry of Health of Ethiopia, 2005, FED MIN HLTH HLTH SE; Feng JY, 2012, CLIN MICROBIOL INFEC, V18, pE331, DOI 10.1111/j.1469-0691.2012.03931.x; Getahun H, 2007, LANCET, V369, P2042, DOI 10.1016/S0140-6736(07)60284-0; Getahun H, 2010, LANCET, V376, P1205, DOI 10.1016/S0140-6736(10)61503-6; Gninafon M, 2011, INT J TUBERC LUNG D, V15, P61; Gosoniu GD, 2008, INT J TUBERC LUNG D, V12, P848; Kritski AL, 1997, CHEST, V111, P1162, DOI 10.1378/chest.111.5.1162; Marais BJ, 2010, LANCET, V375, P2057, DOI 10.1016/S0140-6736(10)60579-X; Mathew TA, 2006, INT J TUBERC LUNG D, V10, P857; Mori T, 2010, INFECT DIS CLIN N AM, V24, P751, DOI 10.1016/j.idc.2010.04.011; Mukherjee A, 2012, LUNG INDIA, V29, P120, DOI 10.4103/0970-2113.95302; Muniyandi M, 2006, J Commun Dis, V38, P204; Muniyandi M, 2008, EXPERT OPIN PHARMACO, V9, P1623, DOI 10.1517/14656566.9.10.1623 ; Munoz-Sellart M, 2010, INT J TUBERC LUNG D, V14, P973; Muture BN, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-696; Oxlade O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047533; Park YK, 2013, TUBERC RESPIR DIS, V74, P104, DOI 10.4046/trd.2013.74.3.104; Schaaf HS, 2010, RESPIROLOGY, V15, P747, DOI 10.1111/j.1440-1843.2010.01784.x; Shargie E. B., 2005, Ethiopian Journal of Health Development, V19, P104; Shargie EB, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-62; Shaweno Debebe, 2012, BMC Res Notes, V5, P682, DOI 10.1186/1756-0500-5-682; Sidama Zone administration, 2012, SID ZON SO PROF; Sidama Zone Health Department, 2012, SID ZON HLTH DEP ANN; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Thorson A, 2001, Curr Opin Pulm Med, V7, P165, DOI 10.1097/00063198-200105000-00009; Wang JM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-354; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Woldeyohannes Desalegn, 2011, Ethiop Med J, V49, P221; Yassin MA, 2006, INT J TUBERC LUNG D, V10, P1166; Yassin MA, 2004, SCAND J INFECT DIS, V36, P670, DOI 10.1080/00365540410020848; Yassin MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063174	49	37	37	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114225	10.1371/journal.pone.0114225	http://dx.doi.org/10.1371/journal.pone.0114225			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460363	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000345869700118
J	Deng, JM; Qin, BQ; Paerl, HW; Zhang, YL; Wu, P; Ma, JR; Chen, YW				Deng, Jianming; Qin, Boqiang; Paerl, Hans W.; Zhang, Yunlin; Wu, Pan; Ma, Jianrong; Chen, Yuwei			Effects of Nutrients, Temperature and Their Interactions on Spring Phytoplankton Community Succession in Lake Taihu, China	PLOS ONE			English	Article							CLIMATE-CHANGE; ALGAL BLOOMS; FRESH-WATER; PHENOLOGY; RESPONSES; CYANOBACTERIAL; EUTROPHICATION; PHOTOSYNTHESIS; VARIABILITY; ENRICHMENT	We examined the potential effects of environmental variables, and their interaction, on phytoplankton community succession in spring using long-term data from 1992 to 2012 in Lake Taihu, China. Laboratory experiments were additionally performed to test the sensitivity of the phytoplankton community to nutrient concentrations and temperature. A phytoplankton community structure analysis from 1992 to 2012 showed that Cryptomonas (Cryptophyta) was the dominant genus in spring during the early 1990s. Dominance then shifted to Ulothrix (Chlorophyta) in 1996 and 1997. However, Cryptomonas again dominated in 1999, 2000, and 2002, with Ulothrix regaining dominance from 2003 to 2006. The bloom-forming cyanobacterial genus Microcystis dominated in 1995, 2001 and 2007-2012. The results of ordinations indicated that the nutrient concentration (as indicated by the trophic state index) was the most important factor affecting phytoplankton community succession during the past two decades. In the laboratory experiments, shifts in dominance among phytoplankton taxa occurred in all nutrient addition treatments. Results of both long term monitoring and experiment indicated that nutrients exert a stronger control than water temperature on phytoplankton communities during spring. Interactive effect of nutrients and water temperature was the next principal factor. Overall, phytoplankton community composition was mediated by nutrients concentrations, but this effect was strongly enhanced by elevated water temperatures.	[Deng, Jianming; Qin, Boqiang; Zhang, Yunlin; Wu, Pan; Ma, Jianrong; Chen, Yuwei] Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, Nanjing 210008, Jiangsu, Peoples R China; [Deng, Jianming; Wu, Pan; Ma, Jianrong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Paerl, Hans W.] Univ North Carolina Chapel Hill, Inst Marine Sci, Morehead City, NC 28557 USA	Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of North Carolina; University of North Carolina Chapel Hill	Qin, BQ (corresponding author), Acad Sci, Nanjing Inst Geog & Limnol, State Key Lab Lake Sci & Environm, 73 East Beijing Rd, Nanjing 210008, Jiangsu, Peoples R China.	qinbq@niglas.ac.cn	Deng, Jianming/F-3822-2011; Deng, Jianming/AAN-2998-2020; Qin, Boqiang/E-5900-2013; Zhang, Yunlin/N-5464-2014	Deng, Jianming/0000-0003-2432-6307; Deng, Jianming/0000-0003-2432-6307; Zhang, Yunlin/0000-0002-3382-4570	National Natural Science Foundation of China [41230744]; External Cooperation Program of the Chinese Academy of Sciences [GJHZ1214]; US National Science Foundation [ENG/CBET 0826819, 1230543, DEB 1240851]; Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences [NIGLAS2012135003]; Div Of Chem, Bioeng, Env, & Transp Sys [1230543] Funding Source: National Science Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); External Cooperation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); US National Science Foundation(National Science Foundation (NSF)); Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences(Chinese Academy of Sciences); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	Research by BQQ, JMD, PW and JRM was funded by the National Natural Science Foundation of China (41230744). Both BQQ and JMD were supported by the External Cooperation Program of the Chinese Academy of Sciences (Grant No. GJHZ1214). Research by HWP was jointly supported by US National Science Foundation Grant Nos. ENG/CBET 0826819, 1230543 (INSPIRE Program) and DEB 1240851 (Dimensions in Biodiversity Program). Research by YLZ was supported by the Key Program of the Nanjing Institute of Geography and Limnology, Chinese Academy of Sciences (NIGLAS2012135003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2004, ENCY SOCIAL SCI RES; Adrian R, 2006, GLOBAL CHANGE BIOL, V12, P652, DOI 10.1111/j.1365-2486.2006.01125.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Anneville O, 2005, FRESHWATER BIOL, V50, P1731, DOI 10.1111/j.1365-2427.2005.01429.x; [Anonymous], 1980, FRESHWATER ALGAE CHI; Apha, 1995, WPCF STAND METH EX W; Badeck FW, 2004, NEW PHYTOL, V162, P295, DOI 10.1111/j.1469-8137.2004.01059.x; Becker V, 2009, HYDROBIOLOGIA, V628, P137, DOI 10.1007/s10750-009-9751-7; BORCARD D, 1992, ECOLOGY, V73, P1045, DOI 10.2307/1940179; Brookes JD, 2011, SCIENCE, V334, P46, DOI 10.1126/science.1207349; Cai LL, 2012, WATER SCI ENG, V5, P361, DOI 10.3882/j.issn.1674-2370.2012.04.001; Carrascal LM, 2009, OIKOS, V118, P681, DOI 10.1111/j.1600-0706.2008.16881.x; Chen YW, 2003, J PLANKTON RES, V25, P445, DOI 10.1093/plankt/25.4.445; Deng JM, 2014, FRESHWATER BIOL, V59, P1076, DOI 10.1111/fwb.12330; Domis LND, 2007, HYDROBIOLOGIA, V584, P403, DOI 10.1007/s10750-007-0609-6; Dong XH, 2012, FRESHWATER BIOL, V57, P2044, DOI 10.1111/j.1365-2427.2011.02670.x; Duan HT, 2009, ENVIRON SCI TECHNOL, V43, P3522, DOI 10.1021/es8031852; EGGE JK, 1992, MAR ECOL PROG SER, V83, P281, DOI 10.3354/meps083281; Egge JK, 1998, J MARINE SYST, V16, P191, DOI 10.1016/S0924-7963(97)00113-9; Elliott JA, 2006, HYDROBIOLOGIA, V559, P401, DOI 10.1007/s10750-005-1233-y; Feuchtmayr H, 2012, FRESHWATER BIOL, V57, P331, DOI 10.1111/j.1365-2427.2011.02671.x; HECKY RE, 1988, LIMNOL OCEANOGR, V33, P796, DOI 10.4319/lo.1988.33.4_part_2.0796; Helsel DR, 1992, 1992 STAT METH WAT R; Ho R, 2006, HDB UNIVARIATE MULTI, DOI DOI 10.1201/9781420011111; Hu H., 2006, FRESHWATER ALGAE CHI; Huang WY, 2001, J LAKE SCI, V13, P356; Izagirre O, 2009, SCI TOTAL ENVIRON, V407, P5694, DOI 10.1016/j.scitotenv.2009.06.049; JENSEN JP, 1994, CAN J FISH AQUAT SCI, V51, P1692, DOI 10.1139/f94-170; Jeppesen E, 2005, FRESHWATER BIOL, V50, P1747, DOI 10.1111/j.1365-2427.2005.01415.x; Jeppesen E., 2010, CLIMATE CHANGE IMPAC; Jeppesen E, 2011, HYDROBIOLOGIA, V663, P1, DOI 10.1007/s10750-010-0547-6; Jeppesen E, 2009, J ENVIRON QUAL, V38, P1930, DOI 10.2134/jeq2008.0113; Jin X., 1990, STANDARD METHODS OBS; Kotta J, 2009, ESTUAR COAST SHELF S, V84, P509, DOI 10.1016/j.ecss.2009.07.014; Liu X, 2011, HARMFUL ALGAE, V10, P337, DOI 10.1016/j.hal.2010.12.002; Low EW, 2010, RAFFLES B ZOOL, V58, P311; LYNCH M, 1981, LIMNOL OCEANOGR, V26, P86, DOI 10.4319/lo.1981.26.1.0086; Moss B, 2011, INLAND WATERS, V1, P101, DOI 10.5268/IW-1.2.359; O'Neil JM, 2012, HARMFUL ALGAE, V14, P313, DOI 10.1016/j.hal.2011.10.027; Orenzen CJ, 1967, LIMNOL OCEANOGR, V12, P343; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Paerl HW, 2006, ECOL ENG, V26, P40, DOI 10.1016/j.ecoleng.2005.09.006; Peperzak L, 2003, ACTA OECOL, V24, pS139, DOI 10.1016/S1146-609X(03)00009-2; Qin B.Q., 2008, MONOGRAPHIAE BIOL, P342; Qin BQ, 2007, HYDROBIOLOGIA, V581, P3, DOI 10.1007/s10750-006-0521-5; Qin BQ, 2010, ENVIRON MANAGE, V45, P105, DOI 10.1007/s00267-009-9393-6; R Core Team, 2021, R LANGUAGE ENV STAT; Reynolds C.S., 1988, P388; REYNOLDS CS, 1980, HOLARCTIC ECOL, V3, P141, DOI 10.1111/j.1600-0587.1980.tb00721.x; RHEE GY, 1981, LIMNOL OCEANOGR, V26, P635, DOI 10.4319/lo.1981.26.4.0635; Rigosi A, 2014, LIMNOL OCEANOGR, V59, P99, DOI 10.4319/lo.2014.59.1.0099; Salmaso N, 2010, FRESHWATER BIOL, V55, P825, DOI 10.1111/j.1365-2427.2009.02325.x; Schreiber U, 2002, J PHYCOL, V38, P125, DOI 10.1046/j.1529-8817.2002.01103.x; Schreiber U, 1998, PHOTOSYNTHESIS: MECHANISMS AND EFFECTS, VOLS I-V, P4253; SPAIN JC, 1980, APPL ENVIRON MICROB, V40, P726, DOI 10.1128/AEM.40.4.726-734.1980; Staehr PA, 2006, FRESHWATER BIOL, V51, P249, DOI 10.1111/j.1365-2427.2005.01490.x; TERBRAAK CJF, 2002, CANOCO WINDOWS VERSI; Thackeray SJ, 2008, J ECOL, V96, P523, DOI 10.1111/j.1365-2745.2008.01355.x; Urrutia MB, 1996, J MAR BIOL ASSOC UK, V76, P431, DOI 10.1017/S0025315400030654; Walters AW, 2013, ECOLOGY, V94, P2188, DOI 10.1890/13-0445.1; Wang S., 1998, LAKES CHINA; Xu H, 2010, LIMNOL OCEANOGR, V55, P420, DOI 10.4319/lo.2010.55.1.0420; Yu T, 2013, ENVIRON SCI TECHNOL, V47, P9093, DOI 10.1021/es401517h; Zhang M, 2012, WATER RES, V46, P442, DOI 10.1016/j.watres.2011.11.013; [赵林林 Zhao Linlin], 2011, [水科学进展, Advances in Water Science], V22, P844	65	59	65	6	145	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113960	10.1371/journal.pone.0113960	http://dx.doi.org/10.1371/journal.pone.0113960			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464517	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700075
J	Mohammad, AA; Rahbar, A; Lui, WO; Davoudi, B; Catrina, A; Stragliotto, G; Mellbin, L; Hamsten, A; Ryden, L; Yaiw, KC; Soderberg-Naucler, C				Mohammad, Abdul-Aleem; Rahbar, Afsar; Lui, Weng-Onn; Davoudi, Belghis; Catrina, Anca; Stragliotto, Giuseppe; Mellbin, Linda; Hamsten, Anders; Ryden, Lars; Yaiw, Koon-Chu; Soderberg-Naucler, Cecilia			Detection of Circulating hcmv-miR-UL112-3p in Patients with Glioblastoma, Rheumatoid Arthritis, Diabetes Mellitus and Healthy Controls	PLOS ONE			English	Article							HUMAN CYTOMEGALOVIRUS-INFECTION; PERIPHERAL-BLOOD; EXPRESSION; ANTIBODIES; MICRORNAS; IDENTIFICATION; MONOCYTES; RNAS	Background: microRNAs (miRNA) are 18-22 nucleotides long non-coding RNAs that regulate gene expression at a post-transcriptional level. Human cytomegalovirus (HCMV) encodes at least 26 known mature miRNAs. hcmv-miR-UL112-3p (miR-UL112-3p) is the most well characterized HCMV miRNA, which is suggested to play role in establishment and maintenance of viral latency. Elevated miR-UL112-3p levels have been reported to be present in plasma of patients with hypertension. Objectives: In this study, we aimed to quantify miR-UL112-3p levels in the plasma/serum of patients with Diabetes Mellitus (DM; from the DIGAMI-2 cohort), Glioblastoma multiforme (GBM), Rheumatoid Arthritis (RA) and Healthy Controls (HC). Study Design: Total RNA was isolated from plasma/serum samples of 87 patients and controls, a TaqMan miRNA assay was performed to detect miR-UL112-3p and the copy numbers were normalized to 10 ng of total RNA. HCMV IgG and IgM were analysed using ELISA. Results: HCMV miR-UL112-3p was detected in 14/27 (52%) of DM, 5/20 (25%) of GBM, 1/20 (5%) of RA patients and in 2/20 (10%) of HC, respectively. Anti-HCMV IgG was detected in 85%, 65%, 75% of patients and 70% of HC, respectively. Anti-HCMV IgM was found only in one GBM patient of 87 examined patients and controls. Conclusions: A higher prevalence of miR-UL112-3p was detected in DM and GBM patients than in RA patients and HC. Elevated levels of miR-UL112-3p and higher prevalence of HCMV IgG were observed in DM patients. Whether the presence of circulating miR-UL112-3p denotes a biomarker of HCMV latency or active replication in patients warrants further investigation.	[Mohammad, Abdul-Aleem; Rahbar, Afsar; Davoudi, Belghis; Stragliotto, Giuseppe; Yaiw, Koon-Chu; Soderberg-Naucler, Cecilia] Karolinska Inst, Ctr Mol Med, Dept Med Solna, Expt Cardiovasc Res Unit, Stockholm, Sweden; [Lui, Weng-Onn] Karolinska Univ Hosp, Canc Ctr Karolinska, Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Catrina, Anca] Karolinska Univ Hosp, Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden; [Hamsten, Anders] Karolinska Inst, Ctr Mol Med, Atherosclerosis Res Unit, Stockholm, Sweden; [Mellbin, Linda; Ryden, Lars] Karolinska Inst, Dept Med Solna, Cardiol Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet	Soderberg-Naucler, C (corresponding author), Karolinska Inst, Ctr Mol Med, Dept Med Solna, Expt Cardiovasc Res Unit, Stockholm, Sweden.	cecilia.naucler@ki.se	Lui, Weng-Onn/G-6703-2013; Yaiw, Koon-Chu/AAJ-9682-2020; Lui, Weng-Onn/X-5957-2019; Mellbin, Linda/L-8779-2017	Lui, Weng-Onn/0000-0003-4717-4473; Yaiw, Koon-Chu/0000-0001-5329-1815; Lui, Weng-Onn/0000-0003-4717-4473; Davoudi, Belghis/0000-0001-8541-2538; Rahbar, Afsar/0000-0003-1158-2512	Sten A Olssons Foundation for Research and Culture; Erling-Persson Family Foundation; Torsten Soderberg Foundation; BILTEMA Foundation; IngaBritt and Arne Lundbergs Foundation; Stichting af Jochnick Foundation; Jane and Dan Olssons Research Foundation; Petrus and Augusta Hedlund Foundation; nxt2b; RATOS; Swedish Cancer Foundation; Children's Cancer Foundation; Swedish Medical Research Council; Thematic Research Center; Stockholm County Council; Swedish Heart-Lung Foundation; Bayer; Karolinska Institution's Foundation	Sten A Olssons Foundation for Research and Culture; Erling-Persson Family Foundation; Torsten Soderberg Foundation; BILTEMA Foundation; IngaBritt and Arne Lundbergs Foundation; Stichting af Jochnick Foundation; Jane and Dan Olssons Research Foundation; Petrus and Augusta Hedlund Foundation; nxt2b; RATOS; Swedish Cancer Foundation; Children's Cancer Foundation; Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Thematic Research Center; Stockholm County Council(Stockholm County Council); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Bayer(Bayer AG); Karolinska Institution's Foundation	This study was funded by: Sten A Olssons Foundation for Research and Culture, Erling-Persson Family Foundation, Torsten Soderberg Foundation, BILTEMA Foundation, IngaBritt and Arne Lundbergs Foundation, Stichting af Jochnick Foundation, Jane and Dan Olssons Research Foundation, Petrus and Augusta Hedlund Foundation, nxt2b, RATOS, Swedish Cancer Foundation, Children's Cancer Foundation, Swedish Medical Research Council, Thematic Research Center and Stockholm County Council, Swedish Heart-Lung Foundation, Bayer and Karolinska Institution's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cobbs CS, 2002, CANCER RES, V62, P3347; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Fu M, 2014, GENE, V536, P272, DOI 10.1016/j.gene.2013.12.012; Grey F, 2008, J CLIN VIROL, V41, P186, DOI 10.1016/j.jcv.2007.11.024; GRILLNER L, 1987, J VIROL METHODS, V17, P133, DOI 10.1016/0166-0934(87)90076-0; Huang YJ, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-51; KRECH U, 1981, B WORLD HEALTH ORGAN, V59, P605; Lasser C, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-9; Li SQ, 2011, CIRCULATION, V124, P175, DOI 10.1161/CIRCULATIONAHA.110.012237; LOHR JM, 1990, LANCET, V336, P644, DOI 10.1016/0140-6736(90)92145-8; Lucas KG, 2011, J NEURO-ONCOL, V103, P231, DOI 10.1007/s11060-010-0383-6; Malmberg K, 2005, EUR HEART J, V26, P650, DOI 10.1093/eurheartj/ehi199; Meshesha Mesfin K, 2012, Open Virol J, V6, P38, DOI 10.2174/1874357901206010038; Mitchell DA, 2008, NEURO-ONCOLOGY, V10, P10, DOI 10.1215/15228517-2007-035; Murphy EJ, 2008, LIPIDS, V43, P105, DOI 10.1007/s11745-008-3156-7; Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746; Rahbar Afsar, 2012, Herpesviridae, V3, P3, DOI 10.1186/2042-4280-3-3; SCHMITZ H, 1977, J CLIN MICROBIOL, V5, P629; Soderberg-Naucler C, 2006, J INTERN MED, V259, P219, DOI 10.1111/j.1365-2796.2006.01618.x; Soderberg-Naucler C, 2001, J VIROL, V75, P7543, DOI 10.1128/JVI.75.16.7543-7554.2001; Stark TJ, 2012, J VIROL, V86, P226, DOI 10.1128/JVI.05903-11; Stern-Ginossar N, 2008, NAT IMMUNOL, V9, P1065, DOI 10.1038/ni.1642; Stern-Ginossar N, 2007, SCIENCE, V317, P376, DOI 10.1126/science.1140956; Stern-Ginossar N, 2012, SCIENCE, V338, P1088, DOI 10.1126/science.1227919; TAMM A, 1993, J RHEUMATOL, V20, P1489; TAYLORWIEDEMAN J, 1991, J GEN VIROL, V72, P2059, DOI 10.1099/0022-1317-72-9-2059; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Warnke C, 2013, J NEUROL NEUROSURG P; Yaiw Koon-Chu, 2013, Herpesviridae, V4, P3, DOI 10.1186/2042-4280-4-3	29	22	25	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113740	10.1371/journal.pone.0113740	http://dx.doi.org/10.1371/journal.pone.0113740			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462570	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700046
J	Rahman, MM; Khan, SB; Marwani, HM; Asiri, AM				Rahman, Mohammed M.; Khan, Sher Bahadar; Marwani, Hadi M.; Asiri, Abdullah M.			Selective Divalent Cobalt Ions Detection Using Ag2O3-ZnO Nanocones by ICP-OES Method for Environmental Remediation	PLOS ONE			English	Article							SOLID-PHASE EXTRACTION; ABSORPTION SPECTROMETRIC DETERMINATION; CHEMICAL SENSOR; IN-SITU; FUNCTIONALIZED SILICA; AQUEOUS-SOLUTIONS; TRACE AMOUNTS; HEAVY-METALS; OXIDE; FABRICATION	Here, we have synthesized Ag2O3-ZnO nanocones (NCs) by a wet-chemical route using reducing agents at low temperature. The structural, optical and morphological properties of Ag2O3-ZnO NCs were investigated by several conventional techniques such as powder XRD, XPS, FESEM, XEDS, FTIR and UV/vis. spectroscopy. The analytical parameters of prepared NCs were also calculated for a selective detection of divalent cobalt [Co(II)] prior to its determination by inductively coupled plasma-optical emission spectrometry (ICP-OES). The selectivity of NCs toward various metal ions, including Cd(II), Co(II), Cr(III), Cu(II), Fe(III), Ni(II), and Zn(II) was studied. Results of the selectivity study demonstrated that Ag2O3-ZnO NC phase was the most selective towards Co(II) ion. The uptake capacity for Co(II) ion was experimentally calculated to be similar to 76.69 mgg(-1). Moreover, adsorption isotherm data provided that the adsorption process was mainly monolayer on homogeneous adsorbent surfaces of Ag2O3-ZnO NCs. Kinetic study revealed that the adsorption of Co(II) on Ag2O3-ZnO NCs phase followed the pseudo-second-order kinetic model. In addition, thermodynamic results provided that the adsorption mechanism of Co(II) ions on Ag2O3-ZnO NCs was a spontaneous process and thermodynamically favorable. Finally, the proposed method was validated by applying it to real environmental water samples with reasonable results.	[Rahman, Mohammed M.; Khan, Sher Bahadar; Marwani, Hadi M.; Asiri, Abdullah M.] King Abdulaziz Univ, Ctr Excellence Adv Mat Res, Jeddah 21413, Saudi Arabia; [Rahman, Mohammed M.; Khan, Sher Bahadar; Marwani, Hadi M.; Asiri, Abdullah M.] King Abdulaziz Univ, Fac Sci, Dept Chem, Jeddah 21413, Saudi Arabia	King Abdulaziz University; King Abdulaziz University	Rahman, MM (corresponding author), King Abdulaziz Univ, Ctr Excellence Adv Mat Res, Jeddah 21413, Saudi Arabia.	mmrahman@kau.edu.sa	Marwani, Hadi M/K-8893-2012; Asiri, Abdullah M./C-3458-2009; Khan, Prof. Sher Bahadar/M-7968-2019; Rahman, Mohammed M./H-5823-2012; Khan, Sher Bahadar/H-5833-2012	Marwani, Hadi M/0000-0003-0199-9488; Asiri, Abdullah M./0000-0001-7905-3209; Khan, Prof. Sher Bahadar/0000-0001-9635-7175; Rahman, Mohammed M./0000-0003-2773-1244; Khan, Sher Bahadar/0000-0001-9635-7175	Center of Excellence for Advanced Materials Research (CEAMR), King Abdulaziz University, Jeddah [CEAMR-SG-4-435]	Center of Excellence for Advanced Materials Research (CEAMR), King Abdulaziz University, Jeddah	This project was funded by Center of Excellence for Advanced Materials Research (CEAMR), King Abdulaziz University, Jeddah, under grant no. (CEAMR-SG-4-435). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2011, CLEAN-SOIL AIR WATER, V39, P74, DOI 10.1002/clen.201000125; Biparva P, 2011, CLEAN-SOIL AIR WATER, V39, P1081, DOI 10.1002/clen.201000198; CAI ZH, 1989, J AM CHEM SOC, V111, P4138, DOI 10.1021/ja00193a077; Castro Gustavo Rocha de, 2004, Mat. Res., V7, P329, DOI 10.1590/S1516-14392004000200018; Cho HJ, 2011, B KOREAN CHEM SOC, V32, P489, DOI 10.5012/bkcs.2011.32.2.489; Dahiya S, 2008, J HAZARD MATER, V150, P376, DOI 10.1016/j.jhazmat.2007.04.134; Faisal M, 2012, APPL SURF SCI, V258, P7515, DOI 10.1016/j.apsusc.2012.04.075; Faisal M, 2011, APPL SURF SCI, V258, P672, DOI 10.1016/j.apsusc.2011.07.067; Faisal M, 2011, CHEM ENG J, V173, P178, DOI 10.1016/j.cej.2011.07.067; Fang GZ, 2010, J CHROMATOGR A, V1217, P1567, DOI 10.1016/j.chroma.2010.01.010; Fujii T, 1999, PHYS REV B, V59, P3195, DOI 10.1103/PhysRevB.59.3195; Gao XY, 2011, THIN SOLID FILMS, V519, P6620, DOI 10.1016/j.tsf.2011.04.028; Ghilane J, 2007, NANO LETT, V7, P1406, DOI 10.1021/nl070268p; Han DM, 2005, J CHROMATOGR A, V1100, P131, DOI 10.1016/j.chroma.2005.09.035; Hara K, 2000, SOL ENERG MAT SOL C, V64, P115, DOI 10.1016/S0927-0248(00)00065-9; Ho YS, 2006, WATER RES, V40, P119, DOI 10.1016/j.watres.2005.10.040; Hu ZS, 2012, APPL SURF SCI, V258, P8049, DOI 10.1016/j.apsusc.2012.04.170; Huang H, 2013, CHEM ENG J, V225, P447, DOI 10.1016/j.cej.2013.04.018; Huang MH, 2001, SCIENCE, V292, P1897, DOI 10.1126/science.1060367; Javed MA, 2007, SEP SCI TECHNOL, V42, P3641, DOI 10.1080/01496390701710794; Langmuir I, 1916, J AM CHEM SOC, V38, P2221, DOI 10.1021/ja02268a002; Lee CJ, 2002, APPL PHYS LETT, V81, P3648, DOI 10.1063/1.1518810; Lesage E, 2007, ECOL ENG, V30, P320, DOI 10.1016/j.ecoleng.2007.04.007; Li QH, 2004, APPL PHYS LETT, V85, P6389, DOI 10.1063/1.1840116; Lin DD, 2009, CHEM MATER, V21, P3479, DOI 10.1021/cm900225p; Liu YH, 2010, CHEM ENG J, V158, P108, DOI 10.1016/j.cej.2009.12.012; Lu WW, 2008, J PHYS CHEM C, V112, P16792, DOI 10.1021/jp803654k; Manzoori JL, 2007, MICROCHIM ACTA, V159, P71, DOI 10.1007/s00604-006-0727-2; Marwani HM, 2012, DESALIN WATER TREAT, V45, P128, DOI 10.1080/19443994.2012.692019; MCKAY G, 1982, J APPL POLYM SCI, V27, P3043, DOI 10.1002/app.1982.070270827; Mohammadi SZ, 2010, CENT EUR J CHEM, V8, P662, DOI 10.2478/s11532-010-0029-8; Nasu A, 1997, ANAL SCI, V13, P903, DOI 10.2116/analsci.13.903; Ng HT, 2004, NANO LETT, V4, P1247, DOI 10.1021/nl049461z; PEI SQ, 1994, ANAL CHIM ACTA, V294, P185, DOI 10.1016/0003-2670(94)80193-2; Pyrzynska K, 2005, SPECTROCHIM ACTA B, V60, P1316, DOI 10.1016/j.sab.2005.06.010; Qiu SP, 2006, MAT SCI ENG A-STRUCT, V435, P327, DOI 10.1016/j.msea.2006.07.062; Raghupathi KR, 2011, LANGMUIR, V27, P4020, DOI 10.1021/la104825u; Rahman MM, 2011, J BIOMED NANOTECHNOL, V7, P351, DOI 10.1166/jbn.2011.1299; Rahman MM, 2009, SENSOR ACTUAT B-CHEM, V137, P327, DOI 10.1016/j.snb.2008.10.060; Rahman MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100327; Rahman MM, 2012, TALANTA, V99, P924, DOI 10.1016/j.talanta.2012.07.060; Rahman MM, 2012, CHEM ENG J, V192, P122, DOI 10.1016/j.cej.2012.03.045; Rahman MM, 2012, TALANTA, V95, P18, DOI 10.1016/j.talanta.2012.03.027; Rahman MM, 2012, MICROCHIM ACTA, V178, P99, DOI 10.1007/s00604-012-0817-2; Rahman MM, 2011, BIOSENS BIOELECTRON, V28, P127, DOI 10.1016/j.bios.2011.07.024; Rahman MM, 2011, J PHYS CHEM C, V115, P9503, DOI 10.1021/jp202252j; Rahman MM, 2011, ACS APPL MATER INTER, V3, P1346, DOI 10.1021/am200151f; Rahman MM, 2011, J NANOPART RES, V13, P3789, DOI 10.1007/s11051-011-0301-7; Sahay PP, 2008, SENSOR ACTUAT B-CHEM, V134, P654, DOI 10.1016/j.snb.2008.06.006; Scheckel KG, 2010, ENVIRON SCI TECHNOL, V44, P1307, DOI 10.1021/es9032265; Sekine R, 2013, ENVIRON SCI TECHNOL, V47, P9308, DOI 10.1021/es400839h; Shaker Medhat A., 2007, American Journal of Applied Sciences, V4, P605, DOI 10.3844/ajassp.2007.605.612; Soci C, 2007, NANO LETT, V7, P1003, DOI 10.1021/nl070111x; Soylak M, 2006, J HAZARD MATER, V137, P1035, DOI 10.1016/j.jhazmat.2006.03.031; Tanikkul S, 2004, TALANTA, V64, P1241, DOI 10.1016/j.talanta.2004.05.060; Tao A, 2003, NANO LETT, V3, P1229, DOI 10.1021/nl0344209; Tao GH, 1998, FRESEN J ANAL CHEM, V360, P156, DOI 10.1007/s002160050667; Toma M, 2013, NANO LETT, V13, P6164, DOI 10.1021/nl403496a; Tong SS, 2011, MICROCHIM ACTA, V174, P257, DOI 10.1007/s00604-011-0622-3; Umar A, 2008, CHEM COMMUN, P166, DOI 10.1039/b711215g; Vijaya JJ, 2008, J HAZARD MATER, V153, P767, DOI 10.1016/j.jhazmat.2007.09.022; Vijayaraghavan K, 2006, BIORESOURCE TECHNOL, V97, P1411, DOI 10.1016/j.biortech.2005.07.001; Wang XD, 2007, SCIENCE, V316, P102, DOI 10.1126/science.1139366; Wang ZL, 2004, J PHYS-CONDENS MAT, V16, pR829, DOI 10.1088/0953-8984/16/25/R01; Wei K, 2011, CHINESE J CHEM, V29, P143, DOI 10.1002/cjoc.201190042; Wei WF, 2011, J MATER CHEM, V21, P432, DOI 10.1039/c0jm02214d; Xu H, 2011, CHINESE J CHEM, V29, P805, DOI 10.1002/cjoc.201190162; Zhang L, 2011, MICROCHIM ACTA, V174, P391, DOI 10.1007/s00604-011-0643-y; Zhang Z, 2008, J PHYS CHEM C, V112, P9579, DOI 10.1021/jp710837h; Zhou L, 2014, NANO LETT, V14, P1093, DOI 10.1021/nl500008y; Zhu J, 2009, NANO LETT, V9, P279, DOI 10.1021/nl802886y; Zubkov T, 2005, J PHYS CHEM B, V109, P14144, DOI 10.1021/jp0517854	72	9	9	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114084	10.1371/journal.pone.0114084	http://dx.doi.org/10.1371/journal.pone.0114084			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464507	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700094
J	Weyler, L; Engelbrecht, M; Forsberg, MM; Brehwens, K; Vare, D; Vielfort, K; Wojcik, A; Aro, H				Weyler, Linda; Engelbrecht, Mattias; Forsberg, Manuel Mata; Brehwens, Karl; Vare, Daniel; Vielfort, Katarina; Wojcik, Andrzej; Aro, Helena			Restriction Endonucleases from Invasive Neisseria gonorrhoeae Cause Double-Strand Breaks and Distort Mitosis in Epithelial Cells during Infection	PLOS ONE			English	Article							PROSTATE-CANCER; SEXUAL-BEHAVIOR; UP-REGULATION; IN-VITRO; HOST; CHECKPOINT; MICRONUCLEUS; TARGETS; ALUI; ORGANIZATION	The host epithelium is both a barrier against, and the target for microbial infections. Maintaining regulated cell growth ensures an intact protective layer towards microbial-induced cellular damage. Neisseria gonorrhoeae infections disrupt host cell cycle regulation machinery and the infection causes DNA double strand breaks that delay progression through the G2/M phase. We show that intracellular gonococci upregulate and release restriction endonucleases that enter the nucleus and damage human chromosomal DNA. Bacterial lysates containing restriction endonucleases were able to fragment genomic DNA as detected by PFGE. Lysates were also microinjected into the cytoplasm of cells in interphase and after 20 h, DNA double strand breaks were identified by 53BP1 staining. In addition, by using live-cell microscopy and NHS-ester stained live gonococci we visualized the subcellular location of the bacteria upon mitosis. Infected cells show dysregulation of the spindle assembly checkpoint proteins MAD1 and MAD2, impaired and prolonged M-phase, nuclear swelling, micronuclei formation and chromosomal instability. These data highlight basic molecular functions of how gonococcal infections affect host cell cycle regulation, cause DNA double strand breaks and predispose cellular malignancies.	[Weyler, Linda; Engelbrecht, Mattias; Forsberg, Manuel Mata; Brehwens, Karl; Vare, Daniel; Wojcik, Andrzej; Aro, Helena] Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, S-10691 Stockholm, Sweden; [Vielfort, Katarina] Univ Gothenburg, Dept Chem & Mol Biol, S-40530 Gothenburg, Sweden	Stockholm University; University of Gothenburg	Aro, H (corresponding author), Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, S-10691 Stockholm, Sweden.	Helena.Aro@su.se		Vare, Daniel/0000-0002-6666-2635; Vielfort, Katarina/0000-0002-9988-6336	Swedish Cancer Society (Cancerfonden); Carl Tryggers stiftelse; Borgstroms stiftelse; Granholms Stiftelse; SE Goljes minne	Swedish Cancer Society (Cancerfonden)(Swedish Cancer Society); Carl Tryggers stiftelse; Borgstroms stiftelse; Granholms Stiftelse; SE Goljes minne	This work was funded by the Swedish Cancer Society (Cancerfonden), Carl Tryggers stiftelse, Borgstroms stiftelse, and Granholms Stiftelse. LW was supported by S&E Goljes minne. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbibe L, 2007, NAT IMMUNOL, V8, P47, DOI 10.1038/ni1423; Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081; Bierne H, 2012, CELL MICROBIOL, V14, P622, DOI 10.1111/j.1462-5822.2012.01758.x; Binnicker MJ, 2003, CELL MICROBIOL, V5, P549, DOI 10.1046/j.1462-5822.2003.00300.x; Chan YA, 2012, MICROB DRUG RESIST, V18, P271, DOI 10.1089/mdr.2012.0001; Cloud KA, 2002, INFECT IMMUN, V70, P2752, DOI 10.1128/IAI.70.6.2752-2757.2002; De Antoni A, 2005, CURR BIOL, V15, P214, DOI 10.1016/j.cub.2005.01.038; Dennis LK, 2002, UROLOGY, V60, P78, DOI 10.1016/S0090-4295(02)01637-0; Evdokimova V, 2012, ENDOCR-RELAT CANCER, V19, P271, DOI 10.1530/ERC-11-0314; Fenech M, 2000, MUTAT RES-FUND MOL M, V455, P81, DOI 10.1016/S0027-5107(00)00065-8; Fenech M, 2011, MUTAGENESIS, V26, P125, DOI 10.1093/mutage/geq052; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Fichorova RN, 2001, INFECT IMMUN, V69, P5840, DOI 10.1128/IAI.69.9.5840-5848.2001; Follows SA, 2009, INFECT IMMUN, V77, P3602, DOI 10.1128/IAI.01366-08; Frisch M, 1997, NEW ENGL J MED, V337, P1350, DOI 10.1056/NEJM199711063371904; Garcia DL, 2006, J BACTERIOL, V188, P7211, DOI 10.1128/JB.00724-06; Hardwick KG, 2005, CURR BIOL, V15, pR122, DOI 10.1016/j.cub.2005.02.008; Hayes RB, 2000, BRIT J CANCER, V82, P718, DOI 10.1054/bjoc.1999.0986; HERRERO R, 1990, CANCER-AM CANCER SOC, V65, P380, DOI 10.1002/1097-0142(19900115)65:2<380::AID-CNCR2820650234>3.0.CO;2-9; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; JOHANNES C, 1991, INT J RADIAT BIOL, V59, P1379, DOI 10.1080/09553009114551241; Jones A, 2007, FASEB J, V21, P345, DOI 10.1096/fj.06-6675com; KELLOGG DS, 1968, J BACTERIOL, V96, P596, DOI 10.1128/JB.96.3.596-605.1968; KHARSANY ABM, 1993, GENITOURIN MED, V69, P357; KJAER SK, 1992, CANCER CAUSE CONTROL, V3, P339, DOI 10.1007/BF00146887; LeVan A, 2012, J BACTERIOL, V194, P6468, DOI 10.1128/JB.00969-12; Lofmark S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016369; Maniotis AJ, 2005, AM J PATHOL, V166, P1187, DOI 10.1016/S0002-9440(10)62338-3; Mazumder A, 2008, BIOPHYS J, V95, P3028, DOI 10.1529/biophysj.108.132274; Muller WU, 2004, STRAHLENTHER ONKOL, V180, P655, DOI 10.1007/s00066-004-1255-9; Nougayrede JP, 2005, TRENDS MICROBIOL, V13, P103, DOI 10.1016/j.tim.2005.01.002; Obaya AJ, 2002, CELL MOL LIFE SCI, V59, P126, DOI 10.1007/s00018-002-8410-1; Pennini ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000995; Ryan SD, 2012, P NATL ACAD SCI USA, V109, pE2205, DOI 10.1073/pnas.1201911109; Schuyler SC, 2012, J CELL SCI, V125, P4197, DOI 10.1242/jcs.107037; Song WX, 2000, J EXP MED, V191, P949, DOI 10.1084/jem.191.6.949; Suzuki Keiji, 2010, Genome Integr, V1, P4, DOI 10.1186/2041-9414-1-4; SWANSON J, 1986, CELL, V47, P267, DOI 10.1016/0092-8674(86)90449-6; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Vielfort K, 2013, J CELL SCI, V126, P339, DOI 10.1242/jcs.117721; Ward D, 2013, GENOME SEQUENCE NEIS; WILSON GG, 1991, NUCLEIC ACIDS RES, V19, P2539, DOI 10.1093/nar/19.10.2539; Wojcik A, 1996, RADIAT RES, V146, P577, DOI 10.2307/3579559	43	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114208	10.1371/journal.pone.0114208	http://dx.doi.org/10.1371/journal.pone.0114208			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460012	gold, Green Published, Green Submitted			2022-12-26	WOS:000345869700116
J	Witowski, V; Foraita, R; Pitsiladis, Y; Pigeot, I; Wirsik, N				Witowski, Vitali; Foraita, Ronja; Pitsiladis, Yannis; Pigeot, Iris; Wirsik, Norman			Using Hidden Markov Models to Improve Quantifying Physical Activity in Accelerometer Data - A Simulation Study	PLOS ONE			English	Article							ENERGY-EXPENDITURE; VALIDATION; CALIBRATION; CHILDREN	Introduction: The use of accelerometers to objectively measure physical activity (PA) has become the most preferred method of choice in recent years. Traditionally, cutpoints are used to assign impulse counts recorded by the devices to sedentary and activity ranges. Here, hidden Markov models (HMM) are used to improve the cutpoint method to achieve a more accurate identification of the sequence of modes of PA. Methods: 1,000 days of labeled accelerometer data have been simulated. For the simulated data the actual sedentary behavior and activity range of each count is known. The cutpoint method is compared with HMMs based on the Poisson distribution (HMM[Pois]), the generalized Poisson distribution (HMM[GenPois]) and the Gaussian distribution (HMM[Gauss]) with regard to misclassification rate (MCR), bout detection, detection of the number of activities performed during the day and runtime. Results: The cutpoint method had a misclassification rate (MCR) of 11% followed by HMM[Pois] with 8%, HMM[GenPois] with 3% and HMM[Gauss] having the best MCR with less than 2%. HMM[Gauss] detected the correct number of bouts in 12.8% of the days, HMM[GenPois] in 16.1%, HMM[Pois] and the cutpoint method in none. HMM[GenPois] identified the correct number of activities in 61.3% of the days, whereas HMM[Gauss] only in 26.8%. HMM[Pois] did not identify the correct number at all and seemed to overestimate the number of activities. Runtime varied between 0.01 seconds (cutpoint), 2.0 minutes (HMM[Gauss]) and 14.2 minutes (HMM[GenPois]). Conclusions: Using simulated data, HMM-based methods were superior in activity classification when compared to the traditional cutpoint method and seem to be appropriate to model accelerometer data. Of the HMM-based methods, HMM[Gauss] seemed to be the most appropriate choice to assess real-life accelerometer data.	[Witowski, Vitali; Foraita, Ronja; Pigeot, Iris; Wirsik, Norman] Leibniz Inst Prevent Res & Epidemiol BIPS, Dept Biometry & Data Management, Bremen, Germany; [Witowski, Vitali; Pigeot, Iris] Univ Bremen, Dept Math & Comp Sci, D-28359 Bremen, Germany; [Pitsiladis, Yannis] Univ Brighton, Sch Sport & Serv Management, Eastbourne, England	Leibniz Institute for Prevention Research & Epidemiology (BIPS); University of Bremen; University of Brighton	Witowski, V (corresponding author), Leibniz Inst Prevent Res & Epidemiol BIPS, Dept Biometry & Data Management, Bremen, Germany.	wirsik@bips.uni-bremen.de	Pigeot, Iris/A-2722-2012	Pigeot, Iris/0000-0001-7483-0726; Pitsiladis, Yannis/0000-0001-6210-2449				Ahrens W, 2011, INT J OBESITY, V35, pS3, DOI 10.1038/ijo.2011.30; BAUM LE, 1970, ANN MATH STAT, V41, P164, DOI 10.1214/aoms/1177697196; Centers for Disease Control and Prevention, 2011, MUCH PHYS ACT DO CHI; Crouter SE, 2012, MED SCI SPORT EXER, V44, P1177, DOI 10.1249/MSS.0b013e3182447825; Ekelund U, 2001, MED SCI SPORT EXER, V33, P275; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; FORNEY GD, 1973, P IEEE, V61, P268, DOI 10.1109/PROC.1973.9030; Freedson P, 2005, MED SCI SPORT EXER, V37, pS523, DOI 10.1249/01.mss.0000185658.28284.ba; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Guinhouya CB, 2009, ACTA PAEDIATR, V98, P708, DOI 10.1111/j.1651-2227.2008.01187.x; Hislop JF, 2012, PEDIATR EXERC SCI, V24, P450, DOI 10.1123/pes.24.3.450; Janz KF, 2010, MED SCI SPORT EXER, V42, P1072, DOI 10.1249/MSS.0b013e3181c619b2; Joe H, 2005, BIOMETRICAL J, V47, P219, DOI 10.1002/bimj.200410102; Kimm SYS, 2005, LANCET, V366, P301, DOI 10.1016/S0140-6736(05)66837-7; Lee IM, 2012, LANCET, V380, P219, DOI 10.1016/S0140-6736(12)61031-9; McTiernan A, 2008, NAT REV CANCER, V8, P205, DOI 10.1038/nrc2325; Ojiambo R, 2012, J APPL PHYSIOL, V113, P1530, DOI 10.1152/japplphysiol.01290.2011; Pate RR, 2006, OBESITY, V14, P2000, DOI 10.1038/oby.2006.234; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Pober DM, 2006, MED SCI SPORT EXER, V38, P1626, DOI 10.1249/01.mss.0000227542.43669.45; Puyau MR, 2002, OBES RES, V10, P150, DOI 10.1038/oby.2002.24; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Rethorst CD, 2009, SPORTS MED, V39, P491, DOI 10.2165/00007256-200939060-00004; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Treuth MS, 2004, MED SCI SPORT EXER, V36, P198, DOI 10.1249/01.MSS.0000113666.98463.B0; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trost SG, 2007, AM J LIFESTYLE MED, V1, P299, DOI 10.1177/1559827607301686; VITERBI AJ, 1967, IEEE T INFORM THEORY, V13, P260, DOI 10.1109/TIT.1967.1054010; Witowski V, 2013, HMMPA ANAL ACCELEROM; Zucchini W, 2009, MONOGR STAT APPL PRO, V110, P3	30	11	11	3	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114089	10.1371/journal.pone.0114089	http://dx.doi.org/10.1371/journal.pone.0114089			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464514	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700095
J	Worker, A; Blain, C; Jarosz, J; Chaudhuri, KR; Barker, GJ; Williams, SCR; Brown, R; Leigh, PN; Simmons, A				Worker, Amanda; Blain, Camilla; Jarosz, Jozef; Chaudhuri, K. Ray; Barker, Gareth J.; Williams, Steven C. R.; Brown, Richard; Leigh, P. Nigel; Simmons, Andrew			Cortical Thickness, Surface Area and Volume Measures in Parkinson's Disease, Multiple System Atrophy and Progressive Supranuclear Palsy	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; MAGNETIC-RESONANCE IMAGES; HUMAN CEREBRAL-CORTEX; GEOMETRICALLY ACCURATE; DIAGNOSTIC-CRITERIA; DISORDERS; DEMENTIA; SURVIVAL; STATE; MRI	Objective: Parkinson's disease (PD), Multiple System Atrophy (MSA) and Progressive Supranuclear Palsy (PSP) are neurodegenerative diseases that can be difficult to distinguish clinically. The objective of the current study was to use surface-based analysis techniques to assess cortical thickness, surface area and grey matter volume to identify unique morphological patterns of cortical atrophy in PD, MSA and PSP and to relate these patterns of change to disease duration and clinical features. Methods: High resolution 3D T1-weighted MRI volumes were acquired from 14 PD patients, 18 MSA, 14 PSP and 19 healthy control participants. Cortical thickness, surface area and volume analyses were carried out using the automated surface-based analysis package FreeSurfer (version 5.1.0). Measures of disease severity and duration were assessed for correlation with cortical morphometric changes in each clinical group. Results: Results show that in PSP, widespread cortical thinning and volume loss occurs within the frontal lobe, particularly the superior frontal gyrus. In addition, PSP patients also displayed increased surface area in the pericalcarine. In comparison, PD and MSA did not display significant changes in cortical morphology. Conclusion: These results demonstrate that patients with clinically established PSP exhibit distinct patterns of cortical atrophy, particularly affecting the frontal lobe. These results could be used in the future to develop a useful clinical application of MRI to distinguish PSP patients from PD and MSA patients.	[Worker, Amanda; Blain, Camilla; Chaudhuri, K. Ray; Barker, Gareth J.; Williams, Steven C. R.; Brown, Richard; Simmons, Andrew] Kings Coll London, Inst Psychiat, London, England; [Worker, Amanda; Chaudhuri, K. Ray; Williams, Steven C. R.; Brown, Richard; Simmons, Andrew] Kings Coll London, South London & Maudsley NHS Fdn Trust, Natl Inst Hlth Res, Biomed Res Ctr Mental Hlth, London, England; [Worker, Amanda; Chaudhuri, K. Ray; Brown, Richard; Simmons, Andrew] Kings Coll London, South London & Maudsley NHS Fdn Trust, Natl Inst Hlth Res, Biomed Res Unit Dementia, London, England; [Blain, Camilla; Jarosz, Jozef; Chaudhuri, K. Ray] Kings Coll Hosp London, London, England; [Leigh, P. Nigel] Trafford Ctr Biomed Res, Brighton, E Sussex, England; [Leigh, P. Nigel] Univ Sussex, Sussex Med Sch, Brighton, E Sussex, England	University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London; South London & Maudsley NHS Trust; University of London; King's College London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of Brighton; University of Sussex	Simmons, A (corresponding author), Kings Coll London, Inst Psychiat, London, England.	andy.simmons@kcl.ac.uk	Simmons, Andrew/B-8848-2008; Leigh, Peter/AAD-5638-2019; Barker, Gareth J/C-9616-2009; Williams, Steve C/D-6979-2011; Brown, Richard G/A-9599-2010	Simmons, Andrew/0000-0003-2306-5811; Barker, Gareth J/0000-0002-5214-7421; Williams, Steve C/0000-0003-4299-1941; Brown, Richard G/0000-0001-9021-0172; opoku, anita/0000-0001-7243-8157; Ray Chaudhuri, K/0000-0003-2815-0505	NIHR Biomedical Research Centre for Mental Health; NIHR Biomedical Research Unit for Dementia at South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London	NIHR Biomedical Research Centre for Mental Health(National Institute for Health Research (NIHR)); NIHR Biomedical Research Unit for Dementia at South London; Maudsley NHS Foundation Trust; Institute of Psychiatry, King's College London	Support for this study was provided by the NIHR Biomedical Research Centre for Mental Health and NIHR Biomedical Research Unit for Dementia at South London and Maudsley NHS Foundation Trust and Institute of Psychiatry, King's College London. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bensimon G, 2009, BRAIN, V132, P156, DOI 10.1093/brain/awn291; Biundo R, 2011, J NEUROL SCI, V310, P64, DOI 10.1016/j.jns.2011.08.001; Blain CRV, 2006, NEUROLOGY, V67, P2199, DOI 10.1212/01.wnl.0000249307.59950.f8; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Brenneis C, 2003, MOVEMENT DISORD, V18, P1132, DOI 10.1002/mds.10502; Brown RG, 2010, BRAIN, V133, P2382, DOI 10.1093/brain/awq158; Burton EJ, 2004, BRAIN, V127, P791, DOI 10.1093/brain/awh088; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Focke NK, 2011, HUM BRAIN MAPP, V32, P1905, DOI 10.1002/hbm.21161; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FOSTER NL, 1988, ANN NEUROL, V24, P399, DOI 10.1002/ana.410240308; Gilman S, 1999, J NEUROL SCI, V163, P94, DOI 10.1016/S0022-510X(98)00304-9; Golbe LI, 2007, BRAIN, V130, P1552, DOI 10.1093/brain/awm032; HUGHES AJ, 1992, NEUROLOGY, V42, P1142, DOI 10.1212/WNL.42.6.1142; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; JOHNSON KA, 1992, J NUCL MED, V33, P704; Josephs KA, 2013, MOVEMENT DISORDERS; Jubault T, 2011, NEUROIMAGE, V55, P462, DOI 10.1016/j.neuroimage.2010.12.043; Litvan I, 2003, MOVEMENT DISORD, V18, P467, DOI 10.1002/mds.10459; Litvan I, 1996, NEUROLOGY, V47, P1, DOI 10.1212/WNL.47.1.1; Lyoo CH, 2010, MOVEMENT DISORD, V25, P496, DOI 10.1002/mds.22975; Marquand AF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069237; Mattis S, 1988, DEMENTIA RATING SCAL; Padovani A, 2006, J NEUROL NEUROSUR PS, V77, P457, DOI 10.1136/jnnp.2005.075713; Pellicano C, 2012, EUR J NEUROL, V19, P172, DOI 10.1111/j.1468-1331.2011.03465.x; Pereira JB, 2012, HUM BRAIN MAPP, V33, P2521, DOI 10.1002/hbm.21378; ROBBINS TW, 1994, J NEUROL NEUROSUR PS, V57, P79, DOI 10.1136/jnnp.57.1.79; Schrag A, 2008, MOVEMENT DISORD, V23, P294, DOI 10.1002/mds.21839; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Talairach J., 1988, COPLANAR STEREOTAXIC; VanEssen DC, 1997, NATURE, V385, P313, DOI 10.1038/385313a0; Whitwell JL, 2011, PARKINSONISM RELAT D, V17, P599, DOI 10.1016/j.parkreldis.2011.05.013	37	32	32	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114167	10.1371/journal.pone.0114167	http://dx.doi.org/10.1371/journal.pone.0114167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463618	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000345869700110
J	Guo, JB; Xu, C; Li, XC; Chen, S				Guo, Jiubiao; Xu, Ci; Li, Xuechen; Chen, Sheng			A Simple, Rapid and Sensitive FRET Assay for Botulinum Neurotoxin Serotype B Detection	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; LASER-DESORPTION IONIZATION; CLOSTRIDIUM-BOTULINUM; SUBSTRATE RECOGNITION; ENDOPEP-MS; TOXINS; IDENTIFICATION; TETANUS; TRANSCYTOSIS; SPECIFICITY	Botulinum neurotoxins (BoNTs), the most potent naturally-occurring neurotoxins known to humans, comprise seven distinct serotypes (BoNT/A-G), each of which exhibits unique substrate specificity. Many methods have been developed for BoNT detection, in particular for BoNT/A, with various complexity and sensitivity, while substrate based FRET assay is considered as the most widely used approach due to its simplicity and sensitivity. In this study, we designed a vesicle-associated membrane protein 2 (VAMP2) based FRET assay based on the understanding of the VAMP2 and light chain/B (LC/B) interactions in our previous studies. The current design constituted the shortest peptide, VAMP2 (63-85), with FRET dyes (EDAN and Dabcyl) labelled at position 76 and 85, respectively, which showed minimal effect on VAMP2 substrate catalysis by LC/B and therefore enhanced the sensitivity of the assay. The FRET peptide, designated as FVP-B, was specific to LC/B, with a detection sensitivity as low as similar to 20 pM in 2 h. Importantly, FVP-B showed the potential to be scaled up and used in high throughput screening of LC/B inhibitor. The currently developed FRET assay is one of the most economic and rapid FRET assays for LC/B detection.	[Guo, Jiubiao; Chen, Sheng] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Kowloon, Hong Kong, Peoples R China; [Xu, Ci; Li, Xuechen] Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China	Hong Kong Polytechnic University; University of Hong Kong	Li, XC (corresponding author), Univ Hong Kong, Dept Chem, Hong Kong, Hong Kong, Peoples R China.	xuechenl@hku.hk; sheng.chen@polyu.edu.hk		Guo, Jiubiao/0000-0003-2716-1712; Chen, Sheng/0000-0003-3526-7808	Hong Kong Research Grant Council [560211]	Hong Kong Research Grant Council(Hong Kong Research Grants Council)	This work was sponsored by the grant from Hong Kong Research Grant Council, 560211 for SC. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anne C, 2001, ANAL BIOCHEM, V291, P253, DOI 10.1006/abio.2001.5028; Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P2081; Barr JR, 2011, ACS SYM SER, V1065, P83; Boldt GE, 2006, J COMB CHEM, V8, P513, DOI 10.1021/cc060010h; Bossi Philippe, 2004, Euro Surveill, V9, pE13; Brunger AT, 2005, Q REV BIOPHYS, V38, P1, DOI 10.1017/S0033583505004051; Chen S, 2008, J BIOL CHEM, V283, P21153, DOI 10.1074/jbc.M800611200; Chen S, 2007, J BIOL CHEM, V282, P25540, DOI 10.1074/jbc.M701922200; Chen S, 2007, J BIOL CHEM, V282, P9621, DOI 10.1074/jbc.M611211200; Chen S, 2011, BIOCHEM J, V433, P277, DOI 10.1042/BJ20101310; Davletov B, 2005, TRENDS NEUROSCI, V28, P446, DOI 10.1016/j.tins.2005.06.001; Dunning FM, 2012, APPL ENVIRON MICROB, V78, P7687, DOI 10.1128/AEM.01664-12; FACH P, 1993, J APPL BACTERIOL, V75, P234, DOI 10.1111/j.1365-2672.1993.tb02771.x; Fach P, 2009, J APPL MICROBIOL, V107, P465, DOI 10.1111/j.1365-2672.2009.04215.x; Feltrup TM, 2012, ANAL CHEM, V84, P10549, DOI 10.1021/ac302997n; Ferreira JL, 2003, J AOAC INT, V86, P314; Fujinaga Y, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/974943; Hill KK, 2007, J BACTERIOL, V189, P818, DOI 10.1128/JB.01180-06; Joshi SG, 2012, J PHARMACOL TOX MET, V65, P8, DOI 10.1016/j.vascn.2011.11.002; Kalb SR, 2006, ANAL BIOCHEM, V351, P84, DOI 10.1016/j.ab.2006.01.027; Kalb SR, 2012, ANAL BIOANAL CHEM, V403, P215, DOI 10.1007/s00216-012-5767-3; Kalb SR, 2008, INT J MASS SPECTROM, V278, P101, DOI 10.1016/j.ijms.2008.04.004; KAUTTER DA, 1977, J ASSOC OFF ANA CHEM, V60, P541; Kirchner S, 2010, APPL ENVIRON MICROB, V76, P4387, DOI 10.1128/AEM.02490-09; Kohler G, 2005, J IMMUNOL, V174, P2453; KOZAKI S, 1979, JPN J MED SCI BIOL, V32, P199, DOI 10.7883/yoken1952.32.199; LANGE DJ, 1991, MUSCLE NERVE, V14, P672, DOI 10.1002/mus.880140711; Liu W, 2003, P NATL ACAD SCI USA, V100, P13621, DOI 10.1073/pnas.2233819100; Maksymowych AB, 1998, J BIOL CHEM, V273, P21950, DOI 10.1074/jbc.273.34.21950; Maksymowych AB, 2004, J PHARMACOL EXP THER, V310, P633, DOI 10.1124/jpet.104.066845; MONTECUCCO C, 1994, MOL MICROBIOL, V13, P1, DOI 10.1111/j.1365-2958.1994.tb00396.x; NOTERMANS S, 1979, APPL ENVIRON MICROB, V37, P1173, DOI 10.1128/AEM.37.6.1173-1175.1979; OHISHI I, 1980, INFECT IMMUN, V28, P303; Pickett Andy, 2011, Int J Neurosci, V121 Suppl 1, P22, DOI 10.3109/00207454.2010.539306; Ruge DR, 2011, ANAL BIOCHEM, V411, P200, DOI 10.1016/j.ab.2011.01.002; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Salzameda NT, 2009, BIOORG MED CHEM LETT, V19, P5848, DOI 10.1016/j.bmcl.2009.08.079; SCHIAVO G, 1994, ANN NY ACAD SCI, V710, P65, DOI 10.1111/j.1749-6632.1994.tb26614.x; SCHIAVO G, 1993, J BIOL CHEM, V268, P23784; Scotcher MC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011047; Sharma SK, 2006, APPL ENVIRON MICROB, V72, P1231, DOI 10.1128/AEM.72.2.1231-1238.2006; van Baar BLM, 2004, J CHROMATOGR A, V1035, P97, DOI 10.1016/j.chroma.2004.02.047; van Baar BLM, 2002, J CHROMATOGR A, V970, P95, DOI 10.1016/S0021-9673(02)00508-3; WANG GT, 1990, TETRAHEDRON LETT, V31, P6493, DOI 10.1016/S0040-4039(00)97099-0; Wictome M, 1999, APPL ENVIRON MICROB, V65, P3787	45	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114124	10.1371/journal.pone.0114124	http://dx.doi.org/10.1371/journal.pone.0114124			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437190	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900122
J	Vanegas, JM; Arroyo, M				Vanegas, Juan M.; Arroyo, Marino			Force Transduction and Lipid Binding in MscL: A Continuum-Molecular Approach	PLOS ONE			English	Article							ION-CHANNEL MSCL; MECHANOSENSITIVE CHANNEL; HYDROPHOBIC MISMATCH; ESCHERICHIA-COLI; MEMBRANE-PROTEIN; LARGE-CONDUCTANCE; CRYSTAL-STRUCTURE; GATING MECHANISM; SIMULATION; RHODOPSIN	The bacterial mechanosensitive channel MscL, a small protein mainly activated by membrane tension, is a central model system to study the transduction of mechanical stimuli into chemical signals. Mutagenic studies suggest that MscL gating strongly depends on both intra-protein and interfacial lipid-protein interactions. However, there is a gap between this detailed chemical information and current mechanical models of MscL gating. Here, we investigate the MscL bilayer-protein interface through molecular dynamics simulations, and take a combined continuum-molecular approach to connect chemistry and mechanics. We quantify the effect of membrane tension on the forces acting on the surface of the channel, and identify interactions that may be critical in the force transduction between the membrane and MscL. We find that the local stress distribution on the protein surface is largely asymmetric, particularly under tension, with the cytoplasmic side showing significantly larger and more localized forces, which pull the protein radially outward. The molecular interactions that mediate this behavior arise from hydrogen bonds between the electronegative oxygens in the lipid headgroup and a cluster of positively charged lysine residues on the amphipathic S1 domain and the C-terminal end of the second trans-membrane helix. We take advantage of this strong interaction (estimated to be 10-13 kT per lipid) to actuate the channel (by applying forces on protein-bound lipids) and explore its sensitivity to the pulling magnitude and direction. We conclude by highlighting the simple motif that confers MscL with strong anchoring to the bilayer, and its presence in various integral membrane proteins including the human mechanosensitive channel K2P1 and bovine rhodopsin.	[Vanegas, Juan M.; Arroyo, Marino] Univ Politecn Cataluna, BarcelonaTech, LaCaN, Barcelona, Spain	Universitat Politecnica de Catalunya	Vanegas, JM (corresponding author), Sandia Natl Labs, Ctr Biol & Mat Sci, POB 5800, Albuquerque, NM 87185 USA.	jmvaneg@sandia.gov	Arroyo, Marino/B-5696-2008	Arroyo, Marino/0000-0003-1647-940X	European Research Council [240487]; "ICREA Academia" for excellence in research - Generalitat de Catalunya	European Research Council(European Research Council (ERC)European Commission); "ICREA Academia" for excellence in research - Generalitat de Catalunya(ICREA)	JMV and MA acknowledge the support of the European Research Council (http://erc.europa.eu/ grant agreement nr 240487 (FP7/2007-2013). MA acknowledges the support received through the prize "ICREA Academia" for excellence in research, funded by the Generalitat de Catalunya (http://www.gencat.cat/generalitat/eng/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackbarow T, 2007, P NATL ACAD SCI USA, V104, P16410, DOI 10.1073/pnas.0705759104; Ajouz B, 2000, J BIOL CHEM, V275, P1015, DOI 10.1074/jbc.275.2.1015; Anishkin A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/45/454120; Blount P, 1996, P NATL ACAD SCI USA, V93, P11652, DOI 10.1073/pnas.93.21.11652; Botelho AV, 2006, BIOPHYS J, V91, P4464, DOI 10.1529/biophysj.106.082776; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; BROWN MF, 1994, CHEM PHYS LIPIDS, V73, P159, DOI 10.1016/0009-3084(94)90180-5; Casado M, 1998, J PHYSIOL-LONDON, V513, P317, DOI 10.1111/j.1469-7793.1998.317bb.x; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Chiu SW, 2009, J PHYS CHEM B, V113, P2748, DOI 10.1021/jp807056c; Corry B, 2010, J GEN PHYSIOL, V136, P483, DOI 10.1085/jgp.200910376; de Jesus AJ, 2013, BBA-BIOMEMBRANES, V1828, P851, DOI 10.1016/j.bbamem.2012.09.012; Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105; Gullingsrud J, 2003, BIOPHYS J, V85, P2087, DOI 10.1016/S0006-3495(03)74637-2; Hase CC, 1997, J MEMBRANE BIOL, V157, P17, DOI 10.1007/s002329900212; Haswell ES, 2011, STRUCTURE, V19, P1356, DOI 10.1016/j.str.2011.09.005; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Iscla I, 2008, BIOPHYS J, V95, P2283, DOI 10.1529/biophysj.107.127423; Iscla I, 2012, BIOPHYS J, V103, P169, DOI 10.1016/j.bpj.2012.06.021; Jeon J, 2008, BIOPHYS J, V94, P3497, DOI 10.1529/biophysj.107.109850; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Keutsch FN, 2001, P NATL ACAD SCI USA, V98, P10533, DOI 10.1073/pnas.191266498; Kim T, 2010, BIOPHYS J, V99, P175, DOI 10.1016/j.bpj.2010.04.015; Lee AG, 2011, BIOCHEM SOC T, V39, P761, DOI 10.1042/BST0390761; Louhivuori M, 2010, P NATL ACAD SCI USA, V107, P19856, DOI 10.1073/pnas.1001316107; Maingret F, 2000, J BIOL CHEM, V275, P10128, DOI 10.1074/jbc.275.14.10128; MARTINAC B, 1990, NATURE, V348, P261, DOI 10.1038/348261a0; Maurer JA, 2003, J BIOL CHEM, V278, P21076, DOI 10.1074/jbc.M302892200; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; Moe P, 2005, BIOCHEMISTRY-US, V44, P12239, DOI 10.1021/bi0509649; Niemela PS, 2010, J AM CHEM SOC, V132, P7574, DOI 10.1021/ja101481b; Ollila OHS, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.078101; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Perozo E, 2003, CURR OPIN STRUC BIOL, V13, P432, DOI 10.1016/S0959-440X(03)00106-4; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Powl AM, 2008, BIOCHEMISTRY-US, V47, P4317, DOI 10.1021/bi702409t; Powl AM, 2007, BIOPHYS J, V93, P113, DOI 10.1529/biophysj.107.105130; Reeves D, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.041901; Rycroft CH, 2009, CHAOS, V19, DOI 10.1063/1.3215722; Sawada Y, 2012, CHANNELS, V6, P317, DOI 10.4161/chan.21895; Schmid N, 2011, EUR BIOPHYS J BIOPHY, V40, P843, DOI 10.1007/s00249-011-0700-9; Sheu SY, 2003, P NATL ACAD SCI USA, V100, P12683, DOI 10.1073/pnas.2133366100; Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9; Strandberg E, 2012, BBA-BIOMEMBRANES, V1818, P1242, DOI 10.1016/j.bbamem.2012.01.023; Sukharev S, 2001, BIOPHYS J, V81, P917, DOI 10.1016/S0006-3495(01)75751-7; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; Tadmor E. B., 2011, MODELING MAT CONTINU; Vanegas JM, 2014, J CHEM THEORY COMPUT, V10, P691, DOI 10.1021/ct4008926; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; Wiggins P, 2005, BIOPHYS J, V88, P880, DOI 10.1529/biophysj.104.047431; Wiggins P, 2004, P NATL ACAD SCI USA, V101, P4071, DOI 10.1073/pnas.0307804101; Wiita AP, 2006, P NATL ACAD SCI USA, V103, P7222, DOI 10.1073/pnas.0511035103; Williamson IM, 2002, BIOPHYS J, V83, P2026, DOI 10.1016/S0006-3495(02)73964-7; Wolf MG, 2010, J COMPUT CHEM, V31, P2169, DOI 10.1002/jcc.21507; Yang LM, 2013, CELL REP, V3, P520, DOI 10.1016/j.celrep.2013.01.018; Yang LM, 2012, ACS NANO, V6, P1134, DOI 10.1021/nn203703j; Yoo J, 2013, BIOPHYS J, V104, P117, DOI 10.1016/j.bpj.2012.11.3812; Yoshimura K, 2004, BIOPHYS J, V86, P2113, DOI 10.1016/S0006-3495(04)74270-8; Zhong DL, 2014, BIOPHYS J, V106, P375, DOI 10.1016/j.bpj.2013.12.006	61	27	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113947	10.1371/journal.pone.0113947	http://dx.doi.org/10.1371/journal.pone.0113947			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437007	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900101
J	Ortiz, A; Lee, YC; Yu, GY; Liu, HC; Lin, SC; Bilen, MA; Cho, HJ; Yu-Lee, LY; Lin, SH				Ortiz, Angelica; Lee, Yu-Chen; Yu, Guoyu; Liu, Hsuan-Chen; Lin, Song-Chang; Bilen, Melmet Asim; Cho, Hyojin; Yu-Lee, Li-Yuan; Lin, Sue-Hwa			Angiomotin is a novel component of cadherin-11/beta-catenin/p120 complex and is critical for cadherin-11-mediated cell migration	FASEB JOURNAL			English	Article						adhesion; E-cadherin; OB-cadherin; prostate cancer	UVOMORULIN-CATENIN COMPLEX; PROSTATE-CANCER CELLS; E-CADHERIN; BETA-CATENIN; N-CADHERIN; ALPHA-CATENIN; ENDOTHELIAL-CELLS; VE-CADHERIN; IN-VIVO; PROTEIN	Loss of E-cadherin and up-regulation of mesenchymal cadherins, a hallmark of the epithelial-mesenchymal transition, contributes to migration and dissemination of cancer cells. Expression of human cadherin-11 (Cad11), also known as osteoblast cadherin, in prostate cancer increases the migration of prostate cancer cells. How Cad11 mediates cell migration is unknown. Using the human Cad11 cytoplasmic domain in pulldown assays, we identified human angiomotin (Amot), known to be involved in cell polarity, migration, and Hippo pathway, as a component of the Cad11 protein complex. Deletion analysis showed that the last C-terminal 10 amino acids in Cad11 cytoplasmic domain are required for Amot binding. Further, Cad11 preferentially interacts with Amot-p80 than Amot-p130 isoform and binds directly to the middle domain of Amot-p80. Cad11-Amot interaction affects Cad11-mediated cell migration, but not homophilic adhesion, as deletion of Amot binding motif of Cad11 (Cad11-Delta Amot) did not abolish Cad11-mediated cell-cell adhesion of mouse L cells, but significantly reduced Cad11-mediated cell migration of human C4-2B4 and PC3-mm2 prostate cancer cells and human HEK293T cells. Together, our studies identified Amot-p80 as a novel component of the Cad11 complex and demonstrated that Amot-p80 is critical for Cad11-mediated cell migration.	[Ortiz, Angelica; Lee, Yu-Chen; Yu, Guoyu; Liu, Hsuan-Chen; Lin, Song-Chang; Bilen, Melmet Asim; Cho, Hyojin; Lin, Sue-Hwa] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA; [Lin, Sue-Hwa] Univ Texas MD Anderson Canc Ctr, Dept Genitourinary Med Oncol, Houston, TX 77030 USA; [Lin, Sue-Hwa] Univ Texas Houston, Grad Sch Biomed Sci, Houston, TX USA; [Yu-Lee, Li-Yuan] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Baylor College of Medicine	Lin, SH (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Unit 89, 1515 Holcombe Blvd, Houston, TX 77030 USA.	slin@mdanderson.org		Liu, Hsuan-Chen/0000-0001-7857-0204	U.S. National Institutes of Health [CA174798, P50 CA140388, CA16672]; Prostate Cancer Foundation; U.S. Department of Defense [PC093132, PC080847]; Cancer Prevention and Research Institute of Texas [CPRIT RP110327]; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA174798, P50CA140388] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Prostate Cancer Foundation; U.S. Department of Defense(United States Department of Defense); Cancer Prevention and Research Institute of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Dr. C. Wells (Indiana University) for providing the p80-Amot and Amot deletion mutant plasmids and Dr. J. L. Kissil (Wistar Institute) for providing p130-Amot, p80-CC, and p80 Delta CC 3xFlag plasmids for our studies. They also thank Dr. H. Zeng for generating PC3-mm2 Amot-p80 and C4-2B4 shAmot cell lines. This work was supported by the U.S. National Institutes of Health (Grants CA174798, P50 CA140388, and CA16672); the Prostate Cancer Foundation; U.S. Department of Defense (Grants PC093132 and PC080847); and the Cancer Prevention and Research Institute of Texas (Grant CPRIT RP110327).	Adler JJ, 2013, J BIOL CHEM, V288, P15181, DOI 10.1074/jbc.M112.446534; Baki L, 2001, P NATL ACAD SCI USA, V98, P2381, DOI 10.1073/pnas.041603398; Balsamo J, 1996, J CELL BIOL, V134, P801, DOI 10.1083/jcb.134.3.801; Baumeister U, 2005, EMBO J, V24, P1686, DOI 10.1038/sj.emboj.7600647; Brady-Kalnay SM, 1998, J CELL BIOL, V141, P287, DOI 10.1083/jcb.141.1.287; Bratt A, 2002, GENE, V298, P69, DOI 10.1016/S0378-1119(02)00928-9; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Chu K, 2008, MOL CANCER RES, V6, P1259, DOI 10.1158/1541-7786.MCR-08-0077; Chumanov RS, 2011, PROTEIN EXPRES PURIF, V76, P145, DOI 10.1016/j.pep.2010.11.010; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Ernkvist M, 2006, FEBS J, V273, P2000, DOI 10.1111/j.1742-4658.2006.05216.x; Ernkvist M, 2008, BBA-MOL CELL RES, V1783, P429, DOI 10.1016/j.bbamcr.2007.11.018; Ernkvist M, 2009, BLOOD, V113, P244, DOI 10.1182/blood-2008-04-153874; EWING CM, 1995, CANCER RES, V55, P4813; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Huang CF, 2010, CANCER RES, V70, P4580, DOI 10.1158/0008-5472.CAN-09-3016; Huber AH, 2001, CELL, V105, P391, DOI 10.1016/S0092-8674(01)00330-0; Jiang WG, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-16; Kiener HP, 2006, MOL BIOL CELL, V17, P2366, DOI 10.1091/mbc.E05-08-0745; Lee YC, 2013, MOL CANCER RES, V11, P1401, DOI 10.1158/1541-7786.MCR-13-0108; Lee YC, 2010, J PATHOL, V221, P68, DOI 10.1002/path.2687; Leung CY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3251; Levchenko T, 2004, ONCOGENE, V23, P1469, DOI 10.1038/sj.onc.1207264; Lira CBB, 2008, PROTEIN EXPRES PURIF, V61, P220, DOI 10.1016/j.pep.2008.06.007; Murali AK, 2012, J UROLOGY, V188, P632, DOI 10.1016/j.juro.2012.03.114; NAGAFUCHI A, 1987, NATURE, V329, P341, DOI 10.1038/329341a0; Oas RG, 2013, MOL BIOL CELL, V24, P704, DOI 10.1091/mbc.E12-06-0471; OZAWA M, 1992, J CELL BIOL, V116, P989, DOI 10.1083/jcb.116.4.989; OZAWA M, 1990, P NATL ACAD SCI USA, V87, P4246, DOI 10.1073/pnas.87.11.4246; Pece S, 2002, NAT CELL BIOL, V4, pE72, DOI 10.1038/ncb0402-e72; Perl AK, 1998, NATURE, V392, P190, DOI 10.1038/32433; Ranahan WP, 2011, CANCER RES, V71, P2203, DOI 10.1158/0008-5472.CAN-10-1995; Sheth P, 2007, BIOCHEM J, V402, P291, DOI 10.1042/BJ20060665; Siu R, 2007, MOL CELL BIOL, V27, P208, DOI 10.1128/MCB.00707-06; Sugihara-Mizuno Y, 2007, GENES CELLS, V12, P473, DOI 10.1111/j.1365-2443.2007.01066.x; Troyanovsky B, 2001, J CELL BIOL, V152, P1247, DOI 10.1083/jcb.152.6.1247; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Wang CJ, 2012, BIOCHEM J, V444, P279, DOI 10.1042/BJ20111983; Wei CJ, 2005, J BIOL CHEM, V280, P19925, DOI 10.1074/jbc.M412921200; Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Winklmeier A, 2009, CANCER SCI, V100, P261, DOI 10.1111/j.1349-7006.2008.01048.x; Wu CS, 2011, J BIOL CHEM, V286, P23511, DOI 10.1074/jbc.M111.245209; Xu G, 2002, J BIOL CHEM, V277, P49989, DOI 10.1074/jbc.M206454200; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yi CL, 2011, CANCER CELL, V19, P527, DOI 10.1016/j.ccr.2011.02.017; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111	49	24	25	3	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					1080	1091		10.1096/fj.14-261594	http://dx.doi.org/10.1096/fj.14-261594			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25466890	Green Published			2022-12-26	WOS:000350633000031
J	Wang, H; Zhou, TT; Peng, JH; Xu, P; Dong, NZ; Chen, SH; Wu, QY				Wang, Hao; Zhou, Tiantian; Peng, Jianhao; Xu, Ping; Dong, Ningzheng; Chen, Shenghan; Wu, Qingyu			Distinct Roles of N-Glycosylation at Different Sites of Corin in Cell Membrane Targeting and Ectodomain Shedding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATRIAL-NATRIURETIC-PEPTIDE; TRANSMEMBRANE SERINE-PROTEASE; EXPERIMENTAL HEART-FAILURE; ZYMOGEN ACTIVATION; BLOOD-PRESSURE; HYPERTENSION; SURFACE; GENE; EXPRESSION; DOMAINS	Corin is a membrane-bound protease essential for activating natriuretic peptides and regulating blood pressure. Human corin has 19 predicted N-glycosylation sites in its extracellular domains. It has been shown that N-glycans are required for corin cell surface expression and zymogen activation. It remains unknown, however, how N-glycans at different sites may regulate corin biosynthesis and processing. In this study, we examined corin mutants, in which each of the 19 predicted N-glycosylation sites was mutated individually. By Western analysis of corin proteins in cell lysate and conditioned medium from transfected HEK293 cells and HL-1 cardiomyocytes, we found that N-glycosylation at Asn-80 inhibited corin shedding in the juxtamembrane domain. Similarly, N-glycosylation at Asn-231 protected corin from autocleavage in the frizzled-1 domain. Moreover, N-glycosylation at Asn-697 in the scavenger receptor domain and at Asn-1022 in the protease domain is important for corin cell surface targeting and zymogen activation. We also found that the location of the N-glycosylation site in the protease domain was not critical. N-Glycosylation at Asn-1022 may be switched to different sites to promote corin zymogen activation. Together, our results show that N-glycans at different sites may play distinct roles in regulating the cell membrane targeting, zymogen activation, and ectodomain shedding of corin.	[Wang, Hao; Peng, Jianhao; Xu, Ping; Chen, Shenghan; Wu, Qingyu] Cleveland Clin, Lerner Res Inst, Dept Mol Cardiol, Cleveland, OH 44195 USA; [Wang, Hao; Wu, Qingyu] Cleveland State Univ, Dept Chem, Cleveland, OH 44115 USA; [Zhou, Tiantian; Dong, Ningzheng; Wu, Qingyu] Soochow Univ, Cyrus Tang Hematol Ctr, Suzhou 215123, Peoples R China; [Zhou, Tiantian; Dong, Ningzheng; Wu, Qingyu] Soochow Univ, Collaborat Innovat Ctr Hematol, Suzhou 215123, Peoples R China	Cleveland Clinic Foundation; University System of Ohio; Cleveland State University; Soochow University - China; Soochow University - China	Wu, QY (corresponding author), Cleveland Clin, 9500 Euclid Ave, Cleveland, OH 44195 USA.	wuq@ccf.org		Wu, Qingyu/0000-0003-0561-9315; Wang, Hao/0000-0001-6881-9977	National Institutes of Health [HL089298, HD064634]; National Natural Science Foundation of China [81370718]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Danish-Chinese Center for Protease and Cancer [31161130356]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064634] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL089298] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Danish-Chinese Center for Protease and Cancer; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL089298 and HD064634. This work was also supported by National Natural Science Foundation of China Grant 81370718, a grant from the Priority Academic Program Development of Jiangsu Higher Education Institutions, and Danish-Chinese Center for Protease and Cancer Grant 31161130356.	Antalis TM, 2011, PROG MOL BIOL TRANSL, V99, P1, DOI 10.1016/S1877-1173(11)99001-2; Armaly Z, 2013, CURR OPIN NEPHROL HY, V22, P713, DOI 10.1097/01.mnh.0000435609.35789.32; Armstrong DWJ, 2013, REGUL PEPTIDES, V186, P108, DOI 10.1016/j.regpep.2013.08.006; Blobel CP, 2005, NAT REV MOL CELL BIO, V6, P32, DOI 10.1038/nrm1548; Bugge TH, 2009, J BIOL CHEM, V284, P23177, DOI 10.1074/jbc.R109.021006; Cannone V, 2013, HYPERTENSION, V62, P860, DOI 10.1161/HYPERTENSIONAHA.113.01344; Chan JCY, 2005, P NATL ACAD SCI USA, V102, P785, DOI 10.1073/pnas.0407234102; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cui YJ, 2012, NATURE, V484, P246, DOI 10.1038/nature10897; Dalziel M, 2014, SCIENCE, V343, P37, DOI 10.1126/science.1235681; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; Dong NZ, 2014, J BIOL CHEM, V289, P17909, DOI 10.1074/jbc.M114.551424; Dong NZ, 2013, J BIOL CHEM, V288, P7867, DOI 10.1074/jbc.M112.411512; Dries DL, 2005, CIRCULATION, V112, P2403, DOI 10.1161/CIRCULATIONAHA.105.568881; Gladysheva IP, 2008, BIOCHEM BIOPH RES CO, V373, P130, DOI 10.1016/j.bbrc.2008.05.181; Gladysheva IP, 2008, J MOL CELL CARDIOL, V44, P131, DOI 10.1016/j.yjmcc.2007.10.002; Haga Y, 2011, J BIOL CHEM, V286, P31320, DOI 10.1074/jbc.M111.253955; Hart GW, 2010, CELL, V143, P672, DOI 10.1016/j.cell.2010.11.008; Hodgson-Zingman DM, 2008, NEW ENGL J MED, V359, P158, DOI 10.1056/NEJMoa0706300; Hooper JD, 2000, EUR J BIOCHEM, V267, P6931, DOI 10.1046/j.1432-1327.2000.01806.x; Ichiki T, 2013, AM J PHYSIOL-REG I, V304, pR102, DOI 10.1152/ajpregu.00233.2012; Ichiki T, 2011, CLIN CHEM, V57, P40, DOI 10.1373/clinchem.2010.153908; Jiang J, 2014, J BIOL CHEM, V289, P19500, DOI 10.1074/jbc.M114.555110; Jiang JJ, 2011, J BIOL CHEM, V286, P10066, DOI 10.1074/jbc.M110.185082; Kaitu'u-Lino TJ, 2013, HUM REPROD, V28, P1172, DOI 10.1093/humrep/det028; KITAMOTO Y, 1994, P NATL ACAD SCI USA, V91, P7588, DOI 10.1073/pnas.91.16.7588; Klein JD, 2010, KIDNEY INT, V78, P635, DOI 10.1038/ki.2010.223; Langenickel TH, 2004, AM J PHYSIOL-HEART C, V287, pH1516, DOI 10.1152/ajpheart.00947.2003; Liao X, 2007, J BIOL CHEM, V282, P27728, DOI 10.1074/jbc.M703687200; Lynch AI, 2009, CURR HYPERTENS REP, V11, P35, DOI 10.1007/s11906-009-0008-7; Martinez-Maza R, 2001, J BIOL CHEM, V276, P2168, DOI 10.1074/jbc.M006774200; Miller GS, 2013, CELL TISSUE RES, V351, P245, DOI 10.1007/s00441-012-1348-1; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Oberst MD, 2003, J BIOL CHEM, V278, P26773, DOI 10.1074/jbc.M304282200; Qi XF, 2011, J BIOL CHEM, V286, P20963, DOI 10.1074/jbc.M110.217570; Rame JE, 2007, HYPERTENSION, V49, P857, DOI 10.1161/01.HYP.0000258566.95867.9e; REISS K, 2009, CELL DEV BIOL, V20, P126; Rubattu S, 2014, CLIN SCI, V127, P1, DOI 10.1042/CS20130427; Schlondorff J, 1999, J CELL SCI, V112, P3603; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sciarretta S, 2013, CIRC RES, V112, P1355, DOI 10.1161/CIRCRESAHA.113.301325; Szabo R, 2011, ANNU REV CELL DEV BI, V27, P213, DOI 10.1146/annurev-cellbio-092910-154247; Vagin O, 2009, AM J PHYSIOL-RENAL, V296, pF459, DOI 10.1152/ajprenal.90340.2008; Webb SL, 2011, FRONT BIOSCI-LANDMRK, V16, P539, DOI 10.2741/3704; Wu F, 2002, J BIOL CHEM, V277, P16900, DOI 10.1074/jbc.M201503200; Wu QY, 2007, FRONT BIOSCI-LANDMRK, V12, P4179, DOI 10.2741/2379; Wu QY, 2009, KIDNEY INT, V75, P142, DOI 10.1038/ki.2008.418; Yamaguchi N, 2002, J BIOL CHEM, V277, P6806, DOI 10.1074/jbc.M103645200; Yan W, 1999, J BIOL CHEM, V274, P14926, DOI 10.1074/jbc.274.21.14926; Yan W, 2000, P NATL ACAD SCI USA, V97, P8525, DOI 10.1073/pnas.150149097; Zheng XL, 1999, J BIOL CHEM, V274, P1596, DOI 10.1074/jbc.274.3.1596; Zhou FF, 2005, MOL PHARMACOL, V67, P868, DOI 10.1124/mol.104.007583; Zhou Y, 2013, PLACENTA, V34, P89, DOI 10.1016/j.placenta.2012.11.016; Zhou YQ, 2014, CURR HYPERTENS REP, V16, DOI 10.1007/s11906-013-0415-7	54	23	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1654	1663		10.1074/jbc.M114.606442	http://dx.doi.org/10.1074/jbc.M114.606442			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25451932	hybrid, Green Published			2022-12-26	WOS:000348056400032
J	Crivello, F; Tzourio-Mazoyer, N; Tzourio, C; Mazoyer, B				Crivello, Fabrice; Tzourio-Mazoyer, Nathalie; Tzourio, Christophe; Mazoyer, Bernard			Longitudinal Assessment of Global and Regional Rate of Grey Matter Atrophy in 1,172 Healthy Older Adults: Modulation by Sex and Age	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; GENERAL ELDERLY POPULATION; CORTICAL THICKNESS; REPLACEMENT THERAPY; ENTORHINAL CORTEX; BRAIN ATROPHY; MRI; HIPPOCAMPAL; VOLUMES; ESTROGEN	To characterize the neuroanatomical changes in healthy older adults is important to differentiate pathological from normal brain structural aging. The present study investigated the annualized rate of GM atrophy in a large sample of older participants, focusing on the hippocampus, and searching for modulation by age and sex. In this 4-year longitudinal community cohort study, we used a VBM analysis to estimate the annualized rate of GM loss, at both the global and regional levels, in 1,172 healthy older adults (65-82 years) scanned at 1.5T. The global annualized rate of GM was -4.0 cm(3)/year (-0.83%/year). The highest rates of regional GM loss were found in the frontal and parietal cortices, middle occipital gyri, temporal cortex and hippocampus. The rate of GM atrophy was higher in women (-4.7 cm(3)/year, 20.91%/year) than men (-3.3 cm(3)/year, -0.65%/year). The global annualized rate of GM atrophy remained constant throughout the age range of the cohort, in both sexes. This pattern was replicated at the regional level, with the exception of the hippocampi, which showed a rate of GM atrophy that accelerated with age (2.8%/year per year of age) similarly for men and women. The present study reports a global and regional description of the annualized rate of grey matter loss and its evolution after the age of 65. Our results suggest greater anatomical vulnerability of women in late life and highlight a specific vulnerability of the hippocampus to the aging processes after 65 years of age.	[Crivello, Fabrice; Tzourio-Mazoyer, Nathalie; Mazoyer, Bernard] Univ Bordeaux, GIN, UMR 5296, Bordeaux, France; [Crivello, Fabrice; Tzourio-Mazoyer, Nathalie; Mazoyer, Bernard] CNRS, GIN, UMR 5296, Bordeaux, France; [Crivello, Fabrice; Tzourio-Mazoyer, Nathalie; Mazoyer, Bernard] CEA, GIN, UMR 5296, Bordeaux, France; [Tzourio, Christophe] Victor Segalen Univ, INSERM, U708, Bordeaux, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux	Crivello, F (corresponding author), Univ Bordeaux, GIN, UMR 5296, Bordeaux, France.	fabrice.crivello@u-bordeaux2.fr	Tzourio, christophe/L-6344-2019; Tzourio-Mazoyer, Nathalie/B-5598-2008; Crivello, Fabrice/ABB-4531-2021; Tzourio, christophe/B-4015-2009; mazoyer, bernard m/A-5369-2009	Tzourio, christophe/0000-0002-6517-2984; Tzourio-Mazoyer, Nathalie/0000-0002-6236-4390; Tzourio, christophe/0000-0002-6517-2984; mazoyer, bernard m/0000-0003-0970-2837; Crivello, Fabrice/0000-0001-6950-984X	Fondation pour la Recherche Medicale; Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante; MGEN; Institut de la Longevite; Conseils Regionaux of Aquitaine and Bourgogne; Fondation de France; Ministry of Research-INSERM Programme "Cohortes et collections de donnees biologiques"	Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Caisse Nationale Maladie des Travailleurs Salaries; Direction Generale de la Sante(General Electric); MGEN; Institut de la Longevite; Conseils Regionaux of Aquitaine and Bourgogne(Region Bourgogne-Franche-ComteRegion Nouvelle-Aquitaine); Fondation de France(Fondation de France); Ministry of Research-INSERM Programme "Cohortes et collections de donnees biologiques"	Funding: The Fondation pour la Recherche Medicale funded the study preparation and initiation. The 3C Study is also supported by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, MGEN, Institut de la Longevite, Conseils Regionaux of Aquitaine and Bourgogne, Fondation de France, and Ministry of Research-INSERM Programme "Cohortes et collections de donnees biologiques." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JS, 2005, NEUROBIOL AGING, V26, P1245, DOI 10.1016/j.neurobiolaging.2005.05.023; Alperovitch A, 2002, CR BIOL, V325, P665, DOI 10.1016/S1631-0691(02)01476-2; [Anonymous], NEUROIMAGE, V20, P22; Ashburner J, 2013, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00197; Ashburner J, 2011, NEUROIMAGE, V55, P954, DOI 10.1016/j.neuroimage.2010.12.049; Barnes J, 2008, NEUROIMAGE, V40, P1655, DOI 10.1016/j.neuroimage.2008.01.012; Barnes J, 2010, NEUROIMAGE, V53, P1244, DOI 10.1016/j.neuroimage.2010.06.025; Burggren AC, 2008, NEUROIMAGE, V41, P1177, DOI 10.1016/j.neuroimage.2008.03.039; Clark VH, 2012, NEUROBIOL AGING, V33, P2733, DOI 10.1016/j.neurobiolaging.2012.01.010; Cook IA, 2002, INT J GERIATR PSYCH, V17, P610, DOI 10.1002/gps.644; Davatzikos C, 2009, BRAIN, V132, P2026, DOI 10.1093/brain/awp091; den Heijer T, 2002, NEUROLOGY, V59, P746, DOI 10.1212/WNL.59.5.746; Dickerson BC, 2008, NEUROIMAGE, V39, P10, DOI 10.1016/j.neuroimage.2007.08.042; Driscoll I, 2009, NEUROLOGY, V72, P1906, DOI 10.1212/WNL.0b013e3181a82634; Du AT, 2006, NEUROBIOL AGING, V27, P733, DOI 10.1016/j.neurobiolaging.2005.03.021; Du AT, 2003, NEUROLOGY, V60, P481, DOI 10.1212/01.WNL.0000044400.11317.EC; Dumurgier J, 2012, NEUROIMAGE, V60, P871, DOI 10.1016/j.neuroimage.2012.01.102; Eberling JL, 2003, NEUROBIOL AGING, V24, P725, DOI 10.1016/S0197-4580(02)00056-8; Erickson KI, 2005, NEUROBIOL AGING, V26, P1205, DOI 10.1016/j.neurobiolaging.2004.11.009; Fjell AM, 2014, CEREB CORTEX, V24, P919, DOI 10.1093/cercor/bhs379; Fjell AM, 2013, NEUROBIOL AGING, V34, P2239, DOI 10.1016/j.neurobiolaging.2013.04.006; Fjell AM, 2010, NEUROIMAGE, V50, P1376, DOI 10.1016/j.neuroimage.2010.01.061; Fjell AM, 2009, J NEUROSCI, V29, P15223, DOI 10.1523/JNEUROSCI.3252-09.2009; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fotenos AF, 2005, NEUROLOGY, V64, P1032, DOI 10.1212/01.WNL.0000154530.72969.11; Fox NC, 2011, NEUROIMAGE, V57, P15, DOI 10.1016/j.neuroimage.2011.01.077; Gandy S, 2003, NEUROCHEM RES, V28, P1003, DOI 10.1023/A:1023246921127; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Goto M, 2011, J MAGN RESON IMAGING, V33, P48, DOI 10.1002/jmri.22328; Greenberg DL, 2008, NEUROBIOL AGING, V29, P290, DOI 10.1016/j.neurobiolaging.2006.09.016; Hutton C, 2009, NEUROIMAGE, V48, P371, DOI 10.1016/j.neuroimage.2009.06.043; Ikram MA, 2008, NEUROBIOL AGING, V29, P882, DOI 10.1016/j.neurobiolaging.2006.12.012; Jernigan TL, 2001, NEUROBIOL AGING, V22, P581, DOI 10.1016/S0197-4580(01)00217-2; Kennedy KM, 2009, NEUROBIOL AGING, V30, P1657, DOI 10.1016/j.neurobiolaging.2007.12.020; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Lemaitre H, 2005, NEUROIMAGE, V24, P1205, DOI 10.1016/j.neuroimage.2004.10.016; Lemaitre H, 2005, NEUROIMAGE, V26, P900, DOI 10.1016/j.neuroimage.2005.02.042; Lerch JP, 2008, NEUROBIOL AGING, V29, P23, DOI 10.1016/j.neurobiolaging.2006.09.013; Pell GS, 2008, NEUROIMAGE, V41, P1324, DOI 10.1016/j.neuroimage.2008.02.050; Pepe A, 2014, NEUROIMAGE, V100, P444, DOI 10.1016/j.neuroimage.2014.06.029; Raz N, 2004, NEUROREPORT, V15, P2531, DOI 10.1097/00001756-200411150-00020; Raz N, 2005, CEREB CORTEX, V15, P1676, DOI 10.1093/cercor/bhi044; Raz N, 2006, NEUROSCI BIOBEHAV R, V30, P730, DOI 10.1016/j.neubiorev.2006.07.001; Raz N, 2010, NEUROIMAGE, V51, P501, DOI 10.1016/j.neuroimage.2010.03.020; Resnick SM, 2009, NEUROLOGY, V72, P135, DOI 10.1212/01.wnl.0000339037.76336.cf; Resnick SM, 2003, J NEUROSCI, V23, P3295; Resnick SM, 2000, CEREB CORTEX, V10, P464, DOI 10.1093/cercor/10.5.464; Reuter M, 2011, NEUROIMAGE, V57, P19, DOI 10.1016/j.neuroimage.2011.02.076; Robertson D, 2009, CLIMACTERIC, V12, P301, DOI 10.1080/13697130902730742; Salmond CH, 2002, NEUROIMAGE, V17, P507, DOI 10.1006/nimg.2002.1191; Smith CD, 2007, NEUROBIOL AGING, V28, P1075, DOI 10.1016/j.neurobiolaging.2006.05.018; Taki Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022734; Thambisetty M, 2010, NEUROIMAGE, V52, P1215, DOI 10.1016/j.neuroimage.2010.04.258; Thomas AG, 2009, NEUROIMAGE, V48, P117, DOI 10.1016/j.neuroimage.2009.05.097; Thompson WK, 2011, NEUROIMAGE, V57, P1, DOI 10.1016/j.neuroimage.2010.11.092; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; van Velsen EFS, 2013, NEUROSCI LETT, V550, P189, DOI 10.1016/j.neulet.2013.06.063; Walhovd KB, 2005, NEUROBIOL AGING, V26, P1261, DOI 10.1016/j.neurobiolaging.2005.05.020; Walhovd KB, 2011, NEUROBIOL AGING, V32, P916, DOI 10.1016/j.neurobiolaging.2009.05.013; West RL, 1996, PSYCHOL BULL, V120, P272, DOI 10.1037/0033-2909.120.2.272; WOODS RP, 1992, J COMPUT ASSIST TOMO, V16, P620, DOI 10.1097/00004728-199207000-00024; Yushkevich PA, 2010, NEUROIMAGE, V50, P434, DOI 10.1016/j.neuroimage.2009.12.007	62	53	53	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114478	10.1371/journal.pone.0114478	http://dx.doi.org/10.1371/journal.pone.0114478			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469789	Green Published, Green Submitted, gold			2022-12-26	WOS:000349128700119
J	Davies, JM; Hua, HU; Dheer, R; Martinez, M; Bhattacharya, SK; Abreu, MT				Davies, Julie M.; Hua, Hong-Uyen; Dheer, Rishu; Martinez, Mitchell; Bhattacharya, Sanjoy K.; Abreu, Maria T.			Stool Phospholipid Signature is Altered by Diet and Tumors	PLOS ONE			English	Article							CHRONIC ULCERATIVE-COLITIS; INFLAMMATORY-BOWEL-DISEASE; BODY-MASS INDEX; COLORECTAL-CANCER; CROHNS-DISEASE; GUT MICROBIOTA; INTESTINAL MUCUS; INDUCED OBESITY; PHOSPHATIDYLCHOLINE; FAT	Intake of saturated fat is a risk factor for ulcerative colitis (UC) and colon cancer. Changes in the microbiota have been implicated in the development of UC and colon cancer. The host and the microbiota generate metabolites that may contribute to or reflect disease pathogenesis. We used lipid class specific quantitative mass spectrometry to assess the phospholipid (PL) profile (phosphatidylcholine [PC], phosphatidylethanolamine [PE], phosphatidylinositol [PI], phosphatidylserine [PS]) of stool from mice fed a high fat (HFD) or control diet with or without induction of colitis-associated tumors using azoxymethane and dextran sodium sulfate. The microbiota was assessed using qPCR for several bacterial groups. Colitis-associated tumors were associated with reduced bulk PI and PE levels in control diet fed mice compared to untreated mice. Significant decreases in the relative quantities of several PC species were found in colitis-associated tumor bearing mice fed either diet. Statistical analysis of the PL profile revealed distinct clustering by treatment group. Partial least squares regression analysis found that the relative quantities of the PS class profile best predicted bacterial abundance of Clostridium leptum and Prevotella groups. Abundance of selected PL species correlated with bacterial group quantities. Thus, we have described that a HFD and colitisassociated tumors are associated with changes in phospholipids and may reflect host-microbial interactions and disease states.	[Davies, Julie M.; Dheer, Rishu; Abreu, Maria T.] Univ Miami, Div Gastroenterol, Dept Med, Miller Sch Med, Miami, FL 33124 USA; [Hua, Hong-Uyen; Martinez, Mitchell; Bhattacharya, Sanjoy K.] Univ Miami, Bascom Palmer Eye Inst, Miami, FL USA	University of Miami; Bascom Palmer Eye Institute; University of Miami	Abreu, MT (corresponding author), Univ Miami, Div Gastroenterol, Dept Med, Miller Sch Med, Miami, FL 33124 USA.	mabreu1@med.miami.edu	Davies, Julie/AAU-7129-2021	Abreu, Maria T./0000-0002-7294-0574; Hua, Hong-Uyen/0000-0001-9541-2558; Davies, Julie/0000-0003-4035-6047	National Institutes of Health, National Cancer Institute [5R01CA137869-05]; National Institute of Diabetes and Digestive and Kidney Diseases [2R01DK099076-06A1]; Crohn's and Colitis Foundation of America; Department of Defense [W81XWH-09-1-0674]; Research to Prevent Blindness;  [EY016112];  [EY016112S1];  [P30-EY14801]; NATIONAL CANCER INSTITUTE [R01CA137869] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY016112, P30EY014801] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Crohn's and Colitis Foundation of America; Department of Defense(United States Department of Defense); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Funding for this study was provided by grants to MTA (National Institutes of Health, National Cancer Institute 5R01CA137869-05, National Institute of Diabetes and Digestive and Kidney Diseases 2R01DK099076-06A1; Crohn's and Colitis Foundation of America Senior Investigator Award) and SKB (EY016112; EY016112S1; P30-EY14801; Department of Defense Grant W81XWH-09-1-0674; Research to Prevent Blindness unrestricted grant to Department of Ophthalmology, University of Miami). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aktas M, 2010, EUR J CELL BIOL, V89, P888, DOI 10.1016/j.ejcb.2010.06.013; Andersen NN, 2013, WORLD J GASTROENTERO, V19, P7561, DOI 10.3748/wjg.v19.i43.7561; Aribindi K, 2013, INVEST OPHTH VIS SCI, V54, P3037, DOI 10.1167/iovs.12-10517; AWAD AB, 1989, J NUTR, V119, P1376, DOI 10.1093/jn/119.10.1376; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Balamurugan R, 2008, J GASTROEN HEPATOL, V23, P1298, DOI 10.1111/j.1440-1746.2008.05490.x; Bernstein C, 2011, ARCH TOXICOL, V85, P863, DOI 10.1007/s00204-011-0648-7; Bezabeh T, 2001, AM J GASTROENTEROL, V96, P442; Bibiloni R, 2006, J MED MICROBIOL, V55, P1141, DOI 10.1099/jmm.0.46498-0; Bjerrum JT, 2010, J PROTEOME RES, V9, P954, DOI 10.1021/pr9008223; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Braun A, 2009, INFLAMM BOWEL DIS, V15, P1705, DOI 10.1002/ibd.20993; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Chan ECY, 2009, J PROTEOME RES, V8, P352, DOI 10.1021/pr8006232; Claus SP, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.56; CUMMINGS JH, 1978, J CLIN INVEST, V61, P953, DOI 10.1172/JCI109020; De Robertis Mariangela, 2011, J Carcinog, V10, P9, DOI 10.4103/1477-3163.78279; Ding SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012191; Doubeni CA, 2012, JNCI-J NATL CANCER I, V104, P1353, DOI 10.1093/jnci/djs346; Eaden JA, 2001, GUT, V48, P526, DOI 10.1136/gut.48.4.526; Edwards G, 2014, BIOCHIMIE; Ehehalt R, 2004, SCAND J GASTROENTERO, V39, P737, DOI 10.1080/00365520410006233; EKBOM A, 1990, NEW ENGL J MED, V323, P1228, DOI 10.1056/NEJM199011013231802; Fisher MM, 1999, APPL ENVIRON MICROB, V65, P4630; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; FRIEDMAN HI, 1980, AM J CLIN NUTR, V33, P1108, DOI 10.1093/ajcn/33.5.1108; Gregory KE, 2013, ANAL CHEM, V85, P1114, DOI 10.1021/ac303011k; Hass DJ, 2006, CLIN GASTROENTEROL H, V4, P482, DOI 10.1016/j.cgh.2005.12.015; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Hong YS, 2010, ARCH PHARM RES, V33, P1091, DOI 10.1007/s12272-010-0716-1; Hou JK, 2011, AM J GASTROENTEROL, V106, P563, DOI 10.1038/ajg.2011.44; Inafuku M, 2013, MOL NUTR FOOD RES, V57, P1671, DOI 10.1002/mnfr.201200607; Iverson SJ, 2001, LIPIDS, V36, P1283, DOI 10.1007/s11745-001-0843-0; Jansson J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006386; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Lam YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034233; Le Gall G, 2011, J PROTEOME RES, V10, P4208, DOI 10.1021/pr2003598; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Li M, 2008, P NATL ACAD SCI USA, V105, P2117, DOI 10.1073/pnas.0712038105; Liao J, 2007, CARCINOGENESIS, V28, P446, DOI 10.1093/carcin/bgl154; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; Manna SK, 2014, GASTROENTEROLOGY, V146, P1313, DOI 10.1053/j.gastro.2014.01.017; Marchesi JR, 2007, J PROTEOME RES, V6, P546, DOI 10.1021/pr060470d; Martin FPJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100153; Martin FPJ, 2010, J PROTEOME RES, V9, P5284, DOI 10.1021/pr100554m; McHardy IH, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-17; Mondot S, 2011, INFLAMM BOWEL DIS, V17, P185, DOI 10.1002/ibd.21436; Murphy TK, 2000, AM J EPIDEMIOL, V152, P847, DOI 10.1093/aje/152.9.847; Musso G, 2010, CURR OPIN LIPIDOL, V21, P76, DOI 10.1097/MOL.0b013e3283347ebb; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Pluskal T, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-395; RAETZ CRH, 1986, ANNU REV GENET, V20, P253, DOI 10.1146/annurev.ge.20.120186.001345; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Shimizu K, 2010, J AGR FOOD CHEM; Sohlenkamp C, 2003, PROG LIPID RES, V42, P115, DOI 10.1016/S0163-7827(02)00050-4; Stremmel W, 2005, GUT, V54, P966, DOI 10.1136/gut.2004.052316; Stremmel W, 2007, ANN INTERN MED, V147, P603, DOI 10.7326/0003-4819-147-9-200711060-00004; Sun W, 2009, TXB GASTROENTEROLOGY; Teixeira LG, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-204; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; van Dieren JM, 2011, EUR J IMMUNOL, V41, P1047, DOI 10.1002/eji.201040899; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Weir TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070803; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yang K, 2009, ANAL CHEM, V81, P4356, DOI 10.1021/ac900241u	67	13	13	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114352	10.1371/journal.pone.0114352	http://dx.doi.org/10.1371/journal.pone.0114352			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469718	Green Submitted, Green Published, gold			2022-12-26	WOS:000349128700104
J	Edelmann, MJ; Shack, LA; Naske, CD; Walters, KB; Nanduri, B				Edelmann, Mariola J.; Shack, Leslie A.; Naske, Caitlin D.; Walters, Keisha B.; Nanduri, Bindu			SILAC-Based Quantitative Proteomic Analysis of Human Lung Cell Response to Copper Oxide Nanoparticles	PLOS ONE			English	Article							RIBOSOMAL-PROTEIN S3; TRANSLATION INITIATION; MOLECULAR RESPONSES; ANDROGEN RECEPTOR; MAMMALIAN TARGET; EPITHELIAL-CELLS; BINDING PROTEIN; EXCISION-REPAIR; PHOSPHATASE 2A; CANCER CELLS	Copper (II) oxide (CuO) nanoparticles (NP) are widely used in industry and medicine. In our study we evaluated the response of BEAS-2B human lung cells to CuO NP, using Stable isotope labeling by amino acids in cell culture (SILAC)-based proteomics and phosphoproteomics. Pathway modeling of the protein differential expression showed that CuO NP affect proteins relevant in cellular function and maintenance, protein synthesis, cell death and survival, cell cycle and cell morphology. Some of the signaling pathways represented by BEAS-2B proteins responsive to the NP included mTOR signaling, protein ubiquitination pathway, actin cytoskeleton signaling and epithelial adherens junction signaling. Follow-up experiments showed that CuO NP altered actin cytoskeleton, protein phosphorylation and protein ubiquitination level.	[Edelmann, Mariola J.; Nanduri, Bindu] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Mississippi State, MS 39762 USA; [Edelmann, Mariola J.; Shack, Leslie A.; Nanduri, Bindu] Mississippi State Univ, Coll Vet Med, Dept Basic Sci, Mississippi State, MS USA; [Naske, Caitlin D.; Walters, Keisha B.] Mississippi State Univ, Dept Chem Engn, Mississippi State, MS USA	Mississippi State University; Mississippi State University; Mississippi State University	Nanduri, B (corresponding author), Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Mississippi State, MS 39762 USA.	bnanduri@cvm.msstate.edu	Walters, Keisha/AAP-9819-2021	Walters, Keisha/0000-0002-0875-2659	National Science Foundation (Mississippi) [EPSCoR-0903787]; MAFES Special Research Initiative [160000-018100-027100-329180]; Mississippi INBRE by an Institutional Development Award (IDeA) from National Institute of General Medical Sciences of the National Institutes of Health [P20GM103476]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103476] Funding Source: NIH RePORTER; EPSCoR [0903787] Funding Source: National Science Foundation	National Science Foundation (Mississippi)(National Science Foundation (NSF)); MAFES Special Research Initiative; Mississippi INBRE by an Institutional Development Award (IDeA) from National Institute of General Medical Sciences of the National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	Funding: The National Science Foundation (Mississippi EPSCoR-0903787), MAFES Special Research Initiative (160000-018100-027100-329180) and the Mississippi INBRE, funded by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the National Institutes of Health under grant number P20GM103476. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altun M, 2011, CHEM BIOL, V18, P1401, DOI 10.1016/j.chembiol.2011.08.018; Aufderheide M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/734137; Baek SH, 2006, P NATL ACAD SCI USA, V103, P3100, DOI 10.1073/pnas.0510842103; Berntsen P, 2010, J R SOC INTERFACE, V7, pS331, DOI 10.1098/rsif.2010.0068.focus; Borkow G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011295; Calvert MEK, 2008, MOL CELL BIOL, V28, P1313, DOI 10.1128/MCB.01035-07; Cao Y, 2000, P NATL ACAD SCI USA, V97, P11280, DOI 10.1073/pnas.200367597; Cayrol C, 2007, BLOOD, V109, P584, DOI 10.1182/blood-2006-03-012013; Chaudhury A, 2010, RNA, V16, P1449, DOI 10.1261/rna.2254110; Chen JX, 2011, J BIOL CHEM, V286, P27436, DOI 10.1074/jbc.M111.232058; Choe J, 2012, J BIOL CHEM, V287, P18500, DOI 10.1074/jbc.M111.327528; Clouaire T, 2005, P NATL ACAD SCI USA, V102, P6907, DOI 10.1073/pnas.0406882102; Cockman ME, 2009, MOL CELL PROTEOMICS, V8, P535, DOI 10.1074/mcp.M800340-MCP200; Dastjerdi R, 2010, COLLOID SURFACE B, V79, P5, DOI 10.1016/j.colsurfb.2010.03.029; Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012; Edelmann MJ, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002031; Edelmann MJ, 2010, FEBS J, V277, P2515, DOI 10.1111/j.1742-4658.2010.07665.x; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Fahmy B, 2009, TOXICOL IN VITRO, V23, P1365, DOI 10.1016/j.tiv.2009.08.005; Hanagata N, 2011, ACS NANO, V5, P9326, DOI 10.1021/nn202966t; Hegde V, 2004, BIOCHEMISTRY-US, V43, P14211, DOI 10.1021/bi049234b; Heinlaan M, 2008, CHEMOSPHERE, V71, P1308, DOI 10.1016/j.chemosphere.2007.11.047; Hunter T, 1998, PHILOS T R SOC B, V353, P583, DOI 10.1098/rstb.1998.0228; Karlsson HL, 2008, CHEM RES TOXICOL, V21, P1726, DOI 10.1021/tx800064j; Kim JT, 2006, FEBS LETT, V580, P6375, DOI 10.1016/j.febslet.2006.10.049; Kim TS, 2009, J BIOL CHEM, V284, P21201, DOI 10.1074/jbc.M109.018168; Laha D, 2014, BBA-GEN SUBJECTS, V1840, P1, DOI 10.1016/j.bbagen.2013.08.011; Lee IH, 2008, J BIOL CHEM, V283, P6312, DOI 10.1074/jbc.M706878200; Linke SP, 1996, GENE DEV, V10, P934, DOI 10.1101/gad.10.8.934; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; MacCoss MJ, 2002, ANAL CHEM, V74, P5593, DOI 10.1021/ac025826t; Macfarlan T, 2005, J BIOL CHEM, V280, P7346, DOI 10.1074/jbc.M411675200; Majumdar S, 2013, SCIENCE, V339, P446, DOI 10.1126/science.1231789; Metral S, 2009, J BIOL CHEM, V284, P2409, DOI 10.1074/jbc.M801324200; Midander K, 2009, SMALL, V5, P389, DOI 10.1002/smll.200801220; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Park EJ, 2008, TOXICOL LETT, V180, P222, DOI 10.1016/j.toxlet.2008.06.869; Parsons JL, 2011, MOL CELL, V41, P609, DOI 10.1016/j.molcel.2011.02.016; Peddinti D, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-19; Pflum MKH, 2001, J BIOL CHEM, V276, P47733, DOI 10.1074/jbc.M105590200; Ray PS, 2009, NATURE, V457, P915, DOI 10.1038/nature07598; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Ren GG, 2009, INT J ANTIMICROB AG, V33, P587, DOI 10.1016/j.ijantimicag.2008.12.004; Scales TME, 2009, J CELL SCI, V122, P2424, DOI 10.1242/jcs.040162; Shi M, 2012, ACS NANO, V6, P2157, DOI 10.1021/nn300445d; Sohaebuddin SK, 2010, PART FIBRE TOXICOL, V7, DOI 10.1186/1743-8977-7-22; Studer AM, 2010, TOXICOL LETT, V197, P169, DOI 10.1016/j.toxlet.2010.05.012; Triboulet S, 2013, MOL CELL PROTEOMICS, V12, P3108, DOI 10.1074/mcp.M113.030742; Valasek LS, 2012, CURR PROTEIN PEPT SC, V13, P305; Wang JY, 2009, NEUROTOXICOLOGY, V30, P926, DOI 10.1016/j.neuro.2009.09.005; Wang L, 2008, J BIOL CHEM, V283, P15619, DOI 10.1074/jbc.M800723200; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Wang ZY, 2012, CHEM RES TOXICOL, V25, P1512, DOI 10.1021/tx3002093; Weichhart T, 2012, METHODS MOL BIOL, V821, P1, DOI 10.1007/978-1-61779-430-8_1; Wilkinson KD, 2009, J CELL SCI, V122, P2325, DOI 10.1242/jcs.041046; Win-Shwe TT, 2011, INT J MOL SCI, V12, P6267, DOI 10.3390/ijms12096267; Wisniewski JR, 2008, PROTEINS, V73, P710, DOI 10.1002/prot.22104; Xi LJ, 2009, ENVIRON TOXICOL, V24, P211, DOI 10.1002/tox.20418; Yadavilli S, 2007, DNA REPAIR, V6, P1453, DOI 10.1016/j.dnarep.2007.04.009; Yadavilli S, 2009, DNA REPAIR, V8, P1215, DOI 10.1016/j.dnarep.2009.07.003; YANG TH, 1994, MOL CELL BIOL, V14, P6068, DOI 10.1128/MCB.14.9.6068; Yang ZM, 2007, MOL ENDOCRINOL, V21, P343, DOI 10.1210/me.2006-0104; Zatcoff Richard C, 2008, Foot (Edinb), V18, P136, DOI 10.1016/j.foot.2008.03.005; Zhen Y, 2012, TRAFFIC, V13, P650, DOI 10.1111/j.1600-0854.2012.01341.x; Zhu CY, 2009, CELL DEATH DIFFER, V16, P395, DOI 10.1038/cdd.2008.160; ZIEMNIAK SE, 1992, J SOLUTION CHEM, V21, P179, DOI 10.1007/BF00647007	66	22	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114390	10.1371/journal.pone.0114390	http://dx.doi.org/10.1371/journal.pone.0114390			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470785	Green Submitted, Green Published, gold			2022-12-26	WOS:000349128700114
J	Ellis, RJ; Duan, ZY; Wang, Y				Ellis, Robert J.; Duan, Zhiyan; Wang, Ye			Quantifying Auditory Temporal Stability in a Large Database of Recorded Music	PLOS ONE			English	Article							PARKINSONS-DISEASE; INFORMATION-RETRIEVAL; PHYSICAL-THERAPY; EXERCISE DOMAIN; BEAT TRACKING; GAIT DYNAMICS; OLDER-ADULTS; TIME; SENSITIVITY; DISCRIMINATION	"Moving to the beat" is both one of the most basic and one of the most profound means by which humans (and a few other species) interact with music. Computer algorithms that detect the precise temporal location of beats (i.e., pulses of musical "energy") in recorded music have important practical applications, such as the creation of playlists with a particular tempo for rehabilitation (e.g., rhythmic gait training), exercise (e.g., jogging), or entertainment (e.g., continuous dance mixes). Although several such algorithms return simple point estimates of an audio file's temporal structure (e.g., "average tempo", "time signature"), none has sought to quantify the temporal stability of a series of detected beats. Such a method-a "Balanced Evaluation of Auditory Temporal Stability" (BEATS)-is proposed here, and is illustrated using the Million Song Dataset (a collection of audio features and music metadata for nearly one million audio files). A publically accessible web interface is also presented, which combines the thresholdable statistics of BEATS with queryable metadata terms, fostering potential avenues of research and facilitating the creation of highly personalized music playlists for clinical or recreational applications.	[Ellis, Robert J.; Duan, Zhiyan; Wang, Ye] Natl Univ Singapore, Sch Comp, Singapore 117548, Singapore	National University of Singapore	Wang, Y (corresponding author), Natl Univ Singapore, Sch Comp, Singapore 117548, Singapore.	wangye@comp.nus.edu.sg		ELLIS, ROBERT/0000-0002-3590-614X	National Research Foundation (NRF)	National Research Foundation (NRF)	This research was supported by the National Research Foundation (NRF; http://www.nrf.gov.sg/) and managed through the multi-agency Interactive & Digital Media Programme Office (IDMPO; http://www.idm.sg/) hosted by the Media Development Authority of Singapore (MDA;http://www.mda.gov.sg/) under the Centre of Social Media Innovations for Communities (COSMIC; http://cosmic.nus.edu.sg/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AllMusic, 2013, ALLMUSIC REL; [Anonymous], 2011, P 12 INT SOC MUSIC I; [Anonymous], 2013, ECHO NEST; Barnes R, 2000, COGNITIVE PSYCHOL, V41, P254, DOI 10.1006/cogp.2000.0738; Bertin-Mahieux Thierry, 2011, P 12 INT SOC MUS INF, DOI DOI 10.7916/D8NZ8J07; Bigand E, 1997, J EXP PSYCHOL HUMAN, V23, P808, DOI 10.1037/0096-1523.23.3.808; Bloem BR, 2004, MOVEMENT DISORD, V19, P871, DOI 10.1002/mds.20115; Botev Z., 2011, KERNEL DENSITY ESTIM; Botev ZI, 2010, ANN STAT, V38, P2916, DOI 10.1214/10-AOS799; BROWNLEY KA, 1995, INT J PSYCHOPHYSIOL, V19, P193, DOI 10.1016/0167-8760(95)00007-F; Cai Z, 2013, P 14 INT C MUS INF R, P541; Casey MA, 2008, P IEEE, V96, P668, DOI 10.1109/JPROC.2008.916370; Chen CW, 2009, EIGHTH INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND APPLICATIONS, PROCEEDINGS, P602, DOI 10.1109/ICMLA.2009.54; Cope TE, 2012, J ACOUST SOC AM, V131, P4013, DOI 10.1121/1.3699266; COPELAND BL, 1991, J SPORT MED PHYS FIT, V31, P100; Davis JC, 2010, OSTEOPOROSIS INT, V21, P1295, DOI 10.1007/s00198-009-1162-0; de Bruin N, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/483530; de Dreu M J, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS114, DOI 10.1016/S1353-8020(11)70036-0; de I'Etoile SK, 2008, INT J REHABIL RES, V31, P155, DOI 10.1097/MRR.0b013e3282fc0f44; Delval A, 2008, MOVEMENT DISORD, V23, P1446, DOI 10.1002/mds.22125; DRAKE C, 1993, PERCEPT PSYCHOPHYS, V54, P277, DOI 10.3758/BF03205262; Ehrle N, 2005, BRAIN COGNITION, V58, P133, DOI 10.1016/j.bandc.2004.09.014; Ellis D, 2011, MATLAB INTRO; Ellis DPW, 2007, J NEW MUSIC RES, V36, P51, DOI 10.1080/09298210701653344; Ellis RJ, 2010, ATTEN PERCEPT PSYCHO, V72, P2274, DOI 10.3758/APP.72.8.2274; FRIBERG A, 1995, J ACOUST SOC AM, V98, P2524, DOI 10.1121/1.413218; GETTY DJ, 1975, PERCEPT PSYCHOPHYS, V18, P1, DOI 10.3758/BF03199358; Gouyon F, 2006, IEEE T AUDIO SPEECH, V14, P1832, DOI 10.1109/TSA.2005.858509; Grieg E, 1888, OP 46 NO 4 HALL MOUN; Grondin S., 2004, Acoustical Science and Technology, V25, P159, DOI 10.1250/ast.25.159; Grondin S, 2001, PSYCHOL BULL, V127, P22, DOI 10.1037//0033-2909.127.1.22; Grondin S, 2010, ATTEN PERCEPT PSYCHO, V72, P561, DOI 10.3758/APP.72.3.561; Guzman-Garcia A, 2013, INT J GERIATR PSYCH, V28, P914, DOI 10.1002/gps.3913; Hausdorff JM, 2007, HUM MOVEMENT SCI, V26, P555, DOI 10.1016/j.humov.2007.05.003; Hausdorff JM, 2009, CHAOS, V19, DOI 10.1063/1.3147408; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Hausdorff JM, 2005, J NEUROENG REHABIL, V2, P19, DOI [DOI 10.1186/1743-0003-2-19, 10.1186/1743-0003-2-19]; Honing H, 2012, ANN NY ACAD SCI, V1252, P85, DOI 10.1111/j.1749-6632.2011.06402.x; Hurt CP, 1998, J MUSIC THER, V35, P228, DOI 10.1093/jmt/35.4.228; Janata P, 2012, J EXP PSYCHOL GEN, V141, P54, DOI 10.1037/a0024208; Jang JSR, 2001, LECT NOTES COMPUT SC, V2195, P590; Jehan T, 2011, ANAL DOCUMENTATION; Johnson G, 2001, J MUSIC THER, V38, P82, DOI 10.1093/jmt/38.2.82; JONES MR, 1989, PSYCHOL REV, V96, P459, DOI 10.1037/0033-295X.96.3.459; Jones MR, 1997, J EXP PSYCHOL HUMAN, V23, P693, DOI 10.1037/0096-1523.23.3.693; Jones MR., 2008, OXFORD HDB MUSIC PSY, P81; Kaminskas M, 2012, COMPUT SCI REV, V6, P89, DOI 10.1016/j.cosrev.2012.04.002; Karageorghis CI, 2012, INT REV SPORT EXER P, V5, P67, DOI 10.1080/1750984X.2011.631027; Karageorghis CI, 2012, J SPORT SCI, V30, P953, DOI 10.1080/02640414.2012.676665; Kattenstroth JC, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00031; Keus SHJ, 2007, MOVEMENT DISORD, V22, P451, DOI 10.1002/mds.21244; Klapuri AP, 2006, IEEE T AUDIO SPEECH, V14, P342, DOI 10.1109/TSA.2005.854090; Krumhansl C.L., 1990, COGNITIVE FDN MUSICA, P77; Krumhansl CL, 2010, SPRINGER HANDB AUDIT, V36, P51, DOI 10.1007/978-1-4419-6114-3_3; Lamere P, 2011, ARTIST TERMS WHAT IS; Large EW, 2010, SPRINGER HANDB AUDIT, V36, P201, DOI 10.1007/978-1-4419-6114-3_7; Large EW, 1999, PSYCHOL REV, V106, P119, DOI 10.1037/0033-295X.106.1.119; Li Z, 2010, P INT C MULT, P627; Lim I, 2005, CLIN REHABIL, V19, P695, DOI 10.1191/0269215505cr906oa; Martin J.P., 1967, BASAL GANGLIA POSTUR; McAuley JD, 2007, PERCEPT PSYCHOPHYS, V69, P709, DOI 10.3758/BF03193773; McAuley JD, 2010, SPRINGER HANDB AUDIT, V36, P165, DOI 10.1007/978-1-4419-6114-3_6; McKinney MF, 2007, J NEW MUSIC RES, V36, P1, DOI 10.1080/09298210701653252; McKinney MF, 2006, MUSIC PERCEPT, V24, P155, DOI 10.1525/mp.2006.24.2.155; Merker BH, 2009, CORTEX, V45, P4, DOI 10.1016/j.cortex.2008.06.011; Miller NS, 2005, PERCEPT PSYCHOPHYS, V67, P1150, DOI 10.3758/BF03193548; MORRIS ME, 1994, BRAIN, V117, P1169, DOI 10.1093/brain/117.5.1169; Nettl B, 2000, ORIGINS OF MUSIC, P463; Pacchetti C, 2000, PSYCHOSOM MED, V62, P386, DOI 10.1097/00006842-200005000-00012; PARZEN E, 1962, ANN MATH STAT, V33, P1065, DOI 10.1214/aoms/1177704472; Patel AD, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00057; Pouliot M, 2005, MUSIC PERCEPT, V22, P389, DOI 10.1525/mp.2005.22.3.389; Ras Z.W., 2010, ADV MUSIC INFORM RET; Repp BH, 2013, PSYCHON B REV, V20, P403, DOI 10.3758/s13423-012-0371-2; Rubinstein TC, 2002, MOVEMENT DISORD, V17, P1148, DOI 10.1002/mds.10259; Salimpoor VN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007487; Schaafsma JD, 2003, J NEUROL SCI, V212, P47, DOI 10.1016/S0022-510X(03)00104-7; Schulze HH, 2005, MUSIC PERCEPT, V22, P461, DOI 10.1525/mp.2005.22.3.461; SCHULZE HH, 1978, PSYCHOL RES-PSYCH FO, V40, P173, DOI 10.1007/BF00308412; SCHULZE HH, 1989, PERCEPT PSYCHOPHYS, V45, P291, DOI 10.3758/BF03204943; SORKIN RD, 1982, J EXP PSYCHOL HUMAN, V8, P46, DOI 10.1037/0096-1523.8.1.46; Spaulding SJ, 2013, ARCH PHYS MED REHAB, V94, P562, DOI 10.1016/j.apmr.2012.10.026; Thaut AH, 2007, NEUROREHAB NEURAL RE, V21, P455, DOI 10.1177/1545968307300523; Thaut M.H., 1993, J NEUROL REHABIL, V7, P9; Thaut MH, 1998, HUM MOVEMENT SCI, V17, P839, DOI 10.1016/S0167-9457(98)00031-1; Thaut MH, 1999, MOVEMENT DISORD, V14, P808, DOI 10.1002/1531-8257(199909)14:5<808::AID-MDS1014>3.0.CO;2-J; Thaut MH, 1996, MOVEMENT DISORD, V11, P193, DOI 10.1002/mds.870110213; The S2S2 Consortium, 2007, ROADM SOUND MUS COMP; Thompson WF, 2001, PSYCHOL SCI, V12, P248, DOI 10.1111/1467-9280.00345; Tomic ST, 2008, J ACOUST SOC AM, V124, P4024, DOI 10.1121/1.3006382; Verghese J, 2006, J AM GERIATR SOC, V54, P1241, DOI 10.1111/j.1532-5415.2006.00808.x; Von Wilzenben HD, 1942, METHODS TREATMENT PO; Wang A, 2006, COMMUN ACM, V49, P44, DOI 10.1145/1145287.1145312; Wikipedia, 2014, COMP ONL MUS STOR; Wikipedia, 2014, LIST ONL MUS DAT; Wikipedia, 2014, COMP ON DEM STREAM M; Winkler I, 2009, P NATL ACAD SCI USA, V106, P2468, DOI 10.1073/pnas.0809035106; Wittwer JE, 2013, DISABIL REHABIL, V35, P164, DOI 10.3109/09638288.2012.690495; Woodrow H., 1951, HDB EXPT PSYCHOL, P1224; Yi Y, 2011, P 1 INT ACM WORKSH M, P13; Zapata JR, 2011, P AUD ENG SOC 42 INT, P1; Zentner M, 2010, P NATL ACAD SCI USA, V107, P5768, DOI 10.1073/pnas.1000121107; Zhu S, 2014, P 22 ACM INT C MULT	103	1	1	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e110452	10.1371/journal.pone.0110452	http://dx.doi.org/10.1371/journal.pone.0110452			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7WS	25469636	Green Published, Green Submitted, gold			2022-12-26	WOS:000349128700005
J	Povero, D; Eguchi, A; Li, HY; Johnson, CD; Papouchado, BG; Wree, A; Messer, K; Feldstein, AE				Povero, Davide; Eguchi, Akiko; Li, Hongying; Johnson, Casey D.; Papouchado, Bettina G.; Wree, Alexander; Messer, Karen; Feldstein, Ariel E.			Circulating Extracellular Vesicles with Specific Proteome and Liver MicroRNAs Are Potential Biomarkers for Liver Injury in Experimental Fatty Liver Disease	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; NONALCOHOLIC STEATOHEPATITIS; ENDOTHELIAL-CELLS; MICROPARTICLES; LIPOTOXICITY; EXOSOMES; HEPATOCYTES; EXPRESSION; BLOOD; MICROVESICLES	Background & Aim: Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in both adult and children. Currently there are no reliable methods to determine disease severity, monitor disease progression, or efficacy of therapy, other than an invasive liver biopsy. Design: Choline Deficient L-Amino Acid (CDAA) and high fat diets were used as physiologically relevant mouse models of NAFLD. Circulating extracellular vesicles were isolated, fully characterized by proteomics and molecular analyses and compared to control groups. Liver-related microRNAs were isolated from purified extracellular vesicles and liver specimens. Results: We observed statistically significant differences in the level of extracellular vesicles (EVs) in liver and blood between two control groups and NAFLD animals. Time-course studies showed that EV levels increase early during disease development and reflect changes in liver histolopathology. EV levels correlated with hepatocyte cell death (r(2)=0.64, p<0.05), fibrosis (r(2)=0.66, p<0.05) and pathological angiogenesis (r(2)=0.71, p<0.05). Extensive characterization of blood EVs identified both microparticles (MPs) and exosomes (EXO) present in blood of NAFLD animals. Proteomic analysis of blood EVs detected various differentially expressed proteins in NAFLD versus control animals. Moreover, unsupervised hierarchical clustering identified a signature that allowed for discrimination between NAFLD and controls. Finally, the liver appears to be an important source of circulating EVs in NAFLD animals as evidenced by the enrichment in blood with miR-122 and 192 - two microRNAs previously described in chronic liver diseases,coupled with a corresponding decrease in expression of these microRNAs in the liver. Conclusions: These findings suggest a potential for using specific circulating EVs as sensitive and specific biomarkers for the noninvasive diagnosis and monitoring of NAFLD.	[Povero, Davide; Eguchi, Akiko; Johnson, Casey D.; Wree, Alexander; Feldstein, Ariel E.] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA; [Li, Hongying; Messer, Karen] Univ Calif San Diego, Moores Canc Ctr, Dept Biostat Bioinformat, La Jolla, CA 92093 USA; [Papouchado, Bettina G.] VA San Diego Healthcare Syst, Dept Pathol, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Feldstein, AE (corresponding author), Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA.	afeldstein@ucsd.edu	Eguchi, Akiko/E-3086-2010	Wree, Alexander/0000-0002-2968-1335	NIH [DK076852, DK082451]; American Liver Foundation Postdoctoral Research Fellowship;  [NS047101]; NATIONAL CANCER INSTITUTE [P30CA023100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082451, R01DK076852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Liver Foundation Postdoctoral Research Fellowship; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: This work was supported by NIH grants DK076852 and DK082451 to AEF, American Liver Foundation Postdoctoral Research Fellowship to DP, grant NS047101 to Jennifer Santini for the UCSD Microscopy Facility and Gilead Sciences Research Scholars Program in Liver Disease to AE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angulo P, 2002, NEW ENGL J MED, V346, P1221, DOI 10.1038/nrdp.2015.80; Ashburner M, 2001, GENOME RES, V11, P1425; Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Bruand J, 2011, J PROTEOME RES, V10, P4734, DOI 10.1021/pr2005378; Bruand J, 2011, J PROTEOME RES, V10, P1915, DOI 10.1021/pr101159e; Buettner R, 2007, OBESITY, V15, P798, DOI 10.1038/oby.2007.608; Caby MP, 2005, INT IMMUNOL, V17, P879, DOI 10.1093/intimm/dxh267; Castoldi M, 2011, J CLIN INVEST, V121, P1386, DOI 10.1172/JCI44883; Chalasani N, 2012, HEPATOLOGY, V55, P2005, DOI 10.1002/hep.25762; Cheung O, 2008, HEPATOLOGY, V48, P1810, DOI 10.1002/hep.22569; Conde-Vancells J, 2008, J PROTEOME RES, V7, P5157, DOI 10.1021/pr8004887; Denzer K, 2000, J CELL SCI, V113, P3365; Diehl P, 2012, CARDIOVASC RES, V93, P633, DOI 10.1093/cvr/cvs007; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Fevrier B, 2004, CURR OPIN CELL BIOL, V16, P415, DOI 10.1016/j.ceb.2004.06.003; Fink K, 2011, CRIT CARE, V15, DOI 10.1186/cc10512; Garzetti L., 2013, J LEUKOC BIOL; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hallsworth K, 2012, J HEPATOL; Kitade M, 2009, WORLD J GASTROENTERO, V15, P5193, DOI 10.3748/wjg.15.5193; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kornek M, 2012, GASTROENTEROLOGY, V143, P448, DOI 10.1053/j.gastro.2012.04.031; Kornek M, 2011, HEPATOLOGY, V53, P230, DOI 10.1002/hep.23999; Li ZZ, 2008, HEPATOLOGY, V47, P1495, DOI 10.1002/hep.22183; Liou I, 2006, J CLIN GASTROENTEROL, V40, pS11; Malhi H, 2008, SEMIN LIVER DIS, V28, P360, DOI 10.1055/s-0028-1091980; McCormack AL, 1997, ANAL CHEM, V69, P767, DOI 10.1021/ac960799q; Miura K, 2012, AM J PHYSIOL-GASTR L, V302, pG1310, DOI 10.1152/ajpgi.00365.2011; Morel O, 2011, SEMIN IMMUNOPATHOL, V33, P469, DOI 10.1007/s00281-010-0239-3; Nanda K, 2004, PEDIATR TRANSPLANT, V8, P613, DOI 10.1111/j.1399-3046.2004.00241.x; Pan QW, 2012, GUT, V61, P1330, DOI 10.1136/gutjnl-2011-300449; Pirola CJ, 2014, GUT; Povero D, 2013, HEPATOLOGY, V58, p574A; Povero D, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004512; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Rautou PE, 2011, CIRC RES, V109, P593, DOI 10.1161/CIRCRESAHA.110.233163; Richardson J, 2006, FRONT BIOSCI-LANDMRK, V11, P1042, DOI 10.2741/1862; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Takaki Y, 2014, CANC SCI; Takeshita J, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000507; Taylor Douglas D., 2013, Frontiers in Genetics, V4, P142, DOI 10.3389/fgene.2013.00142; Teoh NC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104376; Torres DM, 2008, GASTROENTEROLOGY, V134, P1682, DOI 10.1053/j.gastro.2008.02.077; Vrijenhoek JE, 2014, EUR J PREV CARDIOL; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Wieckowska A, 2007, HEPATOLOGY, V46, P582, DOI 10.1002/hep.21768; Williams CD, 2011, GASTROENTEROLOGY, V140, P124, DOI 10.1053/j.gastro.2010.09.038; Witek RP, 2009, GASTROENTEROLOGY, V136, P320, DOI 10.1053/j.gastro.2008.09.066; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Yuana Y, 2011, THROMB HAEMOSTASIS, V105, P396, DOI 10.1160/TH10-09-0595	52	176	189	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113651	10.1371/journal.pone.0113651	http://dx.doi.org/10.1371/journal.pone.0113651			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470250	gold, Green Published, Green Submitted			2022-12-26	WOS:000349128700039
J	Alderliesten, T; Favie, LMA; Neijzen, RW; Auwarter, V; Nijboer, CHA; Marges, REJ; Rademaker, CMA; Kempf, J; van Bel, F; Groenendaal, F				Alderliesten, Thomas; Favie, Laurent M. A.; Neijzen, Robert W.; Auwaerter, Volker; Nijboer, Cora H. A.; Marges, Roland E. J.; Rademaker, Carin M. A.; Kempf, Juergen; van Bel, Frank; Groenendaal, Floris			Neuroprotection by Argon Ventilation after Perinatal Asphyxia: A Safety Study in Newborn Piglets	PLOS ONE			English	Article							HYPOXIA-ISCHEMIA; BIRTH ASPHYXIA; XENON; MODEL; HYPOTHERMIA; INJURY; SYSTEM; PIGS	Hypothermia is ineffective in 45% of neonates with hypoxic-ischemic encephalopathy. Xenon has additive neuroprotective properties, but is expensive, and its application complicated. Argon gas is cheaper, easier to apply, and also has neuroprotective properties in experimental settings. The aim was to explore the safety of argon ventilation in newborn piglets. Methods: Eight newborn piglets (weight 1.4-3.0 kg) were used. Heart rate, blood pressure, regional cerebral saturation, and electrocortical brain activity were measured continuously. All experiments had a 30 min. baseline period, followed by three 60 min. periods of argon ventilation alternated with 30 min argon washout periods. Two animals were ventilated with increasing concentrations of argon (1h 30%, 1 h 50%, and 1 h 80%), two were subjected to 60 min. hypoxia (FiO(2) 0.08) before commencing 50% argon ventilation, and two animals received hypothermia following hypoxia as well as 50% argon ventilation. Two animals served as home cage controls and were terminated immediately. Results: Argon ventilation did not result in a significant change of heart rate (mean +/- s.d. -3.5 +/- 3.6 bpm), blood pressure (-0.60 +/- 1.11 mmHg), cerebral oxygen saturation (0.3 +/- 0.9%), electrocortical brain activity (-0.4 +/- 0.7 mV), or blood gas values. Argon ventilation resulted in elevated argon concentrations compared to the home cage controls (34.5, 25.4, and 22.4 vs. 7.3 mu l/ml). Conclusion: Ventilation with up to 80% argon during normoxia, and 50% argon after hypoxia did not affect heart rate, blood pressure, electrocortical brain activity. Clinical safety studies of argon ventilation in humans seem justified.	[Alderliesten, Thomas] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Dept Neonatol, Utrecht, Netherlands; [Favie, Laurent M. A.; Neijzen, Robert W.; Rademaker, Carin M. A.; van Bel, Frank; Groenendaal, Floris] Univ Med Ctr Utrecht, Div Lab Med & Pharm, Dept Clin Pharm, Utrecht, Netherlands; [Auwaerter, Volker; Kempf, Juergen] Univ Med Ctr Freiburg, Inst Forens Med, Dept Forens Toxicol, Freiburg, Germany; [Nijboer, Cora H. A.] Univ Med Ctr Utrecht, Lab Neuroimmunol & Dev Origins Dis, Utrecht, Netherlands; [Marges, Roland E. J.] Univ Med Ctr Utrecht, Dept Med Technol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; University of Freiburg; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	Groenendaal, F (corresponding author), Univ Med Ctr Utrecht, Div Lab Med & Pharm, Dept Clin Pharm, Utrecht, Netherlands.	F.Groenendaal@umcutrecht.nl	Groenendaal, Floris/P-6872-2019; Auwarter, Volker/D-1075-2012	Groenendaal, Floris/0000-0002-9284-1637; Auwarter, Volker/0000-0002-1883-2804	department of Neonatology, University Medical Center Utrecht, Utrecht, The Netherland; department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands	department of Neonatology, University Medical Center Utrecht, Utrecht, The Netherland; department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands	The Stephanie Neonatal ventilator is a donation of Fritz Stephan GmbH, Gackenbach, Germany. In addition, this study was funded by the departments of Neonatology, and of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands upon request of the authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraini JH, 2003, ANESTH ANALG, V96, P746, DOI 10.1213/01.ANE.0000050282.14291.38; Brucken A, 2013, BRIT J ANAESTH, V110, P106, DOI 10.1093/bja/aes509; Chakkarapani E, 2009, ANESTH ANALG, V109, P451, DOI 10.1213/ane.0b013e3181aa9550; Chakkarapani E, 2012, INTENS CARE MED, V38, P316, DOI 10.1007/s00134-011-2442-7; Dingley J, 2014, PEDIATRICS; Fahlenkamp AV, 2012, EUR J PHARMACOL, V674, P104, DOI 10.1016/j.ejphar.2011.10.045; Faulkner S, 2011, ANN NEUROL, V70, P133, DOI 10.1002/ana.22387; Faulkner SD, 2012, EUR J ANAESTH, V29, P577, DOI 10.1097/EJA.0b013e3283583c4b; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; Garman RH, 2011, TOXICOL PATHOL, V39, P22, DOI 10.1177/0192623310389621; HEISS HW, 1976, BASIC RES CARDIOL, V71, P658, DOI 10.1007/BF01906411; HELLSTROMWESTAS L, 1995, ARCH DIS CHILD-FETAL, V72, pF34, DOI 10.1136/fn.72.1.F34; Jacobs SE, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003311.pub3; Jawad N, 2009, NEUROSCI LETT, V460, P232, DOI 10.1016/j.neulet.2009.05.069; Lemmers PMA, 2013, PEDIATR RES, V74, P180, DOI 10.1038/pr.2013.84; Lingwood BE, 2008, J NEUROSCI METH, V171, P140, DOI 10.1016/j.jneumeth.2008.02.011; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Loetscher PD, 2009, CRIT CARE, V13, DOI 10.1186/cc8214; MAYNARD D, 1969, BRIT MED J, V4, P545, DOI 10.1136/bmj.4.5682.545-a; Pagel PS, 2010, J CARDIOTHOR VASC AN, V24, P143, DOI 10.1053/j.jvca.2009.03.016; RAU G, 1969, ARCH KREISLAUFFORSCH, V58, P322, DOI 10.1007/BF02119667; Ristagno G, 2014, SHOCK, V41, P72, DOI 10.1097/SHK.0000000000000049; Robertson NJ, 2012, J PEDIATR-US, V160, P544, DOI 10.1016/j.jpeds.2011.12.052; Ryang YM, 2011, CRIT CARE MED, V39, P1448, DOI 10.1097/CCM.0b013e31821209be; Thoresen M, 2009, J CEREBR BLOOD F MET, V29, P707, DOI 10.1038/jcbfm.2008.163; Zhuang L, 2012, CRIT CARE MED, V40, P1724, DOI 10.1097/CCM.0b013e3182452164	26	19	19	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113575	10.1371/journal.pone.0113575	http://dx.doi.org/10.1371/journal.pone.0113575			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460166	gold, Green Published			2022-12-26	WOS:000345869700037
J	Brosh, T; Rozitsky, D; Geron, S; Pilo, R				Brosh, Tamar; Rozitsky, Doron; Geron, Silvia; Pilo, Raphael			Tensile Mechanical Properties of Swine Cortical Mandibular Bone	PLOS ONE			English	Article							ORTHODONTIC MINI-IMPLANTS; STRESS-DISTRIBUTION; MINISCREW IMPLANTS; ELASTIC PROPERTIES; THICKNESS; STRENGTH; STABILITY; ANCHORAGE; FAILURE; PRESERVATION	Temporary orthodontic mini implants serve as anchorage devices in orthodontic treatments. Often, they are inserted in the jaw bones, between the roots of the teeth. The stability of the mini implants within the bone is one of the major factors affecting their success and, consequently, that of the orthodontic treatment. Bone mechanical properties are important for implant stability. The aim of this study was to determine the tensile properties of the alveolar and basal mandible bones in a swine model. The diametral compression test was employed to study the properties in two orthogonal directions: mesio-distal and occluso-gingival. Small cylindrical cortical bone specimens (2.6 mm diameter, 1.5 mm thickness) were obtained from 7 mandibles using a trephine drill. The sites included different locations (anterior and posterior) and aspects (buccal and lingual) for a total of 16 specimens from each mandible. The load-displacement curves were continuously monitored while loading half of the specimens in the oclluso-gingival direction and half in the mesiodistal direction. The stiffness was calculated from the linear portion of the curve. The mesio-distal direction was 31% stiffer than the occluso-gingival direction. The basal bone was 40% stiffer than the alveolar bone. The posterior zone was 46% stiffer than the anterior zone. The lingual aspect was stiffer than the buccal aspect. Although bone specimens do not behave as brittle materials, the diametral compression test can be adequately used for determining tensile behavior when only small bone specimens can be obtained. In conclusion, to obtain maximal orthodontic mini implant stability, the force components on the implants should be oriented mostly in the mesio-distal direction.	[Brosh, Tamar] Tel Aviv Univ, Goldschleger Sch Dent Med, Dept Oral Biol, IL-69978 Tel Aviv, Israel; [Rozitsky, Doron] Tel Aviv Univ, Goldschleger Sch Dent Med, IL-69978 Tel Aviv, Israel; [Geron, Silvia] Tel Aviv Univ, Goldschleger Sch Dent Med, Dept Orthodont, IL-69978 Tel Aviv, Israel; [Pilo, Raphael] Tel Aviv Univ, Goldschleger Sch Dent Med, Dept Oral Rehabil, IL-69978 Tel Aviv, Israel	Tel Aviv University; Tel Aviv University; Tel Aviv University; Tel Aviv University	Brosh, T (corresponding author), Tel Aviv Univ, Goldschleger Sch Dent Med, Dept Oral Biol, IL-69978 Tel Aviv, Israel.	tbrosh@post.tau.ac.il		Brosh, Tamar/0000-0001-6181-3310; pilo, raphael/0000-0002-8361-9516	Alfa Omega Foundation [0601913321]; Tel Aviv University	Alfa Omega Foundation; Tel Aviv University	Part of the study was supported by a grant from Alfa Omega Foundation No. 0601913321, Tel Aviv University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional funding sources of this study were received.	Antoszewska J, 2009, AM J ORTHOD DENTOFAC, V136, DOI [10.1016/j.ajodo.2009.03.031, 10.1016/j.ajodo.2009.03.032]; Apicella D, 2010, J BIOMED MATER RES B, V93B, P150, DOI 10.1002/jbm.b.31569; BAN S, 1990, J DENT RES, V69, P1791, DOI 10.1177/00220345900690120201; Baumgaertel S, 2009, AM J ORTHOD DENTOFAC, V136, P230, DOI 10.1016/j.ajodo.2007.10.045; Buchter A, 2005, CLIN ORAL IMPLAN RES, V16, P473, DOI 10.1111/j.1600-0501.2005.01149.x; Chang JZC, 2012, AM J ORTHOD DENTOFAC, V141, P279, DOI 10.1016/j.ajodo.2011.09.008; Chen Y, 2009, AM J ORTHOD DENTOFAC, V135, P284, DOI 10.1016/j.ajodo.2007.08.017; Chun YS, 2009, ORTHOD CRANIOFAC RES, V12, P25, DOI 10.1111/j.1601-6343.2008.01434.x; Chung DH, 2011, J ANAT, V218, P26, DOI 10.1111/j.1469-7580.2010.01320.x; Daegling DJ, 2011, AM J PHYS ANTHROPOL, V144, P421, DOI 10.1002/ajpa.21423; Daegling DJ, 2011, ARCH ORAL BIOL, V56, P220, DOI 10.1016/j.archoralbio.2010.10.008; DECHOW PC, 1993, AM J PHYS ANTHROPOL, V90, P291, DOI 10.1002/ajpa.1330900304; Deguchi T, 2003, J DENT RES, V82, P377, DOI 10.1177/154405910308200510; Farnsworth D, 2011, AM J ORTHOD DENTOFAC, V139, P495, DOI 10.1016/j.ajodo.2009.03.057; Feng LA, 2010, J BIOMED MATER RES A, V95A, P580, DOI 10.1002/jbm.a.32837; Holm L, 2012, ANGLE ORTHOD, V82, P1022, DOI 10.2319/011912-47.1; Huang SH, 2012, ACTA BIOMATER, V8, P1597, DOI 10.1016/j.actbio.2011.12.036; Huja SS, 2007, J DENT RES, V86, P237, DOI 10.1177/154405910708600308; Iijima M, 2013, EUR J ORTHODONT, V35, P583, DOI 10.1093/ejo/cjs066; Kuroda S, 2007, AM J ORTHOD DENTOFAC, V131, P9, DOI 10.1016/j.ajodo.2005.02.032; Kuroda S, 2007, AM J ORTHOD DENTOFAC, V131, pS68, DOI 10.1016/j.ajodo.2006.06.017; Lertchirakarn V, 2001, J DENT RES, V80, P453, DOI 10.1177/00220345010800021001; Lettry S, 2003, BONE, V32, P35, DOI 10.1016/S8756-3282(02)00921-3; Lin TS, 2013, AM J ORTHOD DENTOFAC, V143, P182, DOI 10.1016/j.ajodo.2012.09.012; Liou EJW, 2004, AM J ORTHOD DENTOFAC, V126, P42, DOI 10.1016/j.ajodo.2003.06.018; Misch CE, 2008, CONT IMPLANT DENT, P9; Moreno J, 2002, BIOMATERIALS, V23, P2615, DOI 10.1016/S0142-9612(01)00402-1; Motoyoshi M, 2009, INT J ORAL MAX SURG, V38, P13, DOI 10.1016/j.ijom.2008.09.006; Motoyoshi M, 2007, INT J ORAL MAX IMPL, V22, P779; Nomura T, 2003, DENT MATER, V19, P167, DOI 10.1016/S0109-5641(02)00026-X; Papadopoulos MA, 2011, J DENT RES, V90, P969, DOI 10.1177/0022034511409236; Park HS, 2008, AM J ORTHOD DENTOFAC, V133, P30, DOI 10.1016/j.ajodo.2006.01.044; Rapoff AJ, 2008, AM J PHYS ANTHROPOL, V135, P100, DOI 10.1002/ajpa.20714; Rho JY, 1998, MED ENG PHYS, V20, P92, DOI 10.1016/S1350-4533(98)00007-1; Rozen B, 2009, CELL TISSUE BANK, V10, P27, DOI 10.1007/s10561-008-9106-z; Schwartz-Dabney CL, 2003, AM J PHYS ANTHROPOL, V120, P252, DOI 10.1002/ajpa.10121; Singh S, 2012, AM J ORTHOD DENTOFAC, V141, P327, DOI 10.1016/j.ajodo.2011.07.022; Suzuki M, 2013, AM J ORTHOD DENTOFAC, V144, P251, DOI 10.1016/j.ajodo.2013.03.021; Turner CH, 1999, J BIOMECH, V32, P437, DOI 10.1016/S0021-9290(98)00177-8; van Eijden TMGJ, 2000, CRIT REV ORAL BIOL M, V11, P123, DOI 10.1177/10454411000110010101; van Haaren EH, 2008, ACTA ORTHOP, V79, P708, DOI 10.1080/17453670810016759; WAGNER HD, 1992, J BIOMECH, V25, P1311, DOI 10.1016/0021-9290(92)90286-A	42	4	4	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113229	10.1371/journal.pone.0113229	http://dx.doi.org/10.1371/journal.pone.0113229			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463971	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700031
J	Halldin, M; Brismar, K; Fahlstadius, P; Vikstrom, M; de Faire, U; Hellenius, ML				Halldin, Mats; Brismar, Kerstin; Fahlstadius, Per; Vikstrom, Max; de Faire, Ulf; Hellenius, Mai-Lis			The Metabolic Syndrome and ECG Detected Left Ventricular Hypertrophy - Influences from IGF-1 and IGF-Binding Protein-1	PLOS ONE			English	Article							GROWTH-FACTOR-I; GENDER-DIFFERENCES; INSULIN; SERUM; POPULATION; DETERMINANTS; DIAGNOSIS; GEOMETRY; THERAPY; OBESITY	Background and Aims: The metabolic syndrome (MetS) is associated with an increased risk for left ventricular hypertrophy (LVH) and cardiovascular mortality. The aim of this study was to investigate potential influences from insulin-like growth factor-1 (IGF-1) and IGF binding protein-1 (IGFBP-1) on the relationship between the MetS and LVH, also taking into account the role of physical activity (PA), use of oestrogen and gender. Methods and Results: In a population-based cross-sectional study of 60-year-old men (n=1822) and women (n=2049) participants underwent physical examination and laboratory tests, including electrocardiography (ECG), and completed an extensive questionnaire. Women showed higher levels of IGFBP-1 than men (37.0 vs. 28.0 mu g/l, p<0.001), and women with LVH had lower levels of IGFBP-1 than women without LVH (31.0 mu g/l vs. 37.0 mu g/l, p<0.001). Furthermore, women with low levels of IGFBP-1 had a significantly increased risk of having LVH (crude OR approximate to 2.5). When stratifying for PA and oestrogen, respectively, a weaker association between IGFBP-1 and LVH was demonstrated in physically active men and women, compared to inactive individuals, as well as in women using oestrogen, compared to non-users. Conclusion: In a representative sample of 60-year-old Swedish men and women, the main findings were higher levels of IGFBP-1 in women than in men; lower levels of IGFBP-1 in women with LVH, compared to women without LVH; and an increased risk of having LVH in women with low levels of IGFBP-1. The association between IGFBP-1 and LVH was diminished in physically active men and women, as well as in women using oestrogen.	[Halldin, Mats; Fahlstadius, Per; Vikstrom, Max; de Faire, Ulf] Karolinska Inst, Inst Environm Med, Dept Cardiovasc Epidemiol, S-10401 Stockholm, Sweden; [Brismar, Kerstin] Karolinska Univ Hosp, Rolf Luft Res Ctr Diabet & Endocrinol, Dept Mol Med & Surg, Karolinska Inst, Stockholm, Sweden; [de Faire, Ulf; Hellenius, Mai-Lis] Karolinska Univ Hosp, Karolinska Inst, Dept Cardiol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Halldin, M (corresponding author), Karolinska Inst, Inst Environm Med, Dept Cardiovasc Epidemiol, S-10401 Stockholm, Sweden.	Mats.Halldin@ki.se		Brismar, Kerstin/0000-0002-5241-514X	Stockholm County Council; Swedish Heart and Lung Foundation; Swedish Medical Research Council [04224]; Longitudinal Research; Family Erling-Persson Foundation; King Gustaf V:s and Queen Victoria's Foundation; AstraZeneca; Pfizer	Stockholm County Council(Stockholm County Council); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Longitudinal Research; Family Erling-Persson Foundation; King Gustaf V:s and Queen Victoria's Foundation; AstraZeneca(AstraZeneca); Pfizer(Pfizer)	This study was supported by grants from the Stockholm County Council (UDF, M-LH), the Swedish Heart and Lung Foundation (UDF, M-LH), the Swedish Medical Research Council (04224 (KB), Longitudinal Research (UDF, M-LH)), Family Erling-Persson Foundation (KB), King Gustaf V:s and Queen Victoria's Foundation (M-LH), AstraZeneca and Pfizer (UDF, M-LH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainsworth BE, 2009, BRIT J SPORT MED, V43, P6, DOI 10.1136/bjsm.2008.052449; Akanji AO, 2012, METAB SYNDR RELAT D, V10, P3, DOI 10.1089/met.2011.0083; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; ALLAIN CC, 1974, CLIN CHEM, V20, P470; BANG P, 1991, ACTA ENDOCRINOL-COP, V124, P620, DOI 10.1530/acta.0.1240620; Bohm C, 2013, AM J PHYSIOL-HEART C, V305, pH211, DOI 10.1152/ajpheart.00593.2012; BRISMAR K, 1991, METABOLISM, V40, P728, DOI 10.1016/0026-0495(91)90092-B; da Costa W, 2008, J ELECTROCARDIOL, V41, P724, DOI 10.1016/j.jelectrocard.2008.05.010; Ferrara LA, 2007, J HUM HYPERTENS, V21, P795, DOI 10.1038/sj.jhh.1002232; FOSSATI P, 1980, CLIN CHEM, V26, P227; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Friedrich N, 2010, J HYPERTENS, V28, P856, DOI 10.1097/HJH.0b013e328336274a; Frystyk J, 2002, J CLIN ENDOCR METAB, V87, P260, DOI 10.1210/jc.87.1.260; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Halldin M, 2012, BLOOD PRESSURE, V21, P153, DOI 10.3109/08037051.2012.641267; HILDING A, 1995, J CLIN ENDOCR METAB, V80, P2646, DOI 10.1210/jc.80.9.2646; Hilding A, 1999, J CLIN ENDOCR METAB, V84, P2013, DOI 10.1210/jc.84.6.2013; Hoang Khiet C, 2007, J Cardiometab Syndr, V2, P276, DOI 10.1111/j.1559-4564.2007.07491.x; JONES JI, 1993, P NATL ACAD SCI USA, V90, P10553, DOI 10.1073/pnas.90.22.10553; Kotronen A, 2008, J CLIN ENDOCR METAB, V93, P4867, DOI 10.1210/jc.2008-1245; Light KC, 2001, J HYPERTENS, V19, P269, DOI 10.1097/00004872-200102000-00014; Lim WK, 1999, AM J CARDIOL, V83, P1132, DOI 10.1016/S0002-9149(99)00029-6; Macfarlane PW, 2006, CARDIOL CLIN, V24, P401, DOI 10.1016/j.ccl.2006.04.013; Mule G, 2005, J INTERN MED, V257, P503, DOI 10.1111/j.1365-2796.2005.01493.x; Oberman A, 2006, AM J CARDIOL, V97, P512, DOI 10.1016/j.amjcard.2005.08.071; Okin PM, 2000, HYPERTENSION, V35, P13, DOI 10.1161/01.HYP.35.1.13; POVOA G, 1984, ACTA ENDOCRINOL-COP, V107, P563, DOI 10.1530/acta.0.1070563; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Prineas RJ, 2010, MINNESOTA CODE MANUA; Rajwani A, 2012, DIABETES, V61, P915, DOI 10.2337/db11-0963; Satoh S, 2014, HEART VESSELS, V29, P659, DOI 10.1007/s00380-013-0397-z; Schwarz S, 2010, MATURITAS, V66, P212, DOI 10.1016/j.maturitas.2010.03.014; Soderberg S, 2001, EUR J ENDOCRINOL, V144, P283, DOI 10.1530/eje.0.1440283; Unden AL, 2005, CLIN ENDOCRINOL, V63, P94, DOI 10.1111/j.1365-2265.2005.02306.x; Verdecchia P, 1999, CIRCULATION, V100, P1802, DOI 10.1161/01.CIR.100.17.1802; Wheatcroft SB, 2009, TRENDS ENDOCRIN MET, V20, P153, DOI 10.1016/j.tem.2009.01.002	37	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e108872	10.1371/journal.pone.0108872	http://dx.doi.org/10.1371/journal.pone.0108872			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461385	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700001
J	Hasegawa, A; Sato, K; Shirai, R; Watanabe, R; Yamamoto, K; Watanabe, K; Nohtomi, K; Hirano, T; Watanabe, T				Hasegawa, Akinori; Sato, Kengo; Shirai, Remina; Watanabe, Rena; Yamamoto, Keigo; Watanabe, Kaho; Nohtomi, Kyoko; Hirano, Tsutomu; Watanabe, Takuya			Vasoprotective Effects of Urocortin 1 against Atherosclerosis In Vitro and In Vivo	PLOS ONE			English	Article							FOAM CELL-FORMATION; SMOOTH-MUSCLE-CELLS; SPONTANEOUSLY HYPERTENSIVE-RATS; MONOCYTE-DERIVED MACROPHAGES; ENDOTHELIAL-CELLS; ANGIOTENSIN-II; HEART-FAILURE; EXPRESSION; HUMANS; ATHEROGENESIS	Aim: Atherosclerosis is the complex lesion that consists of endothelial inflammation, macrophage foam cell formation, vascular smooth muscle cell (VSMC) migration and proliferation, and extracellular matrix production. Human urocortin 1 (Ucn1), a 40-amino acid peptide member of the corticotrophin-releasing factor/urotensin I family, has potent cardiovascular protective effects. This peptide induces potent and long-lasting hypotension and coronary vasodilation. However, the relationship of Ucn1 with atherosclerosis remains unclear. The present study was performed to clarify the effects of Ucn1 on atherosclerosis. Methods: We assessed the effects of Ucn1 on the inflammatory response and proliferation of human endothelial cells (ECs), human macrophage foam cell formation, migration and proliferation of human VSMCs, extracellular matrix expression in VSMCs, and the development of atherosclerosis in apolipoprotein E-deficient (Apoe(-/-)) mice. Results: Ucn1 significantly suppressed cell proliferation without inducing apoptosis, and lipopolysaccharide-induced up-regulation of monocyte chemoattractant protein-1 and intercellular adhesion molecule-1 in human ECs. Ucn1 significantly reduced oxidized low-density lipoprotein-induced foam cell formation with a significant down-regulation of CD36 and acyl-CoA: cholesterol acyltransferase 1 in human monocyte-derived macrophages. Ucn1 significantly suppressed the migration and proliferation of human VSMCs and increased the activities of matrix metalloproteinase-2 (MMP2) and MMP9 in human VSMCs.Intraperitoneal injection of Ucn1 into Apoe(-/-) mice for 4 weeks significantly retarded the development of aortic atherosclerotic lesions. Conclusions: This study provided the first evidence that Ucn1 prevents the development of atherosclerosis by suppressing EC inflammatory response and proliferation, macrophage foam cell formation, and VSMC migration and proliferation. Thus, Ucn1 could serve as a novel therapeutic target for atherosclerotic cardiovascular diseases.	[Hasegawa, Akinori; Sato, Kengo; Shirai, Remina; Watanabe, Rena; Yamamoto, Keigo; Watanabe, Kaho; Watanabe, Takuya] Tokyo Univ Pharm & Life Sci, Lab Cardiovasc Med, Tokyo, Japan; [Nohtomi, Kyoko; Hirano, Tsutomu] Showa Univ, Sch Med, Dept Med, Div Endocrinol Diabet & Metab, Tokyo 142, Japan	Tokyo University of Pharmacy & Life Sciences; Showa University	Watanabe, T (corresponding author), Tokyo Univ Pharm & Life Sci, Lab Cardiovasc Med, Tokyo, Japan.	watanabe@toyaku.ac.jp						Allahverdian S, 2012, CARDIOVASC RES, V95, P165, DOI 10.1093/cvr/cvs094; Boonprasert P, 2008, INT J CARDIOL, V127, P307, DOI 10.1016/j.ijcard.2007.11.026; Calderon-Sanchez E, 2009, CARDIOVASC RES, V83, P717, DOI 10.1093/cvr/cvp161; Chen JD, 2009, PEPTIDES, V30, P1117, DOI 10.1016/j.peptides.2009.02.014; Chen ZW, 2005, CARDIOVASC RES, V65, P913, DOI 10.1016/j.cardiores.2004.11.018; Cureton EL, 2009, ENDOCRINOLOGY, V150, P5428, DOI 10.1210/en.2009-0489; Davidson SM, 2009, PHARMACOL REP, V61, P172, DOI 10.1016/S1734-1140(09)70019-2; Davis ME, 2005, CLIN SCI, V109, P381, DOI 10.1042/CS20050079; Davis ME, 2004, J CLIN ENDOCR METAB, V89, P1402, DOI 10.1210/jc.2003-031231; DellItalia LJ, 1997, J CLIN INVEST, V100, P253, DOI 10.1172/JCI119529; Emeto TI, 2014, CLIN SCI, V126, P517, DOI 10.1042/CS20130425; Emeto TI, 2011, J MOL CELL CARDIOL, V51, P299, DOI 10.1016/j.yjmcc.2011.06.002; Gonzalez-Rey E, 2007, ARTHRITIS RHEUM-US, V56, P531, DOI 10.1002/art.22394; Greene EL, 2001, HYPERTENSION, V37, P308, DOI 10.1161/01.HYP.37.2.308; Honjo T, 2006, J VASC RES, V43, P131, DOI 10.1159/000090132; Ikeda K, 2002, LIFE SCI, V71, P1929, DOI 10.1016/S0024-3205(02)01945-8; Ikeda K, 2009, J MOL ENDOCRINOL, V42, P479, DOI 10.1677/JME-08-0151; Kageyama K, 2006, ENDOCRINOLOGY, V147, P4454, DOI 10.1210/en.2006-0008; Knight RA, 2008, FEBS LETT, V582, P984, DOI 10.1016/j.febslet.2008.02.035; Konii H, 2013, HYPERTENSION, V62, P942, DOI 10.1161/HYPERTENSIONAHA.113.01653; Li W, 2005, J CLIN ENDOCR METAB, V90, P6569, DOI 10.1210/jc.2005-1445; Lin CS, 2012, CARDIOVASC RES, V95, P346, DOI 10.1093/cvr/cvs189; Lopez-Andres N, 2010, J HYPERTENS, V28, P1261, DOI 10.1097/HJH.0b013e328337fe42; Nagashima M, 2011, DIABETOLOGIA, V54, P2649, DOI 10.1007/s00125-011-2241-2; Nishikimi T, 2000, AM J PHYSIOL-HEART C, V279, pH3031, DOI 10.1152/ajpheart.2000.279.6.H3031; Obikane H, 2010, ATHEROSCLEROSIS, V212, P116, DOI 10.1016/j.atherosclerosis.2010.05.029; Onorati F, 2013, CARDIOVASC DRUG THER, V27, P451, DOI 10.1007/s10557-013-6468-7; Phrommintikul A, 2010, EUR J CLIN INVEST, V40, P874, DOI 10.1111/j.1365-2362.2010.02343.x; Rademaker MT, 2007, AM J PHYSIOL-HEART C, V293, pH1536, DOI 10.1152/ajpheart.00377.2007; Richards AM, 2013, HDB BIOL ACTIVE PEPT, P1428; ROSS R, 1992, DIABETOLOGIA, V35, pS34, DOI 10.1007/BF00586277; Schulman D, 2002, AM J PHYSIOL-HEART C, V283, pH1481, DOI 10.1152/ajpheart.01089.2001; Takahashi K, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/395284; Torricelli M, 2009, AM J REPROD IMMUNOL, V62, P224, DOI 10.1111/j.1600-0897.2009.00729.x; Tsatsanis C, 2005, FEBS LETT, V579, P4259, DOI 10.1016/j.febslet.2005.06.057; Villalon AL, 2005, BRIT J PHARMACOL, V145, P490; Watanabe T, 2005, HYPERTENSION, V46, P738, DOI 10.1161/01.HYP.0000184226.99196.b5; Watanabe T, 2008, CIRCULATION, V117, P638, DOI 10.1161/CIRCULATIONAHA.107.712539; Wright SP, 2009, CIRC-HEART FAIL, V2, P465, DOI 10.1161/CIRCHEARTFAILURE.108.840207; Xu G, 2009, CIRC RES, V105, P500, DOI 10.1161/CIRCRESAHA.109.193870; Xu Y, 2009, BRIT J PHARMACOL, V157, P1368, DOI 10.1111/j.1476-5381.2009.00210.x; Yang C, 2010, CAN J PHYSIOL PHARM, V88, P168, DOI 10.1139/Y09-119; Zaiou M, 2009, CURR PHARM DESIGN, V15, P3193, DOI 10.2174/138161209789058011; Zhang RJ, 2009, BRIT J PHARMACOL, V158, P819, DOI 10.1111/j.1476-5381.2009.00346.x; Zhu C, 2014, CELL SIGNAL, V26, P1125, DOI 10.1016/j.cellsig.2014.02.002	45	16	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e110866	10.1371/journal.pone.0110866	http://dx.doi.org/10.1371/journal.pone.0110866			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462164	gold, Green Submitted, Green Published			2022-12-26	WOS:000345869700005
J	Jin, XT; Song, L; Liu, XY; Chen, ML; Li, ZY; Cheng, L; Ren, H				Jin, Xiaoting; Song, Li; Liu, Xiangyuan; Chen, Meilan; Li, Zhuoyu; Cheng, Long; Ren, Hua			Protective Efficacy of Vitamins C and E on p,p '-DDT-Induced Cytotoxicity via the ROS-Mediated Mitochondrial Pathway and NF-kappa B/FasL Pathway	PLOS ONE			English	Article							INDUCED OXIDATIVE STRESS; FAS LIGAND; IN-VITRO; ANTIOXIDANT ACTIVITY; HUMAN ERYTHROCYTES; DDT; APOPTOSIS; CELLS; LIVER; EXPOSURE	Dichlorodiphenoxytrichloroethane (DDT) is a known persistent organic pollutant and liver damage toxicant. However, there has been little emphasis on the mechanism underlying liver damage toxicity of DDT and the relevant effective inhibitors. Hence, the present study was conducted to explore the protective effects of vitamin C (VC) and vitamin E (VE) on the cytotoxicity of DDT in HL-7702 cells and elaborate the specific molecular mechanisms. The results demonstrated that p,p'-DDT exposure at over 10 mu M depleted cell viability of HL-7702 cells and led to cell apoptotic. p,p'-DDT treatment elevated the level of reactive oxygen species (ROS) generation, induced mitochondrial membrane potential, and released cytochrome c into the cytosol, with subsequent elevations of Bax and p53, along with suppression of Bcl-2. In addition, the activations of caspase-3 and -8 were triggered. Furthermore, p,p'-DDT promoted the expressions of NF-kappa B and FasL. When the cells were exposed to the NF-kappa B inhibitor (PDTC), the up-regulated expression of FasL was attenuated. Strikingly, these alterations caused by DDT treatment were prevented or reversed by the addition of VC or VE, and the protective effects of co-treatment with VC and VE were higher than the single supplement with p,p'-DDT. Taken together, these findings provide novel experimental evidences supporting that VC or/and VE could reduce p,p'-DDT-induced cytotoxicity of HL-7702 cells via the ROS-mediated mitochondrial pathway and NF-kappa B/FasL pathway.	[Jin, Xiaoting; Song, Li; Liu, Xiangyuan; Chen, Meilan; Li, Zhuoyu] Shanxi Univ, Natl Minist Educ, Key Lab Chem Biol & Mol Engn, Inst Biotechnol, Taiyuan 030006, Peoples R China; [Li, Zhuoyu] Zhejiang Chinese Med Univ, Coll Life Sci, Hangzhou 310053, Zhejiang, Peoples R China; [Cheng, Long] Harvard Univ, Sch Med, Neurosci Program, Boston, MA 02115 USA; [Ren, Hua] Shanxi Coll Tradit Chinese Med, Taiyuan 030013, Peoples R China; [Ren, Hua] Western Med Hosp, Taiyuan 030013, Peoples R China	Shanxi University; Zhejiang Chinese Medical University; Harvard University; Harvard Medical School	Li, ZY (corresponding author), Shanxi Univ, Natl Minist Educ, Key Lab Chem Biol & Mol Engn, Inst Biotechnol, Taiyuan 030006, Peoples R China.	lzy@sxu.edu.cn			National Natural Sciences Foundation of China [31271516, 21207084]; Research Fund for the Doctoral Program of Higher Education of China [20111401110011]; China Postdoctoral Science Foundation [2012M521178]; Natural Science Foundation of Shanxi [2009021035-2]; Oversea scientists funds of Shanxi province [20111009/10]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Natural Science Foundation of Shanxi(Natural Science Foundation of Shanxi Province); Oversea scientists funds of Shanxi province	This work was supported by the National Natural Sciences Foundation of China (No. 31271516, No. 21207084), Research Fund for the Doctoral Program of Higher Education of China (20111401110011), China Postdoctoral Science Foundation (2012M521178) and Natural Science Foundation of Shanxi (2009021035-2) and Oversea scientists funds of Shanxi province (20111009/10), Research Fund for the Doctoral Program of Higher Education of China (20111401110011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahamed M, 2013, CHEMOSPHERE, V93, P2514, DOI 10.1016/j.chemosphere.2013.09.047; Aneck-Hahn NH, 2007, J ANDROL, V28, P423, DOI 10.2164/jandrol.106.001701; Aziz R, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/839538; Beard J, 2006, SCI TOTAL ENVIRON, V355, P78, DOI 10.1016/j.scitotenv.2005.02.022; Bi SX, 2014, J BIOMED MATER RES A, V102, P1518, DOI 10.1002/jbm.a.34794; Blasiak J, 2001, PESTIC BIOCHEM PHYS, V71, P88, DOI 10.1006/pest.2001.2557; Borner C, 2003, MOL IMMUNOL, V39, P615, DOI 10.1016/S0161-5890(02)00252-3; Bratton MR, 2012, ENVIRON HEALTH PERSP, V120, P1291, DOI 10.1289/ehp.1104296; BURTON GW, 1990, ANNU REV NUTR, V10, P357, DOI [10.1146/annurev.nu.10.070190.002041, 10.1146/annurev.nutr.10.1.357]; Castillo J, 2000, J AGR FOOD CHEM, V48, P1738, DOI 10.1021/jf990665o; Cataudella E, 2012, ACTA MEDICA MEDITERR, V28, P245; Chowdhury AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073672; Cinar M, 2014, BIOL TRACE ELEM RES, V158, P186, DOI 10.1007/s12011-014-9926-6; DeMaria R, 1997, SCIENCE, V277, P1652, DOI 10.1126/science.277.5332.1652; Durak D, 2009, ENVIRON TOXICOL, V24, P235, DOI 10.1002/tox.20423; Eroglu S, 2013, BIOL RES, V46, P33, DOI 10.4067/S0716-97602013000100005; Feng G, 2011, TOXICOL APPL PHARM, V251, P245, DOI 10.1016/j.taap.2011.01.009; Feng HP, 2004, J BIOMED BIOTECHNOL, P41; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; FITZHUGH OG, 1947, J PHARMACOL EXP THER, V89, P18; Franks N, 2002, TOXICOL LETT, V130, P1; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Harabawy ASA, 2014, ECOTOX ENVIRON SAFE, V104, P28, DOI 10.1016/j.ecoenv.2014.02.015; Harapanhalli RS, 1996, RES COMMUN MOL PATH, V94, P271; Heaney ML, 2008, CANCER RES, V68, P8031, DOI 10.1158/0008-5472.CAN-08-1490; HODA Q, 1993, MUTAT RES, V299, P29, DOI 10.1016/0165-1218(93)90116-U; Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166; Jaga Kushik, 2003, Int J Occup Med Environ Health, V16, P7; Jin XT, 2014, TOXICOL LETT, V225, P158, DOI 10.1016/j.toxlet.2013.12.006; Karasavvas N, 2005, BLOOD, V105, P4004, DOI 10.1182/blood-2003-03-0772; Kasibhatla S, 1998, MOL CELL, V1, P543, DOI 10.1016/S1097-2765(00)80054-4; Kiyosawa N, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-487; Kobori Y, 2014, ARCH ITAL UROL ANDRO, V86, P1, DOI 10.4081/aiua.2014.1.1; Krieger R.I., 2001, HDB PESTICIDE TOXICO; Lin X, 2012, FOOD CHEM TOXICOL, V50, P3413, DOI 10.1016/j.fct.2012.07.053; Liu FY, 2012, J BIOL CHEM, V287, P25530, DOI 10.1074/jbc.M112.356279; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; MATHUR DS, 1962, EXPERIENTIA, V18, P506, DOI 10.1007/BF02151600; NAGATA S, 1995, SCIENCE, V267, P1449, DOI 10.1126/science.7533326; Organization WH, 1979, DDT ITS DER PUBL JOI; Qiu XH, 2005, ENVIRON SCI TECHNOL, V39, P4385, DOI 10.1021/es050342a; Robinson O, 2014, J HEPATOL, V60, P96, DOI 10.1016/j.jhep.2013.07.039; Rogan WJ, 2005, LANCET, V366, P763, DOI 10.1016/S0140-6736(05)67182-6; Shen Y, 2013, J NAT PROD, V76, P2337, DOI 10.1021/np400784v; Shi Y, 2009, J BIOMEDICINE BIOTEC, V2009; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Song Y, 2008, TOXICOLOGY, V253, P53, DOI 10.1016/j.tox.2008.08.013; Song Y, 2011, TOXICOL LETT, V202, P55, DOI 10.1016/j.toxlet.2011.01.020; Tanaka M, 1998, NAT MED, V4, P31, DOI 10.1038/nm0198-031; Tebourbi O, 2011, PESTICIDES IN THE MODERN WORLD - PESTS CONTROL AND PESTICIDES EXPOSURE AND TOXICITY ASSESSMENT, P297; Tomiyama Naruto, 2004, J Toxicol Sci, V29, P505, DOI 10.2131/jts.29.505; Turusov V, 2002, ENVIRON HEALTH PERSP, V110, P125, DOI 10.1289/ehp.02110125; Van Dyk JC, 2010, SCI TOTAL ENVIRON, V408, P2745, DOI 10.1016/j.scitotenv.2010.03.002; Vatassery GT, 1998, GERIATRICS, V53, pS25; Wu CC, 2013, ANTIOXID REDOX SIGN, V19, P546, DOI 10.1089/ars.2012.4905; Yanez L, 2004, ENVIRON RES, V94, P18, DOI 10.1016/S0013-9351(03)00047-1; Yanez L, 2002, ENVIRON RES, V88, P174, DOI 10.1006/enrs.2002.4333; Zehendner CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082823; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069913; Zhao MR, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0043823, 10.1371/journal.pone.0051910]	60	33	36	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113257	10.1371/journal.pone.0113257	http://dx.doi.org/10.1371/journal.pone.0113257			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464339	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700033
J	Pang, LJ; Li, QX; Wei, CL; Zou, H; Li, SG; Cao, WW; He, JW; Zhou, Y; Ju, XX; Lan, JJ; Wei, YT; Wang, CY; Zhao, W; Hu, JM; Jia, W; Qi, Y; Liu, FD; Jiang, JF; Li, L; Zhao, J; Liang, WH; Xie, JX; Li, F				Pang, Lijuan; Li, Qiuxiang; Wei, Cuilei; Zou, Hong; Li, Shugang; Cao, Weiwei; He, Jianwei; Zhou, Yang; Ju, Xinxin; Lan, Jiaojiao; Wei, Yutao; Wang, Chengyan; Zhao, Wei; Hu, Jianming; Jia, Wei; Qi, Yan; Liu, Fudong; Jiang, Jinfang; Li, Li; Zhao, Jin; Liang, Weihua; Xie, Jianxin; Li, Feng			TGF-beta 1/Smad Signaling Pathway Regulates Epithelial-to-Mesenchymal Transition in Esophageal Squamous Cell Carcinoma: In Vitro and Clinical Analyses of Cell Lines and Nomadic Kazakh Patients from Northwest Xinjiang, China	PLOS ONE			English	Article							ADENOCARCINOMA; METASTASIS; EXPRESSION; RECEPTOR; DISEASE	Invasion and metastasis are the major causes of death in patients with esophageal squamous cell carcinoma (ESCC). Epithelial-mesenchymal transition (EMT) is a critical step in tumor progression and transforming growth factor-beta 1 (TGF-beta 1) signaling has been shown to play an important role in EMT. In this study, we investigated how TGF-beta 1 signaling pathways contributed to EMT in three ESCC cell lines as well as 100 patients of nomadic ethnic Kazakhs residing in northwest Xinjiang Province of China. In vitro analyses included Western blotting to detect the expression of TGF-beta 1/Smad and EMT-associated proteins in Eca109, EC9706 and KYSE150 cell lines following stimulation with recombinant TGF-beta 1 and SB431542, a potent inhibitor of ALK5 that also inhibits TGF-beta type II receptor. TGF-beta-activated Smad2/3 signaling in EMT was significantly upregulated as indicated by mesenchymal markers of N-cadherin and Vimentin, and in the meantime, epithelial marker, E-cadherin, was markedly downregulated. In contrast, SB431542 addition downregulated the expression of N-cadherin and Vimentin, but upregulated the expression of E-cadherin. Moreover, the TGF-beta 1-induced EMT promoted invasion capability of Eca109 cells. Tumor cells undergoing EMT acquire fibroblastoid-like phenotype. Expressed levels of TGF-beta 1/Smad signaling molecules and EMT-associated proteins were examined using immunohistochemical analyses in 100 ESCC tissues of Kazakh patients and 58 matched noncancerous adjacent tissues. The results showed that ESCC tissues exhibited upregulated expression of TGF-beta 1/Smad. We also analyzed the relationship between the above proteins and the patients' clinicopathological characteristics. The TGF-beta 1/Smad signaling pathway in human Eca109 ESCC cells may carry similar features as in Kazakh ESCC patients, suggesting that TGF-beta 1/Smad signaling pathway may be involved in the regulation of EMT in ethnic Kazakh patients with ESCC from Xinjiang, China.	[Pang, Lijuan; Li, Qiuxiang; Wei, Cuilei; Zou, Hong; Cao, Weiwei; Zhou, Yang; Ju, Xinxin; Lan, Jiaojiao; Wang, Chengyan; Zhao, Wei; Hu, Jianming; Jia, Wei; Qi, Yan; Liu, Fudong; Jiang, Jinfang; Zhao, Jin; Liang, Weihua; Xie, Jianxin; Li, Feng] Shihezi Univ, Sch Med, Dept Pathol, Shihezi, Xinjiang, Peoples R China; [Pang, Lijuan; Li, Qiuxiang; Wei, Cuilei; Zou, Hong; Cao, Weiwei; Zhou, Yang; Ju, Xinxin; Lan, Jiaojiao; Wang, Chengyan; Zhao, Wei; Hu, Jianming; Jia, Wei; Qi, Yan; Liu, Fudong; Jiang, Jinfang; Zhao, Jin; Liang, Weihua; Xie, Jianxin; Li, Feng] Shihezi Univ, Sch Med, Minist Educ, Key Lab Xinjiang Endem & Ethn Dis, Shihezi, Xinjiang, Peoples R China; [Li, Shugang] Shihezi Univ, Sch Med, Dept Publ Hlth, Shihezi, Xinjiang, Peoples R China; [He, Jianwei] Shihezi Univ, Sch Med, Affiliated Hosp 1, Dept Clin Diag Lab, Shihezi, Xinjiang, Peoples R China; [Wei, Yutao] Hosp Xingjian Prod, Dept Thorac & Cardiovasc Surg, Urumqi, Xinjiang, Peoples R China; [Wei, Yutao] Construct Corps, Urumqi, Xinjiang, Peoples R China; [Li, Li] Shihezi Univ, Sch Med, Affiliated Hosp 1, Dept Pathol, Shihezi, Xinjiang, Peoples R China; [Li, Qiuxiang; Liu, Fudong] Peoples Hosp Lianyuan, Dept Oncol, Lianyuan, Hunan, Peoples R China	Shihezi University; Shihezi University; Shihezi University; Shihezi University; Shihezi University	Xie, JX (corresponding author), Shihezi Univ, Sch Med, Dept Pathol, Shihezi, Xinjiang, Peoples R China.	xiejianxin9017@sina.com; lifeng7855@126.com	Sui, Yanwei/AAH-9928-2021; zhang, xu/GYE-3558-2022; zhang, xu/GRX-9733-2022		National Natural Science Foundation of China [81160018]; Ministry of Human Resource and Social Security of People's Republic of China [2011LX004]; National Key Technology RD Program [2009BAI82B03]; International S&T Cooperation Program of China [2010DFB34100]; Corps Doctor Foundation [2014BB018, 2014BB019]; One Thousand Youth Talents Plan	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Human Resource and Social Security of People's Republic of China; National Key Technology RD Program(National Key Technology R&D Program); International S&T Cooperation Program of China; Corps Doctor Foundation; One Thousand Youth Talents Plan	This work was supported by the National Natural Science Foundation of China (No. 81160018), Research Scholar Grant from the Ministry of Human Resource and Social Security of People's Republic of China (2011LX004), National Key Technology R&D Program (2009BAI82B03), the International S&T Cooperation Program of China (2010DFB34100), the Corps Doctor Foundation (No. 2014BB018, No. 2014BB019), and the One Thousand Youth Talents Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Borthwick LA, 2012, CANCER MICROENVIRON, V5, P45, DOI 10.1007/s12307-011-0080-9; Di Martino E, 2006, BIOMARKERS, V11, P547, DOI 10.1080/13547500600896791; Ferlay J., 2012, INT AGENCY RES CANC; Gabbert HE, 2000, TUMORS DIGESTIVE SYS, P11; Grandclement C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020444; GREENBURG G, 1982, J CELL BIOL, V95, P333, DOI 10.1083/jcb.95.1.333; Guarino M, 2007, INT J BIOCHEM CELL B, V39, P2153, DOI 10.1016/j.biocel.2007.07.011; Halder SK, 2005, NEOPLASIA, V7, P509, DOI 10.1593/neo.04640; Hongo M, 2009, J GASTROEN HEPATOL, V24, P729, DOI 10.1111/j.1440-1746.2009.05824.x; Jin H, 2010, BIOMED RES-TOKYO, V31, P105, DOI 10.2220/biomedres.31.105; Kaimori A, 2007, J BIOL CHEM, V282, P22089, DOI 10.1074/jbc.M700998200; Li Ke, 2009, Ai Zheng, V28, P8; Natsuizaka M, 2010, CARCINOGENESIS, V31, P1344, DOI 10.1093/carcin/bgq108; Nawshad A, 2005, CELLS TISSUES ORGANS, V179, P11, DOI 10.1159/000084505; Ohashi S, 2010, CANCER RES, V70, P4174, DOI 10.1158/0008-5472.CAN-09-4614; Pi LM, 2012, ZHONGHUA ER BI YAN H, V47, P749; Rees JRE, 2006, CANCER RES, V66, P9583, DOI 10.1158/0008-5472.CAN-06-1842; Shi J, 2009, CANCER RES, V69, P7180, DOI 10.1158/0008-5472.CAN-08-4470; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Voulgari A, 2009, BBA-REV CANCER, V1796, P75, DOI 10.1016/j.bbcan.2009.03.002; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Zhou Q, 2002, DIS ESOPHAGUS, V15, P74, DOI 10.1046/j.1442-2050.2002.00227.x; Zimowska Malgorzata, 2006, Postepy Biochem, V52, P360	23	43	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112300	10.1371/journal.pone.0112300	http://dx.doi.org/10.1371/journal.pone.0112300			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464508	Green Published, Green Submitted, gold			2022-12-26	WOS:000345869700014
J	Wang, AX; Li, ZX; Luo, YX; Liu, XX; Guo, XH; Wu, SL; Zhao, XQ; Jonas, JB				Wang, Anxin; Li, Zhaoxia; Luo, Yanxia; Liu, Xiaoxue; Guo, Xiuhua; Wu, Shouling; Zhao, Xingquan; Jonas, Jost B.			Asymptomatic Intracranial Arterial Stenosis and Metabolic Syndrome: The APAC Study	PLOS ONE			English	Article							SYSTEMATIC ANALYSIS; GLOBAL BURDEN; RISK-FACTORS; ATHEROSCLEROSIS; PREVALENCE; DISEASE; INJURIES; COUNTY; STROKE	Purpose: The metabolic syndrome (MetS) is a major risk factor for cardiovascular diseases. We investigated potential associations between MetS and asymptomatic intracranial arterial stenosis (ICAS) in a general population. Methods: The community-based "Asymptomatic Polyvascular Abnormalities in Community Study'' examined asymptomatic polyvascular abnormalities in a Chinese population aged 40+ years without history of stroke and coronary heart disease. MetS was defined by the International Diabetes Federation criteria. Asymptomatic ICAS was diagnosed by transcranial color-coded Doppler sonography. Results: Out of 5393 study participants, asymptomatic ICAS was detected in 713 (13.2%) participants, and MetS in 1323 (24.5%) individuals. Prevalence of asymptomatic ICAS increased significantly from 7.5% to 24.2% with increasing number of MetS components. After adjusting for age, gender, physical activity, body mass index, low-density lipoprotein cholesterol and high-sensitivity C-reactive protein, MetS was significantly associated with asymptomatic ICAS (OR: 1.50; 95% CI: 1.23,1.83). Compared with the subgroup without MetS, the ORs for asymptomatic ICAS increased (P<0.0001) for each of 5 components of MetS from 1.71 (95% CI: 1.27,2.30), to 2.20 (95% CI: 1.63,2.98), 2.79 (95CI: 2.01,3.88), 3.08 (95% CI: 2.11,4.51) and 4.27 (95% CI: 2.22,8.20). Conclusions: In multivariate analysis, MetS was an independent and additional factor associated with asymptomatic ICAS. Study participants with 5 MetS components had a 4 times higher risk of asymptomatic ICAS than participants with no MetS component.	[Wang, Anxin; Li, Zhaoxia; Zhao, Xingquan] Capital Med Univ, Beijing Tiantan Hosp, Dept Neurol, Beijing, Peoples R China; [Wang, Anxin; Luo, Yanxia; Guo, Xiuhua] Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China; [Wang, Anxin; Luo, Yanxia; Guo, Xiuhua] Capital Med Univ, Beijing Municipal Key Lab Clin Epidemiol, Beijing, Peoples R China; [Liu, Xiaoxue] Tangshan Peoples Hosp, Dept Cardiol, Tangshan, Peoples R China; [Wu, Shouling] Hebei United Univ, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China; [Jonas, Jost B.] Heidelberg Univ, Dept Ophthalmol, Med Fac Mannheim, Seegartenklin Heidelberg, D-69115 Heidelberg, Germany	Capital Medical University; Capital Medical University; Capital Medical University; North China University of Science & Technology; Ruprecht Karls University Heidelberg	Guo, XH (corresponding author), Capital Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Beijing, Peoples R China.	guoxiuh@ccmu.edu.cn; drwusl@163.com; zxq@vip.163.com	Wang, Anxin/AAD-4073-2021		National Natural Science Foundation of China [81202279]; advanced health care professional development project of Beijing Municipal Health Bureau [2009-3-32]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); advanced health care professional development project of Beijing Municipal Health Bureau	This research was supported by a grant from the National Natural Science Foundation of China (Grant No. 81202279), and by a grant from advanced health care professional development project of Beijing Municipal Health Bureau (Grant No. 2009-3-32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Disclosure/Conflict of Interest: None.	Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Bang Oh Young, 2005, J Clin Neurol, V1, P69, DOI 10.3988/jcn.2005.1.1.69; Bang OY, 2005, NEUROLOGY, V65, P296, DOI 10.1212/01.wnl.0000168862.09764.9f; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; De Silva DA, 2009, J STROKE CEREBROVASC, V18, P424, DOI 10.1016/j.jstrokecerebrovasdis.2009.01.010; Ding X, 2014, INT J NEUROSCI, V124, P834, DOI 10.3109/00207454.2013.879580; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Feldmann E, 2007, NEUROLOGY, V68, P2099, DOI 10.1212/01.wnl.0000261488.05906.c1; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Huang HW, 2007, CEREBROVASC DIS, V24, P111, DOI 10.1159/000103125; Jeng JS, 2010, EXPERT REV CARDIOVAS, V8, P1423, DOI 10.1586/ERC.10.129; Lopez-Cancio E, 2012, ATHEROSCLEROSIS, V221, P221, DOI 10.1016/j.atherosclerosis.2011.12.020; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Mi DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051421; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Park JH, 2007, EUR J NEUROL, V14, P379, DOI 10.1111/j.1468-1331.2007.01682.x; Park JH, 2011, STROKE, V42, P3040, DOI 10.1161/STROKEAHA.111.620104; Park Kwang-Yeol, 2006, J Clin Neurol, V2, P29, DOI 10.3988/jcn.2006.2.1.29; SACCO RL, 1995, STROKE, V26, P14, DOI 10.1161/01.STR.26.1.14; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Wang AX, 2014, J HYPERTENS, V32, P1600, DOI 10.1097/HJH.0000000000000230; Wang AX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061665; Wong KS, 2007, NEUROLOGY, V68, P2035, DOI 10.1212/01.wnl.0000264427.09191.89; Wong KS, 2007, NEUROLOGY, V68, P2031, DOI 10.1212/01.wnl.0000264426.63544.ee; Zhang S, 2013, EUR J NEUROL, V20, P1479, DOI 10.1111/ene.12210; Zhou Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084685	29	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113205	10.1371/journal.pone.0113205	http://dx.doi.org/10.1371/journal.pone.0113205			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463628	Green Submitted, Green Published, gold			2022-12-26	WOS:000345869700030
J	Amaya, MJ; Oliveira, AG; Schroeder, LK; Allgeyer, ES; Bewersdorf, J; Nathanson, MH				Amaya, Maria Jimena; Oliveira, Andre G.; Schroeder, Lena K.; Allgeyer, Edward S.; Bewersdorf, Joerg; Nathanson, Michael H.			Apical Localization of Inositol 1,4,5-Trisphosphate Receptors Is Independent of Extended Synaptotagmins in Hepatocytes	PLOS ONE			English	Article							BILE-DUCT EPITHELIA; PANCREATIC ACINAR-CELLS; RAT HEPATOCYTES; SANDWICH CONFIGURATION; BILIARY EPITHELIA; LIPID-TRANSFER; CONTACT SITES; CA2+; PROTEINS; LIVER	Extended synaptotagmins (E-Syts) are a recently identified family of proteins that tether the endoplasmic reticulum (ER) to the plasma membrane (PM) in part by conferring regulation of cytosolic calcium (Ca2+) at these contact sites (Cell, 2013). However, the mechanism by which E-Syts link this tethering to Ca2+ signaling is unknown. Ca2+ waves in polarized epithelia are initiated by inositol 1,4,5-trisphosphate receptors (InsP3Rs), and these waves begin in the apical region because InsP3Rs are targeted to the ER adjacent to the apical membrane. In this study we investigated whether E-Syts are responsible for this targeting. Primary rat hepatocytes were used as a model system, because a single InsP3R isoform (InsP3R-II) is tethered to the peri-apical ER in these cells. Additionally, it has been established in hepatocytes that the apical localization of InsP3Rs is responsible for Ca2+ waves and secretion and is disrupted in disease states in which secretion is impaired. We found that rat hepatocytes express two of the three identified E-Syts (E-Syt1 and E-Syt2). Individual or simultaneous siRNA knockdown of these proteins did not alter InsP3R-II expression levels, apical localization or average InsP3R-II cluster size. Moreover, apical secretion of the organic anion 5-chloromethylfluorescein diacetate (CMFDA) was not changed in cells lacking E-Syts but was reduced in cells in which cytosolic Ca2+ was buffered. These data provide evidence that E-Syts do not participate in the targeting of InsP3Rs to the apical region. Identifying tethers that bring InsP3Rs to the apical region remains an important question, since mis-targeting of InsP3Rs leads to impaired secretory activity.	[Amaya, Maria Jimena; Oliveira, Andre G.; Nathanson, Michael H.] Yale Univ, Dept Internal Med, Sect Digest Dis, New Haven, CT 06520 USA; [Schroeder, Lena K.; Allgeyer, Edward S.; Bewersdorf, Joerg] Yale Univ, Dept Cell Biol, New Haven, CT USA; [Bewersdorf, Joerg] Yale Univ, Dept Biomed Engn, New Haven, CT USA; [Bewersdorf, Joerg] Yale Univ, Kavli Inst Neurosci, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University	Nathanson, MH (corresponding author), Yale Univ, Dept Internal Med, Sect Digest Dis, New Haven, CT 06520 USA.	michael.nathanson@yale.edu		Oliveira, Andre/0000-0002-1744-8229; Bewersdorf, Joerg/0000-0002-4085-7020	National Institutes of Health [DK57751, DK45710, DK34989, DK61747, P30KD034989]; Connecticut Department of Public Health; CAPES (Coordination for the Improvement of Higher Education Personnel); Lemann Foundation; FAPEMIG (Foundation of Support for Research of Minas Gerais); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK057751, R01DK061747, P30DK034989, R29DK045710, R01DK045710] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Connecticut Department of Public Health; CAPES (Coordination for the Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Lemann Foundation; FAPEMIG (Foundation of Support for Research of Minas Gerais)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health (www.nih.gov/) Grants DK57751, DK45710, DK34989, DK61747, P30KD034989, a Biomedical Research Grant from the Connecticut Department of Public Health (www.ct.gov/dph), and grants from CAPES (Coordination for the Improvement of Higher Education Personnel; www.capes.gov.br), Lemann Foundation (www.fundacaolemann.org.br) and FAPEMIG (Foundation of Support for Research of Minas Gerais; www.fapemig.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaya MJ, 2014, CELL CALCIUM, V55, P317, DOI 10.1016/j.ceca.2014.02.003; Amaya MJ, 2013, COMPR PHYSIOL, V3, P515, DOI 10.1002/cphy.c120013; Amaya MJ, 2013, HEPATOLOGY; Berthiaume F, 1996, FASEB J, V10, P1471, DOI 10.1096/fasebj.10.13.8940293; BRUCK R, 1994, HEPATOLOGY, V20, P1032, DOI 10.1002/hep.1840200436; Chang CL, 2013, CELL REP, V5, P813, DOI 10.1016/j.celrep.2013.09.038; Cruz LN, 2010, HEPATOLOGY, V52, P327, DOI 10.1002/hep.23625; Dutta AK, 2008, AM J PHYSIOL-GASTR L, V295, pG1004, DOI 10.1152/ajpgi.90382.2008; Endo M, 2009, PHYSIOL REV, V89, P1153, DOI 10.1152/physrev.00040.2008; FURUICHI T, 1989, NATURE, V342, P32, DOI 10.1038/342032a0; Giordano F, 2013, CELL, V153, P1494, DOI 10.1016/j.cell.2013.05.026; Gould TJ, 2012, ANNU REV BIOMED ENG, V14, P231, DOI [10.1146/annurev-bioeng-071811-150025, 10.1146/annurev.bioeng-071811-150025]; GRAF J, 1990, J HEPATOL, V10, P387, DOI 10.1016/0168-8278(90)90152-H; Haj FG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036633; Hirata K, 2002, HEPATOLOGY, V36, P284, DOI 10.1053/jhep.2002.34432; Hirata K, 2002, GASTROENTEROLOGY, V122, P1088, DOI 10.1053/gast.2002.32363; Jean S, 2010, DEV CELL, V19, P426, DOI 10.1016/j.devcel.2010.08.007; KASAI H, 1990, NATURE, V348, P735, DOI 10.1038/348735a0; Kruglov EA, 2011, HEPATOLOGY, V54, P1790, DOI 10.1002/hep.24548; Lee I, 2006, FASEB J, V20, P202, DOI 10.1096/fj.05-4581hyp; Lee MG, 1997, J BIOL CHEM, V272, P15765, DOI 10.1074/jbc.272.25.15765; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Liu XR, 1999, AM J PHYSIOL-GASTR L, V277, pG12, DOI 10.1152/ajpgi.1999.277.1.G12; Manford AG, 2012, DEV CELL, V23, P1129, DOI 10.1016/j.devcel.2012.11.004; MARANTO AR, 1994, J BIOL CHEM, V269, P1222; Min SW, 2007, P NATL ACAD SCI USA, V104, P3823, DOI 10.1073/pnas.0611725104; Minagawa N, 2007, GASTROENTEROLOGY, V133, P1592, DOI 10.1053/j.gastro.2007.08.020; Nagata J, 2007, GASTROENTEROLOGY, V133, P256, DOI 10.1053/j.gastro.2007.03.115; Nathanson MH, 1996, AM J PHYSIOL-GASTR L, V271, pG86, DOI 10.1152/ajpgi.1996.271.1.G86; Nathanson MH, 1998, J CLIN INVEST, V101, P2665, DOI 10.1172/JCI2835; NATHANSON MH, 1994, J BIOL CHEM, V269, P4693; NATHANSON MH, 1994, AM J PHYSIOL, V267, pG338, DOI 10.1152/ajpgi.1994.267.3.G338; Nievergall E, 2010, J CELL BIOL, V191, P1189, DOI 10.1083/jcb.201005035; Orabi AI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048465; Park CY, 2009, CELL, V136, P876, DOI 10.1016/j.cell.2009.02.014; Roberts SK, 1997, GASTROENTEROLOGY, V112, P269, DOI 10.1016/S0016-5085(97)70244-0; Shibao K, 2003, GASTROENTEROLOGY, V125, P1175, DOI 10.1016/S0016-5085(03)01201-0; Stefan CJ, 2013, CURR OPIN CELL BIOL, V25, P434, DOI 10.1016/j.ceb.2013.02.020; Stefan CJ, 2011, CELL, V144, P389, DOI 10.1016/j.cell.2010.12.034; SUDHOF TC, 1991, EMBO J, V10, P3199, DOI 10.1002/j.1460-2075.1991.tb04882.x; Toulmay A, 2011, CURR OPIN CELL BIOL, V23, P458, DOI 10.1016/j.ceb.2011.04.006; Wang W, 2006, GASTROENTEROLOGY, V131, P878, DOI 10.1053/j.gastro.2006.06.013; WOJCIKIEWICZ RJH, 1995, J BIOL CHEM, V270, P11678, DOI 10.1074/jbc.270.19.11678; Yule DI, 1997, J BIOL CHEM, V272, P9093; Zhang D, 2012, CURR BIOL, V22, P2048, DOI 10.1016/j.cub.2012.08.047; Zhao YX, 2011, SCIENCE, V333, P1888, DOI 10.1126/science.1208592	47	6	6	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114043	10.1371/journal.pone.0114043	http://dx.doi.org/10.1371/journal.pone.0114043			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437447	gold, Green Submitted, Green Published			2022-12-26	WOS:000347114900113
J	Wang, YY; Huang, S; Zhong, JH; Ke, Y; Guo, Z; Liu, JQ; Ma, L; Li, H; Ou, BN; Li, LQ				Wang, Yan-Yan; Huang, Shan; Zhong, Jian-Hong; Ke, Yang; Guo, Zhe; Liu, Jia-Qi; Ma, Liang; Li, Hang; Ou, Bing-Ning; Li, Le-Qun			Impact of Diabetes Mellitus on the Prognosis of Patients with Hepatocellular Carcinoma after Curative Hepatectomy	PLOS ONE			English	Article							PROPENSITY SCORE METHODS; HEPATIC RESECTION; THERAPY OPTIONS; RISK; CANCER; CIRRHOSIS; OUTCOMES; PREVALENCE; RECURRENCE; MORTALITY	Background: The influence of diabetes mellitus (DM) on the prognosis of patients with hepatocellular carcinoma (HCC) remains controversial. Here we investigated the impact of DM on the prognosis of such patients after curative hepatectomy. Methods: A consecutive cohort of 505 patients with HCC (134 with DM, 371 without) underwent curative hepatectomy were retrospectively evaluated. Postoperative morbidity and mortality, overall survival (OS) and disease-free survival (DFS) were compared between patients with or without DM. Independent prognostic predictors were identified using the Cox proportional hazards model. Results: Patients with or without DM showed similar morbidity and 30- and 90-day mortality after curative hepatectomy (all P> 0.05), as well as similar DFS at 1, 3, 5 years (P=0.781). However, the group of patients with DM showed significantly lower OS at 1, 3, 5 years than the group without DM (P=0.038). Similar results were obtained in the propensity-matched cohort. Cox multivariate analysis identified DM as an independent predictor of poor OS, but not of poor DFS. We repeat compared OS and DFS for DM and non-DM subgroups defined according to the presence or absence of hepatitis B virus infection and cirrhosis. Similar results were obtained in all subgroups except the non-cirrhotic subgroup which showed patients with and without DM had similar OS. Conclusions: DM does not significantly affect the postoperative morbidity or mortality or the DFS of patients with HCC after curative hepatectomy. It is, however, associated with significantly lower OS, especially in patients with cirrhosis.	[Wang, Yan-Yan; Huang, Shan; Zhong, Jian-Hong; Ke, Yang; Guo, Zhe; Liu, Jia-Qi; Ma, Liang; Li, Le-Qun] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Hepatobiliary Surg, Nanning, Peoples R China; [Li, Hang] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Ultrasound, Nanning, Peoples R China; [Ou, Bing-Ning] Guangxi Med Univ, Pharmaceut Coll, Nanning, Peoples R China	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University	Li, LQ (corresponding author), Guangxi Med Univ, Affiliated Tumor Hosp, Dept Hepatobiliary Surg, Nanning, Peoples R China.	xitongpingjia@163.com	LI, LI/GVS-5344-2022; Zhong, Jian-Hong/D-6641-2018; LI, LI QING/GRR-8855-2022; wang, yan/GSE-6489-2022; Wang, Yanbo/HFZ-8018-2022; Li, Li/AEM-3636-2022; li, li/HII-4157-2022	Zhong, Jian-Hong/0000-0002-1494-6396; 	National Natural Science Foundation of China [81160262/H1602]; Hepatocellular Carcinoma Bridge Study [CA182023]; Scientific Research and Technical Development Project of Guangxi Province [0632007-1E, 10124001A-4]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hepatocellular Carcinoma Bridge Study; Scientific Research and Technical Development Project of Guangxi Province	This work was supported by funding from the National Natural Science Foundation of China (no. 81160262/H1602), Hepatocellular Carcinoma Bridge Study (no. CA182023), and Scientific Research and Technical Development Project of Guangxi Province (nos. 0632007-1E and 10124001A-4) to LQL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abougalambou SSI, 2013, DIABETES METAB SYND, V7, P64, DOI 10.1016/j.dsx.2013.02.034; Adachi E, 2002, SURGERY, V131, pS148, DOI 10.1067/msy.2002.119496; Adams LA, 2005, J HEPATOL, V42, P132, DOI 10.1016/j.jhep.2004.09.012; Aggarwal G, 2013, PANCREAS, V42, P198, DOI 10.1097/MPA.0b013e3182592c96; Aloia TA, 2009, HPB, V11, P510, DOI 10.1111/j.1477-2574.2009.00095.x; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS11, DOI 10.2337/dc13-S011; Austin PC, 2014, STAT MED, V33, P1242, DOI 10.1002/sim.5984; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Chiang CH, 2014, HEPATOLOGY, V59, P2207, DOI 10.1002/hep.27014; Chiang DAJ, 2011, AM J PHYSIOL-GASTR L, V300, pG697, DOI 10.1152/ajpgi.00426.2010; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; de Ledinghen V, 2006, J HEPATOL, V45, P592, DOI 10.1016/j.jhep.2006.05.008; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; El-Serag HB, 2001, AM J GASTROENTEROL, V96, P2462, DOI 10.1111/j.1572-0241.2001.04054.x; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Guo Z, 2014, ANN SURG ONCOL, V21, P3069, DOI 10.1245/s10434-014-3704-8; Holstein A, 2002, J GASTROEN HEPATOL, V17, P677, DOI 10.1046/j.1440-1746.2002.02755.x; Ikeda Y, 1998, HEPATOLOGY, V27, P1567, DOI 10.1002/hep.510270615; Ke Yang, 2014, Zhonghua Yi Xue Za Zhi, V94, P747; Komura T, 2007, AM J GASTROENTEROL, V102, P1939, DOI 10.1111/j.1572-0241.2007.01354.x; Menon KV, 2006, J AM COLL SURGEONS, V203, P677, DOI 10.1016/j.jamcollsurg.2006.07.025; Molitch ME, 2004, DIABETES CARE, V27, P1240, DOI 10.2337/diacare.27.5.1240-a; Nielsen MF, 2005, AM J PHYSIOL-GASTR L, V288, pG1135, DOI 10.1152/ajpgi.00278.2004; Paradis V, 2001, HEPATOLOGY, V34, P738, DOI 10.1053/jhep.2001.28055; Pol B, 1999, EUR J SURG, V165, P446; Poon RTP, 2002, AM J GASTROENTEROL, V97, P1480, DOI 10.1016/S0002-9270(02)04148-5; Sasazuki S, 2013, CANCER SCI, V104, P1499, DOI 10.1111/cas.12241; Shau WY, 2012, ONCOLOGIST, V17, P856, DOI 10.1634/theoncologist.2012-0065; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Ting CT, 2012, TOHOKU J EXP MED, V227, P73, DOI 10.1620/tjem.227.73; Toyoda H, 2001, CANCER-AM CANCER SOC, V91, P957; Veldt BJ, 2008, HEPATOLOGY, V47, P1856, DOI 10.1002/hep.22251; Wlazlo N, 2010, DIABETIC MED, V27, P1308, DOI 10.1111/j.1464-5491.2010.03093.x; YANAGA K, 1993, ARCH SURG-CHICAGO, V128, P445; Yang WS, 2013, ANN ONCOL, V24, P1679, DOI 10.1093/annonc/mdt017; Yoon JM, 2013, WORLD J GASTROENTERO, V19, P936, DOI 10.3748/wjg.v19.i6.936; Zheng Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084776; Zhong JH, 2012, EJSO-EUR J SURG ONC, V38, P286, DOI 10.1016/j.ejso.2012.01.006; Zhong JH, 2012, INT J CLIN PRACT, V66, P21, DOI 10.1111/j.1742-1241.2011.02814.x; Zhong JH, 2014, GUT; Zhong JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108755; Zhong JH, 2014, SCAND J GASTROENTERO, V49, P649, DOI 10.3109/00365521.2014.905626; Zhong JH, 2014, ANN SURG, V260, P329, DOI 10.1097/SLA.0000000000000236; Zhong JH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068193	46	21	26	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113858	10.1371/journal.pone.0113858	http://dx.doi.org/10.1371/journal.pone.0113858			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436613	Green Submitted, gold, Green Published			2022-12-26	WOS:000347114900088
J	Huang, X; Guo, Y; Huang, WH; Zhang, W; Tan, ZR; Peng, JB; Wang, YC; Hu, DL; Ouyang, DS; Xiao, J; Wang, Y; Luo, M; Chen, Y				Huang, Xi; Guo, Ying; Huang, Wei-hua; Zhang, Wei; Tan, Zhi-rong; Peng, Jing-bo; Wang, Yi-cheng; Hu, Dong-li; Ouyang, Dong-sheng; Xiao, Jian; Wang, Yang; Luo, Min; Chen, Yao			Searching the Cytochrome P450 Enzymes for the Metabolism of Meranzin Hydrate: A Prospective Antidepressant Originating from Chaihu-Shugan-San	PLOS ONE			English	Article							HUMAN LIVER-MICROSOMES; SEROTONIN REUPTAKE INHIBITORS; DEPRESSION; POLYMORPHISM; AGOMELATINE; POPULATION; VOLUNTEERS; EXTRACT; CYP2C19; CYP1A2	Meranzin hydrate (MH), an absorbed bioactive compound from the Traditional Chinese Medicine (TCM) Chaihu-Shugan-San (CSS), was first isolated in our laboratory and was found to possess anti-depression activity. However, the role of cytochrome P450s (CYPs) in the metabolism of MH was unclear. In this study, we screened the CYPs for the metabolism of MH in vitro by human liver microsomes (HLMs) or human recombinant CYPs. MH inhibited the enzyme activities of CYP1A2 and CYP2C19 in a concentration-dependent manner in the HLMs. The K-m and V-max values of MH were 10.3 +/- 1.3 mu M and 99.1 +/- 3.3 nmol/mg protein/min, respectively, for the HLMs; 8.0 +/- 1.6 mu M and 112.4 +/- 5.7 nmol/nmol P450/min, respectively, for CYP1A2; and 25.9 +/- 6.6 mu M and 134.3 +/- 12.4 nmol/nmol P450/min, respectively, for CYP2C19. Other human CYP isoforms including CYP2A6, CYP2C9, CYP2D6, CYP2E1 and CYP3A4 showed minimal or no effect on MH metabolism. The results suggested that MH was simultaneously a substrate and an inhibitor of CYP1A2 and CYP2C9, and MH had the potential to perpetrate drug-drug interactions with other CYP1A2 and CYP2C19 substrates.	[Huang, Xi; Guo, Ying; Huang, Wei-hua; Zhang, Wei; Tan, Zhi-rong; Peng, Jing-bo; Wang, Yi-cheng; Hu, Dong-li; Ouyang, Dong-sheng; Chen, Yao] Cent S Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha 410078, Hunan, Peoples R China; [Huang, Xi; Guo, Ying; Huang, Wei-hua; Zhang, Wei; Tan, Zhi-rong; Peng, Jing-bo; Wang, Yi-cheng; Hu, Dong-li; Ouyang, Dong-sheng; Chen, Yao] Cent S Univ, Inst Clin Pharmacol, Hunan Key Lab Pharmacogenet, Changsha 410078, Hunan, Peoples R China; [Huang, Xi; Xiao, Jian; Wang, Yang; Luo, Min; Chen, Yao] Cent S Univ, Xiangya Hosp, Inst Integrated Tradit Chinese & Western Med, Lab Ethnopharmacol, Changsha 410078, Hunan, Peoples R China	Central South University; Central South University; Central South University	Chen, Y (corresponding author), Cent S Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha 410078, Hunan, Peoples R China.	cbohua@163.com	Chen, Yao/AAJ-5658-2020	Chen, Yao/0000-0001-7231-9860; Huang, Wei-Hua/0000-0003-4167-8304	National Scientific Foundation of China [81302850]; China Postdoctoral Science Foundation [2013M531817, 2014T70793, 2013M542146]; Science and Technology Plan Projects of Hunan Province [2014RS4011]; 863 Project [2012AA02A518]; Key Laboratory Funds of Hunan Province [13K003]; Fundamental Research Funds for the Central South University [1681-7608040003]	National Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Science and Technology Plan Projects of Hunan Province; 863 Project(National High Technology Research and Development Program of China); Key Laboratory Funds of Hunan Province; Fundamental Research Funds for the Central South University	National Scientific Foundation of China (No. 81302850), General Financial Grant from the China Postdoctoral Science Foundation (No. 2013M531817 and 2014T70793), Science and Technology Plan Projects of Hunan Province (2014RS4011) to YC, General Financial Grant from the China Postdoctoral Science Foundation (No. 2013M542146) to JBP, 863 Project (No. 2012AA02A518) to WZ, Key Laboratory Funds of Hunan Province (13K003) and the Fundamental Research Funds for the Central South University (No. 1681-7608040003) to WHH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourrie M, 1996, J PHARMACOL EXP THER, V277, P321; Chancellor D, 2011, NAT REV DRUG DISCOV, V10, P809, DOI 10.1038/nrd3585; Chen SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072428; Chen Y, 2009, XENOBIOTICA, V39, P508, DOI 10.1080/00498250902951763; CHING MS, 1995, BIOCHEM PHARMACOL, V50, P833, DOI 10.1016/0006-2952(95)00207-G; De Crescenzo F, 2014, J AFFECT DISORDERS, V152, P39, DOI 10.1016/j.jad.2013.09.019; Gebhardt AC, 1997, HEPATOLOGY, V26, P957, DOI 10.1053/jhep.1997.v26.pm0009328319; Graf H., 2013, PHARM BIOCH BEHAV; GREENBERG PE, 1993, J CLIN PSYCHIAT, V54, P419; Huang W, 2011, J GASTROINTEST SURG, V15, P87, DOI 10.1007/s11605-010-1374-9; Johnson TN, 2009, PHARM STAT, V8, P186, DOI 10.1002/pst.373; Keers R, 2011, EXPERT REV NEUROTHER, V11, P101, DOI [10.1586/ern.10.186, 10.1586/ERN.10.186]; Kim SH, 2005, LIFE SCI, V76, P1297, DOI 10.1016/j.lfs.2004.10.022; Kocsis JH, 2013, EVID-BASED MENT HEAL, V16, P82, DOI 10.1136/eb-2013-101268; Kong WM, 2011, MOLECULES, V16, P7344, DOI 10.3390/molecules16097344; Lee YC, 2013, J CLIN PSYCHOPHARM, V33, P782, DOI 10.1097/JCP.0b013e31829c970e; Li X, 2013, CHEM-BIOL INTERACT, V204, P140, DOI 10.1016/j.cbi.2013.05.007; McInerney M, 2013, J HEALTH ECON, V32, P1090, DOI 10.1016/j.jhealeco.2013.09.002; Plesnicar BK, 2014, PATIENT PREFER ADHER, V8, P603, DOI 10.2147/PPA.S.12789; Qin CZ, 2014, BIOMED CHROMATOGR, V28, P197, DOI 10.1002/bmc.3003; Ring BJ, 1996, BRIT J CLIN PHARMACO, V41, P181, DOI 10.1111/j.1365-2125.1996.tb00180.x; Schurink B, 2014, J CLIN PSYCHOPHARM, V34, P66, DOI 10.1097/JCP.0000000000000055; Song L, 2014, J CLIN PHARM THER, V39, P204, DOI 10.1111/jcpt.12118; Taavitsainen P, 2001, DRUG METAB DISPOS, V29, P217; Tan E, 2013, CAN FAM PHYSICIAN, V59, P263; Tang C, 2005, DRUG METAB DISPOS, V33, P603, DOI 10.1124/dmd.104.003236; Tombal B, 2010, EUR UROL, V57, P396, DOI 10.1016/j.eururo.2009.11.039; Walker J, 2011, PSYCHOSOMATICS, V52, P424, DOI 10.1016/j.psym.2011.02.003; Weeke P, 2012, CLIN PHARMACOL THER, V92, P72, DOI 10.1038/clpt.2011.368; Xie Y, 2013, NEUROPHARMACOLOGY, V67, P318, DOI 10.1016/j.neuropharm.2012.10.003; Xie Y, 2013, AMINO ACIDS, V44, P413, DOI 10.1007/s00726-012-1347-2; Xu C, 2013, DRUG METAB PHARMACOK, V28, P362, DOI 10.2133/dmpk.DMPK-12-RG-124; Yamamoto Y, 2013, THER DRUG MONIT, V35, P305, DOI 10.1097/FTD.0b013e318283b49a	33	9	11	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113819	10.1371/journal.pone.0113819	http://dx.doi.org/10.1371/journal.pone.0113819			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427198	Green Submitted, gold, Green Published			2022-12-26	WOS:000349145400089
J	Fresques, T; Niles, B; Aronova, S; Mogri, H; Rakhshandehroo, T; Powers, T				Fresques, Tara; Niles, Brad; Aronova, Sofia; Mogri, Huzefa; Rakhshandehroo, Taha; Powers, Ted			Regulation of Ceramide Synthase by Casein Kinase 2-dependent Phosphorylation in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPHINGOLIPID METABOLISM; ENDOPLASMIC-RETICULUM; PROTEINS; CK2; BIOSYNTHESIS; ACTIVATION; SYSTEM; TARGET; YPK1	Complex sphingolipids are important components of eukaryotic cell membranes and, together with their biosynthetic precursors, including sphingoid long chain bases and ceramides, have important signaling functions crucial for cell growth and survival. Ceramides are produced at the endoplasmic reticulum (ER) membrane by a multicomponent enzyme complex termed ceramide synthase (CerS). In budding yeast, this complex is composed of two catalytic subunits, Lac1 and Lag1, as well as an essential regulatory subunit, Lip1. Proper formation of ceramides by CerS has been shown previously to require the Cka2 subunit of casein kinase 2 (CK2), a ubiquitous enzyme with multiple cellular functions, but the precise mechanism involved has remained unidentified. Here we present evidence that Lac1 and Lag1 are direct targets for CK2 and that phosphorylation at conserved positions within the C-terminal cytoplasmic domain of each protein is required for optimal CerS activity. Our data suggest that phosphorylation of Lac1 and Lag1 is important for proper localization and distribution of CerS within the ER membrane and that phosphorylation of these sites is functionally linked to the COP I-dependent C-terminal dilysine ER retrieval pathway. Together, our data identify CK2 as an important regulator of sphingolipid metabolism, and additionally, because both ceramides and CK2 have been implicated in the regulation of cancer, our findings may lead to an enhanced understanding of their relationship in health and disease.	[Fresques, Tara; Niles, Brad; Aronova, Sofia; Mogri, Huzefa; Rakhshandehroo, Taha; Powers, Ted] Univ Calif Davis, Dept Mol & Cellular Biol, Coll Biol Sci, Davis, CA 95616 USA	University of California System; University of California Davis	Powers, T (corresponding author), Univ Calif Davis, Dept Mol & Cellular Biol, Coll Biol Sci, One Shields Ave, Davis, CA 95616 USA.	tpowers@ucdavis.edu			National Institutes of Health [GM086387]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086387] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM086387 (to T. P.).	Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Cowart LA, 2007, BBA-MOL CELL BIOL L, V1771, P421, DOI 10.1016/j.bbalip.2006.08.005; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; Dilova I, 2004, J BIOL CHEM, V279, P46527, DOI 10.1074/jbc.M409012200; Faust M, 2001, MOL CELL BIOCHEM, V227, P73, DOI 10.1023/A:1013129410551; Furuya H, 2011, CANCER METAST REV, V30, P567, DOI 10.1007/s10555-011-9304-1; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Gietz D, 1998, METHOD MICROBIOL, V26, P53; Hannich JT, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004762; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2001, BIOCHEMISTRY-US, V40, P4893, DOI 10.1021/bi002836k; Homma MK, 2008, MOL CELL BIOCHEM, V316, P49, DOI 10.1007/s11010-008-9823-4; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Kageyama-Yahara N, 2006, BIOCHEM J, V398, P585, DOI 10.1042/BJ20060697; Kobayashi SD, 2003, EUKARYOT CELL, V2, P284, DOI 10.1128/EC.2.2.284-294.2003; Koyanagi S, 2003, INT J CANCER, V105, P1, DOI 10.1002/ijc.11024; Koybasi S, 2004, J BIOL CHEM, V279, P44311, DOI 10.1074/jbc.M406920200; KUENZEL EA, 1987, J BIOL CHEM, V262, P9136; Leroy D, 1999, MOL CELL BIOCHEM, V191, P85, DOI 10.1023/A:1006858210835; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Maiti T, 2003, YEAST, V20, P97, DOI 10.1002/yea.937; Marx CJ, 2002, BIOTECHNIQUES, V33, P1062, DOI 10.2144/02335rr01; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Muir A, 2014, ELIFE, V3, DOI 10.7554/eLife.03779; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MUNSTERMANN U, 1990, EUR J BIOCHEM, V189, P251, DOI 10.1111/j.1432-1033.1990.tb15484.x; Niles BJ, 2014, CELL REP, V6, P541, DOI 10.1016/j.celrep.2013.12.040; Niles BJ, 2012, P NATL ACAD SCI USA, V109, P1536, DOI 10.1073/pnas.1117563109; Ogretmen B, 2004, NAT REV CANCER, V4, P604, DOI 10.1038/nrc1411; Popoff V, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005231; Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Russo GL, 2000, BIOCHEM J, V351, P143, DOI 10.1042/0264-6021:3510143; Saba JD, 2004, CIRC RES, V94, P724, DOI 10.1161/01.RES.0000122383.60368.24; Sarno S, 2008, MOL BIOSYST, V4, P889, DOI 10.1039/b805534c; Schiffmann S, 2009, CARCINOGENESIS, V30, P745, DOI 10.1093/carcin/bgp061; Schorling S, 2001, MOL BIOL CELL, V12, P3417, DOI 10.1091/mbc.12.11.3417; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; SIKORSKI RS, 1989, GENETICS, V122, P19; Sims KJ, 2004, BIOCHEM CELL BIOL, V82, P45, DOI 10.1139/o03-086; Trembley JH, 2009, CELL MOL LIFE SCI, V66, P1858, DOI 10.1007/s00018-009-9154-y; Vallee B, 2005, EMBO J, V24, P730, DOI 10.1038/sj.emboj.7600562	44	21	21	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1395	1403		10.1074/jbc.M114.621086	http://dx.doi.org/10.1074/jbc.M114.621086			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25429105	Green Published, hybrid			2022-12-26	WOS:000348056400009
J	Martinelli, L; Lalli, D; Garcia-Morales, L; Ratera, M; Querol, E; Pinol, J; Fita, I; Calisto, BM				Martinelli, Luca; Lalli, Daniela; Garcia-Morales, Luis; Ratera, Merce; Querol, Enrique; Pinol, Jaume; Fita, Ignacio; Calisto, Barbara M.			A Major Determinant for Gliding Motility in Mycoplasma genitalium THE INTERACTION BETWEEN THE TERMINAL ORGANELLE PROTEINS MG200 AND MG491	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NMR-SPECTROSCOPY; ATTACHMENT ORGANELLE; MINIMAL BACTERIUM; BINDING SURFACE; PNEUMONIAE; CYTADHERENCE; DOMAIN; CELL; EVOLUTION; GENES	Several mycoplasmas, such as the emergent human pathogen Mycoplasma genitalium, developed a complex polar structure, known as the terminal organelle (TO), responsible for a new type of cellular motility, which is involved in a variety of cell functions: cell division, adherence to host cells, and virulence. The TO cytoskeleton is organized as a multisubunit dynamic motor, including three main ultrastructures: the terminal button, the electrodense core, and the wheel complex. Here, we describe the interaction between MG200 and MG491, two of the main components of the TO wheel complex that connects the TO with the cell body and the cell membrane. The interaction between MG200 and MG491 has a K-D in the 80 nM range, as determined by surface plasmon resonance. The interface between the two partners was confined to the "enriched in aromatic and glycine residues" (EAGR) box of MG200, previously described as a protein-protein interaction domain, and to a 25-residue-long peptide from the C-terminal region of MG491 by surface plasmon resonance and NMR spectroscopy studies. An atomic description of the MG200 EAGR box binding surface was also provided by solution NMR. An M. genitalium mutant lacking the MG491 segment corresponding to the peptide reveals specific alterations in cell motility and cell morphology indicating that the MG200-MG491 interaction plays a key role in the stability and functioning of the TO.	[Martinelli, Luca; Fita, Ignacio] Inst Biol Mol Barcelona IBMB CSIC, Barcelona 08028, Spain; [Lalli, Daniela] Univ Florence, Magnet Resonance Ctr, I-50019 Sesto Fiorentino, Italy; [Lalli, Daniela] Univ Florence, Dept Chem, I-50019 Sesto Fiorentino, Italy; [Garcia-Morales, Luis; Ratera, Merce; Querol, Enrique; Pinol, Jaume] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain; [Garcia-Morales, Luis; Ratera, Merce; Querol, Enrique; Pinol, Jaume] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, E-08193 Barcelona, Spain; [Calisto, Barbara M.] European Synchrotron Radiat Facil, Struct Biol Grp, F-38043 Grenoble, France; [Calisto, Barbara M.] Univ Porto, Inst Biol Mol & Celular IBMC, P-4150180 Oporto, Portugal	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); University of Florence; University of Florence; Autonomous University of Barcelona; Autonomous University of Barcelona; European Synchrotron Radiation Facility (ESRF); Universidade do Porto	Calisto, BM (corresponding author), European Synchrotron Radiat Facil, Struct Biol Grp, CS 40220, F-38043 Grenoble, France.	barbara.calisto@esrf.fr	Garcia-Morales, Luis/Q-7461-2018; Fita, Ignasi/R-4515-2019	Garcia-Morales, Luis/0000-0002-3037-4519; Fita, Ignasi/0000-0002-7521-2679; Martinelli, Luca/0000-0003-2004-3932; Calisto, Barbara/0000-0003-1732-571X; Pinol, Jaume/0000-0002-9055-8934; Ratera, Merce/0000-0001-5224-9172	FRISBI [ANR-10-INSB-05-02]; GRAL [ANR-10-LABX-49-01]	FRISBI; GRAL	We especially thank the Instruct Centre CERM (Italy) for access to the NMR Research Infrastructure. We also acknowledge Isabel Bally from the Institut de Biologie Structurale (CEA, CNRS, Universite Joseph Fourier, Grenoble, France) for access to the SPR technical platform of the Grenoble Partnership for Structural Biology (PSB) and Nicole Thielens (CEA, CNRS, Universite Joseph Fourier, Grenoble, France) for help in the acquisition and interpretation of SPR data. This work used the platforms of the Grenoble Instruct Centre (ISBG; UMS, 3518 CNRS-CEA-UJF-EMBL) with support from FRISBI (ANR-10-INSB-05-02) and GRAL (ANR-10-LABX-49-01) within the Grenoble PSB. Many thanks are given to M. Pons (BioNMR Group, Facultat de Quimica, UB, Spain) and Daniele de Sanctis (Structural Biology Group, ESRF, France) for helpful scientific discussions.	Balish MF, 2001, J BACTERIOL, V183, P3680, DOI 10.1128/JB.183.12.3680-3688.2001; Balish MF, 2006, J MOL MICROB BIOTECH, V11, P244, DOI 10.1159/000094058; Blanchard A, 2011, ANN NY ACAD SCI, V1230, pE61, DOI 10.1111/j.1749-6632.2011.06418.x; Burgos R, 2008, MOL MICROBIOL, V69, P1029, DOI 10.1111/j.1365-2958.2008.06343.x; Burgos R, 2006, J BACTERIOL, V188, P8627, DOI 10.1128/JB.00978-06; Calisto BM, 2012, MOL MICROBIOL, V86, P382, DOI 10.1111/j.1365-2958.2012.08200.x; Catrein I, 2011, PROTEOMICS, V11, P3614, DOI 10.1002/pmic.201100076; Citti C, 2013, TRENDS MICROBIOL, V21, P196, DOI 10.1016/j.tim.2013.01.003; Cloward JM, 2010, MOL MICROBIOL, V77, P158, DOI 10.1111/j.1365-2958.2010.07196.x; Cloward JM, 2009, MOL MICROBIOL, V71, P1296, DOI 10.1111/j.1365-2958.2009.06602.x; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; Fielding L, 2007, PROG NUCL MAG RES SP, V51, P219, DOI 10.1016/j.pnmrs.2007.04.001; Garrett DS, 1997, BIOCHEMISTRY-US, V36, P4393, DOI 10.1021/bi970221q; Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Hasselbring BM, 2007, J BACTERIOL, V189, P7442, DOI 10.1128/JB.00867-07; Hasselbring BM, 2007, MOL MICROBIOL, V63, P44, DOI 10.1111/j.1365-2958.2006.05507.x; Hatchel JM, 2008, MICROBIOL-SGM, V154, P286, DOI 10.1099/mic.0.2007/012765-0; Hegermann J, 2002, NATURWISSENSCHAFTEN, V89, P453, DOI 10.1007/s00114-002-0359-2; Henderson GP, 2006, MOL MICROBIOL, V60, P376, DOI 10.1111/j.1365-2958.2006.05113.x; Johansson K.E., 2002, MOL BIOL PATHOGENICI; Jordan JL, 2007, INFECT IMMUN, V75, P518, DOI 10.1128/IAI.01344-06; Kay Lewis E, 2011, J Magn Reson, V213, P423, DOI 10.1016/j.jmr.2011.09.004; Kenri T, 2004, J BACTERIOL, V186, P6944, DOI 10.1128/JB.186.20.6944-6955.2004; KIRCHHOFF H, 1992, INT J SYST BACTERIOL, V42, P506, DOI 10.1099/00207713-42-3-506; KIRCHHOFF H, 1984, ISRAEL J MED SCI, V20, P848; Krause DC, 1997, J BACTERIOL, V179, P2668, DOI 10.1128/jb.179.8.2668-2677.1997; Lluch-Senar M, 2010, MOL MICROBIOL, V78, P278, DOI 10.1111/j.1365-2958.2010.07306.x; McGowin CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001324; Meyer B, 2003, ANGEW CHEM INT EDIT, V42, P864, DOI 10.1002/anie.200390233; Miyata M, 2008, TRENDS MICROBIOL, V16, P6, DOI 10.1016/j.tim.2007.11.002; Pich OQ, 2006, MICROBIOL-SGM, V152, P519, DOI 10.1099/mic.0.28287-0; Pich OQ, 2006, MOL MICROBIOL, V60, P1509, DOI 10.1111/j.1365-2958.2006.05187.x; Proft T, 1996, GENE, V171, P79, DOI 10.1016/0378-1119(96)00014-5; Sambrook J., 2001, MOL CLONING LAB MANU; Seybert A, 2006, J STRUCT BIOL, V156, P342, DOI 10.1016/j.jsb.2006.04.010; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sirand-Pugnet P, 2007, RES MICROBIOL, V158, P754, DOI 10.1016/j.resmic.2007.09.007; Sweet RL, 2012, CURR INFECT DIS REP, V14, P194, DOI 10.1007/s11908-012-0243-y; Taylor-Robinson D, 1997, J ANTIMICROB CHEMOTH, V40, P622, DOI 10.1093/jac/40.5.622; TULLY JG, 1979, J INFECT DIS, V139, P478, DOI 10.1093/infdis/139.4.478; Wider G, 1999, CURR OPIN STRUC BIOL, V9, P594, DOI 10.1016/S0959-440X(99)00011-1; WUTHRICH K, 1990, J BIOL CHEM, V265, P22059	43	7	9	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1699	1711		10.1074/jbc.M114.594762	http://dx.doi.org/10.1074/jbc.M114.594762			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25471372	Green Published, hybrid			2022-12-26	WOS:000348056400036
J	Stephenson, R; Hosler, MR; Gavande, NS; Ghosh, AK; Weake, VM				Stephenson, Robert; Hosler, Marcus R.; Gavande, Navnath S.; Ghosh, Arun K.; Weake, Vikki M.			Characterization of a Drosophila Ortholog of the Cdc7 Kinase A ROLE FOR Cdc7 IN ENDOREPLICATION INDEPENDENT OF CHIFFON	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE CDC7; CHORION GENE AMPLIFICATION; CELL-CYCLE REGULATION; HUMAN CDC7-RELATED KINASE; IN-VITRO PHOSPHORYLATION; S-PHASE; DNA-REPLICATION; PROTEIN-KINASE; CHROMOSOMAL LOCALIZATION; REGULATORY SUBUNIT	Cdc7 is a serine-threonine kinase that phosphorylates components of the pre-replication complex during DNA replication initiation. Cdc7 is highly conserved, and Cdc7 orthologs have been characterized in organisms ranging from yeast to humans. Cdc7 is activated specifically during late G1/S phase by binding to its regulatory subunit, Dbf4. Drosophila melanogaster contains a Dbf4 ortholog, Chiffon, which is essential for chorion amplification in Drosophila egg chambers. However, no Drosophila ortholog of Cdc7 has yet been characterized. Here, we report the functional and biochemical characterization of a Drosophila ortholog of Cdc7. Co-expression of Drosophila Cdc7 and Chiffon is able to complement a growth defect in yeast containing a temperature-sensitive Cdc7 mutant. Cdc7 and Chiffon physically interact and can be co-purified from insect cells. Cdc7 phosphorylates the known Cdc7 substrates Mcm2 and histone H3 in vitro, and Cdc7 kinase activity is stimulated by Chiffon and inhibited by the Cdc7-specific inhibitor XL413. Drosophila egg chamber follicle cells deficient for Cdc7 have a defect in two types of DNA replication, endoreplication and chorion gene amplification. However, follicle cells deficient for Chiffon have a defect in chorion gene amplification but still undergo endocycling. Our results show that Cdc7 interacts with Chiffon to form a functional Dbf4-dependent kinase complex and that Cdc7 is necessary for DNA replication in Drosophila egg chamber follicle cells. Additionally, we show that Chiffon is a member of an expanding subset of DNA replication initiation factors that are not strictly required for endoreplication in Drosophila.	[Stephenson, Robert; Hosler, Marcus R.; Weake, Vikki M.] Purdue Univ, Dept Biochem, W Lafayette, IN 47907 USA; [Gavande, Navnath S.; Ghosh, Arun K.] Purdue Univ, Dept Chem & Med Chem, W Lafayette, IN 47907 USA; [Ghosh, Arun K.; Weake, Vikki M.] Purdue Univ, Ctr Canc Res, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Weake, VM (corresponding author), Purdue Univ, Dept Biochem, 175 S Univ St, W Lafayette, IN 47907 USA.	vweake@purdue.edu	Weake, Vikki/A-5722-2018	Weake, Vikki/0000-0002-5933-9952; Gavande, Navnath/0000-0002-2413-0235	National Institutes of Health [P40OD018537, OD010949-10, P30 CA023168]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053386] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010949, P40OD018537] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The chif<SUP>ETBE3</SUP> flies were kindly provided by John Tower, and the cdc7-90 yeast strain was kindly provided by Ann Kirchmaier. We thank Jie Li and Xiaoqi Liu for assistance with the kinase assays. Fly stocks were from the Bloomington Drosophila Stock Center (supported by National Institutes of Health Grant P40OD018537); plasmids were from the Drosophila Genomics Resource Center (supported by National Institutes of Health Grant OD010949-10), and information was from FlyBase and FlyMine. NMR, mass spectrometry, and DNA sequencing data were acquired by core facilities supported by National Institutes of Health Grant P30 CA023168.	AXELROD A, 1991, MOL CELL BIOL, V11, P1080, DOI 10.1128/MCB.11.2.1080; BAHMAN M, 1988, BIOCHIM BIOPHYS ACTA, V951, P335, DOI 10.1016/0167-4781(88)90104-2; Baker SP, 2010, NAT CELL BIOL, V12, P294, DOI 10.1038/ncb2030; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Brown GW, 1998, J BIOL CHEM, V273, P22083, DOI 10.1074/jbc.273.34.22083; Bruck I, 2009, J BIOL CHEM, V284, P28823, DOI 10.1074/jbc.M109.039123; Bunt SM, 2012, GENESIS, V50, P914, DOI 10.1002/dvg.22341; Calvi BR, 1999, METHODS, V18, P407, DOI 10.1006/meth.1999.0799; Calvi BR, 1998, GENE DEV, V12, P734, DOI 10.1101/gad.12.5.734; CHAPMAN JW, 1989, EXP CELL RES, V180, P419, DOI 10.1016/0014-4827(89)90068-2; Cheng LA, 1999, MOL CELL BIOL, V19, P4270; Clontech Laboratories Inc., 2007, BACPAK BAC EXPR SYST; Davey MJ, 2011, G3-GENES GENOM GENET, V1, P317, DOI 10.1534/g3.111.000430; Davoli T, 2011, ANNU REV CELL DEV BI, V27, P585, DOI 10.1146/annurev-cellbio-092910-154234; DePamphilis ML, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00368; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Faul T, 1999, CHROMOSOMA, V108, P26, DOI 10.1007/s004120050348; FEGER G, 1995, EMBO J, V14, P5387, DOI 10.1002/j.1460-2075.1995.tb00223.x; Ferreira MG, 2000, MOL CELL BIOL, V20, P242; Follette PJ, 1998, CURR BIOL, V8, P235, DOI 10.1016/S0960-9822(98)70089-2; Fox DT, 2013, DEVELOPMENT, V140, P3, DOI 10.1242/dev.080531; Francis LI, 2009, GENE DEV, V23, P643, DOI 10.1101/gad.1759609; Furukohri A, 2003, J BIOCHEM, V134, P447, DOI 10.1093/jb/mvg163; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Guo BQ, 1999, SOMAT CELL MOLEC GEN, V25, P159, DOI 10.1023/A:1018841506868; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Hess GF, 1998, GENE, V211, P133, DOI 10.1016/S0378-1119(98)00094-8; HOLLINGSWORTH RE, 1990, P NATL ACAD SCI USA, V87, P6272, DOI 10.1073/pnas.87.16.6272; Hong A, 2007, EMBO J, V26, P2071, DOI 10.1038/sj.emboj.7601648; Hughes S, 2012, NAT STRUCT MOL BIOL, V19, P1101, DOI 10.1038/nsmb.2404; Hughes S, 2010, J BIOL CHEM, V285, P541, DOI 10.1074/jbc.M109.036491; JACKSON AL, 1993, MOL CELL BIOL, V13, P2899, DOI 10.1128/MCB.13.5.2899; Jares P, 2004, BMC MOL BIOL, V5, DOI 10.1186/1471-2199-5-5; Jares P, 2000, GENE DEV, V14, P1528; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; JOHNSTON LH, 1982, MOL GEN GENET, V186, P445, DOI 10.1007/BF00729467; Kim JM, 1998, J BIOL CHEM, V273, P23248, DOI 10.1074/jbc.273.36.23248; Kim JM, 2002, EMBO J, V21, P2168, DOI 10.1093/emboj/21.9.2168; KITADA K, 1992, GENETICS, V131, P21; Kitamura R, 2011, J BIOL CHEM, V286, P23031, DOI 10.1074/jbc.M111.243311; KNOBLICH JA, 1994, CELL, V77, P107, DOI 10.1016/0092-8674(94)90239-9; Koltun ES, 2012, BIOORG MED CHEM LETT, V22, P3727, DOI 10.1016/j.bmcl.2012.04.024; Kumagai H, 1999, MOL CELL BIOL, V19, P5083; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Lake CM, 2007, GENETICS, V176, P2151, DOI 10.1534/genetics.107.073551; Landis G, 1999, DEVELOPMENT, V126, P4281; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; Lepke M, 1999, MOL GEN GENET, V262, P220, DOI 10.1007/s004380051078; Lilly MA, 1996, GENE DEV, V10, P2514, DOI 10.1101/gad.10.19.2514; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Marston AL, 2009, CURR BIOL, V19, pR74, DOI 10.1016/j.cub.2008.12.003; Masai H, 2000, BIOCHEM BIOPH RES CO, V275, P228, DOI 10.1006/bbrc.2000.3281; MASAI H, 1995, EMBO J, V14, P3094, DOI 10.1002/j.1460-2075.1995.tb07312.x; Masai H, 2002, J CELL PHYSIOL, V190, P287, DOI 10.1002/jcp.10070; Masai H, 2000, J BIOL CHEM, V275, P29042, DOI 10.1074/jbc.M002713200; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Matthews LA, 2013, CELL CYCLE, V12, P1180, DOI 10.4161/cc.24416; Montagnoli A, 2002, EMBO J, V21, P3171, DOI 10.1093/emboj/cdf290; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Nakamura T, 2000, GENES CELLS, V5, P463, DOI 10.1046/j.1365-2443.2000.00343.x; Nakamura T, 2002, MOL CELL BIOL, V22, P309, DOI 10.1128/MCB.22.1.309-320.2002; Ogino K, 2001, J BIOL CHEM, V276, P31376, DOI 10.1074/jbc.M102197200; Park SY, 2008, P NATL ACAD SCI USA, V105, P12343, DOI 10.1073/pnas.0805189105; PATTERSON M, 1986, MOL CELL BIOL, V6, P1590, DOI 10.1128/MCB.6.5.1590; Perrimon N, 1998, INT J DEV BIOL, V42, P243; Peter A, 2002, EMBO REP, V3, P34, DOI 10.1093/embo-reports/kvf012; Ramer MD, 2013, J BIOL CHEM, V288, P14926, DOI 10.1074/jbc.M112.392910; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Roberts BT, 1999, P NATL ACAD SCI USA, V96, P2800, DOI 10.1073/pnas.96.6.2800; Sacco E, 2012, BIOTECHNOL ADV, V30, P73, DOI 10.1016/j.biotechadv.2011.09.009; Sato N, 2003, GENES CELLS, V8, P451, DOI 10.1046/j.1365-2443.2003.00647.x; Sato N, 1997, EMBO J, V16, P4340, DOI 10.1093/emboj/16.14.4340; Schwed G, 2002, MOL BIOL CELL, V13, P607, DOI 10.1091/mbc.01-08-0400; Sclafani RA, 2000, J CELL SCI, V113, P2111; Sher N, 2012, GENOME RES, V22, P64, DOI 10.1101/gr.126003.111; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Shi N, 2012, J BIOL CHEM, V287, P6860, DOI 10.1074/jbc.M111.306209; SIKORSKI RS, 1989, GENETICS, V122, P19; Silva T, 2006, J BIOL CHEM, V281, P11569, DOI 10.1074/jbc.M510278200; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; Su TT, 1998, J CELL BIOL, V140, P451, DOI 10.1083/jcb.140.3.451; Su TT, 1996, MOL BIOL CELL, V7, P319, DOI 10.1091/mbc.7.2.319; Takahashi TS, 2005, GENE DEV, V19, P2295, DOI 10.1101/gad.1339805; Takeda T, 1999, MOL CELL BIOL, V19, P5535; Tanaka S, 2010, CHROMOSOMA, V119, P565, DOI 10.1007/s00412-010-0291-8; Theodosiou NA, 1998, METHODS, V14, P355, DOI 10.1006/meth.1998.0591; Tower J, 2004, ANNU REV GENET, V38, P273, DOI 10.1146/annurev.genet.37.110801.143851; TREISMAN JE, 1995, GENE DEV, V9, P1709, DOI 10.1101/gad.9.14.1709; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Walter JC, 2000, J BIOL CHEM, V275, P39773, DOI 10.1074/jbc.M008107200; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Weiss A, 1998, CURR BIOL, V8, P239, DOI 10.1016/S0960-9822(98)70090-9; Yanow SK, 2003, J BIOL CHEM, V278, P41083, DOI 10.1074/jbc.M307144200; YOON HJ, 1993, MOL BIOL CELL, V4, P195, DOI 10.1091/mbc.4.2.195; Yoshizawa-Sugata N, 2005, J BIOL CHEM, V280, P13062, DOI 10.1074/jbc.M411653200; Zhang HJ, 2004, DEVELOPMENT, V131, P2089, DOI 10.1242/dev.01064	101	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1332	1347		10.1074/jbc.M114.597948	http://dx.doi.org/10.1074/jbc.M114.597948			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25451925	hybrid, Green Published			2022-12-26	WOS:000348056400004
J	Kalderon, Z; Kumar, S; Engelberg-Kulka, H				Kalderon, Ziva; Kumar, Sathish; Engelberg-Kulka, Hanna			The SOS Response is Permitted in Escherichia coli Strains Deficient in the Expression of the mazEF Pathway	PLOS ONE			English	Article							MEDIATED CELL-DEATH; BACTERIOPHAGE-LAMBDA; MESSENGER-RNAS; MUTATION; MODULE	The Escherichia coli (E. coli) SOS response is the largest, most complex, and best characterized bacterial network induced by DNA damage. It is controlled by a complex network involving the RecA and LexA proteins. We have previously shown that the SOS response to DNA damage is inhibited by various elements involved in the expression of the E. coli toxin-antitoxin mazEF pathway. Since the mazEF module is present on the chromosomes of most E. coli strains, here we asked: Why is the SOS response found in so many E. coli strains? Is the mazEF module present but inactive in those strains? We examined three E. coli strains used for studies of the SOS response, strains AB1932, BW25113, and MG1655. We found that each of these strains is either missing or inhibiting one of several elements involved in the expression of the mazEF-mediated death pathway. Thus, the SOS response only takes place in E. coli cells in which one or more elements of the E. coli toxin-antitoxin module mazEF or its downstream pathway is not functioning.	[Kalderon, Ziva; Kumar, Sathish; Engelberg-Kulka, Hanna] Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Microbiol & Mol Genet, IL-91010 Jerusalem, Israel	Hebrew University of Jerusalem	Engelberg-Kulka, H (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, IMRIC, Dept Microbiol & Mol Genet, IL-91010 Jerusalem, Israel.	hanita@cc.huji.il	Kumar, Sathish/L-1367-2019; Kumar, Sathish/Y-9397-2018	Kumar, Sathish/0000-0001-8875-9537	Israel Science Foundation [66/10]; United States Army [W911NF-09-1-0212]	Israel Science Foundation(Israel Science Foundation); United States Army(United States Department of DefenseUnited States Army)	Funding: This work was supported by the Israel Science Foundation (grant 66/10) and the United States Army (grant W911NF-09-1-0212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenman E, 1996, P NATL ACAD SCI USA, V93, P6059, DOI 10.1073/pnas.93.12.6059; Amitai S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000390; Beaber JW, 2004, NATURE, V427, P72, DOI 10.1038/nature02241; BELFORT M, 1978, J VIROL, V28, P270, DOI 10.1128/JVI.28.1.270-278.1978; Belitsky M, 2011, MOL CELL, V41, P625, DOI 10.1016/j.molcel.2011.02.023; Courcelle J, 2001, GENETICS, V158, P41; Datsenko A, 2005, P NATL ACAD SCI USA, V97, P6640; Davies BW, 2009, MOL CELL, V36, P845, DOI 10.1016/j.molcel.2009.11.024; Engelberg-Kulka H, 1998, P NATL ACAD SCI USA, V95, P15481, DOI 10.1073/pnas.95.26.15481; Engelberg-Kulka H, 2005, J CELL SCI, V118, P4327, DOI 10.1242/jcs.02619; Erental A, 2014, MBIO, V5, DOI 10.1128/mBio.01426-14; Erental A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001281; Fernandez de Henestrosa AR, 2000, MOL MICROBIOL, V35, P1560, DOI 10.1046/j.1365-2958.2000.01826.x; HAYES S, 1973, MOL GEN GENET, V126, P275, DOI 10.1007/BF00269438; Hazan R, 2004, J BACTERIOL, V186, P3663, DOI 10.1128/JB.186.11.3663-3669.2004; Hersh MN, 2004, RES MICROBIOL, V155, P352, DOI 10.1016/j.resmic.2004.01.020; Kolodkin-Gal A, 2008, J BACTERIOL, V190, P3169, DOI 10.1128/JB.01918-07; Kolodkin-Gal I, 2007, SCIENCE, V318, P652, DOI 10.1126/science.1147248; LANDSMANN J, 1982, GENE, V20, P11, DOI 10.1016/0378-1119(82)90083-X; LITTLE JW, 1984, P NATL ACAD SCI-BIOL, V81, P1375, DOI 10.1073/pnas.81.5.1375; LITTLE JW, 1991, BIOCHIMIE, V73, P411, DOI 10.1016/0300-9084(91)90108-D; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; METZGER S, 1989, J BIOL CHEM, V264, P21146; Mittenhuber Gerhard, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P295; Moolenaar GF, 2002, P NATL ACAD SCI USA, V99, P1467, DOI 10.1073/pnas.032584099; MOUNT DW, 1972, J BACTERIOL, V112, P886, DOI 10.1128/JB.112.2.886-893.1972; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Sutton MD, 2000, ANNU REV GENET, V34, P479, DOI 10.1146/annurev.genet.34.1.479; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; Walker GC., 1996, E COLI SALMONELLA CE, V2, P1400; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	31	5	5	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114380	10.1371/journal.pone.0114380	http://dx.doi.org/10.1371/journal.pone.0114380			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470502	Green Submitted, Green Published, gold			2022-12-26	WOS:000349128700111
J	Pan, H; He, MH; Liu, RX; Brecha, NC; Yu, ACH; Pu, ML				Pan, Hong; He, Meihua; Liu, Ruixing; Brecha, Nicholas C.; Yu, Albert Cheung Hoi; Pu, Mingliang			Sulforaphane Protects Rodent Retinas against Ischemia-Reperfusion Injury through the Activation of the Nrf2/HO-1 Antioxidant Pathway	PLOS ONE			English	Article							NRF2-DEPENDENT PHASE-2 ENZYME; OXIDATIVE STRESS; HEME OXYGENASE-1; ISCHEMIA/REPERFUSION INJURY; PHARMACOLOGICAL INDUCTION; CALCIUM DOBESILATE; RESPONSE ELEMENT; KAPPA-B; CELLS; GENE	Retinal ischemia-reperfusion (I/R) injury induces oxidative stress, leukocyte infiltration, and neuronal cell death. Sulforaphane (SF), which can be obtained in cruciferous vegetables such as broccoli, exerts protective effects in response to oxidative stress in various tissues. These effects can be initiated through nuclear factor E2-related factor 2 (Nrf2)-mediated induction of heme oxygenase-1 (HO-1). This investigation was designed to elucidate the neural protective mechanisms of SF in the retinal I/R rat model. Animals were intraperitoneally (i.p.) injected with SF (12.5 mg/kg) or vehicle (corn oil) once a day for 7 consecutive days. Then, retinal I/R was made by elevating the intraocular pressure (IOP) to 130 mmHg for 1 h. To determine if HO-1 was involved in the Nrf2 antioxidant pathway, rats were subjected to protoporphyrin IX zinc (II) (ZnPP, 30 mg/kg, i.p.) treatments at 24 h before retinal ischemia. The neuroprotective effects of SF were assessed by determining the morphology of the retina, counting the infiltrating inflammatory cells and the surviving retinal ganglion cells (RGCs) and amacrine cells, and measuring apoptosis in the retinal layers. The expression of Nrf2 and HO-1 was studied by immunofluorescence analysis and western blotting. I/R induced a marked increase of ROS generation, caused pronounced inflammation, increased the apoptosis of RGCs and amacrine cells and caused the thinning of the inner retinal layer (IRL), and these effects were diminished or abolished by SF pretreatment. Meanwhile, SF pretreatment significantly elevated the nuclear accumulation of Nrf2 and the level of HO-1 expression in the I/R retinas; however, ZnPP reversed the protective effects of SF on I/R retinas. Together, we offer direct evidence that SF had protective effects on I/R retinas, which could be attributed, at least in part, to the activation of the Nrf2/HO-1 antioxidant pathway.	[Pan, Hong; Yu, Albert Cheung Hoi] Peking Univ, Neurosci Res Inst, Dept Neurobiol, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Pan, Hong; He, Meihua; Liu, Ruixing; Pu, Mingliang] Peking Univ, Dept Anat Embryol, Sch Basic Med Sci, Beijing 100871, Peoples R China; [Pan, Hong] Binzhou Med Coll, Dept Phys, Yantai, Shandong, Peoples R China; [Pan, Hong; He, Meihua; Liu, Ruixing; Pu, Mingliang] Peking Univ, Key Lab Machine Percept, Minist Educ, Beijing 100871, Peoples R China; [Pan, Hong; He, Meihua; Liu, Ruixing; Pu, Mingliang] Peking Univ, Key Lab Visual Impairment & Restorat, Minist Educ, Beijing 100871, Peoples R China; [Brecha, Nicholas C.] Univ Calif Los Angeles, Dept Med, David Geffen Sch Med Los Angeles, Jules Stein Eye Inst,CURE Digest Dis Res Ctr,Dept, Los Angeles, CA 90024 USA; [Brecha, Nicholas C.] Vet Adm Greater Los Angeles Hlth Syst, Los Angeles, CA USA	Peking University; Peking University; Binzhou Medical University; Peking University; Peking University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Pu, ML (corresponding author), Peking Univ, Dept Anat Embryol, Sch Basic Med Sci, Beijing 100871, Peoples R China.	mpu@hsc.pku.edu.cn	He, Meihua/D-4312-2017		National Basic Research Program of China (973 Program) [2011CB510206]; National Science Foundation of China [30831160516, 81200691]; Ministry of Education of China [20090001120075]; Azalea Endowment Fund; Fundamental Research Fund for the Central Universities [21609101]; NIH [EY04067]; VA Merit Review; NATIONAL EYE INSTITUTE [R56EY004067, R01EY004067] Funding Source: NIH RePORTER	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Azalea Endowment Fund; Fundamental Research Fund for the Central Universities; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Review(US Department of Veterans Affairs); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by grants obtained from the National Basic Research Program of China (973 Program, 2011CB510206 [MP]), the National Science Foundation of China (30831160516 [MP] and 81200691 [MH]), the Ministry of Education of China (20090001120075 [MH]), Azalea (1972) Endowment Fund (KS & RC), and the Fundamental Research Fund for the Central Universities (21609101, KS), NIH EY04067 (NCB) and VA Merit Review (NB). NCB is a VA Career Research Scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alp H, 2012, EUR REV MED PHARMACO, V16, P144; Arai-Gaun S, 2004, INVEST OPHTH VIS SCI, V45, P4226, DOI 10.1167/iovs.04-0450; Berberat PO, 2003, FASEB J, V17, P1724, DOI 10.1096/fj.03-0229fje; Cekauskas A, 2013, ANN TRANSPL, V18, P488, DOI 10.12659/AOT.884013; Chao HM, 2013, J OCUL PHARMACOL TH, V29, P539, DOI 10.1089/jop.2012.0179; Da T, 2004, INVEST OPHTH VIS SCI, V45, P4477, DOI 10.1167/iovs.04-0940; Dvoriantchikova G, 2012, INVEST OPHTH VIS SCI, V53, P2823, DOI 10.1167/iovs.12-9526; Guerrero-Beltran CE, 2012, J NUTR BIOCHEM, V23, P494, DOI 10.1016/j.jnutbio.2011.02.004; Fan JW, 2012, INVEST OPHTH VIS SCI, V53, P6541, DOI 10.1167/iovs.11-9241; Fang IM, 2013, EXP EYE RES, V113, P49, DOI 10.1016/j.exer.2013.05.007; Gao XQ, 2004, P NATL ACAD SCI USA, V101, P10446, DOI 10.1073/pnas.0403886101; Gunhan E, 2002, J NEUROSCI, V22, P2265, DOI 10.1523/JNEUROSCI.22-06-02265.2002; He MH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084800; He MH, 2013, INVEST OPHTH VIS SCI, V54, P4092, DOI 10.1167/iovs.13-12004; Ho YS, 2010, J ALZHEIMERS DIS, V19, P813, DOI 10.3233/JAD-2010-1280; Hornberg H, 2013, J NEUROSCI, V33, P10384, DOI 10.1523/JNEUROSCI.5858-12.2013; Hong Seong Min, 2012, Korean J Ophthalmol, V26, P248, DOI 10.3341/kjo.2012.26.4.248; Ishizuka F, 2013, INVEST OPHTH VIS SCI, V54, P5807, DOI 10.1167/iovs.13-11932; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jeong WS, 2006, ANTIOXID REDOX SIGN, V8, P99, DOI 10.1089/ars.2006.8.99; Kang KW, 2005, ANTIOXID REDOX SIGN, V7, P1664, DOI 10.1089/ars.2005.7.1664; Kaur C, 2008, PROG RETIN EYE RES, V27, P622, DOI 10.1016/j.preteyeres.2008.09.003; Kleszczynski K, 2013, PHARMACOL RES, V78, P28, DOI 10.1016/j.phrs.2013.09.009; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Kong L, 2007, J NEUROCHEM, V101, P1041, DOI 10.1111/j.1471-4159.2007.04481.x; Kusari J, 2011, INVEST OPHTH VIS SCI, V52, P5424, DOI 10.1167/iovs.10-6262; Kwong JMK, 2011, INVEST OPHTH VIS SCI, V52, P9694, DOI 10.1167/iovs.11-7869; Leal EC, 2010, DIABETES, V59, P2637, DOI 10.2337/db09-1421; Li JB, 2014, CELL BIOCHEM BIOPHYS, V68, P275, DOI 10.1007/s12013-013-9707-4; Liu Y, 2012, FREE RADICAL BIO MED, V52, P909, DOI 10.1016/j.freeradbiomed.2011.12.013; McMahon M, 2004, J BIOL CHEM, V279, P31556, DOI 10.1074/jbc.M403061200; Mi XS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045469; Nakao A, 2005, AM J TRANSPLANT, V5, P282, DOI 10.1111/j.1600-6143.2004.00695.x; Nerland DE, 2007, DRUG METAB REV, V39, P235, DOI 10.1080/03602530601125000; Oharazawa H, 2010, INVEST OPHTH VIS SCI, V51, P487, DOI 10.1167/iovs.09-4089; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Owuor ED, 2002, BIOCHEM PHARMACOL, V64, P765, DOI 10.1016/S0006-2952(02)01137-1; Park J, 2013, EUR J PHARMACOL, V707, P61, DOI 10.1016/j.ejphar.2013.03.026; Piao CS, 2010, PHARMACOL RES, V61, P342, DOI 10.1016/j.phrs.2009.11.009; Pickering AM, 2012, J BIOL CHEM, V287, P10021, DOI 10.1074/jbc.M111.277145; Ping Z, 2010, BRAIN RES, V1343, P178, DOI 10.1016/j.brainres.2010.04.036; Poss KD, 1997, P NATL ACAD SCI USA, V94, P10925, DOI 10.1073/pnas.94.20.10925; Ren JW, 2011, NEUROCHEM RES, V36, P2352, DOI 10.1007/s11064-011-0561-8; Sakamoto K, 2009, EXP EYE RES, V88, P974, DOI 10.1016/j.exer.2008.12.011; Satoh T, 2006, P NATL ACAD SCI USA, V103, P768, DOI 10.1073/pnas.0505723102; Shah ZA, 2010, J CEREBR BLOOD F MET, V30, P1951, DOI 10.1038/jcbfm.2010.53; Shima C, 2012, OPHTHALMIC RES, V48, P199, DOI 10.1159/000340059; Sun MH, 2010, INVEST OPHTH VIS SCI, V51, P4798, DOI 10.1167/iovs.09-4086; Szabo ME, 2001, EUR J PHARMACOL, V428, P277, DOI 10.1016/S0014-2999(01)01196-7; Tanito M, 2005, INVEST OPHTH VIS SCI, V46, P979, DOI 10.1167/iovs.04-1120; Tsuji Y, 2005, ONCOGENE, V24, P7567, DOI 10.1038/sj.onc.1208901; Wang LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023194; Wei YH, 2011, FREE RADICAL BIO MED, V51, P216, DOI 10.1016/j.freeradbiomed.2011.04.026; Yang LP, 2007, INVEST OPHTH VIS SCI, V48, P4766, DOI 10.1167/iovs.06-0871; Yoon HY, 2008, BIOCHEM PHARMACOL, V75, P2214, DOI 10.1016/j.bcp.2008.02.029; ZHANG YS, 1992, P NATL ACAD SCI USA, V89, P2399, DOI 10.1073/pnas.89.6.2399; ZHANG YS, 1994, P NATL ACAD SCI USA, V91, P3147, DOI 10.1073/pnas.91.8.3147; Zhang ZZ, 2012, CURR EYE RES, V37, P429, DOI 10.3109/02713683.2011.653616; Zhao HD, 2010, WORLD J GASTROENTERO, V16, P3002, DOI 10.3748/wjg.v16.i24.3002; Zheng HT, 2011, DIABETES, V60, P3055, DOI 10.2337/db11-0807	60	54	61	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114186	10.1371/journal.pone.0114186	http://dx.doi.org/10.1371/journal.pone.0114186			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470382	gold, Green Submitted, Green Published			2022-12-26	WOS:000349128700082
J	Thanassekos, S; Cox, MJ; Reid, K				Thanassekos, Stephane; Cox, Martin J.; Reid, Keith			Investigating the Effect of Recruitment Variability on Length-Based Recruitment Indices for Antarctic Krill Using an Individual-Based Population Dynamics Model	PLOS ONE			English	Article							SOUTH SHETLAND ISLANDS; EUPHAUSIA-SUPERBA; BIOMASS; DENSITY; GROWTH; MORTALITY; ECOSYSTEM; LINKS; AGE	Antarctic krill (Euphausia superba; herein krill) is monitored as part of an on-going fisheries observer program that collects length-frequency data. A krill feedback management programme is currently being developed, and as part of this development, the utility of data-derived indices describing population level processes is being assessed. To date, however, little work has been carried out on the selection of optimum recruitment indices and it has not been possible to assess the performance of length-based recruitment indices across a range of recruitment variability. Neither has there been an assessment of uncertainty in the relationship between an index and the actual level of recruitment. Thus, until now, it has not been possible to take into account recruitment index uncertainty in krill stock management or when investigating relationships between recruitment and environmental drivers. Using length-frequency samples from a simulated population - where recruitment is known - the performance of six potential length-based recruitment indices is assessed, by exploring the index-to-recruitment relationship under increasing levels of recruitment variability (from +/- 10% to +/- 100% around a mean annual recruitment). The annual minimum of the proportion of individuals smaller than 40 mm (F40 min, %) was selected because it had the most robust index-to-recruitment relationship across differing levels of recruitment variability. The relationship was curvilinear and best described by a power law. Model uncertainty was described using the 95% prediction intervals, which were used to calculate coverage probabilities and assess model performance. Despite being the optimum recruitment index, the performance of F40 min degraded under high (>50%) recruitment variability. Due to the persistence of cohorts in the population over several years, the inclusion of F40 min values from preceding years in the relationship used to estimate recruitment in a given year improved its accuracy (mean bias reduction of 8.3% when including three F40 min values under a recruitment variability of 60%).	[Thanassekos, Stephane; Reid, Keith] Commiss Conservat Antarct Marine Living Resources, Hobart, Tas, Australia; [Cox, Martin J.] Southern Ocean Ecosyst Change, Australian Antarct Div, Kingston, Tas, Australia	Australian Antarctic Division	Thanassekos, S (corresponding author), Virginia Inst Marine Sci, Coll William & Mary, Gloucester Point, VA 23062 USA.	thanassekos@vims.edu			Australian Research Council [FS110200057]	Australian Research Council(Australian Research Council)	MJC is funded by the Australian Research Council's 'Superscience' fellowship scheme FS110200057 (http://www.arc.gov.au/ncgp/ssf/ssf_default.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson A, 2009, DEEP-SEA RES PT I, V56, P727, DOI 10.1016/j.dsr.2008.12.007; CCAMLR, 2013, 32 M SCI COMM HOB; Constable AJ, 2012, REP WORK GR ECOSYST; Coulson T, 2001, SCIENCE, V292, P1528, DOI 10.1126/science.292.5521.1528; de la Mare W., 1994, CCAMLR SCI, V1, P55; Hewitt RP, 2003, AQUAT LIVING RESOUR, V16, P205, DOI 10.1016/S0990-7440(03)00019-6; Houde Edward D., 2002, P64; Kawaguchi S, 2009, FISHERIES MANAG ECOL, V16, P424, DOI 10.1111/j.1365-2400.2009.00686.x; Kawaguchi S, 2007, MAR ECOL PROG SER, V345, P199, DOI 10.3354/meps06934; Kinzey D, 2013, CCAMLR SCI, V20, P81; Kinzey D, 2011, WGEMM1143; Krag LA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102168; Loeb V, 1997, NATURE, V387, P897, DOI 10.1038/43174; Murphy EJ, 2007, PHILOS T R SOC B, V362, P113, DOI 10.1098/rstb.2006.1957; Nicol S, 2000, NATURE, V406, P504, DOI 10.1038/35020053; Nicol S, 2000, CAN J FISH AQUAT SCI, V57, P168, DOI 10.1139/cjfas-57-S3-168; Nicol S, 2006, BIOSCIENCE, P56; Nicol S, 2012, FISH FISH, V13, P30, DOI 10.1111/j.1467-2979.2011.00406.x; Quetin LB, 2003, MAR ECOL PROG SER, V259, P185, DOI 10.3354/meps259185; R Core Team, 2014, R LANG ENV STAT COMP, DOI [10.4000/etudesromanes.3205, DOI 10.4000/ETUDESROMANES.3205]; Reid K, 2010, MAR ECOL PROG SER, V399, P243, DOI 10.3354/meps08356; Reiss CS, 2008, ICES J MAR SCI, V65, P497, DOI 10.1093/icesjms/fsn033; ROSENBERG AA, 1986, NATURE, V324, P152, DOI 10.1038/324152a0; Siegel V, 1998, POLAR BIOL, V19, P393, DOI 10.1007/s003000050264; SIEGEL V, 1987, MAR BIOL, V96, P483, DOI 10.1007/BF00397966; SIEGEL V, 1995, MAR ECOL PROG SER, V123, P45, DOI 10.3354/meps123045; Siegel V, 2000, CAN J FISH AQUAT SCI, V57, P130, DOI 10.1139/cjfas-57-S3-130; Siegel V., 1997, CCAMLR Science, V4, P19; Trivelpiece WZ, 2011, P NATL ACAD SCI USA, V108, P7625, DOI 10.1073/pnas.1016560108; Wiedenmann J, 2009, LIMNOL OCEANOGR, V54, P799, DOI 10.4319/lo.2009.54.3.0799; Ziegler PE, 2011, CCAMLR SCI, V18, P57	31	2	2	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114378	10.1371/journal.pone.0114378	http://dx.doi.org/10.1371/journal.pone.0114378			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470296	Green Published, gold			2022-12-26	WOS:000349128700109
J	Becker, K; Hahn, CM; Saghafi, S; Jahrling, N; Wanis, M; Dodt, HU				Becker, Klaus; Hahn, Christian Markus; Saghafi, Saiedeh; Jaehrling, Nina; Wanis, Martina; Dodt, Hans-Ulrich			Reduction of Photo Bleaching and Long Term Archiving of Chemically Cleared GFP-Expressing Mouse Brains	PLOS ONE			English	Article							EPOXY-RESIN; MICROSCOPY; SECTIONS	Tissue clearing allows microscopy of large specimens as whole mouse brains or embryos. However, lipophilic tissue clearing agents as dibenzyl ether limit storage time of GFP-expressing samples to several days and do not prevent them from photobleaching during microscopy. To preserve GFP fluorescence, we developed a transparent solid resin formulation, which maintains the specimens' transparency and provides a constant signal to noise ratio even after hours of continuous laser irradiation. If required, high-power illumination or long exposure times can be applied with virtually no loss in signal quality and samples can be archived for years.	[Becker, Klaus; Hahn, Christian Markus; Saghafi, Saiedeh; Jaehrling, Nina; Wanis, Martina; Dodt, Hans-Ulrich] Vienna Univ Technol, FKE, Chair Bioelect, A-1040 Vienna, Austria; [Becker, Klaus; Hahn, Christian Markus; Saghafi, Saiedeh; Jaehrling, Nina; Wanis, Martina; Dodt, Hans-Ulrich] Med Univ Vienna, Ctr Brain Res, Vienna, Austria	Technische Universitat Wien; Medical University of Vienna	Becker, K (corresponding author), Vienna Univ Technol, FKE, Chair Bioelect, A-1040 Vienna, Austria.	klaus.becker@tuwien.ac.at		saghafi, saiedeh/0000-0002-7598-541X; Becker, Klaus/0000-0002-2406-0476	Austrian "Fonds zur Forderung der wissenschaftlichen Forschung'' (FWF); Austrian Science Fund (FWF) [P 23102] Funding Source: researchfish	Austrian "Fonds zur Forderung der wissenschaftlichen Forschung'' (FWF)(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Austrian "Fonds zur Forderung der wissenschaftlichen Forschung'' (FWF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alnuami AA, 2008, INT J BIOL MACROMOL, V43, P182, DOI 10.1016/j.ijbiomac.2008.05.002; Becker K, 2012, PLOS ONE, V7; Brorson SH, 1998, MICRON, V29, P89, DOI 10.1016/S0968-4328(98)00010-9; CAVEY MJ, 1993, T AM MICROSC SOC, V112, P81, DOI 10.2307/3226787; DENT JA, 1989, DEVELOPMENT, V105, P61; Dodt HU, 2007, NAT METHODS, V4, P331, DOI 10.1038/NMETH1036; EICHEL FG, 1949, IND ENG CHEM, V41, P2623, DOI 10.1021/ie50479a054; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Groos S, 2001, J HISTOCHEM CYTOCHEM, V49, P397, DOI 10.1177/002215540104900313; Hardie NA, 2004, BRAIN RES, V1000, P200, DOI 10.1016/j.brainres.2003.10.071; Lee H, 1981, HDB RESINS; Lockwood WR, 1964, ANAT REC; Luft J, 1961, CYTOLOGY, V9, P409; Murray JM, 2007, J MICROSCOPY, V228, P30; SPURR AR, 1969, J ULTRA MOL STRUCT R, V26, P31, DOI 10.1016/S0022-5320(69)90033-1; Tuchin VV, 2005, J PHYS D APPL PHYS, V38, P2497, DOI 10.1088/0022-3727/38/15/001; Willig KI, 2006, NAT METHODS, V3, P721, DOI 10.1038/NMETH922	17	14	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114149	10.1371/journal.pone.0114149	http://dx.doi.org/10.1371/journal.pone.0114149			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463047	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700108
J	Lu, S; Ren, TS; Lu, YL; Meng, P; Sun, SY				Lu, Sen; Ren, Tusheng; Lu, Yili; Meng, Ping; Sun, Shiyou			Extrapolative Capability of Two Models That Estimating Soil Water Retention Curve between Saturation and Oven Dryness	PLOS ONE			English	Article							DESCRIBE; EQUATION	Accurate estimation of soil water retention curve (SWRC) at the dry region is required to describe the relation between soil water content and matric suction from saturation to oven dryness. In this study, the extrapolative capability of two models for predicting the complete SWRC from limited ranges of soil water retention data was evaluated. When the model parameters were obtained from SWRC data in the 0-1500 kPa range, the FX model (Fredlund and Xing, 1994) estimations agreed well with measurements from saturation to oven dryness with RMSEs less than 0.01. The GG model (Groenevelt and Grant, 2004) produced larger errors at the dry region, with significantly larger RMSEs and MEs than the FX model. Further evaluations indicated that when SWRC measurements in the 0-100 kPa suction range was applied for model establishment, the FX model was capable of producing acceptable SWRCs across the entire water content range. For a higher accuracy, the FX model requires soil water retention data at least in the 0- to 300-kPa range to extend the SWRC to oven dryness. Comparing with the Khlosi et al. (2006) model, which requires measurements in the 0-500 kPa range to reproduce the complete SWRCs, the FX model has the advantage of requiring less SWRC measurements. Thus the FX modeling approach has the potential to eliminate the processes for measuring soil water retention in the dry range.	[Lu, Sen; Meng, Ping] Chinese Acad Forestry, Res Inst Forestry, State Forestry Adm, Key Lab Tree Breeding & Cultivat, Beijing 100091, Peoples R China; [Lu, Sen; Meng, Ping] Nanjing Forestry Univ, Collaborat Innovat Ctr Sustaintable Forestry Sout, Nanjing 210037, Jiangsu, Peoples R China; [Ren, Tusheng; Lu, Yili] China Agr Univ, Dept Soil & Water, Beijing 100193, Peoples R China; [Sun, Shiyou] Hebei Acad Agr & Forestry Sci, Inst Agroresources & Environm, Shijiazhuang 050051, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; Nanjing Forestry University; China Agricultural University; Hebei Academy of Agricultural & Forestry Sciences	Ren, TS (corresponding author), China Agr Univ, Dept Soil & Water, Beijing 100193, Peoples R China.	tsren@cau.edu.cn	Lu, Yili/AAQ-2041-2020	Lu, Yili/0000-0001-7716-7173	Natural Science Foundation of China [41371240]; Beijing Natural Science Foundation [6133035]; Basic Research Fund of RIF [RIF2014-09]; CFERN & GENE Award Funds on Ecological Paper	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Basic Research Fund of RIF; CFERN & GENE Award Funds on Ecological Paper	This study was funded by the Natural Science Foundation of China (No. 41371240), the Beijing Natural Science Foundation (No. 6133035), the Basic Research Fund of RIF (No. RIF2014-09), and the CFERN & GENE Award Funds on Ecological Paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders are not linked in any way to a profit making organization.	Campbell G., 1992, P INT WORKSH IND MET, P317; FAYER MJ, 1995, WATER RESOUR RES, V31, P1233, DOI 10.1029/95WR00173; FREDLUND DG, 1994, CAN GEOTECH J, V31, P521, DOI 10.1139/t94-061; Groenevelt PH, 2004, EUR J SOIL SCI, V55, P479, DOI 10.1111/j.1365-2389.2004.00617.x; Khlosi M, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004699; Khlosi M, 2008, VADOSE ZONE J, V7, P87, DOI 10.2136/vzj2007.0099; Lu S, 2008, SOIL SCI SOC AM J, V72, P1542, DOI 10.2136/sssaj2007.0307N; PREBBLE RE, 1991, 113 CSIRO DIV SOILS; ROSS PJ, 1991, SOIL SCI SOC AM J, V55, P923, DOI 10.2136/sssaj1991.03615995005500040004x; ROSSI C, 1994, WATER RESOUR RES, V30, P701, DOI 10.1029/93WR03238; Schneider M, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR011049; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Wang HF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059475; Webb SW, 2000, WATER RESOUR RES, V36, P1425, DOI 10.1029/2000WR900057; Wolfram S., 2003, MATH BOOK	15	6	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113518	10.1371/journal.pone.0113518	http://dx.doi.org/10.1371/journal.pone.0113518			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464503	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700034
J	van de Put, MAJ; Hoeksema, L; Wanders, W; Nolte, IM; Hooymans, JMM; Los, LI				van de Put, Mathijs A. J.; Hoeksema, Lisette; Wanders, Wouter; Nolte, Ilja M.; Hooymans, Johanna M. M.; Los, Leonoor I.			Postoperative Vision-Related Quality of Life in Macula-Off Rhegmatogenous Retinal Detachment Patients and Its Relation to Visual Function	PLOS ONE			English	Article							FUNCTION QUESTIONNAIRE; CONTRAST SENSITIVITY; HOLE SURGERY; VITRECTOMY; CLASSIFICATION; RECOVERY; DURATION; HEIGHT	Objective: To determine the vision-related quality of life (VR-QOL) after surgery for macula-off rhegmatogenous retinal detachment (RRD) in relation to visual acuity, contrast acuity, and color vision. Methods: In a prospective observational study, we included 55 patients with a macula-off RRD. Best corrected visual acuity (BCVA), color vision (saturated and desaturated color confusion indices (CCI)) and contrast acuity were measured at 12 months postoperatively in both the RRD eye and the fellow control eye, and the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25) was filled out. Results: Operated and fellow control eyes differed significantly in mean LogMAR BCVA (P<0.0001), median Log contrast acuity (P<0.0001), saturated CCI (P=0.009), and desaturated CCI (P=0.016). Significant correlations were observed between the NEI VFQ-25 overall composite score and postoperative LogMAR BCVA (R=-0.551, P<0.0001), contrast acuity (R=0.472, P<0.0001), saturated CCI (R=-0.315, P=0.023), and desaturated CCI (R=-0.283, P=0.044). Conclusions: A lower VR-QOL was highly correlated to a worse postoperative BCVA and contrast acuity and to a lesser extent to color vision disturbances.	[van de Put, Mathijs A. J.; Hoeksema, Lisette; Wanders, Wouter; Hooymans, Johanna M. M.; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Nolte, Ilja M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Hoeksema, Lisette; Hooymans, Johanna M. M.; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, WJ Kolff Inst, Grad Sch Med Sci, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	van de Put, MAJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands.	m.a.j.van.de.put@umcg.nl			Professor Mulder Stichting; Stichting Nederlands Oogheelkundig Onderzoek; Stichting blindenhulp	Professor Mulder Stichting; Stichting Nederlands Oogheelkundig Onderzoek; Stichting blindenhulp	Financial support was provided by Professor Mulder Stichting, Stichting Nederlands Oogheelkundig Onderzoek, and Stichting blindenhulp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON C, 1981, ACTA OPHTHALMOL, V59, P161; BOWMAN KJ, 1982, ACTA OPHTHALMOL, V60, P907; Burton T C, 1982, Trans Am Ophthalmol Soc, V80, P475; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; D'Amico DJ, 2008, NEW ENGL J MED, V359, P2346, DOI 10.1056/NEJMcp0804591; Diederen RMH, 2007, OPHTHALMOLOGY, V114, P705, DOI 10.1016/j.ophtha.2006.09.004; Ghazi-Nouri SMS, 2006, BRIT J OPHTHALMOL, V90, P559, DOI 10.1136/bjo.2005.085142; GRIZZARD WS, 1994, GRAEF ARCH CLIN EXP, V232, P1, DOI 10.1007/BF00176431; Hassan TS, 2002, OPHTHALMOLOGY, V109, P146, DOI 10.1016/S0161-6420(01)00886-7; HILTON G, 1983, OPHTHALMOLOGY, V90, P121, DOI 10.1016/s0161-6420(83)34588-7; Hirneiss C, 2007, BRIT J OPHTHALMOL, V91, P481, DOI 10.1136/bjo.2006.102376; Hirneiss C, 2010, GRAEF ARCH CLIN EXP, V248, P85, DOI 10.1007/s00417-009-1186-3; Klein R, 2001, ARCH OPHTHALMOL; Kreissig I, 1981, Dev Ophthalmol, V2, P77; Maguire M, 2004, OPHTHALMOLOGY, V111, P1307; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P227; Mangione CM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1050, DOI 10.1001/archopht.119.7.1050; Mangione CM, 1998, ARCH OPHTHALMOL-CHIC, V116, P1496, DOI 10.1001/archopht.116.11.1496; Mangione CM, 2013, NEI VFQ SCORING ALGO; Mantyjarvi M, 2001, J CATARACT REFR SURG, V27, P261, DOI 10.1016/S0886-3350(00)00562-9; Matsuoka Y, 2012, INVEST OPHTH VIS SCI, V53, P3054, DOI 10.1167/iovs.11-9153; Mitry D, 2012, BR J OPHTHALMOL, P1; Mowatt L, 2010, EYE, V24, P323, DOI 10.1038/eye.2009.74; Okamoto F, 2008, AM J OPHTHALMOL, V146, P85, DOI 10.1016/j.ajo.2008.02.011; Okamoto F, 2010, INVEST OPHTH VIS SCI, V51, P744, DOI 10.1167/iovs.09-3992; Ozgur S, 2007, RETINA, V27, P359; Pastor JC, 2008, BRIT J OPHTHALMOL, V92, P378, DOI 10.1136/bjo.2007.129437; Ross W, 2005, OPHTHALMOLOGY, V112, P1213, DOI 10.1016/j.ophtha.2005.01.040; Ross WH, 1998, OPHTHALMOLOGY, V105, P2149, DOI 10.1016/S0161-6420(98)91142-3; Rosser DA, 2003, INVEST OPHTH VIS SCI, V44, P3278, DOI 10.1167/iovs.02-1100; RUBIN GS, 1994, OPTOMETRY VISION SCI, V71, P750, DOI 10.1097/00006324-199412000-00005; Schweitzer KD, 2011, CAN J OPHTHALMOL, V46, P232, DOI 10.1016/j.jcjo.2011.05.010; SHARMA T, 1994, RETINA-J RET VIT DIS, V14, P338, DOI 10.1097/00006982-199414040-00008; TANI P, 1981, AM J OPHTHALMOL, V92, P611, DOI 10.1016/S0002-9394(14)74651-3; Tranos PG, 2004, AM J OPHTHALMOL, V138, P995, DOI 10.1016/j.ajo.2004.07.049; Van de Put MAJ, 2014, POSTOPERATIVE RECOVE; van de Put MAJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062518; Van de Put MAJ, 2013, OPHTHALMOLOGY, V120, P616, DOI 10.1016/j.ophtha.2012.09.001; Van der Sterre GW, 2013, NATL EYE I VISUAL FU; Zou HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028597	40	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114489	10.1371/journal.pone.0114489	http://dx.doi.org/10.1371/journal.pone.0114489			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460011	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700136
J	De Backer, O; Arnous, S; Lonborg, J; Brooks, M; Biasco, L; Joensson, A; Franzen, OW; Sondergaard, L				De Backer, Ole; Arnous, Samer; Lonborg, Jacob; Brooks, Matthew; Biasco, Luigi; Joensson, Anders; Franzen, Olaf W.; Sondergaard, Lars			Recovery from Anemia in Patients with Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Implantation - Prevalence, Predictors and Clinical Outcome	PLOS ONE			English	Article							VON-WILLEBRAND-SYNDROME; HIGH-RISK PATIENTS; PREOPERATIVE ANEMIA; PARAVALVULAR LEAKS; HEYDES SYNDROME; REPLACEMENT; TRANSFUSION; MORTALITY; ANGIODYSPLASIA; SURGERY	Introduction: Preoperative anemia is common in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation (TAVI) and has been linked to a poorer outcome - including a higher 1-year mortality. The aim of this study was to investigate the impact of successful TAVI on baseline anemia. Methods: A total of 253 patients who survived at least 1 year following TAVI were included in this study. The prevalence, predictors and clinical outcome of hemoglobin (Hb)-recovery were assessed. Results: The prevalence of baseline anemia was 49% (n=124) -recovery from anemia occurred in 40% of the anemic patients (n=49) at 1 year after TAVI with an increase in mean Hb-level of 1.35 g/dL from baseline. This increase was not related to an improvement in renal function. At multivariate analysis, a high peak gradient (OR 4.82, P=0.003) was shown to be an independent predictor for Hb-recovery, while blood transfusion (OR 0.31, P=0.038) and chronic kidney disease (CKD, OR 0.33, P=0.043) were identified as negative predictors at, respectively, one and two years after TAVI. When compared to patients without baseline anemia, those anemic patients with Hb-recovery had a similar functional improvement (OR 0.98, P=0.975), whereas those without Hb-recovery had a significantly lower likelihood of functional improvement with >= 2 NYHA classes (OR 0.49, P=0.034) and a higher likelihood of re-hospitalization within the first year after TAVI (OR 1.91, P=0.024). Conclusion: Recovery from anemia occurs in 40% of anemic patients at 1 year after TAVI - mainly in those with a high gradient and without CKD. Blood transfusion was found to have a transient adverse effect on this Hb-recovery. Finally, anemic patients without Hb-recovery experience less functional improvement and have a higher re-hospitalization rate within the first year after TAVI.	[De Backer, Ole; Arnous, Samer; Lonborg, Jacob; Brooks, Matthew; Biasco, Luigi; Joensson, Anders; Franzen, Olaf W.; Sondergaard, Lars] Rigshosp Univ Hosp, Dept Cardiol, Sjaelland, Denmark	Rigshospitalet	De Backer, O (corresponding author), Rigshosp Univ Hosp, Dept Cardiol, Sjaelland, Denmark.	ole.debacker@gmail.com	De Backer, Ole/AAQ-2369-2020; Biasco, Luigi/X-1217-2019	De Backer, Ole/0000-0002-9674-0278; 	Abbott Vascular	Abbott Vascular(Abbott Laboratories)	Anders Jonsson and Lars Sondergaard: proctoring for Medtronic. Olaf W. Franzen: proctoring for and research grant from Abbott Vascular. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials. All other authors have no conflicts of interest.	D'Ascenzo F, 2013, INT J CARDIOL, V167, P1514, DOI 10.1016/j.ijcard.2012.04.161; Elmariah S, 2013, CIRC-CARDIOVASC INTE, V6, P604, DOI 10.1161/CIRCINTERVENTIONS.113.000650; Elmistekawy E, 2013, EUR J CARDIO-THORAC, V44, P1051, DOI 10.1093/ejcts/ezt143; Godino C, 2013, J AM COLL CARDIOL, V61, P687, DOI 10.1016/j.jacc.2012.10.041; Grube E, 2007, J AM COLL CARDIOL, V50, P69, DOI 10.1016/j.jacc.2007.04.047; HEYDE EC, 1958, NEW ENGL J MED, V259, P196; Jelkmann W, 2011, J PHYSIOL-LONDON, V589, P1251, DOI 10.1113/jphysiol.2010.195057; Kappetein AP, 2013, J THORAC CARDIOV SUR, V145, P6, DOI 10.1016/j.jtcvs.2012.09.002; Keles T, 2013, J GERIATR CARDIOL, V10, P317, DOI 10.3969/j.issn.1671-5411.2013.04.010; Kliger C, 2013, EUR HEART J, V34, P638, DOI 10.1093/eurheartj/ehs347; Leon MB, 2010, NEW ENGL J MED, V363, P1597, DOI 10.1056/NEJMoa1008232; Loscalzo J, 2012, NEW ENGL J MED, V367, P1954, DOI 10.1056/NEJMcibr1205363; Marggraf O, 2012, AM HEAR ASS SCI SESS; Nuis RJ, 2013, CIRC-CARDIOVASC INTE, V6, P625, DOI 10.1161/CIRCINTERVENTIONS.113.000409; Nuis RJ, 2012, CIRC-CARDIOVASC INTE, V5, P680, DOI 10.1161/CIRCINTERVENTIONS.112.971291; Nutritional Anaemias, 1968, WHO TECH REP SER, V405, P5; Pasricha SR, 2013, BLOOD, V122, P124, DOI 10.1182/blood-2012-12-471441; Ruiz CE, 2011, J AM COLL CARDIOL, V58, P2210, DOI 10.1016/j.jacc.2011.03.074; Shander A, 2011, BRIT J ANAESTH, V107, P41, DOI 10.1093/bja/aer350; Shapira Y, 2009, CARDIOL REV, V17, P121, DOI 10.1097/CRD.0b013e31819f1a83; Smith CR, 2011, NEW ENGL J MED, V364, P2187, DOI 10.1056/NEJMoa1103510; Tang YD, 2006, CIRCULATION, V113, P2454, DOI 10.1161/CIRCULATIONAHA.105.583666; Tchetche D, 2012, AM HEART J, V164, P402, DOI 10.1016/j.ahj.2012.07.003; Van Mieghem NM, 2012, CATHETER CARDIO INTE, V79, P726, DOI 10.1002/ccd.23275; van Straten AHM, 2013, J CARDIOTHOR VASC AN, V27, P716, DOI 10.1053/j.jvca.2012.12.021; Vincentelli A, 2003, NEW ENGL J MED, V349, P343, DOI 10.1056/NEJMoa022831; Warkentin TE, 2003, TRANSFUS MED REV, V17, P272, DOI 10.1016/S0887-7963(03)00037-3; Warkentin TE, 2002, NEW ENGL J MED, V347, P858, DOI 10.1056/NEJM200209123471122	28	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114038	10.1371/journal.pone.0114038	http://dx.doi.org/10.1371/journal.pone.0114038			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437191	gold, Green Submitted, Green Published			2022-12-26	WOS:000347114900112
J	Jitraruch, S; Dhawan, A; Hughes, RD; Filippi, C; Soong, D; Philippeos, C; Lehec, SC; Heaton, ND; Longhi, MS; Mitry, RR				Jitraruch, Suttiruk; Dhawan, Anil; Hughes, Robin D.; Filippi, Celine; Soong, Daniel; Philippeos, Christina; Lehec, Sharon C.; Heaton, Nigel D.; Longhi, Maria S.; Mitry, Ragai R.			Alginate Microencapsulated Hepatocytes Optimised for Transplantation in Acute Liver Failure	PLOS ONE			English	Article							IMMORTALIZED XENOGENEIC HEPATOCYTES; CELL TRANSPLANTATION; IMPROVED SURVIVAL; HEPATIC-FAILURE; IN-VITRO; MICROCAPSULES; RAT; BIOCOMPATIBILITY; CRYOPRESERVATION; ENCAPSULATION	Background and Aim: Intraperitoneal transplantation of alginate-microencapsulated human hepatocytes is an attractive option for the management of acute liver failure (ALF) providing short-term support to allow native liver regeneration. The main aim of this study was to establish an optimised protocol for production of alginate-encapsulated human hepatocytes and evaluate their suitability for clinical use. Methods: Human hepatocyte microbeads (HMBs) were prepared using sterile GMP grade materials. We determined physical stability, cell viability, and hepatocyte metabolic function of HMBs using different polymerisation times and cell densities. The immune activation of peripheral blood mononuclear cells (PBMCs) after co-culture with HMBs was studied. Rats with ALF induced by galactosamine were transplanted intraperitoneally with rat hepatocyte microbeads (RMBs) produced using a similar optimised protocol. Survival rate and biochemical profiles were determined. Retrieved microbeads were evaluated for morphology and functionality. Results: The optimised HMBs were of uniform size (583.5 +/- 3.3 mm) and mechanically stable using 15 min polymerisation time compared to 10 min and 20 min (p< 0.001). 3D confocal microscopy images demonstrated that hepatocytes with similar cell viability were evenly distributed within HMBs. Cell density of 3.56106 cells/ml provided the highest viability. HMBs incubated in human ascitic fluid showed better cell viability and function than controls. There was no significant activation of PBMCs co-cultured with empty or hepatocyte microbeads, compared to PBMCs alone. Intraperitoneal transplantation of RMBs was safe and significantly improved the severity of liver damage compared to control groups (empty microbeads and medium alone; p < 0.01). Retrieved RMBs were intact and free of immune cell adherence and contained viable hepatocytes with preserved function. Conclusion: An optimised protocol to produce GMP grade alginate-encapsulated human hepatocytes has been established. Transplantation of microbeads provided effective metabolic function in ALF. These high quality HMBs should be suitable for use in clinical transplantation.	[Jitraruch, Suttiruk; Dhawan, Anil; Hughes, Robin D.; Filippi, Celine; Philippeos, Christina; Lehec, Sharon C.; Heaton, Nigel D.; Longhi, Maria S.; Mitry, Ragai R.] Kings Coll London, Sch Med, Inst Liver Studies, London WC2R 2LS, England; [Soong, Daniel] Kings Coll London, Sch Med, British Heart Fdn Ctr, Excellence Cardiovasc Div, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Dhawan, A (corresponding author), Kings Coll London, Sch Med, Inst Liver Studies, London WC2R 2LS, England.	anil.dhawan@kcl.ac.uk; ragai.mitry@kcl.ac.uk	Philippeos, Christina/S-3780-2019; Heaton, Nigel/AAK-8363-2020; Filippi, Celine/H-3140-2019	Philippeos, Christina/0000-0001-8654-0291; Filippi, Celine/0000-0002-4679-3275; Dhawan, Anil/0000-0002-4942-0845	National Institute for Health Research; WellChild; Medical Research Council [MR/J006742/1] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); WellChild; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the National Institute for Health Research (AD and RDH), funds for consumables; and WellChild (RRM and AD), funds were given to purchase the encapsulator used in the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki T, 2005, CELL TRANSPLANT, V14, P609, DOI 10.3727/000000005783982710; Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7; BURCH RE, 1979, ARCH INTERN MED, V139, P680, DOI 10.1001/archinte.139.6.680; Chang TMS, 2005, NAT REV DRUG DISCOV, V4, P221, DOI 10.1038/nrd1659; de Groot M, 2004, J SURG RES, V121, P141, DOI 10.1016/j.jss.2004.02.018; DONATO MT, 1993, ANAL BIOCHEM, V213, P29, DOI 10.1006/abio.1993.1381; Durkut S, 2013, ARTIF CELLS IN PRESS; Fisher RA, 2006, TRANSPLANTATION, V82, P441, DOI 10.1097/01.tp.0000231689.44266.ac; Fitzpatrick E, 2013, CELL TRANSP IN PRESS, V18; Gazvani R, 2002, REPRODUCTION, V123, P217, DOI 10.1530/rep.0.1230217; HABIBULLAH CM, 1994, TRANSPLANTATION, V58, P951, DOI 10.1097/00007890-199410270-00016; Haque T, 2005, BIOTECHNOL LETT, V27, P317, DOI 10.1007/s10529-005-0687-3; Hernandez RM, 2010, ADV DRUG DELIVER REV, V62, P711, DOI 10.1016/j.addr.2010.02.004; Kim AR, 2013, J BIOMAT SCI-POLYM E, V24, P1084, DOI 10.1080/09205063.2012.735100; Kusano T, 2008, HEPATOL RES, V38, P593, DOI 10.1111/j.1872-034X.2007.00311.x; Longhi MS, 2004, J HEPATOL, V41, P31, DOI 10.1016/j.jhep.2004.03.008; Mai G, 2005, TRANSPL P, V37, P527, DOI 10.1016/j.transproceed.2005.01.017; Mai G, 2005, XENOTRANSPLANTATION, V12, P457, DOI 10.1111/j.1399-3089.2005.00248.x; Mei J, 2009, CELL TRANSPLANT, V18, P101, DOI 10.3727/096368909788237168; Mitry Ragai R., 2009, V481, P17, DOI 10.1007/978-1-59745-201-4_2; Mitry RR, 2005, TRANSPLANT P, V37, P2391, DOI 10.1016/j.transproceed.2005.03.019; Neufeld D S, 1997, Methods Mol Biol, V75, P145; Orive G, 2002, BIOMATERIALS, V23, P3825, DOI 10.1016/S0142-9612(02)00118-7; Puppi J, 2014, CELL TRANSPLANT, V23, P329, DOI 10.3727/096368913X663596; Reebye V, 2014, HEPATOLOGY IN PRESS, V59; Rokstad AM, 2011, ACTA BIOMATER, V7, P2566, DOI 10.1016/j.actbio.2011.03.011; Sgroi A, 2011, CELL TRANSPLANT, V20, P1791, DOI 10.3727/096368911X564976; Tam SK, 2011, ACTA BIOMATER, V7, P1683, DOI 10.1016/j.actbio.2010.12.006; Terry C, 2010, LIVER TRANSPLANT, V16, P229, DOI 10.1002/lt.21983; Thu B, 2000, BIOPOLYMERS, V53, P60, DOI 10.1002/(SICI)1097-0282(200001)53:1<60::AID-BIP6>3.0.CO;2-F; Umehara Y, 2001, SURGERY, V130, P513, DOI 10.1067/msy.2001.116929; Vaithilingam V, 2011, J MICROENCAPSUL, V28, P499, DOI 10.3109/02652048.2011.586067; Wang LS, 2000, ARTIF CELL BLOOD SUB, V28, P215, DOI 10.3109/10731190009119353; Wu Yao-Ming, 2009, V481, P107, DOI 10.1007/978-1-59745-201-4_10; Zhang FT, 2011, WORLD J GASTROENTERO, V17, P938, DOI 10.3748/wjg.v17.i7.938; Zimmermann H, 2005, J MATER SCI-MATER M, V16, P491, DOI 10.1007/s10856-005-0523-2	36	86	86	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113609	10.1371/journal.pone.0113609	http://dx.doi.org/10.1371/journal.pone.0113609			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438038	gold, Green Published			2022-12-26	WOS:000347114900055
J	Wagner, BG; Behrend, MR; Klein, DJ; Upfill-Brown, AM; Eckhoff, PA; Hu, H				Wagner, Bradley G.; Behrend, Matthew R.; Klein, Daniel J.; Upfill-Brown, Alexander M.; Eckhoff, Philip A.; Hu, Hao			Quantifying the Impact of Expanded Age Group Campaigns for Polio Eradication	PLOS ONE			English	Article							LONG-TERM IMMUNITY; ACQUIRED-IMMUNITY; FOLLOW-UP; VACCINE; POLIOMYELITIS; CHILDREN; TRANSMISSION; IMMUNIZATION; ANTIBODIES; EXCRETION	A priority of the Global Polio Eradication Initiative (GPEI) 2013-2018 strategic plan is to evaluate the potential impact on polio eradication resulting from expanding one or more Supplementary Immunization Activities (SIAs) to children beyond age five-years in polio endemic countries. It has been hypothesized that such expanded age group (EAG) campaigns could accelerate polio eradication by eliminating immunity gaps in older children that may have resulted from past periods of low vaccination coverage. Using an individual-based mathematical model, we quantified the impact of EAG campaigns in terms of probability of elimination, reduction in polio transmission and age stratified immunity levels. The model was specifically calibrated to seroprevalence data from a polio-endemic region: Zaria, Nigeria. We compared the impact of EAG campaigns, which depend only on age, to more targeted interventions which focus on reaching missed populations. We found that EAG campaigns would not significantly improve prospects for polio eradication; the probability of elimination increased by 8% (from 24% at baseline to 32%) when expanding three annual SIAs to 5-14 year old children and by 18% when expanding all six annual SIAs. In contrast, expanding only two of the annual SIAs to target hard-to-reach populations at modest vaccination coverage-representing less than one tenth of additional vaccinations required for the six SIA EAG scenario-increased the probability of elimination by 55%. Implementation of EAG campaigns in polio endemic regions would not improve prospects for eradication. In endemic areas, vaccination campaigns which do not target missed populations will not benefit polio eradication efforts.	[Wagner, Bradley G.; Behrend, Matthew R.; Klein, Daniel J.; Upfill-Brown, Alexander M.; Eckhoff, Philip A.; Hu, Hao] Inst Dis Modeling, Bellevue, WA 98009 USA		Wagner, BG (corresponding author), Inst Dis Modeling, Bellevue, WA 98009 USA.	bwagner@intven.com			Global Good Fund	Global Good Fund	The authors gratefully acknowledge financial support from the Global Good Fund (BGW, MRB, DJK, AUB, PAE, and HH; http://www.intellectualventures.com/globalgood/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander JP, 1997, J INFECT DIS, V175, pS176, DOI 10.1093/infdis/175.Supplement_1.S176; [Anonymous], 2013, POL ER ENDG STRAT PL; Behrend MR, 2014, INT J INFECT DIS, V18, P4, DOI 10.1016/j.ijid.2013.09.005; Blake IM, 2014, P NATL ACAD SCI USA, V111, P10604, DOI 10.1073/pnas.1323688111; BOTTIGER M, 1984, REV INFECT DIS, V6, pS548; BOTTIGER M, 1990, VACCINE, V8, P443, DOI 10.1016/0264-410X(90)90244-G; Callaway E, 2013, NATURE, V496, P290, DOI 10.1038/496290a; DAVIS DC, 1958, PEDIATRICS, V22, P33; DICK GW, 1961, BRIT MED J, V2, P266, DOI 10.1136/bmj.2.5247.266; FADEN H, 1993, J INFECT DIS, V168, P452, DOI 10.1093/infdis/168.2.452; Fine PEM, 1999, AM J EPIDEMIOL, V150, P1001, DOI 10.1093/oxfordjournals.aje.a009924; FOX JP, 1984, REV INFECT DIS, V6, pS352; GHENDON YZ, 1961, ACTA VIROL, V5, P265; Giwa FJ, 2012, VACCINE, V30, P6759, DOI 10.1016/j.vaccine.2012.09.023; GREEN MS, 1993, VACCINE, V11, P75, DOI 10.1016/0264-410X(93)90342-U; Grotto I, 2001, VACCINE, V19, P4162, DOI 10.1016/S0264-410X(01)00165-7; Haas CN, 2014, QUANTITATIVE MICROBIAL RISK ASSESSMENT, 2ND EDITION, P1, DOI 10.1002/9781118910030; Mayer BT, 2013, AM J EPIDEMIOL, V177, P1236, DOI 10.1093/aje/kws378; Nates SV, 2007, VIRAL IMMUNOL, V20, P3, DOI 10.1089/vim.2006.0071; NATHANSON N, 1979, AM J EPIDEMIOL, V110, P672, DOI 10.1093/oxfordjournals.aje.a112848; NISHIO O, 1984, J BIOL STAND, V12, P1, DOI 10.1016/S0092-1157(84)80015-3; Poole D, 2000, J AM STAT ASSOC, V95, P1244, DOI 10.2307/2669764; Raftery AE, 2010, BIOMETRICS, V66, P1162, DOI 10.1111/j.1541-0420.2010.01399.x; World Health Assembly, 2012, WORLD HLTH ASS RES C; Wringe A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003433; Zhang J, 1997, J INFECT DIS, V175, pS210, DOI 10.1093/infdis/175.Supplement_1.S210	26	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113538	10.1371/journal.pone.0113538	http://dx.doi.org/10.1371/journal.pone.0113538			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437014	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900051
J	Weber, B; Tranfield, EM; Hoog, JL; Baum, D; Antony, C; Hyman, T; Verbavatz, JM; Prohaska, S				Weber, Britta; Tranfield, Erin M.; Hoeoeg, Johanna L.; Baum, Daniel; Antony, Claude; Hyman, Tony; Verbavatz, Jean-Marc; Prohaska, Steffen			Automated Stitching of Microtubule Centerlines across Serial Electron Tomograms	PLOS ONE			English	Article							MICROSCOPY; ELEGANS; YEAST; RECONSTRUCTION; REGISTRATION; CYTOSKELETON; ARCHITECTURE; PARAMETERS; ALIGNMENT; FEATURES	Tracing microtubule centerlines in serial section electron tomography requires microtubules to be stitched across sections, that is lines from different sections need to be aligned, endpoints need to be matched at section boundaries to establish a correspondence between neighboring sections, and corresponding lines need to be connected across multiple sections. We present computational methods for these tasks: 1) An initial alignment is computed using a distance compatibility graph. 2) A fine alignment is then computed with a probabilistic variant of the iterative closest points algorithm, which we extended to handle the orientation of lines by introducing a periodic random variable to the probabilistic formulation. 3) Endpoint correspondence is established by formulating a matching problem in terms of a Markov random field and computing the best matching with belief propagation. Belief propagation is not generally guaranteed to converge to a minimum. We show how convergence can be achieved, nonetheless, with minimal manual input. In addition to stitching microtubule centerlines, the correspondence is also applied to transform and merge the electron tomograms. We applied the proposed methods to samples from the mitotic spindle in C. elegans, the meiotic spindle in X. laevis, and sub-pellicular microtubule arrays in T. brucei. The methods were able to stitch microtubules across section boundaries in good agreement with experts' opinions for the spindle samples. Results, however, were not satisfactory for the microtubule arrays. For certain experiments, such as an analysis of the spindle, the proposed methods can replace manual expert tracing and thus enable the analysis of microtubules over long distances with reasonable manual effort.	[Weber, Britta; Baum, Daniel; Prohaska, Steffen] Zuse Inst Berlin, Berlin, Germany; [Tranfield, Erin M.; Antony, Claude] European Mol Biol Lab, D-69012 Heidelberg, Germany; [Weber, Britta; Hoeoeg, Johanna L.; Hyman, Tony; Verbavatz, Jean-Marc] Max Planck Inst Mol Biol & Genet, Dresden, Germany; [Hoeoeg, Johanna L.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England	Zuse Institute Berlin; European Molecular Biology Laboratory (EMBL); Max Planck Society; University of Oxford	Verbavatz, JM (corresponding author), Max Planck Inst Mol Biol & Genet, Dresden, Germany.	verbavat@mpi-cbg.de; prohaska@zib.de	Tranfield, Erin M/AAU-4177-2020; Hyman, Tony/F-1923-2011; Hyman, Anthony A/B-3917-2017	Tranfield, Erin M/0000-0002-1542-7459; Hyman, Anthony A/0000-0003-3664-154X; Hoog, Johanna/0000-0003-2162-3816; Baum, Daniel/0000-0003-1550-7245; Verbavatz, Jean-Marc/0000-0002-4654-1174	Sir Henry Wellcome postdoctoral fellowship; NIH-NCRR [P41-RR000592]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000592] Funding Source: NIH RePORTER	Sir Henry Wellcome postdoctoral fellowship; NIH-NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Funding: JLH's research was funded by a Sir Henry Wellcome postdoctoral fellowship. JLH's imaging at The Boulder Lab for 3D Electron Microscopy was supported by NIH-NCRR, Grant P41-RR000592 to Andreas Hoenger. The other authors received no specific funding for this work.	Amat F, 2008, J STRUCT BIOL, V161, P260, DOI 10.1016/j.jsb.2007.07.007; Baum D, 2006, LECT NOTES COMPUT SC, V4216, P183; Bishop C. M., 2006, J ELECT IMAG, V16, P140; BRON C, 1973, COMMUN ACM, V16, P575, DOI 10.1145/362342.362367; Brugues J, 2012, CELL, V149, P554, DOI 10.1016/j.cell.2012.03.027; Caetano TS, 2006, IEEE T PATTERN ANAL, V28, P1646, DOI 10.1109/TPAMI.2006.207; Dekking F, 2010, SPRINGER TEXTS STAT; Dercksen VJ, 2009, I S BIOMED IMAGING, P971, DOI 10.1109/ISBI.2009.5193216; DING R, 1993, J CELL BIOL, V120, P141, DOI 10.1083/jcb.120.1.141; Elidan G, 2006, P 22 C UNC AI UAI BO; Farr H, 2012, CYTOSKELETON, V69, P931, DOI 10.1002/cm.21074; FISCHLER MA, 1981, COMMUN ACM, V24, P381, DOI 10.1145/358669.358692; Frank J., 2006, ELECT TOMOGRAPHY MET, P17, DOI 10.1007/978-0-387-69008-7_2; Gull K, 2003, CURR OPIN MICROBIOL, V6, P365, DOI 10.1016/S1369-5274(03)00092-4; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; Hoog JL, 2007, METHOD CELL BIOL, V79, P145, DOI 10.1016/S0091-679X(06)79006-9; Hoog JL, 2007, DEV CELL, V12, P349, DOI 10.1016/j.devcel.2007.01.020; Hoog JL, 2014, ELIFE, V3, DOI 10.7554/eLife.01479; Hoog JL, 2011, J CELL SCI, V124, P693, DOI 10.1242/jcs.072967; Hoog JL, 2010, METHOD CELL BIOL, V96, P175, DOI 10.1016/S0091-679X(10)96008-1; Hogrebe L, 2012, J NEUROSCI METH, V207, P200, DOI 10.1016/j.jneumeth.2012.03.002; Jian B, 2011, IEEE T PATTERN ANAL, V33, P1633, DOI 10.1109/TPAMI.2010.223; KOLLER D., 2009, PROBABILISTIC GRAPHI; Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013; Lacomble S, 2009, J CELL SCI, V122, P1081, DOI 10.1242/jcs.045740; Li J, 2008, NEUROCOMPUTING, V71, P1771, DOI 10.1016/j.neucom.2007.11.032; Loughlin R, 2010, J CELL BIOL, V191, P1239, DOI 10.1083/jcb.201006076; Mardia K.V., 2000, WILEY SERIES PROBABI; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; MCDONALD KL, 1992, J CELL BIOL, V118, P369, DOI 10.1083/jcb.118.2.369; McIntosh JR, 2013, J CELL BIOL, V200, P459, DOI 10.1083/jcb.201209154; Mooij JM, 2010, J MACH LEARN RES, V11, P2169; Muller-Reichert T, 2007, METHOD CELL BIOL, V79, P101, DOI 10.1016/S0091-679X(06)79004-5; Muller-Reichert T, 2010, CELL MOL LIFE SCI, V67, P2195, DOI 10.1007/s00018-010-0324-8; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Myronenko A., 2009, CLOSED FORM SOLUTION; Myronenko A, 2010, IEEE T PATTERN ANAL, V32, P2262, DOI 10.1109/TPAMI.2010.46; O'Toole E, 2012, PLOS ONE, V7, P140, DOI 10.1371/journal.pone.0029795; O'Toole ET, 2002, METHOD ENZYMOL, V351, P81; Preibisch S, 2010, NAT METHODS, V7, P418, DOI 10.1038/nmeth0610-418; Rangarajan A, 1997, Med Image Anal, V1, P379; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Rusinkiewicz S, 2001, THIRD INTERNATIONAL CONFERENCE ON 3-D DIGITAL IMAGING AND MODELING, PROCEEDINGS, P145, DOI 10.1109/IM.2001.924423; Saalfeld S, 2012, NAT METHODS, V9, P717, DOI [10.1038/NMETH.2072, 10.1038/nmeth.2072]; Sanghavi S, 2011, IEEE T INFORM THEORY, V57, P2203, DOI 10.1109/TIT.2011.2110170; Schaefer S, 2006, ACM T GRAPHIC, V25, P533, DOI 10.1145/1141911.1141920; Sorokine V, 1998, IEEE T INFORM THEORY, V44, P410, DOI 10.1109/18.651072; Stalling D., 2005, VISUAL HDB, V38, P749, DOI DOI 10.1016/B978-012387582-2/50040-X; UMEYAMA S, 1991, IEEE T PATTERN ANAL, V13, P376, DOI 10.1109/34.88573; Wachter A, 2006, MATH PROGRAM, V106, P25, DOI 10.1007/s10107-004-0559-y; WALKER MW, 1991, CVGIP-IMAG UNDERSTAN, V54, P358, DOI 10.1016/1049-9660(91)90036-O; Weber B, 2012, J STRUCT BIOL, V178, P129, DOI 10.1016/j.jsb.2011.12.004; Wells WM, 1997, INT J COMPUT VISION, V21, P63, DOI 10.1023/A:1007923522710; Yao JA, 2010, IEEE IMAGE PROC, P4321, DOI 10.1109/ICIP.2010.5652449	55	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113222	10.1371/journal.pone.0113222	http://dx.doi.org/10.1371/journal.pone.0113222			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438148	Green Published, gold, Green Submitted			2022-12-26	WOS:000347114900035
J	Wen, C; Chen, YP; Wu, P; Wang, T; Zhou, YM				Wen, Chao; Chen, Yueping; Wu, Ping; Wang, Tian; Zhou, Yanmin			MSTN, mTOR and FoxO4 Are Involved in the Enhancement of Breast Muscle Growth by Methionine in Broilers with Lower Hatching Weight	PLOS ONE			English	Article							SKELETAL-MUSCLE; DIETARY METHIONINE; PROTEIN-METABOLISM; BODY-WEIGHT; EXPRESSION; PERFORMANCE; IMPROVES; DNA; METHYLATION; MECHANISMS	Broilers with lower hatching weight (HW) present poorer performance than those with high HW, but there is limited research on the growth regulation of broilers with lower HW. The objective of this study was to investigate the effect of dietary methionine (Met) levels on the growth performance and breast muscle yield of broilers with different HW and underlying mechanisms. A total of 192 one-day-old Arbor Acres broiler chicks with different HW (heavy: 48.3 +/- 0.1 g, and light: 41.7 +/- 0.1 g) were allocated to a 262 factorial arrangement with 6 replicates of 8 chicks per replicate cage. Control starter (1-21 d) and finisher (22-42 d) diets were formulated to contain 0.50% and 0.43% Met, respectively. Corresponding values for a high Met treatment were 0.60% and 0.53%. Light chicks had lower body weight gain (BWG) and breast muscle yield than heavy chicks when the broilers were fed the control diets. High Met diets improved BWG, gain to feed ratio and breast muscle yield in light but not heavy chicks. Decreased DNA content and increased RNA/DNA and protein/DNA ratios in breast muscle were induced by high Met diets only in light chicks. MSTN mRNA level was decreased by high Met diets only in light chicks, and this decrease was accompanied by a significant increase in MSTN gene exon 1 methylation. In addition, high Met diets increased mTOR phosphorylation, but decreased FoxO4 phosphorylation in breast muscle of light chicks. In conclusion, the BWG and breast muscle yield of light chicks were improved by increasing dietary Met levels probably through alterations of MSTN transcription and phosphorylation of mTOR and FoxO4.	[Wen, Chao; Chen, Yueping; Wu, Ping; Wang, Tian; Zhou, Yanmin] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Zhou, YM (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	zhouym6308@163.com						Amirouche A, 2009, ENDOCRINOLOGY, V150, P286, DOI 10.1210/en.2008-0959; Blattler A, 2013, J BIOL CHEM, V288, P34287, DOI 10.1074/jbc.R113.512517; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chambard JC, 2007, BBA-MOL CELL RES, V1773, P1299, DOI 10.1016/j.bbamcr.2006.11.010; Chen J, 2011, ANIMAL, V5, P1082, DOI 10.1017/S1751731111000085; Goodman CA, 2011, CELL SIGNAL, V23, P1896, DOI 10.1016/j.cellsig.2011.07.013; HICKLING D, 1990, CAN J ANIM SCI, V70, P673, DOI 10.4141/cjas90-079; Huang ZQ, 2011, CELL SIGNAL, V23, P1441, DOI 10.1016/j.cellsig.2011.05.003; JOHNSON LR, 1973, AM J PHYSIOL, V224, P937, DOI 10.1152/ajplegacy.1973.224.4.937; Jones NC, 2001, J CELL PHYSIOL, V186, P104, DOI 10.1002/1097-4652(200101)186:1<104::AID-JCP1015>3.0.CO;2-0; Kim JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048455; Kogut MH, 2005, DEV COMP IMMUNOL, V29, P791, DOI 10.1016/j.dci.2005.02.002; Li J, 2006, BIOCHEM BIOPH RES CO, V345, P1425, DOI 10.1016/j.bbrc.2006.05.051; Liu GQ, 2010, AGR SCI CHINA, V9, P1338, DOI 10.1016/S1671-2927(09)60224-8; Mendes AS, 2011, BRAZ J POULTRY SCI, V13, P165, DOI 10.1590/S1516-635X2011000300001; Metayer S, 2008, J NUTR BIOCHEM, V19, P207, DOI 10.1016/j.jnutbio.2007.05.006; Mogyca Leandro NS, 2006, REV BRAS ZOOTECN, V35, P2314, DOI 10.1590/S1516-35982006000800017; Singh PM, 2006, INDIAN J ANIM SCI, V76, P1043; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Reed SA, 2012, FASEB J, V26, P987, DOI 10.1096/fj.11-189977; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; SHANAWANY MM, 1987, WORLD POULTRY SCI J, V43, P107, DOI 10.1079/WPS19870008; Sklan D, 2003, POULTRY SCI, V82, P1778, DOI 10.1093/ps/82.11.1778; Tesseraud S, 2011, WORLD POULTRY SCI J, V67, P243, DOI 10.1017/S0043933911000274; Uni Z, 1996, BRIT POULTRY SCI, V37, P63, DOI 10.1080/00071669608417837; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang XQ, 2013, J ANIM PHYSIOL AN N, V97, P797, DOI 10.1111/j.1439-0396.2012.01320.x; Wang YX, 2012, BRIT J NUTR, V108, P1371, DOI 10.1017/S0007114511006763; Waterland RA, 2006, J NUTR, V136, p1706S, DOI 10.1093/jn/136.6.1706S; Wen C, 2012, ANIM FEED SCI TECH, V172, P180, DOI 10.1016/j.anifeedsci.2011.11.012; Wen C, 2014, BRIT J NUTR, V111, P201, DOI 10.1017/S0007114513002419; Willemsen H, 2008, POULTRY SCI, V87, P2358, DOI 10.3382/ps.2008-00095; Zhai W, 2012, POULTRY SCI, V91, P2548, DOI 10.3382/ps.2012-02213	33	13	16	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114236	10.1371/journal.pone.0114236	http://dx.doi.org/10.1371/journal.pone.0114236			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437444	Green Published, gold, Green Submitted			2022-12-26	WOS:000347114900133
J	Zhang, XS; Bian, XW; Kong, J				Zhang, Xiaosha; Bian, Xiuwu; Kong, Jiming			The Proapoptotic Protein BNIP3 Interacts with VDAC to Induce Mitochondrial Release of Endonuclease G	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; CELL-DEATH; NEURONAL DEATH; UP-REGULATION; CYTOCHROME-C; APOPTOSIS; EXPRESSION; HYPOXIA; TRANSLOCATION; CASPASE-3	BNIP3 is a proapoptotic protein that induces cell death through a mitochondria-mediated pathway. We reported previously that mitochondrial localization of BNIP3 and translocation of EndoG from mitochondria to the nucleus are critical steps of the BNIP3 pathway. It is not clear, however, that how BNIP3 interacts with mitochondria. Here we show that expression of BNIP3 resulted in mitochondrial release and nuclear translocation of EndoG. Incubation of a recombinant GST-BNIP3 protein with freshly isolated mitochondria led to the integration of BNIP3 into mitochondria, reduction in the levels of EndoG in mitochondria and the presence of EndoG in the supernatant that was able to cleave chromatin DNA. Co-immunoprecipitation and mass spectrometry analysis reveals that BNIP3 interacted with the voltage-dependent anion channel (VDAC) to increase opening probabilities of mitochondrial permeability transition (PT) pores and induce mitochondrial release of EndoG. Blocking VDAC with a VDAC antibody largely abolished mitochondrial localization of BNIP3 and prevented EndoG release. Together, the data identify VDAC as an interacting partner of BNIP3 and support endonuclease G as a mediator of the BNIP3 pathway.	[Zhang, Xiaosha; Bian, Xiuwu; Kong, Jiming] Third Mil Med Univ, Inst Pathol, Chongqing, Peoples R China; [Zhang, Xiaosha; Bian, Xiuwu; Kong, Jiming] Third Mil Med Univ, Southwest Canc Ctr, Chongqing, Peoples R China; [Zhang, Xiaosha; Kong, Jiming] Univ Manitoba, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada	Army Medical University; Army Medical University; University of Manitoba	Bian, XW (corresponding author), Third Mil Med Univ, Inst Pathol, Chongqing, Peoples R China.	bianxiuwu@263.net; Jiming.Kong@med.umanitoba.ca	Bian, Xiu-Wu/D-4736-2017	Bian, Xiu-Wu/0000-0003-4383-0197; Kong, Jiming/0000-0002-2859-9831	Canadian Stroke Network; Manitoba Health Research Council; Canadian Institutes of Health Research; China Scholarship Council	Canadian Stroke Network; Manitoba Health Research Council; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); China Scholarship Council(China Scholarship Council)	The project was supported by Canadian Stroke Network, Manitoba Health Research Council and Canadian Institutes of Health Research. X. Zhang received a studentship from the China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; BOYD JM, 1994, CELL, V79, P341, DOI 10.1016/0092-8674(94)90202-X; Bruick RK, 2000, P NATL ACAD SCI USA, V97, P9082, DOI 10.1073/pnas.97.16.9082; Brustovetsky N, 2002, J NEUROCHEM, V80, P207, DOI 10.1046/j.0022-3042.2001.00671.x; Buttner S, 2013, EMBO J, V32, P3041, DOI 10.1038/emboj.2013.228; Burton TR, 2009, CELL DEATH DIFFER, V16, P515, DOI 10.1038/cdd.2008.185; Chen G, 1997, J EXP MED, V186, P1975, DOI 10.1084/jem.186.12.1975; Cizeau J, 2000, ONCOGENE, V19, P5453, DOI 10.1038/sj.onc.1203929; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; Cymerman IA, 2008, NUCLEIC ACIDS RES, V36, P1369, DOI 10.1093/nar/gkm1169; Erkan M, 2005, ONCOGENE, V24, P4421, DOI 10.1038/sj.onc.1208642; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Li CR, 2013, J NEUROCHEM, V127, P426, DOI 10.1111/jnc.12314; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; McDermott-Roe C, 2011, NATURE, V478, P114, DOI 10.1038/nature10490; Rajapakse N, 2001, BRAIN RES PROTOC, V8, P176, DOI 10.1016/S1385-299X(01)00108-8; Ray R, 2000, J BIOL CHEM, V275, P1439, DOI 10.1074/jbc.275.2.1439; Rostovtseva TK, 2004, J BIOL CHEM, V279, P13575, DOI 10.1074/jbc.M310593200; Schafer P, 2004, J MOL BIOL, V338, P217, DOI 10.1016/j.jmb.2004.02.069; Shi Y, 2003, BIOCHEM BIOPH RES CO, V305, P989, DOI 10.1016/S0006-291X(03)00871-4; Tomicic MT, 2001, BIOCHEM BIOPH RES CO, V281, P404, DOI 10.1006/bbrc.2001.4367; Uren RT, 2005, J BIOL CHEM, V280, P2266, DOI 10.1074/jbc.M411106200; Vande Velde C, 2000, MOL CELL BIOL, V20, P5454, DOI 10.1128/MCB.20.15.5454-5468.2000; Zhang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017998; Zhang SR, 2007, BRAIN RES, V1138, P221, DOI 10.1016/j.brainres.2006.12.086; Zhang ZF, 2007, STROKE, V38, P1606, DOI 10.1161/STROKEAHA.106.475129; Zhao ST, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-113	29	9	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113642	10.1371/journal.pone.0113642	http://dx.doi.org/10.1371/journal.pone.0113642			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436615	gold, Green Published, Green Submitted			2022-12-26	WOS:000347114900058
J	Poosti, F; Bansal, R; Yazdani, S; Prakash, J; Post, E; Klok, P; van den Born, J; de Borst, MH; van Goor, H; Poelstra, K; Hillebrands, JL				Poosti, Fariba; Bansal, Ruchi; Yazdani, Saleh; Prakash, Jai; Post, Eduard; Klok, Pieter; van den Born, Jacob; de Borst, Martin H.; van Goor, Harry; Poelstra, Klaas; Hillebrands, Jan-Luuk			Selective delivery of IFN-gamma to renal interstitial myofibroblasts: a novel strategy for the treatment of renal fibrosis	FASEB JOURNAL			English	Article						drug targeting; PDGFR beta; kidney; unilateral ureteral obstruction	CD4(+) T-CELLS; INTERFERON-GAMMA; GROWTH-FACTOR; UP-REGULATION; FIBROBLASTS; DISEASE; HEALTH; LYMPHANGIOGENESIS; ANGIOGENESIS; TRANSITION	Renal fibrosis leads to end-stage renal disease demanding renal replacement therapy because no adequate treatment exists. IFN-gamma is an antifibrotic cytokine that may attenuate renal fibrosis. Systemically administered IFN-gamma causes side effects that may be prevented by specific drug targeting. Interstitial myofibroblasts are the effector cells in renal fibrogenesis. Here, we tested the hypothesis that cell-specific delivery of IFN-gamma to platelet-derived growth factor receptor beta (PDGFR beta)-expressing myofibroblasts attenuates fibrosis in an obstructive nephropathy [unilateral ureteral obstruction (UUO)] mouse model. PEGylated IFN-gamma conjugated to PDGFR beta-recognizing peptide [(PPB)-polyethylene glycol (PEG)-IFN-gamma] was tested in vitro and in vivo for antifibrotic properties and compared with free IFN-gamma. PDGFR beta expression was >3-fold increased (P < 0.05) in mouse fibrotic UUO kidneys and colocalized with alpha-smooth muscle actin-positive (SMA(+)) myofibroblasts. In vitro, PPB-PEG-IFN-gamma significantly inhibited colla1, colla2, and alpha-SMA mRNA expression in TGF-beta-activated NIH3T3 fibroblasts (P < 0.05). In vivo, PPB-PEG-IFN-g gamma specifically accumulated in PDGFR beta-positive myofibroblasts. PPB-PEG-IFN-gamma treatment significantly reduced renal collagen I, fibronectin, and alpha-SMA mRNA and protein expression. Compared with vehicle treatment, PPB-PEG-IFN-gamma preserved tubular morphology, reduced interstitial T-cell infiltration, and attenuated lymphangiogenesis (all P < 0.05) without affecting peritubular capillary density. PPB-PEG-IFN-gamma reducedIFN-gamma-related side effects as manifested by reducedmajor histocompatibility complex class II expression in brain tissue (P < 0.05 vs. free IFN-gamma). Our findings demonstrate that specific targeting of IFN-gamma to PDGFR-beta-expressing myofibroblasts attenuates renal fibrosis and reduces systemic adverse effects.	[Poosti, Fariba; Klok, Pieter; van Goor, Harry; Hillebrands, Jan-Luuk] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Pathol, Groningen, Netherlands; [Yazdani, Saleh; van den Born, Jacob; de Borst, Martin H.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands; [Post, Eduard; Poelstra, Klaas] Univ Groningen, Dept Pharmacokinet Toxicol & Targeting, NL-9700 RB Groningen, Netherlands; [Bansal, Ruchi; Yazdani, Saleh; Prakash, Jai] Univ Twente, MIRA Inst, NL-7500 AE Enschede, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Twente	Poosti, F (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol Pathol, HPC EA10,POB 30001, NL-9700 RB Groningen, Netherlands.	f.poosti@umcg.nl; j.l.hillebrands@umcg.nl	Yazdani, Saleh/K-9640-2015; Bansal, Ruchi/F-4649-2014; Prakash, Jai/C-8015-2014; Bansal, Ruchi/D-4796-2016; van+Goor, Harry/AAS-7712-2020	Yazdani, Saleh/0000-0002-5162-9904; Prakash, Jai/0000-0003-1050-650X; Bansal, Ruchi/0000-0003-2470-5876; Hillebrands, Jan-Luuk/0000-0003-3135-3274; De Borst, Martin/0000-0002-4127-8733; Post, Eduard/0000-0001-5885-0081; van Goor, Harry/0000-0002-6670-1577	J.K. de Cock Foundation (University Medical Center Groningen); Netherlands Organisation for Health Research and Development (ZonMW) [40-00506-98-9021]; Graduate School of Medical Sciences (University of Groningen, Groningen, The Netherlands); Netherlands Organization for Scientific Research (Veni grant)	J.K. de Cock Foundation (University Medical Center Groningen); Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development); Graduate School of Medical Sciences (University of Groningen, Groningen, The Netherlands); Netherlands Organization for Scientific Research (Veni grant)(Netherlands Organization for Scientific Research (NWO))	The authors thank Catharina Reker-Smit, Geert Harms, Marian Bulthuis, and Sippie Huitema for their technical assistance. This work was supported by the J.K. de Cock Foundation (University Medical Center Groningen). Microscopical imaging was performed at the UMCG Imaging Center, which is supported by The Netherlands Organisation for Health Research and Development (ZonMW Grant 40-00506-98-9021). F.P. was supported by the Graduate School of Medical Sciences (University of Groningen, Groningen, The Netherlands). M.H.d.B. was supported by a grant from The Netherlands Organization for Scientific Research (Veni grant).	Ahmed CML, 2003, J CELL SCI, V116, P3089, DOI 10.1242/jcs.00528; Aldigier JC, 2005, J AM SOC NEPHROL, V16, P3306, DOI 10.1681/asn.2004090804; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Bansal R, 2012, MOL CANCER THER, V11, P2419, DOI 10.1158/1535-7163.MCT-11-0758; Bansal R, 2011, J CONTROL RELEASE, V154, P233, DOI 10.1016/j.jconrel.2011.05.027; Bansal R, 2011, HEPATOLOGY, V54, P586, DOI 10.1002/hep.24395; Barisal R, 2011, MOL PHARMACEUT, V8, P1899, DOI 10.1021/mp200263q; Beljaars L, 2003, BIOCHEM PHARMACOL, V66, P1307, DOI 10.1016/S0006-2952(03)00445-3; Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Broekema M, 2007, J AM SOC NEPHROL, V18, P165, DOI 10.1681/ASN.2005070730; Chade AR, 2013, COMPR PHYSIOL, V3, P817, DOI 10.1002/cphy.c120012; Chang FC, 2012, J FORMOS MED ASSOC, V111, P589, DOI 10.1016/j.jfma.2012.09.008; Chen YT, 2011, KIDNEY INT, V80, P1170, DOI 10.1038/ki.2011.208; Cleland JL, 1996, PHARMACEUT RES, V13, P1464, DOI 10.1023/A:1016063109373; Duffield JS, 2014, J CLIN INVEST, V124, P2299, DOI 10.1172/JCI72267; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Fioretto P, 1998, NEW ENGL J MED, V339, P69, DOI 10.1056/NEJM199807093390202; Floege J, 2008, J AM SOC NEPHROL, V19, P12, DOI 10.1681/ASN.2007050532; Forbes MS, 2012, AM J PHYSIOL-RENAL, V303, pF120, DOI 10.1152/ajprenal.00110.2012; Friedman SL, 2013, J HEPATOL, V58, P1, DOI 10.1016/j.jhep.2012.10.014; GonzalezCuadrado S, 1996, CLIN EXP IMMUNOL, V106, P518, DOI 10.1046/j.1365-2249.1996.d01-864.x; Gu F, 2005, J CONTROL RELEASE, V102, P607, DOI 10.1016/j.jconrel.2004.10.020; Heldin CH, 1999, PHYSIOL REV, V79, P1283, DOI 10.1152/physrev.1999.79.4.1283; Johnson HM, 1998, BIOCHEM BIOPH RES CO, V244, P607, DOI 10.1006/bbrc.1998.8254; Kerjaschki D, 2014, J CLIN INVEST, V124, P874, DOI 10.1172/JCI74854; Kida Y, 2014, PEDIATR NEPHROL, V29, P333, DOI 10.1007/s00467-013-2430-y; King TE, 2009, LANCET, V374, P222, DOI 10.1016/S0140-6736(09)60551-1; Konda R, 1999, AM J PATHOL, V155, P1587, DOI 10.1016/S0002-9440(10)65475-2; Krensky AM, 2007, NAT CLIN PRACT NEPHR, V3, P164, DOI 10.1038/ncpneph0418; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; LeBleu VS, 2011, KIDNEY INT, V80, P1119, DOI 10.1038/ki.2011.300; Lee AS, 2013, KIDNEY INT, V83, P50, DOI 10.1038/ki.2012.312; Lee J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060900; Levey AS, 2007, KIDNEY INT, V72, P247, DOI 10.1038/sj.ki.5002343; Li JH, 2007, STEM CELLS, V25, P697, DOI 10.1634/stemcells.2006-0133; Li JH, 2009, AM J PATHOL, V175, P1380, DOI 10.2353/ajpath.2009.090096; Lin SL, 2011, AM J PATHOL, V178, P911, DOI 10.1016/j.ajpath.2010.10.012; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Lu XL, 2012, UROL RES, V40, P717, DOI 10.1007/s00240-012-0507-x; Ma LJ, 2005, J AM SOC NEPHROL, V16, P966, DOI 10.1681/ASN.2004060492; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; MULLER GA, 1991, AM J KIDNEY DIS, V17, P680; Nikolic-Paterson DJ, 2010, KIDNEY INT, V78, P333, DOI 10.1038/ki.2010.182; Oldroyd SD, 1999, KIDNEY INT, V56, P2116, DOI 10.1046/j.1523-1755.1999.00775.x; Ostendorf T, 2012, PEDIATR NEPHROL, V27, P1041, DOI 10.1007/s00467-011-1892-z; Poosti F, 2012, EUR J PHARMACOL, V694, P111, DOI 10.1016/j.ejphar.2012.08.010; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; Rienstra H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009095; RODEMANN HP, 1991, AM J KIDNEY DIS, V17, P684, DOI 10.1016/S0272-6386(12)80352-0; Sakamoto I, 2009, KIDNEY INT, V75, P828, DOI 10.1038/ki.2008.661; Seikrit C, 2013, NEPHROL DIAL TRANSPL, V28, P889, DOI 10.1093/ndt/gfs509; Shao XJ, 2006, J INTERF CYTOK RES, V26, P568, DOI 10.1089/jir.2006.26.568; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Strutz F, 2000, NEPHROL DIAL TRANSPL, V15, P1535, DOI 10.1093/ndt/15.10.1535; Strutz F, 2006, J AM SOC NEPHROL, V17, P2992, DOI 10.1681/ASN.2006050420; Subramaniam PS, 1999, J BIOL CHEM, V274, P403, DOI 10.1074/jbc.274.1.403; Tanaka T, 2013, NAT REV NEPHROL, V9, P211, DOI 10.1038/nrneph.2013.35; Tapmeier TT, 2010, KIDNEY INT, V78, P351, DOI 10.1038/ki.2010.177; Weng HL, 2005, CLIN GASTROENTEROL H, V3, P819, DOI 10.1016/S1542-3565(05)00404-0; Wu MJ, 2006, KIDNEY INT, V69, P2029, DOI 10.1038/sj.ki.5000161; Yao Y, 2011, UROLOGY, V77, DOI 10.1016/j.urology.2010.10.015; Yazdani S, 2014, EXPERT REV MOL MED, V16, DOI 10.1017/erm.2014.18; Yazdani S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050209; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9; Zhang GQ, 2003, J AM SOC NEPHROL, V14, P1234, DOI 10.1097/01.ASN.0000064701.70231.3F	66	54	58	3	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					1029	1042		10.1096/fj.14-258459	http://dx.doi.org/10.1096/fj.14-258459			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25466892	Green Submitted			2022-12-26	WOS:000350633000027
J	Sato, S; Ogura, Y; Tajrishi, MM; Kumar, A				Sato, Shuichi; Ogura, Yuji; Tajrishi, Marjan M.; Kumar, Ashok			Elevated levels of TWEAK in skeletal muscle promote visceral obesity, insulin resistance, and metabolic dysfunction	FASEB JOURNAL			English	Article						Fn14; GLUT4; type 2 diabetes; AMPK; PGC-1 alpha	ACTIVATED PROTEIN-KINASE; BODY GLUCOSE DISPOSAL; NECROSIS-FACTOR-ALPHA; HEXOKINASE-II; TNF-ALPHA; GENE-EXPRESSION; TRANSGENIC MICE; WEAK INDUCER; DIABETES-MELLITUS; GLUT4 EXPRESSION	Skeletal muscle is responsible for the majority of glucose disposal in body. Impairment in skeletal muscle glucose handling capacity leads to the state of insulin resistance. The TNF-like weak inducer of apoptosis (TWEAK) cytokine has now emerged as a major regulator of skeletal muscle mass and function. However, the role of TWEAK in skeletal muscle metabolic function remains less understood. Here, we demonstrate that with progressive age, skeletal muscle-specific TWEAK-transgenic (TWEAK-Tg) mice gain increased body weight (similar to 16%) and fat mass (similar to 64%) and show glucose intolerance and insulin insensitivity. TWEAK-Tg mice also exhibit adipocyte hypertrophy in the epididymal fat. Oxygen uptake, voluntary physical activity, and exercise capacity were significantly reduced in TWEAK-Tg mice compared with controls. Overexpression of TWEAK inhibited (similar to 31%) 5' AMP-activated protein kinase (AMPK) and reduced (similar to 31%) the levels of glucose transporter type 4 (GLUT4) without affecting the Akt pathway. TWEAK also inhibited insulin-stimulated glucose uptake (similar to 32%) and repressed the levels of GLUT4 (similar to 50%) in cultured myotubes from C57BL6 mice. TWEAK represses the levels of Kruppel-like factor 15; myocyte enhancer factor 2, and peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, which are required for the activation of the GLUT4 locus. Collectively our study demonstrates that elevated levels of TWEAK in skeletal muscle cause metabolic abnormalities. Inhibition of TWEAK could be a potential approach to prevent weight gain and type 2 diabetes.	[Sato, Shuichi; Ogura, Yuji; Tajrishi, Marjan M.; Kumar, Ashok] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, Louisville, KY 40202 USA	University of Louisville	Kumar, A (corresponding author), Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, 500 South Preston St, Louisville, KY 40202 USA.	ashok.kumar@louisville.edu		Kumar, Ashok/0000-0001-8571-2848	U.S. National Institutes of Health [R01-AG029623]; NATIONAL INSTITUTE ON AGING [R01AG029623] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Bradford Hill and Dr. Daniel Conklin of Diabetes and Obesity Center of University of Louisville for their help and discussion on metabolic cage analysis. This work was supported by the U.S. National Institutes of Health (Grant R01-AG029623) (to A.K.).	Atkinson BJ, 2013, DIABETES, V62, P2249, DOI 10.2337/db12-1146; Bennett G, 2014, OBESITY, V22, P1485, DOI 10.1002/oby.20726; Bogan JS, 2012, ANNU REV BIOCHEM, V81, P507, DOI 10.1146/annurev-biochem-060109-094246; Bouskila M, 2008, AM J PHYSIOL-ENDOC M, V294, pE28, DOI 10.1152/ajpendo.00481.2007; Bouzakri K, 2003, DIABETES, V52, P1319, DOI 10.2337/diabetes.52.6.1319; BRAITHWAITE SS, 1995, DIABETES, V44, P43, DOI 10.2337/diabetes.44.1.43; Chacon MR, 2006, CYTOKINE, V33, P129, DOI 10.1016/j.cyto.2005.12.005; Chang PY, 1996, J BIOL CHEM, V271, P14834, DOI 10.1074/jbc.271.25.14834; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Christ-Roberts CY, 2004, METABOLISM, V53, P1233, DOI 10.1016/j.metabol.2004.03.022; Crunkhorn S, 2007, J BIOL CHEM, V282, P15439, DOI 10.1074/jbc.M611214200; Cusi K, 2000, J CLIN INVEST, V105, P311, DOI 10.1172/JCI7535; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; DeFronzo RA, 2009, DIABETES CARE, V32, pS157, DOI 10.2337/dc09-S302; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Dogra C, 2007, FASEB J, V21, P1857, DOI 10.1096/fj.06-7537com; Feng F, 2008, ENDOCRINOLOGY, V149, P1505, DOI 10.1210/en.2007-1119; FRANK SK, 1986, ARCH BIOCHEM BIOPHYS, V249, P61, DOI 10.1016/0003-9861(86)90560-6; Fueger PT, 2007, DIABETES, V56, P2476, DOI 10.2337/db07-0532; GARVEY WT, 1992, DIABETES, V41, P465, DOI 10.2337/diabetes.41.4.465; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; HANDBERG A, 1990, DIABETOLOGIA, V33, P625, DOI 10.1007/BF00400207; Hindi SM, 2014, FASEB J, V28, P1398, DOI 10.1096/fj.13-242123; Hojlund K, 2009, J CLIN ENDOCR METAB, V94, P4547, DOI 10.1210/jc.2009-0897; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Im SS, 2007, IUBMB LIFE, V59, P134, DOI 10.1080/15216540701313788; Itani SI, 2003, DIABETES, V52, P1635, DOI 10.2337/diabetes.52.7.1635; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Jensen Jorgen, 2009, Archives of Physiology and Biochemistry, V115, P13, DOI 10.1080/13813450902778171; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kalupahana NS, 2012, MOL ASPECTS MED, V33, P26, DOI 10.1016/j.mam.2011.10.011; KORANYI LI, 1991, DIABETOLOGIA, V34, P763, DOI 10.1007/BF00401526; Krook A, 2000, DIABETES, V49, P284, DOI 10.2337/diabetes.49.2.284; Kruszynska YT, 1998, DIABETES, V47, P1107, DOI 10.2337/diabetes.47.7.1107; Leturque A, 1996, DIABETES, V45, P23, DOI 10.2337/diabetes.45.1.23; LIU ML, 1994, J BIOL CHEM, V269, P28514; Mcgee SL, 2008, DIABETES, V57, P860, DOI 10.2337/db07-0843; McGee SL, 2006, CLIN EXP PHARMACOL P, V33, P395, DOI 10.1111/j.1440-1681.2006.04362.x; Michael LF, 2001, P NATL ACAD SCI USA, V98, P3820, DOI 10.1073/pnas.061035098; Mingrone G, 2002, INT J OBESITY, V26, P1165, DOI 10.1038/sj.ijo.0802053; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Mittel A, 2010, AM J PATHOL, V177, P1732, DOI 10.2353/ajpath.2010.100335; Ng Y, 2008, CELL METAB, V7, P348, DOI 10.1016/j.cmet.2008.02.008; Nieto-Vazquez Iria, 2008, Archives of Physiology and Biochemistry, V114, P183, DOI [10.1080/13813450802181047, 10.1080/13813450802181047 ]; Ofei F, 1996, DIABETES, V45, P881, DOI 10.2337/diabetes.45.7.881; Paul PK, 2012, MOL CELL BIOL, V32, P1248, DOI 10.1128/MCB.06351-11; Pendergrass M, 1998, DIABETES, V47, P387, DOI 10.2337/diabetes.47.3.387; REN JM, 1995, J CLIN INVEST, V95, P429, DOI 10.1172/JCI117673; Ruderman NB, 2013, J CLIN INVEST, V123, P2764, DOI 10.1172/JCI67227; Sakoda H, 2002, AM J PHYSIOL-ENDOC M, V282, pE1239, DOI 10.1152/ajpendo.00455.2001; Sato S, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-18; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Steinberg GR, 2006, CELL METAB, V4, P465, DOI 10.1016/j.cmet.2006.11.005; SUTHERLAND C, 1993, BIOCHEM J, V296, P15, DOI 10.1042/bj2960015; Suzuki T, 2013, MOL CELL, V50, P407, DOI 10.1016/j.molcel.2013.03.022; TAI MM, 1994, DIABETES CARE, V17, P152, DOI 10.2337/diacare.17.2.152; Tajrishi MM, 2014, J BIOL CHEM, V289, P19985, DOI 10.1074/jbc.M114.568626; Tajrishi MM, 2014, CYTOKINE GROWTH F R, V25, P215, DOI 10.1016/j.cytogfr.2013.12.004; Tajrishi MM, 2014, BIOCHEM BIOPH RES CO, V446, P1219, DOI 10.1016/j.bbrc.2014.03.084; THIEBAUD D, 1982, DIABETES, V31, P957, DOI 10.2337/diacare.31.11.957; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; WALKER PS, 1990, J BIOL CHEM, V265, P1516; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; WOODGETT JR, 1991, TRENDS BIOCHEM SCI, V16, P177, DOI 10.1016/0968-0004(91)90071-3; Zisman A, 2000, NAT MED, V6, P924, DOI 10.1038/78693	65	19	20	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					988	1002		10.1096/fj.14-260703	http://dx.doi.org/10.1096/fj.14-260703			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25466899	Green Published			2022-12-26	WOS:000350633000023
J	Ahles, A; Rodewald, F; Rochais, F; Bunemann, M; Engelhardt, S				Ahles, Andrea; Rodewald, Fabian; Rochais, Francesca; Buenemann, Moritz; Engelhardt, Stefan			Interhelical Interaction and Receptor Phosphorylation Regulate the Activation Kinetics of Different Human beta(1)-Adrenoceptor Variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; NERVOUS-SYSTEM; BLOOD-PRESSURE; BETA-ARRESTIN; POLYMORPHISM; MECHANISM; PHARMACOGENOMICS; HYPERTENSION	G protein-coupled receptors represent the largest class of drug targets, but genetic variation within G protein-coupled receptors leads to variable drug responses and, thereby, compromises their therapeutic application. One of the most intensely studied examples is a hyperfunctional variant of the human beta(1)-adrenoceptor that carries an arginine at position 389 in helix 8 (Arg-389-ADRB1). However, the mechanism underlying the higher efficacy of the Arg-389 variant remained unclear to date. Despite its hyperfunctionality, we found the Arg-389 variant of ADRB1 to be hyperphosphorylated upon continuous stimulation with norepinephrine compared with the Gly-389 variant. Using ADRB1 sensors to monitor activation kinetics by fluorescence resonance energy transfer, Arg-389-ADRB1 exerted faster activation speed and arrestin recruitment than the Gly-389 variant. Both activation speed and arrestin recruitment depended on phosphorylation of the receptor, as shown by knockdown of G protein-coupled receptor kinases and phosphorylation-deficient ADRB1 mutants. Structural modeling of the human beta(1)-adrenoceptor suggested interaction of the side chain of Arg-389 with opposing amino acid residues in helix 1. Site-directed mutagenesis of Lys-85 and Thr-86 in helix 1 revealed that this interaction indeed determined ADRB1 activation kinetics. Taken together, these findings indicate that differences in interhelical interaction regulate the different activation speed and efficacy of ADRB1 variants.	[Ahles, Andrea; Rodewald, Fabian; Engelhardt, Stefan] Tech Univ Munich, Inst Pharmacol & Toxicol, D-80802 Munich, Germany; [Rochais, Francesca] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97080 Wurzburg, Germany; [Buenemann, Moritz] Univ Marburg, Inst Pharmacol & Clin Pharm, D-35043 Marburg, Germany; [Engelhardt, Stefan] German Ctr Cardiovasc Res, Partner Site Munich Heart Alliance, D-80802 Munich, Germany	Technical University of Munich; University of Wurzburg; Philipps University Marburg; German Centre for Cardiovascular Research; Munich Heart Alliance	Engelhardt, S (corresponding author), Tech Univ Munich, Inst Pharmacol & Toxicol, Biedersteiner Str 29, D-80802 Munich, Germany.	stefan.engelhardt@tum.de	Rochais, Francesca/ABF-4675-2021; Engelhardt, Stefan/AAA-9329-2019; Rochais, Francesca/A-5326-2017	Rochais, Francesca/0000-0001-9355-8916; Engelhardt, Stefan/0000-0001-5378-8661; Rochais, Francesca/0000-0001-9355-8916				Ahles A, 2014, PHARMACOL REV, V66, P598, DOI 10.1124/pr.113.008219; Ahles A, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001681; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; FREEDMAN NJ, 1995, J BIOL CHEM, V270, P17953, DOI 10.1074/jbc.270.30.17953; Gjesing AP, 2007, DIABETIC MED, V24, P392, DOI 10.1111/j.1464-5491.2006.02031.x; Johnson AD, 2011, HYPERTENSION, V57, P903, DOI 10.1161/HYPERTENSIONAHA.110.158667; Joseph SS, 2004, BRIT J PHARMACOL, V142, P51, DOI 10.1038/sj.bjp.0705753; Kenakin T, 2013, BRIT J PHARMACOL, V168, P554, DOI 10.1111/j.1476-5381.2012.02223.x; Kim IM, 2014, CIRC RES, V114, P833, DOI 10.1161/CIRCRESAHA.114.302766; Kirstein SL, 2004, PHARMACOL REV, V56, P31, DOI 10.1124/pr.56.1.2; Liang W, 2003, J BIOL CHEM, V278, P39773, DOI 10.1074/jbc.M304482200; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Lymperopoulos A, 2013, CIRC RES, V113, P739, DOI 10.1161/CIRCRESAHA.113.300308; Mason DA, 1999, J BIOL CHEM, V274, P12670, DOI 10.1074/jbc.274.18.12670; Nobles KN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001707; Noma T, 2007, J CLIN INVEST, V117, P2445, DOI 10.1172/JCI31901; Nygaard R, 2013, CELL, V152, P532, DOI 10.1016/j.cell.2013.01.008; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Rapacciuolo A, 2003, J BIOL CHEM, V278, P35403, DOI 10.1074/jbc.M305675200; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Rochais F, 2007, J CLIN INVEST, V117, P229, DOI 10.1172/JCI30012; Rosskopf D, 2008, PHARMACOL REV, V60, P513, DOI 10.1124/pr.108.000612; Tesson F, 1999, J MOL CELL CARDIOL, V31, P1025, DOI 10.1006/jmcc.1999.0947; Tikhonoff V, 2008, J HUM HYPERTENS, V22, P864, DOI 10.1038/jhh.2008.73; Tilley DG, 2009, J BIOL CHEM, V284, P20375, DOI 10.1074/jbc.M109.005793; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Vilardaga JP, 2003, NAT BIOTECHNOL, V21, P807, DOI 10.1038/nbt838; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2012, STRUCTURE, V20, P841, DOI 10.1016/j.str.2012.03.014; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Zhang F, 2013, PHYSIOL GENOMICS, V45, P1186, DOI 10.1152/physiolgenomics.00087.2013	34	10	10	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1760	1769		10.1074/jbc.M114.607333	http://dx.doi.org/10.1074/jbc.M114.607333			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25451930	Green Published, hybrid			2022-12-26	WOS:000348056400041
J	dos Santos, FK; Maia, JAR; Gomes, TNQF; Daca, T; Madeira, A; Katzmarzyk, PT; Prista, A				dos Santos, Fernanda Karina; Maia, Jose A. R.; Gomes, Thayse Natacha Q. F.; Daca, Timoteo; Madeira, Aspacia; Katzmarzyk, Peter T.; Prista, Antonio			Secular Trends in Growth and Nutritional Status of Mozambican School-Aged Children and Adolescents	PLOS ONE			English	Article							HEIGHT; OBESITY; WEIGHT; HEALTH; UNDERWEIGHT; TRANSITION	Objectives: The purpose of this study was to examine secular changes in growth and nutritional status of Mozambican children and adolescents between 1992, 1999 and 2012. Methods: 3374 subjects (1600 boys, 1774 girls), distributed across the three time points (523 subjects in 1992; 1565 in 1999; and 1286 in 2012), were studied. Height and weight were measured, BMI was computed, and WHO cut-points were used to define nutritional status. ANCOVA models were used to compare height, weight and BMI across study years; chi-square was used to determine differences in the nutritional status prevalence across the years. Results: Significant differences for boys were found for height and weight (p<0.05) across the three time points, where those from 2012 were the heaviest, but those in 1999 were the tallest, and for BMI the highest value was observed in 2012 (1992<2012, 1999<2012). Among girls, those from 1999 were the tallest (1992<1999, 1999>2012), and those from 2012 had the highest BMI (1999<2012). In general, similar patterns were observed when mean values were analyzed by age. A positive trend was observed for overweight and obesity prevalences, whereas a negative trend emerged for wasting, stunting-wasting (in boys), and normal-weight (in girls); no clear trend was evident for stunting. Conclusion: Significant positive changes in growth and nutritional status were observed among Mozambican youth from 1992 to 2012, which are associated with economic, social and cultural transitional processes, expressing a dual burden in this population, with reduction in malnourished youth in association with an increase in the prevalence of overweight and obesity.	[dos Santos, Fernanda Karina; Maia, Jose A. R.; Gomes, Thayse Natacha Q. F.] Univ Porto, Fac Sport, Kinanthropometry Lab, CIFI2D, P-4100 Oporto, Portugal; [dos Santos, Fernanda Karina] Minist Educ Brazil, CAPES Fdn, Brasilia, DF, Brazil; [Daca, Timoteo; Madeira, Aspacia; Prista, Antonio] Pedag Univ, Fac Phys Educ & Sports, Maputo, Mozambique; [Katzmarzyk, Peter T.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Baton Rouge, LA USA	Universidade do Porto; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Prista, A (corresponding author), Pedag Univ, Fac Phys Educ & Sports, Maputo, Mozambique.	aprista1@gmail.com	Katzmarzyk, Peter T/N-1974-2017; Prista, António/ABE-7056-2020; Daca, Timoteo Salvador Lucas/AAE-5460-2022; Daca, Timoteo/AAE-5432-2022; Gomes, Thayse Natacha Queiroz Ferreira/AAL-5002-2020	Katzmarzyk, Peter T/0000-0002-9280-6022; Daca, Timoteo/0000-0002-7914-4984; Queiroz Ferreira Gomes, Thayse Natacha/0000-0003-4991-1238				African Development Bank Group, 2011, REP MOZ COUNTR STRAT; Akachi Y, 2007, ANN HUM BIOL, V34, P397, DOI 10.1080/03014460701452868; Amugsi DA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-960; [Anonymous], 2013, WHO GLOBAL HLTH OBSE; Araujo M., 2003, GEOUSP ESPACO TEMPO, V14, P165, DOI DOI 10.11606/ISSN.2179-0892.GEOUSP.2003.123846; Armstrong MEG, 2011, EUR J CLIN NUTR, V65, P835, DOI 10.1038/ejcn.2011.46; Berndt SI, 2013, NAT GENET, V45, P501, DOI 10.1038/ng.2606; Bi ZW, 2005, ANN HUM BIOL, V32, P650, DOI 10.1080/03014460500154418; Castilho LV, 2001, ANN HUM BIOL, V28, P564, DOI 10.1080/03014460110045146; Danker-Hopfe H, 2000, ANN HUM BIOL, V27, P263; de Onis M, 2004, INT J EPIDEMIOL, V33, P1260, DOI 10.1093/ije/dyh202; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Deaton A, 2007, P NATL ACAD SCI USA, V104, P13232, DOI 10.1073/pnas.0611500104; Garcia J, 2007, ECON HUM BIOL, V5, P340, DOI 10.1016/j.ehb.2007.02.002; Instituto Nacional de Estatistica IP, 2013, EST CPLP 2012; Krawczynski M, 2003, ACTA PAEDIATR, V92, P277, DOI 10.1080/08035250310009176; Lohman T. G., 1998, ANTROPOMETRIC STANDA; Malina R.M., 2004, GROWTH MATURATION PH, V2nd ed., DOI DOI 10.1016/j.jsams.2011.04.003; Marques-Vidal P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-166; Ministerio do Plano e Financas, 1998, MOC POL NAC POP; Nhampoca JMD, 2013, RURAL URBANO COEXIST; OECD, 2008, AFR EC OUTL 2008, P459; Padez C, 2003, ANN HUM BIOL, V30, P262, DOI 10.1080/0301446031000064530; Poskitt EME, 2009, ANN TROP PAEDIATR, V29, P1, DOI 10.1179/146532809X401971; Prista A, 2010, DESAFIO CALANGA LUGA, P29; Prista A, 2002, SAUDE CRESCIMENTO DE, P7; Republica de Mocambique, 2010, REL OBJ DES MIL; Saranga S, 2008, R BRAS CI MOV, V16, P17; Shrimpton R, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.5.e75; Tanner J.M., 1982, ATLAS CHILDRENS GROW; Tanner JM., 1990, GROWTH MIRROR CONDIT, P9; Uauy R, 2002, PUBLIC HEALTH NUTR, V5, P223, DOI 10.1079/PHN2001297; UNICEF, 2013, MOZ STAT; United Nations Children's Fund WHO The World Bank. UNICEF-WHO-World Bank, 2012, JOINT CHILD MALN EST; United Nations Development Programme (UNDP), 2000, MOZ NAT HUM DEV REP; United Nations Development Programme (UNDP), 2014, HUM DEV REP 2013 RIS; United Nations Human Settlements Programme, 2008, MOZ URB SECT PROF; Vorster HH, 2010, LINK POVERTY MALNUTR; Wang YF, 2002, AM J CLIN NUTR, V75, P971, DOI 10.1093/ajcn/75.6.971; WHO, 2000, OB PREV MAN GLOB EP; World health organization, 2013, WORLD HLTH STAT 2013; World Health Organization, 2013, WHO AFR REG MOZ SAT; World Health Organization, 1995, PHYS STAT US INT ANT; Zellner K, 2004, ECON HUM BIOL, V2, P281, DOI 10.1016/j.ehb.2004.04.006	44	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114068	10.1371/journal.pone.0114068	http://dx.doi.org/10.1371/journal.pone.0114068			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473837	Green Published, gold, Green Submitted			2022-12-26	WOS:000346382500108
J	Bouillot, P; Brina, O; Ouared, R; Lovblad, KO; Farhat, M; Pereira, VM				Bouillot, Pierre; Brina, Olivier; Ouared, Rafik; Lovblad, Karl-Olof; Farhat, Mohamed; Pereira, Vitor Mendes			Particle Imaging Velocimetry Evaluation of Intracranial Stents in Sidewall Aneurysm: Hemodynamic Transition Related to the Stent Design	PLOS ONE			English	Article							CEREBRAL ANEURYSMS; IN-VITRO; PULSATILE FLOWS; PARENT VESSEL; BLOOD-FLOW; MODEL; PLACEMENT; STRAIGHT; STEADY; THROMBOSIS	We investigated the flow modifications induced by a large panel of commercial-off-the-shelf (COTS) intracranial stents in an idealized sidewall intracranial aneurysm (IA). Flow velocities in IA silicone model were assessed with and without stent implantation using particle imaging velocimetry (PIV). The use of the recently developed multi-time-lag method has allowed for uniform and precise measurements of both high and low velocities at IA neck and dome, respectively. Flow modification analysis of both regular (RSs) and flow diverter stents (FDSs) was subsequently correlated with relevant geometrical stent parameters. Flow reduction was found to be highly sensitive to stent porosity variations for regular stents RSs and moderately sensitive for FDSs. Consequently, two distinct IA flow change trends, with velocity reductions up to 50% and 90%, were identified for high-porosity RS and low-porosity FDS, respectively. The intermediate porosity (88%) regular braided stent provided the limit at which the transition in flow change trend occurred with a flow reduction of 84%. This transition occurred with decreasing stent porosity, as the driving force in IA neck changed from shear stress to differential pressure. Therefore, these results suggest that stents with intermediate porosities could possibly provide similar flow change patterns to FDS, favourable to curative thrombogenesis in IAs.	[Bouillot, Pierre; Brina, Olivier; Ouared, Rafik; Lovblad, Karl-Olof; Pereira, Vitor Mendes] Univ Hosp Geneva, Serv Neuroradiol, Intervent Neuroradiol Unit, Geneva, Switzerland; [Bouillot, Pierre; Farhat, Mohamed] Ecole Polytech Fed Lausanne, Lab Hydraul Machines, Lausanne, Switzerland; [Pereira, Vitor Mendes] Toronto Western Hosp, Univ Hlth Network, Dept Med Imaging, Div Neuroradiol, Toronto, ON M5T 2S8, Canada; [Pereira, Vitor Mendes] Toronto Western Hosp, Univ Hlth Network, Dept Surg, Div Neurosurg, Toronto, ON M5T 2S8, Canada	University of Geneva; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Bouillot, P (corresponding author), Univ Hosp Geneva, Serv Neuroradiol, Intervent Neuroradiol Unit, Geneva, Switzerland.	pierre.bouillot@unige.ch	Farhat, Mohamed/H-9463-2012; Lövblad, Karl/AAF-7678-2020	Farhat, Mohamed/0000-0002-4782-2170; lovblad, karl-olof/0000-0003-2768-9779	Swiss National Science Foundation [SNF 32003B_141192]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Funding: This study was supported by Swiss National Science Foundation grant (SNF 32003B_141192). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aenis M, 1997, J BIOMECH ENG-T ASME, V119, P206, DOI 10.1115/1.2796081; Augsburger L, 2009, J NEURORADIOLOGY, V36, P270, DOI 10.1016/j.neurad.2009.03.001; Augsburger L, 2009, CLIN NEURORADIOL, V19, P204, DOI 10.1007/s00062-009-9005-0; Aurboonyawat T, 2011, NEURORADIOLOGY, V53, P659, DOI 10.1007/s00234-010-0784-4; Babiker MH, 2012, J BIOMECH, V45, P440, DOI 10.1016/j.jbiomech.2011.12.016; Becske T, 2013, RADIOLOGY, V267, P858, DOI 10.1148/radiol.13120099; Bouillot P, 2014, EXP FLUIDS, V55, DOI 10.1007/s00348-014-1746-0; Brinjikji W, 2013, STROKE, V44, P442, DOI 10.1161/STROKEAHA.112.678151; Canton G, 2005, J NEUROSURG, V103, P891, DOI 10.3171/jns.2005.103.5.0891; Canton G, 2005, J NEUROSURG, V103, P146, DOI 10.3171/jns.2005.103.1.0146; Chien AC, 2013, J NEUROINTERV SURG, V5, pIII43, DOI 10.1136/neurintsurg-2012-010613; Chong W, 2014, AM J NEURORADIOL, V35, P136, DOI 10.3174/ajnr.A3790; Chopard B, 2007, INT J MOD PHYS C, V18, P712, DOI 10.1142/S0129183107010978; Hirabayashi M, 2006, MATH COMPUT SIMULAT, V72, P128, DOI 10.1016/j.matcom.2006.05.037; Hoi Y, 2006, J BIOMECH ENG-T ASME, V128, P844, DOI 10.1115/1.2354209; Ionita CN, 2004, PRO BIOMED OPT IMAG, V5, P295, DOI 10.1117/12.534274; Krischek O, 2012, MINIM INVAS NEROSURG, V54, P12; Kulcsar Z, 2012, ACTA NEUROCHIR, V154, P1827, DOI 10.1007/s00701-012-1482-2; Le TB, 2013, ANN BIOMED ENG, V41, P2157, DOI 10.1007/s10439-013-0811-9; Le TB, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4002702; Lieber BB, 2002, ANN BIOMED ENG, V30, P768, DOI 10.1114/1.1495867; Liou TM, 2004, J BIOMECH ENG-T ASME, V126, P36, DOI 10.1115/1.1644566; Liou TM, 2004, EXP MECH, V44, P253, DOI 10.1177/0014485104039770; Liou TM, 2008, PHYS MED BIOL, V53, P3763, DOI 10.1088/0031-9155/53/14/004; Liou TM, 2008, J BIOMECH, V41, P1174, DOI 10.1016/j.jbiomech.2008.01.025; Mut F, 2014, J NEUROINTERV SURG; O'Kelly CJ, 2010, INTERV NEURORADIOL, V16, P133, DOI 10.1177/159101991001600204; Ouared R, 2008, COMPUT PHYS COMMUN, V179, P128, DOI 10.1016/j.cpc.2008.01.021; Pereira VM, 2013, AM J NEURORADIOL, V34, P808, DOI 10.3174/ajnr.A3322; Piotin M, 2010, STROKE, V41, P110, DOI 10.1161/STROKEAHA.109.558114; Rayz VL, 2008, ANN BIOMED ENG, V36, P1793, DOI 10.1007/s10439-008-9561-5; Reymond P, 2009, AM J PHYSIOL-HEART C, V297, pH208, DOI 10.1152/ajpheart.00037.2009; Roszelle BN, 2013, NEURORADIOLOGY, V55, P751, DOI 10.1007/s00234-013-1169-2; Roszelle BN, 2013, J NEUROINTERV SURG, V5, P354, DOI 10.1136/neurintsurg-2012-010322; Scheidegger, 1963, PHYS FLOW POROUS MED; Seong J, 2007, J BIOMECH ENG-T ASME, V129, P863, DOI 10.1115/1.2800787; Shapiro M, 2014, AM J NEURORADIOL, V35, P727, DOI 10.3174/ajnr.A3742; Sobera MP, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036301; Tateshima S, 2009, J NEUROSURG, V111, P22, DOI 10.3171/2009.2.JNS081324; Trager AL, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006454; Trager AL, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3049528; Wang ZJ, 2005, PHYS MED BIOL, V50, P3171, DOI 10.1088/0031-9155/50/13/014; Yip J, 2005, IUBMB LIFE, V57, P103, DOI 10.1080/15216540500078962; Yu CH, 2012, J MECH SCI TECHNOL, V26, P1333, DOI 10.1007/s12206-012-0322-x; Yu SCM, 1999, MED ENG PHYS, V21, P133, DOI 10.1016/S1350-4533(99)00037-5; Yu SCM, 1999, EXP FLUIDS, V26, P505, DOI 10.1007/s003480050317; Zenteno MA, 2008, J NEUROSURG, V108, P1104, DOI 10.3171/JNS/2008/108/6/1104	47	47	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113762	10.1371/journal.pone.0113762	http://dx.doi.org/10.1371/journal.pone.0113762			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470724	Green Published, gold, Green Submitted			2022-12-26	WOS:000349128700043
J	Urlacher, E; Tarr, IS; Mercer, AR				Urlacher, Elodie; Tarr, Ingrid S.; Mercer, Alison R.			Social Modulation of Stress Reactivity and Learning in Young Worker Honey Bees	PLOS ONE			English	Article							DIVISION-OF-LABOR; JUVENILE-HORMONE; PROTEIN-KINASE; ANTENNAL LOBE; OLFACTORY MEMORY; QUEEN PHEROMONE; GENE-EXPRESSION; TERM-MEMORY; ACTIVATION; BEHAVIOR	Alarm pheromone and its major component isopentylacetate induce stress-like responses in forager honey bees, impairing their ability to associate odors with a food reward. We investigated whether isopentylacetate exposure decreases appetitive learning also in young worker bees. While isopentylacetate-induced learning deficits were observed in guards and foragers collected from a queen-right colony, learning impairments resulting from exposure to this pheromone could not be detected in bees cleaning cells. As cell cleaners are generally among the youngest workers in the colony, effects of isopentylacetate on learning behavior were examined further using bees of known age. Adult workers were maintained under laboratory conditions from the time of adult emergence. Fifty percent of the bees were exposed to queen mandibular pheromone during this period, whereas control bees were not exposed to this pheromone. Isopentylacetate-induced learning impairments were apparent in young (less than one week old) controls, but not in bees of the same age exposed to queen mandibular pheromone. This study reveals young worker bees can exhibit a stress-like response to alarm pheromone, but isopentylacetate-induced learning impairments in young bees are suppressed by queen mandibular pheromone. While isopentylacetate exposure reduced responses during associative learning (acquisition), it did not affect one-hour memory retrieval.	[Urlacher, Elodie; Tarr, Ingrid S.; Mercer, Alison R.] Dept Zool, Dunedin 9054, New Zealand		Urlacher, E (corresponding author), Dept Zool, 340 Great King St,POB 56, Dunedin 9054, New Zealand.	elodie.urlacher@otago.ac.nz		Tarr, Ingrid/0000-0002-4847-2838; Mercer, Alison/0000-0001-8110-4247	Fyssen Foundation; Royal Society of New Zealand Marsden Fund [U00-1207]	Fyssen Foundation; Royal Society of New Zealand Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	Funding: This work was supported by grants from the Fyssen Foundation (www.fondation-fyssen.org, post doctoral fellowship for EU) and the Royal Society of New Zealand Marsden Fund (http://www.royalsociety.org.nz, U00-1207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaux C, 2007, J CHEM ECOL, V33, P1346, DOI 10.1007/s10886-007-9301-6; Balderrama N, 2002, J COMP PHYSIOL A, V188, P485, DOI 10.1007/s00359-002-0321-y; Bates D, 2012, LME4 LINEAR MIXED EF; Beggs KT, 2005, INSECT BIOCHEM MOLEC, V35, P873, DOI 10.1016/j.ibmb.2005.03.005; Beggs KT, 2009, CURR BIOL, V19, P1206, DOI 10.1016/j.cub.2009.05.051; Behrends A, 2012, J EXP BIOL, V215, P1076, DOI 10.1242/jeb.063297; Behrends A, 2009, ANIM COGN, V12, P249, DOI 10.1007/s10071-008-0187-7; Ben-Shahar Y, 2001, J COMP PHYSIOL A, V187, P891, DOI 10.1007/s00359-001-0260-z; BITTERMAN ME, 1983, J COMP PSYCHOL, V97, P107, DOI 10.1037/0735-7036.97.2.107; Breed MD, 2004, ANNU REV ENTOMOL, V49, P271, DOI 10.1146/annurev.ento.49.061802.123155; COLLINS AM, 1983, J CHEM ECOL, V9, P57, DOI 10.1007/BF00987770; COLLINS AM, 1980, ANN ENTOMOL SOC AM, V73, P307, DOI 10.1093/aesa/73.3.307; COLLINS AM, 1982, J CHEM ECOL, V8, P463, DOI 10.1007/BF00987794; Elekonich MM, 2005, COMP BIOCHEM PHYS A, V141, P362, DOI 10.1016/j.cbpb.2005.04.014; ERBER J, 1980, PHYSIOL ENTOMOL, V5, P343, DOI 10.1111/j.1365-3032.1980.tb00244.x; FLURI P, 1982, J INSECT PHYSIOL, V28, P61, DOI 10.1016/0022-1910(82)90023-3; FREE J. B., 1961, ANIMAL BEHAVIOUR, V9, P193, DOI 10.1016/0003-3472(61)90008-2; FREE JB, 1968, Z VERGL PHYSIOL, V61, P361, DOI 10.1007/BF00428008; Friedrich A, 2004, J NEUROSCI, V24, P4460, DOI 10.1523/JNEUROSCI.0669-04.2004; Giray T, 2000, BEHAV ECOL, V11, P44, DOI 10.1093/beheco/11.1.44; Grozinger CM, 2003, P NATL ACAD SCI USA, V100, P14519, DOI 10.1073/pnas.2335884100; Grunbaum L, 1998, J NEUROSCI, V18, P4384; Haehnel M, 2012, J EXP BIOL, V215, P559, DOI 10.1242/jeb.059626; HILDEBRANDT H, 1995, BRAIN RES, V679, P281, DOI 10.1016/0006-8993(95)00246-M; HUANG ZY, 1994, J COMP PHYSIOL A, V174, P731, DOI 10.1007/BF00192722; Hunt GJ, 2007, J INSECT PHYSIOL, V53, P399, DOI 10.1016/j.jinsphys.2007.01.010; Jarriault D, 2012, APIDOLOGIE, V43, P292, DOI 10.1007/s13592-011-0117-6; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; KAATZ HH, 1992, J COMP PHYSIOL B, V162, P588, DOI 10.1007/BF00296638; Le Conte Y, 2001, P ROY SOC B-BIOL SCI, V268, P163, DOI 10.1098/rspb.2000.1345; Ledoux MN, 2001, INSECT SOC, V48, P14, DOI 10.1007/PL00001738; Louis T, 2012, EUR J NEUROSCI, V36, P3438, DOI 10.1111/j.1460-9568.2012.08261.x; Maleszka R, 2001, HORM BEHAV, V40, P403, DOI 10.1006/hbeh.2001.1705; McQuillan HJ, 2012, LEARN MEMORY, V19, P151, DOI 10.1101/lm.025353.111; McQuillan HJ, 2012, J COMP PHYSIOL A, V198, P753, DOI 10.1007/s00359-012-0745-y; Menzel R, 1996, ANNU REV NEUROSCI, V19, P379, DOI 10.1146/annurev.ne.19.030196.002115; Menzel R., 1974, P195; Menzel R, 1999, J COMP PHYSIOL A, V185, P323, DOI 10.1007/s003590050392; Menzel R, 2013, HDB BEHAV NEUROSCIEN, V22, P347; Menzel R, 2012, NAT REV NEUROSCI, V13, P758, DOI 10.1038/nrn3357; Morgado-Bernal I, 2011, NEUROSCIENCE, V176, P12, DOI 10.1016/j.neuroscience.2010.12.056; Morgan SM, 1998, BEHAV BRAIN RES, V91, P115, DOI 10.1016/S0166-4328(97)00118-6; Muller U, 2012, APIDOLOGIE, V43, P322, DOI 10.1007/s13592-011-0115-8; Muller U, 2000, NEURON, V27, P159, DOI 10.1016/S0896-6273(00)00017-9; Nunez J, 1997, PHYSIOL BEHAV, V63, P75, DOI 10.1016/S0031-9384(97)00391-0; Pankiw T, 1998, J INSECT PHYSIOL, V44, P685, DOI 10.1016/S0022-1910(98)00040-7; R Core Team, 2021, R LANGUAGE ENV STAT; Ray S, 1999, DEV PSYCHOBIOL, V34, P21, DOI 10.1002/(SICI)1098-2302(199901)34:1<21::AID-DEV4>3.3.CO;2-B; Ray S, 1997, NEUROREPORT, V8, P789, DOI 10.1097/00001756-199702100-00042; ROBINSON GE, 1987, J COMP PHYSIOL A, V160, P613, DOI 10.1007/BF00611934; ROBINSON GE, 1989, SCIENCE, V246, P109, DOI 10.1126/science.246.4926.109; RUTZ W, 1976, J INSECT PHYSIOL, V22, P1485, DOI 10.1016/0022-1910(76)90214-6; Sakagami S. F., 1954, Insectes Sociaux Paris, V1, P331, DOI 10.1007/BF02329618; Sandoz JC, 2007, FRONT BEHAV NEUROSCI, V1, DOI 10.3389/neuro.08.005.2007; Scheiner R, 2004, APIDOLOGIE, V35, P133, DOI 10.1051/apido:2004001; Scheiner R, 2001, BEHAV BRAIN RES, V120, P67, DOI 10.1016/S0166-4328(00)00359-4; Slessor KN, 2005, J CHEM ECOL, V31, P2731, DOI 10.1007/s10886-005-7623-9; Urlacher E, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00157; Vaitkevieiene G, 1999, PHEROMONES, V6, P39; Vergoz V, 2007, SCIENCE, V317, P384, DOI 10.1126/science.1142448; Wang SP, 2008, J INSECT PHYSIOL, V54, P833, DOI 10.1016/j.jinsphys.2008.03.004; Winston M.L., 1991, BIOL HONEY BEE	62	6	6	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113630	10.1371/journal.pone.0113630	http://dx.doi.org/10.1371/journal.pone.0113630			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470128	gold, Green Submitted, Green Published			2022-12-26	WOS:000349128700038
J	Habermehl, D; Ilicic, K; Dehne, S; Rieken, S; Orschiedt, L; Brons, S; Haberer, T; Weber, KJ; Debus, J; Combs, SE				Habermehl, Daniel; Ilicic, Katarina; Dehne, Sarah; Rieken, Stefan; Orschiedt, Lena; Brons, Stephan; Haberer, Thomas; Weber, Klaus-Josef; Debus, Juergen; Combs, Stephanie E.			The Relative Biological Effectiveness for Carbon and Oxygen Ion Beams Using the Raster-Scanning Technique in Hepatocellular Carcinoma Cell Lines	PLOS ONE			English	Article							STEREOTACTIC BODY RADIOTHERAPY; PHASE-I; THERAPY; TEMOZOLOMIDE; IRRADIATION; SURVIVAL; DAMAGE; LIVER; MODEL	Background: Aim of this study was to evaluate the relative biological effectiveness (RBE) of carbon (12C) and oxygen ion (16O)-irradiation applied in the raster-scanning technique at the Heidelberg Ion beam Therapy center (HIT) based on clonogenic survival in hepatocellular carcinoma cell lines compared to photon irradiation. Methods: Four human HCC lines Hep3B, PLC, HepG2 and HUH7 were irradiated with photons, 12C and 16O using a customized experimental setting at HIT for invitro trials. Cells were irradiated with increasing physical photon single doses of 0, 2, 4 and 6 Gy and heavy ionsingle doses of 0, 0.125, 0.5, 1, 2, 3 Gy (12C and 16O). SOBP-penetration depth and extension was 35 mm +/-4 mm and 36 mm +/-5 mm for carbon ions and oxygen ions respectively. Mean energy level and mean linear energy transfer (LET) were 130 MeV/u and 112 keV/um for 12C, and 154 MeV/u and 146 keV/um for 16O. Clonogenic survival was computated and realtive biological effectiveness (RBE) values were defined. Results: For all cell lines and both particle modalities alpha- and beta-values were determined. As expected, alpha-values were significantly higher for 12C and 16O than for photons, reflecting a steeper decline of the initial slope of the survival curves for high-LET beams. RBE-values were in the range of 2.1-3.3 and 1.9-3.1 for 12C and 16O, respectively. Conclusion: Both irradiation with 12C and 16O using the rasterscanning technique leads to an enhanced RBE in HCC cell lines. No relevant differences between achieved RBE-values for 12C and 16O were found. Results of this work will further influence biological-adapted treatment planning for HCC patients that will undergo particle therapy with 12C or 16O.	[Habermehl, Daniel; Ilicic, Katarina; Dehne, Sarah; Rieken, Stefan; Orschiedt, Lena; Weber, Klaus-Josef; Debus, Juergen] Dept Radiat Oncol, D-69120 Heidelberg, Germany; [Brons, Stephan; Haberer, Thomas] Heidelberg Ion Beam Therapy Ctr HIT, D-69120 Heidelberg, Germany; [Habermehl, Daniel; Combs, Stephanie E.] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-81675 Munich, Germany	Ruprecht Karls University Heidelberg; Technical University of Munich	Habermehl, D (corresponding author), Dept Radiat Oncol, Neuenheimer Feld 400, D-69120 Heidelberg, Germany.	daniel.habermehl@tum.de		Combs, Stephanie/0000-0002-6934-2864	Klinische Forschergruppe Schwerionentherapie of the University of Heidelberg (GERMAN RESEARCH FOUNDATION) [KFO 214]	Klinische Forschergruppe Schwerionentherapie of the University of Heidelberg (GERMAN RESEARCH FOUNDATION)	The study was supported by the Klinische Forschergruppe Schwerionentherapie (KFO 214) of the University of Heidelberg (GERMAN RESEARCH FOUNDATION). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonovic L, 2013, J RADIAT RES, V54, P18, DOI 10.1093/jrr/rrs070; Bassler N, 2014, ACTA ONCOL, V53, P25, DOI 10.3109/0284186X.2013.832835; Bujold A, 2013, J CLIN ONCOL, V31, P1631, DOI 10.1200/JCO.2012.44.1659; Colombo M, 2013, EUR J GASTROEN HEPAT, V25, P639, DOI 10.1097/MEG.0b013e32835e33bb; Combs SE, 2007, INT J RADIAT ONCOL, V68, P873, DOI 10.1016/j.ijrobp.2007.03.002; Combs SE, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-67; Combs SE, 2009, INT J RADIAT BIOL, V85, P126, DOI 10.1080/09553000802641151; El Shafie RA, 2013, J RADIAT RES, V54, P113, DOI 10.1093/jrr/rrt052; Friedrich T, 2012, INT J RADIAT BIOL, V88, P103, DOI 10.3109/09553002.2011.611213; Habermehl D, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-59; Harrabi S, 2013, INT J RADIAT BIOL, V89, P692, DOI 10.3109/09553002.2013.791406; Imada H, 2010, RADIOTHER ONCOL, V96, P231, DOI 10.1016/j.radonc.2010.05.019; Jung J, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-249; Komatsu S, 2011, CANCER-AM CANCER SOC, V117, P4890, DOI 10.1002/cncr.26134; NCCN, 2013, HEP CANC; Ofuchi T, 1999, J RADIAT RES, V40, P125, DOI 10.1269/jrr.40.125; Pathak R, 2007, MUTAT RES-GEN TOX EN, V632, P58, DOI 10.1016/j.mrgentox.2007.04.007; Scholz M, 1997, RADIAT ENVIRON BIOPH, V36, P59, DOI 10.1007/s004110050055; Son SH, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-61; Xi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063864; Zheng SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065753	21	27	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113591	10.1371/journal.pone.0113591	http://dx.doi.org/10.1371/journal.pone.0113591			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460352	gold, Green Published, Green Submitted			2022-12-26	WOS:000345869700038
J	Snider, AJ; Ali, WH; Sticca, JA; Coant, N; Ghaleb, AM; Kawamori, T; Yang, VW; Hannun, YA; Obeid, LM				Snider, Ashley J.; Ali, Wahida H.; Sticca, Jonathan A.; Coant, Nicolas; Ghaleb, Amr M.; Kawamori, Toshihiko; Yang, Vincent W.; Hannun, Yusuf A.; Obeid, Lina M.			Distinct Roles for Hematopoietic and Extra-Hematopoietic Sphingosine Kinase-1 in Inflammatory Bowel Disease	PLOS ONE			English	Article							NEUTROPHIL-LYMPHOCYTE RATIO; ULCERATIVE-COLITIS; TNF-ALPHA; KNOCKOUT MICE; CELL-DEATH; SPHINGOSINE-1-PHOSPHATE; RECEPTORS; CERAMIDE; EGRESS; CHEMOTAXIS	Sphingosine kinase 1 (SK1), one of two SK enzymes, is highly regulated and has been shown to act as a focal point for the action of many growth factors and cytokines. SK1 leads to generation of sphingosine-1-phosphate (S1P) and potentially the activation of S1P receptors to mediate biologic effects. Our previous studies implicated SK1/S1P in the regulation of inflammatory processes, specifically in inflammatory bowel disease (IBD). These studies were conducted using a total body knockout mouse for SK1 and were unable to determine the source of SK1/S1P (hematopoietic or extra-hematopoietic) involved in the inflammatory responses. Therefore, bone marrow transplants were performed with wild-type (WT) and SK1-/- mice and colitis induced with dextran sulfate sodium (DSS). Irrespective of the source of SK1/S1P, bone marrow or tissue, DSS induced colitis in all mice; however, mice lacking SK1 in both hematopoietic and extra-hematopoietic compartments exhibited decreased crypt damage. Systemic inflammation was assessed, and mice with WT bone marrow demonstrated significant neutrophilia in response to DSS. In the local inflammatory response, mice lacking SK1/S1P in either bone marrow or tissue exhibited decreased induction of cytokines and less activation of STAT3 (signal transducer and activator of transcription 3). Interestingly, we determined that extra-hematopoietic SK1 is necessary for the induction of cyclooxygenase 2 (COX2) in colon epithelium in response to DSS-induced colitis. Taken together our data suggest that hematopoietic-derived SK1/S1P regulates specific aspects of the systemic inflammatory response, while extra-hematopoietic SK1 in the colon epithelium is necessary for the autocrine induction of COX2 in DSS-induced colitis.	[Snider, Ashley J.; Obeid, Lina M.] Northport Vet Affairs Med Ctr, Northport, NY 11768 USA; [Snider, Ashley J.; Ali, Wahida H.; Coant, Nicolas; Ghaleb, Amr M.; Yang, Vincent W.; Hannun, Yusuf A.; Obeid, Lina M.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Snider, Ashley J.; Ghaleb, Amr M.; Yang, Vincent W.; Hannun, Yusuf A.; Obeid, Lina M.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Sticca, Jonathan A.] Univ S Carolina, Sch Med, Columbia, SC USA; [Kawamori, Toshihiko] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA; [Kawamori, Toshihiko] Ichinomiya Nishi Hosp, Dept Pathol, Nagoya, Aichi, Japan	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of South Carolina; University of South Carolina System; University of South Carolina Columbia; Cancer Research Center of Hawaii; University of Hawaii System	Snider, AJ (corresponding author), Northport Vet Affairs Med Ctr, Northport, NY 11768 USA.	ashley.snider@stonybrook.edu		COANT, Nicolas/0000-0001-9237-2132; obeid, lina/0000-0002-0734-0847; Hanel, Wahida/0000-0003-0196-8040	Veterans Affairs Career Development Award; Veterans Affairs Merit Award; NIH [GM062887, CA124687]; NATIONAL CANCER INSTITUTE [P01CA097132, R01CA124687, P30CA138313, R01CA172517] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062887] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000156] Funding Source: NIH RePORTER	Veterans Affairs Career Development Award; Veterans Affairs Merit Award(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by a Veterans Affairs Career Development Award (AJS), a Veterans Affairs Merit Award (LMO) and as well as NIH Grant GM062887 (LMO), and CA124687 (TK). Lipid analyses provided by the Lipidomics Shared Resource, Hollings Cancer Center, Medical University of South Carolina (P30 CA138313) and the Lipidomics Core in the South Carolina Lipidomics and Pathobiology COBRE, Department Biochemistry, MUSC (P20 RR017677). Animal experiments were performed using mice from the Animal Pathobiology Core (P01CA097132). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adada MM, 2013, J BIOL CHEM; Allende ML, 2011, J BIOL CHEM, V286, P7348, DOI 10.1074/jbc.M110.171819; Allende ML, 2004, J BIOL CHEM, V279, P52487, DOI 10.1074/jbc.M406512200; Rosillo MA, 2012, PHARMACOL RES, V66, P235, DOI 10.1016/j.phrs.2012.05.006; Baker DA, 2012, RHEUMATOL INT; Baker DA, 2010, J IMMUNOL, V185, P2570, DOI 10.4049/jimmunol.1000644; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; Billich A, 2005, CELL SIGNAL, V17, P1203, DOI 10.1016/j.cellsig.2004.12.005; Celikbilek M, 2013, J CLIN LAB ANAL, V27, P72, DOI 10.1002/jcla.21564; Chiba K, 2005, PHARMACOL THERAPEUT, V108, P308, DOI 10.1016/j.pharmthera.2005.05.002; Chiba K, 2006, CELL MOL IMMUNOL, V3, P11; Heffernan-Stroud LA, 2012, ONCOGENE, V31, P1166, DOI 10.1038/onc.2011.302; Ibrahim FBM, 2004, J BIOL CHEM, V279, P44802, DOI 10.1074/jbc.M403977200; Jolly PS, 2004, J EXP MED, V199, P959, DOI 10.1084/jem.20030680; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; Lee C, 2004, J TRAUMA, V57, P955, DOI 10.1097/01.ta.0000149495.44582.76; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Maines LW, 2008, DIGEST DIS SCI, V53, P997, DOI 10.1007/s10620-007-0133-6; Melendez AJ, 2004, J IMMUNOL, V173, P1596, DOI 10.4049/jimmunol.173.3.1596; Michaud J, 2006, FEBS LETT, V580, P4607, DOI 10.1016/j.febslet.2006.07.035; Mullen TD, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.230870; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; OBEID LM, 1993, SCIENCE, V259, P1769, DOI 10.1126/science.8456305; Orr Gandy KA, 2013, FASEB J, DOI 10.1096/fj.13-228460; Pappu R, 2007, SCIENCE, V316, P295, DOI 10.1126/science.1139221; Paugh BS, 2009, J BIOL CHEM, V284, P3408, DOI 10.1074/jbc.M807170200; Pettus BJ, 2003, FASEB J, V17, P1411, DOI 10.1096/fj.02-1038com; Pushparaj PN, 2009, J IMMUNOL, V183, P221, DOI 10.4049/jimmunol.0803430; Pyne S, 2000, PHARMACOL THERAPEUT, V88, P115, DOI 10.1016/S0163-7258(00)00084-X; Ross JS, 2013, J BIOL CHEM, V288, P22193, DOI 10.1074/jbc.M113.477786; Sanchez-Fidalgo S, 2010, EUR J PHARMACOL, V633, P78, DOI 10.1016/j.ejphar.2010.01.025; Sarkar S, 2005, FEBS LETT, V579, P5313, DOI 10.1016/j.febslet.2005.08.055; Snider AJ, 2012, PROSTAG OTH LIPID M, V99, P124, DOI 10.1016/j.prostaglandins.2012.08.003; Snider AJ, 2009, FASEB J, V23, P143, DOI 10.1096/fj.08-118109; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Torun S, 2012, CLIN RES HEPATOL GAS, V36, P491, DOI 10.1016/j.clinre.2012.06.004; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; Vogel P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004112; Zemann B, 2007, IMMUNOL LETT, V109, P56, DOI 10.1016/j.imlet.2007.01.001	39	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113998	10.1371/journal.pone.0113998	http://dx.doi.org/10.1371/journal.pone.0113998			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460165	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700077
J	Wu, CX; Cheng, WY; Sun, Y; Dang, YH; Gong, FY; Zhu, HJ; Li, NS; Li, F; Zhu, ZH				Wu, Chenxi; Cheng, Wuying; Sun, Yi; Dang, Yonghong; Gong, Fengying; Zhu, Huijuan; Li, Naishi; Li, Fang; Zhu, Zhaohui			Activating Brown Adipose Tissue for Weight Loss and Lowering of Blood Glucose Levels: A MicroPET Study Using Obese and Diabetic Model Mice	PLOS ONE			English	Article							SYMPATHETIC-NERVOUS-SYSTEM; INSULIN-RESISTANCE; FAT; THERMOGENESIS; MECHANISMS; BRL-37344	Purpose: This study aims at using F-18-FDG microPET to monitor the brown adipose tissue (BAT) glucose metabolism in obese and diabetic mouse models under different interventions, and study the therapeutic potential of BAT activation for weight loss and lowering of blood glucose in these models. Methods: Obese mice were established by a high-fat diet for eight weeks, and diabetes mellitus(DM) models were induced with Streptozocin in obese mice. F-18-FDG microPET was used to monitor BAT function during obese and DM modeling, and also after BRL37344 (a beta(3)-adrenergic receptor agonist) or levothyroxine treatment. The BAT function was correlated with the body weight and blood glucose levels. Results: Compared with the controls, the obese mice and DM mice showed successively lower F-18-FDG uptake in the interscapular BAT (P=0.036 and <0.001, respectively). After two-week BRL37344 treatment, the BAT uptake was significantly elevated in both obese mice (P=0.010) and DM mice (P=0.004), accompanied with significantly decreased blood glucose levels (P=0.023 and 0.036, respectively). The BAT uptake was negatively correlated with the blood glucose levels in both obese mice (r=-0.71, P=0.003) and DM mice (r=-0.74, P=0.010). BRL37344 treatment also caused significant weight loss in the obese mice (P=0.001). Levothyroxine treatment increased the BAT uptake in the control mice (P=0.025) and obese mice (P=0.013), but not in the DM mice (P=0.45). Conclusion: The inhibited BAT function in obese and DM mice can be re-activated by beta(3)-adrenergic receptor agonist or thyroid hormone, and effective BAT activation DMmay lead to weight loss and blood glucose lowering. Activating BAT can provide a new treatment strategy for obesity and DM.	[Wu, Chenxi; Cheng, Wuying; Sun, Yi; Dang, Yonghong; Li, Fang; Zhu, Zhaohui] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Nucl Med, Beijing 100730, Peoples R China; [Wu, Chenxi; Cheng, Wuying; Sun, Yi; Dang, Yonghong; Gong, Fengying; Zhu, Huijuan; Li, Naishi; Li, Fang; Zhu, Zhaohui] Peking Union Med Coll, Beijing 100730, Peoples R China; [Gong, Fengying; Zhu, Huijuan; Li, Naishi] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Endocrinol, Beijing 100730, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Cheng, WY (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Nucl Med, Beijing 100730, Peoples R China.	cwypumch@126.com; zhuzhh@pumch.cn	Zhu, Zhaohui/CAA-1003-2022; Li, Naishi/ABI-7607-2020	Li, Naishi/0000-0002-2261-7349	National Natural Science Foundation of China (NSFC) [81101074, 81371588]; Graduate Student Innovation Foundation of PUMCH [2011-1002-25]; Young and Middle-aged Researcher Science Fund of PUMCH from Key Laboratory of Endocrinology of Health and Family Planning Committee; UCSF-PUMCH RAP	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Graduate Student Innovation Foundation of PUMCH; Young and Middle-aged Researcher Science Fund of PUMCH from Key Laboratory of Endocrinology of Health and Family Planning Committee; UCSF-PUMCH RAP	This work is supported by National Natural Science Foundation of China (NSFC) (No. 81101074, No. 81371588); Graduate Student Innovation Foundation of PUMCH (No. 2011-1002-25); 2012 Young and Middle-aged Researcher Science Fund of PUMCH, funding from Key Laboratory of Endocrinology of Health and Family Planning Committee, and an UCSF-PUMCH RAP funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bhadada SV, 2011, THER ADV ENDOCRINOL, V2, P65, DOI 10.1177/2042018810390259; Bianco AC, 2013, LANCET DIABETES ENDO, V1, P250, DOI 10.1016/S2213-8587(13)70069-X; Bredella MA, 2012, J CLIN ENDOCR METAB, V97, pE584, DOI 10.1210/jc.2011-2246; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cheng WY, 2012, CLIN NUCL MED, V37, P514, DOI 10.1097/RLU.0b013e31824d2121; Cypess AM, 2010, CURR OPIN ENDOCRINOL, V17, P143, DOI 10.1097/MED.0b013e328337a81f; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dora JM, 2010, EUR J ENDOCRINOL, V163, P427, DOI 10.1530/EJE-10-0419; Drubach LA, 2011, J PEDIATR-US, V159, P939, DOI 10.1016/j.jpeds.2011.06.028; Esler M, 2001, AM J HYPERTENS, V14, p304S, DOI 10.1016/S0895-7061(01)02236-1; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Fueger BJ, 2006, J NUCL MED, V47, P999; Gavrilova O, 2000, J CLIN INVEST, V105, P271, DOI 10.1172/JCI7901; GRANNEMAN JG, 1990, J PHARMACOL EXP THER, V254, P508; HEATON GM, 1978, EUR J BIOCHEM, V82, P515, DOI 10.1111/j.1432-1033.1978.tb12045.x; Jacene HA, 2011, MOL IMAGING BIOL, V13, P1278, DOI 10.1007/s11307-010-0379-9; Kaptein EM, 2009, J CLIN ENDOCR METAB, V94, P3663, DOI 10.1210/jc.2009-0899; Kontani Y, 2005, AGING CELL, V4, P147, DOI 10.1111/j.1474-9726.2005.00157.x; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liu XL, 1998, AM J PHYSIOL-REG I, V274, pR1212, DOI 10.1152/ajpregu.1998.274.5.R1212; Masuo K, 2011, J OBES, V2011, DOI 10.1155/2011/609485; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; NISOLI E, 1995, J NEUROCHEM, V65, P1580; RICHARDSON JM, 1991, J BIOL CHEM, V266, P12690; Sacks H, 2013, DIABETES, V62, P1783, DOI 10.2337/db12-1430; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Seale P, 2009, DIABETES, V58, P1482, DOI 10.2337/db09-0622; Straznicky NE, 2012, J CLIN ENDOCR METAB, V97, P605, DOI 10.1210/jc.2011-2320; Suarez J, 2014, DIS MODEL MECH, V7, P129, DOI 10.1242/dmm.013110; Vasilijevic A, 2010, NITRIC OXIDE-BIOL CH, V23, P42, DOI 10.1016/j.niox.2010.04.001; Vijgen GHEJ, 2012, J CLIN ENDOCR METAB, V97, pE1229, DOI 10.1210/jc.2012-1289; Vijgen GHEJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017247; Villarroya F, 2013, CELL METAB, V17, P638, DOI 10.1016/j.cmet.2013.02.020; Vosselman MJ, 2013, MOL CELL ENDOCRINOL; Wijers SLJ, 2011, J CLIN ENDOCR METAB, V96, pE598, DOI 10.1210/jc.2010-1957; Williams CA, 1999, BRIT J PHARMACOL, V128, P1586, DOI 10.1038/sj.bjp.0702946; Williams G, 2008, AM J ROENTGENOL, V190, P1406, DOI 10.2214/AJR.07.3205; Wu CX, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/159834	40	18	19	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113742	10.1371/journal.pone.0113742	http://dx.doi.org/10.1371/journal.pone.0113742			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462854	Green Published, Green Submitted, gold			2022-12-26	WOS:000345869700047
J	Zhang, Y; Wang, YF; Yang, K; Tian, LC; Fu, X; Wang, Y; Sun, YQ; Jiang, Q; Lu, WJ; Wang, J				Zhang, Yi; Wang, Yingfeng; Yang, Kai; Tian, Lichun; Fu, Xin; Wang, Yan; Sun, Yueqian; Jiang, Qian; Lu, Wenju; Wang, Jian			BMP4 Increases the Expression of TRPC and Basal [Ca2+](i) via the p38MAPK and ERK1/2 Pathways Independent of BMPRII in PASMCs	PLOS ONE			English	Article							ARTERIAL SMOOTH-MUSCLE; PRIMARY PULMONARY-HYPERTENSION; CAPACITATIVE CA2+ ENTRY; RECEPTOR POTENTIAL EXPRESSION; BONE MORPHOGENETIC PROTEIN-4; II RECEPTOR; SIGNAL-TRANSDUCTION; GERMLINE MUTATIONS; INTRACELLULAR CA2+; UP-REGULATION	Multiple abnormalities of bone morphogenetic protein (BMPs) signaling are implicated in the process of pulmonary arterial hypertension (PAH). BMP4 plays an important role during the process of pulmonary arterial remodeling and mutant of the principle BMP4 receptor, BMP receptors II (BMPRII), is found to associate with the development of PAH. However, the likely mechanism defining the contribution of BMPRII to BMP4 mediated signaling in pulmonary arterial smooth muscle cells (PASMCs) remains comprehensively unclear. We previously found that enhanced store operated calcium entry (SOCE) and basal intracellular calcium concentration [Ca2+](i) were induced by BMP4 via upregulation of TRPC1, 4 and 6 expression in PASMCs, and that BMP4 modulated TRPC channel expression through activating p38MAPK and ERK1/2 signaling pathways. In this study, BMPRII siRNA was used to knockdown BMPRII expression to investigate whether BMP4 upregulates the expression of TRPC and activating Smad1/5/8, ERK1/2 and p38MAPK pathway via BMPRII in distal PASMCs. Our results showed that knockdown of BMPRII: 1) attenuated BMP4 induced activation of P-Smad1/5/8, without altering BMP4 induced P-p38MAPK and P-ERK1/2 activation in PASMCs; 2) did not attenuate the BMP4-induced TRPC1, 4 and 6 expression; 3) did not affect BMP4-enhanced SOCE and basal [Ca2+](i). Thus, we concluded that BMP4 activated Smad1/5/8 pathway is BMPRII-dependent, while the BMP4 - ERK/p-P38 - TRPC - SOCE signaling axis are likely mediated through other receptor rather than BMPRII.	[Zhang, Yi; Wang, Yingfeng; Yang, Kai; Tian, Lichun; Fu, Xin; Wang, Yan; Jiang, Qian; Lu, Wenju; Wang, Jian] Guangzhou Med Univ, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China; [Lu, Wenju] Guangzhou Med Univ, Affiliated Hosp 1, Dept Lab Med, Guangzhou, Guangdong, Peoples R China; [Zhang, Yi] Guangzhou Med Univ, Affiliated Hosp 2, Guangzhou, Guangdong, Peoples R China; [Zhang, Yi; Yang, Kai; Wang, Jian] Johns Hopkins Univ, Sch Med, Div Pulm & Crit Care Med, Baltimore, MD USA; [Sun, Yueqian] Univ Toronto, Dept Arts & Sci, Toronto, ON, Canada; [Wang, Jian] Inner Mongolia Peoples Hosp, Dept Pulm, Hohhot, Inner Mongolia, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Guangzhou Medical University; Guangzhou Medical University; Johns Hopkins University; University of Toronto	Lu, WJ (corresponding author), Guangzhou Med Univ, Guangzhou Inst Resp Dis, State Key Lab Resp Dis, Guangzhou, Guangdong, Peoples R China.	wlu92@yahoo.com; jwang31@jhmi.edu	Yang, Kai/I-6524-2019	Yang, Kai/0000-0003-3044-2240	National Institutes of Health (NIH) [R01HL093020]; National Natural Science Foundation of China [81173112, 81170052, 81220108001]; Guangdong Natural Science Foundation; Guangzhou Department of Education [12A001S]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL093020] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangzhou Department of Education; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health (NIH) Research Grants (R01HL093020), National Natural Science Foundation of China (81173112, 81170052, 81220108001), Guangdong Natural Science Foundation team grant (2010), and Guangzhou Department of Education Yangcheng Scholarship (12A001S). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariano P, 2011, CELL CALCIUM, V49, P387, DOI 10.1016/j.ceca.2011.03.007; Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERRIDGE MJ, 1995, BIOESSAYS, V17, P491, DOI 10.1002/bies.950170605; Bertolino P, 2005, CHEST, V128, p585S, DOI 10.1378/chest.128.6_suppl.585S; Davies RJ, 2008, CHEST, V134, P1271, DOI 10.1378/chest.08-1341; Eickelberg O, 2007, TRENDS CARDIOVAS MED, V17, P263, DOI 10.1016/j.tcm.2007.09.003; Frank DB, 2005, CIRC RES, V97, P496, DOI 10.1161/01.RES.0000181152.65534.07; Golovina VA, 2001, AM J PHYSIOL-HEART C, V280, pH746, DOI 10.1152/ajpheart.2001.280.2.H746; GUTIERREZ FR, 1980, AM J ROENTGENOL, V135, P177, DOI 10.2214/ajr.135.1.177; Harper JF, 2005, NAT REV MOL CELL BIO, V6, P555, DOI 10.1038/nrm1679; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Hyvelin JM, 1998, AM J PHYSIOL-LUNG C, V275, pL269, DOI 10.1152/ajplung.1998.275.2.L269; Karaki H, 1997, PHARMACOL REV, V49, P157; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Lin MJ, 2004, CIRC RES, V95, P496, DOI 10.1161/01.RES.0000138952.16382.ad; LIU F, 1995, MOL CELL BIOL, V15, P3479; Long L, 2006, CIRC RES, V98, P818, DOI 10.1161/01.RES.0000215809.47923.fd; Lu WJ, 2010, AM J PHYSIOL-CELL PH, V299, pC1370, DOI 10.1152/ajpcell.00040.2010; Lu WJ, 2010, AM J PHYSIOL-CELL PH, V298, pC114, DOI 10.1152/ajpcell.00629.2008; Machado RD, 2001, AM J HUM GENET, V68, P92, DOI 10.1086/316947; Massague J, 2003, GENE DEV, V17, P2993, DOI 10.1101/gad.1167003; Mazerbourg S, 2005, J BIOL CHEM, V280, P32122, DOI 10.1074/jbc.M504629200; McDaniel SS, 2001, AM J PHYSIOL-LUNG C, V280, pL870, DOI 10.1152/ajplung.2001.280.5.L870; Morty RE, 2007, ARTERIOSCL THROM VAS, V27, P1072, DOI 10.1161/ATVBAHA.107.141200; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; NOHNO T, 1995, J BIOL CHEM, V270, P22522, DOI 10.1074/jbc.270.38.22522; Reynolds AM, 2007, AM J PHYSIOL-LUNG C, V292, pL1182, DOI 10.1152/ajplung.00020.2006; ROSENZWEIG BL, 1995, P NATL ACAD SCI USA, V92, P7632, DOI 10.1073/pnas.92.17.7632; Rudarakanchana N, 2002, HUM MOL GENET, V11, P1517, DOI 10.1093/hmg/11.13.1517; Selvaraj S, 2009, CELL CALCIUM, V46, P209, DOI 10.1016/j.ceca.2009.07.008; Sweeney M, 2002, AM J PHYSIOL-LUNG C, V283, pL144, DOI 10.1152/ajplung.00412.2001; Tada Y, 2007, AM J PHYSIOL-LUNG C, V292, pL1556, DOI 10.1152/ajplung.00305.2006; Takahashi H, 2006, AM J PHYSIOL-LUNG C, V290, pL450, DOI 10.1152/ajplung.00206.2005; Takeda M, 2004, ENDOCRINOLOGY, V145, P4344, DOI 10.1210/en.2004-0234; Thomson JR, 2000, J MED GENET, V37, P741, DOI 10.1136/jmg.37.10.741; Wang J, 2005, AM J PHYSIOL-LUNG C, V288, pL1059, DOI 10.1152/ajplung.00448.2004; Wang J, 2004, AM J PHYSIOL-LUNG C, V286, pL848, DOI 10.1152/ajplung.00319.2003; Wang J, 2006, CIRC RES, V98, P1528, DOI 10.1161/01.RES.0000227551.68124.98; Xia Y, 2007, J BIOL CHEM, V282, P18129, DOI 10.1074/jbc.M701679200; Yang XD, 2005, CIRC RES, V96, P1053, DOI 10.1161/01.RES.0000166926.54293.68; Yang XD, 2007, AM J RESP CELL MOL, V37, P598, DOI 10.1165/rcmb.2006-0360OC; Young KA, 2006, AM J PHYSIOL-LUNG C, V290, pL841, DOI 10.1152/ajplung.00158.2005; Yu PB, 2005, J BIOL CHEM, V280, P24443, DOI 10.1074/jbc.M502825200	45	9	13	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112695	10.1371/journal.pone.0112695	http://dx.doi.org/10.1371/journal.pone.0112695			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461595	Green Published, Green Submitted, gold			2022-12-26	WOS:000345869700022
J	Durmaz, R; Kalaycioglu, AT; Acar, S; Bakkaloglu, Z; Karagoz, A; Korukluoglu, G; Ertek, M; Torunoglu, MA				Durmaz, Riza; Kalaycioglu, Atila Taner; Acar, Sumeyra; Bakkaloglu, Zekiye; Karagoz, Alper; Korukluoglu, Gulay; Ertek, Mustafa; Torunoglu, Mehmet Ali		Turkish Rotavirus Surveillance Net	Prevalence of Rotavirus Genotypes in Children Younger than 5 Years of Age before the Introduction of a Universal Rotavirus Vaccination Program: Report of Rotavirus Surveillance in Turkey	PLOS ONE			English	Article							ACUTE GASTROENTERITIS; CHANGING PATTERNS; STRAINS; DIVERSITY; POPULATION; DIARRHEA; HUNGARY; EPIDEMIOLOGY; EMERGENCE; MORTALITY	Background: Group A rotaviruses are the most common causative agent of acute gastroenteritis among children less than 5 years of age throughout the world. This sentinel surveillance study was aimed to obtain baseline data on the rotavirus G and P genotypes across Turkey before the introduction of a universal rotavirus vaccination program. Methods: Rotavirus antigen-positive samples were collected from 2102 children less than 5 years of age who attended hospitals participating in the Turkish Rotavirus Surveillance Network. Rotavirus antigen was detected in the laboratories of participating hospitals by commercial serological tests such as latex agglutination, immunochromatographic test or enzyme immunoassay. Rotavirus G and P genotypes were determined by reverse transcription polymerase chain reaction (RT-PCR) using consensus primers detecting the VP7 and VP4 genes, followed by semi-nested type-specific multiplex PCR. Results: RT-PCR found rotavirus RNA in 1644 (78.2%) of the samples tested. The highest rate of rotavirus positivity (38.7%) was observed among children in the 13 to 24 month age group, followed by children in the age group of 25 to 36 months (28.3%). A total of eight different G types, six different P types, and 42 different G-P combinations were obtained. Four common G types (G1, G2, G3, and G9) and two common P types (P[8] and P[4]) accounted for 95.1% and 98.8% of the strains, respectively. G9P[8] was the most common G/P combination found in 40.5% of the strains followed by G1P[8] (21.6%), G2P[8] (9.3%), G2P[4] (6.5%), G3P[8] (3.5%), and finally, G4P[8] (3.4%). These six common genotypes included 83.7% of the strains tested in this study. The rate of uncommon genotypes was 14%. Conclusion: The majority of the strains analyzed belonged to the G1-G4 and G9 genotypes, suggesting high coverage of current rotavirus vaccines. This study also demonstrates a dramatic increase in G9 genotype across the country.	[Durmaz, Riza; Kalaycioglu, Atila Taner; Acar, Sumeyra; Bakkaloglu, Zekiye; Karagoz, Alper; Ertek, Mustafa; Torunoglu, Mehmet Ali] Publ Hlth Agcy Turkey, Mol Microbiol Res & Appl Lab, Ankara, Turkey; [Durmaz, Riza] Yildirim Beyazit Univ, Fac Med, Dept Med Microbiol, Ankara, Turkey; [Korukluoglu, Gulay] Publ Hlth Agcy Turkey, Virol Reference Cent Lab, Ankara, Turkey	Ankara Yildirim Beyazit University	Durmaz, R (corresponding author), Publ Hlth Agcy Turkey, Mol Microbiol Res & Appl Lab, Ankara, Turkey.	rdurmaz@ybu.edu.tr	Ozgur Gundeslioglu, Ozlem/T-1959-2018; Bakkaloğlu, Zekiye/K-9150-2019; Emiroğlu, Melike/AAH-3566-2019; NUHOĞLU, ÇAĞATAY/A-3223-2019; Korukluoglu, Gulay/AAB-5176-2022; ALDEMİR KOCABAŞ, Bilge/J-7145-2018; Feyzioğlu, Bahadır/W-4440-2017; Temel, Fehminaz/V-7066-2018	NUHOĞLU, ÇAĞATAY/0000-0003-2187-4121; ALDEMİR KOCABAŞ, Bilge/0000-0002-6396-5243; Feyzioğlu, Bahadır/0000-0002-0991-2132; Emiroglu, Melike/0000-0003-1307-0246; Temel, Fehminaz/0000-0003-3470-3823; Bayram, Nuri/0000-0003-1802-2518; TOPAL, SELMUR/0000-0002-6325-9760; saz, eylem ulas/0000-0002-2555-2712; Bakkaloglu, Zekiye/0000-0001-9137-016X; saz, eylem ulas/0000-0002-0012-544X; aksaray, sebahat/0000-0002-0552-1337	Turkish Ministry of Health, National Public Health Agency of Turkey [B.10.1.HSK.O.16.00.00/94/6386]	Turkish Ministry of Health, National Public Health Agency of Turkey(Ministry of Health - Turkey)	This sentinel surveillance study was supported by the Turkish Ministry of Health, National Public Health Agency of Turkey (B.10.1.HSK.O.16.00.00/94/6386). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067998; Altindis M, 2010, CENT EUR J MED, V5, P640, DOI 10.2478/s11536-009-0130-6; Anca Ioana Alina, 2014, Germs, V4, P30, DOI 10.11599/germs.2014.1053; Armah GE, 2003, J CLIN MICROBIOL, V41, P2317, DOI 10.1128/JCM.41.6.2317-2322.2003; Banyai K, 2005, J MED VIROL, V76, P414, DOI 10.1002/jmv.20372; Banyai K, 2009, J MED VIROL, V81, P362, DOI 10.1002/jmv.21375; Benhafid M, 2013, J MED VIROL, V85, P354, DOI 10.1002/jmv.23445; Bernstein DI, 2006, PEDIATR ANN, V35, P38, DOI 10.3928/0090-4481-20060101-12; Bozdayi G, 2008, J MED VIROL, V80, P733, DOI 10.1002/jmv.21120; Bresee J, 2004, EMERG INFECT DIS, V10, P988, DOI 10.3201/eid1006.030519; Cataloluk O, 2005, EPIDEMIOL INFECT, V133, P673, DOI 10.1017/S0950268805003882; Ceyhan M, 2009, J INFECT DIS, V200, pS234, DOI 10.1086/605056; Cunliffe NA, 1998, B WORLD HEALTH ORGAN, V76, P525; Dennehy PH, 2008, CLIN MICROBIOL REV, V21, P198, DOI 10.1128/CMR.00029-07; Gentsch JR, 2005, J INFECT DIS, V192, pS146, DOI 10.1086/431499; Hacimustafaoglu M, 2011, TURKISH J PEDIATR, V53, P604; Hull JJ, 2011, PEDIATR INFECT DIS J, V30, pS42, DOI 10.1097/INF.0b013e3181fefd78; Ianiro G, 2014, J MED VIROL, V86, P1073, DOI 10.1002/jmv.23871; Iturriza-Gomara M, 2004, J CLIN VIROL, V31, P259, DOI 10.1016/j.jcv.2004.04.009; Iturriza-gomara M, 2011, ROTAVIRUS STRAIN SUR; Jin Y, 2008, WORLD J PEDIATR, V4, P197, DOI 10.1007/s12519-008-0036-4; Kirkwood CD, 2011, COMMUN DIS INTELL, V35, P281; Kirkwood CD, 2010, COMMUN DIS INTELL, V34, P427; Konstantopoulos A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003570; Kurugol Z, 2003, TURKISH J PEDIATR, V45, P290; Laszlo B, 2012, J CLIN VIROL, V55, P140, DOI 10.1016/j.jcv.2012.06.016; Li Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084699; Matthijnssens J, 2011, ARCH VIROL, V156, P1397, DOI 10.1007/s00705-011-1006-z; Meral M, 2011, MIKROBIYOL BUL, V45, P104; Midgley S, 2014, INFECT GENET EVOL, V27, P114, DOI 10.1016/j.meegid.2014.07.008; Mladenova Z, 2010, EUR J CLIN MICROBIOL, V29, P555, DOI 10.1007/s10096-010-0895-1; Moyo SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097562; Ndze VN, 2013, J MED VIROL, V85, P1485, DOI 10.1002/jmv.23603; Offit PA, 2006, PEDIATR ANN, V35, P29, DOI 10.3928/0090-4481-20060101-11; Ogilvie I, 2011, HUM VACCINES, V7, P523, DOI 10.4161/hv.7.5.14819; Oh Ho-Kyung, 2012, Osong Public Health Res Perspect, V3, P36, DOI 10.1016/j.phrp.2012.01.006; Ozdemir S, 2010, MIKROBIYOL BUL, V44, P571; Parashar UD, 2009, J INFECT DIS, V200, pS9, DOI 10.1086/605025; Pukuta ES, 2014, PEDIATR INFECT DIS J, V33, P355, DOI 10.1097/INF.0000000000000212; Ramig RF, 1997, ANNU REV MICROBIOL, V51, P225, DOI 10.1146/annurev.micro.51.1.225; Santos N, 2005, REV MED VIROL, V15, P29, DOI 10.1002/rmv.448; Simmonds MK, 2008, J CLIN VIROL, V42, P368, DOI 10.1016/j.jcv.2008.02.011; Soares LD, 2014, J MED VIROL, V86, P1065, DOI 10.1002/jmv.23797; Stupka JA, 2012, J CLIN VIROL, V54, P162, DOI 10.1016/j.jcv.2012.02.011; Tapisiz A, 2011, CURR MICROBIOL, V63, P517, DOI 10.1007/s00284-011-0014-2; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; World Health Organization, GEN PROT MON IMP POT; Zeller M, 2010, VACCINE, V28, P7507, DOI 10.1016/j.vaccine.2010.09.004	48	39	44	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113674	10.1371/journal.pone.0113674	http://dx.doi.org/10.1371/journal.pone.0113674			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437502	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900063
J	LaPlante, RA; Douw, L; Tang, W; Stufflebeam, SM				LaPlante, Roan A.; Douw, Linda; Tang, Wei; Stufflebeam, Steven M.			The Connectome Visualization Utility: Software for Visualization of Human Brain Networks	PLOS ONE			English	Article							HUMAN CEREBRAL-CORTEX; SMALL-WORLD NETWORKS; FUNCTIONAL CONNECTIVITY; ANATOMICAL NETWORKS; COMMUNITY STRUCTURE; DIFFUSION MRI; MEG; PARCELLATION; ORGANIZATION; DYNAMICS	In analysis of the human connectome, the connectivity of the human brain is collected from multiple imaging modalities and analyzed using graph theoretical techniques. The dimensionality of human connectivity data is high, and making sense of the complex networks in connectomics requires sophisticated visualization and analysis software. The current availability of software packages to analyze the human connectome is limited. The Connectome Visualization Utility (CVU) is a new software package designed for the visualization and network analysis of human brain networks. CVU complements existing software packages by offering expanded interactive analysis and advanced visualization features, including the automated visualization of networks in three different complementary styles and features the special visualization of scalar graph theoretical properties and modular structure. By decoupling the process of network creation from network visualization and analysis, we ensure that CVU can visualize networks from any imaging modality. CVU offers a graphical user interface, interactive scripting, and represents data uses transparent neuroimaging and matrix-based file types rather than opaque application-specific file formats.	[LaPlante, Roan A.; Douw, Linda; Tang, Wei; Stufflebeam, Steven M.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Douw, Linda] Vrije Univ Amsterdam Med Ctr, Dept Anat & Clin Neurosci, Amsterdam, Netherlands; [Stufflebeam, Steven M.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Stufflebeam, Steven M.] Harvard MIT Hlth Sci & Technol, Cambridge, MA USA	Harvard University; Massachusetts General Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Harvard University; Harvard Medical School; Harvard University	LaPlante, RA (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA.	rlaplant@nmr.mgh.harvard.edu		Tang, Wei/0000-0003-3550-4076; Douw, Linda/0000-0001-7058-4062	National Institute of Health [R01-NS069696, U01-MH093765, P41-RR14075]; Defense Advanced Research Projects Agency; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR014075] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH093765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069696] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health (http://www.nih.gov/) grants R01-NS069696, U01-MH093765, and P41-RR14075 provided to SMS, and by the Defense Advanced Research Projects Agency (http://www.darpa.mil/) provided to SMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2006, J NEUROSCI, V26, P63, DOI 10.1523/JNEUROSCI.3874-05.2006; Bassett DS, 2011, NEUROIMAGE, V54, P1262, DOI 10.1016/j.neuroimage.2010.09.006; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Bastian M., 2009, INT AAAI C WEBL SOC, V8, P361, DOI DOI 10.13140/2.1.1341.1520; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Beckmann CF, 2005, PHILOS T R SOC B, V360, P1001, DOI 10.1098/rstb.2005.1634; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Blumensath T, 2013, NEUROIMAGE, V76, P313, DOI 10.1016/j.neuroimage.2013.03.024; Bonacich P, 2007, SOC NETWORKS, V29, P555, DOI 10.1016/j.socnet.2007.04.002; Brookes MJ, 2012, NEUROIMAGE, V63, P910, DOI 10.1016/j.neuroimage.2012.03.048; Brookes MJ, 2011, P NATL ACAD SCI USA, V108, P16783, DOI 10.1073/pnas.1112685108; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Brown J, 2012, FRONT NEUROINFORM, V6, DOI 10.3389/fninf.2012.00028; Cammoun L, 2012, J NEUROSCI METH, V203, P386, DOI 10.1016/j.jneumeth.2011.09.031; Cook P.A., 2006, 14 SCI M INT SOC MAG; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Daducci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048121; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davis FC, 2013, CEREB CORTEX, V23, P1444, DOI 10.1093/cercor/bhs126; de Pasquale F, 2012, NEURON, V74, P753, DOI 10.1016/j.neuron.2012.03.031; de Pasquale F, 2010, P NATL ACAD SCI USA, V107, P6040, DOI 10.1073/pnas.0913863107; DeSalvo MN, 2014, RADIOLOGY, V270, P842, DOI 10.1148/radiol.13131044; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fornito A, 2013, NEUROIMAGE, V80, P426, DOI 10.1016/j.neuroimage.2013.04.087; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Garyfallidis E, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00008; Gerhard S, 2011, FRONT NEUROINFORM, V5; Ghoniem M., 2005, Information Visualization, V4, P114, DOI 10.1057/palgrave.ivs.9500092; Gramfort A, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00267; Gramfort A, 2014, NEUROIMAGE, V86, P446, DOI 10.1016/j.neuroimage.2013.10.027; Gray WR, 2012, IEEE PULSE, V3, P42, DOI 10.1109/MPUL.2011.2181023; Greenblatt RE, 2012, J NEUROSCI METH, V207, P1, DOI 10.1016/j.jneumeth.2012.02.025; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hagmann P, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00043; Hagmann P, 2010, J NEUROSCI METH, V194, P34, DOI 10.1016/j.jneumeth.2010.01.014; HAMALAINEN MS, 1994, MED BIOL ENG COMPUT, V32, P35, DOI 10.1007/BF02512476; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005226; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Holten D, 2006, IEEE T VIS COMPUT GR, V12, P741, DOI 10.1109/TVCG.2006.147; Horstmann MT, 2010, CLIN NEUROPHYSIOL, V121, P172, DOI 10.1016/j.clinph.2009.10.013; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Johansen-Berg H, 2004, P NATL ACAD SCI USA, V101, P13335, DOI 10.1073/pnas.0403743101; Klein JC, 2007, NEUROIMAGE, V34, P204, DOI 10.1016/j.neuroimage.2006.08.022; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Liu Y, 2008, BRAIN, V131, P945, DOI 10.1093/brain/awn018; Melhem ER, 2002, AM J ROENTGENOL, V178, P3, DOI 10.2214/ajr.178.1.1780003; Meunier D., 2009, FRONT NEUROINFORM, V30, DOI [10.3389/neuro.11.037.2009, 10.3389/neuro.11.037.2009.eCollection2009]; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nolte G, 2004, CLIN NEUROPHYSIOL, V115, P2292, DOI 10.1016/j.clinph.2004.04.029; Oliphant TE, 2007, COMPUT SCI ENG, V9, P10, DOI 10.1109/MCSE.2007.58; Ponten SC, 2007, CLIN NEUROPHYSIOL, V118, P918, DOI 10.1016/j.clinph.2006.12.002; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ramachandran P, 2011, COMPUT SCI ENG, V13, P40, DOI 10.1109/MCSE.2011.35; Roca P, 2009, LECT NOTES COMPUT SC, V5761, P935, DOI 10.1007/978-3-642-04268-3_115; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stam CJ, 2002, PHYSICA D, V163, P236, DOI 10.1016/S0167-2789(01)00386-4; Stam CJ, 2004, NEUROSCI LETT, V355, P25, DOI 10.1016/j.neulet.2003.10.063; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Sun Y, 2009, EPL-EUROPHYS LETT, V86, DOI 10.1209/0295-5075/86/28004; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; van den Heuvel MP, 2013, JAMA PSYCHIAT, V70, P783, DOI 10.1001/jamapsychiatry.2013.1328; van den Heuvel MP, 2011, J NEUROSCI, V31, P15775, DOI 10.1523/JNEUROSCI.3539-11.2011; van den Heuvel MP, 2010, J NEUROSCI, V30, P15915, DOI 10.1523/JNEUROSCI.2874-10.2010; van Dixhoorn A, 2010, EUR WORKSH VIS COMP, V2010; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Vinck M, 2011, NEUROIMAGE, V55, P1548, DOI 10.1016/j.neuroimage.2011.01.055; Wang JH, 2009, HUM BRAIN MAPP, V30, P1511, DOI 10.1002/hbm.20623; Wang L, 2009, HUM BRAIN MAPP, V30, P638, DOI 10.1002/hbm.20530; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062789; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yeh F-C, 2010, IEEE T MED IMAGING, V27, P1415; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang ZQ, 2011, BRAIN, V134, P2912, DOI 10.1093/brain/awr223	88	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113838	10.1371/journal.pone.0113838	http://dx.doi.org/10.1371/journal.pone.0113838			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437873	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900084
J	Solund, C; Krarup, H; Ramirez, S; Thielsen, P; Roge, BT; Lunding, S; Barfod, TS; Madsen, LG; Tarp, B; Christensen, PB; Gerstoft, J; Laursen, AL; Bukh, J; Weis, N				Solund, Christina; Krarup, Henrik; Ramirez, Santseharay; Thielsen, Peter; Roge, Birgit T.; Lunding, Suzanne; Barfod, Toke S.; Madsen, Lone G.; Tarp, Britta; Christensen, Peer B.; Gerstoft, Jan; Laursen, Alex L.; Bukh, Jens; Weis, Nina		DANHEP Grp	Nationwide Experience of Treatment with Protease Inhibitors in Chronic Hepatitis C Patients in Denmark: Identification of Viral Resistance Mutations	PLOS ONE			English	Article							DIRECT-ACTING ANTIVIRALS; VIRUS; INFECTION; TELAPREVIR; INITIATION; THERAPY; REGION	Background and Aims: The first standard of care in treatment of chronic HCV genotype 1 infection involving directly acting antivirals was protease inhibitors telaprevir or boceprevir combined with pegylated-interferon and ribavirin (triple therapy). Phase III studies include highly selected patients. Thus, treatment response and development of viral resistance during triple therapy in a routine clinical setting needs to be determined. The aims of this study were to investigate treatment outcome and identify sequence variations after triple therapy in patients with chronic HCV genotype 1 infection in a routine clinical setting. Methods: 80 patients, who initiated and completed triple therapy in Denmark between May 2011 and November 2012, were included. Demographic data and treatment response were obtained from the Danish Database for Hepatitis B and C. Direct sequencing and clonal analysis of the RT-PCR amplified NS3 protease were performed in patients without cure following triple therapy. Results: 38 (47%) of the patients achieved cure, 15 (19%) discontinued treatment due to adverse events and remained infected, and 27 (34%) experienced relapse or treatment failure of whom 15 of 21 analyzed patients had well-described protease inhibitor resistance variants detected. Most frequently detected protease variants were V36M and/or R155K, and V36M, in patients with genotype 1a and 1b infection, respectively. Conclusions: The cure rate after triple therapy in a routine clinical setting was 47%, which is substantially lower than in clinical trials. Resistance variants towards protease inhibitors were seen in 71% of patients failing therapy indicating that resistance could have an important role in treatment response.	[Solund, Christina; Ramirez, Santseharay; Bukh, Jens; Weis, Nina; DANHEP Grp] Copenhagen Univ Hosp, Dept Infect Dis, Hvidovre, Denmark; [Solund, Christina; Ramirez, Santseharay; Bukh, Jens] Copenhagen Univ Hosp, Copenhagen Hepatitis Program CO HEP C, Dept Infect Dis, Hvidovre, Denmark; [Solund, Christina; Ramirez, Santseharay; Bukh, Jens] Copenhagen Univ Hosp, Copenhagen Hepatitis Program CO HEP C, Clin Res Ctr, Hvidovre, Denmark; [Solund, Christina; Ramirez, Santseharay; Bukh, Jens] Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Fac Hlth & Med Sci, Copenhagen, Denmark; [Krarup, Henrik] Aalborg Univ Hosp, Sect Mol Diagnost, Aalborg, Denmark; [Krarup, Henrik] Aalborg Univ Hosp, Dept Med Gastroenterol, Aalborg, Denmark; [Thielsen, Peter] Copenhagen Univ Hosp, Dept Gastroenterol, Herlev, Denmark; [Roge, Birgit T.] Kolding Cty Hosp, Dept Med, Kolding, Denmark; [Lunding, Suzanne] Copenhagen Univ Hosp, Dept Infect Dis, Hillerod, Denmark; [Barfod, Toke S.] Roskilde Hosp, Dept Infect Dis, Roskilde, Denmark; [Madsen, Lone G.] Koge Hosp, Dept Gastroenterol, Koge, Denmark; [Tarp, Britta] Silkeborg Reg Hosp, Ctr Diagnost, Silkeborg, Denmark; [Christensen, Peer B.] Odense Univ Hosp, Dept Infect Dis, DK-5000 Odense, Denmark; [Gerstoft, Jan] Rigshosp, Dept Infect Dis, Copenhagen Univ Hosp, DK-2100 Copenhagen, Denmark; [Laursen, Alex L.] Aarhus Univ Hosp, Dept Infect Dis, DK-8000 Aarhus, Denmark; [Weis, Nina] Univ Copenhagen, Dept Clin Med, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; Aalborg University; Aalborg University Hospital; Aalborg University; Aalborg University Hospital; University of Copenhagen; Kolding Hospital; University of Copenhagen; Aarhus University; Silkeborg Central Hospital; University of Southern Denmark; Odense University Hospital; Rigshospitalet; University of Copenhagen; Aarhus University; University of Copenhagen	Weis, N (corresponding author), Copenhagen Univ Hosp, Dept Infect Dis, Hvidovre, Denmark.	ninaweis@dadlnet.dk	Christensen, Peer B./B-8042-2015; Weis, Nina/GLT-4232-2022; Tarp, Britta/R-2229-2019; Ramirez, Santseharay/R-9257-2016	Tarp, Britta/0000-0003-3611-4440; Ramirez, Santseharay/0000-0003-3699-1814; Solund, Christina/0000-0001-8149-3780; Weis, Nina/0000-0002-3133-2724; Bukh, Jens/0000-0002-7815-4806; Laursen, Alex Lund/0000-0002-1206-156X; Christensen, Peer Brehm/0000-0003-1394-058X; Thomsen, Reimar/0000-0001-9135-3474; Krarup, Henrik/0000-0001-5294-2428	Danish Cancer Society [R47-A2555]; Lundbeck Foundation; Danish Cancer Society; Novo Nordisk Foundation; A.P. Moller Foundation for the Advancement of Medical Science; Danish Council for Independent Research - Medical Sciences; Novo Nordisk Fonden [NNF12OC0002037] Funding Source: researchfish	Danish Cancer Society(Danish Cancer Society); Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); A.P. Moller Foundation for the Advancement of Medical Science; Danish Council for Independent Research - Medical Sciences(Det Frie Forskningsrad (DFF)); Novo Nordisk Fonden(Novo Nordisk Foundation)	Funding: This study was supported partly by a scholarship stipend from The Danish Cancer Society; R47-A2555 (CS) and research grants from The Lundbeck Foundation (JB), The Danish Cancer Society (JB), The Novo Nordisk Foundation (JB), A.P. Moller Foundation for the Advancement of Medical Science (NW), and the Danish Council for Independent Research - Medical Sciences (SR, JB and NW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chevaliez S, 2007, HEPATOLOGY, V46, P22, DOI 10.1002/hep.21656; Christensen PB, 2012, SCAND J GASTROENTERO, V47, P1115, DOI 10.3109/00365521.2012.694905; Christensen PB, 2012, DAN MED J, V59; Corbet S, 2003, J CLIN MICROBIOL, V41, P1091, DOI 10.1128/JCM.41.3.1091-1100.2003; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Dusheiko G, 2012, GUT, V61, P1647, DOI 10.1136/gutjnl-2012-302910; Gaudieri S, 2009, HEPATOLOGY, V49, P1069, DOI 10.1002/hep.22773; Gottwein JM, 2011, GASTROENTEROLOGY, V141, P1067, DOI 10.1053/j.gastro.2011.06.004; Halfon P, 2012, LIVER INT, V32, P79, DOI 10.1111/j.1478-3231.2011.02716.x; Halfon P, 2011, J HEPATOL, V55, P192, DOI 10.1016/j.jhep.2011.01.011; Hansen N, 2009, J VIRAL HEPATITIS, V16, P659, DOI 10.1111/j.1365-2893.2009.01126.x; Hansen N, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-177; Hezode C, 2013, J HEPATOL, V59, P434, DOI 10.1016/j.jhep.2013.04.035; Krarup HB, 1998, SCAND J CLIN LAB INV, V58, P415, DOI 10.1080/00365519850186391; Krarup HB, 2000, J VIRAL HEPATITIS, V7, P435, DOI 10.1046/j.1365-2893.2000.00258.x; Lauck M, 2012, J VIROL, V86, P3952, DOI 10.1128/JVI.06627-11; Li H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019562; Maasoumy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055285; Macartney MJ, 2014, ANTIVIR RES, V105, P112, DOI 10.1016/j.antiviral.2014.02.019; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; Paolucci S, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-245; Pockros PJ, 2011, EXPERT OPIN BIOL TH, V11, P1611, DOI 10.1517/14712598.2011.627851; POORDAD F, 2013, GASTROENTEROLOGY, V10; Shimakami T, 2011, GASTROENTEROLOGY, V140, P667, DOI 10.1053/j.gastro.2010.10.056; Soriano V, 2011, J ANTIMICROB CHEMOTH, V66, P1673, DOI 10.1093/jac/dkr215; Susser S, 2011, J CLIN VIROL, V52, P321, DOI 10.1016/j.jcv.2011.08.015; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vermehren J, 2012, BEST PRACT RES CL GA, V26, P487, DOI 10.1016/j.bpg.2012.09.011; Wyles DL, 2013, J INFECT DIS, V207, pS33, DOI 10.1093/infdis/jis761	29	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113034	10.1371/journal.pone.0113034	http://dx.doi.org/10.1371/journal.pone.0113034			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438153	Green Published, gold, Green Submitted			2022-12-26	WOS:000347114900026
J	Talla, C; Diallo, D; Dia, I; Ba, Y; Ndione, JA; Sall, AA; Morse, A; Diop, A; Diallo, M				Talla, Cheikh; Diallo, Diawo; Dia, Ibrahima; Ba, Yamar; Ndione, Jacques-Andre; Sall, Amadou Alpha; Morse, Andy; Diop, Aliou; Diallo, Mawlouth			Statistical Modeling of the Abundance of Vectors of West African Rift Valley Fever in Barkedji, Senegal	PLOS ONE			English	Article							CULEX-POICILIPES DIPTERA; AEDES-VEXANS; POPULATION-DYNAMICS; VIRUS TRANSMISSION; MOSQUITO VECTORS; TEMPERATURE; RAINFALL; RISK; PATTERNS; CLIMATE	Rift Valley fever is an emerging mosquito-borne disease that represents a threat to human and animal health. The exophilic and exophagic behavior of the two main vector in West Africa (Aedes vexans and Culex poicilipes), adverse events post-vaccination, and lack of treatment, render ineffective the disease control. Therefore it is essential to develop an information system that facilitates decision-making and the implementation of adaptation strategies. In East Africa, RVF outbreaks are linked with abnormally high rainfall, and can be predicted up to 5 months in advance by modeling approaches using climatic and environmental parameters. However, the application of these models in West Africa remains unsatisfactory due to a lack of data for animal and human cases and differences in the dynamics of the disease emergence and the vector species involved in transmission. Models have been proposed for West Africa but they were restricted to rainfall impact analysis without a spatial dimension. In this study, we developed a mixed Bayesian statistical model to evaluate the effects of climatic and ecological determinants on the spatiotemporal dynamics of the two main vectors. Adult mosquito abundance data were generated from July to December every fortnight in 2005-2006 at 79 sites, including temporary ponds, bare soils, shrubby savannah, wooded savannah, steppes, and villages in the Barkedji area. The results demonstrate the importance of environmental factors and weather conditions for predicting mosquito abundance. The rainfall and minimum temperature were positively correlated with the abundance of Cx. poicilipes, whereas the maximum temperature had negative effects. The rainfall was negatively correlated with the abundance of Ae. vexans. After combining land cover classes, weather conditions, and vector abundance, our model was used to predict the areas and periods with the highest risks of vector pressure. This information could support decision-making to improve RVF surveillance activities and to implement better intervention strategies.	[Talla, Cheikh; Diallo, Diawo; Dia, Ibrahima; Ba, Yamar; Diallo, Mawlouth] Inst Pasteur, Unite Entomol Med, Dakar, Senegal; [Talla, Cheikh; Diop, Aliou] Univ Gaston Berger, Lab Etud & Rech Stat & Dev, St Louis, Senegal; [Ndione, Jacques-Andre] Ctr Suivi Ecol, Dakar, Senegal; [Sall, Amadou Alpha] Inst Pasteur, Unite Arbovirus & Virus Fievres Hemorrag, Dakar, Senegal; [Morse, Andy] Univ Liverpool, Sch Environm Sci, Liverpool L69 3BX, Merseyside, England	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; University of Liverpool	Diallo, M (corresponding author), Inst Pasteur, Unite Entomol Med, Dakar, Senegal.	diallo@pasteur.sn	Talla, Cheikh/AAZ-5134-2020	Talla, Cheikh/0000-0003-0678-1226; DIOP, Aliou/0000-0002-0808-5622; DIALLO, Diawo/0000-0002-7478-5248; Morse, Andrew/0000-0002-0413-2065	EU - European Commission [243964]; Institut Pasteur de Dakar	EU - European Commission(European CommissionEuropean Commission Joint Research Centre); Institut Pasteur de Dakar	This study was partially supported by the EU project QWeCI (Quantifying Weather and Climate Impacts on Health in Developing Countries; funded by the European Commission's Seventh Framework Research Programme under the grant agreement 243964) and The Institut Pasteur de Dakar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu A, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-30; [Anonymous], 1956, REUN SPEC CSE MAT PH, P22; Anyamba A, 2006, EMERG INFECT DIS, V12, P518, DOI 10.3201/eid1203.050973; Anyamba A, 2002, PHOTOGRAMM ENG REM S, V68, P137; Anyamba A, 2010, AM J TROP MED HYG, V83, P43, DOI 10.4269/ajtmh.2010.09-0289; Ba Y., 2006, Bulletin de la Societe de Pathologie Exotique, V99, P283; Ba Y, 2005, J MED ENTOMOL, V42, P739, DOI 10.1603/0022-2585(2005)042[0739:AOBOTR]2.0.CO;2; Ba Y, 2012, J AM MOSQUITO CONTR, V28, P170, DOI 10.2987/12-5725.1; BESAG J, 1995, STAT SCI, V10, P3, DOI 10.1214/ss/1177010123; Bicout DJ, 2004, VECTOR-BORNE ZOONOT, V4, P33, DOI 10.1089/153036604773082979; Blanford JI, 2013, SCI REP-UK, V3, DOI 10.1038/srep01300; Botros B, 2006, J MED VIROL, V78, P787, DOI 10.1002/jmv.20624; Bouloy M, 2009, ANTIVIR RES, V84, P101, DOI 10.1016/j.antiviral.2009.08.002; BREELAND S. G., 1967, MOSQUITO NEWS, V27, P343; Chuang TW, 2012, J MED ENTOMOL, V49, P851, DOI 10.1603/ME11150; Clements AN, 1999, BIOL MOSQUITOES SENS, V2, P752; Clements ACA, 2007, VECTOR-BORNE ZOONOT, V7, P203, DOI 10.1089/vbz.2006.0600; Cressie N., 2011, STAT SPATIO TEMPORAL; Dangles O, 2008, ECOL APPL, V18, P1795, DOI 10.1890/07-1638.1; DAVIES FG, 1985, B WORLD HEALTH ORGAN, V63, P941; DIAGNE N, 1994, B SOC PATHOL EXOT, V87, P267; Diallo D, 2008, Bull Soc Pathol Exot, V101, P410; Diallo D, 2011, J VECTOR ECOL, V36, P426, DOI 10.1111/j.1948-7134.2011.00184.x; Diallo M, 2005, MED VET ENTOMOL, V19, P119, DOI 10.1111/j.0269-283X.2005.00564.x; Diallo M, 2000, AM J TROP MED HYG, V62, P702, DOI 10.4269/ajtmh.2000.62.702; Easterday B C, 1965, Adv Vet Sci, V10, P65; Edwards F.W., 1941, MOSQUITOES ETHIOPIAN; Fao, 1997, AFRICOVER CLASS OCC, P80; Favier C, 2006, TROP MED INT HEALTH, V11, P1878, DOI 10.1111/j.1365-3156.2006.01746.x; Fontenille D, 1998, EMERG INFECT DIS, V4, P289, DOI 10.3201/eid0402.980218; Gage KL, 2008, AM J PREV MED, V35, P436, DOI 10.1016/j.amepre.2008.08.030; Ganser C, 2013, J VECTOR ECOL, V38, P229, DOI 10.1111/j.1948-7134.2013.12035.x; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gilks WR, 1996, MARKOV CHAIN MONTE C, P512; Hunter P, 2002, ONDERSTEPOORT J VET, V69, P95; Janousek TE, 1999, J AM MOSQUITO CONTR, V15, P253; JOUAN A, 1988, ANN INST PASTEUR VIR, V139, P307, DOI 10.1016/S0769-2617(88)80046-7; Kamal SA, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-94; Katz MH., 2011, MULTIVARIABLE ANAL A; Kendall M.G., 1975, RANK CORRELATION MEA; Kovats RS, 2003, LANCET, V362, P1481, DOI 10.1016/S0140-6736(03)14695-8; Kutner M. H., 2004, APPL LINEAR REGRESSI; Lacaux JP, 2007, REMOTE SENS ENVIRON, V106, P66, DOI 10.1016/j.rse.2006.07.012; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; LAUGHLIN LW, 1979, T ROY SOC TROP MED H, V73, P630, DOI 10.1016/0035-9203(79)90006-3; Linthicum Kenneth J, 2007, Vet Ital, V43, P663; Linthicum KJ, 1999, SCIENCE, V285, P397, DOI 10.1126/science.285.5426.397; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; McCulloch CE, 2001, GEN LINEAR MIXED MOD, P99; Meegan J, 1988, RIFT VALLEY FEVER AR; Mellor PS, 2000, REV SCI TECH OIE, V19, P41, DOI 10.20506/rst.19.1.1211; Mondet B, 2005, J VECTOR ECOL, V30, P102; MULLER R, 1995, AM J TROP MED HYG, V53, P405, DOI 10.4269/ajtmh.1995.53.405; Muturi EJ, 2007, AM J TROP MED HYG, V76, P95, DOI 10.4269/ajtmh.2007.76.95; Ndiaye PI, 2006, J THEOR BIOL, V243, P222, DOI 10.1016/j.jtbi.2006.06.005; Ndione J-A, 2008, CLIMATOLOGIE, V5, P83, DOI [10.4267/climatologie.794, DOI 10.4267/CLIMATOLOGIE.794]; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Paaijmans KP, 2009, P NATL ACAD SCI USA, V106, P13844, DOI 10.1073/pnas.0903423106; Pebesma EJ, 2004, COMPUT GEOSCI-UK, V30, P683, DOI 10.1016/j.cageo.2004.03.012; Pittman PR, 1999, VACCINE, V18, P181, DOI 10.1016/S0264-410X(99)00218-2; Plummer M., 2005, OUTPUT ANAL DIAGNOST; Porphyre T, 2005, ECOL MODEL, V183, P173, DOI 10.1016/j.ecolmodel.2004.06.044; R Development Core Team, 2013, R LANG ENV STAT COMP, P409, DOI DOI 10.1007/978-3-540-74686-7; SALUZZO JF, 1990, VACCINE, V8, P369, DOI 10.1016/0264-410X(90)90096-5; SMITHBURN KC, 1949, BRIT J EXP PATHOL, V30, P1; Soti V, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-10; Soti V, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001795; Spiegelhalter D., 2003, WINBUGS USER MANUAL; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Sturtz S, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i03; Traore-Lamizana M, 2001, J MED ENTOMOL, V38, P480, DOI 10.1603/0022-2585-38.4.480; TRPIS M, 1970, CAN ENTOMOL, V102, P1048, DOI 10.4039/Ent1021048-8; Vignolles C, 2009, GEOSPATIAL HEALTH, V3, P211, DOI 10.4081/gh.2009.221; Wilberg MJ, 2008, FISH RES, V93, P212, DOI 10.1016/j.fishres.2008.04.010; Yamana TK, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-235	75	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114047	10.1371/journal.pone.0114047	http://dx.doi.org/10.1371/journal.pone.0114047			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437856	gold, Green Published, Green Submitted			2022-12-26	WOS:000347114900114
J	Toledo, M; Penna, F; Busquets, S; Lopez-Soriano, FJ; Argiles, JM				Toledo, Miriam; Penna, Fabio; Busquets, Silvia; Lopez-Soriano, Francisco J.; Argiles, Josep M.			Distinct Behaviour of Sorafenib in Experimental Cachexia-Inducing Tumours: The Role of STAT3	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; LEWIS LUNG-CARCINOMA; CANCER CACHEXIA; HEPATOCELLULAR-CARCINOMA; RAF/MEK/ERK PATHWAY; ACTRIIB ANTAGONISM; CACHECTIC PATIENTS; PANCREATIC-CANCER; PHYSICAL-ACTIVITY; LEAN TISSUE	The presence of a tumour is very often associated with wasting in the host, affecting both skeletal muscle and adipose tissue. In the present study we used sorafenib, a multi-kinase inhibitor with anti-tumour activity, in order to investigate the effects of chemotherapy on wasting. Three different experimental mouse tumour models were included: C26 colon carcinoma, B16 melanoma and Lewis lung carcinoma (LLC). The results obtained clearly show that sorafenib was effective in reducing tumour growth in LLC and B16 models, while it had no effect on C26. Interestingly, sorafenib treatment reduced the signs of muscle wasting and improved the physical activity in the LLC model and also in the C26, despite the absence of antineoplastic action in the latter. Our results discard a role for IL-6 in the action of sorafenib since the drug did not affect the levels of this cytokine. Conversely, sorafenib seems to act by influencing both STAT3 and ERK activity at muscle level, leading to reduced accumulation of Pax7 and atrogin-1. Sorafenib may interfere with muscle wasting by decreasing the activation of these signal transduction pathways.	[Toledo, Miriam; Penna, Fabio; Busquets, Silvia; Lopez-Soriano, Francisco J.; Argiles, Josep M.] Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Canc Res Grp, Barcelona, Spain; [Busquets, Silvia; Lopez-Soriano, Francisco J.; Argiles, Josep M.] Univ Barcelona, Inst Biomed, Barcelona, Spain; [Penna, Fabio] Univ Turin, Dept Clin & Biol Sci, Turin, Italy	University of Barcelona; University of Barcelona; University of Turin	Busquets, S (corresponding author), Univ Barcelona, Fac Biol, Dept Bioquim & Biol Mol, Canc Res Grp, Barcelona, Spain.	silviabusquets@ub.edu	Toledo, Miriam/B-1229-2019; Argiles, Josep M/L-5741-2014; Penna, Fabio/K-5090-2016; Busquets, Silvia/C-5544-2017; Lopez-Soriano, Francisco J./W-4947-2018	Toledo, Miriam/0000-0002-1332-7454; Penna, Fabio/0000-0002-2774-6027; Busquets, Silvia/0000-0002-9319-3555; Lopez-Soriano, Francisco J./0000-0003-1493-3023; Argiles, Josep M./0000-0003-4683-5428	grant for the Ministerio de Ciencia y Tecnologia [SAF-26091-2011]	grant for the Ministerio de Ciencia y Tecnologia	This work was supported by a grant for the Ministerio de Ciencia y Tecnologia (SAF-26091-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antoun S, 2010, J CLIN ONCOL, V28, P1054, DOI 10.1200/JCO.2009.24.9730; Argiles JM, 1997, MED RES REV, V17, P477, DOI 10.1002/(SICI)1098-1128(199709)17:5<477::AID-MED3>3.0.CO;2-R; Argiles JM, 2012, NUTR METAB CARDIOVAS, P1; Argiles Josep M, 2009, Curr Opin Support Palliat Care, V3, P263, DOI 10.1097/SPC.0b013e3283311d09; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; Busquets S, 2012, J CACHEXIA SARCOPENI, V3, P37, DOI 10.1007/s13539-011-0049-z; Chai H, 2010, INT J CLIN EXP PATHO, V3, P408; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; DONATI MB, 1978, EUR J CANCER, V14, P343, DOI 10.1016/0014-2964(78)90203-7; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Fouladiun M, 2005, CANCER-AM CANCER SOC, V103, P2189, DOI 10.1002/cncr.21013; Greig CA, 2014, SUPPORT CARE CANCER, V22, P1269, DOI 10.1007/s00520-013-2081-3; Hasselgren PO, 2001, ANN SURG, V233, P9, DOI 10.1097/00000658-200101000-00003; He WA, 2013, J CLIN INVEST, V123, P4821, DOI 10.1172/JCI68523; Hulmi JJ, 2013, AM J PHYSIOL-ENDOC M, V305, pE171, DOI 10.1152/ajpendo.00065.2013; Kane RC, 2006, CLIN CANCER RES, V12, P7271, DOI 10.1158/1078-0432.CCR-06-1249; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Loberg RD, 2007, CA-CANCER J CLIN, V57, P225, DOI 10.3322/canjclin.57.4.225; Maccio A, 2012, GYNECOL ONCOL, V124, P417, DOI 10.1016/j.ygyno.2011.12.435; Moses AGW, 2009, ONCOL REP, V21, P1091, DOI 10.3892/or_00000328; Moses AWG, 2004, BRIT J CANCER, V90, P996, DOI 10.1038/sj.bjc.6601620; Murphy KT, 2012, DIS MODEL MECH, V5, P533, DOI 10.1242/dmm.008839; Muscaritoli M, 2006, EUR J CANCER, V42, P31, DOI 10.1016/j.ejca.2005.07.026; Muscaritoli M, 2010, CLIN NUTR, V29, P154, DOI 10.1016/j.clnu.2009.12.004; NG EH, 1991, HEMATOL ONCOL CLIN N, V5, P161, DOI 10.1016/S0889-8588(18)30460-X; Penna F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013604; Penna F, 2010, INT J CANCER, V127, P1706, DOI 10.1002/ijc.25146; Prado CMM, 2011, CURR OPIN CLIN NUTR, V14, P250, DOI 10.1097/MCO.0b013e3283455d45; Price FD, 2014, NAT MED, V20, P1174, DOI 10.1038/nm.3655; Schiaffino S, 2013, FEBS J, V280, P4294, DOI 10.1111/febs.12253; Scott HR, 1996, BRIT J CANCER, V73, P1560, DOI 10.1038/bjc.1996.294; Skipworth RJE, 2006, SURG-J R COLL SURG E, V4, P273, DOI 10.1016/S1479-666X(06)80004-1; Tierney MT, 2014, NAT MED, V20, P1182, DOI 10.1038/nm.3656; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475, DOI 10.1093/ajcn/84.3.475; YANG F, 2012, SORAFENIB INHIBITS E, V13, P534; Yang F, 2010, MOL CANCER THER, V9, P953, DOI 10.1158/1535-7163.MCT-09-0947; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011	40	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113931	10.1371/journal.pone.0113931	http://dx.doi.org/10.1371/journal.pone.0113931			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436606	Green Submitted, Green Published, gold			2022-12-26	WOS:000347114900098
J	Yang, MY; Stowe, DF; Udoh, KB; Heisner, JS; Camara, AKS				Yang, Meiying; Stowe, David F.; Udoh, Kenechukwu B.; Heisner, James S.; Camara, Amadou K. S.			Reversible Blockade of Complex I or Inhibition of PKC beta Reduces Activation and Mitochondria Translocation of p66(Shc) to Preserve Cardiac Function after Ischemia	PLOS ONE			English	Article							KINASE-C-BETA; REACTIVE OXYGEN; REPERFUSION INJURY; RESPIRATORY-CHAIN; OXIDATIVE STRESS; CYTOCHROME-C; LIFE-SPAN; ELECTRON; HEART; ROS	Aim: Excess mitochondrial reactive oxygen species (mROS) play a vital role in cardiac ischemia reperfusion (IR) injury. P66(Shc), a splice variant of the ShcA adaptor protein family, enhances mROS production by oxidizing reduced cytochrome c to yield H2O2. Ablation of p66(Shc) protects against IR injury, but it is unknown if and when p66(Shc) is activated during cardiac ischemia and/or reperfusion and if attenuating complex I electron transfer or deactivating PKC beta alters p66(Shc) activation during IR is associated with cardioprotection. Methods: Isolated guinea pig hearts were perfused and subjected to increasing periods of ischemia and reperfusion with or without amobarbital, a complex I blocker, or hispidin, a PKC beta inhibitor. Phosphorylation of p66(Shc) at serine 36 and levels of p66(Shc) in mitochondria and cytosol were measured. Cardiac functional variables and redox states were monitored online before, during and after ischemia. Infarct size was assessed in some hearts after 120 min reperfusion. Results: Phosphorylation of p66(Shc) and its translocation into mitochondria increased during reperfusion after 20 and 30 min ischemia, but not during ischemia only, or during 5 or 10 min ischemia followed by 20 min reperfusion. Correspondingly, cytosolic p66(Shc) levels decreased during these ischemia and reperfusion periods. Amobarbital or hispidin reduced phosphorylation of p66(Shc) and its mitochondrial translocation induced by 30 min ischemia and 20 min reperfusion. Decreased phosphorylation of p66(Shc) by amobarbital or hispidin led to better functional recovery and less infarction during reperfusion. Conclusion: Our results show that IR activates p66(Shc) and that reversible blockade of electron transfer from complex I, or inhibition of PKC beta activation, decreases p66(Shc) activation and translocation and reduces IR damage. These observations support a novel potential therapeutic intervention against cardiac IR injury.	[Yang, Meiying; Stowe, David F.; Udoh, Kenechukwu B.; Heisner, James S.; Camara, Amadou K. S.] Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA; [Stowe, David F.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA; [Stowe, David F.; Camara, Amadou K. S.] Med Coll Wisconsin, Cardiovasc Res Ctr, Milwaukee, WI 53226 USA; [Stowe, David F.] Zablocki VA Med Ctr, Res Serv, Milwaukee, WI USA; [Stowe, David F.] Marquette Univ, Dept Biomed Engn, Milwaukee, WI 53233 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin; Marquette University	Camara, AKS (corresponding author), Med Coll Wisconsin, Dept Anesthesiol, Milwaukee, WI 53226 USA.	aksc@mcw.edu		STOWE, DAVID/0000-0003-2180-4844	National Heart Lung and Blood Institute of the National Institutes of Health [R01 HL 095122 NIH, R01 HL 089514 NIH]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095122, R01HL089514] Funding Source: NIH RePORTER	National Heart Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by funding from the National Heart Lung and Blood Institute of the National Institutes of Health R01 HL 095122 NIH (awarded to Dr. Camara) and R01 HL 089514 NIH (awarded to Dr. Stowe). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidakkak M, 2008, CARDIOVASC RES, V77, P406, DOI 10.1016/j.cardiores.2007.08.008; Aldakkak M, 2012, J CARDIOVASC PHARM T, V17, P93, DOI 10.1177/1074248410389815; Aldakkak M, 2010, AM J PHYSIOL-CELL PH, V298, pC530, DOI 10.1152/ajpcell.00468.2009; Aldakkak M, 2009, J CARDIOVASC PHARM, V54, P298, DOI 10.1097/FJC.0b013e3181b2b842; Camara AK, 2014, SYSTEM BIOL FREE RAD, P1; Camara AKS, 2004, AM J PHYSIOL-HEART C, V286, pH1289, DOI 10.1152/ajpheart.00811.2003; Camara AKS, 2007, AM J PHYSIOL-CELL PH, V292, pC2021, DOI 10.1152/ajpcell.00231.2006; Camara AKS, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00013; Camara AKS, 2010, ANTIOXID REDOX SIGN, V13, P279, DOI 10.1089/ars.2009.2788; Carpi A, 2009, BBA-BIOENERGETICS, V1787, P774, DOI 10.1016/j.bbabio.2009.04.001; Chahdi A, 2010, CELL SIGNAL, V22, P325, DOI 10.1016/j.cellsig.2009.09.039; CHANCE B, 1963, J BIOL CHEM, V238, P418; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chen Q, 2008, AM J PHYSIOL-CELL PH, V294, pC460, DOI 10.1152/ajpcell.00211.2007; Chen Q, 2011, FEBS LETT, V585, P921, DOI 10.1016/j.febslet.2011.02.029; Gadicherla AK, 2012, BBA-BIOENERGETICS, V1817, P419, DOI 10.1016/j.bbabio.2011.11.021; Galimov ER, 2010, ACTA NATURAE, V2, P44, DOI 10.32607/20758251-2010-2-4-44-51; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gorenkova N, 2013, ANTIOXID REDOX SIGNA; Graham J M, 2001, Curr Protoc Cell Biol, VChapter 3, DOI [10.1002/0471143030.cb0306s07, 10.1002/0471143030.cb0309s10]; Haga S, 2008, J HEPATOL, V48, P422, DOI 10.1016/j.jhep.2007.11.018; Haumann J, 2010, BIOPHYS J, V99, P997, DOI 10.1016/j.bpj.2010.04.069; Heinen A, 2007, AM J PHYSIOL-HEART C, V293, pH1400, DOI 10.1152/ajpheart.00198.2007; Hiona A, 2011, J THORAC CARDIOV SUR, V142, P396, DOI 10.1016/j.jtcvs.2010.07.097; HORGAN DJ, 1968, J BIOL CHEM, V243, P834; Kanski J, 2005, AM J PHYSIOL-HEART C, V288, pH371, DOI 10.1152/ajpheart.01030.2003; Kevin LG, 2003, AM J PHYSIOL-HEART C, V284, pH566, DOI 10.1152/ajpheart.00711.2002; Kong L, 2008, AM J PHYSIOL-HEART C, V294, pH1862, DOI 10.1152/ajpheart.01346.2007; Lesnefsky EJ, 2001, J MOL CELL CARDIOL, V33, P1065, DOI 10.1006/jmcc.2001.1378; Liu B, 2009, BBA-PROTEINS PROTEOM, V1794, P476, DOI 10.1016/j.bbapap.2008.12.008; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Novalija E, 2002, AM J PHYSIOL-HEART C, V283, pH44, DOI 10.1152/ajpheart.01056.2001; Pagliaro P, 2011, ANTIOXID REDOX SIGN, V14, P833, DOI 10.1089/ars.2010.3245; Piantadosi CA, 1996, STROKE, V27, P327, DOI 10.1161/01.STR.27.2.327; Pinton P, 2007, SCIENCE, V315, P659, DOI 10.1126/science.1135380; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Riess ML, 2002, AM J PHYSIOL-HEART C, V283, pH53, DOI 10.1152/ajpheart.01057.2001; Sack MN, 2006, CARDIOVASC RES, V72, P210, DOI 10.1016/j.cardiores.2006.07.010; Shi Y, 2011, ARTERIOSCL THROM VAS, V31, P2090, DOI 10.1161/ATVBAHA.111.229260; SPIEGEL HE, 1969, J PHARMACOL EXP THER, V165, P23; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Stowe DF, 2009, ANTIOXID REDOX SIGN, V11, P1373, DOI [10.1089/ars.2008.2331, 10.1089/ARS.2008.2331]; Stowe DF, 2013, BBA-BIOMEMBRANES, V1828, P427, DOI 10.1016/j.bbamem.2012.08.031; Stowe DF, 2006, AM J PHYSIOL-HEART C, V290, pH434, DOI 10.1152/ajpheart.00763.2005; VEITCH K, 1992, BIOCHEM J, V281, P709, DOI 10.1042/bj2810709; Yang CPH, 2002, BBA-MOL CELL RES, V1590, P76, DOI 10.1016/S0167-4889(02)00200-8; Yang MY, 2012, BBA-BIOENERGETICS, V1817, P2049, DOI 10.1016/j.bbabio.2012.06.004; Zaccagnini G, 2004, CIRCULATION, V109, P2917, DOI 10.1161/01.CIR.0000129309.58874.0F	48	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113534	10.1371/journal.pone.0113534	http://dx.doi.org/10.1371/journal.pone.0113534			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436907	gold, Green Published, Green Submitted			2022-12-26	WOS:000347114900050
J	Augner, K; Eichler, J; Utz, W; Pischetsrieder, M				Augner, Kerstin; Eichler, Jutta; Utz, Wolfgang; Pischetsrieder, Monika			Influence of Nonenzymatic Posttranslational Modifications on Constitution, Oligomerization and Receptor Binding of S100A12	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; BETA-LACTOGLOBULIN MODIFICATIONS; CELL-SURFACE RECEPTOR; HUMAN SERUM-ALBUMIN; CALGRANULIN-C; PROTEINS; RAGE; SITE; IDENTIFICATION; METHYLGLYOXAL	This study examined the effect of methylglyoxal (MGO)-derived nonenzymatic posttranslational modifications (nePTMs) on the binding affinity of S100A12 to its natural receptor for advanced glycation end-products (RAGE). Binding of MGO-modified S100A12 to RAGE decreased significantly with increasing MGO concentration and incubation time. Ca2+-induced S100A12 hexamerization was impaired only at higher MGO concentrations indicating that the loss of affinity is not predominantly caused by disturbance of ligand oligomerization. nePTM mapping showed carboxyethylation of lysine (CEL) and the N-terminus without preferential modification sites. Besides, hydroimidazolone, hemiaminals, argpyrimidine, and tetrahydropyrimidine rapidly formed at R21. Even at the highest modification rate, hexamerization of synthesized CEL-S100A12 was unaffected and RAGE-binding only slightly impaired. Thus, nePTMs at R21 seem to be the major cause of MGO-induced impairment of S100A12 oligomerization and RAGE binding.	[Augner, Kerstin; Utz, Wolfgang; Pischetsrieder, Monika] Univ Erlangen Nurnberg, Dept Chem & Pharm, Food Chem Div, D-91054 Erlangen, Germany; [Eichler, Jutta] Univ Erlangen Nurnberg, Dept Chem & Pharm, Div Med Chem, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg	Pischetsrieder, M (corresponding author), Univ Erlangen Nurnberg, Dept Chem & Pharm, Food Chem Div, D-91054 Erlangen, Germany.	monika.pischetsrieder@fau.de	Eichler, Jutta/H-7847-2018	Eichler, Jutta/0000-0001-6683-9456				Ahmed MU, 1997, BIOCHEM J, V324, P565, DOI 10.1042/bj3240565; Ahmed N, 2002, BIOCHEM J, V364, P15, DOI 10.1042/bj3640015; Ahmed N, 2005, J BIOL CHEM, V280, P5724, DOI 10.1074/jbc.M410973200; Ahmed N, 2005, DIABETOLOGIA, V48, P1590, DOI 10.1007/s00125-005-1810-7; Anderson MM, 1999, J CLIN INVEST, V104, P103, DOI 10.1172/JCI3042; Andrassy M, 2006, AM J PATHOL, V169, P1223, DOI 10.2353/ajpath.2006.050713; Bank RA, 1998, BIOCHEM J, V330, P345, DOI 10.1042/bj3300345; Brock JWC, 2003, J PROTEOME RES, V2, P506, DOI 10.1021/pr0340173; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; DELLANGELICA EC, 1994, J BIOL CHEM, V269, P28929; Foell D, 2003, GUT, V52, P847, DOI 10.1136/gut.52.6.847; Fogliano V, 1998, BBA-PROTEIN STRUCT M, V1388, P295, DOI 10.1016/S0167-4838(98)00177-0; Fritz G, 2004, HDB METALLOPROTEINS, V3, P529, DOI [10.1002/0470028637.met046, DOI 10.1002/0470028637.MET046]; Fritz G, 2011, TRENDS BIOCHEM SCI, V36, P625, DOI 10.1016/j.tibs.2011.08.008; Gao Y, 2006, BIOCHEMISTRY-US, V45, P15654, DOI 10.1021/bi061410o; GLOMB MA, 1995, J BIOL CHEM, V270, P10017, DOI 10.1074/jbc.270.17.10017; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Kislinger T, 1999, J BIOL CHEM, V274, P31740, DOI 10.1074/jbc.274.44.31740; Klopfer A, 2011, J AGR FOOD CHEM, V59, P394, DOI 10.1021/jf103116c; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; Koito W, 2004, J BIOCHEM, V136, P831, DOI 10.1093/jb/mvh193; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Lennon G, 1996, GENOMICS, V33, P151, DOI 10.1006/geno.1996.0177; Lim SY, 2011, ANTIOXID REDOX SIGN, V15, P2235, DOI 10.1089/ars.2010.3641; Meltretter J, 2008, J AGR FOOD CHEM, V56, P5165, DOI 10.1021/jf800571j; Meltretter J, 2007, J AGR FOOD CHEM, V55, P6096, DOI 10.1021/jf0705567; Meltretter J, 2013, J AGR FOOD CHEM, V61, P6971, DOI 10.1021/jf401549j; Mittelmaier S, 2011, ANAL CHEM, V83, P9660, DOI 10.1021/ac2025706; Moroz OV, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-11; Moroz OV, 2002, ACTA CRYSTALLOGR D, V58, P407, DOI 10.1107/S0907444901021278; Nagaraj RH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030257; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Oya T, 1999, J BIOL CHEM, V274, P18492, DOI 10.1074/jbc.274.26.18492; Srikrishna G, 2010, J CELL BIOCHEM, V110, P645, DOI 10.1002/jcb.22575; Strohalm M, 2010, ANAL CHEM, V82, P4648, DOI 10.1021/ac100818g; Tae HJ, 2013, J MOL MED, V91, P1369, DOI 10.1007/s00109-013-1091-4; TAKAHASHI M, 1995, BIOCHEMISTRY-US, V34, P1433, DOI 10.1021/bi00004a038; Thornalley PJ, 2006, J RENAL NUTR, V16, P178, DOI 10.1053/j.jrn.2006.04.012; Thornalley PJ, 2003, BIOCHEM J, V375, P581, DOI 10.1042/BJ20030763; WESTWOOD ME, 1995, J PROTEIN CHEM, V14, P359, DOI 10.1007/BF01886793; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Xue J, 2011, STRUCTURE, V19, P722, DOI 10.1016/j.str.2011.02.013; Yagmur E, 2006, CLIN BIOCHEM, V39, P39, DOI 10.1016/j.clinbiochem.2005.07.016	44	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113418	10.1371/journal.pone.0113418	http://dx.doi.org/10.1371/journal.pone.0113418			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426955	Green Published, gold, Green Submitted			2022-12-26	WOS:000349145400049
J	Gaffney, PM; Imai, DM; Clifford, DL; Ghassemian, M; Sasik, R; Chang, AN; O'Brien, TD; Coppinger, J; Trejo, M; Masliah, E; Munson, L; Sigurdson, C				Gaffney, Patricia M.; Imai, Denise M.; Clifford, Deana L.; Ghassemian, Majid; Sasik, Roman; Chang, Aaron N.; O'Brien, Timothy D.; Coppinger, Judith; Trejo, Margarita; Masliah, Eliezer; Munson, Linda; Sigurdson, Christina			Proteomic Analysis of Highly Prevalent Amyloid A Amyloidosis Endemic to Endangered Island Foxes	PLOS ONE			English	Article							HUMAN SECONDARY AMYLOIDOSIS; HIGH-DENSITY-LIPOPROTEIN; AMINO-ACID-SEQUENCE; E-DEFICIENT MICE; SHAR-PEI DOGS; APOLIPOPROTEIN-E; PROTEIN-AA; UROCYON-CINEREOARGENTEUS; RHEUMATOID-ARTHRITIS; HEPARAN-SULFATE	Amyloid A (AA) amyloidosis is a debilitating, often fatal, systemic amyloid disease associated with chronic inflammation and persistently elevated serum amyloid A (SAA). Elevated SAA is necessary but not sufficient to cause disease and the risk factors for AA amyloidosis remain poorly understood. Here we identify an extraordinarily high prevalence of AA amyloidosis (34%) in a genetically isolated population of island foxes (Urocyon littoralis) with concurrent chronic inflammatory diseases. Amyloid deposits were most common in kidney (76%), spleen (58%), oral cavity (45%), and vasculature (44%) and were composed of unbranching, 10 nm in diameter fibrils. Peptide sequencing by mass spectrometry revealed that SAA peptides were dominant in amyloid-laden kidney, together with high levels of apolipoprotein E, apolipoprotein A-IV, fibrinogen-alpha chain, and complement C3 and C4 (false discovery rate <= 0.05). Reassembled peptide sequences showed island fox SAA as an 111 amino acid protein, most similar to dog and artic fox, with 5 unique amino acid variants among carnivores. SAA peptides extended to the last two C-terminal amino acids in 5 of 9 samples, indicating that near full length SAA was often present in amyloid aggregates. These studies define a remarkably prevalent AA amyloidosis in island foxes with widespread systemic amyloiddeposition, a unique SAA sequence, and the co-occurrence of AA with apolipoproteins.	[Gaffney, Patricia M.; Coppinger, Judith; Trejo, Margarita; Masliah, Eliezer; Sigurdson, Christina] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA; [Gaffney, Patricia M.; Coppinger, Judith; Sigurdson, Christina] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Gaffney, Patricia M.; Imai, Denise M.; Munson, Linda; Sigurdson, Christina] Univ Calif Davis, Dept Pathol Immunol & Microbiol, Davis, CA 95616 USA; [Clifford, Deana L.] Calif Dept Fish & Wildlife, Wildlife Invest Lab, Rancho Cordova, CA USA; [Clifford, Deana L.] Univ Calif Davis, Dept Vet Med & Epidemiol, Davis, CA 95616 USA; [Ghassemian, Majid] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Sasik, Roman; Chang, Aaron N.] Univ Calif San Diego, Ctr Computat Biol, Inst Genom Med, La Jolla, CA 92093 USA; [O'Brien, Timothy D.] Univ Minnesota, Vet Populat Med Dept, Vet Diagnost Lab, St Paul, MN 55108 USA; [Trejo, Margarita; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Minnesota System; University of Minnesota Twin Cities; University of California System; University of California San Diego	Sigurdson, C (corresponding author), Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA.	csigurdson@ucsd.edu		Lipton, Stuart/0000-0002-3490-1259; O'Brien, Timothy/0000-0001-9742-0930; coppinger, judith/0000-0001-6813-9840	University of California San Diego Academic Senate Award; ARCS Foundation; Dr. Linda Munson Fellowship for Wildlife Pathology Research; Dr. Peter C. Kennedy Endowed Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS076411] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG018440] Funding Source: NIH RePORTER	University of California San Diego Academic Senate Award; ARCS Foundation; Dr. Linda Munson Fellowship for Wildlife Pathology Research; Dr. Peter C. Kennedy Endowed Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by a University of California San Diego Academic Senate Award and the ARCS Foundation (https://www.arcsfoundation.org/). PMG was supported by the Dr. Linda Munson Fellowship for Wildlife Pathology Research organized by the ACVP/STP Coalition (http://www.vetpathcoalition.org/) and the Dr. Peter C. Kennedy Endowed Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMUNDSON TE, 1981, J WILDLIFE DIS, V17, P17, DOI 10.7589/0090-3558-17.1.17; Ancsin JB, 1999, J BIOL CHEM, V274, P7172, DOI 10.1074/jbc.274.11.7172; [Anonymous], 2014, STAT FED LIST END TH, P12; BENDITT EP, 1982, ANN NY ACAD SCI, V389, P183, DOI 10.1111/j.1749-6632.1982.tb22136.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Booth DR, 1998, AMYLOID, V5, P262, DOI 10.3109/13506129809007299; Cangul IT, 2002, J VET MED A, V49, P307, DOI 10.1046/j.1439-0442.2002.00456.x; Caughey B, 2008, P NATL ACAD SCI USA, V105, P7113, DOI 10.1073/pnas.0803438105; COHEN AS, 1959, NATURE, V183, P1202, DOI 10.1038/1831202a0; DAVIDSON WR, 1992, J WILDLIFE DIS, V28, P28, DOI 10.7589/0090-3558-28.1.28; DIBARTOLA SP, 1990, J AM VET MED ASSOC, V197, P483; Elimova E, 2004, FASEB J, V18, P1749, DOI 10.1096/fj.03-1436fje; Elimova E, 2009, FASEB J, V23, P3436, DOI 10.1096/fj.09-134981; Fernandez-Escamilla AM, 2004, NAT BIOTECHNOL, V22, P1302, DOI 10.1038/nbt1012; Gershoni-Baruch R, 2003, ARTHRITIS RHEUM, V48, P1149, DOI 10.1002/art.10944; GILBERT DA, 1990, NATURE, V344, P764, DOI 10.1038/344764a0; Gillmore JD, 2001, LANCET, V358, P24, DOI 10.1016/S0140-6736(00)05252-1; Gouvea AF, 2012, J ORAL PATHOL MED, V41, P178, DOI 10.1111/j.1600-0714.2011.01073.x; Hagihara K, 2005, GENES CELLS, V10, P1051, DOI 10.1111/j.1365-2443.2005.00900.x; HAWKINS PN, 1993, Q J MED, V86, P365; HAWKINS PN, 1990, NEW ENGL J MED, V323, P508, DOI 10.1056/NEJM199008233230803; Hoshii Y, 1997, AM J PATHOL, V151, P911; HUSEBEKK A, 1985, SCAND J IMMUNOL, V21, P283, DOI 10.1111/j.1365-3083.1985.tb01431.x; JOHNSON KH, 1995, AMYLOID, V2, P92, DOI 10.3109/13506129509031893; Kelly TR, 2003, J WILDLIFE DIS, V39, P467, DOI 10.7589/0090-3558-39.2.467; Kindy MS, 1998, AM J PATHOL, V152, P1387; Kisilevsky R, 1997, CRIT REV BIOCHEM MOL, V32, P361, DOI 10.3109/10409239709082674; Kobayashi H, 1996, BRIT J RHEUMATOL, V35, P44; Koivuniemi R, 2008, AMYLOID, V15, P262, DOI 10.1080/13506120802524676; Li JP, 2005, P NATL ACAD SCI USA, V102, P6473, DOI 10.1073/pnas.0502287102; Li LL, 2011, EMERG INFECT DIS, V17, P1876, DOI 10.3201/eid1710.110233; LIEPNIEKS JJ, 1995, BBA-MOL BASIS DIS, V1270, P81, DOI 10.1016/0925-4439(94)00076-3; Lindsay DS, 2001, VET PARASITOL, V97, P159, DOI 10.1016/S0304-4017(01)00390-9; LINKE RP, 1991, BIOL CHEM H-S, V372, P835, DOI 10.1515/bchm3.1991.372.2.835; LOWELL CA, 1986, J BIOL CHEM, V261, P8442; Lu JH, 2014, P NATL ACAD SCI USA, V111, P5189, DOI 10.1073/pnas.1322357111; Lundmark K, 2002, P NATL ACAD SCI USA, V99, P6979, DOI 10.1073/pnas.092205999; Maurer-Stroh S, 2010, NAT METHODS, V7, P237, DOI [10.1038/NMETH.1432, 10.1038/nmeth.1432]; MCADAM KPWJ, 1976, J EXP MED, V144, P1121, DOI 10.1084/jem.144.4.1121; Mereuta OM, 2014, BLOOD, V123, P1479, DOI 10.1182/blood-2013-07-517938; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Moriguchi M, 1999, HUM GENET, V105, P360, DOI 10.1007/s004390051115; Moriguchi M, 2005, AMYLOID, V12, P26, DOI 10.1080/13506120500032394; Murakami T, 2013, AMYLOID, V20, P80, DOI 10.3109/13506129.2013.783474; Niewold TA, 1999, AMYLOID, V6, P205, DOI 10.3109/13506129909007328; Noborn F, 2012, J BIOL CHEM, V287, P25669, DOI 10.1074/jbc.M112.363895; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Papendick RE, 1997, VET PATHOL, V34, P549, DOI 10.1177/030098589703400602; Patel H, 1996, BIOCHEM J, V318, P1041, DOI 10.1042/bj3181041; Penner CR, 2006, ORAL ONCOL, V42, P421, DOI 10.1016/j.oraloncology.2005.09.010; Rocken C, 2005, ANN RHEUM DIS, V64, P808, DOI 10.1136/ard.2004.030429; ROWLAND PH, 1991, VET PATHOL, V28, P125, DOI 10.1177/030098589102800204; Sethi S, 2012, KIDNEY INT, V82, P226, DOI 10.1038/ki.2012.108; Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200; Simons JP, 2013, P NATL ACAD SCI USA, V110, P16115, DOI 10.1073/pnas.1306621110; SIPE JD, 1976, J IMMUNOL, V116, P1151; SOTO C, 1995, FEBS LETT, V371, P110, DOI 10.1016/0014-5793(95)00863-5; SUZUKI A, 1994, J RHEUMATOL, V21, P33; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Theis JD, 2013, J MASS SPECTROM, V48, P1067, DOI 10.1002/jms.3264; Thompson MJ, 2006, P NATL ACAD SCI USA, V103, P4074, DOI 10.1073/pnas.0511295103; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uhlar CM, 1999, EUR J BIOCHEM, V265, P501, DOI 10.1046/j.1432-1327.1999.00657.x; Vrana JA, 2009, BLOOD, V114, P4957, DOI 10.1182/blood-2009-07-230722; WESTERMARK GT, 1990, AM J PATHOL, V137, P377; WESTERMARK GT, 1992, BIOCHEM BIOPH RES CO, V182, P27, DOI 10.1016/S0006-291X(05)80107-X; WESTERMARK P, 1985, COMP BIOCHEM PHYS B, V82, P211, DOI 10.1016/0305-0491(85)90228-7; WISNIEWSKI T, 1992, NEUROSCI LETT, V135, P235, DOI 10.1016/0304-3940(92)90444-C; Yu JT, 2014, ANNU REV NEUROSCI, V37, P79, DOI 10.1146/annurev-neuro-071013-014300; Zhang BR, 2008, P NATL ACAD SCI USA, V105, P7263, DOI 10.1073/pnas.0800367105; Zhang B, 2008, J HERED, V99, P355, DOI 10.1093/jhered/esn015; Zhuo L, 2008, CONNECT TISSUE RES, V49, P311, DOI 10.1080/03008200802325458	72	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113765	10.1371/journal.pone.0113765	http://dx.doi.org/10.1371/journal.pone.0113765			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25429466	gold, Green Published, Green Submitted			2022-12-26	WOS:000349145400085
J	Loe, H; Steinshamn, S; Wisloff, U				Loe, Henrik; Steinshamn, Sigurd; Wisloff, Ulrik			Cardio-Respiratory Reference Data in 4631 Healthy Men and Women 20-90 Years: The HUNT 3 Fitness Study	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; LEFT-VENTRICULAR DYSFUNCTION; AEROBICALLY TRAINED MEN; PEAK OXYGEN-UPTAKE; ANAEROBIC THRESHOLD; VENTILATORY THRESHOLD; REFERENCE VALUES; GAS-EXCHANGE; CARDIOPULMONARY RESPONSES; EXERCISE CAPACITY	Purpose: To provide a large reference material on key cardio-respiratory variables in a healthy population of Norwegian men and women aged 20-90 years. Methods: Sub maximal and peak levels of cardio-respiratory variables were measured using cardiopulmonary exercise testing during treadmill running. Results: The highest peak ventilation among men (141.9 +/- 24.5 L.min(-1)) and women (92.0 +/- 16.5 L.min(-1)) was observed in the youngest age group (20-29 years, sex differences p<0.001) with an average 7% reduction per decade. The highest tidal volumes were observed in the 30-39 and 40-49 year age groups among men (2.94 +/- 0.46 L) and women (2.06 +/- 0.32 L) (sex differences p<0.001), with a subsequent average 6% reduction per decade. Ventilatory threshold and respiratory compensation point were observed at approximately 77% and 87% of peak oxygen uptake (VO2peak) among men and women, respectively. The best ventilatory efficiency (EqVCO(2Than)) was observed in the youngest age group (2029 years) in both men (26.2 +/- 2.8) and woman (27.5 +/- 2.7) (sex differences p<0.001) with an average 3% deterioration in ventilatory efficiency per decade. Conclusion: This is the largest European reference material of cardio-respiratory variables in healthy men and women aged 20-90 years, establishing normal values for, and associations between key cardio-respiratory parameters. This will be useful in clinical decision making when evaluating cardiopulmonary health in similar populations.	[Loe, Henrik; Steinshamn, Sigurd; Wisloff, Ulrik] Norwegian Univ Sci & Technol, KG Jebsen Ctr Exercise Med, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway; [Loe, Henrik] Valnesfjord Rehabil Ctr, Valnesfjord, Norway; [Steinshamn, Sigurd] Univ Trondheim Hosp, St Olavs Hosp, Dept Thorac Med, Trondheim, Norway	Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU)	Wisloff, U (corresponding author), Norwegian Univ Sci & Technol, KG Jebsen Ctr Exercise Med, Dept Circulat & Med Imaging, N-7034 Trondheim, Norway.	ulrik.wisloff@ntnu.no	Wisloff, Ulrik/K-2899-2012	Wisloff, Ulrik/0000-0002-7211-3587	K.G. Jebsen Foundation; Norwegian Council on Cardiovascular Disease; Research Council of Norway; Foundation for Cardiovascular Research at St. Olav's Hospital; Norwegian State Railways; Roche Norway Incorporated; Valnesfjord Rehabilitation Center	K.G. Jebsen Foundation; Norwegian Council on Cardiovascular Disease; Research Council of Norway(Research Council of Norway); Foundation for Cardiovascular Research at St. Olav's Hospital; Norwegian State Railways; Roche Norway Incorporated; Valnesfjord Rehabilitation Center	This study was funded by K.G. Jebsen Foundation, The Norwegian Council on Cardiovascular Disease, The Research Council of Norway, Foundation for Cardiovascular Research at St. Olav's Hospital, Norwegian State Railways, Roche Norway Incorporated and Valnesfjord Rehabilitation Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Ghobain MO, 2013, CLIN RESP J; Aspenes ST, 2011, MED SCI SPORT EXER, V43, P1465, DOI 10.1249/MSS.0b013e31820ca81c; ATS, 2003, AM J RESP CRIT CARE, V167, P211, DOI 10.1164/rccm.167.2.211; Balady GJ, 2010, CIRCULATION, V122, P191, DOI 10.1161/CIR.0b013e3181e52e69; Baur X, 2013, Pneumologie, V67, P401, DOI 10.1055/s-0033-1344331; BEAVER WL, 1986, J APPL PHYSIOL, V60, P2020, DOI 10.1152/jappl.1986.60.6.2020; BLACKIE SP, 1991, CHEST, V100, P136, DOI 10.1378/chest.100.1.136; Bradshaw DI, 2005, RES Q EXERCISE SPORT, V76, P426; Cao ZB, 2009, EUR J APPL PHYSIOL, V105, P289, DOI 10.1007/s00421-008-0902-8; CUNNINGHAM DA, 1985, J GERONTOL, V40, P703, DOI 10.1093/geronj/40.6.703; DAVIS JA, 1979, J APPL PHYSIOL, V46, P1039, DOI 10.1152/jappl.1979.46.6.1039; Davis JA, 1997, EUR J APPL PHYSIOL O, V76, P157, DOI 10.1007/s004210050228; Dejsomritrutai W, 2000, J Med Assoc Thai, V83, P457; Dempsey JA, 1999, J APPL PHYSIOL, V87, P1997, DOI 10.1152/jappl.1999.87.6.1997; Dempsey JA, 2012, J PHYSIOL-LONDON, V590, P4129, DOI 10.1113/jphysiol.2012.233908; Deruelle F, 2004, CAN J APPL PHYSIOL, V29, P564, DOI 10.1139/h04-036; Edvardsen E, 2013, CHEST, V144, P241, DOI 10.1378/chest.12-1458; Fabre N, 2008, J STRENGTH COND RES, V22, P1977, DOI 10.1519/JSC.0b013e3181874ae9; George JD, 1997, MED SCI SPORT EXER, V29, P415, DOI 10.1097/00005768-199703000-00019; Gonzales JU, 2012, INT J SPORTS MED, V33, P537, DOI 10.1055/s-0032-1304659; Guazzi M, 2012, CIRCULATION, V126, P2261, DOI 10.1161/CIR.0b013e31826fb946; Habedank D, 1998, EUR J APPL PHYSIOL O, V77, P421, DOI 10.1007/s004210050354; Hankinson JL, 2010, CHEST, V137, P138, DOI 10.1378/chest.09-0919; HELGERUD J, 1994, EUR J APPL PHYSIOL O, V68, P155, DOI 10.1007/BF00244029; HELGERUD J, 1990, EUR J APPL PHYSIOL O, V61, P433, DOI 10.1007/BF00236064; Herdy AH, 2011, ARQ BRAS CARDIOL, V96, P54, DOI 10.1590/S0066-782X2010005000155; HERMANSE.L, 1969, J APPL PHYSIOL, V26, P31, DOI 10.1152/jappl.1969.26.1.31; Hollenberg M, 2000, J AM COLL CARDIOL, V36, P194, DOI 10.1016/S0735-1097(00)00691-4; Hopker JG, 2011, ANAESTHESIA, V66, P111, DOI 10.1111/j.1365-2044.2010.06604.x; INBAR O, 1994, MED SCI SPORT EXER, V26, P538; Itoh H, 2013, J CARDIOL, V61, P71, DOI 10.1016/j.jjcc.2012.09.010; Jakovljevic DG, 2012, CLIN PHYSIOL FUNCT I, V32, P388, DOI 10.1111/j.1475-097X.2012.01143.x; JOHNSON BD, 1991, AM REV RESPIR DIS, V143, P960, DOI 10.1164/ajrccm/143.5_Pt_1.960; JONES NL, 1985, AM REV RESPIR DIS, V131, P700; Kamen G, 2004, J GERONTOL A-BIOL, V59, P1334, DOI 10.1093/gerona/59.12.1334; Kift J, 2008, LUNG, V186, P345, DOI 10.1007/s00408-008-9101-y; Kilbride E, 2003, EUR J APPL PHYSIOL, V89, P595, DOI 10.1007/s00421-003-0853-z; Kjelkenes I, 2010, CLIN PHYSIOL FUNCT I, V30, P333, DOI 10.1111/j.1475-097X.2010.00948.x; Kleber FX, 2000, CIRCULATION, V101, P2803, DOI 10.1161/01.CIR.101.24.2803; KNUDSON RJ, 1983, AM REV RESPIR DIS, V127, P725; Koch B, 2011, RESP MED, V105, P352, DOI 10.1016/j.rmed.2010.10.014; Larsen GE, 2002, RES Q EXERCISE SPORT, V73, P66, DOI 10.1080/02701367.2002.10608993; Lenti M, 2011, J STRENGTH COND RES, V25, P1326, DOI 10.1519/JSC.0b013e3181d99061; Loe H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064319; Loth DW, 2013, EUR J EPIDEMIOL, V28, P329, DOI 10.1007/s10654-013-9800-4; Ma YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063875; Malek MH, 2005, J STRENGTH COND RES, V19, P559; Malek MH, 2009, CLIN PHYSIOL FUNCT I, V29, P143, DOI 10.1111/j.1475-097X.2008.00850.x; Markovic G, 2007, ANN HUM BIOL, V34, P315, DOI 10.1080/03014460701219358; Marques-Neto SR, 2012, J STRENGTH COND RES, V26, P1967, DOI 10.1519/JSC.0b013e318234eb5d; McArdle W, 2010, EXERCISE PHYS NUTR E; MEYER K, 1994, CARDIOLOGY, V85, P341, DOI 10.1159/000176733; Meyer T, 2004, BRIT J SPORT MED, V38, P622, DOI 10.1136/bjsm.2003.007815; Mikulski MA, 2013, J OCCUP ENVIRON MED, V55, P802, DOI 10.1097/JOM.0b013e31828b22cc; Neder JA, 1999, EUR RESPIR J, V14, P1304, DOI 10.1183/09031936.99.14613049; Nelson MD, 2010, MED SCI SPORT EXER, V42, P255, DOI 10.1249/MSS.0b013e3181b0e534; Nes BM, 2011, MED SCI SPORT EXER, V43, P2024, DOI 10.1249/MSS.0b013e31821d3f6f; Nikooie R, 2009, J STRENGTH COND RES, V23, P2107, DOI 10.1519/JSC.0b013e3181b73bc2; Paterson DH, 1999, MED SCI SPORT EXER, V31, P1813, DOI 10.1097/00005768-199912000-00018; Pessoa DM, 2012, INT J SPORTS MED, V33, P744, DOI 10.1055/s-0031-1299753; Piepoli MF, 2006, EUR J CARDIOV PREV R, V13, P300; Piepoli MF, 2006, EUR J CARDIOV PREV R, V13, P150; POSNER JD, 1987, J APPL PHYSIOL, V63, P1519, DOI 10.1152/jappl.1987.63.4.1519; Rissanen APE, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00265; Roca J, 1997, EUR RESPIR J, V10, P2662; Sanada K, 2007, EUR J APPL PHYSIOL, V99, P475, DOI 10.1007/s00421-006-0375-6; Stathokostas L, 2004, J APPL PHYSIOL, V97, P781, DOI 10.1152/japplphysiol.00447.2003; SULLIVAN MJ, 1988, CIRCULATION, V77, P552, DOI 10.1161/01.CIR.77.3.552; Sun XG, 2002, AM J RESP CRIT CARE, V166, P1443, DOI 10.1164/rccm.2202033; Venturelli M, 2012, MATURITAS, V73, P115, DOI 10.1016/j.maturitas.2012.07.009; Vogel T, 2011, J NUTR HEALTH AGING, V15, P905, DOI 10.1007/s12603-011-0087-4; Wasserman K, 2012, EXERCISE TESTING INT, V167, P200; Yu F, 2007, ACTA PHYSIOL, V190, P229, DOI 10.1111/j.1748-1716.2007.01699.x	73	37	37	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113884	10.1371/journal.pone.0113884	http://dx.doi.org/10.1371/journal.pone.0113884			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426954	Green Submitted, Green Published, gold			2022-12-26	WOS:000349145400094
J	Tillgren, V; Ho, JCS; Onnerfjord, P; Kalamajski, S				Tillgren, Viveka; Ho, James C. S.; Onnerfjord, Patrik; Kalamajski, Sebastian			The Novel Small Leucine-rich Protein Chondroadherin-like (CHADL) Is Expressed in Cartilage and Modulates Chondrocyte Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN FIBRILLOGENESIS; TARGETED DISRUPTION; MATRIX PROTEIN; FIBROMODULIN; LUMICAN; DECORIN; DEFICIENT; SEQUENCE; RECEPTOR; LEADS	The constitution and biophysical properties of extracellular matrices can dramatically influence cellular phenotype during development, homeostasis, or pathogenesis. These effects can be signaled through a differentially regulated assembly of collagen fibrils, orchestrated by a family of collagen-associated small leucine-rich proteins (SLRPs). In this report, we describe the tissue-specific expression and function of a previously uncharacterized SLRP, chondroadherin-like (CHADL). We developed antibodies against CHADL and, by immunohistochemistry, detected CHADL expression mainly in skeletal tissues, particularly in fetal cartilage and in the pericellular space of adult chondrocytes. In situ hybridizations and immunoblots on tissue lysates confirmed this tissue-specific expression pattern. Recombinant CHADL bound collagen in cell culture and inhibited in vitro collagen fibrillogenesis. After Chadl shRNA knockdown, chondrogenic ATDC5 cells increased their differentiation, indicated by increased transcript levels of Sox9, Ihh, Col2a1, and Col10a1. The knockdown increased collagen II and aggrecan deposition in the cell layers. Microarray analysis of the knockdown samples suggested collagen receptor-related changes, although other upstream effects could not be excluded. Together, our data indicate that the novel SLRP CHADL is expressed in cartilaginous tissues, influences collagen fibrillogenesis, and modulates chondrocyte differentiation. CHADL appears to have a negative regulatory role, possibly ensuring the formation of a stable extracellular matrix.	[Tillgren, Viveka; Onnerfjord, Patrik; Kalamajski, Sebastian] Lund Univ, Dept Clin Sci, S-22184 Lund, Sweden; [Ho, James C. S.] Lund Univ, Dept Expt Med Sci, S-22184 Lund, Sweden	Lund University; Lund University	Kalamajski, S (corresponding author), Lund Univ, Dept Clin Sci, BMC C12,Klinikgatan 28, S-22184 Lund, Sweden.	Sebastian.Kalamajski@med.lu.se	Ho, James CS/ADQ-2735-2022; Ho, James CS/AAF-8197-2022; Onnerfjord, Patrik/R-3131-2019	Ho, James CS/0000-0002-6131-1297; Ho, James CS/0000-0002-6131-1297; Onnerfjord, Patrik/0000-0002-2345-2937; Kalamajski, Sebastian/0000-0002-6600-9302	Swedish Research Council; Crafoord Foundation; Magnus Bergvall Foundation; Ake Wiberg Foundation; Greta and Johan Kock Foundation; Alfred Osterlund Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Crafoord Foundation; Magnus Bergvall Foundation; Ake Wiberg Foundation; Greta and Johan Kock Foundation; Alfred Osterlund Foundation	This study was supported by grants from the Swedish Research Council, the Crafoord Foundation, the Magnus Bergvall Foundation, the Ake Wiberg Foundation, the Greta and Johan Kock Foundation, and the Alfred Osterlund Foundation.	Calamajski S., 2007, J BIOL CHEM, V282, P6740; Camper L, 1997, J CELL BIOL, V138, P1159, DOI 10.1083/jcb.138.5.1159; Caron MMJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033467; Chakravarti S, 2000, INVEST OPHTH VIS SCI, V41, P3365; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; Haglund L, 2011, J BIOL CHEM, V286, P3925, DOI 10.1074/jbc.M110.161141; HEDBOM E, 1989, J BIOL CHEM, V264, P6898; Hessle L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063080; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jepsen KJ, 2002, J BIOL CHEM, V277, P35532, DOI 10.1074/jbc.M205398200; Kalamajski S, 2007, J BIOL CHEM, V282, P16062, DOI 10.1074/jbc.M700073200; Kalamajski S, 2014, J BIOL CHEM, V289, P18873, DOI 10.1074/jbc.M114.572941; Kalamajski S, 2010, MATRIX BIOL, V29, P248, DOI 10.1016/j.matbio.2010.01.001; Kalamajski S, 2009, BIOCHEM J, V423, P53, DOI 10.1042/BJ20090542; Kalamajski S, 2009, J BIOL CHEM, V284, P534, DOI 10.1074/jbc.M805721200; LANDEGREN U, 1984, J IMMUNOL METHODS, V67, P379, DOI 10.1016/0022-1759(84)90477-0; LARSSON T, 1991, J BIOL CHEM, V266, P20428; NEAME PJ, 1994, J BIOL CHEM, V269, P21547; Svensson L, 2000, FEBS LETT, V470, P178, DOI 10.1016/S0014-5793(00)01314-4; Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449; Xu HF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052209; Xu L, 2007, ARTHRITIS RHEUM, V56, P2663, DOI 10.1002/art.22761; Xu TS, 1998, NAT GENET, V20, P78, DOI 10.1038/1746; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200	27	15	17	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					918	925		10.1074/jbc.M114.593541	http://dx.doi.org/10.1074/jbc.M114.593541			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25451920	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000347778200026
J	Amoako, N; Asante, KP; Adjei, G; Awandare, GA; Bimi, L; Owusu-Agyei, S				Amoako, Nicholas; Asante, Kwaku Poku; Adjei, George; Awandare, Gordon A.; Bimi, Langbong; Owusu-Agyei, Seth			Associations between Red Cell Polymorphisms and Plasmodium falciparum Infection in the Middle Belt of Ghana	PLOS ONE			English	Article							GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; MALARIA TRANSMISSION; IMMUNE-RESPONSES; TRAIT; PROTECTION; MORBIDITY; CHILDREN; PREVALENCE; RESISTANCE; INFANTS	Background: Red blood cell (RBC) polymorphisms are common in malaria endemic regions and are known to protect against severe forms of the disease. Therefore, it is important to screen for these polymorphisms in drugs or vaccines efficacy trials. This study was undertaken to evaluate associations between clinical malaria and RBC polymorphisms to assess biological interactions that may be necessary for consideration when designing clinical trials. Method: In a cross-sectional study of 341 febrile children less than five years of age, associations between clinical malaria and common RBC polymorphisms including the sickle cell gene and G6PD deficiency was evaluated between November 2008 and June 2009 in the middle belt of Ghana, Kintampo. G6PD deficiency was determined by quantitative methods whiles haemoglobin variants were determined by haemoglobin titan gel electrophoresis. Blood smears were stained with Giemsa and parasite densities were determined microscopically. Results: The prevalence of clinical malarial among the enrolled children was 31.9%. The frequency of G6PD deficiency was 19.0% and that for the haemoglobin variants were 74.7%, 14.7%, 9.1%, 0.9% respectively for HbAA, HbAC, HbAS and HbSS. In Multivariate regression analysis, children with the HbAS genotype had 79% lower risk of malaria infection compared to those with the HbAA genotypes (OR=0.21, 95% CI: 0.06-0.73, p=0.01). HbAC genotype was not significantly associated with malaria infection relative to the HbAA genotype (OR=0.70, 95% CI: 0.35-1.42, p=0.33). G6PD deficient subgroup had a marginally increased risk of malaria infection compared to the G6PD normal subgroup (OR=1.76, 95% CI: 0.98-3.16, p=0.06). Conclusion: These results confirm previous findings showing a protective effect of sickle cell trait on clinical malaria infection. However, G6PD deficiency was associated with a marginal increase in susceptibility to clinical malaria compared to children without G6PD deficiency.	[Amoako, Nicholas; Asante, Kwaku Poku; Adjei, George; Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Kintampo, Brong Ahafo Reg, Ghana; [Awandare, Gordon A.] Univ Ghana, Dept Biochem Cell & Mol Biol, Infect Dis Res Lab, Legon, Ghana; [Bimi, Langbong] Univ Ghana, Dept Anim Biol & Conservat Sci, Legon, Ghana	Kintampo Health Research Centre; University of Ghana; University of Ghana	Amoako, N (corresponding author), Kintampo Hlth Res Ctr, Kintampo, Brong Ahafo Reg, Ghana.	nicholas.amoako@kintampo-hrc.org	Awandare, Gordon/J-1392-2019	Awandare, Gordon/0000-0002-8793-3641; BIMI, Langbong/0000-0002-8536-4828; Amoako, Nicholas/0000-0001-9737-4401; Owusu-Agyei, Seth/0000-0002-0807-1781	Management of Kintampo Health Research Centre (KHRC), Ghana Health Service; KHRC Research Capacity Programme	Management of Kintampo Health Research Centre (KHRC), Ghana Health Service; KHRC Research Capacity Programme	The Sponsor is the Management of Kintampo Health Research Centre (KHRC), Ghana Health Service. The grant was KHRC Research Capacity Programme. KHRC management reviewed and approved all study procedures and the study manuscript.	Agarwal A, 2000, BLOOD, V96, P2358, DOI 10.1182/blood.V96.7.2358.h8002358_2358_2363; Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; ALLEN SJ, 1992, T ROY SOC TROP MED H, V86, P494, DOI 10.1016/0035-9203(92)90083-O; Amaratunga C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014798; Asante KP, 2013, J INFECT DIS, V208, P1504, DOI 10.1093/infdis/jit366; Ayi K, 2004, BLOOD, V104, P3364, DOI 10.1182/blood-2003-11-3820; BIENZLE U, 1972, LANCET, V1, P107; Breman JG, 2001, AM SOC TROPICAL MED, P1824, DOI American Society of Tropical Medicine and Hygiene; Carter N, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-241; Davenport GC, 2010, ROLE HIV 1 BACTERMIA; Dery DB, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-314; Dosoo DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036308; GILL FM, 1995, BLOOD, V86, P776, DOI 10.1182/blood.V86.2.776.bloodjournal862776; GILLES HM, 1967, LANCET, V1, P138; Gong L, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-317; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Guinet F, 1997, ACTA TROP, V68, P175, DOI 10.1016/S0001-706X(97)00089-2; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; KORNBERG A, 1955, METHOD ENZYMOL, V1, P323, DOI 10.1016/0076-6879(55)01046-X; Kreuels B, 2010, BLOOD, V115, P4551, DOI 10.1182/blood-2009-09-241844; LaMonte G, 2012, CELL HOST MICROBE, V12, P187, DOI 10.1016/j.chom.2012.06.007; Lohr G. W., 1974, METHODS ENZYMATIC AN, V2, P636, DOI [DOI 10.1016/B978-0-12-091302-2.50026-8, 10.1016/B978-0-12-091302-2.50026-8]; LUZZATTO L, 1979, LANCET, V1, P1183; Mackinnon MJ, 2000, P NATL ACAD SCI USA, V97, P12661, DOI 10.1073/pnas.220267997; MARTIN SK, 1979, LANCET, V1, P524; Masiye F, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-60; Mockenhaupt FP, 2003, TROP MED INT HEALTH, V8, P118, DOI 10.1046/j.1365-3156.2003.01008.x; Modiano D, 2001, NATURE, V414, P305, DOI 10.1038/35104556; MODIANO G, 1991, AM J HUM GENET, V48, P390; Moormann AM, 2003, T ROY SOC TROP MED H, V97, P513, DOI 10.1016/S0035-9203(03)80010-X; Ohene-Frempong K, 2008, PEDIATRICS, V121, pS120, DOI 10.1542/peds.2007-2022UUU; Owusu-Agyei S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-220; Rumisha SF, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-124; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Sehgal V M, 1989, Trans R Soc Trop Med Hyg, V83 Suppl, P105, DOI 10.1016/0035-9203(89)90616-0; VULLIAMY T, 1992, TRENDS GENET, V8, P138, DOI 10.1016/0168-9525(92)90372-B; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Williams TN, 2005, NAT GENET, V37, P1253, DOI 10.1038/ng1660; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744; Yazdani SS, 2006, CURR MOL MED, V6, P187, DOI 10.2174/156652406776055212	40	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e112868	10.1371/journal.pone.0112868	http://dx.doi.org/10.1371/journal.pone.0112868			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470251	Green Published, gold			2022-12-26	WOS:000349128700011
J	Brayton, KM; Hirsch, AT; O'Brien, PJ; Cheville, A; Karaca-Mandic, P; Rockson, SG				Brayton, Kimberly M.; Hirsch, Alan T.; O'Brien, Patricia J.; Cheville, Andrea; Karaca-Mandic, Pinar; Rockson, Stanley G.			Lymphedema Prevalence and Treatment Benefits in Cancer: Impact of a Therapeutic Intervention on Health Outcomes and Costs	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; LYMPHATIC VASCULAR-DISEASE; BREAST-CANCER; PNEUMATIC COMPRESSION; EXTREMITY LYMPHEDEMA; SECONDARY LYMPHEDEMA; TRIAL; MANAGEMENT; WOMEN; LIMB	Background: Lymphedema is a common complication of cancer therapeutics; its prevalence, treatment outcomes, and costs have been poorly defined. The objective of this study was to examine lymphedema prevalence among cancer survivors and to characterize changes in clinical outcomes and costs associated with a defined therapeutic intervention (use of a pneumatic compression devices [PCD]) in a representative, privately insured population. Methods and Findings: Retrospective analysis of de-identified health claims data from a large national insurer for calendar years 2007 through 2013. Patients were required to have 12 months of continuous insurance coverage prior to PCD receipt (baseline), as well as a 12-month follow-up period. Analyses were performed for individuals with cancer-related lymphedema (n=1,065). Lymphedema prevalence was calculated: number of patients with a lymphedema claim in a calendar year divided by total number of enrollees. The impact of PCD use was evaluated by comparing rates of a pre-specified set of health outcomes and costs for the 12 months before and after, respectively, PCD receipt. Lymphedema prevalence among cancer survivors increased from 0.95% in 2007 to 1.24% in 2013. PCD use was associated with decreases in rates of hospitalizations (45% to 32%, p<0.0001), outpatient hospital visits (95% to 90%, p<0.0001), cellulitis diagnoses (28% to 22%, p=0.003), and physical therapy use (50% to 41%, p<0.0001). The average baseline health care costs were high ($53,422) but decreased in the year after PCD acquisition (-$11,833, p<0.0001). Conclusions: Lymphedema is a prevalent medical condition that is often a defining attribute of cancer survivorship. The problem is associated with high health care costs; Treatment (in this instance, use of PCD) is associated with significant decreases in adverse clinical outcomes and costs.	[Brayton, Kimberly M.; Rockson, Stanley G.] Stanford Univ, Stanford Ctr Lymphat & Venous Disorders, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Hirsch, Alan T.] Univ Minnesota, Sch Med, Div Cardiovasc, Minneapolis, MN 55455 USA; [O'Brien, Patricia J.] Univ Vermont, Div Hematol Oncol, Burlington, VT USA; [Cheville, Andrea] Mayo Clin, Phys Med & Rehabil, Rochester, MN USA; [Karaca-Mandic, Pinar] Univ Minnesota, Sch Publ Hlth, Div Hlth Policy & Management, Minneapolis, MN USA	Stanford University; University of Minnesota System; University of Minnesota Twin Cities; University of Vermont; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities	Rockson, SG (corresponding author), Stanford Univ, Stanford Ctr Lymphat & Venous Disorders, Sch Med, Div Cardiovasc Med, Stanford, CA 94305 USA.	rockson@stanford.edu		rockson, stanley/0000-0003-1253-474X	NIH [HS000028]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000028, F32HS000028] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Funding: Kimberly Brayton, MD, is supported by Grant Number HS000028 from the NIH. The contents of this manuscript are solely the responsibility of the authors and do not necessarily represent the official views of the AHRQ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed RL, 2006, J CLIN ONCOL, V24, P2765, DOI 10.1200/JCO.2005.03.6749; [Anonymous], 2012, CURRENT POPULATION S; Badger CMA, 2000, CANCER, V88, P2832, DOI 10.1002/1097-0142(20000615)88:12<2832::AID-CNCR24>3.3.CO;2-L; Chang Christine J, 2013, Semin Oncol Nurs, V29, P28, DOI 10.1016/j.soncn.2012.11.005; Cull DL, 2010, J AM COLL SURGEONS, V210, P555, DOI 10.1016/j.jamcollsurg.2009.12.019; Eslami MH, 2007, J VASC SURG, V45, P55, DOI 10.1016/j.jvs.2006.09.044; Hillner BE, 2006, J NATL CANCER I, V98, P660, DOI 10.1093/jnci/djj205; Hirsch AT, 2008, VASC MED, V13, P209, DOI 10.1177/1358863X08089277; Lawenda BD, 2009, CA-CANCER J CLIN, V59, P8, DOI 10.3322/caac.20001; Margolis Jay, 2005, J Manag Care Pharm, V11, P727; McKenzie DC, 2003, J CLIN ONCOL, V21, P463, DOI 10.1200/JCO.2003.04.069; McWayne J, 2005, CANCER, V104, P457, DOI 10.1002/cncr.21195; Moffatt CJ, 2003, QJM-INT J MED, V96, P731, DOI 10.1093/qjmed/hcg126; Mondry TE, 2004, CANCER J, V10, P42, DOI 10.1097/00130404-200401000-00009; Muluk SC, 2013, EUR J VASC ENDOVASC, V46, P480, DOI 10.1016/j.ejvs.2013.07.012; Paskett ED, 2007, CANCER EPIDEM BIOMAR, V16, P775, DOI 10.1158/1055-9965.EPI-06-0168; Radhakrisihnan K, 2008, ANN NY ACAD SCI, V1131, P155, DOI 10.1196/annals.1413.015; Ridner Sheila H., 2009, Lymphatic Research and Biology, V7, P109, DOI 10.1089/lrb.2009.0004; Rockson SG, 2001, AM J MED, V110, P288, DOI 10.1016/S0002-9343(00)00727-0; Rockson SG, 2008, J AM COLL CARDIOL, V52, P799, DOI 10.1016/j.jacc.2008.06.005; Rockson SG, 2010, VASC MED, V15, P223, DOI 10.1177/1358863X10364553; Schmitz KH, 2009, NEW ENGL J MED, V361, P664, DOI 10.1056/NEJMoa0810118; Shih YCT, 2009, J CLIN ONCOL, V27, P2007, DOI 10.1200/JCO.2008.18.3517; Snyder JJ, 2006, J AM SOC NEPHROL, V17, P2056, DOI 10.1681/ASN.2006030201; Stout NL, 2013, LYMPHOLOGY, V46, P27; Szuba A, 2003, J NUCL MED, V44, P43; Szuba A, 2002, CANCER, V95, P2260, DOI 10.1002/cncr.10976	27	58	59	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114597	10.1371/journal.pone.0114597	http://dx.doi.org/10.1371/journal.pone.0114597			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470383	gold, Green Published, Green Submitted			2022-12-26	WOS:000349128700124
J	Sadeh, S; Rotter, S				Sadeh, Sadra; Rotter, Stefan			Distribution of Orientation Selectivity in Recurrent Networks of Spiking Neurons with Different Random Topologies	PLOS ONE			English	Article							CONTRAST INVARIANCE; VISUAL-CORTEX; CONNECTIVITY; EMERGENCE; INPUT; NOISE; MODEL; MICROCIRCUITS; ORGANIZATION; INHIBITION	Neurons in the primary visual cortex are more or less selective for the orientation of a light bar used for stimulation. A broad distribution of individual grades of orientation selectivity has in fact been reported in all species. A possible reason for emergence of broad distributions is the recurrent network within which the stimulus is being processed. Here we compute the distribution of orientation selectivity in randomly connected model networks that are equipped with different spatial patterns of connectivity. We show that, for a wide variety of connectivity patterns, a linear theory based on firing rates accurately approximates the outcome of direct numerical simulations of networks of spiking neurons. Distance dependent connectivity in networks with a more biologically realistic structure does not compromise our linear analysis, as long as the linearized dynamics, and hence the uniform asynchronous irregular activity state, remain stable. We conclude that linear mechanisms of stimulus processing are indeed responsible for the emergence of orientation selectivity and its distribution in recurrent networks with functionally heterogeneous synaptic connectivity.	[Rotter, Stefan] Univ Freiburg, Bernstein Ctr Freiburg, D-79106 Freiburg, Germany; Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Rotter, S (corresponding author), Univ Freiburg, Bernstein Ctr Freiburg, Hugstetter Str 55, D-79106 Freiburg, Germany.	stefan.rotter@biologie.uni-freiburg.de		Sadeh, Sadra/0000-0001-8159-5461	German Ministry of Education and Research (BMBF; BFNT-F*T) [01GQ0830]; German Research Foundation (DFG) [EXC 1086]; University of Freiburg	German Ministry of Education and Research (BMBF; BFNT-F*T)(Federal Ministry of Education & Research (BMBF)); German Research Foundation (DFG)(German Research Foundation (DFG)); University of Freiburg	Funding by the German Ministry of Education and Research (BMBF; BFNT-F*T, grant 01GQ0830) and the German Research Foundation (DFG; grant EXC 1086) is gratefully acknowledged. The article processing charge was covered by the open access publication fund of the University of Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; Anderson JS, 2000, SCIENCE, V290, P1968, DOI 10.1126/science.290.5498.1968; BENYISHAI R, 1995, P NATL ACAD SCI USA, V92, P3844, DOI 10.1073/pnas.92.9.3844; BLASDEL GG, 1986, NATURE, V321, P579, DOI 10.1038/321579a0; BONHOEFFER T, 1991, NATURE, V353, P429, DOI 10.1038/353429a0; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Carandini M, 2000, J NEUROSCI, V20, P470, DOI 10.1523/JNEUROSCI.20-01-00470.2000; Fino E, 2011, NEURON, V69, P1188, DOI 10.1016/j.neuron.2011.02.025; Hansel D, 2002, J NEUROSCI, V22, P5118, DOI 10.1523/JNEUROSCI.22-12-05118.2002; Hansel D, 2012, J NEUROSCI, V32, P4049, DOI 10.1523/JNEUROSCI.6284-11.2012; Harris KD, 2013, NATURE, V503, P51, DOI 10.1038/nature12654; Helias M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000929; Hofer SB, 2011, NAT NEUROSCI, V14, P1045, DOI 10.1038/nn.2876; Ishikawa AW, 2014, J NEUROSCI, V34, P12576, DOI 10.1523/JNEUROSCI.1346-14.2014; Jia HB, 2010, NATURE, V464, P1307, DOI 10.1038/nature08947; Ko H, 2014, J NEUROSCI, V34, P9812, DOI 10.1523/JNEUROSCI.0875-14.2014; Ko H, 2013, NATURE, V496, P96, DOI 10.1038/nature12015; Ko H, 2011, NATURE, V473, P87, DOI 10.1038/nature09880; Kuhn A, 2004, J NEUROSCI, V24, P2345, DOI 10.1523/JNEUROSCI.3349-03.2004; Kumar A, 2008, J NEUROSCI, V28, P5268, DOI 10.1523/JNEUROSCI.2542-07.2008; Li LY, 2013, NAT NEUROSCI, V16, P1179, DOI 10.1038/nn.3493; Li YT, 2013, NAT NEUROSCI, V16, P1324, DOI 10.1038/nn.3494; Lien AD, 2013, NAT NEUROSCI, V16, P1315, DOI 10.1038/nn.3488; Miller KD, 2002, J NEUROPHYSIOL, V87, P653, DOI 10.1152/jn.00425.2001; Niell CM, 2008, J NEUROSCI, V28, P7520, DOI 10.1523/JNEUROSCI.0623-08.2008; Ohki K, 2006, NATURE, V442, P925, DOI 10.1038/nature05019; Ostojic S, 2014, NAT NEUROSCI, V17, P594, DOI 10.1038/nn.3658; Packer AM, 2011, J NEUROSCI, V31, P13260, DOI 10.1523/JNEUROSCI.3131-11.2011; Pehlevan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089992; Pernice V, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002059; PETERS A, 1993, CEREB CORTEX, V3, P69, DOI 10.1093/cercor/3.1.69; Priebe NJ, 2008, NEURON, V57, P482, DOI 10.1016/j.neuron.2008.02.005; Priebe NJ, 2012, NEURON, V75, P194, DOI 10.1016/j.neuron.2012.06.011; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Ricciardi L.M., 1977, DIFFUSION PROCESSES, V14; Ringach DL, 2002, J NEUROSCI, V22, P5639; Rosenbaum R, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.021039; Sadeh S, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-148; SIEGERT AJF, 1951, PHYS REV, V81, P617, DOI 10.1103/PhysRev.81.617; SOMERS DC, 1995, J NEUROSCI, V15, P5448; Tetzlaff T, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002596; van Vreeswijk C, 1998, NEURAL COMPUT, V10, P1321, DOI 10.1162/089976698300017214; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Yger P, 2011, J COMPUT NEUROSCI, V31, P229, DOI 10.1007/s10827-010-0310-z; Yim MY, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.032710	45	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114237	10.1371/journal.pone.0114237	http://dx.doi.org/10.1371/journal.pone.0114237			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469704	gold, Green Published, Green Submitted			2022-12-26	WOS:000349128700090
J	Just, MA; Cherkassky, VL; Buchweitz, A; Keller, TA; Mitchell, TM				Just, Marcel Adam; Cherkassky, Vladimir L.; Buchweitz, Augusto; Keller, Timothy A.; Mitchell, Tom M.			Identifying Autism from Neural Representations of Social Interactions: Neurocognitive Markers of Autism	PLOS ONE			English	Article							PERSPECTIVE-TAKING; BRAIN ACTIVITY; CLASSIFICATION; SPECTRUM; INDIVIDUALS; DEACTIVATE; DISORDER; STATES; SELF	Autism is a psychiatric/neurological condition in which alterations in social interaction (among other symptoms) are diagnosed by behavioral psychiatric methods. The main goal of this study was to determine how the neural representations and meanings of social concepts (such as to insult) are altered in autism. A second goal was to determine whether these alterations can serve as neurocognitive markers of autism. The approach is based on previous advances in fMRI analysis methods that permit (a) the identification of a concept, such as the thought of a physical object, from its fMRI pattern, and (b) the ability to assess the semantic content of a concept from its fMRI pattern. These factor analysis and machine learning methods were applied to the fMRI activation patterns of 17 adults with high-functioning autism and matched controls, scanned while thinking about 16 social interactions. One prominent neural representation factor that emerged (manifested mainly in posterior midline regions) was related to self-representation, but this factor was present only for the control participants, and was near-absent in the autism group. Moreover, machine learning algorithms classified individuals as autistic or control with 97% accuracy from their fMRI neurocognitive markers. The findings suggest that psychiatric alterations of thought can begin to be biologically understood by assessing the form and content of the altered thought's underlying brain activation patterns.	[Just, Marcel Adam; Cherkassky, Vladimir L.; Buchweitz, Augusto; Keller, Timothy A.] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA; [Just, Marcel Adam; Cherkassky, Vladimir L.; Buchweitz, Augusto; Keller, Timothy A.] Carnegie Mellon Univ, Ctr Cognit Brain Imaging, Pittsburgh, PA 15213 USA; [Mitchell, Tom M.] Carnegie Mellon Univ, Machine Learning Dept, Pittsburgh, PA 15213 USA; [Buchweitz, Augusto] Pontificia Univ Catolica Rio Grande do Sul, Brain Inst Rio Grande do Sul InsCer RS, Porto Alegre, RS, Brazil	Carnegie Mellon University; Carnegie Mellon University; Carnegie Mellon University; Pontificia Universidade Catolica Do Rio Grande Do Sul	Just, MA (corresponding author), Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA.	just@cmu.edu	Buchweitz, Augusto/J-5384-2019; Buchweitz, Augusto/G-3829-2012	Buchweitz, Augusto/0000-0003-3791-7472; Buchweitz, Augusto/0000-0003-3791-7472; Just, Marcel/0000-0003-1245-3050	National Institute of Mental Health Grant [MH029617]; National Institute of Child Health and Human Development Grant [HD055748]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P50HD055748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH029617] Funding Source: NIH RePORTER	National Institute of Mental Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Child Health and Human Development Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the National Institute of Mental Health Grant MH029617 and the National Institute of Child Health and Human Development Grant HD055748. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JS, 2011, BRAIN, V134, P3739, DOI 10.1093/brain/awr263; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Benton AL, 1987, TEST FACIAL RECOGNIT; Calamante F, 2010, NEUROIMAGE, V53, P1233, DOI 10.1016/j.neuroimage.2010.07.024; Ecker C, 2010, J NEUROSCI, V30, P10612, DOI 10.1523/JNEUROSCI.5413-09.2010; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; Frings L, 2006, EXP BRAIN RES, V173, P661, DOI 10.1007/s00221-006-0408-8; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Geschwind DH, 2007, CURR OPIN NEUROBIOL, V17, P103, DOI 10.1016/j.conb.2007.01.009; Gilman SR, 2011, NEURON, V70, P898, DOI 10.1016/j.neuron.2011.05.021; Grandin T, 1992, J Child Adolesc Psychopharmacol, V2, P63, DOI 10.1089/cap.1992.2.63; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Iacoboni M, 2006, TRENDS COGN SCI, V10, P431, DOI 10.1016/j.tics.2006.08.002; Just MA, 2012, NEUROSCI BIOBEHAV R, V36, P1292, DOI 10.1016/j.neubiorev.2012.02.007; Just MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008622; Kana RK, 2009, SOC NEUROSCI-UK, V4, P135, DOI 10.1080/17470910802198510; Kanner L, 1943, NERV CHILD, V2, P217; Kassam KS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066032; Kay KN, 2008, NATURE, V452, P352, DOI 10.1038/nature06713; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Lord C, 2000, J AUTISM DEV DISORD, V30, P205, DOI 10.1023/A:1005592401947; LORD C, 1994, J AUTISM DEV DISORD, V24, P659, DOI 10.1007/BF02172145; Mitchell TM, 2008, SCIENCE, V320, P1191, DOI 10.1126/science.1152876; Mizuno A, 2011, BRAIN, V134, P2422, DOI 10.1093/brain/awr151; Morita T, 2011, SOC NEUROSCI, V22, P1; Murdaugh DL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050064; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Reitan RM, 1985, HALSTEAD REITAN NEUR; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Sacks O., 1996, ANTHROPOLOGIST MARS; Schultz RT, 2000, ARCH GEN PSYCHIAT, V57, P331, DOI 10.1001/archpsyc.57.4.331; Shinkareva SV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001394; Sorensen AG, 2007, P INT SOC MAG RESON, V15, P3720, DOI [DOI 10.1128/MCB.25.11.4371, DOI 10.1038/SJ.IJ0.0803354]; Uddin LQ, 2007, TRENDS COGN SCI, V11, P153, DOI 10.1016/j.tics.2007.01.001; Uddin LQ, 2011, BIOL PSYCHIAT, V70, P833, DOI 10.1016/j.biopsych.2011.07.014; Uddin LQ, 2011, NEUROCASE, V17, P201, DOI 10.1080/13554794.2010.509320; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Wechsler D., 1997, WECHSLER MEMORY SCAL, Vthird; Zaehle T, 2007, BRAIN RES, V1137, P92, DOI 10.1016/j.brainres.2006.12.044	40	53	53	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113879	10.1371/journal.pone.0113879	http://dx.doi.org/10.1371/journal.pone.0113879			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU8TQ	25461818	Green Published, gold			2022-12-26	WOS:000345869700063
J	He, S; Feng, M; Liu, M; Yang, SB; Yan, S; Zhang, W; Wang, ZZ; Hu, CF; Xu, Q; Chen, LC; Zhu, HX; Xu, NZ				He, Shun; Feng, Min; Liu, Mei; Yang, Shangbin; Yan, Shuang; Zhang, Wei; Wang, Zaozao; Hu, Chenfei; Xu, Qing; Chen, Lechuang; Zhu, Hongxia; Xu, Ningzhi			P21-Activated Kinase 7 Mediates Cisplatin-Resistance of Esophageal Squamous Carcinoma Cells with Aurora-A Overexpression	PLOS ONE			English	Article							DOWN-REGULATION; GASTRIC-CANCER; OVARIAN-CANCER; C-MYC; PAK5; PROGRESSION; MIGRATION; BRAIN	Aurora-A overexpression is common in various types of cancers and has been shown to be involved in tumorigenesis through different signaling pathways, yet how the deregulation affects cancer therapeutics remains elusive. Here we showed that overexpression of Aurora-A rendered esophageal cancer cells resistance to cisplatin (CDDP) by inhibiting apoptosis. By using an apoptosis array, we identified a downstream gene, p21-activated kinase 7 (PAK7). PAK7 was upregulated by Aurora-A overexpression at both mRNA and protein levels. Importantly, the expression levels of Aurora-A and PAK7 were correlated in ESCC primary samples. Chromatin immunoprecipitation (ChIP) assay revealed that binding of E2F1 to the promoter of PAK7 was significantly enhanced upon Aurora-A activation, and knockdown of transcription factor E2F1 decreased PAK7 expression, suggesting that Aurora-A regulated PAK7 through E2F1. Furthermore, we demonstrated that PAK7 knockdown led to increased apoptosis, and Aurora-A-induced resistance to CDDP was reversed by downregulation of PAK7, suggesting PAK7 was a downstream player of Aurora-A that mediated chemoresistance of ESCC cells to CDDP. Our data suggest that PAK7 may serve as an attractive candidate for therapeutics in ESCC patients with Aurora-A abnormality.	[He, Shun; Liu, Mei; Yang, Shangbin; Yan, Shuang; Zhang, Wei; Wang, Zaozao; Hu, Chenfei; Xu, Qing; Chen, Lechuang; Zhu, Hongxia; Xu, Ningzhi] Chinese Acad Med Sci, Canc Hosp, Lab Cell & Mol Biol, Beijing 100730, Peoples R China; [He, Shun; Liu, Mei; Yang, Shangbin; Yan, Shuang; Zhang, Wei; Wang, Zaozao; Hu, Chenfei; Xu, Qing; Chen, Lechuang; Zhu, Hongxia; Xu, Ningzhi] Chinese Acad Med Sci, Canc Hosp, State Key Lab Mol Oncol, Beijing 100730, Peoples R China; [He, Shun; Liu, Mei; Yang, Shangbin; Yan, Shuang; Zhang, Wei; Wang, Zaozao; Hu, Chenfei; Xu, Qing; Chen, Lechuang; Zhu, Hongxia; Xu, Ningzhi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Feng, Min] Sichuan Univ, West China Womens & Childrens Hosp, West China Univ Hosp 2, Dept Pathol, Chengdu, Sichuan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Sichuan University	Zhu, HX (corresponding author), Chinese Acad Med Sci, Canc Hosp, Lab Cell & Mol Biol, Beijing 100730, Peoples R China.	drhxzhu@cicams.ac.cn; xningzhi@public.bta.net.cn	Liu, Mei/GWN-1774-2022; He, Shun/K-7448-2014; Chen, Lechuang/AAF-8351-2020		Beijing Natural Science Foundation [5102038]; National Natural Science Foundation [81321091, 81021061, 31171322]; Chinese Hi-Tech RD Program [2012AA02A503]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Hi-Tech RD Program	This work was supported by the Beijing Natural Science Foundation (5102038), National Natural Science Foundation (81321091, 81021061, 31171322), Chinese Hi-Tech R&D Program (2012AA02A503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cotteret S, 2006, MOL CELL BIOL, V26, P3215, DOI 10.1128/MCB.26.8.3215-3230.2006; Cotteret S, 2003, MOL CELL BIOL, V23, P5526, DOI 10.1128/MCB.23.16.5526-5539.2003; Dan C, 2002, MOL CELL BIOL, V22, P567, DOI 10.1128/MCB.22.2.567-577.2002; Dar AA, 2009, ONCOGENE, V28, P866, DOI 10.1038/onc.2008.434; Gong W, 2009, INT J CANCER, V125, P548, DOI 10.1002/ijc.24428; Gu J, 2013, FEBS J, V280, P46, DOI 10.1111/febs.12048; Han Yaling, 2002, Zhonghua Yi Xue Yi Chuan Xue Za Zhi, V19, P455; He S, 2010, CELL MOL LIFE SCI, V67, P2069, DOI 10.1007/s00018-010-0340-8; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Katayama H, 2004, NAT GENET, V36, P55, DOI 10.1038/ng1279; Kollareddy M, 2012, INVEST NEW DRUG, V30, P2411, DOI 10.1007/s10637-012-9798-6; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Li DY, 2013, MOL CELL BIOCHEM, V383, P191, DOI 10.1007/s11010-013-1767-7; Nekrasova T, 2008, DEV BIOL, V322, P95, DOI 10.1016/j.ydbio.2008.07.006; Nikonova AS, 2013, CELL MOL LIFE SCI, V70, P661, DOI 10.1007/s00018-012-1073-7; Pandey A, 2002, ONCOGENE, V21, P3939, DOI 10.1038/sj.onc.1205478; Reiter R, 2006, CLIN CANCER RES, V12, P5136, DOI 10.1158/1078-0432.CCR-05-1650; Sen S, 2002, JNCI-J NATL CANCER I, V94, P1320; Strochlic TI, 2012, P NATL ACAD SCI USA, V109, P4116, DOI 10.1073/pnas.1116560109; Tanner MM, 2000, CLIN CANCER RES, V6, P1833; Tong T, 2004, CLIN CANCER RES, V10, P7304, DOI 10.1158/1078-0432.CCR-04-0806; Wang X, 2010, TUMOR BIOL, V31, P575, DOI 10.1007/s13277-010-0071-3; Wang XX, 2013, TUMOR BIOL, V34, P2721, DOI 10.1007/s13277-013-0824-x; Wang YH, 2005, CANCER BIOL THER, V4, P974, DOI 10.4161/cbt.4.9.1914; Xu YP, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-173; Yang H, 2004, CANCER RES, V64, P463, DOI 10.1158/0008-5472.CAN-03-2907; Yang SB, 2010, EXP MOL MED, V42, P759, DOI 10.3858/emm.2010.42.11.077	27	16	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113989	10.1371/journal.pone.0113989	http://dx.doi.org/10.1371/journal.pone.0113989			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436453	Green Submitted, Green Published, gold			2022-12-26	WOS:000347114900107
J	Iizuka, S; Oridate, N; Nashimoto, M; Fukuda, S; Tamura, M				Iizuka, Satoshi; Oridate, Nobuhiko; Nashimoto, Masayuki; Fukuda, Satoshi; Tamura, Masato			Growth Inhibition of Head and Neck Squamous Cell Carcinoma Cells by sgRNA Targeting the Cyclin D1 mRNA Based on TRUE Gene Silencing	PLOS ONE			English	Article							HEPTAMER-TYPE SGRNA; PROGNOSTIC-SIGNIFICANCE; ANTISENSE; CANCER; EXPRESSION; PROLIFERATION; APOPTOSIS; TRNASE; OLIGODEOXYNUCLEOTIDES; TUMORIGENICITY	Head and neck squamous cell carcinoma (HNSCC) exhibits increased expression of cyclin D1 (CCND1). Previous studies have shown a correlation between poor prognosis of HNSCC and cyclin D1 overexpression. tRNase ZL-utilizing efficacious gene silencing (TRUE gene silencing) is one of the RNA-mediated gene expression control technologies that have therapeutic potential. This technology is based on a unique enzymatic property of mammalian tRNase ZL, which is that it can cleave any target RNA at any desired site by recognizing a pre-tRNA-like complex formed between the target RNA and an artificial small guide RNA (sgRNA). In this study, we designed several sgRNAs targeting human cyclin D1 mRNA to examine growth inhibition of HNSCC cells. Transfection of certain sgRNAs decreased levels of cyclin D1 mRNA and protein in HSC-2 and HSC-3 cells, and also inhibited their proliferation. The combination of these sgRNAs and cisplatin showed more than additive inhibition of cancer cell growth. These findings demonstrate that TRUE gene silencing of cyclin D1 leads to inhibition of the growth of HNSCC cells and suggest that these sgRNAs alone or combined with cisplatin may be a useful new therapy for HNSCCs.	[Iizuka, Satoshi; Fukuda, Satoshi] Hokkaido Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sapporo, Hokkaido, Japan; [Oridate, Nobuhiko] Yokohama City Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Yokohama, Kanagawa 232, Japan; [Nashimoto, Masayuki] Niigata Univ Pharm & Appl Life Sci, Res Inst Healthy Living, Niigata, Japan; [Tamura, Masato] Hokkaido Univ, Dept Biochem & Mol Biol, Grad Sch Dent Med, Sapporo, Hokkaido, Japan	Hokkaido University; Yokohama City University; Niigata University; Hokkaido University	Tamura, M (corresponding author), Hokkaido Univ, Dept Biochem & Mol Biol, Grad Sch Dent Med, Sapporo, Hokkaido, Japan.	mtamura@den.hokudai.ac.jp	Oridate, Nobuhiko/ABC-4116-2020; tamura, masato/B-7304-2009	Oridate, Nobuhiko/0000-0002-6968-3028; tamura, masato/0000-0003-3700-5203	JSPS [24592588]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the JSPS Grants-in-Aid for scientific research #24592588 (NO). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arber N, 1997, CANCER RES, V57, P1569; Bali A, 2004, CLIN CANCER RES, V10, P5168, DOI 10.1158/1078-0432.CCR-03-0751; BILLIAU A, 1977, ANTIMICROB AGENTS CH, V12, P11, DOI 10.1128/AAC.12.1.11; Bova RJ, 1999, CLIN CANCER RES, V5, P2810; Cagnoli M, 1998, GYNECOL ONCOL, V70, P372, DOI 10.1006/gyno.1998.5062; Driscoll B, 1997, AM J PHYSIOL-LUNG C, V273, pL941, DOI 10.1152/ajplung.1997.273.5.L941; Elbarbary RA, 2009, BIOCHEM BIOPH RES CO, V379, P924, DOI 10.1016/j.bbrc.2008.12.173; Higuchl E, 2007, HEAD NECK-J SCI SPEC, V29, P940, DOI 10.1002/hed.20632; Hung WC, 1996, BIOCHEM BIOPH RES CO, V220, P719, DOI 10.1006/bbrc.1996.0470; Izzo JG, 1998, ONCOGENE, V17, P2313, DOI 10.1038/sj.onc.1202153; Jares P, 2007, NAT REV CANCER, V7, P750, DOI 10.1038/nrc2230; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kastelein JJP, 2006, CIRCULATION, V114, P1729, DOI 10.1161/CIRCULATIONAHA.105.606442; Koller E, 2011, NUCLEIC ACIDS RES, V39, P4795, DOI 10.1093/nar/gkr089; Kornmann M, 1998, J CLIN INVEST, V101, P344, DOI 10.1172/JCI1323; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; LOKE SL, 1989, P NATL ACAD SCI USA, V86, P3474, DOI 10.1073/pnas.86.10.3474; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mineta H, 2000, ORAL ONCOL, V36, P194, DOI 10.1016/S1368-8375(99)00078-0; MOMOSE F, 1989, J ORAL PATHOL MED, V18, P391, DOI 10.1111/j.1600-0714.1989.tb01570.x; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Nakashima A, 2007, GENE THER, V14, P78, DOI 10.1038/sj.gt.3302841; Nashimoto M, 2000, FEBS LETT, V472, P179, DOI 10.1016/S0014-5793(00)01462-9; Nashimoto M, 1998, NUCLEIC ACIDS RES, V26, P2565, DOI 10.1093/nar/26.11.2565; Oridate N, 2005, CANCER BIOL THER, V4, P318, DOI 10.4161/cbt.4.3.1504; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sano T, 2011, BIOCHEM BIOPH RES CO, V416, P427, DOI 10.1016/j.bbrc.2011.11.091; Santarius T, 2010, NAT REV CANCER, V10, P59, DOI 10.1038/nrc2771; Sato MM, 2009, GENES CELLS, V14, P141, DOI 10.1111/j.1365-2443.2008.01258.x; Sauter ER, 1999, CANCER RES, V59, P4876; Sazani P, 2002, NAT BIOTECHNOL, V20, P1228, DOI 10.1038/nbt759; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schrump DS, 1996, CANCER GENE THER, V3, P131; Scott EN, 2009, CANCER CHEMOTH PHARM, V64, P425, DOI 10.1007/s00280-009-0968-y; Shibata HS, 2005, J BIOL CHEM, V280, P22326, DOI 10.1074/jbc.M502048200; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Sledz CA, 2003, NAT CELL BIOL, V5, P834, DOI 10.1038/ncb1038; Stein CA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp841; Takahashi M, 2014, LEUKEMIA RES, V38, P808, DOI 10.1016/j.leukres.2014.03.021; Takahashi M, 2013, CANCER LETT, V328, P362, DOI 10.1016/j.canlet.2012.10.016; Takaku H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh092; Tamura M, 2003, NUCLEIC ACIDS RES, V31, P4354, DOI 10.1093/nar/gkg641; Thomas GR, 2005, INT J EXP PATHOL, V86, P347, DOI 10.1111/j.0959-9673.2005.00447.x; TONKINSON JL, 1994, NUCLEIC ACIDS RES, V22, P4268, DOI 10.1093/nar/22.20.4268; Vickers TA, 2006, J IMMUNOL, V176, P3652, DOI 10.4049/jimmunol.176.6.3652; Volavsek M, 2003, J LARYNGOL OTOL, V117, P286, DOI 10.1258/00222150360600896; Wang MB, 1998, OTOLARYNG HEAD NECK, V119, P593, DOI 10.1016/S0194-5998(98)70017-8; WANG TC, 1994, NATURE, V369, P669, DOI 10.1038/369669a0; Watanabe N, 2013, LEUKEMIA RES, V37, P580, DOI 10.1016/j.leukres.2013.01.015; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; ZHOU P, 1995, ONCOGENE, V11, P571	53	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114121	10.1371/journal.pone.0114121	http://dx.doi.org/10.1371/journal.pone.0114121			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437003	Green Published, gold, Green Submitted			2022-12-26	WOS:000347114900121
J	Liu, HF; Chang, QL; Feng, WJ; Zhang, BG; Wu, T; Li, N; Yao, FY; Ding, XH; Chu, ZH				Liu, Haifeng; Chang, Qingle; Feng, Wenjie; Zhang, Baogang; Wu, Tao; Li, Ning; Yao, Fangyin; Ding, Xinhua; Chu, Zhaohui			Domain Dissection of AvrRxo1 for Suppressor, Avirulence and Cytotoxicity Functions	PLOS ONE			English	Article							ORYZAE-PV. ORYZAE; DISEASE-SUSCEPTIBILITY GENE; PAMP-TRIGGERED IMMUNITY; PROGRAMMED CELL-DEATH; XANTHOMONAS-ORYZAE; BACTERIAL-BLIGHT; III EFFECTORS; PROTEIN; PLANT; HOST	AvrRxo1, a type III effector from Xanthomonas oryzae pv. oryzicola (Xoc) which causes bacterial leaf streak (BLS) in rice, can be recognised by non-host resistance protein Rxo1. It triggers a hypersensitive response (HR) in maize. Little is known regarding the virulence function of AvrRxo1. In this study, we determined that AvrRxo1 is able to suppress the HR caused by the non-host resistance recognition of Xanthomonas oryzae pv. oryzae (Xoo) by Nicotiana benthamiana. It is toxic, inducing cell death from transient expression in N. benthamiana, as well as in yeast. Among the four AvrRxo1 alleles from different Xoc strains, we concluded that the toxicity is abolished by a single amino acid substitution at residue 344 in two AvrRxo1 alleles. A series of truncations from the carboxyl terminus (C-terminus) indicate that the complete C-terminus of AvrRxo1 plays an essential role as a suppressor or cytotoxic protein. The C-terminus was also required for the avirulence function, but the last two residues were not necessary. The first 52 amino acids of N-terminus are unessential for toxicity. Point mutagenesis experiments indicate that the ATP/GTP binding site motif A is required for all three functions of AvrRxo1, and NLS is required for both the avirulence and the suppression of non-host resistance. The putative thiol protease site is only required for the cytotoxicity function. These results determine that AvrRxo1 plays a role in the complex interaction with host proteins after delivery into plant cells.	[Liu, Haifeng; Chang, Qingle; Feng, Wenjie; Zhang, Baogang; Wu, Tao; Li, Ning; Ding, Xinhua; Chu, Zhaohui] Shandong Agr Univ, Shandong Prov Key Lab Agr Microbiol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China; [Yao, Fangyin] Shandong Acad Agr Sci, Biotechnol Res Ctr, Jinan, Shandong, Peoples R China	Shandong Agricultural University; Shandong Academy of Agricultural Sciences	Ding, XH (corresponding author), Shandong Agr Univ, Shandong Prov Key Lab Agr Microbiol, State Key Lab Crop Biol, Tai An, Shandong, Peoples R China.	xhding@sdau.edu.cn; zchu@sdau.edu.cn	ding, xinhua/AAV-2612-2020; Chu, Zhaohui/AAX-9925-2021	ding, xinhua/0000-0002-6510-5992; Zhang, Baogang/0000-0002-5448-0092	National Natural Science Foundation of China [3 0900050]; Ph.D. Programs Foundation of Ministry of Education of China [20093702120013]; Shandong Province Science Foundation for Youths [BS2010NY017]; Foundation for the Author of National Excellent Doctoral Dissertation of PR China [201132]; Taishan Scholar of Shandong Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of Ministry of Education of China(Ministry of Education, China); Shandong Province Science Foundation for Youths; Foundation for the Author of National Excellent Doctoral Dissertation of PR China(Foundation for the Author of National Excellent Doctoral Dissertation of China); Taishan Scholar of Shandong Province	This work was supported by National Natural Science Foundation of China (Grant No. 3 0900050) and Ph.D. Programs Foundation of Ministry of Education of China (Grant No. 20093702120013). XD was granted from Shandong Province Science Foundation for Youths (BS2010NY017) and Foundation for the Author of National Excellent Doctoral Dissertation of PR China (Grant No. 201132). ZC was granted from Taishan Scholar of Shandong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Akimoto-Tomiyama C, 2012, MOL PLANT MICROBE IN, V25, P505, DOI 10.1094/MPMI-06-11-0167; Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Ali GS, 2008, PLANT SIGNAL BEHAV, V3, P423, DOI 10.4161/psb.3.6.5472; Antony G, 2010, PLANT CELL, V22, P3864, DOI 10.1105/tpc.110.078964; Bahadur RP, 2014, J BIOMOL STRUCT DYN, V32, P669, DOI 10.1080/07391102.2013.787370; Bartetzko V, 2009, MOL PLANT MICROBE IN, V22, P655, DOI 10.1094/MPMI-22-6-0655; Bogdanove AJ, 2011, J BACTERIOL, V193, P5450, DOI 10.1128/JB.05262-11; Buell CR, 2003, P NATL ACAD SCI USA, V100, P10181, DOI 10.1073/pnas.1731982100; Canonne J, 2011, PLANT CELL, V23, P3498, DOI 10.1105/tpc.111.088815; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Chen SB, 2009, PLANT PHYSIOL, V150, P1111, DOI 10.1104/pp.109.137125; CHOI SH, 1994, MOL GEN GENET, V244, P383, DOI 10.1007/BF00286690; Chu ZH, 2006, GENE DEV, V20, P1250, DOI 10.1101/gad.1416306; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cui YP, 2013, MOL PLANT PATHOL, V14, P678, DOI 10.1111/mpp.12039; Espinosa A, 2003, MOL MICROBIOL, V49, P377, DOI 10.1046/j.1365-2958.2003.03588.x; [冯雯杰 Feng Wenjie], 2013, [植物病理学报, Acta Phytopathologica Sinica], V43, P581; Galan JE, 1999, SCIENCE, V284, P1322, DOI 10.1126/science.284.5418.1322; Gietz RD, 2007, NAT PROTOC, V2, P1, DOI 10.1038/nprot.2007.17; Goehre V, 2008, CURR BIOL, V18, P1824, DOI 10.1016/j.cub.2008.10.063; Guo Xiaoxia, 2010, Wei Sheng Wu Xue Bao, V50, P1155; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kang L, 2004, MOL PLANT MICROBE IN, V17, P1328, DOI 10.1094/MPMI.2004.17.12.1328; Kang MJ, 2008, J MICROBIOL BIOTECHN, V18, P1492; Kim JG, 2009, PLANT CELL, V21, P1305, DOI 10.1105/tpc.108.063123; Li W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042796; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Lopez-Solanilla E, 2004, MOL MICROBIOL, V54, P353, DOI 10.1111/j.1365-2958.2004.04285.x; Makino S, 2006, MOL PLANT MICROBE IN, V19, P240, DOI 10.1094/MPMI-19-0240; Maurer-Stroh S, 2004, TRENDS MICROBIOL, V12, P178, DOI 10.1016/j.tim.2004.02.006; Metz M, 2005, PLANT J, V41, P801, DOI 10.1111/j.1365-313X.2005.02338.x; Nino-Liu DO, 2006, MOL PLANT PATHOL, V7, P303, DOI 10.1111/j.1364-3703.2006.00344.x; Salomon D, 2011, MOL PLANT MICROBE IN, V24, P305, DOI 10.1094/MPMI-09-10-0196; Shan LB, 2000, PLANT CELL, V12, P2323, DOI 10.1105/tpc.12.12.2323; Sinha D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075867; Song CF, 2010, MOL PLANT MICROBE IN, V23, P893, DOI 10.1094/MPMI-23-7-0893; Sugio A, 2007, P NATL ACAD SCI USA, V104, P10720, DOI 10.1073/pnas.0701742104; Szurek B, 2001, PLANT J, V26, P523, DOI 10.1046/j.0960-7412.2001.01046.x; VandenAckerveken G, 1996, CELL, V87, P1307, DOI 10.1016/S0092-8674(00)81825-5; White FF, 2009, MOL PLANT PATHOL, V10, P749, DOI 10.1111/j.1364-3703.2009.00590.x; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103; Yu YH, 2011, MOL PLANT MICROBE IN, V24, P1102, DOI 10.1094/MPMI-11-10-0254; Yuan M, 2010, PLANT CELL, V22, P3164, DOI 10.1105/tpc.110.078022; Zhang HT, 2013, CURR OPIN PLANT BIOL, V16, P188, DOI 10.1016/j.pbi.2013.02.008; Zhang J, 2007, CELL HOST MICROBE, V1, P175, DOI 10.1016/j.chom.2007.03.006; Zhao BY, 2005, P NATL ACAD SCI USA, V102, P15383, DOI 10.1073/pnas.0503023102; Zhao BY, 2004, MOL PLANT MICROBE IN, V17, P771, DOI 10.1094/MPMI.2004.17.7.771; Zhao S, 2013, WORLD J MICROB BIOT, V29, P733, DOI 10.1007/s11274-012-1229-5; Zhu WG, 2000, J BACTERIOL, V182, P1844, DOI 10.1128/JB.182.7.1844-1853.2000	51	9	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113875	10.1371/journal.pone.0113875	http://dx.doi.org/10.1371/journal.pone.0113875			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437277	gold, Green Published, Green Submitted			2022-12-26	WOS:000347114900092
J	Stevens, AJ; Stuffrein-Roberts, S; Cree, SL; Gibb, A; Miller, AL; Doudney, K; Aitchison, A; Eccles, MR; Joyce, PR; Filichev, VV; Kennedy, MA				Stevens, Aaron J.; Stuffrein-Roberts, Selma; Cree, Simone L.; Gibb, Andrew; Miller, Allison L.; Doudney, Kit; Aitchison, Alan; Eccles, Michael R.; Joyce, Peter R.; Filichev, Vyacheslav V.; Kennedy, Martin A.			G-Quadruplex Structures and CpG Methylation Cause Drop-Out of the Maternal Allele in Polymerase Chain Reaction Amplification of the Imprinted MEST Gene Promoter	PLOS ONE			English	Article							NUCLEOTIDE-SEQUENCES; HUMAN PEG1/MEST; HUMAN GENOME; DNA METHYLATION; PCR ASSAY; IDENTIFICATION; MOTIFS; SERVER; CHROMOSOME-7; CYTOSINE	We observed apparent non-Mendelian behaviour of alleles when genotyping a region in a CpG island at the 59 end of the maternally imprinted human MEST isoform. This region contains three single nucleotide polymorphisms (SNPs) in total linkage disequilibrium, such that only two haplotypes occur in the human population. Only one haplotype was detectable in each subject, never both, despite the use of multiple primers and several genotyping methods. We observed that this region contains motifs capable of forming several G-quadruplex structures. Circular dichroism spectroscopy and native polyacrylamide gel electrophoresis confirmed that at least three G-quadruplexes form in vitro in the presence of potassium ions, and one of these structures has a Tm of greater than 99 degrees C in polymerase chain reaction (PCR) buffer. We demonstrate that it is the methylated maternal allele that is always lost during PCR amplification, and that formation of G-quadruplexes and presence of methylated cytosines both contributed to this phenomenon. This observed parent-of-origin specific allelic drop-out has important implications for analysis of imprinted genes in research and diagnostic settings.	[Stevens, Aaron J.; Stuffrein-Roberts, Selma; Cree, Simone L.; Gibb, Andrew; Miller, Allison L.; Doudney, Kit; Aitchison, Alan; Kennedy, Martin A.] Univ Otago, Dept Pathol, Christchurch 8140, New Zealand; [Eccles, Michael R.] Univ Otago, Dunedin Sch Med, Dept Pathol, Dunedin, New Zealand; [Joyce, Peter R.] Univ Otago, Dept Psychol Med, Christchurch 8140, New Zealand; [Filichev, Vyacheslav V.] Massey Univ, Inst Fundamental Sci, Palmerston North, New Zealand	University of Otago; University of Otago; University of Otago; Massey University	Kennedy, MA (corresponding author), Univ Otago, Dept Pathol, Christchurch 8140, New Zealand.	martin.kennedy@otago.ac.nz	Doudney, Kit/Q-9728-2019; Stevens, Aaron J./Y-2145-2019; Kennedy, Martin/O-4540-2019; Kennedy, Martin A/A-4942-2008	Doudney, Kit/0000-0002-0089-1152; Stevens, Aaron J./0000-0001-9148-8045; Kennedy, Martin/0000-0002-6445-8526; Kennedy, Martin A/0000-0002-6445-8526; Miller, Allison/0000-0003-3816-2251; Filichev, Vyacheslav/0000-0002-7383-3025; Cree, Simone/0000-0002-7349-422X; Aitchison, Alan/0000-0002-0857-1815	Marsden Fund Council from New Zealand Government; Marsden Fund [11-UOO-175 BMS]	Marsden Fund Council from New Zealand Government(Royal Society of New ZealandMarsden Fund (NZ)); Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	This work was supported by the Marsden Fund Council from New Zealand Government funding, administered by the Royal Society of New Zealand. Funding for open access charge was provided by Marsden Fund (11-UOO-175 BMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boan F, 2004, FEBS LETT, V571, P112, DOI 10.1016/j.febslet.2004.06.062; Bugaut A, 2012, NUCLEIC ACIDS RES, V40, P4727, DOI 10.1093/nar/gks068; Bunyan DJ, 2011, OPEN J GENET, V1, P234; Burge S, 2006, NUCLEIC ACIDS RES, V34, P5402, DOI 10.1093/nar/gkl655; Butler MG, 2009, J ASSIST REPROD GEN, V26, P477, DOI 10.1007/s10815-009-9353-3; Eddy J, 2006, NUCLEIC ACIDS RES, V34, P3887, DOI 10.1093/nar/gkl529; EHRLICH M, 1975, BIOCHIM BIOPHYS ACTA, V395, P109, DOI 10.1016/0005-2787(75)90149-5; Ferguson-Smith AC, 2011, NAT REV GENET, V12, P565, DOI 10.1038/nrg3032; GELLERT M, 1962, P NATL ACAD SCI USA, V48, P2013, DOI 10.1073/pnas.48.12.2013; Gill GE, 1974, BIOCHIM BIOPHYS ACTA, V335, P330; Halder R, 2010, MOL BIOSYST, V6, P2439, DOI 10.1039/c0mb00009d; Han HY, 1999, NUCLEIC ACIDS RES, V27, P537, DOI 10.1093/nar/27.2.537; HARDIN CC, 1993, BIOCHEMISTRY-US, V32, P5870, DOI 10.1021/bi00073a021; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Joyce PR, 2009, BIOL PSYCHIAT, V66, P717, DOI 10.1016/j.biopsych.2009.03.005; Kikin O, 2006, NUCLEIC ACIDS RES, V34, pW676, DOI 10.1093/nar/gkl253; Kobayashi S, 1997, HUM MOL GENET, V6, P781, DOI 10.1093/hmg/6.5.781; Kosaki K, 2000, AM J HUM GENET, V66, P309, DOI 10.1086/302712; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; Lefebvre L, 1998, NAT GENET, V20, P163, DOI 10.1038/2464; Lin J, 2013, BIOCHEM BIOPH RES CO, V433, P368, DOI 10.1016/j.bbrc.2012.12.040; Maizels N, 2006, NAT STRUCT MOL BIOL, V13, P1055, DOI 10.1038/nsmb1171; Maizels N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003468; McMinn J, 2006, PLACENTA, V27, P119, DOI 10.1016/j.placenta.2004.12.003; Meaney Michael J, 2005, Dialogues Clin Neurosci, V7, P103; Menendez C, 2012, NUCLEIC ACIDS RES, V40, pW96, DOI 10.1093/nar/gks422; Moore MW, 2003, HUM MUTAT, V21, P645, DOI 10.1002/humu.10222; Murphy SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040924; Riesewijk AM, 1997, GENOMICS, V42, P236, DOI 10.1006/geno.1997.4731; Saunders CJ, 2010, GENET TEST MOL BIOMA, V14, P241, DOI 10.1089/gtmb.2009.0178; Scaria V, 2006, NUCLEIC ACIDS RES, V34, pW683, DOI 10.1093/nar/gkl299; SEN D, 1988, NATURE, V334, P364, DOI 10.1038/334364a0; SMITH SS, 1991, J MOL BIOL, V217, P39, DOI 10.1016/0022-2836(91)90609-A; Stuffrein-Roberts S, 2008, THESIS U OTAGO CHRIS; SUNDQUIST WI, 1989, NATURE, V342, P825, DOI 10.1038/342825a0; SZER W, 1966, J MOL BIOL, V17, P174, DOI 10.1016/S0022-2836(66)80102-X; Tomaz RA, 2010, GENET TEST MOL BIOMA, V14, P455, DOI 10.1089/gtmb.2010.0029; Wenzel JJ, 2009, CLIN CHEM, V55, P1361, DOI 10.1373/clinchem.2008.118661; WOODFORD K, 1995, NUCLEIC ACIDS RES, V23, P539, DOI 10.1093/nar/23.3.539; Xiao WZ, 2001, HUM MUTAT, V17, P439, DOI 10.1002/humu.1130.abs; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	42	26	26	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113955	10.1371/journal.pone.0113955	http://dx.doi.org/10.1371/journal.pone.0113955			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437198	Green Published, gold, Green Submitted			2022-12-26	WOS:000347114900102
J	Yan, S; Zhang, HL; Hou, GJ; Ahmed, S; Williams, JC; Polenova, T				Yan, Si; Zhang, Huilan; Hou, Guangjin; Ahmed, Shubbir; Williams, John C.; Polenova, Tatyana			Internal Dynamics of Dynactin CAP-Gly Is Regulated by Microtubules and Plus End Tracking Protein EB1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINNING NMR-SPECTROSCOPY; SOLID-STATE; MAMMALIAN DYNACTIN; ORDER PARAMETERS; CHEMICAL-SHIFTS; P150(GLUED); DOMAIN; RELAXATION; TRANSPORT; BINDING	CAP-Gly domain of dynactin, a microtubule-associated activator of dynein motor, participates in multiple cellular processes, and its point mutations are associated with neurodegenerative diseases. Recently, we have demonstrated that conformational plasticity is an intrinsic property of CAP-Gly. To understand its origin, we addressed internal dynamics of CAP-Gly assembled on polymeric microtubules, bound to end-binding protein EB1 and free, by magic angle spinning NMR and molecular dynamics simulations. The analysis of residue-specific dynamics of CAP-Gly on time scales spanning nano-through milliseconds reveals its unusually high mobility, both free and assembled on polymeric microtubules. On the contrary, CAP-Gly bound to EB1 is significantly more rigid. Molecular dynamics simulations indicate that these motions are strongly temperature-dependent, and loop regions are surprisingly mobile. These findings establish the connection between conformational plasticity and internal dynamics in CAP-Gly, which is essential for the biological functions of CAP-Gly and its ability to bind to polymeric microtubules and multiple binding partners. In this work, we establish an approach, for the first time, to probe atomic resolution dynamic profiles of a microtubule-associated protein assembled on polymeric microtubules. More broadly, the methodology established here can be applied for atomic resolution analysis of dynamics in other microtubule-associated protein assemblies, including but not limited to dynactin, dynein, and kinesin motors assembled on microtubules.	[Yan, Si; Zhang, Huilan; Hou, Guangjin; Polenova, Tatyana] Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA; [Ahmed, Shubbir; Williams, John C.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Med, Duarte, CA 91010 USA	University of Delaware; City of Hope; Beckman Research Institute of City of Hope	Polenova, T (corresponding author), Univ Delaware, Dept Chem & Biochem, Newark, DE 19716 USA.	tpolenov@udel.edu	Ahmed, Shubbir/AAC-4289-2019; Hou, Guangjin/AAW-6736-2021	Ahmed, Shubbir/0000-0003-1655-6735; 	National Institutes of Health [R01GM085306, P30GM103519]; National Science Foundation [CHE0959496]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103519, R01GM085306] Funding Source: NIH RePORTER; Office of Integrative Activities [1301765] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM085306 and P30GM103519. This work was also supported in part by National Science Foundation Grant CHE0959496 (to the University of Delaware).	Ahmed S, 2010, BIOCHEMISTRY-US, V49, P5083, DOI 10.1021/bi100235z; AKKE M, 1993, J AM CHEM SOC, V115, P9832, DOI 10.1021/ja00074a073; Baldus M, 1998, MOL PHYS, V95, P1197, DOI 10.1080/00268979809483251; Berjanskii MV, 2005, J AM CHEM SOC, V127, P14970, DOI 10.1021/ja054842f; CARLIER MF, 1984, P NATL ACAD SCI-BIOL, V81, P771, DOI 10.1073/pnas.81.3.771; Caviston JP, 2006, TRENDS CELL BIOL, V16, P530, DOI 10.1016/j.tcb.2006.08.002; Chevelkov V, 2010, J AM CHEM SOC, V132, P5015, DOI 10.1021/ja100645k; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Farrer MJ, 2009, NAT GENET, V41, P163, DOI 10.1038/ng.293; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Hayashi I, 2005, MOL CELL, V19, P449, DOI 10.1016/j.molcel.2005.06.034; Hayashi I, 2007, NAT STRUCT MOL BIOL, V14, P980, DOI 10.1038/nsmb1299; Honnappa S, 2006, MOL CELL, V23, P663, DOI 10.1016/j.molcel.2006.07.013; Hou GJ, 2013, J AM CHEM SOC, V135, P1358, DOI 10.1021/ja3084972; Hou GJ, 2011, J AM CHEM SOC, V133, P18646, DOI 10.1021/ja203771a; Li K, 2014, J AM CHEM SOC, V136, P11402, DOI 10.1021/ja504677d; Li SL, 2002, J BIOL CHEM, V277, P48596, DOI 10.1074/jbc.M208512200; Li ZG, 1996, PROTEIN SCI, V5, P2647, DOI 10.1002/pro.5560051228; Mahoney MW, 2000, J CHEM PHYS, V112, P8910, DOI 10.1063/1.481505; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Puls I, 2005, ANN NEUROL, V57, P687, DOI 10.1002/ana.20468; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Sparky D. G., 2000, J MAGN RESON, V147, P296; Sun SJ, 2009, J AM CHEM SOC, V131, P10113, DOI 10.1021/ja902003u; Thurber KR, 2009, J MAGN RESON, V196, P84, DOI 10.1016/j.jmr.2008.09.019; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vaughan PS, 2002, J CELL BIOL, V158, P305, DOI 10.1083/jcb.200201029; WATERMANSTORER CM, 1995, P NATL ACAD SCI USA, V92, P1634, DOI 10.1073/pnas.92.5.1634; Weisbrich A, 2007, NAT STRUCT MOL BIOL, V14, P959, DOI 10.1038/nsmb1291; Yan S, 2013, J MOL BIOL, V425, P4249, DOI 10.1016/j.jmb.2013.04.027; Yang DW, 1996, J MOL BIOL, V263, P369, DOI 10.1006/jmbi.1996.0581; Yang J, 2009, J AM CHEM SOC, V131, P13690, DOI 10.1021/ja9037802	35	10	10	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1607	1622		10.1074/jbc.M114.603118	http://dx.doi.org/10.1074/jbc.M114.603118			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25451937	Green Published, hybrid			2022-12-26	WOS:000348056400029
J	Gong, XC; Zhang, Y; Pan, JY; Qu, HB				Gong, Xingchu; Zhang, Ying; Pan, Jianyang; Qu, Haibin			Optimization of the Ethanol Recycling Reflux Extraction Process for Saponins Using a Design Space Approach	PLOS ONE			English	Article							PANAX-NOTOGINSENG; MAILLARD REACTION; SUGAR; WATER; PRECIPITATION; QUALITY; TRANSFORMATION; CHROMATOGRAPHY; GINSENOSIDES; COMPONENTS	A solvent recycling reflux extraction process for Panax notoginseng was optimized using a design space approach to improve the batch-to-batch consistency of the extract. Saponin yields, total saponin purity, and pigment yield were defined as the process critical quality attributes (CQAs). Ethanol content, extraction time, and the ratio of the recycling ethanol flow rate and initial solvent volume in the extraction tank (RES) were identified as the critical process parameters (CPPs) via quantitative risk assessment. Box-Behnken design experiments were performed. Quadratic models between CPPs and process CQAs were developed, with determination coefficients higher than 0.88. As the ethanol concentration decreases, saponin yields first increase and then decrease. A longer extraction time leads to higher yields of the ginsenosides Rb-1 and Rd. The total saponin purity increases as the ethanol concentration increases. The pigment yield increases as the ethanol concentration decreases or extraction time increases. The design space was calculated using a Monte-Carlo simulation method with an acceptable probability of 0.90. Normal operation ranges to attain process CQA criteria with a probability of more than 0.914 are recommended as follows: ethanol content of 79-82%, extraction time of 6.1-7.1 h, and RES of 0.039-0.040 min(-1). Most of the results of the verification experiments agreed well with the predictions. The verification experiment results showed that the selection of proper operating ethanol content, extraction time, and RES within the design space can ensure that the CQA criteria are met.	[Gong, Xingchu; Zhang, Ying; Pan, Jianyang; Qu, Haibin] Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Qu, HB (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310058, Zhejiang, Peoples R China.	quhb@zju.edu.cn			National S&T Major Project of China [2012ZX09101201-003]; Research Fund for the Doctoral Program of Higher Education of China [20110101120149]	National S&T Major Project of China; Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National S&T Major Project of China (2012ZX09101201-003) and Research Fund for the Doctoral Program of Higher Education of China (20110101120149). Haibin Qu received the first fund. The website is (http://www.most.gov.cn/). Xingchu Gong received the second fund. The website is (http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm). Funds were used to buy materials, chemicals, and pay labor costs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Bai Changcai, 2009, Zhongguo Zhong Yao Za Zhi, V34, P677; Bouchard A, 2007, J CHEM ENG DATA, V52, P1838, DOI 10.1021/je700190m; Chen J., 2013, CHINESE J EXPT TRADI, V19, P59; Coca M, 2004, FOOD CHEM, V86, P421, DOI 10.1016/j.foodchem.2003.09.017; Davidek T, 2006, J AGR FOOD CHEM, V54, P6677, DOI 10.1021/jf060668i; Debrus B, 2011, ANAL CHIM ACTA, V691, P33, DOI 10.1016/j.aca.2011.02.035; Dong TTX, 2005, PHYTOTHER RES, V19, P684, DOI 10.1002/ptr.1728; Gong XC, 2014, SEP PURIF TECHNOL, V132, P126, DOI 10.1016/j.seppur.2014.05.014; Gong XC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104493; Gong XC, 2013, SEP PURIF TECHNOL, V107, P273, DOI 10.1016/j.seppur.2013.01.029; Gong XC, 2012, J CHEM ENG DATA, V57, P3264, DOI 10.1021/je300885g; Gong XC, 2011, IND ENG CHEM RES, V50, P7542, DOI 10.1021/ie2004972; Gong XC, 2011, CHINESE J CHEM ENG, V19, P217, DOI 10.1016/S1004-9541(11)60157-2; ICH, 2009, PHARM DEV Q8 R2; Kim JS, 2008, FOOD CHEM, V108, P582, DOI 10.1016/j.foodchem.2007.11.014; Lebrun P, 2012, EUR J PHARM BIOPHARM, V80, P226, DOI 10.1016/j.ejpb.2011.09.014; Li SP, 2013, J CHROMATOGR A, V1313, P302, DOI 10.1016/j.chroma.2013.07.025; Li SX, 2013, J AGR FOOD CHEM, V61, P10599, DOI 10.1021/jf402993a; Li ZX, 2009, PHARM ENG DESIGN, V30, P35; Nistor I, 2013, J PHARMACEUT BIOMED, V74, P273, DOI 10.1016/j.jpba.2012.10.015; Peterson JJ, 2008, J BIOPHARM STAT, V18, P959, DOI 10.1080/10543400802278197; Qu Lin-hai, 2006, Zhong Yao Cai, V29, P593; Rozet E, 2013, TRAC-TREND ANAL CHEM, V42, P157, DOI 10.1016/j.trac.2012.09.007; Rozet E, 2012, BIOANALYSIS, V4, P755, DOI [10.4155/bio.12.47, 10.4155/BIO.12.47]; Sun S, 2011, FOOD CHEM, V125, P1299, DOI 10.1016/j.foodchem.2010.10.049; Sun S, 2010, FOOD CHEM, V118, P307, DOI 10.1016/j.foodchem.2009.04.122; Tsavas P, 2004, IND ENG CHEM RES, V43, P8391, DOI 10.1021/ie049353n; Wan JB, 2006, J PHARMACEUT BIOMED, V41, P1596, DOI 10.1016/j.jpba.2006.01.058; Wang D, 2012, FOOD CHEM, V132, P1808, DOI 10.1016/j.foodchem.2011.12.010; Wang LL, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/652373; Wang YT, 2008, FOOD CHEM, V110, P161, DOI 10.1016/j.foodchem.2008.01.028; Wu M, 2013, J JIANGXI U TCM, V25, P66; Wu W, 2012, J AGR FOOD CHEM, V60, P10007, DOI 10.1021/jf302638f; Yang G., 2012, CHIN MED J RES PRAC, V26, P29; Yu LX, 2008, PHARM RES, V25, P781, DOI 10.1007/s11095-007-9511-1; Zhang L, 2013, AAPS PHARMSCITECH, V14, P277, DOI 10.1208/s12249-012-9919-8; [赵永亮 Zhao Yongliang], 2011, [中南大学学报. 自然科学版, Journal of Central South University of Science and Technology], V42, P38; Zhu JQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087462	39	13	21	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114300	10.1371/journal.pone.0114300	http://dx.doi.org/10.1371/journal.pone.0114300			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470598	gold, Green Published, Green Submitted			2022-12-26	WOS:000349128700098
J	Jarocki, P; Podlesny, M; Glibowski, P; Targonski, Z				Jarocki, Piotr; Podlesny, Marcin; Glibowski, Pawel; Targonski, Zdzislaw			A New Insight into the Physiological Role of Bile Salt Hydrolase among Intestinal Bacteria from the Genus Bifidobacterium	PLOS ONE			English	Article							SODIUM DEOXYCHOLATE; CHOLESTEROL; ACID; BSH; LACTOBACILLI; PURIFICATION; STRAINS; DECONJUGATION; PROBIOTICS; SELECTION	This study analyzes the occurrence of bile salt hydrolase in fourteen strains belonging to the genus Bifidobacterium. Deconjugation activity was detected using a plate test, two-step enzymatic reaction and activity staining on a native polyacrylamide gel. Subsequently, bile salt hydrolases from B. pseudocatenulatum and B. longum subsp. suis were purified using a two-step chromatographic procedure. Biochemical characterization of the bile salt hydrolases showed that the purified enzymes hydrolyzed all of the six major human bile salts under the pH and temperature conditions commonly found in the human gastrointestinal tract. Next, the dynamic rheometry was applied to monitor the gelation process of deoxycholic acid under different conditions. The results showed that bile acids displayed aqueous media gelating properties. Finally, gel-forming abilities of bifidobacteria exhibiting bile salt hydrolase activity were analyzed. Our investigations have demonstrated that the release of deconjugated bile acids led to the gelation phenomenon of the enzymatic reaction solution containing purified BSH. The presented results suggest that bile salt hydrolase activity commonly found among intestinal microbiota increases hydrogel-forming abilities of certain bile salts. To our knowledge, this is the first report showing that bile salt hydrolase activity among Bifidobacterium is directly connected with the gelation process of bile salts. In our opinion, if such a phenomenon occurs in physiological conditions of human gut, it may improve bacterial ability to colonize the gastrointestinal tract and their survival in this specific ecological niche.	[Jarocki, Piotr; Podlesny, Marcin; Targonski, Zdzislaw] Univ Life Sci Lublin, Dept Biotechnol Human Nutr & Food Commod, Lublin, Poland; [Glibowski, Pawel] Univ Life Sci Lublin, Dept Milk Technol & Hydrocolloids, Lublin, Poland	University of Life Sciences in Lublin; University of Life Sciences in Lublin	Jarocki, P (corresponding author), Univ Life Sci Lublin, Dept Biotechnol Human Nutr & Food Commod, Lublin, Poland.	piotr.jarocki@wp.pl	Glibowski, Paweł/AAG-9546-2019; Glibowski, Paweł/AFO-5720-2022	Glibowski, Pawel/0000-0003-1774-6899; Jarocki, Piotr/0000-0002-0714-4512	National Science Centre [DEC-2011/01/N/NZ9/04575]; Ministry of Science and Higher Education [0195/IP1/2011/71]	National Science Centre(National Science Centre, Poland); Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported by grant DEC-2011/01/N/NZ9/04575 from National Science Centre (http://www.ncn.gov.pl/?language=en) and partially by grant Nr 0195/IP1/2011/71 from Ministry of Science and Higher Education (http://www.nauka.gov.pl/en/). The funding was received by PJ, MP, and ZT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Begley M, 2006, APPL ENVIRON MICROB, V72, P1729, DOI 10.1128/AEM.72.3.1729-1738.2006; Begley M, 2005, INFECT IMMUN, V73, P894, DOI 10.1128/IAI.73.2.894-904.2005; Bernstein H, 2005, MUTAT RES-REV MUTAT, V589, P47, DOI 10.1016/j.mrrev.2004.08.001; Berr F, 1996, GASTROENTEROLOGY, V111, P1611, DOI 10.1016/S0016-5085(96)70024-0; Bhat S, 2007, TETRAHEDRON, V63, P7309, DOI 10.1016/j.tet.2007.03.118; Bielecka M, 2002, FOOD RES INT, V35, P125, DOI 10.1016/S0963-9969(01)00173-9; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Choi SB, 2015, CRIT REV BIOTECHNOL, V35, P392, DOI 10.3109/07388551.2014.889077; Christl SU, 1996, DIGEST DIS SCI, V41, P2477, DOI 10.1007/BF02100146; COLEMAN JP, 1995, APPL ENVIRON MICROB, V61, P2514, DOI 10.1128/AEM.61.7.2514-2520.1995; Dambekodi PC, 1998, J DAIRY SCI, V81, P1818, DOI 10.3168/jds.S0022-0302(98)75751-0; DASHKEVICZ MP, 1989, APPL ENVIRON MICROB, V55, P11, DOI 10.1128/AEM.55.1.11-16.1989; De Smet I, 1998, BRIT J NUTR, V79, P185, DOI 10.1079/BJN19980030; DESMET I, 1995, J APPL BACTERIOL, V79, P292; du Toit M, 1998, INT J FOOD MICROBIOL, V40, P93, DOI 10.1016/S0168-1605(98)00024-5; FEIGHNER SD, 1987, APPL ENVIRON MICROB, V53, P331, DOI 10.1128/AEM.53.2.331-336.1987; Franz CMAP, 2001, J FOOD PROTECT, V64, P725, DOI 10.4315/0362-028X-64.5.725; GILLILAND SE, 1977, APPL ENVIRON MICROB, V33, P15, DOI 10.1128/AEM.33.1.15-18.1977; Glibowski P, 2011, CARBOHYD POLYM, V83, P635, DOI 10.1016/j.carbpol.2010.08.028; Grill JP, 2000, CAN J MICROBIOL, V46, P878, DOI 10.1139/cjm-46-10-878; Grill JP, 2000, J APPL MICROBIOL, V89, P553, DOI 10.1046/j.1365-2672.2000.01147.x; GRILL JP, 1995, APPL ENVIRON MICROB, V61, P2577, DOI 10.1128/AEM.61.7.2577-2582.1995; Grill JP, 1997, MICROBIOLOGIE ALIMEN, V15, P307; Jarocki P, 2013, CURR MICROBIOL, V67, P286, DOI 10.1007/s00284-013-0362-1; Jarocki P, 2011, J MICROBIOL BIOTECHN, V21, P838, DOI 10.4014/jmb.1103.03028; Jones BV, 2008, P NATL ACAD SCI USA, V105, P13580, DOI 10.1073/pnas.0804437105; Jones ML, 2013, EXPERT OPIN BIOL TH, V13, P631, DOI 10.1517/14712598.2013.758706; Jover A, 2002, LANGMUIR, V18, P987, DOI 10.1021/la011178h; KAWAMOTO K, 1989, J BIOCHEM-TOKYO, V106, P1049, DOI 10.1093/oxfordjournals.jbchem.a122962; Kim GB, 2004, APPL ENVIRON MICROB, V70, P5603, DOI 10.1128/AEM.70.9.5603-5612.2004; Kim GB, 2004, J DAIRY SCI, V87, P258, DOI 10.3168/jds.S0022-0302(04)73164-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Liong MT, 2005, FOOD RES INT, V38, P135, DOI 10.1016/j.foodres.2004.08.003; Oner O, 2014, J MOL MICROB BIOTECH, V24, P12, DOI 10.1159/000354316; Patel AK, 2010, APPL BIOCHEM BIOTECH, V162, P166, DOI 10.1007/s12010-009-8738-1; Ridlon JM, 2006, J LIPID RES, V47, P241, DOI 10.1194/jlr.R500013-JLR200; Ruiz L, 2012, APPL ENVIRON MICROB, V78, P644, DOI 10.1128/AEM.05455-11; Sridevi N, 2009, EXTREMOPHILES, V13, P363, DOI 10.1007/s00792-008-0224-0; Sun XF, 2014, J PHYS CHEM B, V118, P824, DOI 10.1021/jp409626s; Tanaka H, 1999, J DAIRY SCI, V82, P2530, DOI 10.3168/jds.S0022-0302(99)75506-2; Tanaka H, 2000, APPL ENVIRON MICROB, V66, P2502, DOI 10.1128/AEM.66.6.2502-2512.2000; TANNOCK GW, 1989, APPL ENVIRON MICROB, V55, P1848, DOI 10.1128/AEM.55.7.1848-1851.1989; Taranto MP, 1998, J DAIRY SCI, V81, P2336, DOI 10.3168/jds.S0022-0302(98)70123-7; Taranto MP, 2003, J APPL MICROBIOL, V95, P86, DOI 10.1046/j.1365-2672.2003.01962.x; VanEldere J, 1996, APPL ENVIRON MICROB, V62, P656, DOI 10.1128/AEM.62.2.656-661.1996; Vlahcevic ZR, 1996, HEPATOLOGY TXB LIVER, V1, P376; Xue M, 2009, TETRAHEDRON, V65, P3369, DOI 10.1016/j.tet.2009.02.056; Yin S, 2011, J BIOTECHNOL, V152, P49, DOI 10.1016/j.jbiotec.2011.01.018	48	44	45	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114379	10.1371/journal.pone.0114379	http://dx.doi.org/10.1371/journal.pone.0114379			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470405	gold, Green Published, Green Submitted			2022-12-26	WOS:000349128700110
J	Kiffner, C; Kioko, J; Leweri, C; Krause, S				Kiffner, Christian; Kioko, John; Leweri, Cecilia; Krause, Stefan			Seasonal Patterns of Mixed Species Groups in Large East African Mammals	PLOS ONE			English	Article							SOCIAL NETWORKS; GROUP-SIZE; BODY-SIZE; ASSOCIATION; WILD; PREDATION; NUTRIENT; UNGULATE; RISK; ORGANIZATION	Mixed mammal species groups are common in East African savannah ecosystems. Yet, it is largely unknown if co-occurrences of large mammals result from random processes or social preferences and if interspecific associations are consistent across ecosystems and seasons. Because species may exchange important information and services, understanding patterns and drivers of heterospecific interactions is crucial for advancing animal and community ecology. We recorded 5403 single and multi-species clusters in the Serengeti-Ngorongoro and Tarangire-Manyara ecosystems during dry and wet seasons and used social network analyses to detect patterns of species associations. We found statistically significant associations between multiple species and association patterns differed spatially and seasonally. Consistently, wildebeest and zebras preferred being associated with other species, whereas carnivores, African elephants, Maasai giraffes and Kirk's dik-diks avoided being in mixed groups. During the dry season, we found that the betweenness (a measure of importance in the flow of information or disease) of species did not differ from a random expectation based on species abundance. In contrast, in the wet season, we found that these patterns were not simply explained by variations in abundances, suggesting that heterospecific associations were actively formed. These seasonal differences in observed patterns suggest that interspecific associations may be driven by resource overlap when resources are limited and by resource partitioning or anti-predator advantages when resources are abundant. We discuss potential mechanisms that could drive seasonal variation in the cost-benefit tradeoffs that underpin the formation of mixed-species groups.	[Kiffner, Christian; Kioko, John; Leweri, Cecilia] Ctr Wildlife Management Studies, Sch Field Studies, Karatu, Tanzania; [Leweri, Cecilia] Tanzania Wildlife Res Inst, Arusha, Tanzania; [Krause, Stefan] Lubeck Univ Appl Sci, Lubeck, Germany	Luebeck University of Applied Sciences	Kiffner, C (corresponding author), Ctr Wildlife Management Studies, Sch Field Studies, Karatu, Tanzania.	ckiffne@gwdg.de	Kiffner, Christian/F-4088-2012	Kiffner, Christian/0000-0002-7475-9023; Leweri, Cecilia/0000-0002-1051-6022	School For Field Studies (SFS), Centre for Wildlife Management Studies	School For Field Studies (SFS), Centre for Wildlife Management Studies	Funding: The authors received no specific funding for this work. This project was part of School For Field Studies (SFS), Centre for Wildlife Management Studies, five year research plan activities and was solely funded by the centre's budget. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altizer S, 2003, ANNU REV ECOL EVOL S, V34, P517, DOI 10.1146/annurev.ecolsys.34.030102.151725; Anderson TM, 2010, ECOLOGY, V91, P1519, DOI 10.1890/09-0739.1; [Anonymous], NATURE ED KNOWLEDGE; Aplin LM, 2012, P ROY SOC B-BIOL SCI, V279, P4199, DOI 10.1098/rspb.2012.1591; Astaras C, 2011, AM J PRIMATOL, V73, P127, DOI 10.1002/ajp.20877; BAENNINGER R, 1977, E AFR WILDL J, V15, P327; BELL RHV, 1982, ECOL STUD, V42, P193; BESAG J, 1989, BIOMETRIKA, V76, P633; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boone RB, 2006, ECOLOGY, V87, P1987, DOI 10.1890/0012-9658(2006)87[1987:SWMPMF]2.0.CO;2; Brashares JS, 2000, BEHAV ECOL, V11, P452, DOI 10.1093/beheco/11.4.452; Caillaud D, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0206; Caro T.M., 1989, Special Publication of the British Ecological Society, P41; Clutton-Brock T, 2002, SCIENCE, V296, P69, DOI 10.1126/science.296.5565.69; Colwell RK, 2012, ANNU REV ECOL EVOL S, V43, P183, DOI 10.1146/annurev-ecolsys-110411-160304; COOPER SM, 1991, AFR J ECOL, V29, P130, DOI 10.1111/j.1365-2028.1991.tb00993.x; Cords M., 1987, University of California Publications in Zoology, V117, P1; CORDS M, 1990, AM J PRIMATOL, V21, P101, DOI 10.1002/ajp.1350210204; COTE IM, 1995, BEHAV ECOL, V6, P159, DOI 10.1093/beheco/6.2.159; Craft Meggan E, 2011, Interdiscip Perspect Infect Dis, V2011, P676949, DOI 10.1155/2011/676949; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Creel S, 2011, ECOLOGY, V92, P2190, DOI 10.1890/11-0327.1; Croft DP, 2011, TRENDS ECOL EVOL, V26, P502, DOI 10.1016/j.tree.2011.05.012; Croft DP, 2008, EXPLORING ANIMAL SOCIAL NETWORKS, P1; Cross PC, 2004, ANN ZOOL FENN, V41, P879; Desbiez ALJ, 2010, ACTA ETHOL, V13, P137, DOI 10.1007/s10211-010-0068-3; Dolby AS, 2000, BEHAV ECOL, V11, P110, DOI 10.1093/beheco/11.1.110; Durant SM, 2011, J APPL ECOL, V48, P1490, DOI 10.1111/j.1365-2664.2011.02042.x; ELDER W H, 1970, Mammalia, V34, P356, DOI 10.1515/mamm.1970.34.3.356; ESTES RD, 1991, BEHAV GUIDE AFRICAN; Farine DR, 2014, BEHAV ECOL, V25, P574, DOI 10.1093/beheco/aru023; Farine DR, 2014, ANIM BEHAV, V89, P141, DOI 10.1016/j.anbehav.2014.01.001; Farine DR, 2012, ANIM BEHAV, V84, P1271, DOI 10.1016/j.anbehav.2012.08.008; Fischhoff IR, 2007, BEHAV ECOL, V18, P725, DOI 10.1093/beheco/arm036; FITZGIBBON CD, 1990, ANIM BEHAV, V39, P1116, DOI 10.1016/S0003-3472(05)80784-5; Frantzis Alexandros, 2002, Aquatic Mammals, V28, P188; GARTLAN JS, 1972, J ZOOL, V68, P221; Goodale E, 2010, TRENDS ECOL EVOL, V25, P354, DOI 10.1016/j.tree.2010.01.002; Goodale E, 2010, J AVIAN BIOL, V41, P99, DOI 10.1111/j.1600-048X.2009.04828.x; Grant CC, 2006, BIOL CONSERV, V130, P426, DOI 10.1016/j.biocon.2006.01.004; Gueron S, 1996, J THEOR BIOL, V182, P85, DOI 10.1006/jtbi.1996.0144; GWYNNE MD, 1968, NATURE, V220, P390, DOI 10.1038/220390a0; Harrison NM, 2011, ANIM BEHAV, V81, P675, DOI 10.1016/j.anbehav.2011.01.013; Heymann EW, 1997, FOLIA PRIMATOL, V68, P287, DOI 10.1159/000157254; Hopcraft JGC, 2012, J ANIM ECOL, V81, P201, DOI 10.1111/j.1365-2656.2011.01885.x; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Kiffner C, 2015, AFR J ECOL, V53, P156, DOI 10.1111/aje.12160; King AJ, 2009, J ZOOL, V277, P111, DOI 10.1111/j.1469-7998.2008.00504.x; Kitchen DM, 2010, ANIM COGN, V13, P861, DOI 10.1007/s10071-010-0334-9; Krause J, 1998, OECOLOGIA, V114, P67, DOI 10.1007/s004420050421; Krause J, 2013, TRENDS ECOL EVOL, V28, P541, DOI 10.1016/j.tree.2013.06.002; Krause S, 2009, BEHAV ECOL SOCIOBIOL, V63, P1089, DOI 10.1007/s00265-009-0746-1; Li ZQ, 2010, J MAMMAL, V91, P674, DOI 10.1644/09-MAMM-A-203.1; MCNAUGHTON SJ, 1985, ECOL MONOGR, V55, P259, DOI 10.2307/1942578; MCNAUGHTON SJ, 1988, NATURE, V334, P343, DOI 10.1038/334343a0; MONTGOMERY WL, 1981, COPEIA, P477, DOI 10.2307/1444245; Morrison TA, 2012, J ANIM ECOL, V81, P543, DOI 10.1111/j.1365-2656.2011.01941.x; MORSE DH, 1970, ECOL MONOGR, V40, P119, DOI 10.2307/1942443; Msoffe F. U., 2011, International Journal of Biodiversity and Conservation, V3, P280; MWALYOSI RBB, 1992, J APPL ECOL, V29, P581, DOI 10.2307/2404465; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Newmark WD, 1996, CONSERV BIOL, V10, P1549, DOI 10.1046/j.1523-1739.1996.10061549.x; Newmark WD, 2008, FRONT ECOL ENVIRON, V6, P321, DOI 10.1890/070003; OATES JF, 1990, AM J PRIMATOL, V21, P129, DOI 10.1002/ajp.1350210206; Odadi WO, 2011, EVOL ECOL RES, V13, P237; Odadi WO, 2011, SCIENCE, V333, P1753, DOI 10.1126/science.1208468; Olff H, 2002, NATURE, V415, P901, DOI 10.1038/415901a; Osofsky S. A., 2005, CONSERVATION DEV INT; Ostfeld RS, 2012, ANNU REV ECOL EVOL S, V43, P157, DOI 10.1146/annurev-ecolsys-102710-145022; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; Perreault C, 2010, ANIM BEHAV, V80, P551, DOI 10.1016/j.anbehav.2010.06.020; Pettorelli N, 2010, ANIM CONSERV, V13, P131, DOI 10.1111/j.1469-1795.2009.00309.x; PRINS HHT, 1988, J BIOGEOGR, V15, P451, DOI 10.2307/2845275; PULLIAM HR, 1973, J THEOR BIOL, V38, P419, DOI 10.1016/0022-5193(73)90184-7; Rasmussen GSA, 2008, AM NAT, V172, P508, DOI 10.1086/590965; Roberts G, 1996, ANIM BEHAV, V51, P1077, DOI 10.1006/anbe.1996.0109; Rubenstein DI, 1986, ECOLOGICAL ASPECTS O; SHELDEN KEW, 1995, MAR MAMMAL SCI, V11, P231, DOI 10.1111/j.1748-7692.1995.tb00521.x; Sinclair A.R.E., 2008, P7; SINCLAIR ARE, 1985, J ANIM ECOL, V54, P899, DOI 10.2307/4386; SMOLKER RA, 1992, BEHAVIOUR, V123, P38, DOI 10.1163/156853992X00101; Stensland E, 2003, MAMMAL REV, V33, P205, DOI 10.1046/j.1365-2907.2003.00022.x; Thomas L., 2002, ENCY ENV, V1, P544, DOI [10.2307/2532812, DOI 10.2307/2532812]; Tsuji Y, 2007, ACTA THERIOL, V52, P427, DOI 10.1007/BF03194240; VanderWaal KL, 2014, BIOL CONSERV, V169, P136, DOI 10.1016/j.biocon.2013.11.008; Ward AJW, 2002, BEHAV ECOL SOCIOBIOL, V52, P182, DOI 10.1007/s00265-002-0505-z; Wilson ADM, 2014, BEHAV ECOL SOCIOBIOL, V68, P915, DOI 10.1007/s00265-014-1704-0; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	88	20	20	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113446	10.1371/journal.pone.0113446	http://dx.doi.org/10.1371/journal.pone.0113446			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470495	Green Submitted, Green Published, gold			2022-12-26	WOS:000349128700027
J	Kubler, A; Holz, EM; Riccio, A; Zickler, C; Kaufmann, T; Kleih, SC; Staiger-Salzer, P; Desideri, L; Hoogerwerf, EJ; Mattia, D				Kuebler, Andrea; Holz, Elisa M.; Riccio, Angela; Zickler, Claudia; Kaufmann, Tobias; Kleih, Sonja C.; Staiger-Saelzer, Pit; Desideri, Lorenzo; Hoogerwerf, Evert-Jan; Mattia, Donatella			The User-Centered Design as Novel Perspective for Evaluating the Usability of BCI-Controlled Applications	PLOS ONE			English	Article							BRAIN-COMPUTER-INTERFACE; PEOPLE; ALS; HEALTHY	Albeit research on brain-computer interfaces (BCI) for controlling applications has expanded tremendously, we still face a translational gap when bringing BCI to end-users. To bridge this gap, we adapted the user-centered design (UCD) to BCI research and development which implies a shift from focusing on single aspects, such as accuracy and information transfer rate (ITR), to a more holistic user experience. The UCD implements an iterative process between end-users and developers based on a valid evaluation procedure. Within the UCD framework usability of a device can be defined with regard to its effectiveness, efficiency, and satisfaction. We operationalized these aspects to evaluate BCI-controlled applications. Effectiveness was regarded equivalent to accuracy of selections and efficiency to the amount of information transferred per time unit and the effort invested (workload). Satisfaction was assessed with questionnaires and visual-analogue scales. These metrics have been successfully applied to several BCI-controlled applications for communication and entertainment, which were evaluated by end-users with severe motor impairment. Results of four studies, involving a total of N=19 end-users revealed: effectiveness was moderate to high; efficiency in terms of ITR was low to high and workload low to medium; depending on the match between user and technology, and type of application satisfaction was moderate to high. The here suggested evaluation metrics within the framework of the UCD proved to be an applicable and informative approach to evaluate BCI controlled	[Kuebler, Andrea; Holz, Elisa M.; Kaufmann, Tobias; Kleih, Sonja C.] Univ Wurzburg, Inst Psychol, D-97070 Wurzburg, Germany; [Riccio, Angela; Mattia, Donatella] IRCCS, Fdn Santa Lucia, Lab Neuroelect Imaging, Rome, Italy; [Riccio, Angela; Mattia, Donatella] IRCCS, Fdn Santa Lucia, BCI, Rome, Italy; [Zickler, Claudia] Univ Tubingen, Inst Med Psychol & Behav Neurobiol, Tubingen, Germany; [Kaufmann, Tobias] Univ Oslo, Inst Clin Med, Psychosis Res Ctr, Oslo, Norway; [Staiger-Saelzer, Pit] BUK, Bad Kreuznach, Germany; [Desideri, Lorenzo; Hoogerwerf, Evert-Jan] AIAS Bologna Onlus Ausilioteca, Bologna, Italy	University of Wurzburg; IRCCS Santa Lucia; IRCCS Santa Lucia; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Oslo	Kubler, A (corresponding author), Univ Wurzburg, Inst Psychol, D-97070 Wurzburg, Germany.	andrea.kuebler@uni-wuerzburg.de	Kleih-Dahms, Sonja/AAA-6650-2022; Kaufmann, Tobias/M-8972-2017; Mattia, Donatella/D-7569-2012; Riccio, Angela/K-2745-2016	Kaufmann, Tobias/0000-0002-4003-1018; Mattia, Donatella/0000-0002-3092-2511; Riccio, Angela/0000-0002-4098-9461; Kubler, Andrea/0000-0003-4876-0415; Desideri, Lorenzo/0000-0003-2091-2907	European ICT Program Project [FP7-224631, FP7- 288566]; German Research Foundation (DFG); University of Wuerzburg	European ICT Program Project; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	This work was supported by the European ICT Program Project FP7-224631 (TOBI) and FP7- 288566 (BackHome) (http://ec.europa.eu/research/fp7/index_en.cfm). This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, 9241210 ISO; Arthanat S, 2007, DISABIL REHABIL-ASSI, V2, P235, DOI 10.1080/17483100701343665; BATAVIA A I, 1990, Journal of Rehabilitation Research and Development, V27, P425, DOI 10.1682/JRRD.1990.10.0425; Birbaumer N, 1999, NATURE, V398, P297, DOI 10.1038/18581; Blankertz B, 2010, NEUROIMAGE, V51, P1303, DOI 10.1016/j.neuroimage.2010.03.022; Choi YM, 2011, ASSIST TECHNOL, V23, P36, DOI 10.1080/10400435.2010.541407; Cincotti F, 2012, IEEE ENG MED BIO, P4112, DOI 10.1109/EMBC.2012.6346871; Corradi F, 2012, ASSIST TECHNOL, P49, DOI DOI 10.1201/B11821-5; Dal Seno B, 2010, IEEE T NEUR SYS REH, V18, P20, DOI 10.1109/TNSRE.2009.2032642; Demers L., 2002, TECHNOL DISABIL, V14, P101, DOI [10.3233/TAD-2002-14304, DOI 10.3233/TAD-2002-14304]; Friedrich EVC, 2013, CLIN NEUROPHYSIOL, V124, P916, DOI 10.1016/j.clinph.2012.11.010; HART S G, 1988, P139; Hohne J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104854; Holz EM, 2013, ARTIF INTELL MED, V59, P111, DOI 10.1016/j.artmed.2013.08.001; Holz EM, 2013, 5 INT BCI M AS PAC G; Holz EM, 2013, TOBI WORKSH IV SION; Holz EM, 2013, TOBI WORKSH 4 SION S; Holz EM, 2014, ARCH PHYS M IN PRESS; Hoogerwerf EJ, 2013, AAATE VIL ALG PORT; Kaiser V, 2011, FRONT NEUROSCI-SWITZ, V5, DOI [10.3389/fnins.2011.00086, 10.3389/fninf.2011.00030]; Kaufmann T, 2013, CLIN NEUROPHYSIOL, V124, P893, DOI 10.1016/j.clinph.2012.11.006; Kleih SC, 2011, PROG BRAIN RES, V194, P27, DOI 10.1016/B978-0-444-53815-4.00019-4; Kubler A, 2005, NEUROLOGY, V64, P1775, DOI 10.1212/01.WNL.0000158616.43002.6D; Kubler A, 2001, ARCH PHYS MED REHAB, V82, P1533, DOI 10.1053/apmr.2001.26621; Kubler A, 2008, 4 INT BRAIN COMP INT, P361; Kubler A, 2013, BRAIN-COMPUTER INTERFACE SYSTEMS - RECENT PROGRESS AND FUTURE PROSPECTS, P1, DOI 10.5772/55802; Kubler A, 2013, ARTIF INTELL MED, V59, P55, DOI 10.1016/j.artmed.2013.08.002; Kubler A, 2013, BRAIN, V136, DOI [10.1093/brain/awt156, 10.1093/brain/awt200]; Lorenz R, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/035007; McCane LM, 2014, AMYOTROPH LAT SCL FR, V15, P207, DOI 10.3109/21678421.2013.865750; Munssinger JI, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00182; Neuper C, 2005, COGNITIVE BRAIN RES, V25, P668, DOI 10.1016/j.cogbrainres.2005.08.014; Nijboer F, 2008, CLIN NEUROPHYSIOL, V119, P1909, DOI 10.1016/j.clinph.2008.03.034; Nykopp T., 2001, STAT MODELLING ISSUE; Pasqualotto E, 2011, INT J BIOELECTROMAGN, V13, P121; Pasqualotto E, 2009, ASSIST TECHNOL RES S, V25, P882, DOI 10.3233/978.1.60750.042.1.882; Pfurtscheller G, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnpro.2010.00003; Piccione F, 2006, CLIN NEUROPHYSIOL, V117, P531, DOI 10.1016/j.clinph.2005.07.024; Ramos-Murguialday A, 2013, ANN NEUROL, V74, P100, DOI 10.1002/ana.23879; Riccio A, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025028; Riccio A, 2013, 5TH INTERNATIONAL BC; Riccio A, 2011, 5 INT BRAIN COMP INT; Riccio A, 2013, TOBI WORKSH 4 SION S; Riccio A, 2015, ARCH PHYS MED REHAB, V96, pS54, DOI 10.1016/j.apmr.2014.05.029; Riccio A, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00732; Rohm M, 2013, ARTIF INTELL MED, V59, P133, DOI 10.1016/j.artmed.2013.07.004; Scherer MJ, 1997, DISABIL REHABIL, V19, P528, DOI 10.3109/09638289709166046; Schlogl A, 2007, BRAIN COMPUTER INTER, P373; Schreuder M, 2013, ARTIF INTELL MED, V59, P71, DOI 10.1016/j.artmed.2013.07.005; Sellers EW, 2006, CLIN NEUROPHYSIOL, V117, P538, DOI 10.1016/j.clinph.2005.06.027; van de Laar B, 2011, INT J BIOELECTROMAG, V13, P157; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055344; Wolpaw J R, 1998, IEEE Trans Rehabil Eng, V6, P326, DOI 10.1109/86.712231; Wolpaw J.R., 2012, BRAIN COMPUTER INTER, V3, P123, DOI [DOI 10.1093/ACPROF:OSO/9780195388855.001.0001, 10.1093/acprof:oso/9780195388855.003.0001]; Wolpaw JR, 2004, P NATL ACAD SCI USA, V101, P17849, DOI 10.1073/pnas.0403504101; Zander TO, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/2/025005; Zickler C, 2013, ARTIF INTELL MED, V59, P99, DOI 10.1016/j.artmed.2013.08.003; Zickler C, 2011, CLIN EEG NEUROSCI, V42, P236, DOI 10.1177/155005941104200409; Zickler C, 2009, ASSIST TECHNOL RES S, V25, P185, DOI 10.3233/978.1.60750.042.1.185	59	120	122	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e112392	10.1371/journal.pone.0112392	http://dx.doi.org/10.1371/journal.pone.0112392			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469774	Green Published, gold, Green Submitted			2022-12-26	WOS:000349128700007
J	Tsai, CC; Chiang, YC; Weng, IS; Lin, YS; Chou, CH				Tsai, Chi-Chu; Chiang, Yu-Chung; Weng, I-Szu; Lin, Yu-Shium; Chou, Chang-Hung			Evidence of Purifying Selection and Co-Evolution at the Fold-Back Arm of the Novel Precursor MicroRNA159 Gene in Phalaenopsis Species (Orchidaceae)	PLOS ONE			English	Article							PLANT MICRORNAS; ARABIDOPSIS; MIRNA; IDENTIFICATION; POLYMORPHISM; BIOGENESIS; SEQUENCE; DNA; CONSTRAINTS; EXPRESSION	Background: MicroRNAs (miRNAs) are small, endogenously transcribed, non-protein-coding RNAs that play important roles in regulation of gene expression in animals and plants. Here, selective constraints on the novel precursor microRNA159 (pre-miR159) gene were investigated in 42 Phalaenopsis species (Orchidaceae). Methods/Results: A novel precursor microRNA159 gene was isolated from 42 Phalaenopsis species using a new microRNA-PCR (miR-PCR) approach. Sequencing of pre-miR159 genes revealed differences from the canonical pre-miR159 gene in Phalaenopsis species and other plants. Results demonstrated that the 5' and 3' fold-back arms and the terminal loop of the novel pre-miR159 gene have undergone purifying selection and selective constraint for stabilizing the secondary hairpin structure. Two conserved motifs within the 5' fold-back arm had the highest purifying selective pressure within the novel pre-miR159 gene. Evidence of sequence co-evolution between the 5' and 3' fold-back regions was observed. Conclusions: Functional selective pressure might arise from the constraint of forming a hairpin structure and demonstrate co-evolution of sequences between the 5' and 3' fold-back regions of the novel pre-miR159 gene in Phalaenopsis species.	[Tsai, Chi-Chu; Weng, I-Szu; Lin, Yu-Shium] Kaohsiung Dist Agr Res & Extens Stn, Pingtung 908, Taiwan; [Tsai, Chi-Chu] Natl Pingtung Univ Sci & Technol, Dept Biol Sci & Technol, Pingtung 912, Taiwan; [Chiang, Yu-Chung] Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 804, Taiwan; [Chou, Chang-Hung] China Med Univ, Res Ctr Biodivers, Taichung 404, Taiwan	National Pingtung University Science & Technology; National Sun Yat Sen University; China Medical University Taiwan	Chiang, YC (corresponding author), Natl Sun Yat Sen Univ, Dept Biol Sci, Kaohsiung 804, Taiwan.	yuchung@mail.nsysu.edu.tw; choumasa@mail.cmu.edu.tw	Chiang, Yu-Chung/E-9143-2011		Ministry of Science and Technology, Taiwan	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	Funding: This research was supported by funding from the Ministry of Science and Technology, Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard P, 2004, DEVELOPMENT, V131, P3357, DOI 10.1242/dev.01206; An FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018937; Arenas-Huertero C, 2009, PLANT MOL BIOL, V70, P385, DOI 10.1007/s11103-009-9480-3; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blow MJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-r27; Bologna NG, 2009, EMBO J, V28, P3646, DOI 10.1038/emboj.2009.292; Chao YT, 2014, PLANT MOL BIOL, V84, P529, DOI 10.1007/s11103-013-0150-0; Chen CN, 2004, MOL PHYLOGENET EVOL, V32, P616, DOI 10.1016/j.ympev.2004.01.015; Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910; Chiang YC, 2004, MOL PHYLOGENET EVOL, V31, P929, DOI 10.1016/j.ympev.2003.09.017; Choudhury NR, 2013, GENE DEV, V27, P24, DOI 10.1101/gad.199190.112; Christenson EA, 2001, PHALAENOPSIS MONOGRA, P27; Contreras-Cubas C, 2012, PLANT MOL BIOL, V80, P103, DOI 10.1007/s11103-011-9847-0; Cuperus JT, 2011, PLANT CELL, V23, P431, DOI 10.1105/tpc.110.082784; de Hoon MJL, 2010, GENOME RES, V20, P257, DOI 10.1101/gr.095273.109; de Meaux J, 2008, P NATL ACAD SCI USA, V105, P8994, DOI 10.1073/pnas.0803218105; Dezulian T., 2005, GENOME BIOL, V6, pP13, DOI DOI 10.1186/GB-2005-6-11-P13; Doyle J. J., 1987, PHYTOCHEM B, P11; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; GOJOBORI T, 1982, J MOL EVOL, V18, P414, DOI 10.1007/BF01840889; Guo XY, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-208; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; JUKES T H, 1969, P21; KIMURA M, 1983, P NATL ACAD SCI-BIOL, V80, P1048, DOI 10.1073/pnas.80.4.1048; Kulcheski FR, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-307; Kurihara Y, 2006, RNA, V12, P206, DOI 10.1261/rna.2146906; Kurihara Y, 2004, P NATL ACAD SCI USA, V101, P12753, DOI 10.1073/pnas.0403115101; Lee EJ, 2008, RNA, V14, P35, DOI 10.1261/rna.804508; Li Y, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-122; Liu Q, 2013, PLANT PHYSIOL, V163, P108, DOI 10.1104/pp.113.219071; Lu J, 2008, NAT GENET, V40, P351, DOI 10.1038/ng.73; Luciano DJ, 2004, RNA, V10, P1174, DOI 10.1261/rna.7350304; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Meyers BC, 2006, CURR OPIN BIOTECH, V17, P139, DOI 10.1016/j.copbio.2006.01.008; Moxon S, 2008, GENOME RES, V18, P1602, DOI 10.1101/gr.080127.108; Nei M, 2000, MOL EVOLUTION PHYLOG, P191; OCHMAN H, 1988, GENETICS, V120, P621; Palatnik JF, 2007, DEV CELL, V13, P115, DOI 10.1016/j.devcel.2007.04.012; Parizotto EA, 2004, GENE DEV, V18, P2237, DOI 10.1101/gad.307804; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Rhoades MW, 2002, CELL, V110, P513, DOI 10.1016/S0092-8674(02)00863-2; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Schwab R, 2005, DEV CELL, V8, P517, DOI 10.1016/j.devcel.2005.01.018; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Song L, 2010, CURR BIOL, V20, P37, DOI 10.1016/j.cub.2009.10.076; Subramanian S, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-160; Suzuki MT, 1996, APPL ENVIRON MICROB, V62, P625, DOI 10.1128/AEM.62.2.625-630.1996; Tsai CC, 2010, PLANT SYST EVOL, V288, P77, DOI 10.1007/s00606-010-0314-1; Tsai CC, 2005, PLANT SYST EVOL, V256, P1, DOI 10.1007/s00606-005-0356-y; Unver T, 2010, MOL GENET GENOMICS, V283, P397, DOI 10.1007/s00438-010-0526-7; Warthmann N, 2008, MOL BIOL EVOL, V25, P892, DOI 10.1093/molbev/msn029; Werner S, 2010, CURR BIOL, V20, P42, DOI 10.1016/j.cub.2009.10.073; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2003, MOL PHYLOGENET EVOL, V26, P1, DOI 10.1016/S1055-7903(02)00326-3; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Xie ZX, 2005, PLANT PHYSIOL, V138, P2145, DOI 10.1104/pp.105.062943; Xu Q, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-246; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zhao CZ, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-3; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	68	3	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114493	10.1371/journal.pone.0114493	http://dx.doi.org/10.1371/journal.pone.0114493			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470008	Green Published, Green Submitted, gold			2022-12-26	WOS:000349128700121
J	Hayat, T; Tanveer, A; Yasmin, H; Alsaedi, A				Hayat, Tasawar; Tanveer, Anum; Yasmin, Humaira; Alsaedi, Ahmed			Homogeneous-Heterogeneous Reactions in Peristaltic Flow with Convective Conditions	PLOS ONE			English	Article							MICROPOLAR FLUID; POROUS-MEDIUM; NANOFLUID; TRANSPORT	This article addresses the effects of homogeneous-heterogeneous reactions in peristaltic transport of Carreau fluid in a channel with wall properties. Mathematical modelling and analysis have been carried out in the presence of Hall current. The channel walls satisfy the more realistic convective conditions. The governing partial differential equations along with long wavelength and low Reynolds number considerations are solved. The results of temperature and heat transfer coefficient are analyzed for various parameters of interest.	[Hayat, Tasawar; Tanveer, Anum; Yasmin, Humaira] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Hayat, Tasawar; Alsaedi, Ahmed] King Abdulaziz Univ, Dept Math, NAAM Res Grp, Jeddah 21413, Saudi Arabia	Quaid I Azam University; King Abdulaziz University	Yasmin, H (corresponding author), Quaid I Azam Univ, Dept Math, Islamabad, Pakistan.	qau2011@gmail.com	Yasmin, Humaira/U-4171-2018; Alsaedi, Ahmed/A-2094-2013; Hayat, Tasawar/A-3853-2013; Hayat, Tasawar/E-9449-2015; Hayat, Tasawar/Y-2524-2019	Yasmin, Humaira/0000-0003-0199-6850; Alsaedi, Ahmed/0000-0003-3452-8922; 				Abd Elmaboud Y, 2012, COMMUN NONLINEAR SCI, V17, P685, DOI 10.1016/j.cnsns.2011.05.039; Abd-Alla AM, 2013, J MAGN MAGN MATER, V348, P33, DOI 10.1016/j.jmmm.2013.06.030; Abelman S, 2009, NONLINEAR ANAL-REAL, V10, P3322, DOI 10.1016/j.nonrwa.2008.10.067; Ali N, 2010, INT J NUMER METH FL, V64, P992, DOI 10.1002/fld.2184; Awais M, 2014, INT J BIOMATH, V7, DOI 10.1142/S1793524514500235; Ebaid A, 2014, COMPUT MATH APPL, V68, P77, DOI 10.1016/j.camwa.2014.05.008; El Koumy SR, 2012, TRANSPORT POROUS MED, V94, P643, DOI 10.1007/s11242-012-0016-y; Ellahi R, 2014, INT J HEAT MASS TRAN, V71, P706, DOI 10.1016/j.ijheatmasstransfer.2013.12.038; Ellahi R, 2013, APPL MATH MODEL, V37, P1451, DOI 10.1016/j.apm.2012.04.004; Hayat T, 2015, J BRAZ SOC MECH SCI, V37, P463, DOI 10.1007/s40430-014-0177-4; Hayat T, 2010, COMMUN NONLINEAR SCI, V15, P2407, DOI 10.1016/j.cnsns.2009.09.032; Hina S, 2014, ARAB J SCI ENG, V39, P593, DOI 10.1007/s13369-013-0692-0; Kameswaran PK, 2013, INT J HEAT MASS TRAN, V57, P465, DOI 10.1016/j.ijheatmasstransfer.2012.10.047; Mekheimer K., 2014, J EGYPT MATH SOC, V22, P143, DOI [10.1016/j.joems.2013.05.003, DOI 10.1016/J.JOEMS.2013.05.003]; Mekheimer KS, 2008, PHYS LETT A, V372, P4271, DOI 10.1016/j.physleta.2008.03.059; Merkin JH, 1996, MATH COMPUT MODEL, V24, P125, DOI 10.1016/0895-7177(96)00145-8; Mustafa M, 2012, INT J HEAT MASS TRAN, V55, P4871, DOI 10.1016/j.ijheatmasstransfer.2012.04.060; Mustafa M, 2014, J TAIWAN INST CHEM E, V45, P308, DOI 10.1016/j.jtice.2013.07.010; Parsa AB, 2013, HEAT TRANSF-ASIAN RE, V42, P500, DOI 10.1002/htj.21054; Rashidi MM, 2014, ABSTR APPL ANAL, DOI 10.1155/2014/923487; Riaz A, 2014, ALEX ENG J, V53, P475, DOI 10.1016/j.aej.2014.01.005; Shaw S, 2013, BOUND VALUE PROBL, DOI 10.1186/1687-2770-2013-77; Tripathi D, 2014, INT J HEAT MASS TRAN, V70, P61, DOI 10.1016/j.ijheatmasstransfer.2013.10.044; Yasmin H, 2014, APPL MATH MECH-ENGL, V35, P697, DOI 10.1007/s10483-014-1823-6; Zhang Y, 2013, J ENVIRON SCI, V25, P1817, DOI 10.1016/S1001-0742(12)60233-2	25	29	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113851	10.1371/journal.pone.0113851	http://dx.doi.org/10.1371/journal.pone.0113851			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460608	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700059
J	Hendre, PS; Aggarwal, RK				Hendre, Prasad S.; Aggarwal, Ramesh K.			Development of Genic and Genomic SSR Markers of Robusta Coffee (Coffea canephora Pierre Ex A. Froehner)	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEATS; MICROSATELLITE MARKERS; PLANTS; GENUS; TRANSFERABILITY; IDENTIFICATION; AMPLIFICATION; ARABICA	Coffee breeding and improvement efforts can be greatly facilitated by availability of a large repository of simple sequence repeats (SSRs) based microsatellite markers, which provides efficiency and high-resolution in genetic analyses. This study was aimed to improve SSR availability in coffee by developing new genic-/genomic-SSR markers using in-silico bioinformatics and streptavidin-biotin based enrichment approach, respectively. The expressed sequence tag (EST) based genic microsatellite markers (EST-SSRs) were developed using the publicly available dataset of 13,175 unigene ESTs, which showed a distribution of 1 SSR/3.4 kb of coffee transcriptome. Genomic SSRs, on the other hand, were developed from an SSR-enriched small-insert partial genomic library of robusta coffee. In total, 69 new SSRs (44 EST-SSRs and 25 genomic SSRs) were developed and validated as suitable genetic markers. Diversity analysis of selected coffee genotypes revealed these to be highly informative in terms of allelic diversity and PIC values, and eighteen of these markers (similar to 27%) could be mapped on a robusta linkage map. Notably, the markers described here also revealed a very high cross-species transferability. In addition to the validated markers, we have also designed primer pairs for 270 putative EST-SSRs, which are expected to provide another ca. 200 useful genetic markers considering the high success rate (88%) of marker conversion of similar pairs tested/validated in this study.	[Hendre, Prasad S.; Aggarwal, Ramesh K.] Ctr Cellular & Mol Biol CSIR CCMB, Hyderabad, Telangana, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Centre for Cellular & Molecular Biology (CCMB)	Aggarwal, RK (corresponding author), Ctr Cellular & Mol Biol CSIR CCMB, Hyderabad, Telangana, India.	rameshka@ccmb.res.in	HENDRE, PRASAD/ABF-7486-2021; Hendre, Prasad S/D-1256-2010	HENDRE, PRASAD/0000-0003-1691-183X; Hendre, Prasad S/0000-0003-1691-183X	FYP project from the Council of Scientific & Industrial Research (Govt of India) [PLOMICS_BSC0301]; Department of Biotechnology (Govt of India) [BT/PR/6292/Agr/16/575/2005]	FYP project from the Council of Scientific & Industrial Research (Govt of India); Department of Biotechnology (Govt of India)(Department of Biotechnology (DBT) India)	This work was supported by: the FYP project, PLOMICS_BSC0301, to RKA, from the Council of Scientific & Industrial Research (Govt of India); and Project grant "BT/PR/6292/Agr/16/575/2005, dated 4/12/2006," to RKA from the Department of Biotechnology (Govt of India), under which some of the DNA samples/sequences used in the present study were collected/carried out. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal RK, 2007, THEOR APPL GENET, V114, P359, DOI 10.1007/s00122-006-0440-x; Aggarwal RK, 2002, THEOR APPL GENET, V105, P680, DOI 10.1007/s00122-002-0973-6; Aggarwal RK, 2004, P 20 INT C COFF SCI, P751; [Anonymous], 2005, PHYLIP PHYLOGENY INF; Baruah A, 2003, MOL ECOL NOTES, V3, P647, DOI 10.1046/j.1471-8286.2003.00544.x; Bhat PR, 2005, MOL ECOL NOTES, V5, P80, DOI 10.1111/j.1471-8286.2004.00839.x; CHEVALIER A, 1947, ENCY BIOL, P356; Combes MC, 2000, MOL ECOL, V9, P1178, DOI 10.1046/j.1365-294x.2000.00954-5.x; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Edwards KJ, 1996, BIOTECHNIQUES, V20, P758; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Glaubitz JC, 2004, MOL ECOL NOTES, V4, P309, DOI 10.1111/j.1471-8286.2004.00597.x; Hendre Prasad S., 2007, P399, DOI 10.1007/978-1-4020-6297-1_15; Hendre PS, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-51; Hendre PS, 2004, COURSE MANUAL HANDS; Hendre PS, 2007, THESIS JAWAHARLAL NE; Kumpatla S. P, 2004, THESIS; Lashermes P, 1997, THEOR APPL GENET, V94, P947, DOI 10.1007/s001220050500; Lin CW, 2005, THEOR APPL GENET, V112, P114, DOI 10.1007/s00122-005-0112-2; Moncada P, 2004, GENOME, V47, P501, DOI 10.1139/G03-129; Moriguchi Y, 2003, THEOR APPL GENET, V106, P751, DOI 10.1007/s00122-002-1149-0; OrozcoCastillo C, 1996, PLANT CELL REP, V15, P337, DOI 10.1007/BF00232367; Page RDM, 2001, TREEVIEW SOFTWARE; Peakall R, 1998, MOL BIOL EVOL, V15, P1275, DOI 10.1093/oxfordjournals.molbev.a025856; Plechakova O, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-123; Poncet V, 2004, GENOME, V47, P1071, DOI 10.1139/G04-064; Poncet V, 2007, GENOME, V50, P1156, DOI 10.1139/G07-073; Poncet V, 2006, MOL GENET GENOMICS, V276, P436, DOI 10.1007/s00438-006-0153-5; Riar DS, 2010, J HERED, DOI [10.1093/jhered/esg103, DOI 10.1093/JHERED/ESG103]; Rovelli P, 2000, COFFEE BIOTECHNOLOGY, P123; Ruas PM, 2003, GENET MOL BIOL, V26, P319, DOI 10.1590/S1415-47572003000300017; Squirrell J, 2003, MOL ECOL, V12, P1339, DOI 10.1046/j.1365-294X.2003.01825.x; Van Ooijen J.W, 2006, JOINMAP R 4 SOFTWARE; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Varshney RK, 2002, CELL MOL BIOL LETT, V7, P537; [No title captured]	36	15	15	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113661	10.1371/journal.pone.0113661	http://dx.doi.org/10.1371/journal.pone.0113661			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461752	Green Published, Green Submitted, gold			2022-12-26	WOS:000345869700043
J	Kleinman, CL; Doria, M; Orecchini, E; Giuliani, E; Galardi, S; De Jay, N; Michienzi, A				Kleinman, Claudia L.; Doria, Margherita; Orecchini, Elisa; Giuliani, Erica; Galardi, Silvia; De Jay, Nicolas; Michienzi, Alessandro			HIV-1 Infection Causes a Down-Regulation of Genes Involved in Ribosome Biogenesis	PLOS ONE			English	Article							POLYMERASE-I TRANSCRIPTION; UPSTREAM-BINDING-FACTOR; NUCLEOLAR TRAFFICKING; MEDIATED INHIBITION; PROTEOMIC ANALYSIS; RNA; PROTEIN; REPLICATION; CELL; ACTIVATION	HIV-1 preferentially infects CD4(+) T cells, causing fundamental changes that eventually lead to the release of new viral particles and cell death. To investigate in detail alterations in the transcriptome of the CD4(+) T cells upon viral infection, we sequenced polyadenylated RNA isolated from Jurkat cells infected or not with HIV-1. We found a marked global alteration of gene expression following infection, with an overall trend toward induction of genes, indicating widespread modification of the host biology. Annotation and pathway analysis of the most deregulated genes showed that viral infection produces a down-regulation of genes associated with the nucleolus, in particular those implicated in regulating the different steps of ribosome biogenesis, such as ribosomal RNA ( rRNA) transcription, pre-rRNA processing, and ribosome maturation. The impact of HIV-1 infection on genes involved in ribosome biogenesis was further validated in primary CD4(+) T cells. Moreover, we provided evidence by Northern Blot experiments, that host pre-rRNA processing in Jurkat cells might be perturbed during HIV-1 infection, thus strengthening the hypothesis of a crosstalk between nucleolar functions and viral pathogenesis.	[Kleinman, Claudia L.; De Jay, Nicolas] McGill Univ, Sir Mortimer B Davis Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada; [Kleinman, Claudia L.; De Jay, Nicolas] McGill Univ, Dept Human Genet, Montreal, PQ H3T 1E2, Canada; [Doria, Margherita; Giuliani, Erica] IRCCS, Bambino Gesu Childrens Hosp, Lab Immunoinfectivol, Rome, Italy; [Orecchini, Elisa; Galardi, Silvia; Michienzi, Alessandro] Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy	Lady Davis Institute; McGill University; McGill University; IRCCS Bambino Gesu; University of Rome Tor Vergata	Michienzi, A (corresponding author), Univ Roma Tor Vergata, Dept Biomed & Prevent, Rome, Italy.	alessandro.michienzi@uniroma2.it	Doria, Margherita/K-3157-2016; michienzi, alessandro/I-5106-2014; Giuliani, Erica/K-3958-2016; Orecchini, Elisa/AAQ-4441-2020	Doria, Margherita/0000-0001-5533-0304; michienzi, alessandro/0000-0002-9133-8482; Giuliani, Erica/0000-0002-4190-6963; Orecchini, Elisa/0000-0002-0654-4696; GALARDI, SILVIA/0000-0002-3646-4064; Kleinman, Claudia/0000-0002-5158-7126	Ministry of Health; ISS; Ministry of Health, Ricerca Finalizzata, and Ricerca Corrente; Fonds de Recherche du Quebec-Sante	Ministry of Health; ISS; Ministry of Health, Ricerca Finalizzata, and Ricerca Corrente; Fonds de Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This study was supported in part by the Ministry of Health, 'Programma Nazionale di ricerca sull'AIDS' in collaboration with ISS to A. M. and by grants of the Ministry of Health, Ricerca Finalizzata, and Ricerca Corrente co-funded by the Italian 5 x 1000 contribution to M.D. C.L.K. was the recipient of a fellowship award from the Fonds de Recherche du Quebec-Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas W, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-103; Alexandrov A, 2011, GENE DEV, V25, P1078, DOI 10.1101/gad.2045411; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Banerjee R, 2005, J GEN VIROL, V86, P2315, DOI 10.1099/vir.0.80817-0; Belin S, 2010, RNA, V16, P131, DOI 10.1261/rna.1935610; Beyer AR, 2013, J VIROL, V87, P1069, DOI 10.1128/JVI.02463-12; Calle A, 2008, J VIROL, V82, P4762, DOI 10.1128/JVI.00077-08; Chang ST, 2011, MBIO, V2, DOI 10.1128/mBio.00134-11; Choesmel V, 2007, BLOOD, V109, P1275, DOI 10.1182/blood-2006-07-038372; Doria M, 2009, NUCLEIC ACIDS RES, V37, P5848, DOI 10.1093/nar/gkp604; Duan ZQ, 2014, VIROLOGY, V452, P212, DOI 10.1016/j.virol.2014.01.011; Emmott E, 2010, J PROTEOME RES, V9, P5335, DOI 10.1021/pr100593g; Henning D, 2003, J BIOL CHEM, V278, P52307, DOI 10.1074/jbc.M310846200; Hiscox JA, 2010, PROTEOMICS, V10, P4077, DOI 10.1002/pmic.201000251; Horigome C, 2012, NUCLEUS-PHILA, V3, P22, DOI 10.4161/nucl.18930; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jarboui MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048702; Jarboui MA, 2011, MOL IMMUNOL, V49, P441, DOI 10.1016/j.molimm.2011.09.005; Kao CF, 2004, J BIOMED SCI, V11, P72, DOI 10.1159/000075291; Lalonde E, 2011, GENOME RES, V21, P545, DOI 10.1101/gr.111211.110; Lam YW, 2010, MOL CELL PROTEOMICS, V9, P117, DOI 10.1074/mcp.M900338-MCP200; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lefebvre G, 2011, J VIROL, V85, P6205, DOI 10.1128/JVI.00252-11; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lochmann TL, 2013, VIRUS RES, V171, P304, DOI 10.1016/j.virusres.2012.09.011; Lymberopoulos MH, 2011, VIROLOGY, V412, P341, DOI 10.1016/j.virol.2011.01.016; Matusali G, 2012, J VIROL, V86, P4496, DOI 10.1128/JVI.05788-11; Michienzi A, 2002, P NATL ACAD SCI USA, V99, P14047, DOI 10.1073/pnas.212229599; Michienzi A, 2000, P NATL ACAD SCI USA, V97, P8955, DOI 10.1073/pnas.97.16.8955; Michienzi Alessandro, 2006, AIDS Res Ther, V3, P13, DOI 10.1186/1742-6405-3-13; Mohammadi P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003161; Ni LW, 2012, J MED MICROBIOL, V61, P1637, DOI 10.1099/jmm.0.045963-0; Orecchini E, 2014, RNA BIOL, V11, P334, DOI 10.4161/rna.28372; Pederson T, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000521; Peng QH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014244; Ponti D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-32; Prieto JL, 2007, GENE DEV, V21, P2041, DOI 10.1101/gad.436707; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Salvetti A, 2014, BBA-MOL BASIS DIS, V1842, P840, DOI 10.1016/j.bbadis.2013.12.010; Scherl A, 2002, MOL BIOL CELL, V13, P4100, DOI 10.1091/mbc.E02-05-0271; Sharma A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002612; St-Pierre C, 2011, J VIROL, V85, P11742, DOI 10.1128/JVI.05351-11; Stow ND, 2009, J GEN VIROL, V90, P69, DOI 10.1099/vir.0.006353-0; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang Y, 2007, BBA-MOL CELL RES, V1773, P863, DOI 10.1016/j.bbamcr.2007.04.002; Wilson EB, 2011, CURR TOP MICROBIOL, V350, P39, DOI 10.1007/82_2010_96; Zhang YD, 2011, MOL CELL BIOL, V31, P4676, DOI 10.1128/MCB.05832-11; ZIEGLER SF, 1994, STEM CELLS, V12, P456, DOI 10.1002/stem.5530120502	50	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113908	10.1371/journal.pone.0113908	http://dx.doi.org/10.1371/journal.pone.0113908			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462981	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700067
J	Lubnow, M; Philipp, A; Foltan, M; Enger, TB; Lunz, D; Bein, T; Haneya, A; Schmid, C; Riegger, G; Muller, T; Lehle, K				Lubnow, Matthias; Philipp, Alois; Foltan, Maik; Enger, Tone Bull; Lunz, Dirk; Bein, Thomas; Haneya, Assad; Schmid, Christof; Riegger, Guenter; Mueller, Thomas; Lehle, Karla			Technical Complications during Veno-Venous Extracorporeal Membrane Oxygenation and Their Relevance Predicting a System-Exchange - Retrospective Analysis of 265 Cases	PLOS ONE			English	Article							RESPIRATORY-DISTRESS-SYNDROME; LIFE-SUPPORT; FAILURE; LUNG; INFLUENZA; ADULTS; DEPOSITS	Objectives: Technical complications are a known hazard in veno-venous extracorporeal membrane oxygenation (vvECMO). Identifying these complications and predictive factors indicating a developing system-exchange was the goal of the study. Methods: Retrospective study on prospectively collected data of technical complications including 265 adult patients (Regensburg ECMO Registry, 20092013) with acute respiratory failure treated with vvECMO. Alterations in blood flow resistance, gas transfer capability, hemolysis, coagulation and hemostasis parameters were evaluated in conjunction with a system-exchange in all patients with at least one exchange (n=83). Results: Values presented as median (interquartile range). Patient age was 50(36-60) years, the SOFA score 11(8-14.3) and the Murray lung injury Score 3.33(3.3-3.7). Cumulative ECMO support time 3411 days, 9(6-15) days per patient. Mechanical failure of the blood pump (n=5), MO (n=2) or cannula (n=1) accounted for 10% of the exchanges. Acute clot formation within the pump head (visible clots, increase in plasma free hemoglobin (frHb), serum lactate dehydrogenase (LDH), n=13) and MO (increase in pressure drop across the MO, n=16) required an urgent system-exchange, of which nearly 50% could be foreseen by measuring the parameters mentioned below. Reasons for an elective system-exchange were worsening of gas transfer capability (n=10) and device-related coagulation disorders (n=32), either local fibrinolysis in the MO due to clot formation (increased D-dimers [DD]), decreased platelet count; n=24), or device-induced hyperfibrinolysis (increased DD, decreased fibrinogen [FG], decreased platelet count, diffuse bleeding tendency; n=8), which could be reversed after system-exchange. Four MOs were exchanged due to suspicion of infection. Conclusions: The majority of ECMO system-exchanges could be predicted by regular inspection of the complete ECMO circuit, evaluation of gas exchange, pressure drop across the MO and laboratory parameters (DD, FG, platelets, LDH, frHb). These parameters should be monitored in the daily routine to reduce the risk of unexpected ECMO failure.	[Philipp, Alois; Foltan, Maik; Enger, Tone Bull; Haneya, Assad; Schmid, Christof; Lehle, Karla] Univ Med Ctr Regensburg, Dept Cardiothorac Surg, D-93042 Regensburg, Germany; [Lubnow, Matthias; Riegger, Guenter; Mueller, Thomas] Univ Med Ctr Regensburg, Dept Internal Med 2, D-93042 Regensburg, Germany; [Lunz, Dirk; Bein, Thomas] Univ Med Ctr Regensburg, Dept Anesthesiol, D-93042 Regensburg, Germany	University of Regensburg; University of Regensburg; University of Regensburg	Lubnow, M (corresponding author), Univ Med Ctr Regensburg, Dept Internal Med 2, Franz Josef Strauss Allee 11, D-93042 Regensburg, Germany.	matthias.lubnow@ukr.de	Haneya, Assad/Q-7748-2017; Haneya, Assad/ABE-6281-2020	Foltan, Maik/0000-0001-9350-3368	Departments of Cardiothoracic Surgery; Internal Medicine 2 of the University Medical Center Regensburg	Departments of Cardiothoracic Surgery; Internal Medicine 2 of the University Medical Center Regensburg	The study was funded by departmental resources of the Departments of Cardiothoracic Surgery and Internal Medicine 2 of the University Medical Center Regensburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no specific other funding for this work.	Allen Steve, 2011, J Intensive Care Med, V26, P13, DOI 10.1177/0885066610384061; Brogan TV, 2009, INTENS CARE MED, V35, P2105, DOI 10.1007/s00134-009-1661-7; Byrnes J, 2011, ASAIO J, V57, P456, DOI 10.1097/MAT.0b013e31822e2475; Combes A, 2012, CURR OPIN CRIT CARE, V18, P99, DOI 10.1097/MCC.0b013e32834ef412; Combes A, 2011, SEMIN RESP CRIT CARE, V32, P188, DOI 10.1055/s-0031-1275531; Conrad SA, 2005, ASAIO J, V51, P4, DOI 10.1097/01.mat.0000151922.67540.E9; Davies A, 2009, JAMA-J AM MED ASSOC, V302, P1888, DOI 10.1001/jama.2009.1535; Dornia C, 2013, ASAIO J, V59, P439, DOI 10.1097/MAT.0b013e3182976eff; HILL JD, 1972, NEW ENGL J MED, V286, P629, DOI 10.1056/NEJM197203232861204; Kniazeva T, 2012, LAB CHIP, V12, P1686, DOI 10.1039/c2lc21156d; Kuehn C, 2013, ASAIO J, V59, P368, DOI 10.1097/MAT.0b013e318299fd07; Lehle K, 2013, ARTIF ORGANS; Lehle K, 2008, ASAIO J, V54, P612, DOI 10.1097/MAT.0b013e318186a807; Lubnow M, 2013, J CRIT CARE; MacLaren G, 2012, INTENS CARE MED, V38, P210, DOI 10.1007/s00134-011-2439-2; Muller T, 2013, DTSCH ARZTEBL INT, V110, P159, DOI 10.3238/arztebl.2013.0159; Muller T, 2011, ARTIF ORGANS, V35, pE84, DOI 10.1111/j.1525-1594.2010.01185.x; Napolitano LM, 2010, CRIT CARE MED, V38, pE74, DOI 10.1097/CCM.0b013e3181cc5373; Nolan H, 2011, ORGANOGENESIS, V7, P23, DOI 10.4161/org.7.1.14025; Park PK, 2011, CRIT CARE CLIN, V27, P627, DOI 10.1016/j.ccc.2011.05.009; Peek GJ, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14350; Peek GJ, 2009, LANCET, V374, P1351, DOI 10.1016/S0140-6736(09)61069-2; Schmid C, 2012, J HEART LUNG TRANSPL, V31, P9, DOI 10.1016/j.healun.2011.07.013; Sethi S, 2011, ANN CARD ANAESTH, V14, P156, DOI [10.4103/0971-9784.81576, 10.4103/0971-9784.84030]; Sidebotham D, 2010, J CARDIOTHOR VASC AN, V24, P164, DOI 10.1053/j.jvca.2009.08.002; Yu K, 2011, ARTIF ORGANS, V35, P733, DOI 10.1111/j.1525-1594.2010.01173.x	26	101	102	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112316	10.1371/journal.pone.0112316	http://dx.doi.org/10.1371/journal.pone.0112316			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464516	Green Published, Green Submitted, gold			2022-12-26	WOS:000345869700015
J	Nabeka, H; Uematsu, K; Takechi, H; Shimokawa, T; Yamamiya, K; Li, C; Doihara, T; Saito, S; Kobayashi, N; Matsuda, S				Nabeka, Hiroaki; Uematsu, Keigo; Takechi, Hiroko; Shimokawa, Tetsuya; Yamamiya, Kimiko; Li, Cheng; Doihara, Takuya; Saito, Shouichiro; Kobayashi, Naoto; Matsuda, Seiji			Prosaposin Overexpression following Kainic Acid-Induced Neurotoxicity	PLOS ONE			English	Article							SPHINGOLIPID ACTIVATOR PROTEINS; INDUCED LEARNING-DISABILITY; FACIAL-NERVE TRANSECTION; IN-VIVO; CEREBRAL-ISCHEMIA; BETA-GLUCOSIDASE; NEURONAL DAMAGE; MESSENGER-RNA; RAT; EXPRESSION	Because excessive glutamate release is believed to play a pivotal role in numerous neuropathological disorders, such as ischemia or seizure, we aimed to investigate whether intrinsic prosaposin (PS), a neuroprotective factor when supplied exogenously in vivo or in vitro, is up-regulated after the excitotoxicity induced by kainic acid (KA), a glutamate analog. In the present study, PS immunoreactivity and its mRNA expression in the hippocampal and cortical neurons showed significant increases on day 3 after KA injection, and high PS levels were maintained even after 3 weeks. The increase in PS, but not saposins, detected by immunoblot analysis suggests that the increase in PS-like immunoreactivity after KA injection was not due to an increase in saposins as lysosomal enzymes after neuronal damage, but rather to an increase in PS as a neurotrophic factor to improve neuronal survival. Furthermore, several neurons with slender nuclei inside/outside of the pyramidal layer showed more intense PS mRNA expression than other pyramidal neurons. Based on the results from double immunostaining using anti-PS and anti-GABA antibodies, these neurons were shown to be GABAergic interneurons in the extraand intra-pyramidal layers. In the cerebral cortex, several large neurons in the V layer showed very intense PS mRNA expression 3 days after KA injection. The choroid plexus showed intense PS mRNA expression even in the normal rat, and the intensity increased significantly after KA injection. The present study indicates that inhibitory interneurons as well as stimulated hippocampal pyramidal and cortical neurons synthesize PS for neuronal survival, and the choroid plexus is highly activated to synthesize PS, which may prevent neurons from excitotoxic neuronal damage. To the best of our knowledge, this is the first study that demonstrates axonal transport and increased production of neurotrophic factor PS after KA injection.	[Nabeka, Hiroaki; Uematsu, Keigo; Takechi, Hiroko; Shimokawa, Tetsuya; Yamamiya, Kimiko; Li, Cheng; Doihara, Takuya; Matsuda, Seiji] Ehime Univ, Grad Sch Med, Dept Anat & Embryol, Toon, Ehime, Japan; [Saito, Shouichiro] Gifu Univ, Fac Appl Biol Sci, Lab Vet Anat, Yanagi, Gifu, Japan; [Kobayashi, Naoto] Ehime Univ, Grad Sch Med, Med Educ Ctr, Toon, Ehime, Japan	Ehime University; Gifu University; Ehime University	Shimokawa, T (corresponding author), Ehime Univ, Grad Sch Med, Dept Anat & Embryol, Toon, Ehime, Japan.	tshimo@m.ehime-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, of Japan [25450466, 24590254, 25462295]; Grants-in-Aid for Scientific Research [24590254] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by grants to TS (No. 25450466), NK (No. 24590254), and SM (No. 25462295), from the Ministry of Education, Culture, Sports, Science and Technology, of Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Campana WM, 1998, NEUROTOXICOLOGY, V19, P237; Chen J, 2008, NEUROSCI RES, V60, P82, DOI 10.1016/j.neures.2007.09.010; COLLARD MW, 1988, BIOCHEMISTRY-US, V27, P4557, DOI 10.1021/bi00412a050; COYLE JT, 1987, CIBA F SYMP, V126, P186; FERKANY JW, 1982, NATURE, V298, P757, DOI 10.1038/298757a0; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gao HL, 2013, NEUROSCIENCE, V236, P373, DOI 10.1016/j.neuroscience.2013.01.007; Gao HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080032; HEGGLI DE, 1981, BRAIN RES, V230, P253, DOI 10.1016/0006-8993(81)90405-4; HINENO T, 1991, BIOCHEM BIOPH RES CO, V176, P668, DOI 10.1016/S0006-291X(05)80236-0; Hiraiwa M, 2003, J NEUROTRAUM, V20, P755, DOI 10.1089/089771503767869980; HIRAIWA M, 1992, P NATL ACAD SCI USA, V89, P11254, DOI 10.1073/pnas.89.23.11254; Hiraiwa M, 1999, GLIA, V26, P353, DOI 10.1002/(SICI)1098-1136(199906)26:4<353::AID-GLIA9>3.0.CO;2-G; Hiraiwa M, 1997, ARCH BIOCHEM BIOPHYS, V341, P17, DOI 10.1006/abbi.1997.9958; Hosoda Y, 2007, CELL TISSUE RES, V330, P197, DOI 10.1007/s00441-007-0464-9; KISHIMOTO Y, 1992, J LIPID RES, V33, P1255; KONDOH K, 1993, J COMP NEUROL, V334, P590, DOI 10.1002/cne.903340407; KONDOH K, 1991, BIOCHEM BIOPH RES CO, V181, P286, DOI 10.1016/S0006-291X(05)81415-9; Kotani Y, 1996, J NEUROCHEM, V66, P2197; Kotani Y, 1996, J NEUROCHEM, V66, P2019; Levesque M, 2013, NEUROSCI BIOBEHAV R, V37, P2887, DOI 10.1016/j.neubiorev.2013.10.011; Li C, 2013, HISTOL HISTOPATHOL, V28, P875, DOI 10.14670/HH-28.875; Liang R, 2009, NEUROSCIENCE, V160, P412, DOI 10.1016/j.neuroscience.2009.02.046; LOTHMAN EW, 1981, BRAIN RES, V218, P299, DOI 10.1016/0006-8993(81)91308-1; Matsuda S, 1997, BRAIN RES, V769, P321, DOI 10.1016/S0006-8993(97)00724-5; Matsuda S, 1996, NEUROSCI LETT, V204, P109, DOI 10.1016/0304-3940(96)12340-5; Meyer RC, 2013, P NATL ACAD SCI USA, V110, P9529, DOI 10.1073/pnas.1219004110; Morales CR, 1998, J ANDROL, V19, P156; MORIMOTO S, 1989, P NATL ACAD SCI USA, V86, P3389, DOI 10.1073/pnas.86.9.3389; NADLER JV, 1981, NEUROSCIENCE, V6, P2505, DOI 10.1016/0306-4522(81)90096-8; NADLER JV, 1980, BRAIN RES, V195, P47; OBRIEN JS, 1988, SCIENCE, V241, P1098, DOI 10.1126/science.2842863; OBRIEN JS, 1994, P NATL ACAD SCI USA, V91, P9593, DOI 10.1073/pnas.91.20.9593; OBRIEN JS, 1991, FASEB J, V5, P301, DOI 10.1096/fasebj.5.3.2001789; OLNEY JW, 1978, NATURE, V271, P557, DOI 10.1038/271557a0; Qi XY, 2001, PROG NUCLEIC ACID RE, V66, P203; Saito S, 2014, CELL TISSUE RES, V356, P231, DOI 10.1007/s00441-013-1773-9; SANO A, 1988, J BIOL CHEM, V263, P19597; SANO A, 1992, BIOCHIM BIOPHYS ACTA, V1120, P75, DOI 10.1016/0167-4838(92)90426-E; SANO A, 1994, BIOCHEM BIOPH RES CO, V204, P994, DOI 10.1006/bbrc.1994.2558; SANO A, 1989, BIOCHEM BIOPH RES CO, V165, P1191, DOI 10.1016/0006-291X(89)92728-9; Sato K, 1998, METHOD ENZYMOL, V293, P155; SCHWOB JE, 1980, NEUROSCIENCE, V5, P991, DOI 10.1016/0306-4522(80)90181-5; Shimokawa T, 2013, CELL TISSUE RES, V352, P685, DOI 10.1007/s00441-013-1575-0; Terashita T, 2007, NEUROSCI RES, V57, P372, DOI 10.1016/j.neures.2006.11.006; Tsuboi K, 1998, DEV BRAIN RES, V110, P249, DOI 10.1016/S0165-3806(98)00109-6; Unuma K, 2005, NEUROSCI RES, V52, P220, DOI 10.1016/j.neures.2005.03.009; Wang Q, 2005, MOL NEUROBIOL, V31, P3, DOI 10.1385/MN:31:1-3:003; Yokota N, 2001, STROKE, V32, P168, DOI 10.1161/01.STR.32.1.168; Zhao Q, 2000, J BIOL CHEM, V275, P24829, DOI 10.1074/jbc.M003497200	50	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e110534	10.1371/journal.pone.0110534	http://dx.doi.org/10.1371/journal.pone.0110534			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461957	gold, Green Submitted, Green Published			2022-12-26	WOS:000345869700004
J	Chen, R; Tao, F; Ma, Y; Zhong, LQ; Qin, X; Hu, Z				Chen, Ren; Tao, Feng; Ma, Ying; Zhong, Liqin; Qin, Xia; Hu, Zhi			Associations between Social Support and Condom Use among Commercial Sex Workers in China: A Cross-Sectional Study	PLOS ONE			English	Article							YUNNAN PROVINCE; HIV-INFECTION; MENTAL-HEALTH; RISK BEHAVIORS; KAIYUAN CITY; GAY; FAMILY; IMPACT; DISCRIMINATION; PREVALENCE	Objective: The aim of this study was to investigate the association between social support and AIDS high-risk behaviors in commercial sex workers (CSWs) in China. Methods: A cross-sectional study was performed based on a convenience sample. Data were collected through questionnaire interviews including information about social demographic characteristics, the Social Support Rating Scale (SSRS) and AIDS knowledge. Multiple logistic regression was performed to evaluate the association between social support and AIDS high-risk behaviors, specifically condom use during commercial sex. Results: A total of 581 commercial sex workers from 4 counties in East China participated in the study. The majority of the participants were 15 to 30 years old (79.7%). Sources of individual and family support were mainly provided by their parents (50.3%), relatives and friends (46.3%), spouses (18.4%), respectively. Univariate analysis revealed that marital status, hobbies, smoking habit, individual monthly income and family monthly income were all significantly correlated with current levels of social support being received (P=0.04, P=0.00, P=0.01, P=0.01, P=0.01, respectively). Furthermore, Multiple logistic regression analysis indicated that after adjusting for confounding factors, high levels of social support were significantly correlated with increased condom use at the last sexual encounter (P=0.02, OR=1.86, 95% CI: 1.10-3.16); and consistently in the past month with clients (P=0.03, OR=2.10, 95% CI: 1.09-4.04). Conclusion: CSWs with high levels of social support are more likely to use condoms during commercial sex. This suggests that increasing social support can potentially reduce AIDS-related high-risk behaviors and accordingly play an important role in AIDS prevention.	[Chen, Ren; Hu, Zhi] Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Hefei, Anhui, Peoples R China; [Chen, Ren; Tao, Feng; Ma, Ying; Zhong, Liqin; Qin, Xia; Hu, Zhi] Anhui Med Univ, Sch Hlth Serv Management, Hefei, Anhui, Peoples R China	Anhui Medical University; Anhui Medical University	Hu, Z (corresponding author), Anhui Med Univ, Sch Publ Hlth, Dept Epidemiol & Hlth Stat, Hefei, Anhui, Peoples R China.	aywghz@126.com	Chen, Ren/AAV-5572-2021		National Natural Science Foundation of China [70973001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was funded by the National Natural Science Foundation of China (Grant No. 70973001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam N, 2013, INT J STD AIDS, V24, P813, DOI 10.1177/0956462413486452; Angadi M M, 2013, J Indian Med Assoc, V111, P30; Bai Y, 2003, MED PHILOS, V24, P27; Baum A, 1984, HDB PSYCHOL HLTH; Benoit C, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-76; Cao H, 2003, CHINESE J AIDS STD, V9, P185; Chen XS, 2005, AIDS PATIENT CARE ST, V19, P853, DOI 10.1089/apc.2005.19.853; COHEN S, 1983, J APPL SOC PSYCHOL, V13, P99, DOI 10.1111/j.1559-1816.1983.tb02325.x; Cullen F. T., 1994, JUSTICE Q, V11, P527, DOI [10.1080/07418829400092421, DOI 10.1080/07418829400092421]; Dandona R, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-87; Diaz RM, 2001, AM J PUBLIC HEALTH, V91, P927, DOI 10.2105/AJPH.91.6.927; GALAVOTTI C, 1995, HEALTH PSYCHOL, V14, P570, DOI 10.1037/0278-6133.14.6.570; Hall V P, 1999, J Assoc Nurses AIDS Care, V10, P74, DOI 10.1016/S1055-3290(05)60121-5; Hong Y, 2008, AIDS BEHAV, V12, P623, DOI 10.1007/s10461-007-9287-7; Hong Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062290; House JS, 1981, WORK STRESS SOCIAL S; Ingram KM, 1999, AIDS CARE, V11, P313, DOI 10.1080/09540129947947; JACKSON L, 1992, SOC SCI MED, V35, P281, DOI 10.1016/0277-9536(92)90024-K; Kalinka J, 2005, AM J PERINAT, V22, P41, DOI 10.1055/s-2004-837266; Kimberly JA, 1999, AIDS EDUC PREV, V11, P465; LEMP GF, 1994, JAMA-J AM MED ASSOC, V272, P449, DOI 10.1001/jama.272.6.449; Li L, 2006, AIDS BEHAV, V10, P509, DOI 10.1007/s10461-006-9071-0; Li X, 2007, MED PHILOS HUMANISTI, V28, P28, DOI DOI 10.1016/J.M0LCEL.2007.07.032; Liu L, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-324; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Ma Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048888; Mays VM, 2001, AM J PUBLIC HEALTH, V91, P1869, DOI 10.2105/AJPH.91.11.1869; MORRIS M, 1995, AIDS, V9, P507, DOI 10.1097/00002030-199509050-00014; Nyamathi A, 2000, NURS RES, V49, P318, DOI 10.1097/00006199-200011000-00004; Parker RG, 2000, AIDS, V14, pS22, DOI 10.1097/00002030-200006001-00004; Robinson NJ, 1996, 11 INT C AIDS; Sarason I. G., 1985, SOCIAL SUPPORT THEOR; Satcher D, 1996, PUBLIC HEALTH REP, V111, P1; SHUMAKER SA, 1984, J SOC ISSUES, V40, P11, DOI 10.1111/j.1540-4560.1984.tb01105.x; Spittal PM, 2002, CAN MED ASSOC J, V166, P894; Takahashi LM, 2008, HEALTH PLACE, V14, P182, DOI 10.1016/j.healthplace.2007.06.002; The National Health and Family Planning Commission, 2012, CHIN AIDS PREV CONTR; THOITS PA, 1986, J CONSULT CLIN PSYCH, V54, P416, DOI 10.1037/0022-006X.54.4.416; Turner-Cobb JM, 2002, J BEHAV MED, V25, P337, DOI 10.1023/A:1015814431481; Wang HB, 2008, INT J STD AIDS, V19, P635, DOI 10.1258/ijsa.2008.008013; Wang HB, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-198; Wang HB, 2009, INT J INFECT DIS, V13, P162, DOI 10.1016/j.ijid.2008.05.1229; Wang Y., 2002, CHINESE J AIDS STD, V8, P166; Wang Y, 2009, AIDS BEHAV, V13, P866, DOI 10.1007/s10461-008-9446-5; Wu QB, 2010, AM J COMMUN PSYCHOL, V45, P1, DOI 10.1007/s10464-009-9284-2; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Xiao S., 1994, J CLIN PSYCHIAT, V4, P98, DOI DOI 10.1186/S12913-016-1423-5; Xu JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079045; Yang HM, 2005, SEX TRANSM DIS, V32, P572, DOI 10.1097/01.olq.0000175418.48665.95; Yang HM, 2005, SEX TRANSM DIS, V32, P270, DOI 10.1097/01.olq.0000162360.11910.5a; Yoshikawa H, 2004, AIDS EDUC PREV, V16, P84, DOI 10.1521/aeap.16.1.84.27719; Zhang S, 2000, J CHINA AIDS STD, V6, P344; Zhong L, 2011, THESIS ANHUI MED U	53	9	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113794	10.1371/journal.pone.0113794	http://dx.doi.org/10.1371/journal.pone.0113794			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7SK	25436910	Green Published, gold, Green Submitted			2022-12-26	WOS:000347114900080
J	Garcia, JC; Posada-Suarez, H; Laderach, P				Garcia L, Juan Carlos; Posada-Suarez, Huver; Laederach, Peter			Recommendations for the Regionalizing of Coffee Cultivation in Colombia: A Methodological Proposal Based on Agro-Climatic Indices	PLOS ONE			English	Article							MODELS; RADIATION; CANADA	The Colombian National Federation of Coffee Growers (FNC) conducted an agro-ecological zoning study based on climate, soil, and terrain of the Colombian coffee-growing regions (CCGR) located in the tropics, between 1 degrees and 11.5 degrees N, in areas of complex topography. To support this study, a climate baseline was constructed at a spatial resolution of 5 km. Twenty-one bioclimatic indicators were drawn from this baseline data and from yield data for different coffee genotypes evaluated under conditions at eight experimental stations (ESs) belonging to the National Center for Coffee Research (CENICAFE). Three topographic indicators were obtained from a digital elevation model (DEM). Zoning at a national level resulted in the differentiation of 12 agro-climatic zones. Altitude notably influenced zone differentiation, however other factors such as large air currents, low-pressure atmospheric systems, valleys of the great rivers, and physiography also played an important role. The strategy of zoning according to coffee-growing conditions will enable areas with the greatest potential for the development of coffee cultivation to be identified, criteria for future research to be generated, and the level of technology implementation to be assessed.	[Garcia L, Juan Carlos] Natl Ctr Coffee Res CENICAFE, Prod & Prod Program, Manizales, Colombia; [Garcia L, Juan Carlos] Univ Caldas, Agr Sci Fac, Manizales, Colombia; [Posada-Suarez, Huver] Natl Federat Coffee Growers Colombia FNC, Tech Div, Bogota, Colombia; [Laederach, Peter] Int Ctr Trop Agr CIAT, Decis & Policy Anal DAPA, Cali, Colombia	Universidad de Caldas; Alliance; International Center for Tropical Agriculture - CIAT	Garcia, JC (corresponding author), Natl Ctr Coffee Res CENICAFE, Prod & Prod Program, Manizales, Colombia.	juan.garcia@cafedecolombia.com.co		Laderach, Peter/0000-0001-8708-6318	Colombian National Federation of Coffee Growers (FNC)	Colombian National Federation of Coffee Growers (FNC)	The Colombian National Federation of Coffee Growers (FNC, its Spanish acronym) funded Juan Carlos Garcia L.'s doctoral program. The FNC provided the information used in the development of the thesis, as research outcome data, the coffee weather information network, and the coffee information system (SICA (R), its Spanish acronym), which is related to the characterization of coffee farms. The base information used by Juan Carlos Garcia L. as part of his doctoral thesis was restricted to the scope thereof and the results generated from this will be public, with priority use for the Colombian coffee growers. The salary of researchers Huver Posada and Juan Carlos Garcia L. is in charge of the FNC. The salary of Peter Laderach and the logistics of the seven months internship conducted by Juan Carlos Garcia L. was assumed by CIAT (Centro Internacional de Agricultura Tropical). The donors had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arcila J, 2001, APLICACION ESCALA BB, P32; Arcila J, 1993, AVANCE TECNICOS CENI, V193, P1; Arcila-Pulgarin J., 2007, SISTEMAS PRODUCCION, P61; Arcila-Pulgarin J., 2003, AVANCES TECNICOS CEN, V311, P1; Baldion J, 1992, ESTUDIO AGROCLIMATIC; CAMARGO M. B. P., 2007, INFORM AGROPECUARIO, V28, P58; Camayo-Velez GC, 2003, REV CENICAFE, V54, P35; Cano C.G., 2012, BORRADORES EC, V7, P1; Caramori P. H., 2007, Informe Agropecuario, V28, P66; Carbonell J, 2011, ZONIFICACION AGROECO, P119; Carvalho HD, 2011, REV BRAS ENG AGR AMB, V15, P601, DOI 10.1590/S1415-43662011000600010; Chessel D., 2012, ANAL ECOLOGICAL DATA; Cock J, 2011, AGR SYST, V104, P755, DOI 10.1016/j.agsy.2011.07.001; Diaz L, 2007, ESTADISTICA MUTIVARI; Dimitriadou E, 2012, CONVEX CLUSTERING ME; Farfan F, 2013, ESTABLECIMIENTO SIST, P44; Federacion Nacional de Cafeteros de Colombia (FNC), 2012, 77 C NAC CAF 2012; Florez C, 2013, ESTRUCTURA FUNCIONAM, P123; Gomez L, 1995, REV CENICAFE, V46, P205; Gomez L, 1991, ECOTOPOS CAFETEROS C, P131; Guzman M.O., 1984, CENICAFE COLOMBIA, V35, P57; Hijmans R, 2010, INRO RASTER PACKAGE; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hurtado G, 1988, CARACTERIZACION AGRO; Hutchinson M, 2006, ANUSPLIN VERSION 4 3, P54; Hutchinson M.F., 1998, J GEOGR INF DECIS AN, V2, P139; Hutchinson MF, 2009, J APPL METEOROL CLIM, V48, P725, DOI 10.1175/2008JAMC1979.1; Jaramillo, 2009, AVANCES TECNICOS CE, V379, P1; Jaramillo A, 2011, AVANCE TECNICOS CENI, V411, P1; Jaramillo A, 2009, AVANCES TECNICOS CEN, V390, P1; Jaramillo A, 2005, CLIMA ANDINO CAFE CO; Jaramillo A, 1982, REV CENICAFE, V33, P15; Jaramillo A, 2002, DESARROLLO APLICACIO; Jaramillo A, 1996, AVANCE TECNICOS CENI, V229; Jaramillo-Robledo A., 2009, AVANCES TECNICOS CEN, V389, P1; Laderach P., 2012, ESCENARIOS IMPACTO C; Leibovich J, 2008, ENSAYOS EC CAFETERA, V21, P67; Liao TW, 2005, PATTERN RECOGN, V38, P1857, DOI 10.1016/j.patcog.2005.01.025; Pezzopane JRM, 2008, CIENC AGROTEC, V32, P1781, DOI 10.1590/S1413-70542008000600016; Malagon D, 1995, FACTORES BIOCLIMATIC, P221; McKenney DW, 2006, AGR FOREST METEOROL, V138, P69, DOI 10.1016/j.agrformet.2006.03.012; Meireles E. J. L., 2007, Informe Agropecuario, V28, P50; Meza F, 2000, AGR FOREST METEOROL, V100, P231, DOI 10.1016/S0168-1923(99)00090-8; Niekerk A, 2011, WATER SA, V37; Nunes Fabiana Lataro, 2010, Bragantia, V69, P1011, DOI 10.1590/S0006-87052010000400029; Oberthur T, 2011, FOOD POLICY, V36, P783, DOI 10.1016/j.foodpol.2011.07.005; OVALLE O., 2011, CAFE MESOAMERICANO D; Palmer W.C., 1965, METEOROLOGICAL DROUG; Pena Daniel, 2002, ANAL DATOS MULTIVARI; Ramirez J., 2010, DOWNSCALING GLOBAL C; Ramirez V, 2013, ESTABLECIMIENTO CAFE, P28; Ramirez V, 2013, GESTION RIESGO AGROC, P91; Ramirez V, 2010, REV CENICAFE, V61, P132; Reuter HI, 2007, INT J GEOGR INF SCI, V21, P983, DOI 10.1080/13658810601169899; Reymondin L, 2011, NEAR REAL TIME PAN T; Rivington M, 2005, AGR FOREST METEOROL, V132, P228, DOI 10.1016/j.agrformet.2005.07.013; Rivington M, 2002, P INT ENV MOD SOFTW, V3, P193; Sadeghian S, 2013, NUTR CAFETALES MANUA, P85; Salazar L, 2013, MANEJO INTEGRADO ARV, P117; Salazar L, 2013, CONSERVACION SUELOS, P287; Santos Marco Antonio dos, 2006, Bragantia, V65, P173; Silva F, 2000, DELIMITACAO AREAS AP, P123; Suarez S, 2000, CARACTERISTICAS FISI; Team RDC, 2019, R LANG ENV STAT COMP; Trojer H, 1959, REV CENICAFE, V10, P287; Trojer H, 1954, REV CENICAFE, V5, P22; Trojer H., 1968, P READ S UNESCO PAR, P107; UPME I. D. E. A. M, 2005, ATL RAD SOL COL	68	13	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113510	10.1371/journal.pone.0113510	http://dx.doi.org/10.1371/journal.pone.0113510			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436456	Green Submitted, Green Published, gold			2022-12-26	WOS:000347114900047
J	Beutner, G; Eliseev, RA; Porter, GA				Beutner, Gisela; Eliseev, Roman A.; Porter, George A., Jr.			Initiation of Electron Transport Chain Activity in the Embryonic Heart Coincides with the Activation of Mitochondrial Complex 1 and the Formation of Supercomplexes	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; CYTOCHROME-C-OXIDASE; IN-VIVO; OXIDATIVE-PHOSPHORYLATION; RESPIRATORY-CHAIN; FUNCTIONAL ASSAYS; CELL-DEATH; PROTEIN; DIFFERENTIATION; METABOLISM	Mitochondria provide energy in form of ATP in eukaryotic cells. However, it is not known when, during embryonic cardiac development, mitochondria become able to fulfill this function. To assess this, we measured mitochondrial oxygen consumption and the activity of the complexes (Cx) 1 and 2 of the electron transport chain (ETC) and used immunoprecipitation to follow the generation of mitochondrial supercomplexes. We show that in the heart of mouse embryos at embryonic day (E) 9.5, mitochondrial ETC activity and oxidative phosphorylation (OXPHOS) are not coupled, even though the complexes are present. We show that Cx-1 of the ETC is able to accept electrons from the Krebs cycle, but enzyme assays that specifically measure electron flow to ubiquinone or Cx-3 show no activity at this early embryonic stage. At E11.5, mitochondria appear functionally more mature; ETC activity and OXPHOS are coupled and respond to ETC inhibitors. In addition, the assembly of highly efficient respiratory supercomplexes containing Cx-1, -3, and -4, ubiquinone, and cytochrome c begins at E11.5, the exact time when Cx-1 becomes functional activated. At E13.5, ETC activity and OXPHOS of embryonic heart mitochondria are indistinguishable from adult mitochondria. In summary, our data suggest that between E9.5 and E11.5 dramatic changes occur in the mitochondria of the embryonic heart, which result in an increase in OXPHOS due to the activation of complex 1 and the formation of supercomplexes.	[Beutner, Gisela; Porter, George A., Jr.] Univ Rochester, Med Ctr, Dept Pediat, Div Cardiol, Rochester, NY 14642 USA; [Eliseev, Roman A.] Univ Rochester, Ctr Musculoskeletal Res, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Porter, GA (corresponding author), Univ Rochester, Med Ctr, Dept Pediat, Div Cardiol, 601 Elmwood Ave,Box 631, Rochester, NY 14642 USA.	george_porter@urmc.rochester.edu	George A, Porter/E-7315-2013	George A, Porter/0000-0003-0726-9988	American Heart Association [12GRNT12060233]; National Institutes of Health (NIH) grant (National Institute of Arthritis and Musculoskeletal and Skin Diseases) [5K01 AR064610]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042, KL2TR000095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR064610] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health (NIH) grant (National Institute of Arthritis and Musculoskeletal and Skin Diseases); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	GP is supported by American Heart Association Founder's Affiliate (12GRNT12060233). RE is supported by a National Institutes of Health (NIH) grant (National Institute of Arthritis and Musculoskeletal and Skin Diseases) award number 5K01 AR064610.	Acin-Perez R, 2014, BBA-BIOENERGETICS, V1837, P444, DOI 10.1016/j.bbabio.2013.12.009; Acin-Perez R, 2008, MOL CELL, V32, P529, DOI 10.1016/j.molcel.2008.10.021; Alavian KN, 2014, P NATL ACAD IN PRESS; Ascuitto RJ, 1996, SEMIN PERINATOL, V20, P542, DOI 10.1016/S0146-0005(96)80068-1; Babot M, 2014, BIOCH BIOPHYS ACTA; Babot M, 2014, BBA-BIOENERGETICS, V1837, P929, DOI 10.1016/j.bbabio.2014.02.013; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Baker CN, 2013, OA BIOTECHNOLOGY, V2; Beutner G, 2005, BBA-BIOMEMBRANES, V1717, P1, DOI 10.1016/j.bbamem.2005.09.016; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Bushdid PB, 2003, CIRC RES, V92, P1305, DOI 10.1161/01.RES.0000077045.84609.9F; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; COX SJ, 1972, J EMBRYOL EXP MORPH, V28, P235; Dahout-Gonzalez C, 2006, PHYSIOLOGY, V21, P242, DOI 10.1152/physiol.00005.2006; Devlin TM, 1997, TXB BIOCH CLIN CORRE; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; Esposti MD, 2001, METHOD CELL BIOL, V65, P75; Folmes CDL, 2012, CIRC RES, V110, P526, DOI 10.1161/RES.0b013e31824ae5c1; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Galkin A, 2009, J BIOL CHEM, V284, P36055, DOI 10.1074/jbc.M109.054346; Genova ML, 2014, BBA-BIOENERGETICS, V1837, P427, DOI 10.1016/j.bbabio.2013.11.002; Halestrap AP, 2009, BBA-BIOENERGETICS, V1787, P1402, DOI 10.1016/j.bbabio.2008.12.017; Haworth RA, 2000, J BIOENERG BIOMEMBR, V32, P91, DOI 10.1023/A:1005568630151; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Hom JR, 2011, DEV CELL, V21, P469, DOI 10.1016/j.devcel.2011.08.008; Huang GC, 2004, MOL CELL BIOL, V24, P8447, DOI 10.1128/MCB.24.19.8447-8456.2004; Huang TT, 2006, HUM MOL GENET, V15, P1187, DOI 10.1093/hmg/ddl034; Ingraham CA, 2009, MITOCHONDRION, V9, P204, DOI 10.1016/j.mito.2009.02.001; Koushik SV, 2001, FASEB J, V15, P1209, DOI 10.1096/fj.00-0696fje; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lapuente-Brun E, 2013, SCIENCE, V340, P1567, DOI 10.1126/science.1230381; Lenaz G, 2006, BBA-BIOENERGETICS, V1757, P1406, DOI 10.1016/j.bbabio.2006.05.007; Lopaschuk GD, 2010, J CARDIOVASC PHARM, V56, P130, DOI 10.1097/FJC.0b013e3181e74a14; Marzo I, 1998, J EXP MED, V187, P1261, DOI 10.1084/jem.187.8.1261; Mimaki M, 2012, BBA-BIOENERGETICS, V1817, P851, DOI 10.1016/j.bbabio.2011.08.010; Moreno-Lastres D, 2012, CELL METAB, V15, P324, DOI 10.1016/j.cmet.2012.01.015; Nicholls DG, 2013, BIONENERGETIS, V4, P60; Owen OE, 2002, J BIOL CHEM, V277, P30409, DOI 10.1074/jbc.R200006200; Porter GA, 2011, PROG PEDIATR CARDIOL, V31, P75, DOI 10.1016/j.ppedcard.2011.02.002; Reisch AS, 2007, METHOD CELL BIOL, V80, P199, DOI 10.1016/S0091-679X(06)80010-5; Ruiz-Lozano P, 1998, DEVELOPMENT, V125, P533; Saks V, 2010, BBA-BIOENERGETICS, V1797, P678, DOI 10.1016/j.bbabio.2010.01.011; SCALETTAR BA, 1991, P NATL ACAD SCI USA, V88, P8057, DOI 10.1073/pnas.88.18.8057; Sokolova N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083214; Stroud DA, 2013, J BIOL CHEM, V288, P1685, DOI 10.1074/jbc.C112.436766; Villani G, 1998, J BIOL CHEM, V273, P31829, DOI 10.1074/jbc.273.48.31829; Villani G, 2001, METHOD CELL BIOL, V65, P119, DOI 10.1016/S0091-679X(01)65007-6; Wittig I, 2007, ELECTROPHORESIS, V28, P3811, DOI 10.1002/elps.200700367; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2006, BBA-BIOENERGETICS, V1757, P1066, DOI 10.1016/j.bbabio.2006.05.006	51	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113330	10.1371/journal.pone.0113330	http://dx.doi.org/10.1371/journal.pone.0113330			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427064	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400043
J	Dillenburg-Pilla, P; Patel, V; Mikelis, CM; Zarate-Blades, CR; Doci, CL; Amornphimoltham, P; Wang, ZY; Martin, D; Leelahavanichkul, K; Dorsam, RT; Masedunskas, A; Weigert, R; Molinolo, AA; Gutkind, JS				Dillenburg-Pilla, Patricia; Patel, Vyomesh; Mikelis, Constantinos M.; Zarate-Blades, Carlos Rodrigo; Doci, Colleen L.; Amornphimoltham, Panomwat; Wang, Zhiyong; Martin, Daniel; Leelahavanichkul, Kantima; Dorsam, Robert T.; Masedunskas, Andrius; Weigert, Roberto; Molinolo, Alfredo A.; Gutkind, J. Silvio			SDF-1/CXCL12 induces directional cell migration and spontaneous metastasis via a CXCR4/G alpha i/mTORC1 axis	FASEB JOURNAL			English	Article						mTOR; rapamycin; cancer; lymphangiogenesis; chemotaxis	MAMMALIAN TARGET; BREAST-CANCER; RAPID MOBILIZATION; CHEMOKINE RECEPTORS; HEMATOPOIETIC STEM; KINASE INHIBITOR; CXCR4 ANTAGONIST; PROGENITOR CELLS; KAPOSIS-SARCOMA; MTOR INHIBITION	Multiple human malignancies rely on C-X-C motif chemokine receptor type 4 (CXCR4) and its ligand, SDF-1/CXCL12 (stroma cell-derived factor 1/C-X-C motif chemokine 12), to metastasize. CXCR4 inhibitors promote the mobilization of bone marrow stem cells, limiting their clinical application for metastasis prevention. We investigated the CXCR4-initiated signaling circuitry to identify new potential therapeutic targets. We used HeLa human cancer cells expressing high levels of CXCR4 endogenously. We found that CXCL12 promotes their migration in Boyden chamber assays and single cell tracking. CXCL12 activated mTOR (mechanistic target of rapamycin) potently in a pertussis-sensitive fashion. Inhibition of mTOR complex 1 (mTORC1) by rapamycin [drug concentration causing 50% inhibition (IC50) = 5 nM] and mTORC1/mTORC2 by Torin2 (IC50 = 6 nM), or by knocking downkey mTORC1/2 components, Raptor and Rictor, respectively, decreased directional cell migration toward CXCL12. We developed a CXCR4-mediated spontaneous metastasis model by implanting HeLa cells in the tongue of SCID-NOD mice, in which 80% of the animals develop lymph node metastasis. It is surprising that mTORC1 disruption by Raptor knockdown was sufficient to reduce tumor growth by 60% and spontaneous metastasis by 72%, which were nearly abolished by rapamycin. In contrast, disrupting mTORC2 had no effect in tumor growth or metastasis compared with control short hairpin RNAs. These data suggest that mTORC1 may represent a suitable therapeutic target in human malignancies using CXCR4 for their metastatic spread.	[Dillenburg-Pilla, Patricia; Patel, Vyomesh; Mikelis, Constantinos M.; Doci, Colleen L.; Amornphimoltham, Panomwat; Wang, Zhiyong; Martin, Daniel; Leelahavanichkul, Kantima; Dorsam, Robert T.; Masedunskas, Andrius; Weigert, Roberto; Molinolo, Alfredo A.; Gutkind, J. Silvio] Natl Inst Dent & Craniofacial Research, Oral & Pharyngeal Canc Branch, Bethesda, MD 20892 USA; [Zarate-Blades, Carlos Rodrigo] US Natl Inst Hlth, Immunol Lab, NEI, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI)	Gutkind, JS (corresponding author), Natl Inst Dent & Craniofacial Research, NIH, 30 Convent Dr,Bldg 30,Room 320, Bethesda, MD 20892 USA.	sg39v@nih.gov	Mikelis, Constantinos/AGF-9423-2022; Gutkind, J. Silvio/J-1201-2016; Zárate-Bladés, Carlos R/C-9663-2015; Doci, Colleen L/M-4389-2015; Amornphimoltham, Walt/AAP-9654-2020	Gutkind, J. Silvio/0000-0002-5150-4482; Zárate-Bladés, Carlos R/0000-0002-7728-7869; Martin Izquierdo, Daniel/0000-0002-8880-9087	Intramural Research Program of U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000717, ZIADE000551] Funding Source: NIH RePORTER	Intramural Research Program of U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by the Intramural Research Program of U.S. National Institutes of Health, National Institute of Dental and Craniofacial Research. The authors apologize to all of their colleagues for not citing some of their original studies as a result of space limitations.	Amornphimoltham P, 2013, CLIN CANCER RES, V19, P1375, DOI 10.1158/1078-0432.CCR-12-2858; Atkins MB, 2004, J CLIN ONCOL, V22, P909, DOI 10.1200/JCO.2004.08.185; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Chen G, 2012, J BIOL CHEM, V287, P12132, DOI 10.1074/jbc.M111.302299; Cristofalo VJ, 1998, P NATL ACAD SCI USA, V95, P10614, DOI 10.1073/pnas.95.18.10614; Dancey J, 2010, NAT REV CLIN ONCOL, V7, P209, DOI 10.1038/nrclinonc.2010.21; Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002; Darash-Yahana M, 2004, FASEB J, V18, P1240, DOI 10.1096/fj.03-0935fje; Devine SM, 2004, J CLIN ONCOL, V22, P1095, DOI 10.1200/JCO.2004.07.131; Devine SM, 2008, BLOOD, V112, P990, DOI 10.1182/blood-2007-12-130179; Duenne AA, 2000, RECENT RES CANCER, V157, P82; Dutt P, 1998, J IMMUNOL, V161, P3652; Eckhardt BL, 2012, NAT REV DRUG DISCOV, V11, P479, DOI 10.1038/nrd2372; Gan XQ, 2012, NAT CELL BIOL, V14, P686, DOI 10.1038/ncb2507; Garcia-Garcia C, 2012, CLIN CANCER RES, V18, P2603, DOI 10.1158/1078-0432.CCR-11-2750; Hernandez-Negrete I, 2007, J BIOL CHEM, V282, P23708, DOI 10.1074/jbc.M703771200; Iglesias-Bartolome R, 2012, CELL STEM CELL, V11, P401, DOI 10.1016/j.stem.2012.06.007; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Janes MR, 2013, LEUKEMIA, V27, P586, DOI 10.1038/leu.2012.276; KEMPHUES KJ, 1988, CELL, V52, P311, DOI 10.1016/S0092-8674(88)80024-2; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim EK, 2011, ONCOGENE, V30, P2954, DOI 10.1038/onc.2011.22; Kumar V, 2014, ROBBINS COTRAN PATHO; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liu L, 2010, J BIOL CHEM, V285, P38362, DOI 10.1074/jbc.M110.141168; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; Liu QS, 2011, J MED CHEM, V54, P1473, DOI 10.1021/jm101520v; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; Mo W, 2013, CELL, V152, P1077, DOI 10.1016/j.cell.2013.01.053; Molinolo AA, 2012, CLIN CANCER RES, V18, P2558, DOI 10.1158/1078-0432.CCR-11-2824; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Narita M, 2011, SCIENCE, V332, P966, DOI 10.1126/science.1205407; Patel V, 2011, CANCER RES, V71, P7103, DOI 10.1158/0008-5472.CAN-10-3192; Plas DR, 2009, CURR OPIN CELL BIOL, V21, P230, DOI 10.1016/j.ceb.2008.12.013; Posch C, 2013, P NATL ACAD SCI USA, V110, P4015, DOI 10.1073/pnas.1216013110; Pusic I, 2010, CURR OPIN HEMATOL, V17, P319, DOI 10.1097/MOH.0b013e328338b7d5; Rosenbluth JM, 2011, P NATL ACAD SCI USA, V108, P2076, DOI 10.1073/pnas.1011936108; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Schrader AJ, 2002, BRIT J CANCER, V86, P1250, DOI 10.1038/sj.bjc.6600221; Sosa MS, 2010, MOL CELL, V40, P877, DOI 10.1016/j.molcel.2010.11.029; Sotsios Y, 1999, J IMMUNOL, V163, P5954; Stallone G, 2005, NEW ENGL J MED, V352, P1317, DOI 10.1056/NEJMoa042831; Stallone G, 2008, TRANSPL INT, V21, P825, DOI 10.1111/j.1432-2277.2008.00697.x; Wingo SN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005137; Yagi H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002221; Yanagiya A, 2012, MOL CELL, V46, P847, DOI 10.1016/j.molcel.2012.04.004; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhou Y, 2002, J BIOL CHEM, V277, P49481, DOI 10.1074/jbc.M206222200; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008; Zlotnik A, 2011, NAT REV IMMUNOL, V11, P597, DOI 10.1038/nri3049; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	54	49	51	0	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					1056	1068		10.1096/fj.14-260083	http://dx.doi.org/10.1096/fj.14-260083			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25466898	Green Published			2022-12-26	WOS:000350633000029
J	Zhang, BH; Denomme, MM; White, CR; Leung, KY; Lee, MB; Greene, NDE; Mann, MRW; Trasler, JM; Baltz, JM				Zhang, Baohua; Denomme, Michelle M.; White, Carlee R.; Leung, Kit-Yi; Lee, Martin B.; Greene, Nicholas D. E.; Mann, Mellissa R. W.; Trasler, Jacquetta M.; Baltz, Jay M.			Both the folate cycle and betaine-homocysteine methyltransferase contribute methyl groups for DNA methylation in mouse blastocysts	FASEB JOURNAL			English	Article						embryo; epigenetics; inner cell mass; methionine; S-adenosylmethionine	ONE-CARBON METABOLISM; PREIMPLANTATION EMBRYO DEVELOPMENT; METHYLENETETRAHYDROFOLATE REDUCTASE; S-ADENOSYLMETHIONINE; METHOTREXATE; MAINTENANCE; TRANSPORT; CULTURE; MICE; EXPRESSION	The embryonic pattern of global DNA methylation is first established in the inner cellmass (ICM) of the mouse blastocyst. The methyl donor S-adenosylmethionine (SAM) is produced inmost cells through the folate cycle, but only a few cell types generate SAM from betaine (N,N,N-trimethylglycine) via betaine-homocysteine methyltransferase (BHMT), which is expressed in the mouse ICM. Here, mean ICM cell numbers decreased from 18-19 in controls to 11-13 when the folate cycle was inhibited by the antifolate methotrexate and to 12-14 when BHMT expression was knocked down by antisense morpholinos. Inhibiting both pathways, however, much more severely affected ICM development (7-8 cells). Total SAMlevels in mouse blastocysts decreased significantly only when both pathways were inhibited (from 3.1 to 1.6 pmol/100 blastocysts). DNA methylation, detected as 5-methylcytosine (5-MeC) immunofluorescence in isolated ICMs, was minimally affected by inhibition of either pathway alone but decreased by at least 45-55% when both BHMT and the folate cycle were inhibited simultaneously. Effects on cell numbers and 5-MeC levels in the ICM were completely rescued by methionine (immediate SAM precursor) or SAM. Both the folate cycle and betaine/BHMT appear to contribute to a methyl pool required for normal ICM development and establishing initial embryonic DNA methylation.	[Zhang, Baohua; Lee, Martin B.; Baltz, Jay M.] Ottawa Hosp, Res Inst, Ottawa, ON K1H 8L6, Canada; [Zhang, Baohua; Lee, Martin B.; Baltz, Jay M.] Univ Ottawa, Fac Med, Dept Obstet & Gynecol, Ottawa, ON, Canada; [Zhang, Baohua; Lee, Martin B.; Baltz, Jay M.] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Denomme, Michelle M.; White, Carlee R.; Mann, Mellissa R. W.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Obstet & Gynecol & Biochem, London, ON, Canada; [Denomme, Michelle M.; White, Carlee R.; Mann, Mellissa R. W.] Childrens Hlth Res Inst, London, ON, Canada; [Leung, Kit-Yi; Greene, Nicholas D. E.] UCL, Inst Child Hlth, Dev Biol & Canc Program, London, England; [Trasler, Jacquetta M.] McGill Univ, Montreal Childrens Hosp, Res Inst, Ctr Hlth, Montreal, PQ H3H 1P3, Canada; [Trasler, Jacquetta M.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Trasler, Jacquetta M.] McGill Univ, Dept Pediat, Montreal, PQ H3A 2T5, Canada; [Trasler, Jacquetta M.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa; Western University (University of Western Ontario); University of London; University College London; McGill University; McGill University; McGill University; McGill University	Baltz, JM (corresponding author), Ottawa Hosp, Res Inst, 501 Smyth Rd,Mailbox 411, Ottawa, ON K1H 8L6, Canada.	jbaltz@ohri.ca	Mann, Mellissa/L-9006-2015	Mann, Mellissa/0000-0002-8075-3824; Greene, Nicholas D.E./0000-0002-4170-5248; Baltz, Jay/0000-0002-9749-2480	Canadian Institutes of Health Research Operating Grant [MOP97972]; Lalor Foundation; CIHR Training Program in Reproduction, Early Development; Impact on Health [TGF96122]; Medical Research Council, London, United Kingdom [J003794]; Fonds de la Recherche du Quebec-Sante; Medical Research Council [MR/J003794/1] Funding Source: researchfish; MRC [MR/J003794/1] Funding Source: UKRI	Canadian Institutes of Health Research Operating Grant(Canadian Institutes of Health Research (CIHR)); Lalor Foundation; CIHR Training Program in Reproduction, Early Development; Impact on Health; Medical Research Council, London, United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Fonds de la Recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Canadian Institutes of Health Research Operating Grant MOP97972 (to J.M.B. and J.M.T.). B.Z. was partially supported by a Lalor Foundation postdoctoral fellowship. M.M.D. and C.R.W. were partially supported by CIHR Training Program in Reproduction, Early Development, and the Impact on Health (TGF96122) studentships and laboratory exchange visit awards. K.Y.L. and N.D.E.G. were supported by the Medical Research Council, London, United Kingdom (J003794). J.M.T. is a James McGill Professor at McGill University and a member of the Research Institute of the McGill University Health Centre, which is supported in part by the Fonds de la Recherche du Quebec-Sante.	ALLEGRA CJ, 1986, J BIOL CHEM, V261, P6478; Anas MKI, 2008, DEVELOPMENT, V135, P4123, DOI 10.1242/dev.026575; BARAM J, 1987, J CLIN INVEST, V79, P692, DOI 10.1172/JCI112872; BIGGERS JD, 1988, AM J PHYSIOL, V255, pC419, DOI 10.1152/ajpcell.1988.255.4.C419; Bolusani S, 2011, J BIOL CHEM, V286, P5166, DOI 10.1074/jbc.M110.196840; Burren KA, 2006, J CHROMATOGR B, V844, P112, DOI 10.1016/j.jchromb.2006.07.012; Chen ZT, 2001, HUM MOL GENET, V10, P433, DOI 10.1093/hmg/10.5.433; Cirio MC, 2008, DEV BIOL, V324, P139, DOI 10.1016/j.ydbio.2008.09.015; Delgado-Reyes CV, 2001, ARCH BIOCHEM BIOPHYS, V393, P184, DOI 10.1006/abbi.2001.2474; Denomme M. M., 2012, JOVE-J VIS EXP, V64, P4046; Denomme MM, 2012, REPRODUCTION, V144, P393, DOI 10.1530/REP-12-0237; Dobbs KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066230; Fiskerstrand T, 1997, J PHARMACOL EXP THER, V282, P1305; Fleming TP, 2004, BIOL REPROD, V71, P1046, DOI 10.1095/biolreprod.104.030957; Fowler B, 2001, KIDNEY INT, V59, pS221, DOI 10.1046/j.1523-1755.2001.07851.x; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; Garrow TA, 1996, J BIOL CHEM, V271, P22831, DOI 10.1074/jbc.271.37.22831; Guo HS, 2014, NATURE, V511, P606, DOI 10.1038/nature13544; Hewitson LC, 1996, MOL REPROD DEV, V43, P323, DOI 10.1002/(SICI)1098-2795(199603)43:3&lt;323::AID-MRD6&gt;3.0.CO;2-S; Hirasawa R, 2008, GENE DEV, V22, P1607, DOI 10.1101/gad.1667008; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Hudson QJ, 2010, HEREDITY, V105, P45, DOI 10.1038/hdy.2010.23; HUENNEKENS FM, 1994, ADV ENZYME REGUL, V34, P397, DOI 10.1016/0065-2571(94)90025-6; Ikeda S, 2012, J REPROD DEVELOP, V58, P91, DOI 10.1262/jrd.11-096H; Ikeda S, 2012, J REPROD DEVELOP, V58, P38, DOI 10.1262/jrd.2011-002; Ikeda S, 2010, J EXP ZOOL PART A, V313A, P129, DOI 10.1002/jez.581; Katz JE, 2003, MOL CELL PROTEOMICS, V2, P525, DOI 10.1074/mcp.M300037-MCP200; Kooistra M, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111146; Kurihara Y, 2008, DEV BIOL, V313, P335, DOI 10.1016/j.ydbio.2007.10.033; Kwong WY, 2010, REPRODUCTION, V139, P705, DOI 10.1530/REP-09-0517; LAWITTS JA, 1993, METHOD ENZYMOL, V225, P153; Lawrance AK, 2011, J INHERIT METAB DIS, V34, P147, DOI 10.1007/s10545-010-9127-1; Lee MB, 2012, J BIOL CHEM, V287, P33094, DOI 10.1074/jbc.M112.365478; Lu SC, 2000, INT J BIOCHEM CELL B, V32, P391, DOI 10.1016/S1357-2725(99)00139-9; Market-Velker BA, 2010, BIOL REPROD, V83, P938, DOI 10.1095/biolreprod.110.085480; MENEZO Y, 1989, LIFE SCI, V44, P1601, DOI 10.1016/0024-3205(89)90455-4; MILLER JGO, 1985, J EMBRYOL EXP MORPH, V89, P149; O'Neill C, 1998, HUM REPROD, V13, P1312, DOI 10.1093/humrep/13.5.1312; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Sakaue M, 2010, CURR BIOL, V20, P1452, DOI 10.1016/j.cub.2010.06.050; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Santos F, 2006, METH MOL B, V325, P129; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Shi LJ, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-59; Siddall LS, 2002, MOL REPROD DEV, V63, P413, DOI 10.1002/mrd.10202; Sinclair KD, 2007, THERIOGENOLOGY, V67, P43, DOI 10.1016/j.theriogenology.2006.09.017; Smith ZD, 2014, NATURE, V511, P611, DOI 10.1038/nature13581; Smith ZD, 2012, NATURE, V484, P339, DOI 10.1038/nature10960; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; Steegers-Theunissen RPM, 2013, HUM REPROD UPDATE, V19, P640, DOI 10.1093/humupd/dmt041; Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348; Thouas G. A., 2001, Reprod Biomed Online, V3, P25; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Velker BAM, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096602	56	29	32	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					1069	1079		10.1096/fj.14-261131	http://dx.doi.org/10.1096/fj.14-261131			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25466894				2022-12-26	WOS:000350633000030
J	Drew, BG; Hamidi, H; Zhou, ZQ; Villanueva, CJ; Krum, SA; Calkin, AC; Parks, BW; Ribas, V; Kalajian, NY; Phun, J; Daraei, P; Christofk, HR; Hewitt, SC; Korach, KS; Tontonoz, P; Lusis, AJ; Slamon, DJ; Hurvitz, SA; Hevener, AL				Drew, Brian G.; Hamidi, Habib; Zhou, Zhenqi; Villanueva, Claudio J.; Krum, Susan A.; Calkin, Anna C.; Parks, Brian W.; Ribas, Vicent; Kalajian, Nareg Y.; Phun, Jennifer; Daraei, Pedram; Christofk, Heather R.; Hewitt, Sylvia C.; Korach, Kenneth S.; Tontonoz, Peter; Lusis, Aldons J.; Slamon, Dennis J.; Hurvitz, Sara A.; Hevener, Andrea L.			Estrogen Receptor (ER)alpha-regulated Lipocalin 2 Expression in Adipose Tissue Links Obesity with Breast Cancer Progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; ALPHA GENE; METABOLIC SYNDROME; LUNG METASTASIS; INFLAMMATION; CELLS; MICE; FAT; ADIPOCYTES; BINDING	Obesity is associated with increased breast cancer (BrCA) incidence. Considering that inactivation of estrogen receptor (ER)alpha promotes obesity and metabolic dysfunction in women and female mice, understanding the mechanisms and tissue-specific sites of ER alpha action to combat metabolic-related disease, including BrCA, is of clinical importance. To study the role of ERa in adipose tissue we generated fat-specific ERa knock-out (FERKO) 'mice. Herein we show that ERa deletion increased adipocyte size, fat pad weight, and tissue expression and circulating levels of the secreted glycoprotein, lipocalin 2 (Lcn2), an adipokine previously associated with BrCA development. Chromatin immunoprecipitation and luciferase reporter studies showed that ER alpha binds the Lcn2 promoter to repress its expression. Because adipocytes constitute an important cell type of the breast microenvironment, we examined the impact of adipocyte ERa deletion on cancer cell behavior. Conditioned medium from ER alpha-null adipocytes and medium containing pure Lcn2 increased proliferation and migration of a subset of BrCA cells in culture. The proliferative and promigratory effects of ER alpha-deficient adipocyte-conditioned medium on BrCA cells was reversed by Lcn2 deletion. BrCA cell responsiveness to exogenous Lcn2 was heightened in cell types where endogenous Lcn2 expression was minimal, but components of the Lcn2 signaling pathway were enriched, i.e. SLC22A17 and 3 -hydroxybutyrate dehydrogenase (BDH2). In breast tumor biopsies from women diagnosed with BrCA we found that BDH2 expression was positively associated with adiposity and circulating Lcn2 levels. Collectively these data suggest that reduction of ERa expression in adipose tissue promotes adiposity and is linked with the progression and severity of BrCA via increased adipocyte-specific Lcn2 production and enhanced tumor cell Lcn2 sensitivity.	[Drew, Brian G.; Zhou, Zhenqi; Ribas, Vicent; Kalajian, Nareg Y.; Phun, Jennifer; Daraei, Pedram; Hevener, Andrea L.] Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, Dept Med, Los Angeles, CA 90095 USA; [Hamidi, Habib; Slamon, Dennis J.; Hurvitz, Sara A.] Univ Calif Los Angeles, Div Hematol Oncol, Los Angeles, CA 90095 USA; [Hamidi, Habib; Christofk, Heather R.; Slamon, Dennis J.; Hurvitz, Sara A.; Hevener, Andrea L.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Villanueva, Claudio J.; Calkin, Anna C.; Tontonoz, Peter] Univ Calif Los Angeles, Howard Hughes Med Inst, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Krum, Susan A.] Univ Calif Los Angeles, Dept Orthopaed Surg, Orthopaed Hosp, Los Angeles, CA 90095 USA; [Krum, Susan A.] Univ Calif Los Angeles, Orthopaed Hosp, Res Ctr, Los Angeles, CA 90095 USA; [Parks, Brian W.; Lusis, Aldons J.] Univ Calif Los Angeles, Dept Human Genet, Los Angeles, CA 90095 USA; [Christofk, Heather R.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Hewitt, Sylvia C.; Korach, Kenneth S.] NIEHS, Receptor Biol Sect, Reprod & Dev Biol Lab, NIH, Res Triangle Pk, NC 27709 USA; [Slamon, Dennis J.; Hurvitz, Sara A.] Translat Res Oncol US, Los Angeles, CA 90095 USA; [Hevener, Andrea L.] Iiris Cantor UCLA Womens Hlth Ctr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Hevener, AL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Div Endocrinol Diabet & Hypertens, 900 Vet Ave,Warren Hall Suite 24-130, Los Angeles, CA 90095 USA.	ahevener@mednet.ucla.edu	Krum, Susan A./D-7282-2013; Hamidi, Habib/H-8030-2016; Ribas, Vicent/K-1390-2014; Hewitt, Sylvia/W-8752-2019	Krum, Susan A./0000-0002-6414-6397; Hamidi, Habib/0000-0003-0196-9852; Ribas, Vicent/0000-0003-3380-2256; Hewitt, Sylvia/0000-0001-7713-0805; Christofk, Heather/0000-0002-8662-4425; Korach, Kenneth/0000-0002-7765-418X; Calkin, Anna/0000-0002-9861-0602; Villanueva, Claudio/0000-0002-9731-7463	UCLA Jonsson Comprehensive Cancer Center; UCLA Iris Cantor Women's Health Foundation; UCSD-UCLA Diabetes Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007228] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL123021, P01HL090553, K99HL123021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, K01DK060484, R21DK073227, P30DK041301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES070065, ZIAES070065] Funding Source: NIH RePORTER	UCLA Jonsson Comprehensive Cancer Center; UCLA Iris Cantor Women's Health Foundation; UCSD-UCLA Diabetes Research Center; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We are grateful for the continued support of our research from the UCLA Jonsson Comprehensive Cancer Center, the UCLA Iris Cantor Women's Health Foundation, and the UCSD-UCLA Diabetes Research Center. Intellectual contributions by Richard Finn, Jerrold Olefsky, Ronald Evans, Hussy Cohen, and Chris Glass were also helpful in advancing this research. We are grateful for the technical support from Rima Boyadjian (UCLA Inflammation Core), the UCLA Tissue Procurement and Histology Core, and the UCSD Moores Cancer Center Histology and Immunohistochemistry Shared Resource directed by Nissi Varki.	Ahlbory-Dieker DL, 2009, MOL ENDOCRINOL, V23, P1544, DOI 10.1210/me.2009-0045; Bauer M, 2008, BREAST CANCER RES TR, V108, P389, DOI 10.1007/s10549-007-9619-3; Berger T, 2010, P NATL ACAD SCI USA, V107, P2995, DOI 10.1073/pnas.1000101107; Boruk M, 1998, MOL ENDOCRINOL, V12, P1749, DOI 10.1210/me.12.11.1749; Bryzgalova G, 2006, DIABETOLOGIA, V49, P588, DOI 10.1007/s00125-005-0105-3; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Carr MC, 2003, J CLIN ENDOCR METAB, V88, P2404, DOI 10.1210/jc.2003-030242; Carter JC, 2012, EXP MOL PATHOL, V92, P312, DOI 10.1016/j.yexmp.2012.03.005; Chakraborty S, 2012, BBA-REV CANCER, V1826, P129, DOI 10.1016/j.bbcan.2012.03.008; Dahlman I, 2008, PHARMACOGENET GENOM, V18, P967, DOI 10.1097/FPC.0b013e32831101ef; Devireddy LR, 2010, CELL, V141, P1006, DOI 10.1016/j.cell.2010.04.040; Devireddy LR, 2005, CELL, V123, P1293, DOI 10.1016/j.cell.2005.10.027; Dirat B, 2011, CANCER RES, V71, P2455, DOI 10.1158/0008-5472.CAN-10-3323; Fernandez CA, 2005, CLIN CANCER RES, V11, P5390, DOI 10.1158/1078-0432.CCR-04-2391; Harima S, 2013, HEPATO-GASTROENTEROL, V60, P733, DOI 10.5754/hge12895; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hewitt SC, 2014, MOL ENDOCRINOL, V28, P899, DOI 10.1210/me.2014-1051; Hewitt SC, 2010, FASEB J, V24, P4660, DOI 10.1096/fj.10-163428; Hewitt SC, 2010, J BIOL CHEM, V285, P2676, DOI 10.1074/jbc.M109.043471; Hurvitz SA, 2010, CLIN BREAST CANCER, V10, P307, DOI 10.3816/CBC.2010.n.040; Iyengar P, 2003, ONCOGENE, V22, P6408, DOI 10.1038/sj.onc.1206737; Jiralerspong S, 2013, ANN ONCOL, V24, P2506, DOI 10.1093/annonc/mdt224; Lee YH, 2010, ATHEROSCLEROSIS, V213, P592, DOI 10.1016/j.atherosclerosis.2010.09.012; Leng XH, 2011, J CELL PHYSIOL, V226, P309, DOI 10.1002/jcp.22403; Leng XH, 2009, CANCER RES, V69, P8579, DOI 10.1158/0008-5472.CAN-09-1934; Maccio A, 2009, OBES REV, V10, P660, DOI 10.1111/j.1467-789X.2009.00592.x; Murray D, 2008, BRIT J CANCER, V99, P1322, DOI 10.1038/sj.bjc.6604688; NECHAD M, 1983, EXP CELL RES, V149, P119, DOI 10.1016/0014-4827(83)90385-3; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nilsson M, 2007, INT J OBESITY, V31, P900, DOI 10.1038/sj.ijo.0803528; Okura T, 2003, INT J OBESITY, V27, P1020, DOI 10.1038/sj.ijo.0802378; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Panidis D, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-151; Park J, 2012, J CLIN INVEST, V122, P4243, DOI 10.1172/JCI63930; Park J, 2011, ENDOCR REV, V32, P550, DOI 10.1210/er.2010-0030; Park J, 2011, ENDOCR-RELAT CANCER, V18, pC25, DOI 10.1530/ERC-11-0163; Parks BW, 2013, CELL METAB, V17, P141, DOI 10.1016/j.cmet.2012.12.007; Reimann M, 2006, CLIMACTERIC, V9, P215, DOI 10.1080/13697130600733758; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Ribas V, 2011, P NATL ACAD SCI USA, V108, P16457, DOI 10.1073/pnas.1104533108; Ribas V, 2010, AM J PHYSIOL-ENDOC M, V298, pE304, DOI 10.1152/ajpendo.00504.2009; Rodriguez-Cuenca S, 2007, CELL PHYSIOL BIOCHEM, V20, P877, DOI 10.1159/000110448; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Seth P, 2002, CANCER RES, V62, P4540; Shi H, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-83; SMITH EP, 1994, NEW ENGL J MED, V331, P1056, DOI 10.1056/NEJM199410203311604; Sparano JA, 2012, CANCER-AM CANCER SOC, V118, P5937, DOI 10.1002/cncr.27527; STEIN B, 1995, MOL CELL BIOL, V15, P4971; Stoesz SP, 1995, ONCOGENE, V11, P2233; Tan JX, 2011, INT J DEV BIOL, V55, P851, DOI 10.1387/ijdb.113365jt; Turati F, 2013, BRIT J CANCER, V108, P222, DOI 10.1038/bjc.2012.492; Villanueva CJ, 2011, CELL METAB, V13, P413, DOI 10.1016/j.cmet.2011.02.014; Vona-Davis L, 2007, ENDOCR-RELAT CANCER, V14, P189, DOI 10.1677/ERC-06-0068; Wang YY, 2012, CANCER LETT, V324, P142, DOI 10.1016/j.canlet.2012.05.019; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Yan L, 2001, J BIOL CHEM, V276, P37258, DOI 10.1074/jbc.M106089200; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007; Yang J, 2009, CELL CYCLE, V8, P2347, DOI 10.4161/cc.8.15.9224; Yang J, 2009, P NATL ACAD SCI USA, V106, P3913, DOI 10.1073/pnas.0810617106; Zhang SQ, 2014, ONCOL LETT, V7, P1375, DOI 10.3892/ol.2014.1918	61	52	54	3	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 27	2015	290	9					5566	5581		10.1074/jbc.M114.606459	http://dx.doi.org/10.1074/jbc.M114.606459			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CC0RS	25468909	Green Published, hybrid			2022-12-26	WOS:000350044200028
J	Jin, Y; Liu, YS; Nelin, LD				Jin, Yi; Liu, Yusen; Nelin, Leif D.			Extracellular Signal-regulated Kinase Mediates Expression of Arginase II but Not Inducible Nitric-oxide Synthase in Lipopolysaccharide-stimulated Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; TOLL-LIKE RECEPTOR; NEGATIVE REGULATION; PATHWAY; P38; RAS; INVOLVEMENT; INDUCTION; APOPTOSIS; ABILITY	The mitogen-activated protein kinases (MAPK) have been shown to participate in iNOS induction following lipopolysaccharide (LPS) stimulation, while the role of MAPKs in the regulation of arginase remains unclear. We hypothesized that different MAPK family members are involved in iNOS and arginase expression following LPS stimulation. LPS-stimulated RAW 264.7 cells exhibited increased protein and mRNA levels for iNOS, arginase I, and arginase II; although the induction of arginase II was more robust than that for arginase I. A p38 inhibitor completely prevented iNOS expression while it only attenuated arginase II induction. In contrast, a MEK1/2 inhibitor (ERK pathway) completely abolished arginase II expression while actually enhancing iNOS induction in LPS-stimulated cells. Arginase II promoter activity was increased by similar to 4-fold following LPS-stimulation, which was prevented by the ERK pathway inhibitor. Arginase II promoter activity was unaffected by a p38 inhibitor or JNK pathway interference. Transfection with a construct expressing a constitutively active RAS mutant increased LPS-induced arginase II promoter activity, while transfection with a vector expressing a dominant negative ERK2 mutant or a vector expressing MKP-3 inhibited the arginase II promoter activity. LPS-stimulated nitric oxide (NO) production was increased following siRNA-mediated knockdown of arginase II and decreased when arginase II was overexpressed. Our results demonstrate that while both the ERK and p38 pathways regulate arginase II induction in LPS-stimulated macrophages, iNOS induction by LPS is dependent on p38 activation. These results suggest that differential inhibition of the MAPK pathway may be a potential therapeutic strategy to regulate macrophage phenotype.	[Jin, Yi; Liu, Yusen; Nelin, Leif D.] Nationwide Childrens Hosp, Res Inst, Ctr Perinatal Res, Pulm Hypertens Grp, Columbus, OH 43205 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital	Nelin, LD (corresponding author), Nationwide Childrens Hosp, Res Inst, Ctr Perinatal Res, 575 Childrens Crossrd, Columbus, OH 43205 USA.	Leif.Nelin@nationwidechildrens.org	Liu, Yusen/E-3527-2011; Nelin, Leif/AAC-8475-2020	Liu, Yusen/0000-0002-0994-0109	NHLBI [R01HL075261]; NIAID, National Institutes of Health [R01AI068956]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL075261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068956] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by Grant Number R01HL075261 from the NHLBI and Grant Number R01AI068956 from the NIAID, National Institutes of Health.	Barra V, 2011, CELL MOL LIFE SCI, V68, P1815, DOI 10.1007/s00018-010-0537-x; Chang CI, 1998, AM J PHYSIOL-HEART C, V274, pH342, DOI 10.1152/ajpheart.1998.274.1.H342; Chang CI, 2000, J IMMUNOL, V165, P2134, DOI 10.4049/jimmunol.165.4.2134; Chen CC, 1999, MOL PHARMACOL, V55, P481; Chen PL, 2001, J BIOL CHEM, V276, P29440, DOI 10.1074/jbc.M103463200; Chen PL, 2002, PROTEIN EXPRES PURIF, V24, P481, DOI 10.1006/prep.2001.1599; Das P., 2010, PLANT SIGNAL BEHAV, V6, P1; Dean JLE, 2004, CELL SIGNAL, V16, P1113, DOI 10.1016/j.cellsig.2004.04.006; Deng QD, 2004, J BIOL CHEM, V279, P1050, DOI 10.1074/jbc.M308644200; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Douda D.N., 2010, OPEN NITRIC OXIDE J, V12, P69; Downward J, 1998, CURR OPIN CELL BIOL, V10, P262, DOI 10.1016/S0955-0674(98)80149-X; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Foxwell B, 1998, P NATL ACAD SCI USA, V95, P8211, DOI 10.1073/pnas.95.14.8211; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; Gotoh T, 1999, J CELL BIOL, V144, P427, DOI 10.1083/jcb.144.3.427; Johann AM, 2007, FASEB J, V21, P2704, DOI 10.1096/fj.06-7815com; Joneson T, 1996, SCIENCE, V271, P810, DOI 10.1126/science.271.5250.810; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Lang T, 2007, IMMUNOL CELL BIOL, V85, P425, DOI 10.1038/sj.icb.7100094; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Lee TY, 2009, BIOCHEM BIOPH RES CO, V382, P134, DOI 10.1016/j.bbrc.2009.02.160; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Monick MM, 2002, J BIOL CHEM, V277, P32992, DOI 10.1074/jbc.M203218200; Mori M, 2007, J NUTR, V137, p1616S, DOI 10.1093/jn/137.6.1616S; Morris MC, 2014, J BIOL CHEM, V289, P21584, DOI 10.1074/jbc.M114.583518; Nelin LD, 2007, AM J PHYSIOL-CELL PH, V293, pC632, DOI 10.1152/ajpcell.00137.2006; Pelegrin P, 2009, EMBO J, V28, P2114, DOI 10.1038/emboj.2009.163; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; ROSSOMANDO A, 1992, P NATL ACAD SCI USA, V89, P5221, DOI 10.1073/pnas.89.12.5221; SANCHEZ I, 1994, NATURE, V372, P794, DOI 10.1038/372794a0; Wang XZ, 2009, STUD FUZZ SOFT COMP, V245, P1; WHITE MA, 1995, CELL, V80, P533, DOI 10.1016/0092-8674(95)90507-3; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052	35	28	29	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2099	2111		10.1074/jbc.M114.599985	http://dx.doi.org/10.1074/jbc.M114.599985			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25451938	Green Published, hybrid			2022-12-26	WOS:000348588000016
J	Liu, ZY; Zhang, WC; Zhang, M; Zhu, HP; Moriasi, C; Zou, MH				Liu, Zhaoyu; Zhang, Wencheng; Zhang, Miao; Zhu, Huaiping; Moriasi, Cate; Zou, Ming-Hui			Liver Kinase B1 Suppresses Lipopolysaccharide-induced Nuclear Factor kappa B (NF-kappa B) Activation in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE; INFLAMMATORY MEDIATORS; GLUCOSE-HOMEOSTASIS; INNOCENT BYSTANDER; C-ZETA; LKB1; PHOSPHORYLATION; RECEPTOR; SERINE-428; IMPROVES	Liver kinase B1 (LKB1), a serine/threonine kinase, is a tumor suppressor and metabolic regulator. Recent data suggest that LKB1 is essential in regulating homeostasis of hematopoietic cells and immune responses. However, its role in macrophages and innate immune system remains unclear. Here we report that macrophage LKB1 inhibits pro-inflammatory signaling in response to LPS. LPS-induced pro-inflammatory cytokines and pro-inflammatory enzymes were monitored in bone marrow-derived macrophages isolated from myeloid cell-specific LKB1 knock out mice and their wild type littermate control mice. LPS induced higher levels of pro-inflammatory cytokines and pro-inflammatory enzymes in bone marrow-derived macrophages from LKB1 KO than those from wild type mice. Consistently, LPS induced higher levels of NF-kappa B activation in LKB1-deficient macrophages than those in wild type. Further, LPS stimulation significantly increased LKB1 phosphorylation at serine 428, which promoted its binding to I kappa B kinase beta (IKK beta), resulting in the inhibition of NF-kappa B. Finally, LPS injection caused higher levels of cytokine release and more severe tissue injury in the lung tissues of LKB1 KO mice than in those of control mice. We conclude that LKB1 inhibits LPS-induced NF-kappa B activation in macrophages.	[Liu, Zhaoyu; Zhang, Wencheng; Zhang, Miao; Zhu, Huaiping; Moriasi, Cate; Zou, Ming-Hui] Univ Oklahoma, Hlth Sci Ctr, Dept Med, Sect Mol Med, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Zou, MH (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Med, 941 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	mzou@ouhsc.edu	liu, zhao/GXV-6141-2022; Zhang, Wencheng/AAO-8445-2020		National Institutes of Health [HL079584, HL080499, HL074399, HL089920, HL096032, HL105157, HL110488, AG047776]; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074399, R01HL110488, R01HL096032, R01HL089920, R01HL079584, R01HL105157, R01HL080499] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047776] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants HL079584, HL080499, HL074399, HL089920, HL096032, HL105157, HL110488, and AG047776 (to M. H. Z.).; A recipient of the National Established Investigator Award of the American Heart Association.	Alexander C, 2001, J ENDOTOXIN RES, V7, P167, DOI 10.1179/096805101101532675; Chen F, 2005, BIOCHEM BIOPH RES CO, V332, P1, DOI 10.1016/j.bbrc.2005.03.075; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Collins T, 2001, J CLIN INVEST, V107, P255, DOI 10.1172/JCI10373; De Castro C, 2010, METHOD ENZYMOL, V480, P89, DOI 10.1016/S0076-6879(10)80005-9; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Filippov S, 2013, J LIPID RES, V54, P2095, DOI 10.1194/jlr.M035212; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; He JL, 2013, ARTERIOSCL THROM VAS, V33, P1297, DOI 10.1161/ATVBAHA.113.301296; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Hirsch HA, 2013, P NATL ACAD SCI USA, V110, P972, DOI 10.1073/pnas.1221055110; Ikeda Y, 2009, J BIOL CHEM, V284, P35839, DOI 10.1074/jbc.M109.057273; Isoda K, 2006, ARTERIOSCL THROM VAS, V26, P611, DOI 10.1161/01.ATV.0000201938.78044.75; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Jenne DE, 1998, NAT GENET, V18, P38, DOI 10.1038/ng0198-38; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kim MJ, 2014, MOL PHARMACOL, V86, P284, DOI 10.1124/mol.114.093039; Kita Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043056; Koh HJ, 2006, MOL CELL BIOL, V26, P8217, DOI 10.1128/MCB.00979-06; LASKIN DL, 1995, ANNU REV PHARMACOL, V35, P655, DOI 10.1146/annurev.pharmtox.35.1.655; Lawrence T, 2005, NATURE, V434, P1138, DOI 10.1038/nature03491; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; MacIver NJ, 2011, J IMMUNOL, V187, P4187, DOI 10.4049/jimmunol.1100367; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Morio LA, 2001, TOXICOL APPL PHARM, V177, P188, DOI 10.1006/taap.2001.9316; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; NEWMAN JH, 1985, CLIN CHEST MED, V6, P371; Ohashi K, 2010, J BIOL CHEM, V285, P22291, DOI 10.1074/jbc.M110.123794; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Park CS, 2012, BIOCHEM PHARMACOL, V84, P1660, DOI 10.1016/j.bcp.2012.09.025; Rhee SH, 2000, J BIOL CHEM, V275, P34035, DOI 10.1074/jbc.M007386200; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; SAUKKONEN K, 1990, J EXP MED, V171, P439, DOI 10.1084/jem.171.2.439; Schulte W, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/165974; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Song P, 2008, J BIOL CHEM, V283, P12446, DOI 10.1074/jbc.M708208200; Tamas P, 2010, EUR J IMMUNOL, V40, P242, DOI 10.1002/eji.200939677; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Xie Z, 2008, CIRCULATION, V117, P952, DOI 10.1161/CIRCULATIONAHA.107.744490; Yang F, 2003, J IMMUNOL, V170, P5630, DOI 10.4049/jimmunol.170.11.5630; Ylikorkala A, 2001, SCIENCE, V293, P1323, DOI 10.1126/science.1062074	45	31	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2312	2320		10.1074/jbc.M114.616441	http://dx.doi.org/10.1074/jbc.M114.616441			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25451940	Green Published, hybrid			2022-12-26	WOS:000348588000036
J	Nawae, W; Hannongbua, S; Ruengjitchatchawalya, M				Nawae, Wanapinun; Hannongbua, Supa; Ruengjitchatchawalya, Marasri			Dynamic Scenario of Membrane Binding Process of Kalata B1	PLOS ONE			English	Article							GRAINED MD SIMULATIONS; MOLECULAR-DYNAMICS; DRUG DESIGN; ANTIMICROBIAL PEPTIDES; SCANNING MUTAGENESIS; BIOLOGICAL-ACTIVITY; STRUCTURAL MOTIF; PLANT CYCLOTIDES; FORCE-FIELD; PROTEINS	Kalata B1 (kB1), a cyclotide that has been used in medical applications, displays cytotoxicity related to membrane binding and oligomerization. Our molecular dynamics simulation results demonstrate that Trp19 in loop 5 of both monomeric and tetrameric kB1 is a key residue for initial anchoring in the membrane binding process. This residue also facilitates the formation of kB1 tetramers. Additionally, we elucidate that kB1 preferentially binds to the membrane interfacial zone and is unable to penetrate into the membrane. In particular, significant roles of amino acid residues in loop 5 and loop 6 on the localization of kB1 to this membrane-water interface zone are found. This study reveals the roles of amino acid residues in the bioactivity of kB1, which is information that can be useful for designing new therapeutic cyclotides with less toxicity.	[Nawae, Wanapinun] King Mongkuts Univ Technol Thonburi, Fac Engn, Biol Engn Program, Bangkok, Thailand; [Hannongbua, Supa] Kasetsart Univ, Fac Sci, Dept Chem, Bangkok, Thailand; [Ruengjitchatchawalya, Marasri] King Mongkuts Univ Technol Thonburi Bang Khun Thi, Bioinformat & Syst Biol Program, Bangkok, Thailand; [Ruengjitchatchawalya, Marasri] King Mongkuts Univ Technol Thonburi Bang Khun Thi, Sch Bioresources & Technol, Biotechnol Program, Bangkok, Thailand	King Mongkuts University of Technology Thonburi; Kasetsart University; King Mongkuts University of Technology Thonburi; King Mongkuts University of Technology Thonburi	Ruengjitchatchawalya, M (corresponding author), King Mongkuts Univ Technol Thonburi Bang Khun Thi, Bioinformat & Syst Biol Program, Bangkok, Thailand.	marasri.rue@kmutt.ac.th	Hannongbua, Supa/F-8062-2011; Hannongbua, Supa/ABD-9307-2021; Ruengjitchatchawalya, Marasri/N-5694-2014	Hannongbua, Supa/0000-0002-9901-4466; Hannongbua, Supa/0000-0002-9901-4466; 	National Research Council of Thailand [57000139]; National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Thailand [P-11-01089]	National Research Council of Thailand(National Research Council of Thailand (NRCT)); National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Thailand	This work was partly supported by a research grant (NRMJ: 2557A30602295#57000139) from the National Research Council of Thailand (http://en.nrct.go.th) and a grant (P-11-01089) from the National Center for Genetic Engineering and Biotechnology, National Science and Technology Development Agency, Thailand (http://www.biotec.or.th). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboye TL, 2012, J MED CHEM, V55, P10729, DOI 10.1021/jm301468k; ALOIA RC, 1993, P NATL ACAD SCI USA, V90, P5181, DOI 10.1073/pnas.90.11.5181; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Chan LY, 2011, BLOOD, V118, P6709, DOI 10.1182/blood-2011-06-359141; Clark RJ, 2006, BIOCHEM J, V394, P85, DOI 10.1042/BJ20051691; Craik DJ, 2010, TOXICON, V56, P1092, DOI 10.1016/j.toxicon.2010.02.021; Craik DJ, 1999, J MOL BIOL, V294, P1327, DOI 10.1006/jmbi.1999.3383; Daly NL, 2004, FEBS LETT, V574, P69, DOI 10.1016/j.febslet.2004.08.007; Daly NL, 2009, ADV DRUG DELIVER REV, V61, P918, DOI 10.1016/j.addr.2009.05.003; de Jesus AJ, 2013, BBA-BIOMEMBRANES, V1828, P864, DOI 10.1016/j.bbamem.2012.09.009; Eliasen R, 2012, J BIOL CHEM, V287, P40493, DOI 10.1074/jbc.M112.395442; Fantini Jacques, 2002, Expert Rev Mol Med, V4, P1, DOI 10.1017/S1462399402005392; Garcia Angie E, 2010, Curr Mol Pharmacol, V3, P153; Gerlach SL, 2010, BIOPOLYMERS, V94, P617, DOI 10.1002/bip.21435; Getz JA, 2011, ACS CHEM BIOL, V6, P837, DOI 10.1021/cb200039s; Gkeka P, 2010, J PHYS CHEM B, V114, P826, DOI 10.1021/jp908320b; Gould A, 2011, CURR PHARM DESIGN, V17, P4294, DOI 10.2174/138161211798999438; GRAN L, 1973, ACTA PHARMACOL TOX, V33, P400; Gunasekera S, 2008, J MED CHEM, V51, P7697, DOI 10.1021/jm800704e; Henriques ST, 2010, DRUG DISCOV TODAY, V15, P57, DOI 10.1016/j.drudis.2009.10.007; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Huang YH, 2010, J BIOL CHEM, V285, P10797, DOI 10.1074/jbc.M109.089854; Huang YH, 2009, J BIOL CHEM, V284, P20699, DOI 10.1074/jbc.M109.003384; Hub JS, 2010, J CHEM THEORY COMPUT, V6, P3713, DOI 10.1021/ct100494z; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jagadish K, 2010, BIOPOLYMERS, V94, P611, DOI 10.1002/bip.21433; Kaas Q, 2010, BIOPOLYMERS, V94, P584, DOI 10.1002/bip.21424; Kastner J, 2011, WIRES COMPUT MOL SCI, V1, P932, DOI 10.1002/wcms.66; Khalfa A, 2010, J PHYS CHEM B, V114, P2676, DOI 10.1021/jp9064196; Kimura RH, 2012, CLIN CANCER RES, V18, P839, DOI 10.1158/1078-0432.CCR-11-1116; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Marrink SJ, 2007, J PHYS CHEM B, V111, P7812, DOI 10.1021/jp071097f; Marrink SJ, 2004, J PHYS CHEM B, V108, P750, DOI 10.1021/jp036508g; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Mulvenna JP, 2006, NUCLEIC ACIDS RES, V34, pD192, DOI 10.1093/nar/gkj005; Nawae W, 2014, SCI REP-UK, V4, DOI 10.1038/srep03933; Poth AG, 2013, BIOPOLYMERS, V100, P480, DOI 10.1002/bip.22284; Risselada HJ, 2008, P NATL ACAD SCI USA, V105, P17367, DOI 10.1073/pnas.0807527105; Rosengren KJ, 2013, BIOPOLYMERS, V100, P453, DOI 10.1002/bip.22269; Rosengren KJ, 2003, J BIOL CHEM, V278, P8606, DOI 10.1074/jbc.M211147200; Scott KA, 2008, STRUCTURE, V16, P621, DOI 10.1016/j.str.2008.01.014; Shenkarev ZO, 2006, FEBS J, V273, P2658, DOI 10.1111/j.1742-4658.2006.05282.x; Simonsen SM, 2008, J BIOL CHEM, V283, P9805, DOI 10.1074/jbc.M709303200; Sommerhoff CP, 2010, J MOL BIOL, V395, P167, DOI 10.1016/j.jmb.2009.10.028; Su ZY, 2011, J PHYS CHEM B, V115, P796, DOI 10.1021/jp107599v; Takada S, 2012, CURR OPIN STRUC BIOL, V22, P130, DOI 10.1016/j.sbi.2012.01.010; Tam JP, 1999, P NATL ACAD SCI USA, V96, P8913, DOI 10.1073/pnas.96.16.8913; Thongyoo P, 2008, ORG BIOMOL CHEM, V6, P1462, DOI 10.1039/b801667d; Thongyoo P, 2009, J MED CHEM, V52, P6197, DOI 10.1021/jm901233u; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wang CK, 2012, J BIOL CHEM, V287, P43884, DOI 10.1074/jbc.M112.421198; Wang CKL, 2008, J NAT PROD, V71, P47, DOI 10.1021/np070393g; Wimley WC, 2010, ACS CHEM BIOL, V5, P905, DOI 10.1021/cb1001558; Yau WM, 1998, BIOCHEMISTRY-US, V37, P14713, DOI 10.1021/bi980809c; Zhao J, 2013, J CHEM INF MODEL, V53, P3280, DOI 10.1021/ci400477e	55	8	8	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114473	10.1371/journal.pone.0114473	http://dx.doi.org/10.1371/journal.pone.0114473			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473840	Green Published, gold, Green Submitted			2022-12-26	WOS:000346382500039
J	Bredeson, S; Papaconstantinou, J; Deford, JH; Kechichian, T; Syed, TA; Saade, GR; Menon, R				Bredeson, Sarah; Papaconstantinou, John; Deford, James H.; Kechichian, Talar; Syed, Tariq A.; Saade, George R.; Menon, Ramkumar			HMGB1 Promotes a p38MAPK Associated Non-Infectious Inflammatory Response Pathway in Human Fetal Membranes	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; GROUP BOX PROTEIN-1; PRETERM BIRTH; ALARMIN HMGB1; IN-VITRO; CYTOKINE; DNA; EXPRESSION; PHOSPHORYLATION; CELLS	Objective: Spontaneous preterm birth (PTB) and preterm prelabor rupture of membranes (pPROM) are major pregnancy complications often associated with a fetal inflammatory response. Biomolecular markers of this fetal inflammatory response to both infectious and non-infectious risk factors and their contribution to PTB and pPROM mechanism are still unclear. This study examined fetal membrane production, activation and mechanistic properties of high mobility group box 1 (HMGB1) as a contributor of the non-infectious fetal inflammatory response. Materials and Methods: HMGB1 transcripts and active HMGB1 were profiled in fetal membranes and amniotic fluids collected from PTB and normal term birth. In vitro, normal term not in labor fetal membranes were exposed to lipopolysaccharide (LPS) and water soluble cigarette smoke extract (CSE). HMGB1-transcripts and its protein concentrations were documented by RT-PCR and ELISA. Recombinant HMGB1 treated membranes and media were subjected to RT-PCR for HMGB1 receptors, mitogen activated protein kinase pathway analysis, cytokine levels, and Western blot for p38MAPK. Results: HMGB1 expression and its active forms were higher in PTB and pPROM than normal term membranes and amniotic fluid samples. Both LPS and CSE enhanced HMGB1 expression and release in vitro. Fetal membrane exposure to HMGB1 resulted in increased expression of TLR2 and 4 and dose-dependent activation of p38MAPK-mediated inflammation. Conclusions: HMGB1 increase by fetal membrane cells in response to either oxidative stress or infection can provide a positive feedback loop generating noninfectious inflammatory activation. Activation of p38MAPK by HMGB1 promotes development of the senescence phenotype and senescence associated sterile inflammation. HMGB1 activity is an important regulator of the fetal inflammatory response regardless of infection.	[Bredeson, Sarah; Kechichian, Talar; Syed, Tariq A.; Saade, George R.; Menon, Ramkumar] Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med & Perinatal Res, Galveston, TX 77555 USA; [Papaconstantinou, John; Deford, James H.] Univ Texas Med Branch, Dept Biochem & Mol Biol, NHLBI Prote Ctr Airway Inflammat, Galveston, TX 77555 USA; [Papaconstantinou, John; Deford, James H.] Univ Texas Med Branch, UTMB Biomol Resource Facil, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Menon, R (corresponding author), Univ Texas Med Branch, Dept Obstet & Gynecol, Div Maternal Fetal Med & Perinatal Res, Galveston, TX 77555 USA.	ra2menon@utmb.edu	Zheng, Yun/AAS-1149-2021	Zheng, Yun/0000-0003-4292-9806	dept of OB&GYN at The University of Texas Medical Branch at Galveston, Texas United States of America	dept of OB&GYN at The University of Texas Medical Branch at Galveston, Texas United States of America	Funding: The study is conducted using developmental funds provided to Dr. R. Menon by the dept of OB&GYN at The University of Texas Medical Branch at Galveston, Texas United States of America. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2002, J LEUKOCYTE BIOL, V72, P1084; Andersson U, 2000, J EXP MED, V192, P565, DOI 10.1084/jem.192.4.565; Bartling B, 2007, MOL NUTR FOOD RES, V51, P479, DOI 10.1002/mnfr.200600223; Buhimschi CS, 2009, AM J PATHOL, V175, P958, DOI 10.2353/ajpath.2009.090156; Chen XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050668; Chen Y, 2013, RHEUMATOLOGY, V52, P1739, DOI 10.1093/rheumatology/ket134; Ciucci A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023766; Combs CA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.11.032; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dubicke A, 2010, J REPROD IMMUNOL, V84, P86, DOI 10.1016/j.jri.2009.09.010; FORTUNATO SJ, 1994, AM J REPROD IMMUNOL, V32, P184, DOI 10.1111/j.1600-0897.1994.tb01112.x; Freund A, 2011, EMBO J, V30, P1536, DOI 10.1038/emboj.2011.69; Gong HJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S7-S10; Guo ZS, 2013, AM J CANCER RES, V3, P1; Harris HE, 2004, EUR J IMMUNOL, V34, P1503, DOI 10.1002/eji.200424916; Harris HE, 2012, NAT REV RHEUMATOL, V8, P195, DOI 10.1038/nrrheum.2011.222; He ZW, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/596716; Holmlund U, 2007, IMMUNOLOGY, V122, P430, DOI 10.1111/j.1365-2567.2007.02662.x; Kalmes A, 1999, FEBS LETT, V444, P71, DOI 10.1016/S0014-5793(99)00034-4; Kim SW, 2012, NEUROBIOL DIS, V46, P147, DOI 10.1016/j.nbd.2011.12.056; Lali FV, 2000, J BIOL CHEM, V275, P7395, DOI 10.1074/jbc.275.10.7395; Lange SS, 2009, MOL CARCINOGEN, V48, P571, DOI 10.1002/mc.20544; Lee KB, 2000, J MOL BIOL, V304, P135, DOI 10.1006/jmbi.2000.4206; Li JH, 2004, J IMMUNOL METHODS, V289, P211, DOI 10.1016/j.jim.2004.04.019; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594; Menon R, 2011, PLACENTA, V32, P317, DOI 10.1016/j.placenta.2011.01.015; Menon R, 2014, AM J REPROD IMMUNOL, V72, P75, DOI 10.1111/aji.12220; Menon R, 2014, AM J PATHOL, V184, P1740, DOI 10.1016/j.ajpath.2014.02.011; Menon R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083416; Menon R, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.06.027; Menon R, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.12.051; Mollica L, 2007, CHEM BIOL, V14, P431, DOI 10.1016/j.chembiol.2007.03.007; Qin YH, 2009, J IMMUNOL, V183, P6244, DOI 10.4049/jimmunol.0900390; Romero R, 2007, SEMIN REPROD MED, V25, P21, DOI 10.1055/s-2006-956773; Romero R, 2014, AM J REPROD IMMUNOL, V72, P458, DOI 10.1111/aji.12296; Romero R, 2012, J MATERN-FETAL NEO M, V25, P558, DOI 10.3109/14767058.2011.599083; Romero R, 2011, J MATERN-FETAL NEO M, V24, P1444, DOI 10.3109/14767058.2011.591460; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; SHEFLIN LG, 1993, BIOCHEMISTRY-US, V32, P3238, DOI 10.1021/bi00064a005; Tang DL, 2011, ANTIOXID REDOX SIGN, V15, P2185, DOI 10.1089/ars.2010.3666; Thomas JO, 2012, BIOCHEM SOC T, V40, P341, DOI 10.1042/BST20120014; Yanai H, 2012, TRENDS IMMUNOL, V33, P633, DOI 10.1016/j.it.2012.10.005; Yang H, 2005, J LEUKOCYTE BIOL, V78, P1, DOI 10.1189/jlb.1104648; Zicari A, 2008, REPROD SCI, V15, P559, DOI 10.1177/1933719107312560	46	90	97	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113799	10.1371/journal.pone.0113799	http://dx.doi.org/10.1371/journal.pone.0113799			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469638	Green Published, gold, Green Submitted			2022-12-26	WOS:000349128700047
J	Guralnick, R; Conlin, T; Deck, J; Stucky, BJ; Cellinese, N				Guralnick, Robert; Conlin, Tom; Deck, John; Stucky, Brian J.; Cellinese, Nico			The Trouble with Triplets in Biodiversity Informatics: A Data-Driven Case against Current Identifier Practices	PLOS ONE			English	Article								The biodiversity informatics community has discussed aspirations and approaches for assigning globally unique identifiers (GUIDs) to biocollections for nearly a decade. During that time, and despite misgivings, the de facto standard identifier has become the ``Darwin Core Triplet'', which is a concatenation of values for institution code, collection code, and catalog number associated with biocollections material. Our aim is not to rehash the challenging discussions regarding which GUID system in theory best supports the biodiversity informatics use case of discovering and linking digital data across the Internet, but how well we can link those data together at this moment, utilizing the current identifier schemes that have already been deployed. We gathered Darwin Core Triplets from a subset of VertNet records, along with vertebrate records from GenBank and the Barcode of Life Data System, in order to determine how Darwin Core Triplets are deployed ``in the wild''. We asked if those triplets follow the recommended structure and whether they provide an easy and unambiguous means to track from specimen records to genetic sequence records. We show that Darwin Core Triplets are often riddled with semantic and syntactic errors when deployed and curated in practice, despite specifications about how to construct them. Our results strongly suggest that Darwin Core Triplets that have not been carefully curated are not currently serving a useful role for relinking data. We briefly consider needed next steps to overcome current limitations.	[Guralnick, Robert; Stucky, Brian J.] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Guralnick, Robert; Conlin, Tom] Univ Colorado, CU Museum Nat Hist, Boulder, CO 80309 USA; [Deck, John] Univ Calif Berkeley, Berkeley Nat Hist Museums, Berkeley, CA 94720 USA; [Cellinese, Nico] Univ Florida, Florida Museum Nat Hist, Gainesville, FL 32611 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of California System; University of California Berkeley; State University System of Florida; University of Florida	Guralnick, R (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	robert.guralnick@colorado.edu		Deck, John/0000-0002-5905-1617; Cellinese, Nico/0000-0002-7157-9414	National Science Foundation [DBI-0956371, DBI-0956350, DBI-0956426]	National Science Foundation(National Science Foundation (NSF))	This work was formulated as part of this BiSciCol project (http://biscicol.org/), which was supported by the National Science Foundation (DBI-0956371, DBI-0956350, and DBI-0956426). The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chavan VS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S2; Clark T, 2004, BRIEF BIOINFORM, V5, P59, DOI 10.1093/bib/5.1.59; Constable H, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000309; Cryer P, 2009, AD PERS ID BIOD INF; Heath T., 2011, LINKED DATA EVOLVING; Page RDM, 2008, BRIEF BIOINFORM, V9, P345, DOI 10.1093/bib/bbn022; Page RDM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S14-S5; Paskin N, 2005, DATA SCI J, V4, P12, DOI DOI 10.2481/DSJ.4.12; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Robertson T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102623; Stucky BJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-257; Walls RL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089606; Wieczorek J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029715	13	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114069	10.1371/journal.pone.114069	http://dx.doi.org/10.1371/journal.pone.114069			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470125				2022-12-26	WOS:000349128700066
J	Ohmiya, A; Hirashima, M; Yagi, M; Tanase, K; Yamamizo, C				Ohmiya, Akemi; Hirashima, Masumi; Yagi, Masafumi; Tanase, Koji; Yamamizo, Chihiro			Identification of Genes Associated with Chlorophyll Accumulation in Flower Petals	PLOS ONE			English	Article							HARVESTING COMPLEX-II; STAY-GREEN PROTEIN; LEAF SENESCENCE; ARABIDOPSIS; DEGRADATION; PHEOPHORBIDE; BREAKDOWN; BIOSYNTHESIS; EXPRESSION; MUTATIONS	Plants have an ability to prevent chlorophyll accumulation, which would mask the bright flower color, in their petals. In contrast, leaves contain substantial amounts of chlorophyll, as it is essential for photosynthesis. The mechanisms of organ-specific chlorophyll accumulation are unknown. To identify factors that determine the chlorophyll content in petals, we compared the expression of genes related to chlorophyll metabolism in different stages of non-green (red and white) petals (very low chlorophyll content), pale-green petals (low chlorophyll content), and leaves (high chlorophyll content) of carnation (Dianthus caryophyllus L.). The expression of many genes encoding chlorophyll biosynthesis enzymes, in particular Mg-chelatase, was lower in non-green petals than in leaves. Non-green petals also showed higher expression of genes involved in chlorophyll degradation, including STAY-GREEN gene and pheophytinase. These data suggest that the absence of chlorophylls in carnation petals may be caused by the low rate of chlorophyll biosynthesis and high rate of degradation. Similar results were obtained by the analysis of Arabidopsis microarray data. In carnation, most genes related to chlorophyll biosynthesis were expressed at similar levels in pale-green petals and leaves, whereas the expression of chlorophyll catabolic genes was higher in pale-green petals than in leaves. Therefore, we hypothesize that the difference in chlorophyll content between non-green and pale-green petals is due to different levels of chlorophyll biosynthesis. Our study provides a basis for future molecular and genetic studies on organ-specific chlorophyll accumulation.	[Ohmiya, Akemi; Hirashima, Masumi; Yagi, Masafumi; Tanase, Koji; Yamamizo, Chihiro] Natl Agr & Food Res Org, Natl Inst Floricultural Sci, Tsukuba, Ibaraki 3058519, Japan	National Agriculture & Food Research Organization - Japan	Ohmiya, A (corresponding author), Natl Agr & Food Res Org, Natl Inst Floricultural Sci, Fujimoto 2-1, Tsukuba, Ibaraki 3058519, Japan.	ohmiya@affrc.go.jp	Yagi, Masafumi/S-2830-2019		National Agriculture and Food Research Organization (NARO); JSPS KAKENHI [25292025]	National Agriculture and Food Research Organization (NARO); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding: This work was supported in part by a Grant-in-Aid from the National Agriculture and Food Research Organization (NARO) and JSPS KAKENHI Grant Number 25292025. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aschan G, 2003, FLORA, V198, P81, DOI 10.1078/0367-2530-00080; Aubry S, 2008, PLANT MOL BIOL, V67, P243, DOI 10.1007/s11103-008-9314-8; Barry CS, 2008, PLANT PHYSIOL, V147, P179, DOI 10.1104/pp.108.118430; BEATOR J, 1993, PLANT PHYSIOL, V103, P191, DOI 10.1104/pp.103.1.191; Causier B, 2010, SEMIN CELL DEV BIOL, V21, P73, DOI 10.1016/j.semcdb.2009.10.005; Croce R, 2012, ADV PHOTOSYNTH RESP, V34, P127, DOI 10.1007/978-94-007-1579-0_6; Eckhardt U, 2004, PLANT MOL BIOL, V56, P1, DOI 10.1007/s11103-004-2331-3; Hansson A, 1999, P NATL ACAD SCI USA, V96, P1744, DOI 10.1073/pnas.96.4.1744; Hirashima M, 2009, PLANT CELL PHYSIOL, V50, P719, DOI 10.1093/pcp/pcp035; Hortensteiner S, 2013, PLANT MOL BIOL, V82, P505, DOI 10.1007/s11103-012-9940-z; Hortensteiner S, 2009, TRENDS PLANT SCI, V14, P155, DOI 10.1016/j.tplants.2009.01.002; Horie Y, 2009, J BIOL CHEM, V284, P17449, DOI 10.1074/jbc.M109.008912; Ito T, 2011, CURR OPIN PLANT BIOL, V14, P53, DOI 10.1016/j.pbi.2010.08.013; Jensen PE, 1996, MOL GEN GENET, V250, P383; Juneau P, 2002, PHOTOCHEM PHOTOBIOL, V75, P377, DOI 10.1562/0031-8655(2002)075<0377:RBTSAF>2.0.CO;2; Kannangara CG, 1997, MOL GEN GENET, V254, P85, DOI 10.1007/s004380050394; Kariola T, 2005, PLANT CELL, V17, P282, DOI 10.1105/tpc.104.025817; KIM J, 1994, PLANT PHYSIOL, V104, P907, DOI 10.1104/pp.104.3.907; Kruse E, 1997, PLANTA, V202, P235, DOI 10.1007/s004250050124; Kusaba M, 2007, PLANT CELL, V19, P1362, DOI 10.1105/tpc.106.042911; Liao Y, 2007, J INTEGR PLANT BIOL, V49, P531, DOI 10.1111/j.1744-7909.2007.00444.x; Lysenko V, 2013, SCI REP-UK, V3, DOI 10.1038/srep03373; Masuda T, 2008, PHOTOCH PHOTOBIO SCI, V7, P1131, DOI 10.1039/b807210h; Mayak S, 1998, PLANT PHYSIOL BIOCH, V36, P835, DOI 10.1016/S0981-9428(99)80021-7; Niyogi KK, 2000, CURR OPIN PLANT BIOL, V3, P455, DOI 10.1016/S1369-5266(00)00113-8; Ohmiya A, 2013, PLANT BREEDING, V132, P423, DOI 10.1111/pbr.12061; PLUMLEY FG, 1995, PLANT CELL, V7, P689, DOI 10.2307/3870172; Pontier D, 2007, J BIOL CHEM, V282, P2297, DOI 10.1074/jbc.M610286200; Pose D, 2012, CURR OPIN PLANT BIOL, V15, P45, DOI 10.1016/j.pbi.2011.09.002; Reinbothe S, 1996, CELL, V86, P703, DOI 10.1016/S0092-8674(00)80144-0; Ren GD, 2007, PLANT PHYSIOL, V144, P1429, DOI 10.1104/pp.107.100172; Sakuraba Y, 2014, FEBS LETT IN PRESS; Sakuraba Y, 2014, MOL PLANT, V7, P1288, DOI 10.1093/mp/ssu045; Sakuraba Y, 2013, BIOCHEM BIOPH RES CO, V430, P32, DOI 10.1016/j.bbrc.2012.11.050; Sakuraba Y, 2012, PLANT CELL, V24, P507, DOI 10.1105/tpc.111.089474; Sakuta M., 2011, PLANT METABOLISM BIO, P343; Sato Y, 2007, P NATL ACAD SCI USA, V104, P14169, DOI 10.1073/pnas.0705521104; Schelbert S, 2009, PLANT CELL, V21, P767, DOI 10.1105/tpc.108.064089; Schenk N, 2007, FEBS LETT, V581, P5517, DOI 10.1016/j.febslet.2007.10.060; Shemer TA, 2008, PLANT PHYSIOL, V148, P108, DOI 10.1104/pp.108.124933; Tanaka A, 2006, CURR OPIN PLANT BIOL, V9, P248, DOI 10.1016/j.pbi.2006.03.011; Tanaka R, 2003, PLANT CELL PHYSIOL, V44, P1266, DOI 10.1093/pcp/pcg172; Tanaka Y, 2008, PLANT J, V54, P733, DOI 10.1111/j.1365-313X.2008.03447.x; Tanase K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-292; WEISS D, 1990, PHYSIOL PLANTARUM, V78, P345, DOI 10.1111/j.1399-3054.1990.tb09046.x; Zapata M, 2000, MAR ECOL PROG SER, V195, P29, DOI 10.3354/meps195029	46	50	57	10	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113738	10.1371/journal.pone.0113738	http://dx.doi.org/10.1371/journal.pone.0113738			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470367	Green Submitted, Green Published, gold			2022-12-26	WOS:000349128700040
J	Fodale, V; Kegulian, NC; Verani, M; Cariulo, C; Azzollini, L; Petricca, L; Daldin, M; Boggio, R; Padova, A; Kuhn, R; Pacifici, R; Macdonald, D; Schoenfeld, RC; Park, H; Isas, JM; Langen, R; Weiss, A; Caricasole, A				Fodale, Valentina; Kegulian, Natalie C.; Verani, Margherita; Cariulo, Cristina; Azzollini, Lucia; Petricca, Lara; Daldin, Manuel; Boggio, Roberto; Padova, Alessandro; Kuhn, Rainer; Pacifici, Robert; Macdonald, Douglas; Schoenfeld, Ryan C.; Park, Hyunsun; Isas, J. Mario; Langen, Ralf; Weiss, Andreas; Caricasole, Andrea			Polyglutamine- and Temperature-Dependent Conformational Rigidity in Mutant Huntingtin Revealed by Immunoassays and Circular Dichroism Spectroscopy	PLOS ONE			English	Article							N-TERMINAL FRAGMENTS; SECONDARY STRUCTURE; FLANKING SEQUENCES; POSTTRANSLATIONAL MODIFICATIONS; MONOCLONAL-ANTIBODIES; STRUCTURAL FEATURES; DYSTROPHIC NEURITES; EXPANDED HUNTINGTIN; NEURONAL NUCLEI; EXPORT SIGNAL	Background: In Huntington's disease, expansion of a CAG triplet repeat occurs in exon 1 of the huntingtin gene (HTT), resulting in a protein bearing>35 polyglutamine residues whose N-terminal fragments display a high propensity to misfold and aggregate. Recent data demonstrate that polyglutamine expansion results in conformational changes in the huntingtin protein (HTT), which likely influence its biological and biophysical properties. Developing assays to characterize and measure these conformational changes in isolated proteins and biological samples would advance the testing of novel therapeutic approaches aimed at correcting mutant HTT misfolding. Time-resolved Forster energy transfer (TR-FRET)-based assays represent high-throughput, homogeneous, sensitive immunoassays widely employed for the quantification of proteins of interest. TR-FRET is extremely sensitive to small distances and can therefore provide conformational information based on detection of exposure and relative position of epitopes present on the target protein as recognized by selective antibodies. We have previously reported TR-FRET assays to quantify HTT proteins based on the use of antibodies specific for different amino-terminal HTT epitopes. Here, we investigate the possibility of interrogating HTT protein conformation using these assays. Methodology/Principal Findings: By performing TR-FRET measurements on the same samples (purified recombinant proteins or lysates from cells expressing HTT fragments or full length protein) at different temperatures, we have discovered a temperature-dependent, reversible, polyglutamine-dependent conformational change of wild type and expanded mutant HTT proteins. Circular dichroism spectroscopy confirms the temperature and polyglutamine-dependent change in HTTstructure, revealing an effect of polyglutamine length and of temperature on the alpha-helical content of the protein. Conclusions/Significance: The temperature-and polyglutamine-dependent effects observed with TR-FRET on HTT proteins represent a simple, scalable, quantitative and sensitive assay to identify genetic and pharmacological modulators of mutant HTT conformation, and potentially to assess the relevance of conformational changes during onset and progression of Huntington's disease.	[Fodale, Valentina; Verani, Margherita; Cariulo, Cristina; Azzollini, Lucia; Petricca, Lara; Daldin, Manuel; Boggio, Roberto; Padova, Alessandro; Kuhn, Rainer; Weiss, Andreas; Caricasole, Andrea] IRBM Promidis, Rome, Italy; [Kegulian, Natalie C.; Isas, J. Mario; Langen, Ralf] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA; [Pacifici, Robert; Macdonald, Douglas; Schoenfeld, Ryan C.; Park, Hyunsun] CHDI Management CHDI Fdn, Los Angeles, CA USA	University of Southern California	Langen, R (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Zilkha Neurogenet Inst, Los Angeles, CA 90033 USA.	langen@usc.edu; andreas.weiss@evotec.com; a.caricasole@irbm.it	Kegulian, Natalie/AFF-8981-2022	Kegulian, Natalie/0000-0002-8574-1099	CHDI Foundation; Hereditary Disease Foundation; European Community [264508]	CHDI Foundation; Hereditary Disease Foundation; European Community(European Commission)	CHDI Foundation is a privately funded nonprofit biomedical research organization exclusively dedicated to discovering and developing therapeutics that slow the progression of Huntington's disease. CHDI Foundation conducts research in a number of different ways; for the purposes of this manuscript, research was conducted at IRBM Promidis and the University of Southern California under a sponsored research agreement. RL, MJI and NCK are also supported by the Hereditary Disease Foundation. LP has received funding from the European Community's Seventh Framework Programme FP7/2010 under grant agreement no. 264508. The authors listed all contributed to the conception, planning, and direction of the research, including generation, analysis, and interpretation of the data.	Aiken CT, 2009, J BIOL CHEM, V284, P29427, DOI 10.1074/jbc.M109.013193; [Anonymous], 1993, CELL, V72, P971; Ansaloni A, 2014, ANGEW CHEM INT EDIT, V53, P1928, DOI 10.1002/anie.201307510; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Atwal RS, 2011, NAT CHEM BIOL, V7, P453, DOI [10.1038/NCHEMBIO.582, 10.1038/nchembio.582]; Baldo B, 2012, CHEM BIOL, V19, P264, DOI 10.1016/j.chembiol.2011.12.020; Bennett MJ, 2002, P NATL ACAD SCI USA, V99, P11634, DOI 10.1073/pnas.182393899; Blum ES, 2013, TRENDS CELL BIOL, V23, P168, DOI 10.1016/j.tcb.2012.11.003; Brooks Elizabeth, 2004, V277, P103; Bugg CW, 2012, J BIOL CHEM, V287, P31739, DOI 10.1074/jbc.M112.353839; Caron NS, 2013, P NATL ACAD SCI USA, V110, P14610, DOI 10.1073/pnas.1301342110; Crick SL, 2013, P NATL ACAD SCI USA, V110, P20075, DOI 10.1073/pnas.1320626110; Cui XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep05601; Darnell G, 2007, J MOL BIOL, V374, P688, DOI 10.1016/j.jmb.2007.09.023; Darnell GD, 2009, BIOPHYS J, V97, P2295, DOI 10.1016/j.bpj.2009.07.062; Degorce Francois, 2009, Curr Chem Genomics, V3, P22, DOI 10.2174/1875397300903010022; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Dlugosz M, 2011, J PHYS CHEM B, V115, P11597, DOI 10.1021/jp206373g; Duennwald ML, 2006, P NATL ACAD SCI USA, V103, P11045, DOI 10.1073/pnas.0604547103; Ehrnhoefer DE, 2011, NEUROSCIENTIST, V17, P475, DOI 10.1177/1073858410390378; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Gusella J, 2002, NAT REV GENET, V3, P72, DOI 10.1038/nrg706; Gusella JF, 2000, NAT REV NEUROSCI, V1, P109, DOI 10.1038/35039051; Gutekunst CA, 1999, J NEUROSCI, V19, P2522; Hazeki N, 1999, BIOCHEM BIOPH RES CO, V256, P361, DOI 10.1006/bbrc.1999.0337; Hoffner G, 2005, J NEUROCHEM, V95, P125, DOI 10.1111/j.1471-4159.2005.03348.x; Jayasinghe SA, 2004, J BIOL CHEM, V279, P48420, DOI 10.1074/jbc.M406853200; Khoshnan A, 2002, P NATL ACAD SCI USA, V99, P1002, DOI 10.1073/pnas.022631799; Kim MW, 2009, STRUCTURE, V17, P1205, DOI 10.1016/j.str.2009.08.002; Kim M, 2013, PRION, V7, P221, DOI 10.4161/pri.23807; Klein FAC, 2013, HUM MOL GENET, V22, P4215, DOI 10.1093/hmg/ddt273; Ko J, 2001, BRAIN RES BULL, V56, P319, DOI 10.1016/S0361-9230(01)00599-8; Kuemmerle S, 1999, ANN NEUROL, V46, P842; Lakhani VV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000772; Landles C, 2010, J BIOL CHEM, V285, P8808, DOI 10.1074/jbc.M109.075028; LANGSETMO K, 1989, BIOCHEMISTRY-US, V28, P3211, DOI 10.1021/bi00434a015; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; Legleiter J, 2010, J BIOL CHEM, V285, P14777, DOI 10.1074/jbc.M109.093708; Legleiter J, 2009, J BIOL CHEM, V284, P21647, DOI 10.1074/jbc.M109.016923; Lennon BW, 2000, SCIENCE, V289, P1190, DOI 10.1126/science.289.5482.1190; Liebman SW, 2010, NAT CHEM BIOL, V6, P7, DOI 10.1038/nchembio.279; Lunkes A, 2002, MOL CELL, V10, P259, DOI 10.1016/S1097-2765(02)00602-0; Luo PZ, 1997, BIOCHEMISTRY-US, V36, P8413, DOI 10.1021/bi9707133; Ma K, 2003, BIOCHEM J, V374, P687, DOI 10.1042/BJ20030702; Maat-Schieman MLC, 1999, J NEUROPATH EXP NEUR, V58, P129, DOI 10.1097/00005072-199902000-00003; Maiuri T, 2013, HUM MOL GENET, V22, P1383, DOI 10.1093/hmg/dds554; MATHIS G, 1993, CLIN CHEM, V39, P1953; Michalek M, 2013, BIOPHYS J, V105, P699, DOI 10.1016/j.bpj.2013.06.030; Nucifora LG, 2012, J BIOL CHEM, V287, P16017, DOI 10.1074/jbc.M111.252577; O'Rourke JG, 2013, CELL REP, V4, P362, DOI 10.1016/j.celrep.2013.06.034; Orr HT, 2012, CURR OPIN GENET DEV, V22, P251, DOI 10.1016/j.gde.2012.01.001; Paganetti P, 2009, CHEMBIOCHEM, V10, P1678, DOI 10.1002/cbic.200900131; Peters-Libeu C, 2005, ACTA CRYSTALLOGR F, V61, P1065, DOI 10.1107/S1744309105036547; Ratovitski T, 2009, J BIOL CHEM, V284, P10855, DOI 10.1074/jbc.M804813200; Rohl CA, 1997, BIOCHEMISTRY-US, V36, P8435, DOI 10.1021/bi9706677; Southwell AL, 2008, J NEUROSCI, V28, P9013, DOI 10.1523/JNEUROSCI.2747-08.2008; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; Steffan JS, 2001, NATURE, V413, P739, DOI 10.1038/35099568; Tam S, 2009, NAT STRUCT MOL BIOL, V16, P1279, DOI 10.1038/nsmb.1700; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Todd TW, 2013, MOL CELLS, V36, P185, DOI 10.1007/s10059-013-0167-x; Truant R, 2008, FEBS J, V275, P4252, DOI 10.1111/j.1742-4658.2008.06561.x; Wang CE, 2008, HUM MOL GENET, V17, P2738, DOI 10.1093/hmg/ddn175; Wanker EE, 2000, BIOL CHEM, V381, P937, DOI 10.1515/BC.2000.114; Weiss A, 2009, ANAL BIOCHEM, V395, P8, DOI 10.1016/j.ab.2009.08.001; Wetzel R, 2012, J MOL BIOL, V421, P466, DOI 10.1016/j.jmb.2012.01.030; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Williamson TE, 2010, J MOL BIOL, V396, P1295, DOI 10.1016/j.jmb.2009.12.017; Zheng ZQ, 2013, J BIOL CHEM, V288, P6063, DOI 10.1074/jbc.M112.413575	70	29	29	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112262	10.1371/journal.pone.0112262	http://dx.doi.org/10.1371/journal.pone.0112262			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464275	Green Submitted, gold, Green Published			2022-12-26	WOS:000345869700012
J	Jahangiri-Noudeh, Y; Akbarpour, S; Lotfaliany, M; Zafari, N; Khalili, D; Tohidi, M; Mansournia, MA; Azizi, F; Hadaegh, F				Jahangiri-Noudeh, Younes; Akbarpour, Samaneh; Lotfaliany, Mojtaba; Zafari, Neda; Khalili, Davood; Tohidi, Maryam; Mansournia, Mohammad Ali; Azizi, Fereidoun; Hadaegh, Farzad			Trends in Cardiovascular Disease Risk Factors in People with and without Diabetes Mellitus: A Middle Eastern Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; BODY-MASS INDEX; FOLLOW-UP; SECULAR TRENDS; NUTRITION TRANSITION; NATIONAL-HEALTH; OBESITY; WEIGHT; ADULTS; HYPERTENSION	Aims/Hypothesis: To investigate secular trends in cardiovascular disease (CVD) risk factors during a decade of follow-up in a Middle Eastern cohort, and to compare observed trends between diabetic and non-diabetic populations. Methods: In a population of 6181 participants (2622 males and 3559 females), diabetes status and CVD risk factors were evaluated in 4 study phases from 1999-2011. 1045 subjects had type 2 diabetes mellitus at baseline and 5136 participants were diabetes-free. To examine the trends of CVD risk factors, generalized estimation equation models were constructed. The interaction between the diabetes status and each phase of the study was checked in a separate model. Results: During the follow-up period diabetic females significantly gained better control of their blood pressure, serum low density lipoprotein cholesterol and general and central obesity measures compared to non-diabetic counterparts, although 60% of them had high BP and 64% had high serum LDL-C levels till the end of the study. Diabetic males however, experienced significantly better control on their serum LDL-C and general and central obesity measures compared to their non-diabetic controls; but 24% of them were still smoker, 63% had high BP and 60% had high serum LDL-C levels at the end of the follow-up (all Ps(interaction)<0.05). Use of lipid-lowering and antihypertensive medications increased consistently in both diabetic and non-diabetic populations. Conclusions/Interpretation: Although CVD risk factors have been controlled to some extent among diabetic population in Iran, still high numbers of people with diabetes have uncontrolled CVD risk factors that prompt more attention.	[Jahangiri-Noudeh, Younes; Akbarpour, Samaneh; Lotfaliany, Mojtaba; Zafari, Neda; Khalili, Davood; Tohidi, Maryam; Hadaegh, Farzad] Shahid Beheshti Univ Med Sci, Prevent Metab Disorders Res Ctr, Res Inst Endocrine Sci, Tehran, Iran; [Mansournia, Mohammad Ali] Univ Tehran Med Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Tehran, Iran; [Azizi, Fereidoun] Shahid Beheshti Univ Med Sci, Endocrine Res Ctr, Res Inst Endocrine Sci, Tehran, Iran	Shahid Beheshti University Medical Sciences; Tehran University of Medical Sciences; Shahid Beheshti University Medical Sciences	Hadaegh, F (corresponding author), Shahid Beheshti Univ Med Sci, Prevent Metab Disorders Res Ctr, Res Inst Endocrine Sci, Tehran, Iran.	fzhadaegh@endocrine.ac.ir	Azizi, Fereidoun/ABD-4136-2021; Lotfaliany, Mojtaba/ABB-6325-2020; Khalili, Davood/T-2913-2017; Zafari, Neda/X-7116-2019; hadaegh, farzad/K-2460-2017; Tohidi, Maryam/V-2261-2019	Azizi, Fereidoun/0000-0002-6470-2517; Khalili, Davood/0000-0003-4956-1039; Mansournia, Mohammad Ali/0000-0003-3343-2718; hadaegh, farzad/0000-0002-0352-8666; Hadaegh, Farzad/0000-0002-8935-2744; Jahangiri, Younes/0000-0002-3328-2919; Lotfaliany Abrand Abadi, Mojtaba/0000-0001-6594-9004	National Research Council of the Islamic Republic of Iran [121]	National Research Council of the Islamic Republic of Iran	This study was supported by Grant No. 121 from the National Research Council of the Islamic Republic of Iran. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Arnett DK, 2002, AM J EPIDEMIOL, V156, P929, DOI 10.1093/aje/kwf133; Azizi F, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-5; Bozorgmanesh M, 2013, BLOOD PRESSURE, V22, P317, DOI 10.3109/08037051.2013.769294; Bozorgmanesh M, 2012, ACTA DIABETOL, V49, P341, DOI 10.1007/s00592-011-0298-5; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Collins R, 2003, LANCET, V361, P2005; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; Derakhshan A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102563; Ehteshami-Afshar S, 2014, ANN HUM BIOL, V41, P249, DOI 10.3109/03014460.2013.853834; Erlich DR, 2014, AM FAM PHYSICIAN, V89, P256; Fagard RH, 2009, DIABETES CARE, V32, pS429, DOI 10.2337/dc09-S354; Ford ES, 2011, DIABETES CARE, V34, P1337, DOI 10.2337/dc10-2251; Ford ES, 2013, CARDIOVASC; Ghassemi H, 2002, PUBLIC HEALTH NUTR, V5, P149, DOI 10.1079/PHN2001287; Global Health Observatory Data Repository WHO, 2013, OV OB MEAN BOD MASS; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Hadaegh F, 2009, INT J OBESITY, V33, P1437, DOI 10.1038/ijo.2009.180; Hadaegh F, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-84; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; Hata J, 2013, CIRCULATION, V128, P1198, DOI 10.1161/CIRCULATIONAHA.113.002424; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Imperatore G, 2004, AM J EPIDEMIOL, V160, P531, DOI 10.1093/aje/kwh232; Ingelsson E, 2009, ARCH INTERN MED, V169, P279, DOI 10.1001/archinternmed.2008.561; Keaney JF, 2014, NEW ENGL J MED, V370, P275, DOI 10.1056/NEJMms1314569; Kheirandish M, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-20; Leibson CL, 2001, DIABETES CARE, V24, P1584, DOI 10.2337/diacare.24.9.1584; Looker HC, 2001, DIABETES CARE, V24, P1917, DOI 10.2337/diacare.24.11.1917; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Motlagh B, 2009, EUR J CARDIOV PREV R, V16, P268, DOI 10.1097/HJR.0b013e328322ca1b; Onat A, 2014, CURR PHARM DESIGN, V20, P575, DOI 10.2174/138161282004140213145551; Preis SR, 2009, CIRCULATION, V120, P212, DOI 10.1161/CIRCULATIONAHA.108.846519; Rasouli B, 2013, DIABETES CARE, V36, P604, DOI 10.2337/dc12-0913; Ridderstrale M, 2006, J INTERN MED, V259, P314, DOI 10.1111/j.1365-2796.2006.01617.x; Romero-Corral A, 2010, EUR HEART J, V31, P737, DOI 10.1093/eurheartj/ehp487; Samaranayaka S, 2013, HLTH SURVEY ENGLAND; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Shepherd J, 2006, DIABETES CARE, V29, P1220, DOI 10.2337/dc05-2465; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; Wing RR, 2011, DIABETES CARE, V34, P1481, DOI 10.2337/dc10-2415; Wing RR, 2010, ARCH INTERN MED, V170, P1566, DOI 10.1001/archinternmed.2010.334; Yunqin C, 2010, LIPIDS HLTH DIS, V9; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248	43	35	36	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112639	10.1371/journal.pone.0112639	http://dx.doi.org/10.1371/journal.pone.0112639			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461381	gold, Green Published			2022-12-26	WOS:000345869700021
J	Li, XM; Fan, T; Song, JJ; Sun, W; Xia, KF; Liao, JP; Zhang, MY				Li, Xiumei; Fan, Tian; Song, Juanjuan; Sun, Wei; Xia, Kuaifei; Liao, Jingping; Zhang, Mingyong			Functional Conservation and Divergence of Four Ginger AP1/AGL9 MADS-Box Genes Revealed by Analysis of Their Expression and Protein-Protein Interaction, and Ectopic Expression of AhFUL Gene in Arabidopsis	PLOS ONE			English	Article							FLORAL HOMEOTIC GENES; BIMOLECULAR FLUORESCENCE COMPLEMENTATION; DNA-BINDING PROPERTIES; FLOWER DEVELOPMENT; ORGAN IDENTITY; DOMAIN PROTEINS; EVOLUTIONARY ANALYSIS; TRANSCRIPTION FACTORS; MOLECULAR EVOLUTION; AP1/SQUA SUBFAMILY	Alpinia genus are known generally as ginger-lilies for showy flowers in the ginger family, Zingiberaceae, and their floral morphology diverges from typical monocotyledon flowers. However, little is known about the functions of ginger MADS-box genes in floral identity. In this study, four AP1/AGL9 MADS-box genes were cloned from Alpinia hainanensis, and protein-protein interactions (PPIs) and roles of the four genes in floral homeotic conversion and in floral evolution are surveyed for the first time. AhFUL is clustered to the AP1lineage, AhSEP4 and AhSEP3b to the SEP lineage, and AhAGL6-like to the AGL6 lineage. The four genes showed conserved and divergent expression patterns, and their encoded proteins were localized in the nucleus. Seven combinations of PPI (AhFUL-AhSEP4, AhFUL-AhAGL6-like, AhFUL-AhSEP3b, AhSEP4-AhAGL6-like, AhSEP4-AhSEP3b, AhAGL6-like-AhSEP3b, and AhSEP3b-AhSEP3b) were detected, and the PPI patterns in the AP1/AGL9 lineage revealed that five of the 10 possible combinations are conserved and three are variable, while conclusions cannot yet be made regarding the other two. Ectopic expression of AhFUL in Arabidopsis thaliana led to early flowering and floral organ homeotic conversion to sepal-like or leaf-like. Therefore, we conclude that the four A. hainanensis AP1/AGL9 genes show functional conservation and divergence in the floral identity from other MADS-box genes.	[Li, Xiumei; Fan, Tian; Song, Juanjuan; Liao, Jingping] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou 510650, Guangdong, Peoples R China; [Li, Xiumei; Fan, Tian] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Sun, Wei] Chinese Acad Chinese Med Sci, Inst Chinese Mat Med, Beijing 100700, Peoples R China; [Xia, Kuaifei; Zhang, Mingyong] Chinese Acad Sci, South China Bot Garden, Key Lab South China Agr Plant Mol Anal & Genet Im, Guangzhou 510650, Guangdong, Peoples R China	Chinese Academy of Sciences; South China Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; China Academy of Chinese Medical Sciences; Institute of Chinese Materia Medica, CACMS; Chinese Academy of Sciences; South China Botanical Garden, CAS	Liao, JP (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou 510650, Guangdong, Peoples R China.	liaojp@scbg.ac.cn; zhangmy@scbg.ac.cn	Zhang, Mingyong/GQZ-6217-2022; li, xiu/GXV-1745-2022		South China Botanical Garden-Shanghai Institute of Plant Physiology & Ecology Joint Fund; National Natural Science Foundation of China [30870173, 31200176, 30900089, 31272240]; Natural Science Foundation of Guangdong [S2013020012830]	South China Botanical Garden-Shanghai Institute of Plant Physiology & Ecology Joint Fund; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province)	This work was supported by South China Botanical Garden-Shanghai Institute of Plant Physiology & Ecology Joint Fund, the National Natural Science Foundation of China (grants 30870173/31200176/30900089/31272240), and the Natural Science Foundation of Guangdong (S2013020012830). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez B, 2010, FLOWER DEV; ANGENENT GC, 1994, PLANT J, V5, P33, DOI 10.1046/j.1365-313X.1994.5010033.x; Bartlett ME, 2010, NEW PHYTOL, V187, P521, DOI 10.1111/j.1469-8137.2010.03279.x; BENFEY PN, 1990, SCIENCE, V250, P959, DOI 10.1126/science.250.4983.959; Bernaudat F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029191; BOWMAN JL, 1991, DEVELOPMENT, V112, P1; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; Burko Y, 2013, PLANT CELL, V25, P2070, DOI 10.1105/tpc.113.113035; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Chanderbali AS, 2006, INT J PLANT SCI, V167, P1075, DOI 10.1086/507586; Chang YY, 2009, PLANT CELL PHYSIOL, V50, P1425, DOI 10.1093/pcp/pcp087; Chen DH, 2007, PLANTA, V226, P369, DOI 10.1007/s00425-007-0488-0; Chen MK, 2008, PLANT CELL PHYSIOL, V49, P704, DOI 10.1093/pcp/pcn046; Christensen AR, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-4; Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Cui RF, 2010, PLANT J, V61, P767, DOI 10.1111/j.1365-313X.2009.04101.x; Ditta G, 2004, CURR BIOL, V14, P1935, DOI 10.1016/j.cub.2004.10.028; Doi K, 2004, GENE DEV, V18, P926, DOI 10.1101/gad.1189604; DOYLE JJ, 1994, SYST BIOL, V43, P307; Egea-Cortines M, 1999, EMBO J, V18, P5370, DOI 10.1093/emboj/18.19.5370; Elitzur T, 2010, J EXP BOT, V61, P1523, DOI 10.1093/jxb/erq017; Favaro R, 2003, PLANT CELL, V15, P2603, DOI 10.1105/tpc.015123; Ferrandiz C, 2000, DEVELOPMENT, V127, P725; Ferrario S, 2006, PLANT PHYSIOL, V140, P890, DOI 10.1104/pp.105.072660; Ferrario S, 2003, PLANT CELL, V15, P914, DOI 10.1105/tpc.010280; Ferrario S, 2004, CURR OPIN PLANT BIOL, V7, P84, DOI 10.1016/j.pbi.2003.11.003; Fornara F, 2004, PLANT PHYSIOL, V135, P2207, DOI 10.1104/pp.104.045039; Gu Q, 1998, DEVELOPMENT, V125, P1509; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; GUSTAFSONBROWN C, 1994, CELL, V76, P131, DOI 10.1016/0092-8674(94)90178-3; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hernandez-Hernandez T, 2007, MOL BIOL EVOL, V24, P465, DOI 10.1093/molbev/msl182; Honma T, 2001, NATURE, V409, P525, DOI 10.1038/35054083; Hsu HF, 2003, PLANT CELL PHYSIOL, V44, P783, DOI 10.1093/pcp/pcg099; Hsu WH, 2014, PLANT J, V77, P1, DOI 10.1111/tpj.12363; Huang H, 1996, PLANT CELL, V8, P81, DOI 10.1105/tpc.8.1.81; HUIJSER P, 1992, EMBO J, V11, P1239, DOI 10.1002/j.1460-2075.1992.tb05168.x; Immink RGH, 2002, P NATL ACAD SCI USA, V99, P2416, DOI 10.1073/pnas.042677699; Immink RGH, 2010, SEMIN CELL DEV BIOL, V21, P87, DOI 10.1016/j.semcdb.2009.10.004; Irish VF, 2005, CURR OPIN GENET DEV, V15, P454, DOI 10.1016/j.gde.2005.06.001; Kanno A, 2003, PLANT MOL BIOL, V52, P831, DOI 10.1023/A:1025070827979; Kaufmann K, 2005, GENE, V347, P183, DOI 10.1016/j.gene.2004.12.014; Kaufmann K, 2009, PLOS BIOL, V7, P854, DOI 10.1371/journal.pbio.1000090; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kim S, 2005, PLANT J, V43, P724, DOI 10.1111/j.1365-313X.2005.02487.x; Kim S, 2006, MOL BIOL EVOL, V23, P107, DOI 10.1093/molbev/msj014; Kirchoff B. K., 1988, Aspects of floral development. Proceedings of the double symposium "Floral development: evolutionary aspects and special topics" held at the 14th International Botanical Congress in West Berlin, 24 July-1 Aug. 1987., P45; KIRCHOFF BK, 1991, AM J BOT, V78, P833, DOI 10.2307/2445074; Kobayashi K, 2012, PLANT CELL, V24, P1848, DOI 10.1105/tpc.112.097105; Kojima S, 2002, PLANT CELL PHYSIOL, V43, P1096, DOI 10.1093/pcp/pcf156; KOMAKI MK, 1988, DEVELOPMENT, V104, P195; Komiya R, 2009, DEVELOPMENT, V136, P3443, DOI 10.1242/dev.040170; Kramer EM, 2005, CURR OPIN PLANT BIOL, V8, P13, DOI 10.1016/j.pbi.2004.09.019; Kress WJ, 2001, SYST BIOL, V50, P926, DOI 10.1080/106351501753462885; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Lee LY, 2008, PLANT METHODS, V4, DOI 10.1186/1746-4811-4-24; Leseberg CH, 2008, J EXP BOT, V59, P2253, DOI 10.1093/jxb/ern094; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Li HF, 2011, PLANT CELL, V23, P2536, DOI 10.1105/tpc.111.087262; Li HF, 2010, CELL RES, V20, P299, DOI 10.1038/cr.2009.143; Li QJ, 2001, NATURE, V411, P260; Lin EP, 2009, PLANTA, V231, P109, DOI 10.1007/s00425-009-1033-0; Litt A, 2003, GENETICS, V165, P821; Litt A, 2007, INT J PLANT SCI, V168, P73, DOI 10.1086/509662; Liu C, 2009, DEV CELL, V16, P711, DOI 10.1016/j.devcel.2009.03.011; Ma H, 2000, CELL, V101, P5, DOI 10.1016/S0092-8674(00)80618-2; Malcomber ST, 2005, TRENDS PLANT SCI, V10, P427, DOI 10.1016/j.tplants.2005.07.008; MANDEL MA, 1995, NATURE, V377, P522, DOI 10.1038/377522a0; MANDEL MA, 1995, PLANT CELL, V7, P1763, DOI 10.1105/tpc.7.11.1763; Mendes MA, 2013, PLANT CELL, V25, P2560, DOI 10.1105/tpc.112.108688; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nam J, 2003, MOL BIOL EVOL, V20, P1435, DOI 10.1093/molbev/msg152; Ohmori S, 2009, PLANT CELL, V21, P3008, DOI 10.1105/tpc.109.068742; Pan ZJ, 2014, NEW PHYTOL, V202, P1024, DOI 10.1111/nph.12723; Pelaz S, 2000, NATURE, V405, P200, DOI 10.1038/35012103; PNUELI L, 1994, PLANT CELL, V6, P175, DOI 10.1105/tpc.6.2.175; Purugganan MD, 1997, J MOL EVOL, V45, P392, DOI 10.1007/PL00006244; PURUGGANAN MD, 1995, GENETICS, V140, P345; Reinheimer R, 2009, PLANT CELL, V21, P2591, DOI 10.1105/tpc.109.068239; Riechmann JL, 1996, NUCLEIC ACIDS RES, V24, P3134, DOI 10.1093/nar/24.16.3134; Riechmann JL, 1996, P NATL ACAD SCI USA, V93, P4793, DOI 10.1073/pnas.93.10.4793; Rijpkema AS, 2007, CURR OPIN PLANT BIOL, V10, P32, DOI 10.1016/j.pbi.2006.11.010; Rijpkema AS, 2009, PLANT J, V60, P1, DOI 10.1111/j.1365-313X.2009.03917.x; Ruelens P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3280; Ruokolainen S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-129; SAVIDGE B, 1995, PLANT CELL, V7, P721, DOI 10.1105/tpc.7.6.721; SCHULTZ EA, 1993, DEVELOPMENT, V119, P745; Shan HY, 2007, MOL PHYLOGENET EVOL, V44, P26, DOI 10.1016/j.ympev.2007.02.016; Shchennikova AV, 2004, PLANT PHYSIOL, V134, P1632, DOI 10.1104/pp.103.036665; Soltis DE, 2002, TRENDS PLANT SCI, V7, P22, DOI 10.1016/S1360-1385(01)02098-2; Soltis DE, 2007, TRENDS PLANT SCI, V12, P358, DOI 10.1016/j.tplants.2007.06.012; Song JJ, 2010, PLANT MOL BIOL REP, V28, P264, DOI 10.1007/s11105-009-0147-7; Song JJ, 2010, MOL BIOL REP, V37, P917, DOI 10.1007/s11033-009-9719-8; Sun W, 2014, ANN BOT-LONDON, V113, P653, DOI 10.1093/aob/mct301; Tang XA, 2010, PLANT PHYSIOL, V154, P1855, DOI 10.1104/pp.110.161661; Theissen G, 2001, CURR OPIN PLANT BIOL, V4, P75, DOI 10.1016/S1369-5266(00)00139-4; Theissen G, 2000, PLANT MOL BIOL, V42, P115, DOI 10.1023/A:1006332105728; Theissen G, 1996, J MOL EVOL, V43, P484, DOI 10.1007/PL00006110; Theissen G, 2001, NATURE, V409, P469, DOI 10.1038/35054172; Theissen G, 2007, ANN BOT-LONDON, V100, P603, DOI 10.1093/aob/mcm143; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TROBNER W, 1992, EMBO J, V11, P4693, DOI 10.1002/j.1460-2075.1992.tb05574.x; Van Tunen A.J., 1993, FLOWERING NEWSLETTER, V16, P33; Vandenbussche M, 2003, NUCLEIC ACIDS RES, V31, P4401, DOI 10.1093/nar/gkg642; Veron AS, 2007, MOL BIOL EVOL, V24, P670, DOI 10.1093/molbev/ms1197; Viaene T, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-148; Wang BG, 2011, J PLANT GROWTH REGUL, V30, P343, DOI 10.1007/s00344-011-9196-x; Wu FH, 2009, PLANT METHODS, V5, DOI 10.1186/1746-4811-5-16; Xia YM, 2009, J INTEGR PLANT BIOL, V51, P155, DOI 10.1111/j.1744-7909.2008.00782.x; Yano M, 2000, PLANT CELL, V12, P2473, DOI 10.1105/tpc.12.12.2473; Yockteng R, 2013, MOL BIOL EVOL, V30, P2401, DOI 10.1093/molbev/mst137; Yoo MJ, 2010, INT J PLANT SCI, V171, P121, DOI 10.1086/648986; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yoo SK, 2011, PLANT J, V65, P62, DOI 10.1111/j.1365-313X.2010.04402.x; Zahn LM, 2005, GENETICS, V169, P2209, DOI 10.1534/genetics.104.037770; Zhang WX, 2013, J INTEGR PLANT BIOL, V55, P597, DOI 10.1111/jipb.12075	119	24	27	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114134	10.1371/journal.pone.0114134	http://dx.doi.org/10.1371/journal.pone.0114134			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461565	gold, Green Submitted, Green Published			2022-12-26	WOS:000345869700102
J	Xi, HF; Ma, L; Liu, GT; Wang, N; Wang, JF; Wang, LN; Dai, ZW; Li, SH; Wang, LJ				Xi, Huifen; Ma, Ling; Liu, Guotian; Wang, Nian; Wang, Junfang; Wang, Lina; Dai, Zhanwu; Li, Shaohua; Wang, Lijun			Transcriptomic Analysis of Grape (Vitis vinifera L.) Leaves after Exposure to Ultraviolet C Irradiation	PLOS ONE			English	Article							UV-C; CABERNET-SAUVIGNON; ANTIOXIDANT ENZYMES; STRESS RESPONSES; RADIATION; BIOSYNTHESIS; PLANTS; RESVERATROL; GENES; ACCUMULATION	Background: Only a small amount of solar ultraviolet C (UV-C) radiation reaches the Earth's surface. This is because of the filtering effects of the stratospheric ozone layer. Artificial UV-C irradiation is used on leaves and fruits to stimulate different biological processes in plants. Grapes are a major fruit crop and are grown in many parts of the world. Research has shown that UV-C irradiation induces the biosynthesis of phenols in grape leaves. However, few studies have analyzed the overall changes in gene expression in grape leaves exposed to UV-C. Methodology/Principal Findings: In the present study, transcriptional responses were investigated in grape (Vitis vinifera L.) leaves before and after exposure to UV-C irradiation (6 W.m(-2) for 10 min) using an Affymetrix Vitis vinifera (Grape) Genome Array (15,700 transcripts). A total of 5274 differentially expressed probe sets were defined, including 3564 (67.58%) probe sets that appeared at both 6 and 12 h after exposure to UV-C irradiation but not before exposure. A total of 468 (8.87%) probe sets and 1242 (23.55%) probe sets were specifically expressed at these times. The probe sets were associated with a large number of important traits and biological pathways, including cell rescue (i.e., antioxidant enzymes), protein fate (i.e., HSPs), primary and secondary metabolism, and transcription factors. Interestingly, some of the genes involved in secondary metabolism, such as stilbene synthase, responded intensely to irradiation. Some of the MYB and WRKY family transcription factors, such as VvMYBPA1, VvMYB14, VvMYB4, WRKY57-like, and WRKY 65, were also strongly up-regulated (about 100 to 200 fold). Conclusions: UV-C irridiation has an important role in some biology processes, especially cell rescue, protein fate, secondary metabolism, and regulation of transcription. These results opened up ways of exploring the molecular mechanisms underlying the effects of UV-C irradiation on grape leaves and have great implications for further studies.	[Xi, Huifen; Ma, Ling; Liu, Guotian; Wang, Junfang; Wang, Lina; Li, Shaohua; Wang, Lijun] Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China; [Xi, Huifen; Ma, Ling; Liu, Guotian; Wang, Junfang; Wang, Lina; Li, Shaohua; Wang, Lijun] Chinese Acad Sci, Inst Bot, Beijing Key Lab Grape Sci & Enol, Beijing, Peoples R China; [Xi, Huifen; Ma, Ling; Liu, Guotian; Wang, Junfang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Lina; Li, Shaohua] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan, Peoples R China; [Dai, Zhanwu] INRA, ISVV, UMR EGFV 1287, Villenave Dornon, France	Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; INRAE; UDICE-French Research Universities; Universite de Bordeaux	Li, SH (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Resources, Beijing, Peoples R China.	Shhli@ibcas.ac.cn; ljwang@ibcas.ac.cn	Dai, Zhanwu/V-6274-2019; Dai, Zhanwu/F-7355-2019	Dai, Zhanwu/0000-0002-7625-8337; Dai, Zhanwu/0000-0002-7625-8337; Wang, lina/0000-0001-5526-5979	National Natural Science Foundation of China [31171918]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 31171918). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bais AJ, 2000, AUST J PLANT PHYSIOL, V27, P425; Bogs J, 2007, PLANT PHYSIOL, V143, P1347, DOI 10.1104/pp.106.093203; Bomal C, 2008, J EXP BOT, V59, P3925, DOI 10.1093/jxb/ern234; Bonomelli A, 2004, AM J ENOL VITICULT, V55, P51; Borie B, 2004, AM J ENOL VITICULT, V55, P60; Britt AB, 1999, TRENDS PLANT SCI, V4, P20, DOI 10.1016/S1360-1385(98)01355-7; Cantos E, 2001, J AGR FOOD CHEM, V49, P5052, DOI 10.1021/jf010366a; Chervin C, 2004, PLANT SCI, V167, P1301, DOI 10.1016/j.plantsci.2004.06.026; Colas S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043681; COOHILL TP, 1989, PHOTOCHEM PHOTOBIOL, V50, P451, DOI 10.1111/j.1751-1097.1989.tb05549.x; Dai R, 2012, PLANT SCI, V197, P70, DOI 10.1016/j.plantsci.2012.09.004; Darras AI, 2012, PLANT GROWTH REGUL, V68, P343, DOI 10.1007/s10725-012-9722-2; de Costa F, 2013, PLANT PHYSIOL BIOCH, V66, P56, DOI 10.1016/j.plaphy.2013.02.003; Deluc L, 2006, PLANT PHYSIOL, V140, P499, DOI 10.1104/pp.105.067231; Deluc L, 2008, PLANT PHYSIOL, V147, P2041, DOI 10.1104/pp.108.118919; Deluc LG, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-212; Dhiman N, 2001, VACCINE, V20, P22, DOI 10.1016/S0264-410X(01)00319-X; Endt DV, 2002, PHYTOCHEMISTRY, V61, P107, DOI 10.1016/S0031-9422(02)00185-1; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Fini A, 2012, J PLANT PHYSIOL, V169, P929, DOI 10.1016/j.jplph.2012.02.014; FREDERICK JE, 1993, PHOTOCHEM PHOTOBIOL, V57, P175, DOI 10.1111/j.1751-1097.1993.tb02274.x; Frohnmeyer H, 2003, PLANT PHYSIOL, V133, P1420, DOI 10.1104/pp.103.030049; Fujita M, 2006, CURR OPIN PLANT BIOL, V9, P436, DOI 10.1016/j.pbi.2006.05.014; Gonzalez-Aguilar GA, 2001, INT J FOOD SCI TECH, V36, P767, DOI 10.1046/j.1365-2621.2001.00522.x; Grotewold E, 2005, TRENDS PLANT SCI, V10, P57, DOI 10.1016/j.tplants.2004.12.009; Huyskens-Keil S, 2011, J APPL BOT FOOD QUAL, V84, P229; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang F, 2009, GENE, V430, P12, DOI 10.1016/j.gene.2008.09.036; Kobayashi S, 2002, PLANTA, V215, P924, DOI 10.1007/s00425-002-0830-5; Kondo S, 2011, PLANT GROWTH REGUL, V64, P83, DOI 10.1007/s10725-010-9539-9; Kovacik J, 2010, PHOTOCHEM PHOTOBIOL, V86, P612, DOI 10.1111/j.1751-1097.2010.00708.x; Kuniga T, 2011, ACTA HORTIC, V907, P81; Lee MJ, 2014, J SCI FOOD AGR, V94, P197, DOI 10.1002/jsfa.6227; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Ludwig AA, 2005, P NATL ACAD SCI USA, V102, P10736, DOI 10.1073/pnas.0502954102; Mackerness SAH, 1999, J PHOTOCH PHOTOBIO B, V48, P180; MADRONICH S, 1995, AMBIO, V24, P143; Navarro S, 2008, FOOD CHEM, V108, P182, DOI 10.1016/j.foodchem.2007.10.060; Nawkar GM, 2013, INT J MOL SCI, V14, P1608, DOI 10.3390/ijms14011608; Park JM, 2001, PLANT CELL, V13, P1035, DOI 10.1105/tpc.13.5.1035; Petit AN, 2009, J EXP BOT, V60, P1155, DOI 10.1093/jxb/ern361; Potter GA, 2002, BRIT J CANCER, V86, P774, DOI 10.1038/sj.bjc.6600197; Poubol J, 2012, ACTA HORTIC, V943, P235, DOI 10.17660/ActaHortic.2012.943.31; Rao MV, 1996, PLANT PHYSIOL, V110, P125, DOI 10.1104/pp.110.1.125; Rodoni LM, 2012, J FOOD SCI, V77, pC632, DOI 10.1111/j.1750-3841.2012.02746.x; Romanazzi G, 2006, PLANT DIS, V90, P445, DOI 10.1094/PD-90-0445; Schenk PM, 2000, P NATL ACAD SCI USA, V97, P11655, DOI 10.1073/pnas.97.21.11655; Selma MV, 2008, J AGR FOOD CHEM, V56, P9990, DOI 10.1021/jf8018062; Shiu CT, 2005, J EXP BOT, V56, P2851, DOI 10.1093/jxb/eri277; Singh KB, 2012, CURR OPIN PLANT BIOL, V5, P430; STAPLETON AE, 1992, PLANT CELL, V4, P1353, DOI 10.1105/tpc.4.11.1353; Stevens C, 2004, CROP PROT, V23, P551, DOI 10.1016/j.cropro.2003.10.007; Takeuchi Y, 1996, J PLANT PHYSIOL, V147, P589, DOI 10.1016/S0176-1617(96)80050-2; Todorova D, 2013, BIOTECHNOL BIOTEC EQ, V27, P3798, DOI 10.5504/BBEQ.2013.0012; Tohidi-Moghadam HR, 2012, POL J ENVIRON STUD, V21, P1417; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vivier MA, 2002, TRENDS BIOTECHNOL, V20, P472, DOI 10.1016/S0167-7799(02)02058-9; Walker AR, 2007, PLANT J, V49, P772, DOI 10.1111/j.1365-313X.2006.02997.x; Wang LJ, 2013, J AGR FOOD CHEM, V61, P7135, DOI 10.1021/jf401220m; Xie YJ, 2012, J EXP BOT, V63, P3869, DOI [10.1093/jxb/ers078, 10.1093/jxb/ers201]; Zhou X, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-246	61	15	16	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113772	10.1371/journal.pone.0113772	http://dx.doi.org/10.1371/journal.pone.0113772			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464056	Green Published, Green Submitted, gold			2022-12-26	WOS:000345869700052
J	Xue, B; Zhang, C; Wang, YH; Wang, JC; Zhang, J; Lu, M; Li, GD; Cao, ZH; Huang, QS				Xue, Bai; Zhang, Cheng; Wang, Yihan; Wang, Jincheng; Zhang, Jien; Lu, Min; Li, Guodong; Cao, Zhizhong; Huang, Qingshan			A Novel Controlled-Release System for Antibacterial Enzyme Lysostaphin Delivery Using Hydroxyapatite/Chitosan Composite Bone Cement	PLOS ONE			English	Article							CALCIUM-PHOSPHATE CEMENT; MORPHOGENETIC PROTEIN SYSTEM; HYDROGEN-ION CONCENTRATION; DONOR SITE; TISSUE; DIFFERENTIATION; SCAFFOLDS; CHITOSAN; DEFECTS; DESIGN	In this work, a lysostaphin-loaded, control-released, self-setting and injectable porous bone cement with efficient protein delivery was prepared by a novel setting method using hydroxyapatite/chitosan (HA/CS) composite scaffold. The cement samples were made through cementitious reactions by mixing solid powder, a mixture of HA/CS composite particles, lysostaphin, Ca(OH)(2), CaCO3 and NaHCO3, with setting liquid containing citric acid, acetic acid, NaH2PO4, CaCl2 and poloxamer. The setting parameters of the cement samples were determined. The results showed that the final setting time was 96.6 +/- 5.2 min and the pH value increased from approximately 6.2 to nearly 10 during the setting process and the porosity was 34% at the end. And the microstructure and composition were detected by scanning electron microscopy (SEM), x-ray diffraction and Fourier transform-infrared spectroscopy. For the release behavior of lysostaphin loaded in the cement sample, the in vitro cement extract experiment indicated that about 94.2 +/- 10.9% of the loaded protein was released before day 8 and the in vivo Qdot 625 fluorescence tracking experiment showed that the loaded protein released slower than the free one. Then the biocompatibility of the cement samples was evaluated using the methylthiazol tetrazolium assay, SEM and hematoxylin-eosin staining, which suggested good biocompatibility of cement samples with MC 3T3-E1 cells and subcutaneous tissues of mice. Finally the antibacterial activity assay indicated that the loaded lysostaphin had good release ability and strong antibacterial enzymatic activity against methicillin-resistant Staphylococcus aureus. Collectively, all the results suggested that the lysostaphin-loaded self-setting injectable porous bone cement released the protein in a controlled and effective way and the protein activity was well retained during the setting and releasing process. Thus this bone cement can be potentially applied as a combination of artificial bone substitute and controlled-release system for delivery of lysostaphin to treat bone defects and infections.	[Xue, Bai; Zhang, Cheng; Wang, Jincheng; Huang, Qingshan] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Zhang, Cheng; Wang, Yihan; Zhang, Jien; Lu, Min; Li, Guodong; Huang, Qingshan] Shanghai High Tech United Biotechnol R&D Co Ltd, Shanghai 201206, Peoples R China; [Cao, Zhizhong] Second Mil Med Univ, Changhai Hosp, Dept Stomatol, Shanghai 200433, Peoples R China	Fudan University; Naval Medical University	Cao, ZH (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Stomatol, 168 Changhai Rd, Shanghai 200433, Peoples R China.	caozhizh@263.net; qshuang@fudan.edu.cn			Major Scientific and Technological Specialized Projects of China for "Significant New Formulation of New Drugs" [2008ZX09101-032]; Industry-university-research Medical Projects of Science and Technology Commission of Shanghai Municipality [12DZ1940500]; Key Medical Projects of Science and Technology Commission of Shanghai Municipality [13411951202]; Shanghai Engineering Research Center Of Industrial Microorganisms [13DZ2252000]	Major Scientific and Technological Specialized Projects of China for "Significant New Formulation of New Drugs"; Industry-university-research Medical Projects of Science and Technology Commission of Shanghai Municipality; Key Medical Projects of Science and Technology Commission of Shanghai Municipality; Shanghai Engineering Research Center Of Industrial Microorganisms	This work has been funded by the Major Scientific and Technological Specialized Projects of China for "Significant New Formulation of New Drugs" (No. 2008ZX09101-032), the Industry-university-research Medical Projects of Science and Technology Commission of Shanghai Municipality (No. 12DZ1940500), the Key Medical Projects of Science and Technology Commission of Shanghai Municipality (No. 13411951202) and Shanghai Engineering Research Center Of Industrial Microorganisms (No. 13DZ2252000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSEN FA, 1991, ACTA CHEM SCAND, V45, P1018, DOI 10.3891/acta.chem.scand.45-1018; BLOCK JE, 1995, MED HYPOTHESES, V45, P27, DOI 10.1016/0306-9877(95)90195-7; Blom EJ, 2000, J BIOMED MATER RES, V50, P67, DOI 10.1002/(SICI)1097-4636(200004)50:1<67::AID-JBM10>3.0.CO;2-E; BRODA E, 1959, EXP CELL RES, V18, P171, DOI 10.1016/0014-4827(59)90301-5; Byrne FM, 2011, INJURY, V42, pS3, DOI 10.1016/S0020-1383(11)70125-5; Chang MC, 2001, J MATER SCI LETT, V20, P1199, DOI 10.1023/A:1010914621089; Cheng XM, 2009, MAT SCI ENG C-BIO S, V29, P29, DOI 10.1016/j.msec.2008.05.008; Climo MW, 1998, ANTIMICROB AGENTS CH, V42, P1355, DOI 10.1128/AAC.42.6.1355; DOMONKOS J, 1959, J NEUROCHEM, V4, P238, DOI 10.1111/j.1471-4159.1959.tb13199.x; Furukawa T, 2000, BIOMATERIALS, V21, P889, DOI 10.1016/S0142-9612(99)00232-X; GIANNOUDIS PV, 2011, INJURY S5, V42, pS1; Ginebra MP, 2006, J CONTROL RELEASE, V113, P102, DOI 10.1016/j.jconrel.2006.04.007; Ginebra MP, 2012, ADV DRUG DELIVER REV, V64, P1090, DOI 10.1016/j.addr.2012.01.008; GOLDBERG VM, 1987, CLIN ORTHOP RELAT R, P7; [官叶斌 Guan Yebin], 2011, [高校地质学报, Geological Journal of China Universities], V17, P46; HIDALGO DA, 1995, PLAST RECONSTR SURG, V96, P585, DOI 10.1097/00006534-199509000-00010; Kamegai Akihide, 1994, Bio-Medical Materials and Engineering, V4, P291; Kasuga T, 2001, BIOMATERIALS, V22, P19, DOI 10.1016/S0142-9612(00)00091-0; Kerr DE, 2001, NAT BIOTECHNOL, V19, P66, DOI 10.1038/83540; KLINE SA, 1994, ANAL BIOCHEM, V217, P329, DOI 10.1006/abio.1994.1127; Kobayashi H, 2007, NANO LETT, V7, P1711, DOI 10.1021/nl0707003; Kokubo T, 2003, BIOMATERIALS, V24, P2161, DOI 10.1016/S0142-9612(03)00044-9; Komath M, 2000, B MATER SCI, V23, P135, DOI 10.1007/BF02706555; Kong LJ, 2006, EUR POLYM J, V42, P3171, DOI 10.1016/j.eurpolymj.2006.08.009; Kong LJ, 2005, J BIOMED MATER RES A, V75A, P275, DOI 10.1002/jbm.a.30414; Li RH, 2001, TRENDS BIOTECHNOL, V19, P255, DOI 10.1016/S0167-7799(01)01665-1; Martins MA, 2008, J COLLOID INTERF SCI, V318, P210, DOI 10.1016/j.jcis.2007.10.008; Miao JJ, 2011, BIOMATERIALS, V32, P9557, DOI 10.1016/j.biomaterials.2011.08.080; MIRELMAN D, 1967, J BIOL CHEM, V242, P3414; MONGAR JL, 1958, J PHYSIOL-LONDON, V140, P272, DOI 10.1113/jphysiol.1958.sp005933; Ohura K, 1999, J BIOMED MATER RES, V44, P168, DOI 10.1002/(SICI)1097-4636(199902)44:2<168::AID-JBM7>3.0.CO;2-4; Oliveira JM, 2006, BIOMATERIALS, V27, P6123, DOI 10.1016/j.biomaterials.2006.07.034; OTSUKA M, 1994, J PHARM SCI, V83, P255, DOI 10.1002/jps.2600830229; Ruhe PQ, 2004, BIOMATERIALS, V25, P2123, DOI 10.1016/j.biomaterials.2003.09.007; Ruhe PQ, 2003, J BONE JOINT SURG AM, V85A, P75; SAMPATH TK, 1987, P NATL ACAD SCI USA, V84, P7109, DOI 10.1073/pnas.84.20.7109; Sasso RC, 2005, J SPINAL DISORD TECH, V18, pS77, DOI 10.1097/01.bsd.0000112045.36255.83; Sasso RC, 1998, J BONE JOINT SURG AM, V80A, P631, DOI 10.2106/00004623-199805000-00003; Shimasaki S, 1999, P NATL ACAD SCI USA, V96, P7282, DOI 10.1073/pnas.96.13.7282; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; Standardization IOf, 1978, DENT ZINC PHOSPH CEM; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Teng SH, 2009, J BIOMED MATER RES B, V90B, P275, DOI 10.1002/jbm.b.31283; TENHUISEN KS, 1994, J MATER SCI-MATER M, V5, P291, DOI 10.1007/BF00122399; Tigli RS, 2009, J BIOMAT SCI-POLYM E, V20, P1899, DOI 10.1163/156856208X399945; Tran RT, 2010, MATERIALS, V3, P1375, DOI 10.3390/ma3021375; Venkatesan J, 2010, MAR DRUGS, V8, P2252, DOI 10.3390/md8082252; Verron E, 2012, ACTA BIOMATER, V8, P3541, DOI 10.1016/j.actbio.2012.06.022; Wang M, 2001, BIOMATERIALS, V22, P1311, DOI 10.1016/S0142-9612(00)00283-0; Wang X, 2004, CARBOHYD POLYM, V56, P21, DOI 10.1016/j.carbpol.2003.11.007; WOZNEY JM, 1992, MOL REPROD DEV, V32, P160, DOI 10.1002/mrd.1080320212; Yamaguchi I, 2001, J BIOMED MATER RES, V55, P20, DOI 10.1002/1097-4636(200104)55:1<20::AID-JBM30>3.0.CO;2-F; Yamaguchi I, 2000, KEY ENG MATER, V192-1, P673, DOI 10.4028/www.scientific.net/KEM.192-195.673; Yamamoto M, 2006, TISSUE ENG, V12, P1305, DOI 10.1089/ten.2006.12.1305; Zhao D, 2007, INORG CHEM IND, V39, P23	55	17	17	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113797	10.1371/journal.pone.0113797	http://dx.doi.org/10.1371/journal.pone.0113797			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464506	gold, Green Published, Green Submitted			2022-12-26	WOS:000345869700054
J	Zhu, X; Leung, HCM; Chin, FYL; Yiu, SM; Quan, GR; Liu, B; Wang, YD				Zhu, Xiao; Leung, Henry C. M.; Chin, Francis Y. L.; Yiu, Siu Ming; Quan, Guangri; Liu, Bo; Wang, Yadong			PERGA: A Paired-End Read Guided De Novo Assembler for Extending Contigs Using SVM and Look Ahead Approach	PLOS ONE			English	Article							GENERATION SEQUENCING DATA; SHORT DNA-SEQUENCES; BACTERIAL GENOME; ALGORITHMS; ALIGNMENT; MILLIONS; ERROR; IDBA; SNP	Since the read lengths of high throughput sequencing (HTS) technologies are short, de novo assembly which plays significant roles in many applications remains a great challenge. Most of the state-of-the-art approaches base on de Bruijn graph strategy and overlap-layout strategy. However, these approaches which depend on k-mers or read overlaps do not fully utilize information of paired-end and single-end reads when resolving branches. Since they treat all single-end reads with overlapped length larger than a fix threshold equally, they fail to use the more confident long overlapped reads for assembling and mix up with the relative short overlapped reads. Moreover, these approaches have not been special designed for handling tandem repeats (repeats occur adjacently in the genome) and they usually break down the contigs near the tandem repeats. We present PERGA (Paired-End Reads Guided Assembler), a novel sequence-reads-guided de novo assembly approach, which adopts greedy-like prediction strategy for assembling reads to contigs and scaffolds using paired-end reads and different read overlap size ranging from O-max to O-min to resolve the gaps and branches. By constructing a decision model using machine learning approach based on branch features, PERGA can determine the correct extension in 99.7% of cases. When the correct extension cannot be determined, PERGA will try to extend the contig by all feasible extensions and determine the correct extension by using look-ahead approach. Many difficult-resolved branches are due to tandem repeats which are close in the genome. PERGA detects such different copies of the repeats to resolve the branches to make the extension much longer and more accurate. We evaluated PERGA on both Illumina real and simulated datasets ranging from small bacterial genomes to large human chromosome, and it constructed longer and more accurate contigs and scaffolds than other state-of-the-art assemblers. PERGA can be freely downloaded at https://github.com/hitbio/PERGA.	[Zhu, Xiao; Liu, Bo; Wang, Yadong] Harbin Inst Technol, Sch Comp Sci & Technol, Ctr Bioinformat, Harbin 150006, Heilongjiang, Peoples R China; [Leung, Henry C. M.; Chin, Francis Y. L.; Yiu, Siu Ming] Univ Hong Kong, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China; [Quan, Guangri] Harbin Inst Technol, Natl Pilot Sch Software, Weihai, Shandong, Peoples R China	Harbin Institute of Technology; University of Hong Kong; Harbin Institute of Technology	Wang, YD (corresponding author), Harbin Inst Technol, Sch Comp Sci & Technol, Ctr Bioinformat, Harbin 150006, Heilongjiang, Peoples R China.	ydwang@hit.edu.cn	Yiu, Siu Ming/C-1843-2009	Yiu, Siu Ming/0000-0002-3975-8500; Zhu, Xiao/0000-0001-9339-0033	National Nature Science Foundation of China [61173085, 61102149, 11171086]; National High-Tech Research and Development Program (863) of China [2012AA020404, 2012AA02A602, 2012AA02A604]; Hong Kong GRF [HKU 7111/12E, HKU 719709E, 719611E]; Shenzhen Basic Research Project [JCYJ20120618143038947]; Outstanding Researcher Award [102009124]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Development Program (863) of China(National High Technology Research and Development Program of China); Hong Kong GRF(Hong Kong Research Grants Council); Shenzhen Basic Research Project; Outstanding Researcher Award	This work was partially supported by the National Nature Science Foundation of China (61173085, 61102149 and 11171086), the National High-Tech Research and Development Program (863) of China (2012AA020404, 2012AA02A602 and 2012AA02A604), the Hong Kong GRF (HKU 7111/12E, HKU 719709E and 719611E), the Shenzhen Basic Research Project (NO.JCYJ20120618143038947), and the Outstanding Researcher Award (102009124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Blanca JM, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-285; Burrows M, 1994, BLOCK SORTING LOSSLE; Butler J, 2008, GENOME RES, V18, P810, DOI 10.1101/gr.7337908; Chaisson MJ, 2008, GENOME RES, V18, P324, DOI 10.1101/gr.7088808; Dohm JC, 2007, GENOME RES, V17, P1697, DOI 10.1101/gr.6435207; Ferragina P, 2000, ANN IEEE SYMP FOUND, P390, DOI 10.1109/SFCS.2000.892127; Flicek P, 2009, NAT METHODS, V6, pS6, DOI [10.1038/NMETH.1376, 10.1038/nmeth.1376]; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Jeck WR, 2007, BIOINFORMATICS, V23, P2942, DOI 10.1093/bioinformatics/btm451; Kelley DR, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r116; Li H, 2012, BIOINFORMATICS, V28, P1838, DOI 10.1093/bioinformatics/bts280; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McElroy KE, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-74; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Peng Y, 2012, BIOINFORMATICS, V28, P1420, DOI 10.1093/bioinformatics/bts174; Peng Y, 2010, LECT N BIOINFORMAT, V6044, P426, DOI 10.1007/978-3-642-12683-3_28; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Salzberg SL, 2012, GENOME RES, V22, P557, DOI 10.1101/gr.131383.111; Schatz MC, 2010, GENOME RES, V20, P1165, DOI 10.1101/gr.101360.109; Shendure J, 2005, SCIENCE, V309, P1728, DOI 10.1126/science.1117389; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Treangen TJ, 2012, NAT REV GENET, V13, P36, DOI 10.1038/nrg3117; Warren RL, 2007, BIOINFORMATICS, V23, P500, DOI 10.1093/bioinformatics/btl629; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zimin AV, 2013, BIOINFORMATICS, V29, P2669, DOI 10.1093/bioinformatics/btt476	33	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114253	10.1371/journal.pone.0114253	http://dx.doi.org/10.1371/journal.pone.0114253			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461763	gold, Green Published, Green Submitted			2022-12-26	WOS:000345869700123
J	Dao, X; Wang, Z; Lv, YB; Teng, EJ; Zhang, LL; Wang, C				Dao, Xu; Wang, Zhen; Lv, Yibing; Teng, Enjiang; Zhang, Linlin; Wang, Chao			Chemical Characteristics of Water-Soluble Ions in Particulate Matter in Three Metropolitan Areas in the North China Plain	PLOS ONE			English	Article							SOURCE APPORTIONMENT; SEASONAL-VARIATIONS; ATMOSPHERIC PARTICLES; SIZE DISTRIBUTIONS; FINE PARTICLES; AIR-POLLUTION; MASS CLOSURE; PM2.5; AEROSOL; PM10	PM2.5 and PM10 samples were collected simultaneously in each season in Beijing, Tianjin and Shijiazhuang to identify the characteristics of water-soluble ion compositions in the North China Plain. The water-soluble ions displayed significant seasonal variation. The dominant ions were NO3-, SO42-, NH4+ and Cl-, accounting for more than 90% and 86% to the mass of total water- soluble ions in PM2.5 and PM10, respectively. The anion/cation ratio indicated that the ion acidity of each city varied both between sites and seasonally. Over 50% of the ion species were enriched in small particles <= 1 mu m in diameter. The [NO3-]/[SO42-] ratio indicated that vehicles accounted for the majority of the particulate pollution in Beijing. Shijiazhuang, a city highly reliant on coal combustion, had a higher SO42- concentration.	[Dao, Xu; Lv, Yibing; Teng, Enjiang; Zhang, Linlin; Wang, Chao] China Natl Environm Monitoring Ctr, Beijing, Peoples R China; [Wang, Zhen] Wuhan Univ, Sch Resource & Environm Sci, Wuhan 430072, Hubei, Peoples R China; [Wang, Zhen] Univ Calif Santa Barbara, Dept Geog, Santa Barbara, CA 93106 USA	Wuhan University; University of California System; University of California Santa Barbara	Wang, Z (corresponding author), Wuhan Univ, Sch Resource & Environm Sci, Wuhan 430072, Hubei, Peoples R China.	sinoo.whu@gmail.com	Wang, Zhen/V-2047-2019; Wang, Zhen/V-2219-2019	Wang, Zhen/0000-0002-7902-4093	National Natural Science Foundation of China [41101567]; State Scholarship Fund of China Scholarship Council [201308420277]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Scholarship Fund of China Scholarship Council(China Scholarship Council)	This work was supported by National Natural Science Foundation of China (Grant No. 41101567) to ZW. The authors also thank the financial award from State Scholarship Fund of China Scholarship Council (File No. 201308420277) to support the research at UCSB (to ZW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian R, 2013, ATMOS ENVIRON, V78, P268, DOI 10.1016/j.atmosenv.2011.10.066; Beijing Municipal Bureau of Statistics, 2013, BEIJ STAT YB 2013; Bellouin N, 2005, NATURE, V438, P1138, DOI 10.1038/nature04348; Brunekreef B, 2002, LANCET, V360, P1233, DOI 10.1016/S0140-6736(02)11274-8; Cao JJ, 2012, ENVIRON HEALTH PERSP, V120, P373, DOI 10.1289/ehp.1103671; Chen J, 2014, AEROSOL AIR QUAL RES, V14, P260, DOI 10.4209/aaqr.2012.12.0360; Contini D, 2014, SCI TOTAL ENVIRON, V472, P248, DOI 10.1016/j.scitotenv.2013.10.127; Fan J, 2014, J ENVIRON SCI, V26, P353, DOI 10.1016/S1001-0742(13)60431-3; Gao J, 2014, J ENVIRON SCI, V26, P44, DOI 10.1016/S1001-0742(13)60379-4; Gao QingXian, 2002, China Environmental Science, V22, P468; GRAY HA, 1986, ENVIRON SCI TECHNOL, V20, P580, DOI 10.1021/es00148a006; Gu JX, 2010, AEROSOL AIR QUAL RES, V10, P167, DOI 10.4209/aaqr.2009.12.0080; Guo YT, 2011, J ATMOS CHEM, V68, P299, DOI 10.1007/s10874-012-9223-8; Han TT, 2014, ATMOS RES, V137, P25, DOI 10.1016/j.atmosres.2013.10.004; He KB, 2001, ATMOS ENVIRON, V35, P4959, DOI 10.1016/S1352-2310(01)00301-6; Heo JB, 2009, ATMOS CHEM PHYS, V9, P4957, DOI 10.5194/acp-9-4957-2009; Ho KF, 2006, SCI TOTAL ENVIRON, V355, P276, DOI 10.1016/j.scitotenv.2005.03.013; Huang Z, 2004, ATMOS RES, V71, P215, DOI 10.1016/j.atmosres.2004.05.002; Hughes LS, 1999, ENVIRON SCI TECHNOL, V33, P3506, DOI 10.1021/es980884a; Karthikeyan S, 2006, MICROCHEM J, V82, P49, DOI 10.1016/j.microc.2005.07.003; Kawashima H, 2011, ATMOS ENVIRON, V45, P6309, DOI 10.1016/j.atmosenv.2011.08.057; Khan MF, 2010, ATMOS ENVIRON, V44, P2646, DOI 10.1016/j.atmosenv.2010.03.040; Kong LD, 2014, J GEOPHYS RES-ATMOS, V119, P341, DOI 10.1002/2013JD020222; Lai SC, 2007, J ENVIRON SCI, V19, P939, DOI 10.1016/S1001-0742(07)60155-7; Lepeule J, 2012, ENVIRON HEALTH PERSP, V120, P965, DOI 10.1289/ehp.1104660; Li XR, 2012, ATMOS ENVIRON, V50, P278, DOI 10.1016/j.atmosenv.2011.12.021; Liu J, 2011, ENV SCI, V29, P1059; Lopez-Villarrubia E, 2012, ENVIRON RES, V112, P129, DOI 10.1016/j.envres.2011.10.005; Martins LD, 2012, ENVIRON MONIT ASSESS, V184, P2663, DOI 10.1007/s10661-011-2142-3; Mkoma SL, 2014, FUEL, V115, P109, DOI 10.1016/j.fuel.2013.06.044; Ni TR, 2013, AEROSOL AIR QUAL RES, V13, P1832, DOI 10.4209/aaqr.2012.10.0283; Pope CA, 2006, J AIR WASTE MANAGE, V56, P709, DOI 10.1080/10473289.2006.10464485; Rogula-Kozlowska W, 2014, AIR QUAL ATMOS HLTH, V7, P41, DOI 10.1007/s11869-013-0222-y; Satsangi A, 2013, AEROSOL AIR QUAL RES, V13, P1877, DOI 10.4209/aaqr.2012.08.0227; Shen JL, 2011, ATMOS ENVIRON, V45, P5033, DOI 10.1016/j.atmosenv.2011.02.031; Shen Z, 2013, ENVIRON SCI POLLUT R, V21, P3697; Shi Y, 2014, INT J INF TECH DECIS, V13, P1, DOI 10.1142/S0219622014010019; Shijiazhuang Municipal Bureau of Statistics Survey Office of the National Bureau of Statistics in Shijiazhuang, 2013, SHIJ STAT YB 2013; Shon ZH, 2013, ATMOS RES, V132, P309, DOI 10.1016/j.atmosres.2013.06.003; Song Y, 2006, SCI TOTAL ENVIRON, V372, P278, DOI 10.1016/j.scitotenv.2006.08.041; Sun Ying, 2011, Huanjing Kexue, V32, P2732; TANG IN, 1993, ATMOS ENVIRON A-GEN, V27, P467, DOI 10.1016/0960-1686(93)90204-C; Tao J, 2014, ATMOS RES, V135, P48, DOI 10.1016/j.atmosres.2013.08.015; Tianjin Municipal Bureau of Statistics & Survey office of National Bureau of Statistics in Tianjin, 2013, TIANJ STAT YB 2013; United States Environmental Protection Agency, 2004, AIR QUAL CRIT PART M, VI, P1; Wang HL, 2008, J ENVIRON SCI, V20, P1323, DOI 10.1016/S1001-0742(08)62228-7; Wang L, 2013, ATMOS RES, V127, P22, DOI 10.1016/j.atmosres.2013.02.011; Wang SX, 2011, ENVIRON SCI TECHNOL, V45, P9293, DOI 10.1021/es2022347; Wang Y, 2005, ATMOS ENVIRON, V39, P3771, DOI 10.1016/j.atmosenv.2005.03.013; Wang ZS, 2012, AEROSOL AIR QUAL RES, V12, P39, DOI 10.4209/aaqr.2011.04.0045; World Health Organization, 2006, AIR QUAL GUID GLOB U; Xu GJ, 2013, J GEOPHYS RES-ATMOS, V118, P13303, DOI 10.1002/2013JD019496; Yao XH, 2003, ATMOS ENVIRON, V37, P2991, DOI 10.1016/S1352-2310(03)00255-3; Yao XH, 2002, ATMOS ENVIRON, V36, P4223, DOI 10.1016/S1352-2310(02)00342-4; Yin LQ, 2014, ENVIRON SCI POLLUT R, V21, P5141, DOI 10.1007/s11356-013-2134-7; Zhang F, 2014, ATMOS ENVIRON, V86, P193, DOI 10.1016/j.atmosenv.2013.12.008; Zhang R, 2013, ATMOS CHEM PHYS, V13, P7053, DOI 10.5194/acp-13-7053-2013; Zhang WJ, 2006, BIOMED ENVIRON SCI, V19, P461; Zhang YM, 2013, SCI CHINA EARTH SCI, V56, P890, DOI 10.1007/s11430-012-4515-z; Zhou JM, 2012, AEROSOL AIR QUAL RES, V12, P492, DOI 10.4209/aaqr.2011.11.0218	60	31	32	11	108	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113831	10.1371/journal.pone.0113831	http://dx.doi.org/10.1371/journal.pone.0113831			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437210	Green Submitted, Green Published, gold			2022-12-26	WOS:000347114900082
J	Matz, J; Herate, C; Bouchet, J; Dusetti, N; Gayet, O; Baty, D; Benichou, S; Chames, P				Matz, Julie; Herate, Cecile; Bouchet, Jerome; Dusetti, Nelson; Gayet, Odile; Baty, Daniel; Benichou, Serge; Chames, Patrick			Selection of Intracellular Single-Domain Antibodies Targeting the HIV-1 Vpr Protein by Cytoplasmic Yeast Two-Hybrid System	PLOS ONE			English	Article							IN-VITRO; PHAGE DISPLAY; LIFE-CYCLE; INTRABODIES; REPLICATION; FRAGMENT; INHIBITORS; ANTIGEN; BINDING; MATRIX	The targeting of HIV-1 using antibodies is of high interest as molecular tools to better understand the biology of the virus or as a first step toward the design of new inhibitors targeting critical viral intracellular proteins. Small and highly stable llama-derived single-domain antibodies can often be functionally expressed as intracellular antibodies in the cytoplasm of eukaryotic cells. Using a selection method based on the Sos Recruitment System, a cytoplasmic yeast two-hybrid approach, we have isolated single-domain antibodies able to bind HIV-1 Vpr and Capside proteins in the yeast cytoplasm. One anti-Vpr single domain antibody was able to bind the HIV-1 regulatory Vpr protein in the cytoplasm of eukaryotic cells, leading to its delocalization from the nucleus to the cytoplasm. To our knowledge, this is the first description of a functional single-domain intrabody targeting HIV-1 Vpr, isolated using an in vivo cytoplasmic selection method that alleviates some limitations of the conventional yeast two-hybrid system.	[Matz, Julie; Dusetti, Nelson; Gayet, Odile; Baty, Daniel; Chames, Patrick] Inserm U1068, CRCM, Marseille, France; [Matz, Julie; Dusetti, Nelson; Gayet, Odile; Baty, Daniel; Chames, Patrick] Inst J Paoli I Calmettes, F-13009 Marseille, France; [Matz, Julie; Dusetti, Nelson; Gayet, Odile; Baty, Daniel; Chames, Patrick] Aix Marseille Univ UM105, Marseille, France; [Matz, Julie; Dusetti, Nelson; Gayet, Odile; Baty, Daniel; Chames, Patrick] CNRS, UMR7258, CRCM, Marseille, France; [Herate, Cecile; Bouchet, Jerome; Benichou, Serge] CNRS UMR8104, Inst Cochin, Paris, France; [Herate, Cecile; Bouchet, Jerome; Benichou, Serge] Univ Paris 05, Paris, France; [Herate, Cecile; Bouchet, Jerome; Benichou, Serge] Inserm U1016, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); UNICANCER; Institut Paoli-Calmette (IPC); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Chames, P (corresponding author), Inserm U1068, CRCM, Marseille, France.	patrick.chames@inserm.fr	bouchet, jerome/I-7716-2019; Dusetti, Nelson/O-7919-2017; Chames, Patrick/R-1800-2016	bouchet, jerome/0000-0002-6611-4380; Dusetti, Nelson/0000-0002-6161-8483; Chames, Patrick/0000-0002-6104-6286; Benichou, Serge/0000-0003-3602-3530; Baty, Daniel/0000-0001-8443-4444	Inserm; CNRS; Universite Paris-Descartes; "Agence Nationale de Recherche sur le SIDA (ANRS)"; ANRS	Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Paris-Descartes; "Agence Nationale de Recherche sur le SIDA (ANRS)"(ANRSFrench National Research Agency (ANR)); ANRS(ANRSFrench National Research Agency (ANR))	This work was supported by Inserm, CNRS, Universite Paris-Descartes, and grants from the "Agence Nationale de Recherche sur le SIDA (ANRS)" (SB, DB). JM was supported by a fellowship from ANRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN JB, 1995, TRENDS BIOCHEM SCI, V20, P511, DOI 10.1016/S0968-0004(00)89119-7; Alzogaray V, 2011, FASEB J, V25, P526, DOI 10.1096/fj.10-162958; Arhel N, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-96; Aronheim A, 1997, MOL CELL BIOL, V17, P3094, DOI 10.1128/MCB.17.6.3094; BARBAS CF, 1992, P NATL ACAD SCI USA, V89, P9339, DOI 10.1073/pnas.89.19.9339; Behar G, 2009, FEBS J, V276, P4305, DOI 10.1111/j.1742-4658.2009.07101.x; Bouchet J, 2012, J VIROL; Bouchet J, 2011, BLOOD, V117, P3559, DOI 10.1182/blood-2010-07-296749; De Clercq S, 2013, CELL MOL LIFE SCI, V70, P909, DOI 10.1007/s00018-012-1169-0; DEAN PN, 1974, J CELL BIOL, V60, P523, DOI 10.1083/jcb.60.2.523; Depienne C, 2000, EXP CELL RES, V260, P387, DOI 10.1006/excr.2000.5016; Desmyter A, 1996, NAT STRUCT BIOL, V3, P803, DOI 10.1038/nsb0996-803; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Foster JL, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-84; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Fu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056222; Ghosh RK, 2011, EXPERT OPIN PHARMACO, V12, P31, DOI 10.1517/14656566.2010.509345; Guenzel CA, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00127; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jacquot G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007514; Jarviluoma A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040331; Krichevsky A, 2003, VIROLOGY, V305, P77, DOI 10.1006/viro.2002.1765; Kwong PD, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a007278; Le Rouzic E, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-11; Levin R, 1997, MOL MED, V3, P96, DOI 10.1007/BF03401802; Matz J, 2013, J VIROL, V87, P1137, DOI 10.1128/JVI.00461-12; Mhashilkar AM, 1999, HUM GENE THER, V10, P1453, DOI 10.1089/10430349950017798; Mukhtar MM, 2009, INT J BIOCHEM CELL B, V41, P554, DOI 10.1016/j.biocel.2008.07.001; Muyldermans S, 2001, J Biotechnol, V74, P277; Pellis M, 2012, ARCH BIOCHEM BIOPHYS, V526, P114, DOI 10.1016/j.abb.2012.04.023; Romani B, 2009, J GEN VIROL, V90, P1795, DOI 10.1099/vir.0.011726-0; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Seillier M, 2012, CELL DEATH DIFFER; Staus DP, 2014, MOL PHARMACOL, V85, P472, DOI 10.1124/mol.113.089516; Tanaka T, 2003, J MOL BIOL, V331, P1109, DOI 10.1016/S0022-2836(03)00836-2; Van Impe K, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3585; Vercruysse T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060259; Vercruysse T, 2010, J BIOL CHEM, V285, P21768, DOI 10.1074/jbc.M110.112490; Vielemeyer O, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-59; Visintin M, 1999, P NATL ACAD SCI USA, V96, P11723, DOI 10.1073/pnas.96.21.11723; Worn A, 2000, J BIOL CHEM, V275, P2795, DOI 10.1074/jbc.275.4.2795	42	13	14	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113729	10.1371/journal.pone.0113729	http://dx.doi.org/10.1371/journal.pone.0113729			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436999	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900070
J	Tom, M; Fletcher, TD; McCarthy, DT				Tom, Minna; Fletcher, Tim D.; McCarthy, David T.			Heavy Metal Contamination of Vegetables Irrigated by Urban Stormwater: A Matter of Time?	PLOS ONE			English	Article							PLANT-GROWTH; GENOTYPIC VARIATIONS; OXIDATIVE STRESS; HEALTH-RISKS; WASTE-WATER; ACCUMULATION; RUNOFF; CADMIUM; SOILS; LEAD	Urban stormwater is a crucial resource at a time when climate change and population growth threaten freshwater supplies; but there are health risks from contaminants, such as toxic metals. It is vitally important to understand how to use this resource safely and responsibly. Our study investigated the extent of metal contamination in vegetable crops irrigated with stormwater under short-and longterm conditions. We created artificially aged gardens by adding metal-contaminated sediment to soil, simulating accumulation of metals in the soil from irrigation with raw stormwater over zero, five and ten years. Our crops - French bean (Phaseolus vulgaris), kale (Brassica oleracea var. acephala), and beetroot (Beta vulgaris) were irrigated twice a week for 11 weeks, with either synthetic stormwater or potable water. They were then tested for concentrations of Cd, Cr, Pb, Cu and Zn. An accumulation of Pb was the most marked sign of contamination, with six of nine French bean and seven of nine beetroot leaf samples breaching Australia's existing guidelines. Metal concentration in a crop tended to increase with the effective age of the garden; but importantly, its rate of increase did not match the rate of increase in the soil. Our study also highlighted differences in sensitivity between different crop types. French bean demonstrated the highest levels of uptake, while kale displayed restrictive behaviour. Our study makes it clear: irrigation with stormwater is indeed feasible, as long as appropriate crops are selected and media are frequently turned over. We have also shown that an understanding of such risks yields meaningful information on appropriate safeguards. A holistic approach is needed - to account for all routes to toxic metal exposure, including especially Pb. A major outcome of our study is critical information for minimising health risks from stormwater irrigation of crops.	[Tom, Minna; McCarthy, David T.] Monash Univ, Dept Civil Engn, Environm & Publ Hlth Microbiol Lab, Melbourne, Vic 3004, Australia; [Fletcher, Tim D.] Monash Univ, Fac Sci, Sch Ecosyst & Forest Sci, Waterway Ecosyst Res Grp, Melbourne, Vic 3004, Australia	Monash University; Monash University	McCarthy, DT (corresponding author), Monash Univ, Dept Civil Engn, Environm & Publ Hlth Microbiol Lab, Melbourne, Vic 3004, Australia.	david.mccarthy@monash.edu	Fletcher, Tim/AAB-8356-2019	Fletcher, Tim/0000-0001-8819-5567; McCarthy, David/0000-0001-8845-6501	Melbourne Water (MWC) [11/13]	Melbourne Water (MWC)	Funding: This research was supported by funding from Melbourne Water (MWC 11/13), http://www.melbournewater.com.au/Pages/home.aspx. This funding was received by MT, DM, and TF. The funders assisted with establishing overall study aims and objectives but had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abdu N, 2011, NUTR CYCL AGROECOSYS, V89, P387, DOI 10.1007/s10705-010-9403-3; ABS, 2011, WAT US AUSTR FARMS 2; Ahmed W, 2011, J ENVIRON QUAL, V40, P13, DOI 10.2134/jeq2010.0345; Alexander PD, 2006, ENVIRON POLLUT, V144, P736, DOI 10.1016/j.envpol.2006.03.001; Allen R. G., 1998, FAO Irrigation and Drainage Paper; Alloway B. J., 2004, Land Contamination & Reclamation, V12, P179, DOI 10.2462/09670513.658; ALTMANN L, 1993, TOXICOL LETT, V66, P105, DOI 10.1016/0378-4274(93)90085-C; Angelova V, 2008, COMMUN SOIL SCI PLAN, V39, P344, DOI 10.1080/00103620701826480; Arora M, 2008, FOOD CHEM, V111, P811, DOI 10.1016/j.foodchem.2008.04.049; Bahemuka TE, 1999, FOOD CHEM, V66, P63, DOI 10.1016/S0308-8146(98)00213-1; BANNERMAN RT, 1993, WATER SCI TECHNOL, V28, P241, DOI 10.2166/wst.1993.0426; Barraud S, 1999, WATER SCI TECHNOL, V39, P185, DOI 10.1016/S0273-1223(99)00022-0; Bedan ES, 2009, J AM WATER RESOUR AS, V45, P998, DOI 10.1111/j.1752-1688.2009.00342.x; Berti WR, 1996, J ENVIRON QUAL, V25, P1025, DOI 10.2134/jeq1996.00472425002500050014x; Bester PK, 2013, ECOTOX ENVIRON SAFE, V96, P182, DOI 10.1016/j.ecoenv.2013.06.011; Bratieres K, 2008, WATER RES, V42, P3930, DOI 10.1016/j.watres.2008.06.009; Brattebo BO, 2003, WATER RES, V37, P4369, DOI 10.1016/S0043-1354(03)00410-X; Choe JS, 2002, WATER SCI TECHNOL, V45, P249, DOI 10.2166/wst.2002.0251; Cobb GP, 2000, ENVIRON TOXICOL CHEM, V19, P600, DOI [10.1002/etc.5620190311, 10.1897/1551-5028(2000)019&lt;0600:AOHMBV&gt;2.3.CO;2]; Cui YJ, 2004, ENVIRON INT, V30, P785, DOI 10.1016/j.envint.2004.01.003; Datta S. P., 2000, Journal of the Indian Society of Soil Science, V48, P836; de Meeus C, 2002, SCI TOTAL ENVIRON, V291, P167, DOI 10.1016/S0048-9697(01)01098-1; De Wolf H, 2008, ENVIRON POLLUT, V152, P636, DOI 10.1016/j.envpol.2007.06.064; Dierkes C, 2006, WATER SCI TECHNOL, V54, P291, DOI 10.2166/wst.2006.597; Dimkpa CO, 2009, SOIL BIOL BIOCHEM, V41, P154, DOI 10.1016/j.soilbio.2008.10.010; Duncan H.P., 1999, DATABASE URBAN STORM; Eastmond DA, 2008, CRIT REV TOXICOL, V38, P173, DOI 10.1080/10408440701845401; Eick MJ, 1999, SOIL SCI, V164, P28, DOI 10.1097/00010694-199901000-00005; European Food Safety Authority, 2010, EFSA J, V8, P1570, DOI [10.2903/j.efsa.2010.1570, DOI 10.2903/J.EFSA.2010.1570]; Fang YY, 2012, ENVIRON SCI POLLUT R, V19, P1659, DOI 10.1007/s11356-011-0674-2; Fletcher TD, 2004, 048 COOP RES CTR CAT; Food Standards Australia New Zealand, 2013, 141 FOOD STAND AUSTR; Ford RG, 1999, ENVIRON SCI TECHNOL, V33, P3140, DOI 10.1021/es990271d; Fuerhacker M, 2011, DESALINATION, V275, P118, DOI 10.1016/j.desal.2011.02.041; Fytianos K, 2001, B ENVIRON CONTAM TOX, V67, P423; Gardening Australia, 2011, FACT SHEET MAN NUTR; Gardner T, 2010, ARCHIT SCI REV, V53, P107, DOI 10.3763/asre.2009.0074; Ghosh M., 2005, Applied Ecology and Environmental Research, V3, P67; Gnecco I, 2005, ATMOS RES, V77, P60, DOI 10.1016/j.atmosres.2004.10.017; Goyer, 2004, ISSUE PAPER HUMAN HL; Gromaire-Mertz MC, 1999, WATER SCI TECHNOL, V39, P1, DOI 10.1016/S0273-1223(99)00002-5; Hatt B, 2006, QUANTIFYING STROMWAT; Hatt BE, 2007, WATER SCI TECHNOL, V55, P201, DOI 10.2166/wst.2007.110; Hatt BE, 2004, INT C WAT SENS URB D; HE QB, 1993, J SOIL SCI, V44, P641, DOI 10.1111/j.1365-2389.1993.tb02329.x; HELSEL DR, 1979, J WATER POLLUT CON F, V51, P709; Hooda PS, 1997, J SCI FOOD AGR, V73, P446, DOI [10.1002/(SICI)1097-0010(199704)73:4<446::AID-JSFA749>3.3.CO;2-U, 10.1002/(SICI)1097-0010(199704)73:4&lt;446::AID-JSFA749&gt;3.0.CO;2-2]; Ikeda M, 2000, SCI TOTAL ENVIRON, V249, P373, DOI 10.1016/S0048-9697(99)00527-6; ISHAQ AM, 1988, WATER RESOUR BULL, V24, P1227; Joint FAO/WHO Food Standards Program Codex Committee on Contaminants in Foods, 2011, WORK DOC INF US DISC, P17; Khan FH, 2012, SCI TOTAL ENVIRON, V430, P68, DOI 10.1016/j.scitotenv.2012.04.063; Khan MU, 2013, CHEMOSPHERE, V93, P2230, DOI 10.1016/j.chemosphere.2013.07.067; Khan S, 2008, ENVIRON POLLUT, V152, P686, DOI 10.1016/j.envpol.2007.06.056; KINNERSLEY AM, 1993, PLANT GROWTH REGUL, V12, P207, DOI 10.1007/BF00027200; KLEIN LA, 1974, J WATER POLLUT CON F, V46, P2653; KUBOI T, 1986, PLANT SOIL, V92, P405, DOI 10.1007/BF02372488; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042944; Liu WH, 2005, ENVIRON INT, V31, P805, DOI 10.1016/j.envint.2005.05.042; Luo CL, 2011, J HAZARD MATER, V186, P481, DOI 10.1016/j.jhazmat.2010.11.024; McBride M.B., 1994, ENV CHEM SOILS; McCarthy D, 2011, 4 MON U; McCarthy DT, 2010, EFFECTIVE MONITORING; McGrath SP, 2003, CURR OPIN BIOTECH, V14, P277, DOI 10.1016/S0958-1669(03)00060-0; Melbourne Water, 2012, BUILD PLANT BOX RAIN; Melbourne Water, 2013, DRINK WAT QUAL DAT; Nabulo G, 2010, SCI TOTAL ENVIRON, V408, P5338, DOI 10.1016/j.scitotenv.2010.06.034; Nigg JT, 2008, BIOL PSYCHIAT, V63, P325, DOI 10.1016/j.biopsych.2007.07.013; Occupational Health and Safety Administration (OHSA), 2009, TOX MET; Orsini F, 2013, AGRON SUSTAIN DEV, V33, P695, DOI 10.1007/s13593-013-0143-z; OWE M, 1982, WATER RESOUR BULL, V18, P863; Park JH, 2011, J HAZARD MATER, V185, P829, DOI 10.1016/j.jhazmat.2010.09.095; Philp M, 2008, TECHNICAL REPORT; Piechalak A, 2002, PHYTOCHEMISTRY, V60, P153, DOI 10.1016/S0031-9422(02)00067-5; Rattan R. K., 2002, Fertiliser News, V47, P21; Rattan RK, 2005, AGR ECOSYST ENVIRON, V109, P310, DOI 10.1016/j.agee.2005.02.025; REINELT LE, 1995, ECOL ENG, V4, P77, DOI 10.1016/0925-8574(94)00002-M; Rushton BT, 2001, J WATER RES PL-ASCE, V127, P172, DOI 10.1061/(ASCE)0733-9496(2001)127:3(172); Salnikow K, 2008, CHEM RES TOXICOL, V21, P28, DOI 10.1021/tx700198a; Saravanan VS, 2007, CHEMOSPHERE, V66, P1794, DOI 10.1016/j.chemosphere.2006.07.067; Smit CE, 1996, APPL SOIL ECOL, V3, P127, DOI 10.1016/0929-1393(95)00078-X; SMITH SR, 1994, ENVIRON POLLUT, V86, P5, DOI 10.1016/0269-7491(94)90003-5; Steuer S, 1997, 974242 USGS WAT RES; Tiller K. G., 1986, Transactions. XIII. Congress of the International Society of Soil Science. Plenary Papers. Volume I., P29; Tuccillo ME, 2006, SCI TOTAL ENVIRON, V355, P288, DOI 10.1016/j.scitotenv.2005.03.003; UN-Water, 2006, COP WAT SCARC STRAT; United State Environmental Protection Agency (US-EPA), 2013, LEAD COMP IN CASRN 7; United States Environmental Protection Agency (US-EPA), 2013, CHROM 6 CASRN 18540; United States Environmental Protection Agency (USEPA), 1996, 6010B USEPA; USEPA, 2007, 6020A USEPA; Wang QR, 2002, J ENVIRON SCI HEAL A, V37, P611, DOI 10.1081/ESE-120003241; Wium-Andersen T, 2011, WATER SCI TECHNOL, V64, P503, DOI 10.2166/wst.2011.075; Yadav RK, 2002, ENVIRON INT, V28, P481, DOI 10.1016/S0160-4120(02)00070-3; Yang JX, 2010, J ENVIRON SCI, V22, P1246, DOI 10.1016/S1001-0742(09)60245-X; Zhao LYL, 2007, ENVIRON SCI TECHNOL, V41, P2770, DOI 10.1021/es062032d; Zheng N, 2007, SCI TOTAL ENVIRON, V383, P81, DOI 10.1016/j.scitotenv.2007.05.002	95	27	28	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112441	10.1371/journal.pone.0112441	http://dx.doi.org/10.1371/journal.pone.0112441			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426946	Green Published, gold			2022-12-26	WOS:000349145400014
J	Ryland, KE; Svoboda, LK; Vesely, ED; McIntyre, JC; Zhang, L; Martens, JR; Lawlor, ER				Ryland, K. E.; Svoboda, L. K.; Vesely, E. D.; McIntyre, J. C.; Zhang, L.; Martens, J. R.; Lawlor, E. R.			Polycomb-dependent repression of the potassium channel-encoding gene KCNA5 promotes cancer cell survival under conditions of stress	ONCOGENE			English	Article							STEM-CELLS; DIFFERENTIAL EXPRESSION; GROUP PROTEINS; ION CHANNELS; K+ CHANNELS; KV1.5; APOPTOSIS; HYPOXIA; BMI-1; METABOLISM	Relapse after clinical remission remains a leading cause of cancer-associated death. Although the mechanisms of tumor relapse are complex, the ability of cancer cells to survive physiological stress is a prerequisite for recurrence. Ewing sarcoma (ES) and neuroblastoma (NB) are aggressive cancers that frequently relapse after initial remission. In addition, both tumors overexpress the polycomb group (PcG) proteins BMI-1 and EZH2, which contribute to tumorigenicity. We have discovered that ES and NB resist hypoxic stress-induced death and that survival depends on PcG function. Epigenetic repression of developmental programs is the most well-established cancer-associated function of PcG proteins. However, we noted that voltage-gated potassium (Kv) channel genes are also targets of PcG regulation in stem cells. Given the role of potassium in regulating apoptosis, we reasoned that repression of Kv channel genes might have a role in cancer cell survival. Here we describe our novel finding that PcG-dependent repression of the Kv1.5 channel gene KCNA5 contributes to cancer cell survival under conditions of stress. We show that survival of cancer cells in stress is dependent upon suppression of Kv1.5 channel function. The KCNA5 promoter is marked in cancer cells with PcG-dependent chromatin repressive modifications that increase in hypoxia. Genetic and pharmacological inhibition of BMI-1 and EZH2, respectively, restore KCNA5 expression, which sensitizes cells to stress-induced death. In addition, ectopic expression of the Kv1.5 channel induces apoptotic cell death under conditions of hypoxia. These findings identify a novel role for PcG proteins in promoting cancer cell survival via repression of KCNA5.	[Ryland, K. E.; Vesely, E. D.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [Ryland, K. E.; Svoboda, L. K.; Lawlor, E. R.] Univ Michigan, Translat Oncol Program, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [McIntyre, J. C.; Zhang, L.; Martens, J. R.] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Lawlor, E. R.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; State University System of Florida; University of Florida; University of Michigan System; University of Michigan	Martens, JR (corresponding author), Univ Florida, Coll Med, Dept Pharmacol & Therapeut, POB 100267, Gainesville, FL 32610 USA.	martensj@ufl.edu; elawlor@med.umich.edu			CureSearch Children's Oncology Group; Nick Currey Fund; National Institutes of Health [1R01 CA134604, R01HL070973, AACR-SU2C IRG-1309]; Pharmacological Sciences Training Program [T32 GM007767]; UM Cancer Biology Training grant [5T32 CA009676-20]; NATIONAL CANCER INSTITUTE [R01CA134604, T32CA009676] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL070973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007767] Funding Source: NIH RePORTER	CureSearch Children's Oncology Group; Nick Currey Fund; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmacological Sciences Training Program; UM Cancer Biology Training grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the members of the Lawlor and Martens labs for helpful discussion. This research was supported by grants from the CureSearch Children's Oncology Group and Nick Currey Fund, the National Institutes of Health grants 1R01 CA134604 (to ERL), R01HL070973 (to JRM), AACR-SU2C IRG-1309 (to ERL), Pharmacological Sciences Training Program T32 GM007767 (to KER) and UM Cancer Biology Training grant 5T32 CA009676-20 (to LKS).	Archer SL, 2008, AM J PHYSIOL-HEART C, V294, pH570, DOI 10.1152/ajpheart.01324.2007; Arvind S, 2012, BRIT J NEUROSURG, V26, P16, DOI 10.3109/02688697.2011.583365; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bielanska J, 2009, CURR CANCER DRUG TAR, V9, P904, DOI 10.2174/156800909790192400; Bielanska J, 2012, CANCER INVEST, V30, P203, DOI 10.3109/07357907.2012.654872; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Burg ED, 2006, J MEMBRANE BIOL, V209, P3, DOI 10.1007/s00232-005-0838-4; Cain K, 2001, J BIOL CHEM, V276, P41985, DOI 10.1074/jbc.M107419200; Caouette D, 2003, N-S ARCH PHARMACOL, V368, P479, DOI 10.1007/s00210-003-0834-0; Cooper A, 2011, CLIN CANCER RES, V17, P56, DOI 10.1158/1078-0432.CCR-10-1417; Douglas D, 2008, CANCER RES, V68, P6507, DOI 10.1158/0008-5472.CAN-07-6152; Fedida D, 1995, AM J PHYSIOL-CELL PH, V494, P377; Felipe A, 2012, CURR MED CHEM, V19, P661, DOI 10.2174/092986712798992048; Fiske JL, 2006, CANCER METAST REV, V25, P493, DOI 10.1007/s10555-006-9017-z; Fraser SP, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0105; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Gupta PB, 2009, CELL, V138, P645, DOI 10.1016/j.cell.2009.06.034; Gutman GA, 2003, PHARMACOL REV, V55, P583, DOI 10.1124/pr.55.4.9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heshe D, 2011, CANCER CHEMOTH PHARM, V67, P647, DOI 10.1007/s00280-010-1361-6; Huang X, 2014, J CELL BIOL, V206, P151, DOI 10.1083/jcb.201404136; Hughes FM, 1997, J BIOL CHEM, V272, P30567, DOI 10.1074/jbc.272.48.30567; Ito K, 2014, NAT REV MOL CELL BIO, V15, P243, DOI 10.1038/nrm3772; Karki P, 2007, CELL DEATH DIFFER, V14, P2068, DOI 10.1038/sj.cdd.4402221; Lang F, 2012, COMPR PHYSIOL, V2, P2037, DOI 10.1002/cphy.c110046; Laugesen A, 2014, CELL STEM CELL, V14, P735, DOI 10.1016/j.stem.2014.05.006; Lawlor ER, 2002, ONCOGENE, V21, P307, DOI 10.1038/sj.onc.1205053; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; McCabe MT, 2012, NATURE, V492, P108, DOI 10.1038/nature11606; McEwen DP, 2007, J BIOL CHEM, V282, P29612, DOI 10.1074/jbc.M704402200; Michelakis ED, 2008, BRIT J CANCER, V99, P989, DOI 10.1038/sj.bjc.6604554; MILLER C, 2000, GENOME BIOL, V1, P4; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Monteith GR, 2007, NAT REV CANCER, V7, P519, DOI 10.1038/nrc2171; Nowak K, 2006, NUCLEIC ACIDS RES, V34, P1745, DOI 10.1093/nar/gkl119; Pardo LA, 2005, J MEMBRANE BIOL, V205, P115, DOI 10.1007/s00232-005-0776-1; Pardo LA, 2014, NAT REV CANCER, V14, P39, DOI 10.1038/nrc3635; Platoshyn O, 2006, AM J PHYSIOL-CELL PH, V290, pC907, DOI 10.1152/ajpcell.00028.2005; Richter GHS, 2009, P NATL ACAD SCI USA, V106, P5324, DOI 10.1073/pnas.0810759106; Riggi N, 2008, CANCER RES, V68, P2176, DOI 10.1158/0008-5472.CAN-07-1761; Sachlos E, 2012, CELL, V149, P1284, DOI 10.1016/j.cell.2012.03.049; Schumacher SM, 2010, HEART RHYTHM, V7, P1309, DOI 10.1016/j.hrthm.2010.02.017; Schumacher SM, 2009, CIRC RES, V104, P1390, DOI 10.1161/CIRCRESAHA.108.192773; Semenza GL, 2013, ONCOGENE, V32, P4057, DOI 10.1038/onc.2012.578; Shieh CC, 2000, PHARMACOL REV, V52, P557; Stapels M, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000502; Stump GL, 2005, J PHARMACOL EXP THER, V315, P1362, DOI 10.1124/jpet.105.092197; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Urrego D, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0094; Vallejo-Gracia A, 2013, J LEUKOCYTE BIOL, V94, P779, DOI 10.1189/jlb.0213094; VanWagoner DR, 1997, CIRC RES, V80, P772; von Levetzow C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019305; Wang CX, 2012, CANCER RES, V72, P315, DOI 10.1158/0008-5472.CAN-11-0961; WANG ZG, 1993, CIRC RES, V73, P276, DOI 10.1161/01.RES.73.2.276; Wonderlin WF, 1996, J MEMBRANE BIOL, V154, P91, DOI 10.1007/s002329900135	59	13	13	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 27	2015	34	35					4591	4600		10.1038/onc.2014.384	http://dx.doi.org/10.1038/onc.2014.384			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CP9BS	25435365	Green Accepted			2022-12-26	WOS:000360189300005
J	Elbaz, I; Lerer-Goldshtein, T; Okamoto, H; Appelbaum, L				Elbaz, Idan; Lerer-Goldshtein, Tali; Okamoto, Hitoshi; Appelbaum, Lior			Reduced synaptic density and deficient locomotor response in neuronal activity-regulated pentraxin 2a mutant zebrafish	FASEB JOURNAL			English	Article						NARP; NPTX2; TALEN; synaptophysin; mechanosensory	DEVELOPING VISUAL-SYSTEM; LATERAL-LINE SYSTEM; BINDING PROTEIN 49; PHYLOGENETIC ANALYSIS; EXCITATORY SYNAPSES; HYPOCRETIN NEURONS; PREFRONTAL CORTEX; NARP EXPRESSION; AMPA RECEPTORS; PLASTICITY	Neuronal-activity-regulated pentraxin (NARP/NPTX2/NP2) is a secreted synaptic protein that regulates the trafficking of glutamate receptors and mediates learning, memory, and drug addiction. The role of NPTX2 in regulating structural synaptic plasticity and behavior in a developing vertebrate is indefinite. We characterized the expression of nptx2a in larvae and adult zebrafish and established a transcription activator-like effector nuclease (TALEN)-mediated nptx2a mutant (nptx2a(-/-)) to study the role of Nptx2a in regulating structural synaptic plasticity and behavior. Similar to mammals, the zebrafish nptx2a was expressed in excitatory neurons in the brain and spinal cord. Its expression was induced in response to a mechanosensory stimulus but did not change during day and night. Behavioral assays showed that loss of Nptx2a results in reduced locomotor response to light-to-dark transition states and to a sound stimulus. Live imaging of synapses using the transgenic nptx2a:GAL4VP16 zebrafish and a fluorescent presynaptic synaptophysin (SYP) marker revealed reduced synaptic density in the axons of the spinal motor neurons and the anterodorsal lateral-line ganglion (gAD), which regulate locomotor activity and locomotor response to mechanosensory stimuli, respectively. These results suggest that Nptx2a affects locomotor response to external stimuli by mediating structural synaptic plasticity in excitatory neuronal circuits.	[Elbaz, Idan; Lerer-Goldshtein, Tali; Appelbaum, Lior] Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-5290002 Ramat Gan, Israel; [Elbaz, Idan; Lerer-Goldshtein, Tali; Appelbaum, Lior] Bar Ilan Univ, Leslie & Susan Gonda Multidisciplinary Brain Res, IL-5290002 Ramat Gan, Israel; [Okamoto, Hitoshi] RIKEN, Brain Sci Inst, Lab Dev Gene Regulat, Wako, Saitama, Japan	Bar Ilan University; Bar Ilan University; RIKEN	Appelbaum, L (corresponding author), Bar Ilan Univ, Mina & Everard Goodman Fac Life Sci, IL-5290002 Ramat Gan, Israel.	lior.appelbaum@biu.ac.il	Okamoto, Hitoshi/P-9767-2015	Okamoto, Hitoshi/0000-0002-7512-8549	Israel Science Foundation [366/11]; Brain and Behavior Research Foundation (NARSAD [18751]; Marie Curie International Reintegration Grant (IRG) [274333]	Israel Science Foundation(Israel Science Foundation); Brain and Behavior Research Foundation (NARSAD(NARSAD); Marie Curie International Reintegration Grant (IRG)(European Commission)	The authors thank Dr. Adi Tovin for technical assistance and Dr. Rachel Levy-Drummer, Head of the Biostatistics Unit, Faculty of Life Sciences, Bar-Ilan University. They also thank all members of the Appelbaum lab, and special thanks to Dr. Sally Shpungin, Prof. Zvy Dubinsky, and Mr. Tal Nathansohn for technical assistance. The authors thank Ms. Sharon Victor and Ms. Talia Levitas-Djerbi for assistance in editing the manuscript. This work was supported by the Israel Science Foundation (Grant 366/11), by the Brain and Behavior Research Foundation (NARSAD, Grant 18751), and by a Marie Curie International Reintegration Grant (IRG, Grant 274333). The authors declare no conflict of interest that would prejudice the impartiality of this work.	Agetsuma M, 2010, NAT NEUROSCI, V13, P1354, DOI 10.1038/nn.2654; Appelbaum L, 2010, NEURON, V68, P87, DOI 10.1016/j.neuron.2010.09.006; Baraban SC, 2005, NEUROSCIENCE, V131, P759, DOI 10.1016/j.neuroscience.2004.11.031; Bjartmar L, 2006, J NEUROSCI, V26, P6269, DOI 10.1523/jneurosci.4212-05.2006; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Chang MC, 2010, NAT NEUROSCI, V13, P1090, DOI 10.1038/nn.2621; Cho RW, 2008, NEURON, V57, P858, DOI 10.1016/j.neuron.2008.01.010; Cirelli C, 2004, NEURON, V41, P35, DOI 10.1016/S0896-6273(03)00814-6; Cirelli C, 2000, SLEEP, V23, P453; Crombag HS, 2009, NEUROPSYCHOPHARMACOL, V34, P857, DOI 10.1038/npp.2008.80; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dereeper A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-8; Dodds DC, 1997, J BIOL CHEM, V272, P21488, DOI 10.1074/jbc.272.34.21488; Elbaz I, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00009; Elbaz I, 2012, J NEUROSCI, V32, P12961, DOI 10.1523/JNEUROSCI.1284-12.2012; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Gerrow Kimberly, 2007, Sci STKE, V2007, ppe56, DOI 10.1126/stke.4082007pe56; Gu Y, 2013, NEURON, V79, P335, DOI 10.1016/j.neuron.2013.05.016; HSU YC, 1995, GENOMICS, V28, P220, DOI 10.1006/geno.1995.1134; Huang P, 2011, NAT BIOTECHNOL, V29, P699, DOI 10.1038/nbt.1939; Johnson AW, 2007, J NEUROSCI, V27, P13430, DOI 10.1523/JNEUROSCI.4320-07.2007; Johnson A, 2010, LEARN MEMORY, V17, P620, DOI 10.1101/lm.1937210; Kerstetter AE, 2004, DEV DYNAM, V230, P137, DOI 10.1002/dvdy.20021; Kim SJ, 2007, NEURON, V56, P582, DOI 10.1016/j.neuron.2007.10.030; Kirkpatrick LL, 2000, J BIOL CHEM, V275, P17786, DOI 10.1074/jbc.M002254200; Koch SM, 2010, J NEUROSCI, V30, P5404, DOI 10.1523/JNEUROSCI.4893-09.2010; Lu W, 2002, EUR J NEUROSCI, V15, P2027, DOI 10.1046/j.1460-9568.2002.02036.x; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Meyer D, 2014, NEURON, V82, P430, DOI 10.1016/j.neuron.2014.02.031; Meyer MP, 2006, J NEUROSCI, V26, P3604, DOI 10.1523/JNEUROSCI.0223-06.2006; O'Brien R, 2002, J NEUROSCI, V22, P4487, DOI 10.1523/JNEUROSCI.22-11-04487.2002; O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Raible DW, 2000, J COMP NEUROL, V421, P189, DOI 10.1002/(SICI)1096-9861(20000529)421:2<189::AID-CNE5>3.0.CO;2-K; Reti IM, 2008, NEUROSCIENCE, V151, P352, DOI 10.1016/j.neuroscience.2007.10.040; Reti IM, 2002, J NEUROCHEM, V82, P1561, DOI 10.1046/j.1471-4159.2002.01141.x; Reti IM, 2002, J NEUROCHEM, V82, P935, DOI 10.1046/j.1471-4159.2002.01051.x; Reti IM, 2011, ILAR J, V52, P321, DOI 10.1093/ilar.52.3.321; Sander JD, 2011, NAT BIOTECHNOL, V29, P697, DOI 10.1038/nbt.1934; SCHLIMGEN AK, 1995, NEURON, V14, P519, DOI 10.1016/0896-6273(95)90308-9; Sia GM, 2007, NEURON, V55, P87, DOI 10.1016/j.neuron.2007.06.020; Simmich J, 2012, PROG BRAIN RES, V196, P145, DOI 10.1016/B978-0-444-59426-6.00008-2; Thompson CL, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00165; Tsui CC, 1996, J NEUROSCI, V16, P2463; van Alphen B, 2013, J NEUROSCI, V33, P6917, DOI 10.1523/JNEUROSCI.0061-13.2013; Vatine GD, 2013, J BIOL CHEM, V288, P169, DOI 10.1074/jbc.M112.413831; Wyart C, 2011, REV NEUROSCIENCE, V22, P121, DOI 10.1515/RNS.2011.013; Xu DS, 2003, NEURON, V39, P513, DOI 10.1016/S0896-6273(03)00463-X; Zada D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004615	50	13	13	4	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1220	1234		10.1096/fj.14-258350	http://dx.doi.org/10.1096/fj.14-258350			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25466900				2022-12-26	WOS:000354115000011
J	Sea, K; Sohn, SH; Durazo, A; Sheng, YW; Shaw, BF; Cao, XH; Taylor, AB; Whitson, LJ; Holloway, SP; Hart, PJ; Cabelli, DE; Gralla, EB; Valentine, JS				Sea, Kevin; Sohn, Se Hui; Durazo, Armando; Sheng, Yuewei; Shaw, Bryan F.; Cao, Xiaohang; Taylor, Alexander B.; Whitson, Lisa J.; Holloway, Stephen P.; Hart, P. John; Cabelli, Diane E.; Gralla, Edith Butler; Valentine, Joan Selverstone			Insights into the Role of the Unusual Disulfide Bond in Copper-Zinc Superoxide Dismutase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CU,ZN-SUPEROXIDE DISMUTASE; ATOMIC-RESOLUTION; METAL; YEAST; AGGREGATION; SOD1; MUTATIONS; BINDING; APOPROTEIN; MECHANISM	The functional and structural significance of the intrasubunit disulfide bond in copper-zinc superoxide dismutase (SOD1) was studied by characterizing mutant forms of human SOD1 (hSOD) and yeast SOD1 lacking the disulfide bond. We determined x-ray crystal structures of metal-bound and metal-deficient hC57S SOD1. C57S hSOD1 isolated from yeast contained four zinc ions per protein dimer and was structurally very similar to wild type. The addition of copper to this four-zinc protein gave properly reconstituted 2Cu, 2Zn C57S hSOD, and its spectroscopic properties indicated that the coordination geometry of the copper was remarkably similar to that of holo wild type hSOD1. In contrast, the addition of copper and zinc ions to apo C57S human SOD1 failed to give proper reconstitution. Using pulse radiolysis, we determined SOD activities of yeast and human SOD1s lacking disulfide bonds and found that they were enzymatically active at similar to 10% of the wild type rate. These results are contrary to earlier reports that the intrasubunit disulfide bonds in SOD1 are essential for SOD activity. Kinetic studies revealed further that the yeast mutant SOD1 had less ionic attraction for superoxide, possibly explaining the lower rates. Saccharomyces cerevisiae cells lacking the sod1 gene do not grow aerobically in the absence of lysine, but expression of C57S SOD1 increased growth to 30-50% of the growth of cells expressing wild type SOD1, supporting that C57S SOD1 retained a significant amount of activity.	[Sea, Kevin; Sohn, Se Hui; Durazo, Armando; Sheng, Yuewei; Shaw, Bryan F.; Gralla, Edith Butler; Valentine, Joan Selverstone] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Sea, Kevin] Santa Rosa Jr Coll, Dept Wine Studies, 1501 Mendocino Ave, Santa Rosa, CA 95401 USA; [Sohn, Se Hui] LG Chem Ltd, Taejon 305380, South Korea; [Durazo, Armando] Univ Arizona, Dept Chem & Environm Engn, Tucson, AZ 85721 USA; [Cabelli, Diane E.] Brookhaven Natl Lab, Dept Chem, Upton, NY 11973 USA; [Shaw, Bryan F.] Baylor Univ, Dept Chem & Biochem, Waco, TX 76798 USA; [Cao, Xiaohang; Taylor, Alexander B.; Whitson, Lisa J.; Holloway, Stephen P.; Hart, P. John] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Hart, P. John] South Texas Vet Hlth Care Syst, Dept Vet Affairs, San Antonio, TX 78229 USA; [Valentine, Joan Selverstone] Ewha Womans Univ, Dept Bioinspired Sci, Seoul 120750, South Korea	University of California System; University of California Los Angeles; LG Chem; University of Arizona; United States Department of Energy (DOE); Brookhaven National Laboratory; Baylor University; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; Ewha Womans University	Sea, K (corresponding author), Santa Rosa Jr Coll, Dept Wine Studies, 1501 Mendocino Ave, Santa Rosa, CA 95401 USA.	kevinsea@yahoo.com; jsv@chem.ucla.edu	Valentine, Joan S/B-6665-2008; Shaw, Bryan/A-7001-2008	Valentine, Joan S/0000-0002-7174-925X; Taylor, Alexander/0000-0003-3517-6033	National Institutes of Health [DK46828, GM28222, GM08496, NS39112]; Veterans Affairs [VA 101 BX00506]; U.S. Department of Energy Division of Chemical Sciences, Geosciences, and Biosciences [DE-AC02-98CH10886]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM028222, T32GM008496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039112] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000506] Funding Source: NIH RePORTER; Direct For Mathematical & Physical Scien [1352122] Funding Source: National Science Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs); U.S. Department of Energy Division of Chemical Sciences, Geosciences, and Biosciences(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Veterans Affairs(US Department of Veterans Affairs); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK46828 and GM28222 (to J. S. V.), GM08496 (to K. S.), and NS39112 (to P. J. H.). This work was also supported by Veterans Affairs Grant VA 101 BX00506 (to P. J. H.) and Contract DE-AC02-98CH10886 from the U.S. Department of Energy Division of Chemical Sciences, Geosciences, and Biosciences (to Brookhaven National Laboratory).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Banci L, 2006, J BIOL CHEM, V281, P2333, DOI 10.1074/jbc.M506497200; Banci L, 2013, NAT CHEM BIOL, V9, P297, DOI [10.1038/NCHEMBIO.1202, 10.1038/nchembio.1202]; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bertini I, 1998, ADV INORG CHEM, V45, P127, DOI 10.1016/S0898-8838(08)60026-4; Carroll MC, 2004, P NATL ACAD SCI USA, V101, P5964, DOI 10.1073/pnas.0308298101; Chattopadhyay M, 2009, ANTIOXID REDOX SIGN, V11, P1603, DOI [10.1089/ars.2009.2536, 10.1089/ARS.2009.2536]; Chattopadhyay M, 2008, P NATL ACAD SCI USA, V105, P18663, DOI 10.1073/pnas.0807058105; Culotta VC, 2006, BBA-MOL CELL RES, V1763, P747, DOI 10.1016/j.bbamcr.2006.05.003; Culotta VC, 1997, J BIOL CHEM, V272, P23469, DOI 10.1074/jbc.272.38.23469; Das A, 2013, P NATL ACAD SCI USA, V110, P3871, DOI 10.1073/pnas.1216597110; Doucette P, 2004, THESIS; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; DUNBAR JC, 1981, CLIN RES PROC, V17, P51; Durazo A., 2007, THESIS; Durer ZAO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005004; Elam JS, 2003, J BIOL CHEM, V278, P21032, DOI 10.1074/jbc.M300484200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferraroni M, 1999, J MOL BIOL, V288, P413, DOI 10.1006/jmbi.1999.2681; Field LS, 2003, J BIOL CHEM, V278, P28052, DOI 10.1074/jbc.M304296200; FLOHE L, 1984, METHOD ENZYMOL, V105, P93; FRIDOVICH I, 1989, J BIOL CHEM, V264, P7761; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Furukawa Y, 2004, EMBO J, V23, P2872, DOI 10.1038/sj.emboj.7600276; Furukawa Y, 2006, P NATL ACAD SCI USA, V103, P7148, DOI 10.1073/pnas.0602048103; Ghosh S, 2013, ANTIOXID REDOX SIGN, V18, P412, DOI 10.1089/ars.2012.4566; Goto JJ, 1998, J BIOL CHEM, V273, P30104, DOI 10.1074/jbc.273.46.30104; Goto JJ, 2000, J BIOL CHEM, V275, P1007, DOI 10.1074/jbc.275.2.1007; GRALLA EB, 1991, J BACTERIOL, V173, P5918, DOI 10.1128/jb.173.18.5918-5920.1991; Hart PJ, 2006, CURR OPIN CHEM BIOL, V10, P131, DOI 10.1016/j.cbpa.2006.02.034; Hart PJ, 1998, PROTEIN SCI, V7, P545; Hough MA, 2004, P NATL ACAD SCI USA, V101, P5976, DOI 10.1073/pnas.0305143101; Lamb AL, 2001, NAT STRUCT BIOL, V8, P751, DOI 10.1038/nsb0901-751; Le Moan N, 2006, J BIOL CHEM, V281, P10420, DOI 10.1074/jbc.M513346200; Liba A, 2000, THESIS; Liba A., 2003, THESIS; Lindberg MJ, 2004, P NATL ACAD SCI USA, V101, P15893, DOI 10.1073/pnas.0403979101; LIU XF, 1992, J BIOL CHEM, V267, P18298; Lyons TJ, 2000, J BIOL INORG CHEM, V5, P189, DOI 10.1007/s007750050363; Lyons TJ, 1998, J BIOL INORG CHEM, V3, P650, DOI 10.1007/s007750050279; MING LJ, 1988, INORG CHEM, V27, P728, DOI 10.1021/ic00277a029; Niwa J, 2007, J BIOL CHEM, V282, P28087, DOI 10.1074/jbc.M704465200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PANTOLIANO MW, 1982, J AM CHEM SOC, V104, P6310, DOI 10.1021/ja00387a027; Potter SZ, 2007, J AM CHEM SOC, V129, P4575, DOI 10.1021/ja066690+; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; READ RJ, 1986, ACTA CRYSTALLOGR A, V42, P140, DOI 10.1107/S0108767386099622; Rodriguez JA, 2002, J BIOL CHEM, V277, P15932, DOI 10.1074/jbc.M112088200; Rodriguez JA, 2005, P NATL ACAD SCI USA, V102, P10516, DOI 10.1073/pnas.0502515102; ROE JA, 1988, BIOCHEMISTRY-US, V27, P950, DOI 10.1021/bi00403a017; Sea KW, 2013, J BIOL INORG CHEM, V18, P985, DOI 10.1007/s00775-013-1047-8; Shaw BF, 2007, TRENDS BIOCHEM SCI, V32, P78, DOI 10.1016/j.tibs.2006.12.005; Shaw BF, 2006, J BIOL CHEM, V281, P18167, DOI 10.1074/jbc.M600623200; Sheng YW, 2012, CURR TOP MED CHEM, V12, P2560; SIKORSKI RS, 1989, GENETICS, V122, P19; Sohn S. H., 2006, THESIS; Strange RW, 2003, J MOL BIOL, V328, P877, DOI 10.1016/S0022-2836(03)00355-3; TAINER JA, 1983, NATURE, V306, P284, DOI 10.1038/306284a0; Tiwari A, 2003, J BIOL CHEM, V278, P5984, DOI 10.1074/jbc.M210419200; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Valentine J. S., 1981, METAL IONS BIOL, P291; VONPIECHOWSKI M, 1993, BER BUNSEN PHYS CHEM, V97, P762; Wang J, 2006, J NEUROCHEM, V96, P1277, DOI 10.1111/j.1471-4159.2005.03642.x	63	54	55	0	45	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2405	2418		10.1074/jbc.M114.588798	http://dx.doi.org/10.1074/jbc.M114.588798			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25433341	hybrid, Green Published			2022-12-26	WOS:000348588000043
J	Hense, A; Herman, E; Oldemeyer, S; Kottke, T				Hense, Anika; Herman, Elena; Oldemeyer, Sabine; Kottke, Tilman			Proton Transfer to Flavin Stabilizes the Signaling State of the Blue Light Receptor Plant Cryptochrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED ELECTRON-TRANSFER; COLI DNA PHOTOLYASE; ARABIDOPSIS CRYPTOCHROME; ATP-BINDING; PHOTOACTIVATION MECHANISM; DROSOPHILA CRYPTOCHROME; INFRARED-SPECTROSCOPY; AQUEOUS-SOLUTION; RADICAL-PAIRS; IN-VIVO	Plant cryptochromes regulate the circadian rhythm, flowering time, and photomorphogenesis in higher plants as responses to blue light. In the dark, these photoreceptors bind oxidized FAD in the photolyase homology region (PHR). Upon blue light absorption, FAD is converted to the neutral radical state, the likely signaling state, by electron transfer via a conserved tryptophan triad and proton transfer from a nearby aspartic acid. Here we demonstrate, by infrared and time-resolved UV-visible spectroscopy on the PHR domain, that replacement of the aspartic acid Asp-396 with cysteine prevents proton transfer. The lifetime of the radical is decreased by 6 orders of magnitude. This short lifetime does not permit to drive conformational changes in the C-terminal extension that have been associated with signal transduction. Only in the presence of ATP do both the wild type and mutant form a long-lived radical state. However, in the mutant, an anion radical is formed instead of the neutral radical, as found previously in animal type I cryptochromes. Infrared spectroscopic experiments demonstrate that the light-induced conformational changes of the PHR domain are conserved in the mutant despite the lack of proton transfer. These changes are not detected in the photoreduction of the non-photosensory D-amino acid oxidase to the anion radical. In conclusion, formation of the anion radical is sufficient to generate a protein response in plant cryptochromes. Moreover, the intrinsic proton transfer is required for stabilization of the signaling state in the absence of ATP.	[Hense, Anika; Herman, Elena; Oldemeyer, Sabine; Kottke, Tilman] Univ Bielefeld, Dept Chem, D-33615 Bielefeld, Germany	University of Bielefeld	Kottke, T (corresponding author), Univ Bielefeld, Dept Chem, Univ Str 25, D-33615 Bielefeld, Germany.	tilman.kottke@uni-bielefeld.de	Kottke, Tilman/B-7102-2011	Kottke, Tilman/0000-0001-8080-9579	Deutsche Forschungsgemeinschaft [KO3580/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant KO3580/2-1. Part of these results were presented at the 16th International Congress on Photobiology held in Cordoba, Argentina, in 2014.	AHMAD M, 1995, PLANT J, V8, P653, DOI 10.1046/j.1365-313X.1995.08050653.x; Balland V, 2009, J AM CHEM SOC, V131, P426, DOI 10.1021/ja806540j; Banerjee R, 2007, J BIOL CHEM, V282, P14916, DOI 10.1074/jbc.M700616200; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Bauer C, 2011, PHOTOCHEM PHOTOBIOL, V87, P548, DOI 10.1111/j.1751-1097.2011.00901.x; Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Biskup T, 2013, J BIOL CHEM, V288, P9249, DOI 10.1074/jbc.M112.417725; Biskup T, 2011, ANGEW CHEM INT EDIT, V50, P12647, DOI 10.1002/anie.201104321; Bouly JP, 2007, J BIOL CHEM, V282, P9383, DOI 10.1074/jbc.M609842200; Bouly JP, 2003, EUR J BIOCHEM, V270, P2921, DOI 10.1046/j.1432-1033.2003.03691.x; Brautigam CA, 2004, P NATL ACAD SCI USA, V101, P12142, DOI 10.1073/pnas.0404851101; Brazard J, 2010, J AM CHEM SOC, V132, P4935, DOI 10.1021/ja1002372; Burney S, 2012, ANGEW CHEM INT EDIT, V51, P9356, DOI 10.1002/anie.201203476; Burney S, 2009, FEBS LETT, V583, P1427, DOI 10.1016/j.febslet.2009.03.040; Cailliez F, 2014, J AM CHEM SOC, V136, P12974, DOI 10.1021/ja506084f; Chaves I, 2011, ANNU REV PLANT BIOL, V62, P335, DOI 10.1146/annurev-arplant-042110-103759; Damiani MJ, 2011, J BIOL CHEM, V286, P4382, DOI 10.1074/jbc.M110.194696; Danon A, 2006, P NATL ACAD SCI USA, V103, P17036, DOI 10.1073/pnas.0608139103; Forbes-Stovall J, 2014, PLANT PHYSIOL BIOCH, V75, P14, DOI 10.1016/j.plaphy.2013.12.002; Giovani B, 2003, NAT STRUCT BIOL, V10, P489, DOI 10.1038/nsb933; Goormaghtigh E, 2006, BIOPHYS J, V90, P2946, DOI 10.1529/biophysj.105.072017; Guo HW, 1998, SCIENCE, V279, P1360, DOI 10.1126/science.279.5355.1360; Henbest KB, 2008, P NATL ACAD SCI USA, V105, P14395, DOI 10.1073/pnas.0803620105; Herbel V, 2013, PLANT J, V74, P583, DOI 10.1111/tpj.12144; Hughes RM, 2012, J BIOL CHEM, V287, P22165, DOI 10.1074/jbc.M112.360545; Immeln D, 2007, J BIOL CHEM, V282, P21720, DOI 10.1074/jbc.M700849200; Immeln D, 2012, J AM CHEM SOC, V134, P12536, DOI 10.1021/ja302121z; Immeln D, 2010, J PHYS CHEM B, V114, P17155, DOI 10.1021/jp1076388; Iwata T, 2010, BIOCHEMISTRY-US, V49, P8882, DOI 10.1021/bi1009979; JORNS MS, 1990, BIOCHEMISTRY-US, V29, P552, DOI 10.1021/bi00454a032; Kondoh M, 2011, J MOL BIOL, V413, P128, DOI 10.1016/j.jmb.2011.08.031; KOTAKI A, 1970, J BIOCHEM-TOKYO, V68, P287, DOI 10.1093/oxfordjournals.jbchem.a129358; Kottke T, 2006, BIOCHEMISTRY-US, V45, P2472, DOI 10.1021/bi051964b; Langenbacher T, 2009, J AM CHEM SOC, V131, P14274, DOI 10.1021/ja901628y; Li X, 2011, P NATL ACAD SCI USA, V108, P20844, DOI 10.1073/pnas.1114579108; Lin CT, 1998, P NATL ACAD SCI USA, V95, P2686, DOI 10.1073/pnas.95.5.2686; LIN CT, 1995, SCIENCE, V269, P968, DOI 10.1126/science.7638620; Liu B, 2010, CURR OPIN PLANT BIOL, V13, P578, DOI 10.1016/j.pbi.2010.09.005; Maeda K, 2012, P NATL ACAD SCI USA, V109, P4774, DOI 10.1073/pnas.1118959109; Mao J, 2005, P NATL ACAD SCI USA, V102, P12270, DOI 10.1073/pnas.0501011102; MASSEY V, 1966, BIOCHEMISTRY-US, V5, P3181, DOI 10.1021/bi00874a016; Muller P, 2014, SCI REP-UK, V4, DOI 10.1038/srep05175; Muller P, 2011, J BIOL CHEM, V286, P21033, DOI 10.1074/jbc.M111.228940; MULLER F, 1987, FREE RADICAL BIO MED, V3, P215, DOI 10.1016/0891-5849(87)90009-8; Ozturk N, 2008, J BIOL CHEM, V283, P3256, DOI 10.1074/jbc.M708612200; Partch CL, 2005, BIOCHEMISTRY-US, V44, P3795, DOI 10.1021/bi047545g; Raffelberg S, 2013, BIOL CHEM, V394, P1517, DOI 10.1515/hsz-2013-0163; Reisdorph NA, 2004, PLANT PHYSIOL, V134, P1546, DOI 10.1104/pp.103.031930; Salzmann S, 2008, J PHOTOCH PHOTOBIO A, V198, P221, DOI 10.1016/j.jphotochem.2008.03.015; Schleicher E, 2007, J BIOL CHEM, V282, P4738, DOI 10.1074/jbc.M604734200; Sellaro R, 2010, PLANT PHYSIOL, V154, P401, DOI 10.1104/pp.110.160820; Solov'yov IA, 2012, J AM CHEM SOC, V134, P18046, DOI 10.1021/ja3074819; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Vaidya AT, 2013, P NATL ACAD SCI USA, V110, P20455, DOI 10.1073/pnas.1313336110; Weber S, 2010, J PHYS CHEM B, V114, P14745, DOI 10.1021/jp103401u; Wille G, 2003, BIOCHEMISTRY-US, V42, P14814, DOI 10.1021/bi035219f; Yamada D, 2012, BIOCHEMISTRY-US, V51, P5774, DOI 10.1021/bi300530x; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; Yu XH, 2007, P NATL ACAD SCI USA, V104, P7289, DOI 10.1073/pnas.0701912104; Zeugner A, 2005, J BIOL CHEM, V280, P19437, DOI 10.1074/jbc.C500077200	60	40	41	0	56	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1743	1751		10.1074/jbc.M114.606327	http://dx.doi.org/10.1074/jbc.M114.606327			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25471375	Green Published, hybrid			2022-12-26	WOS:000348056400039
J	Hsu, SH; Lo, YY; Liu, TH; Pan, YJ; Huang, YT; Sun, YJ; Hung, CC; Tseng, FG; Yang, CW; Pan, RL				Hsu, Shen-Hsing; Lo, Yueh-Yu; Liu, Tseng-Huang; Pan, Yih-Jiuan; Huang, Yun-Tzu; Sun, Yuh-Ju; Hung, Cheng-Chieh; Tseng, Fan-Gang; Yang, Chih-Wei; Pan, Rong-Long			Substrate-induced Changes in Domain Interaction of Vacuolar H+-Pyrophosphatase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ATOMIC-FORCE MICROSCOPY; 2-DIMENSIONAL CRYSTALLIZATION; INORGANIC PYROPHOSPHATASE; MEMBRANE-PROTEINS; LIPID LAYER; RECEPTOR 2; PURIFICATION; RESIDUES; BINDING; ROLES	Single molecule atomic force microscopy (smAFM) was employed to unfold transmembrane domain interactions of a unique vacuolar H+-pyrophosphatase (EC 3.6.1.1) from Vigna radiata. H+-Pyrophosphatase is a membrane-embedded homodimeric protein containing a single type of polypeptide and links PPi hydrolysis to proton translocation. Each subunit consists of 16 transmembrane domains with both ends facing the lumen side. In this investigation, H+-pyrophosphatase was reconstituted into the lipid bilayer in the same orientation for efficient fishing out of the membrane by smAFM. The reconstituted H+-pyrophosphatase in the lipid bilayer showed an authentically dimeric structure, and the size of each monomer was similar to 4 nm in length,similar to 2 nm in width, and+1 nm in protrusion height. Upon extracting the H+-pyrophosphatase out of the membrane, force-distance curves containing 10 peaks were obtained and assigned to distinct domains. In the presence of pyrophosphate, phosphate, and imidodiphosphate, the numbers of interaction curves were altered to 7, 8, and 10, respectively, concomitantly with significant modification in force strength. The substrate-binding residues were further replaced to verify these domain changes upon substrate binding. A working model is accordingly proposed to show the interactions between transmembrane domains of H+-pyrophosphatase in the presence and absence of substrate and its analog.	[Hsu, Shen-Hsing; Lo, Yueh-Yu; Hung, Cheng-Chieh; Yang, Chih-Wei] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Nephrol,Kidney Res Ctr, Taoyuan 33333, Taiwan; [Liu, Tseng-Huang; Pan, Yih-Jiuan; Huang, Yun-Tzu; Sun, Yuh-Ju; Pan, Rong-Long] Natl Tsing Hua Univ, Coll Life Sci, Dept Life Sci, Hsinchu 30013, Taiwan; [Liu, Tseng-Huang; Pan, Yih-Jiuan; Huang, Yun-Tzu; Sun, Yuh-Ju; Pan, Rong-Long] Natl Tsing Hua Univ, Coll Life Sci, Inst Bioinformat & Struct Biol, Hsinchu 30013, Taiwan; [Tseng, Fan-Gang] Natl Tsing Hua Univ, Coll Nucl Sci, Dept Engn & Syst Sci, Hsinchu 30013, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; National Tsing Hua University; National Tsing Hua University; National Tsing Hua University	Yang, CW (corresponding author), Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Nephrol,Kidney Res Ctr, Taoyuan 33333, Taiwan.	cwyang@ms1.hinet.net; rlpan@life.nthu.edu.tw		Tseng, Fan-Gang/0000-0001-7654-6905	Chang Gung Memorial Hospital-National Tsing Hua University Joint Research Grants [101N2748E1, CMRPG3D0641]; National Science Council, Republic of China [NSC 101-2627-M-007-008, NSC 102-2321-B-007-005, NSC 102-2311-B-007-001-MY3, NSC 102-2314-B-182-031-MY3, NSC102-2811-B-182-028]	Chang Gung Memorial Hospital-National Tsing Hua University Joint Research Grants; National Science Council, Republic of China(Ministry of Science and Technology, Taiwan)	This work was supported by Chang Gung Memorial Hospital-National Tsing Hua University Joint Research Grants 101N2748E1 (to R.-L. P.) and CMRPG3D0641 (to C.-C. H.), National Science Council, Republic of China, Grants NSC 101-2627-M-007-008, NSC 102-2321-B-007-005, and NSC 102-2311-B-007-001-MY3 (to R.-L. P.), NSC 102-2314-B-182-031-MY3 (to C.-W. Y.), and NSC102-2811-B-182-028 (to Y.-Y. L.).	Belogurov GA, 2002, J BIOL CHEM, V277, P49651, DOI 10.1074/jbc.M210341200; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRITTEN CJ, 1992, J BIOL CHEM, V267, P21850; BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001; Damaghi M, 2010, J MOL BIOL, V397, P878, DOI 10.1016/j.jmb.2010.02.023; Drozdowicz YM, 2001, TRENDS PLANT SCI, V6, P206, DOI 10.1016/S1360-1385(01)01923-9; Drozdowicz YM, 2000, PLANT PHYSIOL, V123, P353, DOI 10.1104/pp.123.1.353; Frederix PLTM, 2009, BIOPHYS J, V96, P329, DOI 10.1016/j.bpj.2008.09.046; Hertadi R, 2003, J MOL BIOL, V333, P993, DOI 10.1016/j.jmb.2003.09.010; Hsiao YY, 2007, BBA-BIOENERGETICS, V1767, P965, DOI 10.1016/j.bbabio.2007.04.007; Hsiao YY, 2004, BBA-BIOENERGETICS, V1608, P190, DOI 10.1016/j.bbabio.2004.01.001; Hsu SH, 2010, BIOCHEMISTRY-US, V49, P5408, DOI 10.1021/bi100058w; Hsu SH, 2009, BOT STUD, V50, P291; Huang YT, 2010, J BIOL CHEM, V285, P23655, DOI 10.1074/jbc.M110.134916; Janovjak H, 2003, EMBO J, V22, P5220, DOI 10.1093/emboj/cdg509; Kedrov A, 2007, ANNU REV BIOPH BIOM, V36, P233, DOI 10.1146/annurev.biophys.36.040306.132640; Kellosalo J, 2012, SCIENCE, V337, P473, DOI 10.1126/science.1222505; Kessler M, 2006, STRUCTURE, V14, P521, DOI 10.1016/j.str.2005.11.023; Lee CH, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.190215; Levy D, 2001, FEBS LETT, V504, P187, DOI 10.1016/S0014-5793(01)02748-X; Levy D, 1999, J STRUCT BIOL, V127, P44, DOI 10.1006/jsbi.1999.4155; Lin HH, 2005, ARCH BIOCHEM BIOPHYS, V442, P206, DOI 10.1016/j.abb.2005.08.010; Lin SM, 2012, NATURE, V484, P399, DOI 10.1038/nature10963; Liu TH, 2009, FEBS J, V276, P4381, DOI 10.1111/j.1742-4658.2009.07146.x; Lo YY, 2013, J BIOL CHEM, V288, P12335, DOI 10.1074/jbc.M112.418699; Lopez-Marques RL, 2005, BBA-BIOMEMBRANES, V1716, P69, DOI 10.1016/j.bbamem.2005.08.004; Maeshima M, 2000, BBA-BIOMEMBRANES, V1465, P37, DOI 10.1016/S0005-2736(00)00130-9; McIntosh MT, 2001, MOL BIOCHEM PARASIT, V114, P183, DOI 10.1016/S0166-6851(01)00251-1; Mimura H, 2004, J BIOL CHEM, V279, P35106, DOI 10.1074/jbc.M406264200; Muller DJ, 2007, NAT PROTOC, V2, P2191, DOI 10.1038/nprot.2007.309; Pan YJ, 2011, BBA-BIOENERGETICS, V1807, P59, DOI 10.1016/j.bbabio.2010.10.006; SARAFIAN V, 1992, BIOCHEM J, V283, P493, DOI 10.1042/bj2830493; SATO MH, 1994, J BIOL CHEM, V269, P6725; Tzeng CM, 1996, BIOCHEM J, V316, P143, DOI 10.1042/bj3160143; Van RC, 2005, BBA-BIOENERGETICS, V1709, P84, DOI 10.1016/j.bbabio.2005.05.011	35	3	4	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1197	1209		10.1074/jbc.M114.568139	http://dx.doi.org/10.1074/jbc.M114.568139			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25451931	Green Published, hybrid			2022-12-26	WOS:000347778200049
J	Foveau, B; Van Der Kraak, L; Beauchemin, N; Albrecht, S; LeBlanc, AC				Foveau, Benedicte; Van Der Kraak, Lauren; Beauchemin, Nicole; Albrecht, Steffen; LeBlanc, Andrea C.			Inflammation-Induced Tumorigenesis in Mouse Colon Is Caspase-6 Independent	PLOS ONE			English	Article							INTESTINAL EPITHELIAL-CELLS; AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; AXON DEGENERATION; SELF-ACTIVATION; HUMAN NEURONS; CANCER CELLS; LAMIN-A; APOPTOSIS; CLEAVAGE	Caspases play an important role in maintaining tissue homeostasis. Active Caspase-6 (Casp6) is considered a novel therapeutic target against Alzheimer disease (AD) since it is present in AD pathological brain lesions, associated with age-dependent cognitive decline, and causes age-dependent cognitive impairment in the mouse brain. However, active Casp6 is highly expressed and activated in normal human colon epithelial cells raising concerns that inhibiting Casp6 in AD may promote colon carcinogenesis. Furthermore, others have reported rare mutations of Casp6 in human colorectal cancers and an effect of Casp6 on apoptosis and metastasis of colon cancer cell lines. Here, we investigated the role of Casp6 in inflammation-associated azoxymethane/dextran sulfate sodium (AOM/DSS) colon cancer in Casp6-overexpressing and -deficient mice. In wild-type mice, AOM/DSS-induced tumors had significantly higher Casp6 mRNA, protein and activity levels compared to normal adjacent colon tissues. Increased human Casp6 or absence of Casp6 expression in mice colon epithelial cells did not change colonic tumor multiplicity, burden or distribution. Nevertheless, the incidence of hyperplasia was slightly reduced in human Casp6-overexpressing colons and increased in Casp6 null colons. Overexpression of Casp6 did not affect the grade of the tumors while all tumors in heterozygous or homozygous Casp6 null colons were high grade compared to only 50% high grade in wild-type mice. Casp6 levels did not alter cellular proliferation and apoptosis. These results suggest that Casp6 is unlikely to be involved in colitis-associated tumors.	[Foveau, Benedicte; LeBlanc, Andrea C.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Foveau, Benedicte; LeBlanc, Andrea C.] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Van Der Kraak, Lauren; Beauchemin, Nicole] McGill Univ, Goodman Canc Res Ctr, Montreal, PQ, Canada; [Van Der Kraak, Lauren; Beauchemin, Nicole] McGill Univ, Dept Biochem, Dept Med, Montreal, PQ, Canada; [Van Der Kraak, Lauren; Beauchemin, Nicole] McGill Univ, Dept Oncol, Montreal, PQ, Canada; [Albrecht, Steffen] McGill Univ, Dept Pathol, Montreal, PQ, Canada	McGill University; Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; McGill University	LeBlanc, AC (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada.	andrea.leblanc@mcgill.ca			Jewish General Hospital Ride to Conquer Cancer Fund; Canadian Foundation of Innovation; Canadian Institutes of Health Research (CIHR) [MOP-243413-BCA-CGAG-45097]; JGH Foundation	Jewish General Hospital Ride to Conquer Cancer Fund; Canadian Foundation of Innovation(Canada Foundation for Innovation); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); JGH Foundation	This work was supported by a research grant from the Jewish General Hospital Ride to Conquer Cancer Fund, The Canadian Foundation of Innovation, Canadian Institutes of Health Research (CIHR) MOP-243413-BCA-CGAG-45097, and the JGH Foundation to ALB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht S, 2007, AM J PATHOL, V170, P1200, DOI 10.2353/ajpath.2007.060974; Albrecht S, 2009, J NEUROPATH EXP NEUR, V68, P1282, DOI 10.1097/NEN.0b013e3181c1da10; Boivin GP, 2003, GASTROENTEROLOGY, V124, P762, DOI 10.1053/gast.2003.50094; Chan JY, 2008, CANCER BIOL THER, V7, P1305, DOI 10.4161/cbt.7.8.6302; Chan JY, 2009, ANTICANCER RES, V29, P3043; Creagh EM, 2003, IMMUNOL REV, V193, P10, DOI 10.1034/j.1600-065X.2003.00048.x; Cusack CL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2910; Dupaul-Chicoine J, 2010, IMMUNITY, V32, P367, DOI 10.1016/j.immuni.2010.02.012; Giaime E, 2010, CELL DEATH DIFFER, V17, P158, DOI 10.1038/cdd.2009.116; Godefroy N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079313; Graham RK, 2011, TRENDS NEUROSCI, V34, P646, DOI 10.1016/j.tins.2011.09.001; Gray DC, 2010, CELL, V142, P637, DOI 10.1016/j.cell.2010.07.014; Grossmann J, 2001, CELL GROWTH DIFFER, V12, P147; Grossmann J, 2001, GASTROENTEROLOGY, V120, P79, DOI 10.1053/gast.2001.20879; Grossmann J, 1998, AM J PHYSIOL-GASTR L, V274, pG1117, DOI 10.1152/ajpgi.1998.274.6.G1117; Guo H, 2006, CELL DEATH DIFFER, V13, P285, DOI 10.1038/sj.cdd.4401753; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Hu B, 2010, P NATL ACAD SCI USA, V107, P21635, DOI 10.1073/pnas.1016814108; Kim YN, 2012, INT J CELL BIOL, V2012, DOI DOI 10.1155/2012/306879; Klaiman G, 2008, MOL CELL PROTEOMICS, V7, P1541, DOI 10.1074/mcp.M800007-MCP200; Klaiman G, 2009, BBA-MOL CELL RES, V1793, P592, DOI 10.1016/j.bbamcr.2008.12.004; LeBlanc A, 1999, J BIOL CHEM, V274, P23426, DOI 10.1074/jbc.274.33.23426; LeBlanc AC, 2014, CELL DEATH DIFFER, V21, P696, DOI 10.1038/cdd.2013.194; Lee AW, 2010, J BIOL CHEM, V285, P31974, DOI 10.1074/jbc.M110.152744; Lee JW, 2006, APMIS, V114, P646, DOI 10.1111/j.1600-0463.2006.apm_417.x; Lee SC, 2006, PROTEOMICS, V6, P2386, DOI 10.1002/pmic.200500366; Lee SC, 2010, CANCER LETT, V288, P36, DOI 10.1016/j.canlet.2009.06.020; MacLachan TK, 2002, P NATL ACAD SCI USA, V99, P9492, DOI 10.1073/pnas.132241599; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Meunier C, 2010, ONCOGENE, V29, P647, DOI 10.1038/onc.2009.369; MOOLENBEEK C, 1981, LAB ANIM, V15, P57, DOI 10.1258/002367781780958577; Neufert C, 2007, NAT PROTOC, V2, P1998, DOI 10.1038/nprot.2007.279; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Orth K, 1996, J BIOL CHEM, V271, P16443, DOI 10.1074/jbc.271.28.16443; Paoni NF, 2003, PHYSIOL GENOMICS, V15, P228, DOI 10.1152/physiolgenomics.00078.2003; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramcharitar J, 2013, NEUROBIOL AGING, V34, P1815, DOI 10.1016/j.neurobiolaging.2013.01.007; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Simon DJ, 2012, J NEUROSCI, V32, P17540, DOI 10.1523/JNEUROSCI.3012-12.2012; Sivananthan SN, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.74; Suboj P, 2012, PHARMACOLOGY, V89, P91, DOI 10.1159/000335659; Takahashi A, 1996, P NATL ACAD SCI USA, V93, P8395, DOI 10.1073/pnas.93.16.8395; Tanaka T, 2003, CANCER SCI, V94, P965, DOI 10.1111/j.1349-7006.2003.tb01386.x; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Tounekti O, 2004, J NEUROCHEM, V89, P561, DOI 10.1111/j.1471-4159.2004.02349.x; Uribe V, 2012, HUM MOL GENET, V21, P1954, DOI 10.1093/hmg/dds005; Van Der Kraak L, 2010, ONCOTARGET, V1, P436; Wang QS, 1998, CARCINOGENESIS, V19, P2001, DOI 10.1093/carcin/19.11.2001; Wang XJ, 2010, EMBO REP, V11, P841, DOI 10.1038/embor.2010.141; Washington MK, 2013, GASTROENTEROLOGY, V144, P705, DOI 10.1053/j.gastro.2013.01.067; Watanabe C, 2008, J IMMUNOL, V181, P6810, DOI 10.4049/jimmunol.181.10.6810	51	8	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114270	10.1371/journal.pone.0114270	http://dx.doi.org/10.1371/journal.pone.0114270			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470254	gold, Green Published, Green Submitted			2022-12-26	WOS:000349128700095
J	Maisch, T; Eichner, A; Spath, A; Gollmer, A; Konig, B; Regensburger, J; Baumler, W				Maisch, Tim; Eichner, Anja; Spaeth, Andreas; Gollmer, Anita; Koenig, Burkhard; Regensburger, Johannes; Baeumler, Wolfgang			Fast and Effective Photodynamic Inactivation of Multiresistant Bacteria by Cationic Riboflavin Derivatives	PLOS ONE			English	Article							SINGLET OXYGEN; PSEUDOMONAS-AERUGINOSA; PORPHYRIN DERIVATIVES; RESISTANCE; THERAPY; COLI; PHOTOINACTIVATION; PHOTOSENSITIZERS; INFECTION; CANDIDA	Photodynamic inactivation of bacteria (PIB) proves to be an additional method to kill pathogenic bacteria. PIB requires photosensitizer molecules that effectively generate reactive oxygen species like singlet oxygen when exposed to visible light. To allow a broad application in medicine, photosensitizers should be safe when applied in humans. Substances like vitamin B2, which are most likely safe, are known to produce singlet oxygen upon irradiation. In the present study, we added positive charges to flavin derivatives to enable attachment of these molecules to the negatively charged surface of bacteria. Two of the synthesized flavin derivatives showed a high quantum yield of singlet oxygen of approximately 75%. Multidrug resistant bacteria like MRSA (Methicillin resistant Staphylococcus aureus), EHEC (enterohemorrhagic Escherichia coli), Pseudomonas aeruginosa, and Acinetobacter baumannii were incubated with these flavin derivatives in vitro and were subsequently irradiated with visible light for seconds only. Singlet oxygen production in bacteria was proved by detecting its luminescence at 1270 nm. After irradiation, the number of viable bacteria decreased up to 6 log(10) steps depending on the concentration of the flavin derivatives and the light dosimetry. The bactericidal effect of PIB was independent of the bacterial type and the corresponding antibiotic resistance pattern. In contrast, the photosensitizer concentration and light parameters used for bacteria killing did not affect cell viability of human keratinocytes (therapeutic window). Multiresistant bacteria can be safely and effectively killed by a combination of modified vitamin B2 molecules, oxygen and visible light, whereas normal skin cells survive. Further work will include these new photosensitizers for topical application to decolonize bacteria from skin and mucosa.	[Maisch, Tim; Eichner, Anja; Gollmer, Anita; Regensburger, Johannes; Baeumler, Wolfgang] Univ Hosp Regensburg, Dept Dermatol, Regensburg, Germany; [Spaeth, Andreas; Koenig, Burkhard] Univ Regensburg, Inst Organ Chem, D-93053 Regensburg, Germany	University of Regensburg; University of Regensburg	Eichner, A (corresponding author), Univ Hosp Regensburg, Dept Dermatol, Regensburg, Germany.	anja.eichner@klinik.uni-regensburg.de	Koenig, Burkhard/A-1362-2009; Koenig, Burkhard/GRX-2026-2022; Koenig, Burkhard/O-8172-2019	Koenig, Burkhard/0000-0002-6131-4850; Koenig, Burkhard/0000-0002-6131-4850; Koenig, Burkhard/0000-0002-6131-4850	German Research Foundation [DFG-RE-3323/2-1, DFG-GO-2340/1-1]; Bavarian Research Foundation [BFS AZ 952-10]	German Research Foundation(German Research Foundation (DFG)); Bavarian Research Foundation	Johannes Regensburger and Anita Gollmer are supported by grants of the German Research Foundation (DFG-RE-3323/2-1 and DFG-GO-2340/1-1, respectively). Part of the study was supported by a grant of the Bavarian Research Foundation (BFS AZ 952-10). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Ortega C, 2011, VIRULENCE, V2, P144, DOI 10.4161/viru.2.2.15014; Alves E, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-70; Arias CA, 2012, NAT REV MICROBIOL, V10, P266, DOI 10.1038/nrmicro2761; Arias CA, 2009, NEW ENGL J MED, V360, P439, DOI 10.1056/NEJMp0804651; Baumler W, 2012, PHOTOCH PHOTOBIO SCI, V11, P107, DOI 10.1039/c1pp05142c; Baier J, 2006, BIOPHYS J, V91, P1452, DOI 10.1529/biophysj.106.082388; Boyle-Vavra S, 2001, ANTIMICROB AGENTS CH, V45, P280, DOI 10.1128/AAC.45.1.280-287.2001; Bradley DG, 2006, J AGR FOOD CHEM, V54, P6016, DOI 10.1021/jf053264j; Cerqueira L, 2013, BIOFOULING, V29, P829, DOI 10.1080/08927014.2013.807913; CHAPPLE RM, 1992, ARCH MICROBIOL, V157, P242, DOI 10.1007/BF00245157; Cieplik F, 2013, FREE RADICAL BIO MED, V65, P477, DOI 10.1016/j.freeradbiomed.2013.07.031; Eichner A, 2013, PHOTOCH PHOTOBIO SCI, V12, P135, DOI 10.1039/c2pp25164g; EXON JH, 1984, VET HUM TOXICOL, V26, P508; FDA, 2002, CLASS 3 SPEC CONTR G; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Food and Nutrition Board IoM, 1998, RIB DIET REF INT THI; Garcez AS, 2008, J ENDODONT, V34, P138, DOI 10.1016/j.joen.2007.10.020; Giuliani F, 2010, ANTIMICROB AGENTS CH, V54, P637, DOI 10.1128/AAC.00603-09; Goldberg M, 2013, MICROBE MAGAZIN, V8, P307; Hagelueken G, 2006, P NATL ACAD SCI USA, V103, P7631, DOI 10.1073/pnas.0510501103; Hoboth C, 2009, J INFECT DIS, V200, P118, DOI 10.1086/599360; IMLAY JA, 1988, SCIENCE, V240, P1302, DOI 10.1126/science.3287616; Kashiwabuchi RT, 2012, ARQ BRAS OFTALMOL, V75, P423, DOI 10.1590/S0004-27492012000600011; Komerik N, 2003, ANTIMICROB AGENTS CH, V47, P932, DOI 10.1128/AAC.47.3.932-940.2003; Krylov V, 2013, VIRUSES-BASEL, V5, P15, DOI 10.3390/v5010015; Kuhn R, 1935, BER DTSCH CHEM GES, V68, P1282, DOI 10.1002/cber.19350680711; Maisch T, 2005, ANTIMICROB AGENTS CH, V49, P1542, DOI 10.1128/AAC.49.4.1542-1552.2005; Maisch T, 2009, J APPL MICROBIOL, V107, P1569, DOI 10.1111/j.1365-2672.2009.04342.x; Maisch T, 2007, P NATL ACAD SCI USA, V104, P7223, DOI 10.1073/pnas.0611328104; Maisch T, 2011, LASER SURG MED, V43, P176, DOI 10.1002/lsm.20970; Mansoorabadi SO, 2007, J ORG CHEM, V72, P6329, DOI 10.1021/jo0703092; Miles AA, 1938, J HYG-CAMBRIDGE, V38, P732, DOI 10.1017/S002217240001158X; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Muniesa M, 2012, APPL ENVIRON MICROB, V78, P4065, DOI 10.1128/AEM.00217-12; NITZAN Y, 1995, PHOTOCHEM PHOTOBIOL, V62, P342, DOI 10.1111/j.1751-1097.1995.tb05279.x; Oliveira A, 2009, J APPL MICROBIOL, V106, P1986, DOI 10.1111/j.1365-2672.2009.04168.x; Page AV, 2013, MED CLIN N AM, V97, P681, DOI 10.1016/j.mcna.2013.04.001; Prates RA, 2011, J ANTIMICROB CHEMOTH, V66, P1525, DOI 10.1093/jac/dkr160; Ragas X, 2010, LASER SURG MED, V42, P384, DOI 10.1002/lsm.20922; Regensburger J, 2012, EXP DERMATOL, V21, P135, DOI 10.1111/j.1600-0625.2011.01414.x; Remucal CK, 2011, ENVIRON SCI TECHNOL, V45, P5230, DOI 10.1021/es200411a; Schafer M, 1998, INT J RADIAT BIOL, V74, P249, DOI 10.1080/095530098141636; Scott P, 2007, CLIN INFECT DIS, V44, P1577, DOI 10.1086/518170; Sharma SK, 2011, CURR PHARM DESIGN, V17, P1303, DOI 10.2174/138161211795703735; SNELLINGS WM, 1984, TOXICOL APPL PHARM, V75, P105, DOI 10.1016/0041-008X(84)90081-4; Tavares A, 2010, MAR DRUGS, V8, P91, DOI 10.3390/md8010091; Thakuri P S, 2011, Nepal Med Coll J, V13, P281; Wainwright M, 2010, LETT APPL MICROBIOL, V50, P486, DOI 10.1111/j.1472-765X.2010.02825.x; Wigle DT, 2007, J TOXICOL ENV HEAL B, V10, P3, DOI 10.1080/10937400601034563; Zhang QC, 2011, SCIENCE, V333, P1764, DOI 10.1126/science.1208747	50	75	76	4	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e111792	10.1371/journal.pone.0111792	http://dx.doi.org/10.1371/journal.pone.0111792			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469700	Green Published, gold			2022-12-26	WOS:000349128700006
J	Mhashal, AR; Roy, S				Mhashal, Anil R.; Roy, Sudip			Effect of Gold Nanoparticle on Structure and Fluidity of Lipid Membrane	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; SILVER NANOPARTICLES; COMPUTER-SIMULATION; BILAYERS; THERMODYNAMICS; PHOSPHOLIPIDS; TRANSLOCATION; CYTOTOXICITY; RAFTS	This paper deals with the effect of different size gold nanoparticles on the fluidity of lipid membrane at different regions of the bilayer. To investigate this, we have considered significantly large bilayer leaflets and incorporated only one nanoparticle each time, which was subjected to all atomistic molecular dynamics simulations. We have observed that, lipid molecules located near to the gold nanoparticle interact directly with it, which results in deformation of lipid structure and slower dynamics of lipid molecules. However, lipid molecules far away from the interaction site of the nanoparticle get perturbed, which gives rise to increase in local ordering of the lipid domains and decrease in fluidity. The bilayer thickness and area per head group in this region also get altered. Similar trend, but with different magnitude is also observed when different size nanoparticle interact with the bilayer.	[Mhashal, Anil R.; Roy, Sudip] Natl Chem Lab, Div Phys Chem, Pune 411008, Maharashtra, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Chemical Laboratory (NCL)	Roy, S (corresponding author), Natl Chem Lab, Div Phys Chem, Dr Homi Bhabha Rd, Pune 411008, Maharashtra, India.	s.roy@ncl.res.in	Mhashal, Anil/ABA-7245-2021	Mhashal, Anil/0000-0002-8232-8135; Roy, Sudip/0000-0001-9930-081X	Board of Research in Nuclear Sciences, India [GAP295526]	Board of Research in Nuclear Sciences, India(Department of Atomic Energy (DAE)Board of Research in Nuclear Sciences (BRNS))	Funding: The authors would also like to acknowledge the financial support from Board of Research in Nuclear Sciences (Project code GAP295526), India, for this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen WJ, 2009, J COMPUT CHEM, V30, P1952, DOI 10.1002/jcc.21172; Benting J, 1999, FEBS LETT, V462, P47, DOI 10.1016/S0014-5793(99)01501-X; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Binder WH, 2007, PHYS CHEM CHEM PHYS, V9, P6435, DOI 10.1039/b711470m; Bothun Geoffrey D., 2008, Journal of Nanobiotechnology, V6, P13, DOI 10.1186/1477-3155-6-13; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Caprile L, 2012, NANOSCALE, V4, P7727, DOI 10.1039/c2nr32741d; Chau PL, 1998, MOL PHYS, V93, P511, DOI 10.1080/002689798169195; DAVIS PJ, 1984, BIOCHIM BIOPHYS ACTA, V778, P305, DOI 10.1016/0005-2736(84)90373-0; Donaldson K, 2001, OCCUPATIONAL ENV MED; El-Sayed IH, 2006, CANCER LETT, V239, P129, DOI 10.1016/j.canlet.2005.07.035; Fridriksson EK, 1999, BIOCHEMISTRY-US, V38, P8056, DOI 10.1021/bi9828324; Ghosh P, 2008, ADV DRUG DELIVER REV, V60, P1307, DOI 10.1016/j.addr.2008.03.016; Ginzburg VV, 2007, NANO LETT, V7, P3716, DOI 10.1021/nl072053l; Gopalakrishnan G, 2006, ANGEW CHEM INT EDIT, V45, P5478, DOI 10.1002/anie.200600545; Heinz H, 2008, J PHYS CHEM C, V112, P17281, DOI 10.1021/jp801931d; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hess B, 2009, ABSTR PAP AM CHEM S, V237; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Jain PK, 2007, NANO TODAY, V2, P18, DOI 10.1016/S1748-0132(07)70016-6; Kaneshina S, 1998, BBA-BIOMEMBRANES, V1374, P1, DOI 10.1016/S0005-2736(98)00122-9; Li Y, 2010, J PHYS CHEM B, V114, P2749, DOI 10.1021/jp904550b; Lin JQ, 2010, ACS NANO, V4, P5421, DOI 10.1021/nn1010792; Merga G, 2010, J PHYS CHEM C, V114, P14811, DOI 10.1021/jp104922a; Pan Y, 2007, SMALL, V3, P1941, DOI 10.1002/smll.200700378; Park SH, 2006, COLLOID SURFACE B, V48, P112, DOI 10.1016/j.colsurfb.2006.01.006; Park SH, 2005, COLLOID SURFACE B, V44, P117, DOI 10.1016/j.colsurfb.2005.06.002; Patra M, 2003, BIOPHYS J, V84, P3636, DOI 10.1016/S0006-3495(03)75094-2; Peer D, 2007, NAT NANOTECHNOL, V2, P751, DOI 10.1038/nnano.2007.387; Poger D, 2010, J CHEM THEORY COMPUT, V6, P325, DOI 10.1021/ct900487a; Rasch MR, 2010, NANO LETT, V10, P3733, DOI 10.1021/nl102387n; Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f; Sandhu KK, 2002, BIOCONJUGATE CHEM, V13, P3, DOI 10.1021/bc015545c; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Tieleman DP, 1997, BBA-REV BIOMEMBRANES, V1331, P235, DOI 10.1016/S0304-4157(97)00008-7; TOUKAN K, 1985, PHYS REV B, V31, P2643, DOI 10.1103/PhysRevB.31.2643; Tu YS, 2013, NAT NANOTECHNOL, V8, P594, DOI [10.1038/nnano.2013.125, 10.1038/NNANO.2013.125]; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Wong-Ekkabut J, 2008, NAT NANOTECHNOL, V3, P363, DOI 10.1038/nnano.2008.130; Yang K, 2010, NAT NANOTECHNOL, V5, P579, DOI [10.1038/NNANO.2010.141, 10.1038/nnano.2010.141]; Zhang LW, 2009, TOXICOL LETT, V191, P149, DOI 10.1016/j.toxlet.2009.08.017; Zopes D, 2011, EUR J INORG CHEM, P273, DOI 10.1002/ejic.201000863	42	39	39	2	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114152	10.1371/journal.pone.0114152	http://dx.doi.org/10.1371/journal.pone.0114152			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469786	Green Submitted, gold, Green Published			2022-12-26	WOS:000349128700077
J	Mochida, K; Hasegawa, A; Otaka, N; Hama, D; Furuya, T; Yamaguchi, M; Ichikawa, E; Ijuin, M; Taguma, K; Hashimoto, M; Takashima, R; Kadota, M; Hiraiwa, N; Mekada, K; Yoshiki, A; Ogura, A				Mochida, Keiji; Hasegawa, Ayumi; Otaka, Naoki; Hama, Daiki; Furuya, Takashi; Yamaguchi, Masaki; Ichikawa, Eri; Ijuin, Maiko; Taguma, Kyuichi; Hashimoto, Michiko; Takashima, Rika; Kadota, Masayo; Hiraiwa, Noriko; Mekada, Kazuyuki; Yoshiki, Atsushi; Ogura, Atsuo			Devising Assisted Reproductive Technologies for Wild-Derived Strains of Mice: 37 Strains from Five Subspecies of Mus musculus	PLOS ONE			English	Article							C57BL/6 MOUSE SPERM; IN-VITRO; EMBRYOS; FERTILIZATION; CHOLESTEROL; SPERMATOZOA; MOLOSSINUS; MSM/MS	Wild-derived mice have long offered invaluable experimental models for mouse genetics because of their high evolutionary divergence from laboratory mice. A number of wild-derived strains are available from the RIKEN BioResource Center (BRC), but they have beenmaintained as living stocks because of the unavailability of assisted reproductive technology (ART). In this study, we sought to devise ART for 37 wild-derived strains from five subspecies of Mus musculus maintained at the BRC. Superovulation of females was effective (more than 15 oocytes per female) for 34 out of 37 strains by treatment with either equine chorionic gonadotropin or anti-inhibin serum, depending on their genetic background (subspecies). The collected oocytes could be fertilized in vitro at mean rates of 79.0% and 54.6% by the optimized protocol using fresh or frozen-thawed spermatozoa, respectively. They were cryopreserved at the 2-cell stage by vitrification with an ethylene glycol-based solution. In total, 94.6% of cryopreserved embryos survived the vitrification procedure and restored their normal morphology after warming. A conventional embryo transfer protocol could be applied to 25 out of the 35 strains tested. In the remaining 10 strains, live offspring could be obtained by a modified embryo transfer protocol using cyclosporin A treatment and co-transfer of ICR (laboratory mouse strain) embryos. Thus, ART for 37 wild-derived strains was devised successfully and is now routinely used for their preservation and transportation. The information provided here might facilitate broader use and wider distribution of wild-derived mice for biomedical research.	[Mochida, Keiji; Hasegawa, Ayumi; Otaka, Naoki; Hama, Daiki; Furuya, Takashi; Yamaguchi, Masaki; Ichikawa, Eri; Ijuin, Maiko; Taguma, Kyuichi; Hashimoto, Michiko; Takashima, Rika; Kadota, Masayo; Hiraiwa, Noriko; Mekada, Kazuyuki; Yoshiki, Atsushi; Ogura, Atsuo] RIKEN BioResouce Ctr, Tsukuba, Ibaraki, Japan; [Ogura, Atsuo] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki, Japan; [Ogura, Atsuo] Univ Tokyo, Fac Med, Ctr Dis Biol & Integrat Med, Bunkyo Ku, Tokyo 113, Japan	RIKEN; University of Tsukuba; University of Tokyo	Ogura, A (corresponding author), RIKEN BioResouce Ctr, Tsukuba, Ibaraki, Japan.	ogura@rtc.riken.go.jp	Ogura, Atsuo/J-3916-2014; Yoshiki, Atsushi/O-6162-2019	Ogura, Atsuo/0000-0003-0447-1988; Yoshiki, Atsushi/0000-0002-9450-5151	Ministry of Education, Culture, Sports, Science and Technology of Japan [25112009, 23220011]; RIKEN Epigenetics Program (Strategic Programs for RD)	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN Epigenetics Program (Strategic Programs for RD)	The work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (No. 25112009 and No. 23220011 to AO) and by the RIKEN Epigenetics Program (Strategic Programs for R&D to AO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agca Y, 2012, THERIOGENOLOGY, V78, P1653, DOI 10.1016/j.theriogenology.2012.08.012; Bath ML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009387; Beck JA, 2000, NAT GENET, V24, P23, DOI 10.1038/71641; CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679; Choi YH, 1998, BIOL REPROD, V59, P1328, DOI 10.1095/biolreprod59.6.1328; Hasegawa A, 2012, J REPROD DEVELOP, V58, P156, DOI 10.1262/jrd.11-097N; Hasegawa H, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.110.089896; Holt WV, 1999, REV REPROD, V4, P143, DOI 10.1530/revreprod/4.3.143; Kikkawa Y, 2001, MAMM GENOME, V12, P750, DOI 10.1007/s003350030008; KISHI H, 1995, J ENDOCRINOL, V146, P169, DOI 10.1677/joe.0.1460169; Mochida K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0049316; Moriwaki K, 1999, Prog Exp Tumor Res, V35, P1; Moriwaki K, 2009, EXP ANIM TOKYO, V58, P123, DOI 10.1538/expanim.58.123; ODAKA T, 1981, J NATL CANCER I, V67, P1123; Oka A, 2004, GENETICS, V166, P913, DOI 10.1534/genetics.166.2.913; Ostermeier GC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002792; QUINN P, 1985, FERTIL STERIL, V44, P493; Sakai T, 2005, MAMM GENOME, V16, P11, DOI 10.1007/s00344-004-3013-9; Suzuki O, 1996, REPROD FERT DEVELOP, V8, P975, DOI 10.1071/RD9960975; Takada T, 2008, GENOME RES, V18, P500, DOI 10.1101/gr.7175308; Takada T, 2013, GENOME RES, V23, P1329, DOI 10.1101/gr.156497.113; Takeo T, 2008, BIOL REPROD, V78, P546, DOI 10.1095/biolreprod.107.065359; Takeo T, 2011, BIOL REPROD, V85, P1066, DOI 10.1095/biolreprod.111.092536; Thornton CE, 1999, MAMM GENOME, V10, P987, DOI 10.1007/s003359901145; Tsuchiya K, 2000, KYUSYU J EXP ANIM, V16, P23; Ward MA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.112.100230; WHITTINGHAM DG, 1971, NATURE, V233, P125, DOI 10.1038/233125a0; YONEKAWA H, 1988, MOL BIOL EVOL, V5, P63; Yoshiki A, 2006, ILAR J, V47, P94, DOI 10.1093/ilar.47.2.94; Yoshiki A, 2009, EXP ANIM TOKYO, V58, P85, DOI 10.1538/expanim.58.85	30	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114305	10.1371/journal.pone.0114305	http://dx.doi.org/10.1371/journal.pone.0114305			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470728	gold, Green Submitted, Green Published			2022-12-26	WOS:000349128700099
J	Rath, SN; Brandl, A; Hiller, D; Hoppe, A; Gbureck, U; Horch, RE; Boccaccini, AR; Kneser, U				Rath, Subha N.; Brandl, Andreas; Hiller, Daniel; Hoppe, Alexander; Gbureck, Uwe; Horch, Raymund E.; Boccaccini, Aldo R.; Kneser, Ulrich			Bioactive Copper-Doped Glass Scaffolds Can Stimulate Endothelial Cells in Co-Culture in Combination with Mesenchymal Stem Cells	PLOS ONE			English	Article							ARTERIOVENOUS LOOP; CALCIUM-PHOSPHATE; BONE; ANGIOGENESIS; EXPRESSION; DIFFERENTIATION; PROLIFERATION; OSTEOBLASTS; GROWTH; VASCULARIZATION	Bioactive glass (BG) scaffolds are being investigated for bone tissue engineering applications because of their osteoconductive and angiogenic nature. However, to increase the in vivo performance of the scaffold, including enhancing the angiogenetic growth into the scaffolds, some researchers use different modifications of the scaffold including addition of inorganic ionic components to the basic BG composition. In this study, we investigated the in vitro biocompatibility and bioactivity of Cu2+-doped BG derived scaffolds in either BMSC (bone-marrow derived mesenchymal stem cells)-only culture or co-culture of BMSC and human dermal microvascular endothelial cells (HDMEC). In BMSC-only culture, cells were seeded either directly on the scaffolds (3D or direct culture) or were exposed to ionic dissolution products of the BG scaffolds, kept in permeable cell culture inserts (2D or indirect culture). Though we did not observe any direct osteoinduction of BMSCs by alkaline phosphatase (ALP) assay or by PCR, there was increased vascular endothelial growth factor (VEGF) expression, observed by PCR and ELISA assays. Additionally, the scaffolds showed no toxicity to BMSCs and there were healthy live cells found throughout the scaffold. To analyze further the reasons behind the increased VEGF expression and to exploit the benefits of the finding, we used the indirect method with HDMECs in culture plastic and Cu2+-doped BG scaffolds with or without BMSCs in cell culture inserts. There was clear observation of increased endothelial markers by both FACS analysis and acetylated LDL (acLDL) uptake assay. Only in presence of Cu2+-doped BG scaffolds with BMSCs, a high VEGF secretion was demonstrated by ELISA; and typical tubular structures were observed in culture plastics. We conclude that Cu2+-doped BG scaffolds release Cu2+, which in turn act on BMSCs to secrete VEGF. This result is of significance for the application of BG scaffolds in bone tissue engineering approaches.	[Rath, Subha N.; Brandl, Andreas; Hiller, Daniel; Horch, Raymund E.; Kneser, Ulrich] Univ Erlangen Nurnberg, Dept Plast & Hand Surg, Erlangen, Germany; [Rath, Subha N.] Indian Inst Technol Hyderabad, Dept Biomed Engn, Yeddumailaram, Telangana, India; [Hoppe, Alexander; Boccaccini, Aldo R.] Univ Erlangen Nurnberg, Inst Biomat, Dept Mat Sci & Engn, Erlangen, Germany; [Gbureck, Uwe] Univ Wurzburg, Dept Funct Mat Med & Dent, D-97070 Wurzburg, Germany; [Kneser, Ulrich] Heidelberg Univ, Burn Ctr, Dept Hand Plast & Reconstruct Surg, Ludwigshafen, Germany	University of Erlangen Nuremberg; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Hyderabad; University of Erlangen Nuremberg; University of Wurzburg; Ruprecht Karls University Heidelberg	Kneser, U (corresponding author), Univ Erlangen Nurnberg, Dept Plast & Hand Surg, Erlangen, Germany.	Ulrich.kneser@bgu-ludwigshafen.de	Boccaccini, Aldo R/C-7905-2013; Boccaccini, Aldo R./N-9782-2019; Rath, Subha/AAQ-7705-2020; Horch, Raymund E./H-8128-2019; Gbureck, Uwe/G-1430-2012	Boccaccini, Aldo R./0000-0002-7377-2955; Rath, Subha/0000-0002-3414-2328; Horch, Raymund E./0000-0002-6561-2353; 	Deutsche Forschungsgemeinschaft (DFG) [KN 578/2-1]; Emerging Fields Initiative (EFI) of the University of Erlangen-Nurnberg	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Emerging Fields Initiative (EFI) of the University of Erlangen-Nurnberg	Funding: This study was supported by research grants from the Deutsche Forschungsgemeinschaft (DFG) (KN 578/2-1) and the Emerging Fields Initiative (EFI) of the University of Erlangen-Nurnberg (Project: TOPbiomat). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arkudas A, 2013, TISSUE ENG PART C-ME, V19, P479, DOI [10.1089/ten.tec.2012.0572, 10.1089/ten.TEC.2012.0572]; Baldoli E, 2012, ANGIOGENESIS, V15, P47, DOI 10.1007/s10456-011-9242-0; Barralet J, 2009, TISSUE ENG PT A, V15, P1601, DOI 10.1089/ten.tea.2007.0370; Chen QZZ, 2006, BIOMATERIALS, V27, P2414, DOI 10.1016/j.biomaterials.2005.11.025; d'Angelo I, 2013, ACTA BIOMATER, V9, P7389, DOI 10.1016/j.actbio.2013.03.013; Fatokun AA, 2008, EUR J PHARMACOL, V587, P35, DOI 10.1016/j.ejphar.2008.03.024; Frangoulis M, 2007, PLAST RECONSTR SURG, V119, P837, DOI 10.1097/01.prs.0000252000.59231.5e; Contreras RG, 2010, IN VIVO, V24, P507; Gerard C, 2010, BIOMATERIALS, V31, P824, DOI 10.1016/j.biomaterials.2009.10.009; Gerhardt LC, 2011, BIOMATERIALS, V32, P4096, DOI 10.1016/j.biomaterials.2011.02.032; Han P, 2013, BIOMATERIALS SCI, DOI [10.1039/C1032BM00108J, DOI 10.1039/C1032BM00108J]; Hidalgo-Bastida LA, 2010, TISSUE ENG PART B-RE, V16, P405, DOI [10.1089/ten.teb.2009.0714, 10.1089/ten.TEB.2009.0714]; Hofmann A, 2008, BIOMATERIALS, V29, P4217, DOI 10.1016/j.biomaterials.2008.07.024; Hoppe A, 2011, BIOMATERIALS; Hoppe A, 2013, J MATER CHEM B, V1, P5659, DOI 10.1039/c3tb21007c; Horii A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000190; Kaigler D, 2006, J BONE MINER RES, V21, P735, DOI 10.1359/JBMR.060120; Kasten P, 2012, CELLS TISSUES ORGANS, V196, P523, DOI 10.1159/000337490; Kong N, 2013, J MATER CHEM B, DOI [10.1039/C1033TB21529F, DOI 10.1039/C1033TB21529F]; Li JN, 2010, BIOMATERIALS, V31, P5782, DOI 10.1016/j.biomaterials.2010.04.023; Li S, 2012, EXP BIOL MED, V237, P77, DOI 10.1258/ebm.2011.011267; Liu QH, 2008, BIOMATERIALS, V29, P4792, DOI 10.1016/j.biomaterials.2008.08.039; Marelli B, 2011, BIOMATERIALS, V32, P8915, DOI 10.1016/j.biomaterials.2011.08.016; Martin F, 2005, BLOOD, V105, P4613, DOI 10.1182/blood-2004-10-3980; Okuyama H, 2006, J BIOL CHEM, V281, P15554, DOI 10.1074/jbc.M602003200; Rath SN, 2016, J TISSUE ENG REGEN M, V10, pE497, DOI 10.1002/term.1849; Rath SN, 2012, J BIOMATER APPL, V27, P277, DOI 10.1177/0885328211402243; Rath SN, 2012, J CELL MOL MED, V16, P2350, DOI 10.1111/j.1582-4934.2012.01545.x; Rodriguez JP, 2002, J CELL BIOCHEM, V85, P92, DOI 10.1002/jcb.10111; Santos MI, 2010, MACROMOL BIOSCI, V10, P12, DOI 10.1002/mabi.200900107; Schmidt VJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078782; Sen CK, 2002, AM J PHYSIOL-HEART C, V282, pH1821, DOI 10.1152/ajpheart.01015.2001; Varanasi VG, 2011, J BIOMED MATER RES A, V98A, P177, DOI 10.1002/jbm.a.33102; Wu CT, 2013, BIOMATERIALS, V34, P422, DOI 10.1016/j.biomaterials.2012.09.066; Wu CT, 2012, BIOMATERIALS, V33, P2076, DOI 10.1016/j.biomaterials.2011.11.042; Yang L, 2010, BIOMATERIALS, V31, P2976, DOI 10.1016/j.biomaterials.2010.01.002; Zreiqat H, 2010, BIOMATERIALS, V31, P3175, DOI 10.1016/j.biomaterials.2010.01.024	37	75	75	2	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113319	10.1371/journal.pone.0113319	http://dx.doi.org/10.1371/journal.pone.0113319			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470000	Green Published, gold, Green Submitted			2022-12-26	WOS:000349128700023
J	Scalone, L; Cesana, G; Furneri, G; Ciampichini, R; Beck-Peccoz, P; Chiodini, V; Mangioni, S; Orsi, E; Fornari, C; Mantovani, LG				Scalone, Luciana; Cesana, Giancarlo; Furneri, Gianluca; Ciampichini, Roberta; Beck-Peccoz, Paolo; Chiodini, Virginio; Mangioni, Silvia; Orsi, Emanuela; Fornari, Carla; Mantovani, Lorenzo Giovanni			Burden of Diabetes Mellitus Estimated with a Longitudinal Population-Based Study Using Administrative Databases	PLOS ONE			English	Article							RECORD-LINKAGE; PREVALENCE; COST	Objective: To assess the epidemiologic and economic burden of diabetes mellitus (DM) from a longitudinal population-based study. Research Design and Methods: Lombardy Region includes 9.9 million individuals. Its DM population was identified through a data warehouse (DENALI), which matches with a probabilistic linkage demographic, clinical and economic data of different Healthcare Administrative databases. All individuals, who, during the year 2000 had an hospital discharge with a IDC-9 CM code 250. XX, and/or two consecutive prescriptions of drugs for diabetes (ATC code A10XXXX) within one year, and/or an exemption from co-payment healthcare costs specific for DM, were selected and followed up to 9 years. We calculated prevalence, mortality and healthcare costs (hospitalizations, drugs and outpatient examinations/visits) from the National Health Service's perspective. Results: We identified 312,223 eligible subjects. The study population (51% male) had a mean age of 66 (from 0.03 to 105.12) years at the index date. Prevalence ranged from 0.4% among subjects aged <= 45 years to 10.1% among those >85 years old. Overall 43.4 deaths per 1,000 patients per year were estimated, significantly (p<0.001) higher in men than women. Overall, 3,315(sic)/patient-year were spent on average: hospitalizations were the cost driver (54.2% of total cost). Drugs contributed to 31.5%, outpatient claims represented 14.3% of total costs. Thirty-five percent of hospital costs were attributable to cerebro-/cardiovascular reasons, 6% to other complications of DM, and 4% to DM as a main diagnosis. Cardiovascular drugs contributed to 33.5% of total drug costs, 21.8% was attributable to class A (16.7% to class A10) and 4.3% to class B (2.4% to class B01) drugs. Conclusions: Merging different administrative databases can provide with many data from large populations observed for long time periods. DENALI shows to be an efficient instrument to obtain accurate estimates of burden of diseases such as diabetes mellitus.	[Scalone, Luciana; Cesana, Giancarlo; Ciampichini, Roberta; Chiodini, Virginio; Mangioni, Silvia; Fornari, Carla; Mantovani, Lorenzo Giovanni] Univ Milano Bicocca, CESP Res Ctr Publ Hlth, Milan, Italy; [Scalone, Luciana; Furneri, Gianluca] CHARTA Fdn, Milan, Italy; [Beck-Peccoz, Paolo] Univ Milan, Dept Med Sci, Unit Endocrinol & Diabetol, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Milan, Italy; [Orsi, Emanuela] San Giuseppe Hosp, Fdn IRCSS Ca Granda Osped Maggiore Policlin, Dept Med Sci, Endocrinol & Diabet Unit, Milan, Italy	University of Milano-Bicocca; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico	Ciampichini, R (corresponding author), Univ Milano Bicocca, CESP Res Ctr Publ Hlth, Milan, Italy.	r.ciampichini@campus.unimib.it	Mantovani, Lorenzo Giovanni/AAC-4263-2021; Orsi, Emanuela/Q-3464-2016	Orsi, Emanuela/0000-0002-1255-8437; Fornari, Carla/0000-0002-9609-9556; Mantovani, Lorenzo Giovanni/0000-0003-3866-8199				[Anonymous], DEM BAL RES POP INT; Astrup A, 2001, Public Health Nutr, V4, P499; Ayanian JZ, 1999, EUR HEART J, V20, P1689, DOI 10.1053/euhj.1999.1823; Davis WA, 2006, INTERN MED J, V36, P155, DOI 10.1111/j.1445-5994.2006.01014.x; FELLEGI IP, 1969, J AM STAT ASSOC, V64, P1183, DOI 10.2307/2286061; Fornari C, 2008, EPIDEMIOL PREV, V32, P79; Global Burden of Disease Study, 2010, GBD PROF IT; Gnavi R, 2008, NUTR METAB CARDIOVAS, V18, P678, DOI 10.1016/j.numecd.2007.11.004; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Italian National Institute of Statistics (ISTAT), ANN STAT IT 2013; Jonsson B, 2002, DIABETOLOGIA, V45, pS5, DOI 10.1007/s00125-002-0858-x; Kanavos P, 2012, DIABETES EXPENDITURE; Lombardo F, 2007, 0725 ISTISAN; Mantovani LG, 2011, INT J CARDIOL, V150, P111, DOI 10.1016/j.ijcard.2011.04.030; Marchesini G, 2011, NUTR METAB CARDIOVAS, V21, P339, DOI 10.1016/j.numecd.2009.10.009; Monesi L, 2012, DIABETIC MED, V29, P385, DOI 10.1111/j.1464-5491.2011.03446.x; Newgard CD, 2006, ACAD EMERG MED, V13, P69, DOI 10.1197/j.aem.2005.07.029; Osservatorio ARNO Diabete, 2011, PROF ASS POP CON DIA, VXVII; Schneeweiss S, 2005, J CLIN EPIDEMIOL, V58, P323, DOI 10.1016/j.jclinepi.2004.10.012; Shahian DM, 2007, CIRCULATION, V115, P1518, DOI 10.1161/CIRCULATIONAHA.106.633008; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Suissa S, 2007, NAT CLIN PRACT RHEUM, V3, P725, DOI 10.1038/ncprheum0652; van Dieren S, 2010, EUR J CARDIOV PREV R, V17, pS3, DOI 10.1097/01.hjr.0000368191.86614.5a; WHO consultation, WHO CONS DEF DIAGN C	24	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113741	10.1371/journal.pone.0113741	http://dx.doi.org/10.1371/journal.pone.0113741			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470484	Green Published, Green Submitted, gold			2022-12-26	WOS:000349128700041
J	Benz, R; Maier, E; Bauer, S; Ludwig, A				Benz, Roland; Maier, Elke; Bauer, Susanne; Ludwig, Albrecht			The Deletion of Several Amino Acid Stretches of Escherichia coli Alpha-Hemolysin (HlyA) Suggests That the Channel-Forming Domain Contains Beta-Strands	PLOS ONE			English	Article							PLASMID-ENCODED HEMOLYSIN; ION-PERMEABLE CHANNELS; ADENYLATE-CYCLASE TOXIN; MATRIX PROTEIN PORIN; RTX-TOXINS; MEMBRANE TRANSLOCATION; ELECTRICAL-PROPERTIES; NUCLEOTIDE-SEQUENCE; CRYSTAL-STRUCTURE; ANTHRAX TOXIN	Escherichia coli alpha-hemolysin (HlyA) is a pore-forming protein of 110 kDa belonging to the family of RTX toxins. A hydrophobic region between the amino acid residues 238 and 410 in the N-terminal half of HlyA has previously been suggested to form hydrophobic and/or amphipathic alpha-helices and has been shown to be important for hemolytic activity and pore formation in biological and artificial membranes. The structure of the HlyA transmembrane channel is, however, largely unknown. For further investigation of the channel structure, we deleted in HlyA different stretches of amino acids that could form amphipathic beta-strands according to secondary structure predictions (residues 71-110, 158-167, 180-203, and 264-286). These deletions resulted in HlyA mutants with strongly reduced hemolytic activity. Lipid bilayer measurements demonstrated that HlyA(Delta 71-110) and HlyA(Delta 264-286) formed channels with much smaller single-channel conductance than wildtype HlyA, whereas their channel-forming activity was virtually_as_high as that of the wildtype toxin. HlyA(Delta 158-167) and HlyA(Delta 180-203) were unable to form defined channels in lipid bilayers. Calculations based on the single-channel data indicated that the channels generated by HlyA(Delta 71-110) and HlyA(Delta 264-286) had a smaller size (diameter about 1.4 to 1.8 nm) than wildtype HlyA channels (diameter about 2.0 to 2.6 nm), suggesting that in these mutants part of the channel-forming domain was removed. Osmotic protection experiments with erythrocytes confirmed that HlyA, HlyA(Delta 71-110), and HlyA(Delta 264-286) form defined transmembrane pores and suggested channel diameters that largely agreed with those estimated from the single-channel data. Taken together, these results suggest that the channel-forming domain of HlyA might contain beta-strands, possibly in addition to alpha-helical structures.	[Benz, Roland] Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany; [Maier, Elke; Bauer, Susanne; Ludwig, Albrecht] Univ Wurzburg, Lehrstuhl Mikrobiol, Theodor Boveri Inst Biowissensch, Biozentrum, D-97070 Wurzburg, Germany; [Ludwig, Albrecht] Univ Frankfurt Klinikum, Inst Med Mikrobiol & Krakenhaushyg, Frankfurt, Germany	Jacobs University; University of Wurzburg; Goethe University Frankfurt; Goethe University Frankfurt Hospital	Benz, R (corresponding author), Jacobs Univ Bremen, Sch Sci & Engn, D-28759 Bremen, Germany.	r.benz@jacobs-university.de		Benz, Roland/0000-0002-9510-9265				Basler M, 2007, J BIOL CHEM, V282, P12419, DOI 10.1074/jbc.M611226200; Bauer ME, 1996, INFECT IMMUN, V64, P4665, DOI 10.1128/IAI.64.11.4665-4672.1996; BENZ R, 1979, BIOCHIM BIOPHYS ACTA, V551, P238, DOI 10.1016/0005-2736(89)90002-3; BENZ R, 1978, BIOCHIM BIOPHYS ACTA, V511, P305, DOI 10.1016/0005-2736(78)90269-9; BENZ R, 1993, ZBL BAKT-INT J MED M, V278, P187, DOI 10.1016/S0934-8840(11)80836-4; Benz R, 2003, CEL MOL MEC TOX ACT, V5, P27; BENZ R, 1992, FEMS MICROBIOL IMMUN, V105, P55; BENZ R, 1989, INFECT IMMUN, V57, P887, DOI 10.1128/IAI.57.3.887-895.1989; BENZ R, 1994, EUR J BIOCHEM, V220, P339, DOI 10.1111/j.1432-1033.1994.tb18630.x; BENZ R, 1994, J BIOL CHEM, V269, P27231; Benz R., 1994, BACTERIAL CELL WALL, P397; BHAKDI S, 1986, INFECT IMMUN, V52, P63, DOI 10.1128/IAI.52.1.63-69.1986; BLIGHT MA, 1990, MOL MICROBIOL, V4, P873, DOI 10.1111/j.1365-2958.1990.tb00660.x; BUCKLEY JT, 1992, FEBS LETT, V307, P30, DOI 10.1016/0014-5793(92)80896-O; Cabiaux V, 1997, BIOCHEMISTRY-US, V36, P15224, DOI 10.1021/bi971216p; Caputo GA, 2003, BIOCHEMISTRY-US, V42, P3275, DOI 10.1021/bi026697d; CHAKRABORTY T, 1990, INFECT IMMUN, V58, P2127, DOI 10.1128/IAI.58.7.2127-2132.1990; Cortajarena AL, 2001, J BIOL CHEM, V276, P12513, DOI 10.1074/jbc.M006792200; DANI JA, 1986, BIOPHYS J, V49, P607, DOI 10.1016/S0006-3495(86)83688-8; Degiacomi MT, 2013, NAT CHEM BIOL, V9, P623, DOI [10.1038/NCHEMBIO.1312, 10.1038/nchembio.1312]; Dobereiner A, 1996, EUR J BIOCHEM, V240, P454, DOI 10.1111/j.1432-1033.1996.0454h.x; FELMLEE T, 1985, J BACTERIOL, V163, P94, DOI 10.1128/JB.163.1.94-105.1985; GOEBEL W, 1982, J BACTERIOL, V151, P1290, DOI 10.1128/JB.151.3.1290-1298.1982; Gouaux E, 1998, J STRUCT BIOL, V121, P110, DOI 10.1006/jsbi.1998.3959; GRAY L, 1986, MOL GEN GENET, V205, P127, DOI 10.1007/BF02428042; Herlax V, 2009, J BIOL CHEM, V284, P25199, DOI 10.1074/jbc.M109.009365; HESS J, 1986, FEMS MICROBIOL LETT, V34, P1, DOI 10.1016/0378-1097(86)90261-2; Hyland C, 2001, J BACTERIOL, V183, P5364, DOI 10.1128/JB.183.18.5364-5370.2001; Iacovache I, 2006, EMBO J, V25, P457, DOI 10.1038/sj.emboj.7600959; Iacovache I, 2008, BBA-BIOMEMBRANES, V1778, P1611, DOI 10.1016/j.bbamem.2008.01.026; Iacovache I, 2010, CURR OPIN STRUC BIOL, V20, P241, DOI 10.1016/j.sbi.2010.01.013; ISSARTEL JP, 1991, NATURE, V351, P759, DOI 10.1038/351759a0; JARCHAU T, 1994, MOL GEN GENET, V245, P53, DOI 10.1007/BF00279750; JORDAN PC, 1987, BIOPHYS J, V51, P297, DOI 10.1016/S0006-3495(87)83336-2; Koronakis V, 2000, NATURE, V405, P914, DOI 10.1038/35016007; Koschinski A, 2006, FASEB J, V20, P973, DOI 10.1096/fj.05-4561fje; KRAMER W, 1984, NUCLEIC ACIDS RES, V12, P9441, DOI 10.1093/nar/12.24.9441; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lally ET, 1997, J BIOL CHEM, V272, P30463, DOI 10.1074/jbc.272.48.30463; Ludwig A, 1996, J BACTERIOL, V178, P5422, DOI 10.1128/jb.178.18.5422-5430.1996; LUDWIG A, 1988, MOL GEN GENET, V214, P553, DOI 10.1007/BF00330494; LUDWIG A, 1993, MOL GEN GENET, V241, P89, DOI 10.1007/BF00280205; LUDWIG A, 1987, MOL GEN GENET, V206, P238, DOI 10.1007/BF00333579; LUDWIG A, 1991, MOL GEN GENET, V226, P198, DOI 10.1007/BF00273604; Ludwig A., 2006, COMPREHENSIVE SOURCE, Vthird, P547, DOI DOI 10.1016/B978-012088445-2/50034-2; MACKINNON R, 1989, BIOCHEMISTRY-US, V28, P8092, DOI 10.1021/bi00446a020; Maier E, 1996, INFECT IMMUN, V64, P4415, DOI 10.1128/IAI.64.11.4415-4423.1996; MENESTRINA G, 1988, FEBS LETT, V232, P217, DOI 10.1016/0014-5793(88)80420-4; MENESTRINA G, 1987, BIOCHIM BIOPHYS ACTA, V905, P109, DOI 10.1016/0005-2736(87)90014-9; MOAYERI M, 1994, INFECT IMMUN, V62, P4124, DOI 10.1128/IAI.62.10.4124-4134.1994; Mueller M, 2009, NATURE, V459, P726, DOI 10.1038/nature08026; Nassi S, 2002, BIOCHEMISTRY-US, V41, P1445, DOI 10.1021/bi0119518; NELSON AP, 1975, J THEOR BIOL, V55, P13, DOI 10.1016/S0022-5193(75)80106-8; NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983; Osickova A, 1999, J BIOL CHEM, V274, P37644; Petosa C, 1997, NATURE, V385, P833, DOI 10.1038/385833a0; RENKIN EM, 1954, J GEN PHYSIOL, V38, P225; ROPELE M, 1989, BIOCHIM BIOPHYS ACTA, V985, P9, DOI 10.1016/0005-2736(89)90096-5; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sanchez-Magraner L, 2007, J BIOL CHEM, V282, P11827, DOI 10.1074/jbc.M700547200; Schindel C, 2001, EUR J BIOCHEM, V268, P800, DOI 10.1046/j.1432-1327.2001.01937.x; Schmidt H, 1996, EUR J BIOCHEM, V241, P594, DOI 10.1111/j.1432-1033.1996.00594.x; Soloaga A, 1999, MOL MICROBIOL, V31, P1013, DOI 10.1046/j.1365-2958.1999.01225.x; Song LZ, 1996, SCIENCE, V274, P1859, DOI 10.1126/science.274.5294.1859; STANLEY P, 1994, SCIENCE, V266, P1992, DOI 10.1126/science.7801126; Stanley P, 1999, MOL MICROBIOL, V34, P887, DOI 10.1046/j.1365-2958.1999.01648.x; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRIAS J, 1994, MOL MICROBIOL, V14, P283, DOI 10.1111/j.1365-2958.1994.tb01289.x; Uhlen P, 2000, NATURE, V405, P694, DOI 10.1038/35015091; Valeva A, 2005, J BIOL CHEM, V280, P36657, DOI 10.1074/jbc.M507690200; Valeva A, 2008, BIOL CHEM, V389, P1201, DOI 10.1515/BC.2008.136; VOGEL H, 1986, J MOL BIOL, V190, P191, DOI 10.1016/0022-2836(86)90292-5; VOGEL M, 1988, MOL GEN GENET, V212, P76, DOI 10.1007/BF00322447; Vojtova-Vodolanova J, 2009, FASEB J, V23, P2831, DOI 10.1096/fj.09-131250; WANDERSMAN C, 1990, P NATL ACAD SCI USA, V87, P4776, DOI 10.1073/pnas.87.12.4776; WELCH RA, 1995, VIRULENCE MECHANISMS OF BACTERIAL PATHOGENS, 2ND EDITION, P195	76	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112248	10.1371/journal.pone.0112248	http://dx.doi.org/10.1371/journal.pone.0112248			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463653	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700010
J	Hayano, T; Yokota, Y; Hosomichi, K; Nakaoka, H; Yoshihara, K; Adachi, S; Kashima, K; Tsuda, H; Moriya, T; Tanaka, K; Enomoto, T; Inoue, I				Hayano, Takahide; Yokota, Yuki; Hosomichi, Kazuyoshi; Nakaoka, Hirofumi; Yoshihara, Kosuke; Adachi, Sosuke; Kashima, Katsunori; Tsuda, Hitoshi; Moriya, Takuya; Tanaka, Kenichi; Enomoto, Takayuki; Inoue, Ituro			Molecular Characterization of an Intact p53 Pathway Subtype in High-Grade Serous Ovarian Cancer	PLOS ONE			English	Article							COPY NUMBER; FUNCTIONAL IMPACT; DNA-REPAIR; GENE; EXPRESSION; MUTATIONS; SPINDLE; DISCOVERY; HELICASES; MITOSIS	High-grade serous ovarian cancer (HGSOC) is the most aggressive histological type of epithelial ovarian cancer, which is characterized by a high frequency of somatic TP53 mutations. We performed exome analyses of tumors and matched normal tissues of 34 Japanese patients with HGSOC and observed a substantial number of patients without TP53 mutation (24%, 8/34). Combined with the results of copy number variation analyses, we subdivided the 34 patients with HGSOC into subtypes designated ST1 and ST2. ST1 showed intact p53 pathway and was characterized by fewer somatic mutations and copy number alterations. In contrast, the p53 pathway was impaired in ST2, which is characterized by abundant somatic mutations and copy number alterations. Gene expression profiles combined with analyses using the Gene Ontology resource indicate the involvement of specific biological processes (mitosis and DNA helicase) that are relevant to genomic stability and cancer etiology. In particular we demonstrate the presence of a novel subtype of patients with HGSOC that is characterized by an intact p53 pathway, with limited genomic alterations and specific gene expression profiles.	[Hayano, Takahide; Hosomichi, Kazuyoshi; Nakaoka, Hirofumi; Inoue, Ituro] Natl Inst Genet, Div Human Genet, Mishima, Shizuoka 411, Japan; [Yokota, Yuki; Yoshihara, Kosuke; Adachi, Sosuke; Kashima, Katsunori; Tanaka, Kenichi; Enomoto, Takayuki] Niigata Univ, Grad Sch Med & Dent Sci, Dept Obstet & Gynecol, Niigata, Japan; [Tsuda, Hitoshi] Natl Def Med Coll, Dept Basic Pathol, Tokorozawa, Saitama 359, Japan; [Moriya, Takuya] Kawasaki Med Sch, Dept Pathol, Kurashiki, Okayama, Japan; [Tanaka, Kenichi] Niigata Med Ctr Hosp, Niigata, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Niigata University; National Defense Medical College - Japan; Kawasaki Medical School	Inoue, I (corresponding author), Natl Inst Genet, Div Human Genet, Mishima, Shizuoka 411, Japan.	itinoue@nig.ac.jp	Moriya, Takuya/AAM-6974-2020; Yoshihara, Kosuke/AAU-9874-2020; Hosomichi, Kazuyoshi/K-9477-2015	Yoshihara, Kosuke/0000-0002-2254-3378; Hosomichi, Kazuyoshi/0000-0003-2712-1825; Nakaoka, Hirofumi/0000-0002-8454-1159; Enomoto, Takayuki/0000-0003-4538-5541	Japan Society for the Promotion of Science [23791816]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Young Scientists (B) (grant No. 23791816) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/) (KY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bernardini MQ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-237; Bowtell DDL, 2010, NAT REV CANCER, V10, P803, DOI 10.1038/nrc2946; Broet P, 2011, CLIN CANCER RES, V17, P3542, DOI 10.1158/1078-0432.CCR-10-2185; Brosh RM, 2013, NAT REV CANCER, V13, P542, DOI 10.1038/nrc3560; Croteau DL, 2014, ANN REV BIO IN PRESS; Darvishi K, 2010, CURR PROTOC HUM GENE, V14, P1; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Evangelista M, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1162925; Ferlay J, 2010, CANC INCIDENCE 5 CON; Futami K, 2010, INT J MOL MED, V25, P537, DOI 10.3892/ijmm_00000375; Glessner JT, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1346; Gonzalez-Perez A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks743; Hayashi MT, 2013, ONCOGENE, V32, P4593, DOI 10.1038/onc.2012.615; Higgins J, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-85; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kaneta Y, 2013, BIOCHEM BIOPH RES CO, V442, P139, DOI 10.1016/j.bbrc.2013.04.105; Kawabe T, 2000, ONCOGENE, V19, P4764, DOI 10.1038/sj.onc.1203841; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Kobel M, 2010, INT J GYNECOL PATHOL, V29, P203, DOI 10.1097/PGP.0b013e3181c042b6; Kouprina N, 2005, HUM MOL GENET, V14, P2155, DOI 10.1093/hmg/ddi220; Kurman RJ, 2010, AM J SURG PATHOL, V34, P433, DOI 10.1097/PAS.0b013e3181cf3d79; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu SZ, 2013, P NATL ACAD SCI USA, V110, P2175, DOI 10.1073/pnas.1217781110; LUNA RMD, 1995, NATURE, V378, P203; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Perez-Llamas C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019541; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Siffroi-Fernandez S, 2014, CELL CYCLE, V13, P984, DOI 10.4161/cc.27868; Sivakumar S, 2014, MOL BIOL CELL, V25, P594, DOI 10.1091/mbc.E13-07-0421; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Su YR, 2010, CANCER RES, V70, P9207, DOI 10.1158/0008-5472.CAN-10-1743; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Turley H, 2001, BRIT J CANCER, V85, P261, DOI 10.1054/bjoc.2001.1874; Uchida F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056381; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wang K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn641; Wu ZX, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.011635-1, 10.1074/mcp.M111.011635]; Yoshihara K, 2012, CLIN CANCER RES, V18, P1374, DOI 10.1158/1078-0432.CCR-11-2725; Yoshihara K, 2011, GENE CHROMOSOME CANC, V50, P167, DOI 10.1002/gcc.20841; Yoshihara K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009615; Zhang J, 2006, CYTOGENET GENOME RES, V115, P205, DOI 10.1159/000095916	47	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114491	10.1371/journal.pone.0114491	http://dx.doi.org/10.1371/journal.pone.0114491			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460179	Green Published, Green Submitted, gold			2022-12-26	WOS:000345869700137
J	Laoprasopwattana, K; Chaimongkol, W; Pruekprasert, P; Geater, A				Laoprasopwattana, Kamolwish; Chaimongkol, Wanwipa; Pruekprasert, Pornpimol; Geater, Alan			Acute Respiratory Failure and Active Bleeding Are the Important Fatality Predictive Factors for Severe Dengue Viral Infection	PLOS ONE			English	Article							HEMORRHAGIC-FEVER; SHOCK SYNDROME; MORTALITY; CHILDREN; ADULTS; SINGAPORE; RISK	Objective: To determine the outcome of severe dengue viral infection (DVI) and the main dengue fatality risk factors. Study design: The medical records of patients aged <15 years admitted to Songklanagarind Hospital in southern Thailand during 1989-2011 were reviewed. Patients who had dengue hemorrhagic fever (DHF) grades III-IV, organ failure (cardiovascular, respiratory, liver, renal or hematologic), impaired consciousness, or aspartate aminotransferase more than 1,000 units/L, were classified as having severe DVI. To determine the fatality risk factors of severe DVI, the classification trees were constructed based on manual recursive partitioning. Results: Of the 238 children with severe DVI, 30 (12.6%) died. Compared to the non-fatal DVI cases, the fatal cases had higher rates of DHF grade IV (96.7% vs 24.5%), repeated shock (93.3% vs 27.9%), acute respiratory failure (ARF) (100% vs 6.7%), acute liver failure (ALF) (96.6% vs 6.3%), acute kidney injury (AKI) (79.3% vs 4.5%), and active bleeding requiring blood transfusion (93.3% vs 5.4%), all p<0.01. The combined risk factors of ARF and active bleeding considered together predicted fatal outcome with sensitivity, specificity, and negative and positive predictive values of 0.93 (0.78-0.99), 0.97 (0.93-0.99), 0.99 (0.97-1.00), and 0.82 (0.65-0.93), respectively. The likelihood ratios for a fatal outcome in the patients who had and did not have this risk combination were 32.4 (14.6-71.7) and 0.07 (0.02-0.26), respectively. Conclusion: Severe DVI patients who have ARF and active bleeding are at a high risk of death, while patients without these things together should survive.	[Laoprasopwattana, Kamolwish; Chaimongkol, Wanwipa; Pruekprasert, Pornpimol] Prince Songkla Univ, Dept Pediat, Fac Med, Hat Yai, Songkhla, Thailand; [Geater, Alan] Prince Songkla Univ, Epidemiol Unit, Fac Med, Hat Yai, Songkhla, Thailand	Prince of Songkla University; Prince of Songkla University	Laoprasopwattana, K (corresponding author), Prince Songkla Univ, Dept Pediat, Fac Med, Hat Yai, Songkhla, Thailand.	kamolwish@gmail.com	laoprasopwattana, kamolwish/AAQ-9092-2020	Geater, Alan/0000-0003-1219-9814	Faculty of Medicine, Prince of Songkla University, Songkhla Thailand [53-190-01-1-3]	Faculty of Medicine, Prince of Songkla University, Songkhla Thailand	All the funding was supported by grant no. 53-190-01-1-3 from the Faculty of Medicine, Prince of Songkla University, Songkhla Thailand. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders KL, 2011, AM J TROP MED HYG, V84, P127, DOI 10.4269/ajtmh.2011.10-0476; Chan James C M, 2002, Pediatr Rev, V23, P47, DOI 10.1542/pir.23-2-47; Dhabhar FS, 1996, J IMMUNOL, V157, P1638; Green S, 1999, J INFECT DIS, V179, P755, DOI 10.1086/314680; Juneja D, 2011, J CRIT CARE, V26, P449, DOI 10.1016/j.jcrc.2011.05.007; Kalayanarooj S., 1999, Dengue Bulletin, V23, P1; Kalayanarooj Siripen, 2005, Southeast Asian Journal of Tropical Medicine and Public Health, V36, P378; Lahiri M, 2008, T ROY SOC TROP MED H, V102, P1011, DOI 10.1016/j.trstmh.2008.06.005; Laoprasopwattana K, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002287; Laoprasopwattana K, 2010, J PEDIATR-US, V157, P303, DOI 10.1016/j.jpeds.2010.02.008; Lee IK, 2008, AM J TROP MED HYG, V79, P149, DOI 10.4269/ajtmh.2008.79.149; Lee IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001532; Leo YS, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-123; Magpusao NS, 2003, TROP DOCT, V33, P156, DOI 10.1177/004947550303300312; Ong A, 2007, INT J INFECT DIS, V11, P263, DOI 10.1016/j.ijid.2006.02.012; Lam PK, 2013, CLIN INFECT DIS, V57, P1577, DOI 10.1093/cid/cit594; Pichainarong Natchaporn, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P283; Pollack MM, 1996, CRIT CARE MED, V24, P743, DOI 10.1097/00003246-199605000-00004; Rigau-Perez J G, 1999, P R Health Sci J, V18, P337; Sam SS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002194; Srikiatkhachorn A, 2010, CLIN INFECT DIS, V50, P1135, DOI 10.1086/651268; Taori RN, 2010, INDIAN J PEDIATR, V77, P267, DOI 10.1007/s12098-010-0031-3; Thein TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081060; Wang CC, 2007, AM J TROP MED HYG, V77, P151, DOI 10.4269/ajtmh.2007.77.151; World Health Organization, 2009, DENGUE GUIDELINES DI	25	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114499	10.1371/journal.pone.0114499	http://dx.doi.org/10.1371/journal.pone.0114499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460594	Green Published, Green Submitted, gold			2022-12-26	WOS:000345869700139
J	Lerbech, AM; Opintan, JA; Bekoe, SO; Ahiabu, MA; Tersbol, BP; Hansen, M; Brightson, KTC; Ametepeh, S; Frimodt-Moller, N; Styrishave, B				Lerbech, Anne Mette; Opintan, Japheth A.; Bekoe, Samuel Oppong; Ahiabu, Mary-Anne; Tersbol, Britt Pinkowski; Hansen, Martin; Brightson, Kennedy T. C.; Ametepeh, Samuel; Frimodt-Moller, Niels; Styrishave, Bjarne			Antibiotic Exposure in a Low-Income Country: Screening Urine Samples for Presence of Antibiotics and Antibiotic Resistance in Coagulase Negative Staphylococcal Contaminants	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; SELF-MEDICATION; FOOD ANIMALS; HUMAN HEALTH; GHANA; AUREUS; SUSCEPTIBILITY; HAEMOLYTICUS; CARRIAGE; USAGE	Development of antimicrobial resistance has been assigned to excess and misuse of antimicrobial agents. Staphylococci are part of the normal flora but are also potential pathogens that have become essentially resistant to many known antibiotics. Resistances in coagulase negative staphylococci (CoNS) are suggested to evolve due to positive selective pressure following antibiotic treatment. This study investigated the presence of the nine most commonly used antimicrobial agents in human urine from outpatients in two hospitals in Ghana in relation to CoNS resistance. Urine and CoNS were sampled (n=246 and n=96 respectively) from patients in two hospitals in Ghana. CoNS were identified using Gram staining, coagulase test, and MALDI-TOF/MS, and the antimicrobial susceptibility to 12 commonly used antimicrobials was determined by disk diffusion. Moreover an analytical method was developed for the determination of the nine most commonly used antimicrobial agents in Ghana by using solid-phase extraction in combination with HPLC-MS/MS using electron spray ionization. The highest frequency of resistance to CoNS was observed for penicillin V (98%), trimethoprim (67%), and tetracycline (63%). S. haemolyticus was the most common isolate (75%), followed by S. epidermidis (13%) and S. hominis (6%). S. haemolyticus was also the species displaying the highest resistance prevalence (82%). 69% of the isolated CoNS were multiple drug resistant (>= 4 antibiotics) and 45% of the CoNS were methicillin resistant. Antimicrobial agents were detected in 64% of the analysed urine samples (n=121) where the most frequently detected antimicrobials were ciprofloxacin (30%), trimethoprim (27%), and metronidazole (17%). The major findings of this study was that the prevalence of detected antimicrobials in urine was more frequent than the use reported by the patients and the prevalence of resistant S. haemolyticus was more frequent than other resistant CoNS species when antimicrobial agents were detected in the urine.	[Lerbech, Anne Mette; Bekoe, Samuel Oppong; Hansen, Martin; Styrishave, Bjarne] Univ Copenhagen, Dept Pharm, Toxicol Lab, Fac Hlth & Med Sci, Copenhagen, Denmark; [Opintan, Japheth A.] Univ Ghana, Sch Med, Dept Microbiol, Accra, Ghana; [Ahiabu, Mary-Anne; Tersbol, Britt Pinkowski] Univ Copenhagen, Fac Hlth Sci, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark; [Brightson, Kennedy T. C.] Shai Osudoku Dist Hosp, Maternal Hlth Unit, Dodowa, Ghana; [Ametepeh, Samuel] Shai Osudoku Dist Hosp, Microbiol Lab, Dodowa, Ghana; [Frimodt-Moller, Niels] Hvidovre Univ Hosp, Dept Clin Microbiol, DK-2650 Copenhagen, Denmark	University of Copenhagen; University of Ghana; University of Copenhagen; University of Copenhagen	Styrishave, B (corresponding author), Univ Copenhagen, Dept Pharm, Toxicol Lab, Fac Hlth & Med Sci, Copenhagen, Denmark.	bjarne.styrishave@sund.ku.dk	Frimodt-Moller, Niels/G-1187-2018; Hansen, Martin/B-3121-2010	Frimodt-Moller, Niels/0000-0003-1966-8302; Hansen, Martin/0000-0002-4663-8742; , Britt Pinkowski Tersbol/0000-0001-8260-1317	Danida, the Ministry of Foreign Affairs of Denmark	Danida, the Ministry of Foreign Affairs of Denmark	The project was funded by Danida, the Ministry of Foreign Affairs of Denmark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo VN, 2007, J SCI TECHNOL, V27, P149, DOI [DOI 10.4314/JUST.V27I3.33067, 10.4314/just.v27i3.33067]; AduSarkodie YA, 1997, INT J STD AIDS, V8, P456, DOI 10.1258/0956462971920343; Agvald-Ohman C, 2004, CRIT CARE, V8, pR42, DOI 10.1186/cc2422; Akinkunmi EO, 2012, AFR HEALTH SCI, V12, P381, DOI 10.4314/ahs.v12i3.21; Akinkunmi E O, 2006, Afr J Med Med Sci, V35, P15; Akinkunmi EO, 2010, TROP J PHARM RES, V9, P35; [Anonymous], 2012, J VET ADV; Barbier F, 2010, J INFECT DIS, V202, P270, DOI 10.1086/653483; Barros EM, 2012, J CLIN MICROBIOL, V50, P166, DOI 10.1128/JCM.05563-11; Berglund C, 2008, CLIN MICROBIOL INFEC, V14, P1048, DOI 10.1111/j.1469-0691.2008.02090.x; Bosu WK, 1998, INT J STD AIDS, V9, P551, DOI 10.1258/0956462981922692; COVE JH, 1990, J ANTIMICROB CHEMOTH, V25, P459, DOI 10.1093/jac/25.3.459; De Lencastre H, 2007, CURR OPIN MICROBIOL, V10, P428, DOI 10.1016/j.mib.2007.08.003; Denno Donna M, 2002, West Afr J Med, V21, P233; Donkor ES, 2012, INT J ENV RES PUB HE, V9, P3519, DOI 10.3390/ijerph9103519; Donkor ES, 2012, TROP MED INT HEALTH, V17, P462, DOI 10.1111/j.1365-3156.2012.02955.x; European Committee on Antimicrobial Susceptibility Testing, 2013, BREAKP TABL INT MICS; FROGGATT JW, 1989, ANTIMICROB AGENTS CH, V33, P460, DOI 10.1128/AAC.33.4.460; Germer J, 2010, J AGR RURAL DEV TROP, V111, P41; Ghana Statistical Service, 2008, GHAN LIV STAND SURV; Gold HS, 1996, NEW ENGL J MED, V335, P1445, DOI 10.1056/NEJM199611073351907; Gould I M, 2009, Int J Antimicrob Agents, V34 Suppl 3, pS2, DOI 10.1016/S0924-8579(09)70549-7; Grady KE, 1988, RES HKLTH CARE SETTI; Gustafsson I, 2003, J ANTIMICROB CHEMOTH, V52, P645, DOI 10.1093/jac/dkg427; Hanssen AM, 2006, FEMS IMMUNOL MED MIC, V46, P8, DOI 10.1111/j.1574-695X.2005.00009.x; HOIBY N, 1995, LANCET, V346, P1235, DOI 10.1016/S0140-6736(95)92946-0; Holby N, 1997, LANCET, V349, P167, DOI 10.1016/S0140-6736(96)09229-X; Huebner J, 1999, ANNU REV MED, V50, P223, DOI 10.1146/annurev.med.50.1.223; Isturiz RE, 2000, INFECT CONT HOSP EP, V21, P394, DOI 10.1086/501780; JOHN JF, 1978, J CLIN MICROBIOL, V8, P435; John Joseph F, 2007, Ther Clin Risk Manag, V3, P1143; K'oreje KO, 2012, SCI TOTAL ENVIRON, V437, P153, DOI 10.1016/j.scitotenv.2012.07.052; Khachatourians GG, 1998, CAN MED ASSOC J, V159, P1129; KLOOS WE, 1994, CLIN MICROBIOL REV, V7, P117, DOI 10.1128/CMR.7.1.117-140.1994; KUNIN CM, 1993, ANN INTERN MED, V118, P557, DOI 10.7326/0003-4819-118-7-199304010-00011; Lebeaux D, 2012, ANTIMICROB AGENTS CH, V56, P315, DOI 10.1128/AAC.00547-11; Leclercq R, 2009, CLIN MICROBIOL INFEC, V15, P224, DOI 10.1111/j.1469-0691.2009.02739.x; Levy SB, 1997, CIBA F SYMP, V207, P1; Levy SB, 1998, SCI AM, V278, P46, DOI 10.1038/scientificamerican0398-46; Levy SB, 1997, CIBA F SYMP, V207, P9; Ma XX, 2011, J MED MICROBIOL, V60, P1661, DOI 10.1099/jmm.0.034066-0; Ma XX, 2011, CAN J MICROBIOL, V57, P476, DOI [10.1139/W11-033, 10.1139/w11-033]; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Marshall SA, 1998, DIAGN MICR INFEC DIS, V30, P205, DOI 10.1016/S0732-8893(97)00212-5; Mills-Robertson F, 2002, FEMS MICROBIOL LETT, V215, P249, DOI [10.1016/S0378-1097(02)00967-9, 10.1111/j.1574-6968.2002.tb11398.x]; Ministry of Health, 2010, STAND TREATN GUID; Newman Mercy J, 2011, Infect Drug Resist, V4, P215, DOI 10.2147/IDR.S21769; Nys S, 2004, J ANTIMICROB CHEMOTH, V54, P952, DOI 10.1093/jac/dkh448; Okeke IN, 2007, EMERG INFECT DIS, V13, P1640, DOI 10.3201/eid1311.070674; Polage CR, 2006, AM J TROP MED HYG, V75, P526, DOI 10.4269/ajtmh.2006.75.526; Radyowijati A, 2003, SOC SCI MED, V57, P733, DOI 10.1016/S0277-9536(02)00422-7; Senah KA, 1997, MONEY PROPULARITY ME, Vxvi; Tollefson L, 2004, MED MALADIES INFECT, V34, P514, DOI [10.1016/j.medmal.2004.07.028, 10.1016/j/medmal.2004.07.028]; Turkson P.K., 2008, AGR SCI REV, V41, P23; Valentin T, 2011, J INFECTION, V62, P34, DOI 10.1016/j.jinf.2010.11.004; van den Bogaard AE, 1999, DRUGS, V58, P589, DOI 10.2165/00003495-199958040-00002; Wilcox Mark H, 2009, Int J Antimicrob Agents, V34 Suppl 3, pS6, DOI 10.1016/S0924-8579(09)70550-3; WOLFGOULD CS, 1991, SOC SCI MED, V33, P83, DOI 10.1016/0277-9536(91)90459-P; World Bank, 2009, PHARM SECT GHANA POL	59	23	23	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113055	10.1371/journal.pone.0113055	http://dx.doi.org/10.1371/journal.pone.0113055			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462162	gold, Green Published, Green Submitted			2022-12-26	WOS:000345869700025
J	Orozco, JJ; Balkin, ER; Gooley, TA; Kenoyer, A; Hamlin, DK; Wilbur, DS; Fisher, DR; Hylarides, MD; Shadman, M; Green, DJ; Gopal, AK; Press, OW; Pagel, JM				Orozco, Johnnie J.; Balkin, Ethan R.; Gooley, Ted A.; Kenoyer, Aimee; Hamlin, Donald K.; Wilbur, D. Scott; Fisher, Darrell R.; Hylarides, Mark D.; Shadman, Mazyar; Green, Damian J.; Gopal, Ajay K.; Press, Oliver W.; Pagel, John M.			Anti-CD45 Radioimmunotherapy with Y-90 but Not Lu-177 Is Effective Treatment in a Syngeneic Murine Leukemia Model	PLOS ONE			English	Article							TOTAL-BODY IRRADIATION; BONE-MARROW-TRANSPLANTATION; TERM-FOLLOW-UP; PRETARGETED RADIOIMMUNOTHERAPY; MONOCLONAL-ANTIBODY; MYELOID-LEUKEMIA; CELL TRANSPLANTATION; RANDOMIZED-TRIAL; PHASE-I; LYMPHOMA	Radioimmunotherapy (RIT) for treatment of hematologic malignancies has primarily employed monoclonal antibodies (Ab) labeled with I-131 or Y-90 which have limitations, and alternative radionuclides are needed to facilitate wider adoption of RIT. We therefore compared the relative therapeutic efficacy and toxicity of anti-CD45 RIT employing Y-90 and Lu-177 in a syngeneic, disseminated murine myeloid leukemia (B6SJLF1/J) model. Biodistribution studies showed that both Y-90- and Lu-177-anti-murine CD45 Ab conjugates (DOTA-30F11) targeted hematologic tissues, as at 24 hours 48.8 +/- 21.2 and 156 +/- 14.6% injected dose per gram of tissue (% ID/g) of Y-90-DOTA-30F11 and 54.2 +/- 9.5 and 199 +/- 11.7% ID/g of Lu-177-DOTA-30F11 accumulated in bone marrow (BM) and spleen, respectively. However, Y-90-DOTA-30F11 RIT demonstrated a dose-dependent survival benefit: 60% of mice treated with 300 mu Ci Y-90-DOTA-30F11 lived over 180 days after therapy, and mice treated with 100 mu Ci Y-90-DOTA-30F11 had a median survival 66 days. Y-90-anti-CD45 RIT was associated with transient, mild myelotoxicity without hepatic or renal toxicity. Conversely, Lu-177-anti-CD45 RIT yielded no long-term survivors. Thus, Y-90 was more effective than Lu-177 for anti-CD45 RIT of AML in this murine leukemia model.	[Orozco, Johnnie J.; Gooley, Ted A.; Kenoyer, Aimee; Hylarides, Mark D.; Shadman, Mazyar; Green, Damian J.; Gopal, Ajay K.; Press, Oliver W.; Pagel, John M.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98104 USA; [Orozco, Johnnie J.; Shadman, Mazyar] Univ Washington, Div Hematol, Seattle, WA 98195 USA; [Balkin, Ethan R.; Hamlin, Donald K.; Wilbur, D. Scott; Green, Damian J.; Gopal, Ajay K.; Press, Oliver W.; Pagel, John M.] Univ Washington, Seattle, WA 98195 USA; [Fisher, Darrell R.] Dade Moeller Hlth Grp, Richland, WA USA	Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Pagel, JM (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	jpagel@fhcrc.org		Press, Oliver/0000-0002-3147-8037; Gopal, Ajay/0000-0003-3023-6834	National Institutes of Health [R01 CA109663, R01 CA138720, R01 CA076287, R01 CA136639, R01 CA154897, P01 CA044991]; Lymphoma Research Foundation; Damon Runyon Cancer Foundation; Leukemia and Lymphoma Society; American Society of Blood and Marrow Transplantation; NATIONAL CANCER INSTITUTE [R01CA136639, P01CA044991, R01CA154897, R01CA138720, R01CA076287, R01CA109663] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lymphoma Research Foundation; Damon Runyon Cancer Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); American Society of Blood and Marrow Transplantation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health (R01 CA109663, R01 CA138720, R01 CA076287, R01 CA136639, R01 CA154897, P01 CA044991) and awards from the Lymphoma Research Foundation (OWP and JMP), Damon Runyon Cancer Foundation (JMP), Leukemia and Lymphoma Society (OWP, JMP, AKG, and JJO), and the American Society of Blood and Marrow Transplantation (JJO), as well as Frederick Kullman (JMP) and by a gift from James and Sherry Raisbeck. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEATTY BG, 1994, CANCER, V73, P958, DOI 10.1002/1097-0142(19940201)73:3+<958::AID-CNCR2820731331>3.0.CO;2-E; Bouchet LG, 2000, J NUCL MED, V41, P682; Bunjes DW, 2001, BLOOD, V98, p197A; Burke JM, 2003, BONE MARROW TRANSPL, V32, P549, DOI 10.1038/sj.bmt.1704201; CLIFT RA, 1990, BLOOD, V76, P1867; Clift RA, 1998, BLOOD, V92, P1455, DOI 10.1182/blood.V92.4.1455; CLIFT RA, 1991, BLOOD, V77, P1660; COSSET JM, 1989, RADIOTHER ONCOL, V15, P151, DOI 10.1016/0167-8140(89)90129-1; de Jong M, 2005, J NUCL MED, V46, p13S; FISHER DR, 1991, ANTIBODY IMMUNOCONJ, V4, P655; GOLDENBERG DM, 1991, J CLIN ONCOL, V9, P548, DOI 10.1200/JCO.1991.9.4.548; HUI TE, 1994, CANCER, V73, P951; MATTHEWS DC, 1991, BLOOD, V78, P1864; Matthews DC, 1999, BLOOD, V94, P1237, DOI 10.1182/blood.V94.4.1237.416k34_1237_1247; Mitchell GS, 2011, PHILOS T R SOC A, V369, P4605, DOI 10.1098/rsta.2011.0271; NAKANO A, 1990, ACTA PATHOL JAPON, V40, P107; OMARY MB, 1980, J EXP MED, V152, P842, DOI 10.1084/jem.152.4.842; Pagel JM, 2006, BLOOD, V107, P2184, DOI 10.1182/blood-2005-06-2317; Pagel JM, 2003, BLOOD, V101, P2340, DOI 10.1182/blood-2002-03-0874; Pagel JM, 2008, BLOOD, V111, P2261, DOI 10.1182/blood-2007-06-097451; Pagel JM, 2011, BLOOD, V118, P703, DOI 10.1182/blood-2011-04-347039; PRESS OW, 1993, NEW ENGL J MED, V329, P1219, DOI 10.1056/NEJM199310213291702; Press OW, 2001, BLOOD, V98, P2535, DOI 10.1182/blood.V98.8.2535; Robertson R, 2009, PHYS MED BIOL, V54, pN355, DOI 10.1088/0031-9155/54/16/N01; Robertson R, 2011, J NUCL MED, V52, P1764, DOI 10.2967/jnumed.111.091710; ROSEN ST, 1987, J CLIN ONCOL, V5, P562, DOI 10.1200/JCO.1987.5.4.562; Ruggiero A, 2010, J NUCL MED, V51, P1123, DOI 10.2967/jnumed.110.076521; SCHEINBERG DA, 1990, J CLIN ONCOL, V8, P792, DOI 10.1200/JCO.1990.8.5.792; SCHWARTZ MA, 1993, J CLIN ONCOL, V11, P294, DOI 10.1200/JCO.1993.11.2.294; SHANK B, 1981, INT J RADIAT ONCOL, V7, P1240, DOI 10.1016/0360-3016(81)90567-8; SIEGEL JA, 1994, J NUCL MED, V35, P152; SOCIE G, 1991, INT J RADIAT ONCOL, V20, P397, DOI 10.1016/0360-3016(91)90048-9; TAETLE R, 1991, LEUKEMIA, V5, P309; VANDERJAGT RHC, 1992, CANCER RES, V52, P89; VANOS R, 1993, RADIAT RES, V136, P118, DOI 10.2307/3578648	35	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113601	10.1371/journal.pone.0113601	http://dx.doi.org/10.1371/journal.pone.0113601			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460570	Green Published, Green Submitted, gold			2022-12-26	WOS:000345869700039
J	Whitaker, KL; Scott, SE; Winstanley, K; Macleod, U; Wardle, J				Whitaker, Katriina L.; Scott, Suzanne E.; Winstanley, Kelly; Macleod, Una; Wardle, Jane			Attributions of Cancer 'Alarm' Symptoms in a Community Sample	PLOS ONE			English	Article							PATIENT DELAY; HELP-SEEKING; POPULATION-SAMPLE; PRIMARY-CARE; DIAGNOSIS; AWARENESS; INEQUALITIES; HEALTH; OVARIAN; LUNG	Background: Attribution of early cancer symptoms to a non-serious cause may lead to longer diagnostic intervals. We investigated attributions of potential cancer 'alarm' and non-alarm symptoms experienced in everyday life in a community sample of adults, without mention of a cancer context. Methods: A questionnaire was mailed to 4858 adults (>= 50 years old, no cancer diagnosis) through primary care, asking about symptom experiences in the past 3 months. The word cancer was not mentioned. Target 'alarm' symptoms, publicised by Cancer Research UK, were embedded in a longer symptom list. For each symptom experienced, respondents were asked for their attribution ('what do you think caused it'), concern about seriousness ('not at all' to 'extremely'), and help-seeking ('did you contact a doctor about it': Yes/No). Results: The response rate was 35% (n=1724). Over half the respondents (915/1724; 53%) had experienced an 'alarm' symptom, and 20 (2%) cited cancer as a possible cause. Cancer attributions were highest for 'unexplained lump'; 7% (6/87). Cancer attributions were lowest for 'unexplained weight loss' (0/47). A higher proportion (375/1638; 23%) were concerned their symptom might be 'serious', ranging from 12% (13/112) for change in a mole to 41% (100/247) for unexplained pain. Just over half had contacted their doctor about their symptom (59%), although this varied by symptom. Alarm symptoms were appraised as more serious than non-alarm symptoms, and were more likely to trigger help-seeking. Conclusions: Consistent with retrospective reports from cancer patients, 'alarm' symptoms experienced in daily life were rarely attributed to cancer. These results have implications for understanding how people appraise and act on symptoms that could be early warning signs of cancer.	[Whitaker, Katriina L.; Winstanley, Kelly; Wardle, Jane] UCL, Dept Epidemiol & Publ Hlth, Hlth Behav Res Ctr, London WC1E 6BT, England; [Scott, Suzanne E.; Macleod, Una] Kings Coll London, Inst Dent, Unit Social & Behav Sci, London SE5 9RW, England; Hull York Med Sch, Ctr Hlth & Populat Sci, Kingston Upon Hull HU6 7RX, N Humberside, England	University of London; University College London; University of London; King's College London; University of Hull; University of York - UK	Whitaker, KL (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Hlth Behav Res Ctr, London WC1E 6BT, England.	k.whitaker@ucl.ac.uk	Whitaker, Katriina/AAA-6593-2020; Scott, Suzanne/A-4697-2009	Whitaker, Katriina/0000-0002-0947-1840; Scott, Suzanne/0000-0001-5536-9612	Cancer Research UK [C33872/A13216]; Cancer Research UK [13276] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was supported by a Cancer Research UK Postdoctoral Fellowship grant (C33872/A13216) awarded to Dr Katriina Whitaker. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson J, 2003, SOC SCI MED, V57, P895, DOI 10.1016/S0277-9536(02)00458-6; ANDERSEN BL, 1995, BRIT J SOC PSYCHOL, V34, P33, DOI 10.1111/j.2044-8309.1995.tb01047.x; Andersen RS, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-189; Baker D, 2002, BRIT J GEN PRACT, V52, P124; Brindle L, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001977; Cancer Research UK, 2014, CANC AW MEAS CAMS; Cancer Research UK, 2013, KEY SIGNS SYMPT; Cancer Research UK, 2013, CANC INC AGE; Carletta J, 1996, COMPUT LINGUIST, V22, P249; Elliott AM, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-21; Forbes LJL, 2013, BRIT J CANCER, V108, P292, DOI 10.1038/bjc.2012.542; Hamilton W, 2009, BRIT J CANCER, V101, pS80, DOI 10.1038/sj.bjc.6605396; Health and Social Care Information Centre, 2012, ATTR DAT SET GP REG; IBM Corp Released, 2021, IBM SPSS STAT WINDOW; Jones R, 2007, BMJ-BRIT MED J, V334, P1040, DOI 10.1136/bmj.39171.637106.AE; Korkeila K, 2001, EUR J EPIDEMIOL, V17, P991, DOI 10.1023/A:1020016922473; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Low EL, 2013, J FAM PLAN REPROD H, V39, P163, DOI 10.1136/jfprhc-2012-100473; Lyratzopoulos G, 2013, ANN ONCOL, V24, P843, DOI 10.1093/annonc/mds526; Lyratzopoulos G, 2012, LANCET ONCOL, V13, P353, DOI 10.1016/S1470-2045(12)70041-4; Mayor S, 2014, LANCET ONCOL, V15, pE7, DOI 10.1016/S1470-2045(13)70577-1; Molassiotis A, 2010, EUR J CANCER CARE, V19, P98, DOI 10.1111/j.1365-2354.2008.01020.x; ONS, 2005, FOC ETHN ID DAT; ONS, 2001, CENS 2001 NAT REP 1; Pennebaker J.W., 1982, PSYCHOL PHYS SYMPTOM; Public Health England, 2014, BE CLEAR CANC; Quaife SL, 2014, BRIT J CANCER, V110, P12, DOI 10.1038/bjc.2013.684; Ristvedt SL, 2005, PSYCHO-ONCOLOGY, V14, P339, DOI 10.1002/pon.850; Robb K, 2009, BRIT J CANCER, V101, pS18, DOI 10.1038/sj.bjc.6605386; ROBBINS JM, 1991, PSYCHOL MED, V21, P1029, DOI 10.1017/S0033291700030026; Scott SE, 2013, BRIT J HEALTH PSYCH, V18, P45, DOI 10.1111/j.2044-8287.2012.02077.x; Scott S, 2010, SOC PERSONAL PSYCHOL, V4, P531, DOI 10.1111/j.1751-9004.2010.00287.x; Simon AE, 2010, CANCER EPIDEM BIOMAR, V19, P2272, DOI 10.1158/1055-9965.EPI-10-0219; Svendsen RP, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-686; Svendsen RP, 2010, SCAND J PRIM HEALTH, V28, P132, DOI 10.3109/02813432.2010.505412; von Wagner C, 2011, EPIDEMIOL REV, V33, P135, DOI 10.1093/epirev/mxq018; Walter F, 2012, J HEALTH SERV RES PO, V17, P110, DOI 10.1258/jhsrp.2011.010113; Walter FM, 2010, BMC FAM PRACT, V11, DOI 10.1186/1471-2296-11-62	38	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114028	10.1371/journal.pone.0114028	http://dx.doi.org/10.1371/journal.pone.0114028			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU8TQ	25461959	Green Published, gold			2022-12-26	WOS:000345869700084
J	Yee, K; Malliaras, K; Kanazawa, H; Tseliou, E; Cheng, K; Luthringer, DJ; Ho, CS; Takayama, K; Minamino, N; Dawkins, JF; Chowdhury, S; Duong, DT; Seinfeld, J; Middleton, RC; Dharmakumar, R; Li, DB; Marban, L; Makkar, RR; Marban, E				Yee, Kristine; Malliaras, Konstantinos; Kanazawa, Hideaki; Tseliou, Eleni; Cheng, Ke; Luthringer, Daniel J.; Ho, Chak-Sum; Takayama, Kentaro; Minamino, Naoto; Dawkins, James F.; Chowdhury, Supurna; Doan Trang Duong; Seinfeld, Jeffrey; Middleton, Ryan C.; Dharmakumar, Rohan; Li, Debiao; Marban, Linda; Makkar, Raj R.; Marban, Eduardo			Allogeneic Cardiospheres Delivered via Percutaneous Transendocardial Injection Increase Viable Myocardium, Decrease Scar Size, and Attenuate Cardiac Dilatation in Porcine Ischemic Cardiomyopathy	PLOS ONE			English	Article							STEM-CELL THERAPY; BRAIN NATRIURETIC PEPTIDE; MOLECULAR-FORMS; HEART-FAILURE; FUNCTIONAL CONSEQUENCES; INFARCTION; TRANSPLANTATION; MODEL; OPTIMIZATION; REGENERATION	Background: Epicardial injection of heart-derived cell products is safe and effective post-myocardial infarction (MI), but clinically-translatable transendocardial injection has never been evaluated. We sought to assess the feasibility, safety and efficacy of percutaneous transendocardial injection of heart-derived cells in porcine chronic ischemic cardiomyopathy. Methods and Results: We studied a total of 89 minipigs; 63 completed the specified protocols. After NOGA-guided transendocardial injection, we quantified engraftment of escalating doses of allogeneic cardiospheres or cardiosphere-derived cells in minipigs (n=22) post-MI. Next, a dose-ranging, blinded, randomized, placebo-controlled ("dose optimization'') study of transendocardial injection of the better-engrafting product was performed in infarcted minipigs (n=16). Finally, the superior product and dose (150 million cardiospheres) were tested in a blinded, randomized, placebo-controlled ("pivotal'') study (n=22). Contrast-enhanced cardiac MRI revealed that all cardiosphere doses preserved systolic function and attenuated remodeling. The maximum feasible dose (150 million cells) was most effective in reducing scar size, increasing viable myocardium and improving ejection fraction. In the pivotal study, eight weeks post-injection, histopathology demonstrated no excess inflammation, and no myocyte hypertrophy, in treated minipigs versus controls. No alloreactive donor-specific antibodies developed over time. MRI showed reduced scar size, increased viable mass, and attenuation of cardiac dilatation with no effect on ejection fraction in the treated group compared to placebo. Conclusions: Dose-optimized injection of allogeneic cardiospheres is safe, decreases scar size, increases viable myocardium, and attenuates cardiac dilatation in porcine chronic ischemic cardiomyopathy. The decreases in scar size, mirrored by increases in viable myocardium, are consistent with therapeutic regeneration.	[Yee, Kristine; Malliaras, Konstantinos; Kanazawa, Hideaki; Tseliou, Eleni; Cheng, Ke; Luthringer, Daniel J.; Dawkins, James F.; Chowdhury, Supurna; Doan Trang Duong; Seinfeld, Jeffrey; Middleton, Ryan C.; Marban, Linda; Makkar, Raj R.; Marban, Eduardo] Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA; [Cheng, Ke] N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC USA; [Cheng, Ke] N Carolina State Univ, Coll Vet Med, Ctr Comparat Med & Translat Res, Raleigh, NC USA; [Cheng, Ke] Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC 27695 USA; [Cheng, Ke] N Carolina State Univ, Raleigh, NC 27695 USA; [Ho, Chak-Sum] Gift Life Michigan, Ann Arbor, MI USA; [Takayama, Kentaro; Minamino, Naoto] Natl Cerebral & Cardiovasc Ctr Res Inst, Osaka, Japan; [Dharmakumar, Rohan; Li, Debiao] Cedars Sinai Biomed Imaging Res Inst, Los Angeles, CA USA; [Marban, Linda; Marban, Eduardo] Capricor, Beverly Hills, CA USA	Cedars Sinai Medical Center; University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; North Carolina State University; National Cerebral & Cardiovascular Center - Japan; Cedars Sinai Medical Center	Marban, E (corresponding author), Cedars Sinai Heart Inst, Los Angeles, CA 90048 USA.	marbane@cshs.org	Cheng, Ke/HCH-8846-2022; Marban, Eduardo/GWC-8514-2022		California Institute for Regenerative Medicine (San Francisco, CA) [DR1-01461]; International Society for Heart and Lung Transplantation (Addison, TX) fellowship; Lincy Foundation (Las Vegas, NV); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL116273] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (San Francisco, CA)(California Institute for Regenerative Medicine); International Society for Heart and Lung Transplantation (Addison, TX) fellowship; Lincy Foundation (Las Vegas, NV); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding came from the California Institute for Regenerative Medicine (#DR1-01461, San Francisco, CA) to EM, http://www.cirm.ca.gov/. Additional support came from the International Society for Heart and Lung Transplantation (Addison, TX) fellowship to KM, http://www.ishlt.org/. Support came from the Lincy Foundation (Las Vegas, NV) to RRM, http://www.unlv.edu/lincyinstitute/foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABURAYA M, 1989, BIOCHEM BIOPH RES CO, V165, P872, DOI 10.1016/S0006-291X(89)80047-6; Bolli R, 2011, LANCET, V378, P1847, DOI 10.1016/S0140-6736(11)61590-0; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Cheng K, 2010, CIRC RES, V106, P1570, DOI 10.1161/CIRCRESAHA.109.212589; Cho PS, 2008, BLOOD, V111, P430, DOI 10.1182/blood-2007-03-078774; Crisostomo Veronica, 2013, ISRN Cardiol, V2013, P781762, DOI 10.1155/2013/781762; Dauwe DF, 2011, CURR PHARM DESIGN, V17, P3328; Dib N, 2011, J CARDIOVASC TRANSL, V4, P177, DOI 10.1007/s12265-010-9253-z; George JC, 2008, J INTERV CARDIOL, V21, P424, DOI 10.1111/j.1540-8183.2008.00390.x; Ho CS, 2010, ANIM GENET, V41, P428, DOI 10.1111/j.1365-2052.2010.02019.x; Ho CS, 2009, ANIM GENET, V40, P468, DOI 10.1111/j.1365-2052.2009.01860.x; Hou DM, 2005, CIRCULATION, V112, pI150, DOI 10.1161/CIRCULATIONAHA.104.526749; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; Kanazawa H, 2011, CIRCULATION, V124; Krause K, 2010, CARDIOVASC THER, V28, pe101, DOI 10.1111/j.1755-5922.2010.00208.x; Lee ST, 2011, J AM COLL CARDIOL, V57, P455, DOI 10.1016/j.jacc.2010.07.049; Lehrke S, 2006, CIRC RES, V99, P553, DOI 10.1161/01.RES.0000238375.88582.d8; Li QH, 2011, BASIC RES CARDIOL, V106, P849, DOI 10.1007/s00395-011-0180-1; Li TS, 2010, STEM CELLS, V28, P2088, DOI 10.1002/stem.532; Liu JW, 2012, CIRC-CARDIOVASC IMAG, V5, P481, DOI 10.1161/CIRCIMAGING.111.969329; Makela J, 2009, SCAND CARDIOVASC J, V43, P366, DOI 10.3109/14017430903045350; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Malliaras K, 2011, CLIN PHARMACOL THER, V90, P532, DOI 10.1038/clpt.2011.175; Malliaras K, 2013, CIRCULATION; Malliaras K, 2013, EMBO MOL MED, V5, P191, DOI 10.1002/emmm.201201737; Malliaras K, 2012, CIRCULATION, V125, P100, DOI 10.1161/CIRCULATIONAHA.111.042598; Malliaras K, 2011, BRIT MED BULL, V98, P161, DOI 10.1093/bmb/ldr018; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; MIYATA A, 1985, BIOCHEM BIOPH RES CO, V129, P248, DOI 10.1016/0006-291X(85)91429-9; Nishikimi T, 2010, HEART, V96, P432, DOI 10.1136/hrt.2009.178392; Penn EC, 2008, J MOL CELL CARDIOL, V44, P486, DOI 10.1016/j.yjmcc.2007.09.012; Perin EC, 2011, CARDIOVASC THER, V29, P211, DOI 10.1111/j.1755-5922.2010.00214.x; Poncelet AJ, 2007, TRANSPLANTATION, V83, P783, DOI 10.1097/01.tp.0000258649.23081.a3; Raake PWJ, 2013, EUR HEART J, V34, P1437, DOI 10.1093/eurheartj/ehr447; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sasano T, 2006, NAT MED, V12, P1256, DOI 10.1038/nm1503; Schuleri KH, 2008, COMPARATIVE MED, V58, P568; Sisson DD, 2004, VET CLIN N AM-SMALL, V34, P1105, DOI 10.1016/j.cvsm.2004.05.005; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Stewart S, 2005, J HEART LUNG TRANSPL, V24, P1710, DOI 10.1016/j.healun.2005.03.019; Suzuki G, 2011, CIRC RES, V109, P1044, DOI 10.1161/CIRCRESAHA.111.245969; Terrovitis J, 2009, J AM COLL CARDIOL, V54, P1619, DOI 10.1016/j.jacc.2009.04.097; Terrovitis JV, 2010, CIRC RES, V106, P479, DOI 10.1161/CIRCRESAHA.109.208991; Theilmeier G, 2002, CIRCULATION, V106, P1140, DOI 10.1161/01.CIR.0000026805.41747.54; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; Tseliou E, 2011, CIRCULATION, V124; van der Spoel TIG, 2012, J CELL MOL MED, V16, P2768, DOI 10.1111/j.1582-4934.2012.01594.x; Vrtovec B, 2013, CIRCULATION, V128, pS42, DOI 10.1161/CIRCULATIONAHA.112.000230; Vrtovec B, 2013, CIRC RES, V112, P165, DOI 10.1161/CIRCRESAHA.112.276519; Wang XH, 2009, CIRCULATION, V120, pS238, DOI 10.1161/CIRCULATIONAHA.109.885236; Weil BR, 2013, CLIN SCI, V125, P109, DOI 10.1042/CS20120641; Williams AR, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000140; Xiong Q, 2013, CIRCULATION, V127, P997, DOI 10.1161/CIRCULATIONAHA.112.000641; Xiong Q, 2012, CIRC RES, V111, P455, DOI 10.1161/CIRCRESAHA.112.269894; 2014, LANCET, V383, P1279	56	44	44	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113805	10.1371/journal.pone.0113805	http://dx.doi.org/10.1371/journal.pone.0113805			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460005	Green Submitted, Green Published, gold			2022-12-26	WOS:000345869700056
J	Coutu, DL; Mahfouz, W; Loutochin, O; Galipeau, J; Corcos, J				Coutu, Daniel L.; Mahfouz, Wally; Loutochin, Oleg; Galipeau, Jacques; Corcos, Jacques			Tissue Engineering of Rat Bladder Using Marrow-Derived Mesenchymal Stem Cells and Bladder Acellular Matrix	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; URINARY-BLADDER; EXTRACELLULAR-MATRIX; IMMUNE-RESPONSE; DECELLULARIZATION; AUGMENTATION; REPLACEMENT	Bladder replacement or augmentation is required in congenital malformations or following trauma or cancer. The current surgical solution involves enterocystoplasty but is associated with high complication rates. Strategies for bladder tissue engineering are thus actively sought to address this unmet clinical need. Because of the poor efficacy of synthetic polymers, the use of bladder acellular matrix (BAM) has been proposed. Indeed when cellular components are removed from xenogenic or allogeneic bladders, the extracellular matrix scaffold thus obtained can be used alone or in combination with stem cells. In this study, we propose the use of BAM seeded with marrow-derived mesenchymal stem cells (MSCs) for bladder tissue engineering. We optimized a protocol for decellularization of bladder tissue from different species including rat, rabbit and swine. We demonstrate the use of non-ionic detergents followed by nuclease digestion results in efficient decellularization while preserving the extracellular matrix. When MSCs were seeded on acellular matrix scaffold, they remained viable and proliferative while adopting a cellular phenotype consistent with their microenvironment. Upon transplantation in rats after partial cystectomy, MSC-seeded BAM proved superior to unseeded BAM with animals recovering nearly 100% normal bladder capacity for up to six months. Histological analyses also demonstrated increased muscle regeneration.	[Coutu, Daniel L.] Swiss Fed Inst Technol, Dept Biosyst Sci & Engn, Basel, Switzerland; [Mahfouz, Wally; Loutochin, Oleg; Corcos, Jacques] McGill Univ, Jewish Gen Hosp, Dept Urol, Montreal, PQ H3T 1E2, Canada; [Mahfouz, Wally] Univ Alexandria, Dept Urol, Alexandria, Egypt; [Galipeau, Jacques] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA	ETH Zurich; McGill University; Egyptian Knowledge Bank (EKB); Alexandria University; Emory University	Corcos, J (corresponding author), McGill Univ, Jewish Gen Hosp, Dept Urol, Montreal, PQ H3T 1E2, Canada.	jcorcos@uro.jgh.mcgill.ca	Galipeau, Jacques/R-9909-2019; Coutu, Daniel/AAD-5292-2022	Galipeau, Jacques/0000-0002-9374-1996; Coutu, Daniel/0000-0002-4641-0115; Mahfouz, Wally/0000-0002-0289-6758	Urology Department, Jewish General Hospital, Montreal, Canada; Canadian Institutes of Health Research	Urology Department, Jewish General Hospital, Montreal, Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding: This project was funded by Urology Department, Jewish General Hospital, Montreal, Canada to WM, OL and JC. DLC holds a Canadian Institutes of Health Research postdoctoral fellowship. JG is a Georgia Cancer Coalition Distinguished Cancer Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken KJ, 2009, NAT REV UROL, V6, P612, DOI 10.1038/nrurol.2009.202; Antoon R, 2012, J BIOMED MATER RES A, V100A, P72, DOI 10.1002/jbm.a.33230; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Atala A, 2011, BRIT MED BULL, V97, P81, DOI 10.1093/bmb/ldr003; Badylak SE, 2008, SEMIN IMMUNOL, V20, P109, DOI 10.1016/j.smim.2007.11.003; Badylak SF, 2007, BIOMATERIALS, V28, P3587, DOI 10.1016/j.biomaterials.2007.04.043; Bergwerf I, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-1; Bolland F, 2007, BIOMATERIALS, V28, P1061, DOI 10.1016/j.biomaterials.2006.10.005; Bono A V, 1966, Minerva Urol, V18, P43; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Comer MT, 1999, ADV EXP MED BIOL, V462, P43; Coutu DL, 2011, BLOOD, V117, P6801, DOI 10.1182/blood-2010-12-321539; Coutu DL, 2009, J CELL BIOCHEM, V108, P537, DOI 10.1002/jcb.22296; Elbahnasy AM, 1998, J UROLOGY, V159, P628, DOI 10.1016/S0022-5347(01)63690-5; Farhat WA, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/2/025015; Faulk DM, 2014, ACTA BIOMATER, V10, P183, DOI 10.1016/j.actbio.2013.09.006; Gambotto A, 2000, GENE THER, V7, P2036, DOI 10.1038/sj.gt.3301335; Gilbert TW, 2006, BIOMATERIALS, V27, P3675, DOI 10.1016/j.biomaterials.2006.02.014; KELAMI A, 1970, EUR SURG RES, V2, P195, DOI 10.1159/000127514; Pattison MA, 2005, BIOMATERIALS, V26, P2491, DOI 10.1016/j.biomaterials.2004.07.011; Probst M, 1997, BRIT J UROL, V79, P505, DOI 10.1046/j.1464-410X.1997.00103.x; Prockop DJ, 2010, J CELL MOL MED, V14, P2190, DOI 10.1111/j.1582-4934.2010.01151.x; Prockop DJ, 2010, CYTOTHERAPY, V12, P576, DOI 10.3109/14653249.2010.507330; Rieder E, 2004, J THORAC CARDIOV SUR, V127, P399, DOI 10.1016/j.jtcvs.2003.06.017; Rosario DJ, 2008, REGEN MED, V3, P145, DOI 10.2217/17460751.3.2.145; Sharma AK, 2011, STEM CELLS, V29, P241, DOI 10.1002/stem.568; Shukla D, 2008, WORLD J UROL, V26, P341, DOI 10.1007/s00345-008-0311-y; Soergel TM, 2004, J UROLOGY, V172, P1649, DOI 10.1097/01.ju.0000140194.87974.56; Stripecke R, 1999, GENE THER, V6, P1305, DOI 10.1038/sj.gt.3300951; Yang B, 2010, TISSUE ENG PART C-ME, V16, P1201, DOI [10.1089/ten.tec.2009.0311, 10.1089/ten.TEC.2009.0311]; Yuan HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080959	31	31	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e111966	10.1371/journal.pone.0111966	http://dx.doi.org/10.1371/journal.pone.0111966			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437001	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900010
J	Hollerhage, M; Deck, R; De Andrade, A; Respondek, G; Xu, H; Rosler, TW; Salama, M; Carlsson, T; Yamada, ES; El Hak, SAG; Goedert, M; Oertel, WH; Hoglinger, GU				Hoellerhage, Matthias; Deck, Roman; De Andrade, Anderson; Respondek, Gesine; Xu, Hong; Rosler, Thomas W.; Salama, Mohamed; Carlsson, Thomas; Yamada, Elizabeth S.; El Hak, Seham A. Gad; Goedert, Michel; Oertel, Wolfgang H.; Hoeglinger, Guenter U.			Piericidin A Aggravates Tau Pathology in P301S Transgenic Mice	PLOS ONE			English	Article							MITOCHONDRIAL COMPLEX-I; PROGRESSIVE SUPRANUCLEAR PALSY; ATYPICAL PARKINSONISM; FRONTOTEMPORAL DEMENTIA; STREPTOMYCES PNEUMONIA; SYNAPSE LOSS; PROTEIN-TAU; MUTATION; GUADELOUPE; INHIBITOR	Objective: The P301S mutation in exon 10 of the tau gene causes a hereditary tauopathy. While mitochondrial complex I inhibition has been linked to sporadic tauopathies. Piericidin A is a prototypical member of the group of the piericidins, a class of biologically active natural complex I inhibitors, isolated from streptomyces spp. with global distribution in marine and agricultural habitats. The aim of this study was to determine whether there is a pathogenic interaction of the environmental toxin piericidin A and the P301S mutation. Methods: Transgenic mice expressing human tau with the P301S-mutation (P301S(+/+)) and wild-type mice at 12 weeks of age were treated subcutaneously with vehicle (N=10 P301S(+/+), N = 7 wild-type) or piericidin A (N = 9 P301S(+/+), N = 9 wild-type mice) at a dose of 0.5 mg/kg/d for a period of 28 days via osmotic minipumps. Tau pathology was measured by stereological counts of cells immunoreative with antibodies against phosphorylated tau (AD2, AT8, AT180, and AT100) and corresponding Western blot analysis. Results: Piericidin A significantly increased the number of phospho-tau immunoreactive cells in the cerebral cortex in P301S(+/+) mice, but only to a variable and mild extent in wild-type mice. Furthermore, piericidin A led to increased levels of pathologically phosphorylated tau only in P301S(+/+) mice. While we observed no apparent cell loss in the frontal cortex, the synaptic density was reduced by piericidin A treatment in P301S(+/+) mice. Discussion: This study shows that exposure to piericidin A aggravates the course of genetically determined tau pathology, providing experimental support for the concept of gene-environment interaction in the etiology of tauopathies.	[Hoellerhage, Matthias; Deck, Roman; De Andrade, Anderson; Respondek, Gesine; Xu, Hong; Rosler, Thomas W.; Salama, Mohamed; Carlsson, Thomas; Yamada, Elizabeth S.; Oertel, Wolfgang H.; Hoeglinger, Guenter U.] Univ Marburg, Dept Neurol, Marburg, Germany; [Hoellerhage, Matthias; De Andrade, Anderson; Respondek, Gesine; Xu, Hong; Rosler, Thomas W.; Hoeglinger, Guenter U.] German Ctr Neurodegenerat Dis, Dept Translat Neurodegenerat, Munich, Germany; [Hoellerhage, Matthias; Respondek, Gesine; Hoeglinger, Guenter U.] Tech Univ Munich, Dept Neurol, D-80290 Munich, Germany; [Salama, Mohamed; El Hak, Seham A. Gad] Mansoura Univ, Dept Toxicol, Mansoura, Egypt; [Carlsson, Thomas] Univ Gothenburg, Dept Pharmacol, Inst Neurosci & Physiol, Sahlgrenska Acad, Gothenburg, Sweden; [Yamada, Elizabeth S.] Fed Univ Para, Expt Neuropathol Lab, BR-66059 Belem, Para, Brazil; [Goedert, Michel] Univ Cambridge, Div Neurobiol, Cambridge, England	Philipps University Marburg; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; Egyptian Knowledge Bank (EKB); Mansoura University; University of Gothenburg; Universidade Federal do Para; University of Cambridge	Hoglinger, GU (corresponding author), Univ Marburg, Dept Neurol, Marburg, Germany.	guenter.hoeglinger@dzne.de	Höglinger, Günter U/F-2388-2015; Xu, Hong/AAP-6568-2020	Höglinger, Günter U/0000-0001-7587-6187; Carlsson, Thomas/0000-0003-3632-8959; Salama, Mohamed/0000-0003-1644-0273	Deutsche Forschungsgemeinschaft [HO2402/6-1, HO2402/8-1]; German Ministry of Education and Research [BMBF GEF 10-54]; Science and Technology Development Fund (Egypt) [GEF 1054]; German Academic Exchange Service (DAAD); MRC [MC_U105184291] Funding Source: UKRI; Medical Research Council [MC_U105184291] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Science and Technology Development Fund (Egypt)(Science and Technology Development Fund (STDF)); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Deutsche Forschungsgemeinschaft (HO2402/6-1, HO2402/8-1), the German Ministry of Education and Research (BMBF GEF 10-54), Science and Technology Development Fund (Egypt, GEF 1054), and the German Academic Exchange Service (DAAD to ACdA, HX, MS). Wolfgang H. Oertel is Senior research Professor of the Charitable Hertie Foundation, Frankfurt/Main, Germany. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen B, 2002, J NEUROSCI, V22, P9340; ANDREADIS A, 1992, BIOCHEMISTRY-US, V31, P10626, DOI 10.1021/bi00158a027; Baba Y, 2007, J NEURAL TRANSM, V114, P947, DOI 10.1007/s00702-007-0632-9; Bigio EH, 2001, J NEUROPATH EXP NEUR, V60, P403, DOI 10.1093/jnen/60.5.403; Bigio EH, 1999, J NEUROPATH EXP NEUR, V58, P359, DOI 10.1097/00005072-199904000-00006; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Bugiani O, 1999, J NEUROPATH EXP NEUR, V58, P667, DOI 10.1097/00005072-199906000-00011; Caparros-Lefebvre D, 1999, LANCET, V354, P281, DOI 10.1016/S0140-6736(98)10166-6; Caparros-Lefebvre D, 2005, MOVEMENT DISORD, V20, pS114, DOI 10.1002/mds.20553; Cave A, 1997, Fortschr Chem Org Naturst, V70, P81; Champy P, 2005, MOVEMENT DISORD, V20, P1629, DOI 10.1002/mds.20632; Champy P, 2004, J NEUROCHEM, V88, P63, DOI 10.1046/j.1471-4159.2003.02138.x; Chater KF, 2006, FEMS MICROBIOL REV, V30, P651, DOI 10.1111/j.1574-6976.2006.00033.x; Dunne EF, 1998, CLIN INFECT DIS, V27, P93, DOI 10.1086/514612; Escobar-Khondiker M, 2007, J NEUROSCI, V27, P7827, DOI 10.1523/JNEUROSCI.1644-07.2007; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2011, J MOL NEUROSCI, V45, P425, DOI 10.1007/s12031-011-9593-4; Han D, 2009, J BIOL CHEM, V284, P13422, DOI 10.1074/jbc.M901095200; Hernandez F, 2007, CELL MOL LIFE SCI, V64, P2219, DOI 10.1007/s00018-007-7220-x; Hoglinger GU, 2011, NAT GENET, V43, P699, DOI 10.1038/ng.859; Hollerhage M, 2009, EXP NEUROL, V220, P133, DOI 10.1016/j.expneurol.2009.08.004; Hoglinger GU, 2005, J NEUROCHEM, V95, P930, DOI 10.1111/j.1471-4159.2005.03493.x; JENG M, 1968, BIOCHEMISTRY-US, V7, P1311, DOI 10.1021/bi00844a010; Kofteridis DP, 2007, DIAGN MICR INFEC DIS, V59, P459, DOI 10.1016/j.diagmicrobio.2007.06.009; Lannuzel A, 2007, BRAIN, V130, P816, DOI 10.1093/brain/awl347; Lossos A, 2003, J NEUROL, V250, P733, DOI 10.1007/s00415-003-1074-4; Mandelkow EM, 2003, NEUROBIOL AGING, V24, P1079, DOI 10.1016/j.neurobiolaging.2003.04.007; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; NEVE RL, 1986, MOL BRAIN RES, V1, P271, DOI 10.1016/0169-328X(86)90033-1; Ostojic J, 2004, DEMENT GERIATR COGN, V17, P298, DOI 10.1159/000077158; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Petry FR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094251; Sperfeld AD, 1999, ANN NEUROL, V46, P708, DOI 10.1002/1531-8249(199911)46:5<708::AID-ANA5>3.0.CO;2-K; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; TAKAHASHI N, 1965, J AM CHEM SOC, V87, P2066, DOI 10.1021/ja01087a050; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Yamada ES, 2014, EXP NEUROL, V253, P113, DOI 10.1016/j.expneurol.2013.12.017; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; ZafraPolo MC, 1996, PHYTOCHEMISTRY, V42, P253, DOI 10.1016/0031-9422(95)00836-5	39	11	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113557	10.1371/journal.pone.0113557	http://dx.doi.org/10.1371/journal.pone.0113557			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437199	Green Published, gold, Green Submitted			2022-12-26	WOS:000347114900052
J	Levett, PA; Hutmacher, DW; Malda, J; Klein, TJ				Levett, Peter A.; Hutmacher, Dietmar W.; Malda, Jos; Klein, Travis J.			Hyaluronic Acid Enhances the Mechanical Properties of Tissue-Engineered Cartilage Constructs	PLOS ONE			English	Article							STEM-CELLS; GELATIN; HYDROGELS; OSTEOARTHRITIS; CHONDROCYTES; DEFECTS; DESIGN; MATRIX; REPAIR	There is a need for materials that are well suited for cartilage tissue engineering. Hydrogels have emerged as promising biomaterials for cartilage repair, since, like cartilage, they have high water content, and they allow cells to be encapsulated within the material in a genuinely three-dimensional microenvironment. In this study, we investigated the mechanical properties of tissue-engineered cartilage constructs using in vitro culture models incorporating human chondrocytes from osteoarthritis patients. We evaluated hydrogels formed from mixtures of photocrosslinkable gelatin-methacrylamide (Gel-MA) and varying concentrations (0-2%) of hyaluronic acid methacrylate (HA-MA). Initially, only small differences in the stiffness of each hydrogel existed. After 4 weeks of culture, and to a greater extent 8 weeks of culture, HA-MA had striking and concentration dependent impact on the changes in mechanical properties. For example, the initial compressive moduli of cell-laden constructs with 0 and 1% HA-MA were 29 and 41 kPa, respectively. After 8 weeks of culture, the moduli of these constructs had increased to 66 and 147 kPa respectively, representing a net improvement of 69 kPa for gels with 1% HA-MA. Similarly the equilibrium modulus, dynamic modulus, failure strength and failure strain were all improved in constructs containing HA-MA. Differences in mechanical properties did not correlate with glycosaminoglycan content, which did not vary greatly between groups, yet there were clear differences in aggrecan intensity and distribution as assessed using immunostaining. Based on the functional development with time in culture using human chondrocytes, mixtures of Gel-MA and HA-MA are promising candidates for cartilage tissueengineering applications.	[Levett, Peter A.; Hutmacher, Dietmar W.; Malda, Jos; Klein, Travis J.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Kelvin Grove, Qld 4059, Australia; [Levett, Peter A.; Malda, Jos] Univ Med Ctr Utrecht, Dept Orthopaed, NL-3508 GA Utrecht, Netherlands; [Malda, Jos] Univ Utrecht, Dept Equine Sci, NL-3508 TD Utrecht, Netherlands	Queensland University of Technology (QUT); Utrecht University; Utrecht University Medical Center; Utrecht University	Klein, TJ (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, 60 Musk Ave, Kelvin Grove, Qld 4059, Australia.	t2.klein@qut.edu.au	Malda, Jos/ABA-9685-2021; Klein, Travis/J-1117-2012	Klein, Travis/0000-0002-6669-7766; Hutmacher, Dietmar Werner/0000-0001-5678-2134; Malda, Jos/0000-0002-9241-7676	Australian Research Council [DP110103543, FT110100166, FT110101117]; European Union [309962]; National Health and Medical Research Council Australian - European Union Health Research Collaboration [APP1067108]	Australian Research Council(Australian Research Council); European Union(European Commission); National Health and Medical Research Council Australian - European Union Health Research Collaboration(National Health and Medical Research Council (NHMRC) of Australia)	Funding: The research leading to these results has received funding from the Australian Research Council (TK, DH and PL; DP110103543, FT110100166, FT110101117, http://.arc.gov.au/), the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreement number 309962 (project HydroZONES), and a National Health and Medical Research Council Australian - European Union Health Research Collaboration (APP1067108).	Abate M, 2010, CURR PHARM DESIGN, V16, P631, DOI 10.2174/138161210790883859; Adkisson HD, 2010, AM J SPORT MED, V38, P1324, DOI 10.1177/0363546510361950; Ahearne M, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/3/035004; Baker MI, 2012, J BIOMED MATER RES B, V100B, P1451, DOI 10.1002/jbm.b.32694; Bastow ER, 2008, CELL MOL LIFE SCI, V65, P395, DOI 10.1007/s00018-007-7360-z; Benders KEM, 2010, OSTEOARTHR CARTILAGE, V18, P1586, DOI 10.1016/j.joca.2010.10.005; Boere KWM, 2014, ACTA BIOMAT IN PRESS; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Bryant SJ, 2000, J BIOMAT SCI-POLYM E, V11, P439, DOI 10.1163/156856200743805; Camci-Unal G, 2013, BIOMACROMOLECULES, V14, P1085, DOI 10.1021/bm3019856; Erickson IE, 2012, ACTA BIOMATER, V8, P3027, DOI 10.1016/j.actbio.2012.04.033; Erickson IE, 2012, BIOMED MATER, V7, DOI 10.1088/1748-6041/7/2/024110; Fairbanks BD, 2009, BIOMATERIALS, V30, P6702, DOI 10.1016/j.biomaterials.2009.08.055; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; Fedorovich NE, 2009, BIOMATERIALS, V30, P344, DOI 10.1016/j.biomaterials.2008.09.037; Gobbi A, 2014, AM J SPORT MED, V42, P648, DOI 10.1177/0363546513518007; Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907; HARDINGHAM TE, 1979, BIOCHEM J, V177, P237, DOI 10.1042/bj1770237; Hutson CB, 2011, TISSUE ENG PT A, V17, P1713, DOI 10.1089/ten.tea.2010.0666; Jeon JE, 2012, OSTEOARTHR CARTILAGE, V20, P906, DOI 10.1016/j.joca.2012.04.019; Kafedjiiski K, 2007, INT J PHARMACEUT, V343, P48, DOI 10.1016/j.ijpharm.2007.04.019; Kim IL, 2011, BIOMATERIALS, V32, P8771, DOI 10.1016/j.biomaterials.2011.08.073; Kim M, 2012, BIOMACROMOLECULES, V13, P2287, DOI 10.1021/bm3005353; Klein TJ, 2010, SOFT MATTER, V6, P5175, DOI 10.1039/c0sm00229a; Levett PA, 2013, J BIOMEDI A IN PRESS; Levett PA, 2014, ACTA BIOMATER, V10, P214, DOI 10.1016/j.actbio.2013.10.005; Malda J, 2013, ADV MATER, V25, P5011, DOI 10.1002/adma.201302042; Marcacci M, 2005, CLIN ORTHOP RELAT R, P96, DOI 10.1097/01.blo.0000165737.87628.5b; Mastbergen SC, 2013, NAT REV RHEUMATOL, V9, P277, DOI 10.1038/nrrheum.2013.29; McCormick F, 2008, SPORTS MED ARTHROSC, V16, P217, DOI 10.1097/JSA.0b013e31818e0e4a; Morita K, 2007, J EXP MED, V204, P1613, DOI 10.1084/jem.20062525; Nguyen QT, 2012, BIOMATERIALS, V33, P6682, DOI 10.1016/j.biomaterials.2012.06.005; Nichol JW, 2010, BIOMATERIALS, V31, P5536, DOI 10.1016/j.biomaterials.2010.03.064; O'Brien AK, 2006, J POLYM SCI POL CHEM, V44, P2007, DOI 10.1002/pola.21304; Palmer AW, 2006, P NATL ACAD SCI USA, V103, P19255, DOI 10.1073/pnas.0606406103; Poole AR, 2001, CLIN ORTHOP RELAT R, pS26, DOI 10.1097/00003086-200110001-00004; Roberts JJ, 2013, BIOMATERIAL IN PRESS; Schuurman W, 2013, MACROMOL BIOSCI, V13, P551, DOI 10.1002/mabi.201200471; Seidlits SK, 2010, BIOMATERIALS, V31, P3930, DOI 10.1016/j.biomaterials.2010.01.125; Sharma B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004838; Smeds KA, 2001, J BIOMED MATER RES, V54, P115, DOI 10.1002/1097-4636(200101)54:1<115::AID-JBM14>3.0.CO;2-Q; Spiller KL, 2011, TISSUE ENG PART B-RE, V17, P281, DOI [10.1089/ten.TEB.2011.0077, 10.1089/ten.teb.2011.0077]; Van den Bulcke AI, 2000, BIOMACROMOLECULES, V1, P31, DOI 10.1021/bm990017d; Williamson AK, 2001, J ORTHOPAED RES, V19, P1113, DOI 10.1016/S0736-0266(01)00052-3; Wilson W, 2007, BIOMECH MODEL MECHAN, V6, P43, DOI 10.1007/s10237-006-0044-z; Woodfield TBF, 2004, BIOMATERIALS, V25, P4149, DOI 10.1016/j.biomaterials.2003.10.056	46	91	92	1	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113216	10.1371/journal.pone.0113216	http://dx.doi.org/10.1371/journal.pone.0113216			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438040	Green Submitted, Green Published, gold			2022-12-26	WOS:000347114900034
J	Ottone, VD; Magalhaes, FD; de Paula, F; Avelar, NCP; Aguiar, PF; Sampaio, PFD; Duarte, TC; Costa, KB; Araujo, TL; Coimbra, CC; Nakamura, FY; Amorim, FT; Rocha-Vieira, E				Ottone, Vinicius de Oliveira; Magalhaes, Flavio de Castro; de Paula, Fabricio; Pereira Avelar, Nubia Carelli; Aguiar, Paula Fernandes; da Matta Sampaio, Pamela Fiche; Duarte, Tamiris Campos; Costa, Karine Beatriz; Araujo, Tatiane Liliam; Coimbra, Candido Celso; Nakamura, Fabio Yuzo; Amorim, Fabiano Trigueiro; Rocha-Vieira, Etel			The Effect of Different Water Immersion Temperatures on Post-Exercise Parasympathetic Reactivation	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; RATE RECOVERY; VENTRICULAR-FIBRILLATION; EXERCISE PERFORMANCE; RATE DYNAMICS; BLOOD-FLOW; COLD; INTENSITY; ENDURANCE; HUMANS	Purpose: We evaluated the effect of different water immersion (WI) temperatures on post-exercise cardiac parasympathetic reactivation. Methods: Eight young, physically active men participated in four experimental conditions composed of resting (REST), exercise session (resistance and endurance exercises), post-exercise recovery strategies, including 15 min of WI at 15 degrees C (CWI), 28 degrees C (TWI), 38 degrees C (HWI) or control (CTRL, seated at room temperature), followed by passive resting. The following indices were assessed before and during WI, 30 min post-WI and 4 hours post-exercise: mean R-R (mRR), the natural logarithm (ln) of the square root of the mean of the sum of the squares of differences between adjacent normal R-R (ln rMSSD) and the ln of instantaneous beat-to-beat variability (ln SD1). Results: The results showed that during WI mRR was reduced for CTRL, TWI and HWI versus REST, and ln rMSSD and ln SD1 were reduced for TWI and HWI versus REST. During post-WI, mRR, ln rMSSD and ln SD1 were reduced for HWI versus REST, and mRR values for CWI were higher versus CTRL. Four hours post exercise, mRR was reduced for HWI versus REST, although no difference was observed among conditions. Conclusions: We conclude that CWI accelerates, while HWI blunts post-exercise parasympathetic reactivation, but these recovery strategies are short-lasting and not evident 4 hours after the exercise session.	[Ottone, Vinicius de Oliveira; Magalhaes, Flavio de Castro; de Paula, Fabricio; Aguiar, Paula Fernandes; da Matta Sampaio, Pamela Fiche; Duarte, Tamiris Campos; Costa, Karine Beatriz; Araujo, Tatiane Liliam; Amorim, Fabiano Trigueiro; Rocha-Vieira, Etel] Univ Fed Vales Jequitinhonha & Mucuri, Lab Biol Exercicio, Ctr Integrado Pesquisa Saude, Programa Multicentr Posgrad Ciencias Fisiol, Diamantina, Brazil; [Pereira Avelar, Nubia Carelli] Univ Fed Santa Catarina, Nucleo Estudos Reumatol Esport & Recursos Terapeu, Ararangua, Brazil; [Coimbra, Candido Celso] Univ Fed Minas Gerais, Inst Ciencias Biol, Lab Endocrinol, Belo Horizonte, MG, Brazil; [Nakamura, Fabio Yuzo] Univ Estadual Londrina, Dept Educ Fis, Londrina, Brazil	Universidade Federal dos Vales do Jequitinhonha e Mucuri (UFVJM); Universidade Federal de Santa Catarina (UFSC); Universidade Federal de Minas Gerais; Universidade Estadual de Londrina	Magalhaes, FD (corresponding author), Univ Fed Vales Jequitinhonha & Mucuri, Lab Biol Exercicio, Ctr Integrado Pesquisa Saude, Programa Multicentr Posgrad Ciencias Fisiol, Diamantina, Brazil.	flavio.magalhaes@ufvjm.edu.br	Rocha-Vieira, Etel/A-2524-2017; Nakamura, Fábio Yuzo/AAC-3069-2020; Magalhães, Flávio/AAE-9680-2020; de Castro Magalhaes, Flavio/AAB-5540-2022	Rocha-Vieira, Etel/0000-0001-6908-7237; Nakamura, Fábio Yuzo/0000-0002-5336-3652; de Castro Magalhaes, Flavio/0000-0002-1963-982X	FAPEMIG (the Minas Gerais State Research Fundation, Brazil) [CDS - APQ-00908-08]; CNPq (The National Council for Scientific and Technological Development, Brazil); FAPEMIG	FAPEMIG (the Minas Gerais State Research Fundation, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq (The National Council for Scientific and Technological Development, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This study was financially supported by FAPEMIG (the Minas Gerais State Research Fundation, Brazil - http://www.fapemig.br/), process number CDS - APQ-00908-08. V. O. O. was a recipient of an undergraduate scholarship from the CNPq (The National Council for Scientific and Technological Development, Brazil); F. C. M. is a post-doctoral fellow (CAPES 2455/2011 - http://.www.capes.gov.br/), F. P. and N. C. P. A. were recipients of master's scholarships from FAPEMIG; P. F. A., P. F. M. S., T. C. D., K. B. C. and T. L. A. were recipients of an undergraduate scholarship from FAPEMIG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Haddad H, 2012, INT J SPORT PHYSIOL, V7, P33, DOI 10.1123/ijspp.7.1.33; Al Haddad H, 2010, AUTON NEUROSCI-BASIC, V156, P111, DOI 10.1016/j.autneu.2010.03.017; Al Haddad H, 2010, EUR J APPL PHYSIOL, V108, P599, DOI 10.1007/s00421-009-1253-9; Bastos FN, 2012, INT J SPORTS MED, V33, P873, DOI 10.1055/s-0032-1301905; Billman GE, 2002, J APPL PHYSIOL, V92, P446, DOI 10.1152/japplphysiol.00874.2001; Billman GE, 2006, AM J PHYSIOL-HEART C, V291, pH429, DOI 10.1152/ajpheart.00020.2006; BONDEPETERSEN F, 1992, AVIAT SPACE ENVIR MD, V63, P346; Boullosa DA, 2013, INT J SPORT PHYSIOL, V8, P400, DOI 10.1123/ijspp.8.4.400; Buchheit M, 2009, AM J PHYSIOL-HEART C, V296, pH421, DOI 10.1152/ajpheart.01017.2008; Buchheit M, 2007, AM J PHYSIOL-HEART C, V293, pH133, DOI 10.1152/ajpheart.00062.2007; Buchheit M, 2010, EUR J APPL PHYSIOL, V108, P1153, DOI 10.1007/s00421-009-1317-x; Cole CR, 1999, NEW ENGL J MED, V341, P1351, DOI 10.1056/NEJM199910283411804; FORTNEY SM, 1985, SPORTS MED, V2, P8, DOI 10.2165/00007256-198502010-00002; Gabrielsen A, 1996, J Gravit Physiol, V3, P22; Hautala A, 2001, CLIN PHYSIOL, V21, P238, DOI 10.1046/j.1365-2281.2001.00309.x; Heffernan KS, 2006, EUR J CARDIOV PREV R, V13, P80; Hopkins WG, 2009, MED SCI SPORT EXER, V41, P3, DOI 10.1249/MSS.0b013e31818cb278; Kiviniemi AM, 2007, EUR J APPL PHYSIOL, V101, P743, DOI 10.1007/s00421-007-0552-2; Kiviniemi AM, 2010, MED SCI SPORT EXER, V42, P1355, DOI 10.1249/MSS.0b013e3181cd5f39; KNIGHT KL, 1980, MED SCI SPORT EXER, V12, P76; Lamberts RP, 2009, EUR J APPL PHYSIOL, V105, P705, DOI 10.1007/s00421-008-0952-y; Leicht AS, 2009, EXP PHYSIOL, V94, P695, DOI 10.1113/expphysiol.2009.046714; Leveritt M, 1999, SPORTS MED, V28, P413, DOI 10.2165/00007256-199928060-00004; Maresh CM, 2006, INT J SPORTS MED, V27, P765, DOI 10.1055/s-2005-872932; Park Kwon Sik, 1999, Applied Human Science, V18, P233; Parouty J, 2010, EUR J APPL PHYSIOL, V109, P483, DOI 10.1007/s00421-010-1381-2; PERINI R, 1990, EUR J APPL PHYSIOL O, V61, P143, DOI 10.1007/BF00236709; PERINI R, 1989, EUR J APPL PHYSIOL, V58, P879, DOI 10.1007/BF02332222; PERINI R, 1993, EUR J APPL PHYSIOL O, V66, P500, DOI 10.1007/BF00634299; Pump B, 2001, AM J PHYSIOL-HEART C, V280, pH2607, DOI 10.1152/ajpheart.2001.280.6.H2607; Quintana DS, 2012, EUR J APPL PHYSIOL, V112, P4179, DOI 10.1007/s00421-012-2453-2; Schaal K, 2013, APPL PHYSIOL NUTR ME, V38, P126, DOI 10.1139/apnm-2012-0155; Seiler S, 2007, MED SCI SPORT EXER, V39, P1366, DOI 10.1249/mss.0b013e318060f17d; Smith LL, 2005, AM J PHYSIOL-HEART C, V288, pH1763, DOI 10.1152/ajpheart.00785.2004; Spinelli L, 1999, AM J PHYSIOL-HEART C, V277, pH1361, DOI 10.1152/ajpheart.1999.277.4.H1361; Stanley J, 2013, SPORTS MED, V43, P1259, DOI 10.1007/s40279-013-0083-4; Stanley J, 2012, EUR J APPL PHYSIOL, V112, P951, DOI 10.1007/s00421-011-2052-7; THOMAS S, 1992, CAN J SPORT SCI, V17, P338; Tsuji H, 1996, CIRCULATION, V94, P2850, DOI 10.1161/01.CIR.94.11.2850; Tulppo MP, 1996, AM J PHYSIOL-HEART C, V271, pH244, DOI 10.1152/ajpheart.1996.271.1.H244; Vaile J, 2008, EUR J APPL PHYSIOL, V102, P447, DOI 10.1007/s00421-007-0605-6; Verdijk LB, 2009, J GERONTOL A-BIOL, V64, P332, DOI 10.1093/gerona/gln050; Versey N, 2011, EUR J APPL PHYSIOL, V111, P37, DOI 10.1007/s00421-010-1614-4; Versey NG, 2013, SPORTS MED, V43, P1101, DOI 10.1007/s40279-013-0063-8; Watanabe N, 2007, CHIROPRACTIC OSTEOPA, V15, P19, DOI DOI 10.1186/1746-1340-15-19; Weippert M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083690; WESTON CFM, 1987, CLIN SCI, V73, P613, DOI 10.1042/cs0730613; WHIPP BJ, 1981, J APPL PHYSIOL, V50, P217, DOI 10.1152/jappl.1981.50.1.217; Wilcock IM, 2006, SPORTS MED, V36, P747, DOI 10.2165/00007256-200636090-00003; Yamane M, 2006, EUR J APPL PHYSIOL, V96, P572, DOI 10.1007/s00421-005-0095-3	50	21	21	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113730	10.1371/journal.pone.0113730	http://dx.doi.org/10.1371/journal.pone.0113730			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437181	Green Submitted, Green Published, gold			2022-12-26	WOS:000347114900071
J	Sanger, PC; Hartzler, A; Han, SM; Armstrong, CAL; Stewart, MR; Lordon, RJ; Lober, WB; Evans, HL				Sanger, Patrick C.; Hartzler, Andrea; Han, Sarah M.; Armstrong, Cheryl A. L.; Stewart, Mark R.; Lordon, Ross J.; Lober, William B.; Evans, Heather L.			Patient Perspectives on Post-Discharge Surgical Site Infections: Towards a Patient-Centered Mobile Health Solution	PLOS ONE			English	Article							IMPACT; CARE; SURVEILLANCE	Background: Post-discharge surgical site infections (SSI) are a major source of morbidity, expense and anxiety for patients. However, patient perceptions about barriers experienced while seeking care for post-discharge SSI have not been assessed in depth. We explored patient experience of SSI and openness to a mobile health (mHealth) wound monitoring "app'' as a novel solution to address this problem. Methods: Mixed method design with semi-structured interviews and surveys. Participants were patients who had post-discharge surgical wound complications after undergoing operations with high risk of SSI, including open colorectal or ventral hernia repair surgery. The study was conducted at two affiliated teaching hospitals, including an academic medical center and a level 1 trauma center. Results: From interviews with 13 patients, we identified 3 major challenges that impact patients' ability to manage post-discharge surgical wound complications, including required knowledge for wound monitoring from discharge teaching, self-efficacy for wound monitoring at home, and accessible communication with their providers about wound concerns. Patients found an mHealth wound monitoring application highly acceptable and articulated its potential to provide more frequent, thorough, and convenient follow-up that could reduce post-discharge anxiety compared to the current practice. Major concerns with mHealth wound monitoring were lack of timely response from providers and inaccessibility due to either lack of an appropriate device or usability challenges. Conclusions: Our findings reveal gaps and frustrations with post-discharge care after surgery which could negatively impact clinical outcomes and quality of life. To address these issues, we are developing mPOWEr, a patient-centered mHealth wound monitoring application for patients and providers to collaboratively bridge the care transition between hospital and home.	[Sanger, Patrick C.; Lordon, Ross J.] Univ Washington, Dept Biomed Informat & Med Educ, Seattle, WA 98195 USA; [Hartzler, Andrea] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Han, Sarah M.; Armstrong, Cheryl A. L.; Evans, Heather L.] Univ Washington, Dept Surg, Seattle, WA 98195 USA; [Stewart, Mark R.; Lober, William B.] Univ Washington, Dept Biobehav Nursing & Hlth Syst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Group Health Cooperative; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Sanger, PC (corresponding author), Univ Washington, Dept Biomed Informat & Med Educ, Seattle, WA 98195 USA.	psanger@uw.edu	Evans, Heather/F-9113-2014	Evans, Heather/0000-0002-3661-0666; HARTZLER, ANDREA/0000-0003-4932-7314	University of Washington Department of Surgery; University of Washington/Agency for Healthcare Research & Quality Comparative Effectiveness Research Award [K12 HS019482]; University of Washington/National Center for Advancing Translational Sciences [TL1 TR000422]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [K12HS019482] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [TL1TR000422] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007442] Funding Source: NIH RePORTER	University of Washington Department of Surgery; University of Washington/Agency for Healthcare Research & Quality Comparative Effectiveness Research Award; University of Washington/National Center for Advancing Translational Sciences; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was supported by the University of Washington Department of Surgery (HLE), the University of Washington/Agency for Healthcare Research & Quality Comparative Effectiveness Research Award (HLE; K12 HS019482; www.ahrq.gov) and University of Washington/National Center for Advancing Translational Sciences Training Grant (PCS; TL1 TR000422; www.ncats.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilimoria KY, 2014, JAMA SURG, V149, P505, DOI 10.1001/jamasurg.2013.5285; Chell E., 1998, QUALITATIVE METHODS, P51; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Daneman N, 2010, J HOSP INFECT, V75, P188, DOI 10.1016/j.jhin.2010.01.029; Gaynes R, 2001, EMERG INFECT DIS, V7, P295, DOI 10.3201/eid0702.010230; Gibson A, 2014, AM J SURG, V207, P832, DOI 10.1016/j.amjsurg.2013.05.017; HALEY RW, 1995, J HOSP INFECT, V30, P3, DOI 10.1016/0195-6701(95)90001-2; Hoch D, 2005, PLOS MED, V2, P728, DOI 10.1371/journal.pmed.0020206; Institute of Medicine, 2001, CROSSING QUALITY CHA; Kazaure HS, 2012, ARCH SURG-CHICAGO, V147, P1000, DOI 10.1001/2013.jamasurg.114; Klasnja P, 2012, J BIOMED INFORM, V45, P184, DOI 10.1016/j.jbi.2011.08.017; Krieger BR, 2011, DIS COLON RECTUM, V54, P1014, DOI 10.1097/DCR.0b013e31821c495d; Limon E, 2014, J HOSP INFECT, V86, P127, DOI 10.1016/j.jhin.2013.11.004; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; Perencevich EN, 2003, EMERG INFECT DIS, V9, P196; Petherick ES, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-170; Pew, 2013, TRACK HLTH; PEW, 2013, HLTH ONL 2013; Pieper B, 2007, J WOUND OSTOMY CONT, V34, P245, DOI 10.1097/01.WON.0000270817.06942.00; Pinkney TD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4305; Rhodes KV, 2013, JAMA INTERN MED, V173, P1723, DOI 10.1001/jamainternmed.2013.7854; Sanger P, 2013, P AMIA ANN S WASH DC, P1236; Sanger PC, 2014, P AMIA ANN IN PRESS; Saunders RS, 2014, SURGERY, V156, P949, DOI 10.1016/j.surg.2014.06.041; SEAMAN M, 1991, Journal of Emergency Medicine, V9, P215, DOI 10.1016/0736-4679(91)90416-D; Stewart M, 2000, J FAM PRACTICE, V49, P796; Strauss A., 1990, BASICS QUALITATIVE R; Tanner J, 2013, J HOSP INFECT, V83, P41, DOI 10.1016/j.jhin.2012.07.025; Zimlichman E, 2013, JAMA INTERN MED, V173, P2039, DOI 10.1001/jamainternmed.2013.9763	29	71	71	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114016	10.1371/journal.pone.0114016	http://dx.doi.org/10.1371/journal.pone.0114016			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436912	gold, Green Published, Green Submitted			2022-12-26	WOS:000347114900110
J	Lundstrom, SL; Fernandes-Cerqueira, C; Ytterberg, AJ; Ossipova, E; Hensvold, AH; Jakobsson, PJ; Malmstrom, V; Catrina, AI; Klareskog, L; Lundberg, K; Zubarev, RA				Lundstrom, Susanna L.; Fernandes-Cerqueira, Catia; Ytterberg, A. Jimmy; Ossipova, Elena; Hensvold, Aase H.; Jakobsson, Per-Johan; Malmstrom, Vivianne; Catrina, Anca I.; Klareskog, Lars; Lundberg, Karin; Zubarev, Roman A.			IgG Antibodies to Cyclic Citrullinated Peptides Exhibit Profiles Specific in Terms of IgG Subclasses, Fc-Glycans and a Fab-Peptide Sequence	PLOS ONE			English	Article							EARLY RHEUMATOID-ARTHRITIS; ANTIINFLAMMATORY ACTIVITY; IMMUNOGLOBULIN PEPTIDES; PROTEIN ANTIBODIES; CONSTANT-REGION; SYNOVIAL-FLUID; GAMMA-RIII; DISEASE; BINDING; SERUM	The Fc-glycan profile of IgG(1) anti-citrullinated peptide antibodies (ACPA) in rheumatoid arthritis (RA) patients has recently been reported to be different from non-ACPA IgG(1), a phenomenon which likely plays a role in RA pathogenesis. Herein we investigate the Fc-glycosylation pattern of all ACPA-IgG isotypes and simultaneously investigate in detail the IgG protein-chain sequence repertoire. IgG from serum or plasma (S/P, n=14) and synovial fluid (SF, n=4) from 18 ACPA-positive RA-patients was enriched using Protein G columns followed by ACPA-purification on cyclic citrullinated peptide-2 (CCP2)-coupled columns. Paired ACPA (anti-CCP2 eluted IgG) and IgG flow through (FT) fractions were analyzed by LC-MS/MS-proteomics. IgG peptides, isotypes and corresponding Fc-glycopeptides were quantified and interrogated using uni- and multivariate statistics. The Fc-glycans from the IgG(4) peptide EEQFNSTYR was validated using protein A column purification. Relative to FT-IgG(4), the ACPA-IgG(4) Fc-glycan-profile contained lower amounts (p=0.002) of the agalacto and asialylated core-fucosylated biantennary form (FA2) and higher content (p=0.001) of sialylated glycans. Novel differences in the Fc-glycan-profile of ACPA-IgG(1) compared to FT-IgG(1) were observed in the distribution of bisected forms (n=5, p=0.0001, decrease) and mono-antennnary forms (n=3, p=0.02, increase). Our study also confirmed higher abundance of FA2 (p=0.002) and lower abundance of afucosylated forms (n=4, p=0.001) in ACPA-IgG(1) relative to FT-IgG(1) as well as lower content of IgG2 (p=0.0000001) and elevated content of IgG(4) (p=0.004) in ACPA compared to FT. One lambda-variable peptide sequence was significantly increased in ACPA (p=0.0001). In conclusion, the Fc-glycan profile of both ACPA-IgG(1) and ACPA-IgG(4) are distinct. Given that IgG(1) and IgG(4) have different Fcreceptor and complement binding affinities, this phenomenon likely affects ACPA effector-and immune-regulatory functions in an IgG isotype-specific manner. These findings further highlight the importance of antibody characterization in relation to functional in vivo and in vitro studies.	[Lundstrom, Susanna L.; Ytterberg, A. Jimmy; Zubarev, Roman A.] Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 1, Stockholm, Sweden; [Lundstrom, Susanna L.; Fernandes-Cerqueira, Catia; Ytterberg, A. Jimmy; Ossipova, Elena; Hensvold, Aase H.; Jakobsson, Per-Johan; Malmstrom, Vivianne; Catrina, Anca I.; Klareskog, Lars; Lundberg, Karin] Karolinska Inst, Dept Med, Rheumatol Unit, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet	Lundstrom, SL (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Div Physiol Chem 1, Stockholm, Sweden.	Susanna.Lundstrom@ki.se; Roman.Zubarev@ki.se	Zubarev, Roman A/W-7891-2018; Jakobsson, Per-Johan/ABC-5594-2021; Cerqueira, Catia/AAU-6375-2020; Ytterberg, Anders/E-1773-2016	Zubarev, Roman A/0000-0001-9839-2089; Cerqueira, Catia/0000-0001-7020-0954; Ytterberg, Anders/0000-0002-1485-2314; Klareskog, Lars/0000-0001-9601-6186; Ossipova, Elena/0000-0002-2090-7705; Lundstrom, Susanna/0000-0003-2363-4287	Swedish Strategic Research Funds (SSF); Swedish Research Council (VR); European Research Council (ERC); EU [261460, 306029, 305549-2]; Innovative Medicine Initiative BTCure [115142-2]	Swedish Strategic Research Funds (SSF); Swedish Research Council (VR)(Swedish Research Council); European Research Council (ERC)(European Research Council (ERC)European Commission); EU(European Commission); Innovative Medicine Initiative BTCure	This study was supported by funds from the Swedish Strategic Research Funds (SSF), from the Swedish Research Council (VR), from the European Research Council (ERC), the EU projects Gums&Joints (contract No. 261460) and Trigger (contract No. 306029) as well as Innovative Medicine Initiative BTCure (115142-2) and EU project FP7-HEALTH-2012-INNOVATION-1 Euro-TEAM (305549-2). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aalberse RC, 2009, CLIN EXP ALLERGY, V39, P469, DOI 10.1111/j.1365-2222.2009.03207.x; ABEL CA, 1968, BIOCHEMISTRY-US, V7, P1271, DOI 10.1021/bi00844a004; Amara K, 2013, J EXP MED, V210, P445, DOI 10.1084/jem.20121486; Anthony RM, 2012, ANN NY ACAD SCI, V1253, P170, DOI 10.1111/j.1749-6632.2011.06305.x; Anthony RM, 2008, P NATL ACAD SCI USA, V105, P19571, DOI 10.1073/pnas.0810163105; Arend WP, 2012, NAT REV RHEUMATOL, V8, P573, DOI 10.1038/nrrheum.2012.134; BALBIN M, 1994, IMMUNOGENETICS, V39, P187, DOI 10.1007/BF00241259; Bruhns P, 2009, BLOOD, V113, P3716, DOI 10.1182/blood-2008-09-179754; BURTON DR, 1992, ADV IMMUNOL, V51, P1, DOI 10.1016/S0065-2776(08)60486-1; Chapuy-Regaud S, 2005, CLIN EXP IMMUNOL, V139, P542, DOI 10.1111/j.1365-2249.2004.02708.x; COHEN PL, 1987, J IMMUNOL, V139, P1466; Conrad K, 2010, AUTOIMMUN REV, V9, P431, DOI 10.1016/j.autrev.2009.11.017; Davies J, 2001, BIOTECHNOL BIOENG, V74, P288, DOI 10.1002/bit.1119.abs; Engelmann R, 2008, RHEUMATOLOGY, V47, P1489, DOI 10.1093/rheumatology/ken336; Gornik I, 1999, CLIN BIOCHEM, V32, P605, DOI 10.1016/S0009-9120(99)00060-0; Hoogeboom R, 2013, J EXP MED, V210, P59, DOI 10.1084/jem.20121801; HUCK S, 1986, NUCLEIC ACIDS RES, V14, P1779, DOI 10.1093/nar/14.4.1779; Jefferis R, 2009, MABS, V1, P332, DOI 10.4161/mabs.1.4.9122; Karsten CM, 2012, IMMUNOBIOLOGY, V217, P1067, DOI 10.1016/j.imbio.2012.07.015; Kastbom A, 2004, ANN RHEUM DIS, V63, P1085, DOI 10.1136/ard.2003.016808; Kawa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001637; Klareskog L, 2013, ADV IMMUNOL, V118, P129, DOI 10.1016/B978-0-12-407708-9.00003-0; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Kolfschoten MV, 2007, SCIENCE, V317, P1554, DOI 10.1126/science.1144603; Lundstrom SL, 2014, J ALZHEIMERS DIS, V38, P567, DOI 10.3233/JAD-131088; Lyutvinskiy Y, 2013, MOL CELL PROTEOMICS, V12, P2324, DOI 10.1074/mcp.O112.023804; Maat P, 2012, J AUTOIMMUN, V38, P354, DOI 10.1016/j.jaut.2012.02.002; MALHOTRA R, 1995, NAT MED, V1, P237, DOI 10.1038/nm0395-237; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Nakagawa H, 2007, J CHROMATOGR B, V853, P133, DOI 10.1016/j.jchromb.2007.03.003; Ossipova E, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4683; Oxelius VA, 1996, CLIN EXP IMMUNOL, V106, P203, DOI 10.1046/j.1365-2249.1996.d01-851.x; PAREKH RB, 1988, LANCET, V1, P966; Pucic M, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.010090; Rantapaa-Dahlqvist S, 2003, ARTHRITIS RHEUM, V48, P2741, DOI 10.1002/art.11223; Raza K, 2012, ANN RHEUM DIS, V71, P1921, DOI 10.1136/annrheumdis-2012-201893; Rispens T, 2009, J IMMUNOL, V182, P4275, DOI 10.4049/jimmunol.0804338; Rombouts Y., 2013, ANN RHEUM DIS; Royle L, 2008, ANAL BIOCHEM, V376, P1, DOI 10.1016/j.ab.2007.12.012; Scheid JF, 2011, SCIENCE, V333, P1633, DOI 10.1126/science.1207227; Scherer HU, 2010, ARTHRITIS RHEUM-US, V62, P1620, DOI 10.1002/art.27414; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Singh V, 2013, MOL CELL PROTEOMICS, V12, P3924, DOI 10.1074/mcp.M113.030346; SKINNER M, 1975, J IMMUNOL, V114, P1433; Skriner K, 2006, ARTHRITIS RHEUM, V54, P3809, DOI 10.1002/art.22276; SLETTEN K, 1981, BIOCHEM J, V195, P561, DOI 10.1042/bj1950561; Thurgood LA, 2013, CLIN EXP IMMUNOL, V174, P237, DOI 10.1111/cei.12171; Tissot JD, 2002, ELECTROPHORESIS, V23, P1203, DOI 10.1002/1522-2683(200204)23:7/8<1203::AID-ELPS1203>3.0.CO;2-1; van de Geijn FE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2892; VanDuijn MM, 2010, J BIOL CHEM, V285, P29247, DOI 10.1074/jbc.M110.139071; Willemze A, 2013, ANN RHEUM DIS, V72, P1059, DOI 10.1136/annrheumdis-2012-202747; ZACK DJ, 1995, J IMMUNOL, V155, P5057	52	27	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113924	10.1371/journal.pone.0113924	http://dx.doi.org/10.1371/journal.pone.0113924			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426976	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400102
J	Tsuchiya, M; Nakajima, Y; Waku, T; Hiyoshi, H; Morishita, T; Furumai, R; Hayashi, Y; Kishimoto, H; Kimura, K; Yanagisawa, J				Tsuchiya, M.; Nakajima, Y.; Waku, T.; Hiyoshi, H.; Morishita, T.; Furumai, R.; Hayashi, Y.; Kishimoto, H.; Kimura, K.; Yanagisawa, J.			CHIP buffers heterogeneous Bcl-2 expression levels to prevent augmentation of anticancer drug-resistant cell population	ONCOGENE			English	Article							BREAST-CANCER CELLS; MORPHOLOGICAL EVOLUTION; UBIQUITIN LIGASE; PROTEINS; HSP90; IDENTIFICATION; CAPACITOR; MCF7; GENE; TRANSCRIPTION	Many types of cancer display heterogeneity in various features, including gene expression and malignant potential. This heterogeneity is associated with drug resistance and cancer progression. Recent studies have shown that the expression of a major protein quality control ubiquitin ligase, carboxyl terminus of Hsc70-interacting protein (CHIP), is negatively correlated with breast cancer clinicopathological stages and poor overall survival. Here we show that CHIP acts as a capacitor of heterogeneous Bcl-2 expression levels and prevents an increase in the anticancer drug-resistant population in breast cancer cells. CHIP knockdown in breast cancer cells increased variation in Bcl-2 expression levels, an antiapoptotic protein, among the cells. Our results also showed that CHIP knockdown increased the proportion of anticancer drug-resistant cells. These findings suggest that CHIP buffers variation in gene expression levels, affecting resistance to anticancer drugs. In single-cell clones derived from breast cancer cell lines, CHIP knockdown did not alter the variation in Bcl-2 expression levels and the proportion of anticancer drug-resistant cells. In contrast, when clonal cells were treated with a mutagen, the variation in Bcl-2 expression levels and proportion of anticancer drug-resistant cells were altered by CHIP knockdown. These results suggest that CHIP masks genetic variations to suppress heterogeneous Bcl-2 expression levels and prevents augmentation of the anticancer drug-resistant population of breast cancer cells. Because genetic variation is a major driver of heterogeneity, our results suggest that the degree of heterogeneity in expression levels is decided by a balance between genetic variation and the buffering capacity of CHIP.	[Tsuchiya, M.; Nakajima, Y.; Hiyoshi, H.; Morishita, T.; Hayashi, Y.; Kishimoto, H.; Kimura, K.; Yanagisawa, J.] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058577, Japan; [Nakajima, Y.; Hiyoshi, H.; Furumai, R.; Kishimoto, H.; Yanagisawa, J.] Univ Tsukuba, Life Sci Ctr, Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058577, Japan; [Waku, T.] Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo, Japan	University of Tsukuba; University of Tsukuba; University of Tokyo	Kimura, K (corresponding author), Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tenno Dai, Tsukuba, Ibaraki 3058577, Japan.	kekimura@tara.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We would like to thank Enago (www.enago.jp) for the English language review.	Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Banerji S, 2012, NATURE, V486, P405, DOI 10.1038/nature11154; BUTLER WB, 1986, CANCER RES, V46, P6339; Coley HM, 2009, EJC SUPPL, V7, P3, DOI 10.1016/S1359-6349(09)70003-5; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Davis JM, 2003, CLIN CANCER RES, V9, P1161; Decary S, 2002, MOL CELL BIOL, V22, P7877, DOI 10.1128/MCB.22.22.7877-7888.2002; Ding L, 2012, NATURE, V481, P506, DOI 10.1038/nature10738; DREWINKO B, 1973, CANCER RES, V33, P3091; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Gomez-Manzano C, 2001, CANCER RES, V61, P6693; HEWITT SM, 1995, CANCER RES, V55, P5386; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Kajiro M, 2009, NAT CELL BIOL, V11, P312, DOI 10.1038/ncb1839; Kampinga HH, 2003, MOL CELL BIOL, V23, P4948, DOI 10.1128/MCB.23.14.4948-4958.2003; Kurland JF, 2001, J BIOL CHEM, V276, P45380, DOI 10.1074/jbc.M108294200; Lambert G, 2011, NAT REV CANCER, V11, P375, DOI 10.1038/nrc3039; Lee JH, 2004, J BIOL CHEM, V279, P42758, DOI 10.1074/jbc.M407357200; Lima RT, 2004, CANCER GENE THER, V11, P309, DOI 10.1038/sj.cgt.7700706; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; McDiarmid HM, 2001, MUTAT RES-GEN TOX EN, V497, P39, DOI 10.1016/S1383-5718(01)00245-5; MIYASHITA T, 1994, CANCER RES, V54, P3131; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; PAPENDORP JT, 1985, J CELL PHYSIOL, V125, P591, DOI 10.1002/jcp.1041250331; Patani Neill, 2010, J Carcinog, V9, P9, DOI 10.4103/1477-3163.72505; Polyak K, 2007, J CLIN INVEST, V117, P3155, DOI 10.1172/JCI33295; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; RESNICOFF M, 1987, P NATL ACAD SCI USA, V84, P7295, DOI 10.1073/pnas.84.20.7295; Rudin CM, 2003, CANCER RES, V63, P312; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sierra A, 1996, CLIN CANCER RES, V2, P1887; Sollars V, 2003, NAT GENET, V33, P70, DOI 10.1038/ng1067; Stevenson HS, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1766; Tabuchi Y, 2009, INT J ONCOL, V34, P313, DOI 10.3892/ijo_00000153; Theodoraki MA, 2012, BBA-MOL CELL RES, V1823, P683, DOI 10.1016/j.bbamcr.2011.08.006; Tsujimoto Y, 2000, CELL DEATH DIFFER, V7, P1174, DOI 10.1038/sj.cdd.4400780; Wilson BE, 1996, MOL CELL BIOL, V16, P5546; Yang JY, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-388; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; YOUNG RL, 1993, MOL CELL BIOL, V13, P3686, DOI 10.1128/MCB.13.6.3686	43	9	9	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 27	2015	34	35					4656	4663		10.1038/onc.2014.387	http://dx.doi.org/10.1038/onc.2014.387			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CP9BS	25435366	Bronze			2022-12-26	WOS:000360189300011
J	Lin, Y; Li, DJ; Liang, Q; Liu, SQ; Zuo, XL; Li, L; Sun, XM; Li, WX; Guo, MX; Huang, Z				Lin, Yi; Li, Dengju; Liang, Qing; Liu, Shangqing; Zuo, Xuelan; Li, Lin; Sun, Xuemei; Li, Wenxin; Guo, Mingxiong; Huang, Zan			miR-638 Regulates Differentiation and Proliferation in Leukemic Cells by Targeting Cyclin-dependent Kinase 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE MYELOID-LEUKEMIA; CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE PROMYELOCYTIC LEUKEMIA; BINDING-PROTEIN-ALPHA; DOWN-REGULATION; TERMINAL DIFFERENTIATION; STEM-CELLS; EXPRESSION; MICRORNA-223; GENES	MicroRNAs have been extensively studied as regulators of hematopoiesis and leukemogenesis. We identified miR-638 as a novel regulator in myeloid differentiation and proliferation of leukemic cells. We found that miR-638 was developmentally up-regulated in cells of myeloid but not lymphoid lineage. Furthermore, significant miR-638 down-regulation was observed in primary acute myeloid leukemia (AML) blasts, whereas miR-638 expression was dramatically up-regulated in primary AML blasts and leukemic cell lines undergoing forced myeloid differentiation. These observations suggest that miR-638 might play a role in myeloid differentiation, and its dysregulation may contribute to leukemogenesis. Indeed, ectopic expression of miR-638 promoted phorbol 12-myristate 13-acetate- or all-transretinoic acid-induced differentiation of leukemic cell lines and primary AML blasts, whereas miR-638 inhibition caused an opposite phenotype. Consistently, miR-638 overexpression induced G(1) cell cycle arrest and reduced colony formation in soft agar. Cyclin-dependent kinase 2 (CDK2) was found to be a target gene of miR-638. CDK2 inhibition phenotypically mimicked the overexpression of miR-638. Moreover, forced expression of CDK2 restored the proliferation and the colony-forming ability inhibited by miR-638. Our data suggest that miR-638 regulates proliferation and myeloid differentiation by targeting CDK2 and may serve as a novel target for leukemia therapy or marker for AML diagnosis and prognosis.	[Lin, Yi; Li, Wenxin; Guo, Mingxiong; Huang, Zan] Wuhan Univ, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China; [Li, Dengju] Huazhong Technol Univ, Tongji Hosp, Dept Hematol, Wuhan 430030, Hubei, Peoples R China; [Liang, Qing; Liu, Shangqing; Zuo, Xuelan] Wuhan Univ, Dept Hematol, Zhongnan Hosp, Wuhan 430071, Hubei, Peoples R China; [Li, Lin; Sun, Xuemei] Nanjing Univ Chinese Med, Dept Hematol, Jiangsu Prov Hosp Tradit Chinese Med TCM, Nanjing 210029, Jiangsu, Peoples R China	Wuhan University; Huazhong University of Science & Technology; Wuhan University; Nanjing University of Chinese Medicine	Guo, MX (corresponding author), Wuhan Univ, State Key Lab Virol, Coll Life Sci, Wuhan 430072, Hubei, Peoples R China.	guomx@whu.edu.cn; z-huang@whu.edu.cn	LIN, YI/AAC-3335-2020	LIN, YI/0000-0001-8209-1185; Huang, Zan/0000-0001-5623-6950	National Natural Science Foundation of China [31371481, 81000201, 31271511, 81272627]; Ph.D. Programs Foundation of the Ministry of Education of China [20110141110016]; New Century Excellent Talents in University (NCET) of the Ministry of Education of China [NCET-12-0422]; Fundamental Research Funds for the Central Universities [2042014KF0243]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ph.D. Programs Foundation of the Ministry of Education of China(Ministry of Education, China); New Century Excellent Talents in University (NCET) of the Ministry of Education of China(Program for New Century Excellent Talents in University (NCET)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by National Natural Science Foundation of China Grants 31371481 (to Z. H.), 81000201 (to L. L.), 31271511 (to M. G.), and 81272627 (to S. L.); Ph.D. Programs Foundation of the Ministry of Education of China Grant 20110141110016 (to Z. H.); New Century Excellent Talents in University (NCET) of the Ministry of Education of China Grant NCET-12-0422 (to Z. H.), and Fundamental Research Funds for the Central Universities Grant 2042014KF0243 (to M. G.).	Aref S, 2006, HEMATOLOGY, V11, P31, DOI 10.1080/10245330500322321; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Benedetti L, 1996, BLOOD, V87, P1939; Buschges R, 1999, BRAIN PATHOL, V9, P435; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Dobashi Y, 2000, J BIOL CHEM, V275, P12572, DOI 10.1074/jbc.275.17.12572; DUBOIS C, 1994, BLOOD, V83, P3264; Duprez E, 1997, ONCOGENE, V14, P1563, DOI 10.1038/sj.onc.1200995; Eyholzer M, 2010, BRIT J CANCER, V103, P275, DOI 10.1038/sj.bjc.6605751; Favreau AJ, 2012, AM J HEMATOL, V87, P442, DOI 10.1002/ajh.23129; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Fukao T, 2007, CELL, V129, P617, DOI 10.1016/j.cell.2007.02.048; GALLAGHER R, 1979, BLOOD, V54, P713; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Garzon R, 2009, BLOOD, V113, P6411, DOI 10.1182/blood-2008-07-170589; Hackanson B, 2008, CANCER RES, V68, P3142, DOI 10.1158/0008-5472.CAN-08-0483; Jaiswal R, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-37; Jiang X, 2012, P NATL ACAD SCI USA, V109, P19397, DOI 10.1073/pnas.1217519109; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kharfan-Dabaja MA, 2005, CANCER IMMUNOL IMMUN, V54, P25, DOI 10.1007/s00262-004-0562-4; Klausen P, 2004, J LEUKOCYTE BIOL, V75, P569, DOI 10.1189/jlb.1003474; Lal A, 2009, NAT STRUCT MOL BIOL, V16, P492, DOI 10.1038/nsmb.1589; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li DC, 2012, TOXICOL SCI, V125, P382, DOI 10.1093/toxsci/kfr299; Li JH, 2013, NAT IMMUNOL, V14, P793, DOI 10.1038/ni.2647; Li P, 2013, CARDIOVASC RES, V99, P185, DOI 10.1093/cvr/cvt082; Lim S, 2012, STEM CELLS, V30, P1509, DOI 10.1002/stem.1114; Lin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069230; Liu L, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.512; Ma KL, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-118; Martinez LA, 1999, ONCOGENE, V18, P397, DOI 10.1038/sj.onc.1202300; Mineno J, 2006, NUCLEIC ACIDS RES, V34, P1765, DOI 10.1093/nar/gkl096; Mrozek K, 2004, BLOOD REV, V18, P115, DOI 10.1016/S0268-960X(03)00040-7; Mukai HY, 2006, MOL CELL BIOL, V26, P7953, DOI 10.1128/MCB.00718-06; O'Connell RM, 2008, J EXP MED, V205, P585, DOI 10.1084/jem.20072108; Palma CA, 2012, J CELL MOL MED, V16, P978, DOI 10.1111/j.1582-4934.2011.01514.x; Pulikkan JA, 2010, BLOOD, V115, P1768, DOI 10.1182/blood-2009-08-240101; Radomska HS, 1998, MOL CELL BIOL, V18, P4301, DOI 10.1128/MCB.18.7.4301; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Salvatori Beatrice, 2011, Genes Cancer, V2, P585, DOI 10.1177/1947601911416357; Schmitz NMR, 2005, LEUKEMIA, V19, P1783, DOI 10.1038/sj.leu.2403900; Seca H, 2010, EUR J CANCER, V46, P1520, DOI 10.1016/j.ejca.2010.03.031; Subramanian S, 2010, J PATHOL, V220, P58, DOI 10.1002/path.2633; Tanaka M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005532; Tikoo R, 1997, J BIOL CHEM, V272, P442; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; Tsukamoto Y, 2010, CANCER RES, V70, P2339, DOI 10.1158/0008-5472.CAN-09-2777; Wang J, 2011, J CELL BIOCHEM, V112, P2443, DOI 10.1002/jcb.23165; Wang K, 2015, TUMOR BIOL, V36, P393, DOI 10.1007/s13277-014-2655-9; Wang XS, 2012, BLOOD, V119, P4992, DOI 10.1182/blood-2011-10-385716; Wang XN, 2009, CELL CYCLE, V8, P736, DOI 10.4161/cc.8.5.7870; WEIL SC, 1987, P NATL ACAD SCI USA, V84, P2057, DOI 10.1073/pnas.84.7.2057; Wessendorf S, 2003, ONCOGENE, V22, P1425, DOI 10.1038/sj.onc.1206297; Zhao LY, 2014, DIGEST DIS SCI, V59, P1743, DOI 10.1007/s10620-014-3087-5; Zhu DX, 2012, CARCINOGENESIS, V33, P1294, DOI 10.1093/carcin/bgs179	57	43	44	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1818	1828		10.1074/jbc.M114.599191	http://dx.doi.org/10.1074/jbc.M114.599191			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25451924	Green Published, hybrid			2022-12-26	WOS:000348056400046
J	Lee, WL; Tan, JWM; Tan, CN; Loo, SCJ				Lee, Wei Li; Tan, Jun Wei Melvin; Tan, Chaoyang Nicholas; Loo, Say Chye Joachim			Modulating Drug Release from Gastric-Floating Microcapsules through Spray-Coating Layers	PLOS ONE			English	Article							RIBOFLAVIN-CONTAINING MICROBALLOONS; IN-VIVO EVALUATION; SUSTAINED-RELEASE; DELIVERY-SYSTEMS; VITRO; MICROSPHERES; PHARMACOKINETICS; BIOAVAILABILITY; MICROPARTICLES; FENOFIBRATE	Floating dosage forms with prolonged gastric residence time have garnered much interest in the field of oral delivery. However, studies had shown that slow and incomplete release of hydrophobic drugs during gastric residence period would reduce drug absorption and cause drug wastage. Herein, a spray-coated floating microcapsule system was developed to encapsulate fenofibrate and piroxicam, as model hydrophobic drugs, into the coating layers with the aim of enhancing and tuning drug release rates. Incorporating fenofibrate into rubbery poly(caprolactone) (PCL) coating layer resulted in a complete and sustained release for up to 8 h, with outermost non-drug-holding PCL coating layer serving as a rate-controlling membrane. To realize a multidrug-loaded system, both hydrophilic metformin HCl and hydrophobic fenofibrate were simultaneously incorporated into these spray-coated microcapsules, with metformin HCl and fenofibrate localized within the hollow cavity of the capsule and coating layer, respectively. Both drugs were observed to be completely released from these coated microcapsules in a sustained manner. Through specific tailoring of coating polymers and their configurations, piroxicam loaded in both the outer polyethylene glycol and inner PCL coating layers was released in a double-profile manner (i.e. an immediate burst release as the loading dose, followed by a sustained release as the maintenance dose). The fabricated microcapsules exhibited excellent buoyancy in simulated gastric fluid, and provided controlled and sustained release, thus revealing its potential as a rate-controlled oral drug delivery system.	[Lee, Wei Li; Tan, Jun Wei Melvin; Tan, Chaoyang Nicholas; Loo, Say Chye Joachim] Nanyang Technol Univ, Sch Mat Sci & Engn, Singapore 639798, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Loo, SCJ (corresponding author), Nanyang Technol Univ, Sch Mat Sci & Engn, 50 Nanyang Ave, Singapore 639798, Singapore.	joachimloo@ntu.edu.sg	Loo, Say Chye Joachim/A-2234-2011; Lee, Wei Li/F-9095-2010	Loo, Say Chye Joachim/0000-0001-5300-1275; Lee, Wei Li/0000-0002-9720-3407	Singapore Centre on Environmental Life Sciences Engineering (SCELSE) [M4330001.C70.703012]; School of Materials Science and Engineering [M020070110]; Solar Fuels Laboratory Nanyang Technological University [M060070008]; NTU-National Healthcare Group (NTU-NHG) [ARG/14012]	Singapore Centre on Environmental Life Sciences Engineering (SCELSE); School of Materials Science and Engineering; Solar Fuels Laboratory Nanyang Technological University(Nanyang Technological University); NTU-National Healthcare Group (NTU-NHG)	The authors would also like to acknowledge the financial support from the Singapore Centre on Environmental Life Sciences Engineering (SCELSE) (M4330001.C70.703012), the School of Materials Science and Engineering (M020070110), Solar Fuels Laboratory Nanyang Technological University (M060070008), and the NTU-National Healthcare Group (NTU-NHG) grant (ARG/14012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali J, 2007, EUR J PHARM BIOPHARM, V67, P196, DOI 10.1016/j.ejpb.2006.12.015; Arifin DY, 2006, ADV DRUG DELIVER REV, V58, P1274, DOI 10.1016/j.addr.2006.09.007; Danki L., 2010, INT J PHARM BIO SCI, V1, P1; Dashevsky A, 2004, EUR J PHARM BIOPHARM, V58, P45, DOI 10.1016/j.ejpb.2004.03.013; DAVIES NM, 1995, DIS COLON RECTUM, V38, P1311, DOI 10.1007/BF02049158; ERNI W, 1987, European Neurology, V27, P21, DOI 10.1159/000116171; Frank A, 2005, J CONTROL RELEASE, V102, P333, DOI 10.1016/j.jconrel.2004.10.019; Girotto C, 2009, SOL ENERG MAT SOL C, V93, P454, DOI 10.1016/j.solmat.2008.11.052; Girotto C, 2009, ORG ELECTRON, V10, P735, DOI 10.1016/j.orgel.2009.03.006; He W, 2011, INT J NANOMED, V6, P521, DOI 10.2147/IJN.S17282; Hwang SJ, 1998, CRIT REV THER DRUG, V15, P243; Joseph NJ, 2002, J CONTROL RELEASE, V79, P71, DOI 10.1016/S0168-3659(01)00507-7; Krishnamachari Y, 2007, INT J PHARM, V338, P238, DOI 10.1016/j.ijpharm.2007.02.015; Kumar A., 2011, PHARM GLOBALE IJCP, V3, P1, DOI DOI 10.7763/IJET.2011.V3.191; Lao LL, 2008, EUR J PHARM BIOPHARM, V70, P796, DOI 10.1016/j.ejpb.2008.05.024; Lee WL, 2013, J MATER CHEM B, V1, P1090, DOI 10.1039/c2tb00495j; Lee WL, 2012, J BIOMED MATER RES A, V100A, P3353, DOI 10.1002/jbm.a.34292; Lee WL, 2012, J PHARM SCI-US, V101, P2787, DOI 10.1002/jps.23191; Lee WL, 2011, J CONTROL RELEASE, V151, P229, DOI 10.1016/j.jconrel.2011.02.012; Liu YF, 2011, INT J PHARMACEUT, V413, P103, DOI 10.1016/j.ijpharm.2011.04.030; Ma NN, 2008, INT J PHARMACEUT, V358, P82, DOI 10.1016/j.ijpharm.2008.02.024; Meka L, 2008, AAPS PHARMSCITECH, V9, P612, DOI 10.1208/s12249-008-9090-4; Naha PC, 2008, J MICROENCAPSUL, V25, P248, DOI [10.1080/02652040801903843, 10.1080/02652040801903843 ]; Nayak A, 2011, MOL PHARMACEUT, V8, P2273, DOI 10.1021/mp2001395; Sastry, 2000, Pharm Sci Technol Today, V3, P138; Sato Y, 2004, J CONTROL RELEASE, V98, P75, DOI 10.1016/j.jconrel.2004.04.021; Sato Y, 2004, INT J PHARM, V275, P97, DOI 10.1016/j.ijpharm.2004.01.036; Sato Y, 2004, EUR J PHARM BIOPHARM, V57, P235, DOI 10.1016/s0939-6411(03)00185-1; Siepmann J, 2001, ADV DRUG DELIVER REV, V48, P139, DOI 10.1016/S0169-409X(01)00112-0; Singh A., 2008, WO Pat., Patent No. [WO/2008/062,440, 2008062440, WO/2008/062440]; Singh BN, 2000, J CONTROL RELEASE, V63, P235, DOI 10.1016/S0168-3659(99)00204-7; Streubel Alexander, 2006, Expert Opin Drug Deliv, V3, P217, DOI 10.1517/17425247.3.2.217; Tang YD, 2007, INT J PHARMACEUT, V336, P159, DOI 10.1016/j.ijpharm.2006.11.060; Van Speybroeck M, 2010, EUR J PHARM SCI, V41, P623, DOI 10.1016/j.ejps.2010.09.002; VERBEECK RK, 1986, J RHEUMATOL, V13, P789; Zhu T, 2010, J CLIN PHARMACOL, V50, P914, DOI 10.1177/0091270009354995	36	14	14	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114284	10.1371/journal.pone.0114284	http://dx.doi.org/10.1371/journal.pone.0114284			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470374	Green Published, gold			2022-12-26	WOS:000349128700096
J	McCrea, K; Ward, R; LaRosa, SP				McCrea, Keith; Ward, Robert; LaRosa, Steven P.			Removal of Carbapenem-Resistant Enterobacteriaceae (CRE) from Blood by Heparin-Functional Hemoperfusion Media	PLOS ONE			English	Article								Bloodstream infections due to Carbapenem-Resistant Enterobacteriaceae (CRE) are becoming more frequent and are associated with a high mortality. At present, combination antimicrobial therapy yields the best outcomes, but treatment options are limited. Many bacteria utilize heparan sulfate to bind to human cells. We studied the ability of a biomimetic device composed of polyethylene beads with endpoint-attached heparin to bind both sensitive and (CRE) E. coli and Klebsiella pneumoniae from spiked blood samples. Greater than 90% of susceptible, E. coli, CRE E. coli and CRE Klebsiella were removed by the beads. Future studies in human bacteremia with this technology are planned.	[McCrea, Keith; Ward, Robert] ExThera Med Corp, Berkeley, CA 94710 USA; [LaRosa, Steven P.] Beverly Hosp, Lahey Hlth Syst, Beverly, MA 01915 USA	Lahey Hospital & Medical Center	LaRosa, SP (corresponding author), Beverly Hosp, Lahey Hlth Syst, 85 Herrick St, Beverly, MA 01915 USA.	slarosamd@gmail.com			ExThera Medical Corporation; ExThera	ExThera Medical Corporation; ExThera	This work was funded by ExThera Medical Corporation. This study was funded by ExThera and two of the authors RW and KM are employees of ExThera. Author SPL is a paid consultant of Exthera. All three authors played an active role in study design, data collection, and analysis, decision to publish and the preparation of this manuscript.	Arnold RS, 2011, SOUTH MED J, V104, P40, DOI 10.1097/SMJ.0b013e3181fd7d5a; Bartlett AH, 2011, BIOL EXTRACELL MATR, P31, DOI 10.1007/978-3-642-16833-8_2; Ben-David D, 2012, CLIN MICROBIOL INFEC, V18, P54, DOI 10.1111/j.1469-0691.2011.03478.x; Falagas ME, 2014, ANTIMICROB AGENTS CH, V58, P654, DOI 10.1128/AAC.01222-13; Jacob JT, 2013, MMWR-MORBID MORTAL W, V62, P165; LARM O, 1983, BIOMATER ARTIF CELL, V11, P161, DOI 10.3109/10731198309118804; Mattsby-Baltzer I, 2011, J MICROBIOL BIOTECHN, V21, P659, DOI 10.4014/jmb.1102.02016; Neuner EA, 2011, DIAGN MICR INFEC DIS, V69, P357, DOI 10.1016/j.diagmicrobio.2010.10.013; Sahly H, 2008, ANTIMICROB AGENTS CH, V52, P3029, DOI 10.1128/AAC.00010-08	9	30	30	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e11424	10.1371/journal.pone.0114242	http://dx.doi.org/10.1371/journal.pone.0114242			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469782	Green Published, gold, Green Submitted			2022-12-26	WOS:000349128700091
J	Pauletto, M; Milan, M; de Sousa, JT; Huvet, A; Joaquim, S; Matias, D; Leitao, A; Patarnello, T; Bargelloni, L				Pauletto, Marianna; Milan, Massimo; de Sousa, Joana Teixeira; Huvet, Arnaud; Joaquim, Sandra; Matias, Domitilia; Leitao, Alexandra; Patarnello, Tomaso; Bargelloni, Luca			Insights into Molecular Features of Venerupis decussata Oocytes: A Microarray-Based Study	PLOS ONE			English	Article							INDUCED MEIOSIS REINITIATION; DEDUCED PRIMARY-STRUCTURE; BARNEA-CANDIDA MOLLUSCA; PLANAR CELL POLARITY; VITELLOGENIN VG GENE; MEIOTIC MATURATION; IN-VITRO; PATINOPECTEN-YESSOENSIS; FUNDULUS-HETEROCLITUS; POSSIBLE INVOLVEMENT	The production of Venerupis decussata relies on wild seed collection, which has been recently compromised due to recruitment failure and severe mortalities. To address this issue and provide an alternative source of seed, artificial spawning and larval rearing programs were developed. However, hatchery-based seed production is a relatively new industry and it is still underdeveloped. A major hurdle in the European clam seed production is the control of spawning and reproduction, which is further hindered by the impossibility of obtaining fertile gametes by gonadal "stripping'', as meiosis re-initiation is constrained to a maturation process along the genital ducts. In the present study, oocytes were collected from 15 females and microarray analyses was performed to investigate gene expression profiles characterizing released and stripped ovarian oocytes. A total of 198 differentially expressed transcripts between stripped and spawned oocytes were detected. Functional analysis carried out on these transcripts highlighted the importance of a few biological processes, which are most probably implicated in the control of oocyte competence. Significant differences were observed for transcripts encoding proteins involved in meiosis progression (e.g. dual specificity phosphatase CDC25), WNT signalling (e.g. frizzled class receptor 8, wingless-type MMTV integration site family member 4), steroid synthesis (e.g. progestin and adipoQ receptor family member 3, cytochrome P450-C17), mRNA processing (e.g. zinc finger protein XlCOF28), calcium regulation (e.g. regucalcin, calmodulin) and ceramide metabolism (ceramidase B, sphingomyelinase). This study provides new information on transcriptional profiles putatively associated with ovarian egg infertility, and suggests potential mechanisms regulating early oocyte development in clams. Genes which were differentially expressed between stripped and spawned oocytes might have a pivotal role during maturation process in the gonadal duct and could be interesting targets for further functional studies aiming to make ovarian oocytes fertilizable.	[Pauletto, Marianna; Milan, Massimo; Patarnello, Tomaso; Bargelloni, Luca] Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, Italy; [de Sousa, Joana Teixeira; Huvet, Arnaud] IFREMER, Lab Sci Environm Marin, Plouzane, France; [de Sousa, Joana Teixeira; Joaquim, Sandra; Matias, Domitilia; Leitao, Alexandra] IPMA, Olhao, Portugal; [Joaquim, Sandra; Matias, Domitilia] Univ Porto, CIIMAR, Interdisciplinary Ctr Marine & Environm Res, P-4100 Oporto, Portugal; [Leitao, Alexandra] Qatar Univ, Ctr Environm Studies, Doha, Qatar	University of Padua; Centre National de la Recherche Scientifique (CNRS); Ifremer; Institut de Recherche pour le Developpement (IRD); Instituto Portugues do Mar e da Atmosfera; Universidade do Porto; Qatar University	Pauletto, M (corresponding author), Univ Padua, Dept Comparat Biomed & Food Sci, Legnaro, Italy.	marianna.pauletto@unipd.it	Pauletto, Marianna/K-5518-2019; Quality, Aquaculture Seafood/AAD-7718-2019; Milan, Massimo/H-7428-2019; MILAN, MASSIMO/ABE-6936-2021	Pauletto, Marianna/0000-0002-2424-7484; MILAN, MASSIMO/0000-0003-0246-9008; Huvet, Arnaud/0000-0001-6912-881X; Leitao-BenHamadou, Alexandra/0000-0001-8903-3797; Joaquim, Sandra/0000-0002-6324-5908; PATARNELLO, Tomaso/0000-0003-1794-5791; Matias, Domitilia/0000-0002-2191-7497	EU [FP 7-KBBE-2009-1-2-11]	EU(European Commission)	Funding: This research was supported by the EU Project "Research to improve Production of SEED" (REPROSEED: FP 7-KBBE-2009-1-2-11) (http://www.reproseed.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDELMAJID H, 1993, INT J DEV BIOL, V37, P279; ALLEN RD, 1953, BIOL BULL, V105, P213, DOI 10.2307/1538639; ALPHEY L, 1992, CELL, V69, P977, DOI 10.1016/0092-8674(92)90616-K; Aoki K, 1997, FEBS LETT, V401, P109, DOI 10.1016/S0014-5793(96)01444-5; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Bosveld F, 2012, SCIENCE, V336, P724, DOI 10.1126/science.1221071; BRASSARD M, 1988, GAMETE RES, V20, P43, DOI 10.1002/mrd.1120200105; Buschiazzo J, 2011, BIOL REPROD, V85, P808, DOI 10.1095/biolreprod.110.090365; Castro A, 2000, BIOCHEM BIOPH RES CO, V276, P515, DOI 10.1006/bbrc.2000.3482; Cesari P., 1990, TAPES PHILIPPINARUM, P23; Cho YS, 2004, J BIOL CHEM, V279, P31514, DOI 10.1074/jbc.M401442200; Chu T, 2001, GENESIS, V29, P141, DOI 10.1002/gene.1017; CLAPHAM DE, 1995, CELL, V80, P259, DOI 10.1016/0092-8674(95)90408-5; Colas P, 1998, SEMIN CELL DEV BIOL, V9, P539, DOI 10.1006/scdb.1998.0248; Coll O, 2007, J LIPID RES, V48, P1924, DOI 10.1194/jlr.M700069-JLR200; Corporeau C, 2012, J PROTEOMICS, V75, P5554, DOI 10.1016/j.jprot.2012.07.040; Corporeau C, 2011, MAR BIOTECHNOL, V13, P971, DOI 10.1007/s10126-010-9361-4; Cuomo A, 2005, J EXP ZOOL PART A, V303A, P193, DOI 10.1002/jez.a.152; de Sousa JT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092202; DEGUCHI R, 1995, DEV BIOL, V171, P483, DOI 10.1006/dbio.1995.1298; DEGUCHI R, 1994, DEV BIOL, V166, P587, DOI 10.1006/dbio.1994.1339; Dheilly NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036353; DUBE F, 1988, DEV BIOL, V126, P233, DOI 10.1016/0012-1606(88)90134-0; DUBE F, 1982, DEV BIOL, V92, P408, DOI 10.1016/0012-1606(82)90186-5; Eichenlaub-Ritter U, 2002, HUM REPROD UPDATE, V8, P21, DOI 10.1093/humupd/8.1.21; Fabioux C, 2009, FEBS J, V276, P2566, DOI 10.1111/j.1742-4658.2009.06982.x; FAO, 2014, CULT AQ INF PROGR RU; Gaffre M, 2011, DEVELOPMENT, V138, P3735, DOI 10.1242/dev.063974; GOBET I, 1994, DEV BIOL, V164, P540, DOI 10.1006/dbio.1994.1222; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; GUERRIER P, 1993, DEV BIOL, V159, P474, DOI 10.1006/dbio.1993.1257; Guerrier P, 1996, INVERTEBR REPROD DEV, V30, P39, DOI 10.1080/07924259.1996.9672530; Guidugli KR, 2005, ARCH INSECT BIOCHEM, V59, P211, DOI 10.1002/arch.20061; Hall TMT, 2005, CURR OPIN STRUC BIOL, V15, P367, DOI 10.1016/j.sbi.2005.04.004; Hamida L, 2004, AQUACULTURE, V239, P413, DOI 10.1016/j.aquaculture.2004.05.010; Heikinheimo O, 1998, MOL HUM REPROD, V4, P745, DOI 10.1093/molehr/4.8.745; HIRAI S, 1988, J EXP ZOOL, V245, P318, DOI 10.1002/jez.1402450312; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huvet A, 2012, MAR BIOTECHNOL, V14, P402, DOI 10.1007/s10126-011-9421-4; Hwang DS, 2010, COMP BIOCHEM PHYS C, V151, P360, DOI 10.1016/j.cbpc.2009.12.010; Jeays-Ward K, 2004, DEV BIOL, V276, P431, DOI 10.1016/j.ydbio.2004.08.049; Jin F, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001147; Joaquim S, 2008, CULTIVO BIVALVES MAT; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Jones KT, 2004, MOL HUM REPROD, V10, P1, DOI 10.1093/molehr/gah009; JUNEJA R, 1994, CELL CALCIUM, V15, P1, DOI 10.1016/0143-4160(94)90099-X; KANUNGO J, 1990, J EXP ZOOL, V254, P313, DOI 10.1002/jez.1402540310; Kaymak E, 2013, J BIOL CHEM, V288, P30463, DOI 10.1074/jbc.M113.496547; Kemler R, 2004, DEVELOPMENT, V131, P5817, DOI 10.1242/dev.01458; Khananshvili D, 2014, PFLUG ARCH EUR J PHY, V466, P43, DOI 10.1007/s00424-013-1405-y; Kim J, 2010, J CELL SCI, V123, P993, DOI 10.1242/jcs.060442; KRANTIC S, 1991, DEV BIOL, V146, P491, DOI 10.1016/0012-1606(91)90250-7; LAFLEUR GJ, 1995, J MOL EVOL, V41, P505, DOI 10.1007/BF00160323; LaFleur GJ, 2005, BIOL REPROD, V73, P815, DOI 10.1095/biolreprod.105.041335; Lee KW, 2008, COMP BIOCHEM PHYS B, V150, P395, DOI 10.1016/j.cbpb.2008.04.009; Li Q, 1998, INVERTEBR REPROD DEV, V33, P1, DOI 10.1080/07924259.1998.9652337; Li Q, 1998, INVERTEBR REPROD DEV, V33, P87, DOI 10.1080/07924259.1998.9652345; Li ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001940; Lim J, 2005, GENESIS, V42, P150, DOI 10.1002/gene.20142; Lincoln AJ, 2002, NAT GENET, V30, P446, DOI 10.1038/ng856; Liu QH, 2009, IMMUNOBIOLOGY, V214, P257, DOI 10.1016/j.imbio.2008.10.003; Llera-Herrera R, 2014, AQUAC RES, V45, P448, DOI 10.1111/j.1365-2109.2012.03246.x; Longo FJ, 1983, MOLLUSCA, V3, P48; Machaty Z, 2002, BIOL REPROD, V67, P1133, DOI 10.1095/biolreprod67.4.1133; Matsumoto T, 2003, ZOOL SCI, V20, P37, DOI 10.2108/zsj.20.37; Matsumoto T, 1997, COMP BIOCHEM PHYS B, V118, P811, DOI 10.1016/S0305-0491(97)00233-2; Matsumoto T, 2008, COMP BIOCHEM PHYS A, V149, P293, DOI 10.1016/j.cbpa.2008.01.003; Miao YL, 2005, BIOL REPROD, V73, P1025, DOI 10.1095/biolreprod.105.043703; MILLAR JBA, 1991, EMBO J, V10, P4301, DOI 10.1002/j.1460-2075.1991.tb05008.x; Moreau M, 1996, ZYGOTE, V4, P151, DOI 10.1017/S0967199400003038; Morrill GA, 1998, BIOCHEM BIOPH RES CO, V246, P359, DOI 10.1006/bbrc.1998.8620; Mouchel N, 1996, GENE, V174, P59, DOI 10.1016/0378-1119(96)00336-8; Naillat F, 2010, HUM MOL GENET, V19, P1539, DOI 10.1093/hmg/ddq027; Nakagawa T, 2006, J CELL BIOCHEM, V99, P1064, DOI 10.1002/jcb.20863; Ni JB, 2012, COMP BIOCHEM PHYS B, V163, P246, DOI 10.1016/j.cbpb.2012.06.006; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Oh JS, 2010, J CELL BIOL, V188, P199, DOI 10.1083/jcb.200907161; Okazaki K, 1996, GENE, V178, P111, DOI 10.1016/0378-1119(96)00344-7; Okuno A, 2002, J EXP ZOOL, V292, P417, DOI 10.1002/jez.10083; Osada M, 2004, COMP BIOCHEM PHYS B, V139, P123, DOI 10.1016/j.cbpc.2004.07.002; Osada M, 2003, J EXP ZOOL PART A, V299A, P172, DOI 10.1002/jez.a.10276; OSADA M, 1992, NIPPON SUISAN GAKK, V58, P223; OSANAI K, 1985, Bulletin of the Marine Biological Station of Asamushi, V18, P1; OSANAI K, 1988, Bulletin of the Marine Biological Station of Asamushi, V18, P45; Perez GI, 2005, FASEB J, V19, P860, DOI 10.1096/fj.04-2903fje; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; PIPE RK, 1987, MAR BIOL, V95, P405, DOI 10.1007/BF00409571; Ray D, 2007, CANCER RES, V67, P6605, DOI 10.1158/0008-5472.CAN-06-4815; REISHENRIQUES MA, 1990, COMP BIOCHEM PHYS A, V95, P343, DOI 10.1016/0300-9629(90)90230-P; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Scott AP, 2013, STEROIDS, V78, P268, DOI 10.1016/j.steroids.2012.11.006; Solc P, 2008, DEV BIOL, V317, P260, DOI 10.1016/j.ydbio.2008.02.028; Song JL, 2005, DIFFERENTIATION, V73, P1, DOI 10.1111/j.1432-0436.2005.07301005.x; STRAUSFELD U, 1991, NATURE, V351, P242, DOI 10.1038/351242a0; STRUM JC, 1995, J BIOL CHEM, V270, P13541, DOI 10.1074/jbc.270.22.13541; Sun L, 2004, J CELL BIOL, V165, P63, DOI 10.1083/jcb.200309138; SUZUKI T, 1992, MAR BIOL, V113, P239; Swan A, 2007, DEVELOPMENT, V134, P891, DOI 10.1242/dev.02784; Tadjuidje E, 2011, DEV DYNAM, V240, P1727, DOI 10.1002/dvdy.22671; Timmins-Schiffman Emma, 2012, BMC Research Notes, V5, P502, DOI 10.1186/1756-0500-5-502; Tong Z, 2010, IMMUNOBIOLOGY, V215, P898, DOI 10.1016/j.imbio.2009.10.001; Tosti E, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-26; Trunnell NB, 2011, MOL CELL, V41, P263, DOI 10.1016/j.molcel.2011.01.012; Tsutsui N, 2000, ZOOL SCI, V17, P651, DOI 10.2108/zsj.15.651; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; van der Voet M, 2009, NAT CELL BIOL, V11, P269, DOI 10.1038/ncb1834; Varaksina GS, 1991, BIOL MORYA, V3, P61; Varaksina GS, 1992, BIOL MORYA MAR, V3, P77; Wang CD, 2003, INVERTEBR REPROD DEV, V44, P89, DOI 10.1080/07924259.2003.9652559; Wang C, 2007, COMP BIOCHEM PHYS B, V148, P303, DOI 10.1016/j.cbpb.2007.06.008; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Wassarman PM, 1996, J CELL SCI, V109, P2001; WASSERMAN WJ, 1981, J CELL BIOL, V89, P389, DOI 10.1083/jcb.89.3.389; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Wilkinson MF, 2001, BIOESSAYS, V23, P775, DOI 10.1002/bies.1113; Yamamoto TM, 2013, BBA-GENE REGUL MECH, V1829, P1034, DOI 10.1016/j.bbagrm.2013.06.001; Yang WL, 2014, THERIOGENOLOGY, V81, P535, DOI 10.1016/j.theriogenology.2013.11.005; Yin S, 2007, CELL CYCLE, V6, P2990, DOI 10.4161/cc.6.23.4993; Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang SC, 2005, FISH SHELLFISH IMMUN, V19, P93, DOI 10.1016/j.fsi.2004.10.008; Zhang SC, 2011, INT J BIOCHEM CELL B, V43, P303, DOI 10.1016/j.biocel.2010.11.003; Zheng HP, 2012, AQUACULTURE, V366, P46, DOI 10.1016/j.aquaculture.2012.08.031; Zheng P, 2006, MOL REPROD DEV, V73, P667, DOI 10.1002/mrd.20428	124	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113925	10.1371/journal.pone.0113925	http://dx.doi.org/10.1371/journal.pone.0113925			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470487	Green Published, Green Submitted, gold			2022-12-26	WOS:000349128700055
J	Popovic, M; Stefancic, H; Sluban, B; Novak, PK; Grcar, M; Mozetic, I; Puliga, M; Zlatic, V				Popovic, Marko; Stefancic, Hrvoje; Sluban, Borut; Novak, Petra Kralj; Grcar, Miha; Mozetic, Igor; Puliga, Michelangelo; Zlatic, Vinko			Extraction of Temporal Networks from Term Co-Occurrences in Online Textual Sources	PLOS ONE			English	Article								A stream of unstructured news can be a valuable source of hidden relations between different entities, such as financial institutions, countries, or persons. We present an approach to continuously collect online news, recognize relevant entities in them, and extract time-varying networks. The nodes of the network are the entities, and the links are their co-occurrences. We present a method to estimate the significance of co-occurrences, and a benchmark model against which their robustness is evaluated. The approach is applied to a large set of financial news, collected over a period of two years. The entities we consider are 50 countries which issue sovereign bonds, and which are insured by Credit Default Swaps (CDS) in turn. We compare the country co-occurrence networks to the CDS networks constructed from the correlations between the CDS. The results show relatively small, but significant overlap between the networks extracted from the news and those from the CDS correlations.	[Popovic, Marko; Stefancic, Hrvoje; Zlatic, Vinko] Rudjer Boskovic Inst, Div Theoret Phys, HR-10002 Zagreb, Croatia; [Stefancic, Hrvoje] Catholic Univ Croatia, Zagreb, Croatia; [Sluban, Borut; Novak, Petra Kralj; Grcar, Miha; Mozetic, Igor] Jozef Stefan Inst, Ljubljana, Slovenia; [Puliga, Michelangelo] IMT Alti Lucca, Lucca, Italy	Rudjer Boskovic Institute; Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; IMT School for Advanced Studies Lucca	Zlatic, V (corresponding author), Rudjer Boskovic Inst, Div Theoret Phys, POB 180, HR-10002 Zagreb, Croatia.	vinko.zlatic@irb.hr	Popovic, Marko/I-9838-2014; Zlatic, Vinko/H-9321-2012; puliga, michelangelo/AAS-9954-2020; Popovic, Marko/M-2895-2019; Novak, Petra Kralj/AAE-5852-2020; Zlatić, Vinko/AAW-2781-2020	Popovic, Marko/0000-0003-2360-3982; Zlatic, Vinko/0000-0001-7101-2154; Popovic, Marko/0000-0003-2360-3982; Mozetic, Igor/0000-0002-5466-0608; Kralj Novak, Petra/0000-0003-3385-6430	European Commission under the FP7 projects FOC) [255987]; MULTIPLEX (Foundational Research on MULTIlevel comPLEX networks and systems) [317532]; Slovenian Research Agency programme Knowledge Technologies [P2-103]	European Commission under the FP7 projects FOC); MULTIPLEX (Foundational Research on MULTIlevel comPLEX networks and systems); Slovenian Research Agency programme Knowledge Technologies	This work was supported in part by the European Commission under the FP7 projects FOC (Forecasting financial crises, grant no. 255987) and MULTIPLEX (Foundational Research on MULTIlevel comPLEX networks and systems, grant no. 317532), and by the Slovenian Research Agency programme Knowledge Technologies (grant no. P2-103). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizenman J, 2012, J INT MONEY FINANCE; [Anonymous], 2011, SCIENCE, DOI [DOI 10.21055/0370-1069-2020-1-51-60, DOI 10.1016/j.jocs.2010.12.007]; [Anonymous], 2010, SOCIAL EC NETWORKS; [Anonymous], 2008, 19 ACM C HYPERTEXT H; Apache, 2010, OPENNLP; Asur S., 2010, Proceedings 2010 IEEE/ACM International Conference on Web Intelligence-Intelligent Agent Technology (WI-IAT), P492, DOI 10.1109/WI-IAT.2010.63; BONACICH P, 1972, J MATH SOCIOL, V2, P113, DOI 10.1080/0022250X.1972.9989806; Caldarelli G, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.258702; Caldarelli G., 2007, SCALE FREE NETWORKS; Cattuto C, 2007, AI COMMUN, V20, P245; Cohen AM, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-103; Edmonds P, 1997, 35TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS AND THE 8TH CONFERENCE OF THE EUROPEAN CHAPTER OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P507; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Freilich S, 2010, NUCLEIC ACIDS RES, V38, P3857, DOI 10.1093/nar/gkq118; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD436, DOI 10.1093/nar/gkj003; Jursic M, 2010, J UNIVERS COMPUT SCI, V16, P1190; Kaushik R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061815; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Mane KK, 2004, P NATL ACAD SCI USA, V101, P5287, DOI 10.1073/pnas.0307626100; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Mishne G., 2006, AAAI SPRING S COMP A, P155; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Pan J, 2008, J FINANC, V63, P2345, DOI 10.1111/j.1540-6261.2008.01399.x; Popovic M, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.208701; RAGHAVAN VV, 1989, ACM T INFORM SYST, V7, P205, DOI 10.1145/65943.65945; Ruiz E. J., 2012, P 5 ACM INT C WEB SE, P513, DOI DOI 10.1145/2124295.2124358; SEIDMAN SB, 1983, SOC NETWORKS, V5, P269, DOI 10.1016/0378-8733(83)90028-X; Shalgi R, 2007, PLOS COMPUT BIOL, V3, P1291, DOI 10.1371/journal.pcbi.0030131; Sluban B, 2013, ACM INT C INF KNOWL; Tibely G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084133; Wilkinson DM, 2004, P NATL ACAD SCI USA, V101, P5241, DOI 10.1073/pnas.0307740100; Zlatic V, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.036118	33	4	4	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e99515	10.1371/journal.pone.0099515	http://dx.doi.org/10.1371/journal.pone.0099515			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470498	Green Submitted, Green Published, gold			2022-12-26	WOS:000349128700001
J	Chen, DY; Chen, YM; Tzang, BS; Lan, JL; Hsu, TC				Chen, Der-Yuan; Chen, Yi-Ming; Tzang, Bor-Show; Lan, Joung-Liang; Hsu, Tsai-Ching			Th17-Related Cytokines in Systemic Lupus Erythematosus Patients with Dilated Cardiomyopathies: A Possible Linkage to Parvovirus B19 Infection	PLOS ONE			English	Article							ACUTE VIRAL MYOCARDITIS; UNIQUE REGION PROTEIN; LEFT-VENTRICULAR DYSFUNCTION; NECROSIS-FACTOR-ALPHA; EFFECTOR T-CELLS; NONSTRUCTURAL PROTEIN; STRUCTURAL PROTEINS; HIGH PREVALENCE; TH17 CELLS; INTERLEUKIN-6	Dilated cardiomyopathies (DCM) are a major cause of mortality in patients with systemic lupus erythematosus (SLE). Immune responses induced by human parvovirus B19 (B19) are considered an important pathogenic mechanism in myocarditis or DCM. However, little is known about Th17-related cytokines in SLE patients with DCM about the linkage with B19 infection. IgM and IgG against B19 viral protein, and serum levels of Th17-related cytokines were determined using ELISA in eight SLE patients with DCM and six patients with valvular heart disease (VHD). Humoral responses of anti-B19-VP1u and anti-B19-NS1 antibody were assessed using Western blot and B19 DNA was detected by nested Polymerase Chain Reaction (PCR). Levels of interleukin (IL)-17, IL-6, IL-1 beta, and tumor necrosis factor (TNF)-alpha were significantly higher in SLE patients with DCM (mean +/- SEM, 390.99 +/- 125.48 pg/ml, 370.24 +/- 114.09 pg/ml, 36.01 +/- 16.90 pg/ml, and 183.84 +/- 82.94 pg/ml, respectively) compared to healthy controls (51.32 +/- 3.04 pg/ml, p<0.001; 36.88 +/- 6.64 pg/ml, p<0.001; 5.39 +/- 0.62 pg/ml, p<0.005; and 82.13 +/- 2.42 pg/ml, p<0.005, respectively). Levels of IL-17 and IL-6 were higher in SLE patients with DCM versus those with VHD (both p<0.01). Five (62.5%) of DCM patients had detectable anti-B19-NS1 IgG and four (50.0%) of them had anti-B19-VP1u IgG, whereas only one (16.7%) of VHD patients had detectable anti-B19-NS1 IgG and anti-B19-VP1u IgG. Serum levels of IL-17, IL-6 and IL-1 beta were markedly higher in SLE patients with anti-B19-VP1u IgG and anti-B19-NS1 IgG compared to those without anti-B19-VP1u IgG or anti-B19-NS1 IgG, respectively. These suggest a potential association of B19 with DCM and Th17-related cytokines implicated in the pathogenesis of DCM in SLE patients.	[Chen, Der-Yuan; Chen, Yi-Ming] Taichung Vet Gen Hosp, Dept Med Educ, Div Allergy Immunol & Rheumatol, Taichung, Taiwan; [Chen, Der-Yuan; Chen, Yi-Ming] Natl Yang Ming Univ, Fac Med, Taipei 112, Taiwan; [Chen, Der-Yuan; Chen, Yi-Ming] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Chen, Der-Yuan; Chen, Yi-Ming] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 40227, Taiwan; [Chen, Der-Yuan; Hsu, Tsai-Ching] Chung Shan Med Univ, Inst Microbiol & Immunol, Taichung, Taiwan; [Tzang, Bor-Show] Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan; [Tzang, Bor-Show] Chung Shan Med Univ, Sch Med, Dept Biochem, Taichung, Taiwan; [Tzang, Bor-Show; Hsu, Tsai-Ching] Chung Shan Med Univ, Immunol Res Ctr, Taichung, Taiwan; [Tzang, Bor-Show; Hsu, Tsai-Ching] Chung Shan Med Univ Hosp, Clin Lab, Taichung, Taiwan; [Lan, Joung-Liang] China Med Univ Hosp, Div Rheumatol & Immunol, Taichung, Taiwan; [Lan, Joung-Liang] China Med Univ, Coll Med, Taichung, Taiwan	Taichung Veterans General Hospital; National Yang Ming Chiao Tung University; National Chung Hsing University; National Chung Hsing University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University; Chung Shan Medical University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Tzang, BS (corresponding author), Chung Shan Med Univ, Inst Biochem & Biotechnol, Taichung, Taiwan.	bstzang@csmu.edu.tw; htc@csmu.edu.tw	Chen, Yi-Ming/AAV-3806-2021	Chen, Yi-Ming/0000-0001-7593-3065; Bor-Show, Tzang/0000-0003-0140-9943	National Science Council, Taiwan, Republic of China [NSC 97-2314-B040-009, NSC-98-2314-B040-008-MY3]	National Science Council, Taiwan, Republic of China(Ministry of Science and Technology, Taiwan)	This study was supported by the grants NSC 97-2314-B040-009 and NSC-98-2314-B040-008-MY3 from the National Science Council, Taiwan, Republic of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON S, 1995, VIROLOGY, V206, P626, DOI 10.1016/S0042-6822(95)80079-4; Andreoletti L, 2009, ARCH CARDIOVASC DIS, V102, P559, DOI 10.1016/j.acvd.2009.04.010; Baldeviano GC, 2010, CIRC RES, V106, P1646, DOI 10.1161/CIRCRESAHA.109.213157; Corcoran A, 2004, J MED MICROBIOL, V53, P459, DOI 10.1099/jmm.0.05485-0; Daniels MD, 2008, AUTOIMMUNITY, V41, P490, DOI 10.1080/08916930802167902; Dennert R, 2008, EUR HEART J, V29, P2073, DOI 10.1093/eurheartj/ehn296; Doria A, 2005, LUPUS, V14, P683, DOI 10.1191/0961203305lu2200oa; Dorsch S, 2002, J VIROL, V76, P2014, DOI 10.1128/JVI.76.4.2014-2018.2002; Escher F, 2008, MED SCI MONITOR, V14, pCR589; Fairweather D, 2005, REV MED VIROL, V15, P17, DOI 10.1002/rmv.445; Feldman AM, 2000, NEW ENGL J MED, V343, P1388, DOI 10.1056/NEJM200011093431908; Francis SE, 1998, J MOL CELL CARDIOL, V30, P215, DOI 10.1006/jmcc.1997.0592; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Hsu TC, 2006, CLIN EXP IMMUNOL, V144, P152, DOI 10.1111/j.1365-2249.2006.03023.x; HUBER SA, 1994, J VIROL, V68, P195, DOI 10.1128/JVI.68.1.195-206.1994; Kanda T, 2004, JPN HEART J, V45, P183, DOI 10.1536/jhj.45.183; Kerr JR, 2000, RHEUMATOLOGY, V39, P903, DOI 10.1093/rheumatology/39.8.903; Korn T, 2007, SEMIN IMMUNOL, V19, P362, DOI 10.1016/j.smim.2007.10.007; Kuhl U, 2008, J MED VIROL, V80, P1243, DOI 10.1002/jmv.21187; Kuhl U, 2005, CIRCULATION, V111, P887, DOI 10.1161/01.CIR.0000155616.07901.35; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leisi R, 2013, J VIROL, V87, P13161, DOI 10.1128/JVI.02548-13; Manger K, 2002, ANN RHEUM DIS, V61, P1065, DOI 10.1136/ard.61.12.1065; Mitchell LA, 2002, J MED VIROL, V67, P267, DOI 10.1002/jmv.2217; Moffatt S, 1996, J VIROL, V70, P8485, DOI 10.1128/JVI.70.12.8485-8491.1996; Musiani M, 2000, J MED VIROL, V60, P347, DOI 10.1002/(SICI)1096-9071(200003)60:3<347::AID-JMV15>3.0.CO;2-T; NEUMANN DA, 1993, CLIN IMMUNOL IMMUNOP, V68, P181, DOI 10.1006/clin.1993.1116; Noutsias M, 2003, INT J CARDIOL, V91, P153, DOI 10.1016/S0167-5273(03)00033-0; Omdal R, 2001, SCAND J RHEUMATOL, V30, P275; Pankuweit S, 2003, HUM PATHOL, V34, P497, DOI 10.1016/S0046-8177(03)00078-9; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Pauschinger M, 1999, CIRCULATION, V99, P1348, DOI 10.1161/01.CIR.99.10.1348; Satoh M, 1999, CIRCULATION, V99, P3260, DOI 10.1161/01.CIR.99.25.3260; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tschope C, 2005, CIRCULATION, V111, P879, DOI 10.1161/01.CIR.0000155615.68924.B3; Tzang BS, 2008, CLIN CHIM ACTA, V395, P77, DOI 10.1016/j.cca.2008.05.012; Tzang BS, 2011, MOL IMMUNOL, V48, P1518, DOI 10.1016/j.molimm.2011.04.013; Tzang BS, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-13; YAMADA T, 1994, CIRCULATION, V89, P846, DOI 10.1161/01.CIR.89.2.846; Young NS, 2004, NEW ENGL J MED, V350, P586, DOI 10.1056/NEJMra030840; Yuan J, 2010, J IMMUNOL, V185, P4004, DOI 10.4049/jimmunol.1001718; Yuan J, 2010, INT IMMUNOPHARMACOL, V10, P272, DOI 10.1016/j.intimp.2009.11.010; Yuan J, 2010, J CLIN IMMUNOL, V30, P226, DOI 10.1007/s10875-009-9355-z; Zadori Z, 2001, DEV CELL, V1, P291, DOI 10.1016/S1534-5807(01)00031-4; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	46	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113889	10.1371/journal.pone.0113889	http://dx.doi.org/10.1371/journal.pone.0113889			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462010	Green Submitted, gold, Green Published			2022-12-26	WOS:000345869700064
J	Rudin-Bitterli, TS; Tills, O; Spicer, JI; Culverhouse, PF; Wielhouwer, EM; Richardson, MK; Rundle, SD				Rudin-Bitterli, Tabitha S.; Tills, Oliver; Spicer, John I.; Culverhouse, Phil F.; Wielhouwer, Eric M.; Richardson, Michael K.; Rundle, Simon D.			Combining Motion Analysis and Microfluidics - A Novel Approach for Detecting Whole-Animal Responses to Test Substances	PLOS ONE			English	Article							ZEBRAFISH EMBRYOS; LARVAL ZEBRAFISH; BEHAVIOR; SYSTEM; DISEASE; QUALITY; ETHANOL; MODELS; SPERM	Small, early life stages, such as zebrafish embryos are increasingly used to assess the biological effects of chemical compounds in vivo. However, behavioural screens of such organisms are challenging in terms of both data collection (culture techniques, drug delivery and imaging) and data evaluation (very large data sets), restricting the use of high throughput systems compared to in vitro assays. Here, we combine the use of a microfluidic flow-through culture system, or BioWell plate, with a novel motion analysis technique, (sparse optic flow - SOF) followed by spectral analysis (discrete Fourier transformation - DFT), as a first step towards automating data extraction and analysis for such screenings. Replicate zebrafish embryos housed in a BioWell plate within a custom-built imaging system were subject to a chemical exposure (1.5% ethanol). Embryo movement was videoed before (30 min), during (60 min) and after (60 min) exposure and SOF was then used to extract data on movement (angles of rotation and angular changes to the centre of mass of embryos). DFT was subsequently used to quantify the movement patterns exhibited during these periods and Multidimensional Scaling and ANOSIM were used to test for differences. Motion analysis revealed that zebrafish had significantly altered movements during both the second half of the alcohol exposure period and also the second half of the recovery period compared to their pretreatment movements. Manual quantification of tail flicking revealed the same differences between exposure-periods as detected using the automated approach. However, the automated approach also incorporates other movements visible in the organism such as blood flow and heart beat, and has greater power to discern environmentally-driven changes in the behaviour and physiology of organisms. We suggest that combining these technologies could provide a highly efficient, high throughput assay, for assessing whole embryo responses to various drugs and chemicals.	[Rudin-Bitterli, Tabitha S.; Tills, Oliver; Spicer, John I.; Rundle, Simon D.] Univ Plymouth, Sch Marine Sci & Engn, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England; [Culverhouse, Phil F.] Univ Plymouth, Sch Comp & Math, Ctr Robot & Neural Syst, Plymouth PL4 8AA, Devon, England; [Wielhouwer, Eric M.; Richardson, Michael K.] Leiden Univ, Inst Biol, Sylvius Lab, Leiden, Netherlands; [Wielhouwer, Eric M.] Syntecnos, Leiden, Netherlands	University of Plymouth; University of Plymouth; Leiden University; Leiden University - Excl LUMC	Tills, O (corresponding author), Univ Plymouth, Sch Marine Sci & Engn, Marine Biol & Ecol Res Ctr, Plymouth PL4 8AA, Devon, England.	oliver.tills@plymouth.ac.uk		Tills, Oliver/0000-0001-8527-8383; Rudin-Bitterli, Tabitha/0000-0002-2779-714X; Culverhouse, Phil/0000-0002-7586-6496	Marine Institute at Plymouth University through the HEIF4 programme	Marine Institute at Plymouth University through the HEIF4 programme	The work was funded by the Marine Institute at Plymouth University through the HEIF4 programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad F, 2012, BEHAVIOUR, V149, P1241, DOI 10.1163/1568539X-00003020; Ali Shaukat, 2011, PLoS One, V6, pe20037, DOI 10.1371/journal.pone.0020037; Ali S, 2011, BIRTH DEFECTS RES C, V93, P115, DOI 10.1002/bdrc.20206; Amsler MO, 2006, MAR FRESHW BEHAV PHY, V39, P259, DOI 10.1080/10236240600980640; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 2010, MIN 16 STAT SOFTW; Bilotta J, 2002, NEUROTOXICOL TERATOL, V24, P759, DOI 10.1016/S0892-0362(02)00319-7; Brittijn SA, 2009, INT J DEV BIOL, V53, P835, DOI 10.1387/ijdb.082615sb; Champagne DL, 2010, BEHAV BRAIN RES, V214, P332, DOI 10.1016/j.bbr.2010.06.001; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; de Esch C, 2012, NEUROTOXICOL TERATOL, V34, P425, DOI 10.1016/j.ntt.2012.03.002; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Gerlai R, 2005, 5 INT C METH TECHN B; Gerlai R, 2010, MOLECULES, V15, P2609, DOI 10.3390/molecules15042609; Greer SP, 2006, BIOFOULING, V22, P125, DOI 10.1080/08927010600602082; Hicks C, 2006, J NEUROBIOL, V66, P977, DOI 10.1002/neu.20290; Iken K, 2003, BIOFOULING, V19, P327, DOI 10.1080/08927010310001612045; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kokel D, 2012, TRENDS BIOTECHNOL, V30, P421, DOI 10.1016/j.tibtech.2012.05.001; Larsen L, 2000, HUM REPROD, V15, P1562, DOI 10.1093/humrep/15.7.1562; Lieschke GJ, 2007, NAT REV GENET, V8, P353, DOI 10.1038/nrg2091; Liu QH, 2007, AQUACULTURE, V263, P20, DOI 10.1016/j.aquaculture.2006.11.017; Lockwood B, 2004, PHARMACOL BIOCHEM BE, V77, P647, DOI 10.1016/j.pbb.2004.01.003; Lucas B. D., 1981, IJCAI, P121, DOI DOI 10.5555/1623264.1623280; MacPhail RC, 2009, NEUROTOXICOLOGY, V30, P52, DOI 10.1016/j.neuro.2008.09.011; Noldus LPJJ, 2001, BEHAV RES METH INS C, V33, P398, DOI 10.3758/BF03195394; Pardo-Martin C, 2010, NAT METHODS, V7, P634, DOI [10.1038/NMETH.1481, 10.1038/nmeth.1481]; Parng C, 2002, ASSAY DRUG DEV TECHN, V1, P41, DOI 10.1089/154065802761001293; Parng Chuenlei, 2007, Journal of Pharmacological and Toxicological Methods, V55, P103, DOI 10.1016/j.vascn.2006.04.004; Peng HC, 2008, BIOINFORMATICS, V24, P1827, DOI 10.1093/bioinformatics/btn346; Press William H., 1989, ART SCI COMPUTING, P494; Puttonen HAJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00102; Senst T, 2010, LECT NOTES COMPUT SC, V6111, P240, DOI 10.1007/978-3-642-13772-3_25; Suzuki T, 2002, INT J ANDROL, V25, P49, DOI 10.1046/j.1365-2605.2002.00324.x; Tills O, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-37; Wielhouwer EM, 2011, LAB CHIP, V11, P1815, DOI 10.1039/c0lc00443j; Williams LR, 2012, COMP BIOCHEM PHYS C, V155, P33, DOI 10.1016/j.cbpc.2011.02.010	37	8	9	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113235	10.1371/journal.pone.0113235	http://dx.doi.org/10.1371/journal.pone.0113235			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464030	gold, Green Published, Green Submitted			2022-12-26	WOS:000345869700032
J	Santos, M; Domingues, SC; Costa, P; Muller, T; Galozzi, S; Marcus, K; Silva, EFDE; Silva, OADE; Rebelo, S				Santos, Mariana; Domingues, Sara C.; Costa, Patricia; Muller, Thorsten; Galozzi, Sara; Marcus, Katrin; da Cruz e Silva, Edgar F.; da Cruz e Silva, Odete A.; Rebelo, Sandra			Identification of a Novel Human LAP1 Isoform That Is Regulated by Protein Phosphorylation	PLOS ONE			English	Article							INTEGRAL MEMBRANE-PROTEINS; AMYLOID PRECURSOR PROTEIN; INNER NUCLEAR-MEMBRANE; ALTERNATIVE PROMOTERS; MUSCULAR-DYSTROPHY; TORSINA; LAMINA; EXPRESSION; COMPLEX; INTERACTS	Lamina associated polypeptide 1 (LAP1) is an integral protein of the inner nuclear membrane that is ubiquitously expressed. LAP1 binds to lamins and chromatin, probably contributing to the maintenance of the nuclear envelope architecture. Moreover, LAP1 also interacts with torsinA and emerin, proteins involved in DYT1 dystonia and X-linked Emery-Dreifuss muscular dystrophy disorder, respectively. Given its relevance to human pathological conditions, it is important to better understand the functional diversity of LAP1 proteins. In rat, the LAP1 gene (TOR1AIP1) undergoes alternative splicing to originate three LAP1 isoforms (LAP1A, B and C). However, it remains unclear if the same occurs with the human TOR1AIP1 gene, since only the LAP1B isoform had thus far been identified in human cells. In silico analysis suggested that, across different species, potential new LAP1 isoforms could be generated by alternative splicing. Using shRNA to induce LAP1 knockdown and HPLC-mass spectrometry analysis the presence of two isoforms in human cells was described and validated: LAP1B and LAP1C; the latter is putatively N-terminal truncated. LAP1B and LAP1C expression profiles appear to be dependent on the specific tissues analyzed and in cultured cells LAP1C was the major isoform detected. Moreover, LAP1B and LAP1C expression increased during neuronal maturation, suggesting that LAP1 is relevant in this process. Both isoforms were found to be post-translationallymodified by phosphorylation and methionine oxidation and two LAP1B/LAP1C residues were shown to be dephosphorylated by PP1. This study permitted the identification of the novel human LAP1C isoform and partially unraveled the molecular basis of LAP1 regulation.	[Santos, Mariana; Domingues, Sara C.; Costa, Patricia; da Cruz e Silva, Edgar F.; da Cruz e Silva, Odete A.; Rebelo, Sandra] Univ Aveiro, SACS, Ctr Biol Celular, Lab Neurociencias & Sinalizacao, P-3800 Aveiro, Portugal; [Muller, Thorsten; Galozzi, Sara; Marcus, Katrin] Ruhr Univ Bochum, Med Proteome Ctr, Dept Funct Prote, Bochum, Germany	Universidade de Aveiro; Ruhr University Bochum	Rebelo, S (corresponding author), Univ Aveiro, SACS, Ctr Biol Celular, Lab Neurociencias & Sinalizacao, P-3800 Aveiro, Portugal.	srebelo@ua.pt	Müller, Thorsten/AAX-1652-2021; da Cruz e Silva, Odete A B/F-4072-2010; Rebelo, S/B-8973-2008; Rebelo, Sandra/Q-2215-2019; Cruz e Silva, Odete/AAH-5595-2020; Santos, Mariana/AAO-2021-2020	da Cruz e Silva, Odete A B/0000-0003-3718-9874; Rebelo, S/0000-0002-5862-5797; Rebelo, Sandra/0000-0002-5862-5797; Santos, Mariana/0000-0002-2343-2215	Fundacao para a Ciencia e Tecnologia of the Portuguese Ministry of Science and Technology (Centro de Biologia Celular, Universidade de Aveiro) [PEst-OE/SAU/UI0482/2014-, PTDC/QUI-BIQ/101317/2008, PTDC/BEX-BCM/0493/2012]; FCT [SFRH/BD/65353/2009]	Fundacao para a Ciencia e Tecnologia of the Portuguese Ministry of Science and Technology (Centro de Biologia Celular, Universidade de Aveiro); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	The authors thank Dr. William Dauer (Columbia University, USA) for providing the LAP1 antibody and Dr. Celso Cunha (Instituto de Higiene e Medicina Tropical, Lisbon) for supplying the pSIREN-RetroQ vector. The authors also thank Liliana Carvalho for her assistance in sequencing analysis. This work was financed by the Fundacao para a Ciencia e Tecnologia of the Portuguese Ministry of Science and Technology (PEst-OE/SAU/UI0482/2014- the Centro de Biologia Celular, Universidade de Aveiro but also made viable by PTDC/QUI-BIQ/101317/2008 and PTDC/BEX-BCM/0493/2012). MS was recipient of a FCT fellowship (SFRH/BD/65353/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu RD, 2009, MOL BIOSYST, V5, P1512, DOI 10.1039/b908315d; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; BIONE S, 1994, NAT GENET, V8, P323, DOI 10.1038/ng1294-323; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Casaca Ana, 2011, Open Virol J, V5, P12, DOI 10.2174/1874357901105010012; Charron M, 1998, P NATL ACAD SCI USA, V95, P14805, DOI 10.1073/pnas.95.25.14805; COHEN P, 1989, ANNU REV BIOCHEM, V58, P453, DOI 10.1146/annurev.bi.58.070189.002321; Espona-Fiedler M, 2012, BIOCHEM PHARMACOL, V83, P489, DOI 10.1016/j.bcp.2011.11.027; Fardilha M, 2010, CURR MED CHEM, V17, P3996, DOI 10.2174/092986710793205363; FOISNER R, 1993, CELL, V73, P1267, DOI 10.1016/0092-8674(93)90355-T; GERACE L, 1988, ANNU REV CELL BIOL, V4, P335, DOI 10.1146/annurev.cb.04.110188.002003; Gerace L, 2012, J STRUCT BIOL, V177, P24, DOI 10.1016/j.jsb.2011.11.007; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Goodchild RE, 2005, J CELL BIOL, V168, P855, DOI 10.1083/jcb.200411026; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; Han BG, 2003, ONCOGENE, V22, P5325, DOI 10.1038/sj.onc.1206783; Henriques AG, 2007, J ALZHEIMERS DIS, V11, P85; Kayman-Kurekci G, 2014, NEUROMUSCULAR DISORD, V24, P624, DOI 10.1016/j.nmd.2014.04.007; Kim CE, 2010, P NATL ACAD SCI USA, V107, P9861, DOI 10.1073/pnas.0912877107; Kim G, 2013, BIOCH BIOPHYS ACTA; KLEIN D, 1995, BIOCHEM MOL BIOL INT, V36, P59; Kondo Y, 2002, BIOCHEM BIOPH RES CO, V294, P770, DOI 10.1016/S0006-291X(02)00563-6; Korrodi-Gregorio L, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-15; Landry CR, 2009, TRENDS GENET, V25, P193, DOI 10.1016/j.tig.2009.03.003; Landry JR, 2003, TRENDS GENET, V19, P640, DOI 10.1016/j.tig.2003.09.014; Maison C, 1997, EMBO J, V16, P4839, DOI 10.1093/emboj/16.16.4839; MARTIN L, 1995, J BIOL CHEM, V270, P8822, DOI 10.1074/jbc.270.15.8822; Meshorer E, 2004, J BIOL CHEM, V279, P29740, DOI 10.1074/jbc.M402752200; Naismith TV, 2004, P NATL ACAD SCI USA, V101, P7612, DOI 10.1073/pnas.0308760101; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Rebelo S, 2004, J NEUROSCI RES, V76, P406, DOI 10.1002/jnr.20091; Rebelo S, 2007, NEURODEGENER DIS, V4, P78, DOI 10.1159/000101831; Rebelo S, 2013, J ALZHEIMERS DIS, V35, P761, DOI 10.3233/JAD-130095; Rebelo S, 2008, AM J ALZHEIMERS DIS, V23, P602, DOI 10.1177/1533317508323572; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; ROCHA JF, 2012, MICROSC MICROANAL S5, V18, P57, DOI DOI 10.1017/S1431927612012949; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Santos MA, 2014, MOL BIOL CELL, V25; Santos M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076788; Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176; SENIOR A, 1988, J CELL BIOL, V107, P2029, DOI 10.1083/jcb.107.6.2029; Shin JY, 2013, DEV CELL, V26, P591, DOI 10.1016/j.devcel.2013.08.012; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; SILVA EFDE, 1995, J NEUROSCI, V15, P3375; Solovyev V, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P294; Tadokoro K, 2005, J HUM GENET, V50, P382, DOI 10.1007/s10038-005-0261-9; Trinklein ND, 2003, GENOME RES, V13, P308, DOI 10.1101/gr.794803; Tsai KW, 2007, MOL CELL BIOL, V27, P5835, DOI 10.1128/MCB.00363-07; Vieira SI, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-40; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Xin DD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002377; Zhang SXL, 2007, PHYSIOL GENOMICS, V32, P95, DOI 10.1152/physiolgenomics.00192.2007	56	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113732	10.1371/journal.pone.0113732	http://dx.doi.org/10.1371/journal.pone.0113732			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461922	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700044
J	Aharon, R; Janes, PW; Burgess, AW; Hamza, K; Klebaner, F; Lackmann, M				Aharon, Rotem; Janes, Peter W.; Burgess, Anthony W.; Hamza, Kais; Klebaner, Fima; Lackmann, Martin			A Mathematical Model for Eph/Ephrin-Directed Segregation of Intermingled Cells	PLOS ONE			English	Article							EPH RECEPTOR FUNCTION; DIFFERENTIAL ADHESION; NEURAL MAP; E-CADHERIN; MOTILITY; EPHRINS; MIGRATION; CANCER; POPULATIONS; ACTIVATION	Eph receptors, the largest family of receptor tyrosine kinases, control cell-cell adhesion/de-adhesion, cell morphology and cell positioning through interaction with cell surface ephrin ligands. Bi-directional signalling from the Eph and ephrin complexes on interacting cells have a significant role in controlling normal tissue development and oncogenic tissue patterning. Eph-mediated tissue patterning is based on the fine-tuned balance of adhesion and de-adhesion reactions between distinct Eph- and ephrin-expressing cell populations, and adhesion within like populations (expressing either Eph or ephrin). Here we develop a stochastic, Lagrangian model that is based on Eph/ephrin biology: incorporating independent Brownian motion to describe cell movement and a deterministic term (the drift term) to represent repulsive and adhesive interactions between neighbouring cells. Comparison between the experimental and computer simulated Eph/ephrin cell patterning events shows that the model recapitulates the dynamics of cell-cell segregation and cell cluster formation. Moreover, by modulating the term for Eph/ephrin-mediated repulsion, the model can be tuned to match the actual behaviour of cells with different levels of Eph expression or activity. Together the results of our experiments and modelling suggest that the complexity of Eph/ephrin signalling mechanisms that control cell-cell interactions can be described well by a mathematical model with a single term balancing adhesion and de-adhesion between interacting cells. This model allows reliable prediction of Eph/ephrindependent control of cell patterning behaviour.	[Aharon, Rotem; Hamza, Kais; Klebaner, Fima] Monash Univ, Sch Math Sci, Clayton, Vic, Australia; [Janes, Peter W.; Lackmann, Martin] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Burgess, Anthony W.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Struct Biol Div, Parkville, Vic 3050, Australia	Monash University; Monash University; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Aharon, R (corresponding author), Monash Univ, Sch Math Sci, Clayton, Vic, Australia.	rotem.aharon@monash.edu; peter.janes@monash.edu	Klebaner, Fima C/G-2556-2010	Klebaner, Fima C/0000-0001-8044-9761; Hamza, Kais/0000-0001-9444-3600; Janes, Peter/0000-0002-9039-1097	Australian Research Council [1201022728]; Human Frontiers in Science Program [RGP0039/2009-C]; National Health and Medical Research Council of Australia [487922, 1003908]	Australian Research Council(Australian Research Council); Human Frontiers in Science Program(Human Frontier Science Program); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funding: This study was funded by the Australian Research Council #1201022728, www.arc.gov.au; Human Frontiers in Science Program #RGP0039/2009-C, www.hfsp.org to ML; National Health and Medical Research Council of Australia #487922 and #1003908, www.nhmrc.gov.au to ML. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt W, 1999, MATH BIOSCI, V156, P207, DOI 10.1016/S0025-5564(98)10067-6; Baker RE, 2010, B MATH BIOL, V72, P719, DOI 10.1007/s11538-009-9467-x; Batlle E, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008227; Bindschadler M, 2004, BIOPHYS J, V86, P2720, DOI 10.1016/S0006-3495(04)74326-X; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; Carter N, 2002, NAT CELL BIOL, V4, P565, DOI 10.1038/ncb823; Cooke JE, 2005, CURR BIOL, V15, P536, DOI 10.1016/j.cub.2005.02.019; Deroulers C, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.031917; DICKINSON RB, 1993, J MATH BIOL, V31, P563, DOI 10.1007/BF00161199; Fernando AE, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.011903; Flanagan JG, 2006, CURR OPIN NEUROBIOL, V16, P59, DOI 10.1016/j.conb.2006.01.010; Gatenby RA, 1996, CANCER RES, V56, P5745; Genander M, 2010, CURR OPIN CELL BIOL, V22, P611, DOI 10.1016/j.ceb.2010.08.005; Genander M, 2009, CELL, V139, P679, DOI 10.1016/j.cell.2009.08.048; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; Gracheva ME, 2004, B MATH BIOL, V66, P167, DOI 10.1016/j.bulm.2003.08.007; Huynh-Do U, 1999, EMBO J, V18, P2165, DOI 10.1093/emboj/18.8.2165; Ionides EL, 2004, J MATH BIOL, V48, P23, DOI 10.1007/s00285-003-0220-z; Janes PW, 2012, SEMIN CELL DEV BIOL, V23, P43, DOI 10.1016/j.semcdb.2012.01.001; Janes PW, 2011, J CELL BIOL, V195, P1033, DOI 10.1083/jcb.201104037; Janes PW, 2008, CURR CANCER DRUG TAR, V8, P473, DOI 10.2174/156800908785699315; Jorgensen C, 2009, SCIENCE, V326, P1502, DOI 10.1126/science.1176615; KELLER EF, 1971, J THEOR BIOL, V30, P225, DOI 10.1016/0022-5193(71)90050-6; Klein R, 2012, DEVELOPMENT, V139, P4105, DOI 10.1242/dev.074997; Lawrenson ID, 2002, J CELL SCI, V115, P1059; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Miao H, 2005, J BIOL CHEM, V280, P923, DOI 10.1074/jbc.M411383200; Mogilner A, 2009, J MATH BIOL, V58, P105, DOI 10.1007/s00285-008-0182-2; Nievergall E, 2012, CELL MOL LIFE SCI, V69, P1813, DOI 10.1007/s00018-011-0900-6; Nievergall E, 2010, J CELL BIOL, V191, P1189, DOI 10.1083/jcb.201005035; Orsulic S, 2000, J CELL SCI, V113, P1793; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Poliakov A, 2008, J CELL BIOL, V183, P933, DOI 10.1083/jcb.200807151; Reber M, 2004, NATURE, V431, P847, DOI 10.1038/nature02957; Salaita K, 2010, SCIENCE, V327, P1380, DOI 10.1126/science.1181729; Shao DY, 2012, P NATL ACAD SCI USA, V109, P6851, DOI 10.1073/pnas.1203252109; Shaw G, 2002, FASEB J; Simpson MJ, 2010, PHYSICA A, V389, P1412, DOI 10.1016/j.physa.2009.12.010; Solanas G, 2011, NAT CELL BIOL, V13, P1100, DOI 10.1038/ncb2298; Steinberg MS, 2007, CURR OPIN GENET DEV, V17, P281, DOI 10.1016/j.gde.2007.05.002; Taylor W, 2011, J BIOINF COMPUT BIOL, V9, P91, DOI 10.1142/S0219720011005318; Taylor WR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043226; Tognolini M, 2014, DRUG DISCOV TODAY, V19, P661, DOI 10.1016/j.drudis.2013.11.017; Triplett JW, 2012, SEMIN CELL DEV BIOL, V23, P7, DOI 10.1016/j.semcdb.2011.10.026; Wimmer-Kleikamp SH, 2008, BLOOD, V112, P721, DOI 10.1182/blood-2007-11-121681; Wong SY, 2010, J R SOC INTERFACE, V7, pS351, DOI 10.1098/rsif.2010.0018.focus; Xu QL, 2000, PHILOS T ROY SOC B, V355, P993, DOI 10.1098/rstb.2000.0635	47	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e111803	10.1371/journal.pone.0111803	http://dx.doi.org/10.1371/journal.pone.0111803			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436892	Green Published, gold			2022-12-26	WOS:000347114900009
J	Ferguson, DJP; Balaban, AE; Patzewitz, EM; Wall, RJ; Hopp, CS; Poulin, B; Mohmmed, A; Malhotra, P; Coppi, A; Sinnis, P; Tewari, R				Ferguson, David J. P.; Balaban, Amanda E.; Patzewitz, Eva-Maria; Wall, Richard J.; Hopp, Christine S.; Poulin, Benoit; Mohmmed, Asif; Malhotra, Pawan; Coppi, Alida; Sinnis, Photini; Tewari, Rita			The Repeat Region of the Circumsporozoite Protein is Critical for Sporozoite Formation and Maturation in Plasmodium	PLOS ONE			English	Article							MALARIA PARASITE; SPOROGONIC DEVELOPMENT; SALIVARY-GLANDS; FALCIPARUM; BERGHEI; VACCINE; CELL; INFECTIVITY; MOTILITY; EFFICACY	The circumsporozoite protein (CSP) is the major surface protein of the sporozoite stage of malaria parasites and has multiple functions as the parasite develops and then migrates from the mosquito midgut to the mammalian liver. The overall structure of CSP is conserved among Plasmodium species, consisting of a species-specific central tandem repeat region flanked by two conserved domains: the NH2-terminus and the thrombospondin repeat (TSR) at the COOH-terminus. Although the central repeat region is an immunodominant B-cell epitope and the basis of the only candidate malaria vaccine in Phase III clinical trials, little is known about its functional role(s). We used the rodent malaria model Plasmodium berghei to investigate the role of the CSP tandem repeat region during sporozoite development. Here we describe two mutant parasite lines, one lacking the tandem repeat region (Delta Rep) and the other lacking the NH2-terminus as well as the repeat region (Delta N Delta Rep). We show that in both mutant lines oocyst formation is unaffected but sporozoite development is defective.	[Ferguson, David J. P.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Lab Sci, Oxford OX3 9DU, England; [Balaban, Amanda E.; Hopp, Christine S.; Coppi, Alida; Sinnis, Photini] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA; [Patzewitz, Eva-Maria; Wall, Richard J.; Poulin, Benoit; Tewari, Rita] Univ Nottingham, Queens Med Ctr, Sch Life Sci, Ctr Genet & Genom, Nottingham NG2 7UH, England; [Mohmmed, Asif; Malhotra, Pawan] Int Ctr Genet Engn & Biotechnol, New Delhi 110067, India	University of Oxford; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Nottingham; Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi	Sinnis, P (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA.	psinnis@jhsph.edu; rita.tewari@nottingham.ac.uk		Ferguson, David/0000-0001-5045-819X; Hopp, Christine/0000-0002-0528-9531; Wall, Richard J./0000-0003-3487-3187; Tewari, Rita/0000-0003-3943-1847	MRC [G0900109, G0900278, MR/K011782/1]; Wellcome Trust Equipment Grant; NIH [R01AI056840, T32AI107417]; Johns Hopkins Malaria Institute; Medical Research Council [G0900278, MR/K011782/1]; Department of Biotechnology (DBT) [BT/o1/CEIB/11/V/01, BT/PR5267/Med/15/87/2012]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007417, R01AI056840] Funding Source: NIH RePORTER; Medical Research Council [G0900109] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Equipment Grant(Wellcome Trust); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Johns Hopkins Malaria Institute; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work in RT laboratory is funded by MRC Investigator Award and project grants [G0900109, G0900278, MR/K011782/1]; DJPF is funded by a Wellcome Trust Equipment Grant [http://www.wellcome.ac.uk/. PS is funded by NIH R01AI056840 and AB is supported by NIH T32AI107417 [http://www.nih.gov/]. CH was supported by a fellowship from the Johns Hopkins Malaria Institute [http://www.jhsph.edu/]. EMP, BP and RJW were funded under a Medical Research Council grant [http:/www.mrc.ac.uk/] to RT (G0900278, MR/K011782/1). PM and AM were trained in parasite genetic manipulation technique under a European Commission, Director General XII INCO-DC programme. PM and AM also acknowledge the financial support provided by Department of Biotechnology (DBT) under (BT/o1/CEIB/11/V/01 and BT/PR5267/Med/15/87/2012) [http://dbtindia.nic.in/index.asp]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032524; Aly ASI, 2009, ANNU REV MICROBIOL, V63, P195, DOI 10.1146/annurev.micro.091208.073403; Aly ASI, 2005, J EXP MED, V202, P225, DOI 10.1084/jem.20050545; Bejon P, 2013, LANCET INFECT DIS, V13, P319, DOI 10.1016/S1473-3099(13)70005-7; Coppi A, 2005, J EXP MED, V201, P27, DOI 10.1084/jem.20040989; Coppi A, 2007, CELL HOST MICROBE, V2, P316, DOI 10.1016/j.chom.2007.10.002; Coppi A, 2011, J EXP MED, V208, P341, DOI 10.1084/jem.20101488; DAME JB, 1984, SCIENCE, V225, P593, DOI 10.1126/science.6204383; Espinosa DA, 2013, INFECT IMMUN, V81, P2882, DOI 10.1128/IAI.00461-13; GODSON GN, 1983, NATURE, V305, P29, DOI 10.1038/305029a0; Guttery DS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002948; Janse CJ, 2006, MOL BIOCHEM PARASIT, V145, P60, DOI 10.1016/j.molbiopara.2005.09.007; KLAR A, 1992, CELL, V69, P95, DOI 10.1016/0092-8674(92)90121-R; LEUNGHAGESTEIJN CY, 1992, CELL, V71, P289, DOI 10.1016/0092-8674(92)90357-I; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; McCutchan TF, 1996, P NATL ACAD SCI USA, V93, P11889, DOI 10.1073/pnas.93.21.11889; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; NUSSENZWEIG RS, 1967, NATURE, V216, P160, DOI 10.1038/216160a0; Persson C, 2002, J IMMUNOL, V169, P6681, DOI 10.4049/jimmunol.169.12.6681; Proto WR, 2013, NAT REV MICROBIOL, V11, P58, DOI 10.1038/nrmicro2929; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; Sidjanski SP, 1997, MOL BIOCHEM PARASIT, V90, P33, DOI 10.1016/S0166-6851(97)00124-2; SINDEN RE, 1978, T ROY SOC TROP MED H, V72, P477, DOI 10.1016/0035-9203(78)90167-0; SINDEN RE, 1973, T ROY SOC TROP MED H, V67, P631, DOI 10.1016/0035-9203(73)90031-X; Sinnis P, 2002, CHEM IMMUNOL, V80, P70; Tewari R, 2005, CELL MICROBIOL, V7, P699, DOI 10.1111/j.1462-5822.2005.00503.x; Tewari R, 2002, J BIOL CHEM, V277, P47613, DOI 10.1074/jbc.M208453200; Thathy V, 2002, EMBO J, V21, P1586, DOI 10.1093/emboj/21.7.1586; Tucker RP, 2004, INT J BIOCHEM CELL B, V36, P969, DOI 10.1016/j.biocel.2003.12.011; VANDERBE.J, 1967, J CELL BIOL, V32, pC7, DOI 10.1083/jcb.32.3.C7; Wang Q, 2005, CELL MICROBIOL, V7, P1616, DOI 10.1111/j.1462-5822.2005.00579.x; Wang Q, 2005, PLOS PATHOG, V1, P72, DOI 10.1371/journal.ppat.0010009; WHO, 2013, WORLD MALARIA REPORT 2013, P1; YOSHIDA N, 1980, SCIENCE, V207, P71, DOI 10.1126/science.6985745	35	30	31	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113923	10.1371/journal.pone.0113923	http://dx.doi.org/10.1371/journal.pone.0113923			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438048	gold, Green Published, Green Submitted			2022-12-26	WOS:000347114900095
J	Heyland, A; Hodin, J; Bishop, C				Heyland, Andreas; Hodin, Jason; Bishop, Cory			Manipulation of Developing Juvenile Structures in Purple Sea Urchins (Strongylocentrotus purpuratus) by Morpholino Injection into Late Stage Larvae	PLOS ONE			English	Article							LIFE-HISTORY EVOLUTION; CONNECTIVE-TISSUE; ECHINODERMATA; CLONING	Sea urchins have been used as experimental organisms for developmental biology for over a century. Yet, as is the case for many other marine invertebrates, understanding the development of the juveniles and adults has lagged far behind that of their embryos and larvae. The reasons for this are, in large part, due to the difficulty of experimentally manipulating juvenile development. Here we develop and validate a technique for injecting compounds into juvenile rudiments of the purple sea urchin, Strongylocentrotus purpuratus. We first document the distribution of rhodaminated dextran injected into different compartments of the juvenile rudiment of sea urchin larvae. Then, to test the potential of this technique to manipulate development, we injected Vivo-Morpholinos (vMOs) designed to knock down p58b and p16, two proteins involved in the elongation of S. purpuratus larval skeleton. Rudiments injected with these vMOs showed a delay in the growth of some juvenile skeletal elements relative to controls. These data provide the first evidence that vMOs, which are designed to cross cell membranes, can be used to transiently manipulate gene function in later developmental stages in sea urchins. We therefore propose that injection of vMOs into juvenile rudiments, as shown here, is a viable approach to testing hypotheses about gene function during development, including metamorphosis.	[Heyland, Andreas] Univ Guelph, Guelph, ON N1G 2W1, Canada; [Hodin, Jason] Stanford Univ, Hopkins Marine Stn, Pacific Grove, CA 93950 USA; [Bishop, Cory] St Francis Xavier Univ, Dept Biol, Antigonish, NS B2G 1C0, Canada	University of Guelph; Stanford University; Saint Francis Xavier University - Canada	Heyland, A (corresponding author), Univ Guelph, Guelph, ON N1G 2W1, Canada.	aheyland@uoguelph.ca			Evo-Devo-Eco Network (EDEN) Fellowship; Natural Sciences and Engineering Research Council of Canada (NSERC); National Science Foundation [NSF 1357033]; Directorate For Geosciences [1357077, 1357033] Funding Source: National Science Foundation	Evo-Devo-Eco Network (EDEN) Fellowship; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); National Science Foundation(National Science Foundation (NSF)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding was provided by an Evo-Devo-Eco Network (EDEN; http://edenrcn.com) Fellowship (AH), Discovery Grants from the Natural Sciences and Engineering Research Council of Canada (NSERC, CB and AH; http://www.nserc-crsng.gc.ca) and the National Science Foundation (NSF 1357033, JH and Christopher Lowe; http://www.nsf.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adomako-Ankomah A, 2011, DEV BIOL, V353, P81, DOI 10.1016/j.ydbio.2011.02.021; Arnone MI, 2004, METHOD CELL BIOL, V74, P621; Bishop CD, 2006, INTEGR COMP BIOL, V46, P655, DOI 10.1093/icb/icl004; CAMERON RA, 1978, J MORPHOL, V157, P21, DOI 10.1002/jmor.1051570103; Cheers MS, 2004, METHOD CELL BIOL, V74, P287; Cheers MS, 2005, DEV BIOL, V283, P384, DOI 10.1016/j.ydbio.2005.02.037; CHINO Y, 1994, DEV BIOL, V161, P1, DOI 10.1006/dbio.1994.1001; Driesch H., 1893, Anatomischer Anzeiger, Vviii, P348; Driesch H., 1892, POTENCY 1 2 CLEAVAGE; Duboc V, 2005, DEV CELL, V9, P147, DOI 10.1016/j.devcel.2005.05.008; Eaves AA, 2005, INVERTEBR BIOL, V124, P174, DOI 10.1111/j.1744-7410.2005.00017.x; Eaves AA, 2003, NATURE, V425, P146, DOI 10.1038/425146a; Emlet RB, 2010, INTEGR COMP BIOL, V50, P571, DOI 10.1093/icb/icq073; Gao F, 2008, P NATL ACAD SCI USA, V105, P6091, DOI 10.1073/pnas.0801201105; Gordon I, 1926, PHILOS T R SOC LON B, V214, P259, DOI 10.1098/rstb.1926.0007; Gordon I, 1929, PHILOS T R SOC LON B, V217, P289, DOI 10.1098/rstb.1929.0005; Hadfield MG, 2000, AM ZOOL, V40, P1038; Hart M, 2000, SEMIN CELL DEV BIOL, V11, P411, DOI 10.1006/scdb.2000.0194; Heasman J, 2002, DEV BIOL, V243, P209, DOI 10.1006/dbio.2001.0565; Heyland A, 2014, BMC DEV BIOL, V14, DOI 10.1186/1471-213X-14-22; Heyland A, 2012, ENDOCRINOLOGY, V153, P5440, DOI 10.1210/en.2012-1677; HINEGARDNER RT, 1969, BIOL BULL-US, V137, P465, DOI 10.2307/1540168; Hodin J, 2006, INTEGR COMP BIOL, V46, P719, DOI 10.1093/icb/icl038; Howard EW, 2001, DEVELOPMENT, V128, P365; Hyman L.H., 1955, ECHINODERMATA; Jasny BR, 2006, SCIENCE, V314, P938, DOI 10.1126/science.314.5801.938; Luo YJ, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001402; MacBride EW, 1903, PHILOS T R SOC LON B, V195, P285, DOI 10.1098/rstb.1903.0006; MacBride EW, 1918, DEV ECHINOCARDIUM 1, P471; MacBride EW, 1914, P R SOC B, V90, P259; McClay DR, 2011, DEVELOPMENT, V138, P2639, DOI 10.1242/dev.048967; McHugh D, 1998, TRENDS ECOL EVOL, V13, P182, DOI 10.1016/S0169-5347(97)01285-8; Morcos PA, 2008, BIOTECHNIQUES, V45, P613, DOI 10.2144/000113005; MOTOKAWA T, 1984, BIOL REV, V59, P255, DOI 10.1111/j.1469-185X.1984.tb00409.x; Muller W, 1997, DEV BIOL; Raff RA, 2008, PHILOS T R SOC B, V363, P1473, DOI 10.1098/rstb.2007.2237; Rafiq K, 2012, DEVELOPMENT, V139, P579, DOI 10.1242/dev.073049; Smith AB, 2001, T ROY SOC EDIN-EARTH, V92, P137, DOI 10.1017/S0263593300000109; Smith J, 2007, SCIENCE, V318, P794, DOI 10.1126/science.1146524; Smith MM, 2008, J MORPHOL, V269, P713, DOI 10.1002/jmor.10618; Sodergren E, 2006, SCIENCE, V314, P941, DOI 10.1126/science.1133609; Strathmann MF, 1987, REPROD DEV MARINE IN; STRATHMANN RR, 1978, EVOLUTION, V32, P894, DOI 10.1111/j.1558-5646.1978.tb04642.x; STRATHMANN RR, 1994, AM ZOOL, V34, P502; STRATHMANN RR, 1985, ANNU REV ECOL SYST, V16, P339, DOI 10.1146/annurev.es.16.110185.002011; Sugni M, 2014, MAR ENVIRON RES, V93, P123, DOI 10.1016/j.marenvres.2013.07.010; Sutherby J, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-14; Vaughn D, 2008, SCIENCE, V319, P1503, DOI 10.1126/science.1151995; Vaughn D, 2010, MAR BIOL, V157, P1301, DOI 10.1007/s00227-010-1410-z; von Ubisch L, 1913, Z WISS ZOOL ABT A, V106, P409; Williams H, 2002, SEA URCHIN FISHERIES	51	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113866	10.1371/journal.pone.0113866	http://dx.doi.org/10.1371/journal.pone.0113866			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436992	gold, Green Published			2022-12-26	WOS:000347114900090
J	Starenki, D; Hong, SK; Lloyd, RV; Park, JI				Starenki, D.; Hong, S-K; Lloyd, R. V.; Park, J-I			Mortalin (GRP75/HSPA9) upregulation promotes survival and proliferation of medullary thyroid carcinoma cells	ONCOGENE			English	Article							INHIBITORY FACTOR/JAK/STAT PATHWAY; BREAST-CANCER; HSP70 FAMILY; MITOCHONDRIA; STRESS; RET; 2-DEOXYGLUCOSE; MUTATIONS; PROTEINS; KINASE	Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor mainly caused by mutations in the rearranged during transfection (RET) proto-oncogene. For therapy of advanced MTC, the Food and Drug Administration recently approved vandetanib and cabozantinib, the tyrosine kinase inhibitors targeting RET, vascular endothelial growth factor receptor, epidermal growth factor receptor and/or c-MET. Nevertheless, not all patients respond to these drugs, demanding additional therapeutic strategies. We found that mortalin (HSPA9/GRP75), a member of HSP70 family, is upregulated in human MTC tissues and that its depletion robustly induces cell death and growth arrest in MTC cell lines in culture and in mouse xenografts. These effects were accompanied by substantial downregulation of RET, induction of the tumor-suppressor TP53 and altered expression of cell cycle regulatory machinery and apoptosis markers, including E2F-1, p21(CIP1), p27(KIP1) and Bcl-2 family proteins. Our investigation of the molecular mechanisms underlying these effects revealed that mortalin depletion induces transient MEK/ERK (extracellular signal-regulated kinase) activation and altered mitochondrial bioenergetics in MTC cells, as indicated by depolarized mitochondrial membrane, decreased oxygen consumption and extracellular acidification and increased oxidative stress. Intriguingly, mortalin depletion induced growth arrest partly via the MEK/ERK pathway, whereas it induced cell death by causing mitochondrial dysfunction in a Bcl-2-dependent manner. However, TP53 was not necessary for these effects except for p21CIP1 induction. Moreover, mortalin depletion downregulated RET expression independently of MEK/ERK and TP53. These data demonstrate that mortalin is a key regulator of multiple signaling and metabolic pathways pivotal to MTC cell survival and proliferation, proposing mortalin as a novel therapeutic target for MTC.	[Starenki, D.; Hong, S-K; Park, J-I] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Lloyd, R. V.] Univ Wisconsin, Dept Pathol & Lab Med, Madison, WI USA	Medical College of Wisconsin; University of Wisconsin System; University of Wisconsin Madison	Park, JI (corresponding author), Med Coll Wisconsin, Dept Biochem, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	jipark@mcw.edu	Starenki, Dmytro/D-9241-2014	Park, Jong-In/0000-0001-7248-4735	American Cancer Society [RSGM-10-189-01-TBE]; National Cancer Institute [R01CA138441]; NATIONAL CANCER INSTITUTE [R01CA138441] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Sergey Tarima at the Division of Biostatistics, Medical College of Wisconsin (MCW) for statistical analysis; Dr Alexandra F Lerch-Gaggl (Pediatric BioBank and Analytical Tissue Core, MCW) for imaging immunohistochemistry data; and the MCW Cancer Center Bioenergetics shared resource and Advancing Healthier Wisconsin for Seahorse analysis. This work was supported by the American Cancer Society (RSGM-10-189-01-TBE) and the National Cancer Institute (R01CA138441) to J-IP.	Agrawal N, 2013, J CLIN ENDOCR METAB, V98, pE364, DOI 10.1210/jc.2012-2703; Arthan D, 2010, CANCER LETT, V297, P31, DOI 10.1016/j.canlet.2010.04.021; Boichard A, 2012, J CLIN ENDOCR METAB, V97, pE2031, DOI 10.1210/jc.2012-2092; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Cheng G, 2012, CANCER RES, V72, P2634, DOI 10.1158/0008-5472.CAN-11-3928; Ciampi R, 2013, THYROID, V1, P1, DOI DOI 10.1089/THY.2013.2301.OB; Degrauwe N., 2012, CLIN MED INSIGHTS ON, V6, P243; Deocaris CC, 2007, ANN NY ACAD SCI, V1119, P165, DOI 10.1196/annals.1404.007; Dundas SR, 2005, J PATHOL, V205, P74, DOI 10.1002/path.1672; Hong SK, 2009, J BIOL CHEM, V284, P33006, DOI 10.1074/jbc.M109.012591; Ichihara M, 2004, CANCER LETT, V204, P197, DOI 10.1016/S0304-3835(03)00456-7; Iosefson O, 2010, FEBS LETT, V584, P1080, DOI 10.1016/j.febslet.2010.02.019; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kaul SC, 2005, J BIOL CHEM, V280, P39373, DOI 10.1074/jbc.M500022200; Kaul SC, 2007, EXP GERONTOL, V42, P263, DOI 10.1016/j.exger.2006.10.020; Khalil AA, 2011, BBA-REV CANCER, V1816, P89, DOI 10.1016/j.bbcan.2011.05.001; LEUSTEK T, 1989, P NATL ACAD SCI USA, V86, P7805, DOI 10.1073/pnas.86.20.7805; Lu WJ, 2011, CELL DEATH DIFFER, V18, P1046, DOI 10.1038/cdd.2010.177; Lu WJ, 2011, INT J CANCER, V129, P1806, DOI 10.1002/ijc.25857; Merrick BA, 1997, CANCER LETT, V119, P185, DOI 10.1016/S0304-3835(97)00270-X; Mooi WJ, 2006, NEW ENGL J MED, V355, P1037, DOI 10.1056/NEJMra062285; Nagilla M, 2012, ADV THER, V29, P925, DOI 10.1007/s12325-012-0060-6; Park JI, 2005, CYTOKINE, V29, P125, DOI 10.1016/j.cyto.2004.10.005; Park JI, 2003, MOL CELL BIOL, V23, P543, DOI 10.1128/MCB.23.2.543-554.2003; Park Jong-In, 2014, Front Biol (Beijing), V9, P95; Ryter SW, 2007, ANTIOXID REDOX SIGN, V9, P49, DOI 10.1089/ars.2007.9.49; Sarosiek KA, 2013, TRENDS CELL BIOL, V23, P612, DOI 10.1016/j.tcb.2013.08.003; SCHNEIDER HC, 1994, NATURE, V371, P768, DOI 10.1038/371768a0; Sosonkina N., 2011, Experimental Oncology, V33, P42; Sosonkina N, 2014, CANCERS, V6, P526, DOI 10.3390/cancers6010526; Starenki D, 2013, CANCER LETT, V339, P144, DOI 10.1016/j.canlet.2013.07.006; Starenki D, 2013, J CLIN ENDOCR METAB, V98, P1529, DOI 10.1210/jc.2012-3671; Tuttle RM, 2010, J NATL COMPR CANC NE, V8, P512, DOI 10.6004/jnccn.2010.0040; Wadhwa R, 1998, J BIOL CHEM, V273, P29586, DOI 10.1074/jbc.273.45.29586; Wadhwa R, 2003, BIOCHEM BIOPH RES CO, V302, P735, DOI 10.1016/S0006-291X(03)00226-2; Wadhwa R, 2006, INT J CANCER, V118, P2973, DOI 10.1002/ijc.21773; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Wells SA, 2012, J CLIN ONCOL, V30, P134, DOI 10.1200/JCO.2011.35.5040; Wu PK, 2013, MOL CELL BIOL, V33, P4051, DOI 10.1128/MCB.00021-13	40	58	61	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 27	2015	34	35					4624	4634		10.1038/onc.2014.392	http://dx.doi.org/10.1038/onc.2014.392			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CP9BS	25435367	Green Accepted			2022-12-26	WOS:000360189300008
J	Liu, W; Lin, YT; Yan, XL; Ding, YL; Wu, YL; Chen, WN; Lin, X				Liu, Wei; Lin, Yan-Ting; Yan, Xiao-Li; Ding, Ya-Lan; Wu, Yun-Li; Chen, Wan-Nan; Lin, Xu			Hepatitis B virus core protein inhibits Fas-mediated apoptosis of hepatoma cells via regulation of mFas/FasL and sFas expression	FASEB JOURNAL			English	Article						p53; chronic HBV infection; PTBP1; FASTK	TRAIL-INDUCED APOPTOSIS; SOLUBLE FAS/APO-1 CD95; WILD-TYPE P53; SERUM-LEVELS; HEPATOCELLULAR-CARCINOMA; RECEPTOR/LIGAND SYSTEM; NUCLEAR-LOCALIZATION; CHRONIC HBV; DNA-DAMAGE; GENE	Hepatitis B virus core protein (HBc) has been implicated in hepatocarcinogenesis through several mechanisms. Resistance of hepatitis B virus (HBV)-infected hepatocytes to apoptosis is considered one of the major contributors to the progression of chronic hepatitis to cirrhosis and ultimately to hepatocellular carcinoma. The Fas receptor/ligand (Fas/FasL) system plays a prominent role in hepatocyte death during HBV infection. Here we report that HBc mediates resistance of hepatoma cells to agonistic anti-Fas antibody (CH11)-induced apoptosis. WhenHBc was introduced into human hepatoma cells, the cells became resistant to CH11 cytotoxicity in a p53-dependent manner. HBc significantly down-regulated the expression of p53, total Fas, and membrane-bound Fas at them RNA and protein levels and reduced FasL mRNA expression. In contrast, HBc upregulated the expression of soluble forms of Fas by increasing Fas alternative mRNA splicing. Mechanistically, HBc-mediated Fas alternative mRNA splicing was associated with up-regulation of polypyrimidine tract-binding protein 1 and down-regulation of Fas-activated serine/threonine kinase. These results indicated that HBc may preventhepatocytes from Fas-induced apoptosis by the dual effects of reducing the expression of the proapoptotic form of Fas and enhancing the expression of the antiapoptotic form of the receptor, which may contribute to the survival and persistence of infected hepatocytes during chronic infection.	[Liu, Wei; Lin, Yan-Ting; Yan, Xiao-Li; Ding, Ya-Lan; Wu, Yun-Li; Chen, Wan-Nan; Lin, Xu] Fujian Med Univ, Sch Basic Med Sci, Key Lab, Minist Educ Gastrointestinal Canc, Minhou 350108, Fujian, Peoples R China; [Liu, Wei; Wu, Yun-Li; Chen, Wan-Nan; Lin, Xu] Fujian Med Univ, Dept Med Microbiol, Key Lab Tumor Microbiol, Minhou 350108, Fujian, Peoples R China	Fujian Medical University; Fujian Medical University	Lin, X (corresponding author), Fujian Med Univ, Sch Basic Med Sci, Key Lab, Minist Educ Gastrointestinal Canc, 1 Xueyuan Rd, Minhou 350108, Fujian, Peoples R China.	linxu@mail.fjmu.edu.cn	Liu, Wei/ABX-2014-2022	Liu, Wei/0000-0001-7118-815X	State Key Project Specialized for Infectious Diseases [2012ZX10002002-004-006, 2013ZX10002006-002-002]; Key Program of Scientific Research [09ZD004]; Program for Innovative Research Team in Science and Technology from Fujian Medical University [FMU-RT001]	State Key Project Specialized for Infectious Diseases; Key Program of Scientific Research; Program for Innovative Research Team in Science and Technology from Fujian Medical University	The authors thank Drs. Christopher W. J. Smith and J. Valca'rcel for providing pCMV56-Fas vector. This work was supported by grants from State Key Project Specialized for Infectious Diseases (2012ZX10002002-004-006 and 2013ZX10002006-002-002), Key Program of Scientific Research (09ZD004), and Program for Innovative Research Team in Science and Technology from Fujian Medical University (FMU-RT001).	Back SH, 2002, J BIOL CHEM, V277, P27200, DOI 10.1074/jbc.M203887200; Bortolami M, 2008, J VIRAL HEPATITIS, V15, P515, DOI 10.1111/j.1365-2893.2008.00974.x; CASCINO I, 1995, J IMMUNOL, V154, P2706; Chen WN, 2010, J GEN VIROL, V91, P2592, DOI 10.1099/vir.0.022517-0; Chen XC, 2004, VACCINE, V22, P439, DOI 10.1016/j.vaccine.2003.07.014; CHENG JH, 1994, SCIENCE, V263, P1759, DOI 10.1126/science.7510905; Du J, 2009, CELL DEATH DIFFER, V16, P219, DOI 10.1038/cdd.2008.144; ECKHARDT SG, 1991, J VIROL, V65, P575, DOI 10.1128/JVI.65.2.575-582.1991; Forch P, 2000, MOL CELL, V6, P1089, DOI 10.1016/S1097-2765(00)00107-6; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Fukazawa T, 1999, ONCOGENE, V18, P2189, DOI 10.1038/sj.onc.1202561; GALLE PR, 1995, J EXP MED, V182, P1223, DOI 10.1084/jem.182.5.1223; Guicciardi ME, 2009, FASEB J, V23, P1625, DOI 10.1096/fj.08-111005; Guo YH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-563; Hatano E, 2007, J GASTROEN HEPATOL, V22, pS43, DOI 10.1111/j.1440-1746.2006.04645.x; HATTON T, 1992, J VIROL, V66, P5232, DOI 10.1128/JVI.66.9.5232-5241.1992; Haupt S, 2003, J CELL SCI, V116, P4077, DOI 10.1242/jcs.00739; HSU IC, 1993, CARCINOGENESIS, V14, P987, DOI 10.1093/carcin/14.5.987; Izquierdo JM, 2005, MOL CELL, V19, P475, DOI 10.1016/j.molcel.2005.06.015; Izquierdo JM, 2008, MOL BIOL CELL, V19, P3299, DOI 10.1091/mbc.E07-11-1125; Izquierdo JM, 2007, J BIOL CHEM, V282, P1539, DOI 10.1074/jbc.C600198200; Jeong H, 2014, FEBS LETT, V588, P851, DOI 10.1016/j.febslet.2014.01.020; Jodo S, 1998, CLIN EXP IMMUNOL, V112, P166; Jodo S, 1997, CLIN EXP IMMUNOL, V107, P89, DOI 10.1046/j.1365-2249.1997.d01-901.x; Kew MC, 2010, PATHOL BIOL, V58, P273, DOI 10.1016/j.patbio.2010.01.005; KNIPPING E, 1995, BLOOD, V85, P1562, DOI 10.1182/blood.V85.6.1562.bloodjournal8561562; Kondo T, 1997, NAT MED, V3, P409, DOI 10.1038/nm0497-409; Kwon JA, 2003, BIOL CHEM, V384, P203, DOI 10.1515/BC.2003.022; Li HC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001162; Liang XH, 2007, J IMMUNOL, V178, P503, DOI 10.4049/jimmunol.178.1.503; LIAO W, 1995, J VIROL, V69, P1025, DOI 10.1128/JVI.69.2.1025-1029.1995; Lok AS, 2001, GASTROENTEROLOGY, V120, P1828, DOI 10.1053/gast.2001.24839; MILICH DR, 1986, SCIENCE, V234, P1398, DOI 10.1126/science.3491425; Muller M, 1998, J EXP MED, V188, P2033, DOI 10.1084/jem.188.11.2033; Muller M, 1997, J CLIN INVEST, V99, P403, DOI 10.1172/JCI119174; Nakamoto Y, 1997, J IMMUNOL, V158, P5692; Nakamura M, 2007, J HEPATOL, V46, P77, DOI 10.1016/j.jhep.2006.07.032; PONCHEL F, 1994, CANCER RES, V54, P2064; Rawat S, 2012, VIRUSES-BASEL, V4, P2945, DOI 10.3390/v4112945; Rivero M, 2002, J VIRAL HEPATITIS, V9, P107, DOI 10.1046/j.1365-2893.2002.00338.x; Robinson F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001801; Schuler M, 2000, J BIOL CHEM, V275, P7337, DOI 10.1074/jbc.275.10.7337; Shim HY, 2011, VIROLOGY, V410, P161, DOI 10.1016/j.virol.2010.11.005; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Vakifahmetoglu H, 2006, ONCOGENE, V25, P5683, DOI 10.1038/sj.onc.1209569; Yin Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022524	46	36	40	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					1113	1123		10.1096/fj.14-263822	http://dx.doi.org/10.1096/fj.14-263822			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25466893				2022-12-26	WOS:000350633000034
J	Choi, YS; Lee, YJ; Lee, SY; Shi, L; Ha, JH; Cheong, HK; Cheong, C; Cohen, RE; Ryu, KS				Choi, Yun-Seok; Lee, Yun-Ju; Lee, Seo-Yeon; Shi, Lei; Ha, Jung-Hye; Cheong, Hae-Kap; Cheong, Chaejoon; Cohen, Robert E.; Ryu, Kyoung-Seok			Differential Ubiquitin Binding by the Acidic Loops of Ube2g1 and Ube2r1 Enzymes Distinguishes Their Lys-48-ubiquitylation Activities	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONJUGATING ENZYME; CRYSTAL-STRUCTURE; HUMAN CDC34; MECHANISM; REVEALS; COMPLEX; SYSTEM; INTERMEDIATE; SUBSTRATE; E2	The ubiquitin E2 enzymes, Ube2g1 and Ube2r1, are able to synthesize Lys-48-linked polyubiquitins without an E3 ligase but how that is accomplished has been unclear. Although both E2s contain essential acidic loops, only Ube2r1 requires an additional C-terminal extension (184-196) for efficient Lys-48-ubiquitylation activity. The presence of Tyr-102 and Tyr-104 in the Ube2g1 acidic loop enhanced both ubiquitin binding and Lys-48-ubiquitylation and distinguished Ube2g1 from the otherwise similar truncated Ube2r1(1-183) (Ube2r1C). Replacement of Gln-105-Ser-106-Gly-107 in the acidic loop of Ube2r1C (Ube2r1C(YGY)) by the corresponding residues from Ube2g1 (Tyr-102-Gly-103-Tyr-104) increased Lys-48-ubiquitylation activity and ubiquitin binding. Two E2 similar to UB thioester mimics (oxyester and disulfide) were prepared to characterize the ubiquitin binding activity of the acidic loop. The oxyester but not the disulfide derivative was found to be a functional equivalent of the E2 similar to UB thioester. The ubiquitin moiety of the Ube2r1C(C93S)-[N-15]UBK48R oxyester displayed two-state conformational exchange, whereas the Ube2r1C(C93S/YGY)-[N-15]UBK48R oxyester showed predominantly one state. Together with NMR studies that compared UBK48R oxyesters of the wild-type and the acidic loop mutant (Y102G/Y104G) forms of Ube2g1, in vitro ubiquitylation assays with various mutation forms of the E2s revealed how the intramolecular interaction between the acidic loop and the attached donor ubiquitin regulates Lys-48-ubiquitylation activity.	[Choi, Yun-Seok; Lee, Yun-Ju; Lee, Seo-Yeon; Ha, Jung-Hye; Cheong, Hae-Kap; Cheong, Chaejoon; Ryu, Kyoung-Seok] Korea Basic Sci Inst, Div Magnet Resonance, Chungcheongbuk Do 363883, South Korea; [Choi, Yun-Seok; Ha, Jung-Hye; Cheong, Chaejoon; Ryu, Kyoung-Seok] Univ Sci & Technol, Dept Bioanalyt Sci, Taejon 305333, South Korea; [Shi, Lei] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Choi, Yun-Seok; Cohen, Robert E.] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80521 USA	Korea Basic Science Institute (KBSI); University of Washington; University of Washington Seattle; Colorado State University	Ryu, KS (corresponding author), Korea Basic Sci Inst, Div Magnet Resonance, Ochang Campus,Yangcheong Ri 804-1, Chungcheongbuk Do 363883, South Korea.	ksryu@kbsi.re.kr	Cheong, Chaejoon/GWC-3135-2022		National Institutes of Health [GM097452]; Korea Basic Science Institute (KBSI); KBSI [T33410]; University of Science and Technology Post-Doc research program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097452] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korea Basic Science Institute (KBSI); KBSI; University of Science and Technology Post-Doc research program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM097452 (to R. E. C.). This study was also supported by the high-field NMR research program from Korea Basic Science Institute (KBSI; to K.-S. R.) and KBSI Grant T33410 (to H.-K. C.).; Supported by University of Science and Technology Post-Doc research program.	Brzovic PS, 2006, MOL CELL, V21, P873, DOI 10.1016/j.molcel.2006.02.008; Choi YS, 2010, J BIOL CHEM, V285, P17754, DOI 10.1074/jbc.M109.090621; Choi YS, 2009, FEBS LETT, V583, P3323, DOI 10.1016/j.febslet.2009.09.034; Das R, 2013, EMBO J, V32, P2504, DOI 10.1038/emboj.2013.174; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eddins MJ, 2006, NAT STRUCT MOL BIOL, V13, P915, DOI 10.1038/nsmb1148; Fiaux J, 2004, J BIOMOL NMR, V29, P289, DOI 10.1023/B:JNMR.0000032523.00554.38; Gazdoiu S, 2005, P NATL ACAD SCI USA, V102, P15053, DOI 10.1073/pnas.0507646102; Goddard T. D., SPARKY 3; Haldeman MT, 1997, BIOCHEMISTRY-US, V36, P10526, DOI 10.1021/bi970750u; Hamilton KS, 2001, STRUCTURE, V9, P897, DOI 10.1016/S0969-2126(01)00657-8; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Houben K, 2004, J MOL BIOL, V344, P513, DOI 10.1016/j.jmb.2004.09.054; Ju TT, 2010, PROTEINS, V78, P1291, DOI 10.1002/prot.22648; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kleiger G, 2009, CELL, V139, P957, DOI 10.1016/j.cell.2009.10.030; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Liu WX, 2014, EMBO J, V33, P46, DOI 10.1002/embj.201385315; Maspero E, 2013, NAT STRUCT MOL BIOL, V20, P696, DOI 10.1038/nsmb.2566; Merkley N, 2005, J BIOL CHEM, V280, P31732, DOI 10.1074/jbc.M505205200; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Petroski MD, 2005, CELL, V123, P1107, DOI 10.1016/j.cell.2005.09.033; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; Pruneda JN, 2012, MOL CELL, V47, P933, DOI 10.1016/j.molcel.2012.07.001; Pruneda JN, 2011, BIOCHEMISTRY-US, V50, P1624, DOI 10.1021/bi101913m; Ryu KS, 2008, BMB REP, V41, P852, DOI 10.5483/BMBRep.2008.41.12.852; Saha A, 2011, MOL CELL, V42, P75, DOI 10.1016/j.molcel.2011.03.016; Sakata E, 2010, STRUCTURE, V18, P138, DOI 10.1016/j.str.2009.11.007; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Shekhtman A, 2002, FEBS LETT, V524, P177, DOI 10.1016/S0014-5793(02)03051-X; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Spratt DE, 2011, J MOL BIOL, V407, P425, DOI 10.1016/j.jmb.2011.01.047; VanDemark AP, 2001, CELL, V105, P711, DOI 10.1016/S0092-8674(01)00387-7; Wickliffe KE, 2011, CELL, V144, P769, DOI 10.1016/j.cell.2011.01.035; Wu K, 2010, MOL CELL, V37, P784, DOI 10.1016/j.molcel.2010.02.025; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501	39	18	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2251	2263		10.1074/jbc.M114.624809	http://dx.doi.org/10.1074/jbc.M114.624809			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25471371	hybrid, Green Published			2022-12-26	WOS:000348588000029
J	White, MR; Khan, MM; Deredge, D; Ross, CR; Quintyn, R; Zucconi, BE; Wysocki, VH; Wintrode, PL; Wilson, GM; Garcin, ED				White, Michael R.; Khan, Mohd M.; Deredge, Daniel; Ross, Christina R.; Quintyn, Royston; Zucconi, Beth E.; Wysocki, Vicki H.; Wintrode, Patrick L.; Wilson, Gerald M.; Garcin, Elsa D.			A Dimer Interface Mutation in Glyceraldehyde-3-Phosphate Dehydrogenase Regulates Its Binding to AU-rich RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OVARIAN-CANCER CELLS; ALPHA MESSENGER-RNA; POSTTRANSCRIPTIONAL REGULATION; HIGH-RESOLUTION; 3-PHOSPHATE DEHYDROGENASE; REVERSIBLE DISSOCIATION; ADENOSINE-TRIPHOSPHATE; NUCLEAR TRANSLOCATION; FUNCTIONAL DIVERSITY; MASS-SPECTROMETRY	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is an enzyme best known for its role in glycolysis. However, extra-glycolytic functions of GAPDH have been described, including regulation of protein expression via RNA binding. GAPDH binds to numerous adenine-uridine rich elements (AREs) from various mRNA 3'-untranslated regions in vitro and in vivo despite its lack of a canonical RNA binding motif. How GAPDH binds to these AREs is still unknown. Here we discovered that GAPDH binds with high affinity to the core ARE from tumor necrosis factor-alpha mRNA via a two-step binding mechanism. We demonstrate that a mutation at the GAPDH dimer interface impairs formation of the second RNA-GAPDH complex and leads to changes in the RNA structure. We investigated the effect of this interfacial mutation on GAPDH oligomerization by crystallography, small-angle x-ray scattering, nano-electrospray ionization native mass spectrometry, and hydrogen-deuterium exchange mass spectrometry. We show that the mutation does not significantly affect GAPDH tetramerization as previously proposed. Instead, the mutation promotes short-range and long-range dynamic changes in regions located at the dimer and tetramer interface and in the NAD+ binding site. These dynamic changes are localized along the P axis of the GAPDH tetramer, suggesting that this region is important for RNA binding. Based on our results, we propose a model for sequential GAPDH binding to RNA via residues located at the dimer and tetramer interfaces.	[White, Michael R.; Khan, Mohd M.; Garcin, Elsa D.] Univ Maryland Baltimore Cty, Dept Chem & Biochem, Baltimore, MD 21250 USA; [Deredge, Daniel; Wintrode, Patrick L.] Univ Maryland, Dept Pharmaceut Sci, Sch Pharm, Baltimore, MD 21201 USA; [Ross, Christina R.; Zucconi, Beth E.; Wilson, Gerald M.] Univ Maryland, Dept Biochem & Mol Biol, Sch Med, Baltimore, MD 21201 USA; [Quintyn, Royston; Wysocki, Vicki H.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA	University System of Maryland; University of Maryland Baltimore County; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Ohio; Ohio State University	Garcin, ED (corresponding author), Univ Maryland Baltimore Cty, Dept Chem & Biochem, 1000 Hilltop Circle, Baltimore, MD 21250 USA.	egarcin@umbc.edu	Garcin, Elsa D/C-1556-2013; Wilson, Gerald/AAF-3874-2019; Khan, Mohd M./D-4451-2015	Garcin, Elsa D/0000-0003-0501-8421; Khan, Mohd M./0000-0003-2793-1705; Wilson, Gerald/0000-0002-1273-7507; Wysocki, Vicki/0000-0003-0495-2538	National Institutes of Health [R01 CA102428, T32 GM066706]; National Science Foundation [DBI 0923551]; American Heart Association [PRE6900008]; NATIONAL CANCER INSTITUTE [R01CA102428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM066706] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01 CA102428 (to G. M. W.). This work was also supported in part by National Science Foundation Grant DBI 0923551 (to V. H. W.) and the American Heart Association Grant PRE6900008 (to B. E. Z.).; Supported in part by National Institutes of Health Grant T32 GM066706.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Backlund M, 2009, NUCLEIC ACIDS RES, V37, P2346, DOI 10.1093/nar/gkp098; Barreau C, 2005, NUCLEIC ACIDS RES, V33, P7138, DOI 10.1093/nar/gki1012; BAXI MD, 1995, BIOCHEMISTRY-US, V34, P9700, DOI 10.1021/bi00030a007; Bonafe N, 2005, CANCER RES, V65, P3762, DOI 10.1158/0008-5472.CAN-04-3954; Brewer G, 2003, J INTERF CYTOK RES, V23, P553, DOI 10.1089/107999003322485053; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Carmona P, 1999, BBA-PROTEIN STRUCT M, V1432, P222, DOI 10.1016/S0167-4838(99)00113-2; Chakravarti R, 2010, P NATL ACAD SCI USA, V107, P18004, DOI 10.1073/pnas.1008133107; Chang BS, 1996, J PHARM SCI, V85, P1325, DOI 10.1021/js960080y; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; CONSTANTINIDES SM, 1969, J BIOL CHEM, V244, P5695; De BP, 1996, J BIOL CHEM, V271, P24728, DOI 10.1074/jbc.271.40.24728; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evguenieva-Hackenberg E, 2002, J BIOL CHEM, V277, P46145, DOI 10.1074/jbc.M208717200; Fialcowitz EJ, 2005, J BIOL CHEM, V280, P22406, DOI 10.1074/jbc.M500618200; Galhena AS, 2008, ANAL CHEM, V80, P1425, DOI 10.1021/ac701782q; Gao XF, 2013, CELL HOST MICROBE, V13, P87, DOI 10.1016/j.chom.2012.11.010; GLASER PE, 1995, BIOCHEMISTRY-US, V34, P12193, DOI 10.1021/bi00038a013; GRIKO YV, 1988, P NATL ACAD SCI USA, V85, P3343, DOI 10.1073/pnas.85.10.3343; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; HOAGLAND VD, 1969, BIOCHEMISTRY-US, V8, P594, DOI 10.1021/bi00830a020; Houde D, 2011, J PHARM SCI-US, V100, P2071, DOI 10.1002/jps.22432; Huang QJ, 2011, J BIOL CHEM, V286, P42211, DOI 10.1074/jbc.M111.296905; Jenkins JL, 2006, ACTA CRYSTALLOGR D, V62, P290, DOI 10.1107/S0907444905042289; Jia J, 2012, MOL CELL, V47, P656, DOI 10.1016/j.molcel.2012.06.006; KARPEL RL, 1981, BIOCHIM BIOPHYS ACTA, V654, P256, DOI 10.1016/0005-2787(81)90180-5; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Kramer K, 2014, NAT METHODS, V11, P1064, DOI [10.1038/NMETH.3092, 10.1038/nmeth.3092]; Lai WS, 1999, MOL CELL BIOL, V19, P4311; Lakowicz J.R, 1999, PRINCIPLES FLUORESCE, P368; Mazzola JL, 2002, MOL BRAIN RES, V100, P95, DOI 10.1016/S0169-328X(02)00160-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MURONETZ VI, 1994, ARCH BIOCHEM BIOPHYS, V313, P253, DOI 10.1006/abbi.1994.1385; Myer VE, 1997, EMBO J, V16, P2130, DOI 10.1093/emboj/16.8.2130; Nagy E, 2000, BIOCHEM BIOPH RES CO, V275, P253, DOI 10.1006/bbrc.2000.3246; NAGY E, 1995, J BIOL CHEM, V270, P2755, DOI 10.1074/jbc.270.6.2755; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Nicholls C, 2012, P NATL ACAD SCI USA, V109, P13308, DOI 10.1073/pnas.1206672109; Norman DG, 2000, BIOCHEMISTRY-US, V39, P6317, DOI 10.1021/bi992944a; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park J, 2009, BBA-PROTEINS PROTEOM, V1794, P254, DOI 10.1016/j.bbapap.2008.10.003; Parker R, 2004, NAT STRUCT MOL BIOL, V11, P121, DOI 10.1038/nsmb724; Peng SSY, 1998, EMBO J, V17, P3461, DOI 10.1093/emboj/17.12.3461; PERUCHO M, 1977, EUR J BIOCHEM, V81, P557, DOI 10.1111/j.1432-1033.1977.tb11982.x; PERUCHO M, 1980, BIOCHIM BIOPHYS ACTA, V606, P181, DOI 10.1016/0005-2787(80)90028-3; Rodriguez-Pascual F, 2008, MOL CELL BIOL, V28, P7139, DOI 10.1128/MCB.01145-08; Sarkar B, 2003, MOL CELL BIOL, V23, P6685, DOI 10.1128/MCB.23.18.6685-6693.2003; Schultz DE, 1996, J BIOL CHEM, V271, P14134, DOI 10.1074/jbc.271.24.14134; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Seo J, 2008, J PROTEOME RES, V7, P587, DOI 10.1021/pr700657y; Shim J, 2002, MOL CELLS, V14, P323; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; Sirover MA, 1999, BBA-PROTEIN STRUCT M, V1432, P159, DOI 10.1016/S0167-4838(99)00119-3; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; STANCEL GM, 1969, BIOCHEMISTRY-US, V8, P4005, DOI 10.1021/bi00838a017; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Ventura M, 2010, INT J BIOCHEM CELL B, V42, P1672, DOI 10.1016/j.biocel.2010.06.014; Wang EH, 1997, CANCER RES, V57, P5426; Wang RYL, 2008, CELL HOST MICROBE, V3, P178, DOI 10.1016/j.chom.2008.02.005; White EJF, 2013, BBA-GENE REGUL MECH, V1829, P680, DOI 10.1016/j.bbagrm.2012.12.002; Wilson GM, 1999, J BIOL CHEM, V274, P33374, DOI 10.1074/jbc.274.47.33374; Wilson GM, 2001, J BIOL CHEM, V276, P38400, DOI 10.1074/jbc.M106509200; Wilson GM, 1999, PROG NUCLEIC ACID RE, V62, P257; Wilson GM, 2001, J BIOL CHEM, V276, P8695, DOI 10.1074/jbc.M009848200; Wilusz CJ, 2001, NAT REV MOL CELL BIO, V2, P237, DOI 10.1038/35067025; Yogalingam G, 2013, J BIOL CHEM, V288, P18947, DOI 10.1074/jbc.M113.466870; Zhang A, 2012, PHARM RES-DORDR, V29, P236, DOI 10.1007/s11095-011-0538-y; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952; Zhou MW, 2012, ANGEW CHEM INT EDIT, V51, P4336, DOI 10.1002/anie.201108700; Zhou Y, 2008, MOL CANCER RES, V6, P1375, DOI 10.1158/1541-7786.MCR-07-2170; Zucconi BE, 2010, J BIOL CHEM, V285, P39127, DOI 10.1074/jbc.M110.180182	73	28	28	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1770	1785		10.1074/jbc.M114.618165	http://dx.doi.org/10.1074/jbc.M114.618165			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25451934	Green Published, hybrid			2022-12-26	WOS:000348056400042
J	Fatima, S; Haque, R; Jadiya, P; Shamsuzzama; Kumar, L; Nazir, A				Fatima, Soobiya; Haque, Rizwanul; Jadiya, Pooja; Shamsuzzama; Kumar, Lalit; Nazir, Aamir			Ida-1, the Caenorhabditis elegans Orthologue of Mammalian Diabetes Autoantigen IA-2, Potentially Acts as a Common Modulator between Parkinson's Disease and Diabetes: Role of Daf-2/Daf-16 Insulin Like Signalling Pathway	PLOS ONE			English	Article							C-ELEGANS; LIFE-SPAN; TRANSMEMBRANE PROTEIN; FAMILY; GENES; CHEMOTAXIS; EXPRESSION; DAF-16; MODELS	The lack of cure to age associated Parkinson's disease (PD) has been challenging the efforts of researchers as well as health care providers. Recent evidences suggest that diabetic patients tend to show a higher future risk for PD advocating a strong correlation between PD and Diabetes, thus making it intriguing to decipher common genetic cues behind these ailments. We carried out studies on ida-1, the C. elegans orthologue of mammalian type-1 diabetes auto-antigen IA-2 towards achieving its functional workup vis-a-vis various associated endpoints of PD and Diabetes. Employing transgenic C. elegans strain expressing "human'' alpha synuclein (NL5901) under normal and increased glucose concentrations, we studied aggregation of alpha synuclein, content of dopamine, expression of dopamine transporter, content of reactive oxygen species, locomotor activity, nuclear translocation of FOXO transcription factor Daf-16, and quantification of Daf2/Daf-16 mRNA. Our findings indicate that ida-1 affords protection in the studied disease conditions as absence of ida-1 resulted in higher alpha-synuclein aggregation under conditions that mimic the blood glucose levels of diabetic patients. We also observed reduced dopamine content, decreased motility, defective Daf-16 translocation and reduced expression of Daf-2 and Daf-16. Our studies establish important function of ida-1 as a modulator in Daf-2/Daf-16 insulin like signalling pathway thus possibly being a common link between PD and Diabetes.	[Fatima, Soobiya; Haque, Rizwanul; Jadiya, Pooja; Shamsuzzama; Kumar, Lalit; Nazir, Aamir] CSIR Cent Drug Res Inst, Div Toxicol, Lab Funct Genom & Mol Toxicol, Lucknow, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI)	Nazir, A (corresponding author), CSIR Cent Drug Res Inst, Div Toxicol, Lab Funct Genom & Mol Toxicol, Lucknow, Uttar Pradesh, India.	anazir@cdri.res.in		, Shamsuzzama/0000-0001-5289-338X; Haque, Rizwanul/0000-0002-3968-6359; Jadiya, Pooja/0000-0003-4807-9304; Nazir, Aamir/0000-0002-2503-1335	National Institutes of Health (NIH) Office of Research Infrastructure Programs [P40 OD010440]; Department of Science and Technology, Govt. of India under Cognitive Science Research Initiative [SR/CSI/17/2012 (G)]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Office of Research Infrastructure Programs; Department of Science and Technology, Govt. of India under Cognitive Science Research Initiative; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: The authors thank Caenorhabditis Genetics Center (CGC), University of Minnesota, MN, USA for providing the worm strains used in this study. Caenorhabditis Genetics Center is funded by National Institutes of Health (NIH) Office of Research Infrastructure Programs (P40 OD010440). AN thanks Department of Science and Technology, Govt. of India for funding under Cognitive Science Research Initiative [SR/CSI/17/2012 (G)]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; BARGMANN CI, 1991, NEURON, V7, P729, DOI 10.1016/0896-6273(91)90276-6; BRENNER S, 1974, GENETICS, V77, P71; Cai T, 2004, J NEUROSCI, V24, P3115, DOI 10.1523/JNEUROSCI.0101-04.2004; Cai T, 2001, DIABETOLOGIA, V44, P81, DOI 10.1007/s001250051583; Chiang WC, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002948; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Craft S, 2004, LANCET NEUROL, V3, P169, DOI 10.1016/S1474-4422(04)00681-7; Fraser AG, 2000, NATURE, V408, P325, DOI 10.1038/35042517; Jadiya P, 2012, CNS NEUROL DISORD-DR, V11, P1001; Jadiya P, 2012, CNS NEUROL DISORD-DR, V11, P976; Jadiya P, 2011, BIOCHEM BIOPH RES CO, V413, P605, DOI 10.1016/j.bbrc.2011.09.010; Jadiya P, 2011, BIOCHEM BIOPH RES CO, V413, P306, DOI 10.1016/j.bbrc.2011.08.092; Kaletta T, 2006, NAT REV DRUG DISCOV, V5, P387, DOI 10.1038/nrd2031; Kaur S, 2012, CNS NEUROL DISORD-DR, V11, P387, DOI 10.2174/187152712800792811; Lan MS, 1996, P NATL ACAD SCI USA, V93, P6367, DOI 10.1073/pnas.93.13.6367; Lee SS, 2003, SCIENCE, V300, P644, DOI 10.1126/science.1083614; Mahoney TR, 2006, NAT PROTOC, V1, P1772, DOI 10.1038/nprot.2006.281; Munoz-Lobato F, 2014, ANTIOXID REDOX SIGN, V20, P217, DOI 10.1089/ars.2012.5051; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nazir A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015312; Notkins AL, 2002, J BIOL CHEM, V277, P43545, DOI 10.1074/jbc.R200012200; Schaffitzel E, 2006, EXP GERONTOL, V41, P557, DOI 10.1016/j.exger.2006.02.008; Schlotterer A, 2009, DIABETES, V58, P2450, DOI 10.2337/db09-0567; Schulz TJ, 2007, CELL METAB, V6, P280, DOI 10.1016/j.cmet.2007.08.011; Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531; Skovronsky DM, 2006, ANNU REV PATHOL-MECH, V1, P151, DOI 10.1146/annurev.pathol.1.110304.100113; Stiernagle Theresa, 2006, WormBook, P1; Taylor R.C., 2011, COLD SPRING HARB PER, V3; Torii S, 2009, ENDOCR J, V56, P639, DOI 10.1507/endocrj.K09E-157; WARD S, 1973, P NATL ACAD SCI USA, V70, P817, DOI 10.1073/pnas.70.3.817; WHITE JG, 1976, PHILOS T R SOC B, V275, P327, DOI 10.1098/rstb.1976.0086; Xu Q, 2011, DIABETES CARE, V34, P910, DOI 10.2337/dc10-1922; Yen K, 2011, ANTIOXID REDOX SIGN, V14, P623, DOI 10.1089/ars.2010.3490; Zhong WW, 2006, SCIENCE, V311, P1481, DOI 10.1126/science.1123287	35	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113986	10.1371/journal.pone.0113986	http://dx.doi.org/10.1371/journal.pone.0113986			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469508	Green Published, Green Submitted, gold			2022-12-26	WOS:000349128700060
J	Franke, FA; Mayer, G				Franke, Franziska Anni; Mayer, Georg			Controversies Surrounding Segments and Parasegments in Onychophora: Insights from the Expression Patterns of Four "Segment Polarity Genes'' in the Peripatopsid Euperipatoides rowelli	PLOS ONE			English	Article							GLOMERIS-MARGINATA MYRIAPODA; HOX GENES; ENGRAILED GENE; EMBRYONIC-DEVELOPMENT; NERVOUS-SYSTEM; CELL LINEAGE; EVOLUTION; HEDGEHOG; WINGLESS; SUPPORT	Arthropods typically show two types of segmentation: the embryonic parasegments and the adult segments that lie out of register with each other. Such a dual nature of body segmentation has not been described from Onychophora, one of the closest arthropod relatives. Hence, it is unclear whether onychophorans have segments, parasegments, or both, and which of these features was present in the last common ancestor of Onychophora and Arthropoda. To address this issue, we analysed the expression patterns of the "segment polarity genes'' engrailed, cubitus interruptus, wingless and hedgehog in embryos of the onychophoran Euperipatoides rowelli. Our data revealed that these genes are expressed in repeated sets with a specific anterior-to-posterior order along the body in embryos of E. rowelli. In contrast to arthropods, the expression occurs after the segmental boundaries have formed. Moreover, the initial segmental furrow retains its position within the engrailed domain throughout development, whereas no new furrow is formed posterior to this domain. This suggests that no re-segmentation of the embryo occurs in E. rowelli. Irrespective of whether or not there is a morphological or genetic manifestation of parasegments in Onychophora, our data clearly show that parasegments, even if present, cannot be regarded as the initial metameric units of the onychophoran embryo, because the expression of key genes that define the parasegmental boundaries in arthropods occurs after the segmental boundaries have formed. This is in contrast to arthropods, in which parasegments rather than segments are the initial metameric units of the embryo. Our data further revealed that the expression patterns of "segment polarity genes'' correspond to organogenesis rather than segment formation. This is in line with the concept of segmentation as a result of concerted evolution of individual periodic structures rather than with the interpretation of 'segments' as holistic units.	[Franke, Franziska Anni; Mayer, Georg] Univ Leipzig, Inst Biol, D-04103 Leipzig, Germany	Leipzig University	Franke, FA (corresponding author), Univ Leipzig, Inst Biol, Talstr 33, D-04103 Leipzig, Germany.	FranziskaAnniFranke@uni-leipzig.de	Mayer, Georg/Y-9581-2018	Mayer, Georg/0000-0003-0737-2440	Emmy Noether Programme of the German Research Foundation (DFG) [Ma 4147/3-1]; German Research Foundation (DFG); Leipzig University	Emmy Noether Programme of the German Research Foundation (DFG)(German Research Foundation (DFG)); German Research Foundation (DFG)(German Research Foundation (DFG)); Leipzig University	Funding: This work was supported by the Emmy Noether Programme of the German Research Foundation (DFG, http://www.dfg.de/index.jsp) to GM (Ma 4147/3-1). The authors acknowledge support from the German Research Foundation (DFG) and Leipzig University within the program of Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allwood J, 2010, J BIOGEOGR, V37, P669, DOI 10.1111/j.1365-2699.2009.02233.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ARIAS AM, 1988, DEVELOPMENT, V103, P157; Baer A, 2014, J ZOOL SYST EVOL RES, V52, P265, DOI 10.1111/jzs.12070; Baer A, 2012, J MORPHOL, V273, P1079, DOI 10.1002/jmor.20044; Balavoine G, 2003, INTEGR COMP BIOL, V43, P137, DOI 10.1093/icb/43.1.137; Barclay S, 2000, J ZOOL, V250, P425, DOI 10.1111/j.1469-7998.2000.tb00786.x; Barclay SD, 2000, J ZOOL, V250, P437; Blaxter M, 2011, CURR BIOL, V21, pR238, DOI 10.1016/j.cub.2011.02.017; Browne WE, 2005, GENESIS, V42, P124, DOI 10.1002/gene.20145; Budd GE, 2001, EVOL DEV, V3, P332, DOI 10.1046/j.1525-142X.2001.01041.x; Campos-Ortega J, 1997, EMBRYONIC DEV DROSOP; CARROLL SB, 2005, DNA DIVERSITY MOL GE; Damen WGM, 2002, DEVELOPMENT, V129, P1239; Damen WGM, 2007, DEV DYNAM, V236, P1379, DOI 10.1002/dvdy.21157; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Dearden PK, 2002, DEVELOPMENT, V129, P5461, DOI 10.1242/dev.00099; Deutsch JS, 2004, BIOESSAYS, V26, P1117, DOI 10.1002/bies.20111; DINARDO S, 1994, CURR OPIN GENET DEV, V4, P529, DOI 10.1016/0959-437X(94)90068-E; DINARDO S, 1988, NATURE, V332, P604, DOI 10.1038/332604a0; Dohle W, 2004, CRUSTACEAN ISS, V15, P95; DOHLE W, 1988, DEVELOPMENT, V104, P147; Dray N, 2010, SCIENCE, V329, P339, DOI 10.1126/science.1188913; Eriksson BJ, 2010, DEV GENES EVOL, V220, P117, DOI 10.1007/s00427-010-0329-1; Eriksson BJ, 2009, DEV GENES EVOL, V219, P249, DOI 10.1007/s00427-009-0287-7; Farzana L, 2008, DEV GENES EVOL, V218, P181, DOI 10.1007/s00427-008-0207-2; Franke FA, EVOL DEV; Fusco Giuseppe, 2013, P197; Giribet G, 2012, ANNU REV ENTOMOL, V57, P167, DOI 10.1146/annurev-ento-120710-100659; Goodrich E. S., 1897, Quarterly J Micr Soc, Vxl, P247; Graham A, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-24; Grenier JK, 1997, CURR BIOL, V7, P547, DOI 10.1016/S0960-9822(06)00253-3; Hannibal RL, 2013, EVODEVO, V4, DOI 10.1186/2041-9139-4-35; Hering L, 2012, MOL BIOL EVOL, V29, P3451, DOI 10.1093/molbev/mss148; Hogvall M, 2014, EVODEVO, V5, DOI 10.1186/2041-9139-5-14; Hughes CL, 2002, EVOL DEV, V4, P459, DOI 10.1046/j.1525-142X.2002.02034.x; Hughes CL, 2002, DEVELOPMENT, V129, P1225; Hughes CL, 2002, DEV BIOL, V247, P47, DOI 10.1006/dbio.2002.0683; INGHAM PW, 1992, CELL, V68, P221, DOI 10.1016/0092-8674(92)90467-Q; Janssen R, 2004, DEV BIOL, V268, P89, DOI 10.1016/j.ydbio.2003.12.021; Janssen R, 2008, DEV GENES EVOL, V218, P361, DOI 10.1007/s00427-008-0231-2; Janssen R, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-22; Janssen R, 2013, DEV BIOL, V382, P224, DOI 10.1016/j.ydbio.2013.07.010; Janssen R, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-374; Jeffery NW, 2012, GENETICA, V140, P497, DOI 10.1007/s10709-013-9698-5; Kanayama M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1510; Kang DM, 2003, DEVELOPMENT, V130, P1645, DOI 10.1242/dev.00395; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Lawrence P., 1992, MAKING FLY GENETICS; LAWRENCE PA, 1988, DEVELOPMENT, V104, P61; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Martin C, 2014, FRONT NEUROSCI-SWITZ, V8, DOI [10.3389/fnins.2014.00211, 10.3389/fnana.2014.00007]; MARTINEZARIAS A, 1985, NATURE, V313, P639, DOI 10.1038/313639a0; Mayer G, 2006, ZOOMORPHOLOGY, V125, P1, DOI 10.1007/s00435-005-0006-5; Mayer G, 2005, ARTHROPOD STRUCT DEV, V34, P471, DOI 10.1016/j.asd.2005.03.004; Mayer G, NATURE; Mayer G, STRUCTURE EVOLUTION, P20; Mayer G, EVOLUTIONARY DEV BIO, V65; Mayer G, 2008, J COMP NEUROL, V507, P1196, DOI 10.1002/cne.21603; Mayer G, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-118; Mayer G, 2007, ZOOTAXA, P21, DOI 10.11646/zootaxa.1440.1.2; Mayer Georg, 2010, BMC Evol Biol, V10, P255, DOI 10.1186/1471-2148-10-255; Mayer G, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-230; Mayer G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059090; Mayer G, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-339; Mayer G, 2009, DEV BIOL, V335, P263, DOI 10.1016/j.ydbio.2009.08.011; Mayer G, 2009, P ROY SOC B-BIOL SCI, V276, P3571, DOI 10.1098/rspb.2009.0950; Mayer G, 2009, ZOOL J LINN SOC-LOND, V157, P17, DOI 10.1111/j.1096-3642.2009.00523.x; Murdock DJE, BMC EVOL BI IN PRESS; Murienne J, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2648; NAGY LM, 1994, NATURE, V367, P460, DOI 10.1038/367460a0; Nielsen C, 2012, ANIMAL EVOLUTION: INTERRELATIONSHIPS OF THE LIVING PHYLA, 3RD EDITION, P1; Oda H, 2007, DEVELOPMENT, V134, P2195, DOI 10.1242/dev.004598; Oliveira ID, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-73; Oliveira ID, 2013, J MORPHOL, V274, P1180, DOI 10.1002/jmor.20171; Oliveira IDS, 2013, ZOOL ANZ, V252, P495, DOI 10.1016/j.jcz.2013.01.001; Oliveira ID, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051220; Ou Q, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2272; Pang K., 2010, MNEMIONSIS LEIDYI EV, V1, P10, DOI DOI 10.1186/2041-9139-1-10; PATEL NH, 1994, DEVELOPMENT, P201; PATEL NH, 1989, DEVELOPMENT, V107, P201; PATEL NH, 1989, GENE DEV, V3, P890, DOI 10.1101/gad.3.6.890; Piepenburg O, 2000, MOL CELL, V6, P203, DOI 10.1016/S1097-2765(00)00022-8; Prpic NM, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-17; Prpic NM, 2003, DEV BIOL, V260, P97, DOI 10.1016/S0012-1606(03)00217-3; Prud'homme B, 2003, CURR BIOL, V13, P1876, DOI 10.1016/j.cub.2003.10.006; Reid AL, 1996, INVERTEBR TAXON, V10, P663, DOI 10.1071/IT9960663; ROBSON EA, 1966, NATURE, V209, P533, DOI 10.1038/209533a0; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Sanson B, 2001, EMBO REP, V2, P1083, DOI 10.1093/embo-reports/kve255; Saudemont A, 2008, DEV BIOL, V317, P430, DOI 10.1016/j.ydbio.2008.02.013; Schinko J, 2009, COLD SPRING HARB PRO, V8; SCHOLTZ G, 1995, BIOL BULL, V188, P157, DOI 10.2307/1542081; Scholtz G, 2002, ORG DIVERS EVOL, V2, P197, DOI 10.1078/1439-6092-00046; Scholtz G, 1996, INT J DEV BIOL, V40, P211; Schwager EE, 2007, FRONT ZOOL, V4, DOI 10.1186/1742-9994-4-10; Seaver EC, 2001, DEV BIOL, V236, P195, DOI 10.1006/dbio.2001.0309; Seaver EC, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-8; Simonnet F, 2004, DEV GENES EVOL, V214, P537, DOI 10.1007/s00427-004-0435-z; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Sunnucks P, 2000, J ZOOL, V250, P447, DOI 10.1111/j.1469-7998.2000.tb00788.x; Tautz D, 2004, DEV CELL, V7, P301, DOI 10.1016/j.devcel.2004.08.008; Treffkorn S, 2013, GENE EXPR PATTERNS, V13, P384, DOI 10.1016/j.gep.2013.07.004; Walker MH, 2004, J ZOOL, V264, P333, DOI 10.1017/s0952836904005837; Whitington PM, 2011, ARTHROPOD STRUCT DEV, V40, P193, DOI 10.1016/j.asd.2011.01.006; Zhang ZQ, 2011, ZOOTAXA, P7, DOI 10.11646/zootaxa.3148.1.3; Zhang Zhi-Qiang, 2011, Zootaxa, V3148, P1, DOI 10.11646/zootaxa.3703.1.1	109	26	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114383	10.1371/journal.pone.0114383	http://dx.doi.org/10.1371/journal.pone.0114383			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470738	Green Submitted, Green Published, gold			2022-12-26	WOS:000349128700113
J	Watts, NS; Pajuelo, M; Clark, T; Loader, MCI; Verastegui, MR; Sterling, C; Friedland, JS; Garcia, HH; Gilman, RH				Watts, Nathaniel S.; Pajuelo, Monica; Clark, Taryn; Loader, Maria-Cristina I.; Verastegui, Manuela R.; Sterling, Charles; Friedland, Jon S.; Garcia, Hector H.; Gilman, Robert H.		Cysticercosis Working Grp Peru	Taenia solium Infection in Peru: A Collaboration between Peace Corps Volunteers and Researchers in a Community Based Study	PLOS ONE			English	Article							RISK-FACTORS; PORCINE CYSTICERCOSIS; RURAL VILLAGE; HYPERENDEMIC HUMAN; MASS CHEMOTHERAPY; TAPEWORM CARRIERS; NEUROCYSTICERCOSIS; PREVALENCE; FASCIOLIASIS; CAJAMARCA	Background: Neurocysticercosis is a leading cause of seizures and epilepsy in most of the world, and it occurs when Taenia solium larval cysts infect the central nervous system. T. solium tapeworm infection is endemic in much of Peru, but there are scarce data on the prevalence in many rural highland communities where it is likely to be hyper-endemic. Peace Corps Volunteers live and work in these communities; however, to our knowledge, they have not been used to facilitate public health research. Materials and Methods: We utilized Peace Corps Volunteers to estimate the prevalence of T. solium tapeworm infection in seven rural communities in northern Peru. A convenience non-random sampling frame was used. Peace Corps Volunteers facilitated the collection of stool samples (N=2,328), which were analyzed by sedimentation and microscopy. Niclosamide treatment and purgation preceded species identification, which was done by PCR-REA. Results: Taenia sp. egg-positive stool samples were found in three of the seven communities we surveyed. The overall prevalence of Taenia sp. egg positivity was 2.1% (49/2,328) (95% CI=1.6-2.8%) with prevalence up to 4.3% (42/977) (95% CI=3.1-5.8%) by community. All 34 of the specimens tested by PCR-REA were T. solium. The overall prevalence of T. solium tapeworm infection was 1.5% (34/2,328) (95% CI=1.0-2.0%). Prevalence up to 2.9% (28/977) (95% CI=1.9-4.1%) by community was observed. Conclusion/Significance: This study recorded high T. solium tapeworm prevalence, and identified hyper-endemic rural communities. It demonstrates that synergy between researchers and Peace Corps Volunteers can be an effective means to conducting large-scale, community-based studies in remote areas of Peru.	[Watts, Nathaniel S.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA; [Pajuelo, Monica] Univ Peruana Cayetano Heredia, Sch Sci & Philosophy, Unit Bioinformat & Mol Biol, Lima, Peru; [Clark, Taryn] Weill Cornell Med Coll, New York, NY USA; [Loader, Maria-Cristina I.; Friedland, Jon S.] Univ London Imperial Coll Sci Technol & Med, Wellcome Trust Imperial Ctr Global Hlth, London, England; [Verastegui, Manuela R.; Garcia, Hector H.] Univ Peruana Cayetano Heredia, Sch Sci & Philosophy, Dept Microbiol, Lima, Peru; [Sterling, Charles] Univ Arizona, Sch Anim & Comparat Biomed Sci, Tucson, AZ USA; [Gilman, Robert H.] Asociac Benef Proyectos Informat Salud Med & Agr, Lima, Peru; [Gilman, Robert H.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA	Boston University; Universidad Peruana Cayetano Heredia; Cornell University; Imperial College London; Universidad Peruana Cayetano Heredia; University of Arizona; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Watts, NS (corresponding author), Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA.	natswatts@gmail.com		Friedland, Jonathan S/0000-0001-7789-9649; Verastegui, Manuela/0000-0002-7500-1353; pajuelo, monica/0000-0003-3662-2250; Loader, Maria Cristina/0000-0003-0556-2363	D43 International Global Infectious Disease Research Training Grant [5D43TW006581-10]; RG-ER fund; MRC [MR/K007467/1] Funding Source: UKRI; Medical Research Council [MR/K007467/1] Funding Source: researchfish; National Institute for Health Research [ACF-2012-21-008] Funding Source: researchfish; FOGARTY INTERNATIONAL CENTER [D43TW006581] Funding Source: NIH RePORTER	D43 International Global Infectious Disease Research Training Grant; RG-ER fund; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was funded by the D43 International Global Infectious Disease Research Training Grant 5D43TW006581-10. The authors also acknowledge the anonymous RG-ER fund for funding NW and TC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The anonymous RG-ER fund is an anonymous donor who is a person and not a fund. There is no expansion of the name possible. There is no conflict of interest with this fund. It is not an organization or a company.	ALLAN JC, 1990, PARASITOLOGY, V101, P473, DOI 10.1017/S0031182000060686; Allan JC, 1997, T ROY SOC TROP MED H, V91, P595, DOI 10.1016/S0035-9203(97)90042-0; Allan JC, 1996, AM J TROP MED HYG, V54, P352, DOI 10.4269/ajtmh.1996.54.352; [Anonymous], 2005, AIDS Policy Law, V20, P2; Barnes Shawn, 2009, Community Eye Health, V22, pS1; CAMACHO SD, 1990, T ROY SOC TROP MED H, V84, P563, DOI 10.1016/0035-9203(90)90041-C; CAMACHO SPD, 1991, AM J TROP MED HYG, V45, P522, DOI 10.4269/ajtmh.1991.45.522; Gonzalez LC, 2011, ACTA TROP, V120, P119, DOI 10.1016/j.actatropica.2011.07.002; CRUZ M, 1989, B WORLD HEALTH ORGAN, V67, P401; Esteban JG, 2002, TROP MED INT HEALTH, V7, P339, DOI 10.1046/j.1365-3156.2002.00870.x; Garcia HH, 2006, AM J TROP MED HYG, V74, P850, DOI 10.4269/ajtmh.2006.74.850; Garcia Hector H., 2010, Rev. perú. med. exp. salud publica, V27, P592, DOI 10.1590/s1726-46342010000400016; Garcia HH, 2003, AM J TROP MED HYG, V68, P268, DOI 10.4269/ajtmh.2003.68.268; Garcia HH, 2003, LANCET, V362, P547, DOI 10.1016/S0140-6736(03)14117-7; Huisa BN, 2005, AM J TROP MED HYG, V73, P496, DOI 10.4269/ajtmh.2005.73.496; Jayashi CM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001733; Jeri C, 2004, LANCET, V363, P949, DOI 10.1016/S0140-6736(04)15791-7; Krecek RC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037718; Lescano AG, 2007, AM J TROP MED HYG, V76, P376, DOI 10.4269/ajtmh.2007.76.376; Lescano AG, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000371; Mayta H, 2000, J CLIN MICROBIOL, V38, P133; Montano SM, 2005, NEUROLOGY, V65, P229, DOI 10.1212/01.wnl.0000168828.83461.09; Morales J, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000284; Moyano LM, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002692; Mullan F, 2007, JAMA-J AM MED ASSOC, V297, P744, DOI 10.1001/jama.297.7.744; Mwanjali G, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002102; Mwape KE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002142; Mwape KE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001594; Nash TE, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001964; Ngowi HA, 2004, VET PARASITOL, V120, P275, DOI 10.1016/j.vetpar.2004.01.015; Nyberg BJ, 2012, JAIDS-J ACQ IMM DEF, V60, pS127, DOI 10.1097/QAI.0b013e31825da836; O'Neal SE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001953; Rinaldi L, 2012, GEOSPATIAL HEALTH, V6, pS67; Rodriguez-Canul R, 1999, ANN TROP MED PARASIT, V93, P57, DOI 10.1080/00034989958807; Rodriguez-Hidalgo R, 2006, MEM I OSWALDO CRUZ, V101, P779, DOI 10.1590/S0074-02762006000700012; Roldan WH, 2009, REV INST MED TROP SP, V51, P67, DOI 10.1590/S0036-46652009000200002; SARTI E, 1992, AM J TROP MED HYG, V46, P677, DOI 10.4269/ajtmh.1992.46.677; SARTI E, 1994, T ROY SOC TROP MED H, V88, P49, DOI 10.1016/0035-9203(94)90493-6; Sikasunge CS, 2007, VET PARASITOL, V143, P59, DOI 10.1016/j.vetpar.2006.07.023; Somers R, 2006, TROP MED INT HEALTH, V11, P65, DOI 10.1111/j.1365-3156.2005.01537.x; Tello R, 1988, 6 JORN CIENT; Turaga Kiran K, 2006, Hernia, V10, P294, DOI 10.1007/s10029-006-0111-5; Villaran MV, 2009, NEUROEPIDEMIOLOGY, V33, P25, DOI 10.1159/000210019	43	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113239	10.1371/journal.pone.0113239	http://dx.doi.org/10.1371/journal.pone.0113239			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469506	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000349128700018
J	Breda, AP; de Albuquerque, ALP; Jardim, C; Morinaga, LK; Suesada, MM; Fernandes, CJC; Dias, B; Lourenco, RB; Salge, JM; Souza, R				Breda, Ana Paula; Pereira de Albuquerque, Andre Luis; Jardim, Carlos; Morinaga, Luciana Kato; Suesada, Milena Mako; Cesar Fernandes, Caio Julio; Dias, Bruno; Lourenco, Rafael Burgomeister; Salge, Joao Marcos; Souza, Rogerio			Skeletal Muscle Abnormalities in Pulmonary Arterial Hypertension	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; LUNG-FUNCTION TESTS; 6-MINUTE WALK TEST; BODY-COMPOSITION; PROGNOSTIC-SIGNIFICANCE; REFERENCE VALUES; EXERCISE; DYSFUNCTION; SURVIVAL; DISEASE	Background: Pulmonary arterial hypertension is a progressive disease that is characterized by dyspnea and exercise intolerance. Impairment in skeletal muscle has recently been described in PAH, although the degree to which this impairment is solely determined by the hemodynamic profile remains uncertain. The aim of this study was to verify the association of structural and functional skeletal muscle characteristics with maximum exercise in PAH. Methods: The exercise capacity, body composition, CT area of limb muscle, quality of life, quadriceps biopsy and hemodynamics of 16 PAH patients were compared with those of 10 controls. Results: PAH patients had a significantly poorer quality of life, reduced percentage of lean body mass, reduced respiratory muscle strength, reduced resistance and strength of quadriceps and increased functional limitation at 6MWT and CPET. VO2 max was correlated with muscular variables and cardiac output. Bivariate linear regression models showed that the association between muscular structural and functional variables remained significant even after correcting for cardiac output. Conclusion: Our study showed the coexistence of ventilatory and quadriceps weakness in face of exercise intolerance in the same group of PAH patients. More interestingly, it is the first time that the independent association between muscular pattern and maximum exercise capacity is evidenced in PAH, independently of cardiac index highlighting the importance of considering rehabilitation in the treatment strategy for PAH.	[Breda, Ana Paula; Pereira de Albuquerque, Andre Luis; Jardim, Carlos; Morinaga, Luciana Kato; Suesada, Milena Mako; Cesar Fernandes, Caio Julio; Dias, Bruno; Salge, Joao Marcos; Souza, Rogerio] Univ Sao Paulo, Sch Med, Dept Pulm, Inst Heart, Sao Paulo, Brazil; [Lourenco, Rafael Burgomeister] Univ Sao Paulo, Sch Med, Dept Radiol, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Souza, R (corresponding author), Univ Sao Paulo, Sch Med, Dept Pulm, Inst Heart, Sao Paulo, Brazil.	rogerio.souza@incor.usp.br	Jardim, Carlos V P/N-8061-2017; Fernandes, Caio/W-8676-2019; Fernandes, Caio JCS/K-9194-2016; Salge, Joao M/B-5157-2015; Souza, Rogerio/I-3584-2013; Albuquerque, Andre/C-8835-2012	Jardim, Carlos V P/0000-0003-0425-5548; Fernandes, Caio/0000-0002-4912-021X; Fernandes, Caio JCS/0000-0002-4912-021X; Salge, Joao M/0000-0001-5121-0129; Souza, Rogerio/0000-0003-2789-9143; Albuquerque, Andre/0000-0003-3486-5240	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo) [2007/04862-6]	FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This study has been done with the support of FAPESP (Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; grant 2007/04862-6). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Thoracic Society European Respiratory Society, 2002, AM J RESP CRIT CARE, V166; [Anonymous], 2002, AM J RESP CRIT CARE, V166, P111; Badesch DB, 2009, J AM COLL CARDIOL, V54, pS55, DOI 10.1016/j.jacc.2009.04.011; Batt J, 2014, AM J RESP CELL MOL, V50, P74, DOI 10.1165/rcmb.2012-0506OC; Bauer R, 2007, RESP MED, V101, P2366, DOI 10.1016/j.rmed.2007.06.014; Fernandes CJCD, 2010, J AM COLL CARDIOL, V56, P715, DOI 10.1016/j.jacc.2010.03.065; Dall'Ago P, 2006, J AM COLL CARDIOL, V47, P757, DOI 10.1016/j.jacc.2005.09.052; Debigare R, 2003, CHEST, V124, P83, DOI 10.1378/chest.124.1.83; Deboeck G, 2004, EUR RESPIR J, V23, P747, DOI 10.1183/09031936.04.00111904; Dorfmuller P, 2003, EUR RESPIR J, V22, P358, DOI 10.1183/09031936.03.00038903; Futter JE, 2011, EUR J HEART FAIL, V13, P207, DOI 10.1093/eurjhf/hfq218; Galie N, 2009, EUR RESP J; Hassoun PM, 2009, J AM COLL CARDIOL, V54, pS10, DOI 10.1016/j.jacc.2009.04.006; Humbert M, 2004, NEW ENGL J MED, V351, P1425, DOI 10.1056/NEJMra040291; Humbert M, 2010, EUR RESPIR J, V36, P549, DOI 10.1183/09031936.00057010; Humbert M, 2010, CIRCULATION, V122, P156, DOI 10.1161/CIRCULATIONAHA.109.911818; Jardim C, 2010, EUR RESPIR REV, V19, P266, DOI 10.1183/09059180.00008810; Lapa M, 2009, CIRCULATION, V119, P1518, DOI 10.1161/CIRCULATIONAHA.108.803221; Lerario MC, 2006, BRIT J NUTR, V96, P86, DOI 10.1079/BJN20061798; Mainguy V, 2010, J CARDIOPULM REHABIL, V30, P319, DOI 10.1097/HCR.0b013e3181d6f962; Mainguy V, 2010, THORAX, V65, P113, DOI 10.1136/thx.2009.117168; Mereles D, 2006, CIRCULATION, V114, P1482, DOI 10.1161/CIRCULATIONAHA.106.618397; Meyer FJ, 2005, EUR RESPIR J, V25, P125, DOI 10.1183/09031936.04.00095804; Meyer FJ, 2001, CIRCULATION, V103, P2153; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Miyamoto S, 2000, AM J RESP CRIT CARE, V161, P487, DOI 10.1164/ajrccm.161.2.9906015; Neder JA, 1999, EUR RESPIR J, V14, P1304, DOI 10.1183/09031936.99.14613049; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P729, DOI 10.1590/S0100-879X1999000600008; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P703, DOI 10.1590/S0100-879X1999000600006; Pereira CAC SB, 1992, BRAZILIAN J PULMONOL, V18, P10; Provencher S, 2010, EUR RESPIR J, V35, P958, DOI 10.1183/09031936.00007110; Satta A, 1997, EUR RESPIR J, V10, P2853, DOI 10.1183/09031936.97.10122853; Schols AMWJ, 2005, AM J CLIN NUTR, V82, P53, DOI 10.1093/ajcn/82.1.53; Sun XG, 2001, CIRCULATION, V104, P429, DOI 10.1161/hc2901.093198; Tolle J, 2008, MED SCI SPORT EXER, V40, P3, DOI 10.1249/mss.0b013e318159d1b8; Uszko-Lencer NHMK, 2006, EUR J HEART FAIL, V8, P208, DOI 10.1016/j.ejheart.2005.07.007; Velez-Roa S, 2004, CIRCULATION, V110, P1308, DOI 10.1161/01.CIR.0000140724.90898.D3; Wanger J, 2005, EUR RESPIR J, V26, P511, DOI 10.1183/09031936.05.00035005; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002	39	37	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114101	10.1371/journal.pone.0114101	http://dx.doi.org/10.1371/journal.pone.0114101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460348	Green Submitted, Green Published, gold			2022-12-26	WOS:000345869700098
J	Sridharamurthy, M; Kovach, A; Zhao, Y; Zhu, JK; Xu, HE; Swaminathan, K; Melcher, K				Sridharamurthy, Madhuri; Kovach, Amanda; Zhao, Yang; Zhu, Jian-Kang; Xu, H. Eric; Swaminathan, Kunchithapadam; Melcher, Karsten			H2O2 Inhibits ABA-Signaling Protein Phosphatase HAB1	PLOS ONE			English	Article							ABSCISIC-ACID ACTIVATION; INDUCED STOMATAL CLOSURE; HYDROGEN-PEROXIDE; REVERSIBLE INACTIVATION; NEGATIVE REGULATOR; ANION CHANNEL; WATER-STRESS; GUARD-CELLS; 2C; ARABIDOPSIS	Due to its ability to be rapidly generated and propagated over long distances, H2O2 is an important second messenger for biotic and abiotic stress signaling in plants. In response to low water potential and high salt concentrations sensed in the roots of plants, the stress hormone abscisic acid (ABA) activates NADPH oxidase to generate H2O2, which is propagated in guard cells in leaves to induce stomatal closure and prevent water loss from transpiration. Using a reconstituted system, we demonstrate that H2O2 reversibly prevents the protein phosphatase HAB1, a key component of the core ABA-signaling pathway, from inhibiting its main target in guard cells, SnRK2.6/OST1 kinase. We have identified HAB1 C186 and C274 as H2O2-sensitive thiols and demonstrate that their oxidation inhibits both HAB1 catalytic activity and its ability to physically associate with SnRK2.6 by formation of intermolecular dimers.	[Sridharamurthy, Madhuri; Kovach, Amanda; Xu, H. Eric; Melcher, Karsten] Van Andel Res Inst, Lab Struct Sci Struct Biol, Grand Rapids, MI USA; [Sridharamurthy, Madhuri; Kovach, Amanda; Xu, H. Eric; Melcher, Karsten] Van Andel Res Inst, Biochem Lab, Grand Rapids, MI USA; [Sridharamurthy, Madhuri; Swaminathan, Kunchithapadam] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Zhao, Yang; Zhu, Jian-Kang] Purdue Univ, Dept Hort & Landscape Architecture, W Lafayette, IN 47906 USA; [Xu, H. Eric] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai Inst Biol Sci,Ctr Struct & Funct Drug Ta, State Key Lab Drug Res,VARI SIMM Ctr, Shanghai 200031, Peoples R China	Van Andel Institute; Van Andel Institute; National University of Singapore; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Chinese Academy of Sciences; Shanghai Institute of Materia Medica, CAS; Shanghai Institutes for Biological Sciences, CAS	Swaminathan, K (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.	dbsks@nus.edu.sg; karsten.melcher@vai.org	Xu, H. Eric/ABD-7487-2021; Melcher, Karsten/AAZ-3861-2020; Zhao, Yang/H-2827-2014; Zhu, Jian-Kang/F-7658-2011	Melcher, Karsten/0000-0002-9125-4027; Zhao, Yang/0000-0003-0302-3470; Zhu, Jian-Kang/0000-0001-5134-731X; Xu, H. Eric/0000-0002-6829-8144	Jay and Betty Van Andel Foundation; National Institutes of Health from the Academic Research Fund of Singapore [R01 GM102545]; National University of Singapore; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM102545] Funding Source: NIH RePORTER	Jay and Betty Van Andel Foundation; National Institutes of Health from the Academic Research Fund of Singapore(Ministry of Education, Singapore); National University of Singapore(National University of Singapore); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Jay and Betty Van Andel Foundation (HEX and KM), by the National Institutes of Health (grant R01 GM102545 to KM), from the Academic Research Fund of Singapore (KS and MS), and by a Research Scholarship from the National University of Singapore (MS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya BR, 2013, NEW PHYTOL, V200, P1049, DOI 10.1111/nph.12469; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Baxter A, 2014, J EXP BOT, V65, P1229, DOI 10.1093/jxb/ert375; Brandt B, 2012, P NATL ACAD SCI USA, V109, P10593, DOI 10.1073/pnas.1116590109; Chaves MM, 2002, ANN BOT-LONDON, V89, P907, DOI 10.1093/aob/mcf105; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Creissen G, 1999, PLANT CELL, V11, P1277, DOI 10.1105/tpc.11.7.1277; Danquah A, 2014, BIOTECHNOL ADV, V32, P40, DOI 10.1016/j.biotechadv.2013.09.006; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Di YJ, 2012, EMBO J, V31, P563, DOI 10.1038/emboj.2011.438; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Geiger D, 2009, P NATL ACAD SCI USA, V106, P21425, DOI 10.1073/pnas.0912021106; Gosti F, 1999, PLANT CELL, V11, P1897, DOI 10.1105/tpc.11.10.1897; Grill E, 1998, CURR OPIN PLANT BIOL, V1, P412, DOI 10.1016/S1369-5266(98)80265-3; Himmelbach A, 1998, PHILOS T R SOC B, V353, P1439, DOI 10.1098/rstb.1998.0299; Hubbard KE, 2010, GENE DEV, V24, P1695, DOI 10.1101/gad.1953910; Jannat R, 2011, J PLANT PHYSIOL, V168, P1919, DOI 10.1016/j.jplph.2011.05.006; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Meinhard M, 2002, PLANTA, V214, P775, DOI 10.1007/s00425-001-0675-3; Meinhard M, 2001, FEBS LETT, V508, P443, DOI 10.1016/S0014-5793(01)03106-4; Melcher K, 2009, NATURE, V462, P602, DOI 10.1038/nature08613; Merlot S, 2001, PLANT J, V25, P295, DOI 10.1046/j.1365-313x.2001.00965.x; MEYER K, 1994, SCIENCE, V264, P1452, DOI 10.1126/science.8197457; Miller G, 2008, PHYSIOL PLANTARUM, V133, P481, DOI 10.1111/j.1399-3054.2008.01090.x; Miyazono K, 2009, NATURE, V462, P609, DOI 10.1038/nature08583; Murata Y, 2001, PLANT CELL, V13, P2513, DOI 10.1105/tpc.13.11.2513; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Nakashima K, 2009, PLANT CELL PHYSIOL, V50, P1345, DOI 10.1093/pcp/pcp083; Ng LM, 2014, ACTA PHARMACOL SIN, V35, P567, DOI 10.1038/aps.2014.5; Nishimura N, 2010, PLANT J, V61, P290, DOI 10.1111/j.1365-313X.2009.04054.x; Nishimura N, 2009, SCIENCE, V326, P1373, DOI 10.1126/science.1181829; Okamoto M, 2013, P NATL ACAD SCI USA, V110, P12132, DOI 10.1073/pnas.1305919110; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Pei ZM, 2000, NATURE, V406, P731, DOI 10.1038/35021067; Puli MR, 2012, J EXP BOT, V63, P1349, DOI 10.1093/jxb/err364; Quan LJ, 2008, J INTEGR PLANT BIOL, V50, P2, DOI 10.1111/j.1744-7909.2007.00599.x; Rhee S G, 2000, Sci STKE, V2000, ppe1; Robert N, 2006, FEBS LETT, V580, P4691, DOI 10.1016/j.febslet.2006.07.047; Rodriguez PL, 1998, FEBS LETT, V421, P185, DOI 10.1016/S0014-5793(97)01558-5; Saez A, 2004, PLANT J, V37, P354, DOI 10.1046/j.1365-313X.2003.01966.x; Saez A, 2006, PLANT PHYSIOL, V141, P1389, DOI 10.1104/pp.106.081018; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Sato A, 2009, BIOCHEM J, V424, P439, DOI 10.1042/BJ20091221; Schroeder JI, 2001, ANNU REV PLANT PHYS, V52, P627, DOI 10.1146/annurev.arplant.52.1.627; Sirichandra C, 2009, FEBS LETT, V583, P2982, DOI 10.1016/j.febslet.2009.08.033; Slesak I, 2007, ACTA BIOCHIM POL, V54, P39, DOI 10.18388/abp.2007_3267; Song YW, 2014, NEW PHYTOL, V201, P1121, DOI 10.1111/nph.12565; Soon FF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047857; Soon FF, 2012, SCIENCE, V335, P85, DOI 10.1126/science.1215106; Van Breusegem F, 2001, PLANT SCI, V161, P405, DOI 10.1016/S0168-9452(01)00452-6; van Montfort RLM, 2003, NATURE, V423, P773, DOI 10.1038/nature01681; Walchli S, 2005, BIOCHEM BIOPH RES CO, V331, P497, DOI 10.1016/j.bbrc.2005.03.196; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Yoshida T, 2010, PLANT J, V61, P672, DOI 10.1111/j.1365-313X.2009.04092.x; Zhang X, 2001, PLANT PHYSIOL, V126, P1438, DOI 10.1104/pp.126.4.1438	59	19	19	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113643	10.1371/journal.pone.0113643	http://dx.doi.org/10.1371/journal.pone.0113643			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460914	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700040
J	Stowe, HM; Calcatera, SM; Dimmick, MA; Andrae, JG; Duckett, SK; Pratt, SL				Stowe, Heather M.; Calcatera, Samantha M.; Dimmick, Marcy A.; Andrae, John G.; Duckett, Susan K.; Pratt, Scott L.			The Bull Sperm MicroRNAome and the Effect of Fescue Toxicosis on Sperm MicroRNA Expression	PLOS ONE			English	Article							INFECTED TALL FESCUE; SPERMATOGONIAL DIFFERENTIATION; RETINOIC ACID; RNA; FERTILITY; CLUSTERS	Tall fescue [Schedonorus phoenix (Scop.) Holub] accounts for nearly 16 million hectares of pasture in the Southeastern and Mid-Atlantic U.S. due to its heat, drought, and pest resistance, conferred to the plant by its symbiotic relationship with the endophyte Neotyphodium coenophialum. The endophyte produces ergot alkaloids that have negative effects on the growth and reproduction of animals, resulting in the syndrome known as fescue toxicosis. The objectives of our study were to identify microRNA (miRNA) present in bovine sperm and to evaluate the effects of fescue toxicosis on sperm miRNA expression. Angus bulls were assigned to treatments of either toxic or non-toxic fescue seed diets. Semen was collected and subjected to RNA isolation. Three samples from each treatment group were chosen and pooled for deep sequencing. To compare miRNA expression between treatment groups, a microarray was designed and conducted. For each of the top ten expressed miRNA, target prediction analysis was conducted using TargetScan. Gene ontology enrichment was assessed using the Database for Annotation, Visualization and Integrated Discovery. Sequencing results elucidated the presence of 1,582 unique small RNA present in sperm. Of those sequences, 382 were known Bos taurus miRNA, 22 were known but novel to Bos taurus, and 816 were predicted candidate miRNA that did not map to any currently reported miRNA. Of the sequences chosen for microarray, twenty-two showed significant differential expression between treatment groups. Gene pathways of interest included: regulation of transcription, embryonic development (including blastocyst formation), Wnt and Hedgehog signaling, oocyte meiosis, and kinase and phosphatase activity. MicroRNA present in mature sperm appears to not only be left over from spermatogenic processes, but may actually serve important regulatory roles in fertilization and early developmental processes. Further, our results indicate the possibility that environmental changes may impact the expression of specific miRNA.	[Stowe, Heather M.; Calcatera, Samantha M.; Dimmick, Marcy A.; Andrae, John G.; Duckett, Susan K.; Pratt, Scott L.] Clemson Univ, Dept Anim & Vet Sci, Clemson, SC 29631 USA	Clemson University	Stowe, HM (corresponding author), Clemson Univ, Dept Anim & Vet Sci, Clemson, SC 29631 USA.	hmstowe@gmail.com			National Institute of Food and Agriculture (NIFA) of the United States Department of Agriculture (USDA) [SC-1700376]; National Research Initiative Competitive Grant from the USDA NIFA [2010-38942-20745]; Cooperative State Research, Education, and Extension Service	National Institute of Food and Agriculture (NIFA) of the United States Department of Agriculture (USDA); National Research Initiative Competitive Grant from the USDA NIFA; Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture)	This material is based upon work supported by the National Institute of Food and Agriculture (NIFA) of the United States Department of Agriculture (USDA), under project number SC-1700376 and was supported by National Research Initiative Competitive Grant no. 2010-38942-20745 from the USDA NIFA and the Cooperative State Research, Education, and Extension Service (SKD, SLP, JGA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Halima M, 2013, FERTIL STERIL, V99, P1249, DOI 10.1016/j.fertnstert.2012.11.054; Allen VG, 2001, J RANGE MANAGE, V54, P409, DOI 10.2307/4003111; BACON CW, 1995, J ANIM SCI, V73, P861; BEERS KW, 1987, ARKANSAS FARM RES, V36, P7; Belesky D. P., 2009, TALL FESCUE 21 CENTU, P49; BOLING JA, 1985, PROF ANIM SCI, V1; Cloonan N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-12-r126; Cui XS, 2013, REPROD FERT DEVELOP, V25, P691, DOI 10.1071/RD12138; Curry E, 2009, MOL REPROD DEV, V76, DOI 10.1002/mrd.20980; Curry E, 2011, THERIOGENOLOGY, V76, P1532, DOI 10.1016/j.theriogenology.2011.06.025; EVANS KL, 1988, THERIOGENOLOGY, V30, P169, DOI 10.1016/0093-691X(88)90274-9; GAY N, 1988, APPL AGR RES, V3; Govindaraju A, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-82; Grandjean V, 2009, DEVELOPMENT, V136, P3647, DOI 10.1242/dev.041061; Guo L, 2012, MOL BIOL REP, V39, P6699, DOI 10.1007/s11033-012-1493-3; He ZP, 2009, REPRODUCTION, V137, P901, DOI 10.1530/REP-08-0494; HOVELAND CS, 1993, AGR ECOSYST ENVIRON, V44, P3, DOI 10.1016/0167-8809(93)90036-O; HUANG K, 2014, BIOCHIMIE; Huszar JM, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.103747; Jones K. L., 2004, Professional Animal Scientist, V20, P437; Kocamis H, 2013, POULTRY SCI, V92, P787, DOI 10.3382/ps.2012-02691; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krawetz SA, 2011, HUM REPROD, V26, P3401, DOI 10.1093/humrep/der329; Le MTN, 2009, GENE DEV, V23, P862, DOI 10.1101/gad.1767609; Lee LW, 2010, RNA, V16, P2170, DOI 10.1261/rna.2225110; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06; Liu WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037039; Liu WM, 2012, P NATL ACAD SCI USA, V109, P490, DOI 10.1073/pnas.1110368109; Looper ML, 2009, J ANIM SCI, V87, P1184, DOI 10.2527/jas.2008-1258; McIver SC, 2012, HUM REPROD UPDATE, V18, P44, DOI 10.1093/humupd/dmr041; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Niu ZY, 2011, P NATL ACAD SCI USA, V108, P12740, DOI 10.1073/pnas.1109987108; Ostermeier GC, 2004, NATURE, V429, P154, DOI 10.1038/429154a; PORTER JK, 1992, J ANIM SCI, V70, P1594, DOI 10.2527/1992.7051594x; Rodgers AB, 2013, J NEUROSCI, V33, P9003, DOI 10.1523/JNEUROSCI.0914-13.2013; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; SCHMIDT SP, 1986, FESCUE FUNGUS SUPPRE, V3315; Schuenemann GM, 2005, REPROD FERT DEVELOP, V17, P479, DOI 10.1071/RD05005; Schuenemann GM, 2005, THERIOGENOLOGY, V63, P1407, DOI 10.1016/j.theriogenology.2004.07.014; Stowe HM, 2013, J ANIM SCI, V91, P3686, DOI 10.2527/jas.2012-6078; Strickland JR, 2011, J ANIM SCI, V89, P1603, DOI 10.2527/jas.2010-3478; Tong MH, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096313; Tong MH, 2011, BIOL REPROD, V85, P189, DOI 10.1095/biolreprod.110.089458; Wang J, 2012, STEM CELLS DEV, V21, P1524, DOI 10.1089/scd.2011.0350; WASHBURN SP, 1991, P 40 ANN C N CAR CAT, V2	46	24	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113163	10.1371/journal.pone.0113163	http://dx.doi.org/10.1371/journal.pone.0113163			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462855	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700027
J	Coluzza, I				Coluzza, Ivan			Transferable Coarse-Grained Potential for De Novo Protein Folding and Design	PLOS ONE			English	Article							MOLECULAR-DYNAMICS; SEQUENCES; MODELS; STATE	Protein folding and design are major biophysical problems, the solution of which would lead to important applications especially in medicine. Here we provide evidence of how a novel parametrization of the Caterpillar model may be used for both quantitative protein design and folding. With computer simulations it is shown that, for a large set of real protein structures, the model produces designed sequences with similar physical properties to the corresponding natural occurring sequences. The designed sequences require further experimental testing. For an independent set of proteins, previously used as benchmark, the correct folded structure of both the designed and the natural sequences is also demonstrated. The equilibrium folding properties are characterized by free energy calculations. The resulting free energy profiles not only are consistent among natural and designed proteins, but also show a remarkable precision when the folded structures are compared to the experimentally determined ones. Ultimately, the updated Caterpillar model is unique in the combination of its fundamental three features: its simplicity, its ability to produce natural foldable designed sequences, and its structure prediction precision. It is also remarkable that low frustration sequences can be obtained with such a simple and universal design procedure, and that the folding of natural proteins shows funnelled free energy landscapes without the need of any potentials based on the native structure.	Univ Vienna, Fac Phys, Vienna, Austria	University of Vienna	Coluzza, I (corresponding author), Univ Vienna, Fac Phys, Vienna, Austria.	ivan.coluzza@univie.ac.at	Coluzza, Ivan/I-4170-2015	Coluzza, Ivan/0000-0001-7728-6033	Austrian Science Fund (FWF) [P23846-N16]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	Funding: We acknowledge support from the Austrian Science Fund (FWF) project P23846-N16. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeln S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000241; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bereau T, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3152842; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BRYNGELSON JD, 1987, P NATL ACAD SCI USA, V84, P7524, DOI 10.1073/pnas.84.21.7524; Coluzza I, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.051917; Coluzza I, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.046703; Coluzza I, 2012, SOFT MATTER, DOI [10.1039/c2sm26967h, DOI 10.1039/C2SM26967H.]; Coluzza I, 2007, BIOPHYS J, V92, P1150, DOI 10.1529/biophysj.106.084236; Coluzza I, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.075501; Coluzza I, 2012, J PHYS-CONDENS MAT, V24, DOI 10.1088/0953-8984/24/28/284111; Coluzza I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034228; Coluzza I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020853; Dahiyat BI, 1997, P NATL ACAD SCI USA, V94, P10172, DOI 10.1073/pnas.94.19.10172; Dahiyat BI, 1997, SCIENCE, V278, P82, DOI 10.1126/science.278.5335.82; Desjarlais JR, 1999, J MOL BIOL, V290, P305, DOI 10.1006/jmbi.1999.2866; DESJARLAIS JR, 1995, PROTEIN SCI, V4, P2006, DOI 10.1002/pro.5560041006; DiStasio RA, 2012, P NATL ACAD SCI USA, V109, P14791, DOI 10.1073/pnas.1208121109; Dolittle RF, 1989, PREDICTION PROTEIN S, P599; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; GO N, 1978, P NATL ACAD SCI USA, V75, P559, DOI 10.1073/pnas.75.2.559; GO N, 1983, ANNU REV BIOPHYS BIO, V12, P183, DOI 10.1146/annurev.bb.12.060183.001151; GUTIN AM, 1993, J CHEM PHYS, V98, P8174, DOI 10.1063/1.464522; Hamelberg D, 2004, J CHEM PHYS, V120, P11919, DOI 10.1063/1.1755656; HELLINGA HW, 1991, J MOL BIOL, V222, P763, DOI 10.1016/0022-2836(91)90510-D; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Huang XH, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2908251; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ikebe J, 2011, PROTEIN SCI, V20, P187, DOI 10.1002/pro.553; Kapoor A, 2013, PROTEINS, V81, P1200, DOI 10.1002/prot.24269; Kellogg EH, 2012, J PHYS CHEM B, V116, P11405, DOI 10.1021/jp3044303; Kinch LN, 2011, PROTEINS, V79, P21, DOI 10.1002/prot.23190; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Laio A, 2008, REP PROG PHYS, V71, DOI 10.1088/0034-4885/71/12/126601; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Mu Y, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2768062; Pande VS, 2003, BIOPOLYMERS, V68, P91, DOI 10.1002/bip.10219; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Seibert MM, 2005, J MOL BIOL, V354, P173, DOI 10.1016/j.jmb.2005.09.030; Seno F, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.078102; SHAKHNOVICH EI, 1990, NATURE, V346, P773, DOI 10.1038/346773a0; SHAKHNOVICH EI, 1993, P NATL ACAD SCI USA, V90, P7195, DOI 10.1073/pnas.90.15.7195; SHAKHNOVICH EI, 1994, PHYS REV LETT, V72, P3907, DOI 10.1103/PhysRevLett.72.3907; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Smith AV, 2001, PROTEINS, V44, P344, DOI 10.1002/prot.1100; Tozzini V, 2005, CURR OPIN STRUC BIOL, V15, P144, DOI 10.1016/j.sbi.2005.02.005; Tsai J, 2003, PROTEINS, V53, P76, DOI 10.1002/prot.10454; Wolynes PG, 2012, P NATL ACAD SCI USA, V109, P17770, DOI 10.1073/pnas.1215733109; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Zhang C, 2012, P NATL ACAD SCI USA, V109, P8139, DOI 10.1073/pnas.1112143109; Zhang C, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3435332; Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264	53	22	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112852	10.1371/journal.pone.0112852	http://dx.doi.org/10.1371/journal.pone.0112852			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436908	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900020
J	Campbell, P; Pasch, B; Warren, AL; Phelps, SM				Campbell, Polly; Pasch, Bret; Warren, Ashley L.; Phelps, Steven M.			Vocal Ontogeny in Neotropical Singing Mice (Scotinomys)	PLOS ONE			English	Article							ULTRASONIC VOCALIZATIONS; GEOGRAPHIC-VARIATION; VOLES; CALLS; BAT; EVOLUTION; BEHAVIOR; SOUND; SONG	Isolation calls produced by dependent young are a fundamental form of communication. For species in which vocal signals remain important to adult communication, the function and social context of vocal behavior changes dramatically with the onset of sexual maturity. The ontogenetic relationship between these distinct forms of acoustic communication is surprisingly understudied. We conducted a detailed analysis of vocal development in sister species of Neotropical singing mice, Scotinomys teguina and S. xerampelinus. Adult singing mice are remarkable for their advertisement songs, rapidly articulated trills used in long-distance communication; the vocal behavior of pups was previously undescribed. We recorded 30 S. teguina and 15 S. xerampelinus pups daily, from birth to weaning; 23 S. teguina and 11 S. xerampelinus were recorded until sexual maturity. Like other rodent species with poikilothermic young, singing mice were highly vocal during the first weeks of life and stopped vocalizing before weaning. Production of first advertisement songs coincided with the onset of sexual maturity after a silent period of >= 2 weeks. Species differences in vocal behavior emerged early in ontogeny and notes that comprise adult song were produced from birth. However, the organization and relative abundance of distinct note types was very different between pups and adults. Notably, the structure, note repetition rate, and intra-individual repeatability of pup vocalizations did not become more adult-like with age; the highly stereotyped structure of adult song appeared de novo in the first songs of young adults. We conclude that, while the basic elements of adult song are available from birth, distinct selection pressures during maternal dependency, dispersal, and territorial establishment favor major shifts in the structure and prevalence of acoustic signals. This study provides insight into how an evolutionarily conserved form of acoustic signaling provides the raw material for adult vocalizations that are highly species specific.	[Campbell, Polly] Oklahoma State Univ, Dept Zool, Stillwater, OK 74078 USA; [Pasch, Bret] Cornell Lab Ornithol, Bioacoust Res Program, Ithaca, NY USA; [Pasch, Bret] Cornell Lab Ornithol, Macaulay Lib, Ithaca, NY USA; [Warren, Ashley L.] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA; [Phelps, Steven M.] Univ Texas Austin, Dept Integrat Biol, Austin, TX 78712 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Cornell University; Cornell University; Cornell University; University of Texas System; University of Texas Austin	Campbell, P (corresponding author), Oklahoma State Univ, Dept Zool, Stillwater, OK 74078 USA.	polly.campbell@okstate.edu	Campbell, Polly/I-6252-2015	Campbell, Polly/0000-0001-7660-9814	National Science Foundation [IOS 0548404, 0845455]; National Institutes of Health NRSA fellowship from National Institute on Deafness and Other Communication Disorders [F32 DC008269]; National Science Foundation DDIG [0909769]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F32DC008269] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health NRSA fellowship from National Institute on Deafness and Other Communication Disorders; National Science Foundation DDIG(National Science Foundation (NSF)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Funding: The research was funded by grants from the National Science Foundation to SMP (IOS 0548404, CAREER 0845455). PC was supported by a National Institutes of Health NRSA fellowship from the National Institute on Deafness and Other Communication Disorders (F32 DC008269). BP was supported by a National Science Foundation DDIG (0909769). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arriaga G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046610; Arriaga G, 2013, BRAIN LANG, V124, P96, DOI 10.1016/j.bandl.2012.10.002; Badyaev AV, 2001, ECOLOGY, V82, P2948, DOI 10.1890/0012-9658(2001)082[2948:EOLHAE]2.0.CO;2; Blake BH, 2012, J MAMMAL, V93, P1051, DOI 10.1644/11-MAMM-A-356.2; Blake BH, 2002, J MAMMAL, V83, P536, DOI 10.1644/1545-1542(2002)083<0536:UCIIIP>2.0.CO;2; BLAKE BH, 1992, DEV PSYCHOBIOL, V25, P581, DOI 10.1002/dev.420250805; Blumstein DT, 2009, ETHOLOGY, V115, P1074, DOI 10.1111/j.1439-0310.2009.01691.x; Blumstein DT, 1997, AM NAT, V150, P179, DOI 10.1086/286062; Bradbury Jack W., 1998, pi; Branchi I, 2001, BEHAV BRAIN RES, V125, P49, DOI 10.1016/S0166-4328(01)00277-7; Branchi I, 1998, DEV PSYCHOBIOL, V33, P249, DOI 10.1002/(SICI)1098-2302(199811)33:3<249::AID-DEV5>3.0.CO;2-R; Brudzynski SM, 2005, BEHAV GENET, V35, P85, DOI 10.1007/s10519-004-0858-3; Brudzynski SM, 1999, DEV PSYCHOBIOL, V34, P195, DOI 10.1002/(SICI)1098-2302(199904)34:3<195::AID-DEV4>3.0.CO;2-S; Campbell P, 2010, EVOLUTION, V64, P1955, DOI 10.1111/j.1558-5646.2010.00962.x; Davidson SM, 2004, ANIM BEHAV, V67, P883, DOI 10.1016/j.anbehav.2003.06.016; DEFANIS E, 1995, J ZOOL, V235, P85; Ehret G, 2005, BEHAV GENET, V35, P19, DOI 10.1007/s10519-004-0853-8; Ey E, 2013, BEHAV BRAIN RES, V256, P677, DOI 10.1016/j.bbr.2013.08.031; Fernandez-Vargas M, 2011, BEHAVIOUR, V148, P945, DOI 10.1163/000579511X584591; Fitch WT, 2002, ANIM BEHAV, V63, P407, DOI 10.1006/anbe.2001.1912; GANNON WL, 1989, J MAMMAL, V70, P740, DOI 10.2307/1381708; Gaub S, 2005, J COMP PHYSIOL A, V191, P1131, DOI 10.1007/s00359-005-0036-y; Grimsley JMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017460; Haack B., 1983, AUDITORY PSYCHOBIOLO, P57; Hammerschmidt K, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-40; Hoffmann F, 2012, J ETHOL, V30, P173, DOI 10.1007/s10164-011-0312-y; Hoffmann F, 2012, PHYSIOL BEHAV, V105, P766, DOI 10.1016/j.physbeh.2011.10.011; Holy TE, 2005, PLOS BIOL, V3, P2177, DOI 10.1371/journal.pbio.0030386; Hooper E.T., 1976, Miscellaneous Publs Mus Zool Univ Mich, VNo. 151, P1; Kikusui T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017721; Mahrt EJ, 2013, J NEUROSCI, V33, P5573, DOI 10.1523/JNEUROSCI.5054-12.2013; Mandelli MJ, 2004, J MAMMAL, V85, P282, DOI 10.1644/1545-1542(2004)085<0282:UVOISF>2.0.CO;2; Miller JR, 2007, J MAMMAL, V88, P1447, DOI 10.1644/06-MAMM-A-386R.1; Monroy JA, 2011, J COMP PHYSIOL A, V197, P459, DOI 10.1007/s00359-010-0614-5; Moss CF, 1997, ANIM BEHAV, V54, P131, DOI 10.1006/anbe.1996.0410; Nelson R.J., 2011, INTRO BEHAV ENDOCRIN; Pasch B, 2013, AM NAT, V182, pE161, DOI 10.1086/673263; Pasch B, 2011, ANIM BEHAV, V82, P177, DOI 10.1016/j.anbehav.2011.04.018; Pasch B, 2011, HORM BEHAV, V59, P90, DOI 10.1016/j.yhbeh.2010.10.011; Petric R, 2013, BEHAVIOUR, V150, P1747, DOI 10.1163/1568539X-00003118; PONTET A, 1989, BEHAVIOUR, V108, P241, DOI 10.1163/156853989X00321; Schneiderova I, 2014, ACTA THERIOL, V59, P149, DOI 10.1007/s13364-013-0141-1; Sen A, 2014, P NATL ACAD SCI USA, V111, P3008, DOI 10.1073/pnas.1318978111; Slobodchikoff CN, 1998, J MAMMAL, V79, P1265, DOI 10.2307/1383018; SMITH JC, 1976, J COMP PHYSIOL PSYCH, V90, P1105, DOI 10.1037/h0077287; Snell-Rood EC, 2008, OECOLOGIA, V157, P545, DOI 10.1007/s00442-008-1092-0; Sterbing SJ, 2002, J MAMMAL, V83, P516, DOI 10.1644/1545-1542(2002)083<0516:PDOVAH>2.0.CO;2; Vieira ML, 2002, BEHAV PROCESS, V59, P147, DOI 10.1016/S0376-6357(02)00089-X; Wright SL, 2004, BEHAV PROCESS, V65, P155, DOI 10.1016/j.beproc.2003.09.004	49	25	25	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113628	10.1371/journal.pone.0113628	http://dx.doi.org/10.1371/journal.pone.0113628			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469986	Green Published, Green Submitted, gold			2022-12-26	WOS:000349128700037
J	Inoue, H; Yoshimura, J; Iwabuchi, K				Inoue, Hiroki; Yoshimura, Jin; Iwabuchi, Kikuo			Gene Expression of Protein-Coding and Non-Coding RNAs Related to Polyembryogenesis in the Parasitic Wasp, Copidosoma floridanum	PLOS ONE			English	Article							ZYGOTIC TRANSITION; HOST EMBRYO; MICRORNA; IDENTIFICATION; HYMENOPTERA; ANNOTATION; EVOLUTION; TUDOR	Polyembryony is a unique form of development in which many embryos are clonally produced from a single egg. Polyembryony is known to occur in many animals, but the underlying genetic mechanism responsible is unknown. In a parasitic wasp, Copidosoma floridanum, polyembryogenesis is initiated during the formation and division of the morula. In the present study, cDNA libraries were constructed from embryos at the cleavage and subsequent primary morula stages, times when polyembryogenesis is likely to be controlled genetically. Of 182 and 263 cDNA clones isolated from these embryos, 38% and 70%, respectively, were very similar to protein-coding genes obtained from BLAST analysis and 55 and 65 clones, respectively, were stage-specific. In our libraries we also detected a high frequency of long non-coding RNA. Some of these showed stage-specific expression patterns in reverse transcription quantitative polymerase chain reaction (RT-qPCR) analysis. The stage-specificity of expression implies that these protein-coding and non-coding genes are related to polyembryogenesis in C. floridanum. The non-coding genes are not similar to any known non-coding RNAs and so are good candidates as regulators of polyembryogenesis.	[Inoue, Hiroki; Iwabuchi, Kikuo] Tokyo Univ Agr & Technol, Fac Agr, Fuchu, Tokyo 183, Japan; [Yoshimura, Jin] Shizuoka Univ, Grad Sch Sci & Technol, Hamamatsu, Shizuoka 4328011, Japan; [Yoshimura, Jin] Shizuoka Univ, Dept Math & Syst Engn, Hamamatsu, Shizuoka, Japan; [Yoshimura, Jin] SUNY Coll Environm Sci & Forestry, Dept Environm & Forest Biol, Syracuse, NY 13210 USA; [Yoshimura, Jin] Chiba Univ, Marine Biosyst Res Ctr, Kamogawa, Chiba, Japan	Tokyo University of Agriculture & Technology; Shizuoka University; Shizuoka University; State University of New York (SUNY) System; State University of New York (SUNY) College of Environmental Science & Forestry; Chiba University	Iwabuchi, K (corresponding author), Tokyo Univ Agr & Technol, Fac Agr, Fuchu, Tokyo 183, Japan.	kikkuo@cc.tuat.ac.jp	Satoh, Toshiyuki/C-8374-2013; Iwabuchi, Kikuo/I-7530-2012	Satoh, Toshiyuki/0000-0002-7475-6746; 	Japan Society for the Promotion of Science (JSPS) [22658015, 22255004, 22370010, 26257405]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The study was supported by Grant Number 22658015 to KI, 22255004, 22370010 and 26257405 to JY from Japan Society for the Promotion of Science (JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avner P, 2001, NAT REV GENET, V2, P59, DOI 10.1038/35047580; BAEHRECKE EH, 1990, INT J INSECT MORPHOL, V19, P165, DOI 10.1016/0020-7322(90)90002-7; BAEHRECKE EH, 1992, J EXP ZOOL, V262, P30, DOI 10.1002/jez.1402620106; BAEHRECKE EH, 1993, DEV BIOL, V158, P275, DOI 10.1006/dbio.1993.1188; BARDSLEY A, 1993, DEVELOPMENT, V119, P207; BOSWELL RE, 1985, CELL, V43, P97, DOI 10.1016/0092-8674(85)90015-7; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; CHAPMAN KB, 1991, CELL, V65, P483, DOI 10.1016/0092-8674(91)90466-C; Cheng DF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057718; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Development Core Team R, 2011, R LANG ENV STAT COMP; Donnell DM, 2006, INSECT BIOCHEM MOLEC, V36, P141, DOI 10.1016/j.ibmb.2005.11.009; Gillespie JJ, 2005, MOL BIOL EVOL, V22, P1593, DOI 10.1093/molbev/msi152; GRBIC M, 1992, NATURE, V360, P254, DOI 10.1038/360254a0; Grbic M, 1998, DEV GENES EVOL, V208, P69, DOI 10.1007/s004270050156; Hannafon BN, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2839; He SM, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-236; Inagaki S, 2005, GENES CELLS, V10, P1163, DOI 10.1111/j.1365-2443.2005.00910.x; IWABUCHI K, 1991, APPL ENTOMOL ZOOL, V26, P563, DOI 10.1303/aez.26.563; IWABUCHI K, 1995, IN VITRO CELL DEV-AN, V31, P803, DOI 10.1007/BF02634123; Kelley AE, 2004, NEURON, V44, P161, DOI 10.1016/j.neuron.2004.09.016; LaSalle J, 1991, REDIA, V74, P515; Marone R, 2004, NAT CELL BIOL, V6, P515, DOI 10.1038/ncb1134; Meller VH, 2002, EMBO J, V21, P1084, DOI 10.1093/emboj/21.5.1084; Nakaguchi A, 2006, CELL TISSUE RES, V324, P167, DOI 10.1007/s00441-005-0111-2; Ninova M, 2014, RNA, V20, P360, DOI 10.1261/rna.041657.113; Numata K, 2003, GENOME RES, V13, P1301, DOI 10.1101/gr.1011603; Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; Pauli A, 2011, NAT REV GENET, V12, P136, DOI 10.1038/nrg2904; Plath K, 2002, ANNU REV GENET, V36, P233, DOI 10.1146/annurev.genet.36.042902.092433; Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Rymarquis LA, 2008, TRENDS PLANT SCI, V13, P329, DOI 10.1016/j.tplants.2008.02.009; Scharlaken B, 2008, J INSECT SCI, V8, DOI 10.1673/031.008.3301; Schier AF, 2007, SCIENCE, V316, P406, DOI 10.1126/science.1140693; Strand MR, 1997, CURR TOP DEV BIOL, V35, P121, DOI 10.1016/S0070-2153(08)60258-6; STRAND MR, 1989, J INSECT BEHAV, V2, P355, DOI 10.1007/BF01068061; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Takahashi-Nakaguchi A, 2010, J MORPHOL, V271, P750, DOI 10.1002/jmor.10831; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Utsunomiya A, 2002, ENTOMOL EXP APPL, V104, P353, DOI 10.1023/A:1021205421400; Wang H, 2004, J BIOL CHEM, V279, P1468, DOI 10.1074/jbc.M309106200; Yao Y, 2009, MOL MED REP, V2, P963, DOI 10.3892/mmr_00000199; Zhu QH, 2012, GENES-BASEL, V3, P176, DOI 10.3390/genes3010176; Zhurov V, 2007, CELL MOL LIFE SCI, V64, P2790, DOI 10.1007/s00018-007-7047-5; Zondag L, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-211	47	4	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114372	10.1371/journal.pone.0114372	http://dx.doi.org/10.1371/journal.pone.0114372			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469914	Green Submitted, gold, Green Published			2022-12-26	WOS:000349128700106
J	Mehrabi, Z; Slade, EM; Solis, A; Mann, DJ				Mehrabi, Zia; Slade, Eleanor M.; Solis, Angel; Mann, Darren J.			The Importance of Microhabitat for Biodiversity Sampling	PLOS ONE			English	Article							DUNG BEETLES SCARABAEIDAE; SEED DISPERSAL; COMMUNITY STRUCTURE; ECOSYSTEM SERVICES; FOREST; COLEOPTERA; DIVERSITY; MONKEYS; FRAGMENTATION; CONSERVATION	Responses to microhabitat are often neglected when ecologists sample animal indicator groups. Microhabitats may be particularly influential in non-passive biodiversity sampling methods, such as baited traps or light traps, and for certain taxonomic groups which respond to fine scale environmental variation, such as insects. Here we test the effects of microhabitat on measures of species diversity, guild structure and biomass of dung beetles, a widely used ecological indicator taxon. We demonstrate that choice of trap placement influences dung beetle functional guild structure and species diversity. We found that locally measured environmental variables were unable to fully explain trap-based differences in species diversity metrics or microhabitat specialism of functional guilds. To compare the effects of habitat degradation on biodiversity across multiple sites, sampling protocols must be standardized and scale-relevant. Our work highlights the importance of considering microhabitat scale responses of indicator taxa and designing robust sampling protocols which account for variation in microhabitats during trap placement. We suggest that this can be achieved either through standardization of microhabitat or through better efforts to record relevant environmental variables that can be incorporated into analyses to account for microhabitat effects. This is especially important when rapidly assessing the consequences of human activity on biodiversity loss and associated ecosystem function and services.	[Mehrabi, Zia] Univ Oxford, Dept Zool, Biodivers Inst, Oxford, England; [Mehrabi, Zia; Mann, Darren J.] Univ Oxford, Museum Nat Hist, Hope Entomol Collect, Oxford, England; [Slade, Eleanor M.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Abingdon, Oxon, England; [Slade, Eleanor M.] Univ Helsinki, Dept Agr Sci, Spatial Foodweb Ecol Grp, Helsinki, Finland; [Solis, Angel] Inst Nacl Biodiversidad, Unidad Artropodos, Santo Domingo De Heredia, Costa Rica	University of Oxford; University of Oxford; University of Oxford; University of Helsinki	Mehrabi, Z (corresponding author), Univ Oxford, Dept Zool, Biodivers Inst, S Parks Rd, Oxford, England.	zia.mehrabi@zoo.ox.ac.uk	Mann, Darren/AAC-1049-2020; Slade, Eleanor M/O-3874-2014	Mann, Darren/0000-0002-6732-6940; Slade, Eleanor M/0000-0002-6108-1196	British Ecological Society small research grant; Royal Geographic Society; IBG geographical fieldwork grant; Oxford University Expeditions Council	British Ecological Society small research grant; Royal Geographic Society; IBG geographical fieldwork grant; Oxford University Expeditions Council	This project was funded by a British Ecological Society small research grant, a Royal Geographic Society with IBG geographical fieldwork grant (Goldsmiths), Oxford University Expeditions Council (Alexander Allan Paton Memorial Fund), The Duke of Edinburgh, St Hilda's College (Muriel Wise Trust Fund), and The Explorers Club; www.britishecologicalsociety.org, www.rgs.org,www.explorers.org, www.st-hildas.ox.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlHouty W, 1997, J ARID ENVIRON, V35, P511, DOI 10.1006/jare.1996.0179; Allsopp P. G., 1999, Diversity and Distributions, V5, P143, DOI 10.1046/j.1472-4642.1999.00050.x; Andresen E, 1999, BIOTROPICA, V31, P145, DOI 10.1111/j.1744-7429.1999.tb00125.x; Andresen E, 2002, ECOL ENTOMOL, V27, P257, DOI 10.1046/j.1365-2311.2002.00408.x; Andresen E, 2008, INSECT CONSERV DIVER, V1, P120, DOI 10.1111/j.1752-4598.2008.00013.x; Arellano L, 2005, BIODIVERS CONSERV, V14, P601, DOI 10.1007/s10531-004-3918-3; Barton PS, 2009, BIOL CONSERV, V142, P1701, DOI 10.1016/j.biocon.2009.03.005; Bates R, 2014, LME4 LINEAR MIXED EF; Brown N, 2000, J APPL ECOL, V37, P1044, DOI 10.1046/j.1365-2664.2000.00573.x; Cambefort Y., 1991, P51; Cardoso P, 2011, BIOL CONSERV, V144, P2647, DOI 10.1016/j.biocon.2011.07.024; Carrillo E, 2002, BIOL CONSERV, V108, P317, DOI 10.1016/S0006-3207(02)00118-0; Chave J, 2005, OECOLOGIA, V145, P87, DOI 10.1007/s00442-005-0100-x; Chown Steven L., 2011, P200; Christensen R., 2013, R PACKAGE VERSION 20, P08; Cohen J.E., 1988, STAT POWER ANAL BEHA; Davis AJ, 2001, J APPL ECOL, V38, P593, DOI 10.1046/j.1365-2664.2001.00619.x; Davis ALV, 2005, COMMUNITY ECOSYSTEM; Duncan FD, 2000, OECOLOGIA, V122, P452, DOI 10.1007/s004420050966; ESTRADA A, 1991, J TROP ECOL, V7, P459, DOI 10.1017/S026646740000585X; Gardner TA, 2008, ECOL LETT, V11, P139, DOI 10.1111/j.1461-0248.2007.01133.x; Gaston KJ, 2000, NATURE, V405, P220, DOI 10.1038/35012228; Gerlach J, 2013, J INSECT CONSERV, V17, P831, DOI 10.1007/s10841-013-9565-9; Gill B.D., 1991, P211; Gonzalez-Megias A, 2007, ECOGRAPHY, V30, P31, DOI 10.1111/j.0906-7590.2007.04867.x; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; JANZEN DH, 1983, OIKOS, V41, P274, DOI 10.2307/3544274; KLEIN BC, 1989, ECOLOGY, V70, P1715, DOI 10.2307/1938106; Kohlmann B, 2007, ZOOTAXA, P1; Kuznetsova A, 2014, LMERTEST TESTS RANDO; Larsen TH, 2005, ECOL LETT, V8, P538, DOI 10.1111/j.1461-0248.2005.00749.x; Larsen TH, 2005, BIOTROPICA, V37, P322, DOI 10.1111/j.1744-7429.2005.00042.x; Larsen TH, 2006, COLEOPTS BULL, V60, P315, DOI 10.1649/0010-065X(2006)60[315:ETAHSB]2.0.CO;2; Lawson CR, 2012, BIOTROPICA, V44, P271, DOI 10.1111/j.1744-7429.2012.00871.x; Levine N, 2002, CRIMESTAT 2 SPATIAL; Marsh CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073147; May RM, 2009, SCIENCE, V323, P687, DOI 10.1126/science.1170937; Mehrabi Z, 2014, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.p0c10, DOI 10.5061/DRYAD.P0C10]; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000606; Nakagawa S, 2007, BIOL REV, V82, P591, DOI 10.1111/j.1469-185X.2007.00027.x; NEALIS VG, 1977, CAN J ZOOL, V55, P138, DOI 10.1139/z77-017; Nichols E, 2008, BIOL CONSERV, V141, P1461, DOI 10.1016/j.biocon.2008.04.011; Nichols E, 2007, BIOL CONSERV, V137, P1, DOI 10.1016/j.biocon.2007.01.023; Nicholson E, 2009, J APPL ECOL, V46, P1139, DOI 10.1111/j.1365-2664.2009.01716.x; PECK SB, 1982, CAN J ZOOL, V60, P1624, DOI 10.1139/z82-213; Plowes R, 2005, THESIS U TEXAS AUSTI; R Core Team, 2021, R LANGUAGE ENV STAT; Rosenzweig Michael L., 1995, DOI 10.1017/CBO9780511623387.002; Scheffler PY, 2005, J TROP ECOL, V21, P9, DOI 10.1017/S0266467404001683; Slade EM, 2007, J ANIM ECOL, V76, P1094, DOI 10.1111/j.1365-2656.2007.01296.x; Slade EM, 2011, BIOL CONSERV, V144, P166, DOI 10.1016/j.biocon.2010.08.011; Solis A, 2012, ZOOTAXA, V32, P5326; SOWIG P, 1995, ECOGRAPHY, V18, P147, DOI 10.1111/j.1600-0587.1995.tb00335.x; Spector S, 2006, COLEOPTS BULL, V60, P71, DOI 10.1649/0010-065X(2006)60[71:SDBCSS]2.0.CO;2; Vaz-de-Mello FZ, 2011, ZOOTAXA, P1; Vulinec K, 2006, INT J PRIMATOL, V27, P855, DOI 10.1007/s10764-006-9027-2; Warton DI, 2011, ECOLOGY, V92, P3, DOI 10.1890/10-0340.1; Weghorst JA, 2007, PRIMATES, V48, P108, DOI 10.1007/s10329-006-0025-y; Willis KJ, 2002, SCIENCE, V295, P1245, DOI 10.1126/science.1067335	60	23	24	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114015	10.1371/journal.pone.0114015	http://dx.doi.org/10.1371/journal.pone.0114015			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469770	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000349128700063
J	Mourad, R; Hsu, PY; Juan, LR; Shen, CY; Koneru, P; Lin, H; Liu, YL; Nephew, K; Huang, TH; Li, L				Mourad, Raphael; Hsu, Pei-Yin; Juan, Liran; Shen, Changyu; Koneru, Prasad; Lin, Hai; Liu, Yunlong; Nephew, Kenneth; Huang, Tim H.; Li, Lang			Estrogen Induces Global Reorganization of Chromatin Structure in Human Breast Cancer Cells	PLOS ONE			English	Article							HI-C DATA; GENE-EXPRESSION; CHIP-SEQ; ELEMENTS; ALPHA; ORGANIZATION; ARCHITECTURE; PRINCIPLES; TAMOXIFEN; CORRELATE	In the cell nucleus, each chromosome is confined to a chromosome territory. This spatial organization of chromosomes plays a crucial role in gene regulation and genome stability. An additional level of organization has been discovered at the chromosome scale: the spatial segregation into open and closed chromatins to form two genome-wide compartments. Although considerable progress has been made in our knowledge of chromatin organization, a fundamental issue remains the understanding of its dynamics, especially in cancer. To address this issue, we performed genome-wide mapping of chromatin interactions (Hi-C) over the time after estrogen stimulation of breast cancer cells. To biologically interpret these interactions, we integrated with estrogen receptor alpha (ER alpha) binding events, gene expression and epigenetic marks. We show that gene-rich chromosomes as well as areas of open and highly transcribed chromatins are rearranged to greater spatial proximity, thus enabling genes to share transcriptional machinery and regulatory elements. At a smaller scale, differentially interacting loci are enriched for cancer proliferation and estrogen-related genes. Moreover, these loci are correlated with higher ERa binding events and gene expression. Taken together these results reveal the role of a hormone - estrogen - on genome organization, and its effect on gene regulation in cancer.	[Mourad, Raphael; Juan, Liran; Koneru, Prasad; Lin, Hai; Liu, Yunlong; Li, Lang] Indiana Univ, Indiana Sch Med, Ctr Computat Biol & Bioinformat, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Shen, Changyu] Indiana Univ, Indiana Sch Med, Ctr Computat Biol & Bioinformat, Dept Biostat, Indianapolis, IN 46202 USA; [Hsu, Pei-Yin; Huang, Tim H.] Univ Texas Hlth Sci Ctr San Antonio, Inst Biotechnol, Dept Mol Med, San Antonio, TX 78245 USA; [Nephew, Kenneth] Indiana Univ, Lab Ovarian Canc Epigen, Bloomington, IN 47405 USA	Indiana University System; Indiana University Bloomington; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University-Purdue University Indianapolis; University of Texas System; University of Texas Health San Antonio; Indiana University System; Indiana University Bloomington	Li, L (corresponding author), Indiana Univ, Indiana Sch Med, Ctr Computat Biol & Bioinformat, Dept Med & Mol Genet, Indianapolis, IN 46202 USA.	lali@iupui.edu	Lin, Hai/N-3860-2016	Lin, Hai/0000-0002-2094-758X	Integrative Cancer Biology Program (ICBP): Centers for Cancer Systems Biology (CCSB);  [NCI- U54 CA113001-07]; NATIONAL CANCER INSTITUTE [U54CA113001, P30CA082709] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR002529, UL1TR001108] Funding Source: NIH RePORTER	Integrative Cancer Biology Program (ICBP): Centers for Cancer Systems Biology (CCSB); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Funding: This study was funded by NCI- U54 CA113001-07, The Integrative Cancer Biology Program (ICBP): Centers for Cancer Systems Biology (CCSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri M, 2012, P NATL ACAD SCI USA, V109, P16173, DOI 10.1073/pnas.1204799109; Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Botta M, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.79; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Cavalli G, 2007, CURR OPIN GENET DEV, V17, P443, DOI 10.1016/j.gde.2007.08.013; Cicatiello L, 2010, AM J PATHOL, V176, P2113, DOI 10.2353/ajpath.2010.090837; Cournac A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-436; Cowper-Sal-lari R, 2012, NAT GENET, V44, P1191, DOI 10.1038/ng.2416; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Fan MY, 2006, CANCER RES, V66, P11954, DOI 10.1158/0008-5472.CAN-06-1666; Fudenberg G, 2012, CURRENT OPINION GENE, V22, P1; Fudenberg G, 2011, NAT BIOTECHNOL, V29, P1109, DOI 10.1038/nbt.2049; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Gasser SM, 2002, SCIENCE, V296, P1412, DOI 10.1126/science.1067703; Gerlich D, 2003, CELL, V112, P751, DOI 10.1016/S0092-8674(03)00189-2; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Hampton OA, 2009, GENOME RES, V19, P167, DOI 10.1101/gr.080259.108; Hsu PY, 2013, CANCER CELL, V24, P197, DOI 10.1016/j.ccr.2013.07.007; Hsu PY, 2010, GENOME RES, V20, P733, DOI 10.1101/gr.101923.109; Hsu YT, 1997, P NATL ACAD SCI USA, V94, P3668, DOI 10.1073/pnas.94.8.3668; Hu M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002893; Hu M, 2012, BIOINFORMATICS, V28, P3131, DOI 10.1093/bioinformatics/bts570; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Hua S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.25; Hubner MR, 2010, ANNU REV BIOPHYS, V39, P471, DOI 10.1146/annurev.biophys.093008.131348; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Kalhor R, 2012, NAT BIOTECHNOL, V30, P90, DOI 10.1038/nbt.2057; Kocanova S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000922; Lan X, 2012, NUCLEIC ACIDS RES, V40, P7690, DOI 10.1093/nar/gks501; Lanctot C, 2007, NAT REV GENET, V8, P104, DOI 10.1038/nrg2041; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Meaburn KJ, 2007, NATURE, V445, P379, DOI 10.1038/445379a; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mirny LA, 2011, CHROMOSOME RES, V19, P37, DOI 10.1007/s10577-010-9177-0; Nye AC, 2002, MOL CELL BIOL, V22, P3437, DOI 10.1128/MCB.22.10.3437-3449.2002; Osmanbeyoglu HU, 2013, NUCLEIC ACIDS RES, V41, P8061, DOI 10.1093/nar/gkt586; Perillo B, 2000, MOL CELL BIOL, V20, P2890, DOI 10.1128/MCB.20.8.2890-2901.2000; Putnik M, 2012, BIOCHEM BIOPH RES CO, V426, P26, DOI 10.1016/j.bbrc.2012.08.007; Rickman DS, 2012, P NATL ACAD SCI USA, V109, P9083, DOI 10.1073/pnas.1112570109; Ross-Innes CS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-593; Rousseau M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-414; Sabo PJ, 2006, NAT METHODS, V3, P511, DOI 10.1038/NMETH890; Sabo PJ, 2004, P NATL ACAD SCI USA, V101, P16837, DOI 10.1073/pnas.0407387101; Sexton T, 2007, NAT STRUCT MOL BIOL, V14, P1049, DOI 10.1038/nsmb1324; Sexton T, 2012, CELL, V148, P458, DOI 10.1016/j.cell.2012.01.010; Shavit Y, 2013, BIOINFORMATICS, V29, P1206, DOI 10.1093/bioinformatics/btt120; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; van Berkum Nynke L, 2010, J Vis Exp, DOI 10.3791/1869; Wang GH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013798; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Wijchers PJ, 2011, TRENDS GENET, V27, P63, DOI 10.1016/j.tig.2010.11.001; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947; Yang XL, 1997, CELL, V89, P1067, DOI 10.1016/S0092-8674(00)80294-9; Zhang XS, 2012, P NATL ACAD SCI USA, V109, P13331, DOI 10.1073/pnas.1203280109; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	61	37	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113354	10.1371/journal.pone.0113354	http://dx.doi.org/10.1371/journal.pone.0113354			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470140	gold, Green Published			2022-12-26	WOS:000349128700024
J	Stanne, TM; Tjarnlund-Wolf, A; Olsson, S; Jood, K; Blomstrand, C; Jern, C				Stanne, Tara M; Tjarnlund-Wolf, Anna; Olsson, Sandra; Jood, Katarina; Blomstrand, Christian; Jern, Christina			Genetic Variation at the BDNF Locus: Evidence for Association with Long-Term Outcome after Ischemic Stroke	PLOS ONE			English	Article							REDUCES INFARCT SIZE; ACTIVITY-DEPENDENT SECRETION; FACTOR G196A POLYMORPHISM; FOCAL CEREBRAL-ISCHEMIA; NEUROTROPHIC FACTOR; VAL66MET POLYMORPHISM; SUBARACHNOID HEMORRHAGE; MOTOR CORTEX; HUMAN BRAIN; RECOVERY	Background and Purpose: Rates and extent of recovery after stroke vary considerably between individuals and genetic factors are thought to contribute to post-stroke outcome. Brain-derived neurotrophic factor (BDNF) plays important roles in brain plasticity and repair and has been shown to be involved in stroke severity, recovery, and outcome in animal models. Few clinical studies on BDNF genotypes in relation to ischemic stroke have been performed. The aims of the present study are therefore to investigate whether genetic variation at the BDNF locus is associated with initial stroke severity, recovery and/or short-term and long-term functional outcome after ischemic stroke. Methods: Four BDNF tagSNPs were analyzed in the Sahlgrenska Academy Study on Ischemic Stroke (SAHLSIS; 600 patients and 600 controls, all aged 18-70 years). Stroke severity was assessed using the NIH Stroke Scale (NIHSS). Stroke recovery was defined as the change in NIHSS over a 3-month period. Short-and long-term functional outcome post-stroke was assessed using the modified Rankin Scale at 3 months and at 2 and 7 years after stroke, respectively. Results: No SNP was associated with stroke severity or recovery at 3 months and no SNP had an impact on short-term outcome. However, rs11030119 was independently associated with poor functional outcome 7-years after stroke (OR 0.66, 95% CI 0.46-0.92; P = 0.006). Conclusions: BDNF gene variants were not major contributors to ischemic stroke severity, recovery, or short-term functional outcome. However, this study suggests that variants in the BDNF gene may contribute to poor long-term functional outcome after ischemic stroke.	[Stanne, Tara M; Jern, Christina] Univ Gothenburg, Sahlgrenska Acad, Clin Genet Sect, Inst Biomed, Gothenburg, Sweden; [Tjarnlund-Wolf, Anna; Olsson, Sandra; Jood, Katarina; Blomstrand, Christian] Univ Gothenburg, Sahlgrenska Acad, Sect Clin Neurosci & Rehabil, Inst Neurosci & Physiol, Gothenburg, Sweden	University of Gothenburg; University of Gothenburg	Stanne, TM (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Clin Genet Sect, Inst Biomed, Gothenburg, Sweden.	tara.stanne@gu.se			Swedish Research Council [K2011-65X-14605-09-6, K2010-61X-20378-04-3, 2011-3891]; Swedish Heart and Lung Foundation [20100256, 20100244, 20100228]; Swedish Stroke Association; Edit Jacobson foundation; Per-Olof Ahl foundation; Rune and Ulla Amlov foundation; John and Brit Wennerstrom foundation; Tore Nilsson foundation;  [ALFGBG-148861]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Stroke Association; Edit Jacobson foundation; Per-Olof Ahl foundation; Rune and Ulla Amlov foundation; John and Brit Wennerstrom foundation; Tore Nilsson foundation; 	This study was supported by the Swedish Research Council (K2011-65X-14605-09-6, K2010-61X-20378-04-3, and 2011-3891), the Swedish state (ALFGBG-148861), the Swedish Heart and Lung Foundation (20100256, 20100244 and 20100228), the Swedish Stroke Association, and the Edit Jacobson, Per-Olof Ahl, Rune and Ulla Amlov, John and Brit Wennerstrom, and Tore Nilsson foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Almeida RD, 2005, CELL DEATH DIFFER, V12, P1329, DOI 10.1038/sj.cdd.4401662; Bejot Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029405; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Cerasa A, 2010, BEHAV BRAIN RES, V207, P377, DOI 10.1016/j.bbr.2009.10.022; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Cramer SC, 2012, EUR J NEUROL, V19, P718, DOI 10.1111/j.1468-1331.2011.03615.x; Cramer SC, 2008, ANN NEUROL, V63, P272, DOI 10.1002/ana.21393; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Flossmann E, 2004, STROKE, V35, P212, DOI 10.1161/01.STR.0000107187.84390.AA; Gao L, 2010, ACTA NEUROL SCAND, V122, P41, DOI 10.1111/j.1600-0404.2009.01253.x; Gray LJ, 2009, J STROKE CEREBROVASC, V18, P466, DOI 10.1016/j.jstrokecerebrovasdis.2009.02.003; Huang R, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.044883; Jood K, 2005, STROKE, V36, P1383, DOI 10.1161/01.STR.0000169944.46025.09; Kim JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051280; Kleim JA, 2006, NAT NEUROSCI, V9, P735, DOI 10.1038/nn1699; Kurozumi K, 2004, MOL THER, V9, P189, DOI 10.1016/j.ymthe.2003.10.012; Lopez AD, 2006, ANN TROP MED PARASIT, V100, P481, DOI 10.1179/136485906X97417; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; MacLellan CL, 2011, NEUROREHAB NEURAL RE, V25, P740, DOI 10.1177/1545968311407517; Madinier A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008101; Manso H, 2012, EUR J NEUROL, V19, P1151, DOI 10.1111/j.1468-1331.2011.03625.x; Martinez-Gonzalez NA, 2006, J NEUROL NEUROSUR PS, V77, P1329, DOI 10.1136/jnnp.2006.097543; McHughen SA, 2010, CEREB CORTEX, V20, P1254, DOI 10.1093/cercor/bhp189; Mirowska-Guzel D, 2012, J NEUROIMMUNOL, V249, P71, DOI 10.1016/j.jneuroim.2012.04.011; Nudo RJ, 2007, STROKE, V38, P840, DOI 10.1161/01.STR.0000247943.12887.d2; Olsson S, 2012, STROKE, V43, P2278, DOI 10.1161/STROKEAHA.111.647446; Pezawas L, 2004, J NEUROSCI, V24, P10099, DOI 10.1523/JNEUROSCI.2680-04.2004; Quinn TJ, 2007, STROKE, V38, P2257, DOI 10.1161/STROKEAHA.106.480723; Schabitz WR, 1997, J CEREBR BLOOD F MET, V17, P500, DOI 10.1097/00004647-199705000-00003; Schabitz WR, 2000, STROKE, V31, P2212, DOI 10.1161/01.STR.31.9.2212; Schabitz WR, 2007, STROKE, V38, P2165, DOI 10.1161/STROKEAHA.106.477331; Shimizu E, 2004, AM J MED GENET B, V126B, P122, DOI 10.1002/ajmg.b.20118; Siironen J, 2007, STROKE, V38, P2858, DOI 10.1161/STROKEAHA.107.485441; Sulejczak D, 2007, J NEUROTRAUM, V24, P1362, DOI 10.1089/neu.2006.0261; Yamashita K, 1997, METAB BRAIN DIS, V12, P271, DOI 10.1007/BF02674671; Zhao J, 2013, BRAIN RES, V1537, P312, DOI 10.1016/j.brainres.2013.08.061	37	26	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114156	10.1371/journal.pone.0114156	http://dx.doi.org/10.1371/journal.pone.0114156			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470006	gold, Green Published, Green Submitted			2022-12-26	WOS:000349128700079
J	Yun, YJ; Srinivas, G; Kuenzel, S; Linnenbrink, M; Alnahas, S; Bruce, KD; Steinhoff, U; Baines, JF; Schaible, UE				Yun, Yeojun; Srinivas, Girish; Kuenzel, Sven; Linnenbrink, Miriam; Alnahas, Safa; Bruce, Kenneth D.; Steinhoff, Ulrich; Baines, John F.; Schaible, Ulrich E.			Environmentally Determined Differences in the Murine Lung Microbiota and Their Relation to Alveolar Architecture	PLOS ONE			English	Article							BACTERIA; IDENTIFICATION; DIVERSITY; GLYCOSPHINGOLIPIDS; COMMUNITIES; INFECTIONS; EXPRESSION; PICKETTII; ALLERGY; MICE	Commensal bacteria control the micro-ecology of metazoan epithelial surfaces with pivotal effect on tissue homeostasis and host defense. In contrast to the upper respiratory tract, the lower respiratory tract of healthy individuals has largely been considered free of microorganisms. To understand airway micro-ecology we studied microbiota of sterilely excised lungs from mice of different origin including outbred wild mice caught in the natural environment or kept under non-specific-pathogen-free (SPF) conditions as well as inbred mice maintained in non-SPF, SPF or germ-free (GF) facilities. High-throughput pyrosequencing of reverse transcribed 16S rRNA revealed metabolically active murine lung microbiota in all but GF mice. The overall composition across samples was similar at the phylum and family level. However, species richness was significantly different between lung microbiota from SPF and non-SPF mice. Non-cultivatable Betaproteobacteria such as Ralstonia spp. made up the major constituents and were also confirmed by 16S rRNA gene cloning analysis. Additionally, Pasteurellaceae, Enterobacteria and Firmicutes were isolated from lungs of non-SPF mice. Bacterial communities were detectable by fluorescent in situ hybridization (FISH) at alveolar epithelia in the absence of inflammation. Notably, higher bacterial abundance in non-SPF mice correlated with more and smaller size alveolae, which was corroborated by transplanting Lactobacillus spp. lung isolates into GF mice. Our data indicate a common microbial composition of murine lungs, which is diversified through different environmental conditions and affects lung architecture. Identification of the microbiota of murine lungs will pave the path to study their influence on pulmonary immunity to infection and allergens using mouse models.	[Yun, Yeojun; Schaible, Ulrich E.] Res Ctr Borstel, Dept Mol Infect Biol, Cellular Microbiol Grp, Borstel, Germany; [Srinivas, Girish; Kuenzel, Sven; Linnenbrink, Miriam; Baines, John F.] MPI Evolutionary Biol, Plon, Germany; [Srinivas, Girish] Med Univ Lubeck, Dept Dermatol, D-23538 Lubeck, Germany; [Kuenzel, Sven; Linnenbrink, Miriam; Baines, John F.] Univ Kiel, Inst Expt Med, Kiel, Germany; [Alnahas, Safa; Steinhoff, Ulrich] Univ Marburg, Inst Med Microbiol & Hosp Hyg, Marburg, Germany; [Bruce, Kenneth D.] Kings Coll London, Inst Pharmaceut Sci, London WC2R 2LS, England	Forschungszentrum Borstel; University of Lubeck; University of Kiel; Philipps University Marburg; University of London; King's College London	Schaible, UE (corresponding author), Res Ctr Borstel, Dept Mol Infect Biol, Cellular Microbiol Grp, Borstel, Germany.	uschaible@fz-borstel.de	Baines, John F/B-3580-2010	Baines, John F/0000-0002-8132-4909; Steinhoff, Ulrich/0000-0003-2141-7756; Linnenbrink, Miriam/0000-0003-0163-3056	Research Center Borstel	Research Center Borstel	Funding: This research is supported by Research Center Borstel in house funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann R, 2008, NAT REV MICROBIOL, V6, P339, DOI 10.1038/nrmicro1888; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Barfod KK, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-303; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bik EM, 2006, P NATL ACAD SCI USA, V103, P732, DOI 10.1073/pnas.0506655103; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Charlson ES, 2011, AM J RESP CRIT CARE, V184, P957, DOI 10.1164/rccm.201104-0655OC; Coenye T, 2002, EMERG INFECT DIS, V8, P692, DOI 10.3201/eid0807.010472; Daims H, 1999, SYST APPL MICROBIOL, V22, P434, DOI 10.1016/S0723-2020(99)80053-8; Dammann P, 2011, LAB ANIM-UK, V45, P271, DOI 10.1258/la.2011.010183; Debarry J, 2007, J ALLERGY CLIN IMMUN, V119, P1514, DOI 10.1016/j.jaci.2007.03.023; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Erb-Downward JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016384; Falk PG, 1998, MICROBIOL MOL BIOL R, V62, P1157, DOI 10.1128/MMBR.62.4.1157-1170.1998; Fredricks DN, 2005, NEW ENGL J MED, V353, P1899, DOI 10.1056/NEJMoa043802; Fujimura KE, 2014, P NATL ACAD SCI USA, V111, P805, DOI 10.1073/pnas.1310750111; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Goulding John, 2007, Proc Am Thorac Soc, V4, P618, DOI 10.1513/pats.200706-066TH; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hilty M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008578; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Hooper LV, 2009, NAT REV MICROBIOL, V7, P367, DOI 10.1038/nrmicro2114; Huang YJ, 2011, J ALLERGY CLIN IMMUN, V127, P372, DOI 10.1016/j.jaci.2010.10.048; Kinjo Y, 2005, NATURE, V434, P520, DOI 10.1038/nature03407; Kleerebezem M, 2010, FEMS MICROBIOL REV, V34, P199, DOI [10.1111/j.1574-6976.2010.00208.x, 10.1111/j.1574-6976.2009.00208.x]; KRZIWON C, 1995, INFECT IMMUN, V63, P2899, DOI 10.1128/IAI.63.8.2899-2905.1995; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; Linnenbrink M, 2013, MOL ECOL, V22, P1904, DOI 10.1111/mec.12206; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Madan JC, 2012, MBIO, V3, DOI 10.1128/mBio.00251-12; Mazmanian SK, 2008, NATURE, V453, P620, DOI 10.1038/nature07008; McLoughlin RM, 2011, J ALLERGY CLIN IMMUN, V127, P1097, DOI 10.1016/j.jaci.2011.02.012; Mohammadi T, 2005, J MICROBIOL METH, V61, P285, DOI 10.1016/j.mimet.2004.11.018; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Patten CC, 2010, COMPARATIVE MED, V60, P18; Pezzulo AA, 2013, APPL ENVIRON MICROB, V79, P5936, DOI 10.1128/AEM.01752-13; Rausch P, 2011, P NATL ACAD SCI USA, V108, P19030, DOI 10.1073/pnas.1106408108; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Rogers GB, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-49; Sasaki H, 2006, J VET MED SCI, V68, P639, DOI 10.1292/jvms.68.639; Stecher B, 2008, TRENDS MICROBIOL, V16, P107, DOI 10.1016/j.tim.2007.12.008; Stelzmueller I, 2006, CLIN MICROBIOL INFEC, V12, P99, DOI 10.1111/j.1469-0691.2005.01309.x; Tunney MM, 2008, AM J RESP CRIT CARE, V177, P995, DOI 10.1164/rccm.200708-1151OC; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Wei B, 2010, J IMMUNOL	48	65	71	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113466	10.1371/journal.pone.0113466	http://dx.doi.org/10.1371/journal.pone.0113466			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470730	gold, Green Published			2022-12-26	WOS:000349128700029
J	Archer, DC; Costain, DA; Sherlock, C				Archer, Debra C.; Costain, Deborah A.; Sherlock, Chris			Idiopathic Focal Eosinophilic Enteritis (IFEE), an Emerging Cause of Abdominal Pain in Horses: The Effect of Age, Time and Geographical Location on Risk	PLOS ONE			English	Article							SMALL-INTESTINAL OBSTRUCTION; EPITHELIOTROPIC DISEASE; EQUINE; GASTROENTERITIS; DERMATITIS	Background: Idiopathic focal eosinophilic enteritis (IFEE) is an emerging cause of abdominal pain (colic) in horses that frequently requires surgical intervention to prevent death. The epidemiology of IFEE is poorly understood and it is difficult to diagnose pre-operatively. The aetiology of this condition and methods of possible prevention are currently unknown. The aims of this study were to investigate temporal and spatial heterogeneity in IFEE risk and to ascertain the effect of horse age on risk. Methodology/Principal Findings: A retrospective, nested case-control study was undertaken using data from 85 IFEE cases and 848 randomly selected controls admitted to a UK equine hospital for exploratory laparotomy to investigate the cause of colic over a 10-year period. Generalised additive models (GAMs) were used to quantify temporal and age effects on the odds of IFEE and to provide mapped estimates of 'residual' risk over the study region. The relative risk of IFEE increased over the study period (p=0.001) and a seasonal pattern was evident (p<0.01) with greatest risk of IFEE being identified between the months of July and November. IFEE risk decreased with increasing age (p<0.001) with younger (0-5 years old) horses being at greatest risk. The mapped surface estimate exhibited significantly atypical sub-regions (p<0.001) with increased IFEE risk in horses residing in the North-West of the study region. Conclusions/Significance: IFEE was found to exhibit both spatial and temporal variation in risk and is more likely to occur in younger horses. This information may help to identify horses at increased risk of IFEE, provide clues about the aetiology of this condition and to identify areas that require further research.	[Archer, Debra C.] Univ Liverpool, Inst Infect & Global Hlth, Sch Vet Sci, Neston, England; [Costain, Deborah A.; Sherlock, Chris] Univ Lancaster, Dept Math & Stat, Lancaster, England	University of Liverpool; Lancaster University	Archer, DC (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Sch Vet Sci, Leahurst Campus, Neston, England.	darcher@liv.ac.uk		Sherlock, Chris/0000-0002-2429-3157; Costain, Deborah/0000-0002-6187-1411	Horse Trust; Petplan Charitable Trust	Horse Trust; Petplan Charitable Trust	The authors are grateful to the Horse Trust and Petplan Charitable Trust for funding the colic survival study at the hospital from which some of the data were obtained. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLISON N, 1990, J AM VET MED ASSOC, V196, P462; [Anonymous], 2014, R LANG ENV STAT COMP; Archer DC, 2008, EQUINE VET J, V40, P405, DOI 10.2746/042516408X312149; Archer DC, 2008, EQUINE VET J, V40, P224, DOI 10.2746/042516408X266079; Archer DC, 2006, VET J, V172, P29, DOI 10.1016/j.tvjl.2005.04.002; Archer D.C., 2008, 9 INT COL RES S LIV, P164; Archer DC, 2006, VET J, V171, P504, DOI 10.1016/j.tvjl.2005.02.031; Archer Debra C, 2006, BMC Vet Res, V2, P27, DOI 10.1186/1746-6148-2-27; BLIKSLAGER AT, 1992, J AM VET MED ASSOC, V201, P1249; Boden LA, 2012, BMC VET RES, V8, DOI 10.1186/1746-6148-8-43; Breslow NE, 1980, STAT METHODS CANC RE, V1, P28; COHEN ND, 1992, J AM VET MED ASSOC, V200, P1518; Davis BP, 2013, EOSINOPHILS IN HEALTH AND DISEASE, P484; Davison AC, 1997, BOOTSTRAP METHODS TH; Edwards G B, 2000, Equine Vet J Suppl, P86; French NP, 2005, EPIDEMIOL INFECT, V133, P343, DOI 10.1017/S0950268804003322; GIBSON KT, 1987, EQUINE VET J, V19, P247, DOI 10.1111/j.2042-3306.1987.tb01397.x; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hillyer MH, 2002, EQUINE VET J, V34, P455, DOI 10.2746/042516402776117746; Kay AB, 2001, NEW ENGL J MED, V344, P30, DOI 10.1056/NEJM200101043440106; Mair T, 2004, BEVA EVIDENCE BASED, P58; Makinen PE, 2008, EQUINE VET J, V40, P386, DOI [10.2746/042516408X312112, 10.2746/042516408X284646]; Marshall JF BA, 2012, EQUINE SURG, P402; Masterson JC, 2011, CURR OPIN GASTROEN, V27, P515, DOI 10.1097/MOG.0b013e32834b314c; McCue ME, 2003, J AM VET MED ASSOC, V223, P1320, DOI 10.2460/javma.2003.223.1320; McCullagh P, 1989, GEN LINEAR MODELS; Odemuyiwa SO, 2013, EOSINOPHILS IN HEALTH AND DISEASE, P567; Olmos JFP, 2006, EQUINE VET J, V38, P354, DOI 10.2746/042516406777749308; PASS DA, 1982, VET PATHOL, V19, P486, DOI 10.1177/030098588201900504; Powell N, 2010, NAT REV GASTRO HEPAT, V7, P146, DOI 10.1038/nrgastro.2010.5; Proudman CJ, 2006, EQUINE VET J, V38, P290, DOI 10.2746/042516406777749209; Proudman CJ, 2002, EQUINE VET J, V34, P438, DOI 10.2746/042516402776117881; Schumacher J, 2000, J VET INTERN MED, V14, P258, DOI 10.1892/0891-6640(2000)014&lt;0258:CIIBDO&gt;2.3.CO;2; Scott EA, 1999, J AM VET MED ASSOC, V214, P1527; Southwood LL, 2000, VET SURG, V29, P415, DOI 10.1053/jvet.2000.7543; Stanar LS, 2002, COMP CONT EDUC PRACT, V24, P342; Suthers JM, 2013, EQUINE VET J, V45, P558, DOI 10.1111/evj.12039; Swain JM, 2003, VET REC, V152, P648, DOI 10.1136/vr.152.21.648; Tinker MK, 1997, EQUINE VET J, V29, P448, DOI 10.1111/j.2042-3306.1997.tb03157.x; Traub-Dargatz JL, 2001, J AM VET MED ASSOC, V219, P67, DOI 10.2460/javma.2001.219.67; WILKIE JSN, 1985, VET PATHOL, V22, P297, DOI 10.1177/030098588502200401; Wood S.N., 2017, GEN ADDITIVE MODELS, V2nd ed., DOI [10.1201/9781315370279, DOI 10.1201/9781315370279]; Yun MY, 2007, WORLD J GASTROENTERO, V13, P1758, DOI 10.3748/wjg.v13.i11.1758	43	12	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112072	10.1371/journal.pone.0112072	http://dx.doi.org/10.1371/journal.pone.0112072			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463382	Green Accepted, Green Submitted, Green Published, gold			2022-12-26	WOS:000345869700009
J	Chen, HL; Lin, LL; Xie, MH; Zhang, GL; Su, WH				Chen, Haoliang; Lin, Lulu; Xie, Minghui; Zhang, Guangling; Su, Weihua			De novo Sequencing, Assembly and Characterization of Antennal Transcriptome of Anomala corpulenta Motschulsky (Coleoptera: Rutelidae)	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS STRAIN; PHEROMONE-BINDING-PROTEIN; IMMUNOCYTOCHEMICAL LOCALIZATION; TOOL; EXPRESSION; MODEL	Background: Anomala corpulenta is an important insect pest and can cause enormous economic losses in agriculture, horticulture and forestry. It is widely distributed in China, and both larvae and adults can cause serious damage. It is difficult to control this pest because the larvae live underground. Any new control strategy should exploit alternatives to heavily and frequently used chemical insecticides. However, little genetic research has been carried out on A. corpulenta due to the lack of genomic resources. Genomic resources could be produced by next generation sequencing technologies with low cost and in a short time. In this study, we performed de novo sequencing, assembly and characterization of the antennal transcriptome of A. corpulenta. Results: Illumina sequencing technology was used to sequence the antennal transcriptome of A. corpulenta. Approximately 76.7 million total raw reads and about 68.9 million total clean reads were obtained, and then 35,656 unigenes were assembled. Of these unigenes, 21,463 of them could be annotated in the NCBI nr database, and, among the annotated unigenes, 11,154 and 6,625 unigenes could be assigned to GO and COG, respectively. Additionally, 16,350 unigenes could be annotated in the Swiss-Prot database, and 14,499 unigenes could map onto 258 pathways in the KEGG Pathway database. We also found 24 unigenes related to OBPs, 6 to CSPs, and in total 167 unigenes related to chemodetection. We analyzed 4 OBPs and 3CSPs sequences and their RT-qPCR results agreed well with their FPKM values. Conclusion: We produced the first large-scale antennal transcriptome of A. corpulenta, which is a species that has little genomic information in public databases. The identified chemodetection unigenes can promote the molecular mechanistic study of behavior in A. corpulenta. These findings provide a general sequence resource for molecular genetics research on A. corpulenta.	[Chen, Haoliang; Lin, Lulu; Xie, Minghui; Zhang, Guangling; Su, Weihua] Anhui Acad Agr Sci, Inst Plant Protect & Agroprod Safety, Hefei, Peoples R China	Anhui Academy of Agricultural Sciences	Su, WH (corresponding author), Anhui Acad Agr Sci, Inst Plant Protect & Agroprod Safety, Hefei, Peoples R China.	suwh850@163.com		Chen, Haoliang/0000-0002-8997-3129	Anhui Natural Science Foundation [1308085QC52]; Anhui Academy of Agricultural Sciences [201003025, 11C1106]	Anhui Natural Science Foundation(Natural Science Foundation of Anhui Province); Anhui Academy of Agricultural Sciences	This research was supported by the Anhui Natural Science Foundation (1308085QC52), Chinese Special Fund for Agro-scientific Research in the Public Interest (201003025), and Innovation team (11C1106) from Anhui Academy of Agricultural Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angeli S, 1999, EUR J BIOCHEM, V262, P745, DOI 10.1046/j.1432-1327.1999.00438.x; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Chen SL, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0008613, 10.1371/journal.pone.0015633]; Cheng S, 2008, J PEANUT SCI, V37, P38; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Crawford JE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014202; Deng SS, 2012, CHEM SENSES, V37, P141, DOI 10.1093/chemse/bjr084; Feldmeyer B, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-317; Ge Z, 1959, ACTA ENTOMOLOGICAL S, V9, P491; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hallem EA, 2006, ANNU REV ENTOMOL, V51, P113, DOI 10.1146/annurev.ento.51.051705.113646; Huang H, 2011, THESIS SHENGYANG U S; Huang YW, 2010, TECHNOL CANCER RES T, V9, P139, DOI 10.1177/153303461000900203; Kaissling KE, 2001, CHEM SENSES, V26, P125, DOI 10.1093/chemse/26.2.125; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Leal WS, 1999, FEBS LETT, V464, P85, DOI 10.1016/S0014-5793(99)01683-X; Matsuo T, 2007, PLOS BIOL, V5, P985, DOI 10.1371/journal.pbio.0050118; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Mikheyev AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011212; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nobuta K, 2010, METHODS MOL BIOL, V592, P89, DOI 10.1007/978-1-60327-005-2_7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Poelchau MF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-619; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Shu C, 2007, CURR MICROBIOL, V55, P492, DOI 10.1007/s00284-007-9018-3; Tao X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036234; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Yan GX, 2009, BIOTECHNOL LETT, V31, P697, DOI 10.1007/s10529-009-9913-8; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zeng V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061479; Zhang XM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042082; Zhong T, 2012, J INSECT PHYSIOL, V58, P771, DOI 10.1016/j.jinsphys.2012.01.011; Zhou SS, 2014, COMP BIOCHEM PHYS D, V9, P31, DOI 10.1016/j.cbd.2013.12.002; Zhu KY, 2009, HDB NUCL ACID PURIFI, P297	40	22	23	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114238	10.1371/journal.pone.0114238	http://dx.doi.org/10.1371/journal.pone.0114238			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461610	Green Submitted, gold, Green Published			2022-12-26	WOS:000345869700122
J	Davies, TK; Mees, CC; Milner-Gulland, EJ				Davies, Tim K.; Mees, Chris C.; Milner-Gulland, E. J.			Modelling the Spatial Behaviour of a Tropical Tuna Purse Seine Fleet	PLOS ONE			English	Article							LOCATION CHOICE; TRIP CHOICE; FISHERIES; DYNAMICS; FISH; DISTRIBUTIONS; UNCERTAINTY; PREDICTION; KNOWLEDGE; CATCH	Industrial tuna fisheries operate in the Indian, Atlantic and Pacific Oceans, but concerns over sustainability and environmental impacts of these fisheries have resulted in increased scrutiny of how they are managed. An important but often overlooked factor in the success or failure of tuna fisheries management is the behaviour of fishers and fishing fleets. Uncertainty in how a fishing fleet will respond to management or other influences can be reduced by anticipating fleet behaviour, although to date there has been little research directed at understanding and anticipating the human dimension of tuna fisheries. The aim of this study was to address gaps in knowledge of the behaviour of tuna fleets, using the Indian Ocean tropical tuna purse seine fishery as a case study. We use statistical modelling to examine the factors that influence the spatial behaviour of the purse seine fleet at broad spatiotemporal scales. This analysis reveals very high consistency between years in the use of seasonal fishing grounds by the fleet, as well as a forcing influence of biophysical ocean conditions on the distribution of fishing effort. These findings suggest strong inertia in the spatial behaviour of the fleet, which has important implications for predicting the response of the fleet to natural events or management measures (e. g., spatial closures).	[Davies, Tim K.; Mees, Chris C.] MRAG Ltd, London, England; [Milner-Gulland, E. J.] Univ London Imperial Coll Sci Technol & Med, London, England	Imperial College London	Davies, TK (corresponding author), MRAG Ltd, London, England.	t.davies@mrag.co.uk			NERC/ESRC grant: Natural Environment Research Council (NERC); Economic and Social Research Council (ESRC)	NERC/ESRC grant: Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Economic and Social Research Council (ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The study was part of a PhD funded under a joint NERC/ESRC grant: Natural Environment Research Council (NERC), http://www.nerc.ac.uk/; Economic and Social Research Council (ESRC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy KE, 2007, CAN J FISH AQUAT SCI, V64, P1595, DOI 10.1139/F07-125; Branch TA, 2006, CAN J FISH AQUAT SCI, V63, P1647, DOI 10.1139/F06-072; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Camerer C, 1997, Q J ECON, V112, P407, DOI 10.1162/003355397555244; Cullis-Suzuki S, 2010, MAR POLICY, V34, P1036, DOI 10.1016/j.marpol.2010.03.002; Curtis RE, 2004, MAR RESOUR ECON, V19, P131, DOI DOI 10.1086/MRE.19.1.42629422; Dagorn L, 2013, FISH FISH, V14, P391, DOI 10.1111/j.1467-2979.2012.00478.x; Davies TK, 2014, MAR POLICY, V45, P163, DOI 10.1016/j.marpol.2013.12.014; Dempster T, 2004, REV FISH BIOL FISHER, V14, P21, DOI 10.1007/s11160-004-3151-x; Dormann CF, 2007, ECOGRAPHY, V30, P609, DOI 10.1111/j.2007.0906-7590.05171.x; Dowling NA, 2012, FISH FISH, V13, P139, DOI 10.1111/j.1467-2979.2011.00422.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Fulton EA, 2011, FISH FISH, V12, P2, DOI 10.1111/j.1467-2979.2010.00371.x; Gaertner D, 1996, AQUAT LIVING RESOUR, V56, P394; Gelman A., 2006, DATA ANAL USING REGR, DOI DOI 10.1017/CBO9780511790942.005; Gillis DM, 2003, CAN J ZOOL, V81, P177, DOI 10.1139/Z02-240; Gilman EL, 2011, MAR POLICY, V35, P590, DOI 10.1016/j.marpol.2011.01.021; Grafton RQ, 2006, CAN J FISH AQUAT SCI, V63, P699, DOI 10.1139/f05-247; HILBORN R, 1985, CAN J FISH AQUAT SCI, V42, P2, DOI 10.1139/f85-001; Holland DS, 2000, LAND ECON, V76, P133, DOI 10.2307/3147262; Hutton T, 2004, ICES J MAR SCI, V61, P1443, DOI 10.1016/j.icesjms.2004.08.016; ISSF, 2013, ISSF TUN STOCK STAT; Joseph JA, 2010, CONSERVATION MANAGEM, P11; LAURS RM, 1984, DEEP-SEA RES, V31, P1085, DOI 10.1016/0198-0149(84)90014-1; Marsac F., 1999, IOTC P, P147; Marsac F, 2012, IOTC P; MilnerGulland EJ, 2011, ANIMAL MIGRATION: A SYNTHESIS, P1, DOI 10.1093/acprof:oso/9780199568994.001.0001; Mohri Masahiko, 2000, Journal of National Fisheries University, V49, P1; Moreno G, 2007, CAN J FISH AQUAT SCI, V64, P1517, DOI 10.1139/F07-113; Powers JE, 2009, FISH RES, V99, P216, DOI 10.1016/j.fishres.2009.06.011; Pradhan NC, 2004, FISH RES, V68, P209, DOI 10.1016/j.fishres.2003.12.006; Robinson J, 2010, CLIM RES, V43, P149, DOI 10.3354/cr00890; Salas S, 2004, FISH FISH, V5, P153, DOI 10.1111/j.1467-2979.2004.00146.x; Song LM, 2008, FISH OCEANOGR, V17, P239, DOI 10.1111/j.1365-2419.2008.00476.x; Tidd AN, 2012, FISH RES, V125, P243, DOI 10.1016/j.fishres.2012.03.004; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Valcic B, 2009, MAR POLICY, V33, P215, DOI 10.1016/j.marpol.2008.06.001; van Putten IE, 2012, FISH FISH, V13, P216, DOI 10.1111/j.1467-2979.2011.00430.x; Venables WN, 2009, ICES J MAR SCI, V66, P631, DOI 10.1093/icesjms/fsp063; Vermard Y, 2008, CAN J FISH AQUAT SCI, V65, P2444, DOI 10.1139/F08-147; WILEN JE, 1979, J FISH RES BOARD CAN, V36, P855, DOI 10.1139/f79-123; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zainuddin M, 2008, FISH OCEANOGR, V17, P61, DOI 10.1111/j.1365-2419.2008.00461.x	44	25	25	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114037	10.1371/journal.pone.0114037	http://dx.doi.org/10.1371/journal.pone.0114037			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462165	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700085
J	Guo, CY; Pan, WC; Chen, MJ; Tsai, CW; Chen, NT; Su, HJ				Guo, Chao-Yu; Pan, Wen-Chi; Chen, Mu-Jean; Tsai, Chen-Wei; Chen, Nai-Tzu; Su, Huey-Jen			When Are We Most Vulnerable to Temperature Variations in a Day?	PLOS ONE			English	Article							HEAT WAVES; MORTALITY; COLD; WEATHER; EXTREMES; CITIES; RISK; POPULATIONS	Daily temperature measures are commonly used when examining the association between temperature and mortality. In fact, temperature measures are available 24 hours a day and more detailed records may provide a better prediction of mortality compared to daily statistics. In this article, monthly stratified analysis modeling for mortality is conducted for the total population as well as the stratified elderly and younger subgroups. We identified the most significant time during the day that is associated with daily mortality. Surprisingly, the estimates of relative risk and magnitude of associations derived from the hourly temperature measures are similar or even stronger compared to those modeled by the daily statistics. This phenomenon remains true for lagged hourly temperature measures and the changing patterns of associations from January through December are revealed. In summary, people are the most vulnerable to temperature variations in the early morning around 5 am and the night time around 8 pm.	[Guo, Chao-Yu; Tsai, Chen-Wei] Natl Yang Ming Univ, Inst Publ Hlth, Div Biostat, Taipei 112, Taiwan; [Guo, Chao-Yu] Natl Yang Ming Univ, Aging & Hlth Res Ctr, Taipei 112, Taiwan; [Guo, Chao-Yu] Natl Yang Ming Univ, Biostat Consulting Ctr, Taipei 112, Taiwan; [Pan, Wen-Chi; Chen, Mu-Jean; Chen, Nai-Tzu; Su, Huey-Jen] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Pan, Wen-Chi] Brown Univ, Dept Epidemiol, Sch Publ Hlth, Providence, RI 02912 USA; [Chen, Mu-Jean] Natl Hlth Res Inst, Natl Environm Hlth Res Ctr, Miaoli, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Cheng Kung University; Brown University; National Health Research Institutes - Taiwan	Su, HJ (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan.	hjsu@mail.ncku.edu.tw		Guo, Chao-Yu/0000-0002-9066-9933; Pan, Wen-Chi/0000-0002-0588-8083	Taiwan National Science Council [NSC 99-2621-M-006-008, NSC 100-2621-M-006-001, NSC 100-2314-B-010-057-MY2, NSC 101-2621-M-006-001, NSC 101-2625-M- 006-009, NSC102-2621-M-006-001]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	This work was supported by the Taiwan National Science Council [NSC 99-2621-M-006-008, NSC 100-2621-M-006-001, NSC 100-2314-B-010-057-MY2, NSC 101-2621-M-006-001, NSC 101-2625-M- 006-009, and NSC102-2621-M-006-001]. The funders had no role in study design, data collection and analysis.	Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266; Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Ballester F, 1997, INT J EPIDEMIOL, V26, P551, DOI 10.1093/ije/26.3.551; Barnett AG, 2005, J EPIDEMIOL COMMUN H, V59, P551, DOI 10.1136/jech.2004.028514; Basu R, 2005, EPIDEMIOLOGY, V16, P58, DOI 10.1097/01.ede.0000147117.88386.fe; Braga ALF, 2001, EPIDEMIOLOGY, V12, P662; Carrier J, 1996, CHRONOBIOL INT, V13, P373, DOI 10.3109/07420529609012661; Chang KJ, 2014, ARCH GERONTOL GERIAT, V59, P468, DOI 10.1016/j.archger.2014.04.007; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; Gao Y, 2014, PLOS ONE, V18; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gasparrini A, 2009, DISTRIBUTED LAG NONL; Gasparrini A, 2010, ENVIRON RES, V110, P633, DOI 10.1016/j.envres.2010.06.005; Goodman PG, 2004, ENVIRON HEALTH PERSP, V112, P179, DOI 10.1289/ehp.6451; Huynen MMTE, 2001, ENVIRON HEALTH PERSP, V109, P463, DOI 10.2307/3454704; Ingole V, 2012, GLOB HLTH ACTION, V5, P1; Keatinge WR, 2000, BRIT MED J, V321, P670, DOI 10.1136/bmj.321.7262.670; Keatinge WR, 1997, LANCET, V349, P1341, DOI 10.1016/S0140-6736(96)12338-2; Lin YK, 2011, ENVIRON RES, V111, P1156, DOI 10.1016/j.envres.2011.06.008; McGeehin MA, 2001, ENVIRON HEALTH PERSP, V109, P185, DOI 10.2307/3435008; Mercer JB, 2003, ENVIRON RES, V92, P8, DOI 10.1016/S0013-9351(02)00009-9; O'Neill MS, 2003, AM J EPIDEMIOL, V157, P1074, DOI 10.1093/aje/kwg096; Ou CQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077150; Rocklov J, 2008, SCAND J PUBLIC HEALT, V36, P516, DOI 10.1177/1403494807088458; Schifano P, 2013, ENVIRON INT, V61, P77, DOI 10.1016/j.envint.2013.09.005; Schwartz J, 2005, EPIDEMIOLOGY, V16, P67, DOI 10.1097/01.ede.0000147114.25957.71; Sung TI, 2013, SCI TOTAL ENVIRON, V442, P275, DOI 10.1016/j.scitotenv.2012.09.068; Ye XF, 2012, ENVIRON HEALTH PERSP, V120, P19, DOI [10.1289/ehp.1003198, 10.1289/ehp.120-a19]; Zanobetti A, 2008, EPIDEMIOLOGY, V19, P563, DOI 10.1097/EDE.0b013e31816d652d; Zanobetti A, 2013, EPIDEMIOLOGY, V24, P809, DOI 10.1097/01.ede.0000434432.06765.91	30	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113195	10.1371/journal.pone.0113195	http://dx.doi.org/10.1371/journal.pone.0113195			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463354	Green Published, Green Submitted, gold			2022-12-26	WOS:000345869700029
J	Atherton, MA; Bates, RA; Wynn, HP				Atherton, Mark A.; Bates, Ronald A.; Wynn, Henry P.			Dimensional Analysis Using Toric Ideals: Primitive Invariants	PLOS ONE			English	Article								Classical dimensional analysis in its original form starts by expressing the units for derived quantities, such as force, in terms of power products of basic units M, L, T etc. This suggests the use of toric ideal theory from algebraic geometry. Within this the Graver basis provides a unique primitive basis in a well-defined sense, which typically has more terms than the standard Buckingham approach. Some textbook examples are revisited and the full set of primitive invariants found. First, a worked example based on convection is introduced to recall the Buckingham method, but using computer algebra to obtain an integer K matrix from the initial integer A matrix holding the exponents for the derived quantities. The K matrix defines the dimensionless variables. But, rather than this integer linear algebra approach it is shown how, by staying with the power product representation, the full set of invariants (dimensionless groups) is obtained directly from the toric ideal defined by A. One candidate for the set of invariants is a simple basis of the toric ideal. This, although larger than the rank of K, is typically not unique. However, the alternative Graver basis is unique and defines a maximal set of invariants, which are primitive in a simple sense. In addition to the running example four examples are taken from: a windmill, convection, electrodynamics and the hydrogen atom. The method reveals some named invariants. A selection of computer algebra packages is used to show the considerable ease with which both a simple basis and a Graver basis can be found.	[Atherton, Mark A.; Bates, Ronald A.] Brunel Univ, Dept Mech Engn, London, England; [Wynn, Henry P.] London Sch Econ, Dept Stat, London WC2A 2AE, England	Brunel University; University of London; London School Economics & Political Science	Wynn, HP (corresponding author), London Sch Econ, Dept Stat, London WC2A 2AE, England.	h.wynn@lse.ac.uk	Atherton, Mark/C-3310-2017	Atherton, Mark/0000-0002-3293-4241; Wynn, Henry/0000-0002-6448-1080	Leverhulme Trust Emeritus Fellowship [1-SST-U445]; United Kingdom EPSRC [MUCM EP/D049993/1]	Leverhulme Trust Emeritus Fellowship(Leverhulme Trust); United Kingdom EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding: The third author received funding from Leverhulme Trust Emeritus Fellowship (1-SST-U445) and United Kingdom EPSRC grant: MUCM EP/D049993/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht MC, 2013, TECHNOMETRICS, V55, P257, DOI 10.1080/00401706.2012.746207; Barnett W, 2007, Q J AUSTRIAN EC, V1, P95; BHASKAR R, 1990, ARTIF INTELL, V45, P73, DOI 10.1016/0004-3702(90)90038-2; Bolster D, 2011, PHYS TODAY, V64, P42, DOI 10.1063/PT.3.1258; Buckingham E, 1916, NATURE, V96, P396, DOI 10.1038/096396d0; Buckingham E, 1914, PHYS REV, V4, P345, DOI 10.1103/PhysRev.4.345; Buckingham E., 1915, T AM SOC MECH ENG, V37, P263; Chapman SC, 2009, PLASMA PHYS CONTR F, V51, DOI 10.1088/0741-3335/51/12/124006; Chapman SC, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3057392; Cox D. A., 2007, IDEALS VARIETIES ALG; Cox D. A., 2011, GRADUATE STUDIES MAT, V124; D'Agostino S, 2002, HIST IDEAS THEORETIC; Davis T, 2013, TECHNOMETRICS, V55, P271, DOI 10.1080/00401706.2013.804881; Gibbings JC, 2011, DIMENSIONAL ANALYSIS, P1, DOI 10.1007/978-1-84996-317-6; Gibbings JC, 1986, SYSTEMATIC EXPT; Grove DM, 1992, ENG QUALITY EXPT DES; Hubert E, 2013, JOURNEES NATL CALCUL, V3; Hubert E, 2007, J SYMB COMPUT, V42, P203, DOI 10.1016/j.jsc.2006.03.005; Hubert E, 2013, FOUND COMPUT MATH, V13, P479, DOI 10.1007/s10208-013-9165-9; Jensen A.N, 2011, GFAN SOFTWARE SYSTEM; Margaria G, 2001, MATH BIOSCI, V174, P1, DOI 10.1016/S0025-5564(01)00079-7; Olver P.J., 1986, APPL LIE GROUPS DIFF; Smith H., 1991, INTRO QUANTUM MECH; Sturmfels B, 1996, U LECT NOTE SERIES, V8; Szirtes T, 2007, APPLIED DIMENSIONAL ANALYSIS AND MODELING, 2ND EDITION, P1	25	2	2	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112827	10.1371/journal.pone.0112827	http://dx.doi.org/10.1371/journal.pone.0112827			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436774	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000347114900019
J	Marchetti, L; De Nadai, T; Bonsignore, F; Calvello, M; Signore, G; Viegi, A; Beltram, F; Luin, S; Cattaneo, A				Marchetti, Laura; De Nadai, Teresa; Bonsignore, Fulvio; Calvello, Mariantonietta; Signore, Giovanni; Viegi, Alessandro; Beltram, Fabio; Luin, Stefano; Cattaneo, Antonino			Site-Specific Labeling of Neurotrophins and Their Receptors via Short and Versatile Peptide Tags	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; SINGLE-PARTICLE TRACKING; AXONAL-TRANSPORT; NGF-RECEPTOR; QUANTUM DOTS; LIVING CELLS; TRAFFICKING; COMPLEXES; DYNAMICS; MOLECULE	We present a toolbox for the study of molecular interactions occurring between NGF and its receptors. By means of a suitable insertional mutagenesis method we show the insertion of an 8 amino acid tag (A4) into the sequence of NGF and of 12 amino acid tags (A1 and S6) into the sequence of TrkA and P75NTR NGF-receptors. These tags are shortened versions of the acyl and peptidyl carrier proteins; they are here covalently conjugated to the biotin-substituted arm of a coenzyme A (coA) substrate by phosphopantetheinyl transferase enzymes (PPTases). We demonstrate site-specific biotinylation of the purified recombinant tagged neurotrophin, in both the immature proNGF and mature NGF forms. The resulting tagged NGF is fully functional: it can signal and promote PC12 cells differentiation similarly to recombinant wild-type NGF. Furthermore, we show that the insertion of A1 and S6 tags into human TrkA and P75NTR sequences leads to the site-specific biotinylation of these receptors at the cell surface of living cells. Crucially, the two tags are labeled selectively by two different PPTases: this is exploited to reach orthogonal fluorolabeling of the two receptors co-expressed at low density in living cells. We describe the protocols to obtain the enzymatic, site-specific biotinylation of neurotrophins and their receptors as an alternative to their chemical, nonspecific biotinylation. The present strategy has three main advantages: i) it yields precise control of stoichiometry and site of biotin conjugation; ii) the tags used can be functionalized with virtually any small probe that can be carried by coA substrates, besides (and in addition to) biotin; iii) above all it makes possible to image and track interacting molecules at the single-molecule level in living systems.	[Marchetti, Laura; Bonsignore, Fulvio; Beltram, Fabio; Luin, Stefano] Scuola Normale Super Pisa, NEST, Pisa, Italy; [Marchetti, Laura; De Nadai, Teresa; Bonsignore, Fulvio; Calvello, Mariantonietta; Viegi, Alessandro; Beltram, Fabio; Luin, Stefano; Cattaneo, Antonino] CNR, Ist Nanosci, I-56100 Pisa, Italy; [Marchetti, Laura; De Nadai, Teresa; Calvello, Mariantonietta; Viegi, Alessandro; Cattaneo, Antonino] Scuola Normale Super Pisa, BioSNS Lab, Pisa, Italy; [Signore, Giovanni; Beltram, Fabio] Ctr Nanotechnol Innovat, IIT NEST, Pisa, Italy	Scuola Normale Superiore di Pisa; Consiglio Nazionale delle Ricerche (CNR); Istituto Nanoscienze (NANO-CNR); Scuola Normale Superiore di Pisa; Istituto Italiano di Tecnologia - IIT	Luin, S (corresponding author), Scuola Normale Super Pisa, NEST, Pisa, Italy.	s.luin@sns.it; antonino.cattaneo@sns.it	Signore, Giovanni/J-8465-2019; Cattaneo, Antonino/AAA-7252-2019; Cattaneo, Antonino/K-4471-2016; Beltram, Fabio/L-9486-2019; Marchetti, Laura/AAB-9843-2019; signore, giovanni/GOV-6118-2022; Beltram, Fabio/F-2920-2013; Luin, Stefano/B-5532-2012	Signore, Giovanni/0000-0002-0067-2240; Cattaneo, Antonino/0000-0002-6975-8923; Beltram, Fabio/0000-0002-6081-436X; Marchetti, Laura/0000-0002-2110-9481; Beltram, Fabio/0000-0002-6081-436X; Luin, Stefano/0000-0003-2673-366X	MIUR [FIRB RBAP10L8TY, PRIN 2010N8PBAA_006]; Regione Toscana	MIUR(Ministry of Education, Universities and Research (MIUR)); Regione Toscana(Regione Toscana)	Support from MIUR (grants FIRB RBAP10L8TY and PRIN 2010N8PBAA_006 to AC) and from Regione Toscana (grant POR FSE 2007-2013 to SL) is acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barde I, 2006, MOL THER, V13, P382, DOI 10.1016/j.ymthe.2005.09.012; Bronfman FC, 2003, J NEUROSCI, V23, P3209; Callegari A, 2012, J NEUROSCI METH, V204, P82, DOI 10.1016/j.jneumeth.2011.10.019; Covaceuszach S, 2010, BIOCHEM BIOPH RES CO, V391, P824, DOI 10.1016/j.bbrc.2009.11.146; Cui BX, 2007, P NATL ACAD SCI USA, V104, P13666, DOI 10.1073/pnas.0706192104; Das KP, 2004, NEUROTOXICOL TERATOL, V26, P397, DOI 10.1016/j.ntt.2004.02.006; Echarte MM, 2007, FEBS LETT, V581, P2905, DOI 10.1016/j.febslet.2007.05.041; Gong Y, 2008, NATURE, V454, P789, DOI 10.1038/nature07089; He XL, 2004, SCIENCE, V304, P870, DOI 10.1126/science.1095190; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102; Johnsson N, 2005, CHEMBIOCHEM, V6, P47, DOI 10.1002/cbic.200400290; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Lu Y, 2011, J NEUROSCI, V31, P11762, DOI 10.1523/JNEUROSCI.2707-11.2011; Luna EJ, 2001, CURR PROTOC PROTEIN; Marchetti L, 2013, J CELL SCI, V126, P4445, DOI 10.1242/jcs.129916; Nomura M, 2011, DEV NEUROBIOL, V71, P634, DOI 10.1002/dneu.20879; Paoletti F, 2009, PROTEINS, V75, P990, DOI 10.1002/prot.22311; Rajan SS, 2008, ACS NANO, V2, P1153, DOI 10.1021/nn700399e; Rattenholl A, 2001, EUR J BIOCHEM, V268, P3296, DOI 10.1046/j.1432-1327.2001.02232.x; Shibata SC, 2006, BIOCHEM BIOPH RES CO, V342, P316, DOI 10.1016/j.bbrc.2006.01.126; Sung KJ, 2011, J NEUROSCI METH, V200, P121, DOI 10.1016/j.jneumeth.2011.06.020; Tani T, 2005, J NEUROSCI, V25, P2181, DOI 10.1523/JNEUROSCI.4570-04.2005; Wang WY, 1999, BIOTECHNIQUES, V26, P680, DOI 10.2144/99264st03; Wombacher R, 2011, J BIOPHOTONICS, V4, P391, DOI 10.1002/jbio.201100018; Yin J, 2006, NAT PROTOC, V1, P280, DOI 10.1038/nprot.2006.43; Zhou Z, 2008, J AM CHEM SOC, V130, P9925, DOI 10.1021/ja802657n; Zhou Z, 2007, ACS CHEM BIOL, V2, P337, DOI 10.1021/cb700054k	28	18	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113708	10.1371/journal.pone.0113708	http://dx.doi.org/10.1371/journal.pone.0113708			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426999	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400080
J	Wang, P; Chen, SH; Hung, WC; Paul, C; Zhu, F; Guan, PP; Huso, DL; Kontrogianni-Konstantopoulos, A; Konstantopoulos, K				Wang, P.; Chen, S-H; Hung, W-C; Paul, C.; Zhu, F.; Guan, P-P; Huso, D. L.; Kontrogianni-Konstantopoulos, A.; Konstantopoulos, K.			Fluid shear promotes chondrosarcoma cell invasion by activating matrix metalloproteinase 12 via IGF-2 and VEGF signaling pathways	ONCOGENE			English	Article							MACROPHAGE METALLOELASTASE MMP-12; 15-DEOXY-DELTA(12,14)-PROSTAGLANDIN J(2); INTERSTITIAL CONVECTION; ENDOTHELIAL-CELLS; LOCAL RECURRENCE; EXPRESSION; METASTASIS; CHONDROCYTES; STRESS; FLOW	Interstitial fluid flow in and around the tumor tissue is a physiologically relevant mechanical signal that regulates intracellular signaling pathways throughout the tumor. Yet, the effects of interstitial flow and associated fluid shear stress on the tumor cell function have been largely overlooked. Using in vitro bioengineering models in conjunction with molecular cell biology tools, we found that fluid shear (2 dyn/cm(2)) markedly upregulates matrix metalloproteinase 12 (MMP-12) expression and its activity in human chondrosarcoma cells. MMP-12 expression is induced in human chondrocytes during malignant transformation. However, the signaling pathway regulating MMP-12 expression and its potential role in human chondrosarcoma cell invasion and metastasis have yet to be delineated. We discovered that fluid shear stress induces the synthesis of insulin growth factor-2 (IGF-2) and vascular endothelial growth factor (VEGF) B and D, which in turn transactivate MMP-12 via PI3-K, p38 and JNK signaling pathways. IGF-2-, VEGF-B-or VEGF-D-stimulated chondrosarcoma cells display markedly higher migratory and invasive potentials in vitro, which are blocked by inhibiting MMP-12, PI3-K, p38 or JNK activity. Moreover, recombinant human MMP-12 or MMP-12 overexpression can potentiate chondrosarcoma cell invasion in vitro and the lung colonization in vivo. By reconstructing and delineating the signaling pathway regulating MMP-12 activation, potential therapeutic strategies that interfere with chondrosarcoma cell invasion may be identified.	[Wang, P.; Guan, P-P] Northeastern Univ, Coll Life & Hlth Sci, Shenyang 110819, Peoples R China; [Wang, P.; Chen, S-H; Hung, W-C; Paul, C.; Zhu, F.; Guan, P-P; Konstantopoulos, K.] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Chen, S-H; Konstantopoulos, K.] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Baltimore, MD 21218 USA; [Hung, W-C; Konstantopoulos, K.] Johns Hopkins Univ, Ctr Canc Nanotechonol Excellence, Baltimore, MD 21218 USA; [Paul, C.; Konstantopoulos, K.] Johns Hopkins Univ, Johns Hopkins Inst NanoBioTechnol, Baltimore, MD 21218 USA; [Huso, D. L.] Johns Hopkins Med Inst, Dept Mol & Comparat Pathobiol, Baltimore, MD 21205 USA; [Huso, D. L.] Johns Hopkins Med Inst, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21205 USA; [Kontrogianni-Konstantopoulos, A.] Univ Maryland, Sch Med, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA; [Kontrogianni-Konstantopoulos, A.] Univ Maryland, Sch Med, Marlene & Stewart Greenebaum Natl Canc Inst Canc, Baltimore, MD 21201 USA; [Konstantopoulos, K.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA	Northeastern University - China; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Johns Hopkins University	Wang, P (corresponding author), Northeastern Univ, Coll Life & Hlth Sci, 3-11 Wenhua Rd, Shenyang 110819, Peoples R China.	wangpu@mail.neu.edu.cn; konstant@jhu.edu			NCI [R01 CA186286, U54 CA143868]; Kleberg Foundation; National Science Foundation [1159823]; Natural Science Foundation of China [31300777]; Fundamental Research Funds of China [N120520001, N120320001, N130120002]; Liaoning Provincial Talent Support Program [LJQ2013029]; NATIONAL CANCER INSTITUTE [P30CA006973, R01CA186286, U54CA143868] Funding Source: NIH RePORTER; Div Of Chem, Bioeng, Env, & Transp Sys [1159823] Funding Source: National Science Foundation	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kleberg Foundation; National Science Foundation(National Science Foundation (NSF)); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds of China; Liaoning Provincial Talent Support Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported in part or in whole by the NCI (R01 CA186286, U54 CA143868), the Kleberg Foundation, the National Science Foundation (1159823), the Natural Science Foundation of China (31300777), the Fundamental Research Funds of China (N120520001, N120320001 and N130120002) and the Liaoning Provincial Talent Support Program (LJQ2013029).	Abulencia JP, 2003, J BIOL CHEM, V278, P28388, DOI 10.1074/jbc.M301378200; Aigner T, 2002, CANCER, V94, P2273, DOI 10.1002/cncr.10461; Balzer EM, 2012, FASEB J, V26, P4045, DOI 10.1096/fj.12-211441; Berend KR, 1998, J BONE JOINT SURG AM, V80A, P11, DOI 10.2106/00004623-199801000-00004; Chang SF, 2008, P NATL ACAD SCI USA, V105, P3927, DOI 10.1073/pnas.0712353105; Chao W, 2008, CYTOKINE GROWTH F R, V19, P111, DOI 10.1016/j.cytogfr.2008.01.005; CHARY SR, 1989, P NATL ACAD SCI USA, V86, P5385, DOI 10.1073/pnas.86.14.5385; Chen SH, 2013, SCI REP-UK, V3, DOI 10.1038/srep01870; Cheng P, 2010, DIGEST DIS SCI, V55, P3138, DOI 10.1007/s10620-010-1127-3; Dafni H, 2002, CANCER RES, V62, P6731; Dallas MR, 2012, FASEB J, V26, P2648, DOI 10.1096/fj.12-203786; dela Paz NG, 2012, J CELL SCI, V125, P831, DOI 10.1242/jcs.084301; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Friedl P, 2011, CELL, V147, P992, DOI 10.1016/j.cell.2011.11.016; Fritton SP, 2009, ANNU REV FLUID MECH, V41, P347, DOI 10.1146/annurev.fluid.010908.165136; Gunningham SP, 2001, J PATHOL, V193, P325, DOI 10.1002/path.814; Hamamura K, 2008, CELL BIOL INT, V32, P1238, DOI 10.1016/j.cellbi.2008.07.007; Healy ZR, 2008, AM J PHYSIOL-CELL PH, V294, pC1146, DOI 10.1152/ajpcell.00542.2007; Healy ZR, 2005, P NATL ACAD SCI USA, V102, P14010, DOI 10.1073/pnas.0506620102; HILLSLEY MV, 1994, BIOTECHNOL BIOENG, V43, P573, DOI 10.1002/bit.260430706; Hofmann HS, 2005, CLIN CANCER RES, V11, P1086; Houghton AM, 2006, CANCER RES, V66, P6149, DOI 10.1158/0008-5472.CAN-04-0297; Hung WC, 2013, J CELL BIOL, V202, P807, DOI 10.1083/jcb.201302132; Jain RK, 2007, CANCER RES, V67, P2729, DOI 10.1158/0008-5472.CAN-06-4102; Jia HY, 2004, J BIOL CHEM, V279, P36148, DOI 10.1074/jbc.M401538200; Karnezis T, 2012, CANCER CELL, V21, P181, DOI 10.1016/j.ccr.2011.12.026; Kerkela E, 2001, BONE, V29, P487, DOI 10.1016/S8756-3282(01)00595-6; Milkiewicz M, 2001, MICROCIRCULATION, V8, P229, DOI 10.1038/sj.mn.7800074; Orr AW, 2005, J CELL BIOL, V169, P191, DOI 10.1083/jcb.200410073; Ottaviano L, 2010, GENE CHROMOSOME CANC, V49, P40, DOI 10.1002/gcc.20717; Qazi H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020348; Rago C, 2007, CANCER RES, V67, P9364, DOI 10.1158/0008-5472.CAN-07-0605; Rutkowski JM, 2007, TRENDS CELL BIOL, V17, P44, DOI 10.1016/j.tcb.2006.11.007; Salven P, 1998, AM J PATHOL, V153, P103, DOI 10.1016/S0002-9440(10)65550-2; Sarkar S, 2006, CANCER RES, V66, P11771, DOI 10.1158/0008-5472.CAN-05-0470; Soderstrom M, 2001, APMIS, V109, P305, DOI 10.1034/j.1600-0463.2001.d01-125.x; Stroka KM, 2014, CELL, V157, P611, DOI 10.1016/j.cell.2014.02.052; Tang CH, 2012, BIOMEDICINE-TAIWAN, V2, P92, DOI 10.1016/j.biomed.2012.01.001; Tong ZQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029211; Wang P, 2012, J BIOL CHEM, V287, P31877, DOI 10.1074/jbc.M112.362731; Yang W, 2001, CANCER, V91, P1277, DOI 10.1002/1097-0142(20010401)91:7<1277::AID-CNCR1129>3.0.CO;2-H; Yang XS, 2007, PATHOL RES PRACT, V203, P499, DOI 10.1016/j.prp.2007.03.008; Yilmaz A, 2003, BIOCHEM BIOPH RES CO, V306, P730, DOI 10.1016/S0006-291X(03)01064-7; Zhu F, 2010, CELL DEATH DIFFER, V17, P1325, DOI 10.1038/cdd.2010.13	44	43	45	4	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 27	2015	34	35					4558	4569		10.1038/onc.2014.397	http://dx.doi.org/10.1038/onc.2014.397			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CP9BS	25435370	Green Accepted			2022-12-26	WOS:000360189300002
J	Borg, A; Holm, M; Shiroyama, I; Hauryliuk, V; Pavlov, M; Sanyal, S; Ehrenberg, M				Borg, Anneli; Holm, Mikael; Shiroyama, Ikue; Hauryliuk, Vasili; Pavlov, Michael; Sanyal, Suparna; Ehrenberg, Mans			Fusidic Acid Targets Elongation Factor G in Several Stages of Translocation on the Bacterial Ribosome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EF-G; RNA TRANSLOCATION; PROTEIN SYNTHESIS; ESCHERICHIA-COLI; RIBONUCLEIC-ACID; TRANSLATION; HYDROLYSIS; RELEASE; STATE; TRIPHOSPHATE	The antibiotic fusidic acid (FA) targets elongation factor G (EF-G) and inhibits ribosomal peptide elongation and ribosome recycling, but deeper mechanistic aspects of FA action have remained unknown. Using quench flow and stopped flow experiments in a biochemical system for protein synthesis and taking advantage of separate time scales for inhibited (10 s) and uninhibited (100 ms) elongation cycles, a detailed kinetic model of FA action was obtained. FA targets EF-G at an early stage in the translocation process (I), which proceeds unhindered by the presence of the drug to a later stage (II), where the ribosome stalls. Stalling may also occur at a third stage of translocation(III), just before release of EF-G from the post-translocation ribosome. We show that FA is a strong elongation inhibitor (K-50% approximate to 1 mu M), discuss the identity of the FA targeted states, and place existing cryo-EM and crystal structures in their functional context.	[Borg, Anneli; Holm, Mikael; Shiroyama, Ikue; Hauryliuk, Vasili; Pavlov, Michael; Ehrenberg, Mans] Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, S-75124 Uppsala, Sweden; [Borg, Anneli] 3H Biomed AB, S-75183 Uppsala, Sweden	Uppsala University	Ehrenberg, M (corresponding author), Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, Box 596, S-75124 Uppsala, Sweden.	ehrenberg@xray.bmc.uu.se	Hauryliuk, Vasili/J-3930-2019	Hauryliuk, Vasili/0000-0003-2389-5057	Swedish Research Council; Knut and Alice Wallenberg Foundation, RiboCORE; European Regional Development Fund through Centre of Excellence in Chemical Biology; Estonian Science Foundation [ETF9012, PUT37]; Umea University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation, RiboCORE; European Regional Development Fund through Centre of Excellence in Chemical Biology; Estonian Science Foundation; Umea University	This work was supported by the Swedish Research Council (to M. E., A. B., S. S., and V. H.); the Knut and Alice Wallenberg Foundation, RiboCORE (to M. E. and S. S.); the European Regional Development Fund through Centre of Excellence in Chemical Biology, Estonian Science Foundation, Grants ETF9012 and PUT37 (to V. H.); and Umea University (to V. H.).	Antoun Ayman, 2004, Biol Proced Online, V6, P35, DOI 10.1251/bpo71; BODLEY JW, 1970, J BIOL CHEM, V245, P5662; Bremer H., 1996, E COLI SALMONELLA CE, V2, P1553; Burdett V, 1996, J BACTERIOL, V178, P3246, DOI 10.1128/jb.178.11.3246-3251.1996; CHA S, 1975, BIOCHEM PHARMACOL, V24, P2177, DOI 10.1016/0006-2952(75)90050-7; Chen J, 2013, NAT STRUCT MOL BIOL, V20, P718, DOI 10.1038/nsmb.2567; CUNDLIFF.E, 1972, BIOCHEM BIOPH RES CO, V46, P1794, DOI 10.1016/0006-291X(72)90053-8; Fange D, 2011, BIOCHIMIE, V93, P1623, DOI 10.1016/j.biochi.2011.05.031; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; HIRASHIM.A, 1973, J BIOL CHEM, V248, P7580; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; Johansson M, 2008, MOL CELL, V30, P589, DOI 10.1016/j.molcel.2008.04.010; Karimi R, 1999, MOL CELL, V3, P601, DOI 10.1016/S1097-2765(00)80353-6; Keilson J., 1979, MARKOV CHAIN MODELS, P57; Kelmers A., 1971, METHODS ENZYMOL, V20, P3; OKURA A, 1971, J ANTIBIOT, V24, P655, DOI 10.7164/antibiotics.24.655; Pavlov MY, 1996, ARCH BIOCHEM BIOPHYS, V328, P9, DOI 10.1006/abbi.1996.0136; PESTKA S, 1968, P NATL ACAD SCI USA, V61, P726, DOI 10.1073/pnas.61.2.726; Ramrath DJF, 2013, P NATL ACAD SCI USA, V110, P20964, DOI 10.1073/pnas.1320387110; Rao AR, 2001, EMBO J, V20, P2977, DOI 10.1093/emboj/20.11.2977; Savelsbergh A, 2009, RNA, V15, P772, DOI 10.1261/rna.1592509; Semenkov YP, 2000, NAT STRUCT BIOL, V7, P1027; Studer SM, 2003, J MOL BIOL, V327, P369, DOI 10.1016/S0022-2836(03)00146-3; TANAKA N, 1968, BIOCHEM BIOPH RES CO, V30, P278, DOI 10.1016/0006-291X(68)90447-6; Valle M, 2003, CELL, V114, P123, DOI 10.1016/S0092-8674(03)00476-8; Wilden B, 2006, P NATL ACAD SCI USA, V103, P13670, DOI 10.1073/pnas.0606099103; WILLIE GR, 1975, BIOCHEMISTRY-US, V14, P1713, DOI 10.1021/bi00679a025; Wilson DN, 2014, NAT REV MICROBIOL, V12, P35, DOI 10.1038/nrmicro3155; Yonath A, 2005, ANNU REV BIOCHEM, V74, P649, DOI 10.1146/annurev.biochem.74.082803.133130; YOUNG R, 1976, BIOCHEM J, V160, P185, DOI 10.1042/bj1600185; Zavialov AV, 2005, MOL CELL, V18, P675, DOI 10.1016/j.molcel.2005.05.016	31	31	31	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3440	3454		10.1074/jbc.M114.611608	http://dx.doi.org/10.1074/jbc.M114.611608			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25451927	Green Published, hybrid			2022-12-26	WOS:000349456000020
J	Delley, CL; Laederach, J; Ziemski, M; Bolten, M; Boehringer, D; Weber-Ban, E				Delley, Cyrille L.; Laederach, Juerg; Ziemski, Michal; Bolten, Marcel; Boehringer, Daniel; Weber-Ban, Eilika			Bacterial Proteasome Activator Bpa (Rv3780) Is a Novel Ring-Shaped Interactor of the Mycobacterial Proteasome	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; UBIQUITIN-LIKE PROTEIN; WEB-SERVER; COMPLEX; TUBERCULOSIS; DEGRADATION; PATHWAY; ATPASE; PUPYLATION; BINDING	The occurrence of the proteasome in bacteria is limited to the phylum of actinobacteria, where it is maintained in parallel to the usual bacterial compartmentalizing proteases. The role it plays in these organisms is still not fully understood, but in the human pathogen Mycobacterium tuberculosis (Mtb) the proteasome supports persistence in the host. In complex with the ring-shaped ATPase Mpa (called ARC in other actinobacteria), the proteasome can degrade proteins that have been post-translationally modified with the prokaryotic ubiquitin-like protein Pup. Unlike for the eukaryotic proteasome core particle, no other bacterial proteasome interactors have been identified to date. Here we describe and characterize a novel bacterial proteasome activator of Mycobacterium tuberculosis we termed Bpa (Rv3780), using a combination of biochemical and biophysical methods. Bpa features a canonical C-terminal proteasome interaction motif referred to as the HbYX motif, and its orthologs are only found in those actinobacteria encoding the proteasomal subunits. Bpa can inhibit degradation of Pup-tagged substrates in vitro by competing with Mpa for association with the proteasome. Using negative-stain electron microscopy, we show that Bpa forms a ring-shaped homooligomer that can bind coaxially to the face of the proteasome cylinder. Interestingly, Bpa can stimulate the proteasomal degradation of the model substrate beta-casein, which suggests it could play a role in the removal of non-native or damaged proteins.	[Delley, Cyrille L.; Laederach, Juerg; Ziemski, Michal; Bolten, Marcel; Boehringer, Daniel; Weber-Ban, Eilika] Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Weber-Ban, E (corresponding author), Swiss Fed Inst Technol, Inst Mol Biol & Biophys, Zurich, Switzerland.	eilika@mol.biol.ethz.ch		Laederach, Juerg/0000-0003-0726-1070; Ziemski, Michal/0000-0001-6285-8852; Bolten, Marcel/0000-0002-3808-2481; Weber-Ban, Eilika/0000-0002-5773-9274	Swiss National Science Foundation [31003A_141236]; ETH Research Grant [ETH-13 11-2]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Research Grant	This work was supported by the Swiss National Science Foundation Grant 31003A_141236 to EWB (http://www.snf.ch/en/Pages/default.aspx), and this work was supported by ETH Research Grant ETH-13 11-2 to EWB (https://www.ethz.ch/en.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anandan T, 2014, J MICROBIOL, V52, P743, DOI 10.1007/s12275-014-4416-2; Barandun J, 2013, J AM CHEM SOC, V135, P6794, DOI 10.1021/ja4024012; Barandun J, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-95; Battesti A, 2012, METHODS, V58, P325, DOI 10.1016/j.ymeth.2012.07.018; BENOIST P, 1992, J BACTERIOL, V174, P1495, DOI 10.1128/jb.174.5.1495-1504.1992; Bhattacharyya S, 2014, NAT REV MOL CELL BIO, V15, P122, DOI 10.1038/nrm3741; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Burns KE, 2009, J BIOL CHEM, V284, P3069, DOI 10.1074/jbc.M808032200; Cascio P, 2014, BIOMOLECULES, V4, P566, DOI 10.3390/biom4020566; Ciechanover A, 2014, BBA-MOL CELL RES, V1843, P86, DOI 10.1016/j.bbamcr.2013.07.007; Darwin KH, 2005, MOL MICROBIOL, V55, P561, DOI 10.1111/j.1365-2958.2004.04403.x; Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176; De Mot R, 1999, TRENDS MICROBIOL, V7, P88, DOI 10.1016/S0966-842X(98)01432-2; DEMARTINO GN, 1994, J BIOL CHEM, V269, P20878; Elharar Y, 2014, EMBO J, V33, P1802, DOI 10.15252/embj.201387076; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Gandotra S, 2007, NAT MED, V13, P1515, DOI 10.1038/nm1683; Gandotra S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001040; Hill CP, 2002, CURR TOP MICROBIOL, V268, P73; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Kusmierczyk AR, 2011, NAT STRUCT MOL BIOL, V18, P622, DOI 10.1038/nsmb.2027; MA CP, 1994, J BIOL CHEM, V269, P3539; Matyskiela ME, 2013, NAT STRUCT MOL BIOL, V20, P781, DOI 10.1038/nsmb.2616; Matyskiela ME, 2013, J MOL BIOL, V425, P199, DOI 10.1016/j.jmb.2012.11.001; Miller JH., 1972, EXPT MOL GENETICS; Oberto J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-4; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Sadre-Bazzaz K, 2010, MOL CELL, V37, P728, DOI 10.1016/j.molcel.2010.02.002; Samanovic Marie I, 2013, Subcell Biochem, V66, P267, DOI 10.1007/978-94-007-5940-4_10; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Schubert OT, 2013, CELL HOST MICROBE, V13, P602, DOI 10.1016/j.chom.2013.04.008; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Stadtmueller BM, 2012, J BIOL CHEM, V287, P37371, DOI 10.1074/jbc.M112.367003; Striebel F, 2014, BBA-MOL CELL RES, V1843, P103, DOI 10.1016/j.bbamcr.2013.03.022; Striebel F, 2010, EMBO J, V29, P1262, DOI 10.1038/emboj.2010.23; Striebel F, 2009, NAT STRUCT MOL BIOL, V16, P647, DOI 10.1038/nsmb.1597; Striebel F, 2009, CURR OPIN STRUC BIOL, V19, P209, DOI 10.1016/j.sbi.2009.02.006; TAMURA T, 1995, CURR BIOL, V5, P766, DOI 10.1016/S0960-9822(95)00153-9; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Wang T, 2009, STRUCTURE, V17, P1377, DOI 10.1016/j.str.2009.08.010; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Zuhl F, 1997, FEBS LETT, V418, P189, DOI 10.1016/S0014-5793(97)01370-7	47	25	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114348	10.1371/journal.pone.0114348	http://dx.doi.org/10.1371/journal.pone.0114348			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469515	Green Submitted, Green Published, gold			2022-12-26	WOS:000349128700102
J	Gokce, SK; Guo, SX; Ghorashian, N; Everett, WN; Jarrell, T; Kottek, A; Bovik, AC; Ben-Yakar, A				Gokce, Sertan Kutal; Guo, Samuel X.; Ghorashian, Navid; Everett, W. Neil; Jarrell, Travis; Kottek, Aubri; Bovik, Alan C.; Ben-Yakar, Adela			A Fully Automated Microfluidic Femtosecond Laser Axotomy Platform for Nerve Regeneration Studies in C. elegans	PLOS ONE			English	Article							NEMATODE CAENORHABDITIS-ELEGANS; MANIPULATION; BEHAVIOR; NEUROSURGERY; NANOSURGERY; MECHANISMS; MICROSCOPY; RECOVERY; NEURONS; PROTEIN	Femtosecond laser nanosurgery has been widely accepted as an axonal injury model, enabling nerve regeneration studies in the small model organism, Caenorhabditis elegans. To overcome the time limitations of manual worm handling techniques, automation and new immobilization technologies must be adopted to improve throughput in these studies. While new microfluidic immobilization techniques have been developed that promise to reduce the time required for axotomies, there is a need for automated procedures to minimize the required amount of human intervention and accelerate the axotomy processes crucial for high-throughput. Here, we report a fully automated microfluidic platform for performing laser axotomies of fluorescently tagged neurons in living Caenorhabditis elegans. The presented automation process reduces the time required to perform axotomies within individual worms to similar to 17 s/worm, at least one order of magnitude faster than manual approaches. The full automation is achieved with a unique chip design and an operation sequence that is fully computer controlled and synchronized with efficient and accurate image processing algorithms. The microfluidic device includes a T-shaped architecture and three-dimensional microfluidic interconnects to serially transport, position, and immobilize worms. The image processing algorithms can identify and precisely position axons targeted for ablation. There were no statistically significant differences observed in reconnection probabilities between axotomies carried out with the automated system and those performed manually with anesthetics. The overall success rate of automated axotomies was 67.4 +/- 3.2% of the cases (236/350) at an average processing rate of 17.0 +/- 2.4 s. This fully automated platform establishes a promising methodology for prospective genome-wide screening of nerve regeneration in C. elegans in a truly high-throughput manner.	[Gokce, Sertan Kutal; Bovik, Alan C.; Ben-Yakar, Adela] Univ Texas Austin, Austin, TX 78712 USA; [Guo, Samuel X.; Ghorashian, Navid; Everett, W. Neil; Jarrell, Travis; Kottek, Aubri; Ben-Yakar, Adela] Univ Texas Austin, Austin, TX 78705 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Ben-Yakar, A (corresponding author), Univ Texas Austin, Austin, TX 78712 USA.	ben-yakar@mail.utexas.edu	Everett, William Neil/AAE-2101-2021; Bovik, Alan/B-6717-2012	Bovik, Alan/0000-0001-6067-710X; Kottek, Aubri/0000-0002-8625-2326; Ghorashian, Navid/0000-0002-5783-4933	National Institutes of Health (NIH) [R01 AG041135, R21 NS067340, R21 NS058646]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS058646, R21NS067340] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041135] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: The authors would like to thank the National Institutes of Health (NIH) (www.nih.gov) for its generous support of this research. Specifically, the grants that made this work possible are the NIH Director's Transformative Award (NIH R01 AG041135), NIH R21 NS067340, and NIH R21 NS058646. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen PB, 2008, J NEUROSCI METH, V173, P20, DOI 10.1016/j.jneumeth.2008.05.007; Altun ZF, 2009, INTRO WORM ATLAS; AVERY L, 1993, GENETICS, V133, P897; Ben-Yakar A, 2009, CURR OPIN NEUROBIOL, V19, P561, DOI 10.1016/j.conb.2009.10.010; Ben-Yakar A, 2009, CURR OPIN BIOTECH, V20, P100, DOI 10.1016/j.copbio.2009.01.008; Bourgeois F, 2007, OPT EXPRESS, V15, P8521, DOI 10.1364/OE.15.008521; Bovik A, 2009, ESSENTIAL GUIDE TO VIDEO PROCESSING, 2ND EDITION, P1; Britt JM, 2010, J NEUROPHYSIOL, V104, P695, DOI 10.1152/jn.01051.2009; Chalasani SH, 2007, NATURE, V450, P63, DOI 10.1038/nature06292; Chen LZ, 2011, TRENDS CELL BIOL, V21, P577, DOI 10.1016/j.tcb.2011.08.003; Chen LZ, 2011, NEURON, V71, P1043, DOI 10.1016/j.neuron.2011.07.009; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Chuang HS, 2011, LAB CHIP, V11, P599, DOI 10.1039/c0lc00532k; Chung KH, 2008, NAT METHODS, V5, P637, DOI 10.1038/nmeth.1227; Chung K, 2011, LAB CHIP, V11, P3689, DOI 10.1039/c1lc20400a; Chung K, 2009, LAB CHIP, V9, P2764, DOI 10.1039/b910703g; Clark SG, 2003, DEVELOPMENT, V130, P3781, DOI 10.1242/dev.00571; Di Carlo D, 2008, ANAL CHEM, V80, P2204, DOI 10.1021/ac702283m; Ding XY, 2012, P NATL ACAD SCI USA, V109, P11105, DOI 10.1073/pnas.1209288109; Ducic I, 2012, ANN PLAS SURG, V68, P180, DOI 10.1097/SAP.0b013e3182361b23; El Bejjani R, 2012, ANNU REV GENET, V46, P499, DOI 10.1146/annurev-genet-110711-155550; Ghorashian N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074480; GROEN FCA, 1985, CYTOMETRY, V6, P81, DOI 10.1002/cyto.990060202; Guo SX, 2008, NAT METHODS, V5, P531, DOI 10.1038/NMETH.1203; Hilliard MA, 2005, EMBO J, V24, P63, DOI 10.1038/sj.emboj.7600493; Hulme SE, 2007, LAB CHIP, V7, P1515, DOI 10.1039/b707861g; Krajniak J, 2013, LAB CHIP, V13, P2963, DOI 10.1039/c3lc50300c; Lange D, 2005, SENSOR ACTUAT B-CHEM, V107, P904, DOI 10.1016/j.snb.2004.12.039; Massie MR, 2003, CELL STRESS CHAPERON, V8, P1, DOI 10.1379/1466-1268(2003)8<1:ETTMIS>2.0.CO;2; Neumann B, 2011, DEV DYNAM, V240, P1365, DOI 10.1002/dvdy.22606; Rohde CB, 2007, P NATL ACAD SCI USA, V104, P13891, DOI 10.1073/pnas.0706513104; Rohde CB, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1266; Samara C, 2010, P NATL ACAD SCI USA, V107, P18342, DOI 10.1073/pnas.1005372107; Sun Y, 2004, MICROSC RES TECHNIQ, V65, P139, DOI 10.1002/jemt.20118; Unger MA, 2000, SCIENCE, V288, P113, DOI 10.1126/science.288.5463.113; Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6; Yanik MF, 2004, NATURE, V432, P822, DOI 10.1038/432822a; Zeng F, 2008, LAB CHIP, V8, P653, DOI 10.1039/b804808h	38	28	28	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113917	10.1371/journal.pone.0113917	http://dx.doi.org/10.1371/journal.pone.0113917			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470130	Green Published, gold, Green Submitted			2022-12-26	WOS:000349128700052
J	Li, S; Wei, Z; Chen, J; Chen, YH; Lv, ZB; Yu, W; Meng, QH; Jin, YF				Li, Si; Wei, Zhen; Chen, Jian; Chen, Yanhong; Lv, Zhengbing; Yu, Wei; Meng, Qiaohong; Jin, Yongfeng			Oral Administration of a Fusion Protein between the Cholera Toxin B Subunit and the 42-Amino Acid Isoform of Amyloid-beta Peptide Produced in Silkworm Pupae Protects against Alzheimer's Disease in Mice	PLOS ONE			English	Article							BOMBYX-MORI; MOUSE MODEL; GM-CSF; VACCINE; SYSTEM; IMMUNOTHERAPY; IMMUNIZATION; BURDEN; SAFETY; CELLS	A key molecule in the pathogenesis of Alzheimer's disease (AD) is a 42-amino acid isoform of the amyloid-beta peptide (A beta 42), which is the most toxic element of senile plaques. In this study, to develop an edible, safe, low-cost vaccine for AD, a cholera toxin B subunit (CTB)-A beta 42 fusion protein was successfully expressed in silkworm pupae. We tested the silkworm pupae-derived oral vaccination containing CTB-A beta 42 in a transgenic mouse model of AD. Anti-A beta 42 antibodies were induced in these mice, leading to a decreased A beta deposition in the brain. We also found that the oral administration of the silk worm pupae vaccine improved the memory and cognition of mice, as assessed using a water maze test. These results suggest that the new edible CTB-A beta 42 silkworm pupae-derived vaccine has potential clinical application in the prevention of AD.	[Li, Si; Jin, Yongfeng] Zhejiang Univ, Coll Life Sci, Inst Biochem, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Si; Chen, Jian; Lv, Zhengbing; Yu, Wei] Zhejiang Sci Tech Univ, Coll Life Sci, Inst Biochem, Hangzhou, Zhejiang, Peoples R China; [Wei, Zhen; Chen, Yanhong] Zhejiang Univ, Lab Anim Ctr, Hangzhou 310003, Zhejiang, Peoples R China; [Meng, Qiaohong] Hangzhou Normal Univ, Sch Med, Inst Aging Res, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang Sci-Tech University; Zhejiang University; Hangzhou Normal University	Jin, YF (corresponding author), Zhejiang Univ, Coll Life Sci, Inst Biochem, Hangzhou 310003, Zhejiang, Peoples R China.	jinyf@zju.edu.cn			Natural Science Foundation of Zhejiang Province [Y3110354]; National High Technology Research and Development Programs of China [2012ZX09102301-009, 2011AA100603]; Open Fund of Zhejiang Provincial Top Key Discipline of Biology; Education Department of Zhejiang Province [Z201018783, Y200909617]	Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); National High Technology Research and Development Programs of China(National High Technology Research and Development Program of China); Open Fund of Zhejiang Provincial Top Key Discipline of Biology; Education Department of Zhejiang Province	Funding: This work was financially supported by research grants from the Natural Science Foundation of Zhejiang Province (Y3110354), National High Technology Research and Development Programs of China (2012ZX09102301-009, 2011AA100603), the Open Fund of Zhejiang Provincial Top Key Discipline of Biology, and the Project of Education Department of Zhejiang Province (Z201018783, Y200909617). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arendash GW, 2001, DNA CELL BIOL, V20, P737, DOI 10.1089/10445490152717604; Bacskai BJ, 2002, J NEUROSCI, V22, P7873; BRAKE AJ, 1984, P NATL ACAD SCI-BIOL, V81, P4642, DOI 10.1073/pnas.81.15.4642; Chen J, 2006, J BIOTECHNOL, V123, P236, DOI 10.1016/j.jbiotec.2005.11.015; DaSilva KA, 2006, NEUROBIOL DIS, V23, P433, DOI 10.1016/j.nbd.2006.03.013; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; George-Chandy A, 2001, INFECT IMMUN, V69, P5716, DOI 10.1128/IAI.69.9.5716-5725.2001; Ghochikyan A, 2006, VACCINE, V24, P2275, DOI 10.1016/j.vaccine.2005.11.039; Ghochikyan A, 2006, DNA CELL BIOL, V25, P571, DOI 10.1089/dna.2006.25.571; Gong ZH, 2005, J BIOTECHNOL, V119, P93, DOI 10.1016/j.jbiotec.2005.05.027; HERRINGTON DA, 1992, VACCINE, V10, P841, DOI 10.1016/0264-410X(92)90047-N; Ishii-Katsuno R, 2010, BIOCHEM BIOPH RES CO, V399, P593, DOI 10.1016/j.bbrc.2010.07.120; Jin RZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003933; Kim HD, 2007, IMMUNOL LETT, V112, P30, DOI 10.1016/j.imlet.2007.06.006; Limaye A, 2006, FASEB J, V20, P959, DOI 10.1096/fj.05-5134fje; Lu M, 1997, J BIOL CHEM, V272, P30724, DOI 10.1074/jbc.272.49.30724; Maier M, 2005, VACCINE, V23, P5149, DOI 10.1016/j.vaccine.2005.06.018; [倪红 Ni Hong], 2003, [湖北大学学报. 自然科学版, Journal of Hubei University.Natural Science Edition], V25, P263; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Nojima J, 2011, VACCINE, V29, P6252, DOI 10.1016/j.vaccine.2011.06.073; PRODROMOU C, 1992, PROTEIN ENG, V5, P827, DOI 10.1093/protein/5.8.827; Schenk D, 2001, J MOL NEUROSCI, V17, P259, DOI 10.1385/JMN:17:2:259; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sigurdsson EM, 2002, NEUROBIOL AGING, V23, P1001, DOI 10.1016/S0197-4580(02)00124-0; SUN JB, 1994, P NATL ACAD SCI USA, V91, P10795, DOI 10.1073/pnas.91.23.10795; Weiner HL, 2000, ANN NEUROL, V48, P567, DOI 10.1002/1531-8249(200010)48:4<567::AID-ANA3>3.3.CO;2-N; WOOGEN SD, 1993, J IMMUNOL, V150, P3274; Zhang JM, 2003, NEUROBIOL DIS, V14, P365, DOI 10.1016/j.nbd.2003.07.005; Zhou J, 2006, FOOD CHEM TOXICOL, V44, P1123, DOI 10.1016/j.fct.2006.01.009	29	10	12	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113585	10.1371/journal.pone.0113585	http://dx.doi.org/10.1371/journal.pone.0113585			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469702	Green Submitted, gold, Green Published			2022-12-26	WOS:000349128700034
J	Sahini, N; Selvaraj, S; Borlak, J				Sahini, Nishika; Selvaraj, Saravanakumar; Borlak, Juergen			Whole Genome Transcript Profiling of Drug Induced Steatosis in Rats Reveals a Gene Signature Predictive of Outcome	PLOS ONE			English	Article							ACID-BINDING PROTEIN; POLYCHLORINATED-BIPHENYLS PCBS; RECEPTOR-DEFICIENT MICE; HEPATIC STEATOSIS; FATTY LIVER; DOWN-REGULATION; INDUCED PHOSPHOLIPIDOSIS; PLASMA-LIPOPROTEINS; GLUCOSE-TOLERANCE; CELLULAR UPTAKE	Drug induced steatosis (DIS) is characterised by excess triglyceride accumulation in the form of lipid droplets (LD) in liver cells. To explore mechanisms underlying DIS we interrogated the publically available microarray data from the Japanese Toxicogenomics Project (TGP) to study comprehensively whole genome gene expression changes in the liver of treated rats. For this purpose a total of 17 and 12 drugs which are diverse in molecular structure and mode of action were considered based on their ability to cause either steatosis or phospholipidosis, respectively, while 7 drugs served as negative controls. In our efforts we focused on 200 genes which are considered to be mechanistically relevant in the process of lipid droplet biogenesis in hepatocytes as recently published (Sahini and Borlak, 2014). Based on mechanistic considerations we identified 19 genes which displayed dose dependent responses while 10 genes showed time dependency. Importantly, the present study defined 9 genes (ANGPTL4, FABP7, FADS1, FGF21, GOT1, LDLR, GK, STAT3, and PKLR) as signature genes to predict DIS. Moreover, cross tabulation revealed 9 genes to be regulated >= 10 times amongst the various conditions and included genes linked to glucose metabolism, lipid transport and lipogenesis as well as signalling events. Additionally, a comparison between drugs causing phospholipidosis and/or steatosis revealed 26 genes to be regulated in common including 4 signature genes to predict DIS (PKLR, GK, FABP7 and FADS1). Furthermore, a comparison between in vivo single dose (3, 6, 9 and 24 h) and findings from rat hepatocyte studies (2 h, 8 h, 24 h) identified 10 genes which are regulated in common and contained 2 DIS signature genes (FABP7, FGF21). Altogether, our studies provide comprehensive information on mechanistically linked gene expression changes of a range of drugs causing steatosis and phospholipidosis and encourage the screening of DIS signature genes at the preclinical stage.	[Sahini, Nishika; Selvaraj, Saravanakumar; Borlak, Juergen] Hannover Med Sch, Ctr Pharmacol & Toxicol, Hannover, Germany	Hannover Medical School	Borlak, J (corresponding author), Hannover Med Sch, Ctr Pharmacol & Toxicol, Hannover, Germany.	borlak.juergen@mh-hannover.de			Virtual Liver Network of the German Federal Ministry of Education and Research (BMBF) [031 6154]; Deutsche Forschungsgemeinschaft; DFG	Virtual Liver Network of the German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	We gratefully acknowledge support from The Virtual Liver Network (grant 031 6154) of the German Federal Ministry of Education and Research (BMBF). We also acknowledge support by Deutsche Forschungsgemeinschaft; the charge for this publication was covered by the DFG sponsorship "open access publication." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn J, 2012, MOL NUTR FOOD RES, V56, P1665, DOI 10.1002/mnfr.201200182; Amacher DE, 2014, SEMIN LIVER DIS, V34, P205, DOI 10.1055/s-0034-1375960; Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Anderson N, 2006, FEBS LETT, V580, P5533, DOI 10.1016/j.febslet.2006.08.061; Antherieu S, 2012, TOXICOL IN VITRO, V26, P1278, DOI 10.1016/j.tiv.2012.05.008; Antherieu S, 2011, HEPATOLOGY, V53, P1895, DOI 10.1002/hep.24290; Begriche K, 2011, J HEPATOL, V54, P773, DOI 10.1016/j.jhep.2010.11.006; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; BENNETT E, 1994, J NEUROCHEM, V63, P1616; Bjornsson ES, 2013, GASTROENTEROLOGY, V144, P1419, DOI 10.1053/j.gastro.2013.02.006; BORLAKOGLU JT, 1990, BIOCHEM PHARMACOL, V40, P273, DOI 10.1016/0006-2952(90)90688-H; BORLAKOGLU JT, 1990, BIOCHEM PHARMACOL, V40, P265, DOI 10.1016/0006-2952(90)90687-G; Dahlhoff C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057387; Depner CM, 2013, J NUTR, V143, P315, DOI 10.3945/jn.112.171322; Fromenty B, 1997, J HEPATOL, V26, P43, DOI 10.1016/S0168-8278(97)80496-5; Guo X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039286; Guzman C, 2013, BBA-MOL CELL BIOL L, V1831, P803, DOI 10.1016/j.bbalip.2012.12.014; Hirode M, 2008, TOXICOL APPL PHARM, V229, P290, DOI 10.1016/j.taap.2008.01.036; Holmgren G, 2014, DRUG METAB DISPOS, V42, P1401, DOI 10.1124/dmd.114.059154; Jiang S, 2014, J BIOL CHEM IN PRESS; Jozefczuk J, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00339; Kawano Y, 2010, ARCH BIOCHEM BIOPHYS, V504, P221, DOI 10.1016/j.abb.2010.09.001; Koliwad SK, 2009, J BIOL CHEM, V284, P25593, DOI 10.1074/jbc.M109.025452; Kuo TY, 2014, J LIPID RES, V55, P919, DOI 10.1194/jlr.M047860; Lomonaco R, 2011, THER ADV ENDOCRINOL, V2, P211, DOI 10.1177/2042018811419157; Malloy VL, 2013, METABOLISM, V62, P1651, DOI 10.1016/j.metabol.2013.06.012; Massart J, 2013, CURR PATHOBIOL REP, V1, P147, DOI DOI 10.1007/s40139-013-0022-y; Miller AM, 2011, HEPATOLOGY, V54, P846, DOI 10.1002/hep.24517; Moon YA, 2009, J LIPID RES, V50, P412, DOI 10.1194/jlr.M800383-JLR200; Obert LA, 2007, TOXICOL PATHOL, V35, P728, DOI 10.1080/01926230701481956; PANDIT MK, 1993, ANN INTERN MED, V118, P529, DOI 10.7326/0003-4819-118-7-199304010-00008; Park S, 2012, J TOXICOL SCI, V37, P261, DOI 10.2131/jts.37.261; Persico M, 2010, WORLD J GASTROENTERO, V16, P1171, DOI 10.3748/wjg.v16.i10.1171; Portois L, 2012, INT J MOL MED, V29, P1121, DOI 10.3892/ijmm.2012.943; Powell EE, 2005, HEPATOLOGY, V42, P5, DOI 10.1002/hep.20750; Sahini N, 2014, PROG LIPID RES, V54, P86, DOI 10.1016/j.plipres.2014.02.002; Shimizu F, 1997, BBA-GENE STRUCT EXPR, V1354, P24, DOI 10.1016/S0167-4781(97)00115-2; Spener F, 2006, EUR J LIPID SCI TECH, V108, P625, DOI 10.1002/ejlt.200690056; Straub BK, 2008, HEPATOLOGY, V47, P1936, DOI 10.1002/hep.22268; Subramanian S, 2011, J LIPID RES, V52, P1626, DOI 10.1194/jlr.M016246; Takashima K, 2006, LIFE SCI, V78, P2787, DOI 10.1016/j.lfs.2005.11.010; Tateno C, 2011, ENDOCRINOLOGY, V152, P1479, DOI 10.1210/en.2010-0953; Donato MT, 2012, CURR DRUG METAB, V13, P1160; Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699; Uehara T, 2010, MOL NUTR FOOD RES, V54, P218, DOI 10.1002/mnfr.200900169; Vassiliadis E, 2012, AM J TRANSL RES, V4, P403; Vinciguerra M, 2008, GASTROENTEROLOGY, V134, P268, DOI 10.1053/j.gastro.2007.10.010; Wang L, 2014, HEPATOLOGY IN PRESS; Wang Q, 2009, HEPATOLOGY, V49, P1166, DOI 10.1002/hep.22774; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yachi R, 2010, J CLIN BIOCHEM NUTR, V47, P148, DOI 10.3164/jcbn.10-35; Yu XX, 2005, HEPATOLOGY, V42, P362, DOI 10.1002/hep.20783; Zhang Y, 2012, BIOCHEM CELL BIOL, V90, P548, DOI [10.1139/O2012-012, 10.1139/o2012-012]	53	31	31	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114085	10.1371/journal.pone.0114085	http://dx.doi.org/10.1371/journal.pone.0114085			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470483	Green Published, Green Submitted, gold			2022-12-26	WOS:000349128700069
J	Zhang, B; Roh, YS; Liang, S; Liu, C; Naiki, M; Masuda, K; Seki, E				Zhang, Bi; Roh, Yoon Seok; Liang, Shuang; Liu, Cheng; Naiki, Mitsuru; Masuda, Koichi; Seki, Ekihiro			Neurotropin Suppresses Inflammatory Cytokine Expression and Cell Death through Suppression of NF-kappa B and JNK in Hepatocytes	PLOS ONE			English	Article							INDUCED NEUROPATHY; RAT MODEL; LIVER; ACTIVATION; FIBROSIS; HYPERNOCICEPTION; MICE	Inflammatory response and cell death in hepatocytes are hallmarks of chronic liver disease, and, therefore, can be effective therapeutic targets. Neurotropin (R) (NTP) is a drug widely used in Japan and China to treat chronic pain. Although NTP has been demonstrated to suppress chronic pain through the descending pain inhibitory system, the action mechanism of NTP remains elusive. We hypothesize that NTP functions to suppress inflammatory pathways, thereby attenuating disease progression. In the present study, we investigated whether NTP suppresses inflammatory signaling and cell death pathways induced by interleukin-1 beta (IL-1b) and tumor necrosis factor-alpha (TNF alpha) in hepatocytes. NTP suppressed nuclear factor-kappa B (NF-kappa B) activation induced by IL-1 beta and TNF alpha assessed by using hepatocytes isolated from NF-kappa B-green fluorescent protein (GFP) reporter mice and an NF-kappa B-luciferase reporter system. The expression of NF-kappa B target genes, II6, Nos2, Cxcl1, ccl5 and Cxcl2 induced by IL-1 beta and TNF alpha was suppressed after NTP treatment. We also found that NTP suppressed the JNK phosphorylation induced by IL-1 beta and TNF alpha. Because JNK activation contributes to hepatocyte death, we determined that NTP treatment suppressed hepatocyte death induced by IL-1 beta and TNF alpha in combination with actinomycin D. Taken together, our data demonstrate that NTP attenuates IL-1 beta and TNF alpha-mediated inflammatory cytokine expression and cell death in hepatocytes through the suppression of NF-kappa B and JNK. The results from the present study suggest that NTP may become a preventive or therapeutic strategy for alcoholic and non-alcoholic fatty liver disease in which NF-kappa B and JNK are thought to take part.	[Zhang, Bi; Roh, Yoon Seok; Liang, Shuang; Liu, Cheng; Seki, Ekihiro] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Seki, Ekihiro] Univ Calif San Diego, Sch Med, Dept Surg, La Jolla, CA 92093 USA; [Masuda, Koichi] Univ Calif San Diego, Sch Med, Dept Orthopaed Surg, La Jolla, CA 92093 USA; [Naiki, Mitsuru] Nippon Zoki Pharmaceut Co Ltd, Inst Bioact Sci, Dept Pharmacol Res, Kato, Hyogo, Japan	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Seki, E (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA.	ekseki@ucsd.edu	Liu, Cheng/I-3979-2015; Seki, Ekihiro/K-2481-2016	Seki, Ekihiro/0000-0002-9472-6085	Nippon Zoki Pharmaceutical Company Ltd	Nippon Zoki Pharmaceutical Company Ltd	Research grant from Nippon Zoki Pharmaceutical Company Ltd. The funder provided support in the form of a salary for author MN but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the author is articulated in the author contributions section.	Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; Bieghs V, 2013, TRENDS IMMUNOL, V34, P446, DOI 10.1016/j.it.2013.04.005; Cunha TM, 2008, EUR J PAIN, V12, P1059, DOI 10.1016/j.ejpain.2008.02.003; Cunha TM, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-63; Isonaka R, 2013, NEUROSCI LETT, V543, P101, DOI 10.1016/j.neulet.2013.03.051; Kamo A, 2013, CLIN EXP DERMATOL, V38, P665, DOI 10.1111/ced.12100; Kawashiri T, 2011, EUR J PAIN, V15, P344, DOI 10.1016/j.ejpain.2010.08.006; Kawashiri T, 2009, EUR J CANCER, V45, P154, DOI 10.1016/j.ejca.2008.10.004; Kodama Y, 2009, GASTROENTEROLOGY, V136, P1423, DOI 10.1053/j.gastro.2008.12.064; Kudo T, 2011, NEUROSCI LETT, V503, P20, DOI 10.1016/j.neulet.2011.07.056; Luedde T, 2011, NAT REV GASTRO HEPAT, V8, P108, DOI 10.1038/nrgastro.2010.213; Magness ST, 2004, J IMMUNOL, V173, P1561, DOI 10.4049/jimmunol.173.3.1561; Masuguchi K, 2014, LIFE SCI, V98, P49, DOI 10.1016/j.lfs.2013.12.229; Miura K, 2010, GASTROENTEROLOGY, V139, P323, DOI 10.1053/j.gastro.2010.03.052; Narita M, 2008, NEUROSCIENCE, V152, P477, DOI 10.1016/j.neuroscience.2007.10.039; Okazaki R, 2008, ANESTH ANALG, V107, P1064, DOI 10.1213/ane.0b013e31817e7a59; Petrasek J, 2012, J CLIN INVEST, V122, P3476, DOI 10.1172/JCI60777; Roh YS, 2014, J GASTROENTEROL, V49, P185, DOI 10.1007/s00535-013-0931-x; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Starr SP, 2011, AM FAM PHYSICIAN, V84, P1353; Sunami Y, 2012, HEPATOLOGY, V56, P1117, DOI 10.1002/hep.25711; Suzuki T, 2005, ANESTH ANALG, V101, P793, DOI 10.1213/01.ANE.0000160582.25368.B9; Takayasu K, 2007, JPN J CLIN ONCOL, V37, P233, DOI 10.1093/jjco/hym012; Toda K, 1998, LIFE SCI, V62, P913, DOI 10.1016/S0024-3205(98)00009-5; Yang L, 2013, GASTROENTEROLOGY, V144, P1042, DOI 10.1053/j.gastro.2013.01.056	26	13	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114071	10.1371/journal.pone.0114071	http://dx.doi.org/10.1371/journal.pone.0114071			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470242	Green Published, gold, Green Submitted			2022-12-26	WOS:000349128700067
J	Avila-Moreno, F; Armas-Lopez, L; Alvarez-Moran, AM; Lopez-Bujanda, Z; Ortiz-Quintero, B; Hidalgo-Miranda, A; Urrea-Ramirez, F; Rivera-Rosales, RM; Vazquez-Manriquez, E; Pena-Mirabal, E; Morales-Gomez, J; Vazquez-Minero, JC; Tellez-Becerra, JL; Ramirez-Mendoza, R; Avalos-Bracho, A; de Alba, EG; Vazquez-Santillan, K; Maldonado-Lagunas, V; Santillan-Doherty, P; Pina-Sanchez, P; Zuniga-Ramos, J				Avila-Moreno, Federico; Armas-Lopez, Leonel; Alvarez-Moran, Aldo M.; Lopez-Bujanda, Zoila; Ortiz-Quintero, Blanca; Hidalgo-Miranda, Alfredo; Urrea-Ramirez, Francisco; Maria Rivera-Rosales, R.; Vazquez-Manriquez, Eugenia; Pena-Mirabal, Erika; Morales-Gomez, Jose; Vazquez-Minero, Juan C.; Tellez-Becerra, Jose L.; Ramirez-Mendoza, Roberto; Avalos-Bracho, Alejandro; Guzman de Alba, Enrique; Vazquez-Santillan, Karla; Maldonado-Lagunas, Vilma; Santillan-Doherty, Patricio; Pina-Sanchez, Patricia; Zuniga-Ramos, Joaquin			Overexpression of MEOX2 and TWIST1 Is Associated with H3K27me3 Levels and Determines Lung Cancer Chemoresistance and Prognosis	PLOS ONE			English	Article							DNA METHYLATION MARKERS; SQUAMOUS-CELL CARCINOMA; GENE-EXPRESSION; IDENTIFICATION; STATISTICS; LINE; ADENOCARCINOMA; AMPLIFICATION; TRANSCRIPTION; CHROMOSOME-7	Lung cancer is the leading cause of death from malignant diseases worldwide, with the non-small cell (NSCLC) subtype accounting for the majority of cases. NSCLC is characterized by frequent genomic imbalances and copy number variations (CNVs), but the epigenetic aberrations that are associated with clinical prognosis and therapeutic failure remain not completely identify. In the present study, a total of 55 lung cancer patients were included and we conducted genomic and genetic expression analyses, immunohistochemical protein detection, DNA methylation and chromatin immunoprecipitation assays to obtain genetic and epigenetic profiles associated to prognosis and chemoresponse of NSCLC patients. Finally, siRNA transfection-mediated genetic silencing and cisplatinum cellular cytotoxicity assays in NSCLC cell lines A-427 and INER-37 were assessed to describe chemoresistance mechanisms involved. Our results identified high frequencies of CNVs (66-51% of cases) in the 7p22.3-p21.1 and 7p15.3-p15.2 cytogenetic regions. However, overexpression of genes, such as MEOX2, HDAC9, TWIST1 and AhR, at 7p21.2-p21.1 locus occurred despite the absence of CNVs and little changes in DNA methylation. In contrast, the promoter sequences of MEOX2 and TWIST1 displayed significantly lower/decrease in the repressive histone mark H3K27me3 and increased in the active histone mark H3K4me3 levels. Finally these results correlate with poor survival in NSCLC patients and cellular chemoresistance to oncologic drugs in NSCLC cell lines in a MEOX2 and TWIST1 overexpression dependent-manner. In conclusion, we report for the first time that MEOX2 participates in chemoresistance irrespective of high CNV, but it is significantly dependent upon H3K27me3 enrichment probably associated with aggressiveness and chemotherapy failure in NSCLC patients, however additional clinical studies must be performed to confirm our findings as new probable clinical markers in NSCLC patients.	[Avila-Moreno, Federico; Armas-Lopez, Leonel; Lopez-Bujanda, Zoila; Ramirez-Mendoza, Roberto] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Biomed Res Unit UBIMED, Tlalnepantla, Mexico State, Mexico; [Avila-Moreno, Federico; Alvarez-Moran, Aldo M.; Lopez-Bujanda, Zoila; Ortiz-Quintero, Blanca; Urrea-Ramirez, Francisco; Maria Rivera-Rosales, R.; Vazquez-Manriquez, Eugenia; Pena-Mirabal, Erika; Morales-Gomez, Jose; Vazquez-Minero, Juan C.; Tellez-Becerra, Jose L.; Avalos-Bracho, Alejandro; Guzman de Alba, Enrique; Santillan-Doherty, Patricio; Zuniga-Ramos, Joaquin] Inst Nacl Enfermedades Resp, Mexico City, DF, Mexico; [Lopez-Bujanda, Zoila] Johns Hopkins Univ, Inst Med, Baltimore, MD USA; [Hidalgo-Miranda, Alfredo; Vazquez-Santillan, Karla; Maldonado-Lagunas, Vilma] Inst Nacl Med Genom INMEGEN, Mexico City, DF, Mexico; [Pina-Sanchez, Patricia] Ctr Med Nacl, Inst Mexicano Seguro Social, Unidad Invest Med Enfermedades Oncol, Mexico City, DF, Mexico	Universidad Nacional Autonoma de Mexico; Johns Hopkins University; Instituto Nacional de Medicina Genomica; Instituto Mexicano del Seguro Social	Avila-Moreno, F (corresponding author), Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, Biomed Res Unit UBIMED, Canc Epigen Lab 12, Tlalnepantla, Mexico State, Mexico.	avilamore@hotmail.com	Hidalgo-Miranda, Alfredo/B-2123-2010; Vazquez, Karla/ABG-7256-2020	Hidalgo-Miranda, Alfredo/0000-0003-2315-3977; Vazquez, Karla/0000-0003-1380-2494; Zuniga, Joaquin/0000-0002-7143-0281; Lopez Bujanda, Zoila/0000-0001-5729-7309; ortiz, blanca/0000-0001-6298-0073; Armas Lopez, Leonel/0000-0001-9490-4294	National Council of Science and Technology (CONACyT) [0053643]; Research Direction of the National Institute of Respiratory Diseases (INER); National Autonomous University of Mexico, UNAM [IACOD-PAPIIT IA201611, PAPIIT IB202512, PAPIIT RR282512]	National Council of Science and Technology (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Research Direction of the National Institute of Respiratory Diseases (INER); National Autonomous University of Mexico, UNAM(Universidad Nacional Autonoma de Mexico)	FAM author was supported by the National Council of Science and Technology (CONACyT), Funds for Research in Basic Science, Project 0053643; Research Direction of the National Institute of Respiratory Diseases (INER); and the National Autonomous University of Mexico, UNAM, Projects IACOD-PAPIIT IA201611, PAPIIT IB202512 and PAPIIT RR282512. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anglim PP, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-62; Aviel-Ronen S, 2008, P NATL ACAD SCI USA, V105, P10155, DOI 10.1073/pnas.0709618105; Barlesi F, 2007, J CLIN ONCOL, V25, P4358, DOI 10.1200/JCO.2007.11.2599; Bjorkqvist AM, 1998, GENE CHROMOSOME CANC, V22, P79; Campbell JM, 2008, GENOME, V51, P1032, DOI 10.1139/G08-086; Castillo SD, 2010, J PATHOL, V222, P89, DOI 10.1002/path.2732; Cortese R, 2008, INT J BIOCHEM CELL B, V40, P1494, DOI 10.1016/j.biocel.2007.11.018; De Carvalho DD, 2012, CANCER CELL, V21, P655, DOI 10.1016/j.ccr.2012.03.045; de Lucio B, 2005, CANCER SCI, V96, P774, DOI 10.1111/j.1349-7006.2005.00111.x; Douville JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029099; Frullanti E, 2011, CLIN CANCER RES, V17, P2410, DOI 10.1158/1078-0432.CCR-10-2394; Garnis C, 2005, ONCOGENE, V24, P4806, DOI 10.1038/sj.onc.1208643; Gorringe KL, 2007, CLIN CANCER RES, V13, P4731, DOI 10.1158/1078-0432.CCR-07-0502; Harris T, 2011, CLIN CANCER RES, V17, P690, DOI 10.1158/1078-0432.CCR-10-1892; Hoglund M, 2004, CANCER GENET CYTOGEN, V154, P99, DOI 10.1016/j.cancergencyto.2004.01.030; Irelan JT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005067; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jiang W, 2012, CLIN LUNG CANCER, V13, P280, DOI 10.1016/j.cllc.2011.11.005; Kitada K, 2008, CANCER GENET CYTOGEN, V185, P11, DOI 10.1016/j.cancergencyto.2008.04.005; Kitada K, 2007, CANCER GENET CYTOGEN, V178, P120, DOI 10.1016/j.cancergencyto.2007.06.014; Lau SK, 2007, J CLIN ONCOL, V25, P5562, DOI 10.1200/JCO.2007.12.0352; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Luk C, 2001, CANCER GENET CYTOGEN, V125, P87, DOI 10.1016/S0165-4608(00)00363-0; Mankoo BS, 2003, DEVELOPMENT, V130, P4655, DOI 10.1242/dev.00687; McCabe MT, 2009, CANCER RES, V69, P282, DOI 10.1158/0008-5472.CAN-08-3274; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Okudela K, 2014, INT J CLIN EXP PATHO, V7, P213; Patel S, 2005, CANCER RES, V65, P1414, DOI 10.1158/0008-5472.CAN-04-3431; Pei JM, 2001, GENE CHROMOSOME CANC, V31, P282, DOI 10.1002/gcc.1145; Petersen I, 1997, CANCER RES, V57, P2331; Ponce de Leon Valeria, 2005, Cancer Cell Int, V5, P20; Rauch T, 2007, P NATL ACAD SCI USA, V104, P5527, DOI 10.1073/pnas.0701059104; Rauch TA, 2008, P NATL ACAD SCI USA, V105, P252, DOI 10.1073/pnas.0710735105; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Silva-Zolezzi I, 2009, P NATL ACAD SCI USA, V106, P8611, DOI 10.1073/pnas.0903045106; Stransky N, 2006, NAT GENET, V38, P1386, DOI 10.1038/ng1923; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Todd RC, 2010, CHEM BIOL, V17, P1334, DOI 10.1016/j.chembiol.2010.10.018; Tsou JA, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-70; Ubagai T, 2001, ONCOL REP, V8, P83; Van Den Broeck A, 2008, CLIN CANCER RES, V14, P7237, DOI 10.1158/1078-0432.CCR-08-0869; Wang XH, 2004, ONCOGENE, V23, P474, DOI 10.1038/sj.onc.1207128; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Watanabe H, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-15; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Zhu H, 2007, CANCER LETT, V245, P303, DOI 10.1016/j.canlet.2006.01.020; Zhu KX, 2012, ONCOL REP, V27, P1027, DOI 10.3892/or.2012.1633	50	32	34	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114104	10.1371/journal.pone.0114104	http://dx.doi.org/10.1371/journal.pone.0114104			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460568	gold, Green Published			2022-12-26	WOS:000345869700099
J	Li, J; Shen, BX; Ma, C; Liu, L; Ren, L; Fang, YB; Dai, DW; Chen, SY; Lu, JP				Li, Jing; Shen, Bixia; Ma, Chao; Liu, Li; Ren, Li; Fang, Yibin; Dai, Dongwei; Chen, Shiyue; Lu, Jianping			3D Contrast Enhancement-MR Angiography for Imaging of Unruptured Cerebral Aneurysms: A Hospital-Based Prevalence Study	PLOS ONE			English	Article							MAGNETIC-RESONANCE ANGIOGRAPHY; TIME-OF-FLIGHT; INTRACRANIAL ANEURYSMS; SUBARACHNOID HEMORRHAGE; CT ANGIOGRAPHY; NEUROLOGIC COMPLICATIONS; INCIDENTAL FINDINGS; NATURAL-HISTORY; RISK-FACTORS; NEPHROPATHY	Background and Purpose: Contrast enhanced MRA (CE-MRA) can help to overcome the limitations of other techniques to clearly display the details of cerebral aneurysms at 1.5-T MR system. We investigated the prevalence of unruptured cerebral aneurysms (UCAs) using three dimensional (3D) CE-MRA in a tertiary comprehensive hospital in China. Materials and Methods: The cases were prospectively recorded at our hospital between February 2009 and October 2010. 3D CE-MRA, interpreted by 2 observers blinded to the participants' information, was used to identify the location and size of UCAs and to estimate the overall, age-specific, and sex-specific prevalence. Results: Of the 3993 patients (men: women=2159:1834), 408 UCAs were found in 350 patients (men: women=151:199). The prevalence was 8.8% overall (95% CI, 8.0-10.0%), with 7.0% for men (CI, 6.0-8.0%) and 10.9% for women (CI, 9.0-12.0%). The overall prevalence of UCAs was higher in women than in men (P<0.001) and increased with age both in men and women. Prevalence peaked at age group 75-80 years. Forty-two patients (11.7%) had multiple aneurysms, including 10 (2.9%) male patients and 32 (9.1%) female patients. The most common site of aneurysm was the carotid siphon, and most lesions (71.3%) had a maximum diameter of 3-5 mm. Conclusion: This hospital-based prevalence study suggested a high prevalence (8.8%) of UCAs and most lesions (71.3%) had a maximum diameter of 3-5 mm observed by 3D CE-MRA. Because the rupture of small cerebral aneurysms was not uncommon, an appropriate follow-up care strategy must be formulated.	[Li, Jing; Shen, Bixia; Ma, Chao; Liu, Li; Ren, Li; Chen, Shiyue; Lu, Jianping] Second Mil Med Univ, Changhai Hosp Shanghai, Dept Radiol, Shanghai 200433, Peoples R China; [Fang, Yibin; Dai, Dongwei] Second Mil Med Univ, Changhai Hosp Shanghai, Dept Neurosurg, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University	Lu, JP (corresponding author), Second Mil Med Univ, Changhai Hosp Shanghai, Dept Radiol, Shanghai 200433, Peoples R China.	cjr.lujianping@vip.163.com		Ma, Chao/0000-0002-2473-387X	National Key Technology R&D Program of China [2007BAI05B07]; Shanghai Changhai Hospital [CH125520800]	National Key Technology R&D Program of China(National Key Technology R&D Program); Shanghai Changhai Hospital	This work was supported by the National Key Technology R&D Program of China [2007BAI05B07]; 1255 Academic Discipline Project of Shanghai Changhai Hospital [CH125520800]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2013.01.082; Barrett BJ, 2006, NEW ENGL J MED, V354, P379, DOI 10.1056/NEJMcp050801; BRODERICK JP, 1993, J NEUROSURG, V78, P188, DOI 10.3171/jns.1993.78.2.0188; Burns JD, 2009, CURR NEUROL NEUROSCI, V9, P6, DOI 10.1007/s11910-009-0002-0; Cirillo M, 2013, EUR J RADIOL, V82, pE853, DOI 10.1016/j.ejrad.2013.08.052; Edlow JA, 2000, NEW ENGL J MED, V342, P29, DOI 10.1056/NEJM200001063420106; Feigin VL, 2005, STROKE, V36, P2773, DOI 10.1161/01.STR.0000190838.02954.e8; FOGELHOLM R, 1993, STROKE, V24, P1649, DOI 10.1161/01.STR.24.11.1649; Grobner T, 2006, NEPHROL DIAL TRANSPL, V21, P1104, DOI 10.1093/ndt/gfk062; HEISERMAN JE, 1994, AM J NEURORADIOL, V15, P1401; HIJDRA A, 1987, STROKE, V18, P1061, DOI 10.1161/01.STR.18.6.1061; Horikoshi T, 2002, NEUROL MED-CHIR, V42, P105, DOI 10.2176/nmc.42.105; Hunt CH, 2009, AM J ROENTGENOL, V193, P1124, DOI 10.2214/AJR.09.2520; Igase K, 2012, CEREBROVASC DIS, V33, P348, DOI 10.1159/000336015; Iwamoto H, 1999, STROKE, V30, P1390, DOI 10.1161/01.STR.30.7.1390; Jayaraman MV, 2004, RADIOLOGY, V230, P510, DOI 10.1148/radiol.2302021465; Jeon TY, 2011, KOREAN J RADIOL, V12, P547, DOI 10.3348/kjr.2011.12.5.547; JUVELA S, 1993, STROKE, V24, P639, DOI 10.1161/01.STR.24.5.639; Katzman GL, 1999, JAMA-J AM MED ASSOC, V282, P36, DOI 10.1001/jama.282.1.36; Korogi Y, 1999, RADIOLOGY, V211, P497, DOI 10.1148/radiology.211.2.r99ma02497; KOROGI Y, 1994, RADIOLOGY, V193, P181, DOI 10.1148/radiology.193.1.8090889; Krings T, 2002, NEUROSCI LETT, V326, P46, DOI 10.1016/S0304-3940(02)00308-7; Leclerc X, 2002, AM J NEURORADIOL, V23, P1121; Li MH, 2014, RADIOLOGY, V271, P553, DOI 10.1148/radiol.14122770; Li MH, 2013, ANN INTERN MED, V159, P514, DOI 10.7326/0003-4819-159-8-201310150-00004; Metens T, 2000, RADIOLOGY, V216, P39, DOI 10.1148/radiology.216.1.r00jl1139; Nael K, 2008, AM J ROENTGENOL, V190, P389, DOI 10.2214/AJR.07.2297; Numminen J, 2011, ACTA RADIOL, V52, P670, DOI 10.1258/ar.2011.100421; Ozsarlak O, 2004, NEURORADIOLOGY, V46, P955, DOI 10.1007/s00234-004-1297-9; Polmear A, 2003, CEPHALALGIA, V23, P935, DOI 10.1046/j.1468-2982.2003.00596.x; Prokop M, 2003, EUR J RADIOL, V45, pS4, DOI 10.1016/S0720-048X(02)00358-3; Qu F, 2004, J NEUROSURG, V100, P244, DOI 10.3171/jns.2004.100.2.0244; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Solomon R, 2006, INVEST RADIOL, V41, P651, DOI 10.1097/01.rli.0000229742.54589.7b; Tepel M, 2006, CIRCULATION, V113, P1799, DOI 10.1161/CIRCULATIONAHA.105.595090; UJIIE H, 1993, STROKE, V24, P1850, DOI 10.1161/01.STR.24.12.1850; Vernooij MW, 2007, NEW ENGL J MED, V357, P1821, DOI 10.1056/NEJMoa070972; Villablanca JP, 2013, RADIOLOGY, V269, P258, DOI 10.1148/radiol.13121188; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Wardlaw JM, 2000, BRAIN, V123, P205, DOI 10.1093/brain/123.2.205; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Wiebers D, 1998, NEW ENGL J MED, V339, P1725, DOI 10.1056/nejm199812103392401; WILCOCK DJ, 1995, CLIN RADIOL, V50, P526, DOI 10.1016/S0009-9260(05)83186-1; Willinsky RA, 2003, RADIOLOGY, V227, P522, DOI 10.1148/radiol.2272012071	44	13	17	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114157	10.1371/journal.pone.0114157	http://dx.doi.org/10.1371/journal.pone.0114157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463352	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700109
J	Marangon, M; Van Sluyter, SC; Waters, EJ; Menz, RI				Marangon, Matteo; Van Sluyter, Steven C.; Waters, Elizabeth J.; Menz, Robert I.			Structure of Haze Forming Proteins in White Wines: Vitis vinifera Thaumatin-Like Proteins	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; MACROMOLECULAR CRYSTALLOGRAPHY; ANTIFUNGAL PROTEIN; ACID PROTEASE; STABILITY; WINEMAKING; CHITINASES; ACCUMULATE; RESOLUTION; REDUCTION	Grape thaumatin-like proteins (TLPs) play roles in plant-pathogen interactions and can cause protein haze in white wine unless removed prior to bottling. Different isoforms of TLPs have different hazing potential and aggregation behavior. Here we present the elucidation of the molecular structures of three grape TLPs that display different hazing potential. The three TLPs have very similar structures despite belonging to two different classes (F2/4JRU is a thaumatin-like protein while I/4L5H and H2/4MBT are VVTL1), and having different unfolding temperatures (56 vs. 62 degrees C), with protein F2/4JRU being heat unstable and forming haze, while I/4L5H does not. These differences in properties are attributable to the conformation of a single loop and the amino acid composition of its flanking regions.	[Marangon, Matteo; Van Sluyter, Steven C.; Waters, Elizabeth J.] Australian Wine Res Inst, Adelaide, SA, Australia; [Menz, Robert I.] Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia; [Van Sluyter, Steven C.] Univ Melbourne, Sch Bot, Melbourne, Vic 3010, Australia	Australian Wine Research Institute; Flinders University South Australia; University of Melbourne	Menz, RI (corresponding author), Flinders Univ S Australia, Sch Biol Sci, Adelaide, SA 5001, Australia.	ian.menz@flinders.edu.au	Marangon, Matteo/N-2430-2016	Marangon, Matteo/0000-0001-5358-2428	Australia's grapegrowers and winemakers; Australian Grape and Wine Authority; Australian Government; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	Australia's grapegrowers and winemakers; Australian Grape and Wine Authority(Australian Grape and Wine Authority); Australian Government(Australian GovernmentCGIAR); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported financially by Australia's grapegrowers and winemakers through their investment body, the Australian Grape and Wine Authority, with matching funds from the Australian Government. The funder provided support in the form of salaries for author EJW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the "author contributions" section.	BAKALINSKY AT, 1985, AM J ENOL VITICULT, V36, P23; Batalia MA, 1996, NAT STRUCT BIOL, V3, P19, DOI 10.1038/nsb0196-19; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BAYLY FRANCIS, 1967, AMER J ENOL VITICULT, V18, P18; Booth DR, 1997, NATURE, V385, P787, DOI 10.1038/385787a0; Charron C, 2004, ACTA CRYSTALLOGR D, V60, P83, DOI 10.1107/S0907444903022613; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dall'Antonia Y, 2005, ACTA CRYSTALLOGR F, V61, P186, DOI 10.1107/S1744309104033822; Dufrechou M, 2013, LANGMUIR, V29, P10475, DOI 10.1021/la401524w; Esteruelas M, 2009, FOOD CHEM, V113, P28, DOI 10.1016/j.foodchem.2008.07.031; Esti M, 2013, FOOD BIOPROD PROCESS, V91, P595, DOI 10.1016/j.fbp.2013.02.003; Falconer RJ, 2010, J AGR FOOD CHEM, V58, P975, DOI 10.1021/jf902843b; Ferreira RB, 2001, TRENDS FOOD SCI TECH, V12, P230, DOI 10.1016/S0924-2244(01)00080-2; Fukui M, 2003, AM J ENOL VITICULT, V54, P178; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, DOI DOI 10.1385/1592598900; Gazzola D, 2012, J AGR FOOD CHEM, V60, P10666, DOI 10.1021/jf302916n; Ghosh R, 2008, PLANTA, V228, P883, DOI 10.1007/s00425-008-0790-5; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Koiwa H, 1997, PLANT CELL PHYSIOL, V38, P783, DOI 10.1093/oxfordjournals.pcp.a029236; Kopec J, 2012, HIGH RESOLUTION STRU; LAGACE LS, 1990, AM J ENOL VITICULT, V41, P147; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leone P, 2006, BIOCHIMIE, V88, P45, DOI 10.1016/j.biochi.2005.07.001; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Majewski P., 2011, Australian & New Zealand Grapegrower & Winemaker, P58; Marangon M, 2012, FOOD CHEM, V135, P1157, DOI 10.1016/j.foodchem.2012.05.042; Marangon M, 2011, J AGR FOOD CHEM, V59, P2652, DOI 10.1021/jf104334v; Marangon M, 2011, J AGR FOOD CHEM, V59, P733, DOI 10.1021/jf1038234; Marangon M, 2010, ANAL CHIM ACTA, V660, P110, DOI 10.1016/j.aca.2009.10.038; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Min K, 2004, PROTEINS, V54, P170, DOI 10.1002/prot.10571; Monteiro S, 2003, J AGR FOOD CHEM, V51, P4046, DOI 10.1021/jf020456v; Monteiro S, 2001, J AGR FOOD CHEM, V49, P3999, DOI 10.1021/jf0013914; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; OGATA CM, 1992, J MOL BIOL, V228, P893, DOI 10.1016/0022-2836(92)90873-I; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pocock KF, 2006, AUST J GRAPE WINE R, V12, P212, DOI 10.1111/j.1755-0238.2006.tb00061.x; Pocock KF, 2000, J AGR FOOD CHEM, V48, P1637, DOI 10.1021/jf9905626; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Sauvage FX, 2010, FOOD CHEM, V118, P26, DOI 10.1016/j.foodchem.2009.02.080; Sillitoe I, 2013, NUCLEIC ACIDS RES, V41, pD490, DOI 10.1093/nar/gks1211; Stamm M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057731; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Van Sluyter SC, 2013, J AGR FOOD CHEM, V61, P9705, DOI 10.1021/jf402762k; Van Sluyter SC, 2009, J AGR FOOD CHEM, V57, P11376, DOI 10.1021/jf902365r; Vincenzi S, 2005, AM J ENOL VITICULT, V56, P246; Vincenzi S, 2011, AUST J GRAPE WINE R, V17, P20, DOI 10.1111/j.1755-0238.2010.00113.x; Waters EJ, 2005, AUST J GRAPE WINE R, V11, P215, DOI 10.1111/j.1755-0238.2005.tb00289.x; Waters EJ, 1996, J AGR FOOD CHEM, V44, P3, DOI 10.1021/jf9505584; WATERS EJ, 1992, J AGR FOOD CHEM, V40, P1514, DOI 10.1021/jf00021a008; WATERS EJ, 1991, AM J ENOL VITICULT, V42, P123; Waters EJ, 1998, J AGR FOOD CHEM, V46, P4950, DOI 10.1021/jf980421o; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524	56	45	47	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113757	10.1371/journal.pone.0113757	http://dx.doi.org/10.1371/journal.pone.0113757			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463627	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700050
J	Ortin-Martinez, A; Valiente-Soriano, FJ; Garcia-Ayuso, D; Alarcon-Martinez, L; Jimenez-Lopez, M; Bernal-Garro, JM; Nieto-Lopez, L; Nadal-Nicolas, FM; Villegas-Perez, MP; Wheeler, LA; Vidal-Sanz, M				Ortin-Martinez, Arturo; Javier Valiente-Soriano, Francisco; Garcia-Ayuso, Diego; Alarcon-Martinez, Luis; Jimenez-Lopez, Manuel; Manuel Bernal-Garro, Jose; Nieto-Lopez, Leticia; Manuel Nadal-Nicolas, Francisco; Paz Villegas-Perez, Maria; Wheeler, Larry A.; Vidal-Sanz, Manuel			A Novel In Vivo Model of Focal Light Emitting Diode-Induced Cone-Photoreceptor Phototoxicity: Neuroprotection Afforded by Brimonidine, BDNF, PEDF or bFGF	PLOS ONE			English	Article							RETINAL GANGLION-CELLS; OPTICAL COHERENCE TOMOGRAPHY; FIBROBLAST-GROWTH-FACTOR; CILIARY NEUROTROPHIC FACTOR; EPITHELIUM-DERIVED FACTOR; ALBINO SWISS MICE; RAT RETINA; ADULT ALBINO; PIGMENT-EPITHELIUM; SPATIAL-DISTRIBUTION	We have investigated the effects of light-emitting diode (LED)-induced phototoxicity (LIP) on cone-photoreceptors and their protection with brimonidine (BMD), brain-derived neurotrophic factor (BDNF), pigment epithelium-derived factor (PEDF), ciliary neurotrophic factor (CNTF) or basic fibroblast growth factor (bFGF). In anesthetized, dark adapted, adult albino rats a blue (400 nm) LED was placed perpendicular to the cornea (10 sec, 200 lux) and the effects were investigated using Spectral Domain Optical Coherence Tomography (SD-OCT) and/or analysing the retina in oriented cross-sections or wholemounts immune-labelled for L-and S-opsin and counterstained with the nuclear stain DAPI. The effects of topical BMD (1%) or, intravitreally injected BDNF (5 mu g), PEDF (2 mu g), CNTF (0.4 mu g) or bFGF (1 mu g) after LIP were examined on wholemounts at 7 days. SD-OCT showed damage in a circular region of the superotemporal retina, whose diameter varied from 1,842.4 +/- 84.5 mu m (at 24 hours) to 1,407.7 +/- 52.8 mu m (at 7 days). This region had a progressive thickness diminution from 183.4 +/- 5 mu m (at 12 h) to 114.6 +/- 6 mu m (at 7 d). Oriented cross-sections showed within the light-damaged region of the retina massive loss of rods and cone-photoreceptors. Wholemounts documented a circular region containing lower numbers of L- and S-cones. Within a circular area (1 mm or 1.3 mm radius, respectively) in the left and in its corresponding region of the contralateral-fellow-retina, total L- or S-cones were 7,118 +/- 842 or 661 +/- 125 for the LED exposed retinas (n=7) and 14,040 +/- 1,860 or 2,255 +/- 193 for the fellow retinas (n=7), respectively. BMD, BDNF, PEDF and bFGF but not CNTF showed significant neuroprotective effects on L- or S-cones. We conclude that LIP results in rod and cone-photoreceptor loss, and is a reliable, quantifiable model to study cone-photoreceptor degeneration. Intravitreal BDNF, PEDF or bFGF, or topical BMD afford significant cone neuroprotection in this model.	[Ortin-Martinez, Arturo; Javier Valiente-Soriano, Francisco; Garcia-Ayuso, Diego; Alarcon-Martinez, Luis; Jimenez-Lopez, Manuel; Manuel Bernal-Garro, Jose; Nieto-Lopez, Leticia; Manuel Nadal-Nicolas, Francisco; Paz Villegas-Perez, Maria; Vidal-Sanz, Manuel] Univ Murcia, Fac Med, Dept Oftalmol, Murcia, Spain; [Ortin-Martinez, Arturo; Javier Valiente-Soriano, Francisco; Garcia-Ayuso, Diego; Alarcon-Martinez, Luis; Jimenez-Lopez, Manuel; Manuel Bernal-Garro, Jose; Nieto-Lopez, Leticia; Manuel Nadal-Nicolas, Francisco; Paz Villegas-Perez, Maria; Vidal-Sanz, Manuel] Inst Murciano Invest Biosanitaria Virgen de la Ar, Murcia, Spain; [Wheeler, Larry A.] Zeteo Drug Discovery LLC, Irvine, CA USA	University of Murcia	Vidal-Sanz, M (corresponding author), Univ Murcia, Fac Med, Dept Oftalmol, Murcia, Spain.	manuel.vidal@um.es	Valiente-Soriano, Francisco J./Z-4980-2019; Vidal-Sanz, Manuel/J-6989-2016; García-Ayuso, Diego/AAC-4954-2020	Vidal-Sanz, Manuel/0000-0002-9216-1615; García-Ayuso, Diego/0000-0002-7639-5366	Fundacion Seneca [04446/GERM/07]; Spanish Ministry of Economy and Competitiveness [SAF-2012-38328]; ISCIII-FEDER [PI10/01496, PI10/00187]; RETICS [RD07/0062/0001]; Allergan Sales LLC.	Fundacion Seneca(Fundacion Seneca); Spanish Ministry of Economy and Competitiveness(Spanish Government); ISCIII-FEDER(Spanish Government); RETICS; Allergan Sales LLC.(AbbVieAllergan)	This work was supported by Fundacion Seneca: 04446/GERM/07; Spanish Ministry of Economy and Competitiveness: SAF-2012-38328; ISCIII-FEDER: PI10/01496, PI10/00187; RETICS: RD07/0062/0001; and an unrestricted grant from Allergan Sales LLC. to MVS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal N, 2002, EXP EYE RES, V74, P445, DOI 10.1006/exer.2001.1145; Arnault E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071398; Aviles-Trigueros M, 2003, EXP NEUROL, V184, P767, DOI 10.1016/S0014-4886(03)00298-X; Beatty S, 2000, SURV OPHTHALMOL, V45, P115, DOI 10.1016/S0039-6257(00)00140-5; Berger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096494; BORGES JM, 1990, CURR EYE RES, V9, P799, DOI 10.3109/02713689008999576; Busch EM, 1999, VISION RES, V39, P1233, DOI 10.1016/S0042-6989(98)00233-8; Busch EM, 1999, EXP EYE RES, V68, P485, DOI 10.1006/exer.1998.0628; Cao W, 2001, INVEST OPHTH VIS SCI, V42, P1646; Casson RJ, 2004, INVEST OPHTH VIS SCI, V45, P685, DOI 10.1167/iovs.03-0674; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Cruickshanks KJ, 2001, ARCH OPHTHALMOL-CHIC, V119, P246; Cuenca N, 2010, EXP EYE RES, V91, P273, DOI 10.1016/j.exer.2010.05.020; Dai XF, 2014, INVEST OPHTH VIS SCI, V55, P1724, DOI 10.1167/iovs.13-13654; FAKTOROVICH EG, 1992, J NEUROSCI, V12, P3554; Fishkin NE, 2005, P NATL ACAD SCI USA, V102, P7091, DOI 10.1073/pnas.0501266102; Gabriele ML, 2011, INVEST OPHTH VIS SCI, V52, P2425, DOI 10.1167/iovs.10-6312; Galindo-Romero C, 2013, EXP EYE RES, V108, P84, DOI 10.1016/j.exer.2012.12.010; Galindo-Romero C, 2011, EXP EYE RES, V92, P377, DOI 10.1016/j.exer.2011.02.008; Galindo-Romero C, 2013, INVEST OPHTH VIS SCI, V54, P974, DOI 10.1167/iovs.12-11207; Gao H, 2002, ARCH OPHTHALMOL-CHIC, V120, P797; Garcia-Ayuso D, 2014, BRIT J OPHTHALMOL, V98, P396, DOI 10.1136/bjophthalmol-2013-303958; Garcia-Ayuso D, 2013, INVEST OPHTH VIS SCI, V54, P5888, DOI 10.1167/iovs.13-12643; Garcia-Ayuso D, 2011, MOL VIS, V17, P1716; Garcia-Ayuso D, 2010, EXP EYE RES, V91, P800, DOI 10.1016/j.exer.2010.10.003; Gauthier R, 2005, INVEST OPHTH VIS SCI, V46, P3383, DOI 10.1167/iovs.05-0362; Glickman RD, 2002, INT J TOXICOL, V21, P473, DOI 10.1080/10915810290169909; GORGELS TGMF, 1995, INVEST OPHTH VIS SCI, V36, P851; HAM WT, 1978, INVEST OPHTH VIS SCI, V17, P1029; Harun-Or-Rashid M, 2014, INVEST OPHTH VIS SCI, V55, P3385, DOI 10.1167/iovs.13-13823; Hojo M, 2004, INVEST OPHTH VIS SCI, V45, P3721, DOI 10.1167/iovs.04-0059; Hunter JJ, 2012, PROG RETIN EYE RES, V31, P28, DOI 10.1016/j.preteyeres.2011.11.001; Imai D, 2005, J CELL PHYSIOL, V202, P570, DOI 10.1002/jcp.20155; Jehle T, 2008, GRAEF ARCH CLIN EXP, V246, P1255, DOI 10.1007/s00417-007-0746-7; Joly S, 2007, INVEST OPHTH VIS SCI, V48, P2311, DOI 10.1167/iovs.06-1205; Kano T, 2002, INVEST OPHTH VIS SCI, V43, P3744; Kim SR, 2007, P NATL ACAD SCI USA, V104, P19273, DOI 10.1073/pnas.0708714104; Kolomeyer AM, 2014, SURV OPHTHALMOL, V59, P134, DOI 10.1016/j.survophthal.2013.09.004; Kusari J, 2011, INVEST OPHTH VIS SCI, V52, P5424, DOI 10.1167/iovs.10-6262; Kusari J, 2010, INVEST OPHTH VIS SCI, V51, P1044, DOI 10.1167/iovs.08-3293; Lambert WS, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-4; LAVAIL MM, 1987, EXP EYE RES, V44, P877, DOI 10.1016/S0014-4835(87)80050-7; LAVAIL MM, 1992, P NATL ACAD SCI USA, V89, P11249, DOI 10.1073/pnas.89.23.11249; LAVAIL MM, 1976, INVEST OPHTH VISUAL, V15, P64; LaVail MM, 1998, INVEST OPHTH VIS SCI, V39, P592; Leveillard T, 2004, NAT GENET, V36, P755, DOI 10.1038/ng1386; Li YW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009495; Liu Y, 2014, INVEST OPHTH VIS SCI, V55, P3766, DOI 10.1167/iovs.14-13895; Lonngren U, 2006, BRAIN RES BULL, V71, P208, DOI 10.1016/j.brainresbull.2006.09.005; Lopez-Herrera MPL, 2002, EXP NEUROL, V178, P243, DOI 10.1006/exnr.2002.8043; MANSOURROBAEY S, 1994, P NATL ACAD SCI USA, V91, P1632, DOI 10.1073/pnas.91.5.1632; Marc RE, 2008, MOL VIS, V14, P782; Marco-Gomariz MA, 2006, J COMP NEUROL, V498, P163, DOI 10.1002/cne.21028; MASUDA K, 1995, INVEST OPHTH VIS SCI, V36, P2142; Mayor-Torroglosa S, 2005, INVEST OPHTH VIS SCI, V46, P3825, DOI 10.1167/iovs.05-0392; McGill TJ, 2007, INVEST OPHTH VIS SCI, V48, P5756, DOI 10.1167/iovs.07-0054; Montalban-Soler L, 2012, MOL VIS, V18, P675; Nadal-Nicolas FM, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00099; Nadal-Nicolas FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049830; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Nguyen JV, 2011, P NATL ACAD SCI USA, V108, P1176, DOI 10.1073/pnas.1013965108; Noell W K, 1966, Invest Ophthalmol, V5, P450; O'Driscoll C, 2008, J NEUROCHEM, V105, P524, DOI 10.1111/j.1471-4159.2007.05189.x; Okoye G, 2003, J NEUROSCI, V23, P4164; Organisciak DT, 2010, PROG RETIN EYE RES, V29, P113, DOI 10.1016/j.preteyeres.2009.11.004; Organisciak DT, 2000, INVEST OPHTH VIS SCI, V41, P3694; Ortin-Martinez A, 2014, EXP EYE RES UNPUB; Ortin-Martinez A, 2014, IOVS, V55; Ortin-Martinez A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102392; Ortin-Martinez A, 2010, INVEST OPHTH VIS SCI, V51, P3171, DOI 10.1167/iovs.09-4861; Parrilla-Reverter G, 2009, EXP EYE RES, V89, P32, DOI 10.1016/j.exer.2009.02.015; Paskowitz DM, 2007, INVEST OPHTH VIS SCI, V48, P430, DOI 10.1167/iovs.06-0690; PeinadoRamon P, 1996, INVEST OPHTH VIS SCI, V37, P489; Peng M, 1998, INVEST OPHTH VIS SCI, V39, P1721; Peterson WM, 2000, J NEUROSCI, V20, P4081; Podoleanu AG, 2012, J MICROSC-OXFORD, V247, P209, DOI 10.1111/j.1365-2818.2012.03619.x; Provis JM, 2013, PROG RETIN EYE RES, V35, P63, DOI 10.1016/j.preteyeres.2013.01.005; Ramirez AI, 2010, INVEST OPHTH VIS SCI, V51, P5690, DOI 10.1167/iovs.10-5248; RAPP LM, 1980, VISION RES, V20, P1127, DOI 10.1016/0042-6989(80)90050-4; Reme CE, 2000, NEWS PHYSIOL SCI, V15, P120, DOI 10.1152/physiologyonline.2000.15.3.120; Salinas-Navarro M, 2009, VISION RES, V49, P637, DOI 10.1016/j.visres.2009.01.010; Salinas-Navarro M, 2009, VISION RES, V49, P115, DOI 10.1016/j.visres.2008.09.029; Salinas-Navarro M, 2009, MOL VIS, V15, P2578; Salinas-Navarro M, 2010, EXP EYE RES, V90, P168, DOI 10.1016/j.exer.2009.10.003; Sanchez-Migallon MC, 2011, EXP EYE RES, V92, P260, DOI 10.1016/j.exer.2011.02.001; Saylor M, 2009, ARCH OPHTHALMOL-CHIC, V127, P402, DOI 10.1001/archophthalmol.2009.9; Schnebelen C, 2009, GRAEF ARCH CLIN EXP, V247, P1191, DOI 10.1007/s00417-009-1094-6; Sobrado-Calvo P, 2007, J COMP NEUROL, V501, P866, DOI 10.1002/cne.21279; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; SZEL A, 1992, EXP EYE RES, V55, P47; Tanito M, 2008, EXP EYE RES, V87, P292, DOI 10.1016/j.exer.2008.06.002; TAYLOR HR, 1992, ARCH OPHTHALMOL-CHIC, V110, P99, DOI 10.1001/archopht.1992.01080130101035; Tsukahara N, 2014, J VET MED SCI, V76, P93, DOI 10.1292/jvms.13-0293; Ueki Y, 2010, ADV EXP MED BIOL, V664, P655, DOI 10.1007/978-1-4419-1399-9_75; Valiente-Soriano FJ, 2014, IOVS, V55; Valiente-Soriano FJ, 2014, FRONT NEURO IN PRESS; VANNORREN D, 1990, VISION RES, V30, P1517, DOI 10.1016/0042-6989(90)90032-G; Vaughan DK, 2002, PHOTOCHEM PHOTOBIOL, V75, P547, DOI 10.1562/0031-8655(2002)075<0547:EFACRO>2.0.CO;2; Vidal-Sanz M, 2007, EYE, V21, pS42, DOI 10.1038/sj.eye.6702888; Vidal-Sanz M, 2012, PROG RETIN EYE RES, V31, P1, DOI 10.1016/j.preteyeres.2011.08.001; Vidal-Sanz M, 2000, NEUROTOX RES, V2, P215, DOI 10.1007/BF03033795; Villegas-Perez MP, 1998, J COMP NEUROL, V392, P58, DOI 10.1002/(SICI)1096-9861(19980302)392:1<58::AID-CNE5>3.0.CO;2-O; VillegasPerez MP, 1996, NEUROREPORT, V7, P1995, DOI 10.1097/00001756-199608120-00028; Wang S, 2003, CURR EYE RES, V27, P183, DOI 10.1076/ceyr.27.3.183.16053; Wang SM, 2000, INVEST OPHTH VIS SCI, V41, P537; Wasowicz M, 2002, INVEST OPHTH VIS SCI, V43, P813; Wen R, 1996, J NEUROSCI, V16, P5986; Wen R, 2006, J NEUROSCI, V26, P13523, DOI 10.1523/JNEUROSCI.4021-06.2006; Wen R, 2012, PROG RETIN EYE RES, V31, P136, DOI 10.1016/j.preteyeres.2011.11.005; Wen R, 2012, ADV EXP MED BIOL, V723, P93, DOI 10.1007/978-1-4614-0631-0_13; Wheeler L, 2003, SURV OPHTHALMOL, V48, pS47, DOI 10.1016/S0039-6257(03)00004-3; WILLIAMS TP, 1983, INVEST OPHTH VIS SCI, V24, P285; Wilson RB, 2007, INVEST OPHTH VIS SCI, V48, P2877, DOI 10.1167/iovs.06-1079; Yang P, 2005, INVEST OPHTH VIS SCI, V46, P1755, DOI 10.1167/iovs.04-1039; Yang YP, 2014, INVEST OPHTH VIS SCI, V55, P1696, DOI 10.1167/iovs.13-12477	115	46	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113798	10.1371/journal.pone.0113798	http://dx.doi.org/10.1371/journal.pone.0113798			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464513	gold, Green Published, Green Submitted			2022-12-26	WOS:000345869700055
J	Adduri, RSR; Katamoni, R; Pandilla, R; Madana, SN; Paripati, AK; Kotapalli, V; Bashyam, MD				Adduri, Raju S. R.; Katamoni, Rajender; Pandilla, Ramaswamy; Madana, Sandeep N.; Paripati, Arun Kumar; Kotapalli, Viswakalyan; Bashyam, Murali Dharan			TP53 Pro72 Allele Is Enriched in Oral Tongue Cancer and Frequently Mutated in Esophageal Cancer in India	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; P53 CODON-72 POLYMORPHISM; HUMAN-PAPILLOMAVIRUS INFECTION; HIGH-RISK AREA; NASOPHARYNGEAL CARCINOMA; PROGNOSTIC-SIGNIFICANCE; GENETIC POLYMORPHISMS; NECK-CANCER; MUTATIONS; ASSOCIATION	Purpose: The tumor suppressor p53 is known to be inactivated frequently in various cancers. In addition, germline polymorphisms in TP53 are known to affect protein function and influence risk of developing different types of cancers. In this study, we analyzed the association of TP53 Pro72Arg polymorphism with squamous cell carcinoma of oral tongue (SCCOT) and esophagus (ESCC) in India. Methods: We assessed the distribution of TP53 Pro72Arg polymorphism in one hundred and fifteen and eighty two SCCOT and ESCC patients, respectively, with respect to one hundred and ten healthy controls from the same population. In addition, we analyzed association of the polymorphism with several clinicopathological and molecular parameters. Results: Pro72 allele was significantly enriched in SCCOT patients compared to the healthy control group but neither allele was enriched in ESCC. Interestingly, Pro72 allele was preferentially mutated in ESCC which was confirmed by analysis of samples heterozygous for Pro72Arg. Conclusions: Our study revealed the association of Pro72 allele with SCCOT suggesting the effect of this polymorphism on SCCOT risk. Preferential mutation of Pro72 allele exclusively in ESCC indicates the need for further studies to understand the tissue specific effect of p53 polymorphism.	[Adduri, Raju S. R.; Katamoni, Rajender; Pandilla, Ramaswamy; Madana, Sandeep N.; Paripati, Arun Kumar; Kotapalli, Viswakalyan; Bashyam, Murali Dharan] Ctr DNA Fingerprinting & Diagnost, Mol Oncol Lab, Hyderabad, Andhra Pradesh, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD)	Bashyam, MD (corresponding author), Ctr DNA Fingerprinting & Diagnost, Mol Oncol Lab, Hyderabad, Andhra Pradesh, India.	bashyam@cdfd.org.in	Adduri, Sitaramaraju/AAW-7232-2021	Adduri, Sitaramaraju/0000-0003-2529-2196	Indian Council for Medical Research (ICMR), Govt. of India [5/13/129/2009-NCD-III]; Council of Scientific and Industrial Research (CSIR), Govt. of India [27(265)/12/EMR-II]; Department of Biotechnology, Govt. of India [BT/PR11873/MED/30/173/2009]; Department of Biotechnology, Govt. of India	Indian Council for Medical Research (ICMR), Govt. of India(Indian Council of Medical Research (ICMR)); Council of Scientific and Industrial Research (CSIR), Govt. of India(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	MDB received Indian Council for Medical Research (ICMR), Govt. of India (Grant No. 5/13/129/2009-NCD-III), Council of Scientific and Industrial Research (CSIR), Govt. of India (Grant No. 27(265)/12/EMR-II), Department of Biotechnology, Govt. of India (Grant No. BT/PR11873/MED/30/173/2009) and a core grant from the Department of Biotechnology, Govt. of India to Centre for DNA Fingerprinting and Diagnostics (CDFD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedi-Ardekani B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029488; Adduri RSR, 2014, BMC CLIN PATHOL, V14, DOI 10.1186/1472-6890-14-37; Azzam GA, 2011, CELL CYCLE, V10, P1352, DOI 10.4161/cc.10.9.15344; BAKER SJ, 1990, CANCER RES, V50, P7717; Bello IO, 2010, ORAL ONCOL, V46, P630, DOI 10.1016/j.oraloncology.2010.06.006; Bergamaschi D, 2003, CANCER CELL, V3, P387, DOI 10.1016/S1535-6108(03)00079-5; Cai L, 2006, CANCER EPIDEM BIOMAR, V15, P294, DOI 10.1158/1055-9965.EPI-05-0680; Cai YYC, 2000, CARCINOGENESIS, V21, P683, DOI 10.1093/carcin/21.4.683; Devesa SS, 1998, CANCER, V83, P2049, DOI 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2; Dong HJ, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0908-5; Dumont P, 2003, NAT GENET, V33, P357, DOI 10.1038/ng1093; Gaur D, 1997, CLIN CANCER RES, V3, P2129; Gloria-Bottini F, 2012, AM J MED SCI, V343, P127, DOI 10.1097/MAJ.0b013e318223ac71; GROENEN PJ, 1988, FOOD CHEM TOXICOL, V26, P215, DOI 10.1016/0278-6915(88)90122-6; Guimaraes DP, 2001, CANCER LETT, V162, P231, DOI 10.1016/S0304-3835(00)00643-1; HAGGITT RC, 1978, AM J CLIN PATHOL, V70, P1; Hainaut P, 2000, ADV CANCER RES, V77, P81; Hamel N, 2000, BRIT J CANCER, V82, P757, DOI 10.1054/bjoc.1999.0993; Hammarstedt L, 2011, ORAL ONCOL, V47, P636, DOI 10.1016/j.oraloncology.2011.04.012; Ho KY, 2011, J GASTROEN HEPATOL, V26, P816, DOI 10.1111/j.1440-1746.2011.06669.x; Hong Y, 2005, CANCER RES, V65, P9582, DOI 10.1158/0008-5472.CAN-05-1460; Hu YC, 2005, CLIN CANCER RES, V11, P2502, DOI 10.1158/1078-0432.CCR-04-1913; Ji XM, 2008, CARCINOGENESIS, V29, P875, DOI 10.1093/carcin/bgn039; Jia ST, 2012, ARCH GYNECOL OBSTET, V285, P1657, DOI 10.1007/s00404-012-2226-5; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Kankova K, 2014, J NEPHROLOGY THERAPE, V04; Katkoori VR, 2009, CLIN CANCER RES, V15, P2406, DOI 10.1158/1078-0432.CCR-08-1719; Larsson SC, 2006, INT J CANCER, V119, P915, DOI 10.1002/ijc.21925; Lee JM, 2000, INT J CANCER, V89, P458, DOI 10.1002/1097-0215(20000920)89:5<458::AID-IJC10>3.0.CO;2-R; Lee YH, 2012, LUPUS, V21, P430, DOI 10.1177/0961203311434941; Lin HJ, 2002, BRIT J OPHTHALMOL, V86, P767, DOI 10.1136/bjo.86.7.767; Marin MC, 2000, NAT GENET, V25, P47, DOI 10.1038/75586; McWilliams JE, 2000, HEAD NECK-J SCI SPEC, V22, P609, DOI 10.1002/1097-0347(200009)22:6<609::AID-HED10>3.0.CO;2-L; Mir MM, 2005, INT J CANCER, V116, P62, DOI 10.1002/ijc.21002; Miyaki M, 2002, ONCOGENE, V21, P6689, DOI 10.1038/sj.onc.1205887; Moore SR, 2000, ORAL DIS, V6, P75; Myers JN, 2000, OTOLARYNG HEAD NECK, V122, P44, DOI 10.1016/S0194-5998(00)70142-2; Pandilla R, 2013, EUR J CLIN INVEST, V43, P1233, DOI 10.1111/eci.12163; Pantelis A, 2007, ONCOL REP, V17, P1243; Petitjean A, 2007, HUM MUTAT, V28, P622, DOI 10.1002/humu.20495; Putz A, 2002, INT J CANCER, V98, P99, DOI 10.1002/ijc.10128; Rethman MP, 2010, J AM DENT ASSOC, V141, P509, DOI 10.14219/jada.archive.2010.0223; Schneider-Stock R, 2004, AM J PATHOL, V164, P1233, DOI 10.1016/S0002-9440(10)63211-7; Shao Y, 2008, DIS ESOPHAGUS, V21, P139, DOI 10.1111/j.1442-2050.2007.00746.x; Siddique MM, 2005, CANCER EPIDEM BIOMAR, V14, P2245, DOI 10.1158/1055-9965.EPI-05-0153; Siewert JR, 2001, ANN SURG, V234, P360, DOI 10.1097/00000658-200109000-00010; Sousa H, 2006, EUR J CANCER PREV, V15, P362, DOI 10.1097/00008469-200608000-00010; Storey A, 1998, NATURE, V393, P229, DOI 10.1038/30400; Summersgill KF, 2000, ORAL SURG ORAL MED O, V90, P334, DOI 10.1067/moe.2000.107359; Tada M, 2001, CARCINOGENESIS, V22, P515, DOI 10.1093/carcin/22.3.515; Tiwawech D, 2003, CANCER LETT, V198, P69, DOI 10.1016/S0304-3835(03)00283-0; Tommasino M, 2003, HUM MUTAT, V21, P307, DOI 10.1002/humu.10178; Tsai MH, 2002, LARYNGOSCOPE, V112, P116, DOI 10.1097/00005537-200201000-00020; Vaji S, 2011, INT J COLORECTAL DIS, V26, P235, DOI 10.1007/s00384-010-1021-7; WALKER EA, 1979, J NATL CANCER I, V63, P947; Whibley C, 2009, NAT REV CANCER, V9, P95, DOI 10.1038/nrc2584; Xu Y, 2005, CLIN CANCER RES, V11, P7328, DOI 10.1158/1078-0432.CCR-05-0507; Yang WJ, 2008, MOL CARCINOGEN, V47, P100, DOI 10.1002/mc.20368; Zini A, 2010, J ORAL PATHOL MED, V39, P299, DOI 10.1111/j.1600-0714.2009.00845.x	59	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114002	10.1371/journal.pone.0114002	http://dx.doi.org/10.1371/journal.pone.0114002			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436609	gold, Green Published, Green Submitted			2022-12-26	WOS:000347114900108
J	Puttamuk, T; Zhou, LJ; Thaveechai, N; Zhang, SA; Armstrong, CM; Duan, YP				Puttamuk, Thamrongjet; Zhou, Lijuan; Thaveechai, Niphone; Zhang, Shouan; Armstrong, Cheryl M.; Duan, Yongping			Genetic Diversity of Candidatus Liberibacter asiaticus Based on Two Hypervariable Effector Genes in Thailand	PLOS ONE			English	Article							REAL-TIME PCR; GREENING DISEASE; CITRUS; SEQUENCE; PROPHAGE; IDENTIFICATION; BACTERIUM; CLUSTER; GENOME	Huanglongbing (HLB), also known as citrus greening, is one of the most destructive diseases of citrus worldwide. HLB is associated with three species of 'Candidatus Liberibacter' with 'Ca. L. asiaticus' (Las) being the most widely distributed around the world, and the only species detected in Thailand. To understand the genetic diversity of Las bacteria in Thailand, we evaluated two closely-related effector genes, lasA(I) and lasA(II), found within the Las prophages from 239 infected citrus and 55 infected psyllid samples collected from different provinces in Thailand. The results indicated that most of the Las-infected samples collected from Thailand contained at least one prophage sequence with 48.29% containing prophage 1 (FP1), 63.26% containing prophage 2 (FP2), and 19.38% containing both prophages. Interestingly, FP2 was found to be the predominant population in Las-infected citrus samples while Las-infected psyllids contained primarily FP1. The multiple banding patterns that resulted from amplification of lasAI imply extensive variation exists within the full and partial repeat sequence while the single band from lasAII indicates a low amount of variation within the repeat sequence. Phylogenetic analysis of Las-infected samples from 22 provinces in Thailand suggested that the bacterial pathogen may have been introduced to Thailand from China and the Philippines. This is the first report evaluating the genetic variation of a large population of Ca. L. asiaticus infected samples in Thailand using the two effector genes from Las prophage regions.	[Puttamuk, Thamrongjet; Thaveechai, Niphone] Kasetsart Univ, Dept Plant Pathol, Fac Agr, Bangkok, Thailand; [Puttamuk, Thamrongjet; Zhou, Lijuan; Armstrong, Cheryl M.; Duan, Yongping] ARS, US Hort Res Lab, USDA, Ft Pierce, FL 34945 USA; [Zhang, Shouan] Univ Florida, Ctr Trop Res & Educ, Homestead, FL 33031 USA	Kasetsart University; United States Department of Agriculture (USDA); State University System of Florida; University of Florida	Duan, YP (corresponding author), ARS, US Hort Res Lab, USDA, Ft Pierce, FL 34945 USA.	yongping.duan@ars.usda.gov	Zhou, Li/GSE-4531-2022		Royal Golden Jubilee Ph.D. program through Thailand Research Fund (TRF); USDA-ARS-USHRL, Ft. Pierce, Florida; ARS [ARS-0423073] Funding Source: Federal RePORTER	Royal Golden Jubilee Ph.D. program through Thailand Research Fund (TRF); USDA-ARS-USHRL, Ft. Pierce, Florida; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	Funding: This work was supported by the Royal Golden Jubilee Ph.D. program through Thailand Research Fund (TRF), and the USDA-ARS-USHRL, Ft. Pierce, Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Alexander PJ, 2007, MOL ECOL NOTES, V7, P5, DOI 10.1111/j.1471-8286.2006.01549.x; Boykin LM, 2012, B ENTOMOL RES, V102, P573, DOI 10.1017/S0007485312000181; CHEETHAM BF, 1995, GENE, V162, P53, DOI 10.1016/0378-1119(95)00315-W; Ding F, 2009, EUR J PLANT PATHOL, V124, P495, DOI 10.1007/s10658-009-9436-0; Drummond A, 2001, BIOINFORMATICS, V17, P662, DOI 10.1093/bioinformatics/17.7.662; Duan Y, 2014, DIVERSITY PLASTICITY; Duan YP, 2009, MOL PLANT MICROBE IN, V22, P1011, DOI 10.1094/MPMI-22-8-1011; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hao GX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068921; Islam MS, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-39; JAGOUEIX S, 1994, INT J SYST BACTERIOL, V44, P379, DOI 10.1099/00207713-44-3-379; Jagoueix S, 1996, MOL CELL PROBE, V10, P43, DOI 10.1006/mcpr.1996.0006; Jagoueix S, 1997, INT J SYST BACTERIOL, V47, P224, DOI 10.1099/00207713-47-1-224; Lee HA, 1912, PHILIPP J SCI, V18, P85; Li WB, 2006, J MICROBIOL METH, V66, P104, DOI 10.1016/j.mimet.2005.10.018; Liu R, 2011, PLANT DIS, V95, P431, DOI 10.1094/PDIS-04-10-0300; Maddison W., 2018, MESQUITE MODULAR SYS; Miller M.A., 2010, P GAT COMP ENV WORKS; Morgan JK, 2012, MOL CELL PROBE, V26, P90, DOI 10.1016/j.mcp.2011.12.001; Ohtsu Yoshihiro, 1998, Annals of the Phytopathological Society of Japan, V64, P539; Reinking O, 1919, PHYTOPATHOLOGY, V9, P114; Roistacher CN, 1994, REPORT TECHNICAL VIS; Roistacher CN, 1996, EC LIVING CITRUS DIS, P279; Schwarz R. E., 1973, B PPST, V20, P17; SCHWARZ RE, 1973, FAO PLANT PROTECT B, V21, P132; Teixeira DC, 2008, INT J SYST EVOL MICR, V58, P1414, DOI 10.1099/ijs.0.65641-0; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomimura K, 2009, PHYTOPATHOLOGY, V99, P1062, DOI 10.1094/PHYTO-99-9-1062; Varani AM, 2013, ANNU REV PHYTOPATHOL, V51, P429, DOI 10.1146/annurev-phyto-081211-173010; VILLECHANOUX S, 1993, CURR MICROBIOL, V26, P161, DOI 10.1007/BF01577372; Wang XF, 2012, BMC MICROBIOL, V12, DOI [10.1186/1471-2180-12-18, 10.1186/1471-2105-13-113]; Zhang SJ, 2011, MOL PLANT MICROBE IN, V24, P458, DOI 10.1094/MPMI-11-10-0256; ZHOU L, 2013, PLOS ONE, V8; Zhou LJ, 2007, PLANT DIS, V91, P227, DOI 10.1094/PDIS-91-2-0227B; Zhou LJ, 2011, APPL ENVIRON MICROB, V77, P6663, DOI 10.1128/AEM.05111-11	36	16	18	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112968	10.1371/journal.pone.0112968	http://dx.doi.org/10.1371/journal.pone.0112968			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437428	Green Published, gold, Green Submitted			2022-12-26	WOS:000347114900023
J	Chen, Y; Takeda, T; Aoki, Y; Fujita, K; Suzuki, S; Igarashi, D				Chen, Yang; Takeda, Taito; Aoki, Yoshinao; Fujita, Keiko; Suzuki, Shunji; Igarashi, Daisuke			Peptidoglycan from Fermentation By-Product Triggers Defense Responses in Grapevine	PLOS ONE			English	Article							INNATE IMMUNITY; GLUTAMATE PRODUCTION; EF-TU; ARABIDOPSIS; PERCEPTION; RECEPTOR; RESISTANCE; FLAGELLIN; PROTEINS; KINASE	Plants are constantly under attack from a variety of microorganisms, and rely on a series of complex detection and response systems to protect themselves from infection. Here, we found that a by-product of glutamate fermentation triggered defense responses in grapevine, increasing the expression of defense response genes in cultured cells, foliar chitinase activity, and resistance to infection by downy mildew in leaf explants. To identify the molecule that triggered this innate immunity, we fractionated and purified candidates extracted from Corynebacterium glutamicum, a bacterium used in the production of amino acids by fermentation. Using hydrolysis by lysozyme, a silkworm larva plasma detection system, and gel filtration analysis, we identified peptidoglycan as inducing the defense responses. Peptidoglycans of Escherichia coli, Bacillus subtilis, and Staphylococcus aureus also generated similar defensive responses.	[Chen, Yang; Takeda, Taito; Igarashi, Daisuke] Ajinomoto Co Inc, Inst Innovat, Kawasaki, Kanagawa, Japan; [Aoki, Yoshinao; Fujita, Keiko; Suzuki, Shunji] Univ Yamanashi, Inst Enol & Viticulture, Kofu, Yamanashi, Japan; [Fujita, Keiko] Prefectural Univ Hiroshima, Fac Life & Environm Sci, Shobara, Hiroshima, Japan	Ajinomoto Co Inc; University of Yamanashi	Igarashi, D (corresponding author), Ajinomoto Co Inc, Inst Innovat, Kawasaki, Kanagawa, Japan.	daisuke_igarashi@ajinomoto.com	Fujita, Keiko/HGU-4137-2022		Ajinomoto Co., Inc.	Ajinomoto Co., Inc.	Yang Chen, Taito Takeda, and Daisuke Igarashi are the employees of Ajinomoto Co., Inc. Ajinomoto Co., Inc. provided support in the form of salaries for these authors [YC, TT, DI], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. There is no further employment, consultancy, patents, products in development or marketed products to declare. This does not alter our adherence to all of the PLOS ONE policies on sharing data and materials.''	Chinen A, 2007, J BIOSCI BIOENG, V103, P262, DOI 10.1263/jbb.103.262; Desaki Y, 2006, PLANT CELL PHYSIOL, V47, P1530, DOI 10.1093/pcp/pcl019; Desaki Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051953; Erbs G, 2008, CHEM BIOL, V15, P438, DOI 10.1016/j.chembiol.2008.03.017; Faurie B, 2009, J PLANT PHYSIOL, V166, P1863, DOI 10.1016/j.jplph.2009.05.015; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Felix G, 2003, J BIOL CHEM, V278, P6201, DOI 10.1074/jbc.M209880200; Furukawa T, 2014, MOL PLANT MICROBE IN, V27, P113, DOI 10.1094/MPMI-10-13-0304-R; Gomez-Gomez L, 2000, MOL CELL, V5, P1003, DOI 10.1016/S1097-2765(00)80265-8; Gust AA, 2007, J BIOL CHEM, V282, P32338, DOI 10.1074/jbc.M704886200; Igarashi D, 2010, J PHYTOPATHOL, V158, P668, DOI 10.1111/j.1439-0434.2010.01678.x; Iketani M, 1999, INSECT BIOCHEM MOLEC, V29, P19, DOI 10.1016/S0965-1748(98)00099-X; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kaku H, 2006, P NATL ACAD SCI USA, V103, P11086, DOI 10.1073/pnas.0508882103; Kunze G, 2004, PLANT CELL, V16, P3496, DOI 10.1105/tpc.104.026765; Le Henanff G, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-54; LISWIDOWATI F, 1991, PLANTA, V183, P307; Liu B, 2012, PLANT CELL, V24, P3406, DOI 10.1105/tpc.112.102475; McDonald C, 2005, J BIOL CHEM, V280, P20177, DOI 10.1074/jbc.R500001200; Miya A, 2007, P NATL ACAD SCI USA, V104, P19613, DOI 10.1073/pnas.0705147104; Nguyen HP, 2010, MOL PLANT MICROBE IN, V23, P991, DOI 10.1094/MPMI-23-8-0991; Sano C, 2009, AM J CLIN NUTR, V90, p728S, DOI 10.3945/ajcn.2009.27462F; Tsuchiya M, 1996, FEMS IMMUNOL MED MIC, V15, P129, DOI 10.1016/0928-8244(96)00053-3; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Wan JR, 2008, PLANT CELL, V20, P471, DOI 10.1105/tpc.107.056754; Willmann R, 2011, P NATL ACAD SCI USA, V108, P19824, DOI 10.1073/pnas.1112862108; Wuisman Yimiti, 2006, Grassland Science, V52, P73, DOI 10.1111/j.1744-697X.2006.00050.x; Zeidler D, 2004, P NATL ACAD SCI USA, V101, P15811, DOI 10.1073/pnas.0404536101; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	30	1	1	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113340	10.1371/journal.pone.0113340	http://dx.doi.org/10.1371/journal.pone.0113340			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427192	Green Submitted, Green Published, gold			2022-12-26	WOS:000349145400044
J	Faisal, A; Peltonen, J; Georgii, E; Rung, J; Kaski, S				Faisal, Ali; Peltonen, Jaakko; Georgii, Elisabeth; Rung, Johan; Kaski, Samuel			Toward Computational Cumulative Biology by Combining Models of Biological Datasets	PLOS ONE			English	Article							EXPRESSION; VISUALIZATION; RETRIEVAL	A main challenge of data-driven sciences is how to make maximal use of the progressively expanding databases of experimental datasets in order to keep research cumulative. We introduce the idea of a modeling-based dataset retrieval engine designed for relating a researcher's experimental dataset to earlier work in the field. The search is (i) data-driven to enable new findings, going beyond the state of the art of keyword searches in annotations, (ii) modeling-driven, to include both biological knowledge and insights learned from data, and (iii) scalable, as it is accomplished without building one unified grand model of all data. Assuming each dataset has been modeled beforehand, by the researchers or automatically by database managers, we apply a rapidly computable and optimizable combination model to decompose a new dataset into contributions from earlier relevant models. By using the data-driven decomposition, we identify a network of interrelated datasets from a large annotated human gene expression atlas. While tissue type and disease were major driving forces for determining relevant datasets, the found relationships were richer, and the model-based search was more accurate than the keyword search; moreover, it recovered biologically meaningful relationships that are not straightforwardly visible from annotations for instance, between cells in different developmental stages such as thymocytes and T-cells. Data-driven links and citations matched to a large extent; the data-driven links even uncovered corrections to the publication data, as two of the most linked datasets were not highly cited and turned out to have wrong publication entries in the database.	[Faisal, Ali; Peltonen, Jaakko; Georgii, Elisabeth; Kaski, Samuel] Aalto Univ, Helsinki Inst Informat Technol, Dept Informat & Comp Sci, Espoo, Finland; [Rung, Johan] European Bioinformat Inst, European Mol Biol Lab, Hinxton, England; [Kaski, Samuel] Univ Helsinki, Helsinki Inst Informat Technol, Dept Comp Sci, Helsinki, Finland	Aalto University; University of Helsinki; European Molecular Biology Laboratory (EMBL); University of Helsinki	Kaski, S (corresponding author), Aalto Univ, Helsinki Inst Informat Technol, Dept Informat & Comp Sci, Espoo, Finland.	samuel.kaski@aalto.fi	Faisal, Ali/A-4613-2012; Kaski, Samuel/B-6684-2008; Peltonen, Jaakko T/O-5172-2016; Peltonen, Jaakko/ABD-1698-2020; Faisal, Aldo/A-2367-2009	Faisal, Ali/0000-0001-9607-9371; Kaski, Samuel/0000-0003-1925-9154; Peltonen, Jaakko T/0000-0003-3485-8585; Peltonen, Jaakko/0000-0003-3485-8585; Rung, Johan/0000-0001-5875-8429; Faisal, Aldo/0000-0003-0813-7207; Al-khazraji, Ali M. A./0000-0003-0756-0556	Academy of Finland, Finnish Centre of Excellence in Computational Inference Research COIN [251170]	Academy of Finland, Finnish Centre of Excellence in Computational Inference Research COIN(Academy of Finland)	Funding: Academy of Finland (http://www.aka.fi), Finnish Centre of Excellence in Computational Inference Research COIN, 251170, to AF, JP, EG, SK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-12-r139; Barrett T, 2011, NUCLEIC ACIDS RES, V39, pD1005, DOI 10.1093/nar/gkq1184; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Baxter J, 1997, MACH LEARN, V28, P7, DOI 10.1023/A:1007327622663; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Caldas J, 2012, BIOINFORMATICS, V28, P246, DOI 10.1093/bioinformatics/btr634; Caldas J, 2009, BIOINFORMATICS, V25, pI145, DOI 10.1093/bioinformatics/btp215; Caruana R, 1997, MACH LEARN, V28, P41, DOI 10.1023/A:1007379606734; Culligan K, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-2; Engreitz JM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-603; Gerber GK, 2007, PLOS COMPUT BIOL, V3, P1426, DOI 10.1371/journal.pcbi.0030148; Gionis A, 1999, PROCEEDINGS OF THE TWENTY-FIFTH INTERNATIONAL CONFERENCE ON VERY LARGE DATA BASES, P518; Greene CS, 2011, NUCLEIC ACIDS RES, V39, pW368, DOI 10.1093/nar/gkr440; Huttenhower C, 2008, BIOINFORMATICS, V24, pI330, DOI 10.1093/bioinformatics/btn160; Jensen LJ, 2006, NAT REV GENET, V7, P119, DOI 10.1038/nrg1768; Kitazawa M, 2008, ANN NEUROL, V64, P15, DOI 10.1002/ana.21325; Lukk M, 2010, NAT BIOTECHNOL, V28, P322, DOI 10.1038/nbt0410-322; Martinsson L, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.37; Meinicke P, 2011, BIOINFORMATICS, V27, P1618, DOI 10.1093/bioinformatics/btr266; Mourkioti F, 2013, NAT CELL BIOL, V15, P895, DOI 10.1038/ncb2790; Nigam K, 2000, MACH LEARN, V39, P103, DOI 10.1023/A:1007692713085; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Pritchard JK, 2000, GENETICS, V155, P945; Rung J, 2013, NAT REV GENET, V14, P89, DOI 10.1038/nrg3394; Russ J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-305; Rzhetsky A, 2008, CELL, V134, P9, DOI 10.1016/j.cell.2008.06.029; SAMMON JW, 1969, IEEE T COMPUT, VC 18, P401, DOI 10.1109/T-C.1969.222678; Schmid PR, 2012, P NATL ACAD SCI USA, V109, P5594, DOI 10.1073/pnas.1118792109; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suthram S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000662; Tanay A, 2005, MOL SYST BIOL, V1, pe1; Tripathi A, 2011, DATA MIN KNOWL DISC, V23, P300, DOI 10.1007/s10618-010-0205-7; Tseng GC, 2012, NUCLEIC ACIDS RES, V40, P3785, DOI 10.1093/nar/gkr1265; van Dongen S, 2000, THESIS U UTRECHT; Virtanen S., 2012, P 15 INT C ARTIFICIA, V22, P1269; Wise A, 2012, BIOINFORMATICS, V28, pI258, DOI 10.1093/bioinformatics/bts205; Zheng J, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar045; Zhu YL, 2008, BIOINFORMATICS, V24, P2798, DOI 10.1093/bioinformatics/btn520	38	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113053	10.1371/journal.pone.0113053	http://dx.doi.org/10.1371/journal.pone.0113053			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427176	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400030
J	Lelliott, CJ; Ahnmark, A; Admyre, T; Ahlstedt, I; Irving, L; Keyes, F; Patterson, L; Mumphrey, MB; Bjursell, M; Gorman, T; Bohlooly-Y, M; Buchanan, A; Harrison, P; Vaughan, T; Berthoud, HR; Linden, D				Lelliott, Christopher J.; Ahnmark, Andrea; Admyre, Therese; Ahlstedt, Ingela; Irving, Lorraine; Keyes, Feenagh; Patterson, Laurel; Mumphrey, Michael B.; Bjursell, Mikael; Gorman, Tracy; Bohlooly-Y, Mohammad; Buchanan, Andrew; Harrison, Paula; Vaughan, Tristan; Berthoud, Hans-Rudolf; Linden, Daniel			Monoclonal Antibody Targeting of Fibroblast Growth Factor Receptor 1c Ameliorates Obesity and Glucose Intolerance via Central Mechanisms	PLOS ONE			English	Article							FOOD-INTAKE; RAT-BRAIN; INDUCED SUPPRESSION; ENERGY HOMEOSTASIS; INSULIN-RESISTANCE; SIGNALING PATHWAY; SUBFORNICAL ORGAN; FGF FAMILY; LEPTIN; MICE	We have generated a novel monoclonal antibody targeting human FGFR1c (R1c mAb) that caused profound body weight and body fat loss in diet-induced obese mice due to decreased food intake (with energy expenditure unaltered), in turn improving glucose control. R1c mAb also caused weight loss in leptin-deficient ob/ob mice, leptin receptor-mutant db/db mice, and in mice lacking either the melanocortin 4 receptor or the melanin-concentrating hormone receptor 1. In addition, R1c mAb did not change hypothalamic mRNA expression levels of Agrp, Cart, Pomc, Npy, Crh, Mch, or Orexin, suggesting that R1c mAb could cause food intake inhibition and body weight loss via other mechanisms in the brain. Interestingly, peripherally administered R1c mAb accumulated in the median eminence, adjacent arcuate nucleus and in the circumventricular organs where it activated the early response gene c-Fos. As a plausible mechanism and coinciding with the initiation of food intake suppression, R1c mAb induced hypothalamic expression levels of the cytokines Monocyte chemoattractant protein 1 and 3 and ERK1/2 and p70 S6 kinase 1 activation.	[Lelliott, Christopher J.; Ahnmark, Andrea; Ahlstedt, Ingela; Linden, Daniel] AstraZeneca, Dept Biosci Diabet, Cardiovasc & Metab Dis Innovat Med, Molndal, Sweden; [Admyre, Therese; Bjursell, Mikael; Bohlooly-Y, Mohammad] AstraZeneca, Discovery Sci Transgen, Molndal, Sweden; [Irving, Lorraine; Keyes, Feenagh; Buchanan, Andrew; Harrison, Paula; Vaughan, Tristan] MedImmune, Antibody Discovery & Prot Engn, Cambridge, England; [Patterson, Laurel; Mumphrey, Michael B.; Berthoud, Hans-Rudolf] Pennington Biomed Res Ctr, Neurobiol Nutr Lab, Baton Rouge, LA 70808 USA; [Gorman, Tracy] AstraZeneca, Discovery Sci, Macclesfield, Cheshire, England	AstraZeneca; Medimmune; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; AstraZeneca	Linden, D (corresponding author), AstraZeneca, Dept Biosci Diabet, Cardiovasc & Metab Dis Innovat Med, Molndal, Sweden.	daniel.linden@astrazeneca.com	Berthoud, Hans-Rudolf/N-1950-2017	Mumphrey, Michael/0000-0003-3150-8694; Buchanan, Andrew/0000-0002-5191-7682	AstraZeneca; MedImmune	AstraZeneca(AstraZeneca); MedImmune(AstraZenecaMedimmune)	Funding: The study was funded by AstraZeneca and MedImmune. The funders provided support in the form of salaries for authors (all authors except L.P., M.B.M., and H-R.B) and a research grant for author H-R.B, but did not have any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "author contributions" section.	Astrand A, 2004, AM J PHYSIOL-REG I, V287, pR749, DOI 10.1152/ajpregu.00134.2004; Balland E, 2014, CELL METAB, V19, P293, DOI 10.1016/j.cmet.2013.12.015; Banisadr G, 2005, J COMP NEUROL, V489, P275, DOI 10.1002/cne.20598; Banisadr G, 2002, J NEUROCHEM, V81, P257, DOI 10.1046/j.1471-4159.2002.00809.x; Beenken A, 2009, NAT REV DRUG DISCOV, V8, P235, DOI 10.1038/nrd2792; Blouet C, 2008, CELL METAB, V8, P459, DOI 10.1016/j.cmet.2008.10.004; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; DeBoer MD, 2009, PEPTIDES, V30, P210, DOI 10.1016/j.peptides.2008.10.019; Dobson CL, 2009, MABS-AUSTIN, V1, P552, DOI 10.4161/mabs.1.6.10057; Foltz IN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004690; Fry M, 2007, EXP BIOL MED, V232, P14; Garcia-Maya M, 2006, J CELL PHYSIOL, V206, P386, DOI 10.1002/jcp.20483; Gayle D, 1998, BRAIN RES, V795, P77, DOI 10.1016/S0006-8993(98)00280-7; Gerdin AK, 2006, BIOCHEM BIOPH RES CO, V349, P825, DOI 10.1016/j.bbrc.2006.08.103; GONZALEZ AM, 1995, BRAIN RES, V701, P201, DOI 10.1016/0006-8993(95)01002-X; Grossberg AJ, 2010, PHYSIOL BEHAV, V100, P478, DOI 10.1016/j.physbeh.2010.03.011; HANAI K, 1989, AM J PHYSIOL, V256, pR217, DOI 10.1152/ajpregu.1989.256.1.R217; Hart AW, 2000, NATURE, V408, P864, DOI 10.1038/35048589; Hotta M, 2001, EUR J PHARMACOL, V416, P101, DOI 10.1016/S0014-2999(01)00767-1; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Itoh N, 2011, J BIOCHEM, V149, P121, DOI 10.1093/jb/mvq121; Jiao H, 2011, J CLIN ENDOCR METAB, V96, pE962, DOI 10.1210/jc.2010-2639; Kleinridders A, 2009, CELL METAB, V10, P249, DOI 10.1016/j.cmet.2009.08.013; Li AJ, 1996, EXP NEUROL, V137, P318, DOI 10.1006/exnr.1996.0032; Milanski M, 2009, J NEUROSCI, V29, P359, DOI 10.1523/JNEUROSCI.2760-08.2009; OOMURA Y, 1992, American Journal of Clinical Nutrition, V55, p278S, DOI 10.1093/ajcn/55.1.278s; PLATASALAMAN CR, 1994, AM J PHYSIOL, V266, pR1711, DOI 10.1152/ajpregu.1994.266.5.R1711; Posey KA, 2009, AM J PHYSIOL-ENDOC M, V296, pE1003, DOI 10.1152/ajpendo.90377.2008; Potes CS, 2012, AM J PHYSIOL-REG I, V302, pR340, DOI 10.1152/ajpregu.00380.2011; Rahmouni K, 2009, DIABETES, V58, P536, DOI 10.2337/db08-0822; Robins SC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3049; Romero-Fernandez W, 2011, BIOCHEM BIOPH RES CO, V409, P764, DOI 10.1016/j.bbrc.2011.05.085; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Shirazi R, 2013, P NATL ACAD SCI USA, V110, P16199, DOI 10.1073/pnas.1306799110; Smith PM, 2009, AM J PHYSIOL-REG I, V296, pR512, DOI 10.1152/ajpregu.90858.2008; Smith PM, 2010, PHYSIOL BEHAV, V99, P534, DOI 10.1016/j.physbeh.2010.01.013; Sun G, 2010, DIABETOLOGIA, V53, P924, DOI 10.1007/s00125-010-1692-1; Sun HJD, 2007, AM J PHYSIOL-ENDOC M, V292, pE964, DOI 10.1152/ajpendo.00089.2006; Sutton GM, 2004, J NEUROSCI, V24, P10240, DOI 10.1523/JNEUROSCI.2764-04.2004; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Thaler JP, 2010, FRONT NEUROENDOCRIN, V31, P79, DOI 10.1016/j.yfrne.2009.10.002; Wu AL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002669; Zhang XQ, 2008, CELL, V135, P61, DOI 10.1016/j.cell.2008.07.043	43	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112109	10.1371/journal.pone.0112109	http://dx.doi.org/10.1371/journal.pone.0112109			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427253	Green Published, gold, Green Submitted			2022-12-26	WOS:000349145400009
J	Zhang, JY; Cui, L; Xu, MH; Zheng, YL				Zhang, Junye; Cui, Lei; Xu, Minhua; Zheng, Yuanli			Restoring the Secretory Function of Irradiation-Damaged Salivary Gland by Administrating Deferoxamine in Mice	PLOS ONE			English	Article							INDUCED APOPTOSIS; IRON CHELATORS; GROWTH-FACTOR; CELLS; INHIBITION; PROTECTION; HEAD; PREVENTION; RESCUE	Objectives: One of the major side effects of radiotherapy for treatments of the head and neck cancer is the radiation-induced dysfunction of salivary glands. The aim of the present study is to investigate the efficacy of deferoxamine (DFO) to restore the secretory function of radiation-damaged salivary glands in mice. Methods: DFO (50 mg/kg/d) was administered intraperitoneally in C57BL/6 mice for 3 days before and/or after point-fixed irradiation (18 Gy) of submandibular glands. The total 55 mice were randomly divided into: (1) Normal group: mice received no treatment (n=5); (2) Irradiation group (IR): mice only received irradiation (n=5); (3) Pre-DFO group (D+IR) (n=10); (4) Pre+Post DFO group (D+IR+D) (n=10); (5) Post-DFO group (IR+D) (n=10); (6) For each DFO-treated group, the mice were intraperitoneally injected with 0.1 ml sterilized water alone (by which DFO was dissolved) for 3 days before and/or after irradiation, and served as control. Sham1: Pre-sterilized water group (n=5); sham2: Pre+Post sterilized water group (n=5); sham3: Post-sterilized water group (n=5). The salivary flow rate (SFR) was assessed at 30th, 60th an d 90th day after irradiation, respectively. After 90 days, all mice were sacrificed and their submandibular glands were removed for further examinations. Results: The salivary glands showed remarkable dysfunction and tissue damage after irradiation. DFO restored SFR in the irradiated glands to a level comparable to that in normal glands and angiogenesis in damaged tissue was greatly increased. DFO also increased the expression levels of HIF-1 alpha and VEGF while reduced apoptotic cells. Furthermore, Sca-1-(+)cells were preserved in the salivary glands treated with DFO before IR. Conclusions: Our results indicate DFO could prevent the radiation-induced dysfunction of salivary glands in mice. The mechanism of this protective effect may involve increased angiogenesis, reduced apoptosis of acinar cells and more preserved stem cells.	[Zhang, Junye; Zheng, Yuanli] Shanghai Jiao Tong Univ, Stomatol Special Consultat Clin, Shanghai Key Lab Stomatol, Peoples Hosp 9,Sch Med, Shanghai 200030, Peoples R China; [Zhang, Junye; Xu, Minhua] Branch Shanghai First Peoples Hosp, Dept Stomatol, Shanghai, Peoples R China; [Cui, Lei] Shanghai Jiao Tong Univ, Dept Plast & Reconstruct Surg, Peoples Hosp 9, Sch Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zheng, YL (corresponding author), Shanghai Jiao Tong Univ, Stomatol Special Consultat Clin, Shanghai Key Lab Stomatol, Peoples Hosp 9,Sch Med, Shanghai 200030, Peoples R China.	zhengyuanli@yahoo.com			Science and Technology Commission of Shanghai Municipality Foundation [0941195470]	Science and Technology Commission of Shanghai Municipality Foundation(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was financially supported by the Science and Technology Commission of Shanghai Municipality Foundation (grant no. 0941195470). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, CHINESE SOC ORAL MAX, V03, P395; BECTON DL, 1988, CANCER RES, V48, P7189; Beerepoot LV, 1996, CANCER RES, V56, P3747; BRODIE C, 1993, CANCER RES, V53, P3968; Burlage FR, 2001, RADIOTHER ONCOL, V61, P271, DOI 10.1016/S0167-8140(01)00427-3; Buss JL, 2003, CURR MED CHEM, V10, P1021, DOI 10.2174/0929867033457638; Cotrim AP, 2007, MOL THER, V15, P2101, DOI 10.1038/sj.mt.6300296; DONFRANCESCO A, 1990, CANCER RES, V50, P4929; ESTROV Z, 1987, BLOOD, V69, P757; FUKUCHI K, 1994, FEBS LETT, V350, P139, DOI 10.1016/0014-5793(94)00755-1; HANN HWL, 1990, HEPATOLOGY, V11, P566, DOI 10.1002/hep.1840110407; Ikeda Y, 2011, ATHEROSCLEROSIS, V215, P339, DOI 10.1016/j.atherosclerosis.2011.01.009; Kojima T, 2011, LARYNGOSCOPE, V121, P1864, DOI 10.1002/lary.22080; Lee SK, 2006, LIFE SCI, V79, P1419, DOI 10.1016/j.lfs.2006.04.011; Lim JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071167; Lombaert IMA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002063; Nagler R, 1998, RADIAT RES, V149, P271, DOI 10.2307/3579960; NAGLER RM, 1993, RADIAT RES, V136, P42, DOI 10.2307/3578638; Nagler RM, 2002, ORAL DIS, V8, P141, DOI 10.1034/j.1601-0825.2002.02838.x; Oki T, 2006, BIOL PHARM BULL, V29, P1397, DOI 10.1248/bpb.29.1397; Pahl PMB, 2005, CANCER INVEST, V23, P683, DOI 10.1080/07357900500359976; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; Pena LA, 2000, CANCER RES, V60, P321; RIAZULHAQ, 1995, EXP HEMATOL, V23, P428; RICHARDSON D, 1994, CANCER RES, V54, P685; Richardson DR, 2005, CURR MED CHEM, V12, P2711, DOI 10.2174/092986705774462996; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Shen X, 2009, J ORTHOP RES, V27, P1298, DOI 10.1002/jor.20886; Simonart T, 2000, J INVEST DERMATOL, V115, P893, DOI 10.1046/j.1523-1747.2000.00119.x; Simonart T, 2002, GYNECOL ONCOL, V85, P95, DOI 10.1006/gyno.2001.6570; Song DQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065721; Sumita Y, 2011, INT J BIOCHEM CELL B, V43, P80, DOI 10.1016/j.biocel.2010.09.023; Vissink A, 2003, CRIT REV ORAL BIOL M, V14, P213, DOI 10.1177/154411130301400306; Vissink A, 2003, CRIT REV ORAL BIOL M, V14, P199, DOI 10.1177/154411130301400305	34	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113721	10.1371/journal.pone.0113721	http://dx.doi.org/10.1371/journal.pone.0113721			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427160	gold, Green Submitted, Green Published			2022-12-26	WOS:000349145400081
J	Matsuda, H; Yamada, T; Yoshida, M; Nishimura, T				Matsuda, Hiroko; Yamada, Takayuki; Yoshida, Miki; Nishimura, Takashi			Flies without Trehalose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA-MELANOGASTER; INSULIN-SECRETION; LIPID-METABOLISM; FAT-BODY; GROWTH; CELLS; GLUCOSE; HOMEOSTASIS; EXPRESSION; NEURONS	Living organisms adapt to environmental changes through metabolic homeostasis. Sugars are used primarily for the metabolic production of ATP energy and carbon sources. Trehalose is a nonreducing disaccharide that is present in many organisms. In insects, the principal hemolymph sugar is trehalose instead of glucose. As in mammals, hemolymph sugar levels in Drosophila are regulated by the action of endocrine hormones. Therefore, the mobilization of trehalose to glucose is thought to be critical for metabolic homeostasis. However, the physiological role of trehalose as a hemolymph sugar during insect development remains largely unclear. Here, we demonstrate that mutants of the trehalose-synthesizing enzyme Tps1 failed to produce trehalose as expected but survived into the late pupal period and died before eclosion. Larvae without trehalose grew normally, with a slight reduction in body size, under normal food conditions. However, these larvae were extremely sensitive to starvation, possibly due to a local defect in the central nervous system. Furthermore, Tps1 mutant larvae failed to grow on a low-sugar diet and exhibited severe growth defects on a low-protein diet. These diet-dependent phenotypes of Tps1 mutants demonstrate the critical role of trehalose during development in Drosophila and reveal how animals adapt to changes in nutrient availability.	[Matsuda, Hiroko; Yamada, Takayuki; Yoshida, Miki; Nishimura, Takashi] RIKEN Ctr Dev Biol, Lab Growth Control Signaling, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Yoshida, Miki; Nishimura, Takashi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	RIKEN; Nara Institute of Science & Technology	Nishimura, T (corresponding author), RIKEN Ctr Dev Biol, Lab Growth Control Signaling, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	t-nishimura@cdb.riken.jp	Nishimura, Takashi/AAQ-9299-2020; Nishimura, Takashi/D-7672-2017	Nishimura, Takashi/0000-0002-6773-0302; Nishimura, Takashi/0000-0002-6773-0302	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)	Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by scientific research grants from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT; to T. N.).	Becker A, 1996, EXPERIENTIA, V52, P433, DOI 10.1007/BF01919312; Bharucha KN, 2008, J EXP BIOL, V211, P3103, DOI 10.1242/jeb.016451; CANDY DJ, 1959, NATURE, V183, P1594, DOI 10.1038/1831594a0; Chen QF, 2002, J BIOL CHEM, V277, P3274, DOI 10.1074/jbc.M109479200; Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73; Davis MM, 2007, DEVELOPMENT, V134, P4395, DOI 10.1242/dev.009902; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Geminard C, 2009, CELL METAB, V10, P199, DOI 10.1016/j.cmet.2009.08.002; Gronke S, 2007, PLOS BIOL, V5, P1248, DOI 10.1371/journal.pbio.0050137; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Havula E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003438; Havula E, 2012, SEMIN CELL DEV BIOL, V23, P640, DOI 10.1016/j.semcdb.2012.02.007; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Honegger Basil, 2008, J Biol, V7, P10, DOI 10.1186/jbiol72; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Kikawada T, 2007, P NATL ACAD SCI USA, V104, P11585, DOI 10.1073/pnas.0702538104; Kim SK, 2004, NATURE, V431, P316, DOI 10.1038/nature02897; McNabb SL, 1997, NEURON, V19, P813, DOI 10.1016/S0896-6273(00)80963-0; Muller YL, 2013, HUM GENET, V132, P697, DOI 10.1007/s00439-013-1278-3; MURPHY TA, 1965, J BIOL CHEM, V240, P1500; Okamoto N, 2013, GENE DEV, V27, P87, DOI 10.1101/gad.204479.112; Okamoto N, 2012, P NATL ACAD SCI USA, V109, P2406, DOI 10.1073/pnas.1116050109; Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009; An PNT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099519; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Ruaud AF, 2011, MOL ENDOCRINOL, V25, P83, DOI 10.1210/me.2010-0337; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Tennessen JM, 2014, G3-GENES GENOM GENET, V4, P839, DOI 10.1534/g3.114.010652; Tennessen JM, 2011, CELL METAB, V13, P139, DOI 10.1016/j.cmet.2011.01.005; Wirtz-Peitz F, 2008, CELL, V135, P161, DOI 10.1016/j.cell.2008.07.049; WYATT GR, 1957, J GEN PHYSIOL, V40, P833, DOI 10.1085/jgp.40.6.833; Zirin J, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001708	35	77	81	1	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1244	1255		10.1074/jbc.M114.619411	http://dx.doi.org/10.1074/jbc.M114.619411			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25451929	Green Published, hybrid			2022-12-26	WOS:000347778200053
J	Fernandez-Arias, M; Acuna-Villaorduna, A; Miranda, JJ; Diez-Canseco, F; Malaga, G				Fernandez-Arias, Marta; Acuna-Villaorduna, Ana; Miranda, J. Jaime; Diez-Canseco, Francisco; Malaga, German			Adherence to Pharmacotherapy and Medication-Related Beliefs in Patients with Hypertension in Lima, Peru	PLOS ONE			English	Article							BLOOD-PRESSURE; MEDICINES; IMPACT	Objective: To characterize adherence to pharmacological medication and beliefs towards medication in a group of patients with hypertension in a large national hospital. Materials and Methods: Cross-sectional survey among patients with hypertension attending the outpatient clinic of a large national hospital. Exposure of interest was the patient's beliefs towards general medication and antihypertensive drugs, i.e. beliefs of harm, overuse, necessity and concern, measured using the Beliefs about Medication questionnaire. Main outcome was adherence measured using the Morisky Medication Adherence Scale-8. Multivariate analysis was conducted using Poisson distribution logistic regression, prevalence ratios and 95% confidence intervals were calculated. Results: Data from 115 participants, 67% females and mean age 62.7 years were analyzed. Low adherence was found in 57.4%. Highest scores were on the ideas of necessity and one of the most rated statements was "physicians would prescribe less medication if they spent more time with patients". Beliefs of harm about medications and concerns about antihypertensive drugs were higher in the low adherence group (p, 0.01). Those who scored higher on ideas of harm were 52% less likely of being high adherents (PR 0.48; 95% CI 0.25-0.93) and those with higher scores on concerns were 41% less likely of being high adherents (PR 0.59; 95% CI 0.39-0.91). Patients whose ideas of necessity outweighed their concerns were more likely to be adherent (PR 2.65; 95% CI 1.21-5.81). Conclusions: Low adherence to antihypertensive medication is common. High scores on ideas of harm, concern and a high necessity-concern differential were predictors of medication adherence.	[Fernandez-Arias, Marta; Acuna-Villaorduna, Ana; Miranda, J. Jaime; Diez-Canseco, Francisco; Malaga, German] Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru; [Fernandez-Arias, Marta] Global Hlth Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Acuna-Villaorduna, Ana; Malaga, German] Univ Peruana Cayetano Heredia, Unidad Conocimiento & Evidencia, Lima, Peru; [Miranda, J. Jaime; Malaga, German] Univ Peruana Cayetano Heredia, Fac Med Alberto Hurtado, Lima, Peru; [Malaga, German] Hosp Nacl Cayetano Heredia, Serv Med Interna, Lima, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia	Acuna-Villaorduna, A (corresponding author), Univ Peruana Cayetano Heredia, CRONICAS Ctr Excellence Chron Dis, Lima, Peru.	ana.acuna.vi@gmail.com		Malaga, German/0000-0002-7828-300X; Diez-Canseco, Francisco/0000-0002-7611-8190; Miranda, J. Jaime/0000-0002-4738-5468	CRONICAS Center of Excellence in Chronic Diseases at Universidad Peruana Cayetano Heredia; United States National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services [HHSN268200900033C]	CRONICAS Center of Excellence in Chronic Diseases at Universidad Peruana Cayetano Heredia; United States National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services	The authors did not receive any external funding for this work. Please note that authors JJM and FDC received funding in the form of salaries from the CRONICAS Center of Excellence in Chronic Diseases at Universidad Peruana Cayetano Heredia, which is supported with Federal funds from the United States National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services under Contract No. HHSN268200900033C.	Buendia JA, 2012, BIOMEDICA, V32, P578, DOI [10.7705/biomedica.v32i4.421, 10.1590/S0120-41572012000400013]; Arana Morales G, 2001, REV MED HERED, V12, P120; Belendez-Vazquez M, 2007, INT J CLIN HLTH PSYC, V7, P767; Bravo Paulina, 2013, Rev. perú. med. exp. salud publica, V30, P691; Carhuallanqui Rolando, 2010, Rev Med Hered, V21, P197; Davies Alisha R, 2008, BMC Res Notes, V1, P2, DOI 10.1186/1756-0500-1-2; Del Aguila-Diaz J, 1994, REV MED IPSS, V3, P23; Haynes RB, 2002, JAMA-J AM MED ASSOC, V288, P2880, DOI 10.1001/jama.288.22.2880; Horne R, 1999, J PSYCHOSOM RES, V47, P555, DOI 10.1016/S0022-3999(99)00057-4; Horne R, 1999, J PSYCHOSOM RES, V47, P491, DOI 10.1016/S0022-3999(99)00058-6; Horne R, 1999, PSYCHOL HEALTH, V14, P1, DOI 10.1080/08870449908407311; Instituto Nacional de Salud del Peru, 2010, CARG ENF LES PER; Carlos Alberto Isaza, 2004, Biomed., V24, P273; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Law M, 2003, Health Technol Assess, V7, P1; Ledur PS, 2013, J AM SOC HYPERTENS, V7, P477, DOI 10.1016/j.jash.2013.07.006; Lerner Alana G, 2013, Crit Pathw Cardiol, V12, P53, DOI 10.1097/HPC.0b013e318285ef60; Matsumura K, 2013, QJM-INT J MED, V106, P909, DOI 10.1093/qjmed/hct121; Medina-Lezama J, 2007, J AM SOC HYPERTENS, V1, P216, DOI 10.1016/j.jash.2007.02.003; Morisky DE, 2008, J CLIN HYPERTENS, V10, P348, DOI 10.1111/j.1751-7176.2008.07572.x; Natarajan N, 2013, CAN FAM PHYSICIAN, V59, pE93; Perel P, 2006, PLOS MED, V3, P1448, DOI 10.1371/journal.pmed.0030344; Rajpura J, 2014, J MANAGE CARE PHARM, V20, P58, DOI 10.18553/jmcp.2014.20.1.58; Ruppar TM, 2012, GERIATR NURS, V33, P89, DOI 10.1016/j.gerinurse.2012.01.006; Shin S, 2013, HYPERTENS RES, V36, P1000, DOI 10.1038/hr.2013.85; Stiggelbout AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e256; Val Jimenez A, 1992, Aten Primaria, V10, P767; Wong MCS, 2013, INT J CARDIOL, V167, P1438, DOI 10.1016/j.ijcard.2012.04.060; World Health Organisation, 2013, ADHERENCE LONG TERM; World Health Organization, 2008, GLOB HLTH OBS BLOOD; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487	31	21	23	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e112875	10.1371/journal.pone.0112875	http://dx.doi.org/10.1371/journal.pone.0112875			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7WS	25470372	Green Submitted, gold, Green Published			2022-12-26	WOS:000349128700012
J	Tranquilli, S; Abedi-Lartey, M; Abernethy, K; Amsini, F; Asamoah, A; Balangtaa, C; Blake, S; Bouanga, E; Breuer, T; Brncic, TM; Campbell, G; Chancellor, R; Chapman, CA; Davenport, TRB; Dunn, A; Dupain, J; Ekobo, A; Eno-Nku, M; Etoga, G; Furuichi, T; Gatti, S; Ghiurghi, A; Hashimoto, C; Hart, JA; Head, J; Hega, M; Herbinger, I; Hicks, TC; Holbech, LH; Huijbregts, B; Kuhl, HS; Imong, I; Yeno, SLD; Linder, J; Marshall, P; Lero, PM; Morgan, D; Mubalama, L; N'Goran, PK; Nicholas, A; Nixon, S; Normand, E; Nziguyimpa, L; Nzooh-Dongmo, Z; Ofori-Amanfo, R; Ogunjemite, BG; Petre, CA; Rainey, HJ; Regnaut, S; Robinson, O; Rundus, A; Sanz, CM; Okon, DT; Todd, A; Warren, Y; Sommer, V				Tranquilli, Sandra; Abedi-Lartey, Michael; Abernethy, Katharine; Amsini, Fidele; Asamoah, Augustus; Balangtaa, Cletus; Blake, Stephen; Bouanga, Estelle; Breuer, Thomas; Brncic, Terry M.; Campbell, Genevieve; Chancellor, Rebecca; Chapman, Colin A.; Davenport, Tim R. B.; Dunn, Andrew; Dupain, Jef; Ekobo, Atanga; Eno-Nku, Manasseh; Etoga, Gilles; Furuichi, Takeshi; Gatti, Sylvain; Ghiurghi, Andrea; Hashimoto, Chie; Hart, John A.; Head, Josephine; Hega, Martin; Herbinger, Ilka; Hicks, Thurston C.; Holbech, Lars H.; Huijbregts, Bas; Kuhl, Hjalmar S.; Imong, Inaoyom; Yeno, Stephane Le-Duc; Linder, Joshua; Marshall, Phil; Lero, Peter Minasoma; Morgan, David; Mubalama, Leonard; N'Goran, Paul K.; Nicholas, Aaron; Nixon, Stuart; Normand, Emmanuelle; Nziguyimpa, Leonidas; Nzooh-Dongmo, Zacharie; Ofori-Amanfo, Richard; Ogunjemite, Babafemi G.; Petre, Charles-Albert; Rainey, Hugo J.; Regnaut, Sebastien; Robinson, Orume; Rundus, Aaron; Sanz, Crickette M.; Okon, David Tiku; Todd, Angelique; Warren, Ymke; Sommer, Volker			Protected Areas in Tropical Africa: Assessing Threats and Conservation Activities	PLOS ONE			English	Article							MAMMAL POPULATION DECLINES; MODEL SELECTION; CONGO BASIN; WEST; FORESTS; BUSHMEAT; EXTINCTION; BIODIVERSITY; ENFORCEMENT; MANAGEMENT	Numerous protected areas (PAs) have been created in Africa to safeguard wildlife and other natural resources. However, significant threats from anthropogenic activities and decline of wildlife populations persist, while conservation efforts in most PAs are still minimal. We assessed the impact level of the most common threats to wildlife within PAs in tropical Africa and the relationship of conservation activities with threat impact level. We collated data on 98 PAs with tropical forest cover from 15 countries across West, Central and East Africa. For this, we assembled information about local threats as well as conservation activities from published and unpublished literature, and questionnaires sent to long-term field workers. We constructed general linear models to test the significance of specific conservation activities in relation to the threat impact level. Subsistence and commercial hunting were identified as the most common direct threats to wildlife and found to be most prevalent in West and Central Africa. Agriculture and logging represented the most common indirect threats, and were most prevalent in West Africa. We found that the long-term presence of conservation activities (such as law enforcement, research and tourism) was associated with lower threat impact levels. Our results highlight deficiencies in the management effectiveness of several PAs across tropical Africa, and conclude that PA management should invest more into conservation activities with long-term duration.	[Tranquilli, Sandra; Sommer, Volker] UCL, Dept Biol Anthropol, London, England; [Abedi-Lartey, Michael] Max Planck Inst Ornithol, Dept Migrat & Immuno Ecol, Radolfzell am Bodensee, Germany; [Abedi-Lartey, Michael] Univ Konstanz, Dept Biol, Constance, Germany; [Abernethy, Katharine] Univ Stirling, Sch Nat Sci, African Forest Ecol Grp, Stirling FK9 4LA, Scotland; [Abernethy, Katharine] IRET, Libreville, Gabon; [Amsini, Fidele] Frankfurt Zool Soc, Tshopo, DEM REP CONGO; [Asamoah, Augustus] Ghana Cocoa Board, Environm Sustainabil Project, United Nations Dev Programme, Adabraka, Accra, Ghana; [Balangtaa, Cletus] Ankasa Conservat Area, Wildlife Div Forestry Commiss Ghana, Elubo, Takoradi, Ghana; [Blake, Stephen; Chapman, Colin A.; Rainey, Hugo J.] Wildlife Conservat Soc, New York, NY USA; [Blake, Stephen] Univ Missouri, Whitney Harris World Ecol Ctr, St Louis, MO 63121 USA; [Bouanga, Estelle] Minist Foret Environm & Protect Ressources Nat, Libreville, Gabon; [Breuer, Thomas] Wildlife Conservat Soc, Congo Program, Brazzaville, Rep Congo; [Brncic, Terry M.] Tacugama Chimpanzee Sanctuary, Freetown, Sierra Leone; [Campbell, Genevieve] Independent Researcher, Montreal, PQ, Canada; [Chancellor, Rebecca] W Chester Univ, Dept Anthropol & Sociol & Psychol, W Chester, PA 19380 USA; [Chapman, Colin A.] McGill Univ, Dept Anthropol, Montreal, PQ, Canada; [Chapman, Colin A.] McGill Univ, McGill Sch Environm, Montreal, PQ, Canada; [Davenport, Tim R. B.] Wildlife Conservat Soc, Tanzania Program, Zanzibar, Tanzania; [Dunn, Andrew; Imong, Inaoyom] Wildlife Conservat Soc, Calabar, Nigeria; [Dupain, Jef] African Wildlife Fdn, Nairobi, Kenya; [Ekobo, Atanga] World Wide Fund Nat, Limbe, Cameroon; [Eno-Nku, Manasseh] World Wide Fund Nat, Mt Cameroon NP, Limbe, Cameroon; [Etoga, Gilles; Nzooh-Dongmo, Zacharie] World Wide Fund Nat CARPO, Jengi Tridom, Yaunde, Cameroon; [Furuichi, Takeshi; Hashimoto, Chie] Kyoto Univ, Primate Res Inst, Kyoto, Japan; [Furuichi, Takeshi; Hashimoto, Chie] Support Conservat Bonobos, Luo Reserve, DEM REP CONGO; [Gatti, Sylvain] West African Primate Conservat Act, Accra, Ghana; [Ghiurghi, Andrea] Independent Researcher, Rome, Italy; [Hart, John A.] Lukuru Wildlife Res Fdn, Kinshasa, DEM REP CONGO; [Head, Josephine; Hicks, Thurston C.; Kuhl, Hjalmar S.; Imong, Inaoyom] Max Planck Inst Evolutionary Anthropol, Dept Primatol, Leipzig, Germany; [Hega, Martin] Wildlife Conservat Soc, Monts Cristal, Gabon; [Herbinger, Ilka] World Wide Fund Nat, Berlin, Germany; [Hicks, Thurston C.] Univ Amsterdam, Inst Biodivers & Ecosyst Dynam, Amsterdam, Netherlands; [Holbech, Lars H.] Univ Ghana, Dept Anim Biol & Conservat Sci, Legon, Ghana; [Huijbregts, Bas] Cent Africa Reg Programme Off, World Wide Fund Nat, Yaounde, Cameroon; [Kuhl, Hjalmar S.] German Ctr Integrat Biodivers Res iDiv, Leipzig, Germany; [Yeno, Stephane Le-Duc] World Wide Fund Nat, Gamba, Libreville, Gabon; [Linder, Joshua] James Madison Univ, Dept Sociol & Anthropol, Harrisonburg, VA 22807 USA; [Marshall, Phil] North Eastern Parks Programme, Windhoek, Namibia; [Lero, Peter Minasoma] Minist Interior & Wildlife Conservat, Directorate Wildlife Serv, Juba, Sudan; [Morgan, David] Lester E Fisher Ctr Great Ape Res, Chicago, IL USA; [Mubalama, Leonard] World Wide Fund Nat, Itombwe Conservat Programme, Bukavu, South Kivu Prov, DEM REP CONGO; [N'Goran, Paul K.] Ctr Suisse Recherches Scientif Cote Ivoire, Abidjan, Cote Ivoire; [Nicholas, Aaron] Wildlife Conservat Soc, Ruaha Katavi Landscape, Tanzania; [Nixon, Stuart] Zool Soc London, London, England; [Normand, Emmanuelle] Wild Chimpanzee Fdn, Abidjan, Cote Ivoire; [Nziguyimpa, Leonidas] Inst Natl Environm & Conservat Nat, Bururi, Burundi; [Ofori-Amanfo, Richard] Bia Conservat Area, Sefwi Wiawso, Ghana; [Ogunjemite, Babafemi G.] Fed Univ Technol Akure, Dept Ecotourism & Wildlife Management, Akure, Nigeria; [Petre, Charles-Albert] Univ Liege, Gembloux Agro Bio Tech, Unit Forest & Nat Management, Lab Trop & Subtrop Forestry, Gembloux, Belgium; [Petre, Charles-Albert] Royal Belgian Inst Nat Sci, Conservat Biol Unit, Brussels, Belgium; [Regnaut, Sebastien] West & Cent Afr, Protected Areas Program, Int Union Conservat Nat, Ouagadougou, Burkina Faso; [Robinson, Orume] Minist Forestry & Wildlife, Ndian, Cameroon; [Rundus, Aaron] W Chester Univ, Dept Psychol, W Chester, PA 19380 USA; [Sanz, Crickette M.] Washington Univ, Dept Anthropol, St Louis, MO 63130 USA; [Okon, David Tiku] World Wide Fund Nat, Limbe, Cameroon; [Todd, Angelique] World Wide Fund Nat, Bangui, Cent Afr Republ; [Warren, Ymke] Wildlife Conservat Soc, Limbe, Cameroon	University of London; University College London; Max Planck Society; University of Konstanz; University of Stirling; Wildlife Conservation Society; University of Missouri System; University of Missouri Saint Louis; Pennsylvania State System of Higher Education (PASSHE); West Chester University of Pennsylvania; McGill University; McGill University; World Wildlife Fund; World Wildlife Fund; Kyoto University; Max Planck Society; University of Amsterdam; University of Ghana; World Wildlife Fund; World Wildlife Fund; James Madison University; World Wildlife Fund; Zoological Society of London; University of Liege; Royal Belgian Institute of Natural Sciences; Pennsylvania State System of Higher Education (PASSHE); West Chester University of Pennsylvania; Washington University (WUSTL); World Wildlife Fund; World Wildlife Fund	Tranquilli, S (corresponding author), UCL, Dept Biol Anthropol, London, England.	sandra.tranq@gmail.com	Chapman, Colin/S-1911-2019; Todd, Angelique/AAR-3087-2021; Regnaut, Sebastien/B-2433-2012; Ogunjemite, Babafemi/P-8321-2019; Hicks, Thurston/AAP-4835-2021; Holbech, Lars Haubye/W-2281-2019	Chapman, Colin/0000-0002-8827-8140; Ogunjemite, Babafemi/0000-0001-7220-2427; Morgan, Dorcas/0000-0003-0596-0572; Haubye Holbech, Lars/0000-0002-9975-7825; Abernethy, Katharine/0000-0002-0393-9342; Todd, Angelique/0000-0002-9207-4925				Abernethy KA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0303; [Anonymous], 2010, R LANG ENV STAT COMP; Baayen R. H., 2008, ANAL LINGUISTIC DATA; Barnes RFW, 2002, ORYX, V36, P236, DOI 10.1017/S0030605302000443; Bates D. M., 2010, LME4 MIXED EFFECTS M; Beier P, 2002, CONSERV BIOL, V16, P1097, DOI 10.1046/j.1523-1739.2002.01003.x; Bi SG, 2012, FOLIA PRIMATOL, V83, P11, DOI 10.1159/000338752; Blom A, 2004, BIODIVERS CONSERV, V13, P2661, DOI 10.1007/s10531-004-2138-1; Blom A, 2004, AFR J ECOL, V42, P23, DOI 10.1111/j.0141-6707.2004.00441.x; Brashares JS, 2004, SCIENCE, V306, P1180, DOI 10.1126/science.1102425; Brashares JS, 2001, P ROY SOC B-BIOL SCI, V268, P2473, DOI 10.1098/rspb.2001.1815; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Buckland ST, 1997, BIOMETRICS, V53, P603, DOI 10.2307/2533961; Campbell G, 2011, BIOL LETTERS, V7, P723, DOI 10.1098/rsbl.2011.0155; Campbell G, 2008, CURR BIOL, V18, pR903, DOI 10.1016/j.cub.2008.08.015; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Chape S., 2009, BIOSCIENCE, V59, P623; Coad L, 2013, PARKS, V19, P1, DOI DOI 10.2305/IUCN.CH; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; Davenport L, 2002, MAKING PARKS WORK: STRATEGIES FOR PRESERVING TROPICAL NATURE, P279; de Merode E, 2004, BIOL CONSERV, V118, P573, DOI 10.1016/j.biocon.2003.10.005; de Merode E, 2007, PACHYDERM, P52; Di Marco M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0198; Dirzo R, 2003, ANNU REV ENV RESOUR, V28, P137, DOI 10.1146/annurev.energy.28.050302.105532; Fa JE, 2009, MAMMAL REV, V39, P231, DOI 10.1111/j.1365-2907.2009.00149.x; Geldmann J, 2013, BIOL CONSERV, V161, P230, DOI 10.1016/j.biocon.2013.02.018; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Greengrass EJ, 2009, PRIMATE CONSERVATION, V24, P1; Henschel P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083500; Hilborn R, 2006, SCIENCE, V314, P1266, DOI 10.1126/science.1132780; Hockings M, 2003, BIOSCIENCE, V53, P823, DOI 10.1641/0006-3568(2003)053[0823:SFATEO]2.0.CO;2; Hodgkinson C, 2009, THESIS; Holbech LH, 2005, BIRD CONSERV INT, V15, P27, DOI 10.1017/S0959270905000031; Isaac NJB, 2004, P ROY SOC B-BIOL SCI, V271, P1135, DOI 10.1098/rspb.2004.2724; IUCN, 2013, IUCN RED LIST THREAT; Jachmann H, 2008, BIOL CONSERV, V141, P1906, DOI 10.1016/j.biocon.2008.05.009; Jachmann H, 2008, BIOL CONSERV, V141, P89, DOI 10.1016/j.biocon.2007.09.012; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Johnson JB, 2004, TRENDS ECOL EVOL, V19, P101, DOI 10.1016/j.tree.2003.10.013; JUSTE J, 1995, J APPL ECOL, V32, P454, DOI 10.2307/2404644; Keane A, 2008, ANIM CONSERV, V11, P75, DOI 10.1111/j.1469-1795.2008.00170.x; Kuehl HS, 2009, BIOL CONSERV, V142, P1500, DOI 10.1016/j.biocon.2009.02.032; Laurance WF, 1999, BIOL CONSERV, V91, P109, DOI 10.1016/S0006-3207(99)00088-9; LAURANCE WF, 2006, EMERGING THREATS TRO; Laurance WF, 2013, TRENDS ECOL EVOL, V28, P261, DOI 10.1016/j.tree.2013.01.017; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; LEADERWILLIAMS N, 1988, NATURE, V336, P533, DOI 10.1038/336533a0; Leverington F, 2010, MANAGEMENT EFFECTIVE; Maiorano L, 2008, P ROY SOC B-BIOL SCI, V275, P1297, DOI 10.1098/rspb.2007.1756; Malhi Y, 2013, PHILOS T R SOC B, V368, DOI [10.1098/rstb.2012.0293, 10.1098/rstb.2012.0312]; Mubalama L, 2010, THESIS; N'Goran PK, 2012, CONSERV BIOL, V0, P1; Nasi R, 2011, INT FOREST REV, V13, P355, DOI 10.1505/146554811798293872; Newmark WD, 2008, FRONT ECOL ENVIRON, V6, P321, DOI 10.1890/070003; Norris K, 2010, BIOL CONSERV, V143, P2341, DOI 10.1016/j.biocon.2009.12.032; Oates J. F., 1999, MYTH REALITY RAIN FO; Oates JF, 2000, CONSERV BIOL, V14, P1526, DOI 10.1046/j.1523-1739.2000.99230.x; Plumptre A. J., 2001, IMPACT CIVIL WAR CON; REDFORD KH, 1992, BIOSCIENCE, V42, P412, DOI 10.2307/1311860; Remis MJ, 2011, AFR J ECOL, V49, P70, DOI 10.1111/j.1365-2028.2010.01229.x; Scholte P, 2011, TROP CONSERV SCI, V4, P1, DOI 10.1177/194008291100400102; Sinclair A.R.E., 1995, SERENGETI; Sodhi NS., 2007, TROPICAL CONSERVATIO; Sommer V, 2011, DEV PRIMATOL-PROG PR, P1, DOI 10.1007/978-1-4419-7403-7_1; Stoner KE, 2007, BIOTROPICA, V39, P385, DOI 10.1111/j.1744-7429.2007.00291.x; Sutherland WJ, 2009, CONSERV BIOL, V23, P557, DOI 10.1111/j.1523-1739.2009.01212.x; Symonds MRE, 2011, BEHAV ECOL SOCIOBIOL, V65, P13, DOI 10.1007/s00265-010-1037-6; Terborgh J., 2002, Seed dispersal and frugivory: ecology, evolution and conservation. Third International Symposium-Workshop on Frugivores and Seed Dispersal, Sao Pedro, Brazil, 6-11 August 2000, P1, DOI 10.1079/9780851995250.0001; Terborgh J., 2010, TROPHIC CASCADES PRE; Thiollay JM, 2007, ORYX, V41, P322, DOI 10.1017/S0030605307000809; Tranquilli S, 2012, CONSERV LETT, V5, P48, DOI 10.1111/j.1755-263X.2011.00211.x; Venables WN., 2002, MODERN APPL STAT S 4; Wilkie DS, 2011, ANN NY ACAD SCI, V1223, P120, DOI 10.1111/j.1749-6632.2010.05908.x; Wilkie DS, 2001, BIODIVERS CONSERV, V10, P691, DOI 10.1023/A:1016662027017; Wittemyer G, 2008, SCIENCE, V321, P123, DOI 10.1126/science.1158900; Wright SJ, 2007, BIOTROPICA, V39, P289, DOI 10.1111/j.1744-7429.2007.00293.x; Zar JH, 1999, BIOSTATISTICAL ANAL; Zimmerman BL, 2012, BIOSCIENCE, V62, P479, DOI 10.1525/bio.2012.62.5.9	78	71	72	4	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114154	10.1371/journal.pone.0114154	http://dx.doi.org/10.1371/journal.pone.0114154			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469888	Green Published, Green Submitted, gold			2022-12-26	WOS:000349128700078
J	Frank, CL; Michalski, A; McDonough, AA; Rahimian, M; Rudd, RJ; Herzog, C				Frank, Craig L.; Michalski, Andrew; McDonough, Anne A.; Rahimian, Marjon; Rudd, Robert J.; Herzog, Carl			The Resistance of a North American Bat Species (Eptesicus fuscus) to White-Nose Syndrome (WNS)	PLOS ONE			English	Article							HIBERNATION; PATHOGEN	White-nose Syndrome (WNS) is the primary cause of over-winter mortality for little brown (Myotis lucifugus), northern (Myotis septentrionalis), and tricolored (Perimyotis subflavus) bats, and is due to cutaneous infection with the fungus Pseudogymnoascus (Geomyces) destructans (Pd). Cutaneous infection with P. destructans disrupts torpor patterns, which is thought to lead to a premature depletion of body fat reserve. Field studies were conducted at 3 WNS-affected hibernation sites to determine if big brown bats (Eptesicus fuscus) are resistant to Pd. Radio telemetry studies were conducted during 2 winters to determine the torpor patterns of 23 free-ranging E. fuscus hibernating at a site where Pd occurs. The body fat contents of free-ranging E. fuscus and M. lucifugus during hibernation at 2 different WNS-affected sites were also determined. The numbers of bats hibernating at the same site was determined during both: a) 4-7 years prior to the arrival of Pd, and, b) 2-3 years after it first appeared at this site. The torpor bouts of big brown bats hibernating at a WNS-affected site were not significantly different in length from those previously reported for this species. The mean body fat content of E. fuscus in February was nearly twice that of M. lucifugus hibernating at the same WNS-affected sites during this month. The number of M. lucifugus hibernating at one site decreased by 99.6% after P. destructans first appeared, whereas the number of E. fuscus hibernating there actually increased by 43% during the same period. None of the E. fuscus collected during this study had any visible fungal growth or lesions on their skin, whereas virtually all the M. lucifugus collected had visible fungal growth on their wings, muzzle, and ears. These findings indicate that big brown bats are resistant to WNS.	[Frank, Craig L.; McDonough, Anne A.; Rahimian, Marjon] Fordham Univ, Louis Calder Ctr, Dept Biol Sci, Armonk, NY 10504 USA; [Michalski, Andrew] Fordham Univ, Environm Sci Program, Bronx, NY 10458 USA; [Rudd, Robert J.] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA; [Herzog, Carl] New York State Dept Environm Conservat, Albany, NY 12233 USA	Fordham University; Fordham University; State University of New York (SUNY) System; Wadsworth Center	Frank, CL (corresponding author), Fordham Univ, Louis Calder Ctr, Dept Biol Sci, POB 887, Armonk, NY 10504 USA.	frank@fordham.edu	Frank, Craig/AFQ-3761-2022	Frank, Craig/0000-0002-4340-4422	National Science Foundation (NSF) [IOS-0818222]; Fordham University	National Science Foundation (NSF)(National Science Foundation (NSF)); Fordham University	This study was supported by National Science Foundation (NSF) grant IOS-0818222 awarded to C.L.F. (www.nsf.gov) and a Fordham University Summer Science Internship awarded to M.R. (www.fordham.edu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES BM, 1989, SCIENCE, V244, P1593, DOI 10.1126/science.2740905; Blanton JD, 2009, JAVMA-J AM VET MED A, V235, P676, DOI 10.2460/javma.235.6.676; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; BRACK V, 1985, CAN J ZOOL, V63, P2952, DOI 10.1139/z85-442; Chaturvedi V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010783; Cryan PM, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-47; Cryan PM, 2013, J WILDLIFE DIS, V49, P398, DOI 10.7589/2012-04-121; Dark J, 2005, ANNU REV NUTR, V25, P469, DOI 10.1146/annurev.nutr.25.050304.092514; DOBUSH GR, 1985, CAN J ZOOL, V63, P1917, DOI 10.1139/z85-285; Dunbar MB, 2010, J COMP PHYSIOL B, V180, P885, DOI 10.1007/s00360-010-0457-y; Feldhamer GA, 2007, MAMMALOGY ADAPTATION, P643; Frank Craig L., 2012, P271; Gargas A, 2009, MYCOTAXON, V108, P147, DOI 10.5248/108.147; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Gunstone F.D., 1996, FATTY ACID LIPID CHE; Hood WR, 2006, J COMP PHYSIOL B, V176, P807, DOI 10.1007/s00360-006-0102-y; Karpovich SA, 2009, J COMP PHYSIOL B, V179, P691, DOI 10.1007/s00360-009-0350-8; Kayser C, 1965, PHYSL MAMMALOGY, P180; Kunz TH, 1998, ECOSCIENCE, V5, P8, DOI 10.1080/11956860.1998.11682443; Lorch JM, 2011, NATURE, P10590; Mondul A, 2003, J AM VET MED ASSOC, V222, P633, DOI 10.2460/javma.2003.222.633; Moosman PR, 2013, NORTHEAST NAT, V20, P552, DOI 10.1656/045.020.0405; Pond C.M., 1998, FATS LIFE; Puechmaille SJ, 2010, EMERG INFECT DIS, V16, P290, DOI 10.3201/eid1602.091391; Reeder DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038920; Reynolds DS, 2000, ECOSCIENCE, V7, P10; Thomas DW, 1997, FUNCT ECOL, V11, P585, DOI 10.1046/j.1365-2435.1997.00129.x; Turner GG, 2014, J WILDLIFE DIS, V50, P566, DOI 10.7589/2014-03-058; Turner Gregory G., 2011, Bat Research News, V52, P13; Warnecke L, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0177; Warnecke L, 2012, P NATL ACAD SCI USA, V109, P6999, DOI 10.1073/pnas.1200374109; Wibbelt G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074105; Wibbelt G, 2010, EMERG INFECT DIS, V16, P1237, DOI 10.3201/eid1608.100002; Wilcox A, 2014, ANIM BEHAV, V88, P157, DOI 10.1016/j.anbehav.2013.11.026; Willis CKR, 2003, J COMP PHYSIOL B, V173, P379, DOI 10.1007/s00360-003-0343-y	35	40	42	2	124	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113958	10.1371/journal.pone.0113958	http://dx.doi.org/10.1371/journal.pone.0113958			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437448	gold, Green Submitted, Green Published			2022-12-26	WOS:000347114900103
J	Kim, YP; Park, D; Kim, JJ; Choi, WJ; Lee, SH; Lee, SY; Kim, S; Chung, JM; Jeon, J; Lee, BD; Shin, JH; Lee, YI; Cho, H; Lee, JM; Kang, HC				Kim, Young Pil; Park, Dongsun; Kim, Jae Jin; Choi, Won-Jae; Lee, Sun Hee; Lee, Seo Yun; Kim, Soyeon; Chung, Jee Min; Jeon, Jinseon; Lee, Byoung Dae; Shin, Joo-Ho; Lee, Yun-Il; Cho, Hyeseong; Lee, Jeong-Min; Kang, Ho Chul			Effective Therapeutic Approach for Head and Neck Cancer by an Engineered Minibody Targeting the EGFR Receptor	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; SINGLE-CHAIN FV; ANTIBODY FRAGMENT; ESCHERICHIA-COLI; STABILITY; CETUXIMAB; ANTAGONISTS; INHIBITION; CONSTRUCTS; EXPRESSION	Cetuximab, a chimeric monoclonal antibody developed for targeting the Epidermal Growth Factor Receptor (EGFR), has been intensively used to treat cancer patients with metastatic colorectal cancer and head and neck cancer. Intact immunoglobulin G (IgG) antibody like cetuximab, however, has some limitations such as high production cost and low penetration rate from vasculature into solid tumor mass due to its large size. In attempt to overcome these limitations, we engineered cetuximab to create single chain variable fragments (scFv-CH3; Minibody) that were expressed in bacterial system. Among three engineered minibodies, we found that MI061 minibody, which is composed of the variable heavy (V-H) and light (V-L) region joined by an 18-residue peptide linker, displays higher solubility and better extraction properties from bacterial lysate. In addition, we validated that purified MI061 significantly interferes ligand binding to EGFR and blocks EGFR's phosphorylation. By using a protein microarray composed of 16,368 unique human proteins covering around 2,400 plasma membrane associated proteins such as receptors and channels, we also demonstrated that MI061 only recognizes the EGFR but not other proteins as compared with cetuximab. These results indicated that engineered MI061 retains both binding specificity and affinity of cetuximab for EGFR. Although it had relatively short half-life in serum, it was shown to be highly significant anti-tumor effect by inhibiting ERK pathway in A431 xenograft model. Taken together, our present study provides compelling evidence that engineered minibody is more effective and promising agent for in vivo targeting of solid tumors.	[Kim, Young Pil; Choi, Won-Jae; Lee, Sun Hee; Lee, Jeong-Min] Sinil Pharmaceut Co, Life Sci RD Ctr, Dept Bioengn, Songnam, South Korea; [Park, Dongsun; Kim, Jae Jin; Lee, Seo Yun; Kim, Soyeon; Chung, Jee Min; Jeon, Jinseon; Kang, Ho Chul] Ajou Univ, Sch Med, Dept Physiol, Suwon 441749, South Korea; [Kim, Jae Jin; Lee, Seo Yun; Kim, Soyeon; Chung, Jee Min; Cho, Hyeseong; Kang, Ho Chul] Ajou Univ, Dept Biomed Sci, Grad Sch, Suwon 441749, South Korea; [Lee, Byoung Dae] Kyung Hee Univ, Sch Med, Dept Neurosci, Seoul, South Korea; [Shin, Joo-Ho] Sungkyunkwan Univ, Div Pharmacol, Dept Mol Cell Biol, Samsung Biomed Res Inst,Sch Med, Suwon, South Korea; [Lee, Yun-Il] Samsung Adv Inst Technol SAIT, Well Aging Res Ctr, Suwon, South Korea; [Cho, Hyeseong] Ajou Univ, Dept Biochem, Sch Med, Suwon 441749, South Korea	Ajou University; Ajou University; Kyung Hee University; Sungkyunkwan University (SKKU); Samsung; Ajou University	Cho, H (corresponding author), Ajou Univ, Dept Biomed Sci, Grad Sch, Suwon 441749, South Korea.	hscho@ajou.ac.kr; jmlee777@hanafos.com; hckang@ajou.ac.kr	Shin, Joo-Ho/P-1417-2018	Cho, Hyeseong/0000-0002-4672-8887; Chung, Jee Min/0000-0003-1725-0770	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [2011-0030043, 2012-R1A1A1013558]; National R&D program for Cancer Control, Ministry for Health and Welfare, Korea [131280]; Samsung Advanced Institute of Technology (SAIT)	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; National R&D program for Cancer Control, Ministry for Health and Welfare, Korea; Samsung Advanced Institute of Technology (SAIT)	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (No. 2011-0030043 & 2012-R1A1A1013558). This work was also supported in part by a grant from the National R&D program for Cancer Control, Ministry for Health and Welfare, Korea (131280). Sinil Pharmaceutical Company provided support in the form of salaries for authors YPK, SHL, WC, and JL. YL also received salary from Samsung Advanced Institute of Technology (SAIT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arteaga CL, 2002, SEMIN ONCOL, V29, P3, DOI 10.1053/sonc.2002.35642; Asano R, 2013, FEBS J, V280, P4816, DOI 10.1111/febs.12451; AYALA M, 1995, BIOTECHNIQUES, V18, P832; Beckman RA, 2007, CANCER-AM CANCER SOC, V109, P170, DOI 10.1002/cncr.22402; Bhopale GM, 2005, CURR SCI INDIA, V89, P614; Boerner JL, 2003, EXP CELL RES, V284, P111, DOI 10.1016/S0014-4827(02)00096-4; Bonner JA, 2006, NEW ENGL J MED, V354, P567, DOI 10.1056/NEJMoa053422; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Chames P, 2009, BRIT J PHARMACOL, V157, P220, DOI 10.1111/j.1476-5381.2009.00190.x; GILL GN, 1984, J BIOL CHEM, V259, P7755; Hu SZ, 1996, CANCER RES, V56, P3055; Hu XJ, 2005, J BIOTECHNOL, V120, P38, DOI 10.1016/j.jbiotec.2005.05.018; HUSTON JS, 1988, P NATL ACAD SCI USA, V85, P5879, DOI 10.1073/pnas.85.16.5879; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Lee YI, 2014, MOL CELL PROTEOMICS, V13, P63, DOI 10.1074/mcp.M113.032235; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; MASUI H, 1984, CANCER RES, V44, P1002; McKillop D, 2005, MOL CANCER THER, V4, P641, DOI 10.1158/1535-7163.MCT-04-0329; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Normanno N, 2006, GENE, V366, P2, DOI 10.1016/j.gene.2005.10.018; RAAG R, 1995, FASEB J, V9, P73, DOI 10.1096/fasebj.9.1.7821762; Tang Y, 1996, J BIOL CHEM, V271, P15682, DOI 10.1074/jbc.271.26.15682; Wang T, 2011, PROTEIN ENG DES SEL, V24, P649, DOI 10.1093/protein/gzr029; WHITLOW M, 1993, PROTEIN ENG, V6, P989, DOI 10.1093/protein/6.8.989; Wittel UA, 2005, NUCL MED BIOL, V32, P157, DOI 10.1016/j.nucmedbio.2004.11.003; Worn A, 1998, BIOCHEMISTRY-US, V37, P13120, DOI 10.1021/bi980712q; Worn A, 2001, J MOL BIOL, V305, P989, DOI 10.1006/jmbi.2000.4265; Wu JW, 1999, ACTA BIOCHIM POL, V46, P591, DOI 10.18388/abp.1999_4131	29	7	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113442	10.1371/journal.pone.0113442	http://dx.doi.org/10.1371/journal.pone.0113442			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438047	gold, Green Submitted, Green Published			2022-12-26	WOS:000347114900045
J	Zhou, W; Zhao, M; Wang, X; Schilling, RF; Zhou, S; Qiu, HY; Xie, NH; Liu, MQ; Dong, HS; Yao, ZZ; Cai, T				Zhou, Wang; Zhao, Min; Wang, Xia; Schilling, Robert F.; Zhou, Sheng; Qiu, Hong-Yan; Xie, Nian-Hua; Liu, Man-Qing; Dong, Han-Sheng; Yao, Zhong-Zhao; Cai, Thomas			Treatment Adherence and Health Outcomes in MSM with HIV/AIDS: Patients Enrolled in "One-Stop'' and Standard Care Clinics in Wuhan China	PLOS ONE			English	Article							HIV-INFECTED PATIENTS; ANTIRETROVIRAL THERAPY; LOW-INCOME; SEX; PREVENTION; STRATEGIES; MORTALITY; BARRIERS; MEN	Background: Conducted in Wuhan China, this study examined follow-up and health markers in HIV patients receiving care in two treatment settings. Participants, all men who have sex with men, were followed for18-24 months. Method: Patients in a "one-stop'' service (ACC; N589) vs those in standard care clinics (CDC; N5243) were compared on HIV treatment and retention in care outcomes. Results: Among patients with CD4 cell count 350 cells/mL, the proportion receiving cART did not differ across clinic groups. The ACC was favored across five other indicators: proportion receiving tests for CD4 cell count at the six-month interval (98.2% vs. 79.4%, 95% CI 13.3-24.3, p=0.000), proportion with HIV suppression for patients receiving cART for 6 months (86.5% vs. 57.1%, 95% CI 14.1-44.7, p=0.000), proportion with CD4 cell recovery for patients receiving cART for 12 months (55.8% vs. 22.2%, 95% CI 18.5-48.6, p=0.000), median time from HIV confirmation to first test for CD4 cell count (7 days, 95% CI 4-8 vs. 10 days, 95% CI 9-12, log-rank p=0.000) and median time from first CD4 cell count 350 cells/mL to cART initiation (26 days, 95% CI 16-37 vs. 41.5 days, 95% CI 35-46, log-rank p=0.031). Clinic groups did not differ on any biomedical indicator at baseline, and no baseline biomedical or demographic variables remained significant in the multivariate analysis. Nonetheless, post-hoc analyses suggest the possibility of self-selection bias. Conclusions: Study findings lend preliminary support to a one-stop patient-centered care model that may be useful across various HIV care settings.	[Zhou, Wang; Wang, Xia; Xie, Nian-Hua; Liu, Man-Qing; Yao, Zhong-Zhao] Wuhan Ctr Dis Control & Prevent, Wuhan, Hubei, Peoples R China; [Zhao, Min; Qiu, Hong-Yan; Dong, Han-Sheng] Wuhan Inst Dermatovenereol, Wuhan, Hubei, Peoples R China; [Schilling, Robert F.] Univ Calif Los Angeles, Dept Social Welf, Luskin Sch Publ Affairs, Los Angeles, CA USA; [Zhou, Sheng] Johns Hopkins Univ, Dept Epidemiol, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Cai, Thomas] AIDS Care China, Nanning, Guangxi, Peoples R China	University of California System; University of California Los Angeles; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Zhou, W (corresponding author), Wuhan Ctr Dis Control & Prevent, Wuhan, Hubei, Peoples R China.	rising-up@hotmail.com	Liu, Man-Qing/M-9598-2014	Liu, Man-Qing/0000-0002-9754-3102	Wuhan Municipal Health Bureau, China; Pangaea Global AIDS Foundation, USA [OPPGH5180]	Wuhan Municipal Health Bureau, China; Pangaea Global AIDS Foundation, USA	This study was supported by the Wuhan Municipal Health Bureau, China (to WZ) and the Pangaea Global AIDS Foundation, USA (grant number OPPGH5180 to TC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altice FL, 2001, J ACQ IMMUN DEF SYND, V28, P47, DOI 10.1097/00042560-200109010-00008; Amico K Rivet, 2008, Curr HIV/AIDS Rep, V5, P172, DOI 10.1007/s11904-008-0026-0; [Anonymous], 2011, CHINA AIDS EPIDEMIC; [Anonymous], 2012, CHINA AIDS REPORT; Bradford JB, 2007, AIDS PATIENT CARE ST, V21, pS49, DOI 10.1089/apc.2007.9987; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Dou ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022707; Gao L, 2009, SEX TRANSM INFECT, V85, P354, DOI 10.1136/sti.2008.034702; Gardner EM, 2011, CLIN INFECT DIS, V52, P793, DOI 10.1093/cid/ciq243; Higa DH, 2012, CURR HIV-AIDS REP, V9, P313, DOI 10.1007/s11904-012-0136-6; Kredo T, 2013, COCHRANE DB SYST REV, V6, DOI DOI 10.102/14651858.CD009987; Lamb MR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038443; Li XF, 2012, AIDS BEHAV, V16, P499, DOI 10.1007/s10461-012-0161-x; Lu L, 2008, NATURE, V455, P609, DOI 10.1038/455609a; Mannheimer SB, 2005, AIDS CARE, V17, P10, DOI 10.1080/09540120412331305098; Mayer KH, 2012, LANCET, V380, P378, DOI 10.1016/S0140-6736(12)60835-6; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; Ortego C, 2012, AIDS CARE, V24, P1519, DOI 10.1080/09540121.2012.672722; Podlekareva DN, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-229; Posse M, 2008, TROP MED INT HEALTH, V13, P904, DOI 10.1111/j.1365-3156.2008.02091.x; Ray M, 2010, AIDS, V24, P123, DOI 10.1097/QAD.0b013e3283324283; Robiner WN, 2005, CONTEMP CLIN TRIALS, V26, P59, DOI 10.1016/j.cct.2004.11.015; Rosen S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001056; Shah B, 2007, CLIN INFECT DIS, V44, P1235, DOI 10.1086/513429; Sterne JAC, 2009, LANCET, V373, P1352, DOI 10.1016/S0140-6736(09)60612-7; Swendeman D, 2009, AIDS CARE, V21, P1321, DOI 10.1080/09540120902803158; Tassie JM, 2011, CURR OPIN HIV AIDS, V6, P233, DOI 10.1097/COH.0b013e328347798d; Wang HH, 2008, AIDS PATIENT CARE ST, V22, P71, DOI 10.1089/apc.2007.0047; WHO UNAIDS Unicef, 2011, GLOB HIV AIDS RESP E; World Health Organization, 2012, STRAT US ANT HELP EN; Zhang FJ, 2012, HDB CHINAS NATL FREE; Zhang Y, 2012, JAIDS-J ACQ IMM DEF, V60, P59, DOI 10.1097/QAI.0b013e31824c3d9f; Zhang Y, 2011, CHINESE MED J-PEKING, V124, P1488, DOI 10.3760/cma.j.issn.0366-6999.2011.10.009; Zhao Y, 2012, CHINESE MED J-PEKING, V125, P1331, DOI 10.3760/cma.j.issn.0366-6999.2012.07.025; Zhou JL, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-361	36	5	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113736	10.1371/journal.pone.0113736	http://dx.doi.org/10.1371/journal.pone.0113736			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7SK	25438039	Green Published, gold, Green Submitted			2022-12-26	WOS:000347114900074
J	Li, AN; Xia, XC; Yeh, J; Kua, HY; Liu, HJ; Mishina, Y; Hao, AJ; Li, BJ				Li, Anna; Xia, Xuechun; Yeh, James; Kua, Huiyi; Liu, Huijuan; Mishina, Yuji; Hao, Aijun; Li, Baojie			PDGF-AA Promotes Osteogenic Differentiation and Migration of Mesenchymal Stem Cell by Down-Regulating PDGFR alpha and Derepressing BMP-Smad1/5/8 Signaling	PLOS ONE			English	Article							GROWTH-FACTOR; OSTEOBLAST DIFFERENTIATION; BONE-FORMATION; TGF-BETA; RECEPTOR-BETA; EXPRESSION; PROTEIN; PROLIFERATION; INDUCTION; CULTURES	Platelet-derived growth factors (PDGFs) play important roles in skeletal development and bone fracture healing, yet how PDGFs execute their functions remains incompletely understood. Here we show that PDGF-AA, but not -AB or -BB, could activate the BMP-Smad1/5/8 pathway in mesenchymal stem cells (MSCs), which requires BMPRIA as well as PDGFR alpha. PDGF-AA promotes MSC osteogenic differentiation through the BMP-Smad1/5/8-Runx2/Osx axis and MSC migration via the BMP-Smad1/5/8-Twist1/Atf4 axis. Mechanistic studies show that PDGF-AA activates BMP-Smad1/5/8 signaling by feedback down-regulating PDGFRa, which frees BMPRI and allows for BMPRI-BMPRII complex formation to activate smad1/5/8, using BMP molecules in the microenvironment. This study unravels a physical and functional interaction between PDGFRa and BMPRI, which plays an important role in MSC differentiation and migration, and establishes a link between PDGF-AA and BMPs pathways, two essential regulators of embryonic development and tissue homeostasis.	[Li, Anna; Hao, Aijun] Shandong Univ, Sch Med, Dept Histol & Embryol, Jinan 250012, Shandong, Peoples R China; [Li, Anna; Xia, Xuechun; Yeh, James; Liu, Huijuan; Li, Baojie] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, Bio X Inst, Shanghai 200030, Peoples R China; [Kua, Huiyi] Agcy Sci Technol & Res, Inst Mol & Cell Biol, Singapore 138632, Singapore; [Mishina, Yuji] Univ Michigan, Sch Dent, Dept Biol & Mat Sci, Ann Arbor, MI 48109 USA	Shandong University; Shanghai Jiao Tong University; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); University of Michigan System; University of Michigan	Hao, AJ (corresponding author), Shandong Univ, Sch Med, Dept Histol & Embryol, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	aijunhao@sdu.edu.cn; libj@sjtu.edu.cn			Ministry of Science and Technology of China [2012CB966901]; National Natural Science Foundation of China [81130039, 31071229, 81121001]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: The work was supported by grants from the Ministry of Science and Technology of China (The National Key Scientific Program (2012CB966901, to BL))(http://www.most.gov.cn/) and the National Natural Science Foundation of China (81130039, 31071229, and 81121001(http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Ball SG, 2012, STEM CELLS, V30, P548, DOI 10.1002/stem.1015; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Bordei P, 2011, J BONE JOINT SURG BR, V93B, P1653, DOI 10.1302/0301-620X.93B12.27244; Canalis E, 2009, J CELL BIOCHEM, V108, P769, DOI 10.1002/jcb.22322; Caplan AI, 2011, J ORTHOP RES, V29, P1795, DOI 10.1002/jor.21462; Caverzasio J, 2013, J BONE MINER RES, V28, P260, DOI 10.1002/jbmr.1748; CENTRELLA M, 1992, J CLIN INVEST, V89, P1076, DOI 10.1172/JCI115687; Chau JFL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1832; Chaudhary LR, 2004, BONE, V34, P402, DOI 10.1016/j.bone.2003.11.014; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Chen PH, 2013, BBA-PROTEINS PROTEOM, V1834, P2176, DOI 10.1016/j.bbapap.2012.10.015; Czarkowska-Paczek B, 2006, J PHYSIOL PHARMACOL, V57, P189; Darby S, 2008, J PATHOL, V214, P394, DOI 10.1002/path.2292; Donovan J, 2013, FRONT BIOSCI-LANDMRK, V18, P106, DOI 10.2741/4090; Eivers E, 2009, CYTOKINE GROWTH F R, V20, P357, DOI 10.1016/j.cytogfr.2009.10.017; Fantauzzo KA, 2014, GENE DEV, V28, P1005, DOI 10.1101/gad.238709.114; Fierro FA, 2011, STEM CELLS, V29, P1727, DOI 10.1002/stem.720; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Graham S, 2009, EXPERT OPIN INV DRUG, V18, P1633, DOI 10.1517/13543780903241607; Hoch RV, 2003, DEVELOPMENT, V130, P4769, DOI 10.1242/dev.00721; HOCK JM, 1994, ENDOCRINOLOGY, V134, P1423, DOI 10.1210/en.134.3.1423; HUANG JS, 1983, J CELL BIOL, V97, P383, DOI 10.1083/jcb.97.2.383; Huang W, 2012, ONCOGENE, V31, P4527, DOI 10.1038/onc.2011.573; Inai K, 2008, DEV BIOL, V315, P383, DOI 10.1016/j.ydbio.2007.12.028; JOLY M, 1994, SCIENCE, V263, P684, DOI 10.1126/science.8303278; Karlsson L, 2000, DEVELOPMENT, V127, P3457; Karlsson S, 2006, MOL BIOL CELL, V17, P4846, DOI 10.1091/mbc.E06-04-0306; Kua HY, 2012, NAT CELL BIOL, V14, P727, DOI 10.1038/ncb2528; Kubota K, 2002, J BONE MINER RES, V17, P257, DOI 10.1359/jbmr.2002.17.2.257; LEVEEN P, 1994, GENE DEV, V8, P1875, DOI 10.1101/gad.8.16.1875; Li Baojie, 2008, Endocrine Metabolic & Immune Disorders-Drug Targets, V8, P208, DOI 10.2174/187153008785700127; Ma G, 2012, J MOL CELL BIOL, V4, P118, DOI 10.1093/jmcb/mjs006; Malabanan KP, 2012, AM J PATHOL, V180, P2590, DOI 10.1016/j.ajpath.2012.02.009; Massague J, 2003, GENE DEV, V17, P2993, DOI 10.1101/gad.1167003; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Mishina Y, 2004, J BIOL CHEM, V279, P27560, DOI 10.1074/jbc.M404222200; O'Sullivan S, 2007, J BONE MINER RES, V22, P1679, DOI 10.1359/JBMR.070719; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Pickett EA, 2008, DEVELOPMENT, V135, P589, DOI 10.1242/dev.013763; RYDZIEL S, 1994, ENDOCRINOLOGY, V134, P2541, DOI 10.1210/en.134.6.2541; Sanchez-Fernandez MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003537; Shah P, 2012, J ORAL IMPLANTOL; Sieber C, 2009, CYTOKINE GROWTH F R, V20, P343, DOI 10.1016/j.cytogfr.2009.10.007; Soriano P, 1997, DEVELOPMENT, V124, P2691; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; Tokunaga A, 2008, J BONE MINER RES, V23, P1519, DOI 10.1359/JBMR.080409; Verheyen EM, 2007, DEV CELL, V13, P755, DOI 10.1016/j.devcel.2007.11.006; Wang XY, 2007, ENDOCRINOLOGY, V148, P1629, DOI 10.1210/en.2006-1000; Wang Y, 2004, J BIOL CHEM, V279, P8038, DOI 10.1074/jbc.M311494200; Xu C, 2005, GENE, V357, P1, DOI 10.1016/j.gene.2005.06.017; Yang DH, 2000, CYTOKINE, V12, P1271, DOI 10.1006/cyto.2000.0707; Yu XH, 1997, AM J PHYSIOL-CELL PH, V272, pC1709, DOI 10.1152/ajpcell.1997.272.5.C1709; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang JW, 2005, DEV BIOL, V284, P1, DOI 10.1016/j.ydbio.2005.05.009; Zhang YY, 2012, BIOSCI TRENDS, V6, P130, DOI 10.5582/bst.2012.v6.3.130	56	65	70	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113785	10.1371/journal.pone.0113785	http://dx.doi.org/10.1371/journal.pone.0113785			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470749	Green Published, Green Submitted, gold			2022-12-26	WOS:000349128700044
J	Merikanto, I; Lahti, T; Seitsalo, S; Kronholm, E; Laatikainen, T; Peltonen, M; Vartiainen, E; Partonen, T				Merikanto, Ilona; Lahti, Tuuli; Seitsalo, Seppo; Kronholm, Erkki; Laatikainen, Tiina; Peltonen, Markku; Vartiainen, Erkki; Partonen, Timo			Behavioral Trait of Morningness-Eveningness in Association with Articular and Spinal Diseases in a Population	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; PROSPECTIVE COHORT; DIURNAL-TYPE; SLEEP; CHRONOTYPE; DEPRESSION; ALCOHOL; RISK; PAIN; AGE	Earlier studies have revealed that the more the preference to schedule daily activities towards the evening hours is, the higher the odds for a range of health hazards are. Therefore, we wanted to analyze, whether the behavioral trait of morningness-eveningness is associated with articular and spinal diseases or those with musculoskeletal disorders. Participants (n=6089), as part of the National FINRISK 2007 Study, were derived from the general population, aged 25 to 74 years, living in Finland. Chronotype was assessed based on six items from the original Horne-Ostberg Morningness-Eveningness Questionnaire. Information about risk factors and the diagnoses of articular and spinal diseases were based on the self-reported information. Our results suggest that Evening-types have higher odds for articular and spinal diseases as compared with Morning-types, and this risk is heightened especially regarding spinal disease and backache (odds ratios of 1.8 to 2.1, and 1.6 to 1.8, respectively) and remains significant after controlling for the sex, age, education, civil status, physical activity, alcohol use, and smoking, and additionally for the body-mass index, insufficient sleep, or depressive symptoms.	[Merikanto, Ilona; Lahti, Tuuli; Partonen, Timo] Natl Inst Hlth & Welf, Dept Mental Hlth & Substance Abuse Serv, Helsinki, Finland; [Merikanto, Ilona] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Merikanto, Ilona; Seitsalo, Seppo] Orton Orthopaed Hosp, Helsinki, Finland; [Lahti, Tuuli] Univ Turku, Dept Behav Sci & Philosophy, Turku, Finland; [Kronholm, Erkki; Laatikainen, Tiina; Peltonen, Markku; Vartiainen, Erkki] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Helsinki, Finland; [Kronholm, Erkki; Laatikainen, Tiina; Peltonen, Markku; Vartiainen, Erkki] Natl Inst Hlth & Welf, Dept Chron Dis Prevent, Turku, Finland; [Laatikainen, Tiina] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Laatikainen, Tiina] Hosp Dist North Karelia, Joensuu, Finland	Finland National Institute for Health & Welfare; University of Helsinki; University of Turku; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Eastern Finland	Merikanto, I (corresponding author), Natl Inst Hlth & Welf, Dept Mental Hlth & Substance Abuse Serv, Helsinki, Finland.	ilona.merikanto@helsinki.fi	Peltonen, Markku/F-3037-2015; Partonen, Timo/G-1105-2012; merikanto, ilona/AAF-2395-2021; Laatikainen, Tiina/ABD-6622-2021	Peltonen, Markku/0000-0002-3767-4223; Partonen, Timo/0000-0003-1951-2455; Laatikainen, Tiina/0000-0002-6614-4782; lahti, tuuli/0000-0003-2311-2980; Merikanto, Ilona/0000-0002-1222-6678	Juho Vainio Foundation; Orton Orthopaedics Hospital	Juho Vainio Foundation; Orton Orthopaedics Hospital	Funding: This work was supported by a grant from Juho Vainio Foundation and funding from Orton Orthopaedics Hospital (to Ms. Merikanto). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad VC, 2008, SLEEP MED REV, V12, P211, DOI 10.1016/j.smrv.2007.09.001; ADAN A, 1994, ADDICTION, V89, P455, DOI 10.1111/j.1360-0443.1994.tb00926.x; Apold H, 2014, BMC MUSCULOSKEL DIS, V15, DOI 10.1186/1471-2474-15-217; Broms U, 2011, ADDICTION, V106, P170, DOI 10.1111/j.1360-0443.2010.03112.x; Broms U, 2012, J ADDICTION RES THER, VS2, DOI [10.4172/2155-6105.s2-002, DOI 10.4172/2155-6105.S2-002, 10.4172/2155-6105.S2-002]; Broms U, 2014, CHRONOBIOL INT, V31, P182, DOI 10.3109/07420528.2013.836534; Carrier J, 1999, CHRONOBIOL INT, V16, P79, DOI 10.3109/07420529908998714; De Cata A, 2014, EXPERT REV CLIN IMMU, V10, P687, DOI 10.1586/1744666X.2014.899904; Duffy JF, 1998, AM J PHYSIOL-REG I, V275, pR1478, DOI 10.1152/ajpregu.1998.275.5.R1478; Duffy JF, 1999, J INVEST MED, V47, P141; Duffy JF, 2001, BEHAV NEUROSCI, V115, P895, DOI 10.1037//0735-7044.115.4.895; Gamaldo CE, 2012, NEUROL CLIN, V30, P1313, DOI 10.1016/j.ncl.2012.08.007; Geenen R, 2012, BEST PRACT RES CL RH, V26, P305, DOI 10.1016/j.berh.2012.05.004; Gibbs J, 2014, NAT MED, V20, P919, DOI 10.1038/nm.3599; Gossan N, 2015, BIOGERONTOLOGY, V16, P209, DOI 10.1007/s10522-014-9522-3; Hashmi AM, 2013, J PAK MED ASSOC, V63, P899; Hatonen T, 2008, ALCOHOL ALCOHOLISM, V43, P564, DOI 10.1093/alcalc/agn057; HORNE J A, 1976, International Journal of Chronobiology, V4, P97; Hunt L, 2014, NAT REV RHEUMATOL, V10, P521, DOI 10.1038/nrrheum.2014.82; Irwin MR, 2012, SLEEP, V35, P537, DOI 10.5665/sleep.1742; Kanerva N, 2012, CHRONOBIOL INT, V29, P920, DOI 10.3109/07420528.2012.699128; Konttinen H, 2014, CHRONOBIOL INT, V31, P554, DOI 10.3109/07420528.2013.877922; Koskenvuo M, 2007, J SLEEP RES, V16, P156, DOI 10.1111/j.1365-2869.2007.00580.x; Kouri VP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054049; McBeth J, 2014, ARTHRITIS RHEUMATOL, V66, P757, DOI 10.1002/art.38284; Merikanto I, 2014, CHRONOBIOL INT, V31, P95, DOI 10.3109/07420528.2013.826672; Merikanto I, 2013, CHRONOBIOL INT, V30, P470, DOI 10.3109/07420528.2012.741171; Merikanto I, 2012, CHRONOBIOL INT, V29, P311, DOI 10.3109/07420528.2012.655870; Paine SJ, 2006, J BIOL RHYTHM, V21, P68, DOI 10.1177/0748730405283154; Rathbun AM, 2013, RHEUMATOLOGY, V52, P1785, DOI 10.1093/rheumatology/kes356; Spies CM, 2010, J RHEUMATOL, V37, P894, DOI 10.3899/jrheum.091283; Taillard J, 2001, J BIOL RHYTHM, V16, P183, DOI 10.1177/074873001129001764; Watson NF, 2013, J CLIN SLEEP MED, V9, P1333, DOI 10.5664/jcsm.3282; Wittmann M, 2006, CHRONOBIOL INT, V23, P497, DOI 10.1080/07420520500545979	34	28	28	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114635	10.1371/journal.pone.0114635	http://dx.doi.org/10.1371/journal.pone.0114635			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470493	Green Published, gold, Green Submitted			2022-12-26	WOS:000349128700125
J	Wirth, R; Bodi, N; Maroti, G; Bagyanszki, M; Talapka, P; Fekete, E; Bagi, Z; Kovacs, KL				Wirth, Roland; Bodi, Nikolett; Maroti, Gergely; Bagyanszki, Maria; Talapka, Petra; Fekete, Eva; Bagi, Zoltan; Kovacs, Kornel L.			Regionally Distinct Alterations in the Composition of the Gut Microbiota in Rats with Streptozotocin-Induced Diabetes	PLOS ONE			English	Article							MUCOSA-ASSOCIATED MICROBIOTA; GASTROINTESTINAL-TRACT; INTESTINAL MICROBIOTA; HEALTH; KLEBSIELLA; COMMUNITY; BACTERIA; COLON	The aim of this study was to map the microbiota distribution along the gut and establish whether colon/faecal samples from diabetic rats adequately reflect the diabetic alterations in the microbiome. Streptozotocin-treated rats were used to model type 1 diabetes mellitus (T1D). Segments of the duodenum, ileum and colon were dissected, and the microbiome of the lumen material was analysed by using next-generation DNA sequencing, from phylum to genus level. The intestinal luminal contents were compared between diabetic, insulin-treated diabetic and healthy control rats. No significant differences in bacterial composition were found in the luminal contents from the duodenum of the experimental animal groups, whereas distinct patterns were seen in the ileum and colon, depending on the history of the luminal samples. Ileal samples from diabetic rats exhibited particularly striking alterations, while the richness and diversity obscured some of the modifications in the colon. Characteristic rearrangements in microbiome composition and diversity were detected after insulin treatment, though the normal gut flora was not restored. The Proteobacteria displayed more pronounced shifts than those of the predominant phyla (Firmicutes and Bacteroidetes) in the rat model of T1D. Diabetes and insulin replacement affect the composition of the gut microbiota in different, gut region-specific manners. The luminal samples from the ileum appear more suitable for diagnostic purposes than the colon/faeces. The Proteobacteria should be at the focus of diagnosis and potential therapy. Klebsiella are recommended as biomarkers of T1D.	[Wirth, Roland; Bagi, Zoltan; Kovacs, Kornel L.] Univ Szeged, Dept Biotechnol, Szeged, Hungary; [Bodi, Nikolett; Bagyanszki, Maria; Talapka, Petra; Fekete, Eva] Univ Szeged, Dept Physiol Anat & Neurosci, Szeged, Hungary; [Maroti, Gergely] Hungarian Acad Sci, Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Kovacs, Kornel L.] Hungarian Acad Sci, Biol Res Ctr, Inst Biophys, H-6701 Szeged, Hungary; [Kovacs, Kornel L.] Univ Szeged, Dept Oral Biol & Expt Dent, Szeged, Hungary	Szeged University; Szeged University; Hungarian Academy of Sciences; Hungarian Biological Research Center; Hungarian Academy of Sciences; Hungarian Biological Research Center; Szeged University	Kovacs, KL (corresponding author), Univ Szeged, Dept Biotechnol, Szeged, Hungary.	kovacs.kornel@brc.mta.hu	Dr. Wirth, Roland/L-8886-2018	Dr. Wirth, Roland/0000-0002-2383-2323; Maroti, Gergely/0000-0002-3705-0461	Hungarian Scientific Research Fund, OTKA [PD 108309]; European Union; State of Hungary; European Social Fund [TAMOP 4.2.4.A/2-11-1-2012-0001]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences;  [TAMOP-4.2.2/B-10/1-2010-0012];  [GOP-1.1.1-11-2012-0128]	Hungarian Scientific Research Fund, OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); European Union(European Commission); State of Hungary; European Social Fund(European Social Fund (ESF)); Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); ; 	Funding from TAMOP-4.2.2/B-10/1-2010-0012 and GOP-1.1.1-11-2012-0128 grants is gratefully acknowledged. N.B. was supported by the Hungarian Scientific Research Fund, OTKA grant PD 108309 and by the European Union and the State of Hungary, co-financed by the European Social Fund in the framework of TAMOP 4.2.4.A/2-11-1-2012-0001 'National Excellence Program'. M.B. was supported by the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almiron M, 2013, CURR MICROBIOL, V67, P395, DOI 10.1007/s00284-013-0367-9; Atkinson MA, 2011, DIABETES, V60, P1370, DOI 10.2337/db10-1797; Bodi N, 2012, MICROCIRCULATION, V19, P316, DOI 10.1111/j.1549-8719.2012.00164.x; Boerner BP, 2011, ANN NY ACAD SCI, V1243, P103, DOI 10.1111/j.1749-6632.2011.06340.x; Brugman S, 2006, DIABETOLOGIA, V49, P2105, DOI 10.1007/s00125-006-0334-0; Bytzer P, 2001, ARCH INTERN MED, V161, P1989, DOI 10.1001/archinte.161.16.1989; Demedts I, 2013, J NEUROGASTROENTEROL, V19, P161, DOI 10.5056/jnm.2013.19.2.161; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; Giongo A, 2011, ISME J, V5, P82, DOI 10.1038/ismej.2010.92; Gu SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074957; Gutierrez-Canas I, 2006, RHEUMATOLOGY, V45, P527, DOI 10.1093/rheumatology/kei219; Hanninen A, 2007, AM J PATHOL, V170, P240, DOI 10.2353/ajpath.060142; Hoffmann C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066019; Izbeki F, 2008, DIABETES RES CLIN PR, V80, P192, DOI 10.1016/j.diabres.2007.12.013; King C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017049; Kinross JM, 2011, GENOME MED, V3, DOI 10.1186/gm228; Krause DO, 2011, J BACTERIOL, V193, P583, DOI 10.1128/JB.01290-10; Lau K, 2011, J IMMUNOL, V186, P3538, DOI 10.4049/jimmunol.1001864; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lepage P, 2005, INFLAMM BOWEL DIS, V11, P473, DOI 10.1097/01.MIB.0000159662.62651.06; Lepage P, 2013, GUT, V62, P146, DOI 10.1136/gutjnl-2011-301805; Macpherson AJ, 2005, IMMUNOLOGY, V115, P153, DOI 10.1111/j.1365-2567.2005.02159.x; Marietta EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078687; Nadal I, 2007, J MED MICROBIOL, V56, P1669, DOI 10.1099/jmm.0.47410-0; Neish AS, 2009, GASTROENTEROLOGY, V136, P65, DOI 10.1053/j.gastro.2008.10.080; Ordog T, 2009, Minerva Gastroenterol Dietol, V55, P315; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Prakash S, 2011, BIOL-TARGETS THER, V5, P71, DOI 10.2147/BTT.S19099; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rashid T, 2009, EUR J GASTROEN HEPAT, V21, P843, DOI 10.1097/MEG.0b013e328318ecde; Roesch LFW, 2009, ISME J, V3, P536, DOI 10.1038/ismej.2009.5; Rosztoczy A, 2004, Z GASTROENTEROL, V42, P1295, DOI 10.1055/s-2004-813618; Sartor RB, 2008, GASTROENTEROLOGY, V134, P577, DOI 10.1053/j.gastro.2007.11.059; Schoster Angelika, 2013, BMC Res Notes, V6, P91, DOI 10.1186/1756-0500-6-91; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Ugarte M, 2012, GENOME MED, V4, DOI 10.1186/gm334; Vaarala O, 2008, DIABETES, V57, P2555, DOI 10.2337/db08-0331; Vaarala O, 2012, ARCH PEDIAT ADOL MED, V166, P608, DOI 10.1001/archpediatrics.2011.1559; Vaarala O, 2013, CURR DIABETES REP, V13, P601, DOI 10.1007/s11892-013-0409-5; Valladares R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010507; Vasseur MV, 2014, ANTIMICROB AGENTS CH, V58, P1744, DOI 10.1128/AAC.02135-13; Wang ZK, 2013, WORLD J GASTROENTERO, V19, P1541, DOI 10.3748/wjg.v19.i10.1541; Wheway J, 2005, J EXP MED, V202, P1527, DOI 10.1084/jem.20051971; Willing B, 2009, INFLAMM BOWEL DIS, V15, P653, DOI 10.1002/ibd.20783; Wirth R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-41; Zoetendal EG, 2008, GUT, V57, P1605, DOI 10.1136/gut.2007.133603; Zoetendal EG, 2002, APPL ENVIRON MICROB, V68, P3401, DOI 10.1128/AEM.68.7.3401-3407.2002	48	46	52	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e110440	10.1371/journal.pone.0110440	http://dx.doi.org/10.1371/journal.pone.0110440			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469509	gold, Green Published, Green Submitted			2022-12-26	WOS:000349128700004
J	Kim, H; Park, SH; Kim, EK; Kim, MJ; Park, YN; Park, HJ; Choi, JY				Kim, Honsoul; Park, Seong Ho; Kim, Eun Kyung; Kim, Myeong-Jin; Park, Young Nyun; Park, Hae-Jeong; Choi, Jin-Young			Histogram Analysis of Gadoxetic Acid-Enhanced MRI for Quantitative Hepatic Fibrosis Measurement	PLOS ONE			English	Article							GD-EOB-DTPA; LIVER FIBROSIS; DECREASED EXPRESSION; CLINICAL-EVALUATION; TEXTURE ANALYSIS; SPECTROSCOPY; TRANSPORTER; DIAGNOSIS; SYSTEMS; BIOPSY	Purpose: The diagnosis and monitoring of liver fibrosis is an important clinical issue; however, this is usually achieved by invasive methods such as biopsy. We aimed to determine whether histogram analysis of hepatobiliary phase images of gadoxetic acid-enhanced magnetic resonance imaging (MRI) can provide noninvasive quantitative measurement of liver fibrosis. Methods: This retrospective study was approved by the institutional ethics committee, and a waiver of informed consent was obtained. Hepatobiliary phase images of preoperative gadoxetic acid-enhanced MRI studies of 105 patients (69 males, 36 females; age 56.1 +/- 12.2) with pathologically documented liver fibrosis grades were analyzed. Fibrosis staging was F0/F1/F2/F3/F4 (METAVIR system) for 11/20/13/15/46 patients, respectively. Four regions-of-interest (ROI, each about 2 cm(2)) were placed on predetermined locations of representative images. The measured signal intensity of pixels in each ROI was used to calculate corrected coefficient of variation (cCV), skewness, and kurtosis. An average value of each parameter was calculated for comparison. Statistical analysis was performed by ANOVA, receiver operating characteristic (ROC) curve analysis, and linear regression. Results: The cCV showed statistically significant differences among pathological fibrosis grades (P<0.001) whereas skewness and kurtosis did not. Univariable linear regression analysis suggested cCV to be a meaningful parameter in predicting the fibrosis grade (P<0.001, beta=0.40 and standard error =0.06). For discriminating F0-3 from F4, the area under ROC score was 0.857, standard deviation 0.036, 95% confidence interval 0.785-0.928. Conclusion: Histogram analysis of hepatobiliary phase images of gadoxetic acid-enhanced MRI can provide non-invasive quantitative measurements of hepatic fibrosis.	[Kim, Honsoul; Kim, Myeong-Jin; Choi, Jin-Young] Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Kim, Honsoul; Kim, Myeong-Jin; Choi, Jin-Young] Yonsei Univ, Coll Med, Res Inst Radiol Sci, Seoul, South Korea; [Park, Seong Ho] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea; [Park, Seong Ho] Univ Ulsan, Coll Med, Asan Med Ctr, Res Inst Radiol, Seoul, South Korea; [Kim, Eun Kyung; Park, Young Nyun] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea; [Park, Hae-Jeong] Yonsei Univ, Coll Med, Dept Nucl Med Radiol & Psychiat, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Choi, JY (corresponding author), Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea.	gafield@yuhs.ac	Kim, Eun-Kyung/E-5211-2017; Kim, Myeong-Jin/E-1623-2011	Kim, Eun-Kyung/0000-0002-3368-5013; Park, Hae-Jeong/0000-0002-4633-0756; Kim, Myeong-Jin/0000-0001-7949-5402; Park, Young Nyun/0000-0003-0357-7967; Choi, Jin-Young/0000-0002-9025-6274				Aguirre DA, 2006, RADIOLOGY, V239, P425, DOI 10.1148/radiol.2392050505; Balassy C, 2014, RADIOLOGY, V270, P149, DOI 10.1148/radiol.13122440; BATTS KP, 1995, AM J SURG PATHOL, V19, P1409, DOI 10.1097/00000478-199512000-00007; BEDOSSA P, 1994, HEPATOLOGY, V20, P15; Bonekamp S, 2009, J HEPATOL, V50, P17, DOI 10.1016/j.jhep.2008.10.016; Choi JY, 2014, YONSEI MED J, V55, P651, DOI 10.3349/ymj.2014.55.3.651; Feier D, 2013, RADIOLOGY, V269, P459, DOI 10.1148/radiol.13122482; Godfrey EM, 2012, EUR RADIOL, V22, P2790, DOI 10.1007/s00330-012-2527-x; Goodman ZD, 2007, J HEPATOL, V47, P598, DOI 10.1016/j.jhep.2007.07.006; Goshima S, 2012, HEPATOLOGY, V55, P328, DOI 10.1002/hep.24677; HAMM B, 1995, RADIOLOGY, V195, P785, DOI 10.1148/radiology.195.3.7754011; Hinoshita E, 2001, J HEPATOL, V35, P765, DOI 10.1016/S0168-8278(01)00216-1; ISHAK K, 1995, J HEPATOL, V22, P696, DOI 10.1016/0168-8278(95)80226-6; Jirak D, 2002, J MAGN RESON IMAGING, V15, P68, DOI 10.1002/jmri.10042; Kim Hae-Young, 2013, Restor Dent Endod, V38, P52, DOI 10.5395/rde.2013.38.1.52; Leinhard OD, 2012, EUR RADIOL, V22, P642, DOI 10.1007/s00330-011-2302-4; LERSKI RA, 1993, MAGN RESON IMAGING, V11, P873, DOI 10.1016/0730-725X(93)90205-R; MAHARAJ B, 1986, LANCET, V1, P523; Manning DS, 2008, GASTROENTEROLOGY, V134, P1670, DOI 10.1053/j.gastro.2008.03.001; Materne R, 2002, MAGNET RESON MED, V47, P135, DOI 10.1002/mrm.10045; McPherson S, 2009, J HEPATOL, V51, P389, DOI 10.1016/j.jhep.2009.04.012; Millet P, 2011, J PHARMACOL EXP THER, V336, P624, DOI 10.1124/jpet.110.175406; Nakai K, 2008, DRUG METAB DISPOS, V36, P1786, DOI 10.1124/dmd.107.020073; Nassif A, 2012, RADIOLOGY, V264, P741, DOI 10.1148/radiol.12112061; Nies AT, 2013, GENOME MED, V5, DOI 10.1186/gm405; Noe J, 2007, DRUG METAB DISPOS, V35, P1308, DOI 10.1124/dmd.106.012930; Nojiri S, 2013, J GASTROEN HEPATOL, V28, P1032, DOI 10.1111/jgh.12181; Piscaglia F, 2014, EUR J RADIOL, V83, P450, DOI 10.1016/j.ejrad.2013.06.009; Reimer P, 1996, RADIOLOGY, V199, P177, DOI 10.1148/radiology.199.1.8633143; Rockey DC, 2009, HEPATOLOGY, V49, P1017, DOI 10.1002/hep.22742; Stieger B, 2012, EUR J PHARMACOL, V675, P1, DOI 10.1016/j.ejphar.2011.11.048; Tamada T, 2011, EUR J RADIOL, V80, pE311, DOI 10.1016/j.ejrad.2011.01.020; Tsuda N, 2010, RADIOLOGY, V256, P767, DOI 10.1148/radiol.10092065; Tsuda N, 2010, EUR J RADIOL, V73, P137, DOI 10.1016/j.ejrad.2008.09.036; Valkovic L, 2014, EUR RADIOL, V24, P1602, DOI 10.1007/s00330-014-3141-x; Van Beers BE, 2012, J HEPATOL, V57, P421, DOI 10.1016/j.jhep.2012.01.031; Watanabe H, 2011, RADIOLOGY, V259, P142, DOI 10.1148/radiol.10100621; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506	38	21	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114224	10.1371/journal.pone.0114224	http://dx.doi.org/10.1371/journal.pone.0114224			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460180	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700117
J	Lin, RW; Yang, CN; Ku, SY; Ho, CJ; Huang, SB; Yang, MC; Chang, HW; Lin, CM; Hwang, JL; Chen, YL; Tzeng, CC; Wang, CH				Lin, Ru-Wei; Yang, Chia-Ning; Ku, ShengYu; Ho, Cheng-Jung; Huang, Shih-Bo; Yang, Min-Chi; Chang, Hsin-Wen; Lin, Chun-Mao; Hwang, Jaulang; Chen, Yeh-Long; Tzeng, Cherg-Chyi; Wang, Chihuei			CFS-1686 Causes Cell Cycle Arrest at Intra-S Phase by Interference of Interaction of Topoisomerase 1 with DNA	PLOS ONE			English	Article							I INHIBITORS; MOLECULAR-DYNAMICS; CAMPTOTHECIN; ATM; IDENTIFICATION; ANTICANCER; MECHANISM; DAMAGE; DRUGS	CFS-1686 (chemical name (E)-N-(2-(diethylamino) ethyl)-4-(2-(2-(5-nitrofuran-2yl) vinyl) quinolin-4-ylamino) benzamide) inhibits cell proliferation and triggers late apoptosis in prostate cancer cell lines. Comparing the effect of CFS-1686 on cell cycle progression with the topoisomerase 1 inhibitor camptothecin revealed that CFS-1686 and camptothecin reduced DNA synthesis in S-phase, resulting in cell cycle arrest at the intra-S phase and G1-S boundary, respectively. The DNA damage in CFS-1686 and camptothecin treated cells was evaluated by the level of ATM phosphorylation, gamma H2AX, and gamma H2AX foci, showing that camptothecin was more effective than CFS-1686. However, despite its lower DNA damage capacity, CFS-1686 demonstrated 4-fold higher inhibition of topoisomerase 1 than camptothecin in a DNA relaxation assay. Unlike camptothecin, CFS-1686 demonstrated no activity on topoisomerase 1 in a DNA cleavage assay, but nevertheless it reduced the camptothecin-induced DNA cleavage of topoisomerase 1 in a dose-dependent manner. Our results indicate that CFS-1686 might bind to topoisomerase 1 to inhibit this enzyme from interacting with DNA relaxation activity, unlike campothecin's induction of a topoisomerase 1-DNA cleavage complex. Finally, we used a computer docking strategy to localize the potential binding site of CFS-1686 to topoisomerase 1, further indicating that CFS-1686 might inhibit the binding of Top1 to DNA.	[Lin, Ru-Wei] Natl Cheng Kung Univ, Bone & Joint Res Ctr, Tainan 70101, Taiwan; [Lin, Ru-Wei] Natl Cheng Kung Univ, Med Coll & Hosp, Med Device R&D Core Lab, Tainan 70101, Taiwan; [Yang, Chia-Ning; Chang, Hsin-Wen] Natl Univ Kaohsiung, Dept Life Sci, Kaohsiung, Taiwan; [Ku, ShengYu; Huang, Shih-Bo; Yang, Min-Chi; Wang, Chihuei] Kaohsiung Med Univ, Dept Biotechnol, Kaohsiung, Taiwan; [Ho, Cheng-Jung] Kaohsiung Med Univ Hosp, Dept Orthoped, Kaohsiung, Taiwan; [Lin, Chun-Mao; Hwang, Jaulang] Taipei Med Univ, Sch Med, Dept Biochem, Taipei, Taiwan; [Chen, Yeh-Long; Tzeng, Cherg-Chyi] Kaohsiung Med Univ, Dept Med & Appl Chem, Kaohsiung, Taiwan	National Cheng Kung University; National Cheng Kung University; National University Kaohsiung; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Taipei Medical University; Kaohsiung Medical University	Tzeng, CC (corresponding author), Kaohsiung Med Univ, Dept Med & Appl Chem, Kaohsiung, Taiwan.	tzengch@kmu.edu.tw; chwang@kmu.edu.tw	Huang, Shih-Bo/AAO-9699-2021	Huang, Shih-Bo/0000-0002-1048-2344; Lin, Chun-Mao/0000-0002-8366-4026	Ministry of Science and Technology of Taiwan [NSC99-2320-B-037-013-MY3]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by Grant NSC99-2320-B-037-013-MY3 (to CW) from Ministry of Science and Technology of Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang FS, 2010, BIOORGAN MED CHEM, V18, P124, DOI 10.1016/j.bmc.2009.11.012; Chen SH, 2013, ANNU REV BIOCHEM, V82, P139, DOI 10.1146/annurev-biochem-061809-100002; Chillemi G, 2007, NUCLEIC ACIDS RES, V35, P3032, DOI 10.1093/nar/gkm199; Dexheimer TS, 2008, NAT PROTOC, V3, P1736, DOI 10.1038/nprot.2008.174; HSIANG YH, 1988, CANCER RES, V48, P1722; JAXEL C, 1989, CANCER RES, V49, P1465; Kim SYH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054790, 10.1371/journal.pone.0053908, 10.1371/journal.pone.0063749, 10.1371/journal.pone.0068092]; Pommier Y, 1998, BBA-GENE STRUCT EXPR, V1400, P83, DOI 10.1016/S0167-4781(98)00129-8; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2013, ACS CHEM BIOL, V8, P82, DOI 10.1021/cb300648v; Pommier Y, 2012, NAT REV DRUG DISCOV, V11, P25, DOI 10.1038/nrd3404; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Pommier Y, 2009, CHEM REV, V109, P2894, DOI 10.1021/cr900097c; Redinbo MR, 1998, SCIENCE, V279, P1504, DOI 10.1126/science.279.5356.1504; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Siu FM, 2013, NUCLEIC ACIDS RES, V41, P10010, DOI 10.1093/nar/gkt791; Tanaka T, 2006, CELL PROLIFERAT, V39, P49, DOI 10.1111/j.1365-2184.2006.00364.x; Tomita M, 2010, J RADIAT RES, V51, P493, DOI 10.1269/jrr.10039; Tsai HP, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-49; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wu N, 2010, BIOCHEMISTRY-US, V49, P10131, DOI 10.1021/bi1009419	21	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113832	10.1371/journal.pone.0113832	http://dx.doi.org/10.1371/journal.pone.0113832			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460368	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700058
J	Nielsen, NO; Jorgensen, ME; Friis, H; Melbye, M; Soborg, B; Jeppesen, C; Lundqvist, M; Cohen, A; Hougaard, DM; Bjerregaard, P				Nielsen, Nina O.; Jorgensen, Marit E.; Friis, Henrik; Melbye, Mads; Soborg, Bolette; Jeppesen, Charlotte; Lundqvist, Marika; Cohen, Arieh; Hougaard, David M.; Bjerregaard, Peter			Decrease in Vitamin D Status in the Greenlandic Adult Population from 1987-2010	PLOS ONE			English	Article							SERUM 25-HYDROXYVITAMIN D; GENERAL-POPULATION; INSULIN-RESISTANCE; D INSUFFICIENCY; ARCTIC SOCIETY; D DEFICIENCY; INUIT; ASSOCIATION; CALCIUM; DISEASE	Background: Low vitamin D status may be pronounced in Arctic populations due to limited sun exposure and decreasing intake of traditional food. Objective: To investigate serum 25(OH)D3 as a measure of vitamin D status among adult Inuit in Greenland, predictors of low serum 25(OH)D3 concentrations and the trend from 1987 to 2005-2010. Design: A total of 2877 randomly selected Inuit (>= 18 years) from the Inuit Health in Transition study were included. A sub-sample (n5330) donated a blood sample in 1987 which allowed assessment of time trends in vitamin D status. Results: The geometric mean serum 25(OH)D3 (25[OH]D2 concentrations were negligible and not reported) in 2005-2010 was lowest among the 18-29 year old individuals (30.7 nmol/L; 95% CI: 29.7; 31.7) and increased with age. In all age-groups it decreased from 1987 to 2005-2010 (32%-58%). Low 25(OH)D3 concentrations (<50 nmol/L) were present in 77% of the 18-29 year old and decreased with age. A characteristic seasonal variation in 25(OH)D3 concentrations was observed (range 33.2-57.1 nmol/L, p<0.001), with the highest concentrations in August to October. Age (2.0% per year increase; CI: 1.7, 2.2), female gender (7.1%; CI: 2.0; 12.5), alcohol intake (0.2% per increase in drinks/ week; 0.0; 0.4), and traditional diet (10.0% per 100 g/d increase; CI: 7.9; 12.1) were associated with increased serum 25(OH) D3, whereas smoking (-11.6%; CI: -16.2; -6.9), BMI (20.6%; CI: -1.1; -0.2) and latitude (-0.7% per degree increase; CI: -1.3; -0.2) were associated with decreased concentrations. Conclusion: We identified a remarkable decrease in vitamin D status from 1987 to 2005-2010 and a presently low vitamin D status among Inuit in Greenland. A change away from a traditional diet may well explain the observed decline. The study argues for the need of increased dietary intake of vitamin D and supplementation might be considered.	[Nielsen, Nina O.; Bjerregaard, Peter] Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Jorgensen, Marit E.] Steno Diabet Ctr, DK-2820 Gentofte, Denmark; [Friis, Henrik] Univ Copenhagen, Dept Nutr Exercise & Sports, Copenhagen, Denmark; [Melbye, Mads; Soborg, Bolette] Statens Serum Inst, Dept Epidemiol Res, DK-2300 Copenhagen, Denmark; [Jeppesen, Charlotte] Aarhus Univ, Dept Publ Hlth, Aarhus, Denmark; [Lundqvist, Marika; Cohen, Arieh; Hougaard, David M.] Statens Serum Inst, Dept Clin Biochem & Immunol, DK-2300 Copenhagen, Denmark; [Bjerregaard, Peter] Univ Greenland, Greenland Ctr Hlth Res, Nuuk, Greenland	University of Southern Denmark; Steno Diabetes Center; University of Copenhagen; Statens Serum Institut; Aarhus University; Statens Serum Institut	Nielsen, NO (corresponding author), Univ Southern Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark.	noni@niph.dk	Bjerregaard, Peter/ABD-8894-2020; Friis, Henrik/N-2047-2014; Hougaard, David/AAD-6368-2019; Friis, Henrik/P-2891-2019	Bjerregaard, Peter/0000-0001-7153-8447; Friis, Henrik/0000-0002-2848-2940; Friis, Henrik/0000-0002-2848-2940; Jorgensen, Marit Eika/0000-0001-8356-5565; melbye, mads/0000-0001-8264-6785; Nielsen, Nina Odgaard/0000-0001-6127-5970	Government of Greenland's health department [2011-047012/2012-074239]; Aase and Ejnar Danielsen's Foundation [10-000444]; Dagmar Marshalls Foundation	Government of Greenland's health department; Aase and Ejnar Danielsen's Foundation; Dagmar Marshalls Foundation	The study was supported by the Government of Greenland's health department (2011-047012/2012-074239), Aase and Ejnar Danielsen's Foundation (10-000444), and Dagmar Marshalls Foundation. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate Michele, 2013, Muscles Ligaments Tendons J, V3, P63, DOI 10.11138/mltj/2013.3.2.063; Agborsangaya C, 2010, NUTR CANCER, V62, P51, DOI 10.1080/01635580903191460; Andersen S, 2005, AM J CLIN NUTR, V81, P656; Andersen S, 2013, BRIT J NUTR, V110, P50, DOI 10.1017/S0007114512004709; Andersen S, 2013, BRIT J NUTR, V109, P928, DOI 10.1017/S0007114512002097; [Anonymous], 2008, HLTH TRANSITIONS ARC; Arunabh S, 2003, J CLIN ENDOCR METAB, V88, P157, DOI 10.1210/jc.2002-020978; Bell DSH, 2011, SOUTH MED J, V104, P335, DOI 10.1097/01.SMJ.0000397893.94525.0e; Bjerregaard P, 2004, SCAND J PUBLIC HEALT, V32, P390, DOI 10.1080/14034940410028398; Bjerregaard P, 2010, SIF WRITINGS GREENLA, V19; Cannell JJ, 2009, MED SCI SPORT EXER, V41, P1102, DOI 10.1249/MSS.0b013e3181930c2b; Dahl-Petersen IK, 2011, SCAND J PUBLIC HEALT, V39, P678, DOI 10.1177/1403494811420486; Dahl-Petersen IK, 2013, DIABETES RES CLIN PR, V102, P242, DOI 10.1016/j.diabres.2013.10.004; Deutch B, 2007, SCI TOTAL ENVIRON, V384, P106, DOI 10.1016/j.scitotenv.2007.05.042; Durup D, 2012, J CLIN ENDOCR METAB, V97, P2644, DOI 10.1210/jc.2012-1176; Eyles DW, 2005, J CHEM NEUROANAT, V29, P21, DOI 10.1016/j.jchemneu.2004.08.006; Forouhi NG, 2008, DIABETES, V57, P2619, DOI 10.2337/db08-0593; Friis H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081142; Ginde AA, 2009, ARCH INTERN MED, V169, P626, DOI 10.1001/archinternmed.2008.604; Holick MF, 2004, AM J CLIN NUTR, V80, p1678S, DOI 10.1093/ajcn/80.6.1678S; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Jahnsen J, 2002, SCAND J GASTROENTERO, V37, P192, DOI 10.1080/003655202753416876; Jamal-Allial A, 2014, J STEROID BIOCHEM, V144, P185, DOI 10.1016/j.jsbmb.2013.12.004; Jeppesen C, 2014, PUBLIC HEALTH NUTR, V17, P462, DOI 10.1017/S136898001300013X; Jorde R, 2010, EUR J NUTR, V49, P401, DOI 10.1007/s00394-010-0098-7; Jorgensen ME, 2008, ATHEROSCLEROSIS, V196, P772, DOI 10.1016/j.atherosclerosis.2007.01.008; Jorgensen ME, 2003, INT J OBESITY, V27, P1507, DOI 10.1038/sj.ijo.0802434; Jorgensen ME, 2002, DIABETES CARE, V25, P1766, DOI 10.2337/diacare.25.10.1766; Kouda K, 2013, NUTRITION, V29, P1204, DOI 10.1016/j.nut.2013.03.010; Kuhnlein HV, 2008, PUBLIC HEALTH NUTR, V11, P349, DOI 10.1017/S1368980007000353; Larose TL, 2014, J EPIDEMIOL COMMUN H, V68, P165, DOI 10.1136/jech-2013-202587; Lewis John G, 2008, Clin Chem, V54, P1931, DOI 10.1373/clinchem.2008.111526; Mattila C, 2007, DIABETES CARE, V30, P2569, DOI 10.2337/dc07-0292; McCarty MF, 2003, MED HYPOTHESES, V61, P535, DOI 10.1016/S0306-9877(03)00227-5; Misfeldt J, 1988, Arctic Med Res, V47, P173; Need AG, 2002, OSTEOPOROSIS INT, V13, P83, DOI 10.1007/s198-002-8342-9; Nielsen NO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080686; Nielsen NO, 2010, BRIT J NUTR, V104, P1487, DOI 10.1017/S0007114510002333; Rejnmark L, 2004, CALCIFIED TISSUE INT, V74, P255, DOI 10.1007/s00223-003-0110-9; Sulistyoningrum DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043159; Thuesen B, 2012, BONE, V50, P605, DOI 10.1016/j.bone.2011.12.016; Webb AR, 2006, PROG BIOPHYS MOL BIO, V92, P17, DOI 10.1016/j.pbiomolbio.2006.02.004; Willet W., 2013, NUTR EPIDEMIOLOGY, P306; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690	44	15	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112949	10.1371/journal.pone.0112949	http://dx.doi.org/10.1371/journal.pone.0112949			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461952	Green Published, Green Submitted, gold			2022-12-26	WOS:000345869700024
J	Simmons, AD; Nguyen, TKT; Follis, JL; Ribes-Zamora, A				Simmons, Alexandra D.; Nguyen, Thao K. T.; Follis, Jack L.; Ribes-Zamora, Albert			Using a PyMOL Activity to Reinforce the Connection between Genotype and Phenotype in an Undergraduate Genetics Laboratory	PLOS ONE			English	Article								With the purpose of developing an activity that would help clarify genetic concepts related to the connection between genotype and phenotype and the nature of mutations, we designed a three hour teaching module using the PyMol software. The activity starts with two pre-laboratory assignments, one to learn how to use PyMol and the other to read about a specific protein or protein family. During the laboratory students are given instructions where and how to find additional information on a specific disease and its causal mutations in order to prepare a 10-minute, in-class presentation. Using a post activity, anonymous quiz, we found a statistically significant different grade distribution in students that participated in the PyMol activity relative to a control group. We also found a significant improvement in the student's comprehension when answering questions regarding the nature of mutations and protein structure. This demonstrates the utility of this simulation activity as a vehicle to improve student's understanding of specific key genetic concepts.	[Simmons, Alexandra D.; Nguyen, Thao K. T.; Ribes-Zamora, Albert] Univ St Thomas, Dept Biol, Houston, TX 77006 USA; [Follis, Jack L.] Univ St Thomas, Dept Math Comp Sci & Cooperat Engn, Houston, TX 77006 USA	University of Saint Thomas; University of Saint Thomas	Simmons, AD (corresponding author), Univ St Thomas, Dept Biol, 3800 Montrose Blvd, Houston, TX 77006 USA.	simmonad@stthom.edu		Nguyen, Thao/0000-0002-8272-5819				Bell R. L., 2008, NATL SCI TEACHERS AS, V3, P23; Craciun D, 2009, ROM BIOTECH LETT, V14, P4567; DeHaan R. L., 2005, J SCI EDUC TECHNOL, V14, P253, DOI DOI 10.1007/S10956-005-4425-3; Kulik J., 2002, SCH MATH SCI PROGRAM; R Core Team, 2021, R LANGUAGE ENV STAT; Rutten N, 2012, COMPUT EDUC, V58, P136, DOI 10.1016/j.compedu.2011.07.017; Shaw KRM, 2008, GENETICS, V178, P1157, DOI 10.1534/genetics.107.084194; Wood WB, 2009, ANNU REV CELL DEV BI, V25, P93, DOI 10.1146/annurev.cellbio.24.110707.175306	8	8	8	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114257	10.1371/journal.pone.0114257	http://dx.doi.org/10.1371/journal.pone.0114257			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461967	gold, Green Published, Green Submitted			2022-12-26	WOS:000345869700124
J	Fonseca, JP; Dong, XN				Fonseca, Jose Pedro; Dong, Xinnian			Functional Characterization of a Nudix Hydrolase AtNUDX8 upon Pathogen Attack Indicates a Positive Role in Plant Immune Responses	PLOS ONE			English	Article							SALICYLIC-ACID; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; FAMILY; RESISTANCE; DEFENSE; SYSTEM; NPR1; PYROPHOSPHOHYDROLASE; TRANSCRIPTION	Nudix hydrolases comprise a large gene family of twenty nine members in Arabidopsis, each containing a conserved motif capable of hydrolyzing specific substrates like ADP-glucose and NADH. Until now only two members of this family, AtNUDX6 and AtNUDX7, have been shown to be involved in plant immunity. RPP4 is a resistance gene from a multigene family that confers resistance to downy mildew. A time course expression profiling after Hyaloperonospora arabidopsidis inoculation in both wild-type (WT) and the rpp4 mutant was carried out to identify differentially expressed genes in RPP4-mediated resistance. AtNUDX8 was one of several differentially expressed, downregulated genes identified. A T-DNA knockout mutant (KO-nudx8) was obtained from a Salk T-DNA insertion collection, which exhibited abolished AtNUDX8 expression. The KO-nudx8 mutant was infected separately from the oomycete pathogen Hpa and the bacterial pathogen Pseudomonas syringae pv. maculicola ES4326. The mutant displayed a significantly enhanced disease susceptibility to both pathogens when compared with the WT control. We observed a small, stunted phenotype for KO-nudx8 mutant plants when grown over a 12/12 hour photoperiod but not over a 16/8 hour photoperiod. AtNUDX8 expression peaked at 8 hours after the lights were turned on and this expression was significantly repressed four-fold by salicylic acid (SA). The expression of three pathogen-responsive thioredoxins (TRX-h2, TRX-h3 and TRX-h5) were downregulated at specific time points in the KO-nudx8 mutant when compared with the WT. Furthermore, KO-nudx8 plants like the npr1 mutant, displayed SA hypersensitivity. Expression of a key SA biosynthetic gene ICS1 was repressed at specific time points in the KO-nudx8 mutant suggesting that AtNUDX8 is involved in SA signaling in plants. Similarly, NPR1 and PR1 transcript levels were also downregulated at specific time points in the KO-nudx8 mutant. This study shows that AtNUDX8 is involved in plant immunity as a positive regulator of defense in Arabidopsis.	[Fonseca, Jose Pedro; Dong, Xinnian] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Fonseca, Jose Pedro] Univ Fed Rio de Janeiro, Dept Genet, Rio De Janeiro, RJ, Brazil; [Dong, Xinnian] Duke Univ, Dept Biol, Gordon & Betty Moore Fdn, Howard Hughes Med Inst, Durham, NC USA	Duke University; Universidade Federal do Rio de Janeiro; Duke University; Howard Hughes Medical Institute	Fonseca, JP (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	zepedrof@gmail.com		Fonseca, Jose Pedro/0000-0002-6402-8219	Hargitt Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099839, R01GM069594] Funding Source: NIH RePORTER	Hargitt Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Hargitt Fellowship. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartsch M, 2006, PLANT CELL, V18, P1038, DOI 10.1105/tpc.105.039982; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Durrant WE, 2007, P NATL ACAD SCI USA, V104, P4223, DOI 10.1073/pnas.0609357104; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fan WH, 2002, PLANT CELL, V14, P1377, DOI 10.1105/tpc.001628; Fu ZQ, 2012, NATURE, V486, P228, DOI 10.1038/nature11162; Gelhaye E, 2005, CELL MOL LIFE SCI, V62, P24, DOI 10.1007/s00018-004-4296-4; Gunawardana D, 2009, COMP FUNCT GENOM, DOI 10.1155/2009/820381; Ishikawa K, 2010, PLANT PHYSIOL, V152, P2000, DOI 10.1104/pp.110.153569; Jambunathan N, 2006, PLANTA, V224, P1, DOI 10.1007/s00425-005-0183-y; Jambunathan N, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-173; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kraszewska E, 2008, ACTA BIOCHIM POL, V55, P663; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee OR, 2012, GENE, V506, P85, DOI 10.1016/j.gene.2012.06.039; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mou Z, 2003, CELL, V113, P935, DOI 10.1016/S0092-8674(03)00429-X; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Munoz FJ, 2006, PLANT CELL PHYSIOL, V47, P926, DOI 10.1093/pcp/pcj065; Ogawa T, 2005, J BIOL CHEM, V280, P25277, DOI 10.1074/jbc.M503536200; Ogawa T, 2008, PLANT PHYSIOL, V148, P1412, DOI 10.1104/pp.108.128413; Patykowski J, 2003, J PHYTOPATHOL, V151, P153, DOI 10.1046/j.1439-0434.2003.00697.x; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; Sweat TA, 2007, PLANT CELL, V19, P673, DOI 10.1105/tpc.106.047563; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; van der Biezen EA, 2002, PLANT J, V29, P439, DOI 10.1046/j.0960-7412.2001.01229.x; Volkert MR, 2000, P NATL ACAD SCI USA, V97, P14530, DOI 10.1073/pnas.260495897; Wang W, 2011, NATURE, V470, P110, DOI 10.1038/nature09766; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Xu WL, 2004, J BIOL CHEM, V279, P24861, DOI 10.1074/jbc.M403272200; Yoshimura K, 2007, PLANT CELL PHYSIOL, V48, P1438, DOI 10.1093/pcp/pcm112; Zhang XD, 2010, J PLANT PHYSIOL, V167, P144, DOI 10.1016/j.jplph.2009.08.002	33	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114119	10.1371/journal.pone.0114119	http://dx.doi.org/10.1371/journal.pone.0114119			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436909	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900120
J	Gao, L; Sun, YP; Si, JY; Liu, JH; Sun, GB; Sun, XB; Cao, L				Gao, Li; Sun, Yipeng; Si, Jianyong; Liu, Jinhua; Sun, Guibo; Sun, Xiaobo; Cao, Li			Cryptoporus volvatus Extract Inhibits Influenza Virus Replication In Vitro and In Vivo	PLOS ONE			English	Article							LUNG INJURY; A VIRUS; POLYSACCHARIDE; VACCINE; PATHOGENESIS; EXPRESSION; RESISTANT; MUSHROOMS; INFECTION; THERAPY	Influenza virus is the cause of significant morbidity and mortality, posing a serious health threat worldwide. Here, we evaluated the antiviral activities of Cryptoporus volvatus extract on influenza virus infection. Our results demonstrated that the Cryptoporus volvatus extract inhibited different influenza virus strain replication in MDCK cells. Time course analysis indicated that the extract exerted its inhibition at earlier and late stages in the replication cycle of influenza virus. Subsequently, we confirmed that the extract suppressed virus internalization into and released from cells. Moreover, the extract significantly reduced H1N1/09 influenza virus load in lungs and dramatically decreased lung lesions in mice. And most importantly, the extract protected mice from lethal challenge with H1N1/09 influenza virus. Our results suggest that the Cryptoporus volvatus extract could be a potential candidate for the development of a new anti- influenza virus therapy.	[Gao, Li; Si, Jianyong; Sun, Guibo; Sun, Xiaobo; Cao, Li] Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China; [Gao, Li; Si, Jianyong; Sun, Guibo; Sun, Xiaobo; Cao, Li] Peking Union Med Coll, Beijing 100021, Peoples R China; [Sun, Yipeng; Liu, Jinhua] China Agr Univ, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Coll Vet Med, Beijing 100094, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; China Agricultural University; Ministry of Agriculture & Rural Affairs	Cao, L (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Beijing 100730, Peoples R China.	lcao@implad.ac.cn			Program for Innovative Research Team in IMPLAD (PIRTI)	Program for Innovative Research Team in IMPLAD (PIRTI)	This work was supported by the Program for Innovative Research Team in IMPLAD (PIRTI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adotey G, 2011, INT J MED MUSHROOMS, V13, P109, DOI 10.1615/IntJMedMushr.v13.i2.20; Arguedas A, 2011, HUM VACCINES, V7, P58, DOI 10.4161/hv.7.1.13411; Balzarini J, 1996, P NATL ACAD SCI USA, V93, P13152, DOI 10.1073/pnas.93.23.13152; Belperio JA, 2002, J CLIN INVEST, V110, P1703, DOI 10.1172/JCI200215849; Cheng VCC, 2012, CLIN MICROBIOL REV, V25, P223, DOI 10.1128/CMR.05012-11; Cristiani C, 2011, VACCINE, V29, P3443, DOI 10.1016/j.vaccine.2011.02.068; Cross K J, 2001, Expert Rev Mol Med, V3, P1, DOI 10.1017/S1462399401003453; Deyde VM, 2007, J INFECT DIS, V196, P249, DOI 10.1086/518936; Faccin LC, 2007, LETT APPL MICROBIOL, V45, P24, DOI 10.1111/j.1472-765X.2007.02153.x; Gao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063767; Griffin MR, 2013, S D MED; Harvey AL, 2008, DRUG DISCOV TODAY, V13, P894, DOI 10.1016/j.drudis.2008.07.004; Inoue M, 2010, EMERG INFECT DIS, V16, P1633, DOI 10.3201/eid1610.100688; Jin Sai-hong, 2003, Zhongguo Zhongyao Zazhi, V28, P650; Kumar N, 2011, J VIROL, V85, P2818, DOI 10.1128/JVI.01969-10; Lindequist U, 2005, EVID-BASED COMPL ALT, V2, P285, DOI 10.1093/ecam/neh107; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; Monto AS, 2008, CLIN INFECT DIS, V47, P346, DOI 10.1086/589749; Mothana RAA, 2003, FITOTERAPIA, V74, P177, DOI 10.1016/S0367-326X(02)00305-2; Oldstone MBA, 2013, VIROLOGY, V435, P92, DOI 10.1016/j.virol.2012.09.039; Perwitasari O, 2014, J VIROL, V88, P10228, DOI 10.1128/JVI.01774-14; Pizzorno A, 2011, J INFECT DIS, V203, P25, DOI 10.1093/infdis/jiq010; Stamets P, 2006, COMMUNICATION, V2, P152; Vajo Z, 2010, LANCET, V375, P49, DOI 10.1016/S0140-6736(09)62039-0; Wang C, 2011, ANN INTERN MED, V155, P217, DOI 10.7326/0003-4819-155-4-201108160-00005; Wasser SP, 2011, APPL MICROBIOL BIOT, V89, P1323, DOI 10.1007/s00253-010-3067-4; Wu JZ, 1999, J FUJIAN COLL TCM, V9, P33; Wu ZY, 1990, XIN HUA COMPENDIUM M; Xie QM, 2006, J ETHNOPHARMACOL, V107, P424, DOI 10.1016/j.jep.2006.03.040; Xu J.T., 1997, CHINESE MED MYCOLOGY; Yamamoto KA, 2013, INT J BIOL MACROMOL, V52, P9, DOI 10.1016/j.ijbiomac.2012.09.029; Yao HY, 2011, J ETHNOPHARMACOL, V137, P1267, DOI 10.1016/j.jep.2011.07.058; Zhao XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022091; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535; Zhu LQ, 2014, J VIROL, V88, P417, DOI 10.1128/JVI.02591-13; Zjawiony JK, 2004, J NAT PROD, V67, P300, DOI 10.1021/np030372w	36	15	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113604	10.1371/journal.pone.0113604	http://dx.doi.org/10.1371/journal.pone.0113604			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437846	Green Published, gold, Green Submitted			2022-12-26	WOS:000347114900054
J	Mittal, S; Singh, LR				Mittal, Shruti; Singh, Laishram Rajendrakumar			Macromolecular Crowding Induces Holo alpha-Lactalbumin Aggregation by Converting to Its Apo Form	PLOS ONE			English	Article							PROTEIN AGGREGATION; CALCIUM-CONCENTRATION; FIBRIL FORMATION; EXCLUDED-VOLUME; MUTANT P53; STABILITY; BINDING; BOVINE; EQUILIBRIUM; EXPRESSION	Macromolecular crowding has been shown to have an exacerbating effect on the aggregation propensity of amyloidogenic proteins; while having an inhibitory effect on the non-amyloidogenic proteins. However, the results concerning aggregation propensity of non-amyloidogenic proteins have not been convincing due to the contrasting effect on holo-LA, which despite being a non-amyloidogenic protein was observed to aggregate under crowded conditions. In the present study, we have extensively characterized the crowding-induced holo-LA aggregates and investigated the possible mechanism responsible for the aggregation process. We discovered that macromolecular crowding reduces the calcium binding affinity of holo-LA resulting in the formation of apo-LA (the calcium-depleted form of holo-LA) leading to aggregate formation. Another finding is that calcium acts as a chaperone capable of inhibiting and dissociating crowding-induced holo-LA aggregates. The study has a direct implication to Alzheimer Disease as the results invoke a new mechanism to prevent Ab fibrillation.	[Mittal, Shruti; Singh, Laishram Rajendrakumar] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India	University of Delhi	Singh, LR (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India.	lairksingh@gmail.com		Mittal, Shruti/0000-0002-5318-2763	Department of Science and Technology [SR/SO/BB-0003/2011]; Council of Scientific and Industrial Research [09/045(1047)/2011-EMR-1]	Department of Science and Technology(Department of Science & Technology (India)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work is supported by grant from Department of Science and Technology (Ref No.: SR/SO/BB-0003/2011). SM and LRS acknowledge Council of Scientific and Industrial Research for the financial assistance provided in the form of research fellowship (File No.: 09/045(1047)/2011-EMR-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Casey JR, 2010, NAT REV MOL CELL BIO, V11, P50, DOI 10.1038/nrm2820; CAYLEY S, 1991, J MOL BIOL, V222, P281, DOI 10.1016/0022-2836(91)90212-O; Chrysina ED, 2000, J BIOL CHEM, V275, P37021, DOI 10.1074/jbc.M004752200; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Dobson CM, 2002, NATURE, V418, P729, DOI 10.1038/418729a; DOLGIKH DA, 1981, FEBS LETT, V136, P311, DOI 10.1016/0014-5793(81)80642-4; Ellis RJ, 2006, BIOL CHEM, V387, P485, DOI 10.1515/BC.2006.064; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Emilsson L, 2006, NEUROBIOL DIS, V21, P618, DOI 10.1016/j.nbd.2005.09.004; FULTON AB, 1982, CELL, V30, P345, DOI 10.1016/0092-8674(82)90231-8; GOODSELL DS, 1991, TRENDS BIOCHEM SCI, V16, P203, DOI 10.1016/0968-0004(91)90083-8; Greene LH, 1999, PROTEIN ENG, V12, P581, DOI 10.1093/protein/12.7.581; Gustafsson M, 1999, FEBS LETT, V464, P138, DOI 10.1016/S0014-5793(99)01692-0; Hall D, 2003, BBA-PROTEINS PROTEOM, V1649, P127, DOI 10.1016/S1570-9639(03)00167-5; Harada R, 2013, J AM CHEM SOC, V135, P3696, DOI 10.1021/ja3126992; Hayden MR, 2005, J PANCREAS, V6, P287; Hong JA, 2010, J AM CHEM SOC, V132, P10445, DOI 10.1021/ja103166y; Huang CC, 2010, TOXICOL IN VITRO, V24, P45, DOI 10.1016/j.tiv.2009.09.007; Isaacs AM, 2006, J BIOL CHEM, V281, P27916, DOI 10.1074/jbc.M602061200; KASHKET ER, 1987, FEMS MICROBIOL LETT, V46, P233, DOI 10.1111/j.1574-6968.1987.tb02463.x; Kataoka M, 1997, PROTEIN SCI, V6, P422; Kholova I, 2005, J CLIN PATHOL, V58, P125, DOI 10.1136/jcp.2004.017293; Kosinski-Collins MS, 2003, PROTEIN SCI, V12, P480, DOI 10.1110/ps.0225503; KUWAJIMA K, 1986, INT J PEPT PROT RES, V27, P18; Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342; LESK AM, 1980, J MOL BIOL, V136, P225, DOI 10.1016/0022-2836(80)90373-3; Levy CB, 2011, INT J BIOCHEM CELL B, V43, P60, DOI 10.1016/j.biocel.2010.10.017; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Ma Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036288; Martin J, 2002, BIOCHEMISTRY-US, V41, P5050, DOI 10.1021/bi015925l; Miklos AC, 2011, J AM CHEM SOC, V133, P7116, DOI 10.1021/ja200067p; Miklos AC, 2010, BIOCHEMISTRY-US, V49, P6984, DOI 10.1021/bi100727y; Minton AP, 1997, CURR OPIN BIOTECH, V8, P65, DOI 10.1016/S0958-1669(97)80159-0; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Minton AP, 2005, BIOPHYS J, V88, P971, DOI 10.1529/biophysj.104.050351; Mittal S, 2014, J BIOCH; Mittal S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078936; Morimoto RI, 1997, ESSAYS BIOCHEM, V32, P17; MULQUEEN PM, 1982, ARCH BIOCHEM BIOPHYS, V215, P28, DOI 10.1016/0003-9861(82)90275-2; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; Munishkina LA, 2008, BIOCHEMISTRY-US, V47, P8993, DOI 10.1021/bi8008399; MURRAY FES, 1992, CIBA F SYMP, V169, P201; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; OUYANG YB, 1994, BRAIN RES, V646, P65, DOI 10.1016/0006-8993(94)90058-2; Permyakov SE, 2001, PROTEIN ENG, V14, P785, DOI 10.1093/protein/14.10.785; Pierrot N, 2004, J NEUROCHEM, V88, P1140, DOI 10.1046/j.1471-4159.2003.02227.x; Record MT, 1998, TRENDS BIOCHEM SCI, V23, P190, DOI 10.1016/S0968-0004(98)01207-9; Ross CA, 2004, NAT MED, V10, pS10, DOI 10.1038/nm1066; Sarkar M, 2014, BIOCHEMISTRY-US, V53, P1601, DOI 10.1021/bi4016346; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Sinha A, 2000, BIOCHEM J, V345, P711, DOI 10.1042/0264-6021:3450711; SUGAI S, 1973, BIOCHIM BIOPHYS ACTA, V328, P35, DOI 10.1016/0005-2795(73)90327-9; Tan MG, 2010, J NEUROSCI RES, V88, P1157, DOI 10.1002/jnr.22290; Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122; Uversky VN, 2002, FEBS LETT, V515, P99, DOI 10.1016/S0014-5793(02)02446-8; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; van den Berg B, 1999, EMBO J, V18, P6927, DOI 10.1093/emboj/18.24.6927; Wall J, 1999, METHOD ENZYMOL, V309, P204; Williams Robin A, 2008, Clin Biochem Rev, V29, P31; Xu J, 2011, NAT CHEM BIOL, V7, P285, DOI 10.1038/nchembio.546; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	62	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114029	10.1371/journal.pone.0114029	http://dx.doi.org/10.1371/journal.pone.0114029			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437004	gold, Green Published, Green Submitted			2022-12-26	WOS:000347114900111
J	Palermo, GD; Neri, QV; Schlegel, PN; Rosenwaks, Z				Palermo, Gianpiero D.; Neri, Queenie V.; Schlegel, Peter N.; Rosenwaks, Zev			Intracytoplasmic Sperm Injection (ICSI) in Extreme Cases of Male Infertility	PLOS ONE			English	Article							ASSISTED REPRODUCTIVE TECHNOLOGIES; TESTICULAR SPERM; DNA FRAGMENTATION; HUMAN SPERMATOZOA; EXTRACTION; FERTILIZATION; MEN; PREGNANCIES; INTEGRITY; EJACULATE	Introduction: Severely compromised spermatogenesis typical of men with virtual azoospermia or non-obstructive azoospermia requires an extreme search for spermatozoa. Our goal was to evaluate the usefulness of a meticulous search carried out in ejaculated or surgically retrieved specimens in achieving pre-and post-implantation embryo development. Patients and Methods: In a retrospective cohort study carried out in an academic institution, intracytoplasmic sperm injection (ICSI) outcomes were reviewed as a function of length of microscopic sperm search in ejaculated and surgically retrieved specimens. Couples whose male partner presented with either virtual or non-obstructive azoospermia were treated by ICSI and categorized according to the time spent in identifying and retrieving enough spermatozoa to inject all the oocyte cohort. Semen parameter, fertilization, pregnancies, deliveries, and child welfare in relation to increasing search time were analyzed and compared. Result(s): The maternal and paternal ages were comparable in both ejaculated and testicular sperm extraction (TESE) groups along with the oocytes retrieved. The fertilization rates for both ejaculated and TESE progressively decreased with increasing time (P<0.0001). Clinical pregnancies in the ejaculated cohort remained satifactory. In the TESE cohort, there was a decrease in pregnancy rate with increasing time, from 44% to 23%. In a limited number of cases, offspring health was evaluated in both semen sources and appeared reassuring. Conclusion(s): An extensive and at time exhaustive sperm quest yields kinetically and morphologically impaired spermatozoa without apparent impact on embryo developmental competence. Retrieval of spermatozoa from the seminiferous tubules provided more consistent fertilization and pregnancy outcomes than those retrieved from the ejaculate. A trend indicated that pregnancy rate decreased as search time increased in the TESE group. The utilization of the scarce and unselected spermatozoa did not obviously impair embryo development or cause post-implantation errors.	[Neri, Queenie V.; Rosenwaks, Zev] Weill Cornell Med Coll, Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY USA; [Schlegel, Peter N.] Weill Cornell Med Coll, Dept Urol, New York, NY USA	Cornell University; Cornell University		gdpalerm@med.cornell.edu						Aitken RJ, 2013, MOL HUM REPROD, V19, P475, DOI 10.1093/molehr/gat025; Aitken RJ, 2012, J ANDROL, V33, P1096, DOI 10.2164/jandrol.112.016535; [Anonymous], 2012, WORLDS NUMB IVF ICSI; Ben-Ami I, 2013, FERTIL STERIL, V99, P1867, DOI 10.1016/j.fertnstert.2013.02.025; Bendikson K, 2006, HUM REPROD, V21, pI105; Bendikson KA, 2008, J UROLOGY, V180, P1060, DOI 10.1016/j.juro.2008.05.025; Berkovitz A, 2006, REPROD BIOMED ONLINE, V12, P634, DOI 10.1016/S1472-6483(10)61191-1; Bungum M, 2011, ASIAN J ANDROL, V13, P69, DOI 10.1038/aja.2010.73; Chen C, 2011, HUM REPROD, V26, pI30; Dabaja AA, 2013, ASIAN J ANDROL, V15, P35, DOI 10.1038/aja.2012.141; De Jonge C, 2012, FERTIL STERIL, V97, P260, DOI 10.1016/j.fertnstert.2011.12.045; De Rycke M, 2002, HUM REPROD, V17, P2487, DOI 10.1093/humrep/17.10.2487; Desai NR, 2010, FERTIL STERIL, V94, P1541, DOI 10.1016/j.fertnstert.2009.12.041; Evenson DP, 2006, THERIOGENOLOGY, V65, P979, DOI 10.1016/j.theriogenology.2005.09.011; Evenson DP, 2002, J ANDROL, V23, P25, DOI 10.1002/j.1939-4640.2002.tb02599.x; Harvey L, 2013, HUM REPROD, V28, P67; HOLMES LB, 1976, NEW ENGL J MED, V295, P204, DOI 10.1056/NEJM197607222950406; Hu JCY, 2012, HUM REPROD, V27; Hu JCY, 2010, FERTIL STERIL, V94, pS118, DOI 10.1016/j.fertnstert.2010.07.482; Huang JYJ, 2012, BEST PRACT RES CL OB, V26, P777, DOI 10.1016/j.bpobgyn.2012.08.017; Isachenko E, 2004, HUM REPROD, V19, P932, DOI 10.1093/humrep/deh194; Just A, 2004, FERTIL STERIL, V82, P445, DOI 10.1016/j.fertnstert.2003.12.050; Kocent J, 2011, HUM REPROD, V26, pI248; Kupker W, 2002, SEMIN REPROD MED, V20, P25, DOI 10.1055/s-2002-23517; Lee R, 2009, FERTIL STERIL, V92, P188, DOI 10.1016/j.fertnstert.2008.05.053; Mahfouz R, 2010, FERTIL STERIL, V94, P2141, DOI 10.1016/j.fertnstert.2009.12.030; Monahan D, 2011, HUM REPROD, V26, pI74; Neri QV, 2004, FERTIL STERIL, V82, pS132, DOI 10.1016/j.fertnstert.2004.07.333; Neri QV, 2012, INTRACYTOPLASMIC SPE; PALERMO G, 1992, LANCET, V340, P17, DOI 10.1016/0140-6736(92)92425-F; Palermo GD, 1996, HUM REPROD, V11, P1023; Palermo GD, 1996, JAMA-J AM MED ASSOC, V276, P1893, DOI 10.1001/jama.276.23.1893; Palermo GD, 1999, HUM REPROD, V14, P741, DOI 10.1093/humrep/14.3.741; PALERMO GD, 1995, FERTIL STERIL, V63, P1231, DOI 10.1016/S0015-0282(16)57603-1; PALERMO GD, 1995, HUM REPROD, V10, P120, DOI 10.1093/humrep/10.suppl_1.120; Palermo GD, 2011, THOUGHTS ON IMSI; Palermo GD, 2014, FERTIL STERIL; Palermo GD, 2012, FERTIL STERIL, V97, P248, DOI 10.1016/j.fertnstert.2011.12.037; Palermo GD, 2008, REPROD BIOMED ONLINE, V17, P820, DOI 10.1016/S1472-6483(10)60411-7; Parmegiani L, 2010, FERTIL STERIL, V93, P598, DOI 10.1016/j.fertnstert.2009.03.033; Ramasamy R, 2011, FERTIL STERIL, V96, P299, DOI 10.1016/j.fertnstert.2011.05.033; Ramasamy R, 2011, J UROLOGY, V185, P1027, DOI 10.1016/j.juro.2010.10.066; RonEl R, 1997, HUM REPROD, V12, P1222; Schlegel PN, 1999, HUM REPROD, V14, P131, DOI 10.1093/humrep/14.1.131; Squires J, 2003, FERTIL STERIL, V79, P453, DOI 10.1016/S0015-0282(02)04685-X; Squires J, 1997, J PEDIATR PSYCHOL, V22, P313, DOI 10.1093/jpepsy/22.3.313; Sullivan EA, 2013, HUM REPROD, V28, P1375, DOI 10.1093/humrep/det036; Tournaye H, 1997, HUM REPROD, V12, P80, DOI 10.1093/humrep/12.1.80; Veeck LL, 1999, ATLAS HUMAN GEMETES; Vernaeve V, 2005, INT J ANDROL, V28, P22, DOI 10.1111/j.1365-2605.2004.00501.x; Vernaeve V, 2006, HUM REPROD, V21, P1551, DOI 10.1093/humrep/del012; Vutyavanich T, 2012, ASIAN J ANDROL, V14, P850, DOI 10.1038/aja.2012.106; Walis G, 2010, HUM REPROD, V25, pI145; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Zou YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061593	55	45	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113671	10.1371/journal.pone.0113671	http://dx.doi.org/10.1371/journal.pone.0113671			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437298	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900062
J	McMahon, M; Campbell, KH; MacLeod, AK; McLaughlin, LA; Henderson, CJ; Wolf, CR				McMahon, Michael; Campbell, Kathryn H.; MacLeod, A. Kenneth; McLaughlin, Lesley A.; Henderson, Colin J.; Wolf, C. Roland			HDAC Inhibitors Increase NRF2-Signaling in Tumour Cells and Blunt the Efficacy of Co-Adminstered Cytotoxic Agents	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; ANTIOXIDANT RESPONSE; PROTEASOMAL DEGRADATION; KEAP1-NRF2 PATHWAY; ADAPTIVE RESPONSE; CANCER; ACTIVATION; STRESS; KERATINOCYTES; ELECTROPHILES	The NRF2 signalling cascade provides a primary response against electrophilic chemicals and oxidative stress. The activation of NRF2-signaling is anticipated to have adverse clinical consequences; NRF2 is activated in a number of cancers and, additionally, its pharmacological activation by one compound can reduce the toxicity or efficiency of a second agent administered concomitantly. In this work, we have analysed systematically the ability of 152 research, pre-clinical or clinically used drugs to induce an NRF2 response using the MCF7-AREc32 NRF2 reporter. Ten percent of the tested drugs induced an NRF2 response. The NRF2 activators were not restricted to classical cytotoxic alkylating agents but also included a number of emerging anticancer drugs, including an IGF1-R inhibitor (NVP-AEW541), a PIM-1 kinase inhibitor (Pim1 inhibitor 2), a PLK1 inhibitor (BI 2536) and most strikingly seven of nine tested HDAC inhibitors. These findings were further confirmed by demonstrating NRF2-dependent induction of endogenous AKR genes, biomarkers of NRF2 activity. The ability of HDAC inhibitors to stimulate NRF2-signalling did not diminish their own potency as antitumour agents. However, when used to pre-treat cells, they did reduce the efficacy of acrolein. Taken together, our data suggest that the ability of drugs to stimulate NRF2 activity is common and should be investigated as part of the drug-development process.	[McMahon, Michael; Campbell, Kathryn H.; MacLeod, A. Kenneth; McLaughlin, Lesley A.; Henderson, Colin J.; Wolf, C. Roland] Univ Dundee, Med Res Inst, Dundee, Scotland	University of Dundee	Wolf, CR (corresponding author), Univ Dundee, Med Res Inst, Dundee, Scotland.	c.r.wolf@dundee.ac.uk	Henderson, Colin/AAE-7141-2019; McMahon, Michael J/F-7070-2010	Henderson, Colin/0000-0002-4764-639X; McMahon, Michael J/0000-0001-8615-9351; Wolf, Charles Roland/0000-0002-6969-0113	Cancer Research UK [C4639/A12330]; Cancer Research UK [10822] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was funded by a grant C4639/A12330 awarded to CRW by Cancer Research UK (www.cancerresearchuk.org/). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey-Downs LC, 2012, J GERONTOL A-BIOL, V67, P313, DOI 10.1093/gerona/glr164; Connor TO, 1999, BIOCHEM J, V504, P487; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Frew AJ, 2009, CANCER LETT, V280, P125, DOI 10.1016/j.canlet.2009.02.042; Gao XQ, 2001, P NATL ACAD SCI USA, V98, P15221, DOI 10.1073/pnas.261572998; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Higgins LG, 2009, TOXICOL APPL PHARM, V237, P267, DOI 10.1016/j.taap.2009.03.005; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; MacLeod AK, 2009, CARCINOGENESIS, V30, P1571, DOI 10.1093/carcin/bgp176; Mathijssen RHJ, 2014, NAT REV CLIN ONCOL; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; McMahon M, 2010, P NATL ACAD SCI USA, V107, P18838, DOI 10.1073/pnas.1007387107; McMahon M, 2006, J BIOL CHEM, V281, P24756, DOI 10.1074/jbc.M601119200; Mitsuishi Y, 2012, CANCER CELL, V22, P66, DOI 10.1016/j.ccr.2012.05.016; Schafer M, 2012, EMBO MOL MED, V4, P364, DOI 10.1002/emmm.201200219; Shibata T, 2008, GASTROENTEROLOGY, V135, P1358, DOI 10.1053/j.gastro.2008.06.082; Slocum SL, 2011, ARCH TOXICOL, V85, P273, DOI 10.1007/s00204-011-0675-4; Sporn M, 2012, NAT REV CANCER, V3, P1; Strohecker AM, 2013, CANCER DISCOV, V3, P1272, DOI 10.1158/2159-8290.CD-13-0397; Sun Z, 2009, MOL CELL BIOL, V29, P2658, DOI 10.1128/MCB.01639-08; Suzuki T, 2013, TRENDS PHARMACOL SCI, P1; Taguchi K, 2011, GENES CELLS, V16, P123, DOI 10.1111/j.1365-2443.2010.01473.x; Wang XJ, 2007, P NATL ACAD SCI USA, V104, P19589, DOI 10.1073/pnas.0709483104; Wang XJ, 2006, CANCER RES, V66, P10983, DOI 10.1158/0008-5472.CAN-06-2298; Wolf CR, 2001, P NATL ACAD SCI USA, V98, P2941, DOI 10.1073/pnas.071042698	27	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e114055	10.1371/journal.pone.0114055	http://dx.doi.org/10.1371/journal.pone.0114055			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427220	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400110
J	McNeill, B; Vulesevic, B; Ostojic, A; Ruel, M; Suuronen, EJ				McNeill, Brian; Vulesevic, Branka; Ostojic, Aleksandra; Ruel, Marc; Suuronen, Erik J.			Collagen matrix-induced expression of integrin alpha V beta 3 in circulating angiogenic cells can be targeted by matricellular protein CCN1 to enhance their function	FASEB JOURNAL			English	Article						biomaterial; cardiovascular disease; cell preconditioning; ischemia; neovascularization	ENDOTHELIAL PROGENITOR CELLS; HUMAN SKIN FIBROBLASTS; CYR61; MIGRATION; THERAPY; ALPHA(V)BETA(3); IDENTIFICATION; PROLIFERATION; FIBRONECTIN; MYOCARDIUM	Circulating angiogenic cells (CACs) play an important role in vascular homeostasis and hold therapeutic promise for treating a variety of cardiovascular diseases. However, further improvements are needed because the effects of CAC therapy remain minimal or transient. The regenerative potential of these cells can be improved by culture on a collagen-based matrix through the up-regulation of key integrin proteins. We found that human CAC function was enhanced by using the matricellular protein CCN1 (CYR61/CTGF/NOV family member 1) to target integrin alpha V and beta 3, which are up-regulated on matrix. Compared tomatrix-cultured CACs, CCN1-matrix CACs exhibited a 2.2-fold increase in cell proliferation, 1.8-fold greater migration toward VEGF, and 1.7-fold more incorporation into capillary-like structures in an angiogenesis assay. In vivo, intramuscular injection of CCN1-matrix-cultured CACs into ischemic hind limbs of CD-1 nude mice resulted in blood flow recovery to 80% of baseline, which was greater than matrix-cultured CACs (66%) and PBS (35%) treatment groups. Furthermore, transplanted CCN1-matrix CACs exhibited greater engraftment (11-fold) and stimulated the up-regulation of survival and angiogenic genes (>3-fold). These findings reveal the importance of cell-matrix interactions in regulating CAC function and also reveal a mechanism by which these may be exploited to enhance cell therapies for ischemic disease.	[McNeill, Brian; Vulesevic, Branka; Ostojic, Aleksandra; Ruel, Marc; Suuronen, Erik J.] Univ Ottawa, Inst Heart, Div Cardiac Surg, Ottawa, ON K1Y 4W7, Canada; [Vulesevic, Branka; Ostojic, Aleksandra; Ruel, Marc; Suuronen, Erik J.] Univ Ottawa, Dept Cellular & Mol Med, Ottawa, ON K1Y 4W7, Canada	University of Ottawa; University of Ottawa Heart Institute; University of Ottawa	Suuronen, EJ (corresponding author), Univ Ottawa, Inst Heart, Div Cardiac Surg, 40 Ruskin St,H5227, Ottawa, ON K1Y 4W7, Canada.	esuuronen@ottawaheart.ca		RUEL, MARC/0000-0002-0487-1319; Vulesevic, Branka/0000-0003-2297-2209	Canadian Institutes of Health Research (CIHR) [MOP-77536]; Ottawa Heart Institute Cardiac Surgery Endowed Chair; Ottawa Heart Institute Lawrence Soloway Research Fellowship; Research Fellowship from the Heart & Stroke Foundation of Canada; CIHR Canadian Graduate Scholarship	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Ottawa Heart Institute Cardiac Surgery Endowed Chair; Ottawa Heart Institute Lawrence Soloway Research Fellowship; Research Fellowship from the Heart & Stroke Foundation of Canada; CIHR Canadian Graduate Scholarship(Canadian Institutes of Health Research (CIHR))	This work was supported from the Canadian Institutes of Health Research (CIHR; grant MOP-77536 to M.R. and E.J.S.), and the Ottawa Heart Institute Cardiac Surgery Endowed Chair (to M.R.). B.M. was the recipient of the Ottawa Heart Institute Lawrence Soloway Research Fellowship and a Research Fellowship from the Heart & Stroke Foundation of Canada, and B.V. of a CIHR Canadian Graduate Scholarship.	Ahmadi A, 2014, BIOMATERIALS, V35, P4749, DOI 10.1016/j.biomaterials.2014.02.028; Akita T, 2003, LAB INVEST, V83, P65, DOI 10.1097/01.LAB.0000050761.67879.E4; Asahara T, 2011, STEM CELLS, V29, P1650, DOI 10.1002/stem.745; Bouvard D, 2013, NAT REV MOL CELL BIO, V14, P430, DOI 10.1038/nrm3599; Brenes RA, 2012, VASCULAR, V20, P360, DOI 10.1258/vasc.2011.201205; Campbell ID, 2011, COLD SPRING HARB PER, V1, P3, DOI DOI 10.1101/CSHPERSPECT; Chen CC, 2001, J BIOL CHEM, V276, P10443, DOI 10.1074/jbc.M008087200; Chen CC, 2001, J BIOL CHEM, V276, P47329, DOI 10.1074/jbc.M107666200; Chen NY, 2004, J BIOL CHEM, V279, P44166, DOI 10.1074/jbc.M406813200; Choi S, 2009, BLOOD, V113, P1845, DOI 10.1182/blood-2008-05-160671; Colombo E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066734; Creager MA, 2012, NEW ENGL J MED, V366, P2198, DOI 10.1056/NEJMcp1006054; Danhier F, 2012, MOL PHARMACEUT, V9, P2961, DOI 10.1021/mp3002733; Emre Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3842; Espinoza I, 2014, J CELL COMMUN SIGNAL, V8, P23, DOI 10.1007/s12079-013-0214-6; Fadini GP, 2012, CIRC RES, V110, P624, DOI 10.1161/CIRCRESAHA.111.243386; Fan D, 2014, CIRC RES, V114, P889, DOI 10.1161/CIRCRESAHA.114.302335; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Grzeszkiewicz TM, 2001, J BIOL CHEM, V276, P21943, DOI 10.1074/jbc.M100978200; Heida NM, 2010, ARTERIOSCL THROM VAS, V30, P200, DOI 10.1161/ATVBAHA.109.192807; Jin Y, 2005, AM J RESP CELL MOL, V33, P297, DOI 10.1165/rcmb.2005-0144OC; Jin YJ, 2011, CELL SIGNAL, V23, P125, DOI 10.1016/j.cellsig.2010.08.012; Karl E, 2007, CELL DEATH DIFFER, V14, P1657, DOI 10.1038/sj.cdd.4402174; Kireeva ML, 1996, MOL CELL BIOL, V16, P1326; Krishnamurthy P, 2011, CIRC RES, V109, P1280, DOI 10.1161/CIRCRESAHA.111.248369; Kuraitis D, 2012, BIOMATERIALS, V33, P428, DOI 10.1016/j.biomaterials.2011.09.078; Kuraitis D, 2011, J MOL CELL CARDIOL, V51, P187, DOI 10.1016/j.yjmcc.2011.04.011; Lau LF, 2012, J CELL COMMUN SIGNAL, V6, P121, DOI 10.1007/s12079-012-0169-z; Lau LF, 2011, CELL MOL LIFE SCI, V68, P3149, DOI 10.1007/s00018-011-0778-3; Lau LF, 1999, EXP CELL RES, V248, P44, DOI 10.1006/excr.1999.4456; Leu SJ, 2002, J BIOL CHEM, V277, P46248, DOI 10.1074/jbc.M209288200; Lutolf MP, 2009, NATURE, V462, P433, DOI 10.1038/nature08602; Mackie AR, 2011, TEX HEART I J, V38, P474; Menendez JA, 2005, ONCOGENE, V24, P761, DOI 10.1038/sj.onc.1208238; PYTELA R, 1985, CELL, V40, P191, DOI 10.1016/0092-8674(85)90322-8; Resch T, 2012, STEM CELL REV REP, V8, P926, DOI 10.1007/s12015-011-9332-9; Rozen S, 2000, Methods Mol Biol, V132, P365; Schmidt MR, 2012, J CARDIOVASC MED, V13, P667, DOI 10.2459/JCM.0b013e328357bff2; Silvestre JS, 2013, PHYSIOL REV, V93, P1743, DOI 10.1152/physrev.00006.2013; Sun GM, 2012, MACROMOL BIOSCI, V12, P21, DOI 10.1002/mabi.201100258; Suuronen EJ, 2009, FASEB J, V23, P1447, DOI 10.1096/fj.08-111054; You JJ, 2014, CELL SIGNAL, V26, P133, DOI 10.1016/j.cellsig.2013.08.026; Yu JX, 2009, J VASC SURG, V50, P608, DOI 10.1016/j.jvs.2009.05.049; Yu Y, 2008, EXP CELL RES, V314, P3198, DOI 10.1016/j.yexcr.2008.08.001; Zemani F, 2008, ARTERIOSCL THROM VAS, V28, P644, DOI 10.1161/ATVBAHA.107.160044	45	7	7	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1198	1207		10.1096/fj.14-261586	http://dx.doi.org/10.1096/fj.14-261586			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25466895				2022-12-26	WOS:000354115000009
J	Lu, LY; Kuang, H; Korakavi, G; Yu, XC				Lu, Lin-Yu; Kuang, Henry; Korakavi, Gautam; Yu, Xiaochun			Topoisomerase II Regulates the Maintenance of DNA Methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMIMETHYLATED CPG SITES; HISTONE H3 TAIL; SRA DOMAIN; METHYLTRANSFERASE DNMT1; EPIGENETIC INHERITANCE; LYSINE-9 METHYLATION; STRUCTURAL BASIS; PROTEIN UHRF1; TANDEM TUDOR; RECOGNITION	The maintenance of DNA methylation in nascent DNA is a critical event for numerous biological processes. Following DNA replication, DNMT1 is the key enzyme that strictly copies the methylation pattern from the parental strand to the nascent DNA. However, the mechanism underlying this highly specific event is not thoroughly understood. In this study, we identified topoisomerase II alpha (TopoII alpha) as a novel regulator of the maintenance DNA methylation. UHRF1, a protein important for global DNA methylation, interacts with TopoII alpha and regulates its localization to hemimethylated DNA. TopoII alpha decatenates the hemimethylated DNA following replication, which might facilitate the methylation of the nascent strand by DNMT1. Inhibiting this activity impairs DNA methylation at multiple genomic loci. We have uncovered a novel mechanism during the maintenance of DNA methylation.	[Lu, Lin-Yu] Zhejiang Univ, Womens Hosp, Sch Med, Hangzhou 310006, Zhejiang, Peoples R China; [Lu, Lin-Yu] Zhejiang Univ, Inst Translat Med, Hangzhou 310006, Zhejiang, Peoples R China; [Kuang, Henry; Korakavi, Gautam; Yu, Xiaochun] Univ Michigan, Sch Med, Dept Internal Med, Div Mol Med & Genet, Ann Arbor, MI 48109 USA	Zhejiang University; Zhejiang University; University of Michigan System; University of Michigan	Lu, LY (corresponding author), Zhejiang Univ, Womens Hosp, Sch Med, Hangzhou 310006, Zhejiang, Peoples R China.	lulinyu@zju.edu.cn; xiayu@umich.edu			National Institutes of Health [CA132755, CA130899]; National Natural Science Foundation of China [81471494]; Department of Defense; NATIONAL CANCER INSTITUTE [R01CA130899, R01CA132755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Defense(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA132755 and CA130899 (to X. Y.). This work was also supported by National Natural Science Foundation of China Project 81471494 (to L.-Y. L.).; Recipient of an Era of Hope Scholar Award from the Department of Defense. To whom correspondence may be addressed. Tel.: 734-615-4945; Fax: 734-936-6684; E-mail: xiayu@umich.edu.	Akimitsu N, 2003, GENES CELLS, V8, P393, DOI 10.1046/j.1365-2443.2003.00643.x; Almouzni G, 2011, NUCLEUS-PHILA, V2, P332, DOI 10.4161/nucl.2.5.17707; Arand J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002750; Arita K, 2008, NATURE, V455, P818, DOI 10.1038/nature07249; Arita K, 2012, P NATL ACAD SCI USA, V109, P12950, DOI 10.1073/pnas.1203701109; Avvakumov GV, 2008, NATURE, V455, P822, DOI 10.1038/nature07273; Bashtrykov P, 2014, J BIOL CHEM, V289, P4106, DOI 10.1074/jbc.M113.528893; Bashtrykov P, 2012, CHEM BIOL, V19, P572, DOI 10.1016/j.chembiol.2012.03.010; Berkyurek AC, 2014, J BIOL CHEM, V289, P379, DOI 10.1074/jbc.M113.523209; Boos G, 2001, INT J BIOL MACROMOL, V28, P103, DOI 10.1016/S0141-8130(00)00157-4; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Bulut-Karslioglu A, 2014, MOL CELL, V55, P277, DOI 10.1016/j.molcel.2014.05.029; Cheng JD, 2013, J BIOL CHEM, V288, P1329, DOI 10.1074/jbc.M112.415398; Groth A, 2007, CELL, V128, P721, DOI 10.1016/j.cell.2007.01.030; Hashimoto H, 2008, NATURE, V455, P826, DOI 10.1038/nature07280; Hiratani L, 2009, CURR OPIN GENET DEV, V19, P142, DOI 10.1016/j.gde.2009.02.002; Hu LL, 2011, CELL RES, V21, P1374, DOI 10.1038/cr.2011.124; Lane AB, 2013, J CELL BIOL, V203, P471, DOI 10.1083/jcb.201303045; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Meilinger D, 2009, EMBO REP, V10, P1259, DOI 10.1038/embor.2009.201; Nady N, 2011, J BIOL CHEM, V286, P24300, DOI 10.1074/jbc.M111.234104; Nishiyama A, 2013, NATURE, V502, P249, DOI 10.1038/nature12488; Nitiss JL, 2009, NAT REV CANCER, V9, P327, DOI 10.1038/nrc2608; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Rajakumara E, 2011, MOL CELL, V43, P275, DOI 10.1016/j.molcel.2011.07.006; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Rothbart SB, 2013, GENE DEV, V27, P1288, DOI 10.1101/gad.220467.113; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Song JK, 2012, SCIENCE, V335, P709, DOI 10.1126/science.1214453; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Vilkaitis G, 2005, J BIOL CHEM, V280, P64, DOI 10.1074/jbc.M411126200; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wang CK, 2011, CELL RES, V21, P1379, DOI 10.1038/cr.2011.123; Xie S, 2012, J MOL BIOL, V415, P318, DOI 10.1016/j.jmb.2011.11.012	35	11	12	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					851	860		10.1074/jbc.M114.611509	http://dx.doi.org/10.1074/jbc.M114.611509			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25451918	hybrid, Green Published			2022-12-26	WOS:000347778200015
J	Sieracki, JL; Bossenbroek, JM; Chadderton, WL				Sieracki, Jennifer L.; Bossenbroek, Jonathan M.; Chadderton, W. Lindsay			A Spatial Modeling Approach to Predicting the Secondary Spread of Invasive Species Due to Ballast Water Discharge	PLOS ONE			English	Article							DIKEROGAMMARUS-VILLOSUS CRUSTACEA; GREAT-LAKES; BIOLOGICAL INVASIONS; RUFFE GYMNOCEPHALUS; POTENTIAL SPREAD; MARINE INVASIONS; YELLOW PERCH; DISPERSAL; RISK; MECHANISMS	Ballast water in ships is an important contributor to the secondary spread of invasive species in the Laurentian Great Lakes. Here, we use a model previously created to determine the role ballast water management has played in the secondary spread of viral hemorrhagic septicemia virus (VHSV) to identify the future spread of one current and two potential invasive species in the Great Lakes, the Eurasian Ruffe (Gymnocephalus cernuus), killer shrimp (Dikerogammarus villosus), and golden mussel (Limnoperna fortunei), respectively. Model predictions for Eurasian Ruffe have been used to direct surveillance efforts within the Great Lakes and DNA evidence of ruffe presence was recently reported from one of three high risk port localities identified by our model. Predictions made for killer shrimp and golden mussel suggest that these two species have the potential to become rapidly widespread if introduced to the Great Lakes, reinforcing the need for proactive ballast water management. The model used here is flexible enough to be applied to any species capable of being spread by ballast water in marine or freshwater ecosystems.	[Sieracki, Jennifer L.; Bossenbroek, Jonathan M.] Univ Toledo, Lake Erie Ctr, Dept Environm Sci, Oregon, OH 43607 USA; [Chadderton, W. Lindsay] Univ Notre Dame, Great Lakes Project, Environm Change Initiat, South Bend, IN USA	University of Toledo; University of Notre Dame	Sieracki, JL (corresponding author), Univ Toledo, Lake Erie Ctr, Dept Environm Sci, Oregon, OH 43607 USA.	sier0010@gmail.com	Bossenbroek, Jonathan M/F-3664-2011		USDA NIFA [OHOW-2010-01479, 2010-38927-21048]; National Oceanic and Atmospheric Agency, Center for Sponsored Coastal Ocean Research, NOAA-CSCOR [NA10NOS4780218]	USDA NIFA(United States Department of Agriculture (USDA)); National Oceanic and Atmospheric Agency, Center for Sponsored Coastal Ocean Research, NOAA-CSCOR	Additional funding has been provided by USDA NIFA Project #OHOW-2010-01479, Award Number 2010-38927-21048, as well as National Oceanic and Atmospheric Agency, Center for Sponsored Coastal Ocean Research, NOAA-CSCOR #NA10NOS4780218. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, EC HUM WELL BEING WE; Bailey SA, 2012, 2011104 DFO CAN SCI; Beeton AM, 2002, ENVIRON CONSERV, V29, P21, DOI 10.1017/S0376892902000036; Benson A.J., 2013, QUAGGA ZEBRA MUSSELS, P9, DOI DOI 10.1201/B15437-6; Boets P, 2010, ECOL INFORM, V5, P133, DOI 10.1016/j.ecoinf.2009.12.005; Bossenbroek JM, 2007, CONSERV BIOL, V21, P800, DOI 10.1111/j.1523-1739.2006.00614.x; BRANDT R A M, 1971, Archiv fuer Molluskenkunde, V101, P111; Briski E, 2012, J APPL ECOL, V49, P1124, DOI 10.1111/j.1365-2664.2012.02186.x; Bruijs MCM, 2001, ARCH HYDROBIOL, V152, P633; Buchan LAJ, 2000, ECOL APPL, V10, P1442, DOI 10.1890/1051-0761(2000)010[1442:PTLOEW]2.0.CO;2; Campbell ML, 2007, MAR POLLUT BULL, V55, P360, DOI 10.1016/j.marpolbul.2007.01.015; Carlton James T., 1993, P677; Carrasco LR, 2010, ECOL MODEL, V221, P2068, DOI 10.1016/j.ecolmodel.2010.05.012; Coffin M. F., 2000, P OCEAN DRILLING PRO, V183, P1; Collin SB, 2013, MAR POLLUT BULL, V73, P64, DOI 10.1016/j.marpolbul.2013.05.040; DARRIGRAN G, 1995, VELIGER, V38, P171; Devin S, 2004, INT REV HYDROBIOL, V89, P21, DOI 10.1002/iroh.200310667; Dick JTA, 2000, P ROY SOC B-BIOL SCI, V267, P977, DOI 10.1098/rspb.2000.1099; Dick JTA, 2002, CAN J FISH AQUAT SCI, V59, P1078, DOI 10.1139/F02-074; Drake DAR, 2010, ECOL APPL, V20, P2286, DOI 10.1890/09-2005.1; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fullerton AH, 1998, J GREAT LAKES RES, V24, P319, DOI 10.1016/S0380-1330(98)70823-8; Holeck KT, 2004, BIOSCIENCE, V54, P919, DOI 10.1641/0006-3568(2004)054[0919:BTWBIT]2.0.CO;2; Jerde CL, 2011, CONSERV LETT, V4, P150, DOI 10.1111/j.1755-263X.2010.00158.x; Karatayev AY, 2007, J SHELLFISH RES, V26, P205, DOI 10.2983/0730-8000(2007)26[205:TIBDPA]2.0.CO;2; Karatayev AY, 2007, BIOL INVASIONS, V9, P161, DOI 10.1007/s10530-006-9013-9; Keller RP, 2011, DIVERS DISTRIB, V17, P93, DOI 10.1111/j.1472-4642.2010.00696.x; Keller RP, 2009, CONSERV BIOL, V23, P1526, DOI 10.1111/j.1523-1739.2009.01249.x; Lodge DM, 2006, ECOL APPL, V16, P2035, DOI 10.1890/1051-0761(2006)016[2035:BIRFUP]2.0.CO;2; MacNeil C, 2010, AQUAT INVASIONS, V5, P441, DOI 10.3391/ai.2010.5.4.15; Manel S, 2001, J APPL ECOL, V38, P921, DOI 10.1046/j.1365-2664.2001.00647.x; McGee S, 2006, MAR POLLUT BULL, V52, P1634, DOI 10.1016/j.marpolbul.2006.06.005; Miller AW, 2011, BIOSCIENCE, V61, P880, DOI 10.1525/bio.2011.61.11.7; MILLER R. C., 1931, LINGNAN SCI JOUR, V10, P307; Mizuno T, 1970, Biol. J., V2, P77, DOI 10.1111/j.1095-8312.1970.tb01706.x; Molnar JL, 2008, FRONT ECOL ENVIRON, V6, P485, DOI 10.1890/070064; MORTON B, 1973, Malacologia, V12, P265; Muller JC, 2002, FRESHWATER BIOL, V47, P2039, DOI 10.1046/j.1365-2427.2002.00944.x; MUSKO IB, 1994, CRUSTACEANA, V66, P144, DOI 10.1163/156854094X00639; National Ballast Information Clearinghouse, 2009, NBIC ONL DAT; Nesemann H., 1995, Miscellanea Zoologica Hungarica, V10, P49; Panetta FD, 2005, DIVERS DISTRIB, V11, P435, DOI 10.1111/j.1366-9516.2005.00179.x; Prasad AM, 2010, LANDSCAPE ECOL, V25, P353, DOI 10.1007/s10980-009-9434-9; Ricciardi A, 2006, DIVERS DISTRIB, V12, P425, DOI 10.1111/j.1366-9516.2006.00262.x; Ruiz GM, 1997, AM ZOOL, V37, P621; Ruiz GM, 2013, ECOL APPL, V23, P311, DOI 10.1890/11-1660.1; Rup MP, 2010, CAN J FISH AQUAT SCI, V67, P256, DOI 10.1139/F09-180; Savino JF, 1996, T AM FISH SOC, V125, P562, DOI 10.1577/1548-8659(1996)125<0562:CBNRAN>2.3.CO;2; Schneider DW, 1998, CONSERV BIOL, V12, P788, DOI 10.1046/j.1523-1739.1998.97042.x; Sieracki JL, 2014, BIOL INVASIONS, V16, P1043, DOI 10.1007/s10530-013-0556-2; Sierszen ME, 1996, J GREAT LAKES RES, V22, P436, DOI 10.1016/S0380-1330(96)70968-1; Simberloff D, 2005, FRONT ECOL ENVIRON, V3, P12, DOI 10.2307/3868440; Stepien CA, 1998, J GREAT LAKES RES, V24, P361, DOI 10.1016/S0380-1330(98)70827-5; Stepien CA, 2005, RISK ANAL, V25, P1043, DOI 10.1111/j.1539-6924.2005.00655.x; USEPA, 2013, VESS GEN PERM DISCH; USGS, 2009, NAS NON AQ SPEC DAT	56	15	15	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114217	10.1371/journal.pone.0114217	http://dx.doi.org/10.1371/journal.pone.0114217			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470822	Green Published, gold, Green Submitted			2022-12-26	WOS:000349128700087
J	Yamashita, K; Waraya, M; Kim, MS; Sidransky, D; Katada, N; Sato, T; Nakamura, T; Watanabe, M				Yamashita, Keishi; Waraya, Mina; Kim, Myoung Sook; Sidransky, David; Katada, Natsuya; Sato, Takeo; Nakamura, Takatoshi; Watanabe, Masahiko			Detection of Methylated CDO1 in Plasma of Colorectal Cancer; A PCR Study	PLOS ONE			English	Article							TUMOR-SUPPRESSIVE ACTIVITY; DNA METHYLATION; PROGNOSIS; CARCINOMA; GROWTH; CELLS; BLOOD	Background: Cysteine biology is important for the chemosensitivity of cancer cells. Our research has focused on the epigenetic silencing of cysteine dioxygenase type 1 (CDO1) in colorectal cancer (CRC). In this study, we describe detection of CDO1 methylation in the plasma of CRC patients using methylation specific PCR (Q-MSP) and extensive analysis of the PCR reaction. Methods: DNA was extracted from plasma, and analysed for methylation of the CDO1 gene using Q-MSP. The detection rate of CDO1 gene methylation was calculated and compared with that of diluted DNA extracted from "positive control'' DLD1 cells. CDO1 gene methylation in the plasma of 40 CRC patients that were clinicopathologically analysed was then determined. Results: (1) The cloned sequence analysis detected 93.3% methylation of the promoter CpG islands of the CDO1 gene of positive control DLD1 cells and 4.7% methylation of the negative control HepG2 CDO1 gene. (2) DLD1 CDO1 DNA could not be detected in this assay if the extracted DNA was diluted similar to 1000 fold. The more DNA that was used for the PCR reaction, the more effectively it was amplified in Q-MSP. (3) By increasing the amount of DNA used, methylated CDO1 could be clearly detected in the plasma of 8 (20%) of the CRC patients. However, the percentage of CRC patients detected by methylated CDO1 in plasma was lower than that detected by CEA (35.9%) or CA19-9 (23.1%) in preoperative serum. Combination of CEA/CA19-9 plus plasma methylated CDO1 could increase the rate of detection of curable CRC patients (39.3%) as compared to CEA/CA19-9 (25%). Conclusion: We have described detection of CDO1 methylation in the plasma of CRC patients. Although CDO1 methylation was not detected as frequently as conventional tumor markers, analysis of plasma CDO1 methylation in combination with CEA/CA19-9 levels increases the detection rate of curable CRC patients.	[Yamashita, Keishi; Waraya, Mina; Katada, Natsuya; Sato, Takeo; Nakamura, Takatoshi; Watanabe, Masahiko] Kitasato Univ Hosp, Dept Surg, Minami Ku, Sagamihara, Kanagawa 2520375, Japan; [Kim, Myoung Sook; Sidransky, David] Johns Hopkins Univ, Head & Neck Canc Res Inst, Dept Otolaryngol, Baltimore, MD 21231 USA	Kitasato University; Johns Hopkins University	Yamashita, K (corresponding author), Kitasato Univ Hosp, Dept Surg, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520375, Japan.	keishi23@med.kitasato-u.ac.jp						Brait M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044951; deVos T, 2009, CLIN CHEM, V55, P1337, DOI 10.1373/clinchem.2008.115808; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Grutzmann R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003759; Ishimoto T, 2011, CANCER CELL, V19, P387, DOI 10.1016/j.ccr.2011.01.038; Jeschke J, 2013, CLIN CANCER RES, V19, P3201, DOI 10.1158/1078-0432.CCR-12-3751; Katoh H, 2008, WORLD J SURG, V32, P1130, DOI 10.1007/s00268-008-9535-7; Katoh H, 2008, ANTICANCER RES, V28, P1933; Kawakami K, 2000, J NATL CANCER I, V92, P1805, DOI 10.1093/jnci/92.22.1805; Kim MS, 2008, ONCOGENE, V27, P3624, DOI 10.1038/sj.onc.1211021; Kim MS, 2008, ONCOGENE, V27, P2045, DOI 10.1038/sj.onc.1210842; Kim MS, 2006, CANCER RES, V66, P3409, DOI 10.1158/0008-5472.CAN-05-1608; Kim MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006555; Li M, 2009, NAT BIOTECHNOL, V27, P858, DOI 10.1038/nbt.1559; Lofton-Day C, 2008, CLIN CHEM, V54, P414, DOI 10.1373/clinchem.2007.095992; Matsubayashi H, 2006, CANCER RES, V66, P1208, DOI 10.1158/0008-5472.CAN-05-2664; Nagano O, 2013, ONCOGENE, V32, P5191, DOI 10.1038/onc.2012.638; Prabhu A, 2014, CANCER RES, V74, P787, DOI 10.1158/0008-5472.CAN-13-1423; Toth K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046000; Yamashita K, 2002, CANCER CELL, V2, P485, DOI 10.1016/S1535-6108(02)00215-5; Yamashita K, 2011, SURG TODAY, V41, P24, DOI 10.1007/s00595-010-4370-5; Yamashita K, 2009, CANCER SCI, V100, P195, DOI 10.1111/j.1349-7006.2008.01022.x	22	18	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113546	10.1371/journal.pone.0113546	http://dx.doi.org/10.1371/journal.pone.0113546			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469504	Green Published, gold, Green Submitted			2022-12-26	WOS:000349128700032
J	Dukart, J; Bertolino, A				Dukart, Juergen; Bertolino, Alessandro			When Structure Affects Function - The Need for Partial Volume Effect Correction in Functional and Resting State Magnetic Resonance Imaging Studies	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; VOXEL-BASED MORPHOMETRY; ADULT HUMAN BRAINS; ALZHEIMERS-DISEASE; ELECTROCONVULSIVE-THERAPY; FDG PET; FMRI; CONNECTIVITY; MRI; ACTIVATION	Both functional and also more recently resting state magnetic resonance imaging have become established tools to investigate functional brain networks. Most studies use these tools to compare different populations without controlling for potential differences in underlying brain structure which might affect the functional measurements of interest. Here, we adapt a simulation approach combined with evaluation of real resting state magnetic resonance imaging data to investigate the potential impact of partial volume effects on established functional and resting state magnetic resonance imaging analyses. We demonstrate that differences in the underlying structure lead to a significant increase in detected functional differences in both types of analyses. Largest increases in functional differences are observed for highest signal-to-noise ratios and when signal with the lowest amount of partial volume effects is compared to any other partial volume effect constellation. In real data, structural information explains about 25% of within-subject variance observed in degree centrality - an established resting state connectivity measurement. Controlling this measurement for structural information can substantially alter correlational maps obtained in group analyses. Our results question current approaches of evaluating these measurements in diseased population with known structural changes without controlling for potential differences in these measurements.	[Dukart, Juergen; Bertolino, Alessandro] F Hoffmann La Roche, pRED, NORD DTA, Pharma Res & Early Dev, CH-4070 Basel, Switzerland; [Dukart, Juergen] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Bertolino, Alessandro] Univ Bari, Dept Basic Med Sci Neurosci & Sense Organs, Bari, Italy	Roche Holding; Max Planck Society; Universita degli Studi di Bari Aldo Moro	Dukart, J (corresponding author), F Hoffmann La Roche, pRED, NORD DTA, Pharma Res & Early Dev, Grenzacherstr 124, CH-4070 Basel, Switzerland.	juergen.dukart@gmail.com		Dukart, Juergen/0000-0003-0492-5644				Allen G, 2007, ARCH NEUROL-CHICAGO, V64, P1482, DOI 10.1001/archneur.64.10.1482; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashwin C, 2007, NEUROPSYCHOLOGIA, V45, P2, DOI 10.1016/j.neuropsychologia.2006.04.014; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Cherkassky VL, 2006, NEUROREPORT, V17, P1687, DOI 10.1097/01.wnr.0000239956.45448.4c; Chetelat G, 2005, NEUROIMAGE, V27, P934, DOI 10.1016/j.neuroimage.2005.05.015; Daselaar SM, 2006, CEREB CORTEX, V16, P1771, DOI 10.1093/cercor/bhj112; De Martino F, 2008, NEUROIMAGE, V43, P44, DOI 10.1016/j.neuroimage.2008.06.037; Dennis NA, 2007, NEUROPSYCHOLOGIA, V45, P3157, DOI 10.1016/j.neuropsychologia.2007.07.003; Di Martino A., 2013, MOL PSYCHIAT; Draganski B, 2004, NATURE, V427, P311, DOI 10.1038/427311a; Dukart J, 2014, P NATL ACAD SCI USA, V111, P1156, DOI 10.1073/pnas.1321399111; Dukart J, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002987; Franke K, 2010, NEUROIMAGE, V50, P883, DOI 10.1016/j.neuroimage.2010.01.005; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Gryga M, 2012, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00037; Jacques PS, 2010, NEUROBIOL AGING, V31, P315, DOI 10.1016/j.neurobiolaging.2008.03.012; Johnson SC, 2000, NEUROIMAGE, V11, P179, DOI 10.1006/nimg.1999.0530; Kaiser A, 2007, INT J PSYCHOPHYSIOL, V63, P192, DOI 10.1016/j.ijpsycho.2006.03.008; Kamphausen S., 2012, WORLD J BIOL PSYCHIA; Karama S, 2002, HUM BRAIN MAPP, V16, P1, DOI 10.1002/hbm.10014; Koch W, 2012, NEUROBIOL AGING, V33, P466, DOI 10.1016/j.neurobiolaging.2010.04.013; Koshino H, 2005, NEUROIMAGE, V24, P810, DOI 10.1016/j.neuroimage.2004.09.028; Landman BA, 2011, NEUROIMAGE, V54, P2854, DOI 10.1016/j.neuroimage.2010.11.047; Lee MH, 2013, AM J NEURORADIOL, V34, P1866, DOI 10.3174/ajnr.A3263; Madsen TM, 2005, NEUROPSYCHOPHARMACOL, V30, P27, DOI 10.1038/sj.npp.1300565; MULLERGARTNER HW, 1992, J CEREBR BLOOD F MET, V12, P571, DOI 10.1038/jcbfm.1992.81; Nordanskog P, 2010, J ECT, V26, P62, DOI 10.1097/YCT.0b013e3181a95da8; Nyberg L, 2006, NEUROPSYCHOLOGIA, V44, P711, DOI 10.1016/j.neuropsychologia.2005.08.006; Perrin JS, 2012, P NATL ACAD SCI USA, V109, P5464, DOI 10.1073/pnas.1117206109; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Purdon PL, 1998, HUM BRAIN MAPP, V6, P239, DOI 10.1002/(SICI)1097-0193(1998)6:4<239::AID-HBM4>3.3.CO;2-0; Quarantelli M, 2004, J NUCL MED, V45, P192; Rocca MA, 2005, LANCET NEUROL, V4, P618, DOI 10.1016/S1474-4422(05)70171-X; Rombouts SARB, 2005, HUM BRAIN MAPP, V26, P231, DOI 10.1002/hbm.20160; Rousset OG, 1998, J NUCL MED, V39, P904; Rubia K, 2000, NEUROSCI BIOBEHAV R, V24, P13, DOI 10.1016/S0149-7634(99)00055-X; Rubia K, 2002, BEHAV BRAIN RES, V130, P47, DOI 10.1016/S0166-4328(01)00437-5; Samuraki M, 2007, EUR J NUCL MED MOL I, V34, P1658, DOI 10.1007/s00259-007-0454-x; Sehm B, 2014, NEUROBIOL AGING, V35, P232, DOI 10.1016/j.neurobiolaging.2013.06.021; Selvaraj S, 2012, BIPOLAR DISORD, V14, P135, DOI 10.1111/j.1399-5618.2012.01000.x; Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435; Smith CD, 2007, NEUROBIOL AGING, V28, P1075, DOI 10.1016/j.neurobiolaging.2006.05.018; Smith SM, 2004, BRIT J RADIOL, V77, pS167, DOI 10.1259/bjr/33553595; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sperling R, 2007, ANN NY ACAD SCI, V1097, P146, DOI 10.1196/annals.1379.009; Thomas BA, 2011, EUR J NUCL MED MOL I, V38, P1104, DOI 10.1007/s00259-011-1745-9; Uddin LQ, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00021; van den Heuvel MP, 2010, EUR NEUROPSYCHOPHARM, V20, P519, DOI 10.1016/j.euroneuro.2010.03.008; von Economo C, 1925, CYTOARCHITEKTONIK HI; Wang L, 2006, NEUROIMAGE, V31, P496, DOI 10.1016/j.neuroimage.2005.12.033; Xue G, 2006, NEUROIMAGE, V31, P1315, DOI 10.1016/j.neuroimage.2005.11.055; Yanase D, 2005, EUR J NUCL MED MOL I, V32, P794, DOI 10.1007/s00259-005-1767-2; Zhou J, 2012, NEURON, V73, P1216, DOI 10.1016/j.neuron.2012.03.004; Zhou YA, 2008, SCHIZOPHR RES, V100, P120, DOI 10.1016/j.schres.2007.11.039	59	38	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114227	10.1371/journal.pone.0114227	http://dx.doi.org/10.1371/journal.pone.0114227			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460595	gold, Green Published, Green Submitted			2022-12-26	WOS:000345869700119
J	O'Brien, K; Bhatia, A; Tsen, F; Chen, M; Wong, AK; Woodley, DT; Li, W				O'Brien, Kathryn; Bhatia, Ayesha; Tsen, Fred; Chen, Mei; Wong, Alex K.; Woodley, David T.; Li, Wei			Identification of the Critical Therapeutic Entity in Secreted Hsp90 alpha That Promotes Wound Healing in Newly Re-Standardized Healthy and Diabetic Pig Models	PLOS ONE			English	Article							STRATUM-CORNEUM; CELL MOTILITY; GENE-TRANSFER; EPIDERMIS; GROWTH; MIGRATION; HYPOXIA; TRANSPLANTATION; THICKNESS; RECEPTOR	Chronic and non-healing skin wounds represent a significant clinical, economic and social problem worldwide. Currently, there are few effective treatments. Lack of well-defined animal models to investigate wound healing mechanisms and furthermore to identify new and more effective therapeutic agents still remains a major challenge. Pig skin wound healing is close to humans. However, standardized pig wound healing models with demonstrated validity for testing new wound healing candidates are unavailable. Here we report a systematic evaluation and establishment of both acute and diabetic wound healing models in pigs, including wound-creating pattern for drug treatment versus control, measurements of diabetic parameters and the time for detecting delayed wound healing. We find that treatment and control wounds should be on the opposite and corresponding sides of a pig. We demonstrate a strong correlation between duration of diabetic conditions and the length of delay in wound closure. Using these new models, we narrow down the minimum therapeutic entity of secreted Hsp90 alpha to a 27-amino acid peptide, called fragment-8 (F-8). In addition, results of histochemistry and immunohistochemistry analyses reveal more organized epidermis and dermis in Hsp90 alpha-healed wounds than the control. Finally, Hsp90 alpha uses a similar signaling mechanism to promote migration of isolated pig and human keratinocytes and dermal fibroblasts. This is the first report that shows standardized pig models for acute and diabetic wound healing studies and proves its usefulness with both an approved drug and a new therapeutic agent.	[O'Brien, Kathryn; Bhatia, Ayesha; Tsen, Fred; Chen, Mei; Woodley, David T.; Li, Wei] Univ So Calif, Keck Sch Med, Dept Dermatol, Los Angeles, CA 90033 USA; [O'Brien, Kathryn; Bhatia, Ayesha; Tsen, Fred; Chen, Mei; Woodley, David T.; Li, Wei] Univ So Calif, Keck Sch Med, Norris USC Comprehens Canc Ctr, Los Angeles, CA 90033 USA; [Wong, Alex K.] Univ So Calif, Div Plast & Reconstruct Surg, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California; University of Southern California	Woodley, DT (corresponding author), Univ So Calif, Keck Sch Med, Dept Dermatol, Los Angeles, CA 90033 USA.	dwoodley@usc.edu; wli@usc.edu		Wong, Alex/0000-0002-4068-5230	Whittier Foundation Award; National Institutes of Health (NIH) [GM066193, GM067100, AR46538, AR33625]; VA Merit Award; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR033625, R01AR059853, R01AR046538] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067100, R01GM066193] Funding Source: NIH RePORTER	Whittier Foundation Award; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VA Merit Award(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the Whittier Foundation Award (to W.L.), as well as by National Institutes of Health (NIH) grants GM066193 and GM067100 (to W.L.), AR46538 (to D.T.W.), AR33625 (to M.C. and D.T.W.), and VA Merit Award (to D.T.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaji S, 2014, J SURG RES, V190, P367, DOI 10.1016/j.jss.2014.02.051; Bandyopadhyay B, 2006, J CELL BIOL, V172, P1093, DOI 10.1083/jcb.200507111; Bergmann Juri, 2009, Eplasty, V9, pe49; Bevan S, 1997, BURNS, V23, P525, DOI 10.1016/S0305-4179(97)00018-1; Botusan IR, 2008, P NATL ACAD SCI USA, V105, P19426, DOI 10.1073/pnas.0805230105; Brahmatewari J, 2000, J Cutan Med Surg, V4, P126; Catrina SB, 2004, DIABETES, V53, P3226, DOI 10.2337/diabetes.53.12.3226; Cheng C. Yan, 2008, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V8, P1, DOI 10.2174/187152208783790778; Cheng CF, 2011, J CLIN INVEST, V121, P4348, DOI 10.1172/JCI46475; Davis SC, 2005, ARCH DERMATOL RES, V297, P190, DOI 10.1007/s00403-005-0612-6; Fadini GP, 2006, DIABETOLOGIA, V49, P3075, DOI 10.1007/s00125-006-0401-6; FINLAY AY, 1982, BRIT J DERMATOL, V107, P35, DOI 10.1111/j.1365-2133.1982.tb00287.x; Gao W, 2007, J MOL CELL CARDIOL, V42, P609, DOI 10.1016/j.yjmcc.2006.12.006; GRAY GM, 1982, BRIT J DERMATOL, V106, P59, DOI 10.1111/j.1365-2133.1982.tb00902.x; Hackl F, 2012, PLAST RECONSTR SURG, V129, p443E, DOI 10.1097/PRS.0b013e318241289c; HAYWARD PG, 1991, PROG CLIN BIOL RES, V365, P301; Hirsch T, 2008, J GENE MED, V10, P1247, DOI 10.1002/jgm.1251; Hirsch T, 2009, J GENE MED, V11, P220, DOI 10.1002/jgm.1287; HOLBROOK KA, 1974, J INVEST DERMATOL, V62, P415, DOI 10.1111/1523-1747.ep12701670; Koster MI, 2009, ANN NY ACAD SCI, V1170, P7, DOI 10.1111/j.1749-6632.2009.04363.x; Li W, 2004, MOL BIOL CELL, V15, P294, DOI 10.1091/mbc.e03-05-0352; Li W, 2007, EMBO J, V26, P1221, DOI 10.1038/sj.emboj.7601579; Lindblad WJ, 2008, J BIOMAT SCI-POLYM E, V19, P1087, DOI 10.1163/156856208784909390; Meyer W, 1978, Curr Probl Dermatol, V7, P39; MONTEIRORIVIERE NA, 1990, J INVEST DERMATOL, V95, P582, DOI 10.1111/1523-1747.ep12505567; POTTEN CS, 1987, CELL TISSUE KINET, V20, P461, DOI 10.1111/j.1365-2184.1987.tb01355.x; POTTEN CS, 1975, J INVEST DERMATOL, V65, P488, DOI 10.1111/1523-1747.ep12610194; QUICK DC, 1984, ANAT REC, V208, P491, DOI 10.1002/ar.1092080404; ROTHBERG S, 1961, J INVEST DERMATOL, V37, P497, DOI 10.1038/jid.1961.150; Singer AJ, 2009, J BURN CARE RES, V30, P880, DOI 10.1097/BCR.0b013e3181b48a6b; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Stephens P, 2013, METHODS MOL BIOL, V1037, P177, DOI 10.1007/978-1-62703-505-7_10; Sullivan TP, 2001, WOUND REPAIR REGEN, V9, P66, DOI 10.1046/j.1524-475x.2001.00066.x; Tsen F, 2013, MOL CELL BIOL, V33, P4947, DOI 10.1128/MCB.00559-13; Vardaxis NJ, 1997, J ANAT, V190, P601, DOI 10.1046/j.1469-7580.1997.19040601.x; Velander P, 2008, WOUND REPAIR REGEN, V16, P288, DOI 10.1111/j.1524-475X.2008.00367.x; Velander P, 2009, J SURG RES, V157, P14, DOI 10.1016/j.jss.2008.10.001; WEINSTEIN GD, 1965, J INVEST DERMATOL, V44, P413, DOI 10.1038/jid.1965.75; WEIR GC, 1981, DIABETES, V30, P590, DOI 10.2337/diabetes.30.7.590; Woodley DT, 2007, MOL THER, V15, P628, DOI 10.1038/sj.mt.6300041; Woodley DT, 2009, J CELL SCI, V122, P1495, DOI 10.1242/jcs.047894	41	16	16	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113956	10.1371/journal.pone.0113956	http://dx.doi.org/10.1371/journal.pone.0113956			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464502	Green Submitted, Green Published, gold			2022-12-26	WOS:000345869700073
J	Schiabor, KM; Quan, AS; Eisen, MB				Schiabor, Kelly M.; Quan, Allison S.; Eisen, Michael B.			Saccharomyces cerevisiae Mitochondria Are Required for Optimal Attractiveness to Drosophila melanogaster	PLOS ONE			English	Article							AROMA COMPOUNDS; AMINO-ACIDS; NITROGEN-DEFICIENT; AVOIDANCE-BEHAVIOR; VOLATILE; YEAST; OVIPOSITION; POPULATION; METABOLISM; ETHANOL	While screening a large collection of wild and laboratory yeast strains for their ability to attract Drosophila melanogaster adults, we noticed a large difference in fly preference for two nearly isogenic strains of Saccharomyces cerevisiae, BY4741 and BY4742. Using standard genetic analyses, we tracked the preference difference to the lack of mitochondria in the BY4742 strain used in the initial experiment. We used gas chromatography coupled with mass spectroscopy to examine the volatile compounds produced by BY4741 and the mitochondria-deficient BY4742, and found that they differed significantly. We observed that several ethyl esters are present at much higher levels in strains with mitochondria, even in fermentative conditions. We found that nitrogen levels in the substrate affect the production of these compounds, and that they are produced at the highest level by strains with mitochondria when fermenting natural fruit substrates. Collectively these observations demonstrate that core metabolic processes mediate the interaction between yeasts and insect vectors, and highlight the importance mitochondrial functions in yeast ecology.	[Schiabor, Kelly M.; Quan, Allison S.; Eisen, Michael B.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Eisen, Michael B.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Eisen, Michael B.] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; [Eisen, Michael B.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Eisen, MB (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	mbeisen@berkeley.edu		Eisen, Michael/0000-0002-7528-738X; Schiabor Barrett, Kelly/0000-0001-6194-787X; Quan, Allison/0000-0003-1194-4050	Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000047] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Funded by an investigator award from the Howard Hughes Medical Institute to MBE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arguello JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070219; Azanchi R, 2013, P NATL ACAD SCI USA, V110, P21153, DOI 10.1073/pnas.1320208110; Barbosa C, 2012, INT J FOOD MICROBIOL, V160, P87, DOI 10.1016/j.ijfoodmicro.2012.10.003; Barbosa C, 2009, J BIOSCI BIOENG, V108, P99, DOI 10.1016/j.jbiosc.2009.02.017; Becher PG, 2012, FUNCT ECOL, V26, P822, DOI 10.1111/j.1365-2435.2012.02006.x; Beltran G, 2005, J AGR FOOD CHEM, V53, P996, DOI 10.1021/jf0487001; Blank LM, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-6-r49; Calahan D, 2011, GENETICS, V189, P507, DOI 10.1534/genetics.111.130369; Cha DH, 2014, PEST MANAG SCI, V70, P324, DOI 10.1002/ps.3568; Crabtree HG, 1928, BIOCHEM J, V22, P1289, DOI 10.1042/bj0221289; DEDEKEN RH, 1966, J GEN MICROBIOL, V44, P149, DOI 10.1099/00221287-44-2-149; DOBZHANSKY T, 1956, ECOLOGY, V37, P544, DOI 10.2307/1930178; Garde-Cerdan T, 2008, LWT-FOOD SCI TECHNOL, V41, P501, DOI 10.1016/j.lwt.2007.03.018; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; Hernandez-Orte P, 2006, FOOD CHEM, V98, P300, DOI 10.1016/j.foodchem.2005.05.073; Hernandez-Orte P, 2002, J AGR FOOD CHEM, V50, P2891, DOI 10.1021/jf011395o; Hyma KE, 2013, MOL ECOL, V22, P2917, DOI 10.1111/mec.12155; Jimenez-Marti E, 2007, ANTON LEEUW INT J G, V92, P61, DOI 10.1007/s10482-006-9135-1; Kacsoh BZ, 2013, SCIENCE, V339, P947, DOI 10.1126/science.1229625; Kohlhaw GB, 2003, MICROBIOL MOL BIOL R, V67, P1, DOI 10.1128/MMBR.67.1.1-15.2003; Krishnan P, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-62; Montague SA, 2011, J NEUROSCI, V31, P7891, DOI 10.1523/JNEUROSCI.6254-10.2011; Nara K, 2011, J NEUROSCI, V31, P9179, DOI 10.1523/JNEUROSCI.1282-11.2011; Palanca L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075332; Procopio S, 2013, LWT-FOOD SCI TECHNOL, V51, P423, DOI 10.1016/j.lwt.2012.11.022; Reuter M, 2007, CURR BIOL, V17, pR81, DOI 10.1016/j.cub.2006.11.059; Richgels PK, 2012, CHEM SENSES, V37, P229, DOI 10.1093/chemse/bjr097; Rossouw D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-530; Saerens SMG, 2008, APPL AND, V74; Saerens SMG, 2010, MICROB BIOTECHNOL, V3, P165, DOI 10.1111/j.1751-7915.2009.00106.x; Sang J, 1961, J EXP BIOL, V33, P45; Stamps JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042238; Stensmyr MC, 2003, J EXP BIOL, V206, P715, DOI 10.1242/jeb.00143; Steyer D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-573; Stokl J, 2010, CURR BIOL, V20, P1846, DOI 10.1016/j.cub.2010.09.033; Styger G, 2013, APPL MICROBIOL BIOT, V97, P4429, DOI 10.1007/s00253-012-4522-1; Suh GSB, 2004, NATURE, V431, P854, DOI 10.1038/nature02980; Swiegers JH, 2005, ADV APPL MICROBIOL, V57, P131, DOI 10.1016/S0065-2164(05)57005-9; Torrea D, 2011, FOOD CHEM, V127, P1072, DOI 10.1016/j.foodchem.2011.01.092; Turner SL, 2009, NATURE, V461, P277, DOI 10.1038/nature08295; VACEK DC, 1985, BIOL J LINN SOC, V24, P175, DOI 10.1111/j.1095-8312.1985.tb00168.x; Vilanova M, 2007, APPL MICROBIOL BIOT, V77, P145, DOI 10.1007/s00253-007-1145-z; WANG SS, 1987, MOL CELL BIOL, V7, P4431, DOI 10.1128/MCB.7.12.4431; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901	44	13	14	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113899	10.1371/journal.pone.0113899	http://dx.doi.org/10.1371/journal.pone.0113899			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462617	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700066
J	Graham, KL; Zhang, JV; Lewen, S; Burke, TM; Dang, T; Zoudilova, M; Sobel, RA; Butcher, EC; Zabel, BA				Graham, Kareem L.; Zhang, Jian V.; Lewen, Susanna; Burke, Thomas M.; Dang, Ton; Zoudilova, Maria; Sobel, Raymond A.; Butcher, Eugene C.; Zabel, Brian A.			A Novel CMKLR1 Small Molecule Antagonist Suppresses CNS Autoimmune Inflammatory Disease	PLOS ONE			English	Article							RELAPSING MULTIPLE-SCLEROSIS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PLACEBO-CONTROLLED TRIAL; ORAL FINGOLIMOD; IN-VIVO; CHOLINE-ACETYLTRANSFERASE; COMPLICATING TREATMENT; CHEMOKINE RECEPTORS; DENDRITIC CELLS; INHIBITION DATA	Therapies that target leukocyte trafficking pathways can reduce disease activity and improve clinical outcomes in multiple sclerosis (MS). Experimental autoimmune encephalomyelitis (EAE) is a widely studied animal model that shares many clinical and histological features with MS. Chemokine-like receptor-1 (CMKLR1) is a chemoattractant receptor that is expressed by key effector cells in EAE and MS, including macrophages, subsets of dendritic cells, natural killer cells and microglia. We previously showed that CMKLR1-deficient (CMKLR1 KO) mice develop less severe clinical and histological EAE than wild-type mice. In this study, we sought to identify CMKLR1 inhibitors that would pharmaceutically recapitulate the CMKLR1 KO phenotype in EAE. We identified 2-(alpha-naphthoyl) ethyltrimethylammonium iodide (alpha-NETA) as a CMKLR1 small molecule antagonist that inhibits chemerin-stimulated beta-arrestin2 association with CMKLR1, as well as chemerin-triggered CMKLR1(+) cell migration. alpha-NETA significantly delayed the onset of EAE induced in C57BL/6 mice by both active immunization with myelin oligodendrocyte glycoprotein peptide 35-55 and by adoptive transfer of encephalitogenic T cells. In addition, alpha-NETA treatment significantly reduced mononuclear cell infiltrates within the CNS. This study provides additional proof-of-concept data that targeting CMKLR1:chemerin interactions may be beneficial in preventing or treating MS.	[Graham, Kareem L.; Zhang, Jian V.; Lewen, Susanna; Burke, Thomas M.; Zabel, Brian A.] Palo Alto Vet Inst Res, Palo Alto, CA 94306 USA; [Graham, Kareem L.; Zhang, Jian V.; Lewen, Susanna; Burke, Thomas M.; Zabel, Brian A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Dang, Ton] ChemoCentryx Inc, Mountain View, CA USA; [Zoudilova, Maria; Sobel, Raymond A.; Butcher, Eugene C.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Zabel, BA (corresponding author), Palo Alto Vet Inst Res, Palo Alto, CA 94306 USA.	bazabel@alum.mit.edu		Sobel, Raymond/0000-0002-0477-9002; Burke, Thomas/0000-0003-0942-7580	DoD [W81XWH-11-1-0512]; NIH [R01 AI-079320, R01CAI69354, R01 AI093981, AI059635, R37 AI047822, K22AI87818, 5 T32 AI07290, T32CA09151, AI-079320]; Stanford SPARK award; Department of Veterans Affairs; FACS Core Facility of the Stanford Digestive Disease Center [P30 DK056339]; One hundred Talent Program of CAS; NSFC [31100850];  [GJHZ20130417171414743]; NATIONAL CANCER INSTITUTE [R01CA169354, T32CA009151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI047822, K22AI087818, R01AI079320, R01AI059635, T32AI007290, R21AI059635, R01AI093981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339] Funding Source: NIH RePORTER	DoD(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford SPARK award; Department of Veterans Affairs(US Department of Veterans Affairs); FACS Core Facility of the Stanford Digestive Disease Center; One hundred Talent Program of CAS(Chinese Academy of Sciences); NSFC(National Natural Science Foundation of China (NSFC)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: This work was supported by DoD grant W81XWH-11-1-0512, NIH grant R01 AI-079320, and a Stanford SPARK award to B.A.Z.; by grants R01CAI69354, R01 AI093981 and AI059635 and R37 AI047822 from the NIH and a Merit Award from the Department of Veterans Affairs to E.C.B.; by Research Scholar Development Award K22AI87818 from the NIH to K.L.G.; and by the FACS Core Facility of the Stanford Digestive Disease Center under P30 DK056339. M.Z. was a recipient of fellowship support under NIH training grants 5 T32 AI07290 and T32CA09151. K.L.G. and T.M.B. were supported by diversity supplements from the NIH awarded to parent grant AI-079320. J.V.Z. was supported by the following grants: One hundred Talent Program of CAS, NSFC 31100850, and GJHZ20130417171414743.	Banks WA, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-S1-S3; Bondue B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002358; Cash JL, 2008, J EXP MED, V205, P767, DOI 10.1084/jem.20071601; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Cohen JA, 2010, NEW ENGL J MED, V362, P402, DOI 10.1056/NEJMoa0907839; Cruz-Orengo L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-170; Demoor T, 2011, J IMMUNOL, V186, P5457, DOI 10.4049/jimmunol.1003862; Ernst MC, 2012, ENDOCRINOLOGY, V153, P672, DOI 10.1210/en.2011-1490; Graham KL, 2009, J IMMUNOL, V183, P6717, DOI 10.4049/jimmunol.0803435; Horn JR, 2008, PHARM TIMES, P40; Horuk R, 2009, NAT REV DRUG DISCOV, V8, P23, DOI 10.1038/nrd2734; Issa ME, 2012, AM J PHYSIOL-CELL PH, V302, pC1621, DOI 10.1152/ajpcell.00187.2011; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Kleinschmidt-DeMasters BK, 2005, NEW ENGL J MED, V353, P369, DOI 10.1056/NEJMoa051782; Lande R, 2008, J NEUROPATH EXP NEUR, V67, P388, DOI 10.1097/NEN.0b013e31816fc975; Langer-Gould A, 2005, NEW ENGL J MED, V353, P375, DOI 10.1056/NEJMoa051847; Linda H, 2009, NEW ENGL J MED, V361, P1081, DOI 10.1056/NEJMoa0810316; Luangsay S, 2009, J IMMUNOL, V183, P6489, DOI 10.4049/jimmunol.0901037; Lynch T, 2007, AM FAM PHYSICIAN, V76, P391; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Monnier J, 2012, J IMMUNOL, V189, P956, DOI 10.4049/jimmunol.1102871; Mullen JT, 2008, NEW ENGL J MED, V358, P647, DOI 10.1056/NEJMc0706103; Obach RS, 2006, J PHARMACOL EXP THER, V316, P336, DOI 10.1124/jpet.105.093229; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pardridge William M, 2005, NeuroRx, V2, P3; Parolini S, 2007, BLOOD, V109, P3625, DOI 10.1182/blood-2006-08-038844; Polman CH, 2006, NEW ENGL J MED, V354, P899, DOI 10.1056/NEJMoa044397; PubChem, 2009, NAT CTR BIOT INF PUB; PubChem, 2011, NAT CTR BIOT INF PUB; RACKE MK, 1995, J IMMUNOL, V154, P450; Redfern WS, 2002, FUND CLIN PHARMACOL, V16, P161, DOI 10.1046/j.1472-8206.2002.00098.x; Rudick RA, 2006, NEW ENGL J MED, V354, P911, DOI 10.1056/NEJMoa044396; SANGUINETTI MC, 1995, CELL, V81, P299, DOI 10.1016/0092-8674(95)90340-2; SASTRY BVR, 1988, J PHARMACOL EXP THER, V245, P72; SASTRY BVR, 1988, PHARMACOL RES, V20, P751; Schall TJ, 2011, NAT REV IMMUNOL, V11, P355, DOI 10.1038/nri2972; Schilling S, 2006, CLIN EXP IMMUNOL, V145, P101, DOI 10.1111/j.1365-2249.2006.03094.x; Shenoy SK, 2003, BIOCHEM J, V375, P503, DOI 10.1042/BJ20031076; Springer C, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-167; Steinman L, 2001, NAT IMMUNOL, V2, P762, DOI 10.1038/ni0901-762; Venci JV, 2013, ANN PHARMACOTHER, V47, P1697, DOI 10.1177/1060028013509232; von Degenfeld G, 2007, FASEB J, V21, P3819, DOI 10.1096/fj.07-9597com; Walters MJ, 2010, J PHARMACOL EXP THER, V335, P61, DOI 10.1124/jpet.110.169714; Winkler-Pickett R, 2008, J IMMUNOL, V180, P4495, DOI 10.4049/jimmunol.180.7.4495; Wittamer V, 2003, J EXP MED, V198, P977, DOI 10.1084/jem.20030382; Zabel BA, 2005, J BIOL CHEM, V280, P34661, DOI 10.1074/jbc.M504868200; Zabel BA, 2005, J IMMUNOL, V174, P244, DOI 10.4049/jimmunol.174.1.244; Zabel BA, 2008, J EXP MED, V205, P2207, DOI 10.1084/jem.20080300; Zabel BA, 2006, EXP HEMATOL, V34, P1106, DOI 10.1016/j.exphem.2006.03.011	50	41	43	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112925	10.1371/journal.pone.0112925	http://dx.doi.org/10.1371/journal.pone.0112925			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437209	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900022
J	Guo, DQ; Zhang, H; Tan, SJ; Gu, YC				Guo, Dong-Qing; Zhang, Hao; Tan, Sheng-Jiang; Gu, Yu-Chun			Nifedipine Promotes the Proliferation and Migration of Breast Cancer Cells	PLOS ONE			English	Article							CALCIUM-CHANNEL BLOCKERS; RISK; GROWTH; ANTAGONISTS; METASTASIS; INHIBITION; CARCINOMA; INVASION; ANGIOPOIETIN-LIKE-4; PROGRESSION	Nifedipine is widely used as a calcium channel blocker (CCB) to treat angina and hypertension, but it is controversial with respect the risk of stimulation of cancers. In this study, we demonstrated that nifedipine promoted the proliferation and migration of breast cancer cells both invivo and invitro. However, verapamil, another calcium channel blocker, didn't exert the similar effects. Nifedipine and high concentration KCl failed to alter the [Ca2+](i) in MDA-MB-231 cells, suggesting that such nifedipine effect was not related with calcium channel. Moreover, nifedipine decreased miRNA-524-5p, resulting in the up-regulation of brain protein I3 (BRI3). Erk pathway was consequently activated and led to the proliferation and migration of breast cancer cells. Silencing BRI3 reversed the promoting effect of nifedipine on the breast cancer. In a summary, nifedipine stimulated the proliferation and migration of breast cancer cells via the axis of miRNA-524-5p-BRI3-Erk pathway independently of its calcium channel-blocking activity. Our findings highlight that nifedipine but not verapamil is conducive for breast cancer growth and metastasis, urging that the caution should be taken in clinic to prescribe nifedipine to women who suffering both hypertension and breast cancer, and hypertension with a tendency in breast cancers.	[Guo, Dong-Qing; Gu, Yu-Chun] Peking Univ, Mol Pharmacol Lab, Inst Mol Med, Beijing 100871, Peoples R China; [Zhang, Hao] Fudan Univ, Dept Surg, Huashan Hosp, Shanghai 200433, Peoples R China; [Tan, Sheng-Jiang] Univ Cambridge, Dept Haematol, Cambridge, England	Peking University; Fudan University; University of Cambridge	Gu, YC (corresponding author), Peking Univ, Mol Pharmacol Lab, Inst Mol Med, Beijing 100871, Peoples R China.	ycgu@pku.edu.cn		gu, yuchun/0000-0002-7558-0447	Science Foundation of China [81170236]; 973 Project [2013CB531206, 2012CB517803]	Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Project(National Basic Research Program of China)	This work is supported by the research grants held by YG (National Natural Science Foundation of China No. 81170236, 973 Project No. 2013CB531206 and 973 Project No. 2012CB517803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahr HJ, 1998, CARDIOVASC DRUG THER, V12, P157, DOI 10.1023/A:1007727010076; Arnold SA, 2009, J CELL COMMUN SIGNAL, V3, P255, DOI 10.1007/s12079-009-0072-4; Bandres E, 2007, ONCOL REP, V17, P1089; Bandyopadhyay S, 2013, IEEE ACM T COMPUT BI; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brellier F, 2011, MATRIX BIOL, V30, P225, DOI 10.1016/j.matbio.2011.02.001; Cazes A, 2006, CIRC RES, V99, P1207, DOI 10.1161/01.RES.0000250758.63358.91; Chen YT, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-111; Daling JR, 1996, AM J HYPERTENS, V9, P713; Davis S, 2007, EUR J EPIDEMIOL, V22, P319, DOI 10.1007/s10654-007-9135-0; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Fitzpatrick AL, 1997, CANCER, V80, P1438, DOI 10.1002/(SICI)1097-0142(19971015)80:8<1438::AID-CNCR11>3.0.CO;2-6; Fuse M, 2011, INT J ONCOL, V38, P1093, DOI 10.3892/ijo.2011.919; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jensen RL, 2001, SURG NEUROL, V55, P275, DOI 10.1016/S0090-3019(01)00444-X; Kaplan NM, 1996, LANCET, V348, P541, DOI 10.1016/S0140-6736(96)24034-6; Kim I, 2000, BIOCHEM J, V346, P603, DOI 10.1042/0264-6021:3460603; Lew TS, 2004, J ORAL PATHOL MED, V33, P543, DOI 10.1111/j.1600-0714.2004.00236.x; Louie E, 2013, ONCOGENE, V32, P4064, DOI 10.1038/onc.2012.417; Lu ZM, 2001, MOL CELL BIOL, V21, P4016, DOI 10.1128/MCB.21.12.4016-4031.2001; Nie L, 1997, CELL CALCIUM, V22, P75, DOI 10.1016/S0143-4160(97)90107-X; OPIE L H, 1987, Cardiovascular Drugs and Therapy, V1, P411, DOI 10.1007/BF02209083; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Pahor M, 1996, LANCET, V348, P493, DOI 10.1016/S0140-6736(96)04277-8; Rosenberg L, 1998, JAMA-J AM MED ASSOC, V279, P1000, DOI 10.1001/jama.279.13.1000; Ruark E, 2013, NATURE, V493, P406, DOI 10.1038/nature11725; Shimada H, 2007, INT J ONCOL, V30, P97; Sorensen HT, 2000, CANCER-AM CANCER SOC, V89, P165, DOI 10.1002/1097-0142(20000701)89:1<165::AID-CNCR21>3.0.CO;2-G; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Tai IT, 2008, DRUG RESIST UPDATE, V11, P231, DOI 10.1016/j.drup.2008.08.005; TAYLOR JM, 1992, CANCER RES, V52, P2413; Timcheva CV, 1996, J CHEMOTHERAPY, V8, P295, DOI 10.1179/joc.1996.8.4.295; Wu HQ, 2003, BIOCHEM BIOPH RES CO, V311, P518, DOI 10.1016/j.bbrc.2003.10.038	33	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113649	10.1371/journal.pone.0113649	http://dx.doi.org/10.1371/journal.pone.0113649			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436889	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000347114900059
J	Solberg, MF; Fjelldal, PG; Nilsen, F; Glover, KA				Solberg, Monica Favneboe; Fjelldal, Per Gunnar; Nilsen, Frank; Glover, Kevin Alan			Hatching Time and Alevin Growth Prior to the Onset of Exogenous Feeding in Farmed, Wild and Hybrid Norwegian Atlantic Salmon	PLOS ONE			English	Article							GENE-TRANSCRIPTION PROFILES; SALAR L.; EGG SIZE; FRESH-WATER; COMPETITIVE INTERACTIONS; ONCORHYNCHUS-KETA; INCUBATION-TIME; OFFSPRING SIZE; POPULATIONS; TEMPERATURE	The onset of exogenous feeding, when juveniles emerge from the gravel, is a critical event for salmonids where early emergence and large size provide a competitive advantage in the wild. Studying 131 farmed, hybrid and wild Norwegian Atlantic salmon families, originating from four wild populations and two commercial strains, we investigated whether approximately 10 generations of selection for faster growth has also resulted in increased somatic growth prior to the onset of exogenous feeding. In addition, we tested whether relaxed selection in farms has allowed for alterations in hatching time between farmed and wild salmon. Across three cohorts, wild salmon families hatched earlier than farmed salmon families, while hybrid families displayed intermediate hatching times. While the observed differences were small, i. e., 1-15 degree-days (0-3 days, as water temperatures were c. 5-6 degrees C), these data suggest additive genetic variation for hatching time. Alevin length prior to exogenous feeding was positively related to egg size. After removal of egg size effects, no systematic differences in alevin length were observed between the wild and farmed salmon families. While these results indicate additive genetic variation for egg development timing, and wild salmon families consistently hatched earlier than farmed salmon families, these differences were so small they are unlikely to significantly influence early life history competition of farmed and wild salmon in the natural environment. This is especially the case given that the timing of spawning among females can vary by several weeks in some rivers. The general lack of difference in size between farmed and wild alevins, strongly suggest that the documented differences in somatic growth rate between wild and farmed Norwegian Atlantic salmon under hatchery conditions are first detectable after the onset of exogenous feeding.	[Solberg, Monica Favneboe; Glover, Kevin Alan] Inst Marine Res, Populat Genet Res Grp, N-5024 Bergen, Norway; [Fjelldal, Per Gunnar] Inst Marine Res, Reprod & Dev Biol Res Grp, Matre Res Stn, Matredal, Norway; [Nilsen, Frank; Glover, Kevin Alan] Univ Bergen, Sea Lice Res Ctr, Dept Biol, Bergen, Norway	Institute of Marine Research - Norway; Institute of Marine Research - Norway; University of Bergen	Solberg, MF (corresponding author), Inst Marine Res, Populat Genet Res Grp, POB 1870, N-5024 Bergen, Norway.	monica.solberg@imr.no		Solberg, Monica Favneboe/0000-0002-5844-9498	project INTERACT - Research Council of Norway	project INTERACT - Research Council of Norway	This project was funded within the project INTERACT, funded by the Research Council of Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, STATUS NORSKE LAKSEB, P124; Bates D, 2013, IME4 LINEAR MIXED EF; BEACHAM TD, 1987, CAN J FISH AQUAT SCI, V44, P244, DOI 10.1139/f87-034; BEACHAM TD, 1990, T AM FISH SOC, V119, P927, DOI 10.1577/1548-8659(1990)119&lt;0927:TESADO&gt;2.3.CO;2; BEACHAM TD, 1985, CAN J ZOOL, V63, P847, DOI 10.1139/z85-125; Berg OK, 1999, J FISH BIOL, V54, P636, DOI 10.1111/j.1095-8649.1999.tb00642.x; Bicskei B, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-884; Bourret V, 2011, HEREDITY, V106, P500, DOI 10.1038/hdy.2010.165; BRANNAS E, 1995, EVOL ECOL, V9, P411, DOI 10.1007/BF01237763; CROZIER WW, 1993, AQUACULTURE, V113, P19, DOI 10.1016/0044-8486(93)90337-X; Cutts CJ, 1999, J FISH BIOL, V55, P784, DOI 10.1111/j.1095-8649.1999.tb00717.x; Debes PV, 2013, HEREDITY, V111, P238, DOI 10.1038/hdy.2013.43; Devlin RH, 2009, P NATL ACAD SCI USA, V106, P3047, DOI 10.1073/pnas.0809798106; Donaghy MJ, 1997, J FISH BIOL, V51, P211, DOI 10.1006/jfbi.1997.0417; Einum S, 2000, NATURE, V405, P565, DOI 10.1038/35014600; Einum S, 2000, EVOLUTION, V54, P628, DOI 10.1111/j.0014-3820.2000.tb00064.x; ELLIOTT JM, 1986, J ANIM ECOL, V55, P907, DOI 10.2307/4424; Fleming IA, 1996, J APPL ECOL, V33, P893, DOI 10.2307/2404960; Fleming IA, 2002, CAN J FISH AQUAT SCI, V59, P1323, DOI 10.1139/F02-082; Fleming IA, 2000, P ROY SOC B-BIOL SCI, V267, P1517, DOI 10.1098/rspb.2000.1173; Fraser DJ, 2010, CAN J FISH AQUAT SCI, V67, P1768, DOI 10.1139/F10-094; Fraser DJ, 2010, ECOL APPL, V20, P935, DOI 10.1890/09-0694.1; Friedland KD, 2009, ICES J MAR SCI, V66, P289, DOI 10.1093/icesjms/fsn210; Gilbey J, 2005, J FISH BIOL, V67, P1359, DOI 10.1111/j.0022-1112.2005.00831.x; Gilbey J, 2009, J FISH BIOL, V75, P2820, DOI 10.1111/j.1095-8649.2009.02497.x; GJEDREM T, 1991, AQUACULTURE, V98, P41, DOI 10.1016/0044-8486(91)90369-I; GJEDREM T, 1979, Z TIERZ ZUCHTUNGSBIO, V96, P56; GJEDREM T, 1983, AQUACULTURE, V33, P51, DOI 10.1016/0044-8486(83)90386-1; GJERDE B, 1986, AQUACULTURE, V57, P37, DOI 10.1016/0044-8486(86)90179-1; Glover KA, 2006, AQUACULTURE, V254, P72, DOI 10.1016/j.aquaculture.2005.10.040; Glover KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043129; Glover KA, 2009, AQUACULTURE, V286, P203, DOI 10.1016/j.aquaculture.2008.09.023; Glover KA, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-74; Green BS, 2008, ADV MAR BIOL, V54, P1, DOI 10.1016/S0065-2881(08)00001-1; Hansen MM, 2009, MOL ECOL, V18, P2549, DOI 10.1111/j.1365-294X.2009.04198.x; Heath DD, 1999, EVOLUTION, V53, P1605, DOI 10.1111/j.1558-5646.1999.tb05424.x; HEGGBERGET TG, 1988, CAN J FISH AQUAT SCI, V45, P845, DOI 10.1139/f88-102; Henderson JN, 2003, CAN J FISH AQUAT SCI, V60, P32, DOI 10.1139/F03-001; Houde ALS, 2010, ICES J MAR SCI, V67, P657, DOI 10.1093/icesjms/fsp272; JENSEN AJ, 1991, ENVIRON BIOL FISH, V30, P379, DOI 10.1007/BF02027981; Johnsson JI, 1999, J FISH BIOL, V54, P469, DOI 10.1111/j.1095-8649.1999.tb00846.x; KAZAKOV RV, 1981, J FISH BIOL, V19, P353, DOI 10.1111/j.1095-8649.1981.tb05838.x; Kilkenny C, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000412; Kuznetsova A., 2014, IMERTEST TESTS RANDO; Kvingedal E, 2011, BEHAV ECOL SOCIOBIOL, V65, P1295, DOI 10.1007/s00265-011-1143-0; Lund RA, 1989, RES REPORT NORWEGIAN, V1, P1; McGinnity P, 1997, ICES J MAR SCI, V54, P998, DOI 10.1016/S1054-3139(97)80004-5; McGinnity P, 2003, P ROY SOC B-BIOL SCI, V270, P2443, DOI 10.1098/rspb.2003.2520; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; Overturf K, 2010, AQUACULTURE, V307, P111, DOI 10.1016/j.aquaculture.2010.06.010; Quinn TP, 2002, T AM FISH SOC, V131, P591, DOI 10.1577/1548-8659(2002)131&lt;0591:ASAECC&gt;2.0.CO;2; R Development Core Team, 2014, R LANG ENV STAT COMP; Riedl C, 2013, ECOL FRESHW FISH, V22, P384, DOI 10.1111/eff.12033; Roberge C, 2006, MOL ECOL, V15, P9, DOI 10.1111/j.1365-294X.2005.02807.x; Robertsen G, 2013, CAN J FISH AQUAT SCI, V70, P5, DOI 10.1139/cjfas-2012-0152; Saegrov H, 1997, ICES J MAR SCI, V54, P1166, DOI 10.1016/S1054-3139(97)80023-9; Skaala O, 2005, J FISH BIOL, V67, P118, DOI 10.1111/j.0022-1112.2005.00843.x; Skaala O, 2006, ICES J MAR SCI, V63, P1224, DOI 10.1016/j.icesjms.2006.04.005; Skaala O, 2012, CAN J FISH AQUAT SCI, V69, P1994, DOI 10.1139/f2012-118; Skoglund H, 2012, FUNCT ECOL, V26, P104, DOI 10.1111/j.1365-2435.2011.01901.x; Skoglund H, 2011, CAN J FISH AQUAT SCI, V68, P1470, DOI [10.1139/F2011-056, 10.1139/f2011-056]; Skoglund H, 2011, J ANIM ECOL, V80, P365, DOI 10.1111/j.1365-2656.2010.01783.x; Solberg Monica F., 2012, BMC Research Notes, V5, P672, DOI 10.1186/1756-0500-5-672; Solberg MF, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-234; Solberg MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054469; SRIVASTAVA RK, 1991, CAN J ZOOL, V69, P2436, DOI 10.1139/z91-342; Tatara CP, 2012, ENVIRON BIOL FISH, V94, P7, DOI 10.1007/s10641-011-9906-z; Teletchea F, 2009, J FISH BIOL, V74, P652, DOI 10.1111/j.1095-8649.2008.02160.x; Thodesen J, 2001, AQUACULTURE, V194, P273, DOI 10.1016/S0044-8486(00)00527-5; Thodesen J, 1999, AQUACULTURE, V180, P237, DOI 10.1016/S0044-8486(99)00204-5; THORPE JE, 1984, AQUACULTURE, V43, P289, DOI 10.1016/0044-8486(84)90030-9; Webb JH, 1996, CAN J FISH AQUAT SCI, V53, P2739, DOI 10.1139/cjfas-53-12-2739; Weir LK, 2004, J ANIM ECOL, V73, P1069, DOI 10.1111/j.0021-8790.2004.00876.x	73	23	23	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113697	10.1371/journal.pone.0113697	http://dx.doi.org/10.1371/journal.pone.0113697			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438050	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000347114900065
J	Zhao, HY; Xie, CY; Lin, XY; Zhao, Y; Han, Y; Fan, CF; Zhang, XP; Du, J; Han, Y; Han, Q; Wu, GP; Wang, EH				Zhao, Huanyu; Xie, Chengyao; Lin, Xuyong; Zhao, Yue; Han, Yang; Fan, Chuifeng; Zhang, Xiupeng; Du, Jiang; Han, Yong; Han, Qiang; Wu, Guangping; Wang, Enhua			Coexpression of IQ-Domain GTPase-Activating Protein 1 (IQGAP1) and Dishevelled (Dvl) Is Correlated with Poor Prognosis in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							CDC42; BINDING; PATHWAY; RAC1	Background: IQ-domain GTPase-activating protein 1 (IQGAP1) binds to Dishevelled (Dvl) and functions as a modulator of Dvl nuclear localization in Xenopus embryos. However, the relationship between IQGAP1 and Dvl in tumor tissues is unclear. Materials and Methods: We used immunohistochemistry to assess the expressions of IQGAP1 and Dvl in a cohort of 111 non-small cell lung cancer (NSCLC) patients. Association of their localization expressions with clinicopathological factors was also analyzed. Results: The positive rate of IQGAP1 in primary tumors was 48.6% (54/111) for its cytoplamic expression, 9.0% (10/111) for nuclear expression and 31.5% (35/111) for membranous expression; the positive rate of Dvl was 65.8% (73/111) for cytoplamic expression, 9.9% (11/111) for nuclear expression and 10.8% (12/111) for membranous expression. Coexpression rate of IQGAP1 and Dvl was 77.8% (42/54) in the cytoplasm, 80.0% (8/10) in the nucleus and 8.6% (3/35) in the membrane. Coexpression of IQGAP1 and Dvl in the cytoplasm and nucleus were significantly correlated (P<0.05), but not in the membrane (P>0.05). The positive expression rates of cyclin D1 and c-myc were significantly higher in the group of IQGAP1 and Dvl coexpression in the nucleus than that in the cytoplasm. Coexpression rate of IQGAP1 and Dvl in the cytoplasm and nucleus was significantly higher in lymph nodal metastases (63.3%, 19/30) than in primary growths (38.3%, 31/81), correlating with poor prognosis. Five-year survival time after resection in the group with their coexpression in the cytoplasm and nucleus was significantly lower than that with no coexpression (44.705+/-3.355 vs 58.403+/-2.543 months, p<0.05). Conclusions: Coexpression of IQGAP1 and Dvl in the cytoplasm and nucleus was correlated with the lymph nodal metastase and poor prognosis of NSCLC, and coexpression in nucleus might play a critical role in the activation of canonical Wnt pathway.	[Wang, Enhua] China Med Univ, Affiliated Hosp 1, Dept Pathol, Shenyang, Peoples R China; China Med Univ, Coll Basic Med Sci, Shenyang, Peoples R China	China Medical University; China Medical University	Wang, EH (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Pathol, Shenyang, Peoples R China.	wangeh@hotmail.com	han, yang/GRS-2388-2022; Zhao, Yue/AGZ-4412-2022	Zhao, Yue/0000-0002-0110-0359				Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Fukukawa C, 2009, ONCOGENE, V28, P1110, DOI 10.1038/onc.2008.467; Gan XQ, 2008, J CELL BIOL, V180, P1087, DOI 10.1083/jcb.200710050; Goto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060865; Itoh Keiji, 2005, J Biol, V4, P3, DOI 10.1186/jbiol20; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; Lee HJ, 2010, J BIOL CHEM, V285, P41549, DOI 10.1074/jbc.M110.193383; Liu Y, 2011, HISTOPATHOLOGY, V59, P882, DOI 10.1111/j.1365-2559.2011.04013.x; Mateer SC, 2004, CELL MOTIL CYTOSKEL, V58, P231, DOI 10.1002/cm.20013; Nakamura H, 2005, ONCOL REP, V13, P427; Wang XX, 2013, HEPATOB PANCREAT DIS, V12, P540, DOI 10.1016/S1499-3872(13)60085-5; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; Wei Q, 2008, LUNG CANCER, V62, P181, DOI 10.1016/j.lungcan.2008.06.018; Zhao Y, 2010, MOL CARCINOGEN, V49, P760, DOI 10.1002/mc.20651; Zhu YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037823	16	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							0113713	10.1371/journal.pone.0113713	http://dx.doi.org/10.1371/journal.pone.0113713			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436461	gold, Green Published, Green Submitted			2022-12-26	WOS:000347114900067
J	Zhou, JX; Pisco, AO; Qian, H; Huang, S				Zhou, Joseph Xu; Pisco, Angela Oliveira; Qian, Hong; Huang, Sui			Nonequilibrium Population Dynamics of Phenotype Conversion of Cancer Cells	PLOS ONE			English	Article							EVOLUTION; HETEROGENEITY; PROGRESSION; DIFFERENTIATION; RESISTANCE; LANDSCAPE; SELECTION; GENES	Tumorigenesis is a dynamic biological process that involves distinct cancer cell subpopulations proliferating at different rates and interconverting between them. In this paper we proposed a mathematical framework of population dynamics that considers both distinctive growth rates and intercellular transitions between cancer cell populations. Our mathematical framework showed that both growth and transition influence the ratio of cancer cell subpopulations but the latter is more significant. We derived the condition that different cancer cell types can maintain distinctive subpopulations and we also explain why there always exists a stable fixed ratio after cell sorting based on putative surface markers. The cell fraction ratio can be shifted by changing either the growth rates of the subpopulations (Darwinism selection) or by environment-instructed transitions (Lamarckism induction). This insight can help us to understand the dynamics of the heterogeneity of cancer cells and lead us to new strategies to overcome cancer drug resistance.	[Zhou, Joseph Xu; Pisco, Angela Oliveira; Huang, Sui] Inst Syst Biol, Seattle, WA 98109 USA; [Zhou, Joseph Xu] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Pisco, Angela Oliveira] Univ Manchester, Syst Biol Program, Fac Life Sci, Manchester, Lancs, England; [Qian, Hong] Univ Washington, Dept Appl Math, Seattle, WA 98195 USA; [Zhou, Joseph Xu; Huang, Sui] Univ Calgary, Inst Biocomplex & Informat, Calgary, AB, Canada	Institute for Systems Biology (ISB); University of California System; University of California Santa Barbara; University of Manchester; University of Washington; University of Washington Seattle; University of Calgary	Zhou, JX (corresponding author), Inst Syst Biol, Seattle, WA 98109 USA.	Joseph.Zhou@systemsbiology.org; Sui.Huang@systemsbiology.org	Pisco, Angela Oliveira/K-4563-2012	Pisco, Angela Oliveira/0000-0003-0142-2355	National Science Foundation [PHY11-25915]; iCore (Alberta, Canada); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109964] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); iCore (Alberta, Canada); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: This research was supported by the National Science Foundation under Grant No. PHY11-25915 and iCore (Alberta, Canada). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschuler SJ, 2010, CELL, V141, P559, DOI 10.1016/j.cell.2010.04.033; Armengol G, 2001, LAB INVEST, V81, P1703, DOI 10.1038/labinvest.3780383; Atallah J, 2009, INT REV CEL MOL BIO, V278, P119, DOI 10.1016/S1937-6448(09)78003-7; Attolini CSO, 2009, ANN NY ACAD SCI, V1168, P23, DOI 10.1111/j.1749-6632.2009.04880.x; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bornholdt S, 2008, J R SOC INTERFACE, V5, pS85, DOI 10.1098/rsif.2008.0132.focus; Chaffer CL, 2011, SCIENCE, V331, P1559, DOI 10.1126/science.1203543; Coffman RL, 1999, SCIENCE, V284, P1283, DOI 10.1126/science.284.5418.1283; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; DELBRUCK M, 1949, C INT CTR NAT RECH S; Dowty JG, 2014, MATH MED BIOL, V31, P353, DOI 10.1093/imammb/dqt014; Durrett R, 2010, THEOR POPUL BIOL, V77, P42, DOI 10.1016/j.tpb.2009.10.008; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Enver T, 2009, NATURE, V461, P183, DOI 10.1038/461183a; Fu Y, 2010, PHYS BIOL, V7, DOI 10.1088/1478-3975/7/1/016013; Gupta PB, 2011, CELL, V146, P633, DOI 10.1016/j.cell.2011.07.026; Huang S, 2012, BIOL LETTERS, V8, P222, DOI 10.1098/rsbl.2011.0752; Huang S, 2013, CANCER METAST REV, V32, P423, DOI 10.1007/s10555-013-9435-7; Huang S, 2009, DEVELOPMENT, V136, P3853, DOI 10.1242/dev.035139; KAUFFMAN S, 1969, NATURE, V224, P177, DOI 10.1038/224177a0; Kell DB, 2002, TRENDS GENET, V18, P555, DOI 10.1016/S0168-9525(02)02765-8; Kirouac DC, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.71; Klein CA, 2004, CELL CYCLE, V3, P29; Lagadec C, 2012, STEM CELLS, V30, P833, DOI 10.1002/stem.1058; Lee GY, 2011, INT J HEMATOL, V93, P27, DOI 10.1007/s12185-010-0734-2; Losi L, 2005, CARCINOGENESIS, V26, P916, DOI 10.1093/carcin/bgi044; Mehmood T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-327; Metcalf D, 1998, IMMUNOL CELL BIOL, V76, P441, DOI 10.1046/j.1440-1711.1998.00761.x; Newburger DE, 2013, GENOME RES, V23, P1097, DOI 10.1101/gr.151670.112; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Nuzhdin SV, 2012, TRENDS GENET, V28, P421, DOI 10.1016/j.tig.2012.06.003; Pigliucci M, 2010, PHILOS T R SOC B, V365, P557, DOI 10.1098/rstb.2009.0241; Pisco AO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3467; Saunders NJ, 2003, MICROBIOL-SGM, V149, P485, DOI 10.1099/mic.0.25807-0; Singh DK, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.22; Wang RS, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/5/055001; Wen KM, 2013, CANCER LETT, V333, P56, DOI 10.1016/j.canlet.2013.01.009; Wu C, 2011, BIOCOMPUT-PAC SYM, P62; Yachida S, 2013, ONCOGENE, V32, P5253, DOI 10.1038/onc.2013.29; Yang AD, 2006, CLIN CANCER RES, V12, P4147, DOI 10.1158/1078-0432.CCR-06-0038; Zhang RL, 2004, J NEUROSCI, V24, P5810, DOI 10.1523/JNEUROSCI.1109-04.2004; Zheng Q, 1999, MATH BIOSCI, V162, P1, DOI 10.1016/S0025-5564(99)00045-0; Zhou JX, 2011, TRENDS GENET, V27, P55, DOI 10.1016/j.tig.2010.11.002; Zhou JX, 2012, J R SOC INTERFACE, V9, P3539, DOI 10.1098/rsif.2012.0434; Zhou JX, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019798, 10.1371/journal.pone.0014752, 10.1371/journal.pone.0024340]	45	17	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e110714	10.1371/journal.pone.0110714	http://dx.doi.org/10.1371/journal.pone.0110714			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438251	Green Published, gold, Green Submitted			2022-12-26	WOS:000347114900006
J	Park, JY; Duong, CT; Sharma, AR; Son, KM; Thompson, MS; Park, S; Chang, JD; Nam, JS; Park, S; Lee, SS				Park, Jae-Yong; Cong-Truyen Duong; Sharma, Ashish Ranjan; Son, Kyeong-Min; Thompson, Mark S.; Park, Sungchan; Chang, Jun-Dong; Nam, Ju-Suk; Park, Seonghun; Lee, Sang-Soo			Effects of Hyaluronic Acid and gamma-Globulin Concentrations on the Frictional Response of Human Osteoarthritic Articular Cartilage	PLOS ONE			English	Article							ATOMIC-FORCE MICROSCOPY; INNOVATIVE CHONDROPLASTY MATERIALS; INTERSTITIAL FLUID PRESSURIZATION; SYNOVIAL-FLUID; MOLECULAR-WEIGHT; LUBRICATING ABILITY; BOUNDARY LUBRICATION; PROTEOGLYCAN 4; JOINTS; WEAR	Synovial fluid plays an important role in lubricating synovial joints. Its main constituents are hyaluronic acid (HA) and gamma-globulin, acting as boundary lubricants for articular cartilage. The aim of the study was to demonstrate the concentration-dependent effect of HA and gamma-globulin on the boundary-lubricating ability of human osteoarthritis (OA) cartilage. Normal, early and advance stage articular cartilage samples were obtained from human femoral heads and in presence of either HA or gamma-globulin, cartilage frictional coefficient (mu) was measured by atomic force microscopy (AFM). In advanced stage OA, the cartilage superficial layer was observed to be completely removed and the damaged cartilage surface showed a higher m value (similar to 0.409) than the normal cartilage surface (similar to 0.119) in PBS. Adsorbed HA and gamma-globulin molecules significantly improved the frictional behavior of advanced OA cartilage, while they were ineffective for normal and early OA cartilage. In advanced-stage OA, the concentration-dependent frictional response of articular cartilage was observed with gamma-globulin, but not with HA. Our result suggested that HA and gamma-globulin may play a significant role in improving frictional behavior of advanced OA cartilage. During early-stage OA, though HA and gamma-globulin had no effect on improving frictional behavior of cartilage, however, they might contribute to disease modifying effects of synovial fluid as observed in clinical settings.	[Park, Jae-Yong; Sharma, Ashish Ranjan; Son, Kyeong-Min; Chang, Jun-Dong; Nam, Ju-Suk; Park, Seonghun; Lee, Sang-Soo] Hallym Univ, Chuncheon Sacred Heart Hosp, Inst Skeletal Aging & Orthoped Surg, Chunchon, South Korea; [Cong-Truyen Duong; Park, Seonghun] Pusan Natl Univ, Sch Mech Engn, Pusan, South Korea; [Cong-Truyen Duong] Ind Univ Ho Chi Minh City, Dept Mech Engn, Ho Chi Minh, Vietnam; [Thompson, Mark S.] Univ Oxford, Dept Engn Sci, Oxford OX1 3PJ, England; [Park, Sungchan] Univ Ulsan, Coll Med, Dept Urol, Ulsan 680749, South Korea	Hallym University; Pusan National University; Industrial University of Ho Chi Minh City; University of Oxford; University of Ulsan	Park, S (corresponding author), Hallym Univ, Chuncheon Sacred Heart Hosp, Inst Skeletal Aging & Orthoped Surg, Chunchon, South Korea.	paks@pusan.ac.kr; totalhip@hallym.ac.kr	Sharma, Ashish Ranjan/W-4816-2019; Thompson, Mark/B-9261-2009	Sharma, Ashish Ranjan/0000-0003-3973-6755; Thompson, Mark/0000-0001-8958-0336	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2062436, NRF-2014R1A1A4A03009388]; Leading Foreign Research Institute Recruitment Program through NRF - Ministry of Science, ICT & Future Planning [2009-00495]	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Education; Leading Foreign Research Institute Recruitment Program through NRF - Ministry of Science, ICT & Future Planning	Funding: This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, (NRF-2013R1A1A2062436 & NRF-2014R1A1A4A03009388) and by Leading Foreign Research Institute Recruitment Program through the NRF grant funded by the Ministry of Science, ICT & Future Planning (No. 2009-00495). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonacci JM, 2012, ARTHRITIS RHEUM-US, V64, P2917, DOI 10.1002/art.34520; Ateshian GA, 1998, J TRIBOL-T ASME, V120, P241, DOI 10.1115/1.2834416; Ateshian GA, 2009, J BIOMECH, V42, P1163, DOI 10.1016/j.jbiomech.2009.04.040; Bell CJ, 2006, P I MECH ENG H, V220, P23, DOI 10.1243/095441105X69060; Berenbaum F, 2012, ANN RHEUM DIS, V71, P1454, DOI 10.1136/annrheumdis-2011-200972; BUTT HJ, 1993, J MICROSC-OXFORD, V169, P75, DOI 10.1111/j.1365-2818.1993.tb03280.x; Caligaris M, 2009, OSTEOARTHR CARTILAGE, V17, P1327, DOI 10.1016/j.joca.2009.03.020; Cameron ML, 2003, AM J SPORT MED, V31, P83, DOI 10.1177/03635465030310012601; Chan SMT, 2010, OSTEOARTHR CARTILAGE, V18, P956, DOI 10.1016/j.joca.2010.03.012; CHAPPUIS J, 1983, ANN BIOMED ENG, V11, P435, DOI 10.1007/BF02584218; Coles JM, 2008, J BIOMECH, V41, P541, DOI 10.1016/j.jbiomech.2007.10.013; Duong CT, 2010, P I MECH ENG H, V224, P541, DOI 10.1243/09544119JEIM709; Forsey RW, 2006, BIOMATERIALS, V27, P4581, DOI 10.1016/j.biomaterials.2006.04.018; Forster H, 1999, P I MECH ENG H, V213, P329, DOI 10.1243/0954411991535167; Goldberg VM, 2005, OSTEOARTHR CARTILAGE, V13, P216, DOI 10.1016/j.joca.2004.11.010; Higaki H, 1998, P I MECH ENG H, V212, P337, DOI 10.1243/0954411981534114; Jay GD, 2007, P NATL ACAD SCI USA, V104, P6194, DOI 10.1073/pnas.0608558104; Katta J, 2008, MED ENG PHYS, V30, P1349, DOI 10.1016/j.medengphy.2008.09.004; Kawano T, 2003, ARTHRITIS RHEUM-US, V48, P1923, DOI 10.1002/art.11172; Krishnan R, 2004, OSTEOARTHR CARTILAGE, V12, P947, DOI 10.1016/j.joca.2004.08.009; Kwiecinski JJ, 2011, OSTEOARTHR CARTILAGE, V19, P1356, DOI 10.1016/j.joca.2011.07.019; Lee SS, 2012, P I MECH H IN PRESS; Liu YH, 1996, LANGMUIR, V12, P1235, DOI 10.1021/la950504o; Ludwig TE, 2012, ARTHRITIS RHEUM-US, V64, P3963, DOI 10.1002/art.34674; Mabuchi K, 1999, CLIN BIOMECH, V14, P352, DOI 10.1016/S0268-0033(98)00084-9; MACKIEWICZ S, 1961, ANN RHEUM DIS, V20, P265, DOI 10.1136/ard.20.3.265; McCutchen C. W., 1962, WEAR, V5, P1, DOI [10.1016/0043-1648(62)90176-X, DOI 10.1016/0043-1648(62)90176-X]; McPherson RA., 2006, HENRYS CLIN DIAGNOSI; Mori S, 2002, INT ORTHOP, V26, P116, DOI 10.1007/s00264-002-0330-z; MOW VC, 1992, BIOMATERIALS, V13, P67, DOI 10.1016/0142-9612(92)90001-5; Murakami T, 2011, P I MECH ENG J-J ENG, V225, P1174, DOI 10.1177/1350650111415756; Nagaoka I, 2012, ADV FOOD NUTR RES, V65, P337, DOI 10.1016/B978-0-12-416003-3.00022-6; Nakashima K, 2007, TRIBOL INT, V40, P1423, DOI 10.1016/j.triboint.2007.02.010; Northwood E, 2007, P I MECH ENG H, V221, P263, DOI 10.1243/09544119JEIM178; Northwood E, 2007, CLIN BIOMECH, V22, P834, DOI 10.1016/j.clinbiomech.2007.03.008; Outerbridge RE, 2001, CLIN ORTHOP RELAT R, P5; Park S, 2004, J BIOMECH, V37, P1679, DOI 10.1016/j.jbiomech.2004.02.017; Pickard J, 1998, P I MECH ENG H, V212, P177, DOI 10.1243/0954411981533953; ROBERTS BJ, 1982, ANN RHEUM DIS, V41, P217, DOI 10.1136/ard.41.3.217; Schmidt TA, 2007, ARTHRITIS RHEUM-US, V56, P882, DOI 10.1002/art.22446; STACHOWIAK GW, 1994, WEAR, V171, P135, DOI 10.1016/0043-1648(94)90356-5; Stolz M, 2009, NAT NANOTECHNOL, V4, P186, DOI [10.1038/nnano.2008.410, 10.1038/NNANO.2008.410]; Vincent Heather K, 2013, Open Orthop J, V7, P378, DOI 10.2174/1874325001307010378; Wang CT, 2004, J BONE JOINT SURG AM, V86A, P538, DOI 10.2106/00004623-200403000-00012	44	8	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112684	10.1371/journal.pone.0112684	http://dx.doi.org/10.1371/journal.pone.0112684			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426992	Green Published, gold, Green Submitted			2022-12-26	WOS:000349145400022
J	Wang, YQ; Kim, SM; Trnka, MJ; Liu, Y; Burlingame, AL; Correia, MA				Wang, YongQiang; Kim, Sung-Mi; Trnka, Michael J.; Liu, Yi; Burlingame, A. L.; Correia, Maria Almira			Human Liver Cytochrome P450 3A4 Ubiquitination MOLECULAR RECOGNITION BY UBC7-gp78 AUTOCRINE MOTILITY FACTOR RECEPTOR AND UbcH5a-CHIP-Hsc70-Hsp40 E2-E3 UBIQUITIN LIGASE COMPLEXES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM-ASSOCIATED DEGRADATION; MECHANISM-BASED INACTIVATION; HMG-COA REDUCTASE; IN-VIVO; PHOSPHORYLATED TAU; CONJUGATING ENZYME; MASS-SPECTROMETRY; RAT HEPATOCYTES; QUALITY-CONTROL; RING FINGER	CYP3A4 is an abundant and catalytically dominant human liver endoplasmic reticulum-anchored cytochrome P450 enzyme engaged in the biotransformation of endo- and xenobiotics, including >50% of clinically relevant drugs. Alterations of CYP3A4 protein turnover can influence clinically relevant drug metabolism and bioavailability and drug-drug interactions. This CYP3A4 turnover involves endoplasmic reticulum-associated degradation via the ubiquitin (Ub)-dependent 26 S proteasomal system that relies on two highly complementary E2 Ub-conjugating-E3 Ub-ligase (UBC7-gp78 and UbcH5a-C terminus of Hsc70-interacting protein (CHIP)-Hsc70-Hsp40) complexes, as well as protein kinases (PK) A and C. We have documented that CYP3A4 Ser/Thr phosphorylation (Ser(P)/Thr(P)) by PKA and/or PKC accelerates/enhances its Lys ubiquitination by either of these E2-E3 systems. Intriguingly, CYP3A4 Ser(P)/Thr(P) and ubiquitinated Lys residues reside within the cytosol-accessible surface loop and/or conformationally assembled acidic Asp/Glu clusters, leading us to propose that such post-translational Ser/Thr protein phosphorylation primes CYP3A4 for ubiquitination. Herein, this possibility was examined through various complementary approaches, including site-directed mutagenesis, chemical cross-linking, peptide mapping, and LC-MS/MS analyses. Our findings reveal that such CYP3A4 Asp/Glu/Ser(P)/Thr(P) surface clusters are indeed important for its intermolecular electrostatic interactions with each of these E2-E3 subcomponents. By imparting additional negative charge to these Asp/Glu clusters, such Ser/Thr phosphorylation would generate P450 phosphodegrons for molecular recognition by the E2-E3 complexes, thereby controlling the timing of CYP3A4 ubiquitination and endoplasmic reticulum-associated degradation. Although the importance of phosphodegrons in the CHIP targeting of its substrates is known, to our knowledge this is the first example of phosphodegron involvement in gp78-substrate recruitment, an important step in CYP3A4 proteasomal degradation.	[Wang, YongQiang; Kim, Sung-Mi; Liu, Yi; Correia, Maria Almira] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Trnka, Michael J.; Burlingame, A. L.; Correia, Maria Almira] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA; [Correia, Maria Almira] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Correia, Maria Almira] Univ Calif San Francisco, Ctr Liver, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Correia, MA (corresponding author), Univ Calif San Francisco, Mission Bay Campus,Genentech Hall,600 16th St, San Francisco, CA 94158 USA.	almira.correia@ucsf.edu		Trnka, Michael/0000-0002-8808-5146	Biomedical Technology Research Centers Program of the NIGMS, National Institutes of Health [8P41GM103481]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK026743, R01DK026506, R56DK026506] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103481, R01GM044037] Funding Source: NIH RePORTER	Biomedical Technology Research Centers Program of the NIGMS, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We sincerely thank Dr. A. M. Weissman (NCI, National Institutes of Health) for the UBC7 and gp78C expression plasmids; Dr. R. DeBose-Boyd (University of Texas SouthWestern) for the mammalian gp78 plasmid; Dr. C. Patterson (University of North Carolina) for the CHIP expression plasmid; Dr. L. Waskell (University of Michigan) for the cytochrome b<INF>5</INF> expression plasmid; and Dr. C. B. Kasper (University of Wisconsin) for the CPR expression plasmid. We thank Prof. P. Ortiz de Montellano (University of California at San Francisco) for helpful comments in the course of this project. We acknowledge the mass spectrometric analyses provided by the Bio-Organic Biomedical Mass Spectrometry Resource at University of California at San Francisco (A. L. Burlingame, Director) supported by the Biomedical Technology Research Centers Program of the NIGMS, National Institutes of Health Grant 8P41GM103481.	Acharya P, 2011, J BIOL CHEM, V286, P3815, DOI 10.1074/jbc.M110.186981; Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; Baker PR, 2014, MOL CELL PROTEOMICS, V13, P1392, DOI 10.1074/mcp.O113.037200; Ballinger CA, 1999, MOL CELL BIOL, V19, P4535; Bardag-Gorce F, 2006, EXP MOL PATHOL, V81, P191, DOI 10.1016/j.yexmp.2006.07.007; BLACK SD, 1992, FASEB J, V6, P680, DOI 10.1096/fasebj.6.2.1537456; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; Catic A, 2004, BIOINFORMATICS, V20, P3302, DOI 10.1093/bioinformatics/bth407; Cederbaum AI, 2006, MT SINAI J MED, V73, P657; Chen B, 2006, P NATL ACAD SCI USA, V103, P341, DOI 10.1073/pnas.0506618103; Chen JY, 1997, DRUG METAB DISPOS, V25, P1165; Chen ZL, 2012, CURR PROTEIN PEPT SC, V13, P414, DOI 10.2174/138920312802430590; Christianson JC, 2014, NAT STRUCT MOL BIOL, V21, P325, DOI 10.1038/nsmb.2793; CORREIA MA, 1992, ARCH BIOCHEM BIOPHYS, V297, P228, DOI 10.1016/0003-9861(92)90666-K; Correia MA, 2012, BASIC CLIN PHARM, P53; Correia MA, 2014, IUBMB LIFE, V66, P78, DOI 10.1002/iub.1247; Das R, 2013, EMBO J, V32, P2504, DOI 10.1038/emboj.2013.174; Das R, 2009, MOL CELL, V34, P674, DOI 10.1016/j.molcel.2009.05.010; Dickey CA, 2007, J CLIN INVEST, V117, P648, DOI 10.1172/JCI29715; EDWARDS RJ, 1991, BIOCHEMISTRY-US, V30, P71, DOI 10.1021/bi00215a011; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; ELIASSON E, 1994, J BIOL CHEM, V269, P18378; Faouzi S, 2007, BIOCHEMISTRY-US, V46, P7793, DOI 10.1021/bi700340n; FREY AB, 1985, J BIOL CHEM, V260, P5253; Gao QX, 2006, J BIOL CHEM, V281, P20404, DOI 10.1074/jbc.M601785200; Guengerich F.P., 2005, CYTOCHROME P450 STRU, V3rd ed., P377, DOI [10.1007/0-387-27447-2_10, DOI 10.1007/0-387-27447-2_10]; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Hatakeyama S, 2004, J NEUROCHEM, V91, P299, DOI 10.1111/j.1471-4159.2004.02713.x; Hirsch C, 2009, NATURE, V458, P453, DOI 10.1038/nature07962; Jiang JH, 2001, J BIOL CHEM, V276, P42938, DOI 10.1074/jbc.M101968200; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; Jo Y, 2011, J BIOL CHEM, V286, P15022, DOI 10.1074/jbc.M110.211326; Kalgutkar AS, 2007, CURR DRUG METAB, V8, P407; Kim SM, 2010, J BIOL CHEM, V285, P35866, DOI 10.1074/jbc.M110.167189; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Korsmeyer KK, 1999, ARCH BIOCHEM BIOPHYS, V365, P31, DOI 10.1006/abbi.1999.1138; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Kundrat L, 2010, J MOL BIOL, V395, P587, DOI 10.1016/j.jmb.2009.11.017; Leitner A, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014126; Li W, 2007, NATURE, V446, P333, DOI 10.1038/nature05542; Li W, 2009, P NATL ACAD SCI USA, V106, P3722, DOI 10.1073/pnas.0808564106; Liao M, 2010, ENZYME INHIBITION DR, P363; Liao M, 2006, MOL PHARMACOL, V69, P1897, DOI 10.1124/mol.105.021816; Lin HL, 2012, CHEM RES TOXICOL, V25, P2642, DOI 10.1021/tx3002753; McDonough H, 2003, CELL STRESS CHAPERON, V8, P303, DOI 10.1379/1466-1268(2003)008<0303:CALBTC>2.0.CO;2; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Miao HH, 2010, ACTA BIOCH BIOPH SIN, V42, P303, DOI 10.1093/abbs/gmq022; Morishima Y, 2005, BIOCHEMISTRY-US, V44, P16333, DOI 10.1021/bi0515570; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Murata S, 2001, EMBO REP, V2, P1133, DOI 10.1093/embo-reports/kve246; Murray BP, 2001, ARCH BIOCHEM BIOPHYS, V393, P106, DOI 10.1006/abbi.2001.2482; OMURA T, 1964, J BIOL CHEM, V239, P2370; Pabarcus MK, 2009, ARCH BIOCHEM BIOPHYS, V483, P66, DOI 10.1016/j.abb.2008.12.001; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Petrucelli L, 2004, HUM MOL GENET, V13, P703, DOI 10.1093/hmg/ddh083; Porubsky PR, 2010, J BIOL CHEM, V285, P22282, DOI 10.1074/jbc.M110.109017; Porubsky PR, 2008, J BIOL CHEM, V283, P33698, DOI 10.1074/jbc.M805999200; Pratt WB, 2010, EXP BIOL MED, V235, P278, DOI 10.1258/ebm.2009.009250; Rees I, 2006, BBA-PROTEINS PROTEOM, V1764, P1073, DOI 10.1016/j.bbapap.2006.03.013; Reisinger V, 2006, PROTEOMICS, P6, DOI 10.1002/pmic.200600553; ROBERTS BJ, 1995, J BIOL CHEM, V270, P29632; Rosser MFN, 2007, J BIOL CHEM, V282, P22267, DOI 10.1074/jbc.M700513200; SchmiedlinRen P, 1997, DRUG METAB DISPOS, V25, P1228; Sevrioukova IF, 2012, J BIOL CHEM, V287, P3510, DOI 10.1074/jbc.M111.317081; Shimura H, 2004, J BIOL CHEM, V279, P4869, DOI 10.1074/jbc.M305838200; Sliter DA, 2008, J BIOL CHEM, V283, P35319, DOI 10.1074/jbc.M807288200; SOHN DH, 1991, BIOCHEM BIOPH RES CO, V179, P449, DOI 10.1016/0006-291X(91)91391-O; SONG BJ, 1989, J BIOL CHEM, V264, P3568; Taxis C, 2003, J BIOL CHEM, V278, P35903, DOI 10.1074/jbc.M301080200; Tetzlaff JE, 2008, J BIOL CHEM, V283, P17962, DOI 10.1074/jbc.M802283200; TIERNEY DJ, 1992, ARCH BIOCHEM BIOPHYS, V293, P9, DOI 10.1016/0003-9861(92)90358-4; Trnka MJ, 2014, MOL CELL PROTEOMICS, V13, P420, DOI 10.1074/mcp.M113.034009; Trnka MJ, 2010, MOL CELL PROTEOMICS, V9, P2306, DOI 10.1074/mcp.M110.003764; Udeshi ND, 2012, MOL CELL PROTEOMICS, V11, P148, DOI 10.1074/mcp.M111.016857; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wagner SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/mcp.M112.017905; Wang HF, 1999, ARCH BIOCHEM BIOPHYS, V365, P45, DOI 10.1006/abbi.1999.1139; Wang XY, 2001, BIOCHEMISTRY-US, V40, P11318, DOI 10.1021/bi010690z; Wang Y, 2014, ONCOTARGET, V5, P2044, DOI 10.18632/oncotarget.1478; Wang YQ, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010132; Wang YQ, 2011, J BIOL CHEM, V286, P9443, DOI 10.1074/jbc.M110.176685; Wang YQ, 2009, J BIOL CHEM, V284, P5671, DOI 10.1074/jbc.M806104200; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Xu L, 2009, DRUG METAB DISPOS, V37, P2330, DOI 10.1124/dmd.108.025494; Yang JS, 2008, CURR DRUG METAB, V9, P384, DOI 10.2174/138920008784746382; Yang MX, 1997, ARCH BIOCHEM BIOPHYS, V341, P25, DOI 10.1006/abbi.1997.9907; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; Ying Z, 2011, J BIOL CHEM, V286, P20835, DOI 10.1074/jbc.M110.200808; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Zangar RC, 2004, TOXICOL APPL PHARM, V199, P316, DOI 10.1016/j.taap.2004.01.018; Zhao CS, 2012, BIOCHEMISTRY-US, V51, P9488, DOI 10.1021/bi301069r; Zhao YH, 2006, J BIOL CHEM, V281, P5973, DOI 10.1074/jbc.M511464200; Zhong XY, 2004, J BIOL CHEM, V279, P45676, DOI 10.1074/jbc.M409034200	95	17	18	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 6	2015	290	6					3308	3332		10.1074/jbc.M114.611525	http://dx.doi.org/10.1074/jbc.M114.611525			25	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2KL	25451919	Green Published, hybrid			2022-12-26	WOS:000349456000011
J	Li, S; Fossati, G; Marchetti, C; Modena, D; Pozzi, P; Reznikov, LL; Moras, ML; Azam, T; Abbate, A; Mascagni, P; Dinarello, CA				Li, Suzhao; Fossati, Gianluca; Marchetti, Carlo; Modena, Daniela; Pozzi, Pietro; Reznikov, Leonid L.; Moras, Maria Luisa; Azam, Tania; Abbate, Antonio; Mascagni, Paolo; Dinarello, Charles A.			Specific Inhibition of Histone Deacetylase 8 Reduces Gene Expression and Production of Proinflammatory Cytokines in Vitro and in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERSUS-HOST-DISEASE; CD4(+) T-CELLS; CANDIDA-ALBICANS; HIV-1 EXPRESSION; RENAL-DISEASE; BETA-CELLS; IL-1-BETA; ACID; INFLAMMASOME; VORINOSTAT	ITF2357 (generic givinostat) is an orally active, hydroxamic-containing histone deacetylase (HDAC) inhibitor with broad anti-inflammatory properties, which has been used to treat children with systemic juvenile idiopathic arthritis. ITF2357 inhibits both Class I and II HDACs and reduces caspase-1 activity in human peripheral blood mononuclear cells and the secretion of IL-1 beta and other cytokines at 25-100 nM; at concentrations >200 nM, ITF2357 is toxic in vitro. ITF3056, an analog of ITF2357, inhibits only HDAC8 (IC50 of 285 nM). Here we compared the production of IL-1 beta, IL-1 alpha, TNF alpha, and IL-6 by ITF2357 with that of ITF3056 in peripheral blood mononuclear cells stimulated with lipopolysaccharide (LPS), heat-killed Candida albicans, or anti-CD3/anti-CD28 antibodies. ITF3056 reduced LPS-induced cytokines from 100 to 1000 nM; at 1000 nM, the secretion of IL-1 beta was reduced by 76%, secretion of TNF alpha was reduced by 88%, and secretion of IL-6 was reduced by 61%. The intracellular levels of IL-1 alpha were 30% lower. There was no evidence of cell toxicity at ITF3056 concentrations of 100-1000 nM. Gene expression of TNF alpha was markedly reduced (80%), whereas IL-6 gene expression was 40% lower. Although anti-CD3/28 and Candida stimulation of IL-1 beta and TNF alpha was modestly reduced, IFN gamma production was 75% lower. Mechanistically, ITF3056 reduced the secretion of processed IL-1 beta independent of inhibition of caspase-1 activity; however, synthesis of the IL-1 beta precursor was reduced by 40% without significant decrease in IL-1 beta mRNA levels. In mice, ITF3056 reduced LPS-induced serum TNF alpha by 85% and reduced IL-1 beta by 88%. These data suggest that specific inhibition of HDAC8 results in reduced inflammation without cell toxicity.	[Li, Suzhao; Reznikov, Leonid L.; Azam, Tania; Dinarello, Charles A.] Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA; [Fossati, Gianluca; Modena, Daniela; Pozzi, Pietro; Moras, Maria Luisa; Mascagni, Paolo] Italfarmaco SpA, I-20092 Cinisello Balsamo, Italy; [Marchetti, Carlo; Abbate, Antonio] Virginia Commonwealth Univ, Dept Med, Richmond, VA 23298 USA; [Dinarello, Charles A.] Radboud Univ Nijmegen Med Ctr, Dept Med, NL-6525 HP Nijmegen, Netherlands	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Italfarmaco; Virginia Commonwealth University; Radboud University Nijmegen	Dinarello, CA (corresponding author), Univ Colorado Denver, Dept Med, Aurora, CO 80045 USA.	cdinare333@aol.com	Abbate, Antonio/G-8805-2016; Dinarello, Charles/C-8524-2013	Abbate, Antonio/0000-0002-1930-785X; 	National Institutes of Health [AI-15614, AR-45584]; American Heart Association [12POST12030134]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI015614, R01AI015614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR045584] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI-15614 and AR-45584 (to C. A. D.). This work was also supported by American Heart Association Postdoctoral Fellowship Grant 12POST12030134 (to S. L.).	Andrei C, 2004, P NATL ACAD SCI USA, V101, P9745, DOI 10.1073/pnas.0308558101; Archin NM, 2014, J INFECT DIS, V210, P728, DOI 10.1093/infdis/jiu155; Barton KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102684; Bertos NR, 2001, BIOCHEM CELL BIOL, V79, P243, DOI 10.1139/bcb-79-3-243; Carta S, 2006, BLOOD, V108, P1618, DOI 10.1182/blood-2006-03-014126; CHEDID L, 1977, P NATL ACAD SCI USA, V74, P2089, DOI 10.1073/pnas.74.5.2089; Cheng SC, 2012, INFECT IMMUN, V80, P1304, DOI 10.1128/IAI.06146-11; Cheng SC, 2011, J LEUKOCYTE BIOL, V90, P357, DOI 10.1189/jlb.1210702; Choi SW, 2014, LANCET ONCOL, V15, P87, DOI 10.1016/S1470-2045(13)70512-6; Christensen DP, 2014, P NATL ACAD SCI USA, V111, P1055, DOI 10.1073/pnas.1320850111; Dinarello CA, 2011, MOL MED, V17, P333, DOI 10.2119/molmed.2011.00116; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; Furlan A, 2011, MOL MED, V17, P353, DOI 10.2119/molmed.2011.00020; Gow NAR, 2012, NAT REV MICROBIOL, V10, P112, DOI 10.1038/nrmicro2711; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Icardi L, 2012, CYTOKINE GROWTH F R, V23, P283, DOI 10.1016/j.cytogfr.2012.08.002; Khan N, 2008, BIOCHEM J, V409, P581, DOI 10.1042/BJ20070779; Kolle D, 1998, METHODS, V15, P323, DOI 10.1006/meth.1998.0636; Leoni F, 2005, MOL MED, V11, P1, DOI 10.2119/2006-00005.Dinarello; Leoni F, 2002, P NATL ACAD SCI USA, V99, P2995, DOI 10.1073/pnas.052702999; Levandowski CB, 2013, P NATL ACAD SCI USA, V110, P2952, DOI 10.1073/pnas.1222808110; Lewis EC, 2011, MOL MED, V17, P369, DOI 10.2119/molmed.2010.00152; Lundh M, 2010, DIABETOLOGIA, V53, P2569, DOI 10.1007/s00125-010-1892-8; Marks PA, 2001, NAT REV CANCER, V1, P194, DOI 10.1038/35106079; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Matalon S, 2010, JAIDS-J ACQ IMM DEF, V54, P1, DOI 10.1097/QAI.0b013e3181d3dca3; McManamy Mary E. Manson, 2014, Antiviral Chemistry & Chemotherapy, V23, P145, DOI 10.3851/IMP2551; Mishra N, 2003, J CLIN INVEST, V111, P539, DOI 10.1172/JC1200316153; Netea MG, 2002, J INFECT DIS, V185, P963, DOI 10.1086/339410; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Nold MF, 2010, NAT IMMUNOL, V11, P1014, DOI 10.1038/ni.1944; Qiu ZJ, 2010, J IMMUNOL METHODS, V362, P101, DOI 10.1016/j.jim.2010.09.013; Rasmussen TA, 2013, HUM VACC IMMUNOTHER, V9, P993, DOI 10.4161/hv.23800; Reddy P, 2004, P NATL ACAD SCI USA, V101, P3921, DOI 10.1073/pnas.0400380101; Reilly CM, 2004, J IMMUNOL, V173, P4171, DOI 10.4049/jimmunol.173.6.4171; Rivera VR, 2006, ANAL BIOCHEM, V353, P248, DOI 10.1016/j.ab.2006.02.030; Skov S, 2003, BLOOD, V101, P1430, DOI 10.1182/blood-2002-07-2073; van de Veerdonk FL, 2009, CELL HOST MICROBE, V5, P329, DOI 10.1016/j.chom.2009.02.006; van de Veerdonk FL, 2009, J INFECT DIS, V199, P1087, DOI 10.1086/597274; Vojinovic J, 2011, MOL MED, V17, P397, DOI 10.2119/molmed.2011.00030; Vojinovic J, 2011, ARTHRITIS RHEUM-US, V63, P1452, DOI 10.1002/art.30238; Wang H, 2004, WORLD J GASTROENTERO, V10, P2690, DOI 10.3748/wjg.v10.i18.2690	42	41	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2368	2378		10.1074/jbc.M114.618454	http://dx.doi.org/10.1074/jbc.M114.618454			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25451941	Green Published, hybrid			2022-12-26	WOS:000348588000040
J	Trasino, SE; Benoit, YD; Gudas, LJ				Trasino, Steven E.; Benoit, Yannick D.; Gudas, Lorraine J.			Vitamin A Deficiency Causes Hyperglycemia and Loss of Pancreatic beta-Cell Mass	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN-I; RETINOIC ACID; INSULIN-RESISTANCE; STELLATE CELLS; ALPHA-CELL; ALL-TRANS; ENDOCRINE; DIFFERENTIATION; EXPRESSION; PROLIFERATION	We show that vitamin A (all-trans-retinol) (VA) is required both for the maintenance of pancreatic beta-cell and alpha-cell mass and for glucose-stimulated insulin secretion in adult mice. Dietary VA deprivation (VAD) causes greatly decreased pancreatic VA levels, hyperglycemia, and reduced insulin secretion. Adult mice fed VAD diets display remodeling of the endocrine pancreas, marked beta-cell apoptosis, shifts to smaller islet size distributions, decreased beta-cell mass, increased alpha-cell mass, and hyperglucagonemia. Importantly, although we induced VAD in the entire animal, the pancreatic beta-cells are exquisitely sensitive to VAD-associated apoptosis compared with other cell types in other organs. VAD causes major reductions in levels of the VA intracellular binding protein Crbp1 and the retinoic acid-metabolizing enzyme Cyp26a1 specifically in larger islets, suggesting the use of these proteins as biomarkers for early endocrine mass abnormalities. In the VAD mice, the reductions in pancreatic islet sizes and the associated aberrant endocrine functions, which show similarities to the phenotype in advanced type 2 diabetes, result from reductions in pancreatic VA signaling. Reintroduction of dietary VA to VAD mice restores pancreatic VA levels, glycemic control, normal islet size distributions, beta-cell to alpha-cell ratios, endocrine hormone profiles, and RAR beta 2 and RAR gamma 2 transcript levels. Restoration of beta-cell mass by reintroducing VA to VAD mice does not involve increased beta-cell proliferation or neogenesis. Pharmacologic modulation of pancreatic VA signaling should be explored for the preservation and/or restoration of pancreatic beta-cell mass and function in individuals with diabetes mellitus.	[Trasino, Steven E.; Benoit, Yannick D.; Gudas, Lorraine J.] Weill Cornell Med Coll, Dept Pharmacol, New York, NY 10065 USA	Cornell University	Gudas, LJ (corresponding author), Cornell Univ, Dept Pharmacol, 1300 York Ave, New York, NY 10065 USA.	ljgudas@med.cornell.edu		Benoit, Yannick/0000-0002-6677-4020	National Institutes of Health [R01CA043796, RO1 DE010389, CA062948]; Weill Cornell funds; NATIONAL CANCER INSTITUTE [R01CA043796, T32CA062948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE010389] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Weill Cornell funds; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grants R01CA043796 and RO1 DE010389 (to L. J. G.) and CA062948 (to S. E. T.). This work was also supported by Weill Cornell funds.	Al-Hasani K, 2013, DEV CELL, V26, P86, DOI 10.1016/j.devcel.2013.05.018; Berry DC, 2009, MOL CELL BIOL, V29, P3286, DOI 10.1128/MCB.01742-08; Brissova M, 2005, AM J PHYSIOL-ENDOC M, V288, pE707, DOI 10.1152/ajpendo.00252.2004; Chen H, 1996, CELL, V84, P491, DOI 10.1016/S0092-8674(00)81294-5; Chen YL, 2004, DEV BIOL, V271, P144, DOI 10.1016/j.ydbio.2004.03.030; CHERTOW BS, 1987, J CLIN INVEST, V79, P163, DOI 10.1172/JCI112778; CHERTOW BS, 1994, PANCREAS, V9, P475, DOI 10.1097/00006676-199407000-00010; Chung CH, 2010, STEM CELLS, V28, P1630, DOI 10.1002/stem.482; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Criscimanna A, 2011, GASTROENTEROLOGY, V141, P1451, DOI 10.1053/j.gastro.2011.07.003; Donath MY, 2004, DIABETOLOGIA, V47, P581, DOI 10.1007/s00125-004-1336-4; DURAND B, 1992, CELL, V71, P73, DOI 10.1016/0092-8674(92)90267-G; Ghyselinck NB, 1999, EMBO J, V18, P4903, DOI 10.1093/emboj/18.18.4903; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Gudas LJ, 2013, SEMIN CELL DEV BIOL, V24, P701, DOI 10.1016/j.semcdb.2013.08.002; Gudas LJ, 2011, J CELL PHYSIOL, V226, P322, DOI 10.1002/jcp.22417; Guo LL, 2013, DIABETES, V62, P3459, DOI 10.2337/db12-1833; Haber PS, 1999, AM J PATHOL, V155, P1087, DOI 10.1016/S0002-9440(10)65211-X; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Holland AM, 2005, DIABETES, V54, P2586, DOI 10.2337/diabetes.54.9.2586; Hull RL, 2004, J CLIN ENDOCR METAB, V89, P3629, DOI 10.1210/jc.2004-0405; Jo J, 2012, ISLETS, V4, DOI 10.4161/isl.18660; Kane MA, 2010, P NATL ACAD SCI USA, V107, P21884, DOI 10.1073/pnas.1008859107; Kilimnik G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027445; Kilimnik G, 2009, AM J PHYSIOL-ENDOC M, V297, pE1331, DOI 10.1152/ajpendo.00479.2009; Kim A, 2009, ISLETS, V1, P129, DOI 10.4161/isl.1.2.9480; Kim SC, 2014, HEPATOLOGY, V59, P1750, DOI 10.1002/hep.26699; Krakowski ML, 1999, J ENDOCRINOL, V162, P167, DOI 10.1677/joe.0.1620167; Kulkarni RN, 2004, J CLIN INVEST, V114, P828, DOI 10.1172/JCI200421845; Li Z, 2000, J ENDOCRINOL, V165, P93, DOI 10.1677/joe.0.1650093; Liu LM, 2005, J BIOL CHEM, V280, P40226, DOI 10.1074/jbc.M509643200; Lotan R, 2005, JNCI-J NATL CANCER I, V97, P3, DOI 10.1093/jnci/dji031; Martin M, 2005, DEV BIOL, V284, P399, DOI 10.1016/j.ydbio.2005.05.035; Masaki T, 2008, METABOLISM, V57, P1340, DOI 10.1016/j.metabol.2008.03.013; Matthews KA, 2004, J NUTR, V134, P1958, DOI 10.1093/jn/134.8.1958; Molotkov A, 2005, DEV DYNAM, V232, P950, DOI 10.1002/dvdy.20256; Nagy NE, 1997, J LIPID RES, V38, P645; Niederreither K, 2002, NAT GENET, V31, P84, DOI 10.1038/ng876; Noy N, 2010, ANNU REV NUTR, V30, P201, DOI 10.1146/annurev.nutr.28.061807.155509; O'Byrne SM, 2005, J BIOL CHEM, V280, P35647, DOI 10.1074/jbc.M507924200; Offield MF, 1996, DEVELOPMENT, V122, P983; Ostrom M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002841; Perez RJ, 2013, EXP CELL RES, V319, P2196, DOI 10.1016/j.yexcr.2013.05.032; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Puff R, 2011, HORM METAB RES, V43, P306, DOI 10.1055/s-0031-1271817; Ray WJ, 1997, J BIOL CHEM, V272, P18702, DOI 10.1074/jbc.272.30.18702; Schwarz EJ, 1997, MOL CELL BIOL, V17, P1552, DOI 10.1128/MCB.17.3.1552; Suh JM, 2014, NATURE, V513, P436, DOI 10.1038/nature13540; Talchai C, 2012, NAT GENET, V44, P406, DOI 10.1038/ng.2215; TannousKhuri L, 1997, EXP CELL RES, V230, P38, DOI 10.1006/excr.1996.3399; Tattikota SG, 2014, CELL METAB, V19, P122, DOI 10.1016/j.cmet.2013.11.015; Thatcher JE, 2009, EXPERT OPIN DRUG MET, V5, P875, DOI 10.1517/17425250903032681; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; University of California San Diego, 2000, RAND DOUBL BLIND STU; Van de Casteele M, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.52; Wang XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067454; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zhang YQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036675	61	57	57	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1456	1473		10.1074/jbc.M114.616763	http://dx.doi.org/10.1074/jbc.M114.616763			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25451926	Green Published, hybrid			2022-12-26	WOS:000348056400017
J	Gosney, BJ; Oreilly-Wapstra, JM; Forster, LG; Barbour, RC; Iason, GR; Potts, BM				Gosney, Benjamin J.; Oreilly-Wapstra, Julianne M.; Forster, Lynne G.; Barbour, Robert C.; Iason, Glenn R.; Potts, Brad M.			Genetic and Ontogenetic Variation in an Endangered Tree Structures Dependent Arthropod and Fungal Communities	PLOS ONE			English	Article							EUCALYPTUS-GLOBULUS; RELATIVE IMPORTANCE; PLANT GENOTYPE; DEFENSIVE CHEMISTRY; HERBIVOROUS INSECTS; LEAF-BEETLE; RESISTANCE; CONSTRAINTS; DIVERSITY; APHIDS	Plant genetic and ontogenetic variation can significantly impact dependent fungal and arthropod communities. However, little is known of the relative importance of these extended genetic and ontogenetic effects within a species. Using a common garden trial, we compared the dependent arthropod and fungal community on 222 progeny from two highly differentiated populations of the endangered heteroblastic tree species, Eucalyptus morrisbyi. We assessed arthropod and fungal communities on both juvenile and adult foliage. The community variation was related to previous levels of marsupial browsing, as well as the variation in the physicochemical properties of leaves using near-infrared spectroscopy. We found highly significant differences in community composition, abundance and diversity parameters between eucalypt source populations in the common garden, and these were comparable to differences between the distinctive juvenile and adult foliage. The physicochemical properties assessed accounted for a significant percentage of the community variation but did not explain fully the community differences between populations and foliage types. Similarly, while differences in population susceptibility to a major marsupial herbivore may result in diffuse genetic effects on the dependent community, this still did not account for the large genetic-based differences in dependent communities between populations. Our results emphasize the importance of maintaining the populations of this rare species as separate management units, as not only are the populations highly genetically structured, this variation may alter the trajectory of biotic colonization of conservation plantings.	[Gosney, Benjamin J.; Oreilly-Wapstra, Julianne M.; Barbour, Robert C.; Potts, Brad M.] Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia; [Forster, Lynne G.] Univ Tasmania, Sch Agr Sci, Hobart, Tas, Australia; [Gosney, Benjamin J.; Oreilly-Wapstra, Julianne M.; Potts, Brad M.] Univ Tasmania, NCFFI, Hobart, Tas, Australia; [Iason, Glenn R.] James Hutton Inst, Aberdeen, Scotland	University of Tasmania; University of Tasmania; University of Tasmania; James Hutton Institute	Gosney, BJ (corresponding author), Univ Tasmania, Sch Plant Sci, Hobart, Tas, Australia.	Ben.Gosney@utas.edu.au	Potts, Brad M/C-6489-2013; O'Reilly-Wapstra, Julianne/J-7275-2014	Potts, Brad M/0000-0001-6244-289X; Forster, Lynette/0000-0001-9195-2768; O'Reilly-Wapstra, Julianne/0000-0003-4801-4412	Australian Research Council [DP120102889, LP120200380]; BBSRC [BB/L012227/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L012227/1] Funding Source: researchfish	Australian Research Council(Australian Research Council); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding: The trial studied was established by the CRC for Sustainable Production Forestry. This study is part of a PhD undertaken by Benjamin Gosney, supported by an International Postgraduate Scholarship provided by the University of Tasmania and funded by the Australian government. Trial assessment and data collection was funded by Australian Research Council linkage grants (DP120102889 and LP120200380). The funders had no role in the study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Abbott Ian, 2001, Pacific Conservation Biology, V7, P101; Aitken SN, 2013, ANNU REV ECOL EVOL S, V44, P367, DOI 10.1146/annurev-ecolsys-110512-135747; Anderson MJ, 2008, PERMANOVA PRIMER GUI; Bailey J, 2011, ECOLOGICAL REV ECOLO; Barbour RC, 2009, ECOLOGY, V90, P1762, DOI 10.1890/08-0951.1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bito Darren, 2011, Memoirs of the Queensland Museum, V55, P451; Busby PE, 2014, J ECOL, V102, P1300, DOI 10.1111/1365-2745.12270; Busby PE, 2013, J ECOL, V101, P867, DOI 10.1111/1365-2745.12112; Byrne M., 2008, PLANT GENOME BIODI E, V1, P303; Carvalho MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094950; De Oliveira HG, 2010, REV COLOMB ENTOMOL, V36, P1; Dungey HS, 1997, CAN J FOREST RES, V27, P750, DOI 10.1139/cjfr-27-5-750; Ellison AM, 2005, FRONT ECOL ENVIRON, V3, P479, DOI 10.1890/1540-9295(2005)003[0479:LOFSCF]2.0.CO;2; Fletcher DJ, 2002, J EXP MAR BIOL ECOL, V273, P89, DOI 10.1016/S0022-0981(02)00142-9; FOX LR, 1983, AUST J ECOL, V8, P139, DOI 10.1111/j.1442-9993.1983.tb01601.x; Frascaria-Lacoste N, 2012, RESTOR ECOL, V20, P296, DOI 10.1111/j.1526-100X.2012.00875.x; Hersch-Green EI, 2011, PHILOS T R SOC B, V366, P1453, DOI 10.1098/rstb.2010.0331; Hobbs RJ, 2007, RESTOR ECOL, V15, P354, DOI 10.1111/j.1526-100X.2007.00225.x; HOCKING RR, 1976, BIOMETRICS, V32, P1, DOI 10.2307/2529336; Holeski LM, 2012, OECOLOGIA, V170, P695, DOI 10.1007/s00442-012-2344-6; Johnson MTJ, 2008, ECOLOGY, V89, P145, DOI 10.1890/07-0395.1; Johnson MTJ, 2007, OIKOS, V116, P941, DOI 10.1111/j.0030-1299.2007.15773.x; Jones RC, 2005, AUST J BOT, V53, P367, DOI 10.1071/BT04182; Larson KC, 1997, OECOLOGIA, V109, P575, DOI 10.1007/s004420050119; Lawrence R, 2003, ECOLOGY, V84, P1171, DOI 10.1890/0012-9658(2003)084[1171:RIOPOH]2.0.CO;2; Loch AD, 2010, FOREST ECOL MANAG, V260, P1324, DOI 10.1016/j.foreco.2010.07.025; Maherali H, 2009, NEW PHYTOL, V183, P908, DOI 10.1111/j.1469-8137.2009.02845.x; Mann AN, 2012, OIKOS, V121, P268, DOI 10.1111/j.1600-0706.2011.19667.x; Milgate AW, 2005, AUSTRALAS PLANT PATH, V34, P11, DOI 10.1071/AP04073; Novotny V, 2002, NATURE, V416, P841, DOI 10.1038/416841a; O'Reilly-Wapstra JM, 2013, TREE GENET GENOMES, V9, P943, DOI 10.1007/s11295-013-0607-y; O'Reilly-Wapstra JM, 2004, FUNCT ECOL, V18, P677, DOI 10.1111/j.0269-8463.2004.00887.x; O'Reilly-Wapstra JM, 2002, OECOLOGIA, V130, P289, DOI 10.1007/s004420100797; O'Reilly-Wapstra JM, 2007, J CHEM ECOL, V33, P1876, DOI 10.1007/s10886-007-9366-2; PARSONS R F, 1974, Biotropica, V6, P202, DOI 10.2307/2989653; Quinn G.P., 2002, EXPT DESIGN DATA ANA; R Core Team, 2021, R LANGUAGE ENV STAT; Rapley LP, 2004, AUST J BOT, V52, P747, DOI 10.1071/BT04007; Rapley LP, 2007, CHEMOECOLOGY, V17, P235, DOI 10.1007/s00049-007-0382-z; RAYMOND CA, 1995, FOREST ECOL MANAG, V72, P21, DOI 10.1016/0378-1127(94)03451-2; Robinson KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037679; Salazar D, 2012, P NATL ACAD SCI USA, V109, P12616, DOI 10.1073/pnas.1202907109; Smith DS, 2011, J EVOLUTION BIOL, V24, P422, DOI 10.1111/j.1420-9101.2010.02178.x; Tack AJM, 2012, OIKOS, V121, P481, DOI 10.1111/j.1600-0706.2011.19926.x; Tack AJM, 2011, ECOLOGY, V92, P1594, DOI 10.1890/10-2006.1; Tack AJM, 2010, ECOLOGY, V91, P2660, DOI 10.1890/09-1027.1; Vandegehuchte ML, 2012, INSECT CONSERV DIVER, V5, P453, DOI 10.1111/j.1752-4598.2011.00181.x; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877; Whitham TG, 2012, TRENDS PLANT SCI, V17, P271, DOI 10.1016/j.tplants.2012.01.005; Whitham TG, 2010, MOLECULAR APPROACHES IN NATURAL RESOURCE CONSERVATION AND MANAGEMENT, P50; Wiggins NL, 2006, J CHEM ECOL, V32, P1133, DOI 10.1007/s10886-006-9076-1; Wiltshire RJE, 1998, AUST J BOT, V46, P45, DOI 10.1071/BT97020; Wise MJ, 2007, NEW PHYTOL, V175, P773, DOI 10.1111/j.1469-8137.2007.02143.x; Wise MJ, 2010, ARTHROPOD-PLANT INTE, V4, P159, DOI 10.1007/s11829-010-9094-3; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Zotz G, 2011, BOT REV, V77, P109, DOI 10.1007/s12229-010-9062-8; Zytynska SE, 2011, PHILOS T R SOC B, V366, P1329, DOI 10.1098/rstb.2010.0183	58	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114132	10.1371/journal.pone.0114132	http://dx.doi.org/10.1371/journal.pone.0114132			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469641	gold, Green Published, Green Submitted			2022-12-26	WOS:000349128700075
J	Hui, M; Liu, YA; Song, CW; Li, YD; Shi, GH; Cui, ZX				Hui, Min; Liu, Yuan; Song, Chengwen; Li, Yingdong; Shi, Guohui; Cui, Zhaoxia			Transcriptome Changes in Eriocheir sinensis Megalopae after Desalination Provide Insights into Osmoregulation and Stress Adaption in Larvae	PLOS ONE			English	Article							CHINESE MITTEN CRAB; OLFERSII WIEGMANN CRUSTACEA; LITOPENAEUS-VANNAMEI; ANTIOXIDANT ENZYME; SALINITY STRESS; BINDING PROTEIN; CARCINUS-MAENAS; WHITE SHRIMP; EXPRESSION; ATPASE	Eriocheir sinensis, an extremely invasive alien crab species, has important economic value in China. It encounters different salinities during its life cycle, and at the megalopal stage it faces a turning point regarding the salinity in its environment. We applied RNA sequencing to E. sinensis megalopae before (MB) and after (MA) desalination, resulting in the discovery of 21,042 unigenes and 908 differentially expressed genes (DEGs, 4.32% of the unigenes). The DEGs primarily belonged to the Gene Ontology groups "Energy metabolism," "Oxidoreductase activity," "Translation," "Transport," "Metabolism," and "Stress response." In total, 33 DEGs related to transport processes were found, including 12 proton pump genes, three ATP-binding cassettes (ABCs), 13 solute carrier (SLC) family members, two sweet sugar transporter (ST) family members and three other substance transporters. Mitochondrial genes as well as genes involved in the tricarboxylic acid cycle, glycolytic pathway, or beta-oxidation pathway, which can generate energy in the form of ATP, were typically up-regulated in MA. 11 unigenes related to amino acid metabolism and a large number of genes related to protein synthesis were differentially expressed in MB and MA, indicating that E. sinensis possibly adjusts its concentration of free amino acid osmolytes for hyper-osmoregulation. Additionally, 33 salinity and oxidative stress induced genes were found to be differentially expressed, such as the LEA2, HSPs, GST and coagulation factor genes. Notably, LEA2 is an extremely hydrophilic protein that responds to desiccation and reported for the first time in crabs. Therefore, we suppose that when the environment is hypo-osmotic, the megalopae might compensate for ion loss via hyper-osmoregulation by consuming more energy, accompanied by a series of stress induced adaptions. This study provides the first genome-wide transcriptome analysis of E. sinensis megalopae for studying its osmoregulation and stress adaption mechanisms.	[Hui, Min; Liu, Yuan; Song, Chengwen; Li, Yingdong; Shi, Guohui; Cui, Zhaoxia] Chinese Acad Sci, EMBL, Inst Oceanol, Qingdao 266071, Peoples R China; [Song, Chengwen; Shi, Guohui] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Cui, Zhaoxia] Natl & Local Joint Engn Lab Ecol Mariculture, Qingdao 266071, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Cui, ZX (corresponding author), Chinese Acad Sci, EMBL, Inst Oceanol, Qingdao 266071, Peoples R China.	zhxcui@qdio.ac.cn		Li, Yingdong/0000-0002-9570-3715	Chinese National "863" Project [2012AA10A409]; National Natural Science Foundation of China [31101924, 41276165]	Chinese National "863" Project(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Chinese National "863" Project (No. 2012AA10A409, http://www.most.gov.cn/eng/) and National Natural Science Foundation of China (31101924 and 41276165, http://www.nsfc.gov.cn/publish/portal1/) to ZC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders Simon, 2010, Genome Biol, V11, pR106, DOI 10.1186/gb-2010-11-10-r106; ANGER K, 1991, MAR ECOL PROG SER, V72, P103, DOI 10.3354/meps072103; Barata C, 2005, COMP BIOCHEM PHYS C, V140, P175, DOI 10.1016/j.cca.2005.01.013; BOSRON WF, 1986, HEPATOLOGY, V6, P502, DOI 10.1002/hep.1840060330; CHANCE B, 1956, ADV ENZYMOL REL S BI, V17, P65; Chapman RW, 2011, MOL ECOL, V20, P1431, DOI 10.1111/j.1365-294X.2011.05018.x; CHARMANTIER G, 1988, BIOL BULL-US, V175, P102, DOI 10.2307/1541897; Cheng YX, 2008, REV FISH SCI, V16, P377, DOI 10.1080/10641260701681698; Chiba S, 1997, BIOSCI BIOTECH BIOCH, V61, P1233, DOI 10.1271/bbb.61.1233; Cieluch U, 2007, MAR ECOL PROG SER, V329, P169, DOI 10.3354/meps329169; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; DALLA VIA J, 1986, AQUACULTURE, V55, P307, DOI 10.1016/0044-8486(86)90171-7; de la Vega E, 2007, PHYSIOL GENOMICS, V31, P126, DOI 10.1152/physiolgenomics.00068.2007; Denekamp NY, 2010, BIOL REPROD, V82, P714, DOI 10.1095/biolreprod.109.081091; FOSKETT JK, 1977, BIOL BULL, V153, P505, DOI 10.2307/1540603; FREIRE CA, 1995, GEN COMP ENDOCR, V100, P83, DOI 10.1006/gcen.1995.1136; Freire CA, 2008, COMP BIOCHEM PHYS A, V151, P272, DOI 10.1016/j.cbpa.2007.05.008; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hediger MA, 2004, PFLUG ARCH EUR J PHY, V447, P465, DOI 10.1007/s00424-003-1192-y; Herborg LM, 2003, HYDROBIOLOGIA, V503, P21, DOI 10.1023/B:HYDR.0000008483.63314.3c; Huong DTT, 2001, COMP BIOCHEM PHYS A, V128, P317, DOI 10.1016/S1095-6433(00)00310-X; Item CB, 2001, AM J HUM GENET, V69, P1127, DOI 10.1086/323765; Jiang H, 2008, BIOINFORMATICS, V24, P2395, DOI 10.1093/bioinformatics/btn429; Jiang H, 2009, BIOINFORMATICS, V25, P1026, DOI 10.1093/bioinformatics/btp113; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; KING FD, 1985, COMP BIOCHEM PHYS B, V80, P401, DOI 10.1016/0305-0491(85)90262-7; Kirstein-Miles J, 2013, EMBO J, V32, P1451, DOI 10.1038/emboj.2013.87; Kong XH, 2008, MAR BIOL, V154, P269, DOI 10.1007/s00227-008-0920-4; KREBS H. A., 1960, Metabolic Pathways, V1, P129; Kurz T, 2007, ARCH BIOCHEM BIOPHYS, V462, P220, DOI 10.1016/j.abb.2007.01.013; Le Moullac G, 2000, AQUACULTURE, V191, P121, DOI 10.1016/S0044-8486(00)00422-1; Li EC, 2014, PHYSIOL GENOMICS, V46, P177, DOI 10.1152/physiolgenomics.00191.2013; Liu CH, 2007, FISH SHELLFISH IMMUN, V23, P34, DOI 10.1016/j.fsi.2006.09.002; Luvizotto-Santos R, 2003, J EXP ZOOL PART A, V295A, P200, DOI 10.1002/jez.a.10219; Lv JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082155; MCNAMARA JC, 1990, HYDROBIOLOGIA, V199, P193, DOI 10.1007/BF00006352; McNamara JC, 2012, J COMP PHYSIOL B, V182, P997, DOI 10.1007/s00360-012-0665-8; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nagai T, 2000, J BIOL CHEM, V275, P29264, DOI 10.1074/jbc.M002556200; Paital B, 2010, COMP BIOCHEM PHYS C, V151, P142, DOI 10.1016/j.cbpc.2009.09.007; Perazzolo LM, 2002, AQUACULTURE, V214, P19, DOI 10.1016/S0044-8486(02)00137-0; POLLARD HB, 1990, J MEMBRANE BIOL, V117, P101, DOI 10.1007/BF01868677; Powell S, 2012, NUCLEIC ACIDS RES, V40, pD284, DOI 10.1093/nar/gkr1060; Rainbow PS, 2001, J EXP MAR BIOL ECOL, V264, P1, DOI 10.1016/S0022-0981(01)00289-1; Rodrigues AP, 2012, MAR BIOL, V159, P2061, DOI 10.1007/s00227-012-1992-8; Seasholtz AF, 2002, J ENDOCRINOL, V175, P89, DOI 10.1677/joe.0.1750089; Sharon MA, 2009, BIOCHEM CELL BIOL, V87, P415, DOI [10.1139/o09-001, 10.1139/O09-001]; Silvestre F, 2005, COMP BIOCHEM PHYS C, V140, P29, DOI 10.1016/j.cca.2004.12.007; Sui LY, 2011, AQUACULTURE, V315, P16, DOI 10.1016/j.aquaculture.2010.06.021; Sun HY, 2011, MAR BIOL RES, V7, P623, DOI 10.1080/17451000.2010.538063; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Towle DW, 2011, COMP BIOCHEM PHYS D, V6, P115, DOI 10.1016/j.cbd.2010.11.001; TOWLE DW, 1986, J EXP ZOOL, V239, P311, DOI 10.1002/jez.1402390302; Tsai JR, 2007, J EXP BIOL, V210, P620, DOI 10.1242/jeb.02684; Wang HZ, 2006, AQUACULTURE, V255, P456, DOI 10.1016/j.aquaculture.2006.01.005; Wang YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037316; Weber JM, 2011, J EXP BIOL, V214, P286, DOI 10.1242/jeb.047050; WELCOMME L, 1991, J EXP ZOOL, V257, P150, DOI 10.1002/jez.1402570203; Xu QH, 2011, MAR BIOL, V158, P2161, DOI 10.1007/s00227-011-1721-8; Zhang YQ, 1999, GENETICS, V153, P891; Zhou J, 2009, COMP BIOCHEM PHYS C, V150, P450, DOI 10.1016/j.cbpc.2009.06.012; Zhou J, 2009, COMP BIOCHEM PHYS C, V150, P224, DOI 10.1016/j.cbpc.2009.04.012	63	41	41	2	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114187	10.1371/journal.pone.0114187	http://dx.doi.org/10.1371/journal.pone.0114187			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470496	Green Published, Green Submitted, gold			2022-12-26	WOS:000349128700083
J	Renner, I; Funk, N; Geissler, R; Friedrich, S; Penzel, A; Behrens, SE				Renner, Ivonne; Funk, Nancy; Geissler, Rene; Friedrich, Susann; Penzel, Anika; Behrens, Sven-Erik			Antiviral Interferon-Beta Signaling Induced by Designed Transcription Activator-Like Effectors (TALE)	PLOS ONE			English	Article							HEPATITIS-C VIRUS; RIG-I; RNA REPLICATION; III EFFECTORS; RECOGNITION; MECHANISMS; IMMUNITY; BINDING; CODE	Here we show that designed transcription activator-like effectors (TALEs) that bind to defined areas of the interferon beta promoter are capable to induce IFN-beta expression and signaling in human cells. Importantly, TALE-mediated IFN-beta signaling occurs independently of pathogen pattern recognition but effectively prohibits viral RNA replication as demonstrated with a hepatitis C virus replicon. TALEs were thus indicated to be valuable tools in various applications addressing, for example, virus-host interactions.	[Renner, Ivonne; Funk, Nancy; Geissler, Rene; Friedrich, Susann; Penzel, Anika; Behrens, Sven-Erik] Univ Halle Wittenberg, Sect Microbial Biotechnol, Inst Biochem & Biotechnol, Fac Life Sci NFI, D-06120 Halle, Germany	Martin Luther University Halle Wittenberg	Behrens, SE (corresponding author), Univ Halle Wittenberg, Sect Microbial Biotechnol, Inst Biochem & Biotechnol, Fac Life Sci NFI, Kurt Mothes Str 3, D-06120 Halle, Germany.	sven.behrens@biochemtech.uni-halle.de		Friedrich, Susann/0000-0001-6378-2933	Deutsche Forschungsgemeinschaft [BE 1885/9-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This study was supported by the Deutsche Forschungsgemeinschaft (BE 1885/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Boch J, 2010, ANNU REV PHYTOPATHOL, V48, P419, DOI 10.1146/annurev-phyto-080508-081936; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Doyle EL, 2013, TRENDS CELL BIOL, V23, P390, DOI 10.1016/j.tcb.2013.04.003; Ford E, 2010, BBA-GENE REGUL MECH, V1799, P328, DOI 10.1016/j.bbagrm.2010.01.010; Geissler R, 2012, NUCLEIC ACIDS RES, V40, P4998, DOI 10.1093/nar/gks070; Geissler R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019509; Horner SM, 2009, J INTERF CYTOK RES, V29, P489, DOI 10.1089/jir.2009.0063; Isken O, 2007, RNA, V13, P1675, DOI 10.1261/rna.594207; Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001; Li K, 2013, SEMIN IMMUNOPATHOL, V35, P53, DOI 10.1007/s00281-012-0332-x; MacMicking JD, 2012, NAT REV IMMUNOL, V12, P367, DOI 10.1038/nri3210; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Miller JC, 2011, NAT BIOTECHNOL, V29, P143, DOI 10.1038/nbt.1755; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Schlee M, 2009, IMMUNOL REV, V227, P66, DOI 10.1111/j.1600-065X.2008.00724.x; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang F, 2011, NAT BIOTECHNOL, V29, P149, DOI 10.1038/nbt.1775	28	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114288	10.1371/journal.pone.0114288	http://dx.doi.org/10.1371/journal.pone.0114288			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470486	Green Published, gold, Green Submitted			2022-12-26	WOS:000349128700097
J	Taylor, RA; Hammond, MD; Ai, Y; Sansing, LH				Taylor, Roslyn A.; Hammond, Matthew D.; Ai, Youxi; Sansing, Lauren H.			CX3CR1 Signaling on Monocytes Is Dispensable after Intracerebral Hemorrhage	PLOS ONE			English	Article							SPINAL-CORD-INJURY; INFLAMMATORY MONOCYTES; ISCHEMIC-STROKE; MACROPHAGES; FRACTALKINE; SUBSETS; RECRUITMENT; RECEPTOR; BLOOD; CELLS	Intracerebral hemorrhage is a subset of stroke for which there is no specific treatment. The Ly6C(hi) CCR2(+) monocytes have been shown to contribute to acute injury after intracerebral hemorrhage. The other murine monocyte subset expresses CX3CR1 and lower Ly6C levels, and contributes to repair in other disease models. We hypothesized that the Ly6C(lo) CX3CR1(+) monocytes would contribute to recovery after intracerebral hemorrhage. Intracerebral hemorrhage was modeled by blood injection in WT and CX3CR1-null bone marrow chimeras. Neurological outcomes and leukocyte recruitment were quantified at various time points. Functional outcomes were equal at 1, 3, 7, and 14 days after intracerebral hemorrhage in both genotypes. No differences were observed in leukocyte recruitment between genotypes on either 3 or 7 days after intracerebral hemorrhage. A few hundred Ly6C(lo) monocytes were found in the ipsilateral hemisphere in each genotype and they did not change over time. Peripherally derived CX3CR1(+) monocytes were observed in the perihematomal brain 7 and 14 days after intracerebral hemorrhage. Our data suggests CX3CR1 signaling on monocytes does not play an influential role in acute injury or functional recovery after intracerebral hemorrhage and therefore CX3CR1 is not a therapeutic target to improve outcome after intracerebral hemorrhage.	[Taylor, Roslyn A.] Univ Connecticut, Ctr Hlth, Dept Immunol, Farmington, CT USA; [Taylor, Roslyn A.; Hammond, Matthew D.; Ai, Youxi; Sansing, Lauren H.] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Hammond, Matthew D.] Univ Connecticut, Ctr Hlth, Dept Neurosci, Farmington, CT USA	University of Connecticut; Yale University; University of Connecticut	Sansing, LH (corresponding author), Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA.	lauren.sansing@yale.edu		Sansing, Lauren/0000-0002-6898-1680	NIH [F31NS083231, K08NS078110]; Marlene L. Cohen and Jerome H. Fleisch Scholar Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS078110, F31NS083231] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marlene L. Cohen and Jerome H. Fleisch Scholar Grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding: This work was supported by NIH F31NS083231 (MDH) and K08NS078110 (L.H.S.) and the Marlene L. Cohen and Jerome H. Fleisch Scholar Grant (L.H.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bellavance M.-A., 2014, BRAIN STRUCT FUNCT; Blomster LV, 2013, EXP NEUROL, V247, P226, DOI 10.1016/j.expneurol.2013.05.002; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chapman GA, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-15-j0004.2000; Cipriani R, 2011, J NEUROSCI, V31, P16327, DOI 10.1523/JNEUROSCI.3611-11.2011; Donnelly DJ, 2011, J NEUROSCI, V31, P9910, DOI 10.1523/JNEUROSCI.2114-11.2011; Donohue MM, 2012, STROKE, V43, P2300, DOI 10.1161/STROKEAHA.112.657411; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Hammond M, 2012, TRANSLATIONAL STROKE, V3; Hammond MD, 2014, J NEUROSCI, V34, P3901, DOI 10.1523/JNEUROSCI.4070-13.2014; Huang D, 2006, FASEB J, V20, P896, DOI 10.1096/fj.05-5465com; Jones SR, 2003, EMERG MED J, V20, P453, DOI 10.1136/emj.20.5.453; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Manno Edward M, 2012, Continuum (Minneap Minn), V18, P598, DOI 10.1212/01.CON.0000415430.99394.3e; Michaud JP, 2014, J CEREB BLOOD FLOW M; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Pereira FE, 2013, CARDIOVASC RES, V100, P74, DOI 10.1093/cvr/cvt155; Prinz M, 2010, J NEUROIMMUNOL, V224, P80, DOI 10.1016/j.jneuroim.2010.05.015; Qin WJ, 2014, NEUROSCI LETT, V569, P80, DOI 10.1016/j.neulet.2014.03.052; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Sansing LH, 2011, ANN NEUROL, V70, P646, DOI 10.1002/ana.22528; Sansing LH, 2011, ACTA NEUROCHIR SUPPL, V111, P173, DOI 10.1007/978-3-7091-0693-8_29; Schluns KS, 2004, P NATL ACAD SCI USA, V101, P5616, DOI 10.1073/pnas.0307442101; Shechter R, 2013, IMMUNITY, V38, P555, DOI 10.1016/j.immuni.2013.02.012; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Thawer SG, 2013, J NEUROIMMUNOL, V261, P7, DOI 10.1016/j.jneuroim.2013.04.008; Wang J, 2007, J CEREBR BLOOD F MET, V27, P894, DOI 10.1038/sj.jcbfm.9600403; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Xue MZ, 2000, NEUROSCI LETT, V283, P230, DOI 10.1016/S0304-3940(00)00971-X; Zhou J, 2010, J EXP MED, V207, P1951, DOI 10.1084/jem.20100098	34	11	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114472	10.1371/journal.pone.0114472	http://dx.doi.org/10.1371/journal.pone.0114472			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469644	Green Published, gold, Green Submitted			2022-12-26	WOS:000349128700117
J	Christou, C; Oliver, RA; Yu, Y; Walsh, WR				Christou, Chris; Oliver, Rema A.; Yu, Yan; Walsh, William R.			The Masquelet Technique for Membrane Induction and the Healing of Ovine Critical Sized Segmental Defects	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; ORTHOPEDIC TRAUMA SURGERY; MARROW STROMAL CELLS; GRAFT SUBSTITUTES; GROWTH-FACTORS; PARTICLE-SIZE; TGF-BETA; MODEL; RECONSTRUCTION; RECEPTORS	The healing of critical sized segmental defects is an ongoing clinical problem. No method has achieved pre-eminence. The Masquelet technique is a relatively new innovation involving the induction of a fibrous tissue membrane around the bone defect site taking advantage of the body's foreign body reaction to the presence of a polymethylmethacrylate (PMMA) spacer. The aim of this study was to investigate the properties and characteristics of this induced membrane and its effectiveness when used in conjunction with allograft or an allograft/autograft mix as filler materials in an ovine critical sized defect model. The resultant induced membrane was found to be effective in containing the graft materials in situ. It was demonstrated to be an organised pseudosynovial membrane which expressed bone morphogenic protein 2 (BMP2), transforming growth factor-beta (TGF beta), vascular endothelial growth factor (VEGF), von Willerbrand factor (vWF), interleukin 6 (IL-6) and interleukin 8 (IL-8). While more new bone growth was evident in the test groups compared to the controls animals at 12 weeks, the volumes were not statistically different and no defects were fully bridged. Of the two graft material groups, the allograft/autograft mix was shown to have a more rapid graft resorption rate than the allograft only group. While the Masquelet technique proved effective in producing a membrane to enclose graft materials, its ability to assist in the healing of critical sized segmental defects when compared to empty controls remained inconclusive.	[Christou, Chris; Oliver, Rema A.; Yu, Yan; Walsh, William R.] Univ New South Wales Australia, Surg & Orthopaed Res Labs, Sydney, NSW, Australia	University of New South Wales Sydney	Christou, C (corresponding author), Univ New South Wales Australia, Surg & Orthopaed Res Labs, Sydney, NSW, Australia.	c.christou@unsw.edu.au		Walsh, William/0000-0002-5023-6148; Christou, Chris/0000-0003-3231-0356				Aho OM, 2013, J BONE JOINT SURG AM, V95A, P597, DOI 10.2106/JBJS.L.00310; Antonova E, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-42; Argintar E, 2011, INJURY, V42, P730, DOI 10.1016/j.injury.2010.11.016; Balaguer T, 2010, TISSUE ENG PT A, V16, P3495, DOI [10.1089/ten.tea.2010.0227, 10.1089/ten.TEA.2010.0227]; Bishop GB, 2007, INT ORTHOP, V31, P721, DOI 10.1007/s00264-007-0424-8; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; CHARNLEY J, 1970, Journal of Bone and Joint Surgery British Volume, V52, P340; Cobos JA, 2000, J ORTHOP TRAUMA, V14, P54, DOI 10.1097/00005131-200001000-00011; De Long WG, 2007, J BONE JOINT SURG AM, V89A, P649, DOI 10.2106/JBJS.F.00465; Deckers MML, 2000, ENDOCRINOLOGY, V141, P1667, DOI 10.1210/en.141.5.1667; Dorozhkin SV, 2010, BIOMATERIALS, V31, P1465, DOI 10.1016/j.biomaterials.2009.11.050; Edgar CM, 2007, BONE, V40, P1389, DOI 10.1016/j.bone.2007.01.001; Farhadieh RD, 2004, J CRANIOFAC SURG, V15, P714, DOI 10.1097/00001665-200409000-00003; Feghali Carol A., 1997, Frontiers in Bioscience (online), V2, pD12; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Finkemeier CG, 2002, J BONE JOINT SURG AM, V84A, P454, DOI 10.2106/00004623-200203000-00020; Franchimont N, 2005, BONE, V37, P601, DOI 10.1016/j.bone.2005.06.002; Gabay C, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1917; Geiger F, 2007, BONE, V41, P516, DOI 10.1016/j.bone.2007.06.018; Giannoudis PV, 2005, INJURY, V36, P20, DOI 10.1016/j.injury.2005.07.029; GOLDRING SR, 1983, J BONE JOINT SURG AM, V65, P575, DOI 10.2106/00004623-198365050-00001; Govender S, 2002, J BONE JOINT SURG AM, V84A, P2123, DOI 10.2106/00004623-200212000-00001; Gruber HE, 2013, J ORTHOP TRAUMA, V27, P290, DOI 10.1097/BOT.0b013e3182691288; Gugala Z, 2002, INJURY, V33, P71, DOI 10.1016/S0020-1383(02)00135-3; Jin FC, 2013, CONNECT TISSUE RES, V54, P283, DOI 10.3109/03008207.2013.811499; Malinin Theodore I, 2007, Open Orthop J, V1, P19, DOI 10.2174/1874325000701010019; Masquelet A C, 2000, Ann Chir Plast Esthet, V45, P346; Masquelet AC, 2003, LANGENBECK ARCH SURG, V388, P344, DOI 10.1007/s00423-003-0379-1; Masquelet AC, 2010, ORTHOP CLIN N AM, V41, P27, DOI 10.1016/j.ocl.2009.07.011; McAnulty RJ, 2007, INT J BIOCHEM CELL B, V39, P666, DOI 10.1016/j.biocel.2006.11.005; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Pallesen L, 2002, INT J ORAL MAX IMPL, V17, P498; Pelissier P, 2004, J ORTHOP RES, V22, P73, DOI 10.1016/S0736-0266(03)00165-7; Pluhar GE, 2006, J BONE JOINT SURG BR, V88B, P960, DOI 10.1302/0301-620X.88B7.17056; Rabillard M, 2009, VET COMP ORTHOPAED, V22, P460, DOI 10.3415/VCOT-09-04-0048; Russell N, 2013, BIOMATERIALS, V34, P8185, DOI 10.1016/j.biomaterials.2013.07.022; Sporn MB, 2006, CYTOKINE GROWTH F R, V17, P3, DOI 10.1016/j.cytogfr.2005.09.012; Stafford PR, 2010, INJURY, V41, pS72, DOI 10.1016/S0020-1383(10)70014-0; Starke RD, 2011, BLOOD, V117, P1071, DOI 10.1182/blood-2010-01-264507; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Szpalski Marek, 2005, Acta Orthop Belg, V71, P133; Tate MLK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028702; Taylor BC, 2012, J AM ACAD ORTHOP SUR, V20, P142, DOI 10.5435/JAAOS-20-03-142; VAIL TB, 1994, VET SURG, V23, P386, DOI 10.1111/j.1532-950X.1994.tb00499.x; Viateau V, 2006, VET SURG, V35, P445, DOI 10.1111/j.1532-950X.2006.00173.x; Viateau V, 2010, ORTHOP CLIN N AM, V41, P49, DOI 10.1016/j.ocl.2009.07.010; Wyatt LE, 1998, PLAST RECONSTR SURG, V102, P1922, DOI 10.1097/00006534-199811000-00017; Yu Y, 2002, J BIOMED MATER RES, V60, P392, DOI 10.1002/jbm.1289	48	53	65	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114122	10.1371/journal.pone.0114122	http://dx.doi.org/10.1371/journal.pone.0114122			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461340	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700101
J	Moura, RS; Carvalho-Correia, E; daMota, P; Correia-Pinto, J				Moura, Rute Silva; Carvalho-Correia, Eduarda; daMota, Paulo; Correia-Pinto, Jorge			Canonical Wnt Signaling Activity in Early Stages of Chick Lung Development	PLOS ONE			English	Article							BETA-CATENIN; BRANCHING MORPHOGENESIS; EXPRESSION PATTERNS; PPAR-GAMMA; GENES; PATHWAY; PROLIFERATION; FIBRONECTIN; COMPONENTS; APOPTOSIS	Wnt signaling pathway is an essential player during vertebrate embryonic development which has been associated with several developmental processes such as gastrulation, body axis formation and morphogenesis of numerous organs, namely the lung. Wnt proteins act through specific transmembrane receptors, which activate intracellular pathways that regulate cellular processes such as cell proliferation, differentiation and death. Morphogenesis of the fetal lung depends on epithelial-mesenchymal interactions that are governed by several growth and transcription factors that regulate cell proliferation, fate, migration and differentiation. This process is controlled by different signaling pathways such as FGF, Shh and Wnt among others. Wnt signaling is recognized as a key molecular player in mammalian pulmonary development but little is known about its function in avian lung development. The present work characterizes, for the first time, the expression pattern of several Wnt signaling members, such as wnt-1, wnt-2b, wnt-3a, wnt-5a, wnt-7b, wnt-8b, wnt-9a, lrp5, lrp6, sfrp1, dkk1, beta-catenin and axin2 at early stages of chick lung development. In general, their expression is similar to their mammalian counterparts. By assessing protein expression levels of active/total beta-catenin and phospho-LRP6/LRP6 it is revealed that canonical Wnt signaling is active in this embryonic tissue. In vitro inhibition studies were performed in order to evaluate the function of Wnt signaling pathway in lung branching. Lung explants treated with canonical Wnt signaling inhibitors (FH535 and PK115-584) presented an impairment of secondary branch formation after 48 h of culture along with a decrease in axin2 expression levels. Branching analysis confirmed this inhibition. Wnt-FGF crosstalk assessment revealed that this interaction is preserved in the chick lung. This study demonstrates that Wnt signaling is crucial for precise chick lung branching and further supports the avian lung as a good model for branching studies since it recapitulates early mammalian pulmonary development.	[Moura, Rute Silva; Carvalho-Correia, Eduarda; daMota, Paulo; Correia-Pinto, Jorge] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Moura, Rute Silva; Carvalho-Correia, Eduarda; daMota, Paulo; Correia-Pinto, Jorge] ICVS 3Bs PT Govt Associate Lab, Braga, Portugal; [Moura, Rute Silva] Univ Minho, Sch Sci, Dept Biol, Braga, Portugal; [daMota, Paulo] Hosp Braga, Dept Urol, Braga, Portugal; [Correia-Pinto, Jorge] Hosp Braga, Dept Pediat Surg, Braga, Portugal	Universidade do Minho; Universidade do Minho; Hospital de Braga; Hospital de Braga	Moura, RS (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.	rutemoura@ecsaude.uminho.pt	Correia-Pinto, Jorge/B-3344-2012; Moura, Rute/GYV-3259-2022; Moura, Rute S/B-4208-2011	Correia-Pinto, Jorge/0000-0002-9265-6896; Moura, Rute S/0000-0003-1763-9014; Carvalho-Correia, Eduarda/0000-0001-5821-0893; Mota, Paulo/0000-0002-2316-373X	ON.2 SR&TD Integrated Program [N-01-01-0124-01-07]	ON.2 SR&TD Integrated Program	Rute S. Moura was supported by a grant of ON.2 SR&TD Integrated Program (N-01-01-0124-01-07), ref: UMINHO/BPD/31/2013. The funders had no role in study design, data collection and analysis,	Bellusci S, 1997, DEVELOPMENT, V124, P4867; Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310; Chapman SC, 2004, DEV DYNAM, V229, P668, DOI 10.1002/dvdy.10491; Chen RH, 2000, J BIOL CHEM, V275, P17894, DOI 10.1074/jbc.M905336199; Chen SQ, 2001, J CELL BIOL, V152, P87, DOI 10.1083/jcb.152.1.87; Cheon SS, 2004, EXP CELL RES, V293, P267, DOI 10.1016/j.yexcr.2003.09.029; Church VL, 2002, INT J DEV BIOL, V46, P927; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Colvin JS, 2001, DEVELOPMENT, V128, P2095; De Langhe SP, 2005, DEV BIOL, V277, P316, DOI 10.1016/j.ydbio.2004.09.023; Fokina VM, 2006, DEV DYNAM, V235, P496, DOI 10.1002/dvdy.20621; Foronjy R, 2010, AM J PATHOL, V177, P598, DOI 10.2353/ajpath.2010.090803; Garriock RJ, 2007, DEV DYNAM, V236, P1249, DOI 10.1002/dvdy.21156; Geetha-Loganathan Poongodi, 2008, Organogenesis, V4, P109; Geetha-Loganathan P, 2009, DEV DYNAM, V238, P1150, DOI 10.1002/dvdy.21934; Gibb S, 2009, DEV BIOL, V330, P21, DOI 10.1016/j.ydbio.2009.02.035; Goss AM, 2009, DEV CELL, V17, P290, DOI 10.1016/j.devcel.2009.06.005; Gradl D, 1999, MOL CELL BIOL, V19, P5576; Handeli S, 2008, MOL CANCER THER, V7, P521, DOI 10.1158/1535-7163.MCT-07-2063; Hardy KM, 2008, DEV BIOL, V320, P391, DOI 10.1016/j.ydbio.2008.05.546; Havens BA, 2006, ARCH ORAL BIOL, V51, P134, DOI 10.1016/j.archoralbio.2005.06.011; He B, 2004, NEOPLASIA, V6, P7, DOI 10.1016/S1476-5586(04)80048-4; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063; HOLLYDAY M, 1995, MECH DEVELOP, V52, P9, DOI 10.1016/0925-4773(95)00385-E; Horowitz A, 2009, CIRC RES, V104, pE21, DOI 10.1161/CIRCRESAHA.108.191494; Huang CL, 2008, EUR J CANCER, V44, P2680, DOI 10.1016/j.ejca.2008.08.004; Huelsken J, 2002, J CELL SCI, V115, P3977, DOI 10.1242/jcs.00089; Jansson EA, 2005, P NATL ACAD SCI USA, V102, P1460, DOI 10.1073/pnas.0405928102; Kling DE, 2002, AM J PHYSIOL-LUNG C, V282, pL370, DOI 10.1152/ajplung.00200.2001; Konigshoff M, 2009, J CLIN INVEST, V119, P772, DOI 10.1172/JCI33950; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Lickert H, 2005, DEVELOPMENT, V132, P2599, DOI 10.1242/dev.01842; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Loganathan PG, 2005, HISTOCHEM CELL BIOL, V123, P195, DOI 10.1007/s00418-005-0756-7; Loscertales M, 2008, DEVELOPMENT, V135, P1365, DOI 10.1242/dev.010504; Maina JN, 2003, TISSUE CELL, V35, P375, DOI 10.1016/S0040-8166(03)00058-2; Malpel S, 2000, DEVELOPMENT, V127, P3057; Matsumoto K, 2008, DEV BIOL, V319, P234, DOI 10.1016/j.ydbio.2008.04.021; McBride HJ, 2003, DEV BIOL, V256, P18, DOI 10.1016/S0012-1606(02)00118-5; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Miura T, 2009, MECH DEVELOP, V126, P160, DOI 10.1016/j.mod.2008.11.006; Moura RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017660; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; MUNSTERBERG AE, 1995, GENE DEV, V9, P2911, DOI 10.1101/gad.9.23.2911; Osmon, 2005, ATLAS CHICK DEV; Panhuysen M, 2004, MOL CELL NEUROSCI, V26, P101, DOI 10.1016/j.mcn.2004.01.011; Person AD, 2005, DEV BIOL, V278, P35, DOI 10.1016/j.ydbio.2004.10.013; Pietila I, 2011, DEV BIOL, V353, P50, DOI 10.1016/j.ydbio.2011.02.019; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Quinlan R, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-35; Rajagopal J, 2008, DEVELOPMENT, V135, P1625, DOI 10.1242/dev.015495; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Sakiyama J, 2000, DEV BIOL, V227, P12, DOI 10.1006/dbio.2000.9880; Sakurai R, 2011, EXP LUNG RES, V37, P144, DOI 10.3109/01902148.2010.490288; Schmidt M, 2000, DEVELOPMENT, V127, P4105; Shi ZD, 2012, J NEUROIMMUNE PHARM, V7, P892, DOI 10.1007/s11481-012-9354-3; Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014; Shu WG, 2002, DEVELOPMENT, V129, P4831; Staal FJT, 2002, EMBO REP, V3, P63, DOI 10.1093/embo-reports/kvf002; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Tebar M, 2001, MECH DEVELOP, V109, P437, DOI 10.1016/S0925-4773(01)00556-1; Terry K, 2000, MECH DEVELOP, V97, P177, DOI 10.1016/S0925-4773(00)00407-X; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Wang JB, 2004, CURR OPIN GENET DEV, V14, P533, DOI 10.1016/j.gde.2004.07.013; Wang YP, 2011, DEV BIOL, V349, P250, DOI 10.1016/j.ydbio.2010.11.004; Wang ZS, 2005, MOL CELL BIOL, V25, P5022, DOI 10.1128/MCB.25.12.5022-5030.2005; Weaver M, 2003, DEV BIOL, V258, P169, DOI 10.1016/S0012-1606(03)00117-9; Widelitz R, 2005, GROWTH FACTORS, V23, P111, DOI 10.1080/08977190500125746; Witte F, 2009, GENE EXPR PATTERNS, V9, P215, DOI 10.1016/j.gep.2008.12.009; Yates LL, 2013, DEV BIOL, V373, P267, DOI 10.1016/j.ydbio.2012.11.012; Yates LL, 2010, HUM MOL GENET, V19, P2251, DOI 10.1093/hmg/ddq104; Zhang MF, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-21	77	14	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112388	10.1371/journal.pone.0112388	http://dx.doi.org/10.1371/journal.pone.0112388			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460002	gold, Green Published, Green Submitted			2022-12-26	WOS:000345869700016
J	Schulze, J; Frauenknecht, T; Brodmann, P; Bagutti, C				Schulze, Juerg; Frauenknecht, Tina; Brodmann, Peter; Bagutti, Claudia			Unexpected Diversity of Feral Genetically Modified Oilseed Rape (Brassica napus L.) Despite a Cultivation and Import Ban in Switzerland	PLOS ONE			English	Article							GENE FLOW; DNA-CONTENT; TRANSGENE; SEED; INTROGRESSION; VARIETIES; DYNAMICS; PLANTS	Despite cultivation and seed import bans of genetically modified (GM) oilseed rape (Brassica napus L.), feral GM plants were found growing along railway lines and in port areas at four sites in Switzerland in 2011 and 2012. All GM plants were identified as glyphosate-resistant GM event GT73 (Roundup Ready, Monsanto). The most affected sites were the Rhine port of Basel and the St. Johann freight railway station in Basel. To assess the distribution and intra-and interspecific outcrossing of GM oilseed rape in more detail, we monitored these two sites in 2013. Leaves and seed pods of feral oilseed rape plants, their possible hybridization partners and putative hybrid plants were sampled in monthly intervals and analysed for the presence of transgenes by real-time PCR. Using flow cytometry, we measured DNA contents of cell nuclei to confirm putative hybrids. In total, 2787 plants were sampled. The presence of GT73 oilseed rape could be confirmed at all previously documented sampling locations and was additionally detected at one new sampling location within the Rhine port. Furthermore, we found the glufosinate-resistant GM events MS8xRF3, MS8 and RF3 (all traded as InVigor, Bayer) at five sampling locations in the Rhine port. To our knowledge, this is the first time that feral MS8xRF3, MS8 or RF3 plants were detected in Europe. Real-time PCR analyses of seeds showed outcrossing of GT73 into two non-GM oilseed rape plants, but no outcrossing of transgenes into related wild species was observed. We found no hybrids between oilseed rape and related species. GM plants most frequently occurred at unloading sites for ships, indicating that ship cargo traffic is the main entry pathway for GM oilseed rape. In the future, it will be of major interest to determine the source of GM oilseed rape seeds.	[Schulze, Juerg; Frauenknecht, Tina; Brodmann, Peter; Bagutti, Claudia] State Lab Basel City, Biosafety Lab, Basel, Switzerland		Bagutti, C (corresponding author), State Lab Basel City, Biosafety Lab, Basel, Switzerland.	claudia.bagutti@bs.ch			Swiss Federal Office for the Environment (FOEN)	Swiss Federal Office for the Environment (FOEN)	This work was supported by the Swiss Federal Office for the Environment (FOEN) (http://www.bafu.admin.ch/index.html?lang=en). The funder had no role in study design, data collection and analysis or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aono Mitsuko, 2006, Environmental Biosafety Research, V5, P77, DOI 10.1051/ebr:2006017; Beckie HJ, 2011, FARM POLICY J, V8, P43; Brodtbeck T, 1997, FLORA BASEL UMGEBUNG; Chevre A. M., 2004, Introgression from genetically modified plants into wild relatives, P235, DOI 10.1079/9780851998169.0235; CRAWLEY MJ, 1995, P ROY SOC B-BIOL SCI, V259, P49, DOI 10.1098/rspb.1995.0008; Crawley MJ, 2004, P ROY SOC B-BIOL SCI, V271, P1909, DOI 10.1098/rspb.2004.2814; D'Hertefeldt T, 2008, BIOL LETTERS, V4, P314, DOI 10.1098/rsbl.2008.0123; Damgaard C, 2005, AGR ECOSYST ENVIRON, V108, P291, DOI 10.1016/j.agee.2005.01.007; Devos Y, 2012, TRANSGENIC RES, V21, P1, DOI 10.1007/s11248-011-9515-9; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Elling B, 2009, BASIC APPL ECOL, V10, P544, DOI 10.1016/j.baae.2009.01.005; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; European Commission, EU REG AUTH GMOS ACS; European Commission, EU REG AUTH GMOS GEN; European Commission, 2010, COMM REC 13 JUL 2010; Hecht M, 2014, ENVIRON SCI POLLUT R, V21, P1455, DOI 10.1007/s11356-013-1881-9; Huangfu CH, 2011, CROP PROT, V30, P57, DOI 10.1016/j.cropro.2010.09.009; James C., 2013, GLOBAL STATUS COMMER; Johnston JS, 1999, AM J BOT, V86, P609, DOI 10.2307/2656569; Jorgensen T, 2007, SEED SCI RES, V17, P115, DOI 10.1017/S0960258507708103; Kawata M, 2009, ENVIRON SCI POLLUT R, V16, P120, DOI 10.1007/s11356-008-0074-4; Laube I, 2010, FOOD CHEM, V118, P979, DOI 10.1016/j.foodchem.2008.09.063; Liu YB, 2013, PLANT SCI, V211, P42, DOI 10.1016/j.plantsci.2013.07.002; Londo JP, 2010, ANN BOT-LONDON, V106, P957, DOI 10.1093/aob/mcq190; Lopez-Granados F, 1998, WEED SCI, V46, P419, DOI 10.1017/S0043174500090834; Matsuoka T, 2002, J AGR FOOD CHEM, V50, P2100, DOI 10.1021/jf011157t; Mazzara M, 2007, VERIFICATION PERFORM; Nishizawa Toru, 2009, Environmental Biosafety Research, V8, P33, DOI 10.1051/ebr/2009001; OECD . Organisation for Economic Co-operation and Development, 2012, SER HARM REG OV BIOT, P142; Pallett DW, 2006, ANN APPL BIOL, V148, P147, DOI 10.1111/j.1744-7348.2006.00049.x; Pascher K, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-63; Pekrun C, 1998, J AGR SCI-CAMBRIDGE, V130, P155, DOI 10.1017/S0021859697005169; Saji Hikaru, 2005, Environmental Biosafety Research, V4, P217, DOI 10.1051/ebr:2006003; Schoenenberger Nicola, 2012, Environmental Sciences Europe, V24, P23, DOI 10.1186/2190-4715-24-23; Schweizer Bauernverband, 2013, STAT ERH SCHATZ LAND; Schweizer Bauernverband, 2012, STAT ERH SCHATZ LAND; Schweizer Bauernverband, 2011, STAT ERH SCHATZ LAND; Stewart CN, 2003, NAT REV GENET, V4, P806, DOI 10.1038/nrg1179; SzewcMcFadden AK, 1996, THEOR APPL GENET, V93, P534, DOI 10.1007/BF00417944; The Federal Authorities of the Swiss Confederation, 2001, SWISS FOOD MAN SLMB; The Federal Office for Agriculture FOAG, 2013, AGR 2014 2017; Warwick SI, 2008, MOL ECOL, V17, P1387, DOI 10.1111/j.1365-294X.2007.03567.x; Wilkinson MJ, 2000, MOL ECOL, V9, P983, DOI 10.1046/j.1365-294x.2000.00986.x; Zeitler R, 2002, EUR FOOD RES TECHNOL, V214, P346, DOI 10.1007/s00217-001-0454-1	45	20	21	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114477	10.1371/journal.pone.0114477	http://dx.doi.org/10.1371/journal.pone.0114477			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464509	gold, Green Published			2022-12-26	WOS:000345869700134
J	Deisenroth, C; Black, MB; Pendse, S; Pluta, L; Witherspoon, SM; McMullen, PD; Thomas, RS				Deisenroth, Chad; Black, Michael B.; Pendse, Salil; Pluta, Linda; Witherspoon, Sam M.; McMullen, Patrick D.; Thomas, Russell S.			MYC Is an Early Response Regulator of Human Adipogenesis in Adipose Stem Cells	PLOS ONE			English	Article							C-MYC; GENE-EXPRESSION; DEREGULATED EXPRESSION; MESSENGER-RNA; DIFFERENTIATION; ONCOGENE; PROTEIN; FIBRONECTIN; INHIBITION; ACTIVATION	Adipose stem cell (ASC) differentiation is necessary for the proper maintenance and function of adipose tissue. The procurement and characterization of multipotent ASCs has enabled investigation into the molecular determinants driving human adipogenesis. Here, the transcription factor MYC was identified as a significant regulator of ASC differentiation. Expression of MYC transcript and protein was found to accumulate during the initial course of differentiation. Loss-of-function analysis using siRNA mediated knockdown of MYC demonstrated inhibition of hormonally stimulated adipogenesis. MYC exhibited an early and sustained expression pattern that preceded down regulation of key suppressor genes, as well as induction of transcriptional and functional effectors. Glucocorticoid stimulation was identified as a necessary component for MYC induction and was found to impact adipogenesis in a concentration-dependent manner. Global gene expression analysis of MYC knockdown in ASC enriched for functional pathways related to cell adhesion, cytoskeletal remodeling, and transcriptional components of adipogenesis. These results identify a functional role for MYC in promotion of multipotent ASC to the adipogenic lineage.	[Deisenroth, Chad; Black, Michael B.; Pendse, Salil; Pluta, Linda; McMullen, Patrick D.; Thomas, Russell S.] Inst Chem Safety Sci, Hamner Inst Hlth Sci, Res Triangle Pk, NC 27709 USA; [Witherspoon, Sam M.] N Carolina Cent Univ, Biomfg Res Inst & Technol Enterprise, Durham, NC USA	The Hamner Institutes for Health Sciences; University of North Carolina; North Carolina Central University	Deisenroth, C (corresponding author), Inst Chem Safety Sci, Hamner Inst Hlth Sci, Res Triangle Pk, NC 27709 USA.	CDeisenroth@thehamner.org	; McMullen, Patrick/E-5135-2015	Black, Michael/0000-0002-7314-5441; McMullen, Patrick/0000-0002-9635-932X; Thomas, Russell/0000-0002-2340-0301	American Chemistry Council's Long-Range Research Initiative	American Chemistry Council's Long-Range Research Initiative	This work was supported by the American Chemistry Council's Long-Range Research Initiative (http://lri.americanchemistry.com) for RT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Ayala-Sumuano JT, SCI REP, V3, P2573; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Bellmeyer A, 2003, DEV CELL, V4, P827, DOI 10.1016/S1534-5807(03)00160-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BORTELL R, 1994, J CELL BIOCHEM, V54, P256, DOI 10.1002/jcb.240540214; Bowers RR, 2008, CELL CYCLE, V7, P1191, DOI 10.4161/cc.7.9.5815; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Cristancho AG, 2011, NAT REV MOL CELL BIO, V12, P722, DOI 10.1038/nrm3198; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; DANI C, 1984, P NATL ACAD SCI-BIOL, V81, P7046, DOI 10.1073/pnas.81.22.7046; de Nigris F, 2007, ONCOGENE, V26, P382, DOI 10.1038/sj.onc.1209804; DMITROVSKY E, 1986, NATURE, V322, P748, DOI 10.1038/322748a0; FREYTAG SO, 1988, MOL CELL BIOL, V8, P1614, DOI 10.1128/MCB.8.4.1614; Frye M, 2003, DEVELOPMENT, V130, P2793, DOI 10.1242/dev.00462; Gandarillas A, 1997, GENE DEV, V11, P2869, DOI 10.1101/gad.11.21.2869; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; HANN SR, 1985, NATURE, V314, P366, DOI 10.1038/314366a0; HANN SR, 1984, MOL CELL BIOL, V4, P2486, DOI 10.1128/MCB.4.11.2486; Heath TJ, 2000, BIOCHEM BIOPH RES CO, V269, P438, DOI 10.1006/bbrc.2000.2316; Heath VJ, 2000, EXP CELL RES, V254, P91, DOI 10.1006/excr.1999.4736; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2; LAROCCA SA, 1994, ONCOGENE, V9, P3499; LARSSON LG, 1988, P NATL ACAD SCI USA, V85, P2638, DOI 10.1073/pnas.85.8.2638; Laudes M, J MOL ENDOCRINOL, V46, pR65; Lee HJ, PLOS ONE, V8; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Liu H, 2012, NAT CELL BIOL, V14, P567, DOI 10.1038/ncb2491; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Longo KA, 2004, J BIOL CHEM, V279, P35503, DOI 10.1074/jbc.M402937200; McMullen PD, 2014, CHEM-BIOL INTERACT, V209, P14, DOI 10.1016/j.cbi.2013.11.006; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Nie Z, CELL, V151, P68; Pantoja C, 2008, MOL BIOL CELL, V19, P4032, DOI 10.1091/mbc.E08-04-0420; Peckett AJ, 2011, METABOLISM, V60, P1500, DOI 10.1016/j.metabol.2011.06.012; PROCHOWNIK EV, 1986, NATURE, V322, P848, DOI 10.1038/322848a0; Puri V, 2007, J BIOL CHEM, V282, P34213, DOI 10.1074/jbc.M707404200; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Rangwala SM, 2000, ANNU REV NUTR, V20, P535, DOI 10.1146/annurev.nutr.20.1.535; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Seguro LP, AUTOIMMUN REV, V12, P629; Shen L, EXP CELL RES, V317, P1796; Shi JW, 2013, CELL CYCLE, V12, P1119, DOI 10.4161/cc.24164; Siersbaek R, COLD SPRING HARB S Q, V76, P247; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; SPIEGELMAN BM, 1983, CELL, V35, P657, DOI 10.1016/0092-8674(83)90098-3; SPIEGELMAN BM, 1980, J BIOL CHEM, V255, P8811; SPIEGELMAN BM, 1982, CELL, V29, P53, DOI 10.1016/0092-8674(82)90089-7; THOMPSON CB, 1985, NATURE, V314, P363, DOI 10.1038/314363a0; Treiser MD, 2010, P NATL ACAD SCI USA, V107, P610, DOI 10.1073/pnas.0909597107; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wu ZD, 1996, MOL CELL BIOL, V16, P4128; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859	60	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114133	10.1371/journal.pone.0114133	http://dx.doi.org/10.1371/journal.pone.0114133			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437437	Green Submitted, Green Published, gold			2022-12-26	WOS:000347114900123
J	Deja, S; Wieczorek, PP; Halama, M; Jasicka-Misiak, I; Kafarski, P; Poliwoda, A; Mlynarz, P				Deja, Stanislaw; Wieczorek, Piotr P.; Halama, Marek; Jasicka-Misiak, Izabela; Kafarski, Pawel; Poliwoda, Anna; Mlynarz, Piotr			Do Differences in Chemical Composition of Stem and Cap of Amanita muscaria Fruiting Bodies Correlate with Topsoil Type?	PLOS ONE			English	Article							SWEDISH BEECH FORESTS; ECTOMYCORRHIZA FORMATION; PHALLOIDES TISSUES; COLLECTION SITE; WILD MUSHROOMS; PINUS-RADIATA; SOIL; MACROFUNGI; METALS; ACCUMULATION	Fly agaric (Amanita muscaria) was investigated using a H-1 NMR-based metabolomics approach. The caps and stems were studied separately, revealing different metabolic compositions. Additionally, multivariate data analyses of the fungal basidiomata and the type of soil were performed. Compared to the stems, A. muscaria caps exhibited higher concentrations of isoleucine, leucine, valine, alanine, aspartate, asparagine, threonine, lipids (mainly free fatty acids), choline, glycerophosphocholine (GPC), acetate, adenosine, uridine, 4-aminobutyrate, 6-hydroxynicotinate, quinolinate, UDP-carbohydrate and glycerol. Conversely, they exhibited lower concentrations of formate, fumarate, trehalose, alpha- and beta-glucose. Six metabolites, malate, succinate, gluconate, N-acetylated compounds (NAC), tyrosine and phenylalanine, were detected in whole A. muscaria fruiting bodies but did not show significant differences in their levels between caps and stems (P value >0.05 and/or OPLS-DA loading correlation coefficient <0.4). This methodology allowed for the differentiation between the fruiting bodies of A. muscaria from mineral and mineral-organic topsoil. Moreover, the metabolomic approach and multivariate tools enabled to ascribe the basidiomata of fly agaric to the type of topsoil. Obtained results revealed that stems metabolome is more dependent on the topsoil type than caps. The correlation between metabolites and topsoil contents together with its properties exhibited mutual dependences.	[Deja, Stanislaw; Wieczorek, Piotr P.; Jasicka-Misiak, Izabela; Poliwoda, Anna] Opole Univ, Fac Chem, Opole, Poland; [Halama, Marek] Univ Wroclaw, Museum Nat Hist, PL-50138 Wroclaw, Poland; [Kafarski, Pawel; Mlynarz, Piotr] Wroclaw Univ Technol, Dept Bioorgan Chem, PL-50370 Wroclaw, Poland	University of Opole; University of Wroclaw; Wroclaw University of Science & Technology	Mlynarz, P (corresponding author), Wroclaw Univ Technol, Dept Bioorgan Chem, PL-50370 Wroclaw, Poland.	piotr.mlynarz@pwr.wroc.pl	Deja, Stanislaw/AAI-7526-2020; Wieczorek, Piotr P./A-9649-2012; Kafarski, Paweł/AAA-9112-2019; Poliwoda, Anna/W-2957-2018	Deja, Stanislaw/0000-0002-7714-2547; Wieczorek, Piotr P./0000-0002-0016-0114; Jasicka-Misiak, Izabela/0000-0001-7788-5482; Poliwoda, Anna/0000-0002-0339-3861; Mlynarz, Piotr/0000-0002-8502-4022	Wroclaw Research Centre EIT + under project "Biotechnologies and advanced medical technologies" - BioMed - European Regional Development Fund [POIG.01.01.02-02-003/08]; European Social Fund	Wroclaw Research Centre EIT + under project "Biotechnologies and advanced medical technologies" - BioMed - European Regional Development Fund; European Social Fund(European Social Fund (ESF))	Funding: The research was supported by Wroclaw Research Centre EIT + under the project "Biotechnologies and advanced medical technologies" - BioMed (POIG.01.01.02-02-003/08) financed by the European Regional Development Fund (Operational Programme Innovative Economy, 1.1.2). Stanislaw Deja was recipient of Ph.D. scholarship under a project funded by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RO, 1978, CHEMOSPHERE, V7, P371, DOI 10.1016/0045-6535(78)90138-8; AN Z, 2005, HDB IND MYCOLOGY; Bergemann SE, 2000, FOREST ECOL MANAG, V130, P99, DOI 10.1016/S0378-1127(99)00177-2; Bhatt RP, 2003, MYCOTAXON, V88, P249; Blanusa M, 2001, J AOAC INT, V84, P1964; Carlile M, 2001, FUNGI; Cayir A, 2010, BIOL TRACE ELEM RES, V134, P212, DOI 10.1007/s12011-009-8464-0; Crabtree CD, 2010, MYCOLOGIA, V102, P1229, DOI 10.3852/08-138; Daniele GM, 2005, B SOC ARGENT BOT, V40, P1; [邓旺秋 DENG WangQiu], 2006, [菌物学报, Mygosystema], V25, P109; Dighton J., 2005, FUNGAL COMMUNITY ITS, V3rd; Dighton J, 2016, FUNGI ECOSYSTEM PROC, DOI DOI 10.1201/9781315371528; Dijksterhuis J., 2007, FOOD MYCOLOGY MULTIF; Enjalbert F, 1996, MYCOLOGIA, V88, P909, DOI 10.2307/3761053; ENJALBERT F, 1989, MYCOLOGIA, V81, P266, DOI 10.2307/3759708; ENJALBERT F, 1993, TOXICON, V31, P803, DOI 10.1016/0041-0101(93)90386-W; Enjalbert F, 1999, CR ACAD SCI III-VIE, V322, P855, DOI 10.1016/S0764-4469(00)86651-2; Falandysz J, 1997, SCI TOTAL ENVIRON, V203, P221, DOI 10.1016/S0048-9697(97)00150-2; Garcia MA, 1998, ARCH ENVIRON CON TOX, V34, P330, DOI 10.1007/s002449900326; GAST CH, 1988, CHEMOSPHERE, V17, P789, DOI 10.1016/0045-6535(88)90258-5; Geml J, 2006, MOL ECOL, V15, P225, DOI 10.1111/j.1365-294X.2005.02799.x; Geml J, 2008, MOL PHYLOGENET EVOL, V48, P694, DOI 10.1016/j.ympev.2008.04.029; Geml J, 2010, RELICT SPECIES: PHYLOGEOGRAPHY AND CONSERVATION BIOLOGY, P173, DOI 10.1007/978-3-540-92160-8_9; Gn Guzman, 2000, ANN MUS ROV, V14, P189; Hall I.R., 2003, EDIBLE POISONOUS MUS; HANSEN PA, 1988, VEGETATIO, V78, P31, DOI 10.1007/BF00045637; HANSEN PA, 1989, VEGETATIO, V82, P69; Hawker LE, 1939, ANN BOT-LONDON, V3, P455, DOI 10.1093/oxfordjournals.aob.a085069; Hawkeswood TJ, 2006, CALODEMA, V7, P29; Horak E, 1971, NEW ZEAL J BOT, V9, P402; Hu JS, 2012, J SCI FOOD AGR, V92, P2664, DOI 10.1002/jsfa.5685; Krieglsteiner GJ, 2003, GROSSPILZE BADEN WUR, V4, P8; LEWIS DP, 1981, SOUTHWEST NAT, V26, P1, DOI 10.2307/3671322; MALAJCZUK N, 1984, NEW PHYTOL, V96, P43, DOI 10.1111/j.1469-8137.1984.tb03542.x; MALAJCZUK N, 1982, NEW PHYTOL, V91, P467, DOI 10.1111/j.1469-8137.1982.tb03325.x; McKenzie EHC, 2000, NEW ZEAL J BOT, V38, P635; McKnight TA, 2010, MYCOLOGIA, V102, P763, DOI 10.3852/09-131; Michelot D, 2003, MYCOL RES, V107, P131, DOI 10.1017/S0953756203007305; Mleczek M, 2013, J ENVIRON SCI HEAL B, V48, P69, DOI 10.1080/03601234.2012.716733; Moore D, 1994, GROWING FUNGUS, P423; Moore D., 2003, FUNGAL MORPHOGENESIS; Nehls U, 2001, PLANT CELL ENVIRON, V24, P741, DOI 10.1046/j.1365-3040.2001.00717.x; Neville P, 2004, AMANITEAE AMANITA LI, V9; Nyberg Harri, 1992, Karstenia, V32, P71; Oda T, 2004, MYCOL RES, V108, P885, DOI 10.1017/S0953756204000620; Peintner U, 1996, PHYTON-ANN REI BOT A, V36, P155; Phillips R., 2006, MUSHROOMS COMPREHENS; Rayner MC, 1926, NEW PHYTOL, V25, P338; Robinson Richard, 2010, Australasian Mycologist, V29, P4; RUHLING A, 1990, HOLARCTIC ECOL, V13, P11; SARASWATHIDEVI L, 1955, P INDIAN ACAD SCI  B, V41, P145; Sawyer NA, 2001, MYCOL RES, V105, P966, DOI 10.1016/S0953-7562(08)61953-X; SINGER R, 1953, MYCOLOGIA, V45, P865, DOI 10.1080/00275514.1953.12024322; Sobestiansky G, 2005, BRAZ ARCH BIOL TECHN, V48, P437, DOI 10.1590/S1516-89132005000300015; St'astny F, 2004, REDOX REP, V9, P229, DOI 10.1179/135100004225006001; TRAPPE JM, 1962, BOT REV, V28, P538, DOI 10.1007/BF02868758; Tulloss RE, 2005, MYCOTAXON, V93, P189; Tulloss RE, 2012, AMANITACEAE STUDIES; TYLER G, 1982, T BRIT MYCOL SOC, V79, P239, DOI 10.1016/S0007-1536(82)80109-5; TYLER G, 1985, FOREST ECOL MANAG, V10, P13, DOI 10.1016/0378-1127(85)90011-8; Van Laere A, 1994, GROWING FUNGUS, P211; WHELAN C, 1994, ASIAN FOLKLORE STUD, V53, P163, DOI 10.2307/1178564; Zhang Dan, 2008, Wuhan University Journal of Natural Sciences, V13, P267, DOI 10.1007/s11859-008-0302-2	63	8	8	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e104084	10.1371/journal.pone.0104084	http://dx.doi.org/10.1371/journal.pone.0104084			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437454	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900002
J	Di Lelio, I; Caccia, S; Coppola, M; Buonanno, M; Di Prisco, G; Varricchio, P; Franzetti, E; Corrado, G; Monti, SM; Rao, R; Casartelli, M; Pennacchio, F				Di Lelio, Ilaria; Caccia, Silvia; Coppola, Mariangela; Buonanno, Martina; Di Prisco, Gennaro; Varricchio, Paola; Franzetti, Eleonora; Corrado, Giandomenico; Monti, Simona M.; Rao, Rosa; Casartelli, Morena; Pennacchio, Francesco			A Virulence Factor Encoded by a Polydnavirus Confers Tolerance to Transgenic Tobacco Plants against Lepidopteran Larvae, by Impairing Nutrient Absorption	PLOS ONE			English	Article							INTEGRATED PEST-MANAGEMENT; SPODOPTERA-LITTORALIS; NATURAL-PRODUCTS; AMINO-ACIDS; INSECTICIDES; GENE; RESISTANCE; EVOLUTION; TRANSPORT; PROTEINS	The biological control of insect pests is based on the use of natural enemies. However, the growing information on the molecular mechanisms underpinning the interactions between insects and their natural antagonists can be exploited to develop "bio-inspired'' pest control strategies, mimicking suppression mechanisms shaped by long co-evolutionary processes. Here we focus on a virulence factor encoded by the polydnavirus associated with the braconid wasp Toxoneuron nigriceps (TnBV), an endophagous parasitoid of noctuid moth larvae. This virulence factor (TnBVANK1) is a member of the viral ankyrin (ANK) protein family, and appears to be involved both in immunosuppression and endocrine alterations of the host. Transgenic tobacco plants expressing TnBVANK1 showed insecticide activity and caused developmental delay in Spodoptera littoralis larvae feeding on them. This effect was more evident in a transgenic line showing a higher number of transcripts of the viral gene. However, this effect was not associated with evidence of translocation into the haemocoel of the entire protein, where the receptors of TnBVANK1 are putatively located. Indeed, immunolocalization experiments evidenced the accumulation of this viral protein in the midgut, where it formed a thick layer coating the brush border of epithelial cells. In vitro transport experiments demonstrated that the presence of recombinant TnBVANK1 exerted a dose-dependent negative impact on amino acid transport. These results open new perspectives for insect control and stimulate additional research efforts to pursue the development of novel bioinsecticides, encoded by parasitoid-derived genes. However, future work will have to carefully evaluate any effect that these molecules may have on beneficial insects and on non-target organisms.	[Di Lelio, Ilaria; Caccia, Silvia; Coppola, Mariangela; Di Prisco, Gennaro; Varricchio, Paola; Franzetti, Eleonora; Corrado, Giandomenico; Rao, Rosa; Pennacchio, Francesco] Univ Naples Federico II, Dipartimento Agr, Portici, Italy; [Buonanno, Martina; Monti, Simona M.] CNR, IBB, I-80125 Naples, Italy; [Buonanno, Martina] Univ Naples 2, Dipartimento Sci & Tecnol Ambientali Biol & Farma, Caserta, Italy; [Casartelli, Morena] Univ Milan, Dipartimento Biosci, Milan, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR); Universita della Campania Vanvitelli; University of Milan	Casartelli, M (corresponding author), Univ Milan, Dipartimento Biosci, Milan, Italy.	morena.casartelli@unimi.it; fpennacchio@unina.it	Varricchio, Paola/AAA-8409-2021; Buonanno, Martina/AFS-8501-2022; Di Prisco, Gennaro/AGY-3511-2022; Casartelli, Morena/AAG-1285-2020; MONTI, SIMONA MARIA/GQQ-0129-2022	Buonanno, Martina/0000-0003-4419-4890; Casartelli, Morena/0000-0002-1413-7660; Di Lelio, Ilaria/0000-0001-8933-0919; Corrado, Giandomenico/0000-0002-8681-6988; PENNACCHIO, Francesco/0000-0002-8794-9328; MONTI, SIMONA MARIA/0000-0001-9647-7089; CACCIA, Silvia/0000-0003-1954-7180	PON R&C - Italian Ministry of University and Research (MIUR); European Funds for the Regional Development (FESR), project GenopomPro; project Safe & Smart (Cluster Agroalimentare Nazionale) [CTN01_00230_248064]; POR Campania Region, Project CARINA	PON R&C - Italian Ministry of University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); European Funds for the Regional Development (FESR), project GenopomPro; project Safe & Smart (Cluster Agroalimentare Nazionale); POR Campania Region, Project CARINA	This work was supported by the PON R&C 2007-2013 Grant financed by the Italian Ministry of University and Research (MIUR) in cooperation with the European Funds for the Regional Development (FESR), project GenopomPro, coordinated by the Universita degli Studi di Napoli "Federico II", Dipartimento di Agraria, and by the project Safe & Smart (Cluster Agroalimentare Nazionale - CTN01_00230_248064). GDP is the recipient of a post-doctoral fellowship supported by the POR Campania Region (FSE 2007/2013), Project CARINA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bale JS, 2008, PHILOS T R SOC B, V363, P761, DOI 10.1098/rstb.2007.2182; Bitra K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002722; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brewer MJ, 2012, ANNU REV ENTOMOL, V57, P41, DOI 10.1146/annurev-ento-120709-144748; Caccia S, 2012, J INSECT PHYSIOL, V58, P1177, DOI 10.1016/j.jinsphys.2012.05.014; Campioni S, 2008, J MOL BIOL, V379, P554, DOI 10.1016/j.jmb.2008.04.002; Casartelli M, 2001, INSECT BIOCHEM MOLEC, V31, P621, DOI 10.1016/S0965-1748(00)00167-3; Casida JE, 1998, ANNU REV ENTOMOL, V43, P1, DOI 10.1146/annurev.ento.43.1.1; Casida JE, 2013, ANNU REV ENTOMOL, V58, P99, DOI 10.1146/annurev-ento-120811-153645; Corrado G, 2008, PLANT SCI, V174, P467, DOI 10.1016/j.plantsci.2008.01.009; Danna KJ, 2001, RECENT ADV PHYTOCHEM, V35, P205, DOI 10.1016/S0079-9920(01)80011-3; Di Lelio I, 2014, J INSECT PHYSIOL, V64, P90, DOI 10.1016/j.jinsphys.2014.03.008; Dorak T, 2006, REAL TIME PCR; Duchi S, 2010, CELL MOL LIFE SCI, V67, P1699, DOI 10.1007/s00018-010-0273-2; Ehler LE, 2006, PEST MANAG SCI, V62, P787, DOI 10.1002/ps.1247; Falabella P, 2007, INSECT BIOCHEM MOLEC, V37, P453, DOI 10.1016/j.ibmb.2007.02.005; FULTON TM, 1995, PLANT MOL BIOL REP, V13, P207, DOI 10.1007/BF02670897; Gill TA, 2006, ADV VIRUS RES, V68, P393, DOI 10.1016/S0065-3527(06)68011-1; GIORDANA B, 1982, BIOCHIM BIOPHYS ACTA, V692, P81, DOI 10.1016/0005-2736(82)90504-1; Hilpert K, 2001, PROTEIN ENG, V14, P803, DOI 10.1093/protein/14.10.803; Horowitz AR, 2004, INSECT PEST MANAGEMENT, FIELD AND PROTECTED CROPS, P1; Kirst HA, 2010, J ANTIBIOT, V63, P101, DOI 10.1038/ja.2010.5; Kogan M, 2003, CONCEPTS INTEGRATED, P586; Kroemer JA, 2004, ANNU REV ENTOMOL, V49, P431, DOI 10.1146/annurev.ento.49.072103.120132; Leonardi MG, 2006, J MEMBRANE BIOL, V214, P157, DOI 10.1007/s00232-006-0042-1; Leonardi MG, 1998, AM J PHYSIOL-REG I, V274, pR1372, DOI 10.1152/ajpregu.1998.274.5.R1372; Li HM, 2009, INSECT MOL BIOL, V18, P21, DOI 10.1111/j.1365-2583.2008.00844.x; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Maiti IB, 2003, PLANT BIOTECHNOL J, V1, P209, DOI 10.1046/j.1467-7652.2003.00019.x; Miresmailli S, 2014, TRENDS PLANT SCI, V19, P29, DOI 10.1016/j.tplants.2013.10.002; PARENTI P, 1985, J EXP BIOL, V116, P69; Pennacchio F, 2006, ANNU REV ENTOMOL, V51, P233, DOI 10.1146/annurev.ento.51.110104.151029; Pennacchio F, 2012, PARASITOID VIRUSES: SYMBIONTS AND PATHOGENS, P269, DOI 10.1016/B978-0-12-384858-1.00022-9; Quicke D. L. J., 1997, PARASITIC WASPS; Roh JY, 2007, J MICROBIOL BIOTECHN, V17, P547; Schmitz K. S., 1990, DYNAMIC LIGHT SCATTE; Shewmaker CK, 1190, NUCLEIC ACIDS RES, V14, P4276; Smith JJ, 2013, CELL MOL LIFE SCI, V70, P3665, DOI 10.1007/s00018-013-1315-3; Sparks TC, 2001, PEST MANAG SCI, V57, P896, DOI 10.1002/ps.358; Strand MR, 2012, PARASITOID VIRUSES: SYMBIONTS AND PATHOGENS, P149, DOI 10.1016/B978-0-12-384858-1.00012-6; Thoetkiattikul H, 2005, P NATL ACAD SCI USA, V102, P11426, DOI 10.1073/pnas.0505240102; Tomlin CDS, 2009, PESTICIDE MANUAL WOR; Tornatore L, 2008, J MOL BIOL, V378, P97, DOI 10.1016/j.jmb.2008.01.074; Tortiglione C, 2003, PLANT MOL BIOL, V53, P891, DOI 10.1023/B:PLAN.0000023667.62501.ef; Toyooka K, 2000, J CELL BIOL, V148, P453, DOI 10.1083/jcb.148.3.453; Valzania L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095104; Vandenborre G, 2011, PHYTOCHEMISTRY, V72, P1538, DOI 10.1016/j.phytochem.2011.02.024; Webb BA, 2005, COMPREHENSIVE MOL IN, V6, P323, DOI DOI 10.1016/B0-44-451924-6/00086-7; Whitfield JB, 2003, ADV PARASIT, V54, P69, DOI 10.1016/S0065-308X(03)54002-7; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371	50	12	14	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113988	10.1371/journal.pone.0113988	http://dx.doi.org/10.1371/journal.pone.0113988			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438149	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900106
J	He, ZX; Jiang, XQ; Ratnasekera, D; Grassi, F; Perera, U; Lu, BR				He, Zhuoxian; Jiang, Xiaoqi; Ratnasekera, Disna; Grassi, Fabrizio; Perera, Udugahapattuwage; Lu, Bao-Rong			Seed-Mediated Gene Flow Promotes Genetic Diversity of Weedy Rice within Populations: Implications for Weed Management	PLOS ONE			English	Article							ORYZA-SATIVA; RED RICE; DIFFERENTIATION; DISTANCE; INTROGRESSION; INFERENCE; SOFTWARE; LANDRACE; NUMBER; BARLEY	Increased infestation of weedy rice-a noxious agricultural pest has caused significant reduction of grain yield of cultivated rice (Oryza sativa) worldwide. Knowledge on genetic diversity and structure of weedy rice populations will facilitate the design of effective methods to control this weed by tracing its origins and dispersal patterns in a given region. To generate such knowledge, we studied genetic diversity and structure of 21 weedy rice populations from Sri Lanka based on 23 selected microsatellite (SSR) loci. Results indicated an exceptionally high level of within-population genetic diversity (H-e=0.62) and limited among-population differentiation (F-st=0.17) for this predominantly self-pollinating weed. UPGMA analysis showed a loose genetic affinity of the weedy rice populations in relation to their geographical locations, and no obvious genetic structure among populations across the country. This phenomenon was associated with the considerable amount of gene flow between populations. Limited admixture from STRUCTURE analyses suggested a very low level of hybridization (pollen-mediated gene flow) between populations. The abundant within-population genetic diversity coupled with limited population genetic structure and differentiation is likely caused by the considerable seed-mediated gene flow of weedy rice along with the long-distance exchange of farmer-saved rice seeds between weedy-rice contaminated regions in Sri Lanka. In addition to other effective weed management strategies, promoting the application of certified rice seeds with no weedy rice contamination should be the immediate action to significantly reduce the proliferation and infestation of this weed in rice ecosystems in countries with similar rice farming styles as in Sri Lanka.	[He, Zhuoxian; Jiang, Xiaoqi; Lu, Bao-Rong] Fudan Univ, Minist Educ Key Lab Biodivers & Ecol Engn, Dept Ecol & Evolutionary Biol, Shanghai 200433, Peoples R China; [Ratnasekera, Disna; Perera, Udugahapattuwage] Univ Ruhuna, Dept Agr Biol, Fac Agr, Matara, Sri Lanka; [Grassi, Fabrizio] Univ Bari, Bot Garden, Dept Biol, Bari, Italy; [Grassi, Fabrizio] Univ Milan, Dept Biosci, Milan, Italy	Fudan University; University Ruhuna; Universita degli Studi di Bari Aldo Moro; University of Milan	Lu, BR (corresponding author), Fudan Univ, Minist Educ Key Lab Biodivers & Ecol Engn, Dept Ecol & Evolutionary Biol, Shanghai 200433, Peoples R China.	brlu@fudan.edu.cn	Lu, Bao-Rong/C-3130-2009	Lu, Bao-Rong/0000-0002-0214-2390; RATNASEKERA, DISNA/0000-0003-3176-6888; grassi, fabrizio/0000-0003-3606-6469	"973" program of the Ministry of Science and Technology [2011CB100401]; Natural Science Foundation of China [31271683, 31330014]	"973" program of the Ministry of Science and Technology(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This work was funded by the "973" program of the Ministry of Science and Technology (2011CB100401) and the Natural Science Foundation of China (31271683, 31330014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buhler DD, 2002, WEED SCI, V50, P273, DOI 10.1614/0043-1745(2002)050[0273:AIAAOF]2.0.CO;2; Burgos NR, 2006, FIELD CROP RES, V99, P96, DOI 10.1016/j.fcr.2006.03.009; Burgos NR., 2007, WEEDY RICE ORIGIN BI; Cao QJ, 2006, ANN BOT-LONDON, V98, P1241, DOI 10.1093/aob/mcl210; Census and Statistics, 2007, STAT ABSTR; CHANDRASENA JPNR, 1988, TROP PEST MANAGE, V34, P278; Chen LJ, 2004, ANN BOT-LONDON, V93, P67, DOI 10.1093/aob/mch006; Chin Duongvan, 2001, Weed Biology and Management, V1, P37, DOI 10.1046/j.1445-6664.2001.00009.x; Dai L, 2014, PEST MANAG SCI, V70, P113, DOI 10.1002/ps.3534; Dekker J, 1997, WEED SCI, V45, P357, DOI 10.1017/S0043174500092985; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Ellstrand NC, 2014, AM J BOT, V101, P737, DOI 10.3732/ajb.1400024; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Gealy DR, 2003, WEED TECHNOL, V17, P627, DOI 10.1614/WT02-100; Green JM, 2001, MOL ECOL, V10, P1035, DOI 10.1046/j.1365-294X.2001.01250.x; Gunatilaka GA, 1995, P RIC S 1990, P39; Hedrick PW, 2005, EVOLUTION, V59, P1633, DOI 10.1111/j.0014-3820.2005.tb01814.x; Jiang ZX, 2012, THEOR APPL GENET, V124, P309, DOI 10.1007/s00122-011-1706-5; Londo JP, 2007, MOL ECOL, V16, P4523, DOI 10.1111/j.1365-294X.2007.03489.x; Marambe B, 2000, P WILD WEED RIC RIC, P79; Meirmans PG, 2006, EVOLUTION, V60, P2399, DOI 10.1111/j.0014-3820.2006.tb01874.x; NEI M, 1978, GENETICS, V89, P583; Parzies HK, 2004, GENET RESOUR CROP EV, V51, P471, DOI 10.1023/B:GRES.0000024157.67531.88; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Perera U.I.P., 2010, P 15 INT FOR ENV S 2, P190; Pritchard JK, 2000, GENETICS, V155, P945; Pusadee T, 2009, P NATL ACAD SCI USA, V106, P13880, DOI 10.1073/pnas.0906720106; Ratnasekera D, 2014, WEED BIOL MANAG, V14, P68, DOI 10.1111/wbm.12034; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Rieseberg LH, 2004, NEW PHYTOL, V161, P59, DOI 10.1046/j.1469-8137.2003.00933.x; Rohlf FJ, 1998, NTSYSPC NUMERICAL TA; Rong J, 2007, NEW PHYTOL, V173, P346, DOI 10.1111/j.1469-8137.2006.01906.x; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Shivrain VK, 2010, WEED RES, V50, P289, DOI 10.1111/j.1365-3180.2010.00780.x; SLATKIN M, 1989, EVOLUTION, V43, P1349, DOI 10.1111/j.1558-5646.1989.tb02587.x; SLATKIN M, 1995, GENETICS, V139, P457; SLATKIN M, 1987, SCIENCE, V236, P787, DOI 10.1126/science.3576198; Weerasena SL, 2000, P ANN S DEP AGR ASDA; Xia HB, 2011, NEW PHYTOL, V191, P1119, DOI 10.1111/j.1469-8137.2011.03766.x; Xia HB, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0016189, 10.1371/journal.pone.0028553]	43	21	21	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112778	10.1371/journal.pone.0112778	http://dx.doi.org/10.1371/journal.pone.0112778			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436611	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900018
J	Jansen, K; Du, BG; Kayler, Z; Siegwolf, R; Ensminger, I; Rennenberg, H; Kammerer, B; Jaeger, C; Schaub, M; Kreuzwieser, J; Gessler, A				Jansen, Kirstin; Du, Baoguo; Kayler, Zachary; Siegwolf, Rolf; Ensminger, Ingo; Rennenberg, Heinz; Kammerer, Bernd; Jaeger, Carsten; Schaub, Marcus; Kreuzwieser, Jurgen; Gessler, Arthur			Douglas-Fir Seedlings Exhibit Metabolic Responses to Increased Temperature and Atmospheric Drought	PLOS ONE			English	Article							CARBON-ISOTOPE COMPOSITION; RESPIRED CO2; ELEVATED CO2; CLIMATE-CHANGE; FOREST TREES; HEAT WAVES; PROLINE; STRESS; ARABIDOPSIS; DARK	In the future, periods of strongly increased temperature in concert with drought (heat waves) will have potentially detrimental effects on trees and forests in Central Europe. Norway spruce might be at risk in the future climate of Central Europe. However, Douglas-fir is often discussed as an alternative for the drought and heat sensitive Norway spruce, because some provenances are considered to be well adapted to drier and warmer conditions. In this study, we identified the physiological and growth responses of seedlings from two different Douglas-fir provenances to increased temperature and atmospheric drought during a period of 92 days. We analysed (i) plant biomass, (ii) carbon stable isotope composition as an indicator for time integrated intrinsic water use efficiency, (iii) apparent respiratory carbon isotope fractionation as well as (iv) the profile of polar low molecular metabolites. Plant biomass was only slightly affected by increased temperatures and atmospheric drought but the more negative apparent respiratory fractionation indicated a temperature-dependent decrease in the commitment of substrate to the tricarboxylic acid cycle. The metabolite profile revealed that the simulated heat wave induced a switch in stress protecting compounds from proline to polyols. We conclude that metabolic acclimation successfully contributes to maintain functioning and physiological activity in seedlings of both Douglas-fir provenances under conditions that are expected during heat waves (i.e. elevated temperatures and atmospheric drought). Douglas-fir might be a potentially important tree species for forestry in Central Europe under changing climatic conditions.	[Jansen, Kirstin; Kayler, Zachary; Gessler, Arthur] Leibniz Ctr Agr Landscape Res ZALF, Inst Landscape Biogeochem, Muncheberg, Germany; [Du, Baoguo; Rennenberg, Heinz; Kreuzwieser, Jurgen] Albert Ludwigs Univ Freiburg, Inst Forest Bot & Tree Physiol, Freiburg, Germany; [Du, Baoguo] Mianyang Normal Univ, Sichuan Prov Key Lab Ecol Secur & Protect, Mianyang, Peoples R China; [Siegwolf, Rolf] Paul Scherrer Inst, Lab Atmospher Chem Stable Isotopes & Ecosystem Fl, Villigen, Switzerland; [Ensminger, Ingo] Univ Toronto, Dept Biol, Mississauga, ON, Canada; [Kammerer, Bernd; Jaeger, Carsten] Albert Ludwigs Univ Freiburg, Ctr Biol Syst Anal ZBSA, Core Facil Metabol, Freiburg, Germany; [Schaub, Marcus; Gessler, Arthur] Swiss Fed Inst Forest, Snow & Landscape Res WSL, Birmensdorf, Switzerland; [Gessler, Arthur] Berlin Brandenburg Inst, Adv Biodivers Res BBIB, Berlin, Germany	Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF); University of Freiburg; Mianyang Teachers' College; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Toronto; University Toronto Mississauga; University of Freiburg; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Gessler, A (corresponding author), Leibniz Ctr Agr Landscape Res ZALF, Inst Landscape Biogeochem, Muncheberg, Germany.	arthur.gessler@wsl.ch	Ensminger, Ingo/D-8566-2012; Siegwolf, Rolf Theodor Walter/GLT-9297-2022; Schaub, Marcus/E-4874-2012; Siegwolf, Rolf TW/D-4121-2009; Gessler, Arthur/C-7121-2008	Ensminger, Ingo/0000-0001-9014-2499; Siegwolf, Rolf Theodor Walter/0000-0002-0249-0651; Schaub, Marcus/0000-0002-0158-8892; Siegwolf, Rolf TW/0000-0002-0249-0651; Gessler, Arthur/0000-0002-1910-9589; Rennenberg, Heinz/0000-0001-6224-2927; Jansen, Kirstin/0000-0003-0832-9225; Jaeger, Carsten/0000-0003-2192-1792; Kayler, Zachary/0000-0003-0090-7537	Deutsche Forschungsgemeinschaft (DFG) [GE1090/7-1, KR 2010/4-1, EN829/5-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The authors acknowledge financial support by the Deutsche Forschungsgemeinschaft (DFG) under contract numbers GE1090/7-1 to AG, KR 2010/4-1 to JK, and EN829/5-1 to IE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Bansal S, 2015, GLOBAL CHANGE BIOL, V21, P947, DOI 10.1111/gcb.12719; Barbour MM, 2007, PLANT CELL ENVIRON, V30, P469, DOI 10.1111/j.1365-3040.2007.01634.x; Barbour MM, 2002, PLANT CELL ENVIRON, V25, P1483, DOI 10.1046/j.0016-8025.2002.00931.x; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; BRANDL H, 1989, ALLG FORST JAGDZTG, V160, P91; Breda N, 2006, ANN FOREST SCI, V63, P625, DOI 10.1051/forest:2006042; Buchanan B.B., 2000, BIOCH MOL BIOL PLANT; BUXTON GV, 1988, J PHYS CHEM REF DATA, V17, P513, DOI 10.1063/1.555805; Carter KK, 1996, CAN J FOREST RES, V26, P1089, DOI 10.1139/x26-120; Cavender-Bares J, 2000, OECOLOGIA, V124, P8, DOI 10.1007/PL00008865; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Daly C, 2002, CLIM RES, V22, P99, DOI 10.3354/cr022099; De Boeck HJ, 2010, GLOBAL CHANGE BIOL, V16, P1992, DOI 10.1111/j.1365-2486.2009.02049.x; Deuschle K, 2001, PLANT J, V27, P345, DOI 10.1046/j.1365-313X.2001.01101.x; DOEHLERT DC, 1981, FOREST SCI, V27, P641; Duquesnoy E, 2008, CARBOHYD RES, V343, P893, DOI 10.1016/j.carres.2008.01.001; Duranceau M, 1999, PLANT CELL ENVIRON, V22, P515, DOI 10.1046/j.1365-3040.1999.00420.x; Easterling DR, 2000, B AM METEOROL SOC, V81, P417, DOI 10.1175/1520-0477(2000)081<0417:OVATIE>2.3.CO;2; Edenhofer O., 2014, CONTRIBUTION WORKING; Erxleben A, 2012, PLANT CELL REP, V31, P427, DOI 10.1007/s00299-011-1177-9; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Gessler A, 2004, PLANT BIOLOGY, V6, P289, DOI 10.1055/s-2004-820878; Gessler A, 2009, NEW PHYTOL, V181, P374, DOI 10.1111/j.1469-8137.2008.02672.x; Ghashghaie J, 2001, PLANT CELL ENVIRON, V24, P505, DOI 10.1046/j.1365-3040.2001.00699.x; Griffin JJ, 2004, J AM SOC HORTIC SCI, V129, P497, DOI 10.21273/JASHS.129.4.0497; Hanewinkel M, 2010, AFZ DER WALD, V19, P30; Heidingsfelder A, 2004, SCHRIFTEN FORSTOKONO, V26; Hellmann H, 2000, PLANT PHYSIOL, V122, P357, DOI 10.1104/pp.122.2.357; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Jansen K, 2013, TREES-STRUCT FUNCT, V27, P37, DOI 10.1007/s00468-012-0765-9; Kaplan F, 2004, PLANT PHYSIOL, V136, P4159, DOI 10.1104/pp.104.052142; Kayler ZE, 2010, OECOLOGIA, V163, P227, DOI 10.1007/s00442-009-1531-6; KEELING CD, 1961, GEOCHIM COSMOCHIM AC, V24, P277, DOI 10.1016/0016-7037(61)90023-0; KEELING CD, 1958, GEOCHIM COSMOCHIM AC, V13, P322, DOI 10.1016/0016-7037(58)90033-4; Kodama N, 2011, PLANT BIOLOGY, V13, P115, DOI 10.1111/j.1438-8677.2010.00329.x; Kodama N, 2008, OECOLOGIA, V156, P737, DOI 10.1007/s00442-008-1030-1; Kohnle U, 2012, CAN J FOREST RES, V42, P382, DOI [10.1139/X11-191, 10.1139/x11-191]; Kopka J, 2005, BIOINFORMATICS, V21, P1635, DOI 10.1093/bioinformatics/bti236; Korner C, 2003, J ECOL, V91, P4, DOI 10.1046/j.1365-2745.2003.00742.x; Kreuzwieser J, 2009, PLANT PHYSIOL, V149, P461, DOI 10.1104/pp.108.125989; Kuokkanen K, 2001, TREES-STRUCT FUNCT, V15, P378, DOI 10.1007/s004680100108; Levesque M, 2014, AGR FOREST METEOROL, V197, P1, DOI 10.1016/j.agrformet.2014.06.001; Lewis JD, 2001, PLANT CELL ENVIRON, V24, P539, DOI 10.1046/j.1365-3040.2001.00700.x; Lewis JD, 2000, TREE PHYSIOL, V20, P447; Little E.L., 1971, MISC PUBL, V1146; Macheix J. J., 1990, Fruit phenolics.; Mani S, 2002, PLANT PHYSIOL, V128, P73, DOI 10.1104/pp.010572; Meehl GA, 2004, SCIENCE, V305, P994, DOI 10.1126/science.1098704; Miller JB, 2003, TELLUS B, V55, P207, DOI 10.1034/j.1600-0889.2003.00020.x; Nanjo T, 2003, PLANT CELL PHYSIOL, V44, P541, DOI 10.1093/pcp/pcg066; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Paajanen R, 2011, NEW PHYTOL, V190, P161, DOI 10.1111/j.1469-8137.2010.03583.x; PAUL MJ, 1989, J EXP BOT, V40, P1093, DOI 10.1093/jxb/40.10.1093; Priault P, 2009, NEW PHYTOL, V181, P400, DOI 10.1111/j.1469-8137.2008.02665.x; Randall WK, 2002, WASHINGTON TREE SEED; Rehfeldt GE, 2002, GLOBAL CHANGE BIOL, V8, P912, DOI 10.1046/j.1365-2486.2002.00516.x; Rennenberg H, 2006, PLANT BIOLOGY, V8, P556, DOI 10.1055/s-2006-924084; Riikonen J, 2012, TREE PHYSIOL, V32, P1102, DOI 10.1093/treephys/tps072; Rivas-Ubach A, 2012, P NATL ACAD SCI USA, V109, P4181, DOI 10.1073/pnas.1116092109; Rizhsky L, 2004, PLANT PHYSIOL, V134, P1683, DOI 10.1104/pp.103.033431; Ruehr NK, 2009, NEW PHYTOL, V184, P950, DOI 10.1111/j.1469-8137.2009.03044.x; Ryan MG, 2010, TREE PHYSIOL, V30, P667, DOI 10.1093/treephys/tpq033; Schar C, 2004, NATURE, V427, P332, DOI 10.1038/nature02300; Shen B, 1997, PLANT PHYSIOL, V113, P1177, DOI 10.1104/pp.113.4.1177; SMIRNOFF N, 1985, VEGETATIO, V62, P273, DOI 10.1007/BF00044753; Smith DM, 2007, SCIENCE, V317, P796, DOI 10.1126/science.1139540; Solomon QD, 2007, PHYS SCI BASIS CONTR; SORENSEN FC, 1979, SILVAE GENET, V28, P96; Sork VL, 2013, TREE GENET GENOMES, V9, P901, DOI 10.1007/s11295-013-0596-x; St Clair JB, 2007, GLOBAL CHANGE BIOL, V13, P1441, DOI 10.1111/j.1365-2486.2007.01385.x; Stewart G. R., 1980, The biochemistry of plants. A comprehensive treatise. Volume 5. Amino acids and derivatives., P609; Stoeckli R, 2003, EUROPEAN HEAT WAVE; Sudachkova N. E., 2002, Eurasian Journal of Forest Research, V4, P1; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; Taylor CB, 1996, PLANT CELL, V8, P1221, DOI 10.1105/tpc.8.8.1221; Tcherkez G, 2004, FUNCT PLANT BIOL, V31, P857, DOI 10.1071/FP04053; Tcherkez G, 2003, PLANT PHYSIOL, V131, P237, DOI 10.1104/pp.013078; THOMAS H, 1980, ANNU REV PLANT PHYS, V31, P83, DOI 10.1146/annurev.pp.31.060180.000503; Tjoelker MG, 1999, GLOB CHANGE BIOL, V5, P679, DOI 10.1046/j.1365-2486.1999.00257.x; Wang TL, 2012, J APPL METEOROL CLIM, V51, P16, DOI 10.1175/JAMC-D-11-043.1; Way DA, 2010, TREE PHYSIOL, V30, P669, DOI 10.1093/treephys/tpq015; Werner C, 2011, BIOGEOSCIENCES, V8, P2437, DOI 10.5194/bg-8-2437-2011; Werner RA, 2011, NEW PHYTOL, V191, P10, DOI 10.1111/j.1469-8137.2011.03741.x; Yang YJ, 2013, FOOD CHEM, V138, P2057, DOI 10.1016/j.foodchem.2012.10.122	87	17	17	4	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114165	10.1371/journal.pone.0114165	http://dx.doi.org/10.1371/journal.pone.0114165			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436455	Green Published, gold			2022-12-26	WOS:000347114900127
J	Jia, L; Chen, JY; Wang, Y; Liu, YJ; Zhang, Y; Chen, WZ				Jia, Lang; Chen, Jinyun; Wang, Yan; Liu, Yingjiang; Zhang, Yu; Chen, Wenzhi			Magnetic Resonance Imaging of Osteophytic, Chondral, and Subchondral Structures in a Surgically-Induced Osteoarthritis Rabbit Model	PLOS ONE			English	Article							ARTICULAR-CARTILAGE; KNEE OSTEOARTHRITIS; DISEASE PROGRESSION; HISTOLOGIC-CHANGES; HYALINE CARTILAGE; JOINT SPACE; VOLUME; MRI; SUPPRESSION; DEFECTS	Objective: This study aimed to assess changes in osteophytic, chondral, and subchondral structures in a surgically-induced osteoarthritis (OA) rabbit model in order to correlate MRI findings with the macroscopic progress of OA and to define the timepoint for disease status in this OA model. Methods: The OA model was constructed by surgery in thirty rabbits with ten normal rabbits serving as controls (baseline). High-resolution three-dimensional MRI using a 1.5-T coil was performed at baseline, two, four, and eight weeks post-surgery. MRIs of cartilage lesions, subchondral bone lesions, and osteophyte formations were independently assessed by two blinded radiologists. Ten rabbits were sacrificed at baseline, two, four, and eight weeks post-surgery, and macroscopic evaluation was independently performed by two blinded orthopedic surgeons. Results: The signal intensities and morphologies of chondral and subchondral structures by MRI accurately reflected the degree of OA. Cartilage defects progressed from a grade of 0.05-0.15 to 1.15-1.30 to 1.90-1.97 to 3.00-3.35 at each successive time point, respectively (p< 0.05). Subchondral bone lesions progressed from a grade of 0.00 to 0.78-0.90 to 1.27-1.58 to 1.95-2.23 at each successive time point, respectively (p=0.000). Osteophytes progressed from a size (mm) of 0.00 to 0.87-1.06 to 1.24-1.87 to 2.21-3.21 at each successive time point, respectively (p=0.000). Conclusions: Serial observations revealed that MRI can accurately detect the progression of cartilage lesions and subchondral bone edema over an eight-week period but may not be accurate in detecting osteophyte sizes. Week four post-surgery was considered the timepoint between OA-negative and OA-positive status in this OA model. The combination of this OA model with MRI evaluation should provide a promising tool for the pre-clinical evaluation of new disease-modifying osteoarthritis drugs.	[Jia, Lang; Chen, Jinyun; Wang, Yan; Liu, Yingjiang; Zhang, Yu; Chen, Wenzhi] State Key Lab Ultrasound Engn Med, Chongqing, Peoples R China; [Jia, Lang; Chen, Jinyun; Wang, Yan; Liu, Yingjiang; Zhang, Yu; Chen, Wenzhi] Chongqing Med Univ, Minist Sci & Technol, Coll Biomed Engn, Chongqing, Peoples R China; [Jia, Lang] Chongqing Med Univ, Affiliated Hosp 2, Dept Rehabil Med, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University	Chen, WZ (corresponding author), State Key Lab Ultrasound Engn Med, Chongqing, Peoples R China.	chenwz@cqmu.edu.cn			National Basic Research Program 973 of China [2012CB722402, 2011CB707900]; National Natural Science Foundation of China [81127901, 30830040, 11274404, 31000435, 30970827]; Medical Scientific Research Projects Foundation of ChongQing [2012-2-064]	National Basic Research Program 973 of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medical Scientific Research Projects Foundation of ChongQing	This study was supported in part by the National Basic Research Program 973 of China (Grant No. 2012CB722402 and Grant No. 2011CB707900), National Natural Science Foundation of China (Grant No. 81127901, 30830040, 11274404, 31000435 and 30970827) and by Medical Scientific Research Projects Foundation of ChongQing(Grant No. 2012-2-064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anetzberger H, 2014, KNEE SURG SPORT TR A, V22, P112, DOI 10.1007/s00167-012-2297-7; Baysal O, 2004, SWISS MED WKLY, V134, P283; Boegard T, 1998, ANN RHEUM DIS, V57, P395, DOI 10.1136/ard.57.7.395; Boileau C, 2008, ANN RHEUM DIS, V67, P926, DOI 10.1136/ard.2007.077297; Brandt KD, 2005, ARTHRITIS RHEUM-US, V52, P2015, DOI 10.1002/art.21122; Brandt KD, 1997, OSTEOARTHR CARTILAGE, V5, P438, DOI 10.1016/S1063-4584(97)80048-9; Bruyere O, 2007, OSTEOARTHR CARTILAGE, V15, P98, DOI 10.1016/j.joca.2006.06.018; Calvo E, 2001, OSTEOARTHR CARTILAGE, V9, P463, DOI 10.1053/joca.2001.0413; Caron JP, 1996, ARTHRITIS RHEUM, V39, P1535, DOI 10.1002/art.1780390914; Cicuttini FM, 1996, OSTEOARTHR CARTILAGE, V4, P143, DOI 10.1016/S1063-4584(05)80323-1; Creamer P, 1997, LANCET, V350, P503, DOI 10.1016/S0140-6736(97)07226-7; Dieppe P, 1999, OSTEOARTHR CARTILAGE, V7, P325, DOI 10.1053/joca.1998.0182; Dieppe PA, 1997, OSTEOARTHR CARTILAGE, V5, P87, DOI 10.1016/S1063-4584(97)80002-7; Ding CH, 2005, OSTEOARTHR CARTILAGE, V13, P198, DOI 10.1016/j.joca.2004.11.007; Disler DG, 1997, AM J ROENTGENOL, V169, P1117, DOI 10.2214/ajr.169.4.9308475; Disler DG, 1996, AM J ROENTGENOL, V167, P127, DOI 10.2214/ajr.167.1.8659356; Dougados M, 2001, ARTHRITIS RHEUM-US, V44, P2539, DOI 10.1002/1529-0131(200111)44:11<2539::AID-ART434>3.0.CO;2-T; Dupuy DE, 1996, ACAD RADIOL, V3, P919, DOI 10.1016/S1076-6332(96)80299-6; Eckstein F, 2006, OSTEOARTHR CARTILAGE, V14, pA46, DOI 10.1016/j.joca.2006.02.026; FERNANDEZ JC, 1995, ARTHRITIS RHEUM, V38, P1290, DOI 10.1002/art.1780380918; Guermazi A, 2003, EUR RADIOL, V13, P1370, DOI 10.1007/s00330-002-1554-4; HAMERMAN D, 1993, J AM GERIATR SOC, V41, P760, DOI 10.1111/j.1532-5415.1993.tb07469.x; Hashimoto S, 2002, OSTEOARTHR CARTILAGE, V10, P180, DOI 10.1053/joca.2001.0505; HULTH A, 1970, ACTA ORTHOP SCAND, V41, P522, DOI 10.3109/17453677008991540; Jiang D, 2012, ARTHROSCOPY, V28, P1147, DOI 10.1016/j.arthro.2012.01.001; Jovanovic DV, 2001, ARTHRITIS RHEUM-US, V44, P2320, DOI 10.1002/1529-0131(200110)44:10<2320::AID-ART394>3.0.CO;2-P; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lanyon P, 1998, ANN RHEUM DIS, V57, P595, DOI 10.1136/ard.57.10.595; LUND F, 1980, ACTA RADIOL DIAGN, V21, P413, DOI 10.1177/028418518002100312; MCALINDON T, 1990, BRIT J RHEUMATOL, V29, P471; McAlindon TE, 1999, BEST PRACT RES CL RH, V13, P329, DOI 10.1053/berh.1999.0023; Messner K, 2001, AM J SPORT MED, V29, P151, DOI 10.1177/03635465010290020701; Mihara M, 2007, OSTEOARTHR CARTILAGE, V15, P543, DOI 10.1016/j.joca.2006.11.001; Outerbridge RE, 2001, CLIN ORTHOP RELAT R, P5; Pelletier JP, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2272; PELLETIER JP, 2006, ARTHRITIS RHEUM S, V54, P95; Peterfy CG, 2004, OSTEOARTHR CARTILAGE, V12, P177, DOI 10.1016/j.joca.2003.11.003; Potter HG, 1998, J BONE JOINT SURG AM, V80A, P1276, DOI 10.2106/00004623-199809000-00005; Raynauld JP, 2008, ANN RHEUM DIS, V67, P683, DOI 10.1136/ard.2007.073023; RECHT MP, 1994, AM J ROENTGENOL, V163, P283, DOI 10.2214/ajr.163.2.8037016; RECHT MP, 1993, RADIOLOGY, V187, P473, DOI 10.1148/radiology.187.2.8475293; Rijk PC, 2004, ARTHROSCOPY, V20, P911, DOI 10.1016/j.arthro.2004.06.036; Sittek H, 1996, SKELETAL RADIOL, V25, P55, DOI 10.1007/s002560050032; SMITH MM, 2007, OSTEOARTHRITIS DIAGN, P107; Sonin AH, 2002, AM J ROENTGENOL, V179, P1159, DOI 10.2214/ajr.179.5.1791159; Tessier JJ, 2003, OSTEOARTHR CARTILAGE, V11, P845, DOI 10.1016/S1063-4584(03)00162-6; Wachsmuth L, 2003, OSTEOARTHR CARTILAGE, V11, P891, DOI 10.1016/j.joca.2003.08.008; Wluka A, 2001, ANN RHEUM DIS, V60, P332, DOI 10.1136/ard.60.4.332; YU LP, 1992, ARTHRITIS RHEUM, V35, P1150, DOI 10.1002/art.1780351007	49	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113707	10.1371/journal.pone.0113707	http://dx.doi.org/10.1371/journal.pone.0113707			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438155	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900066
J	Lopez-Falcon, B; Meyer-Nava, S; Hernandez-Rodriguez, B; Campos, A; Montero, D; Rudino, E; Vazquez, M; Zurita, M; Valadez-Graham, V				Lopez-Falcon, Brenda; Meyer-Nava, Silvia; Hernandez-Rodriguez, Benjamin; Campos, Adam; Montero, Daniel; Rudino, Enrique; Vazquez, Martha; Zurita, Mario; Valadez-Graham, Viviana			Characterization of the Drosophila Group Ortholog to the Amino-Terminus of the Alpha-Thalassemia and Mental Retardation X-Linked (ATRX) Vertebrate Protein	PLOS ONE			English	Article							HISTONE CHAPERONE; CHROMATIN; DOMAIN; HETEROCHROMATIN; EXPRESSION; HOMOLOGY; MODEL; LOCALIZATION; RECOGNITION; MUTATIONS	The human ATRX gene encodes hATRX, a chromatin-remodeling protein harboring an helicase/ATPase and ADD domains. The ADD domain has two zinc fingers that bind to histone tails and mediate hATRX binding to chromatin. dAtrx, the putative ATRX homolog in Drosophila melanogaster, has a conserved helicase/ATPase domain but lacks the ADD domain. A bioinformatic search of the Drosophila genome using the human ADD sequence allowed us to identify the CG8290 annotated gene, which encodes three ADD harboring-isoforms generated by alternative splicing. This Drosophila ADD domain is highly similar in structure and in the amino acids which mediate the histone tail contacts to the ADD domain of hATRX as shown by 3D modeling. Very recently the CG8290 annotated gene has been named dadd1. We show through pull-down and CoIP assays that the products of the dadd1 gene interact physically with dAtrx(L) and HP1a and all of them mainly co-localize in the chromocenter, although euchromatic localization can also be observed through the chromosome arms. We confirm through ChIP analyses that these proteins are present in vivo in the same heterochromatic regions. The three isoforms are expressed throughout development. Flies carrying transheterozygous combinations of the dadd1 and atrx alleles are semi-viable and have different phenotypes including the appearance of melanotic masses. Interestingly, the dAdd1-b and c isoforms have extra domains, such as MADF, which suggest newly acquired functions of these proteins. These results strongly support that, in Drosophila, the atrx gene diverged and that the dadd1-encoded proteins participate with dAtrx in some cellular functions such as heterochromatin maintenance.	[Lopez-Falcon, Brenda; Meyer-Nava, Silvia; Hernandez-Rodriguez, Benjamin; Montero, Daniel; Vazquez, Martha; Zurita, Mario; Valadez-Graham, Viviana] Univ Nacl Autonoma Mexico, Dept Genet Desarrollo & Fisiol Mol, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico; [Campos, Adam; Rudino, Enrique] Univ Nacl Autonoma Mexico, Dept Med Mol & Bioproc, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico	Zurita, M (corresponding author), Univ Nacl Autonoma Mexico, Dept Genet Desarrollo & Fisiol Mol, Inst Biotecnol, Cuernavaca 62191, Morelos, Mexico.	marioz@ibt.unam.mx; vvaladez@ibt.unam.mx	Hernández-Rodríguez, Benjamín/B-5697-2018	Hernández-Rodríguez, Benjamín/0000-0002-5118-8715; Vazquez, Martha/0000-0003-0329-8802; Rudino-Pinera, Enrique/0000-0001-8170-6379; Valadez, Viviana/0000-0002-2556-7375; Meyer, Silvia/0000-0003-0219-5959; Campos-Acevedo, Adam/0000-0002-3256-9088	Consejo Nacional de Ciencia y Tecnologia [127440, 177393]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico [IA200613]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding: This work was supported by grant 127440 from Consejo Nacional de Ciencia y Tecnologia to MZ and grants 177393, Joven Investigador, from Consejo Nacional de Ciencia y Tecnologia and IA200613 from Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico to VVG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Alekseyenko AA, 2014, GENE DEV, V28, P1445, DOI 10.1101/gad.241950.114; Antao JM, 2012, MOL CELL BIOL, V32, P2170, DOI 10.1128/MCB.00010-12; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bassett AR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002099; Bhaskar V, 2002, GENE, V299, P173, DOI 10.1016/S0378-1119(02)01058-2; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Casola C, 2007, MOL BIOL EVOL, V24, P1872, DOI 10.1093/molbev/msm116; Chauhan C, 2012, DEVELOPMENT, V139, P1997, DOI 10.1242/dev.076687; Clynes D, 2013, TRENDS BIOCHEM SCI, V38, P461, DOI 10.1016/j.tibs.2013.06.011; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Dhayalan A, 2011, HUM MOL GENET, V20, P2195, DOI 10.1093/hmg/ddr107; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; EISSENBERG JC, 1992, GENETICS, V131, P345; Emelyanov AV, 2010, J BIOL CHEM, V285, P15027, DOI 10.1074/jbc.M109.064790; ENGLAND BP, 1992, P NATL ACAD SCI USA, V89, P683, DOI 10.1073/pnas.89.2.683; Eustermann S, 2011, NAT STRUCT MOL BIOL, V18, P777, DOI 10.1038/nsmb.2070; Frydrychova RC, 2008, GENETICS, V180, P121, DOI 10.1534/genetics.108.090647; Garrick D, 2004, GENE, V326, P23, DOI 10.1016/j.gene.2003.10.026; Gibbons RJ, 2008, HUM MUTAT, V29, P796, DOI 10.1002/humu.20734; Gibbons RJ, 2012, COLD SPRING HARB PER, V2; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Gu TT, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003780; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Herrera-Cruz M, 2012, J BIOL CHEM, V287, P33567, DOI 10.1074/jbc.M112.383505; Iwase S, 2011, NAT STRUCT MOL BIOL, V18, P769, DOI 10.1038/nsmb.2062; Jimenez G, 1997, MOL CELL BIOL, V17, P4355, DOI 10.1128/MCB.17.8.4355; Jung SH, 2005, DEVELOPMENT, V132, P2521, DOI 10.1242/dev.01837; KAMAKAKA RT, 1994, METHOD CELL BIOL, V44, P225, DOI 10.1016/S0091-679X(08)60916-4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Leclerc V, 1996, MOL BIOL CELL, V7, P505, DOI 10.1091/mbc.7.4.505; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Li YY, 2012, ACTA BIOCH BIOPH SIN, V44, P28, DOI 10.1093/abbs/gmr117; Lu BY, 1996, EMBO J, V15, P1323, DOI 10.1002/j.1460-2075.1996.tb00474.x; Maheshwari S, 2008, MOL BIOL EVOL, V25, P2421, DOI 10.1093/molbev/msn190; Minakhina S, 2006, GENETICS, V174, P253, DOI 10.1534/genetics.106.061978; Minakhina S, 2011, DEV BIOL, V352, P308, DOI 10.1016/j.ydbio.2011.01.035; Mitson M, 2011, HUM MOL GENET, V20, P2603, DOI 10.1093/hmg/ddr163; Palomera-Sanchez Z, 2010, J BIOL CHEM, V285, P31370, DOI 10.1074/jbc.M110.128462; Park DJ, 2004, GENE, V339, P39, DOI 10.1016/j.gene.2004.06.025; Rambaldi D, 2009, BIOINFORMATICS, V25, P2281, DOI 10.1093/bioinformatics/btp381; Ren J, 2009, CELL RES, V19, P271, DOI 10.1038/cr.2009.6; St Pierre SE, 2014, NUCLEIC ACIDS RES, V42, pD780, DOI 10.1093/nar/gkt1092; Valadez-Graham V, 2012, NUCLEIC ACIDS RES, V40, P1460, DOI 10.1093/nar/gkr865; Wang W, 2004, NAT GENET, V36, P523, DOI 10.1038/ng1338	48	7	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113182	10.1371/journal.pone.0113182	http://dx.doi.org/10.1371/journal.pone.0113182			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437195	gold, Green Published, Green Submitted			2022-12-26	WOS:000347114900031
J	Ma, QG; Wang, CC; Wang, XY				Ma, Qingguo; Wang, Cuicui; Wang, Xiaoyi			Two-Stage Categorization in Brand Extension Evaluation: Electrophysiological Time Course Evidence	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; SEMANTIC CATEGORIZATION; BRAIN POTENTIALS; ERP; MEMORY; N400; TASK; SIMILARITY; DECISIONS; COMPONENT	A brand name can be considered a mental category. Similarity-based categorization theory has been used to explain how consumers judge a new product as a member of a known brand, a process called brand extension evaluation. This study was an event-related potential study conducted in two experiments. The study found a two-stage categorization process reflected by the P2 and N400 components in brand extension evaluation. In experiment 1, a prime-probe paradigm was presented in a pair consisting of a brand name and a product name in three conditions, i.e., in-category extension, similar-category extension, and out-of-category extension. Although the task was unrelated to brand extension evaluation, P2 distinguished out-of-category extensions from similar-category and in-category ones, and N400 distinguished similar-category extensions from in-category ones. In experiment 2, a prime-probe paradigm with a related task was used, in which product names included subcategory and major-category product names. The N400 elicited by subcategory products was more significantly negative than that elicited by major-category products, with no salient difference in P2. We speculated that P2 could reflect the early low-level and similarity-based processing in the first stage, whereas N400 could reflect the late analytic and category-based processing in the second stage.	[Ma, Qingguo; Wang, Cuicui; Wang, Xiaoyi] Zhejiang Univ, Sch Management, Hangzhou 310027, Zhejiang, Peoples R China; [Ma, Qingguo; Wang, Cuicui; Wang, Xiaoyi] Zhejiang Univ, Neuromanagement Lab, Hangzhou 310003, Zhejiang, Peoples R China; [Wang, Cuicui] Hefei Univ Technol, Sch Management, Hefei, Peoples R China	Zhejiang University; Zhejiang University; Hefei University of Technology	Wang, XY (corresponding author), Zhejiang Univ, Sch Management, Hangzhou 310027, Zhejiang, Peoples R China.	kevinwxy@zju.edu.cn		Wang, Xiaoyi/0000-0001-7748-2296	National Natural Science Foundation [70902061, 71371167]; Zhejiang Provincial National Natural Science Foundation [LY13G020003]; MOE (Ministry of Education in China) [14YJC630129]; Zhejiang University; Technology Innovation Program for Students of Zhejiang Province	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial National Natural Science Foundation; MOE (Ministry of Education in China)(Ministry of Education, China); Zhejiang University; Technology Innovation Program for Students of Zhejiang Province	This work was supported by Grant No. 70902061 (Xiaoyi Wang) and 71371167 (Qingguo Ma) of the National Natural Science Foundation (http://www.nsfc.gov.cn), Grant No. LY13G020003 (Xiaoyi Wang) from the Zhejiang Provincial National Natural Science Foundation (http://www.zjnsf.gov.cn/), grant No. 14YJC630129 (Xiaoyi Wang) from the MOE (Ministry of Education in China) Project of Humanities and Social Sciences (http://www.sinoss.net), Young Funding of Social Science Experimental Study in Zhejiang University (Xiaoyi Wang), and Technology Innovation Program for Students of Zhejiang Province in 2014 (Cuicui Wang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAKER D, 1990, SLOAN MANAGE REV, V31, P47; AAKER DA, 1990, J MARKETING, V54, P27, DOI 10.2307/1252171; Barone MJ, 2002, J CONSUM PSYCHOL, V12, P283; Blanchet S, 2007, BRAIN RES, V1170, P59, DOI 10.1016/j.brainres.2007.07.024; Bless H., 2009, SOCIAL PSYCHOL CONSU, P109; BOUSH DM, 1991, J MARKETING RES, V28, P16, DOI 10.2307/3172723; Crowley KE, 2004, CLIN NEUROPHYSIOL, V115, P732, DOI 10.1016/j.clinph.2003.11.021; Fiske SusanT., 1986, HDB MOTIVATION COGNI, P167; Freunberger R, 2007, NEUROSCI LETT, V426, P181, DOI 10.1016/j.neulet.2007.08.062; Fujihara N, 1998, INT J PSYCHOPHYSIOL, V29, P65, DOI 10.1016/S0167-8760(97)00099-8; Greenhouse S. W., 1959, METHODS ANAL PROFILE; Heinze HJ, 1998, BIOL PSYCHOL, V47, P121, DOI 10.1016/S0301-0511(97)00024-0; HOLCOMB PJ, 1993, PSYCHOPHYSIOLOGY, V30, P47, DOI 10.1111/j.1469-8986.1993.tb03204.x; HOLCOMB PJ, 1991, PSYCHOBIOLOGY, V19, P286; Hong JW, 2010, J CONSUM RES, V37, P456, DOI 10.1086/653492; Koenig P, 2005, NEUROIMAGE, V24, P369, DOI 10.1016/j.neuroimage.2004.08.045; Kranczioch C, 2003, COGNITIVE BRAIN RES, V17, P177, DOI 10.1016/S0926-6410(03)00092-2; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Kutas M, 2000, TRENDS COGN SCI, V4, P463, DOI 10.1016/S1364-6613(00)01560-6; KUTAS M, 1985, PSYCHOPHYSIOLOGY, V22, P575; Lee AY, 1999, J CONSUM RES, V26, P115, DOI 10.1086/209554; Lei Y, 2010, EXP BRAIN RES, V204, P47, DOI 10.1007/s00221-010-2292-5; Liberman N., 2007, SOCIAL PSYCHOL HDB B, P353; Loken B, 2002, J CONSUM PSYCHOL, V12, P149, DOI 10.1207/S15327663JCP1202_07; Ma QG, 2008, NEUROSCI LETT, V431, P57, DOI 10.1016/j.neulet.2007.11.022; Ma QG, 2007, NEUROREPORT, V18, P1031, DOI 10.1097/WNR.0b013e3281667d59; Ma QG, 2010, NEUROSCI LETT, V483, P206, DOI 10.1016/j.neulet.2010.08.009; Mathalon DH, 2010, INT J PSYCHOPHYSIOL, V75, P157, DOI 10.1016/j.ijpsycho.2009.12.003; MEDIN DL, 1993, PSYCHOL REV, V100, P254, DOI 10.1037/0033-295X.100.2.254; MEDIN DL, 1978, PSYCHOL REV, V85, P207, DOI 10.1037/0033-295X.85.3.207; MURPHY GL, 1994, COGNITIVE PSYCHOL, V27, P148, DOI 10.1006/cogp.1994.1015; NAATANEN R, 1982, BIOL PSYCHOL, V14, P53, DOI 10.1016/0301-0511(82)90017-5; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Nunez-Pena MI, 2005, INT J PSYCHOPHYSIOL, V56, P45, DOI 10.1016/j.ijpsycho.2004.09.006; PARK CW, 1991, J CONSUM RES, V18, P185, DOI 10.1086/209251; Pernet C, 2003, COGNITIVE BRAIN RES, V17, P327, DOI 10.1016/S0926-6410(03)00134-4; Poiezzi D, 2008, BEHAV BRAIN RES, V187, P116, DOI 10.1016/j.bbr.2007.09.001; POLICH J, 1985, BRAIN LANG, V26, P304, DOI 10.1016/0093-934X(85)90045-8; Potts GF, 2004, BRAIN COGNITION, V56, P5, DOI 10.1016/j.bandc.2004.03.006; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; SMITH EE, 1974, PSYCHOL REV, V81, P214, DOI 10.1037/h0036351; Smith EE, 1981, CATEGORIES CONCEPTS; Thomas SJ, 2007, INT J PSYCHOPHYSIOL, V63, P221, DOI 10.1016/j.ijpsycho.2006.10.002; Trope Y, 2003, PSYCHOL REV, V110, P403, DOI 10.1037/0033-295X.110.3.403; Wang XY, 2012, NEUROSCI LETT, V525, P76, DOI 10.1016/j.neulet.2012.07.043	45	20	20	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114150	10.1371/journal.pone.0114150	http://dx.doi.org/10.1371/journal.pone.0114150			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7SK	25438152	Green Published, gold, Green Submitted			2022-12-26	WOS:000347114900126
J	Malinowski, JR; Denny, JC; Bielinski, SJ; Basford, MA; Bradford, Y; Peissig, PL; Carrell, D; Crosslin, DR; Pathak, J; Rasmussen, L; Pacheco, J; Kho, A; Newton, KM; Li, RL; Kullo, IJ; Chute, CG; Chisholm, RL; Jarvik, GP; Larson, EB; McCarty, CA; Masys, DR; Roden, DM; de Andrade, M; Ritchie, MD; Crawford, DC				Malinowski, Jennifer R.; Denny, Joshua C.; Bielinski, Suzette J.; Basford, Melissa A.; Bradford, Yuki; Peissig, Peggy L.; Carrell, David; Crosslin, David R.; Pathak, Jyotishman; Rasmussen, Luke; Pacheco, Jennifer; Kho, Abel; Newton, Katherine M.; Li, Rongling; Kullo, Iftikhar J.; Chute, Christopher G.; Chisholm, Rex L.; Jarvik, Gail P.; Larson, Eric B.; McCarty, Catherine A.; Masys, Daniel R.; Roden, Dan M.; de Andrade, Mariza; Ritchie, Marylyn D.; Crawford, Dana C.			Genetic Variants Associated with Serum Thyroid Stimulating Hormone (TSH) Levels in European Americans and African Americans from the eMERGE Network	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ELECTRONIC MEDICAL-RECORDS; REFERENCE LIMITS; NATIONAL-HEALTH; FREE T4; LOCI; CANCER; FOXE1; DIFFERENTIATION; HYPOTHYROIDISM	Thyroid stimulating hormone (TSH) hormone levels are normally tightly regulated within an individual; thus, relatively small variations may indicate thyroid disease. Genome-wide association studies (GWAS) have identified variants in PDE8B and FOXE1 that are associated with TSH levels. However, prior studies lacked racial/ethnic diversity, limiting the generalization of these findings to individuals of non-European ethnicities. The Electronic Medical Records and Genomics (eMERGE) Network is a collaboration across institutions with biobanks linked to electronic medical records (EMRs). The eMERGE Network uses EMR-derived phenotypes to perform GWAS in diverse populations for a variety of phenotypes. In this report, we identified serum TSH levels from 4,501 European American and 351 African American euthyroid individuals in the eMERGE Network with existing GWAS data. Tests of association were performed using linear regression and adjusted for age, sex, body mass index (BMI), and principal components, assuming an additive genetic model. Our results replicate the known association of PDE8B with serum TSH levels in European Americans (rs2046045 p=1.85x10(-17), beta=0.09). FOXE1 variants, associated with hypothyroidism, were not genome-wide significant (rs10759944: p=1.08x10(-6), beta=-0.05). No SNPs reached genome-wide significance in African Americans. However, multiple known associations with TSH levels in European ancestry were nominally significant in African Americans, including PDE8B (rs2046045 p=0.03, beta=-0.09), VEGFA (rs11755845 p=0.01, beta=-0.13), and NFIA (rs334699 p=1.50x10(-3), beta=-0.17). We found little evidence that SNPs previously associated with other thyroid-related disorders were associated with serum TSH levels in this study. These results support the previously reported association between PDE8B and serum TSH levels in European Americans and emphasize the need for additional genetic studies in more diverse populations.	[Denny, Joshua C.; Masys, Daniel R.; Ritchie, Marylyn D.] Vanderbilt Univ, Dept Biomed Informat, Nashville, TN 37235 USA; [Denny, Joshua C.; Roden, Dan M.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Ritchie, Marylyn D.; Crawford, Dana C.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Malinowski, Jennifer R.; Bradford, Yuki; Ritchie, Marylyn D.; Crawford, Dana C.] Vanderbilt Univ, Ctr Human Genet Res, Nashville, TN 37235 USA; [Bielinski, Suzette J.] Mayo Clin, Div Epidemiol, Dept Hlth Sci Res, Rochester, MN USA; [Basford, Melissa A.] Vanderbilt Univ, Res Off, Nashville, TN 37235 USA; [Pathak, Jyotishman; Chute, Christopher G.; de Andrade, Mariza] Mayo Clin, Div Biomed Stat & Informat, Dept Hlth Sci Res, Rochester, MN USA; [Peissig, Peggy L.; Rasmussen, Luke] Marshfield Clin Res Fdn, Biomed Informat Res Ctr, Marshfield, WI USA; [Carrell, David; Newton, Katherine M.; Larson, Eric B.] Grp Hlth Res Inst, Seattle, WA USA; [Pacheco, Jennifer; Kho, Abel] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Li, Rongling] NHGRI, Div Genom Med, Bethesda, MD 20892 USA; [Kullo, Iftikhar J.] Mayo Clin, Div Cardiovasc Dis, Dept Hlth Sci Res, Rochester, MN USA; [Chisholm, Rex L.] Northwestern Univ, Ctr Genet Med, Chicago, IL 60611 USA; [McCarty, Catherine A.] Essentia Inst Rural Hlth, Duluth, MN USA; [Roden, Dan M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA; [Crosslin, David R.; Jarvik, Gail P.] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA; [Crosslin, David R.; Jarvik, Gail P.] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Mayo Clinic; Vanderbilt University; Mayo Clinic; Northwestern University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Mayo Clinic; Northwestern University; Vanderbilt University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Crawford, DC (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	dana.crawford@case.edu	Chute, Christopher/AAT-8540-2021; Roden, Dan/ABD-5412-2021; Denny, Josh/AAL-3359-2021; Bielinski, Suzette/A-2238-2009; Crawford, Dana/O-5578-2019; Chisholm, Rex/B-3418-2009	Denny, Josh/0000-0002-3049-7332; Bielinski, Suzette/0000-0002-2905-5430; Crawford, Dana/0000-0002-6437-6248; McCarty, Catherine/0000-0003-1089-0142; Pacheco, Jennifer/0000-0001-8021-5818; Malinowski, Jennifer/0000-0001-7500-2199; Chisholm, Rex/0000-0002-5638-3990; Rasmussen, Luke/0000-0002-4497-8049	NHGRI; NIGMS [U01HG04599, U01HG006379, U01HG004610, U01HG006375, U01HG004608, U01HG006389, U01HG004609, U01HG006388, U01HG04603, U01HG006378, U01HG006385, U01HG006382, U01HG006380, U01HG006830, U01HG006828]; Group Health/UW ADPR/ACT [UO1 AG 0681]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000427] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006388, U01HG006382, U01HG006378, U01HG006385, U01HG004599, U01HG004610, U01HG006828, U01HG006380, U01HG006389, U01HG004609, U01HG004603, U01HG004608, U01HG006379, U01HG006375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080178, R01GM105688] Funding Source: NIH RePORTER	NHGRI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Group Health/UW ADPR/ACT; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funding: The eMERGE Network is funded by NHGRI, with additional funding from NIGMS through the following grants: U01HG04599 and U01HG006379 to Mayo Clinic; U01HG004610 and U01HG006375 to Group Health Cooperative; U01HG004608 to Marshfield Clinic; U01HG006389 to Essentia Institute of Rural Health; U01HG004609 and U01HG006388 to Northwestern University; U01HG04603 and U01HG006378 to Vanderbilt University; U01HG006385 to the Coordinating Center; U01HG006382 to Geisinger Clinic; U01HG006380 to Icahn School of Medicine at Mount Sinai; U01HG006830 to The Children's Hospital of Philadelphia; and U01HG006828 to Cincinnati Children's Hospital and Boston Children's Hospital. Group Health/University of Washington received additional funding through Group Health/UW ADPR/ACT grant UO1 AG 0681. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alul FY, 2013, HEREDITY, V110, P253, DOI 10.1038/hdy.2012.75; Alul FY, 2013, PEDIATR RES, V73, P484, DOI 10.1038/pr.2013.18; Arnaud-Lopez L, 2008, AM J HUM GENET, V82, P1270, DOI 10.1016/j.ajhg.2008.04.019; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; BAGCHI N, 1990, ARCH INTERN MED, V150, P785, DOI 10.1001/archinte.150.4.785; Boucai L, 2009, CLIN ENDOCRINOL, V70, P788, DOI 10.1111/j.1365-2265.2008.03390.x; Breuleux M, 2007, CELL MOL LIFE SCI, V64, P2358, DOI 10.1007/s00018-007-7120-0; Brix TH, 2000, ARCH INTERN MED, V160, P661, DOI 10.1001/archinte.160.5.661; Chiamolera MI, 2009, ENDOCRINOLOGY, V150, P1091, DOI 10.1210/en.2008-1795; Chu X, 2011, NAT GENET, V43, P897, DOI 10.1038/ng.898; Crosslin DR, 2013, HUM MOL GENET, V22, P2119, DOI 10.1093/hmg/ddt010; Cuesta I, 2007, MOL CELL BIOL, V27, P7302, DOI 10.1128/MCB.00758-07; De Felice M, 2004, ENDOCR REV, V25, P722, DOI 10.1210/er.2003-0028; De Pergola G, 2007, CLIN ENDOCRINOL, V67, P265, DOI 10.1111/j.1365-2265.2007.02874.x; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Ding KY, 2012, MAYO CLIN PROC, V87, P461, DOI 10.1016/j.mayocp.2012.01.016; Eriksson N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034442; Finlayson A, 2014, BRIT J CANCER, V110, P1322, DOI 10.1038/bjc.2014.4; Gauderman WJ, 2002, AM J EPIDEMIOL, V155, P478, DOI 10.1093/aje/155.5.478; Gudmundsson J, 2009, NAT GENET, V41, P460, DOI 10.1038/ng.339; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; Horvath A, 2010, THYROID, V20, P363, DOI 10.1089/thy.2009.0260; Jorde R, 2006, EXP CLIN ENDOCR DIAB, V114, P343, DOI 10.1055/s-2006-924264; Knudsen N, 2005, J CLIN ENDOCR METAB, V90, P4019, DOI 10.1210/jc.2004-2225; Landa I, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000637; Laurberg P, 2005, DRUG AGING, V22, P23, DOI 10.2165/00002512-200522010-00002; Marzullo P, 2010, J CLIN ENDOCR METAB, V95, P3965, DOI 10.1210/jc.2009-2798; McCarty CA, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-13; Means J H, 1940, Bull N Y Acad Med, V16, P14; Medici M, 2011, EUR J ENDOCRINOL, V164, P781, DOI 10.1530/EJE-10-1130; Nyrnes A, 2006, INT J OBESITY, V30, P100, DOI 10.1038/sj.ijo.0803112; Panicker V, 2008, CLIN ENDOCRINOL, V68, P652, DOI 10.1111/j.1365-2265.2007.03079.x; Panicker V, 2008, J CLIN ENDOCR METAB, V93, P3519, DOI 10.1210/jc.2007-2650; Panicker Vijay, 2011, Clin Biochem Rev, V32, P165; Panicker V, 2010, AM J HUM GENET, V87, P430, DOI 10.1016/j.ajhg.2010.08.005; Pendergrass SA, 2010, BIODATA MIN, V3, DOI 10.1186/1756-0381-3-10; Porcu E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003266; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; R Core Team, 2021, R LANGUAGE ENV STAT; Rawal R, 2012, HUM MOL GENET, V21, P3275, DOI 10.1093/hmg/dds136; Ryckman KK, 2014, J PEDIATR ENDOCR MET, V27, P929, DOI 10.1515/jpem-2013-0366; Spencer CA, 2007, J CLIN ENDOCR METAB, V92, P4236, DOI 10.1210/jc.2007-0287; StataCorp, 2011, STAT STAT SOFTW REL, P173; Taylor PN, 2011, EUR J ENDOCRINOL, V164, P773, DOI 10.1530/EJE-10-0938; Tomaz RA, 2012, CLIN ENDOCRINOL, V77, P926, DOI 10.1111/j.1365-2265.2012.04505.x; Turner S, GENETING GENETICS DO; Turner Stephen, 2011, Curr Protoc Hum Genet, VChapter 1, DOI 10.1002/0471142905.hg0119s68; Vanderpump MPJ, 2011, BRIT MED BULL, V99, P39, DOI 10.1093/bmb/ldr030; Zuvich RL, 2011, GENET EPIDEMIOL, V35, P887, DOI 10.1002/gepi.20639	50	28	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e111301	10.1371/journal.pone.0111301	http://dx.doi.org/10.1371/journal.pone.0111301			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436638	Green Published, gold, Green Submitted			2022-12-26	WOS:000347114900008
J	Ohmura-Kakutani, H; Akiyama, K; Maishi, N; Ohga, N; Hida, Y; Kawamoto, T; Iida, J; Shindoh, M; Tsuchiya, K; Shinohara, N; Hida, K				Ohmura-Kakutani, Hitomi; Akiyama, Kosuke; Maishi, Nako; Ohga, Noritaka; Hida, Yasuhiro; Kawamoto, Taisuke; Iida, Junichiro; Shindoh, Masanobu; Tsuchiya, Kunihiko; Shinohara, Nobuo; Hida, Kyoko			Identification of Tumor Endothelial Cells with High Aldehyde Dehydrogenase Activity and a Highly Angiogenic Phenotype	PLOS ONE			English	Article							PROMOTES ANGIOGENESIS; STEM-CELLS; CANCER; VEGF; POPULATION; MARKER; GENES	Tumor blood vessels play an important role in tumor progression and metastasis. It has been reported that tumor endothelial cells (TECs) exhibit highly angiogenic phenotypes compared with those of normal endothelial cells (NECs). TECs show higher proliferative and migratory abilities than those NECs, together with upregulation of vascular endothelial growth factor (VEGF) and VEGF receptor 2 (VEGFR2). Furthermore, compared with NECs, stem cell markers such as Sca-1, CD90, and multidrug resistance 1 are upregulated in TECs, suggesting that stem-like cells exist in tumor blood vessels. In this study, to reveal the biological role of stem-like TECs, we analyzed expression of the stem cell marker aldehyde dehydrogenase (ALDH) in TECs and characterized ALDH(high) TECs. TECs and NECs were isolated from melanoma-xenografted nude mice and normal dermis, respectively. ALDH mRNA expression and activity were higher in TECs than those in NECs. Next, ALDH(high/low) TECs were isolated by fluorescence-activated cell sorting to compare their characteristics. Compared with ALDH(low) TECs, ALDH(high) TECs formed more tubes on Matrigel-coated plates and sustained the tubular networks longer. Furthermore, VEGFR2 expression was higher in ALDHhigh TECs than that in ALDH(low) TECs. In addition, ALDH was expressed in the tumor blood vessels of in vivo mouse models of melanoma and oral carcinoma, but not in normal blood vessels. These findings indicate that ALDH(high) TECs exhibit an angiogenic phenotype. Stem-like TECs may have an essential role in tumor angiogenesis.	[Ohmura-Kakutani, Hitomi; Akiyama, Kosuke; Maishi, Nako; Ohga, Noritaka; Kawamoto, Taisuke; Hida, Kyoko] Hokkaido Univ, Grad Sch Dent Med, Dept Vasc Biol, Sapporo, Hokkaido, Japan; [Akiyama, Kosuke; Maishi, Nako; Hida, Kyoko] Hokkaido Univ, Inst Med Genet, Div Vasc Biol, Sapporo, Hokkaido, Japan; [Hida, Yasuhiro] Hokkaido Univ, Grad Sch Med, Dept Cardiovasc & Thorac Surg, Sapporo, Hokkaido, Japan; [Ohmura-Kakutani, Hitomi; Iida, Junichiro] Hokkaido Univ, Grad Sch Dent Med, Dept Orthodont, Sapporo, Hokkaido, Japan; [Shindoh, Masanobu] Hokkaido Univ, Grad Sch Dent Med, Dept Oral Pathol & Biol, Sapporo, Hokkaido, Japan; [Tsuchiya, Kunihiko; Shinohara, Nobuo] Grad Sch Med, Dept Renal & Genitourinary Surg, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University	Hida, K (corresponding author), Hokkaido Univ, Grad Sch Dent Med, Dept Vasc Biol, Sapporo, Hokkaido, Japan.	khida@igm.hokudai.ac.jp	Shindoh, Masanobu/A-4799-2012; Hida, Kyoko/AAE-3183-2020; Hida, Kyoko/A-8444-2012; Hida, Yasuhiro/A-7761-2012; Maishi, Nako/A-8403-2012	Shindoh, Masanobu/0000-0002-7782-5823; Hida, Kyoko/0000-0002-7968-6062; Hida, Yasuhiro/0000-0003-1759-4215; 				Aird WC, 2009, CELL TISSUE RES, V335, P271, DOI 10.1007/s00441-008-0672-y; Akino T, 2009, AM J PATHOL, V175, P2657, DOI 10.2353/ajpath.2009.090202; Akiyama K, 2012, AM J PATHOL, V180, P1283, DOI 10.1016/j.ajpath.2011.11.029; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Corti S, 2006, STEM CELLS, V24, P975, DOI 10.1634/stemcells.2005-0217; Dudley AC, 2008, CANCER CELL, V14, P201, DOI 10.1016/j.ccr.2008.06.017; Ferrara N, 2004, ENDOCR REV, V25, P581, DOI 10.1210/er.2003-0027; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; Jain RK, 2006, NAT CLIN PRACT ONCOL, V3, P24, DOI 10.1038/ncponc0403; KASTAN MB, 1990, BLOOD, V75, P1947; KOZLOWSKI JM, 1984, J NATL CANCER I, V72, P913; Kurosu T, 2011, BRIT J CANCER, V104, P819, DOI 10.1038/bjc.2011.20; Maishi N, 2012, PATHOL INT, V62, P309, DOI 10.1111/j.1440-1827.2012.02792.x; Matsuda K, 2010, BIOCHEM BIOPH RES CO, V394, P947, DOI 10.1016/j.bbrc.2010.03.089; Naito H, 2012, EMBO J, V31, P842, DOI 10.1038/emboj.2011.465; Ohga N, 2012, AM J PATHOL, V180, P1294, DOI 10.1016/j.ajpath.2011.11.035; Osawa T, 2013, BRIT J CANCER, V109, P2237, DOI 10.1038/bjc.2013.535; Osawa T, 2012, CANCER SCI, V103, P1038, DOI 10.1111/j.1349-7006.2012.02261.x; Seaman S, 2007, CANCER CELL, V11, P539, DOI 10.1016/j.ccr.2007.04.017; Silva IA, 2011, CANCER RES, V71, P3991, DOI 10.1158/0008-5472.CAN-10-3175; St Croix B, 2000, SCIENCE, V289, P1197; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Yamamoto K, 2012, BRIT J CANCER, V106, P1214, DOI 10.1038/bjc.2012.59	25	34	34	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113910	10.1371/journal.pone.0113910	http://dx.doi.org/10.1371/journal.pone.0113910			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437864	Green Published, gold			2022-12-26	WOS:000347114900094
J	Zhang, RL; Chopp, M; Roberts, C; Liu, XS; Wei, M; Nejad-Davarani, SP; Wang, XL; Zhang, ZG				Zhang, Rui Lan; Chopp, Michael; Roberts, Cynthia; Liu, Xianshuang; Wei, Min; Nejad-Davarani, Siamak P.; Wang, Xinli; Zhang, Zheng Gang			Stroke Increases Neural Stem Cells and Angiogenesis in the Neurogenic Niche of the Adult Mouse	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; SUBVENTRICULAR ZONE; PROGENITOR CELLS; NEUROBLAST MIGRATION; STRING VESSELS; VASCULAR NICHE; PROLIFERATION; ISCHEMIA; ARCHITECTURE; ACTIVATION	The unique cellular and vascular architecture of the adult ventricular-subventricular zone (V/SVZ) neurogenic niche plays an important role in regulating neural stem cell function. However, the in vivo identification of neural stem cells and their relationship to blood vessels within this niche in response to stroke remain largely unknown. Using whole-mount preparation of the lateral ventricle wall, we examined the architecture of neural stem cells and blood vessels in the V/SVZ of adult mouse over the course of 3 months after onset of focal cerebral ischemia. Stroke substantially increased the number of glial fibrillary acidic protein (GFAP) positive neural stem cells that are in contact with the cerebrospinal fluid (CSF) via their apical processes at the center of pinwheel structures formed by ependymal cells residing in the lateral ventricle. Long basal processes of these cells extended to blood vessels beneath the ependymal layer. Moreover, stroke increased V/SVZ endothelial cell proliferation from 2% in non-ischemic mice to 12 and 15% at 7 and 14 days after stroke, respectively. Vascular volume in the V/SVZ was augmented from 3% of the total volume prior to stroke to 6% at 90 days after stroke. Stroke-increased angiogenesis was closely associated with neuroblasts that expanded to nearly encompass the entire lateral ventricular wall in the V/SVZ. These data indicate that stroke induces long-term alterations of the neural stem cell and vascular architecture of the adult V/SVZ neurogenic niche. These post-stroke structural changes may provide insight into neural stem cell mediation of stroke-induced neurogenesis through the interaction of neural stem cells with proteins in the CSF and their sub-ependymal neurovascular interaction.	[Zhang, Rui Lan; Chopp, Michael; Roberts, Cynthia; Liu, Xianshuang; Wei, Min; Nejad-Davarani, Siamak P.; Wang, Xinli; Zhang, Zheng Gang] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA; [Chopp, Michael] Oakland Univ, Dept Phys, Rochester, MI USA	Henry Ford Health System; Henry Ford Hospital; Oakland University	Zhang, ZG (corresponding author), Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA.	zhazh@neuro.hfh.edu	Nejad-Davarani, Siamak/AAH-8399-2021; zhang, zheng/HCH-9684-2022	Nejad-Davarani, Siamak/0000-0002-2415-6689	National Institutes of Health [RO1 AG037506, RO1 NS075156]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS075156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG037506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health Grants: RO1 AG037506 (MC) and RO1 NS075156 (ZGZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Brown WR, 2010, J ALZHEIMERS DIS, V21, P725, DOI 10.3233/JAD-2010-100219; Challa VR, 2002, J NEUROL SCI, V203, P165, DOI 10.1016/S0022-510X(02)00284-8; Doetsch F, 1997, J NEUROSCI, V17, P5046; Garcia-Verdugo J, 1998, J NEUROBIOL, V36, P234, DOI 10.1002/(SICI)1097-4695(199808)36:2<234::AID-NEU10>3.0.CO;2-E; Gotts JE, 2005, EXP NEUROL, V194, P139, DOI 10.1016/j.expneurol.2005.02.001; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Kazanis I, 2010, J NEUROSCI, V30, P9771, DOI 10.1523/JNEUROSCI.0700-10.2010; Kokovay E, 2008, NEURON, V60, P420, DOI 10.1016/j.neuron.2008.10.025; Kokovay E, 2012, CELL STEM CELL, V11, P220, DOI 10.1016/j.stem.2012.06.016; Kuan CY, 2004, J NEUROSCI, V24, P10763, DOI 10.1523/JNEUROSCI.3883-04.2004; Liu XS, 2013, J BIOL CHEM, V288, P12478, DOI 10.1074/jbc.M112.449025; Luo J, 2008, J NEUROSCI, V28, P3804, DOI 10.1523/JNEUROSCI.0224-08.2008; Mercier F, 2002, J COMP NEUROL, V451, P170, DOI 10.1002/cne.10342; Miller FD, 2009, CELL STEM CELL, V4, P507, DOI 10.1016/j.stem.2009.05.008; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Silva-Vargas V, 2013, CURR OPIN NEUROBIOL, V23, P935, DOI 10.1016/j.conb.2013.09.004; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Teng H, 2008, J CEREBR BLOOD F MET, V28, P764, DOI 10.1038/sj.jcbfm.9600573; Wang XJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0040084, 10.1371/journal.pone.0040711, 10.1371/journal.pone.0038932, 10.1371/journal.pone.0052707, 10.1371/journal.pone.0036663, 10.1371/journal.pone.0045380, 10.1371/journal.pone.0052082, 10.1371/journal.pone.0040857, 10.1371/journal.pone.0047429, 10.1371/journal.pone.0045939, 10.1371/journal.pone.0045036]; Young CC, 2013, CEREB CORTEX, V23, P647, DOI 10.1093/cercor/bhs049; Zhang L, 2013, STROKE, V44, P1965, DOI 10.1161/STROKEAHA.111.000831; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zhang RL, 2001, NEUROSCIENCE, V105, P33, DOI 10.1016/S0306-4522(01)00117-8; Zhang RL, 2009, J CEREBR BLOOD F MET, V29, P1240, DOI 10.1038/jcbfm.2009.55; Zhang RL, 2007, J CEREBR BLOOD F MET, V27, P1201, DOI 10.1038/sj.jcbfm.9600430; Zhang RL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048141, 10.1371/journal.pone.0050348]; Zhang RL, 2011, J CEREBR BLOOD F MET, V31, P614, DOI 10.1038/jcbfm.2010.134; Zhang ZG, 1999, BRAIN RES, V844, P55, DOI 10.1016/S0006-8993(99)01886-7; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zhang ZG, 1997, J CEREBR BLOOD F MET, V17, P1081, DOI 10.1097/00004647-199710000-00010; Zhang ZG, 2002, J CEREBR BLOOD F MET, V22, P379, DOI 10.1097/00004647-200204000-00002	35	62	64	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113972	10.1371/journal.pone.0113972	http://dx.doi.org/10.1371/journal.pone.0113972			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437857	Green Submitted, Green Published, gold			2022-12-26	WOS:000347114900104
J	Horchani, H; de Saint-Jean, M; Barelli, H; Antonny, B				Horchani, Habib; de Saint-Jean, Maud; Barelli, Helene; Antonny, Bruno			Interaction of the Spo20 Membrane-Sensor Motif with Phosphatidic Acid and Other Anionic Lipids, and Influence of the Membrane Environment	PLOS ONE			English	Article							AMPHIPATHIC HELICES; PLASMA-MEMBRANE; CURVATURE; PROTEIN; LOCALIZATION; METABOLISM; MECHANISMS; YEAST; SPECIFICITY; PACKING	The yeast protein Spo20 contains a regulatory amphipathic motif that has been suggested to recognize phosphatidic acid, a lipid involved in signal transduction, lipid metabolism and membrane fusion. We have investigated the interaction of the Spo20 amphipathic motif with lipid membranes using a bioprobe strategy that consists in appending this motif to the end of a long coiled-coil, which can be coupled to a GFP reporter for visualization in cells. The resulting construct is amenable to in vitro and in vivo experiments and allows unbiased comparison between amphipathic helices of different chemistry. In vitro, the Spo20 bioprobe responded to small variations in the amount of phosphatidic acid. However, this response was not specific. The membrane binding of the probe depended on the presence of phosphatidylethanolamine and also integrated the contribution of other anionic lipids, including phosphatidylserine and phosphatidyl-inositol-(4,5) bisphosphate. Inverting the sequence of the Spo20 motif neither affected the ability of the probe to interact with anionic liposomes nor did it modify its cellular localization, making a stereo-specific mode of phosphatidic acid recognition unlikely. Nevertheless, the lipid binding properties and the cellular localization of the Spo20 alpha-helix differed markedly from that of another amphipathic motif, Amphipathic Lipid Packing Sensor (ALPS), suggesting that even in the absence of stereo specific interactions, amphipathic helices can act as subcellular membrane targeting determinants in a cellular context.	[Barelli, Helene] Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, Valbonne, France; CNRS, F-06560 Valbonne, France	UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS)	Barelli, H (corresponding author), Univ Nice Sophia Antipolis, Inst Pharmacol Mol & Cellulaire, Valbonne, France.	barelli@ipmc.cnrs.fr; antonny@ipmc.cnrs.fr	Horchani, Habib/AAE-4743-2020; Antonny, Bruno/ABH-7434-2020	Antonny, Bruno/0000-0002-9166-8668; BARELLI, Helene/0000-0001-6376-863X	Agence Nationale de la Recherche [ANR-08-0060-01, LABEX SIGNALIFE ANR-11-LABX-0028-01]; European Research Council [ERC 268888]	Agence Nationale de la Recherche(French National Research Agency (ANR)); European Research Council(European Research Council (ERC)European Commission)	This work was supported by grants from the Agence Nationale de la Recherche (ANR-08-0060-01 and "Investments for the Future" LABEX SIGNALIFE ANR-11-LABX-0028-01) and by an advanced grant from the European Research Council (ERC 268888). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antonny B, 2011, ANNU REV BIOCHEM, V80, P101, DOI 10.1146/annurev-biochem-052809-155121; Behnia R, 2005, NATURE, V438, P597, DOI 10.1038/nature04397; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bigay J, 2012, DEV CELL, V23, P886, DOI 10.1016/j.devcel.2012.10.009; Bohdanowicz M, 2013, MOL BIOL CELL, V24, P1700, DOI 10.1091/mbc.E12-11-0789; Boumann HA, 2006, MOL BIOL CELL, V17, P1006, DOI 10.1091/mbc.E05-04-0344; Cardenas J, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-56; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Donaldson JG, 2009, BBA-MOL CELL BIOL L, V1791, P845, DOI 10.1016/j.bbalip.2009.05.011; Drin G, 2009, FEBS LETT; Drin G, 2008, SCIENCE, V320, P670, DOI 10.1126/science.1155821; Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Ferraz-Nogueira JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102526; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Hatzakis NS, 2009, NAT CHEM BIOL, V5, P835, DOI 10.1038/nchembio.213; Hristova K, 1999, J MOL BIOL, V290, P99, DOI 10.1006/jmbi.1999.2840; Janmey PA, 2006, TRENDS CELL BIOL, V16, P538, DOI 10.1016/j.tcb.2006.08.009; Johnson AE, 2005, TRAFFIC, V6, P1078, DOI 10.1111/j.1600-0854.2005.00340.x; Kassas N, 2012, METHOD CELL BIOL, V108, P445, DOI 10.1016/B978-0-12-386487-1.00020-1; Klose C, 2013, CURR OPIN CELL BIOL, V25, P406, DOI 10.1016/j.ceb.2013.03.005; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P17007, DOI 10.1021/bi0518794; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9; MCLAUGHLIN S, 1995, TRENDS BIOCHEM SCI, V20, P272, DOI 10.1016/S0968-0004(00)89042-8; Moravcevic K, 2012, STRUCTURE, V20, P15, DOI 10.1016/j.str.2011.11.012; Nakanishi H, 2004, MOL BIOL CELL, V15, P1802, DOI 10.1091/mbc.e03-11-0798; Neiman AM, 2000, GENETICS, V155, P1643; Neiman AM, 1998, J CELL BIOL, V140, P29, DOI 10.1083/jcb.140.1.29; Papayannopoulos V, 2005, MOL CELL, V17, P181, DOI 10.1016/j.molcel.2004.11.054; Pranke IM, 2011, J CELL BIOL, V194, P88, DOI 10.1083/jcb.201011118; Ren HM, 2010, MOL BIOL CELL, V21, P3171, DOI 10.1091/mbc.E10-01-0073; Schneiter R, 1999, J CELL BIOL, V146, P741, DOI 10.1083/jcb.146.4.741; SEGREST JP, 1990, PROTEINS, V8, P103, DOI 10.1002/prot.340080202; Sharpe HJ, 2010, CELL, V142, P158, DOI 10.1016/j.cell.2010.05.037; Shin JJH, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-85; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Young BP, 2010, SCIENCE, V329, P1085, DOI 10.1126/science.1191026; Zeniou-Meyer M, 2007, J BIOL CHEM, V282, P21746, DOI 10.1074/jbc.M702968200; Zhao C, 2007, NAT CELL BIOL, V9, P706, DOI 10.1038/ncb1594	42	37	37	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113484	10.1371/journal.pone.0113484	http://dx.doi.org/10.1371/journal.pone.0113484			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426975	Green Published, gold, Green Submitted			2022-12-26	WOS:000349145400056
J	Hori, Y; Takeda, S; Cho, H; Wegmann, S; Shoup, TM; Takahashi, K; Irimia, D; Elmaleh, DR; Hyman, BT; Hudry, E				Hori, Yukiko; Takeda, Shuko; Cho, Hansang; Wegmann, Susanne; Shoup, Timothy M.; Takahashi, Kazue; Irimia, Daniel; Elmaleh, David R.; Hyman, Bradley T.; Hudry, Eloise			A Food and Drug Administration-approved Asthma Therapeutic Agent Impacts Amyloid beta in the Brain in a Transgenic Model of Alzheimer Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; PRECURSOR PROTEIN; FIBRIL FORMATION; MUTANT PRESENILIN-1; SYNAPTIC PLASTICITY; SECRETED OLIGOMERS; FLAVONOID FISETIN; OXIDATIVE STRESS; CROMOLYN SODIUM; MOUSE MODEL	Interfering with the assembly of Amyloid beta (A beta) peptides from monomer to oligomeric species and fibrils or promoting their clearance from the brain are targets of anti-A beta-directed therapies in Alzheimer disease. Here we demonstrate that cromolyn sodium (disodium cromoglycate), a Food and Drug Administration-approved drug already in use for the treatment of asthma, efficiently inhibits the aggregation of A beta monomers into higher-order oligomers and fibrils in vitro without affecting A beta production. In vivo, the levels of soluble A beta are decreased by over 50% after only 1 week of daily intraperitoneally administered cromolyn sodium. Additional in vivo microdialysis studies also show that this compound decreases the half-life of soluble A beta in the brain. These data suggest a clear effect of a peripherally administered, Food and Drug Administration-approved medication on A beta economy, supporting further investigation of the potential long-term efficacy of cromolyn sodium in Alzheimer disease.	[Hori, Yukiko; Takeda, Shuko; Wegmann, Susanne; Hyman, Bradley T.; Hudry, Eloise] Massachusetts Gen Hosp, Alzheimers Dis Res Lab, Dept Neurol, MassGen Inst Neurodegenerat Dis, Boston, MA 02129 USA; [Cho, Hansang; Irimia, Daniel] Massachusetts Gen Hosp, BioMEMS Resource Ctr, Boston, MA 02129 USA; [Shoup, Timothy M.; Elmaleh, David R.] Harvard Univ, Med Sch Charlestown, Div Nucl Med & Mol Imaging, Dept Radiol, Boston, MA 02129 USA; [Takahashi, Kazue] Harvard Univ, Med Sch Charlestown, Serv Pediat, Boston, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Hudry, E (corresponding author), MA Gen Hosp, MassGen Inst Neurodegenerat Dis, Dept Neurol, Alzheimers Dis Res Lab, Bldg 114,16th St, Charlestown, MA 02129 USA.	ehudry@partners.org	Irimia, Daniel/A-4095-2008; Cho, Hansang/AAF-6294-2020; Irimia, Daniel/S-5404-2019	Irimia, Daniel/0000-0001-7347-2082; Irimia, Daniel/0000-0001-7347-2082; Cho, Hansang/0000-0003-1829-2462	AZ Therapies Inc.; Uehara Memorial Foundation; Japan Society for the Promotion of Science; Dreyfoos Fund Against Alzheimer's Disease; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS045776] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG005134] Funding Source: NIH RePORTER	AZ Therapies Inc.; Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Dreyfoos Fund Against Alzheimer's Disease; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by AZ Therapies Inc., by a postdoctoral fellowship from the Uehara Memorial Foundation (to Y. H.), by the Postdoctoral Fellowship for Research Abroad from the Japan Society for the Promotion of Science (to S. T.), and by the Dreyfoos Fund Against Alzheimer's Disease.	Abraham JN, 2014, BIOMACROMOLECULES, V15, P3253, DOI 10.1021/bm501004q; Akaishi T, 2008, NEUROSCI LETT, V444, P280, DOI 10.1016/j.neulet.2008.08.052; Anand P, 2013, ARCH PHARM RES, V36, P375, DOI 10.1007/s12272-013-0036-3; Borchelt DR, 1997, NEURON, V19, P939, DOI 10.1016/S0896-6273(00)80974-5; Cho HS, 2013, SCI REP-UK, V3, DOI 10.1038/srep01823; Cirrito JR, 2003, J NEUROSCI, V23, P8844; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; Cockcroft DW, 1999, J CLIN PHARMACOL, V39, P216; Cummings Jeffrey L, 2004, Rev Neurol Dis, V1, P60; Currais A, 2014, AGING CELL, V13, P379, DOI 10.1111/acel.12185; Di Fede G, 2009, SCIENCE, V323, P1473, DOI 10.1126/science.1168979; Doody RS, 2009, NEUROLOGY, V72, P1555, DOI 10.1212/01.wnl.0000344650.95823.03; Ertekin-Taner N, 2000, SCIENCE, V290, P2303, DOI 10.1126/science.290.5500.2303; Gotz J, 2004, INT J DEV NEUROSCI, V22, P453, DOI 10.1016/j.ijdevneu.2004.07.013; Gouras GK, 2010, ACTA NEUROPATHOL, V119, P523, DOI 10.1007/s00401-010-0679-9; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hashimoto T, 2002, EMBO J, V21, P1524, DOI 10.1093/emboj/21.7.1524; Hashimoto T, 2012, J NEUROSCI, V32, P15181, DOI 10.1523/JNEUROSCI.1542-12.2012; Hashimoto T, 2011, J BIOL CHEM, V286, P27081, DOI 10.1074/jbc.M111.257378; Hori Y, 2007, J BIOL CHEM, V282, P4916, DOI 10.1074/jbc.M608220200; Ishige K, 2001, FREE RADICAL BIO MED, V30, P433, DOI 10.1016/S0891-5849(00)00498-6; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Kim Darrick S H L, 2012, Recent Pat CNS Drug Discov, V7, P184; Kim H, 2005, J AGR FOOD CHEM, V53, P8537, DOI 10.1021/jf051985c; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Kurt MA, 2003, NEUROBIOL DIS, V14, P89, DOI 10.1016/S0969-9961(03)00084-6; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LEZA JC, 1995, EUR J PHARMACOL, V285, P95, DOI 10.1016/0014-2999(95)00474-Y; Maher P, 2006, P NATL ACAD SCI USA, V103, P16568, DOI 10.1073/pnas.0607822103; Mansson C, 2014, J BIOL CHEM, V289, P31066, DOI 10.1074/jbc.M114.595124; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Quitschke WW, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt170; Ratner PH, 2002, MAYO CLIN PROC, V77, P350, DOI 10.4065/77.4.350; Reddy PH, 2008, TRENDS MOL MED, V14, P45, DOI 10.1016/j.molmed.2007.12.002; SANMARTINCLARK O, 1995, PSYCHOPHARMACOLOGY, V118, P347, DOI 10.1007/BF02245965; Sciarretta KL, 2006, METHOD ENZYMOL, V413, P273, DOI 10.1016/S0076-6879(06)13015-3; Selkoe DJ, 2001, J ALZHEIMERS DIS, V3, P75, DOI 10.3233/JAD-2001-3111; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Spires TL, 2005, J NEUROSCI, V25, P7278, DOI 10.1523/JNEUROSCI.1879-05.2005; Storms W, 2005, J ASTHMA, V42, P79, DOI 10.1081/JAS-52017; Takeda S, 2011, NEUROSCIENCE, V186, P110, DOI 10.1016/j.neuroscience.2011.04.035; Takeda S, 2013, FASEB J, V27, P3239, DOI 10.1096/fj.13-229666; Tomiyama T, 2008, ANN NEUROL, V63, P377, DOI 10.1002/ana.21321; Tomiyama T, 2010, J NEUROSCI, V30, P4845, DOI 10.1523/JNEUROSCI.5825-09.2010; Townsend M, 2006, J PHYSIOL-LONDON, V572, P477, DOI 10.1113/jphysiol.2005.103754; Ushikubo H, 2012, NEUROSCI LETT, V513, P51, DOI 10.1016/j.neulet.2012.02.006; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wegmann S, 2013, P NATL ACAD SCI USA, V110, pE313, DOI 10.1073/pnas.1212100110; Wu HY, 2010, J NEUROSCI, V30, P2636, DOI 10.1523/JNEUROSCI.4456-09.2010	50	48	57	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					1966	1978		10.1074/jbc.M114.586602	http://dx.doi.org/10.1074/jbc.M114.586602			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25468905	Green Published, hybrid			2022-12-26	WOS:000348588000006
J	Uppal, S; Salhotra, S; Mukhi, N; Zaidi, FK; Seal, M; Dey, SG; Bhat, R; Kundu, S				Uppal, Sheetal; Salhotra, Shikha; Mukhi, Nitika; Zaidi, Fatima Kamal; Seal, Manas; Dey, Somdatta Ghosh; Bhat, Rajiv; Kundu, Suman			Significantly Enhanced Heme Retention Ability of Myoglobin Engineered to Mimic the Third Covalent Linkage by Nonaxial Histidine to Heme (Vinyl) in Synechocystis Hemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNECHOCOCCUS SP PCC-7002; LIGAND-BINDING; HEXACOORDINATE HEMOGLOBIN; BLOOD SUBSTITUTES; DISTAL HISTIDINE; POSTTRANSLATIONAL MODIFICATION; CYANOBACTERIAL HEMOGLOBINS; TRUNCATED HEMOGLOBIN; CRYSTAL-STRUCTURES; NITRIC-OXIDE	Heme proteins, which reversibly bind oxygen and display a particular fold originally identified in myoglobin (Mb), characterize the "(h)emoglobin (Hb) superfamily." The long known and widely investigated Hb superfamily, however, has been enriched by the discovery and investigation of new classes and members. Truncated Hbs typify such novel classes and exhibit a distinct two-on-two alpha-helical fold. The truncated Hb from the freshwater cyanobacterium Synechocystis exhibits hexacoordinate heme chemistry and bears an unusual covalent bond between the nonaxial His(117) and a heme porphyrin 2-vinyl atom, which remains tightly associated with the globin unlike any other. It seems to be the most stable Hb known to date, and His(117) is the dominant force holding the heme. Mutations of amino acid residues in the vicinity did not influence this covalent linkage. Introduction of a nonaxial His into sperm whaleMbat the topologically equivalent position and in close proximity to vinyl group significantly increased the heme stability of this prototype globin. Reversed phase chromatography, electrospray ionization-MS, and MALDI-TOF analyses confirmed the presence of covalent linkage in Mb I107H. The Mb mutant with the engineered covalent linkage was stable to denaturants and exhibited ligand binding and auto-oxidation rates similar to the wild type protein. This indeed is a novel finding and provides a new perspective to the evolution of Hbs. The successful attempt at engineering heme stability holds promise for the production of stable Hb-based blood substitute.	[Uppal, Sheetal; Salhotra, Shikha; Mukhi, Nitika; Kundu, Suman] Univ Delhi, Dept Biochem, New Delhi 110021, India; [Zaidi, Fatima Kamal; Bhat, Rajiv] Jawaharlal Nehru Univ, Sch Biotechnol, New Delhi 110067, India; [Seal, Manas; Dey, Somdatta Ghosh] Indian Assoc Cultivat Sci, Dept Inorgan Chem, Kolkata 700032, India	University of Delhi; Jawaharlal Nehru University, New Delhi; Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur	Kundu, S (corresponding author), Univ Delhi, Dept Biochem, South Campus, New Delhi 110021, India.	surnan.kundu@south.du.ac.in	Uppal, Sheetal/J-8665-2019	Uppal, Sheetal/0000-0002-3685-8602; MUKHI, NITIKA/0000-0001-5717-7948; Ghosh Dey, Somdatta/0000-0002-6142-2202	Indo-US Science and Technology Forum, University of Delhi (research and development grant) Department of Science and Technology (PURSE-Promotion of university research and scientific excellence), Government of India; CSIR, Government of India; UGC, Government of India	Indo-US Science and Technology Forum, University of Delhi (research and development grant) Department of Science and Technology (PURSE-Promotion of university research and scientific excellence), Government of India; CSIR, Government of India(Council of Scientific & Industrial Research (CSIR) - India); UGC, Government of India(University Grants Commission, India)	This work was supported by Indo-US Science and Technology Forum, University of Delhi (research and development grant) Department of Science and Technology (PURSE-Promotion of university research and scientific excellence), Government of India and in the form of research fellowship as a visiting scientist in the laboratory of Prof. Mark Hargrove of Iowa State University (to S. K.); by a research fellowship from CSIR, Government of India (to S. U.); by a research fellowship from UGC, Government of India (to N. M.).	Aicart-Ramos C, 2012, BIOCHEMISTRY-US, V51, P7403, DOI 10.1021/bi300848x; AKIYAMA K, 1994, BBA-PROTEIN STRUCT M, V1208, P306, DOI 10.1016/0167-4838(94)90117-1; Banerjee M, 2011, J BIOSCIENCES, V36, P809, DOI 10.1007/s12038-011-9163-5; Batey S, 2005, J MOL BIOL, V349, P1045, DOI 10.1016/j.jmb.2005.04.028; BRANTLEY RE, 1993, J BIOL CHEM, V268, P6995; Cavalier-Smith T, 2006, PHILOS T R SOC B, V361, P969, DOI 10.1098/rstb.2006.1842; Codutti L, 2009, FEBS J, V276, P5177, DOI 10.1111/j.1742-4658.2009.07214.x; Culbertson DS, 2010, BIOCHEMISTRY-US, V49, P6052, DOI 10.1021/bi1006942; Dou Y, 2002, BIOPHYS CHEM, V98, P127, DOI 10.1016/S0301-4622(02)00090-X; Draghi F, 2002, J BIOL CHEM, V277, P7509, DOI 10.1074/jbc.M109206200; Falcon LI, 2010, ISME J, V4, P777, DOI 10.1038/ismej.2010.2; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hardison R, 1999, AM SCI, V87, P126, DOI 10.1511/1999.20.809; Hargrove MS, 2000, BIOPHYS J, V79, P2733, DOI 10.1016/S0006-3495(00)76512-X; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11310, DOI 10.1021/bi9603736; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11300, DOI 10.1021/bi960372d; HARGROVE MS, 1994, BIOCHEMISTRY-US, V33, P11767, DOI 10.1021/bi00205a012; Hoy JA, 2004, J BIOL CHEM, V279, P16535, DOI 10.1074/jbc.M313707200; Hoy JA, 2007, J MOL BIOL, V371, P168, DOI 10.1016/j.jmb.2007.05.029; Hoy JA, 2007, PROTEIN SCI, V16, P250, DOI 10.1110/ps.062572607; Hvitved AN, 2001, J BIOL CHEM, V276, P34714, DOI 10.1074/jbc.M105175200; Kakar S, 2011, BIOCHEMISTRY-US, V50, P4273, DOI 10.1021/bi2002423; Kumar A., 2008, RED GOLDMINE PROMISE; Kundu S, 2003, PROTEINS, V50, P239, DOI 10.1002/prot.10277; Kundu S, 2002, PROTEINS, V46, P268, DOI 10.1002/prot.10048; Lecomte JTJ, 2001, BIOCHEMISTRY-US, V40, P6541, DOI 10.1021/bi010226u; LEMON DD, 1987, J APPL PHYSIOL, V62, P798, DOI 10.1152/jappl.1987.62.2.798; Liong EC, 2001, J BIOL CHEM, V276, P9093, DOI 10.1074/jbc.M008593200; Maiti R, 2004, NUCLEIC ACIDS RES, V32, pW590, DOI 10.1093/nar/gkh477; Metcalfe CL, 2004, J AM CHEM SOC, V126, P16242, DOI 10.1021/ja048242c; Nothnagel HJ, 2009, J INORG BIOCHEM, V103, P107, DOI 10.1016/j.jinorgbio.2008.09.009; Olson J S, 1981, Methods Enzymol, V76, P631; Olson JM, 2004, PHOTOSYNTH RES, V80, P373, DOI 10.1023/B:PRES.0000030457.06495.83; OLSON JS, 1988, NATURE, V336, P265, DOI 10.1038/336265a0; Olson JS, 1997, ARTIF CELL BLOOD SUB, V25, P227, DOI 10.3109/10731199709118912; PEISACH J, 1969, P NATL ACAD SCI USA, V63, P934, DOI 10.1073/pnas.63.3.934; Pesce A, 2000, EMBO J, V19, P2424, DOI 10.1093/emboj/19.11.2424; Pietra F, 2013, CHEM BIODIVERS, V10, P963, DOI 10.1002/cbdv.201300060; Preimesberger MR, 2013, BIOCHEMISTRY-US, V52, P3478, DOI 10.1021/bi400289e; Ptitsyn OB, 1999, J MOL BIOL, V291, P671, DOI 10.1006/jmbi.1999.2920; QUILLIN ML, 1995, J MOL BIOL, V245, P416, DOI 10.1006/jmbi.1994.0034; QUILLIN ML, 1993, J MOL BIOL, V234, P140, DOI 10.1006/jmbi.1993.1569; Roach MP, 2000, J INORG BIOCHEM, V81, P173, DOI 10.1016/S0162-0134(00)00101-X; Scott EE, 2000, J BIOL CHEM, V275, P27129; Scott MG, 1997, CLIN CHEM, V43, P1724; Scott NL, 2002, BIOCHEMISTRY-US, V41, P6902, DOI 10.1021/bi025609m; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Smagghe BJ, 2006, BIOCHEMISTRY-US, V45, P561, DOI 10.1021/bi051902l; SMERDON SJ, 1993, BIOCHEMISTRY-US, V32, P5132, DOI 10.1021/bi00070a023; Sturms R, 2011, BIOCHEMISTRY-US, V50, P10829, DOI 10.1021/bi201425f; Sturms R, 2011, BIOCHEMISTRY-US, V50, P3873, DOI 10.1021/bi2004312; Tang Q, 1998, BIOCHEMISTRY-US, V37, P7047, DOI 10.1021/bi9729413; TEALE FWJ, 1959, BIOCHIM BIOPHYS ACTA, V35, P543, DOI 10.1016/0006-3002(59)90407-X; Trent JT, 2004, J MOL BIOL, V341, P1097, DOI 10.1016/j.jmb.2004.05.070; Varnado CL, 2013, ANTIOXID REDOX SIGN, V18, P2314, DOI 10.1089/ars.2012.4917; Vinogradov SN, 2013, ADV MICROB PHYSIOL, V63, P391, DOI 10.1016/B978-0-12-407693-8.00009-1; Vinogradov SN, 2013, BBA-PROTEINS PROTEOM, V1834, P1789, DOI 10.1016/j.bbapap.2013.03.021; Vinogradov SN, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-31; Vu BC, 2004, J BIOL INORG CHEM, V9, P183, DOI 10.1007/s00775-003-0512-1; Vu BC, 2002, J AM CHEM SOC, V124, P8544, DOI 10.1021/ja026569c; Wittenberg JB, 2002, J BIOL CHEM, V277, P871, DOI 10.1074/jbc.R100058200	63	11	11	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					1979	1993		10.1074/jbc.M114.603225	http://dx.doi.org/10.1074/jbc.M114.603225			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25451928	hybrid, Green Published			2022-12-26	WOS:000348588000007
J	Brown, DM; Brameld, JM; Parr, T				Brown, David M.; Brameld, John M.; Parr, Tim			Expression of the Myosin Heavy Chain IIB Gene in Porcine Skeletal Muscle: The Role of the CArG-Box Promoter Response Element	PLOS ONE			English	Article							FIBER TYPES; ISOFORMS; LIMB; EXERCISE; BINDING; RABBIT; MOUSE; RAT	Due to its similarity to humans, the pig is increasingly being considered as a good animal model for studying a range of human diseases. Despite their physiological similarities, differential expression of the myosin heavy chain (MyHC) IIB gene (MYH4) exists in the skeletal muscles of these species, which is associated with a different muscle phenotype. The expression of different MyHC isoforms is a critical determinant of the contractile and metabolic characteristics of the muscle fibre. We aimed to elucidate whether a genomic mechanism was responsible for the drastically different expression of MYH4 between pigs and humans, thus improving our understanding of the pig as a model for human skeletal muscle research. We utilized approximately 1 kb of the MYH4 promoter from a domestic pig and a human (which do and do not express MYH4, respectively) to elucidate the role of the promoter sequence in regulating the high expression of MYH4 in porcine skeletal muscle. We identified a 3 bp genomic difference within the proximal CArG and E-box region of the MYH4 promoter of pigs and humans that dictates the differential activity of these promoters during myogenesis. Subtle species-specific genomic differences within the CArG-box region caused differential protein-DNA interactions at this site and is likely accountable for the differential MYH4 promoter activity between pigs and humans. We propose that the genomic differences identified herein explain the differential activity of the MYH4 promoter of pigs and humans, which may contribute to the differential expression patterns displayed in these otherwise physiologically similar mammals. Further, we report that both the pig and human MYH4 promoters can be induced by MyoD over-expression, but the capacity to activate the MYH4 promoter is largely influenced by the 3 bp difference located within the CArG-box region of the proximal MYH4 promoter.	[Brown, David M.; Brameld, John M.; Parr, Tim] Univ Nottingham, Div Nutr Sci, Sch Biosci, Nottingham NG7 2RD, Leics, England	University of Nottingham	Brown, DM (corresponding author), Univ Nottingham, Div Nutr Sci, Sch Biosci, Nottingham NG7 2RD, Leics, England.	D.M.Brown@Liverpool.ac.uk	Brameld, John/AAB-1745-2021	Brameld, John/0000-0003-4942-080X; Parr, Tim/0000-0003-2490-9457	Biotechnology and Biological Sciences Research Council; Zoetis; Biotechnology and Biological Sciences Research Council [976479, BB/J005320/1] Funding Source: researchfish; BBSRC [BB/J005320/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Zoetis; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council (http://www.bbsrc.ac.uk/home/home.aspx) to JB and TP and by Zoetis (formally Pfizer Animal Health) (http://www.zoetis.com/) to JB and TP. The funders had no role in study design, data collection and analysis, or preparation of the manuscript.	Allen DL, 2005, J BIOL CHEM, V280, P17126, DOI 10.1074/jbc.M501207200; Allen DL, 2001, J BIOL CHEM, V276, P43524, DOI 10.1074/jbc.M108017200; Arguello A, 2001, ANAT RECORD, V264, P284, DOI 10.1002/ar.1165; Brown DM, 2012, J MUSCLE RES CELL M, V32, P383, DOI 10.1007/s10974-011-9267-4; CATALA F, 1995, MOL CELL BIOL, V15, P4585; Chikuni K, 2004, MEAT SCI, V67, P87, DOI 10.1016/j.meatsci.2003.09.011; Ekmark M, 2007, J PHYSIOL-LONDON, V584, P637, DOI 10.1113/jphysiol.2007.141457; GORZA L, 1990, J HISTOCHEM CYTOCHEM, V38, P257, DOI 10.1177/38.2.2137154; Grifone R, 2004, MOL CELL BIOL, V24, P6253, DOI 10.1128/MCB.24.14.6253-6267.2004; Groisman R, 1996, J BIOL CHEM, V271, P5258; Gunawan AM, 2007, J ANIM SCI, V85, P2115, DOI 10.2527/jas.2006-540; Harrison BC, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-5; Hemmings KM, 2009, J ANIM SCI, V87, P3915, DOI 10.2527/jas.2009-2067; Lakich MM, 1998, J BIOL CHEM, V273, P15217, DOI 10.1074/jbc.273.24.15217; Lefaucheur L, 1998, J ANIM SCI, V76, P1584; Lefaucheur L, 2004, J ANIM SCI, V82, P1931; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Lucas CA, 2000, BIOCHEM BIOPH RES CO, V272, P303, DOI 10.1006/bbrc.2000.2768; Lunde IG, 2007, J PHYSIOL-LONDON, V582, P1277, DOI 10.1113/jphysiol.2007.133025; Luo YL, 2012, J INHERIT METAB DIS, V35, P695, DOI 10.1007/s10545-012-9475-0; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Narkar VA, 2011, CELL METAB, V13, P283, DOI 10.1016/j.cmet.2011.01.019; Pellegrino MA, 2003, J PHYSIOL-LONDON, V546, P677, DOI 10.1113/jphysiol.2002.027375; Rennie MJ, 2010, SCAND J MED SCI SPOR, V20, P5, DOI 10.1111/j.1600-0838.2009.00967.x; Rivero JLL, 1999, J MUSCLE RES CELL M, V20, P211, DOI 10.1023/A:1005461214800; Ruusunen M, 2004, MEAT SCI, V67, P533, DOI 10.1016/j.meatsci.2003.12.008; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; SMERDU V, 1994, AM J PHYSIOL-CELL PH, V267, pC1723, DOI 10.1152/ajpcell.1994.267.6.C1723; Spangenburg EE, 2003, ACTA PHYSIOL SCAND, V178, P413, DOI 10.1046/j.1365-201X.2003.01158.x; Swoap SJ, 1998, AM J PHYSIOL, V274, P681; TAKEDA S, 1995, J BIOL CHEM, V270, P15664, DOI 10.1074/jbc.270.26.15664; Talmadge RJ, 1996, J EXP ZOOL, V275, P413; Tonge DP, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-52; Toniolo L, 2007, AM J PHYSIOL-CELL PH, V292, pC1915, DOI 10.1152/ajpcell.00601.2006; WADA M, 1995, J MUSCLE RES CELL M, V16, P237, DOI 10.1007/BF00121132; Wheeler MT, 1999, AM J PHYSIOL, V276, P1069	38	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114365	10.1371/journal.pone.0114365	http://dx.doi.org/10.1371/journal.pone.0114365			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469802	Green Published, Green Submitted, gold			2022-12-26	WOS:000349128700105
J	Kindermann, C; Narayan, EJ; Hero, JM				Kindermann, Christina; Narayan, Edward J.; Hero, Jean-Marc			The Neuro-Hormonal Control of Rapid Dynamic Skin Colour Change in an Amphibian during Amplexus	PLOS ONE			English	Article							FROG; HORMONE; TOAD; MELANOPHORES; PIGMENTATION; STIMULATION; SPERMIATION; CAMOUFLAGE; STRESS; SEASON	Sexual signalling using dynamic skin colouration is a key feature in some vertebrates; however, it is rarely studied in amphibians. Consequently, little is known about the hormonal basis of this interesting biological phenomenon for many species. Male stony creek frogs (Litoria wilcoxii) are known to change dorsal colouration from brown to lemon yellow within minutes. This striking change is faster then what has been seen most amphibians, and could therefore be under neuronal regulation, a factor that is rarely observed in amphibians. In this study, we observed colour changes in wild frogs during amplexus to determine the natural timing of colour change. We also investigated the hypothesis that colour change is mediated by either reproductive or neuro-hormones. This was achieved by injecting frogs with epinephrine, testosterone, saline solution (control 1) or sesame oil (control 2). A non-invasive approach was also used wherein hormones and controls were administered topically. Male frogs turned a vivid yellow within 5 minutes of initiation of amplexus and remained so for 3-5 hours before rapidly fading back to brown. Epinephrine-treated frogs showed a significant colour change from brown to yellow within 5 minutes, however, testosterone-treated frogs did not change colour. Our results provide evidence of the role neuronal regulation plays in colour change systems.	[Kindermann, Christina; Narayan, Edward J.; Hero, Jean-Marc] Griffith Univ, Sch Environm, Environm Futures Res Inst, Southport, Qld 4215, Australia	Griffith University	Kindermann, C (corresponding author), Griffith Univ, Sch Environm, Environm Futures Res Inst, Gold Coast Campus, Southport, Qld 4215, Australia.	christina.kindermann@griffithuni.edu.au	Narayan, Edward/E-8238-2016	Narayan, Edward/0000-0003-2719-0900	School of Environment at Griffith University	School of Environment at Griffith University	Funding: This study is part of CK PhD research funded by the School of Environment at Griffith University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AdobeSystems, 2010, AD PHOT EXT; Aspengren S, 2009, CELL MOL LIFE SCI, V66, P187, DOI 10.1007/s00018-008-8541-0; Baayen RH, 2009, LANGUAGER DATA SETS; BAGNARA JT, 1968, J CELL BIOL, V38, P67, DOI 10.1083/jcb.38.1.67; BAGNARA JT, 1964, GEN COMP ENDOCR, V4, P290, DOI 10.1016/0016-6480(64)90024-3; BAGNARA JT, 1969, GEN COMP ENDOCR, P425, DOI 10.1016/0016-6480(69)90052-5; BAKER BI, 1993, ANN NY ACAD SCI, V680, P279, DOI 10.1111/j.1749-6632.1993.tb19690.x; Chan R, 2009, BEHAV ECOL, V20, P1334, DOI 10.1093/beheco/arp136; Volonteri MC, 2010, GEN COMP ENDOCR, V169, P197, DOI 10.1016/j.ygcen.2010.08.011; de Velasco JB, 2008, J COMP PHYSIOL B, V178, P867, DOI 10.1007/s00360-008-0274-8; Doucet SM, 2010, BIOL LETTERS, V6, P63, DOI 10.1098/rsbl.2009.0604; GILTZ M. L., 1955, OHIO JOUR SCI, V55, P47; Greenberg B, 1942, J EXP ZOOL, V91, P435, DOI 10.1002/jez.1400910308; Hayes TB, 1999, GEN COMP ENDOCR, V115, P188, DOI 10.1006/gcen.1999.7321; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kindermann C, 2013, COMP BIOCHEM PHYS A, V165, P223, DOI 10.1016/j.cbpa.2013.03.011; Kouba AJ, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-59; LONGSHORE MA, 1981, AM J PHYSIOL, V241, pE84, DOI 10.1152/ajpendo.1981.241.1.E84; NIELSEN HI, 1978, GEN COMP ENDOCR, V36, P543, DOI 10.1016/0016-6480(78)90094-1; Nordlund J. J., 1998, PIGMENTARY SYSTEM; Novales RR, 1969, CELLULAR ASPECTS CON; Ohta K, 2008, MAR BIOL, V153, P843, DOI 10.1007/s00227-007-0856-0; OSHIMA N, 1986, GEN COMP ENDOCR, V64, P381, DOI 10.1016/0016-6480(86)90072-9; PHILLIPS H. J., 1957, PHYSIOL ZOOL, V30, P155; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Revelle W, 2011, PROCEDURES PSYCHOL P; Ries C, 2008, J ZOOL, V276, P229, DOI 10.1111/j.1469-7998.2008.00456.x; ROBBINS SL, 1949, ENDOCRINOLOGY, V44, P384, DOI 10.1210/endo-44-4-384; Salim S, 2011, CELL MOL BIOL LETT, V16, P162, DOI 10.2478/s11658-010-0044-y; Skold HN, 2012, PIGMENT CELL MELANOM; Stegen JC, 2004, CAN J ZOOL, V82, P889, DOI 10.1139/Z04-068; Stuart-Fox D, 2008, PLOS BIOL, V6, P22, DOI 10.1371/journal.pbio.0060025; Stuart-Fox D, 2006, BIOL J LINN SOC, V88, P437, DOI 10.1111/j.1095-8312.2006.00631.x; Stuart-Fox D, 2009, PHILOS T R SOC B, V364, P463, DOI 10.1098/rstb.2008.0254; Sztatecsny M, 2012, BEHAV ECOL SOCIOBIOL, V66, P1587, DOI 10.1007/s00265-012-1412-6; Tang ZJ, 2014, PHYSIOL BIOCHEM ZOOL, V87, P397, DOI 10.1086/675678; Tattersall GJ, 2006, J EXP BIOL, V209, P1185, DOI 10.1242/jeb.02038; Van Gossum H, 2011, EVOL ECOL, V25, P139, DOI 10.1007/s10682-010-9388-z; Vasquez T, 2007, BEHAV ECOL SOCIOBIOL, V62, P127, DOI 10.1007/s00265-007-0446-7; Wells DK., 2007, ECOLOGY BEHAV AMPHIB; WILSON JX, 1995, GEN COMP ENDOCR, V98, P303, DOI 10.1006/gcen.1995.1072; Woolley SC, 2001, HORM BEHAV, V40, P483, DOI 10.1006/hbeh.2001.1713; Xu MZ, 2011, BEHAV ECOL SOCIOBIOL, V65, P1215, DOI 10.1007/s00265-010-1134-6	44	20	21	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114120	10.1371/journal.pone.0114120	http://dx.doi.org/10.1371/journal.pone.0114120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470775	Green Submitted, gold, Green Published			2022-12-26	WOS:000349128700072
J	Martinez-Sanchez, JM; Ballbe, M; Fu, M; Martin-Sanchez, JC; Gottlieb, M; Salto, E; Vardavas, CI; Daynard, R; Connolly, GN; Fernandez, E				Martinez-Sanchez, Jose M.; Ballbe, Montse; Fu, Marcela; Martin-Sanchez, Juan C.; Gottlieb, Mark; Salto, Esteve; Vardavas, Constantine I.; Daynard, Richard; Connolly, Gregory N.; Fernandez, Esteve			Attitudes towards Electronic Cigarettes Regulation in Indoor Workplaces and Selected Public and Private Places: A Population-Based Cross-Sectional Study	PLOS ONE			English	Article							SMOKE-FREE LEGISLATION; BAR WORKERS; IMPLEMENTATION; EXPOSURE; POLICIES; ADULTS	Background: Currently, there is an intensive debate about the regulation of the use of electronic cigarettes (e-cigarettes) in indoor places. The aim of this study was to assess the attitudes toward e-cigarette use in indoor workplaces and selected public and private venues among the general population in Barcelona (Spain) in 2013-2014. Methods: This is a cross-sectional study of a representative sample of the population of Barcelona (n=736). The field work was conducted between May 2013 and February 2014. We computed the prevalence and the adjusted odds ratios (OR) derived from multivariable logistic regression models. Results: The awareness of e-cigarettes was 82.3%. Forty five percent of respondents did not agree with the use of e-cigarettes in public places and 52.3% in workplaces. The proportion of disapproval of the use of e-cigarettes in indoor places was higher at 71.5% for schools and 65.8% for hospitals and health care centers; while the prevalence of disapproval of e-cigarette use in homes and cars was lower (18.0% and 32.5%, respectively). Respondents who disagreed on the use of e-cigarettes in indoor workplaces were more likely to be older (OR=1.64 and 1.97 for groups 45-64 and >= 65 years old, respectively), those with a high educational level (OR=1.60), and never and former smokers (OR=2.34 and 2.16, respectively). Increased scores in the Fagerstrom test for cigarette dependence were also related to increased support for their use. Conclusions: Based on this population based study, half of the general population of Barcelona does not support the use of e-cigarettes in indoor workplaces and public places, with the percentage reaching 65% for use in schools, hospitals and health care centers. Consequently, there is good societal support in Spain for the politicians and legislators to promote policies restricting e-cigarettes use in workplaces and public places, including hospitality venues.	[Martinez-Sanchez, Jose M.; Ballbe, Montse; Fu, Marcela; Fernandez, Esteve] Inst Catala Oncol, Canc Prevent & Control Program, Tobacco Control Unit, Barcelona, Spain; [Martinez-Sanchez, Jose M.; Ballbe, Montse; Fu, Marcela; Fernandez, Esteve] Inst Invest Biomed Bellvitge IDIBELL, Canc Prevent & Control Grp, Barcelona, Spain; [Martinez-Sanchez, Jose M.; Martin-Sanchez, Juan C.] Univ Int Catalunya, Dept Basic Sci, Biostat Unit, Sant Cugat Del Valles, Spain; [Martinez-Sanchez, Jose M.; Gottlieb, Mark; Daynard, Richard] Northeastern Univ, Sch Law, Publ Hlth Advocacy Inst, Boston, MA 02115 USA; [Ballbe, Montse; Fu, Marcela; Fernandez, Esteve] Univ Barcelona, Dept Clin Sci, Barcelona, Spain; [Ballbe, Montse] Hosp Clin Barcelona, IDIBAPS, Inst Neurosci, Addict Unit, Barcelona, Spain; [Salto, Esteve] Minist Hlth, Hlth Plan Directorate, Generalitat De Catalunya, Spain; [Salto, Esteve] Univ Barcelona, Dept Publ Hlth, Barcelona, Spain; [Vardavas, Constantine I.; Connolly, Gregory N.] Harvard Univ, Sch Publ Hlth, Ctr Global Tobacco Control, Dept Social & Behav Sci, Boston, MA 02115 USA	Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Universitat Internacional de Catalunya (UIC); Northeastern University; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Harvard University; Harvard T.H. Chan School of Public Health	Martinez-Sanchez, JM (corresponding author), Inst Catala Oncol, Canc Prevent & Control Program, Tobacco Control Unit, Barcelona, Spain.	jmmartinez@iconcologia.net	Vardavas, Constantine/O-4961-2016; Fernandez, Esteve/A-9750-2008; Gottlieb, Mark A./ABI-1826-2020; Martínez-Sánchez, Jose M/ABH-3093-2020; Martín, JuanCarlos/AAB-5440-2019; Vardavas, Constantine I/G-7598-2011; Sanchez, Juan Carlos Martin/G-5650-2019; Martínez-Sánchez, Jose/AAA-6343-2019	Vardavas, Constantine/0000-0003-0171-9570; Fernandez, Esteve/0000-0003-4239-723X; Gottlieb, Mark A./0000-0001-8679-307X; Martínez-Sánchez, Jose M/0000-0002-9632-5701; Martín, JuanCarlos/0000-0002-1045-4802; Sanchez, Juan Carlos Martin/0000-0002-1045-4802; Fu, Marcela/0000-0002-4962-0927; Ballbe, Montse/0000-0002-0747-0924; Salto, Esteve/0000-0002-6739-8936	Instituto de Salud Carlos III, Government of Spain [RTICC RD06/0020/0089, RD12/0036/0053, BAE 14/00014, PI12/01114]; Ministry of Universities and Research, Government of Catalonia [2014SGR999]	Instituto de Salud Carlos III, Government of Spain(Instituto de Salud Carlos III); Ministry of Universities and Research, Government of Catalonia	This project was funded by Instituto de Salud Carlos III, Government of Spain (RTICC RD06/0020/0089, RD12/0036/0053, BAE 14/00014, and PI12/01114), and Ministry of Universities and Research, Government of Catalonia (grant 2014SGR999). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballbe M, 2014, ENVIRON RES, V135, P76, DOI 10.1016/j.envres.2014.09.005; Been JV, 2014, LANCET IN PRESS; Chapman S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3840; Corey C, 2013, MMWR-MORBID MORTAL W, V62, P729; Dearlove JV, 2002, TOB CONTROL, V11, P94, DOI 10.1136/tc.11.2.94; Dockrell M, 2013, NICOTINE TOB RES, V15, P1737, DOI 10.1093/ntr/ntt057; Douptcheva N, 2013, J EPIDEMIOL COMMUN H, V67, P1075, DOI 10.1136/jech-2013-203152; Dutra LM, 2014, JAMA PEDIAT IN PRESS; Etter JF, 2011, ADDICTION, V106, P2017, DOI 10.1111/j.1360-0443.2011.03505.x; European Commision, SURV TOB AN REP FLAS; FAGERSTROM K O, 1990, Ear Nose and Throat Journal, V69, P763; Fagerstrom K, 2012, NICOTINE TOB RES, V14, P75, DOI 10.1093/ntr/ntr137; Farsalinos KE, 2014, INT J ENV RES PUB HE, V11, P4356, DOI 10.3390/ijerph110404356; Fichtenberg CM, 2002, BMJ-BRIT MED J, V325, P188, DOI 10.1136/bmj.325.7357.188; Fong GT, 2006, TOB CONTROL, V15, P51, DOI 10.1136/tc.2005.013649; Fu M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-320; Gallus S, 2012, TOB CONTROL, V21, P59, DOI 10.1136/tc.2010.040774; Goniewicz ML, 2012, PEDIATRICS, V130, pE879, DOI 10.1542/peds.2011-3448; Grana RA, 2014, AM J PREV MED, V46, P395, DOI 10.1016/j.amepre.2013.12.010; Grupo de Trabajo sobre Tabaquismo de la Sociedad Espanola de Epidemiologia, 2009, EV IMP LEY MED SAN F; Hilton S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-206; IARC Working Group, 2009, IARC HDB CANC PREV T, P13; King BA, 2013, NICOTINE TOB RES, V15, P1623, DOI 10.1093/ntr/ntt013; Klein EG, 2007, NICOTINE TOB RES, V9, pS49, DOI 10.1080/14622200601083467; Lee YO, 2015, TOB CONTROL, V24, P410, DOI 10.1136/tobaccocontrol-2013-051437; Martinez-Sanchez JM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005894; Martinez-Sanchez JM, 2014, TOB CONTROL, V23, P204, DOI 10.1136/tobaccocontrol-2012-050877; Martinez-Sanchez JM, 2014, TOB CONTROL, V23, P238, DOI 10.1136/tobaccocontrol-2012-050700; Martinez-Sanchez JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013881; Martinez-Sanchez JM, 2010, GAC SANIT, V24, P241, DOI 10.1016/j.gaceta.2010.02.007; Martinez-Sanchez JM, 2009, PREV MED, V48, P218, DOI 10.1016/j.ypmed.2008.12.020; Oberg M, 2011, LANCET, V377, P139, DOI 10.1016/S0140-6736(10)61388-8; Pursell L, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-131; Scollo M, 2003, TOB CONTROL, V12, P13, DOI 10.1136/tc.12.1.13; Tan CE, 2012, CIRCULATION, V126, P2177, DOI 10.1161/CIRCULATIONAHA.112.121301; Thomson G, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-64; Torjesen I, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3859; Vardavas CI, 2014, TOB CONTROL IN PRESS; World Health Organization, WHO FRAM CONV TOB CO; World Health Organization, 2016, C PART WHO FRAM CONV; World Health Organization, 2009, TOB IND INT TOB CONT	41	20	20	2	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114256	10.1371/journal.pone.0114256	http://dx.doi.org/10.1371/journal.pone.0114256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7WS	25469996	Green Submitted, Green Published, gold			2022-12-26	WOS:000349128700093
J	Menezes, C; Ruiz-Jarabo, I; Martos-Sitcha, JA; Leitemperger, J; Baldisserotto, B; Mancera, JM; Rosemberg, DB; Loro, VL				Menezes, Charlene; Ruiz-Jarabo, Ignacio; Antonio Martos-Sitcha, Juan; Leitemperger, Jossiele; Baldisserotto, Bernardo; Miguel Mancera, Juan; Rosemberg, Denis Broock; Loro, Vania Lucia			Diet with Diphenyl Diselenide Mitigates Quinclorac Toxicity in Silver Catfish (Rhamdia quelen)	PLOS ONE			English	Article							OXIDATIVE STRESS; CYPRINUS-CARPIO; SELENIUM; HERBICIDE; ACID; OSMOREGULATION; GROWTH; ACETYLCHOLINESTERASE; PERFORMANCE; FORMULATION	In this study, the protective effects of diphenyl diselenide [(PhSe)(2)] on quincloracinduced toxicity were investigated in silver catfish (Rhamdia quelen). The fish were fed for 60 days with a diet in the absence or in the presence of 3.0 mg/Kg (PhSe)(2). Animals were further exposed to 1 mg/L quinclorac for 8 days. At the end of experimental period, fish were euthanized and biopsies from liver and gills, as well as blood samples, were collected. The cortisol and metabolic parameters were determined in plasma, and those enzyme activities related to osmoregulation were assayed in the gills. In liver, some important enzyme activities of the intermediary metabolism and oxidative stress-related parameters, such as thiobarbituric acid-reactive substance (TBARS), protein carbonyl, catalase (CAT), superoxide dismutase (SOD), glutathione S-transferase (GST), nonprotein thiols (NPSH) and ascorbic acid contents were also evaluated. Compared to the control group, quinclorac exposure significantly decreased hepatosomatic index and increased cortisol and lactate values in plasma. Moreover, the activities of fructose biphosphatase (FBPase), glucose-6-phosphate dehydrogenase (G6Pase), glycogen phosphorilase (GPase) and aspartate aminotransferase (AST) were significantly increased in liver. Quinclorac also induced lipid peroxidation while the activity of SOD, NPSH and ascorbic acid levels decreased in the liver. However, dietary (PhSe) 2 reduced the herbicide-induced effects on the studied parameters. In conclusion, (PhSe) 2 has beneficial properties based on its ability to attenuate toxicity induced by quinclorac by regulating energy metabolism and oxidative stress-related parameters.	[Menezes, Charlene; Leitemperger, Jossiele; Rosemberg, Denis Broock; Loro, Vania Lucia] Univ Fed Santa Maria, Dept Biochem & Mol Biol, BR-97119900 Santa Maria, RS, Brazil; [Ruiz-Jarabo, Ignacio; Antonio Martos-Sitcha, Juan; Miguel Mancera, Juan] Univ Cadiz Puerto Real, Dept Biol, Fac Ciencias Mar & Ambientales, Cadiz, Spain; [Antonio Martos-Sitcha, Juan] Consejo Super Invest Cient ICMA CSIC, Inst Ciencias Marinas Andalucia, Cadiz, Spain; [Baldisserotto, Bernardo] Univ Fed Santa Maria, Dept Fisiol & Farmacol, BR-97119900 Santa Maria, RS, Brazil	Universidade Federal de Santa Maria (UFSM); Universidad de Cadiz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Quimica y Materiales de Aragon (CEQMA); CSIC - Instituto de Ciencia de Materiales de Aragon (ICMA); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN); Universidade Federal de Santa Maria (UFSM)	Menezes, C (corresponding author), Univ Fed Santa Maria, Dept Biochem & Mol Biol, BR-97119900 Santa Maria, RS, Brazil.	charlenemenezes@yahoo.com.br	Rosemberg, Denis B/E-5971-2016; Ruiz-Jarabo, I./AAA-6194-2020; Martos-Sitcha, Juan Antonio/L-6140-2014; Loro, Vania/E-9387-2015	Martos-Sitcha, Juan Antonio/0000-0002-0151-7250; Loro, Vania/0000-0003-2440-8791; Ruiz-Jarabo, Ignacio/0000-0002-3918-0921; Rosemberg, Denis/0000-0003-2538-8761; Wesz Leitemperger, Jossiele/0000-0002-9205-4211	CAPES (Ministry of Education of Brazil, Brazil) through the program PNPD-CAPES (Programa Nacional de PA3s-Doutorado); CNPq; Ministry of Science and Innovation, Spain [AGL2010-14876]	CAPES (Ministry of Education of Brazil, Brazil) through the program PNPD-CAPES (Programa Nacional de PA3s-Doutorado); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Science and Innovation, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This study was supported by CAPES (Ministry of Education of Brazil, Brazil) through the program PNPD-CAPES (Programa Nacional de PA3s-Doutorado) to the student CM; CNPq research fellowship to VLL and BB; and by the project AGL2010-14876 (Ministry of Science and Innovation, Spain) to JMM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbosa NBV, 2006, CHEM-BIOL INTERACT, V163, P230, DOI 10.1016/j.cbi.2006.08.004; Barcelo D, 2002, TRACE DETERMINATION, P1; BOWMAN EJ, 1988, P NATL ACAD SCI USA, V85, P7972, DOI 10.1073/pnas.85.21.7972; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Buege J A, 1978, Methods Enzymol, V52, P302; David M, 2004, CHEMOSPHERE, V56, P347, DOI 10.1016/j.chemosphere.2004.02.024; de Menezes CC, 2012, ECOTOX ENVIRON SAFE, V81, P91, DOI 10.1016/j.ecoenv.2012.04.022; de Menezes CC, 2011, PESTIC BIOCHEM PHYS, V100, P145, DOI 10.1016/j.pestbp.2011.03.002; Elia AC, 2011, ECOTOX ENVIRON SAFE, V74, P166, DOI 10.1016/j.ecoenv.2010.04.006; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Evans DH, 2005, PHYSIOL REV, V85, P97, DOI 10.1152/physrev.00050.2003; Glusczak L, 2007, COMP BIOCHEM PHYS C, V146, P519, DOI 10.1016/j.cbpc.2007.06.004; HABIG WH, 1974, J BIOL CHEM, V249, P7130; Hamilton SJ, 2004, SCI TOTAL ENVIRON, V326, P1, DOI 10.1016/j.scitotenv.2004.01.019; Kim KW, 2003, AQUAC RES, V34, P1053, DOI 10.1046/j.1365-2109.2003.00908.x; Laiz-Carrion R, 2003, J EXP ZOOL PART A, V298A, P105, DOI 10.1002/jez.a.10256; LORENTZEN M, 1994, AQUACULTURE, V121, P359, DOI 10.1016/0044-8486(94)90270-4; Luchese C, 2010, J PHARM PHARMACOL, V62, P1146, DOI 10.1111/j.2042-7158.2010.01147.x; Mancera JM, 2000, J EXP ZOOL, V287, P263, DOI 10.1002/1097-010X(20000901)287:4&lt;263::AID-JEZ1&gt;3.0.CO;2-I; Martos-Sitcha JA, 2014, COMP BIOCHEM PHYS A, V177, P49, DOI 10.1016/j.cbpa.2014.07.021; McCormick SD, 2001, AM ZOOL, V41, P781, DOI 10.1668/0003-1569(2001)041[0781:ECOOIT]2.0.CO;2; Menezes C, 2013, ENVIRON TOXICOL PHAR, V36, P706, DOI 10.1016/j.etap.2013.07.002; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Modesto KA, 2010, CHEMOSPHERE, V78, P294, DOI 10.1016/j.chemosphere.2009.10.047; Mommsen TP, 1999, REV FISH BIOL FISHER, V9, P211, DOI 10.1023/A:1008924418720; Monteiro D. A., 2007, Revista Brasileira de Saude e Producao Animal, V8, P32; Monteiro DA, 2009, COMP BIOCHEM PHYS C, V149, P40, DOI 10.1016/j.cbpc.2008.06.012; Moon Thomas W., 1995, Biochemistry and Molecular Biology of Fishes, V4, P65; MOORE S, 1968, J BIOL CHEM, V243, P6281; NELSON DP, 1972, ANAL BIOCHEM, V49, P474, DOI 10.1016/0003-2697(72)90451-4; Nogueira CW, 2011, ARCH TOXICOL, V85, P1313, DOI 10.1007/s00204-011-0720-3; Nogueira CW, 2010, J BRAZIL CHEM SOC, V21, P2055, DOI 10.1590/S0103-50532010001100006; Paulmier C, 1986, SELENIUM REAGENTS IN, P84; Polakof S, 2006, J COMP PHYSIOL B, V176, P441, DOI 10.1007/s00360-006-0065-z; Pretto A, 2011, ECOTOX ENVIRON SAFE, V74, P336, DOI 10.1016/j.ecoenv.2010.10.003; Roe JH, 1954, METHOD BIOCHEM ANAL, P115; Salbego J, 2010, ARCH ENVIRON CON TOX, V58, P740, DOI 10.1007/s00244-009-9464-y; Sunohara Y, 2011, ENVIRON EXP BOT, V74, P74, DOI 10.1016/j.envexpbot.2011.05.001; YAN LJ, 1995, ANAL BIOCHEM, V228, P349, DOI 10.1006/abio.1995.1362; Zanella R, 2003, J SEP SCI, V26, P935, DOI 10.1002/jssc.200301309	40	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114233	10.1371/journal.pone.0114233	http://dx.doi.org/10.1371/journal.pone.0114233			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469630	Green Published, gold, Green Submitted			2022-12-26	WOS:000349128700089
J	Santala, S; Karp, M; Santala, V				Santala, Suvi; Karp, Matti; Santala, Ville			Rationally Engineered Synthetic Coculture for Improved Biomass and Product Formation	PLOS ONE			English	Article							ACINETOBACTER-BAYLYI ADP1; ESCHERICHIA-COLI; ACETATE; BIOLOGY; GROWTH; EXPRESSION; BATCH	In microbial ecosystems, bacteria are dependent on dynamic interspecific interactions related to carbon and energy flow. Substrates and end-metabolites are rapidly converted to other compounds, which protects the community from high concentrations of inhibitory molecules. In biotechnological applications, pure cultures are preferred because of the more straight-forward metabolic engineering and bioprocess control. However, the accumulation of unwanted side products can limit the cell growth and process efficiency. In this study, a rationally engineered coculture with a carbon channeling system was constructed using two well-characterized model strains Escherichia coli K12 and Acinetobacter baylyi ADP1. The directed carbon flow resulted in efficient acetate removal, and the coculture showed symbiotic nature in terms of substrate utilization and growth. Recombinant protein production was used as a proof-of-principle example to demonstrate the coculture utility and the effects on product formation. As a result, the biomass and recombinant protein titers of E. coli were enhanced in both minimal and rich medium simple batch cocultures. Finally, harnessing both the strains to the production resulted in enhanced recombinant protein titers. The study demonstrates the potential of rationally engineered cocultures for synthetic biology applications.	[Santala, Suvi; Karp, Matti; Santala, Ville] Tampere Univ Technol, Dept Chem & Bioengn, FIN-33101 Tampere, Finland	Tampere University	Santala, S (corresponding author), Tampere Univ Technol, Dept Chem & Bioengn, FIN-33101 Tampere, Finland.	suvi.santala@tut.fi	Karp, Matti/G-4227-2014	Karp, Matti/0000-0001-6686-4416; Santala, Suvi Maarit/0000-0002-0047-5319; Santala, Ville/0000-0002-9084-931X	Academy of Finland [272602]; Suomen Kulttuurirahasto	Academy of Finland(Academy of Finland); Suomen Kulttuurirahasto	Funding: The project was funded by Academy of Finland (project ProChassis 272602, URL: http://www.aka.fi/fi/A/), and by Suomen Kulttuurirahasto (URL: http://www.skr.fi/) to MK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham BG, 2011, BIOCONJUGATE CHEM, V22, P227, DOI 10.1021/bc100372u; Bayer TS, 2009, J AM CHEM SOC, V131, P6508, DOI 10.1021/ja809461u; Bernstein HC, 2012, J BIOTECHNOL, V157, P159, DOI 10.1016/j.jbiotec.2011.10.001; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Bryksin AV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013244; de Berardinis V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.10; De Mey M, 2007, J IND MICROBIOL BIOT, V34, P689, DOI 10.1007/s10295-007-0244-2; Durot M, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-85; Eiteman Mark A, 2008, J Biol Eng, V2, P3, DOI 10.1186/1754-1611-2-3; Eiteman MA, 2006, TRENDS BIOTECHNOL, V24, P530, DOI 10.1016/j.tibtech.2006.09.001; Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155; FRACKMAN S, 1990, J BACTERIOL, V172, P5767, DOI 10.1128/jb.172.10.5767-5773.1990; Goers L, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0065; Hanly TJ, 2011, BIOTECHNOL BIOENG, V108, P376, DOI 10.1002/bit.22954; Hom EFY, 2014, SCIENCE, V345, P94, DOI 10.1126/science.1253320; Keasling JD, 2008, ACS CHEM BIOL, V3, P64, DOI 10.1021/cb7002434; Lee SK, 2008, CURR OPIN BIOTECH, V19, P556, DOI 10.1016/j.copbio.2008.10.014; Li L, 2013, BIORESOURCE TECHNOL, V143, P397, DOI 10.1016/j.biortech.2013.06.023; LULI GW, 1990, APPL ENVIRON MICROB, V56, P1004, DOI 10.1128/AEM.56.4.1004-1011.1990; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Murin CD, 2012, APPL ENVIRON MICROB, V78, P280, DOI 10.1128/AEM.05597-11; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; Rabinovitch-Deere CA, 2013, CHEM REV; Regot S, 2011, NATURE, V469, P207, DOI 10.1038/nature09679; Santala S, 2012, ACS SYNTHETIC BIOL, V1; Santala S, 2014, ACS SYNTH BIOL, V3, P145, DOI 10.1021/sb4000788; Santala S, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-75; Santala S, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-36; Santala V, 2004, J IMMUNOL METHODS, V284, P165, DOI 10.1016/j.jim.2003.10.008; Seppala JJ, 2011, INT J HYDROGEN ENERG, V36, P10701, DOI 10.1016/j.ijhydene.2011.05.189; Shiloach J, 2005, BIOTECHNOL ADV, V23, P345, DOI 10.1016/j.biotechadv.2005.04.004; Swartz JR, 2001, CURR OPIN BIOTECH, V12, P195, DOI 10.1016/S0958-1669(00)00199-3; Tsai SL, 2010, APPL ENVIRON MICROB, V76, P7514, DOI 10.1128/AEM.01777-10; Vemuri GN, 2006, APPL ENVIRON MICROB, V72, P3653, DOI 10.1128/AEM.72.5.3653-3661.2006; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Young DM, 2005, ANNU REV MICROBIOL, V59, P519, DOI 10.1146/annurev.micro.59.051905.105823	36	23	24	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113786	10.1371/journal.pone.0113786	http://dx.doi.org/10.1371/journal.pone.0113786			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470793	Green Published, Green Submitted, gold			2022-12-26	WOS:000349128700045
J	Wathen, S; Thorne, JH; Holguin, A; Schwartz, MW				Wathen, Steve; Thorne, James H.; Holguin, Andrew; Schwartz, Mark W.			Estimating the Spatial and Temporal Distribution of Species Richness within Sequoia and Kings Canyon National Parks	PLOS ONE			English	Article							CLIMATE-CHANGE; SIERRA-NEVADA; ALTITUDINAL GRADIENT; DIVERSITY; CALIFORNIA; PATTERNS; BIODIVERSITY	Evidence for significant losses of species richness or biodiversity, even within protected natural areas, is mounting. Managers are increasingly being asked to monitor biodiversity, yet estimating biodiversity is often prohibitively expensive. As a cost-effective option, we estimated the spatial and temporal distribution of species richness for four taxonomic groups (birds, mammals, herpetofauna (reptiles and amphibians), and plants) within Sequoia and Kings Canyon National Parks using only existing biological studies undertaken within the Parks and the Parks' long-term wildlife observation database. We used a rarefaction approach to model species richness for the four taxonomic groups and analyzed those groups by habitat type, elevation zone, and time period. We then mapped the spatial distributions of species richness values for the four taxonomic groups, as well as total species richness, for the Parks. We also estimated changes in species richness for birds, mammals, and herpetofauna since 1980. The modeled patterns of species richness either peaked at mid elevations (mammals, plants, and total species richness) or declined consistently with increasing elevation (herpetofauna and birds). Plants reached maximum species richness values at much higher elevations than did vertebrate taxa, and nonflying mammals reached maximum species richness values at higher elevations than did birds. Alpine plant communities, including sagebrush, had higher species richness values than did subalpine plant communities located below them in elevation. These results are supported by other papers published in the scientific literature. Perhaps reflecting climate change: birds and herpetofauna displayed declines in species richness since 1980 at low and middle elevations and mammals displayed declines in species richness since 1980 at all elevations.	[Wathen, Steve; Schwartz, Mark W.] Univ Calif Davis, John Muir Inst Environm, Davis, CA 95616 USA; [Thorne, James H.; Holguin, Andrew] Univ Calif Davis, Environm Informat Ctr, Davis, CA 95616 USA; [Schwartz, Mark W.] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Schwartz, MW (corresponding author), Univ Calif Davis, John Muir Inst Environm, Davis, CA 95616 USA.	mwschwartz@ucdavis.edu	Schwartz, Mark/G-1066-2011	Schwartz, Mark/0000-0002-3739-6542; Thorne, James/0000-0002-9130-9921				Austin J, 2013, NATURAL RESOURCE CON; Chao A, 2009, ECOLOGY, V90, P1125, DOI 10.1890/07-2147.1; Colwell RK, 2004, ECOLOGY, V85, P2717, DOI 10.1890/03-0557; Das AJ, 2007, CAN J FOREST RES, V37, P580, DOI 10.1139/X06-262; Drost CA, 1996, CONSERV BIOL, V10, P414, DOI 10.1046/j.1523-1739.1996.10020414.x; Forister ML, 2010, P NATL ACAD SCI USA, V107, P2088, DOI 10.1073/pnas.0909686107; Gamfeldt L, 2008, ECOLOGY, V89, P1223, DOI 10.1890/06-2091.1; Gotelli Nicholas J., 2011, P39; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Grime J. P., 1979, Plant strategies and vegetation processes.; Grinnell J., 1924, ANIMAL LIFE YOSEMITE; Grinnell J, 1912, OUR VANISHING WILD L, P22; Grytnes JA, 2002, AM NAT, V159, P294, DOI 10.1086/338542; Guo QF, 2013, SCI REP-UK, V3, DOI 10.1038/srep03007; HAMILTON AC, 1981, VEGETATIO, V45, P107, DOI 10.1007/BF00119220; HURLBERT SH, 1971, ECOLOGY, V52, P577, DOI 10.2307/1934145; HUSTON MA, 1994, AM NAT, V144, P954, DOI 10.1086/285720; Lomolino MV, 2001, GLOBAL ECOL BIOGEOGR, V10, P3, DOI 10.1046/j.1466-822x.2001.00229.x; Lomolino MV, 2010, BIOGEOGRAPHY; MCCAIN C. M., 2010, ENCY LIFE SCI, DOI [DOI 10.1002/9780470015902.A0022548, 10.1002/9780470015902.a0022548]; Morelli TL, 2012, P ROY SOC B-BIOL SCI, V279, P4279, DOI 10.1098/rspb.2012.1301; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; National Park Service, 2013, NPSSEKINRR2013665; Oksanen J., 2016, R PACKAG; R Core Team, 2018, R LANG ENV STAT COMP; RAHBEK C, 1995, ECOGRAPHY, V18, P200, DOI 10.1111/j.1600-0587.1995.tb00341.x; Rahbek C, 2005, ECOL LETT, V8, P224, DOI 10.1111/j.1461-0248.2004.00701.x; RICHERSON PJ, 1980, AM NAT, V116, P504, DOI 10.1086/283645; Sanchez-Gonzalez A, 2005, DIVERS DISTRIB, V11, P567, DOI 10.1111/j.1366-9516.2005.00186.x; Sanders NJ, 2012, ECOGRAPHY, V35, P1, DOI 10.1111/j.1600-0587.2011.07338.x; Schwartz MW, 2013, NPSSEKINRR2013665; Siegel RB, 2005, LANDBIRD INVENTORY S; Thorne JH, 2009, NAT AREA J, V29, P344, DOI 10.3375/043.029.0402; Thorne James H., 2008, Madrono, V55, P223, DOI 10.3120/0024-9637-55.3.223; Tingley MW, 2013, ECOLOGY, V94, P598, DOI 10.1890/12-0928.1; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Tingley MW, 2009, TRENDS ECOL EVOL, V24, P625, DOI 10.1016/j.tree.2009.05.009; Williams AE, 2005, J FISH BIOL, V67, P278	38	5	5	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e112465	10.1371/journal.pone.0112465	http://dx.doi.org/10.1371/journal.pone.0112465			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469873	Green Published, gold, Green Submitted			2022-12-26	WOS:000349128700008
J	Cui, GG; Zhang, S; Geng, HY				Cui, Gege; Zhang, Shen; Geng, Haiyan			The Impact of Perceived Social Power and Dangerous Context on Social Attention	PLOS ONE			English	Article							SEX-DIFFERENCES; GAZE DIRECTION; EYE GAZE; CUES	Past research has shown that position in a social hierarchy modulates one's social attention, as in the gaze cueing effect. While studies have manipulated the social status of others with whom the participants interact, we believe that a sense of one's own social power is also a crucial factor affecting gaze following. In two experiments, we primed the social power of participants, using different approaches, to investigate the participants' performance in a subsequent gaze cueing task. The results of Experiment 1 showed a stronger gaze cueing effect among participants who were primed with low social power, compared to those primed with high social power. Our predicted gender difference (i.e., women showing a stronger gaze cueing effect than men) was confirmed and this effect was found to be dominated by the lower social power condition. Experiment 2 manipulated the level of danger in the context and replicated the joint impact of gender and one's perceived social power on gaze cueing effect, especially in the low danger context, in comparison to the high danger context. These findings demonstrate that one's perceived social power has a concerted effect on social attention evoked by gaze, along with other factors such as gender and characteristics of the environment, and suggest the importance of further research on the complex relationship between an individual's position in the social hierarchy and social attention.	[Cui, Gege; Geng, Haiyan] Peking Univ, Dept Psychol, Beijing 100871, Peoples R China; [Zhang, Shen] Univ Wisconsin, Dept Psychol, Whitewater, WI 53190 USA	Peking University; University of Wisconsin System	Geng, HY (corresponding author), Peking Univ, Dept Psychol, Beijing 100871, Peoples R China.	hygeng@pku.edu.cn			National Natural Science Foundation of China [31271202]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (31271202). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayliss AP, 2006, PSYCHOL SCI, V17, P514, DOI 10.1111/j.1467-9280.2006.01737.x; Bayliss AP, 2010, VIS COGN, V18, P1214, DOI 10.1080/13506285.2010.484657; Bayliss AP, 2005, Q J EXP PSYCHOL-A, V58, P631, DOI 10.1080/02724980443000124; Dalmaso M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093139; Dalmaso M, 2012, BIOL LETTERS, V8, P450, DOI 10.1098/rsbl.2011.0881; Deaner RO, 2003, CURR BIOL, V13, P1609, DOI 10.1016/j.cub.2003.08.025; Deaner RO, 2007, BIOL LETTERS, V3, P64, DOI 10.1098/rsbl.2006.0564; Driver J, 1999, VIS COGN, V6, P509, DOI 10.1080/135062899394920; Eagly A.H., 2013, SEX DIFFERENCES SOCI; EAGLY AH, 1982, J PERS SOC PSYCHOL, V43, P915, DOI 10.1037/0022-3514.43.5.915; FISKE AP, 1992, PSYCHOL REV, V99, P689, DOI 10.1037/0033-295X.99.4.689; Foulsham T, 2010, COGNITION, V117, P319, DOI 10.1016/j.cognition.2010.09.003; Friesen CK, 2011, COGNITION EMOTION, V25, P73, DOI 10.1080/02699931003672381; Friesen CK, 1998, PSYCHON B REV, V5, P490, DOI 10.3758/BF03208827; Frischen A, 2007, PSYCHOL BULL, V133, P694, DOI 10.1037/0033-2909.133.4.694; Galfano G, 2012, Q J EXP PSYCHOL, V65, P1895, DOI 10.1080/17470218.2012.663765; Galfano G, 2011, SOC NEUROSCI-UK, V6, P257, DOI 10.1080/17470919.2010.515722; Galinsky AD, 2003, J PERS SOC PSYCHOL, V85, P453, DOI 10.1037/0022-3514.85.3.453; Galinsky AD, 2006, PSYCHOL SCI, V17, P1068, DOI 10.1111/j.1467-9280.2006.01824.x; Galinsky AD, 2008, J PERS SOC PSYCHOL, V95, P1450, DOI 10.1037/a0012633; Geary DC, 2021, MALE, FEMALE, 3 EDITION, P1, DOI 10.1037/0000181-000; Graham R, 2010, VIS COGN, V18, P331, DOI 10.1080/13506280802689281; Hadjikhani N, 2008, BRAIN COGNITION, V68, P1, DOI 10.1016/j.bandc.2008.01.008; Hietanen JK, 2008, BRAIN RES, V1215, P123, DOI 10.1016/j.brainres.2008.03.091; Hietanen JK, 2003, J EXP PSYCHOL HUMAN, V29, P1228, DOI 10.1037/0096-1523.29.6.1228; Jones BC, 2010, P ROY SOC B-BIOL SCI, V277, P617, DOI 10.1098/rspb.2009.1575; Kuhn G, 2011, PSYCHON B REV, V18, P89, DOI 10.3758/s13423-010-0033-1; Kuhn G, 2009, ATTEN PERCEPT PSYCHO, V71, P314, DOI 10.3758/APP.71.2.314; Lammers J, 2009, PSYCHOL SCI, V20, P1543, DOI 10.1111/j.1467-9280.2009.02479.x; Liuzza MT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025117; Magee JC, 2008, ACAD MANAG ANN, V2, P351, DOI 10.1080/19416520802211628; Mueller U, 1997, BEHAV ECOL, V8, P569; Ohlsen G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059471; Pavan G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025608; Senju A, 2009, TRENDS COGN SCI, V13, P127, DOI 10.1016/j.tics.2008.11.009; Shepherd SV, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00005; Shepherd SV, 2006, CURR BIOL, V16, pR119, DOI 10.1016/j.cub.2006.02.013; Sidanius J., 2001, SOCIAL DOMINANCE INT; Teglas E, 2012, CURR BIOL, V22, P209, DOI 10.1016/j.cub.2011.12.018; Tipples J, 2006, COGNITION EMOTION, V20, P309, DOI 10.1080/02699930500405550; Tomasello M, 1998, ANIM BEHAV, V55, P1063, DOI 10.1006/anbe.1997.0636; Van Vugt M, 2008, AM PSYCHOL, V63, P182, DOI 10.1037/0003-066X.63.3.182; Van Vugt M, 2007, PSYCHOL SCI, V18, P19, DOI 10.1111/j.1467-9280.2007.01842.x; Watkins CD, 2010, PERS INDIV DIFFER, V49, P967, DOI 10.1016/j.paid.2010.08.006; Wu DWL, 2014, EVOL HUM BEHAV, V35, P211, DOI 10.1016/j.evolhumbehav.2014.01.005; Xu S, 2011, VISION RES, V51, P2048, DOI 10.1016/j.visres.2011.07.023; Zuberbuhler K, 2008, CURR BIOL, V18, pR453, DOI 10.1016/j.cub.2008.03.015	47	8	8	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114077	10.1371/journal.pone.0114077	http://dx.doi.org/10.1371/journal.pone.0114077			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU8TQ	25464385	Green Submitted, Green Published, gold			2022-12-26	WOS:000345869700093
J	Gschwendtner, S; Tejedor, J; Bimueller, C; Dannenmann, M; Knabner, IK; Schloter, M				Gschwendtner, Silvia; Tejedor, Javier; Bimueller, Carolin; Dannenmann, Michael; Knabner, Ingrid Koegel; Schloter, Michael			Climate Change Induces Shifts in Abundance and Activity Pattern of Bacteria and Archaea Catalyzing Major Transformation Steps in Nitrogen Turnover in a Soil from a Mid-European Beech Forest	PLOS ONE			English	Article							AMMONIA-OXIDIZING ARCHAEA; REDUCTASE GENES NIRK; DENITRIFYING BACTERIA; CARBON-DIOXIDE; MICROBIAL COMMUNITIES; ORGANIC NITROGEN; AGGREGATED SOILS; OXIDE REDUCTASE; RIBOSOMAL-RNA; PCR PRIMERS	Ongoing climate change will lead to more extreme weather events, including severe drought periods and intense drying rewetting cycles. This will directly influence microbial nitrogen (N) turnover rates in soil by changing the water content and the oxygen partial pressure. Therefore, a space for time climate change experiment was conducted by transferring intact beech seedling-soil mesocosms from a northwest (NW) exposed site, representing today's climatic conditions, to a southwest (SW) exposed site, providing a model climate for future conditions with naturally occurring increased soil temperature (+0.8 degrees C in average). In addition, severe drought and intense rainfall was simulated by a rainout shelter at SW and manual rewetting after 39 days drought, respectively. Soil samples were taken in June, at the end of the drought period (August), 24 and 72 hours after rewetting (August) and after a regeneration period of four weeks (September). To follow dynamics of bacterial and archaeal communities involved in N turnover, abundance and activity of nitrifiers, denitrifiers, N-2-fixing microbes and N-mineralizers was analyzed based on marker genes and the related transcripts by qPCR from DNA and RNA directly extracted from soil. Abundance of the transcripts was reduced under climate change with most pronounced effects for denitrification. Our results revealed that already a transfer from NW to SW without further treatment resulted in decreased cnor and nosZ transcripts, encoding for nitric oxide reductase and nitrous oxide reductase, respectively, while nirK transcripts, encoding for nitrite reductase, remained unaffected. Severe drought additionally led to reduced nirK and cnor transcripts at SW. After rewetting, nirK transcripts increased rapidly at both sites, while cnor and nosZ transcripts increased only at NW. Our data indicate that the climate change influences activity pattern of microbial communities involved in denitrification processes to a different extend, which may impact emission rates of the greenhouse gas N2O.	[Gschwendtner, Silvia; Schloter, Michael] German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Res Unit Environm Genom, D-85764 Neuherberg, Germany; [Tejedor, Javier; Dannenmann, Michael] Karlsruhe Inst Technol, Atmospher Environm Res IMK IFU, Inst Meteorol & Climate Res, D-82467 Garmisch Partenkirchen, Germany; [Bimueller, Carolin; Knabner, Ingrid Koegel] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, Dept Ecol & Ecosyst Management, Lehrstuhl Bodenkunde, D-85350 Freising Weihenstephan, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Karlsruhe Institute of Technology; Technical University of Munich	Schloter, M (corresponding author), German Res Ctr Environm Hlth GmbH, Helmholtz Zentrum Munchen, Res Unit Environm Genom, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	schloter@helmholtz-muenchen.de	Schloter, 1Michael/H-9151-2013; Tejedor, Javier/AAA-6473-2020; Dannenmann, Michael/A-7278-2013; Kögel-Knabner, Ingrid/A-7905-2008	Kögel-Knabner, Ingrid/0000-0002-7216-8326; Dannenmann, Michael/0000-0001-5924-7612; , Javier/0000-0002-5994-0131	German Science Foundation (DFG) [SCHL 447/11-1, DA 1217/2-1, KO 1035/41-1]	German Science Foundation (DFG)(German Research Foundation (DFG))	This work has been supported by the German Science Foundation (DFG) under the contract numbers SCHL 447/11-1, DA 1217/2-1, and KO 1035/41-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASMAR F, 1994, BIOL FERT SOILS, V17, P32, DOI 10.1007/BF00418669; Bach HJ, 2001, J MICROBIOL METH, V44, P173, DOI 10.1016/S0167-7012(00)00239-6; Barnard R, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002282; Beier C, 2008, SCI TOTAL ENVIRON, V407, P692, DOI 10.1016/j.scitotenv.2008.10.001; Bilela S, 2012, FOREST ECOL MANAG, V275, P60, DOI 10.1016/j.foreco.2012.03.009; Bimuller C, 2014, SOIL BIOL BIOCHEM, V68, P241, DOI 10.1016/j.soilbio.2013.10.003; Borken W, 2003, SOIL SCI SOC AM J, V67, P1888, DOI 10.2136/sssaj2003.1888; Borken W, 2009, GLOBAL CHANGE BIOL, V15, P808, DOI 10.1111/j.1365-2486.2008.01681.x; Braker G, 1998, APPL ENVIRON MICROB, V64, P3769; Braker G, 2003, APPL ENVIRON MICROB, V69, P3476, DOI 10.1128/AEM.69.6.3476-3483.2003; Brankatschk R, 2011, ISME J, V5, P1025, DOI 10.1038/ismej.2010.184; Cleveland CC, 1999, GLOBAL BIOGEOCHEM CY, V13, P623, DOI 10.1029/1999GB900014; COLE DW, 1995, PLANT SOIL, V168, P43, DOI 10.1007/BF00029312; Dannenmann M, 2008, SOIL BIOL BIOCHEM, V40, P2317, DOI 10.1016/j.soilbio.2008.05.009; Dannenmann M, 2006, PLANT SOIL, V287, P279, DOI 10.1007/s11104-006-9077-4; Dannenmann M, 2009, SOIL BIOL BIOCHEM, V41, P1622, DOI 10.1016/j.soilbio.2009.04.024; Domisch T, 2006, EUR J SOIL BIOL, V42, P74, DOI 10.1016/j.ejsobi.2005.09.017; Ekenler M, 2002, BIOL FERT SOILS, V36, P367, DOI 10.1007/s00374-002-0541-x; Ellenberg H., 1996, VEGETATION MITTELEUR, V5th ed; Emmett BA, 2004, ECOSYSTEMS, V7, P625, DOI 10.1007/s10021-004-0220-x; Enwall K, 2010, APPL ENVIRON MICROB, V76, P2243, DOI 10.1128/AEM.02197-09; Fierer N, 2003, SOIL SCI SOC AM J, V67, P798, DOI 10.2136/sssaj2003.0798; Gessler A, 2004, PLANT BIOLOGY, V6, P289, DOI 10.1055/s-2004-820878; Gessler A, 2001, NEW PHYTOL, V150, P653, DOI 10.1046/j.1469-8137.2001.00136.x; Gorissen A, 2004, ECOSYSTEMS, V7, P650, DOI 10.1007/s10021-004-0218-4; Gschwendtner S, 2010, BIOL FERT SOILS, V46, P649, DOI 10.1007/s00374-010-0460-1; Halverson LJ, 2000, SOIL SCI SOC AM J, V64, P1630, DOI 10.2136/sssaj2000.6451630x; Hart SC, 2006, GLOBAL CHANGE BIOL, V12, P1032, DOI 10.1111/j.1365-2486.2006.01159.x; He HY, 2014, BIOMETALS, V27, P219, DOI 10.1007/s10534-014-9711-1; Henry S, 2004, J MICROBIOL METH, V59, P327, DOI 10.1016/j.mimet.2004.07.002; Henry S, 2006, APPL ENVIRON MICROB, V72, P5181, DOI 10.1128/AEM.00231-06; Huang SH, 2007, ECOL ENG, V31, P9, DOI 10.1016/j.ecoleng.2007.04.001; Hwang SJ, 2000, BIORESOURCE TECHNOL, V71, P159, DOI 10.1016/S0960-8524(99)90068-8; IUSS, 2007, WORLD REF BAS SOIL R; Jones CM, 2010, ISME J, V4, P633, DOI 10.1038/ismej.2009.152; Jung J, 2012, J MICROBIOL, V50, P365, DOI 10.1007/s12275-012-1465-2; Kowalchuk GA, 2001, ANNU REV MICROBIOL, V55, P485, DOI 10.1146/annurev.micro.55.1.485; Leininger S, 2006, NATURE, V442, P806, DOI 10.1038/nature04983; Lipson D, 2001, OECOLOGIA, V128, P305, DOI 10.1007/s004420100693; Lueders T, 2004, ENVIRON MICROBIOL, V6, P73, DOI 10.1046/j.1462-2920.2003.00536.x; Michotey V, 2000, APPL ENVIRON MICROB, V66, P1564, DOI 10.1128/AEM.66.4.1564-1571.2000; Mikha MM, 2005, SOIL BIOL BIOCHEM, V37, P339, DOI 10.1016/j.soilbio.2004.08.003; Morley N, 2008, FEMS MICROBIOL ECOL, V65, P102, DOI 10.1111/j.1574-6941.2008.00495.x; Otte S, 1996, APPL ENVIRON MICROB, V62, P2421, DOI 10.1128/AEM.62.7.2421-2426.1996; Paul E. A., 1996, SOIL MICROBIOLOGY BI, P182; Pena R, 2013, ENVIRON EXP BOT, V87, P207, DOI 10.1016/j.envexpbot.2012.11.005; Pesaro M, 2004, APPL ENVIRON MICROB, V70, P2577, DOI 10.1128/AEM.70.5.2577-2587.2004; Prieme A, 2001, SOIL BIOL BIOCHEM, V33, P2083, DOI 10.1016/S0038-0717(01)00140-7; RENAULT P, 1994, SOIL SCI SOC AM J, V58, P1023, DOI 10.2136/sssaj1994.03615995005800040005x; Rennenberg H, 2009, PLANT BIOLOGY, V11, P4, DOI 10.1111/j.1438-8677.2009.00241.x; Roling WFM, 2007, FEMS MICROBIOL ECOL, V62, P202, DOI 10.1111/j.1574-6941.2007.00350.x; Rosch C, 2002, APPL ENVIRON MICROB, V68, P3818, DOI 10.1128/AEM.68.8.3818-3829.2002; Rotthauwe JH, 1997, APPL ENVIRON MICROB, V63, P4704, DOI 10.1128/AEM.63.12.4704-4712.1997; Schauss K, 2009, ENVIRON MICROBIOL, V11, P446, DOI 10.1111/j.1462-2920.2008.01783.x; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Schreiner K, 2010, APPL ENVIRON MICROB, V76, P4703, DOI 10.1128/AEM.00481-10; Schulten H.-R., 1998, Biology and Fertility of Soils, V26, P1, DOI 10.1007/s003740050335; Sharma S, 2005, APPL ENVIRON MICROB, V71, P2001, DOI 10.1128/AEM.71.4.2001-2007.2005; Shaw MR, 2001, ECOL APPL, V11, P1206, DOI 10.2307/3061022; SMITH KA, 1980, J SOIL SCI, V31, P263, DOI 10.1111/j.1365-2389.1980.tb02080.x; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; STARK JM, 1995, APPL ENVIRON MICROB, V61, P218, DOI 10.1128/AEM.61.1.218-221.1995; Stres B, 2008, FEMS MICROBIOL ECOL, V66, P110, DOI 10.1111/j.1574-6941.2008.00555.x; Szukics U, 2010, FEMS MICROBIOL ECOL, V72, P395, DOI 10.1111/j.1574-6941.2010.00853.x; Throback IN, 2004, FEMS MICROBIOL ECOL, V49, P401, DOI 10.1016/j.femsec.2004.04.011; Towe S, 2010, MICROB ECOL, V60, P762, DOI 10.1007/s00248-010-9695-5; Tourna M, 2008, ENVIRON MICROBIOL, V10, P1357, DOI 10.1111/j.1462-2920.2007.01563.x; Voroney RP, 2007, SOIL MICROBIOLOGY EC, pp45, DOI DOI 10.1016/B978-0-08-047514-1.50006-8; Xiao X, 2005, APPL ENVIRON MICROB, V71, P7904, DOI 10.1128/AEM.71.12.7904-7909.2005; Yang LC, 2014, J HAZARD MATER, V271, P292, DOI 10.1016/j.jhazmat.2014.01.058; Zehr JP, 2003, ENVIRON MICROBIOL, V5, P539, DOI 10.1046/j.1462-2920.2003.00451.x	71	18	19	3	129	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114278	10.1371/journal.pone.0114278	http://dx.doi.org/10.1371/journal.pone.0114278			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462589	gold, Green Published, Green Submitted			2022-12-26	WOS:000345869700126
J	Han, L; Liu, XJ; Li, HM; Zou, JQ; Yang, ZL; Han, J; Huang, W; Yu, LL; Zheng, YR; Li, L				Han, Lei; Liu, Xiaojie; Li, Hongmei; Zou, Jiaqun; Yang, Zhiling; Han, Jian; Huang, Wei; Yu, Lili; Zheng, Yingru; Li, Li			Blood Coagulation Parameters and Platelet Indices: Changes in Normal and Preeclamptic Pregnancies and Predictive Values for Preeclampsia	PLOS ONE			English	Article							COMPLICATIONS; FIBRINOLYSIS; DISORDERS; WOMEN; MPV	Background: Preeclampsia (PE) is an obstetric disorder with high morbidity and mortality rates but without clear pathogeny. The dysfunction of the blood coagulation-fibrinolysis system is a salient characteristic of PE that varies in severity, and necessitates different treatments. Therefore, it is necessary to find suitable predictors for the onset and severity of PE. Objectives: We aimed to evaluate blood coagulation parameters and platelet indices as potential predictors for the onset and severity of PE. Methods: Blood samples from 3 groups of subjects, normal pregnant women (n=79), mild preeclampsia (mPE) (n=53) and severe preeclampsia (sPE) (n=42), were collected during early and late pregnancy. The levels of coagulative parameters and platelet indices were measured and compared among the groups. The receiver-operating characteristic (ROC) curves of these indices were generated, and the area under the curve (AUC) was calculated. The predictive values of the selected potential parameters were examined in binary regression analysis. Results: During late pregnancy in the normal pregnancy group, the activated partial thromboplastin time (APTT), prothrombin time (PT), thrombin time (TT) and platelet count decreased, while the fibrinogen level and mean platelet volume (MPV) increased compared to early pregnancy (p<0.05). However, the PE patients presented with increased APTT, TT, MPV and D-dimer (DD) during the third trimester. In the analysis of subjects with and without PE, TT showed the largest AUC (0.743) and high predictive value. In PE patients with different severities, MPV showed the largest AUC (0.671) and ideal predictive efficiency. Conclusion: Normal pregnancy causes a maternal physiological hypercoagulable state in late pregnancy. PE may trigger complex disorders in the endogenous coagulative pathways and consume platelets and FIB, subsequently activating thrombopoiesis and fibrinolysis. Thrombin time and MPV may serve as early monitoring markers for the onset and severity of PE, respectively.	[Han, Lei; Liu, Xiaojie; Li, Hongmei; Yang, Zhiling; Han, Jian; Huang, Wei; Yu, Lili; Zheng, Yingru; Li, Li] Third Mil Med Univ, Inst Surg Res, Daping Hosp, Dept Obstet & Gynecol, Chongqing, Peoples R China; [Han, Lei] 306th Hosp Chinese Peoples Liberat Army, Dept Obstet & Gynecol, Beijing, Peoples R China; [Zou, Jiaqun] Third Mil Med Univ, Inst Surg Res, Daping Hosp, Dept Gen Surg, Chongqing, Peoples R China	Army Medical University; Army Medical University	Li, L (corresponding author), Third Mil Med Univ, Inst Surg Res, Daping Hosp, Dept Obstet & Gynecol, Chongqing, Peoples R China.	cqlili@tmmu.edu.cn			National Natural Foundation of China [81170576, 81401224]	National Natural Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a grant of the National Natural Foundation of China (81170576, 81401224). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOG Committee on Obstetric Practice, 2002, Int J Gynaecol Obstet, V77, P67; Al-Jameil Noura, 2014, J Clin Med Res, V6, P1, DOI 10.4021/jocmr1682w; Altinbas S, 2012, J CLIN LAB ANAL, V26, P403, DOI 10.1002/jcla.21542; Benedetto C, 2010, ANN NY ACAD SCI, V1205, P106, DOI 10.1111/j.1749-6632.2010.05674.x; Boriboonhirunsarn Dittakarn, 1995, Journal of the Medical Association of Thailand, V78, P586; De Vivo A, 2008, ACTA OBSTET GYN SCAN, V87, P837, DOI 10.1080/00016340802253759; Dundar O, 2008, PRENATAL DIAG, V28, P1052, DOI 10.1002/pd.2126; Fatemeh T, 2010, J PAK MED ASSOC, V60, P707; Freitas LG, 2013, HEMATOLOGY, V18, P359, DOI 10.1179/1607845413Y.0000000098; Hayward CPM, 2012, SEMIN THROMB HEMOST, V38, P742, DOI 10.1055/s-0032-1326780; Heilmann L, 2007, CLIN APPL THROMB-HEM, V13, P285, DOI 10.1177/1076029607299986; Irminger-Finger I, 2008, INT J BIOCHEM CELL B, V40, P1979, DOI 10.1016/j.biocel.2008.04.006; Kline JA, 2005, CLIN CHEM, V51, P825, DOI 10.1373/clinchem.2004.044883; Morikawa M, 2006, J PERINAT MED, V34, P392, DOI 10.1515/JPM.2006.078; Oliver JJ, 2005, ARTERIOSCL THROM VAS, V25, P2470, DOI 10.1161/01.ATV.0000189309.05924.88; Pennington KA, 2012, DIS MODEL MECH, V5, P9, DOI 10.1242/dmm.008516; Pinheiro MB, 2013, CLIN CHIM ACTA, V416, P67, DOI 10.1016/j.cca.2012.10.060; Pinheiro MB, 2014, CLIN CHIM ACTA, V427, P65, DOI 10.1016/j.cca.2013.09.050; Portelinha A, 2009, THROMB RES, V124, P52, DOI 10.1016/j.thromres.2008.10.005; Staff AC, 2013, HYPERTENSION, V61, P932, DOI 10.1161/HYPERTENSIONAHA.111.00250; Sultan P, 2013, CLIN APPL THROMB-HEM, V19, P529, DOI 10.1177/1076029612441860; Tanjung MT, 2005, CLIN APPL THROMB-HEM, V11, P467, DOI 10.1177/107602960501100415; Townsley DM, 2013, SEMIN HEMATOL, V50, P222, DOI 10.1053/j.seminhematol.2013.06.004; Tzur T, 2013, HYPERTENS PREGNANCY, V32, P74, DOI 10.3109/10641955.2012.704109; Williams VK, 2007, HYPERTENS PREGNANCY, V26, P415, DOI 10.1080/10641950701548240; Yang SW, 2014, EUR J OBSTET GYNECOL	26	48	55	4	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114488	10.1371/journal.pone.0114488	http://dx.doi.org/10.1371/journal.pone.0114488			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464515	Green Submitted, Green Published, gold			2022-12-26	WOS:000345869700135
J	Meyer, MF; Seuthe, IMC; Drebber, U; Siefer, O; Kreppel, M; Klein, MO; Mikolajczak, S; Klussmann, JP; Preuss, SF; Huebbers, CU				Meyer, Moritz F.; Seuthe, Inga M. C.; Drebber, Uta; Siefer, Oliver; Kreppel, Matthias; Klein, Marcus O.; Mikolajczak, Stefanie; Klussmann, Jens Peter; Preuss, Simon F.; Huebbers, Christian U.			Valosin-Containing Protein (VCP/p97)-Expression Correlates with Prognosis of HPV- Negative Oropharyngeal Squamous Cell Carcinoma (OSCC)	PLOS ONE			English	Article							NF-KAPPA-B; HUMAN-PAPILLOMAVIRUS INFECTION; EXPRESSION LEVEL; CANCER INCIDENCE; ORAL-CAVITY; VIRAL LOAD; HEAD; P97; DEGRADATION; ASSOCIATION	Valosin-containing protein (VCP)/p97 has been shown to be associated with antiapoptotic function via activation of the nuclear factor-kappa B (NF kappa B) signaling pathway and with metastasizing of tumors in several studies. VCP is located on chromosome 9p13-p12, a region often deleted in oropharyngeal squamous cell carcinoma (OSCC). The clinical significance of VCP expression in OSCC however remains unclear. In this study, expression of VCP was determined in 106 patients (77 male (71.3%) and 31 female (28.7%); age-range: 34-79 years (mean age 57 years)) by immunohistochemistry and in a subset of 15 patients by quantitative PCR. HPV-DNA was detected by polymerase chain reaction and p16(INK4a) immunohistochemistry. The experimental findings were correlated with clinicopathological data and survival parameters. 47.2% of all OSCC specimens were analyzed as negative or weak staining intensity for VCP. 52.8% of all specimens showed a high staining intensity for VCP. 73.1% of all patients were tested HPV-negative, 26.9% were HPV-positive. The 5-year disease-free and overall survival probabilities of all patients were 71.2% and 55.7%, respectively. No correlation could be found between HPV-status and VCP expression. VCP overexpression in HPV-negative patients was associated with significantly better 5-year disease-free survival (86.4% vs., 45.6%, p=0.017). The level of VCP-intensity determined by immunohistochemistry could be an additional prognostic marker in HPV-negative OSCC. VCP expression seems not to correlate with the HPV-status.	[Meyer, Moritz F.; Seuthe, Inga M. C.; Mikolajczak, Stefanie; Preuss, Simon F.] Univ Cologne, Dept Otorhinolaryngol Head & Neck Surg, D-50931 Cologne, Germany; [Drebber, Uta] Univ Cologne, Dept Pathol, Cologne, Germany; [Siefer, Oliver; Huebbers, Christian U.] Univ Cologne, Jean Uhmacher Inst, D-50931 Cologne, Germany; [Kreppel, Matthias] Univ Cologne, Dept Oral & Maxillofacial Plast Surg, D-50931 Cologne, Germany; [Klein, Marcus O.] Clin Oral & Maxillofacial Plast Surg, Dusseldorf, Germany; [Klussmann, Jens Peter] Univ Giessen, Dept Otorhinolaryngol Head & Neck Surg, D-35390 Giessen, Germany	University of Cologne; University of Cologne; University of Cologne; University of Cologne; Justus Liebig University Giessen	Meyer, MF (corresponding author), Univ Cologne, Dept Otorhinolaryngol Head & Neck Surg, D-50931 Cologne, Germany.	moritz.meyer@uk-koeln.de		Huebbers, Christian/0000-0002-2934-1218; Klussmann, Jens Peter/0000-0002-8223-7954				Allen C, 2007, CLIN CANCER RES, V13, P3182, DOI 10.1158/1078-0432.CCR-06-3047; American Joint Committee on Cancer Classification, CANC STAG MAN; Ang KK, 2010, NEW ENGL J MED, V363, P24, DOI 10.1056/NEJMoa0912217; Anto RJ, 2002, CARCINOGENESIS, V23, P1511, DOI 10.1093/carcin/23.9.1511; Asai T, 2002, JPN J CANCER RES, V93, P296, DOI 10.1111/j.1349-7006.2002.tb02172.x; Bernier J, 2004, NEW ENGL J MED, V350, P1945, DOI 10.1056/NEJMoa032641; Blomberg M, 2011, INT J CANCER, V129, P733, DOI 10.1002/ijc.25699; Chaturvedi AK, 2011, J CLIN ONCOL, V29, P4294, DOI 10.1200/JCO.2011.36.4596; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Dai RM, 1998, J BIOL CHEM, V273, P3562, DOI 10.1074/jbc.273.6.3562; Eich HT, 2008, STRAHLENTHER ONKOL, V184, P23, DOI 10.1007/s00066-008-1725-6; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Forastiere A, 2001, NEW ENGL J MED, V345, P1890, DOI 10.1056/NEJMra001375; Gillison ML, 2004, LANCET, V363, P1488, DOI 10.1016/S0140-6736(04)16194-1; Gillison ML, 2000, JNCI-J NATL CANCER I, V92, P709, DOI 10.1093/jnci/92.9.709; Hafkamp HC, 2003, INT J CANCER, V107, P394, DOI 10.1002/ijc.11389; Hafner N, 2008, ONCOGENE, V27, P1610, DOI 10.1038/sj.onc.1210791; Huang CF, 2011, ORAL DIS, V17, P328, DOI 10.1111/j.1601-0825.2010.01730.x; Jing M, 2007, J VIROL, V81, P2231, DOI 10.1128/JVI.01979-06; Klussmann JP, 2009, CLIN CANCER RES, V15, P1779, DOI 10.1158/1078-0432.CCR-08-1463; Klussmann JP, 2001, CANCER-AM CANCER SOC, V92, P2875, DOI 10.1002/1097-0142(20011201)92:11&lt;2875::AID-CNCR10130&gt;3.0.CO;2-7; Klussmann JP, 2004, HNO, V52, P208, DOI 10.1007/s00106-004-1069-1; Kreimer AR, 2005, CANCER EPIDEM BIOMAR, V14, P467, DOI 10.1158/1055-9965.EPI-04-0551; Kreppel M, 2012, ORAL DIS, V18, P692, DOI 10.1111/j.1601-0825.2012.01927.x; Li W, 2004, HEAD NECK-J SCI SPEC, V26, P1, DOI 10.1002/hed.10335; Lindel K, 2001, CANCER-AM CANCER SOC, V92, P805, DOI 10.1002/1097-0142(20010815)92:4<805::AID-CNCR1386>3.0.CO;2-9; Mashhadiabbas F, 2012, OR SURG OR MED OR PA, V114, P240, DOI 10.1016/j.oooo.2012.04.009; Mayo MW, 2000, BBA-REV CANCER, V1470, pM55, DOI 10.1016/S0304-419X(00)00002-0; Mellin H, 2002, INT J CANCER, V102, P152, DOI 10.1002/ijc.10669; Meyer MF, 2014, ORAL ONCOL, V50, P27, DOI 10.1016/j.oraloncology.2013.10.009; Preuss SF, 2011, HNO, V59, P1031, DOI 10.1007/s00106-011-2391-z; Preuss SF, 2008, HEAD NECK-J SCI SPEC, V30, P1318, DOI 10.1002/hed.20876; Shiboski CH, 2005, CANCER-AM CANCER SOC, V103, P1843, DOI 10.1002/cncr.20998; Smith EM, 2004, INT J CANCER, V108, P766, DOI 10.1002/ijc.11633; Tsujimoto Y, 2004, CLIN CANCER RES, V10, P3007, DOI 10.1158/1078-0432.CCR-03-0191; Yamamoto S, 2004, CLIN CANCER RES, V10, P5558, DOI 10.1158/1078-0432.CCR-0723-03; Yamamoto S, 2004, ANN SURG ONCOL, V11, P697, DOI 10.1245/ASO.2004.10.018; Yamamoto S, 2003, J CLIN ONCOL, V21, P2537, DOI 10.1200/JCO.2003.12.102; Yang SR, 2006, AM J PHYSIOL-LUNG C, V291, pL46, DOI 10.1152/ajplung.00241.2005	40	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114170	10.1371/journal.pone.0114170	http://dx.doi.org/10.1371/journal.pone.0114170			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463965	gold, Green Submitted, Green Published			2022-12-26	WOS:000345869700111
J	Pujol, M; Barquinero, JF; Puig, P; Puig, R; Caballin, MR; Barrios, L				Pujol, Monica; Barquinero, Joan-Francesc; Puig, Pedro; Puig, Roser; Rosa Caballin, Maria; Barrios, Leonardo			A New Model of Biodosimetry to Integrate Low and High Doses	PLOS ONE			English	Article							PREMATURELY CONDENSED CHROMOSOMES; BIOLOGICAL DOSIMETRY; RADIATION ACCIDENT; MITOTIC DELAY; IN-VITRO; EXPOSURES; GAMMA; LYMPHOCYTES; SUITABILITY; ABERRATIONS	Biological dosimetry, that is the estimation of the dose of an exposure to ionizing radiation by a biological parameter, is a very important tool in cases of radiation accidents. The score of dicentric chromosomes, considered to be the most accurate method for biological dosimetry, for low LET radiation and up to 5 Gy, fits very well to a linear-quadratic model of dose-effect curve assuming the Poisson distribution. The accuracy of this estimation raises difficulties for doses over 5 Gy, the highest dose of the majority of dose-effect curves used in biological dosimetry. At doses over 5 Gy most cells show difficulties in reaching mitosis and cannot be used to score dicentric chromosomes. In the present study with the treatment of lymphocyte cultures with caffeine and the standardization of the culture time, metaphases for doses up to 25 Gy have been analyzed. Here we present a new model for biological dosimetry, which includes a Gompertz-type function as the dose response, and also takes into account the underdispersion of aberration-among-cell distribution. The new model allows the estimation of doses of exposures to ionizing radiation of up to 25 Gy. Moreover, the model is more effective in estimating whole and partial body exposures than the classical method based on linear and linear-quadratic functions, suggesting their effectiveness and great potential to be used after high dose exposures of radiation.	[Pujol, Monica; Barquinero, Joan-Francesc; Puig, Roser; Rosa Caballin, Maria] Univ Autonoma Barcelona, Dept Biol Anim Biol Vegetal & Ecol, Unitat Antropol Biol, Bellaterra, Spain; [Puig, Pedro] Univ Autonoma Barcelona, Dept Matemat, Bellaterra, Spain; [Barrios, Leonardo] Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, Unitat Biol Cellular, Bellaterra, Spain	Autonomous University of Barcelona; Autonomous University of Barcelona; Autonomous University of Barcelona	Barrios, L (corresponding author), Univ Autonoma Barcelona, Dept Biol Cellular Fisiol & Immunol, Unitat Biol Cellular, Bellaterra, Spain.	Lleonard.barrios@uab.cat	Pujol-Canadell, Monica/AAY-1622-2020; Puig, Pedro/K-4414-2014; Barrios, Leonardo/L-3315-2014; Barquinero, Joan Francesc/L-6487-2014; MARIA ROSA, CABALLIN/L-9148-2014	Puig, Pedro/0000-0002-6607-9642; Barrios, Leonardo/0000-0002-6151-8503; Barquinero, Joan Francesc/0000-0003-0084-5268; MARIA ROSA, CABALLIN/0000-0002-0091-5484	Consejo de Seguridad Nuclear	Consejo de Seguridad Nuclear	This work received financial support from the Consejo de Seguridad Nuclear. The sponsor had no role in the study design, data collection, analysis or interpretation. M.R.C., L.B. and J.F.B. belong to a consolidated research group of the Generalitat de Catalunya (2014 SGR 354) and to RTICC RD06/0020/1020. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, CYT DOS APPL PREP RE; Balakrishnan S, 2010, MUTAT RES-GEN TOX EN, V699, P11, DOI 10.1016/j.mrgentox.2010.03.008; Barquinero JF, 1997, INT J RADIAT BIOL, V71, P435, DOI 10.1080/095530097144058; Belloni P, 2008, RADIAT RES, V169, P181, DOI 10.1667/RR1158.1; Chen Y, 2011, RADIAT MEAS, V46, P837, DOI 10.1016/j.radmeas.2011.04.001; Duran A, 2002, RADIAT RES, V157, P461, DOI 10.1667/0033-7587(2002)157[0461:SOFPTF]2.0.CO;2; EDWARDS AA, 1979, RADIAT ENVIRON BIOPH, V16, P89, DOI 10.1007/BF01323216; Gotoh E, 2005, INT J RADIAT BIOL, V81, P33, DOI 10.1080/09553000500092319; Hayata I, 2001, J Radiat Res, V42 Suppl, pS149; Heimers A, 2005, RADIAT ENVIRON BIOPH, V44, P211, DOI 10.1007/s00411-005-0014-3; Kanda R, 1999, INT J RADIAT BIOL, V75, P441, DOI 10.1080/095530099140366; Kemp AW, 2005, WILEY SER PROBAB ST, P343; Kuhne M, 2000, INT J RADIAT BIOL, V76, P891, DOI 10.1080/09553000050050909; Lamadrid AI, 2007, J RADIAT RES, V48, P1, DOI 10.1269/jrr.0625; Lamadrid AI, 2011, J RADIAT RES, V52, P531, DOI 10.1269/jrr.10096; Lindholm C, 2010, RADIAT RES, V173, P71, DOI 10.1667/RR1843.1; Liu Q, 2008, J RADIAT RES, V49, P63, DOI 10.1269/jrr.07071; Lobrich M, 2000, GENE CHROMOSOME CANC, V27, P59; NORMAN A, 1966, INT J RADIAT BIOL RE, V11, P321; PANTELIAS GE, 1984, RADIAT RES, V99, P140, DOI 10.2307/3576452; Puig R, 2013, MUTAT RES-GEN TOX EN, V757, P1, DOI 10.1016/j.mrgentox.2013.03.013; Pujol M, 2012, RADIAT PROT DOSIM, V149, P392, DOI 10.1093/rpd/ncr326; PURROTT RJ, 1980, MUTAT RES, V69, P275, DOI 10.1016/0027-5107(80)90092-5; RAO CR, 1956, BIOMETRICS, V12, P264, DOI 10.2307/3001466; Rao CR, 1965, SANKHYA A, V2, P331; Rodriguez P, 2009, MUTAT RES-FUND MOL M, V670, P53, DOI 10.1016/j.mrfmmm.2009.07.003; Rothkamm K, 2008, RADIAT RES, V169, P639, DOI 10.1667/RR1185.1; ROWLEY R, 1984, RADIAT RES, V97, P178, DOI 10.2307/3576199; Sarkaria JN, 1999, CANCER RES, V59, P4375; Sasaki MS, 2003, INT J RADIAT BIOL, V79, P83, DOI 10.1080/0955300021000045655; Sevan'kaev AV, 2002, RADIAT PROT DOSIM, V102, P201, DOI 10.1093/oxfordjournals.rpd.a006090; SREEDEVI B, 1993, RADIAT PROT DOSIM, V50, P45; Terzoudi GI, 2009, INT J ONCOL, V35, P1223, DOI 10.3892/ijo_00000439; Vinnikov VA, 2013, RADIAT PROT DOSIM, V154, P186, DOI 10.1093/rpd/ncs200; Vinnikov VA, 2010, RADIAT RES, V174, P403, DOI 10.1667/RR2228.1; Weiss CH, 2013, J APPL STAT, V40, P1931, DOI 10.1080/02664763.2013.800034; Wojcik A, 2004, CYTOGENET GENOME RES, V104, P200, DOI 10.1159/000077489; Yao B, 2010, INT J RADIAT BIOL, V86, P800, DOI 10.3109/09553002.2010.481320; Yao B, 2013, MUTAT RES-GEN TOX EN, V751, P66, DOI 10.1016/j.mrgentox.2012.11.005	39	19	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114137	10.1371/journal.pone.0114137	http://dx.doi.org/10.1371/journal.pone.0114137			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461738	gold, Green Published, Green Submitted			2022-12-26	WOS:000345869700103
J	Sangenito, LS; Menna-Barreto, RFS; d'Avila-Levy, CM; Santos, ALS; Branquinha, MH				Sangenito, Leandro S.; Menna-Barreto, Rubem F. S.; d'Avila-Levy, Claudia M.; Santos, Andre L. S.; Branquinha, Marta H.			Decoding the Anti-Trypanosoma cruzi Action of HIV Peptidase Inhibitors Using Epimastigotes as a Model	PLOS ONE			English	Article							RHODNIUS-PROLIXUS-MIDGUT; LEISHMANIA-AMAZONENSIS; PROTEASE INHIBITORS; TRYPOMASTIGOTE FORMS; CHAGAS-DISEASE; CELL-DEATH; IN-VITRO; INFECTION; DRUGS; DIFFERENTIATION	Background: Aspartic peptidase inhibitors have shown antimicrobial action against distinct microorganisms. Due to an increase in the occurrence of Chagas' disease/AIDS co-infection, we decided to explore the effects of HIV aspartic peptidase inhibitors (HIV-PIs) on Trypanosoma cruzi, the etiologic agent of Chagas' disease. Methodology and Principal Findings: HIV-PIs presented an anti-proliferative action on epimastigotes of T. cruzi clone Dm28c, with IC50 values ranging from 0.6 to 14 mu M. The most effective inhibitors, ritonavir, lopinavir and nelfinavir, also had an anti-proliferative effect against different phylogenetic T. cruzi strains. The HIV-PIs induced some morphological alterations in clone Dm28c epimastigotes, as reduced cell size and swollen of the cellular body. Transmission electron microscopy revealed that the flagellar membrane, mitochondrion and reservosomes are the main targets of HIV-PIs in T. cruzi epimastigotes. Curiously, an increase in the epimastigote-into-trypomastigote differentiation process of clone Dm28c was observed, with many of these parasites presenting morphological alterations including the detachment of flagellum from the cell body. The pretreatment with the most effective HIV-PIs drastically reduced the interaction process between epimastigotes and the invertebrate vector Rhodnius prolixus. It was also noted that HIV-PIs induced an increase in the expression of gp63-like and calpain-related molecules, and decreased the cruzipain expression in epimastigotes as judged by flow cytometry and immunoblotting assays. The hydrolysis of a cathepsin D fluorogenic substrate was inhibited by all HIV-PIs in a dose-dependent manner, showing that the aspartic peptidase could be a possible target to these drugs. Additionally, we verified that ritonavir, lopinavir and nelfinavir reduced drastically the viability of clone Dm28c trypomastigotes, causing many morphological damages. Conclusions and Significance: The results contribute to understand the possible role of aspartic peptidases in T. cruzi physiology, adding new in vitro insights into the possibility of exploiting the use of HIV-PIs in the clinically relevant forms of the parasite.	[Sangenito, Leandro S.; Santos, Andre L. S.; Branquinha, Marta H.] Univ Fed Rio de Janeiro UFRJ, Inst Microbiol Paulo de Goes IMPG, Dept Microbiol Geral, Lab Invest Peptidases, Rio De Janeiro, Brazil; [Menna-Barreto, Rubem F. S.] Fundacao Oswaldo Cruz FIOCRUZ, Inst Oswaldo Cruz, Lab Biol Celular, Rio De Janeiro, Brazil; [d'Avila-Levy, Claudia M.] Fiocruz MS, IOC, Lab Biol Mol & Doencas Endem, BR-21045900 Rio De Janeiro, Brazil; [Santos, Andre L. S.] Univ Fed Rio de Janeiro, Inst Quim, Programa Posgrad Bioquim, Rio de Janeiro, Brazil	Universidade Federal do Rio de Janeiro; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal do Rio de Janeiro	Branquinha, MH (corresponding author), Univ Fed Rio de Janeiro UFRJ, Inst Microbiol Paulo de Goes IMPG, Dept Microbiol Geral, Lab Invest Peptidases, Rio De Janeiro, Brazil.	mbranquinha@micro.ufrj.br	Santos, André/Z-5853-2019; Menna-Barreto, Rubem/O-7325-2019; Branquinha, Marta/AAA-3084-2019; d'Avila-Levy, Claudia M/O-7192-2014	Santos, André/0000-0003-0821-8592; Menna-Barreto, Rubem/0000-0002-1352-0641; d'Avila-Levy, Claudia M/0000-0001-8042-4695	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior; Fundacao Oswaldo Cruz	Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Oswaldo Cruz	This work was supported by Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro, Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior, Fundacao Oswaldo Cruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez VE, 2011, BIOCHIM BIOPHYS ACTA, V1824, P195; Alves CR, 2007, EXP PARASITOL, V116, P44, DOI 10.1016/j.exppara.2006.11.012; Alves CR, 2005, EXP PARASITOL, V109, P38, DOI 10.1016/j.exppara.2004.10.005; Alzate JF, 2008, ANTIMICROB AGENTS CH, V52, P3779, DOI 10.1128/AAC.01665-07; Bern C, 2012, CURR OPIN INFECT DIS, V25, P450, DOI 10.1097/QCO.0b013e328354f179; Bisaggio DFR, 2006, ACTA TROP, V98, P162, DOI 10.1016/j.actatropica.2006.04.003; Braga-Silva LA, 2011, CURR MED CHEM, V18, P2401; Castillo E, 2010, CURR MED CHEM, V17, P4027, DOI 10.2174/092986710793205345; Clevenbergh P, 2004, CURR HIV RES, V2, P309, DOI 10.2174/1570162043351129; CONTRERAS VT, 1985, MOL BIOCHEM PARASIT, V16, P315, DOI 10.1016/0166-6851(85)90073-8; Coura JR, 2012, REV SOC BRAS MED TRO, V45, P286, DOI 10.1590/S0037-86822012000300002; Dantas A. P., 2003, Journal of Submicroscopic Cytology and Pathology, V35, P287; de Souza W, 2009, CELL BIO RES PROG, P497; Eder J, 2007, CURR PHARM DESIGN, V13, P271, DOI 10.2174/138161207779313560; Ennes-Vidal V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018371; Fampa P, 2003, INT J PARASITOL, V33, P1019, DOI 10.1016/S0020-7519(03)00124-3; Fampa P, 2010, PARASITOL RES, V107, P443, DOI 10.1007/s00436-010-1888-9; Gallo G, 2011, BIOCHEM BIOPH RES CO, V408, P427, DOI 10.1016/j.bbrc.2011.04.038; Garcia ES, 2007, J INSECT PHYSIOL, V53, P11, DOI 10.1016/j.jinsphys.2006.10.006; GARCIA ES, 1978, ARCH BIOCHEM BIOPHYS, V188, P315, DOI 10.1016/S0003-9861(78)80015-0; Gascon J, 2010, ACTA TROP, V115, P22, DOI 10.1016/j.actatropica.2009.07.019; Giese V, 2008, MEM I OSWALDO CRUZ, V103, P598, DOI 10.1590/S0074-02762008000600015; Guimaraes CA, 2004, EUR J BIOCHEM, V271, P1638, DOI 10.1111/j.1432-1033.2004.04084.x; Haberland A, 2013, CLIN CHEM LAB MED, V51, P271, DOI 10.1515/cclm-2012-0316; Haynes PA, 1996, J CELL SCI, V109, P2979; Pittella JEH, 2009, T ROY SOC TROP MED H, V103, P973, DOI 10.1016/j.trstmh.2009.04.012; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Kulkarni MM, 2009, INFECT IMMUN, V77, P2193, DOI 10.1128/IAI.01542-08; Kumar P, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000642; Lockshin RA, 2004, INT J BIOCHEM CELL B, V36, P2405, DOI 10.1016/j.biocel.2004.04.011; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Mejia AM, 2012, J INFECT DIS, V206, P220, DOI 10.1093/infdis/jis331; Menna-Barreto RFS, 2009, MICRON, V40, P157, DOI 10.1016/j.micron.2008.08.003; Fidalgo LM, 2011, PHARM RES-DORDR, V28, P2758, DOI 10.1007/s11095-011-0586-3; Murta SMF, 1998, MOL BIOCHEM PARASIT, V93, P203, DOI 10.1016/S0166-6851(98)00037-1; Nogueira NFS, 2007, EXP PARASITOL, V116, P120, DOI 10.1016/j.exppara.2006.12.014; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Perteguer MJ, 2013, CELL STRESS CHAPERON, V18, P171, DOI 10.1007/s12192-012-0368-9; Pinho RT, 2009, EXP PARASITOL, V122, P128, DOI 10.1016/j.exppara.2009.02.005; Pozio E, 2005, TRENDS PARASITOL, V21, P58, DOI 10.1016/j.pt.2004.11.003; Rodrigues JCF, 2007, PROTIST, V158, P447, DOI 10.1016/j.protis.2007.05.004; RUCHEL R, 1990, ZBL BAKT-INT J MED M, V273, P391; Salomao K., 2011, EVID-BASED COMPL ALT, V2011; Salomao K, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-196; Sangenito LS, 2009, PARASITOLOGY, V136, P433, DOI 10.1017/S0031182009005629; Sangenito LS, 2012, PARASITOL RES, V110, P2533, DOI 10.1007/s00436-011-2796-3; Santos LO, 2013, CURR MED CHEM, V20, P3116; Santos LO, 2013, J ANTIMICROB CHEMOTH, V68, P348, DOI 10.1093/jac/dks410; Santos LO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004918; Sartori AMC, 2007, ANN TROP MED PARASIT, V101, P31, DOI 10.1179/136485907X154629; Schmunis GA, 2010, ACTA TROP, V115, P14, DOI 10.1016/j.actatropica.2009.11.003; SERRANO AA, 1995, J BIOL CHEM, V270, P27244, DOI 10.1074/jbc.270.45.27244; TEIXEIRA MMG, 1986, MOL BIOCHEM PARASIT, V18, P271, DOI 10.1016/0166-6851(86)90085-X; Tomas AM, 1997, EUR J BIOCHEM, V244, P596, DOI 10.1111/j.1432-1033.1997.t01-1-00596.x; Trudel N, 2008, J INFECT DIS, V198, P1292, DOI 10.1086/592280; Uehara LA, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001958; Valdivieso E, 2007, EXP PARASITOL, V116, P77, DOI 10.1016/j.exppara.2006.10.006; Valdivieso E, 2010, EXP PARASITOL, V126, P557, DOI 10.1016/j.exppara.2010.06.002; Yong V, 2000, MOL BIOCHEM PARASIT, V109, P47, DOI 10.1016/S0166-6851(00)00237-1; Zingales B, 2009, MEM I OSWALDO CRUZ, V104, P1051, DOI 10.1590/S0074-02762009000700021	60	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113957	10.1371/journal.pone.0113957	http://dx.doi.org/10.1371/journal.pone.0113957			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464510	gold, Green Published, Green Submitted			2022-12-26	WOS:000345869700074
J	Sun, PF; Fang, WT; Shin, LY; Wei, JY; Fu, SF; Chou, JY				Sun, Pei-Feng; Fang, Wei-Ta; Shin, Li-Ying; Wei, Jyuan-Yu; Fu, Shih-Feng; Chou, Jui-Yu			Indole-3-Acetic Acid-Producing Yeasts in the Phyllosphere of the Carnivorous Plant Drosera indica L.	PLOS ONE			English	Article							AUREOBASIDIUM-PULLULANS; INDOLEACETIC-ACID; RIBOSOMAL DNA; AZOSPIRILLUM-BRASILENSE; ASCOMYCETOUS YEASTS; TRITICUM-AESTIVUM; AUXIN TRANSPORT; GROWTH; FUNGUS; BIOSYNTHESIS	Yeasts are widely distributed in nature and exist in association with other microorganisms as normal inhabitants of soil, vegetation, and aqueous environments. In this study, 12 yeast strains were enriched and isolated from leaf samples of the carnivorous plant Drosera indica L., which is currently threatened because of restricted habitats and use in herbal industries. According to similarities in large subunit and small subunit ribosomal RNA gene sequences, we identified 2 yeast species in 2 genera of the phylum Ascomycota, and 5 yeast species in 5 genera of the phylum Basidiomycota. All of the isolated yeasts produced indole-3-acetic acid (IAA) when cultivated in YPD broth supplemented with 0.1% L-tryptophan. Growth conditions, such as the pH and temperature of the medium, influenced yeast IAA production. Our results also suggested the existence of a tryptophan-independent IAA biosynthetic pathway. We evaluated the effects of various concentrations of exogenous IAA on yeast growth and observed that IAA produced by wild yeasts modifies auxin-inducible gene expression in Arabidopsis. Our data suggest that yeasts can promote plant growth and support ongoing prospecting of yeast strains for inclusion into biofertilizer for sustainable agriculture.	[Sun, Pei-Feng; Shin, Li-Ying; Wei, Jyuan-Yu; Fu, Shih-Feng; Chou, Jui-Yu] Natl Changhua Univ Educ, Dept Biol, Changhua 500, Taiwan; [Fang, Wei-Ta] Natl Taiwan Normal Univ, Grad Inst Environm Educ, Taipei 116, Taiwan	National Changhua University of Education; National Taiwan Normal University	Chou, JY (corresponding author), Natl Changhua Univ Educ, Dept Biol, Changhua 500, Taiwan.	jackyjau@cc.ncue.edu.tw			Ministry of Science and Technology [NSC102-2218-E-002-008, NSC102-2311-B018-001-MY2, NSC101-2321-B-018002-MY2]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported by grants from the Ministry of Science and Technology (NSC102-2218-E-002-008 to W.-T. Fang; NSC102-2311-B018-001-MY2 to J.-Y. Chou; NSC101-2321-B-018002-MY2 to S.-F. Fu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004572; Agamy R., 2013, African Journal of Agricultural Research, V8, P46; Ahmad F, 2008, MICROBIOL RES, V163, P173, DOI 10.1016/j.micres.2006.04.001; Ali B, 2009, LETT APPL MICROBIOL, V48, P542, DOI 10.1111/j.1472-765X.2009.02565.x; Amprayn KO, 2012, APPL SOIL ECOL, V61, P295, DOI 10.1016/j.apsoil.2011.11.009; Andrews JH, 2002, CAN J MICROBIOL, V48, P500, DOI 10.1139/W02-044; Contreras-Cornejo HA, 2009, PLANT PHYSIOL, V149, P1579, DOI 10.1104/pp.108.130369; Anjali Bose, 2013, Mycology - An International Journal on Fungal Biology, V4, P103, DOI 10.1080/21501203.2013.823891; Asirvatham R, 2013, ADV PHARM BULL, V3, P115, DOI 10.5681/apb.2013.019; Basse CW, 1996, EUR J BIOCHEM, V242, P648, DOI 10.1111/j.1432-1033.1996.0648r.x; Beeckman T, 2009, ANN PLANT REV; Bjorkman T, 1998, J AM SOC HORTIC SCI, V123, P35, DOI 10.21273/JASHS.123.1.35; Buxdorf K, 2013, PLANT PHYSIOL, V161, P2014, DOI 10.1104/pp.112.212969; Casimiro I, 2001, PLANT CELL, V13, P843, DOI 10.1105/tpc.13.4.843; Chi ZM, 2009, APPL MICROBIOL BIOT, V82, P793, DOI 10.1007/s00253-009-1882-2; Chung KR, 2003, FEMS MICROBIOL LETT, V226, P23, DOI 10.1016/S0378-1097(03)00605-0; Ditengou FA, 2008, P NATL ACAD SCI USA, V105, P18818, DOI 10.1073/pnas.0807814105; El-Tarabily KA, 2004, J APPL MICROBIOL, V96, P69, DOI 10.1046/j.1365-2672.2003.02043.x; Felten J, 2009, PLANT PHYSIOL, V151, P1991, DOI 10.1104/pp.109.147231; Ferreira-Pinto M M, 2006, Commun Agric Appl Biol Sci, V71, P973; Gao M, 2013, MAR POLLUT BULL, V77, P172, DOI 10.1016/j.marpolbul.2013.10.008; Ghareeb H, 2011, PLANT PHYSIOL, V156, P2037, DOI 10.1104/pp.111.179499; GOPINATHAN S, 1992, Indian Journal of Experimental Biology, V30, P142; GORDON SA, 1951, PLANT PHYSIOL, V26, P192, DOI 10.1104/pp.26.1.192; GUNASEKARAN M, 1978, MICROBIOS, V22, P85; Hasan H. A. H., 2002, Acta Microbiologica et Immunologica Hungarica, V49, P105, DOI 10.1556/AMicr.49.2002.1.11; Hazelwood LA, 2008, APPL ENVIRON MICROB, V74, P2259, DOI 10.1128/AEM.02625-07; Idris EE, 2007, MOL PLANT MICROBE IN, V20, P619, DOI 10.1094/MPMI-20-6-0619; Inacio J, 2005, FEMS YEAST RES, V5, P1167, DOI 10.1016/j.femsyr.2005.05.007; Jayaram K, 2006, CURR SCI INDIA, V91, P943; Jayaram K, 2007, PLANT BIOTECHNOL REP, V1, P79, DOI 10.1007/s11816-007-0014-7; Jefferson RA, 1987, PLANT MOL BIOL REP, V5, P387, DOI [DOI 10.1007/BF02667740, 10.1007/bf02667740]; Jian OY, 2000, PLANT J, V24, P327, DOI 10.1046/j.1365-313x.2000.00883.x; Kachalkin AV, 2008, MICROBIOLOGY+, V77, P474, DOI 10.1134/S0026261708040140; Kaewchai S, 2009, FUNGAL DIVERS, V38, P25; Kawagishi H, 2006, BIOSCI BIOTECH BIOCH, V70, P2800, DOI 10.1271/bbb.60376; Kulkarni GB, 2013, APPL BIOCHEM BIOTECH, V169, P1292, DOI 10.1007/s12010-012-0037-6; Kurtzman CP, 1997, J CLIN MICROBIOL, V35, P1216, DOI 10.1128/JCM.35.5.1216-1223.1997; Kurtzman CP, 1998, ANTON LEEUW INT J G, V73, P331, DOI 10.1023/A:1001761008817; KVASNIKOV E I, 1975, Mikrobiologiya, V44, P339; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Laskowski M, 2008, PLOS BIOL, V6, P2721, DOI 10.1371/journal.pbio.0060307; Leveau JHJ, 2001, P NATL ACAD SCI USA, V98, P3446, DOI 10.1073/pnas.061629598; Limtong S, 2014, WORLD J MICROB BIOT, V30, P1785, DOI 10.1007/s11274-014-1602-7; Limtong S, 2012, WORLD J MICROB BIOT, V28, P3323, DOI 10.1007/s11274-012-1144-9; Liu P, 2006, P NATL ACAD SCI USA, V103, P4658, DOI 10.1073/pnas.0600366103; Mano Y, 2012, J EXP BOT, V63, P2853, DOI 10.1093/jxb/ers091; McGrath MJ, 2007, APPL ENVIRON MICROB, V73, P1277, DOI 10.1128/AEM.01620-06; McGrath MJ, 2006, APPL ENVIRON MICROB, V72, P6234, DOI 10.1128/AEM.00744-06; McSteen P, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001479; Medeiros AO, 2012, BRAZ J MICROBIOL, V43, P1582, DOI [10.1590/S1517-83822012000400043, 10.1590/S1517-838220120004000043]; Mercier J, 2000, APPL ENVIRON MICROB, V66, P369, DOI 10.1128/AEM.66.1.369-374.2000; Miller WG, 2001, APPL ENVIRON MICROB, V67, P1308, DOI 10.1128/AEM.67.3.1308-1317.2001; Navarro L, 2006, SCIENCE, V312, P436, DOI 10.1126/science.1126088; Patten CL, 1996, CAN J MICROBIOL, V42, P207, DOI 10.1139/m96-032; Prusty R, 2004, P NATL ACAD SCI USA, V101, P4153, DOI 10.1073/pnas.0400659101; Radhakrishnan R, 2013, J MICROBIOL BIOTECHN, V23, P856, DOI 10.4014/jmb.1209.09045; Rao RP, 2010, GENETICS, V185, P211, DOI 10.1534/genetics.109.112854; Reineke G, 2008, MOL PLANT PATHOL, V9, P339, DOI [10.1111/j.1364-3703.2008.00470.x, 10.1111/J.1364-3703.2008.00470.X]; RENEKE JE, 1988, CELL, V55, P221, DOI 10.1016/0092-8674(88)90045-1; Robiglio A, 2011, INT J FOOD MICROBIOL, V147, P211, DOI 10.1016/j.ijfoodmicro.2011.04.007; Ruanpanun P, 2010, WORLD J MICROB BIOT, V26, P1569, DOI 10.1007/s11274-010-0332-8; Sachdev DP, 2009, INDIAN J EXP BIOL, V47, P993; Sasikala C, 1998, ADV MICROB PHYSIOL, V39, P339; Scarpella E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001511; Schirawski J, 2010, SCIENCE, V330, P1546, DOI 10.1126/science.1195330; SHIN M, 1991, CHEM PHARM BULL, V39, P1792; Sitbon F, 2000, PLANTA, V211, P715, DOI 10.1007/s004250000338; Spaepen S, 2007, FEMS MICROBIOL REV, V31, P425, DOI 10.1111/j.1574-6976.2007.00072.x; Spaepen Stijn, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a001438; STRZELCZYK E, 1993, SYMBIOSIS, V14, P201; Tada R, 2009, INT IMMUNOPHARMACOL, V9, P1431, DOI 10.1016/j.intimp.2009.08.014; Tsavkelova EA, 2006, APPL BIOCHEM MICRO+, V42, P117, DOI 10.1134/S0003683806020013; Ulmasov T, 1997, PLANT CELL, V9, P1963, DOI 10.1105/tpc.9.11.1963; Vande Broek A, 2005, MOL PLANT MICROBE IN, V18, P311, DOI 10.1094/MPMI-18-0311; VILGALYS R, 1990, J BACTERIOL, V172, P4238, DOI 10.1128/jb.172.8.4238-4246.1990; Vorholt JA, 2012, NAT REV MICROBIOL, V10, P828, DOI 10.1038/nrmicro2910; Waqas M, 2012, MOLECULES, V17, P10754, DOI 10.3390/molecules170910754; Woody ST, 2003, APPL ENVIRON MICROB, V69, P4892, DOI 10.1128/AEM.69.8.4892-4900.2003; Xin G, 2009, MYCOL RES, V113, P973, DOI 10.1016/j.mycres.2009.06.001; Yazdani M., 2011, Advances in Environmental Biology, V5, P2182; YU PH, 1970, BOT BULL ACAD SINICA, V11, P98; Zakharova EA, 1999, EUR J BIOCHEM, V259, P572, DOI 10.1046/j.1432-1327.1999.00033.x; Zhang JZ, 2012, MYCOL PROG, V11, P499, DOI 10.1007/s11557-011-0765-y; Zhang R, 2008, J INTEGR PLANT BIOL, V50, P1070, DOI 10.1111/j.1744-7909.2008.00729.x	85	88	90	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114196	10.1371/journal.pone.0114196	http://dx.doi.org/10.1371/journal.pone.0114196			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464336	Green Submitted, Green Published, gold			2022-12-26	WOS:000345869700113
J	Gong, YY; Liu, YY; Li, J; Su, L; Yu, S; Zhu, XN; Cao, XP; Xiao, HP				Gong, Ying-Ying; Liu, Yuan-Yuan; Li, Jin; Su, Lei; Yu, Shuang; Zhu, Xiao-Nan; Cao, Xiao-Pei; Xiao, Hai-Peng			Hypermethylation of Cox5a Promoter Is Associated with Mitochondrial Dysfunction in Skeletal Muscle of High Fat Diet-Induced Insulin Resistant Rats	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; DNA METHYLATION; OXIDATIVE-METABOLISM; GLUCOSE-TOLERANCE; INSIGHTS; YEAST; PGC-1-ALPHA; EPIGENETICS; HOMEOSTASIS	High-fat diet (HFD) is an environmental factor that contributes to the pathogenesis of obesity and type 2 diabetes. A number of genes influencing oxidative phosphorylation (OXPHOS) were found to be downregulated in skeletal muscle of humans and rats treated with HFD and have been implicated in mitochondrial dysfunction, insulin resistance, and consequent type 2 diabetes. In this study, we hypothesized that DNA methylation plays a crucial role in the regulation of OXPHOS genes in skeletal muscle of rats exposed to HFD. Using whole genome promoter methylation analysis of skeletal muscle followed by qPCR and bisulfite sequencing analysis, we identified hypermethylation of Cox5a in HFD rats. Furthermore, we found that Cox5a hypermethylation was associated with downregulation of Cox5a expression at the mRNA and protein level, and a reduction in mitochondrial complex IV activity and ATP content in HFD-induced insulin resistant rats compared to controls. Moreover, we found that while exposure to palmitate resulted in hypermethylation of the Cox5a promoter in rat myotubes, demethylation with 5-aza-2'-deoxycytidine was associated with preserved Cox5a expression, as well as restoration of complex IV activity and cellular ATP content. These novel observations indicate that Cox5a hypermethylation is associated with mitochondrial dysfunction in skeletal muscle of HFD-induced insulin resistant rats.	[Liu, Yuan-Yuan; Yu, Shuang; Cao, Xiao-Pei; Xiao, Hai-Peng] Sun Yat Sen Univ, Dept Endocrinol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Gong, Ying-Ying; Li, Jin; Su, Lei] Sun Yat Sen Univ, Dept Geriatr, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China; [Zhu, Xiao-Nan] Sun Yat Sen Univ, Dept Pharmacol, Zhong Shan Sch Med, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Xiao, HP (corresponding author), Sun Yat Sen Univ, Dept Endocrinol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China.	xiaohp@mail.sysu.edu.cn	Su, Lei/U-6875-2019; liu, yuanyuan/GWZ-5838-2022					ALLEN LA, 1995, J BIOL CHEM, V270, P110, DOI 10.1074/jbc.270.1.110; Andrikopoulos S, 2008, AM J PHYSIOL-ENDOC M, V295, pE1323, DOI 10.1152/ajpendo.90617.2008; Barres R, 2011, AM J CLIN NUTR, V93, p897S, DOI 10.3945/ajcn.110.001933; Barres R, 2012, CELL METAB, V15, P405, DOI 10.1016/j.cmet.2012.01.001; Barres R, 2009, CELL METAB, V10, P189, DOI 10.1016/j.cmet.2009.07.011; Barrientos A, 2009, BBA-MOL CELL RES, V1793, P97, DOI 10.1016/j.bbamcr.2008.05.003; Bird A, 2007, NATURE, V447, P396, DOI 10.1038/nature05913; Boden Guenther, 1998, Frontiers in Bioscience, V3, pD169; Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Boyle KE, 2011, J CLIN ENDOCR METAB, V96, P775, DOI 10.1210/jc.2010-2253; Chomentowski P, 2011, J CLIN ENDOCR METAB, V96, P494, DOI 10.1210/jc.2010-0822; Fornuskova D, 2010, BIOCHEM J, V428, P363, DOI 10.1042/BJ20091714; Frayling TM, 2007, NAT REV GENET, V8, P657, DOI 10.1038/nrg2178; Gemma C, 2010, MOL GENET METAB, V100, P83, DOI 10.1016/j.ymgme.2010.02.004; Gillberg L, 2014, METABOLISM, V63, P263, DOI 10.1016/j.metabol.2013.10.003; Jiang MH, 2008, DIABETOLOGIA, V51, P1525, DOI 10.1007/s00125-008-1034-8; Jiang MH, 2011, ENDOCRINOLOGY, V152, P1284, DOI 10.1210/en.2010-1162; Jones PA, 2001, SCIENCE, V293, P1068, DOI 10.1126/science.1063852; Kadenbach B, 2000, FREE RADICAL BIO MED, V29, P211, DOI 10.1016/S0891-5849(00)00305-1; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Khan IY, 2005, AM J PHYSIOL-REG I, V288, pR127, DOI 10.1152/ajpregu.00354.2004; Kristensen JM, 2014, DIABETOLOGIA, V57, P1006, DOI 10.1007/s00125-014-3187-y; Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5; Ling C, 2007, J CLIN INVEST, V117, P3427, DOI 10.1172/JCI30938; Ling C, 2009, DIABETES, V58, P2718, DOI 10.2337/db09-1003; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; MANDEL JL, 1974, NATURE, V251, P618, DOI 10.1038/251618a0; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Richardson DK, 2005, J BIOL CHEM, V280, P10290, DOI 10.1074/jbc.M408985200; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Ronn T, 2008, DIABETOLOGIA, V51, P1159, DOI 10.1007/s00125-008-1018-8; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Simoneau JA, 1997, J APPL PHYSIOL, V83, P166, DOI 10.1152/jappl.1997.83.1.166; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Sreekumar R, 2002, DIABETES, V51, P1913, DOI 10.2337/diabetes.51.6.1913; Sreekumar R, 2002, AM J PHYSIOL-ENDOC M, V282, pE1055, DOI 10.1152/ajpendo.00554.2001; Taylor PD, 2005, AM J PHYSIOL-REG I, V288, pR134, DOI 10.1152/ajpregu.00355.2004; TRUEBLOOD CE, 1987, MOL CELL BIOL, V7, P3520, DOI 10.1128/MCB.7.10.3520; Uddin M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-8; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949	42	6	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113784	10.1371/journal.pone.0113784	http://dx.doi.org/10.1371/journal.pone.0113784			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436770	gold, Green Published, Green Submitted			2022-12-26	WOS:000347114900079
J	Guo, YY; Feng, YJ; Ge, Y; Tetreau, G; Chen, XW; Dong, XH; Shi, WP				Guo, Yanyan; Feng, Yanjie; Ge, Yang; Tetreau, Guillaume; Chen, Xiaowen; Dong, Xuehui; Shi, Wangpeng			The Cultivation of Bt Corn Producing Cry1Ac Toxins Does Not Adversely Affect Non-Target Arthropods	PLOS ONE			English	Article							ENVIRONMENTAL RISK-ASSESSMENT; PRINCIPAL RESPONSE CURVES; COTESIA-MARGINIVENTRIS; FUNCTIONAL GUILDS; MULTIPLE CROPS; PESTICIDE USE; MAIZE; FIELD; IMPACT; COMMUNITY	Transgenic corn producing Cry1Ac toxins from Bacillus thuringiensis (Bt) provides effective control of Asian corn borer, Ostrinia furnacalis (Guenee), and thus reduces insecticide applications. However, whether Bt corn exerts undesirable effects on non-target arthropods (NTAs) is still controversial. We conducted a 2-yr study in Shangzhuang Agricultural Experiment Station to assess the potential impact of Bt corn on field population density, biodiversity, community composition and structure of NTAs. On each sampling date, the total abundance, Shannon's diversity index, Pielou's evenness index and Simpson's diversity index were not significantly affected by Bt corn as compared to non-Bt corn. The "sampling dates'' had a significant effect on these indices, but no clear tendencies related to "Bt corn'' or "sampling dates X corn variety'' interaction were recorded. Principal response curve analysis of variance indicated that Bt corn did not alter the distribution of NTAs communities. Bray-Curtis dissimilarity and distance analysis showed that Cry1Ac toxin exposure did not increase community dissimilarities between Bt and non-Bt corn plots and that the evolution of non-target arthropod community was similar on the two corn varieties. The cultivation of Bt corn failed to show any detrimental evidence on the density of non-target herbivores, predators and parasitoids. The composition of herbivores, predators and parasitoids was identical in Bt and non-Bt corn plots. Taken together, results from the present work support that Bt corn producing Cry1Ac toxins does not adversely affect NTAs.	[Guo, Yanyan; Feng, Yanjie; Ge, Yang; Shi, Wangpeng] China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China; [Guo, Yanyan; Tetreau, Guillaume] Cornell Univ, New York State Agr Expt Stn, Dept Entomol, Geneva, NY 14456 USA; [Chen, Xiaowen; Dong, Xuehui] China Agr Univ, Dept Agr Sci, Beijing 100094, Peoples R China	China Agricultural University; Cornell University; China Agricultural University	Shi, WP (corresponding author), China Agr Univ, Dept Entomol, Beijing 100094, Peoples R China.	wpshi@cau.edu.cn	Tetreau, Guillaume/K-1283-2012; Shi, wp/AAF-9334-2020	Tetreau, Guillaume/0000-0003-3360-4786; 	Chinese Ministry of Agriculture [2014ZX08011-003]	Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs)	This research was funded by the National Special Transgenic Project from the Chinese Ministry of Agriculture (grant No. 2014ZX08011-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Deeb MA, 2001, ENVIRON ENTOMOL, V30, P625, DOI 10.1603/0046-225X-30.3.625; Albajes R., 2013, IOBC/WPRS Bulletin, V97, P1; Albajes R, 2012, SPAN J AGRIC RES, V10, P977, DOI 10.5424/sjar/2012104-691-11; Alcantara EP, 2012, ENVIRON ENTOMOL, V41, P1268, DOI 10.1603/EN10297; Andersson HC, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1879; Bhatti MA, 2005, ENVIRON ENTOMOL, V34, P1336, DOI 10.1603/0046-225X(2005)034[1336:FEOTIO]2.0.CO;2; Blanchet F. G., 2013, VEGAN ECOLOGICAL DIV; BOYLE TP, 1990, RES J WATER POLLUT C, V62, P749; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Candolfi MP, 2004, BIOCONTROL SCI TECHN, V14, P129, DOI 10.1080/09583150310001655701; Clarke KR, 2006, J EXP MAR BIOL ECOL, V330, P55, DOI 10.1016/j.jembe.2005.12.017; Clergue B, 2005, AGRON SUSTAIN DEV, V25, P1, DOI 10.1051/agro:2004049; Collins SL, 2000, OIKOS, V91, P285, DOI 10.1034/j.1600-0706.2000.910209.x; Comas C, 2014, TRANSGENIC RES, V23, P135, DOI 10.1007/s11248-013-9737-0; Comas J, 2013, J ECON ENTOMOL, V106, P1659, DOI 10.1603/EC12508; Cuppen JGM, 2000, AQUAT TOXICOL, V48, P233, DOI 10.1016/S0166-445X(99)00036-3; de la Poza M, 2005, CROP PROT, V24, P677, DOI 10.1016/j.cropro.2004.12.003; Desneux N, 2010, ECOTOXICOLOGY, V19, P1642, DOI 10.1007/s10646-010-0550-8; Desneux N, 2010, ECOTOXICOLOGY, V19, P1183, DOI 10.1007/s10646-010-0502-3; Devos Y, 2012, TRANSGENIC RES, V21, P1, DOI 10.1007/s11248-011-9515-9; Dively GP, 2005, ENVIRON ENTOMOL, V34, P1267, DOI 10.1603/0046-225X(2005)034[1267:IOTVCL]2.0.CO;2; Dutra CC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044867; Dutton A, 2002, ECOL ENTOMOL, V27, P441, DOI 10.1046/j.1365-2311.2002.00436.x; FELKL G, 1988, J APPL ENTOMOL, V105, P379, DOI 10.1111/j.1439-0418.1988.tb00200.x; Frampton G. K., 2000, ACS SYM SER, P54; Freier Bernd, 2004, IOBC-WPRS Bulletin, V27, P79; Gathmann Achim, 2006, Environmental Biosafety Research, V5, P27, DOI 10.1051/ebr:2006014; Gathmann A, 2006, MOL ECOL, V15, P2677, DOI 10.1111/j.1365-294X.2006.02962.x; Graef F, 2005, ENVIRON MONIT ASSESS, V111, P1, DOI 10.1007/s10661-005-8044-5; Groot AT, 2002, PLANT J, V31, P387, DOI 10.1046/j.1365-313X.2002.01366.x; He KL, 2003, J ECON ENTOMOL, V96, P935, DOI 10.1603/0022-0493-96.3.935; HEONG KL, 1991, B ENTOMOL RES, V81, P407, DOI 10.1017/S0007485300031977; Higgins LS, 2009, ENVIRON ENTOMOL, V38, P281, DOI 10.1603/022.038.0135; Jasinski JR, 2003, ENVIRON ENTOMOL, V32, P407, DOI 10.1603/0046-225X-32.2.407; Jensen PD, 2010, ENVIRON ENTOMOL, V39, P707, DOI 10.1603/EN09037; Kim YH, 2012, J ASIA-PAC ENTOMOL, V15, P443, DOI 10.1016/j.aspen.2012.01.005; Kojima W, 2010, J INSECT PHYSIOL, V56, P1349, DOI 10.1016/j.jinsphys.2010.04.021; Krebs C.J., 2014, ECOLOGICAL METHODOLO; Li XG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061670; Lit Ireneo L. Jr., 2012, Philippine Entomologist, V26, P28; Litsinger JA, 1978, PHILIPPINE ENTOMOLOG, V4, P65; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Lumbierres B, 2004, ECOL ENTOMOL, V29, P309, DOI 10.1111/j.0307-6946.2004.00597.x; Lumbierres B, 2011, BIOCONTROL, V56, P133, DOI 10.1007/s10526-010-9317-7; Lundgren JG, 2009, RELATIONSHIPS NATURA; Magurran A.E., 2004, MEASURING BIOL DIVER; Meissle M, 2010, J APPL ENTOMOL, V134, P357, DOI 10.1111/j.1439-0418.2009.01491.x; Minarcikova L., 2013, IOBC/WPRS Bulletin, V97, P89; Moser T, 2007, ECOTOXICOLOGY, V16, P573, DOI 10.1007/s10646-007-0169-6; Mota T. A., 2013, African Journal of Biotechnology, V12, P6086; NAFUS DM, 1987, J ECON ENTOMOL, V80, P411, DOI 10.1093/jee/80.2.411; NAFUS DM, 1991, TROP PEST MANAGE, V37, P41, DOI 10.1080/09670879109371535; Naranjo SE, 2009, NUTR NAT RES, V4, P1; Nienstedt KM, 2012, SCI TOTAL ENVIRON, V415, P31, DOI 10.1016/j.scitotenv.2011.05.057; Pascual S, 2010, J PEST SCI, V83, P121, DOI 10.1007/s10340-009-0278-5; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; PIMENTEL D, 1993, AGR ECOSYST ENVIRON, V46, P273, DOI 10.1016/0167-8809(93)90030-S; Pons X, 2005, EUR J ENTOMOL, V102, P73, DOI 10.14411/eje.2005.010; Prasifka JR, 2005, ENVIRON ENTOMOL, V34, P1181, DOI 10.1603/0046-225X(2005)034[1181:ATEOPM]2.0.CO;2; Priestley AL, 2009, TRANSGENIC RES, V18, P425, DOI 10.1007/s11248-008-9234-z; R Development Core Team, 2014, R LANG ENV STAT COMP; Ramirez-Romero R, 2007, CROP PROT, V26, P953, DOI 10.1016/j.cropro.2006.09.001; Rauschen Stefan, 2010, Environmental Biosafety Research, V9, P87, DOI 10.1051/ebr/2010012; Rauschen S, 2009, TRANSGENIC RES, V18, P203, DOI 10.1007/s11248-008-9207-2; Rodriguez C. P., 1975, Philippine Entomologist, V3, P46; Romeis J, 2006, NAT BIOTECHNOL, V24, P63, DOI 10.1038/nbt1180; Romeis Joerg, 2008, V5, P87, DOI 10.1007/978-1-4020-8373-0_4; SALAMA HS, 1983, Z ANGEW ENTOMOL, V95, P425; Sanvido O, 2007, J VERBRAUCH LEBENSM, V2, P37, DOI 10.1007/s00003-007-0292-6; Sanvido O, 2012, ENVIRON SCI POLICY, V15, P82, DOI 10.1016/j.envsci.2011.08.006; Schorling M., 2006, Journal fur Verbraucherschutz und Lebensmittelsicherheit, V1, P106, DOI 10.1007/s00003-006-0100-8; Shirai Yoichi, 2012, Bulletin of the National Institute of Agro-Environmental Sciences, V30, P1; Thompson GD, 2010, PHILIPP AGRIC SCI, V93, P375; Tian JC, 2014, ENVIRON ENTOMOL, V43, P242, DOI 10.1603/EN13184; Tian JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060125; Todd Jacqui H., 2008, Environmental Biosafety Research, V7, P35, DOI 10.1051/ebr:2008003; Van Den Brink Paul J., 1998, Aquatic Ecology, V32, P163, DOI 10.1023/A:1009944004756; Van den Brink Paul J., 2003, Australasian Journal of Ecotoxicology, V9, P141; van den Brink PJ, 2009, ENVIRON MONIT ASSESS, V152, P271, DOI 10.1007/s10661-008-0314-6; Van den Brink PJ, 1999, ENVIRON TOXICOL CHEM, V18, P138, DOI [10.1897/1551-5028(1999)018&lt;0138:PRCAOT&gt;2.3.CO;2, 10.1002/etc.5620180207]; Wang ZY, 2014, BIOL CONTROL, V68, P136, DOI 10.1016/j.biocontrol.2013.06.015; Wolfenbarger LL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002118; Wu F, 2006, TRANSGENIC RES, V15, P277, DOI 10.1007/s11248-005-5237-1; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Yang B, 2014, APPL SOIL ECOL, V73, P156, DOI 10.1016/j.apsoil.2013.09.001; Zhang BY, 2011, TRANSGENIC RES, V20, P523, DOI 10.1007/s11248-010-9434-1; Zughart W, 2008, EUPHYTICA, V164, P845, DOI 10.1007/s10681-007-9475-6	88	19	20	0	67	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114228	10.1371/journal.pone.0114228	http://dx.doi.org/10.1371/journal.pone.0114228			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437213	Green Submitted, gold, Green Published			2022-12-26	WOS:000347114900132
J	Hedman, E; Andersson, G; Lindefors, N; Gustavsson, P; Lekander, M; Ruck, C; Andersson, E; Ljotsson, B				Hedman, Erik; Andersson, Gerhard; Lindefors, Nils; Gustavsson, Petter; Lekander, Mats; Rueck, Christian; Andersson, Erik; Ljotsson, Brjann			Personality Change following Internet-Based Cognitive Behavior Therapy for Severe Health Anxiety	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; III-R HYPOCHONDRIASIS; SELF-REPORT MEASURES; PSYCHOMETRIC EVALUATION; COST-EFFECTIVENESS; SOCIAL ANXIETY; TRAIT CHANGE; DEPRESSION; DISORDERS; TEMPERAMENT	Personality traits have traditionally been viewed as stable, but recent studies suggest that they could be affected through psychological treatment. Internet-based cognitive behavior therapy (ICBT) for severe health anxiety (DSM-IV hypochondriasis) has been shown to be effective in reducing health anxiety, but its effect on measures of personality traits has not been investigated. The main aim of this study was to investigate the impact of ICBT on personality traits in the three broad dimensions -neuroticism, extraversion and aggression. We hypothesized that participants in ICBT would reduce their level of neuroticism compared to controls that did not receive the active treatment. No specific predictions were made regarding extraversion and aggression. Data from a randomized controlled trial were used in which participants were allocated to 12 weeks of ICBT (n=40) or to a basic attention control condition (n=41). Personality traits were assessed with the Swedish Universities Scales of Personality and the primary outcome of health anxiety was the Health Anxiety Inventory. There was a significant interaction effect of group and time on neuroticism-related scales, indicating larger pre-to post-treatment reductions in the Internet-based CBT group compared to the control condition. Analyses at 6-month follow-up showed that changes were stable. Traits relating to extraversion and aggression were largely unchanged. This study is the first to demonstrate that a brief ICBT intervention for severe health anxiety causes long-term changes in measures of personality traits related to neuroticism. The treatment thus has a broader impact than just reducing health anxiety.	[Hedman, Erik; Andersson, Gerhard; Lindefors, Nils; Rueck, Christian; Andersson, Erik; Ljotsson, Brjann] Karolinska Inst, Div Psychiat, Dept Clin Neurosci, Stockholm, Sweden; [Hedman, Erik; Lekander, Mats] Karolinska Inst, Osher Ctr Integrat Med, Dept Clin Neurosci, Stockholm, Sweden; [Hedman, Erik; Gustavsson, Petter; Ljotsson, Brjann] Karolinska Inst, Div Psychol, Dept Clin Neurosci, Stockholm, Sweden; [Andersson, Gerhard] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden; [Andersson, Gerhard] Linkoping Univ, Swedish Inst Disabil Res, Linkoping, Sweden; [Lekander, Mats] Stockholm Univ, Stress Res Inst, S-10691 Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Linkoping University; Linkoping University; Stockholm University	Hedman, E (corresponding author), Karolinska Inst, Div Psychiat, Dept Clin Neurosci, Stockholm, Sweden.	kire.hedman@ki.se	Andersson, Gerhard/J-8529-2012	Andersson, Gerhard/0000-0003-4753-6745; Gustavsson, Petter/0000-0001-9571-9349; Andersson, Erik/0000-0003-0088-8719; Ruck, Christian/0000-0002-8742-0168; Hedman-Lagerlof, Erik/0000-0002-7939-9848	Stockholm County council; Karolinska Institutet	Stockholm County council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	The funders of the study were Stockholm County council and Karolinska Institutet, which are both public institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguera Z, 2012, EUR EAT DISORD REV, V20, P379, DOI 10.1002/erv.2163; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, Vxxxvii; Andersson G, 2014, WORLD PSYCHIATRY, V13, P288, DOI 10.1002/wps.20151; Andersson G, 2009, BEHAV RES THER, V47, P175, DOI 10.1016/j.brat.2009.01.010; [Anonymous], 1985, PERSONALITY INDIVIDU, DOI 13877; BARSKY AJ, 1990, SOC PSYCH PSYCH EPID, V25, P89; Barsky AJ, 1998, ARCH GEN PSYCHIAT, V55, P737, DOI 10.1001/archpsyc.55.8.737; Brandes Mina, 2006, Curr Psychiatry Rep, V8, P263, DOI 10.1007/s11920-006-0061-8; Burger JM, 1993, PERSONALITY; Carlbring P, 2007, COMPUT HUM BEHAV, V23, P1421, DOI 10.1016/j.chb.2005.05.002; Cervenka S, 2010, NEUROIMAGE, V50, P323, DOI 10.1016/j.neuroimage.2009.12.006; Clark DM, 1998, BRIT J PSYCHIAT, V173, P218, DOI 10.1192/bjp.173.3.218; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Cuijpers P, 2010, ARCH GEN PSYCHIAT, V67, P1086, DOI 10.1001/archgenpsychiatry.2010.130; Eysenck HJ, 1959, BRIT J PSYCHIAT, V105, P61; Farde L, 1997, NATURE, V385, P590, DOI 10.1038/385590a0; Flaskerud Jacquelyn H, 2012, Issues Ment Health Nurs, V33, P631, DOI 10.3109/01612840.2011.647256; FURER P, 2007, TREATING HLTH ANXIET, V15; Furer P, 2005, J CONTEMP PSYCHOTHER, V35, P251, DOI 10.1007/s10879-005-4319-y; Gray J.A., 1991, EXPLORATIONS TEMPERA; Greeven A, 2007, AM J PSYCHIAT, V164, P91, DOI 10.1176/appi.ajp.164.1.91; Gustavsson JP, 2000, ACTA PSYCHIAT SCAND, V102, P217, DOI 10.1034/j.1600-0447.2000.102003217.x; Gustavsson JP, 1997, PERS INDIV DIFFER, V22, P783, DOI 10.1016/S0191-8869(96)00268-1; Hedman E, 2013, PSYCHOL MED, V43, P363, DOI 10.1017/S0033291712001079; Hedman E, 2013, J MED INTERNET RES, V15, P131, DOI 10.2196/jmir.2818; Hedman E, 2012, EXPERT REV PHARM OUT, V12, P745, DOI [10.1586/erp.12.67, 10.1586/ERP.12.67]; Hedman E, 2011, BRIT J PSYCHIAT, V198, P230, DOI 10.1192/bjp.bp.110.086843; Hedman Erik, 2010, Cognitive Behaviour Therapy, V39, P239, DOI 10.1080/16506073.2010.496460; Hedman E, 2010, COMPUT HUM BEHAV, V26, P736, DOI 10.1016/j.chb.2010.01.010; Johansson R, 2013, PEERJ, V1, DOI 10.7717/peerj.39; Karsten J, 2012, J PSYCHIATR RES, V46, P644, DOI 10.1016/j.jpsychires.2012.01.024; Lahey BB, 2009, AM PSYCHOL, V64, P241, DOI 10.1037/a0015309; Lovas DA, 2010, J ANXIETY DISORD, V24, P931, DOI 10.1016/j.janxdis.2010.06.019; Ludtke O, 2011, J PERS SOC PSYCHOL, V101, P620, DOI 10.1037/a0023743; Lyoo IK, 2003, ACTA PSYCHIAT SCAND, V107, P298, DOI 10.1034/j.1600-0447.2003.00054.x; McManus F, 2012, J CONSULT CLIN PSYCH; Mortberg E, 2007, PSYCHIAT RES, V152, P81, DOI 10.1016/j.psychres.2006.10.003; NOYES R, 1994, GEN HOSP PSYCHIAT, V16, P78, DOI 10.1016/0163-8343(94)90049-3; NOYES R, 1993, ARCH GEN PSYCHIAT, V50, P961; NOYES R, 1991, COMPR PSYCHIAT, V32, P283, DOI 10.1016/0010-440X(91)90076-O; Pervin LA., 2008, HDB PERSONALITY THEO; Posternak MA, 2001, J AFFECT DISORDERS, V66, P139, DOI 10.1016/S0165-0327(00)00304-9; REICH J, 1986, AM J PSYCHIAT, V143, P760; Roberts BW, 2008, CURR DIR PSYCHOL SCI, V17, P31, DOI 10.1111/j.1467-8721.2008.00543.x; Rohde P, 1997, AM J PSYCHIAT, V154, P1593, DOI 10.1176/ajp.154.11.1593; Ruck C, 2006, NORD J PSYCHIAT, V60, P486, DOI 10.1080/08039480601022116; Salkovskis PM, 2002, PSYCHOL MED, V32, P843, DOI 10.1017/S0033291702005822; Seivewright H, 2008, BRIT J PSYCHIAT, V193, P332, DOI 10.1192/bjp.bp.108.052936; Sheehan DV, 1998, J CLIN PSYCHIAT S20, V59, pS22; SPECKENS AEM, 1995, BRIT MED J, V311, P1328, DOI 10.1136/bmj.311.7016.1328; Spinhoven P, 2011, ACTA PSYCHIAT SCAND, V124, P462, DOI 10.1111/j.1600-0447.2011.01753.x; STAATS AW, 1993, BEHAV MODIF, V17, P8, DOI 10.1177/01454455930171003; Svanborg P, 1999, J PERS DISORD, V13, P241, DOI 10.1521/pedi.1999.13.3.241; SVANBORG P, 1994, ACTA PSYCHIAT SCAND, V89, P21, DOI 10.1111/j.1600-0447.1994.tb01480.x; Tang TZ, 2009, ARCH GEN PSYCHIAT, V66, P1322, DOI 10.1001/archgenpsychiatry.2009.166; TAYLOR S, 2004, TREATING HLTH ANXIET, V15; Treanor M, 2011, CLIN PSYCHOL REV, V31, P617, DOI 10.1016/j.cpr.2011.02.003; Wilczek A, 2004, J AM PSYCHOANAL ASS, V52, P1163	58	28	28	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113871	10.1371/journal.pone.0113871	http://dx.doi.org/10.1371/journal.pone.0113871			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7SK	25437150	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900091
J	Lemire, P; Roy, D; Fittipaldi, N; Okura, M; Takamatsu, D; Bergman, E; Segura, M				Lemire, Paul; Roy, David; Fittipaldi, Nahuel; Okura, Masatoshi; Takamatsu, Daisuke; Bergman, Eugenia; Segura, Mariela			Implication of TLR- but Not of NOD2-Signaling Pathways in Dendritic Cell Activation by Group B Streptococcus Serotypes III and V	PLOS ONE			English	Article							PATTERN-RECOGNITION RECEPTORS; TOLL-LIKE RECEPTORS; CAPSULAR POLYSACCHARIDES; INNATE IMMUNITY; NONPREGNANT ADULTS; NOD2; PATHOGEN; PHAGOCYTOSIS; DISEASE; COLONIZATION	Group B Streptococcus (GBS) is an important agent of life-threatening invasive infection. It has been previously shown that encapsulated type III GBS is easily internalized by dendritic cells (DCs), and that this internalization had an impact on cytokine production. The receptors underlying these processes are poorly characterized. Knowledge on the mechanisms used by type V GBS to activate DCs is minimal. In this work, we investigated the role of Toll-like receptor (TLR)/MyD88 signaling pathway, the particular involvement of TLR2, and that of the intracellular sensing receptor NOD2 in the activation of DCs by types III and V GBS. The role of capsular polysaccharide (CPS, one of the most important GBS virulence factors) in bacterial-DC interactions was evaluated using non-encapsulated mutants. Despite differences in the role of CPS between types III and V GBS in bacterial internalization and intracellular survival, no major differences were observed in their capacity to modulate release of cytokines by DC. For both serotypes, CPS had a minor role in this response. Production of cytokines by DCs was shown to strongly rely on MyD88-dependent signaling pathways, suggesting that DCs recognize GBS and become activated mostly through TLR signaling. Yet, GBS-infected TLR2(-/-) DCs only showed a partial reduction in the production of IL-6 and CXCL1 compared to control DCs. Surprisingly, CXCL10 release by type III or type V GBS-infected DCs was MyD88-independent. No differences in DC activation were observed between NOD2(-/-) and control DCs. These results demonstrate the involvement of various receptors and the complexity of the cytokine production pathways activated by GBS upon DC infection.	[Lemire, Paul; Roy, David; Bergman, Eugenia; Segura, Mariela] Univ Montreal, Fac Vet Med, Immunol Lab, St Hyacinthe, PQ J2S 7C6, Canada; [Fittipaldi, Nahuel] Publ Hlth Ontario, Toronto, ON, Canada; [Fittipaldi, Nahuel] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Okura, Masatoshi; Takamatsu, Daisuke] Natl Agr & Food Res Org, Natl Inst Anim Hlth, Bacterial & Parasit Dis Res Div, Tsukuba, Ibaraki, Japan; [Takamatsu, Daisuke] Gifu Univ, United Grad Sch Vet Sci, Gifu, Japan	Universite de Montreal; University of Toronto; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Gifu University	Segura, M (corresponding author), Univ Montreal, Fac Vet Med, Immunol Lab, St Hyacinthe, PQ J2S 7C6, Canada.	mariela.segura@umontreal.ca	Segura, Mariela/AAG-5708-2020	Fittipaldi, Nahuel/0000-0001-9553-3798	Natural Sciences and Engineering Research Council of Canada (NSERC) [342150]; "Fonds de recherche du Quebec - Nature et technologies" PhD Awards	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); "Fonds de recherche du Quebec - Nature et technologies" PhD Awards	This work was supported by Natural Sciences and Engineering Research Council of Canada (NSERC, http://www.nserc-crsng.gc.ca/index_eng.asp) through a grant to Mariela Segura (#342150). Paul Lemire and David Roy were the recipients of "Fonds de recherche du Quebec - Nature et technologies" PhD Awards. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alvarez D, 2008, IMMUNITY, V29, P325, DOI 10.1016/j.immuni.2008.08.006; Amaya RA, 2004, J AM GERIATR SOC, V52, P46, DOI 10.1111/j.1532-5415.2004.52009.x; Andrade EB, 2013, J IMMUNOL, V191, P4759, DOI 10.4049/jimmunol.1301752; Bandow K, 2012, FEBS LETT, V586, P1540, DOI 10.1016/j.febslet.2012.04.018; Bebien M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002812; dos Santos MHB, 2013, ANTON LEEUW INT J G, V104, P1125, DOI 10.1007/s10482-013-0034-y; Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158; Bodazewska-Lubas M, 2013, POL J MICROBIOL, V62, P85, DOI 10.33073/pjm-2013-012; Calzas C, 2013, INFECT IMMUN, V81, P3106, DOI 10.1128/IAI.00113-13; Chaffin DO, 2005, J BACTERIOL, V187, P4615, DOI 10.1128/JB.187.13.4615-4626.2005; Charrel-Dennis M, 2008, CELL HOST MICROBE, V4, P543, DOI 10.1016/j.chom.2008.11.002; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Cheng Q, 2001, INFECT IMMUN, V69, P2302, DOI 10.1128/IAI.69.4.2302-2308.2001; Cieslewicz MJ, 2005, INFECT IMMUN, V73, P3096, DOI 10.1128/IAI.73.5.3096-3103.2005; Costa A, 2012, J IMMUNOL, V188, P1953, DOI 10.4049/jimmunol.1102543; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Davies HD, 2001, J INFECT DIS, V184, P285, DOI 10.1086/322029; Davis KM, 2011, J CLIN INVEST, V121, P3666, DOI 10.1172/JCI57761; Deshmukh HS, 2009, INFECT IMMUN, V77, P1376, DOI 10.1128/IAI.00940-08; Deshmukh SD, 2011, EMBO REP, V12, P71, DOI 10.1038/embor.2010.189; Dharancy S, 2010, GASTROENTEROLOGY, V138, P1546, DOI 10.1053/j.gastro.2009.12.008; Draper DW, 2006, IMMUNOL LETT, V102, P202, DOI 10.1016/j.imlet.2005.09.005; Edmond KM, 2012, LANCET, V379, P547, DOI 10.1016/S0140-6736(11)61651-6; Da Costa AFE, 2011, INT J MOL MED, V27, P739, DOI 10.3892/ijmm.2011.635; Edwards MS, 2005, CLIN INFECT DIS, V41, P839, DOI 10.1086/432804; Flo TH, 2000, J IMMUNOL, V164, P2064, DOI 10.4049/jimmunol.164.4.2064; Fujieda M, 2012, INFECT IMMUN, V80, P2053, DOI 10.1128/IAI.06232-11; Henneke P, 2005, J IMMUNOL, V174, P6449, DOI 10.4049/jimmunol.174.10.6449; Henneke P, 2002, J IMMUNOL, V169, P3970, DOI 10.4049/jimmunol.169.7.3970; Henneke P, 2001, J IMMUNOL, V167, P7069, DOI 10.4049/jimmunol.167.12.7069; Johri AK, 2007, INFECT IMMUN, V75, P1473, DOI 10.1128/IAI.00638-06; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kenzel S, 2009, INFECT IMMUN, V77, P2474, DOI 10.1128/IAI.01343-08; Koedel U, 2009, CURR TOP MICROBIOL, V336, P15, DOI 10.1007/978-3-642-00549-7_2; Koenig JM, 2009, PEDIATR CLIN N AM, V56, P689, DOI 10.1016/j.pcl.2009.04.003; Lecours MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044746; Lemire P, 2013, MICROB PATHOGENESIS, V65, P41, DOI 10.1016/j.micpath.2013.09.006; Lemire P, 2012, CELL MICROBIOL, V14, P1707, DOI 10.1111/j.1462-5822.2012.01830.x; Lemire P, 2012, MICROBES INFECT, V14, P1064, DOI 10.1016/j.micinf.2012.05.015; Letiembre M, 2005, INFECT IMMUN, V73, P8397, DOI 10.1128/IAI.73.12.8397-8401.2005; Liu XJ, 2010, GLIA, V58, P839, DOI 10.1002/glia.20968; Lysenko ES, 2007, PLOS PATHOG, V3, P1073, DOI 10.1371/journal.ppat.0030118; Mancuso G, 2004, J IMMUNOL, V172, P6324, DOI 10.4049/jimmunol.172.10.6324; Mancuso G, 2009, NAT IMMUNOL, V10, P587, DOI 10.1038/ni.1733; Monroe KM, 2010, CELL MICROBIOL, V12, P881, DOI 10.1111/j.1462-5822.2010.01478.x; Nagl M, 2002, CLIN DIAGN LAB IMMUN, V9, P1165, DOI 10.1128/CDLI.9.6.1165-1168.2002; Puliti M, 2009, INFECT IMMUN, V77, P1524, DOI 10.1128/IAI.00965-08; Segura M, 2007, EUR J IMMUNOL, V37, P1887, DOI 10.1002/eji.200636553; Selvanantham T, 2013, J IMMUNOL, V191, P5646, DOI 10.4049/jimmunol.1301412; Sendi P, 2008, INFECTION, V36, P100, DOI 10.1007/s15010-007-7251-0; Skoff TH, 2009, CLIN INFECT DIS, V49, P85, DOI 10.1086/599369; Takamatsu D, 2001, PLASMID, V46, P140, DOI 10.1006/plas.2001.1532; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Talati AJ, 2008, MICROBES INFECT, V10, P1106, DOI 10.1016/j.micinf.2008.06.001; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; Tyrrell GJ, 2002, MICROBIOL-SGM, V148, P3921, DOI 10.1099/00221287-148-12-3921; Warner N, 2013, J IMMUNOL, V190, P3, DOI 10.4049/jimmunol.1203103	59	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113940	10.1371/journal.pone.0113940	http://dx.doi.org/10.1371/journal.pone.0113940			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436906	gold, Green Submitted, Green Published			2022-12-26	WOS:000347114900100
J	Wallock-Richards, D; Doherty, CJ; Doherty, L; Clarke, DJ; Place, M; Govan, JRW; Campopiano, DJ				Wallock-Richards, Daynea; Doherty, Catherine J.; Doherty, Lynsey; Clarke, David J.; Place, Marc; Govan, John R. W.; Campopiano, Dominic J.			Garlic Revisited: Antimicrobial Activity of Allicin-Containing Garlic Extracts against Burkholderia cepacia Complex	PLOS ONE			English	Article							CYSTIC-FIBROSIS; ANTIBACTERIAL PRINCIPLE; INFECTION; EPIDEMIOLOGY; INHIBITION; ALLIINASE; PRODUCTS; AJOENE; GROWTH	The antimicrobial activities of garlic and other plant alliums are primarily based on allicin, a thiosulphinate present in crushed garlic bulbs. We set out to determine if pure allicin and aqueous garlic extracts (AGE) exhibit antimicrobial properties against the Burkholderia cepacia complex (Bcc), the major bacterial phytopathogen for alliums and an intrinsicallymultiresistant and life-threatening human pathogen. We prepared an AGE from commercial garlic bulbs and used HPLC to quantify the amount of allicin therein using an aqueous allicin standard (AAS). Initially we determined the minimum inhibitory concentrations (MICs) of the AGE against 38 Bcc isolates; these MICs ranged from 0.5 to 3% (v/v). The antimicrobial activity of pure allicin (AAS) was confirmed by MIC and minimum bactericidal concentration (MBC) assays against a smaller panel of five Bcc isolates; these included three representative strains of the most clinically important species, B. cenocepacia. Time kill assays, in the presence of ten times MIC, showed that the bactericidal activity of AGE and AAS against B. cenocepacia C6433 correlated with the concentration of allicin. We also used protein mass spectrometry analysis to begin to investigate the possible molecular mechanisms of allicin with a recombinant form of a thiol-dependent peroxiredoxin (BCP, Prx) from B. cenocepacia. This revealed that AAS and AGE modifies an essential BCP catalytic cysteine residue and suggests a role for allicin as a general electrophilic reagent that targets protein thiols. To our knowledge, we report the first evidence that allicin and allicin-containing garlic extracts possess inhibitory and bactericidal activities against the Bcc. Present therapeutic options against these lifethreatening pathogens are limited; thus, allicin-containing compounds merit investigation as adjuncts to existing antibiotics.	[Doherty, Catherine J.; Doherty, Lynsey; Place, Marc; Govan, John R. W.] Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland; [Wallock-Richards, Daynea; Clarke, David J.; Campopiano, Dominic J.] Univ Edinburgh, EastChem Sch Chem, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Govan, JRW (corresponding author), Univ Edinburgh, Sch Med, Edinburgh, Midlothian, Scotland.	john.r.w.govan@ed.ac.uk; Dominic.Campopiano@ed.ac.uk	Wallock-Richards, Daynea/AAW-2062-2021	Clarke, David/0000-0002-3741-2952; Campopiano, Dominic/0000-0001-8573-6735	University of Edinburgh; Biotechnology and Biological Sciences Research Council (BBSRC) UK [BB/I013687/1]; Biotechnology and Biological Sciences Research Council [BB/I013687/1] Funding Source: researchfish; BBSRC [BB/I013687/1] Funding Source: UKRI	University of Edinburgh; Biotechnology and Biological Sciences Research Council (BBSRC) UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding: The authors thank The University of Edinburgh for funding a PhD School of Chemistry Tercentenary studentship (DWR). The authors also thank the Biotechnology and Biological Sciences Research Council (BBSRC) UK for funding (award number BB/I013687/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashry NA, 2013, PHARM BIOL, V51, P806, DOI 10.3109/13880209.2013.766895; Balfour-Lynn IM, 2014, J CYST FIBROS, V13, P241, DOI 10.1016/j.jcf.2014.01.003; Banerjee SK, 2002, NUTR J, V1, DOI 10.1186/1475-2891-1-4; Block E., 2010, GARLIC OTHER ALLIUMS; Borlinghaus J, 2014, MOLECULES, V19, P12591, DOI 10.3390/molecules190812591; BURKHOLDER WH, 1950, PHYTOPATHOLOGY, V40, P115; Cavallito CJ, 1944, J AM CHEM SOC, V66, P1950, DOI 10.1021/ja01239a048; CAVALLITO CJ, 1945, J AM CHEM SOC, V67, P1032, DOI 10.1021/ja01222a501; Cavallito CJ, 1944, J AM CHEM SOC, V66, P1952, DOI 10.1021/ja01239a049; Clarke DJ, 2010, BIOCHEMISTRY-US, V49, P1319, DOI 10.1021/bi901703m; Coenye T, 2001, J CLIN MICROBIOL, V39, P3427, DOI 10.1128/JCM.39.10.3427-3436.2001; FELDBERG RS, 1988, ANTIMICROB AGENTS CH, V32, P1763, DOI 10.1128/AAC.32.12.1763; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; FOCKE M, 1990, FEBS LETT, V261, P106, DOI 10.1016/0014-5793(90)80647-2; Fujisawa H, 2008, J AGR FOOD CHEM, V56, P4229, DOI 10.1021/jf8000907; Fujisawa H, 2009, BIOSCI BIOTECH BIOCH, V73, P1948, DOI 10.1271/bbb.90096; Govan JR, 2007, FUTURE MICROBIOL, V2, P153, DOI 10.2217/17460913.2.2.153; Greenberg DE, 2009, CLIN INFECT DIS, V48, P1577, DOI 10.1086/598937; Grimwood K, 2009, J CYST FIBROS, V8, P291, DOI 10.1016/j.jcf.2009.04.002; Holmes A, 1998, EMERG INFECT DIS, V4; Horsley A, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009529.pub2; Horsley A, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00018; Jakobsen TH, 2012, ANTIMICROB AGENTS CH, V56, P2314, DOI 10.1128/AAC.05919-11; Kyung KH, 2012, CURR OPIN BIOTECH, V23, P142, DOI 10.1016/j.copbio.2011.08.004; Lawson LD, 2001, J AGR FOOD CHEM, V49, P2592, DOI 10.1021/jf001287m; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; LiPuma JJ, 2010, CLIN MICROBIOL REV, V23, P299, DOI 10.1128/CMR.00068-09; Loutet Slade A, 2011, Front Cell Infect Microbiol, V1, P6, DOI [10.3389/fmicb.2011.00159, 10.3389/fcimb.2011.00006]; Mahenthiralingam E, 2000, J CLIN MICROBIOL, V38, P910, DOI 10.1128/JCM.38.2.910-913.2000; Mahenthiralingam E, 2011, CHEM BIOL, V18, P665, DOI 10.1016/j.chembiol.2011.01.020; Mil-Homens D, 2012, FEMS MICROBIOL LETT, V328, P61, DOI 10.1111/j.1574-6968.2011.02476.x; Miron T, 2010, EUR J MED CHEM, V45, P1912, DOI 10.1016/j.ejmech.2010.01.031; Naganawa R, 1996, APPL ENVIRON MICROB, V62, P4238, DOI 10.1128/AEM.62.11.4238-4242.1996; National Committee for Clinical Laboratory Standards, 1997, M27A NAT COMM CLIN L, V17, P1; Nzula S, 2002, J ANTIMICROB CHEMOTH, V50, P265, DOI 10.1093/jac/dkf137; O'Sullivan LA, 2005, LETT APPL MICROBIOL, V41, P8, DOI 10.1111/j.1472-765X.2005.01758.x; Papaleo MC, 2012, BIOTECHNOL ADV, V30, P272, DOI 10.1016/j.biotechadv.2011.06.011; Schwan WR, 2010, ANN CLIN MICROB ANTI, V9, DOI 10.1186/1476-0711-9-4; Shimon LJW, 2007, J MOL BIOL, V366, P611, DOI 10.1016/j.jmb.2006.11.041; SMALL LD, 1947, J AM CHEM SOC, V69, P1710, DOI 10.1021/ja01199a040; Smyth AR, 2010, PEDIATR PULM, V45, P356, DOI 10.1002/ppul.21193; Taylor K, 2007, ANTIMICROB AGENTS CH, V51, P1719, DOI 10.1128/AAC.01531-06; Tullis DE, 2014, J CYST FIBROS, V13, P296, DOI 10.1016/j.jcf.2013.08.011; Waag T, 2010, BIOORG MED CHEM LETT, V20, P5541, DOI 10.1016/j.bmcl.2010.07.062; Waters Valerie, 2006, Expert Rev Anti Infect Ther, V4, P807, DOI 10.1586/14787210.4.5.807; Zhang LL, 2013, FOOD FUNCT, V4, P1229, DOI 10.1039/c3fo60057b	46	60	64	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112726	10.1371/journal.pone.0112726	http://dx.doi.org/10.1371/journal.pone.0112726			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438250	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900016
J	Zhu, J; Bi, ZY; Yang, T; Wang, W; Li, Z; Huang, WT; Wang, LP; Zhang, SZ; Zhou, YF; Fan, NN; Bai, Y; Song, WT; Wang, CH; Wang, H; Bi, YY				Zhu, Jie; Bi, Zhuoyue; Yang, Tan; Wang, Wei; Li, Zhen; Huang, Wenting; Wang, Liping; Zhang, Shaozun; Zhou, Yanfeng; Fan, Ningna; Bai, Yue; Song, Wentao; Wang, Chunhong; Wang, Hong; Bi, Yongyi			Regulation of PKM2 and Nrf2-ARE Pathway during Benzoquinone Induced Oxidative Stress in Yolk Sac Hematopoietic Stem Cells	PLOS ONE			English	Article							PYRUVATE-KINASE M2; IN-VITRO; BENZENE; METABOLITES; EXPOSURE; CANCER; TOXICITY; LEUKEMIA; BINDING; INDOOR	Benzene is an occupational toxicant and an environmental pollutant that is able to induce the production of reactive oxygen species (ROS), causing oxidative stress and damages of the macromolecules in target cells, such as the hematopoietic stem cells. We had previously found that embryonic yolk sac hematopoietic stem cells (YS-HSCs) are more sensitive to benzene toxicity than the adult bone marrow hematopoietic stem cells, and that nuclear factor-erythroid-2-related factor 2 (Nrf2) is the major regulator of cytoprotective responses to oxidative stress. In the present report, we investigated the effect of PKM2 and Nrf2-ARE pathway on the cellular antioxidant response to oxidative stress induced by benzene metabolite benzoquinone (BQ) in YS-HSC isolated from embryonic yolk sac and enriched by magnetic-activated cell sorting (MACS). Treatment of the YS-HSC with various concentrations of BQ for 6 hours induces ROS generation in a dose-dependent manner. Additional tests showed that BQ is also capable of inducing expression of NADPH oxidase1 (NOX1), and several other antioxidant enzymes or drug-metabolizing enzymes, including heme oxygenase 1 (HMOX1), superoxide dismutase (SOD), catalase and NAD(P) H dehydrogenase quinone 1 (NQO1). Concomitantly, only the expression of PKM2 protein was decreased by the treatment of BQ but not the PKM2 mRNA, which suggested that BQ may induce PKM2 degradation. Pretreatment of the cells with antioxidant N-acetylcysteine (NAC) decreased ROS generation and prevented BQ-induced PKM2 degradation, suggesting involvement of ROS in the PKM2 protein degradation in cellular response to BQ. These findings suggest that BQ is a potent inducer of ROS generation and the subsequent antioxidant responses of the YS-HSC. The accumulated ROS may attenuate the expression of PKM2, a key regulator of the pyruvate metabolism and glycolysis.	[Zhu, Jie; Yang, Tan; Wang, Wei; Li, Zhen; Huang, Wenting; Zhang, Shaozun; Zhou, Yanfeng; Fan, Ningna; Bai, Yue; Wang, Chunhong; Wang, Hong; Bi, Yongyi] Wuhan Univ, Sch Publ Hlth, Wuhan 430072, Hubei, Peoples R China; [Zhu, Jie; Yang, Tan; Wang, Wei; Li, Zhen; Huang, Wenting; Zhang, Shaozun; Zhou, Yanfeng; Fan, Ningna; Bai, Yue; Wang, Chunhong; Wang, Hong; Bi, Yongyi] Hubei Key Lab Allergy & Immune Related Dis, Wuhan, Hubei, Peoples R China; [Zhu, Jie; Yang, Tan; Wang, Wei; Li, Zhen; Huang, Wenting; Zhang, Shaozun; Zhou, Yanfeng; Fan, Ningna; Bai, Yue; Wang, Chunhong; Wang, Hong; Bi, Yongyi] Wuhan Univ, Hubei Biomassresource Chem & Environm Biotechnol, Wuhan 430072, Hubei, Peoples R China; [Bi, Zhuoyue] Hubei Prov Acad Prevent Med, Hubei Prov Key Lab Appl Toxicol, Wuhan, Peoples R China; [Wang, Liping] Kunming Med Univ, Sch Publ Hlth, Chenggong Dist, Kunming, Peoples R China; [Song, Wentao] Nanchang Ctr Dis Control & Prevent, Nanchang, Peoples R China	Wuhan University; Wuhan University; Kunming Medical University	Wang, H (corresponding author), Wuhan Univ, Sch Publ Hlth, Wuhan 430072, Hubei, Peoples R China.	whwhgyg@163.com; yongyib@aliyun.com		Bi, Zhuoyue/0000-0001-8559-3543	Chinese National Natural Science Foundation [81372961, 81102104]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	The project was supported by Chinese National Natural Science Foundation to YYB (no. 81372961) and Chinese National Natural Science Foundation to HW (grant no. 81102104, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abernethy DJ, 2004, TOXICOL SCI, V79, P82, DOI 10.1093/toxsci/kfh095; Anastasiou D, 2011, SCIENCE, V334, P1278, DOI 10.1126/science.1211485; Badham HJ, 2010, TOXICOL APPL PHARM, V244, P273, DOI 10.1016/j.taap.2010.01.002; Badham HJ, 2010, TOXICOL SCI, V113, P207, DOI 10.1093/toxsci/kfp242; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Chatzis C, 2005, SCI TOTAL ENVIRON, V349, P72, DOI 10.1016/j.scitotenv.2005.01.034; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Eden T, 2010, CANCER TREAT REV, V36, P286, DOI 10.1016/j.ctrv.2010.02.004; Filosa S, 2003, BIOCHEM J, V370, P935, DOI 10.1042/BJ20021614; Ghaffari S, 2008, ANTIOXID REDOX SIGN, V10, P1923, DOI 10.1089/ars.2008.2142; Harrison RM, 1999, OCCUP ENVIRON MED, V56, P774, DOI 10.1136/oem.56.11.774; KOLACHANA P, 1993, CANCER RES, V53, P1023; Kwak MK, 2004, MUTAT RES-FUND MOL M, V555, P133, DOI 10.1016/j.mrfmmm.2004.06.041; Lau A, 2009, MUTAT RES-GEN TOX EN, V676, P74, DOI 10.1016/j.mrgentox.2009.04.001; Nguyen T, 2004, FREE RADICAL BIO MED, V37, P433, DOI 10.1016/j.freeradbiomed.2004.04.033; Nguyen T, 2003, ANNU REV PHARMACOL, V43, P233, DOI 10.1146/annurev.pharmtox.43.100901.140229; Ross D, 2000, J TOXICOL ENV HEAL A, V61, P357, DOI 10.1080/00984100050166361; Rubio V, 2011, TOXICOL IN VITRO, V25, P521, DOI 10.1016/j.tiv.2010.10.021; Shen Y, 1996, HUM EXP TOXICOL, V15, P422, DOI 10.1177/096032719601500510; Smith MT, 2010, ANNU REV PUBL HEALTH, V31, P133, DOI 10.1146/annurev.publhealth.012809.103646; Steffen C, 2004, OCCUP ENVIRON MED, V61, P773, DOI 10.1136/oem.2003.010868; Swaen GMH, 2010, OCCUP ENVIRON MED, V67, P286, DOI 10.1136/oem.2009.047464; Tong KI, 2006, MOL CELL BIOL, V26, P2887, DOI 10.1128/MCB.26.8.2887-2900.2006; Wang YH, 2013, BLOOD, V122; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Zhang JF, 2003, BRIT MED BULL, V68, P209, DOI 10.1093/bmb/ldg029; Zhu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071153	28	12	12	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113733	10.1371/journal.pone.0113733	http://dx.doi.org/10.1371/journal.pone.0113733			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437431	gold, Green Submitted, Green Published			2022-12-26	WOS:000347114900072
J	O'Toole, MD; Lea, MA; Guinet, C; Hindell, MA				O'Toole, Malcolm D.; Lea, Mary-Anne; Guinet, Christophe; Hindell, Mark A.			Estimating Trans-Seasonal Variability in Water Column Biomass for a Highly Migratory, Deep Diving Predator	PLOS ONE			English	Article							SOUTHERN ELEPHANT SEALS; BIOOPTICAL PROPERTIES; MIROUNGA-LEONINA; CASE-1 WATERS; CHLOROPHYLL; PHYTOPLANKTON; SCALE; TEMPERATURE; ABSORPTION; TILETAMINE	The deployment of animal-borne electronic tags is revolutionizing our understanding of how pelagic species respond to their environment by providing in situ oceanographic information such as temperature, salinity, and light measurements. These tags, deployed on pelagic animals, provide data that can be used to study the ecological context of their foraging behaviour and surrounding environment. Satellite-derived measures of ocean colour reveal temporal and spatial variability of surface chlorophyll-a (a useful proxy for phytoplankton distribution). However, this information can be patchy in space and time resulting in poor correspondence with marine animal behaviour. Alternatively, light data collected by animal-borne tag sensors can be used to estimate chlorophyll-a distribution. Here, we use light level and depth data to generate a phytoplankton index that matches daily seal movements. Time-depth-light recorders (TDLRs) were deployed on 89 southern elephant seals (Mirounga leonina) over a period of 6 years (1999-2005). TDLR data were used to calculate integrated light attenuation of the top 250 m of the water column (LA(250)), which provided an index of phytoplankton density at the daily scale that was concurrent with the movement and behaviour of seals throughout their entire foraging trip. These index values were consistent with typical seasonal chl-a patterns as measured from 8-daySea-viewing Wide Field-of-view Sensor (SeaWiFs) images. The availability of data recorded by the TDLRs was far greater than concurrent remotely sensed chl-a at higher latitudes and during winter months. Improving the spatial and temporal availability of phytoplankton information concurrent with animal behaviour has ecological implications for understanding the movement of deep diving predators in relation to lower trophic levels in the Southern Ocean. Light attenuation profiles recorded by animal-borne electronic tags can be used more broadly and routinely to estimate lower trophic distribution at sea in relation to deep diving predator foraging behaviour.	[O'Toole, Malcolm D.; Lea, Mary-Anne; Hindell, Mark A.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Guinet, Christophe] Ctr Eud Biol Chize, Marine Predator Dept, Villiers En Bois, France	University of Tasmania	O'Toole, MD (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	otoolem@utas.edu.au	Guinet, Christophe/AAR-8457-2020; Lea, Mary-Anne/E-9054-2013	Lea, Mary-Anne/0000-0001-8318-9299; Hindell, Mark/0000-0002-7823-7185	Australian Research Council; Natural Sciences and Engineering Research Council of Canada; Sea World Research and Rescue Foundation Inc.; Australian Antarctic Science Programme; Australian Postgraduate Award	Australian Research Council(Australian Research Council); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Sea World Research and Rescue Foundation Inc.; Australian Antarctic Science Programme; Australian Postgraduate Award(Australian Government)	This research was funded by the Australian Research Council, the Natural Sciences and Engineering Research Council of Canada, Sea World Research and Rescue Foundation Inc., and the Australian Antarctic Science Programme. MO was supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvain S, 2005, DEEP-SEA RES PT I, V52, P1989, DOI 10.1016/j.dsr.2005.06.015; Arrigo KR, 2008, J GEOPHYS RES C, V113, P1997; Behrenfeld MJ, 1997, LIMNOL OCEANOGR, V42, P1, DOI 10.4319/lo.1997.42.1.0001; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Bost CA, 2009, J MARINE SYST, V78, P363, DOI 10.1016/j.jmarsys.2008.11.022; Bost CA, 2009, BIOL LETTERS, V5, P473, DOI 10.1098/rsbl.2009.0265; Boyd IL, 1996, CAN J ZOOL, V74, P1696, DOI 10.1139/z96-187; Bradshaw CJA, 2004, ICES J MAR SCI, V61, P1014, DOI 10.1016/j.icesjms.2004.07.012; Bradshaw CJA, 2002, ICES J MAR SCI, V59, P770, DOI 10.1006/jmsc.2002.1246; Bricaud A, 1998, J GEOPHYS RES-OCEANS, V103, P31033, DOI 10.1029/98JC02712; BRICAUD A, 1981, LIMNOL OCEANOGR, V26, P43; Burghart SE, 1999, POLAR BIOL, V22, P279, DOI 10.1007/s003000050421; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Campagna C, 2001, MAR MAMMAL SCI, V17, P402, DOI 10.1111/j.1748-7692.2001.tb01283.x; Cavalieri D.J., 1996, SEA ICE CONCENTRATIO; Charrassin JB, 2008, P NATL ACAD SCI USA, V105, P11634, DOI 10.1073/pnas.0800790105; Costa DP, 2010, INTEGR COMP BIOL, V50, P1018, DOI 10.1093/icb/icq054; d'Ovidio F, 2010, P NATL ACAD SCI USA, V107, P18366, DOI 10.1073/pnas.1004620107; de Baar HJW, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002601; DELONG RL, 1992, MAR MAMMAL SCI, V8, P155, DOI 10.1111/j.1748-7692.1992.tb00375.x; Ekstrom Philip A., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P210; Sala JE, 2011, POLAR BIOL, V34, P1197, DOI 10.1007/s00300-011-0981-6; Fedak MA, 2013, DEEP-SEA RES PT II, V88-89, P7, DOI 10.1016/j.dsr2.2012.07.007; FENTON N, 1994, ANTARCT SCI, V6, P443, DOI 10.1017/S0954102094000684; Field I, 2001, ANTARCT SCI, V13, P371, DOI 10.1017/S0954102001000529; Field IC, 2002, VET REC, V151, P235, DOI 10.1136/vr.151.8.235; Garcia-Munoz C, 2013, POLAR BIOL, V36, P1107, DOI 10.1007/s00300-013-1333-5; Guinet C, 2013, EARTH SYST SCI DATA, V5, P15, DOI 10.5194/essd-5-15-2013; Guinet C, 2001, MAR ECOL PROG SER, V219, P251, DOI 10.3354/meps219251; Guinet C, 2014, MAR ECOL PROG SER, V499, P285, DOI 10.3354/meps10660; Hill C., 2001, ELECT TAGGING TRACKI, P315, DOI DOI 10.1007/978-94-017-1402-0_17; Hill Roger D., 1994, P227; Hindell M, 2010, MARINE MAMMAL ECOLOG, P241; Hindell MA, 1997, MARINE MAMMAL RESEARCH IN THE SOUTHERN HEMISPHERE, VOL 1, P72; Hirawake T, 2000, J OCEANOGR, V56, P245; Holm-Hansen O, 2005, MAR ECOL PROG SER, V297, P71, DOI 10.3354/meps297071; Jaud T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047444; Johnson R, 2013, J GEOPHYS RES-OCEANS, V118, P3694, DOI 10.1002/jgrc.20270; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Lea MA, 2006, MAR ECOL PROG SER, V310, P77, DOI 10.3354/meps310077; Lizotte MP, 2001, AM ZOOL, V41, P57, DOI 10.1668/0003-1569(2001)041[0057:TCOSIA]2.0.CO;2; Loisel H, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015948; McCafferty DJ, 2004, MAR BIOL, V146, P191, DOI 10.1007/s00227-004-1428-1; McCafferty DJ, 1999, MAR BIOL, V134, P387, DOI 10.1007/s002270050555; McClain CR, 1998, SEA TECHNOL, V39, P10; Mcintyre T, 2012, ANTARCT SCI, V24, P561, DOI 10.1017/S0954102012000570; McMahon CR, 2008, J EXP MAR BIOL ECOL, V360, P71, DOI 10.1016/j.jembe.2008.03.012; McMahon CR, 2000, VET REC, V146, P251, DOI 10.1136/vr.146.9.251; Moore JK, 2002, J MARINE SYST, V37, P69, DOI 10.1016/S0924-7963(02)00196-3; MOREL A, 1977, LIMNOL OCEANOGR, V22, P709, DOI 10.4319/lo.1977.22.4.0709; Morel A, 2001, J GEOPHYS RES-OCEANS, V106, P7163, DOI 10.1029/2000JC000319; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Park YH, 1998, J MARINE SYST, V17, P571, DOI 10.1016/S0924-7963(98)00065-7; ROBINS DB, 1995, DEEP-SEA RES PT II, V42, P1137, DOI 10.1016/0967-0645(95)00058-X; Sarkar D., 2019, NLME LINEAR NONLINEA; SMITH RC, 1978, LIMNOL OCEANOGR, V23, P247, DOI 10.4319/lo.1978.23.2.0247; Sokolov S, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004072; Stramski D, 2001, APPL OPTICS, V40, P2929, DOI 10.1364/AO.40.002929; Sumner M, 2010, METROPOLIS SAMPLER S; Sumner MD, 2003, REMOTE SENS ENVIRON, V84, P161, DOI 10.1016/S0034-4257(02)00103-7; Sumner MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007324; Teo SLH, 2009, AQUAT BIOL, V5, P195, DOI 10.3354/ab00152; Thomalla SJ, 2011, BIOGEOSCIENCES, V8, P2849, DOI 10.5194/bg-8-2849-2011; Thums M, 2008, MAR ECOL PROG SER, V370, P249, DOI 10.3354/meps07613; Vacquie-Garcia J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043565; Zhao L, 2013, CHIN J OCEANOL LIMN, V31, P247, DOI 10.1007/s00343-013-2085-3; Zuur Alain F., 2009, P1	67	5	5	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113171	10.1371/journal.pone.0113171	http://dx.doi.org/10.1371/journal.pone.0113171			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427104	gold, Green Submitted, Green Published			2022-12-26	WOS:000349145400036
J	Ye, CY; Lin, ZX; Li, GM; Wang, YY; Qiu, J; Fu, F; Zhang, HQ; Chen, L; Ye, SS; Song, WJ; Jin, GL; Zhu, JW; Lu, YL; Guo, LB; Fan, LJ				Ye, Chu-Yu; Lin, Zhangxiang; Li, Gengmi; Wang, Ying-Ying; Qiu, Jie; Fu, Fei; Zhang, Haiqiang; Chen, Li; Ye, Sisi; Song, Weijie; Jin, Gulei; Zhu, Jinwen; Lu, Yongliang; Guo, Longbiao; Fan, Longjiang			Echinochloa Chloroplast Genomes: Insights into the Evolution and Taxonomic Identification of Two Weedy Species	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; CRUS-GALLI; POPULATION; SEQUENCES; MARKERS; ANGIOSPERMS; ALIGNMENTS; MANAGEMENT; POACEAE; RICE	The genus Echinochloa (Poaceae) includes numerous problematic weeds that cause the reduction of crop yield worldwide. To date, DNA sequence information is still limited in the genus Echinochloa. In this study, we completed the entire chloroplast genomes of two Echinochloa species (Echinochloa oryzicola and Echinochloa crus-galli) based on high-throughput sequencing data from their fresh green leaves. The two Echinochloa chloroplast genomes are 139,891 and 139,800 base pairs in length, respectively, and contain 131 protein-coding genes, 79 indels and 466 substitutions helpful for discrimination of the two species. The divergence between the genus Echinochloa and Panicum occurred about 21.6 million years ago, whereas the divergence between E. oryzicola and E. crus-galli chloroplast genes occurred about 3.3 million years ago. The two reported Echinochloa chloroplast genome sequences contribute to better understanding of the diversification of this genus.	[Ye, Chu-Yu; Lin, Zhangxiang; Wang, Ying-Ying; Qiu, Jie; Fu, Fei; Zhang, Haiqiang; Chen, Li; Ye, Sisi; Fan, Longjiang] Zhejiang Univ, Dept Agron, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Gengmi; Lu, Yongliang; Guo, Longbiao] Chinese Acad Agr Sci, State Key Lab Rice Biol, China Natl Rice Res Inst, Hangzhou, Zhejiang, Peoples R China; [Song, Weijie; Jin, Gulei] Guhe Info Corp, Hangzhou, Zhejiang, Peoples R China; [Zhu, Jinwen] Zhejiang Univ, Dept Plant Protect, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Chinese Academy of Agricultural Sciences; China National Rice Research Institute, CAAS; Zhejiang University	Guo, LB (corresponding author), Chinese Acad Agr Sci, State Key Lab Rice Biol, China Natl Rice Res Inst, Hangzhou, Zhejiang, Peoples R China.	guolongbiao@caas.cn; fanlj@zju.edu.cn	Qiu, Jie/ABC-9247-2021	Qiu, Jie/0000-0003-1799-1907; Wang, Yingying/0000-0002-0603-6691; Fan, Longjiang/0000-0003-4846-0500	National Natural Science Foundation of China [31221004, 31171863]; National Transgenic Research Program [2014ZX001-003]; Fundamental Research Funds for the Central Universities [2014QNA6023]; Guhe info Corp.	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Transgenic Research Program; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Guhe info Corp.	This work was supported by the National Natural Science Foundation of China (31221004, 31171863), the National Transgenic Research Program (2014ZX001-003), and the Fundamental Research Funds for the Central Universities (2014QNA6023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Guhe info Corp. provided support in the form of salaries for authors WS and GJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aliscioni SS, 2003, AM J BOT, V90, P796, DOI 10.3732/ajb.90.5.796; Aoki D, 2008, WEED BIOL MANAG, V8, P233, DOI 10.1111/j.1445-6664.2008.00303.x; Aoki D, 2009, WEED BIOL MANAG, V9, P225, DOI 10.1111/j.1445-6664.2009.00343.x; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Chauhan BS, 2011, CROP PROT, V30, P1385, DOI 10.1016/j.cropro.2011.07.013; Clayton W. D., 1986, Kew Bulletin Additional Series, V13; Clayton W. D., 2006, GRASSBASE ONLINE WOR; Conant GC, 2008, BIOINFORMATICS, V24, P861, DOI 10.1093/bioinformatics/btm598; Doorduin L, 2011, DNA RES, V18, P93, DOI 10.1093/dnares/dsr002; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Giussani LM, 2001, AM J BOT, V88, P1993, DOI 10.2307/3558427; GRAF B, 1992, AGR SYST, V40, P345, DOI 10.1016/0308-521X(92)90046-Q; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HILU KW, 1994, PLANT SYST EVOL, V189, P247, DOI 10.1007/BF00939730; Holm L. G., 1977, The world's worst weeds.; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee RM, 2009, WEED SCI, V57, P463, DOI 10.1614/WS-09-021.1; Leseberg CH, 2009, J MOL EVOL, V69, P311, DOI 10.1007/s00239-009-9275-9; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Liebman M., 2001, WEEDS SOIL ENV; Mayor C, 2000, BIOINFORMATICS, V16, P1046, DOI 10.1093/bioinformatics/16.11.1046; Michael P, 2003, ECHINOCHLOA P BEAUV, V25, P390; Middleton CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085761; Moon ByeongChul, 2010, Journal of Crop Science and Biotechnology, V13, P121; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nie XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036869; Rao AN, 2007, ADV AGRON, V93, P153, DOI 10.1016/S0065-2113(06)93004-1; Raubeson LA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-174; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Scarcelli N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019954; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Small RL, 1999, MOL BIOL EVOL, V16, P491, DOI 10.1093/oxfordjournals.molbev.a026131; Small RL, 2004, AUST SYST BOT, V17, P145, DOI 10.1071/SB03015; Straub SCK, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-211; Tabacchi M, 2006, WEED SCI, V54, P1086, DOI 10.1614/WS-06-018R1.1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tangphatsornruang S, 2010, DNA RES, V17, P11, DOI 10.1093/dnares/dsp025; Tateoka T., 1957, J JPN BOT, V32, P275; Tautz D, 2003, TRENDS ECOL EVOL, V18, P70, DOI 10.1016/S0169-5347(02)00041-1; Tsuchiya T, 1971, BARLEY GENET NWSL, V1, P71; Wang W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022993; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; YABUNO T, 1966, JPN J BOT, V19, P277; YABUNO T, 1981, CYTOLOGIA, V46, P393, DOI 10.1508/cytologia.46.393; Yamaguchi H, 2005, WEED BIOL MANAG, V5, P210, DOI 10.1111/j.1445-6664.2005.00185.x; Yang JB, 2013, BMC EVOL BIOL, V13, DOI [10.1186/1471-2148-13-84, 10.1186/1471-244X-13-150]; Yang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012762; Yasuda Kentaro, 2002, Weed Biology and Management, V2, P11, DOI 10.1046/j.1445-6664.2002.00041.x; Yin P, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-22; Young HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023980; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zhang GY, 2012, NAT BIOTECHNOL, V30, P549, DOI 10.1038/nbt.2195; Zou XH, 2013, NEW PHYTOL, V198, P1155, DOI 10.1111/nph.12230	54	33	33	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113657	10.1371/journal.pone.0113657	http://dx.doi.org/10.1371/journal.pone.0113657			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427255	Green Submitted, Green Published, gold			2022-12-26	WOS:000349145400074
J	Anekal, PV; Yong, J; Manser, E				Anekal, Praju Vikas; Yong, Jeffery; Manser, Ed			Arg Kinase-binding Protein 2 (ArgBP2) Interaction with alpha-Actinin and Actin Stress Fibers Inhibits Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONMUSCLE MYOSIN-II; CYTOSKELETAL ORGANIZATION; EPITHELIAL-CELLS; ADAPTER PROTEIN; Z-DISC; LOCALIZATION; EXPRESSION; ADHESION; FAMILY; PHOSPHORYLATION	Cell migration requires dynamic remodeling of the actomyosin network. We report here that an adapter protein, ArgBP2, is a component of alpha-actinin containing stress fibers and inhibits migration. ArgBP2 is undetectable in many commonly studied cancer-derived cell lines. COS-7 and HeLa cells express ArgBP2 (by Western analysis), but expression was detectable only in approximately half the cells by immunofluorescence. Short term clonal analysis demonstrated 0.2-0.3% of cells switch ArgBP2 expression (on or off) per cell division. ArgBP2 can have a fundamental impact on the actomyosin network: ArgBP2 positive COS-7 cells, for example, are clearly distinguishable by their denser actomyosin (stress fiber) network. ArgBP2 gamma binding to alpha-actinin appears to underlie its ability to localize to stress fibers and decrease cell migration. We map a small alpha-actinin binding region in ArgBP2 (residues 192-228) that is essential for these effects. Protein kinase A phosphorylation of ArgBP2 gamma at neighboring Ser-259 and consequent 14-3-3 binding blocks its interaction with alpha-actinin. ArgBP2 is known to be down-regulated in some aggressively metastatic cancers. Our work provides a biochemical explanation for the anti-migratory effect of ArgBP2.	[Anekal, Praju Vikas; Yong, Jeffery; Manser, Ed] sGSK Grp Inst Mol & Cell Biol IMCB, Singapore 138673, Singapore; [Manser, Ed] IMB, Singapore 138648, Singapore; [Manser, Ed] Natl Univ Singapore, Dept Pharmacol, Singapore 119077, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore	Manser, E (corresponding author), sGSK Grp Inst Mol & Cell Biol IMCB, Proteos Bldg,61 Biopolis Dr, Singapore 138673, Singapore.	ed.manser@imb.a-star.edu.sg	Manser, Edward/ABD-2301-2020		GSK-Institute of Molecular and Cell Biology research fund	GSK-Institute of Molecular and Cell Biology research fund	This work was supported in part by the GSK-Institute of Molecular and Cell Biology research fund.	Backsch C, 2011, CARCINOGENESIS, V32, P1100, DOI 10.1093/carcin/bgr093; Barth AS, 2006, J AM COLL CARDIOL, V48, P1610, DOI 10.1016/j.jacc.2006.07.026; Baumann CA, 2000, NATURE, V407, P202, DOI 10.1038/35025089; Burnette DT, 2014, J CELL BIOL, V205, P83, DOI 10.1083/jcb.201311104; Cestra G, 2005, P NATL ACAD SCI USA, V102, P1731, DOI 10.1073/pnas.0409376102; Chan PM, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.005157; Faul C, 2007, MOL CELL BIOL, V27, P8215, DOI 10.1128/MCB.00950-07; Frank D, 2006, J MOL MED, V84, P446, DOI 10.1007/s00109-005-0033-1; Gao CZ, 2010, BBA-MOL CELL RES, V1803, P1186, DOI 10.1016/j.bbamcr.2010.06.008; GEIGER B, 1981, J CELL BIOL, V91, P614, DOI 10.1083/jcb.91.3.614; Gohla A, 2002, CURR BIOL, V12, P1704, DOI 10.1016/S0960-9822(02)01184-3; Haglund K, 2004, J CELL SCI, V117, P2557, DOI 10.1242/jcs.01148; Hampton CM, 2007, J MOL BIOL, V368, P92, DOI 10.1016/j.jmb.2007.01.071; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Kawabe H, 1999, J BIOL CHEM, V274, P30914, DOI 10.1074/jbc.274.43.30914; Kioka N, 1999, J CELL BIOL, V144, P59, DOI 10.1083/jcb.144.1.59; Kioka N, 2002, CELL STRUCT FUNCT, V27, P1, DOI 10.1247/csf.27.1; Koga Y, 2008, MOL BIOL CELL, V19, P1062, DOI 10.1091/mbc.E07-07-0668; LAZARIDES E, 1975, CELL, V6, P289, DOI 10.1016/0092-8674(75)90180-4; Leung T, 1996, MOL CELL BIOL, V16, P5313; Lopez-Girona A, 1999, NATURE, V397, P172, DOI 10.1038/16488; Mackintosh C, 2004, BIOCHEM J, V381, P329, DOI 10.1042/BJ20031332; Mandai K, 1999, J CELL BIOL, V144, P1001, DOI 10.1083/jcb.144.5.1001; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Martin M, 2013, EMBO J, V32, P2491, DOI 10.1038/emboj.2013.187; Mestre-Escorihuela C, 2007, BLOOD, V109, P271, DOI 10.1182/blood-2006-06-026500; Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7; Murase K, 2012, MED MOL MORPHOL, V45, P22, DOI 10.1007/s00795-010-0537-9; Muslin AJ, 2000, CELL SIGNAL, V12, P703, DOI 10.1016/S0898-6568(00)00131-5; Nakamura T, 2004, ONCOGENE, V23, P2385, DOI 10.1038/sj.onc.1207392; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Pyle WG, 2004, CIRC RES, V94, P296, DOI 10.1161/01.RES.0000116143.74830.A9; Robens JM, 2010, MOL CELL BIOL, V30, P829, DOI 10.1128/MCB.01574-08; Roignot J, 2010, CANCER LETT, V288, P116, DOI 10.1016/j.canlet.2009.06.030; Roignot J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087130; Roignot J, 2009, CELL ADHES MIGR, V3, P167, DOI 10.4161/cam.3.2.7576; Ronty M, 2005, EXP CELL RES, V310, P88, DOI 10.1016/j.yexcr.2005.06.026; SANGER JW, 1983, J CELL BIOL, V96, P961, DOI 10.1083/jcb.96.4.961; Scaife RM, 2000, J CELL SCI, V113, P215; Scaife RM, 2003, J CELL SCI, V116, P463, DOI 10.1242/jcs.00244; Taieb D, 2008, CANCER RES, V68, P4588, DOI 10.1158/0008-5472.CAN-08-0958; Tan I, 2008, CELL, V135, P123, DOI 10.1016/j.cell.2008.09.018; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang BL, 1997, J BIOL CHEM, V272, P17542, DOI 10.1074/jbc.272.28.17542; WAY M, 1992, J CELL BIOL, V119, P835, DOI 10.1083/jcb.119.4.835; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; Yamaguchi H, 2005, CURR OPIN CELL BIOL, V17, P559, DOI 10.1016/j.ceb.2005.08.002; Yuan ZQ, 2005, J BIOL CHEM, V280, P21483, DOI 10.1074/jbc.M500097200	51	23	25	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2112	2125		10.1074/jbc.M114.610725	http://dx.doi.org/10.1074/jbc.M114.610725			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25429109	hybrid, Green Published			2022-12-26	WOS:000348588000017
J	Desai, R; Geeves, MA; Kad, NM				Desai, Rama; Geeves, Michael A.; Kad, Neil M.			Using Fluorescent Myosin to Directly Visualize Cooperative Activation of Thin Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TROPONIN-TROPOMYOSIN; MOLECULE MECHANICS; HEAVY-MEROMYOSIN; ACTIN-FILAMENTS; MUSCLE; SUBFRAGMENT-1; PROTEINS; DYNAMICS; CALCIUM; FORCE	Contraction of striated muscle is tightly regulated by the release and sequestration of calcium within myocytes. At the molecular level, calcium modulates myosin's access to the thin filament. Once bound, myosin is hypothesized to potentiate the binding of further myosins. Here, we directly image single molecules of myosin binding to and activating thin filaments. Using this approach, the cooperative binding of myosin along thin filaments has been quantified. We have found that two myosin heads are required to laterally activate a regulatory unit of thin filament. The regulatory unit is found to be capable of accommodating 11 additional myosins. Three thin filament activation states possessing differential myosin binding capacities are also visible. To describe this system, we have formulated a simple chemical kinetic model of cooperative activation that holds across a wide range of solution conditions. The stochastic nature of activation is strongly highlighted by data obtained in suboptimal activation conditions where the generation of activation waves and their catastrophic collapse can be observed. This suggests that the thin filament has the potential to be turned fully on or off in a binary fashion.	[Desai, Rama; Geeves, Michael A.; Kad, Neil M.] Univ Kent, Sch Biosci, Canterbury C12 7NH, Kent, England	University of Kent	Kad, NM (corresponding author), Univ Kent, Sch Biosci, Canterbury C12 7NH, Kent, England.	n.kad@kent.ac.uk	Geeves, Michael/F-7583-2011	Geeves, Michael/0000-0002-9364-8898; Kad, Neil/0000-0002-3491-8595	Biotechnology and Biological Sciences Research Council [BB/I003460/1]; Wellcome Trust [085309]; BBSRC [BB/I003460/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/I003460/1 (to N. M. K.), and the Wellcome Trust Programme Grant 085309 (to M. A. G.).	COOKE R, 1978, J MOL BIOL, V120, P361, DOI 10.1016/0022-2836(78)90424-2; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; FRASER IDC, 1995, J BIOL CHEM, V270, P7836, DOI 10.1074/jbc.270.14.7836; Fusi L, 2014, P NATL ACAD SCI USA, V111, P4626, DOI 10.1073/pnas.1321868111; Galinska-Rakoczy A, 2008, J MOL BIOL, V379, P929, DOI 10.1016/j.jmb.2008.04.062; Geeves MA, 2011, COMPREHENSIVE BIOPHYSICS, VOL 4: MOLECULAR MOTORS AND MOTILITY, P251, DOI 10.1016/B978-0-12-374920-8.00416-1; GEEVES MA, 1994, BIOPHYS J, V67, P273, DOI 10.1016/S0006-3495(94)80478-3; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Gorga JA, 2003, BIOPHYS J, V85, P2484, DOI 10.1016/S0006-3495(03)74671-2; GREENE LE, 1980, P NATL ACAD SCI-BIOL, V77, P2616, DOI 10.1073/pnas.77.5.2616; Guilford WH, 1997, BIOPHYS J, V72, P1006, DOI 10.1016/S0006-3495(97)78753-8; HACKNEY DD, 1984, P NATL ACAD SCI-BIOL, V81, P5345, DOI 10.1073/pnas.81.17.5345; Homsher E, 1996, BIOPHYS J, V70, P1881, DOI 10.1016/S0006-3495(96)79753-9; Iino R, 2001, BIOPHYS J, V80, P2667, DOI 10.1016/S0006-3495(01)76236-4; Jain A, 2011, NATURE, V473, P484, DOI 10.1038/nature10016; Kad NM, 2010, MOL CELL, V37, P702, DOI 10.1016/j.molcel.2010.02.003; Kad NM, 2005, P NATL ACAD SCI USA, V102, P16990, DOI 10.1073/pnas.0506326102; Kad NM, 2003, J CELL BIOL, V162, P481, DOI 10.1083/jcb.200304023; Kalyva A, 2012, BIOCHEMISTRY-US, V51, P6388, DOI 10.1021/bi300340r; Konopka CA, 2008, PLANT J, V53, P186, DOI 10.1111/j.1365-313X.2007.03306.x; LEHRER SS, 1982, J BIOL CHEM, V257, P8073; Loong CKP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039676; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; Maytum R, 1999, BIOCHEMISTRY-US, V38, P1102, DOI 10.1021/bi981603e; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Mijailovich SM, 2012, EUR BIOPHYS J BIOPHY, V41, P1015, DOI 10.1007/s00249-012-0859-8; MOLLOY JE, 1995, BIOPHYS J, V68, pS298; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Phillips GN, 1996, BIOPOLYMERS, V38, P89, DOI 10.1002/(SICI)1097-0282(199601)38:1<89::AID-BIP7>3.3.CO;2-X; Poole KJV, 2006, J STRUCT BIOL, V155, P273, DOI 10.1016/j.jsb.2006.02.020; Schaertl S, 1995, BIOCHEMISTRY-US, V34, P15890, DOI 10.1021/bi00049a003; SILVERMAN BW, 1984, ANN STAT, V12, P898, DOI 10.1214/aos/1176346710; Smith DA, 2003, BIOPHYS J, V84, P3168, DOI 10.1016/S0006-3495(03)70041-1; Tanaka H, 1998, BIOPHYS J, V75, P1886, DOI 10.1016/S0006-3495(98)77629-5; Tardiff JC, 2005, HEART FAIL REV, V10, P237, DOI 10.1007/s10741-005-5253-5; Tobacman LS, 2000, J BIOL CHEM, V275, P27587; Tobacman LS, 1996, ANNU REV PHYSIOL, V58, P447, DOI 10.1146/annurev.physiol.58.1.447; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Tyska MJ, 1999, P NATL ACAD SCI USA, V96, P4402, DOI 10.1073/pnas.96.8.4402; Ulbrich MH, 2007, NAT METHODS, V4, P319, DOI 10.1038/NMETH1024; Vibert P, 1997, J MOL BIOL, V266, P8, DOI 10.1006/jmbi.1996.0800	42	34	34	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					1915	1925		10.1074/jbc.M114.609743	http://dx.doi.org/10.1074/jbc.M114.609743			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25429108	Green Published, hybrid			2022-12-26	WOS:000348588000002
J	Wei, Y; Stec, B; Redfield, AG; Weerapana, E; Roberts, MF				Wei, Yang; Stec, Boguslaw; Redfield, Alfred G.; Weerapana, Eranthie; Roberts, Mary F.			Phospholipid-binding Sites of Phosphatase and Tensin Homolog (PTEN) EXPLORING THE MECHANISM OF PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIELD-CYCLING NMR; TUMOR-SUPPRESSOR FUNCTION; MEMBRANE ASSOCIATION; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; ANIONIC PHOSPHOLIPIDS; RELAXATION; ACTIVATION; DYNAMICS; PHOSPHOINOSITIDES; MECHANISM	The lipid phosphatase activity of the tumor suppressor phosphatase and tensin homolog (PTEN) is enhanced by the presence of its biological product, phosphatidylinositol 4,5-bisphosphate (PI(4,5)P-2). This enhancement is suggested to occur via the product binding to the N-terminal region of the protein. PTEN effects on short-chain phosphoinositide P-31 linewidths and on the full field dependence of the spin-lattice relaxation rate (measured by high resolution field cycling P-31 NMR using spin-labeled protein) are combined with enzyme kinetics with the same short-chain phospholipids to characterize where PI(4,5)P-2 binds on the protein. The results are used to model a discrete site for a PI(4,5)P-2 molecule close to, but distinct from, the active site of PTEN. This PI(4,5)P-2 site uses Arg-47 and Lys-13 as phosphate ligands, explaining why PTEN R47G and K13E can no longer be activated by that phosphoinositide. Placing a PI(4,5)P-2 near the substrate site allows for proper orientation of the enzyme on interfaces and should facilitate processive catalysis.	[Wei, Yang; Stec, Boguslaw; Weerapana, Eranthie; Roberts, Mary F.] Boston Coll, Dept Chem, Chestnut Hill, MA 02467 USA; [Redfield, Alfred G.] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA	Boston College; Brandeis University	Roberts, MF (corresponding author), Boston Coll, Dept Chem, 2609 Beacon St, Chestnut Hill, MA 02467 USA.	mary.roberts@bc.edu		Stec, Boguslaw/0000-0002-8696-0349	National Science Foundation [MCB-0950331]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant MCB-0950331.	Cai JF, 2013, J BIOL CHEM, V288, P37277, DOI 10.1074/jbc.M113.512186; Campbell RB, 2003, J BIOL CHEM, V278, P33617, DOI 10.1074/jbc.C300296200; Chang N, 2007, TRENDS NEUROSCI, V30, P581, DOI 10.1016/j.tins.2007.08.006; Clore GM, 2009, CHEM REV, V109, P4108, DOI 10.1021/cr900033p; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Das S, 2003, P NATL ACAD SCI USA, V100, P7491, DOI 10.1073/pnas.0932835100; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gradziel CS, 2014, BIOCHEMISTRY-US, V53, P462, DOI 10.1021/bi401720v; Iijima M, 2004, J BIOL CHEM, V279, P16606, DOI 10.1074/jbc.M312098200; Kalli AC, 2014, BIOCHEMISTRY-US, V53, P1724, DOI 10.1021/bi5000299; Klauda JB, 2008, BIOPHYS J, V94, P3074, DOI 10.1529/biophysj.107.121806; Lee JO, 1999, CELL, V99, P323, DOI 10.1016/S0092-8674(00)81663-3; Leslie NR, 2004, BIOCHEM J, V382, P1, DOI 10.1042/BJ20040825; LEWIS KA, 1993, BIOCHEMISTRY-US, V32, P8836, DOI 10.1021/bi00085a014; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Maehama T, 2001, ANNU REV BIOCHEM, V70, P247, DOI 10.1146/annurev.biochem.70.1.247; Maler L, 2018, NUCL SPIN RELAXATION, V2nd; McConnachie G, 2003, BIOCHEM J, V371, P947, DOI 10.1042/BJ20021848; Myers MP, 1998, P NATL ACAD SCI USA, V95, P13513, DOI 10.1073/pnas.95.23.13513; Papa A, 2014, CELL, V157, P595, DOI 10.1016/j.cell.2014.03.027; Pu MM, 2010, J BIOL CHEM, V285, P26916, DOI 10.1074/jbc.M110.123083; Pu MM, 2009, BIOCHEMISTRY-US, V48, P8282, DOI 10.1021/bi901190j; Rahdar M, 2009, P NATL ACAD SCI USA, V106, P480, DOI 10.1073/pnas.0811212106; Redfern RE, 2008, BIOCHEMISTRY-US, V47, P2162, DOI 10.1021/bi702114w; Redfield AG, 2012, J BIOMOL NMR, V52, P159, DOI 10.1007/s10858-011-9594-1; Roberts MF, 2004, P NATL ACAD SCI USA, V101, P17066, DOI 10.1073/pnas.0407565101; Roberts MF, 2004, J AM CHEM SOC, V126, P13765, DOI 10.1021/ja046658k; Salmena L, 2008, CELL, V133, P403, DOI 10.1016/j.cell.2008.04.013; Shenoy SS, 2012, J STRUCT BIOL, V180, P394, DOI 10.1016/j.jsb.2012.10.003; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Vazquez F, 2006, P NATL ACAD SCI USA, V103, P3633, DOI 10.1073/pnas.0510570103; Walker SM, 2004, BIOCHEM J, V379, P301, DOI 10.1042/BJ20031839; Wang Q, 2010, J MOL GRAPH MODEL, V29, P102, DOI 10.1016/j.jmgm.2010.05.004; Wang YLK, 2008, J AM CHEM SOC, V130, P7746, DOI 10.1021/ja710348r; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020	37	25	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1592	1606		10.1074/jbc.M114.588590	http://dx.doi.org/10.1074/jbc.M114.588590			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25429968	Green Published, hybrid			2022-12-26	WOS:000348056400028
J	Landman, NH; Mapes, RH; Cochran, JK; Lignier, V; Hembree, DI; Goiran, C; Folcher, E; Brunet, P				Landman, Neil H.; Mapes, Royal H.; Cochran, J. Kirk; Lignier, Vincent; Hembree, Daniel I.; Goiran, Claire; Folcher, Eric; Brunet, Philippe			An Unusual Occurrence of Nautilus macromphalus in a Cenote in the Loyalty Islands (New Caledonia)	PLOS ONE			English	Article							POMPILIUS; CEPHALOPODA; TAPHONOMY; ISOTOPE; SHELLS; LEVEL; CAVES	Exploration of a landlocked cenote on Lifou (Loyalty Islands) revealed 37 shells of the cephalopod Nautilus macromphalus Sowerby, 1849, in saltwater on the cenote floor, approximately 40 m below the water surface. The occurrence of these shells is unusual because N. macromphalus is restricted to the open marine waters surrounding the island. All of the shells are mature, and nearly all of them are unbroken, with faded red-brown color stripes. We analyzed seven shells to determine their age. Radiocarbon dating yielded ages of 6380 +/- 30 to 7095 +/- 30 y BP. The U-238-series radionuclides Pb-210 (half-life = 522.3 y) and Ra-226 (half-life 51600 y) also were measured. Two of the samples showed radioactive equilibrium between the nuclides, consistent with the old radiocarbon dates, but the other five samples showed excess Pb-210. When corrected for radioactive decay, the Ra-226 activities were much greater than those found in living Nautilus. We conclude that exposure to high activities of Rn-222 and Ra-226 in the salty groundwater of the cenote altered the activities originally incorporated into the shells. Human placement of the shells in the cavity is rejected based on their radiocarbon age and the geometry of the cenote. The most probable explanation is that the animals entered the flooded karstic system through a connection on the seaward side at approximately 7,000 y BP, during an interval of slowly rising sea level. Unable to find an exit and/or due to anoxic bottom waters, the animals were trapped and died inside. The open connection with the sea persisted for similar to 700 y, but after similar to 6400 y BP, the connection was lost, probably due to a roof collapse. This is a rare example of Nautilus in a karstic coastal basin and provides a minimum age for the appearance of N. macromphalus in the Loyalty Islands.	[Landman, Neil H.] Amer Museum Nat Hist, Div Paleontol Invertebrates, New York, NY 10024 USA; [Mapes, Royal H.; Hembree, Daniel I.] North Carolina Museum Nat Sci, Raleigh, NC 27601 USA; [Cochran, J. Kirk] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Lignier, Vincent] Univ Nouvelle Caledonie, Lab PPME, Noumea 98851, New Caledonia; [Goiran, Claire] Univ Nouvelle Caledonie, Labex Corail, Noumea 98851, New Caledonia; [Goiran, Claire] Univ Nouvelle Caledonie, LIVE, Noumea 98851, New Caledonia; [Brunet, Philippe] Inst Rech Dev, Noumea 98848, New Caledonia	American Museum of Natural History (AMNH); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Universite Nouvelle Caledonie; Universite Nouvelle Caledonie; Universite Nouvelle Caledonie; Institut de Recherche pour le Developpement (IRD)	Landman, NH (corresponding author), Amer Museum Nat Hist, Div Paleontol Invertebrates, New York, NY 10024 USA.	landman@amnh.org	Goiran, Claire/Y-5201-2019; Goiran, Claire/L-1257-2015	Goiran, Claire/0000-0002-1649-4418; Goiran, Claire/0000-0002-1649-4418; Hembree, Daniel/0000-0003-3630-7541	Ohio University; Laboratoire PPME, Universite de la Nouvelle Caledonie; N.D. Newell Fund at the American Museum of Natural History; Eramet-Societe Le Nickel, a mining company in New Caledonia; Betco2, a marine transport company	Ohio University; Laboratoire PPME, Universite de la Nouvelle Caledonie; N.D. Newell Fund at the American Museum of Natural History; Eramet-Societe Le Nickel, a mining company in New Caledonia; Betco2, a marine transport company	Funding: Ohio University supported shipping the specimens from New Caledonia to Ohio University. R. H. Mapes and D. I. Hembree were supported by the Baker Grant at Ohio University. V. Lignier was supported by the Laboratoire PPME, Universite de la Nouvelle Caledonie. The radiometric analyses were supported by the N.D. Newell Fund at the American Museum of Natural History. The French Federation of Speleology helped support the dive in 2009. Additional funding for the dive in 2011 was provided by the Eramet-Societe Le Nickel, a mining company in New Caledonia, and Betco2, a marine transport company operating between Noumea and the Loyalty Islands. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonacum J, 2011, AM MALACOL BULL, V29, P77, DOI 10.4003/006.029.0221; CHAMBERLAIN JA, 1981, PALEOBIOLOGY, V7, P494, DOI 10.1017/S0094837300025549; Cochran JK, 2010, AM J SCI, V310, P69, DOI 10.2475/02.2010.01; COCHRAN JK, 1981, PALEOBIOLOGY, V7, P469, DOI 10.1017/S0094837300025525; Genthon P, 2008, CR GEOSCI, V340, P513, DOI 10.1016/j.crte.2008.06.002; Gonneea ME, 2014, GEOCHIM COSMOCHIM AC, V132, P31, DOI 10.1016/j.gca.2014.01.037; Holthuis L.B., 1973, Zoologische Verh Leiden, VNo. 128, P1; Iliffe TM, 1990, NSS NEWS, V48, P88; Mapes RH, 2010, PALAIOS, V25, P597, DOI 10.2110/palo.2009.p09-109r; Mapes RH, 2010, PALAIOS, V25, P656, DOI 10.2110/palo.2010.p10-010r; MARSHALL JF, 1978, QUATERNARY RES, V9, P186, DOI 10.1016/0033-5894(78)90066-2; Sand C, 2006, ANTIQUITY, V80, P523, DOI 10.1017/S0003598X0009400X; Saunders W. B., 1987, NAUTILUS BIOL PALEOB, P137, DOI DOI 10.1007/978-1-4899-5040-6_9; Smart PL, 2006, GEOL SOC AM SPEC PAP, V404, P105, DOI 10.1130/2006.2404(10); Sowerby G.B., 1849, THESAURUS CONCHYLIOR, V2, P463; STOCK JH, 1986, STYGOLOGIA, V2, P90; Stock JH, 1995, CONTRIB ZOOL, V65, P245; STUIVER M, 1977, RADIOCARBON, V19, P355, DOI 10.1017/S0033822200003672; Thomas C, 1987, GROTTES NOUVELLE CAL, P1; van Hengstum PJ, 2011, MAR GEOL, V286, P35, DOI 10.1016/j.margeo.2011.05.004; Wani R, 2008, PALEONTOL RES, V12, P89, DOI 10.2517/1342-8144(2008)12[89:FDOFNP]2.0.CO;2; WARD P, 1980, VELIGER, V23, P119; WARD PD, 1980, VELIGER, V22, P259; WARD PD, 1983, CEPHALOPOD LIFE CYCL, V1, P11; Willey A., 1899, Proceedings of the Zoological Society of London, P7	25	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113372	10.1371/journal.pone.0113372	http://dx.doi.org/10.1371/journal.pone.0113372			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470257	Green Published, gold			2022-12-26	WOS:000349128700025
J	Penarete-Vargas, DM; Boisson, A; Urbach, S; Chantelauze, H; Peyrottes, S; Fraisse, L; Vial, HJ				Penarete-Vargas, Diana Marcela; Boisson, Anais; Urbach, Serge; Chantelauze, Herve; Peyrottes, Suzanne; Fraisse, Laurent; Vial, Henri J.			A Chemical Proteomics Approach for the Search of Pharmacological Targets of the Antimalarial Clinical Candidate Albitiazolium in Plasmodium falciparum Using Photocrosslinking and Click Chemistry	PLOS ONE			English	Article							PHOSPHOLIPID-METABOLISM; MALARIA PARASITE; TRANSPORT; MEMBRANE; DATABASE; INFORMATION; DISRUPTION; INHIBITORS; MOLECULES; FLIPPASES	Plasmodium falciparum is responsible for severe malaria which is one of the most prevalent and deadly infectious diseases in the world. The antimalarial therapeutic arsenal is hampered by the onset of resistance to all known pharmacological classes of compounds, so new drugs with novel mechanisms of action are critically needed. Albitiazolium is a clinical antimalarial candidate from a series of choline analogs designed to inhibit plasmodial phospholipid metabolism. Here we developed an original chemical proteomic approach to identify parasite proteins targeted by albitiazolium during their native interaction in living parasites. We designed a bifunctional albitiazolium-derived compound (photoactivable and clickable) to covalently crosslink drug-interacting parasite proteins in situ followed by their isolation via click chemistry reactions. Mass spectrometry analysis of drug-interacting proteins and subsequent clustering on gene ontology terms revealed parasite proteins involved in lipid metabolic activities and, interestingly, also in lipid binding, transport, and vesicular transport functions. In accordance with this, the albitiazolium-derivative was localized in the endoplasmic reticulum and trans-Golgi network of P. falciparum. Importantly, during competitive assays with albitiazolium, the binding of choline/ethanolamine phosphotransferase (the enzyme involved in the last step of phosphatidylcholine synthesis) was substantially displaced, thus confirming the efficiency of this strategy for searching albitiazolium targets.	[Penarete-Vargas, Diana Marcela; Boisson, Anais; Vial, Henri J.] Univ Montpellier 2, CNRS, UMR 5235, Cc107, F-34095 Montpellier 05, France; [Urbach, Serge] Univ Montpellier 2, Univ Montpellier 1, Inst Genom Fonct, CNRS,UMR 5203,INSERM,U661, F-34094 Montpellier, France; [Chantelauze, Herve; Peyrottes, Suzanne] Univ Montpellier 2, Inst Biomol Max Mousseron, Cc1705, CNRS,UMR 5247, F-34095 Montpellier 05, France; [Fraisse, Laurent] Sanofi, Therapeut Strateg Unit Infect Dis, F-31036 Toulouse, France	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Sanofi-Aventis; Sanofi France	Penarete-Vargas, DM (corresponding author), Univ Montpellier 2, CNRS, UMR 5235, Cc107, Pl Eugene Bataillon, F-34095 Montpellier 05, France.	dpenaret@univ-montp2.fr; vial@univ-montp2.fr	Peyrottes, Suzanne/X-7325-2019	Penarete-Vargas, Diana Marcela/0000-0002-3306-3943; PEYROTTES, Suzanne/0000-0003-1705-0576	European Community [242095]; Sanofi; Eurobiomed competitiveness cluster (Region Languedoc-Roussillon/FEDER/OSEO); InnoMad (Eurobiomed); FP7/EviMalar Network of Excellence	European Community(European Commission); Sanofi; Eurobiomed competitiveness cluster (Region Languedoc-Roussillon/FEDER/OSEO); InnoMad (Eurobiomed); FP7/EviMalar Network of Excellence	Funding: This work was supported the European Community (FP7/EviMalar Network of Excellence No. 242095; http://www.evimalar.org/), by Sanofi (www.sanofi.fr/) and by a InnoMad grant from the Eurobiomed competitiveness cluster (Region Languedoc-Roussillon/FEDER/OSEO) (http://www.eurobiomed.org/). DMPV received funding from InnoMad (Eurobiomed) and Sanofi. AB received funding from InnoMad (Eurobiomed). HC received funding from FP7/EviMalar Network of Excellence. The funders provided support in the form of salaries for authors (DMPV and LF), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alder-Baerens N, 2006, MOL BIOL CELL, V17, P1632, DOI 10.1091/mbc.E05-10-0912; Ancelin ML, 2003, ANTIMICROB AGENTS CH, V47, P2590, DOI 10.1128/AAC.47.8.2590-2597.2003; Ancelin ML, 1998, BLOOD, V91, P1426, DOI 10.1182/blood.V91.4.1426; [Anonymous], MALARIA PARASITE MET; [Anonymous], APICOMPLEXAN PARASIT; Aurrecoechea C, 2009, NUCLEIC ACIDS RES, V37, pD539, DOI 10.1093/nar/gkn814; Bahl A, 2003, NUCLEIC ACIDS RES, V31, P212, DOI 10.1093/nar/gkg081; Biagini GA, 2003, ANTIMICROB AGENTS CH, V47, P2584, DOI 10.1128/AAC.47.8.2584-2589.2003; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Brehelin L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-440; Burrows JN, 2011, FUTURE MED CHEM, V3, P1401, DOI [10.4155/fmc.11.91, 10.4155/FMC.11.91]; Calas M, 1997, J MED CHEM, V40, P3557, DOI 10.1021/jm9701886; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Date SV, 2006, GENOME RES, V16, P542, DOI 10.1101/gr.4573206; Dechamps S, 2010, INT J PARASITOL, V40, P1347, DOI 10.1016/j.ijpara.2010.05.008; Dechamps S, 2010, MOL BIOCHEM PARASIT, V173, P69, DOI 10.1016/j.molbiopara.2010.05.006; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Dimmer EC, 2012, NUCLEIC ACIDS RES, V40, pD565, DOI 10.1093/nar/gkr1048; Dondorp AM, 2011, NEW ENGL J MED, V365, P1073, DOI 10.1056/NEJMp1108322; Hagenstein MC, 2003, ANGEW CHEM INT EDIT, V42, P5635, DOI 10.1002/anie.200352084; Hamze A, 2005, J MED CHEM, V48, P3639, DOI 10.1021/jm0492608; JENSEN JB, 1977, J PARASITOL, V63, P883, DOI 10.2307/3279900; Jordens I, 2005, TRAFFIC, V6, P1070, DOI 10.1111/j.1600-0854.2005.00336.x; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Le Roch KG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-513; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Muthusamy BP, 2009, BBA-MOL CELL BIOL L, V1791, P612, DOI 10.1016/j.bbalip.2009.03.004; Nunes MC, 2007, MOL MICROBIOL, V63, P391, DOI 10.1111/j.1365-2958.2006.05521.x; Petersen I, 2011, FEBS LETT, V585, P1551, DOI 10.1016/j.febslet.2011.04.042; Peyrottes S, 2012, CURR PHARM DESIGN, V18, P3454; Pomorski T, 2003, MOL BIOL CELL, V14, P1240, DOI 10.1091/mbc.E02-08-0501; Raj DK, 2009, J BIOL CHEM, V284, P7687, DOI 10.1074/jbc.M806944200; Rao Aditya, 2009, In Silico Biology, V9, P195, DOI 10.3233/ISB-2009-0403; Rix U, 2009, NAT CHEM BIOL, V5, P616, DOI 10.1038/nchembio.216; Sadakane Y, 2006, ANAL SCI, V22, P209, DOI 10.2116/analsci.22.209; Santiago TC, 2004, J BIOL CHEM, V279, P9222, DOI 10.1074/jbc.M310502200; Sebastian TT, 2012, BBA-MOL CELL BIOL L, V1821, P1068, DOI 10.1016/j.bbalip.2011.12.007; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Speers AE, 2003, J AM CHEM SOC, V125, P4686, DOI 10.1021/ja034490h; Speers AE, 2004, CHEM BIOL, V11, P535, DOI 10.1016/j.chembiol.2004.03.012; Vial HJ, 2005, MOLECULAR APPROACHES TO MALARIA, P327; Vial HJ, 2004, P NATL ACAD SCI USA, V101, P15458, DOI 10.1073/pnas.0404037101; Wein S, 2012, BRIT J PHARMACOL, V166, P2263, DOI 10.1111/j.1476-5381.2012.01966.x; Wein S, 2010, J CLIN MICROBIOL, V48, P1651, DOI 10.1128/JCM.02250-09; Wengelnik K, 2002, SCIENCE, V295, P1311, DOI 10.1126/science.1067236; WHO, 2012, WORLD MALARIA REPORT 2012, P1; Zhou YY, 2005, BIOINFORMATICS, V21, P1237, DOI 10.1093/bioinformatics/bti111	50	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113918	10.1371/journal.pone.0113918	http://dx.doi.org/10.1371/journal.pone.0113918			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470252	gold, Green Published			2022-12-26	WOS:000349128700053
J	Stalenberg, E; Wallis, IR; Cunningham, RB; Allen, C; Foley, WJ				Stalenberg, Eleanor; Wallis, Ian R.; Cunningham, Ross B.; Allen, Chris; Foley, William J.			Nutritional Correlates of Koala Persistence in a Low-Density Population	PLOS ONE			English	Article							PLANT SECONDARY METABOLITES; PHASCOLARCTOS-CINEREUS POPULATIONS; SOUTH-WEST QUEENSLAND; EUCALYPTUS FOLIAGE; HABITAT USE; TREE USE; PSEUDOCHEIRUS-PEREGRINUS; FORAGING BEHAVIOR; BOTTOM-UP; CHEMISTRY	It is widely postulated that nutritional factors drive bottom-up, resource-based patterns in herbivore ecology and distribution. There is, however, much controversy over the roles of different plant constituents and how these influence individual herbivores and herbivore populations. The density of koala (Phascolarctos cinereus) populations varies widely and many attribute population trends to variation in the nutritional quality of the eucalypt leaves of their diet, but there is little evidence to support this hypothesis. We used a nested design that involved sampling of trees at two spatial scales to investigate how leaf chemistry influences free-living koalas from a low-density population in south east New South Wales, Australia. Using koala faecal pellets as a proxy for koala visitation to trees, we found an interaction between toxins and nutrients in leaves at a small spatial scale, whereby koalas preferred trees with leaves of higher concentrations of available nitrogen but lower concentrations of sideroxylonals (secondary metabolites found exclusively in eucalypts) compared to neighbouring trees of the same species. We argue that taxonomic and phenotypic diversity is likely to be important when foraging in habitats of low nutritional quality in providing diet choice to tradeoff nutrients and toxins and minimise movement costs. Our findings suggest that immediate nutritional concerns are an important priority of folivores in low-quality habitats and imply that nutritional limitations play an important role in constraining folivore populations. We show that, with a careful experimental design, it is possible to make inferences about populations of herbivores that exist at extremely low densities and thus achieve a better understanding about how plant composition influences herbivore ecology and persistence.	[Stalenberg, Eleanor; Wallis, Ian R.; Foley, William J.] Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia; [Cunningham, Ross B.] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Allen, Chris] NSW Off Environm & Heritage, Natl Pk & Wildlife Serv, Far South Coast, NSW, Australia	Australian National University; Australian National University; Office of Environment & Heritage - New South Wales	Stalenberg, E (corresponding author), Australian Natl Univ, Res Sch Biol, Div Evolut Ecol & Genet, Canberra, ACT, Australia.	eleanor.stalenberg@anu.edu.au	Foley, William J/C-8069-2009; Stalenberg, Eleanor/N-4123-2013	Foley, William J/0000-0001-8587-1814; Stalenberg, Eleanor/0000-0003-2548-5967	New South Wales (NSW) Department of Environment, Climate Change Water	New South Wales (NSW) Department of Environment, Climate Change Water	Funding: IW and WF received a grant from New South Wales (NSW) Department of Environment, Climate Change & Water. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrestani FS, 2012, J TROP ECOL, V28, P385, DOI 10.1017/S0266467412000302; Andrew RL, 2007, ECOLOGY, V88, P716, DOI 10.1890/05-1858; [Anonymous], 1995, STANDARD PRACTICES I; Au J, 2013, J COMP PHYSIOL B, V183, P993, DOI 10.1007/s00360-013-0754-3; Behmer ST, 2009, ANNU REV ENTOMOL, V54, P165, DOI 10.1146/annurev.ento.54.110807.090537; Bergvall UA, 2005, ECOLOGY, V86, P2450, DOI 10.1890/04-0978; BRAITHWAITE LW, 1984, AUST WILDLIFE RES, V11, P41; Briscoe NJ, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2014.0235; Callaghan J, 2011, WILDLIFE RES, V38, P89, DOI 10.1071/WR07177; Chapman CA, 2002, INT J PRIMATOL, V23, P283, DOI 10.1023/A:1013831511405; Chapman CA, 2004, AM J PRIMATOL, V62, P55, DOI 10.1002/ajp.20006; Cork S. J., 1991, BIOL KOALA, P129; CORK SJ, 1983, J COMP PHYSIOL, V153, P181, DOI 10.1007/BF00689622; Crowther MS, 2014, ECOGRAPHY, V37, P336, DOI 10.1111/j.1600-0587.2013.00413.x; Dearing MD, 2005, ANNU REV ECOL EVOL S, V36, P169, DOI 10.1146/annurev.ecolsys.36.102003.152617; DeGabriel JL, 2008, OECOLOGIA, V156, P107, DOI 10.1007/s00442-008-0960-y; DeGabriel JL, 2014, OIKOS, V123, P298, DOI 10.1111/j.1600-0706.2013.00727.x; DeGabriel JL, 2010, CHEMOECOLOGY, V20, P97, DOI 10.1007/s00049-009-0037-3; Degabriel JL, 2009, ECOLOGY, V90, P711, DOI 10.1890/08-0940.1; Ellis WAH, 2002, WILDLIFE RES, V29, P303, DOI 10.1071/WR00111; Ellis WAH, 1998, WILDLIFE RES, V25, P663, DOI 10.1071/WR97028; Ellis W, 2013, AUST MAMMAL, V35, P160, DOI 10.1071/AM12023; Ellis WAH, 2009, BEHAV ECOL SOCIOBIOL, V63, P1181, DOI 10.1007/s00265-009-0761-2; Eschler BM, 2000, BIOCHEM SYST ECOL, V28, P813, DOI 10.1016/S0305-1978(99)00123-4; Felton AM, 2009, BEHAV ECOL, V20, P685, DOI 10.1093/beheco/arp021; Felton AM, 2009, FUNCT ECOL, V23, P70, DOI 10.1111/j.1365-2435.2008.01526.x; Foley W.J., 2004, P207; FOLEY WJ, 1992, TRENDS ECOL EVOL, V7, P159, DOI 10.1016/0169-5347(92)90210-3; Foley WJ, 1998, OECOLOGIA, V116, P293, DOI 10.1007/s004420050591; FREELAND WJ, 1974, AM NAT, V108, P269, DOI 10.1086/282907; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; GANZHORN JU, 1992, OECOLOGIA, V91, P540, DOI 10.1007/BF00650329; GARBER PA, 1989, AM J PRIMATOL, V19, P203, DOI 10.1002/ajp.1350190403; HAIRSTON NG, 1960, AM NAT, V94, P421, DOI 10.1086/282146; Hegland SJ, 2013, FOREST ECOL MANAG, V310, P267, DOI 10.1016/j.foreco.2013.08.031; Hengeveld GM, 2009, AM NAT, V174, P102, DOI 10.1086/598500; HUNTER MD, 1992, ECOLOGY, V73, P724; Iason GR, 2006, J CHEM ECOL, V32, P1115, DOI 10.1007/s10886-006-9075-2; Jones PD, 2008, SOUTHEAST NAT, V7, P595, DOI 10.1656/1528-7092-7.4.595; Krockenberger A, 2003, J COMP PHYSIOL B, V173, P531, DOI 10.1007/s00360-003-0361-9; Laca EA, 2010, ECOL LETT, V13, P311, DOI 10.1111/j.1461-0248.2009.01423.x; LUNNEY D, 1988, AUST J ECOL, V13, P67, DOI 10.1111/j.1442-9993.1988.tb01417.x; Lunney D, 1997, WILDLIFE RES, V24, P111, DOI 10.1071/WR94034; Lunney D, 2002, BIOL CONSERV, V106, P101, DOI 10.1016/S0006-3207(01)00233-6; Lunney D., 1988, Proceedings of the First national conference on Australian forest history, Canberra, 9-11 May, 1988., P23; Lunney D., 2002, AUSTR EVER CHANGING, VV, P289; Lunney D, 2014, WILDLIFE RES, V41, P22, DOI 10.1071/WR13054; Lunney D, 2009, WILDLIFE RES, V36, P262, DOI 10.1071/WR08079; Lunney Daniel, 2007, Pacific Conservation Biology, V13, P189; Mansson J, 2011, EUR J WILDLIFE RES, V57, P1017, DOI 10.1007/s10344-011-0512-3; Marsh KJ, 2007, OECOLOGIA, V154, P283, DOI 10.1007/s00442-007-0828-6; Marsh KJ, 2006, ECOLOGY, V87, P2103, DOI 10.1890/0012-9658(2006)87[2103:CDODPI]2.0.CO;2; Marsh KJ, 2006, J CHEM ECOL, V32, P1247, DOI 10.1007/s10886-006-9082-3; Marsh KJ, 2014, OECOLOGIA, V174, P873, DOI 10.1007/s00442-013-2808-3; Marsh KJ, 2005, ECOLOGY, V86, P2946, DOI 10.1890/05-0303; Marsh KJ, 2003, J COMP PHYSIOL B, V173, P69, DOI 10.1007/s00360-002-0318-4; Marsh KJ, 2003, AUST J ZOOL, V51, P31, DOI 10.1071/ZO02055; Masters P, 2004, WILDLIFE RES, V31, P267, DOI 10.1071/WR03007; Matthews A, 2007, WILDLIFE RES, V34, P84, DOI 10.1071/WR06075; Mcart SH, 2009, ECOLOGY, V90, P1400, DOI 10.1890/08-1435.1; McGregor DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059713; Melzer Alistair, 1994, Proceedings of the Royal Society of Queensland, V104, P89; Menkhorst P, 2006, TOO CLOSE COMFORT CO, P73; Mitchell P., 1990, P171; Moore B, 2004, CHEM DETERMINANTS DI; Moore BD, 2004, CONSERVATION OF AUTRALIA'S, SECOND EDITION, P549; Moore BD, 2005, NATURE, V435, P488, DOI 10.1038/nature03551; Moore BD, 2005, BIOL LETT-UK, V1, P64, DOI 10.1098/rsbl.2004.0255; Moore BD, 2004, J CHEM ECOL, V30, P1743, DOI 10.1023/B:JOEC.0000042399.06553.c6; Moore BD, 2010, ECOLOGY, V91, P3165, DOI 10.1890/09-1714.1; NAGY KA, 1985, AUST J ZOOL, V33, P655, DOI 10.1071/ZO9850655; Phillips S, 2000, WILDLIFE RES, V27, P509, DOI 10.1071/WR98087; Phillips SS, 2000, CONSERV BIOL, V14, P650, DOI 10.1046/j.1523-1739.2000.99387.x; Phillips Stephen, 2011, Australian Zoologist, V35, P774; Prins Herbert H. T., 2008, V23, P129; Provenza FD, 1996, J ANIM SCI, V74, P2010; PUTMAN RJ, 1984, MAMMAL REV, V14, P79, DOI 10.1111/j.1365-2907.1984.tb00341.x; Raubenheimer D, 2009, FUNCT ECOL, V23, P4, DOI 10.1111/j.1365-2435.2009.01522.x; Reed P.C., 1990, P55; Reed Philip, 1990, P9; Rhodes JR, 2008, J APPL ECOL, V45, P549, DOI 10.1111/j.1365-2664.2007.01407.x; ROBBINS CT, 1987, ECOLOGY, V68, P98, DOI 10.2307/1938809; Schoener T. W., 1971, A Rev Ecol Syst, V2, P369, DOI 10.1146/annurev.es.02.110171.002101; Searle KR, 2007, ISR J ECOL EVOL, V53, P297, DOI 10.1560/IJEE.53.3.297; Searle KR, 2008, BEHAV ECOL, V19, P475, DOI 10.1093/beheco/arn004; Simmen B, 2012, J TROP ECOL, V28, P141, DOI 10.1017/S026646741200003X; SIMPSON SJ, 1995, J INSECT PHYSIOL, V41, P545, DOI 10.1016/0022-1910(95)00006-G; Simpson SJ, 2004, ANIM BEHAV, V68, P1299, DOI 10.1016/j.anbehav.2004.03.003; Simpson SJ, 2010, TRENDS ECOL EVOL, V25, P53, DOI 10.1016/j.tree.2009.06.012; Smyth GK, 1996, J ROY STAT SOC B MET, V58, P565; Speakman JR, 2008, PHILOS T R SOC B, V363, P375, DOI 10.1098/rstb.2007.2145; Stephens D.W., 1986, pi; Sullivan BJ, 2003, WILDLIFE RES, V30, P583, DOI 10.1071/WR02036; Sullivan BJ, 2003, WILDLIFE RES, V30, P331, DOI 10.1071/WR00032; Sullivan BJ, 2002, WILDLIFE RES, V29, P455, DOI 10.1071/WR00110; VANHORNE B, 1983, J WILDLIFE MANAGE, V47, P893; Wallis IR, 2012, OECOLOGIA, V169, P281, DOI 10.1007/s00442-011-2212-9; Wallis IR, 2005, PHYTOCHEM ANALYSIS, V16, P49, DOI 10.1002/pca.810; Wiggins NL, 2006, ECOLOGY, V87, P2236, DOI 10.1890/0012-9658(2006)87[2236:SSOTPO]2.0.CO;2; Wiggins NL, 2006, OECOLOGIA, V147, P272, DOI 10.1007/s00442-005-0268-0; Wiggins NL, 2003, J CHEM ECOL, V29, P1447, DOI 10.1023/A:1024221705354; Wilson GJ, 2001, WILDLIFE RES, V28, P151, DOI 10.1071/WR00033; Zuur Alain F., 2009, P1	103	19	20	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113930	10.1371/journal.pone.0113930	http://dx.doi.org/10.1371/journal.pone.0113930			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470599	Green Submitted, Green Published, gold			2022-12-26	WOS:000349128700056
J	Zangenehpour, S; Javadi, P; Ervin, FR; Palmour, RM; Ptito, M				Zangenehpour, Shahin; Javadi, Pasha; Ervin, Frank R.; Palmour, Roberta M.; Ptito, Maurice			A Deficit in Face-Voice Integration in Developing Vervet Monkeys Exposed to Ethanol during Gestation	PLOS ONE			English	Article							FETAL ALCOHOL SYNDROME; SPECIES INTERSENSORY PERCEPTION; PREFRONTAL CORTEX; TEMPORAL CUES; VISUAL-ATTENTION; HUMAN INFANTS; RAT PUPS; BEHAVIOR; REPRESENTATION; CONSUMPTION	Children with fetal alcohol spectrum disorders display behavioural and intellectual impairments that strongly implicate dysfunction within the frontal cortex. Deficits in social behaviour and cognition are amongst the most pervasive outcomes of prenatal ethanol exposure. Our naturalistic vervet monkey model of fetal alcohol exposure (FAE) provides an unparalleled opportunity to study the neurobehavioral outcomes of prenatal ethanol exposure in a controlled experimental setting. Recent work has revealed a significant reduction of the neuronal population in the frontal lobes of these monkeys. We used an intersensory matching procedure to investigate audiovisual perception of socially relevant stimuli in young FAE vervet monkeys. Here we show a domain-specific deficit in audiovisual integration of socially relevant stimuli. When FAE monkeys were shown a pair of side-by-side videos of a monkey concurrently presenting two different calls along with a single audio track matching the content of one of the calls, they were not able to match the correct video to the single audio track. This was manifest by their average looking time being equally spent towards both the matching and non-matching videos. However, a group of normally developing monkeys exhibited a significant preference for the non-matching video. This inability to integrate and thereby discriminate audiovisual stimuli was confined to the integration of faces and voices as revealed by the monkeys' ability to match a dynamic face to a complex tone or a black-and-white checkerboard to a pure tone, presumably based on duration and/or onset-offset synchrony. Together, these results suggest that prenatal ethanol exposure negatively affects a specific domain of audiovisual integration. This deficit is confined to the integration of information that is presented by the face and the voice and does not affect more elementary aspects of sensory integration.	[Zangenehpour, Shahin] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Javadi, Pasha; Ptito, Maurice] Univ Montreal, Sch Optometry, Montreal, PQ, Canada; [Ervin, Frank R.; Palmour, Roberta M.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [Palmour, Roberta M.] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Ptito, Maurice] Univ Copenhagen, Dept Neurosci & Pharmacol, BRAINlab, Copenhagen, Denmark; [Ptito, Maurice] Univ Copenhagen, Psychiat Ctr Copenhagen, Lab Neuropsychiat, DK-2100 Copenhagen, Denmark; [Ptito, Maurice] Univ Copenhagen, Dept Neurosci & Pharmacol, DK-2100 Copenhagen, Denmark	McGill University; Universite de Montreal; McGill University; McGill University; University of Copenhagen; University of Copenhagen; University of Copenhagen	Ptito, M (corresponding author), Univ Montreal, Sch Optometry, Montreal, PQ, Canada.	maurice.ptito@umontreal.ca	Ptito, Maurice/G-3422-2013	Ptito, Maurice/0000-0002-5173-5862	Canadian Institutes of Health Research (CIHR); GW Stairs Foundation; Canadian Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); GW Stairs Foundation; Canadian Foundation for Innovation(Canada Foundation for Innovation); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	Funding: This work was supported by an Operating Grant from the Canadian Institutes of Health Research (CIHR; FRE, RP, MP and SZ), a CIHR Postdoctoral Fellowship (SZ), a seed grant from GW Stairs Foundation (SZ), a Canadian Foundation for Innovation grant (MP), an operating grant from the Natural Sciences and Engineering Research Council of Canada (MP), and infrastructure support from Behavioural Sciences Foundation (BSF), St Kitts, West Indies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRON S, 1991, PHARMACOL BIOCHEM BE, V39, P423, DOI 10.1016/0091-3057(91)90202-D; Belin P, 2002, COGNITIVE BRAIN RES, V13, P17, DOI 10.1016/S0926-6410(01)00084-2; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Burke MW, 2009, JOVE-J VIS EXP, V29, DOI [10.3791/1260., DOI 10.3791/1260]; Campanella S, 2007, TRENDS COGN SCI, V11, P535, DOI 10.1016/j.tics.2007.10.001; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P1178; Chandrasekaran C, 2009, J NEUROPHYSIOL, V101, P773, DOI 10.1152/jn.90843.2008; Connor PD, 2000, DEV NEUROPSYCHOL, V18, P331, DOI 10.1207/S1532694204Connor; Connor PD, 1999, ALCOHOL CLIN EXP RES, V23, P1395; CONRY J, 1990, ALCOHOL CLIN EXP RES, V14, P650, DOI 10.1111/j.1530-0277.1990.tb01222.x; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; ERVIN FR, 1990, PHARMACOL BIOCHEM BE, V36, P367, DOI 10.1016/0091-3057(90)90417-G; Ghazanfar AA, 2005, J NEUROSCI, V25, P5004, DOI 10.1523/JNEUROSCI.0799-05.2005; Ghazanfar AA, 2003, NATURE, V423, P937, DOI 10.1038/423937a; Ghazanfar AA, 2001, BRAIN BEHAV EVOLUT, V58, P163, DOI 10.1159/000047270; Ghazanfar AA, 2002, ANIM BEHAV, V64, P427, DOI 10.1006/anbe.2002.3074; Ghazanfar AA, 2006, COGNITION, V101, P515, DOI 10.1016/j.cognition.2005.12.007; GIBSON EJ, 1984, CHILD DEV, V55, P453, DOI 10.2307/1129956; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; HESS EH, 1960, SCIENCE, V132, P349, DOI 10.1126/science.132.3423.349; Jirikowic Tracy, 2008, Phys Occup Ther Pediatr, V28, P117, DOI 10.1080/01942630802031800; Jordan KE, 2006, P NATL ACAD SCI USA, V103, P3486, DOI 10.1073/pnas.0508107103; Jordan KE, 2005, CURR BIOL, V15, P1034, DOI 10.1016/j.cub.2005.04.056; JUAREZ J, 1993, PHARMACOL BIOCHEM BE, V46, P985, DOI 10.1016/0091-3057(93)90232-I; Kanwisher N, 1997, J NEUROSCI, V17, P4302; KELLY SJ, 1994, NEUROTOXICOL TERATOL, V16, P377, DOI 10.1016/0892-0362(94)90026-4; Kelly SJ, 2000, NEUROTOXICOL TERATOL, V22, P143, DOI 10.1016/S0892-0362(99)00073-2; Kerns KA, 1997, J LEARN DISABIL-US, V30, P685, DOI 10.1177/002221949703000612; KRSIAK M, 1977, J STUD ALCOHOL, V38, P1696, DOI 10.15288/jsa.1977.38.1696; KUHL PK, 1982, SCIENCE, V218, P1138, DOI 10.1126/science.7146899; Lewkowicz DJ, 2008, BRAIN RES, V1242, P291, DOI 10.1016/j.brainres.2008.03.084; LEWKOWICZ DJ, 1986, INFANT BEHAV DEV, V9, P335, DOI 10.1016/0163-6383(86)90008-1; Lewkowicz DJ, 2006, P NATL ACAD SCI USA, V103, P6771, DOI 10.1073/pnas.0602027103; LIBBY WL, 1973, PSYCHOPHYSIOLOGY, V10, P270, DOI 10.1111/j.1469-8986.1973.tb00526.x; Manning MA, 2007, NEUROSCI BIOBEHAV R, V31, P230, DOI 10.1016/j.neubiorev.2006.06.016; Mukherjee RAS, 2006, J ROY SOC MED, V99, P298, DOI 10.1258/jrsm.99.6.298; Olson HC, 1998, ALCOHOL CLIN EXP RES, V22, P1998, DOI 10.1097/00000374-199812000-00016; Palmour RM, 1998, PSYCHOPHARMACOLOGY, V136, P1, DOI 10.1007/s002130050532; Pascalis O, 2002, SCIENCE, V296, P1321, DOI 10.1126/science.1070223; Patterson ML, 2003, DEVELOPMENTAL SCI, V6, P191, DOI 10.1111/1467-7687.00271; Petrides M, 2007, J NEUROSCI, V27, P11573, DOI 10.1523/JNEUROSCI.2419-07.2007; ROCKWOOD GA, 1990, NEUROTOXICOL TERATOL, V12, P383, DOI 10.1016/0892-0362(90)90058-K; Romanski LM, 2007, CEREB CORTEX, V17, pI61, DOI 10.1093/cercor/bhm099; Romanski LM, 2009, ANNU REV NEUROSCI, V32, P315, DOI 10.1146/annurev.neuro.051508.135431; Romanski LM, 2002, NAT NEUROSCI, V5, P15, DOI 10.1038/nn781; ROYALTY J, 1990, PSYCHOL REP, V66, P551, DOI 10.2466/PR0.66.2.551-560; Sampson PD, 1997, TERATOLOGY, V56, P317, DOI 10.1002/(SICI)1096-9926(199711)56:5<317::AID-TERA5>3.0.CO;2-U; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Smith ZM, 2002, NATURE, V416, P87, DOI 10.1038/416087a; Sowell ER, 2001, NEUROREPORT, V12, P515, DOI 10.1097/00001756-200103050-00018; Stoler JM, 1999, J PEDIATR-US, V135, P430, DOI 10.1016/S0022-3476(99)70164-2; Streissguth AP, 2004, J DEV BEHAV PEDIATR, V25, P228, DOI 10.1097/00004703-200408000-00002; STREISSGUTH AP, 1986, NEUROTOXICOL TERATOL, V8, P717; STREISSGUTH AP, 1994, ALCOHOL CLIN EXP RES, V18, P202, DOI 10.1111/j.1530-0277.1994.tb00904.x; SUBRAMANIAN MG, 1992, ALCOHOL CLIN EXP RES, V16, P891, DOI 10.1111/j.1530-0277.1992.tb01888.x; Sugihara T, 2006, J NEUROSCI, V26, P11138, DOI 10.1523/JNEUROSCI.3550-06.2006; Thomas SE, 1998, ALCOHOL CLIN EXP RES, V22, P528, DOI 10.1111/j.1530-0277.1998.tb03684.x; Wass TS, 2001, AM J OBSTET GYNECOL, V185, P737, DOI 10.1067/mob.2001.117656; Willford JA, 2004, ALCOHOL CLIN EXP RES, V28, P497, DOI 10.1097/01.ALC.0000117868.97486.2D; Zangenehpour S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004302	60	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114100	10.1371/journal.pone.0114100	http://dx.doi.org/10.1371/journal.pone.0114100			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470725	Green Published, gold, Green Submitted			2022-12-26	WOS:000349128700071
J	Zheng, Y; Wang, SP; Sunkar, R				Zheng, Yun; Wang, Shengpeng; Sunkar, Ramanjulu			Genome-Wide Discovery and Analysis of Phased Small Interfering RNAs in Chinese Sacred Lotus	PLOS ONE			English	Article							TRANS-ACTING SIRNAS; ARABIDOPSIS-THALIANA; REGULATORY NETWORKS; STRESS RESPONSES; BIOGENESIS; PLANTS; MICRORNAS; SECONDARY; MIRNAS; ROLES	Phased small interfering RNA (phasiRNA) generating loci (briefly as PHAS) in plants are a novel class of genes that are normally regulated by microRNAs (miRNAs). Similar to miRNAs, phasiRNAs encoded by PHAS play important regulatory roles by targeting protein coding transcripts in plant species. We performed a genome-wide discovery of PHAS loci in Chinese sacred lotus and identified a total of 106 PHAS loci. Of these, 47 loci generate 21 nucleotide (nt) phasiRNAs and 59 loci generate 24 nt phasiRNAs, respectively. We have also identified a new putative TAS3 and a putative TAS4 loci in the lotus genome. Our results show that some of the nucleotide-binding, leucine-rich repeat (NB-LRR) disease resistance proteins and MYB transcription factors potentially generate phasiRNAs. Furthermore, our results suggest that some large subunit (LSU) rRNAs can derive putative phasiRNAs, which is potentially resulted from crosstalk between small RNA biogenesis pathways that are employed to process rRNAs and PHAS loci, respectively. Some of the identified phasiRNAs have putative trans-targets with less than 4 mismatches, suggesting that the identified PHAS are involved in many different pathways. Finally, the discovery of 24 nt PHAS in lotus suggests that there are 24 nt PHAS in dicots.	[Zheng, Yun; Wang, Shengpeng] Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Yunnan, Peoples R China; [Sunkar, Ramanjulu] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Kunming University of Science & Technology; Oklahoma State University System; Oklahoma State University - Stillwater	Zheng, Y (corresponding author), Kunming Univ Sci & Technol, Fac Life Sci & Technol, Kunming, Yunnan, Peoples R China.	zhengyun5488@gmail.com	Zheng, Yun/AAS-1149-2021; Zheng, Yun/I-7011-2012	Zheng, Yun/0000-0003-4292-9806; Zheng, Yun/0000-0003-4292-9806	National Natural Science Foundation of China [31460295]; Kunming University of Science and Technology, China [14078285]; Oklahoma Agricultural Experiment Station	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Kunming University of Science and Technology, China; Oklahoma Agricultural Experiment Station	Funding: The research was supported in part by a grant (No. 31460295) of National Natural Science Foundation of China (http://www.nsfc.gov.cn/) and a start-up grant (No. 14078285) of Kunming University of Science and Technology (http://www.kmust.edu.cn/), China, to YZ, and a grant of Oklahoma Agricultural Experiment Station (www.oaes.okstate.edu) to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen E, 2005, CELL, V121, P207, DOI 10.1016/j.cell.2005.04.004; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Axtell MJ, 2013, ANNU REV PLANT BIOL, V64, P137, DOI 10.1146/annurev-arplant-050312-120043; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen HM, 2007, P NATL ACAD SCI USA, V104, P3318, DOI 10.1073/pnas.0611119104; Chen HM, 2010, P NATL ACAD SCI USA, V107, P15269, DOI 10.1073/pnas.1001738107; Chen XM, 2012, CURR OPIN GENET DEV, V22, P361, DOI 10.1016/j.gde.2012.04.004; Cuperus JT, 2010, NAT STRUCT MOL BIOL, V17, P997, DOI 10.1038/nsmb.1866; De Paoli E, 2009, RNA, V15, P1965, DOI 10.1261/rna.1706109; Fei QL, 2013, PLANT CELL, V25, P2400, DOI 10.1105/tpc.113.114652; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Johnson C, 2009, GENOME RES, V19, P1429, DOI 10.1101/gr.089854.108; Kallman T, 2013, PLANT PHYSIOL, V162, P741, DOI 10.1104/pp.113.214643; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee HC, 2009, NATURE, V459, P274, DOI 10.1038/nature08041; Li F, 2012, P NATL ACAD SCI USA, V109, P1790, DOI 10.1073/pnas.1118282109; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Luo QJ, 2012, PLANT MOL BIOL, V80, P117, DOI 10.1007/s11103-011-9778-9; Manavella PA, 2012, P NATL ACAD SCI USA, V109, P2461, DOI 10.1073/pnas.1200169109; Ming R, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r41; Ouyang S, 2004, NUCLEIC ACIDS RES, V32, pD360, DOI 10.1093/nar/gkh099; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Reinhart BJ, 2002, GENE DEV, V16, P1616, DOI 10.1101/gad.1004402; Ruiz-Ferrer V, 2009, ANNU REV PLANT BIOL, V60, P485, DOI 10.1146/annurev.arplant.043008.092111; Shivaprasad PV, 2012, PLANT CELL, V24, P859, DOI 10.1105/tpc.111.095380; Song XW, 2012, PLANT J, V69, P462, DOI 10.1111/j.1365-313X.2011.04805.x; Sunkar R, 2012, TRENDS PLANT SCI, V17, P196, DOI 10.1016/j.tplants.2012.01.010; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wei HB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056842; Wei W, 2012, CELL, V149, P101, DOI 10.1016/j.cell.2012.03.002; Xia R, 2013, PLANT CELL, V25, P1555, DOI 10.1105/tpc.113.110957; Xia R, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r47; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Zhai JX, 2011, GENE DEV, V25, P2540, DOI 10.1101/gad.177527.111; Zhang CQ, 2014, BIOINFORMATICS, V30, P1045, DOI 10.1093/bioinformatics/btt746; Zhang CQ, 2012, BIOINFORMATICS, V28, P2561, DOI 10.1093/bioinformatics/bts500; Zheng Y, 2013, TROP PLANT BIOL, V6, P117, DOI 10.1007/s12042-013-9127-z; Zheng Y, 2012, NUCLEIC ACIDS RES, V40, DOI [10.1155/2012/360358, 10.1093/nar/gkr1092]; Zheng Yun, 2010, Journal of Bioinformatics and Computational Biology, V8, P763, DOI 10.1142/S0219720010004896; Zhu H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-149; Zhu QH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084390	43	14	16	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113790	10.1371/journal.pone.0113790	http://dx.doi.org/10.1371/journal.pone.0113790			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469507	Green Submitted, Green Published, gold			2022-12-26	WOS:000349128700046
J	Holcombe, LJ; Patel, N; Colyer, A; Deusch, O; O'Flynn, C; Harris, S				Holcombe, Lucy J.; Patel, Niran; Colyer, Alison; Deusch, Oliver; O'Flynn, Ciaran; Harris, Stephen			Early Canine Plaque Biofilms: Characterization of Key Bacterial Interactions Involved in Initial Colonization of Enamel	PLOS ONE			English	Article							FUSOBACTERIUM-NUCLEATUM; PERIODONTAL HEALTH; DENTAL DISEASES; SHIFTS; COAGGREGATION; PREVALENCE; MICROBIOTA; SEARCH; DOGS	Periodontal disease (PD) is a significant problem in dogs affecting between 44% and 63.6% of the population. The main etiological agent for PD is plaque, a microbial biofilm that colonizes teeth and causes inflammation of the gingiva. Understanding how this biofilm initiates on the tooth surface is of central importance in developing interventions against PD. Although the stages of plaque development on human teeth have been well characterized little is known about how canine plaque develops. Recent studies of the canine oral microbiome have revealed distinct differences between the canine and human oral environments and the bacterial communities they support, particularly with respect to healthy plaque. These differences mean knowledge about the nature of plaque formation in humans may not be directly translatable to dogs. The aim of this study was to identify the bacterial species important in the early stages of canine plaque formation in vivo and then use isolates of these species in a laboratory biofilm model to develop an understanding of the sequential processes which take place during the initial colonization of enamel. Supra-gingival plaque samples were collected from 12 dogs at 24 and 48 hour time points following a full mouth descale and polish. Pyrosequencing of the 16S rDNA identified 134 operational taxonomic units after statistical analysis. The species with the highest relative abundance were Bergeyella zoohelcum, Neisseria shayeganii and a Moraxella species. Streptococcal species, which tend to dominate early human plaque biofilms, had very low relative abundance. In vitro testing of biofilm formation identified five primary colonizer species, three of which belonged to the genus Neisseria. Using these pioneer bacteria as a starting point, viable two and three species communities were developed. Combining in vivo and in vitro data has led us to construct novel models of how the early canine plaque biofilm develops.	[Holcombe, Lucy J.; Patel, Niran; Colyer, Alison; Deusch, Oliver; O'Flynn, Ciaran; Harris, Stephen] WALTHAM Ctr Pet Nutr, Leicester, Leics, England	Mars; WALTHAM Petcare Science Institute	Holcombe, LJ (corresponding author), WALTHAM Ctr Pet Nutr, Leicester, Leics, England.	lucy.holcombe@effem.com		Patel, Niran/0000-0002-3668-2707; Harris, Stephen/0000-0002-4422-612X; Deusch, Oliver/0000-0003-3378-6129	Mars Petcare UK	Mars Petcare UK	This work was funded by Mars Petcare UK. The WALTHAMH (R) Centre for Pet Nutrition is the fundamental research center for Mars Petcare; it employs LJH, NP, AC, OD, COF, and SH. WALTHAMH (R) was involved at all levels of this research including study design, data collection and analysis, decision to publish, and preparation of the manuscript. However, there are no conflicts of interest; this survey represents an unbiased view (in the commercial sense) of early canine plaque biofilm formation. There were no external funding sources for this study.	Adler CJ, 2013, NAT GENET, V45, P450, DOI 10.1038/ng.2536; Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ammann TW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083090; BARTHOLOMEW JW, 1954, J BACTERIOL, V67, P689, DOI 10.1128/JB.67.6.689-691.1954; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bradshaw DJ, 1998, INFECT IMMUN, V66, P4729, DOI 10.1128/IAI.66.10.4729-4732.1998; Butkovic V, 2001, ACTA VET BRNO, V70, P203, DOI 10.2754/avb200170020203; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Davis IJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083158; Dewhirst FE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036067; Diaz PI, 2006, APPL ENVIRON MICROB, V72, P2837, DOI 10.1128/AEM.72.4.2837-2848.2006; Dige I, 2009, MICROBIOL-SGM, V155, P2116, DOI 10.1099/mic.0.027706-0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; Elliott DR, 2006, APPL ENVIRON MICROB, V72, P5211, DOI 10.1128/AEM.01060-05; Griffen AL, 2012, ISME J, V6, P1176, DOI 10.1038/ismej.2011.191; Gross EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047722; Haffajee AD, 2005, J CLIN PERIODONTOL, V32, P33, DOI 10.1111/j.1600-051X.2004.00624.x; HAMP SE, 1984, VET RADIOLOGY, V25, P86, DOI 10.1111/j.1740-8261.1984.tb01916.x; Kolenbrander PE, 2010, NAT REV MICROBIOL, V8, P471, DOI 10.1038/nrmicro2381; KOLENBRANDER PE, 1989, INFECT IMMUN, V57, P3194, DOI 10.1128/IAI.57.10.3194-3203.1989; Kortegaard HE, 2008, J SMALL ANIM PRACT, V49, P610, DOI 10.1111/j.1748-5827.2008.00609.x; Kyllar M, 2005, VET MED-CZECH, V50, P496, DOI 10.17221/5654-VETMED; Lavy E, 2012, ISR J VET MED, V67, P244; Li Y, 2014, ISME J, V8, P1879, DOI 10.1038/ismej.2014.28; Loozen G, 2014, J CLIN PERIODONTOL, V41, P1, DOI 10.1111/jcpe.12167; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Peeters E, 2008, J MICROBIOL METH, V72, P157, DOI 10.1016/j.mimet.2007.11.010; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; Quince C, 2009, NAT METHODS, V6, P639, DOI [10.1038/NMETH.1361, 10.1038/nmeth.1361]; Rickard AH, 2003, TRENDS MICROBIOL, V11, P94, DOI 10.1016/S0966-842X(02)00034-3; RITZ HL, 1967, ARCH ORAL BIOL, V12, P1561, DOI 10.1016/0003-9969(67)90190-2; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Sturgeon A, 2013, VET MICROBIOL, V162, P891, DOI 10.1016/j.vetmic.2012.11.018; Teles FR, 2012, J PERIODONTAL RES, V47, P95, DOI 10.1111/j.1600-0765.2011.01409.x; Uzel NG, 2011, J CLIN PERIODONTOL, V38, P612, DOI 10.1111/j.1600-051X.2011.01730.x; Van Dyke TE, 2009, J APPL ORAL SCI, V17; Wiggs RB., 1997, VET DENT PRINCIPLES, P186; Ximenez-Fyvie LA, 2000, J CLIN PERIODONTOL, V27, P722, DOI 10.1034/j.1600-051x.2000.027010722.x; Zijnge V, 2013, ORAL MICROBIAL ECOLOGY: CURRENT RESEARCH AND NEW PERSPECTIVES, P47	47	41	43	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113744	10.1371/journal.pone.0113744	http://dx.doi.org/10.1371/journal.pone.0113744			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463050	gold, Green Published, Green Submitted			2022-12-26	WOS:000345869700048
J	Jauniaux, T; Garigliany, MM; Loos, P; Bourgain, JL; Bouveroux, T; Coignoul, F; Haelters, J; Karpouzopoulos, J; Pezeril, S; Desmecht, D				Jauniaux, Thierry; Garigliany, Mutien-Marie; Loos, Pauline; Bourgain, Jean-Luc; Bouveroux, Thibaut; Coignoul, Freddy; Haelters, Jan; Karpouzopoulos, Jacky; Pezeril, Sylvain; Desmecht, Daniel			Bite Injuries of Grey Seals (Halichoerus grypus) on Harbour Porpoises (Phocoena phocoena)	PLOS ONE			English	Article								Bite-like skin lesions on harbour porpoises (Phocoena phocoena) have been suspected to be caused by grey seals (Halichoerus grypus), and a few field observations have been reported. Bite-like skin lesions observed on stranded animals were characterized by two main components: large flaps of loose or missing skin and blubber with frayed edges and puncture lesions. Definitive demonstration of predation by a grey seal was not reported so far in those stranded animals. In this study, five stranded porpoises with bite-like skin lesions were swabbed for genetic investigations. In addition, the head of a recently dead grey seal was used to mimic bite-like skin injuries on a porpoise carcass. Subsequently, the artificial skin injuries were swabbed, along with the gum of the seal used for inflicting them (positive controls). Total DNA was extracted from the swabs and was used to retrieve a fragment of mitochondrial DNA by PCR. Primers were designed to amplify a specific stretch of mitochondrial DNA known to differ between grey seals and porpoises. The amplicon targeted was successfully amplified from the positive control and from two of the stranded porpoises, and grey seal-specific mitochondrial DNA was retrieved from all those samples. We conclude that (1) it is possible to detect grey seal DNA from dead porpoises even after several days in seawater and (2) bite-like skin lesions found on dead porpoises definitively result from grey seals attacks. The attacks are most likely linked with predation although, in a number of cases, scavenging and aggressive behaviour cannot be excluded.	[Jauniaux, Thierry; Garigliany, Mutien-Marie; Loos, Pauline; Coignoul, Freddy; Desmecht, Daniel] Univ Liege, Dept Vet Pathol Fundamental & Appl Res Anim & Hlt, B-4000 Liege, Belgium; [Bourgain, Jean-Luc; Karpouzopoulos, Jacky] Coordinat Mammal Nord France, F-62850 Alembon, France; [Bouveroux, Thibaut; Pezeril, Sylvain] Observ Conservat & Etud Anim & Milieux Marins, F-59123 Zuydcoote, France; [Haelters, Jan] Royal Belgian Inst Nat Sci, Operat Directorate Nat Environm, B-8400 Oostende, Belgium	University of Liege; Royal Belgian Institute of Natural Sciences	Jauniaux, T (corresponding author), Univ Liege, Dept Vet Pathol Fundamental & Appl Res Anim & Hlt, Sart Tilman B43, B-4000 Liege, Belgium.	t.jauniaux@ulg.ac.be		Bouveroux, Thibaut/0000-0002-7339-0316; Loos, Pauline/0000-0002-0019-5579				Bouveroux T, 2014, MAR MAMMAL SCI, V30, P1542, DOI 10.1111/mms.12111; De Munnynck K, 2002, INT J LEGAL MED, V116, P295, DOI 10.1007/s00414-002-0332-9; Dunshea G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005252; Haelters J, 2012, AQUAT MAMM, V38, P343, DOI 10.1578/AM.38.4.2012.343; Jauniaux T, 2002, J COMP PATHOL, V126, P243, DOI 10.1053/jcpa.2001.0547; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Masland EDP, 2010, MOL ECOL RESOUR, V10, P214, DOI 10.1111/j.1755-0998.2009.02741.x; Mumma MA, 2014, MOL ECOL RESOUR, V14, P100, DOI 10.1111/1755-0998.12153; Ramon-Laca A, 2013, ELECTROPHORESIS, V34, P3370, DOI 10.1002/elps.201300324; Robinson Louise Anne, 2013, P367	10	12	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e108993	10.1371/journal.pone.0108993	http://dx.doi.org/10.1371/journal.pone.0108993			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461599	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700002
J	Rachakonda, V; Gabbert, C; Raina, A; Bell, LN; Cooper, S; Malik, S; Behari, J				Rachakonda, Vikrant; Gabbert, Charles; Raina, Amit; Bell, Lauren N.; Cooper, Sara; Malik, Shahid; Behari, Jaideep			Serum Metabolomic Profiling in Acute Alcoholic Hepatitis Identifies Multiple Dysregulated Pathways	PLOS ONE			English	Article							ACTIVATED RECEPTOR-ALPHA; FATTY-ACID OXIDATION; LIVER-DISEASE; INDOLEAMINE 2,3-DIOXYGENASE; MOLECULAR-MECHANISMS; STEATOHEPATITIS; ASSOCIATION; BIOMARKER; CIRRHOSIS; METSCAPE	Background and Objectives: While animal studies have implicated derangements of global energy homeostasis in the pathogenesis of acute alcoholic hepatitis (AAH), the relevance of these findings to the development of human AAH remains unclear. Using global, unbiased serum metabolomics analysis, we sought to characterize alterations in metabolic pathways associated with severe AAH and identify potential biomarkers for disease prognosis. Methods: This prospective, case-control study design included 25 patients with severe AAH and 25 ambulatory patients with alcoholic cirrhosis. Serum samples were collected within 24 hours of the index clinical encounter. Global, unbiased metabolomics profiling was performed. Patients were followed for 180 days after enrollment to determine survival. Results: Levels of 234 biochemicals were altered in subjects with severe AAH. Random-forest analysis, principal component analysis, and integrated hierarchical clustering methods demonstrated that metabolomics profiles separated the two cohorts with 100% accuracy. Severe AAH was associated with enhanced triglyceride lipolysis, impaired mitochondrial fatty acid beta oxidation, and upregulated omega oxidation. Low levels of multiple lysolipids and related metabolites suggested decreased plasma membrane remodeling in severe AAH. While most measured bile acids were increased in severe AAH, low deoxycholate and glycodeoxycholate levels indicated intestinal dysbiosis. Several changes in substrate utilization for energy homeostasis were identified in severe AAH, including increased glucose consumption by the pentose phosphate pathway, altered tricarboxylic acid (TCA) cycle activity, and enhanced peptide catabolism. Finally, altered levels of small molecules related to glutathione metabolism and antioxidant vitamin depletion were observed in patients with severe AAH. Univariable logistic regression revealed 15 metabolites associated with 180-day survival in severe AAH. Conclusion: Severe AAH is characterized by a distinct metabolic phenotype spanning multiple pathways. Metabolomics profiling revealed a panel of biomarkers for disease prognosis, and future studies are planned to validate these findings in larger cohorts of patients with severe AAH.	[Rachakonda, Vikrant; Gabbert, Charles; Raina, Amit; Malik, Shahid; Behari, Jaideep] Univ Pittsburgh, Div Gastroenterol, Dept Med, Pittsburgh, PA 15213 USA; [Rachakonda, Vikrant; Gabbert, Charles; Raina, Amit; Malik, Shahid; Behari, Jaideep] Univ Pittsburgh, Div Hepatol, Pittsburgh, PA USA; [Rachakonda, Vikrant; Gabbert, Charles; Raina, Amit; Malik, Shahid; Behari, Jaideep] Univ Pittsburgh, Div Nutr, Pittsburgh, PA USA; [Bell, Lauren N.] Metabolon Inc, Durham, NC USA; [Cooper, Sara] Hudson Alpha Inst Biotechnol, Huntsville, AL USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Metabolon	Behari, J (corresponding author), Univ Pittsburgh, Div Gastroenterol, Dept Med, Pittsburgh, PA 15213 USA.	beharij@upmc.edu		Cooper, Sara/0000-0002-9627-0309	National Institutes of Health [5K08AA017622]; University of Pittsburgh Medical Center Pilot Grant; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [K08AA017622] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Pittsburgh Medical Center Pilot Grant; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was funded by Grant 5K08AA017622 from the National Institutes of Health and a University of Pittsburgh Medical Center Pilot Grant to JB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arienti G, 1995, SCAND J GASTROENTERO, V30, P1204, DOI 10.3109/00365529509101632; Beckonert O, 2003, ANAL CHIM ACTA, V490, P3, DOI 10.1016/S0003-2670(03)00060-6; Casazza J P, 1987, Alcohol Alcohol Suppl, V1, P607; Cederbaum AI, 2009, ARCH TOXICOL, V83, P519, DOI 10.1007/s00204-009-0432-0; Crabb DW, 2004, ALCOHOL, V34, P35, DOI 10.1016/j.alcohol.2004.07.005; Dunn W, 2005, HEPATOLOGY, V41, P353, DOI 10.1002/hep.20503; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Fleming KM, 2010, ALIMENT PHARM THER, V32, P1343, DOI 10.1111/j.1365-2036.2010.04473.x; Forrest EH, 2012, J HEPATOL, V56, P1427, DOI 10.1016/j.jhep.2011.12.028; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Gao J, 2010, BIOINFORMATICS, V26, P971, DOI 10.1093/bioinformatics/btq048; Goldstein BA, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-49; GUZMAN M, 1988, ARCH BIOCHEM BIOPHYS, V267, P580, DOI 10.1016/0003-9861(88)90065-3; Hamid R, 2011, GUT, V60, pA233, DOI 10.1136/gut.2011.239301.492; Hartmann P, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00402; Holmes E, 2011, TRENDS MICROBIOL, V19, P349, DOI 10.1016/j.tim.2011.05.006; Kalhan SC, 2011, METABOLISM, V60, P404, DOI 10.1016/j.metabol.2010.03.006; Karnovsky A, 2012, BIOINFORMATICS, V28, P373, DOI 10.1093/bioinformatics/btr661; Lande RG, 2009, J ADDICT DIS, V28, P158, DOI 10.1080/10550880902772506; Larrea E, 2007, J VIROL, V81, P3662, DOI 10.1128/JVI.02248-06; Lieber CS, 2000, ANNU REV NUTR, V20, P395, DOI 10.1146/annurev.nutr.20.1.395; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; MADDREY WC, 1978, GASTROENTEROLOGY, V75, P193; Mathurin P, 1996, GASTROENTEROLOGY, V110, P1847, DOI 10.1053/gast.1996.v110.pm8964410; Mathurin P, 2012, J HEPATOL, V57, P399, DOI 10.1016/j.jhep.2012.04.004; McClain CJ, 2011, ALCOHOL CLIN EXP RES, V35, P815, DOI 10.1111/j.1530-0277.2010.01405.x; Naveau S, 1997, HEPATOLOGY, V25, P108, DOI 10.1002/hep.510250120; Neumann T, 2008, ALCOHOL ALCOHOLISM, V43, P431, DOI 10.1093/alcalc/agn035; Nording ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076575; Reddy JK, 2006, AM J PHYSIOL-GASTR L, V290, pG852, DOI 10.1152/ajpgi.00521.2005; Reddy JK, 2001, ANNU REV NUTR, V21, P193, DOI 10.1146/annurev.nutr.21.1.193; Rooks MG, 2014, ISME J; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Schepers E, 2009, NEPHROL DIAL TRANSPL, V24, P1429, DOI 10.1093/ndt/gfn670; TAYLOR MW, 1991, FASEB J, V5, P2516, DOI 10.1096/fasebj.5.11.1907934; Wong P, 2004, MED HYPOTHESES, V62, P966, DOI 10.1016/j.mehy.2003.12.032; You M, 2004, ALCOHOL, V34, P39, DOI 10.1016/j.alcohol.2004.07.004; You M, 2002, J BIOL CHEM, V277, P29342, DOI 10.1074/jbc.M202411200; Yu ST, 2003, CURR MOL MED, V3, P561, DOI 10.2174/1566524033479537; Zhong W, 2012, AM J PATHOL, V180, P998, DOI 10.1016/j.ajpath.2011.11.017	40	37	37	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113860	10.1371/journal.pone.0113860	http://dx.doi.org/10.1371/journal.pone.0113860			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461442	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000345869700061
J	Sueoka-Aragane, N; Sato, A; Kobayashi, N; Ide, M; Yokoo, M; Nagano, Y; Sueoka, E; Okada, S; Kimura, S				Sueoka-Aragane, Naoko; Sato, Akemi; Kobayashi, Naomi; Ide, Masaru; Yokoo, Masako; Nagano, Yumi; Sueoka, Eisaburo; Okada, Seiji; Kimura, Shinya			Correlation between Plasma DNA and Tumor Status in an Animal Model	PLOS ONE			English	Article							HUMAN LUNG-CANCER; INTRATUMOR HETEROGENEITY; ACQUIRED-RESISTANCE; DETECTION SYSTEM; CIRCULATING DNA; SCID MICE; METASTASIS; CELLS; EVOLUTION; THERAPY	Overcoming metastasis is one of the most important issues with lung cancer. Since metastasis arises through complex steps, a suitable animal model is indispensable for investigation of metastasis. To establish an animal model reflecting human metastatic lung cancers, we used NOD/SCID/Jak3(null) (NOJ) mice, which exhibit deficiencies in NK cell activity, macrophage and dendritic cell function, and complement activation, as well as T and B cell deficiencies. After screening twenty human lung cancer cell lines through expression patterns of E-cadherin and vimentin according to epithelial mesenchymal transition features, an H1975 cell line carrying EGFR mutations, L858R and T790M, was selected for investigation. Inoculation of the cells into the dorsal flanks caused systemic metastases after one month in lymph nodes, liver, lung, and peritoneum, suggesting that metastases occurred both lymphogenically and hematogenously. We confirmed the existence of H1975 cells in metastatic lesions by detection of T790M and L858R using the mutation-biased PCR and quenching probe (MBP-QP) system previously established in our laboratory. In addition, tumor-derived plasma DNA could be detected using the MBP-QP method. The amount of tumor-derived DNA was associated with tumor volume, whereas an unrelated large amount of tumor-derived DNA was circulating in the presence of metastasis. We present a novel animal model with systemic metastasis with human lung cancer cells. The amount of tumor derived DNA would be related with tumor volume and tumor progression such as metastasis.	[Sueoka-Aragane, Naoko; Sato, Akemi; Kobayashi, Naomi; Ide, Masaru; Yokoo, Masako; Nagano, Yumi; Kimura, Shinya] Saga Univ, Div Hematol Resp Med & Oncol, Dept Internal Med, Fac Med, Saga 840, Japan; [Sueoka, Eisaburo] Saga Univ Hosp, Dept Lab Med, Saga, Japan; [Okada, Seiji] Kumamoto Univ, Div Hematopoiesis, Ctr AIDS Res, Kumamoto, Japan	Saga University; Saga University; Kumamoto University	Sueoka-Aragane, N (corresponding author), Saga Univ, Div Hematol Resp Med & Oncol, Dept Internal Med, Fac Med, Saga 840, Japan.	sueokan@cc.saga-u.ac.jp			AstraZeneca [26430144]; Grants-in-Aid for Scientific Research [25461425] Funding Source: KAKEN	AstraZeneca(AstraZeneca); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by an AstraZeneca Research & Development Grant in 2013, and the Grants-in-Aid for Scientific Research-KAKENHI 26430144 (N.S-A.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker P, 1999, CANCER METAST REV, V18, P65, DOI 10.1023/A:1006260319913; Arcila ME, 2011, CLIN CANCER RES, V17, P1169, DOI 10.1158/1078-0432.CCR-10-2277; Bos PD, 2010, CURR OPIN PHARMACOL, V10, P571, DOI 10.1016/j.coph.2010.06.003; Carver BS, 2006, CLIN CANCER RES, V12, P5305, DOI 10.1158/1078-0432.CCR-06-0482; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; FELD R, 1984, J CLIN ONCOL, V2, P1352, DOI 10.1200/JCO.1984.2.12.1352; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Garcia-Olmo DC, 2010, CANCER RES, V70, P560; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Grunert S, 2003, NAT REV MOL CELL BIO, V4, P657, DOI 10.1038/nrm1175; Hisatomi T, 2011, BLOOD, V117, P3575, DOI 10.1182/blood-2010-02-270439; Iorns E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047995; Jahr S, 2001, CANCER RES, V61, P1659; Kondo K, 2004, ONCOL REP, V12, P991; LEON SA, 1977, CANCER RES, V37, P646; Li M, 2012, ONCOL LETT, V3, P802, DOI 10.3892/ol.2012.586; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Murtaza M, 2013, NATURE, V497, P108, DOI 10.1038/nature12065; Nakamura T, 2012, J THORAC ONCOL, V7, P1369, DOI 10.1097/JTO.0b013e31825f2821; Nakamura T, 2011, J THORAC ONCOL, V6, P1639, DOI 10.1097/JTO.0b013e31822956e8; Nguyen DX, 2007, NAT REV GENET, V8, P341, DOI 10.1038/nrg2101; Nguyen DX, 2011, J PATHOL, V223, P195, DOI 10.1002/path.2801; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; O'Shea JJ, 2004, NAT REV DRUG DISCOV, V3, P555, DOI 10.1038/nrd1441; Okada S, 2008, INT J HEMATOL, V88, P476, DOI 10.1007/s12185-008-0215-z; Pearson T, 2008, CLIN EXP IMMUNOL, V154, P270, DOI 10.1111/j.1365-2249.2008.03753.x; Pearson T, 2008, CURR TOP MICROBIOL, V324, P25; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Sawabata N, 2010, J THORAC ONCOL, V5, P1369, DOI 10.1097/JTO.0b013e3181e452b9; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Stroun M, 2001, CLIN CHIM ACTA, V313, P139, DOI 10.1016/S0009-8981(01)00665-9; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; TANIGAWA N, 1984, CANCER RES, V44, P2309; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Ulivi P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057401; Umetani N, 2006, CLIN CHEM, V52, P1062, DOI 10.1373/clinchem.2006.068577; Ureshino N, 2011, ONCOL REP, V26, P609, DOI 10.3892/or.2011.1341; Wen FS, 2013, CANCER RES, V73, P4256, DOI 10.1158/0008-5472.CAN-12-3287; Yano S, 1996, INT J CANCER, V67, P211, DOI 10.1002/(SICI)1097-0215(19960717)67:2<211::AID-IJC11>3.0.CO;2-E; Yano S, 2011, J THORAC ONCOL, V6, P2011, DOI 10.1097/JTO.0b013e31823ab0dd; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246	43	11	14	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e111881	10.1371/journal.pone.0111881	http://dx.doi.org/10.1371/journal.pone.0111881			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462870	Green Published, Green Submitted, gold			2022-12-26	WOS:000345869700007
J	He, Y; Guo, YH; Zhou, Y; Zhang, Y; Fan, C; Ji, GX; Wang, Y; Ma, ZY; Lian, JQ; Hao, CQ; Yao, ZQ; Jia, ZS				He, Yu; Guo, Yonghong; Zhou, Yun; Zhang, Ying; Fan, Chao; Ji, Guangxi; Wang, Yu; Ma, Zhiyuan; Lian, Jianqi; Hao, Chunqiu; Yao, Zhi Q.; Jia, Zhansheng			CD100 Up-Regulation Induced by Interferon-alpha on B Cells Is Related to Hepatitis C Virus Infection	PLOS ONE			English	Article							IV SEMAPHORIN CD100; LYMPHOCYTE SEMAPHORIN; ANTIVIRAL TREATMENT; IMMUNE-RESPONSES; LEUKOCYTE SEMAPHORIN; HCV INFECTION; CD5 EXPANSION; T-CELLS; ACTIVATION; CD81	Objectives: CD100, also known as Sema4D, is a member of the semaphorin family and has important regulatory functions that promote immune cell activation and responses. The role of CD100 expression on B cells in immune regulation during chronic hepatitis C virus (HCV) infection remains unclear. Materials and Methods: We longitudinally investigated the altered expression of CD100, its receptor CD72, and other activation markers CD69 and CD86 on B cells in 20 chronic HCV-infected patients before and after treatment with pegylated interferon-alpha (Peg-IFN-alpha) and ribavirin (RBV) by flow cytometry. Results: The frequency of CD5(+) B cells as well as the expression levels of CD100, CD69 and CD86 was significantly increased in chronic HCV patients and returned to normal in patients with sustained virological response after discontinuation of IFN-alpha/RBV therapy. Upon IFN-alpha treatment, CD100 expression on B cells and the two subsets was further up-regulated in patients who achieved early virological response, and this was confirmed by in vitro experiments. Moreover, the increased CD100 expression via IFN-alpha was inversely correlated with the decline of the HCV-RNA titer during early-phase treatment. Conclusions: Peripheral B cells show an activated phenotype during chronic HCV infection. Moreover, IFN-alpha therapy facilitates the reversion of disrupted B cell homeostasis, and up-regulated expression of CD100 may be indirectly related to HCV clearance.	[He, Yu; Guo, Yonghong; Zhou, Yun; Zhang, Ying; Fan, Chao; Ji, Guangxi; Wang, Yu; Ma, Zhiyuan; Lian, Jianqi; Hao, Chunqiu; Yao, Zhi Q.; Jia, Zhansheng] Fourth Mil Med Univ, Dept Infect Dis, Tangdu Hosp, Xian 710032, Shaanxi, Peoples R China; [He, Yu; Guo, Yonghong; Zhou, Yun; Zhang, Ying; Fan, Chao; Ji, Guangxi; Wang, Yu; Ma, Zhiyuan; Lian, Jianqi; Hao, Chunqiu; Yao, Zhi Q.; Jia, Zhansheng] Fourth Mil Med Univ, Ctr Liver Dis, Tangdu Hosp, Xian 710032, Shaanxi, Peoples R China; [Yao, Zhi Q.] E Tennessee State Univ, James H Quillen Coll Med, Dept Internal Med, Div Infect Dis, Johnson City, TN 37614 USA	Air Force Military Medical University; Air Force Military Medical University; East Tennessee State University	Jia, ZS (corresponding author), Fourth Mil Med Univ, Dept Infect Dis, Tangdu Hosp, Xian 710032, Shaanxi, Peoples R China.	jiazsh@fmmu.edu.cn	Ma, ZhiYuan/GWN-1061-2022	He, Yu/0000-0001-9616-5261	National Natural Science Foundation of China (NSFC) [81170389, 81300314]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	Funding: This study was supported by a National Natural Science Foundation of China (NSFC) grant to Zhansheng Jia (81170389) and Chao Fan (81300314). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Berland R, 2002, ANNU REV IMMUNOL, V20, P253, DOI 10.1146/annurev.immunol.20.100301.064833; BOUGERET C, 1992, J IMMUNOL, V148, P318; Chen ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018933; Ciesek S, 2011, NAT REV GASTRO HEPAT, V8, P69, DOI 10.1038/nrgastro.2010.219; Curry MP, 2003, J HEPATOL, V38, P642, DOI 10.1016/S0168-8278(03)00075-8; Delaire S, 1998, CELL MOL LIFE SCI, V54, P1265, DOI 10.1007/s000180050252; Edlich B, 2012, HEPATOLOGY, V55, P39, DOI 10.1002/hep.24628; Eriksson EM, 2012, BLOOD, V119, P745, DOI 10.1182/blood-2010-12-324848; Fujiwara K, 2013, HEPATOLOGY, V57, P483, DOI 10.1002/hep.25921; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hall KT, 1996, P NATL ACAD SCI USA, V93, P11780, DOI 10.1073/pnas.93.21.11780; Ito M, 2010, J INNATE IMMUN, V2, P607, DOI 10.1159/000317690; Kato T, 2006, NAT PROTOC, V1, P2334, DOI 10.1038/nprot.2006.395; Kumanogoh A, 2002, J IMMUNOL, V169, P1175, DOI 10.4049/jimmunol.169.3.1175; Kumanogoh A, 2001, TRENDS IMMUNOL, V22, P670, DOI 10.1016/S1471-4906(01)02087-7; Kumanogoh A, 2000, IMMUNITY, V13, P621, DOI 10.1016/S1074-7613(00)00062-5; Lan L, 2008, J IMMUNOL, V181, P4926, DOI 10.4049/jimmunol.181.7.4926; Layden TJ, 2000, SEMIN LIVER DIS, V20, P173, DOI 10.1055/s-2000-9940; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Liu B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073958; Meehan TF, 2014, MUCOSAL IMMUNOL, V7, P134, DOI 10.1038/mi.2013.32; Mizrahi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000818; Moorman J, 2009, IMMUNOLOGY, V128, P227, DOI 10.1111/j.1365-2567.2009.03106.x; Oliviero B, 2011, J HEPATOL, V55, P53, DOI 10.1016/j.jhep.2010.10.016; Rosa D, 2005, P NATL ACAD SCI USA, V102, P18544, DOI 10.1073/pnas.0509402102; Santer DM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068308; Shi W, 2000, IMMUNITY, V13, P633, DOI 10.1016/S1074-7613(00)00063-7; Stegmann KA, 2010, GASTROENTEROLOGY, V138, P1885, DOI 10.1053/j.gastro.2010.01.051; Sun HB, 2013, EXP BIOL MED, V238, P1275, DOI 10.1177/1535370213502626; Suzuki K, 2003, CYTOKINE GROWTH F R, V14, P17, DOI 10.1016/S1359-6101(02)00073-4; Takamatsu H, 2012, TRENDS IMMUNOL, V33, P127, DOI 10.1016/j.it.2012.01.008; Takamatsu H, 2010, CELL MOL IMMUNOL, V7, P83, DOI 10.1038/cmi.2009.111; Tucci Felicia, 2014, Virologica Sinica, V29, P3, DOI 10.1007/s12250-014-3414-1; Urbani S, 2008, J HEPATOL, V48, P548, DOI 10.1016/j.jhep.2007.12.014; Wang XS, 2001, BLOOD, V97, P3498, DOI 10.1182/blood.V97.11.3498; Watanabe C, 2001, J IMMUNOL, V167, P4321, DOI 10.4049/jimmunol.167.8.4321; Witherden DA, 2012, IMMUNITY, V37, P314, DOI 10.1016/j.immuni.2012.05.026; Yao ZQ, 2008, IMMUNOLOGY, V125, P197, DOI 10.1111/j.1365-2567.2008.02829.x; Zhang JY, 2013, EUR J IMMUNOL, V43, P1953, DOI 10.1002/eji.201243097; Zhang YS, 2013, CELL MOL IMMUNOL, V10, P97, DOI 10.1038/cmi.2012.65; Zuckerman E, 2003, J VIROL, V77, P10432, DOI 10.1128/JVI.77.19.10432-10436.2003; Zuckerman E, 2002, CLIN EXP IMMUNOL, V128, P353, DOI 10.1046/j.1365-2249.2002.01844.x	43	7	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113338	10.1371/journal.pone.0113338	http://dx.doi.org/10.1371/journal.pone.0113338			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436996	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900040
J	Kalpakidou, AK; Allin, MPG; Walshe, M; Giampietro, V; McGuire, PK; Rifkin, L; Murray, RM; Nosarti, C				Kalpakidou, Anastasia K.; Allin, Matthew P. G.; Walshe, Muriel; Giampietro, Vincent; McGuire, Philip K.; Rifkin, Larry; Murray, Robin M.; Nosarti, Chiara			Functional Neuroanatomy of Executive Function after Neonatal Brain Injury in Adults Who Were Born Very Preterm	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; WORKING-MEMORY; INTRAVENTRICULAR HEMORRHAGE; ULTRASOUND APPEARANCE; ATTENTION ALLOCATION; RESPONSE-INHIBITION; BASAL GANGLIA; GRAY-MATTER; ACTIVATION; TASK	Individuals who were born very preterm (VPT; <33 gestational weeks) are at risk of experiencing deficits in tasks involving executive function in childhood and beyond. In addition, the type and severity of neonatal brain injury associated with very preterm birth may exert differential effects on executive functioning by altering its neuroanatomical substrates. Here we addressed this question by investigating with functional magnetic resonance imaging (fMRI) the haemodynamic response during executive-type processing using a phonological verbal fluency and a working memory task in VPT-born young adults who had experienced differing degrees of neonatal brain injury. 12 VPT individuals with a history of periventricular haemorrhage and ventricular dilatation (PVH+VD), 17 VPT individuals with a history of uncomplicated periventricular haemorrhage (UPVH), 13 VPT individuals with no history of neonatal brain injury and 17 controls received an MRI scan whilst completing a verbal fluency task with two cognitive loads ('easy' and 'hard' letters). Two groups of VPT individuals (PVH+VD; n=10, UPVH; n=8) performed an n-back task with three cognitive loads (1-, 2-, 3-back). Results demonstrated that VPT individuals displayed hyperactivation in frontal, temporal, and parietal cortices and in caudate nucleus, insula and thalamus compared to controls, as demands of the verbal fluency task increased, regardless of type of neonatal brain injury. On the other hand, during the n-back task and as working memory load increased, the PVH+VD group showed less engagement of the frontal cortex than the UPVH group. In conclusion, this study suggests that the functional neuroanatomy of different executive-type processes is altered following VPT birth and that neural activation associated with specific aspects of executive function (i.e., working memory) may be particularly sensitive to the extent of neonatal brain injury.	[Kalpakidou, Anastasia K.; Allin, Matthew P. G.; Walshe, Muriel; McGuire, Philip K.; Rifkin, Larry; Murray, Robin M.; Nosarti, Chiara] Kings Coll London, Kings Hlth Partners, Inst Psychiat, Dept Psychosis Studies, London WC2R 2LS, England; [Giampietro, Vincent] Kings Coll London, Kings Hlth Partners, Inst Psychiat, Dept Neuroimaging, London WC2R 2LS, England	University of London; King's College London; University of London; King's College London	Kalpakidou, AK (corresponding author), Kings Coll London, Kings Hlth Partners, Inst Psychiat, Dept Psychosis Studies, London WC2R 2LS, England.	anastasia.kalpakidou@kcl.ac.uk	Walshe, Muriel/E-5214-2010; Giampietro, Vincent P/D-1279-2011; murray, robin/F-8658-2012; Nosarti, Chiara/G-5638-2010	Walshe, Muriel/0000-0001-6829-1105; Giampietro, Vincent P/0000-0002-9381-8201; McGuire, Philip/0000-0003-4381-0532; murray, robin/0000-0003-0829-0519; Rifkin, Larry/0000-0003-2590-9010; Nosarti, Chiara/0000-0001-6305-9710	March of Dimes Birth Defects Foundation, USA [12-FY03-41]; Cerebra Foundation For The Brain Injured Infant; MRC [MR/K004867/1] Funding Source: UKRI	March of Dimes Birth Defects Foundation, USA(March of Dimes); Cerebra Foundation For The Brain Injured Infant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was funded by the March of Dimes Birth Defects Foundation, USA (12-FY03-41) (www.marchofdimes.com/) and the Cerebra Foundation For The Brain Injured Infant (www.cerebra.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarnoudse-Moens CSH, 2009, PEDIATRICS, V124, P717, DOI 10.1542/peds.2008-2816; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Ali N, 2010, J COGNITIVE NEUROSCI, V22, P2369, DOI 10.1162/jocn.2009.21352; Allin M, 2008, J NEUROL NEUROSUR PS, V79, P381, DOI 10.1136/jnnp.2006.110858; Allin M, 2004, DEV MED CHILD NEUROL, V46, P46, DOI 10.1017/S0012162204000088; Allin MPG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024525; Anderson PJ, 2012, NEUROPSYCHOL REV, V22, P345, DOI 10.1007/s11065-012-9220-3; Anderson PJ, 2004, PEDIATRICS, V114, P50, DOI 10.1542/peds.114.1.50; Baddeley A. D, 1986, WORKING MEMORY; Ballabh P, 2010, PEDIATR RES, V67, P1, DOI 10.1203/PDR.0b013e3181c1b176; Bolisetty S, 2014, PEDIATRICS, V133, P55, DOI 10.1542/peds.2013-0372; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Broome MR, 2009, BRIT J PSYCHIAT, V194, P25, DOI 10.1192/bjp.bp.107.046789; Bullmore E, 1996, MAGN RESON MED, V35, P261, DOI 10.1002/mrm.1910350219; Bullmore ET, 2001, HUM BRAIN MAPP, V12, P61, DOI 10.1002/1097-0193(200102)12:2<61::AID-HBM1004>3.0.CO;2-W; Burton MW, 2005, NEUROIMAGE, V26, P647, DOI 10.1016/j.neuroimage.2005.02.024; CHOW TW, 1999, SCI PRACT NEUROPSYCH, P3; Cohen JD, 1997, NATURE, V386, P604, DOI 10.1038/386604a0; Constable RT, 2013, NEUROIMAGE, V64, P371, DOI 10.1016/j.neuroimage.2012.09.008; COSTELLO AMD, 1988, DEV MED CHILD NEUROL, V30, P711; Crosson B, 2003, J INT NEUROPSYCH SOC, V9, P1061, DOI 10.1017/S135561770397010X; Curtis VA, 1998, AM J PSYCHIAT, V155, P1056, DOI 10.1176/ajp.155.8.1056; Curtis WJ, 2006, DEV NEUROPSYCHOL, V29, P341, DOI 10.1207/s15326942dn2902_4; Dickstein SG, 2006, J CHILD PSYCHOL PSYC, V47, P1051, DOI 10.1111/j.1469-7610.2006.01671.x; EVRARD P, 1992, BIOL NEONATE, V61, P1; Fu CHY, 2002, NEUROIMAGE, V17, P871, DOI 10.1006/nimg.2002.1189; Fu CHY, 1999, PHILOS T R SOC B, V354, P1359, DOI 10.1098/rstb.1999.0484; Fu CHY, 2005, AM J PSYCHIAT, V162, P485, DOI 10.1176/appi.ajp.162.3.485; Griffiths ST, 2013, PEDIATR RES, V74, P196, DOI 10.1038/pr.2013.79; *HMSO, 1991, STAND OCC CLASS; Indefrey P., 2000, NEW COGNITIVE NEUROS, P845; Johnson S, 2011, PEDIATR RES, V69, p11R, DOI 10.1203/PDR.0b013e318212faa0; Just MA, 2007, COGN AFFECT BEHAV NE, V7, P153, DOI 10.3758/CABN.7.3.153; Kalpakidou AK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034858; Kesler SR, 2004, PEDIATR NEUROL, V31, P318, DOI 10.1016/j.pediatrneurol.2004.06.008; Kirschen MP, 2005, NEUROIMAGE, V24, P462, DOI 10.1016/j.neuroimage.2004.08.036; KLEIN D, 1994, NEUROREPORT, V5, P2295, DOI 10.1097/00001756-199411000-00022; Larroque B, 2003, J PEDIATR-US, V143, P477, DOI 10.1067/S0022-3476(03)00417-7; Lawrence EJ, 2010, J PEDIAT; Lawrence EJ, 2009, HUM BRAIN MAPP, V30, P1038, DOI 10.1002/hbm.20564; Lezak M.D., 2012, NEUROPSYCHOLOGICAL A; Low KA, 2009, PSYCHOPHYSIOLOGY, V46, P1069, DOI 10.1111/j.1469-8986.2009.00854.x; Lurito JT, 2000, HUM BRAIN MAPP, V10, P99, DOI 10.1002/1097-0193(200007)10:3<99::AID-HBM10>3.0.CO;2-Q; Menon V, 2001, HUM BRAIN MAPP, V12, P131, DOI 10.1002/1097-0193(200103)12:3<131::AID-HBM1010>3.0.CO;2-C; Mulder H, 2009, DEV NEUROPSYCHOL, V34, P393, DOI 10.1080/87565640902964524; Murphy K, 1997, J APPL PHYSIOL, V83, P1438, DOI 10.1152/jappl.1997.83.5.1438; Nagy Z, 2009, PEDIATRICS, V124, pE964, DOI 10.1542/peds.2008-3801; Narberhaus A, 2009, NEUROIMAGE; Nosarti C, 2002, BRAIN, V125, P1616, DOI 10.1093/brain/awf157; Nosarti C, 2009, NEUROIMAGE; Nosarti C, 2008, BRAIN; Nosarti C, 2007, J INT NEUROPSYCH SOC, V13, P571, DOI 10.1017/S1355617707070725; Nosarti C, 2014, NEUROIMAGE-CLIN, V6, P180, DOI 10.1016/j.nicl.2014.08.005; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; PANETH N, 1994, BRAIN DAMAGE PRETERM; PAULESU E, 1993, NATURE, V362, P342, DOI 10.1038/362342a0; Price CJ, 2012, NEUROIMAGE, V62, P816, DOI 10.1016/j.neuroimage.2012.04.062; ROTH SC, 1993, DEV MED CHILD NEUROL, V35, P755; Rubia K, 2007, BIOL PSYCHIAT, V62, P999, DOI 10.1016/j.biopsych.2007.02.024; Rubia K, 2006, HUM BRAIN MAPP, V27, P973, DOI 10.1002/hbm.20237; Ruff RM, 1997, BRAIN LANG, V57, P394, DOI 10.1006/brln.1997.1755; Rypma B, 1999, NEUROIMAGE, V9, P216, DOI 10.1006/nimg.1998.0404; Sala-Llonch R, 2012, CORTEX, V48, P1187, DOI 10.1016/j.cortex.2011.07.006; Salvan P, 2013, NEUROIMAGE; Shallice T., 1988, NEUROPSYCHOLOGY MENT, DOI DOI 10.1017/IPM.2020.45; Sowell ER, 2001, J NEUROSCI, V21, P8819, DOI 10.1523/JNEUROSCI.21-22-08819.2001; Srinivasan L, 2007, PEDIATRICS, V119, P759, DOI 10.1542/peds.2006-2508; STEWART AL, 1989, DEV MED CHILD NEUROL, V31, P756; Stewart AL, 1999, LANCET, V353, P1653, DOI 10.1016/S0140-6736(98)07130-X; STEWART AL, 1983, ARCH DIS CHILD, V58, P598, DOI 10.1136/adc.58.8.598; Talairach I., 1988, COPLANAR STEREOTACTI; Taylor HG, 2011, DEV NEUROPSYCHOL, V36, P96, DOI 10.1080/87565641.2011.540544; Thuy ML, 2011, PEDIATRICS, V127, pE639, DOI 10.1542/peds.2010-1421; Valera EM, 2010, AM J PSYCHIAT, V167, P86, DOI 10.1176/appi.ajp.2009.09020249; Vasileiadis GT, 2004, PEDIATRICS, V114, pE367, DOI 10.1542/peds.2004-0500; Volpe JJ, 1995, NEUROLOGY NEWBORN, P95; Wechsler D., 2011, WASI 2 WECHSLER ABBR; Woodward LJ, 2005, BRAIN, V128, P2578, DOI 10.1093/brain/awh618; YETKIN FZ, 1995, AM J NEURORADIOL, V16, P1087	79	27	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113975	10.1371/journal.pone.0113975	http://dx.doi.org/10.1371/journal.pone.0113975			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438043	Green Published, gold			2022-12-26	WOS:000347114900105
J	Yan, Q; Li, XP; Tumer, NE				Yan, Qing; Li, Xiao-Ping; Tumer, Nilgun E.			Wild Type RTA and Less Toxic Variants Have Distinct Requirements for Png1 for Their Depurination Activity and Toxicity in Saccharomyces cerevisiae	PLOS ONE			English	Article							RICIN-A-CHAIN; RETICULUM-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM; N-GLYCANASE; RIBOSOME DEPURINATION; SHIGA TOXIN; ENZYMATIC INACTIVATION; CYTOPLASMIC PEPTIDE; GLUTAMIC ACID-177; GENETIC-ANALYSIS	Ricin A chain (RTA) undergoes retrograde trafficking and is postulated to use components of the endoplasmic reticulum (ER) associated degradation (ERAD) pathway to enter the cytosol to depurinate ribosomes. However, it is not known how RTA evades degradation by the proteasome after entry into the cytosol. We observed two distinct trafficking patterns among the precursor forms of wild type RTA and nontoxic variants tagged with enhanced green fluorescent protein (EGFP) at their C-termini in yeast. One group, which included wild type RTA, underwent ER-to-vacuole transport, while another group, which included the G83D variant, formed aggregates in the ER and was not transported to the vacuole. Peptide: N-glycanase (Png1), which catalyzes degradation of unfolded glycoproteins in the ERAD pathway affected depurination activity and toxicity of wild type RTA and G83D variant differently. PreG83D variant was deglycosylated by Png1 on the ER membrane, which reduced its depurination activity and toxicity by promoting its degradation. In contrast, wild type preRTA was deglycosylated by the free pool of Png1 in the cytosol, which increased its depurination activity, possibly by preventing its degradation. These results indicate that wild type RTA has a distinct requirement for Png1 compared to the G83D variant and is deglycosylated by Png1 in the cytosol as a possible strategy to avoid degradation by the ERAD pathway to reach the ribosome.	[Yan, Qing; Li, Xiao-Ping; Tumer, Nilgun E.] Rutgers State Univ, Dept Plant Biol & Pathol, Sch Environm & Biol Sci, New Brunswick, NJ 08903 USA	Rutgers State University New Brunswick	Tumer, NE (corresponding author), Rutgers State Univ, Dept Plant Biol & Pathol, Sch Environm & Biol Sci, New Brunswick, NJ 08903 USA.	tumer@aesop.rutgers.edu			National Institutes of Health [AI072425]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072425] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health Grant AI072425 to Nilgun E. Turner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti S, 2007, YEAST, V24, P913, DOI 10.1002/yea.1502; Barlowe C, 2003, TRENDS CELL BIOL, V13, P295, DOI 10.1016/S0962-8924(03)00082-5; Bassik MC, 2013, CELL, V152, P909, DOI 10.1016/j.cell.2013.01.030; Bellisola G, 2004, BIOCHEM PHARMACOL, V67, P1721, DOI 10.1016/j.bcp.2004.01.013; Byun H, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00330; Cabrera M, 2008, METHOD ENZYMOL, V451, P177, DOI 10.1016/S0076-6879(08)03213-8; Chiou JC, 2011, INT J BIOCHEM CELL B, V43, P1792, DOI 10.1016/j.biocel.2011.08.018; Chiou JC, 2008, MOL MICROBIOL, V70, P1441, DOI 10.1111/j.1365-2958.2008.06492.x; Deeks ED, 2002, BIOCHEMISTRY-US, V41, P3405, DOI 10.1021/bi011580v; Di Cola A, 2001, P NATL ACAD SCI USA, V98, P14726, DOI 10.1073/pnas.251386098; ENDO Y, 1987, J BIOL CHEM, V262, P8128; FRANKEL A, 1990, MOL CELL BIOL, V10, P6257, DOI 10.1128/MCB.10.12.6257; Frigerio L, 2001, PLANT PHYSIOL, V126, P167, DOI 10.1104/pp.126.1.167; Gelperin DM, 2005, GENE DEV, V19, P2816, DOI 10.1101/gad.1362105; Gillece P, 2000, P NATL ACAD SCI USA, V97, P4609, DOI 10.1073/pnas.090083497; Guerriero CJ, 2012, PHYSIOL REV, V92, P537, DOI 10.1152/physrev.00027.2011; Hirsch C, 2003, EMBO J, V22, P1036, DOI 10.1093/emboj/cdg107; Hirsch C, 2004, EMBO REP, V5, P201, DOI 10.1038/sj.embor.7400066; Hosomi A, 2010, J BIOL CHEM, V285, P24324, DOI 10.1074/jbc.M109.095919; Joshi S, 2005, FEBS LETT, V579, P823, DOI 10.1016/j.febslet.2004.12.060; KANE PM, 1992, J BIOL CHEM, V267, P447; Katiyar S, 2004, P NATL ACAD SCI USA, V101, P13774, DOI 10.1073/pnas.0405663101; Kim I, 2006, J CELL BIOL, V172, P211, DOI 10.1083/jcb.200507149; Li SY, 2010, MOL BIOL CELL, V21, P2543, DOI 10.1091/mbc.E09-08-0743; Li XP, 2007, INFECT IMMUN, V75, P417, DOI 10.1128/IAI.01295-06; Li XP, 2013, J BIOL CHEM, V288, P30270, DOI 10.1074/jbc.M113.510966; MAY MJ, 1989, EMBO J, V8, P301, DOI 10.1002/j.1460-2075.1989.tb03377.x; Mayerhofer PU, 2009, J BIOL CHEM, V284, P10232, DOI 10.1074/jbc.M808387200; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Munishkin A, 1995, J BIOL CHEM, V270, P30581, DOI 10.1074/jbc.270.51.30581; Parikh BA, 2005, BIOCHEMISTRY-US, V44, P2478, DOI 10.1021/bi048188c; Pierce M, 2011, RNA, V17, P201, DOI 10.1261/rna.2375411; Redmann V, 2011, J BIOL CHEM, V286, P21231, DOI 10.1074/jbc.M111.234708; Russell SJ, 1999, J BIOL CHEM, V274, P21943, DOI 10.1074/jbc.274.31.21943; Sandvig K, 2002, HISTOCHEM CELL BIOL, V117, P131, DOI 10.1007/s00418-001-0346-2; SCHLOSSMAN D, 1989, MOL CELL BIOL, V9, P5012, DOI 10.1128/MCB.9.11.5012; Simpson JC, 1999, FEBS LETT, V459, P80, DOI 10.1016/S0014-5793(99)01222-3; Spiro RG, 2004, CELL MOL LIFE SCI, V61, P1025, DOI 10.1007/s00018-004-4037-8; Spooner RA, 2008, P NATL ACAD SCI USA, V105, P17408, DOI 10.1073/pnas.0809013105; Spooner RA, 2012, CURR TOP MICROBIOL, V357, P19, DOI 10.1007/82_2011_154; Suzuki T, 2002, FASEB J, V16, DOI 10.1096/fj.01-0889rev; Tanabe K, 2006, METHOD ENZYMOL, V415, P46, DOI 10.1016/S0076-6879(06)15004-1; VANDEURS B, 1986, J CELL BIOL, V102, P37, DOI 10.1083/jcb.102.1.37; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Wesche J, 1999, J BIOL CHEM, V274, P34443, DOI 10.1074/jbc.274.48.34443; WINTHER JR, 1991, P NATL ACAD SCI USA, V88, P9330, DOI 10.1073/pnas.88.20.9330; WINTHER JR, 1994, J BIOL CHEM, V269, P22007; Yan Q, 2012, TRAFFIC, V13, P1508, DOI 10.1111/j.1600-0854.2012.01404.x; Zhang TT, 2011, YEAST, V28, P795, DOI 10.1002/yea.1905; Zhao G, 2009, GLYCOBIOLOGY, V19, P118, DOI 10.1093/glycob/cwn108	50	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113719	10.1371/journal.pone.0113719	http://dx.doi.org/10.1371/journal.pone.0113719			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436896	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900069
J	Jiang, W; Tang, JJ; Miao, HH; Qu, YX; Qin, J; Xu, J; Yang, JB; Li, BL; Song, BL				Jiang, Wei; Tang, Jing-Jie; Miao, Hong-Hua; Qu, Yu-Xiu; Qin, Jie; Xu, Jie; Yang, Jinbo; Li, Bo-Liang; Song, Bao-Liang			Forward Genetic Screening for Regulators Involved in Cholesterol Synthesis Using Validation-Based Insertional Mutagenesis	PLOS ONE			English	Article							HMG-COA REDUCTASE; HAMSTER OVARY CELLS; ENDOPLASMIC-RETICULUM; FEEDBACK-REGULATION; STEROL RESISTANCE; DEGRADATION; INSIG-1; UBIQUITINATION; PROTEIN; BINDING	Somatic cell genetics is a powerful approach for unraveling the regulatory mechanism of cholesterol metabolism. However, it is difficult to identify the mutant gene(s) due to cells are usually mutagenized chemically or physically. To identify important genes controlling cholesterol biosynthesis, an unbiased forward genetics approach named validation-based insertional mutagenesis (VBIM) system was used to isolate and characterize the 25-hydroxycholesterol (25-HC)-resistant and SR-12813-resisitant mutants. Here we report that five mutant cell lines were isolated. Among which, four sterol-resistant mutants either contain a truncated NH2-terminal domain of sterol regulatory element-binding protein (SREBP)-2 terminating at amino acids (aa) 400, or harbor an overexpressed SREBP cleavage-activating protein (SCAP). Besides, one SR-12813 resistant mutant was identified to contain a truncated COOH-terminal catalytic domain of 3-hydroxy-3-methylglutarylcoenzyme A reductase (HMG-CoA reductase). This study demonstrates that the VBIM system can be a powerful tool to screen novel regulatory genes in cholesterol biosynthesis.	[Jiang, Wei; Tang, Jing-Jie; Miao, Hong-Hua; Qu, Yu-Xiu; Qin, Jie; Xu, Jie; Li, Bo-Liang; Song, Bao-Liang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Song, Bao-Liang] Wuhan Univ, Coll Life Sci, Wuhan 430072, Peoples R China; [Yang, Jinbo] Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Wuhan University; Lanzhou University	Yang, JB (corresponding author), Lanzhou Univ, Sch Life Sci, Lanzhou 730000, Peoples R China.	yangjb@lzu.edu.cn; blsong@whu.edu.cn	Yang, Jinbo/AAM-9580-2020	Song, Bao-Liang/0000-0002-6397-5935	Ministry of Science and Technology of China [2011CB910900, 2012CB524900]; National Natural Science Foundation of China [30925012, 31230020, 81260041, 81270155, 91213306]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This work was supported by grants from the Ministry of Science and Technology of China (2011CB910900 and 2012CB524900), http://www.most.gov.cn/; and National Natural Science Foundation of China (30925012, 31230020, 81260041, 81270155, and 91213306), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CM, 2004, J BIOL CHEM, V279, P52772, DOI 10.1074/jbc.M410302200; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Cao J, 2007, CELL METAB, V6, P115, DOI 10.1016/j.cmet.2007.07.002; DeBose-Boyd RA, 2008, CELL RES, V18, P609, DOI 10.1038/cr.2008.61; Elsabrouty R, 2013, MOL BIOL CELL; Faulkner RA, 2013, J LIPID RES, V54, P1011, DOI 10.1194/jlr.M033639; Ge L, 2008, CELL METAB, V7, P508, DOI 10.1016/j.cmet.2008.04.001; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Goldstein JL, 2002, ARCH BIOCHEM BIOPHYS, V397, P139, DOI 10.1006/abbi.2001.2615; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Hua XX, 1996, CELL, V87, P415, DOI 10.1016/S0092-8674(00)81362-8; Jo Y, 2013, MOL BIOL CELL, V24, P169, DOI 10.1091/mbc.E12-07-0564; Lee PCW, 2005, J BIOL CHEM, V280, P25242, DOI 10.1074/jbc.M502989200; Lee PCW, 2007, J LIPID RES, V48, P1944, DOI 10.1194/jlr.M700225-JLR200; LISCUM L, 1985, J BIOL CHEM, V260, P522; Lu T, 2009, COLD SPRING HARBOR P; Lu T, 2009, P NATL ACAD SCI USA, V106, P16339, DOI 10.1073/pnas.0908560106; METHERALL JE, 1989, J BIOL CHEM, V264, P15634; Miao HH, 2010, ACTA BIOCH BIOPH SIN, V42, P303, DOI 10.1093/abbs/gmq022; Nohturfft A, 2000, CELL, V102, P315, DOI 10.1016/S0092-8674(00)00037-4; Sever N, 2004, J BIOL CHEM, V279, P43136, DOI 10.1074/jbc.M406406200; Sever N, 2003, J BIOL CHEM, V278, P52479, DOI 10.1074/jbc.M310053200; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Song BL, 2005, MOL CELL, V19, P829, DOI 10.1016/j.molcel.2005.08.009; YANG JX, 1995, J BIOL CHEM, V270, P12152, DOI 10.1074/jbc.270.20.12152	25	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112632	10.1371/journal.pone.0112632	http://dx.doi.org/10.1371/journal.pone.0112632			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426949	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400021
J	Kim, EY; Jakobson, CM; Tullman-Ercek, D				Kim, Edward Y.; Jakobson, Christopher M.; Tullman-Ercek, Danielle			Engineering Transcriptional Regulation to Control Pdu Microcompartment Formation	PLOS ONE			English	Article							B-12-DEPENDENT 1,2-PROPANEDIOL DEGRADATION; SEROVAR TYPHIMURIUM LT2; COBALAMIN BIOSYNTHETIC COB; III SECRETION SYSTEM; SALMONELLA-TYPHIMURIUM; BACTERIAL MICROCOMPARTMENTS; ESCHERICHIA-COLI; ONE-STEP; PROTEIN; ORGANELLES	Bacterial microcompartments (MCPs) show great promise for the organization of engineered metabolic pathways within the bacterial cytoplasm. This subcellular organelle is composed of a protein shell of 100-200 nm diameter that natively encapsulates multi-enzyme pathways. The high energy cost of synthesizing the thousands of protein subunits required for each MCP demands precise regulation of MCP formation for both native and engineered systems. Here, we study the regulation of the propanediol utilization (Pdu) MCP, for which growth on 1,2-propanediol induces expression of the Pdu operon for the catabolism of 1,2-propanediol. We construct a fluorescence-based transcriptional reporter to investigate the activation of the Ppdu promoter, which drives the transcription of 21 pdu genes. Guided by this reporter, we find that MCPs can be expressed in strains grown in rich media, provided that glucose is not present. We also characterize the response of the Ppdu promoter to a transcriptional activator of the pdu operon, PocR, and find PocR to be a necessary component of Pdu MCP formation. Furthermore, we find that MCPs form normally upon the heterologous expression of PocR even in the absence of the natural inducer 1,2-propanediol and in the presence of glucose, and that Pdu MCPs formed in response to heterologous PocR expression can metabolize 1,2-propanediol in vivo. We anticipate that this technique of overexpressing a key transcription factor may be used to study and engineer the formation, size, and/or number of MCPs for the Pdu and related MCP systems.	[Kim, Edward Y.; Jakobson, Christopher M.; Tullman-Ercek, Danielle] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Tullman-Ercek, D (corresponding author), Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA.	dtercek@berkeley.edu	Tullman-Ercek, Danielle/L-2792-2016		National Science Foundation [1150567]; University of California Berkeley Fellowship	National Science Foundation(National Science Foundation (NSF)); University of California Berkeley Fellowship	This work was supported by the National Science Foundation (1150567; www.nsf.gov) (EYK DTE) and a University of California Berkeley Fellowship (www.berkeley.edu) (CMJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AILION M, 1993, J BACTERIOL, V175, P7200, DOI 10.1128/JB.175.22.7200-7208.1993; Bobik TA, 2006, APPL MICROBIOL BIOT, V70, P517, DOI 10.1007/s00253-005-0295-0; BOBIK TA, 1992, J BACTERIOL, V174, P2253, DOI 10.1128/JB.174.7.2253-2266.1992; Bobik TA, 1999, J BACTERIOL, V181, P5967, DOI 10.1128/JB.181.19.5967-5975.1999; Bobik TA, 1997, J BACTERIOL, V179, P6633, DOI 10.1128/jb.179.21.6633-6639.1997; Bonacci W, 2012, P NATL ACAD SCI USA, V109, P478, DOI 10.1073/pnas.1108557109; CHEN P, 1995, J BACTERIOL, V177, P5401, DOI 10.1128/jb.177.19.5401-5410.1995; CHEN P, 1994, J BACTERIOL, V176, P5474, DOI 10.1128/JB.176.17.5474-5482.1994; Cheng SQ, 2008, BIOESSAYS, V30, P1084, DOI 10.1002/bies.20830; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; ENGLISH RS, 1994, MOL MICROBIOL, V12, P647, DOI 10.1111/j.1365-2958.1994.tb01052.x; Fan CG, 2011, J BACTERIOL, V193, P5623, DOI 10.1128/JB.05661-11; Fan CG, 2010, P NATL ACAD SCI USA, V107, P7509, DOI 10.1073/pnas.0913199107; Havemann GD, 2002, J BACTERIOL, V184, P1253, DOI 10.1128/JB.184.5.1253-1261.2002; Havemann GD, 2003, J BACTERIOL, V185, P5086, DOI 10.1128/JB.185.17.5086-5095.2003; Kim EY, 2013, CURR OPIN BIOTECH, V24, P627, DOI 10.1016/j.copbio.2012.11.012; Kim EY, 2013, BIOTECHNOL J; Kofoid E, 1999, J BACTERIOL, V181, P5317, DOI 10.1128/JB.181.17.5317-5329.1999; Lassila JK, 2014, J MOL BIOL, V426, P2217, DOI 10.1016/j.jmb.2014.02.025; Lawrence AD, 2014, ACS SYNTHETIC BIOL; Metcalf KJ, 2014, APPL ENVIRON MICROB, V80, P5927, DOI 10.1128/AEM.01330-14; Parsons JB, 2008, J BIOL CHEM, V283, P14366, DOI 10.1074/jbc.M709214200; RONDON MR, 1992, J BACTERIOL, V174, P2267, DOI 10.1128/JB.174.7.2267-2272.1992; Rondon MR, 1996, J BACTERIOL, V178, P2196, DOI 10.1128/jb.178.8.2196-2203.1996; ROTH JR, 1993, J BACTERIOL, V175, P3303, DOI 10.1128/jb.175.11.3303-3316.1993; Sampson EM, 2008, J BACTERIOL, V190, P2966, DOI 10.1128/JB.01925-07; Sinha S, 2012, J BACTERIOL, V194, P1912, DOI 10.1128/JB.06529-11; Temme K, 2008, J MOL BIOL, V377, P47, DOI 10.1016/j.jmb.2007.12.044; Tsai Y, 2007, PLOS BIOL, V5, P1345, DOI 10.1371/journal.pbio.0050144; VOGEL HJ, 1956, J BIOL CHEM, V218, P97; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Yeates TO, 2013, J MOL MICROB BIOTECH, V23, P290, DOI 10.1159/000351347; Yeates TO, 2011, CURR OPIN STRUC BIOL, V21, P223, DOI 10.1016/j.sbi.2011.01.006	35	14	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113814	10.1371/journal.pone.0113814	http://dx.doi.org/10.1371/journal.pone.0113814			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427074	Green Submitted, gold, Green Published			2022-12-26	WOS:000349145400088
J	Zhu, KQ; Feng, HJ; Xu, YH; Mao, ZR; Zhang, W; Chen, J; Ma, LQ; Chen, MC; Shi, QN; Zhang, SJ				Zhu, Keqing; Feng, Haijia; Xu, Yinhan; Mao, Zhengrong; Zhang, Wei; Chen, Jian; Ma, Liqing; Chen, Minche; Shi, Qiunian; Zhang, Suojiang			An Analysis of 60 Years of Autopsy Data from Zhejiang University in Hangzhou, China	PLOS ONE			English	Article								Context: The autopsy rate gradually decreased during 1950-1999, and increased during the most recent decade (2000-2009). The diagnostic inaccuracy rate was continuously high during the 60 years. Objective: To investigate disagreement between the pathological and clinical diagnosis during 60 years (1950-2009). Data Sources: A 60-year retrospective study was carried out on the 4140 autopsy cases performed in Zhejiang University School of Medicine. Results: The highest number of cases was 1037 during 1960-1969, while the lowest was 102 during 1990-1999. During the 1999-2009 period, 978 cases were completed, which ranked second within the 60 years. The total clinical misdiagnosis rate was 46.38%, while the highest was 73.82% in 2000-2009. During the 60 years, the diseases associated with highest diagnostic inaccuracy rates were circulatory diseases (76.97%), cancer (60.99%), and brain diseases (54.48%). The invasive fungal infection rate was 1.84% of the 4140 cases, and the diagnostic inaccuracy rate for this condition reached as high as 86.10%. In the autopsied disease spectrum over the 60 years, the most common diseases were respiratory (1349, 32.58%), circulatory (495, 11.96%), and brain diseases (424, 10.24%). Conclusion: Although the number of autopsies decreased from 1950 to 1999, it increased from 2000 to 2009, while the discordance rate between clinical and autopsy diagnosis remained high throughout.	[Zhu, Keqing; Feng, Haijia; Xu, Yinhan; Mao, Zhengrong; Zhang, Wei; Chen, Jian; Ma, Liqing; Chen, Minche; Shi, Qiunian; Zhang, Suojiang] Zhejiang Univ, Sch Med, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Keqing] Zhejiang Univ, Sch Med, Dept Neurosci, Hangzhou 310003, Zhejiang, Peoples R China; [Zhu, Keqing] Zhejiang Univ, Sch Med, China Brain Bank, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Zhu, KQ (corresponding author), Zhejiang Univ, Sch Med, Dept Pathol, Hangzhou 310003, Zhejiang, Peoples R China.	zhukeqing@zju.edu.cn			Zhejiang Provincial Natural Science Foundation [2010R50049]; Zhejiang Medical and Health Science and Technology Plan Project [WKJ2013-2-009]; Scientific Research Foundation for Returned Overseas Scholars (Ministry of Education of China)	Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Zhejiang Medical and Health Science and Technology Plan Project; Scientific Research Foundation for Returned Overseas Scholars (Ministry of Education of China)	Funding: This work was supported by the Zhejiang Provincial Natural Science Foundation (2010R50049), by the Zhejiang Medical and Health Science and Technology Plan Project (WKJ2013-2-009) and by the Scientific Research Foundation for Returned Overseas Scholars (Ministry of Education of China 2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALIC V, 1995, JAMA-J AM MED ASSOC, V273, P1907; Burton EC, 1998, JAMA-J AM MED ASSOC, V280, P1245, DOI 10.1001/jama.280.14.1245; Burton JL, 2007, LANCET, V369, P1471, DOI 10.1016/S0140-6736(07)60376-6; Li G D, 1989, Zhonghua Bing Li Xue Za Zhi, V18, P250; Shojania KG, 2003, JAMA-J AM MED ASSOC, V289, P2849, DOI 10.1001/jama.289.21.2849; Zhu Ke-qing, 2004, Zhonghua Nei Ke Za Zhi, V43, P128; Zhu MH, 2011, CHINESE MED J-PEKING, V124, P3403, DOI 10.3760/cma.j.issn.0366-6999.2011.20.035	7	5	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112500	10.1371/journal.pone.0112500	http://dx.doi.org/10.1371/journal.pone.0112500			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426989	Green Published, gold, Green Submitted			2022-12-26	WOS:000349145400015
J	O'Connell, KE; Guo, W; Serra, C; Beck, M; Wachtman, L; Hoggatt, A; Xia, DL; Pearson, C; Knight, H; O'Connell, M; Miller, AD; Westmoreland, SV; Bhasin, S				O'Connell, Karyn E.; Guo, Wen; Serra, Carlo; Beck, Matthew; Wachtman, Lynn; Hoggatt, Amber; Xia, Dongling; Pearson, Chris; Knight, Heather; O'Connell, Micheal; Miller, Andrew D.; Westmoreland, Susan V.; Bhasin, Shalender			The effects of an ActRIIb receptor Fc fusion protein ligand trap in juvenile simian immunodeficiency virus-infected rhesus macaques	FASEB JOURNAL			English	Article						HIV; AIDS; muscle wasting; cachexia; nonhuman primate	ACTIVE ANTIRETROVIRAL THERAPY; BODY-COMPOSITION CHANGES; CHRONIC KIDNEY-DISEASE; SKELETAL-MUSCLE MASS; WEIGHT-LOSS; CANCER CACHEXIA; GROWTH-HORMONE; HIV-INFECTION; TESTOSTERONE SUPPLEMENTATION; SIGNALING PATHWAYS	There are no approved therapies for muscle wasting in children infected with human immunodeficiency virus (HIV), which portends poor disease outcomes. To determine whether a soluble ActRIIb receptor Fc fusion protein (ActRIIB.Fc), a ligand trap for TGF-beta/activin family members including myostatin, can prevent or restore loss of lean body mass and body weight in simian immunodeficiency virus (SIV)-infected juvenile rhesus macaques (Macaca mulatta). Fourteen pair-housed, juvenile male rhesus macaques were inoculated with SIVmac239 and, 4 wk postinoculation (WPI) treated with intramuscular injections of 10mg.kg(-1).wk(-1) ActRIIB.Fc or saline placebo. Body weight, lean body mass, SIV titers, and somatometric measurements were assessed monthly for 16 wk. Age-matched SIV-infected rhesus macaques were injected with saline. Intervention groups did not differ at baseline. Gains in lean mass were significantly greater in the ActRIIB.Fc group than in the placebo group (P < 0.001). Administration of ActRIIB.Fc was associated with greater gains in body weight (P = 0.01) and upper arm circumference than placebo. Serum CD4(+) T-lymphocyte counts and SIV copy numbers did not differ between groups. Administration of ActRIIB.Fc was associated with higher muscle expression of myostatin than placebo. ActRIIB.Fc effectively blocked and reversed loss of body weight, lean mass, and fat mass in juvenile SIV-infected rhesus macaques.	[O'Connell, Karyn E.; Beck, Matthew; Wachtman, Lynn; Hoggatt, Amber; Xia, Dongling; Pearson, Chris; Knight, Heather; O'Connell, Micheal; Miller, Andrew D.; Westmoreland, Susan V.] New England Primate Res Ctr, Dept Comparat Pathol, Southborough, MA USA; [Guo, Wen; Serra, Carlo; Bhasin, Shalender] Harvard Univ, Brigham & Womens Hosp, Sch Med,Res Program Mens Hlth Aging & Metab, Boston Claude Pepper Older Americans Independence, Boston, MA 01225 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Bhasin, S (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med,Res Program Mens Hlth Aging & Metab, Boston Claude Pepper Older Americans Independence, 221 Longwood Ave, Boston, MA 01225 USA.	sbhasin@partners.org			National Institutes of Health [T32-OD011064]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078512] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD011064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	ActRIIB.Fc was generously provided by Carl Morris, Pfizer, Incorporated, and Ron Desrosiers kindly supplied SIVmac239. Exceptional animal care was provided by the veterinarians and veterinary technicians at New England Primate Research Center (NEPRC). SIV viral loads were analyzed by Jeff Lifson and Mike Piatak at the U.S. National Cancer Institute, AIDS and Cancer Virus Program. Excellent necropsy service was provided by Elizabeth Curran at NEPRC. The authors acknowledge the thoughtful contributions of Keith Mansfield in the conception of these studies and Elizabeth Hutto for review of the manuscript. The authors thank Drs. Thomas G. Travison and Karol Pencina for guidance in statistical analyses. This research was funded, in part, by the National Institutes of Health Grant T32-OD011064.	Braga M, 2008, APOPTOSIS, V13, P822, DOI 10.1007/s10495-008-0216-7; Burgess K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017090; Chen JL, 2014, FASEB J, V28, P1711, DOI 10.1096/fj.13-245894; Chisada S, 2011, DEV BIOL, V359, P82, DOI 10.1016/j.ydbio.2011.08.027; Cline AN, 2005, J MED PRIMATOL, V34, P303; Cuerda Cristina, 2005, Nutr Clin Pract, V20, P93; Datta-Mannan A, 2013, J PHARMACOL EXP THER, V344, P616, DOI 10.1124/jpet.112.201491; Durieux AC, 2007, ENDOCRINOLOGY, V148, P3140, DOI 10.1210/en.2006-1500; Elkina Y, 2011, J CACHEXIA SARCOPENI, V2, P143, DOI 10.1007/s13539-011-0035-5; Elliott B, 2012, ACTA PHYSIOL, V205, P324, DOI 10.1111/j.1748-1716.2012.02423.x; Erlandson KM, 2013, JAIDS-J ACQ IMM DEF, V63, P209, DOI 10.1097/QAI.0b013e318289bb7e; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Freeman LM, 2004, J INFECT DIS, V189, P2010, DOI 10.1086/386290; Freeman LM, 1999, J ACQ IMMUN DEF SYND, V22, P119; Girgenrath S, 2005, MUSCLE NERVE, V31, P34, DOI 10.1002/mus.20175; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; Gullett NP, 2010, AM J CLIN NUTR, V91, p1143S, DOI 10.3945/ajcn.2010.28608E; Guo W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071017; Hendricks EE, 2004, J INFECT DIS, V190, P2187, DOI 10.1086/425904; Hoshikawa Y, 2011, CANCER SCI, V102, P934, DOI 10.1111/j.1349-7006.2011.01889.x; Jackson MF, 2012, J ENDOCRINOL, V213, P263, DOI 10.1530/JOE-11-0455; Kambadur R, 1997, GENOME RES, V7, P910, DOI 10.1101/gr.7.9.910; Klimek MEB, 2010, BIOCHEM BIOPH RES CO, V391, P1548, DOI 10.1016/j.bbrc.2009.12.123; Kovacheva EL, 2010, ENDOCRINOLOGY, V151, P628, DOI 10.1210/en.2009-1177; Kusko RL, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-10; Lazanas Marios C, 2003, Hormones (Athens), V2, P43; Lee SJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000789; Lee SJ, 2010, MOL ENDOCRINOL, V24, P1998, DOI 10.1210/me.2010-0127; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Leyes P, 2008, ANTIVIR THER, V13, P149; Liu Gang, 2005, Curr Opin Investig Drugs, V6, P979; Liu W, 2003, J CLIN ENDOCR METAB, V88, P5490, DOI 10.1210/jc.2003-030497; LOPRINZI CL, 1993, J CLIN ONCOL, V11, P152, DOI 10.1200/JCO.1993.11.1.152; Martins T, 2014, CLIN BIOCHEM, V47, P8, DOI 10.1016/j.clinbiochem.2013.10.025; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; McPherron AC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-24; Meng Y, 2013, CELL PHYSIOL BIOCHEM, V32, P1097, DOI 10.1159/000354509; Montano M, 2007, J CLIN ENDOCR METAB, V92, P2793, DOI 10.1210/jc.2006-2722; Mosher DS, 2007, PLOS GENET, V3, P779, DOI 10.1371/journal.pgen.0030079; Moyle GJ, 2004, JAIDS-J ACQ IMM DEF, V35, P367, DOI 10.1097/00126334-200404010-00006; Mulligan K, 2007, J CLIN ENDOCR METAB, V92, P563, DOI 10.1210/jc.2006-0954; Paul PK, 2010, J CELL BIOL, V191, P1395, DOI 10.1083/jcb.201006098; Rajan VR, 2008, PEDIATR NEPHROL, V23, P527, DOI 10.1007/s00467-007-0594-z; Sako D, 2010, J BIOL CHEM, V285, P21037, DOI 10.1074/jbc.M110.114959; Sattler F, 2011, J GERONTOL A-BIOL, V66, P122, DOI 10.1093/gerona/glq183; Scherzer R, 2011, AIDS, V25, P1405, DOI 10.1097/QAD.0b013e32834884e6; Schuelke M, 2004, NEW ENGL J MED, V350, P2682, DOI 10.1056/NEJMoa040933; Shikuma CM, 2005, CLIN INFECT DIS, V40, P1846, DOI 10.1086/430376; Simon D, 2013, J CLIN ENDOCR METAB, V98, P2746, DOI 10.1210/jc.2012-4201; Vallerie SN, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001007; Verzola D, 2011, KIDNEY INT, V79, P773, DOI 10.1038/ki.2010.494; Wagner KR, 2008, ANN NEUROL, V63, P561, DOI 10.1002/ana.21338; Wanke CA, 2000, CLIN INFECT DIS, V31, P803, DOI 10.1086/314027; Westmoreland SV, 1998, J NEUROVIROL, V4, P260, DOI 10.3109/13550289809114527; Whittemore LA, 2003, BIOCHEM BIOPH RES CO, V300, P965, DOI 10.1016/S0006-291X(02)02953-4; Wust Rob C I, 2007, Int J Chron Obstruct Pulmon Dis, V2, P289; Zhang LP, 2011, FASEB J, V25, P1653, DOI 10.1096/fj.10-176917; Zhao P, 2004, DEV DYNAM, V229, P380, DOI 10.1002/dvdy.10457; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	61	11	11	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1165	1175		10.1096/fj.14-257543	http://dx.doi.org/10.1096/fj.14-257543			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25466897	Green Published			2022-12-26	WOS:000354115000006
J	Bermek, O; Willcox, S; Griffith, JD				Bermek, Oya; Willcox, Smaranda; Griffith, Jack D.			DNA Replication Catalyzed by Herpes Simplex Virus Type 1 Proteins Reveals Trombone Loops at the Fork	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA Replication; Electron Microscopy (EM); Gel Electrophoresis; Herpesvirus; Structural Biology; Virology	LAGGING-STRAND SYNTHESIS; BACTERIOPHAGE-T4 PROTEINS; HELICASE-PRIMASE; IN-VITRO; COMPLEX; ARCHITECTURE; TEMPLATE	Background: DNA is replicated in vitro by proteins encoded by herpes simplex virus type 1. Results: Electron microscopic examination of the replication forks reveals looping of the lagging strand. Conclusion: The trombone model has been demonstrated. Significance: This provides the first evidence of the trombone mechanism in a eukaryotic viral system. Using purified replication factors encoded by herpes simplex virus type 1 and a 70-base minicircle template, we obtained robust DNA synthesis with leading strand products of >20,000 nucleotides and lagging strand fragments from 600 to 9,000 nucleotides as seen by alkaline gel electrophoresis. ICP8 was crucial for the synthesis on both strands. Visualization of the deproteinized products using electron microscopy revealed long, linear dsDNAs, and in 87%, one end, presumably the end with the 70-base circle, was single-stranded. The remaining 13% had multiple single-stranded segments separated by dsDNA segments 500 to 1,000 nucleotides in length located at one end. These features are diagnostic of the trombone mechanism of replication. Indeed, when the products were examined with the replication proteins bound, a dsDNA loop was frequently associated with the replication complex located at one end of the replicated DNA. Furthermore, the frequency of loops correlated with the fraction of DNA undergoing Okazaki fragment synthesis.	[Bermek, Oya; Willcox, Smaranda; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Griffith, JD (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, 450 West Dr, Chapel Hill, NC 27599 USA.	jdg@med.unc.edu			National Institutes of Health [GM31819, CA19014]; NATIONAL CANCER INSTITUTE [P01CA019014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM31819 and CA19014.	ALBERTS BM, 1982, COLD SPRING HARB SYM, V47, P655, DOI 10.1101/SQB.1983.047.01.077; BOEHMER PE, 1993, J VIROL, V67, P711, DOI 10.1128/JVI.67.2.711-715.1993; Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347; Chastain PD, 2000, MOL CELL, V6, P803, DOI 10.1016/S1097-2765(05)00093-6; Chastain PD, 2003, J BIOL CHEM, V278, P21276, DOI 10.1074/jbc.M301573200; Chen Y, 2011, J VIROL, V85, P968, DOI 10.1128/JVI.01690-10; DEBYSER Z, 1994, CELL, V77, P157, DOI 10.1016/0092-8674(94)90243-7; Falkenberg M, 2000, P NATL ACAD SCI USA, V97, P3896, DOI 10.1073/pnas.97.8.3896; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Hamdan SM, 2009, NATURE, V457, P336, DOI 10.1038/nature07512; HERNANDEZ TR, 1990, J BIOL CHEM, V265, P11227; Lee J, 2002, J MOL BIOL, V316, P19, DOI 10.1006/jmbi.2001.5325; Lee J, 1998, MOL CELL, V1, P1001, DOI 10.1016/S1097-2765(00)80100-8; Muylaert I, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.609453; Nossal NG, 2007, J BIOL CHEM, V282, P1098, DOI 10.1074/jbc.M606772200; OKAZAKI T, 1969, P NATL ACAD SCI USA, V64, P1242, DOI 10.1073/pnas.64.4.1242; Park K, 1998, J BIOL CHEM, V273, P5260, DOI 10.1074/jbc.273.9.5260; Ramirez-Aguilar KA, 2002, BIOCHEMISTRY-US, V41, P14569, DOI 10.1021/bi026680v; Skaliter R, 1996, J VIROL, V70, P1132, DOI 10.1128/JVI.70.2.1132-1136.1996; SKALITER R, 1994, P NATL ACAD SCI USA, V91, P10665, DOI 10.1073/pnas.91.22.10665; Stengel G, 2011, J VIROL, V85, P957, DOI 10.1128/JVI.01688-10; Weller SK, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a013011	22	7	7	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2539	2545		10.1074/jbc.M114.623009	http://dx.doi.org/10.1074/jbc.M114.623009			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25471368	Green Published, hybrid			2022-12-26	WOS:000349310700002
J	Shu, C; Du, W; Mao, XF; Li, Y; Zhu, Q; Wang, W; Wu, N; Mao, XM; Jin, HZ; Sun, QN				Shu, Chang; Du, Wei; Mao, Xiaofei; Li, Yun; Zhu, Qin; Wang, Wei; Wu, Nan; Mao, Xuming; Jin, Hongzhong; Sun, Qiuning			Possible Single-Nucleotide Polymorphism Loci Associated with Systemic Sclerosis Susceptibility: A Genetic Association Study in a Chinese Han Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; RHOB; VARIANTS; SHESIS; CELLS	Objective: The aim of this study was to confirm the association of RHOB and FAM167A-BLK gene polymorphisms with susceptibility to systemic sclerosis (SSc) in a Chinese Han population. Methods: A total of 248 SSc patients and 251 healthy controls of Chinese Han ethnicity, which visited the department of dermatology of Peking Union Medical College Hospital, were included in the study. Six selected single nucleotide polymorphisms (SNPs) in the RHOB and FAM167A-BLK regions were selected as markers and were genotyped using a MassARRAY system, which is based on the matrix-assisted laser desorption/ ionization time of flight mass spectrometry technique. Results: Three SNPs in the coding regions of the RHOB and FAM167A-BLK genes displayed an association with SSc: (1) rs1062292T, which is a newly discovered SNP in the RHOB gene (P=0.03, odds ratio [OR] = 1.62, 95% confidence interval (CI)=1.05-2.50), (2) rs2736340T (P=0.03, OR=1.39, 95% CI=1.03-1.85), and (3) rs13277113A (P=0.04, OR=1.34, 95% CI=1.011.76), both in the FAM167A-BLK gene. Our results support previous findings that vaiants in the RHOB and FAM167A-BLK genes may be associated with susceptibility to SSc. However, the loci of the SNPs in RHOB region that displayed an association with SSc are quite different from the loci which were identified in studies of Caucasian populations. Conclusion: Our results confirm that RHOB and FAM167A-BLK polymorphisms exist in Chinese Han SSc patients. Therefore, variants of the RHOB and FAM167ABLK genes are promising genetic markers for SSc.	[Shu, Chang; Du, Wei; Mao, Xiaofei; Li, Yun; Zhu, Qin; Wang, Wei; Jin, Hongzhong; Sun, Qiuning] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Dermatol, Beijing 100005, Peoples R China; [Wu, Nan] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Surg, Beijing 100005, Peoples R China; [Mao, Xuming] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; University of Pennsylvania	Sun, QN (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Dermatol, Beijing 100005, Peoples R China.	sunqnzhy@yahoo.com	Wu, Nan/R-2186-2017; Sun, Qiuning/AAJ-3692-2021	Wu, Nan/0000-0002-9429-2889; Sun, Qiuning/0000-0002-1912-341X	National Natural Science Foundation of China [81071300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81071300). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adini I, 2003, GENE DEV, V17, P2721, DOI 10.1101/gad.1134603; Allanore Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002091; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bossini-Castillo L, 2013, ANN RHEUM DIS, V72, P602, DOI 10.1136/annrheumdis-2012-201888; DYMECKI SM, 1992, J BIOL CHEM, V267, P4815; Elhai M, 2012, RHEUMATOLOGY, V51, P1017, DOI 10.1093/rheumatology/ker269; Martin JE, 2012, HUM GENET, V131, P1023, DOI 10.1007/s00439-011-1137-z; Gorlova O, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002178; Gourh P, 2010, J AUTOIMMUN, V34, P155, DOI 10.1016/j.jaut.2009.08.014; Hom G, 2008, NEW ENGL J MED, V358, P900, DOI 10.1056/NEJMoa0707865; Ito I, 2010, ARTHRITIS RHEUM-US, V62, P890, DOI 10.1002/art.27303; Lessard CJ, 2013, NAT GENET, V45, P1284, DOI 10.1038/ng.2792; Li ZQ, 2009, CELL RES, V19, P519, DOI 10.1038/cr.2009.33; Liu AX, 2001, P NATL ACAD SCI USA, V98, P6192, DOI 10.1073/pnas.111137198; Liu AX, 2001, MOL CELL BIOL, V21, P6906, DOI 10.1128/MCB.21.20.6906-6912.2001; Mayes MD, 2014, AM J HUM GENET, V94, P47, DOI 10.1016/j.ajhg.2013.12.002; Nordmark G, 2011, GENES IMMUN, V12, P100, DOI 10.1038/gene.2010.44; Onouchi Y, 2012, NAT GENET, V44, P517, DOI 10.1038/ng.2220; Radstake TRDJ, 2010, NAT GENET, V42, P426, DOI 10.1038/ng.565; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Tretter T, 2003, J EXP MED, V198, P1863, DOI 10.1084/jem.20030729; Yi L, 2013, INT J IMMUNOPATH PH, V26, P473, DOI 10.1177/039463201302600220; Zhou XD, 2013, INT J IMMUNOPATH PH, V26, P747, DOI 10.1177/039463201302600318	23	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113197	10.1371/journal.pone.0113197	http://dx.doi.org/10.1371/journal.pone.0113197			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470816	Green Submitted, Green Published, gold			2022-12-26	WOS:000349128700017
J	Valle, KC; Nymark, M; Aamot, I; Hancke, K; Winge, P; Andresen, K; Johnsen, G; Brembu, T; Bones, AM				Valle, Kristin Colller; Nymark, Marianne; Aamot, Inga; Hancke, Kasper; Winge, Per; Andresen, Kjersti; Johnsen, Geir; Brembu, Tore; Bones, Atle M.			System Responses to Equal Doses of Photosynthetically Usable Radiation of Blue, Green, and Red Light in the Marine Diatom Phaeodactylum tricornutum	PLOS ONE			English	Article							PHOTOSYSTEM-II; THALASSIOSIRA-PSEUDONANA; CHLOROPHYLL FLUORESCENCE; CARBON METABOLISM; SINGLET OXYGEN; GROWTH; PHYTOPLANKTON; COMPLEX; QUALITY; ACCLIMATION	Due to the selective attenuation of solar light and the absorption properties of seawater and seawater constituents, free-floating photosynthetic organisms have to cope with rapid and unpredictable changes in both intensity and spectral quality. We have studied the transcriptional, metabolic and photo-physiological responses to light of different spectral quality in the marine diatom Phaeodactylum tricornutum through time-series studies of cultures exposed to equal doses of photosynthetically usable radiation of blue, green and red light. The experiments showed that short-term differences in gene expression and profiles are mainly light quality-dependent. Transcription of photosynthesis-associated nuclear genes was activated mainly through a light quality-independent mechanism likely to rely on chloroplast-to-nucleus signaling. In contrast, genes encoding proteins important for photoprotection and PSII repair were highly dependent on a blue light receptor-mediated signal. Changes in energy transfer efficiency by light-harvesting pigments were spectrally dependent; furthermore, a declining trend in photosynthetic efficiency was observed in red light. The combined results suggest that diatoms possess a light quality-dependent ability to activate photoprotection and efficient repair of photodamaged PSII. In spite of approximately equal numbers of PSII-absorbed quanta in blue, green and red light, the spectral quality of light is important for diatom responses to ambient light conditions.	[Valle, Kristin Colller; Nymark, Marianne; Aamot, Inga; Winge, Per; Andresen, Kjersti; Johnsen, Geir; Brembu, Tore; Bones, Atle M.] Norwegian Univ Sci & Technol, Dept Biol, N-7491 Trondheim, Norway; [Hancke, Kasper] Univ Southern Denmark, Inst Biol, DK-5230 Odense M, Denmark	Norwegian University of Science & Technology (NTNU); University of Southern Denmark	Bones, AM (corresponding author), Norwegian Univ Sci & Technol, Dept Biol, N-7491 Trondheim, Norway.	atle.m.bones@ntnu.no	Brembu, Tore/J-7166-2015; Nymark, Marianne/H-2535-2016; Bones, Atle M/C-6202-2014	Brembu, Tore/0000-0001-5622-8037; Nymark, Marianne/0000-0002-0672-0653; Bones, Atle M/0000-0003-0544-7437	Biotechnology and Functional Genomics (FUGE) program of the Norwegian Research Council [NFR 184146/S10]; FUGE; Norwegian University of Science and Technology	Biotechnology and Functional Genomics (FUGE) program of the Norwegian Research Council; FUGE; Norwegian University of Science and Technology	This work was supported by the Biotechnology and Functional Genomics (FUGE) program of the Norwegian Research Council grant NFR 184146/S10 and Ph.D. grants from FUGE and Norwegian University of Science and Technology to KCV and MN, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AE, 2011, NATURE, V473, P203, DOI 10.1038/nature10074; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Asada K, 2006, PLANT PHYSIOL, V141, P391, DOI 10.1104/pp.106.082040; Bailleul B, 2010, P NATL ACAD SCI USA, V107, P18214, DOI 10.1073/pnas.1007703107; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; BRZEZINSKI MA, 1990, MAR ECOL PROG SER, V67, P83, DOI 10.3354/meps067083; Butler W.L., SPECTRAL CHARACTERIS, P343, DOI [10.1016/C2013-0-12536-6, DOI 10.1016/C2013-0-12536-6]; Campbell DA, 2013, PHOTOSYNTH RES, V115, P43, DOI 10.1007/s11120-013-9809-2; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; CLAYTON R, 1980, PHOTOSYNTHESIS PHYS; Coesel S, 2009, EMBO REP, V10, P655, DOI 10.1038/embor.2009.59; Costa BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074451; Costa BS, 2013, J EXP BOT, V64, P483, DOI 10.1093/jxb/ers340; Dambek M, 2012, J EXP BOT; Depauw FA, 2012, J EXP BOT, V63, P1575, DOI 10.1093/jxb/ers005; Dittami SM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-365; Erickson RA, 2013, LAB CHIP, V13, P2893, DOI 10.1039/c3lc41429a; Falkowski P.G., 2007, AQUATIC PHOTOSYNTHES; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; Fey V, 2005, J EXP BOT, V56, P1491, DOI 10.1093/jxb/eri180; Flors C, 2006, J EXP BOT, V57, P1725, DOI 10.1093/jxb/erj181; Franklin KA, 2004, J EXP BOT, V55, P271, DOI 10.1093/jxb/erh026; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; GLOVER HE, 1987, J EXP MAR BIOL ECOL, V105, P137, DOI 10.1016/0022-0981(87)90168-7; GOEDHEER JC, 1969, BIOCHIM BIOPHYS ACTA, V172, P252, DOI 10.1016/0005-2728(69)90068-1; Goss R, 2010, PHOTOSYNTH RES, V106, P103, DOI 10.1007/s11120-010-9536-x; GOVINDJEE, 1995, AUST J PLANT PHYSIOL, V22, P131, DOI 10.1071/PP9950131; Gundermann K, 2013, BBA-BIOENERGETICS, V1827, P303, DOI 10.1016/j.bbabio.2012.10.017; Hancke TB, 2008, J PHYCOL, V44, P803, DOI 10.1111/j.1529-8817.2008.00509.x; Hegemann P, 2008, ANNU REV PLANT BIOL, V59, P167, DOI 10.1146/annurev.arplant.59.032607.092847; HOLDSWORTH ES, 1985, MAR BIOL, V86, P253, DOI 10.1007/BF00397512; HUMPHREY GF, 1983, J EXP MAR BIOL ECOL, V66, P49, DOI 10.1016/0022-0981(83)90027-8; Huysman MJJ, 2013, PLANT CELL, V25, P215, DOI 10.1105/tpc.112.106377; Huysman MJJ, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-2-r17; Ishikawa M, 2009, PLANTA, V230, P543, DOI 10.1007/s00425-009-0967-6; Jeffrey S.W., 2011, PHYTOPLANKTON PIGMEN, P3, DOI [10.1017/cbo9780511732263, DOI 10.1017/CBO9780511732263.004]; Jiao YL, 2007, NAT REV GENET, V8, P217, DOI 10.1038/nrg2049; Johnsen G, 2007, J PHYCOL, V43, P1236, DOI 10.1111/j.1529-8817.2007.00422.x; Juhas M, 2014, FEBS J, V281, P2299, DOI 10.1111/febs.12782; Jungandreas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099727; Kami C, 2010, CURR TOP DEV BIOL, V91, P29, DOI 10.1016/S0070-2153(10)91002-8; Kehoe DM, 2006, ANNU REV PLANT BIOL, V57, P127, DOI 10.1146/annurev.arplant.57.032905.105215; KIEFER DA, 1992, ENVIR SCI R, V43, P155; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Kleine T, 2009, TRENDS GENET, V25, P185, DOI 10.1016/j.tig.2009.02.004; Lamkemeyer P, 2006, PLANT J, V45, P968, DOI 10.1111/j.1365-313X.2006.02665.x; Lepetit B, 2013, PLANT PHYSIOL, V161, P853, DOI 10.1104/pp.112.207811; Lepetit B, 2012, PHOTOSYNTH RES, V111, P245, DOI 10.1007/s11120-011-9633-5; Lepetit B, 2010, PLANT PHYSIOL, V154, P1905, DOI 10.1104/pp.110.166454; Li ZR, 2009, ANNU REV PLANT BIOL, V60, P239, DOI 10.1146/annurev.arplant.58.032806.103844; Lutz VA, 1998, J PHYCOL, V34, P214, DOI 10.1046/j.1529-8817.1998.340214.x; Marchetti J, 2013, J APPL PHYCOL, V25, P109, DOI 10.1007/s10811-012-9844-y; MAXWELL DP, 1995, PLANT PHYSIOL, V109, P787, DOI 10.1104/pp.109.3.787; Maxwell K, 2000, J EXP BOT, V51, P659, DOI 10.1093/jexbot/51.345.659; Mercado JM, 2004, AQUAT BOT, V78, P265, DOI 10.1016/j.aquabot.2003.11.004; Millar AJ, 1996, P NATL ACAD SCI USA, V93, P15491, DOI 10.1073/pnas.93.26.15491; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Mohammady N. G. E., 2007, American Journal of Plant Physiology, V2, P115; Mouget JL, 2004, J PHOTOCH PHOTOBIO B, V75, P1, DOI 10.1016/j.jphotobiol.2004.04.002; NELSON DM, 1995, GLOBAL BIOGEOCHEM CY, V9, P359, DOI 10.1029/95GB01070; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; NIELSEN MV, 1993, LIMNOL OCEANOGR, V38, P1576, DOI 10.4319/lo.1993.38.7.1576; Nixon PJ, 2010, ANN BOT-LONDON, V106, P1, DOI 10.1093/aob/mcq059; Nixon PJ, 2005, J EXP BOT, V56, P357, DOI 10.1093/jxb/eri021; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; Nymark M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058722; Nymark M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007743; Oelze ML, 2008, BBA-GEN SUBJECTS, V1780, P1261, DOI 10.1016/j.bbagen.2008.03.015; Oudot-Le Secq MP, 2007, MOL GENET GENOMICS, V277, P427, DOI 10.1007/s00438-006-0199-4; Pfannschmidt T, 2003, ANTIOXID REDOX SIGN, V5, P95, DOI 10.1089/152308603321223586; Pfannschmidt T, 2010, TRENDS PLANT SCI, V15, P427, DOI 10.1016/j.tplants.2010.05.009; Premvardhan L, 2008, J PHYS CHEM B, V112, P11838, DOI 10.1021/jp802689p; Premvardhan L, 2009, J PHYS CHEM B, V113, P12565, DOI 10.1021/jp903029g; PREZELIN BB, 1981, CAN B FISH AQUAT SCI, P1; Ragni M, 2004, J PLANKTON RES, V26, P433, DOI 10.1093/plankt/fbh044; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; RIVKIN RB, 1989, MAR ECOL PROG SER, V55, P291, DOI 10.3354/meps055291; Rodriguez F, 2006, MAR BIOL, V148, P963, DOI 10.1007/s00227-005-0138-7; Ruban AV, 2012, BBA-BIOENERGETICS, V1817, P977, DOI 10.1016/j.bbabio.2012.03.026; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Shi LX, 2012, BBA-BIOENERGETICS, V1817, P13, DOI 10.1016/j.bbabio.2011.08.008; SIEFERMANNHARMS D, 1987, PHYSIOL PLANTARUM, V69, P561, DOI 10.1111/j.1399-3054.1987.tb09240.x; Takahashi F, 2007, P NATL ACAD SCI USA, V104, P19625, DOI 10.1073/pnas.0707692104; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Triantaphylides C, 2008, PLANT PHYSIOL, V148, P960, DOI 10.1104/pp.108.125690; Tyystjarvi E, 2008, COORDIN CHEM REV, V252, P361, DOI 10.1016/j.ccr.2007.08.021; WALLEN DG, 1971, MAR BIOL, V10, P34, DOI 10.1007/BF02026764; WALLEN DG, 1971, MAR BIOL, V10, P44, DOI 10.1007/BF02026765; Wang F, 2008, PLANT CELL ENVIRON, V31, P982, DOI 10.1111/j.1365-3040.2008.01810.x; Wilhelm C, 2006, PROTIST, V157, P91, DOI 10.1016/j.protis.2006.02.003; Wu HY, 2011, PLANT PHYSIOL, V156, P2184, DOI 10.1104/pp.111.178772; Zhu SH, 2010, BBA-BIOENERGETICS, V1797, P1449, DOI 10.1016/j.bbabio.2010.04.003	93	46	47	2	70	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114211	10.1371/journal.pone.0114211	http://dx.doi.org/10.1371/journal.pone.0114211			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470731	gold, Green Published, Green Submitted			2022-12-26	WOS:000349128700085
J	Wang, G; Liu, K; Li, Y; Yi, W; Yang, Y; Zhao, DJ; Fan, CX; Yang, HG; Geng, T; Xing, JZ; Zhang, Y; Tan, ST; Yi, DH				Wang, Ge; Liu, Kan; Li, Yue; Yi, Wei; Yang, Yang; Zhao, Dajun; Fan, Chongxi; Yang, Honggang; Geng, Ting; Xing, Jianzhou; Zhang, Yu; Tan, Songtao; Yi, Dinghua			Endoplasmic Reticulum Stress Mediates the Anti-Inflammatory Effect of Ethyl Pyruvate in Endothelial Cells	PLOS ONE			English	Article							ER STRESS; INDUCED APOPTOSIS; OX-LDL; INFLAMMATION; PROTEIN; ACTIVATION; 3-BROMOPYRUVATE; ANGIOGENESIS; AUTOPHAGY; PATHWAY	Ethyl pyruvate (EP) is a simple aliphatic ester of the metabolic intermediate pyruvate that has been demonstrated to be a potent anti-inflammatory agent in a variety of in vivo and in vitro model systems. However, the protective effects and mechanisms underlying the actions of EP against endothelial cell (EC) inflammatory injury are not fully understood. Previous studies have confirmed that endoplasmic reticulum stress (ERS) plays an important role in regulating the pathological process of EC inflammation. In this study, our aim was to explore the effects of EP on tumor necrosis factor-alpha (TNF-alpha)-induced inflammatory injury in human umbilical vein endothelial cells (HUVECs) and to explore the role of ERS in this process. TNF-alpha treatment not only significantly increased the adhesion of monocytes to HUVECs and inflammatory cytokine (sICAM1, sE-selectin, MCP-1 and IL-8) production in cell culture supernatants but it also increased ICAM and MMP9 protein expression in HUVECs. TNF-alpha also effectively increased the ERS-related molecules in HUVECs (GRP78, ATF4, caspase12 and p-PERK). EP treatment effectively reversed the effects of the TNF-alpha-induced adhesion of monocytes on HUVECs, inflammatory cytokines and ERS-related molecules. Furthermore, thapsigargin (THA, an ERS inducer) attenuated the protective effects of EP against TNF-alpha-induced inflammatory injury and ERS. The PERK siRNA treatment not only inhibited ERS-related molecules but also mimicked the protective effects of EP to decrease TNF-alpha-induced inflammatory injury. In summary, we have demonstrated for the first time that EP can effectively reduce vascular endothelial inflammation and that this effect at least in part depends on the attenuation of ERS.	[Wang, Ge; Yi, Wei; Yang, Yang; Zhao, Dajun; Zhang, Yu; Yi, Dinghua] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, Xian 710032, Peoples R China; [Liu, Kan] Fourth Mil Med Univ, Sch Basic Med Sci, Xian 710032, Peoples R China; [Wang, Ge; Yang, Honggang; Geng, Ting; Xing, Jianzhou; Tan, Songtao] Guangzhou Med Univ, Chinese Peoples Armed Police Forces, Guangdong Prov Corps Hosp, Dept Cardiovasc Surg, Guangzhou 510507, Guangdong, Peoples R China; [Li, Yue] PLA, Hosp 463, Dept Air Logist, Shenyang 110042, Peoples R China; [Fan, Chongxi] Fourth Mil Med Univ, Tangdu Hosp, Dept Thorac Surg, Xian 710038, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Guangzhou Medical University; Air Force Military Medical University	Tan, ST (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Cardiovasc Surg, 127 Changle West Rd, Xian 710032, Peoples R China.	nicolas.nicolaswong@gmail.com; dinghuayi210@126.com	Li, Yue/AAU-1580-2021	Yi, Wei/0000-0002-4349-910X	12th National Five Years Supporting Project of China [2011BAI11B20]; National Natural Science Foundation of China [81100137, 81000938]	12th National Five Years Supporting Project of China(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This study was supported by grants from the 12th National Five Years Supporting Project of China (2011BAI11B20), the National Natural Science Foundation of China (81100137 and 81000938). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 2013, CIRCULATION, V128, P579, DOI 10.1161/CIRCULATIONAHA.113.004390; Aragon T, 2009, NATURE, V457, P736, DOI 10.1038/nature07641; Basilio J, 2013, BIOCHEM BIOPH RES CO, V442, P221, DOI 10.1016/j.bbrc.2013.11.030; Beck D, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003057; Chen ML, 2013, AUTOPHAGY, V9, P2033, DOI 10.4161/auto.26336; Chen X, 2014, WORLD J GASTROENTERO, V20, P8260, DOI 10.3748/wjg.v20.i25.8260; Chen Y, 2012, DIABETOLOGIA, V55, P2533, DOI 10.1007/s00125-012-2594-1; Das UN, 2006, MED SCI MONITOR, V12, pRA79; Desai A, 2012, ATHEROSCLEROSIS, V223, P130, DOI 10.1016/j.atherosclerosis.2012.05.004; Duan WX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057941; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Ganapathy-Kanniappan S, 2010, CURR PHARM BIOTECHNO, V11, P510, DOI 10.2174/138920110791591427; Ganapathy-Kanniappan S, 2010, ANTICANCER RES, V30, P923; Hong D, 2014, ATHEROSCLEROSIS, V235, P310, DOI 10.1016/j.atherosclerosis.2014.04.028; Ito TK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102186; Jang HJ, 2012, ANTIOXID REDOX SIGN, V17, P878, DOI 10.1089/ars.2011.3994; Jang IS, 2010, YONSEI MED J, V51, P838, DOI 10.3349/ymj.2010.51.6.838; Jang M, 2014, BRAIN BEHAV IMMUN, V38, P151, DOI 10.1016/j.bbi.2014.01.015; Jia ZQ, 2013, INT J CARDIOL, V168, P2637, DOI 10.1016/j.ijcard.2013.03.035; John L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025378; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Kassi E, 2013, CIRCULATION, V128, P2517, DOI 10.1161/CIRCULATIONAHA.113.002654; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Kujiraoka T, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000361; Lee JH, 2013, BIOCHEM BIOPH RES CO, V439, P327, DOI 10.1016/j.bbrc.2013.08.087; Li XF, 2014, CIRCULATION, V129, P1244, DOI 10.1161/CIRCULATIONAHA.113.006840; Liu C, 2014, J CARDIOVASC PHARM; Liu XH, 2012, ATHEROSCLEROSIS, V222, P34, DOI 10.1016/j.atherosclerosis.2011.04.027; Meli G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4867; Nallasamy P, 2014, J NUTR BIOCH; Narasimhulu CA, 2014, ATHEROSCLEROSIS, V236, P133, DOI 10.1016/j.atherosclerosis.2014.06.020; Pan MY, 2012, TOXICOL APPL PHARM, V265, P325, DOI 10.1016/j.taap.2012.08.034; Pulathan Z, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/857109; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Roy A, 2012, CELL SIGNAL, V24, P2123, DOI 10.1016/j.cellsig.2012.07.014; Shinozaki S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075249; Sims CA, 2001, CRIT CARE MED, V29, P1513, DOI 10.1097/00003246-200108000-00003; Yu SJ, 2012, J BIOENERG BIOMEMBR, V44, P101, DOI 10.1007/s10863-012-9416-5; Zeng W, 2014, LIFE SCI, V103, P15, DOI 10.1016/j.lfs.2014.03.007	39	18	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113983	10.1371/journal.pone.0113983	http://dx.doi.org/10.1371/journal.pone.0113983			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470819	gold, Green Published, Green Submitted			2022-12-26	WOS:000349128700059
J	Fukuta, M; Nakai, Y; Kirino, K; Nakagawa, M; Sekiguchi, K; Nagata, S; Matsumoto, Y; Yamamoto, T; Umeda, K; Heike, T; Okumura, N; Koizumi, N; Sato, T; Nakahata, T; Saito, M; Otsuka, T; Kinoshita, S; Ueno, M; Ikeya, M; Toguchida, J				Fukuta, Makoto; Nakai, Yoshinori; Kirino, Kosuke; Nakagawa, Masato; Sekiguchi, Kazuya; Nagata, Sanae; Matsumoto, Yoshihisa; Yamamoto, Takuya; Umeda, Katsutsugu; Heike, Toshio; Okumura, Naoki; Koizumi, Noriko; Sato, Takahiko; Nakahata, Tatsutoshi; Saito, Megumu; Otsuka, Takanobu; Kinoshita, Shigeru; Ueno, Morio; Ikeya, Makoto; Toguchida, Junya			Derivation of Mesenchymal Stromal Cells from Pluripotent Stem Cells through a Neural Crest Lineage using Small Molecule Compounds with Defined Media	PLOS ONE			English	Article							PATIENT-SPECIFIC IPSCS; PARAXIAL MESODERM; BRANCHIAL ARCHES; DIFFERENTIATION; INDUCTION; MOUSE; SPECIFICATION; MAINTENANCE; MELANOCYTES; GENERATION	Neural crest cells (NCCs) are an embryonic migratory cell population with the ability to differentiate into a wide variety of cell types that contribute to the craniofacial skeleton, cornea, peripheral nervous system, and skin pigmentation. This ability suggests the promising role of NCCs as a source for cell-based therapy. Although several methods have been used to induce human NCCs (hNCCs) from human pluripotent stem cells (hPSCs), such as embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), further modifications are required to improve the robustness, efficacy, and simplicity of these methods. Chemically defined medium (CDM) was used as the basal medium in the induction and maintenance steps. By optimizing the culture conditions, the combination of the GSK3 beta inhibitor and TGF beta inhibitor with a minimum growth factor (insulin) very efficiently induced hNCCs (70-80%) from hPSCs. The induced hNCCs expressed cranial NCC-related genes and stably proliferated in CDM supplemented with EGF and FGF2 up to at least 10 passages without changes being observed in the major gene expression profiles. Differentiation properties were confirmed for peripheral neurons, glia, melanocytes, and corneal endothelial cells. In addition, cells with differentiation characteristics similar to multipotent mesenchymal stromal cells (MSCs) were induced from hNCCs using CDM specific for human MSCs. Our simple and robust induction protocol using small molecule compounds with defined media enabled the generation of hNCCs as an intermediate material producing terminally differentiated cells for cell-based innovative medicine.	[Fukuta, Makoto; Sekiguchi, Kazuya; Matsumoto, Yoshihisa; Toguchida, Junya] Kyoto Univ, Inst Frontier Med Sci, Dept Tissue Regenerat, Kyoto, Japan; [Fukuta, Makoto; Sekiguchi, Kazuya; Nagata, Sanae; Matsumoto, Yoshihisa; Ikeya, Makoto; Toguchida, Junya] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Cell Growth & Differentiat, Kyoto, Japan; [Fukuta, Makoto; Matsumoto, Yoshihisa; Otsuka, Takanobu] Nagoya City Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Nagoya, Aichi, Japan; [Nakai, Yoshinori; Sato, Takahiko; Kinoshita, Shigeru; Ueno, Morio] Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan; [Kirino, Kosuke; Nakahata, Tatsutoshi; Saito, Megumu] Kyoto Univ, Dept Clin Applicat, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Nakagawa, Masato; Yamamoto, Takuya] Kyoto Univ, Dept Reprogramming Sci, Ctr iPS Cell Res & Applicat, Kyoto, Japan; [Sekiguchi, Kazuya; Toguchida, Junya] Kyoto Univ, Grad Sch Med, Dept Orthopaed Surg, Kyoto, Japan; [Yamamoto, Takuya] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto, Japan; [Umeda, Katsutsugu; Heike, Toshio] Kyoto Univ, Grad Sch Med, Dept Pediat, Kyoto, Japan; [Okumura, Naoki; Koizumi, Noriko] Doshisha Univ, Fac Life & Med Sci, Dept Biomed Engn, Kyotanabe, Japan	Kyoto University; Kyoto University; Nagoya City University; Kyoto Prefectural University of Medicine; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Doshisha University	Ueno, M (corresponding author), Kyoto Prefectural Univ Med, Dept Ophthalmol, Kyoto, Japan.	mueno@koto.kpu-m.ac.jp; mikeya@cira.kyoto-u.ac.jp; togjun@frontier.kyoto-u.ac.jp	Yamamoto, Takuya/H-2792-2017	Yamamoto, Takuya/0000-0002-0022-3947; Sato, Takahiko/0000-0003-3836-7978; Ikeya, Makoto/0000-0002-3930-8032	JSPS [25293320, 20791288]; JST [AS242Z00931P]; MEXT	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JST(Japan Science & Technology Agency (JST)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-Aid for Scientific Research from JSPS (# 25293320), a grant from Core Center for iPS Cell Research, Research Center Network for Realization of Regenerative Medicine from JST, and the Leading Project for Realization of Regenerative Medicine from MEXT to MI and JT. MI was also supported by the Adaptable and Seamless Technology Transfer Program through target-driven R& D, Exploratory Research from JST (AS242Z00931P). JT was also supported by the Center for Clinical Application Research on Specific Disease/ Organ from JST. MU was also supported by Grants-in-Aid for Scientific Research from JSPS (#20791288). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Cai JL, 2010, STEM CELLS DEV, V19, P1017, DOI 10.1089/scd.2009.0319; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Chimige NO, 2010, J EXP ZOOL PART B, V314B, P95, DOI 10.1002/jez.b.21321; Colleoni S, 2010, EXP CELL RES, V316, P1148, DOI 10.1016/j.yexcr.2010.02.013; Curchoe CL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013890; De Schauwer C, 2011, THERIOGENOLOGY, V75, P1431, DOI 10.1016/j.theriogenology.2010.11.008; Fang D, 2006, STEM CELLS, V24, P1668, DOI 10.1634/stemcells.2005-0414; FITCH JM, 1990, J CELL BIOL, V110, P1457, DOI 10.1083/jcb.110.4.1457; Giuliani M, 2011, BLOOD, V118, P3254, DOI 10.1182/blood-2010-12-325324; Helms JA, 2003, NATURE, V423, P326, DOI 10.1038/nature01656; James MJ, 2006, J BONE MINER RES, V21, P1034, DOI 10.1359/JBMR.060413; Jiang MR, 2011, CURR TOP DEV BIOL, V94, P77, DOI 10.1016/B978-0-12-380916-2.00004-8; JOHNSTON MC, 1979, EXP EYE RES, V29, P27, DOI 10.1016/0014-4835(79)90164-7; Ju CQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042378; Kalcheim C, 2005, INT J DEV BIOL, V49, P105, DOI 10.1387/ijdb.041949ck; Kalcheim C, 2000, INT REV CYTOL, V200, P143, DOI 10.1016/S0074-7696(00)00004-8; Kimura C, 1997, DEVELOPMENT, V124, P3929; Kreitzer FR, 2013, AM J STEM CELLS, V2, P119; Le Douarin NM, 2003, CURR OPIN GENET DEV, V13, P529, DOI 10.1016/j.gde.2003.08.002; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lee G, 2012, NAT BIOTECHNOL, V30, P1244, DOI 10.1038/nbt.2435; Lee G, 2010, NAT PROTOC, V5, P688, DOI 10.1038/nprot.2010.35; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Liu QY, 2012, STEM CELL TRANSL MED, V1, P266, DOI 10.5966/sctm.2011-0042; Liu ZJ, 2007, DEV BIOL, V305, P333, DOI 10.1016/j.ydbio.2007.02.014; Liu ZQ, 2013, J CELL MOL MED, V17, P782, DOI 10.1111/jcmm.12062; MANLEY NR, 1995, DEVELOPMENT, V121, P1989; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Menendez L, 2011, P NATL ACAD SCI USA, V108, P19240, DOI 10.1073/pnas.1113746108; Mica Y, 2013, CELL REP, V3, P1140, DOI 10.1016/j.celrep.2013.03.025; Milet C, 2012, DEV BIOL, V366, P96, DOI 10.1016/j.ydbio.2012.01.016; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Motohashi T, 2006, PIGM CELL RES, V19, P284, DOI 10.1111/j.1600-0749.2006.00317.x; Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594; Nasu A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053771; Neirinckx V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064723; Neirinckx V, 2013, STEM CELL TRANSL MED, V2, P284, DOI 10.5966/sctm.2012-0147; Ohta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016182; Okamoto T, 2002, BIOCHEM BIOPH RES CO, V295, P354, DOI 10.1016/S0006-291X(02)00661-7; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Qiu MS, 1997, DEV BIOL, V185, P165, DOI 10.1006/dbio.1997.8556; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Silva N.A., 2013, PROG NEUROBIOL; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; TRAINOR PA, 1995, DEVELOPMENT, V121, P2569; Umeda K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00455; Villa-Diaz LG, 2012, STEM CELLS, V30, P1174, DOI 10.1002/stem.1084; Vincent SD, 2010, CURR TOP DEV BIOL, V90, P1, DOI 10.1016/S0070-2153(10)90001-X; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105	53	95	101	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112291	10.1371/journal.pone.0112291	http://dx.doi.org/10.1371/journal.pone.0112291			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464501	gold, Green Submitted, Green Published			2022-12-26	WOS:000345869700013
J	Garcia, JD; Dewey, EB; Johnston, CA				Garcia, Joshua D.; Dewey, Evan B.; Johnston, Christopher A.			Dishevelled Binds the Discs Large 'Hook' Domain to Activate GukHolder-Dependent Spindle Positioning in Drosophila	PLOS ONE			English	Article							ASYMMETRIC CELL-DIVISION; GUANYLATE KINASE DOMAINS; NANCE-HORAN-SYNDROME; HETEROTRIMERIC G-PROTEINS; MITOTIC SPINDLE; TUMOR-SUPPRESSOR; SUPERTERTIARY STRUCTURE; SCAFFOLD PROTEINS; ELEGANS EMBRYOS; HUMAN HOMOLOG	Communication between cortical cell polarity cues and the mitotic spindle ensures proper orientation of cell divisions within complex tissues. Defects in mitotic spindle positioning have been linked to various developmental disorders and have recently emerged as a potential contributor to tumorigenesis. Despite the importance of this process to human health, the molecular mechanisms that regulate spindle orientation are not fully understood. Moreover, it remains unclear how diverse cortical polarity complexes might cooperate to influence spindle positioning. We and others have demonstrated spindle orientation roles for Dishevelled (Dsh), a key regulator of planar cell polarity, and Discs large (Dlg), a conserved apico-basal cell polarity regulator, effects which were previously thought to operate within distinct molecular pathways. Here we identify a novel direct interaction between the Dsh-PDZ domain and the alternatively spliced 'I3-insert'' of the Dlg-Hook domain, thus establishing a potential convergent Dsh/Dlg pathway. Furthermore, we identify a Dlg sequence motif necessary for the Dsh interaction that shares homology to the site of Dsh binding in the Frizzled receptor. Expression of Dsh enhanced Dlg-mediated spindle positioning similar to deletion of the Hook domain. This Dsh-mediated activation was dependent on the Dlg-binding partner, GukHolder (GukH). These results suggest that Dsh binding may regulate core interdomain conformational dynamics previously described for Dlg. Together, our results identify Dlg as an effector of Dsh signaling and demonstrate a Dsh-mediated mechanism for the activation of Dlg/GukH-dependent spindle positioning. Cooperation between these two evolutionarily-conserved cell polarity pathways could have important implications to both the development and maintenance of tissue homeostasis in animals.	[Garcia, Joshua D.; Dewey, Evan B.; Johnston, Christopher A.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA	University of New Mexico	Johnston, CA (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	johnstca@unm.edu		Garcia, Joshua D./0000-0002-7572-2062; Dewey, Evan/0000-0003-4330-3450	National Institutes of Health [GM060201, GM108756]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM108756, R25GM060201] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	JDG is an Initiative to Maximize Student Diversity (IMSD) program scholar supported by the National Institutes of Health (GM060201). This work was also supported by the National Institutes of Health grant GM108756 (CAJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertson R, 2003, NAT CELL BIOL, V5, P166, DOI 10.1038/ncb922; Bei YX, 2002, DEV CELL, V3, P113, DOI 10.1016/S1534-5807(02)00185-5; Bellaiche Y, 2004, DEVELOPMENT, V131, P469, DOI 10.1242/dev.00928; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Bellaiche Y, 2001, NAT CELL BIOL, V3, P50, DOI 10.1038/35050558; Berger J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000085; Bergstralh DT, 2013, CURR BIOL, V23, P1707, DOI 10.1016/j.cub.2013.07.017; Bowman SK, 2006, DEV CELL, V10, P731, DOI 10.1016/j.devcel.2006.05.005; Brooks SP, 2004, J MED GENET, V41, P768, DOI 10.1136/jmg.2004.022517; Burdon KP, 2003, AM J HUM GENET, V73, P1120, DOI 10.1086/379381; Doyle DA, 1996, CELL, V85, P1067, DOI 10.1016/S0092-8674(00)81307-0; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Etienne-Manneville S, 2013, ANNU REV CELL DEV BI, V29, P471, DOI 10.1146/annurev-cellbio-101011-155711; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; Fleming ES, 2009, MOL CARCINOGEN, V48, P592, DOI 10.1002/mc.20506; Gho M, 1998, NATURE, V393, P178, DOI 10.1038/30265; Gillies TE, 2011, CURR BIOL, V21, pR599, DOI 10.1016/j.cub.2011.06.055; Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103; Humbert P, 2003, BIOESSAYS, V25, P542, DOI 10.1002/bies.10286; Ishidate T, 2000, ONCOGENE, V19, P365, DOI 10.1038/sj.onc.1203309; Johnston CA, 2013, J CELL SCI, V126, P4436, DOI 10.1242/jcs.129544; Johnston CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036014; Johnston CA, 2011, P NATL ACAD SCI USA, V108, pE973, DOI 10.1073/pnas.1104365108; Johnston CA, 2009, CELL, V138, P1150, DOI 10.1016/j.cell.2009.07.041; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Koles K, 2012, COLD SPRING HARB PER, V4; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Lancaster MA, 2012, CURR OPIN NEUROBIOL; London TBC, 2004, BIOCHEM BIOPH RES CO, V322, P326, DOI 10.1016/j.bbrc.2004.07.113; Lu MS, 2013, DEVELOPMENT, V140, P1843, DOI 10.1242/dev.087627; Lue RA, 1996, J CELL BIOL, V135, P1125, DOI 10.1083/jcb.135.4.1125; LUE RA, 1994, P NATL ACAD SCI USA, V91, P9818, DOI 10.1073/pnas.91.21.9818; Macara IG, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0012; Marcette J, 2009, BIOCHEMISTRY-US, V48, P10014, DOI 10.1021/bi901160f; Mathew D, 2002, CURR BIOL, V12, P531, DOI 10.1016/S0960-9822(02)00758-3; Matsumine A, 1996, SCIENCE, V272, P1020, DOI 10.1126/science.272.5264.1020; McCann JJ, 2012, P NATL ACAD SCI USA, V109, P15775, DOI 10.1073/pnas.1200254109; McGee AW, 2001, MOL CELL, V8, P1291, DOI 10.1016/S1097-2765(01)00411-7; Morin X, 2011, DEV CELL, V21, P102, DOI 10.1016/j.devcel.2011.06.012; Newman RA, 2009, J BIOL CHEM, V284, P12924, DOI 10.1074/jbc.M809304200; Oliva C, 2012, DEV NEUROBIOL, V72, P57, DOI 10.1002/dneu.20949; Qian Y, 2006, J BIOL CHEM, V281, P35757, DOI 10.1074/jbc.M607057200; Rogers SL, 2008, NAT PROTOC, V3, P606, DOI 10.1038/nprot.2008.18; Schaefer M, 2000, CURR BIOL, V10, P353, DOI 10.1016/S0960-9822(00)00401-2; Schaefer M, 2001, CELL, V107, P183, DOI 10.1016/S0092-8674(01)00521-9; Segalen M, 2010, DEV CELL, V19, P740, DOI 10.1016/j.devcel.2010.10.004; Senda Takao, 2005, Anatomical Science International, V80, P121, DOI 10.1111/j.1447-073x.2005.00106.x; Siegrist SE, 2005, CELL, V123, P1323, DOI 10.1016/j.cell.2005.09.043; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Tavares GA, 2001, MOL CELL, V8, P1313, DOI 10.1016/S1097-2765(01)00416-6; Thomas U, 2000, CURR BIOL, V10, P1108, DOI 10.1016/S0960-9822(00)00696-5; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wallingford JB, 2012, ANNU REV CELL DEV BI, V28, P627, DOI 10.1146/annurev-cellbio-092910-154208; WALPOLE IR, 1990, J MED GENET, V27, P632, DOI 10.1136/jmg.27.10.632; Walston T, 2004, DEV CELL, V7, P831, DOI 10.1016/j.devcel.2004.10.008; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; WOODS DF, 1989, DEV BIOL, V134, P222, DOI 10.1016/0012-1606(89)90092-4; Wu HJ, 1998, J CELL SCI, V111, P2365; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Zhang J, 2013, STRUCTURE, V21, P402, DOI 10.1016/j.str.2012.12.014; Zhang YN, 2009, NAT CHEM BIOL, V5, P217, DOI 10.1038/nchembio.152; Zhu JW, 2011, EMBO J, V30, P4986, DOI 10.1038/emboj.2011.428	63	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114235	10.1371/journal.pone.0114235	http://dx.doi.org/10.1371/journal.pone.0114235			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461409	gold, Green Published, Green Submitted			2022-12-26	WOS:000345869700121
J	Huang, WL; Ling, SQ; Jia, XH; Lin, BW; Huang, X; Zhong, J; Li, WH; Lin, XL; Sun, YF; Yuan, J				Huang, Weilan; Ling, Shiqi; Jia, Xiuhua; Lin, Binwu; Huang, Xi; Zhong, Jing; Li, Weihua; Lin, Xiaolei; Sun, Yifang; Yuan, Jin			Tacrolimus (FK506) Suppresses TREM-1 Expression at an Early but Not at a Late Stage in a Murine Model of Fungal Keratitis	PLOS ONE			English	Article							SUSPENSION EYE DROPS; MYELOID CELLS-1; ASPERGILLUS-FUMIGATUS; REPERFUSION INJURY; IMMUNE-RESPONSES; CYCLOSPORINE-A; MOUSE MODEL; INFLAMMATION; MACROPHAGES; ISCHEMIA	Purpose: To investigate the efficacy and mechanism of tacrolimus(FK506), which is a novel macrolide immunosuppressant, in inhibiting triggering receptor expressed on myeloid cells-1 (TREM-1) expression in a murine keratitis model induced by Aspergillus fumigatus. Method: TREM-1 was detected in 11 fungus-infected human corneas by quantitative real-time PCR (qRT-PCR). RAW264.7 macrophages were divided into four groups, which received treatment with zymosan (100 mg/ml), zymosan (100 mu g/ml) + mTREM-1/Fc protein (1 mu g/ml), or zymosan (100 mu g/ml) + FK506 (20 mu M) or negative-control treatment. After this treatment, the expression of TREM-1, interleukin-1 beta (IL-1 beta) and tumor necrosis factor alpha (TNF alpha) was assayed using qRT-PCR and ELISA. The mouse model of fungal keratitis was created by intrastromal injection with Aspergillus fumigatus, and the mice were divided into 2 groups: group A received vehicle eye drops 4 times each day, and group B received 4 doses of FK506 eye drops each day. Corneal damage was evaluated by clinical scoring and histologic examination, and myeloperoxidase (MPO) protein levels were also detected by ELISA. The expression of TREM-1, IL-1 beta and TNFa was then determined at different time points using qRT-PCR and ELISA. Results: TREM-1 expression dramatically increased in the human corneas with fungal keratitis. In contrast, FK506 reduced the expression of TREM-1, IL-1b and TNF alpha in RAW264.7 macrophages stimulated with zymosan. In the mouse model, at day 1 post-infection, the corneal score of the FK506-treated group was lower than that of the control, and polymorphonuclear neutrophil (PMN) infiltration was diminished. TREM-1, IL-1 beta and TNF alpha expression was significantly reduced at the same time point. However, the statistically significant differences in cytokine expression, clinical scores and infiltration disappeared at 5 days post-infection. Conclusions: FK506 may inhibit the inflammation induced by fungi and alleviate the severity of corneal damage at an early stage of fungal keratitis by downregulating TREM-1 expression.	[Huang, Weilan; Lin, Binwu; Huang, Xi; Zhong, Jing; Li, Weihua; Lin, Xiaolei; Sun, Yifang; Yuan, Jin] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China; [Ling, Shiqi; Jia, Xiuhua] Sun Yat Sen Univ, Dept Ophthalmol, Affiliated Hosp 3, Guangzhou 510275, Guangdong, Peoples R China; [Huang, Weilan] Sun Yat Sen Univ, Phys Examinat Ctr, Affiliated Hosp 3, Lingnan Hosp, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University	Yuan, J (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	yuanjincornea@126.com	Zhang, jun/E-9359-2011	Zhang, jun/0000-0001-7835-9871	Natural Science Foundation of China [81270972]; Fundamental Research Funds for the Central Universities [11ykpy66]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the Natural Science Foundation of China (81270972) and the Fundamental Research Funds for the Central Universities (11ykpy66). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRY AL, 1987, ANTIMICROB AGENTS CH, V31, P343, DOI 10.1128/AAC.31.2.343; Bleharski JR, 2003, J IMMUNOL, V170, P3812, DOI 10.4049/jimmunol.170.7.3812; Bosnar M, 2011, INT IMMUNOPHARMACOL, V11, P424, DOI 10.1016/j.intimp.2010.12.010; Bouchon A, 2000, J IMMUNOL, V164, P4991, DOI 10.4049/jimmunol.164.10.4991; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Brown GD, 2003, J EXP MED, V197, P1119, DOI 10.1084/jem.20021890; Buckland KF, 2011, IMMUNOL INVEST, V40, P692, DOI 10.3109/08820139.2011.578270; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Dang SC, 2012, GASTROENT RES PRACT, V2012, DOI 10.1155/2012/720865; DEREPENTIGNY L, 1993, INFECT IMMUN, V61, P3791, DOI 10.1128/IAI.61.9.3791-3802.1993; Fei WL, 2008, J OCUL PHARMACOL TH, V24, P235, DOI 10.1089/jop.2007.0059; Gibot S, 2004, J EXP MED, V200, P1419, DOI 10.1084/jem.20040708; Guidera AC, 2001, OPHTHALMOLOGY, V108, P936, DOI 10.1016/S0161-6420(00)00538-8; HENDRICKS RL, 1991, INVEST OPHTH VIS SCI, V32, P366; HIGH KP, 1994, TRANSPLANTATION, V57, P1689, DOI 10.1097/00007890-199457120-00001; Hikita N, 1997, INVEST OPHTH VIS SCI, V38, P901; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; Hogan AC, 2007, OPHTHALMOLOGY, V114, P1000, DOI 10.1016/j.ophtha.2007.01.026; Hutchinson IV, 1998, TRANSPLANT P, V30, P959, DOI 10.1016/S0041-1345(98)00110-9; Ianaro A, 2000, J PHARMACOL EXP THER, V292, P156; KAWANO K, 1994, EUR SURG RES, V26, P108, DOI 10.1159/000129325; KEICHO N, 1991, CELL IMMUNOL, V132, P285, DOI 10.1016/0008-8749(91)90028-A; Kikuchi T, 2002, J ANTIMICROB CHEMOTH, V49, P745, DOI 10.1093/jac/dkf008; Lee HN, 2013, SEMIN IMMUNOPATHOL, V35, P151, DOI 10.1007/s00281-013-0363-y; Lee RKK, 1999, J NEUROSCI, V19, P940; LIN CS, 1991, CELL IMMUNOL, V133, P269, DOI 10.1016/0008-8749(91)90103-I; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; Mansour MK, 2012, ANN NY ACAD SCI, V1273, P78, DOI 10.1111/j.1749-6632.2012.06837.x; Meyer M, 2009, AM J RESP CELL MOL, V41, P590, DOI 10.1165/rcmb.2008-0155OC; Netea MG, 2006, J LEUKOCYTE BIOL, V80, P1454, DOI 10.1189/jlb.1205758; Ohashi Y, 2010, J OCUL PHARMACOL TH, V26, P165, DOI 10.1089/jop.2009.0087; Pereira R, 2006, TRANSPL IMMUNOL, V16, P105, DOI 10.1016/j.trim.2006.04.001; SAWADA S, 1987, J IMMUNOL, V139, P1797; Schenk M, 2007, J CLIN INVEST, V117, P3097, DOI 10.1172/JCI30602; Sieber M, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-25; SOUZA GEP, 1988, AGENTS ACTIONS, V24, P377, DOI 10.1007/BF02028296; SUZUKI S, 1993, TRANSPLANTATION, V55, P1265; Taylor SRJ, 2010, OPHTHALMOLOGICA, V224, P46, DOI 10.1159/000318021; Tessarz AAS, 2008, IMMUNOL LETT, V116, P111, DOI 10.1016/j.imlet.2007.11.021; Thomas PA, 2003, EYE, V17, P852, DOI 10.1038/sj.eye.6700557; Thomas PA, 2003, CLIN MICROBIOL REV, V16, P730, DOI 10.1128/CMR.16.4.730-797.2003; Wakita H, 1998, BRAIN RES, V792, P105, DOI 10.1016/S0006-8993(98)00126-7; Whitcher JP, 2001, B WORLD HEALTH ORGAN, V79, P214; Wu MH, 2011, INFECT IMMUN, V79, P2709, DOI 10.1128/IAI.00144-11; Wu TG, 2003, INVEST OPHTH VIS SCI, V44, P210, DOI 10.1167/iovs.02-0446; Xie LX, 2006, OPHTHALMOLOGY, V113, P1943, DOI 10.1016/j.ophtha.2006.05.035; YOUNG RA, 1989, DRUGS, V37, P8, DOI 10.2165/00003495-198937010-00002; Yuan J, 2012, J OCUL PHARMACOL TH, V28, P153, DOI 10.1089/jop.2011.0108; Zribi H, 2009, J EUR ACAD DERMATOL, V23, P489, DOI 10.1111/j.1468-3083.2008.02933.x	49	9	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114386	10.1371/journal.pone.0114386	http://dx.doi.org/10.1371/journal.pone.0114386			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464008	Green Submitted, Green Published, gold			2022-12-26	WOS:000345869700131
J	Iacovitti, L; Wei, XT; Cai, JL; Kostuk, EW; Lin, RH; Gorodinsky, A; Roman, P; Kusek, G; Das, SS; Dufour, A; Martinez, TN; Dave, KD				Iacovitti, Lorraine; Wei, Xiaotao; Cai, Jingli; Kostuk, Eric W.; Lin, Ruihe; Gorodinsky, Alexander; Roman, Philip; Kusek, Gretchen; Das, Sonal S.; Dufour, Audrey; Martinez, Terina N.; Dave, Kuldip D.			The hTH-GFP Reporter Rat Model for the Study of Parkinson's Disease	PLOS ONE			English	Article							TYROSINE-HYDROXYLASE GENE; MIDBRAIN DOPAMINE NEURONS; EMBRYONIC STEM-CELLS; TRANSGENIC MICE; HIGH-LEVEL; IN-VITRO; TRANSPLANTATION; DIFFERENTIATION; EXPRESSION; DEGENERATION	Parkinson disease (PD) is the second leading neurodegenerative disease in the US. As there is no known cause or cure for PD, researchers continue to investigate disease mechanisms and potential new therapies in cell culture and in animal models of PD. In PD, one of the most profoundly affected neuronal populations is the tyrosine hydroxylase (TH)-expressing dopaminergic (DA) neurons of the substantia nigra pars compacta (SNpc). These DA-producing neurons undergo degeneration while neighboring DA-producing cells of the ventral tegmental area (VTA) are largely spared. To aid in these studies, The Michael J. Fox Foundation (MJFF) partnered with Thomas Jefferson University and Taconic Inc. to generate new transgenic rat lines carrying the human TH gene promoter driving EGFP using a 11 kb construct used previously to create a hTH-GFP mouse reporter line. Of the five rat founder lines that were generated, three exhibited high level specific GFP fluorescence in DA brain structures (ie. SN, VTA, striatum, olfactory bulb, hypothalamus). As with the hTH-GFP mouse, none of the rat lines exhibit reporter expression in adrenergic structures like the adrenal gland. Line 12141, with its high levels of GFP in adult DA brain structures and minimal ectopic GFP expression in non-DA structures, was characterized in detail. We show here that this line allows for anatomical visualization and microdissection of the rat midbrain into SNpc and/or VTA, enabling detailed analysis of midbrain DA neurons and axonal projections after toxin treatment in vivo. Moreover, we further show that embryonic SNpc and/or VTA neurons, enriched by microdissection or FACS, can be used in culture or transplant studies of PD. Thus, the hTH-GFP reporter rat should be a valuable tool for Parkinson's disease research.	[Iacovitti, Lorraine; Wei, Xiaotao; Cai, Jingli; Kostuk, Eric W.; Lin, Ruihe] Thomas Jefferson Univ, Dept Neurosci, Farber Inst Neurosci, Philadelphia, PA 19107 USA; [Gorodinsky, Alexander; Roman, Philip; Kusek, Gretchen] Tacon Farms Inc, Hudson, NY USA; [Das, Sonal S.; Dufour, Audrey; Martinez, Terina N.; Dave, Kuldip D.] Michael J Fox Fdn Parkinsons Res, New York, NY USA	Jefferson University	Iacovitti, L (corresponding author), Thomas Jefferson Univ, Dept Neurosci, Farber Inst Neurosci, Philadelphia, PA 19107 USA.	lorraine.iacovitti@jefferson.edu		Lin, Ruihe/0000-0002-7475-6359	Michael J. Fox Foundation	Michael J. Fox Foundation	This work was generously supported by a grant from the Michael J. Fox Foundation to LI. The funders: Sonal S. Das, Audrey Dufour, Terina N. Martinez, and Kuldip D. Dave analyzed the data. In addition, Kuldip D. Dave conceived and designed the experiments, and contributed to writing the manuscript.	Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; BANERJEE SA, 1992, J NEUROSCI, V12, P4460; Baptista MAS, 2013, DIS MODEL MECH, V6, P1316, DOI 10.1242/dmm.011940; Cai JL, 2010, STEM CELLS DEV, V19, P1017, DOI 10.1089/scd.2009.0319; Cai JL, 2009, STEM CELLS, V27, P220, DOI 10.1634/stemcells.2008-0734; Donaldson AE, 2005, MOL CELL NEUROSCI, V30, P601, DOI 10.1016/j.mcn.2005.06.010; KANEDA N, 1991, NEURON, V6, P583, DOI 10.1016/0896-6273(91)90061-4; Kessler MA, 2003, MOL BRAIN RES, V112, P8, DOI 10.1016/S0169-328X(02)00694-0; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; MIN N, 1994, MOL BRAIN RES, V27, P281, DOI 10.1016/0169-328X(94)90011-6; Nakatani T, 2010, DEV BIOL, V339, P101, DOI 10.1016/j.ydbio.2009.12.017; Phani S, 2013, BRAIN RES, V1500, P88, DOI 10.1016/j.brainres.2013.01.017; Prakash N, 2006, CELL MOL LIFE SCI, V63, P187, DOI 10.1007/s00018-005-5387-6; Roybon L, 2008, J NEUROSCI, V28, P3644, DOI 10.1523/JNEUROSCI.0311-08.2008; Sawamoto K, 2001, P NATL ACAD SCI USA, V98, P6423, DOI 10.1073/pnas.111152398; Schleidt S, 2012, 2012 NEUR M PLANN; Stull ND, 2002, BRAIN RES, V931, P181, DOI 10.1016/S0006-8993(02)02269-2; Tang MZ, 2010, J NEUROSCI, V30, P9280, DOI 10.1523/JNEUROSCI.0860-10.2010; Ungerstedt U, 1973, Neurosci Res (N Y), V5, P73; UNGERSTEDT U, 1968, EUR J PHARMACOL, V5, P107, DOI 10.1016/0014-2999(68)90164-7; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; Yang M, 2002, EXP NEUROL, V177, P50, DOI 10.1006/exnr.2002.7989; Yang M, 2003, CELL MOL NEUROBIOL, V23, P851, DOI 10.1023/A:1025017423102; Zhao SL, 2004, EUR J NEUROSCI, V19, P1133, DOI 10.1111/j.1460-9568.2004.03206.x; Zhou WB, 2009, STEM CELLS, V27, P2952, DOI 10.1002/stem.216	25	14	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113151	10.1371/journal.pone.0113151	http://dx.doi.org/10.1371/journal.pone.0113151			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462571	Green Submitted, Green Published, gold			2022-12-26	WOS:000345869700026
J	Jansen, CJ; Absalom, AR; de Bock, GH; van Leeuwen, BL; Izaks, GJ				Jansen, Carolien J.; Absalom, Anthony R.; de Bock, Geertruida H.; van Leeuwen, Barbara L.; Izaks, Gerbrand J.			Performance and Agreement of Risk Stratification Instruments for Postoperative Delirium in Persons Aged 50 Years or Older	PLOS ONE			English	Article							PREDICTION RULE; EXECUTIVE FUNCTION; DEPRESSION; VALIDATION; SEVERITY	Several risk stratification instruments for postoperative delirium in older people have been developed because early interventions may prevent delirium. We investigated the performance and agreement of nine commonly used risk stratification instruments in an independent validation cohort of consecutive elective and emergency surgical patients aged >= 50 years with >= 1 risk factor for postoperative delirium. Data was collected prospectively. Delirium was diagnosed according to DSM-IV-TR criteria. The observed incidence of postoperative delirium was calculated per risk score per risk stratification instrument. In addition, the risk stratification instruments were compared in terms of area under the receiver operating characteristic (ROC) curve (AUC), and positive and negative predictive value. Finally, the positive agreement between the risk stratification instruments was calculated. When data required for an exact implementation of the original risk stratification instruments was not available, we used alternative data that was comparable. The study population included 292 patients: 60% men; mean age (SD), 66 (8) years; 90% elective surgery. The incidence of postoperative delirium was 9%. The maximum observed incidence per risk score was 50% (95% CI, 15-85%); for eight risk stratification instruments, the maximum observed incidence per risk score was <= 25%. The AUC (95% CI) for the risk stratification instruments varied between 0.50 (0.36-0.64) and 0.66 (0.48-0.83). No AUC was statistically significant from 0.50 (p >= 0.11). Positive predictive values of the risk stratification instruments varied between 0-25%, negative predictive values between 89-95%. Positive agreement varied between 0-66%. No risk stratification instrument showed clearly superior performance. In conclusion, in this independent validation cohort, the performance and agreement of commonly used risk stratification instruments for postoperative delirium was poor. Although some caution is needed because the risk stratification instruments were not implemented exactly as described in the original studies, we think that their usefulness in clinical practice can be questioned.	[Jansen, Carolien J.; Izaks, Gerbrand J.] Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Geriatr Med, NL-9713 AV Groningen, Netherlands; [Absalom, Anthony R.] Univ Groningen, Univ Med Ctr Groningen, Dept Anesthesiol, NL-9713 AV Groningen, Netherlands; [de Bock, Geertruida H.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, NL-9713 AV Groningen, Netherlands; [van Leeuwen, Barbara L.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, NL-9713 AV Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Izaks, GJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Univ Ctr Geriatr Med, NL-9713 AV Groningen, Netherlands.	g.j.izaks@umcg.nl	Absalom, Anthony/GPG-1582-2022; de Bock, Geertruida Hendrika/F-6529-2014; Izaks, Gerbrand/F-5089-2014	de Bock, Geertruida Hendrika/0000-0003-3104-4471; Izaks, Gerbrand/0000-0003-3213-7637; Absalom, Anthony/0000-0001-7563-9157; van Leeuwen, Barbara/0000-0002-6745-4424	University Medical Center Groningen, Groningen, the Netherlands	University Medical Center Groningen, Groningen, the Netherlands(Netherlands Government)	This study was supported by a grant from the University Medical Center Groningen, Groningen, the Netherlands, for pilot studies on cost-effectiveness (BLL GJI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Martinez JA, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001599; Carthon JMB, 2013, J AM GERIATR SOC, V61, P1499, DOI 10.1111/jgs.12419; Chow WB, 2012, J AM COLL SURGEONS, V215, P453, DOI 10.1016/j.jamcollsurg.2012.06.017; CICCHETTI DV, 1990, J CLIN EPIDEMIOL, V43, P551, DOI 10.1016/0895-4356(90)90159-M; Etzioni DA, 2003, ANN SURG, V238, P170, DOI 10.1097/01.SLA.0000081085.98792.3d; Freter SH, 2005, AGE AGEING, V34, P387, DOI 10.1093/ageing/afi099; Freter SH, 2005, AGE AGEING, V34, P169, DOI 10.1093/ageing/afh245; Greene NH, 2009, ANESTHESIOLOGY, V110, P788, DOI 10.1097/ALN.0b013e31819b5ba6; Inouye SK, 2014, LANCET, V383, P911, DOI 10.1016/S0140-6736(13)60688-1; INOUYE SK, 1993, ANN INTERN MED, V119, P474, DOI 10.7326/0003-4819-119-6-199309150-00005; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kobayashi D, 2013, AM J GERIAT PSYCHIAT, V21, P957, DOI 10.1016/j.jagp.2012.08.009; Koster S, 2009, EUR J CARDIOVASC NUR, V8, P309, DOI 10.1016/j.ejcnurse.2009.02.006; Mackinnon A, 2000, COMPUT BIOL MED, V30, P127, DOI 10.1016/S0010-4825(00)00006-8; MARCANTONIO ER, 1994, JAMA-J AM MED ASSOC, V271, P134, DOI 10.1001/jama.271.2.134; Newcombe RG, 2000, STAT CONFIDENCE, P46; OKeeffe ST, 1996, AGE AGEING, V25, P317, DOI 10.1093/ageing/25.4.317; POMPEI P, 1994, J AM GERIATR SOC, V42, P809, DOI 10.1111/j.1532-5415.1994.tb06551.x; Rudolph JL, 2009, CIRCULATION, V119, P229, DOI 10.1161/CIRCULATIONAHA.108.795260; Scheffer AC, 2011, INT J GERIATR PSYCH, V26, P284, DOI 10.1002/gps.2526; Schuurmans H, 2004, J GERONTOL A-BIOL, V59, P962; Schuurmans Marieke J, 2003, Res Theory Nurs Pract, V17, P31, DOI 10.1891/088971803780956425; Smith PJ, 2009, ANESTHESIOLOGY, V110, P781, DOI 10.1097/ALN.0b013e31819b5bc2; Van Gemert LA, 2007, BMC NURS, V6, DOI 10.1186/1472-6955-6-3	25	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113946	10.1371/journal.pone.0113946	http://dx.doi.org/10.1371/journal.pone.0113946			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU8TQ	25464335	Green Submitted, Green Published, gold			2022-12-26	WOS:000345869700072
J	Lute, ML; Bump, A; Gore, ML				Lute, Michelle L.; Bump, Adam; Gore, Meredith L.			Identity-Driven Differences in Stakeholder Concerns about Hunting Wolves	PLOS ONE			English	Article							SOCIAL IDENTITY; SELF-CATEGORIZATION; INTERGROUP CONFLICT; VALUE ORIENTATIONS; WILDLIFE; ATTITUDES; WOLF; CONSERVATION; PERCEPTIONS; NETWORKS	Whereas past wolf management in the United States was restricted to recovery, managers must now contend with publicly contentious post-recovery issues including regulated hunting seasons. Understanding stakeholder concerns associated with hunting can inform stakeholder engagement, communication, and policy development and evaluation. Social identity theory (SIT) has been used to understand how groups interact, why they conflict, and how collaboration may be achieved. Applying SIT to stakeholder conflicts about wolf hunting may help delineate groups according to their concern about, support for or opposition to the policy choice of hunting wolves. Our objective was to assess concerns about hunting as a tool to resolve conflict in Michigan, using SIT as a framework. We used a mixed-modal sampling approach (e.g., paper, Internet) with wolf hunting-related public meeting participants in March 2013. Survey questions focused on 12 concerns previously identified as associated with hunting as a management tool to resolve conflict. Respondents (n = 666) cared greatly about wolves but were divided over hunting wolves. Wolf conflicts, use of science in policy decisions, and maintaining a wolf population were the highest ranked concerns. Principle components analysis reduced concerns into three factors that explained 50.7% of total variance; concerns crystallized over justifications for hunting. General linear models revealed a lack of geographic influence on care, fear and support for hunting related to wolves. These findings challenge assumptions about regional differences and suggest a strong role for social identity in driving dichotomized public perceptions in wildlife management.	[Lute, Michelle L.] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Bump, Adam] Michigan Dept Nat Resources, Wildlife Div, Lansing, MI USA; [Gore, Meredith L.] Michigan State Univ, Sch Criminal Justice, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Lute, ML (corresponding author), Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA.	mlute@indiana.edu	Gore, Meredith/AAY-4350-2020	Gore, Meredith/0000-0002-2613-4715	federal Pittman-Robertson Wildlife Restoration Act grant [W-147-R]; MDNR-Wildlife Division; School of Criminal Justice at Michigan State University; Department of Fisheries Wildlife	federal Pittman-Robertson Wildlife Restoration Act grant; MDNR-Wildlife Division; School of Criminal Justice at Michigan State University; Department of Fisheries Wildlife	Support for this project was provided by the MDNR-Wildlife Division with funds from the federal Pittman-Robertson Wildlife Restoration Act grant administered by the United States Fish and Wildlife Service (W-147-R: Michigan's Statewide Wildlife Research and Restoration Program), the Department of Fisheries & Wildlife, and School of Criminal Justice at Michigan State University. Authors were independent of funders for the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS D, 1990, BRIT J SOC PSYCHOL, V29, P97, DOI 10.1111/j.2044-8309.1990.tb00892.x; [Anonymous], MICH DEP NAT RES EC; Ashforth BE, 2001, SOC IDENTITY PROCESS, P31, DOI DOI 10.4324/9781315800530; BEYER D, 2006, REV SOCIAL BIOL SCI; Bright AD, 2000, WILDLIFE SOC B, V28, P218; Brown R, 2000, EUR J SOC PSYCHOL, V30, P745, DOI 10.1002/1099-0992(200011/12)30:6<745::AID-EJSP24>3.0.CO;2-O; Bruskotter JT, 2011, SCIENCE, V333, P1828, DOI 10.1126/science.1207803; Cantrill James G., 2011, Human Dimensions of Wildlife, V16, P73, DOI 10.1080/10871209.2011.542555; Danter K J., 2010, ENV COMMUNICATION; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Dillman D.A., 2014, INTERNET PHONE MAIL, V4th ed.; Ellemers N, 2013, ACAD MANAGE REV, V29, P459; Enck JW, 2002, WILDLIFE SOC B, V30, P16; Ford J, 2013, HUM FACTORS, V55, P499, DOI 10.1177/0018720812465311; Frawley B. J., 2013, 2012 MICHIGAN FURBEA; Glikman J. A., 2010, Human Dimensions of Wildlife, V15, P347, DOI 10.1080/10871209.2010.505598; Gore ML, 2013, CONSERV LETT, V6, P430, DOI 10.1111/conl.12032; Gore ML, 2013, MICH WOLF FOR DEC 20; Grey ME, 2012, INTERPRETING SIGNIFI; GRUNIG JE, 1979, ACAD MANAGE J, V22, P738, DOI 10.2307/255812; Halpern D, 2013, COMPUT HUM BEHAV, V29, P1159, DOI 10.1016/j.chb.2012.10.008; Hogg MA, 2006, LEADERSHIP QUART, V17, P335, DOI 10.1016/j.leaqua.2006.04.007; Hornsey MJ, 2008, SOC PERSONAL PSYCHOL, V2, P204, DOI 10.1111/j.1751-9004.2007.00066.x; JACKSON JW, 1993, PSYCHOL REC, V43, P395; Jacobson CA, 2010, J WILDLIFE MANAGE, V74, P203, DOI 10.2193/2008-485; Jetten J, 2002, EUR J SOC PSYCHOL, V32, P189, DOI 10.1002/ejsp.65; Jorgensen BS, 2001, J ENVIRON PSYCHOL, V21, P233, DOI 10.1006/jevp.2001.0226; Kahan D, 2010, NATURE, V463, P296, DOI 10.1038/463296a; Kaltenborn BP, 1999, HUMAN DIMENSIONS WIL, V4, P37; Keane A, 2008, ANIM CONSERV, V11, P75, DOI 10.1111/j.1469-1795.2008.00170.x; Kellert S, 1990, PUBLIC ATTITUDES BEL; Kellon D, 2011, J ENVIRON MANAGE, V92, P363, DOI 10.1016/j.jenvman.2010.10.010; Knezevic I., 2009, Human Dimensions of Wildlife, V14, P12, DOI 10.1080/10871200802562372; KROSNICK J, 1990, POLITICAL BEHAV, V0012; Labianca G, 1998, ACAD MANAGE J, V41, P55, DOI 10.2307/256897; Leong KM, 2007, ENVIRON PRAC, V9, P195, DOI 10.1017/S1466046607070330; Lute Michelle L., 2014, Human Dimensions of Wildlife, V19, P267; Lute ML, 2013, HUMAN DIMENSIONS WOL; Madden Francine, 2004, Human Dimensions of Wildlife, V9, P247, DOI 10.1080/10871200490505675; Manfredo M.J., 2008, WHO CARES WILDLIFE, DOI 10.1007/978-0-387-77040-6_1; MERTIG AG, 2004, ATTITUDES WOLVES MIC; Michigan Dep Nat Resour, WOLF BIOL ID; Minnis DL, 1998, WILDLIFE SOC B, V26, P75; Naughton-Treves L, 2003, CONSERV BIOL, V17, P1500, DOI 10.1111/j.1523-1739.2003.00060.x; Nie M, 2003, POLICY SCI, V36, P307, DOI 10.1023/B:OLIC.0000017484.35981.b6; Nie Martin A., 2002, Ethics Place and Environment, V5, P65, DOI 10.1080/13668790220146465; Olson ER, 2014, CONSERV LETT; Oosting J., 2013, NEW MICHIGAN GROUP S; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Peyton R., 2007, MEASURING SOCIAL CAR; Press A, 2013, WOLF HUNT REFERENDUM; Rhue L, 2014, SOC NETWORKS, V36, P40, DOI 10.1016/j.socnet.2012.06.007; Rigg R, 2011, ORYX, V45, P272, DOI 10.1017/S0030605310000074; RYAN EL, 2011, HUM DIMENS WILDL, V16, P311, DOI DOI 10.1080/10871209.2011.559530; Scales IR, 2012, GEOGR J, V178, P67, DOI 10.1111/j.1475-4959.2011.00432.x; Sherif M., 1966, GROUP CONFLICT COOPE; Skogen K, 2003, SOCIOL RURALIS, V43, P309, DOI 10.1111/1467-9523.00247; Skogen K, 2001, RURAL SOCIOL, V66, P203, DOI 10.1111/j.1549-0831.2001.tb00064.x; Slagle Kristina M., 2012, Human Dimensions of Wildlife, V17, P44, DOI 10.1080/10871209.2012.633237; Spears R, 2011, HANDBOOK OF IDENTITY THEORY AND RESEARCH, VOLS 1 AND 2, P201, DOI 10.1007/978-1-4419-7988-9_9; Sponarski Carly C., 2013, Human Dimensions of Wildlife, V18, P239, DOI 10.1080/10871209.2013.792022; TAJFEL H, 1982, ANNU REV PSYCHOL, V33, P1, DOI 10.1146/annurev.ps.33.020182.000245; Tajfel H., 1979, SOCIAL PSYCHOL INTER, P33, DOI DOI 10.1016/S0065-2601(05)37005-5; Treves Adrian, 2006, Human Dimensions of Wildlife, V11, P383, DOI 10.1080/10871200600984265; Treves A, 2013, CONSERV BIOL, V27, P315, DOI 10.1111/cobi.12009; Treves A, 2009, J APPL ECOL, V46, P1350, DOI 10.1111/j.1365-2664.2009.01729.x; Treves A, 2009, CONSERV BIOL, V23, P1577, DOI 10.1111/j.1523-1739.2009.01242.x; Triezenberg Heather A., 2011, Human Dimensions of Wildlife, V16, P381, DOI 10.1080/10871209.2011.608182; TYLER TR, 1994, J PERS SOC PSYCHOL, V67, P850, DOI 10.1037/0022-3514.67.5.850; Tyler TR, 2000, INT J PSYCHOL, V35, P117, DOI 10.1080/002075900399411; Vaske J., 2008, SURVEY RES ANAL APPL; Vaske JJ, 2001, SOC NATUR RESOUR, V14, P761, DOI 10.1080/089419201753210585; Warriner GK, 1996, CANADIAN WATER RESOU, V21, P253; Webler T, 2001, ENVIRON MANAGE, V27, P435; Williamson SJ, 2008, HUM DIMENS WILDL MAN, V3, P51; Winter SC, 2001, J POLICY ANAL MANAG, V20, P675, DOI 10.1002/pam.1023; Zajac RM, 2012, J WILDLIFE MANAGE, V76, P1331, DOI 10.1002/jwmg.398	77	34	34	4	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114460	10.1371/journal.pone.0114460	http://dx.doi.org/10.1371/journal.pone.0114460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AU8TQ	25464276	gold, Green Published			2022-12-26	WOS:000345869700132
J	Nicolau, DV; Paszek, E; Fulga, F; Nicolau, DV				Nicolau, Dan V., Jr.; Paszek, Ewa; Fulga, Florin; Nicolau, Dan V.			Mapping Hydrophobicity on the Protein Molecular Surface at Atom-Level Resolution	PLOS ONE			English	Article							SPATIAL-ORGANIZATION; ORGANIC-MOLECULES; LIGAND-BINDING; FORCE-FIELD; FREE-ENERGY; K+-ATPASE; MEMBRANE; PREDICTION; RECOGNITION; EFFICIENT	A precise representation of the spatial distribution of hydrophobicity, hydrophilicity and charges on the molecular surface of proteins is critical for the understanding of the interaction with small molecules and larger systems. The representation of hydrophobicity is rarely done at atom-level, as this property is generally assigned to residues. A new methodology for the derivation of atomic hydrophobicity from any amino acid-based hydrophobicity scale was used to derive 8 sets of atomic hydrophobicities, one of which was used to generate the molecular surfaces for 35 proteins with convex structures, 5 of which, i.e., lysozyme, ribonuclease, hemoglobin, albumin and IgG, have been analyzed in more detail. Sets of the molecular surfaces of the model proteins have been constructed using spherical probes with increasingly large radii, from 1.4 to 20 angstrom, followed by the quantification of (i) the surface hydrophobicity; (ii) their respective molecular surface areas, i. e., total, hydrophilic and hydrophobic area; and (iii) their relative densities, i. e., divided by the total molecular area; or specific densities, i. e., divided by property-specific area. Compared with the amino acid-based formalism, the atom-level description reveals molecular surfaces which (i) present an approximately two times more hydrophilic areas; with (ii) less extended, but between 2 to 5 times more intense hydrophilic patches; and (iii) 3 to 20 times more extended hydrophobic areas. The hydrophobic areas are also approximately 2 times more hydrophobicity-intense. This, more pronounced "leopard skin"-like, design of the protein molecular surface has been confirmed by comparing the results for a restricted set of homologous proteins, i. e., hemoglobins diverging by only one residue (Trp37). These results suggest that the representation of hydrophobicity on the protein molecular surfaces at atom-level resolution, coupled with the probing of the molecular surface at different geometric resolutions, can capture processes that are otherwise obscured to the amino acid-based formalism.	[Nicolau, Dan V., Jr.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Paszek, Ewa; Fulga, Florin; Nicolau, Dan V.] Univ Liverpool, Dept Elect Engn & Elect, Liverpool, Merseyside, England; [Nicolau, Dan V.] McGill Univ, Dept Bioengn, Montreal, PQ, Canada	University of California System; University of California Berkeley; University of Liverpool; McGill University	Nicolau, DV (corresponding author), Univ Liverpool, Dept Elect Engn & Elect, Liverpool, Merseyside, England.	dan.nicolau@mcgill.ca		Nicolau, Dan V/0000-0002-9956-0600	Defense Advanced Research Projects Agency (DARPA) [F30602-00-2-0614]; European Union [214538]	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); European Union(European Commission)	This work has been supported by the Defense Advanced Research Projects Agency (DARPA, www.darpa.mil), under SymBioSys Program, Grant Contract No. F30602-00-2-0614); and by the European Union Seventh Framework Programme (FP7/2007-2013, http://ec.europa.eu/research/fp7/index_en.cfm) under grant agreement no. 214538 project Bio-Inspired Self-assembled Nano-Enabled Surfaces (BISNES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAHAM DJ, 1987, PROTEINS, V2, P130, DOI 10.1002/prot.340020207; Banerji A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007361; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bonvin AM, 2006, CURR OPIN STRUC BIOL, V16, P194, DOI 10.1016/j.sbi.2006.02.002; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; Bretschneider T, 2009, BIOPHYS J, V96, P2888, DOI 10.1016/j.bpj.2008.12.3942; Brockwell DJ, 2000, CURR OPIN STRUC BIOL, V10, P16, DOI 10.1016/S0959-440X(99)00043-3; Can T, 2006, J MOL GRAPH MODEL, V25, P442, DOI 10.1016/j.jmgm.2006.02.012; Caron G, 2003, MINI-REV MED CHEM, V3, P821, DOI 10.2174/1389557033487665; CASARI G, 1992, J MOL BIOL, V224, P725, DOI 10.1016/0022-2836(92)90556-Y; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; CONNOLLY ML, 1985, J APPL CRYSTALLOGR, V18, P499, DOI 10.1107/S0021889885010779; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Cozzini P, 2004, CURR MED CHEM, V11, P3093, DOI 10.2174/0929867043363929; Cristea PD, 2012, PROTEIN SURFACE ATOM, P147; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; EDELSBRUNNER H, 1994, ACM T GRAPHIC, V13, P43, DOI 10.1145/174462.156635; Efremov RG, 1999, BIOPHYS J, V76, P2448, DOI 10.1016/S0006-3495(99)77400-X; EFREMOV RG, 1992, J PROTEIN CHEM, V11, P699, DOI 10.1007/BF01024971; EFREMOV RG, 1992, J PROTEIN CHEM, V11, P665, DOI 10.1007/BF01024968; EISENBERG D, 1986, NATURE, V319, P199, DOI 10.1038/319199a0; EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303; Eyrisch S, 2009, J COMPUT AID MOL DES, V23, P73, DOI 10.1007/s10822-008-9239-y; FAUCHERE JL, 1988, J MOL GRAPHICS, V6, P203, DOI 10.1016/S0263-7855(98)80004-0; Fersht A., 1985, ENZYME STRUCTURE MEC; Gabdoulline RR, 2003, NUCLEIC ACIDS RES, V31, P3349, DOI 10.1093/nar/gkg588; Ghose AK, 1998, J PHYS CHEM A, V102, P3762, DOI 10.1021/jp980230o; GORDON EM, 1994, J MED CHEM, V37, P1385, DOI 10.1021/jm00036a001; Hawkins KR, 2007, LAB CHIP, V7, P281, DOI 10.1039/b612894g; Hessa T, 2007, NATURE, V450, P1026, DOI 10.1038/nature06387; Hooper NM, 1997, BIOCHEM J, V321, P265, DOI 10.1042/bj3210265; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Jamadagni SN, 2011, ANNU REV CHEM BIOMOL, V2, P147, DOI 10.1146/annurev-chembioeng-061010-114156; JANIN J, 1990, J BIOL CHEM, V265, P16027; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Karplus PA, 1997, PROTEIN SCI, V6, P1302; KATCHALSKIKATZIR E, 1992, P NATL ACAD SCI USA, V89, P2195, DOI 10.1073/pnas.89.6.2195; Kavanaugh JS, 1998, BIOCHEMISTRY-US, V37, P4358, DOI 10.1021/bi9708702; KAWABATA S, 1991, NATURE, V354, P476, DOI 10.1038/354476a0; Kellogg GE, 2000, EUR J MED CHEM, V35, P651, DOI 10.1016/S0223-5234(00)00167-7; KELLOGG GE, 1991, J COMPUT AID MOL DES, V5, P545, DOI 10.1007/BF00135313; Koehler J, 2009, PROTEINS, V76, P13, DOI 10.1002/prot.22315; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Langer R, 2003, AICHE J, V49, P2990, DOI 10.1002/aic.690491202; LAWRENCE CE, 1991, METHOD ENZYMOL, V202, P20; LESSER GJ, 1990, PROTEINS, V8, P6, DOI 10.1002/prot.340080104; MEEK JL, 1980, P NATL ACAD SCI-BIOL, V77, P1632, DOI 10.1073/pnas.77.3.1632; Moon CP, 2011, P NATL ACAD SCI USA, V108, P10174, DOI 10.1073/pnas.1103979108; Mukhopadhyay R, 2006, ANAL CHEM, V78, P7379, DOI 10.1021/ac069476c; Nagase K, 2009, J R SOC INTERFACE, V6, pS293, DOI 10.1098/rsif.2008.0499.focus; Nicolau DV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058896; Nicolau DV, 2006, MOL CELL BIOL, V26, P313, DOI 10.1128/MCB.26.1.313-323.2006; OOI T, 1987, P NATL ACAD SCI USA, V84, P3086, DOI 10.1073/pnas.84.10.3086; RADZICKA A, 1988, BIOCHEMISTRY-US, V27, P1664, DOI 10.1021/bi00405a042; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; Sandelin E, 2004, BIOPHYS J, V86, P23, DOI 10.1016/S0006-3495(04)74080-1; Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.0.CO;2-Y; SCHIFFER CA, 1993, MOL SIMULAT, V10, P121, DOI 10.1080/08927029308022162; SHARP KA, 1991, SCIENCE, V252, P106, DOI 10.1126/science.2011744; Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9; Takano K, 2001, BIOCHEMISTRY-US, V40, P4853, DOI 10.1021/bi002792f; VILA J, 1991, PROTEINS, V10, P199, DOI 10.1002/prot.340100305; WESSON L, 1992, PROTEIN SCI, V1, P227; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; WOLFENDEN R, 1981, BIOCHEMISTRY-US, V20, P849, DOI 10.1021/bi00507a030; Yamaotsu N, 2008, BIOL PHARM BULL, V31, P1552, DOI 10.1248/bpb.31.1552; ZAUHAR RJ, 1990, J COMPUT CHEM, V11, P603, DOI 10.1002/jcc.540110509	68	19	19	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114042	10.1371/journal.pone.0114042	http://dx.doi.org/10.1371/journal.pone.0114042			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462574	Green Published, gold			2022-12-26	WOS:000345869700086
J	Sun, Y; Yi, XP; Peng, M; Zeng, HC; Wang, D; Li, B; Tong, Z; Chang, LL; Jin, X; Wang, XC				Sun, Yong; Yi, Xiaoping; Peng, Ming; Zeng, Huicai; Wang, Dan; Li, Bo; Tong, Zheng; Chang, Lili; Jin, Xiang; Wang, Xuchu			Proteomics of Fusarium oxysporum Race 1 and Race 4 Reveals Enzymes Involved in Carbohydrate Metabolism and Ion Transport That Might Play Important Roles in Banana Fusarium Wilt	PLOS ONE			English	Article							S-ADENOSYLMETHIONINE SYNTHETASE; RICE BLAST FUNGUS; CATALASE-PEROXIDASE; FRUCTOSE-1,6-BISPHOSPHATE ALDOLASE; MAGNAPORTHE-GRISEA; EXPRESSED PROTEINS; GENE CLONING; COLONIZATION; GRAMINEARUM; INFECTION	Banana Fusarium wilt is a soil-spread fungal disease caused by Fusarium oxysporum. In China, the main virulence fungi in banana are F. oxysporum race 1 (F1, weak virulence) and race 4 (F4, strong virulence). To date, no proteomic analyses have compared the two races, but the difference in virulence between F1 and F4 might result from their differentially expressed proteins. Here we report the first comparative proteomics of F1 and F4 cultured under various conditions, and finally identify 99 protein species, which represent 59 unique proteins. These proteins are mainly involved in carbohydrate metabolism, post-translational modification, energy production, and inorganic ion transport. Bioinformatics analysis indicated that among the 46 proteins identified from F4 were several enzymes that might be important for virulence. Reverse transcription PCR analysis of the genes for 15 of the 56 proteins revealed that their transcriptional patterns were similar to their protein expression patterns. Taken together, these data suggest that proteins involved in carbohydrate metabolism and ion transport may be important in the pathogenesis of banana Fusarium wilt. Some enzymes such as catalase-peroxidase, galactosidase and chitinase might contribute to the strong virulence of F4. Overexpression or knockout of the genes for the F4-specific proteins will help us to further understand the molecular mechanism of Fusarium-induced banana wilt.	[Sun, Yong; Yi, Xiaoping; Peng, Ming; Zeng, Huicai; Wang, Dan; Li, Bo; Tong, Zheng; Chang, Lili; Jin, Xiang; Wang, Xuchu] Chinese Acad Trop Agr Sci Haikou City, Inst Trop Biosci & Biotechnol, Minist Agr, Key Lab Trop Crop Biotechnol, Haikou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs	Peng, M (corresponding author), Chinese Acad Trop Agr Sci Haikou City, Inst Trop Biosci & Biotechnol, Minist Agr, Key Lab Trop Crop Biotechnol, Haikou, Hainan, Peoples R China.	mmpeng_2000@yahoo.com; xchwanghainan@163.com	Wang, Xuchu/E-7133-2016	Wang, Xuchu/0000-0003-3137-4390	Agro-scientific Research in Public Interest [200903049-02]; Major Technology Project of Hainan [ZDZX2013023-1]; National Natural Science Foundation [31000291, 31270712]; Grant for Top Young Talents in CATAS [ITBB130102]	Agro-scientific Research in Public Interest; Major Technology Project of Hainan; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Grant for Top Young Talents in CATAS	This work was supported by the Agro-scientific Research in Public Interest (No. 200903049-02), the Major Technology Project of Hainan (No. ZDZX2013023-1), the National Natural Science Foundation (No. 31000291; 31270712), and the Grant for Top Young Talents in CATAS (No. ITBB130102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amalfitano C, 2002, PHYTOCHEM ANALYSIS, V13, P277, DOI 10.1002/pca.648; Asano K, 2012, BIOCHIMIE, V94, P1291, DOI 10.1016/j.biochi.2012.02.026; Garcia-Sanchez MA, 2010, FUNGAL GENET BIOL, V47, P216, DOI 10.1016/j.fgb.2009.11.006; Caracuel Z, 2003, MOL MICROBIOL, V48, P765, DOI 10.1046/j.1365-2958.2003.03465.x; [陈石 Chen Shi], 2011, [热带作物学报, Chinese Journal of Tropical Crops], V32, P1503; Chivasa S, 2006, J EXP BOT, V57, P1553, DOI 10.1093/jxb/erj149; Dita MA, 2010, PLANT PATHOL, V59, P348, DOI 10.1111/j.1365-3059.2009.02221.x; DIXON RA, 1994, ANNU REV PHYTOPATHOL, V32, P479, DOI 10.1146/annurev.py.32.090194.002403; Dong ZY, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-51; Gastebois A, 2010, EUKARYOT CELL, V9, P1294, DOI 10.1128/EC.00107-10; Gerke J, 2012, FUNGAL GENET BIOL, V49, P443, DOI 10.1016/j.fgb.2012.04.003; Getha K, 2002, J IND MICROBIOL BIOT, V28, P303, DOI [10.1038/sj/jim/7000247, 10.1038/sj.jim.7000247]; [郭立佳 GUO LiJia], 2007, [生物技术, Biotechnology], V17, P1; Hilti N, 2000, YEAST, V16, P1; Inoue I, 2002, PLANT CELL, V14, P1869, DOI 10.1105/tpc.002576; Iozzo RV, 1998, ANNU REV BIOCHEM, V67, P609, DOI 10.1146/annurev.biochem.67.1.609; Keller T, 1998, PLANT CELL, V10, P255, DOI 10.1105/tpc.10.2.255; Kim HS, 2011, MOL PLANT MICROBE IN, V24, P719, DOI 10.1094/MPMI-11-10-0267; Kim ST, 2004, PROTEOMICS, V4, P3579, DOI 10.1002/pmic.200400969; Labroussaa F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017357; Lan X, 2008, BIOSCI BIOTECH BIOCH, V72, P492, DOI 10.1271/bbb.70573; Larriba E, 2012, CAN J MICROBIOL, V58, P815, DOI [10.1139/w2012-054, 10.1139/W2012-054]; Lee HS, 2008, TOXICON, V51, P1178, DOI 10.1016/j.toxicon.2008.02.002; Li C, 2011, CATAL TODAY, V175, P1, DOI 10.1016/j.cattod.2011.08.002; Li Chi, 2010, Journal of Fruit Science, V27, P969; Li ChunYu, 2011, Acta Horticulturae Sinica, V38, P2092; Lin Fei, 2010, Genomics and Applied Biology, V29, P314; Macomber L, 2011, MOL MICROBIOL, V82, P1291, DOI 10.1111/j.1365-2958.2011.07891.x; Marin S, 1998, INT J FOOD MICROBIOL, V42, P185, DOI 10.1016/S0168-1605(98)00077-4; Moretti M, 2010, PROTEOMICS, V10, P3292, DOI 10.1002/pmic.200900716; Morita H, 2012, APPL ENVIRON MICROB, V78, P8154, DOI 10.1128/AEM.01601-12; Morita H, 2011, BIOSCI BIOTECH BIOCH, V75, P662, DOI 10.1271/bbb.100749; Mouyna I, 2005, MOL MICROBIOL, V56, P1675, DOI 10.1111/j.1365-2958.2005.04654.x; OCHI K, 1982, J BACTERIOL, V152, P400; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Pigosso LL, 2013, FUNGAL GENET BIOL, V60, P87, DOI 10.1016/j.fgb.2013.07.008; Ploetz RC, 2006, PHYTOPATHOLOGY, V96, P653, DOI 10.1094/PHYTO-96-0653; Prados-Rosales R, 2009, PROTEOMICS, V9, P4755, DOI 10.1002/pmic.200800950; [齐兴柱 Qi Xingzhu], 2012, [中国农学通报, Chinese Agricultural Science Bulletin], V28, P163; Rampitsch C, 2010, PROTEOMICS, V10, P124, DOI 10.1002/pmic.200800399; Rodaki A, 2006, EUKARYOT CELL, V5, P1371, DOI 10.1128/EC.00115-06; Sagaram US, 2007, MICROBIOL-SGM, V153, P2850, DOI 10.1099/mic.0.2007/007708-0; Singhal N, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-14; Smulevich G, 2006, J INORG BIOCHEM, V100, P568, DOI 10.1016/j.jinorgbio.2006.01.033; [孙勇 Sun Yong], 2012, [中国农学通报, Chinese Agricultural Science Bulletin], V28, P211; [孙勇 Sun Yong], 2012, [热带作物学报, Chinese Journal of Tropical Crops], V33, P759; Takaya N, 1998, MICROBIOL-SGM, V144, P2647, DOI 10.1099/00221287-144-9-2647; Tanabe S, 2011, MOL PLANT MICROBE IN, V24, P163, DOI 10.1094/MPMI-07-10-0175; Tanabe S, 2009, PHYSIOL PLANTARUM, V137, P148, DOI 10.1111/j.1399-3054.2009.01272.x; Taylor RD, 2008, PROTEOMICS, V8, P2256, DOI 10.1002/pmic.200700610; Van den Berg N, 2007, MOL PLANT PATHOL, V8, P333, DOI 10.1111/J.1364-3703.2007.00389.X; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Wang S, 2005, MOL MICROBIOL, V58, P791, DOI 10.1111/j.1365-2958.2005.04864.x; Wang XC, 2007, ELECTROPHORESIS, V28, P3976, DOI 10.1002/elps.200600805; Wang XC, 2012, ELECTROPHORESIS, V33, P296, DOI 10.1002/elps.201100300; Wang XC, 2009, J PROTEOME RES, V8, P3331, DOI 10.1021/pr801083a; WURSTER B, 1972, FEBS LETT, V23, P341, DOI 10.1016/0014-5793(72)80311-9; Yan SP, 2006, MOL CELL PROTEOMICS, V5, P484, DOI 10.1074/mcp.M500251-MCP200; Yang Y, 2011, CHIN J TROP CROPS, V3, P94; Zamocky M, 2007, J BIOL INORG CHEM, V12, pS97; Zamocky M, 2012, BIOCHIMIE, V94, P673, DOI 10.1016/j.biochi.2011.09.020; Zhang H, 2012, J PROTEOME RES, V11, P49, DOI 10.1021/pr200861w; Zhang SZ, 2011, APPL ENVIRON MICROB, V77, P2676, DOI 10.1128/AEM.02747-10	63	14	14	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113818	10.1371/journal.pone.0113818	http://dx.doi.org/10.1371/journal.pone.0113818			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460190	Green Published, Green Submitted, gold			2022-12-26	WOS:000345869700057
J	Wettersten, HI; Landesman, Y; Friedlander, S; Shacham, S; Kauffman, M; Weiss, RH				Wettersten, Hiromi I.; Landesman, Yosef; Friedlander, Sharon; Shacham, Sharon; Kauffman, Michael; Weiss, Robert H.			Specific Inhibition of the Nuclear Exporter Exportin-1 Attenuates Kidney Cancer Growth	PLOS ONE			English	Article							RENAL-CELL CARCINOMA; P21 EXPRESSION; RESISTANCE; CRM1; IDENTIFICATION; TARGETS; PROTEIN	Purpose: Despite the advent of FDA-approved therapeutics to a limited number of available targets (kinases and mTOR), PFS of kidney cancer (RCC) has been extended only one to two years due to the development of drug resistance. Here, we evaluate a novel therapeutic for RCC which targets the exportin-1 (XPO1) inhibitor. Materials and Methods: RCC cells were treated with the orally available XPO1 inhibitor, KPT-330, and cell viability and Annexin V (apoptosis) assays, and cell cycle analyses were performed to evaluate the efficacy of KPT-330 in two RCC cell lines. Immunoblotting and immunofluorescence analysis were performed to validate mechanisms of XPO1 inhibition. The efficacy and on-target effects of KPT-330 were further analyzed in vivo in RCC xenograft mice, and KPT-330-resistant cells were established to evaluate potential mechanisms of KPT-330 resistance. Results: KPT-330 attenuated RCC viability through growth inhibition and apoptosis induction both in vitro and in vivo, a process in which increased nuclear localization of p21 by XPO1 inhibition played a major role. In addition, KPT-330 resistant cells remained sensitive to the currently approved for RCC multi-kinase inhibitors (sunitinib, sorafenib) and mTOR inhibitors (everolimus, temsirolimus), suggesting that these targeted therapeutics would remain useful as second line therapeutics following KPT-330 treatment. Conclusion: The orally-available XPO1 inhibitor, KPT-330, represents a novel target for RCC whose in vivo efficacy approaches that of sunitinib. In addition, cells resistant to KPT-330 retain their ability to respond to available RCC therapeutics suggesting a novel approach for treatment in KPT-330-naive as well as -resistant RCC patients.	[Wettersten, Hiromi I.; Weiss, Robert H.] Univ Calif Davis, Dept Internal Med, Div Nephrol, Davis, CA 95616 USA; [Weiss, Robert H.] Univ Calif Davis, Ctr Canc, Davis, CA 95616 USA; [Landesman, Yosef; Friedlander, Sharon; Shacham, Sharon; Kauffman, Michael] Karyopharm Therapeut Inc, Natick, MA USA; [Weiss, Robert H.] Sacramento VA Med Ctr, Med Serv, Sacramento, CA USA	University of California System; University of California Davis; University of California System; University of California Davis	Weiss, RH (corresponding author), Univ Calif Davis, Dept Internal Med, Div Nephrol, Davis, CA 95616 USA.	rhweiss@ucdavis.edu			National Institutes of Health [5UO1CA86402, 1R01CA135401-01A1, 1R01DK082690-01A1]; Karyopharm Therapeutics; NATIONAL CANCER INSTITUTE [U01CA086402, P30CA093373, R01CA135401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082690] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Karyopharm Therapeutics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health grants 5UO1CA86402, 1R01CA135401-01A1, and 1R01DK082690-01A1 and by Karyopharm Therapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asada M, 1999, EMBO J, V18, P1223, DOI 10.1093/emboj/18.5.1223; Cowey CL, 2010, CLIN ADV HEMATOL ONC, V8, P357; Dong Y, 2004, CELL SIGNAL, V16, P263, DOI 10.1016/S0898-6568(03)00136-0; Huang WY, 2009, CLIN INVEST MED, V32, pE315; Inoue H, 2011, CANC BIOL THERAPY, V12; Inoue H, 2013, J UROLOGY, V189, P2317, DOI 10.1016/j.juro.2012.10.018; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Koster R, 2010, J CLIN INVEST, V120, P3594, DOI 10.1172/JCI41939; Ljungberg B, 2011, EUR UROL, V60, P615, DOI 10.1016/j.eururo.2011.06.049; Makhov PB, 2012, MOL CANCER THER, V11, P1510, DOI 10.1158/1535-7163.MCT-11-0907; Naniwa J, 2003, CANCER SCI, V94, P1099, DOI 10.1111/j.1349-7006.2003.tb01406.x; Nelson EC, 2007, CANCER TREAT REV, V33, P299, DOI 10.1016/j.ctrv.2006.12.005; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Senapedis WT, 2014, SEMIN CANCER BIOL, V27, P74, DOI 10.1016/j.semcancer.2014.04.005; Shen AG, 2009, NEUROSURGERY, V65, P153, DOI 10.1227/01.NEU.0000348550.47441.4B; Suzuki A, 2000, CELL DEATH DIFFER, V7, P721, DOI 10.1038/sj.cdd.4400706; Turner JG, 2008, CURR MED CHEM, V15, P2648, DOI 10.2174/092986708786242859; Waldman T, 1996, NATURE, V381, P713, DOI 10.1038/381713a0; Weiss RH, 2006, KIDNEY INT, V69, P224, DOI 10.1038/sj.ki.5000065; Weiss RH, 2007, J UROLOGY, V177, P63, DOI 10.1016/j.juro.2006.08.073; Wettersten HI, 2013, NAT REV UROL, V10, P336, DOI 10.1038/nrurol.2013.52; Winters ZE, 2001, EUR J CANCER, V37, P2405, DOI 10.1016/S0959-8049(01)00327-6	22	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113867	10.1371/journal.pone.0113867	http://dx.doi.org/10.1371/journal.pone.0113867			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461627	gold, Green Submitted, Green Published			2022-12-26	WOS:000345869700062
J	Tait, LW; Hawes, I; Schiel, DR				Tait, Leigh W.; Hawes, Ian; Schiel, David R.			Shining Light on Benthic Macroalgae: Mechanisms of Complementarity in Layered Macroalgal Assemblages	PLOS ONE			English	Article							KELP FORESTS; PHYTOPLANKTON COMMUNITIES; BIODIVERSITY EXPERIMENTS; NICHE COMPLEMENTARITY; PRIMARY PRODUCTIVITY; DIVERSITY; ECOSYSTEM; PHOTOSYNTHESIS; CANOPY; PERFORMANCE	Phototrophs underpin most ecosystem processes, but to do this they need sufficient light. This critical resource, however, is compromised along many marine shores by increased loads of sediments and nutrients from degraded inland habitats. Increased attenuation of total irradiance within coastal water columns due to turbidity is known to reduce species' depth limits and affect the taxonomic structure and architecture of algal-dominated assemblages, but virtually no attention has been paid to the potential for changes in spectral quality of light energy to impact production dynamics. Pioneering studies over 70 years ago showed how different pigmentation of red, green and brown algae affected absorption spectra, action spectra, and photosynthetic efficiency across the PAR (photosynthetically active radiation) spectrum. Little of this, however, has found its way into ecological syntheses of the impacts of optically active contaminants on coastal macroalgal communities. Here we test the ability of macroalgal assemblages composed of multiple functional groups (including representatives from the chlorophyta, rhodophyta and phaeophyta) to use the total light resource, including different light wavelengths and examine the effects of suspended sediments on the penetration and spectral quality of light in coastal waters. We show that assemblages composed of multiple functional groups are better able to use light throughout the PAR spectrum. Macroalgal assemblages with four sub-canopy species were between 50-75% more productive than assemblages with only one or two sub-canopy species. Furthermore, attenuation of the PAR spectrum showed both a loss of quanta and a shift in spectral distribution with depth across coastal waters of different clarity, with consequences to productivity dynamics of diverse layered assemblages. The processes of light complementarity may help provide a mechanistic understanding of how altered turbidity affects macroalgal assemblages in coastal waters, which are increasingly threatened by diminishing light quantity and altered spectral distributions through sedimentation and eutrophication.	[Tait, Leigh W.; Schiel, David R.] Univ Canterbury, Sch Biol Sci, Marine Ecol Res Grp, Christchurch 1, New Zealand; [Tait, Leigh W.] Natl Inst Water & Atmosphere, Christchurch, New Zealand; [Hawes, Ian] Univ Canterbury, Christchurch 1, New Zealand	University of Canterbury; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; University of Canterbury	Tait, LW (corresponding author), Univ Canterbury, Sch Biol Sci, Marine Ecol Res Grp, Christchurch 1, New Zealand.	leigh.tait@niwa.co.nz		Hawes, Ian/0000-0003-2471-6903; Tait, Leigh/0000-0001-9153-139X	New Zealand Foundation for Research Science and Technology (Coasts and Oceans OBI); National Institute of Water & Atmosphere (NIWA) under the Coasts and Oceans Research Program 4- Marine Biosecurity	New Zealand Foundation for Research Science and Technology (Coasts and Oceans OBI)(New Zealand Foundation for Research, Science and Technology); National Institute of Water & Atmosphere (NIWA) under the Coasts and Oceans Research Program 4- Marine Biosecurity	The research was funded by the New Zealand Foundation for Research Science and Technology (Coasts and Oceans OBI), the National Institute of Water & Atmosphere (NIWA) under the Coasts and Oceans Research Program 4- Marine Biosecurity (2013-2014 SCI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Airoldi L, 1998, ECOLOGY, V79, P2759, DOI 10.1890/0012-9658(1998)079[2759:RODSSA]2.0.CO;2; Airoldi L, 2008, J EXP MAR BIOL ECOL, V366, P8, DOI 10.1016/j.jembe.2008.07.034; Anthony KRN, 2004, LIMNOL OCEANOGR, V49, P2201, DOI 10.4319/lo.2004.49.6.2201; Babin M, 2003, LIMNOL OCEANOGR, V48, P843, DOI 10.4319/lo.2003.48.2.0843; Behl S, 2011, LIMNOL OCEANOGR, V56, P683, DOI 10.4319/lo.2011.56.2.0683; Behrenfeld MJ, 1997, OCEANOGRAPHY, V42; Binzer T, 2005, MAR ECOL PROG SER, V287, P65, DOI 10.3354/meps287065; Binzer T, 2002, MAR ECOL PROG SER, V235, P53, DOI 10.3354/meps235053; Binzer T, 2006, LIMNOL OCEANOGR, V51, P2722, DOI 10.4319/lo.2006.51.6.2722; Bischof K, 2006, MAR ECOL PROG SER, V306, P165, DOI 10.3354/meps306165; Bracken MES, 2008, P NATL ACAD SCI USA, V105, P924, DOI 10.1073/pnas.0704103105; Bracken MES, 2006, ECOLOGY, V87, P2397, DOI 10.1890/0012-9658(2006)87[2397:SDENUV]2.0.CO;2; BRICAUD A, 1995, J GEOPHYS RES-OCEANS, V100, P13321, DOI 10.1029/95JC00463; Bruno JF, 2005, ECOL LETT, V8, P1165, DOI 10.1111/j.1461-0248.2005.00823.x; Cardinale BJ, 2011, AM J BOT, V98, P572, DOI 10.3732/ajb.1000364; Connell SD, 2005, MAR ECOL PROG SER, V289, P53, DOI 10.3354/meps289053; Connell SD, 2008, MAR ECOL PROG SER, V360, P63, DOI 10.3354/meps07526; DRING MJ, 1981, LIMNOL OCEANOGR, V26, P271, DOI 10.4319/lo.1981.26.2.0271; Emerson R, 1959, PLANT PHYSIOL, P477; ENRIQUEZ S, 1994, OECOLOGIA, V98, P121, DOI 10.1007/BF00341462; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; French CS, 1952, J GEN PHYSIOL, P873; Gollety C, 2008, J PHYCOL, V44, P1146, DOI 10.1111/j.1529-8817.2008.00569.x; Gorman D, 2009, ECOL APPL, V19, P1114, DOI 10.1890/08-0831.1; Griffin JN, 2009, OIKOS, V118, P37, DOI 10.1111/j.1600-0706.2008.16960.x; Grime JP, 2002, J VEG SCI, V13, P457, DOI 10.1111/j.1654-1103.2002.tb02072.x; Harrer SL, 2013, J PHYCOL, V49, P248, DOI 10.1111/jpy.12023; HAXO FT, 1950, J GEN PHYSIOL, V33, P389, DOI 10.1085/jgp.33.4.389; Hector A, 1998, OIKOS, V82, P597, DOI 10.2307/3546380; Hector A, 2002, ECOL LETT, V5, P502, DOI 10.1046/j.1461-0248.2002.00337.x; Hedley JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111454; Jenkins SR, 2004, J MAR BIOL ASSOC UK, V84, P327, DOI 10.1017/S0025315404009221h; Kahmen A, 2006, ECOLOGY, V87, P1244, DOI 10.1890/0012-9658(2006)87[1244:NCFNAE]2.0.CO;2; KAUTSKY N, 1986, MAR ECOL PROG SER, V28, P1, DOI 10.3354/meps028001; Kawana K, 1975, B FACULTY FISHERIES, V26, P235; Kirk J.T.O., 1994, LIGHT PHOTOSYNTHESIS; Lilley SA, 2006, OECOLOGIA, V148, P672, DOI 10.1007/s00442-006-0411-6; Ling SD, 2008, OECOLOGIA, V156, P883, DOI 10.1007/s00442-008-1043-9; Loreau M, 1998, P NATL ACAD SCI USA, V95, P5632, DOI 10.1073/pnas.95.10.5632; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Loreau M, 2001, SCIENCE, V294, P804, DOI 10.1126/science.1064088; LUNING K, 1985, MAR BIOL, V87, P119, DOI 10.1007/BF00539419; Mangialajo L, 2008, MAR ECOL PROG SER, V358, P63, DOI 10.3354/meps07400; Miller RJ, 2012, OECOLOGIA, V168, P797, DOI 10.1007/s00442-011-2143-5; Miller RJ, 2011, LIMNOL OCEANOGR, V56, P119, DOI 10.4319/lo.2011.56.1.0119; NAEEM S, 1994, NATURE, V368, P734, DOI 10.1038/368734a0; Perkol-Finkel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010791; Rabalais NN, 2009, ICES J MAR SCI, V66, P1528, DOI 10.1093/icesjms/fsp047; Reed DC, 2011, ECOLOGY, V92, P2108, DOI 10.1890/11-0377.1; REED DC, 1984, ECOLOGY, V65, P937, DOI 10.2307/1938066; Schiel DR, 2007, MAR ECOL PROG SER, V339, P1, DOI 10.3354/meps339001; Schiel DR, 2006, J EXP MAR BIOL ECOL, V338, P233, DOI 10.1016/j.jembe.2006.06.023; Schiel DR, 2011, J EXP MAR BIOL ECOL, V400, P33, DOI 10.1016/j.jembe.2011.02.026; Schiel DR, 2006, J EXP MAR BIOL ECOL, V331, P158, DOI 10.1016/j.jembe.2005.10.015; Stachowicz JJ, 2008, P NATL ACAD SCI USA, V105, P18842, DOI 10.1073/pnas.0806425105; Stomp M, 2004, NATURE, V432, P104, DOI 10.1038/nature03044; Stomp M, 2007, ECOL LETT, V10, P290, DOI 10.1111/j.1461-0248.2007.01026.x; Striebel M, 2009, AM NAT, V174, P141, DOI 10.1086/599294; Striebel M, 2009, ECOLOGY, V90, P2025, DOI 10.1890/08-1409.1; Tait LW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026986; Tait LW, 2011, MAR ECOL PROG SER, V421, P97, DOI 10.3354/meps08909; Tait LW, 2010, MAR ECOL PROG SER, V416, P115, DOI 10.3354/meps08781; Tilman D, 1997, ECOLOGY, V78, P81, DOI 10.1890/0012-9658(1997)078[0081:CIRLAG]2.0.CO;2; Turnbull MH, 2003, FUNCT ECOL, V17, P101, DOI 10.1046/j.1365-2435.2003.00713.x; Valdivia N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036541; Vojtech E, 2008, OIKOS, V117, P1351, DOI 10.1111/j.0030-1299.2008.16700.x; Walsby AE, 1997, NEW PHYTOL, V136, P189, DOI 10.1046/j.1469-8137.1997.00736.x; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P7, DOI 10.1016/j.jembe.2011.02.021; Yachi S, 2007, ECOL LETT, V10, P54, DOI 10.1111/j.1461-0248.2006.00994.x	70	22	22	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114146	10.1371/journal.pone.0114146	http://dx.doi.org/10.1371/journal.pone.0114146			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438045	Green Submitted, Green Published, gold			2022-12-26	WOS:000347114900125
J	Eberle, CA; Forcella, F; Gesch, R; Weyers, S; Peterson, D; Eklund, J				Eberle, Carrie A.; Forcella, Frank; Gesch, Russ; Weyers, Sharon; Peterson, Dean; Eklund, James			Flowering Dynamics and Pollinator Visitation of Oilseed Echium (Echium plantagineum)	PLOS ONE			English	Article							PYRROLIZIDINE ALKALOIDS; HONEY-BEES; NECTAR; HABITAT; POLLEN	Echium (Echium plantagineum L.) is an alternative oilseed crop in summer-wet temperate regions that provides floral resources to pollinators. Its seed oil is rich in omega-3 fatty acids, such as stearidonic acid, which is desired highly by the cosmetic industry. Seeds were sown in field plots over three years in western Minnesota in spring (early-sown) or early summer (late-sown), and flower abundance, pollinator visitation, and seed yields were studied. Initial flowering commenced 41 to 55 d after sowing, and anthesis duration (first flowering to harvest) was 34 to 70 d. Late sowing dates delayed anthesis, but increased the intensity of visitation by pollinators. Cumulative flower densities ranged from 1 to 4.5 billion ha(-1). Flowers attracted numerous honey bees (Apis mellifera L.), as many as 35 per minute of observation, which represented about 50% of all insect visitors. Early-sown echium produced seed yields up to 750 kg ha(-1), which were 2-29 times higher than those of late-sown echium. Early sowing of echium in Minnesota provides abundant floral resources for pollinators for up to two months and simultaneously produces seed yields whose profits rival those of corn (Zea mays L.).	[Eberle, Carrie A.; Forcella, Frank; Gesch, Russ; Weyers, Sharon; Peterson, Dean; Eklund, James] ARS, USDA, N Cent Soil Conservat Res Lab, Morris, MN 56267 USA	United States Department of Agriculture (USDA)	Eberle, CA (corresponding author), ARS, USDA, N Cent Soil Conservat Res Lab, Morris, MN 56267 USA.	carrie.eberle@ars.usda.gov	Weyers, Sharon/ABA-6454-2020	Weyers, Sharon/0000-0003-3873-7748	USDA-National Institute of Food and Agriculture (NIFA) [2012-67009-20272]; ARS [ARS-0425705] Funding Source: Federal RePORTER	USDA-National Institute of Food and Agriculture (NIFA); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported through the USDA-National Institute of Food and Agriculture (NIFA) award 2012-67009-20272. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australia New Zealand Food Authority, 2001, TECH REP SER ANZFA, V2; Berti M, 2004, ECHIUM E VULGARE E P; Berti M., 2007, ISSUES NEW CROPS NEW, P120; Boppre M, 2008, J AGR FOOD CHEM, V56, P5662, DOI 10.1021/jf800568u; Brodschneider R, 2010, APIDOLOGIE, V41, P278, DOI 10.1051/apido/2010012; BURDON JJ, 1988, BIOL J LINN SOC, V34, P81, DOI 10.1111/j.1095-8312.1988.tb01949.x; Corbet SA, 2003, APIDOLOGIE, V34, P1, DOI 10.1051/apido:2002049; CORBET SA, 1984, AUST J ECOL, V9, P125, DOI 10.1111/j.1442-9993.1984.tb01351.x; Corbet SA, 2001, ANN BOT-LONDON, V87, P219, DOI 10.1006/anbo.2000.1322; Cullen JM, 1984, P 6 INT S BIOL CONTR, P249; CULVENOR CCJ, 1981, J AGR FOOD CHEM, V29, P958, DOI 10.1021/jf00107a018; DAVIS AR, 1992, J APICULT RES, V31, P83, DOI 10.1080/00218839.1992.11101267; Decourtye A., 2011, ECOSYSTEMS BIODIVERS, DOI [10.5772/24523, DOI 10.5772/24523]; ERICKSON EH, 1975, CROP SCI, V15, P84, DOI 10.2135/cropsci1975.0011183X001500010025x; Gray DA, 2010, EUR J LIPID SCI TECH, V112, P741, DOI 10.1002/ejlt.200900280; Groeneveld JH, 2014, GCB BIOENERGY, V6, P242, DOI 10.1111/gcbb.12122; Guil-Guerrero JL, 2007, EUR J LIPID SCI TECH, V109, P1226, DOI 10.1002/ejlt.200700207; HOOPER PT, 1977, AUST VET J, V53, P109, DOI 10.1111/j.1751-0813.1977.tb00129.x; Huang Z, 2010, AM BEE J, V150, P773; JIANG HF, 1993, AGRON J, V85, P221, DOI 10.2134/agronj1993.00021962008500020011x; Mathieson S., 1988, Australasian Beekeeper, V90, P208; McGregor SE, 1976, AGR HDB, V496, P275; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; NNFCC, 2009, ECH CROP FACT SHEET; PIGGIN CM, 1982, J AUST I AGR SCI, V48, P3; PIGGIN CM, 1978, WEED RES, V18, P83, DOI 10.1111/j.1365-3180.1978.tb01140.x; Rader R, 2012, J APPL ECOL, V49, P126, DOI 10.1111/j.1365-2664.2011.02066.x; Rempel R.S., 2009, TRANSECT POINT DENSI; Rempel RS, 2012, CAN J FOREST RES, V42, P2052, DOI 10.1139/x2012-146; Rosa AD, 2011, SCI AGR, V68, P255, DOI 10.1590/S0103-90162011000200018; SEVERSON DW, 1984, ENVIRON ENTOMOL, V13, P1091, DOI 10.1093/ee/13.4.1091; Standifer L.N., 1977, ANN ENTOMOL SOC AM, V70, P691; Technology Crops International, 2010, TECHN CROPS GUID GRO; Vivarelli D, 2007, THESIS U BOLOGNA ITA, P106	34	10	10	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113556	10.1371/journal.pone.0113556	http://dx.doi.org/10.1371/journal.pone.0113556			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427071	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400064
J	Hone, DWE; Farke, AA; Watabe, M; Shigeru, S; Tsogtbaatar, K				Hone, David W. E.; Farke, Andrew A.; Watabe, Mahito; Shigeru, Suzuki; Tsogtbaatar, Khishigjav			A New Mass Mortality of Juvenile Protoceratops and Size-Segregated Aggregation Behaviour in Juvenile Non-Avian Dinosaurs	PLOS ONE			English	Article							SOCIAL-BEHAVIOR; LIFE-HISTORY; SEXUAL-MATURITY; RELATIVE GROWTH; EVOLUTION; GREGARIOUSNESS; NEOCERATOPSIA; PALEOECOLOGY; PATTERNS; MONGOLIA	Background: Monodominant bonebeds are a relatively common occurrence for non-avian dinosaurs, and have been used to infer associative, and potentially genuinely social, behavior. Previously known assemblages are characterized as either mixed size-classes (juvenile and adult-sized specimens together) or single size-classes of individuals (only juveniles or only adult-sized individuals within the assemblage). In the latter case, it is generally unknown if these kinds of size-segregated aggregations characterize only a particular size stage or represent aggregations that happened at all size stages. Ceratopsians ("horned dinosaurs'') are known from both types of assemblages. Methods/Principal Findings: Here we describe a new specimen of the ceratopsian dinosaur Protoceratops andrewsi, Granger and Gregory 1923 from Mongolia representing an aggregation of four mid-sized juvenile animals. In conjunction with existing specimens of groups of P. andrewsi that includes size-clustered aggregations of young juveniles and adult-sized specimens, this new material provides evidence for some degree of size-clustered aggregation behaviour in Protoceratops throughout ontogeny. This continuity of size-segregated (and presumably age-clustered) aggregation is previously undocumented in non-avian dinosaurs. Conclusions: The juvenile group fills a key gap in the available information on aggregations in younger ceratopsians. Although we support the general hypothesis that many non-avian dinosaurs were gregarious and even social animals, we caution that evidence for sociality has been overstated and advocate a more conservative interpretation of some data of 'sociality' in dinosaurs.	[Hone, David W. E.] Univ Bristol, Sch Earth Sci, Bristol, Avon, England; [Hone, David W. E.] Queen Mary Univ London, Sch Biol & Chem Sci, London, England; [Farke, Andrew A.] Raymond M Alf Museum Paleontol, Claremont, CA USA; [Watabe, Mahito; Shigeru, Suzuki] Hayashibara Museum Nat Sci, Okayama, Japan; [Tsogtbaatar, Khishigjav] Mongolian Acad Sci, Paleontol Ctr, Ulaanbaatar, Mongolia	University of Bristol; University of London; Queen Mary University London; Mongolian Academy of Sciences	Hone, DWE (corresponding author), Univ Bristol, Sch Earth Sci, Bristol, Avon, England.	dwe_hone@yahoo.com	Benton, Michael J/A-5639-2008	Benton, Michael J/0000-0002-4323-1824; Farke, Andrew/0000-0002-6930-2002	National Environmental Research Council (NERC), United Kingdom [NE/I027630/1]; NERC [NE/I027630/1] Funding Source: UKRI; Natural Environment Research Council [NE/I027630/1] Funding Source: researchfish	National Environmental Research Council (NERC), United Kingdom; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This research was supported by National Environmental Research Council (NERC), United Kingdom grant NE/I027630/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcock J, 1989, ANIMAL BEHAV EVOLUTI, P483; Anders AD, 1997, CONSERV BIOL, V11, P698, DOI 10.1046/j.1523-1739.1997.95526.x; Auffenberg W., 1981, BEHAV ECOLOGY KOMODO, P406; BEKOFF M, 1984, ANNU REV ECOL SYST, V15, P191, DOI 10.1146/annurev.es.15.110184.001203; Bertram BCR, 1995, SERENGETI DYNAMICS E, P221; BRATTSTROM BH, 1974, AM ZOOL, V14, P35; Brown B., 1940, Annals of the New York Academy of Sciences, V40, P133; BURGHARDT GM, 1977, SCIENCE, V195, P689, DOI 10.1126/science.195.4279.689; Burton R, 1985, BIRD BEHAV, P224; Campione NE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025186; Caro T., 1994, CHEETAHS SERENGETI P, P500; Carpenter K, 1999, EGGS NESTS BABY DINO, P338; Chinnery B, 2004, J VERTEBR PALEONTOL, V24, P572, DOI 10.1671/0272-4634(2004)024[0572:DOPPGE]2.0.CO;2; Colbert E. H, 1989, MUSEUM NO ARIZONA B, V57, P1; Cooper LN, 2008, P ROY SOC B-BIOL SCI, V275, P2609, DOI 10.1098/rspb.2008.0912; Costa JT, 1996, ANN ZOOL FENN, V42, P559; Currie PJ, 2011, ACTA PALAEONTOL POL, V56, P489, DOI 10.4202/app.2010.0055; Currie PJ, 2000, GAIA, V15, P217; DERUITER JR, 1986, BEHAVIOUR, V98, P240, DOI 10.1163/156853986X00982; DODSON P, 1976, J PALEONTOL, V50, P929; Dodson P, 2004, DINOSAURIA, 2ND EDITION, P494; Doody JS, 2013, ETHOLOGY, V119, P95, DOI 10.1111/eth.12047; Eberth DA, 2010, NEW PERSPECTIVES HOR, P447; Erickson GM, 2007, BIOL LETTERS, V3, P558, DOI 10.1098/rsbl.2007.0254; Estes R, 1991, BEHAV GUIDE AFRICAN, P80; Evans R.M., 1980, Behavior of Marine Animals, V4, P271; Farke AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004252; Fastovsky DE, 2011, J PALEONTOL, V85, P1035; Fastovsky DE, 1997, PALAIOS, V12, P59, DOI 10.2307/3515294; Faulkes Chris G., 2007, P427; FORSTER CA, 1990, J PALEONTOL, V64, P164, DOI 10.1017/S0022336000042402; Garrison JR, 2007, CRETACEOUS RES, V28, P461, DOI 10.1016/j.cretres.2006.07.007; Gates TA, 2005, PALAIOS, V20, P363, DOI 10.2110/palo.2003.p03-22; Gilmore, 1917, US GEOLOGICAL SURVEY, V103, P1; Granger W., 1923, American Museum Novitates, VNo. 72, P1; Handa N, 2012, PALEONTOL RES, V16, P179, DOI 10.2517/1342-8144-16.3.179; Hone DWE, 2014, J ZOOL, V292, P260, DOI 10.1111/jzo.12114; Hone David W.E., 2014, P524; Hone DWE, 2012, LETHAIA, V45, P139, DOI 10.1111/j.1502-3931.2011.00300.x; Hone DWE, 2010, LETHAIA, V43, P232, DOI 10.1111/j.1502-3931.2009.00187.x; Horner JR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007626; Horner JR, 2000, J VERTEBR PALEONTOL, V20, P115, DOI 10.1671/0272-4634(2000)020[0115:LBHOTH]2.0.CO;2; HORNER JR, 1982, NATURE, V297, P675, DOI 10.1038/297675a0; Horner JR, 2002, ENCY LIFE SCI, V5, P468; Hunt Rebecca K., 2010, P447; JERZYKIEWICZ T, 1993, CAN J EARTH SCI, V30, P2180, DOI 10.1139/e93-190; Kirkland James I., 2010, P509; Kobayashi Y, 2003, ACTA PALAEONTOL POL, V48, P235; KOMDEUR J, 1995, ANIM BEHAV, V49, P695; Krause J., 2002, LIVING GROUPS, P210; Lambert Olivier, 2001, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V71 Supplement, P5; Lang J.W., 2013, WORLD CROC C P 22 WO, P42; Lee A, 2006, J VERTEBR PALEONTOL, V26, p89A; Lee AH, 2008, P NATL ACAD SCI USA, V105, P582, DOI 10.1073/pnas.0708903105; LOCKLEY M. G, 1991, TRACKING DINOSAURS N; Loope DB, 1998, GEOLOGY, V26, P27, DOI 10.1130/0091-7613(1998)026<0027:LADIAL>2.3.CO;2; Makovicky P, 2007, J VERTEBR PALEONTOL, V27, p109A; Mathews JC, 2009, J VERTEBR PALEONTOL, V29, P286, DOI 10.1080/02724634.2009.10010382; MAZAK V, 1981, Mammalian Species, P1, DOI 10.2307/3504004; McFarland, 1993, ANIM BEHAV; Meng QJ, 2004, NATURE, V431, P145, DOI 10.1038/431145a; Nonacs P, 2001, ANN ZOOL FENN, V38, P239; POWELL GVN, 1974, ANIM BEHAV, V22, P501, DOI 10.1016/S0003-3472(74)80049-7; Qi Z, 2007, PALAEONTOLOGY, V50, P1023, DOI 10.1111/j.1475-4983.2007.00709.x; Raath MA, 1977, THESIS, P356; Roach Brian T., 2007, Bulletin of the Peabody Museum of Natural History, V48, P103, DOI 10.3374/0079-032X(2007)48[103:AROCPH]2.0.CO;2; Salgado L, 2012, J VERTEBR PALEONTOL, V32, P603, DOI 10.1080/02724634.2012.661004; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Saneyoshi M, 2011, PALAEOGEOGR PALAEOCL, V311, P38, DOI 10.1016/j.palaeo.2011.07.024; SCHALLER G B, 1972, P480; Sullivan C, 2009, VERT PAL AS, V37, P45; Sunquist M, 2002, WILD CATS WORLD, P462; Suzuki S, 2000, HAYASHIBARA MUS NAT, V1, P83; Tanke Darren H., 2000, Gaia (Lisboa), V15, P167; van Staaden Moira J., 1994, Mammalian Species, V483, P1; VANSCHAIK CP, 1983, BEHAV ECOL SOCIOBIOL, V13, P173, DOI 10.1007/BF00299920; Varricchio DJ, 2011, HIST BIOL, V23, P91, DOI 10.1080/08912963.2010.500379; Varricchio DJ, 2008, ACTA PALAEONTOL POL, V53, P567, DOI 10.4202/app.2008.0402; Von Richter W, 1994, MAMMAL SPEC, V50, P1; Werning S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033539; Wolfe D.G., 1998, NEW MEXICO MUSEUM NA, V14, P303; Xu Xing, 2013, Vertebrata Palasiatica, V51, P85; Yamashita C., 1991, CSG NEWSLETTER, V10, P13; You Hailu, 2004, P478; Zhao Q, ACTA PALAE IN PRESS	85	14	14	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113306	10.1371/journal.pone.0113306	http://dx.doi.org/10.1371/journal.pone.0113306			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426957	gold, Green Published, Green Submitted			2022-12-26	WOS:000349145400042
J	Gundlach, J; Dickmanns, A; Schroder-Tittmann, K; Neumann, P; Kaesler, J; Kampf, J; Herzberg, C; Hammer, E; Schwede, F; Kaever, V; Tittmann, K; Stulke, J; Ficner, R				Gundlach, Jan; Dickmanns, Achim; Schroeder-Tittmann, Kathrin; Neumann, Piotr; Kaesler, Jan; Kampf, Jan; Herzberg, Christina; Hammer, Elke; Schwede, Frank; Kaever, Volkhard; Tittmann, Kai; Stuelke, Joerg; Ficner, Ralf			Identification, Characterization, and Structure Analysis of the Cyclic di-AMP-binding P-II-like Signal Transduction Protein DarA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacterial Signal Transduction; Crystal Structure; Cyclic Di-GMP (c-di-GMP); Cyclic Diadenosine Monophosphate (c-di-AMP); Isothermal Titration Calorimetry (ITC)	BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; DNA INTEGRITY; CHECKPOINT PROTEIN; ESCHERICHIA-COLI; REVEALS; REGULATOR; COMPLEX; GENE; SPORULATION	Background: Cyclic di-AMP is an essential second messenger in eubacteria. Results: The c-di-AMP receptor DarA was identified in B. subtilis. The crystal structure and ITC data revealed the nucleotide specificity of DarA. Conclusion: DarA is a P-II-like protein that undergoes conformational changes upon c-di-AMP binding. Significance: A novel P-II-like protein is involved in c-di-AMP signaling. The cyclic dimeric AMP nucleotide c-di-AMP is an essential second messenger in Bacillus subtilis. We have identified the protein DarA as one of the prominent c-di-AMP receptors in B. subtilis. Crystal structure analysis shows that DarA is highly homologous to P-II signal transducer proteins. In contrast to P-II proteins, the functionally important B- and T-loops are swapped with respect to their size. DarA is a homotrimer that binds three molecules of c-di-AMP, each in a pocket located between two subunits. We demonstrate that DarA is capable to bind c-di-AMP and with lower affinity cyclic GMP-AMP (33-cGAMP) but not c-di-GMP or 23-cGAMP. Consistently the crystal structure shows that within the ligand-binding pocket only one adenine is highly specifically recognized, whereas the pocket for the other adenine appears to be promiscuous. Comparison with a homologous ligand-free DarA structure reveals that c-di-AMP binding is accompanied by conformational changes of both the fold and the position of the B-loop in DarA.	[Gundlach, Jan; Kampf, Jan; Herzberg, Christina; Stuelke, Joerg] Univ Gottingen, Dept Gen Microbiol, D-37077 Gottingen, Germany; [Dickmanns, Achim; Neumann, Piotr; Kaesler, Jan; Ficner, Ralf] Univ Gottingen, Dept Mol Struct Biol, D-37077 Gottingen, Germany; [Schroeder-Tittmann, Kathrin; Tittmann, Kai] Univ Gottingen, Dept Mol Enzymol, D-37077 Gottingen, Germany; [Hammer, Elke] Univ Med Greifswald, Interfac Inst Genet & Funct Gen, Dept Funct Genom, D-17487 Greifswald, Germany; [Schwede, Frank] BIOLOG Life Sci Inst, D-28199 Bremen, Germany; [Kaever, Volkhard] Hannover Med Sch, Res Core Unit Metabol, D-30625 Hannover, Germany	University of Gottingen; University of Gottingen; University of Gottingen; Greifswald Medical School; Hannover Medical School	Stulke, J (corresponding author), Univ Gottingen, Dept Gen Microbiol, D-37077 Gottingen, Germany.	jstuelk@gwdg.de; rficner@uni-goettingen.de	Stülke, Jörg/AAD-1600-2021; Kaever, Volkhard/G-3280-2013	Hammer, Elke/0000-0002-1507-0402; Stulke, Jorg/0000-0001-5881-5390	Deutsche Forschungsgemeinschaft [HI 291/13-1, SFB860]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft Grants HI 291/13-1 and SFB860.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bai YL, 2014, J BACTERIOL, V196, P614, DOI 10.1128/JB.01041-13; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918; Block KF, 2010, J BACTERIOL, V192, P3983, DOI 10.1128/JB.00450-10; Boutte CC, 2013, TRENDS MICROBIOL, V21, P174, DOI 10.1016/j.tim.2013.01.002; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352; Campos SS, 2014, J BACTERIOL, V196, P568, DOI 10.1128/JB.01259-13; Carr PD, 1996, ACTA CRYSTALLOGR D, V52, P93, DOI 10.1107/S0907444995007293; Chaudhuri RR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-291; Commichau FM, 2007, MOL MICROBIOL, V65, P642, DOI 10.1111/j.1365-2958.2007.05816.x; Commichau FM, 2013, MOL BIOSYST, V9, P1068, DOI 10.1039/c3mb25595f; Conroy MJ, 2007, P NATL ACAD SCI USA, V104, P1213, DOI 10.1073/pnas.0610348104; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Diethmaier C, 2014, J BACTERIOL, V196, P265, DOI 10.1128/JB.00826-13; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Forchhammer K, 2008, TRENDS MICROBIOL, V16, P65, DOI 10.1016/j.tim.2007.11.004; Galinier A, 1997, P NATL ACAD SCI USA, V94, P8439, DOI 10.1073/pnas.94.16.8439; Gao XH, 2013, J BACTERIOL, V195, P4782, DOI 10.1128/JB.00373-13; Gentner M, 2012, J AM CHEM SOC, V134, P1019, DOI 10.1021/ja207742q; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huergo LF, 2013, FEMS MICROBIOL REV, V37, P251, DOI 10.1111/j.1574-6976.2012.00351.x; Jones CP, 2014, EMBO J, V33, P2692, DOI 10.15252/embj.201489209; KABSCH W, 1976, J MOL BIOL, V100, P283, DOI 10.1016/S0022-2836(76)80064-2; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kriel A, 2012, MOL CELL, V48, P231, DOI 10.1016/j.molcel.2012.08.009; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; Maier S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026327; McDonough KA, 2012, NAT REV MICROBIOL, V10, P27, DOI 10.1038/nrmicro2688; Mehne FMP, 2014, J BIOL CHEM, V289, P21098, DOI 10.1074/jbc.M114.562066; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Meyer FM, 2011, METAB ENG, V13, P18, DOI 10.1016/j.ymben.2010.10.001; Michna RH, 2014, NUCLEIC ACIDS RES, V42, pD692, DOI 10.1093/nar/gkt1002; Nelson JW, 2013, NAT CHEM BIOL, V9, P834, DOI [10.1038/NCHEMBIO.1363, 10.1038/nchembio.1363]; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Sambrook J., 2001, MOL CLONING LAB MANU; Schirmer F, 1997, J BACTERIOL, V179, P1329, DOI 10.1128/jb.179.4.1329-1336.1997; SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sureka K, 2014, CELL, V158, P1389, DOI 10.1016/j.cell.2014.07.046; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Yildiz O, 2007, EMBO J, V26, P589, DOI 10.1038/sj.emboj.7601492; Zeth K, 2012, ACTA CRYSTALLOGR D, V68, P901, DOI 10.1107/S0907444912016447; Zhang L, 2013, J BIOL CHEM, V288, P22426, DOI 10.1074/jbc.M113.464883; Zhao MX, 2010, J MOL BIOL, V402, P552, DOI 10.1016/j.jmb.2010.08.006	55	57	58	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					3069	3080		10.1074/jbc.M114.619619	http://dx.doi.org/10.1074/jbc.M114.619619			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25433025	hybrid, Green Published			2022-12-26	WOS:000349310700043
J	Tagami, T; Yamashita, K; Okuyama, M; Mori, H; Yao, M; Kimura, A				Tagami, Takayoshi; Yamashita, Keitaro; Okuyama, Masayuki; Mori, Haruhide; Yao, Min; Kimura, Atsuo			Structural Advantage of Sugar Beet alpha-Glucosidase to Stabilize the Michaelis Complex with Long-chain Substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MALTASE-GLUCOAMYLASE; RECOGNITION; SPECIFICITY; BINDING; DEGRADATION; REFINEMENT; RESOLUTION; RESIDUES; AMYLASE; FORMS	The alpha-glucosidase from sugar beet (SBG) is an exo-type glycosidase. The enzyme has a pocket-shaped active site, but efficiently hydrolyzes longer maltooligosaccharides and soluble starch due to lower K-m and higher k(cat)/K-m for such substrates. To obtain structural insights into the mechanism governing its unique substrate specificity, a series of acarviosyl-maltooligo-saccharides was employed for steady-state kinetic and structural analyses. The acarviosyl-maltooligosaccharides have a longer maltooligosaccharide moiety compared with the maltose moiety of acarbose, which is known to be the transition state analog of alpha-glycosidases. The clear correlation obtained between log K-i of the acarviosyl-maltooligosaccharides and log(K-m/k(cat)) for hydrolysis of maltooligosaccharides suggests that the acarviosyl-maltooligosaccharides are transition state mimics. The crystal structure of the enzyme bound with acarviosyl-maltohexaose reveals that substrate binding at a distance from the active site is maintained largely by van der Waals interactions, with the four glucose residues at the reducing terminus of acarviosyl-maltohexaose retaining a left-handed single-helical conformation, as also observed in cycloamyloses and single helical V-amyloses. The kinetic behavior and structural features suggest that the subsite structure suitable for the stable conformation of amylose lowers the K-m for long-chain substrates, which in turn is responsible for higher specificity of the longer substrates.	[Tagami, Takayoshi; Okuyama, Masayuki; Mori, Haruhide; Kimura, Atsuo] Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan; [Yamashita, Keitaro; Yao, Min] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0608589, Japan; [Yao, Min] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido 0608589, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Okuyama, M (corresponding author), Hokkaido Univ, Res Fac Agr, Kita Ku, Kita 9 Nishi 9, Sapporo, Hokkaido, Japan.	okuyama@abs.agr.hokudai.ac.jp; kimura@abs.agr.hokudai.ac.jp	Mori, Haruhide/AAV-6374-2021; Okuyama, Masayuki/D-8739-2012; Tagami, Takayoshi/Q-3953-2019; yao, min/F-5287-2011	Mori, Haruhide/0000-0001-7346-9131; Okuyama, Masayuki/0000-0001-7013-6032; yao, min/0000-0003-1687-5904; Tagami, Takayoshi/0000-0002-4004-1558; Yamashita, Keitaro/0000-0002-5442-7582				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; CHIBA S, 1979, AGR BIOL CHEM TOKYO, V43, P237, DOI 10.1080/00021369.1979.10863439; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ernst HA, 2006, J MOL BIOL, V358, P1106, DOI 10.1016/j.jmb.2006.02.056; Gessler K, 1999, P NATL ACAD SCI USA, V96, P4246, DOI 10.1073/pnas.96.8.4246; Hasegawa H, 2009, CURR OPIN STRUC BIOL, V19, P341, DOI 10.1016/j.sbi.2009.04.003; HIZUKURI S, 1978, CARBOHYD RES, V63, P261, DOI 10.1016/S0008-6215(00)80950-7; Jacob J, 1999, CARBOHYD RES, V322, P228, DOI 10.1016/S0008-6215(99)00216-5; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Koropatkin NM, 2010, STRUCTURE, V18, P200, DOI 10.1016/j.str.2009.12.010; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mader MM, 1997, CHEM REV, V97, P1281, DOI 10.1021/cr960435y; MATSUI H, 1978, AGR BIOL CHEM TOKYO, V42, P1855, DOI 10.1080/00021369.1978.10863265; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MIKAMI B, 1993, BIOCHEMISTRY-US, V32, P6836, DOI 10.1021/bi00078a006; Mosi R, 1998, BIOCHEMISTRY-US, V37, P17192, DOI 10.1021/bi981109a; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakai H, 2007, BIOCHIMIE, V89, P49, DOI 10.1016/j.biochi.2006.09.014; Prates ET, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059069; RADZICKA A, 1995, SCIENCE, V267, P90, DOI 10.1126/science.7809611; Ren LM, 2011, PROTEIN CELL, V2, P827, DOI 10.1007/s13238-011-1105-3; Robert X, 2005, J BIOL CHEM, V280, P32968, DOI 10.1074/jbc.M505515200; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; Sauer J, 2000, BBA-PROTEIN STRUCT M, V1543, P275, DOI 10.1016/S0167-4838(00)00232-6; Sim L, 2008, J MOL BIOL, V375, P782, DOI 10.1016/j.jmb.2007.10.069; Sim L, 2010, J BIOL CHEM, V285, P17763, DOI 10.1074/jbc.M109.078980; SUGIMOTO M, 1995, BIOSCI BIOTECH BIOCH, V59, P673, DOI 10.1271/bbb.59.673; Suzuki N, 2012, J BIOL CHEM, V287, P19916, DOI 10.1074/jbc.M112.342444; Tagami T, 2013, J BIOL CHEM, V288, P19296, DOI 10.1074/jbc.M113.465211; Tagami T, 2013, BIOSCI BIOTECH BIOCH, V77, P312, DOI 10.1271/bbb.120732; Tagami T, 2013, BBA-PROTEINS PROTEOM, V1834, P329, DOI 10.1016/j.bbapap.2012.08.007; Tamura M, 2012, FEBS J, V279, P1871, DOI 10.1111/j.1742-4658.2012.08568.x; Tan KM, 2010, FASEB J, V24, P3939, DOI 10.1096/fj.10-156257	36	11	11	1	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1796	1803		10.1074/jbc.M114.606939	http://dx.doi.org/10.1074/jbc.M114.606939			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25451917	Green Published, hybrid			2022-12-26	WOS:000348056400044
J	Roed, SN; Nohr, AC; Wismann, P; Iversen, H; Brauner-Osborne, H; Knudsen, SM; Waldhoer, M				Roed, Sarah Noerklit; Nohr, Anne Cathrine; Wismann, Pernille; Iversen, Helle; Brauner-Osborne, Hans; Knudsen, Sanne Moeller; Waldhoer, Maria			Functional Consequences of Glucagon-like Peptide-1 Receptor Cross-talk and Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PANCREATIC BETA-CELLS; MEMBRANE TRAFFICKING; INSULIN-SECRETION; TERMINAL DOMAIN; INTERNALIZATION; POLYPEPTIDE; ENDOCYTOSIS; ACTIVATION; FAMILY; ALPHA	The signaling capacity of seven-transmembrane/G-protein-coupled receptors (7TM/GPCRs) can be regulated through ligand-mediated receptor trafficking. Classically, the recycling of internalized receptors is associated with resensitization, whereas receptor degradation terminates signaling. We have shown previously that the incretin glucagon-like peptide-1 receptor (GLP-1R) internalizes fast and is primarily resensitized through recycling back to the cell surface. GLP-1R is expressed in pancreatic islets together with the closely related glucose-dependent insulinotropic polypeptide (GIPR) and glucagon (GCGR) receptors. The interaction and cross-talk between coexpressed receptors is a wide phenomenon of the 7TM/GPCR superfamily. Numerous reports show functional consequences for signaling and trafficking of the involved receptors. On the basis of the high structural similarity and tissue coexpression, we here investigated the potential cross-talk between GLP-1R and GIPR or GCGR in both trafficking and signaling pathways. Using a real-time time-resolved FRET-based internalization assay, we show that GLP-1R, GIPR, and GCGR internalize with differential properties. Remarkably, upon coexpression of the internalizing GLP-1R and the non-internalizing GIPR, GLP-1-mediated GLP-1R internalization was impaired in a GIPR concentration-dependent manner. As a functional consequence of such impaired internalization capability, GLP-1-mediated GLP-1R signaling was abrogated. A similar compromised signaling was found when GLP-1R internalization was abrogated by a dominant-negative version of dynamin (dynamin-1 K44E), which provides a mechanistic link between GLP-1R trafficking and signaling. This study highlights the importance of receptor internalization for full functionality of GLP-1R. Moreover, cross-talk between the two incretin receptors GLP-1R and GIPR is shown to alter receptor trafficking with functional consequences for GLP-1R signaling.	[Roed, Sarah Noerklit; Wismann, Pernille; Iversen, Helle; Knudsen, Sanne Moeller; Waldhoer, Maria] Novo Nordisk AS, Dept Incretin Biol, DK-2760 Malov, Denmark; [Nohr, Anne Cathrine; Brauner-Osborne, Hans] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, DK-1165 Copenhagen, Denmark	Novo Nordisk; University of Copenhagen	Roed, SN (corresponding author), Novo Nordisk AS, Dept Incretin Biol, Novo Nordisk Pk, DK-2760 Malov, Denmark.	snro@novonordisk.com	Bräuner-Osborne, Hans/D-7260-2011; Iversen, Helle Klingenberg/P-5726-2019; Waldhoer, Maria/HDO-0619-2022	Bräuner-Osborne, Hans/0000-0001-9495-7388; Iversen, Helle Klingenberg/0000-0002-5880-6352; Waldhoer, Maria/0000-0003-3534-1959				Buggy JJ, 1997, DIABETES, V46, P1400, DOI 10.2337/diabetes.46.9.1400; Calebiro D, 2010, TRENDS PHARMACOL SCI, V31, P221, DOI 10.1016/j.tips.2010.02.002; Calebiro D, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000172; Chini B, 2004, J MOL ENDOCRINOL, V32, P325, DOI 10.1677/jme.0.0320325; DEBLASI A, 1989, TRENDS PHARMACOL SCI, V10, P227, DOI 10.1016/0165-6147(89)90266-6; Doyle ME, 2007, PHARMACOL THERAPEUT, V113, P546, DOI 10.1016/j.pharmthera.2006.11.007; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferrandon S, 2009, NAT CHEM BIOL, V5, P734, DOI 10.1038/nchembio.206; GALLWITZ B, 1993, J MOL ENDOCRINOL, V10, P259, DOI 10.1677/jme.0.0100259; Gromada J, 1997, PFLUG ARCH EUR J PHY, V434, P515, DOI 10.1007/s004240050431; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Harikumar KG, 2008, J MOL NEUROSCI, V36, P279, DOI 10.1007/s12031-008-9060-z; Harper CB, 2013, TRENDS CELL BIOL, V23, P90, DOI 10.1016/j.tcb.2012.10.007; HERSKOVITS JS, 1993, J CELL BIOL, V122, P565, DOI 10.1083/jcb.122.3.565; Holst Jens Juul, 2007, Immunology Endocrine & Metabolic Agents in Medicinal Chemistry, V7, P49; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Irannejad R, 2014, CURR OPIN CELL BIOL, V27, P109, DOI 10.1016/j.ceb.2013.10.003; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898; Jorgensen R, 2007, J PHARMACOL EXP THER, V322, P148, DOI 10.1124/jpet.107.120006; Jorgensen R, 2011, PHARMACOLOGY, V88, P174, DOI 10.1159/000330742; Kedees MH, 2009, MOL CELL ENDOCRINOL, V311, P69, DOI 10.1016/j.mce.2009.07.024; Kieffer TJ, 1996, ENDOCRINOLOGY, V137, P5119, DOI 10.1210/en.137.11.5119; Krilov L, 2011, EXP CELL RES, V317, P2981, DOI 10.1016/j.yexcr.2011.10.001; Kuna RS, 2013, AM J PHYSIOL-ENDOC M, V305, pE161, DOI 10.1152/ajpendo.00551.2012; Mayo KE, 2003, PHARMACOL REV, V55, P167, DOI 10.1124/pr.55.1.6; Merlen C, 2006, FEBS LETT, V580, P5697, DOI 10.1016/j.febslet.2006.09.021; Moens K, 1996, DIABETES, V45, P257, DOI 10.2337/diabetes.45.2.257; Moens K, 1998, DIABETES, V47, P66, DOI 10.2337/diabetes.47.1.66; Montrose-Rafizadeh C, 1999, ENDOCRINOLOGY, V140, P1132, DOI 10.1210/en.140.3.1132; Pamir N, 2003, AM J PHYSIOL-ENDOC M, V284, pE931, DOI 10.1152/ajpendo.00270.2002; Quoyer J, 2010, J BIOL CHEM, V285, P1989, DOI 10.1074/jbc.M109.067207; Roed SN, 2014, MOL CELL ENDOCRINOL, V382, P938, DOI 10.1016/j.mce.2013.11.010; Roed Sarah Norklit, 2012, Front Endocrinol (Lausanne), V3, P62, DOI 10.3389/fendo.2012.00062; Schelshorn D, 2012, MOL PHARMACOL, V81, P309, DOI 10.1124/mol.111.074757; Syme CA, 2006, MOL ENDOCRINOL, V20, P3400, DOI 10.1210/me.2006-0178; van Rijn RM, 2010, CURR OPIN PHARMACOL, V10, P73, DOI 10.1016/j.coph.2009.09.007; Wheeler MB, 1999, J BIOL CHEM, V274, P24593, DOI 10.1074/jbc.274.35.24593; Whitaker GM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032675; WIDMANN C, 1995, BIOCHEM J, V310, P203, DOI 10.1042/bj3100203	40	51	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1233	1243		10.1074/jbc.M114.592436	http://dx.doi.org/10.1074/jbc.M114.592436			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25451942	hybrid, Green Published			2022-12-26	WOS:000347778200052
J	Pomilla, C; Amaral, AR; Collins, T; Minton, G; Findlay, K; Leslie, MS; Ponnampalam, L; Baldwin, R; Rosenbaum, H				Pomilla, Cristina; Amaral, Ana R.; Collins, Tim; Minton, Gianna; Findlay, Ken; Leslie, Matthew S.; Ponnampalam, Louisa; Baldwin, Robert; Rosenbaum, Howard			The World's Most Isolated and Distinct Whale Population? Humpback Whales of the Arabian Sea	PLOS ONE			English	Article							MITOCHONDRIAL-DNA VARIATION; MEGAPTERA-NOVAEANGLIAE; GENETIC-STRUCTURE; COMPUTER-PROGRAM; SIZE; ATLANTIC; ABUNDANCE; CONSERVATION; INFERENCE; COALESCENT	A clear understanding of population structure is essential for assessing conservation status and implementing management strategies. A small, non-migratory population of humpback whales in the Arabian Sea is classified as "Endangered" on the IUCN Red List of Threatened Species, an assessment constrained by a lack of data, including limited understanding of its relationship to other populations. We analysed 11 microsatellite markers and mitochondrial DNA sequences extracted from 67 Arabian Sea humpback whale tissue samples and compared them to equivalent datasets from the Southern Hemisphere and North Pacific. Results show that the Arabian Sea population is highly distinct; estimates of gene flow and divergence times suggest a Southern Indian Ocean origin but indicate that it has been isolated for approximately 70,000 years, remarkable for a species that is typically highly migratory. Genetic diversity values are significantly lower than those obtained for Southern Hemisphere populations and signatures of ancient and recent genetic bottlenecks were identified. Our findings suggest this is the world's most isolated humpback whale population, which, when combined with low population abundance estimates and anthropogenic threats, raises concern for its survival. We recommend an amendment of the status of the population to "Critically Endangered" on the IUCN Red List.	[Pomilla, Cristina; Amaral, Ana R.; Leslie, Matthew S.; Rosenbaum, Howard] Amer Museum Nat Hist, Sackler Inst Comparat Gen, New York, NY 10024 USA; [Amaral, Ana R.] Univ Nova Lisboa, Fac Ciencias, Ctr Biol Ambiental, P-1200 Lisbon, Portugal; [Collins, Tim; Leslie, Matthew S.; Rosenbaum, Howard] Wildlife Conservat Soc, Ocean Giants Program, Bronx, NY USA; [Minton, Gianna; Ponnampalam, Louisa; Baldwin, Robert] Environm Soc Oman, Muscat, Oman; [Minton, Gianna] World Wide Fund Nat, Libreville, Gabon; [Findlay, Ken] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0002 Pretoria, South Africa; Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia	American Museum of Natural History (AMNH); Universidade de Lisboa; Universidade Nova de Lisboa; Wildlife Conservation Society; World Wildlife Fund; University of Pretoria; Universiti Malaya	Collins, T (corresponding author), Wildlife Conservat Soc, Ocean Giants Program, Bronx, NY USA.	tcollins@wcs.org; hrosenbaum@wcs.org	Findlay, Ken P/A-5766-2019; Amaral, Ana Rita/ABG-4271-2021; Amaral, Ana/D-1060-2010; Pomilla, Cristina/AAC-4035-2020; Pomilla, Cristina/GYD-9678-2022	Findlay, Ken P/0000-0001-7154-8805; Amaral, Ana Rita/0000-0002-0595-0086; Amaral, Ana/0000-0002-0595-0086; Pomilla, Cristina/0000-0002-2581-8365; Ponnampalam, Louisa/0000-0003-0371-2620; Collins, Tim/0000-0002-7124-4876	Environment Society of Oman; Shell Oman Marketing; Petroleum Development Oman; UK Foreign and Commonwealth Office; Ford Middle East; Veritas Geophysical; Salalah Port Services; Five Oceans LLC; Tawoos LLC; Peter Scott Trust for Education Research in Conservation; Marina Bandar al Rowdha; DHL; Mustafa Sultan Communications; ABA School Muscat; British School Muscat; Sultan School Muscat; Embassy of the United States in Muscat; Emirates Airlines; Oman Air; Cathay Pacific; KPMG; Muscat Pharmacy; OHI Marine; Truck Oman; W.J. Towell and Co.; Han Padron Associates; Mark Rental Cars; WS Atkins; Wildlife Conservation Society	Environment Society of Oman; Shell Oman Marketing; Petroleum Development Oman; UK Foreign and Commonwealth Office; Ford Middle East; Veritas Geophysical; Salalah Port Services; Five Oceans LLC; Tawoos LLC; Peter Scott Trust for Education Research in Conservation; Marina Bandar al Rowdha; DHL; Mustafa Sultan Communications; ABA School Muscat; British School Muscat; Sultan School Muscat; Embassy of the United States in Muscat; Emirates Airlines; Oman Air; Cathay Pacific; KPMG; Muscat Pharmacy; OHI Marine; Truck Oman; W.J. Towell and Co.; Han Padron Associates; Mark Rental Cars; WS Atkins; Wildlife Conservation Society	Funding and other in-kind support for the work was provided by: The Environment Society of Oman, Shell Oman Marketing, Petroleum Development Oman, The UK Foreign and Commonwealth Office, Ford Middle East, Veritas Geophysical, Salalah Port Services, Five Oceans LLC, Tawoos LLC, The Peter Scott Trust for Education Research in Conservation, Marina Bandar al Rowdha, DHL, Mustafa Sultan Communications, The ABA School Muscat, The British School Muscat, The Sultan School Muscat, The Embassy of the United States in Muscat, Emirates Airlines, Oman Air, Cathay Pacific, KPMG, Muscat Pharmacy, OHI Marine, Truck Oman, W.J. Towell and Co., Han Padron Associates, Mark Rental Cars, WS Atkins and the Wildlife Conservation Society. The funders of this study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter SE, 2007, P NATL ACAD SCI USA, V104, P15162, DOI 10.1073/pnas.0706056104; Amos Bill, 1996, Report of the International Whaling Commission, V46, P657; Ayres KL, 2004, MOL ECOL NOTES, V4, P315, DOI 10.1111/j.1471-8286.2004.00616.x; Baker CS, 2013, MAR ECOL PROG SER, V494, P291, DOI 10.3354/meps10508; Baker Charles Scott, 2002, P84; Baker CS, 1998, MAR MAMMAL SCI, V14, P721, DOI 10.1111/j.1748-7692.1998.tb00758.x; Baker CS, 2004, TRENDS ECOL EVOL, V19, P365, DOI 10.1016/j.tree.2004.05.005; BAKER CS, 1993, P NATL ACAD SCI USA, V90, P8239, DOI 10.1073/pnas.90.17.8239; Baker CS, 1998, MOL ECOL, V7, P695, DOI 10.1046/j.1365-294x.1998.00384.x; Baldwin R, 2000, J OMAN STUDIES, V11, P11; Banakar VK, 2010, QUATERNARY RES, V73, P535, DOI 10.1016/j.yqres.2010.02.002; BEST PB, 1993, ICES J MAR SCI, V50, P169, DOI 10.1006/jmsc.1993.1018; Bouzat JL, 2010, CONSERV GENET, V11, P463, DOI 10.1007/s10592-010-0049-0; Bradford AL, 2006, MAR ECOL PROG SER, V315, P293, DOI 10.3354/meps315293; Braulik GT, J CETACEAN IN PRESS; Brown S. G., 1957, Marine Observer, V27, P157; Cheesman R.E., 1926, UNKNOWN ARABIA; Clapham PJ, 2008, MAR MAMMAL SCI, V24, P183, DOI 10.1111/j.1748-7692.2007.00175.x; Clapham PJ, 1999, MAMMAL REV, V29, P35; Do C, 2014, MOL ECOL RESOUR, V14, P209, DOI 10.1111/1755-0998.12157; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ehlersa J, 2004, QUATERNARY GLACIAT 3; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Findlay K., 2001, MEMOIRS QUEENSLAND M, V47, P411; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Fujiwara M, 2001, NATURE, V414, P537, DOI 10.1038/35107054; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; George JCC, 2004, MAR MAMMAL SCI, V20, P755, DOI 10.1111/j.1748-7692.2004.tb01191.x; Gervais P, 1888, NOUVELLE ARCH MUSEUM, P199; Gilpin M, 1986, CONSERVATION BIOL SC, P13; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Gupta AK, 2003, NATURE, V421, P354, DOI 10.1038/nature01340; HARPENDING HC, 1993, CURR ANTHROPOL, V34, P483, DOI 10.1086/204195; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Ivashchenko Yulia V., 2012, Endangered Species Research, V18, P201, DOI 10.3354/esr00443; Jackson JA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3222; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kiefer T, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027097; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kraus SD, 2005, SCIENCE, V309, P561, DOI 10.1126/science.1111200; Lacy RC, 1997, J MAMMAL, V78, P320, DOI 10.2307/1382885; LAMBERTSEN RH, 1987, J MAMMAL, V68, P443, DOI 10.2307/1381495; Lang A.R., 2010, THESIS U CALIFORNIA; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; MADDISON WP, 1992, MACCLADE ANAL PHYLOG; Mikhalev YA, 1997, MAR ECOL PROG SER, V149, P13, DOI 10.3354/meps149013; Mikhalev YA, 2000, SOVIET WHALING DATA, P408; Minton G., 2011, Journal of Cetacean Research and Management, P185; Minton G., 2010, Journal of Cetacean Research and Management, V11, P65; Minton G, 2008, 2009 IUCN RED LIST T; Minton G, J CETACEAN IN PRESS; Minton G, 2004, ECOLOGY CONSERVATION; Mullen KA, 2013, MAR POLICY, V42, P293, DOI 10.1016/j.marpol.2013.03.021; Nei M., 1987, MOL EVOLUTIONARY GEN; Nielsen R, 2001, GENETICS, V158, P885; Olavarria C, 2007, MAR ECOL PROG SER, V330, P257, DOI 10.3354/meps330257; Palsboll PJ, 1997, MOL ECOL, V6, P893; PALSBOLL PJ, 1995, MAR ECOL PROG SER, V116, P1, DOI 10.3354/meps116001; PARK S, 2001, MS TOOLKIT EXCEL ADD; Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Pritchard JK, 2000, GENETICS, V155, P945; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reeves RR, 1991, POSSIBLE STOCK AFFIN, P259; Robaae K.A., 1974, Bulletin Basrah nat Hist Mus, V1, P7; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosenbaum HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007318; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Ruegg K, 2013, CONSERV GENET, V14, P103, DOI 10.1007/s10592-012-0432-0; Rugh David J., 2005, Journal of Cetacean Research and Management, V7, P1; SCHLOTTERER C, 1991, NATURE, V354, P63, DOI 10.1038/354063a0; Singh AD, 2011, PALEOCEANOGRAPHY, V26, DOI 10.1029/2009PA001923; Slijper EJ, 1964, BIJDRAGEN DIERKUNDE, V34, P4; TAJIMA F, 1993, MECHANISMS OF MOLECULAR EVOLUTION, P37; TAJIMA F, 1989, GENETICS, V123, P597; Taylor B. L., 2007, LJ0701 NAT MAR FISH; Tomilin AG, 1967, MAMMALS USSR ADJACEN, VIX; Valsecchi E, 1996, MOL ECOL, V5, P151, DOI 10.1111/j.1365-294X.1996.tb00301.x; Van Bressem MF, 2009, DIS AQUAT ORGAN, V86, P143, DOI 10.3354/dao02101; VanBressem MF, 1996, MAR MAMMAL SCI, V12, P371; Wade PR, 2011, BIOL LETTERS, V7, P83, DOI 10.1098/rsbl.2010.0477; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Weller David W., 2002, Journal of Cetacean Research and Management, V4, P7; WHITEHEAD H, 1985, Investigations on Cetacea, V17, P157; Witteveen BH, 2004, CAN J ZOOL, V82, P1352, DOI 10.1139/Z04-120; Zhdanova OL, 2008, J HERED, V99, P694, DOI 10.1093/jhered/esn061	93	27	29	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114162	10.1371/journal.pone.0114162	http://dx.doi.org/10.1371/journal.pone.0114162			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470144	Green Published, gold			2022-12-26	WOS:000349128700080
J	Tufts, JAM; Meyer, KM; Calfee, MW; Lee, SD				Tufts, Jenia A. M.; Meyer, Kathryn M.; Calfee, Michael Worth; Lee, Sang Don			Composite Sampling of a Bacillus anthracis Surrogate with Cellulose Sponge Surface Samplers from a Nonporous Surface	PLOS ONE			English	Article							FOODBORNE PATHOGENS; STAINLESS-STEEL; SPORES; SURVIVAL	A series of experiments was conducted to explore the utility of composite-based collection of surface samples for the detection of a Bacillus anthracis surrogate using cellulose sponge samplers on a nonporous stainless steel surface. Two composite-based collection approaches were evaluated over a surface area of 3716 cm(2) (four separate 929 cm(2) areas), larger than the 645 cm(2) prescribed by the standard Centers for Disease Control (CDC) and Prevention cellulose sponge sampling protocol for use on nonporous surfaces. The CDC method was also compared to a modified protocol where only one surface of the sponge sampler was used for each of the four areas composited. Differences in collection efficiency compared to positive controls and the potential for contaminant transfer for each protocol were assessed. The impact of the loss of wetting buffer from the sponge sampler onto additional surface areas sampled was evaluated. Statistical tests of the results using ANOVA indicate that the collection of composite samples using the modified sampling protocol is comparable to the collection of composite samples using the standard CDC protocol (p = 0.261). Most of the surface-bound spores are collected on the first sampling pass, suggesting that multiple passes with the sponge sampler over the same surface may be unnecessary. The effect of moisture loss from the sponge sampler on collection efficiency was not significant (p = 0.720) for both methods. Contaminant transfer occurs with both sampling protocols, but the magnitude of transfer is significantly greater when using the standard protocol than when the modified protocol is used (p<0.001). The results of this study suggest that composite surface sampling, by either method presented here, could successfully be used to increase the surface area sampled per sponge sampler, resulting in reduced sampling times in the field and decreased laboratory processing cost and turn-around times.	[Tufts, Jenia A. M.; Meyer, Kathryn M.] Oak Ridge Inst Sci & Educ, Res Triangle Pk, NC USA; [Tufts, Jenia A. M.; Meyer, Kathryn M.; Calfee, Michael Worth; Lee, Sang Don] US EPA, Natl Homeland Secur Res Ctr, Off Res & Dev, Res Triangle Pk, NC 27711 USA	Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education; United States Environmental Protection Agency	Calfee, MW (corresponding author), US EPA, Natl Homeland Secur Res Ctr, Off Res & Dev, Res Triangle Pk, NC 27711 USA.	calfee.worth@epa.gov		Calfee, Michael/0000-0001-6544-329X	US EPA through an Interagency Agreement; US Department of Energy's ORISE program; US EPA; ORISE	US EPA through an Interagency Agreement; US Department of Energy's ORISE program; US EPA(United States Environmental Protection Agency); ORISE(United States Department of Energy (DOE))	This work was funded by the US EPA through an Interagency Agreement with the US Department of Energy's ORISE program. Authors MWC and SDL received salary funds from the US EPA; JAT and KM received fellowship stipends through ORISE.	Calfee MW, 2013, J MICROBIOL METH, V92, P375, DOI 10.1016/j.mimet.2013.01.015; Centers for Disease Control and Prevention,, 2012, SURF SAMPL PROC BAC; EPA, 2013, 600R13068 EPA; Johnson GD, 2001, ENVIRON ECOL STAT, V8, P91, DOI 10.1023/A:1011374330176; Josephson KL, 1997, J APPL MICROBIOL, V83, P737, DOI 10.1046/j.1365-2672.1997.00308.x; Kesavan J, 2013, AEROSOL SCI TECH, V47, P1108, DOI 10.1080/02786826.2013.824552; Knobben BAS, 2007, J BIOMED MATER RES A, V80A, P790, DOI 10.1002/jbm.a.30978; Kusumaningrum HD, 2003, INT J FOOD MICROBIOL, V85, P227, DOI 10.1016/S0168-1605(02)00540-8; Lee SD, 2013, ENVIRON SCI TECHNOL, V47, P2595, DOI 10.1021/es4000356; Mattick K, 2003, INT J FOOD MICROBIOL, V85, P213, DOI 10.1016/S0168-1605(02)00510-X; Patil GP, 2010, COMPOSITE SAMPLING N; Patrick DR, 1997, EPIDEMIOL INFECT, V119, P319, DOI 10.1017/S0950268897008261; Rose LJ, 2011, APPL ENVIRON MICROB, V77, P8355, DOI 10.1128/AEM.05377-11; Rossi EM, 2013, J INFECT DEV COUNTR, V7, P229, DOI 10.3855/jidc.2472; Teshale EH, 2002, EMERG INFECT DIS, V8, P1083, DOI 10.3201/eid0810.020398	15	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114082	10.1371/journal.pone.0114082	http://dx.doi.org/10.1371/journal.pone.0114082			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470365	Green Published, Green Submitted, gold			2022-12-26	WOS:000349128700068
J	Wielgus, RB; Peebles, KA				Wielgus, Robert B.; Peebles, Kaylie A.			Effects of Wolf Mortality on Livestock Depredations	PLOS ONE			English	Article							AMERICAN BLACK BEAR; CONSERVATION; VIABILITY; CATTLE; AGE	Predator control and sport hunting are often used to reduce predator populations and livestock depredations, - but the efficacy of lethal control has rarely been tested. We assessed the effects of wolf mortality on reducing livestock depredations in Idaho, Montana and Wyoming from 1987-2012 using a 25 year time series. The number of livestock depredated, livestock populations, wolf population estimates, number of breeding pairs, and wolves killed were calculated for the wolf-occupied area of each state for each year. The data were then analyzed using a negative binomial generalized linear model to test for the expected negative relationship between the number of livestock depredated in the current year and the number of wolves controlled the previous year. We found that the number of livestock depredated was positively associated with the number of livestock and the number of breeding pairs. However, we also found that the number of livestock depredated the following year was positively, not negatively, associated with the number of wolves killed the previous year. The odds of livestock depredations increased 4% for sheep and 5-6% for cattle with increased wolf control - up until wolf mortality exceeded the mean intrinsic growth rate of wolves at 25%. Possible reasons for the increased livestock depredations at <= 25% mortality may be compensatory increased breeding pairs and numbers of wolves following increased mortality. After mortality exceeded 25%, the total number of breeding pairs, wolves, and livestock depredations declined. However, mortality rates exceeding 25% are unsustainable over the long term. Lethal control of individual depredating wolves may sometimes necessary to stop depredations in the near-term, but we recommend that non-lethal alternatives also be considered.	[Wielgus, Robert B.; Peebles, Kaylie A.] Washington State Univ, Sch Environm, Large Carnivore Conservat Lab, Pullman, WA 99164 USA	Washington State University	Peebles, KA (corresponding author), Washington State Univ, Sch Environm, Large Carnivore Conservat Lab, Pullman, WA 99164 USA.	kaylie.peebles@email.wsu.edu			Washington Department of Fish and Wildlife	Washington Department of Fish and Wildlife	Funding: Funding for this research was provided solely by a research grant from the Washington Department of Fish and Wildlife. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agresti A., 1996, INTRO CATEGORICAL DA; Balme GA, 2013, MAMMAL REV, V43, P221, DOI 10.1111/j.1365-2907.2012.00219.x; Biondi F, 2014, FRONT ECOL EVOL, V2, DOI 10.3389/fevo.2014.00050; Bradley EH, 2005, WILDLIFE SOC B, V33, P1256, DOI 10.2193/0091-7648(2005)33[1256:AFRTWD]2.0.CO;2; Brainerd SM, 2008, J WILDLIFE MANAGE, V72, P89, DOI 10.2193/2006-305; Burnham K.P., 2010, MODEL SELECTION MULT; Collins GH, 2002, URSUS, V13, P231; Creel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012918; Fritts Steven H., 2003, P289; Haber GC, 1996, CONSERV BIOL, V10, P1068, DOI 10.1046/j.1523-1739.1996.10041068.x; Jimenez M.D., 2012, NO ROCKY MOUNTAIN WO, P59601; Jimenez M.D., 2013, NO ROCKY MOUNTAIN WO, P59601; Lambert CMS, 2006, J WILDLIFE MANAGE, V70, P246, DOI 10.2193/0022-541X(2006)70[246:CPDAVI]2.0.CO;2; Mech LD, 2010, J WILDLIFE MANAGE, V74, P1421, DOI 10.2193/2009-540; MOSTELLE.F, 1968, J AM STAT ASSOC, V63, P1, DOI 10.2307/2283825; Murray DL, 2010, BIOL CONSERV, V143, P2514, DOI 10.1016/j.biocon.2010.06.018; Musiani M, 2003, CONSERV BIOL, V17, P1538, DOI 10.1111/j.1523-1739.2003.00063.x; Packer C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005941; Peebles KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079713; Rabinowitz A, 2005, CONSERV BIOL SER, V9, P278; Sand H, 2006, ANIM BEHAV, V72, P781, DOI 10.1016/j.anbehav.2005.11.030; Stahler DR, 2006, J NUTR, V136, p1923S, DOI 10.1093/jn/136.7.1923S; Treves A, 2010, URSUS, V21, P30, DOI 10.2192/09GR012.1; Treves A, 2009, J APPL ECOL, V46, P1350, DOI 10.1111/j.1365-2664.2009.01729.x; United States Department of Agriculture, 2012, WASH LIV STAT; Vonholdt BM, 2008, MOL ECOL, V17, P252, DOI 10.1111/j.1365-294X.2007.03468.x; Wielgus RB, 2014, MINIMIZING MITIGATIN; Wiles G.J., 2011, WOLF CONSERVATION MA; Zimmermann B, 2003, URSUS-SERIES, V14, P72	29	65	66	4	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113505	10.1371/journal.pone.0113505	http://dx.doi.org/10.1371/journal.pone.0113505			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470821	Green Published, Green Submitted, gold			2022-12-26	WOS:000349128700031
J	Zille, M; Riabinska, A; Terzi, MY; Balkaya, M; Prinz, V; Schmerl, B; Nieminen-Kelha, M; Endres, M; Vajkoczy, P; Pina, AL				Zille, Marietta; Riabinska, Arina; Terzi, Menderes Yusuf; Balkaya, Mustafa; Prinz, Vincent; Schmerl, Bettina; Nieminen-Kelhae, Melina; Endres, Matthias; Vajkoczy, Peter; Pina, Ana Luisa			Influence of Pigment Epithelium-Derived Factor on Outcome after Striatal Cerebral Ischemia in the Mouse	PLOS ONE			English	Article							CEREBELLAR GRANULE CELLS; FACTOR PEDF; CEREBROSPINAL-FLUID; ARTERY OCCLUSION; GENE-TRANSFER; GROWTH-FACTOR; BRAIN-DAMAGE; ANGIOGENESIS; PROTECTS; INJURY	We here suggest that pigment epithelium-derived factor (PEDF) does not have an effect on lesion size, behavioral outcome, cell proliferation, or cell death after striatal ischemia in the mouse. PEDF is a neurotrophic factor with neuroprotective, antiangiogenic, and antipermeability effects. It influences self-renewal of neural stem cells and proliferation of microglia. We investigated whether intraventricular infusion of PEDF reduces infarct size and cell death, ameliorates behavioral outcome, and influences cell proliferation in the one-hour middle cerebral artery occlusion (MCAO) mouse model of focal cerebral ischemia. C57Bl6/N mice were implanted with PEDF or artificial cerebrospinal fluid (control) osmotic pumps and subjected to 60-minute MCAO 48 hours after pump implantation. They received daily BrdU injections for 7 days after MCAO in order to investigate cell proliferation. Infarct volumes were determined 24 hours after reperfusion using magnetic resonance imaging. We removed the pumps on day 5 and performed behavioral testing between day 7 and 21. Immunohistochemical staining was performed to determine the effect of PEDF on cell proliferation and cell death. Our model produced an ischemic injury confined solely to striatal damage. We detected no reduction in infarct sizes and cell death in PEDF-vs. CSF-infused MCAO mice. Behavioral outcome and cell proliferation did not differ between the groups. However, we cannot exclude that PEDF might work under different conditions in stroke. Further studies will elucidate the effect of PEDF treatment on cell proliferation and behavioral outcome in moderate to severe ischemic injury in the brain.	[Zille, Marietta; Balkaya, Mustafa; Prinz, Vincent; Endres, Matthias] Charite, Ctr Stroke Res Berlin, Dept Expt Neurol, Berlin, Germany; [Riabinska, Arina; Terzi, Menderes Yusuf; Schmerl, Bettina; Nieminen-Kelhae, Melina; Vajkoczy, Peter; Pina, Ana Luisa] Charite, Dept Neurosurg, D-13353 Berlin, Germany; [Endres, Matthias] Charite, Dept Neurol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Pina, AL (corresponding author), Charite, Dept Neurosurg, D-13353 Berlin, Germany.	ana-luisa.pina@charite.de	Terzi, Menderes Yusuf/Z-1999-2018; Zille, Marietta/P-1700-2018	Terzi, Menderes Yusuf/0000-0001-8478-0451; Zille, Marietta/0000-0002-0609-8956; Nieminen-Kelha, Melina/0000-0002-7577-8058; Vajkoczy, Peter/0000-0003-4350-392X; Schmerl, Bettina/0000-0002-6273-3897; Endres, Matthias/0000-0001-6520-3720	Charite-Rahel-Hirsch-Grant; BCRT flexible funds; Stiftung der Deutschen Wirtschaft (Foundation of German Business)	Charite-Rahel-Hirsch-Grant; BCRT flexible funds; Stiftung der Deutschen Wirtschaft (Foundation of German Business)	Funding: This work has been supported by the Charite-Rahel-Hirsch-Grant and the BCRT flexible funds to ALP. MZ was supported by a fellowship granted by the Stiftung der Deutschen Wirtschaft (Foundation of German Business). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balkaya M, 2013, J CEREBR BLOOD F MET, V33, P330, DOI 10.1038/jcbfm.2012.185; Balkaya M, 2013, J NEUROSCI METH, V213, P179, DOI 10.1016/j.jneumeth.2012.12.021; Bert B, 2002, NEUROBIOL LEARN MEM, V78, P11, DOI 10.1006/nlme.2001.4040; Engel O, 2011, JOVE-J VIS EXP, DOI 10.3791/2423; Falk T, 2009, NEUROSCI LETT, V458, P49, DOI 10.1016/j.neulet.2009.04.018; Fitzgerald DP, 2012, CANCER RES, V72, P144, DOI 10.1158/0008-5472.CAN-11-1904; Gertz K, 2012, BRAIN, V135, P1964, DOI 10.1093/brain/aws075; Giampa C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064037; Guan M, 2003, J CLIN PATHOL, V56, P277, DOI 10.1136/jcp.56.4.277; Harker KT, 2002, J NEUROSCI, V22, P1155, DOI 10.1523/JNEUROSCI.22-03-01155.2002; Jinnouchi Y, 2007, BRAIN RES, V1167, P92, DOI 10.1016/j.brainres.2007.04.088; Li H, 2006, EXP EYE RES, V83, P824, DOI 10.1016/j.exer.2006.04.014; Matsuura K, 1997, J NEUROSCI METH, V73, P45, DOI 10.1016/S0165-0270(96)02211-X; Namba T, 2010, NEUROSCIENCE, V167, P372, DOI 10.1016/j.neuroscience.2010.01.033; Pardridge WM, 2011, FLUIDS BARRIERS CNS, V8, DOI 10.1186/2045-8118-8-7; Pillai DR, 2013, J CEREBR BLOOD F MET, V33, P557, DOI 10.1038/jcbfm.2012.201; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Saha B, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00014; Sanagi T, 2008, J NEUROCHEM, V106, P1841, DOI 10.1111/j.1471-4159.2008.05529.x; Sanagi T, 2010, J NEUROPATH EXP NEUR, V69, P224, DOI 10.1097/NEN.0b013e3181cfc46f; Sly DJ, 2012, JARO-J ASSOC RES OTO, V13, P1, DOI 10.1007/s10162-011-0297-9; Sugita Y, 1997, J NEUROSCI RES, V49, P710, DOI 10.1002/(SICI)1097-4547(19970915)49:6<710::AID-JNR5>3.0.CO;2-A; Takita H, 2003, INVEST OPHTH VIS SCI, V44, P4497, DOI 10.1167/iovs.03-0052; TANIWAKI T, 1995, J NEUROCHEM, V64, P2509; Taniwaki T, 1997, J NEUROCHEM, V68, P26; Tombran-Tink J, 2005, FRONT BIOSCI-LANDMRK, V10, P2131, DOI 10.2741/1686; Tombran-Tink J, 1996, Mol Vis, V2, P11; van Wagenen S., 2008, PROTEIN EXPRESSION L; Wardlaw JM, 2012, LANCET, V379, P2364, DOI 10.1016/S0140-6736(12)60738-7; WEIDNER N, 1991, NEW ENGL J MED, V324, P1, DOI 10.1056/NEJM199101033240101; Winner B, 2008, J NEUROPATH EXP NEUR, V67, P105, DOI 10.1097/nen.0b013e3181630cff; Winter B, 2004, STROKE, V35, P191, DOI 10.1161/01.STR.0000107188.29688.2C; Yabe T, 2010, CURR MOL MED, V10, P259, DOI 10.2174/156652410791065354; Yabe T, 2001, J BIOL CHEM, V276, P43313, DOI 10.1074/jbc.M107831200; Yamagishi S, 2004, MED HYPOTHESES, V63, P115, DOI 10.1016/j.mehy.2004.02.022; Yasuda T, 2007, EXP NEUROL, V206, P308, DOI 10.1016/j.expneurol.2007.05.012; Zhu CH, 2012, NEUROCHEM RES, V37, P2099, DOI 10.1007/s11064-012-0831-0	38	8	8	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114595	10.1371/journal.pone.0114595	http://dx.doi.org/10.1371/journal.pone.0114595			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470280	gold, Green Published, Green Submitted			2022-12-26	WOS:000349128700123
J	Santos, PP; Oliveira, F; Ferreira, VCMP; Polegato, BF; Roscani, MG; Fernandes, AA; Modesto, P; Rafacho, BPM; Zanati, SG; Di Lorenzo, A; Matsubara, LS; Paiva, SAR; Zornoff, LAM; Minicucci, MF; Azevedo, PS				Santos, Priscila P.; Oliveira, Fernando; Ferreira, Vanessa C. M. P.; Polegato, Bertha F.; Roscani, Meliza G.; Fernandes, Ana Angelica; Modesto, Pamela; Rafacho, Bruna P. M.; Zanati, Silmeia G.; Di Lorenzo, Annarita; Matsubara, Luiz S.; Paiva, Sergio A. R.; Zornoff, Leonardo A. M.; Minicucci, Marcos F.; Azevedo, Paula S.			The Role of Lipotoxicity in Smoke Cardiomyopathy	PLOS ONE			English	Article							OXIDATIVE STRESS; ENERGY-METABOLISM; HEART-FAILURE; VITAMIN-D; EXPOSURE; NICOTINE; ASSOCIATION; CHOLESTEROL; MECHANISMS; ASSAY	Background/Aims: Experimental and clinical studies have shown the direct toxic effects of cigarette smoke (CS) on the myocardium, independent of vascular effects. However, the underlying mechanisms are not well known. Methods: Wistar rats were allocated to control (C) and cigarette smoke (CS) groups. CS rats were exposed to cigarette smoke for 2 months. Results: After that morphometric, functional and biochemical parameters were measured. The echocardiographic study showed enlargement of the left atria, increase in the left ventricular systolic volume and reduced systolic function. Within the cardiac metabolism, exposure to CS decreased beta hydroxy acyl coenzyme A dehydrogenases and citrate synthases and increased lactate dehydrogenases. Peroxisome proliferator-activated receptor alpha (PPAR alpha) and peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1 alpha) were expressed similarly in both groups. CS increased serum lipids and myocardial triacylglycerols (TGs). These data suggest that impairment in fatty acid oxidation and the accumulation of cardiac lipids characterize lipotoxicity. CS group exhibited increased oxidative stress and decreased antioxidant defense. Finally, the myocyte cross-sectional area and active Caspase 3 were increased in the CS group. Conclusion: The cardiac remodeling that was observed in the CS exposure model may be explained by abnormalities in energy metabolism, including lipotoxicity and oxidative stress.	[Santos, Priscila P.; Oliveira, Fernando; Ferreira, Vanessa C. M. P.; Polegato, Bertha F.; Roscani, Meliza G.; Modesto, Pamela; Rafacho, Bruna P. M.; Zanati, Silmeia G.; Matsubara, Luiz S.; Paiva, Sergio A. R.; Zornoff, Leonardo A. M.; Minicucci, Marcos F.; Azevedo, Paula S.] UNESP Univ Estadual Paulista, Botucatu Med Sch, Dept Internal Med, Botucatu, SP, Brazil; [Fernandes, Ana Angelica] UNESP Univ Estadual Paulista, Inst Biociencias Botucatu, Dept Chem & Biochem, Botucatu, SP, Brazil; [Di Lorenzo, Annarita] Cornell Univ, Weill Med Coll, Ctr Vasc Biol, Dept Pathol & Lab Med, New York, NY 10021 USA	Universidade Estadual Paulista; Instituto de Botanica - Sao Paulo; Universidade Estadual Paulista; Cornell University	Azevedo, PS (corresponding author), UNESP Univ Estadual Paulista, Botucatu Med Sch, Dept Internal Med, Botucatu, SP, Brazil.	paulasa@fmb.unesp.br	Fernandes, Ana Angelica Henrique/D-5291-2012; Polegato, Bertha Furlan/E-8842-2012; Minicucci, Marcos F/A-9094-2008; Rafacho, Bruna Paola Murino/AGW-5794-2022; Zornoff, Leonardo/A-5612-2008; Azevedo, Paula Schmidt/S-1597-2019; ROSCANI, MELIZA/AAA-9666-2019; Ferreira, Virginia Clara Teixeira/I-3612-2016; Paiva, Sergio AR/A-5101-2008; Roscani, Meliza/V-1300-2019; Rafacho, Bruna Paola Murino/B-5460-2013; Azevedo, Paula S/F-2701-2012; dos Santos, Priscila Portugal/U-5345-2018	Polegato, Bertha Furlan/0000-0002-2875-9532; Minicucci, Marcos F/0000-0002-5980-4367; Rafacho, Bruna Paola Murino/0000-0001-8825-6980; Zornoff, Leonardo/0000-0002-9831-8820; Azevedo, Paula Schmidt/0000-0002-5843-6232; ROSCANI, MELIZA/0000-0003-1463-551X; Ferreira, Virginia Clara Teixeira/0000-0002-4648-3461; Paiva, Sergio AR/0000-0003-4412-1990; Rafacho, Bruna Paola Murino/0000-0001-8825-6980; Azevedo, Paula S/0000-0002-5843-6232; Di Lorenzo, Annarita/0000-0003-1239-4222; Zanati Bazan, Silmeia Garcia/0000-0002-0607-8189; dos Santos, Priscila Portugal/0000-0003-1159-5030; Azevedo Perdicoulis, Teresa Paula/0000-0002-3281-5357	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP); Botucatu Medical School, UNESP - Univ Estadual Paulista, Botucatu, Sao Paulo, Brasil	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Botucatu Medical School, UNESP - Univ Estadual Paulista, Botucatu, Sao Paulo, Brasil	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo FAPESP) and Botucatu Medical School, UNESP - Univ Estadual Paulista, Botucatu, Sao Paulo, Brasil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel ED, 2011, CARDIOVASC RES, V90, P234, DOI 10.1093/cvr/cvr015; Ashakumary L, 1997, LIPIDS, V32, P311, DOI 10.1007/s11745-997-0038-8; Assalin HB, 2013, CIRC-HEART FAIL, V6, P809, DOI 10.1161/CIRCHEARTFAILURE.112.000298; Azevedo PS, 2013, CARDIOL REV, V21, P135, DOI 10.1097/CRD.0b013e318274956d; Azevedo PS, 2010, ARQ BRAS CARDIOL; BASS A, 1969, EUR J BIOCHEM, V10, P198, DOI 10.1111/j.1432-1033.1969.tb00674.x; BENOWITZ NL, 1982, CLIN PHARMACOL THER, V32, P758, DOI 10.1038/clpt.1982.233; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Burneiko RCM, 2006, FOOD CHEM TOXICOL, V44, P1167, DOI 10.1016/j.fct.2006.01.004; Campbell SC, 2008, ATHEROSCLEROSIS, V201, P225, DOI 10.1016/j.atherosclerosis.2008.04.046; Castardeli E, 2008, MED SCI MONITOR, V14, pBR62; Castardeli E, 2007, EUR J HEART FAIL, V9, P1081, DOI 10.1016/j.ejheart.2007.09.004; Castardeli Édson, 2005, Arq. Bras. Cardiol., V84, P320, DOI 10.1590/S0066-782X2005000400009; Damasceno DC, 2012, OBESITY; de Paiva Sergio Alberto Rupp, 2003, Arq Bras Cardiol, V81, P221; Denipote F, 2011, CELL PHYSIOL BIOCHEM, V27, P291, DOI 10.1159/000327955; Duarte DR, 2010, MED SCI MONITOR, V16, pBR255; Eaton MM, 2006, J TOXICOL ENV HEAL A, V69, P1497, DOI 10.1080/15287390500364788; Ewing JF, 1995, ANAL BIOCHEM, V232, P243, DOI 10.1006/abio.1995.0014; Faux SP, 2009, BIOMARKERS, V14, P90, DOI 10.1080/13547500902965047; Ferrari R, 2009, CIRC J, V73, P1973, DOI 10.1253/circj.CJ-09-0573; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gepner AD, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.023; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Gu LZ, 2008, EUR J HEART FAIL, V10, P1057, DOI 10.1016/j.ejheart.2008.08.009; Gvozdjak J, 1987, Czech Med, V10, P47; GVOZDJAKOVA A, 1984, CARDIOVASC RES, V18, P229, DOI 10.1093/cvr/18.4.229; HARTZ AJ, 1984, NEW ENGL J MED, V311, P1201, DOI 10.1056/NEJM198411083111901; Heckbert SR, 2006, J AM COLL CARDIOL, V48, P2285, DOI 10.1016/j.jacc.2006.03.072; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; JIANG ZY, 1991, LIPIDS, V26, P853, DOI 10.1007/BF02536169; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; LOPESVIRELLA MF, 1977, CLIN CHEM, V23, P882; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maack C, 2011, J AM COLL CARDIOL, V58, P83, DOI 10.1016/j.jacc.2011.01.032; Minicucci Marcos F., 2012, Inflammation & Allergy Drug Targets, V11, P442; Moura R.A., 1982, TECNICAS LAB; Rafacho BPM, 2012, INT J CARDIOL, V155, P472, DOI 10.1016/j.ijcard.2011.12.078; Parasuraman S, 2012, J PHARMACOL PHARMACO, V3, P172, DOI 10.4103/0976-500X.95521; Rafacho BPM, 2011, CELL PHYSIOL BIOCHEM, V27, P305, DOI 10.1159/000327957; Rosen BD, 2006, J AM COLL CARDIOL, V47, P1150, DOI 10.1016/j.jacc.2005.08.078; Tsutsui H, 2011, AM J PHYSIOL-HEART C, V301, pH2181, DOI 10.1152/ajpheart.00554.2011; Wang XD, 1999, J NATL CANCER I, V91, P60, DOI 10.1093/jnci/91.1.60; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060625; Wattanapitayakul SK, 2001, PHARMACOL THERAPEUT, V89, P187, DOI 10.1016/S0163-7258(00)00114-5; WHO WHA, 2012, WHO GLOB REP MORT AT; Yang QF, 2007, J MOL MED-JMM, V85, P697, DOI 10.1007/s00109-007-0170-9; Zhou X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040424; Zhou X, 2010, CARDIOLOGY, V115, P243, DOI 10.1159/000301278; Zornoff LAM, 2006, TOXICOL SCI, V90, P259, DOI 10.1093/toxsci/kfj080; Zornoff Leonardo A. M., 2006, Arq. Bras. Cardiol., V86, P276, DOI 10.1590/S0066-782X2006000400007	52	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113739	10.1371/journal.pone.0113739	http://dx.doi.org/10.1371/journal.pone.0113739			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462161	Green Submitted, gold, Green Published			2022-12-26	WOS:000345869700045
J	Wang, W; Wei, H; Alahuhta, M; Chen, XW; Hyman, D; Johnson, DK; Zhang, M; Himmel, ME				Wang, Wei; Wei, Hui; Alahuhta, Markus; Chen, Xiaowen; Hyman, Deborah; Johnson, David K.; Zhang, Min; Himmel, Michael E.			Heterologous Expression of Xylanase Enzymes in Lipogenic Yeast Yarrowia lipolytica	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; BETA-XYLOSIDASE; PROTEIN EXPRESSION; CLONING; XLND; TRANSFORMATION; SECRETION	To develop a direct microbial sugar conversion platform for the production of lipids, drop-in fuels and chemicals from cellulosic biomass substrate, we chose Yarrowia lipolytica as a viable demonstration strain. Y. lipolytica is known to accumulate lipids intracellularly and is capable of metabolizing sugars to produce lipids; however, it lacks the lignocellulose-degrading enzymes needed to break down biomass directly. While research is continuing on the development of a Y. lipolytica strain able to degrade cellulose, in this study, we present successful expression of several xylanases in Y. lipolytica. The XynII and XlnD expressing Yarrowia strains exhibited an ability to grow on xylan mineral plates. This was shown by Congo Red staining of halo zones on xylan mineral plates. Enzymatic activity tests further demonstrated active expression of XynII and XlnD in Y. lipolytica. Furthermore, synergistic action in converting xylan to xylose was observed when XlnD acted in concert with XynII. The successful expression of these xylanases in Yarrowia further advances us toward our goal to develop a direct microbial conversion process using this organism.	[Wang, Wei; Wei, Hui; Alahuhta, Markus; Johnson, David K.; Himmel, Michael E.] Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80045 USA; [Chen, Xiaowen; Hyman, Deborah; Zhang, Min] Natl Renewable Energy Lab, Natl Bioenergy Ctr, Golden, CO USA	United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA	Wang, W (corresponding author), Natl Renewable Energy Lab, Biosci Ctr, Golden, CO 80045 USA.	wei.wang@nrel.gov; Hui.Wei@nrel.gov; Min.Zhang@nrel.gov	Alahuhta, Markus/E-9344-2012; Johnson, David K/G-4959-2011	Alahuhta, Markus/0000-0001-9375-778X; Johnson, David K/0000-0003-4815-8782; Zhang, Min/0000-0002-9015-2184	U.S. Department of Energy's Bioenergy Technology Office (DOE-BETO) [DE-AC36-08-GO28308]	U.S. Department of Energy's Bioenergy Technology Office (DOE-BETO)(United States Department of Energy (DOE))	Authors gratefully acknowledge support from the U.S. Department of Energy's Bioenergy Technology Office (DOE-BETO) under Contract No. DE-AC36-08-GO28308 with the National Renewable Energy Laboratory. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAILEY MJ, 1992, J BIOTECHNOL, V23, P257, DOI 10.1016/0168-1656(92)90074-J; Barth G, 1997, FEMS MICROBIOL REV, V19, P219, DOI 10.1016/S0168-6445(97)00002-8; Barth G, 1996, RECHERCHE, V67; Barth G., 1996, NONCONVENTIONAL YEAS; Boonvitthya N, 2013, MOL BIOTECHNOL, P1; Cereghino GPL, 1999, CURR OPIN BIOTECH, V10, P422, DOI 10.1016/S0958-1669(99)00004-X; CHEN DC, 1992, CURR GENET, V21, P83, DOI 10.1007/BF00318659; Collins T, 2005, FEMS MICROBIOL REV, V29, P3, DOI 10.1016/j.femsre.2004.06.005; Dall MT, 1994, CURR GENET, V26, P38; DAVIDOW LS, 1985, CURR GENET, V10, P39, DOI 10.1007/BF00418492; DomOnguez A, 2010, INT MICROBIOL, V1, P131; DomOnguez A, 2008, INT MICROBIOL, V1, P131; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Duquesne S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095128; Juretzek T, 2001, YEAST, V18, P97, DOI 10.1002/1097-0061(20010130)18:2<97::AID-YEA652>3.0.CO;2-U; La Grange DC, 2001, APPL ENVIRON MICROB, V67, P5512, DOI 10.1128/AEM.67.12.5512-5519.2001; LaGrange DC, 1997, APPL MICROBIOL BIOT, V47, P262; Madzak C, 2004, J BIOTECHNOL, V109, P63, DOI 10.1016/j.jbiotec.2003.10.027; Muller S, 1998, YEAST, V14, P1267, DOI 10.1002/(SICI)1097-0061(1998100)14:14<1267::AID-YEA327>3.0.CO;2-2; Nicaud JM, 2002, FEMS YEAST RES, V2, P371, DOI 10.1111/j.1567-1364.2002.tb00106.x; Papanikolaou S, 2009, EUR J LIPID SCI TECH, V111, P1221, DOI 10.1002/ejlt.200900055; Peij N. N. M. E. van, 1997, European Journal of Biochemistry, V245, P164, DOI 10.1111/j.1432-1033.1997.00164.x; Perez-Gonzalez J, 1998, APPL ENVIRON MICROB, V64, P1412; Qing Q, 2011, BIORESOURCE TECHNOL, V102, P1359, DOI 10.1016/j.biortech.2010.09.001; Ratledge C, 2002, ADV APPL MICROBIOL, V51, P1, DOI 10.1016/S0065-2164(02)51000-5; Selig MJ, 2008, APPL BIOCHEM BIOTECH, V146, P57, DOI 10.1007/s12010-007-8069-z; Sherman D, 2006, NUCLEIC ACIDS RES, V34, pD432, DOI 10.1093/nar/gkj160; Sluiter A., 2008, BIOMASS ANAL TECHNOL; Sun J, 2012, APPL ENVIRON MICROB, V78, P3837, DOI 10.1128/AEM.07679-11; Tsigie YA, 2011, BIORESOURCE TECHNOL, V102, P9216, DOI 10.1016/j.biortech.2011.06.047	30	26	26	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e111443	10.1371/journal.pone.0111443	http://dx.doi.org/10.1371/journal.pone.0111443			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462572	Green Submitted, Green Published, gold			2022-12-26	WOS:000345869700006
J	Sharir, R; Semo, J; Shimoni, S; Ben-Mordechai, T; Landa-Rouben, N; Maysel-Auslender, S; Shaish, A; Entin-Meer, M; Keren, G; George, J				Sharir, Rinat; Semo, Jonathan; Shimoni, Sara; Ben-Mordechai, Tamar; Landa-Rouben, Natalie; Maysel-Auslender, Sofia; Shaish, Aviv; Entin-Meer, Michal; Keren, Gad; George, Jacob			Experimental Myocardial Infarction Induces Altered Regulatory T Cell Hemostasis, and Adoptive Transfer Attenuates Subsequent Remodeling	PLOS ONE			English	Article							ANTI-CD25 MONOCLONAL-ANTIBODY; SELF-TOLERANCE; HEART-FAILURE; CORONARY; MECHANISMS; DEPLETION; ISCHEMIA; RECOVERY; TREGS	Background: Ischemic cardiac damage is associated with upregulation of cardiac pro-inflammatory cytokines, as well as invasion of lymphocytes into the heart. Regulatory T cells (Tregs) are known to exert a suppressive effect on several immune cell types. We sought to determine whether the Treg pool is influenced by myocardial damage and whether Tregs transfer and deletion affect cardiac remodeling. Methods and Results: The number and functional suppressive activity of Tregs were assayed in mice subjected to experimental myocardial infarction. The numbers of splenocyte-derived Tregs in the ischemic mice were significantly higher after the injury than in the controls, and their suppressive properties were significantly compromised. Compared with PBS, adoptive Treg transfer to mice with experimental infarction reduced infarct size and improved LV remodeling and functional performance by echocardiography. Treg deletion with blocking anti-CD25 antibodies did not influence infarct size or echocardiographic features of cardiac remodeling. Conclusion: Treg numbers are increased whereas their function is compromised in mice with that underwent experimental infarction. Transfer of exogeneous Tregs results in attenuation of myocardial remodeling whereas their ablation has no effect. Thus, Tregs may serve as interesting potential interventional targets for attenuating left ventricular remodeling.	[Sharir, Rinat; Semo, Jonathan; Shimoni, Sara; Maysel-Auslender, Sofia; Entin-Meer, Michal; George, Jacob] Kaplan Med Ctr, Ctr Heart, Rehovot, Israel; [Sharir, Rinat; Semo, Jonathan; Shimoni, Sara; Maysel-Auslender, Sofia; Entin-Meer, Michal; George, Jacob] Hebrew Univ Jerusalem, Jerusalem, Israel; [Sharir, Rinat; Semo, Jonathan; Keren, Gad] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Cardiol, Lab Cardiovasc Res, IL-69978 Tel Aviv, Israel; [Sharir, Rinat; Shimoni, Sara; Maysel-Auslender, Sofia; Entin-Meer, Michal; Keren, Gad] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel; [Ben-Mordechai, Tamar; Landa-Rouben, Natalie] Tel Aviv Univ, Neufeld Cardiac Res Inst, Sheba Ctr Regenerat Med Stem Cells & Tissue Engn, Ramat Gan, Israel; [Ben-Mordechai, Tamar; Landa-Rouben, Natalie] Tamman Cardiovasc Res Inst, Ramat Gan, Israel; [Shaish, Aviv] Chaim Sheba Med Ctr, Bert W Strassburger Lipid Ctr, Ramat Gan, Israel	Hebrew University of Jerusalem; Kaplan Medical Center; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Chaim Sheba Medical Center	George, J (corresponding author), Kaplan Med Ctr, Ctr Heart, Rehovot, Israel.	jgeorge@bezeqint.net						Abbate A, 2008, HEART, V94, P737, DOI 10.1136/hrt.2007.115329; Alyanakian MA, 2003, P NATL ACAD SCI USA, V100, P15806, DOI 10.1073/pnas.2636971100; Betts RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027849; Cheng X, 2008, CLIN IMMUNOL, V127, P89, DOI 10.1016/j.clim.2008.01.009; Cleland JGF, 2001, EUR HEART J, V22, P623, DOI 10.1053/euhj.2000.2493; de Boer OJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000779; Dobaczewski M, 2010, AM J PATHOL, V176, P2177, DOI 10.2353/ajpath.2010.090759; Frangogiannis NG, 2006, ANTIOXID REDOX SIGN, V8, P1907, DOI 10.1089/ars.2006.8.1907; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; Gao XM, 2000, CARDIOVASC RES, V45, P330, DOI 10.1016/S0008-6363(99)00274-6; GERSHON RK, 1975, TRANSPLANT REV-DENMA, V26, P170; GERSHON RK, 1972, J IMMUNOL, V108, P586; Han SF, 2007, CLIN IMMUNOL, V124, P90, DOI 10.1016/j.clim.2007.03.546; Jugdutt BI, 2003, CIRCULATION, V108, P1395, DOI 10.1161/01.CIR.0000085658.98621.49; Kinsey GR, 2010, KIDNEY INT, V77, P771, DOI 10.1038/ki.2010.12; Kinsey GR, 2009, J AM SOC NEPHROL, V20, P1744, DOI 10.1681/ASN.2008111160; Kohm AP, 2006, J IMMUNOL, V176, P3301, DOI 10.4049/jimmunol.176.6.3301; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Liu MC, 2009, MICROVASC RES, V77, P340, DOI 10.1016/j.mvr.2009.01.011; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Maisel A, 1998, CIRC RES, V82, P458, DOI 10.1161/01.RES.82.4.458; Maloy KJ, 2003, J EXP MED, V197, P111, DOI 10.1084/jem.20021345; Mann DL, 1999, CIRCULATION, V100, P999, DOI 10.1161/01.CIR.100.9.999; Matsumoto K, 2011, INT HEART J, V52, P382, DOI 10.1536/ihj.52.382; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Mor A, 2007, ARTERIOSCL THROM VAS, V27, P893, DOI 10.1161/01.ATV.0000259365.31469.89; Mor A, 2006, EUR HEART J, V27, P2530, DOI 10.1093/eurheartj/ehl222; MOREAU JL, 1987, EUR J IMMUNOL, V17, P929, DOI 10.1002/eji.1830170706; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Patten RD, 1998, AM J PHYSIOL-HEART C, V274, pH1812, DOI 10.1152/ajpheart.1998.274.5.H1812; Petzold C, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/940710; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Sarangi PP, 2008, J IMMUNOL, V180, P6297, DOI 10.4049/jimmunol.180.9.6297; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Sharir R, 2014, CARDIOVASC RES, V103, P585, DOI 10.1093/cvr/cvu159; Sharpe N, 1998, Lancet, V352 Suppl 1, pSI3, DOI 10.1016/S0140-6736(98)90012-5; Sun Y, 2002, BASIC RES CARDIOL, V97, P343, DOI 10.1007/s00395-002-0365-8; Sutton MGS, 2000, CIRCULATION, V101, P2981, DOI 10.1161/01.CIR.101.25.2981; Tang QZ, 2004, J EXP MED, V199, P1455, DOI 10.1084/jem.20040139; Tang TT, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0232-6; Ulrich Hofmann NB, 2012, CIRCULATION; Zouggari Y, 2009, CIRCULATION, V120, P1415, DOI 10.1161/CIRCULATIONAHA.109.875583	44	48	48	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113653	10.1371/journal.pone.0113653	http://dx.doi.org/10.1371/journal.pone.0113653			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436994	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900060
J	Miller, PS; Boone, JD; Briggs, JR; Lawler, DF; Levy, JK; Nutter, FB; Slater, M; Zawistowski, S				Miller, Philip S.; Boone, John D.; Briggs, Joyce R.; Lawler, Dennis F.; Levy, Julie K.; Nutter, Felicia B.; Slater, Margaret; Zawistowski, Stephen			Simulating Free-Roaming Cat Population Management Options in Open Demographic Environments	PLOS ONE			English	Article							TRAP-NEUTER-RETURN; FERAL CATS; EUTHANASIA; CONTRACEPTION; PROGRAMS; MODELS; IMPACT	Large populations of free-roaming cats (FRCs) generate ongoing concerns for welfare of both individual animals and populations, for human public health, for viability of native wildlife populations, and for local ecological damage. Managing FRC populations is a complex task, without universal agreement on best practices. Previous analyses that use simulation modeling tools to evaluate alternative management methods have focused on relative efficacy of removal (or trap-return, TR), typically involving euthanasia, and sterilization (or trap-neuter-return, TNR) in demographically isolated populations. We used a stochastic demographic simulation approach to evaluate removal, permanent sterilization, and two postulated methods of temporary contraception for FRC population management. Our models include demographic connectivity to neighboring untreated cat populations through natural dispersal in a metapopulation context across urban and rural landscapes, and also feature abandonment of owned animals. Within population type, a given implementation rate of the TR strategy results in the most rapid rate of population decline and (when populations are isolated) the highest probability of population elimination, followed in order of decreasing efficacy by equivalent rates of implementation of TNR and temporary contraception. Even low levels of demographic connectivity significantly reduce the effectiveness of any management intervention, and continued abandonment is similarly problematic. This is the first demographic simulation analysis to consider the use of temporary contraception and account for the realities of FRC dispersal and owned cat abandonment.	[Miller, Philip S.] Int Union Conservat Nat, Conservat Breeding Specialist Grp, Species Survival Commiss, Apple Valley, MN 55124 USA; [Boone, John D.] Great Basin Bird Observ, Reno, NV USA; [Briggs, Joyce R.] Alliance Contracept Cats & Dogs, Portland, OR USA; [Lawler, Dennis F.] Illinois State Museum, Springfield, IL USA; [Levy, Julie K.] Univ Florida, Maddies Shelter Med Program, Dept Small Anim Clin Sci, Gainesville, FL USA; [Nutter, Felicia B.] Tufts Univ, Dept Infect Dis & Global Hlth, Cummings Sch Vet Med, North Grafton, MA USA; [Slater, Margaret] Amer Soc Prevent Cruelty Anim, Shelter Res & Dev, Florence, MA USA; [Zawistowski, Stephen] Amer Soc Prevent Cruelty Anim, New York, NY USA	State University System of Florida; University of Florida; Tufts University	Miller, PS (corresponding author), Int Union Conservat Nat, Conservat Breeding Specialist Grp, Species Survival Commiss, Apple Valley, MN 55124 USA.	pmiller@cbsg.org			American Society for the Prevention of Cruelty to Animals; National Science Foundation [EF-0832858]; Division Of Environmental Biology [1146198] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1300426] Funding Source: National Science Foundation	American Society for the Prevention of Cruelty to Animals; National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This research was supported by a grant from the American Society for the Prevention of Cruelty to Animals (www.aspca.org) (no grant number available) to JRB. Additional funding from the National Science Foundation (www.nsf.gov), grant #EF-0832858, to MRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akcakaya HR, RAMAS METAPOP VIABIL; Alliance for Contraception in Cats & Dogs, 2013, CONTR FERT CONTR DOG; Andersen MC, 2004, JAVMA-J AM VET MED A, V225, P1871, DOI 10.2460/javma.2004.225.1871; Bevins SN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031403; Budke CM, 2009, J APPL ANIM WELF SCI, V12, P277, DOI 10.1080/10888700903163419; Castillo D, 2003, NAT AREA J, V23, P247; Centers for Disease Control and Prevention, 2011, COMP AN RAB PREV CON; Centers for Disease Control and Prevention, 2004, TOX IMP MESS CAT OWN; Chu K, 2009, JAVMA-J AM VET MED A, V234, P1023, DOI 10.2460/javma.234.8.1023; Courchamp F, 2000, J APPL ECOL, V37, P903, DOI 10.1046/j.1365-2664.2000.00545.x; CROWDER LB, 1994, ECOL APPL, V4, P437, DOI 10.2307/1941948; Crowell-Davis SL, 2004, J FELINE MED SURG, V6, P19, DOI 10.1016/j.jfms.2003.09.013; Foley P, 2005, JAVMA-J AM VET MED A, V227, P1775, DOI 10.2460/javma.2005.227.1775; Gunther I, 2011, JAVMA-J AM VET MED A, V238, P1134, DOI 10.2460/javma.238.9.1134; Hone J, 2010, J APPL ECOL, V47, P507, DOI 10.1111/j.1365-2664.2010.01812.x; Lacy R.C., 2009, VORTEX STOCHASTIC SI; Lessa ICM, 2012, BRAZ J BIOL, V72, P445, DOI 10.1590/S1519-69842012000300005; Levy JK, 2004, JAVMA-J AM VET MED A, V225, P1354, DOI 10.2460/javma.2004.225.1354; Levy JK, 2008, J AM VET MED ASSOC, V222, P42; Levy JK, 2011, THERIOGENOLOGY, V76, P1517, DOI 10.1016/j.theriogenology.2011.06.022; Lohr CA, 2013, CONSERV BIOL, V27, P64, DOI 10.1111/j.1523-1739.2012.01935.x; Loss SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2380; Loyd KAT, 2013, BIOL CONSERV, V160, P183, DOI 10.1016/j.biocon.2013.01.008; Loyd KAT, 2010, ECOL SOC, V15; McCarthy RJ, 2013, JAVMA-J AM VET MED A, V243, P502, DOI 10.2460/javma.243.4.502; Nutter FB, 2005, THESIS N CAROLINA ST; Patronek GJ, 2010, AM J VET RES, V71, P161, DOI 10.2460/ajvr.71.2.161; Rubion S, 2009, REPROD DOMEST ANIM, V44, P79, DOI 10.1111/j.1439-0531.2009.01415.x; Say L, 1999, P ROY SOC B-BIOL SCI, V266, P2071, DOI 10.1098/rspb.1999.0889; Schmidt PM, 2009, WILDLIFE RES, V36, P117, DOI 10.1071/WR08018; Short J, 2005, WILDLIFE RES, V32, P489, DOI 10.1071/WR04102; Turner D.C., 2000, DOMESTIC CAT BIOL IT; van Aarde R.J., 1984, Acta Zoologica Fennica, P107; Zawistowski S, 1998, J Appl Anim Welf Sci, V1, P193, DOI 10.1207/s15327604jaws0103_1	34	50	50	1	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113553	10.1371/journal.pone.0113553	http://dx.doi.org/10.1371/journal.pone.0113553			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426960	Green Submitted, Green Published, gold			2022-12-26	WOS:000349145400063
J	Qian, J; Pentz, K; Zhu, Q; Wang, Q; He, J; Srivastava, AK; Wani, AA				Qian, J.; Pentz, K.; Zhu, Q.; Wang, Q.; He, J.; Srivastava, A. K.; Wani, A. A.			USP7 modulates UV-induced PCNA monoubiquitination by regulating DNA polymerase eta stability	ONCOGENE			English	Article							NUCLEOTIDE EXCISION-REPAIR; PIGMENTOSUM VARIANT GENE; SENSITIVE SYNDROME; PROTEIN; UVSSA; PROTEOLYSIS; HAUSP; RAD18; P53	DNA polymerase eta (Pol eta) has unique and pivotal functions in several DNA damage-tolerance pathways. Steady-state level of this short-lived protein is tightly controlled by multiple mechanisms including proteolysis. Here, we have identified the deubiquitinating enzyme (DUB), ubiquitin-specific protease 7 (USP7), as a novel regulator of Pol eta stability. USP7 regulates Pol eta stability through both indirect and direct mechanisms. Knockout of USP7 increased the steady-state level of Pol eta and slowed down the turnover of both Pol eta and p53 proteins through destabilizing their E3 ligase murine double minute 2 (Mdm2). Also, USP7 physically binds Pol eta in vitro and in vivo. Overexpression of wild-type USP7 but not its catalytically-defective mutants deubiquitinates Pol eta and increases its cellular steady-state level. Thus, USP7 directly serves as a specific DUB for Pol eta. Furthermore, ectopic expression of USP7 promoted the UV-induced proliferating cell nuclear antigen (PCNA) monoubiquitination in Pol eta-proficient but not in Pol eta-deficient XPV (Xeroderma pigmentosum variant) cells, suggesting that USP7 facilitates UV-induced PCNA monoubiquitination by stabilizing Pol eta. Taken together, our findings reveal a modulatory role of USP7 in PCNA ubiquitination-mediated stress-tolerance pathways by fine-tuning Pol eta turnover.	[Qian, J.; Pentz, K.; Zhu, Q.; Wang, Q.; He, J.; Srivastava, A. K.; Wani, A. A.] Ohio State Univ, Dept Radiol, Columbus, OH 43210 USA; [Wani, A. A.] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Wani, A. A.] Ohio State Univ, James Canc Hosp, Columbus, OH 43210 USA; [Wani, A. A.] Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Qian, J (corresponding author), Ohio State Univ, Dept Radiol, 1020 Biomed Res Tower,460W 12th Ave, Columbus, OH 43210 USA.	Qian.41@osu.edu; wani.2@osu.edu			National Institutes of Health [ES012991, ES023883]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002388, R01ES012991, R21ES023883] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We are thankful to Dr Bert Vogelstein for HCT116, HCT116 p53<SUP>-/-</SUP> and HCT116 USP7<SUP>-/-</SUP> cells; Dr Alan Lehmann for XP30RO and XP30RO-GFP-Pol eta cells; Drs Yanhui Xu and Yang Shi for FLAG-tagged WT and CS USP7 constructs; Dr Carol Prives for Myc-Mdm2 construct. This work was supported by grants from the National Institutes of Health (ES012991 and ES023883) to AAW.	Cummins JM, 2004, CELL CYCLE, V3, P689, DOI 10.4161/cc.3.6.924; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; Durando M, 2013, NUCLEIC ACIDS RES, V41, P3079, DOI 10.1093/nar/gkt016; Faustrup H, 2009, J CELL BIOL, V184, P13, DOI 10.1083/jcb.200807137; Friedberg EC, 2005, MOL CELL, V18, P499, DOI 10.1016/j.molcel.2005.03.032; He JS, 2014, J BIOL CHEM, V289, P27278, DOI 10.1074/jbc.M114.589812; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Jung YS, 2012, DNA REPAIR, V11, P177, DOI 10.1016/j.dnarep.2011.10.017; Kim SH, 2008, MOL CELL, V32, P757, DOI 10.1016/j.molcel.2008.11.016; Lehmann AR, 2007, DNA REPAIR, V6, P891, DOI 10.1016/j.dnarep.2007.02.003; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Liu G, 2006, MOL CELL BIOL, V26, P1398, DOI 10.1128/MCB.26.4.1398-1413.2006; Ma HH, 2012, P NATL ACAD SCI USA, V109, P4828, DOI 10.1073/pnas.1116349109; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Sarasin A, 2012, GENOME MED, V4, DOI 10.1186/gm343; Schwertman P, 2012, NAT GENET, V44, P598, DOI 10.1038/ng.2230; Skoneczna A, 2007, J MOL BIOL, V366, P1074, DOI 10.1016/j.jmb.2006.11.093; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039; Zhang X, 2012, NAT GENET, V44, P593, DOI 10.1038/ng.2228	21	44	44	2	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 3	2015	34	36					4791	4796		10.1038/onc.2014.394	http://dx.doi.org/10.1038/onc.2014.394			6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CQ9JU	25435364	Green Accepted			2022-12-26	WOS:000360931500012
J	Lee, E; Shin, A; Jeong, KW; Jin, B; Jnawali, HN; Shin, S; Shin, SY; Kim, Y				Lee, Eunjung; Shin, Areum; Jeong, Ki-Woong; Jin, Bongwhan; Jnawali, Hum Nath; Shin, Soyoung; Shin, Song Yub; Kim, Yangmee			Role of Phenylalanine and Valine(10) Residues in the Antimicrobial Activity and Cytotoxicity of Piscidin-1	PLOS ONE			English	Article							MOLECULAR RECOGNITION; PEPTIDE ANTIBIOTICS; CATIONIC PEPTIDES; LIPID-BILAYER; MEMBRANE; FISH; ANALOGS; NEUTRALIZATION; CONFORMATION; MECHANISMS	Piscidin-1 (Pis-1) is a linear antibacterial peptide derived from mast cells of aquacultured hybrid striped bass that comprises 22 amino acids with a phenylalanine-rich amino-terminus. Pis-1 exhibits potent antibacterial activity against pathogens but is not selective for distinguishing between bacterial and mammalian cells. To determine the key residues for its antibacterial activity and those for its cytotoxicity, we investigated the role of each Phe residue near the N-terminus as well as the Val(10) residue located near the boundary of the hydrophobic and hydrophilic sectors of the helical wheel diagram. Fluorescence dye leakage and tryptophan fluorescence experiments were used to study peptide-lipid interactions, showing comparable depths of insertion of substituted peptides in different membranes. Phe(2) was found to be the most deeply inserted phenylalanine in both bacterial-and mammalian-mimic membranes. Each Phe was substituted with Ala or Lys to investigate its functional role. Phe(2) plays key roles in the cytotoxicity as well as the antibacterial activities of Pis-1, and Phe(6) is essential for the antibacterial activities of Pis-1. We also designed and synthesized a piscidin analog, Pis-V10K, in which Lys was substituted for Val10, resulting in an elevated amphipathic alpha-helical structure. Pis-V10K showed similar antibacterial activity (average minimum inhibitory concentration (MIC) = 1.6 mu M) to Pis-1 (average MIC = 1.5 mu M). However, it exhibited much lower cytotoxicity than Pis-1. Lys(10-)substituted analogs, Pis-F1K/V10K, Pis-F2K/V10K, and Pis-F6K/V10K in which Lys was substituted for Phe retained antibacterial activity toward standard and drug-resistant bacterial strains with novel bacterial cell selectivity. They exert anti-inflammatory activities via inhibition of nitric oxide production, TNF-alpha secretion, and MIP-1 and MIP-2 production. They may disrupt the binding of LPS to toll-like receptors, eventually suppressing MAPKs-mediated signaling pathways. These peptides may be good candidates for the development of peptide antibiotics with potent antibacterial activity but without cytotoxicity.	[Lee, Eunjung; Shin, Areum; Jeong, Ki-Woong; Jin, Bongwhan; Jnawali, Hum Nath; Shin, Soyoung; Kim, Yangmee] Konkuk Univ, Biomol Informat Ctr, Dept Biosci & Biotechnol, Seoul, South Korea; [Shin, Song Yub] Chosun Univ, Sch Med, Res Ctr Proteineous Mat, Kwangju, South Korea; [Shin, Song Yub] Chosun Univ, Sch Med, Dept Cellular & Mol Med, Kwangju, South Korea	Konkuk University; Chosun University; Chosun University	Kim, Y (corresponding author), Konkuk Univ, Biomol Informat Ctr, Dept Biosci & Biotechnol, Seoul, South Korea.	ymkim@konkuk.ac.kr			Priority Research Centers Program [20090093824]; Basic Science Research Program through National Research Foundation of Korea - Ministry of Education, Science, and Technology [2011-0022873, 2013R1A1A2058021]	Priority Research Centers Program; Basic Science Research Program through National Research Foundation of Korea - Ministry of Education, Science, and Technology	This work was supported by grants from the Priority Research Centers Program (20090093824) and from the Basic Science Research Program (2011-0022873 and 2013R1A1A2058021) through the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell Susan Givens, 2003, Neonatal Netw, V22, P47; Blondelle SE, 1999, BBA-BIOMEMBRANES, V1462, P89, DOI 10.1016/S0005-2736(99)00202-3; Campagna S, 2007, BIOCHEMISTRY-US, V46, P1771, DOI 10.1021/bi0620297; Chekmenev EY, 2006, BBA-BIOMEMBRANES, V1758, P1359, DOI 10.1016/j.bbamem.2006.03.034; Chekmenev EY, 2006, J AM CHEM SOC, V128, P5308, DOI 10.1021/ja058385e; Chinchar VG, 2004, VIROLOGY, V323, P268, DOI 10.1016/j.virol.2004.02.029; Colorni A, 2008, J FISH DIS, V31, P423, DOI 10.1111/j.1365-2761.2008.00922.x; Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1; De Angelis AA, 2011, BIOPHYS J, V101, P1086, DOI 10.1016/j.bpj.2011.07.015; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; Ghosh AK, 1997, BIOCHEMISTRY-US, V36, P14291, DOI 10.1021/bi971933j; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Hancock REW, 1998, TRENDS BIOTECHNOL, V16, P82, DOI 10.1016/S0167-7799(97)01156-6; Hancock REW, 2002, FEMS MICROBIOL LETT, V206, P143, DOI 10.1016/S0378-1097(01)00480-3; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Jing WG, 2006, BIOCHEM CELL BIOL, V84, P312, DOI 10.1139/O06-052; Kim JK, 2010, BBA-BIOMEMBRANES, V1798, P1913, DOI 10.1016/j.bbamem.2010.06.026; Kim KH, 2008, J IMMUNOL METHODS, V333, P38, DOI 10.1016/j.jim.2007.12.017; Lauth X, 2002, J BIOL CHEM, V277, P5030, DOI 10.1074/jbc.M109173200; Lee E, 2013, BMB REP, V46, P282, DOI 10.5483/BMBRep.2013.46.5.252; Lee E, 2013, BBA-BIOMEMBRANES, V1828, P271, DOI 10.1016/j.bbamem.2012.10.028; Lee K, 2004, BIOCHEM BIOPH RES CO, V323, P712, DOI 10.1016/j.bbrc.2004.08.144; Lee SA, 2007, BIOCHEMISTRY-US, V46, P3653, DOI 10.1021/bi062233u; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Noga EJ, 2003, DRUG NEWS PERSPECT, V16, P87, DOI 10.1358/dnp.2003.16.2.829325; Park NG, 2011, BIOCHEMISTRY-US, V50, P3288, DOI 10.1021/bi101395j; Perrin BS, 2014, J AM CHEM SOC, V136, P3491, DOI 10.1021/ja411119m; Rosenfeld Y, 2006, J BIOL CHEM, V281, P1636, DOI 10.1074/jbc.M504327200; Saravanan R, 2012, BBA-BIOMEMBRANES, V1818, P1613, DOI 10.1016/j.bbamem.2012.03.015; Silphaduang U, 2001, NATURE, V414, P268, DOI 10.1038/35104690; Subbalakshmi C, 1998, FEMS MICROBIOL LETT, V160, P91, DOI 10.1016/S0378-1097(98)00008-1; WU CSC, 1981, BIOCHEMISTRY-US, V20, P566, DOI 10.1021/bi00506a019; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yu K, 2000, J PEPT RES, V55, P51, DOI 10.1034/j.1399-3011.2000.00146.x; Yuan TH, 2012, BIOPOLYMERS, V97, P998, DOI 10.1002/bip.22116	35	27	28	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114453	10.1371/journal.pone.0114453	http://dx.doi.org/10.1371/journal.pone.0114453			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473836	Green Published, Green Submitted, gold			2022-12-26	WOS:000346382500030
J	Sanabria, NM; Vetten, M; Andraos, C; Boodhia, K; Gulumian, M				Sanabria, Natasha M.; Vetten, Melissa; Andraos, Charlene; Boodhia, Kailen; Gulumian, Mary			Gold Nanoparticle Interference Study during the Isolation, Quantification, Purity and Integrity Analysis of RNA	PLOS ONE			English	Article							ABSORPTION-SPECTRA; PROTEIN; DNA; DEPENDENCE; NM	Investigations have been conducted regarding the interference of nanoparticles (NPs) with different toxicological assay systems, but there is a lack of validation when conducting routine tests for nucleic acid isolation, quantification, integrity, and purity analyses. The interference of citrate-capped gold nanoparticles (AuNPs) was investigated herein. The AuNPs were added to either BEAS-2B bronchial human cells for 24 h, the isolated pure RNA, or added during the isolation procedure, and the resultant interaction was assessed. Total RNA that was isolated from untreated BEAS-2B cells was spiked with various concentrations (v/v%) of AuNPs and quantified. A decrease in the absorbance spectrum (220-340 nm) was observed in a concentration-dependent manner. The 260 and 280 nm absorbance ratios that traditionally infer RNA purity were also altered. Electrophoresis was performed to determine RNA integrity, but could not differentiate between AuNP-exposed samples. However, the spiked post-isolation samples did produce differences in spectra (190-220 nm), where shifts were observed at a shorter wavelength. These shifts could be due to alterations to chromophores found in nucleic acids. The co-isolation samples, spiked with 100 mu L AuNP during the isolation procedure, displayed a peak shift to a longer wavelength and were similar to the results obtained from a 24 h AuNP treatment, under non-cytotoxic test conditions. Moreover, hyperspectral imaging using CytoViva dark field microscopy did not detect AuNP spectral signatures in the RNA isolated from treated cells. However, despite the lack of AuNPs in the final RNA product, structural changes in RNA could still be observed between 190-220 nm. Consequently, full spectral analyses should replace the traditional ratios based on readings at 230, 260, and 280 nm. These are critical points of analyses, validation, and optimization for RNA-based techniques used to assess AuNPs effects.	[Sanabria, Natasha M.; Vetten, Melissa; Andraos, Charlene; Boodhia, Kailen; Gulumian, Mary] NIOH, Dept Biol Toxicol, Johannesburg, South Africa; [Vetten, Melissa; Andraos, Charlene; Gulumian, Mary] WITS, Johannesburg, South Africa		Gulumian, M (corresponding author), NIOH, Dept Biol Toxicol, Johannesburg, South Africa.	Mary.Gulumian@nioh.nhls.ac.za	Sanabria, Natasha/AAY-4665-2020	Sanabria, Natasha/0000-0002-1613-6178; Vetten, Melissa/0000-0001-5438-5813	South African Department of Science and Technology; National Institute for Occupational Health	South African Department of Science and Technology; National Institute for Occupational Health	Funding: MG received funding for this work from the South African Department of Science and Technology (http://www.dst.gov.za/) and the National Institute for Occupational Health (http://www.nioh.ac.za/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balasubramanian SK, 2010, BIOMATERIALS, V31, P9023, DOI 10.1016/j.biomaterials.2010.08.012; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cantara WA, 2011, NUCLEIC ACIDS RES, V39, pD195, DOI 10.1093/nar/gkq1028; Egli M, 2010, STRUCTURE AND FUNCTION, P177, DOI 10.1007/978-90-481-2888-4_7; Frens G, 1973, PHYS SCI, V241, P20; GOLDFARB AR, 1951, J BIOL CHEM, V193, P397; Goodman CM, 2006, CHEM BIOL DRUG DES, V67, P297, DOI 10.1111/j.1747-0285.2006.00372.x; ITO A, 1986, PHOTOCHEM PHOTOBIOL, V44, P355, DOI 10.1111/j.1751-1097.1986.tb04675.x; ITO T, 1991, PHOTOBIOLOGY, P105; Jang NH, 2002, B KOR CHEM SOC, V23, P1790; KISELEVA MN, 1975, BIOFIZIKA+, V20, P561; Kreumers P, 1969, EUROPEAN J BIOCH, V9, P275; Manchester KL, 1996, BIOTECHNIQUES, V20, P968; Martin LA, 2002, MOL BIOL PROBLEM SOL, P197; Mathews DH, 2004, P NATL ACAD SCI USA, V101, P7287, DOI 10.1073/pnas.0401799101; Ong KJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090650; Patra CR, 2010, ADV DRUG DELIVER REV, V62, P346, DOI 10.1016/j.addr.2009.11.007; Phillips GF, 1995, TABLES PHYS CHEM CON; Railsback JG, 2012, ADV MATER, V24, P4261, DOI 10.1002/adma.201104891; ROSENHECK K, 1961, P NATL ACAD SCI USA, V47, P1775, DOI 10.1073/pnas.47.11.1775; Saptarshi SR, 2013, J NANOBIOTECHNOL, V11, DOI 10.1186/1477-3155-11-26; Schmid F.-X, 2001, ENCY LIFE SCI; SCOPES RK, 1974, ANAL BIOCHEM, V59, P277, DOI 10.1016/0003-2697(74)90034-7; Tan ZJ, 2008, BIOPHYS J, V95, P738, DOI 10.1529/biophysj.108.131524; TURKEVICH J, 1951, DISCUSS FARADAY SOC, P55, DOI 10.1039/df9511100055; Vetten MA, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-50; Warburg O., 1942, BIOCHEM Z, V310, P384; WOLF P, 1983, ANAL BIOCHEM, V129, P145, DOI 10.1016/0003-2697(83)90062-3; Xu X, 2012, NUCLEIC ACIDS RES, V40, P7622, DOI 10.1093/nar/gks517	29	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114123	10.1371/journal.pone.0114123	http://dx.doi.org/10.1371/journal.pone.0114123			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470814	Green Submitted, Green Published, gold			2022-12-26	WOS:000349128700073
J	Schroeder, L; Roseman, CC; Cheverud, JM; Ackermann, RR				Schroeder, Lauren; Roseman, Charles C.; Cheverud, James M.; Ackermann, Rebecca R.			Characterizing the Evolutionary Path(s) to Early Homo	PLOS ONE			English	Article							NATURAL-SELECTION; GENETIC DRIFT; GREAT APE; NEANDERTHAL; AFRICA; DIFFERENTIATION; SPANDRELS; DIVERSITY; FOSSILS; TURKANA	Numerous studies suggest that the transition from Australopithecus to Homo was characterized by evolutionary innovation, resulting in the emergence and coexistence of a diversity of forms. However, the evolutionary processes necessary to drive such a transition have not been examined. Here, we apply statistical tests developed from quantitative evolutionary theory to assess whether morphological differences among late australopith and early Homo species in Africa have been shaped by natural selection. Where selection is demonstrated, we identify aspects of morphology that were most likely under selective pressure, and determine the nature (type, rate) of that selection. Results demonstrate that selection must be invoked to explain an Au. africanus-Au. sediba-Homo transition, while transitions from late australopiths to various early Homo species that exclude Au. sediba can be achieved through drift alone. Rate tests indicate that selection is largely directional, acting to rapidly differentiate these taxa. Reconstructions of patterns of directional selection needed to drive the Au. africanus-Au. sediba-Homo transition suggest that selection would have affected all regions of the skull. These results may indicate that an evolutionary path to Homo without Au. sediba is the simpler path and/or provide evidence that this pathway involved more reliance on cultural adaptations to cope with environmental change.	[Schroeder, Lauren; Ackermann, Rebecca R.] Univ Cape Town, Dept Archaeol, ZA-7701 Rondebosch, South Africa; [Roseman, Charles C.] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; [Cheverud, James M.] Loyola Univ, Dept Biol, Chicago, IL 60626 USA	University of Cape Town; University of Illinois System; University of Illinois Urbana-Champaign; Loyola University Chicago	Ackermann, RR (corresponding author), Univ Cape Town, Dept Archaeol, ZA-7701 Rondebosch, South Africa.	becky.ackermann@uct.ac.za	Roseman, Charles/AAL-6141-2021	Roseman, Charles/0000-0002-4589-0401	Palaeontological Scientific Trust; L.S.B. Leakey Foundation; South African National Research Foundation; University Research Council at the University of Cape Town	Palaeontological Scientific Trust; L.S.B. Leakey Foundation; South African National Research Foundation(National Research Foundation - South Africa); University Research Council at the University of Cape Town	Funding provided by the Palaeontological Scientific Trust (LS), the L.S.B. Leakey Foundation (Baldwin Fellowship; LS), the South African National Research Foundation (LS, RRA), and the University Research Council at the University of Cape Town (RRA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann RR, 2002, AM J PHYS ANTHROPOL, V117, P260, DOI 10.1002/ajpa.10038; Ackermann RR, 2004, P NATL ACAD SCI USA, V101, P17946, DOI 10.1073/pnas.0405919102; ACKERMANN RR, 1998, THESIS WASHINGTON U; Anton SC, 2014, SCIENCE, V345, P45, DOI 10.1126/science.1236828; Anton SC, 2012, CURR ANTHROPOL, V53, pS278, DOI 10.1086/667695; Berger LR, 2010, SCIENCE, V328, P195, DOI 10.1126/science.1184944; Bobe R, 2004, PALAEOGEOGR PALAEOCL, V207, P399, DOI 10.1016/j.palaeo.2003.09.033; BROMAGE TG, 1995, J HUM EVOL, V28, P71, DOI 10.1006/jhev.1995.1007; Cerling TE, 1992, PALAEOGEOGR PALAEOCL, V97, P241, DOI 10.1016/0031-0182(92)90211-M; CHEVERUD JM, 1986, SYST ZOOL, V35, P381, DOI 10.2307/2413389; CLYDE WC, 1994, PALEOBIOLOGY, V20, P506, DOI 10.1017/S0094837300012963; Curnoe D, 2010, HOMO, V61, P151, DOI 10.1016/j.jchb.2010.04.002; de Leon MSP, 2001, NATURE, V412, P534, DOI 10.1038/35087573; de Ruiter DJ, 2013, SCIENCE, V340, DOI 10.1126/science.1232997; deMenocal PB, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P262; GOULD SJ, 1979, PROC R SOC SER B-BIO, V205, P581, DOI 10.1098/rspb.1979.0086; Harvati K, 2003, J HUM EVOL, V44, P107, DOI 10.1016/S0047-2484(02)00208-7; Howells W. W., 1973, PAPERS PEABODY MUSEU, V67; Irish JD, 2013, SCIENCE, V340, DOI 10.1126/science.1233062; Kimbel WH, 1996, J HUM EVOL, V31, P549, DOI 10.1006/jhev.1996.0079; Kimbel William H., 2009, P31, DOI 10.1007/978-1-4020-9980-9_4; KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0; Kimura M, 1984, NEUTRAL THEORY MOL E; Klein R.G., 2009, HUMAN CAREER HUMAN B, V3rd; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; LANDE R, 1980, AM NAT, V116, P463, DOI 10.1086/283642; LANDE R, 1977, EVOLUTION, V31, P442, DOI 10.1111/j.1558-5646.1977.tb01025.x; LANDE R, 1979, EVOLUTION, V33, P234, DOI [10.2307/2407380, 10.1111/j.1558-5646.1979.tb04678.x]; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; LEAKEY LSB, 1964, NATURE, V202, P7, DOI 10.1038/202007a0; Leakey MG, 2012, NATURE, V488, P201, DOI 10.1038/nature11322; Lewontin R.C., 1991, BIOL IDEOLOGY DOCTRI, VReprint ed.; LEWONTIN RC, 1979, BEHAV SCI, V24, P5, DOI 10.1002/bs.3830240103; Lockwood CA, 2004, P NATL ACAD SCI USA, V101, P4356, DOI 10.1073/pnas.0306235101; LOFSVOLD D, 1988, EVOLUTION, V42, P54, DOI [10.2307/2409115, 10.1111/j.1558-5646.1988.tb04107.x]; LYNCH M, 1990, AM NAT, V136, P727, DOI 10.1086/285128; Marroig G, 2004, J EVOLUTION BIOL, V17, P144, DOI 10.1046/j.1420-9101.2003.00653.x; Marroig G, 2004, AM NAT, V163, P417, DOI 10.1086/381693; Marroig G, 2012, EVOLUTION, V66, P1506, DOI 10.1111/j.1558-5646.2011.01555.x; MAYR E, 1983, AM NAT, V121, P324, DOI 10.1086/284064; Pigliucci M, 2000, TRENDS ECOL EVOL, V15, P66, DOI 10.1016/S0169-5347(99)01762-0; Potts R., 2002, PROBING HUMAN ORIGIN, P33; Roseman CC, 2004, P NATL ACAD SCI USA, V101, P12824, DOI 10.1073/pnas.0402637101; Roseman CC, 2010, AM J PHYS ANTHROPOL, V143, P1, DOI 10.1002/ajpa.21341; Shackleton NJ, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P242; Smith HF, 2009, AM J HUM BIOL, V21, P36, DOI 10.1002/ajhb.20805; Spoor F, 2007, NATURE, V448, P688, DOI 10.1038/nature05986; von Cramon-Taubadel N, 2012, J HUM EVOL, V62, P640, DOI 10.1016/j.jhevol.2012.02.007; von Cramon-Taubadel N, 2009, J HUM EVOL, V57, P179, DOI 10.1016/j.jhevol.2009.05.009; Vrba Elisabeth S., 2007, P1441, DOI 10.1007/978-3-540-33761-4_47; Weaver TD, 2007, J HUM EVOL, V53, P135, DOI 10.1016/j.jhevol.2007.03.001; Williams FL, 2003, CLIN ANAT, V16, P494, DOI 10.1002/ca.10095; Willmore KE, 2009, EVOL BIOL, V36, P19, DOI 10.1007/s11692-009-9056-9; Wood B. A., 1991, HOMINID CRANIAL REMA, V4; Wynn JG, 2004, AM J PHYS ANTHROPOL, V123, P106, DOI 10.1002/ajpa.10317; Yu N, 2004, GENETICS, V166, P1375, DOI 10.1534/genetics.166.3.1375	56	28	28	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114307	10.1371/journal.pone.0114307	http://dx.doi.org/10.1371/journal.pone.0114307			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7WS	25470780	Green Published, gold			2022-12-26	WOS:000349128700100
J	Tian, Y; Linden, J; French, BA; Yang, ZQ				Tian, Yikui; Linden, Joel; French, Brent A.; Yang, Zequan			Atorvastatin at Reperfusion Reduces Myocardial Infarct Size in Mice by Activating eNOS in Bone Marrow-Derived Cells	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; COA REDUCTASE INHIBITORS; PERCUTANEOUS CORONARY INTERVENTION; RAT HEARTS; HYPERCHOLESTEROLEMIC PATIENTS; ISCHEMIA/REPERFUSION INJURY; RECEPTOR ACTIVATION; ISCHEMIA; PRETREATMENT; PROTECTION	Background: The current study was designed to test our hypothesis that atorvastatin could reduce infarct size in intact mice by activating eNOS, specifically the eNOS in bone marrow-derived cells. C57BL/6J mice (B6) and congenic eNOS knockout (KO) mice underwent 45 min LAD occlusion and 60 min reperfusion. Chimeric mice, created by bone marrow transplantation between B6 and eNOS KO mice, underwent 40 min LAD occlusion and 60 min reperfusion. Mice were treated either with vehicle or atorvastatin in 5% ethanol at a dose of 10 mg/kg IV 5 min before initiating reperfusion. Infarct size was evaluated by TTC and Phthalo blue staining. Results: Atorvastatin treatment reduced infarct size in B6 mice by 19% (p<0.05). In eNOS KO vehicle-control mice, infarct size was comparable to that of B6 vehicle-control mice (p=NS). Atorvastatin treatment had no effect on infarct size in eNOS KO mice (p=NS). In chimeras, atorvastatin significantly reduced infarct size in B6/B6 (donor/recipient) mice and B6/KO mice (p<0.05), but not in KO/KO mice or KO/B6 mice (p=NS). Conclusions: The results demonstrate that acute administration of atorvastatin significantly reduces myocardial ischemia/reperfusion injury in an eNOS-dependent manner, probably through the post-transcriptional activation of eNOS in bone marrow-derived cells.	[Tian, Yikui; Yang, Zequan] Univ Virginia Hlth Syst, Dept Surg, Charlottesville, VA 22908 USA; [Linden, Joel; French, Brent A.] Univ Virginia Hlth Syst, Dept Med, Charlottesville, VA USA; [French, Brent A.; Yang, Zequan] Univ Virginia Hlth Syst, Dept Biomed Sci, Charlottesville, VA USA; [Linden, Joel] La Jolla Inst Allergy & Immunol, La Jolla, CA USA; [Tian, Yikui] Tianjin Med Univ, Gen Hosp, Dept Cardiovasc Surg, Tianjin, Peoples R China	University of Virginia; University of Virginia; University of Virginia; La Jolla Institute for Immunology; Tianjin Medical University	Yang, ZQ (corresponding author), Univ Virginia Hlth Syst, Dept Surg, Charlottesville, VA 22908 USA.	zy6b@virginia.edu	Tian, Yikui/U-2247-2018; Linden, Joel/AAH-5690-2020	Tian, Yikui/0000-0003-0311-4794; 	ARA Award; Pfizer Inc.;  [R01 HL69494]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069494] Funding Source: NIH RePORTER	ARA Award; Pfizer Inc.(Pfizer); ; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by an ARA Award (sponsored by Pfizer Inc.) to ZY and by R01 HL69494 to BAF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreadou I, 2012, CARDIOVASC RES, V94, P501, DOI 10.1093/cvr/cvs121; Barrabes JA, 2010, THROMB HAEMOSTASIS, V104, P128, DOI 10.1160/TH09-07-0440; Bauer T, 2009, J CARDIOVASC PHARM, V53, P132, DOI 10.1097/FJC.0b013e3181976a3c; Bell RM, 2003, J AM COLL CARDIOL, V41, P508, DOI 10.1016/S0735-1097(02)02816-4; Chen M, 2013, J CARDIOVASC PHARM, V62, P320, DOI 10.1097/FJC.0b013e31829be05b; Day YJ, 2003, J CLIN INVEST, V112, P883, DOI 10.1172/JCI200315483; Freedman JE, 1997, J CLIN INVEST, V100, P350, DOI 10.1172/JCI119540; Gaddam V., 2002, Journal of Cardiovascular Pharmacology and Therapeutics, V7, P247, DOI 10.1177/107424840200700408; Guo Y, 1999, P NATL ACAD SCI USA, V96, P11507, DOI 10.1073/pnas.96.20.11507; Guo YR, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0253-9; Hafezi-Moghadam A, 2002, NAT MED, V8, P473, DOI 10.1038/nm0502-473; Hahn JY, 2011, AM HEART J, V162, P1026, DOI 10.1016/j.ahj.2011.08.011; Harris MB, 2004, AM J PHYSIOL-HEART C, V287, pH560, DOI 10.1152/ajpheart.00214.2004; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Jayachandran M, 2003, PLATELETS, V14, P75, DOI 10.1080/0953710031000080562; Jialal I, 2001, CIRCULATION, V103, P1933; Jones SP, 2001, ACTA PHYSIOL SCAND, V173, P139, DOI 10.1046/j.1365-201X.2001.00899.x; Jones SP, 2002, J AM COLL CARDIOL, V40, P1172, DOI 10.1016/S0735-1097(02)02115-0; Kupatt C, 2002, J LEUKOCYTE BIOL, V72, P455; Laufs U, 2000, STROKE, V31, P2442, DOI 10.1161/01.STR.31.10.2442; Lefer AM, 1999, CIRCULATION, V100, P178, DOI 10.1161/01.CIR.100.2.178; LEUNG WH, 1993, LANCET, V341, P1496, DOI 10.1016/0140-6736(93)90634-S; Li XD, 2012, ACTA PHARMACOL SIN, V33, P879, DOI 10.1038/aps.2012.27; Marzilli M, 2010, AM J CARDIOVASC DRUG, V10, P3, DOI 10.2165/1153644-S0-000000000-00000; Massberg S, 1998, BLOOD, V92, P507, DOI 10.1182/blood.V92.2.507; Mensah K, 2005, J AM COLL CARDIOL, V45, P1287, DOI 10.1016/j.jacc.2005.01.021; Mirabet M, 2002, AM J PHYSIOL-HEART C, V283, pH1134, DOI 10.1152/ajpheart.00065.2002; Olsson AG, 2002, ACTA PHYSIOL SCAND, V176, P147, DOI 10.1046/j.1365-201X.2002.01017.x; Olsson AG, 2002, ANN MED, V34, P37, DOI 10.1080/078538902317338625; Patti G, 2007, J AM COLL CARDIOL, V49, P1272, DOI 10.1016/j.jacc.2007.02.025; Rikitake Y, 2005, CIRC RES, V97, P1232, DOI 10.1161/01.RES.0000196564.18314.23; Rork TH, 2008, AM J PHYSIOL-HEART C, V295, pH1825, DOI 10.1152/ajpheart.495.2008; Sanguigni V, 2005, CIRCULATION, V111, P412, DOI 10.1161/01.CIR.0000153810.81187.7D; Teupser D, 2001, BIOCHEM BIOPH RES CO, V289, P838, DOI 10.1006/bbrc.2001.6066; Undas A, 2001, CIRCULATION, V103, P2248; Wassmann S, 2001, HYPERTENSION, V37, P1450, DOI 10.1161/01.HYP.37.6.1450; Wassmann S, 2003, CIRC RES, V93, pE98, DOI 10.1161/01.RES.0000099503.13312.7B; Waters D, 2001, CURR CONTR TRIALS C, V2, P111; Wolfrum S, 2004, J CARDIOVASC PHARM, V44, P348, DOI 10.1097/01.fjc.0000137162.14735.30; Wright DG, 2005, VASC PHARMACOL, V42, P265, DOI 10.1016/j.vph.2005.02.006; Xu YQ, 2006, AM J PHYSIOL-HEART C, V290, pH692, DOI 10.1152/ajpheart.00634.2005; Yamakuchi M, 2005, CIRC RES, V96, P1185, DOI 10.1161/01.RES.0000170229.49776.81; Yang ZQ, 2005, CIRCULATION, V111, P2190, DOI 10.1161/01.CIR.0000163586.62253.A5; Ye YM, 2008, AM J PHYSIOL-HEART C, V295, pH343, DOI 10.1152/ajpheart.01350.2007; Zuidema MY, 2010, WORLD J CARDIOL, V2, P325, DOI 10.4330/wjc.v2.i10.325	45	4	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114375	10.1371/journal.pone.0114375	http://dx.doi.org/10.1371/journal.pone.0114375			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470018	gold, Green Published, Green Submitted			2022-12-26	WOS:000349128700107
J	Catalao, MJ; Figueiredo, J; Henriques, MX; Gomes, JP; Filipe, SR				Catalao, Maria Joao; Figueiredo, Joana; Henriques, Mafalda X.; Gomes, Joao Paulo; Filipe, Sergio R.			Optimization of Fluorescent Tools for Cell Biology Studies in Gram-Positive Bacteria	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; GENE-EXPRESSION; PROTEIN; IDENTIFICATION; TRANSFORMATION; COLONIZATION; PNEUMOCOCCUS; DISEASE; SYSTEM; OPERON	The understanding of how Gram-positive bacteria divide and ensure the correct localization of different molecular machineries, such as those involved in the synthesis of the bacterial cell surface, is crucial to design strategies to fight bacterial infections. In order to determine the correct subcellular localization of fluorescent proteins in Streptococcus pneumoniae, we have previously described tools to express derivatives of four fluorescent proteins, mCherry, Citrine, CFP and GFP, to levels that allow visualization by fluorescence microscopy, by fusing the first ten amino acids of the S. pneumoniae protein Wze (the i-tag), upstream of the fluorescent protein. Here, we report that these tools can also be used in other Gram-positive bacteria, namely Lactococcus lactis, Staphylococcus aureus and Bacillus subtilis, possibly due to optimized translation rates. Additionally, we have optimized the i-tag by testing the effect of the first ten amino acids of other pneumococcal proteins in the increased expression of the fluorescent protein Citrine. We found that manipulating the structure and stability of the 5' end of the mRNA molecule, which may influence the accessibility of the ribosome, is determinant to ensure the expression of a strong fluorescent signal.	[Catalao, Maria Joao; Figueiredo, Joana; Henriques, Mafalda X.; Filipe, Sergio R.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Bacterial Cell Surfaces & Pathogenesis, P-2781901 Oeiras, Portugal; [Gomes, Joao Paulo] Natl Inst Hlth, Dept Infect Dis, P-1649016 Lisbon, Portugal	Universidade Nova de Lisboa	Filipe, SR (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Lab Bacterial Cell Surfaces & Pathogenesis, Ave Republ,Apartado 127, P-2781901 Oeiras, Portugal.	sfilipe@itqb.unl.pt	Catalão, Maria João/B-6731-2017; Filipe, Sergio Raposo/B-9167-2008; iMed.ULisboa, HPI/B-4239-2014; Catalao, Maria Joao/P-3248-2019; Figueiredo, Joana/T-9046-2017	Catalão, Maria João/0000-0002-3794-457X; Filipe, Sergio Raposo/0000-0002-4485-832X; iMed.ULisboa, HPI/0000-0001-5934-0198; Catalao, Maria Joao/0000-0002-3794-457X; Figueiredo, Joana/0000-0002-6804-0522; Gomes, Joao Paulo/0000-0002-2697-2399	Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal [PTDC/BIA-MIC/111817/2009]; FCT [PEst-OE/EQB/LA0004/2011, SFRH/BD/43797/2008, SFRH/BPD/77758/2011]	Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was funded by Fundacao para a Ciencia e Tecnologia (FCT), Lisbon, Portugal, through research grant PTDC/BIA-MIC/111817/2009 awarded to SRF. The work performed at Instituto de Tecnologia Quimica e Biologica was supported additionally by FCT through grant PEst-OE/EQB/LA0004/2011. MXH and MJC were supported by FCT fellowships SFRH/BD/43797/2008 and SFRH/BPD/77758/2011, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Arnaud M, 2004, APPL ENVIRON MICROB, V70, P6887, DOI 10.1128/AEM.70.11.6887-6891.2004; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; de Palencia PF, 2000, FEMS MICROBIOL LETT, V183, P229, DOI 10.1111/j.1574-6968.2000.tb08963.x; Filipe SR, 2000, J BIOL CHEM, V275, P27768; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Henriques MX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055049; Henriques MX, 2011, MOL MICROBIOL, V82, P515, DOI 10.1111/j.1365-2958.2011.07828.x; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kudla G, 2009, SCIENCE, V324, P255, DOI 10.1126/science.1170160; LACKS S, 1960, BIOCHIM BIOPHYS ACTA, V39, P508, DOI 10.1016/0006-3002(60)90205-5; LACKS SA, 1986, J MOL BIOL, V192, P753, DOI 10.1016/0022-2836(86)90026-4; Lacks SA, 2000, MOL MICROBIOL, V35, P1089, DOI 10.1046/j.1365-2958.2000.01777.x; Lee YS, 2009, GENE DEV, V23, P2639, DOI 10.1101/gad.1837609; Leenhouts K, 1996, MOL GEN GENET, V253, P217, DOI 10.1007/s004380050315; SABELNIKOV AG, 1995, J MOL BIOL, V250, P144, DOI 10.1006/jmbi.1995.0366; Veening JW, 2004, APPL ENVIRON MICROB, V70, P6809, DOI 10.1128/AEM.70.11.6809-6815.2004; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	21	2	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113796	10.1371/journal.pone.0113796	http://dx.doi.org/10.1371/journal.pone.0113796			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464377	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700053
J	Silva, YJ; Costa, L; Pereira, C; Mateus, C; Cunha, A; Calado, R; Gomes, NCM; Pardo, MA; Hernandez, I; Almeida, A				Silva, Yolanda J.; Costa, Liliana; Pereira, Carla; Mateus, Cristiana; Cunha, Angela; Calado, Ricardo; Gomes, Newton C. M.; Pardo, Miguel A.; Hernandez, Igor; Almeida, Adelaide			Phage Therapy as an Approach to Prevent Vibrio anguillarum Infections in Fish Larvae Production	PLOS ONE			English	Article							PSEUDOMONAS-PLECOGLOSSICIDA; BACTERIOPHAGE CONTROL; LYTIC BACTERIOPHAGE; ATLANTIC SALMON; COLONIZATION; ENVIRONMENTS; BIOCONTROL; EFFICACY; DISEASE; SKIN	Fish larvae in aquaculture have high mortality rates due to pathogenic bacteria, especially the Vibrio species, and ineffective prophylactic strategies. Vaccination is not feasible in larvae and antibiotics have reduced efficacy against multidrug resistant bacteria. A novel approach to controlling Vibrio infections in aquaculture is needed. The potential of phage therapy to combat vibriosis in fish larvae production has not yet been examined. We describe the isolation and characterization of two bacteriophages capable of infecting pathogenic Vibrio and their application to prevent bacterial infection in fish larvae. Two groups of zebrafish larvae were infected with V. anguillarum (similar to 10(6) CFU mL(-1)) and one was later treated with a phage lysate (similar to 10(8) PFU mL(-1)). A third group was only added with phages. A fourth group received neither bacteria nor phages (fish control). Larvae mortality, after 72 h, in the infected and treated group was similar to normal levels and significantly lower than that of the infected but not treated group, indicating that phage treatment was effective. Thus, directly supplying phages to the culture water could be an effective and inexpensive approach toward reducing the negative impact of vibriosis in larviculture.	[Silva, Yolanda J.; Costa, Liliana; Pereira, Carla; Mateus, Cristiana; Cunha, Angela; Calado, Ricardo; Gomes, Newton C. M.; Almeida, Adelaide] Univ Aveiro, CESAM, P-3810193 Aveiro, Portugal; [Silva, Yolanda J.; Costa, Liliana; Pereira, Carla; Mateus, Cristiana; Cunha, Angela; Calado, Ricardo; Gomes, Newton C. M.; Almeida, Adelaide] Univ Aveiro, Dept Biol, P-3810193 Aveiro, Portugal; [Pardo, Miguel A.; Hernandez, Igor] Food Res Div AZTI Tecnalia, Derio 48160, Spain	Universidade de Aveiro; Universidade de Aveiro; AZTI	Almeida, A (corresponding author), Univ Aveiro, CESAM, Campus Univ Santiago 11, P-3810193 Aveiro, Portugal.	aalmeida@ua.pt	Calado, Ricardo Jorge Guerra/C-7035-2008; Cunha, Angela/AAC-3830-2019; Pereira, Carla Sofia Gomes/L-8589-2019; Gomes, Newton CM/F-7430-2012; Hernandez, Igor/AAG-6235-2020; Gomes, Newton Carlos Marcial/K-3211-2015; Almeida, Adelaide/D-9899-2011; Gomes, Newton Carlos Marcial/AAV-4603-2021; Pereira, Carla S.G/F-3373-2019; Hernandez, Igor/ADV-0198-2022; Cunha, Angela/E-9537-2011; Pardo, Miguel Angel/H-5133-2015	Calado, Ricardo Jorge Guerra/0000-0002-1670-9335; Cunha, Angela/0000-0002-9118-3521; Pereira, Carla Sofia Gomes/0000-0001-9209-7687; Gomes, Newton CM/0000-0003-1934-0091; Hernandez, Igor/0000-0002-4363-448X; Gomes, Newton Carlos Marcial/0000-0003-1934-0091; Almeida, Adelaide/0000-0002-8422-8664; Gomes, Newton Carlos Marcial/0000-0003-1934-0091; Cunha, Angela/0000-0002-9118-3521; Pardo, Miguel Angel/0000-0002-3395-3380	FEDER COMPETE (Competitiveness Factors Operational Program); FCT (Portuguese Foundation for Science and Technology) [FCOMP-01-0124-FEDER-013934]; Center for Environmental and Marine Studies (CESAM) [Pest-C/MAR/LA0017/2013]; FCTFCT [SFRH/BD/65147/2009, SFRH/BD/ 76414/2011, BI/UI88/5319/2011]	FEDER COMPETE (Competitiveness Factors Operational Program); FCT (Portuguese Foundation for Science and Technology)(Portuguese Foundation for Science and Technology); Center for Environmental and Marine Studies (CESAM); FCTFCT	This work was supported by FEDER COMPETE (Competitiveness Factors Operational Program) and by FCT (Portuguese Foundation for Science and Technology), under the research project FCOMP-01-0124-FEDER-013934; and Center for Environmental and Marine Studies (CESAM) for funding (Project Pest-C/MAR/LA0017/2013). Financial support to Y. J. Silva, C. Pereira, and L. Costa was provided by FCT in the form of PhD grants (SFRH/BD/65147/2009 and SFRH/BD/ 76414/2011) and a BI grant (BI/UI88/5319/2011), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedon ST, 2001, APPL ENVIRON MICROB, V67, P4233, DOI 10.1128/AEM.67.9.4233-4241.2001; Almeida A, 1994, MORFOLOGIA INFECCAO; Almeida A, 2009, MAR DRUGS, V7, P268, DOI 10.3390/md7030268; ALMEIDA MA, 1992, MAR ECOL PROG SER, V89, P165, DOI 10.3354/meps089165; [Anonymous], 1983, LANCET, V2, P1287; Barrow P, 1998, CLIN DIAGN LAB IMMUN, V5, P294, DOI 10.1128/CDLI.5.3.294-298.1998; BEVERIDGE MCM, 1991, J FISH BIOL, V39, P825, DOI 10.1111/j.1095-8649.1991.tb04412.x; Capparelli R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011720; Crothers-Stomps C, 2010, J APPL MICROBIOL, V108, P1744, DOI 10.1111/j.1365-2672.2009.04578.x; Duckworth DH, 2002, BIODRUGS, V16, P57, DOI 10.2165/00063030-200216010-00006; Filippov AA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025486; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; HANSEN GH, 1989, APPL ENVIRON MICROB, V55, P1435, DOI 10.1128/AEM.55.6.1435-1446.1989; Higuera G, 2013, AQUACULTURE, V392, P128, DOI 10.1016/j.aquaculture.2013.02.013; Karunasagar I, 2007, AQUACULTURE, V268, P288, DOI 10.1016/j.aquaculture.2007.04.049; Laanto E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053157; Lan CC, 2012, ISRN MICROBIOL, V14; Levin BR, 2004, NAT REV MICROBIOL, V2, P166, DOI 10.1038/nrmicro822; Louvado A, 2012, J MICROBIOL BIOTECHN, V22, P283, DOI 10.4014/jmb.1110.10041; Martinez JL, 2003, MOL GENETICS MARINE, V10; Martinez-Diaz SF, 2013, AQUACULTURE, V400, P120, DOI 10.1016/j.aquaculture.2013.03.007; Mateus L, 2014, AQUACULTURE, V424, P167, DOI 10.1016/j.aquaculture.2014.01.001; MERINO S, 1990, FEMS MICROBIOL LETT, V68, P239, DOI 10.1016/S0378-1097(05)80047-3; Munro J, 2003, DIS AQUAT ORGAN, V54, P187, DOI 10.3354/dao054187; Nakai T, 1999, DIS AQUAT ORGAN, V37, P33, DOI 10.3354/dao037033; Nakai T, 2002, RES MICROBIOL, V153, P13, DOI 10.1016/S0923-2508(01)01280-3; Noorlis A., 2011, INT FOOD RES J, V18, P689; NOYA M, 1995, P 5 NAT C AQ SANT CA, P734; Olafsen J.A., 1984, Flodevigen Rapportserie, V1, P627; Olafsen JA, 2001, AQUACULTURE, V200, P223, DOI 10.1016/S0044-8486(01)00702-5; OLAFSEN JA, 1992, J FISH BIOL, V40, P141, DOI 10.1111/j.1095-8649.1992.tb02562.x; Oyarbide U, 2012, ZEBRAFISH, V9, P74, DOI 10.1089/zeb.2011.0724; Park SC, 2003, DIS AQUAT ORGAN, V53, P33, DOI 10.3354/dao053033; Park SC, 2000, APPL ENVIRON MICROB, V66, P1416, DOI 10.1128/AEM.66.4.1416-1422.2000; Pasqualina L., 2011, NEW MICROBIOL, V34, P53; Pereira C, 2011, MAR DRUGS, V9, P2236, DOI 10.3390/md9112236; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shao ZZJ, 2001, ADV DRUG DELIVER REV, V50, P229, DOI 10.1016/S0169-409X(01)00159-4; Shivu MM, 2007, ENVIRON MICROBIOL, V9, P322, DOI 10.1111/j.1462-2920.2006.01140.x; Silva YJ, 2014, MICROB BIOTECHNOL, V7, P401, DOI 10.1111/1751-7915.12090; STEVENSON RMW, 1984, APPL ENVIRON MICROB, V47, P1201, DOI 10.1128/AEM.47.6.1201-1205.1984; TORANZO AE, 1991, AQUACULTURE, V99, P1, DOI 10.1016/0044-8486(91)90284-E; Vadstein O, 1997, AQUACULTURE, V155, P401, DOI 10.1016/S0044-8486(97)00114-2; Verner-Jeffreys DW, 2007, AQUACULTURE, V270, P475, DOI 10.1016/j.aquaculture.2007.05.023; Vieira A, 2012, EUR J CLIN MICROBIOL, V31, P3241, DOI 10.1007/s10096-012-1691-x; Vinod MG, 2006, AQUACULTURE, V255, P117, DOI 10.1016/j.aquaculture.2005.12.003; Wagner PL, 2002, INFECT IMMUN, V70, P3985, DOI 10.1128/IAI.70.8.3985-3993.2002; Wahli T, 2002, J FISH DIS, V25, P491, DOI 10.1046/j.1365-2761.2002.00401.x; Weber B, 2010, ENV MICROBIOL REP, V2, P133, DOI 10.1111/j.1758-2229.2009.00120.x; WU J-L, 1981, Fish Pathology, V15, P271; Yan QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030603	51	90	93	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114197	10.1371/journal.pone.0114197	http://dx.doi.org/10.1371/journal.pone.0114197			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464504	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700114
J	Back, M; Avignon, A; Stanke-Labesque, F; Boegner, C; Attalin, V; Leprieur, E; Sultan, A				Back, Magnus; Avignon, Antoine; Stanke-Labesque, Francoise; Boegner, Catherine; Attalin, Vincent; Leprieur, Elodie; Sultan, Ariane			Leukotriene Production Is Increased in Abdominal Obesity	PLOS ONE			English	Article							ADIPOSE-TISSUE INFLAMMATION; BODY-MASS INDEX; INSULIN-RESISTANCE; METABOLIC SYNDROME; AIRWAY INFLAMMATION; ASTHMA; DISEASE; ATHEROSCLEROSIS; RECEPTOR; PROTEIN	Obesity is a major risk factor for insulin resistance and type-2 diabetes. A chronic low grade inflammatory state has been described during obesity and associated with insulin resistance pathogenesis. Results from animal studies are in favor of a role of the leukotriene (LT) pathway in obesity induced-insulin resistance. However, there is a paucity of data regarding this association in human obesity. Therefore, the aim of this study was to investigate whether LT production was associated with insulin resistance and other metabolic parameters in a cohort of obese subjects. Forty-six (70% females) obese subjects (BMI >= 30 kg/m(2)) without known diabetes and without inflammatory disease (CRP<10 mg/l) were included. Median age was 44 years (16-80) with a median BMI of 36.8 kg/m(2) (30-51). Insulin resistance was evaluated by HOMA-IR index and glucose tolerance test. Urinary LTE4 (U-LTE4) concentration was measured by enzyme immune assay. Screening for obstructive sleep apnea was performed. There was a positive association of U-LTE4 with waist to hip ratio, systolic blood pressure and HOMA-IR in univariate analysis. Further, waist to hip ratio remained the only parameter significantly correlated with U-LTE4, in adjusted multivariate analysis. Taken together, these results confirm the previously established notion of chronic low grade inflammation in obesity and further suggests a role for the LT pathway in obesity-associated development of insulin resistance in humans.	[Back, Magnus] Karolinska Inst, Dept Med, Stockholm, Sweden; [Avignon, Antoine; Boegner, Catherine; Attalin, Vincent; Leprieur, Elodie; Sultan, Ariane] CHRU Montpellier, Endocrinol Diabetol Nutr Dept, Montpellier, France; [Avignon, Antoine; Sultan, Ariane] Univ Montpellier I, INSERM, U1046, Montpellier, France; [Stanke-Labesque, Francoise] Univ Grenoble, INSERM, U1042, Grenoble, France	Karolinska Institutet; Universite de Montpellier; CHU de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Institut National de la Sante et de la Recherche Medicale (Inserm)	Back, M (corresponding author), Karolinska Inst, Dept Med, Stockholm, Sweden.	Magnus.Back@ki.se; a-sultan@chu-montpellier.fr	Avignon, Antoine/AAD-5441-2020; Stanke, Francoise/M-7142-2014	Stanke, Francoise/0000-0002-4643-6323	Res Med Foundation (La Jolla, CA, USA); French-Swedish Foundation (Stockholm, Sweden); Swedish Research Council [2011-2988]; Swedish Heart and Lung Foundation [20120474, 20120827]	Res Med Foundation (La Jolla, CA, USA); French-Swedish Foundation (Stockholm, Sweden); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation)	Funding: This study was supported by grants from Res Med Foundation (La Jolla, CA, USA) and the French-Swedish Foundation (Stockholm, Sweden). MB is supported by the Swedish Research Council (grant number 2011-2988), and the Swedish Heart and Lung Foundation (grant numbers 20120474 and 20120827). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Back M, 2007, CIRC RES, V100, P946, DOI 10.1161/01.RES.0000264498.60702.0d; Back M, 2011, PHARMACOL REV, V63, P539, DOI 10.1124/pr.110.004184; Boizel R, 2010, DIABETOLOGIA, V53, P2068, DOI 10.1007/s00125-010-1822-9; Chakrabarti SK, 2011, AM J PHYSIOL-ENDOC M, V300, pE175, DOI 10.1152/ajpendo.00203.2010; Elks CM, 2010, CURR HYPERTENS REP, V12, P99, DOI 10.1007/s11906-010-0096-4; Ferrante AW, 2007, J INTERN MED, V262, P408, DOI 10.1111/j.1365-2796.2007.01852.x; Giouleka P, 2011, EUR J CLIN INVEST, V41, P30, DOI 10.1111/j.1365-2362.2010.02371.x; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Hardy G, 2005, PROSTAG OTH LIPID M, V78, P291, DOI 10.1016/j.prostaglandins.2005.10.001; Horrillo R, 2010, J IMMUNOL, V184, P3978, DOI 10.4049/jimmunol.0901355; Ingelsson E, 2012, J ALLERGY CLIN IMMUN, V129, P702, DOI 10.1016/j.jaci.2011.11.052; Item F, 2012, OBES REV, V13, P30, DOI 10.1111/j.1467-789X.2012.01035.x; Juge-Aubry CE, 2005, BEST PRACT RES CL EN, V19, P547, DOI 10.1016/j.beem.2005.07.009; Kaaman M, 2006, INT J OBESITY, V30, P447, DOI 10.1038/sj.ijo.0803147; Lessard A, 2008, CHEST, V134, P317, DOI 10.1378/chest.07-2959; Martinez-Clemente M, 2011, CURR OPIN CLIN NUTR, V14, P347, DOI 10.1097/MCO.0b013e32834777fa; Matricardi PM, 2007, CLIN EXP ALLERGY, V37, P476, DOI 10.1111/j.1365-2222.2007.02664.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mothe-Satney I, 2012, DIABETES, V61, P2311, DOI 10.2337/db11-1455; Neels JG, 2013, ADIPOCYTE, V2, P262, DOI 10.4161/adip.24835; Odegaard JI, 2013, SCIENCE, V339, P172, DOI 10.1126/science.1230721; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Peters-Golden M, 2006, EUR RESPIR J, V27, P495, DOI 10.1183/09031936.06.00077205; Rafnsson A, 2013, DIS MARKERS, V2013, P475, DOI 10.1155/2013/370461; Ridker PM, 2003, CIRCULATION, V107, P391, DOI 10.1161/01.CIR.0000055014.62083.05; Romeo GR, 2012, ARTERIOSCL THROM VAS, V32, P1771, DOI 10.1161/ATVBAHA.111.241869; Shen YL, 2011, SLEEP, V34, P1135, DOI 10.5665/SLEEP.1178; Shore SA, 2006, PHARMACOL THERAPEUT, V110, P83, DOI 10.1016/j.pharmthera.2005.10.002; Shore SA, 2008, J ALLERGY CLIN IMMUN, V121, P1087, DOI 10.1016/j.jaci.2008.03.004; Spite M, 2011, J IMMUNOL, V187, P1942, DOI 10.4049/jimmunol.1100196; Stanke-Labesque F, 2012, J LIPID RES, V53, P1944, DOI 10.1194/jlr.P022814; Stanke-Labesque F, 2009, J ALLERGY CLIN IMMUN, V124, P364, DOI 10.1016/j.jaci.2009.05.033; Sutherland TJT, 2008, AM J RESP CRIT CARE, V178, P469, DOI 10.1164/rccm.200802-301OC; van Veen IH, 2008, ALLERGY, V63, P570, DOI 10.1111/j.1398-9995.2007.01597.x; Won KB, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-41	37	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e104593	10.1371/journal.pone.0104593	http://dx.doi.org/10.1371/journal.pone.0104593			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437865	Green Submitted, Green Published, gold			2022-12-26	WOS:000347114900003
J	Huc-Brandt, S; Hieu, N; Imberdis, T; Cubedo, N; Silhol, M; Leighton, PLA; Domaschke, T; Allison, WT; Perrier, V; Rossel, M				Huc-Brandt, Sylvaine; Hieu, Nelson; Imberdis, Thibaut; Cubedo, Nicolas; Silhol, Michelle; Leighton, Patricia L. A.; Domaschke, Thomas; Allison, W. Ted; Perrier, Veronique; Rossel, Mireille			Zebrafish Prion Protein PrP2 Controls Collective Migration Process during Lateral Line Sensory System Development	PLOS ONE			English	Article							MORPHOGENESIS; EXPRESSION; CELLS	Prion protein is involved in severe neurodegenerative disorders but its physiological role is still in debate due to an absence of major developmental defects in knockout mice. Previous reports in zebrafish indicate that the two prion genes, PrP1 and PrP2, are both involved in several steps of embryonic development thus providing a unique route to discover prion protein function. Here we investigate the role of PrP2 during development of a mechano-sensory system, the posterior lateral line, using morpholino knockdown and PrP2 targeted inactivation. We confirm the efficiency of the translation blocking morpholino at the protein level. Development of the posterior lateral line is altered in PrP2 morphants, including nerve axonal outgrowth and primordium migration defects. Reduced neuromast deposition was observed in PrP2 morphants as well as in PrP2(-/-) mutants. Rosette formation defects were observed in PrP2 morphants, strongly suggesting an abnormal primordium organization and reflecting loss of cell cohesion during migration of the primordium. In addition, the adherens junction proteins, E-cadherin and beta-catenin, were mis-localized after reduction of PrP2 expression and thus contribute to the primordium disorganization. Consequently, hair cell differentiation and number were affected and this resulted in reduced functional neuromasts. At later developmental stages, myelination of the posterior lateral line nerve was altered. Altogether, our study reports an essential role of PrP2 in collective migration process of the primordium and in neuromast formation, further implicating a role for prion protein in cell adhesion.	[Huc-Brandt, Sylvaine; Hieu, Nelson; Cubedo, Nicolas; Silhol, Michelle; Domaschke, Thomas; Perrier, Veronique; Rossel, Mireille] Univ Montpellier 2, F-34095 Montpellier, France; [Huc-Brandt, Sylvaine; Hieu, Nelson; Cubedo, Nicolas; Silhol, Michelle; Domaschke, Thomas; Perrier, Veronique; Rossel, Mireille] INSERM, U710, F-34095 Montpellier, France; [Huc-Brandt, Sylvaine; Hieu, Nelson; Cubedo, Nicolas; Silhol, Michelle; Domaschke, Thomas; Perrier, Veronique; Rossel, Mireille] EPHE, F-75007 Paris, France; [Imberdis, Thibaut] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Leighton, Patricia L. A.; Allison, W. Ted] Univ Alberta, Ctr Prions & Prot Folding Dis, Edmonton, AB T6G 2E9, Canada; [Leighton, Patricia L. A.; Allison, W. Ted] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada	Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Boston University; University of Alberta; University of Alberta	Rossel, M (corresponding author), Univ Montpellier 2, F-34095 Montpellier, France.	mireille.rossel@univ-montp2.fr	Perrier, Veronique/AAK-3594-2020; Allison, W. Ted/A-2612-2014; Brandt, Sylvaine/AAJ-1277-2021	Allison, W. Ted/0000-0002-8461-4864; Brandt, Sylvaine/0000-0002-5582-4643; Imberdis, thibaut/0000-0002-0818-2617; Rossel, Mireille/0000-0003-2275-0817; perrier, veronique/0000-0002-6570-7504	"Ecole Pratique des Hautes Etudes"; "Chercheur d'Avenir" program; Alzheimer Society of Canada; Alberta Innovates; Erasmus program; Inserm; Region Languedoc-Roussillon [2010-Q-025]; Alberta Prion Research Institute; Alzheimer Society of Alberta; Northwest Territories	"Ecole Pratique des Hautes Etudes"; "Chercheur d'Avenir" program(Region Occitanie); Alzheimer Society of Canada; Alberta Innovates; Erasmus program; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Region Languedoc-Roussillon(Region OccitanieRegion Ile-de-France); Alberta Prion Research Institute; Alzheimer Society of Alberta; Northwest Territories	Funding: The post-doctoral funding for SH-B and the Ph.D. fellowship of TI were provided by the "Ecole Pratique des Hautes Etudes". NH was supported by studentship from the "Chercheur d'Avenir 2009" program and PLAL by studentships from the Alzheimer Society of Canada and Alberta Innovates. TD was supported by an Erasmus program. The research was supported by Inserm dotation, as well as the Region Languedoc-Roussillon, grant 2010-Q-025 "Chercheur d'Avenir 2009". WTA was supported by the Alberta Prion Research Institute and Alzheimer Society of Alberta and Northwest Territories. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aman A, 2011, CELL ADHES MIGR, V5, P499, DOI 10.4161/cam.5.6.19113; Bedell VM, 2011, BRIEF FUNCT GENOMICS, V10, P181, DOI 10.1093/bfgp/elr021; Biasini E, 2012, TRENDS NEUROSCI, V35, P92, DOI 10.1016/j.tins.2011.10.002; Bremer J, 2010, NAT NEUROSCI, V13, P310, DOI 10.1038/nn.2483; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Caetano FA, 2011, J NEUROCHEM, V117, P538, DOI 10.1111/j.1471-4159.2011.07225.x; Chitnis AB, 2012, DEV NEUROBIOL, V72, P234, DOI 10.1002/dneu.20962; Cotto E, 2005, FEBS J, V272, P500, DOI 10.1111/j.1742-4658.2004.04492.x; Czopka T, 2011, METHOD CELL BIOL, V105, P25, DOI 10.1016/B978-0-12-381320-6.00002-3; DeArmond SJ, 1997, NEURON, V19, P1337, DOI 10.1016/S0896-6273(00)80424-9; DeCarvalho AC, 2004, DEV DYNAM, V229, P869, DOI 10.1002/dvdy.10475; Demart S, 1999, BIOCHEM BIOPH RES CO, V265, P652, DOI 10.1006/bbrc.1999.1730; Dutton JR, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-105; Fishman MC, 1997, METHOD CELL BIOL, V52, P67, DOI 10.1016/S0091-679X(08)60374-X; Fleisch VC, 2013, NEUROBIOL DIS, V55, P11, DOI 10.1016/j.nbd.2013.03.007; Ghysen A, 2004, CURR OPIN NEUROBIOL, V14, P67, DOI 10.1016/j.conb.2004.01.012; Ghysen A, 2007, GENE DEV, V21, P2118, DOI 10.1101/gad.1568407; Gilmour DT, 2002, NEURON, V34, P577, DOI 10.1016/S0896-6273(02)00683-9; Gompel N, 2001, MECH DEVELOP, V105, P69, DOI 10.1016/S0925-4773(01)00382-3; Griffiths HH, 2011, J BIOL CHEM, V286, P33489, DOI 10.1074/jbc.M111.278556; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; Kaiser DM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051305; Kanaani J, 2005, J NEUROCHEM, V95, P1373, DOI 10.1111/j.1471-4159.2005.03469.x; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Khalife M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023253; Lauren J, 2014, J ALZHEIMERS DIS, V38, P227, DOI 10.3233/JAD-130950; Lecaudey V, 2008, DEVELOPMENT, V135, P2695, DOI 10.1242/dev.025981; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Malaga-Trillo E, 2009, PLOS BIOL, V7, P576, DOI 10.1371/journal.pbio.1000055; Matsuda M, 2010, DEVELOPMENT, V137, P3477, DOI 10.1242/dev.052761; METCALFE WK, 1985, J COMP NEUROL, V238, P218, DOI 10.1002/cne.902380208; Nechiporuk A, 2008, SCIENCE, V320, P1774, DOI 10.1126/science.1156547; Nourizadeh-Lillabadi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013573; Pantera B, 2009, J NEUROCHEM, V110, P194, DOI 10.1111/j.1471-4159.2009.06123.x; Parkin ET, 2007, P NATL ACAD SCI USA, V104, P11062, DOI 10.1073/pnas.0609621104; Rivera-Milla E, 2006, FASEB J, V20, P317, DOI 10.1096/fj.05-4279fje; Schuster K, 2010, P NATL ACAD SCI USA, V107, P19531, DOI 10.1073/pnas.1002171107; Scott MR, 1997, P NATL ACAD SCI USA, V94, P14279, DOI 10.1073/pnas.94.26.14279; Solis GP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070327; Steele AD, 2009, PRION, V3, P240, DOI 10.4161/pri.3.4.10135; Urso E, 2012, CELL MOL NEUROBIOL, V32, P989, DOI 10.1007/s10571-012-9815-5; van Bebber F, 2013, J NEUROCHEM, V127, P471, DOI 10.1111/jnc.12198	43	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113331	10.1371/journal.pone.0113331	http://dx.doi.org/10.1371/journal.pone.0113331			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436888	Green Submitted, Green Published, gold			2022-12-26	WOS:000347114900039
J	Presslauer, C; Nagasawa, K; Dahle, D; Babiak, J; Fernandes, JMO; Babiak, I				Presslauer, Christopher; Nagasawa, Kazue; Dahle, Dalia; Babiak, Joanna; Fernandes, Jorge M. O.; Babiak, Igor			Induced Autoimmunity against Gonadal Proteins Affects Gonadal Development in Juvenile Zebrafish	PLOS ONE			English	Article							GROWTH-DIFFERENTIATION FACTOR-9; GERM-CELLS; SPATIOTEMPORAL EXPRESSION; MAMMALIAN WILDLIFE; ATLANTIC SALMON; GENE-EXPRESSION; IMMUNE-SYSTEM; DANIO-RERIO; MATURATION; SERTOLI	A method to mitigate or possibly eliminate reproduction in farmed fish is highly demanded. The existing approaches have certain applicative limitations. So far, no immunization strategies affecting gonadal development in juvenile animals have been developed. We hypothesized that autoimmune mechanisms, occurring spontaneously in a number of diseases, could be induced by targeted immunization. We have asked whether the immunization against specific targets in a juvenile zebrafish gonad will produce an autoimmune response, and, consequently, disturbance in gonadal development. Gonadal soma-derived factor (Gsdf), growth differentiation factor (Gdf9), and lymphocyte antigen 75 (Cd205/Ly75), all essential for early gonad development, were targeted with 5 immunization tests. Zebrafish (n5329) were injected at 6 weeks post fertilization, a booster injection was applied 15 days later, and fish were sampled at 30 days. We localized transcripts encoding targeted proteins by in situ hybridization, quantified expression of immune-, apoptosis-, and gonad-related genes with quantitative real-time PCR, and performed gonadal histology and whole-mount immunohistochemistry for Bcl2-interacting-killer (Bik) pro-apoptotic protein. The treatments resulted in an autoimmune reaction, gonad developmental retardation, intensive apoptosis, cell atresia, and disturbed transcript production. Testes were remarkably underdeveloped after anti-Gsdf treatments. Anti-Gdf9 treatments promoted apoptosis in testes and abnormal development of ovaries. Anti-Cd205 treatment stimulated a strong immune response in both sexes, resulting in oocyte atresia and strong apoptosis in supporting somatic cells. The effect of immunization was FSH-independent. Furthermore, immunization against germ cell proteins disturbed somatic supporting cell development. This is the first report to demonstrate that targeted autoimmunity can disturb gonadal development in a juvenile fish. It shows a straightforward potential to develop auto-immunization-based technologies to mitigate fish reproduction before they reach maturation. However, the highly variable results between treatments and individuals suggest significant optimization should be performed to achieve the full potential of this technology.	[Presslauer, Christopher; Nagasawa, Kazue; Dahle, Dalia; Babiak, Joanna; Fernandes, Jorge M. O.; Babiak, Igor] Univ Nordland, Fac Biosci & Aquaculture, N-8049 Bodo, Norway	Nord University	Babiak, I (corresponding author), Univ Nordland, Fac Biosci & Aquaculture, N-8049 Bodo, Norway.	Igor.Babiak@uin.no	Fernandes, Jorge MO/A-3526-2013; Fernandes, Jorge/AAC-4632-2022; Nagasawa, Kazue/ABH-6117-2020	Fernandes, Jorge MO/0000-0002-2550-1640; Fernandes, Jorge/0000-0002-2550-1640; Nagasawa, Kazue/0000-0003-2819-3302; Babiak, Igor/0000-0002-1462-2690	Marine Biotechnology in Northern Norway (MABIT) program [AF0059]; University of Nordland	Marine Biotechnology in Northern Norway (MABIT) program; University of Nordland	The study was funded by Marine Biotechnology in Northern Norway (MABIT) program (www.mabit.no), grant # AF0059; and by University of Nordland (www.uin.no) - all granted to IB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht KH, 2001, DEV BIOL, V240, P92, DOI 10.1006/dbio.2001.0438; Benfey Tillmann J., 1999, Reviews in Fisheries Science, V7, P39, DOI 10.1080/10641269991319162; BOYD JM, 1995, ONCOGENE, V11, P1921; Buonocore F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047957; Chen J, 2013, CHINESE SCI BULL, V58, P7, DOI 10.1007/s11434-012-5577-1; Chinnadurai G, 2008, ONCOGENE, V27, pS20, DOI 10.1038/onc.2009.40; Clelland ES, 2011, GEN COMP ENDOCR, V171, P211, DOI 10.1016/j.ygcen.2011.01.009; Cooper DW, 2006, REPRODUCTION, V132, P821, DOI 10.1530/REP-06-0037; Cooper DW, 2001, REPROD FERT DEVELOP, V13, P451, DOI 10.1071/RD01072; Danilova N, 2002, P NATL ACAD SCI USA, V99, P13711, DOI 10.1073/pnas.212515999; Dong JW, 1996, NATURE, V383, P531, DOI 10.1038/383531a0; Draper Bruce W, 2012, Methods Mol Biol, V916, P157, DOI 10.1007/978-1-61779-980-8_12; Fernandes JMO, 2008, COMP BIOCHEM PHYS B, V150, P23, DOI 10.1016/j.cbpb.2008.01.003; Fernandes JMO, 2007, J EXP BIOL, V210, P3461, DOI 10.1242/jeb.009183; Fernandes JMO, 2006, COMP BIOCHEM PHYS D, V1, P35, DOI 10.1016/j.cbd.2005.09.003; Gautier A, 2011, BIOL REPROD, V85, P1240, DOI 10.1095/biolreprod.111.091892; Gautier A, 2011, GENE, V472, P7, DOI 10.1016/j.gene.2010.10.014; Gui JF, 2012, CHINESE SCI BULL, V57, P1751, DOI 10.1007/s11434-012-5213-0; Gupta SK, 2011, AM J REPROD IMMUNOL, V66, P51, DOI 10.1111/j.1600-0897.2011.01004.x; Hailemichael Y, 2013, NAT MED, V19, P465, DOI 10.1038/nm.3105; He Z, 2012, GEN COMP ENDOCR, V178, P355, DOI 10.1016/j.ygcen.2012.06.016; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Hu YL, 2010, MOL IMMUNOL, V47, P738, DOI 10.1016/j.molimm.2009.10.010; Huttenhuis HBT, 2005, DEV COMP IMMUNOL, V29, P1033, DOI 10.1016/j.dci.2005.03.005; Janz DM, 1997, GEN COMP ENDOCR, V105, P186, DOI 10.1006/gcen.1996.6820; Jorgensen A, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-25; Jorstad KE, 2008, REV FISH SCI, V16, P285, DOI 10.1080/10641260701678017; Juengel JL, 2002, BIOL REPROD, V67, P1777, DOI 10.1095/biolreprod.102.007146; Karlsen O, 2006, AQUACULTURE, V255, P242, DOI 10.1016/j.aquaculture.2005.12.029; KARLSEN O, 1995, AQUACULTURE, V133, P159, DOI 10.1016/0044-8486(94)00399-9; Kato M, 1998, IMMUNOGENETICS, V47, P442, DOI 10.1007/s002510050381; Kirkpatrick JF, 2011, AM J REPROD IMMUNOL, V66, P40, DOI 10.1111/j.1600-0897.2011.01003.x; Krovel AV, 2002, MECH DEVELOP, V116, P141, DOI 10.1016/S0925-4773(02)00154-5; Kurokawa H, 2007, P NATL ACAD SCI USA, V104, P16958, DOI 10.1073/pnas.0609932104; LAIRD LM, 1980, REPROD NUTR DEV, V20, P1781, DOI 10.1051/rnd:19801004; Lam SH, 2004, DEV COMP IMMUNOL, V28, P9, DOI 10.1016/S0145-305X(03)00103-4; Liu L, 2007, BIOL REPROD, V76, P294, DOI 10.1095/biolreprod.106.054668; Liu ZW, 2012, MOL BIOL REP, V39, P3863, DOI 10.1007/s11033-011-1165-8; Maack G, 2003, FISH PHYSIOL BIOCHEM, V28, P125, DOI 10.1023/B:FISH.0000030497.59378.88; Maack G, 2003, J FISH BIOL, V62, P895, DOI 10.1046/j.1095-8649.2003.00074.x; Matthews M, 2002, LAB ANIMAL, V31, P34; McClure CA, 2007, AQUACULTURE, V272, P370, DOI 10.1016/j.aquaculture.2007.08.039; Miller N, 1998, IMMUNOL REV, V166, P187, DOI 10.1111/j.1600-065X.1998.tb01263.x; Nagasawa K, 2012, FISHERIES SCI, V78, P791, DOI 10.1007/s12562-012-0501-9; Nagasawa K, 2010, BIOL REPROD, V83, P597, DOI 10.1095/biolreprod.109.082081; Naz RK, 2011, AM J REPROD IMMUNOL, V66, P2, DOI 10.1111/j.1600-0897.2011.00999.x; Paulini F, 2011, REPROD DOMEST ANIM, V46, P354, DOI 10.1111/j.1439-0531.2010.01739.x; Poon SK, 2009, REPRODUCTION, V138, P709, DOI 10.1530/REP-09-0198; Press CM, 1999, FISH SHELLFISH IMMUN, V9, P309, DOI 10.1006/fsim.1998.0181; Rodriguez-Mari A, 2005, GENE EXPR PATTERNS, V5, P655, DOI 10.1016/j.modgep.2005.02.008; Rodriguez-Mari A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001034; Sambroni E, 2013, J MOL ENDOCRINOL, V50, P1, DOI 10.1530/JME-12-0197; Sawatari E, 2007, DEV BIOL, V301, P266, DOI 10.1016/j.ydbio.2006.10.001; Schulz RW, 2005, BIOL REPROD, V73, P891, DOI 10.1095/biolreprod.105.039891; Shibata Y, 2010, GENE EXPR PATTERNS, V10, P283, DOI 10.1016/j.gep.2010.06.005; Shrimpton RE, 2009, MOL IMMUNOL, V46, P1229, DOI 10.1016/j.molimm.2008.11.016; Slanchev K, 2005, P NATL ACAD SCI USA, V102, P4074, DOI 10.1073/pnas.0407475102; Tang RY, 2007, ACTA BIOCH BIOPH SIN, V39, P384, DOI 10.1111/j.1745-7270.2007.00283.x; Taranger GL, 2010, GEN COMP ENDOCR, V165, P483, DOI 10.1016/j.ygcen.2009.05.004; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; White YAR, 2011, DEV DYNAM, V240, P1929, DOI 10.1002/dvdy.22695; Yang DH, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-319; Yoon C, 1997, DEVELOPMENT, V124, P3157; Zar JH, 1999, BIOSTATISTICAL ANAL; Zhao L, 2011, ACTA HISTOCHEM, V113, P771, DOI 10.1016/j.acthis.2010.11.005	67	10	10	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114209	10.1371/journal.pone.0114209	http://dx.doi.org/10.1371/journal.pone.0114209			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436775	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000347114900129
J	Rojas, C; Pan-Castillo, B; Valls, C; Pujadas, G; Garcia-Vallve, S; Arola, L; Mulero, M				Rojas, Cristina; Pan-Castillo, Belen; Valls, Cristina; Pujadas, Gerard; Garcia-Vallve, Santi; Arola, Lluis; Mulero, Miquel			Resveratrol Enhances Palmitate-Induced ER Stress and Apoptosis in Cancer Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; STEAROYL-COA DESATURASE; UNSATURATED FATTY-ACIDS; ACTIVATING AMPK; HEPG2 CELLS; BETA-CELLS; U937 CELLS; KINASE; DEATH	Background: Palmitate, a saturated fatty acid (FA), is known to induce toxicity and cell death in various types of cells. Resveratrol (RSV) is able to prevent pathogenesis and/or decelerate the progression of a variety of diseases. Several in vitro and in vivo studies have also shown a protective effect of RSV on fat accumulation induced by FAs. Additionally, endoplasmic reticulum (ER) stress has recently been linked to cellular adipogenic responses. To address the hypothesis that the RSV effect on excessive fat accumulation promoted by elevated saturated FAs could be partially mediated by a reduction of ER stress, we studied the RSV action on experimentally induced ER stress using palmitate in several cancer cell lines. Principal Findings: We show that, unexpectedly, RSV promotes an amplification of palmitate toxicity and cell death and that this mechanism is likely due to a perturbation of palmitate accumulation in the triglyceride form and to a less important membrane fluidity variation. Additionally, RSV decreases radical oxygen species (ROS) generation in palmitate-treated cells but leads to enhanced X-box binding protein-1 (XBP1) splicing and C/EBP homologous protein (CHOP) expression. These molecular effects are induced simultaneously to caspase-3 cleavage, suggesting that RSV promotes palmitate lipoapoptosis primarily through an ER stress-dependent mechanism. Moreover, the lipotoxicity reversion induced by eicosapentaenoic acid (EPA) or by a liver X receptor (LXR) agonist reinforces the hypothesis that RSV-mediated inhibition of palmitate channeling into triglyceride pools could be a key factor in the aggravation of palmitate-induced cytotoxicity. Conclusions: Our results suggest that RSV exerts its cytotoxic role in cancer cells exposed to a saturated FA context primarily by triglyceride accumulation inhibition, probably leading to an intracellular palmitate accumulation that triggers a lipid-mediated cell death. Additionally, this cell death is promoted by ER stress through a CHOP-mediated apoptotic process and may represent a potential anticancer strategy.	[Rojas, Cristina; Pan-Castillo, Belen; Valls, Cristina; Pujadas, Gerard; Garcia-Vallve, Santi; Arola, Lluis; Mulero, Miquel] Univ Rovira & Virgili, Dept Biochem & Biotechnol, Nutrigen Res Grp, E-43007 Tarragona, Spain; [Pan-Castillo, Belen] Swansea Univ, Inst Life, Ctr Nanohlth, Reprod Biol & Gynecol Oncol Grp, Swansea SA2 8PP, W Glam, Wales; [Pujadas, Gerard; Garcia-Vallve, Santi; Arola, Lluis] CEICS, TECNIO, CTNS, Reus 43204, Spain	Universitat Rovira i Virgili; Swansea University	Mulero, M (corresponding author), Univ Rovira & Virgili, Dept Biochem & Biotechnol, Nutrigen Res Grp, E-43007 Tarragona, Spain.	miquel.mulero@urv.cat	Pujadas, Gerard/B-1457-2010; Garcia-Vallve, Santi/A-4226-2008; Mulero, Miquel/L-4672-2014; Arola, Lluís/C-6074-2011; Valls-Bautista, Cristina/K-8769-2014; PUJADAS, GERARD/W-9348-2019	Pujadas, Gerard/0000-0003-2598-8089; Garcia-Vallve, Santi/0000-0002-0348-7497; Mulero, Miquel/0000-0003-2545-2065; Arola, Lluís/0000-0003-2767-1974; Valls-Bautista, Cristina/0000-0001-5583-5695; PUJADAS, GERARD/0000-0003-2598-8089	Ministerio de Educacion y Ciencia of the Spanish Goverment [AGL2008-00387/ALI, AGL2011-25831/ALI]	Ministerio de Educacion y Ciencia of the Spanish Goverment(German Research Foundation (DFG))	This reserach was supported by grants from the Ministerio de Educacion y Ciencia of the Spanish Goverment (AGL2008-00387/ALI and AGL2011-25831/ALI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajmo JM, 2008, AM J PHYSIOL-GASTR L, V295, pG833, DOI 10.1152/ajpgi.90358.2008; de la Lastral CA, 2007, BIOCHEM SOC T, V35, P1156, DOI 10.1042/BST0351156; Ariyama H, 2010, J BIOL CHEM, V285, P22027, DOI 10.1074/jbc.M110.126870; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Brittes J, 2010, CHEM PHYS LIPIDS, V163, P747, DOI 10.1016/j.chemphyslip.2010.07.004; CHAJES V, 1995, INT J CANCER, V63, P169, DOI 10.1002/ijc.2910630204; Chen L, 2003, MOL PHARMACOL, V64, P334, DOI 10.1124/mol.64.2.334; Chen SF, 2012, J NUTR BIOCHEM, V23, P1100, DOI 10.1016/j.jnutbio.2011.06.003; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; Eitel K, 2002, BIOCHEM BIOPH RES CO, V299, P853, DOI 10.1016/S0006-291X(02)02752-3; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Ibrahim SH, 2011, J HEPATOL, V54, P765, DOI 10.1016/j.jhep.2010.09.039; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kim JE, 2010, J ENDOCRINOL, V207, P35, DOI 10.1677/JOE-10-0093; Kim S, 2011, BIOCHEM PHARMACOL, V81, P1343, DOI 10.1016/j.bcp.2011.03.012; Kitamura M, 2011, INT REV IMMUNOL, V30, P4, DOI 10.3109/08830185.2010.522281; Kong JY, 2000, BBA-MOL CELL BIOL L, V1485, P45, DOI 10.1016/S1388-1981(00)00028-7; Kotha A, 2006, MOL CANCER THER, V5, P621, DOI 10.1158/1535-7163.MCT-05-0268; Kuhajda FP, 2006, CANCER RES, V66, P5977, DOI 10.1158/0008-5472.CAN-05-4673; Lee AS, 2007, CANCER RES, V67, P3496, DOI 10.1158/0008-5472.CAN-07-0325; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Lin CL, 2007, J LIPID RES, V48, P2334, DOI 10.1194/jlr.M700128-JLR200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu BQ, 2010, BIOCHEM BIOPH RES CO, V391, P778, DOI 10.1016/j.bbrc.2009.11.137; Luo J, 2009, CELL, V138, P807, DOI 10.1016/j.cell.2009.08.006; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mason P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033823; Mayer CM, 2010, ENDOCRINOLOGY, V151, P576, DOI 10.1210/en.2009-1122; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Minville-Walz M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014363; Miyazaki M, 2006, J LIPID RES, V47, P700, DOI 10.1194/jlr.C500025-JLR200; Morgan NG, 2008, BIOCHEM SOC T, V36, P905, DOI 10.1042/BST0360905; Park JW, 2001, CARCINOGENESIS, V22, P1633, DOI 10.1093/carcin/22.10.1633; Park JW, 2001, CANCER LETT, V163, P43, DOI 10.1016/S0304-3835(00)00658-3; Peter A, 2009, DIABETES, V58, P1757, DOI 10.2337/db09-0188; Pfaffenbach KT, 2010, AM J PHYSIOL-ENDOC M, V298, pE1027, DOI 10.1152/ajpendo.00642.2009; RIBONI L, 1984, NEUROCHEM PATHOL, V2, P171, DOI 10.1007/BF02834351; Roongta UV, 2011, MOL CANCER RES, V9, P1551, DOI 10.1158/1541-7786.MCR-11-0126; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; STRITTMATTER P, 1974, P NATL ACAD SCI USA, V71, P4565, DOI 10.1073/pnas.71.11.4565; Swinnen JV, 2003, BIOCHEM BIOPH RES CO, V302, P898, DOI 10.1016/S0006-291X(03)00265-1; Szachowicz-Petelska B, 2007, MOL CELL BIOCHEM, V294, P237, DOI 10.1007/s11010-006-9264-x; Thorn K, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-108; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Walle T, 2004, DRUG METAB DISPOS, V32, P1377, DOI 10.1124/dmd.104.000885; Wang Chun, 2010, Front Biosci (Schol Ed), V2, P515; Wang FM, 2011, EXP HEMATOL, V39, P999, DOI 10.1016/j.exphem.2011.06.007; Wang GL, 2009, BIOCHEM BIOPH RES CO, V380, P644, DOI 10.1016/j.bbrc.2009.01.163; Wang GH, 2010, AM J TRANSL RES, V2, P65; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Yoon DH, 2011, BIOCHEM BIOPH RES CO, V414, P49, DOI 10.1016/j.bbrc.2011.09.019; Young CD, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1852; Zhang LX, 2010, EXP CELL RES, V316, P716, DOI 10.1016/j.yexcr.2009.12.008	54	43	43	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113929	10.1371/journal.pone.0113929	http://dx.doi.org/10.1371/journal.pone.0113929			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436452	gold, Green Published, Green Submitted			2022-12-26	WOS:000347114900097
J	Sterpenich, V; Schwartz, S; Maquet, P; Desseilles, M				Sterpenich, Virginie; Schwartz, Sophie; Maquet, Pierre; Desseilles, Martin			Ability to Maintain Internal Arousal and Motivation Modulates Brain Responses to Emotions	PLOS ONE			English	Article							PERSONALITY-TRAITS; INDIVIDUAL-DIFFERENCES; PARTIAL-REINFORCEMENT; ORBITOFRONTAL CORTEX; DEPRESSIVE SYMPTOMS; MAJOR DEPRESSION; AFFECTIVE STYLE; ANXIETY; TEMPERAMENT; MECHANISMS	Persistence (PS) is defined as the ability to generate and maintain arousal and motivation internally in the absence of immediate external reward. Low PS individuals tend to become discouraged when expectations are not rapidly fulfilled. The goal of this study was to investigate whether individual differences in PS influence the recruitment of brain regions involved in emotional processing and regulation. In a functional MRI study, 35 subjects judged the emotional intensity of displayed pictures. When processing negative pictures, low PS (vs. high PS) subjects showed higher amygdala and right orbito-frontal cortex (OFC) activity but lower left OFC activity. This dissociation in OFC activity suggests greater prefrontal cortical asymmetry for approach/avoidance motivation, suggesting an avoidance response to aversive stimuli in low PS. For positive or neutral stimuli, low PS subjects showed lower activity in the amygdala, striatum, and hippocampus. These results suggest that low PS may involve an imbalance in processing distinct emotional inputs, with greater reactivity to aversive information in regions involved in avoidance behaviour (amygdala, OFC) and dampened response to positive and neutral stimuli across circuits subserving motivated behaviour (striatum, hippocampus, amygdala). Low PS affective style was associated with depression vulnerability. These findings in non-depressed subjects point to a neural mechanism whereby some individuals are more likely to show systematic negative emotional biases, as frequently observed in depression. The assessment of these individual differences, including those that may cause vulnerability to depressive disorders, would therefore constitute a promising approach to risk assessment for depression.	[Sterpenich, Virginie; Maquet, Pierre; Desseilles, Martin] Univ Liege B30, Cyclotron Res Ctr, Liege, Belgium; [Sterpenich, Virginie; Schwartz, Sophie; Desseilles, Martin] Univ Geneva, Dept Neurosci, Geneva, Switzerland; [Schwartz, Sophie] Univ Geneva, Swiss Ctr Affect Sci, Geneva, Switzerland; [Maquet, Pierre] Univ Liege, Dept Neurol, CHU Sart Tilman, Liege, Belgium	University of Liege; University of Geneva; University of Geneva; University of Liege	Sterpenich, V (corresponding author), Univ Liege B30, Cyclotron Res Ctr, Liege, Belgium.	Virginie.Sterpenich@unige.ch; m.desseilles@ulg.ac.be		, Pierre/0000-0003-3106-3357; Sterpenich, Virginie/0000-0002-2125-833X; Schwartz, Sophie/0000-0001-7718-4053; Desseilles, Martin/0000-0003-4748-3401	Fonds National de la Recherche Scientifique (FNRS) Beige; Fondation Medicale Reine Elisabeth (FMRE); Research Fund of the University of Liege; F.N.R.S.; Swiss National Science Fundation; Mercier Foundation; Boninchi Foundation; Belgian American Educational Fundation; Fonds Leon Fredericq	Fonds National de la Recherche Scientifique (FNRS) Beige(Fonds de la Recherche Scientifique - FNRS); Fondation Medicale Reine Elisabeth (FMRE); Research Fund of the University of Liege(University of Liege); F.N.R.S.(Fonds de la Recherche Scientifique - FNRS); Swiss National Science Fundation(Swiss National Science Foundation (SNSF)); Mercier Foundation; Boninchi Foundation; Belgian American Educational Fundation; Fonds Leon Fredericq	Funding: This research was supported by the Fonds National de la Recherche Scientifique (FNRS) Beige, the Fondation Medicale Reine Elisabeth (FMRE), and the Research Fund of the University of Liege. VS, MD and PM are supported by the F.N.R.S. SS is supported by the Swiss National Science Fundation, Mercier Foundation, and Boninchi Foundation. Additional supports come from the Belgian American Educational Fundation and the Fonds Leon Fredericq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Amaral DG, 2003, NEUROSCIENCE, V118, P1099, DOI 10.1016/S0306-4522(02)01001-1; Anand A, 2003, ANN NY ACAD SCI, V985, P370; Arch JJ, 2006, BEHAV RES THER, V44, P1849, DOI 10.1016/j.brat.2005.12.007; AstonJones G, 1996, PROG BRAIN RES, V107, P379; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bermond B, 1999, PSYCHOTHER PSYCHOSOM, V68, P241, DOI 10.1159/000012340; Bishop SJ, 2009, NAT NEUROSCI, V12, P92, DOI 10.1038/nn.2242; Bremner JD, 2002, BIOL PSYCHIAT, V51, P273, DOI 10.1016/S0006-3223(01)01336-1; Carlson JM, 2011, NEUROIMAGE; Chang EC, 2001, J COUNS PSYCHOL, V48, P490, DOI 10.1037/0022-0167.48.4.490; Cloninger C. R., 1994, TEMPERAMENT CHARACTE; Cloninger CR, 2006, J AFFECT DISORDERS, V92, P35, DOI 10.1016/j.jad.2005.12.034; CLONINGER CR, 1993, ARCH GEN PSYCHIAT, V50, P975, DOI 10.1001/archpsyc.1993.01820240059008; Craig AD, 2009, NAT REV NEUROSCI, V10, P59, DOI 10.1038/nrn2555; Dalgleish T, 2004, NAT REV NEUROSCI, V5, P583, DOI 10.1038/nrn1432; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; DAVIDSON RJ, 1990, J PERS SOC PSYCHOL, V58, P330, DOI 10.1037/0022-3514.58.2.330; Davidson RJ, 2000, AM PSYCHOL, V55, P1196, DOI 10.1037/0003-066X.55.11.1196; DAVIDSON RJ, 1993, BEHAV NEUROSCI, V107, P1106, DOI 10.1037/0735-7044.107.6.1106; Delgado MR, 2004, CEREB CORTEX, V14, P1022, DOI 10.1093/cercor/bhh062; Desseilles M, 2009, J NEUROSCI, V29, P1395, DOI 10.1523/JNEUROSCI.3341-08.2009; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Elovainio M, 2004, J AFFECT DISORDERS, V83, P227, DOI 10.1016/j.jad.2004.06.005; Faraone SV, 2009, PSYCHOL MED, V39, P685, DOI 10.1017/S0033291708003917; Friston K, 2007, STATISTICAL PARAMETRIC MAPPING: THE ANALYSIS OF FUNCTIONAL BRAIN IMAGES, P1; Friston KJ, 1999, NEUROIMAGE, V10, P607, DOI 10.1006/nimg.1999.0498; Garcia D, 2011, PERS INDIV DIFFER, V50, P1208, DOI 10.1016/j.paid.2011.02.009; Gardini S, 2009, BRAIN RES BULL, V79, P265, DOI 10.1016/j.brainresbull.2009.03.005; Gerdes ABM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00175; Gitelman DR, 2003, NEUROIMAGE, V19, P200, DOI 10.1016/S1053-8119(03)00058-2; Gross JJ, 1998, PERS SOC PSYCHOL B, V24, P279, DOI 10.1177/0146167298243005; Gusnard DA, 2003, P NATL ACAD SCI USA, V100, P3479, DOI 10.1073/pnas.0538050100; Hamann S, 2004, CURR OPIN NEUROBIOL, V14, P233, DOI 10.1016/j.conb.2004.03.010; Hansenne M, 2009, PSYCHIAT RES, V166, P63, DOI 10.1016/j.psychres.2008.03.015; Jylha P, 2011, PSYCHOL MED, V41, P1579, DOI 10.1017/S0033291710002606; KAGAN J, 1988, SCIENCE, V240, P167, DOI 10.1126/science.3353713; Kawamura KY, 2001, COGNITIVE THER RES, V25, P291, DOI 10.1023/A:1010736529013; Kringelbach ML, 2004, PROG NEUROBIOL, V72, P341, DOI 10.1016/j.pneurobio.2004.03.006; Kuhl BA, 2010, NAT NEUROSCI, V13, P501, DOI 10.1038/nn.2498; Lang P. J., 1999, INT AFFECTIVE PICTUR; Lau MA, 2004, BEHAV RES THER, V42, P1001, DOI 10.1016/j.brat.2004.03.003; Liu X, 2011, NEUROSCI BIOBEHAV R, V35, P1219, DOI 10.1016/j.neubiorev.2010.12.012; Matsudaira T, 2006, J CLIN PSYCHOL, V62, P97, DOI 10.1002/jclp.20215; Meehl PE, 1975, B MENNINGER CLIN, P295; Monkul ES, 2007, MOL PSYCHIATR, V12, P360, DOI 10.1038/sj.mp.4001919; Moresco FM, 2002, NEUROIMAGE, V17, P1470, DOI 10.1006/nimg.2002.1239; Nash MW, 2004, HUM MOL GENET, V13, P2173, DOI 10.1093/hmg/ddh239; NATION JR, 1980, J EXP PSYCHOL GEN, V109, P175, DOI 10.1037/0096-3445.109.2.175; NATION JR, 1978, J EXP PSYCHOL GEN, V107, P436, DOI 10.1037/0096-3445.107.4.436; Ochsner KN, 2005, TRENDS COGN SCI, V9, P242, DOI 10.1016/j.tics.2005.03.010; Ochsner KN, 2007, HDB EMOTION REGULATI, P135; Osher Y, 1996, J PSYCHIAT RES, V30, P353, DOI 10.1016/0022-3956(96)00023-4; Peirson AR, 2001, PERS INDIV DIFFER, V30, P391, DOI 10.1016/S0191-8869(00)00031-3; Pelissolo A, 2005, ACTA PSYCHIAT SCAND, V112, P126, DOI 10.1111/j.1600-0447.2005.00551.x; Pelissolo A, 2000, PSYCHIAT RES, V94, P67, DOI 10.1016/S0165-1781(00)00127-X; Phillips M, 2008, MOL PSYCHIATR, V13, P833, DOI 10.1038/mp.2008.65; Pizzagalli DA, 2005, PSYCHOL SCI, V16, P805, DOI 10.1111/j.1467-9280.2005.01618.x; POLINE JB, 1994, J CEREBR BLOOD F MET, V14, P639, DOI 10.1038/jcbfm.1994.79; Rauch SL, 2003, ANN NY ACAD SCI, V985, P389; Rauchs G, 2011, J NEUROSCI, V31, P2563, DOI 10.1523/JNEUROSCI.3972-10.2011; Richter-Levin G, 2000, MOL NEUROBIOL, V22, P11, DOI 10.1385/MN:22:1-3:011; Rosenkranz MA, 2003, P NATL ACAD SCI USA, V100, P11148, DOI 10.1073/pnas.1534743100; Sergerie K, 2008, NEUROSCI BIOBEHAV R, V32, P811, DOI 10.1016/j.neubiorev.2007.12.002; Siegle G. J., 2004, DEPRESSIVE RUMINATIO, P79; Simpson JR, 2000, J COGNITIVE NEUROSCI, V12, P157, DOI 10.1162/089892900564019; Smith APR, 2004, NEUROIMAGE, V22, P868, DOI 10.1016/j.neuroimage.2004.01.049; Sterpenich V, 2007, PLOS BIOL, V5, P2709, DOI 10.1371/journal.pbio.0050282; Sterpenich V, 2006, J NEUROSCI, V26, P7416, DOI 10.1523/JNEUROSCI.1001-06.2006; Sterpenich V, 2009, J NEUROSCI, V29, P5143, DOI 10.1523/JNEUROSCI.0561-09.2009; Sutton SK, 1997, PSYCHOL SCI, V8, P204, DOI 10.1111/j.1467-9280.1997.tb00413.x; TAI CT, 1991, EXP BRAIN RES, V86, P333; Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037//0022-006X.68.4.615; van Strien NM, 2009, NAT REV NEUROSCI, V10, P272, DOI 10.1038/nrn2614; Vuilleumier P, 2005, TRENDS COGN SCI, V9, P585, DOI 10.1016/j.tics.2005.10.011; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Vuilleumier P, 2003, NAT NEUROSCI, V6, P624, DOI 10.1038/nn1057; Vuilleumier P, 2007, PHILOS T R SOC B, V362, P837, DOI 10.1098/rstb.2007.2092	78	6	6	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112999	10.1371/journal.pone.0112999	http://dx.doi.org/10.1371/journal.pone.0112999			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7SK	25438046	Green Submitted, gold, Green Published			2022-12-26	WOS:000347114900025
J	McNamara, A; Moakes, K; Aston, P; Gavin, C; Sterr, A				McNamara, Adam; Moakes, Kaylee; Aston, Philip; Gavin, Christine; Sterr, Annette			The Importance of the Derivative in Sex-Hormone Cycles: A Reason Why Behavioural Measures in Sex-Hormone Studies Are So Mercurial	PLOS ONE			English	Article							FUNCTIONAL CEREBRAL ASYMMETRIES; MENSTRUAL-CYCLE; MENTAL ROTATION; GENDER SIMILARITIES; SPATIAL ABILITIES; STEREOTYPE THREAT; WOMEN; PERFORMANCE; TASK; PROGESTERONE	To study the dynamic changes in cognition across the human menstrual cycle, twenty, healthy, naturally-cycling women undertook a lateralized spatial figural comparison task on twelve occasions at approximately 3-4 day intervals. Each session was conducted in laboratory conditions with response times, accuracy rates, eye movements, salivary estrogen and progesterone concentrations and Profile of Mood states questionnaire data collected on each occasion. The first two sessions of twelve for the response variables were discarded to avoid early effects of learning thereby providing 10 sessions spread across each participant's complete menstrual cycle. Salivary progesterone data for each participant was utilized to normalize each participant's data to a standard 28 day cycle. Data was analysed categorically by comparing peak progesterone (luteal phase) to low progesterone (follicular phase) to emulate two-session repeated measures typical studies. Neither a significant difference in reaction times or accuracy rates was found. Moreover no significant effect of lateral presentation was observed upon reaction times or accuracy rates although inter and intra individual variance was sizeable. We demonstrate that hormone concentrations alone cannot be used to predict the response times or accuracy rates. In contrast, we constructed a standard linear model using salivary estrogen, salivary progesterone and their respective derivative values and found these inputs to be very accurate for predicting variance observed in the reaction times for all stimuli and accuracy rates for right visual field stimuli but not left visual field stimuli. The identification of sex-hormone derivatives as predictors of cognitive behaviours is of importance. The finding suggests that there is a fundamental difference between the up-surge and decline of hormonal concentrations where previous studies typically assume all points near the peak of a hormonal surge are the same. How contradictory findings in sex-hormone research may have come about are discussed.	[McNamara, Adam; Moakes, Kaylee; Sterr, Annette] Univ Surrey, Sch Psychol, Guildford GU2 5XH, Surrey, England; [Aston, Philip; Gavin, Christine] Univ Surrey, Dept Math, Guildford GU2 5XH, Surrey, England	University of Surrey; University of Surrey	McNamara, A (corresponding author), Univ Surrey, Sch Psychol, Guildford GU2 5XH, Surrey, England.	adamjonmcnamara@gmail.com			Engineering and Physical Sciences Research Council [EP/I000992/1]; ESRC/MRC [G0901322-1/1]; EPSRC [EP/I000992/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC/MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Economic & Social Research Council (ESRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding: This work was supported by the Engineering and Physical Sciences Research Council [grant number EP/I000992/1] and the ESRC/MRC interdisciplinary studentship grant supporting KM [training grant number G0901322-1/1]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, SEX DIFFERENCES BRAI; Astur RS, 2004, BEHAV BRAIN RES, V151, P103, DOI 10.1016/j.bbr.2003.08.024; Bayer U, 2008, NEUROPSYCHOLOGIA, V46, P2415, DOI 10.1016/j.neuropsychologia.2008.02.028; Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; Bennis WM, 2010, BEHAV BRAIN SCI, V33, P85, DOI 10.1017/S0140525X1000004X; BIBAWI D, 1995, NEUROPSYCHOLOGIA, V33, P131, DOI 10.1016/0028-3932(94)00103-V; Cahill L, 2006, NAT REV NEUROSCI, V7, P477, DOI 10.1038/nrn1909; Collins DW, 1997, BEHAV NEUROSCI, V111, P845, DOI 10.1037/0735-7044.111.4.845; Courvoisier DS, 2013, HORM BEHAV, V63, P345, DOI 10.1016/j.yhbeh.2012.12.007; De Vries GJ, 2004, ENDOCRINOLOGY, V145, P1063, DOI 10.1210/en.2003-1504; Eckel LA, 2007, SEX DIFFERENCES BRAI, P35; Ertman N, 2011, LEARN MEMORY, V18, P759, DOI 10.1101/lm.023267.111; Fernandez G, 2003, J NEUROSCI, V23, P3790; Goldberg L.R., 1999, PERSONALITY PSYCHOL, V7, P7; Goldstein JM, 2005, J NEUROSCI, V25, P9309, DOI 10.1523/JNEUROSCI.2239-05.2005; Halari R, 2005, BEHAV NEUROSCI, V119, P104, DOI 10.1037/0735-7044.119.1.104; Hausmann M, 1999, BRAIN COGNITION, V41, P263, DOI 10.1006/brcg.1999.1126; Hausmann M, 2005, NEUROPSYCHOLOGIA, V43, P1559, DOI 10.1016/j.neuropsychologia.2005.01.017; Hausmann M, 2000, BEHAV NEUROSCI, V114, P1245, DOI 10.1037/0735-7044.114.6.1245; Hausmann M, 2002, NEUROPSYCHOLOGIA, V40, P808, DOI 10.1016/S0028-3932(01)00179-8; Hausmann M, 2000, NEUROPSYCHOLOGIA, V38, P1362, DOI 10.1016/S0028-3932(00)00045-2; Hollander A, 2005, J INT NEUROPSYCH SOC, V11, P263, DOI 10.1017/S1355617705050319; Hyde JS, 2007, CURR DIR PSYCHOL SCI, V16, P259, DOI 10.1111/j.1467-8721.2007.00516.x; Hyde JS, 2005, AM PSYCHOL, V60, P581, DOI 10.1037/0003-066X.60.6.581; Langlois J, 2013, ANAT SCI EDUC, V6, P368, DOI 10.1002/ase.1360; LINN MC, 1985, CHILD DEV, V56, P1479, DOI 10.1111/j.1467-8624.1985.tb00213.x; Maeda Y, 2013, EDUC PSYCHOL REV, V25, P69, DOI 10.1007/s10648-012-9215-x; Maki PM, 2002, NEUROPSYCHOLOGIA, V40, P518, DOI 10.1016/S0028-3932(01)00126-9; Mareckova K, 2014, SOC COGN AFFECT NEUR, V9, P191, DOI 10.1093/scan/nss128; McCormick CM, 2001, HORM BEHAV, V39, P29, DOI 10.1006/hbeh.2000.1636; Mihm M, 2011, ANIM REPROD SCI, V124, P229, DOI 10.1016/j.anireprosci.2010.08.030; Miller G, 2012, PERSPECT PSYCHOL SCI, V7, P221, DOI 10.1177/1745691612441215; O'Connor PJ, 2004, J PSYCHOSOM RES, V57, P435, DOI 10.1016/j.jpsychores.2003.12.006; Parsons TD, 2004, NEUROPSYCHOLOGIA, V42, P555, DOI 10.1016/j.neuropsychologia.2003.08.014; Peters M, 2006, CORTEX, V42, P1005, DOI 10.1016/S0010-9452(08)70206-5; Phillips K, 1997, HORM BEHAV, V32, P167, DOI 10.1006/hbeh.1997.1418; PHILLIPS SM, 1992, PSYCHONEUROENDOCRINO, V17, P485, DOI 10.1016/0306-4530(92)90007-T; Pletzer B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053824; RODE C, 1995, NEUROPSYCHOLOGIA, V33, P855, DOI 10.1016/0028-3932(95)00015-U; Sanders G, 1998, NEUROPSYCHOLOGIA, V36, P869, DOI 10.1016/S0028-3932(98)00022-0; Sherwin BB, 2012, BEHAV NEUROSCI, V126, P123, DOI 10.1037/a0025539; Hyde JS, 2006, SCIENCE, V314, P599, DOI 10.1126/science.1132154; Small CM, 2007, ANN EPIDEMIOL, V17, P163, DOI 10.1016/j.annepidem.2006.05.005; Spencer SJ, 1999, J EXP SOC PSYCHOL, V35, P4, DOI 10.1006/jesp.1998.1373; Stein DG, 2005, ANN NY ACAD SCI, V1052, P152, DOI 10.1196/annals.1347.011; Stubbs ML, 2008, ANN NY ACAD SCI, V1135, P58, DOI 10.1196/annals.1429.008; VOYER D, 1995, PSYCHOL BULL, V117, P250, DOI 10.1037/0033-2909.117.2.250; Voyer D, 2011, PSYCHON B REV, V18, P267, DOI 10.3758/s13423-010-0042-0; Weis S, 2010, NEUROSCIENTIST, V16, P132, DOI 10.1177/1073858409341481; Wister JA, 2013, SEX ROLES, V68, P19, DOI 10.1007/s11199-012-0156-0	50	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e111891	10.1371/journal.pone.0111891	http://dx.doi.org/10.1371/journal.pone.0111891			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426968	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400007
J	Agarwal, S; Kazi, JU; Mohlin, S; Pahlman, S; Ronnstrand, L				Agarwal, S.; Kazi, J. U.; Mohlin, S.; Pahlman, S.; Roennstrand, L.			The activation loop tyrosine 823 is essential for the transforming capacity of the c-Kit oncogenic mutant D816V	ONCOGENE			English	Article							HEMATOPOIETIC-CELL LINES; MAST-CELLS; DASATINIB BMS-354825; KINASE INHIBITOR; CATALYTIC DOMAIN; RECEPTOR; MUTATIONS; GROWTH; PHOSPHORYLATION; PROLIFERATION	Oncogenic c-Kit mutations have been shown to display ligand-independent receptor activation and cell proliferation. A substitution of aspartate to valine at amino acid 816 (D816V) is one of the most commonly found oncogenic c-Kit mutations and is found in >90% of cases of mastocytosis and less commonly in germ-cell tumors, core-binding factor acute myeloid leukemia and mucosal melanomas. The mechanisms by which this mutation leads to constitutive activation and transformation are not fully understood. Previous studies have shown that the D816V mutation causes a structural change in the activation loop (A-loop), resulting in weaker binding of the A-loop to the juxtamembrane domain. In this paper, we have investigated the role of Y823, the only tyrosine residue in the A-loop, and its role in oncogenic transformation by c-Kit/D816V by introducing the Y823F mutation. Although dispensable for the kinase activity of c-Kit/D816V, the presence of Y823 was crucial for cell proliferation and survival. Furthermore, mutation of Y823 selectively downregulates the Ras/Erk and Akt pathways as well as the phosphorylation of STAT5 and reduces the transforming capacity of the D816V/c-Kit in vitro. We further show that mice injected with cells expressing c-Kit/ D816V/Y823F display significantly reduced tumor size as well as tumor weight compared with controls. Finally, microarray analysis, comparing Y823F/D816V cells with cells expressing c-Kit/D816V, demonstrate that mutation of Y823 causes upregulation of proapoptotic genes, whereas genes of survival pathways are downregulated. Thus, phosphorylation of Y823 is not necessary for kinase activation, but essential for the transforming ability of the c-Kit/D816V mutant.	[Agarwal, S.; Kazi, J. U.; Mohlin, S.; Pahlman, S.; Roennstrand, L.] Lund Univ, Translat Canc Res, Lund, Sweden; [Agarwal, S.; Kazi, J. U.; Roennstrand, L.] Lund Univ, Lund Stem Cell Ctr, Lund, Sweden; [Mohlin, S.; Pahlman, S.] Lund Univ, CREATE Hlth, Lund, Sweden	Lund University; Lund University; Lund University	Ronnstrand, L (corresponding author), Lund Univ, Translat Canc Res, Scheelevagen 2, Lund, Sweden.	Lars.Ronnstrand@med.lu.se	Kazi, Julhash U./D-9190-2011	Kazi, Julhash U./0000-0002-0719-5336; Ronnstrand, Lars/0000-0003-1275-5809; Mohlin, Sofie/0000-0002-2458-3963	Swedish Research Council; Swedish Cancer Foundation; Gunnar Nilsson Cancer foundation; Stiftelsen Olle Engkvist Byggmastare; Royal Physiographic Society in Lund; Ollie och Elof Ericssons Stiftelse; Stiftelsen Lars Hiertas Minne	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Gunnar Nilsson Cancer foundation; Stiftelsen Olle Engkvist Byggmastare(Swedish Research Council); Royal Physiographic Society in Lund; Ollie och Elof Ericssons Stiftelse; Stiftelsen Lars Hiertas Minne	This work was supported by grants from the Swedish Research Council, the Swedish Cancer Foundation, Gunnar Nilsson Cancer foundation, the Stiftelsen Olle Engkvist Byggmastare, Royal Physiographic Society in Lund, Ollie och Elof Ericssons Stiftelse and Stiftelsen Lars Hiertas Minne.	Agarwal S, 2013, J BIOL CHEM, V288, P22460, DOI 10.1074/jbc.M113.474072; Aichberger KJ, 2009, BLOOD, V114, P5342, DOI 10.1182/blood-2008-08-175190; An NF, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-12; Ashman LK, 1999, INT J BIOCHEM CELL B, V31, P1037, DOI 10.1016/S1357-2725(99)00076-X; Beghini A, 2004, HAEMATOLOGICA, V89, P920; Benekli M, 2003, BLOOD, V101, P2940, DOI 10.1182/blood-2002-04-1204; Blanco-Aparicio C, 2013, BIOCHEM PHARMACOL, V85, P629, DOI 10.1016/j.bcp.2012.09.018; BLUMEJENSEN P, 1993, EMBO J, V12, P4199, DOI 10.1002/j.1460-2075.1993.tb06104.x; Boerner JL, 2005, MOL CARCINOGEN, V44, P262, DOI 10.1002/mc.20138; Boerner JL, 2004, MOL CELL BIOL, V24, P7059, DOI 10.1128/MCB.24.16.7059-7071.2004; Bougherara H, 2013, CL LYMPH MYELOM LEUK, V13, P62, DOI 10.1016/j.clml.2012.08.004; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Cairoli R, 2006, BLOOD, V107, P3463, DOI 10.1182/blood-2005-09-3640; Carlesso N, 1996, J EXP MED, V183, P811, DOI 10.1084/jem.183.3.811; Chaix A, 2013, ONCOGENE; Chaix A, 2011, J BIOL CHEM, V286, P5956, DOI 10.1074/jbc.M110.182642; Chian RJ, 2001, BLOOD, V98, P1365, DOI 10.1182/blood.V98.5.1365; DiNitto JP, 2010, J BIOCHEM, V147, P601, DOI 10.1093/jb/mvq015; Dong LQ, 1997, MOL ENDOCRINOL, V11, P1757, DOI 10.1210/me.11.12.1757; Foster R, 2004, J MOL GRAPH MODEL, V23, P139, DOI 10.1016/j.jmgm.2004.04.003; FURITSU T, 1993, J CLIN INVEST, V92, P1736, DOI 10.1172/JCI116761; Giridhar PV, 2011, CLIN EXP METASTAS, V28, P887, DOI 10.1007/s10585-011-9420-x; Gleixner KV, 2006, BLOOD, V107, P752, DOI 10.1182/blood-2005-07-3022; Goutebroze L, 2000, MOL CELL BIOL, V20, P1699, DOI 10.1128/MCB.20.5.1699-1712.2000; Grundler R, 2009, J EXP MED, V206, P1957, DOI 10.1084/jem.20082074; Hegazy SA, 2010, J BIOL CHEM, V285, P19813, DOI 10.1074/jbc.M110.121988; Heinrich MC, 2002, HUM PATHOL, V33, P484, DOI 10.1053/hupa.2002.124124; Kemmer K, 2004, AM J PATHOL, V164, P305, DOI 10.1016/S0002-9440(10)63120-3; KITAYAMA H, 1995, BLOOD, V85, P790, DOI 10.1182/blood.V85.3.790.bloodjournal853790; Kosmider O, 2007, ONCOGENE, V26, P3904, DOI 10.1038/sj.onc.1210159; Laine E, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002661; Longley BJ, 1999, P NATL ACAD SCI USA, V96, P1609, DOI 10.1073/pnas.96.4.1609; Looijenga LHJ, 2003, CANCER RES, V63, P7674; Makki MS, 2013, EXP CELL RES, V319, P612, DOI 10.1016/j.yexcr.2012.12.021; Masson K, 2009, CELL SIGNAL, V21, P1717, DOI 10.1016/j.cellsig.2009.06.002; Ning ZQ, 2001, LEUKEMIA LYMPHOMA, V41, P513, DOI 10.3109/10428190109060342; Orfao A, 2007, BRIT J HAEMATOL, V138, P12, DOI 10.1111/j.1365-2141.2007.06619.x; Piao XH, 1996, BLOOD, V87, P3117, DOI 10.1182/blood.V87.8.3117.bloodjournal8783117; RODRIGUES CA, 1994, CURR OPIN GENET DEV, V4, P15, DOI 10.1016/0959-437X(94)90086-8; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Schittenhelm MM, 2006, CANCER RES, V66, P473, DOI 10.1158/0008-5472.CAN-05-2050; SERVE H, 1995, EMBO J, V14, P473, DOI 10.1002/j.1460-2075.1995.tb07023.x; Shah NP, 2006, BLOOD, V108, P286, DOI 10.1182/blood-2005-10-3969; Sun JM, 2008, J BIOL CHEM, V283, P27444, DOI 10.1074/jbc.M709703200; Sun JM, 2009, J BIOL CHEM, V284, P11039, DOI 10.1074/jbc.M808058200; Thieblemont C, 2013, BLOOD, V121, P2165, DOI 10.1182/blood-2013-01-480392; Tian QS, 1999, AM J PATHOL, V154, P1643, DOI 10.1016/S0002-9440(10)65419-3; Wardega P, 2010, CELL SIGNAL, V22, P1363, DOI 10.1016/j.cellsig.2010.05.004; Wu N, 2013, CLIN TRANSL ONCOL, V15, P106, DOI 10.1007/s12094-012-0928-6; Yang QS, 2012, BLOOD, V120, P3491, DOI 10.1182/blood-2012-02-412643; Zhu WT, 2009, CIRC RES, V105, P1240, DOI 10.1161/CIRCRESAHA.109.208785; Zhuang WY, 2013, ONCOL REP, V30, P185, DOI 10.3892/or.2013.2459	53	12	12	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 27	2015	34	35					4581	4590		10.1038/onc.2014.383	http://dx.doi.org/10.1038/onc.2014.383			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CP9BS	25435369	Green Submitted			2022-12-26	WOS:000360189300004
J	Parra, ES; Panzoldo, NB; Zago, VHD; Scherrer, DZ; Alexandre, F; Bakkarat, J; Nunes, VS; Nakandakare, ER; Quintao, ECR; Nadruz, W; de Faria, EC; Sposito, AC				Parra, Eliane Soler; Panzoldo, Natalia Baratella; de Souza Zago, Vanessa Helena; Scherrer, Daniel Zanetti; Alexandre, Fernanda; Bakkarat, Jamal; Nunes, Valeria Sutti; Nakandakare, Edna Regina; Rocha Quintao, Eder Carlos; Nadruz-, Wilson, Jr.; de Faria, Eliana Cotta; Sposito, Andrei C.			HDL Size is More Accurate than HDL Cholesterol to Predict Carotid Subclinical Atherosclerosis in Individuals Classified as Low Cardiovascular Risk	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; LIPOPROTEIN; MASS; SUBCLASSES; EFFLUX	Background: Misclassification of patients as low cardiovascular risk (LCR) remains a major concern and challenges the efficacy of traditional risk markers. Due to its strong association with cholesterol acceptor capacity, high-density lipoprotein (HDL) size has been appointed as a potential risk marker. Hence, we investigate whether HDL size improves the predictive value of HDL-cholesterol in the identification of carotid atherosclerotic burden in individuals stratified to be at LCR. Methods and Findings: 284 individuals (40-75 years) classified as LCR by the current US guidelines were selected in a three-step procedure from primary care centers of the cities of Campinas and Americana, SP, Brazil. Apolipoprotein B-containing lipoproteins were precipitated by polyethylene glycol and HDL size was measured by dynamic light scattering (DLS) technique. Participants were classified in tertiles of HDL size (<7.57; 7.57-8.22; >8.22 nm). Carotid intima-media thickness (cIMT) <0.90 mm (80th percentile) was determined by high resolution ultrasonography and multivariate ordinal regression models were used to assess the association between cIMT across HDL size and levels of lipid parameters. HDLcholesterol was not associated with cIMT. In contrast, HDL size >8.22 nm was independently associated with low cIMT in either unadjusted and adjusted models for age, gender and Homeostasis Model Assessment 2 index for insulin sensitivity, ethnicity and body mass index (Odds ratio 0.23; 95% confidence interval 0.07-0.74, p=0.013). Conclusion: The mean HDL size estimated with DLS constitutes a better predictor for subclinical carotid atherosclerosis than the conventional measurements of plasma HDL-cholesterol in individuals classified as LCR.	[Parra, Eliane Soler; Panzoldo, Natalia Baratella; Nadruz-, Wilson, Jr.; Sposito, Andrei C.] Univ Estadual Campinas, Fac Med Sci, Dept Cardiol, Campinas, SP, Brazil; [Parra, Eliane Soler; Panzoldo, Natalia Baratella; de Souza Zago, Vanessa Helena; Scherrer, Daniel Zanetti; Alexandre, Fernanda; Bakkarat, Jamal; de Faria, Eliana Cotta] Univ Estadual Campinas, Dept Clin Pathol, Fac Med Sci, Lipid Lab, Campinas, SP, Brazil; [Parra, Eliane Soler; Panzoldo, Natalia Baratella; de Souza Zago, Vanessa Helena; Scherrer, Daniel Zanetti; Alexandre, Fernanda; Bakkarat, Jamal; de Faria, Eliana Cotta] Univ Estadual Campinas, Ctr Med & Expt Surg, Fac Med Sci, Campinas, SP, Brazil; [Nunes, Valeria Sutti; Nakandakare, Edna Regina; Rocha Quintao, Eder Carlos] Univ Sao Paulo, Lipid Lab, Fac Med Sci, Sao Paulo, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade Estadual de Campinas; Universidade de Sao Paulo	Sposito, AC (corresponding author), Univ Estadual Campinas, Fac Med Sci, Dept Cardiol, Campinas, SP, Brazil.	andreisposito@gmail.com	Sposito, Andrei C/G-4116-2013; Nakandakare, Edna R/D-6625-2012; Nadruz, Wilson/I-3643-2013; Nunes, Valeria S./G-4778-2012; Zago, V/C-3497-2015	Sposito, Andrei C/0000-0001-7127-2052; Nadruz, Wilson/0000-0002-0003-5102; Nunes, Valeria S./0000-0002-6769-5412; Zago, V/0000-0003-2488-0199; Cotta de Faria, Eliana/0000-0002-5208-1274; Quintao, Eder/0000-0001-9810-3259	Brazilian National Research Council (CNPq); State of Sao Paulo Research Foundation (Fapesp) [2006/60585-9, 2011/16476-9]; CNPq [143384/2011-2]	Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); State of Sao Paulo Research Foundation (Fapesp)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	ACS and WN were supported by a fellowship grant of productivity in research from the Brazilian National Research Council (CNPq). This work was supported by the State of Sao Paulo Research Foundation (Fapesp), grant numbers 2006/60585-9 and 2011/16476-9, and by the CNPq, grant number 143384/2011-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cheung MC, 2009, BBA-MOL CELL BIOL L, V1791, P206, DOI 10.1016/j.bbalip.2008.12.010; Chisholm JW, 1999, J LIPID RES, V40, P1512; Cooney MT, 2009, EUR J CARDIOV PREV R, V16, P304, DOI 10.1097/HJR.0b013e3283213140; de Beer MC, 2001, J LIPID RES, V42, P309; de Vries Rindert, 2003, Clin Lab, V49, P601; de Vries R, 2011, ATHEROSCLEROSIS, V217, P253, DOI 10.1016/j.atherosclerosis.2011.03.021; DIAS VC, 1988, CLIN CHEM, V34, P2322; DOBIASOVA M, 1992, J LIPID RES, V33, P1411; Dullaart RPF, 2008, J CLIN ENDOCR METAB, V93, P4860, DOI 10.1210/jc.2008-1213; Ehnholm C, 1986, Methods Enzymol, V129, P716; El Harchaoui K, 2009, ANN INTERN MED, V150, P84, DOI 10.7326/0003-4819-150-2-200901200-00006; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Jarauta E, 2012, NUTR METAB CARDIOVAS, V22, P591, DOI 10.1016/j.numecd.2010.10.011; Jauhiainen M, 2005, METHODS, V36, P97, DOI 10.1016/j.ymeth.2004.11.006; Kahn Henry S, 2005, BMC Cardiovasc Disord, V5, P26, DOI 10.1186/1471-2261-5-26; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Kleemola P, 2002, ATHEROSCLEROSIS, V160, P425, DOI 10.1016/S0021-9150(01)00594-9; Kontush A, 2003, ARTERIOSCL THROM VAS, V23, P1881, DOI 10.1161/01.ATV.0000091338.93223.E8; Lagrost L, 1998, Methods Mol Biol, V110, P231; Lee JY, 2007, J LIPID RES, V48, P1052, DOI 10.1194/jlr.M600417-JLR200; Li XM, 2013, ARTERIOSCL THROM VAS, V33, P1696, DOI 10.1161/ATVBAHA.113.301373; Lima ES, 2004, CLIN CHEM, V50, P1086, DOI 10.1373/clinchem.2004.032383; Mora S, 2009, CIRCULATION, V119, P931, DOI 10.1161/CIRCULATIONAHA.108.816181; Oka T, 2002, J LIPID RES, V43, P1236, DOI 10.1194/jlr.M100349-JLR200; Rosenson RS, 2002, AM J CARDIOL, V90, P89, DOI 10.1016/S0002-9149(02)02427-X; Silbernagel G, 2013, EUR HEART J, V34, P3563, DOI 10.1093/eurheartj/eht343; Sposito AC, 2011, ATHEROSCLEROSIS, V214, P148, DOI 10.1016/j.atherosclerosis.2010.10.034; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; Yancey PG, 2000, J BIOL CHEM, V275, P36596, DOI 10.1074/jbc.M006924200	29	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114212	10.1371/journal.pone.0114212	http://dx.doi.org/10.1371/journal.pone.0114212			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470778	gold, Green Submitted, Green Published			2022-12-26	WOS:000349128700086
J	Apthorp, D; Nagle, F; Palmisano, S				Apthorp, Deborah; Nagle, Fintan; Palmisano, Stephen			Chaos in Balance: Non-Linear Measures of Postural Control Predict Individual Variations in Visual Illusions of Motion	PLOS ONE			English	Article							RECURRENCE QUANTIFICATION ANALYSIS; DETRENDED FLUCTUATION ANALYSIS; SENSORIMOTOR INTEGRATION; CORTICAL AREA; SELF-MOTION; OPTIC FLOW; SWAY; PRESSURE; STANCE; EEG	Visually-induced illusions of self-motion (vection) can be compelling for some people, but they are subject to large individual variations in strength. Do these variations depend, at least in part, on the extent to which people rely on vision to maintain their postural stability? We investigated by comparing physical posture measures to subjective vection ratings. Using a Bertec balance plate in a brightly-lit room, we measured 13 participants' excursions of the centre of foot pressure (CoP) over a 60-second period with eyes open and with eyes closed during quiet stance. Subsequently, we collected vection strength ratings for large optic flow displays while seated, using both verbal ratings and online throttle measures. We also collected measures of postural sway (changes in anterior-posterior CoP) in response to the same visual motion stimuli while standing on the plate. The magnitude of standing sway in response to expanding optic flow (in comparison to blank fixation periods) was predictive of both verbal and throttle measures for seated vection. In addition, the ratio between eyes-open and eyes-closed CoP excursions during quiet stance (using the area of postural sway) significantly predicted seated vection for both measures. Interestingly, these relationships were weaker for contracting optic flow displays, though these produced both stronger vection and more sway. Next we used a non-linear analysis (recurrence quantification analysis, RQA) of the fluctuations in anterior-posterior position during quiet stance (both with eyes closed and eyes open); this was a much stronger predictor of seated vection for both expanding and contracting stimuli. Given the complex multisensory integration involved in postural control, our study adds to the growing evidence that non-linear measures drawn from complexity theory may provide a more informative measure of postural sway than the conventional linear measures.	[Apthorp, Deborah] Australian Natl Univ, Coll Med Biol & Environm, Res Sch Psychol, Canberra, ACT, Australia; [Apthorp, Deborah; Palmisano, Stephen] Univ Wollongong, Fac Social Sci, Sch Psychol, Wollongong, NSW, Australia; [Nagle, Fintan] UCL, Ctr Math Phys & Engn Life Sci & Expt Biol, London, England	Australian National University; University of Wollongong; University of London; University College London	Apthorp, D (corresponding author), Australian Natl Univ, Coll Med Biol & Environm, Res Sch Psychol, Canberra, ACT, Australia.	deborah.apthorp@anu.edu.au	Palmisano, Stephen/O-1553-2018; Apthorp, Deborah/N-5623-2014	Palmisano, Stephen/0000-0002-9140-5681; Apthorp, Deborah/0000-0001-5785-024X	Australian Research Council [DP0772398]	Australian Research Council(Australian Research Council)	Funding provided to SP: Australian Research Council Grant no. DP0772398 - http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Becker K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008876; Berthoz A, 1975, EXPT BRAIN RES, V23; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cardin V, 2011, J NEUROPHYSIOL, V106, P1240, DOI 10.1152/jn.01120.2010; Cardin V, 2010, CEREB CORTEX, V20, P1964, DOI 10.1093/cercor/bhp268; Chagdes JR, 2009, EXP BRAIN RES, V197, P297, DOI 10.1007/s00221-009-1915-1; Chen AH, 2010, J NEUROSCI, V30, P3022, DOI 10.1523/JNEUROSCI.4029-09.2010; Creath R, 2005, NEUROSCI LETT, V377, P75, DOI 10.1016/j.neulet.2004.11.071; Donner RV, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/033025; Doyle TL, 2005, ARCH PHYS MED REHAB, V86, P2034, DOI 10.1016/j.apmr.2005.05.014; Duarte M, 2000, NEUROSCI LETT, V283, P173, DOI 10.1016/S0304-3940(00)00960-5; Duarte M, 2010, REV BRAS FISIOTER, V14, P183, DOI 10.1590/S1413-35552010000300003; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Guerraz M, 2008, NEUROSCI LETT, V443, P12, DOI 10.1016/j.neulet.2008.07.053; Hamadene W, 2005, CAN C EL COMP ENG, V2005, P354; Hasson CJ, 2008, GAIT POSTURE, V27, P416, DOI 10.1016/j.gaitpost.2007.05.010; Huang LY, 2006, LECT NOTES COMPUT SC, V4234, P58; Jeka J, 2006, EXP BRAIN RES, V174, P517, DOI 10.1007/s00221-006-0502-y; Kantelhardt JW, 2001, PHYSICA A, V295, P441, DOI 10.1016/S0378-4371(01)00144-3; Kantelhardt JW, 2002, PHYSICA A, V316, P87, DOI 10.1016/S0378-4371(02)01383-3; Kennedy R. S., 1993, INT J AVIAT PSYCHOL, V3, P203; Kiemel T, 2002, BIOL CYBERN, V87, P262, DOI 10.1007/s00422-002-0333-2; Kim G, 2009, AM J BIOMEDICAL SCI, P364; Kirchner M, 2012, PHYSICA A, V391, P4692, DOI 10.1016/j.physa.2012.05.034; Kuno S, 1999, JPN J PHYSIOL, V49, P417, DOI 10.2170/jjphysiol.49.417; LESTIENNE F, 1977, EXP BRAIN RES, V28, P363; LISHMAN JR, 1973, PERCEPTION, V2, P287, DOI 10.1068/p020287; Liu S, 2009, J NEUROSCI, V29, P8936, DOI 10.1523/JNEUROSCI.1607-09.2009; Marwan N, 2007, PHYS REP, V438, P237, DOI 10.1016/j.physrep.2006.11.001; Marwan N, 2011, INT J BIFURCAT CHAOS, V21, P1003, DOI 10.1142/S0218127411029008; Masson G, 1995, EXPT BRAIN RES, V103; Maurer C, 2005, J NEUROPHYSIOL, V93, P189, DOI 10.1152/jn.00221.2004; Maurer C, 2006, EXP BRAIN RES, V171, P231, DOI 10.1007/s00221-005-0256-y; Mazaheri M, 2010, MED ENG PHYS, V32, P808, DOI 10.1016/j.medengphy.2010.04.019; Mesin L, 2014, J CLIN MONIT COMPUT, V28, P377, DOI 10.1007/s10877-013-9544-4; Mitchell SL, 1995, NEUROSCIENCE; Morrone MC, 2000, NAT NEUROSCI, V3, P1322, DOI 10.1038/81860; Negahban H, 2010, GAIT POSTURE, V31, P450, DOI 10.1016/j.gaitpost.2010.01.020; Oliveira LF, 1996, PHYSIOL MEAS, V17, P305, DOI 10.1088/0967-3334/17/4/008; Palm S., 2014, EUSAR 2014 10 EUR C, P1; Palmisano S, 2009, PERCEPTION, V38, P442, DOI 10.1068/p6159; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Peterka RJ, 2004, J NEUROPHYSIOL, V91, P410, DOI 10.1152/jn.00516.2003; Peterka RJ, 2002, J NEUROPHYSIOL, V88, P1097, DOI 10.1152/jn.2002.88.3.1097; Pitzalis S, 2010, CEREB CORTEX, V20, P411, DOI 10.1093/cercor/bhp112; Pitzalis S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060241; Ramdani S, 2013, ANN BIOMED ENG, V41, P1713, DOI 10.1007/s10439-013-0790-x; Riley MA, 1999, GAIT POSTURE, V9, P65, DOI 10.1016/S0966-6362(98)00044-7; Riley MA, 2003, NEUROSCIENCE LETT; RONNQVIST L, 1995, NEUROPSYCHOLOGIA, V33, P713, DOI 10.1016/0028-3932(95)00006-O; Schinkel S, 2009, J PHYSIOLOGY-PARIS, V103, P315, DOI 10.1016/j.jphysparis.2009.05.007; Schmit JM, 2006, EXP BRAIN RES, V168, P357, DOI 10.1007/s00221-005-0094-y; Schmit JM, 2005, EXP BRAIN RES, V163, P370, DOI 10.1007/s00221-004-2185-6; Seno T, 2013, PERCEPTION, V42, P173; Smart LJ, 2002, HUM FACTORS, V44, P451, DOI 10.1518/0018720024497745; Smith AT, 2011, J VISION, V11, P740; Talebi N, 2010, LECT NOTES ARTIF INT, V6334, P124, DOI 10.1007/978-3-642-15314-3_12; Tallon G, 2013, GAIT POSTURE, V38, P92, DOI 10.1016/j.gaitpost.2012.10.021; Tanahashi S, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-39; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Trulla LL, 1996, PHYS LETT A, V223, P255, DOI 10.1016/S0375-9601(96)00741-4; van der Kooij H, 2011, J COMPUT NEUROSCI, V30, P759, DOI 10.1007/s10827-010-0291-y; Wall MB, 2008, CURR BIOL, V18, P191, DOI 10.1016/j.cub.2007.12.053; Wei KL, 2010, J VISION, V10, DOI 10.1167/10.14.4; ZBILUT JP, 1992, PHYS LETT A, V171, P199, DOI 10.1016/0375-9601(92)90426-M; Zhu TQ, 2008, LECT NOTES COMPUT SC, V5226, P438	67	14	15	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113897	10.1371/journal.pone.0113897	http://dx.doi.org/10.1371/journal.pone.0113897			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462216	Green Published, Green Submitted, gold			2022-12-26	WOS:000345869700065
J	Asmat, TM; Tenenbaum, T; Jonsson, AB; Schwerk, C; Schroten, H				Asmat, Tauseef M.; Tenenbaum, Tobias; Jonsson, Ann-Beth; Schwerk, Christian; Schroten, Horst			Impact of Calcium Signaling during Infection of Neisseria meningitidis to Human Brain Microvascular Endothelial Cells	PLOS ONE			English	Article							PILUS-MEDIATED ADHERENCE; EPITHELIAL-CELLS; ESCHERICHIA-COLI; IV PILI; LISTERIA-MONOCYTOGENES; BINDING-PROTEIN; INVASION; CD46; GONORRHOEAE; BIOGENESIS	The pili and outer membrane proteins of Neisseria meningitidis (meningococci) facilitate bacterial adhesion and invasion into host cells. In this context expression of meningococcal PilC1 protein has been reported to play a crucial role. Intracellular calcium mobilization has been implicated as an important signaling event during internalization of several bacterial pathogens. Here we employed time lapse calcium-imaging and demonstrated that PilC1 of meningococci triggered a significant increase in cytoplasmic calcium in human brain microvascular endothelial cells, whereas PilC1-deficient meningococci could not initiate this signaling process. The increase in cytosolic calcium in response to PilC1-expressing meningococci was due to efflux of calcium from host intracellular stores as demonstrated by using 2-APB, which inhibits the release of calcium from the endoplasmic reticulum. Moreover, pre-treatment of host cells with U73122 (phospholipase C inhibitor) abolished the cytosolic calcium increase caused by PilC1-expressing meningococci demonstrating that active phospholipase C (PLC) is required to induce calcium transients in host cells. Furthermore, the role of cytosolic calcium on meningococcal adherence and internalization was documented by gentamicin protection assay and double immunofluorescence (DIF) staining. Results indicated that chelation of intracellular calcium by using BAPTA-AM significantly impaired PilC1-mediated meningococcal adherence to and invasion into host endothelial cells. However, buffering of extracellular calcium by BAPTA or EGTA demonstrated no significant effect on meningococcal adherence to and invasion into host cells. Taken together, these results indicate that meningococci induce calcium release from intracellular stores of host endothelial cells via PilC1 and cytoplasmic calcium concentrations play a critical role during PilC1 mediated meningococcal adherence to and subsequent invasion into host endothelial cells.	[Asmat, Tauseef M.; Tenenbaum, Tobias; Schwerk, Christian; Schroten, Horst] Heidelberg Univ, Dept Pediat, Med Fac Mannheim, Mannheim, Germany; [Jonsson, Ann-Beth] Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, S-10691 Stockholm, Sweden	Ruprecht Karls University Heidelberg; Stockholm University	Asmat, TM (corresponding author), Heidelberg Univ, Dept Pediat, Med Fac Mannheim, Mannheim, Germany.	tauseef.asmat@medma.uni-heidelberg.de	Schwerk, Christian/GNP-5375-2022; Asmat, Tauseef M/Q-3801-2019					Appleby PA, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0487; Asmat TM, 2012, MICROBIOL-SGM, V158, P771, DOI 10.1099/mic.0.053603-0; Asmat TM, 2011, J BIOL CHEM, V286, P17861, DOI 10.1074/jbc.M110.212225; BALDWIN TJ, 1991, INFECT IMMUN, V59, P1599, DOI 10.1128/IAI.59.5.1599-1604.1991; Barreto-Chang Odmara L, 2009, J Vis Exp, DOI 10.3791/1067; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Bierne H, 2000, CELL MICROBIOL, V2, P465, DOI 10.1046/j.1462-5822.2000.00069.x; BOOTMAN MD, 1995, CELL, V83, P675, DOI 10.1016/0092-8674(95)90179-5; Boulay G, 1999, P NATL ACAD SCI USA, V96, P14955, DOI 10.1073/pnas.96.26.14955; Brown MD, 2008, J BIOL CHEM, V283, P35212, DOI 10.1074/jbc.M803477200; Caugant DA, 2009, VACCINE, V27, pB64, DOI 10.1016/j.vaccine.2009.04.061; Cheng Y, 2013, INFECT IMMUN, V81, P4280, DOI 10.1128/IAI.00493-13; Coureuil M, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012393; Coureuil M, 2012, VIRULENCE, V3, P164, DOI 10.4161/viru.18639; Eichstaedt S, 2009, CELL CALCIUM, V45, P165, DOI 10.1016/j.ceca.2008.09.001; Gekara NO, 2007, CELL MICROBIOL, V9, P2008, DOI 10.1111/j.1462-5822.2007.00932.x; Gewirtz AT, 2000, J CLIN INVEST, V105, P79, DOI 10.1172/JCI8066; Gill DB, 2004, TRENDS MOL MED, V10, P459, DOI 10.1016/j.molmed.2004.07.002; Grab DJ, 2009, CLIN MICROBIOL INFEC, V15, P422, DOI 10.1111/j.1469-0691.2009.02869.x; Greiffenberg L, 1998, INFECT IMMUN, V66, P5260, DOI 10.1128/IAI.66.11.5260-5267.1998; Hu L, 2005, MICROBIOL-SGM, V151, P3097, DOI 10.1099/mic.0.27866-0; Jen FEC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003377; Johansson L, 2003, SCIENCE, V301, P373, DOI 10.1126/science.1086476; Johnson M., 2011, Proceedings 2011 International Symposium on Network Coding (NetCod 2011), DOI 10.1109/ISNETCOD.2011.5978948; JONSSON AB, 1991, EMBO J, V10, P477, DOI 10.1002/j.1460-2075.1991.tb07970.x; JONSSON AB, 1995, MICROBIOL-SGM, V141, P2367, DOI 10.1099/13500872-141-10-2367; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; Kallstrom H, 1998, J BIOL CHEM, V273, P21777, DOI 10.1074/jbc.273.34.21777; Ko Y, 2011, MICROB PATHOGENESIS, V50, P326, DOI 10.1016/j.micpath.2011.02.007; Lee SW, 2002, J CELL BIOL, V156, P951, DOI 10.1083/jcb.200109005; Lindqvist SM, 1998, GASTROENTEROLOGY, V115, P1131, DOI 10.1016/S0016-5085(98)70084-8; MacMillan D, 2010, BRIT J PHARMACOL, V160, P1295, DOI 10.1111/j.1476-5381.2010.00771.x; Magalhaes V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063244; Maiden MCJ, 2012, VACCINE, V30, pB52, DOI 10.1016/j.vaccine.2011.12.068; MAJEED M, 1994, INFECT IMMUN, V62, P126, DOI 10.1128/IAI.62.1.126-134.1994; Merz AJ, 1999, MOL MICROBIOL, V32, P1316, DOI 10.1046/j.1365-2958.1999.01459.x; Mu R, 2014, INFECT IMMUN, V82, P2276, DOI 10.1128/IAI.01559-13; Nagata K, 1992, Nihon Rinsho, V50, P223; Nikulin J, 2006, INT J MED MICROBIOL, V296, P553, DOI 10.1016/j.ijmm.2006.06.006; Opitz D, 2009, CHEMPHYSCHEM, V10, P1614, DOI 10.1002/cphc.200800654; Orans J, 2010, P NATL ACAD SCI USA, V107, P1065, DOI 10.1073/pnas.0911616107; PACE J, 1993, CELL, V72, P505, DOI 10.1016/0092-8674(93)90070-7; PARGE HE, 1995, NATURE, V378, P32, DOI 10.1038/378032a0; Porsch EA, 2013, J BACTERIOL, V195, P886, DOI 10.1128/JB.02186-12; Prasadarao NV, 1999, INFECT IMMUN, V67, P1131, DOI 10.1128/IAI.67.3.1131-1138.1999; Pujol C, 1999, P NATL ACAD SCI USA, V96, P4017, DOI 10.1073/pnas.96.7.4017; Rahman M, 1997, MOL MICROBIOL, V25, P11, DOI 10.1046/j.1365-2958.1997.4601823.x; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Riley-Vargas RC, 2004, TRENDS IMMUNOL, V25, P496, DOI 10.1016/j.it.2004.07.004; RUDEL T, 1992, MOL MICROBIOL, V6, P3439, DOI 10.1111/j.1365-2958.1992.tb02211.x; RUDEL T, 1995, MOL MICROBIOL, V17, P1057, DOI 10.1111/j.1365-2958.1995.mmi_17061057.x; Scheuerpflug I, 1999, INFECT IMMUN, V67, P834, DOI 10.1128/IAI.67.2.834-843.1999; Schwerk C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030069; Seo HS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002947; Shah Sanket, 2013, WMJ, V112, P28; Sim RJ, 2000, LANCET, V356, P1653, DOI 10.1016/S0140-6736(00)03162-7; Sokolova O, 2004, CELL MICROBIOL, V6, P1153, DOI 10.1111/j.1462-5822.2004.00422.x; Son SM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.129; Stins MF, 2001, MICROB PATHOGENESIS, V30, P19, DOI 10.1006/mpat.2000.0406; Strober Warren, 2015, Curr Protoc Immunol, V111, DOI 10.1002/0471142735.ima03bs111; Taha MK, 1998, MOL MICROBIOL, V28, P1153, DOI 10.1046/j.1365-2958.1998.00876.x; Teng CH, 2005, INFECT IMMUN, V73, P2923, DOI 10.1128/IAI.73.5.2923-2931.2005; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; Verkhratsky A, 2004, BIOL RES, V37, P693; Virji M, 2009, NAT REV MICROBIOL, V7, P274, DOI 10.1038/nrmicro2097; Weyand NJ, 2006, INFECT IMMUN, V74, P2428, DOI 10.1128/IAI.74.4.2428-2435.2006; Wolfgang M, 2000, EMBO J, V19, P6408, DOI 10.1093/emboj/19.23.6408; Zeerleder S, 2012, CRIT CARE MED, V40, P3224, DOI 10.1097/CCM.0b013e318265695f; Zhao JF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075652	69	17	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114474	10.1371/journal.pone.0114474	http://dx.doi.org/10.1371/journal.pone.0114474			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464500	Green Published, Green Submitted, gold			2022-12-26	WOS:000345869700133
J	Esteva, MJ; Affranchino, JL; Gonzalez, SA				Esteva, Maria J.; Affranchino, Jose L.; Gonzalez, Silvia A.			Lentiviral Gag Assembly Analyzed through the Functional Characterization of Chimeric Simian Immunodeficiency Viruses Expressing Different Domains of the Feline Immunodeficiency Virus Capsid Protein	PLOS ONE			English	Article							ENVELOPE GLYCOPROTEIN INCORPORATION; NUCLEAR IMPORT; INTERSUBUNIT INTERACTIONS; CYTOPLASMIC DOMAIN; PARTICLE FORMATION; FUSION ACTIVITY; MATRIX PROTEIN; TYPE-1 CORE; N-TERMINUS; ORF-A	To gain insight into the functional relationship between the capsid (CA) domains of the Gag polyproteins of simian and feline immunodeficiency viruses (SIV and FIV, respectively), we constructed chimeric SIVs in which the CA-coding region was partially or totally replaced by the equivalent region of the FIV CA. The phenotypic characterization of the chimeras allowed us to group them into three categories: the chimeric viruses that, while being assembly-competent, exhibit a virion-associated unstable FIV CA; a second group represented only by the chimeric SIV carrying the N-terminal domain (NTD) of the FIV CA which proved to be assembly-defective; and a third group constituted by the chimeric viruses that produce virions exhibiting a mature and stable FIV CA protein, and which incorporate the envelope glycoprotein and contain wild-type levels of viral genome RNA and reverse transcriptase. Further analysis of the latter group of chimeric SIVs demonstrated that they are non-infectious due to a post-entry impairment, such as uncoating of the viral core, reverse transcription or nuclear import of the preintegration complex. Furthermore, we show here that the carboxyl-terminus domain (CTD) of the FIV CA has an intrinsic ability to dimerize in vitro and form high-molecular-weight oligomers, which, together with our finding that the FIV CA-CTD is sufficient to confer assembly competence to the resulting chimeric SIV Gag polyprotein, provides evidence that the CA-CTD exhibits more functional plasticity than the CA-NTD. Taken together, our results provide relevant information on the biological relationship between the CA proteins of primate and nonprimate lentiviruses.	[Gonzalez, Silvia A.] Univ Belgrano, Virol Lab, Buenos Aires, DF, Argentina; Consejo Nacl Invest Cient & Tecn, RA-1033 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Gonzalez, SA (corresponding author), Univ Belgrano, Virol Lab, Buenos Aires, DF, Argentina.	silvia.gonzalez@comunidad.ub.edu.ar		Gonzalez, Silvia Adriana/0000-0001-8744-0874; Affranchino, Jose/0000-0002-1287-9636	National Research Council of Argentina (CONICET) [PIP 0600]; Fundacion Universidad de Belgrano (UB)	National Research Council of Argentina (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion Universidad de Belgrano (UB)	This work was supported by the National Research Council of Argentina (CONICET) Grant PIP 0600 and Fundacion Universidad de Belgrano (UB) to SAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cerfoglio JCA, 2014, J GEN VIROL, V95, P2050, DOI 10.1099/vir.0.065151-0; Accola MA, 1999, J VIROL, V73, P9992, DOI 10.1128/JVI.73.12.9992-9999.1999; Affranchino JL, 2006, VIROLOGY, V347, P217, DOI 10.1016/j.virol.2005.11.032; Affranchino JL, 2014, VIRUSES-BASEL, V6, P264, DOI 10.3390/v6010264; Affranchino JL, 2010, VIRUS RES, V150, P153, DOI 10.1016/j.virusres.2010.03.012; Bharat TAM, 2012, NATURE, V487, P385, DOI 10.1038/nature11169; Borsetti A, 1998, J VIROL, V72, P9313, DOI 10.1128/JVI.72.11.9313-9317.1998; Briggs JAG, 2009, P NATL ACAD SCI USA, V106, P11090, DOI 10.1073/pnas.0903535106; Briggs JAG, 2004, NAT STRUCT MOL BIOL, V11, P672, DOI 10.1038/nsmb785; Briggs JAG, 2011, J MOL BIOL, V410, P491, DOI 10.1016/j.jmb.2011.04.021; Byeon IJL, 2012, J AM CHEM SOC, V134, P6455, DOI 10.1021/ja300937v; Byeon IJL, 2009, CELL, V139, P780, DOI 10.1016/j.cell.2009.10.010; Calistri A, 2009, J CELL PHYSIOL, V218, P175, DOI 10.1002/jcp.21587; Campbell S, 1999, J VIROL, V73, P2270, DOI 10.1128/JVI.73.3.2270-2279.1999; Campos-Olivas R, 2000, J MOL BIOL, V296, P633, DOI 10.1006/jmbi.1999.3475; Cara A, 2004, VIROLOGY, V324, P531, DOI 10.1016/j.virol.2004.04.006; Cardone G, 2009, NATURE, V457, P694, DOI 10.1038/nature07724; Celma CCP, 2004, AIDS RES HUM RETROV, V20, P733, DOI 10.1089/0889222041524580; Celma CCP, 2007, VIROLOGY, V366, P405, DOI 10.1016/j.virol.2007.05.019; Chen K, 2013, J BIOL CHEM, V288, P1511, DOI 10.1074/jbc.M112.425140; Chen ZW, 1997, J VIROL, V71, P2705, DOI 10.1128/JVI.71.4.2705-2714.1997; Cowan S, 2002, P NATL ACAD SCI USA, V99, P11914, DOI 10.1073/pnas.162299499; de Marco A, 2010, J VIROL, V84, P11729, DOI 10.1128/JVI.01423-10; de Parseval A, 2004, P NATL ACAD SCI USA, V101, P13044, DOI 10.1073/pnas.0404006101; DELCHAMBRE M, 1989, EMBO J, V8, P2653, DOI 10.1002/j.1460-2075.1989.tb08405.x; Dismuke DJ, 2006, J VIROL, V80, P3712, DOI 10.1128/JVI.80.8.3712-3720.2006; Edinger AL, 1997, P NATL ACAD SCI USA, V94, P4005, DOI 10.1073/pnas.94.8.4005; Fassati A, 2012, VIRUS RES, V170, P15, DOI 10.1016/j.virusres.2012.09.012; Fletcher TM, 1996, EMBO J, V15, P6155, DOI 10.1002/j.1460-2075.1996.tb01003.x; Forshey BM, 2002, J VIROL, V76, P5667, DOI 10.1128/JVI.76.11.5667-5677.2002; Frey SCS, 2001, J VIROL, V75, P5433, DOI 10.1128/JVI.75.11.5433-5440.2001; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Gemeniano MC, 2004, VIROLOGY, V325, P167, DOI 10.1016/j.virol.2004.05.007; Gemeniano MC, 2003, J VIROL, V77, P8819, DOI 10.1128/JVI.77.16.8819-8830.2003; GHEYSEN D, 1989, CELL, V59, P103, DOI 10.1016/0092-8674(89)90873-8; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Gonzalez SA, 1998, VIROLOGY, V240, P27, DOI 10.1006/viro.1997.8919; Gonzalez SA, 2012, VIROLOGY, V428, P1, DOI 10.1016/j.virol.2012.03.005; Huseby D, 2005, J BIOL CHEM, V280, P17664, DOI 10.1074/jbc.M412325200; Kahl CA, 2008, GENE THER, V15, P1079, DOI 10.1038/gt.2008.50; KLIKOVA M, 1995, J VIROL, V69, P1093, DOI 10.1128/JVI.69.2.1093-1098.1995; Krishnan L, 2010, J VIROL, V84, P397, DOI 10.1128/JVI.01899-09; Lanman J, 2004, NAT STRUCT MOL BIOL, V11, P676, DOI 10.1038/nsmb790; Lee K, 2010, CELL HOST MICROBE, V7, P221, DOI 10.1016/j.chom.2010.02.007; Lee SK, 2012, J BIOL CHEM, V287, P40867, DOI 10.1074/jbc.R112.399444; Lee SK, 2009, J VIROL, V83, P8536, DOI 10.1128/JVI.00317-09; Luttge BG, 2008, J VIROL, V82, P2106, DOI 10.1128/JVI.02337-07; Malim MH, 2008, CELL HOST MICROBE, V3, P388, DOI 10.1016/j.chom.2008.04.008; Manrique JM, 2003, J VIROL, V77, P10881, DOI 10.1128/JVI.77.20.10881-10888.2003; Manrique JM, 2008, VIROLOGY, V374, P273, DOI 10.1016/j.virol.2008.01.015; Manrique ML, 2004, VIROLOGY, V327, P83, DOI 10.1016/j.virol.2004.06.019; Mateu MG, 2009, FEBS J, V276, P6098, DOI 10.1111/j.1742-4658.2009.07313.x; Momany C, 1996, NAT STRUCT BIOL, V3, P763, DOI 10.1038/nsb0996-763; Moore MD, 2008, VIROLOGY, V379, P152, DOI 10.1016/j.virol.2008.06.030; Muller B, 2009, J BIOL CHEM, V284, P29692, DOI 10.1074/jbc.M109.027144; Niepmann M, 2006, ELECTROPHORESIS, V27, P3949, DOI 10.1002/elps.200600172; Owens CA, 2003, J VIROL, V77, P726, DOI 10.1128/JVI.77.1.726-731.2003; Poeschla EM, 1998, J VIROL, V72, P6858, DOI 10.1128/JVI.72.8.6858-6866.1998; Pornillos O, 2011, NATURE, V469, P424, DOI 10.1038/nature09640; Rauddi ML, 2011, AIDS RES HUM RETROV, V27, P303, DOI 10.1089/aid.2010.0137; Rihn SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003461; Rulli SJ, 2006, VIROLOGY, V347, P364, DOI 10.1016/j.virol.2005.12.012; Saenz DT, 2005, J VIROL, V79, P15175, DOI 10.1128/JVI.79.24.15175-15188.2005; Sanz-Ramos M, 2013, J GEN VIROL, V94, P2587, DOI 10.1099/vir.0.058180-0; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Scholz I, 2005, J VIROL, V79, P1470, DOI 10.1128/JVI.79.3.1470-1479.2005; Serriere J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056424; Sharova N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000057; Shimojima M, 2004, SCIENCE, V303, P1192, DOI 10.1126/science.1092124; Sloan RD, 2011, ROLE UNINTEGRATED DN, V8, P52; Srivastava S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000059; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Tang C, 2002, NAT STRUCT BIOL, V9, P537, DOI 10.1038/nsb806; Tang SX, 2001, J VIROL, V75, P9357, DOI 10.1128/JVI.75.19.9357-9366.2001; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; von Schwedler UK, 1998, EMBO J, V17, P1555, DOI 10.1093/emboj/17.6.1555; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Weiss ER, 2011, J MOL BIOL, V410, P525, DOI 10.1016/j.jmb.2011.04.055; WILLS JW, 1991, AIDS, V5, P639, DOI 10.1097/00002030-199106000-00002; Yamashita M, 2007, PLOS PATHOG, V3, P1502, DOI 10.1371/journal.ppat.0030156; Yufenyuy EL, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-29; Zhao GP, 2013, NATURE, V497, P643, DOI 10.1038/nature12162	84	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114299	10.1371/journal.pone.0114299	http://dx.doi.org/10.1371/journal.pone.0114299			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462889	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700127
J	Ma, CH; Yang, L; Li, W; Yue, JQ; Li, J; Zu, YG				Ma, Chunhui; Yang, Lei; Li, Wei; Yue, Jinquan; Li, Jian; Zu, Yuangang			Ultrasound-Assisted Extraction of Arabinogalactan and Dihydroquercetin Simultaneously from Larix gmelinii as a Pretreatment for Pulping and Papermaking	PLOS ONE			English	Article							FLAVONOIDS; TAXIFOLIN	An ultrasound-assisted extraction (UAE) method using ethanol was applied for extracting arabinogalactan (AG) and dihydroquercetin (DHQ) simultaneously from larch wood, as a pretreatment for pulping and papermaking. The extraction parameters were optimized by a Box-Behnken experimental design with the yields of AG and DHQ as the response values. Under optimum conditions (three extractions, each using 40% ethanol, for 50 min, 200 W ultrasound power and 1: 18 solid-liquid ratio), the yields of AG and DHQ were 183.4 and 36.76 mg/g, respectively. After UAE pretreated, the wood chips were used for Kraft pulping (KP) and high boiling solvent pulping (HBSP). The pulping yield after pretreatment was higher than that of untreated (the pulping yields of untreated HBSP and KP were 42.37% and 39.60%, and the pulping yields of HBSP and KP after UAE-pretreated were 44.23% and 41.50% respectively), as indicated by a lower kappa number (77.91 and 27.30 for untreated HBSP and KP; 77.01 and 26.83 for UAE-pretreated HBSP and KP). Furthermore, the characteristics of paper produced from pretreated wood chips were superior to those from the untreated chips: the basis weight was lower (85.67 and 82.48 g.cm(-2) for paper from untreated KP and HBSP; 79.94 and 80.25 g.cm(-2) for paper from UAE-pretreated KP and HBSP), and the tensile strengths, tearing strengths, bursting strengths, and folding strengths were higher than these of paper after UAE-pretreated, respectively.	[Ma, Chunhui; Li, Wei; Yue, Jinquan; Li, Jian] Northeast Forestry Univ, Coll Mat Sci & Engn, Harbin 150040, Peoples R China; [Ma, Chunhui; Yang, Lei; Zu, Yuangang] Northeast Forestry Univ, Key Lab Forest Plant Ecol, Minist Educ, Harbin 150040, Peoples R China	Northeast Forestry University - China; Northeast Forestry University - China	Li, J (corresponding author), Northeast Forestry Univ, Coll Mat Sci & Engn, Harbin 150040, Peoples R China.	nefulijian@163.com; zygorl@163.com			National Natural Science Foundation of China [31470612]; Fundamental Research Funds for the Central Universities [2572014EB01]; Hei Long Jiang Postdoctoral Foundation	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Hei Long Jiang Postdoctoral Foundation	This study was funded by the National Natural Science Foundation of China (31470612), Fundamental Research Funds for the Central Universities (2572014EB01), and the Hei Long Jiang Postdoctoral Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An SM, 2008, PHYTOTHER RES, V22, P1200, DOI 10.1002/ptr.2435; Chen S, 1989, T CHINA PULP PAPER, V4, P61; Chen W, 2012, CARBOHYD POLYM, V87, P614, DOI 10.1016/j.carbpol.2011.08.029; CHU SC, 1992, J NAT PROD, V55, P179, DOI 10.1021/np50080a005; Currier NL, 2003, PHYTOMEDICINE, V10, P145, DOI 10.1078/094471103321659852; Domini C, 2009, ULTRASON SONOCHEM, V16, P564, DOI 10.1016/j.ultsonch.2008.12.006; Gernandt DS, 1999, AM J BOT, V86, P711, DOI 10.2307/2656581; Goellner EM, 2011, CARBOHYD POLYM, V86, P1739, DOI 10.1016/j.carbpol.2011.07.006; Groman EV, 1997, CARBOHYD RES, V301, P69, DOI 10.1016/S0008-6215(97)00077-3; Gros-Louis MC, 2005, TREE GENET GENOMES, V1, P50, DOI 10.1007/s11295-005-0007-z; Hu Y, 2008, CHEM ENG PROCESS, V47, P2256, DOI 10.1016/j.cep.2007.12.013; Iida Y, 2008, INNOV FOOD SCI EMERG, V9, P140, DOI 10.1016/j.ifset.2007.03.029; Josephson L, US Patent, Patent No. [5.336.506, 5336506]; Kawaii S, 1999, ANTICANCER RES, V19, P1261; Li Z, 2012, CHINA PULP PAPER, V31, P6; Liu TT, 2012, IND CROP PROD, V36, P47, DOI 10.1016/j.indcrop.2011.08.004; Ma CH, 2012, CHEM ENG PROCESS, V57-58, P59, DOI 10.1016/j.cep.2012.03.008; Ma CH, 2011, ANAL CHIM ACTA, V689, P110, DOI 10.1016/j.aca.2011.01.012; Marett R, 2004, J AM DIET ASSOC, V104, P636, DOI 10.1016/j.jada.2004.01.017; Maroziene A, 2000, CANCER LETT, V157, P39, DOI 10.1016/S0304-3835(00)00469-9; Ostroukhova EN, 2003, CHEM PLANT STOCK, V1, P27; Peng JY, 2006, J CHROMATOGR A, V1102, P44, DOI 10.1016/j.chroma.2005.10.045; Pietarinen SP, 2006, J WOOD CHEM TECHNOL, V26, P245, DOI 10.1080/02773810601023487; Schinor EC, 2004, ULTRASON SONOCHEM, V11, P415, DOI 10.1016/j.ultsonch.2003.09.005; Sugihara N, 1999, FREE RADICAL BIO MED, V27, P1313, DOI 10.1016/S0891-5849(99)00167-7; Svetlana AM, 2002, CHEM COMPUTATIONAL S, V2, P47; Trouillas P, 2004, FOOD CHEM, V88, P571, DOI 10.1016/j.foodchem.2004.02.009; Wang Y, 2011, FOOD CHEM, V126, P1178, DOI 10.1016/j.foodchem.2010.11.155; Zhang J, 2001, J CELLULOSE SCI TECH, V9, P16, DOI DOI 10.3969/J.ISSN.1004-8405.2001.04.003; Zu G, 2012, INT J MOL SCI, V13, P11027, DOI 10.3390/ijms130911027	30	6	6	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114105	10.1371/journal.pone.0114105	http://dx.doi.org/10.1371/journal.pone.0114105			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460911	gold, Green Published, Green Submitted			2022-12-26	WOS:000345869700100
J	Cao, J; Li, MM; Wang, Y; Yu, GJ; Yan, CH				Cao, Jia; Li, Minming; Wang, Yu; Yu, Guangjun; Yan, Chonghuai			Environmental Lead Exposure among Preschool Children in Shanghai, China: Blood Lead Levels and Risk Factors	PLOS ONE			English	Article							OUTCOMES	Objective: To determine blood lead levels and to identify related risk factors among children in Shanghai; to explore the lead change trend of children after industrial transformation and to provide data for policy development to control environmental lead pollution in Shanghai. Methods: A stratified-clustered-random sampling method was used. A tungsten atomizer absorption spectrophotometer was employed to determine blood lead levels. Results: The arithmetic mean, geometric mean and median of blood lead levels of 0- to 6-year-old children from Shanghai were 22.49 mg/L, 19.65 mg/L and 19.5 mg/L, including 0.26% (6/2291) with concentrations >100 mg/L and 2.7% (61/2291) with concentrations >50 mg/L. Boys' levels (23.57 mg/L) were greater than those of girls (21.2 mg/L). The blood lead levels increased with age. This survey showed that the Chongming district was the highest and Yangpu district was the lowest, this result is completely opposite with the earlier survey in Shanghai. Risk factors for lead contamination included housing environment, parents' education levels, social status, hobbies, and children's nutritional status. Conclusions: The blood lead levels of children in Shanghai were lower than the earlier data of Shanghai and those of published studies in China, but higher than the blood lead levels of developed countries. The blood lead levels of urban districts are higher than the central districts with the industrial transformation. Society and the government should take an active interest in childhood lead poisoning of urban areas.	[Cao, Jia; Li, Minming; Yan, Chonghuai] Shanghai Jiao Tong Univ, Sch Med, Minist Educ Shanghai Key Lab Childrens Environm H, Xinhua Hosp, Shanghai 200030, Peoples R China; [Wang, Yu; Yu, Guangjun] Shanghai Childrens Hosp, Shanghai 200040, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yu, GJ (corresponding author), Shanghai Childrens Hosp, Shanghai 200040, Peoples R China.	yugj1688@shchildren.com.cn; yanch@shkeylab-ceh.org			National Basic Research Program of China ("973" Program) [2012CB525001]; Public Welfare Project of the Chinese Ministry of Environmental Pollution [201309048]; Natural Science Foundation of China [30901205]; Shanghai Science and Technology Committee [124119a1400]	National Basic Research Program of China ("973" Program)(National Basic Research Program of China); Public Welfare Project of the Chinese Ministry of Environmental Pollution; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	Funding: The National Basic Research Program of China ("973" Program) (Grant No. 2012CB525001) and the Public Welfare Project of the Chinese Ministry of Environmental Pollution (Grant No. 201309048) had a role in the study design. The "985" project of Shanghai Jiao Tong University School of Medicine and the Natural Science Foundation of China (Grant No. 30901205) had a role in the data collection and analysis. The Shanghai Science and Technology Committee (Grant No. 124119a1400) had a role in the preparation of the manuscript.	Fadrowski JJ, 2010, ARCH INTERN MED, V170, P75, DOI 10.1001/archinternmed.2009.417; Gao WZ, 2001, ENVIRON RES, V87, P11, DOI 10.1006/enrs.2001.4281; Jakubowski M, 2011, INT J OCCUP MED ENV, V24, P1, DOI 10.2478/s13382-011-0009-z; Krieg EF, 2011, REPROD TOXICOL, V32, P277, DOI 10.1016/j.reprotox.2011.05.012; Lanphear BP, 2005, ENVIRON HEALTH PERSP, V113, P894, DOI 10.1289/ehp.7688; Luo QY ZW, 2011, XIAN DAI YU FANG YI, V38, P614; Oulhote Y, 2013, INT J HYG ENVIR HEAL, V216, P743, DOI 10.1016/j.ijheh.2013.02.007; Piomelli S, 2002, PEDIATR CLIN N AM, V49, P1285, DOI 10.1016/S0031-3955(02)00097-4; Rothenberg SJ, 2000, ENVIRON RES, V82, P81, DOI 10.1006/enrs.1999.4007; Sallmen M, 2000, EPIDEMIOLOGY, V11, P148, DOI 10.1097/00001648-200003000-00011; Wang SQ, 2006, ENVIRON RES, V101, P412, DOI 10.1016/j.envres.2005.11.007; Witt K, 2013, BRAIN, V136, P2109, DOI 10.1093/brain/awt151; Wu MQ, 2009, ZHONGGUO ER TONG BAO, V8, P401; Xie X, 2013, ENVIRON POLLUT, V175, P30, DOI 10.1016/j.envpol.2012.12.013; Xiong GR YZ, 2011, JIAN YAN YI XUE YU L, V8, P443; Yan Chonghuai, 2002, Zhonghua Liu Xing Bing Xue Za Zhi, V23, P172	16	30	35	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113297	10.1371/journal.pone.0113297	http://dx.doi.org/10.1371/journal.pone.0113297			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436459	Green Submitted, Green Published, gold			2022-12-26	WOS:000347114900037
J	Fresno, N; Perez-Fernandez, R; Goicoechea, C; Alkorta, I; Fernandez-Carvajal, A; De la Torre-Martinez, R; Quirce, S; Ferrer-Montiel, A; Martin, MI; Goya, P; Elguero, J				Fresno, Nieves; Perez-Fernandez, Ruth; Goicoechea, Carlos; Alkorta, Ibon; Fernandez-Carvajal, Asia; De la Torre-Martinez, Roberto; Quirce, Susana; Ferrer-Montiel, Antonio; Martin, M. Isabel; Goya, Pilar; Elguero, Jose			Adamantyl Analogues of Paracetamol as Potent Analgesic Drugs via Inhibition of TRPA1	PLOS ONE			English	Article							COVALENT BINDING; CHEMICAL-SHIFTS; ACETAMINOPHEN; PAIN; HEPATOTOXICITY; METABOLISM; MECHANISM; DESIGN	Paracetamol also known as acetaminophen, is a widely used analgesic and antipyretic agent. We report the synthesis and biological evaluation of adamantyl analogues of paracetamol with important analgesic properties. The mechanism of nociception of compound 6a/b, an analog of paracetamol, is not exerted through direct interaction with cannabinoid receptors, nor by inhibiting COX. It behaves as an interesting selective TRPA1 channel antagonist, which may be responsible for its analgesic properties, whereas it has no effect on the TRPM8 nor TRPV1 channels. The possibility of replacing a phenyl ring by an adamantyl ring opens new avenues in other fields of medicinal chemistry.	[Fresno, Nieves; Perez-Fernandez, Ruth; Alkorta, Ibon; Goya, Pilar; Elguero, Jose] CSIC, Inst Quim Med, E-28006 Madrid, Spain; [Goicoechea, Carlos; Martin, M. Isabel] Univ Rey Juan Carlos, Fac Ciencias Salud, Unidad Asociada I D i CSIC, Dept Farmacol & Nutr, Madrid, Spain; [Fernandez-Carvajal, Asia; De la Torre-Martinez, Roberto; Quirce, Susana; Ferrer-Montiel, Antonio] Univ Miguel Hernandez, Inst Mol & Cellular Biol, Alicante, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Quimica Medica (IQM); CSIC - Instituto de Quimica Organica General (IQOG); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Rey Juan Carlos; Universidad Miguel Hernandez de Elche	Alkorta, I (corresponding author), CSIC, Inst Quim Med, Juan Cierva 3, E-28006 Madrid, Spain.	ibon@iqm.csic.es	Carvajal, Asia Fernandez/G-8877-2015; Ferrer-Montiel, Antonio/C-3072-2015; Elguero, Jose/G-8749-2015; alkorta, ibon/I-7828-2014; de la Torre Martinez, Roberto/AAB-2253-2021; Goya, Pilar/I-3243-2015; Pérez-Fernández, Ruth/G-8382-2015; Goicoechea, Carlos/H-6890-2015	Ferrer-Montiel, Antonio/0000-0002-2973-6607; Elguero, Jose/0000-0002-9213-6858; alkorta, ibon/0000-0001-6876-6211; Pérez-Fernández, Ruth/0000-0003-0148-6455; Goicoechea, Carlos/0000-0002-6226-6934; de la Torre-Martinez, Roberto/0000-0001-9872-6050; Fernandez-Carvajal, Asia/0000-0003-2741-1427	grants RTA (RED Trastornos Adictivos) [RD06/001/0014]; CONSOLIDER INGENIO Program [CSD2008-00005];  [SAF2012-40075-C02];  [BFU2009-08346];  [BFU2012-39092-C02-01];  [PROMETEO/2010/046]	grants RTA (RED Trastornos Adictivos); CONSOLIDER INGENIO Program(Spanish Government); ; ; ; 	The present work has been supported by grants RTA (RED Trastornos Adictivos RD06/001/0014), SAF2012-40075-C02, BFU2009-08346, and BFU2012-39092-C02-01, CONSOLIDER INGENIO2010 Program (CSD2008-00005), and PROMETEO/2010/046. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson BJ, 2008, PEDIATR ANESTH, V18, P915, DOI 10.1111/j.1460-9592.2008.02764.x; Andersson DA, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1559; Bertolini A, 2006, CNS DRUG REV, V12, P250, DOI 10.1111/j.1527-3458.2006.00250.x; Beyer RP, 2007, TOXICOL SCI, V99, P326, DOI 10.1093/toxsci/kfm150; Blanco F, 2007, MAGN RESON CHEM, V45, P797, DOI 10.1002/mrc.2053; Blough ER, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00072; Broom DC, 2008, J PHARMACOL EXP THER, V327, P620, DOI 10.1124/jpet.108.141853; CROSBY NJ, 2008, AMANTADINE FOR DYSKI; Dania M, 2007, EUR J PHARMACOL, V573, P214, DOI 10.1016/j.ejphar.2007.07.012; DONETTI A, 1973, SYNTHETIC COMMUN, V3, P165, DOI DOI 10.1080/00397917308062027; Fernandez-Carvajal A, 2012, PHARMACEUTICALS, V5, P16, DOI 10.3390/ph5010016; Ferrer-Montiel A, 2012, EXPERT OPIN THER PAT, V22, P999, DOI 10.1517/13543776.2012.711320; Fischer J., 2006, ANALOGUE BASED DRUG, P419; Gonzalez-Nunez ME, 2000, ORG LETT, V2, P831, DOI 10.1021/ol000017m; Graham Garry G., 2003, Inflammopharmacology, V11, P401, DOI 10.1163/156856003322699573; Graham GG, 2013, INFLAMMOPHARMACOLOGY, V21, P201, DOI 10.1007/s10787-013-0172-x; Guile SD, 2009, J MED CHEM, V52, P3123, DOI 10.1021/jm801528x; James LP, 2003, DRUG METAB DISPOS, V31, P1499, DOI 10.1124/dmd.31.12.1499; Jaroskova L, 2006, TETRAHEDRON LETT, V47, P8063, DOI 10.1016/j.tetlet.2006.09.056; Kolesov BA, 2011, PHYS CHEM CHEM PHYS, V13, P14243, DOI 10.1039/c1cp20139e; Kutchukian PS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048476; Lamoureux G, 2010, CURR MED CHEM, V17, P2967, DOI 10.2174/092986710792065027; Liu J, 2011, EUR J MED CHEM, V46, P1949, DOI 10.1016/j.ejmech.2011.01.047; Mallet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012748; Miao L, 2009, ORG PROCESS RES DEV, V13, P820, DOI 10.1021/op900113b; MOISEEV IK, 1973, B ACAD SCI USSR CH, P2325, DOI DOI 10.1007/BF01199650; Nam TG, 2007, J AM CHEM SOC, V129, P10211, DOI 10.1021/ja072371m; Nam TG, 2009, ORG BIOMOL CHEM, V7, P5103, DOI 10.1039/b912528k; Nelson DW, 2008, J MED CHEM, V51, P3030, DOI 10.1021/jm701516f; Nelyubina YV, 2010, CHEM COMMUN, V46, P3469, DOI 10.1039/b927429d; Obach RS, 2008, CHEM RES TOXICOL, V21, P1814, DOI 10.1021/tx800161s; Orr STM, 2012, J MED CHEM, V55, P4896, DOI 10.1021/jm300065h; Oscier C., 2007, ANAESTHESIA, V23, P112; Pasquini S, 2008, J MED CHEM, V51, P5075, DOI 10.1021/jm800552f; Planells-Cases R, 2007, EXPERT OPIN DRUG DIS, V2, P1053, DOI 10.1517/17460441.2.8.1053; Shchepin RV, 2013, ACS MED CHEM LETT, V4, P710, DOI 10.1021/ml4000904; Silva AMS, 2008, MAGN RESON CHEM, V46, P859, DOI 10.1002/mrc.2272; Sinning C, 2008, J MED CHEM, V51, P7800, DOI 10.1021/jm800807k; Song H, 2001, J BIOCHEM MOL TOXIC, V15, P34, DOI 10.1002/1099-0461(2001)15:1<34::AID-JBT4>3.0.CO;2-U; STREETER AJ, 1984, DRUG METAB DISPOS, V12, P565; Thibault K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091297; Umathe SN, 2009, PROG NEURO-PSYCHOPH, V33, P1191, DOI 10.1016/j.pnpbp.2009.06.020; Vaccarino AL, 2007, BIOORGAN MED CHEM, V15, P2206, DOI 10.1016/j.bmc.2006.07.054; Viana F, 2009, EXPERT OPIN THER PAT, V19, P1787, DOI 10.1517/13543770903393771; Wanka L, 2013, CHEM REV, V113, P3516, DOI 10.1021/cr100264t; Wu ZQ, 2010, BIOORG MED CHEM LETT, V20, P3851, DOI 10.1016/j.bmcl.2010.05.050; Zhang J, 2002, SCIENCE, V298, P422, DOI 10.1126/science.1073502; Zheng J, 2013, COMPR PHYSIOL, V3, P221, DOI 10.1002/cphy.c120001; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	49	11	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113841	10.1371/journal.pone.0113841	http://dx.doi.org/10.1371/journal.pone.0113841			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438056	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900085
J	Kalliokoski, O; Teilmann, AC; Jacobsen, KR; Abelson, KSP; Hau, J				Kalliokoski, Otto; Teilmann, A. Charlotte; Jacobsen, Kirsten R.; Abelson, Klas S. P.; Hau, Jann			The Lonely Mouse - Single Housing Affects Serotonergic Signaling Integrity Measured by 8-OH-DPAT-Induced Hypothermia in Male Mice	PLOS ONE			English	Article							DEPRESSION-RELATED BEHAVIOR; MALE LABORATORY MICE; 5-HT1A RECEPTOR; BODY-TEMPERATURE; SOCIAL-ISOLATION; HOUSED MICE; FEMALE MICE; HEART-RATE; RESPONSES; MODEL	Male BALB/c mice single-housed for a period of three weeks were found to respond with a more marked hypothermia to a challenge with a selective serotonergic agonist (8-OH-DPAT) than their group-housed counterparts. This effect of single housing was verified by screening a genetically heterogeneous population of male mice on a C57BL/6 background from a breeding colony. Enhanced activity of the implicated receptor (5-HT1A) leading to an amplified hypothermic effect is strongly associated with depressive states. We therefore suggest that the 8-OH-DPAT challenge can be used to demonstrate a negative emotional state brought on by e.g. long-term single housing in male laboratory mice. The study emphasizes the importance of social housing, and demonstrates that male mice deprived of social contact respond with altered serotonergic signaling activity. Male mice not only choose social contact when given the option, as has previously been shown, but will also, when it is deprived, be negatively affected by its absence. We propose that the 8-OH-DPAT challenge constitutes a simple, but powerful, tool capable of manifesting the effect of social deprivation in laboratory mice. It potentially allows not only for an unbiased, biochemical evaluation of psychological stressors, but may also allow for determining whether the effect of these can be counteracted.	[Kalliokoski, Otto; Teilmann, A. Charlotte; Jacobsen, Kirsten R.; Abelson, Klas S. P.; Hau, Jann] Univ Copenhagen, Dept Expt Med, Fac Hlth & Med Sci, Copenhagen, Denmark	University of Copenhagen	Kalliokoski, O (corresponding author), Univ Copenhagen, Dept Expt Med, Fac Hlth & Med Sci, Copenhagen, Denmark.	otto.kalliokoski@gmail.com	Kalliokoski, Otto/I-3828-2019; Hau, Jann/C-8692-2012	Kalliokoski, Otto/0000-0001-6531-3487; Hau, Jann/0000-0001-8586-5705; Abelson, Klas/0000-0002-4986-7882; Rosenmay Jacobsen, Kirsten/0000-0002-3211-7890	Faculty of Health and Medical Sciences at the University of Copenhagen	Faculty of Health and Medical Sciences at the University of Copenhagen	Funding: ACT was funded on a scholarship granted by The Faculty of Health and Medical Sciences at the University of Copenhagen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1996, GUIDE CARE USE LAB A; Bartolomucci A, 2003, PSYCHONEUROENDOCRINO, V28, P540, DOI 10.1016/S0306-4530(02)00039-2; Bartolomucci A, 2009, SCAND J LAB ANIM SCI, V36, P87; BAUMEL I, 1970, PSYCHOPHARMACOLOGIA, V18, P320, DOI 10.1007/BF00412678; Beckers J, 2009, NAT REV GENET, V10, P371, DOI 10.1038/nrg2578; Bert B, 2006, BEHAV BRAIN RES, V167, P328, DOI 10.1016/j.bbr.2005.09.020; BILL DJ, 1991, BRIT J PHARMACOL, V103, P1857, DOI 10.1111/j.1476-5381.1991.tb12342.x; Bouwknecht JA, 2000, EUR J PHARMACOL, V400, P59, DOI 10.1016/S0014-2999(00)00387-3; BRAIN P, 1975, LIFE SCI, V16, P187, DOI 10.1016/0024-3205(75)90017-X; Brain PF, 1997, AGGRESSION LAB RODEN; Branchi I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062226; Bundgaard CJ, 2012, IN VIVO, V26, P883; Caramaschi D, 2007, PHYSIOL BEHAV, V90, P590, DOI 10.1016/j.physbeh.2006.11.010; CORNFIELD LJ, 1991, MOL PHARMACOL, V39, P780; Cryan JF, 2004, MOL PSYCHIATR, V9, P326, DOI 10.1038/sj.mp.4001457; El Yacoubi M, 2003, P NATL ACAD SCI USA, V100, P6227, DOI 10.1073/pnas.1034823100; Festing M. F. W., 2011, HDB LAB ANIMAL SCI E, V1, P209; Fournier S, 2012, J APPL PHYSIOL, V112, P1474, DOI 10.1152/japplphysiol.01477.2011; Gilbert C, 2010, BIOL REV, V85, P545, DOI 10.1111/j.1469-185X.2009.00115.x; Gonder JC, 2007, ILAR J, V48, P29, DOI 10.1093/ilar.48.1.29; GOODWIN GM, 1985, NEUROPHARMACOLOGY, V24, P1187, DOI 10.1016/0028-3908(85)90153-4; Gordon CJ, 2004, COMPARATIVE MED, V54, P63; Gordon CJ, 1998, PHYSIOL BEHAV, V65, P255, DOI 10.1016/S0031-9384(98)00148-6; Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a; Gunther L, 2008, EUR J PHARMACOL, V593, P49, DOI 10.1016/j.ejphar.2008.07.011; Hedlund PB, 2004, EUR J PHARMACOL, V487, P125, DOI 10.1016/j.ejphar.2004.01.031; Hubrecht R, 1993, LAB ANIM, V27, P301; Hunt C, 2006, PHYSIOL BEHAV, V87, P519, DOI 10.1016/j.physbeh.2005.11.013; Hurko Orest, 2005, NeuroRx, V2, P671, DOI 10.1602/neurorx.2.4.671; Jacobson LH, 2007, BEHAV GENET, V37, P171, DOI 10.1007/s10519-006-9106-3; Kalliokoski O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058460; Krohn TC, 2006, ANIM WELF, V15; Lerer B, 1999, NEUROPSYCHOPHARMACOL, V20, P628, DOI 10.1016/S0893-133X(98)00106-7; Loo P. L. P. van, 2001, Journal of Applied Animal Welfare Science, V4, P91, DOI 10.1207/S15327604JAWS0402_1; McEnany Geoffry W, 2005, Issues Ment Health Nurs, V26, P781, DOI 10.1080/01612840591008410; MISSLIN R, 1982, PSYCHONEUROENDOCRINO, V7, P217, DOI 10.1016/0306-4530(82)90015-4; OCONNELL MT, 1992, BRIT J PHARMACOL, V106, P603, DOI 10.1111/j.1476-5381.1992.tb14382.x; Olsson IAS, 2007, APPL ANIM BEHAV SCI, V103, P229, DOI 10.1016/j.applanim.2006.05.022; Rainer Q, 2012, MOL PHARMACOL, V81, P106, DOI 10.1124/mol.111.075796; Ramboz S, 1998, P NATL ACAD SCI USA, V95, P14476, DOI 10.1073/pnas.95.24.14476; RAO GN, 1990, GUIDELINES FOR THE WELL-BEING OF RODENTS IN RESEARCH, P47; Richardson-Jones JW, 2010, NEURON, V65, P40, DOI 10.1016/j.neuron.2009.12.003; Rilke O, 1998, PHARMACOL BIOCHEM BE, V59, P891, DOI 10.1016/S0091-3057(97)00509-1; Savitz J, 2009, PROG NEUROBIOL, V88, P17, DOI 10.1016/j.pneurobio.2009.01.009; Schiller L, 2006, BRAIN RES, V1103, P76, DOI 10.1016/j.brainres.2006.05.051; Spani D, 2003, LAB ANIM-UK, V37, P54, DOI 10.1258/002367703762226692; Stearns V, 2002, LANCET, V360, P1851, DOI 10.1016/S0140-6736(02)11774-0; Stockmeier CA, 1998, J NEUROSCI, V18, P7394; Szuba MP, 1997, BIOL PSYCHIAT, V42, P1130, DOI 10.1016/S0006-3223(97)00046-2; Van Loo PLP, 2004, LAB ANIM-UK, V38, P178, DOI 10.1258/002367704322968867; Van Loo PLP, 2003, LAB ANIM-UK, V37, P300, DOI 10.1258/002367703322389870; Wurbel H, 2001, TRENDS NEUROSCI, V24, P207, DOI 10.1016/S0166-2236(00)01718-5	53	27	28	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e111065	10.1371/journal.pone.0111065	http://dx.doi.org/10.1371/journal.pone.0111065			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436462	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900007
J	Liu, YC; Pujara, T; Mehta, JS				Liu, Yu-Chi; Pujara, Tarak; Mehta, Jodhbir S.			New Instruments for Lenticule Extraction in Small Incision Lenticule Extraction (SMILE)	PLOS ONE			English	Article							CONTRAST SENSITIVITY; REFRACTIVE SURGERY; COMPLICATIONS; ABERRATIONS; ASTIGMATISM; SAFETY	Small incision lenticule extraction (SMILE) is an alternative to Laser-Assisted in situ Keratomileusis (LASIK) for correction of myopia. In cases where surgeons inadvertently dissect the posterior surface first, identification of the anterior surface and subsequent removal become difficult since the anterior surface of the lenticule is compacted against the anterior stromal surface. This may result in incomplete lenticule removal, and a remnant of intrastromal lenticule in SMILE may lead to visual sequelae. In order to aid surgeons in lenticule removal, we have designed and developed 5 novel SMILE lenticule strippers to locate and extract the lenticules more easily. The aim of this study was to investigate and compare the efficacy and quality of these lenticule strippers in assisting SMILE. Thirty porcine eyes were used. The ease of extraction and removal of the lenticule with different strippers was graded by an experienced SMILE surgeon, the extracted lenticule circularity was evaluated by calculating the lenticule circularity, and the intactness of the extracted lenticule edge was assessed using scanning electron microscopy. We found these novel strippers can be of great help to improve the safety and quality of SMILE surgery, particularly in those cases of difficult lenticule extraction.	[Liu, Yu-Chi; Mehta, Jodhbir S.] Singapore Eye Res Inst, Singapore, Singapore; [Liu, Yu-Chi; Mehta, Jodhbir S.] Singapore Natl Eye Ctr, Singapore, Singapore; [Pujara, Tarak] Carl Zeiss Meditec AG, Singapore, Singapore; [Mehta, Jodhbir S.] Duke NUS Grad Med Sch, Dept Clin Sci, Singapore, Singapore	National University of Singapore; Singapore National Eye Center; Singapore National Eye Center; Carl Zeiss AG; National University of Singapore	Mehta, JS (corresponding author), Singapore Eye Res Inst, Singapore, Singapore.	jodmehta@gmail.com	Liu, Yu Chi/AAM-7010-2020	Liu, Yu Chi/0000-0001-5408-0382	Singapore National Research Foundation under its Translational and Clinical Research (TCR) Programme [NMRC/TCR/008-SERI/2013]	Singapore National Research Foundation under its Translational and Clinical Research (TCR) Programme	This research was supported by the Singapore National Research Foundation under its Translational and Clinical Research (TCR) Programme (NMRC/TCR/008-SERI/2013) and administered by the Singapore Ministry of Health's National Medical Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ang M, 2014, J CATARACT REFR SURG, V40, P1415, DOI 10.1016/j.jcrs.2013.12.026; Dong ZX, 2013, J CATARACT REFR SURG, V39, P952, DOI 10.1016/j.jcrs.2013.04.016; Ivarsen A, 2014, OPHTHALMOLOGY, V121, P822, DOI 10.1016/j.ophtha.2013.11.006; Mehta JS, 2008, CORNEA, V27, P706, DOI 10.1097/QAI.0b013e31815ee267; Mohamed-Noriega K, 2014, INVEST OPHTH VIS SCI, V55, P1823, DOI 10.1167/iovs.13-13324; Peh GSL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028310; Riau AK, 2014, INVEST OPHTH VIS SCI, V55, P3186, DOI 10.1167/iovs.14-14434; Riau AK, 2013, J REFRACT SURG, V29, P236, DOI 10.3928/1081597X-20130318-02; Sekundo W, 2014, GRAEF ARCH CLIN EXP, V252, P837, DOI 10.1007/s00417-014-2608-4; Sekundo W, 2011, BRIT J OPHTHALMOL, V95, P335, DOI 10.1136/bjo.2009.174284; Shah R, 2011, J CATARACT REFR SURG, V37, P127, DOI 10.1016/j.jcrs.2010.07.033; Vestergaard AH, 2014, J CATARACT REFR SURG, V40, P403, DOI 10.1016/j.jcrs.2013.07.053	12	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113774	10.1371/journal.pone.0113774	http://dx.doi.org/10.1371/journal.pone.0113774			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436451	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900077
J	Lu, PX; Huang, H; Yuan, J; Zhao, F; Chen, ZY; Zhang, QW; Ahuja, AT; Zhou, BP; Wang, YXJ				Lu, Pu-Xuan; Huang, Hua; Yuan, Jing; Zhao, Feng; Chen, Zhi-Yi; Zhang, Qinwei; Ahuja, Anil T.; Zhou, Bo-Ping; Wang, Yi-Xiang J.			Decreases in Molecular Diffusion, Perfusion Fraction and Perfusion-Related Diffusion in Fibrotic Livers: A Prospective Clinical Intravoxel Incoherent Motion MR Imaging Study	PLOS ONE			English	Article							FIBROSIS; DISEASE; CIRRHOSIS; DIAGNOSIS; IVIM	Purpose: This study was aimed to determine whether pure molecular-based diffusion coefficient (D) and perfusion-related diffusion parameters (perfusion fraction f, perfusion-related diffusion coefficient D*) differ in healthy livers and fibrotic livers through intra-voxel incoherent motion (IVIM) MR imaging. Material and Methods: 17 healthy volunteers and 34 patients with histopathologically confirmed liver fibrosis patients (stage 1=14, stage 2=8, stage 3& 4=12, METAVIR grading) were included. Liver MR imaging was performed at 1.5-T. IVIM diffusion weighted imaging sequence was based on standard single-shot DW spin echo-planar imaging, with ten b values of 10, 20, 40, 60, 80, 100, 150, 200, 400, 800 sec/mm(2) respectively. Pixel-wise realization and regions-of-interest based quantification of IVIM parameters were performed. Results: D, f, and D* in healthy volunteer livers and patient livers were 1.096+/-0.155 vs 0.917+/-0.152 (1023 mm(2)/s, p=0.0015), 0.164+/-0.021 vs 0.123+/-0.029 (p< 0.0001), and 13.085+/-2.943 vs 9.423+/-1.737 (1023 mm(2)/s, p< 0.0001) respectively, all significantly lower in fibrotic livers. As the fibrosis severity progressed, D, f, and D* values decreased, with a trend significant for f and D*. Conclusion: Fibrotic liver is associated with lower pure molecular diffusion, lower perfusion volume fraction, and lower perfusion-related diffusion. The decrease of f and D* in the liver is significantly associated liver fibrosis severity.	[Lu, Pu-Xuan; Huang, Hua] Guangdong Med Coll, Shenzhen Peoples Hosp 3, Dept Radiol, Shenzhen, Peoples R China; [Yuan, Jing; Zhao, Feng; Zhang, Qinwei; Ahuja, Anil T.; Wang, Yi-Xiang J.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China; [Chen, Zhi-Yi] Guangzhou Med Univ, Affiliated Hosp 3, Lab Ultrasound Mol Imaging, Guangzhou, Guangdong, Peoples R China; [Zhou, Bo-Ping] Guangdong Med Coll, Shenzhen Peoples Hosp 3, Dept Hepatol, Shenzhen, Peoples R China	Guangdong Medical University; Chinese University of Hong Kong; Prince of Wales Hospital; Guangzhou Medical University; Guangdong Medical University	Wang, YXJ (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Imaging & Intervent Radiol, Shatin, Hong Kong, Peoples R China.	yixiang_wang@cuhk.edu.hk	Ahuja, Anil T/H-4031-2017; Wang, Yi Xiang/I-5952-2016; Yuan, Jing/E-4236-2013	Ahuja, Anil T/0000-0002-0726-5402; Wang, Yi Xiang/0000-0001-5697-0717; Yuan, Jing/0000-0001-8112-3608	Shenzhen municipal government [JCYJ20130401164750006]	Shenzhen municipal government	This study was funded by the Shenzhen municipal government project No. JCYJ20130401164750006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre DA, 2006, RADIOLOGY, V239, P425, DOI 10.1148/radiol.2392050505; Allkemper T, 2014, RADIOLOGY, V271, P408, DOI 10.1148/radiol.13130342; Anania C, 2011, HEPAT MON, V11, P479; Bedossa P, 1996, HEPATOLOGY, V24, P289, DOI 10.1002/hep.510240201; Bokacheva L, 2014, J MAGN RESON IMAGING, V40, P813, DOI 10.1002/jmri.24462; Bonekamp S, 2009, J HEPATOL, V50, P17, DOI 10.1016/j.jhep.2008.10.016; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Chow AM, 2012, J MAGN RESON IMAGING, V36, P159, DOI 10.1002/jmri.23607; Deng M, 2012, BRIT J RADIOL, V85, pE590, DOI 10.1259/bjr/98745548; Faria SC, 2009, RADIOGRAPHICS, V29, P1615, DOI 10.1148/rg.296095512; Federau C, 2014, J MAGN RESON IMAGING, V39, P624, DOI 10.1002/jmri.24195; Gaeta M, 2014, ACAD RADIOL, V21, P1286, DOI 10.1016/j.acra.2014.05.021; Goshima S, 2012, HEPATOLOGY, V55, P328, DOI 10.1002/hep.24677; Guiu B, 2012, RADIOLOGY, V265, P96, DOI 10.1148/radiol.12112478; Guiu B, 2011, EUR RADIOL, V21, P463, DOI 10.1007/s00330-010-2017-y; Hashimoto K, 2006, ONCOL REP, V16, P677; Hollingsworth KG, 2006, NMR BIOMED, V19, P231, DOI 10.1002/nbm.1028; Ito K, 2004, INTERVIROLOGY, V47, P134, DOI 10.1159/000078465; JANES CH, 1993, ANN INTERN MED, V118, P96, DOI 10.7326/0003-4819-118-2-199301150-00003; Joo I, 2014, RADIOLOGY, V270, P131, DOI 10.1148/radiol.13122506; LAUTT WW, 1977, GASTROENTEROLOGY, V73, P1163; LEBIHAN D, 1992, MAGNET RESON MED, V27, P171, DOI 10.1002/mrm.1910270116; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Lee JT, 2012, MAGN RESON IMAGING, V30, P572, DOI 10.1016/j.mri.2011.12.013; Lemke A, 2011, MAGN RESON IMAGING, V29, P766, DOI 10.1016/j.mri.2011.03.004; Ligabue G, 2013, QUANT IMAGING MED SU, V3, P192, DOI 10.3978/j.issn.2223-4292.2013.08.01; Luciani A, 2008, RADIOLOGY, V249, P891, DOI 10.1148/radiol.2493080080; Mannelli L, 2012, J MAGN RESON IMAGING, V36, P1490, DOI 10.1002/jmri.23743; MORENO AH, 1967, J CLIN INVEST, V46, P436, DOI 10.1172/JCI105545; Patel J, 2010, J MAGN RESON IMAGING, V31, P589, DOI 10.1002/jmri.22081; Patel K, 2014, CURR OPIN GASTROEN, V30, P253, DOI 10.1097/MOG.0000000000000059; PEKAR J, 1992, MAGNET RESON MED, V23, P122, DOI 10.1002/mrm.1910230113; Poyraz AK, 2012, J MAGN RESON IMAGING, V35, P1108, DOI 10.1002/jmri.23519; Salameh N, 2009, RADIOLOGY, V253, P90, DOI 10.1148/radiol.2523081817; Shinmoto H, 2012, AM J ROENTGENOL, V199, pW496, DOI 10.2214/AJR.11.8347; Sy S, 2010, PHYS MED BIOL, V55, P7587, DOI 10.1088/0031-9155/55/24/013; Tatsumi C, 2008, INTERVIROLOGY, V51, P27, DOI 10.1159/000122602; Van Beers BE, 2001, AM J ROENTGENOL, V176, P667, DOI 10.2214/ajr.176.3.1760667; Waker-Samuel S, 2011, MAGN RESON MED, V65, P438, DOI 10.1002/mrm.22572; Wallace K, 2008, BIOCHEM J, V411, P1, DOI 10.1042/BJ20071570; Wang YXJ, 2014, QUANT IMAGING MED SU, V4, P152, DOI 10.3978/j.issn.2223-4292.2014.04.04; Wang YXJ, 2011, QUANT IMAGING MED SU, V1, P1, DOI 10.3978/j.issn.2223-4292.2011.09.01; Wang YXJ, 2011, RADIOLOGY, V259, P712, DOI 10.1148/radiol.11101638; Wang YXJ, 2005, CLIN RADIOL, V60, P1051, DOI 10.1016/j.crad.2005.04.016; Watanabe H, 2011, RADIOLOGY, V259, P142, DOI 10.1148/radiol.10100621; Yamada I, 1999, RADIOLOGY, V210, P617, DOI 10.1148/radiology.210.3.r99fe17617; Zhang JL, 2012, MAGN RESON MED, V67, P89, DOI 10.1002/mrm.22982; Zhang QY, 2013, IEEE INT CONGR BIG, P141, DOI 10.1109/BigData.Congress.2013.27; Zhang Y, 2013, MAGN RESON IMAGING, V31, P1017, DOI 10.1016/j.mri.2013.03.007; Zhao F, 2013, QUANT IMAG MED SURG, V3, P308, DOI 10.3978/j.issn.2223-4292.2013.12.10; Zhao F, 2012, KOREAN J RADIOL, V13, P736, DOI 10.3348/kjr.2012.13.6.736; Zhao F, 2012, EUR RADIOL, V22, P1709, DOI 10.1007/s00330-012-2419-0	52	38	43	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113846	10.1371/journal.pone.0113846	http://dx.doi.org/10.1371/journal.pone.0113846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436458	gold, Green Published, Green Submitted			2022-12-26	WOS:000347114900087
J	Zhang, Y; Zhang, YZ; Yun, HL; Lai, R; Su, M				Zhang, Ying; Zhang, Yaozhong; Yun, Hailong; Lai, Raymond; Su, Min			Correlation of STAT1 with Apoptosis and Cell-Cycle Markers in Esophageal Squamous Cell Carcinoma	PLOS ONE			English	Article							BCL-X EXPRESSION; CLINICAL-SIGNIFICANCE; PROTEIN EXPRESSION; CANCER; SURVIVIN; ASSOCIATION; PROGNOSIS; BCL-X(L); D1	We recently found evidence that STAT1 in esophageal squamous carcinoma (ESCC) cells exerts tumor suppressor function, and it regulates five key regulators of apoptosis or cell-cycle progression, including Bcl-2, Bcl-xL, survivin, cyclin D1 and p21. In this study, we confirmed these findings in four ESCC cell lines. Using immunohistochemistry, we also assessed the expression of these proteins in 62 primary tumors. The expression of these markers was heterogeneous, ranging 39 to 69% of the cohort. Significant correlation was found between STAT1 and three proteins (p21, Bcl-xL and survivin), whereas only a trend was identified for cyclin D1 and Bcl-2. We then correlated the expression of these proteins with several clinicopathologic parameters including lymph node metastasis, depth of invasion, clinical stage and overall survival. Significant correlations were found between Bcl-2 and deep invasion (p=0.033), survivin and lymph node metastasis (p=0.006), as well as cyclin D1 and clinical stage (p=0.014). Patients with p21-positive tumors had a significantly longer survival compared to those with p21-negative tumors (p=0.031). To conclude, our findings support the concept that STAT1 exerts its tumor suppressor effects in ESCC via modulating the expression of key regulators of apoptosis and cell-cycle progression.	[Zhang, Ying; Zhang, Yaozhong; Yun, Hailong; Su, Min] Shantou Univ, Coll Med, Dept Pathol, Shantou, Guangdong, Peoples R China; [Zhang, Ying; Lai, Raymond] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada; [Lai, Raymond] Univ Alberta, Dept Oncol, Edmonton, AB, Canada	Shantou University; University of Alberta; University of Alberta	Lai, R (corresponding author), Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB, Canada.	rlai@ualberta.ca; minsu@stu.edu.cn			NSFC-Guangdong joint fund key project [U1132004]; NSFC [31171226, 31240077]; Canadian Institute of Health Research; Guangdong International Cooperative Technical Innovation Platform [gihz1106]	NSFC-Guangdong joint fund key project; NSFC(National Natural Science Foundation of China (NSFC)); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Guangdong International Cooperative Technical Innovation Platform	This study was supported by NSFC-Guangdong joint fund key project (Certificates U1132004), NSFC (Certificates 31171226 and 31240077), an operating research grant from the Canadian Institute of Health Research awarded to RL, and Guangdong International Cooperative Technical Innovation Platform (Certificates gihz1106). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Ahn Myung-Ju, 1998, Journal of Korean Medical Science, V13, P513; Armanious H, 2010, INT J CLIN EXP PATHO, V3, P654; Avalle Lidia, 2012, JAKSTAT, V1, P65, DOI 10.4161/jkst.20045; Bowman T, 2000, ONCOGENE, V19, P2474, DOI 10.1038/sj.onc.1203527; Chang E, 2010, J THORAC CARDIOV SUR, V140, P225, DOI 10.1016/j.jtcvs.2009.11.038; Chang MS, 2005, PATHOL RES PRACT, V201, P417, DOI 10.1016/j.prp.2005.04.005; Cheung CHA, 2013, ONCOTARGETS THER, V6, P1453, DOI 10.2147/OTT.S33374; Deng H, 2012, ONCOL LETT, V3, P193, DOI 10.3892/ol.2011.423; Fukuchi M, 2006, INT J ONCOL, V29, P329; Grimminger P, 2009, J SURG ONCOL, V100, P447, DOI 10.1002/jso.21355; He HY, 2013, CARCINOGENESIS, V34, P139, DOI 10.1093/carcin/bgs301; Hui MKC, 2012, MED ONCOL, V29, P3009, DOI 10.1007/s12032-012-0225-9; Kamel Azza, 2006, J Egypt Natl Canc Inst, V18, P93; Kato J, 2001, INT J CANCER, V95, P92; Kim HS, 2007, CELL SIGNAL, V19, P454, DOI 10.1016/j.cellsig.2006.09.003; Koide N, 1997, SURG TODAY, V27, P685, DOI 10.1007/BF02384977; Kondo S, 1996, INT J CANCER, V68, P727, DOI 10.1002/(SICI)1097-0215(19961211)68:6<727::AID-IJC6>3.0.CO;2-5; Kovarik J, 2003, INT J MOL MED, V12, P335; Li CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044764; Lin De-Chen, 2010, Yichuan, V32, P455, DOI 10.3724/SP.J.1005.2010.00455; Liu J, 2012, DIS ESOPHAGUS, V25, P67, DOI 10.1111/j.1442-2050.2011.01217.x; Marone M, 1998, CLIN CANCER RES, V4, P517; Matsumoto M, 2001, ANN SURG ONCOL, V8, P598, DOI 10.1245/aso.2001.8.7.598; Ohbu M, 1997, CANCER, V79, P1287, DOI 10.1002/(SICI)1097-0142(19970401)79:7<1287::AID-CNCR3>3.0.CO;2-E; Sarbia M, 1998, CLIN CANCER RES, V4, P2615; Sironi JJ, 2004, J BIOL CHEM, V279, P4066, DOI 10.1074/jbc.M307774200; Su M, 2004, WORLD J GASTROENTERO, V10, P2163; Takayama T, 2001, J SURG ONCOL, V78, P116, DOI 10.1002/jso.1130; Takehara T, 2001, HEPATOLOGY, V34, P55, DOI 10.1053/jhep.2001.25387; Troussard X, 2000, Hematol J, V1, P181, DOI 10.1038/sj.thj.6200025; Tu YP, 1998, CANCER RES, V58, P256; Xerri L, 1996, BRIT J HAEMATOL, V92, P900, DOI 10.1046/j.1365-2141.1996.423958.x; Xie YE, 2006, WORLD J GASTROENTERO, V12, P7472, DOI 10.3748/wjg.v12.i46.7472; Zhang Y, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-791; Zhao J, 2012, DIS ESOPHAGUS, V25, P520, DOI 10.1111/j.1442-2050.2011.01278.x	36	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113928	10.1371/journal.pone.0113928	http://dx.doi.org/10.1371/journal.pone.0113928			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438156	Green Submitted, Green Published, gold			2022-12-26	WOS:000347114900096
J	Wang, S; Lu, AX; Chen, XM; Wei, L; Ding, JQ				Wang, Shuang; Lu, Aixia; Chen, Xiangming; Wei, Lin; Ding, Jiqiang			RABEX-5 Is Upregulated and Plays an Oncogenic Role in Gastric Cancer Development by Activating the VEGF Signaling Pathway	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; HUMAN PROSTATE-CANCER; INDUCED APOPTOSIS; BREAST-CANCER; EXPRESSION; GROWTH; RAB5A; METASTASIS; MIGRATION; INVASION	RABEX-5, a guanine-nucleotide exchange factor (GEF) for RAB-5, is implicated in tumorigenesis and in the development of certain human cancers. Here, we report that RABEX-5 promotes tumor growth and the metastatic ability of gastric cancer cells both in vitro and in vivo. Expression of RABEX-5 is significantly higher in gastric cancer tissues and is associated with tumor size and lymph node metastasis. In addition, targeted silencing of RABEX-5 reduced gastric cancer cell proliferation and colony formation in vitro via the induction of a G0/G1 phase arrest, and stimulated gastric cancer cell apoptosis. Knockdown of RABEX-5 also inhibited wound healing, migration and the invasive abilities of gastric cancer cells. The results of in vivo animal experiments were also consistent with these in vitro findings. Silencing of RABEX-5 led to decreased expression of VEGF. These results indicate that RABEX-5 is upregulated and plays an oncogenic role in gastric cancer development by activating the VEGF signaling pathway.	[Wang, Shuang; Chen, Xiangming; Wei, Lin] Cent Hosp Taian, Dept Clin Oncol, Tai An, Shandong, Peoples R China; [Lu, Aixia] Cent Hosp Taian, Dept Nursing, Tai An, Shandong, Peoples R China; [Ding, Jiqiang] Canc Prevent & Control Hosp Taian, Dept Radiat Oncol, Tai An, Shandong, Peoples R China		Ding, JQ (corresponding author), Canc Prevent & Control Hosp Taian, Dept Radiat Oncol, Tai An, Shandong, Peoples R China.	taishandjq@126.com						Barr F, 2010, CURR OPIN CELL BIOL, V22, P461, DOI 10.1016/j.ceb.2010.04.007; Bartling B, 2000, BIOCHEM BIOPH RES CO, V278, P740, DOI 10.1006/bbrc.2000.3873; Beierle EA, 2005, J SURG RES, V127, P21, DOI 10.1016/j.jss.2005.03.009; Chan CM, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056819, 10.1371/journal.pone.0068504]; Coffey JC, 2005, J BIOL CHEM, V280, P20968, DOI 10.1074/jbc.M414696200; Correa P, 2013, GASTROENTEROL CLIN N, V42, P211, DOI 10.1016/j.gtc.2013.01.002; Fukuda M, 2008, CELL MOL LIFE SCI, V65, P2801, DOI 10.1007/s00018-008-8351-4; Fukui K, 2007, HEPATOL RES, V37, P957, DOI 10.1111/j.1872-034X.2007.00143.x; Gao N, 2003, BIOCHEM BIOPH RES CO, V310, P1124, DOI 10.1016/j.bbrc.2003.09.132; Gao N, 2004, AM J PHYSIOL-CELL PH, V287, pC281, DOI 10.1152/ajpcell.00422.2003; Gibson EM, 2002, CANCER RES, V62, P488; Gournier H, 1998, EMBO J, V17, P1930, DOI 10.1093/emboj/17.7.1930; Hill MM, 2002, PHARMACOL THERAPEUT, V93, P243, DOI 10.1016/S0163-7258(02)00193-6; Horiuchi H, 1997, CELL, V90, P1149, DOI 10.1016/S0092-8674(00)80380-3; Hu L, 2014, ONCOTARGET, V5, P1885, DOI 10.18632/oncotarget.1871; Kim J, 2014, WORLD J GASTROENTERO, V20, P9600, DOI 10.3748/wjg.v20.i28.9600; Li NX, 2001, J BIOL CHEM, V276, P8898, DOI 10.1074/jbc.M009809200; Maroof H, 2014, EXP MOL PATHOL; Mendoza P, 2014, SMALL GTPASES, V5; Mendoza P, 2013, J CELL SCI, V126, P3835, DOI 10.1242/jcs.119727; Nimmrich I, 2000, CANCER LETT, V160, P37, DOI 10.1016/S0304-3835(00)00553-X; Olchowik Marta, 2009, Postepy Biochem, V55, P171; Poza-Guedes P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/372567; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Torres VA, 2010, MOL BIOL CELL, V21, P369, DOI 10.1091/mbc.E09-09-0769; Tuck AB, 2003, ONCOGENE, V22, P1198, DOI 10.1038/sj.onc.1206209; Wang Ying-jian, 2011, Sichuan Da Xue Xue Bao Yi Xue Ban, V42, P185; Xin MG, 2005, J BIOL CHEM, V280, P10781, DOI 10.1074/jbc.M500084200; Yang PS, 2011, CANCER SCI, V102, P2172, DOI 10.1111/j.1349-7006.2011.02089.x; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055; Zhang DL, 2003, ONCOGENE, V22, P974, DOI 10.1038/sj.onc.1206197; Zhang HT, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-31; Zhang X, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-52; Zhao Z, 2010, CANCER SCI, V101, P1454, DOI 10.1111/j.1349-7006.2010.01558.x; Zhong H, 2000, CANCER RES, V60, P1541	35	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113891	10.1371/journal.pone.0113891	http://dx.doi.org/10.1371/journal.pone.0113891			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427001	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400095
J	Zhang, X; Pageon, L; Post, SM				Zhang, X.; Pageon, L.; Post, S. M.			Impact of the Mdm2(SNP309-G) allele on a murine model of colorectal cancer	ONCOGENE			English	Article							ESTROGEN-RECEPTOR-ALPHA; SINGLE NUCLEOTIDE POLYMORPHISM; ACCELERATES TUMOR-FORMATION; MDM2 GENE; TRANSCRIPTIONAL ACTIVITY; DIFFERENTIAL REGULATION; P53; PROMOTER; CELL; EXPRESSION	A single-nucleotide polymorphism (SNP) in the promoter of the Mdm2 gene (Mdm2(SNP309-G)) results in an increased Mdm2 expression, partial attenuation of the p53 pathway and accelerated tumor development. Clinical case-control studies indicate the Mdm2(SNP309-G) allele associates with a significant increase in colorectal cancer (CRC) risk that is heightened in women, but the biological significance of this polymorphism has never been directly evaluated. To examine whether the Mdm2(SNP309-G) allele contributes to colorectal cancer, we generated cohorts of mice harboring either the G (minor allelic variant) or T (major allelic variant) allele and treated them with azoxymethane (AOM), a carcinogen that induces sporadic colorectal cancer. Mdm2(SNP309-G/G) mice displayed a significant reduction in survival following AOM treatment with more colonic lesions in a wider distribution throughout the lower and upper colon and an attenuated apoptotic response following exposure. AOM did not significantly induce stabilization of wild-type p53 or activate p53 downstream targets following AOM treatment, regardless of the genotype. Instead, Mdm2(SNP309-G/G) colons had significant changes in the expression of genes that regulate Mdm2 transcription (ERa and Sp1) as well as downstream targets of Mdm2. Together these results suggest the Mdm2(SNP309-G) allele significantly impacts CRC through mechanisms outside the p53 pathway.	[Zhang, X.; Post, S. M.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Pageon, L.] Univ Texas MD Anderson Canc Ctr, Dept Vet Med & Surg, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Post, SM (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA.	spost@mdanderson.org			Cancer Center [CA016672]; Center for Genetics and Genomics; MDACC; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Cancer Center; Center for Genetics and Genomics; MDACC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Maurisa Flynn-Croce and Brittany N Kleb for reviewing and editing the manuscript. These studies were supported by Cancer Center support grant CA016672 and funding from the Center for Genetics and Genomics and MDACC start-up funds to (SMP).	Abdel-Fattah G, 2000, J GASTROINTEST SURG, V4, P109, DOI 10.1016/S1091-255X(00)80041-4; Armstrong CM, 2013, ENDOCR-RELAT CANCER, V20, P515, DOI 10.1530/ERC-12-0308; Barboza JA, 2008, MOL CANCER RES, V6, P947, DOI 10.1158/1541-7786.MCR-07-2079; Bissahoyo A, 2005, TOXICOL SCI, V88, P340, DOI 10.1093/toxsci/kfi313; Bond GL, 2006, J MED GENET, V43, P950, DOI 10.1136/jmg.2006.043539; Bond GL, 2006, CANCER RES, V66, P5104, DOI 10.1158/0008-5472.CAN-06-0180; Bond GL, 2005, CANCER RES, V65, P5481, DOI 10.1158/0008-5472.CAN-05-0825; Bond GL, 2004, CELL, V119, P591, DOI 10.1016/j.cell.2004.11.022; Brekman A, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2804; Brendel A, 2013, RESTOR NEUROL NEUROS, V31, P199, DOI 10.3233/RNN-120272; Chaar I, 2012, EUR J GASTROEN HEPAT, V24, P320, DOI 10.1097/MEG.0b013e32834bdf84; De Robertis Mariangela, 2011, J Carcinog, V10, P9, DOI 10.4103/1477-3163.78279; Duong V, 2007, CANCER RES, V67, P5513, DOI 10.1158/0008-5472.CAN-07-0967; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Ferreira KS, 2012, APOPTOSIS, V17, P503, DOI 10.1007/s10495-011-0691-0; Ferriere F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069081; Firoz EF, 2009, CLIN CANCER RES, V15, P2573, DOI 10.1158/1078-0432.CCR-08-2678; Fu W, 2009, J BIOL CHEM, V284, P13987, DOI 10.1074/jbc.M901758200; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Heijmans J, 2014, GUT, V63, P310, DOI 10.1136/gutjnl-2012-304216; Hu WW, 2007, CANCER RES, V67, P2757, DOI 10.1158/0008-5472.CAN-06-2656; Hu Y, 2005, INT J CANCER, V115, P561, DOI 10.1002/ijc.20876; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Itoh Y, 2007, J IMMUNOL, V178, P3059, DOI 10.4049/jimmunol.178.5.3059; James AW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007120; Jin J, 2014, J RADIAT RES, V55, P443, DOI 10.1093/jrr/rrt132; Kim K, 2011, J MOL ENDOCRINOL, V46, P67, DOI 10.1677/JME-10-0110; Knappskog S, 2012, EUR J CANCER, V48, P1988, DOI 10.1016/j.ejca.2011.10.024; Knappskog S, 2011, CANCER CELL, V19, P273, DOI 10.1016/j.ccr.2010.12.019; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lind H, 2006, INT J CANCER, V119, P718, DOI 10.1002/ijc.21872; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Nambiar PR, 2002, CANCER RES, V62, P3667; Pant V, 2013, GENE DEV, V27, P1857, DOI 10.1101/gad.227249.113; Poole AJ, 2004, ONCOGENE, V23, P8128, DOI 10.1038/sj.onc.1207994; Post SM, 2010, ONCOGENE, V29, P1260, DOI 10.1038/onc.2009.423; Post SM, 2010, CANCER CELL, V18, P220, DOI 10.1016/j.ccr.2010.07.010; Qin X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076031; Riley Maurisa F, 2012, Genes Cancer, V3, P226, DOI 10.1177/1947601912455322; Saville B, 2000, J BIOL CHEM, V275, P5379, DOI 10.1074/jbc.275.8.5379; Spandidos A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-633; Suh YA, 2011, CANCER RES, V71, P7168, DOI 10.1158/0008-5472.CAN-11-0459; Tien JCY, 2012, EXPERT OPIN THER TAR, V16, P1085, DOI 10.1517/14728222.2012.718330; U.S. Department of Health and Human Services, 1999, US CANC STAT 1999 20; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang F, 1998, NUCLEIC ACIDS RES, V26, P3044, DOI 10.1093/nar/26.12.3044; Wang WZ, 2014, SCI REP-UK, V4, DOI 10.1038/srep04851	48	6	6	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 13	2015	34	33					4412	4420		10.1038/onc.2014.377	http://dx.doi.org/10.1038/onc.2014.377			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CO9KK	25435368				2022-12-26	WOS:000359494400012
J	Liu, C; Wajih, N; Liu, XH; Basu, S; Janes, J; Marvel, M; Keggi, C; Helms, CC; Lee, AN; Belanger, AM; Diz, DI; Laurienti, PJ; Caudell, DL; Wang, J; Gladwin, MT; Kim-Shapiro, DB				Liu, Chen; Wajih, Nadeem; Liu, Xiaohua; Basu, Swati; Janes, John; Marvel, Madison; Keggi, Christian; Helms, Christine C.; Lee, Amber N.; Belanger, Andrea M.; Diz, Debra I.; Laurienti, Paul J.; Caudell, David L.; Wang, Jun; Gladwin, Mark T.; Kim-Shapiro, Daniel B.			Mechanisms of Human Erythrocytic Bioactivation of Nitrite	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RED-BLOOD-CELL; DIETARY NITRATE; XANTHINE OXIDOREDUCTASE; DEPENDENT VASODILATION; PLATELET ACTIVATION; MET HEMOGLOBIN; OXIDE; NO; REDUCTION; MYOGLOBIN	Nitrite signaling likely occurs through its reduction to nitric oxide (NO). Several reports support a role of erythrocytes and hemoglobin in nitrite reduction, but this remains controversial, and alternative reductive pathways have been proposed. In this work we determined whether the primary human erythrocytic nitrite reductase is hemoglobin as opposed to other erythrocytic proteins that have been suggested to be the major source of nitrite reduction. We employed several different assays to determine NO production from nitrite in erythrocytes including electron paramagnetic resonance detection of nitrosyl hemoglobin, chemiluminescent detection of NO, and inhibition of platelet activation and aggregation. Our studies show that NO is formed by red blood cells and inhibits platelet activation. Nitric oxide formation and signaling can be recapitulated with isolated deoxyhemoglobin. Importantly, there is limited NO production from erythrocytic xanthine oxidoreductase and nitric-oxide synthase. Under certain conditions we find dorzolamide (an inhibitor of carbonic anhydrase) results in diminished nitrite bioactivation, but the role of carbonic anhydrase is abrogated when physiological concentrations of CO2 are present. Importantly, carbon monoxide, which inhibits hemoglobin function as a nitrite reductase, abolishes nitrite bioactivation. Overall our data suggest that deoxyhemoglobin is the primary erythrocytic nitrite reductase operating under physiological conditions and accounts for nitrite-mediated NO signaling in blood.	[Liu, Chen; Wajih, Nadeem; Liu, Xiaohua; Basu, Swati; Janes, John; Marvel, Madison; Keggi, Christian; Lee, Amber N.; Belanger, Andrea M.; Kim-Shapiro, Daniel B.] Wake Forest Univ, Dept Phys, Winston Salem, NC 27109 USA; [Basu, Swati; Diz, Debra I.; Laurienti, Paul J.; Kim-Shapiro, Daniel B.] Wake Forest Univ, Translat Sci Ctr, Winston Salem, NC 27109 USA; [Helms, Christine C.] Univ Richmond, Dept Phys, Richmond, VA 23173 USA; [Diz, Debra I.; Kim-Shapiro, Daniel B.] Wake Forest Univ, Sch Med, Hypertens & Vasc Res Ctr, Winston Salem, NC 27157 USA; [Basu, Swati; Laurienti, Paul J.] Wake Forest Univ, Sch Med, Dept Radiol, Winston Salem, NC 27157 USA; [Laurienti, Paul J.; Kim-Shapiro, Daniel B.] Wake Forest Univ, Sch Med, Dept Biomed Engn, Winston Salem, NC 27157 USA; [Caudell, David L.] Wake Forest Univ, Sch Med, Dept Pathol Comparat Med, Winston Salem, NC 27157 USA; [Wang, Jun; Gladwin, Mark T.] Univ Pittsburgh, Heart Lung Blood & Vasc Med Inst, Pittsburgh, PA 15213 USA; [Gladwin, Mark T.] Univ Pittsburgh, Dept Med, Div Pulm Allergy & Crit Care Med, Pittsburgh, PA 15213 USA	Wake Forest University; Wake Forest University; University of Richmond; Wake Forest University; Wake Forest University; Wake Forest University; Wake Forest University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kim-Shapiro, DB (corresponding author), Wake Forest Univ, Dept Phys, Olin Phys Lab 208, Winston Salem, NC 27109 USA.	shapiro@wfu.edu	Wajih, Nadeem/GMW-6625-2022; Kim-Shapiro, Daniel/HGA-2682-2022	Keggi, Christian/0000-0002-6190-4893; Wang, Jun/0000-0001-7564-2364	NCI, National Institutes of Health [P30 CA121291-37]; NATIONAL CANCER INSTITUTE [P30CA012197, R01CA121291] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL058091, R01HL058091, R29HL058091, R01HL098032] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We acknowledge services provided by the Flow Cytometry Core Laboratory of the Comprehensive Cancer Center, supported in part by NCI, National Institutes of Health Grant P30 CA121291-37.	Aamand R, 2009, AM J PHYSIOL-HEART C, V297, pH2068, DOI 10.1152/ajpheart.00525.2009; Akrawinthawong K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092435; Angelo M, 2006, P NATL ACAD SCI USA, V103, P8366, DOI 10.1073/pnas.0600942103; AZUMA H, 1986, BRIT J PHARMACOL, V88, P411, DOI 10.1111/j.1476-5381.1986.tb10218.x; Basu S, 2007, NAT CHEM BIOL, V3, P785, DOI 10.1038/nchembio.2007.46; Brooks J, 1937, PROC R SOC SER B-BIO, V123, P368, DOI 10.1098/rspb.1937.0057; CASSOLY R, 1975, J MOL BIOL, V91, P301, DOI 10.1016/0022-2836(75)90382-4; CLASSEN HG, 1990, J AM COLL NUTR, V9, P500, DOI 10.1080/07315724.1990.10720407; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Dalsgaard T, 2007, AM J PHYSIOL-HEART C, V292, pH3072, DOI 10.1152/ajpheart.01298.2006; Dautov RF, 2014, NITRIC OXIDE-BIOL CH, V40, P36, DOI 10.1016/j.niox.2014.05.005; DODGE JT, 1963, ARCH BIOCHEM BIOPHYS, V100, P119, DOI 10.1016/0003-9861(63)90042-0; DOYLE MP, 1981, J INORG BIOCHEM, V14, P351, DOI 10.1016/S0162-0134(00)80291-3; Eich RF, 1996, BIOCHEMISTRY-US, V35, P6976, DOI 10.1021/bi960442g; Ghosh SM, 2013, HYPERTENSION, V61, P1091, DOI 10.1161/HYPERTENSIONAHA.111.00933; Gladwin MT, 2005, NAT CHEM BIOL, V1, P308, DOI 10.1038/nchembio1105-308; Herold S, 2001, BIOCHEMISTRY-US, V40, P3385, DOI 10.1021/bi002407m; Huang KT, 2007, NITRIC OXIDE-BIOL CH, V16, P209, DOI 10.1016/j.niox.2006.11.002; Huang KT, 2005, J BIOL CHEM, V280, P31126, DOI 10.1074/jbc.M501496200; Huang Z, 2005, J CLIN INVEST, V115, P2099, DOI 10.1172/JCI24650; Huang Z, 2001, BBA-GEN SUBJECTS, V1568, P252, DOI 10.1016/S0304-4165(01)00227-6; Isbell TS, 2007, AM J PHYSIOL-HEART C, V293, pH2565, DOI 10.1152/ajpheart.00759.2007; Jeffers A, 2005, COMP BIOCHEM PHYS A, V142, P130, DOI 10.1016/j.cbpb.2005.04.016; Kevil CG, 2011, FREE RADICAL BIO MED, V51, P576, DOI 10.1016/j.freeradbiomed.2011.04.042; Kim-Shapiro DB, 2004, FREE RADICAL BIO MED, V36, P402, DOI 10.1016/j.freeradbiomed.2003.10.030; Koppenol WH, 2012, INORG CHEM, V51, P5637, DOI 10.1021/ic202561f; Larsen FJ, 2006, NEW ENGL J MED, V355, P2792, DOI 10.1056/NEJMc062800; Lauer T, 2001, P NATL ACAD SCI USA, V98, P12814, DOI 10.1073/pnas.221381098; Li HT, 2008, J BIOL CHEM, V283, P17855, DOI 10.1074/jbc.M801785200; Loscalzo J, 2001, CIRC RES, V88, P756, DOI 10.1161/hh0801.089861; Lundberg JO, 2008, NAT REV DRUG DISCOV, V7, DOI [10.1038/nrd2466, 10.1038/nrd2466-c2]; Modin A, 2001, ACTA PHYSIOL SCAND, V171, P9, DOI 10.1046/j.1365-201x.2001.171001009.x; Nagababu E, 2006, NITRIC OXIDE-BIOL CH, V15, P20, DOI 10.1016/j.niox.2006.01.012; Navati MS, 2010, J PHYS CHEM B, V114, P2938, DOI 10.1021/jp909425z; Navati MS, 2009, J AM CHEM SOC, V131, P12273, DOI 10.1021/ja903364h; Ormerod JOM, 2011, CARDIOVASC RES, V89, P560, DOI 10.1093/cvr/cvq299; Patel RP, 2011, CARDIOVASC RES, V89, P507, DOI 10.1093/cvr/cvq323; Robinson JM, 2005, AM J RESP CELL MOL, V32, P257, DOI 10.1165/rcmb.F292; Salgado MT, 2009, J BIOL CHEM, V284, P12710, DOI 10.1074/jbc.M808647200; Schafer A, 2004, CIRCULATION, V109, P1819, DOI 10.1161/01.CIR.0000126837.88743.DD; Srihirun S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030380; Totzeck M, 2012, CIRCULATION, V126, P325, DOI 10.1161/CIRCULATIONAHA.111.087155; Tsai AL, 2012, BIOCHEMISTRY-US, V51, P172, DOI 10.1021/bi2015629; Tu C, 2009, FREE RADICAL BIO MED, V46, P14, DOI 10.1016/j.freeradbiomed.2008.09.016; Webb AJ, 2008, CIRC RES, V103, P957, DOI 10.1161/CIRCRESAHA.108.175810; Webb AJ, 2008, HYPERTENSION, V51, P784, DOI 10.1161/HYPERTENSIONAHA.107.103523; Wollny T, 1997, AM J PHYSIOL-HEART C, V272, pH2875, DOI 10.1152/ajpheart.1997.272.6.H2875	47	61	62	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1281	1294		10.1074/jbc.M114.609222	http://dx.doi.org/10.1074/jbc.M114.609222			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25471374	hybrid, Green Published			2022-12-26	WOS:000347778200056
J	Chun, KT; Li, BH; Dobrota, E; Tate, C; Lee, JH; Khan, S; Haneline, L; HogenEsch, H; Skalnik, DG				Chun, Kristin T.; Li, Binghui; Dobrota, Erika; Tate, Courtney; Lee, Jeong-Heon; Khan, Shehnaz; Haneline, Laura; HogenEsch, Harm; Skalnik, David G.			The Epigenetic Regulator CXXC Finger Protein 1 is Essential for Murine Hematopoiesis	PLOS ONE			English	Article							CPG-BINDING-PROTEIN; GENOMIC CYTOSINE METHYLATION; STEM-CELLS; DNA METHYLTRANSFERASE; SELF-RENEWAL; HUMAN TRITHORAX; IDENTIFICATION; DIFFERENTIATION; PROLIFERATION; INACTIVATION	CXXC finger protein 1 (Cfp1), encoded by the Cxxc1 gene, binds to DNA sequences containing an unmethylated CpG dinucleotide and is an epigenetic regulator of both cytosine and histone methylation. Cxxc1-null mouse embryos fail to gastrulate, and Cxxc1-null embryonic stem cells are viable but cannot differentiate, suggesting that Cfp1 is required for chromatin remodeling associated with stem cell differentiation and embryogenesis. Mice homozygous for a conditional Cxxc1 deletion allele and carrying the inducible Mx1-Cre transgene were generated to assess Cfp1 function in adult animals. Induction of Cre expression in adult animals led to Cfp1 depletion in hematopoietic cells, a failure of hematopoiesis with a nearly complete loss of lineage-committed progenitors and mature cells, elevated levels of apoptosis, and death within two weeks. A similar pathology resulted following transplantation of conditional Cxxc1 bone marrow cells into wild type recipients, demonstrating this phenotype is intrinsic to Cfp1 function within bone marrow cells. Remarkably, the Lin(-)Sca-1(+)c-Kit(+) population of cells in the bone marrow, which is enriched for hematopoietic stem cells and multi-potential progenitor cells, persists and expands in the absence of Cfp1 during this time frame. Thus, Cfp1 is necessary for hematopoietic stem and multi-potential progenitor cell function and for the developmental potential of differentiating hematopoietic cells.	[Chun, Kristin T.; Li, Binghui; Dobrota, Erika; Tate, Courtney; Lee, Jeong-Heon; Khan, Shehnaz; Haneline, Laura; Skalnik, David G.] Indiana Univ Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA; [Chun, Kristin T.; Tate, Courtney; Skalnik, David G.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [HogenEsch, Harm] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Chun, Kristin T.; Skalnik, David G.] Indiana Univ Purdue Univ, Dept Biol, Sch Sci, Indianapolis, IN 46205 USA; [Haneline, Laura] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [Haneline, Laura] Indiana Univ Sch Med, Dept Cellular & Integrat Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Skalnik, DG (corresponding author), Indiana Univ Sch Med, Dept Pediat, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA.	dskalnik@iupui.edu		HogenEsch, Harm/0000-0002-2738-9189	Riley Children's Foundation; Lilly Endowment; National Science Foundation [MCB-0641851]; National Institutes of Health [RO1 DK66603, T32 AI060519]; Department of Education; NATIONAL CANCER INSTITUTE [P30CA082709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060519] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK066603] Funding Source: NIH RePORTER	Riley Children's Foundation; Lilly Endowment; National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Education(US Department of Education); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: This work was supported by the Riley Children's Foundation, the Lilly Endowment, the National Science Foundation grant MCB-0641851 (to DS), and National Institutes of Health grant RO1 DK66603 (to KC). CT was supported by a pre-doctoral fellowship from National Institutes of Health grant T32 AI060519 and a Department of Education training grant in Graduate Assistance in Areas of National Need. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Araki H, 2007, BLOOD, V109, P3570, DOI 10.1182/blood-2006-07-035287; Attema JL, 2007, P NATL ACAD SCI USA, V104, P12371, DOI 10.1073/pnas.0704468104; Beerman I, 2013, CELL STEM CELL, V12, P413, DOI 10.1016/j.stem.2013.01.017; Bledau AS, 2014, DEVELOPMENT, V141, P1022, DOI 10.1242/dev.098152; Broske AM, 2009, NAT GENET, V41, P1207, DOI 10.1038/ng.463; Bug G, 2005, CANCER RES, V65, P2537, DOI 10.1158/0008-5472.CAN-04-3011; Butler JS, 2009, DNA CELL BIOL, V28, P223, DOI 10.1089/dna.2009.0854; Butler JS, 2008, DNA CELL BIOL, V27, P533, DOI 10.1089/dna.2007.0714; Carlone DL, 2002, GENE, V295, P71, DOI 10.1016/S0378-1119(02)00820-X; Carlone DL, 2001, MOL CELL BIOL, V21, P7601, DOI 10.1128/MCB.21.22.7601-7606.2001; Carlone DL, 2005, MOL CELL BIOL, V25, P4881, DOI 10.1128/MCB.25.12.4881-4891.2005; Challen GA, 2012, NAT GENET, V44, P23, DOI 10.1038/ng.1009; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Clouaire T, 2012, GENE DEV, V26, P1714, DOI 10.1101/gad.194209.112; De Felice LD, 2005, CANCER RES, V65, P1505, DOI 10.1158/0008-5472.CAN-04-3063; DEGRE M, 1974, INT J CANCER, V14, P699, DOI 10.1002/ijc.2910140602; GRESSER I, 1981, J IMMUNOL, V127, P1569; Gutierrez L, 2008, BLOOD, V111, P4375, DOI 10.1182/blood-2007-09-115121; Holzenberger M, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.21.e92; Huang HT, 2013, NAT CELL BIOL, V15, P1516, DOI 10.1038/ncb2870; Iwasaki H, 2007, ONCOGENE, V26, P6687, DOI 10.1038/sj.onc.1210754; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Kemp R, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh090; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim A, 2007, BLOOD, V109, P1687, DOI 10.1182/blood-2006-05-025395; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Le DT, 2004, BLOOD, V103, P4243, DOI 10.1182/blood-2003-08-2650; Lee JH, 2007, J BIOL CHEM, V282, P13419, DOI 10.1074/jbc.M609809200; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lee JH, 2002, J BIOL CHEM, V277, P42259, DOI 10.1074/jbc.M205054200; Lee JH, 2001, J BIOL CHEM, V276, P44669, DOI 10.1074/jbc.M107179200; Leung CG, 2007, J EXP MED, V204, P1603, DOI 10.1084/jem.20062395; Li BH, 2003, BLOOD, V101, P1769, DOI 10.1182/blood-2002-05-1517; Li BH, 2007, BLOOD, V110, P2704, DOI 10.1182/blood-2006-12-064154; Mancini SJC, 2005, BLOOD, V105, P2340, DOI 10.1182/blood-2004-08-3207; Mercer K, 2005, CANCER RES, V65, P11493, DOI 10.1158/0008-5472.CAN-05-2211; Milhem M, 2004, BLOOD, V103, P4102, DOI 10.1182/blood-2003-07-2431; NAKAHATA T, 1982, J CELL PHYSIOL, V113, P455, DOI 10.1002/jcp.1041130314; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rice KL, 2007, ONCOGENE, V26, P6697, DOI 10.1038/sj.onc.1210755; Savill J, 1997, BRIT MED BULL, V53, P491; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Suzuki M, 2004, AM J HEMATOL, V77, P313, DOI 10.1002/ajh.20178; Tate CM, 2010, FEBS J, V277, P210, DOI 10.1111/j.1742-4658.2009.07475.x; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Trowbridge JJ, 2009, CELL STEM CELL, V5, P442, DOI 10.1016/j.stem.2009.08.016; Voo KS, 2000, MOL CELL BIOL, V20, P2108; Wahlestedt M, 2013, BLOOD, V121, P4257, DOI 10.1182/blood-2012-11-469080; Waning DL, 2008, BLOOD, V112, P320, DOI 10.1182/blood-2007-11-126300; Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220; Wells CM, 2004, J CELL SCI, V117, P1259, DOI 10.1242/jcs.00997; Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Young SRL, 2007, DNA CELL BIOL, V26, P80, DOI 10.1089/dna.2006.0535; Young SRL, 2006, J BIOL CHEM, V281, P37034, DOI 10.1074/jbc.M604546200; Zardo G, 2008, LEUKEMIA, V22, P1503, DOI 10.1038/leu.2008.141	57	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113745	10.1371/journal.pone.0113745	http://dx.doi.org/10.1371/journal.pone.0113745			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470594	Green Published, gold			2022-12-26	WOS:000349128700042
J	Kuduk, K; Babik, W; Bellemain, E; Valentini, A; Zedrosser, A; Taberlet, P; Kindberg, J; Swenson, JE; Radwan, J				Kuduk, Katarzyna; Babik, Wieslaw; Bellemain, Eva; Valentini, Alice; Zedrosser, Andreas; Taberlet, Pierre; Kindberg, Jonas; Swenson, Jon E.; Radwan, Jacek			No Evidence for the Effect of MHC on Male Mating Success in the Brown Bear	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; LIFETIME REPRODUCTIVE SUCCESS; MATE CHOICE; PARASITE RESISTANCE; CLASS-I; SEXUAL SELECTION; GENETIC COMPATIBILITY; DIVERSITY; POLYMORPHISM; PREFERENCES	Mate choice is thought to contribute to the maintenance of the spectacularly high polymorphism of the Major Histocompatibility Complex (MHC) genes, along with balancing selection from parasites, but the relative contribution of the former mechanism is debated. Here, we investigated the association between male MHC genotype and mating success in the brown bear. We analysed fragments of sequences coding for the peptide-binding region of the highly polymorphic MHC class I and class II DRB genes, while controlling for genome-wide effects using a panel of 18 microsatellite markers. Male mating success did not depend on the number of alleles shared with the female or amino-acid distance between potential mates at either locus. Furthermore, we found no indication of female mating preferences for MHC similarity being contingent on the number of alleles the females carried. Finally, we found no significant association between the number of MHC alleles a male carried and his mating success. Thus, our results provided no support for the role of mate choice in shaping MHC polymorphism in the brown bear.	[Kuduk, Katarzyna; Babik, Wieslaw; Radwan, Jacek] Jagiellonian Univ, Inst Environm Sci, PL-30387 Krakow, Poland; [Bellemain, Eva; Valentini, Alice] Savoie Technolac, SPYGEN, F-73375 Le Bourget Du Lac, France; [Zedrosser, Andreas; Swenson, Jon E.] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, NO-1432 As, Norway; [Zedrosser, Andreas] Univ Nat Resources & Life Sci, Inst Wildlife Biol & Game Management, AT-1180 Vienna, Austria; [Taberlet, Pierre] CNRS, LECA, F-38000 Grenoble, France; [Taberlet, Pierre] Univ Grenoble Alpes, LECA, F-38000 Grenoble, France; [Kindberg, Jonas] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, SE-90183 Umea, Sweden; [Swenson, Jon E.] Norwegian Inst Nat Res, NO-7485 Trondheim, Norway	Jagiellonian University; Norwegian University of Life Sciences; University of Natural Resources & Life Sciences, Vienna; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Universite de Savoie; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Swedish University of Agricultural Sciences; Norwegian Institute Nature Research	Radwan, J (corresponding author), Jagiellonian Univ, Inst Environm Sci, Ul Gronostajowa 7, PL-30387 Krakow, Poland.	jradwan@amu.edu.pl	valentini, alice/S-2040-2019; Taberlet, Pierre/D-1178-2010; Swenson, Jon/AAE-2890-2019; Valentini, Alice/AFS-1389-2022; Kindberg, Jonas/AAA-5058-2020	Taberlet, Pierre/0000-0002-3554-5954; Valentini, Alice/0000-0001-5829-5479; Kindberg, Jonas/0000-0003-1445-4524; Radwan, Jacek/0000-0001-8503-5701; Babik, Wieslaw/0000-0002-1698-6615	Polish Ministry of Science and Higher Education [N N303 457338]; Swedish Environmental Protection Agency; Norwegian Directorate for Nature Management; Swedish Association for Hunting and Wildlife Management; Austrian Science Foundation; Research Council of Norway; SPYGEN	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Swedish Environmental Protection Agency; Norwegian Directorate for Nature Management; Swedish Association for Hunting and Wildlife Management; Austrian Science Foundation(Austrian Science Fund (FWF)); Research Council of Norway(Research Council of Norway); SPYGEN	Funding: This work was supported by grant N N303 457338 from the Polish Ministry of Science and Higher Education to JR. The Scandinavian Brown Bear Research Project (SBBRP) is funded by the Swedish Environmental Protection Agency, Norwegian Directorate for Nature Management, Swedish Association for Hunting and Wildlife Management, the Austrian Science Foundation, and the Research Council of Norway. SPYGEN provided support in the form of salaries for authors EB and EV, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bellemain E, 2006, P ROY SOC B-BIOL SCI, V273, P283, DOI 10.1098/rspb.2005.3331; Bernatchez L, 2003, J EVOLUTION BIOL, V16, P363, DOI 10.1046/j.1420-9101.2003.00531.x; Biedrzycka A, 2011, MAMM BIOL, V76, P672, DOI 10.1016/j.mambio.2011.05.002; BODMER WF, 1972, NATURE, V237, P139, DOI 10.1038/237139a0; Bonneaud C, 2006, P ROY SOC B-BIOL SCI, V273, P1111, DOI 10.1098/rspb.2005.3325; Borghans JAM, 2004, IMMUNOGENETICS, V55, P732, DOI 10.1007/s00251-003-0630-5; Castric V, 2004, MOL ECOL, V13, P2873, DOI 10.1111/j.1365-294X.2004.02267.x; Consuegra S, 2008, P ROY SOC B-BIOL SCI, V275, P1397, DOI 10.1098/rspb.2008.0066; Dahle B, 2003, BEHAV ECOL SOCIOBIOL, V54, P352, DOI 10.1007/s00265-003-0638-8; de Bakker PIW, 2006, NAT GENET, V38, P1166, DOI 10.1038/ng1885; DOHERTY PC, 1975, NATURE, V256, P50, DOI 10.1038/256050a0; Dunn PO, 2013, EVOLUTION, V67, P679, DOI 10.1111/j.1558-5646.2012.01799.x; Eizaguirre C, 2009, MOL ECOL, V18, P3316, DOI 10.1111/j.1365-294X.2009.04243.x; Ejsmond MJ, 2014, P R SOC L B IN PRESS; Ekblom R, 2004, MOL ECOL, V13, P3821, DOI 10.1111/j.1365-294X.2004.02361.x; Freeman-Gallant CR, 2003, MOL ECOL, V12, P3077, DOI 10.1046/j.1365-294X.2003.01968.x; Friebe A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101410; Furlong RF, 2008, J MOL EVOL, V66, P384, DOI 10.1007/s00239-008-9092-6; Hadfield JD, J STAT SOFTWARE, V33, P1; HEDRICK PW, 1992, GENETICS, V132, P575; Hedrick PW, 2001, MOL ECOL, V10, P1399, DOI 10.1046/j.1365-294X.2001.01289.x; Huchard E, 2013, MOL ECOL, V19, P2545; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; Janeway C.A., 2004, IMMUNOBIOLOGY IMMUNE; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kelley J, 2005, IMMUNOGENETICS, V56, P683, DOI 10.1007/s00251-004-0717-7; Kloch A, 2010, MOL ECOL, V19, P255, DOI 10.1111/j.1365-294X.2009.04476.x; Kuduk K, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-197; Lampert KP, 2006, BEHAV ECOL SOCIOBIOL, V59, P796, DOI 10.1007/s00265-005-0125-5; Landry C, 2001, P ROY SOC B-BIOL SCI, V268, P1279, DOI 10.1098/rspb.2001.1659; Lanyon CV, 2007, FEMS MICROBIOL ECOL, V59, P576, DOI 10.1111/j.1574-6941.2006.00252.x; Lariviere S, 2003, J MAMMAL, V84, P937, DOI 10.1644/BME-003; Leinders-Zufall T, 2004, SCIENCE, V306, P1033, DOI 10.1126/science.1102818; Lighten J, 2014, MOL ECOLOGY RESOURCE; Madsen T, 2006, J EVOLUTION BIOL, V19, P1973, DOI 10.1111/j.1420-9101.2006.01158.x; Meyer-Lucht Y, 2005, MOL ECOL, V14, P2233, DOI 10.1111/j.1365-294X.2005.02557.x; Milinski M, 2006, ANNU REV ECOL EVOL S, V37, P159, DOI 10.1146/annurev.ecolsys.37.091305.110242; NOWAK MA, 1992, P NATL ACAD SCI USA, V89, P10896, DOI 10.1073/pnas.89.22.10896; Olsson M, 2003, P ROY SOC B-BIOL SCI, V270, pS254, DOI 10.1098/rsbl.2003.0079; Paterson S, 1997, P ROY SOC B-BIOL SCI, V264, P1813, DOI 10.1098/rspb.1997.0250; Penn D, 1998, TRENDS ECOL EVOL, V13, P391, DOI 10.1016/S0169-5347(98)01473-6; Penn DJ, 2002, ETHOLOGY, V108, P1, DOI 10.1046/j.1439-0310.2002.00768.x; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; POTTS WK, 1990, IMMUNOL TODAY, V11, P39, DOI 10.1016/0167-5699(90)90014-Z; Radwan J, 2008, ETHOLOGY, V114, P827, DOI 10.1111/j.1439-0310.2008.01528.x; Radwan J, 2012, MOL ECOL, V21, P2469, DOI 10.1111/j.1365-294X.2012.05547.x; Reusch TBH, 2001, NATURE, V414, P300, DOI 10.1038/35104547; Sauermann U, 2001, HUM GENET, V108, P249, DOI 10.1007/s004390100485; Schwensow N, 2007, HEREDITY, V99, P265, DOI 10.1038/sj.hdy.6800993; Schwensow N, 2008, P ROY SOC B-BIOL SCI, V275, P555, DOI 10.1098/rspb.2007.1433; Sepil I, 2013, MOL ECOL, V22, P384, DOI 10.1111/mec.12123; Simmons LW, 2005, ANNU REV ECOL EVOL S, V36, P125, DOI 10.1146/annurev.ecolsys.36.102403.112501; Sommer S, 2005, BEHAV ECOL SOCIOBIOL, V58, P181, DOI 10.1007/s00265-005-0909-7; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; Spurgin LG, 2010, P ROY SOC B-BIOL SCI, V277, P979, DOI 10.1098/rspb.2009.2084; Strandh M, 2012, P ROY SOC B-BIOL SCI, V279, P4457, DOI 10.1098/rspb.2012.1562; Swenson JE, 2001, URSUS-SERIES, V12, P69; TAKAHATA N, 1990, GENETICS, V124, P967; Thonhauser KE, 2014, ANIM BEHAV, V93, P135, DOI 10.1016/j.anbehav.2014.04.028; Thoss M, 2011, MOL ECOL, V20, P1546, DOI 10.1111/j.1365-294X.2011.05009.x; Tollenaere C, 2008, J EVOLUTION BIOL, V21, P1307, DOI 10.1111/j.1420-9101.2008.01563.x; Tregenza T, 2000, MOL ECOL, V9, P1013, DOI 10.1046/j.1365-294x.2000.00964.x; WEDEKIND C, 1995, P ROY SOC B-BIOL SCI, V260, P245, DOI 10.1098/rspb.1995.0087; Wegner KM, 2003, SCIENCE, V301, P1343, DOI 10.1126/science.1088293; Winternitz JC, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1605; Woelfing B, 2009, PHILOS T R SOC B, V364, P117, DOI 10.1098/rstb.2008.0174; YAMAZAKI K, 1976, J EXP MED, V144, P1324, DOI 10.1084/jem.144.5.1324; YAMAZAKI K, 1981, BEHAV GENET, V11, P616; Zedrosser A, 2013, ECOLOGY, V94, P231, DOI 10.1890/12-0229.1	70	8	9	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113414	10.1371/journal.pone.0113414	http://dx.doi.org/10.1371/journal.pone.0113414			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470381	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000349128700026
J	Lieverse, AR; Temple, DH; Bazaliiskii, VI				Lieverse, Angela R.; Temple, Daniel H.; Bazaliiskii, Vladimir I.			Paleopathological Description and Diagnosis of Metastatic Carcinoma in an Early Bronze Age (4588+34 Cal. BP) Forager from the Cis-Baikal Region of Eastern Siberia	PLOS ONE			English	Article							MIDDLE HOLOCENE; HUMAN SKELETON; CANCER; ANTIQUITY; MENINGIOMA; DISEASE; REMAINS; LESIONS; PEOPLE; TUMORS	Extensive osteolytic and osteoblastic lesions were observed on the skeletal remains of an adult male excavated from an Early Bronze Age cemetery dated to 4556+32 years BP, located in the Cis-Baikal region of Siberia (Russian Federation). Lytic lesions ranged in size from several mm to over 60 mm in diameter and had irregular, moth-eaten borders. Many of these lesions destroyed trabecular bone, though a hollowed shell of cortical bone often remained observable. Radiographic analysis revealed numerous lytic lesions within trabecular bone that had not yet affected the cortex. Blastic lesions were identified as spiculated lines, bands, or nodules of mostly immature (woven) bone formed at irregular intervals. Anatomical elements with the greatest involvement included those of the axial skeleton (skull, vertebrae, sacrum, ribs, and sternum) as well as proximal appendicular elements (ossa coxae, proximal femora, clavicles, scapulae, and proximal humeri). Osteocoalescence of destructive foci was observed on the ilium and frontal bone, with the largest lesion found on the right ilium. Differential diagnoses include metastatic carcinoma, mycotic infections, tuberculosis, Langerhan's cell histiocytosis, and multiple myeloma. Based on lesion appearance and distribution, age and sex of the individual, as well as pathogen endemism, the most likely diagnostic option for this set of lesions is metastatic carcinoma. The age and sex of this individual and appearance of the lesions may reflect carcinoma of the lung or, possibly, prostate. This represents one of the earliest cases of metastatic carcinoma worldwide and the oldest case documented thus far from Northeast Asia.	[Lieverse, Angela R.] Univ Saskatchewan, Dept Archaeol & Anthropol, Saskatoon, SK S7N 5B1, Canada; [Temple, Daniel H.] George Mason Univ, Dept Sociol & Anthropol, Fairfax, VA 22030 USA; [Bazaliiskii, Vladimir I.] Irkutsk State Univ, Dept Archaeol & Ethnog, Irkutsk 664003, Russia	University of Saskatchewan; George Mason University; Irkutsk State University	Lieverse, AR (corresponding author), Univ Saskatchewan, Dept Archaeol & Anthropol, Saskatoon, SK S7N 5B1, Canada.	angela.lieverse@usask.ca	Bazaliiskii, Vladimir/K-9972-2017; Lieverse, Angela R./AAL-7397-2021	Lieverse, Angela/0000-0003-0711-1793	Social Sciences and Humanities Research Council of Canada [412-2011-1001]; University of Saskatchewan; University of North Carolina Wilmington	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); University of Saskatchewan; University of North Carolina Wilmington	Funding: This research is part of the Baikal-Hokkaido Archaeology Project funded largely by the Social Sciences and Humanities Research Council of Canada (grant #412-2011-1001). Funding was also provided by the University of Saskatchewan and the University of North Carolina Wilmington. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt KW, 2002, INT J OSTEOARCHAEOL, V12, P442, DOI 10.1002/oa.647; Assis S, 2010, INT J OSTEOARCHAEOL, V20, P603, DOI 10.1002/oa.1084; Aufderheide AC, 1998, CAMBRIDGE ENCY HUMAN, P373; Baker BJ, 1999, TUBERCULOSIS PRESENT, P301; Binder M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090924; Brooks S, 1990, HUM EVOL, V5, P227, DOI DOI 10.1007/BF02437238; Brothwell D., 1967, DIS ANTIQUITY, P320; Brothwell D, 2012, BLACKW COMPANION ANT, P420; Bubendorf L, 2000, HUM PATHOL, V31, P578, DOI 10.1053/hp.2000.6698; Buikstra J.E., 1994, STANDARDS DATA COLLE; Buikstra J. E., 1981, PREHISTORIC TUBERCUL, P115; Capasso LL, 2005, INT J CANCER, V113, P2, DOI 10.1002/ijc.20610; Chard C.S., 1974, NE ASIA PREHISTORY; Chick EW, 1971, HUMAN INFECT FUNGI A, P405; Collins Conor D, 2004, Cancer Imaging, V4 Spec No A, pS47, DOI 10.1102/1470-7330.2004.0010; COLLINS VP, 1950, AM J ROENTGENOL, V63, P102; Copeland MM, 1931, RADIOLOGY, V16, P198; CZARNETZKI A, 1980, J HUM EVOL, V9, P15, DOI 10.1016/0047-2484(80)90037-8; David AR, 2010, NAT REV CANCER, V10, P728, DOI 10.1038/nrc2914; DELARUA C, 1995, INT J OSTEOARCHAEOL, V5, P254, DOI 10.1002/oa.1390050304; Domett KM, 2012, INT J OSTEOARCHAEOL, V22, P731, DOI 10.1002/oa.1234; Dorfman H.D., 1998, BONE TUMORS; DRUTZ DJ, 1978, AM REV RESPIR DIS, V117, P559; El-Najjar MY, 1981, PREHISTORIC TUBERCUL, P85; Fink TM, 1985, HLTH DIS PREHISTORIC, P324; Gerszten PC, 2001, NEUROSURGERY, V48, P208, DOI 10.1097/00006123-200101000-00039; Greenspan A, 1998, DIFFERENTIAL DIAGNOS, P368; Grmek M. D., 1975, HIST SCI MED, V1, P1; Halperin EC, 2004, PERSPECT BIOL MED, V47, P1, DOI 10.1353/pbm.2004.0010; Hershkovitz I, 1998, AM J PHYS ANTHROPOL, V106, P47, DOI 10.1002/(SICI)1096-8644(199805)106:1<47::AID-AJPA4>3.0.CO;2-A; Hill K., 1996, ACHE LIFE HIST DEMOG; Holloway KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062798; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jonsdottir B, 2003, AM J PHYS ANTHROPOL, V122, P232, DOI 10.1002/ajpa.10285; KELLEY MA, 1987, MIDCONTINENTAL J ARC, V12, P89; Konigsberg LW, 2006, SCH AM RES, P267; Kozlowski T, 2012, BLACKW COMPANION ANT, P401; Lieverse A. R., 2007, NO HUNTER GATHERERS, V3, P11; Lieverse A.R., 2005, THESIS CORNELL U ITH; Long JC, 1981, PREHISTORIC TUBERCUL, P69; Luna LH, 2008, INT J OSTEOARCHAEOL, V18, P492, DOI 10.1002/oa.950; MANN RW, 1987, J FORENSIC SCI, V32, P148; Marks MK, 2007, INT J OSTEOARCHAEOL, V17, P217, DOI 10.1002/oa.874; Meindl R.S., 1989, AGE MARKERS HUMAN SK, P137; MEINDL RS, 1985, AM J PHYS ANTHROPOL, V68, P57, DOI 10.1002/ajpa.1330680106; MICOZZI MS, 1991, ARCH PATHOL LAB MED, V115, P838; Monge J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064539; Mulligan M E, 2000, Semin Musculoskelet Radiol, V4, P127, DOI 10.1055/s-2000-6860; MUNDY GR, 1974, NEW ENGL J MED, V291, P1041, DOI 10.1056/NEJM197411142912001; Mundy GR, 2002, NAT REV CANCER, V2, P584, DOI 10.1038/nrc867; Nagaoka T, 2008, ANTHROPOL SCI, V116, P161, DOI 10.1537/ase.070724; Nagaoka T, 2012, ANTHROPOL SCI, V120, P103, DOI 10.1537/ase.1107311; Nerlich AG, 2006, ONCOL REP, V16, P197; Okladnikov AP, 1950, NEOLIT BRONZOVYI V 3, V18; Okladnikov AP, 1955, NEOLIT BRONZOVYI V 3, V43; Ortner D. J., 2003, IDENTIFICATION PATHO, V2nd, P45, DOI [10.1016/B978-012528628-2/50041-7, DOI 10.1016/B978-012528628-2/50041-7]; Ortner DJ, 2012, INT J OSTEOARCHAEOL, V22, P245, DOI 10.1002/oa.1196; Paine RR, 2007, PALEODEMOGRAPHIC DAT; Prates C, 2011, INT J PALEOPATHOL, V1, P98, DOI 10.1016/j.ijpp.2011.09.002; RESNICK D., 1995, DIAGNOSIS BONE JOINT, P2325; Roodman GD, 2001, J CLIN ONCOL, V19, P3562, DOI 10.1200/JCO.2001.19.15.3562; Rothschild BM, 1998, AM J PHYS ANTHROPOL, V105, P241, DOI 10.1002/(SICI)1096-8644(199802)105:2<241::AID-AJPA10>3.0.CO;2-0; ROTHSCHILD BM, 1995, AM J PHYS ANTHROPOL, V96, P357, DOI 10.1002/ajpa.1330960404; Salfelder K, 1971, HUMAN INFECTION FUNG, P383; SANDISON AT, 1975, LANCET, V1, P279; Santos AL, 2001, AM J PHYS ANTHROPOL, V115, P38, DOI 10.1002/ajpa.1054; Schillaci M.A., 1999, J PALEOPATHOL, V11, P41; Schultz M., 1997, FORENSIC TAPHONOMY P, P201; Schultz M, 2007, INT J CANCER, V121, P2591, DOI 10.1002/ijc.23073; Sefcakova A, 2001, AM J PHYS ANTHROPOL, V116, P216, DOI 10.1002/ajpa.1117; Smith MO, 2002, INT J OSTEOARCHAEOL, V12, P235, DOI 10.1002/oa.618; STATHOPOULOS G, 1975, LANCET, V1, P165; Steinbock R., 1976, PALEOPATHOLOGICAL DI; STROUHAL E, 1978, B NEW YORK ACAD MED, V54, P290; Strouhal E, 1998, J PALEOPATHOLOGY, V19, P101; SUZUKI T, 1989, Zeitschrift fuer Morphologie und Anthropologie, V78, P73; Temple DH, 2006, INT J OSTEOARCHAEOL, V16, P316, DOI 10.1002/oa.827; TOBIAS PV, 1960, NATURE, V185, P946, DOI 10.1038/185946a0; Turner-Walker G., 2008, ADV HUM PALAEOPATHOL, P3, DOI [10.1002/9780470724187.ch1, DOI 10.1002/9780470724187.CH1]; Ubelaker DH., 1997, FORENSIC TAPHONOMY P, P77; WADA Y, 1987, J ANTHROPOL SOC NIP, V95, P107; WAKELY J, 1995, J ARCHAEOL SCI, V22, P469, DOI 10.1006/jasc.1995.0046; Wasterlain SN, 2011, INT J OSTEOARCHAEOL, V21, P336, DOI 10.1002/oa.1130; WEBER A, 1995, J WORLD PREHIST, V9, P99, DOI 10.1007/BF02221004; Weber AW, 2011, J ANTHROPOL ARCHAEOL, V30, P523, DOI 10.1016/j.jaa.2011.06.006; Weber AW, 2006, RADIOCARBON, V48, P127, DOI 10.1017/S0033822200035463; Weber AW, 2002, J ANTHROPOL ARCHAEOL, V21, P230, DOI 10.1006/jaar.2001.0395; Weber J, 2002, INT J OSTEOARCHAEOL, V12, P385, DOI 10.1002/oa.637; Weiss L, 2000, CANCER METAST REV, V19, P193, DOI 10.1023/A:1010646304844; Zimmerman M.L., 1956, CRYPTOCOCCOSIS TORUL; ZIMMERMAN MR, 1977, CANCER, V40, P1358, DOI 10.1002/1097-0142(197709)40:3<1358::AID-CNCR2820400354>3.0.CO;2-J	91	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113919	10.1371/journal.pone.0113919	http://dx.doi.org/10.1371/journal.pone.0113919			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA7WS	25470373	Green Published, gold			2022-12-26	WOS:000349128700054
J	Naville, M; Chalopin, D; Volff, JN				Naville, Magali; Chalopin, Domitille; Volff, Jean-Nicolas			Interspecies Insertion Polymorphism Analysis Reveals Recent Activity of Transposable Elements in Extant Coelacanths	PLOS ONE			English	Article							NON-LTR RETROTRANSPOSONS; EVOLUTIONARY HISTORY; GENOME; GENES; SEQUENCE; ALIGNMENT; PROVIDES; FISH; DNA	Coelacanths are lobe-finned fish represented by two extant species, Latimeria chalumnae in South Africa and Comoros and L. menadoensis in Indonesia. Due to their intermediate phylogenetic position between ray-finned fish and tetrapods in the vertebrate lineage, they are of great interest from an evolutionary point of view. In addition, extant specimens look similar to 300 million-year-old fossils; because of their apparent slowly evolving morphology, coelacanths have been often described as "living fossils". As an underlying cause of such a morphological stasis, several authors have proposed a slow evolution of the coelacanth genome. Accordingly, sequencing of the L. chalumnae genome has revealed a globally low substitution rate for protein-coding regions compared to other vertebrates. However, genome and gene evolution can also be influenced by transposable elements, which form a major and dynamic part of vertebrate genomes through their ability to move, duplicate and recombine. In this work, we have searched for evidence of transposition activity in coelacanth genomes through the comparative analysis of orthologous genomic regions from both Latimeria species. Comparison of 5.7 Mb (0.2%) of the L. chalumnae genome with orthologous Bacterial Artificial Chromosome clones from L. menadoensis allowed the identification of 27 species-specific transposable element insertions, with a strong relative contribution of CR1 non-LTR retrotransposons. Species-specific homologous recombination between the long terminal repeats of a new coelacanth endogenous retrovirus was also detected. Our analysis suggests that transposon activity is responsible for at least 0.6% of genome divergence between both Latimeria species. Taken together, this study demonstrates that coelacanth genomes are not evolutionary inert: they contain recently active transposable elements, which have significantly contributed to post-speciation genome divergence in Latimeria.	[Naville, Magali; Chalopin, Domitille; Volff, Jean-Nicolas] Ecole Normale Super Lyon, Inst Genom Fonct Lyon, F-69364 Lyon, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Volff, JN (corresponding author), Ecole Normale Super Lyon, Inst Genom Fonct Lyon, F-69364 Lyon, France.	jean-nicolas.volff@ens-lyon.fr			Ecole Normale Superieure de Lyon; French Ministry for Higher Education and Research; "Ligue Contre le Cancer"	Ecole Normale Superieure de Lyon(Grant Agency of the Czech Republic); French Ministry for Higher Education and Research; "Ligue Contre le Cancer"(Ligue nationale contre le cancer)	Funding: MN is supported by the Ecole Normale Superieure de Lyon; DC is supported by a PhD grant from the French Ministry for Higher Education and Research, and by the "Ligue Contre le Cancer". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amemiya CT, 2013, NATURE, V496, P311, DOI 10.1038/nature12027; Amemiya CT, 2010, P NATL ACAD SCI USA, V107, P3622, DOI 10.1073/pnas.0914312107; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bourque G, 2009, CURR OPIN GENET DEV, V19, P607, DOI 10.1016/j.gde.2009.10.013; Burge C, 1997, J MOL BIOL, V268, P78, DOI 10.1006/jmbi.1997.0951; Casane D, 2013, BIOESSAYS, V35, P332, DOI 10.1002/bies.201200145; Chalopin D, 2014, J EXP ZOOL PART B, V322, P322, DOI 10.1002/jez.b.22521; CHARLESWORTH B, 1983, GENET RES, V42, P1, DOI 10.1017/S0016672300021455; Cloutier R, 1996, MORPHOLOGY CHARACTER; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Forconi M, 2014, J EXP ZOOL PART B, V322, P379, DOI 10.1002/jez.b.22527; Fricke H, 2011, MAR BIOL, V158, P1511, DOI 10.1007/s00227-011-1667-x; Friedman M, 2006, P ROY SOC B-BIOL SCI, V273, P245, DOI 10.1098/rspb.2005.3316; Gifford R, 2003, VIRUS GENES, V26, P291, DOI 10.1023/A:1024455415443; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gwee PC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-93; Haas NB, 1997, GENE, V197, P305, DOI 10.1016/S0378-1119(97)00276-X; Hancks DC, 2010, SEMIN CANCER BIOL, V20, P234, DOI 10.1016/j.semcancer.2010.04.001; Higasa K, 2012, GENE, V505, P324, DOI 10.1016/j.gene.2012.05.047; Holder MT, 1999, P NATL ACAD SCI USA, V96, P12616, DOI 10.1073/pnas.96.22.12616; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Jurka J, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-44; Kapitonov VV, 2003, MOL BIOL EVOL, V20, P38, DOI 10.1093/molbev/msg011; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Le Rouzic A, 2005, GENETICS, V169, P1033, DOI 10.1534/genetics.104.031211; Lynch M, 2007, P NATL ACAD SCI USA, V104, P8597, DOI 10.1073/pnas.0702207104; Maisey J.G., 1996, DISCOVERING FOSSIL F; Mills RE, 2006, AM J HUM GENET, V78, P671, DOI 10.1086/501028; Mills RE, 2007, TRENDS GENET, V23, P183, DOI 10.1016/j.tig.2007.02.006; Mulley JF, 2010, MOL BIOL EVOL, V27, P2386, DOI 10.1093/molbev/msq121; Nikaido M, 2013, GENOME RES, V23, P1740, DOI 10.1101/gr.158105.113; Noonan JP, 2004, GENOME RES, V14, P2397, DOI 10.1101/gr.2972804; Oliver KR, 2009, BIOESSAYS, V31, P703, DOI 10.1002/bies.200800219; Pallavicini A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-538; Rebollo R, 2012, ANNU REV GENET, V46, P21, DOI 10.1146/annurev-genet-110711-155621; Smit A, 1996, REPEATMASKER OPEN 30; Smith JLB, 1939, NATURE, V143, P455, DOI 10.1038/143455a0; Smith JLB, 1956, OLD FOURLEGS STORY C; Thomson KS, 1992, LIVING FOSSIL STORY; Volff JN, 2006, BIOESSAYS, V28, P913, DOI 10.1002/bies.20452; Wicker T, 2007, NAT REV GENET, V8, P973, DOI 10.1038/nrg2165; Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478	46	9	9	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114382	10.1371/journal.pone.0114382	http://dx.doi.org/10.1371/journal.pone.0114382			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470617	Green Submitted, gold, Green Published			2022-12-26	WOS:000349128700112
J	Townsend, PD; Jungwirth, B; Pojer, F; Bussmann, M; Money, VA; Cole, ST; Puhler, A; Tauch, A; Bott, M; Cann, MJ; Pohl, E				Townsend, Philip D.; Jungwirth, Britta; Pojer, Florence; Bussmann, Michael; Money, Victoria A.; Cole, Stewart T.; Puehler, Alfred; Tauch, Andreas; Bott, Michael; Cann, Martin J.; Pohl, Ehmke			The Crystal Structures of Apo and cAMP-Bound GlxR from Corynebacterium glutamicum Reveal Structural and Dynamic Changes upon cAMP Binding in CRP/FNR Family Transcription Factors	PLOS ONE			English	Article							AMP RECEPTOR PROTEIN; CAP-DNA COMPLEX; ESCHERICHIA-COLI; BIOTECHNOLOGICAL PRODUCTION; REGULATOR GLXR; IDENTIFICATION; ACTIVATION; RESOLUTION; GENES; SITES	The cyclic AMP-dependent transcriptional regulator GlxR from Corynebacterium glutamicum is a member of the super-family of CRP/FNR (cyclic AMP receptor protein/fumarate and nitrate reduction regulator) transcriptional regulators that play central roles in bacterial metabolic regulatory networks. In C. glutamicum, which is widely used for the industrial production of amino acids and serves as a nonpathogenic model organism for members of the Corynebacteriales including Mycobacterium tuberculosis, the GlxR homodimer controls the transcription of a large number of genes involved in carbon metabolism. GlxR therefore represents a key target for understanding the regulation and coordination of C. glutamicum metabolism. Here we investigate cylic AMP and DNA binding of GlxR from C. glutamicum and describe the crystal structures of apo GlxR determined at a resolution of 2.5 angstrom, and two crystal forms of holo GlxR at resolutions of 2.38 and 1.82 angstrom, respectively. The detailed structural analysis and comparison of GlxR with CRP reveals that the protein undergoes a distinctive conformational change upon cyclic AMP binding leading to a dimer structure more compatible to DNA-binding. As the two binding sites in the GlxR homodimer are structurally identical dynamic changes upon binding of the first ligand are responsible for the allosteric behavior. The results presented here show how dynamic and structural changes in GlxR lead to optimization of orientation and distance of its two DNA-binding helices for optimal DNA recognition.	[Townsend, Philip D.; Money, Victoria A.; Cann, Martin J.; Pohl, Ehmke] Univ Durham, Biophys Sci Inst, Sch Biol & Biomed Sci, Durham, England; [Townsend, Philip D.; Money, Victoria A.; Cann, Martin J.; Pohl, Ehmke] Univ Durham, Biophys Sci Inst, Dept Chem, Durham, England; [Jungwirth, Britta; Puehler, Alfred; Tauch, Andreas] Univ Bielefeld, Ctr Biotechnol CeBiTec, Inst Genome Res & Syst Biol, D-33615 Bielefeld, Germany; [Pojer, Florence; Cole, Stewart T.] Ecole Polytech Fed Lausanne, Global Hlth Inst, Prot Crystallog Core Facil, Lausanne, Switzerland; [Bussmann, Michael; Bott, Michael] Forschungszentrum Julich, IBG Biotechnol 1, Inst Bio & Geosci, D-52425 Julich, Germany	Durham University; Durham University; University of Bielefeld; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Helmholtz Association; Research Center Julich	Pohl, E (corresponding author), Univ Durham, Biophys Sci Inst, Sch Biol & Biomed Sci, Durham, England.	ehmke.pohl@durham.ac.uk	Pohl, Ehmke/I-2408-2012; Cann, Martin/G-2864-2012; Townsend, Phiip/J-3761-2018; Bott, Michael/E-8004-2011	Pohl, Ehmke/0000-0002-9949-4471; Cann, Martin/0000-0001-6305-8769; Townsend, Phiip/0000-0001-9235-3492; Bott, Michael/0000-0002-4701-8254; Puhler, Alfred/0000-0003-4723-2960	Engineering and Physical Sciences Research Council [EP/H051759/1]; Swiss National Science Foundation [31003A_140778]; EPSRC [EP/H051759/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Funding provided by Engineering and Physical Sciences Research Council (www.epsrc.ac.uk), EP/H051759/1 to MJC and EP and Swiss National Science Foundation (www.snf.ch), 31003A_140778 to STC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blombach B, 2011, APPL ENVIRON MICROB, V77, P3300, DOI 10.1128/AEM.02972-10; Bott M, 2007, TRENDS MICROBIOL, V15, P417, DOI 10.1016/j.tim.2007.08.004; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Bussmann M, 2009, J BIOTECHNOL, V143, P173, DOI 10.1016/j.jbiotec.2009.06.025; Chu SY, 2001, J BIOL CHEM, V276, P11230, DOI 10.1074/jbc.M010428200; Cramer A, 2006, J BACTERIOL, V188, P2554, DOI 10.1128/JB.188.7.2554-2567.2006; Deutscher J, 2008, CURR OPIN MICROBIOL, V11, P87, DOI 10.1016/j.mib.2008.02.007; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Frenois F, 2004, MOL CELL, V16, P301, DOI 10.1016/j.molcel.2004.09.020; Gallagher DT, 2009, J BIOL CHEM, V284, P8228, DOI 10.1074/jbc.C800215200; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Han SO, 2007, MICROBIOL-SGM, V153, P2190, DOI 10.1099/mic.0.2006/004366-0; Hong M, 2005, MOL CELL, V20, P131, DOI 10.1016/j.molcel.2005.09.013; Jungwirth B, 2013, MICROBIOL-SGM, V159, P12, DOI 10.1099/mic.0.062059-0; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim HJ, 2004, J BACTERIOL, V186, P3453, DOI 10.1128/JB.186.11.3453-3460.2004; Kohl TA, 2008, J BIOTECHNOL, V135, P340, DOI 10.1016/j.jbiotec.2008.05.011; Krug A, 2005, J BIOL CHEM, V280, P585, DOI 10.1074/jbc.M408271200; Kumar P, 2010, BIOPHYS J, V98, P305, DOI 10.1016/j.bpj.2009.10.016; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee TW, 2001, J BIOCHEM-TOKYO, V130, P57, DOI 10.1093/oxfordjournals.jbchem.a002962; Letek M, 2006, J BACTERIOL, V188, P409, DOI 10.1128/JB.188.2.409-423.2006; Leuchtenberger W, 2005, APPL MICROBIOL BIOT, V69, P1, DOI 10.1007/s00253-005-0155-y; Litsanov B, 2012, APPL ENVIRON MICROB, V78, P3325, DOI 10.1128/AEM.07790-11; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; MCKAY DB, 1981, NATURE, V290, P744, DOI 10.1038/290744a0; Moore JL, 1996, J BIOL CHEM, V271, P21273, DOI 10.1074/jbc.271.35.21273; Mosca R, 2008, NUCLEIC ACIDS RES, V36, pW42, DOI 10.1093/nar/gkn197; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Okino S, 2008, APPL MICROBIOL BIOT, V81, P459, DOI 10.1007/s00253-008-1668-y; Panhorst M, 2011, J BIOTECHNOL, V154, P149, DOI 10.1016/j.jbiotec.2010.07.015; Parkinson G, 1996, J MOL BIOL, V260, P395, DOI 10.1006/jmbi.1996.0409; Passner JM, 1997, P NATL ACAD SCI USA, V94, P2843, DOI 10.1073/pnas.94.7.2843; Passner JM, 2000, J MOL BIOL, V304, P847, DOI 10.1006/jmbi.2000.4231; Pohl E, 1998, J BIOL CHEM, V273, P22420, DOI 10.1074/jbc.273.35.22420; Popovych N, 2006, NAT STRUCT MOL BIOL, V13, P831, DOI 10.1038/nsmb1132; Popovych N, 2009, P NATL ACAD SCI USA, V106, P6927, DOI 10.1073/pnas.0900595106; Reddy MCM, 2009, J BIOL CHEM, V284, P36581, DOI 10.1074/jbc.M109.041343; Rodgers TL, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001651; Rodgers TL, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-183; SCHULTZ SC, 1991, SCIENCE, V253, P1001, DOI 10.1126/science.1653449; Sharma H, 2009, P NATL ACAD SCI USA, V106, P16604, DOI 10.1073/pnas.0908380106; Stapleton M, 2010, J BIOL CHEM, V285, P7016, DOI 10.1074/jbc.M109.047720; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TENG TY, 1990, J APPL CRYSTALLOGR, V23, P387, DOI 10.1107/S0021889890005568; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toncrova H, 2010, BIOPHYS J, V98, P2317, DOI 10.1016/j.bpj.2010.01.039; Toyoda K, 2011, J BACTERIOL, V193, P4123, DOI 10.1128/JB.00384-11; Tzeng SR, 2012, NATURE, V488, P236, DOI 10.1038/nature11271; Tzeng SR, 2009, NATURE, V462, P368, DOI 10.1038/nature08560; Utagawa T, 2004, J NUTR, V134, p2854S, DOI 10.1093/jn/134.10.2854S; Vertes AA, 2008, J MOL MICROB BIOTECH, V15, P16, DOI 10.1159/000111989; Vogt M, 2014, METAB ENG, V22, P40, DOI 10.1016/j.ymben.2013.12.001; Wendisch VF, 2006, CURR OPIN MICROBIOL, V9, P268, DOI 10.1016/j.mib.2006.03.001; Wennerhold J, 2006, J BACTERIOL, V188, P2907, DOI 10.1128/JB.188.8.2907-2918.2006; Wennerhold J, 2005, J BIOL CHEM, V280, P40500, DOI 10.1074/jbc.M508693200; Won HS, 2009, BBA-PROTEINS PROTEOM, V1794, P1299, DOI 10.1016/j.bbapap.2009.04.015; Yu SN, 2004, BIOCHEMISTRY-US, V43, P4662, DOI 10.1021/bi0362166; Yukawa H, 2004, ABSTR PAP AM CHEM S, V227, pU301	59	17	18	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113265	10.1371/journal.pone.0113265	http://dx.doi.org/10.1371/journal.pone.0113265			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469635	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000349128700019
J	Kashiwagi, T; Hara, K; Nakazono, Y; Uemura, Y; Imamura, Y; Hamada, N; Watanabe, H				Kashiwagi, Takahito; Hara, Koyu; Nakazono, Yoko; Uemura, Yusaku; Imamura, Yoshihiro; Hamada, Nobuyuki; Watanabe, Hiroshi			The N-Terminal Fragment of a PB2 Subunit from the Influenza A Virus (A/Hong Kong/156/1997 H5N1) Effectively Inhibits RNP Activity and Viral Replication	PLOS ONE			English	Article							POLYMERASE PA SUBUNIT; NEURAMINIDASE INHIBITOR; PROMOTER-BINDING; PROTEIN; IDENTIFICATION; MECHANISM; SITES; REASSORTMENT; OSELTAMIVIR; RWJ-270201	Background: Influenza A virus has a RNA-dependent RNA polymerase (RdRp) that is composed of three subunits (PB1, PB2 and PA subunit), which assemble with nucleoproteins (NP) and a viral RNA (vRNA) to form a RNP complex in the host nucleus. Recently, we demonstrated that the combination of influenza ribonucleoprotein (RNP) components is important for both its assembly and activity. Therefore, we questioned whether the inhibition of the RNP combination via an incompatible component in the RNP complex could become a methodology for an anti-influenza drug. Methodology/Principal Findings: We found that a H5N1 PB2 subunit efficiently inhibits H1N1 RNP assembly and activity. Moreover, we determined the domains and important amino acids on the N-terminus of the PB2 subunit that are required for a strong inhibitory effect. The NP binding site of the PB2 subunit is important for the inhibition of RNP activity by another strain. A plaque assay also confirmed that a fragment of the PB2 subunit could inhibit viral replication. Conclusions/Significance: Our results suggest that the N-terminal fragment of a PB2 subunit becomes an inhibitor that targets influenza RNP activity that is different from that targeted by current drugs such as M2 and NA inhibitors.	[Kashiwagi, Takahito; Hara, Koyu; Nakazono, Yoko; Uemura, Yusaku; Imamura, Yoshihiro; Hamada, Nobuyuki; Watanabe, Hiroshi] Kurume Univ, Sch Med, Dept Infect Control & Prevent, Fukuoka, Japan	Kurume University	Kashiwagi, T (corresponding author), Kurume Univ, Sch Med, Dept Infect Control & Prevent, Fukuoka, Japan.	takahito@med.kurume-u.ac.jp			Ministry of Education, Science, Sports and Culture, Japan [24591590]; Ishibashi Foundation for the Promotion of Science	Ministry of Education, Science, Sports and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ishibashi Foundation for the Promotion of Science	This study was supported by grants from the Promotion of Science and the Ministry of Education, Science, Sports and Culture, Japan, Grant-in-Aid for Scientific Research (C), 24591590, 2012-2015, and the Ishibashi Foundation for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu YS, 2000, J MED CHEM, V43, P3482, DOI 10.1021/jm0002679; Baranovich T, 2010, J CLIN VIROL, V47, P23, DOI 10.1016/j.jcv.2009.11.003; Biswas SK, 1998, J VIROL, V72, P5493, DOI 10.1128/JVI.72.7.5493-5501.1998; Chase G, 2011, METHODS, V55, P188, DOI 10.1016/j.ymeth.2011.08.007; Chen LM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000072; Deng T, 2005, J VIROL, V79, P8669, DOI 10.1128/JVI.79.13.8669-8674.2005; Fislova T, 2010, J VIROL, V84, P8691, DOI 10.1128/JVI.00813-10; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Fodor E, 2002, PERSP MED V, V7, P1; Furuta Y, 2005, ANTIMICROB AGENTS CH, V49, P981, DOI 10.1128/AAC.49.3.981-986.2005; Graef KM, 2010, J VIROL, V84, P8433, DOI 10.1128/JVI.00879-10; Gubareva LV, 2002, ANTIVIR RES, V53, P47, DOI 10.1016/S0166-3542(01)00192-9; Gubareva LV, 1996, J VIROL, V70, P1818, DOI 10.1128/JVI.70.3.1818-1827.1996; Gubareva LV, 2001, J INFECT DIS, V183, P523, DOI 10.1086/318537; Gubareva LV, 2000, LANCET, V355, P827, DOI 10.1016/S0140-6736(99)11433-8; Hara K, 2001, GENES CELLS, V6, P87, DOI 10.1046/j.1365-2443.2001.00399.x; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; Hara K, 2013, J GEN VIROL, V94, P2406, DOI 10.1099/vir.0.053959-0; HAYDEN FG, 1994, ANTIVIR RES, V25, P123, DOI 10.1016/0166-3542(94)90101-5; Hurt AC, 2009, ANTIVIR RES, V83, P90, DOI 10.1016/j.antiviral.2009.03.003; Kashiwagi T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015140; Kashiwagi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005473; KIDA H, 1994, J GEN VIROL, V75, P2183, DOI 10.1099/0022-1317-75-9-2183; Li CJ, 2010, P NATL ACAD SCI USA, V107, P4687, DOI 10.1073/pnas.0912807107; Li CF, 2013, FEBS J, V280, P1139, DOI 10.1111/febs.12107; Mehle A, 2012, J VIROL, V86, P1750, DOI 10.1128/JVI.06203-11; Momose F, 2002, J BIOL CHEM, V277, P45306, DOI 10.1074/jbc.M206822200; Nakazono Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032634; Ohtsu Y, 2002, MICROBIOL IMMUNOL, V46, P167, DOI 10.1111/j.1348-0421.2002.tb02682.x; PALESE P, 1976, J GEN VIROL, V33, P159, DOI 10.1099/0022-1317-33-1-159; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Poole E, 2004, VIROLOGY, V321, P120, DOI 10.1016/j.virol.2003.12.022; Reuther P, 2011, J VIROL, V85, P13298, DOI 10.1128/JVI.00868-11; Sangawa H, 2013, ANTIMICROB AGENTS CH, V57, P5202, DOI 10.1128/AAC.00649-13; Sidwell RW, 2001, ANTIMICROB AGENTS CH, V45, P749, DOI 10.1128/AAC.45.3.749-757.2001; Smee DF, 2001, ANTIMICROB AGENTS CH, V45, P743, DOI 10.1128/AAC.45.3.743-748.2001; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; Toyoda T, 1996, J GEN VIROL, V77, P2149, DOI 10.1099/0022-1317-77-9-2149; Vreede FT, 2004, J VIROL, V78, P9568, DOI 10.1128/JVI.78.17.9568-9572.2004	39	4	5	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114502	10.1371/journal.pone.0114502	http://dx.doi.org/10.1371/journal.pone.0114502			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460916	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700140
J	Wong, BX; Tsatsanis, A; Lim, LQ; Adlard, PA; Bush, AI; Duce, JA				Wong, Bruce X.; Tsatsanis, Andrew; Lim, Linh Q.; Adlard, Paul A.; Bush, Ashley I.; Duce, James A.			beta-Amyloid Precursor Protein Does Not Possess Ferroxidase Activity but Does Stabilize the Cell Surface Ferrous Iron Exporter Ferroportin	PLOS ONE			English	Article							OXIDATIVE STRESS; CEREBROSPINAL-FLUID; EXPRESSION; CERULOPLASMIN; INCREASES; ROLES; TRANSPORTER; TRANSFERRIN; PHOSPHATE; COMPLEX	Ceruloplasmin is a ferroxidase that interacts with ferroportin to export cellular iron, but is not expressed in neurons. We recently reported that the amyloid precursor protein (APP) is the analogous iron-exporting chaperone for neurons and other cells. The ferroxidase activity of APP has since been called into question. Using a triplex Fe2+ oxidation assay, we analyzed the activity of a soluble form of APP (sAPP alpha) within a buffer of physiological pH and anionic charge, and determined that iron oxidation originated from phosphate. Using various techniques such as flow-cytometry to measure surface presented proteins, we confirmed that endogenous APP is essential for ferroportin persistence on the neuronal surface. Therefore, despite lacking ferroxidase activity, APP still supports iron export from neurons.	[Wong, Bruce X.; Lim, Linh Q.; Adlard, Paul A.; Bush, Ashley I.; Duce, James A.] Univ Melbourne, Oxidat Biol Unit, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Tsatsanis, Andrew; Duce, James A.] Univ Leeds, Fac Biol Sci, Sch Mol & Cellular Biol, Leeds, W Yorkshire, England; [Lim, Linh Q.] Univ Melbourne, Dept Pharmacol & Therapeut, Parkville, Vic 3052, Australia; [Adlard, Paul A.; Bush, Ashley I.; Duce, James A.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia	Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Leeds; University of Melbourne; University of Melbourne	Bush, AI (corresponding author), Univ Melbourne, Oxidat Biol Unit, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia.	ashley.bush@florey.edu.au; J.A.Duce@leeds.ac.uk	Wong, Bruce/AAY-5884-2020; Bush, Ashley I/A-1186-2007; Bush, Ashley/Y-2457-2019	Wong, Bruce/0000-0002-1687-4138; Bush, Ashley I/0000-0001-8259-9069; Bush, Ashley/0000-0001-8259-9069; Duce, James/0000-0002-8762-2245	National Health & Medical Research Council (NHMRC) [1025774, 1044542]; Alzheimer's Research UK fellowship; Victorian Government; Alzheimers Research UK [ART-SRF2011-1] Funding Source: researchfish	National Health & Medical Research Council (NHMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)National Health and Medical Research Council (NHMRC) of Australia); Alzheimer's Research UK fellowship; Victorian Government; Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK))	The work carried out in Australia by BXW, LQL, PAA, AIB and JAD was supported by funding from the National Health & Medical Research Council (NHMRC) (Project grant #1025774 and #1044542). Work based in the United Kingdom by AT and JAD was funded by Alzheimer's Research UK fellowship. The Florey Institute of Neuroscience and Mental Health acknowledges support from the Victorian Government for funding from the Operational Infrastructure Support Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AISEN P, 1967, J BIOL CHEM, V242, P2484; Ayton S, 2013, ANN NEUROL, V73, P554, DOI 10.1002/ana.23817; BARTZOKIS G, 1994, AM J NEURORADIOL, V15, P1129; Cahill CM, 2009, BBA-GEN SUBJECTS, V1790, P615, DOI 10.1016/j.bbagen.2008.12.001; Caldwell JH, 2013, MECH DEVELOP, V130, P433, DOI 10.1016/j.mod.2012.11.001; Castellani RJ, 2004, AGEING RES REV, V3, P319, DOI 10.1016/j.arr.2004.01.002; CONNOR JR, 1990, J NEUROSCI RES, V27, P595, DOI 10.1002/jnr.490270421; Crichton R. R., 2009, INORGANIC BIOCH IRON; DAVIES KJA, 1987, J BIOL CHEM, V262, P9895; De Domenico I, 2007, EMBO J, V26, P2823, DOI 10.1038/sj.emboj.7601735; Duce JA, 2010, CELL, V142, P857, DOI 10.1016/j.cell.2010.08.014; Ebrahimi KH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040287; Erel O, 1998, CLIN CHEM, V44, P2313; Fenton H., 1894, J CHEM SOC T, V65, P899, DOI [10.1039/CT8946500899, DOI 10.1039/CT8946500899]; GORDEUK VR, 1988, J CLIN INVEST, V82, P1934, DOI 10.1172/JCI113812; Gralle M, 2002, BIOPHYS J, V83, P3513, DOI 10.1016/S0006-3495(02)75351-4; Guerreiro PM, 2014, AM J PHYSIOL-RENAL, V306, pF1275, DOI 10.1152/ajprenal.00458.2013; Guillot-Sestier MV, 2012, J BIOL CHEM, V287, P5021, DOI 10.1074/jbc.M111.323626; Haber F., 1934, P R SOC LOND A, V147, P332, DOI [10.1098/rspa.1934.0221, DOI 10.1098/RSPA.1934.0221, DOI 10.1098/rspa.1934.0221]; Harris WR, 2012, BBA-GEN SUBJECTS, V1820, P348, DOI 10.1016/j.bbagen.2011.07.017; Henry A, 1997, PROTEIN EXPRES PURIF, V10, P283, DOI 10.1006/prep.1997.0748; HILBICH C, 1993, J BIOL CHEM, V268, P26571; Hilton RJ, 2012, J INORG BIOCHEM, V110, P1, DOI 10.1016/j.jinorgbio.2012.02.017; Honarnejad K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080645; Honda K, 2004, ANN NY ACAD SCI, V1012, P179, DOI 10.1196/annals.1306.015; Hruska KA, 2011, ADV CHRONIC KIDNEY D, V18, P98, DOI 10.1053/j.ackd.2011.01.001; Ida N, 1996, J BIOL CHEM, V271, P22908, DOI 10.1074/jbc.271.37.22908; Imel EA, 2011, J CLIN ENDOCR METAB, V96, P3541, DOI 10.1210/jc.2011-1239; JANDL JH, 1963, J CLIN INVEST, V42, P314, DOI 10.1172/JCI104718; JOHNSON DA, 1967, CLIN CHEM, V13, P142; Kaneko K, 2002, FREE RADICAL RES, V36, P303, DOI 10.1080/10715760290019327; Knutson MD, 2003, BLOOD, V102, P4191, DOI 10.1182/blood-2003-04-1250; Kosman DJ, 2013, COORDIN CHEM REV, V257, P210, DOI 10.1016/j.ccr.2012.06.030; Lammich S, 1999, P NATL ACAD SCI USA, V96, P3922, DOI 10.1073/pnas.96.7.3922; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; McCarthy RC, 2014, EMBO REP, V15, P809, DOI 10.15252/embr.201338064; MINOTTI G, 1992, J BIOL CHEM, V267, P7611; Needham BE, 2014, METALLOMICS, V6, P598, DOI 10.1039/c3mt00358b; Nevo Y, 2006, BBA-MOL CELL RES, V1763, P609, DOI 10.1016/j.bbamcr.2006.05.007; Patel BN, 2002, J NEUROSCI, V22, P6578; Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010; Schulz K, 2011, J NEUROSCI, V31, P13301, DOI 10.1523/JNEUROSCI.2838-11.2011; VANNOSTRAND WE, 1992, P NATL ACAD SCI USA, V89, P2551, DOI 10.1073/pnas.89.7.2551; Waldron KJ, 2009, NATURE, V460, P823, DOI 10.1038/nature08300; Wan L, 2012, J ALZHEIMERS DIS, V30, P523, DOI 10.3233/JAD-2012-111169; Wan L, 2011, FREE RADICAL BIO MED, V50, P122, DOI 10.1016/j.freeradbiomed.2010.10.707; Weiss G, 2013, NAT REV RHEUMATOL, V9, P205, DOI 10.1038/nrrheum.2012.183; White AR, 1998, J NEUROSCI, V18, P6207; Wong BX, 2014, BBA-GEN SUBJECTS, V1840, P3299, DOI 10.1016/j.bbagen.2014.08.006; Wong BX, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00081; Wong BX, 2014, BBA IN PRESS; Wu LJC, 2004, BRAIN RES, V1001, P108, DOI 10.1016/j.brainres.2003.10.066; Yang FM, 2002, AM J PHYSIOL-LUNG C, V283, pL932, DOI 10.1152/ajplung.00114.2002; Yeh KY, 2011, GASTROENTEROLOGY, V141, P292, DOI 10.1053/j.gastro.2011.03.059; Yoshida K, 2000, J NEUROL SCI, V175, P91, DOI 10.1016/S0022-510X(00)00295-1	55	108	109	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114174	10.1371/journal.pone.0114174	http://dx.doi.org/10.1371/journal.pone.0114174			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464026	Green Published, gold			2022-12-26	WOS:000345869700112
J	Lohr, C; Van Dongen, R; Huntley, B; Gibson, L; Morris, K				Lohr, Cheryl; Van Dongen, Ricky; Huntley, Bart; Gibson, Lesley; Morris, Keith			Remotely Monitoring Change in Vegetation Cover on the Montebello Islands, Western Australia, in Response to Introduced Rodent Eradication	PLOS ONE			English	Article							LAGORCHESTES-HIRSUTUS; NORTHERN-TERRITORY; SEED PREDATION; TANAMI DESERT; BLACK RATS; IMAGERY; HAWAII	The Montebello archipelago consists of 218 islands; 80 km from the north-west coast of Western Australia. Before 1912 the islands had a diverse terrestrial fauna. By 1952 several species were locally extinct. Between 1996 and 2011 rodents and cats were eradicated, and 5 mammal and 2 bird species were translocated to the islands. Monitoring of the broader terrestrial ecosystem over time has been limited. We used 20 dry-season Landsat images from 1988 to 2013 and estimation of green fraction cover in nadir photographs taken at 27 sites within the Montebello islands and six sites on Thevenard Island to assess change in vegetation density over time. Analysis of data averaged across the 26-year period suggests that 719 ha out of 2169 ha have increased in vegetation cover by up to 32%, 955 ha have remained stable and 0.6 ha have declined in vegetation cover. Over 492 ha (22%) had no vegetation cover at any time during the period analysed. Chronological clustering analysis identified two breakpoints in the average vegetation cover data occurring in 1997 and 2003, near the beginning and end of the rodent eradication activities. On many islands vegetation cover was declining prior to 1996 but increased after rodents were eradicated from the islands. Data for North West and Trimouille islands were analysed independently because of the potential confounding effect of native fauna being introduced to these islands. Mala (Lagorchestes hirsutus) and Shark Bay mice (Pseudomys fieldi) both appear to suppress native plant recruitment but not to the same degree as introduced rodents. Future research should assess whether the increase in vegetation cover on the Montebello islands is due to an increase in native or introduced plants.	[Lohr, Cheryl; Morris, Keith] Dept Pk & Wildlife, Sci & Conservat Div, Woodvale, WA, Australia; [Van Dongen, Ricky; Huntley, Bart] Dept Pk & Wildlife, GIS Sect, Kensington, WA, Australia; [Gibson, Lesley] Keiran McNamara Conservat Sci Ctr, Dept Pk & Wildlife, Sci & Conservat Div, Kensington, WA 6151, Australia		Lohr, C (corresponding author), Dept Pk & Wildlife, Sci & Conservat Div, Woodvale, WA, Australia.	cheryl.lohr@dpaw.wa.gov.au	Lohr, Cheryl/T-6744-2019	Lohr, Cheryl/0000-0002-8925-0983; Huntley, Barton/0000-0002-9519-4105	Gorgon Barrow Island Net Conservation Benefits fund; Western Australia Department of Parks and Wildlife	Gorgon Barrow Island Net Conservation Benefits fund; Western Australia Department of Parks and Wildlife	This project was funded by the Gorgon Barrow Island Net Conservation Benefits fund and the Western Australia Department of Parks and Wildlife. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN A, 1999, P WALIS FOR 1999 PER, P74; BOLTON BL, 1978, AUST WILDLIFE RES, V5, P285; BORCHERT MI, 1978, OECOLOGIA, V33, P101, DOI 10.1007/BF00376999; Burbidge AA, 1971, 9 DEP FISH FAUN; Burbidge Andrew A., 2004, Conservation Science Western Australia, V5, P194; Burbidge Andrew A., 2000, CALMScience, V3, P95; Bureau of Meteorology, 2014, DAT SERV; Campbell DJ, 1999, J ROY SOC NEW ZEAL, V29, P265, DOI 10.1080/03014223.1999.9517597; Chevis H, 1990, REPORT VISIT MONTE B; CLARK DA, 1981, BIOTROPICA, V13, P182, DOI 10.2307/2388123; Clout M., 2002, TURNING TIDE ERADICA; Cole JR, 2000, WILDLIFE RES, V27, P437, DOI 10.1071/WR97053; Coops NC, 2003, TREE PHYSIOL, V23, P23, DOI 10.1093/treephys/23.1.23; Graham MF, 2002, TURNING TIDE ERADICA; Hill FL, 1952, LINNEAN, V165, P113; Langford D, 2000, RECOVERY PLAN MALA L; Langford Don, 2001, Australian Mammalogy, V23, P37; LEGENDRE P, 1985, AM NAT, V125, P257, DOI 10.1086/284340; Li G., 2006, EXPLORING DATA TABLE, P281; Macfarlane C, 2012, METHODS ECOL EVOL, V3, P405, DOI 10.1111/j.2041-210X.2011.00151.x; Marshall VM, 2012, J ARID ENVIRON, V78, P1, DOI 10.1016/j.jaridenv.2011.11.005; McClelland PJ, 2002, TURNING TIDE ERADICA; Montague PD, 1914, P ZOOL SOC LOND, V1914, P625; Morris K, 2000, 17 W AUSTR DEP CONS; Murray BR, 1999, WILDLIFE RES, V26, P421, DOI 10.1071/WR97046; Pender RJ, 2013, BIOL INVASIONS, V15, P213, DOI 10.1007/s10530-012-0280-3; Robinson T, 2012, 285 DEP AGR FOOD; Roder A, 2008, REMOTE SENS ENVIRON, V112, P2863, DOI 10.1016/j.rse.2008.01.018; SCOWCROFT PG, 1984, PAC SCI, V38, P80; Shiels AB, 2011, BIOL INVASIONS, V13, P781, DOI 10.1007/s10530-010-9868-7; TOWNS DR, 2002, TURNING TIDE ERADICA; USGS, 2014, LANDS MISS; Wallace Jeremy, 2006, Ecological Management & Restoration, V7, pS31, DOI 10.1111/j.1442-8903.2006.00289.x; WEST CJ, 2002, TURNING TIDE ERADICA; Yabe Tatsuo, 1998, Mammal Study, V23, P123, DOI 10.3106/mammalstudy.23.123; Young LC, 2013, BIOL INVASIONS, V15, P2627, DOI 10.1007/s10530-013-0479-y	36	5	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114095	10.1371/journal.pone.0114095	http://dx.doi.org/10.1371/journal.pone.0114095			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436454	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900117
J	Patel, V; Oh, A; Voit, A; Sultatos, LG; Babu, GJ; Wilson, BA; Ho, MF; McArdle, JJ				Patel, Vishwendra; Oh, Anne; Voit, Antanina; Sultatos, Lester G.; Babu, Gopal J.; Wilson, Brenda A.; Ho, Mengfei; McArdle, Joseph J.			Altered Active Zones, Vesicle Pools, Nerve Terminal Conductivity, and Morphology during Experimental MuSK Myasthenia Gravis	PLOS ONE			English	Article							MUSCLE-SPECIFIC KINASE; NEUROMUSCULAR-JUNCTION FORMATION; TRANSMITTER RELEASE; SYNAPTIC-TRANSMISSION; CLINICAL FINDINGS; DISTINCT ROLES; SAFETY FACTOR; MOTOR-NERVE; END-PLATES; COLLAGEN Q	Recent studies demonstrate reduced motor-nerve function during autoimmune muscle-specific tyrosine kinase (MuSK) myasthenia gravis (MG). To further understand the basis of motor-nerve dysfunction during MuSK-MG, we immunized female C57/B6 mice with purified rat MuSK ectodomain. Nerve-muscle preparations were dissected and neuromuscular junctions (NMJs) studied electrophysiologically, morphologically, and biochemically. While all mice produced antibodies to MuSK, only 40% developed respiratory muscle weakness. In vitro study of respiratory nerve-muscle preparations isolated from these affected mice revealed that 78% of NMJs produced endplate currents (EPCs) with significantly reduced quantal content, although potentiation and depression at 50 Hz remained qualitatively normal. EPC and mEPC amplitude variability indicated significantly reduced number of vesicle-release sites (active zones) and reduced probability of vesicle release. The readily releasable vesicle pool size and the frequency of large amplitude mEPCs also declined. The remaining NMJs had intermittent (4%) or complete (18%) failure of neurotransmitter release in response to 50 Hz nerve stimulation, presumably due to blocked action potential entry into the nerve terminal, which may arise from nerve terminal swelling and thinning. Since MuSK-MG-affected muscles do not express the AChR gamma subunit, the observed prolongation of EPC decay time was not due to inactivity-induced expression of embryonic acetylcholine receptor, but rather to reduced catalytic activity of acetylcholinesterase. Muscle protein levels of MuSK did not change. These findings provide novel insight into the pathophysiology of autoimmune MuSK-MG.	[Patel, Vishwendra; Oh, Anne; Sultatos, Lester G.; McArdle, Joseph J.] Rutgers State Univ, Dept Physiol & Pharmacol, New Jersey Med Sch, Newark, NJ 07102 USA; [Voit, Antanina; Babu, Gopal J.] Rutgers State Univ, Dept Cell Biol & Mol Med, New Jersey Med Sch, Newark, NJ 07102 USA; [Wilson, Brenda A.; Ho, Mengfei] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Illinois System; University of Illinois Urbana-Champaign	McArdle, JJ (corresponding author), Rutgers State Univ, Dept Physiol & Pharmacol, New Jersey Med Sch, Newark, NJ 07102 USA.	mcardle@njms.rutgers.edu	Ho, Mengfei/Q-6844-2019; Patel, Vishwendra/AAC-6817-2022; Babu, Gopal/AAB-7787-2021	Babu, Gopal/0000-0001-7833-5300; Ho, Mengfei/0000-0002-8315-8158	FM Kirby Foundation, Inc.	FM Kirby Foundation, Inc.	Funding: This research was supported by the FM Kirby Foundation, Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANGAUTPETIT D, 1982, PROC R SOC SER B-BIO, V215, P117, DOI 10.1098/rspb.1982.0031; ARGENTIERI TM, 1992, PFLUG ARCH EUR J PHY, V421, P256, DOI 10.1007/BF00374835; Burden SJ, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009167; Cartaud A, 2004, J CELL BIOL, V165, P505, DOI 10.1083/jcb.200307164; Cole RN, 2010, J PHYSIOL-LONDON, V588, P3217, DOI 10.1113/jphysiol.2010.190298; Cole RN, 2008, ANN NEUROL, V63, P782, DOI 10.1002/ana.21371; Court FA, 2008, GLIA, V56, P471, DOI 10.1002/glia.20620; Davis GW, 2013, NEURON, V80, P718, DOI 10.1016/j.neuron.2013.09.044; DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9; Engel AG, 2013, J PHYSIOL-LONDON, V591, P2377, DOI 10.1113/jphysiol.2013.254599; Evoli A, 2003, BRAIN, V126, P2304, DOI 10.1093/brain/awg223; Evoli A, 2008, ANN NY ACAD SCI, V1132, P76, DOI 10.1196/annals.1405.012; Evoli A, 2013, AUTOIMMUN REV, V12, P931, DOI 10.1016/j.autrev.2013.03.004; FAMBROUGH DM, 1973, SCIENCE, V182, P293, DOI 10.1126/science.182.4109.293; Ghazanfari N, 2014, J PHYSIOL-LONDON, V592, P2881, DOI 10.1113/jphysiol.2013.270207; Ghazanfari N, 2011, INT J BIOCHEM CELL B, V43, P295, DOI 10.1016/j.biocel.2010.10.008; Glass DJ, 1996, CELL, V85, P513, DOI 10.1016/S0092-8674(00)81252-0; Glass DJ, 1997, P NATL ACAD SCI USA, V94, P8848, DOI 10.1073/pnas.94.16.8848; Glass DJ, 1996, COLD SPRING HARB SYM, V61, P435; Guptill JT, 2011, MUSCLE NERVE, V44, P36, DOI 10.1002/mus.22006; Guptill JT, 2010, CURR OPIN NEUROL, V23, P530, DOI 10.1097/WCO.0b013e32833c0982; Hesser BA, 2006, MOL CELL NEUROSCI, V31, P470, DOI 10.1016/j.mcn.2005.10.020; Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520; Huijbers MG, 2013, P NATL ACAD SCI USA, V110, P20783, DOI 10.1073/pnas.1313944110; Isabel MPV, 2005, J BIOL CHEM, V280, P31801, DOI 10.1074/jbc.M502874200; Jha S, 2006, J NEUROIMMUNOL, V175, P107, DOI 10.1016/j.jneuroim.2006.03.016; Kawakami Y, 2011, NEUROLOGY, V77, P1819, DOI 10.1212/WNL.0b013e318237f660; Keung B, 2013, J NEUROL NEUROSUR PS, V84, P1407, DOI 10.1136/jnnp-2012-303664; Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002; Klooster R, 2012, BRAIN, V135, P1081, DOI 10.1093/brain/aws025; Koneczny I, 2014, J ANAT, V224, P29, DOI 10.1111/joa.12034; Koneczny I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080695; Lavrnic D, 2005, J NEUROL NEUROSUR PS, V76, P1099, DOI 10.1136/jnnp.2004.052415; MCARDLE JJ, 1983, PROG NEUROBIOL, V21, P135, DOI 10.1016/0301-0082(83)90001-1; MCARDLE JJ, 1981, J NEUROSCI METH, V4, P109, DOI 10.1016/0165-0270(81)90044-3; McConville J, 2004, ANN NEUROL, V55, P580, DOI 10.1002/ana.20061; Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102; Mori S, 2013, AUTOIMMUN REV, V12, P912, DOI 10.1016/j.autrev.2013.03.005; Mori S, 2012, J NEUROIMMUNOL, V245, P75, DOI 10.1016/j.jneuroim.2012.02.010; Mori S, 2012, AM J PATHOL, V180, P798, DOI 10.1016/j.ajpath.2011.10.031; Morsch M, 2013, J PHYSIOL-LONDON, V591, P2747, DOI 10.1113/jphysiol.2013.251827; Morsch M, 2012, EXP NEUROL, V237, P286, DOI 10.1016/j.expneurol.2012.06.034; Niks EH, 2010, MUSCLE NERVE, V42, P283, DOI 10.1002/mus.21642; Nishimune H, 2012, MOL NEUROBIOL, V45, P1, DOI 10.1007/s12035-011-8216-y; Ohara-Imaizumi M, 2005, MOL BIOL CELL, V16, P3289, DOI 10.1091/mbc.E04-09-0816; Ohno K, 2014, J MOL NEUROSCI, V53, P359, DOI 10.1007/s12031-013-0170-x; Ono F, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.12pe3; Pasnoor M, 2010, MUSCLE NERVE, V41, P370, DOI 10.1002/mus.21533; PATON WDM, 1967, J PHYSIOL-LONDON, V191, P59, DOI 10.1113/jphysiol.1967.sp008237; Pires-Alves M, 2009, TOXICON, V53, P392, DOI 10.1016/j.toxicon.2008.12.016; PLOMP JJ, 1992, J PHYSIOL-LONDON, V458, P487, DOI 10.1113/jphysiol.1992.sp019429; PLOMP JJ, 1995, ANN NEUROL, V37, P627, DOI 10.1002/ana.410370513; Polo-Parada L, 2005, NEURON, V46, P917, DOI 10.1016/j.neuron.2005.05.018; Polo-Parada L, 2004, J NEUROSCI, V24, P1852, DOI 10.1523/JNEUROSCI.4406-03.2004; Polo-Parada L, 2001, NEURON, V32, P815, DOI 10.1016/S0896-6273(01)00521-9; Punga AR, 2011, EXP NEUROL, V230, P207, DOI 10.1016/j.expneurol.2011.04.018; Querol L, 2013, CURR OPIN NEUROL, V26, P459, DOI 10.1097/WCO.0b013e328364c079; Richman DP, 2012, ANN NY ACAD SCI, V1274, P140, DOI 10.1111/j.1749-6632.2012.06782.x; Richman DP, 2012, ARCH NEUROL-CHICAGO, V69, P453, DOI 10.1001/archneurol.2011.2200; ROBITAILLE R, 1990, NEURON, V5, P773, DOI 10.1016/0896-6273(90)90336-E; Robitaille R, 1998, NEURON, V21, P847, DOI 10.1016/S0896-6273(00)80600-5; Ruff RL, 2008, J NEUROIMMUNOL, V201, P13, DOI 10.1016/j.jneuroim.2008.04.038; SALPETER MM, 1979, J NEUROCYTOL, V8, P95, DOI 10.1007/BF01206461; Sander A, 2001, J CELL BIOL, V155, P1287, DOI 10.1083/jcb.200105034; Sanders DB, 2003, NEUROLOGY, V60, P1978, DOI 10.1212/01.WNL.0000065882.63904.53; Selcen D, 2004, NEUROLOGY, V62, P1945, DOI 10.1212/01.WNL.0000128048.23930.1D; Serra A, 2012, ANN NY ACAD SCI, V1275, P129, DOI 10.1111/j.1749-6632.2012.06841.x; Shigemoto K, 2006, J CLIN INVEST, V116, P1016, DOI 10.1172/JCI21545; Shiraishi H, 2005, ANN NEUROL, V57, P289, DOI 10.1002/ana.20341; Slater CR, 2008, ANN NY ACAD SCI, V1132, P1, DOI 10.1196/annals.1405.003; Slater Clarke R, 2008, Handb Clin Neurol, V91, P27, DOI 10.1016/S0072-9752(07)01502-3; Slater CR, 2003, J NEUROCYTOL, V32, P505, DOI 10.1023/B:NEUR.0000020607.17881.9b; Sommer Norbert, 2008, Handb Clin Neurol, V91, P169, DOI 10.1016/S0072-9752(07)01505-9; Stiegler AL, 2006, J MOL BIOL, V364, P424, DOI 10.1016/j.jmb.2006.09.019; Sultatos LG, 2008, TOXICOL APPL PHARM, V230, P390, DOI 10.1016/j.taap.2008.03.006; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; Ulusoy C, 2014, CLIN IMMUNOL, V151, P155, DOI 10.1016/j.clim.2014.02.012; Viegas S, 2012, EXP NEUROL, V234, P506, DOI 10.1016/j.expneurol.2012.01.025; Wang XY, 2006, J NEUROSCI, V26, P8983, DOI 10.1523/JNEUROSCI.2493-06.2006; WAUD DR, 1975, AM J PHYSIOL, V229, P1632, DOI 10.1152/ajplegacy.1975.229.6.1632; Weiner GJ, 2010, SEMIN HEMATOL, V47, P115, DOI 10.1053/j.seminhematol.2010.01.011; Wen H, 2010, P NATL ACAD SCI USA, V107, P13906, DOI 10.1073/pnas.1008598107; WITZEMANN V, 1991, J CELL BIOL, V114, P125, DOI 10.1083/jcb.114.1.125; Witzemann V, 2006, CELL TISSUE RES, V326, P263, DOI 10.1007/s00441-006-0237-x; Wolfe GI, 2008, ANN NY ACAD SCI, V1132, P71, DOI 10.1196/annals.1405.005; Yumoto N, 2012, NATURE, V489, P438, DOI 10.1038/nature11348; Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006; Zhou L, 2004, MUSCLE NERVE, V30, P55, DOI 10.1002/mus.20069	88	13	13	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e110571	10.1371/journal.pone.0110571	http://dx.doi.org/10.1371/journal.pone.0110571			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438154	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900005
J	Peters, BA; Hall, MN; Liu, XH; Neugut, YD; Pilsner, JR; Levy, D; Ilievski, V; Slavkovich, V; Islam, T; Factor-Litvak, P; Graziano, JH; Gamble, MV				Peters, Brandilyn A.; Hall, Megan N.; Liu, Xinhua; Neugut, Y. Dana; Pilsner, J. Richard; Levy, Diane; Ilievski, Vesna; Slavkovich, Vesna; Islam, Tariqul; Factor-Litvak, Pam; Graziano, Joseph H.; Gamble, Mary V.			Creatinine, Arsenic Metabolism, and Renal Function in an Arsenic-Exposed Population in Bangladesh	PLOS ONE			English	Article							GLOMERULAR-FILTRATION-RATE; DRINKING-WATER; CYSTATIN-C; URINARY CREATININE; OXIDATIVE STRESS; SERUM CREATININE; NATIONAL-HEALTH; METHYL BALANCE; US POPULATION; SKIN-LESIONS	Kidney disease is emerging as an arsenic (As)-linked disease outcome, however further evidence of this association is warranted. Our first objective for this paper was to examine the potential renal toxicity of As exposure in Bangladesh. Our second objective relates to examining whether the previously reported positive association between urinary creatinine (uCrn) and As methylation may be explained by renal function. We had hypothesized that these associations relate to supply and demand for s-adenosylmethionine, the methyl donor for both creatine synthesis and As methylation. Alternatively, renal function could influence both As and creatinine excretion, or the As metabolites may influence renal function, which in turn influences uCrn. We conducted a cross-sectional study (N=478) of adults, composed of a sample recruited in 2001 and a sample recruited in 2003. We assessed renal function using plasma cystatin C, and calculated the estimated glomerular filtration rate (eGFR). Consistent with renal toxicity of As, log-uAs had a marginal inverse association with eGFR in the 2003 sample (b=-5.6, p=0.07), however this association was not significant in the 2001 sample (b=-1.9, p=0.24). Adjustment for eGFR did not alter the associations between uCrn and the % uAs metabolites, indicating that GFR does not explain these associations. Increased eGFR was associated with increased odds of having % uInAs>12.2% (2001: OR=1.01, 95% CI (1.00,1.03); 2003: OR=1.04, 95% CI (1.01,1.07)). In the 2003 sample only, there was a negative association between eGFR and % uDMA (b=-0.08, p=0.02). These results may indicate differential effects of renal function on excretion of InAs and DMA. Alternatively, a certain methylation pattern, involving decreased % InAs and increased % DMA, may reduce renal function. Given that these studies were cross-sectional, we cannot distinguish between these two possibilities. Discrepancies between the samples may be due to the higher As exposure, poorer nutrition, and lower As methylation capacity in the 2003 sample.	[Peters, Brandilyn A.; Neugut, Y. Dana; Ilievski, Vesna; Slavkovich, Vesna; Graziano, Joseph H.; Gamble, Mary V.] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY 10027 USA; [Hall, Megan N.; Factor-Litvak, Pam] Columbia Univ, Dept Epidemiol, Mailman Sch Publ Hlth, New York, NY USA; [Liu, Xinhua; Levy, Diane] Columbia Univ, Dept Biostat, Mailman Sch Publ Hlth, New York, NY USA; [Pilsner, J. Richard] Univ Massachusetts, Div Environm Hlth Sci, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA; [Islam, Tariqul] Columbia Univ, Arsen Project Bangladesh, Dhaka, Bangladesh	Columbia University; Columbia University; Columbia University; University of Massachusetts System; University of Massachusetts Amherst	Gamble, MV (corresponding author), Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY 10027 USA.	mvg7@columbia.edu		Peters, Brandilyn/0000-0002-1534-2578	National Institutes of Health [R01 ES017875, R01 ES011601, 5P30ES09089, R01 CA133595, 1 P42 ES10349]; NATIONAL CANCER INSTITUTE [R01CA133595] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010349, P30ES009089, R01ES017875, R01ES011601] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants R01 ES017875, R01 ES011601, 5P30ES09089, R01 CA133595, and 1 P42 ES10349 from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan H, 2006, J EXPO SCI ENV EPID, V16, P191, DOI 10.1038/sj.jea.7500449; Ahsan H, 2007, CANCER EPIDEM BIOMAR, V16, P1270, DOI 10.1158/1055-9965.EPI-06-0676; Barr DB, 2005, ENVIRON HEALTH PERSP, V113, P192, DOI 10.1289/ehp.7337; Basu A, 2011, ENVIRON HEALTH PERSP, V119, P1308, DOI 10.1289/ehp.1003393; Bera AK, 2011, HUM EXP TOXICOL, V30, P940, DOI 10.1177/0960327110384521; BOENIGER MF, 1993, AM IND HYG ASSOC J, V54, P615, DOI 10.1202/0002-8894(1993)054<0615:IOURUT>2.0.CO;2; Brosnan JT, 2011, AMINO ACIDS, V40, P1325, DOI 10.1007/s00726-011-0853-y; Brown CDA, 2008, TOXICOL APPL PHARM, V233, P428, DOI 10.1016/j.taap.2008.09.018; BROWN MM, 1976, J TOXICOL ENV HEALTH, V1, P505, DOI 10.1080/15287397609529349; BUCHET JP, 1981, INT ARCH OCC ENV HEA, V48, P71, DOI 10.1007/BF00405933; CHALLENGER F, 1945, CHEM REV, V36, P315, DOI 10.1021/cr60115a003; Challenger F., 1952, ADV ENZYMOLOGY RELAT, P429, DOI 10.1002/9780470122570.ch8; Chen JW, 2011, CHEMOSPHERE, V84, P17, DOI 10.1016/j.chemosphere.2011.02.091; Chen Y, 2013, ENVIRON HEALTH PERSP, V121, P832, DOI 10.1289/ehp.1205797; Chen Y, 2011, INT J EPIDEMIOL, V40, P828, DOI 10.1093/ije/dyr022; Chen Y, 2009, TOXICOL APPL PHARM, V239, P184, DOI 10.1016/j.taap.2009.01.010; Cheng Z, 2004, ANAL BIOANAL CHEM, V379, P512, DOI 10.1007/s00216-004-2618-x; Ciarimboli G, 2012, CLIN CANCER RES, V18, P1101, DOI 10.1158/1078-0432.CCR-11-2503; Drobna Z, 2009, CHEM RES TOXICOL, V22, P1713, DOI 10.1021/tx900179r; Eom SY, 2011, HUM EXP TOXICOL, V30, P1885, DOI 10.1177/0960327111402239; Gamble MV, 2006, AM J CLIN NUTR, V84, P1093, DOI 10.1093/ajcn/84.5.1093; Gamble MV, 2012, ENVIRON HEALTH PERSP, V120, pA145, DOI 10.1289/ehp.1104807; Gamble MV, 2005, ENVIRON HEALTH PERSP, V113, P1683, DOI 10.1289/ehp.8084; Gamble MV, 2005, ENVIRON HEALTH PERSP, V113, pA442, DOI 10.1289/ehp.113-a442a; Gamble MV, 2005, AM J CLIN NUTR, V81, P1372; GINSBURG JM, 1967, AM J PHYSIOL, V212, P1334, DOI 10.1152/ajplegacy.1967.212.6.1334; GINSBURG JM, 1965, AM J PHYSIOL, V208, P832, DOI 10.1152/ajplegacy.1965.208.5.832; GINSBURG JM, 1963, AM J PHYSIOL, V205, P707, DOI 10.1152/ajplegacy.1963.205.4.707; Halatek T, 2009, TOXICOL APPL PHARM, V239, P193, DOI 10.1016/j.taap.2009.04.022; Hall MN, 2012, J TOXICOL-US, V2012, DOI 10.1155/2012/595307; Hall MN, 2009, ENVIRON HEALTH PERSP, V117, P825, DOI 10.1289/ehp.0800164; Hawkesworth S, 2013, INT J EPIDEMIOL, V42, P176, DOI 10.1093/ije/dys215; Hsueh YM, 2009, AM J KIDNEY DIS, V54, P859, DOI 10.1053/j.ajkd.2009.06.016; Huda MN, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/267329; IARC (International Agency for Research on Cancer), 2012, REV HUM CARC ARS MET; Inker LA, 2012, NEW ENGL J MED, V367, P20, DOI 10.1056/NEJMoa1114248; Kielstein JT, 2008, KIDNEY BLOOD PRESS R, V31, P259, DOI 10.1159/000142725; Kile ML, 2009, ENVIRON HEALTH PERSP, V117, P455, DOI 10.1289/ehp.11251; Kinniburgh D., 2001, ARSENIC CONTAMINATIO; Kottgen A, 2008, AM J KIDNEY DIS, V51, P385, DOI 10.1053/j.ajkd.2007.11.019; LEVEY AS, 1988, ANNU REV MED, V39, P465, DOI 10.1146/annurev.me.39.020188.002341; Lewis DR, 1999, ENVIRON HEALTH PERSP, V107, P359, DOI 10.2307/3434539; Lin S, 2002, J BIOL CHEM, V277, P10795, DOI 10.1074/jbc.M110246200; Liu J, 2000, TOXICOLOGY, V147, P157, DOI 10.1016/S0300-483X(00)00194-3; Liu J, 2002, TOXICOLOGY, V170, P55, DOI 10.1016/S0300-483X(01)00532-7; Liu J, 2001, MOL PHARMACOL, V60, P302, DOI 10.1124/mol.60.2.302; Meliker JR, 2007, ENVIRON HEALTH-GLOB, V6, DOI 10.1186/1476-069X-6-4; Mudd SH, 2007, AM J CLIN NUTR, V85, P19, DOI 10.1093/ajcn/85.1.19; MUDD SH, 1975, METABOLISM, V24, P721, DOI 10.1016/0026-0495(75)90040-2; Mussap M, 2004, CRIT REV CL LAB SCI, V41, P467, DOI 10.1080/10408360490504934; Nermell B, 2008, ENVIRON RES, V106, P212, DOI 10.1016/j.envres.2007.08.005; NIXON DE, 1991, CLIN CHEM, V37, P1575; Nordberg GF, 2005, TOXICOL APPL PHARM, V206, P191, DOI 10.1016/j.taap.2004.11.028; Peraza MA, 2003, CELL BIOL TOXICOL, V19, P253, DOI 10.1023/B:CBTO.0000003970.60896.49; Pfeiffer CM, 2005, AM J CLIN NUTR, V82, P442, DOI 10.1093/ajcn/82.2.442; Pfeiffer CM, 1999, CLIN CHEM, V45, P290; Pilsner JR, 2009, ENVIRON HEALTH PERSP, V117, P254, DOI 10.1289/ehp.11872; Poreba R, 2011, TOXICOLOGY, V283, P88, DOI 10.1016/j.tox.2011.02.008; Prabu SM, 2012, MOL BIOL REP, V39, P11201, DOI 10.1007/s11033-012-2029-6; Reuter W, 2003, SPECIATION 5 ARSENIC; Silvera SAN, 2007, CANCER CAUSE CONTROL, V18, P7, DOI 10.1007/s10552-006-0057-z; Sinha Mahua, 2008, Pathophysiology, V15, P147, DOI 10.1016/j.pathophys.2008.03.001; SLOT C, 1965, SCAND J CLIN LAB INV, V17, P381, DOI 10.3109/00365516509077065; Smith AH, 2012, ENVIRON HEALTH PERSP, V120, P1527, DOI 10.1289/ehp.1104867; Stead LM, 2006, AM J CLIN NUTR, V83, P5; Stead LM, 2001, AM J PHYSIOL-ENDOC M, V281, pE1095, DOI 10.1152/ajpendo.2001.281.5.E1095; Steinmaus C, 2010, TOXICOL APPL PHARM, V247, P138, DOI 10.1016/j.taap.2010.06.006; Styblo M, 2002, ENVIRON HEALTH PERSP, V110, P767, DOI 10.1289/ehp.02110s5767; Swan SK, 1997, CLIN CHEM, V43, P913; Sweeney CJ, 2010, CANCER CHEMOTH PHARM, V66, P345, DOI 10.1007/s00280-009-1169-4; Thomas DJ, 2007, EXP BIOL MED, V232, P3; Tsai SM, 1999, ARCH ENVIRON HEALTH, V54, P186, DOI 10.1080/00039899909602258; Tseng CH, 2003, TOXICOL LETT, V137, P15, DOI 10.1016/S0378-4274(02)00377-6; TSUKAMOTO H, 1983, AM J VET RES, V44, P2324; Urakami Y, 2004, PHARM RES-DORDR, V21, P976, DOI 10.1023/B:PHAM.0000029286.45788.ad; Van Geen A, 2005, ENVIRON SCI TECHNOL, V39, P299, DOI 10.1021/es0491073; van Geen A, 2002, B WORLD HEALTH ORGAN, V80, P732; Van Geen A, 2007, J ENVIRON SCI HEAL A, V42, P1729, DOI 10.1080/10934520701564236; Wasserman GA, 2007, ENVIRON HEALTH PERSP, V115, P285, DOI 10.1289/ehp.9501; Wu Fen, 2014, Curr Environ Health Rep, V1, P148; Wyss M, 2000, PHYSIOL REV, V80, P1107, DOI 10.1152/physrev.2000.80.3.1107; Zheng Laura, 2014, Curr Environ Health Rep, V1, P192; Zheng LY, 2013, AM J KIDNEY DIS, V61, P385, DOI 10.1053/j.ajkd.2012.09.011; Zubairi Adnan Mustafa, 2008, J Pak Med Assoc, V58, P182	84	31	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113760	10.1371/journal.pone.0113760	http://dx.doi.org/10.1371/journal.pone.0113760			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438247	gold, Green Published, Green Submitted			2022-12-26	WOS:000347114900076
J	Li, YB; Wang, JX; Gao, X; Han, WH; Zheng, YX; Xu, H; Zhang, CL; He, QC; Zhang, LH; Li, ZX; Zhou, DM				Li, Yingbo; Wang, Jinxi; Gao, Xing; Han, Weihua; Zheng, Yongxiang; Xu, Huan; Zhang, Chuanling; He, Qiuchen; Zhang, Lihe; Li, Zhongxin; Zhou, Demin			c-Met Targeting Enhances the Effect of Irradiation and Chemical Agents against Malignant Colon Cells Harboring a KRAS Mutation	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; HEPATOCYTE GROWTH-FACTOR; K-RAS MUTATIONS; 1ST-LINE TREATMENT; RNA INTERFERENCE; GENE; PROGRESSION; ACTIVATION; INHIBITOR; CARCINOMA	Although EGFR-targeted therapy has been beneficial to colorectal cancer patients, several studies have showed this clinical benefit was restricted to patients with wild-type KRAS exon 2 colorectal cancer. Therefore, it is crucial to explore efficient treatment strategies in patients with KRAS mutations. c-Met is an emerging target for the development of therapeutics against colorectal cancer. In this study, we first used the SW620 cell line, which has an activating KRAS mutation, to generate a stable cell line with conditional regulation of c-Met, which is an essential gene for growth and an oncogene. Using this approach, we evaluated the benefits of combined c-Met-targeted therapy with irradiation or chemical agents. In this cell line, we observed that the proliferation and migration of SW620 cells were reduced by the induction of c-Met shRNA. Furthermore, c-Met knockdown enhanced the anti-proliferative effects of 5-FU and Taxol but not cisplatin, irinotecan or sorafenib. These enhancements were also observed in another colon cancer cells line HCT-116, which also has a KRAS mutation. The response of SW620 cells to irradiation was also enhanced by c-Met knockdown. This method and obtained data might have important implications for exploring the combinatory effects of targeted therapies with conventional medications. Moreover, the data suggested that the combination of c-Met-targeted therapy with chemotherapy or irradiation might be an effective strategy against colorectal cancer harboring a KRAS mutation.	[Li, Yingbo; Wang, Jinxi; Gao, Xing; Zheng, Yongxiang; Xu, Huan; Zhang, Chuanling; He, Qiuchen; Zhang, Lihe; Li, Zhongxin; Zhou, Demin] Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China; [Wang, Jinxi; Gao, Xing; Han, Weihua; Li, Zhongxin] Hebei Med Univ, Hosp 4, Dept Surg 2, Shijiazhuang, Hebei, Peoples R China; [Li, Yingbo; Zheng, Yongxiang; Zhang, Chuanling; He, Qiuchen; Zhang, Lihe; Zhou, Demin] Peking Univ, Sch Pharmaceut Sci, Beijing 100871, Peoples R China	Peking University; Hebei Medical University; Peking University	Li, ZX (corresponding author), Peking Univ, State Key Lab Nat & Biomimet Drugs, Beijing 100871, Peoples R China.	lizhongxin99@163.com; deminzhou@bjmu.edu.cn			National Basic Research Program of China (973 Program) [2010CB12300]; National Natural Science Foundation of China [20932001, 91029711, 81172332, 81301881]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program; Grant No. 2010CB12300) and the National Natural Science Foundation of China (Grants Nos. 20932001, 91029711, 81172332 and 81301881). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen J, 2012, INT J BIOCHEM CELL B, V44, P759, DOI 10.1016/j.biocel.2012.01.015; Chu E, 2012, CLIN COLORECTAL CANC, V11, P1, DOI 10.1016/j.clcc.2011.05.005; Conte P, 2012, CLIN BREAST CANCER, V12, P157, DOI 10.1016/j.clbc.2012.03.005; De Angelis PM, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-20; DIRENZO MF, 1995, CLIN CANCER RES, V1, P147; Douillard JY, 2010, J CLIN ONCOL, V28, P4697, DOI 10.1200/JCO.2009.27.4860; Folprecht G, 2010, LANCET ONCOL, V11, P38, DOI 10.1016/S1470-2045(09)70330-4; Fukuura T, 1998, BRIT J CANCER, V78, P454, DOI 10.1038/bjc.1998.514; Gridelli C, 2011, LUNG CANCER, V71, P249, DOI 10.1016/j.lungcan.2010.12.008; Han J, 2012, AUTOPHAGY, V8, P812, DOI 10.4161/auto.19471; Hannon GJ, 2004, NATURE, V431, P371, DOI 10.1038/nature02870; Iovine B, 2012, CANCER LETT, V315, P122, DOI 10.1016/j.canlet.2011.07.021; Jin X, 2012, NUCLEIC ACIDS RES, V40, P1797, DOI 10.1093/nar/gkr927; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kataoka H, 2000, CANCER RES, V60, P6148; Lesko E, 2008, FRONT BIOSCI-LANDMRK, V13, P1271, DOI 10.2741/2760; Li YB, 2011, PLANTA MED, V77, P354, DOI 10.1055/s-0030-1250385; Li YB, 2013, CANCER LETT, V340, P88, DOI 10.1016/j.canlet.2013.07.005; Liu XD, 2010, TRENDS MOL MED, V16, P37, DOI 10.1016/j.molmed.2009.11.005; McNeil C, 2008, J NATL CANCER I, V100, P1667, DOI 10.1093/jnci/djn429; Osada S, 2010, HEPATO-GASTROENTEROL, V57, P76; Skobeleva N, 2007, MOL CANCER THER, V6, P898, DOI 10.1158/1535-7163.MCT-06-0602; Stintzing S, 2012, ANN ONCOL, V23, P1693, DOI 10.1093/annonc/mdr571; Wen JH, 2007, BIOCHEM BIOPH RES CO, V358, P117, DOI 10.1016/j.bbrc.2007.04.098; Yu HL, 2012, BIOCHEM BIOPH RES CO, V427, P659, DOI 10.1016/j.bbrc.2012.09.117; Zhang J, 2007, RNA, V13, P1375, DOI 10.1261/rna.520707; Zhou DM, 2006, CURR TOP MED CHEM, V6, P901, DOI 10.2174/156802606777303630	27	8	8	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113186	10.1371/journal.pone.0113186	http://dx.doi.org/10.1371/journal.pone.0113186			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427200	Green Published, Green Submitted, gold			2022-12-26	WOS:000349145400037
J	Yang, HW; Kim, TM; Song, SS; Menon, L; Jiang, X; Huang, W; Black, PM; Park, PJ; Carroll, RS; Johnson, MD				Yang, H. W.; Kim, T-M; Song, S. S.; Menon, L.; Jiang, X.; Huang, W.; Black, P. M.; Park, P. J.; Carroll, R. S.; Johnson, M. D.			A small subunit processome protein promotes cancer by altering translation	ONCOGENE			English	Article							INTERNAL RIBOSOME ENTRY; MESSENGER-RNA; CHILDHOOD MEDULLOBLASTOMA; C-MYC; NEUROBLASTOMA; REVEALS; PROGRESSION; INHIBITION; BIOGENESIS; DEFECTS	Dysregulation of ribosome biogenesis or translation can promote cancer, but the underlying mechanisms remain unclear. UTP18 is a component of the small subunit processome, a nucleolar multi-protein complex whose only known function is to cleave pre-ribosomal RNA to yield the 18S ribosomal RNA component of 40S ribosomal subunits. Here, we show that UTP18 also alters translation to promote stress resistance and growth, and that UTP18 is frequently gained and overexpressed in cancer. We observed that UTP18 localizes to the cytoplasm in a subset of cells, and that serum withdrawal increases cytoplasmic UTP18 localization. Cytoplasmic UTP18 associates with the translation complex and Hsp90 to upregulate the translation of IRES-containing transcripts such as HIF1a, Myc and VEGF, thereby inducing stress resistance. Hsp90 inhibition decreases cytoplasmic UTP18 and UTP18-induced increases in translation. Importantly, elevated UTP18 expression correlates with increased aggressiveness and decreased survival in numerous cancers. Enforced UTP18 overexpression promotes transformation and tumorigenesis, whereas UTP18 knockdown inhibits these processes. This stress adaptation mechanism is thus co-opted for growth by cancers, and its inhibition may represent a promising new therapeutic target.	[Yang, H. W.; Song, S. S.; Menon, L.; Jiang, X.; Huang, W.; Black, P. M.; Carroll, R. S.; Johnson, M. D.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurosurg, Boston, MA 02115 USA; [Kim, T-M; Park, P. J.] Harvard Univ, Ctr Biomed Informat, Sch Med, Boston, MA 02115 USA; [Johnson, M. D.] Dana Farber Brigham & Womens Canc Ctr, Program Neurooncol, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Johnson, MD (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA.	mjohnson27@partners.org			Brain Science Foundation; Santos Family Foundation; National Institute of Neurological Disorders and Stroke [R01 NS062219]; NIH [DP2 OD002319]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062219] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002319] Funding Source: NIH RePORTER	Brain Science Foundation; Santos Family Foundation; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a Brain Science Foundation Research Award, the Santos Family Foundation, a Hagerty Fund Research Award, R01 NS062219 from the National Institute of Neurological Disorders and Stroke and an NIH Director's New Innovator Award (DP2 OD002319) to MDJ.	Belin S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007147; Bernstein KA, 2004, EUKARYOT CELL, V3, P1619, DOI 10.1128/EC.3.6.1619-1626.2004; Bert AG, 2006, RNA, V12, P1074, DOI 10.1261/rna.2320506; Calabrese C, 2003, J BIOL CHEM, V278, P24951, DOI 10.1074/jbc.M211600200; Chen QR, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-70; De Preter K, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r84; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Del Prete MJ, 2007, RNA, V13, P414, DOI 10.1261/rna.79407; Fichelson P, 2009, NAT CELL BIOL, V11, P685, DOI 10.1038/ncb1874; Goda N, 2012, INT J HEMATOL, V95, P457, DOI 10.1007/s12185-012-1069-y; Goutagny S, 2010, CLIN CANCER RES, V16, P4155, DOI 10.1158/1078-0432.CCR-10-0891; Holzel M, 2010, J BIOL CHEM, V285, P6364, DOI 10.1074/jbc.M109.054734; Jackson SE, 2013, TOP CURR CHEM, V328, P155, DOI 10.1007/128_2012_356; Kang J, 2006, ANTICANCER RES, V26, P1903; Kim H, 2010, P NATL ACAD SCI USA, V107, P2183, DOI 10.1073/pnas.0909896107; Kim TM, 2013, GENOME RES, V23, P217, DOI 10.1101/gr.140301.112; Kim TM, 2011, CANCER RES, V71, P3387, DOI 10.1158/0008-5472.CAN-10-4117; Lang KJD, 2002, MOL BIOL CELL, V13, P1792, DOI 10.1091/mbc.02-02-0017; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Nanbru C, 1997, J BIOL CHEM, V272, P32061, DOI 10.1074/jbc.272.51.32061; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Pan E, 2005, CLIN CANCER RES, V11, P4733; Pisa V, 2009, GENE, V432, P67, DOI 10.1016/j.gene.2008.11.025; Reardon DA, 1997, CANCER RES, V57, P4042; Sasaki T, 2010, CANCER RES, V70, P10038, DOI 10.1158/0008-5472.CAN-10-2956; Schleiermacher G, 2007, BRIT J CANCER, V97, P238, DOI 10.1038/sj.bjc.6603820; Shi YJ, 2005, J BIOL CHEM, V280, P10964, DOI 10.1074/jbc.M407874200; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Spriggs KA, 2008, BIOL CELL, V100, P27, DOI 10.1042/BC20070098; Stein I, 1998, MOL CELL BIOL, V18, P3112, DOI 10.1128/MCB.18.6.3112; Suzuki Y, 2009, J BIOL CHEM, V284, P35597, DOI 10.1074/jbc.M109.036285; Ujino S, 2012, VIRUS RES, V163, P390, DOI 10.1016/j.virusres.2011.10.003; van Riggelen J, 2010, NAT REV CANCER, V10, P301, DOI 10.1038/nrc2819; Willimott S, 2010, BIOCHEM SOC T, V38, P1571, DOI 10.1042/BST0381571	35	8	8	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 20	2015	34	34					4471	4481		10.1038/onc.2014.376	http://dx.doi.org/10.1038/onc.2014.376			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CP9BR	25435373				2022-12-26	WOS:000360189200006
J	Bartkowiak, B; Greenleaf, AL				Bartkowiak, Bartlomiej; Greenleaf, Arno L.			Expression, Purification, and Identification of Associated Proteins of the Full-length hCDK12/CyclinK Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYMERASE-II CTD; TERMINAL REPEAT DOMAIN; P-TEFB; RNA; KINASE; PHOSPHORYLATION; TRANSCRIPTION; FLAVOPIRIDOL; SPECIFICITY; SUBUNIT	The coupling of transcription and associated processes has been shown to be dependent on the RNA polymerase II (RNA-PII) C-terminal repeat domain (CTD) and the phosphorylation of the heptad repeats of which it is composed (consensus sequence Y1S2P3T4S5P6S7). Two primary S-2 position CTD kinases have been identified in higher eukaryotes: P-TEFb and CDK12/CyclinK. The more recently discovered CDK12 appears to act at the 3'-end of the transcription unit and has been identified as a tumor suppressor for ovarian cancer; however much is still unknown about the in vivo roles of CDK12/CyclinK. In an effort to further characterize these roles we have purified to near homogeneity and characterized, full-length, active, human CDK12/CyclinK, and identified hCDK12-associated proteins via mass spectrometry. We find that employing a "2A" peptide-linked multicistronic construct containing CDK12 and CyclinK results in the efficient production of active, recombinant enzyme in the baculovirus/Sf9 expression system. Using GST-CTD fusion protein substrates we find that CDK12/CyclinK prefers a substrate with unmodified repeats or one that mimics prephosphorylation at the S-7 position of the CTD; also the enzyme is sensitive to the inhibitor flavopiridol at higher concentrations. Identification of CDK12-associating proteins reveals a strong enrichment for RNA-processing factors suggesting that CDK12 affects RNA processing events in two distinct ways: Indirectly through generating factor-binding phos-pho-epitopes on the CTD of elongating RNAPII and directly through binding to specific factors.	[Bartkowiak, Bartlomiej; Greenleaf, Arno L.] Duke Univ, Med Ctr, Dept Biochem, Durham, NC 27710 USA	Duke University	Greenleaf, AL (corresponding author), Duke Univ, Med Ctr, 0034 CARL Bldg, Durham, NC 27710 USA.	arno@duke.edu			National Institutes of Health [GM040505]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040505] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported, in whole or in part, by Grant GM040505 from the National Institutes of Health (to A. L. G.).	Bartkowiak B, 2011, GENET RES INT, V2011, DOI 10.4061/2011/623718; Bartkowiak B, 2011, TRANSCR-AUSTIN, V2, P115, DOI 10.4161/trns.2.3.15004; Bartkowiak B, 2010, GENE DEV, V24, P2303, DOI 10.1101/gad.1968210; Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121; Blazek D, 2011, GENE DEV, V25, P2158, DOI 10.1101/gad.16962311; Blethrow Justin, 2004, Curr Protoc Mol Biol, VChapter 18, DOI 10.1002/0471142727.mb1811s66; Bosken CA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4505; Carey Michael F, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5330; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Cheng SWG, 2012, MOL CELL BIOL, V32, P4691, DOI 10.1128/MCB.06267-11; Corden JL, 2013, CHEM REV, V113, P8423, DOI 10.1021/cr400158h; Czudnochowski N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1846; Davidson L, 2014, GENE DEV, V28, P342, DOI 10.1101/gad.231274.113; Edwards MC, 1998, MOL CELL BIOL, V18, P4291, DOI 10.1128/MCB.18.7.4291; Eick D, 2013, CHEM REV, V113, P8456, DOI 10.1021/cr400071f; Eifler T.T., 2014, MOL CELL BIOL, DOI [10.1128/MCB.01157-14, DOI 10.1128/MCB.01157-14]; Garriga J, 1996, BIOCHEM J, V319, P293, DOI 10.1042/bj3190293; Garriga J, 2010, J CELL PHYSIOL, V222, P200, DOI 10.1002/jcp.21938; Harlow E., 1999, USING ANTIBODIES LAB; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hsin JP, 2012, GENE DEV, V26, P2119, DOI 10.1101/gad.200303.112; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Jones JC, 2004, J BIOL CHEM, V279, P24957, DOI 10.1074/jbc.M402218200; Joshi PM, 2014, J BIOL CHEM, V289, P9247, DOI 10.1074/jbc.M114.551143; Ko TK, 2001, J CELL SCI, V114, P2591; Larochelle S, 2012, NAT STRUCT MOL BIOL, V19, P1108, DOI 10.1038/nsmb.2399; LEE JM, 1989, P NATL ACAD SCI USA, V86, P3624, DOI 10.1073/pnas.86.10.3624; Leroy D, 1996, FEBS LETT, V379, P217, DOI 10.1016/0014-5793(95)01514-0; Loyer P, 2005, CELL SIGNAL, V17, P1033, DOI 10.1016/j.cellsig.2005.02.005; Morris DP, 1997, METHODS, V12, P264, DOI 10.1006/meth.1997.0478; Patturajan M, 1998, J BIOL CHEM, V273, P4689, DOI 10.1074/jbc.273.8.4689; Schmerwitz UK, 2011, ARTERIOSCL THROM VAS, V31, P280, DOI 10.1161/ATVBAHA.110.213934; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; Singh G, 2012, CELL, V151, P750, DOI 10.1016/j.cell.2012.10.007; Szymczak-Workman Andrea L, 2012, Cold Spring Harb Protoc, V2012, P199, DOI 10.1101/pdb.ip067876; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Werner-Allen JW, 2011, J BIOL CHEM, V286, P5717, DOI 10.1074/jbc.M110.197129; Zhang Y, 2011, BIOCHEM J, V434, P435, DOI 10.1042/BJ20101471; Zhong XY, 2009, MOL CELL, V35, P1, DOI 10.1016/j.molcel.2009.06.016	40	35	36	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1786	1795		10.1074/jbc.M114.612226	http://dx.doi.org/10.1074/jbc.M114.612226			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25429106	Green Published, hybrid			2022-12-26	WOS:000348056400043
J	Chen, JQ; Shu, TJ; Lv, ZB; Nie, ZM; Chen, J; Chen, H; Yu, W; Gai, QJ; Zhang, YZ				Chen, Jianqing; Shu, Tejun; Lv, Zhengbing; Nie, Zuoming; Chen, Jian; Chen, Hao; Yu, Wei; Gai, Qijing; Zhang, Yaozhou			Purification and Functional Characterization of a Protein: Bombyx mori Human Growth Hormone Like Protein in Silkworm Pupa	PLOS ONE			English	Article							PROLACTIN-LIKE; SUBSTANCE; CELLS; K562	Human growth hormone (hGH) is a peptide hormone secreted by eosinophils of the human anterior pituitary, and a regulatory factor for a variety of metabolic pathways. A 30-kD protein from the pupa stage of silkworm was detected by Western blotting and confirmed by immunoprecipitation based on its ability to bind to anti-hGH antibody. This protein, named BmhGH-like protein, was purified from fresh silkworm pupas through low-temperature homogenization, filtration, and centrifugation to remove large impurity particles. The supernatants were precipitated, resuspended, and passed through a molecular sieve. Further purification by affinity chromatography and two-dimensional electrophoresis resulted in pure protein for analysis by MS MALDI-TOF-MS analysis. An alignment with predicted proteins indicated that BmhGH-like protein consisted of two lipoproteins, which we named hGH-L1 and hGH-L2. These proteins belong to the beta-trefoil superfamily, with beta domains similar to the spatial structure of hGH. Assays with K562 cells demonstrated that these proteins could promote cell division in vitro. To further validate the growth-promoting effects, hGH-L2 was cloned from pupa cDNA to create recombinant silkworm baculovirus vBmNPV-hGH-L2, which was used to infect silkworm BmN cells at low titer. Flow cytometric analysis demonstrated that the protein shortened the G0/G1 phase of the cells, and enabled the cells to rapidly traverse the G1/S phase transition point to enter S phase and promote cell division. Discovery of hGH-like protein in silkworm will once again arouse people's interest in the potential medicinal value of silkworm and establish the basis for the development of new hormone drugs.	[Chen, Jianqing; Shu, Tejun; Lv, Zhengbing; Nie, Zuoming; Chen, Jian; Chen, Hao; Yu, Wei; Gai, Qijing; Zhang, Yaozhou] Zhejiang Sci Tech Univ, Coll Life Sci, Zhejiang Prov Key Lab Silkworm Bioreactor & Biome, Hangzhou 310018, Zhejiang, Peoples R China; [Zhang, Yaozhou] Tianjin Univ, Coll Pharm, Tianjin 300073, Peoples R China	Zhejiang Sci-Tech University; Tianjin University	Zhang, YZ (corresponding author), Zhejiang Sci Tech Univ, Coll Life Sci, Zhejiang Prov Key Lab Silkworm Bioreactor & Biome, Hangzhou 310018, Zhejiang, Peoples R China.	18822001388@126.com			National High Technology Research and Development Program [2011AA100603, 2012ZX09102301-009]; National Basic Research Program of China [2012CB114600]	National High Technology Research and Development Program(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by financial grants from the National High Technology Research and Development Program (No. 2011AA100603), the National Basic Research Program of China (No. 2012CB114600), the National High Technology Research and Development Program (No. 2012ZX09102301-009). The authors would like to thank the Bombyx mori Bioreactor Pharmaceutical Platform of Tianjin International Joint Academy of Biomedicine in the experimental sites and experimental equipment support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen DH, 2000, CHINESE J IMMUNOLOGY, V16, P651; EMMART EW, 1968, GEN COMP ENDOCR, V11, P515, DOI 10.1016/0016-6480(68)90066-X; Gallardo WG, 2006, FISHERIES SCI, V72, P781, DOI 10.1111/j.1444-2906.2006.01218.x; GAUWERKY C, 1980, J CLIN ENDOCR METAB, V51, P1208, DOI 10.1210/jcem-51-5-1208; KAPLAN GW, 1967, J UROLOGY, V97, P494, DOI 10.1016/S0022-5347(17)63067-2; Lan HL, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/306462; LECHAN RM, 1981, ENDOCRINOLOGY, V109, P1950, DOI 10.1210/endo-109-6-1950; Lin Ling CG, 2006, CHINESE J TRADITIONA, V17, P1556; Obermayr RP, 2003, GERONTOLOGY, V49, P191, DOI 10.1159/000069175; Ominato K, 2002, ZOOL SCI, V19, P1055, DOI 10.2108/zsj.19.1055; Peng HW, 2013, EUR J PHARMACOL, V718, P459, DOI 10.1016/j.ejphar.2013.07.038; SOMERS W, 1994, NATURE, V372, P478, DOI 10.1038/372478a0; SWINNEN K, 1990, COMP BIOCHEM PHYS A, V95, P373, DOI 10.1016/0300-9629(90)90235-K; Yang JP, 2011, J STRUCT BIOL, V175, P97, DOI 10.1016/j.jsb.2011.04.003	14	1	2	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114351	10.1371/journal.pone.0114351	http://dx.doi.org/10.1371/journal.pone.0114351			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469649	Green Published, gold, Green Submitted			2022-12-26	WOS:000349128700103
J	Klemetti, EW; Clynne, MA				Klemetti, Erik W.; Clynne, Michael A.			Localized Rejuvenation of a Crystal Mush Recorded in Zircon Temporal and Compositional Variation at the Lassen Volcanic Center, Northern California	PLOS ONE			English	Article							MAGMATIC EVOLUTION; TRACE-ELEMENT; THERMAL REJUVENATION; SPIRIT MOUNTAIN; SIERRA-NEVADA; CRUSTAL; CONSTRAINTS; TIMESCALES; BATHOLITH; RHYOLITES	Zircon ages and trace element compositions from recent silicic eruptions in the Lassen Volcanic Center (LVC) allow for an evaluation of the timing and conditions of rejuvenation (reheating and mobilization of crystals) within the LVC magmatic system. The LVC is the southernmost active Cascade volcano and, prior to the 1980 eruption of Mount St. Helens, was the site of the only eruption in the Cascade arc during the last century. The three most recent silicic eruptions from the LVC were very small to moderate-sized lava flows and domes of dacite (1915 and 27 ka eruptions of Lassen Peak) and rhyodacite (1.1 ka eruption of Chaos Crags). These eruptions produced mixed and mingled lavas that contain a diverse crystal cargo, including zircon. U-238-Th-230 model ages from interior and surface analyses of zircon reveal ages from similar to 17 ka to secular equilibrium (>350 ka), with most zircon crystallizing during a period between similar to 60-200 ka. These data support a model for localized rejuvenation of crystal mush beneath the LVC. This crystal mush evidently is the remnant of magmatism that ended similar to 190 ka. Most zircon are thought to have been captured from "cold storage" in the crystal mush (670-725 degrees C, Hf.10,000 ppm, Eu/Eu* 0.25-0.4) locally remobilized by intrusion of mafic magma. A smaller population of zircon (>730 degrees C, Hf <10,000 ppm, Eu/Eu*>0.4) grew in, and are captured from, rejuvenation zones. These data suggest the dominant method to produce eruptible melt within the LVC is small-scale, local rejuvenation of the crystal mush accompanied by magma mixing and mingling. Based on zircon stability, the time required to heat, erupt and then cool to background conditions is relatively short, lasting a maximum of 10 s-1000 s years. Rejuvenation events in the LVC are ephemeral and permit eruption within an otherwise waning and cooling magmatic body.	[Klemetti, Erik W.] Denison Univ, Dept Geosci, Granville, OH 43023 USA; [Clynne, Michael A.] US Geol Survey, Volcano Sci Ctr, Menlo Pk, CA 94025 USA	Denison University; United States Department of the Interior; United States Geological Survey	Klemetti, EW (corresponding author), Denison Univ, Dept Geosci, Granville, OH 43023 USA.	klemettie@denison.edu		Klemetti, Erik/0000-0002-0539-979X	National Science Foundation (EAR) [1250323]; Denison University Anderson Scholarship; Directorate For Geosciences [1250256] Funding Source: National Science Foundation	National Science Foundation (EAR); Denison University Anderson Scholarship; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	National Science Foundation (EAR # 1250323 to EWK) http://www.nsf.gov/. Denison University Anderson Scholarship (to EWK) http://www.denison.edu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann O, 2007, J VOLCANOL GEOTH RES, V167, P1, DOI 10.1016/j.jvolgeores.2007.08.002; Bachmann O, 2004, J PETROL, V45, P1565, DOI 10.1093/petrology/egh019; Bachmann O, 2002, J PETROL, V43, P1469, DOI 10.1093/petrology/43.8.1469; Bacon CR, 2005, EARTH PLANET SC LETT, V233, P277, DOI 10.1016/j.epsl.2005.02.012; Barth AP, 2013, GEOLOGY, V41, P223, DOI 10.1130/G33619.1; BENZ HM, 1992, J GEOPHYS RES-SOL EA, V97, P4791, DOI 10.1029/92JB00067; BERGE PA, 1987, J GEOPHYS RES-SOLID, V92, P10571, DOI 10.1029/JB092iB10p10571; Boehnke P, 2013, CHEM GEOL, V351, P324, DOI 10.1016/j.chemgeo.2013.05.028; BULLEN TD, 1990, J GEOPHYS RES-SOLID, V95, P19671, DOI 10.1029/JB095iB12p19671; Chamberlain KJ, 2014, CONTRIB MINERAL PETR, V168, DOI 10.1007/s00410-014-1034-2; Christiansen RL, 2002, GEOLOGIC MAP LASSEN; Claiborne LL, 2010, GEOLOGY, V38, P1011, DOI 10.1130/G31285.1; Claiborne LL, 2010, CONTRIB MINERAL PETR, V160, P511, DOI 10.1007/s00410-010-0491-5; Clynne M, 2001, VOLCANO HAZARDS LASS; Clynne M. A., 2012, VOLCANO HAZARDS ASSE; Clynne M.A., 2010, GEOLOGIC MAP LASSEN, DOI [10.3133/sim2899, DOI 10.3133/SIM2899]; Clynne MA, 1999, J PETROL, V40, P105, DOI 10.1093/petrology/40.1.105; CLYNNE MA, 1990, J GEOPHYS RES-SOLID, V95, P19651, DOI 10.1029/JB095iB12p19651; Clynne MA, 2008, MAJOR EDXRF TRACE EL; Cole JW, 2014, EARTH-SCI REV, V128, P1, DOI 10.1016/j.earscirev.2013.10.008; Cooper K.M., 2008, VOLCANO REKINDLED 1, P827; Cooper KM, 2014, NATURE, V506, P480, DOI 10.1038/nature12991; Feeley TC, 2008, J PETROL, V49, P971, DOI 10.1093/petrology/egn013; Ferry JM, 2007, CONTRIB MINERAL PETR, V154, P429, DOI 10.1007/s00410-007-0201-0; Ghiorso MS, 2013, CONTRIB MINERAL PETR, V165, P73, DOI 10.1007/s00410-012-0792-y; Girard G, 2009, J PETROL, V50, P2095, DOI 10.1093/petrology/egp070; Glazner AF, 2008, GEOLOGY, V36, P183, DOI 10.1130/G24496A.1; Grunder AL, 2006, T ROY SOC EDIN-EARTH, V97, P415, DOI 10.1017/S0263593300001541; Gualda GAR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037492; Guffanti M, 1996, J GEOPHYS RES-SOL EA, V101, P3003, DOI 10.1029/95JB03463; Klemetti EW, 2014, GEOSPHERE, V10, P66, DOI 10.1130/GES00920.1; Klemetti EW, 2011, EARTH PLANET SC LETT, V305, P185, DOI 10.1016/j.epsl.2011.02.054; Lanphere MA, 2004, QUATERNARY RES, V62, P94, DOI 10.1016/j.yqres.2004.03.001; Lipman PW, 2007, GEOSPHERE, V3, P42, DOI 10.1130/GES00061.1; Matthews NE, 2012, J PETROL, V53, P1385, DOI 10.1093/petrology/egs020; Mazdab FK, 2006, GEOCHIM COSMOCHIM AC, V70, pA405, DOI 10.1016/j.gca.2006.06.817; Memeti V, 2010, GEOL SOC AM BULL, V122, P1912, DOI 10.1130/B30004.1; Molloy C, 2008, J GEOL SOC LONDON, V165, P435, DOI 10.1144/0016-76492007-071; Murphy MD, 2000, J PETROL, V41, P21, DOI 10.1093/petrology/41.1.21; Newman S, 1983, 230TH 238U DISEQUILI; Paterson SR, 2009, GEOSPHERE, V5, P496, DOI 10.1130/GES00214.1; Putirka KD, 2008, MINERAL INCLUSIONS V; Quinn ET, 2014, EXPT DETERMINATION P; Reid MR, 1997, EARTH PLANET SC LETT, V150, P27, DOI 10.1016/S0012-821X(97)00077-0; Rusk BG, 2014, GEOL SOC AM ANN M PR; SHERROD DR, 1990, J GEOPHYS RES-SOLID, V95, P19465, DOI 10.1029/JB095iB12p19465; Stelten ME, 2012, EARTH PLANET SC LETT, V313, P1, DOI 10.1016/j.epsl.2011.10.035; Storm S, 2012, CONTRIB MINERAL PETR, V163, P505, DOI 10.1007/s00410-011-0682-8; Storm S, 2011, EARTH PLANET SC LETT, V301, P511, DOI 10.1016/j.epsl.2010.11.034; Trimble DA, 1984, 84371 USGS; Vazquez JA, 2004, SCIENCE, V305, P991, DOI 10.1126/science.1096994; Walker BA, 2007, J VOLCANOL GEOTH RES, V167, P239, DOI 10.1016/j.jvolgeores.2006.12.008; Walker BA, 2010, GEOLOGY, V38, P1007, DOI 10.1130/G31226.1; Watson EB, 1996, T ROY SOC EDIN-EARTH, V87, P43, DOI 10.1017/S0263593300006465; Watts KE, 2012, CONTRIB MINERAL PETR, V164, P45, DOI 10.1007/s00410-012-0724-x; Wiebe RA, 2004, J PETROL, V45, P2133, DOI 10.1093/petrology/egh050; Zellmer GF, 2005, J VOLCANOL GEOTH RES, V140, P171, DOI 10.1016/j.jvolgeores.2004.07.020; Zellmer GF, 2003, J PETROL, V44, P1413, DOI 10.1093/petrology/44.8.1413	58	57	58	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113157	10.1371/journal.pone.0113157	http://dx.doi.org/10.1371/journal.pone.0113157			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470726	Green Published, gold, Green Submitted			2022-12-26	WOS:000349128700015
J	McGraw, KL; Basiorka, AA; Johnson, JO; Clark, J; Caceres, G; Padron, E; Heaton, R; Ozawa, Y; Wei, S; Sokol, L; List, AF				McGraw, Kathy L.; Basiorka, Ashley A.; Johnson, Joseph O.; Clark, Justine; Caceres, Gisela; Padron, Eric; Heaton, Ruth; Ozawa, Yukiyasu; Wei, Sheng; Sokol, Lubomir; List, Alan F.			Lenalidomide Induces Lipid Raft Assembly to Enhance Erythropoietin Receptor Signaling in Myelodysplastic Syndrome Progenitors	PLOS ONE			English	Article							DESTRUCTION; DEGRADATION; ACTIVATION; CEREBLON; TARGET; IKAROS; STAT5	Anemia remains the principal management challenge for patients with lower risk Myelodysplastic Syndromes (MDS). Despite appropriate cytokine production and cellular receptor display, erythropoietin receptor (EpoR) signaling is impaired. We reported that EpoR signaling is dependent upon receptor localization within lipid raft microdomains, and that disruption of raft integrity abolishes signaling capacity. Here, we show that MDS erythroid progenitors display markedly diminished raft assembly and smaller raft aggregates compared to normal controls (p=0.005, raft number; p=0.023, raft size). Because lenalidomide triggers raft coalescence in T-lymphocytes promoting immune synapse formation, we assessed effects of lenalidomide on raft assembly in MDS erythroid precursors and UT7 cells. Lenalidomide treatment rapidly induced lipid raft formation accompanied by EpoR recruitment into raft fractions together with STAT5, JAK2, and Lyn kinase. The JAK2 phosphatase, CD45, a key negative regulator of EpoR signaling, was displaced from raft fractions. Lenalidomide treatment prior to Epo stimulation enhanced both JAK2 and STAT5 phosphorylation in UT7 and primary MDS erythroid progenitors, accompanied by increased STAT5 DNA binding in UT7 cells, and increased erythroid colony forming capacity in both UT7 and primary cells. Raft induction was associated with F-actin polymerization, which was blocked by Rho kinase inhibition. These data indicate that deficient raft integrity impairs EpoR signaling, and provides a novel strategy to enhance EpoR signal fidelity in non-del(5q) MDS.	[McGraw, Kathy L.; Clark, Justine; Padron, Eric; Sokol, Lubomir; List, Alan F.] H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL 33612 USA; [Basiorka, Ashley A.] Univ S Florida, H Lee Moffitt Canc Ctr, Dept Malignant Hematol, Canc Biol PhD Program, Tampa, FL 33612 USA; [Johnson, Joseph O.] H Lee Moffitt Canc Ctr & Res Inst, Analyt Microscopy Core Facil, Tampa, FL 33612 USA; [Caceres, Gisela] H Lee Moffitt Canc Ctr & Res Inst, Morsani Mol Diagnost Lab, Tampa, FL 33612 USA; [Heaton, Ruth] Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA; [Ozawa, Yukiyasu] Japanese Red Cross Nagoya First Hosp, Dept Hematol, Nakamura Ku, Aichi 4538511, Japan; [Wei, Sheng] H Lee Moffitt Canc Ctr & Res Inst, Dept Immunol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; University of Arizona; Red Cross Nagoya Daiichi Hospital; H Lee Moffitt Cancer Center & Research Institute	List, AF (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, 12902 Magnolia Dr, Tampa, FL 33612 USA.	Alan.List@moffitt.org		LIST, ALAN/0000-0002-1647-2972	National Institutes of Health [R01 CA131076]; NATIONAL CANCER INSTITUTE [T32CA115308, R01CA131076, P30CA076292] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded through National Institutes of Health grant number R01 CA131076 and generous support provided by Martin Schaffel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Deng SS, 2014, CELL ADHES MIGR, V8, P49, DOI 10.4161/cam.27480; Ebert BL, 2008, PLOS MED, V5, P312, DOI 10.1371/journal.pmed.0050035; Eisenmann KM, 2007, J BIOL CHEM, V282, P25152, DOI 10.1074/jbc.M703243200; Fuhler GM, 2007, J LEUKOCYTE BIOL, V81, P449, DOI 10.1189/jlb.0506311; Gandhi AK, 2014, BRIT J HAEMATOL, V164, P811, DOI 10.1111/bjh.12708; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hoefsloot LH, 1997, BLOOD, V89, P1690, DOI 10.1182/blood.V89.5.1690.1690_1690_1700; Huang M, 2002, ONCOGENE, V21, P8804, DOI 10.1038/sj.onc.1206028; Ito T, 2010, SCIENCE, V327, P1345, DOI 10.1126/science.1177319; Jobling MG, 2002, INFECT IMMUN, V70, P1260, DOI 10.1128/IAI.70.3.1260-1271.2002; Kabouridis PS, 2008, FEBS LETT, V582, P3711, DOI 10.1016/j.febslet.2008.10.006; Kronke J, 2014, SCIENCE, V343, P301, DOI 10.1126/science.1244851; List A, 2005, NEW ENGL J MED, V352, P549, DOI 10.1056/NEJMoa041668; List A, 2006, NEW ENGL J MED, V355, P1456, DOI 10.1056/NEJMoa061292; Lopez-Girona A, 2012, LEUKEMIA, V26, P2326, DOI 10.1038/leu.2012.119; Lou ZK, 2001, J IMMUNOL, V167, P5749, DOI 10.4049/jimmunol.167.10.5749; Lu G, 2014, SCIENCE, V343, P305, DOI 10.1126/science.1244917; McGraw KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034477; MERRITT EA, 1994, PROTEIN SCI, V3, P166; Narla A, 2011, BLOOD, V118, P2296, DOI 10.1182/blood-2010-11-318543; Padron E, 2013, BLOOD, V121, P5068, DOI 10.1182/blood-2012-10-460170; Raza A, 2008, BLOOD, V111, P86, DOI 10.1182/blood-2007-01-068833; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Sundaravel S, 2012, BLOOD, V120, DOI 10.1182/blood.V120.21.924.924; Toma A, 2013, J CLIN ONCOL S, V15, P7002; Torrino S, 2011, DEV CELL, V21, P959, DOI 10.1016/j.devcel.2011.08.015; Wei S, 2012, ONCOGENE; Wu SD, 2009, MOL CELL, V35, P735, DOI 10.1016/j.molcel.2009.09.012; Xavier R, 1998, IMMUNITY, V8, P723, DOI 10.1016/S1074-7613(00)80577-4; Xu YB, 2009, BLOOD, V114, P338, DOI 10.1182/blood-2009-02-200543; Zhou L, 2011, J BIOL CHEM, V286, P25211, DOI 10.1074/jbc.M111.235028	31	18	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114249	10.1371/journal.pone.0114249	http://dx.doi.org/10.1371/journal.pone.0114249			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469886	gold, Green Submitted, Green Published			2022-12-26	WOS:000349128700092
J	Tudor, CS; Bruns, H; Daniel, C; Distel, LV; Hartmann, A; Gerbitz, A; Buettner, MJ				Tudor, Christiane Silke; Bruns, Heiko; Daniel, Christoph; Distel, Luitpold Valentin; Hartmann, Arndt; Gerbitz, Armin; Buettner, Maike Julia			Macrophages and Dendritic Cells as Actors in the Immune Reaction of Classical Hodgkin Lymphoma	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; COLONY-STIMULATING FACTOR; REED-STERNBERG CELLS; ANTICANCER EFFECTOR FUNCTION; HUMAN BREAST-CANCER; EPSTEIN-BARR-VIRUS; MOLECULAR-MECHANISMS; TUMORICIDAL ACTIVITY; NECROSIS-FACTOR; GROWTH-FACTOR	Background: The inflammatory infiltrate plays a pivotal role in classical Hodgkin lymphoma (cHL). Here, we focussed on the role of macrophages (M Phi) and dendritic cells (DC). Methods: M Phi and DC infiltration was investigated in 106 cHL specimens using immunohistochemistry and cytokine expression was analyzed in a subset by realtime PCR. Human peripheral blood-derived monocytes, DC, M Phi stimulated with GM-CSF (M Phi(GM-CSF), pro-inflammatory M Phi-1-model) or M-CSF (M Phi(M-CSF), immunomodulatory M Phi-2-model) were incubated with cHL cell line (L1236, HDLM2) supernatants (SN). DC maturation or M Phi polarization were investigated by flow cytometry. Furthermore, the impact of DC or M Phi on cHL cell proliferation was analyzed by BrdU/CFSE assay. Results: In cHL tissues mature myeloid (m) DC and M Phi predominated. High numbers of CD83+ mDC and low numbers of CD163+ M Phi were associated with improved disease specific survival. In numerous cHL specimens increased levels of both pro-and anti-inflammatory cytokines and of IL13 and GM-CSF were observed compared to reactive lymphadenopathies. Maturation of DC and induction and maintenance of an immunomodulatory M Phi phenotype were promoted by SN derived from cHL cell lines. TNF alpha neutralization in SN resulted in a significant inhibition of mDC maturation. DC and pro-inflammatory M Phi inhibited the proliferation of cHL cells. Conclusion: Adopting an immunomodulatory phenotype is a potential mechanism for how MW promote immune evasion in cHL. Mature DC, in contrast, might participate in antitumoral immunity.	[Tudor, Christiane Silke; Daniel, Christoph; Buettner, Maike Julia] Univ Erlangen Nurnberg, Inst Pathol, Univ Hosp Erlangen, Dept Nephropathol, D-91054 Erlangen, Germany; [Bruns, Heiko; Gerbitz, Armin] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Univ Hosp, Dept Hematol & Oncol, D-91054 Erlangen, Germany; [Distel, Luitpold Valentin] Univ Erlangen Nurnberg, Univ Hosp, Univ Hosp Erlangen, Dept Radiat Oncol, D-91054 Erlangen, Germany; [Hartmann, Arndt] Univ Erlangen Nurnberg, Univ Hosp Erlangen, Inst Pathol, D-91054 Erlangen, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg	Buettner, MJ (corresponding author), Univ Erlangen Nurnberg, Inst Pathol, Univ Hosp Erlangen, Dept Nephropathol, D-91054 Erlangen, Germany.	maike.buettner@uk-erlangen.de	Daniel, Christoph/AAK-2136-2021; Distel, Luitpold/ABD-9880-2020	Distel, Luitpold/0000-0002-8040-3226; Daniel, Christoph/0000-0002-6803-4755	GRK1071 Viruses of the Immune System of the Deutsche Forschungsgemeinschaft, Germany; ELAN Fond of the University Hospital of Erlangen, Germany; Bavarian Equal Opportunities Sponsorship - Forderung von Frauen in Forschung und Lehre (FFL) - Promotion Equal Opportunities for Women in Research and Teaching of the University of Erlangen, Germany; BayImmunNet consortium of the Government of Bavaria; Deutsche Forschungsgemeinschaft; Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	GRK1071 Viruses of the Immune System of the Deutsche Forschungsgemeinschaft, Germany; ELAN Fond of the University Hospital of Erlangen, Germany; Bavarian Equal Opportunities Sponsorship - Forderung von Frauen in Forschung und Lehre (FFL) - Promotion Equal Opportunities for Women in Research and Teaching of the University of Erlangen, Germany; BayImmunNet consortium of the Government of Bavaria; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU)	MJB and CST were supported by the GRK1071 Viruses of the Immune System of the Deutsche Forschungsgemeinschaft, Germany, the ELAN Fond of the University Hospital of Erlangen, Germany and the Bavarian Equal Opportunities Sponsorship - Forderung von Frauen in Forschung und Lehre (FFL) - Promotion Equal Opportunities for Women in Research and Teaching of the University of Erlangen, Germany. HB was supported by the BayImmunNet consortium of the Government of Bavaria. The authors also acknowledge support by Deutsche Forschungsgemeinschaft and Friedrich-Alexander-Universitat Erlangen-Nurnberg (FAU) within the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou AG, 2013, J ENVIRON PATHOL TOX, V32, P289, DOI 10.1615/JEnvironPatholToxicolOncol.2013007930; Akila P, 2012, CLIN CHIM ACTA, V413, P669, DOI 10.1016/j.cca.2012.01.028; Azambuja D, 2012, ANN ONCOL, V23, P736, DOI 10.1093/annonc/mdr157; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Barros MHM, 2012, CLIN CANCER RES, V18, P3762, DOI 10.1158/1078-0432.CCR-12-0129; Benharroch D, 2010, VIRCHOWS ARCH, V457, P63, DOI 10.1007/s00428-010-0931-7; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Biswas SK, 2008, J IMMUNOL, V180, P2011, DOI 10.4049/jimmunol.180.4.2011; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Bohmann K, 2009, CLIN CHEM, V55, P1719, DOI 10.1373/clinchem.2008.122572; Brower V, 2005, J NATL CANCER I, V97, P1175, DOI 10.1093/jnci/dji269; Chetaille B, 2009, BLOOD, V113, P2765, DOI 10.1182/blood-2008-07-168096; COPPLESON LW, 1973, JNCI-J NATL CANCER I, V51, P379; Coventry BJ, 2003, BRIT J CANCER, V89, P533, DOI 10.1038/sj.bjc.6601114; Coventry BJ, 2002, BRIT J CANCER, V86, P546, DOI 10.1038/sj.bjc.6600132; Demoulin S, 2013, J LEUKOCYTE BIOL, V93, P343, DOI 10.1189/jlb.0812397; Dinarello CA, 2006, CANCER METAST REV, V25, P307, DOI 10.1007/s10555-006-9000-8; Dufresne M, 2011, MOL IMMUNOL, V48, P1556, DOI 10.1016/j.molimm.2011.04.022; Elgert KD, 1998, J LEUKOCYTE BIOL, V64, P275, DOI 10.1002/jlb.64.3.275; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Gottfried E, 2008, CYTOKINE GROWTH F R, V19, P65, DOI 10.1016/j.cytogfr.2007.10.008; GRABSTEIN KH, 1986, SCIENCE, V232, P506, DOI 10.1126/science.3083507; Griffith TS, 1999, J EXP MED, V189, P1343, DOI 10.1084/jem.189.8.1343; Harris JA, 2012, DIAGN PATHOL, V7, DOI 10.1186/1746-1596-7-12; HSU PL, 1991, INT J HEMATOL, V54, P315; Inoshima N, 2002, CLIN CANCER RES, V8, P3480; Ishigami S, 2003, ONCOL REP, V10, P1237; Ishii H, 2012, INT J CANCER, V130, P48, DOI 10.1002/ijc.25969; Iwamoto M, 2003, INT J CANCER, V104, P92, DOI 10.1002/ijc.10915; Janjic BM, 2002, J IMMUNOL, V168, P1823, DOI 10.4049/jimmunol.168.4.1823; Jones K, 2013, CLIN CANCER RES, V19, P731, DOI 10.1158/1078-0432.CCR-12-2693; Kamper P, 2011, HAEMATOL-HEMATOL J, V96, P269, DOI 10.3324/haematol.2010.031542; Kapp U, 1999, J EXP MED, V189, P1939, DOI 10.1084/jem.189.12.1939; Kim R, 2007, IMMUNOLOGY, V121, P149, DOI 10.1111/j.1365-2567.2007.02579.x; KLEIN S, 1992, HEMATOL ONCOL, V10, P319, DOI 10.1002/hon.2900100605; Laoui D, 2011, INT J DEV BIOL, V55, P861, DOI 10.1387/ijdb.113371dl; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Lu GW, 2002, J IMMUNOL, V168, P1831, DOI 10.4049/jimmunol.168.4.1831; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Murdoch C, 2004, BLOOD, V104, P2224, DOI 10.1182/blood-2004-03-1109; Natoli A, 2013, INT J CANCER, V133, P1945, DOI 10.1002/ijc.28189; PAIETTA E, 1990, CANCER RES, V50, P2049; REE HJ, 1985, CANCER, V56, P333, DOI 10.1002/1097-0142(19850715)56:2<333::AID-CNCR2820560222>3.0.CO;2-0; REED SG, 1987, J EXP MED, V166, P1734, DOI 10.1084/jem.166.6.1734; Rogers TL, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-177; Sanchez-Espiridion B, 2012, HAEMATOL-HEMATOL J, V97, P1080, DOI 10.3324/haematol.2011.055459; Sica A, 2000, J IMMUNOL, V164, P762, DOI 10.4049/jimmunol.164.2.762; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Skinnider BF, 2002, BLOOD, V99, P618, DOI 10.1182/blood.V99.2.618; Steidl C, 2011, J CLIN ONCOL, V29, P1812, DOI 10.1200/JCO.2010.32.8401; Steidl C, 2010, NEW ENGL J MED, V362, P875, DOI 10.1056/NEJMoa0905680; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Tan KL, 2012, BLOOD, V120, P3280, DOI 10.1182/blood-2012-04-421057; Tsutsui S, 2005, ONCOL REP, V14, P425; Tudor CS, 2013, HUM PATHOL, V44, P2475, DOI 10.1016/j.humpath.2013.06.006; Vanderheyde N, 2004, IMMUNOL LETT, V91, P99, DOI 10.1016/j.imlet.2003.11.011; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Williams MA, 1997, BRIT J HAEMATOL, V98, P960, DOI 10.1046/j.1365-2141.1997.2923108.x; Wolf J, 1996, BLOOD, V87, P3418, DOI 10.1182/blood.V87.8.3418.bloodjournal8783418; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yoon DH, 2012, EUR J HAEMATOL, V88, P292, DOI 10.1111/j.1600-0609.2011.01731.x; Yung L, 2003, LANCET, V361, P943, DOI 10.1016/S0140-6736(03)12777-8; Zaki MAA, 2011, VIRCHOWS ARCH, V459, P361, DOI 10.1007/s00428-011-1140-8; ZHOU LJ, 1995, J IMMUNOL, V154, P3821	65	24	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114345	10.1371/journal.pone.0114345	http://dx.doi.org/10.1371/journal.pone.0114345			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470820	gold, Green Submitted, Green Published			2022-12-26	WOS:000349128700101
J	Mosca, E; Alfieri, R; Milanesi, L				Mosca, Ettore; Alfieri, Roberta; Milanesi, Luciano			Diffusion of Information throughout the Host Interactome Reveals Gene Expression Variations in Network Proximity to Target Proteins of Hepatitis C Virus	PLOS ONE			English	Article							DISCOVERY; LIVER; INHIBITION; INTERFERON; INITIATION; INFECTION; PACKAGE; AP-1	Hepatitis C virus infection is one of the most common and chronic in the world, and hepatitis associated with HCV infection is a major risk factor for the development of cirrhosis and hepatocellular carcinoma (HCC). The rapidly growing number of viral-host and host protein-protein interactions is enabling more and more reliable network-based analyses of viral infection supported by omics data. The study of molecular interaction networks helps to elucidate the mechanistic pathways linking HCV molecular activities and the host response that modulates the stepwise hepatocarcinogenic process from preneoplastic lesions (cirrhosis and dysplasia) to HCC. Simulating the impact of HCV-host molecular interactions throughout the host protein-protein interaction (PPI) network, we ranked the host proteins in relation to their network proximity to viral targets. We observed that the set of proteins in the neighborhood of HCV targets in the host interactome is enriched in key players of the host response to HCV infection. In opposition to HCV targets, subnetworks of proteins in network proximity to HCV targets are significantly enriched in proteins reported as differentially expressed in preneoplastic and neoplastic liver samples by two independent studies. Using multi-objective optimization, we extracted subnetworks that are simultaneously "guilt-by-association" with HCV proteins and enriched in proteins differentially expressed. These subnetworks contain established, recently proposed and novel candidate proteins for the regulation of the mechanisms of liver cells response to chronic HCV infection.	[Mosca, Ettore; Alfieri, Roberta; Milanesi, Luciano] CNR, Inst Biomed Technol, Milan, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Tecnologie Biomediche (ITB-CNR)	Mosca, E (corresponding author), CNR, Inst Biomed Technol, Milan, Italy.	ettore.mosca@itb.cnr.it	Mosca, Ettore/D-6275-2017; Mosca, Ettore/H-8694-2013; Milanesi, Luciano/AAE-7230-2019; Alfieri, Roberta/AAX-5553-2020	Mosca, Ettore/0000-0002-3102-5150; Mosca, Ettore/0000-0002-3102-5150; Milanesi, Luciano/0000-0002-1201-3939; Alfieri, Roberta/0000-0001-6922-9696	Italian Ministry of Education and Research through the Flagship InterOmics project [PB05]; Italian Ministry of Education and Research through HIRMA project [RBAP11YS7K]; European MIMOmics project [305280]	Italian Ministry of Education and Research through the Flagship InterOmics project; Italian Ministry of Education and Research through HIRMA project; European MIMOmics project	The work has been supported by the Italian Ministry of Education and Research through the Flagship InterOmics (PB05) and HIRMA (RBAP11YS7K) projects, and the European MIMOmics (305280) project to LM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Banerjee A, 2010, VIRUSES-BASEL, V2, P2108, DOI 10.3390/v2092108; Barrett T, 2009, NUCLEIC ACIDS RES, V37, pD885, DOI 10.1093/nar/gkn764; Bauer-Mehren A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020284; Behnke MK, 2014, ANN HEPATOL, V13, P45, DOI 10.1016/S1665-2681(19)30903-2; Bieche I, 2005, VIROLOGY, V332, P130, DOI 10.1016/j.virol.2004.11.009; Chau TKH, 2000, LIFE SCI, V67, P1719, DOI 10.1016/S0024-3205(00)00757-8; Chen H, 2014, WORLD J GASTROENTERO, V20, P8681, DOI 10.3748/wjg.v20.i26.8681; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; de Chassey B, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.66; De Las Rivas J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000807; Dolan PT, 2013, MOL BIOSYST, V9, P3199, DOI 10.1039/c3mb70343f; Drozdov I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035510; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Feranchak AP, 2004, GASTROENTEROLOGY, V127, P903, DOI 10.1053/j.gastro.2004.06.047; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Gulbahce N, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002531; Haw R, 2011, PROTEOMICS, V11, P3598, DOI 10.1002/pmic.201100066; He B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018516; Hermjakob H, 2004, NUCLEIC ACIDS RES, V32, pD452, DOI 10.1093/nar/gkh052; Hofree M, 2013, NAT METHODS, V10, P1108, DOI [10.1038/NMETH.2651, 10.1038/nmeth.2651]; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iorio F, 2010, P NATL ACAD SCI USA, V107, P14621, DOI 10.1073/pnas.1000138107; Itsui Y, 2009, HEPATOLOGY, V50, P1727, DOI 10.1002/hep.23195; Ivanov AA, 2013, TRENDS PHARMACOL SCI, V34, P393, DOI 10.1016/j.tips.2013.04.007; Jackson MA, 2006, TOXICOL SCI, V90, P400, DOI 10.1093/toxsci/kfj101; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kumar R, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S6-S16; Kwofie SK, 2011, INFECT GENET EVOL, V11, P1971, DOI 10.1016/j.meegid.2011.09.001; Lin SY, 2008, CLIN CANCER RES, V14, P4814, DOI 10.1158/1078-0432.CCR-07-5262; Maass T, 2010, CURR GENOMICS, V11, P261, DOI 10.2174/138920210791233063; Marshall A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059459; Mas VR, 2009, MOL MED, V15, P85, DOI 10.2119/molmed.2008.00110; Matteucci C, 2014, HEPATOL RES, V44, P1008, DOI 10.1111/hepr.12239; Milroy LG, 2014, CHEM REV, V114, P4695, DOI 10.1021/cr400698c; Min LH, 2012, NAT CELL BIOL, V14, P1203, DOI 10.1038/ncb2590; Morgan RL, 2013, ANN INTERN MED, V158, P329, DOI 10.7326/0003-4819-158-5-201303050-00005; Mosca E, 2013, MOL BIOSYST, V9, P2971, DOI 10.1039/c3mb70327d; Mukhopadhyay A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094029; Navratil V, 2009, NUCLEIC ACIDS RES, V37, pD661, DOI 10.1093/nar/gkn794; Parisi GF, 2013, HEPAT MON, V13, DOI 10.5812/hepatmon.11215; Pramhas S, 2010, ANTIVIR THER, V15, P831, DOI 10.3851/IMP1654; Qian Y, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S1-S6; Raphael BJ, 2013, NAT METHODS, V10, P1077, DOI 10.1038/nmeth.2704; Rehermann B, 2009, J CLIN INVEST, V119, P1745, DOI 10.1172/JCI39133; Shlomai A, 2014, SEMIN CANCER BIOL, V26, P78, DOI 10.1016/j.semcancer.2014.01.004; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Steuer R. E., 1986, MULTIPLE CRITERIA OP; Stokes ME, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-282; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tran G, 2008, BIOSCIENCE HORIZONS, V1, P167, DOI DOI 10.1093/BIOHORIZONS/HZN020; Tripathi LP, 2010, MOL BIOSYST, V6, P2539, DOI 10.1039/c0mb00103a; Vanunu O, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000641; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Wang PI, 2010, J PROTEOMICS, V73, P2277, DOI 10.1016/j.jprot.2010.07.005; Wang X, 2011, BIOINFORMATICS, V27, P879, DOI 10.1093/bioinformatics/btr028; Wei L, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S1-S13; Wilson CL, 2005, BIOINFORMATICS, V21, P3683, DOI 10.1093/bioinformatics/bti605; Wurmbach E, 2007, HEPATOLOGY, V45, P938, DOI 10.1002/hep.21622; Xiao YF, 2014, BIOINFORMATICS, V30, P801, DOI 10.1093/bioinformatics/btr671; Zender L, 2010, J HEPATOL, V52, P921, DOI 10.1016/j.jhep.2009.12.034; Zhao H, 1996, VIROLOGY, V220, P330, DOI 10.1006/viro.1996.0321; Zheng SY, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-62; Zhou Dengyong, 2003, ADV NEURAL INFORM PR, V16; Zhu ZW, 2010, J MED VIROL, V82, P239, DOI 10.1002/jmv.21644	67	9	9	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113660	10.1371/journal.pone.0113660	http://dx.doi.org/10.1371/journal.pone.0113660			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461596	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700042
J	Xiao, ZS; Cao, L; Liang, YJ; Huang, JS; Stern, AR; Dallas, M; Johnson, M; Quarles, LD				Xiao, Zhousheng; Cao, Li; Liang, Yingjuan; Huang, Jinsong; Stern, Amber Rath; Dallas, Mark; Johnson, Mark; Quarles, Leigh Darryl			Osteoblast-Specific Deletion of Pkd2 Leads to Low-Turnover Osteopenia and Reduced Bone Marrow Adiposity	PLOS ONE			English	Article							POLYCYSTIC KIDNEY-DISEASE; MECHANICAL-PROPERTIES; IMAGE-ANALYSIS; HIPPO PATHWAY; RUNX2-II; GROWTH; TAZ; YAP; DIFFERENTIATION; SKELETOGENESIS	Polycystin-1 (Pkd1) interacts with polycystin-2 (Pkd2) to form an interdependent signaling complex. Selective deletion of Pkd1 in the osteoblast lineage reciprocally regulates osteoblastogenesis and adipogenesis. The role of Pkd2 in skeletal development has not been defined. To this end, we conditionally inactivated Pkd2 in mature osteoblasts by crossing Osteocalcin (Oc)-Cre; Pkd2(+/null) mice with floxed Pkd2 (Pkd2(flox/flox)) mice. Oc-Cre; Pkd2(flox/null) (Pkd2(Oc-cKO)) mice exhibited decreased bone mineral density, trabecular bone volume, cortical thickness, mineral apposition rate and impaired biomechanical properties of bone. Pkd2 deficiency resulted in diminished Runt-related transcription factor 2 (Runx2) expressions in bone and impaired osteoblastic differentiation ex vivo. Expression of osteoblast-related genes, including, Osteocalcin, Osteopontin, Bone sialoprotein (Bsp), Phosphate-regulating gene with homologies to endopeptidases on the X chromosome (Phex), Dentin matrix protein 1 (Dmp1), Sclerostin (Sost), and Fibroblast growth factor 23 (FGF23) were reduced proportionate to the reduction of Pkd2 gene dose in bone of Oc-Cre;Pkd2(flox/+) and Oc-Cre; Pkd2(flox/null) mice. Loss of Pkd2 also resulted in diminished peroxisome proliferator-activated receptor gamma (PPAR gamma) expression and reduced bone marrow fat in vivo and reduced adipogenesis in osteoblast culture ex vivo. Transcriptional co-activator with PDZ-binding motif (TAZ) and Yes-associated protein (YAP), reciprocally acting as co-activators and co-repressors of Runx2 and PPAR gamma, were decreased in bone of Oc-Cre; Pkd2(flox/null) mice. Thus, Pkd1 and Pkd2 have coordinate effects on osteoblast differentiation and opposite effects on adipogenesis, suggesting that Pkd1 and Pkd2 signaling pathways can have independent effects on mesenchymal lineage commitment in bone.	[Xiao, Zhousheng; Cao, Li; Liang, Yingjuan; Huang, Jinsong; Quarles, Leigh Darryl] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38165 USA; [Stern, Amber Rath; Dallas, Mark; Johnson, Mark] Univ Missouri, Dept Oral Biol, Sch Dent, Kansas City, MO 64108 USA; [Stern, Amber Rath] Engn Syst Inc, Charlotte, NC 28227 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Missouri System; University of Missouri Kansas City	Quarles, LD (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38165 USA.	dquarles@uthsc.edu		Quarles, L. Darryl/0000-0002-5082-7896; Stern, Amber/0000-0002-1013-8818; xiao, zhousheng/0000-0002-3363-5673	National Institutes of Health [R01-DK083303]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049712] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083303] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by grant R01-DK083303 to LDQ from the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragona M, 2013, CELL, V154, P1047, DOI 10.1016/j.cell.2013.07.042; Aref M, 2013, BONE, V56, P449, DOI 10.1016/j.bone.2013.07.009; Chen SN, 2014, CIRC RES, V114, P454, DOI 10.1161/CIRCRESAHA.114.302810; Dai B, 2012, KIDNEY INT, V82, P1061, DOI 10.1038/ki.2012.222; Dai B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044161; Diez-Perez A, 2010, J BONE MINER RES, V25, P1877, DOI 10.1002/jbmr.73; Doube M, 2010, BONE, V47, P1076, DOI 10.1016/j.bone.2010.08.023; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Gallant MA, 2013, BONE, V53, P301, DOI 10.1016/j.bone.2012.12.015; Gumbiner BM, 2014, J CELL SCI, V127, P709, DOI 10.1242/jcs.140103; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Hanaoka K, 2000, NATURE, V408, P990, DOI 10.1038/35050128; Happe H, 2011, J PATHOL, V224, P133, DOI 10.1002/path.2856; Harris P.C., 1993, GENEREVIEWS; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Jung H, 2009, BIOCHEM PHARMACOL, V78, P1323, DOI 10.1016/j.bcp.2009.07.001; Khonsari RH, 2013, HUM MOL GENET, V22, P1873, DOI 10.1093/hmg/ddt041; Kim I, 2009, J AM SOC NEPHROL, V20, P2556, DOI 10.1681/ASN.2009030271; Low BC, 2014, FEBS LETT; Mekahli D, 2013, PEDIATR NEPHROL, V28, P2089, DOI 10.1007/s00467-012-2384-5; Mesner LD, 2014, J CLIN INVEST; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2006, J AM SOC NEPHROL, V17, P1015, DOI 10.1681/ASN.2005080830; Pavik I, 2012, CLIN J AM SOC NEPHRO, V7, P248, DOI 10.2215/CJN.09020911; Pavik I, 2011, KIDNEY INT, V79, P234, DOI 10.1038/ki.2010.375; Qian F, 1997, NAT GENET, V16, P179, DOI 10.1038/ng0697-179; Qiu N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046038; Qiu N, 2012, J CELL SCI, V125, P1945, DOI 10.1242/jcs.095893; Qiu N, 2012, J CELL BIOCHEM, V113, P967, DOI 10.1002/jcb.23426; Qiu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015240; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Spichtig D, 2014, KIDNEY INT, V85, P1340, DOI 10.1038/ki.2013.526; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Tsiokas L, 1997, P NATL ACAD SCI USA, V94, P6965, DOI 10.1073/pnas.94.13.6965; Westendorf JJ, 2006, J CELL BIOCHEM, V98, P54, DOI 10.1002/jcb.20805; Wu GQ, 2000, NAT GENET, V24, P75, DOI 10.1038/71724; Xiao Z, 2008, J BIOL CHEM; Xiao ZS, 2007, J BONE MINER RES, V22, pS41; Xiao ZS, 2008, J BIOL CHEM, V283, P12624, DOI 10.1074/jbc.M710407200; Xiao ZS, 2006, J BIOL CHEM, V281, P30884, DOI 10.1074/jbc.M604772200; Xiao ZS, 2011, FASEB J, V25, P2418, DOI 10.1096/fj.10-180299; Xiao ZS, 2010, J BIOL CHEM, V285, P1177, DOI 10.1074/jbc.M109.050906; Xiao ZS, 2005, DEV BIOL, V283, P345, DOI 10.1016/j.ydbio.2005.04.028; Xiao ZS, 2004, J BIOL CHEM, V279, P20307, DOI 10.1074/jbc.M401109200; Yang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056585; Yu FX, 2013, GENE DEV, V27, P1223, DOI 10.1101/gad.219402.113; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yu Y, 2009, P NATL ACAD SCI USA, V106, P11558, DOI 10.1073/pnas.0903684106; Zaidi SK, 2004, EMBO J, V23, P790, DOI 10.1038/sj.emboj.7600073; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhu J, 2011, P NATL ACAD SCI USA, V108, P10133, DOI 10.1073/pnas.1017669108	51	24	25	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114198	10.1371/journal.pone.0114198	http://dx.doi.org/10.1371/journal.pone.0114198			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464512	Green Published, Green Submitted, gold			2022-12-26	WOS:000345869700115
J	Ainy, E; Soori, H; Ganjali, M; Le, H; Baghfalaki, T				Ainy, Elaheh; Soori, Hamid; Ganjali, Mojtaba; Le, Henry; Baghfalaki, Taban			Estimating Cost of Road Traffic Injuries in Iran Using Willingness to Pay (WTP) Method	PLOS ONE			English	Article							STATISTICAL LIFE; SAFETY; RISK	We aimed to use the willingness to pay (WTP) method to calculate the cost of traffic injuries in Iran in 2013. We conducted a cross-sectional questionnaire-based study of 846 randomly selected road users. WTP data was collected for four scenarios for vehicle occupants, pedestrians, vehicle drivers, and motorcyclists. Final analysis was carried out using Weibull and maximum likelihood method. Mean WTP was 2,612,050 Iranian rials (IRR). Statistical value of life was estimated according to 20,408 fatalities 402,314,106,073,648 IRR (US$13,410,470,202 based on purchasing power parity at (February 27th, 2014). Injury cost was US$25,637,870,872 (based on 318,802 injured people in 2013, multiple daily traffic volume of 311, and multiple daily payment of 31,030 IRR for 250 working days). The total estimated cost of injury and death cases was 39,048,341,074$. Gross national income of Iran was, US$604,300,000,000 in 2013 and the costs of traffic injuries constituted 6.46% of gross national income. WTP was significantly associated with age, gender, monthly income, daily payment, more payment for time reduction, trip mileage, drivers and occupants from road users. The costs of traffic injuries in Iran in 2013 accounted for 6.64% of gross national income, much higher than the global average. Policymaking and resource allocation to reduce traffic-related death and injury rates have the potential to deliver a huge economic benefit.	[Ainy, Elaheh; Soori, Hamid] Univ Med Sci, Safety Promot & Injury Prevent Res Ctr Shahid Beh, Tehran, Iran; [Ganjali, Mojtaba; Baghfalaki, Taban] Shahid Beheshti Univ, Fac Math Sci, Dept Stat, Tehran, Iran; [Le, Henry] Transport Modeling AECOM, Melbourne, Vic, Australia	Tehran University of Medical Sciences; Shahid Beheshti University	Soori, H (corresponding author), Univ Med Sci, Safety Promot & Injury Prevent Res Ctr Shahid Beh, Tehran, Iran.	hsoori@yahoo.com	Ainy, Elaheh/AAX-2567-2021; Baghfalaki, Taban/R-7017-2019	Ainy, Elaheh/0000-0002-6423-0310	Rahvar Research Center of NAJA	Rahvar Research Center of NAJA	Funding: Funding provided by Traffic Police of Iran (Rahvar Research Center of NAJA) funded the research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abelson, 2008, ESTABLISHING MONETAR; Antoniou C, 2014, EUR TRANSP RES REV, V6, P31, DOI 10.1007/s12544-013-0103-3; Belin MA, 2012, INT J INJ CONTROL SA, V19, P171, DOI 10.1080/17457300.2011.635213; Bhattacharya S, 2007, J RISK UNCERTAINTY, V34, P21, DOI 10.1007/s11166-006-9002-5; Chhotu AK., 2014, INT J CIVIL ENG RES, V5, P407; de Blaeij A, 2003, ACCIDENT ANAL PREV, V35, P973, DOI 10.1016/S0001-4575(02)00105-7; Dionne G, 2004, J TRANSP ECON POLICY, V38, P247; Gibson J, 2007, WORLD DEV, V35, P512, DOI 10.1016/j.worlddev.2006.05.003; Hensher DA, 2009, TRANSPORT RES A-POL, V43, P692, DOI 10.1016/j.tra.2009.06.001; Hiselius L, 2003, VALUE ROAD RAILWAY S; Hultkrantz L, 2012, HEALTH POLICY, V108, P302, DOI 10.1016/j.healthpol.2012.09.007; Jennings, 2000, J INSURANCE ISSUES, V23, P180; Khosravi A, 2013, MORTALITY PROFILE IR; Le H., 2011, 34 AUSTR TRANSP RES; Leon G, 2013, TRANSPORTATION CHOIC; Litman T, 2007, VALUING TRANSIT SERV; Litman T, 2010, MORE COMPREHENSIVE M; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; McMahon K., 2008, TRUE COST ROAD CRASH; Ministry of Science Research and Technology of Science and Technology University Transportation research center, 2012, THEOR APPL; Organization W. H., 2013, WHO GLOB STAT REP RO; Peden M., 2004, WORLD REPORT ROAD TR; Perovic J, 2009, P 13 ROAD ENG ASS AS, P23; Perovic J, 2008, AUSTR ROAD SAF RES P; Pitel S. G. A., 2013, ESTIMATING NUMBER CO; Rahimi-Movaghar V, 2009, INT J INJ CONTROL SA, V16, P179, DOI 10.1080/17457300903024277; Thailand National Sentinel Injury Surveillance Program, 2007, NCD EP; Trawen A, 2001, INT C TRAFF SAF 3 CO; van Wee B, 2013, TRANSPORTATION, V40, P295, DOI 10.1007/s11116-012-9425-6; Wang Yan, 2008, Journal of Tongji University (Natural Science), V36, P47; WHO, 2011, GLOBAL BURDEN DIS	31	31	31	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112721	10.1371/journal.pone.0112721	http://dx.doi.org/10.1371/journal.pone.0112721			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AX7SK	25438150	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900015
J	Albrecht, L; Angeletti, D; Moll, K; Blomqvist, K; Valentini, D; D'Alexandri, FL; Maurer, M; Wahlgren, M				Albrecht, Letusa; Angeletti, Davide; Moll, Kirsten; Blomqvist, Karin; Valentini, Davide; D'Alexandri, Fabio Luiz; Maurer, Markus; Wahlgren, Mats			B-Cell Epitopes in NTS-DBL1 alpha of PfEMP1 Recognized by Human Antibodies in Rosetting Plasmodium falciparum	PLOS ONE			English	Article							BRAIN ENDOTHELIAL-CELLS; RED-BLOOD-CELLS; INFECTED ERYTHROCYTES; VAR GENES; VARIANT ANTIGENS; ACQUIRED-IMMUNITY; CEREBRAL MALARIA; BINDING; EXPRESSION; CHILDREN	Plasmodium falciparum is the most lethal of the human malaria parasites. The virulence is associated with the capacity of the infected red blood cell (iRBC) to sequester inside the deep microvasculature where it may cause obstruction of the blood-flow when binding is excessive. Rosetting, the adherence of the iRBC to uninfected erythrocytes, has been found associated with severe malaria and found to be mediated by the NTS-DBL1 alpha-domain of Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1). Here we show that the reactivity of plasma of Cameroonian children with the surface of the FCR3S1.2-iRBC correlated with the capacity to disrupt rosettes and with the antibody reactivity with a recombinant PfEMP1 (NTS-DBL1 alpha of IT4(var60)) expressed by parasite FCR3S1.2. The plasma-reactivity in a microarray, consisting of 96 overlapping 15-mer long peptides covering the NTS-DBL1 alpha domain from IT4var60 sequence, was compared with their capacity to disrupt rosettes and we identified five peptides where the reactivity were correlated. Three of the peptides were localized in subdomain-1 and 2. The other two peptide-sequences were localized in the NTS-domain and in subdomain-3. Further, principal component analysis and orthogonal partial least square analysis generated a model that supported these findings. In conclusion, human antibody reactivity with short linear-peptides of NTS-DBL1 alpha of PfEMP1 suggests subdomains 1 and 2 to hold anti-rosetting epitopes recognized by anti-rosetting antibodies. The data suggest rosetting to be mediated by the variable areas of PfEMP1 but also to involve structurally relatively conserved areas of the molecule that may induce biologically active antibodies.	[Albrecht, Letusa; Angeletti, Davide; Moll, Kirsten; Blomqvist, Karin; Wahlgren, Mats] Karolinska Inst, Dept Microbiol Tumor & Cell Biol MTC, Stockholm, Sweden; [Valentini, Davide; Maurer, Markus] Karolinska Inst, Dept Lab Med, Therapeut Immunol TIM, Stockholm, Sweden; [Valentini, Davide; Maurer, Markus] Karolinska Univ Hosp, CAST, Huddinge, Sweden; [D'Alexandri, Fabio Luiz] Univ Estadual Campinas, Dept Biochem, Campinas, SP, Brazil	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Universidade Estadual de Campinas	Albrecht, L (corresponding author), Univ Fed Sao Paulo, UNIFESP, Sao Paulo, Brazil.	letusaa@gmail.com; mats.wahlgren@ki.se	Albrecht, Letusa/I-1837-2012; Angeletti, Davide/H-7350-2019	Albrecht, Letusa/0000-0001-6406-2057; Angeletti, Davide/0000-0002-5256-1972	Swedish Research Council (VR); Swedish Academy of Sciences (KVA, Soderberg Foundation); Karolinska Institutet-DPA; EU Network of Excellence EviMalar	Swedish Research Council (VR)(Swedish Research Council); Swedish Academy of Sciences (KVA, Soderberg Foundation); Karolinska Institutet-DPA; EU Network of Excellence EviMalar	Funding: This work was supported by Swedish Research Council (VR), The Swedish Academy of Sciences (KVA, Soderberg Foundation), Karolinska Institutet-DPA and the EU Network of Excellence EviMalar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht L, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-17; Angeletti D, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-32; Angeletti D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050758; [Anonymous], 2008, METHODS MALARIA RES; Avril M, 2012, P NATL ACAD SCI USA, V109, pE1782, DOI 10.1073/pnas.1120534109; Avril M, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-36; Blomqvist K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052679; Bull PC, 2007, MOL BIOCHEM PARASIT, V154, P98, DOI 10.1016/j.molbiopara.2007.03.011; Bull PC, 2005, PLOS PATHOG, V1, P202, DOI 10.1371/journal.ppat.0010026; CARLSON J, 1994, BLOOD, V84, P3909, DOI 10.1182/blood.V84.11.3909.bloodjournal84113909; CARLSON J, 1990, LANCET, V336, P1457, DOI 10.1016/0140-6736(90)93174-N; Chan JA, 2012, J CLIN INVEST, V122, P3227, DOI 10.1172/JCI62182; Chen QJ, 2000, J EXP MED, V192, P1, DOI 10.1084/jem.192.1.1; Chen QJ, 2004, VACCINE, V22, P2701, DOI 10.1016/j.vaccine.2004.02.015; Chen QJ, 1998, NATURE, V394, P392, DOI 10.1038/28660; Chootong P, 2010, INFECT IMMUN, V78, P1089, DOI 10.1128/IAI.01036-09; Claessens A, 2012, P NATL ACAD SCI USA, V109, pE1772, DOI 10.1073/pnas.1120461109; Dodoo D, 2001, INFECT IMMUN, V69, P3713, DOI 10.1128/IAI.69.6.3713-3718.2001; Fernandez V, 1998, INFECT IMMUN, V66, P2969, DOI 10.1128/IAI.66.6.2969-2975.1998; Flick K, 2004, MOL BIOCHEM PARASIT, V134, P3, DOI 10.1016/j.molbiopara.2003.09.010; Flick K, 2001, SCIENCE, V293, P2098, DOI 10.1126/science.1062891; Gaseitsiwe S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003840; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gething PW, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-378; Ghumra A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002665; Giha HA, 1999, INFECT IMMUN, V67, P4092, DOI 10.1128/IAI.67.8.4092-4098.1999; Giha HA, 1999, PARASITOLOGY, V119, P7, DOI 10.1017/S0031182099004485; Gupta S, 1999, NAT MED, V5, P340, DOI 10.1038/6560; Heddini A, 2001, INFECT IMMUN, V69, P5849, DOI 10.1128/IAI.69.9.5849-5856.2001; Jensen ATR, 2004, J EXP MED, V199, P1179, DOI 10.1084/jem.20040274; Juillerat A, 2011, P NATL ACAD SCI USA, V108, P5243, DOI 10.1073/pnas.1018692108; KAUL DK, 1991, BLOOD, V78, P812; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Leitgeb AM, 2011, AM J TROP MED HYG, V84, P390, DOI 10.4269/ajtmh.2011.10-0256; Luginbuhl A, 2007, INFECT IMMUN, V75, P1771, DOI 10.1128/IAI.01514-06; Mackinnon MJ, 2010, SCIENCE, V328, P866, DOI 10.1126/science.1185410; MARSH K, 1986, SCIENCE, V231, P150, DOI 10.1126/science.2417315; MCGREGOR IA, 1974, B WORLD HEALTH ORGAN, V50, P259; Nielsen MA, 2002, J IMMUNOL, V168, P3444, DOI 10.4049/jimmunol.168.7.3444; Nilsson S, 2011, MALARIA RES TREAT, V2011; Normark J, 2007, P NATL ACAD SCI USA, V104, P15835, DOI 10.1073/pnas.0610485104; Ofori MF, 2002, INFECT IMMUN, V70, P2982, DOI 10.1128/IAI.70.6.2982-2988.2002; Pettersson F, 2005, INFECT IMMUN, V73, P7736, DOI 10.1128/IAI.73.11.7736-7746.2005; Reilly M, 2009, METHODS MOL BIOL, V570, P373, DOI 10.1007/978-1-60327-394-7_21; ROWE A, 1995, INFECT IMMUN, V63, P2323, DOI 10.1128/IAI.63.6.2323-2326.1995; Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888; Snow RW, 1997, LANCET, V349, P1650, DOI 10.1016/S0140-6736(97)02038-2; TAYLOR TE, 1992, CLIN EXP IMMUNOL, V90, P357, DOI 10.1111/j.1365-2249.1992.tb05851.x; Treutiger CJ, 1999, EXP PARASITOL, V93, P215, DOI 10.1006/expr.1999.4454; TREUTIGER CJ, 1992, AM J TROP MED HYG, V46, P503, DOI 10.4269/ajtmh.1992.46.503; Vigan-Womas I, 2008, INFECT IMMUN, V76, P5565, DOI 10.1128/IAI.00901-08; Vigan-Womas I, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002781; Vigan-Womas I, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-267; Vogt AM, 2003, BLOOD, V101, P2405, DOI 10.1182/blood-2002-07-2016; WAHLGREN M, 1990, AM J TROP MED HYG, V43, P333, DOI 10.4269/ajtmh.1990.43.333	55	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113248	10.1371/journal.pone.0113248	http://dx.doi.org/10.1371/journal.pone.0113248			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438249	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900036
J	Bogachev, MI; Kayumov, AR; Bunde, A				Bogachev, Mikhail I.; Kayumov, Airat R.; Bunde, Armin			Universal Internucleotide Statistics in Full Genomes: A Footprint of the DNA Structure and Packaging?	PLOS ONE			English	Article							LONG-RANGE CORRELATIONS; SEQUENCES	Uncovering the fundamental laws that govern the complex DNA structural organization remains challenging and is largely based upon reconstructions from the primary nucleotide sequences. Here we investigate the distributions of the internucleotide intervals and their persistence properties in complete genomes of various organisms from Archaea and Bacteria to H. Sapiens aiming to reveal the manifestation of the universal DNA architecture. We find that in all considered organisms the internucleotide interval distributions exhibit the same q-exponential form. While in prokaryotes a single q-exponential function makes the best fit, in eukaryotes the PDF contains additionally a second q-exponential, which in the human genome makes a perfect approximation over nearly 10 decades. We suggest that this functional form is a footprint of the heterogeneous DNA structure, where the first q-exponential reflects the universal helical pitch that appears both in pro- and eukaryotic DNA, while the second q-exponential is a specific marker of the large-scale eukaryotic DNA organization.	[Bogachev, Mikhail I.] St Petersburg Electrotech Univ, Radio Syst Dept, St Petersburg, Russia; [Bogachev, Mikhail I.] St Petersburg Electrotech Univ, Biomed Engn Res Ctr, St Petersburg, Russia; [Kayumov, Airat R.] Kazan Volga Reg Fed Univ, Dept Genet, Kazan, Tatarstan, Russia; [Kayumov, Airat R.] Kazan Volga Reg Fed Univ, Inst Fundamental Med & Biol, Kazan, Tatarstan, Russia; [Bunde, Armin] Univ Giessen, Inst Theoret Phys, Giessen, Hessen, Germany	Saint Petersburg State Electrotechnical University; Saint Petersburg State Electrotechnical University; Kazan Federal University; Kazan Federal University; Justus Liebig University Giessen	Bogachev, MI (corresponding author), St Petersburg Electrotech Univ, Radio Syst Dept, St Petersburg, Russia.	Mikhail.Bogachev@physik.uni-giessen.de	Bogachev, Mikhail/C-1229-2011; Kayumov, Airat/M-6725-2013	Bogachev, Mikhail/0000-0002-0356-5651; Kayumov, Airat/0000-0001-7195-1557	Deutsche Forschungsgemeinschaft (Justus-Liebig-Universitaet Giessen) [BU 534/24-1]; Ministry of Education and Science of the Russian Federation (St. Petersburg Electrotechnical University) [2014/187]; Russian Government	Deutsche Forschungsgemeinschaft (Justus-Liebig-Universitaet Giessen)(German Research Foundation (DFG)); Ministry of Education and Science of the Russian Federation (St. Petersburg Electrotechnical University); Russian Government	Funding: The financial support of this work was provided by the Deutsche Forschungsgemeinschaft (Justus-Liebig-Universitaet Giessen, project No. BU 534/24-1, AB), by the Ministry of Education and Science of the Russian Federation (St. Petersburg Electrotechnical University, assignment No. 2014/187, MB) and by the subsidy of the Russian Government to support the Program of competitive development of the leading academic centers (Kazan Federal University, AK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann EG, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056106; Andrade JS, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.260601; Antonopoulos CG, 2014, PHYSICA A, V409, P71, DOI 10.1016/j.physa.2014.04.042; ARNEODO A, 1995, PHYS REV LETT, V74, P3293, DOI 10.1103/PhysRevLett.74.3293; Arneodo A, 2011, PHYS REP, V498, P45, DOI 10.1016/j.physrep.2010.10.001; Audit B, 2002, J MOL BIOL, V316, P903, DOI 10.1006/jmbi.2001.5363; Audit B, 2001, PHYS REV LETT, V86, P2471, DOI 10.1103/PhysRevLett.86.2471; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bogachev MI, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.240601; Bogachev MI, 2008, PURE APPL GEOPHYS, V165, P1195, DOI 10.1007/s00024-008-0353-5; Bogachev MI, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/6/063036; BULDYREV SV, 1995, PHYS REV E, V51, P5084, DOI 10.1103/PhysRevE.51.5084; Bunde A, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.048701; CHATZIDIMITRIOUDREISMANN CA, 1993, NATURE, V361, P212, DOI 10.1038/361212b0; Felsenfeld G, 2003, NATURE, V421, P448, DOI 10.1038/nature01411; Goodsell DS, NUCL ACIDS RES, V22; GROSBERG A, 1993, EUROPHYS LETT, V23, P373, DOI 10.1209/0295-5075/23/5/012; Guerra CF, 2000, J AM CHEM SOC, V122, P4117; Hunt CR, 2013, RADIAT RES, V179, P383, DOI 10.1667/RR3308.2; Jurka J, 2000, TRENDS GENET, V16, P418, DOI 10.1016/S0168-9525(00)02093-X; Kantelhardt JW, 2001, PHYSICA A, V295, P441, DOI 10.1016/S0378-4371(01)00144-3; KONG MG, 2009, NEW J PHYS, V11, DOI DOI 10.1088/1367-2630/11/11/115012; Lennartz S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.066101; LI W, 1992, EUROPHYS LETT, V17, P655, DOI 10.1209/0295-5075/17/7/014; Ludescher J, 2011, EPL-EUROPHYS LETT, V95, DOI 10.1209/0295-5075/95/68002; Ludescher J, 2014, PREPRINT; Malacarne LC, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.017106; Nobre FD, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.140601; Pandita TK, 2009, NUCLEIC ACIDS RES, V37, P1363, DOI 10.1093/nar/gkn1071; PANDITA TK, 1995, INT J CANCER, V61, P738, DOI 10.1002/ijc.2910610524; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; PENG CK, 1992, NATURE, V356, P168, DOI 10.1038/356168a0; Peterson J, 2013, P NATL ACAD SCI USA, V110, P20380, DOI 10.1073/pnas.1320578110; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Toro E, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000349; TSALLIS C, 1988, J STAT PHYS, V52, P479, DOI 10.1007/BF01016429; Tsallis C., 2009, SPRINGER; Vaillant C, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.068101; Vaillant C, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.032901; Watson J.D., 2014, MOL BIOL GENE	40	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112534	10.1371/journal.pone.0112534	http://dx.doi.org/10.1371/journal.pone.0112534			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438044	Green Published, gold, Green Submitted			2022-12-26	WOS:000347114900014
J	Desalegn, A; Mossie, A; Gedefaw, L				Desalegn, Amare; Mossie, Andualem; Gedefaw, Lealem			Nutritional Iron Deficiency Anemia: Magnitude and Its Predictors among School Age Children, Southwest Ethiopia: A Community Based Cross-Sectional Study	PLOS ONE			English	Article							FOOD-FREQUENCY QUESTIONNAIRE; ANIMAL SOURCE FOODS; DIETARY DIVERSITY; NUTRIENT ADEQUACY; SCHOOLCHILDREN; COUNTRIES; QUALITY; ADULTS	Background: Iron deficiency anemia (IDA) is a global public health problem among school age children, which retards psychomotor development and impairs cognitive performance. There is limited data on prevalence and risk factors for IDA. Objective: The aim of this study was to determine the prevalence, severity, and predictors of nutritional IDA in school age children in Southwest Ethiopia. Methodology: A community based cross-sectional study was conducted in Jimma Town, Southwest Ethiopia from April to July 2013. A total of 616 school children aged 6 to 12 years were included in the study using multistage sampling technique. A structured questionnaire was used to collect sociodemographic data. Five milliliter venous blood was collected from each child for hematological examinations. Anemia was defined as a hemoglobin level lower than 11.5 g/dl and 12 g/dl for age group of 5-11 years and 12-15 years, respectively. Iron deficiency anemia was defined when serum iron and ferritin levels are below 10 mu mol/l and 15 mu g/dl, respectively. Moreover, fresh stool specimen was collected for diagnosis of intestinal parasitic infection. Stained thick and thin blood films were examined for detection of Plasmodium infection and study of red blood cell morphology. Dietary patterns of the study subjects were assessed using food frequency questionnaire and anthropometric measurements were done. Data were analyzed using SPSS V-20.0 for windows. Result: Overall, prevalence of anemia was 43.7%, and that of IDA was 37.4%. Not-consuming protein source foods [AOR=2.30, 95% CI(1.04,5.14)], not-consuming dairy products [AOR=1.83, 95% CI(1.14,5.14)], not-consuming discretionary calories [AOR=2.77, 95% CI(1.42,5.40)], low family income [AOR=6.14, 95% CI(2.90,12.9)] and intestinal parasitic infections [AOR51.45, 95% CI(1.23, 5. 27)] were predictors of IDA. Conclusion: Iron deficiency anemia is a moderate public health problem in the study site. Dietary deficiencies and intestinal parasitic infections were predictors of IDA. Therefore, emphasis should be given to the strategies for the prevention of risk factors for IDA.	[Desalegn, Amare; Mossie, Andualem] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Biomed Sci, Jimma, Ethiopia; [Gedefaw, Lealem] Jimma Univ, Coll Publ Hlth & Med Sci, Dept Med Lab Sci & Pathol, Jimma, Ethiopia	Jimma University; Jimma University	Gedefaw, L (corresponding author), Jimma Univ, Coll Publ Hlth & Med Sci, Dept Med Lab Sci & Pathol, Jimma, Ethiopia.	lealem.gedefaw@ju.edu.et	Wolide, Amare Desalegn/L-9020-2019	Wolide, Amare Desalegn/0000-0002-6056-4364	Jimma University College of Public Health and Medical Sciences	Jimma University College of Public Health and Medical Sciences	This research article was funded by Jimma University College of Public Health and Medical Sciences. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar A, 2012, INT J ENV RES PUB HE, V9, P3506, DOI 10.3390/ijerph9103506; Alemayehu N, 2005, PREVALENCE HOOK WORM; Allen LH, 2003, J NUTR, V133, p3875S, DOI 10.1093/jn/133.11.3875S; Almaz S, 2000, ANEMIA TESTING POPUL; [Anonymous], [No title captured]; Azadbakht L, 2005, EUR J CLIN NUTR, V59, P1233, DOI 10.1038/sj.ejcn.1602234; Best C, 2010, FOOD NUTR BULL, V31, P400, DOI 10.1177/156482651003100303; DeMaeyer E, 1985, World Health Stat Q, V38, P302; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Fryar CD, 2012, VITAL HLTH STAT, V11; Hall A, 2001, PUBLIC HEALTH NUTR, V4, P749, DOI 10.1079/PHN2000111; HALLBERG L, 1981, ANNU REV NUTR, V1, P123, DOI 10.1146/annurev.nu.01.070181.001011; Hashizume M, 2003, J TROP PEDIATRICS, V49, P172, DOI 10.1093/tropej/49.3.172; Hop LT, 2003, J NUTR, V133, p4006S, DOI 10.1093/jn/133.11.4006S; Le HT, 2006, NUTR J, V5, DOI 10.1186/1475-2891-5-32; Julie M, 2005, AM J CLIN NUTR, V82, P1269; Jyothsna Kudaravalli, 2011, Annals of Biological Research, V2, P209; Kant AK, 1997, NUTR RES, V17, P1443, DOI 10.1016/S0271-5317(97)00135-8; Kennedy G, 2010, J NUTR, V140, p2070S, DOI 10.3945/jn.110.123612; Kennedy GL, 2007, J NUTR, V137, P472, DOI 10.1093/jn/137.2.472; Lee R, 1999, CLIN HEMATOLOGY NUTR, P228; Leenstra T, 2006, AM J CLIN NUTR, V83, P371; Leenstra T, 2004, EUR J CLIN NUTR, V58, P681, DOI 10.1038/sj.ejcn.1601865; Masahiro H, 2004, PUBLIC HEALTH NUTR, V8, P564; Mohamed EI, 2008, PAK J NUTR, V7, P400; Munoz M, 2009, WORLD J GASTROENTERO, V15, P4617, DOI 10.3748/wjg.15.4617; Neumann C, 2002, NUTR RES, V22, P193, DOI 10.1016/S0271-5317(01)00374-8; Onimawo I. A., 2010, African Journal of Food, Agriculture, Nutrition and Development, V10, P2570; Osazuwa F, 2010, J NEW YORK SCI, V2, P212; Osorio MM, 2004, BRIT J NUTR, V91, P307, DOI 10.1079/BJN20031042; Rodriguez MM, 2002, PUBLIC HEALTH NUTR, V5, P691, DOI 10.1079/PHN2002333; Skalicky A, 2006, MATERN CHILD HLTH J, V10, P177, DOI 10.1007/s10995-005-0036-0; Stang J, 2005, LEADERSHIP ED TRAINI; Stoltzfus Rebecca J., 2003, Food and Nutrition Bulletin, V24, pS99; Tatala S, 2008, TANZAN J HLTH RES, V10, P7; Tefera B, 2012, BMC PUBLIC HLTH, V12, P604; Tefera B, 2011, BMC NUTR J, V10, P29; Tefera B, 2013, PLOS ONE, V8, pe5764; Torheim LE, 2004, EUR J CLIN NUTR, V58, P594, DOI 10.1038/sj.ejcn.1601853; USDA, 2005, HOM GARD B; WHO, 2011, HEM CONC DIAGN AN; WHO, 2000, REP WORLD NUTR SIT; WHO, 2009, ANTHROPLUS PERS COMP; WHO/CDC, 2008, WORLDW PREV AN 1993; WHO UNCF UNU, 2001, IR DEF AN ASS PREV C; ZEIN ZA, 1987, ETHIOPIAN MED J, V25, P105; Zimmermann MB, 2005, AM J CLIN NUTR, V81, P615	47	37	38	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114059	10.1371/journal.pone.0114059	http://dx.doi.org/10.1371/journal.pone.0114059			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438147	Green Published, gold, Green Submitted			2022-12-26	WOS:000347114900116
J	Doppler, SA; Werner, A; Barz, M; Lahm, H; Deutsch, MA; Dressen, M; Schiemann, M; Voss, B; Gregoire, S; Kuppusamy, R; Wu, SM; Lange, R; Krane, M				Doppler, Stefanie A.; Werner, Astrid; Barz, Melanie; Lahm, Harald; Deutsch, Marcus-Andre; Dressen, Martina; Schiemann, Matthias; Voss, Bernhard; Gregoire, Serge; Kuppusamy, Rajarajan; Wu, Sean M.; Lange, Ruediger; Krane, Markus			Myeloid Zinc Finger 1 (Mzf1) Differentially Modulates Murine Cardiogenesis by Interacting with an Nkx2.5 Cardiac Enhancer	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; PROGENITOR CELLS; SMOOTH-MUSCLE; GENE-EXPRESSION; PROTEIN MZF1; IN-VITRO; HEART; MOUSE; MESODERM; TRANSCRIPTION	Vertebrate heart development is strictly regulated by temporal and spatial expression of growth and transcription factors (TFs). We analyzed nine TFs, selected by in silico analysis of an Nkx2.5 enhancer, for their ability to transactivate the respective enhancer element that drives, specifically, expression of genes in cardiac progenitor cells (CPCs). Mzf1 showed significant activity in reporter assays and bound directly to the Nkx2.5 cardiac enhancer (Nkx2.5 CE) during murine ES cell differentiation. While Mzf1 is established as a hematopoietic TF, its ability to regulate cardiogenesis is completely unknown. Mzf1 expression was significantly enriched in CPCs from in vitro differentiated ES cells and in mouse embryonic hearts. To examine the effect of Mzf1 overexpression on CPC formation, we generated a double transgenic, inducible, tetOMzf1-Nkx2.5 CE eGFP ES line. During in vitro differentiation an early and continuous Mzf1 overexpression inhibited CPC formation and cardiac gene expression. A late Mzf1 overexpression, coincident with a second physiological peak of Mzf1 expression, resulted in enhanced cardiogenesis. These findings implicate a novel, temporal-specific role of Mzf1 in embryonic heart development. Thereby we add another piece of puzzle in understanding the complex mechanisms of vertebrate cardiac development and progenitor cell differentiation. Consequently, this knowledge will be of critical importance to guide efficient cardiac regenerative strategies and to gain further insights into the molecular basis of congenital heart malformations.	[Doppler, Stefanie A.; Werner, Astrid; Barz, Melanie; Lahm, Harald; Deutsch, Marcus-Andre; Dressen, Martina; Voss, Bernhard; Lange, Ruediger; Krane, Markus] Tech Univ Munich, Dept Expt Surg, Dept Cardiovasc Surg, Deutsch Herzzentrum Munchen, D-80290 Munich, Germany; [Schiemann, Matthias] Tech Univ Munich, Inst Med Microbiol Immunol & Hyg, D-80290 Munich, Germany; [Schiemann, Matthias] TUM, Clin Cooperat Grp Antigen Specif Immunotherapy &, Helmholtz Ctr Munich Neuherberg, Munich, Germany; [Gregoire, Serge] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr,Div Cardiol,Dept Med, Boston, MA USA; [Kuppusamy, Rajarajan; Wu, Sean M.] Stanford Univ, Sch Med, Stanford Cardiovasc Inst, Div Cardiovasc Med, Stanford, CA 94305 USA; [Kuppusamy, Rajarajan; Wu, Sean M.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Lange, Ruediger; Krane, Markus] DZHK German Ctr Cardiovasc Res Partner Site Munic, Munich, Germany	German Heart Centre Munich; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Harvard University; Harvard Medical School; Massachusetts General Hospital; Stanford University; Stanford University; German Centre for Cardiovascular Research	Doppler, SA (corresponding author), Tech Univ Munich, Dept Expt Surg, Dept Cardiovasc Surg, Deutsch Herzzentrum Munchen, D-80290 Munich, Germany.	doppler@dhm.mhn.de	Krane, Markus/AAD-2006-2021; Deutsch, Marcus-Andre/AAL-8367-2020; Deutsch, Marcus-André/AFV-4686-2022	Krane, Markus/0000-0002-5466-9290; Wu, Sean/0000-0002-0000-3821	Deutsche Gesellschaft fur Thorax-, Herz- und Gefasschirurgie; DSHF; DGTHG; Bayerische Forschungsstiftung [AZ-1012-12]; Deutsche Stiftung fur Herzforschung [F/37/11]; Deutsches Zentrum fur Herz Kreislauf Forschung [DZHK B 13-050A, DZHK B 14-013SE]; Deutsche Forschungsgemeinschaft - Sachmittelantrag [KR3770/7-1, KR3770/9-1]	Deutsche Gesellschaft fur Thorax-, Herz- und Gefasschirurgie; DSHF; DGTHG; Bayerische Forschungsstiftung; Deutsche Stiftung fur Herzforschung; Deutsches Zentrum fur Herz Kreislauf Forschung; Deutsche Forschungsgemeinschaft - Sachmittelantrag	This work was supported by the Dr. Rusche Forschungspreis 2011 of the Deutsche Gesellschaft fur Thorax-, Herz- und Gefasschirurgie (http://www.dshf.de/dr_rusche_forschungsprojekt_projekte.php). Grant Support (Doppler et al.): The study was supported by Dr. Rusche Forschungsprojekt (2011) of the DSHF and DGTHG. Marcus-Andre Deutsch (MAD) is supported by Dr. Rusche Forschungsprojekt (2014) of the DSHF and DGTHG. Rudiger Lange (RL) is supported by Bayerische Forschungsstiftung (AZ-1012-12). Markus Krane (MK) is supported by Deutsche Stiftung fur Herzforschung (F/37/11), Deutsches Zentrum fur Herz Kreislauf Forschung (DZHK B 13-050A), Deutsche Forschungsgemeinschaft - Sachmittelantrag (KR3770/7-1), Deutsches Zentrum fur Herz Kreislauf Forschung (DZHK B 14-013SE), and Deutsche Forschungsgemeinschaft - Sachmittelantrag (KR3770/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babu GJ, 2000, J MOL CELL CARDIOL, V32, P1447, DOI 10.1006/jmcc.2000.1185; BAVISOTTO L, 1991, J EXP MED, V174, P1097, DOI 10.1084/jem.174.5.1097; BOBER E, 1991, J CELL BIOL, V113, P1255, DOI 10.1083/jcb.113.6.1255; Bondue A, 2008, CELL STEM CELL, V3, P69, DOI 10.1016/j.stem.2008.06.009; Bondue A, 2010, CIRC RES, V107, P1414, DOI 10.1161/CIRCRESAHA.110.227058; Caprioli A, 2011, CIRCULATION, V123, P1633, DOI 10.1161/CIRCULATIONAHA.110.008185; Chekmenev DS, 2005, NUCLEIC ACIDS RES, V33, pW432, DOI 10.1093/nar/gki441; Chen JX, 2012, CIRC RES, V111, P50, DOI 10.1161/CIRCRESAHA.112.270264; Chen YH, 2007, DEV BIOL, V308, P421, DOI 10.1016/j.ydbio.2007.05.037; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Domian IJ, 2009, SCIENCE, V326, P426, DOI 10.1126/science.1177350; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Firulli AB, 1998, NAT GENET, V18, P266, DOI 10.1038/ng0398-266; Gaboli M, 2001, GENE DEV, V15, P1625, DOI 10.1101/gad.902301; Gregoire S, 2013, CIRC RES, V112, P900, DOI 10.1161/CIRCRESAHA.113.259259; HERRMANN BG, 1990, NATURE, V343, P617, DOI 10.1038/343617a0; HROMAS R, 1991, J BIOL CHEM, V266, P14183; Hsieh YH, 2006, BIOCHEM BIOPH RES CO, V339, P217, DOI 10.1016/j.bbrc.2005.11.015; Hsieh YH, 2007, CHINESE J PHYSIOL, V50, P9; Huang Xiaojing, 2010, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01f10s14; Ismailoglu I, 2008, EXP HEMATOL, V36, P1593, DOI 10.1016/j.exphem.2008.07.005; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kitajima S, 2000, DEVELOPMENT, V127, P3215; Liao XD, 2010, J MOL CELL CARDIOL, V49, P334, DOI 10.1016/j.yjmcc.2010.04.008; Lien CL, 1999, DEVELOPMENT, V126, P75; Liu Y, 2007, P NATL ACAD SCI USA, V104, P3859, DOI 10.1073/pnas.0609100104; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; MORRIS JF, 1995, BLOOD, V86, P3640; MORRIS JF, 1994, MOL CELL BIOL, V14, P1786, DOI 10.1128/MCB.14.3.1786; Mudduluru G, 2010, MOL CANCER RES, V8, P159, DOI 10.1158/1541-7786.MCR-09-0326; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; NGUYEN HT, 1994, P NATL ACAD SCI USA, V91, P7520, DOI 10.1073/pnas.91.16.7520; PERROTTI D, 1995, MOL CELL BIOL, V15, P6075; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Tsai SJ, 2012, BIOCHEM BIOPH RES CO, V425, P462, DOI 10.1016/j.bbrc.2012.07.125; Van Handel B, 2012, CELL, V150, P590, DOI 10.1016/j.cell.2012.06.026; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028	39	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113775	10.1371/journal.pone.0113775	http://dx.doi.org/10.1371/journal.pone.0113775			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436607	Green Submitted, Green Published, gold			2022-12-26	WOS:000347114900078
J	Dubois, M; Le Joncour, V; Tonon, MC; Anouar, Y; Proust, F; Morin, F; Gandolfo, P; Joly, F; Hilber, P; Castel, H				Dubois, Martine; Le Joncour, Vadim; Tonon, Marie-Christine; Anouar, Youssef; Proust, Francois; Morin, Fabrice; Gandolfo, Pierrick; Joly, Florence; Hilber, Pascal; Castel, Helene			Evaluation of the Impact of the Cancer Therapy Everolimus on the Central Nervous System in Mice	PLOS ONE			English	Article							POSTERIOR LEUKOENCEPHALOPATHY SYNDROME; HIPPOCAMPAL CELL-PROLIFERATION; MAMMALIAN TARGET; RAPAMYCIN PATHWAY; COGNITIVE IMPAIRMENTS; SYNAPTIC PLASTICITY; MTOR PATHWAY; FEAR MEMORY; MOUSE MODEL; RAD001	Cancer and treatments may induce cognitive impairments in cancer patients, and the causal link between chemotherapy and cognitive dysfunctions was recently validated in animal models. New cancer targeted therapies have become widely used, and their impact on brain functions and quality of life needs to be explored. We evaluated the impact of everolimus, an anticancer agent targeting the mTOR pathway, on cognitive functions, cerebral metabolism, and hippocampal cell proliferation/vascular density in mice. Adult mice received everolimus daily for 2 weeks, and behavioral tests were performed from 1 week after the last treatment. Everolimus-treated mice displayed a marked reduction in weight gain from the last day of the treatment period. Ex vivo analysis showed altered cytochrome oxidase activity in selective cerebral regions involved in energy balance, food intake, reward, learning and memory modulation, sleep/wake cycle regulation, and arousal. Like chemotherapy, everolimus did not alter emotional reactivity, learning and memory performances, but in contrast to chemotherapy, did not affect behavioral flexibility or reactivity to novelty. In vivo hippocampal neural cell proliferation and vascular density were also unchanged after everolimus treatments. In conclusion, two weeks daily everolimus treatment at the clinical dose did not evoke alteration of cognitive performances evaluated in hippocampal- and prefrontal cortex-dependent tasks that would persist at one to four weeks after the end of the treatment completion. However, acute everolimus treatment caused selective CO modifications without altering the mTOR effector P70S6 kinase in cerebral regions involved in feeding behavior and/or the sleep/wake cycle, at least in part under control of the solitary nucleus and the parasubthalamic region of the hypothalamus. Thus, this area may represent a key target for everolimus-mediating peripheral modifications, which has been previously associated with symptoms such as weight loss and fatigue.	[Dubois, Martine; Le Joncour, Vadim; Tonon, Marie-Christine; Anouar, Youssef; Proust, Francois; Morin, Fabrice; Gandolfo, Pierrick; Castel, Helene] Univ Rouen, Inserm U982, Lab Neuronal & Neuroendocrine Commun & Differenti, Mont St Aignan, France; [Dubois, Martine; Le Joncour, Vadim; Tonon, Marie-Christine; Anouar, Youssef; Proust, Francois; Morin, Fabrice; Gandolfo, Pierrick; Castel, Helene] Univ Rouen, Inst Res & Biomed Innovat IRIB, PRES Normandie Univ, Mont St Aignan, France; [Dubois, Martine; Gandolfo, Pierrick; Joly, Florence; Hilber, Pascal; Castel, Helene] North West Canceropole CNO, Lille, France; [Joly, Florence; Hilber, Pascal] Univ Rouen, Lab Psychol & Neurosci Cognit & Affect PSY NCA, EA4700, Mont St Aignan, France; [Joly, Florence] Ctr Francois Baclesse, F-14021 Caen, France; [Joly, Florence] CHU Caen, F-14000 Caen, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rouen Normandie; Universite de Rouen Normandie; Universite de Rouen Normandie; UNICANCER; Centre Francois Baclesse; CHU de Caen NORMANDIE; Universite de Caen Normandie	Castel, H (corresponding author), Univ Rouen, Inserm U982, Lab Neuronal & Neuroendocrine Commun & Differenti, Mont St Aignan, France.	helene.castel@univ-rouen.fr	Anouar, Youssef/F-9683-2017; JOLY, Florence/L-7752-2015; Le Joncour, Vadim/X-6274-2019; joly, florence/AAF-9191-2020; castel, helene/B-8675-2009	Le Joncour, Vadim/0000-0001-8153-8563; castel, helene/0000-0002-8972-5555; joly, florence/0000-0001-6168-4942; DUBOIS, Martine/0000-0002-7200-9624; Morin, Fabrice/0000-0001-6785-1967	university of Roue; Inserm; Novartis [071160-001141-05]	university of Roue; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Novartis(Novartis)	This work was supported by university of Roue, Inserm and the Baclesse center receiving a grant by Novartis (Novartis) 071160-001141-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albiges L, 2011, J CLIN ONCOL S7, V29; Anandappa G, 2010, Cancer Manag Res, V2, P61; Arabo A, 2005, NEUROSCIENCE, V135, P691, DOI 10.1016/j.neuroscience.2005.06.069; Baldo BA, 2003, J COMP NEUROL, V464, P220, DOI 10.1002/cne.10783; Balenci L, 2007, J NEUROSCI, V27, P4716, DOI 10.1523/JNEUROSCI.0830-07.2007; Barilli A, 2008, CARDIOVASC RES, V78, P563, DOI 10.1093/cvr/cvn024; Bekinschtein P, 2007, NEUROBIOL LEARN MEM, V87, P303, DOI 10.1016/j.nlm.2006.08.007; Bianco R, 2008, BRIT J CANCER, V98, P923, DOI 10.1038/sj.bjc.6604269; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Blundell J, 2008, NEUROBIOL LEARN MEM, V90, P28, DOI 10.1016/j.nlm.2007.12.004; Boulay A, 2004, CANCER RES, V64, P252, DOI 10.1158/0008-5472.CAN-3554-2; Ciriello J, 2008, AM J PHYSIOL-REG I, V294, pR1276, DOI 10.1152/ajpregu.00437.2007; Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147; Dash PK, 2006, J NEUROSCI, V26, P8048, DOI 10.1523/JNEUROSCI.0671-06.2006; Di Lorenzo G, 2011, EUR UROL, V59, P526, DOI 10.1016/j.eururo.2011.01.002; Dowling RJO, 2010, BBA-PROTEINS PROTEOM, V1804, P433, DOI 10.1016/j.bbapap.2009.12.001; Dubois M, 2014, NEUROPHARMACOLOGY, V79, P234, DOI 10.1016/j.neuropharm.2013.11.012; Farb A, 2002, CIRCULATION, V106, P2379, DOI 10.1161/01.CIR.0000033973.06059.04; Fardell JE, 2012, PSYCHOPHARMACOLOGY, V220, P183, DOI 10.1007/s00213-011-2466-2; Fox JH, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-26; Franklin K., 2007, MOUSE BRAIN STEREOTA; Gandal MJ, 2008, NEUROSCIENCE, V157, P95, DOI 10.1016/j.neuroscience.2008.08.060; Glusker P, 2006, NEW ENGL J MED, V354, P980; Goto M, 2004, J COMP NEUROL, V469, P581, DOI 10.1002/cne.11036; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Hallmann R, 2000, ENDOTHELIUM-J ENDOTH, V7, P135, DOI 10.3109/10623320009072208; Hebert M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093691; Hoeffer CA, 2010, TRENDS NEUROSCI, V33, P67, DOI 10.1016/j.tins.2009.11.003; Horvath TL, 1999, J COMP NEUROL, V415, P145; Horwood JM, 2006, EUR J NEUROSCI, V23, P3375, DOI 10.1111/j.1460-9568.2006.04859.x; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Huynh H, 2009, J CELL MOL MED, V13, P1371, DOI 10.1111/j.1582-4934.2008.00364.x; Joly F, 2011, PSYCHO-ONCOLOGY, V20, P1251, DOI 10.1002/pon.1903; Kelley AE, 2005, PHYSIOL BEHAV, V86, P773, DOI 10.1016/j.physbeh.2005.08.066; Krab LC, 2008, TRENDS GENET, V24, P498, DOI 10.1016/j.tig.2008.07.005; Laplante M, 2009, CURR BIOL, V19, pR1046, DOI 10.1016/j.cub.2009.09.058; Larkin JMG, 2010, ONCOLOGIST, V15, P1135, DOI 10.1634/theoncologist.2010-0078; Mabuchi S, 2007, CLIN CANCER RES, V13, P4261, DOI 10.1158/1078-0432.CCR-06-2770; Mabuchi S, 2007, CANCER RES, V67, P2408, DOI 10.1158/0008-5472.CAN-06-4490; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Manegold PC, 2008, CLIN CANCER RES, V14, P892, DOI 10.1158/1078-0432.CCR-07-0955; Martin G, 2007, J CLIN ONCOL, V25, P3559, DOI 10.1200/JCO.2007.12.8710; Martins L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046923; Mascaro MB, 2005, NEUROSCI LETT, V386, P34, DOI 10.1016/j.neulet.2005.05.062; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; Mori H, 2009, AM J PHYSIOL-ENDOC M, V297, pE1013, DOI 10.1152/ajpendo.00262.2009; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Myskiw JC, 2008, NEUROBIOL LEARN MEM, V89, P338, DOI 10.1016/j.nlm.2007.10.002; Narayanan SP, 2009, J NEUROSCI, V29, P6860, DOI 10.1523/JNEUROSCI.0232-09.2009; O'Reilly T, 2010, CANCER CHEMOTH PHARM, V65, P625, DOI 10.1007/s00280-009-1068-8; Okada K, 2011, NEUROSCI LETT, V495, P201, DOI 10.1016/j.neulet.2011.03.065; Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566; Parsons RG, 2006, J NEUROSCI, V26, P12977, DOI 10.1523/JNEUROSCI.4209-06.2006; Pawaskar DK, 2013, CANCER CHEMOTH PHARM, V71, P1219, DOI 10.1007/s00280-013-2116-y; Peyron C, 2009, PEPTIDES, V30, P2052, DOI 10.1016/j.peptides.2009.07.022; Raman L, 2011, PEDIATR RES, V70, P159, DOI 10.1203/PDR.0b013e3182218622; SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815; Sato A, 2010, NEUROSCI LETT, V470, P115, DOI 10.1016/j.neulet.2009.12.067; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seigers R, 2008, BEHAV BRAIN RES, V186, P168, DOI 10.1016/j.bbr.2007.08.004; Soga N, 2001, CELL COMMUN ADHES, V8, P1, DOI 10.3109/15419060109080703; Strazielle C, 1998, EXP BRAIN RES, V121, P35, DOI 10.1007/s002210050434; Tabernero J, 2008, J CLIN ONCOL, V26, P1603, DOI 10.1200/JCO.2007.14.5482; Tanaka Chiaki, 2008, J Clin Oncol, V26, P1596, DOI 10.1200/JCO.2007.14.1127; Tang SJ, 2002, P NATL ACAD SCI USA, V99, P467, DOI 10.1073/pnas.012605299; Tischmeyer W, 2003, EUR J NEUROSCI, V18, P942, DOI 10.1046/j.1460-9568.2003.02820.x; Tsang CK, 2007, DRUG DISCOV TODAY, V12, P112, DOI 10.1016/j.drudis.2006.12.008; Winocur G, 2006, PHARMACOL BIOCHEM BE, V85, P66, DOI 10.1016/j.pbb.2006.07.010; WONGRILEY M, 1979, BRAIN RES, V171, P11, DOI 10.1016/0006-8993(79)90728-5; Xu GY, 2010, PEPTIDES, V31, P2185, DOI 10.1016/j.peptides.2010.08.018; Yang X, 2008, J Anim Sci, V86, pE36; Yasoshima Y, 2006, NEUROSCIENCE, V141, P35, DOI 10.1016/j.neuroscience.2006.03.019; Yee KWL, 2006, CLIN CANCER RES, V12, P5165, DOI 10.1158/1078-0432.CCR-06-0764; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009; Zhu XX, 2012, AM J PHYSIOL-ENDOC M, V303, pE1446, DOI 10.1152/ajpendo.00427.2012	77	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113533	10.1371/journal.pone.0113533	http://dx.doi.org/10.1371/journal.pone.0113533			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436776	Green Published, gold, Green Submitted			2022-12-26	WOS:000347114900049
J	Qureshi, JA; Kostyk, BC; Stansly, PA				Qureshi, Jawwad A.; Kostyk, Barry C.; Stansly, Philip A.			Insecticidal Suppression of Asian Citrus Psyllid Diaphorina citri (Hemiptera: Liviidae) Vector of Huanglongbing Pathogens	PLOS ONE			English	Article							ANTHRANILIC DIAMIDE INSECTICIDE; FIELD POPULATIONS; TAMARIXIA-RADIATA; ABUNDANCE; HOMOPTERA; DISEASE; FLORIDA	Diaphorina citri vectors pathogens that cause 'huanglongbing' or citrus greening disease which poses a serious threat to citrus production worldwide. Vector suppression is critical to reduce disease spread. Efficacy is a main concern when choosing an insecticide. Insecticidal treatments of 49 products or 44 active ingredients (a.i) labeled or experimental were field tested between 2005-2013 as foliar sprays (250 treatments, 39 a.i) or soil applications (47 treatments, 9 a.i) to control D. citri in citrus. A combined effect of nymphal and adult suppression in response to sprays of 23 insecticides representing 9 modes of action (MoA) groups and 3 unknown MoA provided more than 90% reduction of adult D. citri over 24-68 days. Observable effects on nymphs were generally of shorter duration due to rapid maturation of flush. However, reduction of 76-100% nymphs or adults over 99-296 days was seen on young trees receiving drenches of the neonicotinoids imidacloprid, thiamethoxam or clothianidin (MoA 4A) and a novel anthranilic diamide, cyantraniliprole (MoA 28). Effective products identified for foliar sprays to control D. citri provide sufficient MoA groups for rotation to delay evolution of insecticide resistance by D. citri and other pests. However, cyantraniliprole is now the only available alternative for rotation with neonicotinoids in soil application to young trees. Sprays of up to eight of the most effective insecticides could be rotated over a year without repetition of any MoA and little or no recourse to neonicotinoids or cyantraniliprole, so important for protection of young trees. Other considerations effecting decisions of what and when to spray include prevalence of huanglongbing, pest pressure, pre-harvest intervals, overall budget, equipment availability, and conservation of beneficial arthropods. Examples of spray programs utilizing broad-spectrum and relatively selective insecticides are provided to improve vector management and may vary depending on individual or regional assessment of all factors.	[Qureshi, Jawwad A.; Kostyk, Barry C.; Stansly, Philip A.] Univ Florida, Dept Entomol & Nematol, Inst Food & Agr Sci, Southwest Florida Res & Educ Ctr, Immokalee, FL 34142 USA	State University System of Florida; University of Florida	Qureshi, JA (corresponding author), Univ Florida, Dept Entomol & Nematol, Inst Food & Agr Sci, Southwest Florida Res & Educ Ctr, Immokalee, FL 34142 USA.	jawwadq@ufl.edu			Citrus Research and Development Foundation Inc., Florida	Citrus Research and Development Foundation Inc., Florida	Funding: This research was supported by the Citrus Research and Development Foundation Inc., Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belasque J, 2010, J PLANT PATHOL, V92, P285; Bove JM, 2006, J PLANT PATHOL, V88, P7; Croxton S, 2012, ARTHROP MANAG TESTS, P37, DOI [10.4182/amt.2012.D1, DOI 10.4182/AMT.2012.D1]; (FDQO-CG-ACP), 2009, FED DOM QUAR ORD CIT; Foster SP, 2012, PEST MANAG SCI, V68, P629, DOI 10.1002/ps.2306; French J. V., 2001, Subtropical Plant Science, V53, P14; Garnier M, 2000, INT J SYST EVOL MICR, V50, P2119, DOI 10.1099/00207713-50-6-2119; Grafton-Cardwell EE, 2013, ANNU REV ENTOMOL, V58, P413, DOI 10.1146/annurev-ento-120811-153542; Halbert S.E., 2005, PEST ALERT CITRUS GR; Halbert SE, 2004, FLA ENTOMOL, V87, P330, DOI 10.1653/0015-4040(2004)087[0330:ACPSPA]2.0.CO;2; HALBERT SE, 1998, TRIOLOGY, V37, P6; Hall DG, 2007, HORTSCIENCE, V42, P364, DOI 10.21273/HORTSCI.42.2.364; Hall DG, 2010, BIOCONTROL, V55, P601, DOI 10.1007/s10526-010-9283-0; Hodges A, 2012, EC IMPACTS CITRUS GR; Hoy M.A., 2001, CITRUS IND, V81, P48; Jackson L.K., 1999, CITRUS GROWING FLORI; Knapp JL, 1995, CITRUS LEAFMINER PHY; McCoy C. W., 1985, Biological control in agricultural IPM systems, P481; Michaud JP, 2004, BIOL CONTROL, V29, P260, DOI 10.1016/S1049-9644(03)00161-0; Michaud JP, 2002, ENTOMOL NEWS, V113, P216; Qureshi J. A., 2013, CITRUS IND, V94, P6; Qureshi J. A., 2012, CITRUS IND, V93, P14; Qureshi JA, 2010, TAMARIXIA RADIATA WA; Qureshi JA, 2008, PEST MANAG SCI, V64, P1159, DOI 10.1002/ps.1612; Qureshi JA, 2007, PROC FL STATE HORTIC, V120, P110; Qureshi JA, 2011, PROC FL STATE HORTIC, V124, P85; Qureshi JA, 2009, PROC FL STATE HORTIC, V122, P189; Qureshi JA, 2011, ENVIRON ENTOMOL, V40, P1503, DOI 10.1603/EN11171; Qureshi JA, 2010, CROP PROT, V29, P860, DOI 10.1016/j.cropro.2010.04.013; Qureshi JA, 2009, BIOL CONTROL, V50, P129, DOI 10.1016/j.biocontrol.2009.04.001; Qureshi JA, 2009, J ECON ENTOMOL, V102, P247, DOI 10.1603/029.102.0134; Rogers M. E., 2008, CITRUS IND, V89, P12; Rogers M.E., 2007, 2007 FLORIDA CITRUS, DOI [10.32473/edis-in686-2006, DOI 10.32473/EDIS-IN686-2006]; Roistacher C. N., 1996, INT ORG CITRUS VIROL, V13, P279, DOI [10.5070/C53KG8M6JR, DOI 10.5070/C53KG8M6JR]; *SAS I, 2004, SAS WIND VERS 9 1; Stansly P.A., 2011, ARTHROP MGT TESTS, V36, DOI [10.4182/ amt.2011.D4, DOI 10.4182/AMT.2011.D4]; Stansly P.A., 2011, ARTHR MANAG TESTS, V36, pD16, DOI [10.4182/amt.2011.D16, DOI 10.4182/AMT.2011.D16, 10.4182/amt.2011.D16.]; Stansly P.A., 2013, ARTHROPOD MANAGEMENT, V38, P1, DOI [10.4182/amt.2013.D12, DOI 10.4182/AMT.2013.D12]; Stansly P.A., 2007, ARTHR M TESTS, V32, pD11; Stansly P.A., ARTHROP MGT TESTS, V34, DOI [10.4182/amt.2009.D8, DOI 10.4182/AMT.2009.D8]; Stansly P.A., 2007, ARTHROPOD MGT TESTS, V32, pD10; Stansly P A, 2008, ARTHROP MANAG TESTS, V33, pD10; Stansly P. A., 2014, ARTHROP MANAG TESTS, V39, DOI [10.4182/amt.2014, DOI 10.4182/AMT.2014]; Stansly P.A., 2012, ARTHROP MGT TESTS, V37, DOI [10.4182/amt.2012.D15, DOI 10.4182/AMT.2012.D15]; Stansly P. A., 2013, ARTHROP MANAG TESTS, V38, DOI [10.4182/amt.2013.D15, DOI 10.4182/AMT.2013.D15]; Stansly P.A., 2009, CITRUS IND, V90, P14; Stansly PA, 2012, ARTHROPOD MANAGEMENT, V37, DOI [10.4182/amt.2012.D10, DOI 10.4182/AMT.2012.D10]; Stansly PA, 2011, ARTHROP MANAG TESTS, V36, DOI [10.4182/amt.2011.D15., DOI 10.4182/AMT.2011.D15]; Stansly PA, 2012, ARTHROP MANAG TESTS, V37, DOI [10.4182/amt.2012.D8, DOI 10.4182/AMT.2012.D8]; Stansly PA, 2006, ARTHROP MANAG TESTS, V31, pD19; Stansly PA, 2013, ARTHROP MANAG TESTS, V38, DOI [10.4182/amt.2013.D9, DOI 10.4182/AMT.2013.D9]; Stansly PA, 2013, ARTHROP MANAG TESTS, V38, DOI [10.4182/amt.2013.D10, DOI 10.4182/AMT.2013.D10]; Stansly PA, 2012, ARTHROP MANAG TESTS, V37, DOI [10.4182/amt.2012.D7., DOI 10.4182/AMT.2012.D7]; Stansly PA, 2012, ARTHROP MANAG TESTS, V37, DOI [10.4182/amt.2012.D9, DOI 10.4182/AMT.2012.D9]; Stansly PA, 2010, ARTHROP MANAG TESTS, V35, DOI [10.4182/amt.2010.D7, DOI 10.4182/AMT.2010.D7]; Stansly PA, 2010, ARTHROP MANAG TESTS, V35, DOI [10.4182/amt.2010.D9, DOI 10.4182/AMT.2010.D9]; Stansly PA, 2012, ARTHROP MANAG TESTS, V37, DOI [10.4182/amt.2012.D16, DOI 10.4182/AMT.2012.D16]; Stansly PA, 2008, ARTHROP MANAG TESTS, V33, pD13, DOI DOI 10.1093/AMT/33.1.D13; Stansly PA, 2008, ARTHROP MANAG TESTS, V33, pD11; Stansly PA, 2009, ARTHROP MANAG TESTS, V34, DOI [10.4182/amt.2009.D10, DOI 10.4182/AMT.2009.D10]; Stansly PA, 2008, ARTHROP MANAG TESTS, V33, pD12; Stansly PA, 2011, ARTHROP MANAG TESTS, V36, DOI [10.4182/amt.2011.D14, DOI 10.4182/AMT.2011.D14]; Stansly PA, 2012, ARTHROP MANAG TESTS, V37, DOI [10.4182/amt.2012.D14, DOI 10.4182/AMT.2012.D14]; Stansly PA, 2009, ARTHROP MANAG TESTS, V34, DOI [10.4182/amt.2009.D11, DOI 10.4182/AMT.2009.D11]; Stansly PA, 2009, ARTHROP MANAG TESTS, V34, DOI [10.4182/amt.2009.D12., DOI 10.4182/AMT.2009.D12]; Stansly PA, 2009, ARTHROP MANAG TESTS, V34, DOI [10.4182/amt.2009.D2, DOI 10.4182/AMT.2009.D2]; Stansly PA, 2013, ARTHROP MANAG TESTS, V38, DOI [10.4182/amt.2013.D14, DOI 10.4182/AMT.2013.D14]; Stansly PA, 2010, ARTHROP MANAG TESTS, V35, DOI [10.4182/amt.2010.D8, DOI 10.4182/AMT.2010.D8]; Stansly PA, 2009, ARTHROP MANAG TESTS, V34, DOI [10.4182/amt.2009.D13, DOI 10.4182/AMT.2009.D13]; Stansly PA, 2013, ARTHROP MANAG TESTS, V38, DOI [10.4182/amt.2013.D11, DOI 10.4182/AMT.2013.D11]; Stansly PA, 2009, ARTHROPOD MANAGEMENT, V34, DOI [10.4182/amt.2009.D9, DOI 10.4182/AMT.2009.D9]; Stansly PA, 2010, ARTHROP MANAG TESTS, V35, DOI [10.4182/amt.2010.D10., DOI 10.4182/AMT.2010.D10]; Stansly PA, 2014, PEST MANAG SCI, V70, P415, DOI 10.1002/ps.3577; Tiwari S, 2013, PEST MANAG SCI, V69, P1066, DOI 10.1002/ps.3468; Tiwari S, 2011, PEST MANAG SCI, V67, P1258, DOI 10.1002/ps.2181; Tsai JH, 2002, FLA ENTOMOL, V85, P446, DOI 10.1653/0015-4040(2002)085[0446:SAOTAC]2.0.CO;2; Vanden Berg MA, 1992, ENTOMOPHAGA, V37, P599	77	118	126	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112331	10.1371/journal.pone.0112331	http://dx.doi.org/10.1371/journal.pone.0112331			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437858	Green Published, gold			2022-12-26	WOS:000347114900013
J	Dutta, AK; Santra, S; Sharma, H; Voshavar, C; Xu, LP; Mabrouk, O; Antonio, T; Reith, MEA				Dutta, Aloke K.; Santra, Soumava; Sharma, Horrick; Voshavar, Chandrashekhar; Xu, Liping; Mabrouk, Omar; Antonio, Tamara; Reith, Maarten E. A.			Pharmacological and Behavioral Characterization of D-473, an Orally Active Triple Reuptake Inhibitor Targeting Dopamine, Serotonin and Norepinephrine Transporters	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; FREELY MOVING RATS; EXTRACELLULAR DOPAMINE; IN-VIVO; STRUCTURAL EXPLORATION; ATYPICAL DEPRESSION; PYRAN BIOMIMETICS; NUCLEUS-ACCUMBENS; NEXT-GENERATION; HIGH-AFFINITY	Major depressive disorder (MDD) is a debilitating disease affecting a wide cross section of people around the world. The current therapy for depression is less than adequate and there is a considerable unmet need for more efficacious treatment. Dopamine has been shown to play a significant role in depression including production of anhedonia which has been one of the untreated symptoms in MDD. It has been hypothesized that drugs acting at all three monoamine transporters including dopamine transporter should provide more efficacious antidepressants activity. This has led to the development of triple reuptake inhibitor D-473 which is a novel pyran based molecule and interacts with all three monoamine transporters. The monoamine uptake inhibition activity in the cloned human transporters expressed in HEK-293 cells (70.4, 9.18 and 39.7 for DAT, SERT and NET, respectively) indicates a serotonin preferring triple reuptake inhibition profile for this drug. The drug D-473 exhibited good brain penetration and produced efficacious activity in rat forced swim test under oral administration. The optimal efficacy dose did not produce any locomotor activation. Microdialysis experiment demonstrated that systemic administration of D-473 elevated extracellular level of the three monoamines DA, 5-HT, and NE efficaciously in the dorsal lateral striatum (DLS) and the medial prefrontal cortex (mPFC) area, indicating in vivo blockade of all three monoamine transporters by D-473. Thus, the current biological data from D-473 indicate potent antidepressant activity of the molecule.	[Dutta, Aloke K.; Santra, Soumava; Sharma, Horrick; Voshavar, Chandrashekhar; Xu, Liping] Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48202 USA; [Mabrouk, Omar] Univ Michigan, Dept Pharmacol & Chem, Ann Arbor, MI 48109 USA; [Antonio, Tamara; Reith, Maarten E. A.] NYU, Dept Psychiat, New York, NY 10016 USA; [Reith, Maarten E. A.] NYU, Dept Biochem & Mol Pharmacol, New York, NY USA	Wayne State University; University of Michigan System; University of Michigan; New York University; New York University	Dutta, AK (corresponding author), Wayne State Univ, Dept Pharmaceut Sci, Detroit, MI 48202 USA.	adutta@wayne.edu	Voshavar, Chandra/AAG-1587-2020; Santra, Soumava/L-2561-2019; Reith, Maarten E./AAD-2303-2019	Voshavar, Chandra/0000-0003-3350-3977; Reith, Maarten E./0000-0002-1900-842X; Santra, Soumava/0000-0003-4304-4030; dutta, aloke/0000-0003-3347-0538	National Institute of Mental Health/The National Institute of Health [MH084888]; National Center for Advancing Translational Sciences of the National Institutes of Health [2UL1TR000433]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084888] Funding Source: NIH RePORTER	National Institute of Mental Health/The National Institute of Health; National Center for Advancing Translational Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work is supported by National Institute of Mental Health/The National Institute of Health MH084888 (AKD). The microdialysis studies were partly supported by the National Center for Advancing Translational Sciences of the National Institutes of Health under Award Number 2UL1TR000433 (OSM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aluisio L, 2008, EUR J PHARMACOL, V587, P141, DOI 10.1016/j.ejphar.2008.04.008; ASCHER JA, 1995, J CLIN PSYCHIAT, V56, P395; Baldwin DS, 2006, J CLIN PSYCHIAT, V67, P9; CARBONI E, 1990, J NEUROCHEM, V55, P1067, DOI 10.1111/j.1471-4159.1990.tb04599.x; CHEN NH, 1994, J NEUROCHEM, V63, P1701; Corrigan MH, 2000, DEPRESS ANXIETY, V11, P58, DOI 10.1002/(SICI)1520-6394(2000)11:2<58::AID-DA2>3.0.CO;2-H; Darvas M, 2010, J NEUROSCI, V30, P1158, DOI 10.1523/JNEUROSCI.4576-09.2010; Darvas M, 2009, P NATL ACAD SCI USA, V106, P14664, DOI 10.1073/pnas.0907299106; DEWIT H, 1993, PSYCHOPHARMACOLOGY, V112, P324, DOI 10.1007/BF02244928; DILSAVER SC, 1994, AM J PSYCHIAT, V151, P1312; Drevets WC, 1999, ANN NY ACAD SCI, V877, P614, DOI 10.1111/j.1749-6632.1999.tb09292.x; Dunlop BW, 2007, ARCH GEN PSYCHIAT, V64, P327, DOI 10.1001/archpsyc.64.3.327; Dutta AK, 2008, EUR J PHARMACOL, V589, P73, DOI 10.1016/j.ejphar.2008.05.008; Dutta AK, 2011, EUR J PHARMACOL, V671, P39, DOI 10.1016/j.ejphar.2011.09.162; Dwoskin LP, 2006, CNS DRUG REV, V12, P178, DOI 10.1111/j.1527-3458.2006.00178.x; Gold PW, 1999, P ASSOC AM PHYSICIAN, V111, P22, DOI 10.1046/j.1525-1381.1999.09423.x; Gold PW, 2002, MOL PSYCHIATR, V7, P254, DOI 10.1038/sj.mp.4001032; Golembiowska K, 2012, SYNAPSE, V66, P435, DOI 10.1002/syn.21531; Gopishetty B, 2011, J MED CHEM, V54, P2924, DOI 10.1021/jm200020a; Guiard BP, 2009, CURR DRUG TARGETS, V10, P1069, DOI 10.2174/138945009789735156; Howell LL, 2014, ADV PHARMACOL, V69, P129, DOI 10.1016/B978-0-12-420118-7.00004-4; HURD YL, 1989, EUR J PHARMACOL, V166, P251, DOI 10.1016/0014-2999(89)90066-6; Lamers F, 2010, J CLIN PSYCHIAT, V71, P1582, DOI 10.4088/JCP.09m05398blu; Li MY, 1996, J NEUROCHEM, V66, P559; Liang YQ, 2008, J PHARMACOL EXP THER, V327, P573, DOI 10.1124/jpet.108.143610; Marks DM, 2008, CURR NEUROPHARMACOL, V6, P338, DOI 10.2174/157015908787386078; MAURICE T, 1992, NEUROSCI LETT, V138, P63, DOI 10.1016/0304-3940(92)90473-K; Millan MJ, 2009, NEUROTHERAPEUTICS, V6, P53, DOI 10.1016/j.nurt.2008.10.039; Mischoulon D, 2000, CAN J PSYCHIAT, V45, P476, DOI 10.1177/070674370004500509; Morilak DA, 2004, INT J NEUROPSYCHOPH, V7, P193, DOI 10.1017/S1461145704004080; Navarro HA, 2009, BRIT J PHARMACOL, V156, P1178, DOI 10.1111/j.1476-5381.2009.00124.x; NOMIKOS GG, 1989, NEUROPSYCHOPHARMACOL, V2, P273, DOI 10.1016/0893-133X(89)90031-6; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6th ed.; PORSOLT RD, 1977, NATURE, V266, P730, DOI 10.1038/266730a0; Prins J, 2011, EXPERT OPIN INV DRUG, V20, P1107, DOI 10.1517/13543784.2011.594039; Rakofsky JJ, 2009, CURR OPIN CHEM BIOL, V13, P291, DOI 10.1016/j.cbpa.2009.04.617; Reith MEA, 2012, J PHARMACOL EXP THER, V343, P413, DOI 10.1124/jpet.112.193771; Risinger R, 2014, PSYCHOPHARMACOLOGY, V231, P2299, DOI 10.1007/s00213-013-3391-3; Santra S, 2012, CHEMMEDCHEM, V7, P2093, DOI 10.1002/cmdc.201200352; Schmitt KC, 2013, J PHARMACOL EXP THER, V346, P2, DOI 10.1124/jpet.111.191056; Skolnick P, 2006, CNS DRUG REV, V12, P123, DOI 10.1111/j.1527-3458.2006.00123.x; Song P, 2012, ANAL CHEM, V84, P412, DOI 10.1021/ac202794q; Sorensen G, 2014, BASIC CLIN PHARMACOL, V114, P451, DOI 10.1111/bcpt.12182; Strakowski SM, 1996, AM J PSYCHIAT, V153, P674; Tran P, 2012, J PSYCHIATR RES, V46, P64, DOI 10.1016/j.jpsychires.2011.09.003; Trivedi MH, 2006, NEW ENGL J MED, V354, P1243, DOI 10.1056/NEJMoa052964; Zhang SJ, 2006, J MED CHEM, V49, P4239, DOI 10.1021/jm0601699; Zhang SJ, 2005, J MED CHEM, V48, P4962, DOI 10.1021/jm049021k; Zhang SJ, 2004, BIOORGAN MED CHEM, V12, P6301, DOI 10.1016/j.bmc.2004.07.069; Zhang SJ, 2003, BIOORG MED CHEM LETT, V13, P1591, DOI 10.1016/S0960-894X(03)00169-0	50	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113420	10.1371/journal.pone.0113420	http://dx.doi.org/10.1371/journal.pone.0113420			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427177	gold, Green Published, Green Submitted			2022-12-26	WOS:000349145400051
J	Venkataraman, K; Khoo, C; Wee, HL; Tan, CS; Ma, S; Heng, D; Lee, J; Tai, ES; Thumboo, J				Venkataraman, Kavita; Khoo, ChinMeng; Wee, Hwee Lin; Tan, Chuen Seng; Ma, Stefan; Heng, Derrick; Lee, Jeannette; Tai, E. Shyong; Thumboo, Julian			Associations between Disease Awareness and Health-Related Quality of Life in a Multi-Ethnic Asian Population	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; RANDOMIZED CONTROLLED-TRIAL; RISK-FACTORS; DIABETIC-RETINOPATHY; CARDIOVASCULAR RISK; FOOT ULCERATION; SINGAPORE; HYPERTENSION; PREVALENCE; INDIVIDUALS	Background: Health related quality of life (HRQoL) is an important dimension of individuals' well-being, and especially in chronic diseases like diabetes and hypertension. The objective of this study was to evaluate the contributions of disease process, comorbidities, medication or awareness of the disease to HRQoL in diabetes mellitus, hypertension and dyslipidemia. Methods: This was a cross-sectional study of 3514 respondents from the general community in Singapore, assessed for HRQoL, disease and comorbid conditions through self-report, clinical and laboratory investigations. HRQoL was assessed using SF-36 health survey version 2. For each condition, participants were categorized as having 1) no disease, 2) undiagnosed, 3) diagnosed, not taking medication, and 4) diagnosed, taking medication. Analysis used one-way ANOVA and multiple linear regression. Results: Diagnosed disease was associated with lower physical health component summary (PCS) scores across all three conditions. After adjustment for comorbidities, this association remained significant only for those not on medication in diabetes (-2.7 +/- 1.2 points, p=0.03) and dyslipidemia (-1.3 +/- 0.4 points, p=0.003). Diagnosed hypertension (no medication -2.6 +/- 0.9 points, p=0.002; medication -1.4 +/- 0.5 points, p=0.004) and dyslipidemia (no medication -0.9 +/- 0.4 points, p=0.03; medication -1.9 +/- 0.5 points, p<0.001) were associated with lower mental health component summary (MCS) scores. Undiagnosed disease was associated with higher MCS in diabetes (2.4 +/- 1.0 points, p=0.01) and dyslipidemia (0.8 +/- 0.4 points, p=0.045), and PCS in hypertension (1.2 +/- 0.4 points, p=0.004). Conclusions: Disease awareness was associated with lower HRQoL across the diseases studied, with PCS associations partially mediated by comorbidities. Equally importantly, undiagnosed disease was not associated with HRQoL deficits, which may partly explain why these individuals do not seek medical care.	[Venkataraman, Kavita; Tan, Chuen Seng; Lee, Jeannette] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Venkataraman, Kavita; Khoo, ChinMeng; Tan, Chuen Seng; Lee, Jeannette; Tai, E. Shyong; Thumboo, Julian] Natl Univ Hlth Syst, Singapore, Singapore; [Khoo, ChinMeng; Tai, E. Shyong; Thumboo, Julian] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117548, Singapore; [Wee, Hwee Lin] Natl Univ Singapore, Dept Pharm, Singapore 117548, Singapore; [Wee, Hwee Lin; Thumboo, Julian] Singapore Gen Hosp, Dept Rheumatol & Immunol, Singapore, Singapore; [Ma, Stefan; Heng, Derrick] Minist Hlth, Epidemiol & Dis Control Div, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Singapore General Hospital; Ministry of Health-Singapore	Thumboo, J (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117548, Singapore.	julian.thumboo@sgh.com.sg	Tan, Chuen Seng/K-1078-2013; Wee, Hwee Lin/D-4126-2012; Khoo, Chin Meng/AAD-8790-2022; Venkataraman, Kavita/Q-8956-2019; Tan, Chuen Seng/I-6854-2019	Tan, Chuen Seng/0000-0002-6513-2309; Wee, Hwee Lin/0000-0002-7150-1801; Venkataraman, Kavita/0000-0002-3139-6998; Tan, Chuen Seng/0000-0002-6513-2309; Tai, E Shyong/0000-0003-2929-8966	National Medical Research Council, Singapore [0838/2004, IRG07nov013, NMRC/0863/2004]; Biomedical Research Council [03/1/27/18/216, 08/1/35/19/550]; Diabetes Research Fund, National University of Singapore	National Medical Research Council, Singapore(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Diabetes Research Fund, National University of Singapore(National University of Singapore)	This work was supported by grants from the National Medical Research Council, Singapore (Grant numbers: 0838/2004, IRG07nov013, and NMRC/0863/2004); the Biomedical Research Council (Grant numbers: 03/1/27/18/216 and 08/1/35/19/550) and the Diabetes Research Fund, National University of Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso J, 2004, QUAL LIFE RES, V13, P283, DOI 10.1023/B:QURE.0000018472.46236.05; [Anonymous], 2005, NATL HLTH SURVEY 200; [Anonymous], 2011, NATL HLTH SURVEY 201; Carlsson CM, 2002, DRUG AGING, V19, P793, DOI 10.2165/00002512-200219100-00008; Cham S, 2010, PHARMACOTHERAPY, V30, P541, DOI 10.1592/phco.30.6.541; Chiang PPC, 2011, INVEST OPHTH VIS SCI, V52, P7586, DOI 10.1167/iovs.11-7698; Cutter J, 2001, B WORLD HEALTH ORGAN, V79, P908; DOWNS JR, 1993, JAMA-J AM MED ASSOC, V269, P3107, DOI 10.1001/jama.269.24.3107; Eborall HC, 2007, BMJ-BRIT MED J, V335, P486, DOI 10.1136/bmj.39303.723449.55; Edelman D, 2002, DIABETES CARE, V25, P1022, DOI 10.2337/diacare.25.6.1022; Einvik G, 2010, J PSYCHOSOM RES, V68, P567, DOI 10.1016/j.jpsychores.2009.11.004; Evans MA, 2009, PHARMACOTHERAPY, V29, P800, DOI 10.1592/phco.29.7.800; Heyworth ITM, 2009, BRIT J GEN PRACT, V59, P833, DOI 10.3399/bjgp09X453990; Hughes K, 1997, J EPIDEMIOL COMMUN H, V51, P394, DOI 10.1136/jech.51.4.394; HUGHES K, 1990, J EPIDEMIOL COMMUN H, V44, P29, DOI 10.1136/jech.44.1.29; Korhonen PE, 2011, J HYPERTENS, V29, P2070, DOI 10.1097/HJH.0b013e32834bbca7; Kosinski M, 2000, ARTHRITIS RHEUM-US, V43, P1478, DOI 10.1002/1529-0131(200007)43:7<1478::AID-ANR10>3.0.CO;2-M; KUMAR S, 1991, DIABETES RES CLIN PR, V13, P63, DOI 10.1016/0168-8227(91)90034-B; Levey AS, 2003, ANN INTERN MED, V139, P137, DOI 10.7326/0003-4819-139-2-200307150-00013; Maatouk I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031088; Mena-Martin FJ, 2003, J HYPERTENS, V21, P1283, DOI 10.1097/00004872-200307000-00015; Mo Health, 2011, SCREENING CARDIOVASC; Muldoon MF, 2004, AM J MED, V117, P823, DOI 10.1016/j.amjmed.2004.07.041; Nang EEK, 2009, AM J EPIDEMIOL, V169, P1454, DOI 10.1093/aje/kwp076; Park P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-350; Poljicanin T, BMC PUBLIC HLTH, V10, P12; Sabanayagam C, 2009, J HYPERTENS, V27, P2209, DOI 10.1097/HJH.0b013e328330141d; Stein J D, 2002, J Clin Hypertens (Greenwich), V4, P181, DOI 10.1111/j.1524-6175.2002.00970.x; Tan CE, 1999, DIABETES CARE, V22, P241, DOI 10.2337/diacare.22.2.241; TESTA MA, 1993, NEW ENGL J MED, V328, P907, DOI 10.1056/NEJM199304013281302; Thumboo J, 1999, LUPUS, V8, P514, DOI 10.1191/096120399678840747; Thumboo J, 2013, QUAL LIFE RES, V22, P2501, DOI 10.1007/s11136-013-0381-1; Trevisol DJ, 2012, J HUM HYPERTENS, V26, P374, DOI 10.1038/jhh.2011.48; Trevisol DJ, 2011, J HYPERTENS, V29, P179, DOI 10.1097/HJH.0b013e328340d76f; UK Prospective Diabetes Study Grp, 1999, DIABETES CARE, V22, P1125; Vathesatogkit P, PLOS ONE, V7; Venkataraman K, 2013, CLIN ENDOCRINOL, V78, P865, DOI 10.1111/j.1365-2265.2012.04480.x; Ware J, 2007, USERS MANUAL SF36V2; Wexler DJ, 2006, DIABETOLOGIA, V49, P1489, DOI 10.1007/s00125-006-0249-9; Wong TY, 2008, OPHTHALMOLOGY, V115, P1869, DOI 10.1016/j.ophtha.2008.05.014; YOUNG MJ, 1994, DIABETES CARE, V17, P557, DOI 10.2337/diacare.17.6.557	41	13	13	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113802	10.1371/journal.pone.0113802	http://dx.doi.org/10.1371/journal.pone.0113802			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CA8CZ	25426951	Green Published, gold, Green Submitted			2022-12-26	WOS:000349145400087
J	Oghumu, S; Terrazas, CA; Varikuti, S; Kimble, J; Vadia, S; Yu, LB; Seveau, S; Satoskar, AR				Oghumu, Steve; Terrazas, Cesar A.; Varikuti, Sanjay; Kimble, Jennifer; Vadia, Stephen; Yu, Lianbo; Seveau, Stephanie; Satoskar, Abhay R.			CXCR3 expression defines a novel subset of innate CD8(+) T cells that enhance immunity against bacterial infection and cancer upon stimulation with IL-15	FASEB JOURNAL			English	Article						granzyme; interferon; Listeria; cytokine; cytotoxicity	LISTERIA-MONOCYTOGENES INFECTION; RECEPTOR-BETA CHAIN; CATHEPSIN-W; MICE; PROTECTION; DISTINCT; ITK; DEFICIENT; LINEAGES; ABSENCE	Innate CD8(+) T cells are a heterogeneous population with developmental pathways distinct from conventional CD8(+) T cells. However, their biology, classification, and functions remain incompletely understood. We recently demonstrated the existence of a novel population of chemokine (C-X-C motif) receptor 3 (CXCR3)-positive innate CD8(+) T cells. Here, we investigated the functional properties of this subset and identified effector molecules and pathways which mediate their function. Adoptive transfer of IL-15 activated CXCR3(+) innate CD8(+) T cells conferred increased protection against Listeria monocytogenes infection in susceptible IFN-gamma(-/-) mice compared with similarly activated CXCR3(-) subset. This was associated with enhanced proliferation and IFN-gamma production in CXCR3(+) cells. Further, CXCR3(+) innate cells showed enhanced cytotoxicity against a tumor cell line in vitro. In depth analysis of the CXCR3(+) subset showed increased gene expression of Ccl5, Klrc1, CtsW, GP49a, IL-2R beta, Atp5e, and Ly6c but reduced IFN-gamma R2 and Art2 beta. Ingenuity pathway analysis revealed an up-regulation of genes associated with T-cell activation, proliferation, cytotoxicity, and translational initiation in CXCR3(+) populations. Our results demonstrate that CXCR3 expression in innate CD8(+) T cells defines a subset with enhanced cytotoxic potential and protective antibacterial immune functions. Immunotherapeutic approaches against infectious disease and cancer could utilize CXCR3(+) innate CD8(+) T-cell populations as novel clinical intervention strategies.	[Oghumu, Steve; Terrazas, Cesar A.; Varikuti, Sanjay; Kimble, Jennifer; Satoskar, Abhay R.] Ohio State Univ, Med Ctr, Dept Pathol, Columbus, OH 43210 USA; [Oghumu, Steve] Ohio State Univ, Coll Dent, Dept Oral Biol, Columbus, OH 43210 USA; [Vadia, Stephen; Seveau, Stephanie; Satoskar, Abhay R.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA; [Yu, Lianbo] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Seveau, Stephanie] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Satoskar, AR (corresponding author), Dept Pathol, 1645 Neil Ave, Columbus, OH 43210 USA.	abhay.satoskar@osumc.edu	yu, lianbo/B-3472-2010; Satoskar, Abhay/AAB-7748-2019; Oghumu, Steve/Z-3320-2019	Vadia, Stephen/0000-0001-9071-4573	U.S. National Institutes of Health (NIH) [R03-AI090231, RC4-AI092624, R34-AI100789, R21-AT004160, R03-CA164399]; NIH National Institute of Dental and Craniofacial Research [T32DE014320]; National Council of Science and Technology, Mexico (CONACYT); NATIONAL CANCER INSTITUTE [R03CA164399] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [R21AT004160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R34AI100789, RC4AI092624, R03AI090231] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE014320] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); National Council of Science and Technology, Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the U.S. National Institutes of Health (NIH) (Grants R03-AI090231, RC4-AI092624, R34-AI100789, R21-AT004160, and R03-CA164399) (to A.R.S.), NIH National Institute of Dental and Craniofacial Research (Training Grant T32DE014320) (to S.O.), and National Council of Science and Technology, Mexico (CONACYT) (to C.T.).	BACH EA, 1995, SCIENCE, V270, P1215, DOI 10.1126/science.270.5239.1215; Berg LJ, 2007, NAT REV IMMUNOL, V7, P479, DOI 10.1038/nri2091; Berg RE, 2005, J IMMUNOL, V175, P1751, DOI 10.4049/jimmunol.175.3.1751; Berg RE, 2003, J EXP MED, V198, P1583, DOI 10.1084/jem.20031051; Broussard C, 2006, IMMUNITY, V25, P93, DOI 10.1016/j.immuni.2006.05.011; Cerwenka A, 1999, J EXP MED, V189, P423, DOI 10.1084/jem.189.2.423; Chenoweth MJ, 2012, J IMMUNOL, V188, P4149, DOI 10.4049/jimmunol.1101883; Cho HS, 2011, J IMMUNOL, V186, P489, DOI 10.4049/jimmunol.1002639; D'Orazio SEF, 2006, J IMMUNOL, V177, P7146, DOI 10.4049/jimmunol.177.10.7146; D'Orazio SEF, 2003, J IMMUNOL, V171, P291, DOI 10.4049/jimmunol.171.1.291; Dhanji S, 2006, J IMMUNOL, V177, P138, DOI 10.4049/jimmunol.177.1.138; Dubois S, 2006, P NATL ACAD SCI USA, V103, P12075, DOI 10.1073/pnas.0605212103; Grange M, 2013, J IMMUNOL, V191, P3712, DOI 10.4049/jimmunol.1300319; Grange M, 2012, CANCER RES, V72, P76, DOI 10.1158/0008-5472.CAN-11-2187; Hu J, 2007, EUR J IMMUNOL, V37, P2892, DOI 10.1002/eji.200737311; Huang WS, 2013, J IMMUNOL, V190, P2490, DOI 10.4049/jimmunol.1202988; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Itsumi M, 2009, EUR J IMMUNOL, V39, P1784, DOI 10.1002/eji.200839106; Katz HR, 1996, P NATL ACAD SCI USA, V93, P10809, DOI 10.1073/pnas.93.20.10809; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Lee KH, 2000, J IMMUNOL, V165, P4970, DOI 10.4049/jimmunol.165.9.4970; Mitani A, 1999, IMMUNOLOGY, V97, P92; Oghumu S, 2014, IMMUNOLOGY, V143, P109, DOI 10.1111/imm.12293; Oghumu S, 2013, J IMMUNOL, V190, P2229, DOI 10.4049/jimmunol.1201170; Perera LP, 1999, J IMMUNOL, V162, P2606; PERNIS A, 1995, SCIENCE, V269, P245, DOI 10.1126/science.7618088; Rosas LE, 2005, EUR J IMMUNOL, V35, P515, DOI 10.1002/eji.200425422; Seaman MS, 2000, J IMMUNOL, V165, P5192, DOI 10.4049/jimmunol.165.9.5192; Shrestha N, 2012, J BIOL CHEM, V287, P28738, DOI 10.1074/jbc.M112.375915; Shrikant PA, 2010, IMMUNOL RES, V46, P12, DOI 10.1007/s12026-009-8130-9; Sintes J, 2013, J IMMUNOL, V190, P21, DOI 10.4049/jimmunol.1202435; Stoeckle C, 2009, EXP HEMATOL, V37, P266, DOI 10.1016/j.exphem.2008.10.011; Tau GZ, 2000, J EXP MED, V192, P977, DOI 10.1084/jem.192.7.977; Thompson LJ, 2006, J IMMUNOL, V177, P1746, DOI 10.4049/jimmunol.177.3.1746; Verykokakis M, 2010, IMMUNITY, V33, P203, DOI 10.1016/j.immuni.2010.07.013; Wex T, 2003, FEBS LETT, V552, P115, DOI 10.1016/S0014-5793(03)00895-0; Woodland DL, 2003, CURR OPIN IMMUNOL, V15, P336, DOI 10.1016/S0952-7915(03)00037-2; Xu HL, 2006, J EXP MED, V203, P449, DOI 10.1084/jem.20051866	38	15	17	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					1019	1028		10.1096/fj.14-264507	http://dx.doi.org/10.1096/fj.14-264507			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25466888	Green Published			2022-12-26	WOS:000350633000026
J	Schafer, CT; Farrens, DL				Schafer, Christopher T.; Farrens, David L.			Conformational Selection and Equilibrium Governs the Ability of Retinals to Bind Opsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; BETA(2) ADRENERGIC-RECEPTOR; CRYSTAL-STRUCTURE; LIGAND-FREE; ROD OPSIN; FLUORESCENCE SPECTROSCOPY; CONSTITUTIVE ACTIVATION; METARHODOPSIN-II; BOVINE RHODOPSIN; VISUAL PIGMENTS	Despite extensive study, how retinal enters and exits the visual G protein-coupled receptor rhodopsin remains unclear. One clue may lie in two openings between transmembrane helix 1 (TM1) and TM7 and between TM5 and TM6 in the active receptor structure. Recently, retinal has been proposed to enter the inactive apoprotein opsin (ops) through these holes when the receptor transiently adopts the active opsin conformation (ops*). Here, we directly test this "transient activation" hypothesis using a fluorescence-based approach to measure rates of retinal binding to samples containing differing relative fractions of ops and ops*. In contrast to what the transient activation hypothesis model would predict, we found that binding for the inverse agonist, 11-cis-retinal (11CR), slowed when the sample contained more ops* (produced using M257Y, a constitutively activating mutation). Interestingly, the increased presence of ops* allowed for binding of the agonist, all-trans-retinal (ATR), whereas WT opsin showed no binding. Shifting the conformational equilibrium toward even more ops* using a G protein peptide mimic (either free in solution or fused to the receptor) accelerated the rate of ATR binding and slowed 11CR binding. An arrestin peptide mimic showed little effect on 11CR binding; however, it stabilized opsin.ATR complexes. The TM5/TM6 hole is apparently not involved in this conformational selection. Increasing its size by mutagenesis did not enable ATR binding but instead slowed 11CR binding, suggesting that it may play a role in trapping 11CR. In summary, our results indicate that conformational selection dictates stable retinal binding, which we propose involves ATR and 11CR binding to different states, the latter a previously unidentified, open-but-inactive conformation.	[Schafer, Christopher T.; Farrens, David L.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA	Oregon Health & Science University	Farrens, DL (corresponding author), Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	farrensd@ohsu.edu		Schafer, Christopher/0000-0001-9907-295X	National Institutes of Health [R01 EY015436, T32 EY023211, T32 GM071338]; Medical Research Foundation of Oregon; Achievement Rewards for College Scientists Foundation of Portland; Oregon Health and Science University Tartar Trust; NATIONAL EYE INSTITUTE [T32EY023211, R01EY015436] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM071338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Foundation of Oregon; Achievement Rewards for College Scientists Foundation of Portland; Oregon Health and Science University Tartar Trust; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 EY015436 (to D. L. F.) and Training Grants T32 EY023211 and T32 GM071338 (to C. T. S.). This work was also supported by the Medical Research Foundation of Oregon (to D. L. F.).; Supported by the Achievement Rewards for College Scientists Foundation of Portland and Oregon Health and Science University Tartar Trust.	Blakeley LR, 2011, INVEST OPHTH VIS SCI, V52, P3483, DOI 10.1167/iovs.10-6694; Brown MF, 2010, BBA-BIOMEMBRANES, V1798, P177, DOI 10.1016/j.bbamem.2009.08.013; Brueggemann LI, 2001, BIOCHEMISTRY-US, V40, P4446, DOI 10.1021/bi002267g; Buczylko J, 1996, J BIOL CHEM, V271, P20621, DOI 10.1074/jbc.271.34.20621; Chen CH, 2012, J BIOL CHEM, V287, P24662, DOI 10.1074/jbc.M112.354514; Chen MH, 2012, BIOCHEMISTRY-US, V51, P4117, DOI 10.1021/bi201522h; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; COHEN GB, 1992, BIOCHEMISTRY-US, V31, P12592, DOI 10.1021/bi00165a008; COHEN GB, 1993, BIOCHEMISTRY-US, V32, P6111, DOI 10.1021/bi00074a024; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Deupi X, 2010, PHYSIOLOGY, V25, P293, DOI 10.1152/physiol.00002.2010; DRATZ EA, 1993, NATURE, V363, P276, DOI 10.1038/363276a0; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; FARRENS DL, 1995, J BIOL CHEM, V270, P5073, DOI 10.1074/jbc.270.10.5073; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fay JF, 2012, J BIOL CHEM, V287, P33873, DOI 10.1074/jbc.M112.352328; FERRETTI L, 1986, P NATL ACAD SCI USA, V83, P599, DOI 10.1073/pnas.83.3.599; Feuerstein SE, 2009, BIOCHEMISTRY-US, V48, P10733, DOI 10.1021/bi900544p; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Han M, 1998, BIOCHEMISTRY-US, V37, P8253, DOI 10.1021/bi980147r; Hanson SM, 2006, P NATL ACAD SCI USA, V103, P4900, DOI 10.1073/pnas.0600733103; Heck M, 2003, VISION RES, V43, P3003, DOI 10.1016/j.visres.2003.08.011; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Hofmann KP, 2009, TRENDS BIOCHEM SCI, V34, P540, DOI 10.1016/j.tibs.2009.07.005; HOFMANN KP, 1992, J BIOL CHEM, V267, P15701; Hunyady L, 2003, TRENDS PHARMACOL SCI, V24, P81, DOI 10.1016/S0165-6147(02)00050-0; Imamoto Y, 2013, BIOCHEMISTRY-US, V52, P3010, DOI 10.1021/bi3015967; Jager S, 1996, BIOCHEMISTRY-US, V35, P2901, DOI 10.1021/bi9524068; Janz JM, 2004, J BIOL CHEM, V279, P29767, DOI 10.1074/jbc.M402567200; Jastrzebska B, 2013, FASEB J, V27, P1572, DOI 10.1096/fj.12-225383; Jastrzebska B, 2011, J BIOL CHEM, V286, P18930, DOI 10.1074/jbc.M111.234583; Kefalov VJ, 2001, NEURON, V29, P749, DOI 10.1016/S0896-6273(01)00249-5; Kim YJ, 2013, NATURE, V497, P142, DOI 10.1038/nature12133; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kono M, 2008, BIOCHEMISTRY-US, V47, P7567, DOI 10.1021/bi800357b; Lee KA, 2010, BIOCHEMISTRY-US, V49, P2454, DOI 10.1021/bi1001085; LEFF P, 1995, TRENDS PHARMACOL SCI, V16, P89, DOI 10.1016/S0165-6147(00)88989-0; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Liu J, 2011, J BIOL CHEM, V286, P27622, DOI 10.1074/jbc.M111.233312; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2010, P NATL ACAD SCI USA, V107, P8428, DOI 10.1073/pnas.1000640107; Martin EL, 1996, J BIOL CHEM, V271, P361, DOI 10.1074/jbc.271.1.361; Matsumoto H, 2008, PHOTOCHEM PHOTOBIOL, V84, P985, DOI 10.1111/j.1751-1097.2008.00338.x; Melia TJ, 1997, BIOPHYS J, V73, P3182, DOI 10.1016/S0006-3495(97)78344-9; Mustafi D, 2009, MOL PHARMACOL, V75, P1, DOI 10.1124/mol.108.051938; Ostermaier MK, 2014, P NATL ACAD SCI USA, V111, P1825, DOI 10.1073/pnas.1319402111; PALCZEWSKI K, 1994, BIOCHEMISTRY-US, V33, P13741, DOI 10.1021/bi00250a027; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Park JH, 2013, ANGEW CHEM INT EDIT, V52, P11021, DOI 10.1002/anie.201302374; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piechnick R, 2012, P NATL ACAD SCI USA, V109, P5247, DOI 10.1073/pnas.1117268109; Piechnick R, 2011, BIOCHEMISTRY-US, V50, P7168, DOI 10.1021/bi200675y; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; RESEK JF, 1993, BIOCHEMISTRY-US, V32, P12025, DOI 10.1021/bi00096a012; Saari JC, 1998, VISION RES, V38, P1325, DOI 10.1016/S0042-6989(97)00198-3; Sachs K, 2000, J BIOL CHEM, V275, P6189, DOI 10.1074/jbc.275.9.6189; Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103; SAMAMA P, 1993, J BIOL CHEM, V268, P4625; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Shukla AK, 2014, NATURE, V512, P218, DOI 10.1038/nature13430; Sinha A, 2014, BIOCHEMISTRY-US, V53, P3294, DOI 10.1021/bi401534y; Sommer ME, 2006, VISION RES, V46, P4532, DOI 10.1016/j.visres.2006.08.031; Sommer ME, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2000; Sommer ME, 2006, J BIOL CHEM, V281, P9407, DOI 10.1074/jbc.M510037200; Srinivasan S, 2014, CHEM BIOL, V21, P369, DOI 10.1016/j.chembiol.2014.01.006; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; Sugihara M, 2014, J STRUCT BIOL, V188, P79, DOI 10.1016/j.jsb.2014.08.001; Surya A, 1998, EXP EYE RES, V66, P599, DOI 10.1006/exer.1997.0453; SURYA A, 1995, J BIOL CHEM, V270, P5024, DOI 10.1074/jbc.270.10.5024; Swaminath G, 2004, J BIOL CHEM, V279, P686, DOI 10.1074/jbc.M310888200; Szczepek M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5801; Tian H, 2014, CHEMBIOCHEM, V15, P1820, DOI 10.1002/cbic.201402193; Tsukamoto H, 2013, J BIOL CHEM, V288, P28207, DOI 10.1074/jbc.M113.472464; Tsukamoto H, 2011, BIOCHEMISTRY-US, V50, P5086, DOI 10.1021/bi200391a; Tsukamoto H, 2010, J BIOL CHEM, V285, P7351, DOI 10.1074/jbc.M109.078709; Van Eps N, 2010, BIOCHEMISTRY-US, V49, P6877, DOI 10.1021/bi100846c; Vogel R, 2001, J BIOL CHEM, V276, P38487, DOI 10.1074/jbc.M105423200; WALD G, 1968, NATURE, V219, P800, DOI 10.1038/219800a0; Wang T, 2011, J MOL RECOGNIT, V24, P350, DOI 10.1002/jmr.1087; Xie GF, 2003, BIOCHEMISTRY-US, V42, P1995, DOI 10.1021/bi020611z; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Zhuang TD, 2013, P NATL ACAD SCI USA, V110, P942, DOI 10.1073/pnas.1215176110	85	18	18	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 13	2015	290	7					4304	4318		10.1074/jbc.M114.603134	http://dx.doi.org/10.1074/jbc.M114.603134			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB2LH	25451936	Green Published, hybrid			2022-12-26	WOS:000349458400040
J	Kitai, Y; Takeuchi, O; Kawasaki, T; Ori, D; Sueyoshi, T; Murase, M; Akira, S; Kawai, T				Kitai, Yuichi; Takeuchi, Osamu; Kawasaki, Takumi; Ori, Daisuke; Sueyoshi, Takuya; Murase, Motoya; Akira, Shizuo; Kawai, Taro			Negative Regulation of Melanoma Differentiation-associated Gene 5 (MDA5)-dependent Antiviral Innate Immune Responses by Arf-like Protein 5B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-LIKE RECEPTORS; E3 UBIQUITIN LIGASE; SENSORS RIG-I; MULTIPLE-SCLEROSIS; DSRNA RECOGNITION; MDA5; VIRUS; MITOCHONDRIA; ACTIVATION; INFECTION	RIG-I-like receptors (RLRs), including retinoic acid-inducible gene-I (RIG-I) and MDA5, constitute a family of cytoplasmic RNA helicases that senses viral RNA and mounts antiviral innate immunity by producing type I interferons and inflammatory cytokines. Despite their essential roles in antiviral host defense, RLR signaling is negatively regulated to protect the host from excessive inflammation and autoimmunity. Here, we identified ADP-ribosylation factor-like protein 5B (Arl5B), an Arl family small GTPase, as a regulator of RLR signaling through MDA5 but not RIG-I. Overexpression of Arl5B repressed interferon beta promoter activation by MDA5 but not RIG-I, and its knockdown enhanced MDA5-mediated responses. Furthermore, Arl5B-deficient mouse embryonic fibroblast cells exhibited increased type I interferon expression in response to MDA5 agonists such as poly(I:C) and encephalomyocarditis virus. Arl5B-mediated negative regulation of MDA5 signaling does not require its GTP binding ability but requires Arl5B binding to the C-terminal domain of MDA5, which prevents interaction between MDA5 and poly(I: C). Our results, therefore, suggest that Arl5B is a negative regulator for MDA5.	[Kitai, Yuichi; Kawasaki, Takumi; Sueyoshi, Takuya; Murase, Motoya; Kawai, Taro] Nara Inst Sci & Technol NAIST, Grad Sch Biol Sci, Lab Mol Immunobiol, Nara 6300192, Japan; [Kitai, Yuichi; Akira, Shizuo] Osaka Univ, Immunol Frontier Res Ctr IFReC, Host Def Lab, Suita, Osaka 5650871, Japan; [Kitai, Yuichi; Akira, Shizuo] Osaka Univ, Microbial Dis Res Inst, Dept Host Def, Suita, Osaka 5650871, Japan; [Takeuchi, Osamu; Ori, Daisuke] Kyoto Univ, Inst Virus Res, Lab Infect & Prevent, Sakyo Ku, Kyoto 6068507, Japan	Nara Institute of Science & Technology; Osaka University; Osaka University; Kyoto University	Kawai, T (corresponding author), Nara Inst Sci & Technol NAIST, Grad Sch Biol Sci, Lab Mol Immunobiol, 8916-5 Takayama Cho, Nara 6300192, Japan.	tarokawai@bs.naist.jp	Takeuchi, Osamu/AAG-9359-2019; Akira, Shizuo/C-3134-2009	Takeuchi, Osamu/0000-0002-1260-6232; Kawai, Taro/0000-0001-7510-4662	KAKENHI [26293107]; Japan Society for the Promotion of Science through the Program for World-Leading Innovative R&D on Science and Technology (FIRST Program); Cell Science Research Foundation; Naito Foundation	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Society for the Promotion of Science through the Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Cell Science Research Foundation(Cell Science Research Foundation, Japan); Naito Foundation(Naito Memorial Foundation)	This work was supported by a KAKENHI Grant-in-aid for Scientific Research (B) 26293107 and by the Japan Society for the Promotion of Science through the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program), The Cell Science Research Foundation, and The Naito Foundation.	Arimoto KI, 2007, P NATL ACAD SCI USA, V104, P7500, DOI 10.1073/pnas.0611551104; Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157; Berke IC, 2012, P NATL ACAD SCI USA, V109, P18437, DOI 10.1073/pnas.1212186109; Boppana S, 2013, J NEUROIMMUNOL, V265, P68, DOI 10.1016/j.jneuroim.2013.10.007; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Burd CG, 2004, TRENDS CELL BIOL, V14, P687, DOI 10.1016/j.tcb.2004.10.004; Clark K, 2013, NAT REV MOL CELL BIO, V14, P673, DOI 10.1038/nrm3644; Diao FC, 2007, P NATL ACAD SCI USA, V104, P11706, DOI 10.1073/pnas.0700544104; Eckard SC, 2014, NAT IMMUNOL, V15, P839, DOI 10.1038/ni.2948; Enevold C, 2009, J NEUROIMMUNOL, V212, P125, DOI 10.1016/j.jneuroim.2009.04.008; Fan YH, 2014, J EXP MED, V211, P313, DOI 10.1084/jem.20122844; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Funabiki M, 2014, IMMUNITY, V40, P199, DOI 10.1016/j.immuni.2013.12.014; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hauser SL, 2006, NEURON, V52, P61, DOI 10.1016/j.neuron.2006.09.011; Houghton FJ, 2012, EXP CELL RES, V318, P464, DOI 10.1016/j.yexcr.2011.12.023; Jacobs JL, 2013, J MOL BIOL, V425, P5009, DOI 10.1016/j.jmb.2013.10.007; Jiang XM, 2012, IMMUNITY, V36, P959, DOI 10.1016/j.immuni.2012.03.022; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kondo T, 2012, TRENDS IMMUNOL, V33, P449, DOI 10.1016/j.it.2012.05.002; Kuniyoshi K, 2014, P NATL ACAD SCI USA, V111, P5646, DOI 10.1073/pnas.1401674111; Lee H, 2013, P NATL ACAD SCI USA, V110, P12379, DOI 10.1073/pnas.1310604110; Lin RT, 2006, J BIOL CHEM, V281, P2095, DOI 10.1074/jbc.M510326200; Loo YM, 2011, IMMUNITY, V34, P680, DOI 10.1016/j.immuni.2011.05.003; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Okonski KM, 2013, J VIROL, V87, P756, DOI 10.1128/JVI.02270-12; Onomoto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043031; Oshiumi H, 2010, CELL HOST MICROBE, V8, P496, DOI 10.1016/j.chom.2010.11.008; Peisley A, 2011, P NATL ACAD SCI USA, V108, P21010, DOI 10.1073/pnas.1113651108; Pfender N, 2014, EXP NEUROL, V262, P44, DOI 10.1016/j.expneurol.2014.04.015; Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; Torres IL, 2014, J CELL SCI, V127, P2151, DOI 10.1242/jcs.122028; Tuli A, 2013, MOL BIOL CELL, V24, P3721, DOI 10.1091/mbc.E13-05-0259; Walkiewicz MP, 2011, J GEN VIROL, V92, P60, DOI 10.1099/vir.0.025015-0; Wies E, 2013, IMMUNITY, V38, P437, DOI 10.1016/j.immuni.2012.11.018; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Xu LJ, 2009, P NATL ACAD SCI USA, V106, P1530, DOI 10.1073/pnas.0811029106; Yang YK, 2011, J BIOL CHEM, V286, P10568, DOI 10.1074/jbc.M110.206896; Yoo JS, 2014, CURR OPIN MICROBIOL, V20, P131, DOI 10.1016/j.mib.2014.05.011; Zeng WW, 2010, CELL, V141, P315, DOI 10.1016/j.cell.2010.03.029	41	18	19	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1269	1280		10.1074/jbc.M114.611053	http://dx.doi.org/10.1074/jbc.M114.611053			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25451939	Green Published, hybrid			2022-12-26	WOS:000347778200055
J	Ogunbayo, OA; Zhu, YM; Shen, B; Agbani, E; Li, J; Ma, JJ; Zhu, MX; Evans, AM				Ogunbayo, Oluseye A.; Zhu, Yingmin; Shen, Bing; Agbani, Ejaife; Li, Jie; Ma, Jianjie; Zhu, Michael X.; Evans, A. Mark			Organelle-specific Subunit Interactions of the Vertebrate Two-pore Channel Family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM; NAADP; CA2+; REQUIREMENT; RECEPTORS; RELEASE; SODIUM	The organellar targeting of two-pore channels (TPCs) and their capacity to associate as homo-and heterodimers may be critical to endolysosomal signaling. A more detailed understanding of the functional association of vertebrate TPC1-3 is therefore necessary. We report here that when stably expressed in HEK293 cells, human (h) TPC1 and chicken (c) TPC3 were specifically targeted to different subpopulations of endosomes, hTPC2 was specifically targeted to lysosomes, and rabbit (r) TPC3 was specifically targeted to both endosomes and lysosomes. Intracellular dialysis of NAADP evoked a Ca2+ transient in HEK293 cells that stably overexpressed hTPC1, hTPC2, and rTPC3, but not in cells that stably expressed cTPC3. The Ca2+ transients induced in cells that overexpressed endosome-targeted hTPC1 were abolished upon depletion of acidic Ca2+ stores by bafilomycin A(1), but remained unaffected following depletion of endoplasmic reticulum stores by thapsigargin. In contrast, Ca2+ transients induced via lysosome-targeted hTPC2 and endolysosome-targeted rTPC3 were abolished by bafilomycin A(1) and markedly attenuated by thapsigargin. NAADP induced marked Ca2+ transients in HEK293 cells that stably coexpressed hTPC2 with hTPC1 or cTPC3, but failed to evoke any such response in cells that coexpressed interacting hTPC2 and rTPC3 subunits. We therefore conclude that 1) all three TPC subtypes may support Ca2+ signaling from their designate acidic stores, and 2) lysosome-targeted (but not endosome-targeted) TPCs support coupling to the endoplasmic reticulum.	[Ogunbayo, Oluseye A.; Agbani, Ejaife; Evans, A. Mark] Univ Edinburgh, Coll Med & Vet Med, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Zhu, Yingmin; Shen, Bing; Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA; [Shen, Bing; Li, Jie] Anhui Med Univ, Dept Physiol, Hefei 230032, Anhui, Peoples R China; [Ma, Jianjie] Ohio State Univ, Dept Surg, Davis Heart & Lung Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA	University of Edinburgh; University of Texas System; University of Texas Health Science Center Houston; Anhui Medical University; University System of Ohio; Ohio State University	Zhu, MX (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA.	michael.x.zhu@uth.tmc.edu; mark.evans@ed.ac.uk	Agbani, Ejaife O./AAC-9418-2020		National Institutes of Health [R01 GM092759]; British Heart Foundation [PG/10/95/28657, RG/12/14/29885]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092759] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); British Heart Foundation(British Heart Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01 GM092759 (to M. X. Z.) and by British Heart Foundation Project and Programme Grants PG/10/95/28657 and RG/12/14/29885 (to A. M. E.).	Aoyama M, 2004, J CELL SCI, V117, P2813, DOI 10.1242/jcs.01136; Brailoiu E, 2010, J BIOL CHEM, V285, DOI 10.1074/jbc.C109.081943; Brailoiu E, 2009, J CELL BIOL, V186, P201, DOI 10.1083/jcb.200904073; Cai XJ, 2010, MOL BIOL EVOL, V27, P2352, DOI 10.1093/molbev/msq122; Calcraft PJ, 2009, NATURE, V459, P596, DOI 10.1038/nature08030; Cang CL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6015; Ishibashi K, 2000, BIOCHEM BIOPH RES CO, V270, P370, DOI 10.1006/bbrc.2000.2435; Jha A, 2014, EMBO J, V33, P501, DOI 10.1002/embj.201387035; Miller WR, 2011, MOL CELL ENDOCRINOL, V340, P127, DOI 10.1016/j.mce.2011.04.020; Morgan AJ, 2014, BIOESSAYS, V36, P173, DOI 10.1002/bies.201300118; Ogunbayo OA, 2011, J BIOL CHEM, V286, P9136, DOI 10.1074/jbc.M110.202002; Pitt SJ, 2010, J BIOL CHEM, V285, P35039, DOI 10.1074/jbc.M110.156927; Ruas M, 2010, CURR BIOL, V20, P703, DOI 10.1016/j.cub.2010.02.049; Schieder M, 2010, J BIOL CHEM, V285, P21219, DOI 10.1074/jbc.C110.143123; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Wang X, 2012, CELL, V151, P372, DOI 10.1016/j.cell.2012.08.036; Zhu MX, 2010, FEBS LETT, V584, P1966, DOI 10.1016/j.febslet.2010.02.028; Zhu MX, 2010, AM J PHYSIOL-CELL PH, V298, pC430, DOI 10.1152/ajpcell.00475.2009; Zong XG, 2009, PFLUG ARCH EUR J PHY, V458, P891, DOI 10.1007/s00424-009-0690-y	19	18	18	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 9	2015	290	2					1086	1095		10.1074/jbc.M114.610493	http://dx.doi.org/10.1074/jbc.M114.610493			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AY8BA	25451935	Green Published, hybrid			2022-12-26	WOS:000347778200040
J	Ahanda, MLE; Zerjal, T; Dhorne-Pollet, S; Rau, A; Cooksey, A; Giuffra, E				Ahanda, Marie-Laure Endale; Zerjal, Tatiana; Dhorne-Pollet, Sophie; Rau, Andrea; Cooksey, Amanda; Giuffra, Elisabetta			Impact of the Genetic Background on the Composition of the Chicken Plasma MiRNome in Response to a Stress	PLOS ONE			English	Article							RESIDUAL FOOD-INTAKE; CIRCULATING MICRORNAS; CORRELATED RESPONSES; DIVERGENT SELECTION; SKELETAL-MUSCLE; FEED-INTAKE; EXPRESSION; IDENTIFICATION; TRANSCRIPTOME; TISSUES	Circulating extra-cellular microRNAs (miRNAs) have emerged as promising minimally invasive markers in human medicine. We evaluated miRNAs isolated from total plasma as biomarker candidates of a response to an abiotic stress (feed deprivation) in a livestock species. Two chicken lines selected for high (R+) and low (R-) residual feed intake were chosen as an experimental model because of their extreme divergence in feed intake and energy metabolism. Adult R+ and R-cocks were sampled after 16 hours of feed deprivation and again four hours after refeeding. More than 292 million sequence reads were generated by small RNA-seq of total plasma RNA. A total of 649 mature miRNAs were identified; after quality filtering, 148 miRNAs were retained for further analyses. We identified 23 and 19 differentially abundant miRNAs between feeding conditions and between lines respectively, with only two miRNAs identified in both comparisons. We validated a panel of six differentially abundant miRNAs by RT-qPCR on a larger number of plasma samples and checked their response to feed deprivation in liver. Finally, we evaluated the conservation and tissue distribution of differentially abundant miRNAs in plasma across a variety of red jungle fowl tissues. We show that the chicken plasma miRNome reacts promptly to the alteration of the animal physiological condition driven by a feed deprivation stress. The plasma content of stress-responsive miRNAs is strongly influenced by the genetic background, with differences reflecting the phenotypic divergence acquired through long-term selection, as evidenced by the profiles of conserved miRNAs with a regulatory role in energy metabolism (gga-miR-204, gga-miR-let-7f-5p and gga-miR-122-5p). These results reinforce the emerging view in human medicine that even small genetic differences can have a considerable impact on the resolution of biomarker studies, and provide support for the emerging interest in miRNAs as potential novel and minimally invasive biomarkers for livestock species.	[Ahanda, Marie-Laure Endale; Zerjal, Tatiana; Dhorne-Pollet, Sophie; Rau, Andrea; Giuffra, Elisabetta] INRA, UMR Genet Anim & Biol Integrat 1313, Jouy En Josas, France; [Ahanda, Marie-Laure Endale; Zerjal, Tatiana; Dhorne-Pollet, Sophie; Giuffra, Elisabetta] CEA, DSV, IRCM, SREIT,Lab Radiobiol & Etud Genome, Jouy En Josas, France; [Ahanda, Marie-Laure Endale; Zerjal, Tatiana; Dhorne-Pollet, Sophie; Rau, Andrea; Giuffra, Elisabetta] AgroParisTech, UMR Genet Anim & Biol Integrat 1313, Paris, France; [Cooksey, Amanda] Univ Arizona, Sch Anim & Comparat Biomed Sci, Tucson, AZ USA; [Cooksey, Amanda] Univ Arizona, Inst BIO5, Tucson, AZ USA	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; University of Arizona; University of Arizona	Giuffra, E (corresponding author), INRA, UMR Genet Anim & Biol Integrat 1313, Jouy En Josas, France.	elisabetta.giuffra@jouy.inra.fr	Giuffra, Elisabetta/J-8080-2014; zerjal, tatiana/AAO-9473-2020	Endale Ahanda, Marie-Laure/0000-0002-0861-1565; Giuffra, Elisabetta/0000-0001-9568-2056	INRA through the ''miRmarkers'' project (Animal Genetics Div.); ''INRA Package'' grant of EG	INRA through the ''miRmarkers'' project (Animal Genetics Div.); ''INRA Package'' grant of EG	The work was supported by INRA through the ''miRmarkers'' project (Animal Genetics Div.) and the ''INRA Package'' grant of EG (salaries of MLEA and EG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral PP, 2013, BRIEF FUNCT GENOMICS, V12, P254, DOI 10.1093/bfgp/elt016; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berezikov E, 2011, NAT REV GENET, V12, P846, DOI 10.1038/nrg3079; BORDAS A, 1992, BRIT POULTRY SCI, V33, P741, DOI 10.1080/00071669208417515; BORDAS A, 1984, ANN AGR FENN, V23, P233; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Chartoumpekis DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034872; Chemonges S, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-12; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cuk K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076729; Cuk K, 2013, INT J CANCER, V132, P1602, DOI 10.1002/ijc.27799; Daval S, 2000, GENET SEL EVOL, V32, P521, DOI 10.1051/gse:2000134; de Candia P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00043; de Nadal E, 2011, NAT REV GENET, V12, P833, DOI 10.1038/nrg3055; Desert C, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-611; ELKAZZI M, 1995, BRIT POULTRY SCI, V36, P719, DOI 10.1080/00071669508417816; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Frost RJA, 2011, P NATL ACAD SCI USA, V108, P21075, DOI 10.1073/pnas.1118922109; Gabarrou JF, 2000, BRIT J NUTR, V83, P645, DOI 10.1017/S0007114500000829; Garcia DM, 2011, NAT STRUCT MOL BIOL, V18, P1139, DOI 10.1038/nsmb.2115; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Hale A, 2014, BBA-MOL CELL RES, V1843, P2528, DOI 10.1016/j.bbamcr.2014.06.012; Hendrix D, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-4-r39; Kirigin FF, 2012, J IMMUNOL, V188, P3257, DOI 10.4049/jimmunol.1103175; Kuchen S, 2010, IMMUNITY, V32, P828, DOI 10.1016/j.immuni.2010.05.009; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leung AKL, 2010, MOL CELL, V40, P205, DOI 10.1016/j.molcel.2010.09.027; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li TT, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-186; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Luo GZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-727; Martin M, 2011, CUTADAPT REMOVES ADA; Meunier J, 2013, GENOME RES, V23, P34, DOI 10.1101/gr.140269.112; Owczarzy R, 2011, BIOCHEMISTRY-US, V50, P9352, DOI 10.1021/bi200904e; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Pritchard CC, 2012, CANCER PREV RES, V5, P492, DOI 10.1158/1940-6207.CAPR-11-0370; Rau A, 2011, RR7786 INR SACL; Rau A, 2013, BIOINFORMATICS, V29, P2146, DOI 10.1093/bioinformatics/btt350; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Schwarzenbach H, 2014, NAT REV CLIN ONCOL, V11, P145, DOI 10.1038/nrclinonc.2014.5; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Soares AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039417; Sturkie P.D., 1976, AVIAN PHYSIOL; Sun GZ, 2012, ROUTL STUD HIST ECON, V142, P11; Swennen Q, 2007, POULTRY SCI, V86, P895, DOI 10.1093/ps/86.5.895; TixierBoichard M, 1996, ANIM GENET, V27, P163, DOI 10.1111/j.1365-2052.1996.tb00944.x; Tryndyak VP, 2012, TOXICOL APPL PHARM, V262, P52, DOI 10.1016/j.taap.2012.04.018; Turchinovich A, 2012, TRENDS BIOCHEM SCI, V37, P460, DOI 10.1016/j.tibs.2012.08.003; Turchinovich A, 2011, NUCLEIC ACIDS RES, V39, P7223, DOI 10.1093/nar/gkr254; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wainwright EN, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110155; Wang Wang-Xia, 2014, Genomics Proteomics & Bioinformatics, V12, P19, DOI 10.1016/j.gpb.2013.10.003; Wang X, 2013, ANIMAL, V7, P1567, DOI 10.1017/S1751731113001183; Wang XG, 2012, POULTRY SCI, V91, P139, DOI 10.3382/ps.2011-01656; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287; Xu HT, 2006, FEBS LETT, V580, P3610, DOI 10.1016/j.febslet.2006.05.044; Zhao EP, 2009, MAMM GENOME, V20, P476, DOI 10.1007/s00335-009-9217-2; Zhao H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013735; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	63	12	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114598	10.1371/journal.pone.0114598	http://dx.doi.org/10.1371/journal.pone.0114598			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473826	Green Published, gold, Green Submitted			2022-12-26	WOS:000346382500048
J	Nijmeijer, RM; Schaap, FG; Smits, AJJ; Kremer, AE; Akkermans, LMA; Kroese, ABA; Rijkers, GT; Schipper, MEI; Verheem, A; Wijmenga, C; Gooszen, HG; van Erpecum, KJ				Nijmeijer, Rian M.; Schaap, Frank G.; Smits, Alexander J. J.; Kremer, Andreas E.; Akkermans, Louis M. A.; Kroese, Alfons B. A.; Rijkers, Ger. T.; Schipper, Marguerite E. I.; Verheem, Andre; Wijmenga, Cisca; Gooszen, Hein G.; van Erpecum, Karel J.			Impact of Global Fxr Deficiency on Experimental Acute Pancreatitis and Genetic Variation in the FXR Locus in Human Acute Pancreatitis	PLOS ONE			English	Article							INTESTINAL BARRIER DYSFUNCTION; NUCLEAR RECEPTOR FXR; GROWTH-FACTOR 19; GALLSTONE DISEASE; EXOCRINE PANCREAS; BINDING PROTEIN; ORGAN FAILURE; BILE; EXPRESSION; MICE	Background: Infectious complications often occur in acute pancreatitis, related to impaired intestinal barrier function, with prolonged disease course and even mortality as a result. The bile salt nuclear receptor farnesoid X receptor (FXR), which is expressed in the ileum, liver and other organs including the pancreas, exhibits anti-inflammatory effects by inhibiting NF-kappa B activation and is implicated in maintaining intestinal barrier integrity and preventing bacterial overgrowth and translocation. Here we explore, with the aid of complementary animal and human experiments, the potential role of FXR in acute pancreatitis. Methods: Experimental acute pancreatitis was induced using the CCK-analogue cerulein in wild-type and Fxr(-/-) mice. Severity of acute pancreatitis was assessed using histology and a semi-quantitative scoring system. Ileal permeability was analyzed in vitro by Ussing chambers and an in vivo permeability assay. Gene expression of Fxr and Fxr target genes was studied by quantitative RT-PCR. Serum FGF19 levels were determined by ELISA in acute pancreatitis patients and healthy volunteers. A genetic association study in 387 acute pancreatitis patients and 853 controls was performed using 9 tagging single nucleotide polymorphisms (SNPs) covering the complete FXR gene and two additional functional SNPs. Results: In wild-type mice with acute pancreatitis, ileal transepithelial resistance was reduced and ileal mRNA expression of Fxr target genes Fgf15, SHP, and IBABP was decreased. Nevertheless, Fxr(-/-) mice did not exhibit a more severe acute pancreatitis than wild-type mice. In patients with acute pancreatitis, FGF19 levels were lower than in controls. However, there were no associations of FXR SNPs or haplotypes with susceptibility to acute pancreatitis, or its course, outcome or etiology. Conclusion: We found no evidence for a major role of FXR in acute human or murine pancreatitis. The observed altered Fxr activity during the course of disease may be a secondary phenomenon.	[Nijmeijer, Rian M.; Akkermans, Louis M. A.; Kroese, Alfons B. A.; Verheem, Andre; Gooszen, Hein G.] Univ Med Ctr Utrecht, Dept Surg, Utrecht, Netherlands; [Schaap, Frank G.; Kremer, Andreas E.] Univ Amsterdam, Acad Med Ctr, Tytgat Inst Liver & Intestinal Res, NL-1105 AZ Amsterdam, Netherlands; [Schaap, Frank G.] Maastricht Univ, Dept Gen Surg, NL-6200 MD Maastricht, Netherlands; [Smits, Alexander J. J.; Schipper, Marguerite E. I.] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Kremer, Andreas E.] Univ Erlangen Nurnberg, Dept Med 1, D-91054 Erlangen, Germany; [Kroese, Alfons B. A.] Univ Utrecht, Inst Risk Assessment Sci, Neurotoxicol Res Grp, Utrecht, Netherlands; [Rijkers, Ger. T.; Gooszen, Hein G.] Radboud Univ Nijmegen Med Ctr, Dept Operating Rooms, Nijmegen, Netherlands; [Rijkers, Ger. T.] St Antonius Hosp, Dept Med Microbiol & Immunol, Nieuwegein, Netherlands; [Wijmenga, Cisca] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands; [van Erpecum, Karel J.] Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; Utrecht University; Utrecht University Medical Center; University of Erlangen Nuremberg; Utrecht University; Radboud University Nijmegen; St. Antonius Hospital Utrecht; University of Groningen; Utrecht University; Utrecht University Medical Center	van Erpecum, KJ (corresponding author), Univ Med Ctr Utrecht, Dept Gastroenterol & Hepatol, Utrecht, Netherlands.	K.J.vanErpecum@umcutrecht.nl	Wijmenga, Cisca/AAE-7719-2019; Gooszen, H.G./H-8036-2014; Rijkers, Ger/AAW-6143-2020; Wijmenga, Cisca/D-2173-2009; Rijkers, Ger/R-7236-2019	Wijmenga, Cisca/0000-0002-5635-1614; Rijkers, Ger/0000-0001-6948-6123; Kremer, Andreas/0000-0002-9263-948X; Schaap, Frank/0000-0002-1597-572X	University Medical Center Utrecht	University Medical Center Utrecht	Funding: RMN was supported by an Alexandre Suerman stipend from the University Medical Center Utrecht. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ammori BJ, 1999, J GASTROINTEST SURG, V3, P252, DOI 10.1016/S1091-255X(99)80067-5; Banks PA, 2006, AM J GASTROENTEROL, V101, P2379, DOI 10.1111/j.1572-0241.2006.00856.x; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beger HG, 1997, WORLD J SURG, V21, P130, DOI 10.1007/s002689900204; Bergheim I, 2006, J LIPID RES, V47, P42, DOI 10.1194/jlr.M500215-JLR200; Besselink MG, 2009, BRIT J SURG, V96, P267, DOI 10.1002/bjs.6447; Besselink MG, 2009, ANN SURG, V250, P712, DOI 10.1097/SLA.0b013e3181bce5bd; Besselink MGH, 2008, LANCET, V371, P651, DOI 10.1016/S0140-6736(08)60207-X; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; Choi M, 2006, NAT MED, V12, P1253, DOI 10.1038/nm1501; DEITCH EA, 1990, ARCH SURG-CHICAGO, V125, P403; Demols A, 2000, GASTROENTEROLOGY, V118, P582, DOI 10.1016/S0016-5085(00)70265-4; Drafahl KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014412; FALLON MB, 1995, GASTROENTEROLOGY, V108, P1863, DOI 10.1016/0016-5085(95)90151-5; Frossard JL, 2008, LANCET, V371, P143, DOI 10.1016/S0140-6736(08)60107-5; Gadaleta RM, 2011, BBA-MOL BASIS DIS, V1812, P851, DOI 10.1016/j.bbadis.2011.04.005; Gadaleta RM, 2011, GUT, V60, P463, DOI 10.1136/gut.2010.212159; Gadaleta RM, 2010, BBA-MOL CELL BIOL L, V1801, P683, DOI 10.1016/j.bbalip.2010.04.006; Inagaki T, 2006, P NATL ACAD SCI USA, V103, P3920, DOI 10.1073/pnas.0509592103; Jedlitschky G, 1997, BIOCHEM J, V327, P305, DOI 10.1042/bj3270305; Kok T, 2003, J BIOL CHEM, V278, P41930, DOI 10.1074/jbc.M306309200; Kovacs P, 2008, J HEPATOL, V48, P116, DOI 10.1016/j.jhep.2007.07.027; Lutgendorff F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004512; Moschetta A, 2004, NAT MED, V10, P1352, DOI 10.1038/nm1138; Nierman MC, 2005, METABOLISM, V54, P1499, DOI 10.1016/j.metabol.2005.05.016; Nijmeijer RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085870; Nijmeijer RM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023745; Renner O, 2008, J LIPID RES, V49, P2045, DOI 10.1194/jlr.M800162-JLR200; Rizzo Giovanni, 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P289, DOI 10.2174/1568008054863781; Rychter JW, 2009, SURGERY, V145, P157, DOI 10.1016/j.surg.2008.09.011; Schaap FG, 2009, HEPATOLOGY, V49, P1228, DOI 10.1002/hep.22771; Schmitt M, 2004, PANCREAS, V28, P181, DOI 10.1097/00006676-200403000-00010; Schnekenburger J, 2005, GUT, V54, P1445, DOI 10.1136/gut.2004.063164; Van Felius ID, 2003, NEUROGASTROENT MOTIL, V15, P267, DOI 10.1046/j.1365-2982.2003.00410.x; Van Mil SWC, 2007, GASTROENTEROLOGY, V133, P507, DOI 10.1053/j.gastro.2007.05.015; VANLEEUWEN PAM, 1994, GUT, V35, pS28, DOI 10.1136/gut.35.1_Suppl.S28; Vavassori P, 2009, J IMMUNOL, V183, P6251, DOI 10.4049/jimmunol.0803978; Venneman NG, 2005, HEPATOLOGY, V41, P738, DOI 10.1002/hep.20616; Wang YD, 2008, HEPATOLOGY, V48, P1632, DOI 10.1002/hep.22519; Wang YD, 2008, CELL RES, V18, P1087, DOI 10.1038/cr.2008.289; Wapenaar MC, 2008, GUT, V57, P463, DOI 10.1136/gut.2007.133132; Zweers SJLB, 2012, HEPATOLOGY, V55, P575, DOI 10.1002/hep.24702	42	7	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114393	10.1371/journal.pone.0114393	http://dx.doi.org/10.1371/journal.pone.0114393			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470824	Green Submitted, Green Published, gold			2022-12-26	WOS:000349128700115
J	Weber, DG; Casjens, S; Johnen, G; Bryk, O; Raiko, I; Pesch, B; Kollmeier, J; Bauer, TT; Bruning, T				Weber, Daniel G.; Casjens, Swaantje; Johnen, Georg; Bryk, Oleksandr; Raiko, Irina; Pesch, Beate; Kollmeier, Jens; Bauer, Torsten T.; Bruening, Thomas			Combination of MiR-103a-3p and Mesothelin Improves the Biomarker Performance of Malignant Mesothelioma Diagnosis	PLOS ONE			English	Article							PLEURAL MESOTHELIOMA; LUNG-CANCER; MICRORNAS; CA125; BLOOD; SERUM; MORTALITY; PLASMA; TRENDS; GPRC5A	Background: For the detection of malignant mesothelioma no single biomarker with reasonable sensitivity and specificity has been described so far. Mesothelin, the most prominent blood-based biomarker, is characterized by high specificity but low sensitivity. It might be reasonable to combine biomarkers of different molecular classes in order to improve the overall performance. The aim of this study was to assess the performance of the combination of mesothelin and miR-103a-3p as blood-based biomarker for mesothelioma. Methods/Principal Findings: Mesothelin concentration in plasma and miR-103a-3p levels in the cellular blood fraction were analyzed in 43 male mesothelioma patients and 52 male controls formerly exposed to asbestos. For the discrimination of epithelioid and biphasic mesothelioma from asbestos-exposed controls mesothelin and miR-103a-3p showed 74% and 89% sensitivity and 85% and 63% specificity, respectively. For the combination of mesothelin and miR-103a-3p a sensitivity of 95% and a specificity of 81% were calculated. Conclusions/Significance: The results of this study show that the combination of mesothelin and miR-103a-3p improves the diagnostic performance of individual blood-based biomarker to detect malignant mesothelioma. The obtained results indicate that the use of biomarkers of different molecular classes might be a reasonable approach to assemble a biomarker panel.	[Weber, Daniel G.; Casjens, Swaantje; Johnen, Georg; Bryk, Oleksandr; Raiko, Irina; Pesch, Beate; Bruening, Thomas] Inst Ruhr Univ Bochum IPA, Inst Prevent & Occupat Med German Social Accid In, Ctr Mol Med, Bochum, Germany; [Kollmeier, Jens; Bauer, Torsten T.] HELIOS Clin Emil von Behring, Resp Dis Clin Heckeshorn, Berlin, Germany	Ruhr University Bochum	Weber, DG (corresponding author), Inst Ruhr Univ Bochum IPA, Inst Prevent & Occupat Med German Social Accid In, Ctr Mol Med, Bochum, Germany.	weber@ipa-dguv.de	Brüning, Thomas/G-8120-2015; Johnen, Georg/AFG-8027-2022	Brüning, Thomas/0000-0001-9560-5464; Johnen, Georg/0000-0002-3773-5946; Kollmeier, Jens/0000-0002-8048-3895				Acquafreda T, 2009, CANCER BIOL THER, V8, P963, DOI 10.4161/cbt.8.10.8417; Beyer HL, 2007, CLIN CHEM, V53, P666, DOI 10.1373/clinchem.2006.079327; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Corradi M, 2013, ANTICANCER RES, V33, P5517; Creaney J, 2007, CHEST, V132, P1239, DOI 10.1378/chest.07-0013; Cristaudo A, 2011, J THORAC ONCOL, V6, P1587, DOI 10.1097/JTO.0b013e31821e1c08; Cui A, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004145; Di Serio F, 2007, CLIN CHEM LAB MED, V45, P634, DOI 10.1515/CCLM.2007.112; Fraser CG, 2004, CLIN CHEM LAB MED, V42, P758, DOI 10.1515/CCLM.2004.128; Grigoriu B D, 2009, Monaldi Arch Chest Dis, V71, P31; Gube M, 2011, ARCH TOXICOL, V85, P185, DOI 10.1007/s00204-010-0580-2; Henderson DW, 2013, J CLIN PATHOL, V66, P854, DOI 10.1136/jclinpath-2013-201609; Hodgson JT, 2005, BRIT J CANCER, V92, P587, DOI 10.1038/sj.bjc.6602307; Jakubec P, 2014, BIOMED PAP IN PRESS; Kirschner Michaela B., 2013, Frontiers in Genetics, V4, P94, DOI 10.3389/fgene.2013.00094; Kirschner MB, 2012, J THORAC ONCOL, V7, P1184, DOI 10.1097/JTO.0b013e3182572e83; Liu X, 2013, ONCOL REP, V29, P1415, DOI 10.3892/or.2013.2263; Lowe KA, 2008, CANCER EPIDEM BIOMAR, V17, P2480, DOI 10.1158/1055-9965.EPI-08-0150; Muley T, 2013, J THORAC ONCOL, V8, P947, DOI 10.1097/JTO.0b013e31828f696b; Myojin T, 2012, IND HEALTH, V50, P197, DOI 10.2486/indhealth.MS1184; Ordonez NG, 2014, HUM PATHOL, V45, P1529, DOI 10.1016/j.humpath.2014.03.006; Pass HI, 2012, NEW ENGL J MED, V367, P1417, DOI 10.1056/NEJMoa1115050; Pesch B, 2014, BBA-PROTEINS PROTEOM, V1844, P874, DOI 10.1016/j.bbapap.2013.12.007; Price B, 2004, AM J EPIDEMIOL, V159, P107, DOI 10.1093/aje/kwh025; Raiko I, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-242; Robinson BM, 2012, ANN CARDIOTHORAC SUR, V1, P491, DOI 10.3978/j.issn.2225-319X.2012.11.04; Santarelli L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018232; Shen SJ, 2014, CHEM RES TOXICOL, V27, P27, DOI 10.1021/tx400305w; Tan KS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007689; Tang ZW, 2013, ANTI-CANCER AGENT ME, V13, P276, DOI 10.2174/1871520611313020014; Tsongalis GJ, 2013, CLIN CHEM, V59, P343, DOI 10.1373/clinchem.2012.185009; Vogelzang NJ, 2003, J CLIN ONCOL, V21, P2636, DOI 10.1200/JCO.2003.11.136; Weber Daniel G., 2007, Cancer Biomarkers, V3, P287; Weber DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030221; Weber DG, 2010, BIOMARK INSIGHTS, V5, P95; Yoneda K, 2013, ANN SURG ON IN PRESS; Zhou HL, 2014, RNA, V20, P1431, DOI 10.1261/rna.045757.114	37	41	41	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114483	10.1371/journal.pone.0114483	http://dx.doi.org/10.1371/journal.pone.0114483			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469901	Green Published, gold, Green Submitted			2022-12-26	WOS:000349128700120
J	Bates, JL; Karriker, LA; Stock, ML; Pertzborn, KM; Baldwin, LG; Wulf, LW; Lee, CJ; Wang, C; Coetzee, JF				Bates, Jessica L.; Karriker, Locke A.; Stock, Matthew L.; Pertzborn, Kelly M.; Baldwin, Luke G.; Wulf, Larry W.; Lee, C. J.; Wang, Chong; Coetzee, Johann F.			Impact of Transmammary-Delivered Meloxicam on Biomarkers of Pain and Distress in Piglets after Castration and Tail Docking	PLOS ONE			English	Article							INFRARED THERMOGRAPHY; BODY-TEMPERATURE; SUBSTANCE-P; HUMAN-MILK; RESPONSES; STRESS; PERFORMANCE; ANESTHESIA; ANALGESIA; CELECOXIB	To investigate a novel route for providing analgesia to processed piglets via transmammary drug delivery, meloxicam was administered orally to sows after farrowing. The objectives of the study were to demonstrate meloxicam transfer from sows to piglets via milk and to describe the analgesic effects in piglets after processing through assessment of pain biomarkers and infrared thermography (IRT). Ten sows received either meloxicam (30 mg/kg) (n=5) or whey protein (placebo) (n=5) in their daily feedings, starting four days after farrowing and continuing for three consecutive days. During this period, blood and milk samples were collected at 12-hour intervals. On Day 5 after farrowing, three boars and three gilts from each litter were castrated or sham castrated, tail docked, and administered an iron injection. Piglet blood samples were collected immediately before processing and at predetermined times over an 84-hour period. IRT images were captured at each piglet blood collection point. Plasma was tested to confirm meloxicam concentrations using a validated high-performance liquid chromatography-mass spectrometry method. Meloxicam was detected in all piglets nursing on medicated sows at each time point, and the mean (+/- standard error of the mean) meloxicam concentration at castration was 568.9 +/- 105.8 ng/mL. Furthermore, ex-vivo prostaglandin E-2 (PGE(2)) synthesis inhibition was greater in piglets from treated sows compared to controls (p=0.0059). There was a time-by-treatment interaction for plasma cortisol (p=0.0009), with meloxicam-treated piglets demonstrating lower cortisol concentrations than control piglets for 10 hours after castration. No differences in mean plasma substance P concentrations between treatment groups were observed (p=0.67). Lower cranial skin temperatures on IRT were observed in placebo compared to meloxicam- treated piglets (p=0.015). This study demonstrates the successful transfer of meloxicam from sows to piglets through milk and corresponding analgesia after processing, as evidenced by a decrease in cortisol and PGE(2) levels and maintenance of cranial skin temperature.	[Bates, Jessica L.; Karriker, Locke A.; Baldwin, Luke G.] Iowa State Univ, Swine Med Educ Ctr, Coll Vet Med, Ames, IA USA; [Stock, Matthew L.; Pertzborn, Kelly M.; Wulf, Larry W.; Lee, C. J.; Coetzee, Johann F.] Iowa State Univ, Pharmacol Analyt Support Team, Coll Vet Med, Ames, IA 50011 USA; [Wang, Chong] Iowa State Univ, Coll Vet Med, Ames, IA USA	Iowa State University; Iowa State University; Iowa State University	Coetzee, JF (corresponding author), Iowa State Univ, Pharmacol Analyt Support Team, Coll Vet Med, Ames, IA 50011 USA.	hcoetzee@iastate.edu	Coetzee, Hans/GOK-3477-2022; Wang, Chong/AAI-3796-2020	Coetzee, Hans/0000-0003-1802-3991; Wang, Chong/0000-0003-4489-4344	Iowa Livestock Health Advisory Council [109-05-56]; Swine Medicine Education Center; Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture [2013-67015-21332]	Iowa Livestock Health Advisory Council; Swine Medicine Education Center; Agriculture and Food Research Initiative from the USDA National Institute of Food and Agriculture	This study was funded by the Iowa Livestock Health Advisory Council under account #109-05-56 and the Swine Medicine Education Center. Dr. Coetzee is supported by Agriculture and Food Research Initiative Competitive Grant no. 2013-67015-21332 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Veterinary Medical Association, 2013, AVMA GUID EUTH AN 20, P58; Boehringer Ingelheim, 2013, BOEHR ING MET LAB; Brideau C, 2001, AM J VET RES, V62, P1755, DOI 10.2460/ajvr.2001.62.1755; Brown J, 2013, 12063 NAT PORK BOARD; Carroll JA, 2006, J ANIM SCI, V84, P1271, DOI 10.2527/2006.8451271x; Coetzee JF, 2008, AM J VET RES, V69, P751, DOI 10.2460/ajvr.69.6.751; Davidson S, 2014, PAIN, V155, P1861, DOI 10.1016/j.pain.2014.06.017; DeVane CL, 2001, PHARMACOTHERAPY, V21, P1061, DOI 10.1592/phco.21.13.1061.34612; Dockweiler JC, 2013, J DAIRY SCI, V96, P4340, DOI 10.3168/jds.2012-6274; Dzikamunhenga RS, 2014, ANIM HEALTH RES REV, V15, P14, DOI 10.1017/S1466252314000061; Federation of Animal Science Societies Writing Committee, 2010, GUID CAR US AGR AN R, P142; Gardiner SJ, 2005, EUR J CLIN PHARMACOL, V61, P405, DOI 10.1007/s00228-005-0937-2; Giorgi M, 2011, VET J, V190, P143, DOI 10.1016/j.tvjl.2010.09.013; Hale TW, 2004, J HUM LACT, V20, P397, DOI 10.1177/0890334404269875; Hansson M, 2011, ACTA VET SCAND, V53, DOI 10.1186/1751-0147-53-34; Jacqz-Aigrain E, 2007, THER DRUG MONIT, V29, P815, DOI 10.1097/FTD.0b013e31815d0f01; Keita A, 2010, VET ANAESTH ANALG, V37, P367, DOI 10.1111/j.1467-2995.2010.00546.x; Kendall PE, 2009, LIVEST SCI, V125, P155, DOI 10.1016/j.livsci.2009.04.004; Kilching T, 2010, 21 INT PIG VET SOC C, P851; Knoppert DC, 2003, PHARMACOTHERAPY, V23, P97, DOI 10.1592/phco.23.1.97.31925; Liu Z, 2008, CELL MOL NEUROBIOL, V28, P939, DOI 10.1007/s10571-008-9268-z; Malreddy PR, 2013, J VET PHARMACOL THER, V36, P14, DOI 10.1111/j.1365-2885.2012.01384.x; Marchant-Forde JN, 2009, J ANIM SCI, V87, P1479, DOI 10.2527/jas.2008-1080; Mccafferty DJ, 2007, MAMMAL REV, V37, P207, DOI 10.1111/j.1365-2907.2007.00111.x; Moya SL, 2008, APPL ANIM BEHAV SCI, V111, P133, DOI 10.1016/j.applanim.2007.05.019; National Research Council, 2012, NUTR REQ SWIN, P208; O'Connor A, 2014, ANIM HEALTH RES REV, V15, P39, DOI 10.1017/S1466252314000073; O'Connor TM, 2004, J CELL PHYSIOL, V201, P167, DOI 10.1002/jcp.20061; Pairis-Garcia MD, 2015, J VET PHARMACOL THER, V38, P265, DOI 10.1111/jvp.12170; Prunier A, 2005, J ANIM SCI, V83, P216; Reiner G, 2012, BERL MUNCH TIERARZTL, V125, P305, DOI 10.2376/0005-9366-125-305; Reyes L, 2002, PHARMACOL BIOCHEM BE, V73, P521, DOI 10.1016/S0091-3057(02)00820-1; Rohlinger P., 1979, MONATSHEFTE VETERINA, P287; Schmidt M, 2013, J SWINE HEALTH PROD, V21, P203; Stewart M, 2005, ANIM WELFARE, V14, P319; Sutherland MA, 2012, J ANIM SCI, V90, P2211, DOI 10.2527/jas.2011-4260; Tenbergen R, 2014, J SWINE HEALTH PROD, V22, P64; Traulsen I, 2010, ZUCHTUNGSKUNDE, V82, P437; Zoels S, 2006, 22 INT PIG VET SOC C, pWP	39	31	31	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113678	10.1371/journal.pone.0113678	http://dx.doi.org/10.1371/journal.pone.0113678			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437866	gold, Green Published, Green Submitted			2022-12-26	WOS:000347114900064
J	Guo, MH; Gelman, H; Gruebele, M				Guo, Minghao; Gelman, Hannah; Gruebele, Martin			Coupled Protein Diffusion and Folding in the Cell	PLOS ONE			English	Article							RED FLUORESCENT PROTEIN; IN-VIVO; ANOMALOUS DIFFUSION; ESCHERICHIA-COLI; MONOMERIC RED; LIVING CELLS; KINETICS; COMPARTMENTS; AGGREGATION; STABILITY	When a protein unfolds in the cell, its diffusion coefficient is affected by its increased hydrodynamic radius and by interactions of exposed hydrophobic residues with the cytoplasmic matrix, including chaperones. We characterize protein diffusion by photobleaching whole cells at a single point, and imaging the concentration change of fluorescent-labeled protein throughout the cell as a function of time. As a folded reference protein we use green fluorescent protein. The resulting region-dependent anomalous diffusion is well characterized by 2-D or 3-D diffusion equations coupled to a clustering algorithm that accounts for position-dependent diffusion. Then we study diffusion of a destabilized mutant of the enzyme phosphoglycerate kinase (PGK) and of its stable control inside the cell. Unlike the green fluorescent protein control's diffusion coefficient, PGK's diffusion coefficient is a non-monotonic function of temperature, signaling 'sticking' of the protein in the cytosol as it begins to unfold. The temperature-dependent increase and subsequent decrease of the PGK diffusion coefficient in the cytosol is greater than a simple size-scaling model suggests. Chaperone binding of the unfolding protein inside the cell is one plausible candidate for even slower diffusion of PGK, and we test the plausibility of this hypothesis experimentally, although we do not rule out other candidates.	[Guo, Minghao; Gelman, Hannah; Gruebele, Martin] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Gruebele, Martin] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Gruebele, Martin] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Gruebele, M (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	gruebele@scs.uiuc.edu			National Science Foundation [MCB 1413256]; James R. Eiszner Chair in Chemistry; Div Of Molecular and Cellular Bioscience [1413256] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); James R. Eiszner Chair in Chemistry; Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding: This work was supported by a grant from the National Science Foundation (MCB 1413256). Development of FLIP in the authors lab was also supported by the James R. Eiszner Chair in Chemistry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando T, 2010, P NATL ACAD SCI USA, V107, P18457, DOI 10.1073/pnas.1011354107; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Banks DS, 2005, BIOPHYS J, V89, P2960, DOI 10.1529/biophysj.104.051078; Campbell RE, 2002, P NATL ACAD SCI USA, V99, P7877, DOI 10.1073/pnas.082243699; Capoulade J, 2011, NAT BIOTECHNOL, V29, P835, DOI 10.1038/nbt.1928; CLARKE PGH, 1990, ANAT EMBRYOL, V181, P195, DOI 10.1007/bf00174615; De Gennes P.-G., 1979, SCALING CONCEPTS POL; Dhar A, 2011, BIOPHYS J, V101, P421, DOI 10.1016/j.bpj.2011.05.071; Dhar A, 2010, P NATL ACAD SCI USA, V107, P17586, DOI 10.1073/pnas.1006760107; Dix JA, 2008, ANNU REV BIOPHYS, V37, P247, DOI 10.1146/annurev.biophys.37.032807.125824; Ebbinghaus S, 2010, NAT METHODS, V7, P319, DOI [10.1038/NMETH.1435, 10.1038/nmeth.1435]; Ecroyd H, 2008, IUBMB LIFE, V60, P769, DOI 10.1002/iub.117; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Fee CJ, 2004, BIOCONJUGATE CHEM, V15, P1304, DOI 10.1021/bc049843w; Guo MH, 2012, P NATL ACAD SCI USA, V109, P17863, DOI 10.1073/pnas.1201797109; Hageman J, 2009, CELL STRESS CHAPERON, V14, P1, DOI 10.1007/s12192-008-0060-2; Hancock R, 2013, INT REV CEL MOL BIO, V307, pxiii; Hartigan J. A., 1979, Applied Statistics, V28, P100, DOI 10.2307/2346830; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; Judd EM, 2003, P NATL ACAD SCI USA, V100, P8235, DOI 10.1073/pnas.1433105100; Konopka MC, 2006, J BACTERIOL, V188, P6115, DOI 10.1128/JB.01982-05; Kuhn T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022962; Liu F, 2009, J COMPUT APPL MATH, V231, P160, DOI 10.1016/j.cam.2009.02.013; McGuffee SR, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000694; Mogk A, 1999, EMBO J, V18, P6934, DOI 10.1093/emboj/18.24.6934; Monkos K, 2013, GEN PHYSIOL BIOPHYS, V32, P67, DOI 10.4149/gpb_2013011; Mullineaux CW, 2006, J BACTERIOL, V188, P3442, DOI 10.1128/JB.188.10.3442-3448.2006; Mustapha K, 2012, NUMER ALGORITHMS, V61, P525, DOI 10.1007/s11075-012-9547-0; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; Schlimpert S, 2012, CELL, V151, P1270, DOI 10.1016/j.cell.2012.10.046; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Verkman AS, 2002, TRENDS BIOCHEM SCI, V27, P27, DOI 10.1016/S0968-0004(01)02003-5; Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692; Wang SH, 2008, BIOTECHNOL BIOENG, V99, P146, DOI 10.1002/bit.21512; Wirth AJ, 2013, J AM CHEM SOC, V135, P19215, DOI 10.1021/ja4087165; Wustner D, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-296	38	30	31	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113040	10.1371/journal.pone.0113040	http://dx.doi.org/10.1371/journal.pone.0113040			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436502	Green Submitted, Green Published, gold			2022-12-26	WOS:000347114900027
J	Williams, LB; Tessier, L; Koenig, JB; Koch, TG				Williams, Lynn B.; Tessier, Laurence; Koenig, Judith B.; Koch, Thomas G.			Post-Thaw Non-Cultured and Post-Thaw Cultured Equine Cord Blood Mesenchymal Stromal Cells Equally Suppress Lymphocyte Proliferation In Vitro	PLOS ONE			English	Article							STEM-CELLS; INTRAARTICULAR INJECTION; ARTHRITIS; CRYOPRESERVATION; FUSION; SHOCK	Multipotent mesenchymal stromal cells (MSC) are receiving increased attention for their non-progenitor immunomodulatory potential. Cryopreservation is commonly used for long-term storage of MSC. Post-thaw MSC proliferation is associated with a lag-phase in vitro. How this lag-phase affect MSC immunomodulatory properties is unknown. We hypothesized that in vitro there is no difference in lymphocyte suppression potential between quick-thawed cryopreserved equine cord blood (CB) MSC immediately included in mixed lymphocyte reaction (MLR) and same MSC allowed post-thaw culture time prior to inclusion in MLR. Cryopreserved CB-MSC from five unrelated foals were compared using two-way MLR. For each of the five unrelated MSC cultures, paired MLR assays of MSC allowed five days of post-thaw culture and MSC included in MLR assay immediately post-thawing were evaluated. We report no difference in the suppression of lymphocyte proliferation by CB-MSC that had undergone post-thaw culture and MSC not cultured post-thaw (p<0.0001). Also, there was no inter-donor variability between the lymphocyte suppressive properties of MSC harvested from the five different donors (p=0.13). These findings suggest that cryopreserved CB-MSC may have clinical utility immediately upon thawing. One implication hereof is the possibility of using cryopreserved CB-MSC at third party locations without the need for cell culture equipment or competencies.	[Williams, Lynn B.; Koenig, Judith B.] Univ Guelph, Dept Clin Studies, Guelph, ON N1G 2W1, Canada; [Tessier, Laurence; Koch, Thomas G.] Univ Guelph, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada; [Koch, Thomas G.] Aarhus Univ, Dept Clin Studies, Orthopaed Res Lab, Copenhagen, Denmark	University of Guelph; University of Guelph; Aarhus University	Koch, TG (corresponding author), Univ Guelph, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada.	tkoch@uoguelph.ca			Danish Council for Independent Research - Council for Technology and Production Sciences [902539]; Equine Guelph Research Foundation [EG 2012 12]	Danish Council for Independent Research - Council for Technology and Production Sciences; Equine Guelph Research Foundation	These studies were supported by The Danish Council for Independent Research - Council for Technology and Production Sciences (TGK grant #902539; http://ufm.dk/en/research-and-innovation/funding-programmes-for-research-and-innovation/find-danish-funding-programmes/dff-the-danish-council-for-independent-research) and the Equine Guelph Research Foundation (TGK grant #EG 2012 12; http://www.equineguelph.ca/ research/index.php). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carrade DD, 2012, CELL MED, V4, P1, DOI 10.3727/215517912X647217; Carrade DD, 2011, CYTOTHERAPY, V13, P419, DOI 10.3109/14653249.2010.536213; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Francois M, 2012, CYTOTHERAPY, V14, P147, DOI 10.3109/14653249.2011.623691; Frisbie DD., 2012, EQUINE SURG, V4th, P1096; Gallagher KL, 2005, GENE DEV, V19, P189, DOI 10.1101/gad.1271005; Kang JG, 2013, J VET SCI, V14, P367, DOI 10.4142/jvs.2013.14.3.367; Keating A, 2008, CELL STEM CELL, V2, P106, DOI 10.1016/j.stem.2008.01.007; Koch TG, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-26; Koch TG, 2009, CYTOTHERAPY, V11, P443, DOI 10.1080/14653240902887259; Lehle K, 2005, CRYOBIOLOGY, V50, P154, DOI 10.1016/j.cryobiol.2004.12.006; Leri A, 2005, PHYSIOL REV, V85, P1373, DOI 10.1152/physrev.00013.2005; Nyamandi VZ, 2014, OBESITY, V22, P721, DOI 10.1002/oby.20580; Osteoarthritis CJ, 2003, DIAGNOSIS MANAGEMENT, P572; Park JE, 2013, NEUROCHEM INT, V62, P418, DOI 10.1016/j.neuint.2013.02.002; Pigott JH, 2013, VET IMMUNOL IMMUNOP, V156, P99, DOI 10.1016/j.vetimm.2013.09.003; Quintanilha LF, 2014, HEPATOL RES, V44, pE206, DOI 10.1111/hepr.12204; Ricco S, 2013, INT J IMMUNOPATH PH, V26, P61, DOI 10.1177/03946320130260S108; ROY S, 1975, ARCH PATHOL, V99, P44; Rustom A, 2004, SCIENCE, V303, P1007, DOI 10.1126/science.1093133; Shirtliff ME, 2002, CLIN MICROBIOL REV, V15, P527, DOI 10.1128/CMR.15.4.527-544.2002; Sutton EJ, 2009, OPT EXPRESS, V17, P24403, DOI 10.1364/OE.17.024403; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Tessier L, 2013, THESIS U GUELPH; Torrente D., 2013, HUM EXP TOXICOL; Toupet K, 2013, ARTHRITIS RHEUM-US, V65, P1786, DOI 10.1002/art.37960; Xu X, 2012, J BIOTECHNOL, V162, P224, DOI 10.1016/j.jbiotec.2012.09.004; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Zhou YZ, 2013, CYTOTHERAPY, V15, P1195, DOI 10.1016/j.jcyt.2013.05.009	29	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113615	10.1371/journal.pone.0113615	http://dx.doi.org/10.1371/journal.pone.0113615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438145	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900056
J	Zhang, SJ; Yuan, Y; Hao, DP				Zhang, Shaojun; Yuan, Yuan; Hao, Dapeng			A Genomic Instability Score in Discriminating Nonequivalent Outcomes of BRCA1/2 Mutations and in Predicting Outcomes of Ovarian Cancer Treated with Platinum-Based Chemotherapy	PLOS ONE			English	Article							STRAND BREAK REPAIR; DNA-DAMAGE RESPONSE; PATHWAY CHOICE; SURVIVAL; SENSITIVITY; INACTIVATION; CARCINOMA; TUMORS; BRCANESS	Detecting mutation in BRCA1/2 is a generally accepted strategy for screening ovarian cancers that have impaired homologous recombination (HR) ability and improved sensitivity to PARP inhibitor. However, a substantial subset of BRCA-mutant ovarian cancer patients shows less impaired or unimpaired HR ability, resulting in nonequivalent outcome after ovarian cancer development. We hypothesize that genomic instability provides a lifetime record of DNA repair deficiency and predicts ovarian cancer outcome. Based on the multi-dimensional TCGA ovarian cancer data, we developed a biological rationale-driven genomic instability score integrating somatic mutation and copy number change in a tumor genome. The score successfully divided BRCA-mutant ovarian tumors into cases of significantly improved outcome and cases of unimproved outcome. The score was also capable of discriminating HR-deficiency indicated by BRCA1 epigenetically silencing, EMSY amplification and homozygous deletion of core HR genes. We further found that the score was positively correlated with the complete response rate of chemotherapy and the rate of platinum-sensitivity, and predicted improved outcome of ovarian cancer, regardless of BRCA-mutation status. The score may have important value in outcome prediction and clinical trial design.	[Zhang, Shaojun; Yuan, Yuan; Hao, Dapeng] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Peoples R China; [Yuan, Yuan] Harbin Med Univ, Dept Gynecol & Obstet, Affiliated Hosp 4, Harbin 150081, Peoples R China	Harbin Medical University; Harbin Medical University	Hao, DP (corresponding author), Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin 150081, Peoples R China.	haodapeng@ems.hrbmu.edu.cn						Abkevich V, 2012, BRIT J CANCER, V107, P1776, DOI 10.1038/bjc.2012.451; [Anonymous], 2011, NATURE, V474, P609; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Baumbusch LO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054356; Ben David Y, 2002, J CLIN ONCOL, V20, P463, DOI 10.1200/JCO.20.2.463; Birkbak NJ, 2012, CANCER DISCOV, V2, P366, DOI 10.1158/2159-8290.CD-11-0206; Brandsma Inger, 2012, Genome Integr, V3, P9, DOI 10.1186/2041-9414-3-9; Brown LA, 2006, GYNECOL ONCOL, V100, P264, DOI 10.1016/j.ygyno.2005.08.026; Cass I, 2003, CANCER, V97, P2187, DOI 10.1002/cncr.11310; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chetrit A, 2008, J CLIN ONCOL, V26, P20, DOI 10.1200/JCO.2007.11.6905; Chiang JW, 2006, GYNECOL ONCOL, V101, P403, DOI 10.1016/j.ygyno.2005.10.034; D'Andrea AD, 2003, NAT REV CANCER, V3, P23, DOI 10.1038/nrc970; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Helleday T, 2007, DNA REPAIR, V6, P923, DOI 10.1016/j.dnarep.2007.02.006; Herzog TJ, 2003, GYNECOL ONCOL, V90, pS3, DOI 10.1016/S0090-8258(03)00467-0; Huertas P, 2010, NAT STRUCT MOL BIOL, V17, P11, DOI 10.1038/nsmb.1710; Johannsson OT, 1998, J CLIN ONCOL, V16, P397, DOI 10.1200/JCO.1998.16.2.397; Kang J, 2012, JNCI-J NATL CANCER I, V104, P670, DOI 10.1093/jnci/djs177; Kennedy RD, 2006, J CLIN ONCOL, V24, P3799, DOI 10.1200/JCO.2005.05.4171; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Kunos CA, 2011, GYNECOL ONCOL, V120, P224, DOI 10.1016/j.ygyno.2010.10.018; Lord CJ, 2008, DNA REPAIR, V7, P2010, DOI 10.1016/j.dnarep.2008.08.014; Majdak EJ, 2005, CANCER, V104, P1004, DOI 10.1002/cncr.21276; Mendes-Pereira AM, 2009, EMBO MOL MED, V1, P315, DOI 10.1002/emmm.200900041; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; O'Driscoll M, 2008, CURR GENOMICS, V9, P137, DOI 10.2174/138920208784340795; Park S, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.29; Pharoah PDP, 1999, CANCER RES, V59, P868; Pignata S, 2011, CANCER LETT, V303, P73, DOI 10.1016/j.canlet.2011.01.026; Popova T, 2012, CANCER RES, V72, P5454, DOI 10.1158/0008-5472.CAN-12-1470; Ripperger T, 2009, EUR J HUM GENET, V17, P722, DOI 10.1038/ejhg.2008.212; Shrivastav M, 2008, CELL RES, V18, P134, DOI 10.1038/cr.2007.111; Stefansson OA, 2012, EPIGENETICS-US, V7, P1225, DOI 10.4161/epi.22561; Stefansson OA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2334; Tan DSP, 2008, J CLIN ONCOL, V26, P5530, DOI 10.1200/JCO.2008.16.1703; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Venkitaraman AR, 2004, NAT REV CANCER, V4, P266, DOI 10.1038/nrc1321; Wooster R, 2003, NEW ENGL J MED, V348, P2339, DOI 10.1056/NEJMra012284; Yang D, 2011, JAMA-J AM MED ASSOC, V306, P1557, DOI 10.1001/jama.2011.1456	42	18	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113169	10.1371/journal.pone.0113169	http://dx.doi.org/10.1371/journal.pone.0113169			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437005	Green Submitted, Green Published, gold			2022-12-26	WOS:000347114900030
J	Clement, AM; Ahlberg, PE				Clement, Alice M.; Ahlberg, Per E.			The First Virtual Cranial Endocast of a Lungfish (Sarcopterygii: Dipnoi)	PLOS ONE			English	Article							INNER-EAR; TETRAPOD; INTERRELATIONSHIPS; EVOLUTION; BRAIN; COELACANTH	Lungfish, or dipnoans, have a history spanning over 400 million years and are the closest living sister taxon to the tetrapods. Most Devonian lungfish had heavily ossified endoskeletons, whereas most Mesozoic and Cenozoic lungfish had largely cartilaginous endoskeletons and are usually known only from isolated tooth plates or disarticulated bone fragments. There is thus a substantial temporal and evolutionary gap in our understanding of lungfish endoskeletal morphology, between the diverse and highly variable Devonian forms on the one hand and the three extant genera on the other. Here we present a virtual cranial endocast of Rhinodipterus kimberleyensis, from the Late Devonian Gogo Formation of Australia, one of the most derived fossil dipnoans with a well-ossified braincase. This endocast, generated from a Computed Microtomography (mCT) scan of the skull, is the first virtual endocast of any lungfish published, and only the third fossil dipnoan endocast to be illustrated in its entirety. Key features include long olfactory canals, a telencephalic cavity with a moderate degree of ventral expansion, large suparaotic cavities, and moderately enlarged utricular recesses. It has numerous similarities to the endocasts of Chirodipterus wildungensis and Griphognathus whitei, and to a lesser degree to 'Chirodipterus' australis and Dipnorhynchus sussmilchi. Among extant lungfish, it consistently resembles Neoceratodus more closely than Lepidosiren and Protopterus. Several trends in the evolution of the brains and labyrinth regions in dipnoans, such as the expansions of the utricular recess and telencephalic regions over time, are identified and discussed.	[Clement, Alice M.; Ahlberg, Per E.] Uppsala Univ, Evolutionary Biol Ctr, Dept Organismal Biol, Uppsala, Sweden		Clement, AM (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Dept Organismal Biol, Uppsala, Sweden.	alice.clement@ebc.uu.se	Clement, Alice/ABH-2642-2020	Clement, Alice/0000-0003-0380-7347; Ahlberg, Per/0000-0001-9054-2900	Wallenberg Scholarship from the Knut and Alice Wallenberg foundation	Wallenberg Scholarship from the Knut and Alice Wallenberg foundation	This work was funded by a Wallenberg Scholarship from the Knut and Alice Wallenberg foundation, awarded to PEA. https://www.wallenberg.com/kaw/en/foundation/knut-and-alice-wallenberg-foundation. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHLBERG PE, 1991, ZOOL J LINN SOC-LOND, V103, P241, DOI 10.1111/j.1096-3642.1991.tb00905.x; Anthony J., 1958, ANATOMIE LATIMERIA C; BEMIS WE, 1984, PALEOBIOLOGY, V10, P293, DOI 10.1017/S0094837300008277; Betancur-R R, 2013, PLOS CURR-TREE LIFE, DOI 10.1371/currents.tol.53ba26640df0ccaee75bb165c8c26288; Burrow CJ, 2005, MICRON, V36, P551, DOI 10.1016/j.micron.2005.05.005; CAMPBELL K S, 1982, Journal of Vertebrate Paleontology, V2, P286; Campbell K. S. W., 2000, Records of the Australian Museum, V52, P103; Chang M.M., 1984, Proceedings of the Linnean Society of New South Wales, V107, P171; Chang M-M, 1982, BRAINCASE YOUNGOLEPI; Christensen-Dalsgaard J, 2011, BIOL LETTERS, V7, P139, DOI 10.1098/rsbl.2010.0636; Clack JA, 2003, NATURE, V425, P65, DOI 10.1038/nature01904; Clack JA, 2002, J NEUROBIOL, V53, P251, DOI 10.1002/neu.10129; Clack JA, 2011, BIOL LUNGFISHES; Clement AM, 2012, PALAEONTOLOGY, V55, P51, DOI 10.1111/j.1475-4983.2011.01118.x; Clement AM, 2010, BIOL LETTERS, V6, P509, DOI 10.1098/rsbl.2009.1033; Clement Gael, 2010, P363; Cloutier R, 1996, INTERRELATIONSHIPS F, P445, DOI DOI 10.1016/B978-012670950-6/50018-7; Cloutier Richard, 1996, P198; Collin SP, 2007, FISH PHYSIOL, V26, P121, DOI 10.1016/S1546-5098(07)26003-0; Dupret V, 2014, NATURE; Edinger T., 1921, SENCKENBERGIANA, V3, P121, DOI DOI 10.1002/AJMG.A.30539; Friedman M, 2007, EARTH ENV SCI T R SO, V98, P179, DOI 10.1017/S175569100700607X; Friedman M, 2007, ZOOL J LINN SOC-LOND, V151, P115, DOI 10.1111/j.1096-3642.2007.00320.x; Friedman M, 2007, J SYST PALAEONTOL, V5, P289, DOI 10.1017/S1477201907002052; FRITZSCH B, 1987, NATURE, V327, P153, DOI 10.1038/327153a0; Fulliquet G., 1886, RECHERCHES CERVEAU P; GAULDIE RW, 1986, NEW ZEAL J MAR FRESH, V20, P81, DOI 10.1080/00288330.1986.9516132; Heinicke Matthew P., 2009, P348; Holmgren N., 1925, Acta Zoologica Stockholm, V6, P59; JARVIK E, 1972, Meddelelser om Gronland, V187, P1; Jarvik E., 1942, ZOOL BIDR UPPS, V21, P235; Jarvik E., 1980, BASIC STRUCTURE EVOL; Jorgensen JM, 2010, BIOL LUNGFISHES, V1, P489; Joss JMP, 2006, GEN COMP ENDOCR, V148, P285, DOI 10.1016/j.ygcen.2005.10.010; Kardong K., 2006, VERTEBRATES COMP ANA; Long JA, 2004, PHYSIOL BIOCHEM ZOOL, V77, P700, DOI 10.1086/425183; Long JA, 2010, ANN REV EARTH PLANET, V38, P665; Long JA, 2008, NATURE, V453, P650, DOI 10.1038/nature06966; Lu J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2170; Macrini TE, 2009, J VERTEBR PALEONTOL, V29, P1199, DOI 10.1671/039.029.0413; MARSHALL C, 1992, J MOL EVOL, V35, P93; Meyer A, 2003, ANNU REV ECOL EVOL S, V34, P311, DOI 10.1146/annurev.ecolsys.34.011802.132351; MILES RS, 1977, ZOOL J LINN SOC-LOND, V61, P1, DOI 10.1111/j.1096-3642.1977.tb01031.x; Milner AC, 2009, ZOOL J LINN SOC-LOND, V155, P198, DOI 10.1111/j.1096-3642.2008.00443.x; Nieuwenhuys R., 1998, CENTRAL NERVOUS SYST; NORTHCUTT RG, 1986, J MORPHOL, P277; Northcutt RG, 2002, INTEGR COMP BIOL, V42, P743, DOI 10.1093/icb/42.4.743; Platt C, 2004, J COMP NEUROL, V471, P277, DOI 10.1002/cne.20038; PLAYFORD PE, 1980, AAPG BULL, V64, P814; Popper AN, 2000, FISH RES, V46, P15, DOI 10.1016/S0165-7836(00)00129-6; Popper Arthur N., 1993, P99; Pradel A, 2009, P NATL ACAD SCI USA, V106, P5224, DOI 10.1073/pnas.0807047106; PRIDMORE PA, 1994, PHILOS T ROY SOC B, V344, P105, DOI 10.1098/rstb.1994.0058; Retzius G, 1881, GEHORORGAN WIRBELTIE; Rudebeck Birger, 1945, ACTA ZOOL [STOCKHOLM], V26, P9; Sakellariou A, 2004, PHYSICA A, V339, P152, DOI 10.1016/j.physa.2004.03.055; Sanchez S, 2013, PLOS ONE, V8; Sanchez S, 2012, MICROSC MICROANAL, V18, P1095, DOI 10.1017/S1431927612001079; Sandberg C.A., 1988, COUR FORSCH I SENCKE, V102, P263; Save-Soderbergh G., 1952, KUNGLINGA SVENSKA VE, V4, P1; Snitting D, 2008, J VERTEBR PALEONTOL, V28, P637, DOI 10.1671/0272-4634(2008)28[637:AROTAO]2.0.CO;2; Sollas W. J., 1903, Philosophical Transactions, V(B), P259; Stensio E., 1963, SKRIFTER UTGITT NORS, V13, P1; Stensio E. A., 1927, SKR SVALBARD ISHAVET, V12, P1; Tafforeau P, 2006, APPL PHYS A-MATER, V83, P195, DOI 10.1007/s00339-006-3507-2; Wilder B. G., 1887, American Naturalist, Vxxi, P544; Witmer LM, 2003, NATURE, V425, P950, DOI 10.1038/nature02048; Young JZ, 1981, LIFE VERTEBRATES; Zhu Min, 1995, Geobios Memoire Special (Villeurbanne), V19, P293	69	25	25	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113898	10.1371/journal.pone.0113898	http://dx.doi.org/10.1371/journal.pone.0113898			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427173	Green Published, gold, Green Submitted			2022-12-26	WOS:000349145400096
J	Singleton, J; Osborn, JL; Lillis, L; Hawkins, K; Guelig, D; Price, W; Johns, R; Ebels, K; Boyle, D; Weigl, B; LaBarre, P				Singleton, Jered; Osborn, Jennifer L.; Lillis, Lorraine; Hawkins, Kenneth; Guelig, Dylan; Price, Will; Johns, Rachel; Ebels, Kelly; Boyle, David; Weigl, Bernhard; LaBarre, Paul			Electricity-Free Amplification and Detection for Molecular Point-of-Care Diagnosis of HIV-1	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION; REVERSE-TRANSCRIPTION; PLASMODIUM-FALCIPARUM; DNA AMPLIFICATION; RAPID DETECTION; ANTIRETROVIRAL THERAPY; VIRUS; LAMP; TRANSMISSION; IDENTIFICATION	In resource-limited settings, the lack of decentralized molecular diagnostic testing and sparse access to centralized medical facilities can present a critical barrier to timely diagnosis, treatment, and subsequent control and elimination of infectious diseases. Isothermal nucleic acid amplification methods, including reverse transcription loop-mediated isothermal amplification (RT-LAMP), are well-suited for decentralized point-of-care molecular testing in minimal infrastructure laboratories since they significantly reduce the complexity of equipment and power requirements. Despite reduced complexity, however, there is still a need for a constant heat source to enable isothermal nucleic acid amplification. This requirement poses significant challenges for laboratories in developing countries where electricity is often unreliable or unavailable. To address this need, we previously developed a low-cost, electricity-free heater using an exothermic reaction thermally coupled with a phase change material. This heater achieved acceptable performance, but exhibited considerable variability. Furthermore, as an enabling technology, the heater was an incomplete diagnostic solution. Here we describe a more precise, affordable, and robust heater design with thermal standard deviation <0.5 degrees C at operating temperature, a cost of approximately US$.06 per test for heater reaction materials, and an ambient temperature operating range from 16 degrees C to 30 degrees C. We also pair the heater with nucleic acid lateral flow (NALF)-detection for a visual readout. To further illustrate the utility of the electricity-free heater and NALF-detection platform, we demonstrate sensitive and repeatable detection of HIV-1 with a beta-actin positive internal amplification control from processed sample to result in less than 80 minutes. Together, these elements are building blocks for an electricity-free platform capable of isothermal amplification and detection of a variety of pathogens.	[Singleton, Jered; Osborn, Jennifer L.; Lillis, Lorraine; Hawkins, Kenneth; Guelig, Dylan; Johns, Rachel; Ebels, Kelly; Boyle, David; Weigl, Bernhard; LaBarre, Paul] PATH, Seattle, WA 98121 USA; [Price, Will] Oregon Hlth & Sci Univ, Sch Med, Portland, OR 97201 USA	Oregon Health & Science University	LaBarre, P (corresponding author), PATH, Seattle, WA 98121 USA.	plabarre@path.org			NIH [R01 EB012641, NIAID R01AI097038]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB012641] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	Funding was provided by NIH (R01 EB012641) (NIAID R01AI097038); http://nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Ghani R, 2012, ACTA TROP, V122, P233, DOI 10.1016/j.actatropica.2012.02.004; Andresen D, 2009, EXPERT REV MOL DIAGN, V9, P645, DOI 10.1586/ERM.09.46; Aonuma H, 2010, EXP PARASITOL, V125, P179, DOI 10.1016/j.exppara.2009.12.023; Boehme CC, 2007, J CLIN MICROBIOL, V45, P1936, DOI 10.1128/JCM.02352-06; Braun M, 2011, JAIDS-J ACQ IMM DEF, V56, pE122, DOI 10.1097/QAI.0b013e31820a7f2f; Brown J, 2011, AM J TROP MED HYG, V85, P327, DOI 10.4269/ajtmh.2011.10-0399; Caliendo AM, 2013, CLIN INFECT DIS, V57, pS139, DOI 10.1093/cid/cit578; Chilongozi D, 2008, PEDIATR INFECT DIS J, V27, P808, DOI 10.1097/INF.0b013e31817109a4; Cook RE, 2011, JAIDS-J ACQ IMM DEF, V56, pE104, DOI 10.1097/QAI.0b013e318207a535; Craw P, 2012, LAB CHIP, V12, P2469, DOI [10.1039/c2lc40100b, 10.1039/c21c40100b]; Curtis KA, 2008, J VIROL METHODS, V151, P264, DOI 10.1016/j.jviromet.2008.04.011; Curtis KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031432; Curtis KA, 2009, J MED VIROL, V81, P966, DOI 10.1002/jmv.21490; Di Carlo D, 2003, LAB CHIP, V3, P287, DOI 10.1039/b305162e; Domingo G, 2013, Disposable Sample Processing Unit. United States, Patent No. [12/172,086, 20090036665]; Han ET, 2007, J CLIN MICROBIOL, V45, P2521, DOI 10.1128/JCM.02117-06; Hatano B, 2010, JPN J INFECT DIS, V63, P36; Hopkins H, 2013, J INFECT DIS, V208, P645, DOI 10.1093/infdis/jit184; Hosaka N, 2009, J VIROL METHODS, V157, P195, DOI 10.1016/j.jviromet.2009.01.004; Huang SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060059; Inacio J, 2008, J CLIN MICROBIOL, V46, P713, DOI 10.1128/JCM.00514-07; Khamadi S, 2008, J TROP PEDIATRICS, V54, P370, DOI 10.1093/tropej/fmn036; Kuboki N, 2003, J CLIN MICROBIOL, V41, P5517, DOI 10.1128/JCM.41.12.5517-5524.2003; Kurosaki Y, 2007, J VIROL METHODS, V141, P78, DOI 10.1016/j.jviromet.2006.11.031; LaBarre P, 2011, P SPIE; LaBarre P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019738; LaBarre P, 2010, IEEE ENG MED BIO, P1097, DOI 10.1109/IEMBS.2010.5627346; Liang C, 2012, ANAL CHEM, V84, P3758, DOI 10.1021/ac3003825; Liu CC, 2011, ANALYST, V136, P2069, DOI 10.1039/c1an00007a; Mens PF, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-279; Mori Y, 2009, J INFECT CHEMOTHER, V15, P62, DOI 10.1007/s10156-009-0669-9; Morisset D, 2008, EUR FOOD RES TECHNOL, V227, P1287, DOI 10.1007/s00217-008-0850-x; Nature Publishing Group, 2006, EST GLOB HLTH IMP IM; Niemz A, 2011, TRENDS BIOTECHNOL, V29, P240, DOI 10.1016/j.tibtech.2011.01.007; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Nyandiko WM, 2010, JAIDS-J ACQ IMM DEF, V54, P42, DOI 10.1097/QAI.0b013e3181d8ad51; Pai NP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001306; Pilcher CD, 2007, AIDS, V21, P1723, DOI 10.1097/QAD.0b013e3281532c82; Polley SD, 2013, J INFECT DIS, V208, P637, DOI 10.1093/infdis/jit183; Poon LLM, 2006, CLIN CHEM, V52, P303; Powers KA, 2007, AIDS, V21, P2237, DOI 10.1097/QAD.0b013e3282f08b4d; Roskos K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069355; Sibanda EL, 2013, AIDS, V27, P2787, DOI 10.1097/QAD.0000000000000027; Singleton J, 2013, SPIE P, V8615; Tanner NA, 2012, BIOTECHNIQUES, V53, P81, DOI 10.2144/0000113902; Teng PH, 2007, J VIROL METHODS, V146, P317, DOI 10.1016/j.jviromet.2007.07.027; Violari A, 2008, NEW ENGL J MED, V359, P2233, DOI 10.1056/NEJMoa0800971; Wang J, 2006, LAB CHIP, V6, P46, DOI 10.1039/b511494b; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411; Wong AP, 2008, LAB CHIP, V8, P2032, DOI 10.1039/b809830c; Wu WJ, 2009, CLIN LAB MED, V29, P673, DOI 10.1016/j.cll.2009.07.005; Yager P, 2008, ANNU REV BIOMED ENG, V10, P107, DOI 10.1146/annurev.bioeng.10.061807.160524; Yamamura M, 2009, JPN J INFECT DIS, V62, P20; Yeh HY, 2005, J MICROBIOL METH, V63, P36, DOI 10.1016/j.mimet.2005.02.015; Yun SS, 2010, LAB CHIP, V10, P1442, DOI 10.1039/b925244d	55	53	53	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113693	10.1371/journal.pone.0113693	http://dx.doi.org/10.1371/journal.pone.0113693			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426953	gold, Green Published, Green Submitted			2022-12-26	WOS:000349145400079
J	Wright, RC; Khakhar, A; Eshleman, JR; Ostermeier, M				Wright, R. Clay; Khakhar, Arjun; Eshleman, James R.; Ostermeier, Marc			Advancements in the Development of HIF-1 alpha-Activated Protein Switches for Use in Enzyme Prodrug Therapy	PLOS ONE			English	Article							SUICIDE GENE-THERAPY; CREB-BINDING PROTEIN; PHASE-I; ESCHERICHIA-COLI; STRUCTURAL BASIS; BREAST-CANCER; TAZ1 DOMAIN; ACTIVATION; HYPOXIA; DNA	While gene-directed enzyme prodrug therapy has shown potential as a cancer therapeutic in animal and clinical trials, concerns over the efficacy, selectivity, and safety of gene delivery vehicles have restricted its advance. In an attempt to relieve some of the demands on targeted gene delivery vehicles and achieve the full potential of enzyme prodrug therapy, cancer-targeted activity can be engineered into the enzyme itself. We previously engineered a switchable prodrug-activating enzyme that selectively kills human cancer cells accumulating the cancer marker hypoxia-inducible factor-1 alpha (HIF-1 alpha). This HIF-1 alpha-activated protein switch (Haps59) is designed to increase its ability to convert the prodrug 5-fluorocytosine into the chemotherapeutic 5-fluorouracil in a HIF-1 alpha-dependent manner. However, in cancer cell lines expressing Haps59 the 5FC sensitivity difference between the presence and absence of HIF-1 alpha was not as large as desired. In this work, we aimed to improve the cancer specificity of this switch via a directed evolution approach utilizing random mutagenesis, linker mutagenesis, and random insertion and circular permutation. We identified improved HIF-1 alpha-activated protein switches that confer E. coli with modest increases in HIF-1 alpha-dependent 5FC toxicity. Additionally, the current bottleneck in the development of improved HIF-1 alpha-activated protein switches is screening switch candidates in mammalian cells. To accommodate higher throughput and reduce experimental variability, we explored the use of Flp recombinase-mediated isogenic integration in 293 cells. These experiments raised the possibility that Haps59 can be activated by other interactors of the CH1 domain, and experiments in E. coli indicated that CITED2 can also activate Haps59. Although many CH1 binding partners are also oncogenes, CH1's promiscuous binding and subsequent off-target activation of Haps59 needs to be examined under normal physiological conditions to identify off-target activators. With aberrant activating molecules identified, further directed evolution can be performed to improve the cancer specificity of HIF-1 alpha-activated protein switches.	[Wright, R. Clay; Ostermeier, Marc] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; [Khakhar, Arjun] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Eshleman, James R.] Johns Hopkins Univ, Sch Med, Dept Pathol, Sol Goldman Pancreat Canc Ctr, Baltimore, MD 21205 USA; [Eshleman, James R.] Johns Hopkins Univ, Sch Med, Dept Oncol, Sol Goldman Pancreat Canc Ctr, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Ostermeier, M (corresponding author), Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	oster@jhu.edu	Wright, Clay/AAG-3790-2020; Ostermeier, Marc/A-2697-2010	Wright, Clay/0000-0001-7125-3943; Ostermeier, Marc/0000-0003-0900-3665	National Institutes of Health [R01GM066972]; National Science Foundation [GRFP201008916]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066972] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by National Institutes of Health grant R01GM066972 to MO (www.nih.gov) and National Science Foundation fellowship GRFP201008916 to RCW (www.nsf.gov). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAGSHAWE KD, 1987, BRIT J CANCER, V56, P531, DOI 10.1038/bjc.1987.237; Bai L, 2007, FEBS LETT, V581, P5904, DOI 10.1016/j.febslet.2007.11.072; Bosley AD, 2005, BIOMOL ENG, V22, P57, DOI 10.1016/j.bioeng.2004.11.002; Brix G, 1999, MAGN RESON IMAGING, V17, P151, DOI 10.1016/S0730-725X(98)00115-5; Carpentier G, 2008, IMAGEJ DOT BLOT ANAL; Chabner BA, 2005, NAT REV CANCER, V5, P65, DOI 10.1038/nrc1529; CHUNG CT, 1989, P NATL ACAD SCI USA, V86, P2172, DOI 10.1073/pnas.86.7.2172; Crystal RG, 1997, HUM GENE THER, V8, P985, DOI 10.1089/hum.1997.8.8-985; Cunningham C, 2001, Hum Gene Ther, V12, P1594; Dames SA, 2002, P NATL ACAD SCI USA, V99, P5271, DOI 10.1073/pnas.082121399; De Guzman RN, 2004, J BIOL CHEM, V279, P3042, DOI 10.1074/jbc.M310348200; DELHASE M, 1993, J MOL ENDOCRINOL, V11, P129, DOI 10.1677/jme.0.0110129; Duval DL, 2007, MOL ENDOCRINOL, V21, P172, DOI 10.1210/me.2006-0245; Fera D, 2012, BIOCHEMISTRY-US, V51, P9524, DOI 10.1021/bi3011863; FOLKMAN J, 1985, ADV CANCER RES, V43, P175, DOI 10.1016/S0065-230X(08)60946-X; Fox ME, 1996, GENE THER, V3, P173; Freedman SJ, 2002, P NATL ACAD SCI USA, V99, P5367, DOI 10.1073/pnas.082117899; Freytag SO, 2002, CANCER RES, V62, P4968; Freytag SO, 2003, CANCER RES, V63, P7497; FROMANT M, 1995, ANAL BIOCHEM, V224, P347, DOI 10.1006/abio.1995.1050; Gamero AM, 2010, CANCER PREV RES, V3, P495, DOI 10.1158/1940-6207.CAPR-09-0105; Gerritsen ME, 1997, P NATL ACAD SCI USA, V94, P2927, DOI 10.1073/pnas.94.7.2927; Gilkes DM, 2013, P NATL ACAD SCI USA, V104, P7009; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; HARRIS JD, 1994, GENE THER, V1, P170; HARRIS N, 1986, MOL CELL BIOL, V6, P4650, DOI 10.1128/MCB.6.12.4650; Hillson NJ, 2012, ACS SYNTH BIOL, V1, P14, DOI 10.1021/sb2000116; Hottiger MO, 2000, TRENDS MICROBIOL, V8, P560, DOI 10.1016/S0966-842X(00)01874-6; HUBER BE, 1994, ANN NY ACAD SCI, V716, P104, DOI 10.1111/j.1749-6632.1994.tb21706.x; Itaka K, 2011, CURR GENE THER, V11, P457, DOI 10.2174/156652311798192879; Johnson AJ, 2011, CANCER GENE THER, V18, P533, DOI 10.1038/cgt.2011.6; Kanwar M, 2013, METHOD ENZYMOL, V523, P369, DOI 10.1016/B978-0-12-394292-0.00017-5; Kucerova L, 2013, CANC LETT, V59, P5830; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Lau WM, 2010, INT J CANCER, V126, P876, DOI 10.1002/ijc.24780; Lazarevich N. L., 2010, Experimental Oncology, V32, P167; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Liu GH, 2008, BBA-MOL CELL RES, V1783, P713, DOI 10.1016/j.bbamcr.2008.01.002; Lu X, 2010, CLIN CANCER RES, V16, P5928, DOI 10.1158/1078-0432.CCR-10-1360; Madison DL, 2002, J BIOL CHEM, V277, P38755, DOI 10.1074/jbc.M207512200; Matt T, 2004, BIOCHEM J, V381, P685, DOI 10.1042/BJ20040564; Min J, 2010, NAT MED, V16, P286, DOI 10.1038/nm.2100; Ostertag D, 2012, NEURO-ONCOLOGY, V14, P145, DOI 10.1093/neuonc/nor199; Pandha HS, 1999, J CLIN ONCOL, V17, P2180, DOI 10.1200/JCO.1999.17.7.2180; Perez OD, 2012, MOL THER, V20, P1689, DOI 10.1038/mt.2012.83; Quan JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006441; Rasband WS, 2014, IMAGEJ; Rouillard JM, 2004, NUCLEIC ACIDS RES, V32, pW176, DOI 10.1093/nar/gkh401; SCHLAKE T, 1994, BIOCHEMISTRY-US, V33, P12746, DOI 10.1021/bi00209a003; Song C, 2011, HUM GENE THER, V22, P439, DOI 10.1089/hum.2010.116; Stolworthy TS, 2008, J MOL BIOL, V377, P854, DOI 10.1016/j.jmb.2008.01.002; Teufel DP, 2009, ONCOGENE, V28, P2112, DOI 10.1038/onc.2009.71; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; TSCHIERSCH B, 1977, CANCER TREAT REP, V61, P1489; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; Wennbo H, 2000, ONCOGENE, V19, P1072, DOI 10.1038/sj.onc.1203349; Wright CM, 2011, P NATL ACAD SCI USA, V108, P16206, DOI 10.1073/pnas.1102803108; Wu ZZ, 2011, J CELL PHYSIOL, V226, P2415, DOI 10.1002/jcp.22589; Yoshida E, 1997, BIOCHEM BIOPH RES CO, V241, P664, DOI 10.1006/bbrc.1997.7871; Zaoui K, 2012, CANCER GENE THER, V19, P181, DOI 10.1038/cgt.2011.75; Zhang GY, 2009, CLIN CANCER RES, V15, P201, DOI 10.1158/1078-0432.CCR-08-1094; Zhang Y, 2012, MOL THER, V20, P1298, DOI 10.1038/mt.2012.79; Zhong H, 1999, CANCER RES, V59, P5830	64	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e114032	10.1371/journal.pone.0114032	http://dx.doi.org/10.1371/journal.pone.0114032			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426963	Green Submitted, Green Published, gold			2022-12-26	WOS:000349145400108
J	Han, F; Liu, W; Jiang, X; Shi, X; Yin, L; Ao, L; Cui, Z; Li, Y; Huang, C; Cao, J; Liu, J				Han, F.; Liu, W.; Jiang, X.; Shi, X.; Yin, L.; Ao, L.; Cui, Z.; Li, Y.; Huang, C.; Cao, J.; Liu, J.			SOX30, a novel epigenetic silenced tumor suppressor, promotes tumor cell apoptosis by transcriptional activating p53 in lung cancer	ONCOGENE			English	Article							COLORECTAL-CANCER; DNA METHYLATION; BH3-ONLY MEMBER; GENE; EXPRESSION; DEATH; BCL-2; NOXA; INHIBITION; MEDIATOR	Although members of SOX family have been well documented for their essential roles in embryonic development, cell proliferation and disease, the functional role and molecular mechanism of SOX30 in cancer are largely unexplored. Here, we first identified SRY-box containing gene 30 (SOX30) as a novel preferentially methylated gene using genome-wide methylation screening. SOX30 hypermethylation was detected in 100% of lung cancer cell lines (9/9) and 70.83% (85/120) of primary lung tumor tissues compared with none (0/20) of normal and 8.0% (2/25) of peri-tumoral lung tissues (P<0.01). SOX30 was expressed in normal and peri-tumoral lung tissues in which SOX30 was unmethylated, but was silenced or downregulated in lung cancer cell lines and primary lung tumor tissues harboring a hypermethylated SOX30. De-methylation experiments further confirmed that silence of SOX30 was regulated by its hypermethylation. Ectopic expression of SOX30 induces cancer cell apoptosis with inhibiting proliferation in vitro and represses tumor formation in vivo, whereas knockdown of SOX30 demonstrates a reversed effect both in vitro and in vivo. At the molecular level, the antitumorigenic effect of SOX30 is mediated by directly binding to CACTTTG (+115 to +121) of p53 promoter region and activating p53 transcription, suggesting that SOX30 is a novel transcriptional activating factor of p53. Indeed, blockade of p53 attenuates the tumor inhibition of SOX30. Overall, these findings demonstrate that SOX30 is a novel epigenetic silenced tumor suppressor acting through direct regulation of p53 transcription and expression. This study provides novel insights on the mechanism of tumorigenesis in lung cancer.	[Han, F.; Liu, W.; Jiang, X.; Shi, X.; Yin, L.; Ao, L.; Cui, Z.; Li, Y.; Cao, J.; Liu, J.] Third Mil Med Univ, Coll Prevent Med, Inst Toxicol, Chongqing 400038, Peoples R China; [Han, F.; Liu, W.; Jiang, X.; Shi, X.; Yin, L.; Ao, L.; Cui, Z.; Li, Y.; Cao, J.; Liu, J.] Minist Educ China, Key Lab Med Protect Electromagnet Radiat, Chongqing, Peoples R China; [Huang, C.] NYU, Sch Med, Nelson Inst Environm Med, Tuxedo Pk, NY USA	Army Medical University; Ministry of Education, China; New York University	Cao, J (corresponding author), Third Mil Med Univ, Coll Prevent Med, Inst Toxicol, 30 Gaotanyan St, Chongqing 400038, Peoples R China.	caojia1962@126.com; jinyiliutmmu@163.com	Han, Fei/AAG-9260-2020; Han, Fei/AAH-2028-2020	Han, Fei/0000-0002-0265-5487; Huang, Chuanshu/0000-0003-4133-5096; Jiang, Xiao/0000-0001-8881-4890; Cui, Zhihong/0000-0001-9729-5375	National Natural Science Foundation of China [81172714, 81071695]; NATIONAL CANCER INSTITUTE [P30CA016087] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Natural Science Foundation of China (nos. 81172714 and 81071695).	Ballow D, 2006, DEV BIOL, V294, P161, DOI 10.1016/j.ydbio.2006.02.027; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; BRUGAROLAS J, 1995, NATURE, V377, P552, DOI 10.1038/377552a0; Chew LJ, 2009, J NEUROSCI RES, V87, P3277, DOI 10.1002/jnr.22128; Cronauer MV, 2004, ONCOGENE, V23, P3541, DOI 10.1038/sj.onc.1207346; Culmsee C, 2001, J NEUROCHEM, V77, P220, DOI 10.1046/j.1471-4159.2001.00220.x; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Gorgoulis VG, 2003, EMBO J, V22, P1567, DOI 10.1093/emboj/cdg157; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Gudkov AV, 2005, BIOCHEM BIOPH RES CO, V331, P726, DOI 10.1016/j.bbrc.2005.03.153; HALDAR S, 1994, CANCER RES, V54, P2095; Han F, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-98; HARPER JW, 1993, CELL, V75, P805; Hassan M, 2008, ONCOGENE, V27, P4557, DOI 10.1038/onc.2008.90; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; HOCKENBERY DM, 1991, P NATL ACAD SCI USA, V88, P6961, DOI 10.1073/pnas.88.16.6961; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Khare Sharad, 2012, Methods Mol Biol, V863, P177, DOI 10.1007/978-1-61779-612-8_10; Kim HR, 2013, J TOXICOL SCI, V38, P337, DOI 10.2131/jts.38.337; Liu WB, 2012, BIOCHEM BIOPH RES CO, V429, P180, DOI 10.1016/j.bbrc.2012.10.116; Liu WB, 2010, MOL CARCINOGEN, V49, P556, DOI 10.1002/mc.20621; Minguez B, 2011, DIS MARKERS, V31, P181, DOI [10.1155/2011/310675, 10.3233/DMA-2011-0841]; MIYASHITA T, 1995, CELL, V80, P293; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Osaki E, 1999, NUCLEIC ACIDS RES, V27, P2503, DOI 10.1093/nar/27.12.2503; Patai AV, 2012, DIGEST DIS, V30, P310, DOI 10.1159/000337004; Plesnila N, 2007, CELL DEATH DIFFER, V14, P1529, DOI 10.1038/sj.cdd.4402159; Seo YW, 2003, J BIOL CHEM, V278, P48292, DOI 10.1074/jbc.M308785200; Suzuki S, 2009, CANCER SCI, V100, P759, DOI 10.1111/j.1349-7006.2009.01096.x; Tsao CM, 2012, HEPATOLOGY, V56, P2277, DOI 10.1002/hep.25933; Yang IV, 2011, AM J RESP CRIT CARE, V183, P1295, DOI 10.1164/rccm.201010-1579PP; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103; Zitt M, 2007, DIS MARKERS, V23, P51, DOI 10.1155/2007/891967	41	54	57	2	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 13	2015	34	33					4391	4402		10.1038/onc.2014.370	http://dx.doi.org/10.1038/onc.2014.370			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CO9KK	25435374	Green Published, hybrid			2022-12-26	WOS:000359494400010
J	Guan, HF; Zhao, LB; Cao, HJ; Chen, AM; Xiao, J				Guan, Hanfeng; Zhao, Libo; Cao, Huijuan; Chen, Anmin; Xiao, Jun			Epoxyeicosanoids suppress osteoclastogenesis and prevent ovariectomy-induced bone loss	FASEB JOURNAL			English	Article						osteoclast; osteoporosis; RANK; NF-kappa B	SOLUBLE EPOXIDE HYDROLASE; NECROSIS-FACTOR-ALPHA; FACTOR-KAPPA-B; EPOXYEICOSATRIENOIC ACIDS; SIGNALING PATHWAYS; IN-VIVO; CARDIOVASCULAR-DISEASES; THERAPEUTIC TARGET; RECEPTOR ACTIVATOR; ENDOTHELIAL-CELLS	Epoxyeicosatrienoic acids (EETs) are products of arachidonic acid metabolism catalyzed by cytochrome P450 epoxygenases. These small molecules are autocrine and paracrine lipid mediators with important roles in inflammation, cardiovascular function, and angiogenesis. Recent evidence has highlighted EETs as potent promoters of organ regeneration and malignant metastasis. We speculated that EETs might impact osteoclastogenesis and bone loss. Using both in vitro and in vivo studies, we observed that EETs significantly attenuated bone loss and inhibited osteoclast formation and activity, which were associated with a decreased receptor activator of NF-kappa B ligand (RANKL): osteoprotegerin ratio and serum levels of TNF-alpha and IL-1 beta. At the molecular level, EETs abrogated RANKL-induced activation of NF-kappa B, activator protein-1 (AP-1), and MAPKs, including ERK and JNK, but not p38, during osteoclast formation. EETs also prevented the production of reactive oxygen species (ROS) following RANKL stimulation. As a result, EETs suppressed osteoclast-specific gene expression, including tartrate resistant acid phosphatase (TRAP), cathepsin K (CK), matrix metalloproteinase (MMP)-9, and receptor activator of NF-kappa B (RANK). In conclusion, our findings demonstrate that EETs inhibit osteoclastogenesis through modulation of multiple pathways both upstream and downstream of RANKL signaling. The administration or stabilized endogenous levels of EETs could represent a novel therapeutic strategy for osteoclast-related disorders, such as rheumatoid arthritis and postmenopausal osteoporosis.	[Guan, Hanfeng; Zhao, Libo; Chen, Anmin; Xiao, Jun] Huazhong Univ Sci & Technol, Dept Orthopaed Surg, Tongji Hosp, Tongji Med Coll, Wuhan 430030, Peoples R China; [Cao, Huijuan] Chinese Acad Sci, Shenzhen Inst Adv Technol, Translat Med Res & Dev Ctr, Shenzhen, Guangdong, Peoples R China	Huazhong University of Science & Technology; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Xiao, J (corresponding author), Huazhong Univ Sci & Technol, Dept Orthopaed Surg, Tongji Hosp, Tongji Med Coll, 1095 Jiefang Ave, Wuhan 430030, Peoples R China.	xiaojun301@sina.com		Xiao, Jun/0000-0001-6472-1833; Guan, Hanfeng/0000-0002-4683-601X	National Natural Science Foundation of China [81101788, 81272058, 81171696]; Special Fund for nonprofit Health industry [201002018]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for nonprofit Health industry; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars)	The authors thank Dr. Chang Chen at the Tongji School of Pharmacy, Huazhong University of Science & Technology for measurement of EETs levels in the bone tissue. They are grateful to colleague Dr. Jing Li in Department of Orthopaedic Surgery for preparation of Fig. 9. This study was supported in part by National Natural Science Foundation of China (No. 81101788 to H.G., No. 81272058 to J.X., No. 81171696 to A.C.) and Special Fund for nonprofit Health industry (NO. 201002018 to A.C.) and Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry (to H.G.).	Armstrong AP, 2002, J BIOL CHEM, V277, P44347, DOI 10.1074/jbc.M202009200; Asagiri M, 2007, BONE, V40, P251, DOI 10.1016/j.bone.2006.09.023; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Cenci S, 2000, J CLIN INVEST, V106, P1229, DOI 10.1172/JCI11066; Chen JK, 2002, P NATL ACAD SCI USA, V99, P6029, DOI 10.1073/pnas.092671899; Chen JK, 1998, J BIOL CHEM, V273, P29254, DOI 10.1074/jbc.273.44.29254; Dhanasekaran A, 2008, AM J PHYSIOL-HEART C, V294, pH724, DOI 10.1152/ajpheart.00979.2007; Dhanasekaran A, 2006, AM J PHYSIOL-HEART C, V291, pH517, DOI 10.1152/ajpheart.00953.2005; Edwards JR, 2011, NAT REV RHEUMATOL, V7, P235, DOI 10.1038/nrrheum.2011.23; Fleming I, 2001, CIRC RES, V89, P753, DOI 10.1161/hh2101.099268; Fromel T, 2012, P NATL ACAD SCI USA, V109, P9995, DOI 10.1073/pnas.1206493109; Gao YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040258; Gross GJ, 2008, AM J PHYSIOL-HEART C, V294, pH2838, DOI 10.1152/ajpheart.00186.2008; Guan HF, 2013, J PATHOL, V229, P775, DOI 10.1002/path.4164; Guan HF, 2010, BLOOD, V116, P1469, DOI 10.1182/blood-2009-12-256446; Imig JD, 2002, HYPERTENSION, V39, P690, DOI 10.1161/hy0202.103788; Imig JD, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411001773; Imig JD, 2010, J CARDIOVASC PHARM, V56, P329, DOI 10.1097/FJC.0b013e3181e96e0c; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Jimi E, 2004, NAT MED, V10, P617, DOI 10.1038/nm1054; Kikuta J, 2013, RHEUMATOLOGY, V52, P226, DOI 10.1093/rheumatology/kes259; Kim HJ, 2006, FREE RADICAL BIO MED, V40, P1483, DOI 10.1016/j.freeradbiomed.2005.10.066; Koerner IP, 2008, FRONT BIOSCI-LANDMRK, V13, P2833, DOI 10.2741/2889; Kwak HB, 2008, MOL CELLS, V26, P436; Lee CR, 2010, FASEB J, V24, P3770, DOI 10.1096/fj.10-160119; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Lee SE, 2001, J BIOL CHEM, V276, P49343, DOI 10.1074/jbc.M103642200; Lee ZH, 2003, BIOCHEM BIOPH RES CO, V305, P211, DOI 10.1016/S0006-291X(03)00695-8; Li CH, 2011, J BONE MINER RES, V26, P644, DOI 10.1002/jbmr.242; Liu Y, 2005, P NATL ACAD SCI USA, V102, P16747, DOI 10.1073/pnas.0508081102; Manolagas SC, 2013, NAT REV ENDOCRINOL, V9, P699, DOI 10.1038/nrendo.2013.179; Mundy GR, 2007, NUTR REV, V65, pS147, DOI 10.1301/nr.2007.dec.S147-S151; Nakashima T, 2011, NAT MED, V17, P1231, DOI 10.1038/nm.2452; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Panigrahy D, 2013, P NATL ACAD SCI USA, V110, P13528, DOI 10.1073/pnas.1311565110; Panigrahy D, 2012, J CLIN INVEST, V122, P178, DOI 10.1172/JCI58128; Roggia C, 2001, P NATL ACAD SCI USA, V98, P13960, DOI 10.1073/pnas.251534698; Sasaki H., 2009, J MED INVEST, V56, P33; Schmelzer KR, 2005, P NATL ACAD SCI USA, V102, P9772, DOI 10.1073/pnas.0503279102; Seubert JM, 2007, PROSTAG OTH LIPID M, V82, P50, DOI 10.1016/j.prostaglandins.2006.05.017; Smith KR, 2005, P NATL ACAD SCI USA, V102, P2186, DOI 10.1073/pnas.0409591102; Spector AA, 2009, J LIPID RES, V50, pS52, DOI 10.1194/jlr.R800038-JLR200; Takayanagi H, 2007, ANN NY ACAD SCI, V1116, P227, DOI 10.1196/annals.1402.071; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Vanella L, 2011, PROSTAG OTH LIPID M, V96, P54, DOI 10.1016/j.prostaglandins.2011.07.005; Wang DZ, 2012, J CLIN INVEST, V122, P19, DOI 10.1172/JCI61453; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Xu XZ, 2011, ADV DRUG DELIVER REV, V63, P597, DOI 10.1016/j.addr.2011.03.006; Yang SL, 2007, AM J PHYSIOL-HEART C, V293, pH142, DOI 10.1152/ajpheart.00783.2006; Yang WQ, 2007, J PHARMACOL EXP THER, V321, P1023, DOI 10.1124/jpet.107.119651; Yu XF, 2004, J BONE MINER RES, V19, P2065, DOI 10.1359/JBMR.040910	52	48	51	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					1092	1101		10.1096/fj.14-262055	http://dx.doi.org/10.1096/fj.14-262055			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25466887				2022-12-26	WOS:000350633000032
J	Nakashima, H; Nguyen, T; Goins, WF; Chiocca, EA				Nakashima, Hiroshi; Tran Nguyen; Goins, William F.; Chiocca, Ennio Antonio			Interferon-stimulated Gene 15 (ISG15) and ISG15-linked Proteins Can Associate with Members of the Selective Autophagic Process, Histone Deacetylase 6 (HDAC6) and SQSTM1/p62	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINDBIS VIRUS-INFECTION; UBIQUITIN-LIKE PROTEIN; SEQUESTOSOME 1/P62; BINDING; DOMAIN; P62; AGGRESOME; RECOGNITION; CONJUGATION; ACTIVATION	The ubiquitin-like interferon (IFN)-stimulated gene 15 (ISG15) and its specific E1, E2, and E3 enzymes are transcriptionally induced by type I IFNs. ISG15 conjugates newly synthesized proteins. ISG15 linkage to proteins appears to be an important downstream IFN signaling event that discriminates cellular and pathogenic proteins synthesized during IFN stimulation from existing proteins. This eliminates potentially pathogenic proteins as the cell attempts to return to normal homeostasis after IFN "stressed" conditions. However, the molecular events that occur in this process are not well known. Here, we show that the C-terminal LRLRGG of ISG15 interacts with the binder of ubiquitin zinc finger (BUZ) domain of histone deacetylase 6 (HDAC6). Because HDAC6 is involved in the autophagic clearance of ubiquitinated aggregates during which SQSTM1/p62 plays a major role as a cargo adapter, we also were able to confirm that p62 binds to ISG15 protein and its conjugated proteins upon forced expression. Both HDAC6 and p62 co-localized with ISG15 in an insoluble fraction of the cytosol, and this co-localization was magnified by the proteasome inhibitor MG132. In addition, ISG15 was degraded via the lysosome. Overexpression of ISG15, which leads to an increased conjugation level of the cellular proteome, enhanced autophagic degradation independently of IFN signaling transduction. These results thus indicate that ISG15 conjugation marks proteins for interaction with HDAC6 and p62 upon forced stressful conditions likely as a step toward autophagic clearance.	[Nakashima, Hiroshi; Tran Nguyen; Chiocca, Ennio Antonio] Brigham & Womens Hosp, Dept Neurosurg, Harvey Cushing Neurooncol Labs, Harvard Inst Med, Boston, MA 02115 USA; [Nakashima, Hiroshi; Tran Nguyen; Chiocca, Ennio Antonio] Brigham & Womens Hosp, Inst Neurosci, Boston, MA 02115 USA; [Goins, William F.] Univ Pittsburgh, Dept Microbiol & Mol Genet, Sch Med, Pittsburgh, PA 15219 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chiocca, EA (corresponding author), Brigham & Womens Hosp, Dept Neurosurg, 75 Francis St, Boston, MA 02115 USA.	EAChiocca@partners.org	Goins, William/GLT-6681-2022	Goins, William/0000-0001-7744-9891	National Institutes of Health from the NCI [P01 CA069246, P01 CA163205]; Brigham and Women's Hospital; NATIONAL CANCER INSTITUTE [P01CA069246, P01CA163205] Funding Source: NIH RePORTER	National Institutes of Health from the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Brigham and Women's Hospital; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants P01 CA069246 and P01 CA163205 from the NCI. This work was also supported by a sundry fund from the Brigham and Women's Hospital (to E. A. C.).	Babu JR, 2005, J NEUROCHEM, V94, P192, DOI 10.1111/j.1471-4159.2005.03181.x; Boyle KB, 2013, CURR OPIN MICROBIOL, V16, P339, DOI 10.1016/j.mib.2013.03.010; Durfee LA, 2010, MOL CELL, V38, P722, DOI 10.1016/j.molcel.2010.05.002; Geeraert C, 2010, J BIOL CHEM, V285, P24184, DOI 10.1074/jbc.M109.091553; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hao R, 2013, MOL CELL, V51, P819, DOI 10.1016/j.molcel.2013.08.016; Itakura E, 2011, J CELL BIOL, V192, P17, DOI 10.1083/jcb.201009067; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Judith D, 2013, EMBO REP, V14, P534, DOI 10.1038/embor.2013.51; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kirkin V, 2009, MOL CELL, V34, P259, DOI 10.1016/j.molcel.2009.04.026; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lee JY, 2010, EMBO J, V29, P969, DOI 10.1038/emboj.2009.405; Lenschow DJ, 2005, J VIROL, V79, P13974, DOI 10.1128/JVI.79.22.13974-13983.2005; Liu MJ, 2003, J BIOL CHEM, V278, P1594, DOI 10.1074/jbc.M208123200; Long J, 2008, J BIOL CHEM, V283, P5427, DOI 10.1074/jbc.M704973200; Malakhov MP, 2002, J BIOL CHEM, V277, P9976, DOI 10.1074/jbc.M109078200; Morales DJ, 2013, J MOL BIOL, V425, P4995, DOI 10.1016/j.jmb.2013.09.041; Narasimhan J, 2005, J BIOL CHEM, V280, P27356, DOI 10.1074/jbc.M502814200; Olzmann JA, 2007, J CELL BIOL, V178, P1025, DOI 10.1083/jcb.200611128; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Ouyang H, 2012, J BIOL CHEM, V287, P2317, DOI 10.1074/jbc.M111.273730; Pai MT, 2007, J MOL BIOL, V370, P290, DOI 10.1016/j.jmb.2007.04.015; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Potter JL, 1999, J BIOL CHEM, V274, P25061, DOI 10.1074/jbc.274.35.25061; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; Reyes-Turcu FE, 2006, CELL, V124, P1197, DOI 10.1016/j.cell.2006.02.038; Romijn RA, 2003, J BIOL CHEM, V278, P15035, DOI 10.1074/jbc.M208977200; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Sanz L, 2000, EMBO J, V19, P1576, DOI 10.1093/emboj/19.7.1576; Schmeisser H, 2014, J INTERF CYTOK RES, V34, P71, DOI 10.1089/jir.2013.0128; Searle MS, 2012, BIOCHEM SOC T, V40, P404, DOI 10.1042/BST20110729; Seibenhener ML, 2004, MOL CELL BIOL, V24, P8055, DOI 10.1128/MCB.24.18.8055-8068.2004; Shaid S, 2013, CELL DEATH DIFFER, V20, P21, DOI 10.1038/cdd.2012.72; Shi HX, 2010, MOL CELL BIOL, V30, P2424, DOI 10.1128/MCB.01466-09; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Tan JMM, 2008, HUM MOL GENET, V17, P431, DOI 10.1093/hmg/ddm320; Trempe JF, 2010, ACTA CRYSTALLOGR F, V66, P994, DOI 10.1107/S1744309110027600; Wooten MW, 2008, J BIOL CHEM, V283, P6783, DOI 10.1074/jbc.M709496200; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086; Zuin A, 2010, EMBO J, V29, P981, DOI 10.1038/emboj.2009.407	42	64	65	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1485	1495		10.1074/jbc.M114.593871	http://dx.doi.org/10.1074/jbc.M114.593871			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25429107	Green Published, hybrid			2022-12-26	WOS:000348056400019
J	Xu, WW; Ge, Y; Liu, ZH; Gong, RJ				Xu, Weiwei; Ge, Yan; Liu, Zhihong; Gong, Rujun			Glycogen Synthase Kinase 3 beta Orchestrates Microtubule Remodeling in Compensatory Glomerular Adaptation to Podocyte Depletion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; PARIETAL EPITHELIAL-CELLS; ACUTE KIDNEY INJURY; ADRIAMYCIN NEPHROPATHY; PHOSPHORYLATION; LITHIUM; TAU; MICE; INHIBITORS; DISEASES	Reminiscent of neural repair, following podocyte depletion, remnant-surviving podocytes exhibit a considerable adaptive capacity to expand and cover the denuded renal glomerular basement membrane. Microtubules, one of the principal cytoskeletal components of podocyte major processes, play a crucial role in podocyte morphogenesis and podocyte process outgrowth, branching, and elongation. Here, we demonstrated that the microtubule-associated proteins Tau and collapsin response mediator protein (CRMP) 2, key regulators of microtubule dynamics, were abundantly expressed by glomerular podocytes in vivo and in vitro, interacted with glycogen synthase kinase (GSK)3 beta, and served as its putative substrates. GSK3 beta overactivity induced by adriamycin injury or by a constitutively active mutant of GSK3 beta augmented phosphorylation of Tau and CRMP2, concomitant with microtubule depolymerization, cell body shrinkage, and shortening of podocyte processes. Conversely, inhibition of GSK3 beta by a dominant negative mutant or by lithium, a Food and Drug Administration-approved neuroprotective mood stabilizer, diminished Tau and CRMP2 phosphorylation, resulting in microtubule polymerization, podocyte expansion, and lengthening of podocyte processes. In a mouse model of adriamycin-induced podocyte depletion and nephropathy, delayed administration of a single low dose of lithium attenuated proteinuria and ameliorated progressive glomerulosclerosis despite no correction of podocytopenia. Mechanistically, lithium therapy obliterated GSK3 beta overactivity, mitigated phosphorylation of Tau and CRMP2, and enhanced microtubule polymerization and stabilization in glomeruli in adriamycin-injured kidneys, associated with elongation of podocyte major processes. Collectively, our findings suggest that the GSK3 beta-dictated podocyte microtubule dynamics might serve as a novel therapeutic target to reinforce the compensatory glomerular adaptation to podocyte loss.	[Xu, Weiwei; Liu, Zhihong] Nanjing Univ, Sch Med, Jinling Hosp, Natl Clin Res Ctr Kidney Dis, Nanjing 210002, Jiangsu, Peoples R China; [Xu, Weiwei; Ge, Yan; Gong, Rujun] Brown Univ, Rhode Isl Hosp, Div Kidney Dis & Hypertens, Dept Med,Sch Med, Providence, RI 02903 USA	Nanjing University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Gong, RJ (corresponding author), Brown Univ, Rhode Isl Hosp, Div Kidney Dis & Hypertens, Dept Med,Sch Med, 593 Eddy St, Providence, RI 02903 USA.	rujun_gong@Brown.edu	xu, wei/HHD-2891-2022	Liu, Zhi-Hong/0000-0001-6093-0726	National Institutes of Health [R01DK092485]; China 973 Program [2012CB517600]; International Society of Nephrology Sister Renal Center Trio Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092485] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); China 973 Program(National Basic Research Program of China); International Society of Nephrology Sister Renal Center Trio Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK092485. This work was also supported by China 973 Program 2012CB517600 and the International Society of Nephrology Sister Renal Center Trio Program.	Al-Bassam J, 2010, DEV CELL, V19, P245, DOI 10.1016/j.devcel.2010.07.016; Bai XY, 2011, AM J NEPHROL, V33, P91, DOI 10.1159/000322701; Barisoni L, 2007, CLIN J AM SOC NEPHRO, V2, P529, DOI 10.2215/CJN.04121206; Bendz H, 2010, KIDNEY INT, V77, P219, DOI 10.1038/ki.2009.433; Boini KM, 2009, AM J PHYSIOL-RENAL, V296, pF153, DOI 10.1152/ajprenal.90398.2008; Bunker JM, 2004, MOL BIOL CELL, V15, P2720, DOI 10.1091/mbc.E04-01-0062; Caberlotto L, 2013, N-S ARCH PHARMACOL, V386, P893, DOI 10.1007/s00210-013-0893-9; Cho JH, 2004, J NEUROCHEM, V88, P349, DOI 10.1046/j.1471-4159.2003.02155.x; Cullen-McEwen Luise A, 2012, Methods Mol Biol, V886, P333, DOI 10.1007/978-1-61779-851-1_30; D'Agati VD, 2012, CURR OPIN NEPHROL HY, V21, P243, DOI 10.1097/MNH.0b013e32835200df; D'Agati VD, 2011, NEW ENGL J MED, V365, P2398, DOI 10.1056/NEJMra1106556; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; DRENCKHAHN D, 1988, LAB INVEST, V59, P673; EMBI N, 1980, EUR J BIOCHEM, V107, P519, DOI 10.1111/j.1432-1033.1980.tb06059.x; Forlenza OV, 2012, DRUG AGING, V29, P335, DOI 10.2165/11599180-000000000-00000; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; Fukuda A, 2012, J AM SOC NEPHROL, V23, P1351, DOI 10.1681/ASN.2012030271; Gong R, 2008, AM J TRANSPLANT, V8, P1852, DOI 10.1111/j.1600-6143.2008.02319.x; Gong R, 2003, J AM SOC NEPHROL, V14, P3047, DOI 10.1097/01.ASN.0000098686.72971.DB; Gong RJ, 2008, J BIOL CHEM, V283, P7401, DOI 10.1074/jbc.M710396200; Goold RG, 2001, J CELL SCI, V114, P4273; Gu YJ, 1996, J NEUROCHEM, V67, P1235; GUNDERSEN GG, 1984, CELL, V38, P779, DOI 10.1016/0092-8674(84)90273-3; GUNDERSEN HJG, 1988, APMIS, V96, P379, DOI 10.1111/j.1699-0463.1988.tb05320.x; Guzman J, 2014, DIABETES, V63, P701, DOI 10.2337/db13-0752; Hevia D, 2011, PROTOCOL EXCHANGE, DOI [10.1038/protex.2011.272, DOI 10.1038/PROTEX.2011.272]; Hong M, 1997, J BIOL CHEM, V272, P25326, DOI 10.1074/jbc.272.40.25326; Hur EM, 2010, NAT REV NEUROSCI, V11, P539, DOI 10.1038/nrn2870; Kett MM, 2001, J HYPERTENS, V19, P1505, DOI 10.1097/00004872-200108000-00020; Khanfar MA, 2009, BIOORGAN MED CHEM, V17, P6032, DOI 10.1016/j.bmc.2009.06.054; Kobayashi N, 1998, CELL TISSUE RES, V291, P163, DOI 10.1007/s004410050988; Kobayashi N, 2002, MICROSC RES TECHNIQ, V57, P217, DOI 10.1002/jemt.10077; KREIS TE, 1987, EMBO J, V6, P2597, DOI 10.1002/j.1460-2075.1987.tb02550.x; Kretzler M, 2005, J AM SOC NEPHROL, V16, P2830, DOI 10.1681/ASN.2005080841; Kriz W, 2012, NAT REV NEPHROL, V8, P618, DOI 10.1038/nrneph.2012.198; Lasagni L, 2013, CURR MOL MED, V13, P13, DOI 10.2174/156652413804486250; Lee VWS, 2011, NEPHROLOGY, V16, P30, DOI 10.1111/j.1440-1797.2010.01383.x; Li B, 2007, ACTA NEUROPATHOL, V113, P501, DOI 10.1007/s00401-007-0207-8; Liapis H, 2013, AM J PATHOL, V183, P1364, DOI 10.1016/j.ajpath.2013.06.033; Lin CL, 2006, J AM SOC NEPHROL, V17, P2812, DOI 10.1681/ASN.2005121355; Luippold G, 2004, NEPHROL DIAL TRANSPL, V19, P342, DOI 10.1093/ndt/gfg584; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; Macconi D, 2009, AM J PATHOL, V174, P797, DOI 10.2353/ajpath.2009.080227; MANDELKOW EM, 1992, FEBS LETT, V314, P315, DOI 10.1016/0014-5793(92)81496-9; Marmol F, 2008, PROG NEURO-PSYCHOPH, V32, P1761, DOI 10.1016/j.pnpbp.2008.08.012; Matsui I, 2007, LAB INVEST, V87, P273, DOI 10.1038/labinvest.3700518; Meijer L, 2004, TRENDS PHARMACOL SCI, V25, P471, DOI 10.1016/j.tips.2004.07.006; Mundel P, 1997, EXP CELL RES, V236, P248, DOI 10.1006/excr.1997.3739; Munoz-Montano Juan Ramon, 1999, J Alzheimers Dis, V1, P361; Namekata K, 2012, J NEUROSCI, V32, P264, DOI 10.1523/JNEUROSCI.4884-11.2012; NYENGAARD JR, 1993, MICROVASC RES, V45, P243, DOI 10.1006/mvre.1993.1022; Obligado S, 2008, KIDNEY INT, V73, P684, DOI 10.1038/sj.ki.5002731; Pippin JW, 2013, AM J PATHOL, V183, P542, DOI 10.1016/j.ajpath.2013.04.024; Ronconi E, 2009, J AM SOC NEPHROL, V20, P322, DOI 10.1681/ASN.2008070709; Sanchez C, 2000, EUR J CELL BIOL, V79, P252, DOI 10.1078/S0171-9335(04)70028-X; Shankland SJ, 2007, KIDNEY INT, V72, P26, DOI 10.1038/sj.ki.5002291; Shankland SJ, 2013, CURR OPIN NEPHROL HY, V22, P302, DOI 10.1097/MNH.0b013e32835fefd4; Si J, 2013, KIDNEY INT, V83, P635, DOI 10.1038/ki.2012.447; Sun L, 2011, J PATHOL, V225, P364, DOI 10.1002/path.2961; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tan MH, 2013, J NEUROCHEM, V125, P685, DOI 10.1111/jnc.12230; Tulu US, 2003, CURR BIOL, V13, P1894, DOI 10.1016/j.cub.2003.10.002; Wang Y, 2000, KIDNEY INT, V58, P1797, DOI 10.1046/j.1523-1755.2000.00342.x; Wang Z, 2013, FREE RADICAL BIO MED, V65, P849, DOI 10.1016/j.freeradbiomed.2013.08.169; Wang ZY, 2010, J AM SOC NEPHROL, V21, P284, DOI 10.1681/ASN.2009080828; Waters A, 2009, J AM SOC NEPHROL, V20, P1864, DOI 10.1681/ASN.2009070762; Wharram BL, 2005, J AM SOC NEPHROL, V16, P2941, DOI 10.1681/ASN.2005010055; Wiggins JE, 2005, J AM SOC NEPHROL, V16, P2953, DOI 10.1681/ASN.2005050488; Xu W., 2014, J AM SOC NEPHROL, V25, p92A; Yang ES, 2009, J CLIN INVEST, V119, P1124, DOI 10.1172/JCI34051; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zoja C, 2002, J AM SOC NEPHROL, V13, P2898, DOI 10.1097/01.ASN.0000034912.55186.EC	72	29	29	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1348	1363		10.1074/jbc.M114.593830	http://dx.doi.org/10.1074/jbc.M114.593830			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25468908	hybrid, Green Published			2022-12-26	WOS:000348056400005
J	Bhattacharya, S; Pal, K; Sharma, AK; Dutta, SK; Lau, JS; Yan, IK; Wang, E; Elkhanany, A; Alkharfy, KM; Sanyal, A; Patel, TC; Chari, ST; Spaller, MR; Mukhopadhyay, D				Bhattacharya, Santanu; Pal, Krishnendu; Sharma, Anil K.; Dutta, Shamit K.; Lau, Julie S.; Yan, Irene K.; Wang, Enfeng; Elkhanany, Ahmed; Alkharfy, Khalid M.; Sanyal, Arunik; Patel, Tushar C.; Chari, Suresh T.; Spaller, Mark R.; Mukhopadhyay, Debabrata			GAIP Interacting Protein C-Terminus Regulates Autophagy and Exosome Biogenesis of Pancreatic Cancer through Metabolic Pathways	PLOS ONE			English	Article							DOMAIN-CONTAINING PROTEIN; MYOSIN-VI; PDZ DOMAIN; GIPC; AMPK; PHOSPHORYLATION; DEGRADATION; EXPRESSION; BINDING; BREAST	GAIP interacting protein C terminus (GIPC) is known to play an important role in a variety of physiological and disease states. In the present study, we have identified a novel role for GIPC as a master regulator of autophagy and the exocytotic pathways in cancer. We show that depletion of GIPC-induced autophagy in pancreatic cancer cells, as evident from the upregulation of the autophagy marker LC3II. We further report that GIPC regulates cellular trafficking pathways by modulating the secretion, biogenesis, and molecular composition of exosomes. We also identified the involvement of GIPC on metabolic stress pathways regulating autophagy and microvesicular shedding, and observed that GIPC status determines the loading of cellular cargo in the exosome. Furthermore, we have shown the overexpression of the drug resistance gene ABCG2 in exosomes from GIPC-depleted pancreatic cancer cells. We also demonstrated that depletion of GIPC from cancer cells sensitized them to gemcitabine treatment, an avenue that can be explored as a potential therapeutic strategy to overcome drug resistance in cancer.	[Bhattacharya, Santanu; Pal, Krishnendu; Sharma, Anil K.; Dutta, Shamit K.; Lau, Julie S.; Wang, Enfeng; Elkhanany, Ahmed; Alkharfy, Khalid M.; Sanyal, Arunik; Mukhopadhyay, Debabrata] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Alkharfy, Khalid M.] King Saud Univ, Dept Pharm, Riyadh, Saudi Arabia; [Yan, Irene K.; Patel, Tushar C.] Mayo Clin, Dept Transplantat, Jacksonville, FL USA; [Yan, Irene K.; Patel, Tushar C.] Mayo Clin, Dept Canc Biol, Jacksonville, FL USA; [Chari, Suresh T.] Mayo Clin, Dept Internal Med, Rochester, MN USA; [Spaller, Mark R.] Geisel Sch Med Dartmouth, Dept Pharmacol & Toxicol, Lebanon, NH USA; [Spaller, Mark R.] Norris Cotton Canc Ctr, Lebanon, NH USA	Mayo Clinic; King Saud University; Mayo Clinic; Mayo Clinic; Mayo Clinic; Dartmouth College; Norris Cotton Cancer Center	Mukhopadhyay, D (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA.	mukhopadhyay.debabrata@mayo.edu	Sharma, Anil K./AAP-1909-2020; patel, tushar/J-3976-2013; Chari, Suresh/K-9297-2015	Sharma, Anil K./0000-0002-9768-1644; patel, tushar/0000-0001-7021-9532; Chari, Suresh/0000-0002-3924-0971; Elkhanany, Ahmed/0000-0001-7681-6872; Sharma, Anil/0000-0002-4471-7172; Pal, Krishnendu/0000-0002-4006-213X	National Institutes of Health [CA78383, CA150190]; NATIONAL CANCER INSTITUTE [R01CA078383, R01CA150190, R29CA078383] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH2TR000884] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069370] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding: This work is supported by National Institutes of Health grants CA78383 and CA150190(DM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arden SD, 2007, MOL BIOL CELL, V18, P4750, DOI 10.1091/mbc.E07-02-0127; Baietti MF, 2012, NAT CELL BIOL, V14, P677, DOI 10.1038/ncb2502; BLOMMAART EFC, 1995, J BIOL CHEM, V270, P2320, DOI 10.1074/jbc.270.5.2320; Bunn RC, 1999, MOL BIOL CELL, V10, P819, DOI 10.1091/mbc.10.4.819; Chittenden TW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015581; Choi JS, 2010, CANCER LETT, V294, P254, DOI 10.1016/j.canlet.2010.02.007; De Vries L, 1998, P NATL ACAD SCI USA, V95, P12340, DOI 10.1073/pnas.95.21.12340; Favre-Bonvin A, 2005, J VIROL, V79, P4229, DOI 10.1128/JVI.79.7.4229-4237.2005; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Hurley JH, 2010, CRIT REV BIOCHEM MOL, V45, P463, DOI 10.3109/10409238.2010.502516; Inoki K, 2012, ANNU REV PHARMACOL, V52, P381, DOI 10.1146/annurev-pharmtox-010611-134537; Jeanneteau F, 2004, MOL BIOL CELL, V15, P696, DOI 10.1091/mbc.E03-05-0293; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Kang SA, 2013, SCIENCE, V341, P364, DOI 10.1126/science.1236566; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim MS, 2011, APMIS, V119, P802, DOI 10.1111/j.1600-0463.2011.02812.x; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirikoshi H, 2002, INT J MOL MED, V9, P509; Kumar SH, 2009, J VIROL, V83, P8565, DOI 10.1128/JVI.00603-09; Kundu M, 2008, ANNU REV PATHOL-MECH, V3, P427, DOI 10.1146/annurev.pathmechdis.2.010506.091842; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Muders MH, 2006, CANCER RES, V66, P10264, DOI 10.1158/0008-5472.CAN-06-2321; Muders MH, 2009, CLIN CANCER RES, V15, P4095, DOI 10.1158/1078-0432.CCR-08-2837; Nabhan JF, 2012, P NATL ACAD SCI USA, V109, P4146, DOI 10.1073/pnas.1200448109; Naccache SN, 2006, P NATL ACAD SCI USA, V103, P12735, DOI 10.1073/pnas.0605317103; Odorizzi G, 2006, J CELL SCI, V119, P3025, DOI 10.1242/jcs.03072; Pal K, 2014, MOL CANCER THER, V13, P285, DOI 10.1158/1535-7163.MCT-13-0681; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Ramirez-Peinado S, 2013, J BIOL CHEM, V288, P30387, DOI 10.1074/jbc.M113.490581; Reed BC, 2005, MOL BIOL CELL, V16, P4183, DOI 10.1091/mbc.e04-11-0978; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; SAITO H, 1993, CANCER RES, V53, P3382; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sinha S, 2013, INT J CANCER, V132, P1201, DOI 10.1002/ijc.27724; Spicer E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010665; Tripathi DN, 2013, P NATL ACAD SCI USA, V110, pE2950, DOI 10.1073/pnas.1307736110; Valdembri D, 2009, PLOS BIOL, V7, P115, DOI 10.1371/journal.pbio.1000025; Varsano T, 2006, MOL CELL BIOL, V26, P8942, DOI 10.1128/MCB.00305-06; Varsano T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049227; Wang LH, 1999, J BIOL CHEM, V274, P14137, DOI 10.1074/jbc.274.20.14137; Wang L, 2006, FASEB J, V20, P1513, DOI 10.1096/fj.05-5504fje; Wang L, 2010, MOL CANCER RES, V8, P1591, DOI 10.1158/1541-7786.MCR-10-0209; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Wieman HL, 2009, BIOCHEM J, V418, P345, DOI 10.1042/BJ20081422; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yavelsky V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-247	55	42	43	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114409	10.1371/journal.pone.0114409	http://dx.doi.org/10.1371/journal.pone.0114409			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469510	Green Submitted, gold, Green Published			2022-12-26	WOS:000349128700116
J	Cao, BY; Liu, XQ; Yu, X; Chen, M; Feng, L; Wang, L				Cao, Boyang; Liu, Xiangqian; Yu, Xiang; Chen, Min; Feng, Lu; Wang, Lei			A New Oligonucleotide Microarray for Detection of Pathogenic and Non-Pathogenic Legionella spp.	PLOS ONE			English	Article							RIBOSOMAL-RNA GENE; REAL-TIME PCR; SPACER REGION; LEGIONNAIRES-DISEASE; PNEUMOPHILA; IDENTIFICATION; 16S-23S; MIP; INFECTION; SEQUENCES	Legionella pneumophila has been recognized as the major cause of legionellosis since the discovery of the deadly disease. Legionella spp. other than L. pneumophila were later found to be responsible to many non-pneumophila infections. The non-L. pneumophila infections are likely under-detected because of a lack of effective diagnosis. In this report, we have sequenced the 16S-23S rRNA gene internal transcribed spacer (ITS) of 10 Legionella species and subspecies, including L. anisa, L. bozemanii, L. dumoffii, L. fairfieldensis, L. gormanii, L. jordanis, L. maceachernii, L. micdadei, L. pneumophila subspp. fraseri and L. pneumophila subspp. pasculleii, and developed a rapid oligonucleotide microarray detection technique accordingly to identify 12 most common Legionella spp., which consist of 11 pathogenic species of L. anisa, L. bozemanii, L. dumoffii, L. gormanii, L. jordanis, L. longbeachae, L. maceachernii, L. micdadei, and L. pneumophila (including subspp. pneumophila, subspp. fraseri, and subspp. pasculleii) and one non-pathogenic species, L. fairfieldensis. Twenty-nine probes that reproducibly detected multiple Legionella species with high specificity were included in the array. A total of 52 strains, including 30 target pathogens and 22 non-target bacteria, were used to verify the oligonucleotide microarray assay. The sensitivity of the detection was at 1.0 ng with genomic DNA or 13 CFU/100 mL with Legionella cultures. The microarray detected seven samples of air conditioner-condensed water with 100% accuracy, validating the technique as a promising method for applications in basic microbiology, clinical diagnosis, food safety, and epidemiological surveillance. The phylogenetic study based on the ITS has also revealed that the non-pathogenic L. fairfieldensis is the closest to L. pneumophila than the nine other pathogenic Legionella spp.	[Cao, Boyang; Liu, Xiangqian; Yu, Xiang; Chen, Min; Feng, Lu; Wang, Lei] Nankai Univ, Key Lab Mol Microbiol & Technol, Minist Educ, TEDA Coll, Tianjin 300071, Peoples R China; [Cao, Boyang; Liu, Xiangqian; Yu, Xiang; Chen, Min; Feng, Lu; Wang, Lei] Nankai Univ, TEDA Sch Biol Sci & Biotechnol, Tianjin 300071, Peoples R China; [Cao, Boyang; Liu, Xiangqian; Yu, Xiang; Chen, Min; Feng, Lu; Wang, Lei] Nankai Univ, TEDA Coll, Tianjin Res Ctr Funct Genom & Biochips, Tianjin 300071, Peoples R China; [Cao, Boyang; Liu, Xiangqian; Yu, Xiang; Chen, Min; Feng, Lu; Wang, Lei] Nankai Univ, TEDA Coll, Tianjin Key Lab Microbial Funct Genom, Tianjin 300071, Peoples R China	Nankai University; Nankai University; Nankai University; Nankai University	Wang, L (corresponding author), Nankai Univ, Key Lab Mol Microbiol & Technol, Minist Educ, TEDA Coll, Tianjin 300071, Peoples R China.	wanglei@nankai.edu.cn	Wang, Lei/C-5176-2009; feng, lu/M-5113-2015	Wang, Lei/0000-0003-4427-0881; 	National Key Program for Infectious Diseases of China [2013ZX10004216-001-001]; National 863 Program of China [2012AA020103, 2011AA100901-2]; National 973 Program of China [2011CB504900]; National Natural Science Foundation of China (NSFC) [81171524, 31270144, 31170094, 31030002, 31270003]; Tianjin Research Program of Application Foundation; Advanced Technology [13JCQNJC09400, 12JCYBJC15100, 10JCYBJC10000]	National Key Program for Infectious Diseases of China; National 863 Program of China(National High Technology Research and Development Program of China); National 973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Tianjin Research Program of Application Foundation; Advanced Technology	Funding: This work was supported by grants from the National Key Program for Infectious Diseases of China (2013ZX10004216-001-001), the National 863 Program of China (2012AA020103, 2011AA100901-2), the National 973 Program of China (2011CB504900), the National Natural Science Foundation of China (NSFC) Program (81171524, 31270144, 31170094, 31030002 and 31270003), and the Tianjin Research Program of Application Foundation and Advanced Technology (13JCQNJC09400, 12JCYBJC15100 and 10JCYBJC10000). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger P, 2006, EMERG INFECT DIS, V12, P248; Cao BY, 2013, APPL ENVIRON MICROB, V79, P6647, DOI 10.1128/AEM.01957-13; Cao BY, 2009, J MICROBIOL METH, V77, P109, DOI 10.1016/j.mimet.2009.01.024; Carvalho FRS, 2008, CURR MICROBIOL, V57, P294, DOI 10.1007/s00284-008-9192-y; Chun J, 2002, Methods Mol Biol, V179, P171; CIANCIOTTO NP, 1995, CURR MICROBIOL, V30, P149, DOI 10.1007/BF00296200; CIANCIOTTO NP, 1989, INFECT IMMUN, V57, P1255, DOI 10.1128/IAI.57.4.1255-1262.1989; Daniels C, 1998, MOL MICROBIOL, V28, P1211, DOI 10.1046/j.1365-2958.1998.00884.x; Doleans A, 2004, J CLIN MICROBIOL, V42, P458, DOI 10.1128/JCM.42.1.458-460.2004; Fields BS, 2002, CLIN MICROBIOL REV, V15, P506, DOI 10.1128/CMR.15.3.506-526.2002; Guan W, 2012, J MICROBIOL, V50, P127, DOI 10.1007/s12275-012-1243-1; Gurtler V, 1999, GENE, V238, P241, DOI 10.1016/S0378-1119(99)00224-3; Herpers BL, 2003, J CLIN MICROBIOL, V41, P4815, DOI 10.1128/JCM.41.10.4815-4816.2003; Inoue Hiroaki, 2006, Biocontrol Science, V11, P69; Ko KS, 2003, J MICROBIOL METH, V54, P325, DOI 10.1016/S0167-7012(03)00065-4; Luz SP, 1998, J BACTERIOL, V180, P2144, DOI 10.1128/JB.180.8.2144-2151.1998; Maggi RG, 2006, MOL CELL PROBE, V20, P128, DOI 10.1016/j.mcp.2005.11.002; Magray MSUD, 2011, BIOINFORMATION, V6, P370, DOI 10.6026/97320630006370; Muder RR, 2002, CLIN INFECT DIS, V35, P990, DOI 10.1086/342884; Murdoch DR, 2003, CLIN INFECT DIS, V36, P64, DOI 10.1086/345529; Neil K, 2008, CLIN INFECT DIS, V47, P591, DOI 10.1086/590557; Newton HJ, 2010, CLIN MICROBIOL REV, V23, P274, DOI 10.1128/CMR.00052-09; Palusinska-Szysz M, 2009, ARCH IMMUNOL THER EX, V57, P279, DOI 10.1007/s00005-009-0035-8; Qin T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059018; Ratcliff RM, 1997, MOL MICROBIOL, V25, P1149, DOI 10.1046/j.1365-2958.1997.5471908.x; Stolhaug A, 2006, APPL ENVIRON MICROB, V72, P6394, DOI 10.1128/AEM.02839-05; Su HP, 2009, J CLIN MICROBIOL, V47, P1386, DOI 10.1128/JCM.02225-08; THACKER WL, 1991, J CLIN MICROBIOL, V29, P475, DOI 10.1128/JCM.29.3.475-478.1991; Wang M, 2008, J CLIN MICROBIOL, V46, P3555, DOI 10.1128/JCM.00927-08; Wilson DA, 2003, J CLIN MICROBIOL, V41, P3327, DOI 10.1128/JCM.41.7.3327-3330.2003; Wojciech L, 2004, J VET MED B, V51, P238, DOI 10.1111/j.1439-0450.2004.00762.x; Wright AJ, 2012, TRANSPL INFECT DIS, V14, pE30, DOI 10.1111/j.1399-3062.2012.00755.x; Xiong LK, 2006, J CLIN MICROBIOL, V44, P3544, DOI 10.1128/JCM.00633-06; Yang G, 2010, CLIN MICROBIOL INFEC, V16, P255, DOI 10.1111/j.1469-0691.2009.02766.x; Zhou GP, 2011, APPL MICROBIOL BIOT, V91, P777, DOI 10.1007/s00253-011-3283-6; Zhou GP, 2011, INT J FOOD MICROBIOL, V145, P293, DOI 10.1016/j.ijfoodmicro.2011.01.014	36	4	4	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113863	10.1371/journal.pone.0113863	http://dx.doi.org/10.1371/journal.pone.0113863			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469776	Green Published, Green Submitted, gold			2022-12-26	WOS:000349128700049
J	Prusty, BK; Siegl, C; Gulve, N; Mori, Y; Rudel, T				Prusty, Bhupesh K.; Siegl, Christine; Gulve, Nitish; Mori, Yasuko; Rudel, Thomas			GP96 Interacts with HHV-6 during Viral Entry and Directs It for Cellular Degradation	PLOS ONE			English	Article							SHOCK-PROTEIN GP96; HUMAN-HERPESVIRUS-6 VARIANT-A; NEISSERIA-GONORRHOEAE; HUMAN HERPESVIRUS-6; SURFACE EXPRESSION; DNA-POLYMERASE; GLYCOPROTEIN-H; RECEPTOR; CD46; CELLS	CD46 and CD134 mediate attachment of Human Herpesvirus 6A (HHV-6A) and HHV-6B to host cell, respectively. But many cell types interfere with viral infection through rapid degradation of viral DNA. Hence, not all cells expressing these receptors are permissive to HHV-6 DNA replication and production of infective virions suggesting the involvement of additional factors that influence HHV-6 propagation. Here, we used a proteomics approach to identify other host cell proteins necessary for HHV-6 binding and entry. We found host cell chaperone protein GP96 to interact with HHV-6A and HHV-6B and to interfere with virus propagation within the host cell. In human peripheral blood mononuclear cells (PBMCs), GP96 is transported to the cell surface upon infection with HHV-6 and interacts with HHV-6A and -6B through its C-terminal end. Suppression of GP96 expression decreased initial viral binding but increased viral DNA replication. Transient expression of human GP96 allowed HHV-6 entry into CHO-K1 cells even in the absence of CD46. Thus, our results suggest an important role for GP96 during HHV-6 infection, which possibly supports the cellular degradation of the virus.	[Prusty, Bhupesh K.; Siegl, Christine; Gulve, Nitish; Rudel, Thomas] Univ Wurzburg, Chair Microbiol, Bioctr, D-97074 Wurzburg, Germany; [Mori, Yasuko] Kobe Univ, Grad Sch Med, Kobe, Hyogo 6500017, Japan	University of Wurzburg; Kobe University	Prusty, BK (corresponding author), Univ Wurzburg, Chair Microbiol, Bioctr, D-97074 Wurzburg, Germany.	bhupesh.prusty@biozentrum.uni-wuerzburg.de; thomas.rudel@biozentrum.uni-wuerzburg.de	Prusty, Bhupesh/AAF-4843-2020; Gulve, Nitish/AAL-3006-2021	Prusty, Bhupesh/0000-0001-7051-4670; Gulve, Nitish/0000-0001-8511-1065	Deutsch-Israelische Projektkooperation (DIP) [RU 631/5-1]; VolkswagenStiftung under Volkswagen Foundation's funding initiative 'Experiment!' [88773]; German Research Foundation (DFG); University of Wuerzburg	Deutsch-Israelische Projektkooperation (DIP); VolkswagenStiftung under Volkswagen Foundation's funding initiative 'Experiment!'; German Research Foundation (DFG)(German Research Foundation (DFG)); University of Wuerzburg	Funding: This work was supported by the Deutsch-Israelische Projektkooperation (DIP) project RU 631/5-1 to TR. This work was also supported by a grant from the VolkswagenStiftung (grant number 88773) to BKP under Volkswagen Foundation's funding initiative 'Experiment!' This publication was funded by the German Research Foundation (DFG) and the University of Wuerzburg in the funding programme Open Access Publishing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGULNICK AD, 1993, J GEN VIROL, V74, P1003, DOI 10.1099/0022-1317-74-6-1003; Arii J, 2010, NATURE, V467, P859, DOI 10.1038/nature09420; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Binder RJ, 2000, NAT IMMUNOL, V1, P151, DOI 10.1038/77835; Bloor S, 2010, P NATL ACAD SCI USA, V107, P6970, DOI 10.1073/pnas.0908536107; Cabanes D, 2005, EMBO J, V24, P2827, DOI 10.1038/sj.emboj.7600750; Campadelli-Fiume G, 2000, TRENDS MICROBIOL, V8, P436, DOI 10.1016/S0966-842X(00)01804-7; Cassiani-Ingoni R, 2005, GLIA, V52, P252, DOI 10.1002/glia.20219; Crimeen-Irwin B, 2003, J BIOL CHEM, V278, P46927, DOI 10.1074/jbc.M308261200; DORIG RE, 1993, CELL, V75, P295, DOI 10.1016/0092-8674(93)80071-L; Evlashev A, 2000, J VIROL, V74, P1373, DOI 10.1128/JVI.74.3.1373-1382.2000; Gidalevitz T, 2004, J BIOL CHEM, V279, P16543, DOI 10.1074/jbc.M313060200; Iacobelli-Martinez M, 2007, J VIROL, V81, P1305, DOI 10.1128/JVI.01926-06; Kallstrom H, 1997, MOL MICROBIOL, V25, P639, DOI 10.1046/j.1365-2958.1997.4841857.x; Kawabata A, 2011, J VIROL, V85, P12962, DOI 10.1128/JVI.05622-11; Li HT, 2005, J IMMUNOL, V174, P195, DOI 10.4049/jimmunol.174.1.195; Lin K, 1998, VIROLOGY, V250, P210, DOI 10.1006/viro.1998.9348; Loveland B E, 1993, Transpl Immunol, V1, P101, DOI 10.1016/0966-3274(93)90002-P; Lu C, 2005, AM J PATHOL, V166, P173, DOI 10.1016/S0002-9440(10)62242-0; Morales H, 2003, CELL STRESS CHAPERON, V8, P265, DOI 10.1379/1466-1268(2003)008<0265:BSUTSE>2.0.CO;2; Mori Y, 2003, J VIROL, V77, P4992, DOI 10.1128/JVI.77.8.4992-4999.2003; Mori Y, 2002, J VIROL, V76, P6750, DOI 10.1128/JVI.76.13.6750-6761.2002; Mori Y, 2008, TRAFFIC, V9, P1728, DOI 10.1111/j.1600-0854.2008.00796.x; Mueller A, 2002, BLOOD, V99, P785, DOI 10.1182/blood.V99.3.785; Murakami Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-91; NANICHE D, 1993, J GEN VIROL, V74, P1073, DOI 10.1099/0022-1317-74-6-1073; Oldstone MBA, 1999, CELL, V98, P629, DOI 10.1016/S0092-8674(00)80050-1; Prusty BK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004033; Prusty BK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061400; Prusty BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047427; Randow F, 2013, SCIENCE, V340, P701, DOI 10.1126/science.1233028; Rechner C, 2007, CELL HOST MICROBE, V2, P393, DOI 10.1016/j.chom.2007.11.002; Robert J, 1999, J IMMUNOL, V163, P4133; Santoro F, 2003, J BIOL CHEM, V278, P25964, DOI 10.1074/jbc.M302373200; Santoro F, 1999, CELL, V99, P817, DOI 10.1016/S0092-8674(00)81678-5; SenGupta D, 2004, J IMMUNOL, V173, P1987, DOI 10.4049/jimmunol.173.3.1987; Shen LJ, 2004, P NATL ACAD SCI USA, V101, P3035, DOI 10.1073/pnas.0308345101; Staron M, 2011, BLOOD, V117, P7136, DOI 10.1182/blood-2011-01-330464; Tang HM, 2013, P NATL ACAD SCI USA, V110, P9096, DOI 10.1073/pnas.1305187110; Thulke S, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-77; Toledo-Arana A, 2010, NATURE, P1; Turcanova VL, 2009, J CLIN VIROL, V46, P15, DOI 10.1016/j.jcv.2009.05.015; Vabulas RM, 2002, J BIOL CHEM, V277, P20847, DOI 10.1074/jbc.M200425200; Weyand NJ, 2006, INFECT IMMUN, V74, P2428, DOI 10.1128/IAI.74.4.2428-2435.2006; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005	45	10	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113962	10.1371/journal.pone.0113962	http://dx.doi.org/10.1371/journal.pone.0113962			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470779	Green Published, Green Submitted, gold			2022-12-26	WOS:000349128700058
J	Ratnarajah, L; Bowie, AR; Lannuzel, D; Meiners, KM; Nicol, S				Ratnarajah, Lavenia; Bowie, Andrew R.; Lannuzel, Delphine; Meiners, Klaus M.; Nicol, Stephen			The Biogeochemical Role of Baleen Whales and Krill in Southern Ocean Nutrient Cycling	PLOS ONE			English	Article							TRACE-METALS; IRON FERTILIZATION; ANTARCTIC KRILL; PHYTOPLANKTON BLOOM; TOP PREDATORS; WATER COLUMN; ROSS SEA; PLANKTON; CADMIUM; SECTOR	The availability of micronutrients is a key factor that affects primary productivity in High Nutrient Low Chlorophyll (HNLC) regions of the Southern Ocean. Nutrient supply is governed by a range of physical, chemical and biological processes, and there are significant feedbacks within the ecosystem. It has been suggested that baleen whales form a crucial part of biogeochemical cycling processes through the consumption of nutrient-rich krill and subsequent defecation, but data on their contribution are scarce. We analysed the concentration of iron, cadmium, manganese, cobalt, copper, zinc, phosphorus and carbon in baleen whale faeces and muscle, and krill tissue using inductively coupled plasma mass spectrometry. Metal concentrations in krill tissue were between 20 thousand and 4.8 million times higher than typical Southern Ocean HNLC seawater concentrations, while whale faecal matter was between 276 thousand and 10 million times higher. These findings suggest that krill act as a mechanism for concentrating and retaining elements in the surface layer, which are subsequently released back into the ocean, once eaten by whales, through defecation. Trace metal to carbon ratios were also higher in whale faeces compared to whale muscle indicating that whales are concentrating carbon and actively defecating trace elements. Consequently, recovery of the great whales may facilitate the recycling of nutrients via defecation, which may affect productivity in HNLC areas.	[Ratnarajah, Lavenia; Bowie, Andrew R.; Lannuzel, Delphine; Nicol, Stephen] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Ratnarajah, Lavenia; Bowie, Andrew R.; Lannuzel, Delphine; Meiners, Klaus M.; Nicol, Stephen] Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia; [Meiners, Klaus M.] Australian Antarctic Div, Kingston, Tas, Australia	University of Tasmania; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania; Australian Antarctic Division	Ratnarajah, L (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	Lavenia.Ratnarajah@utas.edu.au	Lannuzel, Delphine/J-7937-2014; Bowie, Andrew/C-8677-2013	Lannuzel, Delphine/0000-0001-6154-1837; Ratnarajah, Lavenia/0000-0002-1021-1923; Bowie, Andrew/0000-0002-5144-7799	Australian Government's Cooperative Research Centres Programme through the Antarctic Climate and Ecosystem Cooperative Research Centre; Australian Antarctic Division; Australian Marine Mammal Centre	Australian Government's Cooperative Research Centres Programme through the Antarctic Climate and Ecosystem Cooperative Research Centre(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Antarctic Division; Australian Marine Mammal Centre	This work was supported by the Australian Government's Cooperative Research Centres Programme through the Antarctic Climate and Ecosystem Cooperative Research Centre, by the Australian Antarctic Division and by the Australian Marine Mammal Centre. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON DM, 1978, LIMNOL OCEANOGR, V23, P283, DOI 10.4319/lo.1978.23.2.0283; Annett AL, 2008, LIMNOL OCEANOGR, V53, P2451, DOI 10.4319/lo.2008.53.6.2451; Baden SP, 2006, OCEANOGR MAR BIOL, V44, P61; Barbante C, 2000, J ANAL ATOM SPECTROM, V15, P377, DOI 10.1039/a907403a; Blain S, 2007, NATURE, V446, P1070, DOI 10.1038/nature05700; Bowie AR, 2001, DEEP-SEA RES PT II, V48, P2703, DOI 10.1016/S0967-0645(01)00015-7; Boyd PW, 2007, SCIENCE, V315, P612, DOI 10.1126/science.1131669; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Branch TA, 2004, MAR MAMMAL SCI, V20, P726, DOI 10.1111/j.1748-7692.2004.tb01190.x; Chester R., 1990, MARINE GEOCHEM, P346, DOI [10.1007/978-94-010-9488-7_11, DOI 10.1007/978-94-010-9488-7_11]; Clarke A, 2008, CURR BIOL, V18, P282, DOI 10.1016/j.cub.2008.01.059; Coale KH, 1996, NATURE, V383, P495, DOI 10.1038/383495a0; Corami F, 2005, J ENVIRON MONITOR, V7, P1256, DOI 10.1039/b507323p; Cullen JT, 2003, LIMNOL OCEANOGR, V48, P1079, DOI 10.4319/lo.2003.48.3.1079; Cullen JT, 1999, MAR CHEM, V67, P233, DOI 10.1016/S0304-4203(99)00060-2; de Baar HJW, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002601; DEBAAR HJW, 1995, NATURE, V373, P412, DOI 10.1038/373412a0; Espejo W, 2014, POLAR BIOL, V37, P675, DOI 10.1007/s00300-014-1468-z; FADELY BS, 1990, J WILDLIFE MANAGE, V54, P246, DOI 10.2307/3809037; Fitzwater SE, 2000, DEEP-SEA RES PT II, V47, P3159, DOI 10.1016/S0967-0645(00)00063-1; Frederiksen M, 2006, J ANIM ECOL, V75, P1259, DOI 10.1111/j.1365-2656.2006.01148.x; Frew R, 2001, DEEP-SEA RES PT II, V48, P2467, DOI 10.1016/S0967-0645(01)00004-2; Grotti M, 2001, MAR CHEM, V76, P189, DOI 10.1016/S0304-4203(01)00063-9; Henderson GM, 2007, CHEM ERDE-GEOCHEM, V67, P85, DOI 10.1016/j.chemer.2007.02.001; Hendry KR, 2010, ESTUAR COAST SHELF S, V87, P103, DOI 10.1016/j.ecss.2009.12.017; Honda K., 1987, Proceedings of the NIPR Symposium on Polar Biology, P184; HUNTLEY ME, 1991, SCIENCE, V253, P64, DOI 10.1126/science.1905841; IWC, 2000, J CETACEAN RES MAN S, V2, P167; Jarman SN, 2002, MOL ECOL, V11, P2679, DOI 10.1046/j.1365-294X.2002.01641.x; Jennings S, 2009, J APPL ECOL, V46, P976, DOI 10.1111/j.1365-2664.2009.01682.x; Katija K, 2012, J EXP BIOL, V215, P1040, DOI 10.1242/jeb.059279; KOOYMAN GL, 1981, ANNU REV PHYSIOL, V43, P343, DOI 10.1146/annurev.ph.43.030181.002015; LANDING WM, 1987, GEOCHIM COSMOCHIM AC, V51, P29, DOI 10.1016/0016-7037(87)90004-4; Lane TW, 2000, P NATL ACAD SCI USA, V97, P4627, DOI 10.1073/pnas.090091397; Lannuzel D, 2011, MAR CHEM, V124, P134, DOI 10.1016/j.marchem.2011.01.004; Lavery TJ, 2014, MAR MAMMAL SCI, V30, P888, DOI 10.1111/mms.12108; Lavery TJ, 2010, P ROY SOC B-BIOL SCI, V277, P3527, DOI 10.1098/rspb.2010.0863; Loscher BM, 1998, MAR CHEM, V62, P259, DOI 10.1016/S0304-4203(98)00045-0; Loscher BM, 1999, MAR CHEM, V67, P67, DOI 10.1016/S0304-4203(99)00050-X; Moore JK, 2000, J GEOPHYS RES-OCEANS, V105, P28709, DOI 10.1029/1999JC000043; Morel F.M.M., 2003, TREATISE GEOCHEMISTR, VVolume 6, P625, DOI [10.1016/B0-08-043751-6/06108-9, DOI 10.1016/B0-08-043751-6/06108-9]; Morel F.M.M., 1991, OCEANOGRAPHY, V4, P56, DOI [10.5670/oceanog.1991.03, DOI 10.5670/0CEAN0G.1991.03]; Morel FMM, 2003, SCIENCE, V300, P944, DOI 10.1126/science.1083545; Nemoto T., 1988, P292; NICOL S, 1991, J CRUSTACEAN BIOL, V11, P10, DOI 10.2307/1548539; Nicol S, 2010, FISH FISH, V11, P203, DOI 10.1111/j.1467-2979.2010.00356.x; Ordway GA, 2004, J EXP BIOL, V207, P3441, DOI 10.1242/jeb.01172; ORIANS KJ, 1986, EARTH PLANET SC LETT, V78, P397, DOI 10.1016/0012-821X(86)90006-3; Perissinotto R, 1997, MAR ECOL PROG SER, V160, P77, DOI 10.3354/meps160077; Pershing AJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012444; Planquette H, 2013, MAR CHEM, V153, P15, DOI 10.1016/j.marchem.2013.04.006; REDFIELD AC, 1958, AM SCI, V46, P205; Reinfelder JR, 2011, ANNU REV MAR SCI, V3, P291, DOI 10.1146/annurev-marine-120709-142720; Roman J, 2014, FRONTIERS ECOLOGY EN; Roman J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013255; SANDMANN G, 1985, PHOTOSYNTH RES, V6, P261, DOI 10.1007/BF00049282; SHELDON RW, 1977, J FISH RES BOARD CAN, V34, P2344, DOI 10.1139/f77-314; Smetacek V, 2008, IMPACTS GOBAL WARMIN; Smith LV, 2013, J EXP MAR BIOL ECOL, V446, P1, DOI 10.1016/j.jembe.2013.04.010; Spicer JI, 2010, ADV MAR BIOL, V57, P91, DOI 10.1016/S0065-2881(10)57004-4; SUNDA WG, 1979, J MAR RES, V37, P761; Sunda WG, 1997, NATURE, V390, P389, DOI 10.1038/37093; SZEFER P, 1994, ENVIRON POLLUT, V83, P341, DOI 10.1016/0269-7491(94)90156-2; Townsend AT, 2000, J ANAL ATOM SPECTROM, V15, P307, DOI 10.1039/a904933i; Twining BS, 2004, LIMNOL OCEANOGR, V49, P2115, DOI 10.4319/lo.2004.49.6.2115; Van Mooy BAS, 2009, NATURE, V458, P69, DOI 10.1038/nature07659; WESTERLUND S, 1991, MAR CHEM, V35, P199, DOI 10.1016/S0304-4203(09)90018-4; Wing SR, 2014, MAR ECOL PROG SER, V510, P1, DOI 10.3354/meps10923; Yamamoto Y., 1987, Proceedings of the NIPR Symposium on Polar Biology, P198	69	43	44	1	96	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114067	10.1371/journal.pone.0114067	http://dx.doi.org/10.1371/journal.pone.0114067			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469984	Green Published, gold			2022-12-26	WOS:000349128700065
J	Strier, KB; Lee, PC; Ives, AR				Strier, Karen B.; Lee, Phyllis C.; Ives, Anthony R.			Behavioral Flexibility and the Evolution of Primate Social States	PLOS ONE			English	Article							SEX-BIASED DISPERSAL; OBSERVATIONAL DATA; FEMALE DISPERSAL; MATING SYSTEMS; RED COLOBUS; GROUP-SIZE; MONKEYS; PATTERNS; ECOLOGY; MAMMALS	Comparative approaches to the evolution of primate social behavior have typically involved two distinct lines of inquiry. One has focused on phylogenetic analyses that treat social traits as static, species-specific characteristics; the other has focused on understanding the behavioral flexibility of particular populations or species in response to local ecological or demographic variables. Here, we combine these approaches by distinguishing between constraining traits such as dispersal regimes (male, female, or bi-sexual), which are relatively invariant, and responding traits such as grouping patterns (stable, fission-fusion, sometimes fission-fusion), which can reflect rapid adjustments to current conditions. Using long-term and cross-sectional data from 29 studies of 22 species of wild primates, we confirm that dispersal regime exhibits a strong phylogenetic signal in our sample. We then show that primate species with high variation in group size and adult sex ratios exhibit variability in grouping pattern (i.e., sometimes fission-fusion) with dispersal regime constraining the grouping response. When assessing demographic variation, we found a strong positive relationship between the variability in group size over time and the number of observation years, which further illustrates the importance of long-term demographic data to interpretations of social behavior. Our approach complements other comparative efforts to understand the role of behavioral flexibility by distinguishing between constraining and responding traits, and incorporating these distinctions into analyses of social states over evolutionary and ecological time.	[Strier, Karen B.] Univ Wisconsin, Dept Anthropol, Madison, WI 53705 USA; [Lee, Phyllis C.] Univ Stirling, Sch Nat Sci, Behav & Evolut Res Grp, Stirling FK9 4LA, Scotland; [Ives, Anthony R.] Univ Wisconsin, Dept Zool, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Stirling; University of Wisconsin System; University of Wisconsin Madison	Strier, KB (corresponding author), Univ Wisconsin, Dept Anthropol, Madison, WI 53705 USA.	kbstrier@wisc.edu	Strier, Karen B./AAJ-3482-2020	Strier, Karen/0000-0003-2520-9110; Lee, Phyllis/0000-0002-4296-3513	University of Wisconsin-Madison; CAPES/BRASIL Special Visiting Researcher award; National Science Foundation [DEB-0816613]	University of Wisconsin-Madison; CAPES/BRASIL Special Visiting Researcher award; National Science Foundation(National Science Foundation (NSF))	Partial support for this work was provided by a Vilas Research Professorship from the University of Wisconsin-Madison and a CAPES/BRASIL Special Visiting Researcher award to KBS, and National Science Foundation grant DEB-0816613 to ARI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andelman S.J, 1986, P201; Arnold C, 2010, EVOL ANTHROPOL, V19, P114, DOI 10.1002/evan.20251; Aureli F, 2008, CURR ANTHROPOL, V49, P627, DOI 10.1086/586708; Borries C, 2000, PRIMATE MALES, P146; Clutton-Brock T, 2012, EVOL ANTHROPOL, V21, P136, DOI 10.1002/evan.21316; CROOK JH, 1966, NATURE, V210, P1200, DOI 10.1038/2101200a0; Di Fiore A, 2009, BEHAVIOUR, V146, P437, DOI 10.1163/156853909X426345; DIFIORE A, 1994, P NATL ACAD SCI USA, V91, P9941, DOI 10.1073/pnas.91.21.9941; EISENBER.JF, 1972, SCIENCE, V176, P863, DOI 10.1126/science.176.4037.863; EMLEN ST, 1977, SCIENCE, V197, P215, DOI 10.1126/science.327542; FOLEY RA, 1989, SCIENCE, V243, P901, DOI 10.1126/science.2493158; Futuyma DJ, 2010, EVOLUTION, V64, P1865, DOI 10.1111/j.1558-5646.2010.00960.x; Gittleman JL., 1989, SPRINGER, DOI [10.1007/978-1-4757-4716-4, DOI 10.1007/978-1-4757-4716-4]; GREENWOOD PJ, 1980, ANIM BEHAV, V28, P1140, DOI 10.1016/S0003-3472(80)80103-5; Hall KRL, 1965, PRIMATE BEHAV; Harris TR, 2009, MOL ECOL, V18, P1777, DOI 10.1111/j.1365-294X.2009.04139.x; Hill RA, 1998, J ZOOL, V245, P447, DOI 10.1111/j.1469-7998.1998.tb00119.x; Ives AR, 2010, SYST BIOL, V59, P9, DOI 10.1093/sysbio/syp074; Izar P, 2012, AM J PRIMATOL, V74, P315, DOI 10.1002/ajp.20968; Jack KM, 2004, ANIM BEHAV, V67, P761, DOI 10.1016/j.anbehav.2003.04.015; JARMAN PJ, 1974, BEHAVIOUR, V48, P215, DOI 10.1163/156853974X00345; Kamilar JM, 2008, AM J PRIMATOL, V70, P816, DOI 10.1002/ajp.20553; Kamilar JM, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0341; Kappeler PM, 2012, LONG TERM FIELD STUD; Korstjens AH, 2010, ANIM BEHAV, V79, P361, DOI 10.1016/j.anbehav.2009.11.012; Langergraber KE, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000973; Lee PC, 2010, AM J PRIMATOL, V72, P925, DOI 10.1002/ajp.20789; Lee P.C., 1994, P266; Lee Phyllis C., 2003, P41; Lehmann J, 2010, J BIOGEOGR, V37, P2217, DOI 10.1111/j.1365-2699.2010.02373.x; Lukas D, 2013, SCIENCE, V341, P526, DOI 10.1126/science.1238677; Lukas D, 2011, J EVOLUTION BIOL, V24, P2624, DOI 10.1111/j.1420-9101.2011.02385.x; Mabry KE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057980; McFarland R, 2014, AM J PHYS ANTHROPOL, V154, P357, DOI 10.1002/ajpa.22518; Miyamoto MM, 2013, AM J PRIMATOL, V75, P478, DOI 10.1002/ajp.22124; MOORE J, 1984, INT J PRIMATOL, V5, P537, DOI 10.1007/BF02692285; Opie C, 2013, P NATL ACAD SCI USA, V110, P13328, DOI 10.1073/pnas.1307903110; PACKER C, 1979, FOLIA PRIMATOL, V31, P212, DOI 10.1159/000155884; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Schluter D, 1997, EVOLUTION, V51, P1699, DOI 10.1111/j.1558-5646.1997.tb05095.x; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Shultz S, 2011, NATURE, V479, P219, DOI 10.1038/nature10601; Silk JB, 2009, P ROY SOC B-BIOL SCI, V276, P3099, DOI 10.1098/rspb.2009.0681; Sterck EHM, 2005, BEHAVIOUR, V142, P845, DOI 10.1163/1568539055010093; Strier KB, 2009, CURR ANTHROPOL, V50, P213, DOI 10.1086/592026; Strier Karen B., 1994, Yearbook of Physical Anthropology, V37, P233; Strier KB, DISPERSING IN PRESS; Struhsaker TT, 2004, INT J PRIMATOL, V25, P615, DOI 10.1023/B:IJOP.0000023578.08343.4e; Struhsaker TT, 2000, PRIMATE MALES, P108; Thierry B, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0342; Yamagiwa J, 2014, PRIMATES CETACEANS F	53	16	17	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114099	10.1371/journal.pone.0114099	http://dx.doi.org/10.1371/journal.pone.0114099			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470593	gold, Green Submitted, Green Published			2022-12-26	WOS:000349128700070
J	Suzuki, E; Ochiai-Shino, H; Aoki, H; Onodera, S; Saito, A; Saito, A; Azuma, T				Suzuki, Eiichi; Ochiai-Shino, Hiromi; Aoki, Hideto; Onodera, Shoko; Saito, Akiko; Saito, Atsushi; Azuma, Toshifumi			Akt Activation is Required for TGF-beta 1-Induced Osteoblast Differentiation of MC3T3-E1 Pre-Osteoblasts	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; BONE MORPHOGENETIC PROTEIN-2; MARROW STROMAL CELLS; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; PHOSPHATIDYLINOSITOL 3-KINASE; OSTEOGENIC DIFFERENTIATION; IN-VITRO; EXPRESSION; SMAD3	Background: We have previously reported that repeated treatment of human periodontal ligament cells and murine pre-osteoblast MC3T3-E1 cells with transforming growth factor-beta 1 (TGF-beta 1) inhibited their osteoblastic differentiation because of decreased insulin-like growth factor-1 (IGF-1) secretion. We also found that IGF-1/PI3K signaling plays an important role in osteoblast differentiation induced by TGF-beta 1 treatment; however, the downstream signaling controlling this remains unknown. The aim of this current study is to investigate whether Akt activation is required for osteoblast differentiation. Methodology/Principal Findings: MC3T3-E1 cells were cultured in osteoblast differentiation medium (OBM) with or without 0.1 ng/mL TGF-beta 1. OBM containing TGF-beta 1 was changed every 12 h to provide repeated TGF-beta 1 administration. MC3T3-E1 cells were infected with retroviral vectors expressing constitutively active (CA) or dominant-negative (DN)-Akt. Alkaline phosphatase (ALP) activity and osteoblastic marker mRNA levels were substantially decreased by repeated TGF-beta 1 treatment compared with a single TGF-beta 1 treatment. However, expression of CA-Akt restored ALP activity following TGF-beta 1 treatment. Surprisingly, ALP activity increased following multiple TGF-beta 1 treatments as the number of administrations of TGF-beta 1 increased. Activation of Akt significantly enhanced expression of osteocalcin, but TGF-beta 1 treatment inhibited this. Mineralization of MC3T3-E1 cells was markedly enhanced by CA-Akt expression under all medium conditions. Exogenous IGF-1 restored the down-regulation of osteoblast-related gene expression by repeated TGF-beta 1 administration. However, in cells expressing DN-Akt, these levels remained inhibited regardless of IGF-1 treatment. These findings indicate that Akt activation is required for the early phase of osteoblast differentiation of MC3T3-E1 cells induced by TGF-beta 1. However, Akt activation is insufficient to reverse the inhibitory effects of TGF-beta 1 in the late stages of osteoblast differentiation. Conclusions: TGF-beta 1 could be an inducer or an inhibitor of osteoblastic differentiation of MC3T3-E1 cells depending on the state of Akt phosphorylation. Our results indicate that Akt is the molecular switch for TGF-beta 1-induced osteoblastic differentiation of MC3T3-E1 cells.	[Suzuki, Eiichi; Aoki, Hideto; Saito, Atsushi] Tokyo Dent Coll, Dept Periodontol, Tokyo, Japan; [Ochiai-Shino, Hiromi; Onodera, Shoko; Saito, Akiko; Azuma, Toshifumi] Tokyo Dent Coll, Dept Biochem, Tokyo, Japan; [Suzuki, Eiichi; Saito, Atsushi; Azuma, Toshifumi] Tokyo Dent Coll, Oral Hlth Sci Ctr, Tokyo, Japan	Tokyo Dental College; Tokyo Dental College; Tokyo Dental College	Azuma, T (corresponding author), Tokyo Dent Coll, Dept Biochem, Tokyo, Japan.	tazuma@tdc.ac.jp		Onodera, Shoko/0000-0003-0673-3400	Japan Society for Promotion of Science [25463228, 25462900]	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-Aid for Scientific Research (C) 25463228 (to AS) 25462900 (to TA) from Japan Society for Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Cantrell DA, 2001, J CELL SCI, V114, P1439; CENTRELLA M, 1994, ENDOCR REV, V15, P27, DOI 10.1210/er.15.1.27; CENTRELLA M, 1987, J BIOL CHEM, V262, P2869; CENTRELLA M, 1995, MOL CELL BIOL, V15, P3273; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Chen LL, 2013, TISSUE ENG PT A, V19, P2226, DOI [10.1089/ten.tea.2012.0469, 10.1089/ten.TEA.2012.0469]; Choi JY, 1996, J CELL BIOCHEM, V61, P609, DOI 10.1002/(SICI)1097-4644(19960616)61:4<609::AID-JCB15>3.3.CO;2-Q; Fujita T, 2004, J CELL BIOL, V166, P85, DOI 10.1083/jcb.200401138; Ghosh-Choudhury N, 2002, J BIOL CHEM, V277, P33361, DOI 10.1074/jbc.M205053200; Guntur AR, 2011, J ENDOCRINOL, V211, P123, DOI 10.1530/JOE-11-0175; Janssens K, 2005, ENDOCR REV, V26, P743, DOI 10.1210/er.2004-0001; Kadowaki Takashi, 1996, Endocrine Journal, V43, pS33, DOI 10.1507/endocrj.43.Suppl_S33; Kaji H, 2006, HORM METAB RES, V38, P740, DOI 10.1055/s-2006-955085; Kanaan RA, 2006, MED SCI MONITOR, V12, pRA164; Lee JY, 2006, J BIOMED MATER RES A, V76A, P530, DOI 10.1002/jbm.a.30434; Lee KS, 2002, ONCOGENE, V21, P7156, DOI 10.1038/sj.onc.1205937; Lian N, 2012, J BIOL CHEM, V287, P35975, DOI 10.1074/jbc.M112.372458; Liu XM, 2007, P NATL ACAD SCI USA, V104, P2259, DOI 10.1073/pnas.0604153104; Matarese G, 2012, INT J MOL MED, V30, P502, DOI 10.3892/ijmm.2012.1024; Matsunobu T, 2009, DEV BIOL, V332, P325, DOI 10.1016/j.ydbio.2009.06.002; Mukherjee A, 2009, J CELL SCI, V122, P716, DOI 10.1242/jcs.042770; NODA M, 1989, ENDOCRINOLOGY, V124, P612, DOI 10.1210/endo-124-2-612; Ochiai H, 2012, J BIOL CHEM, V287, P22654, DOI 10.1074/jbc.M111.279091; Ogata N, 2000, J CLIN INVEST, V105, P935, DOI 10.1172/JCI9017; Osyczka AM, 2005, ENDOCRINOLOGY, V146, P3428, DOI 10.1210/en.2005-0303; Ota K, 2013, ENDOCRINOLOGY, V154, P3745, DOI 10.1210/en.2013-1272; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Ramirez-Yanez GO, 2006, PROSTAG LEUKOTR ESS, V74, P183, DOI 10.1016/j.plefa.2006.01.003; Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113; Rios HF, 2011, J PERIODONTOL, V82, P1223, DOI 10.1902/jop.2011.100710; Ripamonti U, 2009, J CRANIOFAC SURG, V20, P1544, DOI 10.1097/SCS.0b013e3181b09ca6; Sanjabi S, 2009, CURR OPIN PHARMACOL, V9, P447, DOI 10.1016/j.coph.2009.04.008; Sowa H, 2002, J BIOL CHEM, V277, P36024, DOI 10.1074/jbc.M206030200; Spinella-Jaegle S, 2001, BONE, V29, P323, DOI 10.1016/S8756-3282(01)00580-4; Stavropoulos A, 2012, J PERIODONTAL RES, V47, P545, DOI 10.1111/j.1600-0765.2012.01478.x; Susin C, 2013, PERIODONTOL 2000, V62, P232, DOI 10.1111/prd.12003; Ulici V, 2009, BONE, V45, P1133, DOI 10.1016/j.bone.2009.08.003; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Yokota J, 2014, INT J MOL MED, V33, P534, DOI 10.3892/ijmm.2013.1606; Zhang H, 2003, BIOMATERIALS, V24, P2013, DOI 10.1016/S0142-9612(02)00616-6; Zhao LM, 2010, TISSUE ENG PT A, V16, P725, DOI [10.1089/ten.tea.2009.0495, 10.1089/ten.TEA.2009.0495]	44	45	49	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e112566	10.1371/journal.pone.0112566	http://dx.doi.org/10.1371/journal.pone.0112566			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470129	gold, Green Published, Green Submitted			2022-12-26	WOS:000349128700010
J	Carter, E; Miron-Buchacra, G; Goldoni, S; Danahay, H; Westwick, J; Watson, ML; Tosh, D; Ward, SG				Carter, Edward; Miron-Buchacra, Gabriela; Goldoni, Silvia; Danahay, Henry; Westwick, John; Watson, Malcolm L.; Tosh, David; Ward, Stephen G.			Phosphoinositide 3-Kinase Alpha-Dependent Regulation of Branching Morphogenesis in Murine Embryonic Lung: Evidence for a Role in Determining Morphogenic Properties of FGF7	PLOS ONE			English	Article							KERATINOCYTE GROWTH-FACTOR; MOUSE LUNG; PHOSPHATIDYLINOSITOL 3-KINASE; DIFFERENTIATION; INHIBITION; EXPRESSION; EPITHELIUM; TARGET; AKT; ORGANOGENESIS	Branching morphogenesis is a critical step in the development of many epithelial organs. The phosphoinositide-3-kinase (PI3K) pathway has been identified as a central component of this process but the precise role has not been fully established. Herein we sought to determine the role of PI3K in murine lung branching using a series of pharmacological inhibitors directed at this pathway. The pan-class I PI3K inhibitor ZSTK474 greatly enhanced the branching potential of whole murine lung explants as measured by an increase in the number of terminal branches compared with controls over 48 hours. This enhancement of branching was also observed following inhibition of the downstream signalling components of PI3K, Akt and mTOR. Isoform selective inhibitors of PI3K identified that the alpha isoform of PI3K is a key driver in branching morphogenesis. To determine if the effect of PI3K inhibition on branching was specific to the lung epithelium or secondary to an effect on the mesenchyme we assessed the impact of PI3K inhibition in cultures of mesenchyme-free lung epithelium. Isolated lung epithelium cultured with FGF7 formed large cyst-like structures, whereas co-culture with FGF7 and ZSTK474 induced the formation of defined branches with an intact lumen. Together these data suggest a novel role for PI3K in the branching program of the murine embryonic lung contradictory to that reported in other branching organs. Our observations also point towards PI3K acting as a morphogenic switch for FGF7 signalling.	[Carter, Edward; Watson, Malcolm L.; Ward, Stephen G.] Univ Bath, Sch Pharm & Pharmacol, Bath BA2 7AY, Avon, England; [Carter, Edward; Miron-Buchacra, Gabriela; Tosh, David] Univ Bath, Dept Biol & Biochem, Ctr Regenerat Med, Bath BA2 7AY, Avon, England; [Goldoni, Silvia; Danahay, Henry; Westwick, John] Novartis Inst Biomed Res, Horsham, W Sussex, England	University of Bath; University of Bath; Novartis	Ward, SG (corresponding author), Univ Bath, Sch Pharm & Pharmacol, Bath BA2 7AY, Avon, England.	S.G.Ward@bath.ac.uk	Ward, Stephen/AAE-4341-2020; Watson, Malcolm/AAA-6435-2020	Watson, Malcolm/0000-0001-9902-9521; Ward, Stephen G./0000-0002-6795-6002; Carter, Edward/0000-0003-4499-1101	Medical Research Council Doctoral Training Grant; Novartis Institute of Biomedical Research; Medical Research Council [1220724] Funding Source: researchfish	Medical Research Council Doctoral Training Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novartis Institute of Biomedical Research; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported my a Medical Research Council Doctoral Training Grant and Novartis Institute of Biomedical Research. Novartis provided reagents for this work and helped in the preparation of the manuscript.	Bellusci S, 1997, DEVELOPMENT, V124, P4867; Bouwens L, 1998, J PATHOL, V184, P234; Cardoso WV, 1997, DEV DYNAM, V208, P398, DOI 10.1002/(SICI)1097-0177(199703)208:3<398::AID-AJA10>3.0.CO;2-X; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Davies SP, 2000, BIOCHEM J, V351, P95, DOI 10.1042/0264-6021:3510095; De Moerlooze L, 2000, DEVELOPMENT, V127, P483; del Moral PM, 2010, METHODS MOL BIOL, V633, P71, DOI 10.1007/978-1-59745-019-5_5; Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; FINCH PW, 1995, DEV DYNAM, V203, P223, DOI 10.1002/aja.1002030210; Foster JG, 2012, PHARMACOL REV, V64, P1027, DOI 10.1124/pr.110.004051; Francavilla C, 2013, MOL CELL, V51, P707, DOI 10.1016/j.molcel.2013.08.002; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Furet P, 2013, BIOORG MED CHEM LETT, V23, P3741, DOI 10.1016/j.bmcl.2013.05.007; Guo LF, 1996, GENE DEV, V10, P165, DOI 10.1101/gad.10.2.165; Hinz Boris, 2010, F1000 Biol Rep, V2, P78, DOI 10.3410/B2-78; Izvolsky KI, 2003, DEV BIOL, V258, P185, DOI 10.1016/S0012-1606(03)00114-3; Jackson SP, 2005, NAT MED, V11, P507, DOI 10.1038/nm1232; Jamieson S, 2011, BIOCHEM J, V438, P53, DOI 10.1042/BJ20110502; Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09; Kong D, 2007, CANCER SCI, V98, P1638, DOI 10.1111/j.1349-7006.2007.00580.x; Larsen M, 2003, DEV BIOL, V255, P178, DOI 10.1016/S0012-1606(02)00047-7; Makarenkova HP, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000304; Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Patel VN, 2008, J BIOL CHEM, V283, P9308, DOI 10.1074/jbc.M709995200; PETERS K, 1994, EMBO J, V13, P3296, DOI 10.1002/j.1460-2075.1994.tb06631.x; Rawlins EL, 2009, DEVELOPMENT, V136, P3741, DOI 10.1242/dev.037317; Sanchez RM, 2012, BIOORG MED CHEM LETT, V22, P3198, DOI 10.1016/j.bmcl.2012.03.039; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Shi W, 2009, RESPIROLOGY, V14, P656, DOI 10.1111/j.1440-1843.2009.01565.x; Turcatel G, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-117; Utermark T, 2012, GENE DEV, V26, P1573, DOI 10.1101/gad.191973.112; Vanhaesebroeck B, 1997, P NATL ACAD SCI USA, V94, P4330, DOI 10.1073/pnas.94.9.4330; Vanhaesebroeck B, 2012, NAT REV MOL CELL BIO, V13, P195, DOI 10.1038/nrm3290; Volckaert T, 2013, DEVELOPMENT, V140, P3731, DOI 10.1242/dev.096560; Wang J, 2005, TISSUE CELL, V37, P25, DOI 10.1016/j.tice.2004.09.002; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; Xing YM, 2008, DEV BIOL, V320, P340, DOI 10.1016/j.ydbio.2008.04.044; Yuan BB, 2000, DEV DYNAM, V217, P180, DOI 10.1002/(SICI)1097-0177(200002)217:2<180::AID-DVDY5>3.0.CO;2-3; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; Zhu WT, 2013, DEV BIOL, V379, P235, DOI 10.1016/j.ydbio.2013.04.029; Zhu WT, 2012, BIOSYSTEMS, V109, P403, DOI 10.1016/j.biosystems.2012.04.004	44	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113555	10.1371/journal.pone.0113555	http://dx.doi.org/10.1371/journal.pone.0113555			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460003	Green Published, Green Submitted, gold			2022-12-26	WOS:000345869700036
J	Hiroshima, Y; Maawy, A; Zhang, Y; Murakami, T; Momiyama, M; Mori, R; Matsuyama, R; Katz, MHG; Fleming, JB; Chishima, T; Tanaka, K; Ichikawa, Y; Endo, I; Hoffman, RM; Bouvet, M				Hiroshima, Yukihiko; Maawy, Ali; Zhang, Yong; Murakami, Takashi; Momiyama, Masashi; Mori, Ryutaro; Matsuyama, Ryusei; Katz, Matthew H. G.; Fleming, Jason B.; Chishima, Takashi; Tanaka, Kuniya; Ichikawa, Yasushi; Endo, Itaru; Hoffman, Robert M.; Bouvet, Michael			Metastatic Recurrence in a Pancreatic Cancer Patient Derived Orthotopic Xenograft (PDOX) Nude Mouse Model Is Inhibited by Neoadjuvant Chemotherapy in Combination with Fluorescence-Guided Surgery with an Anti-CA 19-9-Conjugated Fluorophore	PLOS ONE			English	Article							GEMCITABINE-BASED CHEMORADIATION; HUMAN COLON-CANCER; CEA ANTIBODY; IMAGING-SYSTEM; SURVIVAL; MICE; ADENOCARCINOMA; SPECIMENS; RESECTION; THERAPY	The aim of this study is to determine the efficacy of neoadjuvant chemotherapy (NAC) with gemcitabine (GEM) in combination with fluorescence-guided surgery (FGS) on a pancreatic cancer patient derived orthotopic xenograft (PDOX) model. A PDOX model was established from a CA19-9-positive, CEA-negative tumor from a patient who had undergone a pancreaticoduodenectomy for pancreatic adenocarcinoma. Mice were randomized to 4 groups: bright light surgery (BLS) only; BLS+NAC; FGS only; and FGS+NAC. An anti-CA19-9 or anti-CEA antibody conjugated to DyLight 650 was administered intravenously via the tail vein of mice with the pancreatic cancer PDOX 24 hours before surgery. The PDOX was brightly labeled with fluorophore-conjugated anti-CA19-9, but not with a fluorophore-conjugated anti-CEA antibody. FGS was performed using the fluorophore-conjugated anti-CA19-9 antibody. FGS had no benefit over BLS to prevent metastatic recurrence. NAC in combination with BLS did not convey an advantage over BLS to prevent metastatic recurrence. However, FGS+NAC significantly reduced the metastatic recurrence frequency to one of 8 mice, compared to FGS only after which metastasis recurred in 6 out of 8 mice, and BLS+NAC with metastatic recurrence in 7 out of 8 mice (p=0.041). Thus NAC in combination with FGS can reduce or even eliminate metastatic recurrence of pancreatic cancer sensitive to NAC. The present study further emphasizes the power of the PDOX model which enables metastasis to occur and thereby identify the efficacy of NAC in combination with FGS on metastatic recurrence.	[Hiroshima, Yukihiko; Zhang, Yong; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Hiroshima, Yukihiko; Maawy, Ali; Hoffman, Robert M.; Bouvet, Michael] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Hiroshima, Yukihiko; Murakami, Takashi; Momiyama, Masashi; Mori, Ryutaro; Matsuyama, Ryusei; Chishima, Takashi; Tanaka, Kuniya; Ichikawa, Yasushi; Endo, Itaru] Yokohama City Univ, Grad Sch Med, Yokohama, Kanagawa 232, Japan; [Katz, Matthew H. G.; Fleming, Jason B.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Surg, Houston, TX 77030 USA	Anti Cancer Inc; University of California System; University of California San Diego; Yokohama City University; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Bouvet, M (corresponding author), Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA.	mbouvet@ucsd.edu		Murakami, Takashi/0000-0002-9429-5705	National Cancer Institute [CA132971, 142669]; Japanese Ministry of Education, Culture, Sports, Science and Technology [26830081, 26462070, 24592009]; NATIONAL CANCER INSTITUTE [R01CA142669, R01CA132971] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported in part by National Cancer Institute grants CA132971 and 142669 (to MB and AntiCancer, Inc.); and Japanese Ministry of Education, Culture, Sports, Science and Technology for Fundamental Research Grant Numbers 26830081 to YH; and 26462070 to IE and 24592009 to KT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouvet M, 2011, SCI TRANSL MED, V3, P110; EVANS DB, 1992, ARCH SURG-CHICAGO, V127, P1335; Evans DB, 2008, J CLIN ONCOL, V26, P3496, DOI 10.1200/JCO.2007.15.8634; FU XY, 1993, ANTICANCER RES, V13, P901; FU XY, 1992, P NATL ACAD SCI USA, V89, P5645, DOI 10.1073/pnas.89.12.5645; FU XY, 1993, ANTICANCER RES, V13, P283; FU XY, 1991, P NATL ACAD SCI USA, V88, P9345, DOI 10.1073/pnas.88.20.9345; Hiroshima Y, 2014, J CELL BIOCHEM, V115, P1254, DOI 10.1002/jcb.24769; Hiroshima Y, 2014, J LAPAROENDOSC ADV S, V24, P241, DOI 10.1089/lap.2013.0418; Hiroshima Y, 2014, J SURG RES, V187, P510, DOI 10.1016/j.jss.2013.11.1083; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Kato K, 2009, PANCREAS, V38, P605, DOI 10.1097/MPA.0b013e3181a4891d; Katz MHG, 2012, CANCER-AM CANCER SOC, V118, P5749, DOI 10.1002/cncr.27636; Katz MHG, 2010, ANN SURG ONCOL, V17, P1794, DOI 10.1245/s10434-010-0943-1; Kaushal S, 2008, J GASTROINTEST SURG, V12, P1938, DOI 10.1007/s11605-008-0581-0; Kim MP, 2012, ANN SURG ONCOL, V19, pS395, DOI 10.1245/s10434-011-1839-4; Maawy AA, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.126016; McElroy M, 2008, WORLD J SURG, V32, P1057, DOI 10.1007/s00268-007-9452-1; Metildi CA, 2014, J SURG ONCOL, V109, P451, DOI 10.1002/jso.23507; Metildi CA, 2012, J AM COLL SURGEONS, V215, P126, DOI 10.1016/j.jamcollsurg.2012.02.021; Rosenthal EL, 2013, MOL IMAGING BIOL, V15, P647, DOI 10.1007/s11307-013-0662-7; Takahashi H, 2010, ANN SURG, V251, P461, DOI 10.1097/SLA.0b013e3181cc90a3; WANG XO, 1992, INT J CANCER, V51, P992	23	74	74	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114310	10.1371/journal.pone.0114310	http://dx.doi.org/10.1371/journal.pone.0114310			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463150	Green Published, Green Submitted, gold			2022-12-26	WOS:000345869700128
J	Thompson, LA; Spoon, TR; Goertz, CEC; Hobbs, RC; Romano, TA				Thompson, Laura A.; Spoon, Tracey R.; Goertz, Caroline E. C.; Hobbs, Roderick C.; Romano, Tracy A.			Blow Collection as a Non-Invasive Method for Measuring Cortisol in the Beluga (Delphinapterus leucas)	PLOS ONE			English	Article							EXHALED BREATH CONDENSATE; CORTICOSTEROID-BINDING GLOBULIN; SALIVARY CORTISOL; STEROID-HORMONES; WHALES; BLUBBER; STRESS; TESTOSTERONE; PHYSIOLOGY; PREGNANCY	Non-invasive sampling techniques are increasingly being used to monitor glucocorticoids, such as cortisol, as indicators of stressor load and fitness in zoo and wildlife conservation, research and medicine. For cetaceans, exhaled breath condensate (blow) provides a unique sampling matrix for such purposes. The purpose of this work was to develop an appropriate collection methodology and validate the use of a commercially available EIA for measuring cortisol in blow samples collected from belugas (Delphinapterus leucas). Nitex membrane stretched over a petri dish provided the optimal method for collecting blow. A commercially available cortisol EIA for measuring human cortisol (detection limit 35 pg ml(-1)) was adapted and validated for beluga cortisol using tests of parallelism, accuracy and recovery. Blow samples were collected from aquarium belugas during monthly health checks and during out of water examination, as well as from wild belugas. Two aquarium belugas showed increased blow cortisol between baseline samples and 30 minutes out of water (Baseline, 0.21 and 0.04 mu g dl(-1); 30 minutes, 0.95 and 0.14 mu g dl(-1)). Six wild belugas also showed increases in blow cortisol between pre and post 1.5 hour examination (Pre 0.03, 0.23, 0.13, 0.19, 0.13, 0.04 mu g dl(-1), Post 0.60, 0.31, 0.36, 0.24, 0.14, 0.16 mu g dl(-1)). Though this methodology needs further investigation, this study suggests that blow sampling is a good candidate for non-invasive monitoring of cortisol in belugas. It can be collected from both wild and aquarium animals efficiently for the purposes of health monitoring and research, and may ultimately be useful in obtaining data on wild populations, including endangered species, which are difficult to handle directly.	[Thompson, Laura A.; Spoon, Tracey R.; Romano, Tracy A.] Mystic Aquarium, Mystic, CT 06365 USA; [Thompson, Laura A.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Goertz, Caroline E. C.] Alaska Sea Life Ctr, Seward, AK USA; [Hobbs, Roderick C.] Alaska Fisheries Sci Ctr, Natl Marine Mammal Lab, Washington, DC USA	University of Connecticut; National Oceanic Atmospheric Admin (NOAA) - USA	Romano, TA (corresponding author), Mystic Aquarium, Mystic, CT 06365 USA.	tromano@searesearch.org		Goertz, Caroline/0000-0002-1282-5654	Office of Naval Research [N00014-11-1-0437]; Interdisciplinary Research Initiative in Coastal Health (IRICH); NOAA Oceans and Human Health Initiative (OHHI)	Office of Naval Research(Office of Naval Research); Interdisciplinary Research Initiative in Coastal Health (IRICH); NOAA Oceans and Human Health Initiative (OHHI)	Funding for this work was provided by the Office of Naval Research award #N00014-11-1-0437 awarded to TR. Additional funding for LT was provided by the Interdisciplinary Research Initiative in Coastal Health (IRICH) and NOAA Oceans and Human Health Initiative (OHHI). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Acevedo-Whitehouse K, 2010, ANIM CONSERV, V13, P217, DOI 10.1111/j.1469-1795.2009.00326.x; Amadei E, 2008, P 22 ANN C EUR CET S; Amaral RS, 2010, AQUAT MAMM, V36, P162, DOI 10.1578/AM.36.2.2010.162; Anderson PA, 2011, AQUACULTURE, V311, P129, DOI 10.1016/j.aquaculture.2010.11.013; [Anonymous], 2011, SAL HIGH SENS SAL CO; Bonier F, 2009, TRENDS ECOL EVOL, V24, P634, DOI 10.1016/j.tree.2009.04.013; Borrill ZL, 2008, EUR RESPIR J, V32, P472, DOI 10.1183/09031936.00116107; Bortolotti GR, 2008, FUNCT ECOL, V22, P494, DOI 10.1111/j.1365-2435.2008.01387.x; Breuner CW, 2008, GEN COMP ENDOCR, V157, P288, DOI 10.1016/j.ygcen.2008.05.017; CLERICO A, 1982, CLIN CHEM, V28, P1343; COOLENS JL, 1987, J STEROID BIOCHEM, V26, P197, DOI 10.1016/0022-4731(87)90071-9; Dunstan J., 2012, WATERS APPL NOTE WAT, P1, DOI DOI 10.1038/S41598-018-28200-8; Effros RM, 2004, AM J PHYSIOL-LUNG C, V287, pL1073, DOI 10.1152/ajplung.00069.2004; Frere CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012299; Gozansky WS, 2005, CLIN ENDOCRINOL, V63, P336, DOI 10.1111/j.1365-2265.2005.02349.x; Hogg CJ, 2009, MAR MAMMAL SCI, V25, P605, DOI 10.1111/j.1748-7692.2008.00277.x; Hogg CJ, 2005, J CHROMATOGR B, V814, P339, DOI 10.1016/j.jchromb.2004.10.058; Horvath I, 2005, EUR RESPIR J, V26, P523, DOI 10.1183/09031936.05.00029705; Hunt KE, 2014, MAR MAMMAL SCI, V30, P796, DOI 10.1111/mms.12073; Hunt KE, 2013, M ABSTR SOC INT COMP; Katial RK, 2012, UPDATE BIOMAKERS ALL; Kellar NM, 2009, MAR MAMMAL SCI, V25, P507, DOI 10.1111/j.1748-7692.2009.00291.x; Kellar NM, 2006, MAR MAMMAL SCI, V22, P1, DOI 10.1111/j.1748-7692.2006.00001.x; KIRSCHBAUM C, 1994, PSYCHONEUROENDOCRINO, V19, P313, DOI 10.1016/0306-4530(94)90013-2; Lewis JG, 2005, CLIN CHIM ACTA, V359, P189, DOI 10.1016/j.cccn.2005.03.044; Mansour AAH, 2002, MAR MAMMAL SCI, V18, P112, DOI 10.1111/j.1748-7692.2002.tb01022.x; Mutlu GM, 2001, AM J RESP CRIT CARE, V164, P731, DOI 10.1164/ajrccm.164.5.2101032; Norman SA, 2012, J WILDLIFE DIS, V48, P21, DOI 10.7589/0090-3558-48.1.21; Orlando EF, 2001, HUM REPROD UPDATE, V7, P265, DOI 10.1093/humupd/7.3.265; Pretorius CJ, 2011, CLIN CHIM ACTA, V412, P1043, DOI 10.1016/j.cca.2011.02.019; Reeder DM, 2005, J MAMMAL, V86, P225, DOI 10.1644/BHE-003.1; Romero ML, 2007, INT J COMP PSYCHOL, V20, P89; Schmitt TL, 2010, MAR MAMMAL SCI, V26, P635, DOI 10.1111/j.1748-7692.2009.00366.x; Schwacke LH, 2014, ENVIRON SCI TECHNOL, V48, P93, DOI 10.1021/es403610f; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Suzuki M, 1998, FISHERIES SCI, V64, P643, DOI 10.2331/fishsci.64.643; VINING RF, 1983, CLIN CHEM, V29, P1752	37	35	35	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114062	10.1371/journal.pone.0114062	http://dx.doi.org/10.1371/journal.pone.0114062			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464121	gold, Green Submitted, Green Published			2022-12-26	WOS:000345869700092
J	Zhang, L; Wang, H; Xiao, M; Kudinha, T; Mao, LL; Zhao, HR; Kong, FR; Xu, YC				Zhang, Li; Wang, He; Xiao, Meng; Kudinha, Timothy; Mao, Lei-Li; Zhao, Hao-Ran; Kong, Fanrong; Xu, Ying-Chun			The Widely Used ATB FUNGUS 3 Automated Readings in China and Its Misleading High MICs of Candida spp. to Azoles: Challenges for Developing Countries' Clinical Microbiology Labs	PLOS ONE			English	Article							IN-VITRO SUSCEPTIBILITIES; ANTIFUNGAL SUSCEPTIBILITY; INVASIVE CANDIDIASIS; CLONAL STRAIN; SURVEILLANCE; VORICONAZOLE; FLUCONAZOLE; ALBICANS; AURIS	The rapid development in the clinical microbiology diagnostic assays presents more challenges for developing countries than for the developed world, especially in the area of test validation before the introduction of new tests. Here we report on the misleading high MICs of Candida spp. to azoles using the ATB FUNGUS 3 (bioMerieux, La Balme-les Grottes, France) with automated readings in China to highlight the dangers of introducing a diagnostic assay without validation. ATB FUNGUS 3 is the most commonly used commercial antifungal susceptibility testing method in China. An in-depth analysis of data showed higher levels of resistance to azoles when ATB FUNGUS 3 strips were read automatically than when read visually. Based on this finding, the performance of ATB FUNGUS 3, read both visually and automatically, was evaluated by testing 218 isolates of five clinically important Candida species, using broth microdilution (BMD) following CLSI M27-A3 as the gold-standard. The overall essential agreement (EA) between ATB visual readings and BMD was 99.1%. In contrast, the ATB automated readings showed higher discrepancies with BMD, with overall EA of 86.2%, and specifically lower EA was observed for fluconazole (80.7%), voriconazole (77.5%), and itraconazole (73.4%), which was most likely due to the trailing effect of azoles. The major errors in azole drug susceptibilities by ATB automated readings is a concern in China that can result in misleading clinical antifungal drug selection and pseudo high rates of antifungal resistance. Therefore, the ATB visual reading is generally recommended. In the meantime, we propose a practical algorithm to be followed for ATB FUNGUS 3 antifungal susceptibility for Candida spp. before the improvement in the automated reading system.	[Zhang, Li; Wang, He; Xiao, Meng; Mao, Lei-Li; Zhao, Hao-Ran; Xu, Ying-Chun] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Lab, Beijing 100730, Peoples R China; [Zhang, Li; Wang, He] Chinese Acad Med Sci, Peking Union Med Coll, Grad Sch, Beijing 100730, Peoples R China; [Kudinha, Timothy; Kong, Fanrong] Westmead Hosp, Ctr Infect Dis & Microbiol Lab Serv, Westmead, NSW 2145, Australia	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Sydney	Xu, YC (corresponding author), Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Clin Lab, Beijing 100730, Peoples R China.	xycpumch@139.com	Xiao, Meng/J-6518-2017	Xiao, Meng/0000-0003-2103-7008	Peking Union Medical College [2012-1002-023]	Peking Union Medical College	The work was supported by Innovation Fund of Peking Union Medical College (2012-1002-023). LZ received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Abdeljelil J, 2012, MYCOSES, V55, P493, DOI 10.1111/j.1439-0507.2012.02189.x; Chen PL, 2011, MYCOSES, V54, pE17, DOI 10.1111/j.1439-0507.2009.01818.x; Chowdhary A, 2014, EUR J CLIN MICROBIOL, V33, P919, DOI 10.1007/s10096-013-2027-1; Chowdhary A, 2013, EMERG INFECT DIS, V19, P1670, DOI 10.3201/eid1910.130393; Clinical and Laboratory Standard Institute, 2012, REF METH BROTH DIL A; Clinical and Laboratory Standards Institute, 2008, REF METH BROTH DIL A; Eraso E, 2008, REV IBEROAM MICOL, V25, P3, DOI 10.1016/S1130-1406(08)70002-0; Falagas ME, 2006, EUR J CLIN MICROBIOL, V25, P419, DOI 10.1007/s10096-006-0159-2; Horta JA, 2002, MED MYCOL, V40, P565; Hou DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101447; Huang H, 2012, PRACTICAL PREVENT ME, V19, P1536; Lee MK, 2004, J ANTIMICROB CHEMOTH, V53, P217, DOI 10.1093/jac/dkh040; Li F, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-353; Mi RS, 2008, LAB MED CLIN, V19, P1173; Miceli MH, 2011, LANCET INFECT DIS, V11, P142, DOI 10.1016/S1473-3099(10)70218-8; Pappas PG, 2009, CLIN INFECT DIS, V48, P503, DOI 10.1086/596757; Pfaller MA, 2007, CLIN MICROBIOL REV, V20, P133, DOI 10.1128/CMR.00029-06; Pfaller MA, 2012, J CLIN MICROBIOL, V50, P2846, DOI 10.1128/JCM.00937-12; Pfaller MA, 2010, J CLIN MICROBIOL, V48, P1366, DOI 10.1128/JCM.02117-09; Sanglard D, 2003, MOL MICROBIOL, V48, P959, DOI 10.1046/j.1365-2958.2003.03495.x; Torres-Rodriguez JM, 2007, J ANTIMICROB CHEMOTH, V60, P658, DOI 10.1093/jac/dkm247; Wang H, 2012, J CLIN MICROBIOL, V50, P3952, DOI 10.1128/JCM.01130-12; Wang W, 2012, CHIN MOD MED, V19, P98; Yu JH, 2007, CLIN J MED OFFIC, V35, P268	24	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114004	10.1371/journal.pone.0114004	http://dx.doi.org/10.1371/journal.pone.0114004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460351	Green Submitted, Green Published, gold			2022-12-26	WOS:000345869700078
J	Garrisi, VM; Strippoli, S; De Summa, S; Pinto, R; Perrone, A; Guida, G; Azzariti, A; Guida, M; Stefania, T				Garrisi, Vito Michele; Strippoli, Sabino; De Summa, Simona; Pinto, Rosamaria; Perrone, Antonella; Guida, Gabriella; Azzariti, Amalia; Guida, Michele; Stefania, Tommasi			Proteomic Profile and In Silico Analysis in Metastatic Melanoma with and without BRAF Mutation	PLOS ONE			English	Article							BREAST-CANCER; EXPRESSION; CELLS; VEMURAFENIB; SURVIVAL; PROTEIN	Introduction: Selective inhibitors of BRAF, vemurafenib and dabrafenib are the standard of care for metastatic melanoma patients with BRAF V600, while chemotherapy continued to be widely used in BRAF wild type patients. Materials and Methods: In order to discover novel candidate biomarkers predictive to treatment, serum of 39 metastatic melanoma vemurafenib (n=19) or chemotherapy (n=20) treated patients at baseline, at disease control and at progression, were analyzed using SELDI-TOF technology. In silico analysis was used to identify more significant peaks. Results: In patients with different BRAF status, we found 5 peptides significantly deregulated, with the down-regulation of the m/z 9176 peak strongly associated with BRAF mutation. At baseline as predictive biomarkers we identified 2 peptides m/z 6411, 4075 - as significantly up-regulated in responders to chemotherapy and 4 peaks - m/z 5900, 12544, 49124 and 11724 - significantly up-regulated in longer vs shorter responders to vemurafenib. After response, 3 peptides (m/z 4658, 18639, and 9307) resulted significantly down regulated while 3 peptides m/z 9292, 7765 and 9176 appeared up-regulated respectively in chemotherapy and vemurafenib responder patients. In vemurafenib treated patients, 16 peaks appeared deregulated at progression compared to baseline time. In silico analysis identified proteins involved in invasiveness (SLAIN1) and resistance (ABCC12) as well as in the pathway of detoxification (NQO1) and apoptosis (RBM10, TOX3, MTEFD1, TSPO2). Proteins associated with the modulation of neuronal plasticity (RIN1) and regulatory activity factors of gene transcription (KLF17, ZBTB44) were also highlighted. Conclusion: Our exploratory study highlighted some factors that deserve to be further investigated in order to provide a framework for improving melanoma treatment management through the development of biomarkers which could act as the strongest surrogates of the key biological events in stage IV melanoma.	[Garrisi, Vito Michele; Strippoli, Sabino; De Summa, Simona; Pinto, Rosamaria; Perrone, Antonella; Azzariti, Amalia; Guida, Michele; Stefania, Tommasi] Ist Tumori Giovanni Paolo II, Natl Canc Res Ctr, Bari, Italy; [Guida, Gabriella] Univ Bari, Dept Basic Med Sci, Fac Med & Surg, Sch Med, Bari, Italy	IRCCS Istituto Tumori Bari Giovanni Paolo II; Universita degli Studi di Bari Aldo Moro	Stefania, T (corresponding author), Ist Tumori Giovanni Paolo II, Natl Canc Res Ctr, Bari, Italy.	s.tommasi@oncologico.bari.it	Guida, Michele/AAG-7017-2020; De Summa, Simona/K-2582-2018; Azzariti, Amalia/K-4498-2016; strippoli, sabino/AAF-6774-2021; Tommasi, Stefania/J-6732-2012	De Summa, Simona/0000-0001-9607-3754; Azzariti, Amalia/0000-0002-6149-5049; strippoli, sabino/0000-0001-7982-7788; Tommasi, Stefania/0000-0002-2157-2978; Guida, Gabriella/0000-0003-2345-2838; Guida, michele/0000-0001-8411-0319	IRCCS Istituto Tumori "Giovanni Paolo II"; MIUR Italian Ministry of University [PON01_01297]	IRCCS Istituto Tumori "Giovanni Paolo II"; MIUR Italian Ministry of University(Ministry of Education, Universities and Research (MIUR))	Funding: The study has been supported by internal research grants of IRCCS Istituto Tumori "Giovanni Paolo II" and by MIUR Italian Ministry of University and research) http://www.istruzione.it/, GRANT Number: PON01_01297, Author who received the funding: ST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aihara A, 2014, HEPATOLOGY, V60, P1302, DOI 10.1002/hep.27275; Alcazar O, 2012, INT J CANCER, V131, P18, DOI 10.1002/ijc.26320; Arai E, 2012, CARCINOGENESIS, V33, P1487, DOI 10.1093/carcin/bgs177; Baquero P, 2013, CANCER LETT, V335, P232, DOI 10.1016/j.canlet.2013.02.033; Bechara EG, 2013, MOL CELL, V52, P720, DOI 10.1016/j.molcel.2013.11.010; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen BL, 2008, ONCOL REP, V20, P1093, DOI 10.3892/or_00000114; Clarke HJ, 2014, CANCER CELL, V25, P563, DOI 10.1016/j.ccr.2014.03.015; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Cooper CDO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023916; Croft A, 2014, J INVEST DERMATOL, V134, P488, DOI 10.1038/jid.2013.325; Daniele S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04749; Davidov T, 2014, J SURG RES, V190, P565, DOI 10.1016/j.jss.2014.03.042; Eggermont AMM, 2011, EUR J CANCER, V47, P2150, DOI 10.1016/j.ejca.2011.06.052; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Fang P, 2012, TUMOR BIOL, V33, P1511, DOI 10.1007/s13277-012-0402-7; Fecher LA, 2007, J CLIN ONCOL, V25, P1606, DOI 10.1200/JCO.2006.06.0442; Findeisen P, 2008, JCO, V27, P2199; Forsea AM, 2012, BRIT J DERMATOL, V167, P1124, DOI 10.1111/j.1365-2133.2012.11125.x; Garrisi VM, 2013, CLIN BIOCHEM, V46, P259, DOI 10.1016/j.clinbiochem.2012.11.003; Garrisi VM, 2011, CLIN BIOCHEM, V44, P936, DOI 10.1016/j.clinbiochem.2011.04.013; Garrisi VM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049631; Garrisi VM, 2008, EXPERT REV PROTEOMIC, V5, P779, DOI 10.1586/14789450.5.6.779; Guida M, 2012, EXPERT OPIN THER TAR, V16, pS61, DOI 10.1517/14728222.2011.645807; Guida M, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-115; Hersh E, 2012, PIGM CELL MELANOMA R, V25, P863; Hersh EM, 2010, CANCER-AM CANCER SOC, V116, P155, DOI 10.1002/cncr.24720; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Iwanicki MP, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-244; Jang S, 2014, CLIN PHARMACOL THER, V95, P24, DOI 10.1038/clpt.2013.197; Jones JO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074102; Lundstrom W, 2013, P NATL ACAD SCI USA, V110, pE1761, DOI 10.1073/pnas.1222303110; Mactier S, 2011, J PROTEOME RES, V10, P1030, DOI 10.1021/pr100803b; Massoumi R, 2009, J EXP MED, V206, P221, DOI 10.1084/jem.20082044; Mocellin S, 2012, CURR MED CHEM, V19, P3893, DOI 10.2174/092986712802002509; Mocellin S, 2008, INT J CANCER, V123, P2370, DOI 10.1002/ijc.23794; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Orlandi R, 2014, ANN ONCOL, V25, P352, DOI 10.1093/annonc/mdt490; Pey AL, 2014, BBA-MOL BASIS DIS, V1842, P2163, DOI 10.1016/j.bbadis.2014.08.011; Pooley KA, 2013, HUM MOL GENET, V22, P5056, DOI 10.1093/hmg/ddt355; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Santagata S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007932; Shin N, 2011, INT J CANCER, V128, P2872, DOI 10.1002/ijc.25641; Smith MP, 2013, JNCI-J NATL CANCER I, V105, P33, DOI 10.1093/jnci/djs471; Takeuchi H, 2010, MOL CELL BIOL, V30, P1689, DOI 10.1128/MCB.01105-09; Tay KH, 2014, CELL SIGNAL, V26, P287, DOI 10.1016/j.cellsig.2013.11.008; Verdoliva V, 2013, PONE; Vereecken P, 2012, DERMAT RES PRACT, V2012, DOI 10.1155/2012/260643; Xue Q, 2013, J CANCER RES CLIN, V139, P1539, DOI 10.1007/s00432-013-1474-5; Yang H, 2010, ONCOL REP, V24, P1257, DOI 10.3892/or_00000980	50	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112025	10.1371/journal.pone.0112025	http://dx.doi.org/10.1371/journal.pone.0112025			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437182	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900011
J	Heiden, S; Grund, C; Roder, A; Granzow, H; Kuhnel, D; Mettenleiter, TC; Romer-Oberdorfer, A				Heiden, Sandra; Grund, Christian; Roeder, Anja; Granzow, Harald; Kuehnel, Denis; Mettenleiter, Thomas C.; Roemer-Oberdoerfer, Angela			Different Regions of the Newcastle Disease Virus Fusion Protein Modulate Pathogenicity	PLOS ONE			English	Article							PARAMYXOVIRUS TYPE-1; NUCLEOTIDE-SEQUENCE; CYTOPLASMIC DOMAIN; TISSUE-CULTURE; CLEAVAGE SITE; GLYCOPROTEIN; VIRULENCE; REQUIREMENTS; REPLICATION; CLEAVABILITY	Newcastle disease virus (NDV), also designated as Avian paramyxovirus type 1 (APMV-1), is the causative agent of a notifiable disease of poultry but it exhibits different pathogenicity dependent on the virus strain. The molecular basis for this variability is not fully understood. The efficiency of activation of the fusion protein (F) is determined by presence or absence of a polybasic amino acid sequence at an internal proteolytic cleavage site which is a major determinant of NDV virulence. However, other determinants of pathogenicity must exist since APMV-1 of high (velogenic), intermediate (mesogenic) and low (lentogenic) virulence specify a polybasic F cleavage site. We aimed at elucidation of additional virulence determinants by constructing a recombinant virus that consists of a lentogenic NDV Clone 30 backbone and the F protein gene from a mesogenic pigeon paramyxovirus-1 (PPMV-1) isolate with an intracerebral pathogenicity index (ICPI) of 1.1 specifying the polybasic sequence R-R-K-K-R* F motif at the cleavage site. The resulting virus was characterized by an ICPI of 0.6, indicating a lentogenic pathotype. In contrast, alteration of the cleavage site G-R-Q-G-R* L of the lentogenic Clone 30 to R-R-K-K-R* F resulted in a recombinant virus with an ICPI of 1.36 which was higher than that of parental PPMV-1. Substitution of different regions of the F protein of Clone 30 by those of PPMV-1, while maintaining the polybasic amino acid sequence at the F cleavage site, resulted in recombinant viruses with ICPIs ranging from 0.59 to 1.36 suggesting that virulence is modulated by regions of the F protein other than the polybasic cleavage site.	[Heiden, Sandra; Roeder, Anja; Kuehnel, Denis; Mettenleiter, Thomas C.; Roemer-Oberdoerfer, Angela] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Mol Virol & Cell Biol, Greifswald, Germany; [Grund, Christian] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Diagnost Virol, Greifswald, Germany; [Granzow, Harald] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Infectiol, Greifswald, Germany	Friedrich Loeffler Institute; Friedrich Loeffler Institute; Friedrich Loeffler Institute	Romer-Oberdorfer, A (corresponding author), Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Inst Mol Virol & Cell Biol, Greifswald, Germany.	angela.roemer-oberdoerfer@fli.bund.de	Mettenleiter, h. c. Thomas C./U-1016-2019		MSD Animal Health; Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health of German Federal Ministry of Food and Agriculture	MSD Animal Health(Merck & CompanyIntervet International B.V.); Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health of German Federal Ministry of Food and Agriculture	The study was funded in part by MSD Animal Health (http://www.msd-animal-health.nl/) and supported by the budget of the Friedrich-Loeffler-Institut, Federal Research Institute for Animal Health of German Federal Ministry of Food and Agriculture. No other individuals employed or contracted by the funders (other than the named authors) played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander D. J., 1998, LAB MANUAL ISOLATION, V4, P156; ALEXANDER DJ, 1985, VET REC, V117, P429, DOI 10.1136/vr.117.17.429; Alexander DJ, 2000, REV SCI TECH OIE, V19, P443, DOI 10.20506/rst.19.2.1231; Alexander DJ, 1997, DIS POULTRY, P541; ANTIN PB, 1991, DEV BIOL, V143, P111, DOI 10.1016/0012-1606(91)90058-B; BIANCIFIORI F, 1983, COMP IMMUNOL MICROB, V6, P247, DOI 10.1016/0147-9571(83)90017-6; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; CEC, 1992, OFFICIAL J EUROPEAN, V260, P1; Collins MS, 1996, ARCH VIROL, V141, P635, DOI 10.1007/BF01718322; COLLINS MS, 1993, ARCH VIROL, V128, P363, DOI 10.1007/BF01309446; Czegledi A, 2006, VIRUS RES, V120, P36, DOI 10.1016/j.virusres.2005.11.009; Deng R, 1997, ARCH VIROL, P115; Dolganiuc V, 2003, J VIROL, V77, P12968, DOI 10.1128/JVI.77.24.12968-12979.2003; Dortmans JCFM, 2011, J GEN VIROL, V92, P336, DOI 10.1099/vir.0.026344-0; Dortmans JCFM, 2009, J GEN VIROL, V90, P2746, DOI 10.1099/vir.0.014118-0; Geiser M, 2001, BIOTECHNIQUES, V31, P88, DOI 10.2144/01311st05; GLICKMAN RL, 1988, J VIROL, V62, P354, DOI 10.1128/JVI.62.1.354-356.1988; Gravel KA, 2003, J VIROL, V77, P11040, DOI 10.1128/JVI.77.20.11040-11049.2003; KALETA EF, 1985, AVIAN PATHOL, V14, P553, DOI 10.1080/03079458508436258; KAWAHARA N, 1992, J GEN VIROL, V73, P583, DOI 10.1099/0022-1317-73-3-583; King A M Q, 2012, VIRUS TAXONOMY PARAM, P672; Lyles D. S., 2007, FIELDS VIROLOGY, V1, P1364; Meulemans G, 2002, AVIAN PATHOL, V31, P515, DOI 10.1080/0307945021000005897; MILLAR NS, 1988, J GEN VIROL, V69, P613, DOI 10.1099/0022-1317-69-3-613; Morrison TG, 2001, TRENDS MICROBIOL, V9, P103, DOI 10.1016/S0966-842X(01)01959-X; Morrison TG, 2003, BBA-BIOMEMBRANES, V1614, P73, DOI 10.1016/S0005-2736(03)00164-0; MOSCOVICI C, 1977, CELL, V11, P95, DOI 10.1016/0092-8674(77)90320-8; NAGAI Y, 1976, VIROLOGY, V72, P494, DOI 10.1016/0042-6822(76)90178-1; NAGAI Y, 1977, VIROLOGY, V77, P125, DOI 10.1016/0042-6822(77)90412-3; Paldurai A, 2014, J VIROL, V88, P8579, DOI 10.1128/JVI.00666-14; Panda A, 2004, MICROB PATHOGENESIS, V36, P1, DOI 10.1016/j.micpath.2003.07.003; Pantua HD, 2006, J VIROL, V80, P11062, DOI 10.1128/JVI.00726-06; Peeters BPH, 1999, J VIROL, V73, P5001, DOI 10.1128/JVI.73.6.5001-5009.1999; Ramp K, 2011, AVIAN DIS, V55, P413, DOI 10.1637/9652-011111-Reg.1; Romer-Oberdorfer A, 2006, AVIAN DIS, V50, P259, DOI 10.1637/7471-111505R.1; Romer-Oberdorfer A, 1999, J GEN VIROL, V80, P2987, DOI 10.1099/0022-1317-80-11-2987; SAKAGUCHI T, 1991, VIROLOGY, V184, P504, DOI 10.1016/0042-6822(91)90420-G; Samal S, 2013, J VIROL, V87, P10083, DOI 10.1128/JVI.01446-13; Schmitt AP, 2002, J VIROL, V76, P3952, DOI 10.1128/JVI.76.8.3952-3964.2002; SCHNELL MJ, 1994, EMBO J, V13, P4195, DOI 10.1002/j.1460-2075.1994.tb06739.x; STEWARD M, 1993, J GEN VIROL, V74, P2539, DOI 10.1099/0022-1317-74-12-2539; Takimoto T, 2004, VIRUS RES, V106, P133, DOI 10.1016/j.virusres.2004.08.010; Takimoto T, 2001, J VIROL, V75, P11384, DOI 10.1128/JVI.75.23.11384-11391.2001; Waning DL, 2002, J VIROL, V76, P9284, DOI 10.1128/JVI.76.18.9284-9297.2002; Werner O, 1999, AVIAN PATHOL, V28, P79, DOI 10.1080/03079459995082	45	21	25	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113344	10.1371/journal.pone.0113344	http://dx.doi.org/10.1371/journal.pone.0113344			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437176	Green Submitted, Green Published, gold			2022-12-26	WOS:000347114900041
J	Hammer, A; Oladimeji, P; De Las Casas, LE; Diakonova, M				Hammer, Alan; Oladimeji, Peter; De Las Casas, Luis E.; Diakonova, Maria			Phosphorylation of tyrosine 285 of PAK1 facilitates beta PIX/GIT1 binding and adhesion turnover	FASEB JOURNAL			English	Article						JAK2 kinase; prolactin; cell spreading; breast cancer cells	BREAST-CANCER-CELLS; GROWTH-FACTOR-I; NUCLEOTIDE EXCHANGE FACTORS; HUMAN PROLACTIN RECEPTOR; PAXILLIN KINASE LINKER; P21-ACTIVATED KINASE; PHOSPHATIDYLINOSITOL 3-KINASE; LD4 MOTIF; CYTOSKELETAL REORGANIZATION; INTEGRIN ALPHA-V-BETA-5	The p21-activated serine-threonine kinase (PAK1) regulates cell motility and adhesion. We have previously shown that the prolactin (PRL)-activated tyrosine kinase JAK2 phosphorylates PAK1 in vivo and in vitro and identified tyrosines 153, 201, and 285 in PAK1 as sites of JAK2 tyrosyl phosphorylation. Here, we further investigate the role of the tyrosyl phosphorylated PAK1 (pTyr-PAK1) in regulation of cell adhesion. We use human breast cancer T47D cell lines that stably overexpress PAK1 wild type or PAK1 Y3F mutant in which these 3 JAK2 phosphorylation sites were mutated to phenylalanine. We demonstrate that PRL/JAK2-dependent phosphorylation of these tyrosines promotes a motile phenotype in the cells upon adhesion, participates in regulation of cell adhesion on collagen IV, and is required for maximal PAK1 kinase activity. Downregulation of PAK1 abolishes the effect of PAK1 on cell adhesion. We show that the tyrosyl phosphorylation of PAK1 promotes PAK1 binding to beta-PAK1-interacting guanine-nucleotide exchange factor (beta PIX) and G protein-coupled receptor kinase-interacting target 1 (GIT1), phosphorylation of paxillin on Ser273, and formation and distribution of adhesion complexes. Using phosphospecific antibodies (Abs) directed to single phosphorylated tyrosines on PAK1, we identified Tyr285 as a site of PRL-dependent phosphorylation of PAK1 by JAK2. Furthermore, using PAK1 Y285F mutant, we provide evidence for a role of pTyr285 in cell adhesion, enhanced beta PIX/GIT1 binding, and adhesion turnover. Our immunohistochemistry analysis demonstrates that pTyr285-PAK1 may modulate PAK1 signaling during tumor progression.	[Hammer, Alan; Oladimeji, Peter; Diakonova, Maria] Univ Toledo, Dept Biol Sci, Toledo, OH 43606 USA; [De Las Casas, Luis E.] Univ Toledo, Dept Pathol, Toledo, OH 43606 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Toledo	Diakonova, M (corresponding author), Univ Toledo, Dept Biol Sci, 2801 W Bancroft St, Toledo, OH 43606 USA.	mdiakon@utnet.utoledo.edu		Oladimeji, Peter/0000-0003-2050-5949	U.S. National Institutes of Health [R01-DK88127]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088127] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors are grateful to Dr. Rider (University of Toledo, Toledo, OH, USA) for making T47D cell lines stably expressing GFP, PAK1 WT, or PAK1 Y3F and for characterization of anti-phospho-Tyr-specific Abs. They also thank Dr. Garcia-Mata (University of Toledo) for providing cDNA encoding RFP-vinculin, help with video microscopy, and very helpful discussion; Dr. Webb (Wadsworth Center, New York State Department of Health, Albany, NY, USA) for providing cDNA encoding mCherry-paxillin (Vanderbilt University, Nashville, TN, USA); Dr. Martin Myers (University of Michigan, Ann Arbor, MI, USA) for providing cDNAs encoding JAK2 constructs; and the Michigan Diabetes Research and Training Center Hybridoma Core for the production of the ascites containing mouse alpha myc monoclonal Ab. This work was supported by the U.S. National Institutes of Health (Grant R01-DK88127) (to M.D.).	Acosta JJ, 2003, MOL ENDOCRINOL, V17, P2268, DOI 10.1210/me.2002-0422; Adam L, 2000, J BIOL CHEM, V275, P12041, DOI 10.1074/jbc.275.16.12041; Aksamitiene E, 2011, CELL SIGNAL, V23, P1794, DOI 10.1016/j.cellsig.2011.06.014; Bagheri-Yarmand R, 2001, J BIOL CHEM, V276, P29403, DOI 10.1074/jbc.M103129200; BELLIS SL, 1995, J BIOL CHEM, V270, P17437, DOI 10.1074/jbc.270.29.17437; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; BONNETERRE J, 1987, CANCER RES, V47, P4724; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Brown MC, 2002, MOL BIOL CELL, V13, P1550, DOI 10.1091/mbc.02-02-0015; Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Butler AA, 1997, J BIOL CHEM, V272, P27660, DOI 10.1074/jbc.272.44.27660; Canbay E, 1997, BIOCHEM J, V324, P231, DOI 10.1042/bj3240231; Carver KC, 2009, MOL CELL ENDOCRINOL, V307, P1, DOI 10.1016/j.mce.2009.03.014; Casamassima A, 1998, J BIOL CHEM, V273, P26149, DOI 10.1074/jbc.273.40.26149; Chen RY, 2001, NAT CELL BIOL, V3, P439, DOI 10.1038/35074500; Chen TC, 2012, INVEST OPHTH VIS SCI, V53, P1539, DOI 10.1167/iovs.11-9203; Clevenger CV, 2009, TRENDS ENDOCRIN MET, V20, P223, DOI 10.1016/j.tem.2009.03.001; CLEVENGER CV, 1995, AM J PATHOL, V146, P695; Clevenger CV, 2003, ENDOCR REV, V24, P1, DOI 10.1210/er.2001-0036; Daniels RH, 1999, J BIOL CHEM, V274, P6047, DOI 10.1074/jbc.274.10.6047; de Oca PM, 2005, LAB INVEST, V85, P633, DOI 10.1038/labinvest.3700256; Deakin NO, 2008, J CELL SCI, V121, P2435, DOI 10.1242/jcs.018044; del Pozo MA, 2000, EMBO J, V19, P2008, DOI 10.1093/emboj/19.9.2008; Delorme-Walker VD, 2011, J CELL BIOL, V193, P1289, DOI 10.1083/jcb.201010059; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; Diakonova M, 2002, MOL BIOL CELL, V13, P402, DOI 10.1091/mbc.01-05-0273; Dong JM, 2009, BIOCHEM J, V418, P173, DOI 10.1042/BJ20080170; Dummler B, 2009, CANCER METAST REV, V28, P51, DOI 10.1007/s10555-008-9168-1; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Frost JA, 1998, J BIOL CHEM, V273, P28191, DOI 10.1074/jbc.273.43.28191; Galisteo ML, 1996, J BIOL CHEM, V271, P20997, DOI 10.1074/jbc.271.35.20997; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; GINSBURG E, 1995, CANCER RES, V55, P2591; Hammer A, 2013, MOL ENDOCRINOL, V27, P455, DOI 10.1210/me.2012-1291; He H, 2004, CANCER BIOL THER, V3, P96, DOI 10.4161/cbt.3.1.643; Herrera R, 1998, J CELL SCI, V111, P1039; Howe AK, 2000, NAT CELL BIOL, V2, P593, DOI 10.1038/35023536; Kim S, 2001, J BIOL CHEM, V276, P10581, DOI 10.1074/jbc.C000806200; Kiosses WB, 1999, J CELL BIOL, V147, P831, DOI 10.1083/jcb.147.4.831; Kline JB, 2001, MOL ENDOCRINOL, V15, P832, DOI 10.1210/me.15.5.832; Kloek C, 2002, J BIOL CHEM, V277, P41547, DOI 10.1074/jbc.M205148200; LaPensee EW, 2010, ENDOCR-RELAT CANCER, V17, pR91, DOI 10.1677/ERC-09-0253; Leventhal PS, 1997, J BIOL CHEM, V272, P5214, DOI 10.1074/jbc.272.8.5214; Li QW, 2008, NEOPLASIA, V10, P314, DOI 10.1593/neo.07970; Li ZL, 2010, MOL BIOL CELL, V21, P3317, DOI 10.1091/mbc.E10-03-0245; Liby K, 2003, BREAST CANCER RES TR, V79, P241, DOI 10.1023/A:1023956223037; Liu FM, 2010, MOL CELL BIOL, V30, P1971, DOI 10.1128/MCB.01247-09; Loo TH, 2004, MOL CELL BIOL, V24, P3849, DOI 10.1128/MCB.24.9.3849-3859.2004; Manabe R, 2002, J CELL SCI, V115, P1497; Manser E, 1998, MOL CELL, V1, P183, DOI 10.1016/S1097-2765(00)80019-2; Manser E, 1997, MOL CELL BIOL, V17, P1129, DOI 10.1128/MCB.17.3.1129; Maulik G, 2002, CLIN CANCER RES, V8, P620; Maus MV, 1999, ENDOCRINOLOGY, V140, P5447, DOI 10.1210/en.140.11.5447; Miller SL, 2007, ONCOGENE, V26, P4668, DOI 10.1038/sj.onc.1210264; Miller SL, 2005, MOL ENDOCRINOL, V19, P939, DOI 10.1210/me.2004-0443; Molli PR, 2009, ONCOGENE, V28, P2545, DOI 10.1038/onc.2009.119; Nayal A, 2006, J CELL BIOL, V173, P587, DOI 10.1083/jcb.200509075; Oakes SR, 2007, ONCOGENE, V26, P543, DOI 10.1038/sj.onc.1209838; Paris S, 2003, BIOCHEM J, V372, P391, DOI 10.1042/BJ20030047; Parrini Maria Carla, 2012, Cell Logist, V2, P78; Parrini MC, 2009, J BIOL CHEM, V284, P24133, DOI 10.1074/jbc.M109.015271; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Perks CC, 2004, BRIT J CANCER, V91, P305, DOI 10.1038/sj.bjc.6601947; Premont RT, 2004, CELL SIGNAL, V16, P1001, DOI 10.1016/j.cellsig.2004.02.002; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Qiu Y, 2000, ONCOGENE, V19, P5651, DOI 10.1038/sj.onc.1203958; Rankin S, 1996, J BIOL CHEM, V271, P7829, DOI 10.1074/jbc.271.13.7829; Rayala SK, 2006, CANCER RES, V66, P1694, DOI 10.1158/0008-5472.CAN-05-2922; Rennefahrt UEE, 2007, J BIOL CHEM, V282, P15667, DOI 10.1074/jbc.M700253200; Rider L, 2007, J BIOL CHEM, V282, P30985, DOI 10.1074/jbc.M701794200; Rider L, 2013, MOL ENDOCRINOL, V27, P1048, DOI 10.1210/me.2012-1322; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Robertson SA, 2009, MOL CELL BIOL, V29, P3367, DOI 10.1128/MCB.00278-09; Ryu H, 2000, J IMMUNOL, V165, P2116, DOI 10.4049/jimmunol.165.4.2116; Sachdev S, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-12; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; SCHALLER MD, 1995, MOL CELL BIOL, V15, P2635; Schaller MD, 2001, BIOCHEM J, V360, P57, DOI 10.1042/0264-6021:3600057; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Schmalzigaug R, 2007, CELL SIGNAL, V19, P1733, DOI 10.1016/j.cellsig.2007.03.010; Sells MA, 1997, CURR BIOL, V7, P202, DOI 10.1016/S0960-9822(97)70091-5; Sells MA, 2000, J CELL BIOL, V151, P1449, DOI 10.1083/jcb.151.7.1449; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; SHIU RPC, 1984, CANCER RES, V44, P1178; Smith SD, 2008, J CELL SCI, V121, P3729, DOI 10.1242/jcs.027680; Stofega MR, 2004, MOL BIOL CELL, V15, P2965, DOI 10.1091/mbc.E03-08-0604; Tapia JA, 1999, BBA-MOL CELL RES, V1448, P486, DOI 10.1016/S0167-4889(98)00157-8; ten Klooster JP, 2006, J CELL BIOL, V172, P759, DOI 10.1083/jcb.200509096; Touraine P, 1998, J CLIN ENDOCR METAB, V83, P667, DOI 10.1210/jc.83.2.667; Tsai YT, 2000, MOL CELL BIOL, V20, P2043, DOI 10.1128/MCB.20.6.2043-2054.2000; Turner CE, 1999, J CELL BIOL, V145, P851, DOI 10.1083/jcb.145.4.851; Tworoger SS, 2006, CANCER LETT, V243, P160, DOI 10.1016/j.canlet.2006.01.032; Vadlamudi RK, 2004, EMBO REP, V5, P154, DOI 10.1038/sj.embor.7400079; Vadlamudi RK, 2002, NAT CELL BIOL, V4, P681, DOI 10.1038/ncb838; Vicente-Manzanares M, 2011, J CELL SCI, V124, P3923, DOI 10.1242/jcs.095653; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Vonderhaar BK, 1998, PHARMACOL THERAPEUT, V79, P169, DOI 10.1016/S0163-7258(98)00017-5; Vonderhaar BK, 1999, ENDOCR-RELAT CANCER, V6, P389, DOI 10.1677/erc.0.0060389; Wagner KU, 2008, J MAMMARY GLAND BIOL, V13, P93, DOI 10.1007/s10911-008-9062-z; Webb DJ, 2002, NAT CELL BIOL, V4, pE97, DOI 10.1038/ncb0402-e97; Webb DJ, 2004, NAT CELL BIOL, V6, P154, DOI 10.1038/ncb1094; Webb DJ, 2005, J CELL SCI, V118, P4925, DOI 10.1242/jcs.02563; Wells CM, 2010, J CELL SCI, V123, P1663, DOI 10.1242/jcs.055707; West KA, 2001, J CELL BIOL, V154, P161, DOI 10.1083/jcb.200101039; Xiao GH, 2002, J BIOL CHEM, V277, P883, DOI 10.1074/jbc.C100553200; Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314; Zaidel-Bar R, 2010, J CELL SCI, V123, P1385, DOI 10.1242/jcs.066183; Zegers MMP, 2003, EMBO J, V22, P4155, DOI 10.1093/emboj/cdg398; Zhang HQ, 2002, J CELL BIOL, V158, P1287, DOI 10.1083/jcb.200207008; Zhao ZS, 2000, MOL CELL BIOL, V20, P3906, DOI 10.1128/MCB.20.11.3906-3917.2000; Zhao ZS, 2000, MOL CELL BIOL, V20, P6354, DOI 10.1128/MCB.20.17.6354-6363.2000; Zhao ZS, 2005, BIOCHEM J, V386, P201, DOI 10.1042/BJ20041638; Zhao ZS, 1998, MOL CELL BIOL, V18, P2153, DOI 10.1128/MCB.18.4.2153; Zhu T, 1998, J BIOL CHEM, V273, P10682, DOI 10.1074/jbc.273.17.10682	116	10	10	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					943	959		10.1096/fj.14-259366	http://dx.doi.org/10.1096/fj.14-259366			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25466889	Green Published			2022-12-26	WOS:000350633000020
J	Marques, PAM; Magalhaes, DM; Pereira, SF; Jorge, PE				Marques, Paulo A. M.; Magalhaes, Daniel M.; Pereira, Susana F.; Jorge, Paulo E.			From the Past to the Future: Natural Sound Recordings and the Preservation of the Bioacoustics Legacy in Portugal	PLOS ONE			English	Article								The preservation of historical and contemporary data safeguards our scientific legacy. Bioacoustic recordings can have historical as well as scientific value and should be assessed for their conservation requirements. Unpreserved bioacoustics recordings are generally not referenced and are frequently at high risk of loss by material degradation and/or by misplacement. In this study we investigated the preservation status of sets of natural sound recordings made in Portugal from 1983 until 2010 inclusive. We evaluated the recordings on the basis of their rate of loss, the degree to which unpreserved recordings could be preserved, and their risk of loss. Recordists of animal sounds were surveyed (by questionnaire or interview) to identify sets of recordings and to collect information on their quality and state of preservation. Of the 78 recordists identified, we found that 32% of the recordings have an unclear status and that only 9% of the recordings are lost. Of the c. 6 terabytes of unpreserved sound recordings discovered, an estimated 49% were recoverable. Moreover, 95% of the recoverable sets of recordings were at high risk of loss by their being misplaced. These risks can be minimized if recordists are persuaded to deposit their material in an institution committed to long-term curation of such data (e. g. sound archives). Overall, the study identified a considerable body of unpreserved animal sound recordings that could contribute to our scientific heritage and knowledge of the biodiversity found in Portugal. It highlights the need to implement effective policies to promote the deposit of recordings for preservation and to reverse the present scenario so that scientific material can be preserved for future generations.	[Marques, Paulo A. M.; Magalhaes, Daniel M.; Pereira, Susana F.; Jorge, Paulo E.] ISPA IU, Unidade Invest Ecoetol, Lisbon, Portugal; [Marques, Paulo A. M.; Magalhaes, Daniel M.; Pereira, Susana F.] Univ Lisbon, Museu Nacl Hist Nat & Ciencia, P-1699 Lisbon, Portugal	Instituto Superior Psicologia Aplicada (ISPA); Universidade de Lisboa	Marques, PAM (corresponding author), ISPA IU, Unidade Invest Ecoetol, Lisbon, Portugal.	pamarques@ispa.pt	Jorge, Paulo/I-7049-2013	Jorge, Paulo/0000-0001-9348-6510	Fundacao para a Ciencia e a Tecnologia, MEC (Portugal) [SFRH/BPD/34846/2007, HC/0009/2009 (2010-2012)]	Fundacao para a Ciencia e a Tecnologia, MEC (Portugal)	The study was funded by project HC/0009/2009 (2010-2012), and PAMM was supported by grant SFRH/BPD/34846/2007 both from the Fundacao para a Ciencia e a Tecnologia, MEC (Portugal; http://www.fct.pt/index.phtml.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2005, 03 IASATC; Baptista LF., 2001, HDB BIRDS WORLD, P11; Breen M, 2002, TASK FORCE ESTABLISH; Fletcher N.H., 2007, SPRINGER HDB ACOUSTI, P785, DOI [10.1007/978-1-4939-0755-7_19, DOI 10.1007/978-1-4939-0755-7_19]; Kettle R, 1991, BIOACOUSTICS, V3, P235, DOI DOI 10.1080/09524622.1991.9753183; Marques PAM, 2014, P INV PLAC IN PRESS; Marques PAM, 2011, INVENTARIO AUTORES G; National Recording Preservation Board (Library of Congress), 2006, CAPT AN SOUND DIG PR; Nelson-Strauss B., 2012, LIB C NAT REC PRES P; Obrist Martin K., 2010, Abc Taxa, V8, P68; Ranft R, 2004, AN ACAD BRAS CIENC, V76, P455; Royal Society, 2012, SCI OP ENT OP DAT OP; Vielliard JME, 2003, BRIEF HIST BIOACOUST; Vines TH, 2014, CURR BIOL, V24, P94, DOI 10.1016/j.cub.2013.11.014; Voronin Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027868; Wren JD, 2006, EMBO REP, V7, P122, DOI 10.1038/sj.embor.7400631	16	3	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 4	2014	9	12							e114303	10.1371/journal.pone.0114303	http://dx.doi.org/10.1371/journal.pone.0114303			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AW6MB	25473829	Green Published, Green Submitted, gold			2022-12-26	WOS:000346382500012
J	Giuliano, S; Agresta, AM; De Palma, A; Viglio, S; Mauri, P; Fumagalli, M; Iadarola, P; Montalbetti, L; Salvini, R; Bardoni, A				Giuliano, Serena; Agresta, Anna Maria; De Palma, Antonella; Viglio, Simona; Mauri, Pierluigi; Fumagalli, Marco; Iadarola, Paolo; Montalbetti, Lorenza; Salvini, Roberta; Bardoni, Anna			Proteomic Analysis of Lymphoblastoid Cells from Nasu-Hakola Patients: A Step Forward in Our Understanding of This Neurodegenerative Disorder	PLOS ONE			English	Article							ALZHEIMERS-DISEASE BRAIN; POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA; BINDING ALCOHOL-DEHYDROGENASE; OXIDATIVELY MODIFIED PROTEINS; AMYLOID-BETA; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; PARKINSONS-DISEASE; SCLEROSING LEUKOENCEPHALOPATHY; FRONTAL-CORTEX; MITOCHONDRIAL DYSFUNCTION	Nasu-Hakola disease (NHD) is a recessively inherited rare disorder characterized by a combination of neuropsychiatric and bone symptoms which, while being unique to this disease, do not provide a rationale for the unambiguous identification of patients. These individuals, in fact, are likely to go unrecognized either because they are considered to be affected by other kinds of dementia or by fibrous dysplasia of bone. Given that dementia in NHD has much in common with Alzheimer's disease and other neurodegenerative disorders, it cannot be expected to achieve the differential diagnosis of this disease without performing a genetic analysis. Under this scenario, the availability of protein biomarkers would indeed provide a novel context to facilitate interpretation of symptoms and to make the precise identification of this disease possible. The work here reported was designed to generate, for the first time, protein profiles of lymphoblastoid cells from NHD patients. Two-dimensional electrophoresis (2-DE) and nano liquid chromatography-tandem mass spectrometry (nLC-MS/MS) have been applied to all components of an Italian family (seven subjects) and to five healthy subjects included as controls. Comparative analyses revealed differences in the expression profile of 21 proteins involved in glucose metabolism and information pathways as well as in stress responses.	[Giuliano, Serena; Viglio, Simona; Salvini, Roberta; Bardoni, Anna] Univ Pavia, Dept Mol Med, Biochem Unit, I-27100 Pavia, Italy; [Giuliano, Serena] CNRS, UMR, Lab Excellence Ion Channel Sci & Therapeut, F-06034 Nice, France; [Agresta, Anna Maria; De Palma, Antonella; Mauri, Pierluigi] CNR, Inst Biochem Technol, Prote & Metabol Unit, Segrate, Milano, Italy; [Fumagalli, Marco; Iadarola, Paolo] Univ Pavia, Dept Biol & Biotechnol, Biochem Unit, I-27100 Pavia, Italy; [Montalbetti, Lorenza] Univ Pavia, Dept Brain & Behav Sci, I-27100 Pavia, Italy	University of Pavia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Consiglio Nazionale delle Ricerche (CNR); University of Pavia; University of Pavia	Iadarola, P (corresponding author), Univ Pavia, Dept Biol & Biotechnol, Biochem Unit, Via Palestro 3, I-27100 Pavia, Italy.	piadarol@unipv.it	De Palma, Antonella/K-8451-2016; Mauri, Pietro Luigi/AAC-3095-2019; Agresta, Anna Maria/Q-5650-2018	De Palma, Antonella/0000-0001-5937-8604; Mauri, Pietro Luigi/0000-0003-4364-0393; Agresta, Anna Maria/0000-0002-1173-3205; Giuliano, Serena/0000-0001-8734-3724; Viglio, Simona/0000-0001-5020-478X	Italian Ministry of University and Research for the PON project [01_01426]; CARE-G project - Regione Lombardia; Biochemistry Unit of the Department of Molecular Medicine; Laura Fossati Onlus (Montesegale, Pavia, Italy)	Italian Ministry of University and Research for the PON project; CARE-G project - Regione Lombardia; Biochemistry Unit of the Department of Molecular Medicine; Laura Fossati Onlus (Montesegale, Pavia, Italy)	This study was supported by the Italian Ministry of University and Research for the PON project (01_01426, AMA, PM) and by CARE-G project financed by Regione Lombardia (ADP, PM). The authors are deeply grateful to Laura Fossati Onlus (Montesegale, Pavia, Italy) for the generous financial support provided to the Biochemistry Unit of the Department of Molecular Medicine for the realization of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberio T, 2012, IUBMB LIFE, V64, P846, DOI 10.1002/iub.1073; Antikainen J, 2007, J BACTERIOL, V189, P4539, DOI 10.1128/JB.00378-07; Bekenstein U, 2013, MOL CELL NEUROSCI, V56, P436, DOI 10.1016/j.mcn.2012.12.002; Bianchin MM, 2004, CELL MOL NEUROBIOL, V24, P1, DOI 10.1023/B:CEMN.0000012721.08168.ee; Bigl M, 2003, J NEURAL TRANSM, V110, P77, DOI 10.1007/s00702-002-0772-x; Bock V, 2013, J NEUROL SCI, V326, P115, DOI 10.1016/j.jns.2013.01.021; Borger E, 2013, CURR ALZHEIMER RES, V10, P21; Bouchon A, 2001, J EXP MED, V194, P1111, DOI 10.1084/jem.194.8.1111; Boyd-Kimball D, 2006, NEUROBIOL AGING, V27, P1239, DOI 10.1016/j.neurobiolaging.2005.07.001; Butterfield DA, 2010, J ALZHEIMERS DIS, V20, P369, DOI 10.3233/JAD-2010-1375; Candiano G, 2004, ELECTROPHORESIS, V25, P1327, DOI 10.1002/elps.200305844; Caron M, 2002, J CHROMATOGR B, V771, P197, DOI 10.1016/S1570-0232(02)00040-5; Castegna A, 2002, J NEUROCHEM, V82, P1524, DOI 10.1046/j.1471-4159.2002.01103.x; Castegna A, 2002, FREE RADICAL BIO MED, V33, P562, DOI 10.1016/S0891-5849(02)00914-0; Chen W, 2005, J NEUROPSYCH CLIN N, V17, P364, DOI 10.1176/appi.neuropsych.17.3.364; Choi J, 2004, J BIOL CHEM, V279, P13256, DOI 10.1074/jbc.M314124200; Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902; Colonna M, 2003, NAT REV IMMUNOL, V3, P445, DOI 10.1038/nri1106; Cuadrado-Tejedor M, 2011, J ALZHEIMERS DIS, V23, P195, DOI 10.3233/JAD-2010-100966; De Pinto Vito, 2003, Ital J Biochem, V52, P17; Desrosiers Richard R, 2011, Curr Aging Sci, V4, P8; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Di Domenico F, 2010, BRAIN RES, V1333, P72, DOI 10.1016/j.brainres.2010.03.085; DODDS RA, 1994, J HISTOCHEM CYTOCHEM, V42, P599, DOI 10.1177/42.5.8157931; Donn RP, 2004, J ENDOCRINOL, V182, P1, DOI 10.1677/joe.0.1820001; Doragna D, 2003, J NEUROL NEUROSUR PS, V74, P825, DOI 10.1136/jnnp.74.6.825-a; Drabik A, 2007, MASS SPECTROM REV, V26, P432, DOI 10.1002/mas.20131; Fiszer U, 2001, BIODRUGS, V15, P351, DOI 10.2165/00063030-200115060-00001; Ford JW, 2009, CURR OPIN IMMUNOL, V21, P38, DOI 10.1016/j.coi.2009.01.009; Furuchi T, 2010, CHEM BIODIVERS, V7, P1337, DOI 10.1002/cbdv.200900273; Furukawa A, 2010, MECH AGEING DEV, V131, P379, DOI 10.1016/j.mad.2010.05.002; Gomez A, 2009, J NEUROSCI RES, V87, P1002, DOI 10.1002/jnr.21904; Gong B, 2006, CELL, V126, P775, DOI 10.1016/j.cell.2006.06.046; Hakola H P, 1972, Acta Psychiatr Scand Suppl, V232, P1; HAKOLA HPA, 1970, ACTA NEUROL SCAND, V46, P79; Hamerman Jessica A, 2006, Sci STKE, V2006, pre1, DOI 10.1126/stke.3202006re1; Hargreaves GA, 2009, ALCOHOL CLIN EXP RES, V33, P86, DOI 10.1111/j.1530-0277.2008.00814.x; Ivashkiv LB, 2008, NAT REV IMMUNOL, V8, P816, DOI 10.1038/nri2396; Kim JE, 2008, EXP NEUROL, V211, P128, DOI 10.1016/j.expneurol.2008.01.029; Kim JM, 2007, CELL PHYSIOL BIOCHEM, V20, P935, DOI 10.1159/000110454; Klesney-Tait J, 2006, NAT IMMUNOL, V7, P1266, DOI 10.1038/ni1411; Komatsubara AT, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-74; Korolainen MA, 2006, NEUROBIOL AGING, V27, P42, DOI 10.1016/j.neurobiolaging.2004.11.010; Krauskopf A, 2006, BBA-BIOENERGETICS, V1757, P590, DOI 10.1016/j.bbabio.2006.02.007; Lawen A, 2005, INT J BIOCHEM CELL B, V37, P277, DOI 10.1016/j.biocel.2004.05.013; Lehnardt S, 2010, GLIA, V58, P253, DOI 10.1002/glia.20928; Lehtinen MK, 2009, J NEUROSCI, V29, P5910, DOI 10.1523/JNEUROSCI.0682-09.2009; Leroy E, 1998, NATURE, V395, P451, DOI 10.1038/26652; Linnartz B, 2010, INT J ALZHEIMERS DIS, V2010; Liu J, 2010, ELECTROPHORESIS, V31, P1302, DOI 10.1002/elps.200900733; Lu M, 2001, J BIOL CHEM, V276, P30407, DOI 10.1074/jbc.M008768200; Lyon RC, 2013, NEUROCHEM INT, V62, P113, DOI 10.1016/j.neuint.2012.10.007; Manczak M, 2012, HUM MOL GENET, V21, P5131, DOI 10.1093/hmg/dds360; Manczak M, 2011, HUM MOL GENET, V20, P2495, DOI 10.1093/hmg/ddr139; Martinez A, 2008, J NEURAL TRANSM, V115, P59, DOI 10.1007/s00702-007-0800-y; Mila S, 2009, BIOMARK MED, V3, P117, DOI 10.2217/BMM.09.4; Montalbetti L, 2004, FUNCT NEUROL, V19, P171; Mostafavi S, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-s1-s4; Nakano-Yokomizo T, 2011, J EXP MED, V208, P1661, DOI 10.1084/jem.20101623; NASU T, 1973, ACTA PATHOL JAPON, V23, P539; Neumann H, 2007, J NEUROIMMUNOL, V184, P92, DOI 10.1016/j.jneuroim.2006.11.032; Ohgidani M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04957; Orphanet, 2014, PORT RAR DIS ORPH DR; Paloneva J, 2002, AM J HUM GENET, V71, P656, DOI 10.1086/342259; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Parihar MS, 2010, J ALZHEIMERS DIS, V22, P741, DOI 10.3233/JAD-2010-101020; PEREZ N, 1991, MOL BRAIN RES, V11, P249, DOI 10.1016/0169-328X(91)90033-T; Petersen CAH, 2008, P NATL ACAD SCI USA, V105, P13145, DOI 10.1073/pnas.0806192105; Pierce A, 2008, J MOL BIOL, V382, P1195, DOI 10.1016/j.jmb.2008.07.088; Raghavan A, 2012, BBA-BIOMEMBRANES, V1818, P1477, DOI 10.1016/j.bbamem.2011.10.019; Reddy PH, 2013, BBA-MOL BASIS DIS, V1832, P67, DOI 10.1016/j.bbadis.2012.09.003; Salonen JM, 2006, PROTEOMICS, V6, P5152, DOI 10.1002/pmic.200600156; Seigle JL, 2008, GENETICS, V179, P855, DOI 10.1534/genetics.108.087551; Shalova IN, 2007, BBA-GEN SUBJECTS, V1770, P826, DOI 10.1016/j.bbagen.2007.01.014; Sharif O, 2008, IMMUNOBIOLOGY, V213, P701, DOI 10.1016/j.imbio.2008.07.008; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Stewart JM, 2000, BBA-MOL CELL BIOL L, V1484, P278, DOI 10.1016/S1388-1981(00)00008-1; Sultana R, 2007, J ALZHEIMERS DIS, V11, P153; Sultana R, 2006, J NEUROSCI RES, V84, P409, DOI 10.1002/jnr.20876; Surinova S, 2011, J PROTEOME RES, V10, P5, DOI 10.1021/pr1008515; Takano M, 2013, NEUROSCI LETT, V534, P85, DOI 10.1016/j.neulet.2012.11.010; Toda T, 2003, J CHROMATOGR B, V787, P197, DOI 10.1016/S1570-0232(02)00495-6; Tosato Giovanna, 2007, Curr Protoc Immunol, VChapter 7, DOI 10.1002/0471142735.im0722s76; Tsai YC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069320; Turk V, 2008, FRONT BIOSCI-LANDMRK, V13, P5406, DOI 10.2741/3089; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; United States National Library of Medicine, 2014, GENES; van Serooskerken AMV, 2011, J INVEST DERMATOL, V131, P2249, DOI 10.1038/jid.2011.186; Verloes A, 1997, J MED GENET, V34, P753, DOI 10.1136/jmg.34.9.753; Whetstone H, 2003, BIOCHEMISTRY-US, V42, P1611, DOI 10.1021/bi026735t; Wu HL, 2011, MOL CELL BIOCHEM, V357, P209, DOI 10.1007/s11010-011-0891-5; Yamamoto A, 1998, J NEUROSCI, V18, P2063; Yao J, 2011, J NEUROSCI, V31, P2313, DOI 10.1523/JNEUROSCI.4717-10.2011; Yoo BC, 2001, ELECTROPHORESIS, V22, P172, DOI 10.1002/1522-2683(200101)22:1<172::AID-ELPS172>3.0.CO;2-P; Yoo BC, 2001, BIOCHEM BIOPH RES CO, V280, P249, DOI 10.1006/bbrc.2000.4109; Yoon S, 2009, NEUROTOXICOLOGY, V30, P666, DOI 10.1016/j.neuro.2009.04.013; Zerovnik E, 2009, BIOESSAYS, V31, P597, DOI 10.1002/bies.200900012; Zhang DY, 2002, J BIOL CHEM, V277, P9127, DOI 10.1074/jbc.M112228200	98	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e110073	10.1371/journal.pone.0110073	http://dx.doi.org/10.1371/journal.pone.0110073			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470616	Green Published, gold, Green Submitted			2022-12-26	WOS:000349128700002
J	Kothari, H; Keshava, S; Vatsyayan, R; Mackman, N; Rao, LVM; Pendurthi, UR				Kothari, Hema; Keshava, Shiva; Vatsyayan, Rit; Mackman, Nigel; Rao, L. Vijaya Mohan; Pendurthi, Usha R.			Role of Tissue Factor in Mycobacterium tuberculosis-Induced Inflammation and Disease Pathogenesis	PLOS ONE			English	Article							PROCOAGULANT ACTIVITY; COAGULATION; INFECTION; HEMOSTASIS; EXPRESSION; FIBRIN; CELLS; PROTECTION; PATHWAY; GRANULOMAS	Tuberculosis (TB) is a chronic lung infectious disease characterized by severe inflammation and lung granulomatous lesion formation. Clinical manifestations of TB include hypercoagulable states and thrombotic complications. We previously showed that Mycobacterium tuberculosis (M.tb) infection induces tissue factor (TF) expression in macrophages in vitro. TF plays a key role in coagulation and inflammation. In the present study, we investigated the role of TF in M.tb-induced inflammatory responses, mycobacterial growth in the lung and dissemination to other organs. Wild-type C57BL/6 and transgenic mice expressing human TF, either very low levels (low TF) or near to the level of wild-type (HTF), in place of murine TF were infected with M.tb via aerosol exposure. Levels of TF expression, proinflammatory cytokines and thrombin-antithrombin complexes were measured post M.tb infection and mycobacterial burden in the tissue homogenates were evaluated. Our results showed that M.tb infection did not increase the overall TF expression in lungs. However, macrophages in the granulomatous lung lesions in all M.tb-infected mice, including low TF mice, showed increased levels of TF expression. Conspicuous fibrin deposition in the granuloma was detected in wild-type and HTF mice but not in low TF mice. M.tb infection significantly increased expression levels of cytokines IFN-gamma, TNF-alpha, IL-6 and IL-1 beta in lung tissues. However, no significant differences were found in proinflammatory cytokines among the three experimental groups. Mycobacterial burden in lungs and dissemination into spleen and liver were essentially similar in all three genotypes. Our data indicate, in contrast to that observed in acute bacterial infections, that TF-mediated coagulation and/or signaling does not appear to contribute to the host-defense in experimental tuberculosis.	[Kothari, Hema; Keshava, Shiva; Vatsyayan, Rit; Rao, L. Vijaya Mohan; Pendurthi, Usha R.] Univ Texas Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75708 USA; [Mackman, Nigel] Univ N Carolina, Dept Med, McAllister Heart Inst, Div Hematol & Oncol, Chapel Hill, NC 27599 USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); University of North Carolina; University of North Carolina Chapel Hill	Kothari, H (corresponding author), Univ Texas Hlth Sci Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75708 USA.	Hema.Kothari@uthct.edu; Vijay.rao@uthct.edu			American Heart Association [11POST7430095, 13SDG1690030]; National Heart, Lung, and Blood Institute [HL1074830]	American Heart Association(American Heart Association); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	American Heart Association 11POST7430095 and 13SDG1690030 (HK); National Heart, Lung, and Blood Institute HL1074830 (LVMR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHRENHOLZ DH, 1980, SURGERY, V88, P41; Ambrosetti M, 2006, RESPIRATION, V73, P396, DOI 10.1159/000091188; Antoniak S, 2014, BLOOD, V123, P2605, DOI 10.1182/blood-2013-09-526277; Apt A, 2009, TUBERCULOSIS, V89, P195, DOI 10.1016/j.tube.2009.02.002; Apt AS, 2011, IMMUNOLOGY, V134, P109, DOI 10.1111/j.1365-2567.2011.03472.x; BEHLING CA, 1993, ANN CLIN LAB SCI, V23, P256; Conway EM, 2002, J EXP MED, V196, P565, DOI 10.1084/jem.20020077; DRAKE TA, 1989, AM J PATHOL, V134, P1087; Ehlers S, 2013, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00411; El Fekih Leila, 2009, Tunis Med, V87, P328; Esmon CT, 2011, J THROMB HAEMOST, V9, P182, DOI 10.1111/j.1538-7836.2011.04323.x; FLECK RA, 1990, THROMB RES, V59, P421, DOI 10.1016/0049-3848(90)90148-6; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Gil O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010030; Goncalves Ivone M, 2009, Cases J, V2, P9333, DOI 10.1186/1757-1626-2-9333; Gopalakrishnan R, 2010, J THROMB HAEMOST, V8, P301, DOI 10.1111/j.1538-7836.2009.03696.x; Guirado E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00098; Gupta UD, 2009, INDIAN J MED RES, V129, P11; HernandezPando R, 1996, IMMUNOLOGY, V89, P26; Johnson LL, 2003, J EXP MED, V197, P801, DOI 10.1084/jem.20021493; Junqueira-Kipnis AP, 2003, J IMMUNOL, V171, P6039, DOI 10.4049/jimmunol.171.11.6039; Kager LM, 2013, THROMB HAEMOSTASIS, V109, P726, DOI 10.1160/TH12-11-0859; Kang DD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016161; Kaufmann SHE, 2002, ANN RHEUM DIS, V61, P54; Kim MJ, 2010, EMBO MOL MED, V2, P258, DOI 10.1002/emmm.201000079; Kothari H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045700; Kothari H, 2010, BLOOD, V115, P4273, DOI 10.1182/blood-2009-09-241356; Levi M, 2006, SEMIN THROMB HEMOST, V32, P33, DOI 10.1055/s-2006-933338; Luo DY, 2011, J IMMUNOL, V187, P1866, DOI 10.4049/jimmunol.1101094; LYBERG T, 1982, INFECT IMMUN, V38, P855, DOI 10.1128/IAI.38.3.855-859.1982; Mackman N, 2007, ARTERIOSCL THROM VAS, V27, P1687, DOI 10.1161/ATVBAHA.107.141911; Manly DA, 2011, ANNU REV PHYSIOL, V73, P515, DOI 10.1146/annurev-physiol-042210-121137; Miller DL, 2002, AM J RESP CELL MOL, V26, P650, DOI 10.1165/ajrcmb.26.6.4688; Moller ASW, 2001, THROMB RES, V102, P273, DOI 10.1016/S0049-3848(01)00248-1; Mullarky IK, 2005, INFECT IMMUN, V73, P3888, DOI 10.1128/IAI.73.7.3888-3895.2005; Owens AP, 2011, CIRC RES, V108, P1284, DOI 10.1161/CIRCRESAHA.110.233056; Parry GCN, 1998, J CLIN INVEST, V101, P560, DOI 10.1172/JCI814; Pawlinski R, 2007, J THROMB HAEMOST, V5, P1693, DOI 10.1111/j.1538-7836.2007.02649.x; Pawlinski R, 2004, CRIT CARE MED, V32, pS293, DOI 10.1097/01.CCM.0000128445.95144.B8; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Rao LVM, 2005, ARTERIOSCL THROM VAS, V25, P47, DOI 10.1161/01.ATV.0000151624.45775.13; RAO LVM, 1988, THROMB RES, V51, P373, DOI 10.1016/0049-3848(88)90373-8; RAPAPORT SI, 1995, THROMB HAEMOSTASIS, V74, P7; RICKLES FR, 1973, J CLIN INVEST, V52, P1427, DOI 10.1172/JCI107316; Rijneveld AW, 2006, CRIT CARE MED, V34, P1725, DOI 10.1097/01.CCM.0000218807.20570.C2; Roh IS, 2013, YONSEI MED J, V54, P707, DOI 10.3349/ymj.2013.54.3.707; Ruf W, 2003, CRIT CARE MED, V31, pS231, DOI 10.1097/01.CCM.0000057848.27456.04; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Sakamoto K, 2010, INFECT IMMUN, V78, P1004, DOI 10.1128/IAI.00451-09; SELVARAJ P, 1994, EUR RESPIR J, V7, P1227, DOI 10.1183/09031936.94.07071227; Shitrit David, 2012, Harefuah, V151, P208; Shrivastava S, 2013, IMMUNOLOGY, V139, P219, DOI 10.1111/imm.12073; Tapper H, 2000, BLOOD, V96, P2329; Wang JY, 2005, THROMB HAEMOSTASIS, V93, P729, DOI 10.1160/TH04-09-0562; Weijer S, 2005, BLOOD, V106, P2761, DOI 10.1182/blood-2004-12-4623; Weiler-Guettler H, 1998, J CLIN INVEST, V101, P1983, DOI 10.1172/JCI2006; World Health Organization, 2014, GLOB TUB REP; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	58	12	13	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114141	10.1371/journal.pone.0114141	http://dx.doi.org/10.1371/journal.pone.0114141			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462128	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700105
J	Voss, U; Ekblad, E				Voss, Ulrikke; Ekblad, Eva			Lipopolysaccharide-Induced Loss of Cultured Rat Myenteric Neurons - Role of AMP-Activated Protein Kinase	PLOS ONE			English	Article							VASOACTIVE-INTESTINAL-PEPTIDE; CELL-DEATH; INHIBITION; METFORMIN; TAK1; EXPRESSION; MECHANISM; HEALTH; DRUGS; NEUROPROTECTION	Objective: Intestinal barrier function is vital for homeostasis. Conditions where the mucosal barrier is compromised lead to increased plasma content of lipopolysaccharide (LPS). LPS acts on Toll-like receptor 4 (TLR4) and initiates cellular inflammatory responses. TLR4 receptors have been identified on enteric neurons and LPS exposure causes neuronal loss, counteracted by vasoactive intestinal peptide (VIP), by unknown mechanisms. In addition AMP activated protein kinase (AMPK) stimulation causes loss of enteric neurons. This study investigated a possible role of AMPK activation in LPS-induced neuronal loss. Design: Primary cultures of myenteric neurons isolated from rat small intestine were used. Cultures were treated with LPS (0.2-20 mu g/mL) with and without TAK1-inhibitor (5Z)-7-Oxozeaenol (10(-6) M) or AMPK inhibitor compound C (10(-5) M). AMPK-induced neuronal loss was verified treating cultures with three different AMPK activators, AICAR (10(-4)-3x10(-3) M), metformin (0.2-20 mu g/mL) and A-769662 (10(-5)-3x10(-4) M) with or without the presence of compound C (10(-5) M). Upstream activation of AMPK-induced neuronal loss was tested by treating cultures with AICAR (10(-3) M) in the presence of TAK1 inhibitor (5Z)-7-Oxozeaenol (10(-6) M). Neuronal survival and relative numbers of neurons immunoreactive (IR) for VIP were evaluated using immunocytochemistry. Results: LPS caused a concentration dependent loss of neurons. All AMPK activators induced loss of myenteric neurons in a concentration dependent manner. LPS-, AICAR- and metformin-, but not A-769662-, induced neuronal losses were inhibited by presence of compound C. LPS, AICAR or metformin exposure increased the relative number of VIP-IR neurons; co-treatment with (5Z)-7-Oxozeaenol or compound C reversed the relative increase in VIP-IR neurons induced by LPS. (5Z)-7-Oxozeaenol, compound C or A-769662 did not per se change neuronal survival or relative numbers of VIP-IR neurons. Conclusion: AMPK activation mimics LPS-induced loss of cultured myenteric neurons and LPS-induced neuronal loss is counteracted by TAK1 and AMPK inhibition. This suggests enteric neuroimmune interactions involving AMPK regulation.	[Voss, Ulrikke; Ekblad, Eva] Lund Univ, Dept Expt Med Sci, Lund, Sweden	Lund University	Voss, U (corresponding author), Lund Univ, Dept Expt Med Sci, Lund, Sweden.	Ulrikke.voss@med.lu.se			Pahlsson Foundation; Royal Physiographic Society; Faculty of Medicine, Lund University	Pahlsson Foundation; Royal Physiographic Society; Faculty of Medicine, Lund University	This study was supported by the Pahlsson Foundation, Royal Physiographic Society and Faculty of Medicine, Lund University. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Anitha M, 2012, GASTROENTEROLOGY, V143, P1006, DOI 10.1053/j.gastro.2012.06.034; Arciszewski M, 2005, DIGEST DIS SCI, V50, P1661, DOI 10.1007/s10620-005-2912-2; Arciszewski MB, 2008, REGUL PEPTIDES, V146, P218, DOI 10.1016/j.regpep.2007.09.021; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Bai AP, 2010, BIOCHEM PHARMACOL, V80, P1708, DOI 10.1016/j.bcp.2010.08.009; Camilleri M, 2012, NEUROGASTROENT MOTIL, V24, P503, DOI 10.1111/j.1365-2982.2012.01921.x; Canto C, 2010, CELL MOL LIFE SCI, V67, P3407, DOI 10.1007/s00018-010-0454-z; Chen ZY, 2013, MOL CELL BIOCHEM, V377, P35, DOI 10.1007/s11010-013-1568-z; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; EKBLAD E, 1988, NEUROSCIENCE, V27, P655, DOI 10.1016/0306-4522(88)90296-5; Ekblad E, 1996, REGUL PEPTIDES, V63, P113; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Gadalla AE, 2004, J NEUROCHEM, V88, P1272, DOI 10.1046/j.1471-4159.2003.02253.x; Ghanim H, 2009, DIABETES CARE, V32, P2281, DOI 10.2337/dc09-0979; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Gomariz RP, 2007, PEPTIDES, V28, P1825, DOI 10.1016/j.peptides.2007.07.005; GOODMAN RH, 1990, ANNU REV NEUROSCI, V13, P111, DOI 10.1146/annurev.neuro.13.1.111; Hardie DG, 2012, CHEM BIOL, V19, P1222, DOI 10.1016/j.chembiol.2012.08.019; Hawley SA, 2002, DIABETES, V51, P2420, DOI 10.2337/diabetes.51.8.2420; Jiang PZ, 2013, NEUROBIOL AGING, V34, P1504, DOI 10.1016/j.neurobiolaging.2012.11.001; Kim KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047713; Kim SY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.95; Labuzek K, 2010, NEUROTOXICOLOGY, V31, P134, DOI 10.1016/j.neuro.2009.10.006; Labuzek K, 2010, N-S ARCH PHARMACOL, V381, P41, DOI 10.1007/s00210-009-0472-2; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Lanner JT, 2012, NAT MED, V18, P244, DOI 10.1038/nm.2598; Leff T, 2003, BIOCHEM SOC T, V31, P224; Maeshima N, 2013, FRONTIERS CELLULAR I, V3, P13; McCullough LD, 2005, J BIOL CHEM, V280, P20493, DOI 10.1074/jbc.M409985200; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Momcilovic M, 2006, J BIOL CHEM, V281, P25336, DOI 10.1074/jbc.M604399200; Neubert M, 2011, CELL DEATH DIFFER, V18, P1521, DOI 10.1038/cdd.2011.29; Poels J, 2009, BIOESSAYS, V31, P944, DOI 10.1002/bies.200900003; Sakamoto K, 2004, AM J PHYSIOL-ENDOC M, V287, pE310, DOI 10.1152/ajpendo.00074.2004; Salminen A, 2011, J MOL MED, V89, P667, DOI 10.1007/s00109-011-0748-0; Sand E, 2012, CELL TISSUE RES; Sandgren K, 2003, J NEUROSCI RES, V72, P595, DOI 10.1002/jnr.10612; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Viollet B, 2010, CRIT REV BIOCHEM MOL, V45, P276, DOI 10.3109/10409238.2010.488215; Voss U, 2013, PLOS ONE UNPUB; Voss U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081413; Voss U, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-30; West AP, 2006, ANNU REV CELL DEV BI, V22, P409, DOI 10.1146/annurev.cellbio.21.122303.115827; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; WILCOCK C, 1994, XENOBIOTICA, V24, P49, DOI 10.3109/00498259409043220; Wouters MM, 2011, NETH J MED, V69, P55; Wu JQ, 2013, ACS CHEM BIOL, V8, P643, DOI 10.1021/cb3005897; Xie M, 2006, P NATL ACAD SCI USA, V103, P17378, DOI 10.1073/pnas.0604708103; Zhang D, 2013, NEUROSCIENCE, V238, P209, DOI 10.1016/j.neuroscience.2013.02.022; Zhang YY, 2012, MOL CELL BIOCHEM, V368, P69, DOI 10.1007/s11010-012-1344-5; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	54	16	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114044	10.1371/journal.pone.0114044	http://dx.doi.org/10.1371/journal.pone.0114044			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462874	gold, Green Published, Green Submitted			2022-12-26	WOS:000345869700087
J	Mena, A; Moldes, L; Meijide, H; Canizares, A; Castro-Iglesias, A; Delgado, M; Pertega, S; Pedreira, J; Bou, G; Poveda, E				Mena, Alvaro; Moldes, Luz; Meijide, Hector; Canizares, Angelina; Castro-Iglesias, Angeles; Delgado, Manuel; Pertega, Sonia; Pedreira, Jose; Bou, German; Poveda, Eva			Seroprevalence of HCV and HIV Infections by Year of Birth in Spain: Impact of US CDC and USPSTF Recommendations for HCV and HIV Testing	PLOS ONE			English	Article							C VIRUS-INFECTION; VIRAL-HEPATITIS; NATURAL-HISTORY; DRUG-USERS; EPIDEMIOLOGY; CARE; PREVALENCE; MORTALITY; COHORT	Background: The US Centers for Disease Control and Prevention (CDC) recently add the advice of one-time testing of HCV infection in persons born during 1945-1965. Moreover, the US Preventive Services Task Force (USPSTF) newly recommended one-time HIV testing for persons aged 15-65. Herein, we evaluate the potential impact of these recommendations in a reference medical area of Spain. Methods: All assays results entries for HCV and HIV serological markers ordered at a reference lab from primary care and specialized physicians between 2008 and 2012 were recorded in a medical area which covers 501,526 citizens in Northern Spain. The year of birth were also documented. Results: A total of 108,159 anti-HCV-Ab results were generated during the study period. The global rate of anti-HCV-Ab+ was 7.7% (95% CI: 7.6%-7.9%), being more prevalent in men than women (8.6% vs. 4.5%). By year of birth, the highest prevalence was found in persons born between 1955 and 1970. HCV genotype 1 was the most prevalent (59.7%) followed by genotype 3 (22.7%). Regard HIV infection, among 65,279 anti-HIV results generated the prevalence of anti-HIV+ was 1.1% (95% CI: 1.0%-1.2%), being more frequent in men (2% vs 0.5%). The years of birth with highest rates of HIV infection exactly match with those for HCV infection. Conclusions: The highest rates of HCV and HIV infections are found between 1960 and 1965. Different historical and social circumstances such as the huge intravenous drug use epidemic in the eighties in Spain, might explain it. Therefore, each country needs to determine its own HCV and HIV seroprevalences by year of birth to establish the proper recommendations for the screening of both infections.	[Mena, Alvaro; Meijide, Hector; Castro-Iglesias, Angeles; Delgado, Manuel; Pedreira, Jose; Poveda, Eva] Univ A Coruna, Inst Invest Biomed A Coruna Complexo Hosp Univ A, Grp Virol Clin, La Coruna, Spain; [Moldes, Luz; Canizares, Angelina; Bou, German] Univ A Coruna, Inst Invest Biomed A Coruna Complexo Hosp Univ A, Serv Microbiol, La Coruna, Spain; [Meijide, Hector] Hosp Quiron, Serv Internal Med, La Coruna, Spain; [Delgado, Manuel] Univ A Coruna, Inst Invest Biomed A Coruna Complexo Hosp Univ A, Serv Aparato Digest, La Coruna, Spain; [Pertega, Sonia] Univ A Coruna, Inst Invest Biomed A Coruna Complexo Hosp Univ A, Unidad Epidemiol Clin & Bioestadist, La Coruna, Spain	Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC)	Mena, A (corresponding author), Univ A Coruna, Inst Invest Biomed A Coruna Complexo Hosp Univ A, Grp Virol Clin, La Coruna, Spain.	alvaro.mena.de.cea@sergas.es	Pértega-Díaz, Sonia/E-4353-2013; Bou, German/H-6683-2015	Pértega-Díaz, Sonia/0000-0003-3891-3203; POVEDA, EVA/0000-0003-4835-9875; Bou, German/0000-0001-8837-0062	Fondo de Investigacion Sanitaria [CP08/00214, PI10/02166, PI13/02266, CM13/00328]; Fundacion Profesor Novoa Santos, A Coruna	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Fundacion Profesor Novoa Santos, A Coruna	Funding: This work was supported in part by grants from Fondo de Investigacion Sanitaria (CP08/00214, PI10/02166, PI13/02266, CM13/00328), and Fundacion Profesor Novoa Santos, A Coruna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Centro Nacional de Epidemiologia, 2013, VIG EP VIH SIDA ESP; Denniston MM, 2012, HEPATOLOGY, V55, P1652, DOI 10.1002/hep.25556; Echevarria JM, 2006, ENFERM INFEC MICR CL, V24, P20; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Esteban JI, 2008, J HEPATOL, V48, P148, DOI 10.1016/j.jhep.2007.07.033; Europaisches Zentrum fur die Pravention und die Kontrolle von Krankheiten, 2010, HIV TEST INCR UPT EF; European Center for Disease Prevention and Control (ECDC), 2007, HIV INF EUR 25 YEARS; Hajarizadeh B, 2013, NAT REV GASTRO HEPAT, V10, P553, DOI 10.1038/nrgastro.2013.107; Hall HI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077763; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Ly KN, 2012, ANN INTERN MED, V156, P271, DOI 10.7326/0003-4819-156-4-201202210-00004; Mahajan R, 2014, CLIN INFECT DIS, V58, P1055, DOI 10.1093/cid/ciu077; Mathei C, 2002, J VIRAL HEPATITIS, V9, P157, DOI 10.1046/j.1365-2893.2002.00339.x; Mocroft A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001510; Moshfegh Alanna J., 2012, Morbidity and Mortality Weekly Report, V61, P92; Moyer VA, 2013, ANN INTERN MED, V159, P51, DOI 10.7326/0003-4819-159-1-201307020-00645; Oliva J, 2014, GAC SANIT, V28, P116, DOI 10.1016/j.gaceta.2013.06.009; Pernas B, 2014, AIDS, V28, P1837, DOI 10.1097/QAD.0000000000000326; Rein DB, 2012, ANN INTERN MED, V156, P263, DOI 10.7326/0003-4819-156-4-201202210-00378; Roy K, 2002, EPIDEMIOL INFECT, V129, P577, DOI 10.1017/S0950268802007902; Seeff LB, 2002, HEPATOLOGY, V36, pS35, DOI 10.1053/jhep.2002.36806; Soriano V, 2008, J INFECT DIS, V198, P1337, DOI 10.1086/592171; Spradling PR, 2012, CLIN INFECT DIS, V55, P1047, DOI 10.1093/cid/cis616; Sullivan AK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052845; Watson J C, 1998, MMWR Recomm Rep, V47, P1; World Health Organization, 2010, 63 WORLD HLTH ASS VI	28	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113062	10.1371/journal.pone.0113062	http://dx.doi.org/10.1371/journal.pone.0113062			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436642	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900028
J	Morgan-Bathke, M; Harris, ZI; Arnett, DG; Klein, RR; Burd, R; Ann, DK; Limesand, KH				Morgan-Bathke, Maria; Harris, Zoey I.; Arnett, Deborah G.; Klein, Rob R.; Burd, Randy; Ann, David K.; Limesand, Kirsten H.			The Rapalogue, CCI-779, Improves Salivary Gland Function following Radiation	PLOS ONE			English	Article							NECK-CANCER; MAMMALIAN TARGET; HEAD; AUTOPHAGY; THERAPY; RADIOTHERAPY; INJURY; PROLIFERATION; CHLOROQUINE; APOPTOSIS	The standard of care for head and neck cancer typically includes surgical resection of the tumor followed by targeted head and neck radiation. However depending on tumor location and stage, some cases may not require surgical resection while others may be treated with chemoradiation. Unfortunately, these radiation treatments cause chronic negative side effects for patients. These side effects are associated with damage to surrounding normal salivary gland tissue and include xerostomia, changes in taste and malnutrition. The underlying mechanisms of chronic radiation-induced salivary gland dysfunction are unknown, however, in rodent models persistently elevated proliferation is correlated with reduced stimulated salivary flow. The rapalogue, CCI-779, has been used in other cell systems to induce autophagy and reduce proliferation, therefore the aim of this study was to determine if CCI-779 could be utilized to ameliorate chronic radiation-induced salivary gland dysfunction. Four to six week old Atg5(f/f); Aqp5-Cre, Atg5(+/+); Aqp5-Cre and FVB mice were treated with targeted head and neck radiation. FVB mice were treated with CCI-779, chloroquine, or DMSO post-radiation. Stimulated salivary flow rates were determined and parotid and submandibular salivary gland tissues were collected for analyses. Mice with a defect in autophagy, via a conditional knockout of Atg5 in the salivary glands, display increased compensatory proliferation in the acinar cell compartment and hypertrophy at 24-72 hours following radiation. FVB mice treated with post-therapy CCI-779 have significant improvements in salivary gland physiology as determined by stimulated salivary flow rates, proliferation indices and amylase production and secretion. Consequently, post-radiation use of CCI-779 allows for improvement of salivary gland function and reestablishment of glandular homeostasis. As CCI-779 is already FDA approved for other uses, it could have a secondary use to alleviate the chronic side effects in head and neck cancer patients who have completed antitumor therapy.	[Morgan-Bathke, Maria; Harris, Zoey I.; Arnett, Deborah G.; Burd, Randy; Limesand, Kirsten H.] Univ Arizona, Dept Nutr Sci, Tucson, AZ USA; [Klein, Rob R.] Univ Arizona, Dept Pathol, Tucson, AZ USA; [Ann, David K.] City Hope Natl Med Ctr, Dept Mol Pharmacol, Beckman Res Inst, Duarte, CA 91010 USA	University of Arizona; University of Arizona; City of Hope; Beckman Research Institute of City of Hope	Ann, DK (corresponding author), City Hope Natl Med Ctr, Dept Mol Pharmacol, Beckman Res Inst, Duarte, CA 91010 USA.	dann@coh.org; limesank@u.arizona.edu			National Institutes of Health [R01DE018888, RC1DE20335]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018888] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RC1DE020335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Funding: KHL received funding from National Institutes of Health (R01DE018888); KHL and DKA received funding from National Institutes of Health RC1DE20335. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barker JL, 2004, INT J RADIAT ONCOL, V59, P960, DOI 10.1016/j.ijrobp.2003.12.024; Bhide SA, 2010, INT J RADIAT ONCOL, V76, P1360, DOI 10.1016/j.ijrobp.2009.04.005; Blanchard P, 2011, RADIOTHER ONCOL, V100, P33, DOI 10.1016/j.radonc.2011.05.036; Boraks George, 2008, Braz. Dent. J., V19, P73, DOI 10.1590/S0103-64402008000100013; Bozorgi SS, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.108; Bralic M, 2005, ACTA MED OKAYAMA, V59, P153; Burlage FR, 2009, RADIOTHER ONCOL, V90, P253, DOI 10.1016/j.radonc.2008.11.011; Burris HA, 2013, CANCER CHEMOTH PHARM, V71, P829, DOI 10.1007/s00280-012-2043-3; Cady Jormain, 2007, Clin J Oncol Nurs, V11, P875, DOI 10.1188/07.CJON.875-880; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Denaro N, 2013, ONCOLOGY-BASEL, V84, P174, DOI 10.1159/000346132; Dirix P, 2006, CANCER-AM CANCER SOC, V107, P2525, DOI 10.1002/cncr.22302; Donovan M, 2012, INT J PALLIAT NURS, V18, P448, DOI 10.12968/ijpn.2012.18.9.448; Egger M, 2013, J SURG RES, V4804, P428; Eisbruch A, 2001, INT J RADIAT ONCOL, V45, P577; Fang H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.225; Fernandez-Yunquera Ainhoa, 2014, World J Transplant, V4, P133, DOI 10.5500/wjt.v4.i2.133; Ferriera T, 2012, IMAGEJ; Gera J, 2011, LEUKEMIA LYMPHOMA, V52, P1857, DOI 10.3109/10428194.2011.580478; Grundmann O, 2009, J DENT RES, V88, P894, DOI 10.1177/0022034509343143; Grundmann O, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-417; Hancock Pamela J, 2003, J Can Dent Assoc, V69, P585; Henson BS, 1999, ORAL ONCOL, V35, P234, DOI 10.1016/S1368-8375(98)00104-3; Hoebers FJP, 2008, EUR J NUCL MED MOL I, V35, P509, DOI 10.1007/s00259-007-0624-x; Huang M, 2013, PHARMGENOMICS PERS M, V6, P9; Iglesias-Bartolome R, 2012, CELL STEM CELL, V11, P401, DOI 10.1016/j.stem.2012.06.007; Kimura T, 2013, CANCER RES, V73, P3, DOI 10.1158/0008-5472.CAN-12-2464; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Laplante M, 2013, J CELL SCI, V126, P1713, DOI 10.1242/jcs.125773; Li XH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039690, 10.1371/journal.pone.0036604]; Li Y, 2007, INT J RADIAT ONCOL, V67, P660, DOI 10.1016/j.ijrobp.2006.09.021; Morgan-Bathke M, 2013, J DENT RES, V92, P911, DOI 10.1177/0022034513499350; Morgan-Bathke M, 2014, SCI REP-UK, V4, DOI 10.1038/srep05206; Muhvic-Urek M, 2006, PHYSIOL RES, V55, P89, DOI 10.33549/physiolres.930739; Petrelli F, 2014, ORAL ONCOL EPUB; Pignon JP, 2009, RADIOTHER ONCOL, V92, P4, DOI 10.1016/j.radonc.2009.04.014; Radfar L, 2003, ORAL SURG ORAL MED O, V96, P267, DOI 10.1016/S1079-2104(03)00369-X; Ren GX, 2014, ONCOL REP, V31, P2804, DOI 10.3892/or.2014.3134; Robar JL, 2007, INT J RADIAT ONCOL, V68, P1121, DOI 10.1016/j.ijrobp.2007.01.030; Ryter S, 2013, MOL CELLS; Saba N, 2014, CANCER IN PRESS; Sagowski C, 2003, EUR ARCH OTO-RHINO-L, V260, P513, DOI 10.1007/s00405-003-0631-x; Spiegelberg L, 2014, ORAL DIS, V20, pe111, DOI 10.1111/odi.12162; Vernon PJ, 2013, ANTIOXID REDOX SIGN, V18, P677, DOI 10.1089/ars.2012.4810; Wang XK, 2011, J PHARMACOL EXP THER, V339, P421, DOI 10.1124/jpet.111.185249; Wirawan E, 2012, CELL RES, V22, P43, DOI 10.1038/cr.2011.152	46	17	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113183	10.1371/journal.pone.0113183	http://dx.doi.org/10.1371/journal.pone.0113183			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437438	Green Submitted, Green Published, gold			2022-12-26	WOS:000347114900032
J	Reichert, CF; Maire, M; Gabel, V; Hofstetter, M; Viola, AU; Kolodyazhniy, V; Strobel, W; Goetz, T; Bachmann, V; Landolt, HP; Cajochen, C; Schmidt, C				Reichert, Carolin F.; Maire, Micheline; Gabel, Virginie; Hofstetter, Marcel; Viola, Antoine U.; Kolodyazhniy, Vitaliy; Strobel, Werner; Goetz, Thomas; Bachmann, Valerie; Landolt, Hans-Peter; Cajochen, Christian; Schmidt, Christina			The Circadian Regulation of Sleep: Impact of a Functional ADA-Polymorphism and Its Association to Working Memory Improvements	PLOS ONE			English	Article							INTERNAL BIOLOGICAL TIME; MULTIPLE COMPARISONS; HOMEOSTATIC CONTROL; SPINDLE FREQUENCY; ADENOSINE; MELATONIN; BRAIN; WAKEFULNESS; PRESSURE; PHASE	Sleep is regulated in a time-of-day dependent manner and profits working memory. However, the impact of the circadian timing system as well as contributions of specific sleep properties to this beneficial effect remains largely unexplored. Moreover, it is unclear to which extent inter-individual differences in sleep-wake regulation depend on circadian phase and modulate the association between sleep and working memory. Here, sleep electroencephalography (EEG) was recorded during a 40-h multiple nap protocol, and working memory performance was assessed by the n-back task 10 times before and after each scheduled nap sleep episode. Twenty-four participants were genotyped regarding a functional polymorphism in adenosine deaminase (rs73598374, 12 G/A-, 12 G/G-allele carriers), previously associated with differences in sleep-wake regulation. Our results indicate that genotype-driven differences in sleep depend on circadian phase: heterozygous participants were awake longer and slept less at the end of the biological day, while they exhibited longer non rapid eye movement (NREM) sleep and slow wave sleep concomitant with reduced power between 8-16 Hz at the end of the biological night. Slow wave sleep and NREM sleep delta EEG activity covaried positively with overall working memory performance, independent of circadian phase and genotype. Moreover, REM sleep duration benefitted working memory particularly when occurring in the early morning hours and specifically in heterozygous individuals. Even though based on a small sample size and thus requiring replication, our results suggest genotype-dependent differences in circadian sleep regulation. They further indicate that REM sleep, being under strong circadian control, boosts working memory performance according to genotype in a time-of-day dependent manner. Finally, our data provide first evidence that slow wave sleep and NREM sleep delta activity, majorly regulated by sleep homeostatic mechanisms, is linked to working memory independent of the timing of the sleep episode within the 24-h cycle.	[Reichert, Carolin F.; Maire, Micheline; Gabel, Virginie; Hofstetter, Marcel; Viola, Antoine U.; Cajochen, Christian; Schmidt, Christina] Univ Basel, Hosp Psychiat, Ctr Chronobiol, CH-4012 Basel, Switzerland; [Kolodyazhniy, Vitaliy] Salzburg Univ, Inst Psychol, Div Clin Psychol Psychotherapy & Hlth Psychol, A-5020 Salzburg, Austria; [Strobel, Werner] Univ Basel Hosp, Dept Internal Med, CH-4031 Basel, Switzerland; [Goetz, Thomas] Off Publ Hlth, Dept Psychiat, D-60313 Frankfurt, Germany; [Bachmann, Valerie; Landolt, Hans-Peter] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland	University of Basel; Salzburg University; University of Basel; University of Zurich	Cajochen, C (corresponding author), Univ Basel, Hosp Psychiat, Ctr Chronobiol, CH-4012 Basel, Switzerland.	christian.cajochen@upkbs.ch	Landolt, Hans-Peter/H-6951-2016	Landolt, Hans-Peter/0000-0003-0887-9403; Reichert, Carolin/0000-0003-1535-2386	Swiss National Foundation [310030_130689]; L. & Th. La Roche-Stiftung [DMS2189]; Niklaus und Bertha Burckhardt-Burgin-Stiftung [DPE2110]	Swiss National Foundation(Swiss National Science Foundation (SNSF)); L. & Th. La Roche-Stiftung; Niklaus und Bertha Burckhardt-Burgin-Stiftung	This work was supported by the Swiss National Foundation (grant number #310030_130689; http://www.snf.ch/en/Pages/default.aspx); the L. & Th. La Roche-Stiftung (grant number DMS2189; https://nachwuchs.unibas.ch/004_2_4.html); and the Niklaus und Bertha Burckhardt-Burgin-Stiftung (grant number DPE2110; https://nachwuchs.unibas.ch/004_2_6.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aeschbach D, 2011, RAPID EYE MOVEMENT S, P80; Bachmann V, 2012, CEREB CORTEX, V22, P962, DOI 10.1093/cercor/bhr173; Basheer R, 2004, PROG NEUROBIOL, V73, P379, DOI 10.1016/j.pneurobio.2004.06.004; BATTISTUZZI G, 1981, ANN HUM GENET, V45, P15, DOI 10.1111/j.1469-1809.1981.tb00301.x; Beck AT, 1996, BDI 2 BECK DEPRESSIO; BONNET MH, 1992, SLEEP, V15, P526; Buschkuehl M, 2012, DEV COGN NEUROS-NETH, V2, pS167, DOI 10.1016/j.dcn.2011.10.001; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cajochen C, 2004, BEHAV BRAIN RES, V151, P167, DOI 10.1016/j.bbr.2003.08.013; Cajochen C, 2001, NEUROREPORT, V12, P2277, DOI 10.1097/00001756-200107200-00046; Collette F, 2002, NEUROSCI BIOBEHAV R, V26, P105, DOI 10.1016/S0149-7634(01)00063-X; Curran-Everett D, 2000, AM J PHYSIOL-REG I, V279, pR1, DOI 10.1152/ajpregu.2000.279.1.R1; De Gennaro L, 2003, SLEEP MED REV, V7, P423, DOI 10.1053/smrv.2002.0252; Dijk DJ, 1997, J PHYSIOL-LONDON, V505, P851, DOI 10.1111/j.1469-7793.1997.851ba.x; DIJK DJ, 1994, NEUROSCI LETT, V166, P63, DOI 10.1016/0304-3940(94)90841-9; DIJK DJ, 1995, J NEUROSCI, V15, P3526; Dijk DJ, 1999, LUNG BIOL HEALTH DIS, V133, P111; DIJK DJ, 1992, J SLEEP RES, V1, P112, DOI 10.1111/j.1365-2869.1992.tb00021.x; DINGES DF, 1985, BEHAV RES METH INSTR, V17, P652, DOI 10.3758/BF03200977; Ebrahim IO, 2013, ALCOHOL CLIN EXP RES, V37, DOI 10.1111/acer.12006; EDGAR DM, 1993, J NEUROSCI, V13, P1065; Ehrhart J, 2000, CLIN NEUROPHYSIOL, V111, P940, DOI 10.1016/S1388-2457(00)00247-9; Franken P, 2009, EUR J NEUROSCI, V29, P1820, DOI 10.1111/j.1460-9568.2009.06723.x; Fuxe K, 2007, PHYSIOL BEHAV, V92, P210, DOI 10.1016/j.physbeh.2007.05.034; Gorfine T, 2009, HUM BRAIN MAPP, V30, P541, DOI 10.1002/hbm.20525; HAYTER AJ, 1984, ANN STAT, V12, P61, DOI 10.1214/aos/1176346392; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Jaeggi SM, 2010, MEMORY, V18, P394, DOI 10.1080/09658211003702171; James JE, 2007, HUM PSYCHOPHARM CLIN, V22, P549, DOI 10.1002/hup.881; Kane MJ, 2007, J EXP PSYCHOL LEARN, V33, P615, DOI 10.1037/0278-7393.33.3.615; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Kerkhof GA, 2010, PROG BRAIN RES, V185, P1, DOI 10.1016/B978-0-444-53702-7.00001-4; Knoblauch V, 2005, SLEEP, V28, P1093, DOI 10.1093/sleep/28.9.1093; Knoblauch V, 2002, CEREB CORTEX, V12, P1092, DOI 10.1093/cercor/12.10.1092; Kuriyama K, 2008, J NEUROSCI, V28, P10145, DOI 10.1523/JNEUROSCI.2039-08.2008; Kuriyama K, 2011, SCI REP-UK, V1, DOI 10.1038/srep00127; Landolt HP, 2008, BIOCHEM PHARMACOL, V75, P2070, DOI 10.1016/j.bcp.2008.02.024; Landolt HP, 2011, PROG BRAIN RES, V193, P51, DOI 10.1016/B978-0-444-53839-0.00004-1; Lavie P, 1997, J BIOL RHYTHM, V12, P657, DOI 10.1177/074873049701200622; LAVIE P, 1986, ELECTROEN CLIN NEURO, V63, P414, DOI 10.1016/0013-4694(86)90123-9; Legault G, 2006, BEHAV BRAIN RES, V170, P148, DOI 10.1016/j.bbr.2006.02.010; Leonhart R, 2004, LEHRBUCH STAT; Lo JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045987; Ma WJ, 2014, NAT NEUROSCI, V17, P347, DOI 10.1038/nn.3655; Mackiewicz M, 2003, J NEUROCHEM, V85, P348, DOI 10.1046/j.1471-4159.2003.01687.x; Maire M, 2013, J COGNITIVE BEHAV PS; Mazzotti DR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044154; Mazzotti DR, 2011, SLEEP, V34, P399, DOI 10.1093/sleep/34.3.399; Mistlberger RE, 2005, BRAIN RES REV, V49, P429, DOI 10.1016/j.brainresrev.2005.01.005; Munch M, 2005, NEUROBIOL AGING, V26, P1307, DOI 10.1016/j.neurobiolaging.2005.03.004; Owen AM, 2005, HUM BRAIN MAPP, V25, P46, DOI 10.1002/hbm.20131; Porkka-Heiskanen T, 2011, SLEEP MED REV, V15, P123, DOI 10.1016/j.smrv.2010.06.005; Prat G, 2009, HUM PSYCHOPHARM CLIN, V24, P259, DOI 10.1002/hup.1023; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; Rasch B, 2009, NEUROPSYCHOPHARMACOL, V34, P1843, DOI 10.1038/npp.2009.6; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Reichert CF, 2014, J BIOL RHYTHM, V29, P119, DOI 10.1177/0748730414524898; Retey JV, 2005, P NATL ACAD SCI USA, V102, P15676, DOI 10.1073/pnas.0505414102; Riksen NP, 2008, PHARMACOGENET GENOM, V18, P843, DOI 10.1097/FPC.0b013e328305e630; Sagaspe P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039410; Schmidt C, 2009, SCIENCE, V324, P516, DOI 10.1126/science.1167337; Scullin MK, 2012, BRAIN, V135, P2789, DOI 10.1093/brain/aws192; Shochat T, 1997, AM J PHYSIOL-REG I, V273, pR364, DOI 10.1152/ajpregu.1997.273.1.R364; Smith C, 1996, BEHAV BRAIN RES, V78, P49, DOI 10.1016/0166-4328(95)00218-9; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; STROGATZ SH, 1987, AM J PHYSIOL, V253, pR172, DOI 10.1152/ajpregu.1987.253.1.R172; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Wallace TL, 2013, BIOCHEM PHARMACOL, V85, P1713, DOI 10.1016/j.bcp.2013.04.001; Wright KP, 2006, J COGNITIVE NEUROSCI, V18, P508, DOI 10.1162/jocn.2006.18.4.508; Wyatt JK, 1999, AM J PHYSIOL-REG I, V277, pR1152	70	5	8	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113734	10.1371/journal.pone.0113734	http://dx.doi.org/10.1371/journal.pone.0113734			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437848	Green Submitted, Green Accepted, Green Published, gold			2022-12-26	WOS:000347114900073
J	Camerlink, I; Turner, SP; Ursinus, WW; Reimert, I; Bolhuis, JE				Camerlink, Irene; Turner, Simon P.; Ursinus, Winanda W.; Reimert, Inonge; Bolhuis, J. Elizabeth			Aggression and Affiliation during Social Conflict in Pigs	PLOS ONE			English	Article							ACUTE-PHASE PROTEINS; C-REACTIVE PROTEIN; INDIVIDUAL AGGRESSIVENESS; DOMINANCE RELATIONSHIPS; AGONISTIC BEHAVIOR; DOMESTICATED PIGS; TRANSPORT STRESS; SERUM; HAPTOGLOBIN; BIOMARKERS	Social conflict is mostly studied in relation to aggression. A more integral approach, including aggressive and affiliative behaviour as well as physiology, may however give a better understanding of the animals' experience during social conflict. The experience of social conflict may also be reflected in the spatial distribution between conspecifics. The objective was to assess the relationship between behaviour, physiology, and spatial integration in pigs (Sus scrofa) during social conflict. Hereto, 64 groups of pigs (9 wk of age) were studied in a 24 h regrouping test whereby pairs of familiar pigs were grouped with 2 unfamiliar pairs, in either barren or straw-enriched housing. Data on aggressive and affiliative behaviour, skin lesions, body weight, and haptoglobin could be summarized into three principal component analysis factors. These three factors were analysed in relation to spatial integration, i.e. inter-individual distances and lying in body contact. Pigs stayed up to 24 h after encounter in closer proximity to the familiar pig than to unfamiliar pigs. Pigs with a high factor 1 score were more inactive, gave little social nosing, had many skin lesions and a high body weight. They tended to space further away from the familiar pig (b=1.9 cm; P=0.08) and unfamiliar ones (b=0.7 cm; P=0.05). Pigs that were involved in much aggression (factor 2), and that had a strong increase in haptoglobin (factor 3), tended to be relatively most far away from unfamiliar pigs (b=0.03 times further; P=0.08). Results on lying in body contact were coherent with results on distances. Pigs in enriched housing spaced further apart than pigs in barren housing (P<0.001). The combined analysis of measures revealed animals that may either promote or slow down group cohesion, which may not have become clear from single parameters. This emphasizes the importance of an integral approach to social conflict.	[Camerlink, Irene; Ursinus, Winanda W.; Reimert, Inonge; Bolhuis, J. Elizabeth] Wageningen Univ, Dept Anim Sci, Adaptat Physiol Grp, NL-6700 AP Wageningen, Netherlands; [Camerlink, Irene] Wageningen Univ, Dept Anim Sci, Anim Breeding & Genom Ctr, NL-6700 AP Wageningen, Netherlands; [Turner, Simon P.] SRUC, Edinburgh, Midlothian, Scotland; [Ursinus, Winanda W.] Wageningen UR Livestock Res, Anim Behav & Welf, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	Camerlink, I (corresponding author), Wageningen Univ, Dept Anim Sci, Adaptat Physiol Grp, NL-6700 AP Wageningen, Netherlands.	Irene.Camerlink@sruc.ac.uk	Camerlink, Irene/AAO-9931-2020; Bolhuis, J. Elizabeth/P-7978-2015	Bolhuis, J. Elizabeth/0000-0002-5172-7635; Ursinus, Winanda/0000-0002-3186-6793; Turner, Simon/0000-0001-9198-9448; Camerlink, Irene/0000-0002-3427-2210	Netherlands Organization for Scientific Research (NWO); Dutch Ministry of Economic Affairs	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This study is part of the project, "Seeking sociable swine? Incorporating social genetic effects into pig breeding programs to achieve balanced improvement in productivity and welfare," which is financially supported by the program "The Value of Animal Welfare" of the Netherlands Organization for Scientific Research (NWO) and the Dutch Ministry of Economic Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen IL, 2000, APPL ANIM BEHAV SCI, V68, P107, DOI 10.1016/S0168-1591(00)00092-7; Andersen IL, 2004, ANIM BEHAV, V68, P965, DOI 10.1016/j.anbehav.2003.12.016; Arey DS, 1998, LIVEST PROD SCI, V56, P61, DOI 10.1016/S0301-6226(98)00144-4; Arnold K, 2007, PRIMATES PERSPECTIVE, P592; BENUS RF, 1991, EXPERIENTIA, V47, P1008, DOI 10.1007/BF01923336; Bijma P, 2007, GENETICS, V175, P289, DOI 10.1534/genetics.106.062729; Blumstein DT, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00034; Blumstein DT, 2009, P ROY SOC B-BIOL SCI, V276, P3007, DOI 10.1098/rspb.2009.0703; Bolhuis JE, 2005, ANIM BEHAV, V69, P1085, DOI 10.1016/j.anbehav.2004.09.013; Bonanni R, 2010, ANIM BEHAV, V79, P981, DOI 10.1016/j.anbehav.2010.02.021; Camerlink I, 2014, J ANIM SCI, V92, P2612, DOI 10.2527/jas.2013-7220; Camerlink I, 2013, APPL ANIM BEHAV SCI, V145, P84, DOI 10.1016/j.applanim.2013.02.008; Camerlink I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065136; Chen HH, 2003, CAN J VET RES, V67, P283; Cray C, 2009, COMPARATIVE MED, V59, P517; D'Eath RB, 2002, APPL ANIM BEHAV SCI, V77, P267, DOI 10.1016/S0168-1591(02)00077-1; de Groot J, 2001, PHYSIOL BEHAV, V73, P145, DOI 10.1016/S0031-9384(01)00472-3; De Jong IC, 1999, THESIS U GRONINGEN N; de Waal FBM, 2000, SCIENCE, V289, P586, DOI 10.1126/science.289.5479.586; deJonge FH, 1996, PHYSIOL BEHAV, V60, P389, DOI 10.1016/0031-9384(96)00013-3; Duboscq J, 2014, ANIM BEHAV, V87, P107, DOI 10.1016/j.anbehav.2013.10.018; Durrell JL, 2004, APPL ANIM BEHAV SCI, V89, P41, DOI 10.1016/j.applanim.2004.05.003; Eckersall PD, 2010, VET J, V185, P23, DOI 10.1016/j.tvjl.2010.04.009; El-Deeb W. M., 2014, Comparative Clinical Pathology, V23, P577, DOI 10.1007/s00580-012-1654-8; Elwood RW, 1998, NATURE, V393, P66, DOI 10.1038/29980; Erhard HW, 1997, APPL ANIM BEHAV SCI, V54, P137, DOI 10.1016/S0168-1591(97)00068-3; EWBANK R, 1971, ANIM PROD, V13, P685, DOI 10.1017/S0003356100000179; Febrer K, 2006, ANIM BEHAV, V72, P1291, DOI 10.1016/j.anbehav.2006.03.019; FERNANDEZ X, 1994, PHYSIOL BEHAV, V56, P841, DOI 10.1016/0031-9384(94)90313-1; Francois N, 1999, BEHAV PROCESS, V47, P73, DOI 10.1016/S0376-6357(99)00050-9; FRASER D, 1985, APPL ANIM BEHAV SCI, V14, P117, DOI 10.1016/0168-1591(85)90023-1; FRASER D, 1991, APPL ANIM BEHAV SCI, V30, P307, DOI 10.1016/0168-1591(91)90135-K; Gomez-Laguna J, 2010, VET J, V185, P83, DOI 10.1016/j.tvjl.2010.04.018; GRIFFING B, 1967, AUST J BIOL SCI, V20, P127, DOI 10.1071/BI9670127; Gruys E, 2005, J Zhejiang Univ Sci B, V6, P1045, DOI 10.1631/jzus.2005.B1045; Heegaard PMH, 1998, COMP BIOCHEM PHYS B, V119, P365, DOI 10.1016/S0305-0491(97)00362-3; HUGHES BO, 1988, ANIM BEHAV, V36, P1696, DOI 10.1016/S0003-3472(88)80110-6; Jensen P, 1998, APPL ANIM BEHAV SCI, V58, P49, DOI 10.1016/S0168-1591(97)00097-X; Kaburu SSK, 2013, ANIM BEHAV, V86, P519, DOI 10.1016/j.anbehav.2013.06.003; Kutsukake N, 2008, ANIM BEHAV, V75, P1441, DOI 10.1016/j.anbehav.2007.09.018; Kutsukake N, 2009, ECOL RES, V24, P521, DOI 10.1007/s11284-008-0563-4; LAMPREAVE F, 1994, ELECTROPHORESIS, V15, P672, DOI 10.1002/elps.1150150195; Li YZ, 2009, J ANIM SCI, V87, P1472, DOI 10.2527/jas.2008-1202; Lim MM, 2006, HORM BEHAV, V50, P506, DOI 10.1016/j.yhbeh.2006.06.028; Lomborg SR, 2008, VET RES COMMUN, V32, P575, DOI 10.1007/s11259-008-9057-7; Marchant-Forde J. N., 2005, Pig News and Information, V26, p63N; Marco-Ramell A., 2011, VET J, V190, pe66, DOI DOI 10.1016/J.TVJL.2011.01.003; McBride G, 1995, BEHAV ENV, P53; McComb K, 2000, ANIM BEHAV, V59, P1103, DOI 10.1006/anbe.2000.1406; MCCORT WD, 1982, BEHAV PROCESS, V7, P169, DOI 10.1016/0376-6357(82)90025-0; MENDL M, 1992, ANIM BEHAV, V44, P1107, DOI 10.1016/S0003-3472(05)80323-9; Muir WM, 2005, GENETICS, V170, P1247, DOI 10.1534/genetics.104.035956; Munsterhjelm C, 2009, APPL ANIM BEHAV SCI, V118, P42, DOI 10.1016/j.applanim.2009.01.007; Murata H, 2007, VET J, V173, P473, DOI 10.1016/j.tvjl.2006.05.008; Ott S, 2014, RES VET SCI, V97, P124, DOI 10.1016/j.rvsc.2014.06.002; PETHERICK JC, 1987, AUST J EXP AGR, V27, P605, DOI 10.1071/EA9870605; Piccione G, 2012, SMALL RUMINANT RES, V107, P167, DOI 10.1016/j.smallrumres.2012.05.008; Pineiro C, 2007, ANIMAL, V1, P133, DOI 10.1017/S1751731107283909; Pineiro C, 2004, J ANIM SCI, V82, P277; Rault JL, 2012, APPL ANIM BEHAV SCI, V136, P1, DOI 10.1016/j.applanim.2011.10.002; Reimert I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108700; Reimert I, 2014, PHYSIOL BEHAV, V129, P221, DOI 10.1016/j.physbeh.2014.02.059; Reimert I, 2014, APPL ANIM BEHAV SCI, V151, P24, DOI 10.1016/j.applanim.2013.11.015; Ruis MAW, 2001, APPL ANIM BEHAV SCI, V70, P201, DOI 10.1016/S0168-1591(00)00150-7; RUSHEN J, 1987, CAN J ANIM SCI, V67, P951, DOI 10.4141/cjas87-100; Salamano G, 2008, VET J, V177, P110, DOI 10.1016/j.tvjl.2007.03.015; Soler L, 2013, RES VET SCI, V95, P298, DOI 10.1016/j.rvsc.2013.03.007; SPRUIJT BM, 1992, PHYSIOL REV, V72, P825, DOI 10.1152/physrev.1992.72.3.825; Stukenborg A, 2011, APPL ANIM BEHAV SCI, V129, P28, DOI 10.1016/j.applanim.2010.10.004; Turner SP, 2010, ANIM WELFARE, V19, P123; Turner SP, 2013, APPL ANIM BEHAV SCI, V146, P26, DOI 10.1016/j.applanim.2013.03.012; Turner SP, 2011, APPL ANIM BEHAV SCI, V134, P1, DOI 10.1016/j.applanim.2011.06.001; Turner SP, 2006, APPL ANIM BEHAV SCI, V96, P245, DOI 10.1016/j.applanim.2005.06.009; van de Weerd HA, 2009, APPL ANIM BEHAV SCI, V116, P1, DOI 10.1016/j.applanim.2008.08.001; WARBURTON K, 1991, J THEOR BIOL, V150, P473, DOI 10.1016/S0022-5193(05)80441-2	75	21	21	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113502	10.1371/journal.pone.0113502	http://dx.doi.org/10.1371/journal.pone.0113502			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427249	Green Submitted, Green Published, gold			2022-12-26	WOS:000349145400058
J	Qin, XY; Cheng, Y; Murthy, SRK; Selvaraj, P; Loh, YP				Qin, Xiao-Yan; Cheng, Yong; Murthy, Saravana R. K.; Selvaraj, Prabhuanand; Loh, Y. Peng			Carboxypeptidase E-Delta N, a Neuroprotein Transiently Expressed during Development Protects Embryonic Neurons against Glutamate Neurotoxicity	PLOS ONE			English	Article							NEUROTROPHIC FACTOR; COLORECTAL-CANCER; CEREBRAL-CORTEX; BRAIN; RAT; SURVIVAL; STRESS; GENES; BDNF; EXPOSURE	Neuroprotective proteins expressed in the fetus play a critical role during early embryonic neurodevelopment, especially during maternal exposure to alcohol and drugs that cause stress, glutamate neuroexcitotoxicity, and damage to the fetal brain, if prolonged. We have identified a novel protein, carboxypeptidase E-Delta N (CPE-Delta N), which is a splice variant of CPE that has neuroprotective effects on embryonic neurons. CPE-Delta N is transiently expressed in mouse embryos from embryonic day 5.5 to postnatal day 1. It is expressed in embryonic neurons, but not in 3 week or older mouse brains, suggesting a function primarily in utero. CPE-Delta N expression was up-regulated in embryonic hippocampal neurons in response to dexamethasone treatment. CPE-Delta N transduced into rat embryonic cortical and hippocampal neurons protected them from glutamate and H2O2-induced cell death. When transduced into embryonic cortical neurons, CPE-Delta N was found in the nucleus and enhanced the transcription of FGF2 mRNA. Embryonic cortical neurons challenged with glutamate resulted in attenuated FGF2 levels and cell death, but CPE-Delta N transduced neurons treated in the same manner showed increased FGF2 expression and normal viability. This neuroprotective effect of CPE-Delta N was mediated by secreted FGF2. Through receptor signaling, FGF2 activated the AKT and ERK signaling pathways, which in turn increased BCL-2 expression. This led to inhibition of caspase-3 activity and cell survival. [GRAPHICS] .	[Qin, Xiao-Yan; Cheng, Yong; Murthy, Saravana R. K.; Selvaraj, Prabhuanand; Loh, Y. Peng] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Dev Neurosci, Cellular Neurobiol Sect, NIH, Bethesda, MD 20892 USA; [Qin, Xiao-Yan] Minzu Univ China, Coll Life & Environm Sci, Beijing 100081, Peoples R China	Minzu University of China	Loh, YP (corresponding author), Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Program Dev Neurosci, Cellular Neurobiol Sect, NIH, Bethesda, MD 20892 USA.	lohp@mail.nih.gov		Cheng, Yong/0000-0002-7529-4408; Qin, Xiao-Yan/0000-0001-8847-4267	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000056] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, USA; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding: This research was supported by the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, USA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benediktsson R, 1997, CLIN ENDOCRINOL, V46, P161, DOI 10.1046/j.1365-2265.1997.1230939.x; Cantile M, 2013, INT J MOL SCI, V14, P21727, DOI 10.3390/ijms141121727; Cawley NX, 2012, ENDOCR REV, V33, P216, DOI 10.1210/er.2011-1039; Chen YX, 2014, NEUROSCI BULL, V30, P282, DOI 10.1007/s12264-013-1408-x; Cheng Y, 2015, MOL PSYCHIATR, V20, P744, DOI 10.1038/mp.2014.136; Cheng Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071578; Eide PW, 2013, CELL SIGNAL, V25, P12, DOI 10.1016/j.cellsig.2012.08.012; FRICKER LD, 1988, ANNU REV PHYSIOL, V50, P309, DOI 10.1146/annurev.ph.50.030188.001521; Fujita K, 2011, PLACENTA, V32, P737, DOI 10.1016/j.placenta.2011.07.001; Glazner GW, 1999, J NEUROCHEM, V73, P2341, DOI 10.1046/j.1471-4159.1999.0732341.x; Glazner GW, 2000, EXP NEUROL, V161, P442, DOI 10.1006/exnr.1999.7242; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Gozes I, 2005, CNS DRUG REV, V11, P353; Gressens P, 1997, J CLIN INVEST, V100, P390, DOI 10.1172/JCI119545; Hartl D, 2008, PROTEOMICS, V8, P1257, DOI 10.1002/pmic.200700724; Henderson JL, 1998, DEV BRAIN RES, V105, P287, DOI 10.1016/S0165-3806(97)00192-2; Hirabayashi Y, 2005, NEUROSCI RES, V51, P331, DOI 10.1016/j.neures.2005.01.004; Horing E, 2012, ACTA NEUROPATHOL, V124, P83, DOI 10.1007/s00401-011-0940-x; Johnson-Farley NN, 2007, BRAIN RES, V1154, P40, DOI 10.1016/j.brainres.2007.04.026; Koshimizu H, 2009, J MOL NEUROSCI, V39, P1, DOI 10.1007/s12031-008-9164-5; KUMAR S, 1992, BIOCHEM BIOPH RES CO, V185, P1155, DOI 10.1016/0006-291X(92)91747-E; Lee TK, 2011, J CLIN INVEST, V121, P880, DOI 10.1172/JCI40433; LINDHOLM D, 1993, EUR J NEUROSCI, V5, P1455, DOI 10.1111/j.1460-9568.1993.tb00213.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu X, 2013, ONCOGENE; MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X; McEwen BS, 1997, ANN NY ACAD SCI, V821, P271, DOI 10.1111/j.1749-6632.1997.tb48286.x; Merrill RA, 2004, DEV DYNAM, V231, P564, DOI 10.1002/dvdy.20159; MEYER JS, 1983, EXP NEUROL, V82, P432, DOI 10.1016/0014-4886(83)90415-6; PENNING DH, 1995, ANESTHESIOLOGY, V82, P521, DOI 10.1097/00000542-199502000-00022; Pinhasov A, 2003, DEV BRAIN RES, V144, P83, DOI 10.1016/S0165-3806(03)00162-7; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Rangon CM, 2007, J NEUROSCI, V27, P7532, DOI 10.1523/JNEUROSCI.5330-06.2007; Reynolds JD, 1995, ALCOHOL CLIN EXP RES, V19, P1447, DOI 10.1111/j.1530-0277.1995.tb01006.x; Sari Y, 2013, J MOL NEUROSCI, V49, P150, DOI 10.1007/s12031-012-9921-3; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; STEINBEHRENS BA, 1994, J NEUROCHEM, V63, P596; Stockl S, 2013, J CELL SCI, V126, P2890, DOI 10.1242/jcs.124305; Swinehart IT, 2013, DEVELOPMENT, V140, P4574, DOI 10.1242/dev.096693; Vergun O, 2001, J PHYSIOL-LONDON, V531, P147, DOI 10.1111/j.1469-7793.2001.0147j.x; Wilkemeyer MF, 2003, P NATL ACAD SCI USA, V100, P8543, DOI 10.1073/pnas.1331636100; ZHENG M, 1994, J NEUROSCI, V14, P4656; Zhou FC, 2004, J MOL NEUROSCI, V24, P189, DOI 10.1385/JMN:24:2:189; Zhou K, 2013, TUMOR BIOL, V34, P3691, DOI 10.1007/s13277-013-0952-3	44	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112996	10.1371/journal.pone.0112996	http://dx.doi.org/10.1371/journal.pone.0112996			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25426952	gold, Green Submitted, Green Published			2022-12-26	WOS:000349145400028
J	Pan, JM; Yang, YF; Yang, B; Yu, YH				Pan, Jinming; Yang, Yefeng; Yang, Bo; Yu, Yonghua			Artificial Polychromatic Light Affects Growth and Physiology in Chicks	PLOS ONE			English	Article							BODY-TEMPERATURE; BROILER-CHICKENS; MONOCHROMATIC LIGHT; LOCOMOTOR-ACTIVITY; AMBIENT-TEMPERATURE; CIRCADIAN-RHYTHM; VISUAL PIGMENTS; COLOR-VISION; BIRDS; PHOTORECEPTORS	Despite the overwhelming use of artificial light on captive animals, its effect on those animals has rarely been studied experimentally. Housing animals in controlled light conditions is useful for assessing the effects of light. The chicken is one of the best-studied animals in artificial light experiments, and here, we evaluate the effect of polychromatic light with various green and blue components on the growth and physiology in chicks. The results indicate that green-blue dual light has two side-effects on chick body mass, depending on the various green to blue ratios. Green-blue dual light with depleted and medium blue component decreased body mass, whereas enriched blue component promoted body mass in chicks compared with monochromatic green-or blue spectra-treated chicks. Moreover, progressive changes in the green to blue ratios of green-blue dual light could give rise to consistent progressive changes in body mass, as suggested by polychromatic light with higher blue component resulting in higher body mass. Correlation analysis confirmed that food intake was positively correlated with final body mass in chicks (R-2=0.7664, P=0.0001), suggesting that increased food intake contributed to the increased body mass in chicks exposed to higher blue component. We also found that chicks exposed to higher blue component exhibited higher blood glucose levels. Furthermore, the glucose level was positively related to the final body mass (R-2=0.6406, P=0.0001) and food intake (R-2=0.784, P=0.0001). These results demonstrate that spectral composition plays a crucial role in affecting growth and physiology in chicks. Moreover, consistent changes in spectral components might cause the synchronous response of growth and physiology.	[Pan, Jinming; Yang, Yefeng; Yang, Bo; Yu, Yonghua] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University	Yu, YH (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310058, Zhejiang, Peoples R China.	yhyu@zju.edu.cn	Pan, Jinming/A-7377-2018; Yang, Yefeng/AAB-8118-2022	Pan, Jinming/0000-0003-0228-4564; Yang, Yefeng/0000-0002-8610-4016	Chinese Special Fund for Agro-scientific Research in the Public Interest [201303091]	Chinese Special Fund for Agro-scientific Research in the Public Interest	Funding: This work was supported by the Chinese Special Fund for Agro-scientific Research in the Public Interest (grant numbers 201303091). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apeldoorn EJ, 1999, POULTRY SCI, V78, P223, DOI 10.1093/ps/78.2.223; Benstaali C, 2002, PFLUG ARCH EUR J PHY, V444, P73, DOI 10.1007/s00424-002-0795-z; Bowmaker JK, 1997, VISION RES, V37, P2183, DOI 10.1016/S0042-6989(97)00026-6; Cao J, 2012, POULTRY SCI, V91, P3013, DOI 10.3382/ps.2012-02413; Cassone VM, 2009, GEN COMP ENDOCR, V163, P109, DOI 10.1016/j.ygcen.2009.01.003; Chellappa S. L, 2011, PLOS ONE, V6; Collins S, 2011, APPL ANIM BEHAV SCI, V133, P60, DOI 10.1016/j.applanim.2011.04.013; Davis JF, 1996, AVIAN DIS, V40, P158, DOI 10.2307/1592385; Deboer T, 2007, SLEEP, V30, P257, DOI 10.1093/sleep/30.3.257; Dijk DJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000145; Dominoni D, 2013, P ROY SOC LND B, V280; DONKOH A, 1989, INT J BIOMETEOROL, V33, P259, DOI 10.1007/BF01051087; Dumont M, 2007, SLEEP MED, V8, P557, DOI 10.1016/j.sleep.2006.11.008; Ellis JL, 2009, J ANIM SCI, V87, P1334, DOI 10.2527/jas.2007-0725; Fiske VM, 1941, ENDOCRINOLOGY, V29, P187; Fonken LK, 2010, P NATL ACAD SCI USA, V107, P18664, DOI 10.1073/pnas.1008734107; Fonken LK, 2009, BEHAV BRAIN RES, V205, P349, DOI 10.1016/j.bbr.2009.07.001; Halevy O, 1998, COMP BIOCHEM PHYS A, V120, P317, DOI 10.1016/S1095-6433(98)10032-6; HARTWIG HG, 1979, J COMP PHYSIOL, V130, P277, DOI 10.1007/BF00614615; Hatori M, 2010, TRENDS MOL MED, V16, P435, DOI 10.1016/j.molmed.2010.07.005; Holker F, 2010, ECOL SOC, V15; Idnurm A, 2005, PLOS BIOL, V3, P615, DOI 10.1371/journal.pbio.0030095; Jennissen K, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002867; Ke YY, 2011, POULTRY SCI, V90, P2632, DOI 10.3382/ps.2011-01523; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kohyama J, 2009, BRAIN DEV-JPN, V31, P255, DOI 10.1016/j.braindev.2008.07.006; Kram YA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008992; Kuhi HD, 2003, POULTRY SCI, V82, P1536, DOI 10.1093/ps/82.10.1536; Kumar V, 2010, PHYSIOL BIOCHEM ZOOL, V83, P827, DOI 10.1086/652243; Lewis PD, 2000, WORLD POULTRY SCI J, V56, P189, DOI 10.1079/WPS20000015; MELLOR S., 2001, WORLD POULTRY, V17, P33; Murakami N, 2001, BRAIN RES, V889, P220, DOI 10.1016/S0006-8993(00)03205-4; Nahashon SN, 2010, POULTRY SCI, V89, P52, DOI 10.3382/ps.2009-00219; Olanrewaju H, 2012, INT J POULT SCI, V11; Olanrewaju HA, 2010, POULTRY SCI, V89, P2668, DOI 10.3382/ps.2010-00806; Olanrewaju HA, 2008, POULTRY SCI, V87, P167; ONIKI Y, 1981, IBIS, V123, P349, DOI 10.1111/j.1474-919X.1981.tb04038.x; Peek MS, 2002, OECOLOGIA, V132, P175, DOI 10.1007/s00442-002-0954-0; Prayitno DS, 1997, POULTRY SCI, V76, P452, DOI 10.1093/ps/76.3.452; Prescott NB, 1999, BRIT POULTRY SCI, V40, P332, DOI 10.1080/00071669987412; Prescott NB, 2003, ANIM WELFARE, V12, P269; Pruitt BA, 2002, ANN SURG, V235, P160; REFINETTI R, 1992, PHYSIOL BEHAV, V51, P613, DOI 10.1016/0031-9384(92)90188-8; REFINETTI R, 1994, PHYSIOL BEHAV, V56, P829, DOI 10.1016/0031-9384(94)90251-8; Rodenboog H., 2001, WORLD POULTRY SCI J, V17, P22; Romero LF, 2009, POULTRY SCI, V88, P227, DOI 10.3382/ps.2008-00141; Rozenboim I, 1999, POULTRY SCI, V78, P135, DOI 10.1093/ps/78.1.135; Rozenboim I, 2013, GEN COMP ENDOCR, V190, P214, DOI 10.1016/j.ygcen.2013.06.027; Sadrzadeh A, 2011, AFR J BIOTECHNOL, V10, P9528; Saldanha CJ, 2001, J BIOL RHYTHM, V16, P39, DOI 10.1177/074873040101600105; SALDANHA CJ, 1994, PSYCHONEUROENDOCRINO, V19, P641, DOI 10.1016/0306-4530(94)90047-7; SILVER R, 1988, CELL TISSUE RES, V253, P189; Smith M, 2009, NATURE, V457, P27, DOI 10.1038/457027a; SUWINDRA N, 1986, BRIT POULTRY SCI, V27, P225, DOI 10.1080/00071668608416875; Takahashi H, 2005, DEV BRAIN RES, V157, P58, DOI 10.1016/j.devbrainres.2005.03.004; Thomas BB, 2001, J EXP ZOOL, V289, P59, DOI 10.1002/1097-010X(20010101/31)289:1&lt;59::AID-JEZ6&gt;3.0.CO;2-L; Titulaer M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037377; Vandewalle G, 2010, P NATL ACAD SCI USA, V107, P19549, DOI 10.1073/pnas.1010180107; Vandewalle G, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001247; Warthen DM, 2011, P NATL ACAD SCI USA, V108, P13788, DOI 10.1073/pnas.1103214108; Weinert D, 1998, PHYSIOL BEHAV, V63, P837, DOI 10.1016/S0031-9384(97)00546-5; Xie D, 2011, POULTRY SCI, V90, P2697, DOI 10.3382/ps.2011-01416; YOSHIZAWA T, 1992, PHOTOCHEM PHOTOBIOL, V56, P859, DOI 10.1111/j.1751-1097.1992.tb09707.x; Zhaoping L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019248	64	14	14	3	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113595	10.1371/journal.pone.0113595	http://dx.doi.org/10.1371/journal.pone.0113595			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469877	gold, Green Submitted, Green Published			2022-12-26	WOS:000349128700036
J	Angus, SD; Piotrowska, MJ				Angus, Simon D.; Piotrowska, Monika Joanna			A Matter of Timing: Identifying Significant Multi-Dose Radiotherapy Improvements by Numerical Simulation and Genetic Algorithm Search	PLOS ONE			English	Article							CELLULAR-AUTOMATON MODEL; STRAND BREAK REPAIR; ACCELERATED RADIOTHERAPY; RADIATION RESPONSE; MULTICELLULAR SPHEROIDS; INCOMPLETE-REPAIR; NORMAL TISSUE; LUNG-CANCER; SOLID TUMOR; CELLS	Multi-dose radiotherapy protocols (fraction dose and timing) currently used in the clinic are the product of human selection based on habit, received wisdom, physician experience and intra-day patient timetabling. However, due to combinatorial considerations, the potential treatment protocol space for a given total dose or treatment length is enormous, even for relatively coarse search; well beyond the capacity of traditional in-vitro methods. In constrast, high fidelity numerical simulation of tumor development is well suited to the challenge. Building on our previous single-dose numerical simulation model of EMT6/Ro spheroids, a multi-dose irradiation response module is added and calibrated to the effective dose arising from 18 independent multi-dose treatment programs available in the experimental literature. With the developed model a constrained, non-linear, search for better performing cadidate protocols is conducted within the vicinity of two benchmarks by genetic algorithm (GA) techniques. After evaluating less than 0.01% of the potential benchmark protocol space, candidate protocols were identified by the GA which conferred an average of 9.4% (max benefit 16.5%) and 7.1% (13.3%) improvement (reduction) on tumour cell count compared to the two benchmarks, respectively. Noticing that a convergent phenomenon of the top performing protocols was their temporal synchronicity, a further series of numerical experiments was conducted with periodic time-gap protocols (10 h to 23 h), leading to the discovery that the performance of the GA search candidates could be replicated by 17-18 h periodic candidates. Further dynamic irradiation-response cell-phase analysis revealed that such periodicity cohered with latent EMT6/Ro cell-phase temporal patterning. Taken together, this study provides powerful evidence towards the hypothesis that even simple inter-fraction timing variations for a given fractional dose program may present a facile, and highly cost-effecitive means of significantly improving clinical efficacy.	[Angus, Simon D.] Monash Univ, Dept Econ, Melbourne, Vic 3004, Australia; [Piotrowska, Monika Joanna] Univ Warsaw, Inst Appl Math & Mech, Fac Math Informat & Mech, Warsaw, Mazowieckie, Poland	Monash University; University of Warsaw	Angus, SD (corresponding author), Monash Univ, Dept Econ, Melbourne, Vic 3004, Australia.	simon.angus@monash.edu	Angus, Simon D/AAR-1871-2021	Angus, Simon D/0000-0001-7095-5054; Piotrowska, Monika/0000-0003-0156-8290	Polish Ministry of Science and Higher Education [IP2011041971]	Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was financed in part by the Polish Ministry of Science and Higher Education within the Iuventus Plus Grant: "Mathematical modelling of neoplastic processes" (grant No. IP2011041971) from the budget for science in years the 2012-2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad SU, 2010, BIOMED SIGNAL PROCES, V5, P189, DOI 10.1016/j.bspc.2010.03.001; Angus SD, 2010, APPL MATH WARSAW, V37, P69; Angus SD, 2013, J THEOR BIOL, V320, P23, DOI 10.1016/j.jtbi.2012.11.035; Bertuzzi A, 2010, B MATH BIOL, V72, P1069, DOI 10.1007/s11538-009-9482-y; Bevilacqua V, 2007, IMAGE VISION COMPUT, V25, P196, DOI 10.1016/j.imavis.2006.01.027; Bhide SA, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-25; BIEDERMANN KA, 1991, P NATL ACAD SCI USA, V88, P1394, DOI 10.1073/pnas.88.4.1394; Board of the Faculty of Clinical Oncology, 2006, RAD DOS FRACT; Bortfeld T, 1999, SEMIN RADIAT ONCOL, V9, P20, DOI 10.1016/S1053-4296(99)80052-6; Bourhis J, 2006, LANCET, V368, P843, DOI 10.1016/S0140-6736(06)69121-6; Byrne H, 2009, J MATH BIOL, V58, P657, DOI 10.1007/s00285-008-0212-0; Calzolari D, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000249; Carabe-Fernandez A, 2011, BRIT J RADIOL, V84, P546, DOI 10.1259/bjr/19934996; CASCIARI JJ, 1992, J CELL PHYSIOL, V151, P386, DOI 10.1002/jcp.1041510220; Cotrutz C, 2003, PHYS MED BIOL, V48, P2987, DOI 10.1088/0031-9155/48/18/303; Crone C., 1984, HDB PHYSL CARDIOVASC, P411; DAIRKEE SH, 1995, CANCER RES, V55, P2516; Duchting W, 1996, APPL MATH COMPUT, V74, P191, DOI 10.1016/0096-3003(95)00092-5; DURAND RE, 1984, BRIT J CANCER, V49, P203; DURAND RE, 1980, RADIAT RES, V81, P85, DOI 10.2307/3575364; EMAMI B, 1991, INT J RADIAT ONCOL, V21, P109, DOI 10.1016/0360-3016(91)90171-Y; Engelhart M, 2011, MATH BIOSCI, V229, P123, DOI 10.1016/j.mbs.2010.11.007; Ezzell GA, 1996, MED PHYS, V23, P293, DOI 10.1118/1.597660; Fowler J F, 1992, BJR Suppl, V24, P187; Fowler JF, 2002, RADIAT RES, V158, P141, DOI 10.1667/0033-7587(2002)158[0141:RBDFAS]2.0.CO;2; Fowler JF, 1999, RADIAT RES, V152, P124, DOI 10.2307/3580085; FREYER JP, 1980, CANCER RES, V40, P3956; FREYER JP, 1986, CANCER RES, V46, P3513; FREYER JP, 1986, CANCER RES, V46, P3504; FREYER JP, 1985, J CELL PHYSIOL, V124, P516, DOI 10.1002/jcp.1041240323; Gao N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062156; Haas OCL, 2006, STUD MULTIDISCIP, V3, P447; Haasbeek CJA, 2009, LUNG CANCER, V64, P1, DOI 10.1016/j.lungcan.2008.07.008; HAHN GM, 1974, CANCER RES, V34, P351; HAHN GM, 1973, RADIAT RES, V55, P280, DOI 10.2307/3573683; Hendry J H, 1996, Clin Oncol (R Coll Radiol), V8, P297, DOI 10.1016/S0936-6555(05)80715-0; Holland J.H., 1975, ADAPTATION NATURAL A; Holland JH, 2012, SCHOLARPEDIA, V7, P1482, DOI [DOI 10.4249/SCHOLARPEDIA.1482, DOI 10.4249/SCH0LARPEDIA.1482]; Jiang Y, 2005, BIOPHYS J, V89, P3884, DOI 10.1529/biophysj.105.060640; KAL HB, 1976, CANCER RES, V36, P1923; Kehwar T S, 2005, J Cancer Res Ther, V1, P168; KELLEY SD, 1981, CELL TISSUE KINET, V14, P611, DOI 10.1111/j.1365-2184.1981.tb00846.x; Kempf H, 2010, EUR PHYS J D, V60, P177, DOI 10.1140/epjd/e2010-00178-4; Kempf H, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003295; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; Lei J, 2009, COMPUTER METHODS PRO, V93; Li ZP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083739; Longo JA, 1997, RADIAT RES, V147, P35, DOI 10.2307/3579440; Alfonso JCL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089380; LUK CK, 1986, BRIT J CANCER, V54, P25, DOI 10.1038/bjc.1986.148; LUK CK, 1987, INT J RADIAT ONCOL, V13, P885, DOI 10.1016/0360-3016(87)90104-0; Mak IWY, 2014, AM J TRANSL RES, V6, P114; Mangar SA, 2005, EUR J CANCER, V41, P908, DOI 10.1016/j.ejca.2004.12.028; Mortensen HR, 2012, RADIOTHER ONCOL, V103, P69, DOI 10.1016/j.radonc.2012.01.002; MUSTAFIN AT, 1982, BIOSYSTEMS, V15, P111, DOI 10.1016/0303-2647(82)90025-9; O'Rourke SFC, 2009, J MATH BIOL, V58, P799, DOI 10.1007/s00285-008-0222-y; Otsuka S, 2011, INT J RADIAT ONCOL, V81, P1538, DOI 10.1016/j.ijrobp.2011.05.034; Patel AA, 2001, J THEOR BIOL, V213, P315, DOI 10.1006/jtbi.2001.2385; Petrovic D, 2011, EXPERT SYST APPL, V38, P6994, DOI 10.1016/j.eswa.2010.12.015; Petrovic S, 2011, EXPERT SYST APPL, V38, P10759, DOI 10.1016/j.eswa.2011.01.109; Piotrowska MJ, 2009, J THEOR BIOL, V258, P165, DOI 10.1016/j.jtbi.2009.02.008; Powathil GG, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003120; Powathil GG, 2012, J THEOR BIOL, V308, P1, DOI 10.1016/j.jtbi.2012.05.015; ROCKWELL S, 1980, BRIT J CANCER, V41, P118; Rosenstein BS, 2004, INT J RADIAT ONCOL, V60, P1393, DOI 10.1016/j.ijrobp.2004.05.072; Rothkamm K, 2003, MOL CELL BIOL, V23, P5706, DOI 10.1128/MCB.23.16.5706-5715.2003; Saunders M, 1997, LANCET, V350, P161, DOI 10.1016/S0140-6736(97)06305-8; Sugie C, 2006, INT J RADIAT ONCOL, V64, P619, DOI 10.1016/j.ijrobp.2005.03.032; THAMES HD, 1985, INT J RADIAT BIOL, V47, P319, DOI 10.1080/09553008514550461; UK CR, 2010, RAD BRIEFSH; Venkatasubramanian R, 2006, J THEOR BIOL, V242, P440, DOI 10.1016/j.jtbi.2006.03.011; Wein LM, 2000, INT J RADIAT ONCOL, V47, P1073, DOI 10.1016/S0360-3016(00)00534-4; Wilson GD, 2004, CANCER METAST REV, V23, P209, DOI 10.1023/B:CANC.0000031762.91306.b4; Yu Y, 1997, MED PHYS, V24, P1742, DOI 10.1118/1.597951; Zacharaki EI, 2004, COMPUT METH PROG BIO, V76, P193, DOI 10.1016/j.cmpb.2004.07.003	75	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114098	10.1371/journal.pone.0114098	http://dx.doi.org/10.1371/journal.pone.0114098			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460164	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700097
J	Canello, T; Ovadia, H; Refael, M; Zrihan, D; Siegal, T; Lavon, I				Canello, Tamar; Ovadia, Haim; Refael, Miri; Zrihan, Daniel; Siegal, Tali; Lavon, Iris			Antineoplastic Effect of Decoy Oligonucleotide Derived from MGMT Enhancer	PLOS ONE			English	Article							NF-KAPPA-B; PHASE-II TRIAL; HUMAN O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; ALKYLATING-AGENTS; MALIGNANT GLIOMA; DNA-REPAIR; POLY(ADP-RIBOSE) POLYMERASE; ANTISENSE OLIGONUCLEOTIDES; ADVANCED MELANOMA	Silencing of O(6)-methylguanine-DNA-methyltransferase (MGMT) in tumors, mainly through promoter methylation, correlates with a better therapeutic response and with increased survival. Therefore, it is conceivable to consider MGMT as a potential therapeutic target for the treatment of cancers. Our previous results demonstrated the pivotal role of NF-kappaB in MGMTexpression, mediated mainly through p65/NF-kappaB homodimers. Here we show that the non-canonical NF-KappaB motif (MGMT-kappaB1) within MGMT enhancer is probably the major inducer of MGMTexpression following NF-kappaB activation. Thus, in an attempt to attenuate the transcription activity of MGMT in tumors we designed locked nucleic acids (LNA) modified decoy oligonucleotides corresponding to the specific sequence of MGMT-kappaB1 (MGMT-kB1-LODN). Following confirmation of the ability of MGMT-kB1-LODN to interfere with the binding of p65/NF-kappaB to the NF-KappaB motif within MGMTenhancer, the efficacy of the decoy was studied in-vitro and in-vivo. The results of these experiments show that the decoy MGMT-kB1-LODN have a substantial antineoplastic effect when used either in combination with temozolomide or as monotherapy. Our results suggest that MGMT-kB1-LODN may provide a novel strategy for cancer therapy.	[Lavon, Iris] Hadassah Hebrew Univ Med Ctr, Agnes Ginges Ctr Human Neurogenet, Leslie & Michael Gaffin Ctr Neurooncol, Jerusalem, Israel; Hadassah Hebrew Univ Med Ctr, Agnes Ginges Ctr Human Neurogenet, Dept Neurol, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Lavon, I (corresponding author), Hadassah Hebrew Univ Med Ctr, Agnes Ginges Ctr Human Neurogenet, Leslie & Michael Gaffin Ctr Neurooncol, Jerusalem, Israel.	Irisl@hadassah.org.il	Lavon, Iris/ABE-6651-2021		Kamin, Ministry of Industry, Trade and Labor, office of the Israeli chief scientist [49040]	Kamin, Ministry of Industry, Trade and Labor, office of the Israeli chief scientist	This work was supported by 49040: Kamin, Ministry of Industry, Trade and Labor, office of the Israeli chief scientist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batts ED, 2007, CANCER CHEMOTH PHARM, V60, P415, DOI 10.1007/s00280-007-0442-7; Carlotti F, 2000, J BIOL CHEM, V275, P41028, DOI 10.1074/jbc.M006179200; Cesinaro AM, 2012, PATHOLOGY, V44, P313, DOI 10.1097/PAT.0b013e328353a0ff; Chen FY, 1997, P NATL ACAD SCI USA, V94, P4348, DOI 10.1073/pnas.94.9.4348; CITRON M, 1995, ONCOL RES, V7, P49; Dias N, 2002, MOL CANCER THER, V1, P347; DOLAN ME, 1990, CANCER COMMUN, V2, P371, DOI 10.3727/095535490820873985; DOLAN ME, 1990, P NATL ACAD SCI USA, V87, P5368, DOI 10.1073/pnas.87.14.5368; Drew Y, 2011, JNCI-J NATL CANCER I, V103, P334, DOI 10.1093/jnci/djq509; Esteller M, 2000, NEW ENGL J MED, V343, P1350, DOI 10.1056/NEJM200011093431901; Fluiter K, 2003, NUCLEIC ACIDS RES, V31, P953, DOI 10.1093/nar/gkg185; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Frieden M, 2003, NUCLEIC ACIDS RES, V31, P6365, DOI 10.1093/nar/gkg820; Friedman HS, 1998, J CLIN ONCOL, V16, P3570, DOI 10.1200/JCO.1998.16.11.3570; Friedman HS, 1998, J CLIN ONCOL, V16, P3851, DOI 10.1200/JCO.1998.16.12.3851; Gajewski TF, 2005, CLIN CANCER RES, V11, P7861, DOI 10.1158/1078-0432.CCR-05-0060; Gatenby RA, 2009, NATURE, V459, P508, DOI 10.1038/459508a; Gilbert MR, 2014, NEW ENGL J MED, V370, P699, DOI 10.1056/NEJMoa1308573; Hao Tian-zhi, 2003, Zhonghua Shao Shang Za Zhi, V19, P175; HARRIS LC, 1991, NUCLEIC ACIDS RES, V19, P6163, DOI 10.1093/nar/19.22.6163; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hinz M, 1999, MOL CELL BIOL, V19, P2690; Jaeckle KA, 1998, J CLIN ONCOL, V16, P3310, DOI 10.1200/JCO.1998.16.10.3310; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Kefford RF, 2009, BRIT J CANCER, V100, P1245, DOI 10.1038/sj.bjc.6605016; Klement G, 2000, J CLIN INVEST, V105, pR15, DOI 10.1172/JCI8829; Kokkinakis DM, 1997, CANCER RES, V57, P5360; Konduri SD, 2009, CLIN CANCER RES, V15, P6087, DOI 10.1158/1078-0432.CCR-09-0887; LaCasse EC, 1998, ONCOGENE, V17, P3247, DOI 10.1038/sj.onc.1202569; Lavon I, 2007, CANC RES, V67; Liao D. Joshua, 2007, Critical Reviews in Oncogenesis, V13, P93; Malik PS, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00076; McTigue PM, 2004, BIOCHEMISTRY-US, V43, P5388, DOI 10.1021/bi035976d; Moghimi SM, 2005, MOL THER, V11, P990, DOI 10.1016/j.ymthe.2005.02.010; Niture SK, 2005, BIOCHEM BIOPH RES CO, V337, P1176, DOI 10.1016/j.bbrc.2005.09.177; Plummer R, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2877; Quinn JA, 2005, J CLIN ONCOL, V23, P7178, DOI 10.1200/JCO.2005.06.502; Ranson M, 2006, CLIN CANCER RES, V12, P1577, DOI 10.1158/1078-0432.CCR-05-2198; Ranson M, 2007, J CLIN ONCOL, V25, P2540, DOI 10.1200/JCO.2007.10.8217; Rivera AL, 2010, NEURO-ONCOLOGY, V12, P116, DOI 10.1093/neuonc/nop020; Ryan CW, 2006, CANCER CHEMOTH PHARM, V58, P634, DOI 10.1007/s00280-006-0210-0; Schilsky RL, 2000, CLIN CANCER RES, V6, P3025; SCHOLD SC, 1989, J NEUROSURG, V70, P573, DOI 10.3171/jns.1989.70.4.0573; Schold SC, 2004, NEURO-ONCOLOGY, V6, P28, DOI 10.1215/S115285170300019X; Schraml P, ONCOL REP, V28, P654; Souissi I, 2011, BMC CELL BIOL, V12, DOI 10.1186/1471-2121-12-14; Spiro T, 2000, Forum (Genova), V10, P274; Spiro TP, 1999, CANCER RES, V59, P2402; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tawbi HA, 2011, BRIT J CANCER, V105, P773, DOI 10.1038/bjc.2011.285; Wang HF, 2008, INT J MOL SCI, V9, P1851, DOI 10.3390/ijms9091851; Warren KE, 2005, J CLIN ONCOL, V23, P7646, DOI 10.1200/JCO.2005.02.0024; Weingart J, 2007, J CLIN ONCOL, V25, P399, DOI 10.1200/JCO.2006.06.6290; WU ZN, 1992, CANCER RES, V52, P32; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914	55	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113854	10.1371/journal.pone.0113854	http://dx.doi.org/10.1371/journal.pone.0113854			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460932	Green Published, gold, Green Submitted			2022-12-26	WOS:000345869700060
J	Fujita, Y; Okamoto, M; Goda, H; Tano, T; Nakashiro, K; Sugita, A; Fujita, T; Koido, S; Homma, S; Kawakami, Y; Hamakawa, H				Fujita, Yohei; Okamoto, Masato; Goda, Hiroyuki; Tano, Tomoyuki; Nakashiro, Koh-ichi; Sugita, Atsuro; Fujita, Tomonobu; Koido, Shigeo; Homma, Sadamu; Kawakami, Yutaka; Hamakawa, Hiroyuki			Prognostic Significance of Interleukin-8 and CD163-Positive Cell-Infiltration in Tumor Tissues in Patients with Oral Squamous Cell Carcinoma	PLOS ONE			English	Article							T-CELLS; CANCER; RECURRENCE; EXPRESSION; HEAD	Purpose: We investigated whether serum interleukin (IL)-8 reflects the tumor microenvironment and has prognostic value in patients with oral squamous cell carcinoma (OSCC). Experimental Design: Fifty OSCC patients who received radical resection of their tumor(s) were enrolled. Preoperative sera were measured for IL-8 by ELISA. Expression of IL-8 and the infiltration of immune cells in tumor tissues were analyzed by an immunohistochemical staining of surgical specimens. Results: We found that disease-free survival (DFS) was significantly longer in the Stage I/II OSCC patients with low serum IL-8 levels compared to those with high levels (p=0.001). The tumor expression of IL-8, i.e., IL-8(T) and the density of CD163-positive cells in the tumor invasive front, i.e., CD163(IF) were correlated with the serum IL-8 level (p=0.033 and p=0.038, respectively), and they were associated with poor clinical outcome (p=0.007 and p=0.002, respectively, in DFS) in all patients. A multivariate analysis revealed that N status, IL-8(T) and CD163(IF) significantly affected the DFS of the patients. Further analysis suggested that combination of N status with serum IL-8, IL-8(T) or CD163(IF) may be a new criterion for discriminating between OSCC patients at high and low risk for tumor relapse. Interestingly, the in vitro experiments demonstrated that IL-8 enhanced generation of CD163-positive M2 macrophages from peripheral blood monocytes, and that the cells produced IL-10. Conclusions: These findings indicate that IL-8 may be involved in poor clinical outcomes via generation of CD163-positive M2 macrophages, and that these factors in addition to N status may have prognostic value in patients with resectable OSCSS.	[Fujita, Yohei; Goda, Hiroyuki; Tano, Tomoyuki; Nakashiro, Koh-ichi; Hamakawa, Hiroyuki] Ehime Univ, Grad Sch Med, Dept Oral & Maxillofacial Surg, Matsuyama, Ehime 790, Japan; [Okamoto, Masato] Kitasato Univ, Sch Pharm, Dept Adv Immunotherapeut, Tokyo, Japan; [Okamoto, Masato; Fujita, Tomonobu; Kawakami, Yutaka] Keio Univ, Sch Med, Div Cellular Signaling, Inst Adv Med Res, Tokyo, Japan; [Koido, Shigeo] Jikei Univ, Div Gastroenterol & Hepatol, Dept Internal Med, Sch Med, Tokyo, Japan; [Homma, Sadamu] Jikei Univ, Dept Oncol, Inst DNA Med, Sch Med, Tokyo, Japan	Ehime University; Kitasato University; Keio University; Jikei University; Jikei University	Okamoto, M (corresponding author), Kitasato Univ, Sch Pharm, Dept Adv Immunotherapeut, Tokyo, Japan.	okamotom@pharm.kitasato-u.ac.jp	Nakashiro, Koichi/AAV-6317-2020; Kawakami, Yutaka/E-7429-2013	Kawakami, Yutaka/0000-0003-4836-2855; Nakashiro, Koh-ichi/0000-0002-9975-902X	Ministry of Education, Cultures, Sports, Science and Technology of Japan [25293412]; Grants-in-Aid for Scientific Research [25463119, 26670866] Funding Source: KAKEN	Ministry of Education, Cultures, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Cultures, Sports, Science and Technology of Japan (No. 25293412) (http://www.mext.go.jp/english/) (HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almadori G, 2008, CURR OPIN OTOLARYNGO, V16, P117, DOI 10.1097/MOO.0b013e3282f6a4b0; Biancotto A, 2012, CYTOKINE, V60, P438, DOI 10.1016/j.cyto.2012.05.019; Codony-Servat J, 2013, PROSTATE, V73, P512, DOI 10.1002/pros.22591; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Dhillon N, 2008, CLIN CANCER RES, V14, P4491, DOI 10.1158/1078-0432.CCR-08-0024; Durafourt BA, 2012, GLIA, V60, P717, DOI 10.1002/glia.22298; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Fridman WH, 2013, CANCER MICROENVIRON, V6, P117, DOI 10.1007/s12307-012-0124-9; Greene FL, 2008, CA-CANCER J CLIN, V58, P180, DOI 10.3322/CA.2008.0001; Hasita H, 2010, CANCER SCI, V101, P1913, DOI 10.1111/j.1349-7006.2010.01614.x; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Korkaya H, 2011, CLIN CANCER RES, V17, P6125, DOI 10.1158/1078-0432.CCR-10-2743; Kreppel M, 2011, HEAD NECK-J SCI SPEC, V33, P1467, DOI 10.1002/hed.21630; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Motomura T, 2013, J HEPATOL, V58, P58, DOI 10.1016/j.jhep.2012.08.017; Okamoto M, 2004, CANCER RES, V64, P5461, DOI 10.1158/0008-5472.CAN-03-4005; Onodera T, 1984, Nihon Geka Gakkai Zasshi, V85, P1001; Skov L, 2008, J IMMUNOL, V181, P669, DOI 10.4049/jimmunol.181.1.669; Tano T, 2013, NEOPLASIA, V15, P305, DOI 10.1593/neo.121528; Tartour E, 2011, CANCER METAST REV, V30, P83, DOI 10.1007/s10555-011-9281-4; Tiemessen MM, 2007, P NATL ACAD SCI USA, V104, P19446, DOI 10.1073/pnas.0706832104; Woolgar JA, 2009, FUTURE ONCOL, V5, P51, DOI 10.2217/14796694.5.1.51; YAMAMOTO E, 1983, CANCER, V51, P2175, DOI 10.1002/1097-0142(19830615)51:12<2175::AID-CNCR2820511205>3.0.CO;2-M; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Zhang T, 2010, CANCER IMMUNOL IMMUN, V59, P1097, DOI 10.1007/s00262-010-0836-y	25	44	47	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e110378	10.1371/journal.pone.0110378	http://dx.doi.org/10.1371/journal.pone.0110378			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461761	Green Published, Green Submitted, gold			2022-12-26	WOS:000345869700003
J	Ravinet, M; Takeuchi, N; Kume, M; Mori, S; Kitano, J				Ravinet, Mark; Takeuchi, Naoko; Kume, Manabu; Mori, Seiichi; Kitano, Jun			Comparative Analysis of Japanese Three-Spined Stickleback Clades Reveals the Pacific Ocean Lineage Has Adapted to Freshwater Environments while the Japan Sea Has Not	PLOS ONE			English	Article							LAKE-STREAM STICKLEBACK; THREESPINE STICKLEBACK; GASTEROSTEUS-ACULEATUS; ECOLOGICAL OPPORTUNITY; FORAGING EFFICIENCY; FEEDING PERFORMANCE; GENETIC-DIVERGENCE; STABLE-ISOTOPES; TRADE-OFFS; SPECIATION	Divergent selection and adaptive divergence can increase phenotypic diversification amongst populations and lineages. Yet adaptive divergence between different environments, habitats or niches does not occur in all lineages. For example, the colonization of freshwater environments by ancestral marine species has triggered adaptive radiation and phenotypic diversification in some taxa but not in others. Studying closely related lineages differing in their ability to diversify is an excellent means of understanding the factors promoting and constraining adaptive evolution. A well-known example of the evolution of increased phenotypic diversification following freshwater colonization is the three-spined stickleback. Two closely related stickleback lineages, the Pacific Ocean and the Japan Sea occur in Japan. However, Japanese freshwater stickleback populations are derived from the Pacific Ocean lineage only, suggesting the Japan Sea lineage is unable to colonize freshwater. Using stable isotope data and trophic morphology, we first show higher rates of phenotypic and ecological diversification between marine and freshwater populations within the Pacific Ocean lineage, confirming adaptive divergence has occurred between the two lineages and within the Pacific Ocean lineage but not in the Japan Sea lineage. We further identified consistent divergence in diet and foraging behaviour between marine forms from each lineage, confirming Pacific Ocean marine sticklebacks, from which all Japanese freshwater populations are derived, are better adapted to freshwater environments than Japan Sea sticklebacks. We suggest adaptive divergence between ancestral marine populations may have played a role in constraining phenotypic diversification and adaptive evolution in Japanese sticklebacks.	[Ravinet, Mark; Takeuchi, Naoko; Kitano, Jun] Natl Inst Genet, Ecol Genet Lab, Mishima, Shizuoka 411, Japan; [Kume, Manabu; Mori, Seiichi] Gifu Keizai Univ, Biol Lab, Ogaki, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan	Ravinet, M (corresponding author), Natl Inst Genet, Ecol Genet Lab, Mishima, Shizuoka 411, Japan.	mravinet@nig.ac.jp; jkitano@lab.nig.ac.jp	Kume, Manabu/Y-5237-2018; Kume, Manabu/AAI-7926-2020	Kume, Manabu/0000-0001-7287-029X; Kume, Manabu/0000-0001-7287-029X; Ravinet, Mark/0000-0002-2841-1798	Japan Science and Technology Agency PRESTO program; Center for the Promotion of Integrated Sciences (CPIS) of Sokendai; Ministry of Education, Science, Sports, and Culture [23113007, 23113001]; Japanese Society for the Promotion of Science; NIG Collaborative Research Program [2013-A33, A34]	Japan Science and Technology Agency PRESTO program(Japan Science & Technology Agency (JST)); Center for the Promotion of Integrated Sciences (CPIS) of Sokendai(Graduate University for Advanced Studies - Japan); Ministry of Education, Science, Sports, and Culture(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIG Collaborative Research Program	This research was supported by the Japan Science and Technology Agency PRESTO program, Center for the Promotion of Integrated Sciences (CPIS) of Sokendai, and Grant-in-Aid for Scientific Research on Innovative Areas (23113007 and 23113001) from the Ministry of Education, Science, Sports, and Culture to JK. MR was kindly funded by the Japanese Society for the Promotion of Science on a Short-term Postdoctoral Fellowship and the NIG Collaborative Research Program (2013-A33 and A34). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	ALFORD RA, 1985, ECOLOGY, V66, P1097, DOI 10.2307/1939161; Almany GR, 2003, ECOLOGY, V84, P1920, DOI 10.1890/0012-9658(2003)084[1920:PEICRF]2.0.CO;2; Barrett RDH, 2008, TRENDS ECOL EVOL, V23, P38, DOI 10.1016/j.tree.2007.09.008; Bell Michael A., 1994, P1; Berner D, 2008, J EVOLUTION BIOL, V21, P1653, DOI 10.1111/j.1420-9101.2008.01583.x; Berner D, 2010, MOL ECOL, V19, P4963, DOI 10.1111/j.1365-294X.2010.04858.x; Berner D, 2009, EVOLUTION, V63, P1740, DOI 10.1111/j.1558-5646.2009.00665.x; Boettiger C, 2012, EVOLUTION, V66, P2240, DOI 10.1111/j.1558-5646.2011.01574.x; Bolnick DI, 2009, EVOLUTION, V63, P2004, DOI 10.1111/j.1558-5646.2009.00699.x; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Cassidy LM, 2013, EVOL ECOL RES, V15, P295; Colosimo PF, 2004, PLOS BIOL, V2, P635, DOI 10.1371/journal.pbio.0020109; Crisp MD, 2009, NATURE, V458, P754, DOI 10.1038/nature07764; Deagle BE, 2013, MOL ECOL, V22, P1917, DOI 10.1111/mec.12215; DeFaveri J, 2012, J FISH BIOL, V80, P61, DOI 10.1111/j.1095-8649.2011.03147.x; DeFaveri J, 2011, EVOLUTION, V65, P1800, DOI 10.1111/j.1558-5646.2011.01247.x; Endler J.A., 1986, Monographs in Population Biology, pviii; Flohr RCE, 2013, P NATL ACAD SCI USA, V110, P20663, DOI 10.1073/pnas.1310310110; Gill AB, 1996, J FISH BIOL, V48, P878; GOLDSTEIN DB, 1995, P NATL ACAD SCI USA, V92, P6723, DOI 10.1073/pnas.92.15.6723; Goto A., 2003, NATURAL HIST STICKLE; Gould S. J., 1990, WONDERFUL LIFE BURGE; Grey J., 2000, INT VER F R THEOR AN, V27, P3187, DOI [10.1080/03680770.1998.11898266, DOI 10.1080/03680770.1998.11898266]; Grey J, 2006, POL J ECOL, V54, P563; HAMADA K, 1975, Japanese Journal of Ichthyology, V21, P183; Hansen TF, 1997, EVOLUTION, V51, P1341, DOI 10.1111/j.1558-5646.1997.tb01457.x; Hendry AP, 2009, J FISH BIOL, V75, P2000, DOI 10.1111/j.1095-8649.2009.02419.x; Hendry AP, 2004, EVOLUTION, V58, P2319; HESSLEIN RH, 1993, CAN J FISH AQUAT SCI, V50, P2071, DOI 10.1139/f93-230; Higuchi M, 1996, ENVIRON BIOL FISH, V47, P1, DOI 10.1007/BF00002375; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; HONMA Y, 1977, JPN J ICHTHYOL, V24, P17; HYSLOP EJ, 1980, J FISH BIOL, V17, P411, DOI 10.1111/j.1095-8649.1980.tb02775.x; IBRAHIM AA, 1988, J FISH BIOL, V33, P823, DOI 10.1111/j.1095-8649.1988.tb05528.x; Ikeda K, 1933, ZOOL MAG, V45, P141; Jackson AL, 2011, J ANIM ECOL, V80, P595, DOI 10.1111/j.1365-2656.2011.01806.x; Jones FC, 2012, NATURE, V484, P55, DOI 10.1038/nature10944; Kaeuffer R, 2012, EVOLUTION, V66, P402, DOI 10.1111/j.1558-5646.2011.01440.x; Kiljunen M, 2006, J APPL ECOL, V43, P1213, DOI 10.1111/j.1365-2664.2006.01224.x; Kitano J, 2007, BIOL J LINN SOC, V91, P671, DOI 10.1111/j.1095-8312.2007.00824.x; Kitano J, 2009, NATURE, V461, P1079, DOI 10.1038/nature08441; Kume M, 2005, ICHTHYOL RES, V52, P189, DOI 10.1007/s10228-005-0269-3; Kume M, 2010, J EVOLUTION BIOL, V23, P1436, DOI 10.1111/j.1420-9101.2010.02009.x; Langella O, 2013, POPULATIONS; Lee CE, 1999, TRENDS ECOL EVOL, V14, P284, DOI 10.1016/S0169-5347(99)01596-7; Losos J.B., 2010, EVOLUTION DARWIN 1 1, P381; Losos JB, 1999, ECOLOGY, V80, P252, DOI 10.1890/0012-9658(1999)080[0252:DCSAAI]2.0.CO;2; Losos JB, 2010, AM NAT, V175, P623, DOI 10.1086/652433; Lucek K, 2013, J EVOLUTION BIOL, P1; Makinen HS, 2008, MOL PHYLOGENET EVOL, V46, P167, DOI 10.1016/j.ympev.2007.06.011; McKinnon JS, 2002, TRENDS ECOL EVOL, V17, P480, DOI 10.1016/S0169-5347(02)02579-X; MORI S, 1987, JPN J ICHTHYOL, V34, P33, DOI 10.1007/BF02904141; Nazarkin MV, 2013, PALEONTOL RES, V16, P318, DOI 10.2517/1342-8144-16.4.318; Near TJ, 2012, P NATL ACAD SCI USA, V109, P3434, DOI 10.1073/pnas.1115169109; NEI M, 1983, J MOL EVOL, V19, P153, DOI 10.1007/BF02300753; Nei M., 2000, MOL EVOLUTION PHYLOG; Newsome SD, 2007, FRONT ECOL ENVIRON, V5, P429, DOI 10.1890/060150.1; O'Meara BC, 2006, EVOLUTION, V60, P922; Ord TJ, 2012, J EVOLUTION BIOL, V25, P2047, DOI 10.1111/j.1420-9101.2012.02582.x; Orr HA, 1998, EVOLUTION, V52, P935, DOI [10.2307/2411226, 10.1111/j.1558-5646.1998.tb01823.x]; ORTI G, 1994, EVOLUTION, V48, P608, DOI 10.1111/j.1558-5646.1994.tb01348.x; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parnell AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009672; Peichel CL, 2001, NATURE, V414, P901, DOI 10.1038/414901a; Perga ME, 2005, OECOLOGIA, V144, P598, DOI 10.1007/s00442-005-0069-5; Phillips DL, 2003, OECOLOGIA, V136, P261, DOI 10.1007/s00442-003-1218-3; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; R Development Core Team, 2012, R LANG ENV STAT COMP; Rasanen K, 2008, ECOL LETT, V11, P624, DOI 10.1111/j.1461-0248.2008.01176.x; Ravinet M, 2013, J EVOLUTION BIOL, V26, P186, DOI 10.1111/jeb.12049; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Robinson BW, 2000, ADAPTIVE GENETIC VARIATION IN THE WILD, P65; Robinson BW, 2000, BEHAVIOUR, V137, P865, DOI 10.1163/156853900502501; Roesch C, 2013, J EVOLUTION BIOL, V26, P1578, DOI 10.1111/jeb.12166; Rogers SM, 2012, EVOLUTION, V66, P2439, DOI 10.1111/j.1558-5646.2012.01622.x; Rutschmann S, 2011, MOL ECOL, V20, P4707, DOI 10.1111/j.1365-294X.2011.05279.x; Schindler DE, 2004, FOOD WEB AT THE LANDSCAPE LEVEL, P25; SCHLUTER D, 1995, AM NAT, V146, P292, DOI 10.1086/285799; SCHLUTER D, 1993, ECOLOGY, V74, P699, DOI 10.2307/1940797; SCHLUTER D, 1995, ECOLOGY, V76, P82, DOI 10.2307/1940633; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schluter D, 2009, P NATL ACAD SCI USA, V106, P9955, DOI 10.1073/pnas.0901264106; SHORROCKS B, 1994, J ANIM ECOL, V63, P799, DOI 10.2307/5257; Spoljaric MA, 2007, J FISH BIOL, V70, P1484, DOI 10.1111/j.1095-8649.2007.01425.x; Tsuruta T, 2006, J FISH BIOL, V69, P155, DOI 10.1111/j.1095-8649.2006.01154.x; Wagner CE, 2012, NATURE, V487, P366, DOI 10.1038/nature11144; Waters JM, 2011, MOL ECOL, V20, P4388, DOI 10.1111/j.1365-294X.2011.05286.x; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x; Wu CH, 2011, GENETICS, V188, P151, DOI 10.1534/genetics.110.125260	89	19	19	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112404	10.1371/journal.pone.0112404	http://dx.doi.org/10.1371/journal.pone.0112404			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460163	gold, Green Submitted, Green Published			2022-12-26	WOS:000345869700017
J	Ru, J; Sun, HH; Fan, HX; Wang, CM; Li, YX; Liu, M; Tang, H				Ru, Jing; Sun, Huahui; Fan, Hongxia; Wang, Chunmei; Li, Yixuan; Liu, Min; Tang, Hua			MiR-23a Facilitates the Replication of HSV-1 through the Suppression of Interferon Regulatory Factor 1	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; EPITHELIAL-MESENCHYMAL TRANSITION; REAL-TIME PCR; TRANSCRIPTION FACTOR; ANTIVIRAL DEFENSE; CANCER CELLS; IFN-BETA; MICRORNAS TARGET; INDUCIBLE GENES; DOWN-REGULATION	MicroRNAs (miRNAs) are small, non-coding RNAs that negatively regulate gene expression. It has been reported that miRNAs are involved in host-virus interaction, but evidence that cellular miRNAs promote virus replication has been limited. Here, we found that miR-23a promoted the replication of human herpes simplex virus type 1 (HSV-1) in HeLa cells, as demonstrated by a plaque-formation assay and quantitative real-time PCR. Furthermore, interferon regulatory factor 1 (IRF1), an innate antiviral molecule, is targeted by miR-23a to facilitate viral replication. MiR-23a binds to the 3'UTR of IRF1 and down-regulates its expression. Suppression of IRF1 expression reduced RSAD2 gene expression, augmenting HSV-1 replication. Ectopic expression of IRF1 abrogated the promotion of HSV-1 replication induced by miR-23a. Notably, IRF1 contributes to innate antiviral immunity by binding to IRF-response elements to regulate the expression of interferon-stimulated genes (ISGs) and apoptosis, revealing a complex interaction between miR-23a and HSV-1. MiR-23a thus contributes to HSV-1 replication through the regulation of the IRF1-mediated antiviral signal pathway, which suggests that miR-23a may represent a promising target for antiviral treatments.	[Ru, Jing; Sun, Huahui; Fan, Hongxia; Wang, Chunmei; Li, Yixuan; Liu, Min; Tang, Hua] Tianjin Med Univ, Sch Basic Med Sci, Tianjin Life Sci Res Ctr, Tianjin 300070, Peoples R China; [Ru, Jing; Sun, Huahui; Fan, Hongxia; Wang, Chunmei; Li, Yixuan; Liu, Min; Tang, Hua] Tianjin Med Univ, Sch Basic Med Sci, Dept Microbiol, Tianjin 300070, Peoples R China; [Ru, Jing] Yunnan Univ Tradit Chinese Med, Sch Basic Med Sci, Dept Pathophysiol, Kunming 650500, Peoples R China	Tianjin Medical University; Tianjin Medical University; Yunnan University of Chinese Medicine	Tang, H (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Tianjin Life Sci Res Ctr, Tianjin 300070, Peoples R China.	htang2002@yahoo.com	li, yixuan/P-5376-2016		National Natural Science Foundation of China [31100933, 31270818, 91029714, 31071191, 81201281/H1904]; Natural Science Foundation of Tianjin [12JCZDJC25100, 09JCZDJC17500]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin(Natural Science Foundation of Tianjin)	This work was supported by the National Natural Science Foundation of China (No: 31100933; 31270818; 91029714; 31071191; 81201281/H1904), and the Natural Science Foundation of Tianjin (No: 12JCZDJC25100; 09JCZDJC17500).	An J, 2013, J CELL BIOCHEM, V114, P2160, DOI 10.1002/jcb.24565; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Boudinot P, 1999, J VIROL, V73, P1846, DOI 10.1128/JVI.73.3.1846-1852.1999; Bryant HE, 2001, J VIROL, V75, P4376, DOI 10.1128/JVI.75.9.4376-4385.2001; Cao MR, 2012, INT J ONCOL, V41, P869, DOI 10.3892/ijo.2012.1535; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; FUJITA T, 1988, EMBO J, V7, P3397, DOI 10.1002/j.1460-2075.1988.tb03213.x; FUJITA T, 1989, NATURE, V337, P270, DOI 10.1038/337270a0; Guo XK, 2013, J VIROL, V87, P1159, DOI 10.1128/JVI.02386-12; Guo Z, 2013, J DERMATOL SCI, V69, P68, DOI 10.1016/j.jdermsci.2012.10.014; Havelange V, 2011, CANCER-AM CANCER SOC, V117, P4696, DOI 10.1002/cncr.26096; Hong S, 2013, J BIOL CHEM, V288, P3560, DOI 10.1074/jbc.M112.400408; Jahid S, 2012, CANCER DISCOV, V2, P540, DOI 10.1158/2159-8290.CD-11-0267; Jopling CL, 2008, CELL HOST MICROBE, V4, P77, DOI 10.1016/j.chom.2008.05.013; Kanazawa N, 2004, J VIROL, V78, P9713, DOI 10.1128/JVI.78.18.9713-9720.2004; Koller K, 2013, GENE CHROMOSOME CANC, V52, P709, DOI 10.1002/gcc.22066; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lian J, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.70; Lian SZ, 2013, CURR PHARM DESIGN, V19, P6382; Liu XF, 2013, UNIVERSITAS-TAIWAN, V40, P1; Loveday EK, 2012, J VIROL, V86, P6109, DOI 10.1128/JVI.06892-11; Matzinger SR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029255; Nachmani D, 2009, CELL HOST MICROBE, V5, P376, DOI 10.1016/j.chom.2009.03.003; Nicoll MP, 2012, FEMS MICROBIOL REV, V36, P684, DOI 10.1111/j.1574-6976.2011.00320.x; Ning YX, 2010, MOL CANCER THER, V9, P1274, DOI 10.1158/1535-7163.MCT-09-1169; Nystrom K, 2004, J VIROL METHODS, V118, P83, DOI 10.1016/j.jviromet.2004.01.019; PINE R, 1992, J VIROL, V66, P4470, DOI 10.1128/JVI.66.7.4470-4478.1992; REIS LFL, 1992, EMBO J, V11, P185, DOI 10.1002/j.1460-2075.1992.tb05041.x; Ruan W, 2012, CARDIOVASC RES, V93, P623, DOI 10.1093/cvr/cvr290; Sanfilippo CM, 2006, J VIROL, V80, P6810, DOI 10.1128/JVI.00334-06; Saumet A, 2012, MOL BIOSYST, V8, P3242, DOI 10.1039/c2mb25298h; SCHMIDT OW, 1979, J CLIN MICROBIOL, V9, P722; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Shen GH, 2014, J VIROL, V88, P12163, DOI 10.1128/JVI.01380-14; Singh CP, 2012, J VIROL, V86, P7867, DOI 10.1128/JVI.00064-12; Spear PG, 2003, J VIROL, V77, P10179, DOI 10.1128/JVI.77.19.10179-10185.2003; Stirnweiss A, 2010, J IMMUNOL, V184, P5179, DOI 10.4049/jimmunol.0902264; Su RC, 2011, BLOOD, V117, P2649, DOI 10.1182/blood-2010-10-312462; Takaoka A, 2003, NATURE, V424, P516, DOI 10.1038/nature01850; Tan XC, 2012, P NATL ACAD SCI USA, V109, P15805, DOI 10.1073/pnas.1207787109; Ueki IF, 2013, J EXP MED, V210, P1929, DOI 10.1084/jem.20121401; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Wang B, 2012, HEPATOLOGY, V56, P186, DOI 10.1002/hep.25632; Weidmann M, 2003, J CLIN MICROBIOL, V41, P1565, DOI 10.1128/JCM.41.4.1565-1568.2003; Yan Y, 2013, HEPATOLOGY, V57, P667, DOI 10.1002/hep.26071; Yang XK, 2012, REPRODUCTION, V144, P235, DOI 10.1530/REP-11-0371; Zheng SQ, 2011, ANTIVIR RES, V89, P219, DOI 10.1016/j.antiviral.2011.01.008; Zhu LH, 2010, FEBS J, V277, P3726, DOI 10.1111/j.1742-4658.2010.07773.x	51	45	48	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114021	10.1371/journal.pone.0114021	http://dx.doi.org/10.1371/journal.pone.0114021			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461762	Green Published, Green Submitted, gold			2022-12-26	WOS:000345869700083
J	Vielma, AH; Agurto, A; Valdes, J; Palacios, AG; Schmachtenberg, O				Vielma, Alex H.; Agurto, Adolfo; Valdes, Joaquin; Palacios, Adrian G.; Schmachtenberg, Oliver			Nitric Oxide Modulates the Temporal Properties of the Glutamate Response in Type 4 OFF Bipolar Cells	PLOS ONE			English	Article							SYNTHASE-IMMUNOREACTIVE NEURONS; AMINOBUTYRIC-ACID RELEASE; RETINAL GANGLION-CELLS; CGMP-DEPENDENT KINASE; INNER PLEXIFORM LAYER; MOUSE RETINA; RAT RETINA; KAINATE RECEPTORS; MAMMALIAN RETINA; S-NITROSYLATION	Nitric oxide (NO) is involved in retinal signal processing, but its cellular actions are only partly understood. An established source of retinal NO are NOACs, a group of nNOS-expressing amacrine cells which signal onto bipolar, other amacrine and ganglion cells in the inner plexiform layer. Here, we report that NO regulates glutamate responses in morphologically and electrophysiologically identified type 4 OFF cone bipolar cells through activation of the soluble guanylyl cyclase-cGMP-PKG pathway. The glutamate response of these cells consists of two components, a fast phasic current sensitive to kainate receptor agonists, and a secondary component with slow kinetics, inhibited by AMPA receptor antagonists. NO shortened the duration of the AMPA receptor-dependent component of the glutamate response, while the kainate receptor-dependent component remained unchanged. Application of 8-Br-cGMP mimicked this effect, while inhibition of soluble guanylate cyclase or protein kinase G prevented it, supporting a mechanism involving a cGMP signaling pathway. Notably, perfusion with a NOS-inhibitor prolonged the duration of the glutamate response, while the NO precursor L-arginine shortened it, in agreement with a modulation by endogenous NO. Furthermore, NO accelerated the response recovery during repeated stimulation of type 4 cone bipolar cells, suggesting that the temporal response properties of this OFF bipolar cell type are regulated by NO. These results reveal a novel cellular mechanism of NO signaling in the retina, and represent the first functional evidence of NO modulating OFF cone bipolar cells.	[Vielma, Alex H.; Agurto, Adolfo; Valdes, Joaquin; Palacios, Adrian G.; Schmachtenberg, Oliver] Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso, Chile	Universidad de Valparaiso	Vielma, AH (corresponding author), Univ Valparaiso, Fac Ciencias, Ctr Interdisciplinario Neurociencia Valparaiso, Valparaiso, Chile.	alexvielma@gmail.com	Valdés, Joaquín/O-8478-2019; Palacios, Adrian G/E-9846-2015	Valdés, Joaquín/0000-0003-3222-8440; Palacios, Adrian G/0000-0003-1532-7527; Schmachtenberg, Oliver/0000-0001-7854-5009	CONICYT, Chile [1120513, 3140599]; Millennium Institute Centro Interdisciplinario de Neurociencia de Valparaiso [P09-022-F]	CONICYT, Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Millennium Institute Centro Interdisciplinario de Neurociencia de Valparaiso	Regular FONDECYT grant 1120513 from CONICYT, Chile (to OS), Postdoctoral FONDECYT grant 3140599 from CONICYT, Chile (to AHV) and Millennium Institute Centro Interdisciplinario de Neurociencia de Valparaiso P09-022-F from ICM-1114 ECONOMIA, Chile. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMAD I, 1994, NEURON, V12, P155, DOI 10.1016/0896-6273(94)90160-0; Arman AC, 2012, J NEUROPHYSIOL, V107, P2649, DOI 10.1152/jn.01202.2011; Baden T, 2013, CURR BIOL, V23, P48, DOI 10.1016/j.cub.2012.11.006; Baldridge WH, 2001, VISUAL NEUROSCI, V18, P849, DOI 10.1017/S0952523801186013; Blom J, 2012, J COMP NEUROL, V520, P4204, DOI 10.1002/cne.23148; Blute TA, 2000, VISUAL NEUROSCI, V17, P557, DOI 10.1017/S0952523800174061; Blute TA, 1998, VISUAL NEUROSCI, V15, P485; Borda E, 2005, EXP EYE RES, V80, P391, DOI 10.1016/j.exer.2004.09.016; Borghuis BG, 2014, J NEUROSCI, V34, P6128, DOI 10.1523/JNEUROSCI.4941-13.2014; Cao LX, 2001, VISUAL NEUROSCI, V18, P949, DOI 10.1017/S0952523801186128; da Costa BLDA, 2001, NEUROSCI LETT, V302, P21; DeVries SH, 1999, NATURE, V397, P157, DOI 10.1038/16462; DeVries SH, 2000, NEURON, V28, P847, DOI 10.1016/S0896-6273(00)00158-6; Ding JD, 2007, J COMP NEUROL, V500, P734, DOI 10.1002/cne.21206; Donevan SD, 1998, J PHARMACOL EXP THER, V285, P539; Euler T, 1996, J NEUROSCI, V16, P2934; Euler T, 1998, J NEUROPHYSIOL, V79, P1384, DOI 10.1152/jn.1998.79.3.1384; Euler T, 2014, NAT REV NEUROSCI, V15, P507, DOI 10.1038/nrn3783; Garthwaite J, 2005, FRONT BIOSCI-LANDMRK, V10, P1868; Garthwaite J, 2008, EUR J NEUROSCI, V27, P2783, DOI 10.1111/j.1460-9568.2008.06285.x; Ghosh KK, 2004, J COMP NEUROL, V469, P70, DOI 10.1002/cne.10985; Giove TJ, 2009, J NEUROSCI RES, V87, P3134, DOI 10.1002/jnr.22133; Gotzes S, 1998, VISUAL NEUROSCI, V15, P945, DOI 10.1017/S0952523898155141; Hartveit E, 1997, J NEUROPHYSIOL, V77, P1716, DOI 10.1152/jn.1997.77.4.1716; Haverkamp S, 1998, NEUROREPORT, V9, P2231, DOI 10.1097/00001756-199807130-00015; Haverkamp S, 2003, J COMP NEUROL, V455, P463, DOI 10.1002/cne.10491; Haverkamp S, 2008, J COMP NEUROL, V507, P1087, DOI 10.1002/cne.21612; Helmstaedter M, 2013, NATURE, V500, P168, DOI 10.1038/nature12346; Hess DT, 2012, J BIOL CHEM, V287, P4411, DOI 10.1074/jbc.R111.285742; Hess DT, 2005, NAT REV MOL CELL BIO, V6, P150, DOI 10.1038/nrm1569; Hilgen G, 2011, J COMP NEUROL, V519, P433, DOI 10.1002/cne.22526; Hofmann F, 2006, PHYSIOL REV, V86, P1, DOI 10.1152/physrev.00015.2005; Ivanova E, 2006, EUR J NEUROSCI, V23, P350, DOI 10.1111/j.1460-9568.2005.04557.x; Ivanova E, 2006, VISUAL NEUROSCI, V23, P143, DOI 10.1017/S0952523806232048; Jane DE, 2009, NEUROPHARMACOLOGY, V56, P90, DOI 10.1016/j.neuropharm.2008.08.023; Johansson K, 2000, INVEST OPHTH VIS SCI, V41, P305; Kaupp UB, 2002, PHYSIOL REV, V82, P769, DOI 10.1152/physrev.00008.2002; Kim IB, 1999, NEUROSCI LETT, V267, P193, DOI 10.1016/S0304-3940(99)00363-8; Kim IB, 2000, MICROSC RES TECHNIQ, V50, P112, DOI 10.1002/1097-0029(20000715)50:2<112::AID-JEMT3>3.0.CO;2-S; KOISTINAHO J, 1993, NEUROSCIENCE, V57, P587, DOI 10.1016/0306-4522(93)90008-4; Li W, 2010, NAT NEUROSCI, V13, P414, DOI 10.1038/nn.2507; Lindstrom SH, 2014, J PHYSIOL-LONDON, V592, P1457, DOI 10.1113/jphysiol.2013.265033; Lu Q, 2009, NEUROSCIENCE, V163, P662, DOI 10.1016/j.neuroscience.2009.07.002; MAGUIRE G, 1994, J NEUROSCI, V14, P6094; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; Mastrodimou N, 2006, REGUL PEPTIDES, V133, P41, DOI 10.1016/j.regpep.2005.09.034; MILLS SL, 1995, NATURE, V377, P734, DOI 10.1038/377734a0; Miyagi M, 2002, MOL CELL PROTEOMICS, V1, P293, DOI 10.1074/mcp.M100034-MCP200; Oh SJ, 1999, CELL TISSUE RES, V297, P397, DOI 10.1007/s004410051367; Pang JJ, 2010, J COMP NEUROL, V518, P2456, DOI 10.1002/cne.22347; PATERNAIN AV, 1995, NEURON, V14, P185, DOI 10.1016/0896-6273(95)90253-8; PEREZ MTR, 1995, EXP BRAIN RES, V104, P207; Puller C, 2013, NEUROSCIENCE, V243, P136, DOI 10.1016/j.neuroscience.2013.03.054; SAITO T, 1983, J GEN PHYSIOL, V81, P589, DOI 10.1085/jgp.81.4.589; Savchenko A, 1997, NATURE, V390, P694, DOI 10.1038/37803; Snellman J, 2004, J NEUROSCI, V24, P6621, DOI 10.1523/JNEUROSCI.1474-04.2004; Tooker RE, 2013, J NEUROSCI, V33, P19176, DOI 10.1523/JNEUROSCI.2792-13.2013; Vielma A, 2010, EXP EYE RES, V91, P700, DOI 10.1016/j.exer.2010.08.014; Vielma AH, 2012, BRAIN RES, V1430, P112, DOI 10.1016/j.brainres.2011.10.045; Wassle H, 2009, J NEUROSCI, V29, P106, DOI 10.1523/JNEUROSCI.4442-08.2009; Walter LT, 2014, EXP NEUROL, V261, P510, DOI 10.1016/j.expneurol.2014.07.019; Wang GY, 2003, J NEUROPHYSIOL, V90, P1304, DOI 10.1152/jn.00243.2003; Wexler EM, 1998, J NEUROSCI, V18, P2342; Yu D, 2005, J COMP NEUROL, V483, P278, DOI 10.1002/cne.20416	64	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114330	10.1371/journal.pone.0114330	http://dx.doi.org/10.1371/journal.pone.0114330			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463389	Green Submitted, Green Published, gold			2022-12-26	WOS:000345869700129
J	Wong, KK; Shi, JR; Gao, HJ; Zheteyeva, YA; Lane, K; Copeland, D; Hendricks, J; McMurray, L; Sliger, K; Rainey, JJ; Uzicanin, A				Wong, Karen K.; Shi, Jianrong; Gao, Hongjiang; Zheteyeva, Yenlik A.; Lane, Kimberly; Copeland, Daphne; Hendricks, Jennifer; McMurray, LaFrancis; Sliger, Kellye; Rainey, Jeanette J.; Uzicanin, Amra			Why Is School Closed Today? Unplanned K-12 School Closures in the United States, 2011-2013	PLOS ONE			English	Article							INFLUENZA-A H1N1; PANDEMIC INFLUENZA; OUTBREAK; LESSONS; SANDY	Introduction: We describe characteristics of unplanned school closures (USCs) in the United States over two consecutive academic years during a non-pandemic period to provide context for implementation of school closures during a pandemic. Methods: From August 1, 2011 through June 30, 2013, daily systematic internet searches were conducted for publicly announced USCs lasting >= 1 day. The reason for closure and the closure dates were recorded. Information on school characteristics was obtained from the National Center for Education Statistics. Results: During the two-year study period, 20,723 USCs were identified affecting 27,066,426 students. Common causes of closure included weather (79%), natural disasters (14%), and problems with school buildings or utilities (4%). Only 771 (4%) USCs lasted >= 4 school days. Illness was the cause of 212 (1%) USCs; of these, 126 (59%) were related to respiratory illnesses and showed seasonal variation with peaks in February 2012 and January 2013. Conclusions: USCs are common events resulting in missed school days for millions of students. Illness causes few USCs compared with weather and natural disasters. Few communities have experience with prolonged closures for illness.	[Wong, Karen K.; Shi, Jianrong; Gao, Hongjiang; Zheteyeva, Yenlik A.; Copeland, Daphne; Rainey, Jeanette J.; Uzicanin, Amra] Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA; [Lane, Kimberly] Chenega Govt Consulting, Chesapeake, VA USA; [Hendricks, Jennifer; McMurray, LaFrancis; Sliger, Kellye] Oak Ridge Associated Univ, Oak Ridge, TN USA	Centers for Disease Control & Prevention - USA; United States Department of Energy (DOE); Oak Ridge National Laboratory	Uzicanin, A (corresponding author), Ctr Dis Control & Prevent, Div Global Migrat & Quarantine, Atlanta, GA 30333 USA.	auzicanin@cdc.gov		Wong, Karen/0000-0002-5287-6456	United States Centers for Disease Control and Prevention	United States Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by the United States Centers for Disease Control and Prevention (http://www.cdc.gov/). Several co-authors are or were employees (KW HG YZ DC JR AU) or contractors (JS KL) of the US CDC at the time of the study, and their roles in the study design, data collection and analysis, decision to publish, and preparation of the manuscript are described in the Author Contributions.	Awofisayo A, 2013, PUBLIC HEALTH, V127, P637, DOI 10.1016/j.puhe.2013.04.014; Behr JG, 2013, J PUBLIC HEALTH MAN, V19, pS55, DOI 10.1097/PHH.0b013e318297226a; Berg R., 2013, TROPICAL CYCLONE REP; Bivand R, 2013, RGDAL BINDINGS GEOSP; Bivand RS, 2008, USE R, P1; Casey-Lockyer M, 2013, MMWR-MORBID MORTAL W, V62, P393; Centers for Disease Control and Prevention, 2007, INT PREP PLANN GUID; Centers for Disease Control and Prevention FluView, FLUVIEW INFL LIK ILL; Community Preventive Services Task Force, 2012, EM PREP RESP SCH DIS; Effler PV, 2010, EMERG INFECT DIS, V16, P205, DOI 10.3201/eid1602.091372; GLEZEN WP, 1978, NEW ENGL J MED, V298, P587, DOI 10.1056/NEJM197803162981103; Hansen B, 2008, SCH YEAR LENGT UNPUB; Jackson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097297; Johnson AJ, 2008, EMERG INFECT DIS, V14, P1024, DOI 10.3201/eid1407.080096; Kann L, 2012, DISASTER MED PUBLIC, V6, P104, DOI 10.1001/dmp.2012.13; Lessler J, 2009, NEW ENGL J MED, V361, P2628, DOI 10.1056/NEJMoa0906089; Marchbanks TL, 2011, CLIN INFECT DIS, V52, pS154, DOI 10.1093/cid/ciq058; Marcotte DE, 2007, ECON EDUC REV, V26, P629, DOI 10.1016/j.econedurev.2006.08.001; Marcotte DE, 2008, EDUC FINANC POLICY, V3, P316, DOI 10.1162/edfp.2008.3.3.316; National Center for Education Statistics, 2011, COMM COR DAT PUBL SC; National Weather Service Forecast Office, 2014, SNOWF INF MAPS; Pebesma E., 2005, R NEWS, V5, P9; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Redlener I, 2012, NEW ENGL J MED, V367, P2269, DOI 10.1056/NEJMp1213486; Steelfisher G. K., 2010, Morbidity and Mortality Weekly Report, V59, P1131; SteelFisher GK, 2012, LANCET INFECT DIS, V12, P845, DOI 10.1016/S1473-3099(12)70206-2; Sugisaki K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074716; Timperio C. G., 2009, Morbidity and Mortality Weekly Report, V58, P1405; Viboud C, 2004, BRIT J GEN PRACT, V54, P684	29	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113755	10.1371/journal.pone.0113755	http://dx.doi.org/10.1371/journal.pone.0113755			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463353	Green Published, Green Submitted, gold			2022-12-26	WOS:000345869700049
J	Skrastina, D; Petrovskis, I; Lieknina, I; Bogans, J; Renhofa, R; Ose, V; Dishlers, A; Dekhtyar, Y; Pumpens, P				Skrastina, Dace; Petrovskis, Ivars; Lieknina, Ilva; Bogans, Janis; Renhofa, Regina; Ose, Velta; Dishlers, Andris; Dekhtyar, Yuri; Pumpens, Paul			Silica Nanoparticles as the Adjuvant for the Immunisation of Mice Using Hepatitis B Core Virus-Like Particles	PLOS ONE			English	Article							ALUMINUM-HYDROXIDE; INTERSTITIAL FLUID; IMMUNE-RESPONSE; ANTIGEN; VACCINE; ANTIBODY; CELLS; PROTEIN; ADSORPTION; TOXICITY	Advances in nanotechnology and nanomaterials have facilitated the development of silicon dioxide, or Silica, particles as a promising immunological adjuvant for the generation of novel prophylactic and therapeutic vaccines. In the present study, we have compared the adjuvanting potential of commercially available Silica nanoparticles (initial particles size of 10-20 nm) with that of aluminium hydroxide, or Alum, as well as that of complete and incomplete Freund's adjuvants for the immunisation of BALB/c mice with virus-like particles (VLPs) formed by recombinant full-length Hepatitis B virus core (HBc) protein. The induction of B-cell and T-cell responses was studied after immunisation. Silica nanoparticles were able to adsorb maximally 40% of the added HBc, whereas the adsorption capacity of Alum exceeded 90% at the same VLPs/adjuvant ratio. Both Silica and Alum formed large complexes with HBc VLPs that sedimented rapidly after formulation, as detected by dynamic light scattering, spectrophotometry, and electron microscopy. Both Silica and Alum augmented the humoral response against HBc VLPs to the high anti-HBc level in the case of intraperitoneal immunisation, whereas in subcutaneous immunisation, the Silica-adjuvanted anti-HBc level even exceeded the level adjuvanted by Alum. The adjuvanting of HBc VLPs by Silica resulted in the same typical IgG2a/IgG1 ratios as in the case of the adjuvanting by Alum. The combination of Silica with monophosphoryl lipid A (MPL) led to the same enhancement of the HBc-specific T-cell induction as in the case of the Alum and MPL combination. These findings demonstrate that Silica is not a weaker putative adjuvant than Alum for induction of B-cell and T-cell responses against recombinant HBc VLPs. This finding may have an essential impact on the development of the set of Silica-adjuvanted vaccines based on a long list of HBc-derived virus-like particles as the biological component.	[Skrastina, Dace; Petrovskis, Ivars; Lieknina, Ilva; Bogans, Janis; Renhofa, Regina; Ose, Velta; Dishlers, Andris; Pumpens, Paul] Latvian Biomed Res & Study Ctr, Riga, Latvia; [Dekhtyar, Yuri] Riga Tech Univ, Inst Biomed Engn & Nanotechnol, Riga, Latvia	Latvian Biomedical Research & Study Centre; Riga Technical University	Skrastina, D (corresponding author), Latvian Biomed Res & Study Ctr, Riga, Latvia.	daceskr@biomed.lu.lv	Pumpens, Paul/A-2163-2008	Dishlers, Andris/0000-0002-0112-3948; Petrovskis, Ivars/0000-0002-1382-3466	ERDF [2013/0053/2DP/2.1.1.1.0/13/APIA/VIAA/006]	ERDF(European Commission)	This work was supported by ERDF 2013/0053/2DP/2.1.1.1.0/13/APIA/VIAA/006 (http://biomed.lu.lv/en/research/projects/all-projects/technology-to-obtain-high-quality-virus-like-nanostructures-based-on-hbv-core-antigen/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batista-Duharte A, 2011, TOXICOL LETT, V203, P97, DOI 10.1016/j.toxlet.2011.03.001; BICHKO V, 1985, FEBS LETT, V185, P208, DOI 10.1016/0014-5793(85)80771-7; Blumen SR, 2007, AM J RESP CELL MOL, V36, P333, DOI 10.1165/rcmb.2006-0319OC; Cao TH, 2001, J VIROL, V75, P6359, DOI 10.1128/JVI.75.14.6359-6366.2001; Carvalho LV, 2010, VACCINE, V28, P7829, DOI 10.1016/j.vaccine.2010.09.087; Chang MF, 2001, VACCINE, V19, P2884, DOI 10.1016/S0264-410X(00)00559-4; CHISARI FV, 1995, ANNU REV IMMUNOL, V13, P29, DOI 10.1146/annurev.iy.13.040195.000333; Cielens I, 2014, MOL BIOTECHNOL, V56, P459, DOI 10.1007/s12033-014-9743-3; COLLIER LH, 1979, LANCET, V1, P1364; CROWTHER RA, 1994, CELL, V77, P943, DOI 10.1016/0092-8674(94)90142-2; De Gregorio E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00214; Dekhtyar Yu, 2012, INORGANIC NANOPARTIC; Delany I, 2014, EMBO MOL MED, V6, P708, DOI 10.1002/emmm.201403876; Faquim-Mauro EL, 2000, INT IMMUNOL, V12, P1733, DOI 10.1093/intimm/12.12.1733; FROST L, 1985, ALLERGY, V40, P368, DOI 10.1111/j.1398-9995.1985.tb00249.x; Giannini SL, 2006, VACCINE, V24, P5937, DOI 10.1016/j.vaccine.2006.06.005; Glenny AT, 1921, J HYG-CAMBRIDGE, V20, P176, DOI 10.1017/S0022172400033945; GUPTA RK, 1993, VACCINE, V11, P293, DOI 10.1016/0264-410X(93)90190-9; Han B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017236; HOFFNAGLE JH, 1973, LANCET, V2, P869; Jones LS, 2005, J BIOL CHEM, V280, P13406, DOI 10.1074/jbc.M500687200; Klingstrom J, 2004, VACCINE, V22, P4029, DOI 10.1016/j.vaccine.2004.03.045; Lincopan N, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-5; Liu TL, 2013, J COLLOID INTERF SCI, V400, P168, DOI 10.1016/j.jcis.2013.03.005; Mahony D, 2013, SMALL, V9, P3138, DOI 10.1002/smll.201300012; MANCINO D, 1980, INT ARCH ALLER A IMM, V61, P253, DOI 10.1159/000232443; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; Mendez IZR, 2007, VACCINE, V25, P825, DOI 10.1016/j.vaccine.2006.09.039; Mercuri LP, 2006, SMALL, V2, P254, DOI 10.1002/smll.200500274; MILICH DR, 1986, SCIENCE, V234, P1398, DOI 10.1126/science.3491425; Milich DR, 1997, P NATL ACAD SCI USA, V94, P14648, DOI 10.1073/pnas.94.26.14648; MILICH DR, 1995, J VIROL, V69, P2776, DOI 10.1128/JVI.69.5.2776-2785.1995; MONDELLI M, 1982, J IMMUNOL, V129, P2773; Morefield GL, 2005, VACCINE, V23, P1588, DOI 10.1016/j.vaccine.2004.07.050; Morefield GL, 2004, VACCINE, V22, P1973, DOI 10.1016/j.vaccine.2003.10.040; Pumpens P, 2001, INTERVIROLOGY, V44, P98, DOI 10.1159/000050037; Pumpens Paul, 2009, P205; Pushko P, 2013, INTERVIROLOGY, V56, P141, DOI 10.1159/000346773; Rappuoli R, 2011, NAT REV IMMUNOL, V11, P865, DOI 10.1038/nri3085; Rehermann B, 1996, NAT MED, V2, P1104, DOI 10.1038/nm1096-1104; Riedl P, 2002, J IMMUNOL, V168, P4951, DOI 10.4049/jimmunol.168.10.4951; Roseman AM, 2012, J MOL BIOL, V423, P63, DOI 10.1016/j.jmb.2012.06.032; Sayers S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/831486; Schwarz TF, 2008, EXPERT REV VACCINES, V7, P1465, DOI 10.1586/14760584.7.10.1465; Sominskaya I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075938; Stephens P, 2014, VACCINE, V32, P2139, DOI 10.1016/j.vaccine.2014.02.047; Vallhov H, 2007, NANO LETT, V7, P3576, DOI [10.1021/nl0714785, 10.1021/nI0714785]; Vallhov H, 2012, SMALL, V8, P2116, DOI 10.1002/smll.201102620; Wang J, 2014, BIOMATERIALS, V35, P466, DOI 10.1016/j.biomaterials.2013.09.060; Wang XP, 2013, ACTA BIOMATER, V9, P7480, DOI 10.1016/j.actbio.2013.03.031; Whitacre DC, 2009, EXPERT REV VACCINES, V8, P1565, DOI 10.1586/ERV.09.121; Wibowo N, 2014, VACCINE, V32, P3664, DOI 10.1016/j.vaccine.2014.04.043; WINGFIELD PT, 1995, BIOCHEMISTRY-US, V34, P4919, DOI 10.1021/bi00015a003; Wolff L, 2009, VACCINE, V27, P1834, DOI 10.1016/j.vaccine.2009.01.037; Wynne SA, 1999, MOL CELL, V3, P771, DOI 10.1016/S1097-2765(01)80009-5; Zlotnick A, 1996, BIOCHEMISTRY-US, V35, P7412, DOI 10.1021/bi9604800	56	30	32	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114006	10.1371/journal.pone.0114006	http://dx.doi.org/10.1371/journal.pone.0114006			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436773	Green Published, gold, Green Submitted			2022-12-26	WOS:000347114900109
J	James, KA; Verkhivker, GM				James, Kevin A.; Verkhivker, Gennady M.			Structure-Based Network Analysis of Activation Mechanisms in the ErbB Family of Receptor Tyrosine Kinases: The Regulatory Spine Residues Are Global Mediators of Structural Stability and Allosteric Interactions	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; MOLECULAR-DYNAMICS SIMULATION; FREE-ENERGY LANDSCAPE; EGF RECEPTOR; ONCOGENIC MUTATIONS; PROTEIN-KINASES; LUNG-CANCER; CATALYTIC SUBUNIT; SOMATIC MUTATIONS; DOMAIN	The ErbB protein tyrosine kinases are among the most important cell signaling families and mutation-induced modulation of their activity is associated with diverse functions in biological networks and human disease. We have combined molecular dynamics simulations of the ErbB kinases with the protein structure network modeling to characterize the reorganization of the residue interaction networks during conformational equilibrium changes in the normal and oncogenic forms. Structural stability and network analyses have identified local communities integrated around high centrality sites that correspond to the regulatory spine residues. This analysis has provided a quantitative insight to the mechanism of mutation-induced "superacceptor'' activity in oncogenic EGFR dimers. We have found that kinase activation may be determined by allosteric interactions between modules of structurally stable residues that synchronize the dynamics in the nucleotide binding site and the alpha C-helix with the collective motions of the integrating alpha F-helix and the substrate binding site. The results of this study have pointed to a central role of the conserved His-Arg-Asp (HRD) motif in the catalytic loop and the Asp-Phe-Gly (DFG) motif as key mediators of structural stability and allosteric communications in the ErbB kinases. We have determined that residues that are indispensable for kinase regulation and catalysis often corresponded to the high centrality nodes within the protein structure network and could be distinguished by their unique network signatures. The optimal communication pathways are also controlled by these nodes and may ensure efficient allosteric signaling in the functional kinase state. Structure-based network analysis has quantified subtle effects of ATP binding on conformational dynamics and stability of the EGFR structures. Consistent with the NMR studies, we have found that nucleotide-induced modulation of the residue interaction networks is not limited to the ATP site, and may enhance allosteric cooperativity with the substrate binding region by increasing communication capabilities of mediating residues.	[James, Kevin A.; Verkhivker, Gennady M.] Chapman Univ, Sch Computat Sci, Schmid Coll Sci & Technol, Orange, CA 92866 USA; [James, Kevin A.; Verkhivker, Gennady M.] Chapman Univ, Crean Sch Hlth & Life Sci, Schmid Coll Sci & Technol, Orange, CA USA; [Verkhivker, Gennady M.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA	Chapman University System; Chapman University; Chapman University System; Chapman University; University of California System; University of California San Diego	Verkhivker, GM (corresponding author), Chapman Univ, Sch Computat Sci, Schmid Coll Sci & Technol, Orange, CA 92866 USA.	verkhivk@chapman.edu	Verkhivker, Gennady/V-9404-2018	Verkhivker, Gennady/0000-0002-4507-4471	Chapman University	Chapman University	This work is supported by funding from Chapman University. No additional external was funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcsek B, 2006, BIOINFORMATICS, V22, P1021, DOI 10.1093/bioinformatics/btl039; Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Amitai G, 2004, J MOL BIOL, V344, P1135, DOI 10.1016/j.jmb.2004.10.055; Arkhipov A, 2013, CELL, V152, P557, DOI 10.1016/j.cell.2012.12.030; Artim SC, 2012, BIOCHEM J, V448, P213, DOI 10.1042/BJ20121365; Atilgan AR, 2004, BIOPHYS J, V86, P85, DOI 10.1016/S0006-3495(04)74086-2; Azam M, 2008, NAT STRUCT MOL BIOL, V15, P1109, DOI 10.1038/nsmb.1486; Bae JH, 2010, MOL CELLS, V29, P443, DOI 10.1007/s10059-010-0080-5; Bagler G, 2007, BIOINFORMATICS, V23, P1760, DOI 10.1093/bioinformatics/btm257; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharyya M, 2011, BIOCHEMISTRY-US, V50, P6225, DOI 10.1021/bi200306u; Borgatti SP, 2006, SOC NETWORKS, V28, P466, DOI 10.1016/j.socnet.2005.11.005; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Brinda KV, 2005, BIOPHYS J, V89, P4159, DOI 10.1529/biophysj.105.064485; Carey KD, 2006, CANCER RES, V66, P8163, DOI 10.1158/0008-5472.CAN-06-0453; Cembran A, 2014, PHYS CHEM CHEM PHYS, V16, P6508, DOI 10.1039/c4cp00110a; Cembran A, 2012, BIOCHEMISTRY-US, V51, P10186, DOI 10.1021/bi301279f; Colizza V, 2006, NAT PHYS, V2, P110, DOI 10.1038/nphys209; Dar AC, 2011, ANNU REV BIOCHEM, V80, P769, DOI 10.1146/annurev-biochem-090308-173656; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dawson JP, 2007, STRUCTURE, V15, P942, DOI 10.1016/j.str.2007.06.013; del Sol A, 2006, PROTEIN SCI, V15, P2120, DOI 10.1110/ps.062249106; Dixit A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037605; Dixit A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002179; Dixit A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000487; Eck MJ, 2010, BBA-PROTEINS PROTEOM, V1804, P559, DOI 10.1016/j.bbapap.2009.12.010; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Endres NF, 2013, CELL, V152, P543, DOI 10.1016/j.cell.2012.12.032; Falsone SF, 2004, J MOL BIOL, V344, P281, DOI 10.1016/j.jmb.2004.08.091; Fan YX, 2008, J BIOL CHEM, V283, P1588, DOI 10.1074/jbc.M708116200; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; FLOYD RW, 1962, COMMUN ACM, V5, P345, DOI 10.1145/367766.368168; Fraczkiewicz R, 1998, J COMPUT CHEM, V19, P319, DOI 10.1002/(SICI)1096-987X(199802)19:3<319::AID-JCC6>3.0.CO;2-W; Gajiwala KS, 2013, STRUCTURE, V21, P209, DOI 10.1016/j.str.2012.11.014; Gasper PM, 2012, P NATL ACAD SCI USA, V109, P21216, DOI 10.1073/pnas.1218414109; Ghosh A, 2011, J BIOL CHEM, V286, P37721, DOI 10.1074/jbc.M111.246702; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Gromiha MM, 2004, PROTEINS, V55, P316, DOI 10.1002/prot.20052; Hagberg A, 2008, 7 PYTH SCI C SCIPY20, V7, P11, DOI DOI 10.25080/ISSN.2575-9752; Hao DP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028322; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jura N, 2011, MOL CELL, V42, P9, DOI 10.1016/j.molcel.2011.03.004; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kornev AP, 2010, BBA-PROTEINS PROTEOM, V1804, P440, DOI 10.1016/j.bbapap.2009.10.017; Koukos PI, 2013, J COMPUT CHEM, V34, P2310, DOI 10.1002/jcc.23381; Kumar A, 2008, J CLIN ONCOL, V26, P1742, DOI 10.1200/JCO.2007.12.1178; Lange OF, 2006, J PHYS CHEM B, V110, P22842, DOI 10.1021/jp062548j; Lavery R, 2007, J BIOSCIENCES, V32, P891, DOI 10.1007/s12038-007-0089-x; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Li CQ, 2014, J PHYS CHEM B, V118, P1273, DOI 10.1021/jp411111g; Littlefield P, 2013, P NATL ACAD SCI USA, V110, P15169, DOI 10.1073/pnas.1314719110; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MacKerell Alexander D. Jr., 2000, Biopolymers, V56, P257, DOI 10.1002/1097-0282(2000)56:4<257::AID-BIP10029>3.0.CO;2-W; Magyar C, 2005, NUCLEIC ACIDS RES, V33, pW303, DOI 10.1093/nar/gki409; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Maragakis P, 2005, J MOL BIOL, V352, P807, DOI 10.1016/j.jmb.2005.07.031; Marsh JA, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001870; Marsh JA, 2013, J MOL BIOL, V425, P3250, DOI 10.1016/j.jmb.2013.06.019; Marsh JA, 2011, STRUCTURE, V19, P859, DOI 10.1016/j.str.2011.03.010; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Massarelli E, 2013, LUNG CANCER, V80, P235, DOI 10.1016/j.lungcan.2013.01.018; Masterson LR, 2008, P NATL ACAD SCI USA, V105, P506, DOI 10.1073/pnas.0709214104; Masterson LR, 2012, ADV PROTEIN CHEM STR, V87, P363, DOI 10.1016/B978-0-12-398312-1.00012-3; Masterson LR, 2011, P NATL ACAD SCI USA, V108, P6969, DOI 10.1073/pnas.1102701108; Masterson LR, 2010, NAT CHEM BIOL, V6, P821, DOI 10.1038/NCHEMBIO.452; Meharena HS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001680; Miao YL, 2013, P NATL ACAD SCI USA, V110, P10982, DOI 10.1073/pnas.1309755110; Mirza A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014310; Mustafa M, 2011, PROTEINS, V79, P99, DOI 10.1002/prot.22862; Navizet I, 2004, BIOPHYS J, V87, P1426, DOI 10.1529/biophysj.104.042085; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Oruganty K, 2013, BBA-PROTEINS PROTEOM, V1834, P1322, DOI 10.1016/j.bbapap.2013.02.040; Oruganty K, 2013, P NATL ACAD SCI USA, V110, P924, DOI 10.1073/pnas.1207104110; Oruganty K, 2012, PHILOS T R SOC B, V367, P2529, DOI 10.1098/rstb.2012.0015; Palla G, 2005, NATURE, V435, P814, DOI 10.1038/nature03607; Papakyriakou A, 2009, PROTEINS, V76, P375, DOI 10.1002/prot.22353; Park J, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066117; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Polier S, 2013, NAT CHEM BIOL, V9, P307, DOI [10.1038/NCHEMBIO.1212, 10.1038/nchembio.1212]; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Rader AJ, 2011, MOL BIOSYST, V7, P464, DOI 10.1039/c0mb00054j; Red Brewer M, 2013, P NATL ACAD SCI USA, V110, pE3595, DOI 10.1073/pnas.1220050110; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; Roskoski R, 2014, PHARMACOL RES, V79, P34, DOI 10.1016/j.phrs.2013.11.002; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sacquin-Mora S, 2006, BIOPHYS J, V90, P2706, DOI 10.1529/biophysj.105.074997; Sacquin-Mora S, 2007, PROTEINS, V67, P350, DOI 10.1002/prot.21353; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Shan YB, 2013, P NATL ACAD SCI USA, V110, P7270, DOI 10.1073/pnas.1220843110; Shan YB, 2012, CELL, V149, P860, DOI 10.1016/j.cell.2012.02.063; Shi FM, 2010, P NATL ACAD SCI USA, V107, P7692, DOI 10.1073/pnas.1002753107; Shih Andrew J, 2011, Cancers (Basel), V3, P1195, DOI 10.3390/cancers3011195; Shimamura T, 2005, CANCER RES, V65, P6401, DOI 10.1158/0008-5472.CAN-05-0933; Shimamura T, 2008, CANCER RES, V68, P5827, DOI 10.1158/0008-5472.CAN-07-5428; Shin AJ, 2011, BIOCHEM J, V436, P241, DOI 10.1042/BJ20101791; Sidera K, 2008, J BIOL CHEM, V283, P2031, DOI 10.1074/jbc.M701803200; Sogabe S, 2013, ACS MED CHEM LETT, V4, P201, DOI 10.1021/ml300327z; Stamos J, 2002, J BIOL CHEM, V277, P46265, DOI 10.1074/jbc.M207135200; Strong TC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028100; Sutto L, 2013, P NATL ACAD SCI USA, V110, P10616, DOI 10.1073/pnas.1221953110; Taipale M, 2013, NAT BIOTECHNOL, V31, P630, DOI 10.1038/nbt.2620; Taipale M, 2012, CELL, V150, P987, DOI 10.1016/j.cell.2012.06.047; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Taylor SS, 2013, BBA-PROTEINS PROTEOM, V1834, P1271, DOI 10.1016/j.bbapap.2013.03.007; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Taylor SS, 2012, PHILOS T R SOC B, V367, P2517, DOI 10.1098/rstb.2012.0054; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Telesco SE, 2013, BIOTECHNOL J, V8, P1452, DOI 10.1002/biot.201300022; Telesco SE, 2011, MOL BIOSYST, V7, P2066, DOI 10.1039/c0mb00345j; Telesco SE, 2009, BIOPHYS J, V96, P2321, DOI 10.1016/j.bpj.2008.12.3912; Ten Eyck LF, 2008, BBA-PROTEINS PROTEOM, V1784, P238, DOI 10.1016/j.bbapap.2007.11.002; Tsai CJ, 2014, PHYS CHEM CHEM PHYS, V16, P6332, DOI 10.1039/c3cp54253j; Veglia G, 2013, FEBS J, V280, P5608, DOI 10.1111/febs.12462; Vijayabaskar MS, 2010, BIOPHYS J, V99, P3704, DOI 10.1016/j.bpj.2010.08.079; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wan SZ, 2012, MOL CANCER THER, V11, P2394, DOI 10.1158/1535-7163.MCT-12-0644-T; Wan SZ, 2011, J COMPUT CHEM, V32, P2843, DOI 10.1002/jcc.21866; Wang ZH, 2011, NAT STRUCT MOL BIOL, V18, P1388, DOI 10.1038/nsmb.2168; Whitford PC, 2013, P NATL ACAD SCI USA, V110, P7114, DOI 10.1073/pnas.1305236110; Wood ER, 2008, P NATL ACAD SCI USA, V105, P2773, DOI 10.1073/pnas.0708281105; Wood ER, 2004, CANCER RES, V64, P6652, DOI 10.1158/0008-5472.CAN-04-1168; Yang J, 2005, J MOL BIOL, V346, P191, DOI 10.1016/j.jmb.2004.11.030; Yang SC, 2006, CANCER RES, V66, P6990, DOI 10.1158/0008-5472.CAN-06-1042; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang XW, 2007, NATURE, V450, P741, DOI 10.1038/nature05998; Zhou WJ, 2009, NATURE, V462, P1070, DOI 10.1038/nature08622	140	29	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113488	10.1371/journal.pone.0113488	http://dx.doi.org/10.1371/journal.pone.0113488			46	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427151	Green Published, gold			2022-12-26	WOS:000349145400057
J	Fu, Q; McKnight, RA; Callaway, CW; Yu, X; Lane, RH; Majnik, AV				Fu, Qi; McKnight, Robert A.; Callaway, Christopher W.; Yu, Xing; Lane, Robert H.; Majnik, Amber V.			Intrauterine growth restriction disrupts developmental epigenetics around distal growth hormone response elements on the rat hepatic IGF-1 gene	FASEB JOURNAL			English	Article						prenatal; enhancer; methylation; histone; DNA	RNA-POLYMERASE-II; CHROMATIN CHANGES ACCOMPANY; UTEROPLACENTAL INSUFFICIENCY; HISTONE MODIFICATIONS; SIGNAL TRANSDUCER; RETARDED FETAL; H3K9 METHYLATION; DNA METHYLATION; BINDING-SITES; EXPRESSION	Intrauterine growth restriction (IUGR) decreases serum IGF-1 levels. Postnatal IGF-1 expression is transcriptionally regulated by growth hormone (GH) through growth hormone response elements (GHREs). We hypothesized that IUGR disrupts the normal developmental maturation of hepatic IGF-1 intron 2 growth hormone response element (IN2GHRE) histone methylation of key lysines and DNA methylation. We also evaluated a 5' distal weak enhancer (IGF-1 5'-upstream region growth hormone response element; 5URGHRE) as a GHRE specificity control. IUGR was induced through a well-characterized model of bilateral uterine artery ligation of the pregnant rat. Offspring livers were tested at d 0 and 21. Chromatin immunoprecipitation and bisulfite sequencing quantified epigenetic characteristics. We found that distinct age-related developmental patterns of histone and DNA methylation characterize each GHRE. Development increased H3K4 trimethylation (me3) in both GHREs. However, H3K9me3 decreased with age at IN2GHRE and increased with age at 5URGHRE. IUGR altered the developmental pattern of H3K4me3 and K9me3 around the GHREs in a sex-specific manner at d 21. Developmental and IUGR-induced DNA methylation occurred in a GHRE-, CpG site-, and sex-specific manner. We conclude that IUGR disrupts developmental epigenetics around distal GHREs on the rat hepatic IGF-1 gene.	[Fu, Qi; Lane, Robert H.; Majnik, Amber V.] Med Coll Wisconsin, Dept Pediat, Div Neonatol, Milwaukee, WI 53226 USA; [McKnight, Robert A.; Callaway, Christopher W.; Yu, Xing] Univ Utah, Dept Pediat, Div Neonatol, Salt Lake City, UT USA	Medical College of Wisconsin; Utah System of Higher Education; University of Utah	Majnik, AV (corresponding author), TBRC CRI, Room C2485,8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	amajnik@mcw.edu		Callaway, Christopher/0000-0003-2072-0972	Department of Pediatrics at the Medical College of Wisconsin	Department of Pediatrics at the Medical College of Wisconsin	The authors thank the Department of Pediatrics at the Medical College of Wisconsin for their support and guidance.	Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Baserga M, 2005, AM J PHYSIOL-REG I, V289, pR1348, DOI 10.1152/ajpregu.00211.2005; Bates KA, 2009, MOL PSYCHIATR, V14, P469, DOI 10.1038/mp.2008.96; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; BICHELL DP, 1992, MOL ENDOCRINOL, V6, P1899, DOI 10.1210/me.6.11.1899; Brinkman AB, 2006, EMBO REP, V7, P628, DOI 10.1038/sj.embor.7400686; BUSSEY ME, 1985, PEDIATR RES, V19, P363, DOI 10.1203/00006450-198519040-00010; Chia DJ, 2010, MOL ENDOCRINOL, V24, P2038, DOI 10.1210/me.2010-0234; Chia DJ, 2010, J BIOL CHEM, V285, P17636, DOI 10.1074/jbc.M110.117697; Chia DJ, 2010, MOL ENDOCRINOL, V24, P779, DOI 10.1210/me.2009-0430; Chia DJ, 2006, J BIOL CHEM, V281, P3190, DOI 10.1074/jbc.M510204200; Clodfelter KH, 2006, MOL ENDOCRINOL, V20, P1333, DOI 10.1210/me.2005-0489; Conti E, 2004, CIRCULATION, V110, P2260, DOI 10.1161/01.CIR.0000144309.87183.FB; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; DAUGHADAY WH, 1989, ENDOCR REV, V10, P68, DOI 10.1210/edrv-10-1-68; Davey HW, 2001, ENDOCRINOLOGY, V142, P3836, DOI 10.1210/en.142.9.3836; Ekram MB, 2012, EPIGENETICS-US, V7, P370, DOI 10.4161/epi.19462; Eleswarapu S, 2008, ENDOCRINOLOGY, V149, P2230, DOI 10.1210/en.2007-1344; Flanagan DE, 2000, AM J PHYSIOL-ENDOC M, V278, pE700, DOI 10.1152/ajpendo.2000.278.4.E700; Fu Q, 2004, PHYSIOL GENOMICS, V20, P108, DOI 10.1152/physiolgenomics.00175.2004; Fu Q, 2006, FASEB J, V20, P2127, DOI 10.1096/fj.06-6179fje; Fu Q, 2009, FASEB J, V23, P2438, DOI 10.1096/fj.08-124768; Gerber M, 2003, J BIOL CHEM, V278, P26303, DOI 10.1074/jbc.R300014200; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Ke X, 2006, PHYSIOL GENOMICS, V25, P16, DOI 10.1152/physiolgenomics.00093.2005; Ke XR, 2005, AM J PHYSIOL-REG I, V288, pR1038, DOI 10.1152/ajpregu.00701.2004; KIKUCHI K, 1992, J BIOL CHEM, V267, P21505; Kim A, 2007, MOL CELL BIOL, V27, P1271, DOI 10.1128/MCB.01684-06; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Lane RH, 2003, PEDIATR RES, V53, p149A; Lane RH, 2003, PEDIATR RES, V53, P994, DOI 10.1203/01.PDR.0000064583.40495.51; Lane RH, 2002, ENDOCRINOLOGY, V143, P2486, DOI 10.1210/en.143.7.2486; Lane RH, 1998, PEDIATR RES, V43, P563, DOI 10.1203/00006450-199805000-00001; Lane RH, 2001, BRAIN RES, V895, P186, DOI 10.1016/S0006-8993(01)02074-1; Lane RH, 2001, AM J PHYSIOL-REG I, V280, pR183, DOI 10.1152/ajpregu.2001.280.1.R183; Lane RH, 1999, AM J PHYSIOL-ENDOC M, V276, pE135, DOI 10.1152/ajpendo.1999.276.1.E135; Lane RH, 1996, BIOCHEM MOL MED, V59, P192, DOI 10.1006/bmme.1996.0087; Lane RH, 1996, PEDIATR RES, V39, P390, DOI 10.1203/00006450-199603000-00003; Lanning NJ, 2006, REV ENDOCR METAB DIS, V7, P225, DOI 10.1007/s11154-007-9025-5; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; OGATA ES, 1986, METABOLISM, V35, P970, DOI 10.1016/0026-0495(86)90064-8; OGATA ES, 1985, PEDIATR RES, V19, P32, DOI 10.1203/00006450-198501000-00010; Pham TD, 2003, AM J PHYSIOL-REG I, V285, pR962, DOI 10.1152/ajpregu.00201.2003; Rosenfeld JA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-143; Rosenfeld RG, 2009, HORM RES, V71, P71, DOI 10.1159/000192440; Rotwein P, 2012, TRENDS ENDOCRIN MET, V23, P186, DOI 10.1016/j.tem.2012.01.001; Sadiq HF, 1999, BRAIN RES, V823, P96, DOI 10.1016/S0006-8993(99)01145-2; Santhanam M, 2013, MOL ENDOCRINOL, V27, P2080, DOI 10.1210/me.2013-1181; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schmidl C, 2009, GENOME RES, V19, P1165, DOI 10.1101/gr.091470.109; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Simmons RA, 2001, DIABETES, V50, P2279, DOI 10.2337/diabetes.50.10.2279; Snowden AW, 2002, CURR BIOL, V12, P2159, DOI 10.1016/S0960-9822(02)01391-X; Stadler MB, 2011, NATURE, V480, P490, DOI 10.1038/nature10716; Sugathan A, 2013, MOL CELL BIOL, V33, P3594, DOI 10.1128/MCB.00280-13; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Tanaka S, 2011, NAT IMMUNOL, V12, P77, DOI 10.1038/ni.1966; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Torres-Aleman I, 2010, DEV NEUROBIOL, V70, P384, DOI 10.1002/dneu.20778; Tsirka AE, 2001, J ENDOCRINOL, V169, P373, DOI 10.1677/joe.0.1690373; Udy GB, 1997, P NATL ACAD SCI USA, V94, P7239, DOI 10.1073/pnas.94.14.7239; Vakoc CR, 2006, MOL CELL BIOL, V26, P9185, DOI 10.1128/MCB.01529-06; Vidal OM, 2007, MOL ENDOCRINOL, V21, P293, DOI 10.1210/me.2006-0096; Wang Y, 2005, J BIOL CHEM, V280, P10955, DOI 10.1074/jbc.M412808200; Werner H, 2014, EUR NEUROPSYCHOPHARM, V24, P1947, DOI 10.1016/j.euroneuro.2014.01.020; Wilhelm BT, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-8-r82; Woelfle J, 2003, J BIOL CHEM, V278, P51261, DOI 10.1074/jbc.M309486200; Woelfle J, 2003, J BIOL CHEM, V278, P22696, DOI 10.1074/jbc.M301362200; World Medical A. & American Physiological, 2002, AM J PHYSIOL-REG I, V283, pR281; Xiao TJ, 2007, MOL CELL BIOL, V27, P721, DOI 10.1128/MCB.01628-06; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110; Yu R, 2003, MOL CELL ENDOCRINOL, V204, P31, DOI 10.1016/S0303-7207(03)00145-X; Zhang YJ, 2012, MOL CELL BIOL, V32, P880, DOI 10.1128/MCB.06312-11; Zinkhan EK, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/930364	79	25	27	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1176	1184		10.1096/fj.14-258442	http://dx.doi.org/10.1096/fj.14-258442			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25466885				2022-12-26	WOS:000354115000007
J	Heghinian, MD; Mejia, M; Adams, DJ; Godenschwege, TA; Mari, F				Heghinian, Mari D.; Mejia, Monica; Adams, David J.; Godenschwege, Tanja A.; Mari, Frank			Inhibition of cholinergic pathways in Drosophila melanogaster by alpha-conotoxins	FASEB JOURNAL			English	Article						synaptic transmission; nicotinic acetylcholine receptors; giant fiber system; Conus brunneus	NICOTINIC ACETYLCHOLINE-RECEPTORS; NOREPINEPHRINE RELEASE; SELECTIVITY; ANTAGONIST; D-ALPHA-7; AGONISTS; MODELER; BINDING; ESCAPE; SYSTEM	Nicotinic acetylcholine receptors (nAChRs) play a pivotal role in synaptic transmission of neuronal signaling pathways and are fundamentally involved in neuronal disorders, including Alzheimer's disease, Parkinson's disease, and schizophrenia. In vertebrates, cholinergic pathways can be selectively inhibited by alpha-conotoxins; we show that in the model organism Drosophila, the cholinergic component of the giant fiber system is inhibited by alpha-conotoxins MII, AuIB, BuIA, EI, PeIA, and ImI. The injection of 45 pmol/fly of each toxin dramatically decreases the response of the giant fiber to dorsal longitudinal muscle (GF-DLM) connection to 20 +/- 13.9% for MII; 26 +/- 13.7% for AuIB, 12 +/- 9.9% for BuIA, 30 +/- 11.3% for EI, 1 +/- 1% for PeIA, and 34 +/- 15.4% for ImI. Through bioassay-guided fractionation of the venom of Conus brunneus, we found BruIB, an alpha-conotoxin that inhibits Drosophila nicotinic receptors but not its vertebrate counterparts. GF-DLM responses decreased to 43.7 +/- 8.02% on injection of 45 pmol/fly of BruIB. We manipulated the D alpha 7 nAChR to mimic the selectivity of its vertebrate counterpart by placing structurally guided point mutations in the conotoxin-binding site. This manipulation rendered vertebrate-like behavior in the Drosophila system, enhancing the suitability of Drosophila as an in vivo tool to carry out studies related to human neuronal diseases.	[Heghinian, Mari D.; Mari, Frank] Florida Atlantic Univ, Dept Chem & Biochem, Boca Raton, FL 33431 USA; [Mejia, Monica; Godenschwege, Tanja A.] Florida Atlantic Univ, Dept Biol Sci, Boca Raton, FL 33431 USA; [Adams, David J.] RMIT Univ, Hlth Innovat Res Inst, Melbourne, Vic 3001, Australia	State University System of Florida; Florida Atlantic University; State University System of Florida; Florida Atlantic University; Royal Melbourne Institute of Technology (RMIT)	Mari, F (corresponding author), Florida Atlantic Univ, Dept Chem & Biochem, 777 Glades Rd, Boca Raton, FL 33431 USA.	mari@fau.edu	Adams, David John/K-3578-2019; Godenschwege, Tanja A/A-2830-2010	Adams, David John/0000-0002-7030-2288; Godenschwege, Tanja A/0000-0003-3322-4134	U.S. National Institutes of Health National Institute for Neurological Disorders and Stroke Grant [R21NS06637]; Australian Research Council (ARC) Grant [DP1093115]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS066371] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Institute for Neurological Disorders and Stroke Grant; Australian Research Council (ARC) Grant(Australian Research Council); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded by U.S. National Institutes of Health National Institute for Neurological Disorders and Stroke Grant R21NS06637 (to F.M. and T.A.G.); and Australian Research Council (ARC) Grant DP1093115 (to F.M. and D.J.A.). D.J.A. is an ARC Australian Professorial Fellow.	Akondi KB, 2014, CHEM REV, V114, P5815, DOI 10.1021/cr400401e; Albuquerque EX, 2009, PHYSIOL REV, V89, P73, DOI 10.1152/physrev.00015.2008; Allen MJ, 2006, SEMIN CELL DEV BIOL, V17, P31, DOI 10.1016/j.semcdb.2005.11.011; Azam L, 2005, J BIOL CHEM, V280, P80, DOI 10.1074/jbc.M406281200; Azam L, 2010, FASEB J, V24, P5113, DOI 10.1096/fj.10-166272; Daly NL, 2011, J BIOL CHEM, V286, P10233, DOI 10.1074/jbc.M110.196170; Dupuis J, 2012, NEUROSCI BIOBEHAV R, V36, P1553, DOI 10.1016/j.neubiorev.2012.04.003; Ellison M, 2004, BIOCHEMISTRY-US, V43, P16019, DOI 10.1021/bi048918g; Fayyazuddin A, 2006, PLOS BIOL, V4, P420, DOI 10.1371/journal.pbio.0040063; Franco A, 2006, PROG MOLEC, V43, P83, DOI 10.1007/978-3-540-30880-5_4; Franco A, 2012, BIOCHEM PHARMACOL, V83, P419, DOI 10.1016/j.bcp.2011.11.006; Grishin AA, 2013, J BIOL CHEM, V288, P34428, DOI 10.1074/jbc.M113.512582; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Jones CK, 2012, NEUROPSYCHOPHARMACOL, V37, P16, DOI 10.1038/npp.2011.199; Lansdell SJ, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-73; Lee D, 1999, J NEUROSCI, V19, P5311; Luo SQ, 1998, J NEUROSCI, V18, P8571; LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0; MARTINEZ JS, 1995, BIOCHEMISTRY-US, V34, P14519, DOI 10.1021/bi00044a030; McIntosh JM, 2005, J BIOL CHEM, V280, P30107, DOI 10.1074/jbc.M504102200; MCINTOSH JM, 1994, J BIOL CHEM, V269, P16733; Mejia M., 2012, JOVE-J VIS EXP, V62, pe3597; Mejia M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064685; Mejia M, 2010, TOXICON, V56, P1398, DOI 10.1016/j.toxicon.2010.08.005; Moller C, 2005, BIOCHEMISTRY-US, V44, P15986, DOI 10.1021/bi0511181; Papke RL, 2014, BIOCHEM PHARMACOL, V89, P1, DOI 10.1016/j.bcp.2014.01.029; Ping Y, 2012, FLY, V6, P153, DOI 10.4161/fly.20775; Pucci L, 2011, FASEB J, V25, P3775, DOI 10.1096/fj.10-179853; Puillandre N, 2014, MOL PHYLOGENET EVOL, V78, P290, DOI 10.1016/j.ympev.2014.05.023; Rogers JP, 2000, J MOL BIOL, V304, P911, DOI 10.1006/jmbi.2000.4247; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Thany SH, 2007, TRENDS PHARMACOL SCI, V28, P14, DOI 10.1016/j.tips.2006.11.006; Ulens C, 2006, P NATL ACAD SCI USA, V103, P3615, DOI 10.1073/pnas.0507889103; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Yang Z, 2012, J STRUCT BIOL, V179, P269, DOI 10.1016/j.jsb.2011.09.006; Yu RL, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002011	36	7	8	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2015	29	3					1011	1018		10.1096/fj.14-262733	http://dx.doi.org/10.1096/fj.14-262733			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CC8QK	25466886	Green Published			2022-12-26	WOS:000350633000025
J	Jansen, KB; Baker, SL; Sousa, MC				Jansen, Katarina Bartos; Baker, Susan Lynn; Sousa, Marcelo Carlos			Crystal Structure of BamB Bound to a Periplasmic Domain Fragment of BamA, the Central Component of the beta-Barrel Assembly Machine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUTER-MEMBRANE; BIOGENESIS; COMPLEX; FLEXIBILITY; DISULFIDE; PROTEINS	The beta-barrel assembly machinery (BAM) mediates folding and insertion of beta-barrel outer membrane proteins (OMPs) into the outer membrane of Gram-negative bacteria. BAM is a five-protein complex consisting of the beta-barrel OMP BamA and lipoproteins BamB, -C, -D, and -E. High resolution structures of all the individual BAM subunits and a BamD-BamC complex have been determined. However, the overall complex architecture remains elusive. BamA is the central component of BAM and consists of a membrane-embedded beta-barrel and a periplasmic domain with five polypeptide translocation-associated (POTRA) motifs thought to interact with the accessory lipoproteins. Here we report the crystal structure of a fusion between BamB and a POTRA3-5 fragment of BamA. Extended loops 13 and 17 protruding from one end of the BamB beta-propeller contact the face of the POTRA3 beta-sheet in BamA. The interface is stabilized by several hydrophobic contacts, a network of hydrogen bonds, and a cation-pi interaction between BamA Tyr-255 and BamB Arg-195. Disruption of BamA-BamB binding by BamA Y255A and probing of the interface by disulfide bond cross-linking validate the physiological relevance of the observed interface. Furthermore, the structure is consistent with previously published mutagenesis studies. The periplasmic five-POTRA domain of BamA is flexible in solution due to hinge motions in the POTRA2-3 linker. Modeling BamB in complex with full-length BamA shows BamB binding at the POTRA2-3 hinge, suggesting a role in modulation of BamA flexibility and the conformational changes associated with OMP folding and insertion.	[Jansen, Katarina Bartos; Baker, Susan Lynn; Sousa, Marcelo Carlos] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Sousa, MC (corresponding author), Univ Colorado, Dept Chem & Biochem, 596 UCB, Boulder, CO 80309 USA.	Marcelo.Sousa@colorado.edu			National Institutes of Health [R01 AI080709, T32 GM065103]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080709] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065103] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 AI080709 (to M. C. S.) and Training Grant T32 GM065103 (to K. B. J.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albrecht R, 2014, ACTA CRYSTALLOGR D, V70, P1779, DOI 10.1107/S1399004714007482; Albrecht R, 2011, J BIOL CHEM, V286, P27792, DOI 10.1074/jbc.M111.238931; Anwari K, 2012, MOL MICROBIOL, V84, P832, DOI 10.1111/j.1365-2958.2012.08059.x; Bass RB, 2007, METHOD ENZYMOL, V423, P25, DOI 10.1016/S0076-6879(07)23002-2; Bass RB, 2007, METHOD ENZYMOL, V423, P3, DOI 10.1016/S0076-6879(07)23001-0; Craig DB, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-346; Crowley PB, 2005, PROTEINS, V59, P231, DOI 10.1002/prot.20417; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Endo T, 2011, EMBO REP, V12, P94, DOI 10.1038/embor.2010.217; Gatzeva-Topalova PZ, 2008, STRUCTURE, V16, P1873, DOI 10.1016/j.str.2008.09.014; Gatzeva-Topalova PZ, 2010, STRUCTURE, V18, P1492, DOI 10.1016/j.str.2010.08.012; Gessmann D, 2014, P NATL ACAD SCI USA, V111, P5878, DOI 10.1073/pnas.1322473111; Heuck A, 2011, J MOL BIOL, V406, P659, DOI 10.1016/j.jmb.2011.01.002; Jansen KB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049749; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kim KH, 2011, J BIOL CHEM, V286, P39116, DOI 10.1074/jbc.M111.298166; Kim KH, 2011, J MOL BIOL, V406, P667, DOI 10.1016/j.jmb.2010.12.020; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Knowles TJ, 2011, EMBO REP, V12, P123, DOI 10.1038/embor.2010.202; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Noinaj N, 2011, J MOL BIOL, V407, P248, DOI 10.1016/j.jmb.2011.01.042; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Praznikar J, 2009, ACTA CRYSTALLOGR D, V65, P921, DOI 10.1107/S0907444909021933; Rigel NW, 2013, P NATL ACAD SCI USA, V110, P5151, DOI 10.1073/pnas.1302662110; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; Sandoval CM, 2011, J MOL BIOL, V409, P348, DOI 10.1016/j.jmb.2011.03.035; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Vuong P, 2008, J BACTERIOL, V190, P1507, DOI 10.1128/JB.01477-07; Warner LR, 2011, J MOL BIOL, V411, P83, DOI 10.1016/j.jmb.2011.05.022; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015	33	34	34	2	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 23	2015	290	4					2126	2136		10.1074/jbc.M114.584524	http://dx.doi.org/10.1074/jbc.M114.584524			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CA0EH	25468906	hybrid, Green Published			2022-12-26	WOS:000348588000018
J	Okino, Y; Machida, Y; Frankland-Searby, S; Machida, YJ				Okino, Yuki; Machida, Yuka; Frankland-Searby, Sarah; Machida, Yuichi J.			BRCA1-associated Protein 1 (BAP1) Deubiquitinase Antagonizes the Ubiquitin-mediated Activation of FoxK2 Target Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXK2; HISTONE H2A; MUTATIONS PREDISPOSE; TUMOR-SUPPRESSOR; UVEAL MELANOMA; FHA DOMAIN; CELL; COMPLEX; EXPRESSION; HYDROLASE	BRCA1-associated protein 1 (BAP1), which is frequently mutated in cancer, functions as a deubiquitinase (DUB) for histone H2A. Although BAP1 interacts with a transcriptional regulator, HCF-1, and transcription factors FoxK1 and FoxK2, how BAP1 controls gene expression remains unclear. This study investigates the importance of BAP1 DUB activity and the interactions with FoxK2 and HCF-1 in the regulation of FoxK2 target genes. We show that FoxK2 recruits BAP1 to the target genes through the forkhead-associated domain, which interacts with Thr(P)-493 on BAP1. BAP1, in turn, recruits HCF-1, thereby forming a ternary complex in which BAP1 bridges FoxK2 and HCF-1. BAP1 represses FoxK2 target genes, and this effect requires BAP1 DUB activity but not interaction with HCF-1. Importantly, BAP1 depletion causes up-regulation of FoxK2 target genes only in the presence of the Ring1B-Bmi1 complex, an E3 ubiquitin ligase for histone H2A, indicating an antagonizing role of BAP1 against Ring1B-Bmi1. Our findings suggest that BAP1 deficiency causes increased expression of target genes in a Ring1B-Bmi1-dependent manner.	[Okino, Yuki; Machida, Yuka; Machida, Yuichi J.] Mayo Clin, Dept Oncol, Rochester, MN 55905 USA; [Frankland-Searby, Sarah; Machida, Yuichi J.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Machida, YJ (corresponding author), Mayo Clin, Dept Oncol, 200 First St SW, Rochester, MN 55905 USA.	machida.yuichi@mayo.edu	Machida, Yuichi/AAO-3533-2021	Machida, Yuichi/0000-0003-1414-0568	Minnesota Partnership for Biotechnology and Medical Genomics; Eagles Funds for Cancer Research; NATIONAL CANCER INSTITUTE [P30CA015083] Funding Source: NIH RePORTER	Minnesota Partnership for Biotechnology and Medical Genomics; Eagles Funds for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Minnesota Partnership for Biotechnology and Medical Genomics (to Y. J. M.) and Eagles Funds for Cancer Research (Y. J. M.).	Abdel-Rahman MH, 2011, J MED GENET, V48, P856, DOI 10.1136/jmedgenet-2011-100156; Bott M, 2011, NAT GENET, V43, P668, DOI 10.1038/ng.855; Buchwald G, 2006, EMBO J, V25, P2465, DOI 10.1038/sj.emboj.7601144; Chan-on W, 2013, NAT GENET, V45, P1474, DOI 10.1038/ng.2806; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dey A, 2012, SCIENCE, V337, P1541, DOI 10.1126/science.1221711; Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X; Farley MN, 2013, MOL CANCER RES, V11, P1061, DOI 10.1158/1541-7786.MCR-13-0111; Frangini A, 2013, MOL CELL, V51, P647, DOI 10.1016/j.molcel.2013.08.022; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Garry DJ, 2000, P NATL ACAD SCI USA, V97, P5416, DOI 10.1073/pnas.100501197; Grant GD, 2012, MOL BIOL CELL, V23, P3079, DOI 10.1091/mbc.E11-02-0170; Guo GW, 2012, NAT GENET, V44, P17, DOI 10.1038/ng.1014; Gutierrez L, 2012, DEVELOPMENT, V139, P117, DOI 10.1242/dev.074450; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Hawke TJ, 2003, J BIOL CHEM, V278, P4015, DOI 10.1074/jbc.M209200200; Jensen DE, 1998, ONCOGENE, V16, P1097, DOI 10.1038/sj.onc.1201861; Ji ZL, 2014, NUCLEIC ACIDS RES, V42, P6232, DOI 10.1093/nar/gku274; Ji ZL, 2012, MOL CELL BIOL, V32, P385, DOI 10.1128/MCB.05504-11; Jiao YC, 2013, NAT GENET, V45, P1470, DOI 10.1038/ng.2813; Komorek J, 2010, J VIROL, V84, P2719, DOI 10.1128/JVI.02119-09; Lam EWF, 2013, NAT REV CANCER, V13, P482, DOI 10.1038/nrc3539; Machida YJ, 2009, J BIOL CHEM, V284, P34179, DOI 10.1074/jbc.M109.046755; Mahajan A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.151re12; Marais A, 2010, J BIOL CHEM, V285, P35728, DOI 10.1074/jbc.M110.154005; Matatall KA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-371; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Pena-LlopiS S, 2012, NAT GENET, V44, P751, DOI 10.1038/ng.2323; Popova T, 2013, AM J HUM GENET, V92, P974, DOI 10.1016/j.ajhg.2013.04.012; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Shi XZ, 2012, BIOCHEM J, V446, P349, DOI 10.1042/BJ20120563; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Testa JR, 2011, NAT GENET, V43, P1022, DOI 10.1038/ng.912; Tyagi S, 2007, MOL CELL, V27, P107, DOI 10.1016/j.molcel.2007.05.030; Ventii KH, 2008, CANCER RES, V68, P6953, DOI 10.1158/0008-5472.CAN-08-0365; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wiesner T, 2011, NAT GENET, V43, P1018, DOI 10.1038/ng.910; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yu H, 2010, MOL CELL BIOL, V30, P5071, DOI 10.1128/MCB.00396-10	40	52	53	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1580	1591		10.1074/jbc.M114.609834	http://dx.doi.org/10.1074/jbc.M114.609834			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25451922	hybrid, Green Published			2022-12-26	WOS:000348056400027
J	Ward, MD; Leahy, DJ				Ward, Matthew D.; Leahy, Daniel J.			Kinase Activator-Receiver Preference in ErbB Heterodimers Is Determined by Intracellular Regions and Is Not Coupled to Extracellular Asymmetry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; STRUCTURAL-ANALYSIS; MECHANISM; LIGAND; DOMAIN; DIFFERENTIATION; INHIBITION; PROTEINS; NETWORK; COMPLEX	The EGF receptor (EGFR) family comprises four homologs in humans collectively known as the ErbB or HER proteins. ErbB proteins are receptor tyrosine kinases that become activated when ligands bind to their extracellular regions and promote formation of specific homo- and heterodimers with enhanced tyrosine kinase activity. An essential feature of ErbB activation is formation of an asymmetric kinase dimer in which the C-terminal lobe of one kinase serves as the activator or donor kinase by binding the N-terminal lobe of a receiver or acceptor kinase and stabilizing its active conformation. ErbB extracellular regions are also thought to form active asymmetric dimers in which only one subunit binds ligand. The observation that the unliganded ErbB2 kinase preferentially serves as the activator kinase when paired with EGFR/ErbB1 implied that extracellular asymmetry in ErbB proteins might be coupled to intracellular asymmetry with unliganded partners favoring the activator kinase position. Using cell-based stimulation assays and chimeric ErbB proteins, we show that extracellular asymmetry is not coupled to intracellular asymmetry and that ErbB intracellular regions are sufficient to determine relative kinase activator-receiver orientation. We further show a hierarchy of activator-receiver preferences among ErbB proteins, with EGFR/ErbB1 being the strongest receiver, followed by ErbB2 and then ErbB4, and that cis-phosphorylation of EGFR and ErbB2 appears to be negligible. This hierarchy shapes the nature of signaling responses to different ligands in cells expressing multiple ErbB proteins.	[Ward, Matthew D.; Leahy, Daniel J.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Leahy, DJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, 716 Hunterian Bldg,725 N Wolfe St, Baltimore, MD 21205 USA.	dleahy@jhmi.edu			National Institutes of Health [R01GM099321]; NATIONAL CANCER INSTITUTE [R01CA090466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007445, R01GM099321, R01GM099092] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM099321 (to D. J. L.).	Aertgeerts K, 2011, J BIOL CHEM, V286, P18756, DOI 10.1074/jbc.M110.206193; ALIMANDI M, 1995, ONCOGENE, V10, P1813; Alvarado D, 2010, CELL, V142, P568, DOI 10.1016/j.cell.2010.07.015; Alvarado D, 2009, NATURE, V461, P287, DOI 10.1038/nature08297; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bouyain S, 2005, P NATL ACAD SCI USA, V102, P15024, DOI 10.1073/pnas.0507591102; Burgess AW, 2003, MOL CELL, V12, P541, DOI 10.1016/S1097-2765(03)00350-2; CARPENTER G, 1992, FASEB J, V6, P3283, DOI 10.1096/fasebj.6.14.1385243; Cho HS, 2002, SCIENCE, V297, P1330, DOI 10.1126/science.1074611; Cho HS, 2003, NATURE, V421, P756, DOI 10.1038/nature01392; Costantini DL, 2008, J NUCL MED, V49, P1498, DOI 10.2967/jnumed.108.051771; Dankort DL, 1997, MOL CELL BIOL, V17, P5410, DOI 10.1128/MCB.17.9.5410; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; DOWNWARD J, 1984, NATURE, V307, P521, DOI 10.1038/307521a0; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; GUY PM, 1994, P NATL ACAD SCI USA, V91, P8132, DOI 10.1073/pnas.91.17.8132; Holbro T, 2003, EXP CELL RES, V284, P99, DOI 10.1016/S0014-4827(02)00099-X; HOLMES WE, 1992, SCIENCE, V256, P1205, DOI 10.1126/science.256.5060.1205; Huynh CQ, 1999, J MOL BIOL, V288, P13, DOI 10.1006/jmbi.1999.2674; Inlow D., 1989, J TISSUE CULTURE MET, V12, P13; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Jura N, 2009, P NATL ACAD SCI USA, V106, P21608, DOI 10.1073/pnas.0912101106; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; Knowlden JM, 2003, ENDOCRINOLOGY, V144, P1032, DOI 10.1210/en.2002-220620; LAMMERS R, 1990, J BIOL CHEM, V265, P16886; Leahy DJ, 2004, ADV PROTEIN CHEM, V68, P1; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Liu P, 2012, P NATL ACAD SCI USA, V109, P10861, DOI 10.1073/pnas.1201114109; Lu CF, 2010, MOL CELL BIOL, V30, P5432, DOI 10.1128/MCB.00742-10; Macdonald-Obermann JL, 2012, P NATL ACAD SCI USA, V109, P137, DOI 10.1073/pnas.1111316109; Mendrola JM, 2013, BIOCHEM SOC T, V41, P1029, DOI 10.1042/BST20130104; Mill C. P., 2011, CANC GENES CANC, V2, P792, DOI DOI 10.1177/1947601911431080; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Olayioye MA, 1998, MOL CELL BIOL, V18, P5042, DOI 10.1128/MCB.18.9.5042; Panke C, 2013, PROTEIN ENG DES SEL, V26, P645, DOI 10.1093/protein/gzt035; PELES E, 1992, CELL, V69, P205, DOI 10.1016/0092-8674(92)90131-U; PinkasKramarski R, 1996, J BIOL CHEM, V271, P19029, DOI 10.1074/jbc.271.32.19029; Qiu C, 2008, STRUCTURE, V16, P460, DOI 10.1016/j.str.2007.12.016; Red Brewer M, 2013, P NATL ACAD SCI USA, V110, pE3595, DOI 10.1073/pnas.1220050110; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; RIESE DJ, 1995, MOL CELL BIOL, V15, P5770; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SLIWKOWSKI MX, 1994, J BIOL CHEM, V269, P14661; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Wang S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.79; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang Q, 2012, P NATL ACAD SCI USA, V109, P13237, DOI 10.1073/pnas.1200105109; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	52	15	15	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1570	1579		10.1074/jbc.M114.612085	http://dx.doi.org/10.1074/jbc.M114.612085			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25468910	Green Published, hybrid			2022-12-26	WOS:000348056400026
J	Arcaro, CA; Gutierres, VO; Assis, RP; Moreira, TF; Costa, PI; Baviera, AM; Brunetti, IL				Arcaro, Carlos Alberto; Gutierres, Vania Ortega; Assis, Renata Pires; Moreira, Thais Fernanda; Costa, Paulo Inacio; Baviera, Amanda Martins; Brunetti, Iguatemy Lourenco			Piperine, a Natural Bioenhancer, Nullifies the Antidiabetic and Antioxidant Activities of Curcumin in Streptozotocin-Diabetic Rats	PLOS ONE			English	Article							OXIDATIVE STRESS; GLUTATHIONE-PEROXIDASE; SUPEROXIDE-DISMUTASE; TISSUE DISTRIBUTION; INSULIN-RESISTANCE; BIOAVAILABILITY; TETRAHYDROCURCUMIN; PHARMACOKINETICS; GLUCURONIDATION; ABSORPTION	Knowing that curcumin has low bioavailability when administered orally, and that piperine has bioenhancer activity by inhibition of hepatic and intestinal biotransformation processes, the aim of this study was to investigate the antidiabetic and antioxidant activities of curcumin (90 mg/kg) and piperine (20 or 40 mg/kg), alone or co-administered, incorporated in yoghurt, in streptozotocin (STZ)-diabetic rats. The treatment for 45 days of STZ-diabetic rats with curcuminenriched yoghurt improved all parameters altered in this experimental model of diabetes: the body weight was increased in association with the weight of skeletal muscles and white adipose tissues; the progressive increase in the glycemia levels was avoided, as well as in the glycosuria, urinary urea, dyslipidemia, and markers of liver (alanine and aspartate aminotransferases and alkaline phosphatase) and kidney (urinary protein) dysfunction; the hepatic oxidative stress was decreased, since the activities of the antioxidant enzymes superoxide dismutase, catalase and gluthatione peroxidase were increased, and the levels of malondialdehyde and protein carbonyl groups were reduced. The dose of 20 mg/kg piperine also showed antidiabetic and antioxidant activities. The treatment of STZ-diabetic rats with both curcumin and 20 mg/kg piperine in yoghurt did not change the antidiabetic and antioxidant activities of curcumin; notably, the treatment with both curcumin and 40 mg/kg piperine abrogated the beneficial effects of curcumin. In addition, the alanine aminotransferase levels were further increased in diabetic rats treated with curcumin and 40 mg/kg piperine in comparison with untreated diabetic rats. These findings support that the co-administration of curcumin with a bioenhancer did not bring any advantage to the curcumin effects, at least about the antidiabetic and antioxidant activities, which could be related to changes on its biotransformation.	[Arcaro, Carlos Alberto; Gutierres, Vania Ortega; Assis, Renata Pires; Moreira, Thais Fernanda; Costa, Paulo Inacio; Baviera, Amanda Martins; Brunetti, Iguatemy Lourenco] Sao Paulo State Univ UNESP, Sch Pharmaceut Sci, Dept Clin Anal, Sao Paulo, Brazil	Universidade Estadual Paulista	Brunetti, IL (corresponding author), Sao Paulo State Univ UNESP, Sch Pharmaceut Sci, Dept Clin Anal, Sao Paulo, Brazil.	brunetti@fcfar.unesp.br	Baviera, Amanda Martins/O-2028-2019; Brunetti, Iguatemy/AAS-8362-2021; Assis, Renata/HGD-9366-2022; Costa, Paulo I/D-7039-2018; Baviera, Amanda M/C-2737-2013	Baviera, Amanda Martins/0000-0003-0987-5295; Costa, Paulo I/0000-0002-3350-8308; Baviera, Amanda M/0000-0003-0987-5295; Brunetti, Iguatemy Lourenco/0000-0003-4927-7599; Arcaro Filho, Carlos Alberto/0000-0003-4642-2551; Pires de Assis, Renata/0000-0003-1070-9569	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) for the financial support and the scholarship for C. A. Arcaro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2010, ANNU REV NUTR, V30, P173, DOI 10.1146/annurev.nutr.012809.104755; Ak T, 2008, CHEM-BIOL INTERACT, V174, P27, DOI 10.1016/j.cbi.2008.05.003; Anand P, 2008, BIOCHEM PHARMACOL, V76, P1590, DOI 10.1016/j.bcp.2008.08.008; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; ATAL CK, 1985, J PHARMACOL EXP THER, V232, P258; Barzegar A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026012; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BEERS RF, 1952, J BIOL CHEM, V195, P133; Best L, 2007, BIOCHEM PHARMACOL, V73, P1768, DOI 10.1016/j.bcp.2007.02.006; Bhardwaj RK, 2002, J PHARMACOL EXP THER, V302, P645, DOI 10.1124/jpet.102.034728; BLUM J, 1985, ARCH BIOCHEM BIOPHYS, V240, P500, DOI 10.1016/0003-9861(85)90056-6; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Bruckbauer A, 2013, DIABETES METAB SYNDR, V6, P93, DOI 10.2147/DMSO.S40840; Burgos-Moron E, 2010, INT J CANCER, V126, P1771, DOI 10.1002/ijc.24967; Choi S, 2013, FOOD CHEM, V141, P3627, DOI 10.1016/j.foodchem.2013.06.028; Cubero FJ, 2011, MOL PATHOL LIB, V5, P427, DOI 10.1007/978-1-4419-7107-4_28; Dillard CJ, 2000, J SCI FOOD AGR, V80, P1744, DOI [10.1002/1097-0010(20000915)80:12<1744::AID-JSFA725>3.0.CO;2-W, 10.1002/1097-0010(20000915)80:12&lt;1744::AID-JSFA725&gt;3.0.CO;2-W]; DUBOWSKI KM, 1962, CLIN CHEM, V8, P215; Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966; Fujiwara H, 2008, DIABETES RES CLIN PR, V80, P185, DOI 10.1016/j.diabres.2007.12.004; Gupta SC, 2013, BIOFACTORS, V39, P2, DOI 10.1002/biof.1079; Gutierres VO, 2012, BRIT J NUTR, V108, P440, DOI 10.1017/S0007114511005769; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; International Diabetes Federation (IDF, 2014, IDF DIABETES ATLAS, P29; Kim T, 2009, BIOCHEM BIOPH RES CO, V388, P377, DOI 10.1016/j.bbrc.2009.08.018; Kohn HI, 1944, J PHARMACOL EXP THER, V82, P292; KONO Y, 1983, J BIOL CHEM, V258, P3646; Koruk M, 2004, ANN CLIN LAB SCI, V34, P57; Lee AYW, 1999, FASEB J, V13, P23, DOI 10.1096/fasebj.13.1.23; Leturque A, 2009, AM J PHYSIOL-ENDOC M, V296, pE985, DOI 10.1152/ajpendo.00004.2009; LEVINE RL, 1994, METHOD ENZYMOL, V233, P346; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lucchesi AN, 2013, ACTA CIR BRAS, V28, P505; Madonna R, 2011, VASC PHARMACOL, V54, P68, DOI 10.1016/j.vph.2011.03.005; McCann FJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0049894, 10.1371/journal.pone.0052013]; Meghana K, 2007, EUR J PHARMACOL, V577, P183, DOI 10.1016/j.ejphar.2007.09.002; Meng B, 2013, CURR PHARM DESIGN, V19, P2101; Mori DM, 2003, BIOTECHNOL APPL BIOC, V38, P183, DOI 10.1042/BA20030034; Morsy MA, 2013, ADV PHARMACOL SCI, V2013, DOI 10.1155/2013/387071; Murugan P, 2007, BASIC CLIN PHARMACOL, V101, P241, DOI 10.1111/j.1742-7843.2007.00109.x; Na LX, 2011, NUTR METAB CARDIOVAS, V21, P526, DOI 10.1016/j.numecd.2009.11.009; Nabavi SF, 2012, BIOL TRACE ELEM RES, V145, P369, DOI 10.1007/s12011-011-9194-7; Neyrinck AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081252; Okada K, 2001, J NUTR, V131, P2090, DOI 10.1093/jn/131.8.2090; Pan MH, 1999, DRUG METAB DISPOS, V27, P486; Pari L, 2010, MOL CELL BIOCHEM, V341, P109, DOI 10.1007/s11010-010-0442-5; Perera Pathirage Kamal, 2012, Pharmacogn Rev, V6, P37, DOI 10.4103/0973-7847.95863; Pilz J, 2000, J CHROMATOGR B, V742, P315, DOI 10.1016/S0378-4347(00)00174-2; PIYACHATURAWAT P, 1983, TOXICOL LETT, V16, P351, DOI 10.1016/0378-4274(83)90198-4; Prabhakar PK, 2013, PHYTOMEDICINE, V20, P488, DOI 10.1016/j.phymed.2012.12.004; Prasad S, 2014, CANCER RES TREAT, V46, P2, DOI 10.4143/crt.2014.46.1.2; RAVINDRANATH V, 1980, TOXICOLOGY, V16, P259, DOI 10.1016/0300-483X(80)90122-5; Rush JWE, 2003, CLIN BIOCHEM, V36, P345, DOI 10.1016/S0009-9120(03)00039-0; Sahebkar A, 2013, BIOFACTORS, V39, P197, DOI 10.1002/biof.1062; SEDLAK J, 1968, ANAL BIOCHEM, V25, P192, DOI 10.1016/0003-2697(68)90092-4; Sharma RA, 2004, CLIN CANCER RES, V10, P6847, DOI 10.1158/1078-0432.CCR-04-0744; Shoba G, 1998, PLANTA MED, V64, P353, DOI 10.1055/s-2006-957450; Sindhu RK, 2004, CLIN EXP HYPERTENS, V26, P43, DOI 10.1081/CEH-120027330; Singh DV, 2013, J MOL MODEL, V19, P227, DOI 10.1007/s00894-012-1535-8; SINGH J, 1986, J PHARMACOL EXP THER, V236, P488; Solano Maria P, 2006, Cardiol Rev, V14, P125, DOI 10.1097/01.crd.0000188034.76283.5e; Sun M, 2012, NANOMEDICINE-UK, V7, P1085, DOI [10.2217/NNM.12.80, 10.2217/nnm.12.80]; Suresh D, 2006, CAN J PHYSIOL PHARM, V84, P1259, DOI 10.1139/Y06-074; Suresh D, 2010, INDIAN J MED RES, V131, P682; Taniguchi N, 1996, DIABETES, V45, pS81, DOI 10.2337/diab.45.3.S81; TRINDER P, 1969, J CLIN PATHOL, V22, P246, DOI 10.1136/jcp.22.2.246-b; Vareed SK, 2008, CANCER EPIDEM BIOMAR, V17, P1411, DOI 10.1158/1055-9965.EPI-07-2693; Videla LA, 2009, WORLD J HEPATOL, V1, P72, DOI 10.4254/wjh.v1.i1.72; Volak LP, 2008, DRUG METAB DISPOS, V36, P1594, DOI 10.1124/dmd.108.020552; Wang CZ, 2007, AM J CHINESE MED, V35, P543, DOI 10.1142/S0192415X07005053	70	42	42	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113993	10.1371/journal.pone.0113993	http://dx.doi.org/10.1371/journal.pone.0113993			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469699	Green Submitted, Green Published, gold			2022-12-26	WOS:000349128700062
J	Liu, YG; Guo, QS; Sun, YG; Ma, XY				Liu, Yuangang; Guo, Qingsheng; Sun, Yageng; Ma, Xiaoya			A Combined Approach to Cartographic Displacement for Buildings Based on Skeleton and Improved Elastic Beam Algorithm	PLOS ONE			English	Article							MAP GENERALIZATION	Scale reduction from source to target maps inevitably leads to conflicts of map symbols in cartography and geographic information systems (GIS). Displacement is one of the most important map generalization operators and it can be used to resolve the problems that arise from conflict among two or more map objects. In this paper, we propose a combined approach based on constraint Delaunay triangulation (CDT) skeleton and improved elastic beam algorithm for automated building displacement. In this approach, map data sets are first partitioned. Then the displacement operation is conducted in each partition as a cyclic and iterative process of conflict detection and resolution. In the iteration, the skeleton of the gap spaces is extracted using CDT. It then serves as an enhanced data model to detect conflicts and construct the proximity graph. Then, the proximity graph is adjusted using local grouping information. Under the action of forces derived from the detected conflicts, the proximity graph is deformed using the improved elastic beam algorithm. In this way, buildings are displaced to find an optimal compromise between related cartographic constraints. To validate this approach, two topographic map data sets (i.e., urban and suburban areas) were tested. The results were reasonable with respect to each constraint when the density of the map was not extremely high. In summary, the improvements include (1) an automated parameter-setting method for elastic beams, (2) explicit enforcement regarding the positional accuracy constraint, added by introducing drag forces, (3) preservation of local building groups through displacement over an adjusted proximity graph, and (4) an iterative strategy that is more likely to resolve the proximity conflicts than the one used in the existing elastic beam algorithm.	[Liu, Yuangang; Guo, Qingsheng; Sun, Yageng; Ma, Xiaoya] Wuhan Univ, Sch Resource & Environm Sci, Wuhan 430072, Peoples R China; [Guo, Qingsheng] Wuhan Univ, State Key Lab Informat Engn Surveying Mapping & R, Wuhan 430072, Peoples R China; [Liu, Yuangang] Yangtze Univ, Sch Geosci, Wuhan, Peoples R China	Wuhan University; Wuhan University; Yangtze University	Guo, QS (corresponding author), Wuhan Univ, Sch Resource & Environm Sci, Wuhan 430072, Peoples R China.	guoqingsheng@whu.edu.cn			National Natural Science Foundation of China [41471384, 41171350]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding: This research was supported in part by the National Natural Science Foundation of China (Grant No. 41471384, No. 41171350). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGENT CONS, 2001, DD3 AGENT CONS; Ai T., 2002, P JOINT WORKSH MULT; Ai T.H., 2000, ACTA GEODAETICAET CA, V29, P348, DOI DOI 10.3321/J.1001-1595.2000.04.012; Ai TH, 2007, LECT NOTES GEOINF CA, P153, DOI 10.1007/978-3-540-72385-1_9; [艾廷华 AI Tinghua], 2007, [测绘学报, Acta Geodetica et Cartographica Sinica], V36, P231; Bader M, 2005, INT J GEOGR INF SCI, V19, P915, DOI 10.1080/13658810500161237; Bader M, 2000, P 5 INT C GEOCOMPUTA; Bader M, 2001, THESIS U ZURICH SWIT; Basaraner M, 2011, B CIENC GEOD, V17, P161, DOI 10.1590/S1982-21702011000200001; Beard K., 1991, MAP GENERALISATION M, P121; Bobrich J, 2001, P 3 20 INT CART C BE, V3, P2032; Bundy GL, 1995, GIS GEN METHODOLOGY, P106; Burghardt D., 1997, SMATI 97 SEMANTIC MO, P114; CECCONI A, 2003, THESIS U ZURICH SWIT; Fei LF, 2004, THESIS U HANNOVER HA; Guan T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098806; Guan T, 2014, IEEE MULTIMEDIA, V21, P32, DOI 10.1109/MMUL.2013.31; Guan T, 2013, IEEE T MULTIMEDIA, V15, P1688, DOI 10.1109/TMM.2013.2265674; Guo QS, 2007, SPATIAL REASONING PR, P152; Harrie L, 2003, CARTOGR J, V40, P221, DOI 10.1179/000870403225012925; Harrie L, 2002, GEOINFORMATICA, V6, P233, DOI 10.1023/A:1019765902987; Harrie L.E., 1999, CARTOGR GEOGR INF SC, V26, P55, DOI DOI 10.1559/152304099782424884; Hojholt P., 2000, CARTOGR GEOGRAPH INF, V27, P65, DOI [DOI 10.1559/152304000783548028, 10.1559/152304000783548028]; Jager E., 1991, 15 C ICA, P245; Ji RR, 2014, IEEE T IMAGE PROCESS, V23, P3099, DOI 10.1109/TIP.2014.2324291; Ji RR, 2013, IEEE T MULTIMEDIA, V15, P153, DOI 10.1109/TMM.2012.2225035; Ji RR, 2012, IEEE T IMAGE PROCESS, V21, P2282, DOI 10.1109/TIP.2011.2176950; Jones C.B., 1995, CARTOGR GEOGR INF SC, V22, P317, DOI [DOI 10.1559/152304095782540221, 10.1559/152304095782540221]; Jones C.B., 1997, GEOGRAPHICAL INFORM, DOI 10.4324/9781315846231; Jones CB, 2005, INT J GEOGR INF SCI, V19, P859, DOI 10.1080/13658810500161104; Jones CB, 1999, VISUAL COMPUT, V15, P235, DOI 10.1007/s003710050175; Li Z, 2004, INT J GEOGR INF SCI, V18, P513, DOI 10.1080/13658810410001702021; LICHTNER W, 1979, GEO-PROCESSING, V1, P183; Lonergan M, 2001, ALGORITHMICA, V30, P287, DOI 10.1007/s00453-001-0011-0; Mackaness W.A., 1994, CARTOGR GEOGR INF SC, V21, P219, DOI [https://doi.org/10.1559/152304094782540646, DOI 10.1559/152304094782540646]; Nickerson B.G., 1988, CARTOGR INT J GEOGR, V25, P15, DOI [10.3138/4144-3U7G-MW01-1Q72, DOI 10.3138/4144-3U7G-MW01-1Q72]; Preparata F.P., 1985, COMPUTATIONAL GEOMET; Regnauld N, 2001, ALGORITHMICA, V30, P312, DOI 10.1007/s00453-001-0008-8; Roosta SH, 2000, PARALLEL PROCESSING, P114; Ruas A, 1998, INT J GEOGR INF SCI, V12, P789, DOI 10.1080/136588198241509; Sester M, 2005, INT J GEOGR INF SCI, V19, P871, DOI 10.1080/13658810500161179; Steiniger S, 2007, THESIS U ZURICH SWIT; Stoter J, 2014, CARTOGR GEOGR INF SC, V41, P1, DOI 10.1080/15230406.2013.824637; Swiss Society of Cartography, 2005, TOP MAPS MAP GRAPH G; Thom S, 2006, P 12 INT S SPAT DAT, P659; van der Poorten PM, 2002, INT J GEOGR INF SCI, V16, P773, DOI 10.1080/13658810210149434; Ware J., 2002, P 10 ACM INT S ADV G, P101; Ware J. M., 1998, GeoInformatica, V2, P383, DOI 10.1023/A:1009713606524; Ware JM, 2003, INT J GEOGR INF SCI, V17, P743, DOI 10.1080/13658810310001596085; Weibel R., 1998, P 8 INT S SPAT DAT H, P214; Wilson ID, 2003, COMPUT IND, V52, P291, DOI 10.1016/S0166-3615(03)00132-5; Yan HW, 2008, COMPUT GEOSCI-UK, V34, P939, DOI 10.1016/j.cageo.2007.07.008; Zhang X, 2013, GEOINFORMATICA, V17, P1, DOI 10.1007/s10707-011-0146-3	53	13	13	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113953	10.1371/journal.pone.0113953	http://dx.doi.org/10.1371/journal.pone.0113953			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470727	Green Submitted, gold, Green Published			2022-12-26	WOS:000349128700057
J	Bautista-Amorocho, H; Castellanos-Dominguez, YZ; Rodriguez-Villamizar, LA; Velandia-Cruz, SA; Becerra-Pena, JA; Farfan-Garcia, AE				Bautista-Amorocho, Henry; Zulay Castellanos-Dominguez, Yeny; Andrea Rodriguez-Villamizar, Laura; Alejandra Velandia-Cruz, Sindi; Andrey Becerra-Pena, Jeysson; Elvira Farfan-Garcia, Ana			Epidemiology, Risk Factors and Genotypes of HBV in HIV-Infected Patients in the Northeast Region of Colombia: High Prevalence of Occult Hepatitis B and F3 Subgenotype Dominance	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; C VIRUS; MOLECULAR CHARACTERIZATION; OUTCOMES; ASSOCIATION; COINFECTION; PREDICTORS; FREQUENCY; MUTANTS; AGE	Introduction: Chronic hepatitis B virus (HBV) infection is an increasing cause of morbidity and mortality in human immunodeficiency virus (HIV)-infected individuals. HIV-positive patients are commonly co-infected with HBV due to shared routes of transmission. Objectives: Our aim was to determine the risk factors, prevalence, genotypes, and mutations of the Surface S gene of HBV, and occult hepatitis B infection (OBI) among patients infected with HIV in a northeastern Colombian city. Methods: A cross-sectional study was conducted with 275 HIV-positive patients attending an outpatient clinic in Bucaramanga, Colombia during 2009-2010. Blood samples were collected and screened for serological markers of HBV (anti-HBs, anti-HBc and HBsAg) through ELISA assay. Regardless of their serological profile, all samples were tested for the HBV S gene by nested-PCR and HBV genotypes were determined by phylogenetic inference. Clinical records were used to examine demographic, clinical, virological, immunological and antiretroviral therapy (ART) variables of HIV infection. Results: Participants were on average 37 +/- 11 years old and 65.1% male. The prevalence of HIV-HBV coinfection was 12% (95% CI 8.4-16.4) of which 3.3% had active HBV infection and 8.7% OBI. The prevalence of HIV-HBV coinfection was associated with AIDS stage and ART treatment. Sequence analysis identified genotype F, subgenotype F3 in 93.8% of patients and genotype A in 6.2% of patients. A C149R mutation, which may have resulted from failure in HBsAg detection, was found in one patient with OBI. Conclusions: The present study found a high prevalence of HIV-HBV coinfection with an incidence of OBI 2.6-fold higher compared to active HBV infection. These findings suggest including HBV DNA testing to detect OBI in addition to screening for HBV serological markers in HIV patients.	[Bautista-Amorocho, Henry; Zulay Castellanos-Dominguez, Yeny; Alejandra Velandia-Cruz, Sindi; Andrey Becerra-Pena, Jeysson; Elvira Farfan-Garcia, Ana] Univ Santander UDES, Bacteriol & Clin Lab Program, Dept Hlth Sci, CliniUDES Res Grp,Lab Biomed & Biotechnol Res, Santander, Spain; [Andrea Rodriguez-Villamizar, Laura] Ind Univ Santander UIS, Dept Publ Hlth, Sch Med, Res Grp Demog Publ Hlth & Hlth Syst GUINDESS, Santander, Spain		Bautista-Amorocho, H (corresponding author), Univ Santander UDES, Bacteriol & Clin Lab Program, Dept Hlth Sci, CliniUDES Res Grp,Lab Biomed & Biotechnol Res, Santander, Spain.	henrybau33@gmail.com	Rodriguez, Laura/GWC-8446-2022	Castellanos-Dominguez, Yeny Zulay/0000-0001-5881-1998; Farfan Garcia, Ana Elvira/0000-0002-9691-0759; Rodriguez-Villamizar, Laura Andrea/0000-0002-5551-2586; Velandia, Sindi/0000-0001-8953-6124	Universidad de Santander - UDES [001-12-2012, 025-13 2013]	Universidad de Santander - UDES	The study was funded by Universidad de Santander - UDES research grant numbers 001-12-2012 and 025-13 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Mora MVA, 2011, INFECT GENET EVOL, V11, P103, DOI 10.1016/j.meegid.2010.10.003; Alvarado-Mora MV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018888; [Anonymous], 2013, GLOBAL REPORT UNAIDS; Attia KA, 2012, WORLD J HEPATOL, V4, P218, DOI 10.4254/wjh.v4.i7.218; Avellon A, 2006, J MED VIROL, V78, P24, DOI 10.1002/jmv.20516; Awerkiew S, 2007, J CLIN VIROL, V38, P83, DOI 10.1016/j.jcv.2006.10.006; Badur S, 2001, J CLIN VIROL, V21, P229, DOI 10.1016/S1386-6532(01)00147-0; Chun HM, 2012, J INFECT DIS, V205, P185, DOI 10.1093/infdis/jir720; Day SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059346; Gupta S, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-53; Hoyos-Orrego Alvaro, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P321, DOI 10.1590/S0036-46652006000600004; Ikeda K, 2009, J VIRAL HEPATITIS, V16, P437, DOI 10.1111/j.1365-2893.2009.01085.x; Kew MC, 2010, WORLD J HEPATOL, V2, P65, DOI 10.4254/wjh.v2.i2.65; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kwei K, 2013, J VIROL, V87, P2352, DOI 10.1128/JVI.02701-12; Liang SH, 2010, JAIDS-J ACQ IMM DEF, V54, P122, DOI 10.1097/QAI.0b013e3181daafd5; Lo Re V, 2007, JAIDS-J ACQ IMM DEF, V44, P315, DOI 10.1097/QAI.0b013e31802ea499; Marchesini Angela Mattos, 2007, Rev. Saúde Pública, V41, P57, DOI 10.1590/S0034-89102007000900010; Martin-Carbonero L, 2011, AIDS, V25, P73, DOI 10.1097/QAD.0b013e328340fde2; Martinez E, 2007, HIV MED, V8, P251, DOI 10.1111/j.1468-1293.2007.00468.x; Mendes-Correa Maria Cassia J., 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P81, DOI 10.1590/S0036-46652000000200004; Ministerio de Salud y Proteccion Social. Instituto Nacional de Salud, 2014, PROT VIG SAL PUBL HE; Braga WSM, 2006, REV SOC BRAS MED TRO, V39, P519, DOI 10.1590/S0037-86822006000600001; Moradi A, 2012, VIRUS GENES, V44, P382, DOI 10.1007/s11262-012-0715-z; Mphahlele MJ, 2006, J CLIN VIROL, V35, P14, DOI 10.1016/j.jcv.2005.04.003; Nebbia G, 2007, J MED VIROL, V79, P1464, DOI 10.1002/jmv.20954; Opaleye OO, 2014, J TROP MED-US, V2014, DOI 10.1155/2014/796121; Otero JA, 2013, REV OBSERVATORIO SAL, V2, P3; Pal A, 2013, VIROLOGY, V436, P134, DOI 10.1016/j.virol.2012.11.003; Pereira RARD, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-34; Quarleri J, 2007, AIDS RES HUM RETROV, V23, P525, DOI 10.1089/aid.2006.0172; Raimondo G, 2008, J HEPATOL, V49, P652, DOI 10.1016/j.jhep.2008.07.014; Raimondo G, 2013, SEMIN IMMUNOPATHOL, V35, P39, DOI 10.1007/s00281-012-0327-7; Rodriguez L, 2000, MEM I OSWALDO CRUZ, V95, P243, DOI 10.1590/S0074-02762000000200019; RUSTGI VK, 1984, ANN INTERN MED, V101, P795, DOI 10.7326/0003-4819-101-6-795; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Samal J, 2012, CLIN MICROBIOL REV, V25, P142, DOI 10.1128/CMR.00018-11; Schmeltzer P, 2010, DIGEST DIS SCI, V55, P3328, DOI 10.1007/s10620-010-1413-0; Shi Y, 2012, LIVER INT, V32, P231, DOI 10.1111/j.1478-3231.2011.02481.x; Souza Milta Gomes de, 2004, Rev. Soc. Bras. Med. Trop., V37, P391; Stuart JWTC, 2009, J MED VIROL, V81, P441, DOI 10.1002/jmv.21422; Sucupira MVF, 2006, MEM I OSWALDO CRUZ, V101, P655, DOI 10.1590/S0074-02762006000600013; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Te Helen S, 2010, Clin Liver Dis, V14, P1, DOI 10.1016/j.cld.2009.11.009; Torres-Baranda Rodrigo, 2006, Ann Hepatol, V5, P34; Tyson GL, 2013, HEPATOLOGY, V58, P538, DOI 10.1002/hep.26400; WHO | Age Groups And Populations, 2019, WHO AG GROUPS POP; Zahn A, 2008, J GEN VIROL, V89, P409, DOI 10.1099/vir.0.83347-0; Zobeiri M, 2013, HEPAT RES TREAT, V259148, P1	50	15	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114272	10.1371/journal.pone.0114272	http://dx.doi.org/10.1371/journal.pone.0114272			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25462190	gold, Green Submitted, Green Published			2022-12-26	WOS:000345869700125
J	Kim, S; Jin, B; Choi, SH; Han, KH; Ahn, SH				Kim, Seungtaek; Jin, Bora; Choi, Sung Hoon; Han, Kwang-Hyub; Ahn, Sang Hoon			Casein Kinase II Inhibitor Enhances Production of Infectious Genotype 1a Hepatitis C Virus (H77S)	PLOS ONE			English	Article							NONSTRUCTURAL PROTEIN 5A; PLUS RIBAVIRIN; CK2; PHOSPHORYLATION; REPLICATION; CULTURE; ENTRY; NS2	Genotype 2a JFH1 virus has substantially contributed to the progress of HCV biology by allowing entire viral life cycle of HCV in cell culture. Using this genotype 2a virus, casein kinase II (CKII) was previously identified as a crucial host factor in virus assembly by phosphorylating NS5A. Since most of the prior studies employed genotype 2a JFH1 or JFH1-based intragenotypic chimera, we used genotype 1a H77S to study virus assembly. CKII inhibition by chemical inhibitors enhanced H77S virus production in contrast to that of JFH1 virus, but genetic inhibition of CKII by siRNA did not change H77S virus titer significantly. The different outcomes from these two approaches of CKII inhibition suggested that nonspecific target kinase of CKII inhibitors plays a role in increasing H77S virus production and both viral and host factors were investigated in this study. Our results emphasize substantial differences among the HCV genotypes that should be considered in both basic research and clinical practices.	[Kim, Seungtaek; Han, Kwang-Hyub] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Kim, Seungtaek; Han, Kwang-Hyub; Ahn, Sang Hoon] Yonsei Univ, Coll Med, Dept Internal Med, Inst Gastroenterol, Seoul, South Korea; [Jin, Bora; Choi, Sung Hoon; Han, Kwang-Hyub; Ahn, Sang Hoon] Yonsei Univ, Coll Med, Brain Korea Plus Project Med Sci 21, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, S (corresponding author), Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea.	kimst@yuhs.ac		Han, Kwang-Hyub/0000-0003-3960-6539; Ahn, Sang Hoon/0000-0002-3629-4624	National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A1A2008346]	National Research Foundation of Korea (NRF) - Ministry of Education	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A2008346). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain J, 2003, BIOCHEM J, V371, P199, DOI 10.1042/BJ20021535; Blight KJ, 2002, J VIROL, V76, P13001, DOI 10.1128/JVI.76.24.13001-13014.2002; Cozza G, 2011, CURR MED CHEM, V18, P2867, DOI 10.2174/092986711796150423; Evans MJ, 2004, P NATL ACAD SCI USA, V101, P13038, DOI 10.1073/pnas.0405152101; Franck N, 2005, J VIROL, V79, P2700, DOI 10.1128/JVI.79.5.2700-2708.2005; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Kim J, 1999, BIOCHEM BIOPH RES CO, V257, P777, DOI 10.1006/bbrc.1999.0460; Kim S, 2013, J VIROL, V87, P4214, DOI 10.1128/JVI.00954-12; Kim S, 2011, J VIROL, V85, P6645, DOI 10.1128/JVI.02156-10; Lange CM, 2013, J HEPATOL, V58, P583, DOI 10.1016/j.jhep.2012.10.019; Lemay KL, 2013, J VIROL, V87, P1255, DOI 10.1128/JVI.02154-12; Lemon SM, 2007, FIELDS VIROLOGY, V1, P1253; Lindenbach BD, 2013, NAT REV MICROBIOL, V11, P688, DOI 10.1038/nrmicro3098; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Marjuki Henju, 2008, J Mol Signal, V3, P13, DOI 10.1186/1750-2187-3-13; Masaki T, 2008, J VIROL, V82, P7964, DOI 10.1128/JVI.00826-08; Meggio F, 2003, FASEB J, V17, P349, DOI 10.1096/fj.02-0473rev; Pagano MA, 2004, J MED CHEM, V47, P6239, DOI 10.1021/jm049854a; Pagano MA, 2007, CHEMBIOCHEM, V8, P129, DOI 10.1002/cbic.200600293; Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7; Ross-Thriepland D, 2014, J VIROL, V88, P1421, DOI 10.1128/JVI.03017-13; Sambrook J., 2001, MOL CLONING LAB MANU; Sarno S, 2003, BIOCHEM J, V374, P639, DOI 10.1042/BJ20030674; Scheel TKH, 2013, NAT MED, V19, P837, DOI 10.1038/nm.3248; Shimakami T, 2011, GASTROENTEROLOGY, V140, P667, DOI 10.1053/j.gastro.2010.10.056; Siddiqui-Jain A, 2010, CANCER RES, V70, P10288, DOI 10.1158/0008-5472.CAN-10-1893; Smith DB, 2014, HEPATOLOGY, V59, P318, DOI 10.1002/hep.26744; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Yamane D, 2014, NAT MED, V20, P927, DOI 10.1038/nm.3610; Yi M, 2006, P NATL ACAD SCI USA, V103, P2310, DOI 10.1073/pnas.0510727103; Yi MK, 2007, J VIROL, V81, P629, DOI 10.1128/JVI.01890-06	35	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e113938	10.1371/journal.pone.0113938	http://dx.doi.org/10.1371/journal.pone.0113938			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464014	Green Published, Green Submitted, gold			2022-12-26	WOS:000345869700071
J	Morales-Cano, D; Menendez, C; Moreno, E; Moral-Sanz, J; Barreira, B; Galindo, P; Pandolfi, R; Jimenez, R; Moreno, L; Cogolludo, A; Duarte, J; Perez-Vizcaino, F				Morales-Cano, Daniel; Menendez, Carmen; Moreno, Enrique; Moral-Sanz, Javier; Barreira, Bianca; Galindo, Pilar; Pandolfi, Rachele; Jimenez, Rosario; Moreno, Laura; Cogolludo, Angel; Duarte, Juan; Perez-Vizcaino, Francisco			The Flavonoid Quercetin Reverses Pulmonary Hypertension in Rats	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ARTERIAL-HYPERTENSION; 5-HT2A RECEPTORS; NITRIC-OXIDE; EXPRESSION; SEROTONIN; APOPTOSIS; 5-HYDROXYTRYPTAMINE; PROLIFERATION; INHIBITION	Quercetin is a dietary flavonoid which exerts vasodilator, antiplatelet and antiproliferative effects and reduces blood pressure, oxidative status and end-organ damage in humans and animal models of systemic hypertension. We hypothesized that oral quercetin treatment might be protective in a rat model of pulmonary arterial hypertension. Three weeks after injection of monocrotaline, quercetin (10 mg/kg/d per os) or vehicle was administered for 10 days to adult Wistar rats. Quercetin significantly reduced mortality. In surviving animals, quercetin decreased pulmonary arterial pressure, right ventricular hypertrophy and muscularization of small pulmonary arteries. Classic biomarkers of pulmonary arterial hypertension such as the downregulated expression of lung BMPR2, Kv1.5, Kv2.1, upregulated survivin, endothelial dysfunction and hyperresponsiveness to 5-HT were unaffected by quercetin. Quercetin significantly restored the decrease in Kv currents, the upregulation of 5-HT2A receptors and reduced the Akt and S6 phosphorylation. In vitro, quercetin induced pulmonary artery vasodilator effects, inhibited pulmonary artery smooth muscle cell proliferation and induced apoptosis. In conclusion, quercetin is partially protective in this rat model of PAH. It delayed mortality by lowering PAP, RVH and vascular remodeling. Quercetin exerted effective vasodilator effects in isolated PA, inhibited cell proliferation and induced apoptosis in PASMCs. These effects were associated with decreased 5-HT2A receptor expression and Akt and S6 phosphorylation and partially restored Kv currents. Therefore, quercetin could be useful in the treatment of PAH.	[Morales-Cano, Daniel; Menendez, Carmen; Moreno, Enrique; Moral-Sanz, Javier; Barreira, Bianca; Pandolfi, Rachele; Moreno, Laura; Cogolludo, Angel; Perez-Vizcaino, Francisco] Univ Complutense Madrid, Sch Med, Dept Pharmacol, Madrid, Spain; [Morales-Cano, Daniel; Menendez, Carmen; Moreno, Enrique; Moral-Sanz, Javier; Barreira, Bianca; Pandolfi, Rachele; Moreno, Laura; Cogolludo, Angel; Perez-Vizcaino, Francisco] Ciber Enfermedades Resp CIBERES, Madrid, Spain; [Menendez, Carmen] Univ Autonoma Chile, Fac Hlth Sci, Santiago, Chile; [Galindo, Pilar; Jimenez, Rosario; Duarte, Juan] Univ Granada, Sch Pharm, Dept Pharmacol, Granada, Spain	Complutense University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Universidad Autonoma de Chile; University of Granada	Perez-Vizcaino, F (corresponding author), Univ Complutense Madrid, Sch Med, Dept Pharmacol, Madrid, Spain.	fperez@med.ucm.es	Moral-Sanz, Javier/AAB-1371-2019; JIMENEZ, ROSARIO/K-9701-2014; Moreno, Laura/A-9433-2010; Cogolludo, Angel/A-6129-2011; Duarte, Juan/AAH-1574-2020; Duarte, Juan/K-6472-2014; Perez-Vizcaino, Francisco/A-9735-2011; Cano, Daniel Morales/A-3550-2017	Moral-Sanz, Javier/0000-0001-8602-8554; JIMENEZ, ROSARIO/0000-0003-3872-2669; Moreno, Laura/0000-0001-9028-2299; Duarte, Juan/0000-0002-9153-5857; Duarte, Juan/0000-0002-9153-5857; Perez-Vizcaino, Francisco/0000-0001-6309-7418; Cano, Daniel Morales/0000-0002-1692-4633; Cogolludo, Angel/0000-0002-1382-1698; Barreira, Bianca/0000-0002-0338-8456; Pandolfi, Rachele/0000-0001-7476-2305	Spanish Ministerio de Economia y Competitividad [SAF2011-28150, SAF2010-22066-C02-01, 202]; Instituto de Salud Carlos III Red HERACLES [RD06/0009]; Miguel Servet Program [CP12/03304]; Junta de Andalucia (Proyecto de excelencia) [P12-CTS2722];  [BES-2012-051904]	Spanish Ministerio de Economia y Competitividad(Spanish Government); Instituto de Salud Carlos III Red HERACLES(Instituto de Salud Carlos III); Miguel Servet Program; Junta de Andalucia (Proyecto de excelencia)(Junta de Andalucia); 	This work was supported by grants and fellowships by the Spanish Ministerio de Economia y Competitividad (SAF2011-28150 to F.P-V, SAF2010-22066-C02-01 to JD, and 202 to AC); Instituto de Salud Carlos III Red HERACLES RD06/0009 to JD; Miguel Servet Program CP12/03304 to LM; predoctoral grants BES-2012-051904 to DMS, CM, JMS, and PG; and Junta de Andalucia (Proyecto de excelencia, P12-CTS2722). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkinson C, 2002, CIRCULATION, V105, P1672, DOI 10.1161/01.CIR.0000012754.72951.3D; Bruning A, 2013, ANTI-CANCER AGENT ME, V13, P1025, DOI 10.2174/18715206113139990114; Chan SY, 2008, J MOL CELL CARDIOL, V44, P14, DOI 10.1016/j.yjmcc.2007.09.006; Coggins MP, 2007, ARTERIOSCL THROM VAS, V27, P1877, DOI 10.1161/ATVBAHA.107.142943; Cogolludo A, 2006, CIRC RES, V98, P931, DOI 10.1161/01.RES.0000216858.04599.e1; Cogolludo A, 2007, CARDIOVASC RES, V73, P424, DOI 10.1016/j.cardiores.2006.09.008; DUARTE J, 1993, EUR J PHARMACOL, V239, P1, DOI 10.1016/0014-2999(93)90968-N; Gao HH, 2012, J BIOMED RES, V26, P98, DOI 10.1016/S1674-8301(12)60018-9; Goncharov DA, 2014, CIRCULATION, V129, P864, DOI 10.1161/CIRCULATIONAHA.113.004581; Goncharova EA, 2013, FASEB J, V27, P1796, DOI 10.1096/fj.12-222224; GRYGLEWSKI RJ, 1987, BIOCHEM PHARMACOL, V36, P317, DOI 10.1016/0006-2952(87)90288-7; Henriques-Coelho T, 2008, ENDOCRINOLOGY, V149, P4367, DOI 10.1210/en.2008-0018; Houssaini A, 2013, AM J RESP CELL MOL, V48, P568, DOI 10.1165/rcmb.2012-0429OC; Huxley RR, 2003, EUR J CLIN NUTR, V57, P904, DOI 10.1038/sj.ejcn.1601624; Kim YH, 2008, BIOCHEM PHARMACOL, V75, P1946, DOI 10.1016/j.bcp.2008.02.016; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Liu Y, 2013, EXP LUNG RES, V39, P70, DOI 10.3109/01902148.2012.758191; Lopez-Lopez JG, 2011, J PHARMACOL EXP THER, V338, P400, DOI 10.1124/jpet.111.179515; Mathew R, 2004, CIRCULATION, V110, P1499, DOI 10.1161/01.CIR.0000141576.39579.23; McMurtry MS, 2005, J CLIN INVEST, V115, P1479, DOI 10.1172/JCI23203; Menendez C, 2011, MOL NUTR FOOD RES, V55, P1780, DOI 10.1002/mnfr.201100378; Menendez C, 2011, BRIT J NUTR, V105, P1287, DOI 10.1017/S0007114510004952; Moon SK, 2003, BIOCHEM BIOPH RES CO, V301, P1069, DOI 10.1016/S0006-291X(03)00091-3; Moral-Sanz J, 2012, EXP PHYSIOL, V97, P676, DOI 10.1113/expphysiol.2011.062257; Morecroft I, 2005, J PHARMACOL EXP THER, V313, P539, DOI 10.1124/jpet.104.081182; Morty RE, 2007, ARTERIOSCL THROM VAS, V27, P1072, DOI 10.1161/ATVBAHA.107.141200; Nakamura T, 2011, AM J RESP CELL MOL, V44, P614, DOI 10.1165/rcmb.2010-0338OC; Nasim MT, 2012, HUM MOL GENET, V21, P2548, DOI 10.1093/hmg/dds073; O'Callaghan DS, 2011, NAT REV CARDIOL, V8, P526, DOI 10.1038/nrcardio.2011.104; Perez-Vizcaino F, 2006, FREE RADICAL RES, V40, P1054, DOI 10.1080/10715760600823128; Perez-Vizcaino F, 2006, BIOCHEM BIOPH RES CO, V346, P919, DOI 10.1016/j.bbrc.2006.05.198; Perez-Vizcaino F, 2010, MOL ASPECTS MED, V31, P478, DOI 10.1016/j.mam.2010.09.002; Perez-Vizcaino F, 2009, PHARMACOL REP, V61, P67, DOI 10.1016/S1734-1140(09)70008-8; Pratheeshkumar P, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047516, 10.1371/journal.pone.0052279]; Rabinovitch M, 2008, J CLIN INVEST, V118, P2372, DOI 10.1172/JCI33452; Ramos M, 2007, VASC PHARMACOL, V46, P439, DOI 10.1016/j.vph.2007.01.005; Sahara M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033367; Sanchez M, 2006, J HYPERTENS, V24, P75, DOI 10.1097/01.hjh.0000198029.22472.d9; Sato K, 2000, J SURG RES, V90, P138, DOI 10.1006/jsre.2000.5869; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Stenmark KR, 2009, AM J PHYSIOL-LUNG C, V297, pL1013, DOI 10.1152/ajplung.00217.2009; Thomas BJ, 2003, EUR J PHARMACOL, V477, P153, DOI 10.1016/j.ejphar.2003.08.015; Tribolo S, 2013, J AGR FOOD CHEM, V61, P8589, DOI 10.1021/jf402511c; Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4; Yoshizumi M, 2002, BIOCHEM BIOPH RES CO, V293, P1458, DOI 10.1016/S0006-291X(02)00407-2; Yuan JXJ, 1998, CIRCULATION, V98, P1400, DOI 10.1161/01.CIR.98.14.1400; Zhang Y, 2012, MOL BIOL REP, V39, P7785, DOI 10.1007/s11033-012-1621-0	47	59	62	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114492	10.1371/journal.pone.0114492	http://dx.doi.org/10.1371/journal.pone.0114492			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460361	Green Published, gold			2022-12-26	WOS:000345869700138
J	Westernstroer, B; Terwort, N; Ehmcke, J; Wistuba, J; Schlatt, S; Neuhaus, N				Westernstroeer, Birgit; Terwort, Nicole; Ehmcke, Jens; Wistuba, Joachim; Schlatt, Stefan; Neuhaus, Nina			Profiling of Cxcl12 Receptors, Cxcr4 and Cxcr7 in Murine Testis Development and a Spermatogenic Depletion Model Indicates a Role for Cxcr7 in Controlling Cxcl12 Activity	PLOS ONE			English	Article							GERM-CELL MIGRATION; ATYPICAL CHEMOKINE RECEPTORS; MOUSE SERTOLI-CELLS; STEM-CELLS; UNDIFFERENTIATED SPERMATOGONIA; SELF-RENEWAL; BETA-ARRESTIN; EXPRESSION PATTERNS; NICHE; RECOVERY	In mice the chemokine Cxcl12 and its receptor Cxcr4 participate in maintenance of the spermatogonial population during postnatal development. More complexity arises since Cxcl12 also binds to the non-classical/atypical chemokine receptor Cxcr7. We explored the expression pattern of Cxcl12, Cxcr4 and Cxcr7 during postnatal development in mouse testes and investigated the response of Cxcl12, Cxcr4, Cxcr7 and SSC-niche associated factors to busulfan-induced germ cell depletion and subsequent recovery by RNA expression analysis and localization of the proteins. In neonatal testes transcript levels of Cxcl12, Cxcr4 and Cxcr7 were relatively low and protein expression of Cxcr7 was restricted to gonocytes and spermatogonia. During development, RNA expression of Cxcl12 remained stable but that of Cxcr4 and Cxcr7 increased. Cxcr7 was expressed in germ cells located at the basement membrane of the seminiferous tubules. In adult testes, transcript levels of Cxcl12 were highest while the localization of Cxcr7 did not change. Following germ cell depletion, a significantly increased expression of Cxcl12 and a decreased expression of Cxcr7 were observed. Germ cells repopulating the seminiferous tubules were immunopositive for Cxcr7. We conclude that Cxcr7 expression to be restricted to premeiotic germ cells throughout postnatal testicular development and during testicular recovery. Hence, the spermatogonial population may not only be simply controlled by interaction of Cxcl12 with Cxcr4 but may also involve Cxcr7 as an important player.	[Westernstroeer, Birgit; Terwort, Nicole; Wistuba, Joachim; Schlatt, Stefan; Neuhaus, Nina] Univ Munster, Inst Reprod & Regenerat Biol, Ctr Reprod Med & Androl, D-48149 Munster, Germany; [Ehmcke, Jens] Univ Munster, Fac Med, Cent Anim Facil, D-48149 Munster, Germany	University of Munster; University of Munster	Schlatt, S (corresponding author), Univ Munster, Inst Reprod & Regenerat Biol, Ctr Reprod Med & Androl, D-48149 Munster, Germany.	Stefan.Schlatt@ukmuenster.de		Schlatt, Stefan/0000-0002-7571-5313; Neuhaus, Nina/0000-0003-0181-6194	Innovative Medical Research of the Medical Faculty, University Munster (IMF) [KO 111014]	Innovative Medical Research of the Medical Faculty, University Munster (IMF)	The study was primarily supported by a grant from the Innovative Medical Research of the Medical Faculty, University Munster (IMF, KO 111014). Additional funds for animal handling and histological aspects of the experimental work were provided by the DFG Sachbeihilfen SCHL394/9-1 and 11-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ara T, 2003, P NATL ACAD SCI USA, V100, P5319, DOI 10.1073/pnas.0730719100; Boldajipour B, 2008, CELL, V132, P463, DOI 10.1016/j.cell.2007.12.034; BRINKWORTH MH, 1995, J REPROD FERTIL, V105, P25, DOI 10.1530/jrf.0.1050025; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Cancellieri C, 2013, BIOCHEM SOC T, V41, P231, DOI 10.1042/BST20120246; Comerford I, 2007, BIOESSAYS, V29, P237, DOI 10.1002/bies.20537; Dambly-Chaudiere C, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-23; Decaillot FM, 2011, J BIOL CHEM, V286, P32188, DOI 10.1074/jbc.M111.277038; Dettin L, 2003, BIOL REPROD, V69, P1565, DOI 10.1095/biolreprod.103.016394; Ebata KT, 2005, MOL REPROD DEV, V72, P171, DOI 10.1002/mrd.20324; Ehmcke J, 2007, REPRODUCTION, V133, P75, DOI 10.1530/REP-06-0148; EVA C, 1993, DNA CELL BIOL, V12, P393, DOI 10.1089/dna.1993.12.393; Gassei K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053976; Gaytan F, 2013, ENDOCRINOLOGY, V154, P1321, DOI 10.1210/en.2012-1745; Georgiou KR, 2012, INT J EXP PATHOL, V93, P104, DOI 10.1111/j.1365-2613.2011.00800.x; Hess RA, 2006, CELL CYCLE, V5, P1164, DOI 10.4161/cc.5.11.2775; Kanatsu-Shinohara M, 2012, CELL STEM CELL, V11, P567, DOI 10.1016/j.stem.2012.06.011; Kostereva N, 2008, REPROD DOMEST ANIM, V43, P386, DOI 10.1111/j.1439-0531.2008.01189.x; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Kubota H, 2004, BIOL REPROD, V71, P722, DOI 10.1095/biolreprod.104.029207; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luker KE, 2009, BIOTECHNIQUES, V47, P625, DOI 10.2144/000113126; Mahabaleshwar H, 2012, DEVELOPMENT, V139, P2897, DOI 10.1242/dev.080408; Mahabaleshwar H, 2008, CELL ADHES MIGR, V2, P69, DOI 10.4161/cam.2.2.6027; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; McIver SC, 2013, ANDROLOGY-US, V1, P517, DOI 10.1111/j.2047-2927.2013.00081.x; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Molyneaux KA, 2003, DEVELOPMENT, V130, P4279, DOI 10.1242/dev.00640; Nibbs RJB, 2013, NAT REV IMMUNOL, V13, P815, DOI 10.1038/nri3544; O'Shaughnessy PJ, 2008, REPRODUCTION, V135, P839, DOI 10.1530/REP-08-0012; Oatley JM, 2006, P NATL ACAD SCI USA, V103, P9524, DOI 10.1073/pnas.0603332103; Oatley JM, 2009, DEVELOPMENT, V136, P1191, DOI 10.1242/dev.032243; Payne CJ, 2010, STEM CELLS, V28, P1424, DOI 10.1002/stem.464; Pellegrino J, 2012, DEV BIOL, V369, P349, DOI 10.1016/j.ydbio.2012.07.006; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Rajagopal S, 2010, P NATL ACAD SCI USA, V107, P628, DOI 10.1073/pnas.0912852107; Ryu BY, 2006, STEM CELLS, V24, P1505, DOI 10.1634/stemcells.2005-0580; Shetty G, 2007, CELL STEM CELL, V1, P361, DOI 10.1016/j.stem.2007.09.013; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Staton AA, 2011, NAT GENET, V43, P204, DOI 10.1038/ng.758; Ulvmar MH, 2011, EXP CELL RES, V317, P556, DOI 10.1016/j.yexcr.2011.01.012; VANKEULEN CJ, 1974, CELL TISSUE KINET, V7, P549, DOI 10.1111/j.1365-2184.1974.tb00438.x; VANKEULEN CJG, 1975, CELL TISSUE KINET, V8, P543, DOI 10.1111/j.1365-2184.1975.tb01240.x; Ventea S, 2012, STEM CELLS, V30, P1008, DOI 10.1002/stem.1077; Wang Z, 2008, BRIT J CANCER, V99, P1695, DOI 10.1038/sj.bjc.6604745; Yang QE, 2013, J CELL SCI, V126, P1009, DOI 10.1242/jcs.119826; Yomogida K, 2003, BIOL REPROD, V69, P1303, DOI 10.1095/biolreprod.103.015958; Yoon KB, 2009, TOP CATAL, V52, P1, DOI 10.1007/s11244-008-9132-x; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Zheng K, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-38; Zohni K, 2012, HUM REPROD, V27, P44, DOI 10.1093/humrep/der357	52	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e112598	10.1371/journal.pone.0112598	http://dx.doi.org/10.1371/journal.pone.0112598			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25460567	Green Published, Green Submitted, gold			2022-12-26	WOS:000345869700019
J	Cao, Y; Portela, M; Janikiewicz, J; Doig, J; Abbott, CM				Cao, Yuan; Portela, Miriam; Janikiewicz, Justyna; Doig, Jennifer; Abbott, Catherine M.			Characterisation of Translation Elongation Factor eEF1B Subunit Expression in Mammalian Cells and Tissues and Co-Localisation with eEF1A2	PLOS ONE			English	Article							PROXIMITY LIGATION ASSAY; TRANSFER-RNA-SYNTHETASE; PROTEIN-KINASE CKII; SACCHAROMYCES-CEREVISIAE; SEQUENCING REVEALS; IN-SITU; COMPLEX; PHOSPHORYLATION; EF-1-BETA; CLONING	Translation elongation is the stage of protein synthesis in which the translation factor eEF1A plays a pivotal role that is dependent on GTP exchange. In vertebrates, eEF1A can exist as two separately encoded tissue-specific isoforms, eEF1A1, which is almost ubiquitously expressed, and eEF1A2, which is confined to neurons and muscle. The GTP exchange factor for eEF1A1 is a complex called eEF1B made up of subunits eEF1Ba, eEF1Bd and eEF1Bc. Previous studies have cast doubt on the ability of eEF1B to interact with eEF1A2, suggesting that this isoform might use a different GTP exchange factor. We show that eEF1B subunits are all widely expressed to varying degrees in different cell lines and tissues, and at different stages of development. We show that ablation of any of the subunits in human cell lines has a small but significant impact on cell viability and cycling. Finally, we show that both eEF1A1 and eEF1A2 colocalise with all eEF1B subunits, in such close proximity that they are highly likely to be in a complex.	[Cao, Yuan; Portela, Miriam; Janikiewicz, Justyna; Doig, Jennifer; Abbott, Catherine M.] Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Ctr Genom & Expt Med, Edinburgh, Midlothian, Scotland	University of Edinburgh	Abbott, CM (corresponding author), Univ Edinburgh, Western Gen Hosp, Inst Genet & Mol Med, Ctr Genom & Expt Med, Edinburgh, Midlothian, Scotland.	C.Abbott@ed.ac.uk		Abbott, Catherine/0000-0001-8794-7173; Janikiewicz, Justyna/0000-0002-6484-9164	Wellcome Trust [094180/Z/10/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	The work was supported by Wellcome Trust 094180/Z/10/Z, http://www.wellcome.ac.uk/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEC G, 1994, J BIOL CHEM, V269, P2086; BEC G, 1989, J BIOL CHEM, V264, P21138; Carr-Schmid A, 1999, MOL CELL BIOL, V19, P5257; Chambers DM, 2001, GENOMICS, V77, P145, DOI 10.1006/geno.2001.6626; de Ligt J, 2012, NEW ENGL J MED, V367, P1921, DOI 10.1056/NEJMoa1206524; Fredriksson S, 2002, NAT BIOTECHNOL, V20, P473, DOI 10.1038/nbt0502-473; Guerrucci MA, 1999, GENE, V233, P83, DOI 10.1016/S0378-1119(99)00153-5; HIRAGA K, 1993, FEBS LETT, V316, P165, DOI 10.1016/0014-5793(93)81208-H; JANSSEN GMC, 1988, EUR J BIOCHEM, V171, P119, DOI 10.1111/j.1432-1033.1988.tb13766.x; JANSSEN GMC, 1994, J BIOL CHEM, V269, P31410; Jeppesen MG, 2003, J BIOL CHEM, V278, P47190, DOI 10.1074/jbc.M306630200; Jiang SL, 2005, FEBS LETT, V579, P6049, DOI 10.1016/j.febslet.2005.09.062; Kahns S, 1998, NUCLEIC ACIDS RES, V26, P1884, DOI 10.1093/nar/26.8.1884; Kaitsuka T, 2011, EMBO REP, V12, P673, DOI 10.1038/embor.2011.82; Kim J, 2009, LAB INVEST, V89, P867, DOI 10.1038/labinvest.2009.53; Le Sourd F, 2006, BBA-GENE STRUCT EXPR, V1759, P13, DOI 10.1016/j.bbaexp.2006.02.003; Ling SC, 2010, P NATL ACAD SCI USA, V107, P13318, DOI 10.1073/pnas.1008227107; Mansilla F, 2002, BIOCHEM J, V365, P669, DOI 10.1042/BJ20011681; Mansilla F, 2008, J CELL BIOCHEM, V105, P847, DOI 10.1002/jcb.21880; Minella O, 1998, BIOSCIENCE REP, V18, P119, DOI 10.1023/A:1020140527930; MORALES J, 1992, NUCLEIC ACIDS RES, V20, P4091, DOI 10.1093/nar/20.15.4091; Najmabadi H, 2011, NATURE, V478, P57, DOI 10.1038/nature10423; Newbery HJ, 2007, J BIOL CHEM, V282, P28951, DOI 10.1074/jbc.M703962200; Perez JMJ, 1998, PROTEIN EXPRES PURIF, V13, P259, DOI 10.1006/prep.1998.0895; Pittman YR, 2006, J BIOL CHEM, V281, P19457, DOI 10.1074/jbc.M601076200; PIZZUTI A, 1993, BIOCHEM BIOPH RES CO, V197, P154, DOI 10.1006/bbrc.1993.2454; Sheu GT, 1999, MOL CELL BIOCHEM, V191, P181, DOI 10.1023/A:1006802125856; Sheu GT, 1997, J BIOL CHEM, V272, P33290, DOI 10.1074/jbc.272.52.33290; Soares DC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006315; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Timchenko AA, 2013, BIOCHEMISTRY-US, V52, P5345, DOI 10.1021/bi400400r; Trifilieff P, 2011, BIOTECHNIQUES, V51, P111, DOI 10.2144/000113719; VANDAMME H, 1991, EUR J BIOCHEM, V197, P505, DOI 10.1111/j.1432-1033.1991.tb15938.x; Veeramah KR, 2013, EPILEPSIA, V54, P1270, DOI 10.1111/epi.12201	35	10	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e114117	10.1371/journal.pone.0114117	http://dx.doi.org/10.1371/journal.pone.0114117			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25436608	Green Published, Green Submitted, gold			2022-12-26	WOS:000347114900118
J	Dias, RRF; de Carvalho, ECQ; Leite, CCD; Tedesco, RC; Calabrese, KD; Silva, AC; DaMatta, RA; Sarro-Silva, MD				Furtado Dias, Raul Ramos; Queiroz de Carvalho, Eulogio Carlos; da Silva Leite, Carla Cristina; Tedesco, Roberto Carlos; Calabrese, Katia da Silva; Silva, Antonio Carlos; DaMatta, Renato Augusto; Sarro-Silva, Maria de Fatima			Toxoplasma gondii Oral Infection Induces Intestinal Inflammation and Retinochoroiditis in Mice Genetically Selected for Immune Oral Tolerance Resistance	PLOS ONE			English	Article							OCULAR TOXOPLASMOSIS; IFN-GAMMA; DISEASE; SUSCEPTIBILITY; PATHOGENESIS; NECROSIS	Toxoplasmosis is a worldwide disease with most of the infections originating through the oral route and generates various pathological manifestations, ranging from meningoencephalitis to retinochoroiditis and inflammatory bowel disease. Animal models for these pathologies are scarce and have limitations. We evaluated the outcome of Toxoplasma gondii oral infection with 50 or 100 cysts of the ME-49 strain in two lines of mice with extreme phenotypes of susceptibility (TS) or resistance (TR) to immune oral tolerance. Therefore, the aim of this study was to evaluate the behaviour of TS and TR mice, orally infected by T. gondii, and determine its value as a model for inflammatory diseases study. Mortality during the acute stage of the infection for TR was 50% for both dosages, while 10 and 40% of the TS died after infection with these respective dosages. In the chronic stage, the remaining TS succumbed while TR survived for 90 days. The TS displayed higher parasite load with lower intestinal inflammation and cellular proliferation, notwithstanding myocarditis, pneumonitis and meningoencephalitis. TR presented massive necrosis of villi and crypt, comparable to inflammatory bowel disease, with infiltration of lymphoid cells in the lamina propria of the intestines. Also, TR mice infected with 100 cysts presented intense cellular infiltrate within the photoreceptor layer of the eyes, changes in disposition and morphology of the retina cell layers and retinochoroiditis. During the infection, high levels of IL-6 were detected in the serum of TS mice and TR mice presented high amounts of IFN-gamma and TNF-alpha. Both mice lineages developed different disease outcomes, but it is emphasized that TR and TS mice presented acute and chronic stages of the infection, demonstrating that the two lineages offer an attractive model for studying toxoplasmosis.	[Furtado Dias, Raul Ramos; da Silva Leite, Carla Cristina; DaMatta, Renato Augusto; Sarro-Silva, Maria de Fatima] Univ Estadual Norte Fluminense Darcy Ribeiro UENF, Lab Biol Celular & Tecidual, BR-28013602 Campos Dos Goytacazes, RJ, Brazil; [Furtado Dias, Raul Ramos; Calabrese, Katia da Silva] Fiocruz MS, Lab Imunomodulacao & Protozool, Inst Oswaldo Cruz IOC, BR-21045900 Rio De Janeiro, Brazil; [Queiroz de Carvalho, Eulogio Carlos] Univ Estadual N Fluminen, Lab Sanidade Anim, BR-28013602 Campos dos Goytacazes, RJ, Brazil; [Tedesco, Roberto Carlos] Univ Fed Sao Paulo, Disciplina Anat Topog & Descrit, BR-04023900 Sao Paulo, Brazil; [Silva, Antonio Carlos; Sarro-Silva, Maria de Fatima] Univ Estado Rio de Janeiro UERJ, Lab Imunobiol, BR-20550900 Rio De Janeiro, RJ, Brazil	Universidade Estadual do Norte Fluminense; Fundacao Oswaldo Cruz; Universidade Federal de Sao Paulo (UNIFESP); Universidade do Estado do Rio de Janeiro	DaMatta, RA (corresponding author), Univ Estadual Norte Fluminense Darcy Ribeiro UENF, Lab Biol Celular & Tecidual, BR-28013602 Campos Dos Goytacazes, RJ, Brazil.	renato@uenf.br	DaMatta, Renato/G-8367-2015; Calabrese, Katia S/V-2631-2018	DaMatta, Renato/0000-0002-0108-9268; 	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCT-CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Estadual do Norte Fluminense (FENORTE); Oswaldo Cruz Institute	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCT-CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao Estadual do Norte Fluminense (FENORTE); Oswaldo Cruz Institute	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (MCT-CNPq); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Fundacao Estadual do Norte Fluminense (FENORTE) and Oswaldo Cruz Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barragan A, 2002, J EXP MED, V195, P1625, DOI 10.1084/jem.20020258; Brandtzaeg P, 1996, ANN NY ACAD SCI, V778, P1, DOI 10.1111/j.1749-6632.1996.tb21110.x; Calabrese KS, 2008, MICRON, V39, P1335, DOI 10.1016/j.micron.2008.02.003; Courret N, 2006, BLOOD, V107, P309, DOI 10.1182/blood-2005-02-0666; Csongei V, 2010, WORLD J GASTROENTERO, V16, P176, DOI 10.3748/wjg.v16.i2.176; da Silva AC, 1998, RES IMMUNOL, V149, P151, DOI 10.1016/S0923-2494(98)80298-8; Da Silva MDS, 2004, ANN NY ACAD SCI, V1029, P398, DOI 10.1196/annals.1309.024; Dubey JP, 2004, VET PARASITOL, V126, P57, DOI 10.1016/j.vetpar.2004.09.005; Dubey JP, 1997, J EUKARYOT MICROBIOL, V44, P592, DOI 10.1111/j.1550-7408.1997.tb05965.x; Gazzinelli RT, 1996, J IMMUNOL, V157, P798; Gearry RB, 2010, J GASTROEN HEPATOL, V25, P325, DOI 10.1111/j.1440-1746.2009.06140.x; Gormley PD, 1999, EXP EYE RES, V68, P657, DOI 10.1006/exer.1998.0655; HAY J, 1984, ANN TROP MED PARASIT, V78, P109, DOI 10.1080/00034983.1984.11811784; Heimesaat MM, 2007, GUT, V56, P941, DOI 10.1136/gut.2006.104497; Heimesaat MM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000662; Johnson J, 2002, INT J PARASITOL, V32, P179, DOI 10.1016/S0020-7519(01)00321-6; Kastelein RA, 2007, ANNU REV IMMUNOL, V25, P221, DOI 10.1146/annurev.immunol.22.012703.104758; King MD, 2003, J PARASITOL, V89, P856, DOI 10.1645/GE-79R; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Lahmar I, 2010, EXP PARASITOL, V124, P190, DOI 10.1016/j.exppara.2009.09.010; Lidar M, 2009, ANN NY ACAD SCI, V1173, P640, DOI 10.1111/j.1749-6632.2009.04673.x; Liesenfeld O, 2002, J INFECT DIS, V185, pS96, DOI 10.1086/338006; Liesenfeld O, 1999, PARASITE IMMUNOL, V21, P365, DOI 10.1046/j.1365-3024.1999.00237.x; Liesenfeld O, 1996, J EXP MED, V184, P597, DOI 10.1084/jem.184.2.597; Lu FL, 2005, INFECT IMMUN, V73, P5160, DOI 10.1128/IAI.73.8.5160-5165.2005; McGovern D, 2007, GUT, V56, P1333, DOI 10.1136/gut.2006.115402; Okamoto R, 2005, DIG DIS SCI S1, P34; Tenorio EP, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/786078; Pavesio CE, 1996, BRIT J OPHTHALMOL, V80, P1099, DOI 10.1136/bjo.80.12.1099; ROBERTS CW, 1995, INFECT IMMUN, V63, P2549, DOI 10.1128/IAI.63.7.2549-2555.1995; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Silva AC, 2001, MICROBES INFECT, V3, P1; Silva MF, 2010, IMMUNOLOGY, V130, P447, DOI 10.1111/j.1365-2567.2010.03248.x; Silva MFS, 2006, CLIN EXP ALLERGY, V36, P1; Silver JS, 2011, J IMMUNOL, V187, P350, DOI 10.4049/jimmunol.1004144; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; SUZUKI Y, 1993, RES IMMUNOL, V144, P66, DOI 10.1016/S0923-2494(05)80102-6; Tavares D, 2006, MICROBES INFECT, V8, P957, DOI 10.1016/j.micinf.2005.09.018; Tedesco RC, 2007, MICRON, V38, P729, DOI 10.1016/j.micron.2007.05.005; Tedesco RC, 2005, PARASITOLOGY, V131, P303, DOI 10.1017/S003118200500781X; Tenter AM, 2000, INT J PARASITOL, V30, P1217, DOI 10.1016/S0020-7519(00)00124-7; VAZ NM, 1977, J ALLERGY CLIN IMMUN, V60, P110, DOI 10.1016/0091-6749(77)90035-5; Wallace GR, 2008, CLIN EXP IMMUNOL, V153, P309, DOI 10.1111/j.1365-2249.2008.03692.x; WILLIAMS DM, 1978, INFECT IMMUN, V19, P416, DOI 10.1128/IAI.19.2.416-420.1978; Zenner L, 1998, EXP PARASITOL, V90, P86, DOI 10.1006/expr.1998.4301	45	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113374	10.1371/journal.pone.0113374	http://dx.doi.org/10.1371/journal.pone.0113374			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437299	Green Published, gold, Green Submitted			2022-12-26	WOS:000347114900042
J	Ito, T; Sendai, Y; Yamazaki, S; Seki-Soma, M; Hirose, K; Watanabe, M; Fukawa, K; Nakauchi, H				Ito, Tetsuya; Sendai, Yutaka; Yamazaki, Satoshi; Seki-Soma, Marie; Hirose, Kensuke; Watanabe, Motoo; Fukawa, Kazuo; Nakauchi, Hiromitsu			Generation of Recombination Activating Gene-1-Deficient Neonatal Piglets: A Model of T and B Cell Deficient Severe Combined Immune Deficiency	PLOS ONE			English	Article							RAG MUTATIONS; IN-VIVO; BLASTOCYST COMPLEMENTATION; NUCLEAR TRANSFER; DNA METHYLATION; HUMANIZED MICE; MOUSE MODEL; CLONED PIGS; GENES; IMMUNODEFICIENCY	Although severe combined immune deficiency (SCID) is a very important research model for mice and SCID mice are widely used, there are only few reports describing the SCID pig models. Therefore, additional research in this area is needed. In this study, we describe the generation of Recombination activating gene-1 (Rag-1)-deficient neonatal piglets in Duroc breed using somatic cell nuclear transfer (SCNT) with gene targeting and analysis using fluorescence-activated cell sorting (FACS) and histology. We constructed porcine Rag-1 gene targeting vectors for the Exon 2 region and obtained heterozygous/homozygous Rag-1 knockout cell colonies using SCNT. We generated two Rag-1-deficient neonatal piglets and compared them with wild-type neonatal piglets. FACS analysis showed that Rag-1 disruption causes a lack of Immunoglobulin M-positive B cells and CD3-positive T cells in peripheral blood mononuclear cells. Consistent with FACS analysis, histological analysis revealed structural defects and an absence of mature lymphocytes in the spleen, mesenteric lymph node (MLNs), and thymus in Rag-1-deficient piglets. These results confirm that Rag-1 is necessary for the generation of lymphocytes in pigs, and Rag-1-deficient piglets exhibit a T and B cell deficient SCID (T-B-SCID) phenotype similar to that of rodents and humans. The T-B-SCID pigs with Rag-1 deficiency generated in this study could be a suitably versatile model for laboratory, translational, and biomedical research, including the development of a humanized model and assessment of pluripotent stem cells.	[Ito, Tetsuya; Hirose, Kensuke; Fukawa, Kazuo] ZEN NOH Natl Federat Agr Cooperat Assoc, Cent Res Inst Feed & Livestock, Pig Breeding Lab, Kamishihoro, Hokkaido, Japan; [Sendai, Yutaka] ZEN NOH Natl Federat Agr Cooperat Assoc, Cent Res Inst Feed & Livestock, Biol Sci Sect, Ibaraki, Japan; [Yamazaki, Satoshi; Watanabe, Motoo; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Div Stem Cell Therapy, Tokyo, Japan; [Seki-Soma, Marie] ZEN NOH Natl Federat Agr Cooperat Assoc, Zen Noh Inst Anim Hlth, Chiba, Japan; [Yamazaki, Satoshi; Watanabe, Motoo; Nakauchi, Hiromitsu] Japan Sci & Technol Agcy, Exploratory Res Adv Technol ERATO, Nakauchi Stem Cell & Organ Regenerat Project, Tokyo, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Ito, T (corresponding author), ZEN NOH Natl Federat Agr Cooperat Assoc, Cent Res Inst Feed & Livestock, Pig Breeding Lab, Kamishihoro, Hokkaido, Japan.	itou-tetsuya@zennoh.or.jp			Japan Science and Technology Agency; Ministry of Education, Culture, Sport, Science, and Technology, Japan	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sport, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants from the Japan Science and Technology Agency, the Ministry of Education, Culture, Sport, Science, and Technology, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkina R, 2013, VIROLOGY, V435, P14, DOI 10.1016/j.virol.2012.10.007; Archer GS, 2003, BIOL REPROD, V69, P430, DOI 10.1095/biolreprod.103.016147; Betthauser J, 2000, NAT BIOTECHNOL, V18, P1055, DOI 10.1038/80242; Bility MT, 2012, NAT PROTOC, V7, P1608, DOI 10.1038/nprot.2012.083; Butler JE, 2006, VET RES, V37, P417, DOI 10.1051/vetres:2006009; CHEN JZ, 1993, P NATL ACAD SCI USA, V90, P4528, DOI 10.1073/pnas.90.10.4528; Cho SK, 2007, DEV DYNAM, V236, P3369, DOI 10.1002/dvdy.21308; Corneo B, 2001, BLOOD, V97, P2772, DOI 10.1182/blood.V97.9.2772; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; Deshmukh RS, 2011, EPIGENETICS-US, V6, P177, DOI 10.4161/epi.6.2.13519; Fan NN, 2013, J GENET GENOMICS, V40, P67, DOI 10.1016/j.jgg.2012.07.014; Flisikowska T, 2012, GASTROENTEROLOGY, V143, P1173, DOI 10.1053/j.gastro.2012.07.110; Hasegawa M, 2011, BIOCHEM BIOPH RES CO, V405, P405, DOI 10.1016/j.bbrc.2011.01.042; Huang J, 2014, J IMMUNOL, V193, P1496, DOI 10.4049/jimmunol.1400915; Hwang KC, 2009, DEV DYNAM, V238, P1701, DOI 10.1002/dvdy.21986; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Ito R, 2012, EFFICIENT XENOENGRAF; KARALUS U, 1990, ANIM REPROD SCI, V22, P235, DOI 10.1016/0378-4320(90)90064-M; Kollet O, 2000, BLOOD, V95, P3102, DOI 10.1182/blood.V95.10.3102.010k14_3102_3105; Kuzmuk KN, 2011, GENETICS OF THE PIG, 2ND EDITION, P426, DOI 10.1079/9781845937560.0426; Lee K, 2014, P NATL ACAD SCI USA, V111, P7260, DOI 10.1073/pnas.1406376111; Matsunari H, 2013, P NATL ACAD SCI USA, V110, P4557, DOI 10.1073/pnas.1222902110; MCBLANE JF, 1995, CELL, V83, P387, DOI 10.1016/0092-8674(95)90116-7; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; Mendicino M, 2011, TRANSGENIC RES, V20, P625, DOI 10.1007/s11248-010-9444-z; Menoret S, 2013, FASEB J, V27, P703, DOI 10.1096/fj.12-219907; Meurens F, 2012, TRENDS MICROBIOL, V20, P50, DOI 10.1016/j.tim.2011.11.002; MOMBAERTS P, 1992, CELL, V68, P869, DOI 10.1016/0092-8674(92)90030-G; Nischang M, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13618; Nishana M, 2012, IMMUNOLOGY, V137, P271, DOI 10.1111/imm.12009; Noguchi M, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-157; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; Onishi A, 2000, SCIENCE, V289, P1188, DOI 10.1126/science.289.5482.1188; Peat JR, 2012, NAT GENET, V44, P965, DOI 10.1038/ng.2393; Polejaeva IA, 2000, NATURE, V407, P86, DOI 10.1038/35024082; Prather RS, 2013, ANNU REV ANIM BIOSCI, V1, P203, DOI 10.1146/annurev-animal-031412-103715; Renner S, 2010, DIABETES, V59, P1228, DOI 10.2337/db09-0519; Rogers CS, 2008, SCIENCE, V321, P1837, DOI 10.1126/science.1163600; Ross JW, 2012, INVEST OPHTH VIS SCI, V53, P501, DOI 10.1167/iovs.11-8784; Santagata S, 2000, P NATL ACAD SCI USA, V97, P14572, DOI 10.1073/pnas.97.26.14572; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; Schuetz C, 2008, NEW ENGL J MED, V358, P2030, DOI 10.1056/NEJMoa073966; Schwarz K, 1996, SCIENCE, V274, P97, DOI 10.1126/science.274.5284.97; Sechin A, 1999, THERIOGENOLOGY, V51, P1175, DOI 10.1016/S0093-691X(99)80020-X; Sendai Y, 2006, TRANSPLANTATION, V81, P760, DOI 10.1097/01.tp.0000190422.66657.f1; Shiota K, 2002, DIFFERENTIATION, V69, P162, DOI 10.1046/j.1432-0436.2002.690406.x; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; SHULTZ LD, 1995, J IMMUNOL, V154, P180; Suemizu H, 2008, BIOCHEM BIOPH RES CO, V377, P248, DOI 10.1016/j.bbrc.2008.09.124; Sun XZ, 2012, IMMUNOLOGY, V137, P149, DOI 10.1111/j.1365-2567.2012.03615.x; Suzuki S, 2014, EXP ANIM TOKYO, V63, P215, DOI 10.1538/expanim.63.215; Suzuki S, 2012, CELL STEM CELL, V10, P753, DOI 10.1016/j.stem.2012.04.021; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Villa A, 1998, CELL, V93, P885, DOI 10.1016/S0092-8674(00)81448-8; Villa A, 2001, BLOOD, V97, P81, DOI 10.1182/blood.V97.1.81; Walters EM, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-55; Watanabe M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076478; Yamazaki S, 2011, CELL, V147, P1146, DOI 10.1016/j.cell.2011.09.053; Yoshioka K, 2003, BIOL REPROD, V69, P2092, DOI 10.1095/biolreprod.103.020081; Zhao JG, 2010, CELL TISSUE RES, V341, P13, DOI 10.1007/s00441-010-1000-x; Zschemisch NH, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-60	63	28	28	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113833	10.1371/journal.pone.0113833	http://dx.doi.org/10.1371/journal.pone.0113833			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437445	Green Submitted, gold, Green Published			2022-12-26	WOS:000347114900083
J	Kalimeri, M; Girard, E; Madern, D; Sterpone, F				Kalimeri, Maria; Girard, Eric; Madern, Dominique; Sterpone, Fabio			Interface Matters: The Stiffness Route to Stability of a Thermophilic Tetrameric Malate Dehydrogenase	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; CONFORMATIONAL FLEXIBILITY; LACTATE-DEHYDROGENASES; PROTEIN STABILITY; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ADAPTATION; THERMOSTABILITY; TEMPERATURE; COMPRESSIBILITY	In this work we investigate by computational means the behavior of two orthologous bacterial proteins, a mesophilic and a thermophilic tetrameric malate dehydrogenase (MalDH), at different temperatures. Namely, we quantify how protein mechanical rigidity at different length-and time-scales correlates to protein thermophilicity as commonly believed. In particular by using a clustering analysis strategy to explore the conformational space of the folded proteins, we show that at ambient conditions and at the molecular length-scale the thermophilic variant is indeed more rigid that the mesophilic one. This rigidification is the result of more efficient inter-domain interactions, the strength of which is further quantified via ad hoc free energy calculations. When considered isolated, the thermophilic domain is indeed more flexible than the respective mesophilic one. Upon oligomerization, the induced stiffening of the thermophilic protein propagates from the interface to the active site where the loop, controlling the access to the catalytic pocket, anchors down via an extended network of ion-pairs. On the contrary in the mesophilic tetramer the loop is highly mobile. Simulations at high temperature, could not reactivate the mobility of the loop in the thermophile. This finding opens questions on the similarities of the binding processes for these two homologues at their optimal working temperature and suggests for the thermophilic variant a possible cooperative role of cofactor/substrate.	[Kalimeri, Maria; Sterpone, Fabio] Univ Paris Diderot, Sorbonne Paris Cite, Lab Biochim Theor, Inst Biol Physicochim,CNRS,UPR9080, Paris, France; [Girard, Eric; Madern, Dominique] Univ Grenoble Alpes, Inst Biol Struct, Grenoble, France; [Girard, Eric; Madern, Dominique] CNRS, Inst Biol Struct, Grenoble, France; [Girard, Eric; Madern, Dominique] Commissariat Energie Atom & Energies Alternat, Inst Biol Struct, Grenoble, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS)	Madern, D (corresponding author), Univ Grenoble Alpes, Inst Biol Struct, Grenoble, France.	dominique.madern@ibs.fr; fabio.sterpone@ibpc.fr		Girard, Eric/0000-0002-5758-6095; Kalimeri, Maria/0000-0002-6569-7553	European Research Council under the European Community [258748];  [ANR-11-LABX-0011-01]	European Research Council under the European Community(European Research Council (ERC)); 	The research leading to these results has received funding from the European Research Council under the European Community's Seventh Framework Programme (FP7/2007-2013) Grant Agreement no. 258748. FS and MK also acknowledge the financial support for infrastructures from ANR-11-LABX-0011-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel S, 2012, J CHEM THEORY COMPUT, V8, P4610, DOI 10.1021/ct3003207; [Anonymous], 2014, R LANG ENV STAT COMP; Basu S, 2013, J CHEM INF MODEL, V53, P423, DOI 10.1021/ci300474h; Bjork A, 2004, J MOL BIOL, V341, P1215, DOI 10.1016/j.jmb.2004.06.079; Bjork A, 2003, FEBS LETT, V553, P423, DOI 10.1016/S0014-5793(03)01076-7; Boussau B, 2008, NATURE, V456, P942, DOI 10.1038/nature07393; Butterwick JA, 2004, J MOL BIOL, V339, P855, DOI 10.1016/j.jmb.2004.03.055; Chang YY, 2013, ACTA CRYSTALLOGR F, V69, P1249, DOI 10.1107/S174430911302472X; Chapman ADM, 1999, J MOL BIOL, V285, P703, DOI 10.1006/jmbi.1998.2357; Colombo G, 1999, J AM CHEM SOC, V121, P6895, DOI 10.1021/ja990420s; Coquelle N, 2007, J MOL BIOL, V374, P547, DOI 10.1016/j.jmb.2007.09.049; Dadarlat VM, 2003, P NATL ACAD SCI USA, V100, P14778, DOI 10.1073/pnas.2434157100; Dalhus B, 2002, J MOL BIOL, V318, P707, DOI 10.1016/S0022-2836(02)00050-5; Feller G, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/32/323101; Fitter J, 2000, BIOPHYS J, V79, P1629, DOI 10.1016/S0006-3495(00)76413-7; Gaucher EA, 2008, NATURE, V451, P704, DOI 10.1038/nature06510; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; Groussin M, 2011, MOL BIOL EVOL, V28, P2661, DOI 10.1093/molbev/msr098; Hartigan J., 1975, CLUSTERING ALGORITHM; Hernandez G, 2000, P NATL ACAD SCI USA, V97, P3166, DOI 10.1073/pnas.040569697; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Hummer G, 2005, NEW J PHYS, V7, DOI 10.1088/1367-2630/7/1/034; Hung CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083091; Irimia A, 2004, J MOL BIOL, V335, P343, DOI 10.1016/j.jmb.2003.10.054; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Kalimeri M, 2013, J PHYS CHEM B, V117, P13775, DOI 10.1021/jp407078z; Kamerzell TJ, 2008, J PHARM SCI-US, V97, P3494, DOI 10.1002/jps.21269; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Kumar S, 2001, CELL MOL LIFE SCI, V58, P1216, DOI 10.1007/PL00000935; Lemkul JA, 2010, J PHYS CHEM B, V114, P1652, DOI 10.1021/jp9110794; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; Madern D, 2000, BIOCHEMISTRY-US, V39, P1001, DOI 10.1021/bi9910023; Madern D, 2002, J MOL EVOL, V54, P825, DOI 10.1007/s00239-001-0088-8; Marchi M, 2003, J PHYS CHEM B, V107, P6598, DOI 10.1021/jp0342935; Marcos E, 2012, J CHEM THEORY COMPUT, V8, P1129, DOI 10.1021/ct200877z; McCully ME, 2013, PROTEIN ENG DES SEL, V26, P35, DOI 10.1093/protein/gzs063; Meinhold L, 2008, BIOPHYS J, V94, P4812, DOI 10.1529/biophysj.107.121418; Minarik P, 2002, GEN PHYSIOL BIOPHYS, V21, P257; Missimer JH, 2007, PROTEIN SCI, V16, P1349, DOI 10.1110/ps.062542907; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Radestock S, 2011, PROTEINS, V79, P1089, DOI 10.1002/prot.22946; Rathi PC, 2014, J CHEM INF MODEL, V54, P355, DOI 10.1021/ci400568c; Rycroft CH, 2009, CHAOS, V19, DOI 10.1063/1.3215722; Sanderova H, 2004, PROTEIN SCI, V13, P89, DOI 10.1110/ps.03272504; Schulten K., 2000, LECT THEORETICAL BIO; SOMERO GN, 1978, ANNU REV ECOL SYST, V9, P1, DOI 10.1146/annurev.es.09.110178.000245; Sterpone F, 2012, CHEM SOC REV, V41, P1665, DOI 10.1039/c1cs15199a; Sterpone F, 2009, J PHYS CHEM B, V113, P131, DOI 10.1021/jp805199c; Talon R, 2014, FMICB, V5; Tehei M, 2005, J BIOL CHEM, V280, P40974, DOI 10.1074/jbc.M508417200; Teilum K, 2011, BBA-PROTEINS PROTEOM, V1814, P969, DOI 10.1016/j.bbapap.2010.11.005; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; Wang T, 2007, J CHEM THEORY COMPUT, V3, P1476, DOI 10.1021/ct700063c; Wells SA, 2014, PROTEINS, V82, P2657, DOI 10.1002/prot.24630; Xiao L, 1999, J MOL BIOL, V289, P1435, DOI 10.1006/jmbi.1999.2810; Yesylevskyy SO, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000810; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406	58	9	9	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113895	10.1371/journal.pone.0113895	http://dx.doi.org/10.1371/journal.pone.0113895			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437494	gold, Green Published, Green Submitted			2022-12-26	WOS:000347114900093
J	Samson-Robert, O; Labrie, G; Chagnon, M; Fournier, V				Samson-Robert, Olivier; Labrie, Genevieve; Chagnon, Madeleine; Fournier, Valerie			Neonicotinoid-Contaminated Puddles of Water Represent a Risk of Intoxication for Honey Bees	PLOS ONE			English	Article							INSECT MEMBRANES; MYZUS-PERSICAE; POLLINATORS; PESTICIDE; TOXICITY; DECLINES; EXPOSURE; BINDING; TRENDS; MODE	In recent years, populations of honey bees and other pollinators have been reported to be in decline worldwide. A number of stressors have been identified as potential contributing factors, including the extensive prophylactic use of neonicotinoid insecticides, which are highly toxic to bees, in agriculture. While multiple routes of exposure to these systemic insecticides have been documented for honey bees, contamination from puddle water has not been investigated. In this study, we used a multi-residue method based on LC-MS/MS to analyze samples of puddle water taken in the field during the planting of treated corn and one month later. If honey bees were to collect and drink water from these puddles, our results showed that they would be exposed to various agricultural pesticides. All water samples collected from corn fields were contaminated with at least one neonicotinoid compound, although most contained more than one systemic insecticide. Concentrations of neonicotinoids were higher in early spring, indicating that emission and drifting of contaminated dust during sowing raises contamination levels of puddles. Although the overall average acute risk of drinking water from puddles was relatively low, concentrations of neonicotinoids ranged from 0.01 to 63 mg/L and were sufficient to potentially elicit a wide array of sublethal effects in individuals and colony alike. Our results also suggest that risk assessment of honey bee water resources underestimates the foragers' exposure and consequently miscalculates the risk. In fact, our data shows that honey bees and native pollinators are facing unprecedented cumulative exposure to these insecticides from combined residues in pollen, nectar and water. These findings not only document the impact of this route of exposure for honey bees, they also have implications for the cultivation of a wide variety of crops for which the extensive use of neonicotinoids is currently promoted.	[Samson-Robert, Olivier; Fournier, Valerie] Univ Laval, Ctr Rech Hort, Quebec City, PQ, Canada; [Labrie, Genevieve] Ctr Rech Grains Inc, CEROM, St Mathieu De Beloeil, PQ, Canada; [Chagnon, Madeleine] Univ Quebec, Dept Sci Biol, Montreal, PQ H3C 3P8, Canada	Laval University; University of Quebec; University of Quebec Montreal	Fournier, V (corresponding author), Univ Laval, Ctr Rech Hort, Quebec City, PQ, Canada.	valerie.fournier@fsaa.ulaval.ca	Serrano, Jose/A-2854-2009	Serrano, Jose/0000-0002-1565-5216	Ministere de l'Agriculture, des Pecheries et de l'Alimentation; Centre d'Expertise en Analyses Environnementales du Quebec (CEAEQ)	Ministere de l'Agriculture, des Pecheries et de l'Alimentation; Centre d'Expertise en Analyses Environnementales du Quebec (CEAEQ)	Funding: This research was supported by grants from Prime-Vert sous volet 11,1-Appui a la Strategie phytosanitaire quebecoise en agriculture of the Ministere de l'Agriculture, des Pecheries et de l'Alimentation and the Centre d'Expertise en Analyses Environnementales du Quebec (CEAEQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, ANN BOT-LONDON, V103, P1579, DOI 10.1093/aob/mcp076; Anastassiades M, 2003, J AOAC INT, V86, P412; Baur P., 2007, Pflanzenschutz-Nachrichten Bayer, V60, P27; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; Biocca M, 2011, J ENVIRON SCI HEAL B, V46, P438, DOI 10.1080/03601234.2011.583825; Boily M, 2013, ENVIRON SCI POLLUT R, V20, P5603, DOI 10.1007/s11356-013-1568-2; Brittain C, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2767; Butler CG, 1940, J EXP BIOL, V17, P253; CONNER WE, 1978, PESTIC BIOCHEM PHYS, V9, P131, DOI 10.1016/0048-3575(78)90073-1; Currie RW, 2010, J APICULT RES, V49, P104, DOI 10.3896/IBRA.1.49.1.18; Cutler P, 2013, PEST MANAG SCI, V69, P607, DOI 10.1002/ps.3413; Desjardins EC, 2006, J ECON ENTOMOL, V99, P443, DOI 10.1603/0022-0493-99.2.443; Di Prisco G, 2013, P NATL ACAD SCI USA, V110, P18466, DOI 10.1073/pnas.1314923110; Doublet V, 2015, ENVIRON MICROBIOL, V17, P969, DOI 10.1111/1462-2920.12426; *EC, 2005, CLOTHIANIDIN SANCO 1; *EFSA, 2013, GUIDANCE DOCUMENT ON, DOI DOI 10.2903/J.EFSA.2013.3295; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; Ellis J., 2012, OUTLOOKS PEST MANAG, V23, P35, DOI [DOI 10.1016/j.scitotenv.2019.03.184, 10.1564/22feb10, DOI 10.1564/22FEB10]; Elston C, 2013, APIDOLOGIE, V44, P563, DOI 10.1007/s13592-013-0206-9; European Food Safety Authority, 2013, EFSA J, V11, DOI 10.2903/j.efsa.2013.3067; Fitzpatrick U, 2007, BIOL CONSERV, V136, P185, DOI 10.1016/j.biocon.2006.11.012; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; GARY NE, 2005, THE HIVE AND THE HON, P332; Girolami V, 2013, J APPL ENTOMOL, V137, P35, DOI 10.1111/j.1439-0418.2012.01718.x; Girolami V, 2012, J APPL ENTOMOL, V136, P17, DOI 10.1111/j.1439-0418.2011.01648.x; Girolami V, 2009, J ECON ENTOMOL, V102, P1808, DOI 10.1603/029.102.0511; GIROUX I, 2012, PRESENCE DE PESTICID; Goulson D, 2013, J APPL ECOL, V50, P977, DOI 10.1111/1365-2664.12111; Greatti Moreno, 2006, Bulletin of Insectology, V59, P99; Greatti Moreno, 2003, Bulletin of Insectology, V56, P69; Hatjina F, 2013, APIDOLOGIE, V44, P467, DOI 10.1007/s13592-013-0199-4; Hopwood J., 2012, ARE NEONICOTINOIDS K; Iwasa T, 2004, CROP PROT, V23, P371, DOI 10.1016/j.cropro.2003.08.018; Jeschke P, 2013, ANGEW CHEM INT EDIT, V52, P9464, DOI 10.1002/anie.201302550; Jeschke P, 2011, J AGR FOOD CHEM, V59, P2897, DOI 10.1021/jf101303g; JOHANSSON TSK, 1978, BEE WORLD, V59, P11, DOI 10.1080/0005772X.1978.11097681; Johnson RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054092; Kayser H, 2004, PEST MANAG SCI, V60, P945, DOI 10.1002/ps.919; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; Kevan PG, 1999, AGR ECOSYST ENVIRON, V74, P373, DOI 10.1016/S0167-8809(99)00044-4; Klatt BK, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2440; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Kluser S, 2010, GLOBAL HONEY BEE COL; Krupke CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029268; Kuhnholz S, 1997, BEHAV ECOL SOCIOBIOL, V41, P407, DOI 10.1007/s002650050402; Laurino D, 2013, B INSECTOL, V66, P119; Laycock I, 2012, ECOTOXICOLOGY, V21, P1937, DOI 10.1007/s10646-012-0927-y; LINDAUER M, 1954, Z VERGL PHYSIOL, V36, P391, DOI 10.1007/BF00345028; Main AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092821; Marzaro M, 2011, B INSECTOL, V64, P119; MAUS C, 2012, 11TH INTERNATIONAL S, V437, P199, DOI DOI 10.5073/JKA.2012.437.056; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; *NASS, 2010, UNITED STATES DEPART; Nicolson SW, 2009, J EXP BIOL, V212, P429, DOI 10.1242/jeb.022343; *PANNA, 2012, PESTICIDES AND HONEY; *PMRA, 2013, EVALUATION OF CANADI; Pochi D, 2012, B ENVIRON CONTAM TOX, V89, P354, DOI 10.1007/s00128-012-0664-1; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Ratnieks FLW, 2010, SCIENCE, V327, P152, DOI 10.1126/science.1185563; ROUBIK DW, 1995, FAO AGRICULTURAL SER, V118; Sanchez-Bayo F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094482; Sanchez-Bayo F, 2014, CHEMOSPHERE, V99, P143, DOI 10.1016/j.chemosphere.2013.10.051; Schmaranzer S, 2000, J INSECT PHYSIOL, V46, P1187, DOI 10.1016/S0022-1910(00)00039-1; Schneider CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030023; SEELEY TD, 1996, THE WISDOM OF THE HI; SIMON G, 2013, DRIPPING POISON AN A; Starner K, 2012, B ENVIRON CONTAM TOX, V88, P316, DOI 10.1007/s00128-011-0515-5; Sur Robin, 2003, Bulletin of Insectology, V56, P35; *SYNG GROUP, 2005, SYNGENTA CROP PROTEC; Tapparo A, 2012, ENVIRON SCI TECHNOL, V46, P2592, DOI 10.1021/es2035152; Tapparo A, 2011, J ENVIRON MONITOR, V13, P1564, DOI 10.1039/c1em10085h; Tennekes HA, 2013, TOXICOLOGY, V309, P39, DOI 10.1016/j.tox.2013.04.007; Thompson HM, 2010, PEST MANAG SCI, V66, P1157, DOI 10.1002/ps.1994; *US EPA, 2003, EPA PUBLICATION C, V7501; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Vijver MG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089837; Visscher PK, 1996, J INSECT PHYSIOL, V42, P1089, DOI 10.1016/S0022-1910(96)00058-3; Wellmann H, 2004, PEST MANAG SCI, V60, P959, DOI 10.1002/ps.920; Whitehorn PR, 2012, SCIENCE, V336, P351, DOI 10.1126/science.1215025; Wu JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014720; 2006, DRAFT ASSESSMENT REP, V3	82	88	91	0	121	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e108443	10.1371/journal.pone.0108443	http://dx.doi.org/10.1371/journal.pone.0108443			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25438051	Green Published, gold, Green Submitted			2022-12-26	WOS:000347114900004
J	Boyle, M; Chun, C; Strojny, C; Narayanan, R; Bartholomew, A; Sundivakkam, P; Alapati, S				Boyle, Michael; Chun, Crystal; Strojny, Chelsee; Narayanan, Raghuvaran; Bartholomew, Amelia; Sundivakkam, Premanand; Alapati, Satish			Chronic Inflammation and Angiogenic Signaling Axis Impairs Differentiation of Dental-Pulp Stem Cells	PLOS ONE			English	Article							NF-KAPPA-B; ENDOTHELIAL GROWTH-FACTOR; NECROSIS-FACTOR-ALPHA; SIDE POPULATION; IN-VIVO; TNF; ACTIVATION; EXPRESSION; INDUCTION; LIPOPOLYSACCHARIDES	Dental-pulp tissue is often exposed to inflammatory injury. Sequested growth factors or angiogenic signaling proteins that are released following inflammatory injury play a pivotal role in the formation of reparative dentin. While limited or moderate angiogenesis may be helpful for dental pulp maintenance, the induction of significant level of angiogenesis is probably highly detrimental. Hitherto, several studies have addressed the effects of proinflammatory stimuli on the survival and differentiation of dental-pulp stem cells (DPSC), in vitro. However, the mechanisms communal to the inflammatory and angiogenic signaling involved in DPSC survival and differentiation remain unknown. Our studies observed that short-term exposure to TNF-alpha (6 and 12 hours [hrs]) induced apoptosis with an upregulation of VEGF expression and NF-kappa B signaling. However, long-term (chronic) exposure (14 days) to TNF-alpha resulted in an increased proliferation with a concomitant shortening of the telomere length. Interestingly, DPSC pretreated with Nemo binding domain (NBD) peptide (a cell permeable NF-kappa B inhibitor) significantly ameliorated TNF-alpha-and/or VEGF-induced proliferation and the shortening of telomere length. NBD peptide pretreatment significantly improved TNF-alpha-induced downregulation of proteins essential for differentiation, such as bone morphogenic proteins (BMP)-1 & 2, BMP receptor isoforms-1&2, trasnforming growth factor (TGF), osteoactivin and osteocalcin. Additionally, inhibition of NF-kappa B signaling markedly increased the mineralization potential, a process abrogated by chronic exposure to TNF-alpha. Thus, our studies demonstrated that chronic inflammation mediates telomere shortening via NF-kappa B signaling in human DPSC. Resultant chromosomal instability leads to an emergence of increased proliferation of DPSC, while negatively regulating the differentiation of DPSC, in vitro.	[Boyle, Michael; Chun, Crystal; Strojny, Chelsee; Narayanan, Raghuvaran; Sundivakkam, Premanand; Alapati, Satish] Univ Illinois, Coll Dent, Dept Endodont, Chicago, IL 60607 USA; [Bartholomew, Amelia; Sundivakkam, Premanand] Univ Illinois, Coll Med, Dept Surg, Chicago, IL USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Sundivakkam, P (corresponding author), Univ Illinois, Coll Dent, Dept Endodont, Chicago, IL 60607 USA.	cprem@uic.edu; salapati@uic.edu		Alapati, Satish/0000-0002-4237-5674	NIH/NIDCR [DE019514-SBA]; American Association of Endodontics; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [K08DE019514, R56DE023806] Funding Source: NIH RePORTER	NIH/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); American Association of Endodontics; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study is supported by Grant NIH/NIDCR grant (DE019514-SBA) to SA and American Association of Endodontics (year: 2014) to PS and SA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arfuso F, 2006, ENDOTHELIUM-J ENDOTH, V13, P359, DOI 10.1080/10623320600972101; Baldwin AS, 2001, J CLIN INVEST, V107, P3, DOI 10.1172/JCI11891; Bletsa A, 2004, NEUROIMMUNOMODULAT, V11, P376, DOI 10.1159/000080148; BORREGAARD N, 1994, J LEUKOCYTE BIOL, V56, P80, DOI 10.1002/jlb.56.1.80; Butler WT, 2003, CONNECT TISSUE RES, V44, P171, DOI 10.1080/03008200390152287; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Chang J, 2005, J DENT RES, V84, P994, DOI 10.1177/154405910508401105; Coil J, 2004, J ENDODONT, V30, P88, DOI 10.1097/00004770-200402000-00006; Cordeiro MM, 2008, J ENDODONT, V34, P962, DOI 10.1016/j.joen.2008.04.009; CVEK M, 1992, ENDOD DENT TRAUMATOL, V8, P45; Ding XW, 2010, LIFE SCI, V86, P631, DOI 10.1016/j.lfs.2010.02.012; Felaco M, 2000, LIFE SCI, V68, P297, DOI 10.1016/S0024-3205(00)00935-8; Feng XM, 2013, CELL BIOL INT, V37, P1267, DOI 10.1002/cbin.10141; Gronthos S, 2002, J DENT RES, V81, P531, DOI 10.1177/154405910208100806; Gronthos S, 2000, P NATL ACAD SCI USA, V97, P13625, DOI 10.1073/pnas.240309797; Gronthos S, 2011, METHODS MOL BIOL, V698, P107, DOI 10.1007/978-1-60761-999-4_9; Hahn CL, 2007, J ENDODONT, V33, P213, DOI 10.1016/j.joen.2006.11.008; Iohara K, 2011, TISSUE ENG PT A, V17, P1911, DOI [10.1089/ten.tea.2010.0615, 10.1089/ten.TEA.2010.0615]; Jontell M, 1998, CRIT REV ORAL BIOL M, V9, P179, DOI 10.1177/10454411980090020301; Karaoz E, 2011, HISTOCHEM CELL BIOL, V136, P455, DOI 10.1007/s00418-011-0858-3; Kim MK, 2014, ARCH ORAL BIOL, V59, P102, DOI 10.1016/j.archoralbio.2013.10.009; Kohno S, 2003, J DENT RES, V82, P177, DOI 10.1177/154405910308200306; Le Roy C, 2009, CYTOM PART A, V75A, P882, DOI 10.1002/cyto.a.20774; Lisignoli G, 2004, EXP GERONTOL, V39, P659, DOI 10.1016/j.exger.2003.09.030; Martin M, 2001, J IMMUNOL, V167, P5278, DOI 10.4049/jimmunol.167.9.5278; Matsushita K, 2000, J DENT RES, V79, P1596, DOI 10.1177/00220345000790081201; Mullane EM, 2008, J DENT RES, V87, P1144, DOI 10.1177/154405910808701204; NAKANE A, 1995, J ENDODONT, V21, P128, DOI 10.1016/S0099-2399(06)80437-1; Papagerakis P, 2002, BONE, V30, P377, DOI 10.1016/S8756-3282(01)00683-4; Pezelj-Ribaric S, 2002, ARCH MED RES, V33, P482, DOI 10.1016/S0188-4409(02)00396-X; Rutherford RB, 2000, EUR J ORAL SCI, V108, P202, DOI 10.1034/j.1600-0722.2000.108003202.x; Stashenko P, 1998, CRIT REV ORAL BIOL M, V9, P498, DOI 10.1177/10454411980090040701; Tran-Hung L, 2008, ARCH ORAL BIOL, V53, P9, DOI 10.1016/j.archoralbio.2007.07.001; Tran-Hung L, 2006, J DENT RES, V85, P819, DOI 10.1177/154405910608500908; Ueda M, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt420; Wang CY, 1996, SCIENCE, V274, P784, DOI 10.1126/science.274.5288.784; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Wang JM, 2010, BIOCHEM BIOPH RES CO, V400, P334, DOI 10.1016/j.bbrc.2010.08.058; Wang JM, 2010, J ENDODONT, V36, P453, DOI 10.1016/j.joen.2009.11.018; Yang F, 2004, J IMMUNOL, V172, P2446, DOI 10.4049/jimmunol.172.4.2446	40	40	41	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e113419	10.1371/journal.pone.0113419	http://dx.doi.org/10.1371/journal.pone.0113419			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427002	gold, Green Published, Green Submitted			2022-12-26	WOS:000349145400050
J	Cao, XB; Fan, GQ; Zhao, ZL; Deng, MJ; Dong, YP				Cao, Xibing; Fan, Guoqiang; Zhao, Zhenli; Deng, Minjie; Dong, Yanpeng			Morphological Changes of Paulownia Seedlings Infected Phytoplasmas Reveal the Genes Associated with Witches' Broom through AFLP and MSAP	PLOS ONE			English	Article							DNA METHYLATION; FLAVONOID PATHWAY; EXPRESSION; CLASSIFICATION; IDENTIFICATION; AMPLIFICATION; RESISTANCE; LEAVES; RICE	Paulownia witches' broom (PaWB) caused by phytoplasma might result in devastating damage to the growth and wood production of Paulownia. To study the effect of phytoplasma on DNA sequence and to discover the genes related to PaWB occurrence, DNA polymorphisms and DNA methylation levels and patterns in PaWB seedlings, the ones treated with various concentration of methyl methane sulfonate (MMS) and healthy seedlings were investigated with amplified fragment length polymorphism (AFLP) and methylation-sensitive amplification polymorphism (MSAP). Our results indicated that PaWB seedlings recovered a normal morphology, similar to healthy seedlings, after treatment with more than 20 mg.L-1 MMS; Phytoplasma infection did not change the Paulownia genomic DNA sequence at AFLP level, but changed the global DNA methylation levels and patterns; Genes related to PaWB were discovered through MSAP and validated using quantitative real-time PCR (qRT-PCR). These results implied that changes of DNA methylation levels and patterns were closely related to the morphological changes of seedlings infected with phytoplasmas.	[Cao, Xibing; Fan, Guoqiang; Zhao, Zhenli; Deng, Minjie; Dong, Yanpeng] Henan Agr Univ, Inst Paulownia, Zhengzhou, Henan, Peoples R China; [Cao, Xibing; Fan, Guoqiang; Zhao, Zhenli; Deng, Minjie; Dong, Yanpeng] Henan Agr Univ, Coll Forestry, Zhengzhou, Henan, Peoples R China	Henan Agricultural University; Henan Agricultural University	Fan, GQ (corresponding author), Henan Agr Univ, Inst Paulownia, Zhengzhou, Henan, Peoples R China.	zlxx64@126.com			Zhongyuan Scholarship Foundation of Henan Province [122101110700]	Zhongyuan Scholarship Foundation of Henan Province	This work was funded by Zhongyuan Scholarship Foundation of Henan Province (122101110700), http://www.ha.hrss.gov.cn/viewpage?path=/index.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bertaccini A, 2009, PHYTOPATHOL MEDITERR, V48, P355; Cao XB, 2014, INT J MOL SCI, V15, P14669, DOI 10.3390/ijms150814669; [曹喜兵 Cao Xibing], 2012, [河南农业大学学报, Journal of Henan Agricultural University], V46, P535; [曹喜兵 Cao Xibing], 2012, [植物病理学报, Acta Phytopathologica Sinica], V42, P214; [曹喜兵 Cao Xibing], 2010, [河南农业大学学报, Journal of Henan Agricultural University], V44, P145; Chekanova JA, 2007, CELL, V131, P1340, DOI 10.1016/j.cell.2007.10.056; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Dong ZY, 2006, THEOR APPL GENET, V113, P196, DOI 10.1007/s00122-006-0286-2; Fan GuoQiang, 2007, Scientia Silvae Sinicae, V43, P138; Finnegan EJ, 1998, P NATL ACAD SCI USA, V95, P5824, DOI 10.1073/pnas.95.10.5824; Finnegan EJ, 2000, CURR OPIN GENET DEV, V10, P217, DOI 10.1016/S0959-437X(00)00061-7; Finnegan EJ, 1996, P NATL ACAD SCI USA, V93, P8449, DOI 10.1073/pnas.93.16.8449; Gimenez C, 2006, PLANT MOL BIOL REP, V24, P33, DOI 10.1007/BF02914044; Himeno M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04111; Hiruki C, 1997, ACTA HORTIC, V496, P63, DOI DOI 10.17660/ACTAH0RTIC.1999.496.6; Jin K, 1981, PR FORESTRY TECHNOL, V12, P008; Jorgensen I, 2003, PRIVATE FORESTRY BAS; Kathiria P, 2010, PLANT PHYSIOL, V153, P1859, DOI 10.1104/pp.110.157263; KING GJ, 1995, J HORTIC SCI BIOTECH, V70, P333, DOI 10.1080/14620316.1995.11515304; Kortekamp A, 2006, PLANT PHYSIOL BIOCH, V44, P58, DOI 10.1016/j.plaphy.2006.01.008; Kovi M, 2011, THEOR APPL GENET, V123, P705, DOI 10.1007/s00122-011-1620-x; LEE IM, 1993, PHYTOPATHOLOGY, V83, P834, DOI 10.1094/Phyto-83-834; Lee IM, 1998, INT J SYST BACTERIOL, V48, P1153, DOI 10.1099/00207713-48-4-1153; Leljak-Levanic D, 2010, J APPL MICROBIOL, V109, P2069, DOI 10.1111/j.1365-2672.2010.04837.x; Li Ming, 2008, Scientia Silvae Sinicae, V44, P152; Liu RN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080238; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez F, 2012, BIOMASS BIOENERG, V45, P77, DOI 10.1016/j.biombioe.2012.05.010; Margaria P, 2014, PLANT CELL ENVIRON, V37, P2183, DOI 10.1111/pce.12332; Mason G, 2008, PLANT MOL BIOL REP, V26, P156, DOI 10.1007/s11105-008-0031-x; Miranda M, 2007, MOL PLANT MICROBE IN, V20, P816, DOI 10.1094/MPMI-20-7-0816; Mou HQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077217; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Pracros P, 2007, B INSECTOL, V60, P221; Richards EJ, 1997, TRENDS GENET, V13, P319, DOI 10.1016/S0168-9525(97)01199-2; Rismani-Yazdi H, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-148; Stankovic D, 2009, ARCH BIOL SCI, V61, P827, DOI 10.2298/ABS0904827S; Sung PH, 2011, J AGR FOOD CHEM, V59, P4637, DOI 10.1021/jf200259n; Tran-Nguyen LTT, 2008, J BACTERIOL, V190, P3979, DOI 10.1128/JB.01301-07; Treutter D, 2005, PLANT BIOLOGY, V7, P581, DOI 10.1055/s-2005-873009; Wu Y, 2012, PLANT GROWTH REGUL, V66, P137, DOI 10.1007/s10725-011-9637-3; Yao YL, 2012, PLANT CELL REP, V31, P1549, DOI 10.1007/s00299-012-1269-1; Yu YH, 2013, NEW PHYTOL, V200, P834, DOI 10.1111/nph.12418; Zhai XiaoQiao, 2010, Scientia Silvae Sinicae, V46, P176; [张延召 ZHANG Yan-zhao], 2009, [河南农业大学学报, Journal of Henan Agricultural University], V43, P610; Zilberman D, 2007, NAT GENET, V39, P61, DOI 10.1038/ng1929	46	13	17	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e112533	10.1371/journal.pone.0112533	http://dx.doi.org/10.1371/journal.pone.0112533			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427154	Green Submitted, Green Published, gold			2022-12-26	WOS:000349145400016
J	Bianco, S; Jangal, M; Garneau, D; Gevry, N				Bianco, S.; Jangal, M.; Garneau, D.; Gevry, N.			LRH-1 controls proliferation in breast tumor cells by regulating CDKN1A gene expression	ONCOGENE			English	Article							LIVER RECEPTOR HOMOLOG-1; KINASE INHIBITOR P21; CANCER CELLS; GENOMICS DATA; ALPHA; TRANSCRIPTION; ENHANCERS; CHROMATIN; TARGET; PROGRESSION	Liver receptor homolog-1 (LRH-1, NR5A2) is an orphan nuclear receptor that has an essential role in cancer progression, notably in breast cancer. Although its role in promoting cancer cell proliferation and migration is well documented, the molecular basis is not completely established. Here, we report that LRH-1 inhibition affects two-and three-dimensional cell proliferation of different types of breast cancer cells, including estrogen receptor alpha (ER alpha)-positive and triple-negative cells. This phenotype is accompanied by the upregulation of the cyclin-dependent kinase inhibitor CDKN1A (aka p21(CIP1/WAF1)) in a p53-independent manner. Chromatin immunoprecipitation analysis shows that LRH-1 cooperates with FOXA1 and binds directly to CDKN1A promoter and a distal regulatory region found at - 62 kb from its transcriptional start sites, allowing repression of CDKN1A transcription. LRH-1 or FOXA1 depletion induces CDKN1A upregulation by removing histone deacetylase 2 from the promoter and distal regulatory elements and permitting histone acetylation in these regions. Analysis of breast cancer samples reveals that a high LRH-1 level is inversely correlated with CDKN1A expression in breast cancer patients and is associated with poor prognosis. This study reveals a novel mechanism of control of cell proliferation by LRH-1 regulating CDKN1A transcription in breast cancer cells, independent of ERa and p53 status. Targeting LRH-1 may provide an attractive prospect for treatment of tumors that are resistant to hormonal and targeted therapy.	[Bianco, S.; Jangal, M.; Garneau, D.; Gevry, N.] Univ Sherbrooke, Fac Sci, Dept Biol, Sherbrooke, PQ J1K 2R1, Canada	University of Sherbrooke	Gevry, N (corresponding author), Univ Sherbrooke, Fac Sci, Dept Biol, 2500 Blvd Univ, Sherbrooke, PQ J1K 2R1, Canada.	nicolas.gevry@usherbrooke.ca			Canadian Institute of Health Research (CIHR); Reseau Quebecois en Reproduction (RQR)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Reseau Quebecois en Reproduction (RQR)	We thank Alain Lavigueur and Bruce Murphy for critical comments on the manuscript. We are also grateful to Robert Clark for providing the MCF7/LCC2 and MCF7/LCC9 cell lines and Mien-Chie Hung for the MCF7/HER2-18 cell line. This work was supported with fund from the Canadian Institute of Health Research (CIHR) to NG. SB was the recipient of a postdoctoral fellowship from the Reseau Quebecois en Reproduction (RQR).	Ai NP, 2011, NUCLEIC ACIDS RES, V39, P9592, DOI 10.1093/nar/gkr698; Annicotte JS, 2005, ONCOGENE, V24, P8167, DOI 10.1038/sj.onc.1208950; Atkin SD, 2013, MOL ENDOCRINOL, V27, P598, DOI 10.1210/me.2012-1371; Benod C, 2011, P NATL ACAD SCI USA, V108, P16927, DOI 10.1073/pnas.1112047108; Bianco S, 2012, TRANSCRIPTION, V3, P4165; Bianco S, 2014, CANCER RES, V74, P2015, DOI 10.1158/0008-5472.CAN-13-2351; Botrugno OA, 2004, MOL CELL, V15, P499, DOI 10.1016/j.molcel.2004.07.009; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Brunner N, 1997, CANCER RES, V57, P3486; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chand AL, 2010, ENDOCR-RELAT CANCER, V17, P965, DOI 10.1677/ERC-10-0179; Chand AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031593; Chand AL, 2011, STEROIDS, V76, P741, DOI 10.1016/j.steroids.2011.02.024; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Duggavathi R, 2008, GENE DEV, V22, P1871, DOI 10.1101/gad.472008; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; Han SW, 2004, CLIN CANCER RES, V10, P1911, DOI 10.1158/1078-0432.CCR-03-0985; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hlobilkova A, 2006, ANTICANCER RES, V26, P1015; Holmstrom SR, 2011, GENE DEV, V25, P1674, DOI 10.1101/gad.16860911; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Jangal M, 2014, NUCLEIC ACIDS RES, V42, P11339, DOI 10.1093/nar/gku791; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kawai H, 2003, INT J CANCER, V107, P353, DOI 10.1002/ijc.11403; Knower KC, 2013, BREAST CANCER RES TR, V142, P211, DOI 10.1007/s10549-013-2716-6; Lai CF, 2013, NUCLEIC ACIDS RES, V41, P10228, DOI 10.1093/nar/gkt827; Lam SW, 2014, CANCER TREAT REV, V40, P129, DOI 10.1016/j.ctrv.2013.06.006; Lazarus KA, 2013, BIOCHEM BIOPH RES CO, V438, P533, DOI 10.1016/j.bbrc.2013.07.101; Lazarus KA, 2012, J STEROID BIOCHEM, V130, P138, DOI 10.1016/j.jsbmb.2011.12.017; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lu S, 2000, MOL ENDOCRINOL, V14, P753, DOI 10.1210/me.14.5.753; Madden SF, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3444; Mandal S, 2010, J CELL PHYSIOL, V224, P28, DOI 10.1002/jcp.22078; Miki Y, 2006, CANCER LETT, V244, P24, DOI 10.1016/j.canlet.2005.11.038; Muller PAJ, 2013, NAT CELL BIOL, V15, P2, DOI 10.1038/ncb2641; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Oosterveer MH, 2012, J CLIN INVEST, V122, P2817, DOI 10.1172/JCI62368; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Robinson Jessica L L, 2012, Front Endocrinol (Lausanne), V3, P68, DOI 10.3389/fendo.2012.00068; Sanders DA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r6; Schoonjans K, 2005, P NATL ACAD SCI USA, V102, P2058, DOI 10.1073/pnas.0409756102; Sidler D, 2012, ONCOIMMUNOLOGY, V1, DOI 10.4161/onci.19459; Svotelis A, 2011, EMBO J, V30, P3947, DOI 10.1038/emboj.2011.284; Thiruchelvam PTR, 2011, BREAST CANCER RES TR, V127, P385, DOI 10.1007/s10549-010-0994-9; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang SL, 2008, MOL CELL BIOCHEM, V308, P93, DOI 10.1007/s11010-007-9616-1; Yamaguchi T, 2010, GENE DEV, V24, P455, DOI 10.1101/gad.552310; Zhang C, 2013, NAT MED, V19, P1061, DOI 10.1038/nm.3192; Zupkovitz G, 2010, MOL CELL BIOL, V30, P1171, DOI 10.1128/MCB.01500-09	54	41	42	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 20	2015	34	34					4509	4518		10.1038/onc.2014.382	http://dx.doi.org/10.1038/onc.2014.382			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CP9BR	25435372				2022-12-26	WOS:000360189200010
J	Xu, LL; Huang, S; Hou, YH; Liu, Y; Ni, M; Meng, FB; Wang, KX; Rui, YF; Jiang, XH; Li, G				Xu, Liangliang; Huang, Shuo; Hou, Yonghui; Liu, Yang; Ni, Ming; Meng, Fanbiao; Wang, Kuixing; Rui, Yunfeng; Jiang, Xiaohua; Li, Gang			Sox11-modified mesenchymal stem cells (MSCs) accelerate bone fracture healing: Sox11 regulates differentiation and migration of MSCs	FASEB JOURNAL			English	Article						osteogenesis; chondrogenesis; BMP/Smad; fracture repair	REGENERATION; RECEPTOR; MARROW; TISSUE; CXCR4; GENE; CHEMOKINE; PROTEINS	Mesenchymal stem cells (MSCs) are a promising cell resource for tissue engineering. Sry-related high-mobility group box 11 (Sox11) plays critical roles in neural development and organogenesis. In the present study, we investigated the role of Sox11 in regulating trilineage differentiation (osteogenesis, adipogenesis, and chondrogenesis) and migration of MSCs, and explored the effect of systemically administrated Sox11-modified MSCs on bone fracture healing using the rat model of open femur fracture. Our results demonstrated that Sox11 overexpression increased the trilineage differentiation and migration of MSCs, as well as cell viability under oxidative stress. The effect of Sox11 on osteogenesis was confirmed by ectopic bone formation assay conducted in nude mice. In addition, we found that Sox11 could activate the bone morphogenetic protein (BMP)/Smad signaling pathway in MSCs. By dual-luciferase reporter assay, we also demonstrated that Sox11 could transcriptionally activate runt-related transcription factor 2 (Runx2) and CXC chemokine receptor-4 (CXCR4) expression. The activation of the BMP/Smad signaling pathway and Runx2, CXCR4 expression may have a synergic effect, which largely contributed to the effect of Sox11 on MSC fate determination and migration. Finally, using an open femur fracture model in rats, we found that a larger number of MSCs stably expressing Sox11 migrated to the fracture site and improved bone fracture healing. Taken together, our study shows that Sox11 is an important regulator of MSC differentiation and migration, and Sox11-modified MSCs may have clinical implication for accelerating bone fracture healing, which can reduce the delayed unions or nonunions.	[Xu, Liangliang; Huang, Shuo; Liu, Yang; Ni, Ming; Meng, Fanbiao; Wang, Kuixing; Rui, Yunfeng; Li, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Orthopaed & Traumatol, Shatin, Hong Kong, Peoples R China; [Xu, Liangliang; Hou, Yonghui] Chinese Univ Hong Kong, Prince Wales Hosp, Sch Biomed Sci, Stem Cell & Regenerat Theme, Shatin, Hong Kong, Peoples R China; [Xu, Liangliang; Hou, Yonghui] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China; [Jiang, Xiaohua; Li, Gang] Chinese Univ Hong Kong, Sch Biomed Sci, Epithelial Cell Biol Res Ctr, Shatin, Hong Kong, Peoples R China; [Jiang, Xiaohua; Li, Gang] Chinese Univ Hong Kong, Sch Biomed Sci, MOE Key Lab Regenerat Med, Shatin, Hong Kong, Peoples R China; [Li, Gang] Chinese Univ Hong Kong, Shenzhen Res Inst, CUHK ACC Space Med Ctr Hlth Maintenance Musculosk, Shenzhen, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong, Shenzhen	Li, G (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Room 904, Shatin, Hong Kong, Peoples R China.	gangli@cuhk.edu.hk	Liangliang, XU/K-9185-2019; jiang, cynthia xiaohua/F-7580-2017; H, Leo/AAK-9668-2020; Li, Gang/J-7830-2018	Liangliang, XU/0000-0002-5249-7480; jiang, cynthia xiaohua/0000-0002-7372-4961; H, Leo/0000-0001-9495-4339; Li, Gang/0000-0002-3981-2239	National Natural Science Foundation of China [81371946]; Hong Kong Government Research Grant Council; General Research Fund [CUHK471110, CUHK470813]; National Basic Science and Development Programme of People's Republic of China (973 Programme) [2012CB518105]; SMART program; Lui Che Woo Institute of Innovative Medicine; Faculty of Medicine; Chinese University of Hong Kong; Lui Che Woo Foundation Limited, Hong Kong	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Hong Kong Government Research Grant Council; General Research Fund; National Basic Science and Development Programme of People's Republic of China (973 Programme); SMART program; Lui Che Woo Institute of Innovative Medicine; Faculty of Medicine; Chinese University of Hong Kong(Chinese University of Hong Kong); Lui Che Woo Foundation Limited, Hong Kong	The authors thank Dr. Jin Wang and Mr. Chiwai Man and Sien Lin for their technical support and advice. This work was supported by the National Natural Science Foundation of China (81371946), Hong Kong Government Research Grant Council, and General Research Fund (Grants CUHK471110 and CUHK470813 to G.L.). This study was also supported in part by the National Basic Science and Development Programme of People's Republic of China (973 Programme 2012CB518105), SMART program, Lui Che Woo Institute of Innovative Medicine, Faculty of Medicine, The Chinese University of Hong Kong, and a donation from the Lui Che Woo Foundation Limited, Hong Kong. The authors declare no conflicts of interest.	Azuma T, 1999, DNA Res, V6, P357, DOI 10.1093/dnares/6.5.357; BRUDER SP, 1994, J CELL BIOCHEM, V56, P283, DOI 10.1002/jcb.240560303; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Cheng ZK, 2008, MOL THER, V16, P571, DOI 10.1038/sj.mt.6300374; Deans RJ, 2000, EXP HEMATOL, V28, P875, DOI 10.1016/S0301-472X(00)00482-3; Drissi H, 2000, J CELL PHYSIOL, V184, P341, DOI 10.1002/1097-4652(200009)184:3<341::AID-JCP8>3.0.CO;2-Z; Granero-Molto F, 2009, STEM CELLS, V27, P1887, DOI 10.1002/stem.103; Hao YJ, 2007, BONE, V41, P631, DOI 10.1016/j.bone.2007.06.006; He YX, 2012, OSTEOPOROSIS INT, V23, P377, DOI 10.1007/s00198-011-1812-x; Jiang YH, 2002, NATURE, V418, P41, DOI 10.1038/nature00870; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kubo H, 2009, GENES CELLS, V14, P407, DOI 10.1111/j.1365-2443.2009.01281.x; Kuhlbrodt K, 1998, J BIOL CHEM, V273, P16050, DOI 10.1074/jbc.273.26.16050; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Li Y, 2007, BIOCHEM BIOPH RES CO, V356, P780, DOI 10.1016/j.bbrc.2007.03.049; Lin L, 2011, DEV DYNAM, V240, P52, DOI 10.1002/dvdy.22489; Liu Y, 2011, NAT MED, V17, P1594, DOI 10.1038/nm.2542; Mei W, 2005, BIOCHEM BIOPH RES CO, V328, P651, DOI 10.1016/j.bbrc.2004.11.067; Nagasawa T, 2000, INT J HEMATOL, V72, P408; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ratajczak MZ, 2006, LEUKEMIA, V20, P1915, DOI 10.1038/sj.leu.2404357; Shi HF, 2010, BONE, V46, P1299, DOI 10.1016/j.bone.2009.11.028; Shi MX, 2007, HAEMATOLOGICA, V92, P897, DOI 10.3324/haematol.10669; Sock E, 2004, MOL CELL BIOL, V24, P6635, DOI 10.1128/mcb.24.15.6635-6644.2004; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Tagil M, 2010, BONE, V46, P852, DOI 10.1016/j.bone.2009.11.009; Tran D, 2000, DERMATOL SURG, V26, P197, DOI 10.1046/j.1524-4725.2000.09220.x; Tsai LK, 2010, NEUROPSYCHOPHARMACOL, V35, P2225, DOI 10.1038/npp.2010.97; Tse WT, 2000, BLOOD, V96, p241A; Victoria G, 2009, INDIAN J ORTHOP, V43, P117, DOI 10.4103/0019-5413.50844; Wu XW, 2007, ANN NY ACAD SCI, V1116, P29, DOI 10.1196/annals.1402.053; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Yoon BS, 2004, J CELL BIOCHEM, V93, P93, DOI 10.1002/jcb.20211	35	52	54	3	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2015	29	4					1143	1152		10.1096/fj.14-254169	http://dx.doi.org/10.1096/fj.14-254169			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CH5ZN	25466891				2022-12-26	WOS:000354115000004
J	Mayerhofer, H; Panneerselvam, S; Kaljunen, H; Tuukkanen, A; Mertens, HDT; Mueller-Dieckmann, J				Mayerhofer, Hubert; Panneerselvam, Saravanan; Kaljunen, Heidi; Tuukkanen, Anne; Mertens, Haydyn D. T.; Mueller-Dieckmann, Jochen			Structural Model of the Cytosolic Domain of the Plant Ethylene Receptor 1 (ETR1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Arabidopsis thaliana; Crystal Structure; Histidine Kinase; Plant Hormone; Small Angle X-ray Scattering (SAXS); Ethylene Receptor; Two-component System	RAF-LIKE KINASE; HISTIDINE KINASE; PROTEIN-KINASE; BIOLOGICAL MACROMOLECULES; ENDOPLASMIC-RETICULUM; RESOLUTION STRUCTURE; MUTATIONAL ANALYSIS; SOLUTION SCATTERING; CATALYTIC DOMAIN; ARABIDOPSIS	Background: Signaling of the phytohormone ethylene is initiated by ethylene receptors. Results: We present two crystal structures and a solution model of the entire cytosolic domain of ETR1. Conclusion: This first structural model of the cytosolic domains reveals a flexible receiver domain and asymmetry of the central dimerization domain. Significance: The molecular architecture of the isolated cytosolic domain forms the basis to understand receptor assembly and interaction. Ethylene initiates important aspects of plant growth and development through disulfide-linked receptor dimers located in the endoplasmic reticulum. The receptors feature a small transmembrane, ethylene binding domain followed by a large cytosolic domain, which serves as a scaffold for the assembly of large molecular weight complexes of different ethylene receptors and other cellular participants of the ethylene signaling pathway. Here we report the crystallographic structures of the ethylene receptor 1 (ETR1) catalytic ATP-binding and the ethylene response sensor 1 dimerization histidine phosphotransfer (DHp) domains and the solution structure of the entire cytosolic domain of ETR1, all from Arabidopsis thaliana. The isolated dimeric ethylene response sensor 1 DHp domain is asymmetric, the result of different helical bending angles close to the conserved His residue. The structures of the catalytic ATP-binding, DHp, and receiver domains of ethylene receptors and of a homologous, but dissimilar, GAF domain were refined against experimental small angle x-ray scattering data, leading to a structural model of the entire cytosolic domain of the ethylene receptor 1. The model illustrates that the cytosolic domain is shaped like a dumbbell and that the receiver domain is flexible and assumes a position different from those observed in prokaryotic histidine kinases. Furthermore the cytosolic domain of ETR1 plays a key role, interacting with all other receptors and several participants of the ethylene signaling pathway. Our model, therefore, provides the first step toward a detailed understanding of the molecular mechanics of this important signal transduction process in plants.	[Mayerhofer, Hubert; Panneerselvam, Saravanan; Kaljunen, Heidi; Tuukkanen, Anne; Mertens, Haydyn D. T.; Mueller-Dieckmann, Jochen] Deutsch Elektronen Synchrotron DESY, European Mol Biol Lab EMBL Hamburg, D-22603 Hamburg, Germany	European Molecular Biology Laboratory (EMBL); Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY)	Mueller-Dieckmann, J (corresponding author), Univ Hamburg, Biozentrum Klein Flottbek, Abt Mikrobiol & Biotechnol, Ohnhorststr 18, D-22609 Hamburg, Germany.	jochen.mueller-dieckmann@uni-hamburg.de		Mertens, Haydyn/0000-0002-5664-744X; Mayerhofer, Hubert/0000-0002-3291-2376	EMBL Interdisciplinary Postdocs program	EMBL Interdisciplinary Postdocs program	Supported by fellowships from the EMBL Interdisciplinary Postdocs program.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albanesi D, 2009, P NATL ACAD SCI USA, V106, P16185, DOI 10.1073/pnas.0906699106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bilwes AM, 2001, NAT STRUCT BIOL, V8, P353, DOI 10.1038/86243; Casino P, 2009, CELL, V139, P325, DOI 10.1016/j.cell.2009.08.032; CHANG C, 1993, SCIENCE, V262, P539, DOI 10.1126/science.8211181; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chen YF, 2002, J BIOL CHEM, V277, P19861, DOI 10.1074/jbc.M201286200; Chen YF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008640; Clark KL, 1998, P NATL ACAD SCI USA, V95, P5401, DOI 10.1073/pnas.95.9.5401; Dunin-Horkawicz S, 2010, J STRUCT BIOL, V170, P226, DOI 10.1016/j.jsb.2010.01.023; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eswar N., 2002, CURRENT PROTOCOLS BI; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Ferris HU, 2012, STRUCTURE, V20, P56, DOI 10.1016/j.str.2011.11.014; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gamble RL, 1998, P NATL ACAD SCI USA, V95, P7825, DOI 10.1073/pnas.95.13.7825; Gamble RL, 2002, PLANT PHYSIOL, V128, P1428, DOI 10.1104/pp.010777; Gao Z, 2008, J BIOL CHEM, V283, P23801, DOI 10.1074/jbc.M800641200; Gao ZY, 2003, J BIOL CHEM, V278, P34725, DOI 10.1074/jbc.M305548200; Guinier A., 1939, ANN PHYS-LEIPZIG, DOI DOI 10.1051/ANPHYS/193911120161; Hahn A, 2009, PLANT PHYSIOL, V149, P1207, DOI 10.1104/pp.108.132241; Hua J, 1998, CELL, V94, P261, DOI 10.1016/S0092-8674(00)81425-7; Huang YF, 2003, PLANT J, V33, P221, DOI 10.1046/j.1365-313X.2003.01620.x; Ju CL, 2012, P NATL ACAD SCI USA, V109, P19486, DOI 10.1073/pnas.1214848109; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KIEBER JJ, 1993, CELL, V72, P427, DOI 10.1016/0092-8674(93)90119-B; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Marina A, 2001, J BIOL CHEM, V276, P41182, DOI 10.1074/jbc.M106080200; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; Mayerhofer H, 2013, ACTA CRYSTALLOGR F, V69, P1029, DOI 10.1107/S1744309113021751; Mayerhofer H, 2012, J MOL BIOL, V415, P768, DOI 10.1016/j.jmb.2011.11.046; McDaniel BK, 2012, J BIOL CHEM, V287, P26094, DOI 10.1074/jbc.M112.383034; Moussatche P, 2004, J BIOL CHEM, V279, P48734, DOI 10.1074/jbc.M403100200; Muller-Dieckmann HJ, 1999, STRUCT FOLD DES, V7, P1547, DOI 10.1016/S0969-2126(00)88345-8; Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307; Panneerselvam S, 2013, ACTA CRYSTALLOGR F, V69, P1307, DOI 10.1107/S174430911302842X; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Qiao H, 2012, SCIENCE, V338, P390, DOI 10.1126/science.1225974; Qiu LP, 2012, PLANT PHYSIOL, V159, P1263, DOI 10.1104/pp.112.193979; Qu X, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-3; Rodriguez FI, 1999, SCIENCE, V283, P996, DOI 10.1126/science.283.5404.996; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; SCHALLER GE, 1995, J BIOL CHEM, V270, P12526, DOI 10.1074/jbc.270.21.12526; SCHALLER GE, 1995, SCIENCE, V270, P1809, DOI 10.1126/science.270.5243.1809; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Stepanova AN, 2009, CURR OPIN PLANT BIOL, V12, P548, DOI 10.1016/j.pbi.2009.07.009; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Ulijasz AT, 2010, NATURE, V463, P250, DOI 10.1038/nature08671; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wang C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001493; Yamada S, 2009, STRUCTURE, V17, P1333, DOI 10.1016/j.str.2009.07.016; YANG Y, 1991, P NATL ACAD SCI USA, V88, P11057, DOI 10.1073/pnas.88.24.11057; Zhao Q, 2011, MOL PLANT, V4, P626, DOI 10.1093/mp/ssr042; Zhou P, 2001, J BIOMOL NMR, V20, P11, DOI 10.1023/A:1011258906244	65	22	23	0	23	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 30	2015	290	5					2644	2658		10.1074/jbc.M114.587667	http://dx.doi.org/10.1074/jbc.M114.587667			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	CB0JA	25451923	hybrid, Green Published			2022-12-26	WOS:000349310700010
J	Ding, XF; Zhou, J; Hu, QY; Liu, SC; Chen, G				Ding, Xiao-Fei; Zhou, Jun; Hu, Qiong-Ying; Liu, Shuang-Chun; Chen, Guang			The Tumor Suppressor pVHL Down-regulates Never-in-Mitosis A-related Kinase 8 via Hypoxia-inducible Factors to Maintain Cilia in Human Renal Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-HIPPEL-LINDAU; KIDNEY-DISEASE; NEK FAMILY; PROTEIN; LOCALIZATION; CILIOGENESIS; MUTATIONS; CYSTS; LINKS; CYCLE	NEK8 (never in mitosis gene A (NIMA)-related kinase 8) is involved in cytoskeleton, cilia, and DNA damage response/repair. Abnormal expression and/or dysfunction of NEK8 are related to cancer development and progression. However, the mechanisms that regulate NEK8 are not well declared. We demonstrated here that pVHL may be involved in regulating NEK8. We found that CAK-I cells with wild-type vhl expressed a lower level of NEK8 than the cells loss of vhl, such as 786-O, 769-P, and A-498 cells. Moreover, pVHL overexpression down-regulated the NEK8 protein in 786-O cells, whereas pVHL knockdown up-regulated NEK8 in CAK-I cells. In addition, we found that the positive hypoxia response elements (HREs) are located in the promoter of the nek8 sequence and hypoxia could induce nek8 expression in different cell types. Consistent with this, down-regulation of hypoxia-inducible factors alpha (HIF-1 alpha or HIF-2 alpha) by isoform-specific siRNA reduced the ability of hypoxia inducing nek8 expression. In vivo, NEK8 and HIF-1 alpha expression were increased in kidneys of rats subjected to an experimental hypoxia model of ischemia and reperfusion. Furthermore, NEK8 siRNA transfection significantly blocked pVHL-knockdown-induced cilia disassembling, through impairing the pVHL-knockdown-up-regulated NEK8 expression. These results support that nek8 may be a novel hypoxia-inducible gene. In conclusion, our findings show that nek8 may be a new HIF target gene and pVHL can down-regulate NEK8 via HIFs to maintain the primary cilia structure in human renal cancer cells.	[Ding, Xiao-Fei; Zhou, Jun; Hu, Qiong-Ying; Chen, Guang] Taizhou Univ, Sch Med, Taizhou 318000, Zhejiang, Peoples R China; [Zhou, Jun; Chen, Guang] Taizhou Univ, Inst Tumor, Taizhou 318000, Zhejiang, Peoples R China; [Chen, Guang] Taizhou Univ, Sch Pharmaceut & Chem Engn, Taizhou 318000, Zhejiang, Peoples R China; [Liu, Shuang-Chun] Taizhou Municipal Hosp, Taizhou 318000, Zhejiang, Peoples R China	Taizhou University; Taizhou University; Taizhou University; Taizhou University	Chen, G (corresponding author), 1139 Shi Fu Ave, Taizhou 318000, Zhejiang, Peoples R China.	9220229@qq.com			National Natural Science Foundation of China [81201530]; Zhejiang Provincial Natural Science Foundation of China [Y15H310005, Y15H310006]; Foundation of Zhejiang Educational Committee [Y201121896]; Key Disciplines of Applied Chemistry of Zhejiang Providence, Taizhou University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Foundation of Zhejiang Educational Committee; Key Disciplines of Applied Chemistry of Zhejiang Providence, Taizhou University	This work was supported by National Natural Science Foundation of China Grant 81201530, Zhejiang Provincial Natural Science Foundation of China Grants Y15H310005 and Y15H310006, Foundation of Zhejiang Educational Committee Grant Y201121896, and Key Disciplines of Applied Chemistry of Zhejiang Providence, Taizhou University.	Bowers AJ, 2004, GENE, V328, P135, DOI 10.1016/j.gene.2003.12.002; Cai YQ, 2008, J AM SOC NEPHROL, V19, P418, DOI 10.1681/ASN.2008010084; Chen G, 2012, J BIOL CHEM, V287, P12132, DOI 10.1074/jbc.M111.302299; Choi HJC, 2013, MOL CELL, V51, P423, DOI 10.1016/j.molcel.2013.08.006; Frank V, 2013, HUM MOL GENET, V22, P2177, DOI 10.1093/hmg/ddt070; Frew IJ, 2007, CURR OPIN CELL BIOL, V19, P685, DOI 10.1016/j.ceb.2007.10.001; Fry AM, 2012, J CELL SCI, V125, P4423, DOI 10.1242/jcs.111195; Holland PM, 2002, J BIOL CHEM, V277, P16229, DOI 10.1074/jbc.M108662200; Jackson PK, 2013, MOL CELL, V51, P407, DOI 10.1016/j.molcel.2013.08.013; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Kuehn EW, 2007, CANCER RES, V67, P4537, DOI 10.1158/0008-5472.CAN-07-0391; Li MQ, 2011, J CELL MOL MED, V15, P187, DOI 10.1111/j.1582-4934.2010.01238.x; Mahjoub MR, 2005, J AM SOC NEPHROL, V16, P3485, DOI 10.1681/ASN.2005080824; Manning DK, 2013, J AM SOC NEPHROL, V24, P100, DOI 10.1681/ASN.2012050490; Moniz L, 2011, CELL DIV, V6, DOI 10.1186/1747-1028-6-18; Natoli TA, 2008, AM J PHYSIOL-RENAL, V294, pF73, DOI 10.1152/ajprenal.00362.2007; O'Regan L, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-25; Quarmby LM, 2005, J CELL SCI, V118, P5161, DOI 10.1242/jcs.02681; Schermer B, 2006, J CELL BIOL, V175, P547, DOI 10.1083/jcb.200605092; Semenza G.L., 2007, SCI STKE, V2007, pcm8; Shen C, 2013, SEMIN CANCER BIOL, V23, P18, DOI 10.1016/j.semcancer.2012.06.001; Sohara E, 2008, J AM SOC NEPHROL, V19, P469, DOI 10.1681/ASN.2006090985; Trapp ML, 2008, PEDIATR NEPHROL, V23, P377, DOI 10.1007/s00467-007-0692-y; Valkova N, 2005, MOL CELL PROTEOMICS, V4, P1009, DOI 10.1074/mcp.M500091-MCP200; Xu J., 2010, J AM SOC NEPHROL, V21, P2041; Xu JY, 2010, J AM SOC NEPHROL, V21, P2041, DOI 10.1681/ASN.2010040345; Zalli D, 2012, HUM MOL GENET, V21, P1155, DOI 10.1093/hmg/ddr544	29	25	25	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1389	1394		10.1074/jbc.M114.589226	http://dx.doi.org/10.1074/jbc.M114.589226			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25451921	Green Published, hybrid			2022-12-26	WOS:000348056400008
J	Park, M; Lee, BS; Jeon, SH; Nam, HJ; Lee, G; Kim, CH; Cho, H; Lee, JH				Park, Minseon; Lee, Bok-Soon; Jeon, Soung-Hoo; Nam, Hyun-Ja; Lee, Gwang; Kim, Chul-Ho; Cho, Hyeseong; Lee, Jae-Ho			A Novel Isoform of Met Receptor Tyrosine Kinase Blocks Hepatocyte Growth Factor/Met Signaling and Stimulates Skeletal Muscle Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SATELLITE CELLS; SCATTER FACTOR; MYOGENIC DIFFERENTIATION; GENE-EXPRESSION; IGF-I; REGENERATION; PROLIFERATION; ACTIVATION; CANCER; MIGRATION	Hepatocyte growth factor (HGF) and its receptor, Met, regulate skeletal muscle differentiation. In the present study, we identified a novel alternatively spliced isoform of Met lacking exon 13 (designated Delta 13Met), which is expressed mainly in human skeletal muscle. Alternative splicing yielded a truncated Met having extracellular domain only, suggesting an inhibitory role. Indeed, Delta 13Met expression led to a decrease in HGF-induced tyrosine phosphorylation of Met and ERK phosphorylation, as well as cell proliferation and migration via sequestration of HGF. Interestingly, in human primary myoblasts undergoing differentiation, Delta 13Met mRNA and protein levels were rapidly increased, concomitantly with a decrease in wild type Met mRNA and protein. Inhibition of Delta 13Met with siRNA led to a decreased differentiation, whereas its overexpression potentiated differentiation of human primary myoblasts. Furthermore, in notexin-induced mouse injury model, exogenous Delta 13Met expression enhanced regeneration of skeletal muscle, further confirming a stimulatory role of the isoform in muscle cell differentiation. In summary, we identified a novel alternatively spliced inhibitory isoform of Met that stimulates muscle cell differentiation, which confers a new means to control muscle differentiation and/or regeneration.	[Park, Minseon; Jeon, Soung-Hoo; Nam, Hyun-Ja; Cho, Hyeseong; Lee, Jae-Ho] Ajou Univ, Sch Med, Dept Biochem & Mol Biol, Suwon 443721, South Korea; [Lee, Bok-Soon; Kim, Chul-Ho] Ajou Univ, Sch Med, Dept Otolaryngol, Suwon 443721, South Korea; [Lee, Gwang] Ajou Univ, Sch Med, Dept Physiol, Suwon 443721, South Korea	Ajou University; Ajou University; Ajou University	Lee, JH (corresponding author), Ajou Univ, Sch Med, Dept Biochem & Mol Biol, 5 Woncheon Dong, Suwon 443721, South Korea.	jhlee64@ajou.ac.kr		Cho, Hyeseong/0000-0002-4672-8887	National Research Foundation of Korea - Korean government (Ministry of Science, ICT, and Future Planning) [2011-0030043]	National Research Foundation of Korea - Korean government (Ministry of Science, ICT, and Future Planning)	This work was supported by National Research Foundation of Korea Grant 2011-0030043 funded by the Korean government (Ministry of Science, ICT, and Future Planning).	ALLEN RE, 1990, P SOC EXP BIOL MED, V194, P81; Anastasi S, 1997, J CELL BIOL, V137, P1057, DOI 10.1083/jcb.137.5.1057; Arribas J, 2002, CHEM REV, V102, P4627, DOI 10.1021/cr010202t; AUSTIN L, 1991, J NEUROL SCI, V101, P193, DOI 10.1016/0022-510X(91)90045-9; BHARGAVA M, 1992, CELL GROWTH DIFFER, V3, P11; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Chernyavsky AI, 2005, J BIOL CHEM, V280, P39220, DOI 10.1074/jbc.M504407200; Christ B, 2002, INT J DEV BIOL, V46, P905; Collesi C, 1996, MOL CELL BIOL, V16, P5518; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Cross JC, 2003, PLACENTA, V24, P123, DOI 10.1053/plac.2002.0887; Fiaschi T, 2014, CELL MOL LIFE SCI, V71, P1917, DOI 10.1007/s00018-013-1537-4; Flann KL, 2014, J CELL PHYSIOL, V229, P572, DOI 10.1002/jcp.24479; FLORINI JR, 1991, MOL ENDOCRINOL, V5, P718, DOI 10.1210/mend-5-5-718; Foulstone EJ, 2004, EXP CELL RES, V294, P223, DOI 10.1016/j.yexcr.2003.10.034; Gal-Levi R, 1998, BBA-MOL CELL RES, V1402, P39, DOI 10.1016/S0167-4889(97)00124-9; Garcia-Blanco MA, 2004, NAT BIOTECHNOL, V22, P535, DOI 10.1038/nbt964; Ghigna C, 2005, MOL CELL, V20, P881, DOI 10.1016/j.molcel.2005.10.026; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; Jeffers M, 1997, P NATL ACAD SCI USA, V94, P11445, DOI 10.1073/pnas.94.21.11445; JENNISCHE E, 1993, AM J PHYSIOL, V265, pC122, DOI 10.1152/ajpcell.1993.265.1.C122; Karalaki M, 2009, IN VIVO, V23, P779; KIM DW, 1990, GENE, V91, P217, DOI 10.1016/0378-1119(90)90091-5; Kong-Beltran M, 2004, CANCER CELL, V6, P75, DOI 10.1016/j.ccr.2004.06.013; LEE CC, 1994, J BIOL CHEM, V269, P19457; Lee JH, 2006, EXP MOL MED, V38, P565, DOI 10.1038/emm.2006.66; Lee JH, 2000, ONCOGENE, V19, P4947, DOI 10.1038/sj.onc.1203874; Lin JC, 1998, ONCOGENE, V16, P833, DOI 10.1038/sj.onc.1201599; Liu YH, 1998, GENE, V215, P159, DOI 10.1016/S0378-1119(98)00264-9; Liu YH, 2002, CURR OPIN NEPHROL HY, V11, P23, DOI 10.1097/00041552-200201000-00004; Miller KJ, 2000, AM J PHYSIOL-CELL PH, V278, pC174, DOI 10.1152/ajpcell.2000.278.1.C174; PONZETTO C, 1994, CELL, V77, P261, DOI 10.1016/0092-8674(94)90318-2; Reiser J, 2000, GENE THER, V7, P910, DOI 10.1038/sj.gt.3301188; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; RODRIGUES GA, 1991, MOL CELL BIOL, V11, P2962, DOI 10.1128/MCB.11.6.2962; Schertzer JD, 2006, GENE THER, V13, P1657, DOI 10.1038/sj.gt.3302817; SCHULTZ E, 1994, REV PHYSIOL BIOCH P, V123, P213, DOI 10.1007/BFb0030904; SEGER R, 1995, FASEB J, V9, P726, DOI 10.1096/fasebj.9.9.7601337; Shinomiya N, 2004, CANCER RES, V64, P7962, DOI 10.1158/0008-5472.CAN-04-1043; Tatsumi R, 2002, MOL BIOL CELL, V13, P2909, DOI 10.1091/mbc.E02-01-0062; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Webster MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081757; Yamane A, 2003, DEV GROWTH DIFFER, V45, P1; Zufferey R, 1999, J VIROL, V73, P2886, DOI 10.1128/JVI.73.4.2886-2892.1999	45	5	5	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 16	2015	290	3					1804	1817		10.1074/jbc.M114.596957	http://dx.doi.org/10.1074/jbc.M114.596957			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AZ2IB	25471370	hybrid, Green Published			2022-12-26	WOS:000348056400045
J	Chen, YL; Cheng, LL; Yao, HH; Chen, HY; Wang, YS; Zhao, WP; Pan, CZ; Shu, XH				Chen, Yongle; Cheng, Leilei; Yao, Haohua; Chen, Haiyan; Wang, Yongshi; Zhao, Weipeng; Pan, Cuizhen; Shu, Xianhong			The Myocardial Ischemia Evaluated by Real-Time Contrast Echocardiography May Predict the Response to Cardiac Resynchronization Therapy: A Large Animal Study	PLOS ONE			English	Article							LEFT-VENTRICULAR DYSSYNCHRONY; CORONARY FLOW RESERVE; HEART-FAILURE; BLOOD-FLOW; STRAIN; MORTALITY	Evidence-based criteria for applying cardiac resynchronization therapy (CRT) in patients with ischemic cardiomyopathy are still scarce. The aim of the present study was to evaluate the predictive value of real-time myocardial contrast echocardiography (RT-MCE) in a preclinical canine model of ischemic cardiomyopathy who received CRT. Ischemic cardiomyopathy was produced by ligating the first diagonal branch in 20 beagles. Dogs were subsequently divided into two groups that were either treated with bi-ventricular pacing (CRT group) or left untreated (control group). RT-MCE was performed at baseline, before CRT, and 4 weeks after CRT. Two-dimensional speckle tracking imaging was used to evaluate the standard deviation of circumferential (Cir12SD), radial (R12SD), and longitudinal (L12SD) strains of left ventricular segments at basal as well as middle levels. Four weeks later, the Cir12SD, R12SD, and myocardial blood flow (MBF) of the treated group were significantly improved compared to their non-CRT counterparts. Furthermore, MBF values measured before CRT were significantly higher in responders than in non-responders to bi-ventricular pacing. Meanwhile, no significant differences were observed between the responder and nonresponder groups in terms of Cir12SD, R12SD, and L12SD. A high degree of correlation was found between MBF values before CRT and LVEF after CRT. When MBF value >24.9 dB/s was defined as a cut-off point before CRT, the sensitivity and specificity of RT-MCE in predicting the response to CRT were 83.3% and 100%, respectively. Besides, MBF values increased significantly in the CRT group compared with the control group after 4 weeks of pacing (49.8 +/- 15.5 dB/s vs. 28.5 +/- 4.6 dB/s, p<0.05). Therefore, we considered that myocardial perfusion may be superior to standard metrics of LV synchrony in selecting appropriate candidates for CRT. In addition, CRT can improve myocardial perfusion in addition to cardiac synchrony, especially in the setting of ischemic cardiomyopathy.	[Chen, Yongle; Cheng, Leilei; Yao, Haohua; Chen, Haiyan; Wang, Yongshi; Zhao, Weipeng; Pan, Cuizhen; Shu, Xianhong] Fudan Univ, Shanghai Inst Cardiovasc Dis, Shanghai Inst Med Imaging, Dept Echocardiog,Zhongshan Hosp, Shanghai 200433, Peoples R China	Fudan University	Cheng, LL (corresponding author), Fudan Univ, Shanghai Inst Cardiovasc Dis, Shanghai Inst Med Imaging, Dept Echocardiog,Zhongshan Hosp, Shanghai 200433, Peoples R China.	cheng.leilei@zs-hospital.sh.cn; shu.xianhong@zs-hospital.sh.cn	Wang, Yongshi/GLT-9336-2022; Chen, Haiyan/HGB-6216-2022	Wang, Yongshi/0000-0002-7851-1623; 	Chinese National Scientific Fund [81371576, 81201095]	Chinese National Scientific Fund	The work was supported by Chinese National Scientific Fund (No. 81371576 and No. 81201095) http://www.nsfc.gov.cn/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba T, 2009, CIRCULATION, V119, P1220, DOI 10.1161/CIRCULATIONAHA.108.794834; Fernandes DRA, 2011, ECHOCARDIOGR-J CARD, V28, P342, DOI 10.1111/j.1540-8175.2010.01317.x; Anantharam B, 2011, EUR J ECHOCARDIOGR, V12, P69, DOI 10.1093/ejechocard/jeq109; Ashrafian H, 2007, CIRCULATION, V116, P434, DOI 10.1161/CIRCULATIONAHA.107.702795; Bax JJ, 2004, J AM COLL CARDIOL, V44, P1834, DOI 10.1016/j.jacc.2004.08.016; Beshai JF, 2007, NEW ENGL J MED, V357, P2461, DOI 10.1056/NEJMoa0706695; Biswas M, 2013, ECHOCARDIOGR-J CARD, V30, P88, DOI 10.1111/echo.12079; Bleeker GB, 2006, J AM COLL CARDIOL, V48, P2243, DOI 10.1016/j.jacc.2006.07.067; Chakir K, 2008, CIRCULATION, V117, P1369, DOI 10.1161/CIRCULATIONAHA.107.706291; Chen YP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086159, 10.1371/journal.pone.0109012, 10.1371/journal.pone.0094614]; Choi JO, 2009, EUR J ECHOCARDIOGR, V10, P695, DOI 10.1093/ejechocard/jep041; Chung Eugene S, 2007, Congest Heart Fail, V13, P9, DOI 10.1111/j.1527-5299.2007.05868.x; Chung ES, 2010, CIRC-HEART FAIL, V3, P650, DOI 10.1161/CIRCHEARTFAILURE.110.945881; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Dohi K, 2005, AM J CARDIOL, V96, P112, DOI 10.1016/j.amjcard.2005.03.032; Erol-Yilmaz A, 2007, J CARD FAIL, V13, P95, DOI 10.1016/j.cardfail.2006.10.016; Flevari P, 2006, EUROPACE, V8, P44, DOI 10.1093/europace/euj015; Gorcsan J, 2007, J AM COLL CARDIOL, V50, P1476, DOI 10.1016/j.jacc.2007.06.043; Helm RH, 2005, CIRCULATION, V111, P2760, DOI 10.1161/CIRCULATIONAHA.104.508457; Hickman M, 2010, EUR J ECHOCARDIOGR, V11, P756, DOI 10.1093/ejechocard/jeq062; Hillis GS, 2003, J AM SOC ECHOCARDIOG, V16, P638, DOI 10.1016/S0894-7317(03)00212-8; Holzmeister J, 2011, LANCET, V378, P722, DOI 10.1016/S0140-6736(11)61228-2; Kass DA, 2003, J AM COLL CARDIOL, V42, P2125, DOI 10.1016/j.jacc.2003.09.021; Kydd AC, 2014, JACC-HEART FAIL, V2, P205, DOI 10.1016/j.jchf.2013.11.010; Olszowska M, 2010, ECHOCARDIOGR-J CARD, V27, P430, DOI 10.1111/j.1540-8175.2009.01034.x; Parsai C, 2009, EUR HEART J, V30, P940, DOI 10.1093/eurheartj/ehn481; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Pouleur AC, 2011, EUR HEART J, V32, P1720, DOI 10.1093/eurheartj/ehr185; Shah AM, 2011, LANCET, V378, P704, DOI 10.1016/S0140-6736(11)60894-5; Shanks M, 2010, J AM COLL CARDIOL, V56, P1567, DOI 10.1016/j.jacc.2010.01.077; Valzania C, 2008, EUR J HEART FAIL, V10, P514, DOI 10.1016/j.ejheart.2008.03.011; Wei K, 1998, CIRCULATION, V97, P473	32	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113992	10.1371/journal.pone.0113992	http://dx.doi.org/10.1371/journal.pone.0113992			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469632	gold, Green Published, Green Submitted			2022-12-26	WOS:000349128700061
J	Cusick, SE; Opoka, RO; Lund, TC; John, CC; Polgreen, LE				Cusick, Sarah E.; Opoka, Robert O.; Lund, Troy C.; John, Chandy C.; Polgreen, Lynda E.			Vitamin D Insufficiency Is Common in Ugandan Children and Is Associated with Severe Malaria	PLOS ONE			English	Article							D-BINDING PROTEIN; TUBERCULOSIS; MACROPHAGES; INFANTS	Vitamin D plays an increasingly recognized role in the innate and adaptive immune response to infection. Based on demonstrated roles in up-regulating innate immunity, decreasing inflammation, and reducing the severity of disease in illnesses such as tuberculosis and influenza, we hypothesized that poor vitamin D status would be associated with severe malaria. We measured 25-hydroxyvitamin D [25(OH)D] by immunoassay in a sample of Ugandan children aged 18 months 12 years with severe malaria (cerebral malaria or severe malarial anemia, n=40) and in healthy community children (n=20). Ninety-five percent of children with severe malaria (n=38) and 80% of control children (n=16) were vitamin Dinsufficient [ plasma 25(OH)D <30 ng/mL]. Mean plasma 25(OH)D levels were significantly lower in children with severe malaria than in community children (21.2 vs. 25.3 ng/mL, p=0.03). Logistic regression revealed that for every 1 ng/mL increase in plasma 25(OH)D, the odds of having severe malaria declined by 9% [OR50.91 (95% CI: 0.84, 1.0)]. These preliminary results suggest that vitamin D insufficiency may play a role in the development of severe malaria. Further prospective studies in larger cohorts are indicated to confirm the relationship of vitamin D levels to severity of malaria infection and to investigate causality.	[Cusick, Sarah E.; Opoka, Robert O.; Lund, Troy C.; John, Chandy C.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Opoka, Robert O.] Makerere Univ, Coll Hlth Sci, Dept Paediat, Kampala, Uganda; [Polgreen, Lynda E.] Univ Calif Los Angeles, Dept Pediat, Los Angeles Biomed Res Inst Habor, Los Angeles, CA 90024 USA	University of Minnesota System; University of Minnesota Twin Cities; Makerere University; University of California System; University of California Los Angeles	Cusick, SE (corresponding author), Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA.	scusick@umn.edu	John, Chandy/GNP-8431-2022	John, Chandy/0000-0002-1634-1411	Eunice Kennedy Shriver National Institute of Child Health and Human Development [U01 HD064698-05]; National Institute of Neurological Disorders and Stroke [R01 NS055349-05]; National Center for Advancing Translational Sciences of the National Institutes of Health Award [UL1TR000114, KL2]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD064698] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055349] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Advancing Translational Sciences of the National Institutes of Health Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development [grant number U01 HD064698-05]; the National Institute of Neurological Disorders and Stroke [grant number R01 NS055349-05]; and the National Center for Advancing Translational Sciences of the National Institutes of Health Award [UL1TR000114 to SEC, KL2 Scholar]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amukele TK, 2013, ARCH DIS CHILD, V98, P180, DOI 10.1136/archdischild-2012-302377; Barlow PG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025333; Chua CLL, 2013, TRENDS PARASITOL, V29, P26, DOI 10.1016/j.pt.2012.10.002; Cippitelli M, 1998, EUR J IMMUNOL, V28, P3017, DOI 10.1002/(SICI)1521-4141(199810)28:10<3017::AID-IMMU3017>3.3.CO;2-Y; Cohen ML, 2001, KIDNEY INT, V59, P69, DOI 10.1046/j.1523-1755.2001.00467.x; Dickie LJ, 2010, RHEUMATOLOGY, V49, P1466, DOI 10.1093/rheumatology/keq124; Gordon CM, 2008, ARCH PEDIAT ADOL MED, V162, P505, DOI 10.1001/archpedi.162.6.505; He X, 2014, J IMMUNOL; Hewison M, 2010, ENDOCRIN METAB CLIN, V39, P365, DOI 10.1016/j.ecl.2010.02.010; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Khare D, 2013, EUR J NUTR, V52, P1405, DOI 10.1007/s00394-012-0449-7; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; Newens K, 2006, T ROY SOC TROP MED H, V100, P41, DOI 10.1016/j.trstmh.2005.06.022; Nnoaham KE, 2008, INT J EPIDEMIOL, V37, P113, DOI 10.1093/ije/dym247; Parra M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066115; Powe CE, 2013, NEW ENGL J MED, V369, P1991, DOI 10.1056/NEJMoa1306357; Salahuddin N, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-22; Weintraub SJ, 2014, NEW ENGL J MED, V370, P878, DOI 10.1056/NEJMc1315850	19	26	26	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113185	10.1371/journal.pone.0113185	http://dx.doi.org/10.1371/journal.pone.0113185			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470777	gold, Green Published, Green Submitted			2022-12-26	WOS:000349128700016
J	Price, MR; Hadfield, MG				Price, Melissa R.; Hadfield, Michael G.			Population Genetics and the Effects of a Severe Bottleneck in an Ex Situ Population of Critically Endangered Hawaiian Tree Snails	PLOS ONE			English	Article							INBREEDING DEPRESSION; ACHATINELLA-LILA; COMPUTER-PROGRAM; EXTINCTION; SOFTWARE	As wild populations decline, ex situ propagation provides a potential bank of genetic diversity and a hedge against extinction. These programs are unlikely to succeed if captive populations do not recover from the severe bottleneck imposed when they are founded with a limited number of individuals from remnant populations. In small captive populations allelic richness may be lost due to genetic drift, leading to a decline in fitness. Wild populations of the Hawaiian tree snail Achatinella lila, a hermaphroditic snail with a long life history, have declined precipitously due to introduced predators and other human impacts. A captive population initially thrived after its founding with seven snails, exceeding 600 captive individuals in 2009, but drastically declined in the last five years. Measures of fitness were examined from 2,018 captive snails that died between 1998 and 2012, and compared with genotypic data for six microsatellite loci from a subset of these deceased snails (N=335), as well as live captive snails (N=198) and wild snails (N=92). Surprisingly, the inbreeding coefficient (F-is) declined over time in the captive population, and is now approaching values observed in the 2013 wild population, despite a significant decrease in allelic richness. However, adult annual survival and fecundity significantly declined in the second generation. These measures of fitness were positively correlated with heterozygosity. Snails with higher measures of heterozygosity had more offspring, and third generation offspring with higher measures of heterozygosity were more likely to reach maturity. These results highlight the importance of maintaining genetic diversity in captive populations, particularly those initiated with a small number of individuals from wild remnant populations. Genetic rescue may allow for an increase in genetic diversity in the captive population, as measures of heterozygosity and rarified allelic richness were higher in wild tree snails.	[Price, Melissa R.; Hadfield, Michael G.] Univ Hawaii Manoa, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA; [Price, Melissa R.; Hadfield, Michael G.] Kewalo Marine Labs, Honolulu, HI USA	University of Hawaii System; University of Hawaii Manoa	Price, MR (corresponding author), Univ Hawaii Manoa, Pacific Biosci Res Ctr, Honolulu, HI 96822 USA.	melrprice@gmail.com	Price, Melissa/AAM-7749-2020	Price, Melissa/0000-0003-1836-3769; Hadfield, Michael/0000-0002-8808-5197	United States Fish and Wildlife Service (USFWS);  [12200-B-G009 (F11AP00028)]	United States Fish and Wildlife Service (USFWS)(US Fish & Wildlife Service); 	The work was supported by United States Fish and Wildlife Service (USFWS) Grant Agreement and 12200-B-G009 (F11AP00028). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKANE A, 1994, J FORENSIC SCI, V39, P362; Armbruster P, 2005, HEREDITY, V95, P235, DOI 10.1038/sj.hdy.6800721; AWAD DA, 2014, PLOS ONE, V0009; Bijlsma R, 2001, EVOLUTIONAR BIOL, V13, P502; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; Coron C, 2013, AM NAT, V181, P623, DOI 10.1086/670022; Coutellec MA, 2011, J EVOLUTION BIOL, V24, P2248, DOI 10.1111/j.1420-9101.2011.02355.x; Crnokrak P, 1999, HEREDITY, V83, P260, DOI 10.1038/sj.hdy.6885530; Cunningham AA, 1998, CONSERV BIOL, V12, P1139, DOI 10.1046/j.1523-1739.1998.97485.x; Dabrowski MJ, 2014, MOL ECOL RESOUR, V14, P361, DOI 10.1111/1755-0998.12177; de Cara MAR, 2013, HEREDITY, V110, P530, DOI 10.1038/hdy.2012.119; Erickson PB, 2008, MOL ECOL RESOUR, V8, P808, DOI 10.1111/j.1755-0998.2007.02071.x; Erickson PB, 2014, CONSERV GENET, V15, P1209, DOI 10.1007/s10592-014-0612-1; Escobar JS, 2008, CURR BIOL, V18, P906, DOI 10.1016/j.cub.2008.04.070; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Garza JC, 2001, MOL ECOL, V10, P305, DOI 10.1046/j.1365-294x.2001.01190.x; HADFIELD MG, 1993, AM ZOOL, V33, P610; HADFIELD MG, 1986, MALACOLOGIA, V27, P67; HADFIELD MG, 1980, PAC SCI, V34, P345; Hadfield Michael G., 2004, P16; Holland BS, 2012, AM MALACOL BULL, V30, P153; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; NEW TR, 1995, INTRO INVERTEBRATE C; NUNNEY L, 1994, CONSERV BIOL, V8, P175, DOI 10.1046/j.1523-1739.1994.08010175.x; Pascua MT, 2010, INTEGR COMP BIOL, V50, pE279; Pritchard DJ, 2012, ORYX, V46, P18, DOI 10.1017/S0030605310001766; ROSSGILLESPIE A, 2007, EVOLUTION, V61, P2268; SEVERNS RM, 1981, NAUTILUS, V95, P140; Slate J, 2004, HEREDITY, V93, P255, DOI 10.1038/sj.hdy.6800485; Swindell WR, 2006, EVOLUTION, V60, P1014; Thacker RW, 2000, MOL PHYLOGENET EVOL, V16, P263, DOI 10.1006/mpev.2000.0793; U.S. Fish and Wildlife Service, 1981, FED REGISTER, V46, P3178; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Zheng HP, 2012, AQUACULTURE, V366, P27, DOI 10.1016/j.aquaculture.2012.08.029	36	10	10	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114377	10.1371/journal.pone.0114377	http://dx.doi.org/10.1371/journal.pone.0114377			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25470182	Green Submitted, gold, Green Published			2022-12-26	WOS:000349128700108
J	Zeng, Z; de Gorter, DJJ; Kowalski, M; ten Dijke, P; Shimmi, O				Zeng, Zhao; de Gorter, David J. J.; Kowalski, Maria; ten Dijke, Peter; Shimmi, Osamu			Ter94/VCP Is a Novel Component Involved in BMP Signaling	PLOS ONE			English	Article							TGF-BETA; AAA-ATPASE; DROSOPHILA; IDENTIFICATION; PROTEIN; MORPHOGEN; DIFFERENTIATION; SPECIFICATION; DISEASE; PATTERN	Bone morphogenetic proteins (BMPs), a subgroup of the transforming growth factor (TGF)-beta family, transduce their signal through multiple components downstream of their receptors. Even though the components involved in the BMP signaling pathway have been intensely studied, many molecules mediating BMP signaling remain to be addressed. To identify novel components that participate in BMP signaling, RNA interference (RNAi)-based screening was established by detecting phosphorylated Mad (pMad) in Drosophila S2 cells. Ter94, a member of the family of AAA ATPases, was identified as a novel mediator of BMP signaling, which is required for the phosphorylation of Mad in Drosophila S2 cells. Moreover, the mammalian orthlog of Ter94 valosin-containing protein (VCP) plays a critical role in the BMP-Smad1/5/8 signaling pathway in mammalian cells. Genetic evidence suggests that Ter94 is involved in the dorsal-ventral patterning of the Drosophila early embryo through regulating decapentaplegic (Dpp)/BMP signals. Taken together, our data suggest that Ter94/VCP appears to be an evolutionarily conserved component that regulates BMP-Smad1/5/8 signaling.	[Zeng, Zhao; Kowalski, Maria; Shimmi, Osamu] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [de Gorter, David J. J.; ten Dijke, Peter] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands; [de Gorter, David J. J.; ten Dijke, Peter] Leiden Univ, Med Ctr, Canc Genom Ctr Netherlands, Leiden, Netherlands	University of Helsinki; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Shimmi, O (corresponding author), Univ Helsinki, Inst Biotechnol, Helsinki, Finland.	osamu.shimmi@helsinki.fi	Dijke, Peter ten/AAG-4660-2021; , 0000-0001-6341-9130/P-9094-2018	Dijke, Peter ten/0000-0002-7234-342X; , 0000-0001-6341-9130/0000-0001-6341-9130; Kowalski-Jahn, Maria/0000-0003-1442-3656	Academy of Finland; Sigrid Juselius Foundation; Cancer Genomics Centre Netherlands; Le Ducq Foundation; Helsinki Graduate School in Biotechnology and Molecular Biology	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Genomics Centre Netherlands; Le Ducq Foundation(Leducq Foundation); Helsinki Graduate School in Biotechnology and Molecular Biology	Funding: This work was supported by grants from Academy of Finland and Sigrid Juselius Foundation to O.S., and Cancer Genomics Centre Netherlands and Le Ducq Foundation "Multidisciplinary Program to Elucidate the Role of Bone Morphogenic Protein Signaling in the Pathogenesis of Pulmonary and Systemic Vascular Diseases" to P.tD. Z.Z was supported by Helsinki Graduate School in Biotechnology and Molecular Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARORA K, 1994, GENE DEV, V8, P2588, DOI 10.1101/gad.8.21.2588; Bjorklund M, 2006, NATURE, V439, P1009, DOI 10.1038/nature04469; Cayli S, 2012, REPROD SCI, V19, P190, DOI 10.1177/1933719111417886; Chang CC, 2005, J BIOL CHEM, V280, P10164, DOI 10.1074/jbc.M409161200; Chang YC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001288; Chen HB, 2006, GENE DEV, V20, P648, DOI 10.1101/gad.1384706; Dantuma NP, 2012, TRENDS CELL BIOL, V22, P483, DOI 10.1016/j.tcb.2012.06.003; de Gorter DJJ, 2011, J BONE MINER RES, V26, P1178, DOI 10.1002/jbmr.313; deCelis JF, 1997, DEVELOPMENT, V124, P1007; Eivers E, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002034; FERGUSON EL, 1992, CELL, V71, P451, DOI 10.1016/0092-8674(92)90514-D; Gavin-Smyth J, 2013, CURR BIOL, V23, P2296, DOI 10.1016/j.cub.2013.09.055; Griciuc A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001075; Higashiyama H, 2002, CELL DEATH DIFFER, V9, P264, DOI 10.1038/sj.cdd.4400955; Janiesch PC, 2007, NAT CELL BIOL, V9, P379, DOI 10.1038/ncb1554; Leon A, 1999, MOL BIOL CELL, V10, P3825, DOI 10.1091/mbc.10.11.3825; Liang YY, 2003, J BIOL CHEM, V278, P26307, DOI 10.1074/jbc.C300028200; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Mohr S, 2010, ANNU REV BIOCHEM, V79, P37, DOI 10.1146/annurev-biochem-060408-092949; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9; O'Connor MB, 2006, DEVELOPMENT, V133, P183; Pardali E, 2010, TRENDS CELL BIOL, V20, P556, DOI 10.1016/j.tcb.2010.06.006; Pinto BS, 2008, GENETICS, V180, P133, DOI 10.1534/genetics.108.091371; Podos SD, 2001, DEV CELL, V1, P567, DOI 10.1016/S1534-5807(01)00057-0; Ritson GP, 2010, J NEUROSCI, V30, P7729, DOI 10.1523/JNEUROSCI.5894-09.2010; Ross JJ, 2001, NATURE, V410, P479, DOI 10.1038/35068578; Ruden DM, 2000, DEV BIOL, V218, P314, DOI 10.1006/dbio.1999.9583; Shimmi O, 2003, DEVELOPMENT, V130, P4673, DOI 10.1242/dev.00684; Shimmi O, 2005, CELL, V120, P873, DOI 10.1016/j.cell.2005.02.009; Wagner N, 2010, DEV BIOL, V339, P1, DOI 10.1016/j.ydbio.2009.11.036; Waltzer L, 1999, EMBO J, V18, P1630, DOI 10.1093/emboj/18.6.1630; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; WHARTON KA, 1993, DEVELOPMENT, V117, P807; Wu MY, 2009, DEV CELL, V16, P329, DOI 10.1016/j.devcel.2009.02.012; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Xu L, 2007, J CELL BIOL, V178, P981, DOI 10.1083/jcb.200703106; Yamashita T, 1996, BONE, V19, P429, DOI 10.1016/S8756-3282(96)00255-4	40	5	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e114475	10.1371/journal.pone.0114475	http://dx.doi.org/10.1371/journal.pone.0114475			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	25469707	Green Submitted, Green Published, gold			2022-12-26	WOS:000349128700118
J	Heldal, AT; Eide, GE; Romi, F; Owe, JF; Gilhus, NE				Heldal, Anne Taraldsen; Eide, Geir Egil; Romi, Fredrik; Owe, Jone Furlund; Gilhus, Nils Erik			Repeated Acetylcholine Receptor Antibody-Concentrations and Association to Clinical Myasthenia Gravis Development	PLOS ONE			English	Article							PROTEIN 4; AUTOANTIBODIES; MECHANISMS; KINASE; ASSAYS	Introduction: We aimed to examine the longitudinal association between Myasthenia Gravis (MG) clinical severity and concentration of acetylcholine receptor (AChR)-antibodies to evaluate if AChR-antibody variations correlate to disease severity. A positive AChR-antibody test is specific for MG. Material and Methods: All patients from western Norway who had two or more AChR-antibody tests in the period 1983-2013 were identified. The Myasthenia Gravis Foundation of America (MGFA) Clinical Classification was used to grade disease development. Multiple ordinal logistic regression analysis was used to estimate a possible predictive effect for AChR-antibody concentration on MGFA classification result. Results: In 67 patients two or more AChR-antibody tests with a corresponding MGFA-score were performed, with a total of 309 tests. 56 patients were treated with immunosuppressive drugs and 11 by pyridostigmine only. There was a positive association between concentration of AChR-antibodies and longitudinal MGFA-score for the subgroup with immunosuppressive treatment, but not for those treated with pyridostigmine only. This association between AChR-antibody concentration and MGFA score declined with increasing time since onset (p=0.005 for the interaction of group x time x concentration). Conclusions: For MG patients with immunosuppressive treatment, repeated AChR-antibody measurements give information about clinical development, and can therefore be of support in therapeutic decisions.	[Heldal, Anne Taraldsen; Gilhus, Nils Erik] Univ Bergen, Dept Clin Med, Bergen, Norway; [Eide, Geir Egil] Haukeland Hosp, Clin Res Ctr, N-5021 Bergen, Norway; [Eide, Geir Egil] Univ Bergen, Dept Global Publ Hlth & Primary Care, Bergen, Norway; [Romi, Fredrik; Owe, Jone Furlund; Gilhus, Nils Erik] Haukeland Hosp, Dept Neurol, Bergen, Norway	University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; University of Bergen; Haukeland University Hospital	Heldal, AT (corresponding author), Univ Bergen, Dept Clin Med, Bergen, Norway.	anne.taraldsen.heldal@helse-bergen.no						Godoy DA, 2013, ARQ NEURO-PSIQUIAT, V71, P627, DOI 10.1590/0004-282X20130108; Andersen JB, 2010, EUR J NEUROL, V17, P1445, DOI 10.1111/j.1468-1331.2010.03089.x; Andersen JT, 2011, J BIOL CHEM, V286, P5234, DOI 10.1074/jbc.M110.164848; Baggi F, 2012, ARCH IMMUNOL THER EX, V60, P19, DOI 10.1007/s00005-011-0158-6; Burns TM, 2008, MUSCLE NERVE, V38, P1553, DOI 10.1002/mus.21185; Cavalcante P, 2012, CURR OPIN NEUROL, V25, P621, DOI 10.1097/WCO.0b013e328357a829; DRACHMAN DB, 1987, ANN NY ACAD SCI, V505, P90; ENGEL AG, 1987, ANN NY ACAD SCI, V505, P326, DOI DOI 10.1111/J.1749-6632.1987.TB51301.X; Ferrero B, 1997, CLIN CHEM, V43, P824; Gilhus NE, 2012, CURR OPIN NEUROL, V25, P523, DOI 10.1097/WCO.0b013e3283572588; HEINEMANN S, 1977, P NATL ACAD SCI USA, V74, P3090, DOI 10.1073/pnas.74.7.3090; Heldal AT, 2009, NEUROLOGY, V73, P150, DOI 10.1212/WNL.0b013e3181ad53c2; Higuchi O, 2011, ANN NEUROL, V69, P418, DOI 10.1002/ana.22312; Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520; Jahn K, 2000, NEUROLOGY, V54, P474, DOI 10.1212/WNL.54.2.474; Jaretzki A, 2000, ANN THORAC SURG, V70, P327, DOI 10.1016/S0003-4975(00)01595-2; Kim JY, 2011, J CLIN NEUROL, V7, P173, DOI 10.3988/jcn.2011.7.4.173; Kirmani Jawad F., 2004, Curr Treat Options Neurol, V6, P3, DOI 10.1007/s11940-004-0034-3; Kleinbaum DG, 2010, LOGISTIC REGRESSION, Vxvii; Leite MI, 2010, AUTOIMMUNITY, V43, P371, DOI 10.3109/08916930903541208; Maddison P, 2011, J NEUROL NEUROSUR PS, V82, P671, DOI 10.1136/jnnp.2009.197632; Meriggioli MN, 2009, LANCET NEUROL, V8, P475, DOI 10.1016/S1474-4422(09)70063-8; Mori S, 2013, AUTOIMMUN REV, V12, P912, DOI 10.1016/j.autrev.2013.03.005; Pevzner A, 2012, J NEUROL, V259, P427, DOI 10.1007/s00415-011-6194-7; Sanders DB, 2013, MUSCLE NERVE; Skeie GO, 2010, EUR J NEUROL, V17, P893, DOI 10.1111/j.1468-1331.2010.03019.x; Tsinzerling N, 2007, J NEUROL NEUROSUR PS, V78, P1109, DOI 10.1136/jnnp.2006.109488; Tuzun E, 2013, AUTOIMMUN REV, V12, P904, DOI 10.1016/j.autrev.2013.03.003; Verschuuren JJGM, 2010, AUTOIMMUNITY, V43, P344, DOI 10.3109/08916931003602130; Viera AJ, 2005, FAM MED, V37, P360; VINCENT A, 1985, J NEUROL NEUROSUR PS, V48, P1246, DOI 10.1136/jnnp.48.12.1246; Vincent A, 2003, J NEUROL NEUROSUR PS, V74, P1105, DOI 10.1136/jnnp.74.8.1105; VINCENT A, 1988, MONOGR ALLERGY, V25, P33; Vincent A, 2012, ANN NY ACAD SCI, V1274, P92, DOI 10.1111/j.1749-6632.2012.06789.x; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.3.CO;2-5; Zhang B, 2012, ARCH NEUROL-CHICAGO, V69, P445, DOI 10.1001/archneurol.2011.2393	36	32	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114060	10.1371/journal.pone.0114060	http://dx.doi.org/10.1371/journal.pone.0114060			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25464006	gold, Green Published, Green Submitted			2022-12-26	WOS:000345869700091
J	Langone, F; Cannata, S; Fuoco, C; Lettieri, D; Barbato, DL; Testa, S; Nardozza, AP; Ciriolo, MR; Castagnoli, L; Gargioli, C; Cesareni, G				Langone, Francesca; Cannata, Stefano; Fuoco, Claudia; Lettieri, Daniele; Barbato, Daniele Lettieri; Testa, Stefano; Nardozza, Aurelio Pio; Ciriolo, Maria Rosa; Castagnoli, Luisa; Gargioli, Cesare; Cesareni, Gianni			Metformin Protects Skeletal Muscle from Cardiotoxin Induced Degeneration	PLOS ONE			English	Article							DIABETIC-PATIENTS; MUSCULAR-DYSTROPHY; MAMMALIAN TARGET; BREAST-CANCER; KINASE-C; CALCIUM; CELLS; CA2+; INHIBITION; VENOM	The skeletal muscle tissue has a remarkable capacity to regenerate upon injury. Recent studies have suggested that this regenerative process is improved when AMPK is activated. In the muscle of young and old mice a low calorie diet, which activates AMPK, markedly enhances muscle regeneration. Remarkably, intraperitoneal injection of AICAR, an AMPK agonist, improves the structural integrity of muscles of dystrophin-deficient mdx mice. Building on these observations we asked whether metformin, a powerful anti-hyperglycemic drug, which indirectly activates AMPK, affects the response of skeletal muscle to damage. In our conditions, metformin treatment did not significantly influence muscle regeneration. On the other hand we observed that the muscles of metformin treated mice are more resilient to cardiotoxin injury displaying lesser muscle damage. Accordingly myotubes, originated in vitro from differentiated C2C12 myoblast cell line, become more resistant to cardiotoxin damage after pre-incubation with metformin. Our results indicate that metformin limits cardiotoxin damage by protecting myotubes from necrosis. Although the details of the molecular mechanisms underlying the protective effect remain to be elucidated, we report a correlation between the ability of metformin to promote resistance to damage and its capacity to counteract the increment of intracellular calcium levels induced by cardiotoxin treatment. Since increased cytoplasmic calcium concentrations characterize additional muscle pathological conditions, including dystrophies, metformin treatment could prove a valuable strategy to ameliorate the conditions of patients affected by dystrophies.	[Langone, Francesca; Cannata, Stefano; Fuoco, Claudia; Lettieri, Daniele; Barbato, Daniele Lettieri; Testa, Stefano; Nardozza, Aurelio Pio; Ciriolo, Maria Rosa; Castagnoli, Luisa; Gargioli, Cesare; Cesareni, Gianni] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Cesareni, Gianni] Fdn Santa Lucia Ist Ricovero & Cura Carattere Sci, Rome, Italy	University of Rome Tor Vergata; IRCCS Santa Lucia	Gargioli, C (corresponding author), Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.	cesare.gargioli@uniroma2.it; cesareni@uniroma2.it	Ciriolo, Maria Rosa/K-6572-2016; Cesareni, Gianni/AAW-1382-2020; Testa, Stefano/L-1652-2018; Fuoco, Claudia/AAB-2268-2019; Lettieri Barbato, Daniele/K-8759-2016	Testa, Stefano/0000-0002-5981-504X; Castagnoli, Luisa/0000-0001-5283-8671; Lettieri Barbato, Daniele/0000-0002-1172-814X; Ciriolo, Maria Rosa/0000-0002-7863-9029; Fuoco, Claudia/0000-0001-8372-305X; Langone, Francesca/0000-0002-3623-3004	Italian Ministry of Education [RBAP11LP2W]; European Research Council [322749]	Italian Ministry of Education; European Research Council(European Research Council (ERC)European Commission)	This work was supported by the Oncodiet project of the Italian Ministry of Education (RBAP11LP2W) and by the DEPTH project of the European Research Council (grant agreement 322749). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basset O, 2004, J BIOL CHEM, V279, P47092, DOI 10.1074/jbc.M405054200; Bauman WA, 2000, DIABETES CARE, V23, P1227, DOI 10.2337/diacare.23.9.1227; Berchtold MW, 2000, PHYSIOL REV, V80, P1215, DOI 10.1152/physrev.2000.80.3.1215; BHATTACHARYYA J, 1993, AM J PHYSIOL, V265, pR487, DOI 10.1152/ajpregu.1993.265.3.R487; Bissonnette SL, 2010, TOXICOL SCI, V118, P108, DOI 10.1093/toxsci/kfq256; Branca D, 1999, EUR J BIOCHEM, V265, P839, DOI 10.1046/j.1432-1327.1999.00817.x; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Cerletti M, 2012, CELL STEM CELL, V10, P515, DOI 10.1016/j.stem.2012.04.002; Chan Francis Ka-Ming, 2013, Methods Mol Biol, V979, P65, DOI 10.1007/978-1-62703-290-2_7; DELUCA HF, 1961, P NATL ACAD SCI USA, V47, P1744, DOI 10.1073/pnas.47.11.1744; *DIAB PREV PROGR R, 2009, THE LANCET, V374, P1677; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; DUCHEN LW, 1974, J NEUROL SCI, V21, P391, DOI 10.1016/0022-510X(74)90041-0; DUNCAN CJ, 1987, J CELL SCI, V87, P183; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Fryer MW, 1996, J PHYSIOL-LONDON, V493, P357, DOI 10.1113/jphysiol.1996.sp021388; Gissel H, 2005, ANN NY ACAD SCI, V1066, P166, DOI 10.1196/annals.1363.013; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; HIDALGO C, 1986, BIOCHIM BIOPHYS ACTA, V854, P279, DOI 10.1016/0005-2736(86)90121-5; Hwang YP, 2010, BRIT J PHARMACOL, V160, P1195, DOI 10.1111/j.1476-5381.2010.00762.x; Jahnke VE, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-16; Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410; Lee CK, 1999, SCIENCE, V285, P1390, DOI 10.1126/science.285.5432.1390; Martin-Montalvo A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3192; Mendez I, 2011, TOXICON, V58, P558, DOI 10.1016/j.toxicon.2011.08.018; Millay DP, 2009, P NATL ACAD SCI USA, V106, P19023, DOI 10.1073/pnas.0906591106; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nethery D, 2000, J APPL PHYSIOL, V89, P72, DOI 10.1152/jappl.2000.89.1.72; Overgaard K, 2002, J APPL PHYSIOL, V92, P1891, DOI 10.1152/japplphysiol.00669.2001; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; OWNBY CL, 1993, TOXICON, V31, P697, DOI 10.1016/0041-0101(93)90376-T; Ramadasan-Nair R, 2014, J BIOL CHEM, V289, P485, DOI 10.1074/jbc.M113.493270; RAYNOR RL, 1991, J BIOL CHEM, V266, P2753; Sadeghi N, 2012, CLIN CANCER RES, V18, P2905, DOI 10.1158/1078-0432.CCR-11-2994; Sasaki H, 2009, CIRCULATION, V119, P2568, DOI 10.1161/CIRCULATIONAHA.108.798561; SCHAFER G, 1976, BIOCHEM PHARMACOL, V25, P2015, DOI 10.1016/0006-2952(76)90424-X; Selsby JT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030063; Suh BC, 1996, J BIOL CHEM, V271, P32753, DOI 10.1074/jbc.271.51.32753; SUWA M, 2005, JOURNAL OF APPLIED P, V101, P1685, DOI DOI 10.1152/JAPPLPHYSIOL.00255.2006; Tutdibi O, 1999, J PHYSIOL-LONDON, V515, P859, DOI 10.1111/j.1469-7793.1999.859ab.x; *UKPDS, 1998, THE LANCET, V352, P854; Wang HX, 1997, J MOL CELL CARDIOL, V29, P2759, DOI 10.1006/jmcc.1997.0511; Wang J, 2012, CELL STEM CELL, V11, P23, DOI 10.1016/j.stem.2012.03.016; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	45	36	38	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114018	10.1371/journal.pone.0114018	http://dx.doi.org/10.1371/journal.pone.0114018			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25461598	Green Submitted, Green Published, gold			2022-12-26	WOS:000345869700082
J	Yu, XL; Lu, L; Chen, GZ; Liu, ZG; Lei, H; Song, YZ; Zhang, SL				Yu, Xiao-li; Lu, Lian; Chen, Gao-zhan; Liu, Zhi-Guo; Lei, Hang; Song, Yan-zheng; Zhang, Shu-lin			Identification and Characterization of Non-Tuberculous Mycobacteria Isolated from Tuberculosis Suspects in Southern-Central China	PLOS ONE			English	Article							GROWING MYCOBACTERIA; INFECTIONS; DIFFERENTIATION; PREVALENCE; TAIWAN; SPP.	The incidence of non-tuberculous mycobacteria (NTM)-related death has increased globally recently. To obtain information of the species and characterization of pathogens involved in NTM pulmonary infection in Southern-central China, we identified 160 non-tuberculous infection cases from 3995 acid-fast bacilli (AFB)-positive tuberculous suspects. We then randomly selected 101 non-tuberculous patients, isolated bacteria from their sputa and genotyped the pathogens using the 16S rRNA gene and 16S-23S rRNA internal transcribed spacer sequences. M. intracellulare (32.67%, 33/101), M. abscessus (32.67%, 33/101) and M. fortuitum (7.92%, 8/101) are identified in these isolates. Surprisingly, non-mycobacteria including Gordonia (8.91%, 9/101), Nocardia (5.94%, 6/101) and Tsukamurella (0.99%, 1/101) are also discovered, and the case of Tsukamurella pulmonis infection is first discovered in Southern-central China. Moreover, species of M. mucogenicum group, M. chubuense, M. kansasii, M. gastri, M. avium, M. porcinum and M. smegmatis are identified. In addition, nine immune compromised cases (8.91%, 9/101), including type two diabetes mellitus and HIV/AIDS are found to be infected with non-tuberculous bacteria. This study revealed the distribution and characteristics of non-tuberculous AFB pathogen infection occurred in Southern-central China, and suggested that physicians should be alert of the emerging of NTM and non-mycobacteria infection in AFB positive cases and take caution when choosing chemotherapy for tuberculosis-like pulmonary infections. Generally, this study may help with the development of new strategy for the diagnosis and treatment of mycobacterial infection.	[Yu, Xiao-li; Lu, Lian; Chen, Gao-zhan; Liu, Zhi-Guo; Lei, Hang] Wuhan Polytech Univ, Sch Biol & Pharmaceut Engn, Wuhan, Peoples R China; [Song, Yan-zheng] Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China; [Zhang, Shu-lin] Shanghai Jiao Tong Univ, Sch Med, Dept Immunol & Microbiol, Shanghai 200030, Peoples R China	Wuhan Polytechnic University; Shanghai Jiao Tong University	Zhang, SL (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Immunol & Microbiol, Shanghai 200030, Peoples R China.	shulinzhang@sjtu.edu.cn			China Mega-Projects of Science Research [2012ZX10003002002, 2013ZX10003002-005]; Educational Commission of Hubei, China [D20121809]	China Mega-Projects of Science Research; Educational Commission of Hubei, China	SLZ received Grant 2012ZX10003002002 and 2013ZX10003002-005 from China Mega-Projects of Science Research for the 12th Five Year Plan, http://www.gov.cn/. XLY received Grant D20121809 from Educational Commission of Hubei, China, http://www.hbe.gov.cn/search_list.php. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brown-Elliott BA, 2006, CLIN MICROBIOL REV, V19, P259, DOI 10.1128/CMR.19.2.259-282.2006; Brown-Elliott BA, 2002, CLIN MICROBIOL REV, V15, P716, DOI 10.1128/CMR.15.4.716-746.2002; Camus JC, 2002, MICROBIOL-SGM, V148, P2967, DOI 10.1099/00221287-148-10-2967; Chen Y, 2010, MICROBES INFECT, V5, P93; Gopinath K, 2009, J APPL MICROBIOL, V107, P425, DOI 10.1111/j.1365-2672.2009.04218.x; Gopinath K, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000615; Jing H, 2012, EMERG INFECT DIS, V18, P527, DOI 10.3201/eid1803.110175; Kent PT, 1985, GUIDE LEVEL 3 LAB; Lai CC, 2010, CLIN MICROBIOL INFEC, V16, P1448, DOI [10.1111/j.1469-0691.2010.03085.x, 10.1111/j.1469-0691.2009.03085.x]; Lai CC, 2010, EMERG INFECT DIS, V16, P294, DOI 10.3201/eid1602.090675; Liu CY, 2011, INT J ANTIMICROB AG, V38, P534, DOI 10.1016/j.ijantimicag.2011.07.018; McGrath EE, 2010, PULM PHARMACOL THER, V23, P389, DOI 10.1016/j.pupt.2010.06.002; Montessori V, 1996, CLIN INFECT DIS, V22, P989, DOI 10.1093/clinids/22.6.989; Park YS, 2010, INT J TUBERC LUNG D, V14, P1069; Roth A, 1998, J CLIN MICROBIOL, V36, P139, DOI 10.1128/JCM.36.1.139-147.1998; Simmon KE, 2011, EMERG INFECT DIS, V17, P1692, DOI 10.3201/eid1709.101667; Simons S, 2011, EMERG INFECT DIS, V17, P343, DOI 10.3201/eid1703.100604; Springer B, 1996, J CLIN MICROBIOL, V34, P296, DOI 10.1128/JCM.34.2.296-303.1996; Tachezy M, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-194; Tan CK, 2010, CLIN MICROBIOL INFEC, V16, P966, DOI 10.1111/j.1469-0691.2009.02950.x; Wallace R, 2010, HIST OF MAC; Wang HX, 2010, CHINESE MED J-PEKING, V123, P184, DOI 10.3760/cma.j.issn.0366-6999.2010.02.011; Woo PCY, 2009, J CLIN MICROBIOL, V47, P1953, DOI 10.1128/JCM.00424-09; Yu XL, 2014, J ANTIBIOT, V67, P291, DOI 10.1038/ja.2013.133; Zhang SL, 2007, WORLD J MICROB BIOT, V23, P1779, DOI 10.1007/s11274-007-9428-1	25	22	27	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 2	2014	9	12							e114353	10.1371/journal.pone.0114353	http://dx.doi.org/10.1371/journal.pone.0114353			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AU8TQ	25463697	gold, Green Published, Green Submitted			2022-12-26	WOS:000345869700130
J	Bade, B; Zdebik, A; Wagenpfeil, S; Graber, S; Geisel, J; Vogt, T; Reichrath, J				Bade, Benjamin; Zdebik, Alexander; Wagenpfeil, Stefan; Graeber, Stefan; Geisel, Juergen; Vogt, Thomas; Reichrath, Joerg			Low Serum 25-Hydroxyvitamin D Concentrations Are Associated with Increased Risk for Melanoma and Unfavourable Prognosis	PLOS ONE			English	Article							VITAMIN-D SUPPLEMENTATION; TERM-FOLLOW-UP; PROSTATE-CANCER; SUBSEQUENT RISK; SUN EXPOSURE; COLON-CANCER; CALCIUM; D-3; MORTALITY; CELLS	Background: Low vitamin D status (serum 25(OH) D concentration) is associated with increased incidence and unfavourable outcome of various types of cancer. However, there are limited data on influence of serum 25(OH) D on risk and prognosis of malignant melanoma. Methods: Basal serum 25(OH) D concentrations were retrospectively analyzed in a cohort of melanoma patients (n=324) and healthy controls (n=141). We tested the hypothesis that serum 25(OH) D concentrations are predictive of melanoma risk, thickness of primary melanomas, and overall survival (OS). Results: Median serum 25(OH) D concentrations were significantly lower (p=0.004) in melanoma patients (median=13.6 ng/ml) as compared to controls (median=15.6 ng/ml). Primary tumors of patients with low serum 25(OH) D concentrations (, 10 ng/ml) had significantly (p=0.006) greater Breslow thickness (median: 1.9 mm) as compared to patients with higher levels (>20 ng/ml; median: 1.00 mm). Patients with 25(OH) D serum concentrations in the lowest quartile had inferior overall survival (median: 80 months) comparing with the highest quartile (median: 195 months; p=0.049). Conclusions: Our data support the concept that serum 25(OH) D concentrations are associated with risk and prognosis of melanoma. Whether normalizing serum 25(OH) D concentrations in these patients improves outcomes will require testing in future clinical trials.	[Bade, Benjamin; Zdebik, Alexander; Vogt, Thomas; Reichrath, Joerg] Saarland Univ Hosp, Ctr Clin & Expt Photodermatol, Dept Dermatol, Homburg, Germany; [Wagenpfeil, Stefan; Graeber, Stefan] Saarland Univ Hosp, Inst Med Biometry Epidemiol & Med Informat, Homburg, Germany; [Geisel, Juergen] Saarland Univ Hosp, Dept Clin Chem & Lab Med, Homburg, Germany	Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes; Universitatsklinikum des Saarlandes	Reichrath, J (corresponding author), Saarland Univ Hosp, Ctr Clin & Expt Photodermatol, Dept Dermatol, Homburg, Germany.	joerg.reichrath@uks.eu			program of the medical faculty of the Saarland University [HOMFOR2013]	program of the medical faculty of the Saarland University	Funding: This study has been conducted using infrastructure and personel of the Department of Dermatology of the Saarland University. This study has been supported in part by a research grant of the HOMFOR2013 program of the medical faculty of the Saarland University to JR (http://www.uniklinikum-saarland.de/de/forschung/). There were no other sources of funding that have supported the work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avenell A, 2012, J CLIN ENDOCR METAB, V97, P614, DOI 10.1210/jc.2011-1309; Berwick M, 2005, J NATL CANCER I, V97, P195, DOI 10.1093/jnci/dji019; Berwick M, 2008, ADV EXP MED BIOL, V624, P117, DOI 10.1007/978-0-387-77574-6_10; BRAUN MM, 1995, AM J EPIDEMIOL, V142, P608, DOI 10.1093/oxfordjournals.aje.a117682; CORNWELL ML, 1992, PHOTODERMATOL PHOTO, V9, P109; Diaz GD, 2000, CANCER RES, V60, P2304; Evans SRT, 2000, INT J ONCOL, V16, P1249; Faupel-Badger JM, 2007, CANCER EPIDEM BIOMAR, V16, P2784, DOI 10.1158/1055-9965.EPI-07-0672; Fernandez-Garcia NI, 2005, ONCOGENE, V24, P6533, DOI 10.1038/sj.onc.1208801; Feskanich D, 2004, CANCER EPIDEM BIOMAR, V13, P1502; Gandini S, 2005, EUR J CANCER, V41, P45, DOI 10.1016/j.ejca.2004.10.016; GARLAND CF, 1989, LANCET, V2, P1176, DOI 10.1016/s0140-6736(89)91789-3; Goodwin PJ, 2008, J CLIN ONCOL, V26; Gorham ED, 2007, AM J PREV MED, V32, P210, DOI 10.1016/j.amepre.2006.11.004; Hintzpeter B, 2008, EUR J CLIN NUTR, V62, P1079, DOI 10.1038/sj.ejcn.1602825; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holmberg L, 2009, CANCER CAUSE CONTROL, V20, P663, DOI 10.1007/s10552-008-9279-6; International Agency for Research on Cancer, 2008, IARC WORK GROUP REP, V5; Iseki K, 1999, INT J CANCER, V81, P730, DOI 10.1002/(SICI)1097-0215(19990531)81:5&lt;730::AID-IJC11&gt;3.0.CO;2-Q; Konradsen S, 2008, EUR J NUTR, V47, P87, DOI 10.1007/s00394-008-0700-4; Lamprecht SA, 2001, ANN NY ACAD SCI, V952, P73, DOI 10.1111/j.1749-6632.2001.tb02729.x; Lappe JM, 2007, AM J CLIN NUTR, V85, P1586, DOI 10.1093/ajcn/85.6.1586; MEGGOUH F, 1991, CANCER RES, V51, P1227; Meng JE, 2012, CANCER EPIDEM BIOMAR, V21, P916, DOI 10.1158/1055-9965.EPI-12-0026; Mimouni FB, 2009, CURR OPIN CLIN NUTR, V12, P287, DOI 10.1097/MCO.0b013e32832a1329; NELEMANS PJ, 1993, ENVIRON HEALTH PERSP, V101, P252, DOI 10.2307/3431552; Newton-Bishop JA, 2009, J CLIN ONCOL, V27, P5439, DOI 10.1200/JCO.2009.22.1135; Ng K, 2008, J CLIN ONCOL, V26, P2984, DOI 10.1200/JCO.2007.15.1027; Nurnberg B, 2009, ANTICANCER RES, V29, P3669; Reichrath R, 2004, CANCER CAUSE CONTROL, V15, P97; Rosso S, 2008, EUR J CANCER, V44, P1275, DOI 10.1016/j.ejca.2008.03.009; Scaglione-Sewell BA, 2000, ENDOCRINOLOGY, V141, P3931, DOI 10.1210/en.141.11.3931; Shea MK, 2009, EUR J CLIN NUTR, V63, P458, DOI 10.1038/sj.ejcn.1602959; Tangrea J, 1997, CANCER CAUSE CONTROL, V8, P615, DOI 10.1023/A:1018450531136; Tuohimaa P, 2004, INT J CANCER, V108, P104, DOI 10.1002/ijc.11375; Tuohimaa P., 2009, PSYCHONEUROENDOCRINO, V34, P278; VANDEWALLE B, 1994, CANCER LETT, V86, P67, DOI 10.1016/0304-3835(94)90181-3; VANDEWALLE B, 1995, CANCER LETT, V97, P99, DOI 10.1016/0304-3835(95)03958-Y; Vieth R, 1999, AM J CLIN NUTR, V69, P842; Wactawski-Wende J, 2006, NEW ENGL J MED, V354, P684, DOI 10.1056/NEJMoa055222; Wang TJ, 2010, LANCET, V376, P180, DOI 10.1016/S0140-6736(10)60588-0; Wu K, 2007, J NATL CANCER I, V99, P1120, DOI 10.1093/jnci/djm038; Zehnder D, 2001, J CLIN ENDOCR METAB, V86, P888, DOI 10.1210/jc.86.2.888; Zhou W, 2007, J CLIN ONCOL, V25, P479, DOI 10.1200/JCO.2006.07.5358	44	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e112863	10.1371/journal.pone.0112863	http://dx.doi.org/10.1371/journal.pone.0112863			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437008	gold, Green Published, Green Submitted			2022-12-26	WOS:000347114900021
J	Biran, S; Gat, Y; Fass, D				Biran, Shai; Gat, Yair; Fass, Deborah			The Eps1p Protein Disulfide Isomerase Conserves Classic Thioredoxin Superfamily Amino Acid Motifs but Not Their Functional Geometries	PLOS ONE			English	Article							MACROMOLECULAR CRYSTALLOGRAPHY; SACCHAROMYCES-CEREVISIAE; PDI FAMILY; DOMAIN; SERVER; FOLD	The widespread thioredoxin superfamily enzymes typically share the following features: a characteristic alpha-beta fold, the presence of a Cys-X-X-Cys (or Cys-X-X-Ser) redox-active motif, and a proline in the cis configuration abutting the redox-active site in the tertiary structure. The Cys-X-X-Cys motif is at the solvent-exposed amino terminus of an a-helix, allowing the first cysteine to engage in nucleophilic attack on substrates, or substrates to attack the Cys-X-X-Cys disulfide, depending on whether the enzyme functions to reduce, isomerize, or oxidize its targets. We report here the X-ray crystal structure of an enzyme that breaks many of our assumptions regarding the sequence-structure relationship of thioredoxin superfamily proteins. The yeast Protein Disulfide Isomerase family member Eps1p has Cys-X-X-Cys motifs and proline residues at the appropriate primary structural positions in its first two predicted thioredoxin-fold domains. However, crystal structures show that the Cys-X-X-Cys of the second domain is buried and that the adjacent proline is in the trans, rather than the cis isomer. In these configurations, neither the "active-site" disulfide nor the backbone carbonyl preceding the proline is available to interact with substrate. The Eps1p structures thus expand the documented diversity of the PDI oxidoreductase family and demonstrate that conserved sequence motifs in common folds do not guarantee structural or functional conservation.	[Biran, Shai; Gat, Yair; Fass, Deborah] Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Fass, D (corresponding author), Weizmann Inst Sci, Dept Biol Struct, IL-76100 Rehovot, Israel.	deborah.fass@weizmann.ac.il			European Research Council under the European Union's Seventh Framework Programme [310649]	European Research Council under the European Union's Seventh Framework Programme(European Research Council (ERC))	This research was supported by the European Research Council under the European Union's Seventh Framework Programme, Grant number: 310649 (http://erc.europa.eu). Further support was provided by the Kimmelman Center for Macromolecular Assemblies (http://www.weizmann.ac.il/acadaff/Scientific_Activities/current/kimmelman_center.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonine P., 2005, CCP4 NEWSLETTER, V42; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FARQUHAR R, 1991, GENE, V108, P81, DOI 10.1016/0378-1119(91)90490-3; Gat Y, 2014, PROTEIN SCI, V23, P1102, DOI 10.1002/pro.2496; Gulerez IE, 2012, ACTA CRYSTALLOGR F, V68, P378, DOI 10.1107/S1744309112005866; He JW, 2005, FEBS LETT, V579, P2277, DOI 10.1016/j.febslet.2005.03.019; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; HOLMGREN A, 1975, P NATL ACAD SCI USA, V72, P2305, DOI 10.1073/pnas.72.6.2305; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kozlov G, 2010, FEBS J, V277, P3924, DOI 10.1111/j.1742-4658.2010.07793.x; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Norgaard P, 2001, J CELL BIOL, V152, P553, DOI 10.1083/jcb.152.3.553; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Schmidt B, 2006, BIOCHEMISTRY-US, V45, P7429, DOI 10.1021/bi0603064; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Vavassori S, 2013, MOL CELL, V50, P783, DOI 10.1016/j.molcel.2013.04.016; Vitu E, 2010, J BIOL CHEM, V285, P18155, DOI 10.1074/jbc.M109.064931; Vitu E, 2008, J MOL BIOL, V384, P631, DOI 10.1016/j.jmb.2008.09.052; Wilkinson B, 2005, J BIOL CHEM, V280, P11483, DOI 10.1074/jbc.M414203200	26	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113431	10.1371/journal.pone.0113431	http://dx.doi.org/10.1371/journal.pone.0113431			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25437863	Green Submitted, gold, Green Published			2022-12-26	WOS:000347114900044
J	Cheng, HY; Kang, PJ; Chuang, YH; Wang, YH; Jan, MC; Wu, CF; Lin, CL; Liu, CJ; Liaw, YF; Lin, SM; Chen, PJ; Lee, SD; Yu, MW				Cheng, Hsiang-Yun; Kang, Pei-Jen; Chuang, Ya-Hui; Wang, Ya-Hui; Jan, Meng-Chin; Wu, Chih-Feng; Lin, Chih-Lin; Liu, Chun-Jen; Liaw, Yun-Fan; Lin, Shi-Ming; Chen, Pei-Jer; Lee, Shou-Dong; Yu, Ming-Whei			Circulating Programmed Death-1 as a Marker for Sustained High Hepatitis B Viral Load and Risk of Hepatocellular Carcinoma	PLOS ONE			English	Article							CD8 T-CELLS; SOLUBLE RECEPTORS; PD-1 EXPRESSION; VIRUS; EXHAUSTION; IMMUNITY	Objective: Recent evidence indicates a crucial role of the immunoinhibitory receptor programmed death-1 (PD-1) in enforcing T-cell dysfunction during chronic viral infection and cancer. We assessed the impact of circulating soluble PD-1 (sPD-1) levels on long-term dynamics of hepatitis B virus (HBV) load and hepatocellular carcinoma (HCC) risk. Methods: In a case-cohort study on longitudinal analysis of viral load within a cohort of 2903 men chronically infected with HBV, followed up from baseline (1989-1992) through 2010, we determined sPD-1 levels in baseline plasma with enzyme-linked immunosorbent assay from 126 men who subsequently developed HCC and 1155 men who did not develop HCC. To evaluate whether patients' characteristics involved the use of sPD-1 as a biomarker, sPD-1 was also tested in 614 newly-diagnosed patients with HBV-related HCC recruited from a multicenter study for comparison with the 1155 noncases in the case-cohort study. Results: Plasma quartile levels of sPD-1 were positively associated with HCC risk for men in the case-cohort analysis (vs. quartile 1: adjusted odds ratios [95% confidence intervals] for quartile 2-quartile 4 were 1.51 [0.75-3.03], 2.15 [1.12-4.13], and 2.29 [1.20-4.38], respectively), and in the case-control study regardless of age-of-onset and clinical stage. Furthermore, we found longitudinal effect of elevated sPD-1 levels to maintain higher viral load for 4 or more years, with greater and more prolonged effect among HBV genotype C-vs. non-C-infected participants. High levels of viral load and sPD-1 (vs. absence of both) was associated with a 6.29-fold increase in risk of HCC, and combining both conditions with HBV genotype C yielded an odds ratio of 30.47 with significant additive interaction (relative excess risk due to interaction: 27.08 [95% confidence interval=8.76-45.41]). Conclusions: Our data suggest plasma sPD-1 as an important immune-related marker for assessment of HBV activity and HCC risk.	[Cheng, Hsiang-Yun; Kang, Pei-Jen; Wang, Ya-Hui; Jan, Meng-Chin; Wu, Chih-Feng; Yu, Ming-Whei] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Chuang, Ya-Hui] Natl Taiwan Univ, Coll Med, Dept Clin Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Lin, Chih-Lin] Taipei City Hosp, Dept Gastroenterol, Ren Ai Branch, Taipei, Taiwan; [Liu, Chun-Jen; Chen, Pei-Jer] Natl Taiwan Univ Hosp, Dept Internal Med, Div Gastroenterol, Taipei 100, Taiwan; [Liu, Chun-Jen; Chen, Pei-Jer] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan; [Liaw, Yun-Fan; Lin, Shi-Ming] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Liver Res Unit, Taipei, Taiwan; [Lee, Shou-Dong] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Lee, Shou-Dong] Cheng Hsin Gen Hosp, Taipei, Taiwan	National Taiwan University; National Taiwan University; Taipei City Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University; Taipei Veterans General Hospital; Cheng Hsin General Hospital	Yu, MW (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	yumw@ntu.edu.tw			National Science Council, Taiwan [NSC 101-2314-B-002-077-MY3, NSC 101-2325-B-002-021, NSC 102-2325-B-002-021]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	Funding: This work was supported by grants NSC 101-2314-B-002-077-MY3, NSC 101-2325-B-002-021, and NSC 102-2325-B-002-021 (to MWY) from the National Science Council, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Andersson T, 2005, EUR J EPIDEMIOL, V20, P575, DOI 10.1007/s10654-005-7835-x; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Chan HLY, 2008, J CLIN ONCOL, V26, P177, DOI 10.1200/JCO.2007.13.2043; Dandri M, 2012, GUT, V61, P6, DOI 10.1136/gutjnl-2012-302056; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Desmond CP, 2008, ANTIVIR THER, V13, P161; Evans A, 2008, HEPATOLOGY, V48, P759, DOI 10.1002/hep.22419; Fisicaro P, 2010, GASTROENTEROLOGY, V138, P682, DOI 10.1053/j.gastro.2009.09.052; Heaney ML, 1998, J LEUKOCYTE BIOL, V64, P135, DOI 10.1002/jlb.64.2.135; Huang CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070169; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Nakamoto N, 2008, GASTROENTEROLOGY, V134, P1927, DOI 10.1053/j.gastro.2008.02.033; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Nguyen LH, 2011, HEPATOLOGY, V53, P1839, DOI 10.1002/hep.24308; Perel P, 2007, BMJ-BRIT MED J, V334, P197, DOI 10.1136/bmj.39048.407928.BE; ROSEJOHN S, 1994, BIOCHEM J, V300, P281, DOI 10.1042/bj3000281; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Sanyal AJ, 2010, ONCOLOGIST, V15, P14, DOI 10.1634/theoncologist.2010-S4-14; Shi F, 2011, INT J CANCER, V128, P887, DOI 10.1002/ijc.25397; Shih WL, 2012, INT J CANCER, V131, P2612, DOI 10.1002/ijc.27508; Streeck H, 2008, PLOS MED, V5, P790, DOI 10.1371/journal.pmed.0050100; Sung FY, 2009, GASTROENTEROLOGY, V137, P1687, DOI 10.1053/j.gastro.2009.07.063; Thompson A, 2007, GASTROENTEROLOGY, V133, P1031, DOI 10.1053/j.gastro.2007.07.038; URY HK, 1975, BIOMETRICS, V31, P643, DOI 10.2307/2529548; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Wan B, 2006, J IMMUNOL, V177, P8844, DOI 10.4049/jimmunol.177.12.8844; Wu CF, 2008, CARCINOGENESIS, V29, P106, DOI 10.1093/carcin/bgm252; Xiao H, 2007, CLIN CANCER RES, V13, P1823, DOI 10.1158/1078-0432.CCR-06-2154; Yu MW, 2008, J CLIN ONCOL, V26, P5576, DOI 10.1200/JCO.2008.16.1075; Yu MW, 2005, JNCI-J NATL CANCER I, V97, P265, DOI 10.1093/jnci/dji043; YU MW, 1994, CRIT REV ONCOL HEMAT, V17, P71, DOI 10.1016/1040-8428(94)90020-5	33	25	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 26	2014	9	11							e95870	10.1371/journal.pone.0095870	http://dx.doi.org/10.1371/journal.pone.0095870			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA8CZ	25427199	Green Published, gold, Green Submitted			2022-12-26	WOS:000349145400001
J	Chang, D; Gao, F; Slavney, A; Ma, L; Waldman, YY; Sams, AJ; Billing-Ross, P; Madar, A; Spritz, R; Keinan, A				Chang, Diana; Gao, Feng; Slavney, Andrea; Ma, Li; Waldman, Yedael Y.; Sams, Aaron J.; Billing-Ross, Paul; Madar, Aviv; Spritz, Richard; Keinan, Alon			Accounting for eXentricities: Analysis of the X Chromosome in GWAS Reveals X-Linked Genes Implicated in Autoimmune Diseases	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; HELICOBACTER-PYLORI INFECTION; ONLINE MENDELIAN INHERITANCE; INFLAMMATORY-BOWEL-DISEASE; SEX-DIFFERENCES; SUSCEPTIBILITY LOCI; ULCERATIVE-COLITIS; GENDER-DIFFERENCES; QUALITY-CONTROL; CROHNS-DISEASE	Many complex human diseases are highly sexually dimorphic, suggesting a potential contribution of the X chromosome to disease risk. However, the X chromosome has been neglected or incorrectly analyzed in most genome-wide association studies (GWAS). We present tailored analytical methods and software that facilitate X-wide association studies (XWAS), which we further applied to reanalyze data from 16 GWAS of different autoimmune and related diseases (AID). We associated several X-linked genes with disease risk, among which (1) ARHGEF6 is associated with Crohn's disease and replicated in a study of ulcerative colitis, another inflammatory bowel disease (IBD). Indeed, ARHGEF6 interacts with a gastric bacterium that has been implicated in IBD. (2) CENPI is associated with three different AID, which is compelling in light of known associations with AID of autosomal genes encoding centromere proteins, as well as established autosomal evidence of pleiotropy between autoimmune diseases. (3) We replicated a previous association of FOXP3, a transcription factor that regulates T-cell development and function, with vitiligo; and (4) we discovered that C1GALT1C1 exhibits sex-specific effect on disease risk in both IBDs. These and other X-linked genes that we associated with AID tend to be highly expressed in tissues related to immune response, participate in major immune pathways, and display differential gene expression between males and females. Combined, the results demonstrate the importance of the X chromosome in autoimmunity, reveal the potential of extensive XWAS, even based on existing data, and provide the tools and incentive to properly include the X chromosome in future studies.	[Chang, Diana; Gao, Feng; Slavney, Andrea; Ma, Li; Waldman, Yedael Y.; Sams, Aaron J.; Billing-Ross, Paul; Madar, Aviv; Keinan, Alon] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14850 USA; [Chang, Diana; Keinan, Alon] Cornell Univ, Program Computat Biol & Med, Ithaca, NY USA; [Slavney, Andrea; Billing-Ross, Paul; Keinan, Alon] Cornell Univ, Grad Field Genet Genom & Dev, Ithaca, NY USA; [Ma, Li] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Spritz, Richard] Univ Colorado, Sch Med, Human Med Genet & Genom Program, Aurora, CO USA	Cornell University; Cornell University; Cornell University; University System of Maryland; University of Maryland College Park; University of Colorado System; University of Colorado Anschutz Medical Campus	Keinan, A (corresponding author), Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14850 USA.	ak735@cornell.edu	ma, li/C-1585-2014; Gao, Feng/D-6676-2016; Madar, Aviv/AAO-1540-2020; Sams, Aaron/AAI-6691-2020	Keinan, Alon/0000-0002-9760-1122; Chang, Diana/0000-0002-0832-7177; Sams, Aaron/0000-0002-3800-4459	National Institutes of Health [R01HG006849]; Ellison Medical Foundation; Edward Mallinckrodt, Jr. Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); Edward Mallinckrodt, Jr. Foundation	This work was supported in part by National Institutes of Health Grant R01HG006849. AK was also supported by The Ellison Medical Foundation and the Edward Mallinckrodt, Jr. Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036926; ALSGEN C, 2013, NEUROBIOL AGING, V0034; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Amberger J, 2011, HUM MUTAT, V32, P564, DOI 10.1002/humu.21466; Amberger J, 2009, NUCLEIC ACIDS RES, V37, pD793, DOI 10.1093/nar/gkn665; Amundadottir L, 2009, NAT GENET, V41, P986, DOI 10.1038/ng.429; Andersen K, 1999, NEUROLOGY, V53, P1992, DOI 10.1212/WNL.53.9.1992; ANDERSON KM, 1991, AM HEART J, V121, P293, DOI 10.1016/0002-8703(91)90861-B; Arbiza L, 2014, AM J HUM GENET, V94, P827, DOI 10.1016/j.ajhg.2014.04.011; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baek HY, 2007, ANN NY ACAD SCI, V1096, P18, DOI 10.1196/annals.1397.065; Baranzini SE, 2009, HUM MOL GENET, V18, P767, DOI 10.1093/hmg/ddn388; Barrett JC, 2009, NAT GENET, V41, P1330, DOI 10.1038/ng.483; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; BEESON PB, 1994, AM J MED, V96, P457, DOI 10.1016/0002-9343(94)90173-2; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Beyene J, 2009, GENET EPIDEMIOL, V33, pS105, DOI 10.1002/gepi.20481; Bianchi I, 2012, J AUTOIMMUN, V38, pJ187, DOI 10.1016/j.jaut.2011.11.012; Bierut LJ, 2008, DRUG ALCOHOL DEPEN, V95, P14, DOI 10.1016/j.drugalcdep.2007.11.023; Bierut LJ, 2007, PHARMACOGENOMICS, V8, P881, DOI 10.2217/14622416.8.8.881; Bierut LJ, 2002, ALCOHOL RES HEALTH, V26, P208; Birlea SA, 2011, J INVEST DERMATOL, V131, P371, DOI 10.1038/jid.2010.337; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Calvo JR, 2013, J PINEAL RES, V55, P103, DOI 10.1111/jpi.12075; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chang D, 2014, BIORXIV; Chang D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003820; Choi BG, 2007, ENDOCRIN METAB CLIN, V36, P365, DOI 10.1016/j.ecl.2007.03.011; Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007; Clayton DG, 2009, GENOME MED, V1, DOI 10.1186/gm110; Conde L, 2013, BRIT J HAEMATOL, V162, P858, DOI 10.1111/bjh.12438; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Cotsapas C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002254; Cotton AM, 2011, HUM GENET, V130, P187, DOI 10.1007/s00439-011-1007-8; Cronin S, 2008, HUM MOL GENET, V17, P768, DOI 10.1093/hmg/ddm361; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Dobyns WB, 2004, AM J MED GENET A, V129A, P136, DOI 10.1002/ajmg.20004.a.30123; Duerr RH, 2006, SCIENCE, V314, P1461, DOI 10.1126/science.1135245; Eguchi K, 2001, INTERNAL MED, V40, P275, DOI 10.2169/internalmedicine.40.275; Estrada K, 2012, NAT GENET, V44, P491, DOI 10.1038/ng.2249; Evans DM, 2011, NAT GENET, V43, P761, DOI 10.1038/ng.873; Fish EN, 2008, NAT REV IMMUNOL, V8, P737, DOI 10.1038/nri2394; Fisher R. A, 1925, STAT METHODS RES WOR, V1, DOI DOI 10.1111/J.2397-2335.1926.TB01837.X; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gater R, 1998, ARCH GEN PSYCHIAT, V55, P405, DOI 10.1001/archpsyc.55.5.405; Gleicher N, 2007, J AUTOIMMUN, V28, P1, DOI 10.1016/j.jaut.2006.12.004; Goldstein JM, 2001, CEREB CORTEX, V11, P490, DOI 10.1093/cercor/11.6.490; Gottipati S, 2011, NAT GENET, V43, P741, DOI 10.1038/ng.877; Green ED, 2011, NATURE, V470, P204, DOI 10.1038/nature09764; Hamdouch K, 2011, CLIN CHIM ACTA, V412, P2267, DOI 10.1016/j.cca.2011.08.024; Hammer MF, 2010, NAT GENET, V42, P830, DOI 10.1038/ng.651; Hammer MF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000202; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Heyer E, 2012, MOL ECOL, V21, P597, DOI 10.1111/j.1365-294X.2011.05406.x; Hindorff L., 2013, CATALOG PUBLISHED GE; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hofman A, 2009, EUR J EPIDEMIOL, V24, P553, DOI 10.1007/s10654-009-9386-z; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang HL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002177; Itariu BK, 2014, GERONTOLOGY, V60, P189, DOI 10.1159/000356747; Jacob S, 2002, J PINEAL RES, V33, P186, DOI 10.1034/j.1600-079X.2002.02943.x; Jazin E, 2010, NAT REV NEUROSCI, V11, P9, DOI 10.1038/nrn2754; Jiang B, 2011, J THEOR BIOL, V277, P67, DOI 10.1016/j.jtbi.2011.01.029; Jin X, 2013, INT J MED SCI, V10, P1479, DOI 10.7150/ijms.6934; Jin Y, 2012, NAT GENET, V44, P676, DOI 10.1038/ng.2272; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawakami Atsushi, 2002, Medical Electron Microscopy, V35, P1, DOI 10.1007/s007950200000; Keinan A, 2007, NAT GENET, V39, P1251, DOI 10.1038/ng2116; Keinan A, 2010, MOL BIOL EVOL, V27, P2312, DOI 10.1093/molbev/msq117; Keinan A, 2009, NAT GENET, V41, P66, DOI 10.1038/ng.303; Kemkemer C, 2009, CHROMOSOME RES, V17, P811, DOI 10.1007/s10577-009-9072-8; Konig IR, 2014, GENET EPIDEMIOL, V38, P97, DOI 10.1002/gepi.21782; Laaksovirta H, 2010, LANCET NEUROL, V9, P978, DOI 10.1016/S1474-4422(10)70184-8; Lai F, 1999, NEUROLOGY, V53, P331, DOI 10.1212/WNL.53.2.331; Laurie CC, 2010, GENET EPIDEMIOL, V34, P591, DOI 10.1002/gepi.20516; Lee JH, 2008, ARCH NEUROL-CHICAGO, V65, P1518, DOI 10.1001/archneur.65.11.1518; LERNER DJ, 1986, AM HEART J, V111, P383, DOI 10.1016/0002-8703(86)90155-9; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Li N, 2014, EUR REV MED PHARMACO, V18, P78; Libert C, 2010, NAT REV IMMUNOL, V10, P594, DOI 10.1038/nri2815; Ling Hua, 2009, BMC Proc, V3 Suppl 7, pS57; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Lockshin MD, 2006, LUPUS, V15, P753, DOI 10.1177/0961203306069353; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lohmueller KE, 2010, AM J HUM GENET, V86, P978, DOI 10.1016/j.ajhg.2010.03.021; Loley C, 2011, HUM HERED, V71, P23, DOI 10.1159/000323768; Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2; Luna A, 2007, BIOINFORMATICS, V23, P774, DOI 10.1093/bioinformatics/btl657; Luther J, 2010, INFLAMM BOWEL DIS, V16, P1077, DOI 10.1002/ibd.21116; Ma L, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003321; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Mason KD, 2013, P NATL ACAD SCI USA, V110, P2599, DOI 10.1073/pnas.1215097110; Matanoski G, 2006, CANCER-AM CANCER SOC, V107, P1112, DOI 10.1002/cncr.22008; Matson DR, 2012, GENE DEV, V26, P542, DOI 10.1101/gad.184184.111; Mendelsohn ME, 2005, SCIENCE, V308, P1583, DOI 10.1126/science.1112062; Moretti S, 2009, HISTOL HISTOPATHOL, V24, P849, DOI 10.14670/HH-24.849; Morrow EH, 2013, EVOL APPL, V6, P1208, DOI 10.1111/eva.12097; Muscat JE, 1996, CANCER RES, V56, P5192; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Neale BM, 2010, J AM ACAD CHILD PSY, V49, P884, DOI 10.1016/j.jaac.2010.06.008; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Nelson JL, 1997, RHEUM DIS CLIN N AM, V23, P195, DOI 10.1016/S0889-857X(05)70323-9; Nguyen DK, 2006, BRAIN RES, V1126, P46, DOI 10.1016/j.brainres.2006.08.053; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Ober C, 2008, NAT REV GENET, V9, P911, DOI 10.1038/nrg2415; Oota H, 2001, NAT GENET, V29, P20, DOI 10.1038/ng711; Pagani MR, 2011, NEUROL RES INT, V2011, DOI 10.1155/2011/497080; Patsopoulos NA, 2007, JAMA-J AM MED ASSOC, V298, P880, DOI 10.1001/jama.298.8.880; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Petersen GM, 2010, NAT GENET, V42, P224, DOI 10.1038/ng.522; Pohanka M, 2013, CENT EUR J MED, V8, P369, DOI 10.2478/s11536-013-0177-2; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Quintero OL, 2012, J AUTOIMMUN, V38, pJ109, DOI 10.1016/j.jaut.2011.10.003; Randall JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003500; Ropers HH, 2005, NAT REV GENET, V6, P46, DOI 10.1038/nrg1501; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Saifi GM, 1999, P ROY SOC B-BIOL SCI, V266, P203, DOI 10.1098/rspb.1999.0623; Sawalha AH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001727; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Sayres MAW, 2013, MOL BIOL EVOL, V30, P781, DOI 10.1093/molbev/mss267; Schuster N, 2002, CELL TISSUE RES, V307, P1, DOI 10.1007/s00441-001-0479-6; Selmi C, 2012, AUTOIMMUN REV, V11, pA531, DOI 10.1016/j.autrev.2011.11.024; Sharp A, 2000, HUM GENET, V107, P343, DOI 10.1007/s004390000382; Shen N, 2010, P NATL ACAD SCI USA, V107, P15838, DOI 10.1073/pnas.1001337107; Sirota M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000792; Sivakumaran S, 2011, AM J HUM GENET, V89, P607, DOI 10.1016/j.ajhg.2011.10.004; SLOMINSKI A, 1989, J ROY SOC MED, V82, P539, DOI 10.1177/014107688908200911; SOFAER J, 1993, GUT, V34, P869, DOI 10.1136/gut.34.7.869; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Stouffer S.A., 1949, ADJUSTMENT ARMY LIFE; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tang QZ, 2008, NAT IMMUNOL, V9, P239, DOI 10.1038/ni1572; Tarpey PS, 2009, NAT GENET, V41, P535, DOI 10.1038/ng.367; Terry PD, 2009, INFLAMM BOWEL DIS, V15, P134, DOI 10.1002/ibd.20527; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thornton T, 2012, GENET EPIDEMIOL, V36, P438, DOI 10.1002/gepi.21638; THURNHER M, 1992, EUR J IMMUNOL, V22, P1835, DOI 10.1002/eji.1830220724; Tiniakou E, 2013, CLIN IMMUNOL, V149, P182, DOI 10.1016/j.clim.2013.02.011; Tukiainen T, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004127; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Weatherhead SC, 2011, J INVEST DERMATOL, V131, P1916, DOI 10.1038/jid.2011.134; Weishaupt JH, 2006, J PINEAL RES, V41, P313, DOI 10.1111/j.1600-079X.2006.00377.x; Whitacre CC, 1999, SCIENCE, V283, P1277, DOI 10.1126/science.283.5406.1277; Whitacre CC, 2001, NAT IMMUNOL, V2, P777, DOI 10.1038/ni0901-777; Wilder JA, 2004, NAT GENET, V36, P1122, DOI 10.1038/ng1428; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Wise AL, 2013, AM J HUM GENET, V92, P643, DOI 10.1016/j.ajhg.2013.03.017; Wu CL, 2013, NUCLEIC ACIDS RES, V41, pD561, DOI 10.1093/nar/gks1114; Zang EA, 1996, JNCI-J NATL CANCER I, V88, P183, DOI 10.1093/jnci/88.3-4.183; Zaykin DV, 2002, GENET EPIDEMIOL, V22, P170, DOI 10.1002/gepi.0042; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Zheng G, 2007, GENET EPIDEMIOL, V31, P834, DOI 10.1002/gepi.20244; Ziegler A, 2009, GENET EPIDEMIOL, V33, pS45, DOI 10.1002/gepi.20472	165	96	97	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 5	2014	9	12							e113684	10.1371/journal.pone.0113684	http://dx.doi.org/10.1371/journal.pone.0113684			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX4MS	25479423	Green Published, Green Submitted, gold			2022-12-26	WOS:000346907200028
J	Chang, YM; Chen, LC; Wang, HY; Chiang, CL; Chang, CT; Chung, YC				Chang, Ya-Min; Chen, Li-Chun; Wang, Hsin-Yi; Chiang, Chui-Liang; Chang, Chen-Tien; Chung, Yun-Chin			Characterization of an Acidic Chitinase from Seeds of Black Soybean (Glycine max (L) Merr Tainan No. 3)	PLOS ONE			English	Article							ZEA-MAYS; PURIFICATION	Using 4-methylumbelliferyl-beta-D-N, N', N ''-triacetylchitotrioside (4-MU-GlcNAc(3)) as a substrate, an acidic chitinase was purified from seeds of black soybean (Glycine max Tainan no. 3) by ammonium sulfate fractionation and three successive steps of column chromatography. The purified chitinase was a monomeric enzyme with molecular mass of 20.1 kDa and isoelectric point of 4.34. The enzyme catalyzed the hydrolysis of synthetic substrates p-nitrophenyl N-acetyl chitooligosaccharides with chain length from 3 to 5 (GlcNAc(n), n = 3-5), and pNp-GlcNAc(4) was the most degradable substrate. Using pNp-GlcNAc(4) as a substrate, the optimal pH for the enzyme reaction was 4.0; kinetic parameters K-m and k(cat) were 245 mM and 10.31 min(-1), respectively. This enzyme also showed activity toward CM-chitinRBV, a polymer form of chitin, and N-acetyl chitooligosaccharides, an oligomer form of chitin. The smallest oligomer substrate was an N-acetylglucosamine tetramer. These results suggested that this enzyme was an endo-splitting chitinase with short substrate cleavage activity and useful for biotechnological applications, in particular for the production of N-acetyl chitooligosaccharides.	[Chang, Ya-Min; Chen, Li-Chun; Wang, Hsin-Yi; Chang, Chen-Tien; Chung, Yun-Chin] Providence Univ, Dept Food & Nutr, Taichung, Taiwan; [Chiang, Chui-Liang] Cent Taiwan Univ Sci & Technol, Dept Food Sci, Taichung, Taiwan	Providence University - Taiwan; Central Taiwan University Science & Technology	Chang, CT (corresponding author), Providence Univ, Dept Food & Nutr, Taichung, Taiwan.	ctchang@pu.edu.tw; ycchun@pu.edu.tw	ma, li/C-1585-2014; Gao, Feng/D-6676-2016; Madar, Aviv/AAO-1540-2020; Sams, Aaron/AAI-6691-2020	Keinan, Alon/0000-0002-9760-1122; Chang, Diana/0000-0002-0832-7177; Sams, Aaron/0000-0002-3800-4459	National Science Council of the Republic of China (Taiwan) [NSC-94-2321-B-126-001]	National Science Council of the Republic of China (Taiwan)(Ministry of Science and Technology, Taiwan)	This work was supported by the National Science Council of the Republic of China (Taiwan) (NSC-94-2321-B-126-001). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2009, APPL MICROBIOL BIOT; [Anonymous], 1999, CHITIN AND CHITINASE; [Anonymous], 2000, ENZYME MICROB TECHNO; BERKELEY RC, 1972, ANAL BIOCHEM, V46, P687, DOI 10.1016/0003-2697(72)90343-0; Chiang Chui-Liang, 2006, Taiwanese Journal of Agricultural Chemistry and Food Science, V44, P207; Chiang CL, 2005, J AGR FOOD CHEM, V53, P7579, DOI 10.1021/jf040472n; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Dawson RCM, 1969, DATA BIOCH RES, P483; Gijzen M, 2001, J EXP BOT, V52, P2283, DOI 10.1093/jexbot/52.365.2283; GRAHAM LS, 1994, CAN J BOT, V72, P1057, DOI 10.1139/b94-132; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; Hollis T, 1997, ARCH BIOCHEM BIOPHYS, V344, P335, DOI 10.1006/abbi.1997.0225; ISHIGE F, 1991, PLANT CELL PHYSIOL, V32, P681, DOI 10.1093/oxfordjournals.pcp.a078131; Jrudel J, 1989, ANAL BIOCHEM, V178, P62; Koga D, 1999, EXS, V87, P111; Kuo CJ, 2009, BOT STUD, V50, P281; KUROSAKI F, 1989, PHYTOCHEMISTRY, V28, P2989, DOI 10.1016/0031-9422(89)80265-1; Lai LS, 2006, J AGR FOOD CHEM, V54, P8611, DOI 10.1021/jf060888w; LIN ZF, 1992, PROCESS BIOCHEM, V27, P83, DOI 10.1016/0032-9592(92)80014-T; LIU WH, 1968, BIOCHEMISTRY-US, V7, P2886, DOI 10.1021/bi00848a027; MCBRIDE JD, 1993, ELECTROPHORESIS, V14, P165, DOI 10.1002/elps.1150140126; Neuhaus JM, 1999, PATHOGENESIS-RELATED PROTEINS IN PLANTS, P77; Park SM, 2002, ENZYME MICROB TECH, V30, P697, DOI 10.1016/S0141-0229(02)00042-X; POWNING RF, 1965, COMP BIOCHEM PHYSIOL, V14, P127, DOI 10.1016/0010-406X(65)90013-7; PUNJA ZK, 1993, J NEMATOL, V25, P526; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; VERBURG JG, 1992, J BIOL CHEM, V267, P3886; WADSWORTH SA, 1984, J AGR FOOD CHEM, V32, P1284, DOI 10.1021/jf00126a018; Wang Z, 2007, BIOCHEM BIOPH RES CO, V357, P26, DOI 10.1016/j.bbrc.2007.03.094; WIRTH SJ, 1990, J MICROBIOL METH, V12, P197, DOI 10.1016/0167-7012(90)90031-Z; Yeboah NA, 1998, PLANT MOL BIOL, V36, P407, DOI 10.1023/A:1005921104288	31	96	97	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 1	2014	9	12							e113596	10.1371/journal.pone.0113596	http://dx.doi.org/10.1371/journal.pone.0113596			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AX7SK	25479423	gold, Green Submitted, Green Published			2022-12-26	WOS:000347114900053
J	Zhu, LS; Xing, ZL; Gai, XC; Li, SJ; San, ZH; Wang, XP				Zhu, Lisai; Xing, Zeli; Gai, Xiaochun; Li, Sujing; San, Zhihao; Wang, Xinping			Identification of a Novel Enterovirus E Isolates HY12 from Cattle with Severe Respiratory and Enteric Diseases	PLOS ONE			English	Article							BOVINE ENTEROVIRUSES; CLASSIFICATION; DIVERSITY; ETIOLOGY; VIRUSES; REGION; CALF	In this study, a virus strain designated as HY12 was isolated from cattle with a disease of high morbidity and mortality in Jilin province. Biological and physiochemical properties showed that HY12 isolates is cytopathic with an extremely high infectivity. HY12 is resistant to treatment of organic solvent and acid, and unstable at 60 degrees C for 1 h. Electron microscopy observation revealed the virus is an approximately 22-28 nm in diameter. The complete genome sequence of HY12 consists of 7416 nucleotides, with a typical picornavirus genome organization including a 5'-untranslated region (UTR), a large single ORF encoding a polyprotein of 2176 amino acids, and a 3'-UTR. Phylogenetic analysis clustered HY12 isolates to a new serotype/genotype within the clade of enterovirus E (formerly BEV-A). Alignment analysis revealed a unique insertion of 2 amino acid residues (NF) at the C-terminal of VP1 protein between aa 825 and 826, and several rare mutations in VP1 and VP4 of HY12 isolates in relation to known bovine enterovirus (BEV) strains. This is the first report of an enterovirus E in China, which is potentially associated with an outbreak in cattle with severe respiratory and enteric diseases.	[Zhu, Lisai; Xing, Zeli; Gai, Xiaochun; Li, Sujing; San, Zhihao; Wang, Xinping] Jilin Univ, Coll Vet Med, Changchun 130023, Jilin, Peoples R China	Jilin University	Wang, XP (corresponding author), Jilin Univ, Coll Vet Med, Changchun 130023, Jilin, Peoples R China.	wangxp88@hotmail.com	Wang, Xin/AAN-8435-2021; Liu, Jian/P-4050-2014	Wang, Xin/0000-0002-4457-7376; Liu, Jian/0000-0003-4199-1296	Jilin Province Scientific and Technology Program [20140204064NY]; program fund of Jilin province for high-level creative and talented individuals	Jilin Province Scientific and Technology Program; program fund of Jilin province for high-level creative and talented individuals	This study is supported by the Key Science and Technology projects from Jilin Province Scientific and Technology Program (20140204064NY); program fund of Jilin province for high-level creative and talented individuals to Xinping Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blas-Machado U, 2007, VET PATHOL, V44, P110, DOI 10.1354/vp.44-1-110; Blas-Machado U, 2011, VET PATHOL, V48, P1075, DOI 10.1177/0300985810395728; Boros A, 2012, J GEN VIROL, V93, P1941, DOI 10.1099/vir.0.041335-0; BUCZEK J, 1970, ARCH GES VIRUSFORSCH, V30, P408, DOI 10.1007/BF01258371; BUERKI F, 1962, Pathol Microbiol (Basel), V25, P789; Cho YI, 2013, VET MICROBIOL, V166, P375, DOI 10.1016/j.vetmic.2013.07.001; Dubois E, 2004, INT J FOOD MICROBIOL, V92, P35, DOI 10.1016/j.ijfoodmicro.2003.06.001; DUNNE HW, 1974, J AM VET MED ASSOC, V164, P290; DUNNE HW, 1973, AM J VET RES, V34, P1121; Fong TT, 2005, APPL ENVIRON MICROB, V71, P2070, DOI 10.1128/AEM.71.4.2070-2078.2005; IDE PR, 1970, CANADIAN VET J, V11, P194; Jimenez-Clavero MA, 2005, APPL ENVIRON MICROB, V71, P3536, DOI 10.1128/AEM.71.7.3536-3543.2005; Kim H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068081; KNOWLES NJ, 1985, ARCH VIROL, V83, P141, DOI 10.1007/BF01309912; Knowles NJ, 2012, VIRUS TAXONOMY CLASS, P855, DOI DOI 10.1016/B978-0-12-384684-6.00074-4; Ley V, 2002, APPL ENVIRON MICROB, V68, P3455, DOI 10.1128/AEM.68.7.3455-3461.2002; Li YL, 2012, ARCH VIROL, V157, P2369, DOI 10.1007/s00705-012-1424-6; McCarthy FM, 1999, VET MICROBIOL, V68, P71, DOI 10.1016/S0378-1135(99)00062-0; McClenahan SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068777; McFERRAN J. B., 1958, Veterinary Record, V70, P999; McIntyre CL, 2010, J VIROL, V84, P10297, DOI 10.1128/JVI.00962-10; MOLL T, 1959, AM J VET RES, V20, P27; Nollens HH, 2009, VET MICROBIOL, V139, P170, DOI 10.1016/j.vetmic.2009.05.010; REED L. J., 1938, AMER JOUR HYG, V27, P493; ROVOZZO GC, 1965, CORNELL VET, V55, P121; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smura T, 2007, J GEN VIROL, V88, P2520, DOI 10.1099/vir.0.82866-0; Straub O C, 1965, Berl Munch Tierarztl Wochenschr, V78, P386; STRAUB O. C., 1964, ARCH GESAMTE VIRUS FORSCH, V14, P272, DOI 10.1007/BF01555099; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; VANDERMAATEN MJ, 1967, AM J VET RES, V28, P677; Wang XP, 2001, ONCOGENE, V20, P523, DOI 10.1038/sj.onc.1204115; WELDON SL, 1979, J AM VET MED ASSOC, V174, P168; Yozwiak NL, 2010, J VIROL, V84, P9047, DOI 10.1128/JVI.00698-10; Zell R, 2006, J GEN VIROL, V87, P375, DOI 10.1099/vir.0.81298-0; Zell R, 1997, VIRUS RES, V51, P213, DOI 10.1016/S0168-1702(97)00096-8; Zell R, 1999, J GEN VIROL, V80, P2299, DOI 10.1099/0022-1317-80-9-2299; Zheng T, 2007, ARCH VIROL, V152, P191, DOI 10.1007/s00705-006-0838-4	38	358	389	20	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 15	2014	9	5							e97730	10.1371/journal.pone.0097730	http://dx.doi.org/10.1371/journal.pone.0097730			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI3UI	24830424	Green Published, gold, Green Submitted			2022-12-26	WOS:000336789500108
J	Gai, XP; Wang, HY; Liu, J; Zhai, LM; Liu, S; Ren, TZ; Liu, HB				Gai, Xiapu; Wang, Hongyuan; Liu, Jian; Zhai, Limei; Liu, Shen; Ren, Tianzhi; Liu, Hongbin			Effects of Feedstock and Pyrolysis Temperature on Biochar Adsorption of Ammonium and Nitrate	PLOS ONE			English	Article							BLACK CARBON; NUTRIENT AVAILABILITY; SOIL; SORPTION; RESIDUE; MANURE; SULFAMETHOXAZOLE; PHOSPHATE; AMENDMENT; DYNAMICS	Biochar produced by pyrolysis of biomass can be used to counter nitrogen (N) pollution. The present study investigated the effects of feedstock and temperature on characteristics of biochars and their adsorption ability for ammonium N (NH4+-N) and nitrate N (NO3--N). Twelve biochars were produced from wheat-straw (W-BC), corn-straw (C-BC) and peanut-shell (P-BC) at pyrolysis temperatures of 400, 500, 600 and 700 degrees C. Biochar physical and chemical properties were determined and the biochars were used for N sorption experiments. The results showed that biochar yield and contents of N, hydrogen and oxygen decreased as pyrolysis temperature increased from 400 degrees C to 700 degrees C, whereas contents of ash, pH and carbon increased with greater pyrolysis temperature. All biochars could sorb substantial amounts of NH4+-N, and the sorption characteristics were well fitted to the Freundlich isotherm model. The ability of biochars to adsorb NH4+-N followed: C-BC. P-BC. W-BC, and the adsorption amount decreased with higher pyrolysis temperature. The ability of C-BC to sorb NH4+-N was the highest because it had the largest cation exchange capacity (CEC) among all biochars (e.g., C-BC400 with a CEC of 38.3 cmol kg(-1) adsorbed 2.3 mg NH4+-N g(-1) in solutions with 50 mg NH4+ L-1). Compared with NH4+-N, none of NO3 -N was adsorbed to biochars at different NO3 concentrations. Instead, some NO3- -N was even released from the biochar materials. We conclude that biochars can be used under conditions where NH4+-N (or NH3) pollution is a concern, but further research is needed in terms of applying biochars to reduce NO3--N pollution.	[Gai, Xiapu; Wang, Hongyuan; Liu, Jian; Zhai, Limei; Liu, Shen; Liu, Hongbin] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Nonpoint Source Pollut Control, Beijing 100193, Peoples R China; [Liu, Jian] ARS, USDA, Pasture Syst & Watershed Management Res Unit, University Pk, PA USA; [Ren, Tianzhi] Minist Agr, Inst Agroenvironm Protect, Tianjin, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; United States Department of Agriculture (USDA); Chinese Academy of Agricultural Sciences; Agro-Environmental Protection Institute, CAAS; Ministry of Agriculture & Rural Affairs	Liu, HB (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Nonpoint Source Pollut Control, Beijing 100193, Peoples R China.	liuhongbin@caas.cn	Wang, Xin/AAN-8435-2021; Liu, Jian/P-4050-2014	Wang, Xin/0000-0002-4457-7376; Liu, Jian/0000-0003-4199-1296	National Natural Science Foundation of China [41301311, 41203072]; Special Fund for Agro-scientific Research in the Public Interest [201303095-10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest	Funding: This study was financially supported by the National Natural Science Foundation of China (41301311), the Special Fund for Agro-scientific Research in the Public Interest (201303095-10), and the National Natural Science Foundation of China (41203072). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkhami A, 2007, J HAZARD MATER, V144, P427, DOI 10.1016/j.jhazmat.2006.10.062; Ahmad M, 2013, BIORESOURCE TECHNOL, V143, P615, DOI 10.1016/j.biortech.2013.06.033; Ahmad M, 2012, BIORESOURCE TECHNOL, V118, P536, DOI 10.1016/j.biortech.2012.05.042; Bruun EW, 2011, BIOMASS BIOENERG, V35, P1182, DOI 10.1016/j.biombioe.2010.12.008; Cantrell KB, 2012, BIORESOURCE TECHNOL, V107, P419, DOI 10.1016/j.biortech.2011.11.084; Cao XD, 2010, BIORESOURCE TECHNOL, V101, P5222, DOI 10.1016/j.biortech.2010.02.052; Cayuela ML, 2014, AGR ECOSYST ENVIRON, V191, P5, DOI 10.1016/j.agee.2013.10.009; Chen BL, 2008, ENVIRON SCI TECHNOL, V42, P5137, DOI 10.1021/es8002684; Chun Y, 2004, ENVIRON SCI TECHNOL, V38, P4649, DOI 10.1021/es035034w; Ding Y, 2010, WATER AIR SOIL POLL, V213, P47, DOI 10.1007/s11270-010-0366-4; Galvez A, 2012, AGR ECOSYST ENVIRON, V160, P3, DOI 10.1016/j.agee.2011.06.015; Gaskin JW, 2008, T ASABE, V51, P2061, DOI 10.13031/2013.25409; Gell K, 2011, J HAZARD MATER, V186, P2017, DOI 10.1016/j.jhazmat.2010.12.105; Hollister CC, 2013, J ENVIRON QUAL, V42, P137, DOI 10.2134/jeq2012.0033; Hossain MK, 2011, J ENVIRON MANAGE, V92, P223, DOI 10.1016/j.jenvman.2010.09.008; IFA/IFDC/IPI/PPI/FAO, 2009, FERT US CROP; Ji LL, 2011, ENVIRON SCI TECHNOL, V45, P5580, DOI 10.1021/es200483b; Kameyama K, 2012, J ENVIRON QUAL, V41, P1131, DOI 10.2134/jeq2010.0453; Keiluweit M, 2010, ENVIRON SCI TECHNOL, V44, P1247, DOI 10.1021/es9031419; Knowles OA, 2011, SCI TOTAL ENVIRON, V409, P3206, DOI 10.1016/j.scitotenv.2011.05.011; Laird D, 2010, GEODERMA, V158, P436, DOI 10.1016/j.geoderma.2010.05.012; Lehmann J, 2003, PLANT SOIL, V249, P343, DOI 10.1023/A:1022833116184; Lehmann J, 2009, EARTHSCAN, DOI [10.4324/9780203762264, DOI 10.4324/9780203762264]; Liang B, 2006, SOIL SCI SOC AM J, V70, P1719, DOI 10.2136/sssaj2005.0383; Mimmo T, 2014, BIOMASS BIOENERG, V62, P149, DOI 10.1016/j.biombioe.2014.01.004; Mizuta K, 2004, BIORESOURCE TECHNOL, V95, P255, DOI 10.1016/j.biortech.2004.02.015; Novak J. M., 2009, Annals of Environmental Science, V3, P195; Ohe K, 2003, J CHEM ENG JPN, V36, P511, DOI 10.1252/jcej.36.511; Ok YS, 2007, J HAZARD MATER, V147, P91, DOI 10.1016/j.jhazmat.2006.12.046; Quilliam RS, 2012, AGR ECOSYST ENVIRON, V158, P192, DOI 10.1016/j.agee.2012.06.011; Sohi SP, 2010, ADV AGRON, V105, P47, DOI 10.1016/S0065-2113(10)05002-9; Sun K, 2011, BIORESOURCE TECHNOL, V102, P5757, DOI 10.1016/j.biortech.2011.03.038; Sun L, 2013, BIORESOURCE TECHNOL, V140, P406, DOI 10.1016/j.biortech.2013.04.116; Wu WX, 2012, BIOMASS BIOENERG, V47, P268, DOI 10.1016/j.biombioe.2012.09.034; Yao Y, 2012, CHEMOSPHERE, V89, P1467, DOI 10.1016/j.chemosphere.2012.06.002; Yuan JH, 2011, BIORESOURCE TECHNOL, V102, P3488, DOI 10.1016/j.biortech.2010.11.018; Zhai LM, 2014, BIOL FERT SOILS; Zhang AF, 2013, AGR ECOSYST ENVIRON, V173, P37, DOI 10.1016/j.agee.2013.04.001; Zhao XC, 2013, BIORESOURCE TECHNOL, V147, P338, DOI 10.1016/j.biortech.2013.08.042; Zheng H, 2013, ENVIRON POLLUT, V181, P60, DOI 10.1016/j.envpol.2013.05.056; Zheng H, 2013, BIORESOURCE TECHNOL, V130, P463, DOI 10.1016/j.biortech.2012.12.044; Zhu AN, 2005, ENVIRON INT, V31, P904, DOI 10.1016/j.envint.2005.05.038	42	358	389	20	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 3	2014	9	12							e113888	10.1371/journal.pone.0113888	http://dx.doi.org/10.1371/journal.pone.0113888			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA7WS	24830424	Green Published, Green Submitted, gold			2022-12-26	WOS:000349128700050
